id|nct_id|mesh_term|downcase_mesh_term|mesh_type
20566510|NCT02012556|Tesamorelin|tesamorelin|mesh-list
20566511|NCT02012556|Growth Substances|growth substances|mesh-ancestor
20566512|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566513|NCT02012569|Hemostatics|hemostatics|mesh-list
20566514|NCT02012569|Coagulants|coagulants|mesh-ancestor
20566515|NCT02012595|Donepezil|donepezil|mesh-list
20566516|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20566517|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566518|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566519|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
20566520|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566521|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566522|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
20566523|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
20566524|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566525|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
20566526|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566527|NCT02012777|Propranolol|propranolol|mesh-list
20566528|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20566529|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20566530|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566531|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566532|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566533|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566534|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20566535|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20566536|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566537|NCT02012920|Seviteronel|seviteronel|mesh-list
20566538|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566539|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20566540|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566541|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566542|NCT02012933|Amifampridine|amifampridine|mesh-list
20566543|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20566544|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566545|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566546|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20566547|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566548|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566549|NCT02012946|Simendan|simendan|mesh-list
20566550|NCT02012946|Dobutamine|dobutamine|mesh-list
19467885|NCT03292822|Paclitaxel|paclitaxel|mesh-list
19467886|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19467887|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467888|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
19467889|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
19467890|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
19467891|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467892|NCT03292796|Bimatoprost|bimatoprost|mesh-list
19467893|NCT03292796|Latanoprost|latanoprost|mesh-list
19467894|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19467895|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19467896|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19467897|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
19467898|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
19467899|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19467900|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20566551|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20566552|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566553|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20566554|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20566555|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566556|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566557|NCT02012946|Protective Agents|protective agents|mesh-ancestor
20566558|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566559|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
19467901|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467902|NCT03292744|Vitamins|vitamins|mesh-ancestor
19467903|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
19467904|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19467905|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20018676|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
20566560|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
20566561|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566562|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20566563|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20566564|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20566565|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566566|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566567|NCT02012998|Vaccines|vaccines|mesh-list
20566568|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
20566569|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566570|NCT02013089|Everolimus|everolimus|mesh-list
20566571|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20566572|NCT02013089|Sorafenib|sorafenib|mesh-list
20566573|NCT02013089|Sunitinib|sunitinib|mesh-list
20566574|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
20566575|NCT02013089|Gefitinib|gefitinib|mesh-list
20018677|NCT02495857|Viscosupplements|viscosupplements|mesh-list
20018678|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20018679|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
20566576|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566577|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566578|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
20566579|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566580|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20566581|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566582|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566583|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20566584|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20566585|NCT02013089|Growth Substances|growth substances|mesh-ancestor
20566586|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
20566587|NCT02013102|Decitabine|decitabine|mesh-list
20566588|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20566589|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
20566590|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566591|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566592|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566593|NCT02013115|Budesonide|budesonide|mesh-list
20566594|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20566595|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20566596|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
20566597|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566598|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018680|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018681|NCT02495857|Protective Agents|protective agents|mesh-ancestor
20018682|NCT02495883|Ethanol|ethanol|mesh-list
20018683|NCT02495883|Propranolol|propranolol|mesh-list
20292012|NCT05340465|Iron|iron|mesh-list
20566599|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20566600|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
20566601|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
20566602|NCT02013115|Hormones|hormones|mesh-ancestor
20566603|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566604|NCT02013154|Paclitaxel|paclitaxel|mesh-list
20566605|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
20566606|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20566607|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566608|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
20566609|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
20566610|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
20566611|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566612|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566613|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20566614|NCT02013219|Atezolizumab|atezolizumab|mesh-list
20566615|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566616|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20566617|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566618|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566619|NCT02013232|Aripiprazole|aripiprazole|mesh-list
20566620|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
20566621|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20566622|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20566623|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20566624|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566625|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566626|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
20566627|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
20566628|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566629|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566630|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20566631|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20566632|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
19467906|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19467907|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19467908|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
19467909|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467910|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467911|NCT03292731|Progestins|progestins|mesh-ancestor
19467912|NCT03292731|Hormones|hormones|mesh-ancestor
19467913|NCT03292575|Anticoagulants|anticoagulants|mesh-list
19467914|NCT03292315|Exenatide|exenatide|mesh-list
19467915|NCT03292315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19467916|NCT03292315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467917|NCT03292315|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19467918|NCT03292315|Incretins|incretins|mesh-ancestor
19467919|NCT03292315|Hormones|hormones|mesh-ancestor
19467920|NCT03292315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577457|NCT04385277|Tretinoin|tretinoin|mesh-list
20566633|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20566634|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20566635|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20566636|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20566637|NCT02013258|Oxytocin|oxytocin|mesh-list
20566638|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
20566639|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20566640|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566641|NCT02013271|Paclitaxel|paclitaxel|mesh-list
20566642|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20566643|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566644|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
20566645|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
20566646|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
20566647|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566648|NCT02013362|Folic Acid|folic acid|mesh-list
20566649|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
20566650|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
20566651|NCT02013362|Vitamins|vitamins|mesh-ancestor
20566652|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
20566653|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566654|NCT02013362|Hematinics|hematinics|mesh-ancestor
20566655|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
20566656|NCT02013427|Naproxen|naproxen|mesh-list
20566657|NCT02013427|Omeprazole|omeprazole|mesh-list
20566658|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20566659|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566660|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20566661|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566662|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018684|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20018685|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20018686|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
19467921|NCT03292263|Nivolumab|nivolumab|mesh-list
19467922|NCT03292263|Melphalan|melphalan|mesh-list
19467923|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467924|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467925|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19577458|NCT04385277|Dinutuximab|dinutuximab|mesh-list
20018687|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566663|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20566664|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20566665|NCT02013427|Analgesics|analgesics|mesh-ancestor
20566666|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
20566667|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566668|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566669|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20566670|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20566671|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
20566672|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20566673|NCT02013453|Paclitaxel|paclitaxel|mesh-list
20566674|NCT02013453|Carboplatin|carboplatin|mesh-list
20566675|NCT02013453|Fluorouracil|fluorouracil|mesh-list
20566676|NCT02013453|Pemetrexed|pemetrexed|mesh-list
20566677|NCT02013453|Omeprazole|omeprazole|mesh-list
20566678|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20566679|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566680|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
20566681|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
20566682|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
20566683|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566684|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
20566685|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20566686|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566687|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
20566688|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566689|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566690|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20566691|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20566692|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20566693|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566694|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20566695|NCT02013492|Propranolol|propranolol|mesh-list
20566696|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20566697|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20566698|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566699|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566700|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566701|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566702|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20566703|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20566704|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566705|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
20566706|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20566707|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566708|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566709|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20566710|NCT02013570|Analgesics|analgesics|mesh-ancestor
20566711|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
20566712|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018688|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018689|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018690|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20018691|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20018692|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
20018693|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20566713|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20566714|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20566715|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20566716|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566717|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566718|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566719|NCT02013648|Cytarabine|cytarabine|mesh-list
20566720|NCT02013648|Daunorubicin|daunorubicin|mesh-list
20566721|NCT02013648|Dasatinib|dasatinib|mesh-list
20566722|NCT02013648|Idarubicin|idarubicin|mesh-list
20566723|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20566724|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
20566725|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566726|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566727|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
20018694|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566728|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566729|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566730|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
20566731|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566732|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20566733|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20566734|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20566735|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566736|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20566737|NCT02013700|Remestemcel-l|remestemcel-l|mesh-list
20566738|NCT02013700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20566739|NCT02013700|Antiviral Agents|antiviral agents|mesh-ancestor
20566740|NCT02013700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566741|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
20566742|NCT02013856|Procyanidin|procyanidin|mesh-list
20566743|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
20566744|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566745|NCT02013856|Protective Agents|protective agents|mesh-ancestor
20566746|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566747|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20566748|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20566749|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566750|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
20566751|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20566752|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566753|NCT02013960|Misoprostol|misoprostol|mesh-list
20566754|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20566755|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
20566756|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20566757|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566758|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20566759|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566760|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
19467926|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467927|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20292013|NCT05340465|Dextrans|dextrans|mesh-list
20292014|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
20292015|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20292016|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
20292017|NCT05340465|Trace Elements|trace elements|mesh-ancestor
20292018|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
20292019|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292020|NCT05340465|Hematinics|hematinics|mesh-ancestor
20292021|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20292022|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20292023|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
20292024|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
20292025|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
20292026|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20292027|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20292028|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292029|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566761|NCT02013986|Midazolam|midazolam|mesh-list
20566762|NCT02013986|Propofol|propofol|mesh-list
20566763|NCT02013986|Etomidate|etomidate|mesh-list
20566764|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20566765|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566766|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566767|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20566768|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
20566769|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
20566770|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20566771|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20566772|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20566773|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20566774|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
20566775|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
20566776|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566777|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566778|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20566779|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20566780|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20566781|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566782|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566783|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566784|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566785|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566786|NCT02014103|Tacrolimus|tacrolimus|mesh-list
20566787|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566788|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
20566789|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566790|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20566791|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566792|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604816|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604817|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604818|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
20604819|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604820|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604821|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
20604822|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566793|NCT02014337|Mifepristone|mifepristone|mesh-list
20566794|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20566795|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
20566796|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20566797|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566798|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20566799|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20566800|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20566801|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
20566802|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20566803|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20566804|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
20566805|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566806|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
20566807|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20566808|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20566809|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
20566810|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20566811|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
20566812|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566813|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
20566814|NCT02014428|Protective Agents|protective agents|mesh-ancestor
20566815|NCT02014454|Propranolol|propranolol|mesh-list
20566816|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20566817|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20566818|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20566819|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20566820|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566821|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566822|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566823|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566824|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20566825|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20566826|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566827|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
20566828|NCT02014506|Fludarabine|fludarabine|mesh-list
20566829|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20566830|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566831|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
20566832|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566833|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20566834|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20566835|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
20566836|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566837|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566838|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20566839|NCT02014532|Montelukast|montelukast|mesh-list
20566840|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
20566841|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20566842|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
20566843|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
20566844|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566845|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566846|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20566847|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20018695|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018696|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20018697|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20018698|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20018699|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018700|NCT02496000|Insulin|insulin|mesh-list
20018701|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018702|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467928|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
20018703|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
20566848|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566849|NCT02014545|Lucanthone|lucanthone|mesh-list
20566850|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
20566851|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20566852|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
20566853|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20566854|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566855|NCT02014558|Voriconazole|voriconazole|mesh-list
20566856|NCT02014558|Cephalexin|cephalexin|mesh-list
20566857|NCT02014558|Midazolam|midazolam|mesh-list
20566858|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20566859|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20566860|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566861|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566862|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20566863|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20566864|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20566865|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19467929|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19467930|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467931|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
20566866|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
20566867|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
20566868|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
20566869|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
20566870|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566871|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566872|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
20566873|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566874|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20566875|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20566876|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566877|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20566878|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
20566879|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566880|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20566881|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20566882|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
20566883|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
20566884|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566885|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566886|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566887|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
20566888|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566889|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566890|NCT02014714|Fentanyl|fentanyl|mesh-list
20566891|NCT02014714|Morphine|morphine|mesh-list
20566892|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20566893|NCT02014714|Narcotics|narcotics|mesh-ancestor
20566894|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566895|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566896|NCT02014714|Analgesics|analgesics|mesh-ancestor
20566897|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
20566898|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566899|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20566900|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20566901|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
20566902|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
20566903|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20566904|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20566905|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
20566906|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566907|NCT02014727|Antacids|antacids|mesh-ancestor
20566908|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566909|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566910|NCT02014753|Cobalt|cobalt|mesh-list
20566911|NCT02014753|Chromium|chromium|mesh-list
20566912|NCT02014753|Everolimus|everolimus|mesh-list
20566913|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566914|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566915|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
20566916|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566917|NCT02014753|Trace Elements|trace elements|mesh-ancestor
20566918|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
20566919|NCT02014831|Cetuximab|cetuximab|mesh-list
20566920|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566921|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566922|NCT02014922|Vitamin E|vitamin e|mesh-list
20566923|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
20566924|NCT02014922|Tocopherols|tocopherols|mesh-list
20292030|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20292031|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20292032|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292033|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
20292034|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292035|NCT05340413|Olaparib|olaparib|mesh-list
20292036|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20566925|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20566926|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20566927|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
20566928|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20566929|NCT02014922|Laxatives|laxatives|mesh-ancestor
20566930|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566931|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
20566932|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566933|NCT02014922|Protective Agents|protective agents|mesh-ancestor
20566934|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566935|NCT02014922|Vitamins|vitamins|mesh-ancestor
20566936|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
20566937|NCT02015156|Trastuzumab|trastuzumab|mesh-list
20566938|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566939|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467932|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566940|NCT02015169|Lapatinib|lapatinib|mesh-list
20566941|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566942|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20566943|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467933|NCT03292185|Insulin|insulin|mesh-list
19467934|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19467935|NCT03292185|Liraglutide|liraglutide|mesh-list
19467936|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
19467937|NCT03292185|Xultophy|xultophy|mesh-list
20566944|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566945|NCT02015182|Bupivacaine|bupivacaine|mesh-list
20566946|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
20566947|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
20566948|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566949|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566950|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
20566951|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566952|NCT02015260|Citric Acid|citric acid|mesh-list
20566953|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
20566954|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20566955|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
20566956|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
20566957|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467938|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19467939|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467940|NCT03292185|Incretins|incretins|mesh-ancestor
19467941|NCT03292185|Hormones|hormones|mesh-ancestor
19467942|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467943|NCT03292172|Atezolizumab|atezolizumab|mesh-list
19467944|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467945|NCT03291899|Folfirinox|folfirinox|mesh-list
19467946|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467947|NCT03291886|Exemestane|exemestane|mesh-list
19467948|NCT03291886|Entinostat|entinostat|mesh-list
19467949|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467950|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19467951|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19467952|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467953|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467954|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19467955|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
19467956|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467957|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467958|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19467959|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19467960|NCT03291821|Cetrorelix|cetrorelix|mesh-list
20292037|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292038|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292039|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292040|NCT05340309|Atezolizumab|atezolizumab|mesh-list
20292041|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20292042|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292043|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
20292044|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292045|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20566958|NCT02015299|Linagliptin|linagliptin|mesh-list
19467961|NCT03291821|Menotropins|menotropins|mesh-list
20566959|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20566960|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20566961|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566962|NCT02015299|Incretins|incretins|mesh-ancestor
20566963|NCT02015299|Hormones|hormones|mesh-ancestor
20566964|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566965|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
20566966|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566967|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566968|NCT02015312|Silicon|silicon|mesh-list
20566969|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20566970|NCT02015312|Mannitol|mannitol|mesh-list
20566971|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20566972|NCT02015312|Diuretics|diuretics|mesh-ancestor
20566973|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
20566974|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566975|NCT02015312|Trace Elements|trace elements|mesh-ancestor
20566976|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
20566977|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
20566978|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566979|NCT02015312|Protective Agents|protective agents|mesh-ancestor
20566980|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20566981|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20018704|NCT02496221|Incretins|incretins|mesh-ancestor
20018705|NCT02496221|Hormones|hormones|mesh-ancestor
20018706|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018707|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018708|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20566982|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566983|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20566984|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
20566985|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20566986|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
20566987|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566988|NCT02015403|Expectorants|expectorants|mesh-ancestor
20566989|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
20566990|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20566991|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
20566992|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566993|NCT02015403|Protective Agents|protective agents|mesh-ancestor
20566994|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566995|NCT02015403|Antidotes|antidotes|mesh-ancestor
20566996|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
20566997|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
20018709|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20018710|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
20018711|NCT02497040|Bupivacaine|bupivacaine|mesh-list
20018712|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
20018713|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
20018714|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
20018715|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018716|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018717|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
20018718|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018719|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20018720|NCT02497287|Citalopram|citalopram|mesh-list
20566998|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566999|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
20567000|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
20567001|NCT02015507|Ivacaftor|ivacaftor|mesh-list
20018721|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20567002|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567003|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567004|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20567005|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20567006|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567007|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567008|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567009|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20567010|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20567011|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20567012|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567013|NCT02015559|Protective Agents|protective agents|mesh-list
20567014|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567015|NCT02015598|Carbocysteine|carbocysteine|mesh-list
20567016|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20567017|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567018|NCT02015598|Expectorants|expectorants|mesh-ancestor
20567019|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
20567020|NCT02015611|Vitamin D|vitamin d|mesh-list
20567021|NCT02015611|Vitamins|vitamins|mesh-ancestor
20567022|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
20567023|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567024|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20567025|NCT02015650|Fluorouracil|fluorouracil|mesh-list
20567026|NCT02015650|Cetuximab|cetuximab|mesh-list
20567027|NCT02015650|Mitomycins|mitomycins|mesh-list
20567028|NCT02015650|Mitomycin|mitomycin|mesh-list
20567029|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
20567030|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567031|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567032|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567033|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567034|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
20567035|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567036|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20567037|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20018722|NCT02497287|Sertraline|sertraline|mesh-list
20567038|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
20567039|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20567040|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567041|NCT02015728|Etoposide|etoposide|mesh-list
20567042|NCT02015728|Everolimus|everolimus|mesh-list
20567043|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20567044|NCT02015728|Temozolomide|temozolomide|mesh-list
20567045|NCT02015728|Sorafenib|sorafenib|mesh-list
20567046|NCT02015728|Dasatinib|dasatinib|mesh-list
20567047|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20567048|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567049|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20567050|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20567051|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567052|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567053|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567054|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
20567055|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567056|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20567057|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20567058|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
20567059|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20567060|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567061|NCT02015923|Panitumumab|panitumumab|mesh-list
19467962|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20018723|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
20018724|NCT02497287|Esketamine|esketamine|mesh-list
20567062|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20567063|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567064|NCT02015949|Methylphenidate|methylphenidate|mesh-list
20567065|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20567066|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567067|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20567068|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20567069|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567070|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567071|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
20567072|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567073|NCT02015988|Simvastatin|simvastatin|mesh-list
20567074|NCT02015988|Fenofibrate|fenofibrate|mesh-list
20567075|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20567076|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20567077|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
20567078|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567079|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20567080|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20567081|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567082|NCT02016001|Fluorides|fluorides|mesh-list
20567083|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
20567084|NCT02016001|Protective Agents|protective agents|mesh-ancestor
20567085|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604823|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
20604824|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20604825|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20604826|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604827|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
20604828|NCT02229292|Coagulants|coagulants|mesh-ancestor
20604829|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
20604830|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604831|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604832|NCT02229578|Lidocaine|lidocaine|mesh-list
20604833|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
20604834|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
20604835|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604836|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604837|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
20604838|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604839|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20604840|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20604841|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20604842|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20604843|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604844|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
20604845|NCT02229617|Testosterone|testosterone|mesh-list
20604846|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
20604847|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
20604848|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20604849|NCT02229617|Androgens|androgens|mesh-ancestor
20604850|NCT02229617|Hormones|hormones|mesh-ancestor
20604851|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604852|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604853|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20604854|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604855|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
20604856|NCT02229656|Olaparib|olaparib|mesh-list
20604857|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20604858|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604859|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604860|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604861|NCT02229721|Oxytocin|oxytocin|mesh-list
20604862|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
20604863|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20604864|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604865|NCT02229734|Androgens|androgens|mesh-list
20604866|NCT02229734|Hormones|hormones|mesh-ancestor
20604867|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604868|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604869|NCT02229747|Diclofenac|diclofenac|mesh-list
20604870|NCT02229747|Meloxicam|meloxicam|mesh-list
20604871|NCT02229747|Nimesulide|nimesulide|mesh-list
20604872|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20604873|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20567086|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
20567087|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567088|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567089|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20567090|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19467963|NCT03291821|Ganirelix|ganirelix|mesh-list
19467964|NCT03291821|Hormones|hormones|mesh-ancestor
19467965|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467966|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467967|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
19467968|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19467969|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
19467970|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19467971|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20567091|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567092|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567093|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567094|NCT02016196|Rifaximin|rifaximin|mesh-list
20567095|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567096|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567097|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567098|NCT02016209|Paclitaxel|paclitaxel|mesh-list
20567099|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20567100|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20567101|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567102|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20567103|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
20567104|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
20567105|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567106|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
19467972|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19467973|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467974|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19467975|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
19467976|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
19467977|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
20567107|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20567108|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20567109|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567110|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567111|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20567112|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20567113|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20567114|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567115|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567116|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567117|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
20567118|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20567119|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
20567120|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20567121|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20567122|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567123|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20567124|NCT02016274|Paclitaxel|paclitaxel|mesh-list
20567125|NCT02016274|Cisplatin|cisplatin|mesh-list
20567126|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20567127|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567128|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
20567129|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
20567130|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
20567131|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567132|NCT02016287|Paclitaxel|paclitaxel|mesh-list
20567133|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20567134|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567135|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
20567136|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
20567137|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
20567138|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567139|NCT02016365|Doxycycline|doxycycline|mesh-list
20567140|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20292046|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20292047|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567141|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567142|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567143|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
20567144|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20567145|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20567146|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20567147|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567148|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
20567149|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20567150|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567151|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567152|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467978|NCT03291457|Hormones|hormones|mesh-ancestor
19577459|NCT04385277|Isotretinoin|isotretinoin|mesh-list
20567153|NCT02016391|Analgesics|analgesics|mesh-ancestor
20567154|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
20567155|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567156|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20567157|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20567158|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20567159|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
20567160|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567161|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567162|NCT02016417|Gemcitabine|gemcitabine|mesh-list
20567163|NCT02016417|Cisplatin|cisplatin|mesh-list
20567164|NCT02016417|Docetaxel|docetaxel|mesh-list
20567165|NCT02016417|Fluorouracil|fluorouracil|mesh-list
20567166|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567167|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567168|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
20567169|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567170|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
20567171|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567172|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567173|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567174|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
20567175|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567176|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
20567177|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
20567178|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
20567179|NCT02016443|Tizanidine|tizanidine|mesh-list
20567180|NCT02016443|Analgesics|analgesics|mesh-ancestor
20567181|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
20567182|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567183|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567184|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
19467979|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467980|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467981|NCT03291418|Naproxen|naproxen|mesh-list
19467982|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19467983|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467984|NCT03291418|Analgesics|analgesics|mesh-ancestor
19467985|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
19467986|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467987|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467988|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467989|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467990|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
20018725|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20018726|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20018727|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20018728|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018729|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018730|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
20018731|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567185|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19467991|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19467992|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467993|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467994|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
19467995|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467996|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467997|NCT03291314|Avelumab|avelumab|mesh-list
19467998|NCT03291314|Axitinib|axitinib|mesh-list
19467999|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20567186|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20567187|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
20567188|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
20567189|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20567190|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20567191|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20567192|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
20567193|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567194|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567195|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
20567196|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
20567197|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567198|NCT02016495|Protective Agents|protective agents|mesh-ancestor
20567199|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567200|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
20567201|NCT02016495|Vitamins|vitamins|mesh-ancestor
20567202|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
20567203|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20567204|NCT02016547|Abciximab|abciximab|mesh-list
20567205|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20567206|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20567207|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567208|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
20567209|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20567210|NCT02016664|Ketamine|ketamine|mesh-list
20567211|NCT02016664|Analgesics|analgesics|mesh-ancestor
20567212|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
20567213|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567214|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567215|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20567216|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20567217|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
20567218|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
20567219|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567220|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20567221|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20567222|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567223|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567224|NCT02016703|Erythritol|erythritol|mesh-list
20567225|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
20567226|NCT02016729|Trametinib|trametinib|mesh-list
20567227|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567228|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20567229|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567230|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567231|NCT02016807|Sucralfate|sucralfate|mesh-list
20567232|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20567233|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567234|NCT02016820|Omeprazole|omeprazole|mesh-list
20567235|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20567236|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567237|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20567238|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567239|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567240|NCT02016846|Liraglutide|liraglutide|mesh-list
20567241|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20567242|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567243|NCT02016846|Incretins|incretins|mesh-ancestor
20567244|NCT02016846|Hormones|hormones|mesh-ancestor
20567245|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20567246|NCT02016976|Midazolam|midazolam|mesh-list
20567247|NCT02016976|Meperidine|meperidine|mesh-list
20567248|NCT02016976|Analgesics|analgesics|mesh-list
20567249|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
20567250|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567251|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567252|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20292048|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20292049|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292050|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292051|NCT05340192|Octreotide|octreotide|mesh-list
20292052|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20292053|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20292054|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567253|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20567254|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567255|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20567256|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20567257|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20567258|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20567259|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
20567260|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
20292055|NCT05340153|Lumefantrine|lumefantrine|mesh-list
20567261|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
20567262|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
20567263|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567264|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567265|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20567266|NCT02016976|Narcotics|narcotics|mesh-ancestor
20567267|NCT02017119|Lactulose|lactulose|mesh-list
20567268|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567269|NCT02017197|Warfarin|warfarin|mesh-list
20567270|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
20567271|NCT02017314|Morphine|morphine|mesh-list
20567272|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20567273|NCT02017314|Narcotics|narcotics|mesh-ancestor
20567274|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567275|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567276|NCT02017314|Analgesics|analgesics|mesh-ancestor
20567277|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
20567278|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567279|NCT02017340|Nilvadipine|nilvadipine|mesh-list
20567280|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20567281|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20567282|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567283|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567284|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20567285|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567286|NCT02017392|Lidocaine|lidocaine|mesh-list
20567287|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
20567288|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
20567289|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567290|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567291|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
20567292|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567293|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20567294|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20567295|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20567296|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567297|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567298|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
20567299|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20567300|NCT02017405|Antibodies|antibodies|mesh-list
20567301|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
20567302|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742668|NCT04493151|Imipenem|imipenem|mesh-list
19742669|NCT04493151|Relebactam|relebactam|mesh-list
19742670|NCT04493151|Cilastatin|cilastatin|mesh-list
19742671|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19742672|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742673|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
20567303|NCT02017457|Azacitidine|azacitidine|mesh-list
20567304|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567305|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
20567306|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567307|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567308|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567309|NCT02017561|Metformin|metformin|mesh-list
20567310|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20567311|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567312|NCT02017600|Fluorouracil|fluorouracil|mesh-list
20567313|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567314|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
20567315|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567316|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567317|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567318|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
20567319|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567320|NCT02017613|Tenalisib|tenalisib|mesh-list
20567321|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
20567322|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567323|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567324|NCT02017639|Simvastatin|simvastatin|mesh-list
20567325|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20567326|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20567327|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
20567328|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567329|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20567330|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20567331|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567332|NCT02017704|Leucovorin|leucovorin|mesh-list
20567333|NCT02017704|Capecitabine|capecitabine|mesh-list
20292056|NCT05340153|Artemether|artemether|mesh-list
20292057|NCT05340153|Piperaquine|piperaquine|mesh-list
20292058|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20292059|NCT05340153|Artenimol|artenimol|mesh-list
20567334|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
20567335|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567336|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
20567337|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567338|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567339|NCT02017704|Antidotes|antidotes|mesh-ancestor
20567340|NCT02017704|Protective Agents|protective agents|mesh-ancestor
20567341|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567342|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
20567343|NCT02017704|Vitamins|vitamins|mesh-ancestor
20567344|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
20604874|NCT02229747|Analgesics|analgesics|mesh-ancestor
20604875|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
20604876|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604877|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604878|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20604879|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604880|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20604881|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604882|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604883|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20604884|NCT02229760|Ritonavir|ritonavir|mesh-list
20604885|NCT02229760|Tipranavir|tipranavir|mesh-list
20604886|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20604887|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20292060|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
20604888|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
20604889|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292061|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20567345|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
20567346|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20567347|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567348|NCT02018055|Aspirin|aspirin|mesh-list
20567349|NCT02018055|Clopidogrel|clopidogrel|mesh-list
20567350|NCT02018055|Ticagrelor|ticagrelor|mesh-list
20567351|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20567352|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20567353|NCT02018055|Analgesics|analgesics|mesh-ancestor
20567354|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
20567355|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567356|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567357|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20567358|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018732|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20292062|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20292063|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308311|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577460|NCT04385277|Sargramostim|sargramostim|mesh-list
20308312|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20308313|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308314|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20308315|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308316|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308317|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20308318|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308319|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20308320|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308321|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308322|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308323|NCT00663728|Urological Agents|urological agents|mesh-ancestor
20308324|NCT00663741|Sorafenib|sorafenib|mesh-list
20567359|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20567360|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20567361|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567362|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20567363|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20567364|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567365|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
20567366|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20567367|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20567368|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20567369|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
20567370|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567371|NCT02018081|Levofloxacin|levofloxacin|mesh-list
20567372|NCT02018081|Ofloxacin|ofloxacin|mesh-list
20567373|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20567374|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567375|NCT02018081|Renal Agents|renal agents|mesh-ancestor
20567376|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567377|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20567378|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20567379|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567380|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567381|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567382|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20567383|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20567384|NCT02018094|Iodine|iodine|mesh-list
20567385|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
20567386|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
20567387|NCT02018094|Metronidazole|metronidazole|mesh-list
20567388|NCT02018094|Clindamycin|clindamycin|mesh-list
20567389|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20567390|NCT02018094|Teicoplanin|teicoplanin|mesh-list
20567391|NCT02018094|Povidone|povidone|mesh-list
20567392|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20567393|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567394|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
20567395|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567396|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20567397|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20567398|NCT02018094|Trace Elements|trace elements|mesh-ancestor
20567399|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
20567400|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567401|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20567402|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567403|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567404|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
20567405|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
20567406|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20567407|NCT02018133|Vitamin D|vitamin d|mesh-list
20567408|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
20567409|NCT02018133|Vitamins|vitamins|mesh-ancestor
20567410|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
20567411|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567412|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20567413|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20567414|NCT02018159|Menotropins|menotropins|mesh-list
20567415|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20567416|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
20567417|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20567418|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567419|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
20567420|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
20567421|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
20567422|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567423|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567424|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
20567425|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567426|NCT02018263|Cocaine|cocaine|mesh-list
20567427|NCT02018263|Nicotine|nicotine|mesh-list
20567428|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20567429|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
20567430|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567431|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567432|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20567433|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20567434|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
20567435|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567436|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567437|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
20567438|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
20567439|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567440|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
20567441|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20567442|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20567443|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20567444|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567445|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
20567446|NCT02018276|Lidocaine|lidocaine|mesh-list
20567447|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
20567448|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
20018733|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20292064|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20567449|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567450|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567451|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
20567452|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567453|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20567454|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20567455|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20567456|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567457|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567458|NCT02018289|Triclosan|triclosan|mesh-list
20567459|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20567460|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567461|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20567462|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20567463|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
20567464|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567465|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20567466|NCT02018328|Curcumin|curcumin|mesh-list
20567467|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20567468|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20567469|NCT02018328|Analgesics|analgesics|mesh-ancestor
20567470|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
20567471|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567472|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567473|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20567474|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20567475|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018734|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018735|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20018736|NCT02497287|Analgesics|analgesics|mesh-ancestor
20018737|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
20018738|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
20018739|NCT02497391|Evacetrapib|evacetrapib|mesh-list
20018740|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20018741|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20567476|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567477|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567478|NCT02018367|Proflavine|proflavine|mesh-list
20567479|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20567480|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567481|NCT02018419|Vaccines|vaccines|mesh-list
20567482|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
20567483|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567484|NCT02018523|Lenalidomide|lenalidomide|mesh-list
20567485|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
20567486|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567487|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20567488|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20567489|NCT02018523|Growth Substances|growth substances|mesh-ancestor
20567490|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
20567491|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567492|NCT02018536|Simeprevir|simeprevir|mesh-list
20567493|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
20567494|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567495|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
20567496|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567497|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567498|NCT02018588|Tryptophan|tryptophan|mesh-list
20567499|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20567500|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
20567501|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20567502|NCT02018601|Acetaminophen|acetaminophen|mesh-list
20567503|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20567504|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20567505|NCT02018601|Analgesics|analgesics|mesh-ancestor
19468000|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468001|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19468002|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468003|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468004|NCT03291249|Omeprazole|omeprazole|mesh-list
19468005|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19468006|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19468007|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19468008|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468009|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468010|NCT03291158|Minocycline|minocycline|mesh-list
19468011|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19468012|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468013|NCT03291145|Spironolactone|spironolactone|mesh-list
19468014|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19468015|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19468016|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
19468017|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468018|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468019|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19468020|NCT03291145|Diuretics|diuretics|mesh-ancestor
19468021|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
19468022|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20567506|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
20567507|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567508|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567509|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
20567510|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20567511|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20567512|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20567513|NCT02018731|Metformin|metformin|mesh-list
20567514|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20567515|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567516|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
20567517|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
20567518|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20567519|NCT02018757|Estrogens|estrogens|mesh-ancestor
20567520|NCT02018757|Hormones|hormones|mesh-ancestor
20567521|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468023|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
19468024|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577461|NCT04385277|Vitamins|vitamins|mesh-ancestor
20567522|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567523|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20567524|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567525|NCT02018783|Listerine|listerine|mesh-list
20567526|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
20567527|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
20567528|NCT02018783|Protective Agents|protective agents|mesh-ancestor
20567529|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567530|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20567531|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567532|NCT02018796|Misoprostol|misoprostol|mesh-list
20567533|NCT02018796|Mifepristone|mifepristone|mesh-list
20567534|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20567535|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
20567536|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20567537|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567538|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20567539|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567540|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
20567541|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20567542|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20567543|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20567544|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20567545|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
20567546|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20567547|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20567548|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
20567549|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20567550|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
20567551|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20567552|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20567553|NCT02018861|Rituximab|rituximab|mesh-list
20567554|NCT02018861|Carboplatin|carboplatin|mesh-list
20567555|NCT02018861|Etoposide|etoposide|mesh-list
20567556|NCT02018861|Ifosfamide|ifosfamide|mesh-list
20567557|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20567558|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567559|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
20567560|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567561|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20567562|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20567563|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20567564|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20567565|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567566|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567567|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20567568|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
20567569|NCT02018874|Gemcitabine|gemcitabine|mesh-list
20567570|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567571|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
20567572|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567573|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567574|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
20567575|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567576|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567577|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567578|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
20567579|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567580|NCT02018965|Vitamins|vitamins|mesh-list
20567581|NCT02018965|Niacin|niacin|mesh-list
20567582|NCT02018965|Niacinamide|niacinamide|mesh-list
20567583|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
20567584|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
20567585|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
20567586|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567587|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20567588|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
19468025|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468026|NCT03291093|Flutemetamol|flutemetamol|mesh-list
19468027|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19468028|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468029|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
19468030|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468031|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468032|NCT03290963|Ketamine|ketamine|mesh-list
19468033|NCT03290963|Analgesics|analgesics|mesh-ancestor
19468034|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
20018742|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
20018743|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018744|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20018745|NCT02497404|Fludarabine|fludarabine|mesh-list
20018746|NCT02497404|Azacitidine|azacitidine|mesh-list
20018747|NCT02497404|Melphalan|melphalan|mesh-list
20018748|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
20018749|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018750|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567589|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567590|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20018751|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
20567591|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
20567592|NCT02018991|Everolimus|everolimus|mesh-list
20567593|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567594|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567595|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
20567596|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567597|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
20018752|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018753|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567598|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20567599|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20567600|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20567601|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567602|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567603|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
20567604|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567605|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567606|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20567607|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567608|NCT02019056|Pyridoxine|pyridoxine|mesh-list
20567609|NCT02019056|Metadoxine|metadoxine|mesh-list
19577462|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
20567610|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20567611|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
20567612|NCT02019056|Vitamins|vitamins|mesh-ancestor
20567613|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
20567614|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567615|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
20567616|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20567617|NCT02019160|Fluorides|fluorides|mesh-list
20567618|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
20567619|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
20567620|NCT02019160|Protective Agents|protective agents|mesh-ancestor
20567621|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567622|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20567623|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567624|NCT02019186|Vitamins|vitamins|mesh-list
20567625|NCT02019186|Ascorbic Acid|ascorbic acid|mesh-list
20567626|NCT02019186|Vitamin E|vitamin e|mesh-list
20567627|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
20567628|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567629|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
20567630|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567631|NCT02019186|Protective Agents|protective agents|mesh-ancestor
20567632|NCT02019290|Midazolam|midazolam|mesh-list
20567633|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20567634|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20567635|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567636|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567637|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20567638|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20567639|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20567640|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20567641|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
20567642|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
20567643|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
20567644|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
20567645|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567646|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567647|NCT02019329|Risperidone|risperidone|mesh-list
20567648|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20567649|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
20567650|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567651|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567652|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567653|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20567654|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20567655|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567656|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20567657|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20567658|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
19468035|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468036|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468037|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19468038|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19468039|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
19468040|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
19468041|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468042|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19468043|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19468044|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468045|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468046|NCT03290859|Propofol|propofol|mesh-list
19468047|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20567659|NCT02019355|Fluorouracil|fluorouracil|mesh-list
20567660|NCT02019355|Calcipotriene|calcipotriene|mesh-list
20567661|NCT02019355|Petrolatum|petrolatum|mesh-list
20567662|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
20567663|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567664|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567665|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567666|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567667|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
20567668|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567669|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
20567670|NCT02019355|Emollients|emollients|mesh-ancestor
20567671|NCT02019381|Vitamin D|vitamin d|mesh-list
20567672|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
20567673|NCT02019381|Vitamins|vitamins|mesh-list
20567674|NCT02019381|Calcium|calcium|mesh-list
20567675|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
20567676|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567677|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20567678|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20604890|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604891|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20604892|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20604893|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
20604894|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604895|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20604896|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20604897|NCT02229773|Pravastatin|pravastatin|mesh-list
20604898|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20604899|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20604900|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
20604901|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604902|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20604903|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20604904|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604905|NCT02229786|Acetaminophen|acetaminophen|mesh-list
20604906|NCT02229786|Scopolamine|scopolamine|mesh-list
20604907|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20604908|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20604909|NCT02229786|Analgesics|analgesics|mesh-ancestor
20604910|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
20604911|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604912|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604913|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
20604914|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
20604915|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
20604916|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20604917|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20604918|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
20604919|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604920|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604921|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20604922|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
20604923|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604924|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
20604925|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20604926|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20604927|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20604928|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604929|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20604930|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20604931|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20604932|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604933|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20604934|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20604935|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20604936|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20604937|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604938|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567679|NCT02019446|Terbinafine|terbinafine|mesh-list
20567680|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
20567681|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567682|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567683|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567684|NCT02019459|Nicotine|nicotine|mesh-list
20567685|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20567686|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
20567687|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567688|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567689|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20567690|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20567691|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
20567692|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567693|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567694|NCT02019485|Tapentadol|tapentadol|mesh-list
20567695|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20567696|NCT02019485|Narcotics|narcotics|mesh-ancestor
20567697|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567698|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567699|NCT02019485|Analgesics|analgesics|mesh-ancestor
20567700|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
20567701|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567702|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20567703|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20567704|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567705|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567706|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
20567707|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567708|NCT02019524|Folic Acid|folic acid|mesh-list
20567709|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
20567710|NCT02019524|Molgramostim|molgramostim|mesh-list
20567711|NCT02019524|Vaccines|vaccines|mesh-list
20567712|NCT02019524|Sargramostim|sargramostim|mesh-list
20567713|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
20567714|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468048|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567715|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567716|NCT02019524|Hematinics|hematinics|mesh-ancestor
20567717|NCT02019524|Vitamins|vitamins|mesh-ancestor
20567718|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
20567719|NCT02019784|Rifaximin|rifaximin|mesh-list
20567720|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567721|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468049|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567722|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567723|NCT02019797|Desflurane|desflurane|mesh-list
20567724|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20567725|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
20567726|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
20567727|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567728|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567729|NCT02019810|Dobutamine|dobutamine|mesh-list
20567730|NCT02019810|Norepinephrine|norepinephrine|mesh-list
20567731|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20567732|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20567733|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
20567734|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567735|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567736|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567737|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
20567738|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
20567739|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567740|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20567741|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20567742|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20567743|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20567744|NCT02019810|Protective Agents|protective agents|mesh-ancestor
20567745|NCT02019836|Vitamin D|vitamin d|mesh-list
20567746|NCT02019836|Vitamins|vitamins|mesh-ancestor
20567747|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
20567748|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567749|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20567750|NCT02019875|Clarithromycin|clarithromycin|mesh-list
20567751|NCT02019875|Rifampin|rifampin|mesh-list
20567752|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20567753|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567754|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20567755|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567756|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567757|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20567758|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20567759|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20567760|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
20567761|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
20567762|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20567763|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20567764|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20567765|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20567766|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20567767|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20567768|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20567769|NCT02020005|Nicotine|nicotine|mesh-list
20567770|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20567771|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
20567772|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567773|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567774|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20567775|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20567776|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
20567777|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567778|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567779|NCT02020070|Ipilimumab|ipilimumab|mesh-list
20567780|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20567781|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567782|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20567783|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567784|NCT02020122|Pregabalin|pregabalin|mesh-list
20567785|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20567786|NCT02020122|Analgesics|analgesics|mesh-ancestor
20567787|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
20567788|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567789|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567790|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
19468050|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20018754|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
20018755|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567791|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20567792|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567793|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567794|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20567795|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20567796|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20567797|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567798|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20567799|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20567800|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20567801|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567802|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
20567803|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
20567804|NCT02020161|Methotrexate|methotrexate|mesh-list
20567805|NCT02020161|Idarubicin|idarubicin|mesh-list
20567806|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20567807|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
20567808|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20567809|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567810|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567811|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
20567812|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567813|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567814|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
20567815|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20567816|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20567817|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567818|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
20567819|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20567820|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20567821|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20567822|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20567823|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20567824|NCT02020200|Methylphenidate|methylphenidate|mesh-list
20567825|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20567826|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567827|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20567828|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20567829|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567830|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567831|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
20567832|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567833|NCT02020213|Posaconazole|posaconazole|mesh-list
20567834|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
20567835|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567836|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20567837|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20567838|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20567839|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20567840|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20567841|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018756|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018757|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20018758|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
20018759|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20018760|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018761|NCT02497469|Adalimumab|adalimumab|mesh-list
20018762|NCT02497469|Vedolizumab|vedolizumab|mesh-list
20018763|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292065|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20292066|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292067|NCT05339802|Linezolid|linezolid|mesh-list
20292068|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20292069|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567842|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567843|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20567844|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
20567845|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20567846|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567847|NCT02020330|Lumefantrine|lumefantrine|mesh-list
20567848|NCT02020330|Artemether|artemether|mesh-list
20567849|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20567850|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
20567851|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20567852|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20567853|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567854|NCT02020499|Lanreotide|lanreotide|mesh-list
20567855|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567856|NCT02020551|Lidocaine|lidocaine|mesh-list
20567857|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
20567858|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
20567859|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567860|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567861|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
20567862|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567863|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20567864|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20567865|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20567866|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19468051|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
20567867|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567868|NCT02020603|Epinephrine|epinephrine|mesh-list
20567869|NCT02020603|Racepinephrine|racepinephrine|mesh-list
20567870|NCT02020603|Hemostatics|hemostatics|mesh-list
20567871|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
20567872|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20567873|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20567874|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
20567875|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567876|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567877|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567878|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20567879|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20567880|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
20567881|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567882|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20567883|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
20567884|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
20567885|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
20567886|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20567887|NCT02020603|Coagulants|coagulants|mesh-ancestor
20567888|NCT02020629|Lixisenatide|lixisenatide|mesh-list
20567889|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20567890|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567891|NCT02020681|Fluorides|fluorides|mesh-list
20567892|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
20567893|NCT02020681|Protective Agents|protective agents|mesh-ancestor
20567894|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567895|NCT02020694|Vitamin D|vitamin d|mesh-list
20567896|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
20567897|NCT02020694|Vitamins|vitamins|mesh-list
20567898|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
20567899|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567900|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20567901|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20567902|NCT02020720|Fluorides|fluorides|mesh-list
20567903|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
20567904|NCT02020720|Protective Agents|protective agents|mesh-ancestor
20567905|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567906|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
20567907|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20567908|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20567909|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20567910|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567911|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567912|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
20567913|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567914|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567915|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20567916|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567917|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20567918|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20567919|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
20567920|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20567921|NCT02021097|Estradiol|estradiol|mesh-list
20567922|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20567923|NCT02021097|Estrogens|estrogens|mesh-ancestor
20567924|NCT02021097|Hormones|hormones|mesh-ancestor
20567925|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20567926|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567927|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20567928|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
20567929|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20567930|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20567931|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20567932|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20567933|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20567934|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20567935|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20567936|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567937|NCT02021123|Anidulafungin|anidulafungin|mesh-list
20567938|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
20567939|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20567940|NCT02021201|Risperidone|risperidone|mesh-list
20567941|NCT02021201|Sertindole|sertindole|mesh-list
20567942|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20567943|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
20567944|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567945|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567946|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567947|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20567948|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20567949|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567950|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20292070|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20567951|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20018764|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018765|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567952|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
20567953|NCT02021214|Methylphenidate|methylphenidate|mesh-list
20567954|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20567955|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567956|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20567957|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20567958|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20567959|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567960|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
20567961|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604939|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604940|NCT02229825|Analgesics|analgesics|mesh-ancestor
20604941|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
20604942|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604943|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
20604944|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604945|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
20604946|NCT02229877|Omeprazole|omeprazole|mesh-list
20604947|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20604948|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604949|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20604950|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604951|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567962|NCT02021240|Dexamethasone|dexamethasone|mesh-list
20567963|NCT02021240|Ketamine|ketamine|mesh-list
20567964|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20567965|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
20567966|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
20567967|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20567968|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567969|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20567970|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
20567971|NCT02021240|Hormones|hormones|mesh-ancestor
20567972|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20567973|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20567974|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567975|NCT02021240|Analgesics|analgesics|mesh-ancestor
20567976|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
20567977|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20567978|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20567979|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
20567980|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
20567981|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20567982|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20567983|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20567984|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20567985|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567986|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
20567987|NCT02021409|Hematinics|hematinics|mesh-ancestor
20567988|NCT02021422|Fluorouracil|fluorouracil|mesh-list
20567989|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
20567990|NCT02021422|Irinotecan|irinotecan|mesh-list
20567991|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20567992|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
20567993|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20567994|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20567995|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20567996|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20567997|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
20567998|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20567999|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20568000|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20568001|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568002|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20568003|NCT02021474|Phenol|phenol|mesh-list
20568004|NCT02021474|Histamine|histamine|mesh-list
20018766|NCT02497781|Ceftazidime|ceftazidime|mesh-list
20018767|NCT02497781|Cefepime|cefepime|mesh-list
20018768|NCT02497781|Avibactam|avibactam|mesh-list
20018769|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
20018770|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20018771|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018772|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20018773|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568005|NCT02021474|Histamine phosphate|histamine phosphate|mesh-list
20568006|NCT02021474|Histamine Agonists|histamine agonists|mesh-ancestor
20568007|NCT02021474|Histamine Agents|histamine agents|mesh-ancestor
20568008|NCT02021474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568009|NCT02021474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568010|NCT02021474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568011|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20568012|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568013|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
20568014|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20568015|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20568016|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20568017|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568018|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
20568019|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568020|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568021|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20568022|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
20568023|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568024|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568025|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568026|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
20120638|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20568027|NCT02021825|Analgesics|analgesics|mesh-ancestor
20568028|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
20568029|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568030|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568031|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568032|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20568033|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20568034|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568035|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568036|NCT02021851|Dexamethasone|dexamethasone|mesh-list
20568037|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
20568038|NCT02021851|Ondansetron|ondansetron|mesh-list
20568039|NCT02021851|Aprepitant|aprepitant|mesh-list
20568040|NCT02021851|BB 1101|bb 1101|mesh-list
20568041|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568042|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
20568043|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
20568044|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568045|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568046|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568047|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
20568048|NCT02021851|Hormones|hormones|mesh-ancestor
20568049|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568050|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20568051|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568052|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
20568053|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568054|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568055|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
20568056|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
20568057|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20568058|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
20568059|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568060|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20568061|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20568062|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568063|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20568064|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20568065|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20568066|NCT02021864|Vitamin D|vitamin d|mesh-list
20568067|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
20568068|NCT02021864|Vitamins|vitamins|mesh-ancestor
20568069|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
20568070|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568071|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20292071|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292072|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292073|NCT05339646|Ritonavir|ritonavir|mesh-list
20292074|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20292075|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20292076|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
20292077|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292078|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292079|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20568072|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20568073|NCT02022059|Lidocaine|lidocaine|mesh-list
20568074|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
20568075|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
20568076|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568077|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568078|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
20568079|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568080|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20568081|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20568082|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20568083|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568084|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568085|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20568086|NCT02022163|Vaccines|vaccines|mesh-list
20568087|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
20568088|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568089|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20568090|NCT02022163|Antacids|antacids|mesh-ancestor
20568091|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568092|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568093|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20568094|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20568095|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
20568096|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20568097|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
20568098|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568099|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568100|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20568101|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20568102|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568103|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20568104|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
20568105|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20568106|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
20568107|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568108|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568109|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20568110|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20568111|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568112|NCT02022254|Metformin|metformin|mesh-list
20568113|NCT02022254|Warfarin|warfarin|mesh-list
20568114|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20568115|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568116|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
20568117|NCT02022280|Lansoprazole|lansoprazole|mesh-list
20568118|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
20568119|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20568120|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568121|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19468052|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
19468053|NCT03290846|Secretin|secretin|mesh-list
19468054|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568122|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568123|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568124|NCT02022293|Atorvastatin|atorvastatin|mesh-list
20568125|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20568126|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20568127|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
20568128|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568129|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20568130|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20568131|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568132|NCT02022358|Leucovorin|leucovorin|mesh-list
20568133|NCT02022358|Folic Acid|folic acid|mesh-list
20568134|NCT02022358|Methotrexate|methotrexate|mesh-list
20568135|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
20568136|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20568137|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
20568138|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568139|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568140|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568141|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
20568142|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468055|NCT03290846|Hormones|hormones|mesh-ancestor
20568143|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568144|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
20568145|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568146|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20568147|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568148|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
20568149|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20568150|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20568151|NCT02022358|Antidotes|antidotes|mesh-ancestor
20568152|NCT02022358|Protective Agents|protective agents|mesh-ancestor
20568153|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
20568154|NCT02022358|Vitamins|vitamins|mesh-ancestor
20568155|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
20568156|NCT02022358|Hematinics|hematinics|mesh-ancestor
20568157|NCT02022475|Vitamin D|vitamin d|mesh-list
20568158|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
20568159|NCT02022475|Vitamins|vitamins|mesh-ancestor
20568160|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
20568161|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568162|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20568163|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20568164|NCT02022488|Midazolam|midazolam|mesh-list
20568165|NCT02022488|Ketamine|ketamine|mesh-list
20568166|NCT02022488|Alfentanil|alfentanil|mesh-list
20568167|NCT02022488|Analgesics|analgesics|mesh-ancestor
20568168|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
20568169|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578343|NCT02744092|Apixaban|apixaban|mesh-list
19742674|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742675|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018774|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568170|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568171|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20568172|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20568173|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
20568174|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
20568175|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568176|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20568177|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20568178|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568179|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568180|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20568181|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20568182|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20568183|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20568184|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20568185|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
20568186|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
20568187|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20568188|NCT02022488|Narcotics|narcotics|mesh-ancestor
20568189|NCT02022527|Aspirin|aspirin|mesh-list
20568190|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
20568191|NCT02022527|Salicylates|salicylates|mesh-list
20568192|NCT02022527|Warfarin|warfarin|mesh-list
20568193|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20568194|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20568195|NCT02022527|Analgesics|analgesics|mesh-ancestor
20018775|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
20018776|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20018777|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
20018778|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568196|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
20568197|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568198|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568199|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568200|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20568201|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20568202|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20568203|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568204|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20568205|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20568206|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568207|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
20568208|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
20568209|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568210|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
20568211|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
20568212|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
20568213|NCT02022540|Ranibizumab|ranibizumab|mesh-list
20568214|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20568215|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20568216|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20568217|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20568218|NCT02022540|Growth Substances|growth substances|mesh-ancestor
20568219|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568220|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
20568221|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568222|NCT02022644|Irinotecan|irinotecan|mesh-list
20568223|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20568224|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20568225|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568226|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568227|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568228|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
20568229|NCT02022709|Sertraline|sertraline|mesh-list
20568230|NCT02022709|Fluoxetine|fluoxetine|mesh-list
20568231|NCT02022709|Paroxetine|paroxetine|mesh-list
20568232|NCT02022709|Citalopram|citalopram|mesh-list
19468056|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568233|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
20568234|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20568235|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20568236|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20568237|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568238|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568239|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568240|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
20568241|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568242|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20568243|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20568244|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20568245|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568246|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20568247|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20568248|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568249|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20568250|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20568251|NCT02022722|Triamcinolone|triamcinolone|mesh-list
20568252|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20568253|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20568254|NCT02022722|Bupivacaine|bupivacaine|mesh-list
20568255|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20568256|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
20568257|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
20568258|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568259|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568260|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
20568261|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568262|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568263|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
20568264|NCT02022722|Hormones|hormones|mesh-ancestor
20568265|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568266|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568267|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
20568268|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568269|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568270|NCT02022761|Laninamivir|laninamivir|mesh-list
20568271|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
20568272|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568273|NCT02022852|Capecitabine|capecitabine|mesh-list
20568274|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568275|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
20568276|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568277|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568278|NCT02022917|Bevacizumab|bevacizumab|mesh-list
20568279|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20568280|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568281|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20568282|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20568283|NCT02022917|Growth Substances|growth substances|mesh-ancestor
20568284|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568285|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
20568286|NCT02022930|Triamcinolone|triamcinolone|mesh-list
20018779|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018780|NCT02498236|Oxytocin|oxytocin|mesh-list
20018781|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
20018782|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568287|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20568288|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20568289|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20018783|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578344|NCT02744092|Edoxaban|edoxaban|mesh-list
20018784|NCT02498418|Rifaximin|rifaximin|mesh-list
20568290|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568291|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
20568292|NCT02022930|Hormones|hormones|mesh-ancestor
20568293|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568294|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568295|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568296|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
20568297|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568298|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568299|NCT02023021|Gemcitabine|gemcitabine|mesh-list
20568300|NCT02023021|Paclitaxel|paclitaxel|mesh-list
20568301|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20568302|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568303|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
20568304|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
20568305|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
20568306|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568307|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568308|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
20568309|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
20568310|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568311|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568312|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568313|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
20568314|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568315|NCT02023047|Nifedipine|nifedipine|mesh-list
20568316|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20568317|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568318|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568319|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20568320|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568321|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
20568322|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
20568323|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20604952|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20604953|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20604954|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20604955|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604956|NCT02229942|Rituximab|rituximab|mesh-list
20604957|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604958|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604959|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
20604960|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604961|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604962|NCT02229955|Cyclosporine|cyclosporine|mesh-list
20604963|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20604964|NCT02229955|Cyclosporins|cyclosporins|mesh-list
20604965|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604966|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604967|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604968|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
20604969|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604970|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
20604971|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604972|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
20604973|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578345|NCT02744092|Fondaparinux|fondaparinux|mesh-list
20568324|NCT02023086|Tropicamide|tropicamide|mesh-list
20568325|NCT02023086|Mydriatics|mydriatics|mesh-list
20568326|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
20568327|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568328|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568329|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20568330|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20568331|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
20568332|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568333|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568334|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
20568335|NCT02023164|Promethazine|promethazine|mesh-list
20568336|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20568337|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20568338|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568339|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568340|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
20568341|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
20568342|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
20568343|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568344|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
20568345|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
20568346|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568347|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20568348|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
20568349|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
20568350|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568351|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568352|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20568353|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
20568354|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
20568355|NCT02023359|Everolimus|everolimus|mesh-list
20568356|NCT02023359|Exemestane|exemestane|mesh-list
20568357|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568358|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568359|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
20568360|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568361|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20568362|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20568363|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568364|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568365|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20568366|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
20568367|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568368|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
20568369|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
20568370|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20568371|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
20568372|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568373|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568374|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018785|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20018786|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568375|NCT02023450|Ritonavir|ritonavir|mesh-list
20568376|NCT02023450|Saquinavir|saquinavir|mesh-list
20568377|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20568378|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20568379|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
20568380|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568381|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568382|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20568383|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20568384|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
20568385|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568386|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20568387|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20568388|NCT02023463|Leuprolide|leuprolide|mesh-list
20568389|NCT02023463|Goserelin|goserelin|mesh-list
20568390|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20568391|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
20568392|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568393|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568394|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20568395|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568396|NCT02023554|Azithromycin|azithromycin|mesh-list
20568397|NCT02023554|Theophylline|theophylline|mesh-list
20568398|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20568399|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568400|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20568401|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
20568402|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568403|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568404|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20568405|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
20568406|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20568407|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568408|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568409|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
20568410|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20568411|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20568412|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
20568413|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568414|NCT02023567|Serotonin|serotonin|mesh-list
20568415|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20568416|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20568417|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
20568418|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568419|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568420|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568421|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20568422|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568423|NCT02023593|Leucovorin|leucovorin|mesh-list
20568424|NCT02023593|Fluorouracil|fluorouracil|mesh-list
20568425|NCT02023593|Irinotecan|irinotecan|mesh-list
20568426|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
20568427|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568428|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568429|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018787|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20018788|NCT02498483|Acetaminophen|acetaminophen|mesh-list
20018789|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20018790|NCT02498483|Analgesics|analgesics|mesh-ancestor
20018791|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
20018792|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018793|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018794|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
20018795|NCT02498522|Metformin|metformin|mesh-list
20018796|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018797|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018798|NCT02498652|Allopurinol|allopurinol|mesh-list
20018799|NCT02498652|Verinurad|verinurad|mesh-list
20018800|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
20018801|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018802|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018803|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
20018804|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018805|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20568430|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568431|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
20568432|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568433|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20568434|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20568435|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568436|NCT02023593|Antidotes|antidotes|mesh-ancestor
20568437|NCT02023593|Protective Agents|protective agents|mesh-ancestor
20568438|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
20568439|NCT02023593|Vitamins|vitamins|mesh-ancestor
20568440|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
20568441|NCT02023684|Lidocaine|lidocaine|mesh-list
20568442|NCT02023684|Ropivacaine|ropivacaine|mesh-list
20568443|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
20568444|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
20568445|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568446|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568447|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
20568448|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568449|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20568450|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20568451|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20568452|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568453|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568454|NCT02023710|Paclitaxel|paclitaxel|mesh-list
20568455|NCT02023710|Bevacizumab|bevacizumab|mesh-list
20568456|NCT02023710|Carboplatin|carboplatin|mesh-list
20568457|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20568458|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568459|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
20568460|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
20568461|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
20568462|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568463|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20568464|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20568465|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20568466|NCT02023710|Growth Substances|growth substances|mesh-ancestor
19468057|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468058|NCT03290820|Aspirin|aspirin|mesh-list
19468059|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19468060|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468061|NCT03290820|Analgesics|analgesics|mesh-ancestor
19468062|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
19468063|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468064|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468065|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468066|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468067|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19468068|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19468069|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468070|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19468071|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19468072|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468073|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
19468074|NCT03290703|Rabeprazole|rabeprazole|mesh-list
19468075|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19468076|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19468077|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19468078|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468079|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468080|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
19468081|NCT03290625|Ketamine|ketamine|mesh-list
19468082|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19468083|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468084|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568467|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568468|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
20568469|NCT02023840|Metronidazole|metronidazole|mesh-list
20568470|NCT02023840|Erythritol|erythritol|mesh-list
20568471|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568472|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20568473|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20568474|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20568475|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
20568476|NCT02023853|Metronidazole|metronidazole|mesh-list
20568477|NCT02023853|Erythritol|erythritol|mesh-list
20568478|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568479|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20568480|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20568481|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20568482|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
20568483|NCT02023892|Atorvastatin|atorvastatin|mesh-list
20568484|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20568485|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20568486|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
20568487|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568488|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20568489|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20568490|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568491|NCT02023931|Sulforaphane|sulforaphane|mesh-list
20568492|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20568493|NCT02023931|Protective Agents|protective agents|mesh-ancestor
20568494|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568495|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568496|NCT02024009|Gemcitabine|gemcitabine|mesh-list
20568497|NCT02024009|Nelfinavir|nelfinavir|mesh-list
20568498|NCT02024009|Paclitaxel|paclitaxel|mesh-list
20568499|NCT02024009|Capecitabine|capecitabine|mesh-list
20568500|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20568501|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568502|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468085|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468086|NCT03290625|Analgesics|analgesics|mesh-ancestor
20568503|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
20568504|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
20568505|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568506|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568507|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
20568508|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
20568509|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568510|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568511|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568512|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
20568513|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568514|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20568515|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20568516|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
20568517|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20568518|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20568519|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
20568520|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
20568521|NCT02024022|Cathartics|cathartics|mesh-ancestor
20568522|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568523|NCT02024152|Cetirizine|cetirizine|mesh-list
20568524|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20568525|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20568526|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20568527|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
20568528|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
20568529|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568530|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568531|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568532|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
20568533|NCT02024217|Tegafur|tegafur|mesh-list
20568534|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568535|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568536|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
20568537|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568538|NCT02024230|Warfarin|warfarin|mesh-list
20568539|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
20568540|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
20568541|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20568542|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
20568543|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20568544|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
20568545|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568546|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568547|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
20568548|NCT02024256|Analgesics|analgesics|mesh-ancestor
20568549|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
20568550|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568551|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568552|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
20568553|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568554|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20568555|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
20568556|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20568557|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568558|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568559|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20568560|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
20568561|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568562|NCT02024295|Choline|choline|mesh-list
20568563|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
20568564|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
20568565|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20568566|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
20568567|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568568|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568569|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20568570|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
20568571|NCT02024308|Cytarabine|cytarabine|mesh-list
20568572|NCT02024308|Fludarabine|fludarabine|mesh-list
20568573|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568574|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568575|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
20568576|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568577|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568578|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
19468087|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
20292080|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20292081|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
20568579|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568580|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
20292082|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292083|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20292084|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20292085|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
20292086|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20292087|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20292088|NCT05339542|Prednisolone|prednisolone|mesh-list
20292089|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
20292090|NCT05339542|Lidocaine|lidocaine|mesh-list
20292091|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20292092|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
20292093|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20292094|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
20292095|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568581|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568582|NCT02024334|Leflunomide|leflunomide|mesh-list
20568583|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568584|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568585|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568586|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
20568587|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568588|NCT02024373|Atorvastatin|atorvastatin|mesh-list
20568589|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20568590|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20568591|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
20568592|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568593|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20568594|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20568595|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568596|NCT02024425|Antioxidants|antioxidants|mesh-list
20568597|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568598|NCT02024425|Protective Agents|protective agents|mesh-ancestor
20568599|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568600|NCT02024555|Azithromycin|azithromycin|mesh-list
20568601|NCT02024555|Levofloxacin|levofloxacin|mesh-list
20568602|NCT02024555|Ofloxacin|ofloxacin|mesh-list
20568603|NCT02024555|Rifampin|rifampin|mesh-list
20568604|NCT02024555|Ethambutol|ethambutol|mesh-list
20568605|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20568606|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568607|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20568608|NCT02024555|Renal Agents|renal agents|mesh-ancestor
20568609|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20568610|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20568611|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568612|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568613|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568614|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20568615|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20568616|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20568617|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
20568618|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
20568619|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20568620|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20568621|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20568622|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20568623|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20568624|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20568625|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20568626|NCT02024568|Pregabalin|pregabalin|mesh-list
20568627|NCT02024568|Analgesics|analgesics|mesh-ancestor
20568628|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
20568629|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568630|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568631|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
20568632|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20568633|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568634|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568635|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20568636|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20568637|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20568638|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568639|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20568640|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
20568641|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20568642|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
20568643|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
20568644|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568645|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568646|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20568647|NCT02024594|Analgesics|analgesics|mesh-ancestor
20568648|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
20568649|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568650|NCT02024633|Gemcitabine|gemcitabine|mesh-list
20568651|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568652|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
20568653|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568654|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568655|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
20568656|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568657|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568658|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568659|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
20568660|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568661|NCT02024659|Budesonide|budesonide|mesh-list
20568662|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568663|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20568664|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
20568665|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568666|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568667|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20568668|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
20568669|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
20568670|NCT02024659|Hormones|hormones|mesh-ancestor
20568671|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604974|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20604975|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20604976|NCT02230033|Itraconazole|itraconazole|mesh-list
20604977|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
20604978|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
20604979|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604980|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20604981|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20604982|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604983|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604984|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20604985|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
20568672|NCT02024841|Docetaxel|docetaxel|mesh-list
20568673|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568674|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
20568675|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
20568676|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
20568677|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568678|NCT02024906|Caseins|caseins|mesh-list
20568679|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
20568680|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
20568681|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568682|NCT02024919|Diltiazem|diltiazem|mesh-list
20568683|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20568684|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20568685|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568686|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568687|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20568688|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568689|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
20568690|NCT02024945|Propiverine|propiverine|mesh-list
20568691|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
20568692|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
20568693|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568694|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568695|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20568696|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20568697|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
20568698|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568699|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568700|NCT02024945|Urological Agents|urological agents|mesh-ancestor
20568701|NCT02024984|Clomiphene|clomiphene|mesh-list
20568702|NCT02024984|Enclomiphene|enclomiphene|mesh-list
20568703|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
20568704|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20568705|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
20568706|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568707|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568708|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20568709|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
20568710|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20568711|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20568712|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20568713|NCT02025010|Prednisone|prednisone|mesh-list
20568714|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
20568715|NCT02025010|Glucocorticoids|glucocorticoids|mesh-list
20568716|NCT02025010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568717|NCT02025010|Hormones|hormones|mesh-ancestor
20018806|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
20018807|NCT02498652|Protective Agents|protective agents|mesh-ancestor
20018808|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018809|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
20018810|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20018811|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20568718|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568719|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568720|NCT02025010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20568721|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018812|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20568722|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20568723|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568724|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568725|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
20568726|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20568727|NCT02025023|Triamcinolone|triamcinolone|mesh-list
20568728|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20568729|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20568730|NCT02025023|Fluorouracil|fluorouracil|mesh-list
20568731|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20568732|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
20568733|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568734|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568735|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568736|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568737|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
20568738|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568739|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568740|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
20568741|NCT02025023|Hormones|hormones|mesh-ancestor
20568742|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568743|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568744|NCT02025036|Capecitabine|capecitabine|mesh-list
20568745|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
20568746|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568747|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
20568748|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568749|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568750|NCT02025140|Anesthetics|anesthetics|mesh-list
20568751|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568752|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568753|NCT02025166|Acetaminophen|acetaminophen|mesh-list
20018813|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20018814|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018815|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
20018816|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018817|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018818|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20018819|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018820|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
20018821|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20018822|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
19742676|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20568754|NCT02025166|Lornoxicam|lornoxicam|mesh-list
20568755|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20568756|NCT02025166|Analgesics|analgesics|mesh-ancestor
20568757|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
20568758|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568759|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568760|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
20568761|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20568762|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568763|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20568764|NCT02025192|Capecitabine|capecitabine|mesh-list
20568765|NCT02025192|Trastuzumab|trastuzumab|mesh-list
20568766|NCT02025192|Tucatinib|tucatinib|mesh-list
20568767|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568768|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
20568769|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568770|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568771|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20568772|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20568773|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568774|NCT02025218|Gefitinib|gefitinib|mesh-list
20568775|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568776|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20568777|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568778|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568779|NCT02025348|Metoprolol|metoprolol|mesh-list
20568780|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20568781|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20568782|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
20568783|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
20568784|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568785|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568786|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20568787|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20568788|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20568789|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
20568790|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568791|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568792|NCT02025361|Lidocaine|lidocaine|mesh-list
20568793|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
20568794|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
20568795|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568796|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568797|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
20568798|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568799|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20568800|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20568801|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20568802|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568803|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568804|NCT02025374|Bupivacaine|bupivacaine|mesh-list
20568805|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
20568806|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
20568807|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
20568808|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568809|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568810|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
20568811|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568812|NCT02025465|Metoprolol|metoprolol|mesh-list
20568813|NCT02025465|Diltiazem|diltiazem|mesh-list
20568814|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20568815|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20568816|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
20568817|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
20568818|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568819|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568820|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20568821|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20568822|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20568823|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
20568824|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568825|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568826|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20568827|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20568828|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20568829|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
20568830|NCT02025491|Amphotericin B|amphotericin b|mesh-list
20568831|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20568832|NCT02025491|Amebicides|amebicides|mesh-ancestor
20568833|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20568834|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20568835|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568836|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20568837|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
20568838|NCT02025608|Pramipexole|pramipexole|mesh-list
20568839|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
20568840|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568841|NCT02025608|Protective Agents|protective agents|mesh-ancestor
20568842|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568843|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20568844|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20568845|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
20568846|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
20568847|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568848|NCT02025712|Everolimus|everolimus|mesh-list
20568849|NCT02025712|Exemestane|exemestane|mesh-list
20568850|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568851|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568852|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
20568853|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568854|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20568855|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20568856|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568857|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568858|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20568859|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
20568860|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568861|NCT02025803|Capecitabine|capecitabine|mesh-list
20568862|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20568863|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
20568864|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568865|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568866|NCT02025855|Methadone|methadone|mesh-list
20568867|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20568868|NCT02025855|Narcotics|narcotics|mesh-ancestor
20568869|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20568870|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568871|NCT02025855|Analgesics|analgesics|mesh-ancestor
20568872|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
20568873|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742677|NCT04485325|Etanercept|etanercept|mesh-list
19742678|NCT04485325|Tofacitinib|tofacitinib|mesh-list
19742679|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20018823|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018824|NCT02499029|Expectorants|expectorants|mesh-ancestor
20018825|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
20568874|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
20568875|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
19468088|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468089|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20018826|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20568876|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
20568877|NCT02025868|Darunavir|darunavir|mesh-list
20568878|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20568879|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20568880|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
19468090|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19468091|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20568881|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568882|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20568883|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20568884|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568885|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568886|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20568887|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20568888|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
20568889|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
20568890|NCT02025881|Thiotepa|thiotepa|mesh-list
20568891|NCT02025881|Carboplatin|carboplatin|mesh-list
20568892|NCT02025881|Etoposide|etoposide|mesh-list
20568893|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568894|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
20568895|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568896|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20568897|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20568898|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
20568899|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568900|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568901|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20568902|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20568903|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20568904|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20568905|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568906|NCT02025998|Ibudilast|ibudilast|mesh-list
20568907|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20568908|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
20568909|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568910|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568911|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20568912|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
19468092|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
19468093|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468094|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468095|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19468096|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19468097|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
19468098|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
19468099|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19468100|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19468101|NCT03290495|Ketamine|ketamine|mesh-list
19468102|NCT03290495|Analgesics|analgesics|mesh-ancestor
19468103|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
19468104|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468105|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018827|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
20018828|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018829|NCT02499029|Protective Agents|protective agents|mesh-ancestor
20018830|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018831|NCT02499029|Antidotes|antidotes|mesh-ancestor
20018832|NCT02499081|Ixazomib|ixazomib|mesh-list
20018833|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018834|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
20018835|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018836|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018837|NCT02499120|Cetuximab|cetuximab|mesh-list
20018838|NCT02499120|Palbociclib|palbociclib|mesh-list
20018839|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018840|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568913|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20568914|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568915|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568916|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20568917|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
20568918|NCT02026050|Dexamethasone|dexamethasone|mesh-list
20568919|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
20568920|NCT02026050|BB 1101|bb 1101|mesh-list
20568921|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568922|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
20568923|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
20568924|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568925|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568926|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568927|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
20568928|NCT02026050|Hormones|hormones|mesh-ancestor
20568929|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568930|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20568931|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568932|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
20568933|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568934|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568935|NCT02026219|Clopidogrel|clopidogrel|mesh-list
20018841|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20018842|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018843|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018844|NCT02499146|Letrozole|letrozole|mesh-list
20018845|NCT02499146|Palbociclib|palbociclib|mesh-list
20018846|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018847|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20018848|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20018849|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018850|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018851|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20018852|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
20018853|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018854|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568936|NCT02026219|Ticagrelor|ticagrelor|mesh-list
20568937|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20568938|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20568939|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20568940|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20568941|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
20568942|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568943|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568944|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568945|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
20568946|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
20568947|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20568948|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20568949|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20568950|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568951|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568952|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20568953|NCT02026310|Metformin|metformin|mesh-list
20568954|NCT02026310|Glimepiride|glimepiride|mesh-list
20568955|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20568956|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568957|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20568958|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20568959|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
20292096|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292097|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
20292098|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292099|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20292100|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20292101|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20604986|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604987|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604988|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20604989|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20604990|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
20604991|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20604992|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20604993|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
20604994|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604995|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20604996|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604997|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604998|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
20604999|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605000|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605001|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20605002|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
20605003|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20605004|NCT02230163|Antibodies|antibodies|mesh-list
20605005|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
20605006|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605007|NCT02230176|Sunitinib|sunitinib|mesh-list
20605008|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20605009|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605010|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20605011|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20292102|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20292103|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292104|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292105|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
20292106|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
20292107|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20292108|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
20292109|NCT05339542|Hormones|hormones|mesh-ancestor
20292110|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20292111|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20292112|NCT05339542|Protective Agents|protective agents|mesh-ancestor
20292113|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20605012|NCT02230176|Growth Substances|growth substances|mesh-ancestor
20568960|NCT02026479|Dexamethasone|dexamethasone|mesh-list
20568961|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
20568962|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20568963|NCT02026479|BB 1101|bb 1101|mesh-list
20568964|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20568965|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
20568966|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
20568967|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568968|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568969|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20568970|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
20568971|NCT02026479|Hormones|hormones|mesh-ancestor
20568972|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20568973|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20568974|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568975|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
20568976|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20568977|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568978|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
20568979|NCT02026492|Miotics|miotics|mesh-ancestor
20568980|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
20568981|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20568982|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568983|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20568984|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20568985|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
20568986|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20568987|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20568988|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
20568989|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20568990|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20568991|NCT02026505|Bortezomib|bortezomib|mesh-list
20568992|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20568993|NCT02026518|Vitamin D|vitamin d|mesh-list
20568994|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
20568995|NCT02026518|Vitamins|vitamins|mesh-ancestor
20568996|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
20568997|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20568998|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20568999|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20569000|NCT02026583|Simvastatin|simvastatin|mesh-list
20569001|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20569002|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20569003|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
20569004|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569005|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20569006|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20569007|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569008|NCT02026765|Heparin|heparin|mesh-list
20569009|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
20569010|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20569011|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20569012|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018855|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20018856|NCT02499159|Bupivacaine|bupivacaine|mesh-list
20018857|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
20018858|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
20018859|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018860|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018861|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
20569013|NCT02026778|Betahistine|betahistine|mesh-list
20569014|NCT02026778|Ondansetron|ondansetron|mesh-list
20569015|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
20569016|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
20569017|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569018|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569019|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569020|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
20569021|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
20569022|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20569023|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
20569024|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569025|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569026|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20569027|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20569028|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569029|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20569030|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20569031|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
20569032|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
20569033|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
20569034|NCT02026817|Metformin|metformin|mesh-list
20569035|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20569036|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20569037|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569038|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20569039|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20569040|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
20569041|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569042|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20569043|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20569044|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569045|NCT02026856|Selenious Acid|selenious acid|mesh-list
20569046|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
20569047|NCT02026856|Trace Elements|trace elements|mesh-ancestor
20569048|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
20569049|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569050|NCT02026869|Metformin|metformin|mesh-list
20569051|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20569052|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569053|NCT02026921|Carboplatin|carboplatin|mesh-list
20569054|NCT02026921|Docetaxel|docetaxel|mesh-list
20569055|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569056|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
20569057|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
20569058|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
20569059|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569060|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
20569061|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
20569062|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569063|NCT02026973|Fulvestrant|fulvestrant|mesh-list
20569064|NCT02026973|Anastrozole|anastrozole|mesh-list
20569065|NCT02026973|Somatostatin|somatostatin|mesh-list
20569066|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20569067|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569068|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20569069|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20569070|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
20569071|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569072|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569073|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20569074|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20569075|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569076|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569077|NCT02026973|Hormones|hormones|mesh-ancestor
20569078|NCT02027064|Interferons|interferons|mesh-list
20569079|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
20569080|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569081|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
20569082|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569083|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
20569084|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569085|NCT02027103|Metformin|metformin|mesh-list
20569086|NCT02027103|Pioglitazone|pioglitazone|mesh-list
20569087|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20569088|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569089|NCT02027220|Dexamethasone|dexamethasone|mesh-list
20569090|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
20569091|NCT02027220|Bortezomib|bortezomib|mesh-list
20569092|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569093|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
20569094|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569095|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569096|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20569097|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
20569098|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569099|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569100|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20569101|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569102|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
20569103|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
20569104|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569105|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569106|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
20569107|NCT02027220|Hormones|hormones|mesh-ancestor
20569108|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569109|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20569110|NCT02027298|Abatacept|abatacept|mesh-list
20569111|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20569112|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569113|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569114|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569115|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
20569116|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742680|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742681|NCT04485325|Analgesics|analgesics|mesh-ancestor
20569117|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569118|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
20569119|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
20569120|NCT02027324|Povidone|povidone|mesh-list
20569121|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20569122|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569123|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
20569124|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
20569125|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
20569126|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
20569127|NCT02027337|Drospirenone|drospirenone|mesh-list
20569128|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20569129|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20569130|NCT02027337|Cyproterone|cyproterone|mesh-list
20569131|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
20569132|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20569133|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20569134|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20569135|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
20569136|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20569137|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569138|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20569139|NCT02027337|Estrogens|estrogens|mesh-ancestor
20569140|NCT02027337|Hormones|hormones|mesh-ancestor
20569141|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569142|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20569143|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
20569144|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20569145|NCT02027337|Diuretics|diuretics|mesh-ancestor
20569146|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
20569147|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
20569148|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569149|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20569150|NCT02027363|Capecitabine|capecitabine|mesh-list
20569151|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20569152|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
20569153|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569154|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569155|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
20569156|NCT02027454|Cabotegravir|cabotegravir|mesh-list
20569157|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20569158|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569159|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20569160|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20569161|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569162|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569163|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569164|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20569165|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20569166|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20569167|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20569168|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
20569169|NCT02027493|Interferons|interferons|mesh-list
20569170|NCT02027493|Ribavirin|ribavirin|mesh-list
20569171|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
20569172|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
20569173|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20569174|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569175|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
20569176|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569177|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
20569178|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569179|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
20569180|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569181|NCT02027532|Vancomycin|vancomycin|mesh-list
20569182|NCT02027532|Cefazolin|cefazolin|mesh-list
20569183|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20569184|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569185|NCT02027675|Micronutrients|micronutrients|mesh-list
20569186|NCT02027675|Trace Elements|trace elements|mesh-list
20569187|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569188|NCT02027753|Metformin|metformin|mesh-list
20569189|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
20569190|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20569191|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20569192|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569193|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
20569194|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569195|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569196|NCT02027792|Diclofenac|diclofenac|mesh-list
20569197|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20569198|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569199|NCT02027792|Analgesics|analgesics|mesh-ancestor
20569200|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
20569201|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569202|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569203|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569204|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569205|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20569206|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569207|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569208|NCT02027870|Sirolimus|sirolimus|mesh-list
20569209|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20569210|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569211|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20569212|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569213|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
20569214|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569215|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
20569216|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569217|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
20569218|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
20569219|NCT02027922|Protective Agents|protective agents|mesh-ancestor
20569220|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569221|NCT02027961|Durvalumab|durvalumab|mesh-list
20569222|NCT02027961|Trametinib|trametinib|mesh-list
20569223|NCT02027961|Dabrafenib|dabrafenib|mesh-list
20569224|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20569225|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569226|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578346|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
20569227|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605013|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605014|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
20605015|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20605016|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605017|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605018|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20607957|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607958|NCT02244164|Incretins|incretins|mesh-ancestor
20607959|NCT02244164|Hormones|hormones|mesh-ancestor
20569228|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569229|NCT02027987|Valproic Acid|valproic acid|mesh-list
20569230|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
20569231|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569232|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569233|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
20569234|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569235|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569236|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
20569237|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20569238|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569239|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605019|NCT02230228|Vitamin A|vitamin a|mesh-list
20605020|NCT02230228|Retinol acetate|retinol acetate|mesh-list
20605021|NCT02230228|Vitamins|vitamins|mesh-ancestor
20605022|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
20605023|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605024|NCT02230228|Protective Agents|protective agents|mesh-ancestor
20605025|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20605026|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605027|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20018862|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018863|NCT02499497|Androgens|androgens|mesh-list
20605028|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
20605029|NCT02230319|Paclitaxel|paclitaxel|mesh-list
20605030|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742682|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
20605031|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605032|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
20569240|NCT02028026|Citalopram|citalopram|mesh-list
20569241|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20569242|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20569243|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20569244|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20569245|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569246|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569247|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
20569248|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569249|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20569250|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
20569251|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20569252|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20569253|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20569254|NCT02028078|Insulin|insulin|mesh-list
20569255|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20569256|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20569257|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569258|NCT02028234|Omeprazole|omeprazole|mesh-list
20569259|NCT02028234|Pantoprazole|pantoprazole|mesh-list
20569260|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20569261|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569262|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20569263|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569264|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569265|NCT02028260|Modafinil|modafinil|mesh-list
20569266|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20569267|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569268|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20569269|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20569270|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20569271|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569272|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20569273|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20569274|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
20569275|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20569276|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20569277|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20569278|NCT02028364|Everolimus|everolimus|mesh-list
20569279|NCT02028364|Exemestane|exemestane|mesh-list
20569280|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569281|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569282|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
20569283|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569284|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20569285|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20569286|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569287|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569288|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20569289|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
20569290|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569291|NCT02028403|BMS-936559|bms-936559|mesh-list
20569292|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20018864|NCT02499497|Hormones|hormones|mesh-ancestor
20018865|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018866|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018867|NCT02499575|Bupivacaine|bupivacaine|mesh-list
20018868|NCT02499575|Ropivacaine|ropivacaine|mesh-list
20569293|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20569294|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569295|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
20569296|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569297|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
20569298|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
20569299|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569300|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569301|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
20569302|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
20569303|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20569304|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20569305|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569306|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569307|NCT02028429|Urological Agents|urological agents|mesh-ancestor
20569308|NCT02028494|Capecitabine|capecitabine|mesh-list
20569309|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20569310|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
20569311|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569312|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569313|NCT02028507|Capecitabine|capecitabine|mesh-list
20569314|NCT02028507|Fulvestrant|fulvestrant|mesh-list
20569315|NCT02028507|Palbociclib|palbociclib|mesh-list
20569316|NCT02028507|Exemestane|exemestane|mesh-list
20569317|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20569318|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
20569319|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569320|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569321|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20569322|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20569323|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20569324|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
20569325|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569326|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569327|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20569328|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569329|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20569330|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20569331|NCT02028533|Oxytocin|oxytocin|mesh-list
20569332|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
20569333|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20569334|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569335|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
20569336|NCT02028598|Clomipramine|clomipramine|mesh-list
20569337|NCT02028598|Citric Acid|citric acid|mesh-list
20569338|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
20569339|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
20569340|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20569341|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
20569342|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
20569343|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569344|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
20569345|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20569346|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20569347|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569348|NCT02028598|Urological Agents|urological agents|mesh-ancestor
20569349|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20569350|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
20569351|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20569352|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20569353|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20569354|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20569355|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569356|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
20569357|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569358|NCT02028663|Esomeprazole|esomeprazole|mesh-list
20569359|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20569360|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569361|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20569362|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569363|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569364|NCT02028689|Metformin|metformin|mesh-list
20569365|NCT02028689|Lesinurad|lesinurad|mesh-list
20569366|NCT02028689|Furosemide|furosemide|mesh-list
20569367|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20569368|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569369|NCT02028689|Diuretics|diuretics|mesh-ancestor
20569370|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
20569371|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20569372|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20569373|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569374|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
20569375|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569376|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
20569377|NCT02028689|Renal Agents|renal agents|mesh-ancestor
20569378|NCT02028806|Leucovorin|leucovorin|mesh-list
20569379|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
20569380|NCT02028806|Irinotecan|irinotecan|mesh-list
20569381|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569382|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20569383|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20569384|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569385|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569386|NCT02028806|Antidotes|antidotes|mesh-ancestor
20292114|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292115|NCT05339529|Glycine|glycine|mesh-list
20292116|NCT05339529|Thymalfasin|thymalfasin|mesh-list
20292117|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
20292118|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292119|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292120|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292121|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20292122|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
20292123|NCT05339373|Aceclofenac|aceclofenac|mesh-list
20292124|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20292125|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292126|NCT05339373|Analgesics|analgesics|mesh-ancestor
20292127|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
20292128|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292129|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292130|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569387|NCT02028806|Protective Agents|protective agents|mesh-ancestor
20569388|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569389|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
20569390|NCT02028806|Vitamins|vitamins|mesh-ancestor
20569391|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
20569392|NCT02028819|Dolutegravir|dolutegravir|mesh-list
20569393|NCT02028819|Ibalizumab|ibalizumab|mesh-list
20569394|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20569395|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20569396|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569397|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569398|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20569399|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20569400|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
20569401|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569402|NCT02028910|Ondansetron|ondansetron|mesh-list
20569403|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
20569404|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
20569405|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569406|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569407|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569408|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
20569409|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
20569410|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20569411|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
20569412|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569413|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569414|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20569415|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20569416|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569417|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20569418|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20569419|NCT02028923|Morphine|morphine|mesh-list
19468106|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19468107|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19468108|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
19468109|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
19468110|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468111|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19468112|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20569420|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20569421|NCT02028923|Narcotics|narcotics|mesh-ancestor
19468113|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468114|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566712|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566713|NCT05219487|Risdiplam|risdiplam|mesh-list
19566714|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19566715|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566716|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566717|NCT05218733|Fentanyl|fentanyl|mesh-list
19566718|NCT05218733|Morphine|morphine|mesh-list
19566719|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
19566720|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566721|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566722|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19566723|NCT05218733|Narcotics|narcotics|mesh-ancestor
19566724|NCT05218733|Analgesics|analgesics|mesh-ancestor
19566725|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
19566726|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569422|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569423|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569424|NCT02028923|Analgesics|analgesics|mesh-ancestor
20569425|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
20569426|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569427|NCT02028949|Idarubicin|idarubicin|mesh-list
20569428|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20569429|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569430|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20569431|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20569432|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569433|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569434|NCT02029001|Everolimus|everolimus|mesh-list
20569435|NCT02029001|Sorafenib|sorafenib|mesh-list
20569436|NCT02029001|Durvalumab|durvalumab|mesh-list
20569437|NCT02029001|Olaparib|olaparib|mesh-list
20569438|NCT02029001|Lapatinib|lapatinib|mesh-list
20569439|NCT02029001|Tremelimumab|tremelimumab|mesh-list
20569440|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569441|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569442|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
20569443|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569444|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20569445|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569446|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569447|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20569448|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20569449|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
20569450|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20569451|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
20569452|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569453|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
20569454|NCT02029105|Protective Agents|protective agents|mesh-ancestor
20569455|NCT02029118|Aspirin|aspirin|mesh-list
20569456|NCT02029118|Metoprolol|metoprolol|mesh-list
20569457|NCT02029118|Ramipril|ramipril|mesh-list
20569458|NCT02029118|Atorvastatin|atorvastatin|mesh-list
20569459|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20569460|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569461|NCT02029118|Analgesics|analgesics|mesh-ancestor
20569462|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
20569463|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569464|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569465|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569466|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569467|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20569468|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20569469|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569470|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20569471|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20569472|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569473|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
20569474|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20569475|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20569476|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
20569477|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20569478|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20569479|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20569480|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20569481|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
20569482|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
20569483|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20569484|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20569485|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20569486|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
20569487|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569488|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20569489|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
20569490|NCT02029313|Montelukast|montelukast|mesh-list
20569491|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20569492|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
20569493|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20569494|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
20569495|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569496|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569497|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20569498|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20569499|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569500|NCT02029378|Eculizumab|eculizumab|mesh-list
20569501|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20569502|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569503|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
20569504|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569505|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20569506|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20569507|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20569508|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569509|NCT02029482|Ponesimod|ponesimod|mesh-list
20569510|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20569511|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569512|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569513|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
19468115|NCT03290456|Prednisone|prednisone|mesh-list
19468116|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468117|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
20569514|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569515|NCT02029534|Atorvastatin|atorvastatin|mesh-list
20569516|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20569517|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20569518|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
20569519|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569520|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20569521|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20569522|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569523|NCT02029573|Temozolomide|temozolomide|mesh-list
20569524|NCT02029573|Atorvastatin|atorvastatin|mesh-list
20569525|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20569526|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20569527|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
20569528|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569529|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20569530|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20569531|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569532|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20569533|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
20569534|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569535|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
20569536|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569537|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20569538|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20569539|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569540|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569541|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
20569542|NCT02029599|Acetaminophen|acetaminophen|mesh-list
20569543|NCT02029599|Methotrexate|methotrexate|mesh-list
20569544|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20569545|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
20569546|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20569547|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569548|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20569549|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
20569550|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569551|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468118|NCT03290456|Hormones|hormones|mesh-ancestor
19468119|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468120|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468121|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19468122|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468123|NCT03290430|Nicotine|nicotine|mesh-list
19468124|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20292131|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292132|NCT05339334|Ritonavir|ritonavir|mesh-list
20292133|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20292134|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20292135|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
20292136|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468125|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
19468126|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468127|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468128|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19468129|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19468130|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
19468131|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468132|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468133|NCT03290417|Vitamin D|vitamin d|mesh-list
19468134|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
20292137|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292138|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20292139|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20292140|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
20292141|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292142|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19468135|NCT03290417|Vitamins|vitamins|mesh-list
19468136|NCT03290417|Curcumin|curcumin|mesh-list
19468137|NCT03290417|Turmeric extract|turmeric extract|mesh-list
19468138|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
19468139|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468140|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19468141|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19468142|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20569552|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
20569553|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569554|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20569555|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569556|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
20292143|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20569557|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569558|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20569559|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569560|NCT02029599|Analgesics|analgesics|mesh-ancestor
20569561|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
20569562|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569563|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
20569564|NCT02029612|Nicotine|nicotine|mesh-list
20569565|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20569566|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
20569567|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569568|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569569|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20569570|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20569571|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
20569572|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569573|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569574|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20569575|NCT02029625|Ezetimibe|ezetimibe|mesh-list
20569576|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20569577|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20569578|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
20569579|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569580|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20569581|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20569582|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605033|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
20605034|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
20605035|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605036|NCT02230358|Anesthetics|anesthetics|mesh-list
20605037|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605038|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292144|NCT05339295|Levofloxacin|levofloxacin|mesh-list
20292145|NCT05339295|Ofloxacin|ofloxacin|mesh-list
20292146|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20292147|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292148|NCT05339295|Renal Agents|renal agents|mesh-ancestor
20292149|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20292150|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20292151|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20292152|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292153|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292154|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605039|NCT02230371|Granisetron|granisetron|mesh-list
20605040|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
20605041|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
20605042|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605043|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605044|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569583|NCT02029794|Acetic Acid|acetic acid|mesh-list
20569584|NCT02029794|Retinol acetate|retinol acetate|mesh-list
20569585|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20569586|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569587|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20569588|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
20569589|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569590|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20569591|NCT02029794|Protective Agents|protective agents|mesh-ancestor
20569592|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569593|NCT02029898|Remifentanil|remifentanil|mesh-list
20569594|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20569595|NCT02029898|Narcotics|narcotics|mesh-ancestor
20569596|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569597|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569598|NCT02029898|Analgesics|analgesics|mesh-ancestor
20569599|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
20569600|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569601|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
20569602|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20569603|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569604|NCT02029937|Proflavine|proflavine|mesh-list
20569605|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20569606|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569607|NCT02029950|Cytarabine|cytarabine|mesh-list
20569608|NCT02029950|Etoposide|etoposide|mesh-list
20569609|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
20569610|NCT02029950|Daunorubicin|daunorubicin|mesh-list
20569611|NCT02029950|Idarubicin|idarubicin|mesh-list
20569612|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
20569613|NCT02029950|Pomalidomide|pomalidomide|mesh-list
20569614|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20569615|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569616|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20569617|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20569618|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569619|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569620|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20569621|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
20569622|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
20569623|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569624|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569625|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
20569626|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569627|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20569628|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20569629|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20569630|NCT02029950|Growth Substances|growth substances|mesh-ancestor
20569631|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
20569632|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
20569633|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
20569634|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
20569635|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
20569636|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
20569637|NCT02030054|Atorvastatin|atorvastatin|mesh-list
20569638|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20569639|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20569640|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20569641|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
20569642|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569643|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20569644|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20569645|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569646|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
20569647|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20569648|NCT02030314|Diuretics|diuretics|mesh-ancestor
20569649|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
20569650|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569651|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20569652|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20569653|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569654|NCT02030483|Dexamethasone|dexamethasone|mesh-list
20569655|NCT02030483|Lenalidomide|lenalidomide|mesh-list
20569656|NCT02030483|Palbociclib|palbociclib|mesh-list
20569657|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569658|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
20569659|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
20569660|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569661|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018869|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
20018870|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
20018871|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569662|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569663|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
20569664|NCT02030483|Hormones|hormones|mesh-ancestor
20569665|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569666|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20569667|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569668|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
20569669|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20569670|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20569671|NCT02030483|Growth Substances|growth substances|mesh-ancestor
20569672|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
20569673|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20569674|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569675|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569676|NCT02030561|Trastuzumab|trastuzumab|mesh-list
20569677|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20569678|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569679|NCT02030639|ON 01910|on 01910|mesh-list
20569680|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569681|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20569682|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569683|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569684|NCT02030678|Irinotecan|irinotecan|mesh-list
20018872|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018873|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
20569685|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20569686|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20569687|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569688|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569689|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569690|NCT02030717|Clonidine|clonidine|mesh-list
20569691|NCT02030717|Anesthetics|anesthetics|mesh-list
20569692|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569693|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569694|NCT02030717|Analgesics|analgesics|mesh-ancestor
20569695|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
20569696|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569697|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20569698|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
20569699|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
20569700|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20569701|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20569702|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20569703|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
20569704|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569705|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569706|NCT02030912|Amoxicillin|amoxicillin|mesh-list
20569707|NCT02030912|Minocycline|minocycline|mesh-list
20569708|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20569709|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018874|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018875|NCT02499770|Carboplatin|carboplatin|mesh-list
20018876|NCT02499770|Etoposide|etoposide|mesh-list
20018877|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018878|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20018879|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20018880|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20018881|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018882|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018883|NCT02499783|Adalimumab|adalimumab|mesh-list
20569710|NCT02030964|Eflornithine|eflornithine|mesh-list
20569711|NCT02030964|Celecoxib|celecoxib|mesh-list
20569712|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
20569713|NCT02030964|Topotecan|topotecan|mesh-list
20569714|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569715|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
20569716|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569717|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569718|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20569719|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
20569720|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569721|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569722|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20569723|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20569724|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569725|NCT02030964|Analgesics|analgesics|mesh-ancestor
20569726|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
20569727|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569728|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569729|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20569730|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20569731|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569732|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20569733|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20569734|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20569735|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20569736|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20569737|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569738|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20569739|NCT02030977|Resveratrol|resveratrol|mesh-list
20569740|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
20569741|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569742|NCT02030977|Protective Agents|protective agents|mesh-ancestor
20569743|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569744|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569745|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20569746|NCT02031016|Fentanyl|fentanyl|mesh-list
20569747|NCT02031016|Remifentanil|remifentanil|mesh-list
20569748|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20569749|NCT02031016|Narcotics|narcotics|mesh-ancestor
20569750|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569751|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569752|NCT02031016|Analgesics|analgesics|mesh-ancestor
20569753|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
20569754|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569755|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20569756|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20569757|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
20569758|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
20569759|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20569760|NCT02031081|Prucalopride|prucalopride|mesh-list
20569761|NCT02031081|Laxatives|laxatives|mesh-ancestor
20569762|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569763|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20569764|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20569765|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
20569766|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569767|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569768|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569769|NCT02031211|Etanercept|etanercept|mesh-list
20569770|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20569771|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569772|NCT02031211|Analgesics|analgesics|mesh-ancestor
20569773|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
20018884|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569774|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569775|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569776|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569777|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468143|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569778|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569779|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569780|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
20569781|NCT02031289|Folic Acid|folic acid|mesh-list
20569782|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
20569783|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
20569784|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
20569785|NCT02031289|Vitamins|vitamins|mesh-ancestor
20569786|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
20569787|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569788|NCT02031289|Hematinics|hematinics|mesh-ancestor
20569789|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
19468144|NCT03290417|Analgesics|analgesics|mesh-ancestor
19578347|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20569790|NCT02031367|Triamcinolone|triamcinolone|mesh-list
20569791|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20569792|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20569793|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20569794|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569795|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
20569796|NCT02031367|Hormones|hormones|mesh-ancestor
20569797|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569798|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569799|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20569800|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
20569801|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569802|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569803|NCT02031419|Rituximab|rituximab|mesh-list
20569804|NCT02031419|Spebrutinib|spebrutinib|mesh-list
20569805|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20569806|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569807|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
20569808|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569809|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569810|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20569811|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569812|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605045|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20605046|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
20605047|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605048|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605049|NCT02230553|Lapatinib|lapatinib|mesh-list
20605050|NCT02230553|Trametinib|trametinib|mesh-list
20605051|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605052|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20605053|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605054|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605055|NCT02230618|Insulin|insulin|mesh-list
19578348|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
20018885|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20605056|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
20605057|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20605058|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018886|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
20018887|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018888|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018889|NCT02500602|Doxazosin|doxazosin|mesh-list
20018890|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20018891|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20018892|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20018893|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20018894|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
20018895|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605059|NCT02230735|Epinephrine|epinephrine|mesh-list
20018896|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018897|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018898|NCT02500628|Metformin|metformin|mesh-list
20018899|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018900|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018901|NCT02500641|Naproxen|naproxen|mesh-list
20018902|NCT02500641|Colchicine|colchicine|mesh-list
20018903|NCT02500641|Allopurinol|allopurinol|mesh-list
20018904|NCT02500641|Febuxostat|febuxostat|mesh-list
20018905|NCT02500641|Omeprazole|omeprazole|mesh-list
20018906|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20569813|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
20569814|NCT02031510|Bupivacaine|bupivacaine|mesh-list
20569815|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
20569816|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
20569817|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569818|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569819|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
20569820|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569821|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20569822|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569823|NCT02031510|Analgesics|analgesics|mesh-ancestor
20569824|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20569825|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20569826|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20569827|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
20569828|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569829|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569830|NCT02031523|Analgesics|analgesics|mesh-list
20569831|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
20569832|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569833|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569834|NCT02031601|Carboplatin|carboplatin|mesh-list
20569835|NCT02031601|Docetaxel|docetaxel|mesh-list
20569836|NCT02031601|Pemetrexed|pemetrexed|mesh-list
20569837|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20569838|NCT02031601|Gefitinib|gefitinib|mesh-list
20569839|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569840|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
20569841|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
20569842|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
20569843|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569844|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569845|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20569846|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20569847|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20569848|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
20569849|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
20569850|NCT02031692|Calcium|calcium|mesh-list
20569851|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20569852|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569853|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20569854|NCT02031692|Vitamins|vitamins|mesh-ancestor
20569855|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
20569856|NCT02031692|Antacids|antacids|mesh-ancestor
20569857|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569858|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569859|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20569860|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
20569861|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569862|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20569863|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569864|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20569865|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569866|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569867|NCT02031861|Nifedipine|nifedipine|mesh-list
20569868|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20569869|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20569870|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569871|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20018907|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20018908|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20569872|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569873|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
19468145|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
19468146|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468147|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569874|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
20569875|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20569876|NCT02031939|Capecitabine|capecitabine|mesh-list
20569877|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
20569878|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20569879|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
20569880|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569881|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569882|NCT02031965|Dexamethasone|dexamethasone|mesh-list
20569883|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20569884|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
20569885|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
20569886|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569887|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569888|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569889|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
20569890|NCT02031965|Hormones|hormones|mesh-ancestor
20569891|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569892|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20569893|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569894|NCT02031991|Bevacizumab|bevacizumab|mesh-list
20569895|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20569896|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569897|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20569898|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20569899|NCT02031991|Growth Substances|growth substances|mesh-ancestor
19468148|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468149|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468150|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468151|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018909|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569900|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569901|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
20569902|NCT02032043|Ivermectin|ivermectin|mesh-list
20569903|NCT02032043|Albendazole|albendazole|mesh-list
20569904|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20569905|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569906|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
20569907|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
20569908|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20569909|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20569910|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
20569911|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
20569912|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
20569913|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569914|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569915|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
20569916|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20569917|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
20569918|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20569919|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
20569920|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569921|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20569922|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20569923|NCT02032134|Protective Agents|protective agents|mesh-ancestor
20569924|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569925|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20569926|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
20569927|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569928|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
20569929|NCT02032186|Cathartics|cathartics|mesh-ancestor
20569930|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20569931|NCT02032290|Clopidogrel|clopidogrel|mesh-list
20569932|NCT02032290|Ticagrelor|ticagrelor|mesh-list
20120639|NCT00006381|Analgesics|analgesics|mesh-ancestor
20569933|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20569934|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20569935|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20569936|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20569937|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
20569938|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569939|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569940|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569941|NCT02032303|Ticagrelor|ticagrelor|mesh-list
20569942|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20569943|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20569944|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20569945|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20569946|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20569947|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
20569948|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20569949|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20569950|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569951|NCT02032355|Anesthetics|anesthetics|mesh-list
20569952|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569953|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569954|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
20569955|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20569956|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
20569957|NCT02032394|Povidone|povidone|mesh-list
20569958|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20569959|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569960|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
20569961|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
20569962|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
20569963|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
20569964|NCT02032654|Floxacillin|floxacillin|mesh-list
20569965|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20569966|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20569967|NCT02032784|Octreotide|octreotide|mesh-list
19468152|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
20569968|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605060|NCT02230735|Racepinephrine|racepinephrine|mesh-list
20605061|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
20605062|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20605063|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20605064|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
20605065|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605066|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605067|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605068|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20605069|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605070|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
20605071|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605072|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605073|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605074|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
20605075|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
20605076|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20605077|NCT02230800|Tocovid|tocovid|mesh-list
20605078|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
20605079|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20605080|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20569969|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20569970|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20569971|NCT02032797|Progesterone|progesterone|mesh-list
20569972|NCT02032797|Progestins|progestins|mesh-ancestor
20569973|NCT02032797|Hormones|hormones|mesh-ancestor
20569974|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20569975|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569976|NCT02032836|Iloprost|iloprost|mesh-list
20569977|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20569978|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
20569979|NCT02032927|Acetaminophen|acetaminophen|mesh-list
20569980|NCT02032927|Oxycodone|oxycodone|mesh-list
20569981|NCT02032927|Codeine|codeine|mesh-list
20569982|NCT02032927|Naloxone|naloxone|mesh-list
20569983|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20569984|NCT02032927|Analgesics|analgesics|mesh-ancestor
20569985|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
20569986|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20569987|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569988|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
20569989|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20569990|NCT02032927|Narcotics|narcotics|mesh-ancestor
20569991|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20569992|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20569993|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
19468153|NCT03290417|Protective Agents|protective agents|mesh-ancestor
19468154|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
19468155|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19468156|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
19468157|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468158|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
19468159|NCT03290365|Protective Agents|protective agents|mesh-ancestor
19468160|NCT03290196|Bupivacaine|bupivacaine|mesh-list
19468161|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
19468162|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
19468163|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468164|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468165|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
19468166|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468167|NCT03289949|Ketanserin|ketanserin|mesh-list
19468168|NCT03289949|Psilocybin|psilocybin|mesh-list
19468169|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
19468170|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468171|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19468172|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19468173|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19468174|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19468175|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
19468176|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468177|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468178|NCT03289871|Amorolfine|amorolfine|mesh-list
19468179|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
19468180|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468181|NCT03289819|Paclitaxel|paclitaxel|mesh-list
19468182|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19468183|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
19468184|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
19468185|NCT03289819|Epirubicin|epirubicin|mesh-list
19468186|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19468187|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468188|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468189|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468190|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468191|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468192|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19468193|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
19468194|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20569994|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
20569995|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
19468195|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20569996|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19468196|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20569997|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20569998|NCT02033018|Aflibercept|aflibercept|mesh-list
20569999|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20570000|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20570001|NCT02033018|Growth Substances|growth substances|mesh-ancestor
20570002|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570003|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
20570004|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570005|NCT02033031|Bevacizumab|bevacizumab|mesh-list
20570006|NCT02033031|Ranibizumab|ranibizumab|mesh-list
19468197|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
19468198|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19468199|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468200|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19468201|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19468202|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19468203|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468204|NCT03289728|Dobutamine|dobutamine|mesh-list
19468205|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20570007|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20570008|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570009|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20570010|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20570011|NCT02033031|Growth Substances|growth substances|mesh-ancestor
20570012|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468206|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
19468207|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
19468208|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742683|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570013|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
20570014|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20570015|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570016|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605081|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605082|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20605083|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20605084|NCT02230800|Protective Agents|protective agents|mesh-ancestor
20605085|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605086|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
20605087|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20605088|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
20605089|NCT02230800|Vitamins|vitamins|mesh-ancestor
20605090|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
20605091|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
20605092|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20605093|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20605094|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20605095|NCT02230930|Apomorphine|apomorphine|mesh-list
20605096|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20605097|NCT02230930|Emetics|emetics|mesh-ancestor
20605098|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605099|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
20605100|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605101|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605102|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
20605103|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
20605104|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570017|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
20570018|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20570019|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570020|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
20570021|NCT02033239|Insulin|insulin|mesh-list
20570022|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20570023|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
20570024|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
20570025|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20570026|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20570027|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605105|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605106|NCT02230982|Nintedanib|nintedanib|mesh-list
20605107|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605108|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19468209|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749070|NCT05294588|Vaccines|vaccines|mesh-list
20605109|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605110|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605111|NCT02231021|Pioglitazone|pioglitazone|mesh-list
20605112|NCT02231021|Alogliptin|alogliptin|mesh-list
20570028|NCT02033356|Lidocaine|lidocaine|mesh-list
20570029|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
20570030|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
20570031|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570032|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570033|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
20570034|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570035|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20570036|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20570037|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20570038|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20570039|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570040|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20570041|NCT02033408|Amoxicillin|amoxicillin|mesh-list
20570042|NCT02033408|Metronidazole|metronidazole|mesh-list
20570043|NCT02033408|Vancomycin|vancomycin|mesh-list
20570044|NCT02033408|Doxycycline|doxycycline|mesh-list
20570045|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
20570046|NCT02033408|Gentamicins|gentamicins|mesh-list
20570047|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570048|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20570049|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20570050|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
20570051|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20570052|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20570053|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570054|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570055|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570056|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20570057|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20570058|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20570059|NCT02033434|Ketamine|ketamine|mesh-list
20570060|NCT02033434|Analgesics|analgesics|mesh-ancestor
20570061|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
20570062|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570063|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570064|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20570065|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570066|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
20570067|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
20570068|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570069|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20570070|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20570071|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570072|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570073|NCT02033512|Hormones|hormones|mesh-list
20570074|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018910|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018911|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20018912|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20570075|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570076|NCT02033538|Paclitaxel|paclitaxel|mesh-list
20570077|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20570078|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20570079|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570080|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570081|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570082|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570083|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570084|NCT02033551|Paclitaxel|paclitaxel|mesh-list
20570085|NCT02033551|Carboplatin|carboplatin|mesh-list
20570086|NCT02033551|Veliparib|veliparib|mesh-list
20570087|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20570088|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570089|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570090|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570091|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570092|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570093|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20570094|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570095|NCT02033603|Ropivacaine|ropivacaine|mesh-list
20570096|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
20570097|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
20570098|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570099|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570100|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
20570101|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570102|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20570103|NCT02033707|Scopolamine|scopolamine|mesh-list
20570104|NCT02033707|Hallucinogens|hallucinogens|mesh-list
20570105|NCT02033707|Nicotine|nicotine|mesh-list
20570106|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20570107|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
20570108|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570109|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292155|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20292156|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20292157|NCT05339217|Aldesleukin|aldesleukin|mesh-list
20292158|NCT05339217|Interleukin-2|interleukin-2|mesh-list
20292159|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292160|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20570110|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20570111|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20570112|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570113|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570114|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570115|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20570116|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
20570117|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20570118|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
20570119|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20292161|NCT05339217|Analgesics|analgesics|mesh-ancestor
20570120|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20570121|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20570122|NCT02033733|Cisatracurium|cisatracurium|mesh-list
20570123|NCT02033733|Atracurium|atracurium|mesh-list
20570124|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
20570125|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20570126|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570127|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570128|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20570129|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20570130|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20570131|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570132|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570133|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570134|NCT02033798|Tamsulosin|tamsulosin|mesh-list
20570135|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20570136|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20570137|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20570138|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
20570139|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570140|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570141|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570142|NCT02033798|Urological Agents|urological agents|mesh-ancestor
20570143|NCT02033941|Phenol|phenol|mesh-list
20570144|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20570145|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570146|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
20570147|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20570148|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20570149|NCT02033967|Milrinone|milrinone|mesh-list
20570150|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
20570151|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20570152|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20570153|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20570154|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20570155|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570156|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570157|NCT02033967|Protective Agents|protective agents|mesh-ancestor
20570158|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570159|NCT02034071|Diazoxide|diazoxide|mesh-list
20570160|NCT02034071|Choline|choline|mesh-list
20570161|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
20570162|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20570163|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
20570164|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570165|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20570166|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20570167|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
20570168|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20570169|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
20570170|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20570171|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570172|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20570173|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570174|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570175|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20570176|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20570177|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570178|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20570179|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20570180|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20570181|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570182|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
20570183|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570184|NCT02034253|Risperidone|risperidone|mesh-list
20570185|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20570186|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
20570187|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570188|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570189|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570190|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20570191|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20570192|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570193|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20570194|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20570195|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
20570196|NCT02034292|Aspirin|aspirin|mesh-list
20570197|NCT02034292|Clopidogrel|clopidogrel|mesh-list
20570198|NCT02034292|APD791|apd791|mesh-list
20570199|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20570200|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20570201|NCT02034292|Analgesics|analgesics|mesh-ancestor
20570202|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
20570203|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570204|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570205|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570206|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20570207|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20570208|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20570209|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570210|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20570211|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20570212|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570213|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
19749071|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
20570214|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20570215|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20570216|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20570217|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
20570218|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570219|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20570220|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20570221|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
20570222|NCT02034331|Acetylcholine|acetylcholine|mesh-list
20570223|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570224|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
20570225|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20570226|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570227|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570228|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570229|NCT02034500|Vaccines|vaccines|mesh-list
20570230|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
20570231|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570232|NCT02034604|Tamsulosin|tamsulosin|mesh-list
20570233|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20570234|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20570235|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20570236|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
20570237|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570238|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570239|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570240|NCT02034604|Urological Agents|urological agents|mesh-ancestor
20570241|NCT02034630|Busulfan|busulfan|mesh-list
20570242|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
20570243|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570244|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20570245|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
20570246|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570247|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20570248|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570249|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20570250|NCT02034838|Ritonavir|ritonavir|mesh-list
20570251|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20570252|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20570253|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20570254|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
20570255|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570256|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570257|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20570258|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20570259|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
20570260|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570261|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20570262|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20570263|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
20570264|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20570265|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
20570266|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570267|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
20570268|NCT02034890|Protective Agents|protective agents|mesh-ancestor
20605113|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20605114|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605115|NCT02231021|Incretins|incretins|mesh-ancestor
20605116|NCT02231021|Hormones|hormones|mesh-ancestor
20605117|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605118|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20605119|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
20605120|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605121|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605122|NCT02231125|Losartan|losartan|mesh-list
20605123|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20605124|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605125|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20605126|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20605127|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570269|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
20570270|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20570271|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570272|NCT02035020|Interferons|interferons|mesh-list
20570273|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
20570274|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570275|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
20570276|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570277|NCT02035072|Gemcitabine|gemcitabine|mesh-list
20570278|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
20570279|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20570280|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
20570281|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570282|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570283|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
20570284|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570285|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570286|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20570287|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
20570288|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570289|NCT02035215|Atorvastatin|atorvastatin|mesh-list
20570290|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20570291|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20570292|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
20570293|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570294|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20570295|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20570296|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570297|NCT02035371|Insulin|insulin|mesh-list
20570298|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20570299|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
20570300|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
20570301|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20570302|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20570303|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570304|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
20570305|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20570306|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20570307|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20570308|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20570309|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570310|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570311|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570312|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570313|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20570314|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570315|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20570316|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20570317|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570318|NCT02035488|Tobramycin|tobramycin|mesh-list
20570319|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20570320|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570321|NCT02035527|Docetaxel|docetaxel|mesh-list
20570322|NCT02035527|Sorafenib|sorafenib|mesh-list
20570323|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570324|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570325|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570326|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570327|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570328|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20570329|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570330|NCT02035709|Hydromorphone|hydromorphone|mesh-list
20570331|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20570332|NCT02035709|Narcotics|narcotics|mesh-ancestor
20570333|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570334|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570335|NCT02035709|Analgesics|analgesics|mesh-ancestor
20570336|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
20570337|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570338|NCT02035787|Metformin|metformin|mesh-list
20570339|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20570340|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570341|NCT02035800|Adalimumab|adalimumab|mesh-list
20570342|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570343|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20570344|NCT02035891|Colchicine|colchicine|mesh-list
20570345|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
20570346|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20570347|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570348|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570349|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570350|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570351|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570352|NCT02035904|Morphine|morphine|mesh-list
20570353|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
20570354|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20570355|NCT02035904|Narcotics|narcotics|mesh-ancestor
20570356|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570357|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570358|NCT02035904|Analgesics|analgesics|mesh-ancestor
20570359|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
20570360|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570361|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
20570362|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
20570363|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
20570364|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20570365|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570366|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292162|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
20292163|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292164|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292165|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20292166|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20292167|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
20292168|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292169|NCT05339113|FAPI-46|fapi-46|mesh-list
20292170|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20292171|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570367|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292172|NCT05339087|Riociguat|riociguat|mesh-list
20292173|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
20570368|NCT02035930|Analgesics|analgesics|mesh-ancestor
20570369|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
20605128|NCT02231203|Tocopherols|tocopherols|mesh-list
20605129|NCT02231203|Antioxidants|antioxidants|mesh-list
20605130|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605131|NCT02231203|Protective Agents|protective agents|mesh-ancestor
20605132|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605133|NCT02231203|Vitamins|vitamins|mesh-ancestor
20605134|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
20605135|NCT02231255|Pramipexole|pramipexole|mesh-list
20605136|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
20605137|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605138|NCT02231255|Protective Agents|protective agents|mesh-ancestor
20605139|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605140|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20570370|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570371|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20570372|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20570373|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20570374|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
20570375|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570376|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570377|NCT02035943|Insulin|insulin|mesh-list
20570378|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20570379|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20570380|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570381|NCT02035956|Vaccines|vaccines|mesh-list
20570382|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
20570383|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570384|NCT02035982|Rivastigmine|rivastigmine|mesh-list
20570385|NCT02035982|Donepezil|donepezil|mesh-list
20570386|NCT02035982|Galantamine|galantamine|mesh-list
20570387|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
20570388|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570389|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570390|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570391|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570392|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570393|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
20570394|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20570395|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
20570396|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570397|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20570398|NCT02035982|Protective Agents|protective agents|mesh-ancestor
20570399|NCT02036008|Liver Extracts|liver extracts|mesh-list
20570400|NCT02036008|Hematinics|hematinics|mesh-ancestor
20570401|NCT02036060|Prednisone|prednisone|mesh-list
20570402|NCT02036060|Docetaxel|docetaxel|mesh-list
20570403|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570404|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570405|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570406|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570407|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570408|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570409|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
20570410|NCT02036060|Hormones|hormones|mesh-ancestor
20570411|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570412|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570413|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20570414|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
20570415|NCT02036073|Hematinics|hematinics|mesh-ancestor
20570416|NCT02036086|Vemurafenib|vemurafenib|mesh-list
20570417|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570418|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20570419|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570420|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570421|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
20570422|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20570423|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20570424|NCT02036125|Prednisolone|prednisolone|mesh-list
20570425|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
20570426|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20570427|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
20570428|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570429|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
20570430|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
20570431|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018913|NCT02500641|Analgesics|analgesics|mesh-ancestor
20018914|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
20018915|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018916|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018917|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018918|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018919|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
20018920|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20570432|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570433|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20570434|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
20570435|NCT02036125|Hormones|hormones|mesh-ancestor
20570436|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570437|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20570438|NCT02036125|Protective Agents|protective agents|mesh-ancestor
20570439|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20570440|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570441|NCT02036151|Fluorides|fluorides|mesh-list
20570442|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
20570443|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
20570444|NCT02036151|Protective Agents|protective agents|mesh-ancestor
20570445|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570446|NCT02036164|Paclitaxel|paclitaxel|mesh-list
20570447|NCT02036164|Cisplatin|cisplatin|mesh-list
20570448|NCT02036164|Carboplatin|carboplatin|mesh-list
20570449|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20570450|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570451|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570452|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570453|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570454|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570455|NCT02036229|Ivermectin|ivermectin|mesh-list
20570456|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20570457|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018921|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
20018922|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
20018923|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
20018924|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018925|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
20018926|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20018927|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
20018928|NCT02500641|Protective Agents|protective agents|mesh-ancestor
20018929|NCT02500706|Insulin|insulin|mesh-list
20018930|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20018931|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
20292174|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292175|NCT05339074|Ketamine|ketamine|mesh-list
20292176|NCT05339074|Analgesics|analgesics|mesh-ancestor
20292177|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
20292178|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292179|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292180|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20292181|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20292182|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
20292183|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
20292184|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570458|NCT02036242|Sufentanil|sufentanil|mesh-list
20570459|NCT02036242|Ropivacaine|ropivacaine|mesh-list
20570460|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
20570461|NCT02036242|Anesthetics|anesthetics|mesh-list
20570462|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570463|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570464|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
20570465|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570466|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20570467|NCT02036242|Narcotics|narcotics|mesh-ancestor
20570468|NCT02036242|Analgesics|analgesics|mesh-ancestor
20570469|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20570470|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570471|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
20570472|NCT02036255|Taurolidine|taurolidine|mesh-list
20570473|NCT02036255|Heparin|heparin|mesh-list
20570474|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
20570475|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20570476|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20570477|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570478|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570479|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20570480|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570481|NCT02036281|Substance P|substance p|mesh-list
20570482|NCT02036281|Neurokinin A|neurokinin a|mesh-list
20570483|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570484|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570485|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018932|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
20018933|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20570486|NCT02036359|Docetaxel|docetaxel|mesh-list
20570487|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20570488|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570489|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570490|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570491|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570492|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570493|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20570494|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570495|NCT02036372|Insulin|insulin|mesh-list
20570496|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20570497|NCT02036372|Liraglutide|liraglutide|mesh-list
20570498|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20570499|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570500|NCT02036372|Incretins|incretins|mesh-ancestor
20570501|NCT02036372|Hormones|hormones|mesh-ancestor
20570502|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570503|NCT02036437|Misoprostol|misoprostol|mesh-list
20570504|NCT02036437|Dinoprostone|dinoprostone|mesh-list
20570505|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20570506|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
20570507|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20570508|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570509|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20570510|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20570511|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
20605141|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20605142|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
20605143|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
20605144|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605145|NCT02231281|Ritonavir|ritonavir|mesh-list
20605146|NCT02231281|Lopinavir|lopinavir|mesh-list
20605147|NCT02231281|Tenofovir|tenofovir|mesh-list
20605148|NCT02231281|Lamivudine|lamivudine|mesh-list
20605149|NCT02231281|Zidovudine|zidovudine|mesh-list
20605150|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20605151|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20605152|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
20605153|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605154|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605155|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20605156|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20605157|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
20018934|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018935|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018936|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20018937|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20018938|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20018939|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20018940|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018941|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
20018942|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018943|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018944|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
20018945|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20018946|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018947|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
20018948|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
20018949|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20018950|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
20018951|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20018952|NCT02500836|Cocaine|cocaine|mesh-list
20018953|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20018954|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
20018955|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
20018956|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018957|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605158|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605159|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20605160|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20605161|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20605162|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20018958|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
20570512|NCT02036463|Prednisone|prednisone|mesh-list
20570513|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570514|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
20570515|NCT02036463|Hormones|hormones|mesh-ancestor
20570516|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570517|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018959|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018960|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20018961|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20018962|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20018963|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20570518|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20570519|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570520|NCT02036489|Prednisone|prednisone|mesh-list
20292185|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20292186|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20292187|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292188|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292189|NCT05339022|Coal Tar|coal tar|mesh-list
20292190|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
20292191|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
20292192|NCT05338801|Menthol|menthol|mesh-list
20292193|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
20292194|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
20570521|NCT02036489|Vincristine|vincristine|mesh-list
20570522|NCT02036489|Daunorubicin|daunorubicin|mesh-list
20570523|NCT02036489|Asparaginase|asparaginase|mesh-list
20570524|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
20570525|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570526|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
20570527|NCT02036489|Hormones|hormones|mesh-ancestor
20570528|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570529|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570530|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20570531|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570532|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20570533|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570534|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570535|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570536|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570537|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20570538|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20570539|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20570540|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570541|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
20570542|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20570543|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20570544|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
20570545|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20570546|NCT02036528|Doxycycline|doxycycline|mesh-list
20570547|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
20570548|NCT02036528|Gentamicins|gentamicins|mesh-list
20570549|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20570550|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570551|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
20570552|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20570553|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20570554|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19468210|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19468211|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19468212|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19468213|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
19468214|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468215|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468216|NCT03289728|Protective Agents|protective agents|mesh-ancestor
19468217|NCT03289637|Vitamin D|vitamin d|mesh-list
19468218|NCT03289637|Vitamins|vitamins|mesh-ancestor
19468219|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
19468220|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468221|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19468222|NCT03289559|Testosterone|testosterone|mesh-list
19468223|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19468224|NCT03289559|Androgens|androgens|mesh-ancestor
19468225|NCT03289559|Hormones|hormones|mesh-ancestor
19468226|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468227|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468228|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19468229|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468230|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570555|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20570556|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570557|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570558|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570559|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20292195|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20570560|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19468231|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20570561|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20570562|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
20570563|NCT02036554|Everolimus|everolimus|mesh-list
20570564|NCT02036554|Tacrolimus|tacrolimus|mesh-list
20570565|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20570566|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
20570567|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570568|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20570569|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570570|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570571|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570572|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20570573|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20570574|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
20570575|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20570576|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570577|NCT02036697|Fentanyl|fentanyl|mesh-list
20570578|NCT02036697|Morphine|morphine|mesh-list
20570579|NCT02036697|Bupivacaine|bupivacaine|mesh-list
20570580|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
20570581|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
20570582|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570583|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570584|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
20570585|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570586|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20570587|NCT02036697|Narcotics|narcotics|mesh-ancestor
20570588|NCT02036697|Analgesics|analgesics|mesh-ancestor
20570589|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20570590|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570591|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
20570592|NCT02036723|Bevacizumab|bevacizumab|mesh-list
20570593|NCT02036723|Ranibizumab|ranibizumab|mesh-list
20570594|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20570595|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570596|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20570597|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20570598|NCT02036723|Growth Substances|growth substances|mesh-ancestor
20570599|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570600|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
20570601|NCT02036736|Propofol|propofol|mesh-list
20570602|NCT02036736|Anesthetics|anesthetics|mesh-list
20570603|NCT02036736|Desflurane|desflurane|mesh-list
20570604|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20570605|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570606|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570607|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570608|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
20570609|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20570610|NCT02036827|Bromides|bromides|mesh-list
20570611|NCT02036827|Rocuronium|rocuronium|mesh-list
20570612|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
20570613|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20570614|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20570615|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20570616|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570617|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570618|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20570619|NCT02036879|Norethindrone|norethindrone|mesh-list
20570620|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
20570621|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20570622|NCT02036879|Estradiol|estradiol|mesh-list
20570623|NCT02036879|Estrogens|estrogens|mesh-ancestor
20570624|NCT02036879|Hormones|hormones|mesh-ancestor
20570625|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570626|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570627|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20570628|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
20570629|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20570630|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20570631|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20570632|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20570633|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20570634|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20570635|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20570636|NCT02036983|Anesthetics|anesthetics|mesh-list
20570637|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
20570638|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570639|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570640|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
20570641|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570642|NCT02037009|Anesthetics|anesthetics|mesh-list
20570643|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570644|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570645|NCT02037035|Ketamine|ketamine|mesh-list
20570646|NCT02037035|Analgesics|analgesics|mesh-ancestor
20570647|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
20570648|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570649|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570650|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20570651|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570652|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
20570653|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
20570654|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570655|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20570656|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20570657|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570658|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570659|NCT02037191|Methotrexate|methotrexate|mesh-list
20570660|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20570661|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
20570662|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20570663|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570664|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20570665|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
20570666|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570667|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570668|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
20570669|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570670|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20570671|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20570672|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
20570673|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20570674|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20570675|NCT02037399|Dexamethasone|dexamethasone|mesh-list
20570676|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570677|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
20570678|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
20570679|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570680|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570681|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20570682|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
20570683|NCT02037399|Hormones|hormones|mesh-ancestor
20570684|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570685|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20570686|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570687|NCT02037412|Clopidogrel|clopidogrel|mesh-list
20570688|NCT02037412|Ticagrelor|ticagrelor|mesh-list
20570689|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20570690|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20570691|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20570692|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20570693|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
20570694|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570695|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570696|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570697|NCT02037464|Capsaicin|capsaicin|mesh-list
20570698|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
20570699|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
20570700|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
20570701|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570702|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570703|NCT02037503|Ketamine|ketamine|mesh-list
20570704|NCT02037503|Analgesics|analgesics|mesh-ancestor
20570705|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
20570706|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570707|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570708|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20570709|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20292196|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292197|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292198|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20292199|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20292200|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20292201|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
20292202|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292203|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20292204|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19468232|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
19468233|NCT03289520|Clopidogrel|clopidogrel|mesh-list
19468234|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19468235|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19468236|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20018964|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018965|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
20292205|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292206|NCT05338671|Anesthetics|anesthetics|mesh-list
20570710|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
20570711|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
20570712|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570713|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20570714|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20570715|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570716|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570717|NCT02037516|Neostigmine|neostigmine|mesh-list
20570718|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20570719|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570720|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570721|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570722|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570723|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570724|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20570725|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
20570726|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570727|NCT02037633|Fentanyl|fentanyl|mesh-list
20570728|NCT02037633|Ropivacaine|ropivacaine|mesh-list
20570729|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
20570730|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
20570731|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570732|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570733|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
20570734|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570735|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20570736|NCT02037633|Narcotics|narcotics|mesh-ancestor
20570737|NCT02037633|Analgesics|analgesics|mesh-ancestor
20570738|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20570739|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570740|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
20570741|NCT02037672|Metformin|metformin|mesh-list
20570742|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20570743|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570744|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
20570745|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
20570746|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
20570747|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570748|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570749|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
20570750|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570751|NCT02037724|Iron|iron|mesh-list
20570752|NCT02037724|Trace Elements|trace elements|mesh-ancestor
20570753|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
20570754|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570755|NCT02037737|Abatacept|abatacept|mesh-list
20570756|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20570757|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570758|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570759|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20570760|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
20570761|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570762|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20570763|NCT02037802|Fentanyl|fentanyl|mesh-list
20570764|NCT02037802|Meperidine|meperidine|mesh-list
20570765|NCT02037802|Bupivacaine|bupivacaine|mesh-list
20570766|NCT02037802|Propofol|propofol|mesh-list
20570767|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
20570768|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
20570769|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570770|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018966|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570771|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
20570772|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570773|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20570774|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570775|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
20570776|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20570777|NCT02037802|Narcotics|narcotics|mesh-ancestor
20570778|NCT02037802|Analgesics|analgesics|mesh-ancestor
20570779|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20570780|NCT02037815|Mannitol|mannitol|mesh-list
20570781|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20570782|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20570783|NCT02037815|Diuretics|diuretics|mesh-ancestor
20570784|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
20570785|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570786|NCT02037919|Etonogestrel|etonogestrel|mesh-list
20570787|NCT02037919|Desogestrel|desogestrel|mesh-list
20570788|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20570789|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
20570790|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20570791|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570792|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20570793|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20570794|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20570795|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20570796|NCT02037919|Progestins|progestins|mesh-ancestor
20570797|NCT02037919|Hormones|hormones|mesh-ancestor
20570798|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570799|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
20570800|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20570801|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570802|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
20570803|NCT02037997|Docetaxel|docetaxel|mesh-list
20570804|NCT02037997|Pemetrexed|pemetrexed|mesh-list
20570805|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20570806|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570807|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570808|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570809|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570810|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570811|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570812|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20570813|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20570814|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20570815|NCT02038062|Sevoflurane|sevoflurane|mesh-list
20570816|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20570817|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20570818|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
20570819|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
20570820|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570821|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570822|NCT02038257|Petrolatum|petrolatum|mesh-list
20570823|NCT02038257|Emollients|emollients|mesh-ancestor
20570824|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
20605163|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
20605164|NCT02231294|Pramipexole|pramipexole|mesh-list
20605165|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
20605166|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605167|NCT02231294|Protective Agents|protective agents|mesh-ancestor
20605168|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605169|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20605170|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20605171|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
20605172|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
20605173|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605174|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20605175|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605176|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
20605177|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605178|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605179|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605180|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
20292207|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
20292208|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605181|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
20605182|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20605183|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570825|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20570826|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20570827|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
20570828|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
20570829|NCT02038335|Etonogestrel|etonogestrel|mesh-list
20570830|NCT02038335|Norethindrone|norethindrone|mesh-list
20570831|NCT02038335|Estradiol|estradiol|mesh-list
20570832|NCT02038335|Estrogens|estrogens|mesh-ancestor
20570833|NCT02038335|Hormones|hormones|mesh-ancestor
20570834|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570835|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570836|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20570837|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
20570838|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20570839|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20570840|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20570841|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20570842|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20570843|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20570844|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20570845|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570846|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20570847|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
20570848|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20570849|NCT02038452|Prednisolone|prednisolone|mesh-list
20570850|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
20570851|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20570852|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
20570853|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570854|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
20570855|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
20570856|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570857|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570858|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20018967|NCT02500979|Insulin|insulin|mesh-list
20018968|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20018969|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
20018970|NCT02500979|Pramlintide|pramlintide|mesh-list
20018971|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20018972|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018973|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018974|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
20018975|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20018976|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
20570859|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
20570860|NCT02038452|Hormones|hormones|mesh-ancestor
20570861|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570862|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20570863|NCT02038452|Protective Agents|protective agents|mesh-ancestor
20570864|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20018977|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018978|NCT02501135|Bupivacaine|bupivacaine|mesh-list
20018979|NCT02501135|Ropivacaine|ropivacaine|mesh-list
20018980|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
20018981|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
20570865|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570866|NCT02038491|Anesthetics|anesthetics|mesh-list
20570867|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570868|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570869|NCT02038621|Paclitaxel|paclitaxel|mesh-list
20570870|NCT02038621|Capecitabine|capecitabine|mesh-list
20570871|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
20570872|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20570873|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570874|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570875|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570876|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570877|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570878|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20570879|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
20570880|NCT02038634|Betamethasone|betamethasone|mesh-list
20018982|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570881|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20570882|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
20570883|NCT02038634|Hormones|hormones|mesh-ancestor
20018983|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018984|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
20570884|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570885|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570886|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20570887|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
20570888|NCT02038699|TIC10 compound|tic10 compound|mesh-list
20570889|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570890|NCT02038816|Azacitidine|azacitidine|mesh-list
20570891|NCT02038816|Deferasirox|deferasirox|mesh-list
20570892|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20570893|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
20570894|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570895|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570896|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570897|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20570898|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
20570899|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
20570900|NCT02038842|Vaccines|vaccines|mesh-list
20570901|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
20570902|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570903|NCT02038868|Tamsulosin|tamsulosin|mesh-list
20570904|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20570905|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20570906|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20570907|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
20570908|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570909|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570910|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570911|NCT02038868|Urological Agents|urological agents|mesh-ancestor
20570912|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
20570913|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20570914|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
20570915|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570916|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570917|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20570918|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
20570919|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
20570920|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20570921|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570922|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570923|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570924|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
20570925|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20570926|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
20570927|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570928|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570929|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20570930|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
20570931|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
20570932|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20570933|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
20570934|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20570935|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570936|NCT02039063|Quetmolimab|quetmolimab|mesh-list
20570937|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20570938|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20570939|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
20570940|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570941|NCT02039323|Tenofovir|tenofovir|mesh-list
20570942|NCT02039323|Maraviroc|maraviroc|mesh-list
20570943|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
20570944|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570945|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20570946|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20570947|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570948|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570949|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20570950|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20570951|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20570952|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20570953|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20570954|NCT02039336|Docetaxel|docetaxel|mesh-list
20570955|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20570956|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
20570957|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
20570958|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
20570959|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570960|NCT02039362|Tenofovir|tenofovir|mesh-list
20570961|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
20570962|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20570963|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20570964|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20570965|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570966|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20570967|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20570968|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20570969|NCT02039453|Fentanyl|fentanyl|mesh-list
20570970|NCT02039453|Meperidine|meperidine|mesh-list
20570971|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20570972|NCT02039453|Narcotics|narcotics|mesh-ancestor
20570973|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570974|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570975|NCT02039453|Analgesics|analgesics|mesh-ancestor
20570976|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
20570977|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20570978|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20570979|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20570980|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
20570981|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
20570982|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
20570983|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
20570984|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20570985|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20570986|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468237|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19468238|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
19742684|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570987|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
20570988|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20570989|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20570990|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570991|NCT02039492|Spironolactone|spironolactone|mesh-list
20570992|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20570993|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
20570994|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20570995|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20570996|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20570997|NCT02039492|Diuretics|diuretics|mesh-ancestor
20570998|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
20570999|NCT02039518|Gemcitabine|gemcitabine|mesh-list
20571000|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571001|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
20571002|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571003|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571004|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
20571005|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571006|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571007|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571008|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
20571009|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571010|NCT02039531|Mitogens|mitogens|mesh-list
20571011|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
20571012|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571013|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571014|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20571015|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
20571016|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571017|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
20571018|NCT02039531|Protective Agents|protective agents|mesh-ancestor
20571019|NCT02039661|Lidocaine|lidocaine|mesh-list
20571020|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
20571021|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
20571022|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571023|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571024|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
20571025|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571026|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20571027|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20571028|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20571029|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571030|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571031|NCT02039700|Lesinurad|lesinurad|mesh-list
20571032|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
20571033|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20571034|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
20571035|NCT02039700|Renal Agents|renal agents|mesh-ancestor
20292209|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292210|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
20571036|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20571037|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20571038|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20571039|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20571040|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20571041|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
20571042|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571043|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571044|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571045|NCT02039791|Paclitaxel|paclitaxel|mesh-list
20571046|NCT02039791|Carboplatin|carboplatin|mesh-list
20571047|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
20571048|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20571049|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571050|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571051|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571052|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571053|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571054|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20571055|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20571056|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
20571057|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20571058|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
20571059|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571060|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
20571061|NCT02039804|Protective Agents|protective agents|mesh-ancestor
19468239|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468240|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468241|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468242|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
19468243|NCT03289429|Atorvastatin|atorvastatin|mesh-list
19468244|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19468245|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19468246|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
19468247|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468248|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19468249|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19468250|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571062|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571063|NCT02039869|Omeprazole|omeprazole|mesh-list
20571064|NCT02039869|Sucralfate|sucralfate|mesh-list
20571065|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20571066|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20571067|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20571068|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571069|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571070|NCT02039960|Bupropion|bupropion|mesh-list
20571071|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20571072|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
20571073|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20571074|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20571075|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20571076|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571077|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571078|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
20571079|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571080|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571081|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20571082|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20571083|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605184|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605185|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20605186|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20605187|NCT02231333|Protective Agents|protective agents|mesh-ancestor
20605188|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605189|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
20605190|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20605191|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
20605192|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20605193|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605194|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
20605195|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605196|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605197|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20571084|NCT02039999|Citric Acid|citric acid|mesh-list
20571085|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
20571086|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20571087|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
20571088|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20571089|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
20571090|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
20571091|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571092|NCT02040064|Gefitinib|gefitinib|mesh-list
20571093|NCT02040064|Tremelimumab|tremelimumab|mesh-list
20571094|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571095|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20571096|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571097|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571098|NCT02040142|Mitomycins|mitomycins|mesh-list
20571099|NCT02040142|Mitomycin|mitomycin|mesh-list
20571100|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20571101|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571102|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
20571103|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571104|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20571105|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571106|NCT02040220|Aflibercept|aflibercept|mesh-list
20571107|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20571108|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20571109|NCT02040220|Growth Substances|growth substances|mesh-ancestor
20571110|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571111|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
20571112|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571113|NCT02040246|Metformin|metformin|mesh-list
20571114|NCT02040246|Repaglinide|repaglinide|mesh-list
20571115|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571116|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571117|NCT02040285|Metoclopramide|metoclopramide|mesh-list
20571118|NCT02040285|Bisacodyl|bisacodyl|mesh-list
20571119|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
20571120|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
20571121|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571122|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571123|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20571124|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20571125|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20571126|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
20571127|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571128|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571129|NCT02040285|Cathartics|cathartics|mesh-ancestor
20571130|NCT02040285|Laxatives|laxatives|mesh-ancestor
20571131|NCT02040311|Topiramate|topiramate|mesh-list
20571132|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
20571133|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571134|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571135|NCT02040350|Pralidoxime|pralidoxime|mesh-list
20571136|NCT02040350|Antidotes|antidotes|mesh-ancestor
20571137|NCT02040350|Protective Agents|protective agents|mesh-ancestor
20571138|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571139|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
20571140|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
20571141|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571142|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
20571143|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571144|NCT02040376|Metformin|metformin|mesh-list
20571145|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571146|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571147|NCT02040402|Vaccines|vaccines|mesh-list
20571148|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
20571149|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571150|NCT02040415|Eperisone|eperisone|mesh-list
20571151|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
20571152|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20571153|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571154|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571155|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20571156|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571157|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20571158|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20571159|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571160|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
20571161|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
20292211|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292212|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
20292213|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292214|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292215|NCT05338632|Naloxone|naloxone|mesh-list
20292216|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20571162|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
20571163|NCT02040441|Spironolactone|spironolactone|mesh-list
20571164|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20571165|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
20571166|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571167|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571168|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20018985|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115313|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115314|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
20115315|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571169|NCT02040441|Diuretics|diuretics|mesh-ancestor
20571170|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
20571171|NCT02040454|Paclitaxel|paclitaxel|mesh-list
20571172|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20571173|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571174|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571175|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571176|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571177|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571178|NCT02040571|Insulin|insulin|mesh-list
20115316|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115317|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115318|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20115319|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115320|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115321|NCT00005117|Pravastatin|pravastatin|mesh-list
20115322|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20115323|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20115324|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
20115325|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571179|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571180|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571181|NCT02040597|Beclomethasone|beclomethasone|mesh-list
20571182|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
20571183|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
20571184|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20571185|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
20571186|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571187|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571188|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20571189|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
20571190|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20571191|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20571192|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20571193|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
20571194|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571195|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571196|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20571197|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20571198|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20571199|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
20571200|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571201|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
20571202|NCT02040597|Hormones|hormones|mesh-ancestor
20571203|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571204|NCT02040636|Vaccines|vaccines|mesh-list
20571205|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
20571206|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571207|NCT02040649|Midazolam|midazolam|mesh-list
20571208|NCT02040649|Propofol|propofol|mesh-list
20571209|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20571210|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571211|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571212|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20571213|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
20571214|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
20571215|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20571216|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20571217|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20571218|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20571219|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
20571220|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
20571221|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571222|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571223|NCT02040662|Morphine|morphine|mesh-list
20571224|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20571225|NCT02040662|Narcotics|narcotics|mesh-ancestor
20571226|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571227|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571228|NCT02040662|Analgesics|analgesics|mesh-ancestor
20571229|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
20571230|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571231|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
20571232|NCT02040818|Tigecycline|tigecycline|mesh-list
20571233|NCT02040818|Heparin|heparin|mesh-list
20571234|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20571235|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
20571236|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20571237|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20571238|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571239|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
20571240|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571241|NCT02040818|Expectorants|expectorants|mesh-ancestor
20571242|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
20571243|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20571244|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
20571245|NCT02040818|Protective Agents|protective agents|mesh-ancestor
20571246|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571247|NCT02040818|Antidotes|antidotes|mesh-ancestor
20571248|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20571249|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20571250|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571251|NCT02040831|Vaccines|vaccines|mesh-list
20571252|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
19468251|NCT03289429|Analgesics|analgesics|mesh-ancestor
19468252|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
19468253|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468254|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468255|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
19468256|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468257|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19468258|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
19468259|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19468260|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19468261|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19468262|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
19468263|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19468264|NCT03289390|Acetaminophen|acetaminophen|mesh-list
19468265|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468266|NCT03289390|Analgesics|analgesics|mesh-ancestor
19468267|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
19468268|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468269|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468270|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
19468271|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
19742685|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571253|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571254|NCT02040883|Olanzapine|olanzapine|mesh-list
20571255|NCT02040883|Risperidone|risperidone|mesh-list
20571256|NCT02040883|Aripiprazole|aripiprazole|mesh-list
20571257|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20571258|NCT02040883|Ziprasidone|ziprasidone|mesh-list
20571259|NCT02040883|Tandospirone|tandospirone|mesh-list
20571260|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20571261|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
20571262|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571263|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571264|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571265|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20571266|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20571267|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571268|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20571269|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20571270|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
20571271|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
20571272|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
20571273|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571274|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20571275|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20571276|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20571277|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571278|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
20571279|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
20571280|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20571281|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20571282|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20571283|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20571284|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20571285|NCT02040909|Propofol|propofol|mesh-list
20571286|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20571287|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571288|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571289|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20571290|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
20571291|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
20571292|NCT02040935|Trastuzumab|trastuzumab|mesh-list
20571293|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20571294|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571295|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
20571296|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20571297|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571298|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20571299|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20571300|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571301|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571302|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571303|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20571304|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20571305|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20571306|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
20571307|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571308|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20571309|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20571310|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571311|NCT02041143|Caseins|caseins|mesh-list
20571312|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
20571313|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
20571314|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571315|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20571316|NCT02041234|Liraglutide|liraglutide|mesh-list
20571317|NCT02041234|Empagliflozin|empagliflozin|mesh-list
20571318|NCT02041234|Linagliptin|linagliptin|mesh-list
20571319|NCT02041234|Canagliflozin|canagliflozin|mesh-list
20571320|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20571321|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20571322|NCT02041234|Orlistat|orlistat|mesh-list
20571323|NCT02041234|Incretins|incretins|mesh-list
20571324|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571325|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571326|NCT02041234|Hormones|hormones|mesh-ancestor
20571327|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571328|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
20571329|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571330|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571331|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20571332|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20571333|NCT02041273|Palbociclib|palbociclib|mesh-list
20571334|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571335|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20571336|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571337|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571338|NCT02041338|Paclitaxel|paclitaxel|mesh-list
20571339|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20571340|NCT02041338|Carboplatin|carboplatin|mesh-list
20571341|NCT02041338|Epirubicin|epirubicin|mesh-list
20571342|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20571343|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571344|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571345|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571346|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571347|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571348|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20571349|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20571350|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20571351|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571352|NCT02041351|Docetaxel|docetaxel|mesh-list
20571353|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571354|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571355|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571356|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
20605198|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
19468272|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
19468273|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19468274|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19468275|NCT03289338|Prednisolone|prednisolone|mesh-list
19468276|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
19468277|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19468278|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
19468279|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468280|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
19468281|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
19468282|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468283|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468284|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19468285|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
19468286|NCT03289338|Hormones|hormones|mesh-ancestor
19468287|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468288|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19468289|NCT03289338|Protective Agents|protective agents|mesh-ancestor
19468290|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19468291|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468292|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19468293|NCT03289260|Imiquimod|imiquimod|mesh-list
19468294|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19468295|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
19468296|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468297|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468298|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
19468299|NCT03289182|Rituximab|rituximab|mesh-list
19468300|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468301|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468302|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
19468303|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468304|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468305|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19468306|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19468307|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468308|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571357|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571358|NCT02041455|Amitriptyline|amitriptyline|mesh-list
20571359|NCT02041455|Melatonin|melatonin|mesh-list
20571360|NCT02041455|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20571361|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
20571362|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571363|NCT02041455|Protective Agents|protective agents|mesh-ancestor
20571364|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571365|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571366|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20571367|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
20571368|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20571369|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20571370|NCT02041455|Analgesics|analgesics|mesh-ancestor
20571371|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
20571372|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571373|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20571374|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20571375|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571376|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
20571377|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571378|NCT02041455|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20571379|NCT02041455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20571380|NCT02041481|Leucovorin|leucovorin|mesh-list
20571381|NCT02041481|Fluorouracil|fluorouracil|mesh-list
20571382|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
20571383|NCT02041481|Calcium|calcium|mesh-list
20571384|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
20571385|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20571386|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571387|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
20571388|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571389|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571390|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571391|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571392|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
20571393|NCT02041481|Antidotes|antidotes|mesh-ancestor
20571394|NCT02041481|Protective Agents|protective agents|mesh-ancestor
20571395|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
20571396|NCT02041481|Vitamins|vitamins|mesh-ancestor
20571397|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
20571398|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20571399|NCT02041546|Poractant alfa|poractant alfa|mesh-list
20571400|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
20571401|NCT02041650|Ticagrelor|ticagrelor|mesh-list
20571402|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20571403|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20571404|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20571405|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20571406|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
20571407|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571408|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571409|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605199|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20605200|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605201|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
20605202|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605203|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605204|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605205|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605206|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20605207|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605208|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
20605209|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605210|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605211|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605212|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605213|NCT02231385|Acetic Acid|acetic acid|mesh-list
20605214|NCT02231385|Retinol acetate|retinol acetate|mesh-list
20605215|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20605216|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605217|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20605218|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
20605219|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605220|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20605221|NCT02231385|Protective Agents|protective agents|mesh-ancestor
20605222|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605223|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20605224|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605225|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
20605226|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605227|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605228|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20018986|NCT02501161|Insulin|insulin|mesh-list
20018987|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20018988|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
20018989|NCT02501161|Liraglutide|liraglutide|mesh-list
20018990|NCT02501161|Xultophy|xultophy|mesh-list
20018991|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018992|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018993|NCT02501161|Incretins|incretins|mesh-ancestor
20018994|NCT02501161|Hormones|hormones|mesh-ancestor
20018995|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018996|NCT02501265|Nicotine|nicotine|mesh-list
20018997|NCT02501265|Varenicline|varenicline|mesh-list
20018998|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20018999|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
20019000|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292217|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292218|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
20019001|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019002|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20571410|NCT02041767|Ertapenem|ertapenem|mesh-list
20571411|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20571412|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571413|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
20571414|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20571415|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571416|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20571417|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
20571418|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571419|NCT02042170|Hormones|hormones|mesh-list
20571420|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571421|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571422|NCT02042196|Cetrorelix|cetrorelix|mesh-list
20571423|NCT02042196|Estradiol|estradiol|mesh-list
20571424|NCT02042196|Estrogens|estrogens|mesh-ancestor
20571425|NCT02042196|Hormones|hormones|mesh-ancestor
20571426|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571427|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571428|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019003|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20019004|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
20019005|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019006|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019007|NCT02501473|Rituximab|rituximab|mesh-list
20019008|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
20019009|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20019010|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019011|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
20019012|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019013|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019014|NCT02501629|Reslizumab|reslizumab|mesh-list
20019015|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20019016|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
20019017|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
20019018|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20019019|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20019020|NCT02501902|Paclitaxel|paclitaxel|mesh-list
20019021|NCT02501902|Palbociclib|palbociclib|mesh-list
20019022|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20019023|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019024|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
20019025|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
20019026|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
20019027|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019028|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20019029|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019030|NCT02501928|Fesoterodine|fesoterodine|mesh-list
20019031|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20019032|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20019033|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
20019034|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019035|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019036|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019037|NCT02501928|Urological Agents|urological agents|mesh-ancestor
20019038|NCT02502149|Factor VIII|factor viii|mesh-list
20019039|NCT02502149|Coagulants|coagulants|mesh-ancestor
20019040|NCT02502487|Ropivacaine|ropivacaine|mesh-list
20019041|NCT02502487|Tetracaine|tetracaine|mesh-list
20019042|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
20019043|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
20019044|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019045|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019046|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
20019047|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019048|NCT02502734|Fluticasone|fluticasone|mesh-list
20571429|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20571430|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
20571431|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
20571432|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
20571433|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571434|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
20571435|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571436|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019049|NCT02502734|Xhance|xhance|mesh-list
20019050|NCT02502734|Albuterol|albuterol|mesh-list
20019051|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019052|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20571437|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20571438|NCT02042326|Sirolimus|sirolimus|mesh-list
20019053|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
20019054|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019055|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019056|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20571439|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20571440|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571441|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20571442|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571443|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
20571444|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571445|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
20571446|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571447|NCT02042391|Cytarabine|cytarabine|mesh-list
20571448|NCT02042391|Prednisone|prednisone|mesh-list
20571449|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
20571450|NCT02042391|Rituximab|rituximab|mesh-list
20571451|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
20571452|NCT02042391|Doxorubicin|doxorubicin|mesh-list
20571453|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20571454|NCT02042391|Vincristine|vincristine|mesh-list
20571455|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571456|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
20571457|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571458|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20571459|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20571460|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
20571461|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571462|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571463|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20571464|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20571465|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571466|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
20571467|NCT02042391|Hormones|hormones|mesh-ancestor
20571468|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571469|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20571470|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571471|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
20019057|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
20019058|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
20571472|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
20571473|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571474|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20571475|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20571476|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20571477|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571478|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20571479|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571480|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571481|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571482|NCT02042482|Ubiquinone|ubiquinone|mesh-list
20571483|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
20571484|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
20571485|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571486|NCT02042482|Vitamins|vitamins|mesh-ancestor
20571487|NCT02042495|Metformin|metformin|mesh-list
20571488|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571489|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571490|NCT02042573|Sertraline|sertraline|mesh-list
20571491|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
20571492|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20571493|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20571494|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20571495|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571496|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571497|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571498|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
20571499|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571500|NCT02042599|Sevoflurane|sevoflurane|mesh-list
20571501|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20571502|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20571503|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
20571504|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
20571505|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571506|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468309|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19468310|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19468311|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468312|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
20019059|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20571507|NCT02042612|Sevoflurane|sevoflurane|mesh-list
20571508|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20571509|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20571510|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
20571511|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
20571512|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571513|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571514|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20571515|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20571516|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571517|NCT02042664|Metformin|metformin|mesh-list
20571518|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571519|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571520|NCT02042690|Dexamethasone|dexamethasone|mesh-list
20571521|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
20571522|NCT02042690|Methotrexate|methotrexate|mesh-list
20571523|NCT02042690|Epirubicin|epirubicin|mesh-list
20571524|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
20571525|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571526|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
20571527|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571528|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20571529|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20571530|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
20571531|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571532|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571533|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20571534|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571535|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
20571536|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
20571537|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571538|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20571539|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
20571540|NCT02042690|Hormones|hormones|mesh-ancestor
20571541|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571542|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20571543|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571544|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20571545|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
20571546|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20571547|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571548|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
20571549|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
20571550|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20571551|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20571552|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20571553|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20571554|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20571555|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
20571556|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
20571557|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571558|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
20571559|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571560|NCT02042742|Protective Agents|protective agents|mesh-ancestor
20571561|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571562|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20571563|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20571564|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
20571565|NCT02042989|Vorinostat|vorinostat|mesh-list
20571566|NCT02042989|Ixazomib|ixazomib|mesh-list
20571567|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571568|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20571569|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571570|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571571|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
20571572|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20571573|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20571574|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571575|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20571576|NCT02043054|Liraglutide|liraglutide|mesh-list
20571577|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571578|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571579|NCT02043054|Incretins|incretins|mesh-ancestor
20571580|NCT02043054|Hormones|hormones|mesh-ancestor
20571581|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571582|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20571583|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
20571584|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571585|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571586|NCT02043171|Vitamin D|vitamin d|mesh-list
20571587|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
20571588|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
20571589|NCT02043171|Vitamins|vitamins|mesh-list
20571590|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
20571591|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571592|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20571593|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20571594|NCT02043223|Vitamins|vitamins|mesh-list
20571595|NCT02043223|Vitamin A|vitamin a|mesh-list
20571596|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
20571597|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
20571598|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571599|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
20571600|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571601|NCT02043223|Protective Agents|protective agents|mesh-ancestor
20571602|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20571603|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571604|NCT02043288|Gemcitabine|gemcitabine|mesh-list
20571605|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571606|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
20571607|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571608|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571609|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
20571610|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571611|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571612|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571613|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
20571614|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605229|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
20292219|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292220|NCT05338619|Lazertinib|lazertinib|mesh-list
20605230|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20605231|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605232|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
20605233|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605234|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605235|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605236|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605237|NCT02231606|Methamphetamine|methamphetamine|mesh-list
20605238|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20605239|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605240|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
20605241|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
20605242|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605243|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
20605244|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605245|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605246|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
20605247|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20605248|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20605249|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605250|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20605251|NCT02231632|Vaccines|vaccines|mesh-list
20605252|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
20605253|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571615|NCT02043314|Isoniazid|isoniazid|mesh-list
20571616|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
20571617|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20571618|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571619|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20571620|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20571621|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
20571622|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571623|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20571624|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
20571625|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
20571626|NCT02043457|Hormones|hormones|mesh-list
20571627|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571628|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571629|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
20571630|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20571631|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571632|NCT02043717|Vitamin D|vitamin d|mesh-list
20571633|NCT02043717|Vitamins|vitamins|mesh-ancestor
20571634|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
20571635|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571636|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20571637|NCT02043730|Gemcitabine|gemcitabine|mesh-list
20571638|NCT02043730|Paclitaxel|paclitaxel|mesh-list
20571639|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20571640|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571641|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571642|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571643|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571644|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571645|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571646|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
20571647|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
20571648|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571649|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571650|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571651|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
20019060|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
20571652|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571653|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
20571654|NCT02043756|Analgesics|analgesics|mesh-ancestor
20571655|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
20571656|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571657|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571658|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571659|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20571660|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20019061|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019062|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20019063|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20019064|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20019065|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
20292221|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20571661|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571662|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571663|NCT02043821|Capecitabine|capecitabine|mesh-list
20571664|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571665|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
20571666|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571667|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571668|NCT02043886|Acarbose|acarbose|mesh-list
20571669|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20571670|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571671|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571672|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571673|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571674|NCT02043912|Haloperidol|haloperidol|mesh-list
20571675|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
20571676|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
20571677|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
20571678|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571679|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571680|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20571681|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20571682|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20571683|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571684|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20571685|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20292222|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571686|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
20571687|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571688|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571689|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20571690|NCT02043977|Propofol|propofol|mesh-list
20571691|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20571692|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571693|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571694|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20571695|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
20571696|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
20571697|NCT02044120|Irinotecan|irinotecan|mesh-list
20571698|NCT02044120|Temozolomide|temozolomide|mesh-list
20571699|NCT02044120|Niraparib|niraparib|mesh-list
20571700|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20571701|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20571702|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571703|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571704|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571705|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20571706|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
20571707|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20571708|NCT02044133|Vitamin D|vitamin d|mesh-list
20571709|NCT02044133|Vitamins|vitamins|mesh-ancestor
20571710|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
20571711|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571712|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20571713|NCT02044146|Clopidogrel|clopidogrel|mesh-list
20571714|NCT02044146|Ticagrelor|ticagrelor|mesh-list
20571715|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20571716|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20571717|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20571718|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20571719|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20571720|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
20571721|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571722|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605254|NCT02231658|Liraglutide|liraglutide|mesh-list
20605255|NCT02231658|Lixisenatide|lixisenatide|mesh-list
20605256|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20605257|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605258|NCT02231658|Incretins|incretins|mesh-ancestor
20605259|NCT02231658|Hormones|hormones|mesh-ancestor
20605260|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605261|NCT02231762|Temozolomide|temozolomide|mesh-list
20605262|NCT02231762|Lanreotide|lanreotide|mesh-list
20605263|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20605264|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
20605265|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605266|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605267|NCT02231788|Amlodipine|amlodipine|mesh-list
20605268|NCT02231788|Telmisartan|telmisartan|mesh-list
20605269|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605270|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20605271|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571723|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571724|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
20571725|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20571726|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571727|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571728|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20571729|NCT02044224|Analgesics|analgesics|mesh-ancestor
20571730|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
20571731|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571732|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20292223|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292224|NCT05338606|Bimatoprost|bimatoprost|mesh-list
20292225|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20292226|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
20292227|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20571733|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20571734|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20571735|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
20571736|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571737|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571738|NCT02044250|Aspirin|aspirin|mesh-list
20571739|NCT02044250|Clopidogrel|clopidogrel|mesh-list
20571740|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20571741|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20571742|NCT02044250|Analgesics|analgesics|mesh-ancestor
20571743|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
20571744|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571745|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571746|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571747|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20571748|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20571749|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20571750|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571751|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20571752|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20571753|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571754|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
20571755|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20571756|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20571757|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20571758|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
20571759|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571760|NCT02044354|Docetaxel|docetaxel|mesh-list
20571761|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571762|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571763|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571764|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571765|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571766|NCT02044497|Oxycodone|oxycodone|mesh-list
20571767|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20571768|NCT02044497|Narcotics|narcotics|mesh-ancestor
20571769|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571770|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571771|NCT02044497|Analgesics|analgesics|mesh-ancestor
20571772|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
20571773|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571774|NCT02044549|Oxytocin|oxytocin|mesh-list
20571775|NCT02044549|Carbetocin|carbetocin|mesh-list
20571776|NCT02044549|Methylergonovine|methylergonovine|mesh-list
20571777|NCT02044549|Syntometrine|syntometrine|mesh-list
20571778|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
20571779|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20571780|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571781|NCT02044601|Paclitaxel|paclitaxel|mesh-list
20571782|NCT02044601|Carboplatin|carboplatin|mesh-list
20571783|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20571784|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20571785|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571786|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
20571787|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
20571788|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
20571789|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571790|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20571791|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571792|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20571793|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20571794|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
20571795|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571796|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20571797|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571798|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571799|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571800|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
20571801|NCT02044653|Hematinics|hematinics|mesh-ancestor
20571802|NCT02044809|Cannabidiol|cannabidiol|mesh-list
20571803|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
20571804|NCT02044952|Mesalamine|mesalamine|mesh-list
20571805|NCT02044952|Triptolide|triptolide|mesh-list
20571806|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20571807|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20571808|NCT02044952|Analgesics|analgesics|mesh-ancestor
20571809|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
20571810|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571811|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571812|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571813|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20571814|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571815|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20571816|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20571817|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
20571818|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20571819|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571820|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
20571821|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20571822|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
20571823|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571824|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20571825|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20571826|NCT02044965|Trimethoprim|trimethoprim|mesh-list
20571827|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
20571828|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571829|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20571830|NCT02044965|Renal Agents|renal agents|mesh-ancestor
20571831|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
20571832|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20571833|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20571834|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19742686|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742687|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742688|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742689|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
19742690|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20292228|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742691|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742692|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742693|NCT04484428|Menthol|menthol|mesh-list
20571835|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571836|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571837|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20571838|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20571839|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20571840|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
20571841|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20571842|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571843|NCT02045017|Dexamethasone|dexamethasone|mesh-list
20571844|NCT02045017|Pomalidomide|pomalidomide|mesh-list
20571845|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20571846|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
20571847|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
20571848|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571849|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571850|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20571851|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
20292229|NCT05338502|Omeprazole|omeprazole|mesh-list
20571852|NCT02045017|Hormones|hormones|mesh-ancestor
20571853|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571854|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20571855|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571856|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
20571857|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20571858|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20571859|NCT02045017|Growth Substances|growth substances|mesh-ancestor
20571860|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
20571861|NCT02045030|Aflibercept|aflibercept|mesh-list
20571862|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20571863|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20571864|NCT02045030|Growth Substances|growth substances|mesh-ancestor
20571865|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571866|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
20571867|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571868|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
20571869|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20571870|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
20571871|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571872|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20571873|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20571874|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20571875|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605272|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605273|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605274|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605275|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
20605276|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20605277|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20605278|NCT02231879|Plerixafor|plerixafor|mesh-list
20605279|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20605280|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20605281|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
20605282|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607960|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20607961|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20607962|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
20607963|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571876|NCT02045069|Ivermectin|ivermectin|mesh-list
20571877|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20571878|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571879|NCT02045290|Metformin|metformin|mesh-list
20571880|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20571881|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571882|NCT02045368|Methotrexate|methotrexate|mesh-list
20571883|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20571884|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
20571885|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20571886|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571887|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571888|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
20571889|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571890|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571891|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
20571892|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468313|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468314|NCT03289026|Aripiprazole|aripiprazole|mesh-list
19468315|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
19468316|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19468317|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19468318|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19468319|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468320|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468321|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
19468322|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
19468323|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468324|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571893|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19742694|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
20571894|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571895|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
20571896|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20571897|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20571898|NCT02045589|Gemcitabine|gemcitabine|mesh-list
20571899|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20571900|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571901|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
20571902|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571903|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571904|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
20571905|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571906|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571907|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571908|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
20571909|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571910|NCT02045602|Gemcitabine|gemcitabine|mesh-list
20571911|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20571912|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20571913|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
20571914|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571915|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20571916|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
20571917|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571918|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571919|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20571920|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
20571921|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571922|NCT02045667|Mexiletine|mexiletine|mesh-list
20571923|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20571924|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20571925|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20571926|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571927|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571928|NCT02045693|Buprenorphine|buprenorphine|mesh-list
20571929|NCT02045693|Methadone|methadone|mesh-list
20571930|NCT02045693|Naloxone|naloxone|mesh-list
20571931|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20571932|NCT02045693|Narcotics|narcotics|mesh-ancestor
20571933|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571934|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571935|NCT02045693|Analgesics|analgesics|mesh-ancestor
20571936|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
20571937|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571938|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20571939|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
20571940|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
20571941|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
20571942|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
20571943|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
20571944|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20571945|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571946|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
20571947|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571948|NCT02045849|Itraconazole|itraconazole|mesh-list
20571949|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
20571950|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20571951|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20571952|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20571953|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571954|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571955|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20571956|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
20571957|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571958|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571959|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20571960|NCT02045914|Calcium|calcium|mesh-list
20571961|NCT02045914|Ionophores|ionophores|mesh-list
20571962|NCT02045914|Ionomycin|ionomycin|mesh-list
20571963|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
20571964|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20571965|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571966|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20571967|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571968|NCT02045940|GSK2881078|gsk2881078|mesh-list
20571969|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
20571970|NCT02045940|Hormones|hormones|mesh-ancestor
20571971|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20571972|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571973|NCT02045953|Albuterol|albuterol|mesh-list
20571974|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20571975|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
20571976|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20571977|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571978|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20571979|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
20571980|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
20571981|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20571982|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20571983|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20571984|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20571985|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
20571986|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571987|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571988|NCT02045992|Caffeine|caffeine|mesh-list
20571989|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19468325|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20571990|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20571991|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20571992|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20571993|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20571994|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20571995|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20571996|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
20571997|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20571998|NCT02046044|Digoxin|digoxin|mesh-list
20571999|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20572000|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20572001|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572002|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572003|NCT02046044|Protective Agents|protective agents|mesh-ancestor
20572004|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572005|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
20572006|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20572007|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572008|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
20572009|NCT02046187|Temozolomide|temozolomide|mesh-list
20572010|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20572011|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
20572012|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572013|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572014|NCT02046304|Gemcitabine|gemcitabine|mesh-list
20572015|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20572016|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
20572017|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572018|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572019|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
20572020|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572021|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572022|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572023|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
20572024|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572025|NCT02046421|Gemcitabine|gemcitabine|mesh-list
20572026|NCT02046421|Carboplatin|carboplatin|mesh-list
20572027|NCT02046421|Mifepristone|mifepristone|mesh-list
20572028|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572029|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20572030|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
20572031|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572032|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
20572033|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572034|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572035|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572036|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
20572037|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572038|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20572039|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
20572040|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20572041|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20572042|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20572043|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20572044|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
20572045|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20572046|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20572047|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
20572048|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572049|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
20572050|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20572051|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20572052|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
20572053|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20572054|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20572055|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20572056|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20572057|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
20572058|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572059|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572060|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572061|NCT02046460|Aspirin|aspirin|mesh-list
20572062|NCT02046460|Vitamin K|vitamin k|mesh-list
20572063|NCT02046460|Warfarin|warfarin|mesh-list
20572064|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
20019066|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019067|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019068|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
20019069|NCT02502864|Docetaxel|docetaxel|mesh-list
20019070|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019071|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
20572065|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
20572066|NCT02046460|Vitamins|vitamins|mesh-ancestor
20572067|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
20572068|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572069|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
20572070|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20572071|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572072|NCT02046460|Analgesics|analgesics|mesh-ancestor
20572073|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
20572074|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572075|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572076|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572077|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20572078|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20572079|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572080|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20572081|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20572082|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019072|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019073|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019074|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20019075|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
20019076|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572083|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
20605283|NCT02231905|Pramipexole|pramipexole|mesh-list
20019077|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572084|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20572085|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
20572086|NCT02046460|Coagulants|coagulants|mesh-ancestor
20572087|NCT02046486|Ticagrelor|ticagrelor|mesh-list
20572088|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20572089|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20572090|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20572091|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20572092|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
20572093|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572094|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572095|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572096|NCT02046499|Oxytocin|oxytocin|mesh-list
20572097|NCT02046499|Ergonovine|ergonovine|mesh-list
20572098|NCT02046499|Syntometrine|syntometrine|mesh-list
20572099|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
20572100|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20572101|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572102|NCT02046538|Leucovorin|leucovorin|mesh-list
20572103|NCT02046538|Fluorouracil|fluorouracil|mesh-list
20572104|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
20572105|NCT02046538|Irinotecan|irinotecan|mesh-list
20572106|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
20572107|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292230|NCT05338502|Ranitidine|ranitidine|mesh-list
20292231|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20292232|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20019078|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20292233|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20292234|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20292235|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292236|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292237|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20572108|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20019079|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
20019080|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
20019081|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
20019082|NCT02503085|Ibuprofen|ibuprofen|mesh-list
20019083|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20019084|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019085|NCT02503085|Analgesics|analgesics|mesh-ancestor
20019086|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
20019087|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019088|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292238|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
20572109|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572110|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572111|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
20572112|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572113|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20572114|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20572115|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572116|NCT02046538|Antidotes|antidotes|mesh-ancestor
20572117|NCT02046538|Protective Agents|protective agents|mesh-ancestor
20572118|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
20572119|NCT02046538|Vitamins|vitamins|mesh-ancestor
20572120|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
20572121|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20572122|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20572123|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20572124|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20572125|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572126|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
20572127|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572128|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572129|NCT02046577|Vitamin D|vitamin d|mesh-list
20572130|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
20572131|NCT02046577|Vitamins|vitamins|mesh-ancestor
20572132|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
20572133|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572134|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20572135|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20572136|NCT02046590|Propofol|propofol|mesh-list
20572137|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
20572138|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572139|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572140|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20572141|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20572142|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
20572143|NCT02046629|Teriflunomide|teriflunomide|mesh-list
20572144|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
20572145|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20572146|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572147|NCT02046629|Analgesics|analgesics|mesh-ancestor
20572148|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
20572149|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572150|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572151|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572152|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572153|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572154|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
20572155|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20572156|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20572157|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
20572158|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572159|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20572160|NCT02046668|Spironolactone|spironolactone|mesh-list
20572161|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19742695|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
19742696|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
20572162|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
20572163|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572164|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572165|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20572166|NCT02046668|Diuretics|diuretics|mesh-ancestor
20572167|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
20572168|NCT02046694|Allopurinol|allopurinol|mesh-list
20572169|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
20572170|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572171|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572172|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
20572173|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572174|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20572175|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
20572176|NCT02046694|Protective Agents|protective agents|mesh-ancestor
20572177|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572178|NCT02046720|Propofol|propofol|mesh-list
20572179|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20572180|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572181|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572182|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20572183|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
20572184|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
20572185|NCT02046733|Nivolumab|nivolumab|mesh-list
20572186|NCT02046733|Ipilimumab|ipilimumab|mesh-list
20572187|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20572188|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572189|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20572190|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572191|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20572192|NCT02046850|Rifampin|rifampin|mesh-list
20572193|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20572194|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
20572195|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20572196|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572197|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
20572198|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20572199|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572200|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572201|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20572202|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20572203|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20572204|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20572205|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20572206|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20572207|NCT02046915|Dexamethasone|dexamethasone|mesh-list
20572208|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
20572209|NCT02046915|Pomalidomide|pomalidomide|mesh-list
20572210|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572211|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
20572212|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572213|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572214|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20572215|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
20605284|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
20605285|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605286|NCT02231905|Protective Agents|protective agents|mesh-ancestor
20605287|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605288|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20605289|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20605290|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
20605291|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
20572216|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572217|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572218|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20572219|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572220|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
20572221|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
20572222|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572223|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20572224|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
20572225|NCT02046915|Hormones|hormones|mesh-ancestor
20572226|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572227|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20572228|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20572229|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20572230|NCT02046915|Growth Substances|growth substances|mesh-ancestor
20572231|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
20605292|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605293|NCT02231931|Metformin|metformin|mesh-list
20605294|NCT02231931|Digoxin|digoxin|mesh-list
20605295|NCT02231931|Furosemide|furosemide|mesh-list
20605296|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20605297|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20605298|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605299|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20605300|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605301|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
20605302|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605303|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605304|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20605305|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605306|NCT02231931|Diuretics|diuretics|mesh-ancestor
20605307|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
20605308|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20605309|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605310|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20605311|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20605312|NCT02231931|Protective Agents|protective agents|mesh-ancestor
20605313|NCT02231957|Vaccines|vaccines|mesh-list
20605314|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
20605315|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605316|NCT02232035|Diazepam|diazepam|mesh-list
20605317|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20605318|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
20605319|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
20605320|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
20605321|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605322|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605323|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605324|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20572232|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
20572233|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20572234|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
20572235|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20572236|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
20572237|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572238|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572239|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
20572240|NCT02047019|Candesartan|candesartan|mesh-list
20572241|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
20572242|NCT02047019|Nifedipine|nifedipine|mesh-list
20572243|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20572244|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20572245|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20572246|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572247|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20572248|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20572249|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20572250|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572251|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
20572252|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
20572253|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20572254|NCT02047136|Histamine|histamine|mesh-list
20572255|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
20572256|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
20572257|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572258|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572259|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572260|NCT02047149|Zileuton|zileuton|mesh-list
20572261|NCT02047149|Dasatinib|dasatinib|mesh-list
20572262|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
20572263|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572264|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20572265|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572266|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572267|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20572268|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572269|NCT02047149|Analgesics|analgesics|mesh-ancestor
20572270|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
20572271|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572272|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572273|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572274|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572275|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20572276|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20572277|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
20572278|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572279|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
20572280|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20572281|NCT02047162|Bismuth|bismuth|mesh-list
20572282|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20572283|NCT02047162|Antacids|antacids|mesh-ancestor
20572284|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572285|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20572286|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
20572287|NCT02047175|Niacin|niacin|mesh-list
20572288|NCT02047175|Amlodipine|amlodipine|mesh-list
20572289|NCT02047175|Telmisartan|telmisartan|mesh-list
20572290|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20572291|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20572292|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20572293|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20572294|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572295|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20572296|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572297|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
20572298|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20572299|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20572300|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
20572301|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20572302|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20572303|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572304|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20572305|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20572306|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
20572307|NCT02047175|Vitamins|vitamins|mesh-ancestor
20572308|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
20572309|NCT02047201|Docetaxel|docetaxel|mesh-list
20572310|NCT02047201|Fluorouracil|fluorouracil|mesh-list
20572311|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572312|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
20572313|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
20572314|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
20572315|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572316|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
20572317|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20572318|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572319|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
20572320|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572321|NCT02047292|Tacrine|tacrine|mesh-list
20572322|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20572323|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572324|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572325|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
20572326|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572327|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572328|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20572329|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
20572330|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572331|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
19468326|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19468327|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
19468328|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19468329|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19468330|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19468331|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19468332|NCT03288896|Ethanol|ethanol|mesh-list
19468333|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20292239|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
20292240|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292241|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292242|NCT05338489|Itraconazole|itraconazole|mesh-list
20292243|NCT05338489|Rifampin|rifampin|mesh-list
20572332|NCT02047422|Metolazone|metolazone|mesh-list
19468334|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468335|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468336|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468337|NCT03288870|Docetaxel|docetaxel|mesh-list
20572333|NCT02047422|Furosemide|furosemide|mesh-list
20572334|NCT02047422|Spironolactone|spironolactone|mesh-list
20572335|NCT02047422|Diuretics|diuretics|mesh-ancestor
20572336|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
20572337|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572338|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20572339|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20572340|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572341|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20572342|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
20572343|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572344|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20572345|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20572346|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20572347|NCT02047474|Leucovorin|leucovorin|mesh-list
20292244|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
20572348|NCT02047474|Fluorouracil|fluorouracil|mesh-list
20572349|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
20572350|NCT02047474|Irinotecan|irinotecan|mesh-list
20572351|NCT02047474|Calcium|calcium|mesh-list
20572352|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
20572353|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20572354|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572355|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
20572356|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572357|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20572358|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572359|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292245|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572360|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
20572361|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20572362|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20572363|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572364|NCT02047474|Antidotes|antidotes|mesh-ancestor
20572365|NCT02047474|Protective Agents|protective agents|mesh-ancestor
20572366|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
20572367|NCT02047474|Vitamins|vitamins|mesh-ancestor
20572368|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
20572369|NCT02047539|Aspirin|aspirin|mesh-list
20292246|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20572370|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20572371|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572372|NCT02047539|Analgesics|analgesics|mesh-ancestor
20572373|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
20572374|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572375|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572376|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572377|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572378|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20572379|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20572380|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572381|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20572382|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20572383|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572384|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
20572385|NCT02047552|Iron|iron|mesh-list
20572386|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20572387|NCT02047552|Oxandrolone|oxandrolone|mesh-list
20572388|NCT02047552|Trace Elements|trace elements|mesh-ancestor
20572389|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
20572390|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572391|NCT02047552|Hematinics|hematinics|mesh-ancestor
20572392|NCT02047552|Androgens|androgens|mesh-ancestor
20572393|NCT02047552|Hormones|hormones|mesh-ancestor
20572394|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572395|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
20572396|NCT02047565|Edoxaban|edoxaban|mesh-list
20572397|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19468338|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468339|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468340|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468341|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468342|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468343|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
19468344|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
19468345|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468346|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19468347|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566727|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19566728|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19566729|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
19566730|NCT05213104|Flecainide|flecainide|mesh-list
19566731|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19566732|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19566733|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19566734|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566735|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566736|NCT05209711|Lidocaine|lidocaine|mesh-list
19566737|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566738|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
19566739|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566740|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566741|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
19566742|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566743|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19566744|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19566745|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20572398|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
20572399|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20572400|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
20572401|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572402|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572403|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
20572404|NCT02047578|Busulfan|busulfan|mesh-list
20572405|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
20572406|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572407|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572408|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
20572409|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572410|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20572411|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572412|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20572413|NCT02047630|Latanoprost|latanoprost|mesh-list
20572414|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20572415|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20572416|NCT02047773|Meropenem|meropenem|mesh-list
20572417|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20572418|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572419|NCT02047799|Calcitriol|calcitriol|mesh-list
20572420|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20572421|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572422|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20572423|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20572424|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572425|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20572426|NCT02047799|Vitamins|vitamins|mesh-ancestor
20572427|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
20572428|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20572429|NCT02047838|Hormones|hormones|mesh-list
20572430|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20572431|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572432|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572433|NCT02048007|Azithromycin|azithromycin|mesh-list
20572434|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20572435|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572436|NCT02048020|Paclitaxel|paclitaxel|mesh-list
20572437|NCT02048020|Carboplatin|carboplatin|mesh-list
20572438|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20572439|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572440|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
20572441|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
20572442|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
20572443|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572444|NCT02048085|Clopidogrel|clopidogrel|mesh-list
20572445|NCT02048085|Ticagrelor|ticagrelor|mesh-list
20572446|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20572447|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19468348|NCT03288675|Serotonin|serotonin|mesh-list
20572448|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20572449|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20572450|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
20572451|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572452|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572453|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572454|NCT02048098|Misoprostol|misoprostol|mesh-list
20572455|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20572456|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
19742697|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20019089|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019090|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572457|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20572458|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572459|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20572460|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20572461|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
20572462|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
20572463|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20572464|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572465|NCT02048215|Ephedrine|ephedrine|mesh-list
20572466|NCT02048215|Caffeine|caffeine|mesh-list
20572467|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20572468|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572469|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20572470|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572471|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572472|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20572473|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20572474|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
20572475|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572476|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
20572477|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
20572478|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572479|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20572480|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
20572481|NCT02048228|Clopidogrel|clopidogrel|mesh-list
20572482|NCT02048228|Ticagrelor|ticagrelor|mesh-list
20572483|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20572484|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20572485|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20572486|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20572487|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
20572488|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572489|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572490|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572491|NCT02048293|Remifentanil|remifentanil|mesh-list
20572492|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20572493|NCT02048293|Narcotics|narcotics|mesh-ancestor
20572494|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572495|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572496|NCT02048293|Analgesics|analgesics|mesh-ancestor
20572497|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
20572498|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572499|NCT02048319|Ethanol|ethanol|mesh-list
20572500|NCT02048319|Pasireotide|pasireotide|mesh-list
20572501|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20572502|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572503|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572504|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572505|NCT02048319|Hormones|hormones|mesh-ancestor
20572506|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572507|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20572508|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
20572509|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20572510|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20572511|NCT02048358|Prednisolone|prednisolone|mesh-list
20572512|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
20572513|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20572514|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
20572515|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572516|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
20572517|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
20572518|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572519|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572520|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20572521|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
20572522|NCT02048358|Hormones|hormones|mesh-ancestor
20572523|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572524|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20572525|NCT02048358|Protective Agents|protective agents|mesh-ancestor
20572526|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20572527|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572528|NCT02048384|Metformin|metformin|mesh-list
20572529|NCT02048384|Sirolimus|sirolimus|mesh-list
20572530|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20572531|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572532|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20572533|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572534|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20572535|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572536|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
20572537|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572538|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
20572539|NCT02048423|Ketamine|ketamine|mesh-list
20572540|NCT02048423|Analgesics|analgesics|mesh-ancestor
20572541|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
20572542|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572543|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572544|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20572545|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20572546|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
20572547|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
20572548|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572549|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20572550|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20572551|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572552|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572553|NCT02048475|Desflurane|desflurane|mesh-list
20572554|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20572555|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
20572556|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
20572557|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572558|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572559|NCT02048488|Belizatinib|belizatinib|mesh-list
20572560|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20572561|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572562|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572563|NCT02048540|Bevacizumab|bevacizumab|mesh-list
20572564|NCT02048540|Docetaxel|docetaxel|mesh-list
20572565|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
20572566|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20572567|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572568|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20572569|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20572570|NCT02048540|Growth Substances|growth substances|mesh-ancestor
20572571|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572572|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
20572573|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
20572574|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
20572575|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
20572576|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605325|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572577|NCT02048644|Beclomethasone|beclomethasone|mesh-list
20572578|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
20572579|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20572580|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
20572581|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572582|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572583|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20572584|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
20572585|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20572586|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20572587|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20572588|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
20572589|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572590|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572591|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572592|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
20572593|NCT02048644|Hormones|hormones|mesh-ancestor
20572594|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572595|NCT02048683|Sevoflurane|sevoflurane|mesh-list
20572596|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20572597|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20572598|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
20572599|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
20572600|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572601|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572602|NCT02048761|Metformin|metformin|mesh-list
20572603|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20572604|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572605|NCT02048800|Treosulfan|treosulfan|mesh-list
20572606|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20572607|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
20572608|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572609|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572610|NCT02048852|Menthol|menthol|mesh-list
20572611|NCT02048852|Nicotine|nicotine|mesh-list
20572612|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20572613|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
20572614|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572615|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572616|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20572617|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20572618|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
20572619|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572620|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572621|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
20572622|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
20572623|NCT02048865|Apixaban|apixaban|mesh-list
20572624|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20572625|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
20572626|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20572627|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
20572628|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572629|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572630|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
20572631|NCT02048917|Bupropion|bupropion|mesh-list
20572632|NCT02048917|Varenicline|varenicline|mesh-list
20572633|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20572634|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
20572635|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20572636|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20572637|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20572638|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20572639|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572640|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
20572641|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572642|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572643|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20572644|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20572645|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572646|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20572647|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20572648|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
20572649|NCT02048930|Budesonide|budesonide|mesh-list
20572650|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572651|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20572652|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
20572653|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019091|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20572654|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572655|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20572656|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
20572657|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
20572658|NCT02048930|Hormones|hormones|mesh-ancestor
20572659|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572660|NCT02048943|Gemcitabine|gemcitabine|mesh-list
20572661|NCT02048943|Paclitaxel|paclitaxel|mesh-list
20572662|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20572663|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20572664|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019092|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019093|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019094|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
20019095|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20019096|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468349|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20019097|NCT02503540|Aflibercept|aflibercept|mesh-list
20292247|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20572665|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
20572666|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
20572667|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
20572668|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572669|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20572670|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
20572671|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
20572672|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572673|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572674|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572675|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
20572676|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572677|NCT02048969|Flumazenil|flumazenil|mesh-list
20572678|NCT02048969|Antidotes|antidotes|mesh-ancestor
20572679|NCT02048969|Protective Agents|protective agents|mesh-ancestor
20572680|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572681|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
20572682|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
20019098|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20019099|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19468350|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20572683|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572684|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572685|NCT02049034|Lixisenatide|lixisenatide|mesh-list
20572686|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20572687|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572688|NCT02049047|Everolimus|everolimus|mesh-list
20572689|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572690|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572691|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
20572692|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572693|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
20572694|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20572695|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20572696|NCT02049073|Prednisolone|prednisolone|mesh-list
20572697|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
20572698|NCT02049073|Zonisamide|zonisamide|mesh-list
20572699|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20572700|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
20572701|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572702|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
20572703|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
20572704|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572705|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572706|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20572707|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
20572708|NCT02049073|Hormones|hormones|mesh-ancestor
20572709|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572710|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20572711|NCT02049073|Protective Agents|protective agents|mesh-ancestor
20572712|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20572713|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572714|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
20572715|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20572716|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20572717|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572718|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20572719|NCT02049138|Upadacitinib|upadacitinib|mesh-list
20572720|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20572721|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20572722|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572723|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572724|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572725|NCT02049190|Onapristone|onapristone|mesh-list
20572726|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572727|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20572728|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
20572729|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20572730|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572731|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
20572732|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572733|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
20572734|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
20572735|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572736|NCT02049229|Everolimus|everolimus|mesh-list
20572737|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572738|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572739|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
20572740|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572741|NCT02049255|Bupivacaine|bupivacaine|mesh-list
20572742|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
20572743|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
20572744|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
20572745|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572746|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572747|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
20572748|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572749|NCT02049268|Ethanol|ethanol|mesh-list
20572750|NCT02049268|Nicotine|nicotine|mesh-list
20572751|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20572752|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
20572753|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572754|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572755|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20572756|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20572757|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
20572758|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605326|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20605327|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20605328|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20605329|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20605330|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605331|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20605332|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
20605333|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
20605334|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
20605335|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
20605336|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605337|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605338|NCT02232139|Midazolam|midazolam|mesh-list
20605339|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20605340|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20605341|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605342|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605343|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20605344|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20605345|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605346|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20572759|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572760|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20572761|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572762|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572763|NCT02049294|Omalizumab|omalizumab|mesh-list
20572764|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20572765|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20572766|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
20572767|NCT02049320|Remifentanil|remifentanil|mesh-list
20572768|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20572769|NCT02049320|Narcotics|narcotics|mesh-ancestor
20572770|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468351|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
19468352|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468353|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468354|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468355|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19468356|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19468357|NCT03288636|Ritonavir|ritonavir|mesh-list
19468358|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19468359|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19468360|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
19468361|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468362|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468363|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19468364|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19468365|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
19468366|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468367|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19468368|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19468369|NCT03288610|Vasopressins|vasopressins|mesh-list
19468370|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
19468371|NCT03288610|Coagulants|coagulants|mesh-ancestor
19468372|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19468373|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19468374|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
19468375|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468376|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19468377|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19468378|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468379|NCT03288532|Durvalumab|durvalumab|mesh-list
19468380|NCT03288532|Tremelimumab|tremelimumab|mesh-list
19468381|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468382|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468383|NCT03288428|Morphine|morphine|mesh-list
19468384|NCT03288428|Nalbuphine|nalbuphine|mesh-list
19468385|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19468386|NCT03288428|Narcotics|narcotics|mesh-ancestor
19468387|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468388|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468389|NCT03288428|Analgesics|analgesics|mesh-ancestor
19468390|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
19468391|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468392|NCT03288402|Caffeine|caffeine|mesh-list
19468393|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19468394|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468395|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20572771|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572772|NCT02049320|Analgesics|analgesics|mesh-ancestor
20572773|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
20572774|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572775|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
20572776|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
20572777|NCT02049346|Hematinics|hematinics|mesh-ancestor
20572778|NCT02049411|Ketamine|ketamine|mesh-list
20572779|NCT02049411|Analgesics|analgesics|mesh-ancestor
20572780|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
20572781|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572782|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572783|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20572784|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20572785|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
20019100|NCT02503540|Growth Substances|growth substances|mesh-ancestor
20019101|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019102|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
20019103|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019104|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
20019105|NCT02503735|Ledipasvir|ledipasvir|mesh-list
20019106|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
20019107|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019108|NCT02503865|Orlistat|orlistat|mesh-list
20019109|NCT02503865|Diltiazem|diltiazem|mesh-list
20019110|NCT02503865|Atorvastatin|atorvastatin|mesh-list
20019111|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20019112|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20019113|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
20019114|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019115|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20019116|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20019117|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572786|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
20572787|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572788|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20572789|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20572790|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572791|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572792|NCT02049515|Ofatumumab|ofatumumab|mesh-list
20572793|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572794|NCT02049541|Rituximab|rituximab|mesh-list
20572795|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20572796|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572797|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
20572798|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572799|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468396|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468397|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468398|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19468399|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19468400|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
19468401|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468402|NCT03288350|Avelumab|avelumab|mesh-list
19468403|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468404|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019118|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20019119|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20572800|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
20572801|NCT02049580|Thiotepa|thiotepa|mesh-list
20572802|NCT02049580|Fludarabine|fludarabine|mesh-list
20572803|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572804|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
20572805|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572806|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292248|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572807|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20572808|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
20572809|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572810|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572811|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20572812|NCT02049593|Irinotecan|irinotecan|mesh-list
20572813|NCT02049593|Temozolomide|temozolomide|mesh-list
20572814|NCT02049593|Talazoparib|talazoparib|mesh-list
20572815|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20572816|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20572817|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20572818|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572819|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572820|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572821|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20572822|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
20572823|NCT02049606|Nabumetone|nabumetone|mesh-list
19468405|NCT03288259|Anesthetics|anesthetics|mesh-list
19468406|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
19468407|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468408|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468409|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
19468410|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468411|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
19468412|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
19468413|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468414|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
19468415|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468416|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468417|NCT03288077|Tryptophan|tryptophan|mesh-list
19468418|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19468419|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
19468420|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19468421|NCT03288051|Dobutamine|dobutamine|mesh-list
19468422|NCT03288051|Norepinephrine|norepinephrine|mesh-list
19468423|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19468424|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19468425|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
19468426|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468427|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468428|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468429|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
19468430|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
19468431|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468432|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19468433|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19468434|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19468435|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19468436|NCT03288051|Protective Agents|protective agents|mesh-ancestor
19468437|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20019120|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019121|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19468438|NCT03288038|Ezetimibe|ezetimibe|mesh-list
19468439|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19468440|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20019122|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019123|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
20019124|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20019125|NCT02503982|Valganciclovir|valganciclovir|mesh-list
20019126|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
20019127|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019128|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
20019129|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20019130|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
20019131|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20019132|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
20572824|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19468441|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
20019133|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572825|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572826|NCT02049606|Analgesics|analgesics|mesh-ancestor
20572827|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
20572828|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019134|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019135|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
20019136|NCT02504268|Methotrexate|methotrexate|mesh-list
20019137|NCT02504268|Abatacept|abatacept|mesh-list
20019138|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20019139|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
20019140|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019141|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019142|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20019143|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
20019144|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019145|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019146|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
20019147|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019148|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20019149|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019150|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
20019151|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572829|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742698|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
20572830|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572831|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572832|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20572833|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20572834|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572835|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572836|NCT02049671|Hormones|hormones|mesh-list
20572837|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20572838|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572839|NCT02049736|Telbivudine|telbivudine|mesh-list
20572840|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
20572841|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572842|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20572843|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572844|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572845|NCT02049762|Aspirin|aspirin|mesh-list
20572846|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20572847|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572848|NCT02049762|Analgesics|analgesics|mesh-ancestor
20572849|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
20572850|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572851|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572852|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20572853|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20572854|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20572855|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20572856|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572857|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20572858|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20572859|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468442|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468443|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20572860|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
20572861|NCT02049801|Cytarabine|cytarabine|mesh-list
20572862|NCT02049801|Idarubicin|idarubicin|mesh-list
20572863|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20572864|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
20572865|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572866|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468444|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19468445|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572867|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
20572868|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572869|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572870|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
20572871|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572872|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20572873|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20572874|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20572875|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572876|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
19468446|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
19468447|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
19468448|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468449|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468450|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19468451|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
19468452|NCT03287882|Micronutrients|micronutrients|mesh-list
19468453|NCT03287882|Trace Elements|trace elements|mesh-list
19468454|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468455|NCT03287609|Evolocumab|evolocumab|mesh-list
19468456|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19468457|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19468458|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
19468459|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468460|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19468461|NCT03287505|Aripiprazole|aripiprazole|mesh-list
19468462|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
19468463|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19468464|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19468465|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19468466|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468467|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468468|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
19468469|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
19468470|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468471|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468472|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19468473|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19468474|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
19468475|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19468476|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19468477|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19468478|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19468479|NCT03287388|Rocuronium|rocuronium|mesh-list
19468480|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19468481|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19468482|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19468483|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468484|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468485|NCT03287375|Cisplatin|cisplatin|mesh-list
19468486|NCT03287375|Doxorubicin|doxorubicin|mesh-list
19468487|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
19468488|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468489|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19468490|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19468491|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19468492|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468493|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468494|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
19468495|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19468496|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19468497|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468498|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
19468499|NCT03287336|Coagulants|coagulants|mesh-ancestor
19468500|NCT03287271|Paclitaxel|paclitaxel|mesh-list
19468501|NCT03287271|Carboplatin|carboplatin|mesh-list
19468502|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19468503|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468504|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468505|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468506|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468507|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468508|NCT03287180|Buprenorphine|buprenorphine|mesh-list
19468509|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19468510|NCT03287180|Naloxone|naloxone|mesh-list
19468511|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19468512|NCT03287180|Narcotics|narcotics|mesh-ancestor
20572877|NCT02049970|Bupivacaine|bupivacaine|mesh-list
20572878|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
20572879|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
20572880|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572881|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572882|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
20572883|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572884|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19468513|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468514|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468515|NCT03287180|Analgesics|analgesics|mesh-ancestor
19468516|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
19468517|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468518|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19468519|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
19468520|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468521|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572885|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572886|NCT02049970|Analgesics|analgesics|mesh-ancestor
20572887|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20572888|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20572889|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20572890|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
20572891|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572892|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572893|NCT02050009|Metformin|metformin|mesh-list
20572894|NCT02050009|Paclitaxel|paclitaxel|mesh-list
20572895|NCT02050009|Carboplatin|carboplatin|mesh-list
20572896|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20572897|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572898|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
20572899|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
20572900|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
20572901|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572902|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20572903|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572904|NCT02050074|Metformin|metformin|mesh-list
20572905|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20572906|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20572907|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572908|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20572909|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20572910|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
20572911|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572912|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20572913|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
20572914|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20572915|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
20572916|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
20572917|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572918|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572919|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20572920|NCT02050152|Analgesics|analgesics|mesh-ancestor
20572921|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
20572922|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572923|NCT02050178|Gemcitabine|gemcitabine|mesh-list
20572924|NCT02050178|Paclitaxel|paclitaxel|mesh-list
20572925|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20572926|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572927|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468522|NCT03287076|Exenatide|exenatide|mesh-list
19468523|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19468524|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468525|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19468526|NCT03287076|Incretins|incretins|mesh-ancestor
19468527|NCT03287076|Hormones|hormones|mesh-ancestor
19468528|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468529|NCT03287011|Listerine|listerine|mesh-list
19468530|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
19468531|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
19468532|NCT03287011|Protective Agents|protective agents|mesh-ancestor
19742699|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572928|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
20572929|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468533|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742700|NCT04481035|Expectorants|expectorants|mesh-ancestor
20572930|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572931|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19468534|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19468535|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468536|NCT03286959|Calcium|calcium|mesh-list
19468537|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19468538|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566746|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566747|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566748|NCT05209490|Iodine|iodine|mesh-list
19566749|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20572932|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
20572933|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
20572934|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468539|NCT03286803|Vaccines|vaccines|mesh-list
19468540|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
19468541|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468542|NCT03286764|Peppermint oil|peppermint oil|mesh-list
19468543|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
19468544|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
19468545|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468546|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468547|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742701|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
19742702|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19742703|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
19742704|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742705|NCT04481035|Protective Agents|protective agents|mesh-ancestor
20572935|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572936|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20572937|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
20572938|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605347|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
20605348|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
20605349|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
20605350|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
20605351|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605352|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605353|NCT02232269|Felodipine|felodipine|mesh-list
20605354|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19468548|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
19468549|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
19468550|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
20605355|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605356|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20572939|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
20572940|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
20572941|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20572942|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20572943|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572944|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572945|NCT02050360|Urological Agents|urological agents|mesh-ancestor
20572946|NCT02050529|Hydralazine|hydralazine|mesh-list
20572947|NCT02050529|Labetalol|labetalol|mesh-list
20572948|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20572949|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
20572950|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20572951|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20572952|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20572953|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20572954|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572955|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572956|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
20572957|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
20572958|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20572959|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20572960|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20572961|NCT02050594|Ipilimumab|ipilimumab|mesh-list
20572962|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20572963|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572964|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20572965|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572966|NCT02050672|Inositol|inositol|mesh-list
20572967|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
20572968|NCT02050672|Vitamins|vitamins|mesh-ancestor
20572969|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
20572970|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019152|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20019153|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20019154|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
20019155|NCT02504294|Hematinics|hematinics|mesh-ancestor
20019156|NCT02504320|Febuxostat|febuxostat|mesh-list
19468551|NCT03286673|Calcium|calcium|mesh-list
20019157|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
20019158|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468552|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19468553|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468554|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19468555|NCT03286673|Antacids|antacids|mesh-ancestor
20019159|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
20572971|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
20019160|NCT02504541|Testosterone|testosterone|mesh-list
20019161|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
20019162|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
20019163|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20019164|NCT02504541|Androgens|androgens|mesh-ancestor
20019165|NCT02504541|Hormones|hormones|mesh-ancestor
20019166|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019167|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019168|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20019169|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019170|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
20019171|NCT02504554|Vancomycin|vancomycin|mesh-list
20019172|NCT02504554|Omeprazole|omeprazole|mesh-list
20019173|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20019174|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019175|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20019176|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019177|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20019178|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572972|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20572973|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572974|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
20572975|NCT02050802|Macitentan|macitentan|mesh-list
20572976|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20572977|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20572978|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20572979|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20572980|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20572981|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20572982|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20572983|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20572984|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20572985|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20572986|NCT02050893|Midazolam|midazolam|mesh-list
20572987|NCT02050893|Propofol|propofol|mesh-list
20572988|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20572989|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20572990|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20572991|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20572992|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
20572993|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
20572994|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20572995|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20572996|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20572997|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20572998|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
20572999|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
20573000|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573001|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573002|NCT02050958|Ibuprofen|ibuprofen|mesh-list
20573003|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20573004|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20573005|NCT02050958|Analgesics|analgesics|mesh-ancestor
20573006|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
20573007|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573008|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573009|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573010|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573011|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20573012|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573013|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573014|NCT02051023|Fluorometholone|fluorometholone|mesh-list
20573015|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
20573016|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20573017|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20573018|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573019|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
20573020|NCT02051023|Hormones|hormones|mesh-ancestor
20573021|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573022|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573023|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20573024|NCT02051153|Modafinil|modafinil|mesh-list
20573025|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20573026|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019179|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573027|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20573028|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20573029|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20573030|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573031|NCT02051231|Oxytocin|oxytocin|mesh-list
20573032|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
20573033|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20573034|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468556|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468557|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19468558|NCT03286634|Cytarabine|cytarabine|mesh-list
19468559|NCT03286634|Prednisolone|prednisolone|mesh-list
19468560|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
19468561|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
19468562|NCT03286634|Methotrexate|methotrexate|mesh-list
19468563|NCT03286634|Vincristine|vincristine|mesh-list
19468564|NCT03286634|Daunorubicin|daunorubicin|mesh-list
19468565|NCT03286634|Asparaginase|asparaginase|mesh-list
19468566|NCT03286634|Epirubicin|epirubicin|mesh-list
19468567|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
19468568|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19468569|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
19468570|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468571|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468572|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19468573|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
19468574|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468575|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468576|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19468577|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19468578|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
19468579|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19468580|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19468581|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
19468582|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
19468583|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468584|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19468585|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19468586|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
19468587|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468588|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19468589|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468590|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468591|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468592|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468593|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
19468594|NCT03286634|Hormones|hormones|mesh-ancestor
19468595|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468596|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19468597|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19468598|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19468599|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19468600|NCT03286582|Clobetasol|clobetasol|mesh-list
19468601|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573035|NCT02051387|Cannabidiol|cannabidiol|mesh-list
20573036|NCT02051387|Olanzapine|olanzapine|mesh-list
20573037|NCT02051387|Risperidone|risperidone|mesh-list
20573038|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20573039|NCT02051387|Amisulpride|amisulpride|mesh-list
20573040|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20573041|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
20573042|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573043|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573044|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573045|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20573046|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20573047|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292249|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292250|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20292251|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
20292252|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20292253|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292254|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20292255|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20292256|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
20292257|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20292258|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
20292259|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20292260|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20292261|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20292262|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20573048|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573049|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20573050|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
20573051|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
20573052|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
20573053|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573054|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20573055|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20573056|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20573057|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20573058|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
20573059|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
20573060|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20573061|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20573062|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20573063|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20573064|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20573065|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573066|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573067|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573068|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20573069|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
20573070|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573071|NCT02051530|Tryptophan|tryptophan|mesh-list
20573072|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20573073|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
20573074|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573075|NCT02051569|Tryptophan|tryptophan|mesh-list
20573076|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19468602|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
19468603|NCT03286582|Hormones|hormones|mesh-ancestor
20573077|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
20573078|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573079|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20573080|NCT02051738|Mebendazole|mebendazole|mesh-list
19566750|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573081|NCT02051738|Piperazine|piperazine|mesh-list
20573082|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
20573083|NCT02051738|DMP 777|dmp 777|mesh-list
20573084|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
20573085|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
20573086|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20573087|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573088|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
20573089|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
20573090|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
20573091|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573092|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573093|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573094|NCT02051751|Paclitaxel|paclitaxel|mesh-list
20573095|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20573096|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573097|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468604|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468605|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468606|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
19468607|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19468608|NCT03286296|Antibodies|antibodies|mesh-list
19468609|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19468610|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
19468611|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468612|NCT03286244|Paclitaxel|paclitaxel|mesh-list
19468613|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20019180|NCT02504671|Folic Acid|folic acid|mesh-list
20019181|NCT02504671|Hematinics|hematinics|mesh-ancestor
20019182|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
20019183|NCT02504671|Vitamins|vitamins|mesh-ancestor
20019184|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
20019185|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019186|NCT02504723|Carvedilol|carvedilol|mesh-list
20019187|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20019188|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20019189|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
20019190|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019191|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019192|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019193|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20019194|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
20019195|NCT02504723|Protective Agents|protective agents|mesh-ancestor
20019196|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20019197|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019198|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20019199|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
20019200|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20019201|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20019202|NCT02504775|Acetaminophen|acetaminophen|mesh-list
20019203|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019204|NCT02504775|Analgesics|analgesics|mesh-ancestor
20019205|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
20019206|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019207|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573098|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468614|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019208|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
20573099|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
20573100|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573101|NCT02051842|Metadoxine|metadoxine|mesh-list
20573102|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20573103|NCT02051868|Paclitaxel|paclitaxel|mesh-list
20573104|NCT02051868|Carboplatin|carboplatin|mesh-list
20573105|NCT02051868|Fluorouracil|fluorouracil|mesh-list
20573106|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20573107|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573108|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
20573109|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
20573110|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
20573111|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573112|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
20573113|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20573114|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20573115|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
20573116|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605357|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605358|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605359|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605360|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605361|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
20605362|NCT02232308|Lisinopril|lisinopril|mesh-list
20605363|NCT02232308|Nizatidine|nizatidine|mesh-list
20605364|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20605365|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
20605366|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605367|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605368|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605369|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20605370|NCT02232308|Protective Agents|protective agents|mesh-ancestor
20605371|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605372|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20605373|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605374|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20605375|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
19468615|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468616|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468617|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468618|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468619|NCT03286101|Ivermectin|ivermectin|mesh-list
19468620|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19468621|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468622|NCT03285906|Apatinib|apatinib|mesh-list
19468623|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468624|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19468625|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468626|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468627|NCT03285802|Everolimus|everolimus|mesh-list
19468628|NCT03285802|Letrozole|letrozole|mesh-list
19468629|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468630|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19468631|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
19468632|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468633|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19468634|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19468635|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019209|NCT02504827|Ceftazidime|ceftazidime|mesh-list
20019210|NCT02504827|Avibactam|avibactam|mesh-list
20019211|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
20019212|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20019213|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019214|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20019215|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019216|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019217|NCT02504892|Everolimus|everolimus|mesh-list
20019218|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019219|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019220|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
20019221|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019222|NCT02504931|Sertraline|sertraline|mesh-list
20019223|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
20019224|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20019225|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20605376|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
20019226|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20019227|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019228|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019229|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019230|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
20019231|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019232|NCT02505269|Doxorubicin|doxorubicin|mesh-list
20019233|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20019234|NCT02505269|Dacarbazine|dacarbazine|mesh-list
20019235|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20019236|NCT02505269|Imidazole|imidazole|mesh-list
20019237|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20019238|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019239|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20019240|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20019241|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019242|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019243|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20019244|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
20019245|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20019246|NCT02505334|Liraglutide|liraglutide|mesh-list
20019247|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20573117|NCT02051894|Dobutamine|dobutamine|mesh-list
20573118|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20573119|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
20573120|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
20573121|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573122|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573123|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20573124|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20573125|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20573126|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
20573127|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573128|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573129|NCT02051894|Protective Agents|protective agents|mesh-ancestor
20573130|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
20573131|NCT02051946|Diuretics|diuretics|mesh-ancestor
20573132|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
19468636|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468637|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19468638|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
19468639|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468640|NCT03285607|Paclitaxel|paclitaxel|mesh-list
19468641|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
19468642|NCT03285607|Doxorubicin|doxorubicin|mesh-list
19468643|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19468644|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468645|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468646|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468647|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468648|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468649|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19468650|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
19468651|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468652|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019248|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019249|NCT02505334|Incretins|incretins|mesh-ancestor
20019250|NCT02505334|Hormones|hormones|mesh-ancestor
20019251|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019252|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
20019253|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019254|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
20019255|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292263|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20019256|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573133|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573134|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573135|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573136|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
20573137|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
20573138|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20573139|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20573140|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20573141|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20573142|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573143|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
20573144|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573145|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573146|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20573147|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573148|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20573149|NCT02052128|Onapristone|onapristone|mesh-list
20573150|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573151|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20573152|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
20573153|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20573154|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573155|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
19468653|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19468654|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
19468655|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19468656|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19468657|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19468658|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19468659|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468660|NCT03285568|Palbociclib|palbociclib|mesh-list
19468661|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468662|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19468663|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468664|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468665|NCT03285503|Aripiprazole|aripiprazole|mesh-list
19468666|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
19468667|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19468668|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19468669|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19468670|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468671|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468672|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
20573156|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573157|NCT02052154|Vaccines|vaccines|mesh-list
20573158|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
20573159|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573160|NCT02052167|Methotrexate|methotrexate|mesh-list
19468673|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
19468674|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468675|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468676|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19468677|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19468678|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
19468679|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19468680|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19468681|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19468682|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19468683|NCT03285360|Fluorides|fluorides|mesh-list
19468684|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
19468685|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
19468686|NCT03285360|Protective Agents|protective agents|mesh-ancestor
19468687|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468688|NCT03285165|Propofol|propofol|mesh-list
19468689|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19468690|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468691|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468692|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19468693|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
19468694|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
19468695|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
20019257|NCT02505945|Omeprazole|omeprazole|mesh-list
20573161|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20019258|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20573162|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
20573163|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20573164|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573165|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20573166|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
20573167|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573168|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573169|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
20573170|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573171|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20573172|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20573173|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
20573174|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573175|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20573176|NCT02052180|Bupivacaine|bupivacaine|mesh-list
20573177|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
20573178|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
20573179|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468696|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19468697|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468698|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468699|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468700|NCT03285087|Analgesics|analgesics|mesh-ancestor
19468701|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
19468702|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468703|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19468704|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19468705|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19468706|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
19468707|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468708|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566751|NCT05209490|Trace Elements|trace elements|mesh-ancestor
19566752|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
19566753|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566754|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
19566755|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
19566756|NCT05207358|Rituximab|rituximab|mesh-list
19566757|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566758|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
19566759|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566760|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566761|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19566762|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
19566763|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566764|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566765|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19566766|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566767|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19566768|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19566769|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
19566770|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19566771|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566772|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566773|NCT05205473|Lidocaine|lidocaine|mesh-list
19566774|NCT05205473|Anesthetics|anesthetics|mesh-list
19566775|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566776|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566777|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566778|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
19566779|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566780|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19566781|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19566782|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19566783|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566784|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566785|NCT05201846|Insulin|insulin|mesh-list
19566786|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19566787|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19566788|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566789|NCT05199285|Nivolumab|nivolumab|mesh-list
19566790|NCT05199285|Ipilimumab|ipilimumab|mesh-list
19566791|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566792|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573180|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573181|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
20573182|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573183|NCT02052193|Vemurafenib|vemurafenib|mesh-list
19468709|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
19468710|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19468711|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
19468712|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19468713|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
19468714|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468715|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468716|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
19468717|NCT03284749|Copper|copper|mesh-list
19468718|NCT03284749|Trace Elements|trace elements|mesh-ancestor
19468719|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
19468720|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019259|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019260|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20019261|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468721|NCT03284645|Tenofovir|tenofovir|mesh-list
19468722|NCT03284645|Lamivudine|lamivudine|mesh-list
19468723|NCT03284645|Zidovudine|zidovudine|mesh-list
19468724|NCT03284645|Efavirenz|efavirenz|mesh-list
19468725|NCT03284645|Abacavir|abacavir|mesh-list
19468726|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
19468727|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468728|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19468729|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19468730|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468731|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468732|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19468733|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19468734|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
19468735|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19468736|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20019262|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573184|NCT02052193|Dabrafenib|dabrafenib|mesh-list
20573185|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573186|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20573187|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573188|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573189|NCT02052258|Oxytocin|oxytocin|mesh-list
20573190|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
20573191|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20573192|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573193|NCT02052323|Artesunate|artesunate|mesh-list
20573194|NCT02052323|Mefloquine|mefloquine|mesh-list
20573195|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
20573196|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20573197|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20573198|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573199|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573200|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
20573201|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
20573202|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20573203|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
20573204|NCT02052336|Clarithromycin|clarithromycin|mesh-list
20573205|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20573206|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573207|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20573208|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573209|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573210|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20573211|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20573212|NCT02052388|Daptomycin|daptomycin|mesh-list
20573213|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20573214|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573215|NCT02052492|Vitamin D|vitamin d|mesh-list
20573216|NCT02052492|Vitamins|vitamins|mesh-ancestor
20573217|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
20573218|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573219|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573220|NCT02052609|Brodalumab|brodalumab|mesh-list
20573221|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
20573222|NCT02052687|Imiquimod|imiquimod|mesh-list
20573223|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20573224|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
20573225|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573226|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573227|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
20573228|NCT02052713|Tamsulosin|tamsulosin|mesh-list
20573229|NCT02052713|Dutasteride|dutasteride|mesh-list
20573230|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20573231|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20573232|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20573233|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
20573234|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573235|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573236|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573237|NCT02052713|Urological Agents|urological agents|mesh-ancestor
20573238|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20573239|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20573240|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573241|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
20573242|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573243|NCT02052726|Vaccines|vaccines|mesh-list
20573244|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
20573245|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573246|NCT02052908|Naproxen|naproxen|mesh-list
20573247|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20573248|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468737|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19468738|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19468739|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19468740|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19468741|NCT03284593|Azacitidine|azacitidine|mesh-list
19468742|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19468743|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
19468744|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468745|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468746|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468747|NCT03284515|Vaccines|vaccines|mesh-list
19468748|NCT03284515|Immunologic Factors|immunologic factors|mesh-ancestor
19468749|NCT03284515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468750|NCT03284463|Glyburide|glyburide|mesh-list
19468751|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19468752|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468753|NCT03284307|Midazolam|midazolam|mesh-list
19468754|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
19468755|NCT03284307|Ketamine|ketamine|mesh-list
19468756|NCT03284307|Propofol|propofol|mesh-list
19468757|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19468758|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468759|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468760|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19468761|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
19468762|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
19468763|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468764|NCT03284307|Analgesics|analgesics|mesh-ancestor
19468765|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
19468766|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468767|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19468768|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19468769|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19468770|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
19468771|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468772|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468773|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19468774|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19468775|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19468776|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19468777|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20573249|NCT02052908|Analgesics|analgesics|mesh-ancestor
20573250|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
20573251|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573252|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573253|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573254|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573255|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
20573256|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20573257|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573258|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573259|NCT02052934|Vaccines|vaccines|mesh-list
20573260|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
20573261|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573262|NCT02052973|Propolis|propolis|mesh-list
19468778|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19468779|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19468780|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
19468781|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
19468782|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
19468783|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19468784|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468785|NCT03284294|Vitamins|vitamins|mesh-ancestor
19468786|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
19468787|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19468788|NCT03284177|Calcium|calcium|mesh-list
19468789|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19468790|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468791|NCT03284164|Tenofovir|tenofovir|mesh-list
19468792|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
20019263|NCT02506114|Ipilimumab|ipilimumab|mesh-list
20019264|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20019265|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019266|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20019267|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019268|NCT02506257|Biguanides|biguanides|mesh-list
20019269|NCT02506257|Polihexanide|polihexanide|mesh-list
20019270|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20019271|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019272|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
20019273|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019274|NCT02506634|Esomeprazole|esomeprazole|mesh-list
20019275|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20019276|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019277|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20019278|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019279|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019280|NCT02506660|Dexamethasone|dexamethasone|mesh-list
20019281|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
20019282|NCT02506660|Bupivacaine|bupivacaine|mesh-list
20019283|NCT02506660|BB 1101|bb 1101|mesh-list
20019284|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019285|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
20573263|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573264|NCT02053142|Acyclovir|acyclovir|mesh-list
20573265|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
20573266|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573267|NCT02053298|Timolol|timolol|mesh-list
20573268|NCT02053298|Dorzolamide|dorzolamide|mesh-list
20573269|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20573270|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20573271|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
20573272|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573273|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573274|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573275|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20573276|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20573277|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20573278|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573279|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
20573280|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20573281|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20573282|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573283|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
19468793|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019286|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
20019287|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573284|NCT02053363|Coagulants|coagulants|mesh-ancestor
20573285|NCT02053402|Vitamin D|vitamin d|mesh-list
20573286|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
20573287|NCT02053402|Vitamins|vitamins|mesh-ancestor
20573288|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
20573289|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573290|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573291|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20573292|NCT02053519|Vitamin D|vitamin d|mesh-list
20573293|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
20573294|NCT02053519|Vitamins|vitamins|mesh-ancestor
20573295|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
20573296|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573297|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573298|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20573299|NCT02053558|Lidocaine|lidocaine|mesh-list
20573300|NCT02053558|Ropivacaine|ropivacaine|mesh-list
20573301|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
20573302|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
20573303|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573304|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573305|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
20573306|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573307|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20573308|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20573309|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20573310|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20573311|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573312|NCT02053597|Paclitaxel|paclitaxel|mesh-list
20573313|NCT02053597|Doxorubicin|doxorubicin|mesh-list
20573314|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20573315|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468794|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19468795|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19468796|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468797|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468798|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19468799|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19468800|NCT03283943|Durvalumab|durvalumab|mesh-list
19468801|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468802|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468803|NCT03283917|Dexamethasone|dexamethasone|mesh-list
19468804|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
19468805|NCT03283917|Daratumumab|daratumumab|mesh-list
19468806|NCT03283917|Ixazomib|ixazomib|mesh-list
19468807|NCT03283917|Ichthammol|ichthammol|mesh-list
19468808|NCT03283917|BB 1101|bb 1101|mesh-list
19468809|NCT03283917|Glycine|glycine|mesh-list
19468810|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468811|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
19468812|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
19468813|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468814|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468815|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19468816|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
19468817|NCT03283917|Hormones|hormones|mesh-ancestor
19468818|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468819|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19468820|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468821|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
19468822|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468823|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468824|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
19468825|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
19468826|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573316|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
20573317|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
20573318|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
20573319|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573320|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20573321|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20573322|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20573323|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605377|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605378|NCT02232347|Sufentanil|sufentanil|mesh-list
20605379|NCT02232347|Ketamine|ketamine|mesh-list
20605380|NCT02232347|Analgesics|analgesics|mesh-ancestor
20605381|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
20605382|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605383|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605384|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20605385|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20605386|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
20605387|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
20605388|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605389|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20605390|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20605391|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605392|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605393|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20605394|NCT02232347|Narcotics|narcotics|mesh-ancestor
20605395|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20605396|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20605397|NCT02232360|Fenofibrate|fenofibrate|mesh-list
19468827|NCT03283800|Copper|copper|mesh-list
19468828|NCT03283800|Trace Elements|trace elements|mesh-ancestor
19468829|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
19468830|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468831|NCT03283410|Propofol|propofol|mesh-list
19468832|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19468833|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468834|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468835|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19468836|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
19468837|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
19468838|NCT03283202|Prednisone|prednisone|mesh-list
19468839|NCT03283202|Prednisolone|prednisolone|mesh-list
19468840|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
19468841|NCT03283202|Rituximab|rituximab|mesh-list
19468842|NCT03283202|Vincristine|vincristine|mesh-list
19468843|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19468844|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
19468845|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468846|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468847|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19468848|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
19468849|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468850|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468851|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19468852|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468853|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468854|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
19468855|NCT03283202|Hormones|hormones|mesh-ancestor
19468856|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468857|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19468858|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19468859|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468860|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468861|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468862|NCT03283176|Folic Acid|folic acid|mesh-list
19468863|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
19468864|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
19468865|NCT03283176|Vitamins|vitamins|mesh-ancestor
19468866|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
19468867|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468868|NCT03283176|Hematinics|hematinics|mesh-ancestor
19468869|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
19468870|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
19468871|NCT03283150|Remifentanil|remifentanil|mesh-list
19468872|NCT03283150|Propofol|propofol|mesh-list
20605398|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20605399|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20573324|NCT02053675|Vasopressins|vasopressins|mesh-list
20573325|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
20573326|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
20573327|NCT02053675|Coagulants|coagulants|mesh-ancestor
20573328|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20573329|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20573330|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
20573331|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573332|NCT02053727|Abatacept|abatacept|mesh-list
20573333|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20573334|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573335|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573336|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20573337|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
20573338|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573339|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573340|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
20573341|NCT02053766|Propofol|propofol|mesh-list
20573342|NCT02053766|Sevoflurane|sevoflurane|mesh-list
20573343|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20573344|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573345|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573346|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20573347|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
20573348|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
20573349|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20573350|NCT02053766|Analgesics|analgesics|mesh-ancestor
20573351|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
19468873|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19468874|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468875|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468876|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19468877|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
19468878|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
19468879|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468880|NCT03283150|Analgesics|analgesics|mesh-ancestor
19468881|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
19468882|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468883|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19468884|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19468885|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19468886|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
19468887|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468888|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468889|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20573352|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468890|NCT03283150|Narcotics|narcotics|mesh-ancestor
19468891|NCT03283059|Donepezil|donepezil|mesh-list
19468892|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19468893|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468894|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468895|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
19468896|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468897|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468898|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
19566793|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19566794|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566795|NCT05194189|Ascorbic Acid|ascorbic acid|mesh-list
19566796|NCT05194189|Vitamins|vitamins|mesh-ancestor
19566797|NCT05194189|Micronutrients|micronutrients|mesh-ancestor
19566798|NCT05194189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566799|NCT05194189|Antioxidants|antioxidants|mesh-ancestor
19566800|NCT05194189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566801|NCT05194189|Protective Agents|protective agents|mesh-ancestor
19566802|NCT05189457|Docetaxel|docetaxel|mesh-list
19566803|NCT05189457|Leuprolide|leuprolide|mesh-list
19566804|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19566805|NCT05189457|Hormones|hormones|mesh-list
19566806|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19566807|NCT05189457|Relugolix|relugolix|mesh-list
19566808|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742706|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573353|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20573354|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19566809|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
20573355|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20573356|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
20573357|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573358|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573359|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20573360|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20573361|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20573362|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
20573363|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20573364|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
20573365|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20573366|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573367|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20573368|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20573369|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573370|NCT02053818|Sufentanil|sufentanil|mesh-list
20573371|NCT02053818|Remifentanil|remifentanil|mesh-list
20573372|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20573373|NCT02053818|Narcotics|narcotics|mesh-ancestor
20573374|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573375|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573376|NCT02053818|Analgesics|analgesics|mesh-ancestor
20573377|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
20573378|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573379|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20573380|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20573381|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
20573382|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
20573383|NCT02053857|Amoxicillin|amoxicillin|mesh-list
20573384|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20573385|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573386|NCT02053922|Misoprostol|misoprostol|mesh-list
20573387|NCT02053922|Oxytocin|oxytocin|mesh-list
20573388|NCT02053922|Carbetocin|carbetocin|mesh-list
20573389|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20573390|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
20573391|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19468899|NCT03283046|Dexamethasone|dexamethasone|mesh-list
19468900|NCT03283046|Nivolumab|nivolumab|mesh-list
19468901|NCT03283046|Lenalidomide|lenalidomide|mesh-list
20019288|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019289|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019290|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
19468902|NCT03283046|Ipilimumab|ipilimumab|mesh-list
19468903|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468904|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
20019291|NCT02506660|Hormones|hormones|mesh-ancestor
19742707|NCT04481035|Antidotes|antidotes|mesh-ancestor
19742708|NCT04476420|Betamethasone|betamethasone|mesh-list
19742709|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
19742710|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19742711|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
19742712|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19742713|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742714|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
19742715|NCT04476420|Hormones|hormones|mesh-ancestor
19742716|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742717|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742718|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19742719|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
19742720|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19742721|NCT04476030|Citalopram|citalopram|mesh-list
19742722|NCT04476030|Sertraline|sertraline|mesh-list
19742723|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19742724|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19742725|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19742726|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19742727|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742728|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742729|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
19742730|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019292|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573392|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468905|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
20573393|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19468906|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573394|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20573395|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
20573396|NCT02053935|Dopamine|dopamine|mesh-list
20573397|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20573398|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
20573399|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
20573400|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573401|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573402|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
20573403|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573404|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573405|NCT02053935|Protective Agents|protective agents|mesh-ancestor
20573406|NCT02053974|Spironolactone|spironolactone|mesh-list
20573407|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20573408|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
20573409|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573410|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573411|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20573412|NCT02053974|Diuretics|diuretics|mesh-ancestor
20573413|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
20573414|NCT02054000|Tirofiban|tirofiban|mesh-list
20573415|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20573416|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20573417|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573418|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20573419|NCT02054052|Bevacizumab|bevacizumab|mesh-list
20573420|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20573421|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573422|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20573423|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20573424|NCT02054052|Growth Substances|growth substances|mesh-ancestor
20573425|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573426|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
20573427|NCT02054078|Bevacizumab|bevacizumab|mesh-list
20573428|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20573429|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573430|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20573431|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20573432|NCT02054078|Growth Substances|growth substances|mesh-ancestor
20573433|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573434|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
20573435|NCT02054143|Sevoflurane|sevoflurane|mesh-list
20019293|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20019294|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019295|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
20019296|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468907|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468908|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19468909|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
19468910|NCT03283046|Hormones|hormones|mesh-ancestor
20019297|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019298|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
20019299|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
20573436|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20573437|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20573438|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
20573439|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
20573440|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573441|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573442|NCT02054182|Vitamin D|vitamin d|mesh-list
20573443|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
20573444|NCT02054182|Vitamins|vitamins|mesh-ancestor
20573445|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
20573446|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573447|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573448|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20573449|NCT02054299|Thiamine|thiamine|mesh-list
19468911|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468912|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19468913|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468914|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19468915|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19468916|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468917|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
19468918|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19468919|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19468920|NCT03283046|Growth Substances|growth substances|mesh-ancestor
19468921|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
19468922|NCT03283020|Naltrexone|naltrexone|mesh-list
19468923|NCT03283020|Remifentanil|remifentanil|mesh-list
19468924|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
19468925|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19468926|NCT03283020|Narcotics|narcotics|mesh-ancestor
19468927|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19468928|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468929|NCT03283020|Analgesics|analgesics|mesh-ancestor
19468930|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
19468931|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468932|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19468933|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19468934|NCT03282838|Celecoxib|celecoxib|mesh-list
19468935|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19468936|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19468937|NCT03282838|Analgesics|analgesics|mesh-ancestor
19468938|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
19468939|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19468940|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468941|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468942|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19468943|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19468944|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19468945|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468946|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468947|NCT03282825|Paclitaxel|paclitaxel|mesh-list
19468948|NCT03282825|Decitabine|decitabine|mesh-list
19468949|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19468950|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468951|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
19468952|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19468953|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
19468954|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468955|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19468956|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
19468957|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468958|NCT03282643|Heparin|heparin|mesh-list
19468959|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19468960|NCT03282643|Tinzaparin|tinzaparin|mesh-list
19468961|NCT03282643|Dalteparin|dalteparin|mesh-list
19468962|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
19468963|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
19468964|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19468965|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20573450|NCT02054299|Proguanil|proguanil|mesh-list
19468966|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573451|NCT02054299|Sumatriptan|sumatriptan|mesh-list
20573452|NCT02054299|Amitriptyline|amitriptyline|mesh-list
20573453|NCT02054299|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20573454|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20573455|NCT02054299|Fenoterol|fenoterol|mesh-list
20573456|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20573457|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19468967|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19468968|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
19468969|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19468970|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
19468971|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468972|NCT03282513|Ivosidenib|ivosidenib|mesh-list
19468973|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19468974|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19468975|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019300|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019301|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
20019302|NCT02506673|Midazolam|midazolam|mesh-list
20019303|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20019304|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20019305|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019306|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019307|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20019308|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20019309|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20019310|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20019311|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
20019312|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
20019313|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
20019314|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
20019315|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019316|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573458|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20573459|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
20573460|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573461|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573462|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573463|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20573464|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
20573465|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573466|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20573467|NCT02054299|Analgesics|analgesics|mesh-ancestor
20573468|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
20573469|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573470|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20573471|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20573472|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20573473|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
20573474|NCT02054299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20573475|NCT02054299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20573476|NCT02054299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573477|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
20573478|NCT02054299|Vitamins|vitamins|mesh-ancestor
20573479|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
20573480|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19468976|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
19468977|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19468978|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
19468979|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
19468980|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19468981|NCT03282188|Sargramostim|sargramostim|mesh-list
19468982|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
19468983|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468984|NCT03282162|Oxytocin|oxytocin|mesh-list
19468985|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
19468986|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19468987|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468988|NCT03282136|Incretins|incretins|mesh-list
19468989|NCT03282136|Hormones|hormones|mesh-ancestor
19468990|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19468991|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19468992|NCT03282110|Citalopram|citalopram|mesh-list
19468993|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19468994|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19468995|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19468996|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19468997|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19468998|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
19468999|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469000|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19469001|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
19469002|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469003|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
19469004|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19469005|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469006|NCT03282006|Renal Agents|renal agents|mesh-ancestor
19469007|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19469008|NCT03281954|Atezolizumab|atezolizumab|mesh-list
19469009|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469010|NCT03281941|Capsaicin|capsaicin|mesh-list
19469011|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
19469012|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
19469013|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
19469014|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469015|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469016|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
19469017|NCT03281928|Diuretics|diuretics|mesh-ancestor
19469018|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
19469019|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469020|NCT03281928|Expectorants|expectorants|mesh-ancestor
19469021|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
19469022|NCT03281863|Antibodies|antibodies|mesh-list
19469023|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
19469024|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
19469025|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469026|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19469027|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19469028|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19469029|NCT03281694|Nicotine|nicotine|mesh-list
19469030|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19469031|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
19469032|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469033|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469034|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19469035|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19469036|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
20573481|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
19469037|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469038|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573482|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20573483|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20573484|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573485|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
20573486|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20573487|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
20573488|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20573489|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
20573490|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
20573491|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
20573492|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20573493|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20573494|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20573495|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20573496|NCT02054429|Insulin|insulin|mesh-list
20573497|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20573498|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20573499|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573500|NCT02054442|Methotrexate|methotrexate|mesh-list
19469039|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
20292264|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20292265|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20292266|NCT05338476|Midazolam|midazolam|mesh-list
20292267|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20292268|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20292269|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292270|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292271|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20292272|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20292273|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20292274|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20292275|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
20292276|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
20292277|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
20292278|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
20292279|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292280|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292281|NCT05338450|Clemastine|clemastine|mesh-list
20292282|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
20292283|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
20292284|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20292285|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
20292286|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
20292287|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292288|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292289|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292290|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20292291|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20292292|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20292293|NCT05338398|Benzydamine|benzydamine|mesh-list
20292294|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308325|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308326|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20308327|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308328|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308329|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
20308330|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308331|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308332|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20308333|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20308334|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308335|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308336|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308337|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20308338|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20308339|NCT00663832|Panobinostat|panobinostat|mesh-list
20308340|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308341|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20308342|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308343|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573501|NCT02054442|Cetuximab|cetuximab|mesh-list
20573502|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20573503|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
20573504|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20292295|NCT05338320|Fentanyl|fentanyl|mesh-list
20292296|NCT05338320|Morphine|morphine|mesh-list
20292297|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
20292298|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469040|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19469041|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
19469042|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469043|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566810|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
19566811|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
19566812|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566813|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566814|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566815|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19566816|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
19566817|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19566818|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19566819|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
19566820|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19566821|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
19566822|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19566823|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
19566824|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
19566825|NCT05181462|Gemcitabine|gemcitabine|mesh-list
19566826|NCT05181462|Carboplatin|carboplatin|mesh-list
19566827|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566828|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566829|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
19566830|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566831|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
19566832|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566833|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566834|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566835|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
19566836|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566837|NCT05180708|Sirolimus|sirolimus|mesh-list
19566838|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19566839|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566840|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19566841|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566842|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
19566843|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566844|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
19566845|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566846|NCT05174598|Calcitriol|calcitriol|mesh-list
19566847|NCT05174598|Calcipotriene|calcipotriene|mesh-list
19566848|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
19566849|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19566850|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566851|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19566852|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566853|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566854|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19566855|NCT05174598|Vitamins|vitamins|mesh-ancestor
19566856|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
19566857|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19566858|NCT05151848|Adalimumab|adalimumab|mesh-list
19566859|NCT05151848|Tofacitinib|tofacitinib|mesh-list
19566860|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19566861|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566862|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19566863|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566864|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566865|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
19566866|NCT05134688|Analgesics|analgesics|mesh-ancestor
19566867|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
19566868|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019317|NCT02506816|Olaparib|olaparib|mesh-list
20573505|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566869|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292299|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292300|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20292301|NCT05338320|Narcotics|narcotics|mesh-ancestor
20292302|NCT05338320|Analgesics|analgesics|mesh-ancestor
20292303|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
20292304|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292305|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20573506|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20573507|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
20573508|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573509|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573510|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
20573511|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573512|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20573513|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20573514|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
20573515|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573516|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20573517|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20573518|NCT02054468|Remifentanil|remifentanil|mesh-list
20573519|NCT02054468|Propofol|propofol|mesh-list
20573520|NCT02054468|Rocuronium|rocuronium|mesh-list
20573521|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20573522|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573523|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573524|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20573525|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
20573526|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
20573527|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20573528|NCT02054468|Narcotics|narcotics|mesh-ancestor
20573529|NCT02054468|Analgesics|analgesics|mesh-ancestor
20573530|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
20573531|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573532|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20573533|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20573534|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20573535|NCT02054637|Lanreotide|lanreotide|mesh-list
20573536|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573537|NCT02054663|Clopidogrel|clopidogrel|mesh-list
20573538|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20573539|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20573540|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20573541|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19469044|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
19469045|NCT03281187|Testosterone|testosterone|mesh-list
19469046|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
19469047|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
19469048|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19469049|NCT03281187|Androgens|androgens|mesh-ancestor
19469050|NCT03281187|Hormones|hormones|mesh-ancestor
19469051|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19469052|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469053|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19469054|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469055|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
19469056|NCT03280927|Efinaconazole|efinaconazole|mesh-list
19469057|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
19469058|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469059|NCT03280849|Chitosan|chitosan|mesh-list
19469060|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19469061|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19469062|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
19469063|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469064|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19469065|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
19469066|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
19469067|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
19469068|NCT03280849|Coagulants|coagulants|mesh-ancestor
19469069|NCT03280667|Denosumab|denosumab|mesh-list
19469070|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
19469071|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469072|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469073|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573542|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
19469074|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573543|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469075|NCT03280641|Warfarin|warfarin|mesh-list
19469076|NCT03280641|Dabigatran|dabigatran|mesh-list
20605400|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
20573544|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573545|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573546|NCT02054676|Ibuprofen|ibuprofen|mesh-list
20573547|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20573548|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20573549|NCT02054676|Analgesics|analgesics|mesh-ancestor
20573550|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
20573551|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573552|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573553|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573554|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573555|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20573556|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573557|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573558|NCT02054793|Itraconazole|itraconazole|mesh-list
20573559|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
19469077|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
19469078|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
19469079|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19469080|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
19469081|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469082|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469083|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
19469084|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469085|NCT03280407|Leucovorin|leucovorin|mesh-list
19469086|NCT03280407|Capecitabine|capecitabine|mesh-list
19469087|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
19469088|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
19469089|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19469090|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
19469091|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469092|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469093|NCT03280407|Antidotes|antidotes|mesh-ancestor
19469094|NCT03280407|Protective Agents|protective agents|mesh-ancestor
19469095|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469096|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
19469097|NCT03280407|Vitamins|vitamins|mesh-ancestor
19469098|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
19469099|NCT03280342|Topiramate|topiramate|mesh-list
19469100|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
19469101|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19469102|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469103|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19469104|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
20019318|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20019319|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019320|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019321|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019322|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
20019323|NCT02506868|Hematinics|hematinics|mesh-ancestor
20019324|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
20019325|NCT02506881|Hematinics|hematinics|mesh-ancestor
20019326|NCT02507011|Carvedilol|carvedilol|mesh-list
20019327|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20019328|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20019329|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
20019330|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019331|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019332|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019333|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20019334|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
20019335|NCT02507011|Protective Agents|protective agents|mesh-ancestor
20019336|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20019337|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019338|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19469105|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19469106|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19469107|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19469108|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469109|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469110|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
20019339|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
19469111|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019340|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19469112|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573560|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573561|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20573562|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20573563|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573564|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573565|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20573566|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
20573567|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573568|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573569|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20573570|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
20573571|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20573572|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469113|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19469114|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469115|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19469116|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19469117|NCT03280316|Urological Agents|urological agents|mesh-ancestor
19469118|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19469119|NCT03280277|Hematinics|hematinics|mesh-ancestor
19469120|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19469121|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19469122|NCT03280251|Methylphenidate|methylphenidate|mesh-list
19469123|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19469124|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469125|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20573573|NCT02054884|Paclitaxel|paclitaxel|mesh-list
20573574|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20573575|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20573576|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573577|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
20573578|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
20573579|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
20573580|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573581|NCT02054936|Warfarin|warfarin|mesh-list
20573582|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
20573583|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
20573584|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20573585|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
20573586|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20573587|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
20573588|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573589|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573590|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
20573591|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20573592|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
20573593|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573594|NCT02054949|Expectorants|expectorants|mesh-ancestor
20573595|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
20573596|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20573597|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
20573598|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573599|NCT02054949|Protective Agents|protective agents|mesh-ancestor
20573600|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573601|NCT02054949|Antidotes|antidotes|mesh-ancestor
20573602|NCT02054975|Vitamin D|vitamin d|mesh-list
20573603|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
20573604|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
20573605|NCT02054975|Vitamins|vitamins|mesh-list
20573606|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
20573607|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573608|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573609|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20573610|NCT02054988|Caffeine|caffeine|mesh-list
20573611|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20573612|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573613|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20573614|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573615|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573616|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20573617|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20573618|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
20573619|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469126|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19469127|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469128|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469129|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
19469130|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469131|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
19469132|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19469133|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19469134|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469135|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
19469136|NCT03280212|Coagulants|coagulants|mesh-ancestor
19469137|NCT03280160|Ofatumumab|ofatumumab|mesh-list
19469138|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469139|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19469140|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20573620|NCT02055014|Liraglutide|liraglutide|mesh-list
20573621|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20573622|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573623|NCT02055014|Incretins|incretins|mesh-ancestor
20573624|NCT02055014|Hormones|hormones|mesh-ancestor
20573625|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573626|NCT02055079|Sirolimus|sirolimus|mesh-list
20573627|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20573628|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573629|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20573630|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573631|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
20573632|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19469141|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469142|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
19469143|NCT03280095|Acetaminophen|acetaminophen|mesh-list
19469144|NCT03280095|Codeine|codeine|mesh-list
19469145|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19469146|NCT03280095|Analgesics|analgesics|mesh-ancestor
19469147|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
19469148|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469149|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469150|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
19469151|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19469152|NCT03280095|Narcotics|narcotics|mesh-ancestor
19469153|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469154|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
19469155|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
19469156|NCT03280017|Ketamine|ketamine|mesh-list
19469157|NCT03280017|Analgesics|analgesics|mesh-ancestor
19469158|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
19469159|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469160|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469161|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19469162|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19469163|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
19469164|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
19469165|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469166|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19469167|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19469168|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469169|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469170|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
19469171|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19469172|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19469173|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469174|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19469175|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19469176|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469177|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469178|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469179|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19469180|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
19469181|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19469182|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469183|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19469184|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19469185|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19469186|NCT03279978|Midazolam|midazolam|mesh-list
19469187|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19469188|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19469189|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469190|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469191|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19469192|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19469193|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469194|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19469195|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
19469196|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
19469197|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
19469198|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
19469199|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469200|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469201|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19469202|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469203|NCT03279861|Valsartan|valsartan|mesh-list
20573633|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
20573634|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573635|NCT02055131|Aspirin|aspirin|mesh-list
20573636|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20573637|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20573638|NCT02055131|Analgesics|analgesics|mesh-ancestor
20573639|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
20573640|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573641|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573642|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573643|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573644|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19469204|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19469205|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19469206|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19469207|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19469208|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469209|NCT03279809|Aspirin|aspirin|mesh-list
19469210|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19469211|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19469212|NCT03279809|Analgesics|analgesics|mesh-ancestor
19469213|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
19469214|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469215|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469216|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19469217|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19469218|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19469219|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19469220|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469221|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19469222|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19469223|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469224|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
19469225|NCT03279796|Betamethasone|betamethasone|mesh-list
19469226|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19469227|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
19469228|NCT03279796|Hormones|hormones|mesh-ancestor
19469229|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19469230|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469231|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19469232|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
19469233|NCT03279757|Lidocaine|lidocaine|mesh-list
19469234|NCT03279757|Epinephrine|epinephrine|mesh-list
19469235|NCT03279757|Racepinephrine|racepinephrine|mesh-list
19469236|NCT03279757|Tetracaine|tetracaine|mesh-list
19469237|NCT03279757|Carticaine|carticaine|mesh-list
19469238|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
19469239|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
19469240|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
19469241|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469242|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469243|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
19469244|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469245|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19469246|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19469247|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19469248|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469249|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469250|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19469251|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19469252|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
19469253|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469254|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19469255|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19469256|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
19469257|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19469258|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
19469259|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
19469260|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
19469261|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19566870|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
19566871|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566872|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20573645|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19566873|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
19566874|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20573646|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573647|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20573648|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20573649|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573650|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
20573651|NCT02055170|Finasteride|finasteride|mesh-list
20573652|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20573653|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20573654|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573655|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573656|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
20573657|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573658|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573659|NCT02055170|Urological Agents|urological agents|mesh-ancestor
20573660|NCT02055183|Antitoxins|antitoxins|mesh-list
20573661|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
20573662|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
20573663|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573664|NCT02055196|Irinotecan|irinotecan|mesh-list
20573665|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20573666|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20573667|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573668|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573669|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573670|NCT02055274|Rotigotine|rotigotine|mesh-list
20573671|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
20573672|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
20573673|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573674|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469262|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
19469263|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469264|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469265|NCT03279679|Ropivacaine|ropivacaine|mesh-list
19469266|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
19469267|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
19469268|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469269|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469270|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
19742731|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19742732|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
19742733|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19742734|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742735|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19742736|NCT04476030|Analgesics|analgesics|mesh-ancestor
19742737|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
19742738|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
19742739|NCT04475705|Propofol|propofol|mesh-list
19742740|NCT04475705|Sevoflurane|sevoflurane|mesh-list
19742741|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20573675|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605401|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605402|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605403|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20605404|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605405|NCT02232386|Rituximab|rituximab|mesh-list
20605406|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20605407|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605408|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
20605409|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605410|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573676|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20573677|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20573678|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20573679|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20573680|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573681|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019341|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20019342|NCT02507219|Ibuprofen|ibuprofen|mesh-list
20019343|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20019344|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019345|NCT02507219|Analgesics|analgesics|mesh-ancestor
20019346|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
20019347|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019348|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573682|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573683|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
20573684|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573685|NCT02055378|Atropine|atropine|mesh-list
20573686|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20573687|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20573688|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20573689|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
20573690|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573691|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573692|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20573693|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
20573694|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
20573695|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
20573696|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20573697|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20573698|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
20573699|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573700|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573701|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
20573702|NCT02055456|Nandrolone|nandrolone|mesh-list
20573703|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
20573704|NCT02055456|Androgens|androgens|mesh-ancestor
20573705|NCT02055456|Hormones|hormones|mesh-ancestor
20573706|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573707|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573708|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
20573709|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573710|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
20573711|NCT02055482|Hematinics|hematinics|mesh-ancestor
20573712|NCT02055586|Alovudine|alovudine|mesh-list
20573713|NCT02055586|Fluorides|fluorides|mesh-list
20573714|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
20573715|NCT02055586|Protective Agents|protective agents|mesh-ancestor
20573716|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573717|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
20573718|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573719|NCT02055664|Ropivacaine|ropivacaine|mesh-list
20573720|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
20573721|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
20573722|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573723|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573724|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
20573725|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573726|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
19469271|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469272|NCT03279601|Capecitabine|capecitabine|mesh-list
19469273|NCT03279601|Temozolomide|temozolomide|mesh-list
19469274|NCT03279601|Dacarbazine|dacarbazine|mesh-list
19469275|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19469276|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
19469277|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469278|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469279|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19469280|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
19469281|NCT03279562|Nalmefene|nalmefene|mesh-list
19469282|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20019349|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573727|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20573728|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573729|NCT02055703|Itraconazole|itraconazole|mesh-list
20573730|NCT02055703|Rifampin|rifampin|mesh-list
20573731|NCT02055703|Digoxin|digoxin|mesh-list
20573732|NCT02055703|Donepezil|donepezil|mesh-list
20573733|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20573734|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573735|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573736|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
19469283|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469284|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
19469285|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469286|NCT03279549|Mitogens|mitogens|mesh-list
20573737|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573738|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573739|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
20573740|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
20573741|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573742|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20573743|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20573744|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20573745|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
20573746|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573747|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20573748|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20573749|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
20573750|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20573751|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
20573752|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20573753|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20573754|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20573755|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20573756|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20573757|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20573758|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20573759|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20019350|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019351|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20019352|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019353|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019354|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20019355|NCT02507375|Pertuzumab|pertuzumab|mesh-list
20019356|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019357|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20019358|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019359|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019360|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20019361|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
19469287|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
19469288|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469289|NCT03279536|Lactoferrin|lactoferrin|mesh-list
19469290|NCT03279536|Dextrans|dextrans|mesh-list
19469291|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
19469292|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469293|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
19469294|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
19469295|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
19469296|NCT03279536|Hematinics|hematinics|mesh-ancestor
19469297|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19469298|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19469299|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469300|NCT03279341|Prucalopride|prucalopride|mesh-list
19469301|NCT03279341|Bisacodyl|bisacodyl|mesh-list
19469302|NCT03279341|Laxatives|laxatives|mesh-ancestor
19469303|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19469304|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19469305|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19469306|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
19469307|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469308|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019362|NCT02508077|Leucovorin|leucovorin|mesh-list
20573760|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20573761|NCT02055703|Protective Agents|protective agents|mesh-ancestor
20573762|NCT02055716|Sulforaphane|sulforaphane|mesh-list
20573763|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20573764|NCT02055716|Protective Agents|protective agents|mesh-ancestor
20573765|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573766|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573767|NCT02055911|Ranibizumab|ranibizumab|mesh-list
20573768|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20573769|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20573770|NCT02055911|Growth Substances|growth substances|mesh-ancestor
20573771|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573772|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
20573773|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573774|NCT02056041|Liver Extracts|liver extracts|mesh-list
20573775|NCT02056041|Hematinics|hematinics|mesh-ancestor
20573776|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
20573777|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573778|NCT02056184|Adalimumab|adalimumab|mesh-list
20573779|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573780|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573781|NCT02056210|Plerixafor|plerixafor|mesh-list
20573782|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20573783|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20573784|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
20573785|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573786|NCT02056223|Acetaminophen|acetaminophen|mesh-list
20573787|NCT02056223|Ibuprofen|ibuprofen|mesh-list
20573788|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19469309|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469310|NCT03279341|Cathartics|cathartics|mesh-ancestor
19469311|NCT03279328|Petrolatum|petrolatum|mesh-list
19469312|NCT03279328|Emollients|emollients|mesh-ancestor
19469313|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
19469314|NCT03279250|Prednisone|prednisone|mesh-list
19469315|NCT03279250|Cortisone|cortisone|mesh-list
19469316|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
19469317|NCT03279250|Hormones|hormones|mesh-list
19469318|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19469319|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19469320|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
19469321|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19469322|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469323|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19469324|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469325|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19469326|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469327|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469328|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
19469329|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19469330|NCT03279146|Tenofovir|tenofovir|mesh-list
19469331|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
20019363|NCT02508077|Folic Acid|folic acid|mesh-list
20019364|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20019365|NCT02508077|Panitumumab|panitumumab|mesh-list
20019366|NCT02508077|Fluorouracil|fluorouracil|mesh-list
20019367|NCT02508077|Irinotecan|irinotecan|mesh-list
20019368|NCT02508077|Camptothecin|camptothecin|mesh-list
20019369|NCT02508077|Antibodies|antibodies|mesh-list
20019370|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
20019371|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20019372|NCT02508077|Calcium|calcium|mesh-list
20019373|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
20019374|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
20019375|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019376|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019377|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20019378|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20019379|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
20019380|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019381|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20019382|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019383|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20019384|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20573789|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20573790|NCT02056223|Analgesics|analgesics|mesh-ancestor
19469332|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019385|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573791|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
20573792|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573793|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573794|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573795|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20573796|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20019386|NCT02508077|Antidotes|antidotes|mesh-ancestor
20019387|NCT02508077|Protective Agents|protective agents|mesh-ancestor
20019388|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
20573797|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573798|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573799|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
20573800|NCT02056249|Norepinephrine|norepinephrine|mesh-list
20573801|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20573802|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20573803|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
20573804|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573805|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573806|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573807|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
20573808|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
20573809|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573810|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20573811|NCT02056353|Insulin|insulin|mesh-list
20573812|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20573813|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573814|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
20573815|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
20573816|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573817|NCT02056366|Protective Agents|protective agents|mesh-ancestor
20573818|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573819|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
20573820|NCT02056366|Vitamins|vitamins|mesh-ancestor
20573821|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
20573822|NCT02056379|Dexamethasone|dexamethasone|mesh-list
20573823|NCT02056379|Budesonide|budesonide|mesh-list
20573824|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573825|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
20573826|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
20573827|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573828|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469333|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19469334|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19469335|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469336|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469337|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19469338|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19469339|NCT03279133|Ledipasvir|ledipasvir|mesh-list
19469340|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
19469341|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469342|NCT03279120|Tenofovir|tenofovir|mesh-list
19469343|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
19469344|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
19469345|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469346|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19469347|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19469348|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469349|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469350|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19469351|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19469352|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19469353|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
19469354|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19469355|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469356|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19469357|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19469358|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19469359|NCT03278938|Bupropion|bupropion|mesh-list
19469360|NCT03278938|Citalopram|citalopram|mesh-list
19469361|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19469362|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
19469363|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469364|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19469365|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20019389|NCT02508077|Vitamins|vitamins|mesh-ancestor
20573829|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20573830|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
20573831|NCT02056379|Hormones|hormones|mesh-ancestor
20573832|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573833|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19469366|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469367|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469368|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
19469369|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469370|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469371|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19469372|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19469373|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469374|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19469375|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
19469376|NCT03278860|Oxytocin|oxytocin|mesh-list
19469377|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
19469378|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19469379|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469380|NCT03278808|Azithromycin|azithromycin|mesh-list
19469381|NCT03278808|Chloroquine|chloroquine|mesh-list
19469382|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19469383|NCT03278808|Atovaquone|atovaquone|mesh-list
19469384|NCT03278808|Proguanil|proguanil|mesh-list
19469385|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19469386|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19469387|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469388|NCT03278808|Amebicides|amebicides|mesh-ancestor
19469389|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19469390|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19469391|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
19469392|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19469393|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19469394|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19469395|NCT03278808|Analgesics|analgesics|mesh-ancestor
19469396|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
19469397|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469398|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469399|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19469400|NCT03278808|Filaricides|filaricides|mesh-ancestor
19469401|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
19469402|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
19469403|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469404|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469405|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
19469406|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19469407|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
19469408|NCT03278782|Romidepsin|romidepsin|mesh-list
19469409|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469410|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469411|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469412|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19469413|NCT03278652|Analgesics|analgesics|mesh-list
19469414|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
19469415|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469416|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469417|NCT03278522|Ramosetron|ramosetron|mesh-list
19469418|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
19469419|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
19469420|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469421|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469422|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19469423|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19469424|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
19469425|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292306|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20573834|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469426|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469427|NCT03278483|Rifampin|rifampin|mesh-list
19469428|NCT03278483|Isoniazid|isoniazid|mesh-list
20573835|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20573836|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20573837|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
20573838|NCT02056405|Mosapride|mosapride|mesh-list
20573839|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20573840|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20573841|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
20573842|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573843|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573844|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573845|NCT02056418|Prednisone|prednisone|mesh-list
20573846|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
20573847|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573848|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
20573849|NCT02056418|Hormones|hormones|mesh-ancestor
20573850|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573851|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573852|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20573853|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469429|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19469430|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
19469431|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19469432|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469433|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
19469434|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19469435|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469436|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469437|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19469438|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19469439|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19469440|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19469441|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19469442|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19469443|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19469444|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19469445|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
19469446|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19469447|NCT03278444|Trimetazidine|trimetazidine|mesh-list
19469448|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
19469449|NCT03278431|Albendazole|albendazole|mesh-list
19469450|NCT03278431|Mebendazole|mebendazole|mesh-list
19469451|NCT03278431|Piperazine|piperazine|mesh-list
19469452|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
19469453|NCT03278431|Pyrantel|pyrantel|mesh-list
19469454|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
19469455|NCT03278431|Oxantel|oxantel|mesh-list
19469456|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
19469457|NCT03278431|DMP 777|dmp 777|mesh-list
19469458|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
19469459|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19469460|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469461|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
19469462|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19469463|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19469464|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
19469465|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
19469466|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
19469467|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469468|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469469|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
19469470|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469471|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19469472|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19469473|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19469474|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469475|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469476|NCT03278405|Avelumab|avelumab|mesh-list
19469477|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469478|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469479|NCT03278379|Avelumab|avelumab|mesh-list
19469480|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469481|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469482|NCT03278314|Ivacaftor|ivacaftor|mesh-list
19469483|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19469484|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20573854|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
20573855|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20573856|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20573857|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573858|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
20573859|NCT02056444|Coagulants|coagulants|mesh-ancestor
20573860|NCT02056587|Everolimus|everolimus|mesh-list
20573861|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573862|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20573863|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
20573864|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573865|NCT02056600|Metformin|metformin|mesh-list
20573866|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20573867|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573868|NCT02056665|Minocycline|minocycline|mesh-list
20573869|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20573870|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573871|NCT02056678|Acetaminophen|acetaminophen|mesh-list
20573872|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20573873|NCT02056678|Analgesics|analgesics|mesh-ancestor
20573874|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
20573875|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573876|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573877|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
20573878|NCT02056717|Dexamethasone|dexamethasone|mesh-list
19469485|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469486|NCT03278262|Aflibercept|aflibercept|mesh-list
19469487|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19469488|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19469489|NCT03278262|Growth Substances|growth substances|mesh-ancestor
19469490|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469491|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
19469492|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469493|NCT03278015|Gemcitabine|gemcitabine|mesh-list
19469494|NCT03278015|Paclitaxel|paclitaxel|mesh-list
19469495|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19469496|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19469497|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469498|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
19469499|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
19469500|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
19469501|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469502|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19469503|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
19469504|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
19469505|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469506|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469507|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19469508|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
19469509|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566875|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566876|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566877|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19566878|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
19566879|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19566880|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
19566881|NCT05132504|Folfirinox|folfirinox|mesh-list
19566882|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566883|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566884|NCT05121246|Palivizumab|palivizumab|mesh-list
19566885|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
19566886|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566887|NCT05118776|Bevacizumab|bevacizumab|mesh-list
19566888|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566889|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566890|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19566891|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19566892|NCT05118776|Growth Substances|growth substances|mesh-ancestor
19566893|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566894|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
19566895|NCT05107765|Pioglitazone|pioglitazone|mesh-list
19742742|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573879|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20573880|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
20573881|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
20573882|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573883|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573884|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20573885|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
20573886|NCT02056717|Hormones|hormones|mesh-ancestor
20573887|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20573888|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20573889|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573890|NCT02056730|Calcium|calcium|mesh-list
20573891|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20573892|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573893|NCT02056743|Fexofenadine|fexofenadine|mesh-list
20573894|NCT02056743|Losartan|losartan|mesh-list
20573895|NCT02056743|Midazolam|midazolam|mesh-list
20573896|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
20573897|NCT02056743|Caffeine|caffeine|mesh-list
20573898|NCT02056743|Omeprazole|omeprazole|mesh-list
20573899|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20573900|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20573901|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573902|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573903|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19469510|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
19469511|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
19469512|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
19469513|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
19469514|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
19469515|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469516|NCT03277599|Tramadol|tramadol|mesh-list
19469517|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19469518|NCT03277599|Narcotics|narcotics|mesh-ancestor
20573904|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20573905|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573906|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19469519|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469520|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469521|NCT03277599|Analgesics|analgesics|mesh-ancestor
19469522|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
19469523|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469524|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19469525|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19469526|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019390|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
20019391|NCT02508077|Hematinics|hematinics|mesh-ancestor
19742743|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742744|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742745|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
19742746|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
19742747|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19742748|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19742749|NCT04473508|Ropivacaine|ropivacaine|mesh-list
19742750|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
19742751|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
20292307|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
20573907|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
20573908|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
20573909|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
20573910|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
19469527|NCT03277573|Analgesics|analgesics|mesh-ancestor
20292308|NCT05338190|Rituximab|rituximab|mesh-list
20019392|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292309|NCT05338190|Belimumab|belimumab|mesh-list
20573911|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573912|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573913|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20573914|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20573915|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20573916|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20573917|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20573918|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20573919|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20573920|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573921|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20573922|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20573923|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20573924|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20573925|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
20573926|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
20573927|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
20573928|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20573929|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20573930|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20573931|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20573932|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20573933|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
20573934|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
20573935|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
20573936|NCT02056847|Pitavastatin|pitavastatin|mesh-list
20573937|NCT02056847|Calcium|calcium|mesh-list
20573938|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605411|NCT02232399|Simendan|simendan|mesh-list
20605412|NCT02232399|Milrinone|milrinone|mesh-list
19469528|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
19469529|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469530|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469531|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19469532|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19469533|NCT03277482|Durvalumab|durvalumab|mesh-list
19469534|NCT03277482|Tremelimumab|tremelimumab|mesh-list
19469535|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469536|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469537|NCT03277430|Tacrolimus|tacrolimus|mesh-list
19469538|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19469539|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
19469540|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469541|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19469542|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469543|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469544|NCT03277391|Droperidol|droperidol|mesh-list
19469545|NCT03277391|Morphine|morphine|mesh-list
19469546|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19469547|NCT03277391|Narcotics|narcotics|mesh-ancestor
19469548|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469549|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469550|NCT03277391|Analgesics|analgesics|mesh-ancestor
19469551|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
19469552|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469553|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19469554|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
19469555|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
19469556|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19469557|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19469558|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20605413|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20605414|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
20605415|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20605416|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20605417|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605418|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605419|NCT02232399|Protective Agents|protective agents|mesh-ancestor
20605420|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742752|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742753|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742754|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
19742755|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742756|NCT04471818|Ketamine|ketamine|mesh-list
19742757|NCT04471818|Analgesics|analgesics|mesh-ancestor
19742758|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
19742759|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573939|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573940|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573941|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20573942|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20573943|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20573944|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
20573945|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573946|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573947|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20573948|NCT02056899|Gabapentin|gabapentin|mesh-list
20573949|NCT02056899|Analgesics|analgesics|mesh-ancestor
20573950|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
20573951|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20573952|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573953|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
20573954|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20573955|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20573956|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20573957|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20573958|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20573959|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20573960|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20573961|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573962|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
20605421|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20605422|NCT02232516|Lenalidomide|lenalidomide|mesh-list
20605423|NCT02232516|Romidepsin|romidepsin|mesh-list
20605424|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
20605425|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605426|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20605427|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20605428|NCT02232516|Growth Substances|growth substances|mesh-ancestor
20605429|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
19469559|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469560|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19469561|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19469562|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
19469563|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469564|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469565|NCT03277339|Paroxetine|paroxetine|mesh-list
19469566|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19469567|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19469568|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469569|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469570|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469571|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
19469572|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566896|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19742760|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605430|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605431|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20573963|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20573964|NCT02056938|Basiliximab|basiliximab|mesh-list
20573965|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
20573966|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573967|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20573968|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
20573969|NCT02057003|Grazoprevir|grazoprevir|mesh-list
20573970|NCT02057003|Ledipasvir|ledipasvir|mesh-list
20573971|NCT02057003|Velpatasvir|velpatasvir|mesh-list
20573972|NCT02057003|Simeprevir|simeprevir|mesh-list
20573973|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
20573974|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573975|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
20573976|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573977|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469573|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19469574|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
19469575|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469576|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19469577|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19469578|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469579|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19469580|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
19469581|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469582|NCT03277222|Insulin|insulin|mesh-list
19469583|NCT03277222|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19469584|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19469585|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469586|NCT03277209|Plerixafor|plerixafor|mesh-list
19469587|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19469588|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19469589|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
19469590|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469591|NCT03277079|Ezetimibe|ezetimibe|mesh-list
19469592|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19469593|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19469594|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19469595|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
19742761|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19742762|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742763|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
19742764|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
19742765|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742766|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19742767|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19742768|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742769|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742770|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
19742771|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742772|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742773|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742774|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742775|NCT04471402|Analgesics|analgesics|mesh-ancestor
19742776|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
19742777|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742778|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19742779|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19742780|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19742781|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
19742782|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742783|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742784|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
19742785|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742786|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742787|NCT04462952|Adavosertib|adavosertib|mesh-list
19742788|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742789|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742790|NCT04462328|Durvalumab|durvalumab|mesh-list
19742791|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
19742792|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20573978|NCT02057094|Caseins|caseins|mesh-list
20573979|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
20573980|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
19469596|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469597|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19469598|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20573981|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573982|NCT02057107|Docetaxel|docetaxel|mesh-list
20573983|NCT02057107|Cetuximab|cetuximab|mesh-list
20573984|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20573985|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
20573986|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
20573987|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
20573988|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20573989|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469599|NCT03277001|Enoxaparin|enoxaparin|mesh-list
19469600|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
19469601|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19469602|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
19469603|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19469604|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
19469605|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469606|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469607|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
19469608|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19469609|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19469610|NCT03276858|Midazolam|midazolam|mesh-list
19469611|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19469612|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19469613|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19469614|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469615|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469616|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19469617|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19469618|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469619|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19469620|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
19469621|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
19469622|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
19469623|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
19469624|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469625|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469626|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
19469627|NCT03276832|Imiquimod|imiquimod|mesh-list
19469628|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469629|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469630|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19469631|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
19469632|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469633|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
19469634|NCT03276689|Pregabalin|pregabalin|mesh-list
19469635|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19469636|NCT03276689|Analgesics|analgesics|mesh-ancestor
19469637|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
19469638|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469639|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469640|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
19469641|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19469642|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469643|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469644|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19469645|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19469646|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19469647|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469648|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469649|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19469650|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19469651|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469652|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
19469653|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
19469654|NCT03276598|Losartan|losartan|mesh-list
19469655|NCT03276598|Amlodipine|amlodipine|mesh-list
19469656|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19469657|NCT03276598|Bisoprolol|bisoprolol|mesh-list
19469658|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19469659|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19469660|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469661|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469662|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19742793|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742794|NCT04459234|Ketamine|ketamine|mesh-list
20573990|NCT02057263|Alendronate|alendronate|mesh-list
20573991|NCT02057263|Diphosphonates|diphosphonates|mesh-list
20573992|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20573993|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20573994|NCT02057289|Micafungin|micafungin|mesh-list
20573995|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
20573996|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20573997|NCT02057328|Telmisartan|telmisartan|mesh-list
20573998|NCT02057328|Nebivolol|nebivolol|mesh-list
20573999|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574000|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20574001|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20574002|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574003|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
20574004|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20574005|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20574006|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19742795|NCT04459234|Analgesics|analgesics|mesh-ancestor
19742796|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
20574007|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574008|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574009|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574010|NCT02057367|Bupivacaine|bupivacaine|mesh-list
20574011|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574012|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
20574013|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574014|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574015|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
20574016|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574017|NCT02057484|Tacrolimus|tacrolimus|mesh-list
20574018|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574019|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
20574020|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574021|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20574022|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574023|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574024|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
19469663|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469664|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19469665|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19469666|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19469667|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19469668|NCT03276598|Diuretics|diuretics|mesh-ancestor
19469669|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
19469670|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19469671|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
19469672|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
19469673|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469674|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19469675|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19469676|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19469677|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
19469678|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742797|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742798|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019393|NCT02508103|Oxytocin|oxytocin|mesh-list
20019394|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
20019395|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019396|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019397|NCT02508207|Ivacaftor|ivacaftor|mesh-list
20574025|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574026|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
20574027|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574028|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574029|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
20574030|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574031|NCT02057679|Amoxicillin|amoxicillin|mesh-list
20574032|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574033|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574034|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
20574035|NCT02057770|Busulfan|busulfan|mesh-list
20574036|NCT02057770|Fludarabine|fludarabine|mesh-list
20574037|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
20574038|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574039|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
20574040|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469679|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20574041|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574042|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20574043|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
20574044|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574045|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574046|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20574047|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20574048|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
20574049|NCT02057796|Efavirenz|efavirenz|mesh-list
20574050|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20574051|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20574052|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20574053|NCT02057796|Rifampin|rifampin|mesh-list
20574054|NCT02057796|Isoniazid|isoniazid|mesh-list
20574055|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
20574056|NCT02057796|Ethambutol|ethambutol|mesh-list
20574057|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20574058|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20574059|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574060|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574061|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
20574062|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574063|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20574064|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20574065|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20574066|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20574067|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20574068|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20574069|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20574070|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19469680|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20574071|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20574072|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
19469681|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469682|NCT03276520|Ethanol|ethanol|mesh-list
19469683|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19469684|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469685|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469686|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469687|NCT03276325|Dexamethasone|dexamethasone|mesh-list
19469688|NCT03276325|Nalbuphine|nalbuphine|mesh-list
19469689|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19469690|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
19469691|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
19469692|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469693|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469694|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19469695|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
19469696|NCT03276325|Hormones|hormones|mesh-ancestor
19469697|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19469698|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19469699|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469700|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19469701|NCT03276325|Narcotics|narcotics|mesh-ancestor
19469702|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469703|NCT03276325|Analgesics|analgesics|mesh-ancestor
19469704|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
19566897|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577463|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577464|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20292310|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292311|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292312|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
20292313|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577465|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19577466|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577467|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577468|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292314|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577469|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20574073|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574074|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
20574075|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20574076|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20574077|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20574078|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20574079|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20574080|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
20574081|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20574082|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20574083|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
20574084|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574085|NCT02057926|Tetracycline|tetracycline|mesh-list
20574086|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574087|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574088|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20574089|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574090|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574091|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
19469705|NCT03276156|Apatinib|apatinib|mesh-list
19469706|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469707|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19469708|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469709|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469710|NCT03276143|Enoxaparin|enoxaparin|mesh-list
19469711|NCT03276143|Apixaban|apixaban|mesh-list
19469712|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
19469713|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19469714|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19469715|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469716|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19469717|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
19469718|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19469719|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
19469720|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469721|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
19469722|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469723|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469724|NCT03275818|Paclitaxel|paclitaxel|mesh-list
19469725|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19469726|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469727|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
19469728|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
19469729|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
19469730|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469731|NCT03275701|Triumeq|triumeq|mesh-list
19469732|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19469733|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19469734|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
19469735|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574092|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20574093|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20574094|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574095|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
20574096|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
20574097|NCT02058173|Chloroquine|chloroquine|mesh-list
20574098|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20574099|NCT02058173|Amebicides|amebicides|mesh-ancestor
20574100|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20574101|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20574102|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574103|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
20574104|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574105|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20574106|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574107|NCT02058173|Analgesics|analgesics|mesh-ancestor
20574108|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
20574109|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574110|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574111|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574112|NCT02058173|Filaricides|filaricides|mesh-ancestor
19469736|NCT03275597|Durvalumab|durvalumab|mesh-list
19469737|NCT03275597|Tremelimumab|tremelimumab|mesh-list
19469738|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469739|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574113|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
20574114|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
20574115|NCT02058186|Vitamin D|vitamin d|mesh-list
20574116|NCT02058186|Vitamins|vitamins|mesh-ancestor
20574117|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
20574118|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574119|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20574120|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
20574121|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20574122|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
20574123|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20574124|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
20574125|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574126|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574127|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
20574128|NCT02058212|Vitamin E|vitamin e|mesh-list
20574129|NCT02058212|Selenium|selenium|mesh-list
20574130|NCT02058212|Vitamins|vitamins|mesh-ancestor
20574131|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
20574132|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574133|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
20574134|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574135|NCT02058212|Protective Agents|protective agents|mesh-ancestor
20574136|NCT02058212|Trace Elements|trace elements|mesh-ancestor
20574137|NCT02058277|Aprepitant|aprepitant|mesh-list
20574138|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
20574139|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
20574140|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574141|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574142|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019398|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20019399|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115326|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20574143|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20574144|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574145|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574146|NCT02058303|Bupivacaine|bupivacaine|mesh-list
20574147|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574148|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
20574149|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574150|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574151|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
20574152|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574153|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20574154|NCT02058433|Paclitaxel|paclitaxel|mesh-list
20574155|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20574156|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292315|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292316|NCT05331859|Insulin|insulin|mesh-list
20292317|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20292318|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292319|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
20574157|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574158|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574159|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
20574160|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574161|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574162|NCT02058446|Amlodipine|amlodipine|mesh-list
20574163|NCT02058446|Valsartan|valsartan|mesh-list
20574164|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20574165|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574166|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20574167|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115327|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20115328|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115329|NCT00005118|Ritonavir|ritonavir|mesh-list
20115330|NCT00005118|Indinavir|indinavir|mesh-list
20115331|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20115332|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20115333|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
20115334|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115335|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115336|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20115337|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20115338|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
20115339|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115340|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20115341|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20574168|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574169|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20574170|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574171|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
20574172|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20574173|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20574174|NCT02058485|Midazolam|midazolam|mesh-list
20574175|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
20574176|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20574177|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574178|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574179|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019400|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469740|NCT03275558|Sunitinib|sunitinib|mesh-list
19469741|NCT03275558|Axitinib|axitinib|mesh-list
19469742|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469743|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19469744|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19469745|NCT03275558|Growth Substances|growth substances|mesh-ancestor
19469746|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469747|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
19469748|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19469749|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469750|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469751|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19469752|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19469753|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469754|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
19469755|NCT03275506|Bevacizumab|bevacizumab|mesh-list
19469756|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
19469757|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469758|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469759|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19469760|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19469761|NCT03275506|Growth Substances|growth substances|mesh-ancestor
19469762|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469763|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
19469764|NCT03275415|Budesonide|budesonide|mesh-list
19469765|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19469766|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19469767|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
19469768|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469769|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469770|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19469771|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
19469772|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
19469773|NCT03275415|Hormones|hormones|mesh-ancestor
19469774|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19469775|NCT03275376|Atorvastatin|atorvastatin|mesh-list
19469776|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19469777|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19469778|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
19469779|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469780|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19469781|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19469782|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469783|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
19469784|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19469785|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469786|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469787|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19469788|NCT03275207|Analgesics|analgesics|mesh-ancestor
19469789|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
19469790|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469791|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19469792|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19469793|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19469794|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
19469795|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469796|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019401|NCT02508259|Suramin|suramin|mesh-list
20019402|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
19469797|NCT03275116|Bromides|bromides|mesh-list
20019403|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
20019404|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20019405|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019406|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574180|NCT02058485|Analgesics|analgesics|mesh-ancestor
20574181|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
20574182|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574183|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20574184|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20574185|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20574186|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574187|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574188|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574189|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20574190|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20574191|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20574192|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20574193|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20574194|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
20574195|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
20574196|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
20574197|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
20574198|NCT02058576|Tamsulosin|tamsulosin|mesh-list
19469798|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
19469799|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
19469800|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19469801|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
19469802|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469803|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469804|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19469805|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
19469806|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19469807|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19469808|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19469809|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
19469810|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469811|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469812|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
19469813|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19469814|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
19469815|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
19469816|NCT03275090|SMOFlipid|smoflipid|mesh-list
19469817|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19469818|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19469819|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19469820|NCT03275012|Morphine|morphine|mesh-list
19469821|NCT03275012|Gabapentin|gabapentin|mesh-list
19469822|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19469823|NCT03275012|Narcotics|narcotics|mesh-ancestor
19469824|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469825|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469826|NCT03275012|Analgesics|analgesics|mesh-ancestor
19469827|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
19469828|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469829|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
19469830|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19469831|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19469832|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469833|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19469834|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19469835|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469836|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469837|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
19469838|NCT03274895|Biguanides|biguanides|mesh-list
19469839|NCT03274895|Polihexanide|polihexanide|mesh-list
19469840|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
19469841|NCT03274895|Propamidine|propamidine|mesh-list
19469842|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19469843|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469844|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
20574199|NCT02058576|Dutasteride|dutasteride|mesh-list
20574200|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19469845|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469846|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19469847|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19469848|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20574201|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20574202|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20574203|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574204|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574205|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574206|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574207|NCT02058576|Urological Agents|urological agents|mesh-ancestor
20574208|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20574209|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20574210|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574211|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
20574212|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574213|NCT02058641|Darapladib|darapladib|mesh-list
20574214|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20574215|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574216|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574217|NCT02058667|Paclitaxel|paclitaxel|mesh-list
20574218|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20574219|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574220|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574221|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
20574222|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574223|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574224|NCT02058693|Amphetamine|amphetamine|mesh-list
20574225|NCT02058693|Adderall|adderall|mesh-list
20574226|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20574227|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574228|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
20574229|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
20574230|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574231|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
20574232|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574233|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574234|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574235|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19469849|NCT03274817|Citalopram|citalopram|mesh-list
19469850|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19469851|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19469852|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19469853|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469854|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469855|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469856|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
19469857|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469858|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19469859|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
19469860|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469861|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19469862|NCT03274765|Estradiol|estradiol|mesh-list
19469863|NCT03274765|Estrogens|estrogens|mesh-ancestor
19469864|NCT03274765|Hormones|hormones|mesh-ancestor
19469865|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19469866|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469867|NCT03274752|Paroxetine|paroxetine|mesh-list
19469868|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19469869|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19469870|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19469871|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469872|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469873|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
19469874|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469875|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19469876|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
19469877|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19469878|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19469879|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19469880|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469881|NCT03274700|Tamsulosin|tamsulosin|mesh-list
19469882|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19469883|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19469884|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19469885|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574236|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20574237|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20574238|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20574239|NCT02058706|Leuprolide|leuprolide|mesh-list
20574240|NCT02058706|Goserelin|goserelin|mesh-list
20574241|NCT02058706|Bicalutamide|bicalutamide|mesh-list
20574242|NCT02058706|Androgens|androgens|mesh-list
20574243|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20574244|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
20574245|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20574246|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574247|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20574248|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574249|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
20574250|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
20574251|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574252|NCT02058706|Hormones|hormones|mesh-ancestor
20574253|NCT02058823|Amlodipine|amlodipine|mesh-list
20574254|NCT02058823|Valsartan|valsartan|mesh-list
20574255|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574256|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20019407|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20019408|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20019409|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
19469886|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469887|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469888|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469889|NCT03274700|Urological Agents|urological agents|mesh-ancestor
19469890|NCT03274596|Vitamin E|vitamin e|mesh-list
19469891|NCT03274596|Vitamins|vitamins|mesh-ancestor
19469892|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
19469893|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469894|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
19469895|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469896|NCT03274596|Protective Agents|protective agents|mesh-ancestor
19566898|NCT05087589|Tofacitinib|tofacitinib|mesh-list
19566899|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19566900|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566901|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566902|NCT05079061|Misoprostol|misoprostol|mesh-list
19566903|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19566904|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
19566905|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19566906|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566907|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19566908|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566909|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
19566910|NCT05069545|Insulin|insulin|mesh-list
19566911|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19566912|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
19566913|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19566914|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566915|NCT05064085|Capecitabine|capecitabine|mesh-list
19566916|NCT05064085|Cemiplimab|cemiplimab|mesh-list
19566917|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566918|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
19566919|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566920|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566921|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566922|NCT05057689|Fentanyl|fentanyl|mesh-list
19566923|NCT05057689|Midazolam|midazolam|mesh-list
19566924|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
19566925|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19566926|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566927|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566928|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19566929|NCT05057689|Analgesics|analgesics|mesh-ancestor
19566930|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
19566931|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577470|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
20574257|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605432|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20019410|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
20019411|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574258|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574259|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20574260|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574261|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
20574262|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20574263|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20605433|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20605434|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20019412|NCT02508389|Protective Agents|protective agents|mesh-ancestor
20019413|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019414|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
20019415|NCT02508428|Diuretics|diuretics|mesh-ancestor
20605435|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605436|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605437|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605438|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605439|NCT02232542|Analgesics|analgesics|mesh-ancestor
20605440|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
20605441|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605442|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
20605443|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605444|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
20605445|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20605446|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20605447|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20605448|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605449|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605450|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605451|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605452|NCT02232555|Analgesics|analgesics|mesh-ancestor
20605453|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
20605454|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605455|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
20605456|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605457|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
20605458|NCT02232581|Alovudine|alovudine|mesh-list
20605459|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
20605460|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
20605461|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19469897|NCT03274427|Trimetazidine|trimetazidine|mesh-list
19469898|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
19469899|NCT03274414|Cisplatin|cisplatin|mesh-list
19469900|NCT03274414|Etoposide|etoposide|mesh-list
19469901|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469902|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19469903|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19469904|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19469905|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469906|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469907|NCT03274401|Anticoagulants|anticoagulants|mesh-list
19469908|NCT03274323|Travoprost|travoprost|mesh-list
19469909|NCT03274323|Latanoprost|latanoprost|mesh-list
19469910|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19469911|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19469912|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19469913|NCT03274258|Nivolumab|nivolumab|mesh-list
19469914|NCT03274258|Ipilimumab|ipilimumab|mesh-list
19469915|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469916|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469917|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19469918|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469919|NCT03274167|Gabapentin|gabapentin|mesh-list
19469920|NCT03274167|Analgesics|analgesics|mesh-ancestor
19469921|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
19469922|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469923|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469924|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
19469925|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19469926|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19469927|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469928|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20574264|NCT02058875|Cyclosporine|cyclosporine|mesh-list
20574265|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
20574266|NCT02058875|Prednisone|prednisone|mesh-list
20574267|NCT02058875|Cyclosporins|cyclosporins|mesh-list
20574268|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574269|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
20574270|NCT02058875|Hormones|hormones|mesh-ancestor
20574271|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574272|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574273|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20574274|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574275|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574276|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574277|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574278|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
20574279|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
20574280|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574281|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
20574282|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574283|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20574284|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20574285|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20574286|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
20574287|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574288|NCT02058901|Sunitinib|sunitinib|mesh-list
20574289|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574290|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20574291|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20574292|NCT02058901|Growth Substances|growth substances|mesh-ancestor
20574293|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574294|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
20574295|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20574296|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469929|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19469930|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19469931|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19469932|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469933|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
19469934|NCT03274102|Vaccines|vaccines|mesh-list
19469935|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
19469936|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469937|NCT03274024|Mitomycins|mitomycins|mesh-list
19469938|NCT03274024|Mitomycin|mitomycin|mesh-list
19469939|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19469940|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469941|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
19469942|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469943|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19469944|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469945|NCT03274011|Apatinib|apatinib|mesh-list
19469946|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469947|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19469948|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469949|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469950|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19469951|NCT03273712|Octreotide|octreotide|mesh-list
19469952|NCT03273712|Edotreotide|edotreotide|mesh-list
19469953|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19469954|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19469955|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469956|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19469957|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469958|NCT03273634|Lansoprazole|lansoprazole|mesh-list
19469959|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
19469960|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20605462|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
20605463|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605464|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20605465|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20605466|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574297|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574298|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20574299|NCT02058979|Cefazolin|cefazolin|mesh-list
20574300|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574301|NCT02059018|Diclofenac|diclofenac|mesh-list
20574302|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
20574303|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
19469961|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19469962|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20574304|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20574305|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20574306|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20574307|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574308|NCT02059018|Analgesics|analgesics|mesh-ancestor
20574309|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
20574310|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574311|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292320|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
19469963|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469964|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469965|NCT03273595|Paclitaxel|paclitaxel|mesh-list
19469966|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
19469967|NCT03273595|Trastuzumab|trastuzumab|mesh-list
19469968|NCT03273595|Epirubicin|epirubicin|mesh-list
19469969|NCT03273595|Lapatinib|lapatinib|mesh-list
19469970|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19469971|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19469972|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
19469973|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
19469974|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
19469975|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19469976|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19469977|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
19469978|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469979|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19469980|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19469981|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
19469982|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19469983|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19469984|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19469985|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19469986|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19469987|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19469988|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19469989|NCT03273556|Lidocaine|lidocaine|mesh-list
19469990|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
19469991|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
19469992|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19469993|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19469994|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
19469995|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19469996|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19469997|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19469998|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19469999|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20292321|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292322|NCT05326490|Metformin|metformin|mesh-list
20292323|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20292324|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292325|NCT05325775|SR 142801|sr 142801|mesh-list
20292326|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20292327|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20292328|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574312|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574313|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574314|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574315|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574316|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
20574317|NCT02059031|Cabotegravir|cabotegravir|mesh-list
20574318|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20574319|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20574320|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574321|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574322|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20574323|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20574324|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
20574325|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574326|NCT02059330|Palbociclib|palbociclib|mesh-list
20574327|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470000|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470001|NCT03273296|Amoxicillin|amoxicillin|mesh-list
19470002|NCT03273296|Azithromycin|azithromycin|mesh-list
19470003|NCT03273296|Vancomycin|vancomycin|mesh-list
19470004|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19470005|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470006|NCT03273231|Ketamine|ketamine|mesh-list
19470007|NCT03273231|Analgesics|analgesics|mesh-ancestor
19470008|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
19470009|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470010|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470011|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19470012|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19470013|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
19470014|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
19470015|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470016|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19470017|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19470018|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470019|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470020|NCT03273192|Adalimumab|adalimumab|mesh-list
19470021|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470022|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19470023|NCT03273088|Etanercept|etanercept|mesh-list
19470024|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19470025|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19470026|NCT03273088|Analgesics|analgesics|mesh-ancestor
19470027|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
19470028|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470029|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019416|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
20019417|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019418|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20574328|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20574329|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574330|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574331|NCT02059460|Terlipressin|terlipressin|mesh-list
20574332|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574333|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20574334|NCT02059564|Liraglutide|liraglutide|mesh-list
20574335|NCT02059564|Exenatide|exenatide|mesh-list
20019419|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019420|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019421|NCT02508636|Leuprolide|leuprolide|mesh-list
20019422|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20019423|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
20019424|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019425|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019426|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20019427|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019428|NCT02508701|Vaccines|vaccines|mesh-list
20019429|NCT02508701|Immunologic Factors|immunologic factors|mesh-ancestor
20019430|NCT02508701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574336|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20574337|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574338|NCT02059564|Incretins|incretins|mesh-ancestor
20574339|NCT02059564|Hormones|hormones|mesh-ancestor
20574340|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574341|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20574342|NCT02059590|Isavuconazole|isavuconazole|mesh-list
20574343|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
20574344|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574345|NCT02059616|Amlodipine|amlodipine|mesh-list
19470030|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470031|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574346|NCT02059616|Candesartan|candesartan|mesh-list
20574347|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
20574348|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574349|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20574350|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20574351|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574352|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20574353|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574354|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
20574355|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20574356|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20574357|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
20574358|NCT02059655|Bimatoprost|bimatoprost|mesh-list
20574359|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20574360|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20574361|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574362|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20019431|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20019432|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20019433|NCT02508935|Narcotics|narcotics|mesh-ancestor
20019434|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019435|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019436|NCT02508935|Analgesics|analgesics|mesh-ancestor
20019437|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
20292329|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574363|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574364|NCT02059694|Lidocaine|lidocaine|mesh-list
20574365|NCT02059694|Epinephrine|epinephrine|mesh-list
20574366|NCT02059694|Racepinephrine|racepinephrine|mesh-list
20574367|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
19470032|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19470033|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470034|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
19470035|NCT03273075|Ticagrelor|ticagrelor|mesh-list
19470036|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19470037|NCT03273075|Cangrelor|cangrelor|mesh-list
19470038|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19470039|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19470040|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19470041|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19470042|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
19470043|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470044|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470045|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470046|NCT03273062|Tolcapone|tolcapone|mesh-list
19470047|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19470048|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19470049|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19470050|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470051|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470052|NCT03273036|Triamcinolone|triamcinolone|mesh-list
19470053|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470054|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
19470055|NCT03273036|Hormones|hormones|mesh-ancestor
19470056|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470057|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566932|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19566933|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19566934|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19566935|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
19566936|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566937|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566938|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19566939|NCT05057689|Narcotics|narcotics|mesh-ancestor
19566940|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19566941|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19566942|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
19566943|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
19566944|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19566945|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19566946|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19566947|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
20019438|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574368|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566948|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
20574369|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
20574370|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574371|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574372|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
20574373|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574374|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20574375|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20574376|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20574377|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20574378|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574379|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20574380|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20574381|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574382|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574383|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20574384|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20574385|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
20574386|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20574387|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
20574388|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
20574389|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
20574390|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20574391|NCT02059759|Aldesleukin|aldesleukin|mesh-list
20574392|NCT02059759|Interleukin-2|interleukin-2|mesh-list
20574393|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574394|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574395|NCT02059759|Analgesics|analgesics|mesh-ancestor
19470058|NCT03272867|Mannitol|mannitol|mesh-list
19470059|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19470060|NCT03272867|Diuretics|diuretics|mesh-ancestor
19470061|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
19470062|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470063|NCT03272802|Riluzole|riluzole|mesh-list
20574396|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
20574397|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574398|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574399|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20574400|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20574401|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
20574402|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574403|NCT02059772|Ranibizumab|ranibizumab|mesh-list
20574404|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20574405|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20574406|NCT02059772|Growth Substances|growth substances|mesh-ancestor
20574407|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574408|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
20574409|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574410|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
20574411|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574412|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
20574413|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574414|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574415|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20574416|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
20574417|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574418|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574419|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20574420|NCT02059876|Paclitaxel|paclitaxel|mesh-list
20574421|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20574422|NCT02059876|Carboplatin|carboplatin|mesh-list
20574423|NCT02059876|Trastuzumab|trastuzumab|mesh-list
20574424|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19470064|NCT03272802|Edaravone|edaravone|mesh-list
19470065|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
19470066|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19470067|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19470068|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470069|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470070|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470071|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19470072|NCT03272802|Protective Agents|protective agents|mesh-ancestor
19470073|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20574425|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574426|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574427|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
19470074|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
19470075|NCT03272711|Vortioxetine|vortioxetine|mesh-list
20019439|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20019440|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019441|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019442|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019443|NCT02509026|Etanercept|etanercept|mesh-list
20019444|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20019445|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019446|NCT02509026|Analgesics|analgesics|mesh-ancestor
20574428|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574429|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574430|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20574431|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
20574432|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20574433|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20574434|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574435|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
20574436|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
20574437|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574438|NCT02059915|Oxycodone|oxycodone|mesh-list
20574439|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20574440|NCT02059915|Narcotics|narcotics|mesh-ancestor
20574441|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574442|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574443|NCT02059915|Analgesics|analgesics|mesh-ancestor
20574444|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
20574445|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574446|NCT02059967|Paclitaxel|paclitaxel|mesh-list
20574447|NCT02059967|Carboplatin|carboplatin|mesh-list
20574448|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20574449|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574450|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574451|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
20574452|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574453|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574454|NCT02060006|Meloxicam|meloxicam|mesh-list
20574455|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
20574456|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20574457|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19470076|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
19470077|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19470078|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19470079|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19470080|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470081|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470082|NCT03272711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19470083|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19470084|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19470085|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470086|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470087|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
19470088|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19470089|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19470090|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19470091|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19470092|NCT05075460|Azacitidine|azacitidine|mesh-list
19470093|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19470094|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
20574458|NCT02060006|Analgesics|analgesics|mesh-ancestor
20574459|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
20574460|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574461|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574462|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574463|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574464|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20574465|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574466|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574467|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20574468|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20574469|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20574470|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20574471|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
20574472|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574473|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20574474|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20574475|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574476|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574477|NCT02060032|Atorvastatin|atorvastatin|mesh-list
20574478|NCT02060032|Simvastatin|simvastatin|mesh-list
20574479|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20574480|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20574481|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
20574482|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574483|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20574484|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20574485|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574486|NCT02060149|Minocycline|minocycline|mesh-list
20574487|NCT02060149|Sulbactam|sulbactam|mesh-list
20574488|NCT02060149|Cefoperazone|cefoperazone|mesh-list
20574489|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19470095|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470096|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470097|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470098|NCT05075512|Fulvestrant|fulvestrant|mesh-list
19470099|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19470100|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470101|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19470102|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20574490|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19470103|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
19470104|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470105|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470106|NCT05075265|Methadone|methadone|mesh-list
19470107|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19470108|NCT05075265|Narcotics|narcotics|mesh-ancestor
19470109|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470110|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470111|NCT05075265|Analgesics|analgesics|mesh-ancestor
19470112|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
19470113|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470114|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
19470115|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
19470116|NCT05075499|Vaccines|vaccines|mesh-list
19470117|NCT05075499|Immunologic Factors|immunologic factors|mesh-ancestor
19470118|NCT05075499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470119|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
19470120|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
19470121|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470122|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
19470123|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470124|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470125|NCT05074966|Cetuximab|cetuximab|mesh-list
19470126|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19470127|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470128|NCT05074992|Ipilimumab|ipilimumab|mesh-list
19470129|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19470130|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470131|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19470132|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470133|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
19470134|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19470135|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470136|NCT05074628|Renal Agents|renal agents|mesh-ancestor
19470137|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574491|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574492|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20574493|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574494|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574495|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
20574496|NCT02060201|Saxagliptin|saxagliptin|mesh-list
20574497|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20574498|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574499|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20574500|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574501|NCT02060201|Incretins|incretins|mesh-ancestor
20574502|NCT02060201|Hormones|hormones|mesh-ancestor
20574503|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574504|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20574505|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
20574506|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574507|NCT02060253|Paclitaxel|paclitaxel|mesh-list
20574508|NCT02060253|Trastuzumab|trastuzumab|mesh-list
20574509|NCT02060253|Pertuzumab|pertuzumab|mesh-list
20574510|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20574511|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574512|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574513|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
20574514|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574515|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574516|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20574517|NCT02060279|Carotenoids|carotenoids|mesh-list
20574518|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
20574519|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574520|NCT02060279|Protective Agents|protective agents|mesh-ancestor
20574521|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574522|NCT02060305|Bevacizumab|bevacizumab|mesh-list
20574523|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20574524|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574525|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20574526|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20574527|NCT02060305|Growth Substances|growth substances|mesh-ancestor
20574528|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574529|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
20574530|NCT02060318|Infliximab|infliximab|mesh-list
20574531|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
20574532|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20574533|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574534|NCT02060396|Aspirin|aspirin|mesh-list
19470138|NCT05074602|Fluconazole|fluconazole|mesh-list
19470139|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
19470140|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470141|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19470142|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19470143|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470144|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470145|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20574535|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20574536|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574537|NCT02060396|Analgesics|analgesics|mesh-ancestor
20574538|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
20574539|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574540|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574541|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574542|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574543|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20574544|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20574545|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574546|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20574547|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20574548|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574549|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
20574550|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
20574551|NCT02060552|Colchicine|colchicine|mesh-list
20574552|NCT02060552|Febuxostat|febuxostat|mesh-list
20574553|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
19470146|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
19470147|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470148|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470149|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19470150|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19470151|NCT05074589|Leucovorin|leucovorin|mesh-list
19470152|NCT05074589|Fluorouracil|fluorouracil|mesh-list
19470153|NCT05074589|Irinotecan|irinotecan|mesh-list
19470154|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
19470155|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
19470156|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470157|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19470158|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470159|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470160|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
19470161|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470162|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19470163|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19470164|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470165|NCT05074589|Antidotes|antidotes|mesh-ancestor
19742799|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19742800|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742801|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
20574554|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742802|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
20574555|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574556|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
20574557|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574558|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574559|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574560|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574561|NCT02060591|Bupivacaine|bupivacaine|mesh-list
20574562|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574563|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
20574564|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574565|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574566|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
20574567|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470166|NCT05074589|Protective Agents|protective agents|mesh-ancestor
19470167|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
19470168|NCT05074589|Vitamins|vitamins|mesh-ancestor
19470169|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
19470170|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19470171|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470172|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
19470173|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470174|NCT05073965|Vitamin D|vitamin d|mesh-list
19470175|NCT05073965|Vitamins|vitamins|mesh-ancestor
19470176|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
19470177|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470178|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19470179|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
19470180|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19470181|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470182|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470183|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19470184|NCT05065775|Analgesics|analgesics|mesh-ancestor
19470185|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
19470186|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470187|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19470188|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19470189|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19470190|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
19470191|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470192|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470193|NCT05068063|Bupivacaine|bupivacaine|mesh-list
19470194|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
19470195|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
19470196|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470197|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470198|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
19470199|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470200|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
19470201|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19470202|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
19470203|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470204|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
19470205|NCT05045586|Protective Agents|protective agents|mesh-ancestor
19470206|NCT04962022|Ritonavir|ritonavir|mesh-list
19470207|NCT04962022|Itraconazole|itraconazole|mesh-list
19470208|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19470209|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19470210|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
19470211|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470212|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470213|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19470214|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19470215|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
19470216|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470217|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19470218|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19470219|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
19470220|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19470221|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19470222|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
19470223|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574568|NCT02060604|Ketorolac|ketorolac|mesh-list
19470224|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470225|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
19470226|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574569|NCT02060604|Ranibizumab|ranibizumab|mesh-list
20574570|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20574571|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20574572|NCT02060604|Growth Substances|growth substances|mesh-ancestor
20574573|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574574|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
20574575|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019447|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
19470227|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19470228|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470229|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566949|NCT05054179|Ropivacaine|ropivacaine|mesh-list
19566950|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566951|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
19566952|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566953|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566954|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
19566955|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566956|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
19566957|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566958|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566959|NCT05050318|Vaccines|vaccines|mesh-list
19566960|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
19566961|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566962|NCT05047601|Ritonavir|ritonavir|mesh-list
19566963|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19566964|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19566965|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
19566966|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566967|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566968|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19566969|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19566970|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
19566971|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566972|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19566973|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19566974|NCT05044117|Capecitabine|capecitabine|mesh-list
19566975|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566976|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
19566977|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566978|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566979|NCT05041335|Heparin|heparin|mesh-list
19566980|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
19566981|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19566982|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19566983|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566984|NCT05029466|Psilocybin|psilocybin|mesh-list
19566985|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
19566986|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566987|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19566988|NCT05024006|Interferons|interferons|mesh-list
19566989|NCT05024006|Ritonavir|ritonavir|mesh-list
19566990|NCT05024006|Lopinavir|lopinavir|mesh-list
19566991|NCT05024006|Interferon-beta|interferon-beta|mesh-list
19566992|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
19566993|NCT05024006|Remdesivir|remdesivir|mesh-list
19566994|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
19566995|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
19566996|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566997|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
19566998|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566999|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19567000|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19567001|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
19567002|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567003|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567004|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19567005|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19567006|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19567007|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19470230|NCT04897841|Bupivacaine|bupivacaine|mesh-list
19470231|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
19470232|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
19470233|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470234|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470235|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
19470236|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470237|NCT04878315|Captopril|captopril|mesh-list
20574576|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20574577|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574578|NCT02060604|Analgesics|analgesics|mesh-ancestor
20574579|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
19470238|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19470239|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
19470240|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470241|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574580|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574581|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574582|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574583|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20574584|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574585|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574586|NCT02060656|Gemcitabine|gemcitabine|mesh-list
19470242|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19470243|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19470244|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19470245|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19470246|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
19470247|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470248|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19470249|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19470250|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470251|NCT04877821|Paclitaxel|paclitaxel|mesh-list
19470252|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
19470253|NCT04877821|Carboplatin|carboplatin|mesh-list
19470254|NCT04877821|Epirubicin|epirubicin|mesh-list
19470255|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19470256|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470257|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
19470258|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
19470259|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
19470260|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470261|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470262|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
19470263|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470264|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19470265|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19470266|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
19470267|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19470268|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19470269|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19470270|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19470271|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470272|NCT04824417|Itraconazole|itraconazole|mesh-list
19470273|NCT04824417|Voriconazole|voriconazole|mesh-list
19470274|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
19470275|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470276|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19470277|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19470278|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470279|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470280|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19470281|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
19470282|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470283|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470284|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19470285|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
19470286|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19470287|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19470288|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470289|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
20574587|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
20574588|NCT02060656|Rituximab|rituximab|mesh-list
20574589|NCT02060656|Lenalidomide|lenalidomide|mesh-list
20574590|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574591|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20574592|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
20574593|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574594|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574595|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20574596|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
20574597|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574598|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
20574599|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574600|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574601|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574602|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20574603|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20574604|NCT02060656|Growth Substances|growth substances|mesh-ancestor
20574605|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
20574606|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470290|NCT04818866|Coagulants|coagulants|mesh-ancestor
19470291|NCT04797325|Prednisolone|prednisolone|mesh-list
19470292|NCT04797325|Infliximab|infliximab|mesh-list
19470293|NCT04797325|Vedolizumab|vedolizumab|mesh-list
19470294|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470295|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
19470296|NCT04797325|Hormones|hormones|mesh-ancestor
19470297|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470298|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470299|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19470300|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470301|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19470302|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
19470303|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742803|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742804|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19742805|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19742806|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742807|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742808|NCT04457284|Nivolumab|nivolumab|mesh-list
19742809|NCT04457284|Temozolomide|temozolomide|mesh-list
19742810|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742811|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742812|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19742813|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742814|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19742815|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
19742816|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
19742817|NCT04441034|Convulsants|convulsants|mesh-list
19742818|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
19742819|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19742820|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19742821|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742822|NCT04432376|Miconazole|miconazole|mesh-list
19742823|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
19470326|NCT04744181|Folic Acid|folic acid|mesh-list
19470327|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
19470328|NCT04744181|Vitamins|vitamins|mesh-ancestor
19470329|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
19470330|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470331|NCT04744181|Hematinics|hematinics|mesh-ancestor
19470332|NCT04733560|Bupivacaine|bupivacaine|mesh-list
19470333|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574607|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
20019448|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019449|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019450|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019451|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574608|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
20574609|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574610|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20574611|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
20574612|NCT02060656|Hormones|hormones|mesh-ancestor
20574613|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574614|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20574615|NCT02060656|Protective Agents|protective agents|mesh-ancestor
20574616|NCT02060669|Capecitabine|capecitabine|mesh-list
20574617|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20574618|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
20574619|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574620|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605467|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20605468|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605469|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
20605470|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470334|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
19470335|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470336|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470337|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
19470338|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470339|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19470340|NCT04669561|Lifitegrast|lifitegrast|mesh-list
19470341|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19470342|NCT04647383|Lemborexant|lemborexant|mesh-list
19470343|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19470344|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470345|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470346|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19470347|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19470348|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470349|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470350|NCT04630002|Ritonavir|ritonavir|mesh-list
19470351|NCT04630002|Darunavir|darunavir|mesh-list
19470352|NCT04630002|Etravirine|etravirine|mesh-list
19470353|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20605471|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605472|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605473|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605474|NCT02232607|Lacidipine|lacidipine|mesh-list
20605475|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605476|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20605477|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605478|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605479|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605480|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605481|NCT02232672|Choline|choline|mesh-list
20605482|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
20605483|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605484|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
20019452|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019453|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019454|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
20019455|NCT02509065|Pancrelipase|pancrelipase|mesh-list
20019456|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605485|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605486|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605487|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605488|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
20605489|NCT02232685|Choline|choline|mesh-list
20605490|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
20605491|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605492|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
20605493|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605494|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605495|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605496|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
19470354|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20019457|NCT02509078|Cisatracurium|cisatracurium|mesh-list
20019458|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20019459|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20019460|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574621|NCT02060734|Lidocaine|lidocaine|mesh-list
20574622|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574623|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
20574624|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574625|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574626|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
20574627|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574628|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20574629|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20574630|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20019461|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019462|NCT02509481|Ivermectin|ivermectin|mesh-list
20019463|NCT02509481|Albendazole|albendazole|mesh-list
20574631|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20574632|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574633|NCT02060786|Clopidogrel|clopidogrel|mesh-list
20574634|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20574635|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20574636|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20574637|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20574638|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
20574639|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574640|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574641|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574642|NCT02060851|Iron|iron|mesh-list
20574643|NCT02060851|Trace Elements|trace elements|mesh-ancestor
20574644|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
20574645|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574646|NCT02060916|PAZ320|paz320|mesh-list
20574647|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20574648|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574649|NCT02060929|Esketamine|esketamine|mesh-list
20574650|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
20574651|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20574652|NCT02060955|Bevacizumab|bevacizumab|mesh-list
20574653|NCT02060955|Irinotecan|irinotecan|mesh-list
20574654|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20574655|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574656|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20574657|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20574658|NCT02060955|Growth Substances|growth substances|mesh-ancestor
20574659|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574660|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
20574661|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20574662|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20574663|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574664|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574665|NCT02061007|Misonidazole|misonidazole|mesh-list
20574666|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574667|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20574668|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20574669|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574670|NCT02061124|Sevelamer|sevelamer|mesh-list
20574671|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
20574672|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
20574673|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574674|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19470355|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
19470356|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470357|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470358|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19470359|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19470360|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
19470361|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470362|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19470363|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19470364|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19470365|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19470366|NCT04495452|Fentanyl|fentanyl|mesh-list
20019464|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20574675|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20574676|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574677|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574678|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
20574679|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574680|NCT02061267|Niacin|niacin|mesh-list
20574681|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
20574682|NCT02061267|Vitamins|vitamins|mesh-ancestor
20574683|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
20574684|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574685|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
20574686|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20574687|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
20574688|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574689|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20574690|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
20574691|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
20574692|NCT02061293|Promethazine|promethazine|mesh-list
20574693|NCT02061293|Psilocybin|psilocybin|mesh-list
20574694|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20574695|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20574696|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574697|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574698|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574699|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
20574700|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
20574701|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574702|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
20574703|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
20574704|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20574705|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20574706|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
20574707|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
20574708|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574709|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574710|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20574711|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
20574712|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
20574713|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
20574714|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20574715|NCT02061449|Romidepsin|romidepsin|mesh-list
20574716|NCT02061449|Poly ICLC|poly iclc|mesh-list
20574717|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
20574718|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
20574719|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574720|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20574721|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574722|NCT02061475|Lidocaine|lidocaine|mesh-list
20574723|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
20574724|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
20574725|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574726|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574727|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
20574728|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574729|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20574730|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20574731|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20574732|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20574733|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574734|NCT02061631|Dexamethasone|dexamethasone|mesh-list
20574735|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
20574736|NCT02061631|Docetaxel|docetaxel|mesh-list
20574737|NCT02061631|BB 1101|bb 1101|mesh-list
20574738|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574739|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574740|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
20574741|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
20574742|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574743|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574744|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20574745|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
19470367|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19742824|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574746|NCT02061631|Hormones|hormones|mesh-ancestor
20574747|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574748|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20574749|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
20574750|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574751|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574752|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574753|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
20574754|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574755|NCT02061644|Anesthetics|anesthetics|mesh-list
20574756|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574757|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574758|NCT02061657|Misoprostol|misoprostol|mesh-list
20574759|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20574760|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
20574761|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20574762|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574763|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20574764|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20574765|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
20574766|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
20574767|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20574768|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
19470368|NCT04495452|Narcotics|narcotics|mesh-ancestor
19470369|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470370|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470371|NCT04495452|Analgesics|analgesics|mesh-ancestor
19470372|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
19470373|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470374|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19470375|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19470376|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
19470377|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
19470378|NCT04431466|Ivermectin|ivermectin|mesh-list
19470379|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19470380|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470381|NCT04427904|Lidocaine|lidocaine|mesh-list
19470382|NCT04427904|Epinephrine|epinephrine|mesh-list
19470383|NCT04427904|Racepinephrine|racepinephrine|mesh-list
19470384|NCT04427904|Bupivacaine|bupivacaine|mesh-list
19470385|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
19470386|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
19470387|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
19470388|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470389|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470390|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
19470391|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470392|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19470393|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19470394|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19470395|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19470396|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470397|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19470398|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19470399|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19470400|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470401|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19470402|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19470403|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
19470404|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19470405|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
19470406|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
19470407|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
19470408|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19470409|NCT04416282|Terlipressin|terlipressin|mesh-list
19470410|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19470411|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19470412|NCT04377451|Metformin|metformin|mesh-list
19470413|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19470414|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470415|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19470416|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
19470417|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
19470418|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470419|NCT04239040|Nivolumab|nivolumab|mesh-list
19470420|NCT04239040|Ipilimumab|ipilimumab|mesh-list
20574769|NCT02061800|Melphalan|melphalan|mesh-list
20019465|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574770|NCT02061800|Busulfan|busulfan|mesh-list
19470421|NCT04239040|Vaccines|vaccines|mesh-list
20019466|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
20574771|NCT02061800|Thiotepa|thiotepa|mesh-list
20574772|NCT02061800|Fludarabine|fludarabine|mesh-list
20574773|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
20574774|NCT02061800|Tacrolimus|tacrolimus|mesh-list
20574775|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574776|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
20574777|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574778|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574779|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20574780|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
20574781|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574782|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574783|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20574784|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20574785|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574786|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574787|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
20574788|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
20574789|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574790|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20574791|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
20574792|NCT02061800|Hormones|hormones|mesh-ancestor
20574793|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574794|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19470422|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
19470423|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470424|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19470425|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470426|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19470427|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742825|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20292330|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20574795|NCT02061800|Protective Agents|protective agents|mesh-ancestor
20605497|NCT02232724|Choline|choline|mesh-list
20605498|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
20605499|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605500|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
20605501|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605502|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605503|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605504|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
20605505|NCT02232737|Nicotine|nicotine|mesh-list
20605506|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20605507|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
20605508|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605509|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605510|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20605511|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20605512|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
19470428|NCT04149899|Timolol|timolol|mesh-list
19470429|NCT04149899|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19470430|NCT04149899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19470431|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19470432|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19470433|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
19470434|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470435|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470436|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470437|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19470438|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19567008|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
19567009|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19567010|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19567011|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567012|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
19567013|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567014|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19567015|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
20574796|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20574797|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20574798|NCT02061878|Bexarotene|bexarotene|mesh-list
20574799|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574800|NCT02061917|Lobeline|lobeline|mesh-list
20574801|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20574802|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
20574803|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574804|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019467|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
20019468|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20574805|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20574806|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20574807|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
20574808|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567016|NCT05019703|Atezolizumab|atezolizumab|mesh-list
19567017|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19567018|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567019|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
19567020|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567021|NCT04993027|Vancomycin|vancomycin|mesh-list
19567022|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567023|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567024|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
19567025|NCT04983238|Trastuzumab|trastuzumab|mesh-list
19567026|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567027|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567028|NCT04983238|Antidotes|antidotes|mesh-ancestor
19567029|NCT04983238|Protective Agents|protective agents|mesh-ancestor
19567030|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567031|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
19567032|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567033|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
19567034|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567035|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567036|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
19567037|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
19567038|NCT04956146|Carboplatin|carboplatin|mesh-list
19567039|NCT04956146|Pemetrexed|pemetrexed|mesh-list
19567040|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567041|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567042|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567043|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19567044|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19567045|NCT04942067|Dexamethasone|dexamethasone|mesh-list
19567046|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
19567047|NCT04942067|Lenalidomide|lenalidomide|mesh-list
19567048|NCT04942067|Daratumumab|daratumumab|mesh-list
19567049|NCT04942067|Pomalidomide|pomalidomide|mesh-list
19567050|NCT04942067|BB 1101|bb 1101|mesh-list
20019469|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20019470|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
20019471|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
19567051|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567052|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
19567053|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
19567054|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567055|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019472|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742826|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19470439|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
19470440|NCT04046263|Hematinics|hematinics|mesh-ancestor
19470441|NCT03920527|Itraconazole|itraconazole|mesh-list
19470442|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
20574809|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742827|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742828|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742829|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19742830|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
19742831|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019473|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019474|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292331|NCT05325489|Budesonide|budesonide|mesh-list
20574810|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
20574811|NCT02062034|Vitamins|vitamins|mesh-list
20574812|NCT02062034|Vitamin E|vitamin e|mesh-list
20574813|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
20574814|NCT02062034|Ubiquinone|ubiquinone|mesh-list
20574815|NCT02062034|Antioxidants|antioxidants|mesh-list
20574816|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
20574817|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574818|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574819|NCT02062034|Protective Agents|protective agents|mesh-ancestor
20574820|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
20574821|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20574822|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574823|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
20574824|NCT02062112|Laxatives|laxatives|mesh-list
20574825|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19470443|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470444|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19470445|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19470446|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470447|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470448|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19470449|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
19470450|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470451|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470452|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19470453|NCT03902509|Pirfenidone|pirfenidone|mesh-list
19470454|NCT03902509|Analgesics|analgesics|mesh-ancestor
19470455|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
19470456|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470457|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470458|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19470459|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19470460|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470461|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19470462|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470463|NCT03873480|Epinephrine|epinephrine|mesh-list
19470464|NCT03873480|Bupivacaine|bupivacaine|mesh-list
19470465|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19470466|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19470467|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
19470468|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470469|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470470|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470471|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19470472|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19470473|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
19470474|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470475|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19470476|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
19470477|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
19470478|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
19470479|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19470480|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
19470481|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
19470482|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470483|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
19470484|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
19470485|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
19470486|NCT03854370|Povidone|povidone|mesh-list
20574826|NCT02062190|Resveratrol|resveratrol|mesh-list
20574827|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
20574828|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574829|NCT02062190|Protective Agents|protective agents|mesh-ancestor
20574830|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574831|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574832|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20574833|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
20574834|NCT02062203|Glycine|glycine|mesh-list
20574835|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574836|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574837|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20574838|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20574839|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574840|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574841|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574842|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574843|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
20574844|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470487|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19470488|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470489|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
19470490|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
19470491|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
19470492|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
19470493|NCT03849651|Melphalan|melphalan|mesh-list
19470494|NCT03849651|Thiotepa|thiotepa|mesh-list
19470495|NCT03849651|Fludarabine|fludarabine|mesh-list
19470496|NCT03849651|Blinatumomab|blinatumomab|mesh-list
19470497|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
19470498|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470499|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
19470500|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470501|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19470502|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19470503|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
19470504|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470505|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470506|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20574845|NCT02062255|Aspirin|aspirin|mesh-list
20574846|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20574847|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574848|NCT02062255|Analgesics|analgesics|mesh-ancestor
20574849|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
20574850|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574851|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574852|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20574853|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574854|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20574855|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20574856|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574857|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20574858|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20574859|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574860|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
20574861|NCT02062281|Vaccines|vaccines|mesh-list
20574862|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20574863|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
20574864|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470507|NCT03821883|Aspirin|aspirin|mesh-list
19470508|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19470509|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19470510|NCT03821883|Analgesics|analgesics|mesh-ancestor
19470511|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
19470512|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470513|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470514|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470515|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19470516|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19470517|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19470518|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470519|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20019475|NCT02509624|Selonsertib|selonsertib|mesh-list
20574865|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
20574866|NCT02062333|Esmolol|esmolol|mesh-list
20574867|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20574868|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20574869|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574870|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574871|NCT02062333|Analgesics|analgesics|mesh-ancestor
19470520|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19470521|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470522|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
19470523|NCT03752684|Calcium|calcium|mesh-list
19470524|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19470525|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470526|NCT03545464|Prednisone|prednisone|mesh-list
19470527|NCT03545464|Levocetirizine|levocetirizine|mesh-list
19470528|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470529|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
19470530|NCT03545464|Hormones|hormones|mesh-ancestor
19470531|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470532|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470533|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19470534|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470535|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19470536|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19470537|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
19470538|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
19470539|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470540|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470541|NCT03538938|Nicotine|nicotine|mesh-list
19470542|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19470543|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
19470544|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470545|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470546|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19470547|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19470548|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
19470549|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470550|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470551|NCT03536520|Acetazolamide|acetazolamide|mesh-list
19470552|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
19470553|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19470554|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470555|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470556|NCT03536520|Diuretics|diuretics|mesh-ancestor
19470557|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
19470558|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742832|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742833|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20574872|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
20574873|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574874|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20574875|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20574876|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20574877|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574878|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574879|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574880|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20574881|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19470559|NCT03536455|Acetazolamide|acetazolamide|mesh-list
20574882|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20574883|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20574884|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574885|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20574886|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605513|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605514|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605515|NCT02232763|Losartan|losartan|mesh-list
20605516|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20605517|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605518|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20605519|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20605520|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605521|NCT02232776|Losartan|losartan|mesh-list
20574887|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
20574888|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574889|NCT02062892|Sirolimus|sirolimus|mesh-list
20574890|NCT02062892|Everolimus|everolimus|mesh-list
20574891|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574892|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574893|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
20574894|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574895|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574896|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574897|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20574898|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
20574899|NCT02062944|Sirolimus|sirolimus|mesh-list
20574900|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20574901|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574902|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574903|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20574904|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574905|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
20574906|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
20574907|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574908|NCT02062983|Trastuzumab|trastuzumab|mesh-list
20574909|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20574910|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574911|NCT02062996|Phenylephrine|phenylephrine|mesh-list
20574912|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
20574913|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20574914|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20574915|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20574916|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20574917|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574918|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574919|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
20574920|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
20574921|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574922|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
20574923|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20574924|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
20574925|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20574926|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
20574927|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20574928|NCT02062996|Protective Agents|protective agents|mesh-ancestor
20574929|NCT02063022|Dactinomycin|dactinomycin|mesh-list
20574930|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
20574931|NCT02063022|Melphalan|melphalan|mesh-list
20574932|NCT02063022|Busulfan|busulfan|mesh-list
19470560|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
19470561|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19470562|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470563|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470564|NCT03536455|Diuretics|diuretics|mesh-ancestor
19470565|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
19470566|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470567|NCT03536429|Acetazolamide|acetazolamide|mesh-list
19470568|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
19470569|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19470570|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470571|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470572|NCT03536429|Diuretics|diuretics|mesh-ancestor
19470573|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
19470574|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470575|NCT03529825|Rifaximin|rifaximin|mesh-list
19470576|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19470577|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470578|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19470579|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
19470580|NCT03475134|Nivolumab|nivolumab|mesh-list
19470581|NCT03475134|Fludarabine|fludarabine|mesh-list
19470582|NCT03475134|Interleukin-2|interleukin-2|mesh-list
19470583|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470584|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
19470585|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470586|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574933|NCT02063022|Ifosfamide|ifosfamide|mesh-list
19470587|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20574934|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
20574935|NCT02063022|Doxorubicin|doxorubicin|mesh-list
20574936|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20574937|NCT02063022|Etoposide|etoposide|mesh-list
20574938|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
20574939|NCT02063022|Vincristine|vincristine|mesh-list
20574940|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20574941|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
20574942|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574943|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20574944|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20574945|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
20019476|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20019477|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019478|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574946|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574947|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20574948|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20574949|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20574950|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20574951|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20574952|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574953|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20574954|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
20574955|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
20574956|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
20574957|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20574958|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20574959|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20574960|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20574961|NCT02063100|Losartan|losartan|mesh-list
20574962|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20574963|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20574964|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20574965|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20574966|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574967|NCT02063139|Fluticasone|fluticasone|mesh-list
20574968|NCT02063139|Beclomethasone|beclomethasone|mesh-list
20574969|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470588|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
19470589|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470590|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470591|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19470592|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19470593|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19470594|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20574970|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20574971|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
20574972|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20574973|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574974|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20574975|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
20574976|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
20574977|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20574978|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
20574979|NCT02063139|Hormones|hormones|mesh-ancestor
20574980|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20574981|NCT02063269|Rivastigmine|rivastigmine|mesh-list
20574982|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20574983|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20574984|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20574985|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
20574986|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470595|NCT03475134|Analgesics|analgesics|mesh-ancestor
19470596|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
19470597|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470598|NCT03461120|Anesthetics|anesthetics|mesh-list
19470599|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
19470600|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470601|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470602|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
19470603|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470604|NCT03384212|Cytarabine|cytarabine|mesh-list
19470605|NCT03384212|Fludarabine|fludarabine|mesh-list
19470606|NCT03384212|Busulfan|busulfan|mesh-list
19470607|NCT03384212|Cladribine|cladribine|mesh-list
19470608|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470609|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20574987|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574988|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19470610|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
19470611|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470612|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470613|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
19470614|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470615|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
20574989|NCT02063269|Protective Agents|protective agents|mesh-ancestor
20574990|NCT02063334|Vitamin D|vitamin d|mesh-list
20574991|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
20574992|NCT02063334|Vitamins|vitamins|mesh-ancestor
20574993|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
20574994|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20574995|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20574996|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20574997|NCT02063360|Ritonavir|ritonavir|mesh-list
20574998|NCT02063360|Darunavir|darunavir|mesh-list
20574999|NCT02063360|Fostemsavir|fostemsavir|mesh-list
20575000|NCT02063360|Etravirine|etravirine|mesh-list
20575001|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20575002|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20575003|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
20575004|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575005|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575006|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20575007|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20575008|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
20575009|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575010|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20575011|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20575012|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20575013|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20575014|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20575015|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20575016|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
20575017|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20575018|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
20575019|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575020|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
20575021|NCT02063373|Protective Agents|protective agents|mesh-ancestor
20575022|NCT02063425|Fluoxetine|fluoxetine|mesh-list
20575023|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20575024|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20575025|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575026|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575027|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575028|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
20575029|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470616|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470617|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
19470618|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19470619|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19470620|NCT03384225|Cytarabine|cytarabine|mesh-list
19470621|NCT03384225|Fludarabine|fludarabine|mesh-list
19470622|NCT03384225|Busulfan|busulfan|mesh-list
19470623|NCT03384225|Cladribine|cladribine|mesh-list
19470624|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470625|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19470626|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
19470627|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470628|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470629|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
19470630|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470631|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
20019479|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20019480|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
19470632|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470633|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
19470634|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20575030|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20575031|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
20575032|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20575033|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20575034|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20575035|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575036|NCT02063529|Leucovorin|leucovorin|mesh-list
20575037|NCT02063529|Fluorouracil|fluorouracil|mesh-list
20575038|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
20575039|NCT02063529|Irinotecan|irinotecan|mesh-list
20575040|NCT02063529|Cetuximab|cetuximab|mesh-list
20575041|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
20575042|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
20575043|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575044|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20575045|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575046|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20575047|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
20575048|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575049|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20575050|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20575051|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575052|NCT02063529|Antidotes|antidotes|mesh-ancestor
20575053|NCT02063529|Protective Agents|protective agents|mesh-ancestor
20575054|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
20575055|NCT02063529|Vitamins|vitamins|mesh-ancestor
20575056|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
20575057|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20575058|NCT02063568|Oxytocin|oxytocin|mesh-list
20575059|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
20575060|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20575061|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575062|NCT02063620|Ketamine|ketamine|mesh-list
20575063|NCT02063620|Analgesics|analgesics|mesh-ancestor
20575064|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
19470635|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19470636|NCT03272698|Ketamine|ketamine|mesh-list
19470637|NCT03272698|Analgesics|analgesics|mesh-ancestor
19470638|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
19470639|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470640|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470641|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19470642|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19470643|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
19470644|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
19470645|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470646|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19470647|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19470648|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470649|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470650|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19470651|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
19470652|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470653|NCT03272425|Allopurinol|allopurinol|mesh-list
19470654|NCT03272425|Lesinurad|lesinurad|mesh-list
19470655|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
19470656|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470657|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470658|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
19470659|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19470660|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19470661|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
19470662|NCT03272425|Protective Agents|protective agents|mesh-ancestor
19470663|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470664|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
19470665|NCT03272425|Renal Agents|renal agents|mesh-ancestor
19470666|NCT03272477|Tamoxifen|tamoxifen|mesh-list
19470667|NCT03272477|Paclitaxel|paclitaxel|mesh-list
19470668|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19470669|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
19470670|NCT03272477|Trastuzumab|trastuzumab|mesh-list
19470671|NCT03272477|Letrozole|letrozole|mesh-list
19742834|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19470672|NCT03272477|Epirubicin|epirubicin|mesh-list
20575065|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470673|NCT03272477|Anastrozole|anastrozole|mesh-list
19470674|NCT03272477|Exemestane|exemestane|mesh-list
19470675|NCT03272477|Pertuzumab|pertuzumab|mesh-list
19470676|NCT03272477|Goserelin|goserelin|mesh-list
19470677|NCT03272477|Leuprolide|leuprolide|mesh-list
19470678|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19470679|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470680|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
19470681|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
19470682|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
19470683|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019481|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20019482|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20019483|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20019484|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
20019485|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019486|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019487|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20019488|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20019489|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20019490|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20019491|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019492|NCT02510001|Crizotinib|crizotinib|mesh-list
20019493|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019494|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20575066|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575067|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20575068|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20575069|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
20575070|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
20575071|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575072|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20575073|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20019495|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019496|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019497|NCT02510014|Buprenorphine|buprenorphine|mesh-list
20019498|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20019499|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20019500|NCT02510014|Narcotics|narcotics|mesh-ancestor
19470684|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019501|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019502|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019503|NCT02510014|Analgesics|analgesics|mesh-ancestor
20019504|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
20019505|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019506|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20019507|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
20019508|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20019509|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20019510|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575074|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575075|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575076|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
20575077|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20575078|NCT02063789|Antibodies|antibodies|mesh-list
20575079|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
20575080|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575081|NCT02063802|Metformin|metformin|mesh-list
20575082|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20575083|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575084|NCT02063841|Bismuth|bismuth|mesh-list
20575085|NCT02063841|Antacids|antacids|mesh-ancestor
20575086|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575087|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20575088|NCT02063945|Risperidone|risperidone|mesh-list
20575089|NCT02063945|Methylphenidate|methylphenidate|mesh-list
20575090|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20575091|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
20575092|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575093|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575094|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575095|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20575096|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20575097|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575098|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20575099|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20575100|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
20575101|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20575102|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20575103|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20575104|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575105|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
20575106|NCT02064010|Acamprosate|acamprosate|mesh-list
20575107|NCT02064010|Calcium|calcium|mesh-list
20575108|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575109|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575110|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20575111|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20575112|NCT02064023|Insulin|insulin|mesh-list
20575113|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20575114|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20575115|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019511|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
20019512|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
20575116|NCT02064036|Leuprolide|leuprolide|mesh-list
20575117|NCT02064036|Goserelin|goserelin|mesh-list
20575118|NCT02064036|Bicalutamide|bicalutamide|mesh-list
20575119|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20575120|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
20575121|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20575122|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575123|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20575124|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575125|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
20575126|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
20575127|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470685|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
19470686|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470687|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20575128|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
20115342|NCT00005119|Calcium|calcium|mesh-list
20575129|NCT02064049|Velpatasvir|velpatasvir|mesh-list
20575130|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
20575131|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575132|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
20575133|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
20575134|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
20575135|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575136|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575137|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
20575138|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575139|NCT02064140|Rocuronium|rocuronium|mesh-list
20575140|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20575141|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20575142|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20575143|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575144|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575145|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
20575146|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20575147|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
20605522|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20605523|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605524|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20605525|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20605526|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605527|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20605528|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
20605529|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605530|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605531|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
20605532|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605533|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470688|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19470689|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
19470690|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19470691|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19470692|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19470693|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19470694|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470695|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19470696|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
19470697|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470698|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19470699|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19470700|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19470701|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19470702|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19470703|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19470704|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19470705|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19470706|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
19470707|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19470708|NCT03272503|Pimozide|pimozide|mesh-list
19470709|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19470710|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19470711|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470712|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470713|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19470714|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19470715|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
19470716|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470717|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470718|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19470719|NCT03272412|Progesterone|progesterone|mesh-list
19470720|NCT03272412|Progestins|progestins|mesh-ancestor
19470721|NCT03272412|Hormones|hormones|mesh-ancestor
20575148|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
20575149|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20575150|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575151|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20575152|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20575153|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575154|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575155|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575156|NCT02064374|Metformin|metformin|mesh-list
20575157|NCT02064374|Dolutegravir|dolutegravir|mesh-list
20575158|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20575159|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575160|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20575161|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20575162|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575163|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575164|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20575165|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20575166|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
20575167|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575168|NCT02064465|Lamotrigine|lamotrigine|mesh-list
20575169|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
20575170|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20575171|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575172|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575173|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575174|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575175|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19470722|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470723|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567056|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19567057|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
19567058|NCT04942067|Hormones|hormones|mesh-ancestor
19567059|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567060|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19567061|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567062|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
19567063|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567064|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567065|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
19567066|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19567067|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19567068|NCT04942067|Growth Substances|growth substances|mesh-ancestor
19567069|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
19567070|NCT04931368|Rituximab|rituximab|mesh-list
19567071|NCT04931368|Methotrexate|methotrexate|mesh-list
19567072|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567073|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567074|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
19567075|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567076|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567077|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19567078|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
19567079|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19567080|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19567081|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
19567082|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567083|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19567084|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567085|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19567086|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567087|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19577471|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
19577472|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
19577473|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577474|NCT04357951|Cycloserine|cycloserine|mesh-list
19577475|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19577476|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577477|NCT04357951|Renal Agents|renal agents|mesh-ancestor
19577478|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19577479|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
19577480|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19577481|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
20575176|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19470724|NCT03272126|Vitamin D|vitamin d|mesh-list
19470725|NCT03272126|Vitamins|vitamins|mesh-ancestor
20019513|NCT02510794|Ranibizumab|ranibizumab|mesh-list
20575177|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575178|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20575179|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20019514|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20019515|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20019516|NCT02510794|Growth Substances|growth substances|mesh-ancestor
20019517|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019518|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
20019519|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019520|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
20019521|NCT02511184|Crizotinib|crizotinib|mesh-list
20019522|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20019523|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019524|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20019525|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019526|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019527|NCT02511236|Nicotine|nicotine|mesh-list
20019528|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20019529|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
20019530|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019531|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019532|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20019533|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20575180|NCT02064491|Paclitaxel|paclitaxel|mesh-list
20575181|NCT02064491|Docetaxel|docetaxel|mesh-list
20575182|NCT02064491|Cisplatin|cisplatin|mesh-list
20575183|NCT02064491|Carboplatin|carboplatin|mesh-list
20575184|NCT02064491|Pemetrexed|pemetrexed|mesh-list
20575185|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20575186|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20575187|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575188|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
20575189|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
20575190|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
20575191|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575192|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575193|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20575194|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20575195|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20575196|NCT02064504|Fluticasone|fluticasone|mesh-list
20575197|NCT02064504|Xhance|xhance|mesh-list
20575198|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20575199|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20575200|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
20575201|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575202|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575203|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20575204|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
20575205|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
20575206|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20575207|NCT02064517|Calcium|calcium|mesh-list
20575208|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575209|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575210|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
20575211|NCT02064530|Bupivacaine|bupivacaine|mesh-list
20575212|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
19470726|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
20019534|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
20575213|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
20575214|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575215|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575216|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
20575217|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575218|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20575219|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20575220|NCT02064530|Analgesics|analgesics|mesh-ancestor
20575221|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20575222|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20575223|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20575224|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
20575225|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575226|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575227|NCT02064556|Amlodipine|amlodipine|mesh-list
20575228|NCT02064556|Candesartan|candesartan|mesh-list
20575229|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20575230|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20575231|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575232|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575233|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575234|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575235|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
20575236|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20575237|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20575238|NCT02064621|Amlodipine|amlodipine|mesh-list
20575239|NCT02064621|Candesartan|candesartan|mesh-list
20575240|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
20575241|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20575242|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20575243|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575244|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575245|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575246|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575247|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
20575248|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20575249|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20575250|NCT02064673|Curcumin|curcumin|mesh-list
20575251|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20575252|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20575253|NCT02064673|Analgesics|analgesics|mesh-ancestor
20575254|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
20575255|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575256|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575257|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20575258|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20575259|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575260|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575261|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575262|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
20575263|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
20575264|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
20575265|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575266|NCT02064777|Tacrolimus|tacrolimus|mesh-list
20575267|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20575268|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
20575269|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575270|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20575271|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575272|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575273|NCT02064829|Paclitaxel|paclitaxel|mesh-list
20575274|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20575275|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20575276|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575277|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20575278|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
20575279|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20575280|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575281|NCT02064842|Ritonavir|ritonavir|mesh-list
20575282|NCT02064842|Simeprevir|simeprevir|mesh-list
20575283|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20575284|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20575285|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
20575286|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575287|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575288|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20575289|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20575290|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
20575291|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575292|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20575293|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20575294|NCT02064881|Metformin|metformin|mesh-list
20575295|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20575296|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575297|NCT02064946|Vitamin D|vitamin d|mesh-list
20575298|NCT02064946|Vitamins|vitamins|mesh-ancestor
20575299|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
20575300|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575301|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20575302|NCT02065063|Palbociclib|palbociclib|mesh-list
20575303|NCT02065063|Trametinib|trametinib|mesh-list
20575304|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575305|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20575306|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575307|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575308|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
20575309|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
20575310|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
20575311|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575312|NCT02065128|Capsaicin|capsaicin|mesh-list
20575313|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
19470727|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470728|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19470729|NCT03272321|Oxytocin|oxytocin|mesh-list
19470730|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
19470731|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19470732|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470733|NCT03272295|Menthol|menthol|mesh-list
19470734|NCT03272295|Sorbitol|sorbitol|mesh-list
19470735|NCT03272295|Glycerol|glycerol|mesh-list
19470736|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
19470737|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
19470738|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19470739|NCT03272295|Protective Agents|protective agents|mesh-ancestor
19470740|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470741|NCT03272295|Cathartics|cathartics|mesh-ancestor
19470742|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19470743|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
19470744|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19470745|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470746|NCT03271866|Metformin|metformin|mesh-list
19470747|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19470748|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470749|NCT03271918|Cabergoline|cabergoline|mesh-list
19470750|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19470751|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19470752|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
19470753|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
19470754|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470755|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470756|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470757|NCT03272009|Interferons|interferons|mesh-list
19470758|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
19470759|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
19470760|NCT03272009|Entecavir|entecavir|mesh-list
19470761|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19470762|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470763|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
19470764|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470765|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
19470766|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470767|NCT03271879|Empagliflozin|empagliflozin|mesh-list
19470768|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19470769|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470770|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19470771|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470772|NCT03271983|Metronidazole|metronidazole|mesh-list
19470773|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470774|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20575314|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
20575315|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
20575316|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575317|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575318|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
19470775|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19470776|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19470777|NCT03271905|Bromides|bromides|mesh-list
19470778|NCT03271905|Albuterol|albuterol|mesh-list
19470779|NCT03271905|Ipratropium|ipratropium|mesh-list
19470780|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
19470781|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19470782|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
19470783|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470784|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470785|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19470786|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
19470787|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
19470788|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19470789|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19470790|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19470791|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20575319|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20575320|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
20575321|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470792|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
19470793|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470794|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470795|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19470796|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
19470797|NCT03271749|Anesthetics|anesthetics|mesh-list
19470798|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575322|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20575323|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20575324|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
20575325|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575326|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575327|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20575328|NCT02065219|Bupivacaine|bupivacaine|mesh-list
20575329|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
20575330|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
20575331|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575332|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575333|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
19470799|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470800|NCT03271450|Warfarin|warfarin|mesh-list
20575334|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575335|NCT02065349|ASP8477|asp8477|mesh-list
20575336|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575337|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575338|NCT02065388|Warfarin|warfarin|mesh-list
20575339|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
20575340|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
20575341|NCT02065401|Antacids|antacids|mesh-ancestor
20575342|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575343|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20575344|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
20575345|NCT02065414|Listerine|listerine|mesh-list
20575346|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20575347|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575348|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
20575349|NCT02065466|Paclitaxel|paclitaxel|mesh-list
20575350|NCT02065466|Bevacizumab|bevacizumab|mesh-list
20575351|NCT02065466|Temozolomide|temozolomide|mesh-list
20575352|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20575353|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575354|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
20575355|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
20575356|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
20575357|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575358|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20575359|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20575360|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20575361|NCT02065466|Growth Substances|growth substances|mesh-ancestor
20575362|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575363|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
20575364|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20575365|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
20575366|NCT02065492|Amlodipine|amlodipine|mesh-list
20575367|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
20575368|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575369|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575370|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20575371|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575372|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575373|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
19470801|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
19470802|NCT03271450|Dabigatran|dabigatran|mesh-list
19470803|NCT03271450|Apixaban|apixaban|mesh-list
19470804|NCT03271450|Edoxaban|edoxaban|mesh-list
19470805|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
19470806|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19470807|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
19470808|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19470809|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
19470810|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470811|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470812|NCT03271502|Anesthetics|anesthetics|mesh-list
19470813|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470814|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470815|NCT03271164|Vitamin E|vitamin e|mesh-list
19470816|NCT03271164|Vitamins|vitamins|mesh-ancestor
19470817|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
19470818|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470819|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
19470820|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470821|NCT03271164|Protective Agents|protective agents|mesh-ancestor
19470822|NCT03271255|Bevacizumab|bevacizumab|mesh-list
19470823|NCT03271255|Apatinib|apatinib|mesh-list
19470824|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19470825|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470826|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19470827|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19470828|NCT03271255|Growth Substances|growth substances|mesh-ancestor
19742835|NCT04429321|Nivolumab|nivolumab|mesh-list
20575386|NCT02065609|Trastuzumab|trastuzumab|mesh-list
20575387|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20575388|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575389|NCT02065739|Itraconazole|itraconazole|mesh-list
20575390|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
20575391|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
20575392|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575393|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20575394|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20575395|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292332|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292333|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20292334|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
20575396|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575397|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20575398|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
20575399|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20575400|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575401|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20575402|NCT02065752|Metformin|metformin|mesh-list
20575403|NCT02065752|Canagliflozin|canagliflozin|mesh-list
20575404|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20575405|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575406|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20575407|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575408|NCT02065804|Bupivacaine|bupivacaine|mesh-list
20575409|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
20575410|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
20575411|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575412|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575413|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
20575414|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575415|NCT02065843|Midazolam|midazolam|mesh-list
20575416|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20575417|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20575418|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575419|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470829|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470830|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
19470831|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19470832|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470833|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470834|NCT03271073|Apatinib|apatinib|mesh-list
19470835|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470836|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19470837|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470838|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470839|NCT03270969|Tenofovir|tenofovir|mesh-list
19470840|NCT03270969|Emtricitabine|emtricitabine|mesh-list
19470841|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
19470842|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470843|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19470844|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19470845|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470846|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470847|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19470848|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19470849|NCT03270839|Meclizine|meclizine|mesh-list
19470850|NCT03270839|Scopolamine|scopolamine|mesh-list
19470851|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19470852|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
19470853|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
19470854|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470855|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470856|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19470857|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
19470858|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19470859|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
19470860|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470861|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470862|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20575420|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20575421|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20575422|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20019535|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019536|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019537|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20019538|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20019539|NCT02511431|Ritonavir|ritonavir|mesh-list
20019540|NCT02511431|Lonafarnib|lonafarnib|mesh-list
20019541|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20019542|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19470863|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19470864|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
20575423|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20575424|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
20575425|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
20575426|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
20575427|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
20575428|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470865|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
19470866|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19470867|NCT03270735|Thrombin|thrombin|mesh-list
19470868|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
20575429|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575430|NCT02065947|Lidocaine|lidocaine|mesh-list
20575431|NCT02065947|Epinephrine|epinephrine|mesh-list
20575432|NCT02065947|Racepinephrine|racepinephrine|mesh-list
20575433|NCT02065947|Fentanyl|fentanyl|mesh-list
20575434|NCT02065947|Midazolam|midazolam|mesh-list
20575435|NCT02065947|Ketamine|ketamine|mesh-list
20575436|NCT02065947|Bupivacaine|bupivacaine|mesh-list
20575437|NCT02065947|Propofol|propofol|mesh-list
20575438|NCT02065947|Sevoflurane|sevoflurane|mesh-list
20575439|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
20575440|NCT02065947|Atracurium|atracurium|mesh-list
20575441|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
20575442|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
20575443|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575444|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575445|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
20575446|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575447|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20575448|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20575449|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20575450|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575451|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470869|NCT03270735|Coagulants|coagulants|mesh-ancestor
19567088|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
19567089|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567090|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
19567091|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567092|NCT04899791|Protective Agents|protective agents|mesh-ancestor
19567093|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567094|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19567095|NCT04887506|Prednisone|prednisone|mesh-list
19567096|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
19567097|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567098|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
19567099|NCT04887506|Hormones|hormones|mesh-ancestor
19567100|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019543|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
20019544|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019545|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019546|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20019547|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20019548|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
20019549|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019550|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20019551|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20019552|NCT02511535|Vaccines|vaccines|mesh-list
20019553|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
20019554|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575452|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20575453|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19567101|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567102|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19567103|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567104|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19567105|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567106|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567107|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
19567108|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19567109|NCT04882293|Atorvastatin|atorvastatin|mesh-list
19567110|NCT04882293|Fenofibrate|fenofibrate|mesh-list
19567111|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19567112|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19567113|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
19742836|NCT04429321|Ipilimumab|ipilimumab|mesh-list
20575454|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
20575455|NCT02065947|Analgesics|analgesics|mesh-ancestor
20575456|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20575457|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20575458|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20575459|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575460|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20575461|NCT02065947|Narcotics|narcotics|mesh-ancestor
20575462|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20575463|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20575464|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20575465|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20575466|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
20575467|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
20575468|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20575469|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20575470|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20575471|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20575472|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
20575473|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20575474|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20575475|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
20575476|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20575477|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
20575478|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
20575479|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
20575480|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20575481|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20575482|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20575483|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20575484|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19470870|NCT03270709|Vitamin D|vitamin d|mesh-list
19470871|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
19470872|NCT03270709|Vitamins|vitamins|mesh-ancestor
19470873|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
19470874|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470875|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19470876|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19470877|NCT03270696|Propofol|propofol|mesh-list
19470878|NCT03270696|Rocuronium|rocuronium|mesh-list
19470879|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19470880|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470881|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470882|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19470883|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
19470884|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
19470885|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19470886|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19470887|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19470888|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470889|NCT03270553|Metformin|metformin|mesh-list
19470890|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19470891|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470892|NCT03270462|Tacrolimus|tacrolimus|mesh-list
19470893|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19470894|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
19470895|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470896|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19470897|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470898|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470899|NCT03269929|Midazolam|midazolam|mesh-list
19470900|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19470901|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19470902|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470903|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470904|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19470905|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19470906|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19470907|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19470908|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
19470909|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
19470910|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
19470911|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
19470912|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470913|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470914|NCT03269760|Zolpidem|zolpidem|mesh-list
20575485|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20575486|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
20575487|NCT02065986|Tenofovir|tenofovir|mesh-list
19470915|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19470916|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19470917|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470918|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470919|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19470920|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
19470921|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
19470922|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470923|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470924|NCT03270007|Vinorelbine|vinorelbine|mesh-list
19470925|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19470926|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470927|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
20575488|NCT02065986|Emtricitabine|emtricitabine|mesh-list
20575489|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20575490|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
20575491|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575492|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20575493|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20575494|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470928|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
19470929|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
19470930|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470931|NCT03269786|Bilirubin|bilirubin|mesh-list
19470932|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
19470933|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470934|NCT03269786|Protective Agents|protective agents|mesh-ancestor
19470935|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470936|NCT03270033|Dexamethasone|dexamethasone|mesh-list
19470937|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
19470938|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
19470939|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19470940|NCT03270033|BB 1101|bb 1101|mesh-list
19470941|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19470942|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
19470943|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
19470944|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19470945|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470946|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19470947|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
19470948|NCT03270033|Hormones|hormones|mesh-ancestor
19470949|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470950|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19470951|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470952|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
19470953|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19470954|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470955|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19470956|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19470957|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19470958|NCT03270033|Analgesics|analgesics|mesh-ancestor
19470959|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
19470960|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19470961|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20605534|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19470962|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19470963|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
19470964|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470965|NCT03269916|Hormones|hormones|mesh-list
19470966|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19470967|NCT03269916|Estrogens|estrogens|mesh-list
19470968|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470969|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470970|NCT03269747|Prednisone|prednisone|mesh-list
19470971|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20575495|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575496|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20575497|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20575498|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20575499|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575500|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20575501|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575502|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605535|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20605536|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605537|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
20605538|NCT02232932|Capecitabine|capecitabine|mesh-list
20605539|NCT02232932|Liver Extracts|liver extracts|mesh-list
20605540|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20605541|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
20605542|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605543|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605544|NCT02232932|Hematinics|hematinics|mesh-ancestor
20605545|NCT02232945|Oseltamivir|oseltamivir|mesh-list
20605546|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
20605547|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605548|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605549|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605550|NCT02232971|Glucagon|glucagon|mesh-list
20605551|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605552|NCT02232971|Hormones|hormones|mesh-ancestor
20605553|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605554|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605555|NCT02233023|Dopamine|dopamine|mesh-list
20605556|NCT02233023|Pramipexole|pramipexole|mesh-list
20605557|NCT02233023|Bromocriptine|bromocriptine|mesh-list
20605558|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
20605559|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
20605560|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605561|NCT02233023|Protective Agents|protective agents|mesh-ancestor
20605562|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470972|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
20605563|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20019555|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
20019556|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20019557|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605564|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20605565|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
20605566|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605567|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20605568|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
20605569|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
20605570|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605571|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
20605572|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605573|NCT02233049|Everolimus|everolimus|mesh-list
20605574|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20605575|NCT02233049|Dasatinib|dasatinib|mesh-list
20605576|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605577|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20605578|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
20605579|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605580|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20605581|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605582|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605583|NCT02233075|Interferons|interferons|mesh-list
20019558|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20019559|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19470973|NCT03269747|Hormones|hormones|mesh-ancestor
19470974|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19470975|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470976|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19470977|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470978|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
19470979|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
19470980|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019560|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019561|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019562|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575503|NCT02066077|Propofol|propofol|mesh-list
20575504|NCT02066077|Etomidate|etomidate|mesh-list
20575505|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20575506|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575507|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575508|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20575509|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
20575510|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
19470981|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
19470982|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19470983|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742837|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742838|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742839|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19742840|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742841|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
19742842|NCT04424654|Testosterone|testosterone|mesh-list
19742843|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
19742844|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
19742845|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19742846|NCT04424654|Androgens|androgens|mesh-ancestor
19742847|NCT04424654|Hormones|hormones|mesh-ancestor
19742848|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742849|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742850|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19742851|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742852|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
19742853|NCT04392622|Cisplatin|cisplatin|mesh-list
19742854|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742855|NCT04390958|Paclitaxel|paclitaxel|mesh-list
19742856|NCT04390958|Capecitabine|capecitabine|mesh-list
19742857|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742858|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742859|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742860|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
20019563|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20019564|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20019565|NCT02511587|Vaccines|vaccines|mesh-list
20019566|NCT02511587|Immunologic Factors|immunologic factors|mesh-ancestor
20019567|NCT02511587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019568|NCT02512042|Brinzolamide|brinzolamide|mesh-list
20019569|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20019570|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019571|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019572|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
20575511|NCT02066103|Paclitaxel|paclitaxel|mesh-list
20575512|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20019573|NCT02512302|Bromides|bromides|mesh-list
20019574|NCT02512302|Charcoal|charcoal|mesh-list
20019575|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
20019576|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20019577|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20019578|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20019579|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
20019580|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019581|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019582|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019583|NCT02512302|Antidotes|antidotes|mesh-ancestor
20019584|NCT02512302|Protective Agents|protective agents|mesh-ancestor
20019585|NCT02512575|Prednisolone|prednisolone|mesh-list
20019586|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019587|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
20575513|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19470984|NCT03269955|Thrombin|thrombin|mesh-list
19470985|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
20575514|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
20575515|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
20575516|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
20575517|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575518|NCT02066207|Atorvastatin|atorvastatin|mesh-list
20575519|NCT02066207|Fenofibrate|fenofibrate|mesh-list
20575520|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20019588|NCT02512575|Hormones|hormones|mesh-ancestor
20019589|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20575521|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20575522|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
19470986|NCT03269955|Coagulants|coagulants|mesh-ancestor
19470987|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19470988|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19470989|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19470990|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
19470991|NCT03269799|Ascorbic Acid|ascorbic acid|mesh-list
19470992|NCT03269799|Vitamins|vitamins|mesh-ancestor
19470993|NCT03269799|Micronutrients|micronutrients|mesh-ancestor
19470994|NCT03269799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19470995|NCT03269799|Antioxidants|antioxidants|mesh-ancestor
19470996|NCT03269799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19470997|NCT03269799|Protective Agents|protective agents|mesh-ancestor
19470998|NCT03269591|Diclofenac|diclofenac|mesh-list
19470999|NCT03269591|Progesterone|progesterone|mesh-list
19471000|NCT03269591|Progestins|progestins|mesh-ancestor
19471001|NCT03269591|Hormones|hormones|mesh-ancestor
19471002|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471003|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471004|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471005|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471006|NCT03269591|Analgesics|analgesics|mesh-ancestor
19471007|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
19471008|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471009|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471010|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471011|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19471012|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471013|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471014|NCT03269383|Bupivacaine|bupivacaine|mesh-list
19471015|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471016|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
19471017|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471018|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471019|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
19471020|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471021|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
19471022|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471023|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471024|NCT03269214|Phenytoin|phenytoin|mesh-list
19471025|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
19471026|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19471027|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19471028|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19471029|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471030|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19471031|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19567114|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567115|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19567116|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19567117|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567118|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
19567119|NCT04869137|Lenvatinib|lenvatinib|mesh-list
19567120|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567121|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567122|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19567123|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567124|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567125|NCT04863248|Docetaxel|docetaxel|mesh-list
19567126|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567127|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19567128|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
20575523|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575524|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20575525|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20575526|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575527|NCT02066350|Pancrelipase|pancrelipase|mesh-list
20575528|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20575529|NCT02066454|Apixaban|apixaban|mesh-list
20575530|NCT02066454|Anticoagulants|anticoagulants|mesh-list
20575531|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20575532|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
20575533|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20575534|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
20575535|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575536|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575537|NCT02066532|Trastuzumab|trastuzumab|mesh-list
20575538|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20019590|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575539|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575540|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
20575541|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
20575542|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019591|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20019592|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019593|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
19471032|NCT03269279|Misoprostol|misoprostol|mesh-list
19471033|NCT03269279|Mifepristone|mifepristone|mesh-list
19471034|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20019594|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019595|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
20019596|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019597|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019598|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20019599|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
20019600|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019601|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019602|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20019603|NCT02512783|Lidocaine|lidocaine|mesh-list
20019604|NCT02512783|Propofol|propofol|mesh-list
20019605|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
20019606|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
20019607|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019608|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019609|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
20019610|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019611|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20019612|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20019613|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20292335|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292336|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292337|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20575543|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
20575544|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575545|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471035|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
19471036|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471037|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471038|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19471039|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471040|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
19471041|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19471042|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19471043|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19471044|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19471045|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
19471046|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19471047|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19471048|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
19471049|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471050|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
19471051|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19471052|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20019614|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019615|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575546|NCT02066571|Droxidopa|droxidopa|mesh-list
20575547|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20575548|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20575549|NCT02066610|Selenium|selenium|mesh-list
20575550|NCT02066610|Selenious Acid|selenious acid|mesh-list
20575551|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
20575552|NCT02066610|Selenic Acid|selenic acid|mesh-list
20575553|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
20575554|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575555|NCT02066610|Protective Agents|protective agents|mesh-ancestor
20019616|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20019617|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20575556|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575557|NCT02066610|Trace Elements|trace elements|mesh-ancestor
20575558|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
20019618|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
20019619|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
20019620|NCT02512809|Isoflurane|isoflurane|mesh-list
20575559|NCT02066649|Carvedilol|carvedilol|mesh-list
20575560|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20575561|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20575562|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20575563|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575564|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575565|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575566|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20575567|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
20575568|NCT02066649|Protective Agents|protective agents|mesh-ancestor
20575569|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19471053|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
19471054|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19471055|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471056|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19471057|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471058|NCT03269318|Theophylline|theophylline|mesh-list
19471059|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19471060|NCT03269318|Montelukast|montelukast|mesh-list
19471061|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19471062|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
19471063|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471064|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471065|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19471066|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
19471067|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19471068|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19471069|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19471070|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
19471071|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471072|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471073|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19471074|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
19471075|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471076|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19471077|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19471078|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19471079|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471080|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
19471081|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19471082|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19471083|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
19471084|NCT03268733|Folic Acid|folic acid|mesh-list
19471085|NCT03268733|Hematinics|hematinics|mesh-ancestor
19471086|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
19471087|NCT03268733|Vitamins|vitamins|mesh-ancestor
19471088|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
19471089|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471090|NCT03269162|Docetaxel|docetaxel|mesh-list
19471091|NCT03269162|Pemetrexed|pemetrexed|mesh-list
20019621|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20575570|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575571|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575572|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
20575573|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20575574|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20575575|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
20575576|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
20575577|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20575578|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
20575579|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20575580|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
20575581|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575582|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575583|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
20575584|NCT02066675|Trabectedin|trabectedin|mesh-list
20575585|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20575586|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
20575587|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575588|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575589|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
20575590|NCT02066688|Vitamin D|vitamin d|mesh-list
20575591|NCT02066688|Folic Acid|folic acid|mesh-list
20575592|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
20575593|NCT02066688|Calcium|calcium|mesh-list
20575594|NCT02066688|Vitamins|vitamins|mesh-ancestor
20019622|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019623|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019624|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019625|NCT02512809|Analgesics|analgesics|mesh-ancestor
20019626|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
20019627|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019628|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20019629|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20019630|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20019631|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
20019632|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019633|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019634|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20019635|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
20019636|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
20019637|NCT02512861|Bupivacaine|bupivacaine|mesh-list
20019638|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
20019639|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
20019640|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575595|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
19471092|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471093|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
19471094|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
19471095|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
19471096|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471097|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471098|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19471099|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19471100|NCT03268902|Niacinamide|niacinamide|mesh-list
19471101|NCT03268902|Niacin|niacin|mesh-list
19471102|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
19471103|NCT03268902|Azithromycin|azithromycin|mesh-list
19471104|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
19471105|NCT03268902|Vitamins|vitamins|mesh-ancestor
19471106|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
19471107|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471108|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19471109|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471110|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
19471111|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19471112|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
19471113|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471114|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19471115|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
19471116|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19471117|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19471118|NCT03268525|Bupivacaine|bupivacaine|mesh-list
19471119|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471120|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
20575596|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575597|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19471121|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567129|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
20575598|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20575599|NCT02066688|Hematinics|hematinics|mesh-ancestor
20575600|NCT02066818|Lidocaine|lidocaine|mesh-list
20575601|NCT02066818|Tetracaine|tetracaine|mesh-list
20575602|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
20575603|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
20575604|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575605|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575606|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
19471122|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471123|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
19471124|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471125|NCT03268278|Lidocaine|lidocaine|mesh-list
20575607|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575608|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20575609|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20575610|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20575611|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575612|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575613|NCT02066844|Betamethasone|betamethasone|mesh-list
20575614|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
19471126|NCT03268278|Epinephrine|epinephrine|mesh-list
19471127|NCT03268278|Buprenorphine|buprenorphine|mesh-list
19471128|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
19471129|NCT03268278|Anesthetics|anesthetics|mesh-list
19471130|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471131|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471132|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
19471133|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471134|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19471135|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19471136|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19471137|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19471138|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471139|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19471140|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19471141|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
19471142|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471143|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19471144|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19471145|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
19471146|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19471147|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
19471148|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
19471149|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
19471150|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19471151|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19471152|NCT03268278|Narcotics|narcotics|mesh-ancestor
19471153|NCT03268278|Analgesics|analgesics|mesh-ancestor
19471154|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19471155|NCT03268382|Doxorubicin|doxorubicin|mesh-list
19471156|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19471157|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19471158|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471159|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19471160|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19471161|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471162|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471163|NCT03268226|Beclomethasone|beclomethasone|mesh-list
19471164|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
19471165|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
19471166|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19471167|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
19471168|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471169|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471170|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19742861|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
20575615|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20575616|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
20575617|NCT02066844|Lidocaine|lidocaine|mesh-list
20575618|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20575619|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
20575620|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
20575621|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575622|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575623|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
20575624|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575625|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20575626|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20575627|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20575628|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20575629|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575630|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20575631|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
20575632|NCT02066844|Hormones|hormones|mesh-ancestor
20575633|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20575634|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20575635|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
20575636|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
20575637|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575638|NCT02067013|Ranibizumab|ranibizumab|mesh-list
20575639|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20575640|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20575641|NCT02067013|Growth Substances|growth substances|mesh-ancestor
20575642|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575643|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
20575644|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575645|NCT02067065|Propofol|propofol|mesh-list
20575646|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20575647|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575648|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575649|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20575650|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
20575651|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
20575652|NCT02067078|Dexamethasone|dexamethasone|mesh-list
20575653|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
20575654|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20575655|NCT02067078|Clonidine|clonidine|mesh-list
20575656|NCT02067078|Epinephrine|epinephrine|mesh-list
20575657|NCT02067078|Racepinephrine|racepinephrine|mesh-list
20575658|NCT02067078|Ropivacaine|ropivacaine|mesh-list
20575659|NCT02067078|Bupivacaine|bupivacaine|mesh-list
20575660|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
20575661|NCT02067078|BB 1101|bb 1101|mesh-list
20575662|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20575663|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
20575664|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
20575665|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575666|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575667|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20575668|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
20575669|NCT02067078|Hormones|hormones|mesh-ancestor
20575670|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20575671|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20575672|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575673|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
20575674|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575675|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019641|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019642|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
20019643|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471171|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
20575676|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
20575677|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
20605584|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
20575678|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575679|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
20575680|NCT02067078|Analgesics|analgesics|mesh-ancestor
20575681|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20575682|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
20575683|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20575684|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20575685|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20575686|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
20575687|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575688|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20575689|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20575690|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20575691|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20575692|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19471172|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19471173|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19471174|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19471175|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
19471176|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471177|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471178|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19471179|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19471180|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19471181|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
20019644|NCT02513095|Dantrolene|dantrolene|mesh-list
20019645|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20019646|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019647|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20019648|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019649|NCT02513160|Beclomethasone|beclomethasone|mesh-list
20019650|NCT02513160|Albuterol|albuterol|mesh-list
20019651|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20019652|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
20019653|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019654|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019655|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20019656|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
20019657|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
20019658|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019659|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20019660|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20019661|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20019662|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
20019663|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019664|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019665|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019666|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
20019667|NCT02513160|Hormones|hormones|mesh-ancestor
20019668|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019669|NCT02513212|Fluorides|fluorides|mesh-list
20019670|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
20019671|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
20019672|NCT02513212|Protective Agents|protective agents|mesh-ancestor
20019673|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019674|NCT02513446|Itraconazole|itraconazole|mesh-list
20019675|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
20019676|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019677|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20019678|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20019679|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019680|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019681|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20019682|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
20019683|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019684|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019685|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20019686|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20019687|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
20019688|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019689|NCT02513498|Ixazomib|ixazomib|mesh-list
20019690|NCT02513498|Glycine|glycine|mesh-list
20575693|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19471182|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20575694|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20575695|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
20575696|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
20575697|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
20575698|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20575699|NCT02067143|Cytarabine|cytarabine|mesh-list
20575700|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20575701|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
20575702|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575703|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575704|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
20575705|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575706|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20575707|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
20575708|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575709|NCT02067182|Dabigatran|dabigatran|mesh-list
20575710|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
19471183|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
19471184|NCT03268226|Hormones|hormones|mesh-ancestor
19471185|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471186|NCT03267771|Progesterone|progesterone|mesh-list
19471187|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
19471188|NCT03267771|Progestins|progestins|mesh-ancestor
19471189|NCT03267771|Hormones|hormones|mesh-ancestor
19471190|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471191|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575711|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20575712|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
20575713|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575714|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575715|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
20575716|NCT02067338|Morphine|morphine|mesh-list
20575717|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
20575718|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20575719|NCT02067338|Narcotics|narcotics|mesh-ancestor
20575720|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575721|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575722|NCT02067338|Analgesics|analgesics|mesh-ancestor
20575723|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
20575724|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575725|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
20575726|NCT02067338|Coagulants|coagulants|mesh-ancestor
20575727|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
20575728|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20019691|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575729|NCT02067377|Antibodies|antibodies|mesh-list
20575730|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
20575731|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575732|NCT02067416|Paclitaxel|paclitaxel|mesh-list
20575733|NCT02067416|Docetaxel|docetaxel|mesh-list
20575734|NCT02067416|Epirubicin|epirubicin|mesh-list
20575735|NCT02067416|Taxane|taxane|mesh-list
19471192|NCT03267628|Morphine|morphine|mesh-list
19471193|NCT03267628|Anesthetics|anesthetics|mesh-list
19471194|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
19471195|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19471196|NCT03267628|Narcotics|narcotics|mesh-ancestor
19471197|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471198|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471199|NCT03267628|Analgesics|analgesics|mesh-ancestor
19471200|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
19471201|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471202|NCT03268018|Calcium|calcium|mesh-list
19471203|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19471204|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471205|NCT03267654|Apatinib|apatinib|mesh-list
19471206|NCT03267654|Gefitinib|gefitinib|mesh-list
19471207|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471208|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471209|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471210|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471211|NCT03267680|Indomethacin|indomethacin|mesh-list
20019692|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575736|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20575737|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575738|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
19471212|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
19471213|NCT03267680|Omeprazole|omeprazole|mesh-list
20575739|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
20575740|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
20575741|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575742|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20575743|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20575744|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20575745|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575746|NCT02067442|Acetaminophen|acetaminophen|mesh-list
20575747|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20575748|NCT02067442|Analgesics|analgesics|mesh-ancestor
20575749|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
20575750|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575751|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575752|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
20575753|NCT02067520|Hydromorphone|hydromorphone|mesh-list
20575754|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20575755|NCT02067520|Narcotics|narcotics|mesh-ancestor
20575756|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575757|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575758|NCT02067520|Analgesics|analgesics|mesh-ancestor
20575759|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
20575760|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575761|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20575762|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20575763|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575764|NCT02067767|Lamivudine|lamivudine|mesh-list
20575765|NCT02067767|Abacavir|abacavir|mesh-list
20019693|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
19471214|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471215|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
19471216|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471217|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471218|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19471219|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
19471220|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471221|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471222|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19471223|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19471224|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471225|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19471226|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471227|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471228|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471229|NCT03267680|Analgesics|analgesics|mesh-ancestor
19471230|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
19471231|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471232|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471233|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
19471234|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
19471235|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471236|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19471237|NCT03267407|Fluconazole|fluconazole|mesh-list
19471238|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
19471239|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471240|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19471241|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19471242|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471243|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471244|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19471245|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
19471246|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471247|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471248|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19471249|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19567130|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567131|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19567132|NCT04862962|Ezetimibe|ezetimibe|mesh-list
19567133|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19567134|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19742862|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575766|NCT02067767|Dolutegravir|dolutegravir|mesh-list
20575767|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20575768|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20575769|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019694|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019695|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
20019696|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019697|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019698|NCT02513550|Ixekizumab|ixekizumab|mesh-list
20019699|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
20019700|NCT02513719|Everolimus|everolimus|mesh-list
20575770|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575771|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
20575772|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575773|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19471250|NCT03267316|Gemcitabine|gemcitabine|mesh-list
19471251|NCT03267316|Paclitaxel|paclitaxel|mesh-list
19471252|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19471253|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471254|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
19471255|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
19471256|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
19471257|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471258|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19471259|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
19471260|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
19471261|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471262|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471263|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471264|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
19471265|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471266|NCT03267329|Telmisartan|telmisartan|mesh-list
19471267|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19471268|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19471269|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19471270|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471271|NCT03267121|Apatinib|apatinib|mesh-list
19471272|NCT03267121|Tegafur|tegafur|mesh-list
19471273|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471274|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471275|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471276|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471277|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19471278|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
19471279|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19471280|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19471281|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471282|NCT03266965|Carbidopa|carbidopa|mesh-list
19471283|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19471284|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19471285|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
19471286|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471287|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471288|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471289|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19471290|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471291|NCT03266926|Bupivacaine|bupivacaine|mesh-list
19471292|NCT03266926|Estrogens|estrogens|mesh-list
19471293|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19471294|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471295|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
19471296|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471297|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471298|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
19471299|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471300|NCT03266926|Hormones|hormones|mesh-ancestor
19471301|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471302|NCT03266991|Isoniazid|isoniazid|mesh-list
19471303|NCT03266991|Rifapentine|rifapentine|mesh-list
19471304|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
19471305|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19471306|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471307|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20019701|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019702|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20019703|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
19471308|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20019704|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575774|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20575775|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20575776|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20575777|NCT02067780|Levofloxacin|levofloxacin|mesh-list
20575778|NCT02067780|Ofloxacin|ofloxacin|mesh-list
20575779|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20575780|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575781|NCT02067780|Renal Agents|renal agents|mesh-ancestor
20575782|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20575783|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20575784|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20575785|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575786|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575787|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019705|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20019706|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20019707|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019708|NCT02513771|Incretins|incretins|mesh-ancestor
20019709|NCT02513771|Hormones|hormones|mesh-ancestor
20019710|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20575788|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20575789|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20605585|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
20605586|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20605587|NCT02233075|REP 2139|rep 2139|mesh-list
20605588|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605589|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
20605590|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605591|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
20605592|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605593|NCT02233179|Calpastatin|calpastatin|mesh-list
20605594|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20605595|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
20605596|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605597|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605598|NCT02233205|Gemcitabine|gemcitabine|mesh-list
19471309|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
19471310|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019711|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20019712|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
20019713|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019714|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019715|NCT02513823|Vitamin D|vitamin d|mesh-list
20019716|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
20019717|NCT02513823|Vitamins|vitamins|mesh-ancestor
20019718|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
20019719|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019720|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20019721|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20019722|NCT02513940|Ibutilide|ibutilide|mesh-list
20019723|NCT02513940|Testosterone|testosterone|mesh-list
20019724|NCT02513940|Progesterone|progesterone|mesh-list
19471311|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19471312|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20019725|NCT02513940|Androgens|androgens|mesh-ancestor
20019726|NCT02513940|Hormones|hormones|mesh-ancestor
20605599|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20605600|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
20575790|NCT02067910|Abatacept|abatacept|mesh-list
20575791|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20575792|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575793|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575794|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20575795|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
20575796|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575797|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20575798|NCT02067936|Remifentanil|remifentanil|mesh-list
20575799|NCT02067936|Propofol|propofol|mesh-list
20575800|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20575801|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575802|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575803|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20575804|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
20575805|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
20575806|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20575807|NCT02067936|Narcotics|narcotics|mesh-ancestor
20575808|NCT02067936|Analgesics|analgesics|mesh-ancestor
20575809|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
20575810|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575811|NCT02067949|Simvastatin|simvastatin|mesh-list
20575812|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20575813|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20575814|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
20575815|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575816|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20575817|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20575818|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575819|NCT02068079|Vemurafenib|vemurafenib|mesh-list
20575820|NCT02068079|Trientine|trientine|mesh-list
20575821|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575822|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20575823|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575824|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575825|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
20575826|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
20575827|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
20575828|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575829|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
20575830|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575831|NCT02068092|Protective Agents|protective agents|mesh-ancestor
20575832|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575833|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20575834|NCT02068131|Capecitabine|capecitabine|mesh-list
20575835|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20575836|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
20575837|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575838|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575839|NCT02068170|Azithromycin|azithromycin|mesh-list
20575840|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
20575841|NCT02068170|Clarithromycin|clarithromycin|mesh-list
20575842|NCT02068170|Levofloxacin|levofloxacin|mesh-list
20575843|NCT02068170|Erythromycin|erythromycin|mesh-list
20575844|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
20575845|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19471313|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
19471314|NCT03266731|Aspirin|aspirin|mesh-list
19471315|NCT03266731|Clopidogrel|clopidogrel|mesh-list
19471316|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471317|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471318|NCT03266731|Analgesics|analgesics|mesh-ancestor
19471319|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
19471320|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471321|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471322|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471323|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471324|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19471325|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19471326|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471327|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19471328|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19471329|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575846|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
20575847|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20575848|NCT02068170|Itraconazole|itraconazole|mesh-list
20575849|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20575850|NCT02068170|Fluconazole|fluconazole|mesh-list
20575851|NCT02068170|Ketoconazole|ketoconazole|mesh-list
20575852|NCT02068170|Voriconazole|voriconazole|mesh-list
20575853|NCT02068170|Sunitinib|sunitinib|mesh-list
20575854|NCT02068170|Methadone|methadone|mesh-list
20575855|NCT02068170|Haloperidol|haloperidol|mesh-list
20575856|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
20575857|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20575858|NCT02068170|Tacrolimus|tacrolimus|mesh-list
20575859|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20575860|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
20575861|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575862|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20575863|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575864|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575865|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20575866|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575867|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20575868|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20575869|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575870|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20575871|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
20575872|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20575873|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20575874|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20575875|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20575876|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20575877|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20575878|NCT02068170|Growth Substances|growth substances|mesh-ancestor
20575879|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
19471330|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
19471331|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19471332|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19471333|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19471334|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
19471335|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471336|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19471337|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19471338|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471339|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
19471340|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19471341|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19471342|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471343|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
19471344|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471345|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471346|NCT03266601|Interferons|interferons|mesh-list
19471347|NCT03266601|Ribavirin|ribavirin|mesh-list
19471348|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471349|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
19471350|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471351|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
19471352|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471353|NCT03266393|Tacrolimus|tacrolimus|mesh-list
19471354|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471355|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
19471356|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471357|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19471358|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471359|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471360|NCT03266159|Trametinib|trametinib|mesh-list
19471361|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471362|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471363|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471364|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471365|NCT03266250|Anesthetics|anesthetics|mesh-list
19471366|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471367|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471368|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
20292338|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
20575880|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471369|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19471370|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19471371|NCT03266146|Prednisolone|prednisolone|mesh-list
19471372|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
19471373|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19471374|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
19471375|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471376|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
19471377|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
19471378|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471379|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471380|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471381|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
19471382|NCT03266146|Hormones|hormones|mesh-ancestor
19471383|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471384|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19471385|NCT03266146|Protective Agents|protective agents|mesh-ancestor
19471386|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19471387|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471388|NCT03266445|Buprenorphine|buprenorphine|mesh-list
19471389|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19471390|NCT03266445|Naloxone|naloxone|mesh-list
19742863|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742864|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
19742865|NCT04367233|Anesthetics|anesthetics|mesh-list
19742866|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742867|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742868|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
19742869|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19742870|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19742871|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19742872|NCT04359147|Yohimbine|yohimbine|mesh-list
19742873|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742874|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
19742875|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
19742876|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742877|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742878|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19742879|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19742880|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19742881|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
19742882|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742883|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742884|NCT04359147|Urological Agents|urological agents|mesh-ancestor
19742885|NCT04355585|Colchicine|colchicine|mesh-list
19742886|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
19742887|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742888|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742889|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742890|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742891|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742892|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742893|NCT04352166|Buprenorphine|buprenorphine|mesh-list
19742894|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19742895|NCT04352166|Narcotics|narcotics|mesh-ancestor
19742896|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742897|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742898|NCT04352166|Analgesics|analgesics|mesh-ancestor
19742899|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
19742900|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742901|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19742902|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
19742903|NCT04345666|Testosterone|testosterone|mesh-list
19742904|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
19742905|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
19742906|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19742907|NCT04345666|Androgens|androgens|mesh-ancestor
19742908|NCT04345666|Hormones|hormones|mesh-ancestor
19742909|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742910|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742911|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19742912|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742913|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
19742914|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
19471391|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19742915|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
19471392|NCT03266445|Narcotics|narcotics|mesh-ancestor
19471393|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471394|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471395|NCT03266445|Analgesics|analgesics|mesh-ancestor
19471396|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
19471397|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471398|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19471399|NCT03266081|Bupivacaine|bupivacaine|mesh-list
19471400|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471401|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
19471402|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471403|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471404|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
19471405|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471406|NCT03265886|Bupivacaine|bupivacaine|mesh-list
19471407|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471408|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
19471409|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471410|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471411|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
19471412|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471413|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19471414|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19471415|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471416|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
19471417|NCT03265782|Acetaminophen|acetaminophen|mesh-list
19471418|NCT03265782|Ibuprofen|ibuprofen|mesh-list
19471419|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471420|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471421|NCT03265782|Analgesics|analgesics|mesh-ancestor
19471422|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
19471423|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471424|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471425|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471426|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471427|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19471428|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471429|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471430|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
19567135|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
19567136|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567137|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19567138|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19567139|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567140|NCT04848714|Antivenins|antivenins|mesh-list
19567141|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
19567142|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567143|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
19567144|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19567145|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
19567146|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567147|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
20019727|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019728|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567148|NCT04839692|Protective Agents|protective agents|mesh-ancestor
20019729|NCT02513940|Progestins|progestins|mesh-ancestor
20019730|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20019731|NCT02514044|Adderall|adderall|mesh-list
20019732|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
20019733|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20019734|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019735|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20019736|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20019737|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567149|NCT04829422|Lazertinib|lazertinib|mesh-list
19567150|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19567151|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567152|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567153|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
19567154|NCT04813016|Tramadol|tramadol|mesh-list
20019738|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019739|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
19567155|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20019740|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471431|NCT03265470|Fentanyl|fentanyl|mesh-list
19471432|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
19471433|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19471434|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471435|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471436|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471437|NCT03265470|Analgesics|analgesics|mesh-ancestor
19471438|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
19471439|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471440|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19471441|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19471442|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19471443|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
19471444|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471445|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471446|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19471447|NCT03265470|Narcotics|narcotics|mesh-ancestor
19471448|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19471449|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19471450|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
19471451|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
19471452|NCT03265899|Lactitol|lactitol|mesh-list
19471453|NCT03265899|Oxytocin|oxytocin|mesh-list
19471454|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
19471455|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471456|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471457|NCT03265899|Cathartics|cathartics|mesh-ancestor
19471458|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471459|NCT03265574|Enalapril|enalapril|mesh-list
19471460|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19471461|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
19471462|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471463|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471464|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19471465|NCT03265795|Ether|ether|mesh-list
19471466|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19471467|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
19471468|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
19471469|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471470|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471471|NCT03265002|Psyllium|psyllium|mesh-list
19471472|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
19471473|NCT03265002|Cathartics|cathartics|mesh-ancestor
19471474|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471475|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
19471476|NCT03265288|Fenretinide|fenretinide|mesh-list
19471477|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471478|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19471479|NCT03265288|Protective Agents|protective agents|mesh-ancestor
19471480|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471481|NCT03265171|Plasminogen|plasminogen|mesh-list
19471482|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19471483|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19471484|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471485|NCT03265223|Ropivacaine|ropivacaine|mesh-list
19471486|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471487|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
19471488|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471489|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471490|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
19471491|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471492|NCT03265197|Lidocaine|lidocaine|mesh-list
19471493|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471494|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
19471495|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471496|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471497|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
19471498|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471499|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19471500|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19471501|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19471502|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19471503|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471504|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
19471505|NCT03264638|Cyproterone|cyproterone|mesh-list
19471506|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
19471507|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
19471508|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
20019741|NCT02514122|Ketamine|ketamine|mesh-list
20575881|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20575882|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20575883|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20575884|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
20575885|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20575886|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20575887|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
19471509|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471510|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471511|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471512|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19471513|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
19471514|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471515|NCT03264651|Anastrozole|anastrozole|mesh-list
19471516|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19471517|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471518|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19471519|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19471520|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471521|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471522|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19471523|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
19471524|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471525|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471526|NCT03264794|Gefitinib|gefitinib|mesh-list
19471527|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471528|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471529|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471530|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471531|NCT03264781|CycloProvera|cycloprovera|mesh-list
19471532|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19471533|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19471534|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19471535|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
19471536|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471537|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471538|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19471539|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19471540|NCT03264911|Amoxicillin|amoxicillin|mesh-list
19471541|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19471542|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471543|NCT03264586|Lidocaine|lidocaine|mesh-list
19471544|NCT03264586|Prilocaine|prilocaine|mesh-list
19471545|NCT03264586|Mepivacaine|mepivacaine|mesh-list
19471546|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19471547|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471548|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
19471549|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471550|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471551|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
19471552|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471553|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19471554|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19471555|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19471556|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19471557|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471558|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19471559|NCT03264625|Vitamin D|vitamin d|mesh-list
19471560|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
19471561|NCT03264625|Vitamins|vitamins|mesh-ancestor
19471562|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
19471563|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471564|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19471565|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19471566|NCT03264547|Paclitaxel|paclitaxel|mesh-list
19471567|NCT03264547|Docetaxel|docetaxel|mesh-list
19471568|NCT03264547|Trastuzumab|trastuzumab|mesh-list
19471569|NCT03264547|Pertuzumab|pertuzumab|mesh-list
19471570|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19471571|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471572|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
19471573|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
19471574|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
19471575|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471576|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19471577|NCT03264430|Ketamine|ketamine|mesh-list
19471578|NCT03264430|Bupivacaine|bupivacaine|mesh-list
19471579|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471580|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
19471581|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471582|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471583|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
19471584|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471585|NCT03264430|Analgesics|analgesics|mesh-ancestor
19471586|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19471587|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19471588|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
19471589|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19471590|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19471591|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471592|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471593|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
19471594|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
19471595|NCT03264118|Coagulants|coagulants|mesh-ancestor
19471596|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
19471597|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567156|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567157|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567158|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19567159|NCT04813016|Analgesics|analgesics|mesh-ancestor
19567160|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
19567161|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567162|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19567163|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19567164|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19567165|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
19567166|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567167|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567168|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19567169|NCT04813016|Narcotics|narcotics|mesh-ancestor
19567170|NCT04800822|Cetuximab|cetuximab|mesh-list
19567171|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567172|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567173|NCT04789928|Gentamicins|gentamicins|mesh-list
19567174|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567175|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567176|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19567177|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567178|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567179|NCT04767594|Palbociclib|palbociclib|mesh-list
19567180|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567181|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19567182|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567183|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567184|NCT04752696|Leucovorin|leucovorin|mesh-list
19567185|NCT04752696|Fluorouracil|fluorouracil|mesh-list
19567186|NCT04752696|Irinotecan|irinotecan|mesh-list
19567187|NCT04752696|Onvansertib|onvansertib|mesh-list
19567188|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
19567189|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567190|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19567191|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567192|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567193|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
19567194|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567195|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19567196|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19567197|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567198|NCT04752696|Antidotes|antidotes|mesh-ancestor
19567199|NCT04752696|Protective Agents|protective agents|mesh-ancestor
19567200|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
19567201|NCT04752696|Vitamins|vitamins|mesh-ancestor
19567202|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
19567203|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19567204|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20019742|NCT02514122|Analgesics|analgesics|mesh-ancestor
19471598|NCT03264274|Aflibercept|aflibercept|mesh-list
19471599|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19471600|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19471601|NCT03264274|Growth Substances|growth substances|mesh-ancestor
19471602|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471603|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
19471604|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471605|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19471606|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19471607|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471608|NCT03264079|Itraconazole|itraconazole|mesh-list
19471609|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
19471610|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471611|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20019743|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
20019744|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742916|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19742917|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742918|NCT04338529|Vitamins|vitamins|mesh-ancestor
19742919|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
20019745|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019746|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19742920|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19742921|NCT04338529|Antacids|antacids|mesh-ancestor
19742922|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575888|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20575889|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20575890|NCT02068170|Renal Agents|renal agents|mesh-ancestor
20019747|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20019748|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
20019749|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
20019750|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019751|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20019752|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20019753|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019754|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019755|NCT02514174|Afatinib|afatinib|mesh-list
20019756|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019757|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20019758|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019759|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019760|NCT02514473|Ivacaftor|ivacaftor|mesh-list
20019761|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20019762|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019763|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019764|NCT02514551|Paclitaxel|paclitaxel|mesh-list
20019765|NCT02514551|Ramucirumab|ramucirumab|mesh-list
20019766|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20019767|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019768|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
20019769|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
20019770|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
20292339|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
19471612|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19471613|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471614|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471615|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19471616|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
19471617|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471618|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471619|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19471620|NCT03263936|Cytarabine|cytarabine|mesh-list
19471621|NCT03263936|Fludarabine|fludarabine|mesh-list
19471622|NCT03263936|Decitabine|decitabine|mesh-list
19471623|NCT03263936|Vorinostat|vorinostat|mesh-list
19471624|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471625|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19471626|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
19471627|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471628|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471629|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
19471630|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471631|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
19471632|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471633|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471634|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19471635|NCT03263741|Paclitaxel|paclitaxel|mesh-list
19471636|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19471637|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
19471638|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19471639|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471640|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
19471641|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
19471642|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
19471643|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471644|NCT03263962|Canrenone|canrenone|mesh-list
19471645|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19471646|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
19471647|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471648|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471649|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19471650|NCT03263962|Diuretics|diuretics|mesh-ancestor
19471651|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
19471652|NCT03263871|Micronutrients|micronutrients|mesh-list
19471653|NCT03263871|Trace Elements|trace elements|mesh-list
19471654|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471655|NCT03263689|Morphine|morphine|mesh-list
19471656|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19471657|NCT03263689|Narcotics|narcotics|mesh-ancestor
19471658|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471659|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471660|NCT03263689|Analgesics|analgesics|mesh-ancestor
19471661|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
19471662|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471663|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
19471664|NCT03263767|Fludarabine|fludarabine|mesh-list
19471665|NCT03263767|Clofarabine|clofarabine|mesh-list
19471666|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
19471667|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471668|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
19471669|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471670|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471671|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19471672|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
20292340|NCT05325489|Hormones|hormones|mesh-ancestor
19471673|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471674|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471675|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19471676|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19471677|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
19471678|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
19471679|NCT03263715|Hormones|hormones|mesh-ancestor
19471680|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471681|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471682|NCT03263650|Prednisone|prednisone|mesh-list
19471683|NCT03263650|Carboplatin|carboplatin|mesh-list
19471684|NCT03263650|Olaparib|olaparib|mesh-list
19471685|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471686|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471687|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
19471688|NCT03263650|Hormones|hormones|mesh-ancestor
19471689|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471690|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471691|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19471692|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19471693|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471694|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471695|NCT03263624|Tazarotene|tazarotene|mesh-list
19471696|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
19471697|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
19471698|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
19471699|NCT03263481|Secretin|secretin|mesh-list
19471700|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471701|NCT03263481|Hormones|hormones|mesh-ancestor
19471702|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471703|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471704|NCT03263299|Aspirin|aspirin|mesh-list
19471705|NCT03263299|Cabergoline|cabergoline|mesh-list
19471706|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471707|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471708|NCT03263299|Analgesics|analgesics|mesh-ancestor
19471709|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
19471710|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471711|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471712|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471713|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471714|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19471715|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19471716|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471717|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19471718|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19471719|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471720|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
19471721|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19471722|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19471723|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
19471724|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
19471725|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471726|NCT03263572|Cytarabine|cytarabine|mesh-list
19471727|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19471728|NCT03263572|Methotrexate|methotrexate|mesh-list
19471729|NCT03263572|Blinatumomab|blinatumomab|mesh-list
19471730|NCT03263572|Ponatinib|ponatinib|mesh-list
19471731|NCT03263572|Antibodies|antibodies|mesh-list
19471732|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
19471733|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19471734|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
19471735|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19471736|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
19471737|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471738|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471739|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19471740|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
19471741|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471742|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19471743|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
19471744|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471745|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19471746|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471747|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19471748|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471749|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471750|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19471751|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
19471752|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471753|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471754|NCT03263533|Vorinostat|vorinostat|mesh-list
19471755|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471756|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19471757|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471758|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471759|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
19471760|NCT03263520|Dexamethasone|dexamethasone|mesh-list
19471761|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
19471762|NCT03263520|Nandrolone|nandrolone|mesh-list
19471763|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
19471764|NCT03263520|BB 1101|bb 1101|mesh-list
19471765|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471766|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
19471767|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
19471768|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471769|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471770|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471771|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
19471772|NCT03263520|Hormones|hormones|mesh-ancestor
19471773|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471774|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19471775|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471776|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
19471777|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471778|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471779|NCT03263520|Androgens|androgens|mesh-ancestor
19471780|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
19471781|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19471782|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
19471783|NCT03263208|Fludarabine|fludarabine|mesh-list
19471784|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471785|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
19471786|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471787|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471788|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19471789|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
19471790|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471791|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471792|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19471793|NCT03262857|Lidocaine|lidocaine|mesh-list
19471794|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
19471795|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471796|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
19471797|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471798|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471799|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
19471800|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471801|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19471802|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19471803|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19471804|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19471805|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471806|NCT03262857|Analgesics|analgesics|mesh-ancestor
19471807|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
19471808|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19471809|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19471810|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
19471811|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471812|NCT03262948|Paclitaxel|paclitaxel|mesh-list
19471813|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19471814|NCT03262948|Carboplatin|carboplatin|mesh-list
19471815|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19471816|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471817|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
19471818|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
19471819|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
19471820|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471821|NCT03263065|Psyllium|psyllium|mesh-list
19471822|NCT03263065|Cathartics|cathartics|mesh-ancestor
19471823|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471824|NCT03263052|Tacrolimus|tacrolimus|mesh-list
19471825|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19471826|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
19471827|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471828|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19471829|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471830|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471831|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
19471832|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19471833|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471834|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
19471835|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471836|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
19471837|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19471838|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19471839|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471840|NCT03262961|Urological Agents|urological agents|mesh-ancestor
19471841|NCT03262792|Andrographolide|andrographolide|mesh-list
19471842|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471843|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471844|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471845|NCT03262792|Analgesics|analgesics|mesh-ancestor
19471846|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
19471847|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471848|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471849|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471850|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19471851|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20019771|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019772|NCT02514772|Rituximab|rituximab|mesh-list
20019773|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20019774|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019775|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
20019776|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019777|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019778|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
20019779|NCT02515045|Prednisolone|prednisolone|mesh-list
20019780|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20019781|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
20019782|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20019783|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
19471852|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471853|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
19471854|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19471855|NCT03262545|Apatinib|apatinib|mesh-list
19471856|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019784|NCT02515045|Nepafenac|nepafenac|mesh-list
20019785|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20019786|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
20019787|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019788|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
20019789|NCT02515045|Hormones|hormones|mesh-ancestor
20019790|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019791|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019792|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20019793|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019794|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
20019795|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
20019796|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019797|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019798|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20019799|NCT02515045|Protective Agents|protective agents|mesh-ancestor
20019800|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20019801|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019802|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20019803|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20019804|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019805|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019806|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20019807|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20019808|NCT02515045|Analgesics|analgesics|mesh-ancestor
20019809|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
20019810|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20019811|NCT02515279|Ribavirin|ribavirin|mesh-list
20019812|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20019813|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
20019814|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019815|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
20019816|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019817|NCT02515305|Clindamycin|clindamycin|mesh-list
20019818|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
20019819|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
20019820|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20019821|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20019822|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019823|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20019824|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019825|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019826|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
20019827|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
20019828|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20019829|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471857|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20019830|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471858|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471859|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471860|NCT03262688|Bupivacaine|bupivacaine|mesh-list
19471861|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
19471862|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
19471863|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471864|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471865|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
19471866|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567205|NCT04747847|Atorvastatin|atorvastatin|mesh-list
19567206|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19567207|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19567208|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
19567209|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567210|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19567211|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19567212|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567213|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567214|NCT04743804|Ravulizumab|ravulizumab|mesh-list
19567215|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19567216|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567217|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
19567218|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567219|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
19567220|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19567221|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567222|NCT04730635|Donepezil|donepezil|mesh-list
19567223|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19567224|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567225|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567226|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
19567227|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567228|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567229|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
19567230|NCT04712071|Ketamine|ketamine|mesh-list
19567231|NCT04712071|Analgesics|analgesics|mesh-ancestor
19567232|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
19567233|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567234|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567235|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19567236|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19567237|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
19567238|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
19567239|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567240|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19567241|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19567242|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567243|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567244|NCT04706741|Prednisone|prednisone|mesh-list
19567245|NCT04706741|Prednisolone|prednisolone|mesh-list
19567246|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567247|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
19567248|NCT04706741|Hormones|hormones|mesh-ancestor
19567249|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567250|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567251|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19567252|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567253|NCT04705844|Adalimumab|adalimumab|mesh-list
19567254|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567255|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577482|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577483|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19577484|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19577485|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19577486|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19577487|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577488|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
19577489|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577490|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577491|NCT04324229|Liraglutide|liraglutide|mesh-list
19577492|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19577493|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577494|NCT04324229|Incretins|incretins|mesh-ancestor
19577495|NCT04324229|Hormones|hormones|mesh-ancestor
19471867|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19471868|NCT03262740|Norethindrone|norethindrone|mesh-list
19471869|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
19471870|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19471871|NCT03262740|Estradiol|estradiol|mesh-list
19471872|NCT03262740|Branebrutinib|branebrutinib|mesh-list
19471873|NCT03262740|Estrogens|estrogens|mesh-ancestor
19471874|NCT03262740|Hormones|hormones|mesh-ancestor
19471875|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471876|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471877|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19471878|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
19471879|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471880|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19471881|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19471882|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19471883|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19471884|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19471885|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19471886|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471887|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471888|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471889|NCT03262727|BMS-986165|bms-986165|mesh-list
19471890|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19471891|NCT03262727|Norethindrone|norethindrone|mesh-list
19471892|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
19471893|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19471894|NCT03262727|Estradiol|estradiol|mesh-list
19471895|NCT03262727|Estrogens|estrogens|mesh-ancestor
19471896|NCT03262727|Hormones|hormones|mesh-ancestor
19471897|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19471898|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471899|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19471900|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
19471901|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471902|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19471903|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19471904|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19471905|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19471906|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
19471907|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19471908|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471909|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471910|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19471911|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19471912|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
19471913|NCT03262142|Tazobactam|tazobactam|mesh-list
19471914|NCT03262142|Piperacillin|piperacillin|mesh-list
19471915|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19471916|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19471917|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471918|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19471919|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19471920|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471921|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471922|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471923|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19471924|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19471925|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19471926|NCT03262077|Methylene Blue|methylene blue|mesh-list
19471927|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471928|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471929|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
19471930|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19471931|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19471932|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742923|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742924|NCT04336241|Nivolumab|nivolumab|mesh-list
19742925|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742926|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742927|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19471933|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471934|NCT03262090|Analgesics|analgesics|mesh-ancestor
19471935|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
19471936|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471937|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20575891|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20019831|NCT02515890|Midazolam|midazolam|mesh-list
20019832|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
20019833|NCT02515890|Ketamine|ketamine|mesh-list
20019834|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20019835|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019836|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019837|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471938|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19471939|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19471940|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
19471941|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19471942|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471943|NCT03262116|Insulin|insulin|mesh-list
19471944|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19471945|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
19471946|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
19471947|NCT03262116|Pancrelipase|pancrelipase|mesh-list
19471948|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19471949|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471950|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471951|NCT03262363|Curcumin|curcumin|mesh-list
19471952|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471953|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471954|NCT03262363|Analgesics|analgesics|mesh-ancestor
19471955|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
19471956|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471957|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471958|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471959|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471960|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471961|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471962|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471963|NCT03262376|Vitamins|vitamins|mesh-list
19471964|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
19471965|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471966|NCT03262103|Poly I-C|poly i-c|mesh-list
19471967|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19471968|NCT03262103|Poly ICLC|poly iclc|mesh-list
19471969|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
19471970|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
19471971|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471972|NCT03262103|Laxatives|laxatives|mesh-ancestor
19471973|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19471974|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
19471975|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19471976|NCT03261635|Indomethacin|indomethacin|mesh-list
19471977|NCT03261635|Ranibizumab|ranibizumab|mesh-list
19471978|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19471979|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19471980|NCT03261635|Growth Substances|growth substances|mesh-ancestor
19471981|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19471982|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
19471983|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19471984|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19471985|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19471986|NCT03261635|Analgesics|analgesics|mesh-ancestor
19471987|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
19471988|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19471989|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19471990|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19471991|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
19471992|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
19471993|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19471994|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20019838|NCT02515890|Analgesics|analgesics|mesh-ancestor
20575892|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19471995|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19471996|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19471997|NCT03261570|Digoxin|digoxin|mesh-list
20019839|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
19471998|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19471999|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19472000|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19472001|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019840|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019841|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20019842|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20019843|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20019844|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
20019845|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019846|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019847|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20019848|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20019849|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
20019850|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
20019851|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20019852|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20019853|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20019854|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20019855|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20019856|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20019857|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
20019858|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
20019859|NCT02516098|Scopolamine|scopolamine|mesh-list
20019860|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20019861|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20019862|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
20019863|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
20019864|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019865|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019866|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019867|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
20019868|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20019869|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
20019870|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019871|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567256|NCT04704024|Tenofovir|tenofovir|mesh-list
20019872|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20019873|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
20019874|NCT02516150|Ethanol|ethanol|mesh-list
20019875|NCT02516150|Glucagon|glucagon|mesh-list
20019876|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20019877|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019878|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019879|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019880|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019881|NCT02516150|Hormones|hormones|mesh-ancestor
20019882|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20575893|NCT02068170|Narcotics|narcotics|mesh-ancestor
20575894|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20575895|NCT02068170|Analgesics|analgesics|mesh-ancestor
20019883|NCT02516202|Estradiol|estradiol|mesh-list
20019884|NCT02516202|Estrogens|estrogens|mesh-ancestor
20019885|NCT02516202|Hormones|hormones|mesh-ancestor
20019886|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019887|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019888|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20019889|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20019890|NCT02516332|Citalopram|citalopram|mesh-list
20019891|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20019892|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20019893|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019894|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019895|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019896|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
20019897|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019898|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20019899|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
20019900|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20575896|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
20575897|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575898|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
20575899|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
19472002|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472003|NCT03261570|Protective Agents|protective agents|mesh-ancestor
19472004|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472005|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19472006|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
19472007|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472008|NCT03261921|Dexamethasone|dexamethasone|mesh-list
19472009|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
19472010|NCT03261921|Bupivacaine|bupivacaine|mesh-list
19472011|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472012|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
19472013|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
19472014|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472015|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472016|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472017|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
19472018|NCT03261921|Hormones|hormones|mesh-ancestor
19472019|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472020|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19472021|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472022|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
19472023|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
19472024|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472025|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
19472026|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19472027|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19472028|NCT03261921|Analgesics|analgesics|mesh-ancestor
19472029|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19472030|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19472031|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19472032|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
19472033|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472034|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472035|NCT03261596|Mebendazole|mebendazole|mesh-list
19472036|NCT03261596|Piperazine|piperazine|mesh-list
19472037|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
19472038|NCT03261596|DMP 777|dmp 777|mesh-list
19472039|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
19472040|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
19472041|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19472042|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472043|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
19472044|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
19472045|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19472046|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472047|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472048|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472049|NCT03261791|Apatinib|apatinib|mesh-list
19472050|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472051|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19472052|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472053|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472054|NCT03261284|Warfarin|warfarin|mesh-list
19472055|NCT03261284|Dabigatran|dabigatran|mesh-list
19472056|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
19472057|NCT03261284|Antithrombins|antithrombins|mesh-ancestor
19472058|NCT03261284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19472059|NCT03261284|Protease Inhibitors|protease inhibitors|mesh-ancestor
19472060|NCT03261284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472061|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472062|NCT03261193|Bupivacaine|bupivacaine|mesh-list
19472063|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
19472064|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
19472065|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472066|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472067|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
19472068|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472069|NCT03261427|Pregabalin|pregabalin|mesh-list
19472070|NCT03261427|Analgesics|analgesics|mesh-ancestor
19472071|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
19472072|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472073|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472074|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
19472075|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19472076|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19472077|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472078|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19472079|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19472080|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19472081|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472082|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19472083|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
19472084|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19472085|NCT03261349|Ledipasvir|ledipasvir|mesh-list
19472086|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
19472087|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472088|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
19472089|NCT03261310|Acetaminophen|acetaminophen|mesh-list
19472090|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19472091|NCT03261310|Analgesics|analgesics|mesh-ancestor
19472092|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
19472093|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472094|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472095|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
19472096|NCT03261102|Adalimumab|adalimumab|mesh-list
19472097|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472098|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472099|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
19472100|NCT03260829|Vitamins|vitamins|mesh-ancestor
19472101|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
19472102|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472103|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
19472104|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472105|NCT03260829|Protective Agents|protective agents|mesh-ancestor
19472106|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
19472107|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
19472108|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
19472109|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472110|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472111|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
19472112|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472113|NCT03260920|Oxytocin|oxytocin|mesh-list
19472114|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
19472115|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472116|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567257|NCT04704024|Lamivudine|lamivudine|mesh-list
19567258|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
19567259|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567260|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19567261|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19567262|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567263|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567264|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19567265|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19567266|NCT04688814|Morphine|morphine|mesh-list
19567267|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19567268|NCT04688814|Narcotics|narcotics|mesh-ancestor
19567269|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567270|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567271|NCT04688814|Analgesics|analgesics|mesh-ancestor
19567272|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
19567273|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567274|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
19567275|NCT04678336|Fludarabine|fludarabine|mesh-list
19567276|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567277|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
19567278|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567279|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567280|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19567281|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
19567282|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567283|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567284|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19567285|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
19567286|NCT04674813|Fludarabine|fludarabine|mesh-list
19567287|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567288|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
19567289|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567290|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567291|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19567292|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
19567293|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472117|NCT03261024|Nickel|nickel|mesh-list
19472118|NCT03261024|Trace Elements|trace elements|mesh-ancestor
19472119|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
19472120|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472121|NCT03260634|Voriconazole|voriconazole|mesh-list
19472122|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
19472123|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472124|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19472125|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19472126|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472127|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472128|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19472129|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
19472130|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472131|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472132|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19472133|NCT03261115|Anesthetics|anesthetics|mesh-list
19472134|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472135|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472136|NCT03260439|Tramadol|tramadol|mesh-list
19472137|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19472138|NCT03260439|Narcotics|narcotics|mesh-ancestor
19472139|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472140|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472141|NCT03260439|Analgesics|analgesics|mesh-ancestor
19472142|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
20575900|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20575901|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20575902|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
20575903|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
20575904|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20575905|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20575906|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20575907|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20575908|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20575909|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
20575910|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575911|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19472143|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472144|NCT03260712|Gemcitabine|gemcitabine|mesh-list
19472145|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
19472146|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472147|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472148|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
19472149|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472150|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
19472151|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472152|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472153|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472154|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
19472155|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472156|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472157|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
19472158|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19472159|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
19472160|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472161|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472162|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19472163|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
19472164|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19472165|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
19472166|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472167|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472168|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19472169|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
19472170|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
19472171|NCT03260569|Protective Agents|protective agents|mesh-ancestor
19472172|NCT03260556|Pirfenidone|pirfenidone|mesh-list
19472173|NCT03260556|Analgesics|analgesics|mesh-ancestor
19472174|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
19472175|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472176|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575912|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
19472177|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19472178|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19472179|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472180|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472181|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472182|NCT03260283|Fentanyl|fentanyl|mesh-list
19472183|NCT03260283|Meperidine|meperidine|mesh-list
19472184|NCT03260283|Ropivacaine|ropivacaine|mesh-list
19472185|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
19472186|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
19472187|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472188|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472189|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
19472190|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472191|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19472192|NCT03260283|Narcotics|narcotics|mesh-ancestor
19472193|NCT03260283|Analgesics|analgesics|mesh-ancestor
19472194|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19472195|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19472196|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
19472197|NCT03260166|Niacinamide|niacinamide|mesh-list
19472198|NCT03260166|Niacin|niacin|mesh-list
19472199|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
19472200|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
20575913|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20575914|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20575915|NCT02068196|Ipilimumab|ipilimumab|mesh-list
20575916|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20575917|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575918|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20575919|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472201|NCT03260166|Vitamins|vitamins|mesh-ancestor
20019901|NCT02516410|Ivacaftor|ivacaftor|mesh-list
20019902|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20019903|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20019904|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472202|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
19472203|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472204|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20019905|NCT02516592|Fluticasone|fluticasone|mesh-list
20019906|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20019907|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019908|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20019909|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
20019910|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019911|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019912|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20019913|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
20019914|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
20019915|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20019916|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20019917|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20019918|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20019919|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
20019920|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20019921|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019922|NCT02517021|Dexamethasone|dexamethasone|mesh-list
20019923|NCT02517021|Palonosetron|palonosetron|mesh-list
20019924|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20019925|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
20019926|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
20019927|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019928|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019929|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20019930|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
20019931|NCT02517021|Hormones|hormones|mesh-ancestor
20019932|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019933|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20019934|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20019935|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20019936|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20019937|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
20019938|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575920|NCT02068209|Tramadol|tramadol|mesh-list
19472205|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
19472206|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472207|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19472208|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
19472209|NCT03260010|Fosfomycin|fosfomycin|mesh-list
19472210|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19472211|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472212|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
19472213|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472214|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
19472215|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19472216|NCT03260088|Antibodies|antibodies|mesh-list
19472217|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
19472218|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
19472219|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472220|NCT03259919|Metformin|metformin|mesh-list
19472221|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19472222|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472223|NCT03259958|Donepezil|donepezil|mesh-list
19472224|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19472225|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472226|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472227|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
19472228|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472229|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472230|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
19472231|NCT03259529|Gemcitabine|gemcitabine|mesh-list
19472232|NCT03259529|Rituximab|rituximab|mesh-list
19472233|NCT03259529|Nivolumab|nivolumab|mesh-list
19472234|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19472235|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472236|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472237|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
19472238|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472239|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472240|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472241|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
19472242|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472243|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
19472244|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472245|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472246|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472247|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19472248|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19472249|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
19472250|NCT03259516|Cytarabine|cytarabine|mesh-list
19472251|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
19472252|NCT03259516|Melphalan|melphalan|mesh-list
19472253|NCT03259516|Nivolumab|nivolumab|mesh-list
19472254|NCT03259516|Fludarabine|fludarabine|mesh-list
19472255|NCT03259516|Azacitidine|azacitidine|mesh-list
19472256|NCT03259516|Tretinoin|tretinoin|mesh-list
19472257|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
19472258|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472259|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
19472260|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472261|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472262|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19472263|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
19472264|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472265|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472266|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19472267|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472268|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19472269|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472270|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
19472271|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
19472272|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472273|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472274|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
19472275|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19472276|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19472277|NCT03259516|Urological Agents|urological agents|mesh-ancestor
19472278|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
19472279|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
19472280|NCT03259672|Sevoflurane|sevoflurane|mesh-list
19472281|NCT03259672|Desflurane|desflurane|mesh-list
19472282|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19472283|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19472284|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
19472285|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
19472286|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472287|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472288|NCT03259607|Nicotine|nicotine|mesh-list
19472289|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19472290|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
19472291|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472292|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472293|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19472294|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19472295|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
19472296|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472297|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472298|NCT03259542|Itraconazole|itraconazole|mesh-list
19472299|NCT03259542|Mifepristone|mifepristone|mesh-list
19472300|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
19472301|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472302|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19472303|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19472304|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472305|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472306|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19472307|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
19472308|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472309|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472310|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19472311|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19472312|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
19472313|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472314|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19472315|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19472316|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19472317|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
19472318|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19472319|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19472320|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
19472321|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19472322|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19472323|NCT03259152|Denosumab|denosumab|mesh-list
19472324|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19472325|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472326|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
19472327|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19472328|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19472329|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
19472330|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567294|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567295|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19567296|NCT04663555|Dexamethasone|dexamethasone|mesh-list
19567297|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567298|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
19567299|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
19567300|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567301|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567302|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19567303|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
19567304|NCT04663555|Hormones|hormones|mesh-ancestor
19567305|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567306|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19567307|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742928|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019939|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019940|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
20019941|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20019942|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
20019943|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20019944|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019945|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20019946|NCT02517515|Ritonavir|ritonavir|mesh-list
20019947|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19472331|NCT03258931|Cytarabine|cytarabine|mesh-list
19472332|NCT03258931|Midostaurin|midostaurin|mesh-list
19472333|NCT03258931|Crenolanib|crenolanib|mesh-list
19472334|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472335|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
19472336|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472337|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472338|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
19472339|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472340|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472341|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
19472342|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472343|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19472344|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472345|NCT03259243|Bupivacaine|bupivacaine|mesh-list
19472346|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
19472347|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
19472348|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472349|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472350|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
19472351|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472352|NCT03258684|Ascorbic Acid|ascorbic acid|mesh-list
19472353|NCT03258684|Thiamine|thiamine|mesh-list
19472354|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
19472355|NCT03258684|Vitamins|vitamins|mesh-ancestor
19472356|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
19472357|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472358|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742929|NCT04332367|Paclitaxel|paclitaxel|mesh-list
19742930|NCT04332367|Carboplatin|carboplatin|mesh-list
19742931|NCT04332367|Ramucirumab|ramucirumab|mesh-list
19742932|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742933|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742934|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742935|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742936|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742937|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742938|NCT04324463|Aspirin|aspirin|mesh-list
19742939|NCT04324463|Interferons|interferons|mesh-list
19742940|NCT04324463|Interferon-beta|interferon-beta|mesh-list
19742941|NCT04324463|Colchicine|colchicine|mesh-list
19742942|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
19742943|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742944|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
19742945|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742946|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19742947|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742948|NCT04324463|Analgesics|analgesics|mesh-ancestor
19742949|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
19742950|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742951|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742952|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742953|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742954|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19742955|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19742956|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742957|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19742958|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19742959|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742960|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
19742961|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19742962|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
19742963|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20019948|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20019949|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
20019950|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019951|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019952|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20019953|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20019954|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
19472359|NCT03258684|Antioxidants|antioxidants|mesh-ancestor
19472360|NCT03258684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472361|NCT03258684|Protective Agents|protective agents|mesh-ancestor
19472362|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
19472363|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
19472364|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
19742964|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
19742965|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
19472365|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
19472366|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472367|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472368|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
19472369|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472370|NCT03258866|Rituximab|rituximab|mesh-list
19472371|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472372|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472373|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
19472374|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472375|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472376|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
19472377|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
19472378|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19472379|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
19472380|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472381|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472382|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19472383|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
19472384|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19472385|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19472386|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19472387|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
19472388|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472389|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472390|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
19472391|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19472392|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
19472393|NCT03258723|Metformin|metformin|mesh-list
19472394|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19472395|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472396|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
19472397|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19472398|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472399|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19472400|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19472401|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472402|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472403|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472404|NCT03258372|Rifampin|rifampin|mesh-list
20019955|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019956|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19472405|NCT03258372|Mifepristone|mifepristone|mesh-list
19472406|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19472407|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
19472408|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19472409|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472410|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
19472411|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19472412|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472413|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472414|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19472415|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19472416|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19472417|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19472418|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19472419|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19472420|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19472421|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
19472422|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472423|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472424|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19472425|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19472426|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19472427|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
19472428|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19472429|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19472430|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
19472431|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20019957|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20019958|NCT02517528|Ritonavir|ritonavir|mesh-list
20019959|NCT02517528|Ribavirin|ribavirin|mesh-list
19472432|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
19472433|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19472434|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19472435|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
19472436|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
19472437|NCT03258385|Vitamins|vitamins|mesh-ancestor
19472438|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
19472439|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472440|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
19472441|NCT03258385|Hematinics|hematinics|mesh-ancestor
19472442|NCT03258476|Guanfacine|guanfacine|mesh-list
19472443|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19472444|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19472445|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19472446|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19472447|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
19472448|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472449|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472450|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472451|NCT03258294|Melatonin|melatonin|mesh-list
19472452|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
19472453|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472454|NCT03258294|Protective Agents|protective agents|mesh-ancestor
19472455|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472456|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472457|NCT03258398|Avelumab|avelumab|mesh-list
19472458|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472459|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472460|NCT03257930|Ethanol|ethanol|mesh-list
19472461|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19472462|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472463|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472464|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472465|NCT03257943|Ivermectin|ivermectin|mesh-list
19472466|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19472467|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472468|NCT03257683|Ranolazine|ranolazine|mesh-list
19472469|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19472470|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19472471|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472472|NCT03257670|Lidocaine|lidocaine|mesh-list
19472473|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
19472474|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
19472475|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472476|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472477|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
19472478|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472479|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19472480|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19472481|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19472482|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19472483|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472484|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
19472485|NCT03257722|Idelalisib|idelalisib|mesh-list
19472486|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472487|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472488|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472489|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472490|NCT03257852|Methotrexate|methotrexate|mesh-list
19472491|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19472492|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
19472493|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472494|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472495|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472496|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
19472497|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472498|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472499|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
19472500|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472501|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19472502|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472503|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
19472504|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742966|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
19472505|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19472506|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
19472507|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
19472508|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472509|NCT03257514|Protective Agents|protective agents|mesh-ancestor
19472510|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472511|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
19472512|NCT03257514|Vitamins|vitamins|mesh-ancestor
19472513|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
19472514|NCT03257800|Ketamine|ketamine|mesh-list
19472515|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
19472516|NCT03257800|Sevoflurane|sevoflurane|mesh-list
19472517|NCT03257800|Analgesics|analgesics|mesh-ancestor
19472518|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
19472519|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472520|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472521|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19472522|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19472523|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
19472524|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
19472525|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472526|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19472527|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19472528|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472529|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472530|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19472531|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19472532|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19472533|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
19472534|NCT03257423|Metronidazole|metronidazole|mesh-list
19472535|NCT03257423|Levofloxacin|levofloxacin|mesh-list
19472536|NCT03257423|Ofloxacin|ofloxacin|mesh-list
19472537|NCT03257423|Ertapenem|ertapenem|mesh-list
19472538|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19472539|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472540|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19472541|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19472542|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472543|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472544|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472545|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19472546|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19472547|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19472548|NCT03257423|Renal Agents|renal agents|mesh-ancestor
19472549|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19472550|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19567308|NCT04656652|Docetaxel|docetaxel|mesh-list
19567309|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567310|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
19567311|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
19567312|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
19567313|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567314|NCT04649489|Bevacizumab|bevacizumab|mesh-list
19567315|NCT04649489|Atezolizumab|atezolizumab|mesh-list
19567316|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19567317|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567318|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567319|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19567320|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19567321|NCT04649489|Growth Substances|growth substances|mesh-ancestor
19567322|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567323|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
19567324|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
19567325|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
19567326|NCT04645719|Analgesics|analgesics|mesh-ancestor
19567327|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
19567328|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567329|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567330|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
19567331|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567332|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19567333|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
19567334|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19567335|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567336|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742967|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
19472551|NCT03257319|Morphine|morphine|mesh-list
19472552|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19472553|NCT03257319|Narcotics|narcotics|mesh-ancestor
19472554|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472555|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472556|NCT03257319|Analgesics|analgesics|mesh-ancestor
19472557|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
19472558|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472559|NCT03257241|Cytarabine|cytarabine|mesh-list
19472560|NCT03257241|Fludarabine|fludarabine|mesh-list
19472561|NCT03257241|Daunorubicin|daunorubicin|mesh-list
19472562|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
19472563|NCT03257241|Idarubicin|idarubicin|mesh-list
19472564|NCT03257241|Cladribine|cladribine|mesh-list
19472565|NCT03257241|Lenograstim|lenograstim|mesh-list
19472566|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472567|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472568|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
19472569|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472570|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472571|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
19472572|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472573|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
19472574|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472575|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19472576|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19472577|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19472578|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19472579|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472580|NCT03257241|Analgesics|analgesics|mesh-ancestor
19472581|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
19472582|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472583|NCT03257215|Vitamin D|vitamin d|mesh-list
19472584|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
19472585|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
19472586|NCT03257215|Vitamins|vitamins|mesh-list
19472587|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
19472588|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019960|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20019961|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20019962|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
20019963|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20019964|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019965|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20019966|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20019967|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
20019968|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20019969|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19472589|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19472590|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19472591|NCT03257124|Osimertinib|osimertinib|mesh-list
19472592|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472593|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19472594|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472595|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472596|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
19472597|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19472598|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
19472599|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
19472600|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472601|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472602|NCT03256721|Docetaxel|docetaxel|mesh-list
19472603|NCT03256721|Pemetrexed|pemetrexed|mesh-list
20019970|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19472604|NCT03256721|Apatinib|apatinib|mesh-list
19472605|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472606|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
19472607|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
19472608|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
19472609|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472610|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472611|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19472612|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19472613|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19472614|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
19472615|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19472616|NCT03256864|Everolimus|everolimus|mesh-list
19472617|NCT03256864|Tacrolimus|tacrolimus|mesh-list
19472618|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472619|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
20019971|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
20019972|NCT02517580|Vitamin K|vitamin k|mesh-list
20019973|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
20019974|NCT02517580|Vitamins|vitamins|mesh-ancestor
20019975|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
20019976|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019977|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20019978|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20019979|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019980|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
20019981|NCT02517580|Coagulants|coagulants|mesh-ancestor
20019982|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20019983|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20019984|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20019985|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20019986|NCT02517905|Bupivacaine|bupivacaine|mesh-list
20019987|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
20019988|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
20019989|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019990|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019991|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
20019992|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20019993|NCT02517996|Lidocaine|lidocaine|mesh-list
20019994|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
20019995|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
20019996|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20019997|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20019998|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
20019999|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020000|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20020001|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20020002|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20020003|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020004|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020005|NCT02518113|Dexamethasone|dexamethasone|mesh-list
20020006|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020007|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
20020008|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
20020009|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020010|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020011|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20020012|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
20020013|NCT02518113|Hormones|hormones|mesh-ancestor
20020014|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020015|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20020016|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020017|NCT02518191|Goserelin|goserelin|mesh-list
20020018|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20020019|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020020|NCT02518464|Ticagrelor|ticagrelor|mesh-list
19472620|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472621|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19472622|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472623|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472624|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472625|NCT03256487|Morphine|morphine|mesh-list
19472626|NCT03256487|Buprenorphine|buprenorphine|mesh-list
19472627|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19472628|NCT03256487|Narcotics|narcotics|mesh-ancestor
19472629|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472630|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472631|NCT03256487|Analgesics|analgesics|mesh-ancestor
19472632|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
19472633|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472634|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19472635|NCT03256149|Dexamethasone|dexamethasone|mesh-list
19472636|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472637|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
19472638|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
19472639|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472640|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472641|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472642|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
19472643|NCT03256149|Hormones|hormones|mesh-ancestor
19472644|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472645|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19472646|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472647|NCT03256071|Decitabine|decitabine|mesh-list
19472648|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472649|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
19472650|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472651|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472652|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472653|NCT03256292|Testosterone|testosterone|mesh-list
19472654|NCT03256292|Androgens|androgens|mesh-ancestor
19472655|NCT03256292|Hormones|hormones|mesh-ancestor
19472656|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472657|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472658|NCT03255811|Apatinib|apatinib|mesh-list
19472659|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472660|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19472661|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472662|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472663|NCT03255642|Clonazepam|clonazepam|mesh-list
19472664|NCT03255642|Melatonin|melatonin|mesh-list
19472665|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
19472666|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472667|NCT03255642|Protective Agents|protective agents|mesh-ancestor
19472668|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472669|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472670|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
19472671|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
19472672|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
19472673|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472674|NCT03255629|Glucagon|glucagon|mesh-list
19472675|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19472676|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472677|NCT03255629|Hormones|hormones|mesh-ancestor
19472678|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472679|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472680|NCT03255629|Incretins|incretins|mesh-ancestor
19567337|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19567338|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
19567339|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19567340|NCT04641273|Pregabalin|pregabalin|mesh-list
19567341|NCT04641273|Analgesics|analgesics|mesh-ancestor
19567342|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
19567343|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567344|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567345|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
19567346|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19567347|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567348|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567349|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19567350|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19472681|NCT03255226|Tolvaptan|tolvaptan|mesh-list
19472682|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19472683|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472684|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
19472685|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472686|NCT03255278|Vaccines|vaccines|mesh-list
19472687|NCT03255278|Immunologic Factors|immunologic factors|mesh-ancestor
19472688|NCT03255278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472689|NCT03255330|Dipyrone|dipyrone|mesh-list
19472690|NCT03255330|Gabapentin|gabapentin|mesh-list
19472691|NCT03255330|Tramadol|tramadol|mesh-list
19472692|NCT03255330|Analgesics|analgesics|mesh-ancestor
19472693|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
19472694|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472695|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472696|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
19472697|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19472698|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19472699|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472700|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19472701|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19472702|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19472703|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472704|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472705|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
19472706|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19472707|NCT03255330|Narcotics|narcotics|mesh-ancestor
19472708|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19472709|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19472710|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472711|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472712|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
19472713|NCT03255473|Dexamethasone|dexamethasone|mesh-list
19472714|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
19472715|NCT03255473|Prednisone|prednisone|mesh-list
19472716|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19472717|NCT03255473|BB 1101|bb 1101|mesh-list
19472718|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472719|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
19472720|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
19472721|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472722|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472723|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472724|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
19472725|NCT03255473|Hormones|hormones|mesh-ancestor
19472726|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472727|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19472728|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472729|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
19472730|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472731|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472732|NCT03255148|Oxytocin|oxytocin|mesh-list
19472733|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
19472734|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472735|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472736|NCT03254849|Empagliflozin|empagliflozin|mesh-list
19472737|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19472738|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19472739|NCT03254849|Diuretics|diuretics|mesh-ancestor
19472740|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
19472741|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472742|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19472743|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19472744|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575921|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20575922|NCT02068209|Narcotics|narcotics|mesh-ancestor
19472745|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19472746|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19472747|NCT03254810|Adalimumab|adalimumab|mesh-list
19472748|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472749|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472750|NCT03254927|Cetuximab|cetuximab|mesh-list
19472751|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472752|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472753|NCT03255044|Atorvastatin|atorvastatin|mesh-list
19472754|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19472755|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19472756|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19472757|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
19472758|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472759|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19472760|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19472761|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472762|NCT03254511|Enoxaparin|enoxaparin|mesh-list
19472763|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
19472764|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
19472765|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19472766|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19472767|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472768|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
19472769|NCT03254589|Methotrexate|methotrexate|mesh-list
19472770|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19472771|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
19472772|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472773|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472774|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472775|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
19472776|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472777|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472778|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
19472779|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472780|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19472781|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472782|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
19742968|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742969|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742970|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742971|NCT04322357|Prednisone|prednisone|mesh-list
19742972|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
19742973|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742974|NCT04322357|Hormones|hormones|mesh-ancestor
19742975|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742976|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742977|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19742978|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020021|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20020022|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20020023|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20020024|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20020025|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
20020026|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020027|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020028|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115343|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20115344|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115345|NCT00005120|Calanolide A|calanolide a|mesh-list
20115346|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20115347|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20115348|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
20115349|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120640|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
20120641|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120642|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120643|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20120644|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120645|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19742979|NCT04322305|Pregabalin|pregabalin|mesh-list
19742980|NCT04322305|Analgesics|analgesics|mesh-ancestor
19742981|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
19472783|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19472784|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19472785|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472786|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19472787|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19472788|NCT03254589|Analgesics|analgesics|mesh-ancestor
19472789|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
19472790|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472791|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472792|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472793|NCT03254784|BMS-986165|bms-986165|mesh-list
19472794|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
19472795|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19472796|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472797|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472798|NCT03254628|Misoprostol|misoprostol|mesh-list
19472799|NCT03254628|Oxytocin|oxytocin|mesh-list
19472800|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
19472801|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472802|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472803|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19472804|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
19472805|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19472806|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472807|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19472808|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20292341|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20292342|NCT05322031|Aripiprazole|aripiprazole|mesh-list
20292343|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
20575923|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472809|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472810|NCT03254186|Propranolol|propranolol|mesh-list
19472811|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19472812|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19472813|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
19472814|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472815|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472816|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472817|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19472818|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19472819|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
19472820|NCT03254173|Mirtazapine|mirtazapine|mesh-list
19472821|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
19472822|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19472823|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19472824|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
19472825|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
19472826|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472827|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472828|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472829|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19472830|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19472831|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472832|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19472833|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19472834|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19472835|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19472836|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19472837|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19472838|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
19472839|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19472840|NCT03254368|ZGN-1061|zgn-1061|mesh-list
19472841|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472842|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472843|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19472844|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
19472845|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472846|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472847|NCT03253913|Sirolimus|sirolimus|mesh-list
19472848|NCT03253913|Resveratrol|resveratrol|mesh-list
19472849|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19472850|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472851|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19472852|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472853|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
19472854|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472855|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
19472856|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472857|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
19472858|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472859|NCT03253913|Protective Agents|protective agents|mesh-ancestor
19472860|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472861|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19567351|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19567352|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567353|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19567354|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
19567355|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567356|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567357|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
19567358|NCT04579523|Fludarabine|fludarabine|mesh-list
19567359|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
19567360|NCT04579523|Daratumumab|daratumumab|mesh-list
19567361|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19567362|NCT04579523|Antibodies|antibodies|mesh-list
19567363|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
19567364|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19567365|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567366|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
19567367|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567368|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567369|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19567370|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
19567371|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567372|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567373|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19567374|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19567375|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
19567376|NCT04570644|Ibuprofen|ibuprofen|mesh-list
19567377|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
19567378|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19567379|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19567380|NCT04570644|Analgesics|analgesics|mesh-ancestor
19567381|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
19567382|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567383|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567384|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567385|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567386|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19567387|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567388|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567389|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19567390|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
19567391|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19567392|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
19567393|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19567394|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19567395|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
19567396|NCT04570085|Caffeine|caffeine|mesh-list
19567397|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19567398|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567399|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19567400|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567401|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567402|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19567403|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19567404|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
19567405|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567406|NCT04558216|Rifampin|rifampin|mesh-list
19567407|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19567408|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
19567409|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567410|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567411|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
19567412|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19567413|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567414|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472862|NCT03253887|Ethanol|ethanol|mesh-list
19472863|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19472864|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472865|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472866|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472867|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
19472868|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19472869|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
19472870|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472871|NCT03253328|Expectorants|expectorants|mesh-ancestor
19472872|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
19472873|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19472874|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
19472875|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472876|NCT03253328|Protective Agents|protective agents|mesh-ancestor
19472877|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472878|NCT03253328|Antidotes|antidotes|mesh-ancestor
19472879|NCT03253289|Meclizine|meclizine|mesh-list
19472880|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
19472881|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
19472882|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472883|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472884|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472885|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19472886|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
19472887|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
19472888|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19472889|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472890|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19472891|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19472892|NCT03253276|Cathartics|cathartics|mesh-ancestor
19472893|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472894|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
19472895|NCT03253224|Analgesics|analgesics|mesh-ancestor
19472896|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
19472897|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472898|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472899|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
19472900|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472901|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19472902|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
19472903|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19472904|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19472905|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472906|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19472907|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
19472908|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19472909|NCT03253250|Tenofovir|tenofovir|mesh-list
19472910|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19472911|NCT03253250|Entecavir|entecavir|mesh-list
19472912|NCT03253250|Adefovir|adefovir|mesh-list
19472913|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
19472914|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472915|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20020029|NCT02518971|Tamsulosin|tamsulosin|mesh-list
20020030|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20020031|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20020032|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20020033|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
20020034|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020035|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020036|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020037|NCT02518971|Urological Agents|urological agents|mesh-ancestor
20020038|NCT02519023|Acetaminophen|acetaminophen|mesh-list
20020039|NCT02519023|Ibuprofen|ibuprofen|mesh-list
20020040|NCT02519023|Epinephrine|epinephrine|mesh-list
20020041|NCT02519023|Oxycodone|oxycodone|mesh-list
20020042|NCT02519023|Bupivacaine|bupivacaine|mesh-list
20020043|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020044|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
20020045|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020046|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472916|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19472917|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472918|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020047|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
19472919|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19472920|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19472921|NCT03253562|Metformin|metformin|mesh-list
19472922|NCT03253562|Vildagliptin|vildagliptin|mesh-list
19472923|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19472924|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472925|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19472926|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
19472927|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472928|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472929|NCT03253198|Bupivacaine|bupivacaine|mesh-list
19472930|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
19472931|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
19472932|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472933|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472934|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
19472935|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020048|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020049|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020050|NCT02519023|Analgesics|analgesics|mesh-ancestor
20020051|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
20020052|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20575924|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575925|NCT02068209|Analgesics|analgesics|mesh-ancestor
20575926|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
20575927|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20575928|NCT02068235|Ponesimod|ponesimod|mesh-list
20575929|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20575930|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575931|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20575932|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
20575933|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020053|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020054|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020055|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20020056|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020057|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020058|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20020059|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20020060|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
20020061|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020062|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20020063|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20020064|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
20020065|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020066|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
20020067|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
20020068|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
20020069|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20020070|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20020071|NCT02519023|Narcotics|narcotics|mesh-ancestor
20020072|NCT02519231|Naproxen|naproxen|mesh-list
20020073|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20020074|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020075|NCT02519231|Analgesics|analgesics|mesh-ancestor
20020076|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
20020077|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020078|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020079|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020080|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020081|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
20020082|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20020083|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020084|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575934|NCT02068287|Esmolol|esmolol|mesh-list
20575935|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20575936|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20575937|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20575938|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
20575939|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20575940|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472936|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
20020085|NCT02519387|Buprenorphine|buprenorphine|mesh-list
19472937|NCT03253133|Oxycodone|oxycodone|mesh-list
20020086|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19472938|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472939|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19472940|NCT03253133|Narcotics|narcotics|mesh-ancestor
19472941|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19472942|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472943|NCT03253133|Analgesics|analgesics|mesh-ancestor
19472944|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
19472945|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472946|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
19472947|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472948|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472949|NCT03253107|Trastuzumab|trastuzumab|mesh-list
19472950|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472951|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472952|NCT03252808|Gemcitabine|gemcitabine|mesh-list
19472953|NCT03252808|Paclitaxel|paclitaxel|mesh-list
19472954|NCT03252808|Tegafur|tegafur|mesh-list
19472955|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19472956|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472957|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
19472958|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
19472959|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
19472960|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19472961|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472962|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
19472963|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
19472964|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19472965|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19472966|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19472967|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
19472968|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472969|NCT03252938|Avelumab|avelumab|mesh-list
19472970|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19472971|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472972|NCT03252665|Nicorandil|nicorandil|mesh-list
19472973|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
19472974|NCT03252665|Alprostadil|alprostadil|mesh-list
19472975|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
19472976|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19472977|NCT03252665|Urological Agents|urological agents|mesh-ancestor
19472978|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19472979|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19472980|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
19472981|NCT03252665|Vitamins|vitamins|mesh-ancestor
19472982|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
19472983|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472984|NCT03252457|Dexamethasone|dexamethasone|mesh-list
19472985|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
19472986|NCT03252457|Decitabine|decitabine|mesh-list
19472987|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19472988|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
19472989|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
19472990|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19472991|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19472992|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19472993|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
19472994|NCT03252457|Hormones|hormones|mesh-ancestor
19472995|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19472996|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19472997|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19472998|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19472999|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
19473000|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473001|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473002|NCT03252496|Ephedrine|ephedrine|mesh-list
19473003|NCT03252496|Fentanyl|fentanyl|mesh-list
19473004|NCT03252496|Bupivacaine|bupivacaine|mesh-list
19473005|NCT03252496|Oxytocin|oxytocin|mesh-list
19473006|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
19473007|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
19473008|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473009|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473010|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
19473011|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473012|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19473013|NCT03252496|Narcotics|narcotics|mesh-ancestor
19473014|NCT03252496|Analgesics|analgesics|mesh-ancestor
19473015|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19473016|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473017|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
19473018|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
19473019|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19473020|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19473021|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
19473022|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
19473023|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19473024|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
19473025|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473026|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473027|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
19473028|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
19473029|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473030|NCT03252418|Protective Agents|protective agents|mesh-ancestor
19473031|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473032|NCT03252418|Vitamins|vitamins|mesh-ancestor
19473033|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
19473034|NCT03252561|Anesthetics|anesthetics|mesh-list
19473035|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
19473036|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473037|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473038|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
19473039|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473040|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
20575941|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575942|NCT02068339|Oltipraz|oltipraz|mesh-list
20575943|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
20575944|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575945|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
20575946|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20575947|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
19473041|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
20020087|NCT02519387|Narcotics|narcotics|mesh-ancestor
19473042|NCT03252366|Coagulants|coagulants|mesh-ancestor
19742982|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742983|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742984|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
19567415|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19567416|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19567417|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19567418|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19567419|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19567420|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19567421|NCT04546113|Ropivacaine|ropivacaine|mesh-list
19567422|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
19567423|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
20020088|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020089|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020090|NCT02519387|Analgesics|analgesics|mesh-ancestor
20020091|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
20020092|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020093|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19567424|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567425|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567426|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
19567427|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567428|NCT04539262|Remdesivir|remdesivir|mesh-list
19567429|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
19567430|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567431|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
19567432|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020094|NCT02519595|Ketamine|ketamine|mesh-list
20292344|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020095|NCT02519595|Analgesics|analgesics|mesh-ancestor
20575948|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19473046|NCT03252067|Azithromycin|azithromycin|mesh-list
19473047|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19473048|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19473049|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020096|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
20020097|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020098|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020099|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20020100|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20020101|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
20020102|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
20020103|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020104|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19473050|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19473051|NCT03252223|Hormones|hormones|mesh-list
19473052|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19473053|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473054|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473055|NCT03251690|Tenofovir|tenofovir|mesh-list
19473056|NCT03251690|Emtricitabine|emtricitabine|mesh-list
19473057|NCT03251690|Efavirenz|efavirenz|mesh-list
19473058|NCT03251690|Rilpivirine|rilpivirine|mesh-list
19473059|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
19473060|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020105|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20020106|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020107|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020108|NCT02519842|Dexamethasone|dexamethasone|mesh-list
20020109|NCT02519842|Ondansetron|ondansetron|mesh-list
20020110|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
19473061|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19473062|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19473063|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473064|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473065|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19473066|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19473067|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19473068|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19473069|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19473070|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19473071|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19473072|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19473073|NCT03251859|Ticagrelor|ticagrelor|mesh-list
19473074|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19473075|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19473076|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19473077|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19473078|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
19473079|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473080|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473081|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473082|NCT03251768|Lenograstim|lenograstim|mesh-list
19473083|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19473084|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
19473085|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473086|NCT03251872|Olaparib|olaparib|mesh-list
19473087|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19473088|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473089|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473090|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473091|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
19473092|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19473093|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473094|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473095|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
19473096|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473097|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473098|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
19473099|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
19473100|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
19473101|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20020111|NCT02519842|Aprepitant|aprepitant|mesh-list
20020112|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
19473102|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19473103|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473104|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
19473105|NCT03251469|Coagulants|coagulants|mesh-ancestor
19473106|NCT03251365|Gemcitabine|gemcitabine|mesh-list
19473107|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19473108|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
19473109|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473110|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473111|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
19473112|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473113|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473114|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19473115|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
19473116|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473117|NCT03251300|Mirabegron|mirabegron|mesh-list
19473118|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19473119|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19473120|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19473121|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
19473122|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020113|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020114|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
20020115|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
20020116|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020117|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020118|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20020119|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
20020120|NCT02519842|Hormones|hormones|mesh-ancestor
20020121|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020122|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20020123|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020124|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
20020125|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020126|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20020127|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
20020128|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020129|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020130|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20020131|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20020132|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020133|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020134|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20020135|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20575949|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20575950|NCT02068339|Protective Agents|protective agents|mesh-ancestor
20575951|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575952|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575953|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20575954|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20575955|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575956|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473123|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473124|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020136|NCT02520388|Methylphenidate|methylphenidate|mesh-list
20020137|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20020138|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473125|NCT03251300|Urological Agents|urological agents|mesh-ancestor
19473126|NCT03251417|Irinotecan|irinotecan|mesh-list
19473127|NCT03251417|Apatinib|apatinib|mesh-list
19473128|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19473129|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19473130|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473131|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473132|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473133|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19473134|NCT03251443|Apatinib|apatinib|mesh-list
19742985|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19742986|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19742987|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742988|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19742989|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19742990|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19742991|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742992|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19749072|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749073|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19749074|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749075|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19749076|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19749077|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749078|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749079|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749080|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19749081|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19749082|NCT05281471|Gemcitabine|gemcitabine|mesh-list
19749083|NCT05281471|Paclitaxel|paclitaxel|mesh-list
19749084|NCT05281471|Docetaxel|docetaxel|mesh-list
19749085|NCT05281471|Bevacizumab|bevacizumab|mesh-list
19749086|NCT05281471|Carboplatin|carboplatin|mesh-list
19749087|NCT05281471|Doxorubicin|doxorubicin|mesh-list
19749088|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19749089|NCT05281471|Taxane|taxane|mesh-list
19749090|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19749091|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749092|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749093|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
19749094|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
19749095|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749096|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749097|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749098|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749099|NCT05281471|Growth Substances|growth substances|mesh-ancestor
19749100|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749101|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749102|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19749103|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
19749104|NCT05281471|Antiviral Agents|antiviral agents|mesh-ancestor
19749105|NCT05281471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749106|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749107|NCT05281471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749108|NCT05281471|Immunologic Factors|immunologic factors|mesh-ancestor
19749109|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19749110|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19749111|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19749112|NCT05275686|Fluticasone|fluticasone|mesh-list
19749113|NCT05275686|Xhance|xhance|mesh-list
19749114|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749115|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19749116|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
19749117|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749118|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749119|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20115350|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19473135|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473136|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19473137|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473138|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473139|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19473140|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
19473141|NCT03251040|Coagulants|coagulants|mesh-ancestor
19473142|NCT03250923|Acemannan|acemannan|mesh-list
19473143|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19473144|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
19473145|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473146|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473147|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
19473148|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473149|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473150|NCT03251170|Fentanyl|fentanyl|mesh-list
19473151|NCT03251170|Midazolam|midazolam|mesh-list
19473152|NCT03251170|Ketamine|ketamine|mesh-list
19473153|NCT03251170|Analgesics|analgesics|mesh-ancestor
19473154|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
19473155|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473156|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473157|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19473158|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473159|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
19473160|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
19473161|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473162|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19473163|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19473164|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473165|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473166|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19473167|NCT03251170|Narcotics|narcotics|mesh-ancestor
19473168|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19473169|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19473170|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19473171|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19473172|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19473173|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
19473174|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
19473175|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
19473176|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19473177|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473178|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473179|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19473180|NCT03251222|Analgesics|analgesics|mesh-ancestor
19473181|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
19473182|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473183|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19473184|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19473185|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19473186|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
19473187|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473188|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473189|NCT03250910|Ribavirin|ribavirin|mesh-list
19473190|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
19473191|NCT03250910|Velpatasvir|velpatasvir|mesh-list
19473192|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
19473193|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473194|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
19473195|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473196|NCT03250962|Decitabine|decitabine|mesh-list
19473197|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19473198|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
19473199|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473200|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473201|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473202|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
19473203|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
19473204|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19473205|NCT03250520|Protective Agents|protective agents|mesh-ancestor
19473206|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473207|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
19473208|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19473209|NCT03250494|Dexamethasone|dexamethasone|mesh-list
19473210|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
19473211|NCT03250494|BB 1101|bb 1101|mesh-list
19473212|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19473213|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
19473214|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
19473215|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473216|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473217|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473218|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
19473219|NCT03250494|Hormones|hormones|mesh-ancestor
19473220|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473221|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19473222|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473223|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
19473224|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473225|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473226|NCT03250507|Bupivacaine|bupivacaine|mesh-list
19473227|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
19473228|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
19473229|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473230|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473231|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
19473232|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567450|NCT04527757|Anesthetics|anesthetics|mesh-list
19567451|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567452|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567453|NCT04519164|Eplerenone|eplerenone|mesh-list
19567454|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
19567455|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19567456|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
19567457|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567458|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567459|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19567460|NCT04519164|Diuretics|diuretics|mesh-ancestor
19567461|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
19567462|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19567463|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19567464|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567465|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567466|NCT04517747|Ramucirumab|ramucirumab|mesh-list
19567467|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567468|NCT04511039|Trifluridine|trifluridine|mesh-list
19567469|NCT04511039|Talazoparib|talazoparib|mesh-list
19567470|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19567471|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567472|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567473|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567474|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
19567475|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
19567476|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567477|NCT04477512|Prednisone|prednisone|mesh-list
19567478|NCT04477512|Nivolumab|nivolumab|mesh-list
19567479|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
19567480|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567481|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
19567482|NCT04477512|Hormones|hormones|mesh-ancestor
19567483|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567484|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567485|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19567486|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567487|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567488|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19567489|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567490|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19567491|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567492|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
19567493|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19567494|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
19567495|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567496|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567497|NCT04470674|Carboplatin|carboplatin|mesh-list
19567498|NCT04470674|Pemetrexed|pemetrexed|mesh-list
19567499|NCT04470674|Durvalumab|durvalumab|mesh-list
19567500|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567501|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567502|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567503|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19473233|NCT03250481|Oxycodone|oxycodone|mesh-list
19473234|NCT03250481|Propofol|propofol|mesh-list
19473235|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19473236|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473237|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473238|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473239|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
19473240|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
19473241|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19473242|NCT03250481|Narcotics|narcotics|mesh-ancestor
19473243|NCT03250481|Analgesics|analgesics|mesh-ancestor
19473244|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
19473245|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473246|NCT03250741|Rotigotine|rotigotine|mesh-list
19473247|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
19473248|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
19473249|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473250|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473251|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473252|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
19473253|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19473254|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
19473255|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473256|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19473257|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19473258|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
19473259|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473260|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473261|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19473262|NCT03250338|Cytarabine|cytarabine|mesh-list
19473263|NCT03250338|Fludarabine|fludarabine|mesh-list
19473264|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
19473265|NCT03250338|Idarubicin|idarubicin|mesh-list
19473266|NCT03250338|Crenolanib|crenolanib|mesh-list
19473267|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473268|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19473269|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
19473270|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473271|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19473272|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
19473273|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473274|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
19473275|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473276|NCT03250338|Analgesics|analgesics|mesh-ancestor
19473277|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
19473278|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473279|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19473280|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19473281|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473282|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19473283|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19473284|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473285|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
19473286|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
19473287|NCT03249831|Pentostatin|pentostatin|mesh-list
19473288|NCT03249831|Tacrolimus|tacrolimus|mesh-list
19473289|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
19473290|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19473291|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19473292|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
19473293|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473294|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19473295|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19473296|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
19473297|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473298|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473299|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19473300|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19473301|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473302|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19473303|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19473304|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
19473305|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19473306|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473307|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19473308|NCT03250143|Cyclosporine|cyclosporine|mesh-list
19473309|NCT03250143|Azathioprine|azathioprine|mesh-list
19473310|NCT03250143|Cyclosporins|cyclosporins|mesh-list
19473311|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473312|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473313|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19473314|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
19473315|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473316|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
19473317|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473318|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19473319|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19473320|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19473321|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
19473322|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19473323|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473324|NCT03250039|Abrocitinib|abrocitinib|mesh-list
19473325|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19473326|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473327|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473328|NCT03250052|Linagliptin|linagliptin|mesh-list
19473329|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19473330|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473331|NCT03250052|Incretins|incretins|mesh-ancestor
19473332|NCT03250052|Hormones|hormones|mesh-ancestor
19473333|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473334|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19473335|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
19473336|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473337|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473338|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19473339|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19473340|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473341|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19473342|NCT03249740|Sunitinib|sunitinib|mesh-list
19473343|NCT03249740|Aflibercept|aflibercept|mesh-list
19473344|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020139|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20020140|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20020141|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020142|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020143|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
20020144|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020145|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
20020146|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20020147|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020148|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020149|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020150|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
20020151|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020152|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020153|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
20020154|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020155|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
20020156|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020157|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020158|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20020159|NCT02522299|Nemiralisib|nemiralisib|mesh-list
20020160|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20020161|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020162|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020163|NCT02522325|Cocaine|cocaine|mesh-list
20020164|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
20020165|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020166|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
20020167|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020168|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020169|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
20020170|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020171|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20020172|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20020173|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20020174|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020175|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473345|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19473346|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19473347|NCT03249740|Growth Substances|growth substances|mesh-ancestor
19473348|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473349|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
19473350|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19473351|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473352|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473353|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
19473354|NCT03249506|Empagliflozin|empagliflozin|mesh-list
19473355|NCT03249506|Canagliflozin|canagliflozin|mesh-list
19473356|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19473357|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19473358|NCT03249506|Glucagon|glucagon|mesh-list
19473359|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19473360|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19473361|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473362|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19473363|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473364|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473365|NCT03249506|Hormones|hormones|mesh-ancestor
19473366|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473367|NCT03249506|Incretins|incretins|mesh-ancestor
19473368|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
19473369|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473370|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
19473371|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19473372|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19473373|NCT03249402|Estradiol|estradiol|mesh-list
19473374|NCT03249402|Estrogens|estrogens|mesh-ancestor
19473375|NCT03249402|Hormones|hormones|mesh-ancestor
19473376|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473377|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473378|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19473379|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
19473380|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19473381|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19473382|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19473383|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19473384|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19473385|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19473386|NCT03249558|Morphine|morphine|mesh-list
19473387|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19473388|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19473389|NCT03249558|Narcotics|narcotics|mesh-ancestor
19473390|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473391|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473392|NCT03249558|Analgesics|analgesics|mesh-ancestor
19473393|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
19473394|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473395|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19473396|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19473397|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473398|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473399|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020176|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
20020177|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020178|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20020179|NCT02522377|Midazolam|midazolam|mesh-list
20020180|NCT02522377|Ketamine|ketamine|mesh-list
20020181|NCT02522377|Analgesics|analgesics|mesh-ancestor
20020182|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
20020183|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020184|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020185|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20020186|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20020187|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
20020188|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
20020189|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020190|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20020191|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20020192|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020193|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020194|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20020195|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20020196|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20020197|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20020198|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020199|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
20020200|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
20020201|NCT02522767|Mesalamine|mesalamine|mesh-list
20020202|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20020203|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020204|NCT02522767|Analgesics|analgesics|mesh-ancestor
20020205|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
20020206|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020207|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020208|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020209|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020210|NCT02522780|Mesalamine|mesalamine|mesh-list
20020211|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20020212|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020213|NCT02522780|Analgesics|analgesics|mesh-ancestor
20020214|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
20020215|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020216|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020217|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020218|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020219|NCT02523235|Ropivacaine|ropivacaine|mesh-list
20020220|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020221|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
20020222|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020223|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020224|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
20020225|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292345|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20292346|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20020226|NCT02523586|Anesthetics|anesthetics|mesh-list
19473400|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
19473401|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19473402|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
19473403|NCT03249662|Bupivacaine|bupivacaine|mesh-list
19473404|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
19473405|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
19473406|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473407|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020227|NCT02523586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020228|NCT02523586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473408|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
20020229|NCT02523599|Bupivacaine|bupivacaine|mesh-list
20020230|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020231|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
19742993|NCT04314895|Paclitaxel|paclitaxel|mesh-list
19473409|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473410|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19473411|NCT03249311|Milnacipran|milnacipran|mesh-list
19473412|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
19473413|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19473414|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19473415|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473416|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473417|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473418|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473419|NCT03249311|Analgesics|analgesics|mesh-ancestor
19473420|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
19473421|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473422|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
19473423|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19473424|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
19473425|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19473426|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19473427|NCT03249285|Perindopril|perindopril|mesh-list
19473428|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19473429|NCT03249285|Diuretics|diuretics|mesh-ancestor
19473430|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
19473431|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473432|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19473433|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473434|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473435|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19473436|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
19473437|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473438|NCT03249428|Nicotine|nicotine|mesh-list
19473439|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19473440|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
19473441|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473442|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473443|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19473444|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19473445|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
19473446|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473447|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473448|NCT03249519|Cisplatin|cisplatin|mesh-list
19473449|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473450|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19473451|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19473452|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19473453|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
19473454|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
19473455|NCT03249259|Choline|choline|mesh-list
19473456|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
19473457|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19473458|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
19473459|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473460|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473461|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19473462|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
19473463|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19473464|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19473465|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
19473466|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473467|NCT03249181|Dolutegravir|dolutegravir|mesh-list
19473468|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19473469|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19473470|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473471|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473472|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19473473|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19473474|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
19473475|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473476|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
19473477|NCT03249012|Calcitriol|calcitriol|mesh-list
19473478|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
19473479|NCT03249012|Calcium|calcium|mesh-list
19473480|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19473481|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115351|NCT00005520|Candesartan|candesartan|mesh-list
20575957|NCT02068404|Nifedipine|nifedipine|mesh-list
19473482|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19473483|NCT03249012|Antacids|antacids|mesh-ancestor
19473484|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473485|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473486|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19473487|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473488|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19473489|NCT03249012|Vitamins|vitamins|mesh-ancestor
19473490|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
19473491|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19473492|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19473493|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19473494|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473495|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473496|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473497|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473498|NCT03249168|Analgesics|analgesics|mesh-ancestor
19473499|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
19473500|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473501|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
19473502|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19473503|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
19473504|NCT03248856|Triamcinolone|triamcinolone|mesh-list
19473505|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20020232|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020233|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020234|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
20020235|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020236|NCT02524054|Furosemide|furosemide|mesh-list
20020237|NCT02524054|Diuretics|diuretics|mesh-ancestor
20020238|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
20020239|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020240|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20020241|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473506|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19473507|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19473508|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19473509|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
19473510|NCT03248856|Hormones|hormones|mesh-ancestor
19473511|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473512|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473513|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19473514|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
19473515|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473516|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473517|NCT03249025|Lidocaine|lidocaine|mesh-list
19473518|NCT03249025|Ketamine|ketamine|mesh-list
19473519|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
19473520|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
19473521|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473522|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473523|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
19473524|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473525|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19742994|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19742995|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742996|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742997|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742998|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742999|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
19743000|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743001|NCT04307511|Aspirin|aspirin|mesh-list
19743002|NCT04307511|Ticagrelor|ticagrelor|mesh-list
19743003|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19743004|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743005|NCT04307511|Analgesics|analgesics|mesh-ancestor
19743006|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
19743007|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020242|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020243|NCT02524106|Bococizumab|bococizumab|mesh-list
20020244|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20020245|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20020246|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
19473526|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19473527|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19473528|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473529|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473530|NCT03249025|Analgesics|analgesics|mesh-ancestor
19473531|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19473532|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473533|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
19473534|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19473535|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19473536|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473537|NCT03249142|Durvalumab|durvalumab|mesh-list
19473538|NCT03249142|Tremelimumab|tremelimumab|mesh-list
19473539|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19473540|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19473541|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473542|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
19473543|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567504|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19567505|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567511|NCT04457466|Mitogens|mitogens|mesh-list
19567512|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
19567513|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567514|NCT04457245|Fluorides|fluorides|mesh-list
19567515|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
19567516|NCT04457245|Protective Agents|protective agents|mesh-ancestor
19567517|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577496|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577497|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
19577498|NCT04322318|Ifosfamide|ifosfamide|mesh-list
19577499|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
19577500|NCT04322318|Carboplatin|carboplatin|mesh-list
19577501|NCT04322318|Doxorubicin|doxorubicin|mesh-list
19577502|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19577503|NCT04322318|Irinotecan|irinotecan|mesh-list
19577504|NCT04322318|Etoposide|etoposide|mesh-list
19577505|NCT04322318|Vincristine|vincristine|mesh-list
19577506|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
19577507|NCT04322318|Topotecan|topotecan|mesh-list
19577508|NCT04322318|Daunorubicin|daunorubicin|mesh-list
19577509|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
19577510|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577511|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
19577512|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577513|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577514|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19577515|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
19577516|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577517|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577518|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19577519|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19577520|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19577521|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19577522|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577523|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19577524|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19577525|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577526|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577527|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577528|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
19577529|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577530|NCT04321746|Ketamine|ketamine|mesh-list
19577531|NCT04321746|Analgesics|analgesics|mesh-ancestor
19577532|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
19577533|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577534|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577535|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19577536|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19577537|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
19577538|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
19577539|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473544|NCT03248726|Bisacodyl|bisacodyl|mesh-list
19473545|NCT03248726|Cathartics|cathartics|mesh-ancestor
19473546|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473547|NCT03248726|Laxatives|laxatives|mesh-ancestor
19473548|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
20020247|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020248|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20020249|NCT02524145|Isoproterenol|isoproterenol|mesh-list
20020250|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
20020251|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
20020252|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20020253|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020254|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020255|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020256|NCT02524145|Analgesics|analgesics|mesh-ancestor
20020257|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
20020258|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020259|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20020260|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20020261|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20020262|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
20020263|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020264|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020265|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20020266|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20020267|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20020268|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
20020269|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20020270|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19473549|NCT03248765|Narcotics|narcotics|mesh-ancestor
19473550|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473551|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473552|NCT03248765|Analgesics|analgesics|mesh-ancestor
19473553|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
19473554|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473555|NCT03248817|Phenylephrine|phenylephrine|mesh-list
19473556|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
19473557|NCT03248817|Bupivacaine|bupivacaine|mesh-list
19473558|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
19473559|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
19473560|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473561|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473562|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
19473563|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473564|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19473565|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
19473566|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
19473567|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
19473568|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19473569|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
19473570|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19473571|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19473572|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19473573|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19473574|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
19473575|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473576|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473577|NCT03248817|Protective Agents|protective agents|mesh-ancestor
19473578|NCT03248713|Mifepristone|mifepristone|mesh-list
19473579|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19473580|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
19473581|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19473582|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473583|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19473584|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19473585|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19473586|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
19473587|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19473588|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19473589|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
19473590|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020271|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
20575958|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19473591|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
19567518|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
19473592|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19473593|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19473594|NCT03248544|Vitamin D|vitamin d|mesh-list
19473595|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
19473596|NCT03248544|Vitamins|vitamins|mesh-ancestor
19473597|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
19473598|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473599|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19473600|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19473601|NCT03248973|Ampicillin|ampicillin|mesh-list
19473602|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19473603|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473604|NCT03248791|Phenylephrine|phenylephrine|mesh-list
19473605|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
19473606|NCT03248791|Norepinephrine|norepinephrine|mesh-list
19473607|NCT03248791|Bupivacaine|bupivacaine|mesh-list
19473608|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
19473609|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
19473610|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473611|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473612|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
19473613|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473614|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19473615|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
19473616|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
19473617|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
19473618|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19473619|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
19473620|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
19473621|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19473622|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19473623|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19473624|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
19473625|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473626|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473627|NCT03248791|Protective Agents|protective agents|mesh-ancestor
19473628|NCT03248700|Vitamins|vitamins|mesh-list
19473629|NCT03248700|Vitamin A|vitamin a|mesh-list
19473630|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
19473631|NCT03248700|Retinol acetate|retinol acetate|mesh-list
19473632|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
19473633|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473634|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
19473635|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473636|NCT03248700|Protective Agents|protective agents|mesh-ancestor
19473637|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19473638|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473639|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19473640|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
19473641|NCT03248648|Ketamine|ketamine|mesh-list
19473642|NCT03248648|Neostigmine|neostigmine|mesh-list
19473643|NCT03248648|Analgesics|analgesics|mesh-ancestor
19473644|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
19473645|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473646|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473647|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19473648|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473649|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
19473650|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
19473651|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473652|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19473653|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19473654|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473655|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473656|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19473657|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473658|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
19473659|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19473660|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
19473661|NCT03248401|Aspirin|aspirin|mesh-list
19473662|NCT03248401|Cilostazol|cilostazol|mesh-list
20292347|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473663|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20292348|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473664|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19473665|NCT03248401|Analgesics|analgesics|mesh-ancestor
19473666|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
19473667|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473668|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473669|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19473670|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19473671|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19473672|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19473673|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473674|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19473675|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19473676|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473677|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
19473678|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19473679|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
19473680|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19473681|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
19473682|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
19473683|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19473684|NCT03248401|Protective Agents|protective agents|mesh-ancestor
19473685|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19473686|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19473687|NCT03248427|Paclitaxel|paclitaxel|mesh-list
19473688|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
19473689|NCT03248427|Doxorubicin|doxorubicin|mesh-list
19473690|NCT03248427|Letrozole|letrozole|mesh-list
19473691|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19473692|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473693|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
19473694|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
19473695|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
19473696|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473697|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19473698|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
19473699|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473700|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19473701|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19473702|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
19473703|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19473704|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19473705|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19473706|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19473707|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473708|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19473709|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20020272|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020273|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
20020274|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20020275|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
20020276|NCT02524145|Protective Agents|protective agents|mesh-ancestor
20020277|NCT02524561|Estradiol|estradiol|mesh-list
20020278|NCT02524561|Progesterone|progesterone|mesh-list
20020279|NCT02524561|Estrogens|estrogens|mesh-ancestor
20020280|NCT02524561|Hormones|hormones|mesh-ancestor
20020281|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020282|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020283|NCT02524561|Progestins|progestins|mesh-ancestor
20020284|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
20020285|NCT02524665|Salicylates|salicylates|mesh-list
20020286|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20020287|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020288|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
20020289|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
20020290|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020291|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20020292|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020293|NCT02524665|Analgesics|analgesics|mesh-ancestor
20020294|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
20020295|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020296|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020297|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020298|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020299|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20020300|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575959|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020301|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473710|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19473711|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
19473712|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473713|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20292349|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
20292350|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
20292351|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292352|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292353|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20292354|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20292355|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
20292356|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20575960|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473714|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473715|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
19473716|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19473717|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473718|NCT03248297|Amoxicillin|amoxicillin|mesh-list
19473719|NCT03248297|Azithromycin|azithromycin|mesh-list
19473720|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19473721|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473722|NCT03248063|Cefazolin|cefazolin|mesh-list
19473723|NCT03248063|Cloxacillin|cloxacillin|mesh-list
19473724|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19473725|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473726|NCT03247972|Evolocumab|evolocumab|mesh-list
19473727|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19473728|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19473729|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
19473730|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473731|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19473732|NCT03247998|Remifentanil|remifentanil|mesh-list
19473733|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473734|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473735|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19473736|NCT03247998|Narcotics|narcotics|mesh-ancestor
19473737|NCT03247998|Analgesics|analgesics|mesh-ancestor
19473738|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
19473739|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473740|NCT03248076|Fentanyl|fentanyl|mesh-list
19473741|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19473742|NCT03248076|Narcotics|narcotics|mesh-ancestor
19473743|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473744|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473745|NCT03248076|Analgesics|analgesics|mesh-ancestor
19473746|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
19473747|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473748|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19473749|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473750|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
19473751|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
19473752|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19743008|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743009|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19743010|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743011|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19743012|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20575961|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20575962|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575963|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
20575964|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
20575965|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20575966|NCT02068430|Riboflavin|riboflavin|mesh-list
20575967|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
20575968|NCT02068430|Vitamins|vitamins|mesh-ancestor
20575969|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
20575970|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575971|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20575972|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
20575973|NCT02068482|Rifaximin|rifaximin|mesh-list
20575974|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20575975|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20575976|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473753|NCT03247920|Amoxicillin|amoxicillin|mesh-list
19473754|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
19473755|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
19743013|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292357|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19473756|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19473757|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473758|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19473759|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473760|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473761|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
19473762|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19473763|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473764|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473765|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
19473766|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473767|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473768|NCT03247582|Edoxaban|edoxaban|mesh-list
19473769|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19473770|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
19473771|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19473772|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
19473773|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473774|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473775|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
19473776|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
19473777|NCT03247595|Bisacodyl|bisacodyl|mesh-list
19473778|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19473779|NCT03247595|Cathartics|cathartics|mesh-ancestor
19473780|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473781|NCT03247595|Laxatives|laxatives|mesh-ancestor
19473782|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
19473783|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
19473784|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473785|NCT03247452|Protective Agents|protective agents|mesh-ancestor
19473786|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473787|NCT03247452|Vitamins|vitamins|mesh-ancestor
19473788|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
19473789|NCT03247283|Linrodostat|linrodostat|mesh-list
19473790|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473791|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473792|NCT03247413|Dexamethasone|dexamethasone|mesh-list
19473793|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19473794|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
19473795|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
19473796|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473797|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473798|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20575977|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20575978|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
20575979|NCT02068560|Coagulants|coagulants|mesh-ancestor
20575980|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20575981|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
19473799|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
19473800|NCT03247413|Hormones|hormones|mesh-ancestor
19473801|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473802|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19473803|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473804|NCT03247140|Amlodipine|amlodipine|mesh-list
19473805|NCT03247140|Telmisartan|telmisartan|mesh-list
19473806|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19473807|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19473808|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19473809|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19473810|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473811|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473812|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19473813|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473814|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
19473815|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20575982|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473816|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20020302|NCT02524769|Estrogens|estrogens|mesh-list
20020303|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20020304|NCT02524769|Hormones|hormones|mesh-ancestor
20020305|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473817|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
20020306|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020307|NCT02524847|Methoxsalen|methoxsalen|mesh-list
20575983|NCT02068586|Sunitinib|sunitinib|mesh-list
20575984|NCT02068586|Valproic Acid|valproic acid|mesh-list
19473818|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19473819|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19473820|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473821|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19473822|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19473823|NCT03247400|Atorvastatin|atorvastatin|mesh-list
19473824|NCT03247400|Simvastatin|simvastatin|mesh-list
19473825|NCT03247400|Calcium|calcium|mesh-list
19473826|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19473827|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473828|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19473829|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19473830|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
19473831|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473832|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19473833|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19473834|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473835|NCT03247296|Ribavirin|ribavirin|mesh-list
19473836|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
19473837|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
19473838|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473839|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
19473840|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567519|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
19567520|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
20020308|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20020309|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020310|NCT02525133|Bupivacaine|bupivacaine|mesh-list
20020311|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020312|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
20020313|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020314|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020315|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
20020316|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020317|NCT02525471|RNS60|rns60|mesh-list
20020318|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20020319|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020320|NCT02525471|Analgesics|analgesics|mesh-ancestor
20020321|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
20020322|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020323|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020324|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020325|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020326|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20020327|NCT02525523|Alicaforsen|alicaforsen|mesh-list
20575985|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20575986|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20020328|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20020329|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020330|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
20020331|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020332|NCT02525536|Trebananib|trebananib|mesh-list
20020333|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20020334|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20020335|NCT02525536|Growth Substances|growth substances|mesh-ancestor
20020336|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020337|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
20020338|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020339|NCT02525549|Adapalene|adapalene|mesh-list
20020340|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20020341|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020342|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20020343|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020344|NCT02525549|Analgesics|analgesics|mesh-ancestor
20020345|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
20292358|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20292359|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20292360|NCT05320627|Edoxaban|edoxaban|mesh-list
20292361|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20292362|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
20292363|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20292364|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
20292365|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575987|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19567521|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020346|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473841|NCT03247257|Lidocaine|lidocaine|mesh-list
19473842|NCT03247257|Anesthetics|anesthetics|mesh-list
19473843|NCT03247257|Propofol|propofol|mesh-list
19473844|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
19473845|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473846|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473847|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
19473848|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473849|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19473850|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19473851|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19473852|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473853|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473854|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19473855|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473856|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
19473857|NCT03247218|Memantine|memantine|mesh-list
19473858|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19473859|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19473860|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
19473861|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473862|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473863|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292366|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292367|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
20292368|NCT05319093|Ozanimod|ozanimod|mesh-list
20292369|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20292370|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292371|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292372|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
20292373|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292374|NCT05314660|Fluorides|fluorides|mesh-list
20575988|NCT02068586|Growth Substances|growth substances|mesh-ancestor
20575989|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20575990|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
20575991|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20575992|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20575993|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575994|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
20575995|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
20292375|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
20292376|NCT05314660|Protective Agents|protective agents|mesh-ancestor
20292377|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292378|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20292379|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20292380|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20292381|NCT05307003|Trazodone|trazodone|mesh-list
20292382|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
20292383|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20292384|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20292385|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20292386|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292387|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292388|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20292389|NCT05307003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20292390|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20292391|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20292392|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292393|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292394|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
20292395|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20292396|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20292397|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308344|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20308345|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308346|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20308347|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308348|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308349|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308350|NCT00663845|Urological Agents|urological agents|mesh-ancestor
20575996|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473864|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19473865|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19473866|NCT03246919|Oxytocin|oxytocin|mesh-list
19473867|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
20292398|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
20292399|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
20292400|NCT05293041|Coagulants|coagulants|mesh-ancestor
20292401|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20292402|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20292403|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
20292404|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292405|NCT05282277|Raclopride|raclopride|mesh-list
20292406|NCT05282277|Estradiol|estradiol|mesh-list
20292407|NCT05282277|Progesterone|progesterone|mesh-list
20292408|NCT05282277|Estrogens|estrogens|mesh-ancestor
20292409|NCT05282277|Hormones|hormones|mesh-ancestor
20292410|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20292411|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292412|NCT05282277|Progestins|progestins|mesh-ancestor
20292413|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20292414|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20292415|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292416|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20292417|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20292418|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
20292419|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292420|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292421|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
20292422|NCT05282069|DA-8010|da-8010|mesh-list
20292423|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20292424|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20292425|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
20292426|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292427|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292428|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292429|NCT05282069|Urological Agents|urological agents|mesh-ancestor
20292430|NCT05279833|Sotalol|sotalol|mesh-list
20292431|NCT05279833|Dronedarone|dronedarone|mesh-list
20292432|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20292433|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20292434|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
20292435|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292436|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292437|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292438|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20292439|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
20292440|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
19473868|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19473869|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473870|NCT03246776|Triclosan|triclosan|mesh-list
19473871|NCT03246776|Halometasone|halometasone|mesh-list
19473872|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19473873|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473874|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19473875|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19473876|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
19473877|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473878|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19473879|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19473880|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
19473881|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
19473882|NCT03246776|Hormones|hormones|mesh-ancestor
19473883|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473884|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473885|NCT03246880|Tadalafil|tadalafil|mesh-list
19473886|NCT03246880|Tamsulosin|tamsulosin|mesh-list
19473887|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
20020347|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020348|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020349|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020350|NCT02525653|Gemcitabine|gemcitabine|mesh-list
20575997|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
19473888|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19473889|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19473890|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567522|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292441|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292442|NCT05275439|Azacitidine|azacitidine|mesh-list
20020351|NCT02525653|Paclitaxel|paclitaxel|mesh-list
20020352|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20020353|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20020354|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020355|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
20020356|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
19473891|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473892|NCT03246880|Urological Agents|urological agents|mesh-ancestor
19473893|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19473894|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19473895|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19473896|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19473897|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473898|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473899|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19473900|NCT03246555|Perindopril|perindopril|mesh-list
19473901|NCT03246555|Indapamide|indapamide|mesh-list
19473902|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19473903|NCT03246555|Diuretics|diuretics|mesh-ancestor
19473904|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
19473905|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473906|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19473907|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473908|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473909|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19473910|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
20020357|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
20292443|NCT05275439|Venetoclax|venetoclax|mesh-list
20292444|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20292445|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
20292446|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292447|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292448|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292449|NCT05266417|Insulin|insulin|mesh-list
20292450|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20292451|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292452|NCT05265650|Nivolumab|nivolumab|mesh-list
20292453|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292454|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292455|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20292456|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20575998|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20575999|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576000|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20576001|NCT02068625|Rasagiline|rasagiline|mesh-list
20576002|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20576003|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576004|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576005|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20576006|NCT02068625|Protective Agents|protective agents|mesh-ancestor
20576007|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576008|NCT02068690|BI 425809|bi 425809|mesh-list
20576009|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
20576010|NCT02068859|Diclofenac|diclofenac|mesh-list
20576011|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20576012|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576013|NCT02068859|Analgesics|analgesics|mesh-ancestor
20576014|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
20576015|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292457|NCT05265208|Capecitabine|capecitabine|mesh-list
20292458|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20292459|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
20292460|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292461|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292462|NCT05255003|Enoxaparin|enoxaparin|mesh-list
20292463|NCT05255003|Dalteparin|dalteparin|mesh-list
20292464|NCT05255003|Tinzaparin|tinzaparin|mesh-list
20292465|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20292466|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
20292467|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19473911|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473912|NCT03246620|Diazepam|diazepam|mesh-list
19473913|NCT03246620|Haloperidol|haloperidol|mesh-list
19473914|NCT03246620|Olanzapine|olanzapine|mesh-list
19473915|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
19473916|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
19473917|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
19473918|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473919|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473920|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19473921|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19473922|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19473923|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19473924|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19473925|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19473926|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19473927|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19473928|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473929|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473930|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
19473931|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19473932|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
19473933|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19473934|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19473935|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
19473936|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19473937|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19473938|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19473939|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19473940|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19473941|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
19473942|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
19473943|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
19473944|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
19473945|NCT03246659|Polygeline|polygeline|mesh-list
19473946|NCT03246659|Gastrins|gastrins|mesh-list
19473947|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
19473948|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
19473949|NCT03246659|Hormones|hormones|mesh-ancestor
19473950|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473951|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473952|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
19473953|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19473954|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19473955|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
19473956|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19473957|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
19473958|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19473959|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473960|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19473961|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
19473962|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
19473963|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19473964|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19473965|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19473966|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473967|NCT03246386|Posaconazole|posaconazole|mesh-list
19473968|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
19473969|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473970|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19473971|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19473972|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19473973|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19473974|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19473975|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19473976|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19473977|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19473978|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
19473979|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19473980|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473981|NCT03246451|Metformin|metformin|mesh-list
19473982|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19473983|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473984|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19473985|NCT03246360|Cloxacillin|cloxacillin|mesh-list
19473986|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19473987|NCT03246295|Insulin|insulin|mesh-list
19473988|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19473989|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473990|NCT03246009|Lenograstim|lenograstim|mesh-list
19473991|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19473992|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
19473993|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19473994|NCT03246399|Lorecivivint|lorecivivint|mesh-list
19473995|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19473996|NCT03246113|Temozolomide|temozolomide|mesh-list
19473997|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19473998|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
19473999|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474000|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474001|NCT03245853|Riboflavin|riboflavin|mesh-list
19474002|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
19474003|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
19474004|NCT03245853|Vitamins|vitamins|mesh-ancestor
19474005|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
19474006|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474007|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19474008|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
19474009|NCT03245970|Atenolol|atenolol|mesh-list
19474010|NCT03245970|Labetalol|labetalol|mesh-list
19474011|NCT03245970|Nifedipine|nifedipine|mesh-list
19474012|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19474013|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474014|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474015|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19474016|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474017|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
19474018|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
19474019|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474020|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19474021|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19474022|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
19474023|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
20576016|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576017|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576018|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20576019|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20576020|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576021|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576022|NCT02068937|Furosemide|furosemide|mesh-list
20576023|NCT02068937|Diuretics|diuretics|mesh-ancestor
20576024|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
20576025|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576026|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20576027|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576028|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576029|NCT02069080|Plerixafor|plerixafor|mesh-list
20576030|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20576031|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20576032|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
20576033|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576034|NCT02069132|Warfarin|warfarin|mesh-list
20576035|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
20576036|NCT02069145|Sorafenib|sorafenib|mesh-list
20576037|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20576038|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576039|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20576040|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576041|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576042|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
20576043|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576044|NCT02069158|Paclitaxel|paclitaxel|mesh-list
20576045|NCT02069158|Carboplatin|carboplatin|mesh-list
20576046|NCT02069158|Gedatolisib|gedatolisib|mesh-list
19474024|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474025|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19474026|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19474027|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19474028|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
19474029|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474030|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
19474031|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19474032|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19474033|NCT03245996|Atenolol|atenolol|mesh-list
19474034|NCT03245996|Nebivolol|nebivolol|mesh-list
19474035|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19474036|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19474037|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
19474038|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
19474039|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474040|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474041|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19474042|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19474043|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19474044|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
19474045|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474046|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474047|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
19474048|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19474049|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19474050|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19474051|NCT03245658|Nabiximols|nabiximols|mesh-list
20020358|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474052|NCT03245658|Analgesics|analgesics|mesh-ancestor
19474053|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
19474054|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474055|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474056|NCT03245671|Dexamethasone|dexamethasone|mesh-list
19474057|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
19474058|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19474059|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19474060|NCT03245671|BB 1101|bb 1101|mesh-list
19474061|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474062|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
19474063|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
19474064|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474065|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474066|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474067|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
19474068|NCT03245671|Hormones|hormones|mesh-ancestor
19474069|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474070|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474071|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474072|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
19474073|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474074|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474075|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474076|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
19743014|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19743015|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19743016|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743017|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
19743018|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19743019|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19743020|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19743021|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
19743022|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743023|NCT04307485|Ticagrelor|ticagrelor|mesh-list
19743024|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19743025|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19743026|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19743027|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19743028|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
19743029|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743030|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743031|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474077|NCT03245515|Branebrutinib|branebrutinib|mesh-list
19474078|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474079|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474080|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474081|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
19474082|NCT03245528|Giapreza|giapreza|mesh-list
19474083|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20020359|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20020360|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
20020361|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
19474084|NCT03245424|Ivosidenib|ivosidenib|mesh-list
19474085|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474086|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474087|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474088|NCT03245554|Propranolol|propranolol|mesh-list
19474089|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19474090|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19474091|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
19474092|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576047|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20576048|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020362|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020363|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020364|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020365|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
20020366|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020367|NCT02525718|Dexamethasone|dexamethasone|mesh-list
20020368|NCT02525718|Epinephrine|epinephrine|mesh-list
20020369|NCT02525718|Bupivacaine|bupivacaine|mesh-list
20020370|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020371|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
20020372|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
20020373|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020374|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020375|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474093|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474094|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020376|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
19743032|NCT04301778|Durvalumab|durvalumab|mesh-list
19743033|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743034|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743035|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
19743036|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
19743037|NCT04300985|Anesthetics|anesthetics|mesh-list
19743038|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743039|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743040|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19743041|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743042|NCT04300985|Analgesics|analgesics|mesh-ancestor
20020377|NCT02525718|Hormones|hormones|mesh-ancestor
20020378|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020379|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20020380|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020381|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
19474095|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19474096|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20576049|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
20576050|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
20576051|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
20576052|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576053|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20576054|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576055|NCT02069197|Orlistat|orlistat|mesh-list
20576056|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576057|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020382|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
20020383|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020384|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
20020385|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19474097|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
19474098|NCT03245541|Durvalumab|durvalumab|mesh-list
19474099|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474100|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474101|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
19474102|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474103|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474104|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19474105|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19474106|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19474107|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
19474108|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474109|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19474110|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19474111|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567523|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
19567524|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020386|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20020387|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
20020388|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020389|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020390|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20020391|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20020392|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020393|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
20020394|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
20020395|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
20020396|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20020397|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
20020398|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020399|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020400|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
20020401|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20020402|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020403|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020404|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20020405|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20020406|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20020407|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020408|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020409|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
20020410|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020411|NCT02526212|Buprenorphine|buprenorphine|mesh-list
20020412|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20020413|NCT02526212|Narcotics|narcotics|mesh-ancestor
19567553|NCT04408625|Sirolimus|sirolimus|mesh-list
19567554|NCT04408625|Prednisone|prednisone|mesh-list
19567555|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
19567556|NCT04408625|Rituximab|rituximab|mesh-list
19567557|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567558|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567559|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
19567560|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567561|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567562|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567563|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
19567564|NCT04408625|Hormones|hormones|mesh-ancestor
19567565|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567566|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19567567|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567568|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567569|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19567570|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
19567571|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567572|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
19567573|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
19567574|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567575|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19567576|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19567577|NCT04408625|Protective Agents|protective agents|mesh-ancestor
19567578|NCT04403165|Norepinephrine|norepinephrine|mesh-list
19567579|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19567580|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19567581|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
19567582|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567583|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474112|NCT03245385|Halobetasol|halobetasol|mesh-list
19474113|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19474114|NCT03245333|Hormones|hormones|mesh-list
19474115|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474116|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474117|NCT03245307|Apatinib|apatinib|mesh-list
19474118|NCT03245307|Nifedipine|nifedipine|mesh-list
19474119|NCT03245307|Warfarin|warfarin|mesh-list
19474120|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
19474121|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474122|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474123|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474124|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474125|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19474126|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474127|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19474128|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474129|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
19474130|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
19474131|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474132|NCT03245437|Oxytocin|oxytocin|mesh-list
19474133|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
19474134|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474135|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474136|NCT03245450|Irinotecan|irinotecan|mesh-list
19474137|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19474138|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19474139|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474140|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474141|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474142|NCT03245281|Diuretics|diuretics|mesh-list
19474143|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
19474144|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474145|NCT03245190|Chiauranib|chiauranib|mesh-list
19474146|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474147|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474148|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474149|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474150|NCT03245346|Anesthetics|anesthetics|mesh-list
19474151|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474152|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474153|NCT03245021|Rituximab|rituximab|mesh-list
19474154|NCT03245021|Nivolumab|nivolumab|mesh-list
19474155|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474156|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474157|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
19474158|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474159|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19474160|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19474161|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474162|NCT03244956|Trametinib|trametinib|mesh-list
19474163|NCT03244956|Dabrafenib|dabrafenib|mesh-list
19474164|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474165|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474166|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474167|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474168|NCT03244774|Paclitaxel|paclitaxel|mesh-list
19474169|NCT03244774|Fluorouracil|fluorouracil|mesh-list
19474170|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
19474171|NCT03244774|Apatinib|apatinib|mesh-list
19474172|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19474173|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474174|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
19474175|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
19474176|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
19474177|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474178|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
19474179|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19474180|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474181|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
19474182|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474183|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474184|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474185|NCT03244930|Plerixafor|plerixafor|mesh-list
20020414|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474186|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19474187|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19474188|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
19474189|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474190|NCT03244943|Anesthetics|anesthetics|mesh-list
19474191|NCT03244943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474192|NCT03244943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020415|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020416|NCT02526212|Analgesics|analgesics|mesh-ancestor
20020417|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
20020418|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020419|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20020420|NCT02526550|Vaccines|vaccines|mesh-list
20020421|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
20020422|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020423|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
20020424|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20020425|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20020426|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020427|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
19474193|NCT03244592|Minocycline|minocycline|mesh-list
20020428|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020429|NCT02527265|Insulin|insulin|mesh-list
20020430|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020431|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020432|NCT02527421|Betamethasone|betamethasone|mesh-list
20020433|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020434|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
20020435|NCT02527421|Hormones|hormones|mesh-ancestor
19474194|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19474195|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474196|NCT03244488|Mecamylamine|mecamylamine|mesh-list
19474197|NCT03244488|Scopolamine|scopolamine|mesh-list
19474198|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19474199|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19474200|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
19474201|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
19474202|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474203|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474204|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474205|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
19474206|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19474207|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
19474208|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020436|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020437|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474209|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474210|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19474211|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
19474212|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19474213|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19474214|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19474215|NCT03244319|Warfarin|warfarin|mesh-list
19474216|NCT03244319|Edoxaban|edoxaban|mesh-list
19474217|NCT03244319|Anticoagulants|anticoagulants|mesh-list
19474218|NCT03244319|Coagulants|coagulants|mesh-list
19474219|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19474220|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
19474221|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19474222|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
19474223|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474224|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474225|NCT03244553|Prucalopride|prucalopride|mesh-list
19474226|NCT03244553|Laxatives|laxatives|mesh-ancestor
20020438|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020439|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
20020440|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
20020441|NCT02527512|Povidone|povidone|mesh-list
20020442|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
20020443|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
20020444|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20020445|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576058|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19474227|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474228|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20020446|NCT02528188|Tanezumab|tanezumab|mesh-list
20020447|NCT02528188|Analgesics|analgesics|mesh-ancestor
19474229|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19474230|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
19474231|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474232|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474233|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474234|NCT03244176|Avelumab|avelumab|mesh-list
19474235|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474236|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474237|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
19474238|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19474239|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19474240|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474241|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
19474242|NCT03244423|Coagulants|coagulants|mesh-ancestor
19474243|NCT03244358|Epalrestat|epalrestat|mesh-list
19474244|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474245|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474246|NCT03244462|Methotrexate|methotrexate|mesh-list
19474247|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19474248|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
19474249|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474250|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474251|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19474252|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
19474253|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474254|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474255|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
19474256|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474257|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19474258|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474259|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
19474260|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19474261|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19474262|NCT03244540|Acetaminophen|acetaminophen|mesh-list
19474263|NCT03244540|Dipyrone|dipyrone|mesh-list
19474264|NCT03244540|Ketoprofen|ketoprofen|mesh-list
19474265|NCT03244540|Bupivacaine|bupivacaine|mesh-list
19474266|NCT03244540|Ropivacaine|ropivacaine|mesh-list
19474267|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
19474268|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
19474269|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474270|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474271|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
19474272|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474273|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19474274|NCT03244540|Analgesics|analgesics|mesh-ancestor
19474275|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
19474276|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19474277|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474278|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19474279|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19474280|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474281|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474282|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
19474283|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19474284|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474285|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19474286|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19474287|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474288|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474289|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474290|NCT03244241|Insulin|insulin|mesh-list
19474291|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19474292|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474293|NCT03243903|Insulin|insulin|mesh-list
19474294|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19474295|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19474296|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474297|NCT03243890|Vitamin D|vitamin d|mesh-list
19474298|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
19474299|NCT03243890|Vitamin K|vitamin k|mesh-list
19474300|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
19474301|NCT03243890|Vitamins|vitamins|mesh-ancestor
19474302|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
19474303|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474304|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20308351|NCT00663884|Voglibose|voglibose|mesh-list
19474305|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19474306|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19474307|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474308|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
19474309|NCT03243890|Coagulants|coagulants|mesh-ancestor
19474310|NCT03243864|Ceftazidime|ceftazidime|mesh-list
19474311|NCT03243864|Avibactam|avibactam|mesh-list
19474312|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19474313|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19474314|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474315|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19474316|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474317|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474318|NCT03243851|Metformin|metformin|mesh-list
19474319|NCT03243851|Temozolomide|temozolomide|mesh-list
19474320|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19474321|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474322|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19474323|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
19474324|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474325|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567584|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567585|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
19567586|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
19567587|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567588|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19567589|NCT04393311|Urinastatin|urinastatin|mesh-list
19567590|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19567591|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19567592|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
20020448|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
20020449|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020450|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020451|NCT02528214|Prednisone|prednisone|mesh-list
20020452|NCT02528214|Prednisolone|prednisolone|mesh-list
20020453|NCT02528214|Albuterol|albuterol|mesh-list
20020454|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020455|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
20020456|NCT02528214|Hormones|hormones|mesh-ancestor
20020457|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576059|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20576060|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
20576061|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576062|NCT02069301|Fluoxetine|fluoxetine|mesh-list
20576063|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
20576064|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20576065|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20576066|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576067|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576068|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743043|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
19743044|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743045|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19743046|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19743047|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19743048|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743049|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743050|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743051|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19743052|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
19743053|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19743054|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19743055|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19743056|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
19743057|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19743058|NCT04296006|Amphetamine|amphetamine|mesh-list
19743059|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
19743060|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19743061|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743062|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
19743063|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
20020458|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567593|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577540|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19474326|NCT03243552|Levodopa|levodopa|mesh-list
20020459|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20020460|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020461|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
20020462|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020463|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20020464|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19474327|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19474328|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19474329|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
19474330|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474331|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474332|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474333|NCT03243500|Lidocaine|lidocaine|mesh-list
19474334|NCT03243500|Bupivacaine|bupivacaine|mesh-list
19474335|NCT03243500|Atracurium|atracurium|mesh-list
19474336|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
19474337|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
19474338|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474339|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474340|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
19474341|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474342|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19474343|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19474344|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19474345|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474346|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474347|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19474348|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19474349|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19474350|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19474351|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19474352|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
19474353|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474354|NCT03243643|Apatinib|apatinib|mesh-list
19474355|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474356|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474357|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474358|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474359|NCT03243604|Hormones|hormones|mesh-list
19474360|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474361|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474362|NCT03243461|Temozolomide|temozolomide|mesh-list
19474363|NCT03243461|Valproic Acid|valproic acid|mesh-list
19474364|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19474365|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
19474366|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474367|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474368|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
19474369|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474370|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
19474371|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474372|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474373|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
19474374|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19474375|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474376|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19474377|NCT03243331|Gedatolisib|gedatolisib|mesh-list
19474378|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474379|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474380|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474381|NCT03243344|Surgiflo|surgiflo|mesh-list
19474382|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
19474383|NCT03243344|Coagulants|coagulants|mesh-ancestor
19474384|NCT03243175|Apixaban|apixaban|mesh-list
19474385|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19474386|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
19474387|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19474388|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
19474389|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474390|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474391|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
20576069|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
19474392|NCT03243019|Sirolimus|sirolimus|mesh-list
19474393|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19474394|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474395|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19474396|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474397|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
19474398|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474399|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
19474400|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474401|NCT03243032|Ibuprofen|ibuprofen|mesh-list
19474402|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19474403|NCT03243032|Anesthetics|anesthetics|mesh-list
19474404|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
19474405|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474406|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474407|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19474408|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19474409|NCT03243032|Analgesics|analgesics|mesh-ancestor
19474410|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
19474411|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576070|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576071|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20576072|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20576073|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20576074|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20576075|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576076|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
20576077|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20576078|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576079|NCT02069366|Dronabinol|dronabinol|mesh-list
20576080|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
20576081|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576082|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20576083|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576084|NCT02069366|Analgesics|analgesics|mesh-ancestor
20576085|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
19474412|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020465|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
20020466|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
20020467|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20020468|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20020469|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20020470|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20020471|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
20020472|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020473|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020474|NCT02528253|Tramadol|tramadol|mesh-list
20020475|NCT02528253|Tanezumab|tanezumab|mesh-list
20020476|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20020477|NCT02528253|Narcotics|narcotics|mesh-ancestor
20020478|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020479|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020480|NCT02528253|Analgesics|analgesics|mesh-ancestor
20020481|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
20020482|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115352|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20115353|NCT00005520|Diuretics|diuretics|mesh-ancestor
20115354|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
20115355|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115356|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20115357|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115358|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115359|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20115360|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20120646|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20120647|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120648|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120649|NCT00006383|Vincristine|vincristine|mesh-list
20120650|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120651|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120652|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
20120653|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
20120654|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
20308352|NCT00663884|Mitiglinide|mitiglinide|mesh-list
19474413|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19474414|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474415|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474416|NCT03242993|Folic Acid|folic acid|mesh-list
19474417|NCT03242993|Hematinics|hematinics|mesh-ancestor
19474418|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
19474419|NCT03242993|Vitamins|vitamins|mesh-ancestor
19474420|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
19474421|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474422|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
19474423|NCT03242967|Hematinics|hematinics|mesh-ancestor
19474424|NCT03243006|Acetaminophen|acetaminophen|mesh-list
19474425|NCT03243006|Tramadol|tramadol|mesh-list
20020483|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
20020484|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020485|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020486|NCT02528409|Vortioxetine|vortioxetine|mesh-list
20020487|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
20020488|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020489|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20020490|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20020491|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474426|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20020492|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020493|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20020494|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20020495|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020496|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020497|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020498|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
20020499|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20020500|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19474427|NCT03243006|Analgesics|analgesics|mesh-ancestor
19474428|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
19474429|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474430|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474431|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
19474432|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19474433|NCT03243006|Narcotics|narcotics|mesh-ancestor
19474434|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020501|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20020502|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20020503|NCT02529072|Nivolumab|nivolumab|mesh-list
19474435|NCT03242915|Carboplatin|carboplatin|mesh-list
19474436|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
19474437|NCT03242915|Pemetrexed|pemetrexed|mesh-list
19474438|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474439|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474440|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474441|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474442|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19474443|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19474444|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
19474445|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19474446|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
19474447|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474448|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
19474449|NCT03242707|Protective Agents|protective agents|mesh-ancestor
19474450|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
19474451|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19474452|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474453|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474454|NCT03242382|Palbociclib|palbociclib|mesh-list
19474455|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474456|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474457|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474458|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474459|NCT03242460|Dexamethasone|dexamethasone|mesh-list
19474460|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
19474461|NCT03242460|Pomalidomide|pomalidomide|mesh-list
19474462|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474463|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
19474464|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474465|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19474466|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19474467|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
19474468|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474469|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474470|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19474471|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474472|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
19474473|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
19474474|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474475|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474476|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
19474477|NCT03242460|Hormones|hormones|mesh-ancestor
19474478|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474479|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474480|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19474481|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19474482|NCT03242460|Growth Substances|growth substances|mesh-ancestor
19474483|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
19474484|NCT03242499|Lovastatin|lovastatin|mesh-list
19474485|NCT03242499|L 647318|l 647318|mesh-list
19474486|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
19474487|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19474488|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19474489|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
19474490|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474491|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19474492|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19474493|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474494|NCT03242616|Pemetrexed|pemetrexed|mesh-list
19474495|NCT03242616|Vinorelbine|vinorelbine|mesh-list
19474496|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474497|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474498|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474499|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19474500|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19474501|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19474502|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19474503|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19474504|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19474505|NCT03242317|Mitomycins|mitomycins|mesh-list
19474506|NCT03242317|Mitomycin|mitomycin|mesh-list
19474507|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19474508|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474509|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
19474510|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020504|NCT02529072|Vaccines|vaccines|mesh-list
19474511|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19474512|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474513|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
19474514|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19474515|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
19474516|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19474517|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
19474518|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474519|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474520|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
19474521|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
19474522|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474523|NCT03242239|Trastuzumab|trastuzumab|mesh-list
19474524|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474525|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567594|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567595|NCT04385303|Lorecivivint|lorecivivint|mesh-list
19567596|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567597|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
19567598|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567599|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19567600|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567601|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567602|NCT04360044|Dronabinol|dronabinol|mesh-list
19567603|NCT04360044|Cannabidiol|cannabidiol|mesh-list
19567604|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
19567605|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
19567606|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567607|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19567608|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19567609|NCT04360044|Analgesics|analgesics|mesh-ancestor
19567610|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
19567611|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567612|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19567613|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19567614|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567615|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567616|NCT04360044|Hormones|hormones|mesh-ancestor
19567617|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567618|NCT04356339|Interferons|interferons|mesh-list
19567619|NCT04356339|Interferon-beta|interferon-beta|mesh-list
19567620|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
19567621|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567622|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
19567623|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567624|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
19567625|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567626|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19567627|NCT04353414|Bupivacaine|bupivacaine|mesh-list
19567628|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
19567629|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
19567630|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567631|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567632|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
19567633|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567634|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
19567635|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567636|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567637|NCT04331145|Ticagrelor|ticagrelor|mesh-list
19567638|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19567639|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19567640|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19567641|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19567642|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
19567643|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567644|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567645|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567646|NCT04325802|Naltrexone|naltrexone|mesh-list
19567647|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19567648|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19567649|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567650|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
19567651|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567652|NCT04318704|Ifenprodil|ifenprodil|mesh-list
20576086|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474526|NCT03241875|Pregabalin|pregabalin|mesh-list
19474527|NCT03241875|Gabapentin|gabapentin|mesh-list
19474528|NCT03241875|Analgesics|analgesics|mesh-ancestor
19474529|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
19474530|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474531|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474532|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
19474533|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19474534|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474535|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474536|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19474537|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19474538|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19474539|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474540|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19474541|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19474542|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19474543|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474544|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
19474545|NCT03241901|Lumefantrine|lumefantrine|mesh-list
19474546|NCT03241901|Artemether|artemether|mesh-list
19474547|NCT03241901|Primaquine|primaquine|mesh-list
19474548|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19474549|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
19474550|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19474551|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19474552|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474553|NCT03241914|Megestrol|megestrol|mesh-list
19474554|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
19474555|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
19474556|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19474557|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
19474558|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474559|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474560|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19474561|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19474562|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19474563|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19474564|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474565|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474566|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
19474567|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19474568|NCT03241784|Interleukin-2|interleukin-2|mesh-list
19474569|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474570|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19474571|NCT03241784|Analgesics|analgesics|mesh-ancestor
19474572|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
19474573|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474574|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474575|NCT03242096|Sirolimus|sirolimus|mesh-list
19474576|NCT03242096|Paclitaxel|paclitaxel|mesh-list
19474577|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19474578|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474579|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
19474580|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
19474581|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
19474582|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474583|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19474584|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474585|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19474586|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
20020505|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
20020506|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020507|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020508|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020509|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20020510|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020511|NCT02529995|Osimertinib|osimertinib|mesh-list
20020512|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020513|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20020514|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020515|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020516|NCT02530125|Pidilizumab|pidilizumab|mesh-list
20308353|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19474587|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474588|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
19474589|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474590|NCT03241888|Megestrol|megestrol|mesh-list
19474591|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
19474592|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
20292468|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20292469|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292470|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
20292471|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
20292472|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20292473|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
20292474|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292475|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20292476|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20576087|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20576088|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19474593|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19474594|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
19474595|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474596|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474597|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19474598|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19474599|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19474600|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19474601|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474602|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474603|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
19474604|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19474605|NCT03241472|Letrozole|letrozole|mesh-list
19474606|NCT03241472|Clomiphene|clomiphene|mesh-list
19474607|NCT03241472|Enclomiphene|enclomiphene|mesh-list
19474608|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
19474609|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474610|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474611|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19474612|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19474613|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474614|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19474615|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
19474616|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474617|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474618|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19474619|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
19474620|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474621|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19474622|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19474623|NCT03241563|Triamcinolone|triamcinolone|mesh-list
20020517|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020518|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020519|NCT02530151|Clonidine|clonidine|mesh-list
20576089|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576090|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576091|NCT02069366|Hormones|hormones|mesh-ancestor
20576092|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576093|NCT02069418|Alovudine|alovudine|mesh-list
20020520|NCT02530151|Morphine|morphine|mesh-list
20020521|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20020522|NCT02530151|Narcotics|narcotics|mesh-ancestor
20020523|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020524|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576094|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20020525|NCT02530151|Analgesics|analgesics|mesh-ancestor
20020526|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
20292477|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20576095|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20576096|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576097|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
20576098|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576099|NCT02069431|Oxytocin|oxytocin|mesh-list
20576100|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
20576101|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576102|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020527|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576103|NCT02069522|Carotenoids|carotenoids|mesh-list
20020528|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20020529|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
20020530|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
20020531|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20292478|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20292479|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020532|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19474624|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
19474625|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474626|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
19474627|NCT03241563|Hormones|hormones|mesh-ancestor
19474628|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743064|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743065|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
19743066|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743067|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743068|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743069|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19743070|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19743071|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19743072|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19743073|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
19743074|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19743075|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743076|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743077|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743078|NCT04289142|Analgesics|analgesics|mesh-ancestor
19743079|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
19743080|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743081|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19743082|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19743083|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19743084|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743085|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743086|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743087|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
19743088|NCT04276792|Narcotics|narcotics|mesh-ancestor
19743089|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743090|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743091|NCT04276792|Analgesics|analgesics|mesh-ancestor
19743092|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
19743093|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743094|NCT04275531|Anesthetics|anesthetics|mesh-list
19743095|NCT04275531|Propofol|propofol|mesh-list
20020533|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20020534|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
20020535|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020536|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020537|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
20020538|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
20020539|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020540|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
20020541|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020542|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020543|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
20020544|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20020545|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20020546|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20020547|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
20020548|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020549|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020550|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743096|NCT04275531|Sevoflurane|sevoflurane|mesh-list
19743097|NCT04275531|Isoflurane|isoflurane|mesh-list
19743098|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743099|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743100|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19743101|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20020551|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
20020552|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20292480|NCT05242965|Vaccines|vaccines|mesh-list
19474629|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474630|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19474631|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474632|NCT03241745|Nivolumab|nivolumab|mesh-list
19474633|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474634|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474635|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19474636|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474637|NCT03241602|Lidocaine|lidocaine|mesh-list
19474638|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
19474639|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
19474640|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474641|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474642|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
19474643|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474644|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19474645|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19474646|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19474647|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474648|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474649|NCT03241641|Tenofovir|tenofovir|mesh-list
19474650|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
19474651|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474652|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19474653|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19474654|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474655|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474656|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19474657|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19474658|NCT03241550|Isavuconazole|isavuconazole|mesh-list
19474659|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
19474660|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474661|NCT03241407|Triclosan|triclosan|mesh-list
19474662|NCT03241407|Fluorides|fluorides|mesh-list
19474663|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
19474664|NCT03241407|Protective Agents|protective agents|mesh-ancestor
19474665|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474666|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19474667|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474668|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19474669|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19474670|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
19474671|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474672|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19474673|NCT03241706|Glucagon|glucagon|mesh-list
19474674|NCT03241706|Somatostatin|somatostatin|mesh-list
19474675|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474676|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474677|NCT03241706|Hormones|hormones|mesh-ancestor
19474678|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474679|NCT03241381|Vitamin D|vitamin d|mesh-list
19474680|NCT03241381|Vitamins|vitamins|mesh-ancestor
19474681|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
19474682|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292481|NCT05242965|Sargramostim|sargramostim|mesh-list
20292482|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
20576104|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
20576105|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576106|NCT02069522|Protective Agents|protective agents|mesh-ancestor
19474683|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19474684|NCT03241303|Acarbose|acarbose|mesh-list
19474685|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19474686|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474687|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474688|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19474689|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474690|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
19474691|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474692|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474693|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474694|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474695|NCT03241043|Tacrolimus|tacrolimus|mesh-list
20292483|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474696|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474697|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
19474698|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474699|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19474700|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474701|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474702|NCT03241017|Durvalumab|durvalumab|mesh-list
19474703|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474704|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474705|NCT03240809|Brodalumab|brodalumab|mesh-list
19474706|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19474707|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
19474708|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
19474709|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474710|NCT03240822|Antibodies|antibodies|mesh-list
19474711|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19474712|NCT03240822|Tacrolimus|tacrolimus|mesh-list
19474713|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
19474714|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474715|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474716|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19474717|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474718|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474719|NCT03240939|Tadalafil|tadalafil|mesh-list
19474720|NCT03240939|Dutasteride|dutasteride|mesh-list
19474721|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
19474722|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19474723|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19474724|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474725|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474726|NCT03240939|Urological Agents|urological agents|mesh-ancestor
19474727|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19474728|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19474729|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
19474730|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474731|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474732|NCT03240783|Dexamethasone|dexamethasone|mesh-list
19474733|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
19474734|NCT03240783|Betamethasone|betamethasone|mesh-list
19474735|NCT03240783|BB 1101|bb 1101|mesh-list
19474736|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474737|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
19474738|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
19474739|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474740|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474741|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474742|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
19474743|NCT03240783|Hormones|hormones|mesh-ancestor
19474744|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474745|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474746|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474747|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
19474748|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474749|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474750|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020553|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20020554|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20020555|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
20020556|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020557|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020558|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020559|NCT02530476|Sorafenib|sorafenib|mesh-list
19474751|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
19474752|NCT03240835|Docetaxel|docetaxel|mesh-list
19474753|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474754|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
19474755|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
19474756|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
19474757|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474758|NCT03240471|Calpastatin|calpastatin|mesh-list
20020560|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020561|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20020562|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020563|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020564|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
20020565|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19474759|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19474760|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
19474761|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474762|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474763|NCT03240549|Bevacizumab|bevacizumab|mesh-list
19474764|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474765|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474766|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19474767|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19474768|NCT03240549|Growth Substances|growth substances|mesh-ancestor
19474769|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474770|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
19567653|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19567654|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19567655|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
19567656|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567657|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567658|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567659|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
19567660|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19567661|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19567662|NCT04313088|Eluxadoline|eluxadoline|mesh-list
19567663|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19567664|NCT04302896|Tenofovir|tenofovir|mesh-list
19567665|NCT04302896|Lamivudine|lamivudine|mesh-list
19567666|NCT04302896|Emtricitabine|emtricitabine|mesh-list
19567667|NCT04302896|Dolutegravir|dolutegravir|mesh-list
19567668|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19567669|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
19567670|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567671|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19567672|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19567673|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567674|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567675|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19567676|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19567677|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19567678|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19567679|NCT04298099|Ropivacaine|ropivacaine|mesh-list
19567680|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
19567681|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
19567682|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567683|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567684|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
19567685|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567686|NCT04291820|Anesthetics|anesthetics|mesh-list
19567687|NCT04291820|Sevoflurane|sevoflurane|mesh-list
19567688|NCT04291820|Desflurane|desflurane|mesh-list
19567689|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567690|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567691|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19567692|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19567693|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
19567694|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
19567695|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
19567696|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19567697|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19567698|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567699|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567700|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567701|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567702|NCT04259658|Calcium|calcium|mesh-list
19567703|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19567704|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567713|NCT04251065|Daratumumab|daratumumab|mesh-list
19567714|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567715|NCT04246541|Acetaminophen|acetaminophen|mesh-list
19567716|NCT04246541|Ketorolac|ketorolac|mesh-list
19567717|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19474771|NCT03240120|Tinzaparin|tinzaparin|mesh-list
19474772|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19474773|NCT03240120|Dalteparin|dalteparin|mesh-list
19474774|NCT03240120|Dabigatran|dabigatran|mesh-list
19474775|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
19474776|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19474777|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
19474778|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474779|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474780|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
19474781|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19474782|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19474783|NCT03240055|Etomidate|etomidate|mesh-list
19474784|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
19474785|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474786|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474787|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19474788|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19474789|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
19474790|NCT03239691|ACT-709478|act-709478|mesh-list
19474791|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19474792|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474793|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474794|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19474795|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474796|NCT03239860|Antibodies|antibodies|mesh-list
19474797|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19474798|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
19474799|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474800|NCT03239743|Midazolam|midazolam|mesh-list
19474801|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19474802|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19474803|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474804|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474805|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19474806|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19474807|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19474808|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19474809|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
19474810|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
19474811|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
19474812|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
19474813|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474814|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474815|NCT03239821|Codeine|codeine|mesh-list
19474816|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19474817|NCT03239821|Narcotics|narcotics|mesh-ancestor
19474818|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474819|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474820|NCT03239821|Analgesics|analgesics|mesh-ancestor
19474821|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
19474822|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474823|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
19474824|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
19474825|NCT03239964|Dexamethasone|dexamethasone|mesh-list
19474826|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474827|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
19474828|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
19474829|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474830|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474831|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474832|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
19474833|NCT03239964|Hormones|hormones|mesh-ancestor
19474834|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474835|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474836|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474837|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
19474838|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474839|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19474840|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474841|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576107|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474842|NCT03239600|Methotrexate|methotrexate|mesh-list
19474843|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19474844|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
19474845|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474846|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474847|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19474848|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
19474849|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474850|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474851|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
19474852|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474853|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19474854|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19474855|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
19474856|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19474857|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19474858|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
19474859|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19474860|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474861|NCT03239327|Alprostadil|alprostadil|mesh-list
19474862|NCT03239327|Misoprostol|misoprostol|mesh-list
19474863|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19474864|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
19474865|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474866|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474867|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19474868|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474869|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
19474870|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19474871|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
19474872|NCT03239327|Urological Agents|urological agents|mesh-ancestor
19743102|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
19743103|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19743104|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19743105|NCT04265950|Vaccines|vaccines|mesh-list
19743106|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
19743107|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743108|NCT04263922|Valsartan|valsartan|mesh-list
19743109|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19743110|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19743111|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19743112|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743113|NCT04263909|Sufentanil|sufentanil|mesh-list
19743114|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19743115|NCT04263909|Narcotics|narcotics|mesh-ancestor
19743116|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743117|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743118|NCT04263909|Analgesics|analgesics|mesh-ancestor
19743119|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
19743120|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743121|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19743122|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19743123|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
19743124|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
19743125|NCT04263064|Clonidine|clonidine|mesh-list
19743126|NCT04263064|Analgesics|analgesics|mesh-ancestor
19743127|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
19743128|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743129|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743130|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19743131|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
19743132|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
19743133|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19743134|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19743135|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19743136|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743137|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743138|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743139|NCT04252105|Antioxidants|antioxidants|mesh-list
19743140|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743141|NCT04252105|Protective Agents|protective agents|mesh-ancestor
20020566|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20020567|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020568|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
20020569|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020570|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
20576108|NCT02069665|Ribavirin|ribavirin|mesh-list
19743142|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743143|NCT04251585|Insulin|insulin|mesh-list
20576109|NCT02069665|Ibuprofen|ibuprofen|mesh-list
19474873|NCT03239314|Dexamethasone|dexamethasone|mesh-list
19474874|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19474875|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474876|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
19474877|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
19474878|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474879|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474880|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474881|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
19474882|NCT03239314|Hormones|hormones|mesh-ancestor
19474883|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474884|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474885|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474886|NCT03239353|Entecavir|entecavir|mesh-list
19474887|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
19474888|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19474889|NCT03239236|Anesthetics|anesthetics|mesh-list
19474890|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474891|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474892|NCT03239457|Mitogens|mitogens|mesh-list
19474893|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
19474894|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474895|NCT03239210|Ondansetron|ondansetron|mesh-list
19474896|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
19474897|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
19474898|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474899|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474900|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19474901|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
19474902|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
19474903|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19474904|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
19474905|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474906|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474907|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19474908|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19474909|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474910|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19474911|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19474912|NCT03239080|Denosumab|denosumab|mesh-list
19474913|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19474914|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474915|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
19474916|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19474917|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19474918|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19474919|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474920|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474921|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
19474922|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19474923|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474924|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19474925|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474926|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19474927|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19474928|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567718|NCT04246541|Oxycodone|oxycodone|mesh-list
19567719|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19567720|NCT04246541|Analgesics|analgesics|mesh-ancestor
19567721|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
19567722|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567723|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567724|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
19567725|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19567726|NCT04246541|Narcotics|narcotics|mesh-ancestor
19567727|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567728|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19567729|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567730|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567731|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19567732|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567733|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020571|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19567734|NCT04242238|Avelumab|avelumab|mesh-list
19743144|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19474929|NCT03238703|Tamoxifen|tamoxifen|mesh-list
19474930|NCT03238703|Toremifene|toremifene|mesh-list
19474931|NCT03238703|Letrozole|letrozole|mesh-list
19474932|NCT03238703|Anastrozole|anastrozole|mesh-list
19474933|NCT03238703|Exemestane|exemestane|mesh-list
19474934|NCT03238703|Citric Acid|citric acid|mesh-list
19474935|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
19474936|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
19474937|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19474938|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
19474939|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
19474940|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474941|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474942|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19474943|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19474944|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474945|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19474946|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
19474947|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19474948|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474949|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19474950|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19474951|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19474952|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19474953|NCT03238365|Nivolumab|nivolumab|mesh-list
19474954|NCT03238365|Tadalafil|tadalafil|mesh-list
19474955|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19474956|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19474957|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19474958|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020572|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20020573|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020574|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
20020575|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
19474959|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
19474960|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19474961|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19474962|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19474963|NCT03238365|Urological Agents|urological agents|mesh-ancestor
19474964|NCT03238625|Lidocaine|lidocaine|mesh-list
19474965|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
19474966|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
19474967|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474968|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474969|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
19474970|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474971|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19474972|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19474973|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19474974|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19474975|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19474976|NCT03238430|Morphine|morphine|mesh-list
19474977|NCT03238430|Ropivacaine|ropivacaine|mesh-list
19474978|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19474979|NCT03238430|Narcotics|narcotics|mesh-ancestor
19474980|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19474981|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474982|NCT03238430|Analgesics|analgesics|mesh-ancestor
19474983|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
19474984|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474985|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
19474986|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
19474987|NCT03238482|Fluticasone|fluticasone|mesh-list
19474988|NCT03238482|Xhance|xhance|mesh-list
19474989|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19474990|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19474991|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19474992|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19474993|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
19474994|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19474995|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19474996|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020576|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
20020577|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19474997|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
19474998|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
19474999|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19475000|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19475001|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19475002|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19475003|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
19475004|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475005|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475006|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
19475007|NCT03238482|Hormones|hormones|mesh-ancestor
19475008|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020578|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20020579|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475009|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
19475010|NCT03238560|Montelukast|montelukast|mesh-list
19475011|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19475012|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
19475013|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19475014|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
19475015|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475016|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475017|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19475018|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19475019|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475020|NCT03238612|Clarithromycin|clarithromycin|mesh-list
19475021|NCT03238612|Oseltamivir|oseltamivir|mesh-list
19475022|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
19475023|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475024|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475025|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19475026|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475027|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475028|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19475029|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19475030|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
19743145|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743146|NCT04240054|Dexamethasone|dexamethasone|mesh-list
19743147|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
20020580|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
20020581|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020582|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20020583|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20020584|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020585|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020586|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020587|NCT02531113|Ozanimod|ozanimod|mesh-list
20020588|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20020589|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020590|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020591|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
20020592|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020593|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
20020594|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20020595|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20020596|NCT02531321|Estradiol|estradiol|mesh-list
20020597|NCT02531321|Estrogens|estrogens|mesh-ancestor
20020598|NCT02531321|Hormones|hormones|mesh-ancestor
20020599|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020600|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020601|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20292484|NCT05239910|Tenalisib|tenalisib|mesh-list
20576110|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
19475031|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743148|NCT04240054|Bortezomib|bortezomib|mesh-list
19475032|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475033|NCT03238248|Azacitidine|azacitidine|mesh-list
19475034|NCT03238248|Pevonedistat|pevonedistat|mesh-list
19475035|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19475036|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
19475037|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475038|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475039|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475040|NCT03238131|Ivermectin|ivermectin|mesh-list
19475041|NCT03238131|Albendazole|albendazole|mesh-list
19475042|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19475043|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475044|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
19475045|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
19475046|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19475047|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19475048|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
19475049|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
19475050|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
19475051|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475052|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475053|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
19475054|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19475055|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
19475056|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475057|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19475058|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19475059|NCT03238092|Estradiol|estradiol|mesh-list
19475060|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19475061|NCT03238092|Testosterone|testosterone|mesh-list
19475062|NCT03238092|Estrogens|estrogens|mesh-ancestor
19475063|NCT03238092|Hormones|hormones|mesh-ancestor
19475064|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475065|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475066|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19475067|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
19475068|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19475069|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19475070|NCT03238092|Androgens|androgens|mesh-ancestor
19475071|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19475072|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475073|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
19475074|NCT03238157|Hormones|hormones|mesh-ancestor
19475075|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475076|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475077|NCT03237936|Cyclosporine|cyclosporine|mesh-list
19475078|NCT03237936|Cyclosporins|cyclosporins|mesh-list
19475079|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475080|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475081|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19475082|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
19475083|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475084|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
19475085|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475086|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
19475087|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19475088|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19475089|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
19475090|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19475091|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
19475092|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475093|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
19475094|NCT03238183|Protective Agents|protective agents|mesh-ancestor
19475095|NCT03237637|Propranolol|propranolol|mesh-list
19475096|NCT03237637|Atenolol|atenolol|mesh-list
19475097|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19475098|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19475099|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
19475100|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475101|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475102|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475103|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19475104|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19475105|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
19475106|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
19475107|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
19475108|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475109|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19475110|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
19475111|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475112|NCT03237715|Bilirubin|bilirubin|mesh-list
20020602|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
19475113|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
20020603|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19567735|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19475114|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475115|NCT03237715|Protective Agents|protective agents|mesh-ancestor
19475116|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475117|NCT03237741|Rabeprazole|rabeprazole|mesh-list
19475118|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19475119|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475120|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19475121|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475122|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475123|NCT03237533|Promethazine|promethazine|mesh-list
19475124|NCT03237533|Doxycycline|doxycycline|mesh-list
19475125|NCT03237533|Nystatin|nystatin|mesh-list
19475126|NCT03237533|Dexamethasone|dexamethasone|mesh-list
19475127|NCT03237533|Triamcinolone|triamcinolone|mesh-list
19475128|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475129|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
19475130|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
19475131|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475132|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475133|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475134|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
19475135|NCT03237533|Hormones|hormones|mesh-ancestor
20020604|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20020605|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20020606|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20020607|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20020608|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20020609|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20020610|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
20020611|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020612|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
20020613|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20020614|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020615|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20020616|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20020617|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475136|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475137|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19475138|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475139|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475140|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475141|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475142|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
19475143|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19475144|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19475145|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
19475146|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
19475147|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19475148|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
19475149|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
19475150|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475151|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19475152|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
19475153|NCT03237533|Ionophores|ionophores|mesh-ancestor
19475154|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19475155|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
19475156|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19475157|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475158|NCT03237312|Hormones|hormones|mesh-list
19475159|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475160|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475161|NCT03237507|Paclitaxel|paclitaxel|mesh-list
19475162|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
19475163|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19475164|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475165|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
19475166|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
20020618|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020619|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020620|NCT02531633|Prednisone|prednisone|mesh-list
20020621|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20020622|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475167|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
19475168|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020623|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
20020624|NCT02531633|Hormones|hormones|mesh-ancestor
20020625|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576111|NCT02069665|Albuterol|albuterol|mesh-list
19475169|NCT03237416|Midazolam|midazolam|mesh-list
19475170|NCT03237416|Dabigatran|dabigatran|mesh-list
19475171|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19475172|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19475173|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475174|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475175|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19475176|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19475177|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19475178|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19475179|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
19475180|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
19475181|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
19743149|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743150|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
19743151|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743152|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743153|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19743154|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
20020626|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020627|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20020628|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020629|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
20020630|NCT02531698|Vaccines|vaccines|mesh-list
20020631|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
20020632|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020633|NCT02531971|Fentanyl|fentanyl|mesh-list
20020634|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20020635|NCT02531971|Narcotics|narcotics|mesh-ancestor
20020636|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020637|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020638|NCT02531971|Analgesics|analgesics|mesh-ancestor
20020639|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
20020640|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020641|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20020642|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20020643|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
20020644|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
20020645|NCT02532010|Cytarabine|cytarabine|mesh-list
20020646|NCT02532010|Decitabine|decitabine|mesh-list
20020647|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20020648|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
20020649|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020650|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020651|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
20020652|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576112|NCT02069665|Guaifenesin|guaifenesin|mesh-list
20576113|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20576114|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
20576115|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576116|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
20576117|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576118|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20576119|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576120|NCT02069665|Analgesics|analgesics|mesh-ancestor
20576121|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
20576122|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576123|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576124|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576125|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20576126|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20576127|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576128|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19749120|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
20020653|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020654|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
19475182|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
19475183|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475184|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475185|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
19475186|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19475187|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
19475188|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475189|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
19475190|NCT03237546|Anesthetics|anesthetics|mesh-list
19475191|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475192|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475193|NCT03237624|Chitosan|chitosan|mesh-list
19475194|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19475195|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19475196|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
19475197|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475198|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19475199|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
19475200|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
19475201|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
19475202|NCT03237624|Coagulants|coagulants|mesh-ancestor
19475203|NCT03237117|Hormones|hormones|mesh-list
19475204|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475205|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475206|NCT03237260|Vedolizumab|vedolizumab|mesh-list
19475207|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475208|NCT03237390|Gemcitabine|gemcitabine|mesh-list
19475209|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19475210|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
19475211|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475212|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576129|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
20576130|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020655|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020656|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292485|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
19475213|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
19475214|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475215|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475216|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19475217|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
19475218|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567736|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567737|NCT04231539|Nicotine|nicotine|mesh-list
19567738|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19567739|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
19567740|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567741|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567742|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19567743|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19567744|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
19567745|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567746|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567747|NCT04230681|Fentanyl|fentanyl|mesh-list
19567748|NCT04230681|Hydromorphone|hydromorphone|mesh-list
19567749|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19567750|NCT04230681|Narcotics|narcotics|mesh-ancestor
19567751|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567752|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567753|NCT04230681|Analgesics|analgesics|mesh-ancestor
19567754|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
19567755|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567756|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19567757|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19567758|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
19567759|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
19567760|NCT04225767|Calcium|calcium|mesh-list
19567761|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19567762|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567763|NCT04191382|Letrozole|letrozole|mesh-list
19567764|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567765|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19567766|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19567767|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567768|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567769|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19567770|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
19567771|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576131|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
19567772|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567773|NCT04188392|Pimavanserin|pimavanserin|mesh-list
19567774|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20576132|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
19475219|NCT03236818|Bosentan|bosentan|mesh-list
19475220|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
19475221|NCT03236818|Tadalafil|tadalafil|mesh-list
19475222|NCT03236818|Macitentan|macitentan|mesh-list
19475223|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
19475224|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19475225|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19475226|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475227|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475228|NCT03236818|Urological Agents|urological agents|mesh-ancestor
19475229|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19475230|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19475231|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19475232|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19475233|NCT03236805|Ketamine|ketamine|mesh-list
19475234|NCT03236805|Morphine|morphine|mesh-list
19475235|NCT03236805|Analgesics|analgesics|mesh-ancestor
19475236|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
19475237|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475238|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475239|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19475240|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19475241|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
19475242|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
19475243|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475244|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19475245|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19475246|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475247|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475248|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19475249|NCT03236805|Narcotics|narcotics|mesh-ancestor
19475250|NCT03236974|Fulvestrant|fulvestrant|mesh-list
19475251|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19475252|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475253|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19475254|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19475255|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
19475256|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475257|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475258|NCT03236792|Dexamethasone|dexamethasone|mesh-list
19475259|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
20576133|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576134|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20576135|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20576136|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20576137|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
20576138|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576139|NCT02069665|Expectorants|expectorants|mesh-ancestor
20576140|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20576141|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
20576142|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20576143|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
20576144|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
20576145|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20576146|NCT02069808|Leuprolide|leuprolide|mesh-list
20576147|NCT02069808|Menotropins|menotropins|mesh-list
20576148|NCT02069808|Ganirelix|ganirelix|mesh-list
20576149|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19475260|NCT03236792|Ixazomib|ixazomib|mesh-list
19475261|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19475262|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
19475263|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475264|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19475265|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19475266|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
19475267|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475268|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475269|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19475270|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475271|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
19475272|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
19475273|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475274|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475275|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
19475276|NCT03236792|Hormones|hormones|mesh-ancestor
20576150|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
19475277|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475278|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19475279|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
19475280|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475281|NCT03236883|Gemcitabine|gemcitabine|mesh-list
19475282|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19475283|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
19475284|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475285|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475286|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
19475287|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475288|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475289|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19475290|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
19475291|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475292|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
19475293|NCT03236961|Metronidazole|metronidazole|mesh-list
19475294|NCT03236961|Levofloxacin|levofloxacin|mesh-list
19475295|NCT03236961|Ertapenem|ertapenem|mesh-list
19475296|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475297|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475298|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19475299|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19475300|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475301|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475302|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475303|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19475304|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19475305|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19475306|NCT03236961|Renal Agents|renal agents|mesh-ancestor
19475307|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19475308|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19475309|NCT03236610|Tenofovir|tenofovir|mesh-list
19475310|NCT03236610|Entecavir|entecavir|mesh-list
19475311|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
19475312|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475313|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19475314|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19475315|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475316|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475317|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19475318|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19475319|NCT03236649|Sorafenib|sorafenib|mesh-list
19475320|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475321|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19475322|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475323|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475324|NCT03236740|Metformin|metformin|mesh-list
19475325|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19475326|NCT03236740|Estradiol|estradiol|mesh-list
19475327|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19475328|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475329|NCT03236740|Estrogens|estrogens|mesh-ancestor
20576151|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576152|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576153|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20576154|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576155|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
20576156|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576157|NCT02069886|Deferasirox|deferasirox|mesh-list
20576158|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20576159|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
20576160|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
20576161|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576162|NCT02069977|Aripiprazole|aripiprazole|mesh-list
20576163|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
20576164|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20576165|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20576166|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20576167|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475330|NCT03236740|Hormones|hormones|mesh-ancestor
19475331|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475332|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19475333|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
19475334|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19475335|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19475336|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19475337|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19475338|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
19475339|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19475340|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475341|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475342|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19475343|NCT03236727|Analgesics|analgesics|mesh-ancestor
19475344|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
19475345|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475346|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19475347|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19475348|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19475349|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
19475350|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475351|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475352|NCT03236987|Azithromycin|azithromycin|mesh-list
19475353|NCT03236987|Clarithromycin|clarithromycin|mesh-list
20292486|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292487|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292488|NCT05237687|Sirolimus|sirolimus|mesh-list
20292489|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20292490|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292491|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20292492|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292493|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
20292494|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292495|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
20292496|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292497|NCT05236985|Oxytocin|oxytocin|mesh-list
20292498|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
19475354|NCT03236987|Rifampin|rifampin|mesh-list
19475355|NCT03236987|Ethambutol|ethambutol|mesh-list
19475356|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475357|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475358|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19475359|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475360|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475361|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19475362|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19475363|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19475364|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
19475365|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
19475366|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19475367|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19475368|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19475369|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19475370|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19475371|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19475372|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19475373|NCT03236493|PF-06700841|pf-06700841|mesh-list
19475374|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19475375|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475376|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475377|NCT03236584|Tenofovir|tenofovir|mesh-list
19475378|NCT03236584|Lamivudine|lamivudine|mesh-list
19475379|NCT03236584|Adefovir|adefovir|mesh-list
19475380|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
19475381|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475382|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19475383|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19475384|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475385|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475386|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19475387|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19475388|NCT03236623|Menthol|menthol|mesh-list
19475389|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
19475390|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
20576168|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475391|NCT03236324|Epinephrine|epinephrine|mesh-list
19475392|NCT03236324|Bupivacaine|bupivacaine|mesh-list
20292499|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19475393|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
19475394|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
19475395|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475396|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475397|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
19475398|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475399|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19475400|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19475401|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
19475402|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475403|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475404|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19475405|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19475406|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
19475407|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19475408|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
19475409|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
19475410|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
19475411|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19475412|NCT03236233|PC-786|pc-786|mesh-list
19475413|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
19475414|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475415|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475416|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475417|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
19475418|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19475419|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
19475420|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475421|NCT03236220|Expectorants|expectorants|mesh-ancestor
19475422|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
19475423|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19475424|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
19475425|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475426|NCT03236220|Protective Agents|protective agents|mesh-ancestor
19475427|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475428|NCT03236220|Antidotes|antidotes|mesh-ancestor
19475429|NCT03235947|Trimethoprim|trimethoprim|mesh-list
19475430|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
19475431|NCT03235947|Fosfomycin|fosfomycin|mesh-list
19475432|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19475433|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475434|NCT03235947|Renal Agents|renal agents|mesh-ancestor
19475435|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
19475436|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19475437|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19475438|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19475439|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475440|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475441|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19475442|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19475443|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19475444|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475445|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
19475446|NCT03236155|Narcotics|narcotics|mesh-ancestor
19475447|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475448|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475449|NCT03236155|Analgesics|analgesics|mesh-ancestor
19475450|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
19475451|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475452|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
19475453|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
19475454|NCT03235973|Fludarabine|fludarabine|mesh-list
19475455|NCT03235973|Busulfan|busulfan|mesh-list
19475456|NCT03235973|Cladribine|cladribine|mesh-list
19475457|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576169|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
20576170|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
20576171|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576172|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475458|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020657|NCT02532283|Oseltamivir|oseltamivir|mesh-list
20020658|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
20576173|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19475459|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19475460|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
19475461|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475462|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
19475463|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19475464|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19475465|NCT03235869|Durvalumab|durvalumab|mesh-list
19475466|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19475467|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475468|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
19475469|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19475470|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19475471|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19475472|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19475473|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475474|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
19475475|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475476|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475477|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19475478|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475479|NCT03235609|Fentanyl|fentanyl|mesh-list
19475480|NCT03235609|Ketamine|ketamine|mesh-list
19475481|NCT03235609|Analgesics|analgesics|mesh-ancestor
19475482|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
19475483|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475484|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475485|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19475486|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19475487|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
19475488|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
19475489|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475490|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19475491|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19475492|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475493|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475494|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19475495|NCT03235609|Narcotics|narcotics|mesh-ancestor
19475496|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19475497|NCT03235531|Valproic Acid|valproic acid|mesh-list
19475498|NCT03235531|Lorazepam|lorazepam|mesh-list
19475499|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
19475500|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475501|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475502|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
19475503|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475504|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475505|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
19475506|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19475507|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475508|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19475509|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
19475510|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
19475511|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475512|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475513|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19475514|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19475515|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
19475516|NCT03235700|Nicorandil|nicorandil|mesh-list
19475517|NCT03235700|Adenosine|adenosine|mesh-list
19475518|NCT03235700|Analgesics|analgesics|mesh-ancestor
19475519|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
19475520|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475521|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475522|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19475523|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
19475524|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19475525|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
19475526|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
19475527|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475528|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475529|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19475530|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
19475531|NCT03235700|Vitamins|vitamins|mesh-ancestor
19475532|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
19475533|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
19475534|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20576174|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19475535|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19475536|NCT03235778|Analgesics|analgesics|mesh-ancestor
19475537|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
19475538|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475539|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475540|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475541|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567775|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19567776|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19567777|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19567778|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567779|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567780|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19567781|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19567782|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19567783|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
19567784|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567785|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743155|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743156|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743157|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19743158|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19743159|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
20576175|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
20576176|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20576177|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20576178|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20576179|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20576180|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
20576181|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20576182|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576183|NCT02069990|Vitamins|vitamins|mesh-ancestor
20576184|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
20576185|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20576186|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
20576187|NCT02070003|Narcotics|narcotics|mesh-ancestor
20020659|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020660|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020661|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020662|NCT02532374|Nicotine|nicotine|mesh-list
20020663|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20020664|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
20020665|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020666|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020667|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20020668|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20020669|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
20020670|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020671|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020672|NCT02532647|Midazolam|midazolam|mesh-list
20020673|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20020674|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20020675|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020676|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020677|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20020678|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20020679|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020680|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20020681|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
20020682|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
20020683|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
20020684|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
19567786|NCT04184609|Bromides|bromides|mesh-list
19743160|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
19743161|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743162|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743163|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
19743164|NCT04240054|Hormones|hormones|mesh-ancestor
19743165|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743166|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19743167|NCT04239716|Anesthetics|anesthetics|mesh-list
19743168|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743169|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743170|NCT04235634|Alprostadil|alprostadil|mesh-list
19743171|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20020685|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576188|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475542|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19475543|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
19475544|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19475545|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19475546|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19475547|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
19475548|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475549|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475550|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475551|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19475552|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19475553|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19475554|NCT03235245|Nivolumab|nivolumab|mesh-list
19475555|NCT03235245|Ipilimumab|ipilimumab|mesh-list
19475556|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19475557|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475558|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19475559|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475560|NCT03235037|Levodopa|levodopa|mesh-list
19475561|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19475562|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19475563|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
19475564|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475565|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475566|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475567|NCT03235141|Azithromycin|azithromycin|mesh-list
19475568|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19475569|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475570|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475571|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19475572|NCT03234816|Norepinephrine|norepinephrine|mesh-list
19475573|NCT03234816|Bupivacaine|bupivacaine|mesh-list
19475574|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
19475575|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
19475576|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475577|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475578|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
19475579|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475580|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19475581|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19475582|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
19475583|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475584|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475585|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
19475586|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
19475587|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19475588|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19475589|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
19475590|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475591|NCT03234842|Paclitaxel|paclitaxel|mesh-list
19475592|NCT03234842|Carboplatin|carboplatin|mesh-list
19475593|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19475594|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475595|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
19475596|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
19475597|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
19475598|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475599|NCT03234673|Calcipotriene|calcipotriene|mesh-list
19475600|NCT03234673|Tacrolimus|tacrolimus|mesh-list
19475601|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19475602|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
19475603|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475604|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19475605|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475606|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475607|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
19475608|NCT03234517|Clindamycin|clindamycin|mesh-list
19475609|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
19475610|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
19475611|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20020686|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475612|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475613|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19475614|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475615|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475616|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
19475617|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
19475618|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19475619|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475620|NCT03234244|Vitamins|vitamins|mesh-ancestor
19475621|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
19475622|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19475623|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19475624|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19475625|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
19475626|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475627|NCT03234699|Midazolam|midazolam|mesh-list
19475628|NCT03234699|Cenobamate|cenobamate|mesh-list
19475629|NCT03234699|Bupropion|bupropion|mesh-list
19475630|NCT03234699|Omeprazole|omeprazole|mesh-list
19475631|NCT03234699|Warfarin|warfarin|mesh-list
19475632|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19475633|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19475634|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475635|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475636|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19475637|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19475638|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19475639|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19475640|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
19475641|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
19475642|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
19475643|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
19475644|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475645|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475646|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
19475647|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19475648|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475649|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19475650|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475651|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19475652|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
19475653|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19475654|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19475655|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19475656|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
19475657|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19475658|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19475659|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
19475660|NCT03234400|Dapivirine|dapivirine|mesh-list
19475661|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19475662|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19475663|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
19475664|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475665|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
19475666|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19475667|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19475668|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19475669|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19475670|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475671|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
19475672|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475673|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475674|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19475675|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475676|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
19475677|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19475678|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475679|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475680|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19475681|NCT03234660|Analgesics|analgesics|mesh-ancestor
19475682|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
19475683|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475684|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19475685|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19475686|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19475687|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
19475688|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567787|NCT04184609|Albuterol|albuterol|mesh-list
19475689|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475690|NCT03234296|Metronidazole|metronidazole|mesh-list
19475691|NCT03234296|Levofloxacin|levofloxacin|mesh-list
19475692|NCT03234296|Ertapenem|ertapenem|mesh-list
19475693|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475694|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475695|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19475696|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19475697|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19475698|NCT03234296|Renal Agents|renal agents|mesh-ancestor
19475699|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19475700|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19475701|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475702|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475703|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475704|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19475705|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19475706|NCT03234387|Acetylcholine|acetylcholine|mesh-list
19475707|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475708|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
19475709|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19475710|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
19475711|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475712|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475713|NCT03233828|Aldesleukin|aldesleukin|mesh-list
19475714|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475715|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19475716|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19475717|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
19475718|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475719|NCT03234062|Choline|choline|mesh-list
19475720|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
19475721|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20020687|NCT02532855|Metformin|metformin|mesh-list
20020688|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20020689|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
20020690|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020691|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020692|NCT02532855|Incretins|incretins|mesh-ancestor
20576189|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576190|NCT02070003|Analgesics|analgesics|mesh-ancestor
19475722|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
19475723|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475724|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475725|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19475726|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
19475727|NCT03233932|Leuprolide|leuprolide|mesh-list
19475728|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19475729|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
19475730|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19475731|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475732|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19475733|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475734|NCT03233880|Azithromycin|azithromycin|mesh-list
19475735|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19475736|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19475737|NCT03233815|Propofol|propofol|mesh-list
19475738|NCT03233815|Sevoflurane|sevoflurane|mesh-list
19475739|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19475740|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475741|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475742|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19475743|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
19475744|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
19475745|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19475746|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19475747|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
19475748|NCT03233893|Calcium|calcium|mesh-list
19475749|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19475750|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475751|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19475752|NCT03234153|Durvalumab|durvalumab|mesh-list
19475753|NCT03234153|Tremelimumab|tremelimumab|mesh-list
19475754|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
19475755|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020693|NCT02532855|Hormones|hormones|mesh-ancestor
20020694|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475756|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475757|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475758|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19475759|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567788|NCT04184609|Ipratropium|ipratropium|mesh-list
19567789|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
19567790|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19567791|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
19567792|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567793|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567794|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19567795|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
19567796|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
19567797|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19567798|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19567799|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19567800|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19567801|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19567802|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567803|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567804|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19567805|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
19567806|NCT04181996|Colchicine|colchicine|mesh-list
19567807|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
19567808|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567809|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
19567810|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
19567811|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
19567812|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567813|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577541|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19577542|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577543|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577544|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19577545|NCT04309773|Bezafibrate|bezafibrate|mesh-list
19577546|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19577547|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19577548|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19577549|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
19577550|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577551|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19577552|NCT04300140|Nivolumab|nivolumab|mesh-list
19577553|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577554|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577555|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19577556|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577557|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19577558|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577559|NCT04285853|Oxycodone|oxycodone|mesh-list
19577560|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19577561|NCT04285853|Narcotics|narcotics|mesh-ancestor
19577562|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577563|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577564|NCT04285853|Analgesics|analgesics|mesh-ancestor
19577565|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
19577566|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577567|NCT04224701|Vaccines|vaccines|mesh-list
19577568|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
19577569|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577570|NCT04195399|Imidazole|imidazole|mesh-list
19577571|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577572|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577573|NCT04174196|Lenalidomide|lenalidomide|mesh-list
19577574|NCT04174196|Cc-486|cc-486|mesh-list
19577575|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
19577576|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577577|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19577578|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20576191|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
20576192|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576193|NCT02070120|Mitomycins|mitomycins|mesh-list
20576194|NCT02070120|Mitomycin|mitomycin|mesh-list
20576195|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20576196|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743172|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
19475760|NCT03233750|Vaccines|vaccines|mesh-list
19475761|NCT03233750|Immunologic Factors|immunologic factors|mesh-ancestor
19475762|NCT03233750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475763|NCT03233321|Heparin|heparin|mesh-list
19475764|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19475765|NCT03233321|Tinzaparin|tinzaparin|mesh-list
19475766|NCT03233321|Dalteparin|dalteparin|mesh-list
19475767|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
19475768|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19475769|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19475770|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475771|NCT03233412|Imiquimod|imiquimod|mesh-list
19475772|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19475773|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
19475774|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475775|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475776|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
19475777|NCT03233295|Vitamin D|vitamin d|mesh-list
19475778|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
19475779|NCT03233295|Vitamins|vitamins|mesh-ancestor
19475780|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
19475781|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475782|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19475783|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19475784|NCT03233152|Nivolumab|nivolumab|mesh-list
19475785|NCT03233152|Ipilimumab|ipilimumab|mesh-list
19475786|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19475787|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19475788|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475789|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19475790|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475791|NCT03233035|Ketamine|ketamine|mesh-list
19475792|NCT03233035|Analgesics|analgesics|mesh-ancestor
19475793|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
19475794|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475795|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475796|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19475797|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19475798|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
19475799|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
19475800|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475801|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19475802|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19475803|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475804|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743173|NCT04235634|Urological Agents|urological agents|mesh-ancestor
19743174|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
19743175|NCT04234906|Amiodarone|amiodarone|mesh-list
19743176|NCT04234906|Procainamide|procainamide|mesh-list
19743177|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
19743178|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19743179|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743180|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743181|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743182|NCT04234906|Analgesics|analgesics|mesh-ancestor
19743183|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
19743184|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743185|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19743186|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19743187|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19743188|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743189|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743190|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743191|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
19743192|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19743193|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
19743194|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19743195|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19743196|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19743197|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
19743198|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19743199|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
20292500|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743200|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20292501|NCT05232032|Nociceptin|nociceptin|mesh-list
19475805|NCT03232957|Morphine|morphine|mesh-list
19475806|NCT03232957|Bupivacaine|bupivacaine|mesh-list
19475807|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
19475808|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
19475809|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475810|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475811|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
19475812|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475813|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19475814|NCT03232957|Narcotics|narcotics|mesh-ancestor
19475815|NCT03232957|Analgesics|analgesics|mesh-ancestor
19475816|NCT03232632|Flutemetamol|flutemetamol|mesh-list
19475817|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19475818|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475819|NCT03232710|Aripiprazole|aripiprazole|mesh-list
19475820|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
19475821|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19475822|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19475823|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19475824|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475825|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475826|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
19475827|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
19475828|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475829|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475830|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19475831|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19475832|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
19475833|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19475834|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19475835|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19475836|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19475837|NCT03232554|Iron|iron|mesh-list
19475838|NCT03232554|Trace Elements|trace elements|mesh-ancestor
19475839|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
19475840|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475841|NCT03232450|Aspirin|aspirin|mesh-list
19475842|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19475843|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19475844|NCT03232450|Analgesics|analgesics|mesh-ancestor
19475845|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
19475846|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475847|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475848|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475849|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19475850|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19475851|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19475852|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475853|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19475854|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19475855|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475856|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
19475857|NCT03232424|Temozolomide|temozolomide|mesh-list
19475858|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19475859|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
19475860|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475861|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475862|NCT03232398|Warfarin|warfarin|mesh-list
19475863|NCT03232398|Apixaban|apixaban|mesh-list
19475864|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
19475865|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19475866|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
19475867|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19475868|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
19475869|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475870|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475871|NCT03232307|Dexamethasone|dexamethasone|mesh-list
19475872|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
19475873|NCT03232307|Rituximab|rituximab|mesh-list
19475874|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19475875|NCT03232307|Lenalidomide|lenalidomide|mesh-list
19475876|NCT03232307|Antibodies|antibodies|mesh-list
19475877|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
19475878|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19475879|NCT03232307|BB 1101|bb 1101|mesh-list
19475880|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
19475881|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475882|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19475883|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19475884|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19475885|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
19475886|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
19475887|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475888|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475889|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
19475890|NCT03232307|Hormones|hormones|mesh-ancestor
19475891|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19475892|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19475893|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19475894|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19475895|NCT03232307|Growth Substances|growth substances|mesh-ancestor
19475896|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
19475897|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
19475898|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19475899|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475900|NCT03232346|Buprenorphine|buprenorphine|mesh-list
19475901|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19475902|NCT03232346|Narcotics|narcotics|mesh-ancestor
19475903|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475904|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475905|NCT03232346|Analgesics|analgesics|mesh-ancestor
19475906|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
19475907|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475908|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19475909|NCT03232216|Vitamin D|vitamin d|mesh-list
19475910|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
19475911|NCT03232216|Vitamins|vitamins|mesh-ancestor
19475912|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
19475913|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475914|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19475915|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19475916|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19475917|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19475918|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475919|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475920|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19475921|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19475922|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475923|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
19475924|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475925|NCT03231982|Amlodipine|amlodipine|mesh-list
19475926|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19475927|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19475928|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19475929|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475930|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19475931|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475932|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
19475933|NCT03232034|Calcium|calcium|mesh-list
19475934|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19475935|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475936|NCT03232125|Ramosetron|ramosetron|mesh-list
19475937|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
19475938|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
19475939|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475940|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475941|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19475942|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19475943|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
19475944|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475945|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475946|NCT03232021|Pregabalin|pregabalin|mesh-list
19475947|NCT03232021|Analgesics|analgesics|mesh-ancestor
19475948|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
19475949|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475950|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475951|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
19475952|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19475953|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19475954|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743201|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19475955|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19475956|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19475957|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19475958|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475959|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19475960|NCT03232112|Exenatide|exenatide|mesh-list
19475961|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19475962|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475963|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19475964|NCT03232112|Incretins|incretins|mesh-ancestor
19475965|NCT03232112|Hormones|hormones|mesh-ancestor
19475966|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567814|NCT04180943|Bupivacaine|bupivacaine|mesh-list
19567815|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
19567816|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
19567817|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567818|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567819|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
19567820|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567821|NCT04175626|Sirolimus|sirolimus|mesh-list
19567822|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567823|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567824|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19567825|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567826|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
19567827|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567828|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
19567829|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567830|NCT04170946|Talazoparib|talazoparib|mesh-list
19567831|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19567832|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567833|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567834|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567835|NCT04146571|Ensartinib|ensartinib|mesh-list
19567836|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567837|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19567838|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567839|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567840|NCT04126473|Ivacaftor|ivacaftor|mesh-list
19567841|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19567842|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567843|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567844|NCT04120870|Ketamine|ketamine|mesh-list
19567845|NCT04120870|Etomidate|etomidate|mesh-list
19567846|NCT04120870|Analgesics|analgesics|mesh-ancestor
19567847|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
19567848|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567849|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567850|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19567851|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19567852|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
19567853|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
19567854|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567855|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19567856|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19567857|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567858|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567859|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19567860|NCT04116112|Hydralazine|hydralazine|mesh-list
19567861|NCT04116112|Labetalol|labetalol|mesh-list
19567862|NCT04116112|Nicardipine|nicardipine|mesh-list
19567863|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20020695|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20020696|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
20020697|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020698|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020699|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20020700|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
20020701|NCT02532998|Eplerenone|eplerenone|mesh-list
20020702|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20020703|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
20020704|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567864|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
19567865|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19475967|NCT03231813|Emollients|emollients|mesh-list
19475968|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
19475969|NCT03231683|Ketamine|ketamine|mesh-list
19475970|NCT03231683|Remifentanil|remifentanil|mesh-list
19475971|NCT03231683|Propofol|propofol|mesh-list
19475972|NCT03231683|Esketamine|esketamine|mesh-list
19475973|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19475974|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475975|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475976|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19475977|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
19475978|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
19475979|NCT03231683|Analgesics|analgesics|mesh-ancestor
19475980|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
19475981|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475982|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19475983|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19475984|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19475985|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19475986|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19475987|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19475988|NCT03231683|Narcotics|narcotics|mesh-ancestor
19475989|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
19475990|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19475991|NCT03231436|Bupivacaine|bupivacaine|mesh-list
19475992|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
19475993|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
19475994|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19475995|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19475996|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
19475997|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19475998|NCT03231176|Capecitabine|capecitabine|mesh-list
19475999|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19476000|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
19476001|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476002|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476003|NCT03231215|Dexamethasone|dexamethasone|mesh-list
19476004|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476005|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
19476006|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
19476007|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476008|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476009|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19476010|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
19476011|NCT03231215|Hormones|hormones|mesh-ancestor
19476012|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476013|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19476014|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476015|NCT03231033|Pioglitazone|pioglitazone|mesh-list
19476016|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19476017|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476018|NCT03230786|Metformin|metformin|mesh-list
19476019|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19476020|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476021|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
19476022|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
19476023|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19476024|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476025|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19476026|NCT03230851|Aspirin|aspirin|mesh-list
19476027|NCT03230851|Indobufen|indobufen|mesh-list
19476028|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476029|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476030|NCT03230851|Analgesics|analgesics|mesh-ancestor
19476031|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
20020705|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020706|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20020707|NCT02532998|Diuretics|diuretics|mesh-ancestor
20020708|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
19476032|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476033|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476034|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020709|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19476035|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476036|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19476037|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20020710|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476038|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476039|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19476040|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19476041|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476042|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
19476043|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
19476044|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19476045|NCT03230630|Melatonin|melatonin|mesh-list
19476046|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
19476047|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476048|NCT03230630|Protective Agents|protective agents|mesh-ancestor
19476049|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476050|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476051|NCT03230734|Docetaxel|docetaxel|mesh-list
19476052|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476053|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19476054|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
19476055|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19476056|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476057|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
19476058|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19476059|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
19476060|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19476061|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476062|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19476063|NCT03230474|Morphine|morphine|mesh-list
19476064|NCT03230474|Naloxone|naloxone|mesh-list
19476065|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19476066|NCT03230474|Narcotics|narcotics|mesh-ancestor
19476067|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476068|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476069|NCT03230474|Analgesics|analgesics|mesh-ancestor
19476070|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
19476071|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476072|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19476073|NCT03230227|Bupivacaine|bupivacaine|mesh-list
19476074|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
19476075|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
19476076|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476077|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476078|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
19476079|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567866|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19567867|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
19567868|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567869|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567870|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567871|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
19567872|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
19567873|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567874|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19567875|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19567876|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19567877|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567878|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19567879|NCT04083950|Aspirin|aspirin|mesh-list
19567880|NCT04083950|Vaccines|vaccines|mesh-list
19567881|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
19567882|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567883|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19567884|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19567885|NCT04083950|Analgesics|analgesics|mesh-ancestor
19567886|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
19567887|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567888|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19567889|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567890|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19567891|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19567892|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567893|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19567894|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19567895|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567896|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
19567897|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
19476080|NCT03230162|Heparin|heparin|mesh-list
19476081|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19476082|NCT03230162|Tinzaparin|tinzaparin|mesh-list
19476083|NCT03230162|Dalteparin|dalteparin|mesh-list
19476084|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
19476085|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
19476086|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19476087|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19476088|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476089|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
20020711|NCT02533375|Adalimumab|adalimumab|mesh-list
20576197|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
20576198|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576199|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20576200|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576201|NCT02070133|Simvastatin|simvastatin|mesh-list
20576202|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20576203|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20576204|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
20576205|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576206|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20576207|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20576208|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576209|NCT02070159|Clopidogrel|clopidogrel|mesh-list
20576210|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20576211|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20576212|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20576213|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20576214|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20576215|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
19476090|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19476091|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19476092|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476093|NCT03230162|Urological Agents|urological agents|mesh-ancestor
19476094|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19476095|NCT03229954|Hematinics|hematinics|mesh-ancestor
19476096|NCT03230097|BI 409306|bi 409306|mesh-list
19476097|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19476098|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476099|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476100|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
19476101|NCT03229746|Vincristine|vincristine|mesh-list
19476102|NCT03229746|Azathioprine|azathioprine|mesh-list
19476103|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19476104|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476105|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
19476106|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
19476107|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
19476108|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476109|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
19476110|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19476111|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19476112|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476113|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476114|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476115|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
19476116|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19476117|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19476118|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
19476119|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476120|NCT03229668|Pregabalin|pregabalin|mesh-list
19476121|NCT03229668|Analgesics|analgesics|mesh-ancestor
19476122|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
19476123|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476124|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476125|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
19476126|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19476127|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476128|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476129|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19476130|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19476131|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19476132|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476133|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020712|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476134|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
19476135|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19476136|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476137|NCT03230058|Voriconazole|voriconazole|mesh-list
19476138|NCT03230058|Natamycin|natamycin|mesh-list
19476139|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19476140|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19476141|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
19476142|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476143|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19476144|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19476145|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476146|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476147|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19476148|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
19476149|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476150|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476151|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19476152|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19476153|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19476154|NCT03229694|Bosentan|bosentan|mesh-list
19476155|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
19476156|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19476157|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476158|NCT03230136|Anesthetics|anesthetics|mesh-list
19476159|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476160|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476161|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19476162|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476163|NCT03229798|Sumatriptan|sumatriptan|mesh-list
19476164|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19476165|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19476166|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19476167|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
19476168|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476169|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476170|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476171|NCT03229889|Tadalafil|tadalafil|mesh-list
19476172|NCT03229889|Tamsulosin|tamsulosin|mesh-list
19476173|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
19476174|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19476175|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19476176|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476177|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476178|NCT03229889|Urological Agents|urological agents|mesh-ancestor
19476179|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19476180|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19743202|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19743203|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19743204|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743205|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19743206|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19743207|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19743208|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19743209|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19743210|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20020713|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020714|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
20576216|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576217|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576218|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576219|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20576220|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20576221|NCT02070198|Hormones|hormones|mesh-ancestor
20576222|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576223|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576224|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
20576225|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20020715|NCT02533401|Rituximab|rituximab|mesh-list
20020716|NCT02533401|Fludarabine|fludarabine|mesh-list
20292502|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
19476181|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19476182|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
19476183|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476184|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476185|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
19476186|NCT03229616|Busulfan|busulfan|mesh-list
19476187|NCT03229616|Etoposide|etoposide|mesh-list
19476188|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19476189|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
19476190|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476191|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476192|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19476193|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
19476194|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476195|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476196|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19476197|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19476198|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19476199|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19476200|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476201|NCT03229096|Apatinib|apatinib|mesh-list
19476202|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476203|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19476204|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476205|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476206|NCT03229174|Droxidopa|droxidopa|mesh-list
19476207|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19476208|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19476209|NCT03229148|Anesthetics|anesthetics|mesh-list
19476210|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476211|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476212|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19476213|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476214|NCT03228992|Ibuprofen|ibuprofen|mesh-list
19476215|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476216|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476217|NCT03228992|Analgesics|analgesics|mesh-ancestor
19476218|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
19476219|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476220|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476221|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476222|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476223|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19476224|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476225|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476226|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
19476227|NCT03229278|Nivolumab|nivolumab|mesh-list
19476228|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19476229|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476230|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476231|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19476232|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476233|NCT03228901|Oxytocin|oxytocin|mesh-list
19476234|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
19476235|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19476236|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476237|NCT03228797|Ropivacaine|ropivacaine|mesh-list
19476238|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
19476239|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
19476240|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476241|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476242|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
19476243|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476244|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
19476245|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19476246|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
19476247|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
19476248|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476249|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020717|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020718|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
19476250|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476251|NCT03228628|Analgesics|analgesics|mesh-ancestor
19476252|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
19567898|NCT04083183|Sirolimus|sirolimus|mesh-list
20292503|NCT05227391|Letrozole|letrozole|mesh-list
19476253|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476254|NCT03228823|Amiodarone|amiodarone|mesh-list
19476255|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19476256|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
19476257|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19476258|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476259|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476260|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19476261|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19476262|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19476263|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476264|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19476265|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19476266|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19476267|NCT03228732|Fluoxetine|fluoxetine|mesh-list
19476268|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19476269|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19476270|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19476271|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476272|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476273|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476274|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
19476275|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476276|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19476277|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
19476278|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19476279|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19476280|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19476281|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476282|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19476283|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
19476284|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
19476285|NCT03228667|Nivolumab|nivolumab|mesh-list
19476286|NCT03228667|Durvalumab|durvalumab|mesh-list
19476287|NCT03228667|Avelumab|avelumab|mesh-list
19476288|NCT03228667|Atezolizumab|atezolizumab|mesh-list
19476289|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19476290|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476291|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476292|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19476293|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476294|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
19476295|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476296|NCT03228771|Atorvastatin|atorvastatin|mesh-list
19476297|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19476298|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19476299|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
19476300|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476301|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19476302|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19476303|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567899|NCT04083183|Vidarabine|vidarabine|mesh-list
19567900|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
19743211|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743212|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
20576226|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
20576227|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576228|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20576229|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20576230|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576231|NCT02070289|PF-06372865|pf-06372865|mesh-list
20576232|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
20576233|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
20576234|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576235|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576236|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576237|NCT02070406|Aldesleukin|aldesleukin|mesh-list
19567901|NCT04083183|Fludarabine|fludarabine|mesh-list
19567902|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
19743213|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
20576238|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
20576239|NCT02070406|Fludarabine|fludarabine|mesh-list
19476304|NCT03228576|Everolimus|everolimus|mesh-list
19476305|NCT03228576|Tacrolimus|tacrolimus|mesh-list
19476306|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19476307|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
19476308|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476309|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19476310|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476311|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476312|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476313|NCT03228498|Choline|choline|mesh-list
19476314|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
19476315|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19476316|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
19476317|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576240|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
20576241|NCT02070406|Interleukin-2|interleukin-2|mesh-list
20576242|NCT02070406|Vaccines|vaccines|mesh-list
20576243|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20576244|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576245|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
20576246|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576247|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20576248|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20576249|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
20576250|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576251|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576252|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20576253|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576254|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
20576255|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576256|NCT02070406|Analgesics|analgesics|mesh-ancestor
20576257|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
19476318|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19476319|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19476320|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
19476321|NCT03228368|Atezolizumab|atezolizumab|mesh-list
19476322|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476323|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
19476324|NCT03228862|Vitamin D|vitamin d|mesh-list
20576258|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576259|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20576260|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20576261|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
20576262|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576263|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20576264|NCT02070458|Cytarabine|cytarabine|mesh-list
20576265|NCT02070458|Etoposide|etoposide|mesh-list
20576266|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
20576267|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
20576268|NCT02070458|Ixazomib|ixazomib|mesh-list
20576269|NCT02070458|Glycine|glycine|mesh-list
20576270|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
20576271|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20576272|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476325|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20020719|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020720|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020721|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20020722|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
20020723|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020724|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020725|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20020726|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020727|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20020728|NCT02533427|Norgestimate|norgestimate|mesh-list
20020729|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20020730|NCT02533427|Estradiol|estradiol|mesh-list
20020731|NCT02533427|Estrogens|estrogens|mesh-ancestor
20292504|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20576273|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20576274|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20576275|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576276|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476326|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476327|NCT03228862|Vitamins|vitamins|mesh-ancestor
19476328|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
19476329|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19476330|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
19476331|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476332|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19476333|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476334|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476335|NCT03228238|Vitamins|vitamins|mesh-list
19476336|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
19476337|NCT03228238|Vitamin E|vitamin e|mesh-list
19476338|NCT03228238|Tocopherols|tocopherols|mesh-list
19476339|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
19476340|NCT03228238|Atorvastatin|atorvastatin|mesh-list
19476341|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
19476342|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476343|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19476344|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19476345|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19476346|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
19476347|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476348|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19476349|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19476350|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476351|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
19476352|NCT03228238|Protective Agents|protective agents|mesh-ancestor
19476353|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476354|NCT03228355|Cromakalim|cromakalim|mesh-list
19476355|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19476356|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19476357|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
20292505|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20292506|NCT05227391|Estradiol|estradiol|mesh-list
20292507|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20292508|NCT05227391|Estrogens|estrogens|mesh-ancestor
20292509|NCT05227391|Hormones|hormones|mesh-ancestor
20292510|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20292511|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292512|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20292513|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
20292514|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20292515|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20292516|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292517|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20292518|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20292519|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476358|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476359|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476360|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19476361|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
19476362|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
19476363|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
19476364|NCT03228108|Amoxicillin|amoxicillin|mesh-list
19476365|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
19476366|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19476367|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
19476368|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
19476369|NCT03228108|Fosfomycin|fosfomycin|mesh-list
19476370|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19476371|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
19476372|NCT03228108|Trimethoprim|trimethoprim|mesh-list
19476373|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
19476374|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19476375|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476376|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19476377|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19476378|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476379|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476380|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476381|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19476382|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19476383|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19476384|NCT03228108|Renal Agents|renal agents|mesh-ancestor
19476385|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
19476386|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19476387|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19476388|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19476389|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19476390|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19476391|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19476392|NCT03228030|Thiamine|thiamine|mesh-list
19476393|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
19476394|NCT03228030|Vitamins|vitamins|mesh-ancestor
19476395|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
19476396|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476397|NCT03227731|Tenofovir|tenofovir|mesh-list
19476398|NCT03227731|Emtricitabine|emtricitabine|mesh-list
19476399|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19476400|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
19476401|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476402|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19476403|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19476404|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476405|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476406|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19476407|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19476408|NCT03227900|Lidocaine|lidocaine|mesh-list
19476409|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
19476410|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
19476411|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476412|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476413|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
19476414|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476415|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19476416|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19476417|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19476418|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476419|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476420|NCT03228043|Apatinib|apatinib|mesh-list
19476421|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476422|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19476423|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476424|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476425|NCT03227926|Panitumumab|panitumumab|mesh-list
19476426|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476427|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476428|NCT03227679|Bupropion|bupropion|mesh-list
19476429|NCT03227679|Nicotine|nicotine|mesh-list
19476430|NCT03227679|Varenicline|varenicline|mesh-list
19476431|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19476432|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
19476433|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476434|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476435|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19476436|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19476437|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
19476438|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476439|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476440|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19476441|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
19476442|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19476443|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19476444|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19476445|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476446|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
19476447|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19476448|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19476449|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476450|NCT03227705|Progesterone|progesterone|mesh-list
19476451|NCT03227705|Progestins|progestins|mesh-ancestor
19476452|NCT03227705|Hormones|hormones|mesh-ancestor
19476453|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476454|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476455|NCT03227653|Ritonavir|ritonavir|mesh-list
19476456|NCT03227653|Lopinavir|lopinavir|mesh-list
19476457|NCT03227653|Nevirapine|nevirapine|mesh-list
19476458|NCT03227653|Efavirenz|efavirenz|mesh-list
19476459|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19476460|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19476461|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
19476462|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476463|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476464|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19476465|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19476466|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
19476467|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476468|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19476469|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19476470|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19476471|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19476472|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19476473|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19476474|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19476475|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19476476|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19476477|NCT03227484|Empagliflozin|empagliflozin|mesh-list
19476478|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19476479|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476480|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19476481|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476482|NCT03227419|Abatacept|abatacept|mesh-list
19743214|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
19743215|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
19743216|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743217|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743218|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
19743219|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743220|NCT04205409|Nivolumab|nivolumab|mesh-list
19743221|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743222|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743223|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743224|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743225|NCT04199572|Acetaminophen|acetaminophen|mesh-list
19743226|NCT04199572|Diclofenac|diclofenac|mesh-list
19743227|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743228|NCT04199572|Analgesics|analgesics|mesh-ancestor
19743229|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
19743230|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743231|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743232|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
19743233|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19743234|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19743235|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292520|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292521|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20292522|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
20292523|NCT05207722|Aldesleukin|aldesleukin|mesh-list
20292524|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
20292525|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
20292526|NCT05207722|Trastuzumab|trastuzumab|mesh-list
20292527|NCT05207722|Fludarabine|fludarabine|mesh-list
20292528|NCT05207722|Interleukin-2|interleukin-2|mesh-list
20292529|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292530|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
19743236|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19743237|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743238|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743239|NCT04195958|Omalizumab|omalizumab|mesh-list
19743240|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19743241|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19743242|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
19743243|NCT04188860|Paclitaxel|paclitaxel|mesh-list
19743244|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19743245|NCT04188860|Antibodies|antibodies|mesh-list
19743246|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19743247|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743248|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
19743249|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
19743250|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
19743251|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743252|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
20292531|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292532|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476483|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19476484|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476485|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476486|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19476487|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
19476488|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476489|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476490|NCT03227562|Risperidone|risperidone|mesh-list
19476491|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19476492|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
19476493|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476494|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476495|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476496|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19476497|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19476498|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476499|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19476500|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19476501|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
19476502|NCT03227432|Dexamethasone|dexamethasone|mesh-list
19476503|NCT03227432|Nivolumab|nivolumab|mesh-list
19476504|NCT03227432|Pomalidomide|pomalidomide|mesh-list
19476505|NCT03227432|Elotuzumab|elotuzumab|mesh-list
19476506|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476507|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
19476508|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
19476509|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476510|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476511|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19476512|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
19476513|NCT03227432|Hormones|hormones|mesh-ancestor
19476514|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476515|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19476516|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476517|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476518|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19476519|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476520|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
19476521|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19476522|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19476523|NCT03227432|Growth Substances|growth substances|mesh-ancestor
19476524|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
19567903|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20020732|NCT02533427|Hormones|hormones|mesh-ancestor
19743253|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743254|NCT04188847|Apatinib|apatinib|mesh-list
19743255|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743256|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19743257|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743258|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743259|NCT04173949|Ramipril|ramipril|mesh-list
19743260|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20020733|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020734|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020735|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20020736|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
20020737|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20020738|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20020739|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20020740|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20020741|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20020742|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20020743|NCT02533453|Exenatide|exenatide|mesh-list
20020744|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020745|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020746|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20020747|NCT02533453|Incretins|incretins|mesh-ancestor
20020748|NCT02533453|Hormones|hormones|mesh-ancestor
20020749|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020750|NCT02533466|Listerine|listerine|mesh-list
20020751|NCT02533466|Fluorides|fluorides|mesh-list
20020752|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
19743261|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
19743262|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476525|NCT03227016|Topotecan|topotecan|mesh-list
19476526|NCT03227016|Veliparib|veliparib|mesh-list
19476527|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19476528|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19476529|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19476530|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476531|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476532|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476533|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
19476534|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476535|NCT03226821|Tesamorelin|tesamorelin|mesh-list
19476536|NCT03226821|Growth Substances|growth substances|mesh-ancestor
19476537|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476538|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19476539|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476540|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
19476541|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
19476542|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476543|NCT03226431|Protective Agents|protective agents|mesh-ancestor
20020753|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
20020754|NCT02533466|Protective Agents|protective agents|mesh-ancestor
20020755|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020756|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20020757|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476544|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476545|NCT03226431|Vitamins|vitamins|mesh-ancestor
19476546|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
19476547|NCT03226418|Cytarabine|cytarabine|mesh-list
20292533|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20292534|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
20292535|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292536|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292537|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19476548|NCT03226418|Azacitidine|azacitidine|mesh-list
19476549|NCT03226418|Decitabine|decitabine|mesh-list
19476550|NCT03226418|Daunorubicin|daunorubicin|mesh-list
19476551|NCT03226418|Venetoclax|venetoclax|mesh-list
19476552|NCT03226418|Idarubicin|idarubicin|mesh-list
19476553|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19476554|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
19476555|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476556|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476557|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
19476558|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476559|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19476560|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
19476561|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476562|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476563|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19476564|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19476565|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19476566|NCT03226522|Bupropion|bupropion|mesh-list
19476567|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19476568|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
19476569|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19476570|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19476571|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19476572|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476573|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476574|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
19476575|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476576|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476577|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19476578|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19476579|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476580|NCT03226340|Niacin|niacin|mesh-list
19476581|NCT03226340|Amlodipine|amlodipine|mesh-list
19476582|NCT03226340|Telmisartan|telmisartan|mesh-list
19476583|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
19476584|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19476585|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19476586|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476587|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476588|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19567904|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
19476589|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476590|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
19476591|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19476592|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19476593|NCT03226340|Diuretics|diuretics|mesh-ancestor
19476594|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
19476595|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19476596|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19476597|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
19476598|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19476599|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
19476600|NCT03226340|Vitamins|vitamins|mesh-ancestor
19476601|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
19476602|NCT03226210|Insulin|insulin|mesh-list
19476603|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
19476604|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19476605|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476606|NCT03225937|Trastuzumab|trastuzumab|mesh-list
19476607|NCT03225937|Pertuzumab|pertuzumab|mesh-list
19476608|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19476609|NCT03225937|Lapatinib|lapatinib|mesh-list
19476610|NCT03225937|Maytansine|maytansine|mesh-list
19476611|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476612|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476613|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19476614|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476615|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476616|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19476617|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
19476618|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20020758|NCT02533505|Budesonide|budesonide|mesh-list
20020759|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
20020760|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020761|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20020762|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
20020763|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020764|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476619|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
19476620|NCT03226080|Rocuronium|rocuronium|mesh-list
19476621|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19476622|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19476623|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19476624|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476625|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476626|NCT03225963|Temozolomide|temozolomide|mesh-list
19476627|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19476628|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
19476629|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476630|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476631|NCT03225924|Prednisone|prednisone|mesh-list
19476632|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
19476633|NCT03225924|Rituximab|rituximab|mesh-list
19476634|NCT03225924|Doxorubicin|doxorubicin|mesh-list
19476635|NCT03225924|Vincristine|vincristine|mesh-list
19476636|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19476637|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
19476638|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476639|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476640|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19476641|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
20020765|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20020766|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
20020767|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
19476642|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476643|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476644|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19476645|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476646|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19476647|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19476648|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19476649|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476650|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476651|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
19476652|NCT03225924|Hormones|hormones|mesh-ancestor
20020768|NCT02533505|Hormones|hormones|mesh-ancestor
20115361|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19567905|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19476653|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476654|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19476655|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19476656|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
20020769|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020770|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20020771|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20020772|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20020773|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
20020774|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020775|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020776|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20020777|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20020778|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020779|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020780|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
20020781|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020782|NCT02533674|Gemcitabine|gemcitabine|mesh-list
20020783|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19476657|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
19476658|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
19476659|NCT03226145|Scopolamine|scopolamine|mesh-list
19476660|NCT03226145|Bisacodyl|bisacodyl|mesh-list
19476661|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19476662|NCT03226145|Cathartics|cathartics|mesh-ancestor
19476663|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19476664|NCT03226145|Laxatives|laxatives|mesh-ancestor
19476665|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19476666|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
19476667|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
19476668|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476669|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020784|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
20020785|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020786|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020787|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
20020788|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020789|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020790|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020791|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
20020792|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020793|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20020794|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
20020795|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20020796|NCT02534129|Petrolatum|petrolatum|mesh-list
20020797|NCT02534129|Emollients|emollients|mesh-ancestor
20020798|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020799|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
20020800|NCT02534883|Misoprostol|misoprostol|mesh-list
20020801|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20020802|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
20020803|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20020804|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020805|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20020806|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20020807|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
20020808|NCT02534935|Vaccines|vaccines|mesh-list
20020809|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
20115362|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
19476670|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
19476671|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19476672|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
19476673|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476674|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476675|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19476676|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
19476677|NCT03225950|Antibodies|antibodies|mesh-list
19476678|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
19476679|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476680|NCT03225690|Morphine|morphine|mesh-list
19476681|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19476682|NCT03225690|Narcotics|narcotics|mesh-ancestor
19476683|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476684|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476685|NCT03225690|Analgesics|analgesics|mesh-ancestor
19476686|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
19476687|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476688|NCT03225755|Hormones|hormones|mesh-list
19476689|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476690|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476691|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
19476692|NCT03225664|Trametinib|trametinib|mesh-list
19476693|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476694|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476695|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19476696|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476697|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476698|NCT03225781|Bleomycin|bleomycin|mesh-list
19476699|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19476700|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476701|NCT03225456|Oxytocin|oxytocin|mesh-list
19476702|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
19476703|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19476704|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476705|NCT03225352|Aspirin|aspirin|mesh-list
19476706|NCT03225352|Ibuprofen|ibuprofen|mesh-list
19476707|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476708|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476709|NCT03225352|Analgesics|analgesics|mesh-ancestor
19476710|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
19476711|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476712|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476713|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476714|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476715|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20020810|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020811|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20020812|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20020813|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20020814|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020815|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020816|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020817|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020818|NCT02535000|Analgesics|analgesics|mesh-ancestor
20020819|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
20020820|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020821|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
20020822|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020823|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
20020824|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
20020825|NCT02535416|Promethazine|promethazine|mesh-list
20020826|NCT02535416|Cetirizine|cetirizine|mesh-list
20020827|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20020828|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20020829|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020830|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020831|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020832|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
20020833|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
20020834|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020835|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
20020836|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
20020837|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20020838|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20020839|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
20020840|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
20020841|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020842|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020843|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20020844|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
20020845|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020846|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20020847|NCT02535611|Memantine|memantine|mesh-list
20020848|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20020849|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20020850|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
20020851|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020852|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476716|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19567906|NCT04083183|Antibodies|antibodies|mesh-list
19476717|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476718|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19476719|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19476720|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476721|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
19476722|NCT03225326|Carticaine|carticaine|mesh-list
19476723|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
19476724|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
19476725|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476726|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476727|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
19476728|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567907|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
19567908|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19567909|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
19567910|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19567911|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19567912|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567913|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
19567914|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567915|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19567916|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19567917|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
19567918|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567919|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567920|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19567921|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19567922|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
19567923|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19567924|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19567925|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
19567926|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567927|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567928|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567929|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
19567930|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
19567931|NCT04079881|Insulin|insulin|mesh-list
19567932|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19567933|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19567934|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567935|NCT04075526|Vancomycin|vancomycin|mesh-list
19567936|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
19567937|NCT04075526|Povidone|povidone|mesh-list
19567938|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19567939|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567940|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
19567941|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
19567942|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19567943|NCT04071119|Oxytocin|oxytocin|mesh-list
19567944|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
19567945|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19567946|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567947|NCT04050280|Cytarabine|cytarabine|mesh-list
19567948|NCT04050280|Cladribine|cladribine|mesh-list
19567949|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
19567950|NCT04050280|Sargramostim|sargramostim|mesh-list
19567951|NCT04050280|Lenograstim|lenograstim|mesh-list
19567952|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19567953|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
19567954|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567955|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19567956|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
20020853|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020854|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19567957|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19567958|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19567959|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
19567960|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567961|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19567962|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19567963|NCT04032067|Finasteride|finasteride|mesh-list
19567964|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19749121|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
19567965|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19567966|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19567967|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476729|NCT03224923|Aspirin|aspirin|mesh-list
19476730|NCT03224923|Clopidogrel|clopidogrel|mesh-list
19476731|NCT03224923|Ticagrelor|ticagrelor|mesh-list
19476732|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476733|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476734|NCT03224923|Analgesics|analgesics|mesh-ancestor
19476735|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
19476736|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476737|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476738|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476739|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476740|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19476741|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20020855|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20020856|NCT02535715|Insulin|insulin|mesh-list
20020857|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20020858|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020859|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020860|NCT02535806|Cytarabine|cytarabine|mesh-list
20020861|NCT02535806|Dexamethasone|dexamethasone|mesh-list
20020862|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
20020863|NCT02535806|Methotrexate|methotrexate|mesh-list
20020864|NCT02535806|Vincristine|vincristine|mesh-list
20020865|NCT02535806|Bortezomib|bortezomib|mesh-list
20020866|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
20020867|NCT02535806|Pegaspargase|pegaspargase|mesh-list
20020868|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020869|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
20020870|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
20020871|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020872|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020873|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20020874|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
20020875|NCT02535806|Hormones|hormones|mesh-ancestor
20020876|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020877|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20020878|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020879|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20020880|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
20020881|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20020882|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576277|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576278|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
20576279|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
20576280|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576281|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576282|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
20020883|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
20020884|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020885|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
20020886|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020887|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20020888|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020889|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
20020890|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020891|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19476742|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476743|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19476744|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19476745|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476746|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
19476747|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19476748|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19476749|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19476750|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
19476751|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476752|NCT03224637|Acetaminophen|acetaminophen|mesh-list
19476753|NCT03224637|Ketorolac|ketorolac|mesh-list
19476754|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19476755|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476756|NCT03224637|Analgesics|analgesics|mesh-ancestor
19476757|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
19476758|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020892|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
19476759|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476760|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
20020893|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476761|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476762|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020894|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20020895|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
20020896|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
20020897|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
20020898|NCT02535806|Analgesics|analgesics|mesh-ancestor
20020899|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
20020900|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20020901|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20020902|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
20020903|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20020904|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20020905|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020906|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
20020907|NCT02535949|Coagulants|coagulants|mesh-ancestor
20020908|NCT02536040|Fluorides|fluorides|mesh-list
20020909|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
20020910|NCT02536040|Protective Agents|protective agents|mesh-ancestor
20020911|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020912|NCT02536105|Methylphenidate|methylphenidate|mesh-list
20020913|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20020914|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020915|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20020916|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20020917|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020918|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020919|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
20020920|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020921|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20020922|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20020923|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020924|NCT02536248|Incretins|incretins|mesh-ancestor
20020925|NCT02536248|Hormones|hormones|mesh-ancestor
20020926|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20020927|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20020928|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
20020929|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20020930|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020931|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
20020932|NCT02536313|Velpatasvir|velpatasvir|mesh-list
20020933|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
20020934|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115363|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
20115364|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115365|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115366|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20115367|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20115368|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20115369|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
20115370|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115371|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20115372|NCT00005571|Eculizumab|eculizumab|mesh-list
20115373|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20115374|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115375|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
20115376|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115377|NCT00005574|Gentamicins|gentamicins|mesh-list
20115378|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20115379|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115380|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20115381|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115382|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115383|NCT00005575|Imipramine|imipramine|mesh-list
20115384|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20115385|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
20115386|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20115387|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20115388|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20115389|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115390|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115391|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
20115392|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476763|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476764|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19476765|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476766|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476767|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
19476768|NCT03224572|Vitamins|vitamins|mesh-ancestor
19476769|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
19476770|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476771|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
19476772|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476773|NCT03224572|Protective Agents|protective agents|mesh-ancestor
19476774|NCT03224871|Aldesleukin|aldesleukin|mesh-list
19476775|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
19476776|NCT03224871|Nivolumab|nivolumab|mesh-list
19476777|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476778|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476779|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19476780|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476781|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19476782|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19476783|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
19476784|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476785|NCT03224208|Vemurafenib|vemurafenib|mesh-list
19476786|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476787|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19476788|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476789|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476790|NCT03224338|Dolutegravir|dolutegravir|mesh-list
19476791|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19476792|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19476793|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476794|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476795|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19476796|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19476797|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
19476798|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476799|NCT03224377|Antibodies|antibodies|mesh-list
19476800|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
19476801|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
19476802|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476803|NCT03224221|Fluorouracil|fluorouracil|mesh-list
19476804|NCT03224221|Apatinib|apatinib|mesh-list
19476805|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
19476806|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020935|NCT02536664|Rituximab|rituximab|mesh-list
20020936|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020937|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020938|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
20020939|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020940|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20020941|NCT02536833|Lorecivivint|lorecivivint|mesh-list
20020942|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20020943|NCT02536846|Olanzapine|olanzapine|mesh-list
20020944|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
20020945|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
20020946|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020947|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020948|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20020949|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20020950|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20020951|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020952|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20020953|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20020954|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20020955|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020956|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020957|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020958|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
20020959|NCT02536976|Mirabegron|mirabegron|mesh-list
20020960|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20020961|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20020962|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20020963|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
19476807|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19476808|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476809|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20020964|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20020965|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020966|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020967|NCT02536976|Urological Agents|urological agents|mesh-ancestor
20020968|NCT02537015|Bimatoprost|bimatoprost|mesh-list
20020969|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20020970|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
20020971|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
20020972|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20020973|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20020974|NCT02537873|Cocaine|cocaine|mesh-list
20020975|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020976|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
20020977|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020978|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020979|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
20020980|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020981|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20020982|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20020983|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20020984|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20020985|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20020986|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
20020987|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476810|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
19476811|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476812|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19476813|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476814|NCT03224039|Sufentanil|sufentanil|mesh-list
19476815|NCT03224039|Morphine|morphine|mesh-list
19476816|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19476817|NCT03224039|Narcotics|narcotics|mesh-ancestor
19476818|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476819|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476820|NCT03224039|Analgesics|analgesics|mesh-ancestor
19476821|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
19476822|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476823|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19476824|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19476825|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
20576283|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576284|NCT02070458|Analgesics|analgesics|mesh-ancestor
20576285|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
20576286|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576287|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
20576288|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
19476826|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
19476827|NCT03224416|Ethanol|ethanol|mesh-list
19476828|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19476829|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476830|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476831|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476832|NCT03223779|Trifluridine|trifluridine|mesh-list
19476833|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
19476834|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476835|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
19476836|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749122|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20020988|NCT02537951|Lidocaine|lidocaine|mesh-list
20576289|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576290|NCT02070510|Lisinopril|lisinopril|mesh-list
20576291|NCT02070510|Warfarin|warfarin|mesh-list
20576292|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
20576293|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20576294|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
20576295|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576296|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576297|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20576298|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19476837|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
19567968|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
19567969|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19567970|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567971|NCT04032067|Urological Agents|urological agents|mesh-ancestor
19567972|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
19476838|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19476839|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476840|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19476841|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19476842|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19476843|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476844|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
19476845|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476846|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
19476847|NCT03223961|Hematinics|hematinics|mesh-ancestor
19476848|NCT03223506|Acetaminophen|acetaminophen|mesh-list
19476849|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476850|NCT03223506|Analgesics|analgesics|mesh-ancestor
19476851|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
19476852|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576299|NCT02070510|Protective Agents|protective agents|mesh-ancestor
20576300|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576301|NCT02070653|Ticagrelor|ticagrelor|mesh-list
20576302|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20576303|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20576304|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19476853|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476854|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
19476855|NCT03223896|Naloxone|naloxone|mesh-list
19476856|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20020989|NCT02537951|Prilocaine|prilocaine|mesh-list
20020990|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20020991|NCT02537951|Capsaicin|capsaicin|mesh-list
20020992|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
20020993|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
20020994|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20020995|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20020996|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
20020997|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20020998|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20020999|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20021000|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20021001|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20021002|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021003|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
20021004|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
19476857|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476858|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
19476859|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476860|NCT03223519|Ascorbic Acid|ascorbic acid|mesh-list
19476861|NCT03223519|Ibuprofen|ibuprofen|mesh-list
19476862|NCT03223519|Vitamins|vitamins|mesh-ancestor
19476863|NCT03223519|Micronutrients|micronutrients|mesh-ancestor
19476864|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476865|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476866|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476867|NCT03223519|Analgesics|analgesics|mesh-ancestor
19476868|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
19476869|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476870|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476871|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476872|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19476873|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476874|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476875|NCT03223519|Antioxidants|antioxidants|mesh-ancestor
19476876|NCT03223519|Protective Agents|protective agents|mesh-ancestor
19476877|NCT03223402|Lamivudine|lamivudine|mesh-list
20021005|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20576305|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20576306|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
20576307|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576308|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576309|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576310|NCT02070679|Vitamin E|vitamin e|mesh-list
20576311|NCT02070679|Tocopherols|tocopherols|mesh-list
20576312|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
20576313|NCT02070679|Vitamins|vitamins|mesh-ancestor
20576314|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
20576315|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476878|NCT03223402|Nevirapine|nevirapine|mesh-list
19476879|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19476880|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19476881|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476882|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476883|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
19476884|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476885|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19476886|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19476887|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19476888|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19476889|NCT03223220|Midazolam|midazolam|mesh-list
19476890|NCT03223220|Ketamine|ketamine|mesh-list
19476891|NCT03223220|Analgesics|analgesics|mesh-ancestor
19476892|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
19476893|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476894|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476895|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19476896|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19476897|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
19476898|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
19476899|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476900|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19476901|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19476902|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19476903|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476904|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19476905|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19476906|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19476907|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19476908|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19476909|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
19476910|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
19476911|NCT03223376|Paclitaxel|paclitaxel|mesh-list
19476912|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19476913|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19476914|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476915|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
19476916|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
19476917|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
19476918|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567973|NCT04005599|Remifentanil|remifentanil|mesh-list
19567974|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19567975|NCT04005599|Narcotics|narcotics|mesh-ancestor
19567976|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19567977|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567978|NCT04005599|Analgesics|analgesics|mesh-ancestor
19567979|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
19567980|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567981|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
19567982|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19567983|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
19567984|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19567985|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567986|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567987|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19567988|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
19567989|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19567990|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19567991|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19567992|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19567993|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19567994|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19567995|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19567996|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19567997|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
19567998|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19567999|NCT03988257|Ascorbic Acid|ascorbic acid|mesh-list
19568000|NCT03988257|Vitamins|vitamins|mesh-ancestor
19568001|NCT03988257|Micronutrients|micronutrients|mesh-ancestor
19568002|NCT03988257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568003|NCT03988257|Antioxidants|antioxidants|mesh-ancestor
19568004|NCT03988257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568005|NCT03988257|Protective Agents|protective agents|mesh-ancestor
19476919|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19476920|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19476921|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476922|NCT03223103|Poly ICLC|poly iclc|mesh-list
19476923|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
19476924|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
19476925|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476926|NCT03223025|Hormones|hormones|mesh-list
19476927|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476928|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476929|NCT03222960|Propolis|propolis|mesh-list
19476930|NCT03222960|Fluorides|fluorides|mesh-list
19476931|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
19476932|NCT03222960|Protective Agents|protective agents|mesh-ancestor
20021006|NCT02538016|Tolvaptan|tolvaptan|mesh-list
20021007|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20021008|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021009|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
20021010|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021011|NCT02538042|Nicotine|nicotine|mesh-list
20021012|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20021013|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
20021014|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476933|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476934|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19476935|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
19476936|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476937|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476938|NCT03222544|Methylene Blue|methylene blue|mesh-list
19476939|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476940|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476941|NCT03222765|Metformin|metformin|mesh-list
19476942|NCT03222765|Linagliptin|linagliptin|mesh-list
19476943|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19476944|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476945|NCT03222765|Incretins|incretins|mesh-ancestor
19476946|NCT03222765|Hormones|hormones|mesh-ancestor
19476947|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476948|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19476949|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
19476950|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476951|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476952|NCT03222687|Prednisone|prednisone|mesh-list
20021015|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021016|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20021017|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20021018|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
20021019|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021020|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021021|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
20021022|NCT02538107|Hematinics|hematinics|mesh-ancestor
20021023|NCT02538354|Riboflavin|riboflavin|mesh-list
20021024|NCT02538354|Vitamins|vitamins|mesh-ancestor
20021025|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
20021026|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021027|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
20021028|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20021029|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
20021030|NCT02538614|Idelalisib|idelalisib|mesh-list
19476953|NCT03222687|Tacrolimus|tacrolimus|mesh-list
19476954|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476955|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
19476956|NCT03222687|Hormones|hormones|mesh-ancestor
19476957|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19476958|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476959|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19476960|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476961|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19476962|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
19476963|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19476964|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476965|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476966|NCT03222518|Acetaminophen|acetaminophen|mesh-list
19476967|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19476968|NCT03222518|Piroxicam|piroxicam|mesh-list
20021031|NCT02538614|BI 836826|bi 836826|mesh-list
19476969|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476970|NCT03222518|Analgesics|analgesics|mesh-ancestor
19476971|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
19476972|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476973|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476974|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
19476975|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476976|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476977|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19476978|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19476979|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476980|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19476981|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476982|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19476983|NCT03222206|Analgesics|analgesics|mesh-ancestor
19476984|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
19476985|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19476986|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19476987|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19476988|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19476989|NCT03222076|Nivolumab|nivolumab|mesh-list
19476990|NCT03222076|Ipilimumab|ipilimumab|mesh-list
19476991|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19476992|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19476993|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19476994|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19476995|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
20021032|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021033|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021034|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021035|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20021036|NCT02538679|Epinephrine|epinephrine|mesh-list
20021037|NCT02538679|Racepinephrine|racepinephrine|mesh-list
20021038|NCT02538679|Bupivacaine|bupivacaine|mesh-list
20021039|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
20021040|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
20021041|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
20021042|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021043|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021044|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
20021045|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021046|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20021047|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20021048|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
20021049|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021050|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021051|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20021052|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20021053|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
20021054|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20021055|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
20021056|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
20292538|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292539|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292540|NCT05207722|Analgesics|analgesics|mesh-ancestor
20292541|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
20292542|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292543|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20292544|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20292545|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
20292546|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292547|NCT05206110|Ketorolac|ketorolac|mesh-list
20292548|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19476996|NCT03222323|Ropivacaine|ropivacaine|mesh-list
19476997|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20021057|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
20292549|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19476998|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19476999|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477000|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477001|NCT03222323|Analgesics|analgesics|mesh-ancestor
19477002|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
19477003|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477004|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19477005|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20021058|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20021059|NCT02538965|Lenalidomide|lenalidomide|mesh-list
20021060|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
19477006|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19477007|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477008|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477009|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477010|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
19477011|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
19477012|NCT03222089|Leucovorin|leucovorin|mesh-list
19477013|NCT03222089|Fluorouracil|fluorouracil|mesh-list
19477014|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
19477015|NCT03222089|Irinotecan|irinotecan|mesh-list
19477016|NCT03222089|Interleukin-2|interleukin-2|mesh-list
19477017|NCT03222089|Molgramostim|molgramostim|mesh-list
19477018|NCT03222089|Sargramostim|sargramostim|mesh-list
19477019|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
19477020|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
19477021|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477022|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19477023|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477024|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477025|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
19477026|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477027|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19477028|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19477029|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477030|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477031|NCT03222089|Analgesics|analgesics|mesh-ancestor
19477032|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
19477033|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477034|NCT03222089|Antidotes|antidotes|mesh-ancestor
19477035|NCT03222089|Protective Agents|protective agents|mesh-ancestor
20021061|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021062|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19477036|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
19477037|NCT03222089|Vitamins|vitamins|mesh-ancestor
19477038|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
19477039|NCT03222310|Itraconazole|itraconazole|mesh-list
19477040|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
19477041|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477042|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19477043|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19477044|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477045|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477046|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19477047|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
19477048|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477049|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477050|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19477051|NCT03222167|Grazoprevir|grazoprevir|mesh-list
19477052|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
19477053|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477054|NCT03221816|Folic Acid|folic acid|mesh-list
19477055|NCT03221816|Pyridoxine|pyridoxine|mesh-list
19477056|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
19477057|NCT03221816|Hematinics|hematinics|mesh-ancestor
19477058|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
20021063|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20021064|NCT02538965|Growth Substances|growth substances|mesh-ancestor
20021065|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
20021066|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021067|NCT02539108|Vaccines|vaccines|mesh-list
20021068|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
20021069|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021070|NCT02539342|Calcium|calcium|mesh-list
20021071|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19477059|NCT03221816|Vitamins|vitamins|mesh-ancestor
19477060|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
19477061|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477062|NCT03221855|Domperidone|domperidone|mesh-list
19477063|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
19477064|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
19477065|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477066|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477067|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477068|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19477069|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
19477070|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477071|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477072|NCT03221907|Pregabalin|pregabalin|mesh-list
19477073|NCT03221907|Analgesics|analgesics|mesh-ancestor
19477074|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
19477075|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477076|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477077|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
19477078|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19477079|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477080|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477081|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19477082|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19477083|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477084|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477085|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19477086|NCT03221881|Docetaxel|docetaxel|mesh-list
19477087|NCT03221881|Doxorubicin|doxorubicin|mesh-list
19477088|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19477089|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477090|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
19477091|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19477092|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
19477093|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477094|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19477095|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19477096|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19477097|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477098|NCT03221946|Diclofenac|diclofenac|mesh-list
19477099|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19477100|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477101|NCT03221946|Analgesics|analgesics|mesh-ancestor
19477102|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
19477103|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477104|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477105|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477106|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477107|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19477108|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477109|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477110|NCT03221998|Acetaminophen|acetaminophen|mesh-list
19477111|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477112|NCT03221998|Analgesics|analgesics|mesh-ancestor
19477113|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
19477114|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477115|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477116|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
19477117|NCT03221569|Ketorolac|ketorolac|mesh-list
19477118|NCT03221569|Ketamine|ketamine|mesh-list
19477119|NCT03221569|Analgesics|analgesics|mesh-ancestor
19477120|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
19477121|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477122|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477123|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19477124|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19477125|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
19477126|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
19477127|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477128|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19477129|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19477130|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477131|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477132|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19477133|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477134|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477135|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477136|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19477137|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477138|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
19477139|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19477140|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19477141|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477142|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477143|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477144|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477145|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
19477146|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
19477147|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477148|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
19477149|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19477150|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
19477151|NCT03221426|Leucovorin|leucovorin|mesh-list
19477152|NCT03221426|Docetaxel|docetaxel|mesh-list
19477153|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
19477154|NCT03221426|Fluorouracil|fluorouracil|mesh-list
19477155|NCT03221426|Capecitabine|capecitabine|mesh-list
19477156|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
19477157|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477158|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
19477159|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
19477160|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
19477161|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477162|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477163|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
19477164|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19477165|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477166|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
19477167|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477168|NCT03221426|Antidotes|antidotes|mesh-ancestor
19477169|NCT03221426|Protective Agents|protective agents|mesh-ancestor
19477170|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
19477171|NCT03221426|Vitamins|vitamins|mesh-ancestor
19477172|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
19568006|NCT03978598|Etonogestrel|etonogestrel|mesh-list
19568007|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19568008|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
19568009|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568010|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568011|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19568012|NCT03950674|Folic Acid|folic acid|mesh-list
19568013|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
19568014|NCT03950674|Hydroxocobalamin|hydroxocobalamin|mesh-list
19568015|NCT03950674|Dexamethasone|dexamethasone|mesh-list
19568016|NCT03950674|Carboplatin|carboplatin|mesh-list
20021072|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021073|NCT02539368|Infliximab|infliximab|mesh-list
20021074|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
20021075|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19568017|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
19568018|NCT03950674|Pemetrexed|pemetrexed|mesh-list
19568019|NCT03950674|Vitamins|vitamins|mesh-ancestor
19568020|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
19568021|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568022|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568023|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568024|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
19568025|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
19568026|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568027|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19568028|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
19568029|NCT03950674|Hormones|hormones|mesh-ancestor
19568030|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743263|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743264|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19743265|NCT04170556|Nivolumab|nivolumab|mesh-list
19568031|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568032|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19568033|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749123|NCT05274269|Ivacaftor|ivacaftor|mesh-list
20021076|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477173|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19477174|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
19477175|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477176|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
19477177|NCT03221634|Daratumumab|daratumumab|mesh-list
19477178|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477179|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477180|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
19477181|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19477182|NCT03221166|Thalidomide|thalidomide|mesh-list
19477183|NCT03221166|Infliximab|infliximab|mesh-list
19477184|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
19477185|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477186|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477187|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477188|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
19477189|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477190|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
19477191|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19477192|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477193|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20021077|NCT02539459|Everolimus|everolimus|mesh-list
20021078|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021079|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021080|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
20021081|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021082|NCT02539511|Ketamine|ketamine|mesh-list
20021083|NCT02539511|Analgesics|analgesics|mesh-ancestor
20021084|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
20021085|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021086|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021087|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20021088|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20021089|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
20021090|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
20021091|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021092|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20021093|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20021094|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021095|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021096|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20021097|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
20021098|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021099|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
20021100|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20021101|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20021102|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021103|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
20021104|NCT02540226|Coagulants|coagulants|mesh-ancestor
20021105|NCT02540265|Meloxicam|meloxicam|mesh-list
20021106|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20021107|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021108|NCT02540265|Analgesics|analgesics|mesh-ancestor
20021109|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
20021110|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021111|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021112|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021113|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021114|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20021115|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20021116|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021117|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021118|NCT02540356|Antibodies|antibodies|mesh-list
20021119|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
20021120|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
20021121|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021122|NCT02540668|Warfarin|warfarin|mesh-list
20021123|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
20021124|NCT02540954|Aflibercept|aflibercept|mesh-list
20021125|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20576316|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
19477194|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19477195|NCT03221166|Growth Substances|growth substances|mesh-ancestor
19477196|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
20021126|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20021127|NCT02540954|Growth Substances|growth substances|mesh-ancestor
19477197|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477198|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
19477199|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19477200|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
19477201|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477202|NCT03221231|Expectorants|expectorants|mesh-ancestor
19477203|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
19477204|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19477205|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
19477206|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477207|NCT03221231|Protective Agents|protective agents|mesh-ancestor
19477208|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477209|NCT03221231|Antidotes|antidotes|mesh-ancestor
19477210|NCT03221621|Adalimumab|adalimumab|mesh-list
19477211|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477212|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477213|NCT03221023|Vancomycin|vancomycin|mesh-list
19477214|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19477215|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477216|NCT03220932|Bevacizumab|bevacizumab|mesh-list
19477217|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477218|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477219|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19477220|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19477221|NCT03220932|Growth Substances|growth substances|mesh-ancestor
19477222|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477223|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
19477224|NCT03220815|Methamphetamine|methamphetamine|mesh-list
19477225|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19477226|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477227|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
19477228|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
19477229|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477230|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
19477231|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477232|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477233|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477234|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19477235|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19477236|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477237|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19477238|NCT03220841|Adalimumab|adalimumab|mesh-list
19477239|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477240|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477241|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
19477242|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19477243|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021128|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021129|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
20021130|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021131|NCT02541409|Interferons|interferons|mesh-list
20021132|NCT02541409|Ribavirin|ribavirin|mesh-list
19477244|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477245|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477246|NCT03220880|Analgesics|analgesics|mesh-ancestor
19477247|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
19477248|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477249|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19477250|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19477251|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19477252|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477253|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477254|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477255|NCT03220867|Risperidone|risperidone|mesh-list
19477256|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19477257|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
19477258|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477259|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477260|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477261|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19477262|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477263|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477264|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20021133|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
20021134|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
19477265|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19477266|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
19477267|NCT03220789|Methamphetamine|methamphetamine|mesh-list
19477268|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19477269|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477270|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
19477271|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
19477272|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477273|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
19477274|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477275|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477276|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477277|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19477278|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19477279|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477280|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19477281|NCT03220555|Lidocaine|lidocaine|mesh-list
19477282|NCT03220555|Prilocaine|prilocaine|mesh-list
19477283|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
19477284|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
19477285|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477286|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477287|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
19477288|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477289|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19477290|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19477291|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19477292|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477293|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477294|NCT03220256|Lamotrigine|lamotrigine|mesh-list
19477295|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
19477296|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19477297|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477298|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477299|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19477300|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477301|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19477302|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477303|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477304|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19477305|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19477306|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
19477307|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
20021135|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20021136|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
20021137|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021138|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
20021139|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021140|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
19477308|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19477309|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477310|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477311|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
19477312|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477313|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477314|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477315|NCT03220425|Insulin|insulin|mesh-list
19477316|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19477317|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
19477318|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
19477319|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
19477320|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
19477321|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19477322|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477323|NCT03220542|Amoxicillin|amoxicillin|mesh-list
20608158|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477324|NCT03220542|Clarithromycin|clarithromycin|mesh-list
19477325|NCT03220542|Sulforaphane|sulforaphane|mesh-list
20021141|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608159|NCT02244762|Hydrocodone|hydrocodone|mesh-list
20608160|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20608161|NCT02244762|Narcotics|narcotics|mesh-ancestor
20608162|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477326|NCT03220542|Esomeprazole|esomeprazole|mesh-list
19477327|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19477328|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477329|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19477330|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477331|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19477332|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477333|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477334|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19477335|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19477336|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19477337|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19477338|NCT03220542|Protective Agents|protective agents|mesh-ancestor
19477339|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477340|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477341|NCT03220490|Timolol|timolol|mesh-list
19477342|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19477343|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19477344|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19477345|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477346|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477347|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477348|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477349|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19477350|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19477351|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19477352|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19477353|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19477354|NCT03220152|Tenofovir|tenofovir|mesh-list
19477355|NCT03220152|Emtricitabine|emtricitabine|mesh-list
19477356|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
19477357|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477358|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19477359|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19477360|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477361|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477362|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19477363|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19477364|NCT03220464|Interferons|interferons|mesh-list
19477365|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
19477366|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477367|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
19477368|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477369|NCT03220126|Mirikizumab|mirikizumab|mesh-list
19477370|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19477371|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477372|NCT03220126|Analgesics|analgesics|mesh-ancestor
19477373|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
19477374|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477375|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477376|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477377|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477378|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19477379|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477380|NCT03220191|Palbociclib|palbociclib|mesh-list
19477381|NCT03220191|Rabeprazole|rabeprazole|mesh-list
19477382|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477383|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19477384|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477385|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477386|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19477387|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477388|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19477389|NCT03220113|Thiamine|thiamine|mesh-list
19477390|NCT03220113|Dexamethasone|dexamethasone|mesh-list
19477391|NCT03220113|Lidocaine|lidocaine|mesh-list
19477392|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477393|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
19477394|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
19477395|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477396|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477397|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477398|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
19477399|NCT03220113|Hormones|hormones|mesh-ancestor
19477400|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477401|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19477402|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477403|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
19477404|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
19477405|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477406|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
19477407|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19477408|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19477409|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20021142|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
20021143|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021144|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
20021145|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20021146|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
20292550|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292551|NCT05206110|Analgesics|analgesics|mesh-ancestor
20292552|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
20292553|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292554|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292555|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292556|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292557|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20292558|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021147|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021148|NCT02541422|Expectorants|expectorants|mesh-ancestor
20021149|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
20021150|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20021151|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
20021152|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021153|NCT02541422|Protective Agents|protective agents|mesh-ancestor
20021154|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021155|NCT02541422|Antidotes|antidotes|mesh-ancestor
20021156|NCT02541565|Prednisone|prednisone|mesh-list
20021157|NCT02541565|Cortisone|cortisone|mesh-list
20021158|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
20021159|NCT02541565|Rituximab|rituximab|mesh-list
20021160|NCT02541565|Doxorubicin|doxorubicin|mesh-list
20021161|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20021162|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
20021163|NCT02541565|Vincristine|vincristine|mesh-list
20021164|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20021165|NCT02541565|Antibodies|antibodies|mesh-list
20021166|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
20021167|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20021168|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021169|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
20021170|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021171|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021172|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20021173|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
20021174|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021175|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021176|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20021177|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20021178|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20021179|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20021180|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021181|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021182|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
20021183|NCT02541565|Hormones|hormones|mesh-ancestor
20021184|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021185|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20021186|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20021187|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
20021188|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
20021189|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
20021190|NCT02541604|Atezolizumab|atezolizumab|mesh-list
20021191|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021192|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20021193|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20021194|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20021195|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021196|NCT02541864|Amoxicillin|amoxicillin|mesh-list
20021197|NCT02541864|Metronidazole|metronidazole|mesh-list
19477410|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477411|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477412|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
19477413|NCT03220113|Vitamins|vitamins|mesh-ancestor
19477414|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
19477415|NCT03219788|Remifentanil|remifentanil|mesh-list
19477416|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20021198|NCT02541864|Clarithromycin|clarithromycin|mesh-list
20021199|NCT02541864|Tetracycline|tetracycline|mesh-list
20021200|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20021201|NCT02541864|Pantoprazole|pantoprazole|mesh-list
20021202|NCT02541864|Bismuth|bismuth|mesh-list
19477417|NCT03219788|Narcotics|narcotics|mesh-ancestor
20021203|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20021204|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576317|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576318|NCT02070679|Protective Agents|protective agents|mesh-ancestor
20576319|NCT02070718|Pentazocine|pentazocine|mesh-list
20576320|NCT02070718|Naloxone|naloxone|mesh-list
20576321|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20576322|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576323|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
20576324|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576325|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20576326|NCT02070718|Narcotics|narcotics|mesh-ancestor
20021205|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20021206|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20021207|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20021208|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021209|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021210|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20021211|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20576327|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576328|NCT02070718|Analgesics|analgesics|mesh-ancestor
20021212|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20021213|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021214|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20021215|NCT02541864|Antacids|antacids|mesh-ancestor
20021216|NCT02541903|Afatinib|afatinib|mesh-list
20021217|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021218|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20021219|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576329|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19477418|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576330|NCT02070796|Rotigotine|rotigotine|mesh-list
20021220|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021221|NCT02542150|Ethanol|ethanol|mesh-list
20021222|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20021223|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021224|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021225|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021226|NCT02542410|Cabergoline|cabergoline|mesh-list
20021227|NCT02542410|Norethindrone|norethindrone|mesh-list
20021228|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
20021229|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20021230|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20021231|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20021232|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
20021233|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20021234|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021235|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20021236|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20021237|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20021238|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20021239|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
20021240|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
20021241|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021242|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021243|NCT02542462|Vaccines|vaccines|mesh-list
20021244|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
20021245|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021246|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
20021247|NCT02542605|Erenumab|erenumab|mesh-list
20021248|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20021249|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021250|NCT02542605|Analgesics|analgesics|mesh-ancestor
20021251|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
20021252|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021253|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021254|NCT02542605|Growth Substances|growth substances|mesh-ancestor
20021255|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
20021256|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021257|NCT02542631|Insulin|insulin|mesh-list
20021258|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20021259|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20021260|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021261|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
20021262|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20021263|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021264|NCT02542943|Fluorides|fluorides|mesh-list
20021265|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
20021266|NCT02542943|Protective Agents|protective agents|mesh-ancestor
20021267|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021268|NCT02543346|Cetirizine|cetirizine|mesh-list
20021269|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20021270|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20021271|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20021272|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
20021273|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
20021274|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021275|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021276|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021277|NCT02543658|Neostigmine|neostigmine|mesh-list
19577579|NCT04174196|Growth Substances|growth substances|mesh-ancestor
20021278|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20021279|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021280|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021281|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
20021282|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021283|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021284|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20021285|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
20021286|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021287|NCT02543801|Ketorolac|ketorolac|mesh-list
20021288|NCT02543801|Clonidine|clonidine|mesh-list
20021289|NCT02543801|Epinephrine|epinephrine|mesh-list
20021290|NCT02543801|Bupivacaine|bupivacaine|mesh-list
20021291|NCT02543801|Ropivacaine|ropivacaine|mesh-list
20021292|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
20021293|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
20021294|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021295|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021296|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
20021297|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021298|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20021299|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20021300|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
20021301|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477419|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477420|NCT03219788|Analgesics|analgesics|mesh-ancestor
19477421|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
19477422|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477423|NCT03219853|Selenium|selenium|mesh-list
19477424|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
19477425|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477426|NCT03219853|Protective Agents|protective agents|mesh-ancestor
19477427|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477428|NCT03219853|Trace Elements|trace elements|mesh-ancestor
19477429|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
19477430|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19477431|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477432|NCT03219970|Osimertinib|osimertinib|mesh-list
19477433|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477434|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20021302|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021303|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20021304|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20021305|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
19477435|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477436|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477437|NCT03220009|Nivolumab|nivolumab|mesh-list
19477438|NCT03220009|Ipilimumab|ipilimumab|mesh-list
19477439|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477440|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477441|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19477442|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477443|NCT03219983|Bupivacaine|bupivacaine|mesh-list
19477444|NCT03219983|Ropivacaine|ropivacaine|mesh-list
19477445|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
19477446|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
19477447|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477448|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477449|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
19477450|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568034|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568035|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19568036|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19568037|NCT03950674|Hematinics|hematinics|mesh-ancestor
19568038|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
20021306|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20021307|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
19477451|NCT03219710|Dexamethasone|dexamethasone|mesh-list
19477452|NCT03219710|Ondansetron|ondansetron|mesh-list
19477453|NCT03219710|Olanzapine|olanzapine|mesh-list
19743266|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743267|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743268|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743269|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743270|NCT04166487|Paclitaxel|paclitaxel|mesh-list
19743271|NCT04166487|Carboplatin|carboplatin|mesh-list
19743272|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
19743273|NCT04166487|Pemetrexed|pemetrexed|mesh-list
19743274|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19743275|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743276|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
19743277|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
19743278|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
19743279|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743280|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743281|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743282|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19743283|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19743284|NCT04161066|Psilocybin|psilocybin|mesh-list
20021308|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
20021309|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
20021310|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20021311|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20021312|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021313|NCT02543801|Analgesics|analgesics|mesh-ancestor
20021314|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021315|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021316|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19477454|NCT03219710|Aprepitant|aprepitant|mesh-list
19477455|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477456|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
19477457|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
19477458|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477459|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477460|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477461|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
19477462|NCT03219710|Hormones|hormones|mesh-ancestor
19477463|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477464|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568039|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19568040|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19568041|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568042|NCT03931408|Gentamicins|gentamicins|mesh-list
19568043|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568044|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568045|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19568046|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568047|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568048|NCT03927274|Topotecan|topotecan|mesh-list
19568049|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19568050|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19568051|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568052|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568053|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568054|NCT03922945|Topiramate|topiramate|mesh-list
19568055|NCT03922945|Phentermine|phentermine|mesh-list
19568056|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
19568057|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19568058|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568059|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19568060|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
19568061|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19568062|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
19568063|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
19568064|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568065|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477465|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477466|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
19477467|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
19477468|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19477469|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
19477470|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477471|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477472|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19477473|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477474|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477475|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19477476|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19477477|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19477478|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19477479|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477480|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19477481|NCT03219554|Palbociclib|palbociclib|mesh-list
19477482|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477483|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19477484|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477485|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477486|NCT03219593|Apatinib|apatinib|mesh-list
19477487|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477488|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19477489|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477490|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477491|NCT03219580|Fluorouracil|fluorouracil|mesh-list
19477492|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
19477493|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477494|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19477495|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477496|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477497|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
19477498|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477499|NCT03219476|Tamoxifen|tamoxifen|mesh-list
19477500|NCT03219476|Letrozole|letrozole|mesh-list
19477501|NCT03219476|Anastrozole|anastrozole|mesh-list
19477502|NCT03219476|Exemestane|exemestane|mesh-list
19477503|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477504|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19477505|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19477506|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477507|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477508|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19477509|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
19477510|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477511|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477512|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19477513|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19477514|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19477515|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19477516|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
19477517|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
19477518|NCT03219359|Vedolizumab|vedolizumab|mesh-list
19477519|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
19477520|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477521|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
19477522|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477523|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477524|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19477525|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
19477526|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477527|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477528|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19477529|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477530|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
19477531|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
19477532|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477533|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477534|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
19477535|NCT03219359|Hormones|hormones|mesh-ancestor
19477536|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477537|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19477538|NCT03219359|Protective Agents|protective agents|mesh-ancestor
19477539|NCT03219671|Nivolumab|nivolumab|mesh-list
19477540|NCT03219671|Ipilimumab|ipilimumab|mesh-list
19477541|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477542|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477543|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19477544|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477545|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
19477546|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
19477547|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477548|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
19477549|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477550|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477551|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19477552|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
19477553|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477554|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477555|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19477556|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477557|NCT03219645|Aspirin|aspirin|mesh-list
19477558|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19477559|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477560|NCT03219645|Analgesics|analgesics|mesh-ancestor
20021317|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021318|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19477561|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
19477562|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477563|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477564|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477565|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477566|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19477567|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19477568|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477569|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19477570|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19477571|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477572|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
19477573|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
19477574|NCT03219177|Narcotics|narcotics|mesh-ancestor
19477575|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477576|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477577|NCT03219177|Analgesics|analgesics|mesh-ancestor
19477578|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
19477579|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477580|NCT03218969|Ecopipam|ecopipam|mesh-list
19477581|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19477582|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477583|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477584|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477585|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19477586|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19477587|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
19477588|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477589|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477590|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
19477591|NCT03219008|Mirtazapine|mirtazapine|mesh-list
19477592|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
19477593|NCT03219008|Fluoxetine|fluoxetine|mesh-list
19477594|NCT03219008|Bupropion|bupropion|mesh-list
19477595|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
19477596|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19477597|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19477598|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477599|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477600|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477601|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
19477602|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477603|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19477604|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
19477605|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19477606|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19577580|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
20021319|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
20576331|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
19477607|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19477608|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477609|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
19477610|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477611|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477612|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19477613|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
19477614|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
19477615|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19477616|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19477617|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20292559|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292560|NCT05200988|Nivolumab|nivolumab|mesh-list
19477618|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19477619|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477620|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19477621|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19477622|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19477623|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19477624|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19477625|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19477626|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
19477627|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19477628|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19477629|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477630|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
19477631|NCT03219086|Bupivacaine|bupivacaine|mesh-list
19477632|NCT03219086|Prilocaine|prilocaine|mesh-list
19477633|NCT03219086|Anesthetics|anesthetics|mesh-list
19477634|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
19477635|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477636|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477637|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
19477638|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477639|NCT03218631|Oxandrolone|oxandrolone|mesh-list
19477640|NCT03218631|Androgens|androgens|mesh-ancestor
19477641|NCT03218631|Hormones|hormones|mesh-ancestor
19477642|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477643|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477644|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
20021320|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20021321|NCT02543918|Ixekizumab|ixekizumab|mesh-list
20021322|NCT02543918|Vaccines|vaccines|mesh-list
20021323|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20021324|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
20021325|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021326|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
20021327|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
20021328|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20021329|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
20021330|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021331|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021332|NCT02544152|Lubiprostone|lubiprostone|mesh-list
20021333|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20021334|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20021335|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021336|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
20021337|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
20021338|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021339|NCT02544217|Protective Agents|protective agents|mesh-ancestor
20021340|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477645|NCT03218709|Vitamins|vitamins|mesh-list
19743285|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
19743286|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743287|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19743288|NCT04155411|Dasatinib|dasatinib|mesh-list
19743289|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743290|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19743291|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743292|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743293|NCT04152473|Proglumide|proglumide|mesh-list
19743294|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19743295|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743296|NCT04143061|Vaccines|vaccines|mesh-list
19477646|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
19477647|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477648|NCT03218657|Cyclosporine|cyclosporine|mesh-list
19477649|NCT03218657|Levamisole|levamisole|mesh-list
19477650|NCT03218657|Cyclosporins|cyclosporins|mesh-list
19477651|NCT03218657|Androgens|androgens|mesh-list
19477652|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477653|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477654|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477655|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
19477656|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477657|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
19477658|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477659|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
19477660|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477661|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19477662|NCT03218657|Hormones|hormones|mesh-ancestor
19477663|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477664|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19477665|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
19477666|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
19477667|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19477668|NCT03218553|Dexamethasone|dexamethasone|mesh-list
19477669|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477670|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
19477671|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
19477672|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021341|NCT02544321|Bromocriptine|bromocriptine|mesh-list
20021342|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20021343|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20021344|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
20021345|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021346|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021347|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
20021348|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
20021349|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021350|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021351|NCT02544451|Ivacaftor|ivacaftor|mesh-list
20021352|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20021353|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20021354|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021355|NCT02544607|Ketamine|ketamine|mesh-list
20021356|NCT02544607|Analgesics|analgesics|mesh-ancestor
20021357|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
20021358|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021359|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021360|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20021361|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20021362|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
20021363|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
20021364|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021365|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20021366|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20021367|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021368|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021369|NCT02544763|Cannabidiol|cannabidiol|mesh-list
20021370|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
20021371|NCT02544984|Azithromycin|azithromycin|mesh-list
20021372|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20021373|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477673|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477674|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477675|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
19477676|NCT03218553|Hormones|hormones|mesh-ancestor
19477677|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477678|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19477679|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477680|NCT03218852|Prednisone|prednisone|mesh-list
19477681|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
20292561|NCT05200988|Ipilimumab|ipilimumab|mesh-list
20292562|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292563|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477682|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477683|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
20021374|NCT02545075|Ipilimumab|ipilimumab|mesh-list
19477684|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292564|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20292565|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292566|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20292567|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
20292568|NCT05191797|Atezolizumab|atezolizumab|mesh-list
20292569|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
20292570|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20292571|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
20292572|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292573|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
20292574|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292575|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20576332|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
19477685|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477686|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19477687|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
19477688|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477689|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477690|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19477691|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477692|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
19477693|NCT03218852|Hormones|hormones|mesh-ancestor
19477694|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19477695|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19477696|NCT03218800|Ertapenem|ertapenem|mesh-list
19477697|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19477698|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477699|NCT03218722|Thrombin|thrombin|mesh-list
19477700|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
19477701|NCT03218722|Coagulants|coagulants|mesh-ancestor
19477702|NCT03218514|Dalteparin|dalteparin|mesh-list
19477703|NCT03218514|Tinzaparin|tinzaparin|mesh-list
19477704|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19477705|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
19477706|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19477707|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19477708|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477709|NCT03218254|Methylphenidate|methylphenidate|mesh-list
19477710|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19477711|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477712|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19477713|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19477714|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477715|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477716|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
19477717|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477718|NCT03218280|Ascorbic Acid|ascorbic acid|mesh-list
19477719|NCT03218280|Vitamins|vitamins|mesh-ancestor
19477720|NCT03218280|Micronutrients|micronutrients|mesh-ancestor
19477721|NCT03218280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477722|NCT03218280|Antioxidants|antioxidants|mesh-ancestor
20021375|NCT02545075|Dacarbazine|dacarbazine|mesh-list
20021376|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477723|NCT03218280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477724|NCT03218280|Protective Agents|protective agents|mesh-ancestor
19477725|NCT03218059|Methotrexate|methotrexate|mesh-list
19477726|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19477727|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
19477728|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19477729|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477730|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19477731|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
19477732|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477733|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477734|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
19477735|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477736|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19477737|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477738|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
19477739|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477740|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19743297|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
20021377|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576333|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477741|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
19477742|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19477743|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
19477744|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477745|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19477746|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477747|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
19477748|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477749|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
19477750|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19477751|NCT03217916|Protective Agents|protective agents|mesh-ancestor
19477752|NCT03218124|Remifentanil|remifentanil|mesh-list
19477753|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19477754|NCT03218124|Narcotics|narcotics|mesh-ancestor
19477755|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477756|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477757|NCT03218124|Analgesics|analgesics|mesh-ancestor
19477758|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
19477759|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477760|NCT03217838|Azacitidine|azacitidine|mesh-list
19477761|NCT03217838|Venetoclax|venetoclax|mesh-list
19477762|NCT03217838|Pyrazole|pyrazole|mesh-list
19477763|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19477764|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
19477765|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477766|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477767|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477768|NCT03217825|Losartan|losartan|mesh-list
19477769|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19477770|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19477771|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19477772|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19477773|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477774|NCT03217942|Mitogens|mitogens|mesh-list
19477775|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
19477776|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477777|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
19477778|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477779|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19477780|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19477781|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477782|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19477783|NCT03217409|Ezetimibe|ezetimibe|mesh-list
19477784|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19477785|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19477786|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
19477787|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477788|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19477789|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19477790|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477791|NCT03217292|Tramadol|tramadol|mesh-list
19477792|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19477793|NCT03217292|Narcotics|narcotics|mesh-ancestor
19477794|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743298|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743299|NCT04135989|Everolimus|everolimus|mesh-list
19743300|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743301|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743302|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
19743303|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743304|NCT04130802|Dexamethasone|dexamethasone|mesh-list
19743305|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19743306|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
19743307|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
19743308|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743309|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743310|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743311|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
19743312|NCT04130802|Hormones|hormones|mesh-ancestor
19743313|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743314|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19743315|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743316|NCT04130659|Omeprazole|omeprazole|mesh-list
19743317|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19477795|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477796|NCT03217292|Analgesics|analgesics|mesh-ancestor
19477797|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
19477798|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021378|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20021379|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021380|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20021381|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
19477799|NCT03217448|Warfarin|warfarin|mesh-list
19477800|NCT03217448|Dabigatran|dabigatran|mesh-list
19477801|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
19477802|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
19477803|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19477804|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
19477805|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477806|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477807|NCT03217474|Ganciclovir|ganciclovir|mesh-list
19477808|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19477809|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
19477810|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477811|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19477812|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477813|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477814|NCT03217734|Adalimumab|adalimumab|mesh-list
19477815|NCT03217734|Methotrexate|methotrexate|mesh-list
19477816|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19477817|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
19477818|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19477819|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477820|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19477821|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
19477822|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477823|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477824|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
19477825|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477826|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19477827|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477828|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
19477829|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477830|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19477831|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477832|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19477833|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477834|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477835|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477836|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19477837|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19477838|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
19477839|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
19477840|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19477841|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477842|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477843|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477844|NCT03216759|Analgesics|analgesics|mesh-ancestor
19477845|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
19477846|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477847|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19477848|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19477849|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19477850|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477851|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477852|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477853|NCT03216733|Sirolimus|sirolimus|mesh-list
20115393|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115394|NCT00005576|Aldesleukin|aldesleukin|mesh-list
20115395|NCT00005576|Interleukin-2|interleukin-2|mesh-list
20115396|NCT00005576|Dinutuximab|dinutuximab|mesh-list
20115397|NCT00005576|Isotretinoin|isotretinoin|mesh-list
20115398|NCT00005576|Antibodies|antibodies|mesh-list
20115399|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20115400|NCT00005576|Sargramostim|sargramostim|mesh-list
20115401|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
20115402|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477854|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19477855|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477856|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19477857|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477858|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
19477859|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477860|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
19477861|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477862|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19477863|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19477864|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477865|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19477866|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
19477867|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477868|NCT03216980|Antioxidants|antioxidants|mesh-list
19477869|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477870|NCT03216980|Protective Agents|protective agents|mesh-ancestor
19477871|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477872|NCT03216876|Ursolic acid|ursolic acid|mesh-list
19477873|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477874|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19477875|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19477876|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19477877|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477878|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477879|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19477880|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19477881|NCT03216876|Analgesics|analgesics|mesh-ancestor
19477882|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
19477883|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477884|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477885|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477886|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477887|NCT03217084|Fluorides|fluorides|mesh-list
19477888|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
19477889|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
19477890|NCT03217084|Protective Agents|protective agents|mesh-ancestor
19477891|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477892|NCT03216941|Ketamine|ketamine|mesh-list
19477893|NCT03216941|Olanzapine|olanzapine|mesh-list
19477894|NCT03216941|Analgesics|analgesics|mesh-ancestor
19477895|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
19477896|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477897|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477898|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19477899|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19477900|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
19477901|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
19477902|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19477903|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19477904|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19477905|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477906|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477907|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
19477908|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
19477909|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477910|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20021382|NCT02545504|Leucovorin|leucovorin|mesh-list
20021383|NCT02545504|Fluorouracil|fluorouracil|mesh-list
20021384|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
20021385|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
20021386|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021387|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20021388|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021389|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021390|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
20021391|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021392|NCT02545504|Antidotes|antidotes|mesh-ancestor
20021393|NCT02545504|Protective Agents|protective agents|mesh-ancestor
20021394|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
20021395|NCT02545504|Vitamins|vitamins|mesh-ancestor
20021396|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
20021397|NCT02545907|Thalidomide|thalidomide|mesh-list
20021398|NCT02545907|Dexamethasone|dexamethasone|mesh-list
20021399|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19477911|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19477912|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19477913|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19477914|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19477915|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477916|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
19477917|NCT03216707|Capsaicin|capsaicin|mesh-list
19477918|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
20021400|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
19477919|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19477920|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
19477921|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477922|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477923|NCT03216668|Silymarin|silymarin|mesh-list
19477924|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
19477925|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477926|NCT03216668|Protective Agents|protective agents|mesh-ancestor
19477927|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477928|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19477929|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477930|NCT03216525|Alvimopan|alvimopan|mesh-list
19477931|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19477932|NCT03216278|Metformin|metformin|mesh-list
19477933|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
19477934|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19477935|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477936|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19477937|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477938|NCT03216356|Cycloserine|cycloserine|mesh-list
19477939|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19477940|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19477941|NCT03216356|Renal Agents|renal agents|mesh-ancestor
19477942|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19477943|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
19477944|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19477945|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
19477946|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477947|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
19477948|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19477949|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19477950|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19477951|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477952|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477953|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
19477954|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477955|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477956|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19477957|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477958|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
19477959|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19477960|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19477961|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19477962|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477963|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477964|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
19477965|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477966|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477967|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19477968|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19477969|NCT03216564|Vitamin D|vitamin d|mesh-list
19477970|NCT03216564|Calcitriol|calcitriol|mesh-list
19477971|NCT03216564|Vitamins|vitamins|mesh-ancestor
19477972|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
19477973|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477974|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19477975|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19477976|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19477977|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19477978|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477979|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19568066|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568067|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568068|NCT03919292|Valproic Acid|valproic acid|mesh-list
19568069|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
19568070|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568071|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568072|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
19568073|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568074|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568075|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
19568076|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19568077|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568078|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19568079|NCT03902951|Leuprolide|leuprolide|mesh-list
19568080|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
19568081|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19568082|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
19568083|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568084|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568085|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568086|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568087|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19568088|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568089|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568090|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
19568091|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021401|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
20021402|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021403|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021404|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021405|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
20021406|NCT02545907|Hormones|hormones|mesh-ancestor
20021407|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021408|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20021409|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021410|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021411|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
20021412|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
20021413|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20021414|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021415|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20021416|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20021417|NCT02545907|Growth Substances|growth substances|mesh-ancestor
20021418|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
20021419|NCT02545933|Aspirin|aspirin|mesh-list
20021420|NCT02545933|Ticagrelor|ticagrelor|mesh-list
20021421|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20021422|NCT02545933|Vorapaxar|vorapaxar|mesh-list
20021423|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20021424|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021425|NCT02545933|Analgesics|analgesics|mesh-ancestor
20021426|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
20021427|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021428|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021429|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021430|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021431|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20021432|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20021433|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021434|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20021435|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20021436|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021437|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
20021438|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20021439|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20021440|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20021441|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
20292576|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19477980|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
19477981|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19477982|NCT03216304|Calcium|calcium|mesh-list
19477983|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19477984|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19477985|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19477986|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19477987|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19477988|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
19477989|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477990|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19477991|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19477992|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19477993|NCT03216395|Epinephrine|epinephrine|mesh-list
19477994|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19477995|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19477996|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
19477997|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19477998|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19477999|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478000|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19478001|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19478002|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
19478003|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478004|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19478005|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
19478006|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
19478007|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
19478008|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19478009|NCT03216447|Tacrolimus|tacrolimus|mesh-list
19478010|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19478011|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
19478012|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478013|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19478014|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478015|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478016|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
19478017|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19478018|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
19478019|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478020|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478021|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19478022|NCT03216538|Protective Agents|protective agents|mesh-ancestor
19478023|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19478024|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19478025|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478026|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478027|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
19478028|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478029|NCT03215875|Torsemide|torsemide|mesh-list
19478030|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19478031|NCT03215875|Diuretics|diuretics|mesh-ancestor
20021442|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478032|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
19478033|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478034|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19478035|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478036|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478037|NCT03215797|Phenylephrine|phenylephrine|mesh-list
19478038|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
19478039|NCT03215797|Norepinephrine|norepinephrine|mesh-list
19478040|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
19478041|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19478042|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
19478043|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
19478044|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478045|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478046|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
19478047|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19478048|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
19478049|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
19478050|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19478051|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19478052|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
19478053|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478054|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478055|NCT03215797|Protective Agents|protective agents|mesh-ancestor
19478056|NCT03215693|Ensartinib|ensartinib|mesh-list
19478057|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478058|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20021443|NCT02546193|Misoprostol|misoprostol|mesh-list
20021444|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20021445|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
20021446|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20021447|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021448|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20021449|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021450|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
20021451|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20021452|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20021453|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20021454|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
20021455|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021456|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20021457|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20021458|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021459|NCT02546570|Oxytocin|oxytocin|mesh-list
20021460|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
20021461|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20021462|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478059|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478060|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478061|NCT03216070|Dasatinib|dasatinib|mesh-list
19478062|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478063|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19478064|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478065|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478066|NCT03215602|Pyrantel|pyrantel|mesh-list
19478067|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
19478068|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
19478069|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
19478070|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19478071|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478072|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19478073|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19478074|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19478075|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478076|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478077|NCT03215719|Cisplatin|cisplatin|mesh-list
19478078|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478079|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19478080|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19478081|NCT03215966|Tadalafil|tadalafil|mesh-list
19478082|NCT03215966|Macitentan|macitentan|mesh-list
19478083|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
20021463|NCT02546765|Acetaminophen|acetaminophen|mesh-list
20021464|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
19478084|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20021465|NCT02546765|Propofol|propofol|mesh-list
19478085|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19478086|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478087|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478088|NCT03215966|Urological Agents|urological agents|mesh-ancestor
19478089|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19478090|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19478091|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19478092|NCT03215498|Insulin|insulin|mesh-list
19478093|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19478094|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
19478095|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
19478096|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19478097|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19478098|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478099|NCT03215446|Anesthetics|anesthetics|mesh-list
19478100|NCT03215446|Propofol|propofol|mesh-list
19478101|NCT03215446|Sevoflurane|sevoflurane|mesh-list
19478102|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478103|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478104|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19478105|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19478106|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
19478107|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19478108|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19478109|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
19478110|NCT03215264|Entinostat|entinostat|mesh-list
19478111|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
19478112|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19478113|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19478114|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478115|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478116|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478117|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19478118|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478119|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19478120|NCT03215407|Betamethasone|betamethasone|mesh-list
19478121|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19478122|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
19478123|NCT03215407|Hormones|hormones|mesh-ancestor
19478124|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478125|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478126|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19478127|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
19478128|NCT03215069|Empagliflozin|empagliflozin|mesh-list
19478129|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19478130|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478131|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19478132|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478133|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
19478134|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19478135|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
19478136|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
19478137|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478138|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478139|NCT03215017|Loperamide|loperamide|mesh-list
19478140|NCT03215017|Sorbitol|sorbitol|mesh-list
19478141|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
19478142|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19478143|NCT03215017|Cathartics|cathartics|mesh-ancestor
19478144|NCT03214874|Torsemide|torsemide|mesh-list
19478145|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19478146|NCT03214874|Diuretics|diuretics|mesh-ancestor
19478147|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
19478148|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478149|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19478150|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478151|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478152|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
19478153|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19478154|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478155|NCT03214731|Artesunate|artesunate|mesh-list
20021466|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19478156|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
19478157|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19478158|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19478159|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478160|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478161|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
19478162|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
20021467|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021468|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021469|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20021470|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
20021471|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
20021472|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021473|NCT02546765|Analgesics|analgesics|mesh-ancestor
20021474|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
20021475|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021476|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20021477|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20021478|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20021479|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
20021480|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021481|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021482|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
20021483|NCT02547012|Amoxicillin|amoxicillin|mesh-list
20021484|NCT02547012|Levofloxacin|levofloxacin|mesh-list
20021485|NCT02547012|Ofloxacin|ofloxacin|mesh-list
20021486|NCT02547012|Tetracycline|tetracycline|mesh-list
20021487|NCT02547012|Esomeprazole|esomeprazole|mesh-list
20021488|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20021489|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021490|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20021491|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021492|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20021493|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021494|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021495|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20021496|NCT02547012|Renal Agents|renal agents|mesh-ancestor
20021497|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20021498|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20021499|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021500|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20021501|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20021502|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20021503|NCT02547038|Amoxicillin|amoxicillin|mesh-list
20021504|NCT02547038|Metronidazole|metronidazole|mesh-list
20021505|NCT02547038|Clarithromycin|clarithromycin|mesh-list
20021506|NCT02547038|Tetracycline|tetracycline|mesh-list
20021507|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20021508|NCT02547038|Pantoprazole|pantoprazole|mesh-list
20021509|NCT02547038|Bismuth|bismuth|mesh-list
19478163|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19478164|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
19568092|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19568093|NCT03896685|Linezolid|linezolid|mesh-list
19568094|NCT03896685|Bedaquiline|bedaquiline|mesh-list
19568095|NCT03896685|Clofazimine|clofazimine|mesh-list
19568096|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568097|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568098|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19568099|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568100|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568101|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
19568102|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568103|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
19568104|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19568105|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19568106|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19568107|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
19568108|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568109|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20021510|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20021511|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021512|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19478165|NCT03214536|Ropivacaine|ropivacaine|mesh-list
19478166|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
19478167|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478168|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478169|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
19478170|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
19478171|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478172|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
19478173|NCT03214770|Calcium|calcium|mesh-list
19478174|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19478175|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478176|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19478177|NCT03214653|Propofol|propofol|mesh-list
19478178|NCT03214653|Sevoflurane|sevoflurane|mesh-list
19478179|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19478180|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478181|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478182|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19743318|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743319|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19743320|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743321|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743322|NCT04128436|Progesterone|progesterone|mesh-list
19743323|NCT04128436|Progestins|progestins|mesh-ancestor
19743324|NCT04128436|Hormones|hormones|mesh-ancestor
19743325|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743326|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743327|NCT04121468|Metformin|metformin|mesh-list
19743328|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19743329|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749124|NCT05274269|Elexacaftor|elexacaftor|mesh-list
19749125|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19749126|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19749127|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749128|NCT05269615|Valsartan|valsartan|mesh-list
19749129|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19749130|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19749131|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19749132|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749472|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19749473|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749474|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749475|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19749476|NCT04964544|Calcium|calcium|mesh-list
19749477|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19749478|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749479|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19749480|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19749481|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
19749482|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749483|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19749484|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19749485|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749486|NCT04958226|Midazolam|midazolam|mesh-list
19749487|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19749488|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19749489|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19749490|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749491|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19749492|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19749493|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19749494|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19749495|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
19749496|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
19749497|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
19749498|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
19749499|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749500|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478183|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
19478184|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
19478185|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19478186|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19478187|NCT03214627|Iron|iron|mesh-list
19478188|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19478189|NCT03214627|Hematinics|hematinics|mesh-list
19478190|NCT03214627|Trace Elements|trace elements|mesh-ancestor
19478191|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
19478192|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478193|NCT03214562|Cytarabine|cytarabine|mesh-list
19478194|NCT03214562|Fludarabine|fludarabine|mesh-list
19478195|NCT03214562|Venetoclax|venetoclax|mesh-list
19478196|NCT03214562|Idarubicin|idarubicin|mesh-list
20021513|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20021514|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20021515|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021516|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021517|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20021518|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20021519|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20021520|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021521|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20021522|NCT02547038|Antacids|antacids|mesh-ancestor
20021523|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20021524|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20021525|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021526|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
20021527|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021528|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
20021529|NCT02547454|Hematinics|hematinics|mesh-ancestor
20021530|NCT02547623|Dexamethasone|dexamethasone|mesh-list
20021531|NCT02547623|Prednisolone|prednisolone|mesh-list
20021532|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021533|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
20021534|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
20021535|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021536|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021537|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021538|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
20021539|NCT02547623|Hormones|hormones|mesh-ancestor
20021540|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021541|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19478197|NCT03214562|Lenograstim|lenograstim|mesh-list
19478198|NCT03214562|Sargramostim|sargramostim|mesh-list
19478199|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478200|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19478201|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
19478202|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478203|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19478204|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
19478205|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478206|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
19478207|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478208|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19478209|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19478210|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19478211|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19478212|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478213|NCT03214510|Fentanyl|fentanyl|mesh-list
19478214|NCT03214510|Hydromorphone|hydromorphone|mesh-list
19478215|NCT03214510|Bupivacaine|bupivacaine|mesh-list
19478216|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
19478217|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
19478218|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478219|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478220|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
19478221|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478222|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19478223|NCT03214510|Narcotics|narcotics|mesh-ancestor
19478224|NCT03214510|Analgesics|analgesics|mesh-ancestor
19478225|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19478226|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19478227|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
20021542|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478228|NCT03214354|Sirolimus|sirolimus|mesh-list
19478229|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
19478230|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19478231|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478232|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19478233|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478234|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
19478235|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19478236|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
19478237|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478238|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478239|NCT03214393|Antibodies|antibodies|mesh-list
19478240|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
19478241|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478242|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
19478243|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19478244|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
19478245|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19478246|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
19478247|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478248|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478249|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
19478250|NCT03214003|Cisplatin|cisplatin|mesh-list
19478251|NCT03214003|Etoposide|etoposide|mesh-list
19478252|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
19478253|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478254|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20021543|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20021544|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
20021545|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021546|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20021547|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19478255|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19478256|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19478257|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478258|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478259|NCT03214159|Ritonavir|ritonavir|mesh-list
19478260|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19478261|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19478262|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
19478263|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478264|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478265|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19478266|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19478267|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
19478268|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478269|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19478270|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19478271|NCT03214302|Tenofovir|tenofovir|mesh-list
19478272|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
19478273|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478274|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19478275|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19478276|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478277|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478278|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19478279|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19478280|NCT03214055|Mannitol|mannitol|mesh-list
19478281|NCT03214055|Diuretics|diuretics|mesh-list
20021548|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
20021549|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20021550|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20021551|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
20021552|NCT02547935|Saxagliptin|saxagliptin|mesh-list
20021553|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19478282|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19478283|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
19478284|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478285|NCT03213964|Interleukin-2|interleukin-2|mesh-list
19478286|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478287|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19478288|NCT03213964|Analgesics|analgesics|mesh-ancestor
19478289|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
19478290|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478291|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478292|NCT03213977|Prednisone|prednisone|mesh-list
19478293|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
19478294|NCT03213977|Doxorubicin|doxorubicin|mesh-list
20292577|NCT05170685|Nivolumab|nivolumab|mesh-list
19478295|NCT03213977|Etoposide|etoposide|mesh-list
19478296|NCT03213977|Vincristine|vincristine|mesh-list
19478297|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19478298|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
19478299|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478300|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19478301|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19478302|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
19478303|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478304|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478305|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19478306|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19478307|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19478308|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19478309|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478310|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19478311|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19478312|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
19478313|NCT03213977|Hormones|hormones|mesh-ancestor
19478314|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478315|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19478316|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
19478317|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
19478318|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
19478319|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19478320|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19478321|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19478322|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478323|NCT03213886|Vitamin D|vitamin d|mesh-list
19478324|NCT03213886|Calcifediol|calcifediol|mesh-list
19478325|NCT03213886|Vitamins|vitamins|mesh-ancestor
19478326|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
19478327|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478328|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19478329|NCT03213769|Ubiquinone|ubiquinone|mesh-list
19478330|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
19478331|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
19478332|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478333|NCT03213769|Vitamins|vitamins|mesh-ancestor
19478334|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
19478335|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19478336|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478337|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478338|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19478339|NCT03213743|Analgesics|analgesics|mesh-ancestor
19478340|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
19478341|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478342|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19478343|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19478344|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19478345|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
19478346|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478347|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478348|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
19478349|NCT03213444|Fluorouracil|fluorouracil|mesh-list
19478350|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478351|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
19478352|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478353|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19478354|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19478355|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
19478356|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478357|NCT03213639|Esomeprazole|esomeprazole|mesh-list
19478358|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19478359|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19478360|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19478361|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478362|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478363|NCT03213548|Daminozide|daminozide|mesh-list
19478364|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19478365|NCT03213548|Growth Substances|growth substances|mesh-ancestor
20021554|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021555|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20021556|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021557|NCT02547935|Incretins|incretins|mesh-ancestor
20021558|NCT02547935|Hormones|hormones|mesh-ancestor
19478366|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478367|NCT03213587|Apatinib|apatinib|mesh-list
19478368|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478369|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19478370|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478371|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478372|NCT03213392|Anesthetics|anesthetics|mesh-list
19478373|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478374|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478375|NCT03213353|Acetaminophen|acetaminophen|mesh-list
19478376|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
19478377|NCT03213353|Phenylephrine|phenylephrine|mesh-list
20021559|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021560|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20021561|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
20021562|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021563|NCT02547974|Vaccines|vaccines|mesh-list
20021564|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
20021565|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021566|NCT02547987|Carboplatin|carboplatin|mesh-list
20021567|NCT02547987|Docetaxel|docetaxel|mesh-list
20021568|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021569|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
20021570|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
20021571|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
20021572|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021573|NCT02548078|Vaccines|vaccines|mesh-list
20021574|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
20021575|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021576|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20292578|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478378|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
19478379|NCT03213353|Guaifenesin|guaifenesin|mesh-list
19478380|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19478381|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19478382|NCT03213353|Analgesics|analgesics|mesh-ancestor
19478383|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
19478384|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478385|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478386|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
19478387|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19478388|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
19478389|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
19478390|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
19478391|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19478392|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
19478393|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
19478394|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19478395|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19478396|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19478397|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
19478398|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478399|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478400|NCT03213353|Protective Agents|protective agents|mesh-ancestor
19478401|NCT03213353|Expectorants|expectorants|mesh-ancestor
19478402|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
19478403|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19478404|NCT03213249|Gentamicins|gentamicins|mesh-list
19478405|NCT03213249|Cefazolin|cefazolin|mesh-list
19478406|NCT03213249|Bacitracin|bacitracin|mesh-list
19478407|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19478408|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478409|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19478410|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478411|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478412|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19478413|NCT03213145|Rifampin|rifampin|mesh-list
19478414|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19478415|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
19478416|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19478417|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478418|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
19478419|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19478420|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478421|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478422|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19478423|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19478424|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19478425|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19478426|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19478427|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19568113|NCT03871491|Azithromycin|azithromycin|mesh-list
19568114|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568115|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568116|NCT03868839|Telmisartan|telmisartan|mesh-list
19568117|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19568118|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19568119|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19568120|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568121|NCT03864042|Losartan|losartan|mesh-list
19568122|NCT03864042|Midazolam|midazolam|mesh-list
19568123|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
19568124|NCT03864042|Caffeine|caffeine|mesh-list
19568125|NCT03864042|Modafinil|modafinil|mesh-list
19568126|NCT03864042|Bupropion|bupropion|mesh-list
19568127|NCT03864042|Omeprazole|omeprazole|mesh-list
19568128|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19568129|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19568130|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19568131|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568132|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568133|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19568134|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19568135|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19568136|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19568137|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
19568138|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
19568139|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
19568140|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
19568141|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568142|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568143|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19568144|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19568145|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
19568146|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19568147|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20021577|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20021578|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
20021579|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20021580|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568148|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568149|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19568150|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19568151|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19568152|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19568153|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19568154|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19568155|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19568156|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19568157|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19568158|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19568159|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19568160|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
19568161|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19568162|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
19568163|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19568164|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19568165|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19568166|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
19568167|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19568168|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19568169|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20021581|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20021582|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20021583|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20021584|NCT02548650|Aspirin|aspirin|mesh-list
19568170|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19478428|NCT03213041|Carboplatin|carboplatin|mesh-list
19478429|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
19478430|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478431|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478432|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
19478433|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19478434|NCT03212716|Oseltamivir|oseltamivir|mesh-list
19478435|NCT03212716|Diltiazem|diltiazem|mesh-list
19478436|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
19478437|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478438|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478439|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478440|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19478441|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19478442|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478443|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20021585|NCT02548650|Clopidogrel|clopidogrel|mesh-list
20021586|NCT02548650|Vorapaxar|vorapaxar|mesh-list
20021587|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20021588|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021589|NCT02548650|Analgesics|analgesics|mesh-ancestor
20021590|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
19478444|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478445|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
19478446|NCT03212807|Lenalidomide|lenalidomide|mesh-list
19478447|NCT03212807|Durvalumab|durvalumab|mesh-list
19478448|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
19478449|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478450|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19478451|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19478452|NCT03212807|Growth Substances|growth substances|mesh-ancestor
19478453|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
19478454|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478455|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478456|NCT03213002|Capecitabine|capecitabine|mesh-list
19478457|NCT03213002|Temozolomide|temozolomide|mesh-list
19478458|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19478459|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
19478460|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478461|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478462|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19478463|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
19478464|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
19478465|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478466|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478467|NCT03212742|Temozolomide|temozolomide|mesh-list
19478468|NCT03212742|Olaparib|olaparib|mesh-list
19478469|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19478470|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
19478471|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478472|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478473|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19478474|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478475|NCT03212820|Methamphetamine|methamphetamine|mesh-list
19478476|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19478477|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478478|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
19478479|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
19478480|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478481|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
19478482|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743330|NCT04117932|Ustekinumab|ustekinumab|mesh-list
19743331|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
19743332|NCT04116073|Antibodies|antibodies|mesh-list
19743333|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
19743334|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743335|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
19743336|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
19743337|NCT04108104|Prazosin|prazosin|mesh-list
19743338|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20021591|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021592|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478483|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478484|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743339|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19743340|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19478485|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19478486|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19478487|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478488|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19478489|NCT03212833|Insulin|insulin|mesh-list
19478490|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19478491|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478492|NCT03212677|Iron|iron|mesh-list
19478493|NCT03212677|Trace Elements|trace elements|mesh-ancestor
19478494|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
19478495|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478496|NCT03212950|Insulin|insulin|mesh-list
20021593|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021594|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021595|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20021596|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20021597|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021598|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20021599|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20021600|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021601|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
20021602|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20021603|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20021604|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20021605|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
20021606|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021607|NCT02548728|Oxytocin|oxytocin|mesh-list
20021608|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
19478497|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19478498|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
20021609|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20021610|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021611|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
20021612|NCT02548910|Citric Acid|citric acid|mesh-list
20021613|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
20021614|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20021615|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
20021616|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
20021617|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021618|NCT02548962|Dexamethasone|dexamethasone|mesh-list
20021619|NCT02548962|Pomalidomide|pomalidomide|mesh-list
20021620|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021621|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
20021622|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
20021623|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021624|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021625|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021626|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
20021627|NCT02548962|Hormones|hormones|mesh-ancestor
20021628|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021629|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20021630|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021631|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
20021632|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20021633|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20021634|NCT02548962|Growth Substances|growth substances|mesh-ancestor
20021635|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
20021636|NCT02549196|Donepezil|donepezil|mesh-list
20021637|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
20021638|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20021639|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021640|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021641|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
20021642|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021643|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021644|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
20021645|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20021646|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20021647|NCT02549196|Urological Agents|urological agents|mesh-ancestor
20021648|NCT02549573|Apomorphine|apomorphine|mesh-list
20021649|NCT02549573|Emetics|emetics|mesh-ancestor
20021650|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021651|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
20292579|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478499|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
19749133|NCT05268614|Cisplatin|cisplatin|mesh-list
20021652|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478500|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19478501|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19478502|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478503|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
19478504|NCT03212781|Dextrans|dextrans|mesh-list
19478505|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
19478506|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
19478507|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
19478508|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
19478509|NCT03212781|Trace Elements|trace elements|mesh-ancestor
19478510|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
19478511|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478512|NCT03212781|Hematinics|hematinics|mesh-ancestor
19478513|NCT03212937|Carboplatin|carboplatin|mesh-list
19478514|NCT03212937|Etoposide|etoposide|mesh-list
19478515|NCT03212937|Ifosfamide|ifosfamide|mesh-list
19478516|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478517|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19478518|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19478519|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19478520|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478521|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478522|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19478523|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
19478524|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
19478525|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19478526|NCT03212755|Antibodies|antibodies|mesh-list
19478527|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
19478528|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
19478529|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478530|NCT03212599|Disulfiram|disulfiram|mesh-list
19478531|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19478532|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19478533|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478534|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478535|NCT03212352|Misoprostol|misoprostol|mesh-list
19478536|NCT03212352|Mifepristone|mifepristone|mesh-list
19478537|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19478538|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
19478539|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19478540|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478541|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19478542|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19478543|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
19478544|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19478545|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19478546|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19478547|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19478548|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
19478549|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19478550|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19478551|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
19478552|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478553|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
19478554|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19478555|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19478556|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
19478557|NCT03212456|Ropivacaine|ropivacaine|mesh-list
19478558|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
19478559|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
19478560|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478561|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478562|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
19478563|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478564|NCT03212456|Narcotics|narcotics|mesh-ancestor
19478565|NCT03212456|Analgesics|analgesics|mesh-ancestor
19478566|NCT03212495|Neostigmine|neostigmine|mesh-list
19478567|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478568|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478569|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478570|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478571|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19478572|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478573|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
19478574|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19478575|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
19478576|NCT03212469|Durvalumab|durvalumab|mesh-list
19478577|NCT03212469|Tremelimumab|tremelimumab|mesh-list
19478578|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478579|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478580|NCT03212053|Hemostatics|hemostatics|mesh-list
19478581|NCT03212053|Coagulants|coagulants|mesh-ancestor
19478582|NCT03211949|Mepivacaine|mepivacaine|mesh-list
19478583|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
19478584|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
19478585|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478586|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478587|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
19478588|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478589|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
19478590|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19478591|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478592|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478593|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19478594|NCT03211871|Analgesics|analgesics|mesh-ancestor
19478595|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
19478596|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478597|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19478598|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19478599|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19478600|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
19478601|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478602|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478603|NCT03211897|Midazolam|midazolam|mesh-list
19478604|NCT03211897|Haloperidol|haloperidol|mesh-list
19478605|NCT03211897|Olanzapine|olanzapine|mesh-list
19478606|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
19478607|NCT03211897|Ziprasidone|ziprasidone|mesh-list
19478608|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19478609|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19478610|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478611|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478612|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19478613|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19478614|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19478615|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19478616|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
19478617|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
19478618|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
19478619|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
19478620|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478621|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478622|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
19478623|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
19478624|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478625|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19478626|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19478627|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19478628|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19478629|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478630|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
19478631|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19478632|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
19478633|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19478634|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19478635|NCT03211988|Entinostat|entinostat|mesh-list
19478636|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478637|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19478638|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478639|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478640|NCT03211728|Pregabalin|pregabalin|mesh-list
19478641|NCT03211728|Analgesics|analgesics|mesh-ancestor
19478642|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
19478643|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478644|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478645|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
20021653|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576334|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478646|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19478647|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478648|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478649|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19478650|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19478651|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19478652|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478653|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19478654|NCT03211741|Bevacizumab|bevacizumab|mesh-list
19478655|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478656|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478657|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19478658|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19478659|NCT03211741|Growth Substances|growth substances|mesh-ancestor
19478660|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478661|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
19478662|NCT03211572|Tamoxifen|tamoxifen|mesh-list
19478663|NCT03211572|Anastrozole|anastrozole|mesh-list
19478664|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19478665|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
19478666|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478667|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478668|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19478669|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478670|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19478671|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19478672|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20021654|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
20576335|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478673|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19478674|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19478675|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478676|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478677|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
19478678|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19478679|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
19478680|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478681|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
19478682|NCT03211650|Protective Agents|protective agents|mesh-ancestor
19568171|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19568172|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
19568173|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
19568174|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19568175|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19577581|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577582|NCT04173962|Midazolam|midazolam|mesh-list
19577583|NCT04173962|Ketamine|ketamine|mesh-list
19577584|NCT04173962|Analgesics|analgesics|mesh-ancestor
19577585|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
19577586|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577587|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577588|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19577589|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19577590|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
19577591|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
19577592|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577593|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19577594|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19577595|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577596|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577597|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19577598|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19577599|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19577600|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19577601|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19577602|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
19577603|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
20021655|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
20021656|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576336|NCT02071004|Aspirin|aspirin|mesh-list
20576337|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20576338|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576339|NCT02071004|Analgesics|analgesics|mesh-ancestor
19478683|NCT03211455|Lidocaine|lidocaine|mesh-list
19478684|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
19478685|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
19478686|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478687|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478688|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
19478689|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478690|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19478691|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19478692|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19478693|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478694|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478695|NCT03211338|Progesterone|progesterone|mesh-list
19478696|NCT03211338|Mitogens|mitogens|mesh-list
19478697|NCT03211338|Progestins|progestins|mesh-ancestor
19478698|NCT03211338|Hormones|hormones|mesh-ancestor
19478699|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021657|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021658|NCT02550106|Omalizumab|omalizumab|mesh-list
20021659|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20021660|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20021661|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
20021662|NCT02550743|Capecitabine|capecitabine|mesh-list
20021663|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20021664|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
20021665|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021666|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021667|NCT02550795|Dexamethasone|dexamethasone|mesh-list
20021668|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
20021669|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021670|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
20021671|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
20021672|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021673|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021674|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021675|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
20021676|NCT02550795|Hormones|hormones|mesh-ancestor
20021677|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20021678|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20021679|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021680|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20021681|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021682|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021683|NCT02550795|Analgesics|analgesics|mesh-ancestor
20021684|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
20021685|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20021686|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20021687|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20021688|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
20021689|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021690|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021691|NCT02551055|Paclitaxel|paclitaxel|mesh-list
20021692|NCT02551055|Docetaxel|docetaxel|mesh-list
20021693|NCT02551055|Serabelisib|serabelisib|mesh-list
20021694|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20021695|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021696|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
20021697|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
20021698|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
20021699|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021700|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021701|NCT02551094|Colchicine|colchicine|mesh-list
20021702|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
20021703|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021704|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
20021705|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
20021706|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
20021707|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021708|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021709|NCT02551159|Carboplatin|carboplatin|mesh-list
20021710|NCT02551159|Fluorouracil|fluorouracil|mesh-list
20021711|NCT02551159|Cetuximab|cetuximab|mesh-list
20021712|NCT02551159|Durvalumab|durvalumab|mesh-list
19478700|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021713|NCT02551159|Tremelimumab|tremelimumab|mesh-list
19478701|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
19478702|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478703|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
19478704|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19478705|NCT03211065|Antibodies|antibodies|mesh-list
19478706|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
19478707|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478708|NCT03211052|Leuprolide|leuprolide|mesh-list
19478709|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19478710|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
19478711|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19478712|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478713|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19478714|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478715|NCT03211104|Curcumin|curcumin|mesh-list
19478716|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19478717|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19478718|NCT03211104|Analgesics|analgesics|mesh-ancestor
19478719|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
19478720|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478721|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478722|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19478723|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19478724|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478725|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478726|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478727|NCT03211143|Esomeprazole|esomeprazole|mesh-list
19478728|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19478729|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19478730|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19478731|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478732|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478733|NCT03211013|Oxytocin|oxytocin|mesh-list
19478734|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
19478735|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19478736|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478737|NCT03211351|Dextrans|dextrans|mesh-list
19478738|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
19478739|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
19478740|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
19478741|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19478742|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19478743|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478744|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19478745|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478746|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
19478747|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19478748|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478749|NCT03210610|Colchicine|colchicine|mesh-list
19478750|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
19478751|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19478752|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19478753|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
19478754|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
19478755|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478756|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478757|NCT03210766|Nabilone|nabilone|mesh-list
19478758|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
19478759|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
19478760|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478761|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478762|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19478763|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19478764|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19478765|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478766|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19478767|NCT03210545|Betamethasone|betamethasone|mesh-list
19478768|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19478769|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
19478770|NCT03210545|Hormones|hormones|mesh-ancestor
19478771|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478772|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478773|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19478774|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
19478775|NCT03210558|Testosterone|testosterone|mesh-list
19478776|NCT03210558|Androgens|androgens|mesh-ancestor
19478777|NCT03210558|Hormones|hormones|mesh-ancestor
19478778|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478779|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478780|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19478781|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
19478782|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478783|NCT03210532|Amlodipine|amlodipine|mesh-list
19478784|NCT03210532|Telmisartan|telmisartan|mesh-list
19478785|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19478786|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19478787|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19478788|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19478789|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478790|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478791|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19478792|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478793|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
19478794|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19478795|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19478796|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
19478797|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19478798|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19478799|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478800|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19478801|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19478802|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19478803|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19478804|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19478805|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
19478806|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19478807|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478808|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19478809|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19478810|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19478811|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19478812|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19478813|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19478814|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19478815|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19478816|NCT03210324|Mifepristone|mifepristone|mesh-list
19478817|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19478818|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
19478819|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19478820|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478821|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19478822|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19478823|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19478824|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
19478825|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19478826|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19478827|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
19478828|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478829|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
19478830|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19478831|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19478832|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
19478833|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
19478834|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19478835|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478836|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478837|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
19478838|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19568176|NCT03862495|Azithromycin|azithromycin|mesh-list
20292580|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20292581|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478839|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478840|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478841|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19478842|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
19478843|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478844|NCT03210064|Fluorouracil|fluorouracil|mesh-list
19478845|NCT03210064|Apatinib|apatinib|mesh-list
19478846|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
19478847|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478848|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19478849|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478850|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19478851|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
19478852|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478853|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20021714|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20021715|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021716|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
20021717|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021718|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20021719|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021720|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
20021721|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021722|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20021723|NCT02551432|Paclitaxel|paclitaxel|mesh-list
20021724|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
20021725|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20021726|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021727|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
20021728|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
20021729|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
20021730|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021731|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20021732|NCT02551692|Nicotine|nicotine|mesh-list
20021733|NCT02551692|Varenicline|varenicline|mesh-list
20021734|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20021735|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
20021736|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021737|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021738|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20021739|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20021740|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
20021741|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021742|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021743|NCT02551731|Cannabidiol|cannabidiol|mesh-list
20021744|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
20021745|NCT02551744|Pantoprazole|pantoprazole|mesh-list
20021746|NCT02551744|Famotidine|famotidine|mesh-list
20021747|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20021748|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
20021749|NCT02551744|Histamine|histamine|mesh-list
20021750|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20021751|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021752|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021753|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021754|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
20021755|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
20021756|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021757|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021758|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
20021759|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
20021760|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021761|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021762|NCT02551874|Metformin|metformin|mesh-list
20021763|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
20021764|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
20021765|NCT02551874|Saxagliptin|saxagliptin|mesh-list
20021766|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20021767|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021768|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20021769|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292582|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
19478854|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021770|NCT02551874|Incretins|incretins|mesh-ancestor
20292583|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19478855|NCT03210025|Methyldopa|methyldopa|mesh-list
19478856|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19478857|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
19478858|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
19478859|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478860|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478861|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19478862|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19478863|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19478864|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
19478865|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478866|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478867|NCT03210038|Lidocaine|lidocaine|mesh-list
19478868|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
19478869|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
19478870|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478871|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478872|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
19478873|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478874|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19478875|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19478876|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19478877|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478878|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568177|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568178|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568179|NCT03859427|Dexamethasone|dexamethasone|mesh-list
19568180|NCT03859427|Lenalidomide|lenalidomide|mesh-list
19568181|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568182|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
19568183|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
19568184|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568185|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568186|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19568187|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
19568188|NCT03859427|Hormones|hormones|mesh-ancestor
19568189|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568190|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568191|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568192|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
19568193|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19568194|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19568195|NCT03859427|Growth Substances|growth substances|mesh-ancestor
19568196|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
19568197|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
19568198|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568199|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568200|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19568201|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568202|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568203|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
19568204|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568205|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20292584|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292585|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292586|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292587|NCT05168280|Analgesics|analgesics|mesh-ancestor
20292588|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
20292589|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292590|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20292591|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20292592|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20292593|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
20292594|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292595|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292596|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
20292597|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292598|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292599|NCT05158686|Paclitaxel|paclitaxel|mesh-list
20292600|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292601|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292602|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
19568206|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576340|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
19478879|NCT03209908|Tenofovir|tenofovir|mesh-list
19478880|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
19478881|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478882|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19478883|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19478884|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478885|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478886|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19478887|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19743341|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19743342|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743343|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743344|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743345|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743346|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
19743347|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
19743348|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743349|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19743350|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
19743351|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
19743352|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19743353|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
19743354|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19743355|NCT04098393|Fludarabine|fludarabine|mesh-list
19743356|NCT04098393|Melphalan|melphalan|mesh-list
19743357|NCT04098393|Busulfan|busulfan|mesh-list
19743358|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19743359|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743360|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743361|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743362|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
19743363|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576341|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478888|NCT03209856|Vitamin D|vitamin d|mesh-list
19478889|NCT03209856|Calcitriol|calcitriol|mesh-list
19478890|NCT03209856|Vitamins|vitamins|mesh-ancestor
19478891|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
19478892|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478893|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19478894|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19478895|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19478896|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478897|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478898|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19478899|NCT03209622|Nicotine|nicotine|mesh-list
19478900|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19478901|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
19478902|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478903|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478904|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19478905|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19478906|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
19478907|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478908|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478909|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
19478910|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19478911|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19478912|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478913|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
19478914|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
19478915|NCT03209427|Morphine|morphine|mesh-list
19478916|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19478917|NCT03209427|Narcotics|narcotics|mesh-ancestor
19478918|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478919|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478920|NCT03209427|Analgesics|analgesics|mesh-ancestor
19478921|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
19478922|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478923|NCT03209661|Menthol|menthol|mesh-list
19478924|NCT03209661|Nicotine|nicotine|mesh-list
19478925|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19478926|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
19743364|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19743365|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
19478927|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19478928|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478929|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19478930|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19478931|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
19478932|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478933|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478934|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
19478935|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
19478936|NCT03209648|Itraconazole|itraconazole|mesh-list
19478937|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
19478938|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478939|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19478940|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19478941|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478942|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478943|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19478944|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
19478945|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19478946|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478947|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19478948|NCT03209401|Carboplatin|carboplatin|mesh-list
19478949|NCT03209401|Niraparib|niraparib|mesh-list
19478950|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19478951|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19478952|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19478953|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478954|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19478955|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
19478956|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478957|NCT03209180|Carvedilol|carvedilol|mesh-list
19478958|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19478959|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19478960|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
19478961|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19478962|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19478963|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478964|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19478965|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
19478966|NCT03209180|Protective Agents|protective agents|mesh-ancestor
19478967|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19478968|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19478969|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19478970|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
19478971|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19478972|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19478973|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
19478974|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478975|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
19478976|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
19478977|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
19478978|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
19478979|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
19478980|NCT03209115|Calcium|calcium|mesh-list
19478981|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19478982|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478983|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19478984|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19478985|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19478986|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
19478987|NCT03209193|Sevoflurane|sevoflurane|mesh-list
19478988|NCT03209193|Desflurane|desflurane|mesh-list
19478989|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19478990|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19478991|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
19478992|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
19478993|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19478994|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19478995|NCT03209219|Interferons|interferons|mesh-list
19478996|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
19478997|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
19478998|NCT03209219|Cyclosporine|cyclosporine|mesh-list
19478999|NCT03209219|Cyclosporins|cyclosporins|mesh-list
19479000|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479001|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
19479002|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479003|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479004|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479005|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479006|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
19479007|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479008|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
19479009|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
19479010|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479011|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19479012|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
19479013|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479014|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19479015|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
19479016|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479017|NCT03209206|Docetaxel|docetaxel|mesh-list
19479018|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479019|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19479020|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
19479021|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
20021771|NCT02551874|Hormones|hormones|mesh-ancestor
20021772|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479022|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479023|NCT03209232|Infliximab|infliximab|mesh-list
19479024|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
19479025|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479026|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479027|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19479028|NCT03208972|Menotropins|menotropins|mesh-list
19479029|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19479030|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479031|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19479032|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
19479033|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
19479034|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19479035|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
19479036|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479037|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479038|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19479039|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
19479040|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19479041|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
19479042|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479043|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479044|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19479045|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
19479046|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
19479047|NCT03208764|Protective Agents|protective agents|mesh-ancestor
19479048|NCT03208894|Furosemide|furosemide|mesh-list
19479049|NCT03208894|Diuretics|diuretics|mesh-ancestor
19479050|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
19479051|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479052|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20021773|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20021774|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
20021775|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021776|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
20021777|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20021778|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021779|NCT02552147|Nicotine|nicotine|mesh-list
20021780|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20021781|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
20021782|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021783|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021784|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20021785|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20021786|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
20021787|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021788|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021789|NCT02552225|Amitriptyline|amitriptyline|mesh-list
20021790|NCT02552225|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20021791|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20576342|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479053|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20021792|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
19479054|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479055|NCT03208712|Atezolizumab|atezolizumab|mesh-list
19479056|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479057|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19479058|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
19479059|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479060|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
19479061|NCT03208556|Fludarabine|fludarabine|mesh-list
19479062|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479063|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
19479064|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479065|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479066|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19479067|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
19479068|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479069|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479070|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19479071|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
19479072|NCT03208582|Diphosphonates|diphosphonates|mesh-list
19479073|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19479074|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479075|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479076|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19479077|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479078|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19479079|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
19479080|NCT03208452|Analgesics|analgesics|mesh-ancestor
19479081|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
19479082|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479083|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479084|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
19479085|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479086|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19479087|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
19479088|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19479089|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479090|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479091|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19479092|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
19479093|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19479094|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19479095|NCT03208465|Empagliflozin|empagliflozin|mesh-list
19479096|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479097|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479098|NCT03208465|Incretins|incretins|mesh-ancestor
19479099|NCT03208465|Hormones|hormones|mesh-ancestor
19479100|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479101|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19479102|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
19479103|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479104|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479105|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19479106|NCT03208218|Lenalidomide|lenalidomide|mesh-list
19479107|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
19479108|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479109|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19479110|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19479111|NCT03208218|Growth Substances|growth substances|mesh-ancestor
19479112|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
19479113|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479114|NCT03208413|Thalidomide|thalidomide|mesh-list
19479115|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479116|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
20021793|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20021794|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021795|NCT02552225|Analgesics|analgesics|mesh-ancestor
20021796|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
20021797|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576343|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479117|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479118|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
20021798|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576344|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479119|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19479120|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479121|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19479122|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19479123|NCT03208413|Growth Substances|growth substances|mesh-ancestor
19479124|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
19479125|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479126|NCT03208257|Esmolol|esmolol|mesh-list
19479127|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19479128|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19479129|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19479130|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
19479131|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479132|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479133|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568207|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568208|NCT03842085|Antibodies|antibodies|mesh-list
19568209|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19568210|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19568211|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
19568212|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568213|NCT03837353|Docetaxel|docetaxel|mesh-list
19568214|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568215|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
19568216|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
19568217|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
19568218|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568219|NCT03821246|Atezolizumab|atezolizumab|mesh-list
19568220|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19568221|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568222|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
19568223|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568224|NCT03815019|Megestrol|megestrol|mesh-list
19568225|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
19568226|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19568227|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19568228|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19568229|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
19568230|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568231|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568232|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19568233|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19568234|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568235|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568236|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
19568237|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19568238|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
19568239|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
19568240|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19568241|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19568242|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19568243|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19568244|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568245|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19568246|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568247|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568248|NCT03792256|Cytarabine|cytarabine|mesh-list
19568249|NCT03792256|Prednisone|prednisone|mesh-list
19568250|NCT03792256|Prednisolone|prednisolone|mesh-list
19568251|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
19568252|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19568253|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19568254|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19568255|NCT03792256|Doxorubicin|doxorubicin|mesh-list
19568256|NCT03792256|Methotrexate|methotrexate|mesh-list
19568257|NCT03792256|Vincristine|vincristine|mesh-list
19568258|NCT03792256|Palbociclib|palbociclib|mesh-list
19568259|NCT03792256|Pegaspargase|pegaspargase|mesh-list
19568260|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19568261|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568262|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19568263|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19568264|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568265|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568266|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479134|NCT03208270|Antithrombins|antithrombins|mesh-list
19479135|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
19479136|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19479137|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
19479138|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479139|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479140|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
19479141|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
19479142|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479143|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
19479144|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479145|NCT03208426|Amoxicillin|amoxicillin|mesh-list
19479146|NCT03208426|Metronidazole|metronidazole|mesh-list
19479147|NCT03208426|Clarithromycin|clarithromycin|mesh-list
19479148|NCT03208426|Tetracycline|tetracycline|mesh-list
19479149|NCT03208426|Esomeprazole|esomeprazole|mesh-list
19479150|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19479151|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479152|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19479153|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19479154|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19479155|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479156|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19479157|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479158|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479159|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19479160|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20292603|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
20292604|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
20292605|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292606|NCT05157997|Antibodies|antibodies|mesh-list
20292607|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
20292608|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292609|NCT05153317|Ivacaftor|ivacaftor|mesh-list
20292610|NCT05153317|Elexacaftor|elexacaftor|mesh-list
20292611|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20292612|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20292613|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292614|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19479161|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19479162|NCT03208101|Vaccines|vaccines|mesh-list
19479163|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
19479164|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021799|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20021800|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20021801|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20021802|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021803|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
20021804|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021805|NCT02552225|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20021806|NCT02552225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20021807|NCT02552225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021808|NCT02552303|Modafinil|modafinil|mesh-list
19479165|NCT03208361|Amoxicillin|amoxicillin|mesh-list
20021809|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19479166|NCT03208361|Penicillins|penicillins|mesh-list
19479167|NCT03208361|Penicillin V|penicillin v|mesh-list
19568267|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
19479168|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19479169|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479170|NCT03208335|Endostatins|endostatins|mesh-list
19479171|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479172|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19479173|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19479174|NCT03208335|Growth Substances|growth substances|mesh-ancestor
19743366|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19743367|NCT04098250|Erenumab|erenumab|mesh-list
19743368|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19743369|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743370|NCT04098250|Analgesics|analgesics|mesh-ancestor
19743371|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
19743372|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743373|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743374|NCT04088513|Aspirin|aspirin|mesh-list
19743375|NCT04088513|Clopidogrel|clopidogrel|mesh-list
19743376|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19743377|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743378|NCT04088513|Analgesics|analgesics|mesh-ancestor
19743379|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
19743380|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743381|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743382|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19743383|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743384|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19743385|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19743386|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743387|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19743388|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19743389|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743390|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
19743391|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19743392|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19743393|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19743394|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
20021810|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021811|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20021812|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20021813|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19743395|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743396|NCT04080947|Montelukast|montelukast|mesh-list
19743397|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19743398|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
19743399|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19743400|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
19743401|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743402|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743403|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19743404|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19743405|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743406|NCT04064931|Niacin|niacin|mesh-list
19743407|NCT04064931|Vitamins|vitamins|mesh-ancestor
19743408|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
19743409|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021814|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021815|NCT02552355|Metformin|metformin|mesh-list
20021816|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20021817|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021818|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
20021819|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20021820|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743410|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19743411|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
19743412|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743413|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19743414|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
19743415|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
20021821|NCT02553629|Rocuronium|rocuronium|mesh-list
20021822|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20021823|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20021824|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20021825|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021826|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115403|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479175|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479176|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
19479177|NCT03208179|Azithromycin|azithromycin|mesh-list
19479178|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
19479179|NCT03208179|Piperaquine|piperaquine|mesh-list
19479180|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
19479181|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19479182|NCT03208179|Artenimol|artenimol|mesh-list
19479183|NCT03208179|Artemisinins|artemisinins|mesh-list
19479184|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19479185|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479186|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
19479187|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19479188|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19479189|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19479190|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479191|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115404|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20115405|NCT00005576|Analgesics|analgesics|mesh-ancestor
20115406|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
20115407|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115408|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20115409|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20115410|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
20115411|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115412|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115413|NCT00005577|Gemcitabine|gemcitabine|mesh-list
20115414|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115415|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
20115416|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115417|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115418|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
20115419|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115420|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115421|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479192|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19479193|NCT03208179|Renal Agents|renal agents|mesh-ancestor
19479194|NCT03207698|Metformin|metformin|mesh-list
19479195|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479196|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479197|NCT03207308|Vitamin A|vitamin a|mesh-list
19479198|NCT03207308|Vitamins|vitamins|mesh-ancestor
19479199|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
19479200|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479201|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
19479202|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479203|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479204|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19479205|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
19479206|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479207|NCT03207451|Aspirin|aspirin|mesh-list
19479208|NCT03207451|Clopidogrel|clopidogrel|mesh-list
19479209|NCT03207451|Vorapaxar|vorapaxar|mesh-list
19479210|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19479211|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19479212|NCT03207451|Analgesics|analgesics|mesh-ancestor
19479213|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
20115422|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
20115423|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479214|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479215|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479216|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479217|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479218|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19479219|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19479220|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479221|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19479222|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19479223|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479224|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
19479225|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19479226|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19479227|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19479228|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
19479229|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479230|NCT03207334|Cytarabine|cytarabine|mesh-list
19479231|NCT03207334|Midostaurin|midostaurin|mesh-list
19479232|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19479233|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
19479234|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479235|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479236|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
19479237|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479238|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479239|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
19479240|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479241|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19479242|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479243|NCT03207165|Dobutamine|dobutamine|mesh-list
19479244|NCT03207165|Milrinone|milrinone|mesh-list
19479245|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
19479246|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19479247|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
19479248|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
19479249|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479250|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479251|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19479252|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19479253|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19479254|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
19479255|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479256|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479257|NCT03207165|Protective Agents|protective agents|mesh-ancestor
19479258|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19479259|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
19479260|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19479261|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479262|NCT03207542|Daratumumab|daratumumab|mesh-list
19479263|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479264|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19479265|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
19479266|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19479267|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479268|NCT03207477|Mydriatics|mydriatics|mesh-list
19479269|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
19479270|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479271|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479272|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
19479273|NCT03206957|Endostatins|endostatins|mesh-list
19479274|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
19479275|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479276|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19479277|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19479278|NCT03206957|Growth Substances|growth substances|mesh-ancestor
19479279|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479280|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
19479281|NCT03206944|Aspirin|aspirin|mesh-list
19479282|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19479283|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19479284|NCT03206944|Analgesics|analgesics|mesh-ancestor
19479285|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
19479286|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568268|NCT03792256|Hormones|hormones|mesh-ancestor
19479287|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479288|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479289|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479290|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19479291|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19479292|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479293|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19479294|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19479295|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479296|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
19479297|NCT03206931|Selitrectinib|selitrectinib|mesh-list
19479298|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479299|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479300|NCT03206671|Cytarabine|cytarabine|mesh-list
19479301|NCT03206671|Dexamethasone|dexamethasone|mesh-list
19479302|NCT03206671|Prednisolone|prednisolone|mesh-list
19479303|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
19479304|NCT03206671|Ifosfamide|ifosfamide|mesh-list
19479305|NCT03206671|Rituximab|rituximab|mesh-list
19479306|NCT03206671|Doxorubicin|doxorubicin|mesh-list
19479307|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19479308|NCT03206671|Methotrexate|methotrexate|mesh-list
19479309|NCT03206671|Etoposide|etoposide|mesh-list
19479310|NCT03206671|Vincristine|vincristine|mesh-list
19479311|NCT03206671|Vindesine|vindesine|mesh-list
19479312|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479313|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
19479314|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479315|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479316|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19479317|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
19479318|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479319|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479320|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19479321|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19479322|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479323|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
19479324|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
19479325|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479326|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479327|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
19479328|NCT03206671|Hormones|hormones|mesh-ancestor
19479329|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479330|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19479331|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19479332|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19479333|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19479334|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479335|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19479336|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
19479337|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19479338|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19479339|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
19479340|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
19479341|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19479342|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19479343|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19479344|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
19479345|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479346|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
19479347|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
19479348|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
19479349|NCT03206723|Hydrocodone|hydrocodone|mesh-list
19479350|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19479351|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19479352|NCT03206723|Narcotics|narcotics|mesh-ancestor
19479353|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479354|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479355|NCT03206723|Analgesics|analgesics|mesh-ancestor
19479356|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
19479357|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479358|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
19479359|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
19479360|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19479361|NCT03206658|Spironolactone|spironolactone|mesh-list
19479362|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19479363|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
19479364|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479365|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479366|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19479367|NCT03206658|Diuretics|diuretics|mesh-ancestor
19479368|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
19479369|NCT03206554|Ropivacaine|ropivacaine|mesh-list
19479370|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
19479371|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
19479372|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479373|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479374|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
19479375|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479376|NCT03206866|Antibodies|antibodies|mesh-list
19479377|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
19479378|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568269|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568270|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568271|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568272|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19568273|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
19568274|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568275|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19568276|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
19568277|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
19568278|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19568279|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19568280|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
19568281|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19568282|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19568283|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
19568284|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568285|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19568286|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19743416|NCT04056910|Nivolumab|nivolumab|mesh-list
19743417|NCT04056910|Ivosidenib|ivosidenib|mesh-list
19743418|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743419|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743420|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743421|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479379|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
19479380|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
19479381|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479382|NCT03206138|Imiquimod|imiquimod|mesh-list
19479383|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19479384|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
19479385|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479386|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479387|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
20021827|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20021828|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20021829|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20021830|NCT02553772|Laxatives|laxatives|mesh-ancestor
20021831|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20021832|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
20021833|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20021834|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20021835|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20021836|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
20021837|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021838|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021839|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021840|NCT02553928|Memantine|memantine|mesh-list
20021841|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20021842|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20021843|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
20021844|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292615|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292616|NCT05149898|Cannabidiol|cannabidiol|mesh-list
20292617|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
20292618|NCT05141149|Gemcitabine|gemcitabine|mesh-list
20292619|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20292620|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
20292621|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292622|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292623|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
20292624|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292625|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292626|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292627|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
20292628|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308354|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021845|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021846|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021847|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20021848|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20021849|NCT02554279|Menotropins|menotropins|mesh-list
20021850|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20021851|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
20021852|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20021853|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021854|NCT02554721|Aspirin|aspirin|mesh-list
20021855|NCT02554721|Cilostazol|cilostazol|mesh-list
20021856|NCT02554721|Clopidogrel|clopidogrel|mesh-list
20021857|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20021858|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20021859|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20021860|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20021861|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
20021862|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021863|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021864|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021865|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20021866|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021867|NCT02554721|Analgesics|analgesics|mesh-ancestor
20021868|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
20021869|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021870|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021871|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308355|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20308356|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479388|NCT03206177|Paclitaxel|paclitaxel|mesh-list
19479389|NCT03206177|Carboplatin|carboplatin|mesh-list
20021872|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19479390|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19479391|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479392|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
19479393|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
19479394|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
19479395|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479396|NCT03206255|Vaccines|vaccines|mesh-list
19479397|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
19479398|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479399|NCT03206411|Hormones|hormones|mesh-list
19479400|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479401|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479402|NCT03206203|Carboplatin|carboplatin|mesh-list
19479403|NCT03206203|Atezolizumab|atezolizumab|mesh-list
19479404|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479405|NCT03206320|Lidocaine|lidocaine|mesh-list
19479406|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
19479407|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
19479408|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479409|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479410|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
19479411|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479412|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19479413|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19479414|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19479415|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479416|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479417|NCT03206021|Carboplatin|carboplatin|mesh-list
19479418|NCT03206021|Azacitidine|azacitidine|mesh-list
19479419|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479420|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19479421|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
19479422|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479423|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479424|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
19479425|NCT03206008|Analgesics|analgesics|mesh-ancestor
19479426|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
19479427|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479428|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479429|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
19479430|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479431|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19479432|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
19479433|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19479434|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479435|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479436|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19479437|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
19479438|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19479439|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19479440|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19479441|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479442|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19479443|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
19479444|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479445|NCT03205228|Flupenthixol|flupenthixol|mesh-list
19479446|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
19479447|NCT03205228|Omeprazole|omeprazole|mesh-list
19479448|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19479449|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479450|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19479451|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479452|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479453|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19479454|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19479455|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479456|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479457|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19479458|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19479459|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
19479460|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479461|NCT03205176|Olaparib|olaparib|mesh-list
19479462|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19479463|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479464|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479465|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479466|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
19479467|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19479468|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19479469|NCT03204929|Copper|copper|mesh-list
19479470|NCT03204929|Trace Elements|trace elements|mesh-ancestor
19479471|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
19479472|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479473|NCT03204786|Vasopressins|vasopressins|mesh-list
19479474|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
19479475|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
19479476|NCT03204786|Coagulants|coagulants|mesh-ancestor
19479477|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19479478|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19479479|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
19479480|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479481|NCT03205033|Melatonin|melatonin|mesh-list
19479482|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
19479483|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479484|NCT03205033|Protective Agents|protective agents|mesh-ancestor
19479485|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479486|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479487|NCT03204734|Capecitabine|capecitabine|mesh-list
19479488|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19479489|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
19479490|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479491|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568287|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19568288|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19568289|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19568290|NCT03787095|Cemiplimab|cemiplimab|mesh-list
19568291|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19568292|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568293|NCT03779295|Clindamycin|clindamycin|mesh-list
19568294|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
19568295|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
19568296|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568297|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568298|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19568299|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568300|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568301|NCT03769155|Nivolumab|nivolumab|mesh-list
19568302|NCT03769155|Ipilimumab|ipilimumab|mesh-list
19568303|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19568304|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568305|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19568306|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568307|NCT03765788|Prednisolone|prednisolone|mesh-list
19568308|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568309|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
19568310|NCT03765788|Hormones|hormones|mesh-ancestor
19568311|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568312|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568313|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568314|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568315|NCT03765567|Vancomycin|vancomycin|mesh-list
19568316|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568317|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568318|NCT03762109|Dantrolene|dantrolene|mesh-list
19568319|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19568320|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568321|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19568322|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568323|NCT03746951|Ropivacaine|ropivacaine|mesh-list
19568324|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
19568325|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
19568326|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568327|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568328|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
19479492|NCT03204760|Dexamethasone|dexamethasone|mesh-list
19479493|NCT03204760|Prednisolone|prednisolone|mesh-list
19479494|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479495|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
19479496|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
19479497|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479498|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479499|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479500|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
19479501|NCT03204760|Hormones|hormones|mesh-ancestor
19479502|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479503|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19479504|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479505|NCT03204877|Melatonin|melatonin|mesh-list
19479506|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
19479507|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479508|NCT03204877|Protective Agents|protective agents|mesh-ancestor
19479509|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479510|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479511|NCT03204799|Metformin|metformin|mesh-list
19479512|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19479513|NCT03204799|Ezetimibe|ezetimibe|mesh-list
19479514|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479515|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479516|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19479517|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19479518|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
19479519|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479520|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19479521|NCT03204669|Trace Elements|trace elements|mesh-list
19479522|NCT03204669|Micronutrients|micronutrients|mesh-list
19479523|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479524|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19479525|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19479526|NCT03204331|Norethindrone|norethindrone|mesh-list
19479527|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
19479528|NCT03204331|Estradiol|estradiol|mesh-list
19479529|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19479530|NCT03204331|Relugolix|relugolix|mesh-list
19479531|NCT03204331|Estrogens|estrogens|mesh-ancestor
19479532|NCT03204331|Hormones|hormones|mesh-ancestor
19479533|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479534|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479535|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19479536|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
19479537|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19479538|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19479539|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19479540|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19479541|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19479542|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
19479543|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
19479544|NCT03204578|Midazolam|midazolam|mesh-list
19479545|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19479546|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19479547|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479548|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479549|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19479550|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19479551|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19479552|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19479553|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
19479554|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
19479555|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
19479556|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
19479557|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479558|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479559|NCT03204474|Lacosamide|lacosamide|mesh-list
19479560|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
19479561|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19479562|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19479563|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479564|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479565|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
19479566|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19479567|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
19479568|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479569|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
19479570|NCT03204565|Protective Agents|protective agents|mesh-ancestor
19479571|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19479572|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19479573|NCT03204318|Norethindrone|norethindrone|mesh-list
19479574|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
19479575|NCT03204318|Estradiol|estradiol|mesh-list
19479576|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19479577|NCT03204318|Relugolix|relugolix|mesh-list
19479578|NCT03204318|Estrogens|estrogens|mesh-ancestor
19479579|NCT03204318|Hormones|hormones|mesh-ancestor
19479580|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479581|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479582|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19479583|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
19479584|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19479585|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19479586|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19479587|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19479588|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19479589|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
19479590|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
19479591|NCT03204097|Alendronate|alendronate|mesh-list
19479592|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19479593|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479594|NCT03203967|Morphine|morphine|mesh-list
19479595|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19479596|NCT03203967|Narcotics|narcotics|mesh-ancestor
19479597|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479598|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479599|NCT03203967|Analgesics|analgesics|mesh-ancestor
19479600|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
19479601|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479602|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
19479603|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19479604|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479605|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479606|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19479607|NCT03204006|Analgesics|analgesics|mesh-ancestor
19479608|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
19479609|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479610|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19479611|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19479612|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19479613|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
19479614|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479615|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479616|NCT03204032|Thalidomide|thalidomide|mesh-list
19479617|NCT03204032|Temozolomide|temozolomide|mesh-list
19479618|NCT03204032|Tegafur|tegafur|mesh-list
20021873|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20021874|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20021875|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021876|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
20021877|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20021878|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
20021879|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20292629|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
19479619|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19479620|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
19479621|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479622|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20021880|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
20021881|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
20292630|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479623|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479624|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
19479625|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479626|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
19479627|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19479628|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479629|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19479630|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19479631|NCT03204032|Growth Substances|growth substances|mesh-ancestor
19479632|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
19479633|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19479634|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
19479635|NCT03204045|Fentanyl|fentanyl|mesh-list
19479636|NCT03204045|Oxycodone|oxycodone|mesh-list
19479637|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19479638|NCT03204045|Narcotics|narcotics|mesh-ancestor
19479639|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20021882|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20021883|NCT02554721|Protective Agents|protective agents|mesh-ancestor
20021884|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20021885|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20021886|NCT02554786|Fluticasone|fluticasone|mesh-list
20021887|NCT02554786|Xhance|xhance|mesh-list
20021888|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
20021889|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20021890|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021891|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20021892|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
20021893|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021894|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021895|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20021896|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
20021897|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
20021898|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20021899|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20021900|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20021901|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20021902|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
20021903|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021904|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021905|NCT02554890|Valsartan|valsartan|mesh-list
20021906|NCT02554890|Enalapril|enalapril|mesh-list
20021907|NCT02554890|Enalaprilat|enalaprilat|mesh-list
20021908|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20021909|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20021910|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20021911|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20021912|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021913|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20021914|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
20021915|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021916|NCT02554903|Macitentan|macitentan|mesh-list
20021917|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20021918|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20021919|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021920|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20021921|NCT02554981|Cyclosporine|cyclosporine|mesh-list
20021922|NCT02554981|Cyclosporins|cyclosporins|mesh-list
20021923|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021924|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021925|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021926|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
20021927|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021928|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
20021929|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021930|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
20021931|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021932|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20021933|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20021934|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
20021935|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20021936|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
19479640|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021937|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021938|NCT02555228|Simethicone|simethicone|mesh-list
19479641|NCT03204045|Analgesics|analgesics|mesh-ancestor
19479642|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
19479643|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479644|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19479645|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19479646|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
19479647|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
19479648|NCT03204058|Metformin|metformin|mesh-list
19479649|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19479650|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479651|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479652|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19479653|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19479654|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
19479655|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479656|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19479657|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19479658|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479659|NCT03204071|Metformin|metformin|mesh-list
19479660|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479661|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479662|NCT03204019|Thalidomide|thalidomide|mesh-list
19479663|NCT03204019|Temozolomide|temozolomide|mesh-list
19479664|NCT03204019|Tegafur|tegafur|mesh-list
19479665|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19479666|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
19479667|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479668|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479669|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479670|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
19479671|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479672|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
19479673|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19479674|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479675|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19479676|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19479677|NCT03204019|Growth Substances|growth substances|mesh-ancestor
19479678|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
19479679|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19479680|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
19479681|NCT03203746|Lycopene|lycopene|mesh-list
20021939|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
20021940|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021941|NCT02555228|Emollients|emollients|mesh-ancestor
19479682|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479683|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
19479684|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479685|NCT03203746|Protective Agents|protective agents|mesh-ancestor
19479686|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479687|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19479688|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19479689|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479690|NCT03203668|Choline|choline|mesh-list
19479691|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
19479692|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19479693|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
19479694|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479695|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479696|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19479697|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
19479698|NCT03203356|Hormones|hormones|mesh-list
19479699|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479700|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479701|NCT03203304|Nivolumab|nivolumab|mesh-list
19479702|NCT03203304|Ipilimumab|ipilimumab|mesh-list
19479703|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19479704|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479705|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19479706|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479707|NCT03203590|Carboplatin|carboplatin|mesh-list
19743422|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743423|NCT04053478|Phenylephrine|phenylephrine|mesh-list
19743424|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
20021942|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
19479708|NCT03203590|Vinorelbine|vinorelbine|mesh-list
19743425|NCT04053478|Norepinephrine|norepinephrine|mesh-list
19479709|NCT03203590|Gefitinib|gefitinib|mesh-list
19479710|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479711|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19479712|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
19479713|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
19479714|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
19479715|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479716|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19479717|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479718|NCT03203616|Trastuzumab|trastuzumab|mesh-list
19479719|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19479720|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19479721|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479722|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19479723|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19479724|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19479725|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479726|NCT03203408|Hylan|hylan|mesh-list
19479727|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
19479728|NCT03203408|Protective Agents|protective agents|mesh-ancestor
19479729|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479730|NCT03203317|Insulin|insulin|mesh-list
19479731|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479732|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479733|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
19479734|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
19479735|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19479736|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
19479737|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479738|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479739|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
19479740|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
19479741|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19479742|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19479743|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19479744|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479745|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479746|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
19479747|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479748|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479749|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19479750|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479751|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
19479752|NCT03202836|Progesterone|progesterone|mesh-list
19479753|NCT03202836|Progestins|progestins|mesh-ancestor
19479754|NCT03202836|Hormones|hormones|mesh-ancestor
19479755|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479756|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479757|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19479758|NCT03202979|Trazodone|trazodone|mesh-list
19479759|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19479760|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19479761|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479762|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479763|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19479764|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19479765|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19479766|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479767|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479768|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479769|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
19479770|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19479771|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
19479772|NCT03202849|Vitamin D|vitamin d|mesh-list
19479773|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
19479774|NCT03202849|Vitamins|vitamins|mesh-list
19479775|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
19479776|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479777|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19479778|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19568329|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568330|NCT03746769|Gastrins|gastrins|mesh-list
19568331|NCT03746769|Hormones|hormones|mesh-ancestor
19743426|NCT04053478|Ephedrine|ephedrine|mesh-list
20308940|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021943|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
20021944|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20021945|NCT02555683|Growth Substances|growth substances|mesh-ancestor
20021946|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021947|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
20021948|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20021949|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
20021950|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20021951|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
20021952|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021953|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021954|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
20021955|NCT02556203|Aspirin|aspirin|mesh-list
20021956|NCT02556203|Vitamin K|vitamin k|mesh-list
20021957|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
20021958|NCT02556203|Clopidogrel|clopidogrel|mesh-list
20021959|NCT02556203|Vitamins|vitamins|mesh-ancestor
20021960|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
20021961|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20021962|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20021963|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20021964|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20021965|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20021966|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
20021967|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20021968|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021969|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20021970|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
20021971|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20021972|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
20021973|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20021974|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
20021975|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20021976|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20021977|NCT02556203|Analgesics|analgesics|mesh-ancestor
20021978|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
20021979|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20021980|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20021981|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20021982|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20021983|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20021984|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20021985|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
20021986|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20021987|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
20021988|NCT02556203|Coagulants|coagulants|mesh-ancestor
20021989|NCT02556307|Ribavirin|ribavirin|mesh-list
20021990|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20021991|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
20021992|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20021993|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
20021994|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021995|NCT02556333|Tenofovir|tenofovir|mesh-list
20021996|NCT02556333|Emtricitabine|emtricitabine|mesh-list
20021997|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
20021998|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20021999|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20022000|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20022001|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022002|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022003|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20022004|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20022005|NCT02556632|Curcumin|curcumin|mesh-list
20022006|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20022007|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20022008|NCT02556632|Analgesics|analgesics|mesh-ancestor
20022009|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
20022010|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022011|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022012|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022013|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022014|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022015|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022016|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022017|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
20022018|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19479779|NCT03203031|Anesthetics|anesthetics|mesh-list
19479780|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479781|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479782|NCT03203070|Dipyrone|dipyrone|mesh-list
19479783|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19479784|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19479785|NCT03203070|Analgesics|analgesics|mesh-ancestor
19479786|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
19479787|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479788|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479789|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479790|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479791|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
19479792|NCT03202875|Insulin|insulin|mesh-list
19479793|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19479794|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
19479795|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
19479796|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19479797|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479798|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479799|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
19479800|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479801|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
19479802|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479803|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479804|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19479805|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
19479806|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479807|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479808|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19479809|NCT03202862|Fulvestrant|fulvestrant|mesh-list
19479810|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19479811|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479812|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19479813|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19479814|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
19479815|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479816|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479817|NCT03202784|Berotralstat|berotralstat|mesh-list
19479818|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479819|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479820|NCT03202758|Durvalumab|durvalumab|mesh-list
19479821|NCT03202758|Tremelimumab|tremelimumab|mesh-list
19479822|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19479823|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479824|NCT03202563|Metformin|metformin|mesh-list
19479825|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
19479826|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19479827|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479828|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19479829|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479830|NCT03202615|Lactoferrin|lactoferrin|mesh-list
19479831|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479832|NCT03202459|Pregabalin|pregabalin|mesh-list
19479833|NCT03202459|Gabapentin|gabapentin|mesh-list
19479834|NCT03202459|Analgesics|analgesics|mesh-ancestor
19479835|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
19479836|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479837|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479838|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
19479839|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19479840|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19479841|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479842|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20576345|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19479843|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19479844|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19479845|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479846|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19479847|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19479848|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19479849|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19479850|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
19479851|NCT03202719|Vaccines|vaccines|mesh-list
19479852|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
19479853|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479854|NCT03202407|Calcium|calcium|mesh-list
19479855|NCT03202407|Sevelamer|sevelamer|mesh-list
19479856|NCT03202407|Calcium acetate|calcium acetate|mesh-list
19479857|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19479858|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479859|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
19479860|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
19479861|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479862|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
20022019|NCT02556775|Antibodies|antibodies|mesh-list
20022020|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
20022021|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20022022|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
20022023|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022024|NCT02556788|Trifarotene|trifarotene|mesh-list
20022025|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022026|NCT02556918|Insulin|insulin|mesh-list
20022027|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20022028|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
20022029|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19479863|NCT03202446|Chitosan|chitosan|mesh-list
19479864|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19479865|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
19479866|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479867|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19479868|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19479869|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
19479870|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479871|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479872|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19479873|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19479874|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19479875|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
19479876|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19479877|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
19479878|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
19479879|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
19479880|NCT03202446|Coagulants|coagulants|mesh-ancestor
19479881|NCT03202186|Progesterone|progesterone|mesh-list
19479882|NCT03202186|Progestins|progestins|mesh-ancestor
19479883|NCT03202186|Hormones|hormones|mesh-ancestor
19479884|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022030|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
20022031|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
20022032|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20022033|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022034|NCT02556918|Incretins|incretins|mesh-ancestor
20022035|NCT02556918|Hormones|hormones|mesh-ancestor
20022036|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022037|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19479885|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479886|NCT03202316|Atezolizumab|atezolizumab|mesh-list
19479887|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19479888|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479889|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
19479890|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479891|NCT03201861|Paclitaxel|paclitaxel|mesh-list
19479892|NCT03201861|Docetaxel|docetaxel|mesh-list
19479893|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19479894|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19479895|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479896|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
19479897|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
19479898|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
19479899|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479900|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
19479901|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19479902|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
19479903|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479904|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479905|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022038|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
19479906|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022039|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479907|NCT03201913|Estrogens|estrogens|mesh-list
19479908|NCT03201913|Hormones|hormones|mesh-ancestor
19479909|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479910|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479911|NCT03201796|Levofloxacin|levofloxacin|mesh-list
19479912|NCT03201796|Ofloxacin|ofloxacin|mesh-list
19479913|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
19479914|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19479915|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479916|NCT03201796|Renal Agents|renal agents|mesh-ancestor
19479917|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19479918|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19479919|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19479920|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479921|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479922|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479923|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19479924|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19479925|NCT03201770|Artesunate|artesunate|mesh-list
19479926|NCT03201770|Pyronaridine|pyronaridine|mesh-list
19479927|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
19479928|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19479929|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19479930|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479931|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479932|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
19479933|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
19479934|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19479935|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
19479936|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
19479937|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
19479938|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19479939|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479940|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479941|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
19479942|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19479943|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19479944|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479945|NCT03201835|Nabiximols|nabiximols|mesh-list
19479946|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479947|NCT03201835|Analgesics|analgesics|mesh-ancestor
19479948|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
19479949|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479950|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19479951|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19479952|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479953|NCT03201393|Acetaminophen|acetaminophen|mesh-list
19479954|NCT03201393|Naltrexone|naltrexone|mesh-list
19479955|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19479956|NCT03201393|Analgesics|analgesics|mesh-ancestor
19479957|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
19479958|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479959|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479960|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
20022040|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022041|NCT02557035|Dexamethasone|dexamethasone|mesh-list
20022042|NCT02557035|Palonosetron|palonosetron|mesh-list
20022043|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022044|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
20022045|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
20022046|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022047|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022048|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20022049|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
20022050|NCT02557035|Hormones|hormones|mesh-ancestor
20022051|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022052|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20022053|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022054|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20022055|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19479961|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19479962|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19568332|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479963|NCT03201185|Ramipril|ramipril|mesh-list
19479964|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19479965|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
19479966|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19479967|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479968|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19479969|NCT03201601|Inositol|inositol|mesh-list
19479970|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
20292631|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20292632|NCT05137262|Cisplatin|cisplatin|mesh-list
20292633|NCT05137262|Doxorubicin|doxorubicin|mesh-list
20292634|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20292635|NCT05137262|Methotrexate|methotrexate|mesh-list
20292636|NCT05137262|Durvalumab|durvalumab|mesh-list
20292637|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
20292638|NCT05137262|Vinblastine|vinblastine|mesh-list
19479971|NCT03201601|Vitamins|vitamins|mesh-ancestor
19479972|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
19479973|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479974|NCT03201250|Dexamethasone|dexamethasone|mesh-list
19479975|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19479976|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
19479977|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
19479978|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19479979|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19479980|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479981|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
19479982|NCT03201250|Hormones|hormones|mesh-ancestor
19479983|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19479984|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19479985|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19479986|NCT03201380|Choline|choline|mesh-list
19479987|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
19479988|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19479989|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
19479990|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19479991|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19479992|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19479993|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
19479994|NCT03201159|Pentamidine|pentamidine|mesh-list
19479995|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
19479996|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19479997|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19479998|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19479999|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19480000|NCT03201146|Cisplatin|cisplatin|mesh-list
19480001|NCT03201146|Carboplatin|carboplatin|mesh-list
19480002|NCT03201146|Pemetrexed|pemetrexed|mesh-list
19480003|NCT03201146|Apatinib|apatinib|mesh-list
19480004|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480005|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022056|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
20022057|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022058|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022059|NCT02557100|Adalimumab|adalimumab|mesh-list
20022060|NCT02557100|Methotrexate|methotrexate|mesh-list
20022061|NCT02557100|Abatacept|abatacept|mesh-list
20022062|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20022063|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
20022064|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20022065|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022066|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20022067|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
20022068|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022069|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022070|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022071|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022072|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20022073|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022074|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
20022075|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022076|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20022077|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292639|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292640|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20292641|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19480006|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480007|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19480008|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19480009|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19480010|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
19480011|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19480012|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
19480013|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19743427|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19743428|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
19743429|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
19743430|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743431|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743432|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
19743433|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19743434|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
19743435|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
19743436|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19743437|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19743438|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19743439|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743440|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743441|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743442|NCT04053478|Protective Agents|protective agents|mesh-ancestor
19743443|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19743444|NCT04046549|Abatacept|abatacept|mesh-list
19743445|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743446|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743447|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743448|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743449|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
19743450|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743451|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743452|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
19743453|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743454|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743455|NCT04027309|Midostaurin|midostaurin|mesh-list
19743456|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743457|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19743458|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743459|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743460|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
19743461|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19743462|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19743463|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19743464|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743465|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
19743466|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
19743467|NCT04002297|Rituximab|rituximab|mesh-list
19743468|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19743469|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
19743470|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743471|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743472|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
19743473|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743474|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743475|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19743476|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
19743477|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743478|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19743479|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743480|NCT03985540|Methamphetamine|methamphetamine|mesh-list
19743481|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19743482|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743483|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
19743484|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
20292642|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19480014|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
19480015|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480016|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480017|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
19480018|NCT03200964|Anesthetics|anesthetics|mesh-list
19480019|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480020|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480021|NCT03200938|Zinc|zinc|mesh-list
20292643|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480022|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
19480023|NCT03200938|Trace Elements|trace elements|mesh-ancestor
19480024|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
19480025|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480026|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
19480027|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
19480028|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19480029|NCT03200938|Protective Agents|protective agents|mesh-ancestor
19480030|NCT03200821|Gemcitabine|gemcitabine|mesh-list
19480031|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19480032|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
19480033|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480034|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480035|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
19480036|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480037|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480038|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480039|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
19480040|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480041|NCT03200782|Empagliflozin|empagliflozin|mesh-list
19480042|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19480043|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19480044|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480045|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19480046|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480047|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480048|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
19480049|NCT03200847|Tretinoin|tretinoin|mesh-list
19480050|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480051|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480052|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
19480053|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
19480054|NCT03200808|Methylene Blue|methylene blue|mesh-list
19480055|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480056|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480057|NCT03200691|Antibodies|antibodies|mesh-list
19480058|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
19480059|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480060|NCT03200886|Triamcinolone|triamcinolone|mesh-list
19480061|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19480062|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19480063|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19480064|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480065|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
19480066|NCT03200886|Hormones|hormones|mesh-ancestor
19480067|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480068|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480069|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480070|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
19480071|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480072|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022078|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20022079|NCT02557646|Ribavirin|ribavirin|mesh-list
20022080|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20022081|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
20022082|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022083|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
20022084|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022085|NCT02558231|Selexipag|selexipag|mesh-list
19480073|NCT03200600|Dexamethasone|dexamethasone|mesh-list
19480074|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
19480075|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
19480076|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19480077|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19480078|NCT03200600|BB 1101|bb 1101|mesh-list
19480079|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480080|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
19480081|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
19480082|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480083|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480084|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19480085|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
19480086|NCT03200600|Hormones|hormones|mesh-ancestor
19480087|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022086|NCT02558231|Tadalafil|tadalafil|mesh-list
19480088|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480089|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480090|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
19480091|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480092|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480093|NCT03200600|Analgesics|analgesics|mesh-ancestor
19480094|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
19480095|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19480096|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19480097|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480098|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19480099|NCT03200561|Prednisolone|prednisolone|mesh-list
19480100|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
19480101|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19480102|NCT03200561|Antibodies|antibodies|mesh-list
19480103|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480104|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
19480105|NCT03200561|Hormones|hormones|mesh-ancestor
19480106|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480107|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480108|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480109|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480110|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
19480111|NCT03200613|Heparin|heparin|mesh-list
19480112|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19480113|NCT03200613|Tinzaparin|tinzaparin|mesh-list
19480114|NCT03200613|Dalteparin|dalteparin|mesh-list
19480115|NCT03200613|Apixaban|apixaban|mesh-list
19480116|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
19480117|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19480118|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19480119|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480120|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19480121|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
19480122|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19480123|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
19480124|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480125|NCT03200392|Chromium|chromium|mesh-list
19480126|NCT03200392|Trace Elements|trace elements|mesh-ancestor
19480127|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
19480128|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480129|NCT03200093|Vancomycin|vancomycin|mesh-list
19480130|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19480131|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480132|NCT03200197|Menthol|menthol|mesh-list
19480133|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
19480134|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
19480135|NCT03200210|Febuxostat|febuxostat|mesh-list
19480136|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
19480137|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480138|NCT03200080|Amphetamine|amphetamine|mesh-list
19480139|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
19480140|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19480141|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480142|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
19480143|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
19480144|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480145|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
19480146|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480147|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480148|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
19480149|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19480150|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19480151|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480152|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19480153|NCT03200236|Nicotine|nicotine|mesh-list
19480154|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19480155|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
19480156|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480157|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480158|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19480159|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19480160|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
19480161|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480162|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480163|NCT03200015|Metformin|metformin|mesh-list
19480164|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19480165|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480166|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
19480167|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
19480168|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480169|NCT03199989|Capecitabine|capecitabine|mesh-list
19480170|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
19480171|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19480172|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
19480173|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480174|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480175|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
19480176|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
19480177|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480178|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
19480179|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480180|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480181|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19480182|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
19480183|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480184|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480185|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19480186|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19480187|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19480188|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
19480189|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19480190|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480191|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480192|NCT03199794|Factor VIII|factor viii|mesh-list
19480193|NCT03199794|Coagulants|coagulants|mesh-ancestor
20292644|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292645|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20292646|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
19480194|NCT03199976|Fluticasone|fluticasone|mesh-list
19480195|NCT03199976|Xhance|xhance|mesh-list
19480196|NCT03199976|Bromides|bromides|mesh-list
19480197|NCT03199976|Albuterol|albuterol|mesh-list
19480198|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
19480199|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480200|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19480201|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
19480202|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480203|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480204|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19480205|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
19480206|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
19480207|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19480208|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
19480209|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19480210|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
19480211|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480212|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480213|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
19480214|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
19480215|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19480216|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19480217|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19480218|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19480219|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
19568333|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568334|NCT03699631|Methotrexate|methotrexate|mesh-list
19568335|NCT03699631|Tacrolimus|tacrolimus|mesh-list
19568336|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19568337|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
19568338|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568339|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568340|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19568341|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
19568342|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568343|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568344|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
19568345|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568346|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19568347|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19568348|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
19568349|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19568350|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19480220|NCT03199664|Tacrolimus|tacrolimus|mesh-list
19480221|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480222|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
19480223|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480224|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19480225|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480226|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480227|NCT03199690|Rifampin|rifampin|mesh-list
19480228|NCT03199690|Dolutegravir|dolutegravir|mesh-list
19480229|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19480230|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
19480231|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19480232|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480233|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
19480234|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19480235|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480236|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480237|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19480238|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19480239|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19480240|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19480241|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19480242|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19480243|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19480244|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19480245|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19480246|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19480247|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
19480248|NCT03199950|Haloperidol|haloperidol|mesh-list
20022087|NCT02558231|Macitentan|macitentan|mesh-list
20022088|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
20022089|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20022090|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20022091|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022092|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022093|NCT02558231|Urological Agents|urological agents|mesh-ancestor
20022094|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20022095|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20022096|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20022097|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20022098|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
20022099|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20292647|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20292648|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480249|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
19480250|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
19480251|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
19480252|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480253|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480254|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19480255|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19480256|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19480257|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480258|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19480259|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19480260|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
19480261|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480262|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480263|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19480264|NCT03199677|Apatinib|apatinib|mesh-list
19480265|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480266|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19480267|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480268|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480269|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19480270|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
19480271|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19480272|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
19480273|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19480274|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480275|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19480276|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480277|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480278|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
19480279|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19480280|NCT03199820|Dinoprostone|dinoprostone|mesh-list
19480281|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
19480282|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19480283|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480284|NCT03199339|Midazolam|midazolam|mesh-list
19480285|NCT03199339|Bupropion|bupropion|mesh-list
19480286|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19480287|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19480288|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480289|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480290|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20022100|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480291|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19480292|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19480293|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19480294|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
19480295|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
19480296|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
19480297|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
19480298|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480299|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480300|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19480301|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
19480302|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19480303|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19480304|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480305|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
19480306|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19480307|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19480308|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480309|NCT03199261|Exenatide|exenatide|mesh-list
19480310|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19480311|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480312|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19480313|NCT03199261|Incretins|incretins|mesh-ancestor
19480314|NCT03199261|Hormones|hormones|mesh-ancestor
19480315|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480316|NCT03199300|Trastuzumab|trastuzumab|mesh-list
19480317|NCT03199300|Bleomycin|bleomycin|mesh-list
19480318|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480319|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480320|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19480321|NCT03199482|Dexamethasone|dexamethasone|mesh-list
19480322|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480323|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
19480324|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
19480325|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480326|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480327|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19480328|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
19480329|NCT03199482|Hormones|hormones|mesh-ancestor
19480330|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480331|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480332|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480333|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19480334|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
19480335|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480336|NCT03199430|Protective Agents|protective agents|mesh-ancestor
19480337|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480338|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19480339|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19480340|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480341|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19480342|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
19480343|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19480344|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19480345|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19480346|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480347|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480348|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
20022101|NCT02558374|Timolol|timolol|mesh-list
19480349|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480350|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480351|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19480352|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480353|NCT03199521|Thrombin|thrombin|mesh-list
19480354|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
19480355|NCT03199521|Coagulants|coagulants|mesh-ancestor
19480356|NCT03199170|Morphine|morphine|mesh-list
19480357|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19480358|NCT03199170|Narcotics|narcotics|mesh-ancestor
19480359|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480360|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480361|NCT03199170|Analgesics|analgesics|mesh-ancestor
19480362|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
19480363|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480364|NCT03199157|Fentanyl|fentanyl|mesh-list
19480365|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19480366|NCT03199157|Narcotics|narcotics|mesh-ancestor
19480367|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480368|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480369|NCT03199157|Analgesics|analgesics|mesh-ancestor
19480370|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
19480371|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480372|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19480373|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19480374|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
19480375|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
19480376|NCT03199105|Tetracaine|tetracaine|mesh-list
19480377|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
19480378|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
19480379|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480380|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480381|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
19480382|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480383|NCT03198637|Cisatracurium|cisatracurium|mesh-list
19480384|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19480385|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19480386|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480387|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480388|NCT03198819|Cefotaxime|cefotaxime|mesh-list
19480389|NCT03198819|Cefoxitin|cefoxitin|mesh-list
19480390|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19480391|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480392|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
19480393|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19480394|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19480395|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19480396|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480397|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480398|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
19480399|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480400|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480401|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19480402|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480403|NCT03198676|Poly I-C|poly i-c|mesh-list
19480404|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
19480405|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480406|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
19480407|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
19480408|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480409|NCT03198585|Empagliflozin|empagliflozin|mesh-list
19480410|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19480411|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480412|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19480413|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480414|NCT03198403|Epinephrine|epinephrine|mesh-list
19480415|NCT03198403|Bupivacaine|bupivacaine|mesh-list
19480416|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
19480417|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
19480418|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480419|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480420|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
20292649|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19480421|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480422|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19480423|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19480424|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
19480425|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480426|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480427|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19480428|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19480429|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
19480430|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022102|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20022103|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20022104|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20022105|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20022106|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
20022107|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022108|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022109|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022110|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20022111|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20022112|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20022113|NCT02558400|Latanoprost|latanoprost|mesh-list
20022114|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20022115|NCT02558829|Insulin|insulin|mesh-list
20022116|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20022117|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20022118|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022119|NCT02558894|Durvalumab|durvalumab|mesh-list
20022120|NCT02558894|Tremelimumab|tremelimumab|mesh-list
20022121|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20022122|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20022123|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022124|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
20022125|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022126|NCT02559206|Linaclotide|linaclotide|mesh-list
20022127|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20022128|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
20022129|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022130|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20022131|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
20022132|NCT02559310|Linezolid|linezolid|mesh-list
20022133|NCT02559310|Lefamulin|lefamulin|mesh-list
20022134|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20022135|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022136|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20022137|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20022138|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022139|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022140|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022141|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20022142|NCT02559414|Aspirin|aspirin|mesh-list
20022143|NCT02559414|Clopidogrel|clopidogrel|mesh-list
20022144|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20022145|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20022146|NCT02559414|Analgesics|analgesics|mesh-ancestor
20022147|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
20022148|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022149|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022150|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022151|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022152|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20022153|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20022154|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022155|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20022156|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20022157|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022158|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
20022159|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20022160|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20022161|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20022162|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
20022163|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022164|NCT02559505|Vaccines|vaccines|mesh-list
20022165|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
20022166|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022167|NCT02559570|Linaclotide|linaclotide|mesh-list
20022168|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20022169|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
20022170|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022171|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20022172|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20022173|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
20022174|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022175|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
20022176|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20022177|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480431|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
19480432|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
19480433|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
19480434|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19480435|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19480436|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19480437|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480438|NCT03198949|Everolimus|everolimus|mesh-list
19480439|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480440|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480441|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
19480442|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480443|NCT03198208|Fentanyl|fentanyl|mesh-list
19480444|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19480445|NCT03198208|Narcotics|narcotics|mesh-ancestor
19480446|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480447|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480448|NCT03198208|Analgesics|analgesics|mesh-ancestor
19480449|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
19480450|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480451|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19480452|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19480453|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
19480454|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
19480455|NCT03198338|Bupivacaine|bupivacaine|mesh-list
19480456|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
19480457|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
19480458|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480459|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480460|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
19480461|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480462|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
19480463|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480464|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
19480465|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480466|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480467|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19480468|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
19480469|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480470|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480471|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19743485|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743486|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
19743487|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743488|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743489|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743490|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19743491|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19743492|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19743493|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19743494|NCT03980483|Methotrexate|methotrexate|mesh-list
19743495|NCT03980483|Tofacitinib|tofacitinib|mesh-list
19743496|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19743497|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
19743498|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19743499|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743500|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19743501|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
19743502|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743503|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743504|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
19743505|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022178|NCT02559713|Vedolizumab|vedolizumab|mesh-list
20022179|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19480472|NCT03198130|Cemiplimab|cemiplimab|mesh-list
19480473|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20022180|NCT02559817|Linaclotide|linaclotide|mesh-list
19480474|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480475|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
19480476|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19568351|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19568352|NCT03693781|Colchicine|colchicine|mesh-list
19568353|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
19568354|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022181|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20022182|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
20022183|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022184|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20022185|NCT02560012|Sirolimus|sirolimus|mesh-list
20022186|NCT02560012|Everolimus|everolimus|mesh-list
19568355|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
19568356|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
19568357|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
19568358|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568359|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568360|NCT03690986|Nivolumab|nivolumab|mesh-list
19568361|NCT03690986|Ipilimumab|ipilimumab|mesh-list
19568362|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19568363|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568364|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19568365|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568366|NCT03685747|Vancomycin|vancomycin|mesh-list
19568367|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568368|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568369|NCT03650114|Ofatumumab|ofatumumab|mesh-list
19568370|NCT03650114|Vaccines|vaccines|mesh-list
19568371|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19568372|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19568373|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
19568374|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568375|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568376|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19568377|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
19568378|NCT03640949|Vasopressins|vasopressins|mesh-list
19568379|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
19568380|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568381|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
19568382|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
19568383|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568384|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568385|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19568386|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
19568387|NCT03640949|Hormones|hormones|mesh-ancestor
19568388|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568389|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19568390|NCT03640949|Protective Agents|protective agents|mesh-ancestor
19568391|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
19568392|NCT03640949|Coagulants|coagulants|mesh-ancestor
19568393|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19568394|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19568395|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
19568396|NCT03621761|Modafinil|modafinil|mesh-list
19568397|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19568398|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568399|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19568400|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19568401|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19568402|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568403|NCT03619551|Busulfan|busulfan|mesh-list
19568404|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
19568405|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568406|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19568407|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
19568408|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568409|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20022187|NCT02560012|Sorafenib|sorafenib|mesh-list
20022188|NCT02560012|Sunitinib|sunitinib|mesh-list
20022189|NCT02560012|Axitinib|axitinib|mesh-list
19568410|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022190|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480477|NCT03197961|Tenofovir|tenofovir|mesh-list
19480478|NCT03197961|Emtricitabine|emtricitabine|mesh-list
19480479|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19480480|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
19480481|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
19480482|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480483|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19480484|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19480485|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480486|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480487|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19480488|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19480489|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19480490|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19480491|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19480492|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
19480493|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19480494|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480495|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19480496|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19480497|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19480498|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480499|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480500|NCT03197779|Aspirin|aspirin|mesh-list
19480501|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19480502|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19480503|NCT03197779|Analgesics|analgesics|mesh-ancestor
19480504|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
19480505|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480506|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480507|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480508|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480509|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19480510|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19480511|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480512|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19480513|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19480514|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480515|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
19480516|NCT03197818|Budesonide|budesonide|mesh-list
19480517|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
19480518|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480519|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19480520|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
19480521|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480522|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480523|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19480524|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
19480525|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
19480526|NCT03197818|Hormones|hormones|mesh-ancestor
19480527|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480528|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19480529|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19480530|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19480531|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
20022191|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022192|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
20022193|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022194|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20022195|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022196|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022197|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20022198|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20022199|NCT02560012|Growth Substances|growth substances|mesh-ancestor
20022200|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
20022201|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20022202|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480532|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480533|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480534|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
19480535|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480536|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480537|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
19480538|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480539|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480540|NCT03197623|Alendronate|alendronate|mesh-list
19480541|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19480542|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480543|NCT03197571|Leucovorin|leucovorin|mesh-list
19480544|NCT03197571|Paclitaxel|paclitaxel|mesh-list
19480545|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
19480546|NCT03197571|Bevacizumab|bevacizumab|mesh-list
19480547|NCT03197571|Fluorouracil|fluorouracil|mesh-list
19480548|NCT03197571|Capecitabine|capecitabine|mesh-list
19480549|NCT03197571|Fulvestrant|fulvestrant|mesh-list
19480550|NCT03197571|Avelumab|avelumab|mesh-list
19480551|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19480552|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480553|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
19480554|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
19480555|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
19480556|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480557|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480558|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
19480559|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480560|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480561|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19480562|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
19480563|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19480564|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480565|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19480566|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19480567|NCT03197571|Growth Substances|growth substances|mesh-ancestor
19480568|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
19480569|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
19480570|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19480571|NCT03197571|Antidotes|antidotes|mesh-ancestor
19480572|NCT03197571|Protective Agents|protective agents|mesh-ancestor
19480573|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
19480574|NCT03197571|Vitamins|vitamins|mesh-ancestor
19480575|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
19480576|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480577|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19480578|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19480579|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
19480580|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480581|NCT03198013|Prednisolone|prednisolone|mesh-list
19480582|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480583|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
19480584|NCT03198013|Hormones|hormones|mesh-ancestor
19480585|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480586|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480587|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480588|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480589|NCT03197584|Leucovorin|leucovorin|mesh-list
19480590|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
19480591|NCT03197584|Bevacizumab|bevacizumab|mesh-list
19480592|NCT03197584|Fluorouracil|fluorouracil|mesh-list
19480593|NCT03197584|Capecitabine|capecitabine|mesh-list
19480594|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
19480595|NCT03197584|Fulvestrant|fulvestrant|mesh-list
19480596|NCT03197584|Avelumab|avelumab|mesh-list
19480597|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480598|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480599|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480600|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
19480601|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480602|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480603|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19480604|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
19480605|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20292650|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
20115424|NCT00005578|Prednisone|prednisone|mesh-list
19480606|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480607|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19480608|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19480609|NCT03197584|Growth Substances|growth substances|mesh-ancestor
19480610|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
19480611|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
19480612|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19480613|NCT03197584|Antidotes|antidotes|mesh-ancestor
19480614|NCT03197584|Protective Agents|protective agents|mesh-ancestor
19480615|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
19480616|NCT03197584|Vitamins|vitamins|mesh-ancestor
19480617|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
19480618|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480619|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19480620|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19480621|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
19480622|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480623|NCT03197493|Levodopa|levodopa|mesh-list
19480624|NCT03197493|Carbidopa|carbidopa|mesh-list
19480625|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19480626|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19480627|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19480628|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
19480629|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480630|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480631|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480632|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19480633|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480634|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19480635|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
19480636|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
19480637|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
19480638|NCT03197506|Temozolomide|temozolomide|mesh-list
19480639|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480640|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480641|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19480642|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
19480643|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480644|NCT03197480|Aflibercept|aflibercept|mesh-list
19480645|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19480646|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19480647|NCT03197480|Growth Substances|growth substances|mesh-ancestor
19480648|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480649|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
19480650|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480651|NCT03197402|Caseins|caseins|mesh-list
19480652|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
19480653|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
19480654|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480655|NCT03197298|Clopidogrel|clopidogrel|mesh-list
19480656|NCT03197298|Ticagrelor|ticagrelor|mesh-list
19480657|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19480658|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19480659|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19480660|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19480661|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
19480662|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480663|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480664|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480665|NCT03197207|Camphor|camphor|mesh-list
19480666|NCT03197207|Salicylates|salicylates|mesh-list
19480667|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
19480668|NCT03197207|Menthol|menthol|mesh-list
19480669|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19480670|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480671|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
20022203|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20022204|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
20022205|NCT02560025|Cytarabine|cytarabine|mesh-list
20022206|NCT02560025|Daunorubicin|daunorubicin|mesh-list
20022207|NCT02560025|Idarubicin|idarubicin|mesh-list
20022208|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20022209|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
20022210|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022211|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022212|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
20022213|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480672|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022214|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19480673|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19480674|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19480675|NCT03197207|Analgesics|analgesics|mesh-ancestor
19480676|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
19480677|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480678|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480679|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480680|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19480681|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19480682|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480683|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480684|NCT03197740|Donepezil|donepezil|mesh-list
19480685|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19480686|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480687|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480688|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
19480689|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480690|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480691|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
19480692|NCT03197233|Vitamin D|vitamin d|mesh-list
19480693|NCT03197233|Vitamins|vitamins|mesh-list
19480694|NCT03197233|Vitamin A|vitamin a|mesh-list
19480695|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
19480696|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
19480697|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480698|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
19480699|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480700|NCT03197233|Protective Agents|protective agents|mesh-ancestor
19480701|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19480702|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480703|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19480704|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
19480705|NCT03197077|Desogestrel|desogestrel|mesh-list
19480706|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
19480707|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19480708|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19480709|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19480710|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480711|NCT03197077|Hormones|hormones|mesh-ancestor
19480712|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480713|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19480714|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19480715|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19480716|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19480717|NCT03197077|Progestins|progestins|mesh-ancestor
19480718|NCT03196869|Cisplatin|cisplatin|mesh-list
19480719|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480720|NCT03196921|Amphotericin B|amphotericin b|mesh-list
19480721|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19480722|NCT03196921|Amebicides|amebicides|mesh-ancestor
19480723|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20292651|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
20292652|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20292653|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292654|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
19480724|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19480725|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480726|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19480727|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
19480728|NCT03196986|Bevacizumab|bevacizumab|mesh-list
19480729|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480730|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480731|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19480732|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19480733|NCT03196986|Growth Substances|growth substances|mesh-ancestor
19480734|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480735|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
19480736|NCT03196934|Cannabidiol|cannabidiol|mesh-list
19480737|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
19480738|NCT03197012|Octreotide|octreotide|mesh-list
19480739|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19480740|NCT03197012|Edotreotide|edotreotide|mesh-list
19480741|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
19480742|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
19480743|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480744|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19480745|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19480746|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19480747|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480748|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
19743506|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19743507|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743508|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
19743509|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743510|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19743511|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19743512|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
19743513|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19743514|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
19743515|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743516|NCT03976973|Expectorants|expectorants|mesh-ancestor
19743517|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
19743518|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19743519|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
19743520|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743521|NCT03976973|Protective Agents|protective agents|mesh-ancestor
19743522|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743523|NCT03976973|Antidotes|antidotes|mesh-ancestor
19743524|NCT03970837|Tofacitinib|tofacitinib|mesh-list
19743525|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20292655|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292656|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20292657|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743526|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743527|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743528|NCT03968406|Talazoparib|talazoparib|mesh-list
19743529|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19743530|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743531|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743532|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743533|NCT03964532|Avelumab|avelumab|mesh-list
19743534|NCT03964532|Talazoparib|talazoparib|mesh-list
19743535|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743536|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743537|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19743538|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743539|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743540|NCT03920267|BMS-986165|bms-986165|mesh-list
19743541|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
19743542|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19743543|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743544|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743545|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
19743546|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19743547|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743548|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19743549|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
19743550|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743551|NCT03873311|Cytarabine|cytarabine|mesh-list
19743552|NCT03873311|Azacitidine|azacitidine|mesh-list
19743553|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19743554|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
19743555|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743556|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743557|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
19743558|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743559|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743560|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
19743561|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743562|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743563|NCT03847428|Bevacizumab|bevacizumab|mesh-list
20292658|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20292659|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
19480749|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19480750|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
19480751|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480752|NCT03197103|Expectorants|expectorants|mesh-ancestor
19480753|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
19480754|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19743564|NCT03847428|Durvalumab|durvalumab|mesh-list
19480755|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
19480756|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480757|NCT03197103|Protective Agents|protective agents|mesh-ancestor
19480758|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480759|NCT03197103|Antidotes|antidotes|mesh-ancestor
19480760|NCT03196817|Betamethasone|betamethasone|mesh-list
19480761|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
19480762|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19480763|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
19480764|NCT03196817|Lidocaine|lidocaine|mesh-list
19480765|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19480766|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
19480767|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
19480768|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480769|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480770|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
19480771|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480772|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19480773|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19480774|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19480775|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480776|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480777|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480778|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
19480779|NCT03196817|Hormones|hormones|mesh-ancestor
19480780|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480781|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19480782|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19480783|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
19480784|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480785|NCT03196882|Iron|iron|mesh-list
19480786|NCT03196882|Trace Elements|trace elements|mesh-ancestor
19480787|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
19480788|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480789|NCT03196843|Raltitrexed|raltitrexed|mesh-list
19480790|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19480791|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
19480792|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480793|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480794|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19480795|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480796|NCT03196648|Fluorides|fluorides|mesh-list
19480797|NCT03196648|Antioxidants|antioxidants|mesh-list
19480798|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
19480799|NCT03196648|Protective Agents|protective agents|mesh-ancestor
19480800|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480801|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480802|NCT03196466|Topiramate|topiramate|mesh-list
19480803|NCT03196466|Pregabalin|pregabalin|mesh-list
19480804|NCT03196466|Lamotrigine|lamotrigine|mesh-list
19480805|NCT03196466|Zonisamide|zonisamide|mesh-list
19480806|NCT03196466|Lacosamide|lacosamide|mesh-list
19480807|NCT03196466|Carbamazepine|carbamazepine|mesh-list
19480808|NCT03196466|Phenytoin|phenytoin|mesh-list
19480809|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
19480810|NCT03196466|Rufinamide|rufinamide|mesh-list
19480811|NCT03196466|Cannabidiol|cannabidiol|mesh-list
19480812|NCT03196466|Levetiracetam|levetiracetam|mesh-list
19480813|NCT03196466|Valproic Acid|valproic acid|mesh-list
19480814|NCT03196466|Brivaracetam|brivaracetam|mesh-list
19480815|NCT03196466|Phenobarbital|phenobarbital|mesh-list
19480816|NCT03196466|Clobazam|clobazam|mesh-list
19480817|NCT03196466|Ethosuximide|ethosuximide|mesh-list
19480818|NCT03196466|Tiagabine|tiagabine|mesh-list
19480819|NCT03196466|Stiripentol|stiripentol|mesh-list
19480820|NCT03196466|Primidone|primidone|mesh-list
19480821|NCT03196466|Felbamate|felbamate|mesh-list
19480822|NCT03196466|Analgesics|analgesics|mesh-ancestor
19480823|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
19480824|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480825|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480826|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
19480827|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19480828|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480829|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480830|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19480831|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19480832|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19480833|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480834|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19480835|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19480836|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
19480837|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19480838|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19480839|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480840|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
19480841|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480842|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
19480843|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19480844|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19480845|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19480846|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19480847|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19480848|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19480849|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19480850|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19480851|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
19480852|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19480853|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19480854|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
19480855|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
19480856|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19480857|NCT03196401|Durvalumab|durvalumab|mesh-list
19480858|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480859|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480860|NCT03196479|Ketamine|ketamine|mesh-list
19480861|NCT03196479|Propofol|propofol|mesh-list
19480862|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19480863|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480864|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480865|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19480866|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
19480867|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
19480868|NCT03196479|Analgesics|analgesics|mesh-ancestor
19480869|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
19480870|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480871|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19480872|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19480873|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19480874|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480875|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568411|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19568412|NCT03616886|Paclitaxel|paclitaxel|mesh-list
19568413|NCT03616886|Carboplatin|carboplatin|mesh-list
19568414|NCT03616886|Durvalumab|durvalumab|mesh-list
19568415|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19568416|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568417|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
19568418|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
19568419|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
19568420|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568421|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19568422|NCT03616574|Trifluridine|trifluridine|mesh-list
19568423|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
19568424|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568425|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
19568426|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568427|NCT03615508|Phenylephrine|phenylephrine|mesh-list
19568428|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
19568429|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19568430|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
19568431|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
19568432|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568433|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568434|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
19480876|NCT03196531|Loratadine|loratadine|mesh-list
19480877|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
19480878|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
19480879|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19480880|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19480881|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19480882|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
19480883|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
19480884|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480885|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480886|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480887|NCT03196362|Metformin|metformin|mesh-list
19480888|NCT03196362|Pioglitazone|pioglitazone|mesh-list
19480889|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19480890|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480891|NCT03196154|Insulin|insulin|mesh-list
19480892|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19480893|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480894|NCT03195634|Carvedilol|carvedilol|mesh-list
19480895|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19480896|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19480897|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19480898|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480899|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480900|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480901|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19480902|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
19480903|NCT03195634|Protective Agents|protective agents|mesh-ancestor
19480904|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19480905|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480906|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19480907|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
19480908|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20022215|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
20022216|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022217|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20022218|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20022219|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19480909|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19480910|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
19480911|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19480912|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19480913|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480914|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
19480915|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
19480916|NCT03195569|Paclitaxel|paclitaxel|mesh-list
19480917|NCT03195569|Bevacizumab|bevacizumab|mesh-list
19480918|NCT03195569|Carboplatin|carboplatin|mesh-list
19480919|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19480920|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480921|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
19480922|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
19480923|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
19480924|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480925|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480926|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19480927|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19480928|NCT03195569|Growth Substances|growth substances|mesh-ancestor
19480929|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480930|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
20022220|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022221|NCT02560038|Gemcitabine|gemcitabine|mesh-list
20022222|NCT02560038|Paclitaxel|paclitaxel|mesh-list
20022223|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20022224|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022225|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022226|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
20022227|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022228|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022229|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20022230|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
20292660|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19480931|NCT03195946|Midazolam|midazolam|mesh-list
19480932|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20022231|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
19480933|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19480934|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480935|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480936|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20022232|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022233|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480937|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19480938|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19480939|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19480940|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
19480941|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
19480942|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
19480943|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
19480944|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480945|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480946|NCT03195673|Terazosin|terazosin|mesh-list
19480947|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19480948|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19480949|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19480950|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
19480951|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19480952|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480953|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480954|NCT03195673|Urological Agents|urological agents|mesh-ancestor
19480955|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
19480956|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19480957|NCT03195543|Thrombin|thrombin|mesh-list
19480958|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
19480959|NCT03195543|Coagulants|coagulants|mesh-ancestor
19480960|NCT03195530|Propofol|propofol|mesh-list
19480961|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19480962|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480963|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480964|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19480965|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
19480966|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
19480967|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
19480968|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19480969|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19480970|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19480971|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
19480972|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19480973|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19480974|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19480975|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19480976|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480977|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19480978|NCT03195491|Nivolumab|nivolumab|mesh-list
19480979|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19480980|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19480981|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19480982|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480983|NCT03195413|Lidocaine|lidocaine|mesh-list
19480984|NCT03195413|Epinephrine|epinephrine|mesh-list
19480985|NCT03195413|Racepinephrine|racepinephrine|mesh-list
19480986|NCT03195413|Bupivacaine|bupivacaine|mesh-list
19480987|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
19480988|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
19480989|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
19480990|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19480991|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19480992|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
19480993|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19480994|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19480995|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19480996|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19480997|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19480998|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19480999|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19481000|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19481001|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
19481002|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022234|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481003|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19481004|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19481005|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
19481006|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19481007|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
19481008|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
19481009|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
19481010|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19481011|NCT03195205|Antibodies|antibodies|mesh-list
19481012|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
19481013|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481014|NCT03195257|Glucagon|glucagon|mesh-list
19481015|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
19481016|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19481017|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481018|NCT03195257|Hormones|hormones|mesh-ancestor
19481019|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481020|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481021|NCT03195257|Incretins|incretins|mesh-ancestor
19481022|NCT03195049|Bilirubin|bilirubin|mesh-list
19481023|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
19481024|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481025|NCT03195049|Protective Agents|protective agents|mesh-ancestor
19481026|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481027|NCT03195153|Allopurinol|allopurinol|mesh-list
19481028|NCT03195153|Atorvastatin|atorvastatin|mesh-list
19481029|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19481030|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19481031|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
19481032|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481033|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19481034|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20022235|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
20022236|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022237|NCT02560051|Ketoconazole|ketoconazole|mesh-list
20022238|NCT02560051|Docetaxel|docetaxel|mesh-list
20022239|NCT02560051|Doxorubicin|doxorubicin|mesh-list
20022240|NCT02560051|Estramustine|estramustine|mesh-list
20022241|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022242|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022243|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
19481035|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022244|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022245|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022246|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20022247|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20022248|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20022249|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481036|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
19481037|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481038|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20022250|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
20022251|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022252|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20022253|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20022254|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20022255|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
20022256|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022257|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022258|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19481039|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
19481040|NCT03195153|Protective Agents|protective agents|mesh-ancestor
19481041|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481042|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19481043|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19481044|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481045|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19481046|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19481047|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481048|NCT03195309|Fentanyl|fentanyl|mesh-list
19481049|NCT03195309|Ropivacaine|ropivacaine|mesh-list
19481050|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
19481051|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
19481052|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481053|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481054|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
19481055|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292661|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20292662|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292663|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
19481056|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20022259|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20022260|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
19481057|NCT03195309|Narcotics|narcotics|mesh-ancestor
19481058|NCT03195309|Analgesics|analgesics|mesh-ancestor
19481059|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19481060|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19481061|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
19481062|NCT03195023|Amlodipine|amlodipine|mesh-list
19481063|NCT03195023|Lisinopril|lisinopril|mesh-list
19481064|NCT03195023|Lercanidipine|lercanidipine|mesh-list
19481065|NCT03195023|Furosemide|furosemide|mesh-list
19481066|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19481067|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19481068|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19481069|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19481070|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481071|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481072|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19481073|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481074|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
19481075|NCT03195023|Diuretics|diuretics|mesh-ancestor
19481076|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
19481077|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19481078|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
19481079|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19481080|NCT03195023|Protective Agents|protective agents|mesh-ancestor
19481081|NCT03194815|Rituximab|rituximab|mesh-list
19481082|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
19481083|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19481084|NCT03194815|Antibodies|antibodies|mesh-list
19481085|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
19481086|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19481087|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481088|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481089|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
19481090|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481091|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481092|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
19481093|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
19481094|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19481095|NCT03194620|Procyanidin|procyanidin|mesh-list
19481096|NCT03194620|Theaflavin|theaflavin|mesh-list
19481097|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
19481098|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481099|NCT03194620|Protective Agents|protective agents|mesh-ancestor
19481100|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481101|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19481102|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19481103|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481104|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19481105|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481106|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
19481107|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481108|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19481109|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19481110|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19481111|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
19481112|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
19481113|NCT03194685|FF-10101|ff-10101|mesh-list
19481114|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19481115|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481116|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743565|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743566|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743567|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19743568|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19743569|NCT03847428|Growth Substances|growth substances|mesh-ancestor
19743570|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743571|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
20022261|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20022262|NCT02560389|Levodopa|levodopa|mesh-list
19481117|NCT03194724|Vitamin A|vitamin a|mesh-list
19481118|NCT03194724|Vitamins|vitamins|mesh-ancestor
19481119|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
19481120|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568435|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19568436|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
19568437|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
19568438|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19568439|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19568440|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19568441|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19568442|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568443|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568444|NCT03615508|Protective Agents|protective agents|mesh-ancestor
19568445|NCT03612791|Atezolizumab|atezolizumab|mesh-list
19568446|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568447|NCT03609840|Thiotepa|thiotepa|mesh-list
19568448|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
19568449|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
19568450|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
19568451|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568452|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20022263|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20022264|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20022265|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
20292664|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
20292665|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
20292666|NCT05128071|Progesterone|progesterone|mesh-list
20022266|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022267|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022268|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022269|NCT02560558|Abatacept|abatacept|mesh-list
20292667|NCT05128071|Progestins|progestins|mesh-ancestor
20292668|NCT05128071|Hormones|hormones|mesh-ancestor
20292669|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20292670|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292671|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
20292672|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20576346|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20576347|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576348|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20576349|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20576350|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576351|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
20576352|NCT02071043|Capecitabine|capecitabine|mesh-list
20576353|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
20576354|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576355|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
20576356|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022270|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20022271|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022272|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022273|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022274|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
20022275|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292673|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576357|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576358|NCT02071069|Fluorouracil|fluorouracil|mesh-list
20576359|NCT02071069|Irinotecan|irinotecan|mesh-list
20576360|NCT02071069|Cetuximab|cetuximab|mesh-list
20576361|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
20576362|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576363|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576364|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576365|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022276|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022277|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20022278|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20022279|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022280|NCT02560779|Sorafenib|sorafenib|mesh-list
20022281|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022282|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20022283|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022284|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481121|NCT03194633|Nifedipine|nifedipine|mesh-list
19481122|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19481123|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481124|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481125|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19481126|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481127|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
19481128|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
19481129|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19481130|NCT03194659|Choline|choline|mesh-list
19481131|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
19481132|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19481133|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
19481134|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481135|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481136|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19481137|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
19481138|NCT03194594|Dexamethasone|dexamethasone|mesh-list
19481139|NCT03194594|Ketamine|ketamine|mesh-list
19481140|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481141|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
19481142|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
19481143|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481144|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481145|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481146|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
19481147|NCT03194594|Hormones|hormones|mesh-ancestor
19481148|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481149|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19481150|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481151|NCT03194594|Analgesics|analgesics|mesh-ancestor
19481152|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
19481153|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19481154|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19481155|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
19481156|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
19481157|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481158|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19481159|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19481160|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19481161|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481162|NCT03194555|Acetaminophen|acetaminophen|mesh-list
19481163|NCT03194555|Naltrexone|naltrexone|mesh-list
19481164|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481165|NCT03194555|Analgesics|analgesics|mesh-ancestor
19481166|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
19481167|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481168|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481169|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
19481170|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19481171|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19481172|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
19481173|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
19481174|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481175|NCT03194139|Protective Agents|protective agents|mesh-ancestor
19481176|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481177|NCT03194204|Doxycycline|doxycycline|mesh-list
19481178|NCT03194204|Uric Acid|uric acid|mesh-list
19481179|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
19481180|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19481181|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481182|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
19481183|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19481184|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19481185|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
19481186|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481187|NCT03194204|Protective Agents|protective agents|mesh-ancestor
19481188|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481189|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
19481190|NCT03194126|Misoprostol|misoprostol|mesh-list
19481191|NCT03194126|Mifepristone|mifepristone|mesh-list
19481192|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19481193|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
19481194|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19481195|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481196|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19481197|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481198|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
19481199|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19481200|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19481201|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19481202|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19481203|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
19481204|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19481205|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19481206|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
19481207|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481208|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
19481209|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19481210|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19481211|NCT03194061|Cisplatin|cisplatin|mesh-list
19481212|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481213|NCT03194074|Propofol|propofol|mesh-list
19481214|NCT03194074|Desflurane|desflurane|mesh-list
19481215|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19481216|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481217|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481218|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19481219|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
19481220|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
19481221|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19481222|NCT03193749|Amiodarone|amiodarone|mesh-list
19481223|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19481224|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
19481225|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19481226|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481227|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481228|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19481229|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19481230|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19481231|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481232|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19481233|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19481234|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19481235|NCT03193684|Dapagliflozin|dapagliflozin|mesh-list
19481236|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19481237|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481238|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19481239|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481240|NCT03193944|Vitamin D|vitamin d|mesh-list
19481241|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
19481242|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
19481243|NCT03193944|Vitamins|vitamins|mesh-list
19481244|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
19481245|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481246|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19481247|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19481248|NCT03193957|Etanercept|etanercept|mesh-list
19481249|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19481250|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481251|NCT03193957|Analgesics|analgesics|mesh-ancestor
19481252|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
19481253|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481254|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481255|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481256|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481257|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481258|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481259|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
19481260|NCT03193814|Apatinib|apatinib|mesh-list
19481261|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481262|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19481263|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481264|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481265|NCT03193788|Folic Acid|folic acid|mesh-list
19481266|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
19481267|NCT03193788|Hydroxocobalamin|hydroxocobalamin|mesh-list
20022285|NCT02561078|Insulin|insulin|mesh-list
19481268|NCT03193788|Dexamethasone|dexamethasone|mesh-list
19481269|NCT03193788|Pemetrexed|pemetrexed|mesh-list
20022286|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19481270|NCT03193788|Vitamins|vitamins|mesh-ancestor
19481271|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
19481272|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481273|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481274|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
19481275|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
19481276|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481277|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481278|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
19481279|NCT03193788|Hormones|hormones|mesh-ancestor
19481280|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481281|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19481282|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481283|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481284|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481285|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19481286|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19481287|NCT03193788|Hematinics|hematinics|mesh-ancestor
19481288|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
19743572|NCT03841292|Varenicline|varenicline|mesh-list
19743573|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19743574|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19743575|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
19743576|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743577|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743578|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743579|NCT03840291|Edoxaban|edoxaban|mesh-list
19743580|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19481298|NCT03193723|Anesthetics|anesthetics|mesh-list
19481299|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481300|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481301|NCT03193710|Remifentanil|remifentanil|mesh-list
19481302|NCT03193710|Propofol|propofol|mesh-list
19481303|NCT03193710|Sevoflurane|sevoflurane|mesh-list
19481304|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19481305|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481306|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481307|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19481308|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
19481309|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
19481310|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19481311|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19481312|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19481313|NCT03193710|Narcotics|narcotics|mesh-ancestor
19481314|NCT03193710|Analgesics|analgesics|mesh-ancestor
19481315|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
19481316|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481317|NCT03193918|Paclitaxel|paclitaxel|mesh-list
19481318|NCT03193918|Ramucirumab|ramucirumab|mesh-list
19481319|NCT03193918|Crenolanib|crenolanib|mesh-list
20292674|NCT05111574|Nivolumab|nivolumab|mesh-list
20292675|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292676|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292677|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20292678|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292679|NCT05109416|Bupivacaine|bupivacaine|mesh-list
19481320|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19481321|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481322|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
19481323|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
19481324|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
19481325|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022287|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20022288|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022289|NCT02561130|Metformin|metformin|mesh-list
20022290|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
20022291|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
20022292|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20022293|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481326|NCT03194009|Metformin|metformin|mesh-list
20022294|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20022295|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481327|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19481328|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481329|NCT03193372|Azelaic acid|azelaic acid|mesh-list
19481330|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481331|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
19481332|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
19481333|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19481334|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
19481335|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19481336|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
19481337|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481338|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481339|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
19481340|NCT03193424|Docetaxel|docetaxel|mesh-list
19481341|NCT03193424|Apatinib|apatinib|mesh-list
19481342|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481343|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
19481344|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
19481345|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
19481346|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481347|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19481348|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481349|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
19481350|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19481351|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19481352|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19481353|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481354|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481355|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
19481356|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19481357|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481358|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19481359|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481360|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
19481361|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19481362|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19481363|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19481364|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481365|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481366|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
19481367|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19481368|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481369|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19481370|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481371|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19481372|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19481373|NCT03193307|BI 409306|bi 409306|mesh-list
19481374|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19481375|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481376|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481377|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19481378|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
19481379|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19481380|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481381|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19481382|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19481383|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19481384|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19481385|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19481386|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19481387|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19481388|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19481389|NCT03193463|Topotecan|topotecan|mesh-list
19481390|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19481391|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19481392|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481393|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481394|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022296|NCT02561273|Prednisone|prednisone|mesh-list
20022297|NCT02561273|Cortisone|cortisone|mesh-list
20022298|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
20022299|NCT02561273|Doxorubicin|doxorubicin|mesh-list
20022300|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20022301|NCT02561273|Etoposide|etoposide|mesh-list
20022302|NCT02561273|Vincristine|vincristine|mesh-list
20022303|NCT02561273|Lenalidomide|lenalidomide|mesh-list
20022304|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
20022305|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
19481395|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
19481396|NCT03193281|Dasatinib|dasatinib|mesh-list
19481397|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481398|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19481399|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481400|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481401|NCT03193606|Fluorides|fluorides|mesh-list
20115425|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
19481402|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
19481403|NCT03193606|Protective Agents|protective agents|mesh-ancestor
19481404|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481405|NCT03193203|Etanercept|etanercept|mesh-list
19481406|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19743581|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
19743582|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19743583|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
19743584|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743585|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743586|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
19743587|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19743588|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19743589|NCT03824106|Vitamin D|vitamin d|mesh-list
19743590|NCT03824106|Vitamins|vitamins|mesh-ancestor
19743591|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
19743592|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743593|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19743594|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
19743595|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
19743596|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19743597|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19743598|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743599|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743600|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743601|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743602|NCT03818776|Durvalumab|durvalumab|mesh-list
19743603|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743604|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743605|NCT03817515|Sirolimus|sirolimus|mesh-list
19743606|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19743607|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743608|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19743609|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743610|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
19743611|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743612|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
19743613|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743614|NCT03786796|Olaparib|olaparib|mesh-list
19743615|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19743616|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743617|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743618|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743619|NCT03779074|Amoxicillin|amoxicillin|mesh-list
19743620|NCT03779074|Metronidazole|metronidazole|mesh-list
19743621|NCT03779074|Clarithromycin|clarithromycin|mesh-list
19743622|NCT03779074|Tetracycline|tetracycline|mesh-list
19743623|NCT03779074|Rabeprazole|rabeprazole|mesh-list
19743624|NCT03779074|Bismuth|bismuth|mesh-list
19743625|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19743626|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743627|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19743628|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19743629|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19743630|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743631|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743632|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19743633|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19481407|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743634|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19743635|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20292680|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
19481408|NCT03193203|Analgesics|analgesics|mesh-ancestor
19481409|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
19481410|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481411|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481412|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481413|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481414|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481415|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481416|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
19481417|NCT03192878|Infliximab|infliximab|mesh-list
19481418|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
19481419|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481420|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481421|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
19481422|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481423|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481424|NCT03193073|Mitogens|mitogens|mesh-list
19481425|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
19481426|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481427|NCT03192943|Nivolumab|nivolumab|mesh-list
19481428|NCT03192943|Linrodostat|linrodostat|mesh-list
19481429|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481430|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481431|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19481432|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481433|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481434|NCT03193112|S 20098|s 20098|mesh-list
19481435|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19481436|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481437|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481438|NCT03192969|Abatacept|abatacept|mesh-list
19481439|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
19481440|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19481441|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481442|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481443|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481444|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
19481445|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481446|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481447|NCT03192969|Hormones|hormones|mesh-ancestor
19481448|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568453|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19568454|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
19568455|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568456|NCT03606642|Aspirin|aspirin|mesh-list
19568457|NCT03606642|Clopidogrel|clopidogrel|mesh-list
19568458|NCT03606642|Ticagrelor|ticagrelor|mesh-list
19568459|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19568460|NCT03606642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19568461|NCT03606642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19568462|NCT03606642|Analgesics|analgesics|mesh-ancestor
19568463|NCT03606642|Sensory System Agents|sensory system agents|mesh-ancestor
19568464|NCT03606642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568465|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568466|NCT03606642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568467|NCT03606642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19568468|NCT03606642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19568469|NCT03606642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19568470|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568471|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19568472|NCT03606642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19568473|NCT03606642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568474|NCT03606642|Antipyretics|antipyretics|mesh-ancestor
19568475|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19568476|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19568477|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19568478|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
19568479|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568480|NCT03586687|Triamcinolone|triamcinolone|mesh-list
19568481|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568482|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
19568483|NCT03586687|Hormones|hormones|mesh-ancestor
19568484|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568485|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568486|NCT03573024|Azacitidine|azacitidine|mesh-list
19481449|NCT03192566|Acetaminophen|acetaminophen|mesh-list
19481450|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481451|NCT03192566|Analgesics|analgesics|mesh-ancestor
19481452|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
19481453|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481454|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481455|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
19481456|NCT03192618|Leucovorin|leucovorin|mesh-list
19481457|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
19481458|NCT03192618|Calcium|calcium|mesh-list
19481459|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
19481460|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19481461|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481462|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481463|NCT03192618|Antidotes|antidotes|mesh-ancestor
19481464|NCT03192618|Protective Agents|protective agents|mesh-ancestor
19481465|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
19481466|NCT03192618|Vitamins|vitamins|mesh-ancestor
19481467|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
19481468|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19481469|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19481470|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19481471|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
19481472|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481473|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19481474|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19481475|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481476|NCT03192657|Basiliximab|basiliximab|mesh-list
19481477|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19481478|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481479|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
19481480|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481481|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481482|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481483|NCT03192644|Leucovorin|leucovorin|mesh-list
19481484|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
19481485|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
19481486|NCT03192644|Epirubicin|epirubicin|mesh-list
19481487|NCT03192644|Calcium|calcium|mesh-list
19481488|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
19481489|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481490|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19481491|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481492|NCT03192644|Antidotes|antidotes|mesh-ancestor
19481493|NCT03192644|Protective Agents|protective agents|mesh-ancestor
19481494|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
19481495|NCT03192644|Vitamins|vitamins|mesh-ancestor
19481496|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
19481497|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19481498|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19481499|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19481500|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481501|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481502|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19481503|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
19481504|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19481505|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
19481506|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19481507|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481508|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19481509|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19481510|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481511|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
19481512|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
19481513|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19481514|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19481515|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481516|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481517|NCT03192709|Urological Agents|urological agents|mesh-ancestor
19481518|NCT03192449|Albendazole|albendazole|mesh-list
19481519|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
19481520|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19481521|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481522|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
19481523|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19481524|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19481525|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
19481526|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
19481527|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
19481528|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481529|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481530|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
19481531|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481532|NCT03192371|Vaccines|vaccines|mesh-list
19481533|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
19481534|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481535|NCT03192111|Entinostat|entinostat|mesh-list
19481536|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481537|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19481538|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481539|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481540|NCT03192293|Metformin|metformin|mesh-list
19481541|NCT03192293|Fulvestrant|fulvestrant|mesh-list
19481542|NCT03192293|Simvastatin|simvastatin|mesh-list
19481543|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19481544|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481545|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19481546|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19481547|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
19481548|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481549|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19481550|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19481551|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481552|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19481553|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481554|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19481555|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19481556|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
19481557|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481558|NCT03192332|Plasminogen|plasminogen|mesh-list
19481559|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19481560|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19481561|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19481562|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481563|NCT03192059|Aspirin|aspirin|mesh-list
19481564|NCT03192059|Vitamin D|vitamin d|mesh-list
19481565|NCT03192059|Curcumin|curcumin|mesh-list
19481566|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
19481567|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
19481568|NCT03192059|Lansoprazole|lansoprazole|mesh-list
19481569|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
19481570|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481571|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
19481572|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481573|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481574|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19481575|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
20022306|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022307|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
20022308|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022309|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022310|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20022311|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
20022312|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022313|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022314|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20022315|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20022316|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20022317|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20022318|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022319|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022320|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
20022321|NCT02561273|Hormones|hormones|mesh-ancestor
20022322|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022323|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20022324|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20022325|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
20292681|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
20292682|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292683|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481576|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481577|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292684|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
20292685|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292686|NCT05104866|Gemcitabine|gemcitabine|mesh-list
20292687|NCT05104866|Capecitabine|capecitabine|mesh-list
20292688|NCT05104866|Vinorelbine|vinorelbine|mesh-list
20292689|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20292690|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
20292691|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292692|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292693|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
20292694|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292695|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292696|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292697|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
20292698|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292699|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292700|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
20292701|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
20292702|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
19481578|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19481579|NCT03192059|Vitamins|vitamins|mesh-ancestor
19481580|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
19481581|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19481582|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481583|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19481584|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481585|NCT03192059|Analgesics|analgesics|mesh-ancestor
19481586|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
19481587|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481588|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481589|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19481590|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19481591|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19481592|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19481593|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481594|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
19481595|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19481596|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481597|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19481598|NCT03192033|Hemostatics|hemostatics|mesh-list
19481599|NCT03192033|Coagulants|coagulants|mesh-ancestor
19481600|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
19481601|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
19481602|NCT03191981|Lenalidomide|lenalidomide|mesh-list
19481603|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481604|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
19481605|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481606|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481607|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19481608|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
19481609|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481610|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481611|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19481612|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481613|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19481614|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19481615|NCT03191981|Growth Substances|growth substances|mesh-ancestor
19481616|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
19481617|NCT03191903|Triamcinolone|triamcinolone|mesh-list
19481618|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19481619|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19481620|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19481621|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481622|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
19481623|NCT03191903|Hormones|hormones|mesh-ancestor
19481624|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481625|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481626|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481627|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
19481628|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481629|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481630|NCT03191721|Triclosan|triclosan|mesh-list
19481631|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
19481632|NCT03191721|Fluorides|fluorides|mesh-list
19481633|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
19481634|NCT03191721|Protective Agents|protective agents|mesh-ancestor
19481635|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481636|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19481637|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19481638|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19481639|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
19481640|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481641|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19481642|NCT03191539|Apremilast|apremilast|mesh-list
19481643|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19481644|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481645|NCT03191539|Analgesics|analgesics|mesh-ancestor
19481646|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
19481647|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481648|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481649|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481650|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481651|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19481652|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19481653|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481654|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481655|NCT03191461|Adenosine|adenosine|mesh-list
19481656|NCT03191461|Analgesics|analgesics|mesh-ancestor
19481657|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
19481658|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481659|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481660|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19481661|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
19481662|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19481663|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
19481664|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
19481665|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19481666|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481667|NCT03191383|Vaccines|vaccines|mesh-list
19481668|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
19481669|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481670|NCT03191370|Anesthetics|anesthetics|mesh-list
19481671|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
19481672|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481673|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481674|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
19481675|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481676|NCT03191162|Benzonidazole|benzonidazole|mesh-list
19481677|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481678|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
19481679|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481680|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19481681|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19481682|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19481683|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481684|NCT03191305|Warfarin|warfarin|mesh-list
19481685|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
19568487|NCT03573024|Venetoclax|venetoclax|mesh-list
19568488|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19568489|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
19568490|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568491|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568492|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568493|NCT03570437|Paclitaxel|paclitaxel|mesh-list
19568494|NCT03570437|Olaparib|olaparib|mesh-list
19568495|NCT03570437|Cediranib|cediranib|mesh-list
19568496|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19568497|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743636|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19743637|NCT03779074|Antacids|antacids|mesh-ancestor
19568498|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
20292703|NCT05097599|Trastuzumab|trastuzumab|mesh-list
19568499|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
19568500|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
19743638|NCT03773666|Durvalumab|durvalumab|mesh-list
19481686|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
19481687|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
19481688|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481689|NCT03190798|Canagliflozin|canagliflozin|mesh-list
19481690|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19481691|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481692|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19481693|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481694|NCT03190681|Methylphenidate|methylphenidate|mesh-list
19481695|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19481696|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481697|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19481698|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19481699|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481700|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481701|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
19481702|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19481703|NCT03190733|Fludarabine|fludarabine|mesh-list
19481704|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481705|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
19481706|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
19481707|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481708|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
19481709|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19481710|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481711|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19481712|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481713|NCT03190603|Celecoxib|celecoxib|mesh-list
19481714|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19481715|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481716|NCT03190603|Analgesics|analgesics|mesh-ancestor
19481717|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
19481718|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481719|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481720|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481721|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481722|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19481723|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19481724|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481725|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481726|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
19481727|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19481728|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19481729|NCT03190642|Prednisolone|prednisolone|mesh-list
19481730|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
19481731|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19481732|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
19481733|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481734|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
19481735|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
19481736|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481737|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481738|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481739|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
19481740|NCT03190642|Hormones|hormones|mesh-ancestor
19481741|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481742|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19481743|NCT03190642|Protective Agents|protective agents|mesh-ancestor
19481744|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20022326|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
20022327|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022328|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20022329|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20022330|NCT02561273|Growth Substances|growth substances|mesh-ancestor
20022331|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
20022332|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
20022333|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022334|NCT02561481|Sulforaphane|sulforaphane|mesh-list
20022335|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20022336|NCT02561481|Protective Agents|protective agents|mesh-ancestor
20022337|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022338|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022339|NCT02561702|Mexiletine|mexiletine|mesh-list
20022340|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20022341|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20022342|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20022343|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20022344|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022345|NCT02561806|Ustekinumab|ustekinumab|mesh-list
20022346|NCT02561806|Ixekizumab|ixekizumab|mesh-list
20022347|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022348|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
20022349|NCT02561832|Carboplatin|carboplatin|mesh-list
20022350|NCT02561832|Olaparib|olaparib|mesh-list
20022351|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022352|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
20022353|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022354|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022355|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20022356|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
20022357|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022358|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022359|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20022360|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20022361|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022362|NCT02561897|Warfarin|warfarin|mesh-list
20022363|NCT02561897|Edoxaban|edoxaban|mesh-list
20022364|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
20022365|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20022366|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
20022367|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20022368|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
20022369|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022370|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115426|NCT00005578|Doxorubicin|doxorubicin|mesh-list
20115427|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19481745|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481746|NCT03190616|Apatinib|apatinib|mesh-list
19481747|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481748|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19481749|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481750|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481751|NCT03190668|Cefazolin|cefazolin|mesh-list
19481752|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
19481753|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19481754|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481755|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19481756|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19481757|NCT03190447|Laxatives|laxatives|mesh-ancestor
19481758|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481759|NCT03190304|Enalapril|enalapril|mesh-list
19481760|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19481761|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19481762|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
19481763|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481764|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19481765|NCT03189953|Exenatide|exenatide|mesh-list
19481766|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19481767|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481768|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19481769|NCT03189953|Incretins|incretins|mesh-ancestor
19481770|NCT03189953|Hormones|hormones|mesh-ancestor
19481771|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481772|NCT03190239|Pemetrexed|pemetrexed|mesh-list
19481773|NCT03190239|Apatinib|apatinib|mesh-list
19481774|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481775|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481776|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481777|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19481778|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19481779|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19481780|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19481781|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481782|NCT03189836|Rituximab|rituximab|mesh-list
19481783|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481784|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481785|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
19481786|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115428|NCT00005578|Etoposide|etoposide|mesh-list
20115429|NCT00005578|Vincristine|vincristine|mesh-list
20115430|NCT00005578|Bleomycin|bleomycin|mesh-list
19481787|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481788|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
19481789|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481790|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
19481791|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
19481792|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
19481793|NCT03189901|Simendan|simendan|mesh-list
19481794|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19481795|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
19481796|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19481797|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19481798|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481799|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481800|NCT03189901|Protective Agents|protective agents|mesh-ancestor
19481801|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481802|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
19481803|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
19481804|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568501|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568502|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19568503|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568504|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19568505|NCT03532880|Olaparib|olaparib|mesh-list
19568506|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19568507|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568508|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568509|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568510|NCT03502070|Tobramycin|tobramycin|mesh-list
19568511|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568512|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022371|NCT02562066|Amifampridine|amifampridine|mesh-list
20022372|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20022373|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022374|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022375|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20022376|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20022377|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022378|NCT02562521|Nicotine|nicotine|mesh-list
20022379|NCT02562521|Varenicline|varenicline|mesh-list
19577617|NCT04158258|Bevacizumab|bevacizumab|mesh-list
19577618|NCT04158258|Trastuzumab|trastuzumab|mesh-list
19577619|NCT04158258|Pertuzumab|pertuzumab|mesh-list
19577620|NCT04158258|Capecitabine|capecitabine|mesh-list
19577621|NCT04158258|Atezolizumab|atezolizumab|mesh-list
19577622|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577623|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577624|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19577625|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19577626|NCT04158258|Growth Substances|growth substances|mesh-ancestor
19577627|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577628|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
19577629|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577630|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
19577631|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577632|NCT04154956|Docetaxel|docetaxel|mesh-list
19577633|NCT04154956|Maytansine|maytansine|mesh-list
19577634|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577635|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577636|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577637|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577638|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577639|NCT04154956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19577640|NCT04126200|Dexamethasone|dexamethasone|mesh-list
19577641|NCT04126200|Lenalidomide|lenalidomide|mesh-list
19577642|NCT04126200|Pomalidomide|pomalidomide|mesh-list
19577643|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577644|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
19577645|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
19577646|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577647|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577648|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19577649|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
19577650|NCT04126200|Hormones|hormones|mesh-ancestor
19577651|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577652|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19481805|NCT03189732|Metformin|metformin|mesh-list
19481806|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19481807|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481808|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
19481809|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19481810|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
19481811|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481812|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481813|NCT03189069|Warfarin|warfarin|mesh-list
19481814|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
19481815|NCT03189069|Dabigatran|dabigatran|mesh-list
19481816|NCT03189069|Apixaban|apixaban|mesh-list
19481817|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
19481818|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19481819|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
19481820|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19481821|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
19481822|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481823|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481824|NCT03189329|Lidocaine|lidocaine|mesh-list
19481825|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
19481826|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19481827|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
20022380|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20022381|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
20022382|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022383|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022384|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20022385|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20022386|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
20022387|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022388|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022389|NCT02562755|Sorafenib|sorafenib|mesh-list
20022390|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022391|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20022392|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481828|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481829|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481830|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
19481831|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481832|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19481833|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19481834|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19481835|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481836|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481837|NCT03188978|Atorvastatin|atorvastatin|mesh-list
19481838|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19481839|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19481840|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
19481841|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481842|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19481843|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19481844|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481845|NCT03188835|Glycerol|glycerol|mesh-list
19481846|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19481847|NCT03188835|Protective Agents|protective agents|mesh-ancestor
19481848|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481849|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
19481850|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
19481851|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19481852|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
19481853|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481854|NCT03188445|Protective Agents|protective agents|mesh-ancestor
19481855|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481856|NCT03188445|Vitamins|vitamins|mesh-ancestor
19481857|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
19481858|NCT03188445|Trace Elements|trace elements|mesh-ancestor
19481859|NCT03188445|Hematinics|hematinics|mesh-ancestor
19481860|NCT03188471|Aspirin|aspirin|mesh-list
19481861|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481862|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20022393|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481863|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481864|NCT03188471|Analgesics|analgesics|mesh-ancestor
19481865|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
19568513|NCT03485911|Berotralstat|berotralstat|mesh-list
19481866|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481867|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481868|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481869|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19481870|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19481871|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481872|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19481873|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19481874|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481875|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
19481876|NCT03188510|Mirikizumab|mirikizumab|mesh-list
19481877|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19481878|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19481879|NCT03188510|Analgesics|analgesics|mesh-ancestor
19481880|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
19481881|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481882|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481883|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481884|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481885|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19481886|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481887|NCT03188198|Prednisone|prednisone|mesh-list
19481888|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
19481889|NCT03188198|Rituximab|rituximab|mesh-list
19481890|NCT03188198|Doxorubicin|doxorubicin|mesh-list
19481891|NCT03188198|Etoposide|etoposide|mesh-list
19481892|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
19481893|NCT03188198|Vincristine|vincristine|mesh-list
19481894|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19481895|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
19481896|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481897|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19481898|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19481899|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
19481900|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481901|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481902|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19481903|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481904|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19481905|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19481906|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19481907|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19481908|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19481909|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
19481910|NCT03188198|Hormones|hormones|mesh-ancestor
19481911|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19481912|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19481913|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19481914|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
19481915|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
19481916|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
19481917|NCT03188289|Chitosan|chitosan|mesh-list
19481918|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
19481919|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19481920|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
19481921|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481922|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
19481923|NCT03188289|Protective Agents|protective agents|mesh-ancestor
19481924|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19481925|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19481926|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
19481927|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481928|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19481929|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
19481930|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
19481931|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
19481932|NCT03188289|Coagulants|coagulants|mesh-ancestor
19481933|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
19481934|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19481935|NCT03188276|Ledipasvir|ledipasvir|mesh-list
20022394|NCT02562898|Gemcitabine|gemcitabine|mesh-list
20292704|NCT05097599|Talazoparib|talazoparib|mesh-list
19481936|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
19481937|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481938|NCT03188159|Vinorelbine|vinorelbine|mesh-list
19481939|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292705|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19481940|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481941|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
19481942|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
19481943|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
19481944|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481945|NCT03187912|Riboflavin|riboflavin|mesh-list
19481946|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
19481947|NCT03187912|Vitamins|vitamins|mesh-ancestor
19481948|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
19481949|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481950|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19481951|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022395|NCT02562898|Paclitaxel|paclitaxel|mesh-list
20022396|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20022397|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022398|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022399|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
20022400|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022401|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022402|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20022403|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
20022404|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
20022405|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022406|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022407|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022408|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
20022409|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022410|NCT02562924|Prednisone|prednisone|mesh-list
20022411|NCT02562924|Budesonide|budesonide|mesh-list
20022412|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022413|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
20022414|NCT02562924|Hormones|hormones|mesh-ancestor
20022415|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022416|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022417|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20022418|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022419|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20022420|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
20022421|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022422|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022423|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022424|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
20022425|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20022426|NCT02563067|Growth Substances|growth substances|mesh-ancestor
20022427|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022428|NCT02563093|Vaccines|vaccines|mesh-list
20022429|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
20022430|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022431|NCT02563496|Chloroquine|chloroquine|mesh-list
20022432|NCT02563496|Tafenoquine|tafenoquine|mesh-list
20022433|NCT02563496|Amebicides|amebicides|mesh-ancestor
20022434|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20022435|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20022436|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022437|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
20022438|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022439|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
20022440|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20022441|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022442|NCT02563561|Apaziquone|apaziquone|mesh-list
20022443|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022444|NCT02563834|Insulin|insulin|mesh-list
20022445|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20022446|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022447|NCT02563860|Lovastatin|lovastatin|mesh-list
20022448|NCT02563860|L 647318|l 647318|mesh-list
20022449|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
20022450|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20022451|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20022452|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
20022453|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022454|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20292706|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19481952|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19481953|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20022455|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20022456|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022457|NCT02564029|Lorazepam|lorazepam|mesh-list
19481954|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19481955|NCT03187899|Ropivacaine|ropivacaine|mesh-list
19481956|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
19481957|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
19481958|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19481959|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481960|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
19481961|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481962|NCT03187795|Mirabegron|mirabegron|mesh-list
19481963|NCT03187795|Oxybutynin|oxybutynin|mesh-list
19481964|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19481965|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19481966|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19481967|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
19481968|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19481969|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481970|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481971|NCT03187795|Urological Agents|urological agents|mesh-ancestor
19481972|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
19481973|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
19481974|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481975|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19481976|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19481977|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
19481978|NCT03187691|Amphotericin B|amphotericin b|mesh-list
19481979|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19481980|NCT03187691|Amebicides|amebicides|mesh-ancestor
19481981|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19481982|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19481983|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19481984|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19481985|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
19568514|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568515|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568516|NCT03481660|Aflibercept|aflibercept|mesh-list
19568517|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19568518|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19568519|NCT03481660|Growth Substances|growth substances|mesh-ancestor
19568520|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568521|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
19568522|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568523|NCT03459846|Durvalumab|durvalumab|mesh-list
19568524|NCT03459846|Olaparib|olaparib|mesh-list
19568525|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19568526|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568527|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19568528|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568529|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568530|NCT03403634|Interferons|interferons|mesh-list
19568531|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
19568532|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
19568533|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19568534|NCT03403634|Celecoxib|celecoxib|mesh-list
19568535|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
19568536|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568537|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
19568538|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568539|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
19568540|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568541|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19568542|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19568543|NCT03403634|Analgesics|analgesics|mesh-ancestor
19568544|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
19568545|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568546|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568547|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19568548|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19568549|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19568550|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568551|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568552|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19568553|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
19568554|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19568555|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568556|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
19568557|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19481986|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
19481987|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19481988|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19481989|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19481990|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19481991|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19481992|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
19481993|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19481994|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19481995|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19481996|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19481997|NCT03187548|Calcium|calcium|mesh-list
19481998|NCT03187548|Caseins|caseins|mesh-list
19481999|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19482000|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743639|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743640|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743641|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
19743642|NCT03760575|Pemetrexed|pemetrexed|mesh-list
19743643|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743644|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743645|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743646|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743647|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19743648|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19743649|NCT03756961|Lidocaine|lidocaine|mesh-list
19743650|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
19743651|NCT03756961|Remifentanil|remifentanil|mesh-list
19743652|NCT03756961|Oxycodone|oxycodone|mesh-list
19743653|NCT03756961|Propofol|propofol|mesh-list
19743654|NCT03756961|Desflurane|desflurane|mesh-list
19743655|NCT03756961|Esketamine|esketamine|mesh-list
20022458|NCT02564029|PF-06372865|pf-06372865|mesh-list
20022459|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
20022460|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
20022461|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
20022462|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022463|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022464|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20022465|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19743656|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
19743657|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
19743658|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743659|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743660|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
19743661|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743662|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19743663|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19743664|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19743665|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19743666|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743667|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19743668|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19743669|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
19743670|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743671|NCT03756961|Analgesics|analgesics|mesh-ancestor
19743672|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19743673|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19743674|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19743675|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
19743676|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743677|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19743678|NCT03756961|Narcotics|narcotics|mesh-ancestor
19743679|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19743680|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
19743681|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19743682|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
19743683|NCT03735537|Teriparatide|teriparatide|mesh-list
19743684|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19743685|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19743686|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743687|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20022466|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482001|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
19743688|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
19482002|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
19482003|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022467|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20022468|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20022469|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20022470|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
20022471|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
20022472|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022473|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022474|NCT02564198|Ramucirumab|ramucirumab|mesh-list
19482004|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19482005|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19482006|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19482007|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482008|NCT03187457|Metronidazole|metronidazole|mesh-list
19482009|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482010|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19482011|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19482012|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19482013|NCT03187093|Vortioxetine|vortioxetine|mesh-list
19482014|NCT03187093|Citalopram|citalopram|mesh-list
19482015|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19482016|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19482017|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482018|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482019|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482020|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
19482021|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482022|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19482023|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
19482024|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482025|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19482026|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482027|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482028|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19482029|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19482030|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19482031|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19482032|NCT03187223|Melphalan|melphalan|mesh-list
19482033|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19482034|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19482035|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
19482036|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482037|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482038|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19482039|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482040|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
19482041|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482042|NCT03187392|Lidocaine|lidocaine|mesh-list
19482043|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482044|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
19482045|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482046|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482047|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
19482048|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482049|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19482050|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19482051|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19482052|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482053|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482054|NCT03187106|Metronidazole|metronidazole|mesh-list
19482055|NCT03187106|Cephalexin|cephalexin|mesh-list
19482056|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482057|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19482058|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19482059|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19482060|NCT03187496|Midazolam|midazolam|mesh-list
19482061|NCT03187496|Caffeine|caffeine|mesh-list
19482062|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19482063|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20022475|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482064|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19482065|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482066|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482067|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19482068|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482069|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482070|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19482071|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
19482072|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
19482073|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
19482074|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
19482075|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482076|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482077|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19482078|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19482079|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
19482080|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19482081|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19482082|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482083|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19482084|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19482085|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19482086|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19482087|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
19482088|NCT03187015|Entinostat|entinostat|mesh-list
19482089|NCT03187015|Midazolam|midazolam|mesh-list
19482090|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19482091|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19482092|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482093|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482094|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19482095|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482096|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482097|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19482098|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
19482099|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
19482100|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
19482101|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
19482102|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482103|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482104|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482105|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19482106|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482107|NCT03187080|Bupivacaine|bupivacaine|mesh-list
19482108|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
19482109|NCT03187080|Anesthetics|anesthetics|mesh-list
19482110|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482111|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482112|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
19482113|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482114|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19482115|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19482116|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482117|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19482118|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19482119|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
19482120|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19482121|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19482122|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
19482123|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482124|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
20022476|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20022477|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
20022478|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20022479|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022480|NCT02564211|Incretins|incretins|mesh-ancestor
20022481|NCT02564211|Hormones|hormones|mesh-ancestor
20022482|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022483|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19482125|NCT03186755|Protective Agents|protective agents|mesh-ancestor
19482126|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19482127|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19482128|NCT03186755|Analgesics|analgesics|mesh-ancestor
19482129|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
19482130|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022484|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
19482131|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482132|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482133|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19482134|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19482135|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19482136|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
19482137|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
19482138|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482139|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482140|NCT03186742|Eplerenone|eplerenone|mesh-list
19482141|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19482142|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
19482143|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19482144|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482145|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19482146|NCT03186742|Diuretics|diuretics|mesh-ancestor
19482147|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
19482148|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19482149|NCT03186664|Nabiximols|nabiximols|mesh-list
19482150|NCT03186664|Analgesics|analgesics|mesh-ancestor
19482151|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
19482152|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482153|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482154|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
19482155|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19482156|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
19482157|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19482158|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482159|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19482160|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
19482161|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19482162|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19482163|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19482164|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482165|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482166|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
19482167|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482168|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482169|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19482170|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482171|NCT03186482|Rifampin|rifampin|mesh-list
19482172|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19482173|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19482174|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
19482175|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19482176|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482177|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
19482178|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19482179|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482180|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482181|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20022485|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022486|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022487|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20022488|NCT02564471|Doxycycline|doxycycline|mesh-list
20022489|NCT02564471|Chloroquine|chloroquine|mesh-list
20022490|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20022491|NCT02564471|Atovaquone|atovaquone|mesh-list
20022492|NCT02564471|Proguanil|proguanil|mesh-list
20022493|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20022494|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022495|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
20022496|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20022497|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20022498|NCT02564471|Amebicides|amebicides|mesh-ancestor
20022499|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022500|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20022501|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20022502|NCT02564471|Analgesics|analgesics|mesh-ancestor
20022503|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
20022504|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022505|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022506|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022507|NCT02564471|Filaricides|filaricides|mesh-ancestor
19482182|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19482183|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19482184|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19482185|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19482186|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19482187|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
19482188|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20022508|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
20022509|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
20022510|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022511|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022512|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
20022513|NCT02564497|Abatacept|abatacept|mesh-list
20022514|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20022515|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022516|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022517|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482189|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19482190|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19482191|NCT03186313|Ribavirin|ribavirin|mesh-list
19482192|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
20022518|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
20022519|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022520|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022521|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
20022522|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20022523|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
20022524|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20022525|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
20292707|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20576366|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
19482193|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
19482194|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482195|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
19482196|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482197|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
19482198|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19482199|NCT03186053|Protective Agents|protective agents|mesh-ancestor
20576367|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022526|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022527|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022528|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
20022529|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
20022530|NCT02564926|Glimepiride|glimepiride|mesh-list
20022531|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20576368|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20576369|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20576370|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576371|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20576372|NCT02071160|Melatonin|melatonin|mesh-list
20576373|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
20576374|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576375|NCT02071160|Protective Agents|protective agents|mesh-ancestor
20576376|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576377|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605601|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605602|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605603|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
20605604|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605605|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605606|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20605607|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
20605608|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605609|NCT02233218|Amlodipine|amlodipine|mesh-list
20605610|NCT02233218|Telmisartan|telmisartan|mesh-list
20605611|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20605612|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20022532|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022533|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19482200|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022534|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482201|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
19482202|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19482203|NCT03186326|Bevacizumab|bevacizumab|mesh-list
19482204|NCT03186326|Cetuximab|cetuximab|mesh-list
19482205|NCT03186326|Avelumab|avelumab|mesh-list
19482206|NCT03186326|Panitumumab|panitumumab|mesh-list
19482207|NCT03186326|Aflibercept|aflibercept|mesh-list
19482208|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19482209|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482210|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19482211|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19482212|NCT03186326|Growth Substances|growth substances|mesh-ancestor
19482213|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482214|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
19482215|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19482216|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
19482217|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482218|NCT03186443|Pregabalin|pregabalin|mesh-list
19482219|NCT03186443|Gabapentin|gabapentin|mesh-list
19482220|NCT03186443|Analgesics|analgesics|mesh-ancestor
19482221|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
19482222|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482223|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482224|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
19482225|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19482226|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482227|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482228|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19482229|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19482230|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482231|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482232|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482233|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19482234|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19482235|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482236|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
19482237|NCT03186027|Ascorbic Acid|ascorbic acid|mesh-list
19482238|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
19482239|NCT03186027|Ubiquinone|ubiquinone|mesh-list
19482240|NCT03186027|Vitamins|vitamins|mesh-ancestor
19482241|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
19482242|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482243|NCT03186027|Antioxidants|antioxidants|mesh-ancestor
19482244|NCT03186027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482245|NCT03186027|Protective Agents|protective agents|mesh-ancestor
19482246|NCT03186131|Vitamin D|vitamin d|mesh-list
19482247|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
19482248|NCT03186131|Vitamins|vitamins|mesh-ancestor
19482249|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
19482250|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482251|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19482252|NCT03186040|Lacosamide|lacosamide|mesh-list
19482253|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
19482254|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19482255|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19482256|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482257|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568558|NCT03369301|Antibodies|antibodies|mesh-list
19568559|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
19568560|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568561|NCT03359538|Sirolimus|sirolimus|mesh-list
19568562|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568563|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568564|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19568565|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568566|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
19568567|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19568568|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
19568569|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568570|NCT03342456|Amoxicillin|amoxicillin|mesh-list
19568571|NCT03342456|Doxycycline|doxycycline|mesh-list
19568572|NCT03342456|Furazolidone|furazolidone|mesh-list
19568573|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
19568574|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568575|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568576|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568577|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
20576378|NCT02071212|Ticagrelor|ticagrelor|mesh-list
19482258|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19482259|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19482260|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19482261|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20022535|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20022536|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022537|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
20022538|NCT02564952|Cannabidiol|cannabidiol|mesh-list
20022539|NCT02564952|Clobazam|clobazam|mesh-list
20022540|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
20022541|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20022542|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20022543|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022544|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022545|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20022546|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20022547|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
20022548|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
20022549|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022550|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022551|NCT02565108|Cannabidiol|cannabidiol|mesh-list
20022552|NCT02565108|Clobazam|clobazam|mesh-list
20022553|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
20022554|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19482262|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482263|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
19482264|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482265|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482266|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19482267|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482268|NCT03185871|Celecoxib|celecoxib|mesh-list
19482269|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19482270|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19482271|NCT03185871|Analgesics|analgesics|mesh-ancestor
19482272|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
19482273|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482274|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482275|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482276|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482277|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19482278|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19482279|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482280|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482281|NCT03185988|Trastuzumab|trastuzumab|mesh-list
19482282|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19482283|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482284|NCT03185845|Warfarin|warfarin|mesh-list
19482285|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
19482286|NCT03185611|Rifaximin|rifaximin|mesh-list
19482287|NCT03185611|Azathioprine|azathioprine|mesh-list
19482288|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19482289|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482290|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482291|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
19482292|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482293|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19568578|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19743689|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743690|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743691|NCT03723967|Paclitaxel|paclitaxel|mesh-list
20022555|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20022556|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022557|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022558|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20022559|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20022560|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
20022561|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
19743692|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19743693|NCT03723967|Carboplatin|carboplatin|mesh-list
19743694|NCT03723967|Durvalumab|durvalumab|mesh-list
19743695|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20022562|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022563|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576379|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19743696|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20022564|NCT02565147|Heparin|heparin|mesh-list
19482294|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482295|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482296|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
19482297|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482298|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482299|NCT03185624|Rifaximin|rifaximin|mesh-list
19482300|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19482301|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482302|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482303|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
19482304|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
19482305|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482306|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482307|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482308|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19482309|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
20022565|NCT02565147|Bivalirudin|bivalirudin|mesh-list
20022566|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
20022567|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19482310|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482311|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482312|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19482313|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
19482314|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482315|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
19482316|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19482317|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19482318|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482319|NCT03185364|Urological Agents|urological agents|mesh-ancestor
19482320|NCT03185403|Sufentanil|sufentanil|mesh-list
19482321|NCT03185403|Ropivacaine|ropivacaine|mesh-list
19482322|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482323|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
20022568|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20022569|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022570|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
20292708|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292709|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292710|NCT05091905|Ropivacaine|ropivacaine|mesh-list
20292711|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
20292712|NCT05091905|Anesthetics|anesthetics|mesh-list
20292713|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292714|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292715|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
20576380|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20576381|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20022571|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20022572|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
20022573|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022574|NCT02565186|Lasmiditan|lasmiditan|mesh-list
20022575|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20022576|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
20022577|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022578|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022579|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022580|NCT02565381|Nicotine|nicotine|mesh-list
20022581|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20022582|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
20022583|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022584|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022585|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20022586|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20022587|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
20022588|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022589|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022590|NCT02565511|CNP520|cnp520|mesh-list
20022591|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022592|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022593|NCT02565628|PF-06669571|pf-06669571|mesh-list
20022594|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
20022595|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
20022596|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308941|NCT00666354|Methotrexate|methotrexate|mesh-list
19482324|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482325|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482326|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
19482327|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482328|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19482329|NCT03185403|Narcotics|narcotics|mesh-ancestor
19482330|NCT03185403|Analgesics|analgesics|mesh-ancestor
20022597|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022598|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022599|NCT02565810|Adalimumab|adalimumab|mesh-list
19482331|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19482332|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19482333|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
19482334|NCT03185793|Benzbromarone|benzbromarone|mesh-list
19482335|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
20022600|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022601|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022602|NCT02565901|Sirolimus|sirolimus|mesh-list
20022603|NCT02565901|Carboplatin|carboplatin|mesh-list
20022604|NCT02565901|Docetaxel|docetaxel|mesh-list
20022605|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022606|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022607|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
20022608|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022609|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022610|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20022611|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022612|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20022613|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
20022614|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022615|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
20576382|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20576383|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
20022616|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022617|NCT02566005|Misoprostol|misoprostol|mesh-list
20022618|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20022619|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
19482336|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
19482337|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482338|NCT03185793|Renal Agents|renal agents|mesh-ancestor
19482339|NCT03185351|Midazolam|midazolam|mesh-list
19482340|NCT03185351|Bupivacaine|bupivacaine|mesh-list
19482341|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482342|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
19482343|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482344|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482345|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
19482346|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482347|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19482348|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19482349|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19482350|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482351|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482352|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19482353|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
19482354|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
19482355|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
19482356|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576384|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576385|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576386|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576387|NCT02071303|Celecoxib|celecoxib|mesh-list
20292716|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292717|NCT05074823|Ketamine|ketamine|mesh-list
20292718|NCT05074823|Analgesics|analgesics|mesh-ancestor
20022620|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20022621|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022622|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20022623|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482357|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482358|NCT03185104|Fluorides|fluorides|mesh-list
19482359|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
20292719|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
19482360|NCT03185104|Protective Agents|protective agents|mesh-ancestor
19482361|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482362|NCT03185156|Propofol|propofol|mesh-list
19482363|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19482364|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482365|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482366|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19482367|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
19482368|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
19482369|NCT03184844|Thalidomide|thalidomide|mesh-list
20022624|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
20022625|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
20022626|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
20022627|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20022628|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
20022629|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022630|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022631|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022632|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022633|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
19482370|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482371|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
19482372|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482373|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
19482374|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19482375|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482376|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19482377|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19482378|NCT03184844|Growth Substances|growth substances|mesh-ancestor
19482379|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
19482380|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482381|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
19482382|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
20022634|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20022635|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
20022636|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022637|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022638|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20022639|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20022640|NCT02566369|Trifarotene|trifarotene|mesh-list
20022641|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022642|NCT02566889|Infliximab|infliximab|mesh-list
20022643|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022644|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20022645|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022646|NCT02566902|Albuterol|albuterol|mesh-list
20022647|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20022648|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
20022649|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022650|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022651|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022652|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022653|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
20022654|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20022655|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20022656|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20022657|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20022658|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
20022659|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022660|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022661|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
20022662|NCT02566993|Doxorubicin|doxorubicin|mesh-list
20022663|NCT02566993|Vincristine|vincristine|mesh-list
20022664|NCT02566993|Topotecan|topotecan|mesh-list
20022665|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022666|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
20022667|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022668|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022669|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20022670|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
20022671|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482383|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482384|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022672|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022673|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19482385|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482386|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
19482387|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482388|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022674|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20022675|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20022676|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19482389|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482390|NCT03185143|Acetaminophen|acetaminophen|mesh-list
19482391|NCT03185143|Sumatriptan|sumatriptan|mesh-list
19482392|NCT03185143|Naltrexone|naltrexone|mesh-list
20022677|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022678|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20022679|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022680|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
20022681|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022682|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20022683|NCT02567552|Progesterone|progesterone|mesh-list
20022684|NCT02567552|Progestins|progestins|mesh-ancestor
20022685|NCT02567552|Hormones|hormones|mesh-ancestor
20022686|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022687|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022688|NCT02567656|Tenalisib|tenalisib|mesh-list
20022689|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
20022690|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022691|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022692|NCT02567708|Nemiralisib|nemiralisib|mesh-list
20022693|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20022694|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022695|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022696|NCT02567968|Caffeine|caffeine|mesh-list
20022697|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
20022698|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022699|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20022700|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022701|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20022702|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022703|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20022704|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20022705|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
20022706|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022707|NCT02568046|Leucovorin|leucovorin|mesh-list
20022708|NCT02568046|Fluorouracil|fluorouracil|mesh-list
20022709|NCT02568046|Irinotecan|irinotecan|mesh-list
20022710|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
20022711|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022712|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20022713|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022714|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022715|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
20022716|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022717|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20022718|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20022719|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022720|NCT02568046|Antidotes|antidotes|mesh-ancestor
20022721|NCT02568046|Protective Agents|protective agents|mesh-ancestor
20022722|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
20022723|NCT02568046|Vitamins|vitamins|mesh-ancestor
20022724|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
20022725|NCT02568397|Dabigatran|dabigatran|mesh-list
20022726|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
20022727|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20022728|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
20022729|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022730|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022731|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
20022732|NCT02568644|Ketoprofen|ketoprofen|mesh-list
20022733|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20022734|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19482393|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20022735|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20022736|NCT02568644|Analgesics|analgesics|mesh-ancestor
20022737|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
20022738|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022739|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022740|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022741|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20022742|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482394|NCT03185143|Analgesics|analgesics|mesh-ancestor
19482395|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
19482396|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482397|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482398|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
19482399|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19482400|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19482401|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19482402|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19482403|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19482404|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
19482405|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482406|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482407|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19482408|NCT03184870|Leucovorin|leucovorin|mesh-list
19482409|NCT03184870|Gemcitabine|gemcitabine|mesh-list
19482410|NCT03184870|Paclitaxel|paclitaxel|mesh-list
19482411|NCT03184870|Fluorouracil|fluorouracil|mesh-list
19482412|NCT03184870|Nivolumab|nivolumab|mesh-list
19482413|NCT03184870|Irinotecan|irinotecan|mesh-list
19482414|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19482415|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482416|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
19482417|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
19482418|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
19482419|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482420|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19482421|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
19482422|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
19482423|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482424|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482425|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482426|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
19482427|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482428|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19482429|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19482430|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19482431|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19482432|NCT03184870|Antidotes|antidotes|mesh-ancestor
19482433|NCT03184870|Protective Agents|protective agents|mesh-ancestor
19482434|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
19482435|NCT03184870|Vitamins|vitamins|mesh-ancestor
19482436|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
19482437|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
19482438|NCT03185130|Promethazine|promethazine|mesh-list
19482439|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
20022743|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022744|NCT02568683|Vincristine|vincristine|mesh-list
20022745|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19482440|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19482441|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19482442|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568579|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19482443|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482444|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482445|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
19482446|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
19482447|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482448|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
19482449|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
19482450|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482451|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19482452|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
19482453|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
19482454|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482455|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482456|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19482457|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
19482458|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
19482459|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19482460|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482461|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482462|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19482463|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
19482464|NCT03184805|Aspirin|aspirin|mesh-list
19482465|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19482466|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20022746|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022747|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022748|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
20022749|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022750|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022751|NCT02568852|Anesthetics|anesthetics|mesh-list
20022752|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022753|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022754|NCT02569437|Fluticasone|fluticasone|mesh-list
20022755|NCT02569437|Doxycycline|doxycycline|mesh-list
20022756|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
20022757|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20022758|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20022759|NCT02569437|Prednisolone|prednisolone|mesh-list
20022760|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
20022761|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20022762|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
20022763|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022764|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
20022765|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
20022766|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022767|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022768|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20022769|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
20022770|NCT02569437|Hormones|hormones|mesh-ancestor
20022771|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022772|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20022773|NCT02569437|Protective Agents|protective agents|mesh-ancestor
20022774|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20022775|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022776|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20022777|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022778|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
20022779|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20022780|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20022781|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20022782|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022783|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022784|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022785|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20022786|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
20022787|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20022788|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022789|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20022790|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022791|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022792|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
19482467|NCT03184805|Analgesics|analgesics|mesh-ancestor
19482468|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
20022793|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20022794|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19482469|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482470|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482471|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482472|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482473|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19482474|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19482475|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482476|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19482477|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19482478|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482479|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
19482480|NCT03184649|Acetaminophen|acetaminophen|mesh-list
19482481|NCT03184649|Ibuprofen|ibuprofen|mesh-list
19482482|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19482483|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19482484|NCT03184649|Analgesics|analgesics|mesh-ancestor
19482485|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
19482486|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482487|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482488|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482489|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482490|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19482491|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482492|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482493|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
19482494|NCT03184480|Fluticasone|fluticasone|mesh-list
19482495|NCT03184480|Xhance|xhance|mesh-list
20022795|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022796|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
20022797|NCT02569658|Coagulants|coagulants|mesh-ancestor
20022798|NCT02569710|Simeprevir|simeprevir|mesh-list
20022799|NCT02569710|Odalasvir|odalasvir|mesh-list
19482496|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482497|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19482498|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
20022800|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
20022801|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022802|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
20022803|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022804|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022805|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
20022806|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482499|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482500|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022807|NCT02569801|Fulvestrant|fulvestrant|mesh-list
20022808|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20022809|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022810|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20022811|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20022812|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
20022813|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022814|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022815|NCT02569996|Rituximab|rituximab|mesh-list
20022816|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19482501|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19482502|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
19482503|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
19482504|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19482505|NCT03184493|Metformin|metformin|mesh-list
19482506|NCT03184493|Celecoxib|celecoxib|mesh-list
19482507|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20022817|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482508|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482509|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20022818|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
19482510|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19482511|NCT03184493|Analgesics|analgesics|mesh-ancestor
19482512|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
19482513|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482514|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482515|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482516|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19482517|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19482518|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482519|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482520|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19482521|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19482522|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19482523|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482524|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482525|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19482526|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482527|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482528|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
19482529|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568580|NCT03342456|Diuretics|diuretics|mesh-ancestor
19568581|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
19568582|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568583|NCT03342456|Expectorants|expectorants|mesh-ancestor
19568584|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
19568585|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19568586|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19568587|NCT03342456|Renal Agents|renal agents|mesh-ancestor
19568588|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19568589|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19568590|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568591|NCT03332095|Tenofovir|tenofovir|mesh-list
20022819|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568592|NCT03332095|Lamivudine|lamivudine|mesh-list
19568593|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19568594|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
19568595|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568596|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19568597|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19568598|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568599|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568600|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19568601|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
19568602|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19568603|NCT03322280|Estrogens|estrogens|mesh-ancestor
19568604|NCT03322280|Hormones|hormones|mesh-ancestor
19568605|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568606|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568607|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568608|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568609|NCT03318952|Lidocaine|lidocaine|mesh-list
19568610|NCT03318952|Carticaine|carticaine|mesh-list
19568611|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-ancestor
19568612|NCT03318952|Anesthetics|anesthetics|mesh-ancestor
19568613|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568614|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568615|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
19568616|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568617|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19568618|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20022820|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20022821|NCT02570022|Bupivacaine|bupivacaine|mesh-list
20022822|NCT02570022|Ropivacaine|ropivacaine|mesh-list
20022823|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
20022824|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
20022825|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022826|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022827|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
20022828|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022829|NCT02570074|Fosfomycin|fosfomycin|mesh-list
20022830|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20022831|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022832|NCT02570139|Protective Agents|protective agents|mesh-list
20022833|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115431|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
19482530|NCT03184766|Ibuprofen|ibuprofen|mesh-list
19482531|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
19482532|NCT03184766|Ephedrine|ephedrine|mesh-list
19482533|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19482534|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19482535|NCT03184766|Analgesics|analgesics|mesh-ancestor
20022834|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20022835|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022836|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022837|NCT02570711|Gemcitabine|gemcitabine|mesh-list
20022838|NCT02570711|Paclitaxel|paclitaxel|mesh-list
20022839|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
20022840|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20022841|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022842|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022843|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
19482536|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
19482537|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482538|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482539|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482540|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482541|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19482542|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022844|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
20022845|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022846|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19482543|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482544|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19482545|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
19482546|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19482547|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
19482548|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
19482549|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19482550|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19743697|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743698|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
19743699|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
19743700|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
19743701|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743702|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743703|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
19743704|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743705|NCT03711058|Nivolumab|nivolumab|mesh-list
19743706|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20022847|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
20022848|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
20022849|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022850|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022851|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20022852|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
20022853|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022854|NCT02571049|Sumatriptan|sumatriptan|mesh-list
19482551|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
19482552|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
19482553|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482554|NCT03184324|Esomeprazole|esomeprazole|mesh-list
19482555|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19482556|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482557|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19482558|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482559|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482560|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
19482561|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
19482562|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
19482563|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482564|NCT03184090|Palbociclib|palbociclib|mesh-list
19482565|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482566|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19482567|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482568|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482569|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
19482570|NCT03184194|Nivolumab|nivolumab|mesh-list
19482571|NCT03184194|Daratumumab|daratumumab|mesh-list
19482572|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20022855|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20022856|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20022857|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20292720|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292721|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292722|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20292723|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20292724|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
20292725|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
20292726|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292727|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20292728|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20292729|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292730|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292731|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
20292732|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292733|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292734|NCT05067894|Vaccines|vaccines|mesh-list
20292735|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
20292736|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292737|NCT05067634|Cenobamate|cenobamate|mesh-list
20292738|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
20292739|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
20292740|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20292741|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
20292742|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292743|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292744|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022858|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
20022859|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022860|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022861|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022862|NCT02571153|Ketamine|ketamine|mesh-list
19482573|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482574|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
19482575|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482576|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482577|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19482578|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
19482579|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482580|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482581|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19482582|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19482583|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19482584|NCT03183752|Metformin|metformin|mesh-list
19482585|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19482586|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482587|NCT03183843|Warfarin|warfarin|mesh-list
19482588|NCT03183843|Dabigatran|dabigatran|mesh-list
19482589|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
19482590|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
19482591|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19482592|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
20022863|NCT02571153|Analgesics|analgesics|mesh-ancestor
20022864|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
20022865|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022866|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022867|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20022868|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20022869|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
20022870|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
20022871|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022872|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20022873|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20022874|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022875|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022876|NCT02571439|Ropivacaine|ropivacaine|mesh-list
20022877|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
20022878|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
20022879|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022880|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292745|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
20292746|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20022881|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
20292747|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
20022882|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022883|NCT02571634|Fentanyl|fentanyl|mesh-list
20022884|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20022885|NCT02571634|Narcotics|narcotics|mesh-ancestor
20022886|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20022887|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022888|NCT02571634|Analgesics|analgesics|mesh-ancestor
20022889|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
20022890|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482593|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482594|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022891|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20022892|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20022893|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
20022894|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
20022895|NCT02571777|Fluticasone|fluticasone|mesh-list
20022896|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20022897|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022898|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20022899|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
20022900|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022901|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022902|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022903|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022904|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022905|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20022906|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20022907|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20022908|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20022909|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
20022910|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022911|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022912|NCT02571972|Timolol|timolol|mesh-list
20022913|NCT02571972|Dorzolamide|dorzolamide|mesh-list
20022914|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20022915|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20022916|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
20022917|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022918|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022919|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022920|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20022921|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20022922|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20022923|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20022924|NCT02572167|Nivolumab|nivolumab|mesh-list
20022925|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20576388|NCT02071303|Tramadol|tramadol|mesh-list
20022926|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20022927|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022928|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20022929|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022930|NCT02572609|Ambroxol|ambroxol|mesh-list
20022931|NCT02572609|Expectorants|expectorants|mesh-ancestor
20022932|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022933|NCT02572752|Nintedanib|nintedanib|mesh-list
20022934|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022935|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20022936|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482595|NCT03183674|Oxytocin|oxytocin|mesh-list
19482596|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
19482597|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19482598|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482599|NCT03183596|Dexamethasone|dexamethasone|mesh-list
19482600|NCT03183596|Bupivacaine|bupivacaine|mesh-list
19482601|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482602|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
19482603|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
19482604|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482605|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482606|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482607|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
19482608|NCT03183596|Hormones|hormones|mesh-ancestor
19482609|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022937|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022938|NCT02573012|Prednisone|prednisone|mesh-list
19482610|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19482611|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482612|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482613|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
19482614|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482615|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
19482616|NCT03183557|Vitamin D|vitamin d|mesh-list
19482617|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
19482618|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
19482619|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19482620|NCT03183557|Vitamins|vitamins|mesh-ancestor
19482621|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
20022939|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022940|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
20022941|NCT02573012|Hormones|hormones|mesh-ancestor
20022942|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20022943|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022944|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19482622|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482623|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19482624|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
19482625|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482626|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
19482627|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482628|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482629|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19482630|NCT03183297|Fexofenadine|fexofenadine|mesh-list
19482631|NCT03183297|Naproxen|naproxen|mesh-list
20022945|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022946|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
20022947|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20022948|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
20022949|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20022950|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022951|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022952|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022953|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
20022954|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20022955|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
20022956|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022957|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022958|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20022959|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
20022960|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022961|NCT02573311|Tamsulosin|tamsulosin|mesh-list
19482632|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19482633|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20022962|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20022963|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20022964|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20022965|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
20022966|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20022967|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292748|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482634|NCT03183297|Analgesics|analgesics|mesh-ancestor
19482635|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
19482636|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482637|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482638|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482639|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482640|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
19482641|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19482642|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482643|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482644|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20115432|NCT00005578|Razoxane|razoxane|mesh-list
20292749|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292750|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20292751|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
20292752|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
20292753|NCT05052229|Protective Agents|protective agents|mesh-ancestor
20292754|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
19482645|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19743707|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482646|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19482647|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
19482648|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
19482649|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482650|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
19482651|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
19482652|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
19482653|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482654|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482655|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482656|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19482657|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482658|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482659|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482660|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19482661|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
19482662|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482663|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482664|NCT03183492|Vaccines|vaccines|mesh-list
19482665|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
19482666|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482667|NCT03183115|Lugol's solution|lugol's solution|mesh-list
19482668|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
19482669|NCT03183115|Coagulants|coagulants|mesh-ancestor
19482670|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
19482671|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
19482672|NCT03182894|Azacitidine|azacitidine|mesh-list
19482673|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19482674|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482675|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19482676|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
19482677|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482678|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482679|NCT03182803|Antibodies|antibodies|mesh-list
19482680|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
19482681|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482682|NCT03183024|Benralizumab|benralizumab|mesh-list
19482683|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19482684|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
19568619|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19568620|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19568621|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568622|NCT03277495|Nicotine|nicotine|mesh-list
19568623|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19568624|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
19568625|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568626|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568627|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19568628|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19568629|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
19568630|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568631|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568632|NCT03246529|Lenograstim|lenograstim|mesh-list
19568633|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19568634|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
19568635|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568636|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19568637|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
19568638|NCT03201419|Coagulants|coagulants|mesh-ancestor
19568639|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19568640|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
19568641|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568642|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
19568643|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
19568644|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568645|NCT05345327|Metformin|metformin|mesh-list
19568646|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
19568647|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19568648|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568649|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19568650|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568651|NCT05345249|Ropivacaine|ropivacaine|mesh-list
20022968|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576389|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19568652|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
19568653|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
19482685|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19482686|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482687|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482688|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482689|NCT03182855|Ticagrelor|ticagrelor|mesh-list
19482690|NCT03182855|Cangrelor|cangrelor|mesh-list
19482691|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19482692|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19482693|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19482694|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19482695|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
19482696|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482697|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482698|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482699|NCT03182634|Olaparib|olaparib|mesh-list
19482700|NCT03182634|Fulvestrant|fulvestrant|mesh-list
19482701|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19482702|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482703|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482704|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022969|NCT02573311|Urological Agents|urological agents|mesh-ancestor
20022970|NCT02573493|Paclitaxel|paclitaxel|mesh-list
20022971|NCT02573493|Cisplatin|cisplatin|mesh-list
20022972|NCT02573493|Cetuximab|cetuximab|mesh-list
20022973|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20022974|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20022975|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
20022976|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
20022977|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
19482705|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19482706|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19482707|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19482708|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
19482709|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19482710|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022978|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20022979|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20022980|NCT02573857|Artefenomel|artefenomel|mesh-list
20022981|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
20022982|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20022983|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20022984|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20022985|NCT02573870|Fluticasone|fluticasone|mesh-list
20022986|NCT02573870|Xhance|xhance|mesh-list
20022987|NCT02573870|Albuterol|albuterol|mesh-list
20022988|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20022989|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20022990|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
20022991|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482711|NCT03182595|Acetaminophen|acetaminophen|mesh-list
19482712|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19482713|NCT03182595|Analgesics|analgesics|mesh-ancestor
19482714|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
19482715|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482716|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482717|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
19482718|NCT03182413|Modafinil|modafinil|mesh-list
19482719|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19482720|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482721|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20022992|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20022993|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20022994|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
20022995|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
20022996|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20022997|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
20022998|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20022999|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20023000|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20023001|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20023002|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
20023003|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023004|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023005|NCT02573883|Clobetasol|clobetasol|mesh-list
20023006|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292755|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19482722|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19482723|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19482724|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482725|NCT03182504|Meropenem|meropenem|mesh-list
19482726|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19482727|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482728|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
19482729|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
19482730|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482731|NCT03182218|Heparin|heparin|mesh-list
19482732|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20292756|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292757|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20292758|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292759|NCT05049525|Itraconazole|itraconazole|mesh-list
20292760|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20292761|NCT05049525|Terbinafine|terbinafine|mesh-list
20292762|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
20292763|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292764|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20292765|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20292766|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292767|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292768|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20292769|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
20292770|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20292771|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292772|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20292773|NCT05042128|Gemcitabine|gemcitabine|mesh-list
20292774|NCT05042128|Paclitaxel|paclitaxel|mesh-list
20292775|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292776|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482733|NCT03182218|Tinzaparin|tinzaparin|mesh-list
19482734|NCT03182218|Dalteparin|dalteparin|mesh-list
19482735|NCT03182218|Anticoagulants|anticoagulants|mesh-list
19482736|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19482737|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19482738|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482739|NCT03182296|Exenatide|exenatide|mesh-list
19482740|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19482741|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482742|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19482743|NCT03182296|Incretins|incretins|mesh-ancestor
19482744|NCT03182296|Hormones|hormones|mesh-ancestor
19482745|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19482746|NCT03182257|ONO-7579|ono-7579|mesh-list
19482747|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19482748|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482749|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482750|NCT03182374|Hylan|hylan|mesh-list
19482751|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
19482752|NCT03182374|Protective Agents|protective agents|mesh-ancestor
19482753|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482754|NCT03182322|Insulin|insulin|mesh-list
19482755|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19482756|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482757|NCT03182231|Exenatide|exenatide|mesh-list
19482758|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19482759|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482760|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19482761|NCT03182231|Incretins|incretins|mesh-ancestor
19482762|NCT03182231|Hormones|hormones|mesh-ancestor
19482763|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19482764|NCT03181919|Letrozole|letrozole|mesh-list
19482765|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482766|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19482767|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19482768|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482769|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482770|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19482771|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
19482772|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19482773|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482774|NCT03182088|Norepinephrine|norepinephrine|mesh-list
19482775|NCT03182088|Bupivacaine|bupivacaine|mesh-list
19482776|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482777|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
19482778|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482779|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482780|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
19482781|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482782|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20023007|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
20023008|NCT02573883|Hormones|hormones|mesh-ancestor
20023009|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023010|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023011|NCT02574078|Gemcitabine|gemcitabine|mesh-list
20023012|NCT02574078|Paclitaxel|paclitaxel|mesh-list
20023013|NCT02574078|Docetaxel|docetaxel|mesh-list
20023014|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20023015|NCT02574078|Bevacizumab|bevacizumab|mesh-list
20023016|NCT02574078|Carboplatin|carboplatin|mesh-list
20023017|NCT02574078|Nivolumab|nivolumab|mesh-list
20023018|NCT02574078|Pemetrexed|pemetrexed|mesh-list
20023019|NCT02574078|Crizotinib|crizotinib|mesh-list
20023020|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19482783|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19482784|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
19482785|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482786|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482787|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
19482788|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
19482789|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19482790|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
19482791|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19482792|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
19482793|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19482794|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482795|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19482796|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20023021|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023022|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
20023023|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
20023024|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
20023025|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023026|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023027|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20023028|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20023029|NCT02574078|Growth Substances|growth substances|mesh-ancestor
20576390|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023030|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023031|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023032|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20023033|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
20023034|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
19482797|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19482798|NCT03182192|Exenatide|exenatide|mesh-list
19482799|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19482800|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576391|NCT02071303|Analgesics|analgesics|mesh-ancestor
20576392|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
20576393|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576394|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576395|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576396|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20576397|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20576398|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20023035|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576399|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023036|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023037|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023038|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
20023039|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20023040|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20023041|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20023042|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20023043|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20023044|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023045|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023046|NCT02574520|Bupivacaine|bupivacaine|mesh-list
20023047|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20023048|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023049|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
20023050|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023051|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023052|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
20023053|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023054|NCT02574598|Docetaxel|docetaxel|mesh-list
20023055|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
20023056|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482801|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19482802|NCT03182192|Incretins|incretins|mesh-ancestor
19482803|NCT03182192|Hormones|hormones|mesh-ancestor
19482804|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19482805|NCT03181880|Bromides|bromides|mesh-list
19482806|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
19482807|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19482808|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
19482809|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482810|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482811|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19482812|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
19482813|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19482814|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20023057|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
20023058|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
20023059|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
20023060|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023061|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023062|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20023063|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
20023064|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023065|NCT02574832|Lidocaine|lidocaine|mesh-list
20023066|NCT02574832|Fentanyl|fentanyl|mesh-list
20023067|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023068|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
20023069|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023070|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023071|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
20023072|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292777|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
20292778|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
20292779|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
20023073|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20023074|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20023075|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20023076|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20023077|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023078|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20023079|NCT02574832|Narcotics|narcotics|mesh-ancestor
20023080|NCT02574832|Analgesics|analgesics|mesh-ancestor
20023081|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20023082|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20023083|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
20023084|NCT02574845|Metformin|metformin|mesh-list
20023085|NCT02574845|Furosemide|furosemide|mesh-list
20292780|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292781|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20292782|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
20292783|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
20292784|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292785|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292786|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292787|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
20292788|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292789|NCT05028634|Vaccines|vaccines|mesh-list
20292790|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20292791|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
20292792|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292793|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20292794|NCT05025423|Venetoclax|venetoclax|mesh-list
20292795|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292796|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20292797|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
20292798|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292799|NCT05024552|Cytarabine|cytarabine|mesh-list
20292800|NCT05024552|Daunorubicin|daunorubicin|mesh-list
20292801|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20292802|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
20292803|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292804|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292805|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
20292806|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292807|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482815|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19482816|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19482817|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482818|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482819|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
19482820|NCT03182114|Bupivacaine|bupivacaine|mesh-list
19482821|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482822|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
19482823|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482824|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482825|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
19482826|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482827|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19482828|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
19482829|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482830|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482831|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
19482832|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482833|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482834|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19482835|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19482836|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482837|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
19482838|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19482839|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
19482840|NCT03181685|Cetrorelix|cetrorelix|mesh-list
19482841|NCT03181685|Progesterone|progesterone|mesh-list
19482842|NCT03181685|Progestins|progestins|mesh-ancestor
19482843|NCT03181685|Hormones|hormones|mesh-ancestor
19482844|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19482845|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292808|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
20292809|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292810|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20292811|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20292812|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20292813|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292814|NCT05013437|Acetaminophen|acetaminophen|mesh-list
20292815|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
20292816|NCT05013437|Promethazine|promethazine|mesh-list
20023086|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20023087|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023088|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023089|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20023090|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20023091|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
20023092|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292817|NCT05013437|Melphalan|melphalan|mesh-list
20292818|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
20292819|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292820|NCT05013437|Analgesics|analgesics|mesh-ancestor
20292821|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
20292822|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605613|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20023093|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20292823|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292824|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
20023094|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19482846|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19482847|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
19482848|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19482849|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
19482850|NCT03181464|Lidocaine|lidocaine|mesh-list
19482851|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
19482852|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
19482853|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482854|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023095|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023096|NCT02574845|Diuretics|diuretics|mesh-ancestor
20023097|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
19482855|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
19482856|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482857|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19482858|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19482859|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19482860|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19482861|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482862|NCT03181243|Anesthetics|anesthetics|mesh-list
19482863|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482864|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482865|NCT03181360|Tenecteplase|tenecteplase|mesh-list
19482866|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19482867|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19482868|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482869|NCT03181815|Cytarabine|cytarabine|mesh-list
19482870|NCT03181815|Cladribine|cladribine|mesh-list
19743708|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743709|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743710|NCT03692325|Nivolumab|nivolumab|mesh-list
19743711|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743712|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743713|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743714|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743715|NCT03668392|Asparaginase|asparaginase|mesh-list
19743716|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743717|NCT03668119|Nivolumab|nivolumab|mesh-list
19743718|NCT03668119|Ipilimumab|ipilimumab|mesh-list
19743719|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743720|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023098|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19743721|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743722|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743723|NCT03661723|Bevacizumab|bevacizumab|mesh-list
19743724|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
19743725|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743726|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743727|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19743728|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19743729|NCT03661723|Growth Substances|growth substances|mesh-ancestor
19743730|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743731|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
19743732|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20023099|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20023100|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
20023101|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023102|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023103|NCT02575833|Erenumab|erenumab|mesh-list
20023104|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20023105|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023106|NCT02575833|Analgesics|analgesics|mesh-ancestor
20292825|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19482871|NCT03181815|Aclarubicin|aclarubicin|mesh-list
19482872|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
19482873|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19482874|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
19482875|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482876|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482877|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
19482878|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482879|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19482880|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
19482881|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482882|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19482883|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19482884|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19482885|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482886|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19482887|NCT03181386|Warfarin|warfarin|mesh-list
19482888|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
19482889|NCT03181386|Dabigatran|dabigatran|mesh-list
19482890|NCT03181386|Apixaban|apixaban|mesh-list
19482891|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
19482892|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19482893|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
19482894|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19482895|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
19482896|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482897|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482898|NCT03181178|Micronutrients|micronutrients|mesh-list
19482899|NCT03181178|Trace Elements|trace elements|mesh-list
19482900|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482901|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20023107|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
20023108|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482902|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19482903|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
20023109|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023110|NCT02576067|Methotrexate|methotrexate|mesh-list
20023111|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20023112|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
20023113|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20023114|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023115|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20023116|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
20023117|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023118|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023119|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
19482904|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482905|NCT03181100|Paclitaxel|paclitaxel|mesh-list
19482906|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19482907|NCT03181100|Bevacizumab|bevacizumab|mesh-list
19482908|NCT03181100|Atezolizumab|atezolizumab|mesh-list
19482909|NCT03181100|Vemurafenib|vemurafenib|mesh-list
19482910|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19482911|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
19482912|NCT03181100|Antibodies|antibodies|mesh-list
19482913|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
19482914|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19482915|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
19482916|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19482917|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482918|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
19743733|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023120|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023121|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20023122|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023123|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
19482919|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
19482920|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
19482921|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023124|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20023125|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20023126|NCT02576145|Daclizumab|daclizumab|mesh-list
20023127|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023128|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
20023129|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023130|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
20023131|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20023132|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20023133|NCT02576249|Prednisolone|prednisolone|mesh-list
20023134|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
20023135|NCT02576249|Ropivacaine|ropivacaine|mesh-list
20023136|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20023137|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
20023138|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023139|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
20023140|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023141|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023142|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
20023143|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023144|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292826|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
20292827|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292828|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292829|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19482922|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19482923|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19482924|NCT03181100|Growth Substances|growth substances|mesh-ancestor
19482925|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482926|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
19482927|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
19482928|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19482929|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568654|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568655|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568656|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
19568657|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568658|NCT05345236|Aflibercept|aflibercept|mesh-list
19568659|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19568660|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19568661|NCT05345236|Growth Substances|growth substances|mesh-ancestor
19568662|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568663|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
19568664|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568665|NCT05345210|Amoxicillin|amoxicillin|mesh-list
19568666|NCT05345210|Clarithromycin|clarithromycin|mesh-list
19568667|NCT05345210|Tetracycline|tetracycline|mesh-list
19568668|NCT05345210|Furazolidone|furazolidone|mesh-list
19568669|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568670|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568671|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19568672|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568673|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568674|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19568675|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19568676|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19568677|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19568678|NCT05345210|Renal Agents|renal agents|mesh-ancestor
19568679|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19568680|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19568681|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19568682|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20292830|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023145|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
20023146|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
19568683|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
20023147|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20023148|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
20292831|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
19568684|NCT05345132|Nifedipine|nifedipine|mesh-list
20023149|NCT02576249|Hormones|hormones|mesh-ancestor
20292832|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19482930|NCT03180957|Adalimumab|adalimumab|mesh-list
19482931|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482932|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482933|NCT03180970|Lugol's solution|lugol's solution|mesh-list
19482934|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19482935|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
19482936|NCT03180970|Coagulants|coagulants|mesh-ancestor
19482937|NCT03180879|Ibuprofen|ibuprofen|mesh-list
19482938|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19482939|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19482940|NCT03180879|Analgesics|analgesics|mesh-ancestor
19482941|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
19482942|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482943|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482944|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19482945|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482946|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19482947|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482948|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482949|NCT03180944|Lugol's solution|lugol's solution|mesh-list
19482950|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19482951|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
19482952|NCT03180944|Coagulants|coagulants|mesh-ancestor
19482953|NCT03180775|Glycine|glycine|mesh-list
19482954|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
19482955|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482956|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482957|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482958|NCT03180723|Cyclosporine|cyclosporine|mesh-list
19482959|NCT03180723|Rituximab|rituximab|mesh-list
19482960|NCT03180723|Cyclosporins|cyclosporins|mesh-list
19482961|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19482962|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482963|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
19482964|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482965|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19482966|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19482967|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482968|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023150|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023151|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20023152|NCT02576249|Protective Agents|protective agents|mesh-ancestor
20023153|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20023154|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023155|NCT02576639|CNP520|cnp520|mesh-list
20023156|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023157|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023158|NCT02576652|Tetracycline|tetracycline|mesh-list
20023159|NCT02576652|Demeclocycline|demeclocycline|mesh-list
20023160|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20023161|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023162|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20023163|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023164|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023165|NCT02576678|Apremilast|apremilast|mesh-list
20023166|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20292833|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20292834|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292835|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
20292836|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
20292837|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
20292838|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
20292839|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20292840|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19482969|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
19482970|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482971|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
19482972|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19482973|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
20292841|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
19482974|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19482975|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482976|NCT03180476|Apatinib|apatinib|mesh-list
19482977|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19482978|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19482979|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023167|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023168|NCT02576678|Analgesics|analgesics|mesh-ancestor
19482980|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482981|NCT03180632|Lorazepam|lorazepam|mesh-list
19482982|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
19482983|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
19482984|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
19482985|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19482986|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19482987|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19482988|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19482989|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19482990|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19482991|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19482992|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19482993|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
19482994|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
19482995|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19482996|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19482997|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
19482998|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19482999|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
19483000|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
19483001|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
19483002|NCT03180593|Valsartan|valsartan|mesh-list
19483003|NCT03180593|Nebivolol|nebivolol|mesh-list
19483004|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19483005|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19483006|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19483007|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023169|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
20023170|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483008|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
19483009|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19483010|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19743734|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023171|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023172|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023173|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20023174|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20023175|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20023176|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023177|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483011|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19483012|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19483013|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483014|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483015|NCT03180229|Granisetron|granisetron|mesh-list
20023178|NCT02576938|Triamcinolone|triamcinolone|mesh-list
20023179|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023180|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
20023181|NCT02576938|Hormones|hormones|mesh-ancestor
20023182|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023183|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023184|NCT02576977|Dexamethasone|dexamethasone|mesh-list
20023185|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
20023186|NCT02576977|Pomalidomide|pomalidomide|mesh-list
20023187|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023188|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
20023189|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
20023190|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023191|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023192|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20023193|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
19483016|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
19483017|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
19483018|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023194|NCT02576977|Hormones|hormones|mesh-ancestor
20115433|NCT00005578|Lenograstim|lenograstim|mesh-list
19483019|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483020|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483021|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19483022|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
19483023|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483024|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483025|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19483026|NCT03180346|Laxatives|laxatives|mesh-ancestor
19483027|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483028|NCT03180359|Vaccines|vaccines|mesh-list
19483029|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
19483030|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483031|NCT03180125|Lidocaine|lidocaine|mesh-list
19483032|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
19483033|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
19483034|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
19483035|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483036|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483037|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
19483038|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483039|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19483040|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19483041|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19483042|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19483043|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483044|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19483045|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
19483046|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
19483047|NCT03180125|Protective Agents|protective agents|mesh-ancestor
19483048|NCT03180242|Trastuzumab|trastuzumab|mesh-list
19483049|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19483050|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483051|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19483052|NCT03180281|Glimepiride|glimepiride|mesh-list
19483053|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19483054|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483055|NCT03180281|Incretins|incretins|mesh-ancestor
19483056|NCT03180281|Hormones|hormones|mesh-ancestor
20023195|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023196|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20023197|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023198|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19483057|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023199|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
20023200|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20023201|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20023202|NCT02576977|Growth Substances|growth substances|mesh-ancestor
20023203|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023204|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
20023205|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023206|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023207|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20023208|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
20023209|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023210|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023211|NCT02577003|Incretins|incretins|mesh-ancestor
20023212|NCT02577003|Hormones|hormones|mesh-ancestor
20023213|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023214|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20023215|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023216|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023217|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023218|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20023219|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20023220|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
19483058|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20023221|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023222|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483059|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
19483060|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483061|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483062|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19483063|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483064|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
19483065|NCT03180255|Dexamethasone|dexamethasone|mesh-list
19483066|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
19483067|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19483068|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483069|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
19483070|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
19483071|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483072|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023223|NCT02577016|Incretins|incretins|mesh-ancestor
20023224|NCT02577016|Hormones|hormones|mesh-ancestor
19483073|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483074|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
19483075|NCT03180255|Hormones|hormones|mesh-ancestor
19483076|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483077|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19483078|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483079|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
19483080|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
19483081|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
19483082|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19483083|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19483084|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483085|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483086|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483087|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483088|NCT03180099|Bupivacaine|bupivacaine|mesh-list
19483089|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
19483090|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
19483091|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483092|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483093|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
19483094|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743735|NCT03659461|Incretins|incretins|mesh-ancestor
19743736|NCT03659461|Hormones|hormones|mesh-ancestor
19743737|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743738|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19483099|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
19483100|NCT03179839|Sertraline|sertraline|mesh-list
19483101|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
19483102|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19483103|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19483104|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19483105|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19483106|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483107|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483108|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
19483109|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483110|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19483111|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19483112|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483113|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19483114|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19483115|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19483116|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483117|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19483118|NCT03179904|Paclitaxel|paclitaxel|mesh-list
19483119|NCT03179904|Trastuzumab|trastuzumab|mesh-list
19483120|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19483121|NCT03179904|Letrozole|letrozole|mesh-list
19483122|NCT03179904|Fulvestrant|fulvestrant|mesh-list
19483123|NCT03179904|Anastrozole|anastrozole|mesh-list
19483124|NCT03179904|Exemestane|exemestane|mesh-list
19483125|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19483126|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19483127|NCT03179904|Antibodies|antibodies|mesh-list
20115434|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483128|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
19483129|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19483130|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19483131|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483132|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
19483133|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
19483134|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
19483135|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483136|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
19483137|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483138|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19743739|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
19743740|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743741|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743742|NCT03643133|Mifamurtide|mifamurtide|mesh-list
19743743|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19743744|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
19743745|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743746|NCT03642067|Nivolumab|nivolumab|mesh-list
19743747|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743748|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743749|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743750|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743751|NCT03632720|Vaccines|vaccines|mesh-list
19743752|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
19743753|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743754|NCT03607890|Nivolumab|nivolumab|mesh-list
19743755|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743756|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743757|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743758|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743759|NCT03605927|Sirolimus|sirolimus|mesh-list
19743760|NCT03605927|Tacrolimus|tacrolimus|mesh-list
19743761|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743762|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
19743763|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743764|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19743765|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743766|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743767|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19743768|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743769|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19743770|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743771|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
19743772|NCT03583307|Sirolimus|sirolimus|mesh-list
19743773|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19743774|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743775|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20023225|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023226|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20023227|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
19743776|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743777|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
19743778|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743779|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
19743780|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749134|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749135|NCT05262244|Bevacizumab|bevacizumab|mesh-list
19749136|NCT05262244|Vedolizumab|vedolizumab|mesh-list
19749137|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749138|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749139|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749140|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749141|NCT05262244|Growth Substances|growth substances|mesh-ancestor
19749142|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749143|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023228|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023229|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023230|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20023231|NCT02577029|Interferons|interferons|mesh-list
20023232|NCT02577029|Tenofovir|tenofovir|mesh-list
20023233|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
20023234|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
20292842|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
19749144|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20292843|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023235|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20023236|NCT02577029|Entecavir|entecavir|mesh-list
20023237|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
20023238|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19483139|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19483140|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483141|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19483142|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
19483143|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483144|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19483145|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19483146|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
19483147|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483148|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
19483149|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19483150|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483151|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
19483152|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19483153|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
19483154|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19483155|NCT03179449|Hematinics|hematinics|mesh-ancestor
19483156|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19483157|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19483158|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
19483159|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
20023239|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023240|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
20023241|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023242|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20023243|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20023244|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023245|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023246|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20023247|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023248|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
20023249|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023250|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
20023251|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023252|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
20023253|NCT02577042|Atorvastatin|atorvastatin|mesh-list
20023254|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20023255|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20023256|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
20023257|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023258|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20023259|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20023260|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023261|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20023262|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023263|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
20023264|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023265|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20023266|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20023267|NCT02577107|Ranibizumab|ranibizumab|mesh-list
20023268|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20023269|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20023270|NCT02577107|Growth Substances|growth substances|mesh-ancestor
20023271|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023272|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023273|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023274|NCT02577315|Metformin|metformin|mesh-list
20023275|NCT02577315|Empagliflozin|empagliflozin|mesh-list
20023276|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023277|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023278|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20023279|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023280|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
20023281|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20023282|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
20023283|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
20023284|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20023285|NCT02577601|Estradiol|estradiol|mesh-list
20023286|NCT02577601|Estrogens|estrogens|mesh-ancestor
19483160|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023287|NCT02577601|Hormones|hormones|mesh-ancestor
20023288|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483161|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483162|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
19483163|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19483164|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
19483165|NCT03179605|Clobetasol|clobetasol|mesh-list
19483166|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483167|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
19483168|NCT03179605|Hormones|hormones|mesh-ancestor
19483169|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483170|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483171|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
19483172|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19483173|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
19483174|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
19483175|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19483176|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483177|NCT03179293|Propofol|propofol|mesh-list
19483178|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19483179|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483180|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483181|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19483182|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
19483183|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
19483184|NCT03179280|Insulin|insulin|mesh-list
19483185|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
19483186|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19483187|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568685|NCT05345132|Analgesics|analgesics|mesh-ancestor
19568686|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
19568687|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568688|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568689|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
19568690|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568691|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19568692|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
19568693|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19568694|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19568695|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568696|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19568697|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
19568698|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568699|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
19568700|NCT05345119|Sirolimus|sirolimus|mesh-list
19568701|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
19568702|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19568703|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19568704|NCT05345119|Prednisolone|prednisolone|mesh-list
19568705|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
19568706|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19568707|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
19568708|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19568709|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568710|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19568711|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568712|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
19568713|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19568714|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
19568715|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568716|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568717|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
19568718|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
19568719|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568720|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20023289|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023290|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20023291|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
20023292|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20023293|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20023294|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20023295|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20292844|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19568721|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
19568722|NCT05345119|Hormones|hormones|mesh-ancestor
19568723|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023296|NCT02577718|Ethanol|ethanol|mesh-list
20023297|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
20023298|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19483188|NCT03178994|Ketoconazole|ketoconazole|mesh-list
19483189|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
19483190|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483191|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19483192|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19483193|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483194|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483195|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19483196|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
19483197|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483198|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483199|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19483200|NCT03179254|Metformin|metformin|mesh-list
20292845|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
20292846|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20292847|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20292848|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20023299|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023300|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023301|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023302|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
20023303|NCT02577991|Triamcinolone|triamcinolone|mesh-list
20023304|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023305|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023306|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
20023307|NCT02577991|Hormones|hormones|mesh-ancestor
20023308|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023309|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
20023310|NCT02578186|Promethazine|promethazine|mesh-list
20023311|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20023312|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20023313|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023314|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023315|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023316|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
20023317|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
20023318|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483201|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19483202|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483203|NCT03178708|Amantadine|amantadine|mesh-list
19483204|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19483205|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19483206|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
19483207|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483208|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
19483209|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483210|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483211|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483212|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483213|NCT03178708|Analgesics|analgesics|mesh-ancestor
19483214|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
19483215|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483216|NCT03178955|Etanercept|etanercept|mesh-list
19483217|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19483218|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483219|NCT03178955|Analgesics|analgesics|mesh-ancestor
19483220|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
19483221|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023319|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
20023320|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
20023321|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20023322|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20023323|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
20023324|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
20023325|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023326|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023327|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20023328|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
20023329|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
20023330|NCT02578316|Lenvatinib|lenvatinib|mesh-list
20023331|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023332|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20292849|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20023333|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023334|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023335|NCT02578706|Aspirin|aspirin|mesh-list
20023336|NCT02578706|Clopidogrel|clopidogrel|mesh-list
20023337|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20023338|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023339|NCT02578706|Analgesics|analgesics|mesh-ancestor
19483222|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483223|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483224|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483225|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483226|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483227|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
19483228|NCT03178864|Heparin|heparin|mesh-list
19483229|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
19483230|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
19483231|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19483232|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20023340|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
20023341|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023342|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023343|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023344|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20023345|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20023346|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20023347|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023348|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19483233|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483234|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19483235|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
19483236|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19483237|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
19483238|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483239|NCT03178656|Sorafenib|sorafenib|mesh-list
20023349|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20023350|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023351|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
20023352|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19483240|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483241|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19483242|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483243|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483244|NCT03178721|Calcium|calcium|mesh-list
20023353|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20023354|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20023355|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
20023356|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023357|NCT02578862|Propofol|propofol|mesh-list
20023358|NCT02578862|Sevoflurane|sevoflurane|mesh-list
20023359|NCT02578862|Isoflurane|isoflurane|mesh-list
20023360|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20023361|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023362|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023363|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20023364|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
20023365|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
20023366|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20023367|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20023368|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
20023369|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20023370|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20023371|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023372|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
20023373|NCT02578901|Coagulants|coagulants|mesh-ancestor
20023374|NCT02579057|Furosemide|furosemide|mesh-list
20023375|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19483245|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19483246|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483247|NCT03178643|Piperaquine|piperaquine|mesh-list
19483248|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
19483249|NCT03178643|Amodiaquine|amodiaquine|mesh-list
20023376|NCT02579057|Diuretics|diuretics|mesh-ancestor
20023377|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
20023378|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483250|NCT03178643|Artenimol|artenimol|mesh-list
19483251|NCT03178643|Proguanil|proguanil|mesh-list
19483252|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
19483253|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19483254|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19483255|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483256|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19483257|NCT03178643|Renal Agents|renal agents|mesh-ancestor
20023379|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20023380|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20023381|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023382|NCT02579343|Dexetimide|dexetimide|mesh-list
20023383|NCT02579343|Citalopram|citalopram|mesh-list
20023384|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20023385|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20023386|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20023387|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023388|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023389|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
20023390|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023391|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20023392|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
20023393|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20023394|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20023395|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20023396|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
20023397|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
20023398|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023399|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20023400|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20023401|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
20023402|NCT02579382|Vesatolimod|vesatolimod|mesh-list
20023403|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
20023404|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483258|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
19483259|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483260|NCT03178747|Methylene Blue|methylene blue|mesh-list
19483261|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483262|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483263|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
19483264|NCT03178591|Vildagliptin|vildagliptin|mesh-list
19483265|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19483266|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483267|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19483268|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483269|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19483270|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
19483271|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483272|NCT03178292|Levofloxacin|levofloxacin|mesh-list
19483273|NCT03178292|Ofloxacin|ofloxacin|mesh-list
19483274|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19483275|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483276|NCT03178292|Renal Agents|renal agents|mesh-ancestor
19483277|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19483278|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19483279|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19483280|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483281|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483282|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483283|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19483284|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19483285|NCT03178422|Nicotine|nicotine|mesh-list
19483286|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19483287|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
19483288|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483289|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483290|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19483291|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19483292|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
19483293|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483294|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483295|NCT03178396|Melatonin|melatonin|mesh-list
19483296|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
19483297|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483298|NCT03178396|Protective Agents|protective agents|mesh-ancestor
19483299|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483300|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483301|NCT03178409|Liver Extracts|liver extracts|mesh-list
19483302|NCT03178409|Hematinics|hematinics|mesh-ancestor
19483303|NCT03178539|Diclofenac|diclofenac|mesh-list
19483304|NCT03178539|Ketorolac|ketorolac|mesh-list
19483305|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19483306|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483307|NCT03178539|Analgesics|analgesics|mesh-ancestor
19483308|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
19483309|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483310|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483311|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483312|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483313|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19483314|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483315|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483316|NCT03178500|Clomiphene|clomiphene|mesh-list
19483317|NCT03178500|Enclomiphene|enclomiphene|mesh-list
19483318|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
19483319|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19483320|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
19483321|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483322|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483323|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19483324|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
19483325|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19483326|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19483327|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20023405|NCT02579421|Progesterone|progesterone|mesh-list
20023406|NCT02579421|Progestins|progestins|mesh-ancestor
20023407|NCT02579421|Hormones|hormones|mesh-ancestor
20023408|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483328|NCT03178526|Lovastatin|lovastatin|mesh-list
20023409|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483329|NCT03178526|L 647318|l 647318|mesh-list
19483330|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
19483331|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19483332|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19483333|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
19483334|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483335|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19483336|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19483337|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115435|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
20115436|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115437|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115438|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115439|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
20115440|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115441|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115442|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115443|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115444|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115445|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115446|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115447|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115448|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
20115449|NCT00005578|Hormones|hormones|mesh-ancestor
20115450|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115451|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115452|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115453|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20115454|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115455|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115456|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115457|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20115458|NCT00005578|Protective Agents|protective agents|mesh-ancestor
20115459|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
20115460|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115461|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115462|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115463|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
19483338|NCT03178123|Interferons|interferons|mesh-list
19483339|NCT03178123|Antibodies|antibodies|mesh-list
20023410|NCT02579603|Pirfenidone|pirfenidone|mesh-list
20023411|NCT02579603|Nintedanib|nintedanib|mesh-list
20023412|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023413|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20023414|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023415|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023416|NCT02579603|Analgesics|analgesics|mesh-ancestor
20023417|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
20023418|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023419|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023420|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20023421|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023422|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023423|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483340|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19483341|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
19483342|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483343|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483344|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
19483345|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483346|NCT03177993|Ivermectin|ivermectin|mesh-list
19483347|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19483348|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483349|NCT03178084|Lamivudine|lamivudine|mesh-list
19483350|NCT03178084|Zidovudine|zidovudine|mesh-list
19483351|NCT03178084|Efavirenz|efavirenz|mesh-list
19483352|NCT03178084|Maraviroc|maraviroc|mesh-list
19483353|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19483354|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19483355|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483356|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483357|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
19483358|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483359|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19483360|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19483361|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
19483362|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19483363|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19483364|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19483365|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19483366|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19483367|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19483368|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19483369|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19483370|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19483371|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
19483372|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483373|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
19483374|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20023424|NCT02579616|Lenvatinib|lenvatinib|mesh-list
20023425|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023426|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20023427|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023428|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023429|NCT02579629|Ropivacaine|ropivacaine|mesh-list
20023430|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023431|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
20023432|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023433|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023434|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
20023435|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023436|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
20023437|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20023438|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
20023439|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023440|NCT02579772|Expectorants|expectorants|mesh-ancestor
20023441|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
20023442|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20023443|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
20023444|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023445|NCT02579772|Protective Agents|protective agents|mesh-ancestor
20023446|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483375|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19483376|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023447|NCT02579772|Antidotes|antidotes|mesh-ancestor
20023448|NCT02579811|Axitinib|axitinib|mesh-list
20023449|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023450|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20023451|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023452|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023453|NCT02579863|Dexamethasone|dexamethasone|mesh-list
20023454|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
20023455|NCT02579863|Lenalidomide|lenalidomide|mesh-list
20023456|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023457|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
20023458|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
20023459|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023460|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483377|NCT03177824|Urological Agents|urological agents|mesh-ancestor
19483378|NCT03177837|Acetazolamide|acetazolamide|mesh-list
19483379|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
20023461|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20023462|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
20023463|NCT02579863|Hormones|hormones|mesh-ancestor
20023464|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023465|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20023466|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023467|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023468|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
20023469|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20023470|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20023471|NCT02579863|Growth Substances|growth substances|mesh-ancestor
20023472|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023473|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
20023474|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023475|NCT02579928|Midazolam|midazolam|mesh-list
20023476|NCT02579928|Ketamine|ketamine|mesh-list
20023477|NCT02579928|Analgesics|analgesics|mesh-ancestor
20023478|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
20023479|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023480|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023481|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20023482|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20023483|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
20023484|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
20023485|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023486|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20023487|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20023488|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023489|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023490|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20023491|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20023492|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20023493|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20023494|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20023495|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
20023496|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
20023497|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
20023498|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023499|NCT02580591|Empagliflozin|empagliflozin|mesh-list
20023500|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20023501|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023502|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023503|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023504|NCT02580877|Insulin|insulin|mesh-list
20023505|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20023506|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
20023507|NCT02580877|Methamphetamine|methamphetamine|mesh-list
20023508|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023509|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023510|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20023511|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
20023512|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
19483380|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19483381|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483382|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483383|NCT03177837|Diuretics|diuretics|mesh-ancestor
19483384|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
19483385|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483386|NCT03177811|Acetazolamide|acetazolamide|mesh-list
20023513|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483387|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
19483388|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19483389|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483390|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483391|NCT03177811|Diuretics|diuretics|mesh-ancestor
19483392|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
19483393|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023514|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
20023515|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023516|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023517|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
20023518|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20023519|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20023520|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20023521|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20023522|NCT02581111|Naloxone|naloxone|mesh-list
20023523|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20023524|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023525|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
20023526|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023527|NCT02581163|Ritonavir|ritonavir|mesh-list
20023528|NCT02581163|Ribavirin|ribavirin|mesh-list
20023529|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20023530|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20023531|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023532|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023533|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023534|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19483394|NCT03177980|Clonidine|clonidine|mesh-list
19483395|NCT03177980|Fentanyl|fentanyl|mesh-list
19483396|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19483397|NCT03177980|Narcotics|narcotics|mesh-ancestor
19483398|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483399|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483400|NCT03177980|Analgesics|analgesics|mesh-ancestor
19483401|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
19483402|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483403|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19483404|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19483405|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
19483406|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
19483407|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20023535|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023536|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
20023537|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023538|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20023539|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20023540|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
20023541|NCT02581189|Ritonavir|ritonavir|mesh-list
20023542|NCT02581189|Ribavirin|ribavirin|mesh-list
20023543|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20023544|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20023545|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023546|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023547|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023548|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20023549|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023550|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
20023551|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023552|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20023553|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20023554|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
20023555|NCT02581202|Ritonavir|ritonavir|mesh-list
20023556|NCT02581202|Lopinavir|lopinavir|mesh-list
20023557|NCT02581202|Lamivudine|lamivudine|mesh-list
20023558|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20023559|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20023560|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023561|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023562|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023563|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20023564|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023565|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
19483408|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
19483409|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
20023566|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292850|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19483410|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19483411|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19483412|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19483413|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
19483414|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483415|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483416|NCT03177850|Acetazolamide|acetazolamide|mesh-list
19483417|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
19483418|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19483419|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483420|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483421|NCT03177850|Diuretics|diuretics|mesh-ancestor
19483422|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
19483423|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483424|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
19483425|NCT03177720|Imipenem|imipenem|mesh-list
19483426|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19483427|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483428|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19483429|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19483430|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483431|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483432|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483433|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19483434|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19568724|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19568725|NCT05345119|Protective Agents|protective agents|mesh-ancestor
19568726|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568727|NCT05344911|Remifentanil|remifentanil|mesh-list
19568728|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20023567|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20023568|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20023569|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20023570|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20023571|NCT02581345|Adalimumab|adalimumab|mesh-list
20023572|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023573|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20023574|NCT02581839|Dexamethasone|dexamethasone|mesh-list
20023575|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
20023576|NCT02581839|Ondansetron|ondansetron|mesh-list
20023577|NCT02581839|BB 1101|bb 1101|mesh-list
20023578|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023579|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
19568729|NCT05344911|Narcotics|narcotics|mesh-ancestor
19568730|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568731|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568732|NCT05344911|Analgesics|analgesics|mesh-ancestor
19568733|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
19568734|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568735|NCT05344833|Lenalidomide|lenalidomide|mesh-list
19568736|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
19568737|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568738|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19568739|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19568740|NCT05344833|Growth Substances|growth substances|mesh-ancestor
19568741|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
19568742|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568743|NCT05344742|Paclitaxel|paclitaxel|mesh-list
19568744|NCT05344742|Capecitabine|capecitabine|mesh-list
19568745|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
19568746|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19568747|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568748|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
19743781|NCT03546894|Ceritinib|ceritinib|mesh-list
19743782|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743783|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19743784|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743785|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743786|NCT03535727|Gemcitabine|gemcitabine|mesh-list
19743787|NCT03535727|Paclitaxel|paclitaxel|mesh-list
19743788|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19743789|NCT03535727|Cisplatin|cisplatin|mesh-list
19743790|NCT03535727|Capecitabine|capecitabine|mesh-list
19743791|NCT03535727|Irinotecan|irinotecan|mesh-list
19743792|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20023580|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
20023581|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483435|NCT03177538|Menotropins|menotropins|mesh-list
19483436|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19483437|NCT03177538|Hormones|hormones|mesh-ancestor
19483438|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483439|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483440|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19483441|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
19483442|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19483443|NCT03177434|Lactulose|lactulose|mesh-list
19483444|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483445|NCT03177174|Docetaxel|docetaxel|mesh-list
19483446|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483447|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
19483448|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
19483449|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
19483450|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483451|NCT03177252|Lidocaine|lidocaine|mesh-list
19483452|NCT03177252|Bupivacaine|bupivacaine|mesh-list
19483453|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
19483454|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
19483455|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483456|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483457|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
20023582|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023583|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20023584|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
19483458|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483459|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20023585|NCT02581839|Hormones|hormones|mesh-ancestor
20023586|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023587|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20023588|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023589|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023590|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023591|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023592|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
20023593|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
20023594|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20023595|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
20023596|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023597|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20023598|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20023599|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023600|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20023601|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20023602|NCT02581891|Aflibercept|aflibercept|mesh-list
20023603|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20023604|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20023605|NCT02581891|Growth Substances|growth substances|mesh-ancestor
20023606|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023607|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023608|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023609|NCT02581995|Aflibercept|aflibercept|mesh-list
19483460|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19483461|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19483462|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19483463|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483464|NCT03177317|Dexamethasone|dexamethasone|mesh-list
19483465|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483466|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
19483467|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
19483468|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483469|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483470|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483471|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
19483472|NCT03177317|Hormones|hormones|mesh-ancestor
19483473|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483474|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19483475|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483476|NCT03177239|Nivolumab|nivolumab|mesh-list
19483477|NCT03177239|Ipilimumab|ipilimumab|mesh-list
19483478|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023610|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20023611|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19483479|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023612|NCT02581995|Growth Substances|growth substances|mesh-ancestor
20023613|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023614|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023615|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023616|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
19483480|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19483481|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483482|NCT03176849|Vitamin D|vitamin d|mesh-list
19483483|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
19483484|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
19483485|NCT03176849|Vitamins|vitamins|mesh-list
19483486|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
19483487|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483488|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19483489|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19483490|NCT03177109|Fluorides|fluorides|mesh-list
19483491|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
19483492|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
19483493|NCT03177109|Protective Agents|protective agents|mesh-ancestor
19483494|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483495|NCT03176966|Vitamin E|vitamin e|mesh-list
19483496|NCT03176966|Ropinirole|ropinirole|mesh-list
19483497|NCT03176966|Vitamins|vitamins|mesh-ancestor
19483498|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
19483499|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483500|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
19483501|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483502|NCT03176966|Protective Agents|protective agents|mesh-ancestor
19483503|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19483504|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19483505|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
19483506|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
19483507|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483508|NCT03177083|Interferons|interferons|mesh-list
19483509|NCT03177083|Interferon-beta|interferon-beta|mesh-list
19483510|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
19483511|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
19483512|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483513|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
19483514|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483515|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
19483516|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023617|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
20023618|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20023619|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023620|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483517|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19483518|NCT03176758|Anesthetics|anesthetics|mesh-list
19483519|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
19483520|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483521|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483522|NCT03176693|Doxazosin|doxazosin|mesh-list
19483523|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
19483524|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19483525|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19483526|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19483527|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19483528|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20023621|NCT02582515|Cycloserine|cycloserine|mesh-list
20023622|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20023623|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023624|NCT02582515|Renal Agents|renal agents|mesh-ancestor
20023625|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20023626|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
20023627|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20023628|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
20023629|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023630|NCT02582632|Ritonavir|ritonavir|mesh-list
20023631|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20023632|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20023633|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023634|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023635|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483529|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483530|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483531|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483532|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19483533|NCT03177070|Methylene Blue|methylene blue|mesh-list
19483534|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483535|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483536|NCT03176628|Niacinamide|niacinamide|mesh-list
19483537|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
19483538|NCT03176628|Vitamins|vitamins|mesh-ancestor
19483539|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
19483540|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483541|NCT03176524|Glucagon|glucagon|mesh-list
19483542|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19483543|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483544|NCT03176524|Hormones|hormones|mesh-ancestor
19483545|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483546|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483547|NCT03176524|Incretins|incretins|mesh-ancestor
19483548|NCT03176264|Bevacizumab|bevacizumab|mesh-list
19483549|NCT03176264|Spartalizumab|spartalizumab|mesh-list
19483550|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19483551|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483552|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19483553|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19483554|NCT03176264|Growth Substances|growth substances|mesh-ancestor
19483555|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483556|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
19483557|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19483558|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483559|NCT03176563|Fosfomycin|fosfomycin|mesh-list
19483560|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19483561|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483562|NCT03176316|Naloxone|naloxone|mesh-list
19483563|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19483564|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483565|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
19483566|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483567|NCT03176472|Ricolinostat|ricolinostat|mesh-list
19483568|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483569|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19483570|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483571|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483572|NCT03176446|Anesthetics|anesthetics|mesh-list
19483573|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
19483574|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483575|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483576|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
19483577|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483578|NCT03176537|Testosterone|testosterone|mesh-list
19483579|NCT03176537|Androgens|androgens|mesh-ancestor
19483580|NCT03176537|Hormones|hormones|mesh-ancestor
19483581|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483582|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483583|NCT03176212|Milk fat globule|milk fat globule|mesh-list
19483584|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483585|NCT03176121|Oxycodone|oxycodone|mesh-list
19483586|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19483587|NCT03176121|Narcotics|narcotics|mesh-ancestor
19483588|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483589|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483590|NCT03176121|Analgesics|analgesics|mesh-ancestor
19483591|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
19483592|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483593|NCT03176199|Oxycodone|oxycodone|mesh-list
19483594|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19483595|NCT03176199|Narcotics|narcotics|mesh-ancestor
19483596|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483597|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483598|NCT03176199|Analgesics|analgesics|mesh-ancestor
19483599|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
19483600|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483601|NCT03176186|Xenon|xenon|mesh-list
19483602|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20023636|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19483603|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
19483604|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
19483605|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483606|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483607|NCT03175978|Methotrexate|methotrexate|mesh-list
19483608|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483609|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19483610|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
19483611|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19483612|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19483613|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
20023637|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023638|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
20023639|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023640|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20023641|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19483614|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483615|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483616|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
19483617|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483618|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19483619|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483620|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
19483621|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483622|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19483623|NCT03175939|Fluorouracil|fluorouracil|mesh-list
19483624|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483625|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
19483626|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483627|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19483628|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483629|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
19483630|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483631|NCT03175926|Budesonide|budesonide|mesh-list
19483632|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483633|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19483634|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
19483635|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483636|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483637|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19483638|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
19483639|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
19483640|NCT03175926|Hormones|hormones|mesh-ancestor
19483641|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568749|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
19568750|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
19568751|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568752|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19568753|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
19568754|NCT05344742|Analgesics|analgesics|mesh-ancestor
19568755|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
19568756|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568757|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568758|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19568759|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19568760|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568761|NCT05344625|Ketamine|ketamine|mesh-list
19568762|NCT05344625|Analgesics|analgesics|mesh-ancestor
19568763|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
19568764|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568765|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568766|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19568767|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19568768|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
19568769|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
19568770|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568771|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19568772|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19568773|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568774|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023642|NCT02582671|Ritonavir|ritonavir|mesh-list
19483642|NCT03175679|Interleukin-2|interleukin-2|mesh-list
19483643|NCT03175679|Tegafur|tegafur|mesh-list
19483644|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483645|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483646|NCT03175679|Analgesics|analgesics|mesh-ancestor
19483647|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
19483648|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483649|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483650|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19483651|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
19483652|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483653|NCT03175666|Leucovorin|leucovorin|mesh-list
19483654|NCT03175666|Paclitaxel|paclitaxel|mesh-list
19483655|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
19483656|NCT03175666|Bevacizumab|bevacizumab|mesh-list
19483657|NCT03175666|Fluorouracil|fluorouracil|mesh-list
19483658|NCT03175666|Capecitabine|capecitabine|mesh-list
19483659|NCT03175666|Avelumab|avelumab|mesh-list
19483660|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19483661|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483662|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
19483663|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
19483664|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
19483665|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483666|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483667|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
19483668|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483669|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483670|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19483671|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
19483672|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19483673|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19483674|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19483675|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19483676|NCT03175666|Growth Substances|growth substances|mesh-ancestor
19483677|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
19483678|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
19483679|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19483680|NCT03175666|Antidotes|antidotes|mesh-ancestor
19483681|NCT03175666|Protective Agents|protective agents|mesh-ancestor
19483682|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
19483683|NCT03175666|Vitamins|vitamins|mesh-ancestor
19483684|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
19483685|NCT03175705|Interleukin-2|interleukin-2|mesh-list
19483686|NCT03175705|Tegafur|tegafur|mesh-list
19483687|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483688|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483689|NCT03175705|Analgesics|analgesics|mesh-ancestor
19483690|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
19483691|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483692|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483693|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19483694|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
19483695|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483696|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19483697|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19483698|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19483699|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
19483700|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483701|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19483702|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19483703|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483704|NCT03175653|Oxycodone|oxycodone|mesh-list
19483705|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19483706|NCT03175653|Narcotics|narcotics|mesh-ancestor
19483707|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483708|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483709|NCT03175653|Analgesics|analgesics|mesh-ancestor
19483710|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
19483711|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483712|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
19483713|NCT03175341|Vitamins|vitamins|mesh-ancestor
20023643|NCT02582671|Ribavirin|ribavirin|mesh-list
19483714|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
19483715|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483716|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
19483717|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483718|NCT03175341|Protective Agents|protective agents|mesh-ancestor
19483719|NCT03175549|Apremilast|apremilast|mesh-list
19483720|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19483721|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483722|NCT03175549|Analgesics|analgesics|mesh-ancestor
19483723|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
19483724|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483725|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483726|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483727|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483728|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19483729|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19483730|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483731|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483732|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
19483733|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19483734|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
19483735|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483736|NCT03175081|Ropivacaine|ropivacaine|mesh-list
19483737|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
19483738|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
19483739|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483740|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483741|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
19483742|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483743|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
19483744|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19483745|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19483746|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
19483747|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483748|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19483749|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19483750|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023644|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20023645|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20023646|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023647|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023648|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023649|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20023650|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023651|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
20023652|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023653|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20023654|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20023655|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
20023656|NCT02582684|Lamivudine|lamivudine|mesh-list
20292851|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
20292852|NCT05009862|Aspirin|aspirin|mesh-list
20292853|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
19483751|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023657|NCT02582684|Dolutegravir|dolutegravir|mesh-list
20023658|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20023659|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20023660|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023661|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023662|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
20023663|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023664|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20023665|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023666|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20023667|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20023668|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
20023669|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20023670|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023671|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023672|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023673|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
20023674|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20023675|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023676|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023677|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483752|NCT03175016|Irinotecan|irinotecan|mesh-list
19483753|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19483754|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19483755|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483756|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483757|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483758|NCT03174938|Flutemetamol|flutemetamol|mesh-list
19483759|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19483760|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483761|NCT03174860|Diclofenac|diclofenac|mesh-list
19483762|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19483763|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483764|NCT03174860|Analgesics|analgesics|mesh-ancestor
19483765|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
19483766|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483767|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483768|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483769|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483770|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19483771|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483772|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483773|NCT03174821|Insulin|insulin|mesh-list
19483774|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19483775|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20023678|NCT02582866|Lacosamide|lacosamide|mesh-list
19483776|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483777|NCT03174795|Meropenem|meropenem|mesh-list
19483778|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19483779|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483780|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19483781|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19483782|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483783|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19483784|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483785|NCT03174561|Choline|choline|mesh-list
19483786|NCT03174561|Silymarin|silymarin|mesh-list
19483787|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
19483788|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19483789|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
19483790|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483791|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19483792|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19483793|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
19483794|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
19483795|NCT03174561|Protective Agents|protective agents|mesh-ancestor
19483796|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483797|NCT03174782|Bupivacaine|bupivacaine|mesh-list
19483798|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
19483799|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
19483800|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483801|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483802|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
19483803|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483804|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
19483805|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19483806|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483807|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
19483808|NCT03174483|Fluticasone|fluticasone|mesh-list
19483809|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483810|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19483811|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
19483812|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483813|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483814|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19483815|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
19483816|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
19483817|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19483818|NCT03174457|Micafungin|micafungin|mesh-list
19483819|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
19483820|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483821|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
19483822|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19483823|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023679|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
20023680|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20023681|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20023682|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20023683|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023684|NCT02582970|Bevacizumab|bevacizumab|mesh-list
20023685|NCT02582970|Fluorouracil|fluorouracil|mesh-list
20023686|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
20023687|NCT02582970|Irinotecan|irinotecan|mesh-list
20023688|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023689|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023690|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19483824|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483825|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19483826|NCT03174678|Analgesics|analgesics|mesh-ancestor
19483827|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
19483828|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483829|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19483830|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19483831|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19483832|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
19483833|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483834|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577653|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577654|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
19577655|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19577656|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19577657|NCT04126200|Growth Substances|growth substances|mesh-ancestor
19577658|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
19577659|NCT04117074|Bupivacaine|bupivacaine|mesh-list
19577660|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
19577661|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
19577662|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577663|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577664|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
19577665|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577666|NCT04115189|Sunitinib|sunitinib|mesh-list
19577667|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577668|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19577669|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19577670|NCT04115189|Growth Substances|growth substances|mesh-ancestor
19577671|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577672|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19577673|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19577674|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577675|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577676|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19577677|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
19577678|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577679|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19577680|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
19577681|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577682|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577683|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19577684|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19577685|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19577686|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
19578349|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19578350|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
19578351|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578352|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023691|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20023692|NCT02582970|Growth Substances|growth substances|mesh-ancestor
19483835|NCT03174171|Everolimus|everolimus|mesh-list
19483836|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483837|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483838|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
19483839|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483840|NCT03174080|Fluorides|fluorides|mesh-list
19483841|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
20023693|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023694|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023695|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
20023696|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023697|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19483842|NCT03174080|Protective Agents|protective agents|mesh-ancestor
19483843|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483844|NCT03174236|Metronidazole|metronidazole|mesh-list
19483845|NCT03174236|Gentamicins|gentamicins|mesh-list
19483846|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
19483847|NCT03174236|Penicillins|penicillins|mesh-list
19483848|NCT03174236|Penicillin G|penicillin g|mesh-list
19483849|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19483850|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
19483851|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483852|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19483853|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19483854|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19483855|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19483856|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483857|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483858|NCT03174288|Spironolactone|spironolactone|mesh-list
19483859|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19483860|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
19483861|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483862|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483863|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19483864|NCT03174288|Diuretics|diuretics|mesh-ancestor
19483865|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
19483866|NCT03174353|Lanreotide|lanreotide|mesh-list
19483867|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483868|NCT03174067|Clonidine|clonidine|mesh-list
19483869|NCT03174067|Buprenorphine|buprenorphine|mesh-list
19483870|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19483871|NCT03174067|Narcotics|narcotics|mesh-ancestor
19483872|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483873|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483874|NCT03174067|Analgesics|analgesics|mesh-ancestor
19483875|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
19483876|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483877|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19483878|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19483879|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
19483880|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
19483881|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19483882|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19483883|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19483884|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
19483885|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483886|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483887|NCT03174041|Itraconazole|itraconazole|mesh-list
19483888|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19483889|NCT03174041|Midazolam|midazolam|mesh-list
19483890|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19483891|NCT03174041|Simvastatin|simvastatin|mesh-list
19483892|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19483893|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19483894|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483895|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483896|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19483897|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19483898|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19483899|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19483900|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
20023698|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023699|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
20023700|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20023701|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20023702|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023703|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
20023704|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20023705|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20023706|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023707|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20023708|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20023709|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
20023710|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023711|NCT02583399|Ibuprofen|ibuprofen|mesh-list
20023712|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20023713|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023714|NCT02583399|Analgesics|analgesics|mesh-ancestor
20023715|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
20023716|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023717|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023718|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023719|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20023720|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20023721|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023722|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023723|NCT02583477|Gemcitabine|gemcitabine|mesh-list
20023724|NCT02583477|Paclitaxel|paclitaxel|mesh-list
20023725|NCT02583477|Durvalumab|durvalumab|mesh-list
20023726|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20023727|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20023728|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023729|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
20023730|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
20023731|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
20023732|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023733|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20023734|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
20023735|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
20023736|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023737|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023738|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023739|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
20023740|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023741|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023742|NCT02584257|Albuterol|albuterol|mesh-list
20023743|NCT02584257|Procaterol|procaterol|mesh-list
20023744|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
20023745|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20023746|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
20023747|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023748|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023749|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20023750|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
20023751|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
20023752|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20023753|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20023754|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20023755|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20023756|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
20023757|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023758|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023759|NCT02584257|Miotics|miotics|mesh-ancestor
20023760|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20023761|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19483901|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
19483902|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
19483903|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
19483904|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483905|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023762|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20023763|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19483906|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20023764|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
19483907|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19483908|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
19483909|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19483910|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19483911|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483912|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
19483913|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483914|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19483915|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19483916|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19483917|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
19483918|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19483919|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19483920|NCT03173898|Anesthetics|anesthetics|mesh-list
19483921|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483922|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483923|NCT03173781|Droxidopa|droxidopa|mesh-list
19483924|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19483925|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19483926|NCT03173963|Empagliflozin|empagliflozin|mesh-list
19483927|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19483928|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483929|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19483930|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483931|NCT03173612|Cytarabine|cytarabine|mesh-list
19483932|NCT03173612|Etoposide|etoposide|mesh-list
19483933|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
19483934|NCT03173612|Idarubicin|idarubicin|mesh-list
19483935|NCT03173612|Dasatinib|dasatinib|mesh-list
19483936|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
19483937|NCT03173612|Sargramostim|sargramostim|mesh-list
19483938|NCT03173612|Lenograstim|lenograstim|mesh-list
19483939|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19483940|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19483941|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19483942|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19483943|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19483944|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483945|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19483946|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
19483947|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
19483948|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19483949|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483950|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
19483951|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483952|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19483953|NCT03173612|Analgesics|analgesics|mesh-ancestor
19483954|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
19483955|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483956|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19483957|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19483958|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
19483959|NCT03173417|Fludarabine|fludarabine|mesh-list
19483960|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19483961|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
19483962|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483963|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19483964|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19483965|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
19483966|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483967|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023765|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
20023766|NCT02584452|Dexamethasone|dexamethasone|mesh-list
20023767|NCT02584452|Fentanyl|fentanyl|mesh-list
20023768|NCT02584452|Bupivacaine|bupivacaine|mesh-list
20023769|NCT02584452|Ropivacaine|ropivacaine|mesh-list
19483968|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19483969|NCT03173235|Vitamin D|vitamin d|mesh-list
19483970|NCT03173235|Vitamins|vitamins|mesh-ancestor
19483971|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
19483972|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483973|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19483974|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19483975|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20023770|NCT02584452|Mepivacaine|mepivacaine|mesh-list
20023771|NCT02584452|Propofol|propofol|mesh-list
20023772|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19483976|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19483977|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19483978|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19483979|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
19483980|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19483981|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19483982|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483983|NCT03173339|Remifentanil|remifentanil|mesh-list
19483984|NCT03173339|Sevoflurane|sevoflurane|mesh-list
19483985|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19483986|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19483987|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
19483988|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
19483989|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483990|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483991|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19483992|NCT03173339|Narcotics|narcotics|mesh-ancestor
19483993|NCT03173339|Analgesics|analgesics|mesh-ancestor
19483994|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
19483995|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19483996|NCT03173326|Anesthetics|anesthetics|mesh-list
19483997|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19483998|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19483999|NCT03173508|Acetazolamide|acetazolamide|mesh-list
19484000|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
19484001|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19484002|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484003|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484004|NCT03173508|Diuretics|diuretics|mesh-ancestor
19484005|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
19484006|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484007|NCT03173430|Blinatumomab|blinatumomab|mesh-list
19484008|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484009|NCT03172858|Oxytocin|oxytocin|mesh-list
19484010|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
19484011|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19484012|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484013|NCT03172871|Aripiprazole|aripiprazole|mesh-list
19484014|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
19484015|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19484016|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19484017|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19484018|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484019|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484020|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
19484021|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
19484022|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484023|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484024|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19484025|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19484026|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
19484027|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19484028|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19484029|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19484030|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19484031|NCT03172988|Dexamethasone|dexamethasone|mesh-list
19484032|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
19484033|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
19484034|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19484035|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19484036|NCT03172988|BB 1101|bb 1101|mesh-list
19484037|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484038|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
19484039|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
19484040|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484041|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484042|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19484043|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
19484044|NCT03172988|Hormones|hormones|mesh-ancestor
19484045|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484046|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484047|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484048|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
19484049|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484050|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484051|NCT03172988|Analgesics|analgesics|mesh-ancestor
19484052|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
19484053|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19484054|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484055|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484056|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20023773|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
20023774|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
20023775|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023776|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023777|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20023778|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
20023779|NCT02584452|Hormones|hormones|mesh-ancestor
20023780|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484100|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19484101|NCT03173066|Hematinics|hematinics|mesh-ancestor
19484102|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19484103|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19484104|NCT03173092|Dexamethasone|dexamethasone|mesh-list
19484105|NCT03173092|Lenalidomide|lenalidomide|mesh-list
19484106|NCT03173092|Ixazomib|ixazomib|mesh-list
19484107|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484108|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
19484109|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
19484110|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484111|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484112|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19484113|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
20023781|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484114|NCT03173092|Hormones|hormones|mesh-ancestor
19484115|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484116|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484117|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484118|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
19484119|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484120|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484121|NCT03173092|Growth Substances|growth substances|mesh-ancestor
19484122|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484123|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
19484124|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484125|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484126|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
19484127|NCT03173131|Narcotics|narcotics|mesh-ancestor
19484128|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484129|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484130|NCT03173131|Analgesics|analgesics|mesh-ancestor
20023782|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023783|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023784|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
20023785|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023786|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
20023787|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20023788|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20023789|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
20023790|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20023791|NCT02584452|Narcotics|narcotics|mesh-ancestor
20023792|NCT02584452|Analgesics|analgesics|mesh-ancestor
20023793|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20023794|NCT02584504|Atorvastatin|atorvastatin|mesh-list
20023795|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20023796|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20023797|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
20023798|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023799|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20023800|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20023801|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023802|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
20023803|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
20292854|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20023804|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023805|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
20023806|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20023807|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
20023808|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20023809|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023810|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023811|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023812|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
20023813|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
20023814|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20023815|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20023816|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20023817|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20023818|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023819|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
20023820|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023821|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023822|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20023823|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023824|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
20023825|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20023826|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20023827|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023828|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
20023829|NCT02584725|Coagulants|coagulants|mesh-ancestor
20023830|NCT02584855|Ixekizumab|ixekizumab|mesh-list
20023831|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
19484131|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
19484132|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484133|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
19484134|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484135|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484136|NCT03172676|Amoxicillin|amoxicillin|mesh-list
19484137|NCT03172676|Clarithromycin|clarithromycin|mesh-list
19484138|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19484139|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19484140|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484141|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19484142|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484143|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484144|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19484145|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19484146|NCT03172793|Telavancin|telavancin|mesh-list
19484147|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19484148|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484149|NCT03172741|Dronabinol|dronabinol|mesh-list
19484150|NCT03172741|Cannabidiol|cannabidiol|mesh-list
19484151|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
19484152|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
19484153|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484154|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19484155|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484156|NCT03172741|Analgesics|analgesics|mesh-ancestor
19484157|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
19484158|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484159|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19484160|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20023832|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20023833|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
20023834|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
19484161|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484162|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484163|NCT03172741|Hormones|hormones|mesh-ancestor
19484164|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568788|NCT05344443|Lemborexant|lemborexant|mesh-list
19568789|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19568790|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568791|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568792|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19568793|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19568794|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568795|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568796|NCT05344417|Iodine|iodine|mesh-list
19568797|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19568798|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743793|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743794|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
19743795|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
19743796|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
19743797|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743798|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19743799|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
19743800|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
19743801|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743802|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743803|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743804|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
19743805|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743806|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19743807|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19743808|NCT03526874|Lidocaine|lidocaine|mesh-list
19743809|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
19743810|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
19743811|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743812|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743813|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
19743814|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743815|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19743816|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19743817|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20023835|NCT02584959|Complement C1s|complement c1s|mesh-list
19484165|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19484166|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19484167|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19484168|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
19484169|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484170|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484171|NCT03172624|Nivolumab|nivolumab|mesh-list
19484172|NCT03172624|Ipilimumab|ipilimumab|mesh-list
20292855|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292856|NCT05009862|Analgesics|analgesics|mesh-ancestor
20292857|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
20292858|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292859|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292860|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292861|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484173|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484174|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484175|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19484176|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484177|NCT03172377|Adalimumab|adalimumab|mesh-list
19484178|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484179|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20023836|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20023837|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20023838|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
20023839|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023840|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20023841|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023842|NCT02585713|Dalteparin|dalteparin|mesh-list
19484186|NCT03172299|Aflibercept|aflibercept|mesh-list
19484187|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484188|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484189|NCT03172299|Growth Substances|growth substances|mesh-ancestor
19484190|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484191|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484192|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484193|NCT03172533|Dienogest|dienogest|mesh-list
19484194|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19484195|NCT03172533|Estradiol|estradiol|mesh-list
19484196|NCT03172533|Estrogens|estrogens|mesh-ancestor
19484197|NCT03172533|Hormones|hormones|mesh-ancestor
19484198|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484199|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484200|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19484201|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
19484202|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19484203|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19484204|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19484205|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19484206|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19484207|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
19484208|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484209|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484210|NCT03172234|Amantadine|amantadine|mesh-list
19484211|NCT03172234|Gabapentin|gabapentin|mesh-list
19484212|NCT03172234|Analgesics|analgesics|mesh-ancestor
19484213|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
19484214|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484215|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484216|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
19484217|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19484218|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19484219|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484220|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19484221|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19484222|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19484223|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023843|NCT02585713|Tinzaparin|tinzaparin|mesh-list
20023844|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20023845|NCT02585713|Apixaban|apixaban|mesh-list
19484224|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484225|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
19484226|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19484227|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19484228|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
19484229|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484230|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
19484231|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484232|NCT03171974|Dexamethasone|dexamethasone|mesh-list
19484233|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484234|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
19484235|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
19484236|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484237|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484238|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19484239|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
19484240|NCT03171974|Hormones|hormones|mesh-ancestor
19484241|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023846|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20023847|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
20023848|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20023849|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
20023850|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023851|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023852|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
19484242|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484243|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484244|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
19484245|NCT03171987|Lidocaine|lidocaine|mesh-list
19484246|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
19484247|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
19484248|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023853|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20023854|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20023855|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19484249|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484250|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
19484251|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484252|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19484253|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19484254|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19484255|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19484256|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484257|NCT03171987|Analgesics|analgesics|mesh-ancestor
19484258|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19484259|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484260|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484261|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484262|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19484263|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484264|NCT03172052|Streptokinase|streptokinase|mesh-list
19484265|NCT03172052|Mesna|mesna|mesh-list
19484266|NCT03172052|Protective Agents|protective agents|mesh-ancestor
19484267|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484268|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19484269|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19484270|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023856|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023857|NCT02585843|Spironolactone|spironolactone|mesh-list
20023858|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20023859|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
20023860|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023861|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023862|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20023863|NCT02585843|Diuretics|diuretics|mesh-ancestor
20023864|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
20023865|NCT02585895|Evolocumab|evolocumab|mesh-list
20023866|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20023867|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20023868|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
20023869|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023870|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20023871|NCT02585960|Factor VIII|factor viii|mesh-list
20023872|NCT02585960|BAX 855|bax 855|mesh-list
20023873|NCT02585960|Coagulants|coagulants|mesh-ancestor
20023874|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
20023875|NCT02585999|Ortho Evra|ortho evra|mesh-list
20023876|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19484271|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
19484272|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19484273|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484274|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484275|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484276|NCT03172065|Analgesics|analgesics|mesh-ancestor
19484277|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
19484278|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484279|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19484280|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19484281|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19484282|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
19484283|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484284|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484285|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
19484286|NCT03171818|Hematinics|hematinics|mesh-ancestor
19484287|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
19484288|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
19484289|NCT03171831|Busulfan|busulfan|mesh-list
19484290|NCT03171831|Methotrexate|methotrexate|mesh-list
19484291|NCT03171831|Fludarabine|fludarabine|mesh-list
19484292|NCT03171831|Tacrolimus|tacrolimus|mesh-list
19484293|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
19484294|NCT03171831|Basiliximab|basiliximab|mesh-list
19484295|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19484296|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
19484297|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484298|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484299|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19484300|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
19484301|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484302|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484303|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19484304|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19484305|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
19484306|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19484307|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19484308|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
19484309|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
19484310|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484311|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19484312|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19484313|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19484314|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19484315|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19484316|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
19484317|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19484318|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484319|NCT03171727|Heparin|heparin|mesh-list
19484320|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19484321|NCT03171727|Tinzaparin|tinzaparin|mesh-list
19484322|NCT03171727|Dalteparin|dalteparin|mesh-list
19484323|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
19484324|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19484325|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19484326|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484327|NCT03171740|Midazolam|midazolam|mesh-list
19484328|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
19484329|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19484330|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19484331|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484332|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484333|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484334|NCT03171740|Analgesics|analgesics|mesh-ancestor
19484335|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
19484336|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484337|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19484338|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19484339|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19484340|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19484341|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484342|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484343|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19484344|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19484345|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19484346|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19484347|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19484348|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
19484349|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
19484350|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
19484351|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
19484352|NCT03171584|Itraconazole|itraconazole|mesh-list
19484353|NCT03171584|Fluconazole|fluconazole|mesh-list
19484354|NCT03171584|Terbinafine|terbinafine|mesh-list
19484355|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
19484356|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484357|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19484358|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19484359|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484360|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484361|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19484362|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
19484363|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484364|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484365|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19484366|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19484367|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19484368|NCT03171610|Fentanyl|fentanyl|mesh-list
19484369|NCT03171610|Sufentanil|sufentanil|mesh-list
19484370|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19484371|NCT03171610|Narcotics|narcotics|mesh-ancestor
19484372|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484373|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484374|NCT03171610|Analgesics|analgesics|mesh-ancestor
19484375|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
19484376|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484377|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19484378|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19484379|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
19484380|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
19484381|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
19484382|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19484383|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
19484384|NCT03171389|Ponatinib|ponatinib|mesh-list
19484385|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484386|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19484387|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023877|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023878|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20023879|NCT02586155|Atorvastatin|atorvastatin|mesh-list
20023880|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20023881|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20023882|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20023883|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
20023884|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023885|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20023886|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20023887|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023888|NCT02586727|Aflibercept|aflibercept|mesh-list
20023889|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20023890|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20023891|NCT02586727|Growth Substances|growth substances|mesh-ancestor
20023892|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023893|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
20023894|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023895|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20023896|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
19484388|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484389|NCT03171090|Anesthetics|anesthetics|mesh-list
19484390|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
19484391|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484392|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484393|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
19484394|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568799|NCT05344417|Trace Elements|trace elements|mesh-ancestor
19568800|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
19568801|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568802|NCT05344365|Iloperidone|iloperidone|mesh-list
19568803|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19568804|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19568805|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568806|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568807|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19568808|NCT05344248|Antibodies|antibodies|mesh-list
19568809|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19568810|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
19568811|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568812|NCT05344209|Sargramostim|sargramostim|mesh-list
19568813|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
19743818|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19743819|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743820|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
19743821|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743822|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743823|NCT03487666|Capecitabine|capecitabine|mesh-list
19743824|NCT03487666|Nivolumab|nivolumab|mesh-list
19743825|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19743826|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
19743827|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743828|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743829|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743830|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743831|NCT03485950|Meropenem|meropenem|mesh-list
19743832|NCT03485950|Tazobactam|tazobactam|mesh-list
19743833|NCT03485950|Piperacillin|piperacillin|mesh-list
19743834|NCT03485950|Cefepime|cefepime|mesh-list
19743835|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19743836|NCT03485950|Ceftolozane|ceftolozane|mesh-list
19743837|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19743838|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19743839|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19743840|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743841|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743842|NCT03467958|Ozanimod|ozanimod|mesh-list
20023897|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023898|NCT02587065|Interferons|interferons|mesh-list
20023899|NCT02587065|Interferon-beta|interferon-beta|mesh-list
19743843|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19743844|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743845|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19743846|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
19743847|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743848|NCT03467867|Rituximab|rituximab|mesh-list
19743849|NCT03467867|Venetoclax|venetoclax|mesh-list
19743850|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743851|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743852|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
19743853|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743854|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743855|NCT03457701|Iron|iron|mesh-list
19743856|NCT03457701|Trace Elements|trace elements|mesh-ancestor
20023900|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
20023901|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023902|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
20023903|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20023904|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
20023905|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023906|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20023907|NCT02587117|Prednisolone|prednisolone|mesh-list
20023908|NCT02587117|Lycopene|lycopene|mesh-list
20023909|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20023910|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
20023911|NCT02587117|Hormones|hormones|mesh-ancestor
20023912|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20023913|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568814|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743857|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
19743858|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484395|NCT03170895|Sorafenib|sorafenib|mesh-list
19484396|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
19484397|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484398|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19484399|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484400|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484401|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19484402|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19484403|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
19484404|NCT03171220|Fludarabine|fludarabine|mesh-list
19484405|NCT03171220|Interleukin-2|interleukin-2|mesh-list
19484406|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19484407|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
19484408|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484409|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484410|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19484411|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
19484412|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484413|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484414|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19484415|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023914|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20023915|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023916|NCT02587117|Protective Agents|protective agents|mesh-ancestor
20023917|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
20023918|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484416|NCT03171220|Analgesics|analgesics|mesh-ancestor
19484417|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
19484418|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484419|NCT03170713|Ibuprofen|ibuprofen|mesh-list
19484420|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19484421|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19484422|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484423|NCT03170713|Analgesics|analgesics|mesh-ancestor
19484424|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
19484425|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484426|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484427|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484428|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484429|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19484430|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484431|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484432|NCT03170596|Tazarotene|tazarotene|mesh-list
19484433|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
19484434|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
19484435|NCT03170687|Calpastatin|calpastatin|mesh-list
19484436|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19484437|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
19484438|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484439|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484440|NCT03170726|Ibuprofen|ibuprofen|mesh-list
19484441|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19484442|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19484443|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484444|NCT03170726|Analgesics|analgesics|mesh-ancestor
19484445|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
19484446|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484447|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484448|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484449|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484450|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19484451|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484452|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484453|NCT03170739|Dopamine|dopamine|mesh-list
19484454|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
19484455|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19484456|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484457|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484458|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484459|NCT03170739|Analgesics|analgesics|mesh-ancestor
19484460|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
20023919|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19484461|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023920|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19484462|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19484463|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19484464|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19484465|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
19484466|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484467|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484468|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19484469|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
19484470|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
19484471|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
19484472|NCT03170739|Protective Agents|protective agents|mesh-ancestor
19484473|NCT03170310|Apatinib|apatinib|mesh-list
19484474|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484475|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19484476|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484477|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484478|NCT03170323|Cyclosporine|cyclosporine|mesh-list
19484479|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
19484480|NCT03170323|Cyclosporins|cyclosporins|mesh-list
19484481|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484482|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484483|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19484484|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
19484485|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484486|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
19484487|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484488|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
19484489|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484490|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19484491|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19484492|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484493|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19484494|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
19484495|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19484496|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19484497|NCT03170336|Amiloride|amiloride|mesh-list
19484498|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19484499|NCT03170336|Diuretics|diuretics|mesh-ancestor
19484500|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
19484501|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484502|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19484503|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19484504|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484505|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19484506|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19484507|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19484508|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19484509|NCT03170284|Bevacizumab|bevacizumab|mesh-list
19484510|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484511|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484512|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484513|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484514|NCT03170284|Growth Substances|growth substances|mesh-ancestor
19484515|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484516|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484517|NCT03170050|Lidocaine|lidocaine|mesh-list
19484518|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
19484519|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
19484520|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484521|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484522|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
19484523|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484524|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19484525|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19484526|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19484527|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19484528|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484529|NCT03170115|Aspirin|aspirin|mesh-list
19484530|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19484531|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023921|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
20023922|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023923|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
19484532|NCT03170115|Analgesics|analgesics|mesh-ancestor
19484533|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
19484534|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484535|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484536|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484537|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484538|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19484539|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19484540|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484541|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19484542|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19484543|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484544|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
19484545|NCT03169959|Metformin|metformin|mesh-list
19484546|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
19484547|NCT03169959|Saxagliptin|saxagliptin|mesh-list
19484548|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19484549|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484550|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19484551|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484552|NCT03169959|Incretins|incretins|mesh-ancestor
19484553|NCT03169959|Hormones|hormones|mesh-ancestor
19484554|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484555|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19484556|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
19484557|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484558|NCT03169751|Caffeine|caffeine|mesh-list
19484559|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19484560|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484561|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19484562|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484563|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484564|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19484565|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19484566|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
19484567|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484568|NCT03169764|Leucovorin|leucovorin|mesh-list
19484569|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
19484570|NCT03169764|Bevacizumab|bevacizumab|mesh-list
19484571|NCT03169764|Fluorouracil|fluorouracil|mesh-list
19484572|NCT03169764|Capecitabine|capecitabine|mesh-list
19484573|NCT03169764|Nivolumab|nivolumab|mesh-list
19484574|NCT03169764|Cetuximab|cetuximab|mesh-list
19484575|NCT03169764|Fulvestrant|fulvestrant|mesh-list
19484576|NCT03169764|Avelumab|avelumab|mesh-list
19484577|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484578|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484579|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20023924|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023925|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023926|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
20023927|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023928|NCT02587351|Metoprolol|metoprolol|mesh-list
20023929|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20023930|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20023931|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
20023932|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
20023933|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023934|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023935|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20023936|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20023937|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20023938|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
20023939|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023940|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023941|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
20023942|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20023943|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115464|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115465|NCT00005580|Fludarabine|fludarabine|mesh-list
20115466|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
20115467|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
20115468|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484580|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
19484581|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484582|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484583|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19484584|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
19484585|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19484586|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484587|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484588|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484589|NCT03169764|Growth Substances|growth substances|mesh-ancestor
19484590|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484591|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
19484592|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19484593|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19484594|NCT03169764|Antidotes|antidotes|mesh-ancestor
19484595|NCT03169764|Protective Agents|protective agents|mesh-ancestor
19484596|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
19484597|NCT03169764|Vitamins|vitamins|mesh-ancestor
20023944|NCT05249556|Ganaxolone|ganaxolone|mesh-list
20023945|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
20023946|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023947|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023948|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023949|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
20023950|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
20023951|NCT05249478|Fentanyl|fentanyl|mesh-list
20023952|NCT05249478|Bupivacaine|bupivacaine|mesh-list
20023953|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
20023954|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
20023955|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023956|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023957|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
20023958|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484598|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
19484599|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484600|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19484601|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19484602|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
19484603|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484604|NCT03169738|Leucovorin|leucovorin|mesh-list
19484605|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
19484606|NCT03169738|Bevacizumab|bevacizumab|mesh-list
19484607|NCT03169738|Fluorouracil|fluorouracil|mesh-list
19484608|NCT03169738|Capecitabine|capecitabine|mesh-list
19484609|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
19484610|NCT03169738|Nivolumab|nivolumab|mesh-list
19484611|NCT03169738|Fulvestrant|fulvestrant|mesh-list
19484612|NCT03169738|Avelumab|avelumab|mesh-list
19484613|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023959|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20023960|NCT05249478|Narcotics|narcotics|mesh-ancestor
20023961|NCT05249478|Analgesics|analgesics|mesh-ancestor
20023962|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20023963|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20023964|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
19484614|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484615|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19484616|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
19484617|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484618|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484619|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19484620|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
19484621|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19484622|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484623|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484624|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484625|NCT03169738|Growth Substances|growth substances|mesh-ancestor
19484626|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484627|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
19484628|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19484629|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19484630|NCT03169738|Antidotes|antidotes|mesh-ancestor
19484631|NCT03169738|Protective Agents|protective agents|mesh-ancestor
19484632|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
20023965|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
19484633|NCT03169738|Vitamins|vitamins|mesh-ancestor
19484634|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
19484635|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568815|NCT05344027|Mitotane|mitotane|mesh-list
19484636|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19484637|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19484638|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
19484639|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484640|NCT03169725|Vaccines|vaccines|mesh-list
19484641|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
19484642|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484643|NCT03170479|Vitamin D|vitamin d|mesh-list
19484644|NCT03170479|Vitamins|vitamins|mesh-ancestor
19484645|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
19484646|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484647|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19484648|NCT03169933|Androgens|androgens|mesh-list
19484649|NCT03169933|Hormones|hormones|mesh-ancestor
19484650|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484651|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484652|NCT03170180|Sunitinib|sunitinib|mesh-list
19484653|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
19484654|NCT03170180|Gefitinib|gefitinib|mesh-list
19484655|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484656|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484657|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484658|NCT03170180|Growth Substances|growth substances|mesh-ancestor
19484659|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484660|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484661|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19484662|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484663|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484664|NCT03169790|Leucovorin|leucovorin|mesh-list
19484665|NCT03169790|Paclitaxel|paclitaxel|mesh-list
19484666|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
19484667|NCT03169790|Bevacizumab|bevacizumab|mesh-list
19484668|NCT03169790|Rituximab|rituximab|mesh-list
19484669|NCT03169790|Fluorouracil|fluorouracil|mesh-list
19484670|NCT03169790|Capecitabine|capecitabine|mesh-list
19484671|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
19484672|NCT03169790|Avelumab|avelumab|mesh-list
19484673|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19484674|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484675|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
19484676|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
19484677|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
19484678|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484679|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19484680|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
19484681|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484682|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484683|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19484684|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
19484685|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19484686|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484687|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484688|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484689|NCT03169790|Growth Substances|growth substances|mesh-ancestor
19484690|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484691|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
19484692|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19484693|NCT03169790|Antidotes|antidotes|mesh-ancestor
19484694|NCT03169790|Protective Agents|protective agents|mesh-ancestor
19484695|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
19484696|NCT03169790|Vitamins|vitamins|mesh-ancestor
19484697|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
19484698|NCT03169660|Aflibercept|aflibercept|mesh-list
19484699|NCT03169660|Mitogens|mitogens|mesh-list
19484700|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
19484701|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
19484702|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484703|NCT03169660|Growth Substances|growth substances|mesh-ancestor
19484704|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484705|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484706|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484707|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484708|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484709|NCT03169777|Leucovorin|leucovorin|mesh-list
19484710|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
19484711|NCT03169777|Bevacizumab|bevacizumab|mesh-list
19484712|NCT03169777|Fluorouracil|fluorouracil|mesh-list
19484713|NCT03169777|Capecitabine|capecitabine|mesh-list
19484714|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
20576400|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484715|NCT03169777|Nivolumab|nivolumab|mesh-list
19484716|NCT03169777|Cetuximab|cetuximab|mesh-list
19484717|NCT03169777|Fulvestrant|fulvestrant|mesh-list
19484718|NCT03169777|Avelumab|avelumab|mesh-list
19484719|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484720|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484721|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19484722|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
19484723|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484724|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484725|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19484726|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
19484727|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19484728|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484729|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484730|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484731|NCT03169777|Growth Substances|growth substances|mesh-ancestor
19484732|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484733|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
19484734|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19484735|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19484736|NCT03169777|Antidotes|antidotes|mesh-ancestor
19484737|NCT03169777|Protective Agents|protective agents|mesh-ancestor
19484738|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
19484739|NCT03169777|Vitamins|vitamins|mesh-ancestor
19484740|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
19484741|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484742|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19484743|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19484744|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
19484745|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484746|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
19484747|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
19484748|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19484749|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20023966|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20023967|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
20023968|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20023969|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023970|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20023971|NCT05249309|Ketamine|ketamine|mesh-list
20023972|NCT05249309|Analgesics|analgesics|mesh-ancestor
20023973|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
20023974|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292862|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20292863|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20292864|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292865|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20292866|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20292867|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484750|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484751|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484752|NCT03169582|Urological Agents|urological agents|mesh-ancestor
19484753|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
19484754|NCT03169348|Ledipasvir|ledipasvir|mesh-list
19484755|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19484756|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
20023975|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023976|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20023977|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20023978|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
20023979|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
20023980|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023981|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20023982|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20023983|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20023984|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20023985|NCT05249231|Fluorides|fluorides|mesh-list
20023986|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
20292868|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
20023987|NCT05249231|Protective Agents|protective agents|mesh-ancestor
20023988|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023989|NCT05249153|Sufentanil|sufentanil|mesh-list
20023990|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
20023991|NCT05249153|Dsuvia|dsuvia|mesh-list
20023992|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20023993|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20023994|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20023995|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20023996|NCT05249153|Analgesics|analgesics|mesh-ancestor
20023997|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
20023998|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20023999|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20024000|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20024001|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19484757|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484758|NCT03169504|Fluticasone|fluticasone|mesh-list
19484759|NCT03169504|Xhance|xhance|mesh-list
19484760|NCT03169504|Bromides|bromides|mesh-list
19484761|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
19484762|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484763|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19484764|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
19484765|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484766|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484767|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19484768|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
19484769|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
19484770|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19484771|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
19484772|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19484773|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
19484774|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484775|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484776|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
19484777|NCT03169426|Carvedilol|carvedilol|mesh-list
19743859|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
19743860|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19743861|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19743862|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743863|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743864|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19743865|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19743866|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
19743867|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743868|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743869|NCT03448783|Apixaban|apixaban|mesh-list
19743870|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19743871|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
19743872|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19743873|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
19743874|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743875|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743876|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
19743877|NCT03435458|Misoprostol|misoprostol|mesh-list
19743878|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19743879|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
19743880|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19743881|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743882|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19743883|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743884|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
19743885|NCT03434444|Propranolol|propranolol|mesh-list
19743886|NCT03434444|Oxytocin|oxytocin|mesh-list
19743887|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
19743888|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19743889|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743890|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19743891|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19743892|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
19484778|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19484779|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19743893|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743894|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484780|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
19484781|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484782|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484783|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484784|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19484785|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
19484786|NCT03169426|Protective Agents|protective agents|mesh-ancestor
20024002|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024003|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024004|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024005|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20024006|NCT05249153|Narcotics|narcotics|mesh-ancestor
20024007|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20024008|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20024009|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
20024010|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
19484787|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19484788|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19484789|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19484790|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
19484791|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19484792|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19484793|NCT03169569|Hemostatics|hemostatics|mesh-list
19484794|NCT03169569|Coagulants|coagulants|mesh-ancestor
19484795|NCT03169413|Adenosine|adenosine|mesh-list
19484796|NCT03169413|Analgesics|analgesics|mesh-ancestor
19484797|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
19484798|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484799|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484800|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19484801|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
19484802|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19484803|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
19484804|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
19484805|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484806|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484807|NCT03169335|Paclitaxel|paclitaxel|mesh-list
19484808|NCT03169335|Bevacizumab|bevacizumab|mesh-list
19484809|NCT03169335|Carboplatin|carboplatin|mesh-list
19484810|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20024011|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20024012|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20024013|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024014|NCT05249101|Capecitabine|capecitabine|mesh-list
20024015|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024016|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
20024017|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484811|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484812|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
19484813|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
19484814|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
19484815|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484816|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484817|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484818|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484819|NCT03169335|Growth Substances|growth substances|mesh-ancestor
19484820|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484821|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
19568816|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568817|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568818|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
19568819|NCT05343806|Nifedipine|nifedipine|mesh-list
19568820|NCT05343806|Analgesics|analgesics|mesh-ancestor
19568821|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
19568822|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024018|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024019|NCT05249023|Butyric Acid|butyric acid|mesh-list
19568823|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568824|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
19568825|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568826|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19743895|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20024020|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
20292869|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20292870|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
19484822|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
19484823|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19484824|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484825|NCT03168997|Memantine|memantine|mesh-list
19484826|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19484827|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19484828|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
19484829|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484830|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484831|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484832|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19484833|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19484834|NCT03169114|Amikacin|amikacin|mesh-list
19484835|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19484836|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484837|NCT03169127|Ibuprofen|ibuprofen|mesh-list
19484838|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19484839|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484840|NCT03169127|Analgesics|analgesics|mesh-ancestor
19484841|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
19484842|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484843|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024021|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
20024022|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484844|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484845|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19484846|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19484847|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484848|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484849|NCT03168958|Methadone|methadone|mesh-list
19484850|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19484851|NCT03168958|Narcotics|narcotics|mesh-ancestor
19484852|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484853|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484854|NCT03168958|Analgesics|analgesics|mesh-ancestor
19484855|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
19484856|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484857|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
19484858|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
19484859|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19484860|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19484861|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484862|NCT03168828|Trospium chloride|trospium chloride|mesh-list
19484863|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
19484864|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
19484865|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484866|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484867|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19484868|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19484869|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
19484870|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484871|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484872|NCT03168828|Urological Agents|urological agents|mesh-ancestor
19484873|NCT03168698|Oxytocin|oxytocin|mesh-list
19484874|NCT03168698|Carbetocin|carbetocin|mesh-list
19484875|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
19484876|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19484877|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484878|NCT03168594|Cisplatin|cisplatin|mesh-list
19484879|NCT03168594|Irinotecan|irinotecan|mesh-list
20576401|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19484880|NCT03168594|Etoposide|etoposide|mesh-list
19484881|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484882|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19484883|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19484884|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484885|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484886|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19484887|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19484888|NCT03168568|Valsartan|valsartan|mesh-list
19484889|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19484890|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19484891|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19484892|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484893|NCT03168191|Menthol|menthol|mesh-list
19484894|NCT03168191|Nicotine|nicotine|mesh-list
19484895|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19484896|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
19484897|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484898|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484899|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19484900|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19484901|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
19484902|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19484903|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484904|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
19484905|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19484906|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19484907|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19484908|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484909|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
19484910|NCT03168412|Vaccines|vaccines|mesh-list
19484911|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
19484912|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484913|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
19484914|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484915|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484916|NCT03168074|Lenvatinib|lenvatinib|mesh-list
19484917|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484918|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19484919|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484920|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19484921|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
19484922|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19484923|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19484924|NCT03168035|NC-4016|nc-4016|mesh-list
19484925|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484926|NCT03168100|Dexamethasone|dexamethasone|mesh-list
19484927|NCT03168100|Lenalidomide|lenalidomide|mesh-list
19484928|NCT03168100|Bortezomib|bortezomib|mesh-list
19484929|NCT03168100|Elotuzumab|elotuzumab|mesh-list
19484930|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19484931|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
19484932|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
19484933|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484934|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484935|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19484936|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
19484937|NCT03168100|Hormones|hormones|mesh-ancestor
19484938|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19484939|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19484940|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484941|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
19484942|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19484943|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19484944|NCT03168100|Growth Substances|growth substances|mesh-ancestor
19484945|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
19484946|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
19484947|NCT03167918|Metformin|metformin|mesh-list
19484948|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
19484949|NCT03167918|Calcium|calcium|mesh-list
19484950|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19484951|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484952|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19484953|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19484954|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
19484955|NCT03167918|Coagulants|coagulants|mesh-ancestor
19484956|NCT03167905|Fentanyl|fentanyl|mesh-list
19484957|NCT03167905|Meperidine|meperidine|mesh-list
19484958|NCT03167905|Remifentanil|remifentanil|mesh-list
19484959|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
19484960|NCT03167905|Ropivacaine|ropivacaine|mesh-list
19484961|NCT03167905|Entonox|entonox|mesh-list
19484962|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
19484963|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
19484964|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19484965|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484966|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
19484967|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19484968|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19484969|NCT03167905|Narcotics|narcotics|mesh-ancestor
19484970|NCT03167905|Analgesics|analgesics|mesh-ancestor
19484971|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19484972|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19484973|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
19484974|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19484975|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19484976|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19484977|NCT03167957|Amphotericin B|amphotericin b|mesh-list
19484978|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19484979|NCT03167957|Amebicides|amebicides|mesh-ancestor
19484980|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19484981|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19484982|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19484983|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19484984|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
19484985|NCT03167853|Antibodies|antibodies|mesh-list
19484986|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19484987|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
19484988|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19484989|NCT03167619|Durvalumab|durvalumab|mesh-list
20024023|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024024|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024025|NCT05248945|Carbamazepine|carbamazepine|mesh-list
20024026|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
20024027|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
20024028|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19484990|NCT03167619|Olaparib|olaparib|mesh-list
20024029|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024030|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024031|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20024032|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20024033|NCT05248945|Analgesics|analgesics|mesh-ancestor
20024034|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
20024035|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024036|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20024037|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024038|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024039|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20024040|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20024041|NCT05248932|Norepinephrine|norepinephrine|mesh-list
20024042|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20024043|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20024044|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024045|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024046|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024047|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024048|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
20024049|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
20024050|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024051|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20024052|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20024053|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20024054|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024055|NCT05248334|Ranibizumab|ranibizumab|mesh-list
20024056|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20024057|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20024058|NCT05248334|Growth Substances|growth substances|mesh-ancestor
20024059|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024060|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
20024061|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024062|NCT05248152|Acetaminophen|acetaminophen|mesh-list
19484991|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19484992|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19484993|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19484994|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19484995|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568827|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
19568828|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19568829|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19568830|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568831|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19568832|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
20024063|NCT05248152|Ibuprofen|ibuprofen|mesh-list
20024064|NCT05248152|Pregabalin|pregabalin|mesh-list
20024065|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19568833|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568834|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
19568835|NCT05343728|Hemostatics|hemostatics|mesh-list
19568836|NCT05343728|Coagulants|coagulants|mesh-ancestor
20024066|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20024067|NCT05248152|Analgesics|analgesics|mesh-ancestor
20024068|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
20024069|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024070|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024071|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024072|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024073|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19568837|NCT05343702|Rocuronium|rocuronium|mesh-list
19568838|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19568839|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19568840|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19568841|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568842|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568843|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19568844|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
19568845|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19568846|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19568847|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568848|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568849|NCT05343637|Urological Agents|urological agents|mesh-ancestor
20024074|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024075|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024076|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
20024077|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20024078|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19568855|NCT05343546|Copper|copper|mesh-list
19568856|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
19568857|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19568858|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
19568859|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568860|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568861|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20024079|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20024080|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20024081|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19568862|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19568863|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19484996|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
19484997|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19484998|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
20024082|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024083|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20024084|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
20024085|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20024086|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024087|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024088|NCT05247905|Capecitabine|capecitabine|mesh-list
20024089|NCT05247905|Temozolomide|temozolomide|mesh-list
20024090|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19484999|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485000|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
19485001|NCT03167333|Protective Agents|protective agents|mesh-ancestor
19485002|NCT03167372|Imidacloprid|imidacloprid|mesh-list
19485003|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
19485004|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485005|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485006|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485007|NCT03167385|Apatinib|apatinib|mesh-list
19485008|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485009|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19485010|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292871|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20292872|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
20292873|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
20292874|NCT05007782|Pembrolizumab|pembrolizumab|mesh-list
19485011|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485012|NCT03167268|Lycopene|lycopene|mesh-list
19485013|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485014|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
19485015|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485016|NCT03167268|Protective Agents|protective agents|mesh-ancestor
19485017|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485018|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19485019|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19485020|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485021|NCT03167216|Cetirizine|cetirizine|mesh-list
19485022|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
19485023|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19485024|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19485025|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19485026|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
19485027|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
19485028|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485029|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485030|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485031|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
20024091|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024092|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
20024093|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024094|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024095|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20024096|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
20024097|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20024098|NCT05247788|Ethanol|ethanol|mesh-list
20024099|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20024100|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024101|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292875|NCT05007782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292876|NCT05007782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292877|NCT04989218|Gemcitabine|gemcitabine|mesh-list
20292878|NCT04989218|Cisplatin|cisplatin|mesh-list
20576402|NCT02071303|Narcotics|narcotics|mesh-ancestor
20024102|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024103|NCT05247697|Mirtazapine|mirtazapine|mesh-list
20024104|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
20024105|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19485032|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
19485033|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485034|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19485035|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
19485036|NCT03166956|Ascorbic Acid|ascorbic acid|mesh-list
20292879|NCT04989218|Durvalumab|durvalumab|mesh-list
19485037|NCT03166956|Vitamins|vitamins|mesh-ancestor
19485038|NCT03166956|Micronutrients|micronutrients|mesh-ancestor
19485039|NCT03166956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485040|NCT03166956|Antioxidants|antioxidants|mesh-ancestor
19485041|NCT03166956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485042|NCT03166956|Protective Agents|protective agents|mesh-ancestor
19485043|NCT03167164|Leucovorin|leucovorin|mesh-list
19485044|NCT03167164|Paclitaxel|paclitaxel|mesh-list
19485045|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
19485046|NCT03167164|Bevacizumab|bevacizumab|mesh-list
19485047|NCT03167164|Fluorouracil|fluorouracil|mesh-list
19485048|NCT03167164|Capecitabine|capecitabine|mesh-list
19485049|NCT03167164|Avelumab|avelumab|mesh-list
19485050|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19485051|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485052|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
19485053|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
19485054|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
19485055|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485056|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485057|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
19485058|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485059|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485060|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19485061|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
19485062|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19485063|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485064|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19485065|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19485066|NCT03167164|Growth Substances|growth substances|mesh-ancestor
19485067|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
19485068|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
19485069|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024106|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20024107|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
20024108|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
20024109|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024110|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485070|NCT03167164|Antidotes|antidotes|mesh-ancestor
19485071|NCT03167164|Protective Agents|protective agents|mesh-ancestor
19485072|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
19485073|NCT03167164|Vitamins|vitamins|mesh-ancestor
19485074|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
19485075|NCT03166891|Chiauranib|chiauranib|mesh-list
19485076|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024111|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024112|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20024113|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20576403|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485077|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19485078|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485079|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485080|NCT03167112|Leucovorin|leucovorin|mesh-list
19485081|NCT03167112|Fluorouracil|fluorouracil|mesh-list
19485082|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
19485083|NCT03167112|Irinotecan|irinotecan|mesh-list
19485084|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
19485085|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485086|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19485087|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485088|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485089|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
19485090|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485091|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19485092|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19485093|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485094|NCT03167112|Antidotes|antidotes|mesh-ancestor
19485095|NCT03167112|Protective Agents|protective agents|mesh-ancestor
19485096|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
19485097|NCT03167112|Vitamins|vitamins|mesh-ancestor
19485098|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
19485099|NCT03167034|Acetazolamide|acetazolamide|mesh-list
19485100|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
19485101|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19485102|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485103|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485104|NCT03167034|Diuretics|diuretics|mesh-ancestor
19485105|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
19485106|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485107|NCT03167177|Leucovorin|leucovorin|mesh-list
19485108|NCT03167177|Paclitaxel|paclitaxel|mesh-list
19485109|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
20024114|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024115|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20024116|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19485110|NCT03167177|Bevacizumab|bevacizumab|mesh-list
19485111|NCT03167177|Fluorouracil|fluorouracil|mesh-list
19485112|NCT03167177|Capecitabine|capecitabine|mesh-list
19485113|NCT03167177|Nivolumab|nivolumab|mesh-list
19485114|NCT03167177|Avelumab|avelumab|mesh-list
19485115|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19485116|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485117|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
19485118|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
19485119|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
19485120|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485121|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485122|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
19485123|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485124|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485125|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19485126|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
19485127|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19485128|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485129|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19485130|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19485131|NCT03167177|Growth Substances|growth substances|mesh-ancestor
19485132|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
19485133|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
19485134|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19485135|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19485136|NCT03167177|Antidotes|antidotes|mesh-ancestor
19485137|NCT03167177|Protective Agents|protective agents|mesh-ancestor
19485138|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
19485139|NCT03167177|Vitamins|vitamins|mesh-ancestor
19485140|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
19485141|NCT03166644|Sufentanil|sufentanil|mesh-list
19485142|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19485143|NCT03166644|Narcotics|narcotics|mesh-ancestor
19485144|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485145|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485146|NCT03166644|Analgesics|analgesics|mesh-ancestor
19485147|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
19485148|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485149|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19485150|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20024117|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20024118|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024119|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20024120|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20024121|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
20024122|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20024123|NCT05247684|Paclitaxel|paclitaxel|mesh-list
20024124|NCT05247684|Carboplatin|carboplatin|mesh-list
20024125|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20024126|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024127|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
20024128|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
20024129|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024130|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024131|NCT05247619|Paclitaxel|paclitaxel|mesh-list
20024132|NCT05247619|Bevacizumab|bevacizumab|mesh-list
20024133|NCT05247619|Carboplatin|carboplatin|mesh-list
20024134|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20024135|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024136|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
20024137|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
20024138|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024139|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485151|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
19485152|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
19485153|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
19485154|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19485155|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
19485156|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485157|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
19485158|NCT03166865|Protective Agents|protective agents|mesh-ancestor
19485159|NCT03166787|Ascorbic Acid|ascorbic acid|mesh-list
19485160|NCT03166787|Tadalafil|tadalafil|mesh-list
19485161|NCT03166787|Charcoal|charcoal|mesh-list
19485162|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
19485163|NCT03166787|Vitamins|vitamins|mesh-ancestor
19485164|NCT03166787|Micronutrients|micronutrients|mesh-ancestor
19485165|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485166|NCT03166787|Antioxidants|antioxidants|mesh-ancestor
19485167|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485168|NCT03166787|Protective Agents|protective agents|mesh-ancestor
19485169|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
19485170|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19485171|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19485172|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485173|NCT03166787|Urological Agents|urological agents|mesh-ancestor
19485174|NCT03166787|Antidotes|antidotes|mesh-ancestor
19485175|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
19485176|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
19485177|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485178|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
19485179|NCT03166254|Vaccines|vaccines|mesh-list
19485180|NCT03166254|Poly ICLC|poly iclc|mesh-list
19485181|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
19485182|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485183|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485184|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485185|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
19485186|NCT03166306|Bevacizumab|bevacizumab|mesh-list
20024140|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024141|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19485187|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485188|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485189|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19485190|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19485191|NCT03166306|Growth Substances|growth substances|mesh-ancestor
19485192|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485193|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
19485194|NCT03166228|Glycine|glycine|mesh-list
20576404|NCT02071316|Esomeprazole|esomeprazole|mesh-list
20576405|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
20576406|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20576407|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20576408|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576409|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
20576410|NCT02071316|Coagulants|coagulants|mesh-ancestor
19485195|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
19485196|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485197|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485198|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485199|NCT03166605|Simethicone|simethicone|mesh-list
19485200|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
19485201|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485202|NCT03166605|Emollients|emollients|mesh-ancestor
19485203|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
19485204|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
19485205|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485206|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
19485207|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
19485208|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485209|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
19485210|NCT03166397|Fludarabine|fludarabine|mesh-list
19485211|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485212|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
19485213|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485214|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485215|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19485216|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
19485217|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485218|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485219|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19485220|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
20576411|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19485221|NCT03166527|Antibodies|antibodies|mesh-list
19485222|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
19485223|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19485224|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19485225|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
19485226|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485227|NCT03166111|Lidocaine|lidocaine|mesh-list
19485228|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
19485229|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
19485230|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485231|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485232|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
19485233|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485234|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19485235|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19485236|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19485237|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19485238|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485239|NCT03165890|Acetazolamide|acetazolamide|mesh-list
19485240|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
19485241|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19485242|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485243|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485244|NCT03165890|Diuretics|diuretics|mesh-ancestor
19485245|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
19485246|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485247|NCT03165942|Ethanol|ethanol|mesh-list
19485248|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19485249|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485250|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485251|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568864|NCT05343546|Trace Elements|trace elements|mesh-ancestor
19568865|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
19568866|NCT05343507|Ketamine|ketamine|mesh-list
19568867|NCT05343507|Analgesics|analgesics|mesh-ancestor
19568868|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
19568869|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024142|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20024143|NCT05247619|Growth Substances|growth substances|mesh-ancestor
20024144|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024145|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
20024146|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
20024147|NCT05247554|Prednisone|prednisone|mesh-list
19568870|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568871|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20576412|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576413|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20576414|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576415|NCT02071342|Everolimus|everolimus|mesh-list
19568872|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19568873|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
19568874|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
19568875|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568876|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19568877|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19568878|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568879|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568880|NCT05343481|Nivolumab|nivolumab|mesh-list
19568881|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19568882|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568883|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19568884|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568885|NCT05343338|Sivelestat|sivelestat|mesh-list
19568886|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19568887|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
19568888|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19568889|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568890|NCT05343325|Paclitaxel|paclitaxel|mesh-list
20024148|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024149|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
20024150|NCT05247554|Hormones|hormones|mesh-ancestor
20024151|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20024152|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024153|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20024154|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024155|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
20024156|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19485252|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
19485253|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19485254|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485255|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
19485256|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
19485257|NCT03165929|Analgesics|analgesics|mesh-ancestor
19485258|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
19485259|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485260|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485261|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19485262|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19485263|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485264|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485265|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19485266|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485267|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485268|NCT03165825|Dexamethasone|dexamethasone|mesh-list
19485269|NCT03165825|Betamethasone|betamethasone|mesh-list
19485270|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485271|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
19485272|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
19485273|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485274|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485275|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485276|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
19485277|NCT03165825|Hormones|hormones|mesh-ancestor
19485278|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19485279|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19485280|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485281|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19485282|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
19485283|NCT03165344|Prednisone|prednisone|mesh-list
19485284|NCT03165344|Triamcinolone|triamcinolone|mesh-list
19485285|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19485286|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19485287|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
19485288|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19485289|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19485290|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19485291|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
19485292|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19485293|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485294|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
19485295|NCT03165344|Hormones|hormones|mesh-ancestor
19485296|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19485297|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485298|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19485299|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485300|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485301|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
19485302|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485303|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485304|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19485305|NCT03165344|Antacids|antacids|mesh-ancestor
19485306|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485307|NCT03165383|Morphine|morphine|mesh-list
19485308|NCT03165383|Bupivacaine|bupivacaine|mesh-list
19485309|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
19485310|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
19485311|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485312|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485313|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
19485314|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024157|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20024158|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024159|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024160|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024161|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024162|NCT05231694|Mitogens|mitogens|mesh-list
20024163|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024164|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024165|NCT05227131|Capecitabine|capecitabine|mesh-list
20024166|NCT05227131|Tucatinib|tucatinib|mesh-list
19485315|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19485316|NCT03165383|Narcotics|narcotics|mesh-ancestor
20024167|NCT05227131|Margetuximab|margetuximab|mesh-list
19485317|NCT03165383|Analgesics|analgesics|mesh-ancestor
19485318|NCT03165591|Vaccines|vaccines|mesh-list
19485319|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
19485320|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485321|NCT03165500|Midazolam|midazolam|mesh-list
19485322|NCT03165500|Diazepam|diazepam|mesh-list
19485323|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
19485324|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19485325|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485326|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485327|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485328|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19485329|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19485330|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19485331|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19485332|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
19485333|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
19485334|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
19485335|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
19485336|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485337|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485338|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19485339|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19485340|NCT03165500|Analgesics|analgesics|mesh-ancestor
19485341|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
19485342|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485343|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
19485344|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
19485345|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
19485346|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485347|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19485348|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19485349|NCT03165396|Propofol|propofol|mesh-list
19485350|NCT03165396|Sevoflurane|sevoflurane|mesh-list
19485351|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485352|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485353|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485354|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19485355|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
19485356|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
19485357|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19485358|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19485359|NCT03165253|Amoxicillin|amoxicillin|mesh-list
19485360|NCT03165253|Clarithromycin|clarithromycin|mesh-list
19485361|NCT03165253|Omeprazole|omeprazole|mesh-list
19485362|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485363|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485364|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19485365|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485366|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19743896|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19743897|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
20292880|NCT04989218|Tremelimumab|tremelimumab|mesh-list
20292881|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743898|NCT03431948|Nivolumab|nivolumab|mesh-list
19743899|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743900|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743901|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19743902|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743903|NCT03427463|Morphine|morphine|mesh-list
19743904|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19743905|NCT03427463|Narcotics|narcotics|mesh-ancestor
19743906|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743907|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743908|NCT03427463|Analgesics|analgesics|mesh-ancestor
19743909|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
19743910|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743911|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
19743912|NCT03426891|Temozolomide|temozolomide|mesh-list
19743913|NCT03426891|Vorinostat|vorinostat|mesh-list
19743914|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19743915|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743916|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743917|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19485367|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743918|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
19485368|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485369|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19485370|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19485371|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19485372|NCT03165123|Azithromycin|azithromycin|mesh-list
19485373|NCT03165123|Dexamethasone|dexamethasone|mesh-list
19485374|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485375|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
19485376|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
19485377|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485378|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485379|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485380|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
19485381|NCT03165123|Hormones|hormones|mesh-ancestor
19485382|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19485383|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19485384|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485385|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485386|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485387|NCT03165240|Eplerenone|eplerenone|mesh-list
19485388|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19485389|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
19485390|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19485391|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485392|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19485393|NCT03165240|Diuretics|diuretics|mesh-ancestor
19485394|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
19485395|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19485396|NCT03165097|ACT-709478|act-709478|mesh-list
19485397|NCT03165097|Midazolam|midazolam|mesh-list
19485398|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19485399|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485400|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485401|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485402|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19485403|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19485404|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19485405|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19485406|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
19485407|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
19485408|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
19485409|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
19485410|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485411|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485412|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19485413|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19485414|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19485415|NCT03165292|Topotecan|topotecan|mesh-list
19485416|NCT03165292|Thiotepa|thiotepa|mesh-list
19485417|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19485418|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19485419|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485420|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485421|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485422|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19485423|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
19485424|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19485425|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485426|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
19485427|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485428|NCT03165409|Nivolumab|nivolumab|mesh-list
19485429|NCT03165409|Ipilimumab|ipilimumab|mesh-list
19485430|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485431|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485432|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19485433|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485434|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
19485435|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19485436|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485437|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
19485438|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
19485439|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485440|NCT03164694|Carboplatin|carboplatin|mesh-list
19485441|NCT03164694|Pemetrexed|pemetrexed|mesh-list
19485442|NCT03164694|Apatinib|apatinib|mesh-list
19485443|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485444|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485445|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485446|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19485447|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19485448|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19485449|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
19485450|NCT03164590|Ketamine|ketamine|mesh-list
19485451|NCT03164590|Bupivacaine|bupivacaine|mesh-list
19485452|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
19485453|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
19485454|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485455|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485456|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
19485457|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485458|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485459|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19485460|NCT03164590|Analgesics|analgesics|mesh-ancestor
19485461|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19485462|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19485463|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19485464|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
19485465|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485466|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485467|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19485468|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19485469|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
19485470|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19485471|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19485472|NCT03164668|Menthol|menthol|mesh-list
19485473|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
19485474|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
19485475|NCT03164512|Cannabidiol|cannabidiol|mesh-list
19485476|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
19485477|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
19485478|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19485479|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
19485480|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485481|NCT03164421|Expectorants|expectorants|mesh-ancestor
19485482|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
19485483|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19485484|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
19485485|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485486|NCT03164421|Protective Agents|protective agents|mesh-ancestor
19485487|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485488|NCT03164421|Antidotes|antidotes|mesh-ancestor
19485489|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
19485490|NCT03164304|Analgesics|analgesics|mesh-ancestor
19485491|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
19485492|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485493|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485494|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
19485495|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485496|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20024168|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024169|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
20024170|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024171|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024172|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20024173|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115469|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115470|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
20115471|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115472|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115473|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
20115474|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115475|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20115476|NCT00005581|Paclitaxel|paclitaxel|mesh-list
20115477|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
20115478|NCT00005581|Fluorouracil|fluorouracil|mesh-list
20115479|NCT00005581|Epirubicin|epirubicin|mesh-list
20115480|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115481|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115482|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115483|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
19485497|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
19485498|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19485499|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19485500|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485501|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19485502|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
19485503|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19568891|NCT05343325|Cisplatin|cisplatin|mesh-list
19568892|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19568893|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19568894|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568895|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
19568896|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
19568897|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
19568898|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568899|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19568900|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
19568901|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19568902|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19568903|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568904|NCT05343299|Lidocaine|lidocaine|mesh-list
19568905|NCT05343299|Ropivacaine|ropivacaine|mesh-list
19568906|NCT05343299|Anesthetics|anesthetics|mesh-list
19568907|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
19568908|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568909|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568910|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
19568911|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568912|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19568913|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19568914|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19568915|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19568916|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568917|NCT05343169|Naloxone|naloxone|mesh-list
19568918|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19568919|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568920|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
19568921|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568922|NCT05343156|Dexamethasone|dexamethasone|mesh-list
19568923|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19568924|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19568925|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
19568926|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
19568927|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568928|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568929|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19568930|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
19568931|NCT05343156|Hormones|hormones|mesh-ancestor
19568932|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19568933|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19568934|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568935|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19568936|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
19568937|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19568938|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568939|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19568940|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568941|NCT05343013|Trifluridine|trifluridine|mesh-list
19568942|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
19568943|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568944|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
19568945|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19568946|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
19568947|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19568948|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568949|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568950|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19568951|NCT05342870|Analgesics|analgesics|mesh-ancestor
19568952|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
19568953|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568954|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19568955|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19568956|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19568957|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
19568958|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749145|NCT05258773|Azasetron|azasetron|mesh-list
19485504|NCT03164382|Sorafenib|sorafenib|mesh-list
19485505|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485506|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19485507|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485508|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485509|NCT03164291|Rifabutin|rifabutin|mesh-list
19485510|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485511|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485512|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19485513|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
19485514|NCT03164096|Bupivacaine|bupivacaine|mesh-list
19485515|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
19485516|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
19485517|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485518|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485519|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
19485520|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485521|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
19485522|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
19485523|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485524|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485525|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19485526|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19485527|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485528|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485529|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485530|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485531|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
19485532|NCT03164109|Protective Agents|protective agents|mesh-ancestor
19485533|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
19485534|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19485535|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19485536|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485537|NCT03163914|Phenylephrine|phenylephrine|mesh-list
19485538|NCT03163914|Epinephrine|epinephrine|mesh-list
19485539|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
19485540|NCT03163914|Norepinephrine|norepinephrine|mesh-list
19485541|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19485542|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19485543|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
19485544|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485545|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485546|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485547|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19485548|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19485549|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
19485550|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485551|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19485552|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
19485553|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
19485554|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
19485555|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19485556|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19485557|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
19485558|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20024174|NCT05220813|Lidocaine|lidocaine|mesh-list
20024175|NCT05220813|Bupivacaine|bupivacaine|mesh-list
20024176|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
20024177|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
20024178|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024179|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485559|NCT03163914|Protective Agents|protective agents|mesh-ancestor
19485560|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
19485561|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485562|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485563|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485564|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19485565|NCT03163693|Analgesics|analgesics|mesh-ancestor
19485566|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
19485567|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485568|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19485569|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19485570|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20024180|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
20024181|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485571|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
19485572|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19743919|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743920|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743921|NCT03417544|Trastuzumab|trastuzumab|mesh-list
19743922|NCT03417544|Pertuzumab|pertuzumab|mesh-list
19743923|NCT03417544|Atezolizumab|atezolizumab|mesh-list
19743924|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743925|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743926|NCT03404518|Acetaminophen|acetaminophen|mesh-list
19743927|NCT03404518|Ibuprofen|ibuprofen|mesh-list
19743928|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19743929|NCT03404518|Hydrocodone|hydrocodone|mesh-list
19743930|NCT03404518|Narcotics|narcotics|mesh-list
19743931|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19743932|NCT03404518|Analgesics|analgesics|mesh-ancestor
19743933|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
19743934|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743935|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743936|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
19743937|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19743938|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19743939|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743940|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19743941|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743942|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743943|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19743944|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743945|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
19743946|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
19743947|NCT03402841|Olaparib|olaparib|mesh-list
19743948|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19743949|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743950|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743951|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743952|NCT03376672|Dexamethasone|dexamethasone|mesh-list
19743953|NCT03376672|Lenalidomide|lenalidomide|mesh-list
19743954|NCT03376672|Ixazomib|ixazomib|mesh-list
19743955|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19743956|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
19743957|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
19743958|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19743959|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743960|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743961|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
19743962|NCT03376672|Hormones|hormones|mesh-ancestor
19743963|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743964|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19743965|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743966|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
19743967|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19743968|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19743969|NCT03376672|Growth Substances|growth substances|mesh-ancestor
19743970|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
20024182|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20024183|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20024184|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20024185|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115484|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
19485573|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485574|NCT03163680|Omeprazole|omeprazole|mesh-list
19485575|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19485576|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485577|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19485578|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485579|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485580|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19485581|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19485582|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485583|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
19485584|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19743971|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
19743972|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743973|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485585|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19485586|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485587|NCT03164161|Endorphins|endorphins|mesh-list
19485588|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485589|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485590|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485591|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
19485592|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
19485593|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485594|NCT03163966|Methotrexate|methotrexate|mesh-list
19485595|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19485596|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
19485597|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19485598|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485599|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19485600|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
19485601|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485602|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485603|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
19485604|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485605|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19485606|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485607|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
19485608|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485609|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19485610|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
19485611|NCT03163589|Hematinics|hematinics|mesh-ancestor
19485612|NCT03163277|Emtricitabine|emtricitabine|mesh-list
19485613|NCT03163277|Maraviroc|maraviroc|mesh-list
19485614|NCT03163277|Darunavir|darunavir|mesh-list
19485615|NCT03163277|Cobicistat|cobicistat|mesh-list
19485616|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
19485617|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485618|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19485619|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19485620|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485621|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485622|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19485623|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19485624|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19485625|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19485626|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19485627|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19485628|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19485629|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
19485630|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19485631|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19485632|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
19485633|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485634|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485635|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485636|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19485637|NCT03163238|Analgesics|analgesics|mesh-ancestor
19485638|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
19485639|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485640|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19485641|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19485642|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19485643|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
19485644|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485645|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485646|NCT03163420|Diclofenac|diclofenac|mesh-list
19485647|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19485648|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19485649|NCT03163420|Analgesics|analgesics|mesh-ancestor
19485650|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
19485651|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485652|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485653|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485654|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485655|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19485656|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485657|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485658|NCT03163407|Norepinephrine|norepinephrine|mesh-list
19485659|NCT03163407|Ephedrine|ephedrine|mesh-list
19485660|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19485661|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19485662|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
19485663|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485664|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485665|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485666|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
19485667|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
19485668|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485669|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19485670|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19485671|NCT03163381|Apatinib|apatinib|mesh-list
19485672|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485673|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19485674|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485675|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485676|NCT03163576|Niacin|niacin|mesh-list
19485677|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19485678|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
19485679|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485680|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19485681|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
19485682|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
19485683|NCT03163576|Vitamins|vitamins|mesh-ancestor
19485684|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
19485685|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485686|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
19485687|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
19485688|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485689|NCT03163173|Protective Agents|protective agents|mesh-ancestor
19485690|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485691|NCT03163212|Lactoferrin|lactoferrin|mesh-list
19485692|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485693|NCT03163121|Vaccines|vaccines|mesh-list
19485694|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
19485695|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485696|NCT03162861|Anesthetics|anesthetics|mesh-list
19485697|NCT03162861|Propofol|propofol|mesh-list
19485698|NCT03162861|Sevoflurane|sevoflurane|mesh-list
19485699|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485700|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485701|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485702|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19485703|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
19485704|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19485705|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19485706|NCT03162653|Allopurinol|allopurinol|mesh-list
19485707|NCT03162653|Mannitol|mannitol|mesh-list
19485708|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
19485709|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485710|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024186|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024187|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
20024188|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
20024189|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024190|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
20024191|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20024192|NCT05215236|Narcotics|narcotics|mesh-ancestor
20024193|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024194|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024195|NCT05215236|Analgesics|analgesics|mesh-ancestor
20024196|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
20024197|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024198|NCT05184348|Acitretin|acitretin|mesh-list
20024199|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
20024200|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
20024201|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
19485711|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
20024202|NCT05159193|Carboplatin|carboplatin|mesh-list
20024203|NCT05159193|Docetaxel|docetaxel|mesh-list
19485712|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485713|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19485714|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
19485715|NCT03162653|Protective Agents|protective agents|mesh-ancestor
19485716|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485717|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19485718|NCT03162653|Diuretics|diuretics|mesh-ancestor
19485719|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
19485720|NCT03162731|Nivolumab|nivolumab|mesh-list
19485721|NCT03162731|Ipilimumab|ipilimumab|mesh-list
19485722|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485723|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485724|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19485725|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568959|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568960|NCT05342857|Aflibercept|aflibercept|mesh-list
19568961|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19568962|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19568963|NCT05342857|Growth Substances|growth substances|mesh-ancestor
19568964|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568965|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
19568966|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19568967|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
19568968|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19568969|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568970|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568971|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19568972|NCT05342844|Analgesics|analgesics|mesh-ancestor
19568973|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
19568974|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568975|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19568976|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19568977|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19568978|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
19568979|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568980|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568981|NCT05342818|Ondansetron|ondansetron|mesh-list
19568982|NCT05342818|Metoclopramide|metoclopramide|mesh-list
19568983|NCT05342818|Neostigmine|neostigmine|mesh-list
19568984|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
19568985|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
19568986|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19568987|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19568988|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19568989|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
19568990|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
19568991|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19568992|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
19568993|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19568994|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19568995|NCT05342818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19568996|NCT05342818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19568997|NCT05342818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19568998|NCT05342818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19568999|NCT05342818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19569000|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19569001|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569002|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
19569003|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19569004|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19569005|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19569006|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
20024204|NCT05159193|Doxorubicin|doxorubicin|mesh-list
20024205|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20024206|NCT05159193|Trastuzumab|trastuzumab|mesh-list
20024207|NCT05159193|Pertuzumab|pertuzumab|mesh-list
20024208|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024209|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
20024210|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024211|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024212|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20024213|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
20024214|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024215|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024216|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20024217|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
20024218|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
20024219|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024220|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20576416|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576417|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024221|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20292882|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20292883|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
20292884|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292885|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
20292886|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292887|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292888|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292889|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
20292890|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292891|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292892|NCT04984798|Vitamin E|vitamin e|mesh-list
20292893|NCT04984798|Tocopherols|tocopherols|mesh-list
20024222|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20024223|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024224|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024225|NCT05156437|Amoxicillin|amoxicillin|mesh-list
20024226|NCT05156437|Vancomycin|vancomycin|mesh-list
20024227|NCT05156437|Levofloxacin|levofloxacin|mesh-list
19485726|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
19485727|NCT03162588|Hematinics|hematinics|mesh-ancestor
19485728|NCT03162406|Vitamin D|vitamin d|mesh-list
19485729|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
19485730|NCT03162406|Vitamins|vitamins|mesh-ancestor
19485731|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
19485732|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485733|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19485734|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19485735|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
19485736|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485737|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485738|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19485739|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19485740|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485741|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485742|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485743|NCT03162432|Vitamin D|vitamin d|mesh-list
19485744|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
19485745|NCT03162432|Vitamins|vitamins|mesh-ancestor
19485746|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
19485747|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485748|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19485749|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19485750|NCT03162562|Oregovomab|oregovomab|mesh-list
20024228|NCT05156437|Rifampin|rifampin|mesh-list
20024229|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
20024230|NCT05156437|Linezolid|linezolid|mesh-list
20024231|NCT05156437|Daptomycin|daptomycin|mesh-list
20024232|NCT05156437|Cephalexin|cephalexin|mesh-list
20024233|NCT05156437|Ampicillin|ampicillin|mesh-list
19485751|NCT03162562|Poly ICLC|poly iclc|mesh-list
19485752|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
19485753|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
19485754|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485755|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485756|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485757|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
19485758|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19485759|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485760|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485761|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19485762|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19485763|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
19485764|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19485765|NCT03162224|Durvalumab|durvalumab|mesh-list
19485766|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485767|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485768|NCT03162185|Citalopram|citalopram|mesh-list
19485769|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19485770|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19485771|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19485772|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485773|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485774|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
19569007|NCT05342792|Capecitabine|capecitabine|mesh-list
20292894|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
20292895|NCT04984798|Vitamins|vitamins|mesh-ancestor
20024234|NCT05156437|Cefepime|cefepime|mesh-list
20024235|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20024236|NCT05156437|Oxacillin|oxacillin|mesh-list
19485775|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485776|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19485777|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
19485778|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19485779|NCT03162120|Metoprolol|metoprolol|mesh-list
19485780|NCT03162120|Flecainide|flecainide|mesh-list
19485781|NCT03162120|Ranolazine|ranolazine|mesh-list
20024237|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
20024238|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20024239|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024240|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20024241|NCT05156437|Renal Agents|renal agents|mesh-ancestor
20024242|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20024243|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20024244|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024245|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024246|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024247|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20024248|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20024249|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20024250|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
20024251|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
20024252|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20024253|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20024254|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20024255|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20024256|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20024257|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20024258|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20024259|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20024260|NCT05143424|Morphine|morphine|mesh-list
19485782|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19485783|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19485784|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
19485785|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
19485786|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485787|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485788|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19485789|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19485790|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19485791|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
19485792|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485793|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485794|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19485795|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19485796|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19485797|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19485798|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19485799|NCT03161977|Mannitol|mannitol|mesh-list
19485800|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19485801|NCT03161977|Diuretics|diuretics|mesh-ancestor
19485802|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
19485803|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485804|NCT03161652|Ranibizumab|ranibizumab|mesh-list
19485805|NCT03161652|Dopamine|dopamine|mesh-list
19485806|NCT03161652|Sulpiride|sulpiride|mesh-list
19485807|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19485808|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19485809|NCT03161652|Growth Substances|growth substances|mesh-ancestor
19485810|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485811|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
19485812|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485813|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19485814|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
19485815|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
19485816|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485817|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
19485818|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485819|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485820|NCT03161652|Protective Agents|protective agents|mesh-ancestor
19485821|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19485822|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19569008|NCT05342792|Antibodies|antibodies|mesh-list
19485823|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485824|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19485825|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19485826|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19485827|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
20024261|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20024262|NCT05143424|Narcotics|narcotics|mesh-ancestor
20024263|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024264|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024265|NCT05143424|Analgesics|analgesics|mesh-ancestor
20024266|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
20024267|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024268|NCT05132166|Sirolimus|sirolimus|mesh-list
20024269|NCT05132166|Everolimus|everolimus|mesh-list
19485828|NCT03161353|Tamoxifen|tamoxifen|mesh-list
19485829|NCT03161353|Carboplatin|carboplatin|mesh-list
19485830|NCT03161353|Docetaxel|docetaxel|mesh-list
19485831|NCT03161353|Trastuzumab|trastuzumab|mesh-list
19485832|NCT03161353|Letrozole|letrozole|mesh-list
19485833|NCT03161353|Pertuzumab|pertuzumab|mesh-list
19485834|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485835|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
19485836|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
19485837|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
19485838|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485839|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485840|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19485841|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19485842|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292896|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
20292897|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292898|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
20292899|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292900|NCT04984798|Protective Agents|protective agents|mesh-ancestor
20292901|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
19485843|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19485844|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
19485845|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19743974|NCT03374800|Pantoprazole|pantoprazole|mesh-list
19743975|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19743976|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19743977|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19743978|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19743979|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19743980|NCT03367312|Xenon|xenon|mesh-list
20024270|NCT05132166|Vedolizumab|vedolizumab|mesh-list
20292902|NCT04977453|Lenvatinib|lenvatinib|mesh-list
19485846|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485847|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749146|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
20292903|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485848|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19485849|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19485850|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19485851|NCT03161509|Acetaminophen|acetaminophen|mesh-list
19485852|NCT03161509|Lamotrigine|lamotrigine|mesh-list
19485853|NCT03161509|Carbamazepine|carbamazepine|mesh-list
19485854|NCT03161509|Phenytoin|phenytoin|mesh-list
19485855|NCT03161509|Valproic Acid|valproic acid|mesh-list
19485856|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
19485857|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19485858|NCT03161509|Analgesics|analgesics|mesh-ancestor
19485859|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
19485860|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485861|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485862|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
19485863|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19485864|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19485865|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485866|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19485867|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19485868|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19485869|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485870|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19485871|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19485872|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485873|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
19485874|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485875|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
19485876|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19485877|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19485878|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19485879|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19485880|NCT03161457|Rituximab|rituximab|mesh-list
19485881|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485882|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485883|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
19485884|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485885|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19485886|NCT03161522|Fluorouracil|fluorouracil|mesh-list
19485887|NCT03161522|Capecitabine|capecitabine|mesh-list
19485888|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
19485889|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485890|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19485891|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485892|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485893|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
19485894|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485895|NCT03161340|Sirolimus|sirolimus|mesh-list
19485896|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485897|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485898|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19485899|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485900|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
19485901|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485902|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
19485903|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485904|NCT03161210|Anesthetics|anesthetics|mesh-list
19485905|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485906|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485907|NCT03161574|Fluorouracil|fluorouracil|mesh-list
19485908|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
19485909|NCT03161574|Irinotecan|irinotecan|mesh-list
19485910|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
19485911|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485912|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19485913|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485914|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19485915|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
19485916|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485917|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19485918|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19485919|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485920|NCT03160872|Hormones|hormones|mesh-list
19485921|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569009|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
19485922|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485923|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19485924|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19485925|NCT03161132|Doxorubicin|doxorubicin|mesh-list
19485926|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19485927|NCT03161132|Olaparib|olaparib|mesh-list
19485928|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19485929|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485930|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19485931|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19485932|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485933|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485934|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19485935|NCT03161041|Bevacizumab|bevacizumab|mesh-list
19485936|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
19485937|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19485938|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485939|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19485940|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19485941|NCT03161041|Growth Substances|growth substances|mesh-ancestor
19485942|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485943|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
19485944|NCT03160911|Hemostatics|hemostatics|mesh-list
20024271|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20024272|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024273|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024274|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
20024275|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024276|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20024277|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024278|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20024279|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
20024280|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20024281|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
20024282|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
20024283|NCT05115630|Melphalan|melphalan|mesh-list
20024284|NCT05115630|Fludarabine|fludarabine|mesh-list
20024285|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
20024286|NCT05115630|Tacrolimus|tacrolimus|mesh-list
20024287|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024288|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
20024289|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024290|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024291|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20024292|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
20024293|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024294|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024295|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20024296|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024297|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
20024298|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20024299|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024300|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20024301|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20024302|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
20024303|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20024304|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024305|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20024313|NCT05078606|Anesthetics|anesthetics|mesh-list
20024314|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024315|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024316|NCT05055050|Imiquimod|imiquimod|mesh-list
20024317|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20024318|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
20024319|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576418|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
19485945|NCT03160911|Coagulants|coagulants|mesh-ancestor
20576419|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485946|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
19485947|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485948|NCT03161106|Lactulose|lactulose|mesh-list
19485949|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485950|NCT03160807|Levofloxacin|levofloxacin|mesh-list
19485951|NCT03160807|Ofloxacin|ofloxacin|mesh-list
19485952|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19485953|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19485954|NCT03160807|Renal Agents|renal agents|mesh-ancestor
19485955|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19485956|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19485957|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19485958|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19485959|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485960|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485961|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19485962|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19485963|NCT03160729|Dexamethasone|dexamethasone|mesh-list
19485964|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485965|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
19485966|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
19485967|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485968|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485969|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485970|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
19485971|NCT03160729|Hormones|hormones|mesh-ancestor
19485972|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19485973|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19485974|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19485975|NCT03160404|Zolpidem|zolpidem|mesh-list
19485976|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19485977|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19485978|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19485979|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485980|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19485981|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
19485982|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
19485983|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19485984|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19485985|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
19485986|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19485987|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19485988|NCT03160651|Prednisolone|prednisolone|mesh-list
19485989|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
19485990|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19485991|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
19485992|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19485993|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
19485994|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
19485995|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19485996|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19485997|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19485998|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
19485999|NCT03160651|Hormones|hormones|mesh-ancestor
19486000|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486001|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19486002|NCT03160651|Protective Agents|protective agents|mesh-ancestor
19486003|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19486004|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486005|NCT03160339|Vaccines|vaccines|mesh-list
19486006|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
19486007|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486008|NCT03160248|Apremilast|apremilast|mesh-list
19486009|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19486010|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486011|NCT03160248|Analgesics|analgesics|mesh-ancestor
19486012|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
19486013|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486014|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486015|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486016|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486017|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19486018|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19486019|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486020|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486021|NCT03160001|Niclosamide|niclosamide|mesh-list
19486022|NCT03160001|Etanercept|etanercept|mesh-list
19486023|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19486024|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486025|NCT03160001|Analgesics|analgesics|mesh-ancestor
19486026|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
19486027|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486028|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486029|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486030|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486031|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19486032|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19486033|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
19486034|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
19486035|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19486036|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
19486037|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19486038|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486039|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
19486040|NCT03160040|Minocycline|minocycline|mesh-list
19486041|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486042|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486043|NCT03160261|Exenatide|exenatide|mesh-list
19486044|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19486045|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486046|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19486047|NCT03160261|Incretins|incretins|mesh-ancestor
19486048|NCT03160261|Hormones|hormones|mesh-ancestor
19486049|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486050|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19486051|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19486052|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
19486053|NCT03159741|Glucagon|glucagon|mesh-list
19486054|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19486055|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19486056|NCT03159741|Hormones|hormones|mesh-ancestor
19486057|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486058|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486059|NCT03159741|Incretins|incretins|mesh-ancestor
19486060|NCT03159845|Levofloxacin|levofloxacin|mesh-list
19486061|NCT03159845|Ofloxacin|ofloxacin|mesh-list
19486062|NCT03159845|Fluconazole|fluconazole|mesh-list
19486063|NCT03159845|Acyclovir|acyclovir|mesh-list
19486064|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
19486065|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19486066|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486067|NCT03159845|Renal Agents|renal agents|mesh-ancestor
19486068|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486069|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19486070|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19486071|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486072|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486073|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486074|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19486075|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19486076|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
19486077|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19486078|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19486079|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
19486080|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486081|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486082|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19486083|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19486084|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
19486085|NCT03159845|Astringents|astringents|mesh-ancestor
19486086|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486087|NCT03159598|Urethane|urethane|mesh-list
20024320|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024321|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
20024322|NCT05035836|Tamoxifen|tamoxifen|mesh-list
20024323|NCT05035836|Letrozole|letrozole|mesh-list
19486088|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486089|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19486090|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
20024324|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024325|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19486091|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
19486092|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486093|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486094|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19486095|NCT03159754|Metronidazole|metronidazole|mesh-list
19486096|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
19486097|NCT03159754|Tazobactam|tazobactam|mesh-list
19486098|NCT03159754|Piperacillin|piperacillin|mesh-list
19486099|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19486100|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486101|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19486102|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19486103|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19486104|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19486105|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486106|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486107|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486108|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19486109|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19486110|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19486111|NCT03159702|Fludarabine|fludarabine|mesh-list
19486112|NCT03159702|Melphalan|melphalan|mesh-list
19486113|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486114|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486115|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19486116|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
19486117|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486118|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19486119|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
19486120|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19486121|NCT03159559|Aspirin|aspirin|mesh-list
19486122|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19486123|NCT03159559|Alprostadil|alprostadil|mesh-list
19486124|NCT03159559|Clopidogrel|clopidogrel|mesh-list
19486125|NCT03159559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19486126|NCT03159559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486127|NCT03159559|Analgesics|analgesics|mesh-ancestor
19486128|NCT03159559|Sensory System Agents|sensory system agents|mesh-ancestor
19486129|NCT03159559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486130|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486131|NCT03159559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486132|NCT03159559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486133|NCT03159559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19486134|NCT03159559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19486135|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486136|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19486137|NCT03159559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19486138|NCT03159559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486139|NCT03159559|Antipyretics|antipyretics|mesh-ancestor
19486140|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19486141|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19486142|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19486143|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
19486144|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486145|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
19486146|NCT03159559|Urological Agents|urological agents|mesh-ancestor
19486147|NCT03159403|Oritavancin|oritavancin|mesh-list
19486148|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486149|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486150|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
19486151|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19486152|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
19486153|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486154|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486155|NCT03159078|Imipenem|imipenem|mesh-list
19486156|NCT03159078|Polymyxins|polymyxins|mesh-list
19486157|NCT03159078|Polymyxin B|polymyxin b|mesh-list
19486158|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486159|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569010|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569011|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569012|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
19569013|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569014|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577687|NCT04024254|Folic Acid|folic acid|mesh-list
19577688|NCT04024254|Hematinics|hematinics|mesh-ancestor
19577689|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
19577690|NCT04024254|Vitamins|vitamins|mesh-ancestor
19577691|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
19577692|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577693|NCT04007029|Vidarabine|vidarabine|mesh-list
19577694|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
19577695|NCT04007029|Fludarabine|fludarabine|mesh-list
19577696|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
19577697|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
19577698|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
19577699|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577700|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
19577701|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577702|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577703|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19577704|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
19577705|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577706|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577707|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19577708|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577709|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
19577710|NCT04007029|Antiviral Agents|antiviral agents|mesh-ancestor
19577711|NCT04007029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577712|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
19577713|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743981|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19743982|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
19743983|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
19743984|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19743985|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743986|NCT03361852|Rituximab|rituximab|mesh-list
19743987|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
19743988|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19743989|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19743990|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
19743991|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19743992|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19743993|NCT03358706|Vitamin K|vitamin k|mesh-list
19743994|NCT03358706|Midazolam|midazolam|mesh-list
19743995|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
19743996|NCT03358706|Caffeine|caffeine|mesh-list
19743997|NCT03358706|Ustekinumab|ustekinumab|mesh-list
19743998|NCT03358706|Omeprazole|omeprazole|mesh-list
19743999|NCT03358706|Warfarin|warfarin|mesh-list
19744000|NCT03358706|Vitamins|vitamins|mesh-ancestor
19744001|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
19744002|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744003|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19744004|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19744005|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19744006|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19744007|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19744008|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19744009|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19744010|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
19744011|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
19744012|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
20576420|NCT02071355|Simeprevir|simeprevir|mesh-list
19577714|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577715|NCT03983031|Rituximab|rituximab|mesh-list
19744013|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
19744014|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744015|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744016|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
19577716|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577717|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577718|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
19486160|NCT03159234|Epinephrine|epinephrine|mesh-list
19486161|NCT03159234|Racepinephrine|racepinephrine|mesh-list
19486162|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
19486163|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19486164|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19486165|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
19486166|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486167|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486168|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486169|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19486170|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19486171|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
19486172|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486173|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19486174|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
19486175|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
19486176|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
19486177|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19486178|NCT03158935|Aldesleukin|aldesleukin|mesh-list
19486179|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
19486180|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
19486181|NCT03158935|Fludarabine|fludarabine|mesh-list
19486182|NCT03158935|Interleukin-2|interleukin-2|mesh-list
20024326|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20024327|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024328|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024329|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20024330|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
20024331|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20024332|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024333|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20024334|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20024335|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20024336|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20024337|NCT05028829|Atorvastatin|atorvastatin|mesh-list
20024338|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20024339|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20024340|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
20024341|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024342|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20024343|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20024344|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024345|NCT04990128|Triamcinolone|triamcinolone|mesh-list
20024346|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024347|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
20024348|NCT04990128|Hormones|hormones|mesh-ancestor
20024349|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20024350|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024351|NCT04969224|Ivacaftor|ivacaftor|mesh-list
20024352|NCT04969224|Elexacaftor|elexacaftor|mesh-list
20024353|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20024354|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024355|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024356|NCT04932915|Niclosamide|niclosamide|mesh-list
20024357|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
20024358|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20024359|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
20024360|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20024361|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024362|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
20024363|NCT04874038|Lidocaine|lidocaine|mesh-list
20024364|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
20024365|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
20024366|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024367|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024368|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
20024369|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024370|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20024371|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19486183|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19486184|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
19486185|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486186|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486187|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19486188|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
19486189|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486190|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486191|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19486192|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19486193|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486194|NCT03158935|Analgesics|analgesics|mesh-ancestor
19486195|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
19486196|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486197|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19486198|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19486199|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
19486200|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486201|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
19486202|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
19486203|NCT03158584|Morphine|morphine|mesh-list
19486204|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19486205|NCT03158584|Narcotics|narcotics|mesh-ancestor
19486206|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486207|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486208|NCT03158584|Analgesics|analgesics|mesh-ancestor
19486209|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
19486210|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486211|NCT03158610|Capecitabine|capecitabine|mesh-list
19486212|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19486213|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
19486214|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486215|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486216|NCT03158792|Enoxaparin|enoxaparin|mesh-list
19486217|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
19486218|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
19486219|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19486220|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19486221|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486222|NCT03158376|Gabapentin|gabapentin|mesh-list
19486223|NCT03158376|Analgesics|analgesics|mesh-ancestor
19486224|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
19486225|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486226|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486227|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
19486228|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19486229|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19486230|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486231|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19486232|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19486233|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19486234|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486235|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486236|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
19486237|NCT03158142|Atropine|atropine|mesh-list
19486238|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19486239|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19486240|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19486241|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
19486242|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486243|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486244|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19486245|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
19486246|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
19486247|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
19486248|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19486249|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19486250|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
19486251|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486252|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486253|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
19486254|NCT03158168|Astringents|astringents|mesh-ancestor
19486255|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486256|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486257|NCT03158129|Cisplatin|cisplatin|mesh-list
19486258|NCT03158129|Carboplatin|carboplatin|mesh-list
19486259|NCT03158129|Docetaxel|docetaxel|mesh-list
19486260|NCT03158129|Nivolumab|nivolumab|mesh-list
19486261|NCT03158129|Pemetrexed|pemetrexed|mesh-list
19486262|NCT03158129|Ipilimumab|ipilimumab|mesh-list
19486263|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486264|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
19486265|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
19486266|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
19486267|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486268|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19486269|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19486270|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486271|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19486272|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19486273|NCT03158246|Vitamin D|vitamin d|mesh-list
19486274|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
19486275|NCT03158246|Calcium|calcium|mesh-list
19486276|NCT03158246|Vitamins|vitamins|mesh-ancestor
19486277|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
19486278|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486279|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19486280|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19486281|NCT03158025|Zolpidem|zolpidem|mesh-list
19486282|NCT03158025|Suvorexant|suvorexant|mesh-list
19486283|NCT03158025|Lemborexant|lemborexant|mesh-list
19486284|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19486285|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19486286|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486287|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486288|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19486289|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
19486290|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
19486291|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486292|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486293|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19486294|NCT03157843|Heparin|heparin|mesh-list
19486295|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19486296|NCT03157843|Tinzaparin|tinzaparin|mesh-list
19486297|NCT03157843|Dalteparin|dalteparin|mesh-list
19486298|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
19486299|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19486300|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19486301|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486302|NCT03157804|Plerixafor|plerixafor|mesh-list
19486303|NCT03157804|Lenograstim|lenograstim|mesh-list
19486304|NCT03157804|Sargramostim|sargramostim|mesh-list
19486305|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19486306|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
19486307|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486308|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19486309|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19486310|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
19486311|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486312|NCT03157791|Simethicone|simethicone|mesh-list
19486313|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
19486314|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486315|NCT03157791|Emollients|emollients|mesh-ancestor
19486316|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486317|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
19486318|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486319|NCT03157479|Anesthetics|anesthetics|mesh-list
19486320|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19486321|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486322|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486323|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
19569015|NCT05342662|Methamphetamine|methamphetamine|mesh-list
19569016|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19569017|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569018|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
19569019|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
19569020|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569021|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
19569022|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569023|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569024|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
19569025|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19569026|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19569027|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19569028|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19569029|NCT05331911|Propofol|propofol|mesh-list
19569030|NCT05331911|Sevoflurane|sevoflurane|mesh-list
19569031|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
19569032|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486324|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
19486325|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19486326|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19486327|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486328|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
19486329|NCT03157401|Coagulants|coagulants|mesh-ancestor
19486330|NCT03157310|Gefitinib|gefitinib|mesh-list
19486331|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486332|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19486333|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486334|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486335|NCT03157414|Empagliflozin|empagliflozin|mesh-list
19486336|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19486337|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486338|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19486339|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486340|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
19486341|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19486342|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
19486343|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486344|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
19486345|NCT03157193|Protective Agents|protective agents|mesh-ancestor
19486346|NCT03157388|Vancomycin|vancomycin|mesh-list
19486347|NCT03157388|Gentamicins|gentamicins|mesh-list
19486348|NCT03157388|Meropenem|meropenem|mesh-list
19486349|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486350|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486351|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19486352|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486353|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486354|NCT03156855|Bismuth|bismuth|mesh-list
19486355|NCT03156855|Antacids|antacids|mesh-ancestor
19486356|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486357|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19486358|NCT03156920|Sumatriptan|sumatriptan|mesh-list
19486359|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19486360|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19486361|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19486362|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
19486363|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486364|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486365|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486366|NCT03156842|Amlodipine|amlodipine|mesh-list
19486367|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19486368|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19486369|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19486370|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19486371|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486372|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19486373|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486374|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
19486375|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19486376|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19486377|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
19486378|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19486379|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19486380|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486381|NCT03156907|Buprenorphine|buprenorphine|mesh-list
19486382|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19486383|NCT03156907|Narcotics|narcotics|mesh-ancestor
19486384|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486385|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486386|NCT03156907|Analgesics|analgesics|mesh-ancestor
19486387|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
19486388|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486389|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19486390|NCT03156790|Asparaginase|asparaginase|mesh-list
19486391|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486392|NCT03156829|Betamethasone|betamethasone|mesh-list
20024372|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20024373|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024374|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486393|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486394|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
19486395|NCT03156829|Hormones|hormones|mesh-ancestor
19486396|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486397|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486398|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19486399|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
19486400|NCT03156439|Huperzine A|huperzine a|mesh-list
19486401|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19486402|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486403|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486404|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
19486405|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486406|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486407|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19486408|NCT03156439|Protective Agents|protective agents|mesh-ancestor
19486409|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
19486410|NCT03156452|Prednisolone|prednisolone|mesh-list
19486411|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19486412|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486413|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19486414|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
19486415|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486416|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486417|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486418|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486419|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486420|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
19486421|NCT03156452|Hormones|hormones|mesh-ancestor
19486422|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486423|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486424|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19486425|NCT03156361|Insulin|insulin|mesh-list
19486426|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19486427|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
19486428|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19486429|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486430|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
19486431|NCT03156296|Bupivacaine|bupivacaine|mesh-list
19486432|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
19486433|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
19486434|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486435|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486436|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
19486437|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486438|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19486439|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486440|NCT03156296|Analgesics|analgesics|mesh-ancestor
19486441|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19486442|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19486443|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19486444|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
19486445|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486446|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486447|NCT03156322|Fentanyl|fentanyl|mesh-list
19486448|NCT03156322|Bupivacaine|bupivacaine|mesh-list
19486449|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
19486450|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
19486451|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486452|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486453|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
19486454|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486455|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19486456|NCT03156322|Narcotics|narcotics|mesh-ancestor
19486457|NCT03156322|Analgesics|analgesics|mesh-ancestor
19486458|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19486459|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19486460|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
19486461|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19486462|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486463|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486464|NCT03156036|Capecitabine|capecitabine|mesh-list
19486465|NCT03156036|Temozolomide|temozolomide|mesh-list
19486466|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024375|NCT04867785|Dulaglutide|dulaglutide|mesh-list
19486467|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
19569033|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486468|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486469|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486470|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19486471|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
19486472|NCT03156179|Calcium|calcium|mesh-list
19486473|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19486474|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486475|NCT03156153|Bumetanide|bumetanide|mesh-list
19486476|NCT03156153|Diuretics|diuretics|mesh-ancestor
19486477|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
19486478|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486479|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19486480|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19569034|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19744017|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19744018|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744019|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19744020|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744021|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19744022|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19744023|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19744024|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19744025|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
19744026|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
19744027|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19744028|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19744029|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
19744030|NCT03358706|Coagulants|coagulants|mesh-ancestor
19744031|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
19744032|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
19744033|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19744034|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19744035|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
19744036|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
19744037|NCT03350516|Calcium|calcium|mesh-list
19744038|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19744039|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744040|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19744041|NCT03350516|Antacids|antacids|mesh-ancestor
19744042|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744043|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744044|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
19744045|NCT03323476|Prednisone|prednisone|mesh-list
19744046|NCT03323476|Rituximab|rituximab|mesh-list
19744047|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19744048|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744049|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744050|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
19744051|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744052|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744053|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744054|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19744055|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
19744056|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19744057|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744058|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744059|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744060|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744061|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
19744062|NCT03323476|Hormones|hormones|mesh-ancestor
19744063|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744064|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744065|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
19744066|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744067|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744068|NCT03318094|Nitroprusside|nitroprusside|mesh-list
19744069|NCT03318094|Phentolamine|phentolamine|mesh-list
19744070|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19744071|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
19744072|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19744073|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
19744074|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19744075|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744076|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024376|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20024377|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024378|NCT04845490|Mitomycins|mitomycins|mesh-list
20024379|NCT04845490|Mitomycin|mitomycin|mesh-list
20024380|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20024381|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024382|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
20024383|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024384|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20024385|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024386|NCT04830397|Timolol|timolol|mesh-list
20024387|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20024388|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20024389|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024390|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024391|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024392|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024393|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20024394|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20024395|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
20024396|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20024397|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19486481|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486482|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
19486483|NCT03156062|Salicylates|salicylates|mesh-list
19486484|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486485|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
19486486|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
19486487|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486488|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19486489|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486490|NCT03156062|Analgesics|analgesics|mesh-ancestor
19486491|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
19486492|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486493|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486494|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486495|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486496|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19486497|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486498|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486499|NCT03156231|Acetazolamide|acetazolamide|mesh-list
19486500|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
19486501|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19486502|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486503|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486504|NCT03156231|Diuretics|diuretics|mesh-ancestor
19486505|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
19486506|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486507|NCT03155971|Paclitaxel|paclitaxel|mesh-list
19486508|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19486509|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024398|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024399|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024400|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20024401|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024402|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024403|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
20024404|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024405|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20024406|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20024407|NCT04819360|Urological Agents|urological agents|mesh-ancestor
20024408|NCT04808466|Paclitaxel|paclitaxel|mesh-list
20024409|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20024410|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024411|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
20024412|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
20024413|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024414|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115485|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115486|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115487|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
20115488|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115489|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486510|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
19486511|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
19486512|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
19486513|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569035|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19569036|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
19569037|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19569038|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19569039|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
19569040|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19569041|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
19569042|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569043|NCT05329779|Pregnanolone|pregnanolone|mesh-list
19569044|NCT05329779|Brexanolone|brexanolone|mesh-list
19569045|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
19569046|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569047|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569048|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
19569049|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569050|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569051|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
19569052|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
19569053|NCT05329155|Heparin|heparin|mesh-list
19569054|NCT05329155|Calcium heparin|calcium heparin|mesh-list
19569055|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
19569056|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19569057|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19569058|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569059|NCT05321160|Ketamine|ketamine|mesh-list
19569060|NCT05321160|Sevoflurane|sevoflurane|mesh-list
19569061|NCT05321160|Esketamine|esketamine|mesh-list
19569062|NCT05321160|Analgesics|analgesics|mesh-ancestor
19569063|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
19569064|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569065|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569066|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19569067|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19569068|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
19569069|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
19569070|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569071|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19569072|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19569073|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569074|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569075|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19569076|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19569077|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
19569078|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19569079|NCT05288023|Azithromycin|azithromycin|mesh-list
19569080|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19569081|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569082|NCT05278351|Irinotecan|irinotecan|mesh-list
19569083|NCT05278351|Cetuximab|cetuximab|mesh-list
19569084|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19569085|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19569086|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569087|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569088|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569089|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569090|NCT05268419|Ethanol|ethanol|mesh-list
19569091|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19569092|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569093|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569094|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569095|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19569096|NCT05267873|Vortioxetine|vortioxetine|mesh-list
19569097|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19569098|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19569099|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19569100|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569101|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024415|NCT04787354|Capecitabine|capecitabine|mesh-list
20024416|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
19569102|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569103|NCT05267873|Analgesics|analgesics|mesh-ancestor
20024417|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024418|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
20024419|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024420|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486514|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
19486515|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
19486516|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19486517|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486518|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486519|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19486520|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19486521|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486522|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486523|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486524|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19486525|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
19486526|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19486527|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486528|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19486529|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19486530|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19486531|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
19486532|NCT03155984|Antibodies|antibodies|mesh-list
19486533|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
19486534|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486535|NCT03155568|Bupivacaine|bupivacaine|mesh-list
19486536|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
19486537|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
19486538|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486539|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486540|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
19486541|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486542|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
19486543|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19486544|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486545|NCT03155477|Vitamins|vitamins|mesh-ancestor
19486546|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
19486547|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19486548|NCT03155646|Clonidine|clonidine|mesh-list
19486549|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
19486550|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
19486551|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19486552|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486553|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486554|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486555|NCT03155646|Analgesics|analgesics|mesh-ancestor
19486556|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
19486557|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486558|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19486559|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19486560|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19486561|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
19486562|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486563|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486564|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19486565|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
19486566|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
19486567|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
19486568|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
19486569|NCT03155087|Metformin|metformin|mesh-list
19486570|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19486571|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486572|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
19486573|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19486574|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
19486575|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486576|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486577|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19486578|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
19486579|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
19486580|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19486581|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
19486582|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486583|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486584|NCT03155048|Estradiol|estradiol|mesh-list
19486585|NCT03155048|Estrogens|estrogens|mesh-list
19486586|NCT03155048|Hormones|hormones|mesh-ancestor
19486587|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486588|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486589|NCT03154827|Atezolizumab|atezolizumab|mesh-list
19486590|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486591|NCT03155035|Vitamin D|vitamin d|mesh-list
19486592|NCT03155035|Albendazole|albendazole|mesh-list
19486593|NCT03155035|Calcium|calcium|mesh-list
19486594|NCT03155035|Vitamins|vitamins|mesh-ancestor
19486595|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
19486596|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486597|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19486598|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19486599|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
19486600|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19486601|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486602|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
19486603|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19486604|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19486605|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
19486606|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
19486607|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
19486608|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486609|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486610|NCT03154814|Urinastatin|urinastatin|mesh-list
19486611|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19486612|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19486613|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
19486614|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486615|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486616|NCT03154723|Vitamin A|vitamin a|mesh-list
19486617|NCT03154723|Vitamins|vitamins|mesh-ancestor
19486618|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
19486619|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486620|NCT03154918|Gemcitabine|gemcitabine|mesh-list
19486621|NCT03154918|Dexamethasone|dexamethasone|mesh-list
19486622|NCT03154918|Etoposide|etoposide|mesh-list
19486623|NCT03154918|Ifosfamide|ifosfamide|mesh-list
19486624|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486625|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
19486626|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
19486627|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486628|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486629|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19486630|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
19486631|NCT03154918|Hormones|hormones|mesh-ancestor
19486632|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486633|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19486634|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486635|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486636|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486637|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19486638|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
19486639|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
19486640|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486641|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19486642|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
19486643|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19486644|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19486645|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19486646|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19486647|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
19486648|NCT03154983|Docetaxel|docetaxel|mesh-list
19486649|NCT03154983|Apatinib|apatinib|mesh-list
19486650|NCT03154983|Tegafur|tegafur|mesh-list
19486651|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486652|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
19486653|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
19486654|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
19486655|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486656|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19486657|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486658|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19486659|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
19486660|NCT03154567|Yohimbine|yohimbine|mesh-list
19486661|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
19486662|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
19486663|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486664|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486665|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19486666|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20024421|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
20024422|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20024423|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024424|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20024425|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024426|NCT04730206|Camostat|camostat|mesh-list
20024427|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
20024428|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024429|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024430|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20024431|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20024432|NCT04670679|Cetuximab|cetuximab|mesh-list
20024433|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024434|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024435|NCT04647916|Camptothecin|camptothecin|mesh-list
20024436|NCT04647916|Irinotecan|irinotecan|mesh-list
20024437|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
20024438|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
20024439|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024440|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20024441|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024442|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20024443|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20024444|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024445|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024446|NCT04631510|Gabapentin|gabapentin|mesh-list
20024447|NCT04631510|Analgesics|analgesics|mesh-ancestor
20024448|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
20024449|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024450|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024451|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
20024452|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20024453|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20024454|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024455|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20024456|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20024457|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20024458|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024459|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024460|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
20024461|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
20024462|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
20024463|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024464|NCT04603898|Protective Agents|protective agents|mesh-ancestor
20024465|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024466|NCT04603898|Vitamins|vitamins|mesh-ancestor
20024467|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
20024468|NCT04590664|Verteporfin|verteporfin|mesh-list
20024469|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20024470|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
20024471|NCT04571619|Buprenorphine|buprenorphine|mesh-list
20024472|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20024473|NCT04571619|Narcotics|narcotics|mesh-ancestor
20024474|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024475|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024476|NCT04571619|Analgesics|analgesics|mesh-ancestor
20024477|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
20024478|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024479|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20024480|NCT04563923|Avdoralimab|avdoralimab|mesh-list
20024481|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024482|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
20024483|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024484|NCT04555577|Temozolomide|temozolomide|mesh-list
20024485|NCT04555577|Peposertib|peposertib|mesh-list
19486667|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19486668|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024486|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20024487|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
20024488|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486669|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486670|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486671|NCT03154567|Urological Agents|urological agents|mesh-ancestor
19486672|NCT03154645|Ibuprofen|ibuprofen|mesh-list
19486673|NCT03154645|Acetazolamide|acetazolamide|mesh-list
19486674|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19486675|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486676|NCT03154645|Analgesics|analgesics|mesh-ancestor
19486677|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
19744077|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744078|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744079|NCT03314181|Dexamethasone|dexamethasone|mesh-list
19744080|NCT03314181|Bortezomib|bortezomib|mesh-list
19744081|NCT03314181|Venetoclax|venetoclax|mesh-list
19744082|NCT03314181|Daratumumab|daratumumab|mesh-list
19744083|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744084|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
19744085|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
19744086|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744087|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744088|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744089|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
19744090|NCT03314181|Hormones|hormones|mesh-ancestor
19744091|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744092|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744093|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744094|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
19744095|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744096|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744097|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19744098|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
19744099|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19744100|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744101|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744102|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744103|NCT03301038|Rifampin|rifampin|mesh-list
19744104|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19744105|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
19744106|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19744107|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744108|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
19744109|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19744110|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744111|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744112|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19744113|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19744114|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19744115|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19744116|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19744117|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19744118|NCT03283605|Durvalumab|durvalumab|mesh-list
19744119|NCT03283605|Tremelimumab|tremelimumab|mesh-list
19744120|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744121|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744122|NCT03270020|Denosumab|denosumab|mesh-list
19744123|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19744124|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744125|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
19744126|NCT03266783|Apixaban|apixaban|mesh-list
19744127|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19744128|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
19744129|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19744130|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
19744131|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744132|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744133|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
19744134|NCT03253679|Adavosertib|adavosertib|mesh-list
19744135|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744136|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744137|NCT03233633|Cannabidiol|cannabidiol|mesh-list
19744138|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
19744139|NCT03218683|Venetoclax|venetoclax|mesh-list
19744140|NCT03218683|AZD5991|azd5991|mesh-list
20024489|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744141|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744142|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
19486678|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486679|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486680|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486681|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486682|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19486683|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486684|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486685|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
19486686|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19486687|NCT03154645|Diuretics|diuretics|mesh-ancestor
19486688|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
19486689|NCT03154385|Rituximab|rituximab|mesh-list
19486690|NCT03154385|Belimumab|belimumab|mesh-list
19486691|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19486692|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486693|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
19486694|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486695|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486696|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19486697|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
19486698|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
19486699|NCT03154528|Vitamin D|vitamin d|mesh-list
19486700|NCT03154528|Vitamins|vitamins|mesh-ancestor
19486701|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
19486702|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486703|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19569104|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
19569105|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569106|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
19569107|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19569108|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
19569109|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19569110|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19569111|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569112|NCT05267873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19569113|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
19569114|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19569115|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19569116|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19569117|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19569118|NCT05251233|Pantoprazole|pantoprazole|mesh-list
19569119|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19569120|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19569121|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19569122|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569123|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569124|NCT05249959|Rituximab|rituximab|mesh-list
19569125|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19569126|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19569127|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569128|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569129|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
19569130|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569131|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569132|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19569133|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
19569134|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569135|NCT05247320|Sotalol|sotalol|mesh-list
19569136|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19569137|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19569138|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
19569139|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569140|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569141|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569142|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19569143|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
19569144|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
20024490|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20024491|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024492|NCT04542434|Niclosamide|niclosamide|mesh-list
20024493|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
19569145|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569146|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
19569147|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024494|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20024495|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
20024496|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20024497|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024498|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
20024499|NCT04526795|Cytarabine|cytarabine|mesh-list
20024500|NCT04526795|Fludarabine|fludarabine|mesh-list
20024501|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024502|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024503|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
20024504|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024505|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024506|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
20024507|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024508|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
20024509|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024510|NCT04516057|Nabilone|nabilone|mesh-list
20024511|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
20576421|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
19486704|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
19486705|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
19486706|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486707|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19486708|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19486709|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19486710|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19486711|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486712|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
19486713|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486714|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486715|NCT03154372|Metronidazole|metronidazole|mesh-list
19486716|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486717|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486718|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19486719|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19486720|NCT03154294|Paclitaxel|paclitaxel|mesh-list
19486721|NCT03154294|Serabelisib|serabelisib|mesh-list
19486722|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19486723|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486724|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
19486725|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
19486726|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
19486727|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486728|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486729|NCT03154606|Calcium|calcium|mesh-list
19486730|NCT03154606|Caseins|caseins|mesh-list
19486731|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19486732|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486733|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
19486734|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
19486735|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486736|NCT03154281|Everolimus|everolimus|mesh-list
19486737|NCT03154281|Niraparib|niraparib|mesh-list
19486738|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486739|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19486740|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
19486741|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486742|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19486743|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486744|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486745|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19486746|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
19486747|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19486748|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19486749|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19486750|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
19486751|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19486752|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486753|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19486754|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19486755|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19486756|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19486757|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024512|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
20024513|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486758|NCT03153852|Glycolic acid|glycolic acid|mesh-list
19486759|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
19486760|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486761|NCT03153813|Capsaicin|capsaicin|mesh-list
19486762|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
20024514|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024515|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20024516|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19486763|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486764|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
19486765|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486766|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486767|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
19486768|NCT03153917|Melatonin|melatonin|mesh-list
19486769|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
19486770|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486771|NCT03153917|Protective Agents|protective agents|mesh-ancestor
19486772|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486773|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486774|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486775|NCT03153657|Piroxicam|piroxicam|mesh-list
19486776|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
19486777|NCT03153657|Betadex|betadex|mesh-list
19486778|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19486779|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486780|NCT03153657|Analgesics|analgesics|mesh-ancestor
19486781|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
19486782|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486783|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486784|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486785|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486786|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19486787|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486788|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486789|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
19486790|NCT03153267|Doxycycline|doxycycline|mesh-list
19486791|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19486792|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486793|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
19486794|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19486795|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19486796|NCT03153436|Inositol|inositol|mesh-list
19486797|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
19486798|NCT03153436|Vitamins|vitamins|mesh-ancestor
19486799|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
19486800|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486801|NCT03152942|Aminophylline|aminophylline|mesh-list
19486802|NCT03152942|Progesterone|progesterone|mesh-list
19486803|NCT03152942|Progestins|progestins|mesh-ancestor
19486804|NCT03152942|Hormones|hormones|mesh-ancestor
19486805|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486806|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486807|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19486808|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
19486809|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486810|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19486811|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
19486812|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19486813|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19486814|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486815|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486816|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19486817|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19486818|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
19486819|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486820|NCT03152942|Protective Agents|protective agents|mesh-ancestor
19486821|NCT03153072|Amiodarone|amiodarone|mesh-list
19486822|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19486823|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
19486824|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20024517|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20024518|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486825|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19486826|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486827|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19486828|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19486829|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19486830|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486831|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19486832|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19486833|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19486834|NCT03152981|Remifentanil|remifentanil|mesh-list
20576422|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576423|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
20576424|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576425|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576426|NCT02071368|Metformin|metformin|mesh-list
20576427|NCT02071368|Canagliflozin|canagliflozin|mesh-list
20576428|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20576429|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576430|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20576431|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576432|NCT02071394|Xenon|xenon|mesh-list
20576433|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20576434|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
20576435|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
20576436|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576437|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576438|NCT02071407|Midazolam|midazolam|mesh-list
20576439|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20576440|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20576441|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576442|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576443|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20576444|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20576445|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20576446|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20576447|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
20576448|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
20576449|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
20576450|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
20576451|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576452|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576453|NCT02071433|Iodine|iodine|mesh-list
20024519|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20024520|NCT04477733|Butorphanol|butorphanol|mesh-list
20024521|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20024522|NCT04477733|Narcotics|narcotics|mesh-ancestor
20024523|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024524|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024525|NCT04477733|Analgesics|analgesics|mesh-ancestor
20024526|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
20024527|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024528|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
20024529|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
20024530|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20024531|NCT04436731|Phentolamine|phentolamine|mesh-list
20024532|NCT04436731|Phenylephrine|phenylephrine|mesh-list
20024533|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
20024534|NCT04436731|Norepinephrine|norepinephrine|mesh-list
20024535|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
20024536|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20024537|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024538|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024539|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20024540|NCT04436731|Analgesics|analgesics|mesh-ancestor
20024541|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
20024542|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024543|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20024544|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20024545|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20024546|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024547|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024548|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024549|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20024550|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
20024551|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
20576454|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20576455|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024552|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
20576456|NCT02071433|Trace Elements|trace elements|mesh-ancestor
20024553|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19486835|NCT03152981|Propofol|propofol|mesh-list
19486836|NCT03152981|Desflurane|desflurane|mesh-list
19486837|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19486838|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486839|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486840|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19486841|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
19486842|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
19486843|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19486844|NCT03152981|Narcotics|narcotics|mesh-ancestor
19486845|NCT03152981|Analgesics|analgesics|mesh-ancestor
19486846|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
19486847|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486848|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19486849|NCT03153163|Trastuzumab|trastuzumab|mesh-list
19486850|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19486851|NCT03153163|Maytansine|maytansine|mesh-list
19486852|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19486853|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486854|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19486855|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19486856|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19486857|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19486858|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486859|NCT03153085|Ipilimumab|ipilimumab|mesh-list
19486860|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19486861|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486862|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19486863|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486864|NCT03153137|Macitentan|macitentan|mesh-list
19486865|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19486866|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19486867|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486868|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19486869|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
19486870|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19486871|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486872|NCT03152955|Sufentanil|sufentanil|mesh-list
19486873|NCT03152955|Ketamine|ketamine|mesh-list
19486874|NCT03152955|Ondansetron|ondansetron|mesh-list
19486875|NCT03152955|Analgesics|analgesics|mesh-ancestor
19486876|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
19486877|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486878|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486879|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19486880|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19486881|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
19486882|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
19486883|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486884|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19486885|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19486886|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19486887|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486888|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
19486889|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
19486890|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19486891|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
19486892|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486893|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19486894|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
19486895|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19486896|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19486897|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19486898|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19486899|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19486900|NCT03152955|Narcotics|narcotics|mesh-ancestor
19486901|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19486902|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
19486903|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19486904|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
19486905|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024554|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
20024555|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
19486906|NCT03152565|Avelumab|avelumab|mesh-list
19749147|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
19569148|NCT05244538|Remifentanil|remifentanil|mesh-list
19486907|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19486908|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486909|NCT03152890|Insulin|insulin|mesh-list
19486910|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19486911|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486912|NCT03152578|Capsaicin|capsaicin|mesh-list
19486913|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
19486914|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486915|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
19486916|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486917|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569149|NCT05244538|Propofol|propofol|mesh-list
19569150|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19569151|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569152|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569153|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19569154|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
19569155|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
19569156|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19569157|NCT05244538|Narcotics|narcotics|mesh-ancestor
19569158|NCT05244538|Analgesics|analgesics|mesh-ancestor
19569159|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
19569160|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569161|NCT05229445|Insulin|insulin|mesh-list
19569162|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19569163|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569164|NCT05208307|Dexamethasone|dexamethasone|mesh-list
19569165|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
19569166|NCT05208307|Pomalidomide|pomalidomide|mesh-list
19569167|NCT05208307|Ichthammol|ichthammol|mesh-list
19569168|NCT05208307|BB 1101|bb 1101|mesh-list
19569169|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569170|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
19569171|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
19569172|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569173|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569174|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19569175|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
19569176|NCT05208307|Hormones|hormones|mesh-ancestor
19569177|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20024556|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20024557|NCT04436731|Protective Agents|protective agents|mesh-ancestor
20024558|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20024559|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20024560|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20024561|NCT04436458|Niclosamide|niclosamide|mesh-list
20024562|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
20024563|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20024564|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
20024565|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20024566|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569178|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19569179|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569180|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
19569181|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569182|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569183|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
19569184|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19569185|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19569186|NCT05208307|Growth Substances|growth substances|mesh-ancestor
19569187|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
19569188|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
19569189|NCT05198791|Eplerenone|eplerenone|mesh-list
19569190|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19569191|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
19569192|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569193|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569194|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19569195|NCT05198791|Diuretics|diuretics|mesh-ancestor
19569196|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
19569197|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19569198|NCT05193071|Aspirin|aspirin|mesh-list
20024567|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
19569199|NCT05193071|Clopidogrel|clopidogrel|mesh-list
19569200|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569201|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569202|NCT05193071|Analgesics|analgesics|mesh-ancestor
19486918|NCT03152877|Bupivacaine|bupivacaine|mesh-list
19486919|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
19486920|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
19486921|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19486922|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486923|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
19486924|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486925|NCT03152370|Leucovorin|leucovorin|mesh-list
19486926|NCT03152370|Folic Acid|folic acid|mesh-list
19486927|NCT03152370|Capecitabine|capecitabine|mesh-list
19486928|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
19486929|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
19486930|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19486931|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
19486932|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486933|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486934|NCT03152370|Antidotes|antidotes|mesh-ancestor
19486935|NCT03152370|Protective Agents|protective agents|mesh-ancestor
19486936|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486937|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
19486938|NCT03152370|Vitamins|vitamins|mesh-ancestor
19486939|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
19486940|NCT03152370|Hematinics|hematinics|mesh-ancestor
19486941|NCT03152409|Aspirin|aspirin|mesh-list
19486942|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
19486943|NCT03152409|Salicylates|salicylates|mesh-list
19486944|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19486945|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19486946|NCT03152409|Analgesics|analgesics|mesh-ancestor
19486947|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
19486948|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486949|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486950|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486951|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486952|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19486953|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19486954|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486955|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19486956|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19486957|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19486958|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
19486959|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19486960|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
19486961|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
19486962|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
19486963|NCT03152474|Vitamin A|vitamin a|mesh-list
19486964|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
19486965|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19486966|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19486967|NCT03152474|Prednisolone|prednisolone|mesh-list
19486968|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
19486969|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19486970|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
19486971|NCT03152474|Vitamins|vitamins|mesh-ancestor
19486972|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
19486973|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486974|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19486975|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
19486976|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
19486977|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19486978|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19486979|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
19486980|NCT03152474|Hormones|hormones|mesh-ancestor
19486981|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19486982|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19486983|NCT03152474|Protective Agents|protective agents|mesh-ancestor
19486984|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19486985|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486986|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
19486987|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19486988|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
19486989|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19486990|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19486991|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19486992|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
19486993|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19486994|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19486995|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19486996|NCT03152175|Propranolol|propranolol|mesh-list
19486997|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19486998|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19486999|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487000|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487001|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487002|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487003|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19487004|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19487005|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
19487006|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
19487007|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19487008|NCT03152097|Protective Agents|protective agents|mesh-ancestor
19487009|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487010|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487011|NCT03152149|Fluticasone|fluticasone|mesh-list
19487012|NCT03152149|Xhance|xhance|mesh-list
19487013|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
19487014|NCT03152149|Olodaterol|olodaterol|mesh-list
19487015|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19487016|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19487017|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
19487018|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487019|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487020|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19487021|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
19487022|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
19487023|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19487024|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
19487025|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19487026|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
19487027|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487028|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487029|NCT03152123|Phentermine|phentermine|mesh-list
19487030|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19487031|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487032|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
19487033|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19487034|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
19487035|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
19487036|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487037|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487038|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487039|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487040|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
19487041|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
19487042|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19487043|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487044|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487045|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19487046|NCT03151863|Analgesics|analgesics|mesh-ancestor
19487047|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
19487048|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487049|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19487050|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19487051|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19487052|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024568|NCT04428385|Artemisinins|artemisinins|mesh-list
20024569|NCT04428385|Artemisinin|artemisinin|mesh-list
20024570|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
20024571|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20024572|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20024573|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024574|NCT04404088|Rituximab|rituximab|mesh-list
20024575|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20024576|NCT04404088|Lenalidomide|lenalidomide|mesh-list
20024577|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
20024578|NCT04404088|Antibodies|antibodies|mesh-list
20024579|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
20024580|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20024581|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
20024582|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024583|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024584|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487053|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024585|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20024586|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19487054|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487055|NCT03151863|Narcotics|narcotics|mesh-ancestor
19487056|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19487057|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19487058|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19487059|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487060|NCT03151772|Metformin|metformin|mesh-list
19487061|NCT03151772|Disulfiram|disulfiram|mesh-list
19487062|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19487063|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487064|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19487065|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20292904|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292905|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20292906|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292907|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024587|NCT04404088|Growth Substances|growth substances|mesh-ancestor
20024588|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
20024589|NCT04339101|Sirolimus|sirolimus|mesh-list
20024590|NCT04339101|Fludarabine|fludarabine|mesh-list
19487066|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292908|NCT04973891|Metformin|metformin|mesh-list
20292909|NCT04973891|Canagliflozin|canagliflozin|mesh-list
20292910|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20292911|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487067|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487068|NCT03151876|Gemcitabine|gemcitabine|mesh-list
19487069|NCT03151876|Busulfan|busulfan|mesh-list
19487070|NCT03151876|Cladribine|cladribine|mesh-list
19487071|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19487072|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
19487073|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487074|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487075|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
19487076|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487077|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487078|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19487079|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
19487080|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487081|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
19487082|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19487083|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19487084|NCT03151720|Loratadine|loratadine|mesh-list
19487085|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
19487086|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
19487087|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19487088|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19487089|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19487090|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
19487091|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
19487092|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487093|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487094|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487095|NCT03151681|Propranolol|propranolol|mesh-list
19487096|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19487097|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19487098|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487099|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487100|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487101|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487102|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19487103|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19487104|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
19487105|NCT03151707|Niacinamide|niacinamide|mesh-list
19487106|NCT03151707|Niacin|niacin|mesh-list
19487107|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
19487108|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
19487109|NCT03151707|Vitamins|vitamins|mesh-ancestor
19487110|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
19487111|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292912|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19487112|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19487113|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
20024591|NCT04339101|Melphalan|melphalan|mesh-list
19487114|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024592|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
19487115|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19487116|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
19487117|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
19487118|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19487119|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487120|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487121|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19487122|NCT03151668|Analgesics|analgesics|mesh-ancestor
19487123|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
19487124|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487125|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19487126|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19487127|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19487128|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487129|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487130|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487131|NCT03151525|Azathioprine|azathioprine|mesh-list
19487132|NCT03151525|Infliximab|infliximab|mesh-list
19487133|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
19487134|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487135|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487136|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
19487137|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487138|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19487139|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487140|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19487141|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
19487142|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487143|NCT03151499|Rifampin|rifampin|mesh-list
19487144|NCT03151499|BI 409306|bi 409306|mesh-list
19487145|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19487146|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
19487147|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487148|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487149|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
19487150|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19487151|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487152|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487153|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19487154|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19487155|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19487156|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19487157|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19487158|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19487159|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19487160|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19487161|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
19487162|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487163|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487164|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487165|NCT03151460|Dopamine|dopamine|mesh-list
19487166|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
19487167|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19487168|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
19487169|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
19487170|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487171|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487172|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487173|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487174|NCT03151460|Protective Agents|protective agents|mesh-ancestor
19487175|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
19487176|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
19487177|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19487178|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19487179|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
19487180|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487181|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487182|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487183|NCT03151603|Fosfomycin|fosfomycin|mesh-list
19487184|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487185|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487186|NCT03151343|Empagliflozin|empagliflozin|mesh-list
19569203|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
19487187|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19487188|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487189|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19487190|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487191|NCT03151369|Morphine|morphine|mesh-list
19487192|NCT03151369|Analgesics|analgesics|mesh-list
19487193|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19487194|NCT03151369|Narcotics|narcotics|mesh-ancestor
19487195|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487196|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487197|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
19487198|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487199|NCT03151213|Pregabalin|pregabalin|mesh-list
19487200|NCT03151213|Analgesics|analgesics|mesh-ancestor
19487201|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
19487202|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487203|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487204|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
19487205|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19487206|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19487207|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487208|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19487209|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19487210|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19487211|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487212|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19487213|NCT03151382|Tandospirone|tandospirone|mesh-list
19487214|NCT03151382|Donepezil|donepezil|mesh-list
19487215|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487216|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19487217|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487218|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
19487219|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487220|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487221|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
19487222|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19487223|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19487224|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487225|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19487226|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19487227|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
19487228|NCT03151174|Vitamin D|vitamin d|mesh-list
19487229|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
19487230|NCT03151174|Vitamins|vitamins|mesh-list
19487231|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
19487232|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487233|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19487234|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19487235|NCT03151044|Rituximab|rituximab|mesh-list
19487236|NCT03151044|Epirubicin|epirubicin|mesh-list
19487237|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487238|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487239|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
19487240|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487241|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487242|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19487243|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19487244|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19487245|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487246|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487247|NCT03151161|Carboplatin|carboplatin|mesh-list
19487248|NCT03151161|Pemetrexed|pemetrexed|mesh-list
19487249|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487250|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487251|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487252|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19487253|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19487254|NCT03151096|Riboflavin|riboflavin|mesh-list
19487255|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
19487256|NCT03151096|Vitamins|vitamins|mesh-ancestor
19487257|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
19487258|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487259|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19487260|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
19569204|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487261|NCT03151005|Metformin|metformin|mesh-list
19487262|NCT03151005|Liraglutide|liraglutide|mesh-list
19487263|NCT03151005|Exenatide|exenatide|mesh-list
19487264|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
19487265|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
19487266|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19487267|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487268|NCT03151005|Incretins|incretins|mesh-ancestor
19487269|NCT03151005|Hormones|hormones|mesh-ancestor
19487270|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19487271|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19487272|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19487273|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19487274|NCT03151239|Niacinamide|niacinamide|mesh-list
19487275|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
19487276|NCT03151239|Vitamins|vitamins|mesh-ancestor
19487277|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
19487278|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487279|NCT03150680|Clopidogrel|clopidogrel|mesh-list
19487280|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19487281|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19487282|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19487283|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19487284|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
19487285|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487286|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487287|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487288|NCT03150706|Avelumab|avelumab|mesh-list
19487289|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024593|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20024594|NCT04339101|Tacrolimus|tacrolimus|mesh-list
20024595|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024596|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024597|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292913|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292914|NCT04967664|Capsaicin|capsaicin|mesh-list
20292915|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
20292916|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
20292917|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
20024598|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
20024599|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024600|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20024601|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024602|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20024603|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024604|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20024605|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
20024606|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20024607|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
20024608|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20024609|NCT04336098|Gemcitabine|gemcitabine|mesh-list
20024610|NCT04336098|Paclitaxel|paclitaxel|mesh-list
20024611|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
20024612|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20024613|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20024614|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024615|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
20024616|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
20024617|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024618|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024619|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024620|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
20024621|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
20024622|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024623|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024624|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024625|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
20024626|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024627|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024628|NCT04329728|Dexamethasone|dexamethasone|mesh-list
20024629|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20024630|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576457|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
19487290|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487291|NCT03150771|Aripiprazole|aripiprazole|mesh-list
19487292|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
19487293|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19487294|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19487295|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19487296|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024631|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
20024632|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
20024633|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024634|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024635|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20024636|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
20024637|NCT04329728|Hormones|hormones|mesh-ancestor
20024638|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19487297|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487298|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
19487299|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
19487300|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487301|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487302|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19487303|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19487304|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
19487305|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19487306|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19487307|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19487308|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19487309|NCT03150576|Paclitaxel|paclitaxel|mesh-list
19487310|NCT03150576|Carboplatin|carboplatin|mesh-list
19487311|NCT03150576|Olaparib|olaparib|mesh-list
19487312|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744143|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744144|NCT03199040|Durvalumab|durvalumab|mesh-list
19744145|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744146|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749148|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749149|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749150|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19749151|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19749152|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
19749153|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749154|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749155|NCT05250973|Dexamethasone|dexamethasone|mesh-list
19749156|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
19749157|NCT05250973|Bortezomib|bortezomib|mesh-list
19749158|NCT05250973|Daratumumab|daratumumab|mesh-list
20292918|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292919|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292920|NCT04966546|Memantine|memantine|mesh-list
19749159|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749160|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
19749161|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749162|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749163|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19749164|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
19749165|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749166|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749167|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19749168|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749169|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
19749170|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
19749171|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749172|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19749173|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
20292921|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19487313|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487314|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
19487315|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
19487316|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
19487317|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487318|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19487319|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487320|NCT03150667|Clopidogrel|clopidogrel|mesh-list
19487321|NCT03150667|Ticagrelor|ticagrelor|mesh-list
19487322|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19487323|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19487324|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19487325|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19487326|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
19487327|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487328|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487329|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487330|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
19487331|NCT03150836|Durvalumab|durvalumab|mesh-list
19487332|NCT03150836|Tremelimumab|tremelimumab|mesh-list
19487333|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487334|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487335|NCT03150316|Dexamethasone|dexamethasone|mesh-list
19487336|NCT03150316|Lenalidomide|lenalidomide|mesh-list
19487337|NCT03150316|CKD-581|ckd-581|mesh-list
19487338|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19487339|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
19487340|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
19487341|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487342|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487343|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487344|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
19487345|NCT03150316|Hormones|hormones|mesh-ancestor
19487346|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19487347|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19487348|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487349|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487350|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487351|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
19487352|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19487353|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19487354|NCT03150316|Growth Substances|growth substances|mesh-ancestor
19487355|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
19487356|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19487357|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19487358|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19487359|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487360|NCT03150459|Rifaximin|rifaximin|mesh-list
19487361|NCT03150459|Simvastatin|simvastatin|mesh-list
19487362|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19487363|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19487364|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
19487365|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487366|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19487367|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19487368|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487369|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487370|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487371|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487372|NCT03150524|Verapamil|verapamil|mesh-list
19487373|NCT03150524|Nimodipine|nimodipine|mesh-list
19487374|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19487375|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19487376|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19487377|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487378|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19487379|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487380|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
19487381|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19487382|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
19487383|NCT03150420|Antidotes|antidotes|mesh-ancestor
19487384|NCT03150420|Protective Agents|protective agents|mesh-ancestor
19487385|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487386|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
19487387|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487388|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
19487389|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487390|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487391|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
19487392|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
19487393|NCT03150134|Cyclosporine|cyclosporine|mesh-list
19487394|NCT03150134|Cyclosporins|cyclosporins|mesh-list
19487395|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19487396|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487397|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487398|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
19487399|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487400|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
19487401|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487402|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
19487403|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487404|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19487405|NCT03149939|Febuxostat|febuxostat|mesh-list
19487406|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
19487407|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487408|NCT03149913|Paclitaxel|paclitaxel|mesh-list
19487409|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19487410|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487411|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
19487412|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
19487413|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
19487414|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487415|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19487416|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487417|NCT03149783|Ropivacaine|ropivacaine|mesh-list
19487418|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
19487419|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
19487420|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20292922|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20292923|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
20292924|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292925|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292926|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576458|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487421|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487422|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
19487423|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487424|NCT03149653|SMOFlipid|smoflipid|mesh-list
19487425|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19487426|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19487427|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19487428|NCT03149432|Gabapentin|gabapentin|mesh-list
19487429|NCT03149432|Analgesics|analgesics|mesh-ancestor
19487430|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
19487431|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487432|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487433|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
19487434|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19487435|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19487436|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487437|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19487438|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19487439|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19487440|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487441|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487442|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
19487443|NCT03149419|Paroxetine|paroxetine|mesh-list
19487444|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19487445|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19487446|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19487447|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487448|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487449|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
19487450|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487451|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20292927|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20576459|NCT02071459|Droxidopa|droxidopa|mesh-list
20576460|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19487452|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
19487453|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19487454|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19487455|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19487456|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487457|NCT03149588|Propofol|propofol|mesh-list
19487458|NCT03149588|Sevoflurane|sevoflurane|mesh-list
19487459|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19487460|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487461|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487462|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19487463|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
19487464|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
19487465|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19487466|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19487467|NCT03149640|Amikacin|amikacin|mesh-list
19487468|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487469|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487470|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
19487471|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19487472|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
19487473|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487474|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487475|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19487476|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
19487477|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487478|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487479|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19487480|NCT03149575|Carboplatin|carboplatin|mesh-list
19487481|NCT03149575|Temozolomide|temozolomide|mesh-list
19487482|NCT03149575|Lomustine|lomustine|mesh-list
19487483|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
19487484|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487485|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19487486|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
19487487|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487488|NCT03149445|Metoprolol|metoprolol|mesh-list
19487489|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19487490|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19487491|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
19487492|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
19487493|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487494|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487495|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19487496|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19487497|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20024639|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20024640|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024641|NCT04321954|Lenvatinib|lenvatinib|mesh-list
20024642|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024643|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20024644|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024645|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024646|NCT04283656|Tenofovir|tenofovir|mesh-list
19487498|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487499|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487500|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487501|NCT03149393|Mosapride|mosapride|mesh-list
19487502|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487503|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20024647|NCT04283656|Lamivudine|lamivudine|mesh-list
20024648|NCT04283656|Spironolactone|spironolactone|mesh-list
20024649|NCT04283656|Estradiol|estradiol|mesh-list
19487504|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19487505|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
19487506|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487507|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487508|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
19487509|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569205|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569206|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569207|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569208|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20024650|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
20024651|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487510|NCT03148990|Vaccines|vaccines|mesh-list
19487511|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
19487512|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487513|NCT03149159|Nivolumab|nivolumab|mesh-list
19487514|NCT03149159|Ipilimumab|ipilimumab|mesh-list
19487515|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487516|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487517|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19487518|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487519|NCT03149120|Nivolumab|nivolumab|mesh-list
19487520|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487521|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487522|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19487523|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487524|NCT03149250|Hemostatics|hemostatics|mesh-list
19487525|NCT03149250|Coagulants|coagulants|mesh-ancestor
19487526|NCT03148717|Misoprostol|misoprostol|mesh-list
19487527|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19487528|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
19487529|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19487530|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487531|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19487532|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487533|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
19487534|NCT03148704|Palonosetron|palonosetron|mesh-list
19487535|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
19487536|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
19487537|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487538|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487539|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487540|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19487541|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19487542|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
19487543|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487544|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487545|NCT03148561|Misoprostol|misoprostol|mesh-list
19487546|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19487547|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
19487548|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19487549|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487550|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19487551|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487552|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
19487553|NCT03148574|Misoprostol|misoprostol|mesh-list
19487554|NCT03148574|Oxytocin|oxytocin|mesh-list
19487555|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
19487556|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19487557|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487558|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19487559|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
19487560|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19487561|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487562|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
19487563|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
20024652|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20024653|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20024654|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024655|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024656|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20024657|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20024658|NCT04283656|Estrogens|estrogens|mesh-ancestor
20024659|NCT04283656|Hormones|hormones|mesh-ancestor
20024660|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20024661|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024662|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20024663|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
20024664|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20024665|NCT04283656|Diuretics|diuretics|mesh-ancestor
20024666|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
20024667|NCT04250805|Lidocaine|lidocaine|mesh-list
20024668|NCT04250805|Ropivacaine|ropivacaine|mesh-list
20024669|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
20024670|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
19487564|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19744147|NCT03187509|Torsemide|torsemide|mesh-list
20024671|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487565|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487566|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487567|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
19487568|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19487569|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487570|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487571|NCT03148509|Risperidone|risperidone|mesh-list
19487572|NCT03148509|Aripiprazole|aripiprazole|mesh-list
19487573|NCT03148509|Bupropion|bupropion|mesh-list
19487574|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19487575|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
19487576|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487577|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487578|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487579|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19487580|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19487581|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487582|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19487583|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19487584|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
19487585|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19487586|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
19487587|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19487588|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19487589|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19487590|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19487591|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20024672|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024673|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
20024674|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024675|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20024676|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20024677|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19487592|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487593|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
19487594|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19487595|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19487596|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19487597|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19487598|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19487599|NCT03148522|Mirtazapine|mirtazapine|mesh-list
19487600|NCT03148522|Citalopram|citalopram|mesh-list
20024678|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024679|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487601|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19487602|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19487603|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19487604|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487605|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487606|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
19487607|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487608|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19487609|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
19487610|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19487611|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487612|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19487613|NCT03148522|Analgesics|analgesics|mesh-ancestor
19487614|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
19487615|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
19487616|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19487617|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
19487618|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
19487619|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19487620|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19487621|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487622|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19487623|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19487624|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19487625|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487626|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19487627|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19487628|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19487629|NCT03148444|Cephalexin|cephalexin|mesh-list
19487630|NCT03148444|Roxithromycin|roxithromycin|mesh-list
19487631|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487632|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487633|NCT03148366|Levofloxacin|levofloxacin|mesh-list
19487634|NCT03148366|Ofloxacin|ofloxacin|mesh-list
19487635|NCT03148366|Bismuth|bismuth|mesh-list
19487636|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19487637|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487638|NCT03148366|Renal Agents|renal agents|mesh-ancestor
19487639|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487640|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19487641|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20024680|NCT04242173|Cemiplimab|cemiplimab|mesh-list
20024681|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024682|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024683|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
20024684|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20024685|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20024686|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
20024687|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
20024688|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024689|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487642|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487643|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487644|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487645|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19487646|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19487647|NCT03148366|Antacids|antacids|mesh-ancestor
19487648|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487649|NCT03148132|Bevacizumab|bevacizumab|mesh-list
19487650|NCT03148132|Ranibizumab|ranibizumab|mesh-list
19487651|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487652|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487653|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19487654|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19487655|NCT03148132|Growth Substances|growth substances|mesh-ancestor
19487656|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487657|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
19487658|NCT03148314|Misoprostol|misoprostol|mesh-list
19487659|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19487660|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
19487661|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19487662|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487663|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19487664|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487665|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
19487666|NCT03148288|Vitamin D|vitamin d|mesh-list
19487667|NCT03148288|Vitamins|vitamins|mesh-ancestor
19487668|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
19487669|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487670|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19487671|NCT03148002|Lactulose|lactulose|mesh-list
19487672|NCT03148002|Sennosides|sennosides|mesh-list
19487673|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487674|NCT03148002|Laxatives|laxatives|mesh-ancestor
19487675|NCT03147963|Docetaxel|docetaxel|mesh-list
19487676|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487677|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
19487678|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
19487679|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
19487680|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024690|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
19487681|NCT03147638|Warfarin|warfarin|mesh-list
19487682|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
19744148|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19487683|NCT03147859|Vedolizumab|vedolizumab|mesh-list
19487684|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19569209|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19569210|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569211|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19569212|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19569213|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569214|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
19569215|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19569216|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19569217|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19569218|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
19569219|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569220|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
19569221|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
19569222|NCT05176470|Fludarabine|fludarabine|mesh-list
19569223|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19569224|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
19569225|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569226|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569227|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19569228|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
19569229|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569230|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569231|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19569232|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577719|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577720|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577721|NCT03983018|Rituximab|rituximab|mesh-list
19577722|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577723|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577724|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
19577725|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577726|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024691|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024692|NCT04218773|Phenylephrine|phenylephrine|mesh-list
20024693|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
20024694|NCT04218773|Norepinephrine|norepinephrine|mesh-list
20024695|NCT04218773|Synephrine|synephrine|mesh-list
20024696|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20024697|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
20024698|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
20024699|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577736|NCT03967847|Ketorolac|ketorolac|mesh-list
19577737|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19577738|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19577739|NCT03967847|Analgesics|analgesics|mesh-ancestor
19577740|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
19577741|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577742|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577743|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577744|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577745|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19577746|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577747|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577748|NCT03953898|Olaparib|olaparib|mesh-list
19577749|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19577750|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577751|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577752|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577753|NCT03944954|Dronabinol|dronabinol|mesh-list
19577754|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
19577755|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577756|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19577757|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19577758|NCT03944954|Analgesics|analgesics|mesh-ancestor
19577759|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
19577760|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577761|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19577762|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19577763|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577764|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024700|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577765|NCT03944954|Hormones|hormones|mesh-ancestor
20024701|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
19487685|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
19487686|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19487687|NCT03147677|Irbesartan|irbesartan|mesh-list
19487688|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19487689|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19487690|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19487691|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487692|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19487693|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487694|NCT03147677|Vitamins|vitamins|mesh-ancestor
19487695|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
19487696|NCT03147599|Mebeverine|mebeverine|mesh-list
19487697|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
19487698|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
19487699|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
19487700|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487701|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487702|NCT03147404|Avelumab|avelumab|mesh-list
19487703|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487704|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487705|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
19487706|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
19487707|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487708|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19487709|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
19487710|NCT03146962|Vitamins|vitamins|mesh-ancestor
19487711|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
19487712|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487713|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
19487714|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487715|NCT03146962|Protective Agents|protective agents|mesh-ancestor
19487716|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
19487717|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19487718|NCT03147066|Dezocine|dezocine|mesh-list
20024702|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20024703|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
20024704|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
20024705|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20024706|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20024707|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20024708|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487719|NCT03147066|Analgesics|analgesics|mesh-ancestor
19487720|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
19487721|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487722|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487723|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19487724|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19487725|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19487726|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487727|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19487728|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487729|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487730|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19487731|NCT03147066|Narcotics|narcotics|mesh-ancestor
19487732|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487733|NCT03147092|Losartan|losartan|mesh-list
19487734|NCT03147092|Atenolol|atenolol|mesh-list
19487735|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19487736|NCT03147092|Clonidine|clonidine|mesh-list
19487737|NCT03147092|Captopril|captopril|mesh-list
19487738|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19487739|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19487740|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19487741|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19487742|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487743|NCT03147092|Diuretics|diuretics|mesh-ancestor
19487744|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
19487745|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487746|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19487747|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19487748|NCT03147092|Analgesics|analgesics|mesh-ancestor
20024709|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20115490|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19487749|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
19487750|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487751|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
19487752|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
19487753|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19487754|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19487755|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19487756|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487757|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487758|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19487759|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19487760|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19487761|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19487762|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
19487763|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487764|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19487765|NCT03147196|Bicalutamide|bicalutamide|mesh-list
19487766|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
19487767|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
19487768|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19487769|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487770|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487771|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19487772|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19487773|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19487774|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19487775|NCT03146858|Enoxaparin|enoxaparin|mesh-list
19487776|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
19487777|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19487778|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19487779|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487780|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
19487781|NCT03146793|Antidotes|antidotes|mesh-ancestor
19487782|NCT03146793|Protective Agents|protective agents|mesh-ancestor
19487783|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487784|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
19487785|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487786|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
19487787|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487788|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487789|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
19487790|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
19487791|NCT03147157|Tacrolimus|tacrolimus|mesh-list
19487792|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19487793|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
19487794|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487795|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19487796|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487797|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487798|NCT03146871|Azacitidine|azacitidine|mesh-list
19487799|NCT03146871|Decitabine|decitabine|mesh-list
19487800|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19487801|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
19487802|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487803|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487804|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487805|NCT03146650|Nivolumab|nivolumab|mesh-list
19487806|NCT03146650|Ipilimumab|ipilimumab|mesh-list
19487807|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487808|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487809|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19487810|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487811|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
19487812|NCT03146533|Fludarabine|fludarabine|mesh-list
19487813|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19487814|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
19487815|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487816|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487817|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19487818|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
19487819|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487820|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487821|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19487822|NCT03146689|Ibuprofen|ibuprofen|mesh-list
19487823|NCT03146689|Capsaicin|capsaicin|mesh-list
19487824|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19487825|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19487826|NCT03146689|Analgesics|analgesics|mesh-ancestor
19487827|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
19487828|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487829|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487830|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19487831|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487832|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19487833|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487834|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487835|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
19487836|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
19487837|NCT03146481|Aceclofenac|aceclofenac|mesh-list
19487838|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19487839|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19487840|NCT03146481|Analgesics|analgesics|mesh-ancestor
19487841|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
19487842|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487843|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487844|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19487845|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487846|NCT03146468|Nivolumab|nivolumab|mesh-list
19487847|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487848|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487849|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19487850|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487851|NCT03146377|Capecitabine|capecitabine|mesh-list
19487852|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
19487853|NCT03146377|Irinotecan|irinotecan|mesh-list
19487854|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19487855|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
19487856|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487857|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487858|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19487859|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19487860|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487861|NCT03146390|Listerine|listerine|mesh-list
19487862|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
19487863|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19487864|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487865|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
19487866|NCT03146390|Protective Agents|protective agents|mesh-ancestor
19487867|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487868|NCT03146247|Apremilast|apremilast|mesh-list
19487869|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19487870|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20024710|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024711|NCT04218773|Protective Agents|protective agents|mesh-ancestor
20024712|NCT04201262|Ravulizumab|ravulizumab|mesh-list
20024713|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20024714|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024715|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
20024716|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024717|NCT04186286|Propranolol|propranolol|mesh-list
20024718|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20024719|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20024720|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
20024721|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024722|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024723|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024724|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20024725|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20024726|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
20024727|NCT04178460|Niraparib|niraparib|mesh-list
20024728|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20024729|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024730|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024731|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115491|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
20115492|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115493|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
20115494|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115495|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19487871|NCT03146247|Analgesics|analgesics|mesh-ancestor
19487872|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
20024732|NCT04055012|Metformin|metformin|mesh-list
19487873|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487874|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487875|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19487876|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487877|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19487878|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19487879|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487880|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487881|NCT03146000|Meloxicam|meloxicam|mesh-list
19487882|NCT03146000|Lidocaine|lidocaine|mesh-list
19487883|NCT03146000|Prilocaine|prilocaine|mesh-list
19487884|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19487885|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
19487886|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
19487887|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487888|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487889|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
19487890|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487891|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19487892|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19487893|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19487894|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19487895|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487896|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19487897|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20024733|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20024734|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024735|NCT04044560|Blinatumomab|blinatumomab|mesh-list
19487898|NCT03146000|Analgesics|analgesics|mesh-ancestor
19487899|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19487900|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19487901|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20024736|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487902|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19487903|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487904|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19487905|NCT03146325|Metronidazole|metronidazole|mesh-list
19487906|NCT03146325|Tetracycline|tetracycline|mesh-list
19487907|NCT03146325|Omeprazole|omeprazole|mesh-list
19487908|NCT03146325|Bismuth|bismuth|mesh-list
19487909|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487910|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19487911|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19487912|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19487913|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19487914|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487915|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19487916|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487917|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487918|NCT03146325|Antacids|antacids|mesh-ancestor
19487919|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19569233|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
19569234|NCT05167409|Cetuximab|cetuximab|mesh-list
19569235|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569236|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569237|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
19569238|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19569239|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19569240|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569241|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
19569242|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569243|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569244|NCT05156281|Teriflunomide|teriflunomide|mesh-list
19569245|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569246|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569247|NCT05156281|Analgesics|analgesics|mesh-ancestor
19569248|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
19569249|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569250|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569251|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569252|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569253|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744149|NCT03187509|Diuretics|diuretics|mesh-ancestor
20024737|NCT03990896|Talazoparib|talazoparib|mesh-list
19487920|NCT03146052|Simethicone|simethicone|mesh-list
19487921|NCT03146052|Bisacodyl|bisacodyl|mesh-list
19487922|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487923|NCT03146052|Cathartics|cathartics|mesh-ancestor
19487924|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19487925|NCT03146052|Laxatives|laxatives|mesh-ancestor
19487926|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
19487927|NCT03146052|Emollients|emollients|mesh-ancestor
19487928|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
19487929|NCT03145649|Insulin|insulin|mesh-list
19487930|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19487931|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487932|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
19487933|NCT03145714|Anesthetics|anesthetics|mesh-list
19487934|NCT03145714|Propofol|propofol|mesh-list
19487935|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487936|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487937|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19487938|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19487939|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
19487940|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20024738|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20024739|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024740|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024741|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024742|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
20024743|NCT03959566|Bedaquiline|bedaquiline|mesh-list
20024744|NCT03959566|Midazolam|midazolam|mesh-list
20024745|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20024746|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20024747|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024748|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024749|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20024750|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20024751|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20024752|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20024753|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
20024754|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
20024755|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
19487941|NCT03145714|Analgesics|analgesics|mesh-ancestor
19487942|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
19487943|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19487944|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19487945|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19487946|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19487947|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
19487948|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19487949|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487950|NCT03145610|Triclosan|triclosan|mesh-list
19487951|NCT03145610|Fluorides|fluorides|mesh-list
19487952|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
19487953|NCT03145610|Protective Agents|protective agents|mesh-ancestor
19487954|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487955|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20024756|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
20024757|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20024758|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024759|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20024760|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292928|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19487956|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487957|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19487958|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19487959|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
19487960|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487961|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19487962|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19487963|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487964|NCT03146104|Propofol|propofol|mesh-list
19487965|NCT03146104|Isoflurane|isoflurane|mesh-list
19487966|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19487967|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19487968|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487969|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19487970|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
20292929|NCT04954742|Riociguat|riociguat|mesh-list
19487971|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
19487972|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19487973|NCT03145623|Grazoprevir|grazoprevir|mesh-list
19487974|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
19487975|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19487976|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
19487977|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19487978|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487979|NCT03145896|Vitamin D|vitamin d|mesh-list
19487980|NCT03145896|Vitamins|vitamins|mesh-ancestor
19487981|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
19487982|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19487983|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19487984|NCT03145675|Enoxaparin|enoxaparin|mesh-list
19487985|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
19487986|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
19487987|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19487988|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19487989|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487990|NCT03145558|Doxorubicin|doxorubicin|mesh-list
19487991|NCT03145558|Tirapazamine|tirapazamine|mesh-list
19487992|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19487993|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19487994|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19487995|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19487996|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19487997|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19487998|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
19487999|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488000|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488001|NCT03145272|Oxycodone|oxycodone|mesh-list
19488002|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19488003|NCT03145272|Narcotics|narcotics|mesh-ancestor
19488004|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488005|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488006|NCT03145272|Analgesics|analgesics|mesh-ancestor
19488007|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
19488008|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488009|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
19488010|NCT05255666|Irinotecan|irinotecan|mesh-list
19488011|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488012|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488013|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19488014|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19488015|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488016|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488017|NCT05255575|Ertapenem|ertapenem|mesh-list
19488018|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488019|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488020|NCT05255523|Capecitabine|capecitabine|mesh-list
19488021|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19488022|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
19488023|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488024|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744150|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
19744151|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744152|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19744153|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19744154|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744155|NCT03158090|Lanreotide|lanreotide|mesh-list
19744156|NCT03158090|Octreotide|octreotide|mesh-list
19744157|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744158|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744159|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744160|NCT03156504|Ketamine|ketamine|mesh-list
19744161|NCT03156504|Analgesics|analgesics|mesh-ancestor
19744162|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
19744163|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744164|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744165|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19744166|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19744167|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
19744168|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
20292930|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
19488025|NCT05255484|Antibodies|antibodies|mesh-list
19488026|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
19488027|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488028|NCT05255406|Aflutinib|aflutinib|mesh-list
19488029|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19488030|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488031|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488032|NCT05255367|Phenol|phenol|mesh-list
19488033|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19488034|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488035|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
19488036|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19488037|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19488038|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
19488039|NCT05255302|Pemetrexed|pemetrexed|mesh-list
19488040|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488041|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488042|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488043|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488044|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19488045|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19488046|NCT05255276|Itraconazole|itraconazole|mesh-list
19488047|NCT05255276|Rifampin|rifampin|mesh-list
19488048|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
19488049|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488050|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19488051|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19488052|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488053|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488054|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19488055|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
19488056|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488057|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488058|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19488059|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19488060|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
19488061|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488062|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
19488063|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19488064|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19488065|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19488066|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19488067|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19488068|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19488069|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19488070|NCT05255211|Propofol|propofol|mesh-list
19488071|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19488072|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488073|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488074|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19488075|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
19488076|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
19488077|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
19488078|NCT05254925|Petrolatum|petrolatum|mesh-list
19488079|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19488080|NCT05254925|Protective Agents|protective agents|mesh-ancestor
19488081|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488082|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
19488083|NCT05254925|Emollients|emollients|mesh-ancestor
19488084|NCT05254899|Gemcitabine|gemcitabine|mesh-list
19488085|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
19488086|NCT05254899|Pegaspargase|pegaspargase|mesh-list
19488087|NCT05254899|Antibodies|antibodies|mesh-list
19488088|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19488089|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
19488090|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488091|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19488092|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
19488093|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488094|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488095|NCT05254899|Antiviral Agents|antiviral agents|mesh-ancestor
19488096|NCT05254899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488097|NCT05254899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488098|NCT05254899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488099|NCT05254665|Docetaxel|docetaxel|mesh-list
19488100|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292931|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488101|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
19488102|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
19488103|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
19488104|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488105|NCT05254652|Pregabalin|pregabalin|mesh-list
19488106|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19488107|NCT05254652|Analgesics|analgesics|mesh-ancestor
19488108|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
19488109|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488110|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488111|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
19488112|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19488113|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024761|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19744169|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20024762|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19488114|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488115|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19488116|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19488117|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19488118|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488119|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19488120|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19488121|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20024763|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024764|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024765|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
19488122|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488123|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
19488124|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
19488125|NCT05254574|Diclofenac|diclofenac|mesh-list
19488126|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19488127|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488128|NCT05254574|Analgesics|analgesics|mesh-ancestor
19488129|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
19488130|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488131|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488132|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488133|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488134|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19488135|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488136|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569254|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
19569255|NCT05147220|Teriflunomide|teriflunomide|mesh-list
19569256|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569257|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569258|NCT05147220|Analgesics|analgesics|mesh-ancestor
19569259|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
19569260|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024766|NCT03952130|Insulin|insulin|mesh-list
20024767|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20024768|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
20024769|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
20024770|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20024771|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024772|NCT03922477|Atezolizumab|atezolizumab|mesh-list
20024773|NCT03922477|Magrolimab|magrolimab|mesh-list
20024774|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024775|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024776|NCT03915405|Avelumab|avelumab|mesh-list
19569261|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569262|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569263|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569264|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19569265|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
19569266|NCT05141682|Azacitidine|azacitidine|mesh-list
19569267|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569268|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
19569269|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569270|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569271|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569272|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19569273|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
20024777|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024778|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488137|NCT05254405|Brexanolone|brexanolone|mesh-list
19488138|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
19488139|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488140|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488141|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488142|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
19488143|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
19488144|NCT05254236|Vaccines|vaccines|mesh-list
19488145|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
19488146|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488147|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19488148|NCT05254171|Gemcitabine|gemcitabine|mesh-list
19488149|NCT05254171|Paclitaxel|paclitaxel|mesh-list
19488150|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19488151|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488152|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
19488153|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
19488154|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
19488155|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488156|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19488157|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
19488158|NCT05254171|Antiviral Agents|antiviral agents|mesh-ancestor
19488159|NCT05254171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488160|NCT05254171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488161|NCT05254171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488162|NCT05254171|Immunologic Factors|immunologic factors|mesh-ancestor
19488163|NCT05254171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488164|NCT05253781|Aspirin|aspirin|mesh-list
19488165|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19488166|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488167|NCT05253781|Analgesics|analgesics|mesh-ancestor
19488168|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
19488169|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488170|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488171|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488172|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488173|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19488174|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19488175|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024779|NCT03907176|Acetaminophen|acetaminophen|mesh-list
20024780|NCT03907176|Ibuprofen|ibuprofen|mesh-list
20024781|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488176|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19488177|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19488178|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488179|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
19488180|NCT05253768|Glycerol|glycerol|mesh-list
19488181|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19488182|NCT05253768|Protective Agents|protective agents|mesh-ancestor
19488183|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488184|NCT05253573|Nicotine|nicotine|mesh-list
19488185|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19488186|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
19488187|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024782|NCT03907176|Analgesics|analgesics|mesh-ancestor
20024783|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
20024784|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024785|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024786|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
20024787|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20024788|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024789|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024790|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20024791|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024792|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024793|NCT03807440|Empagliflozin|empagliflozin|mesh-list
20024794|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20024795|NCT03807440|Linagliptin|linagliptin|mesh-list
20024796|NCT03807440|Metformin|metformin|mesh-list
20024797|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20024798|NCT03807440|Glucagon|glucagon|mesh-list
20024799|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20024800|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292932|NCT04952402|Vaccines|vaccines|mesh-list
19488188|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024801|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19488189|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19488190|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19488191|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
19488192|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488193|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488194|NCT05230810|Fulvestrant|fulvestrant|mesh-list
19488195|NCT05230810|Tucatinib|tucatinib|mesh-list
19488196|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19488197|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488198|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19488199|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19488200|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
19488201|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488202|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488203|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19488204|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488205|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488206|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19488207|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488208|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
19488209|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
19488210|NCT05178823|Fluorides|fluorides|mesh-list
19488211|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
19488212|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
19488213|NCT05178823|Protective Agents|protective agents|mesh-ancestor
19488214|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488215|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19488216|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488217|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
19488218|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
19488219|NCT05166304|Rebamipide|rebamipide|mesh-list
19488220|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19488221|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19488222|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
19488223|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488224|NCT05166304|Protective Agents|protective agents|mesh-ancestor
19488225|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488226|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488227|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
19488228|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19488229|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488230|NCT05149638|Cosyntropin|cosyntropin|mesh-list
19488231|NCT05149638|Hormones|hormones|mesh-ancestor
19488232|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488233|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488234|NCT05143970|Trastuzumab|trastuzumab|mesh-list
19488235|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488236|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488237|NCT05096442|Paclitaxel|paclitaxel|mesh-list
19488238|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19488239|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19488240|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488241|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19488242|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19488243|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19488244|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488245|NCT05093322|Gemcitabine|gemcitabine|mesh-list
19488246|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19488247|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
19488248|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488249|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488250|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
19488251|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488252|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488253|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488254|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
19488255|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488256|NCT05084586|Epirubicin|epirubicin|mesh-list
19488257|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19488258|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19488259|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488260|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19488261|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19488262|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488263|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488264|NCT05074290|Taxane|taxane|mesh-list
19488265|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488266|NCT05022004|Brinzolamide|brinzolamide|mesh-list
19488267|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19488268|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488269|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488270|NCT05017610|Lomustine|lomustine|mesh-list
19488271|NCT05017610|Methimazole|methimazole|mesh-list
19488272|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19488273|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
19488274|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488275|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488276|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
19488277|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
19488278|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488279|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488280|NCT05013801|Hydroquinone|hydroquinone|mesh-list
19488281|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
20024802|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024803|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20024804|NCT03807440|Hormones|hormones|mesh-ancestor
20024805|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20024806|NCT03807440|Incretins|incretins|mesh-ancestor
20024807|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
19488282|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488283|NCT05013801|Protective Agents|protective agents|mesh-ancestor
19488284|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488285|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19488286|NCT05012865|Avelumab|avelumab|mesh-list
19488287|NCT05012865|Axitinib|axitinib|mesh-list
19488288|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488289|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488290|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19488291|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488292|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488293|NCT04998669|Rituximab|rituximab|mesh-list
19488294|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19488295|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488296|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488297|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
19488298|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488299|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569274|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569275|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19569276|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
19569277|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569278|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569279|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19569280|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19569281|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19569282|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
19569283|NCT05136846|Paclitaxel|paclitaxel|mesh-list
19569284|NCT05136846|Carboplatin|carboplatin|mesh-list
19569285|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19569286|NCT05136846|Durvalumab|durvalumab|mesh-list
19569287|NCT05136846|Papaverine|papaverine|mesh-list
19569288|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
19569289|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19569290|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
19569291|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19569292|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569293|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19569294|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19569295|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19569296|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569297|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024808|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024809|NCT03801369|Durvalumab|durvalumab|mesh-list
20024810|NCT03801369|Olaparib|olaparib|mesh-list
20024811|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20024812|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
19569298|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
20024813|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20024814|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
20024815|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024816|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024817|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
20024818|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024819|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024820|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024821|NCT03787680|Olaparib|olaparib|mesh-list
20024822|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20024823|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024824|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024825|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024826|NCT03777436|Apremilast|apremilast|mesh-list
20024827|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20024828|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20024829|NCT03777436|Analgesics|analgesics|mesh-ancestor
19488300|NCT04935476|Dapsone|dapsone|mesh-list
19488301|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488302|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
19488303|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19488304|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19488305|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19488306|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488307|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488308|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
19488309|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488310|NCT04930107|Fluconazole|fluconazole|mesh-list
19488311|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
19488312|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488313|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19488314|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19488315|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488316|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488317|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19488318|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
19488319|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488320|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488321|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19488322|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19488323|NCT04889547|Dexamethasone|dexamethasone|mesh-list
19488324|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
19488325|NCT04889547|BB 1101|bb 1101|mesh-list
19488326|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488327|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
19488328|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
19488329|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488330|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488331|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19488332|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
19488333|NCT04889547|Hormones|hormones|mesh-ancestor
19488334|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488335|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19488336|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488337|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
19488338|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488339|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024830|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
20024831|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024832|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024833|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024834|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024835|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20024836|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20024837|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024838|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024839|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
20024840|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024841|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024842|NCT03753919|Durvalumab|durvalumab|mesh-list
20024843|NCT03753919|Tremelimumab|tremelimumab|mesh-list
20024844|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024845|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024846|NCT03675672|Misoprostol|misoprostol|mesh-list
20292933|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
19488340|NCT04875364|Eszopiclone|eszopiclone|mesh-list
19488341|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19488342|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488343|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488344|NCT04873453|Cannabidiol|cannabidiol|mesh-list
19488345|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
19488346|NCT04862949|Bevacizumab|bevacizumab|mesh-list
19488347|NCT04862949|Atezolizumab|atezolizumab|mesh-list
19488348|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488349|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488350|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19488351|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19488352|NCT04862949|Growth Substances|growth substances|mesh-ancestor
19488353|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488354|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
19488355|NCT04861064|Sirolimus|sirolimus|mesh-list
19488356|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488357|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488358|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19488359|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488360|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
19488361|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488362|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
19488363|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488364|NCT04860635|Celecoxib|celecoxib|mesh-list
19488365|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19488366|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488367|NCT04860635|Analgesics|analgesics|mesh-ancestor
19488368|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
19488369|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488370|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488371|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488372|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488373|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19488374|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19488375|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488376|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488377|NCT04852367|Doxorubicin|doxorubicin|mesh-list
19488378|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19488379|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488380|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19488381|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19488382|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488383|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488384|NCT04850495|Prednisone|prednisone|mesh-list
19488385|NCT04850495|Cortisone|cortisone|mesh-list
19488386|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
19488387|NCT04850495|Rituximab|rituximab|mesh-list
19488388|NCT04850495|Doxorubicin|doxorubicin|mesh-list
19488389|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19488390|NCT04850495|Vincristine|vincristine|mesh-list
19488391|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
19488392|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19488393|NCT04850495|Antibodies|antibodies|mesh-list
19488394|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
19488395|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19488396|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488397|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
19488398|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488399|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488400|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19488401|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
19488402|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488403|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488404|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19488405|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19488406|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19488407|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19488408|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488409|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488410|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
19488411|NCT04850495|Hormones|hormones|mesh-ancestor
19488412|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488413|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19488414|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19488415|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
19488416|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
19488417|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
19488418|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19488419|NCT04844905|Ivermectin|ivermectin|mesh-list
19488420|NCT04844905|Piperaquine|piperaquine|mesh-list
19488421|NCT04844905|Artenimol|artenimol|mesh-list
19488422|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19488423|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488424|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
19488425|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19488426|NCT04824274|Fentanyl|fentanyl|mesh-list
19488427|NCT04824274|Morphine|morphine|mesh-list
19488428|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19488429|NCT04824274|Narcotics|narcotics|mesh-ancestor
19488430|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488431|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488432|NCT04824274|Analgesics|analgesics|mesh-ancestor
19488433|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
19488434|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488435|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19488436|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19488437|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
19488438|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
19488439|NCT04774991|Azithromycin|azithromycin|mesh-list
19488440|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488441|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488442|NCT04771923|Epinephrine|epinephrine|mesh-list
19488443|NCT04771923|Racepinephrine|racepinephrine|mesh-list
19488444|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
19488445|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
19488446|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19488447|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19488448|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488449|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
19488450|NCT04771923|Coagulants|coagulants|mesh-ancestor
19488451|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19488452|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20024847|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20024848|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
20024849|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20024850|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024851|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20024852|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20024853|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
20024854|NCT03664830|Plerixafor|plerixafor|mesh-list
20024855|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19488453|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
19744170|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19744171|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19744172|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744173|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744174|NCT03155100|Dexamethasone|dexamethasone|mesh-list
19744175|NCT03155100|Elotuzumab|elotuzumab|mesh-list
19744176|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19744177|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744178|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
19744179|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
19744180|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744181|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744182|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744183|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
19744184|NCT03155100|Hormones|hormones|mesh-ancestor
19744185|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744186|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744187|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744188|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
19744189|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744190|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744191|NCT03142893|Ketoconazole|ketoconazole|mesh-list
19744192|NCT03142893|Dexamethasone|dexamethasone|mesh-list
20024856|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20024857|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
20024858|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488454|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488455|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488456|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19488457|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19744193|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
20024859|NCT03639948|Carboplatin|carboplatin|mesh-list
19488458|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
19488459|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024860|NCT03639948|Docetaxel|docetaxel|mesh-list
20024861|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
20024862|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024863|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
20024864|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
20024865|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024866|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024867|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024868|NCT03619707|Progesterone|progesterone|mesh-list
20024869|NCT03619707|Progestins|progestins|mesh-ancestor
20024870|NCT03619707|Hormones|hormones|mesh-ancestor
20024871|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20024872|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488460|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19488461|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19488462|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
19488463|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
19488464|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19488465|NCT04762459|Pemetrexed|pemetrexed|mesh-list
19488466|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488467|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488468|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488469|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19488470|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19488471|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
19488472|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19488473|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19488474|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488475|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
19488476|NCT04754230|Coagulants|coagulants|mesh-ancestor
19488477|NCT04745949|Prednisone|prednisone|mesh-list
19488478|NCT04745949|Cortisone|cortisone|mesh-list
19488479|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
19488480|NCT04745949|Rituximab|rituximab|mesh-list
19488481|NCT04745949|Doxorubicin|doxorubicin|mesh-list
19488482|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19488483|NCT04745949|Nivolumab|nivolumab|mesh-list
19488484|NCT04745949|Daunorubicin|daunorubicin|mesh-list
19488485|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19488486|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19488487|NCT04745949|Antibodies|antibodies|mesh-list
19488488|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
19488489|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19488490|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
19488491|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488492|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
19488493|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488494|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488495|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20024873|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
20024874|NCT03539900|Naltrexone|naltrexone|mesh-list
20024875|NCT03539900|Bupropion|bupropion|mesh-list
20024876|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20024877|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20024878|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024879|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
19488496|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
19488497|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488498|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488499|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20024880|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024881|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20024882|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
20024883|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20024884|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20024885|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20024886|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024887|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024888|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
19488500|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19488501|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19488502|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20024889|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488503|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488504|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488505|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
19488506|NCT04745949|Hormones|hormones|mesh-ancestor
19488507|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488508|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19488509|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19488510|NCT04718415|Paclitaxel|paclitaxel|mesh-list
19488511|NCT04718415|Carboplatin|carboplatin|mesh-list
19488512|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19488513|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488514|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
19488515|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
19488516|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
19488517|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488518|NCT04718025|Aspirin|aspirin|mesh-list
19488519|NCT04718025|Ticagrelor|ticagrelor|mesh-list
19488520|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19488521|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488522|NCT04718025|Analgesics|analgesics|mesh-ancestor
19488523|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
19488524|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488525|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488526|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488527|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488528|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19488529|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19488530|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488531|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19488532|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19488533|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488534|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
19488535|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19488536|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19488537|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19488538|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
19488539|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488540|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
19488541|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488542|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488543|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
19488544|NCT04710628|Lenvatinib|lenvatinib|mesh-list
19488545|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488546|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488547|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19488548|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488549|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488550|NCT04708067|Atezolizumab|atezolizumab|mesh-list
19488551|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488552|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
19488553|NCT04688203|Labetalol|labetalol|mesh-list
19488554|NCT04688203|Analgesics|analgesics|mesh-ancestor
19488555|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
19488556|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488557|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488558|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
19488559|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488560|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19488561|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
19488562|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19488563|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19488564|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488565|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19488566|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
19488567|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19488568|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19488569|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19488570|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
19488571|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488572|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19488573|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
20024890|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19488574|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
19488575|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19488576|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19488577|NCT04672395|Vaccines|vaccines|mesh-list
19488578|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
19488579|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
19488580|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488581|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19488582|NCT04636437|Tenofovir|tenofovir|mesh-list
19488583|NCT04636437|Lamivudine|lamivudine|mesh-list
19488584|NCT04636437|Emtricitabine|emtricitabine|mesh-list
19488585|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
19488586|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
19488587|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488588|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19488589|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19488590|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488591|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488592|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19488593|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19488594|NCT04630938|Lidocaine|lidocaine|mesh-list
19488595|NCT04630938|Morphine|morphine|mesh-list
19488596|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
19488597|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
19488598|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488599|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488600|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
19488601|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488602|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19488603|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19488604|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19488605|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19488606|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488607|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19488608|NCT04630938|Narcotics|narcotics|mesh-ancestor
19488609|NCT04630938|Analgesics|analgesics|mesh-ancestor
19488610|NCT04624451|Dalbavancin|dalbavancin|mesh-list
19488611|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488612|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488613|NCT04594746|Amiodarone|amiodarone|mesh-list
20024891|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20024892|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024893|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20024894|NCT03500380|Capecitabine|capecitabine|mesh-list
20024895|NCT03500380|Lapatinib|lapatinib|mesh-list
20024896|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024897|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
20024898|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024899|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024900|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20024901|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024902|NCT03494569|Fludarabine|fludarabine|mesh-list
20024903|NCT03494569|Melphalan|melphalan|mesh-list
20024904|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
20024905|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20024906|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024907|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024908|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024909|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
20024910|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024911|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20024912|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
20024913|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20024914|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
20024915|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024916|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024917|NCT03401853|Rituximab|rituximab|mesh-list
20024918|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20024919|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
20024920|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
20024921|NCT03401853|Antibodies|antibodies|mesh-list
20024922|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
20024923|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20576461|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19488614|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19488615|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
19488616|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19488617|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20024924|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
19488618|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488619|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19488620|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19488621|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19488622|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488623|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19488624|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19488625|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19488626|NCT04592237|Carboplatin|carboplatin|mesh-list
19488627|NCT04592237|Niraparib|niraparib|mesh-list
19488628|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488629|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19488630|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488631|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488632|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
19488633|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488634|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488635|NCT04542135|Sulindac|sulindac|mesh-list
19488636|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19488637|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488638|NCT04542135|Analgesics|analgesics|mesh-ancestor
19488639|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
19488640|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488641|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488642|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488643|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488644|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488645|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19488646|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488647|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488648|NCT04509973|Dexamethasone|dexamethasone|mesh-list
19488649|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488650|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
19488651|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
19488652|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488653|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488654|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19488655|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
19488656|NCT04509973|Hormones|hormones|mesh-ancestor
19488657|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488658|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19488659|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569299|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569300|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19569301|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569302|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
19569303|NCT05136846|Urological Agents|urological agents|mesh-ancestor
19569304|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
19569305|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19569306|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569307|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569308|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569309|NCT05134363|Analgesics|analgesics|mesh-ancestor
19569310|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
19569311|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569312|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19569313|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19569314|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19569315|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
19569316|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569317|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569318|NCT05078866|Vaccines|vaccines|mesh-list
19569319|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
19569320|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569321|NCT05078060|Vaccines|vaccines|mesh-list
19569322|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
19569323|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569324|NCT05073003|Vaccines|vaccines|mesh-list
20292934|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292935|NCT04951362|Ivermectin|ivermectin|mesh-list
19569325|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
19578353|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19488660|NCT04482621|Decitabine|decitabine|mesh-list
19488661|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19488662|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
19488663|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488664|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488665|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488666|NCT04469959|Levodopa|levodopa|mesh-list
19488667|NCT04469959|Carbidopa|carbidopa|mesh-list
19488668|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19488669|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19488670|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19488671|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
19488672|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488673|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488674|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488675|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19488676|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488677|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19488678|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
19488679|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
19488680|NCT04443569|Lidocaine|lidocaine|mesh-list
19488681|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
19488682|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
19488683|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488684|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488685|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
19488686|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488687|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19488688|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19488689|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19488690|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19488691|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488692|NCT04357795|Cyclosporine|cyclosporine|mesh-list
19488693|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19488694|NCT04357795|Cyclosporins|cyclosporins|mesh-list
19488695|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488696|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488697|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488698|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
19488699|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488700|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
19488701|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488702|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
19488703|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488704|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19488705|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19488706|NCT04356638|Midazolam|midazolam|mesh-list
19488707|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
19488708|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19488709|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488710|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488711|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488712|NCT04356638|Analgesics|analgesics|mesh-ancestor
19488713|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
19488714|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488715|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19488716|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19488717|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19488718|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
19488719|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744194|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
20024925|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488720|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488721|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19488722|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19488723|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19488724|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19488725|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19488726|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
19488727|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
19488728|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
19488729|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
19488730|NCT04352608|Vaccines|vaccines|mesh-list
19488731|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
19488732|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488733|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
19488734|NCT04346108|Antibodies|antibodies|mesh-list
19488735|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
19488736|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19488737|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20024926|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024927|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024928|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
20024929|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024930|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024931|NCT03389620|Dexamethasone|dexamethasone|mesh-list
20024932|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20024933|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
20024934|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
20024935|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20024936|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024937|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20024938|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
20024939|NCT03389620|Hormones|hormones|mesh-ancestor
20024940|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488738|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
19488739|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
19488740|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488744|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19488745|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488746|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
19488747|NCT04237792|Propofol|propofol|mesh-list
19488748|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19488749|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488750|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488751|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19488752|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
19488753|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
19488754|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488755|NCT04237792|Analgesics|analgesics|mesh-ancestor
19488756|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
19488757|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488758|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19488759|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19488760|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19488761|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
20292936|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19488762|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488763|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488764|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
19488765|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19488766|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19488767|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488768|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
19488769|NCT04233749|Coagulants|coagulants|mesh-ancestor
19488770|NCT04229095|Suvorexant|suvorexant|mesh-list
19488771|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19488772|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19488773|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19488774|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488775|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19488776|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488777|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488778|NCT04210180|Varenicline|varenicline|mesh-list
19488779|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19488780|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19488781|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
19488782|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488783|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488784|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488785|NCT04175886|Tofacitinib|tofacitinib|mesh-list
19488786|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19488787|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488788|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488789|NCT04169737|Venetoclax|venetoclax|mesh-list
19488790|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
19488791|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
19488792|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488793|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488794|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19488795|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
19488796|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
19488797|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19488798|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19488799|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488800|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488801|NCT04044001|Isoniazid|isoniazid|mesh-list
19488802|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
19488803|NCT04044001|Ethambutol|ethambutol|mesh-list
19488804|NCT04044001|Dolutegravir|dolutegravir|mesh-list
19488805|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
19488806|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488807|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488808|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488809|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488810|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19488811|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19488812|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
19488813|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19488814|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19488815|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19488816|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19488817|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19488818|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
19488819|NCT04031729|Aspirin|aspirin|mesh-list
19488820|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19488821|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19488822|NCT04031729|Analgesics|analgesics|mesh-ancestor
19488823|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
19488824|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488825|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488826|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19488827|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488828|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19488829|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19488830|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488831|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19488832|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19488833|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488834|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
20024941|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20024942|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024943|NCT03386721|Gemcitabine|gemcitabine|mesh-list
20024944|NCT03386721|Atezolizumab|atezolizumab|mesh-list
20024945|NCT03386721|Vinorelbine|vinorelbine|mesh-list
20024946|NCT03386721|Antibodies|antibodies|mesh-list
20024947|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
20024948|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024949|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20024950|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
20024951|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024952|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024953|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
20024954|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024955|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024956|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20024957|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20024958|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
20024959|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
20024960|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
20024961|NCT03345849|Upadacitinib|upadacitinib|mesh-list
20024962|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20024963|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20024964|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024965|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024966|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20024967|NCT03342001|Calcitonin|calcitonin|mesh-list
19488835|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19488836|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
19488837|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024968|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
20024969|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20024970|NCT03342001|Katacalcin|katacalcin|mesh-list
20024971|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20024972|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024973|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20024974|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
20024975|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
20024976|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024977|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024978|NCT03317119|Trifluridine|trifluridine|mesh-list
20024979|NCT03317119|Trametinib|trametinib|mesh-list
20024980|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20024981|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20024982|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20024983|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024984|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
20024985|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
20024986|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024987|NCT03297710|Trifluridine|trifluridine|mesh-list
20024988|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
20024989|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024990|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
20024991|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20024992|NCT03256916|Nelfinavir|nelfinavir|mesh-list
20024993|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19488838|NCT03982030|Dalbavancin|dalbavancin|mesh-list
19488839|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488840|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488841|NCT03977363|Anticoagulants|anticoagulants|mesh-list
19488842|NCT03971110|Goserelin|goserelin|mesh-list
19488843|NCT03971110|Bicalutamide|bicalutamide|mesh-list
19488844|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19488845|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488846|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
19488847|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
19488848|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19488849|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488850|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
19488851|NCT03942653|Goserelin|goserelin|mesh-list
20024994|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20024995|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
19488852|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20024996|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488853|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488854|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19488855|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19488856|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
19488857|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
19488858|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19488859|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19488860|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488861|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569326|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569327|NCT05058924|Aspirin|aspirin|mesh-list
19569328|NCT05058924|Heparin|heparin|mesh-list
19569329|NCT05058924|Calcium heparin|calcium heparin|mesh-list
19569330|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19569331|NCT05058924|Tinzaparin|tinzaparin|mesh-list
19569332|NCT05058924|Dalteparin|dalteparin|mesh-list
19569333|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569334|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569335|NCT05058924|Analgesics|analgesics|mesh-ancestor
19569336|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
19569337|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569338|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569339|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569340|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569341|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19569342|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19569343|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569344|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19569345|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19569346|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569347|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
19569348|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
19569349|NCT05042531|Azacitidine|azacitidine|mesh-list
19569350|NCT05042531|Dasatinib|dasatinib|mesh-list
19569351|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569352|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
19569353|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569354|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569355|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569356|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19569357|NCT05042440|Factor VIII|factor viii|mesh-list
19569358|NCT05042440|BAX 855|bax 855|mesh-list
19569359|NCT05042440|Coagulants|coagulants|mesh-ancestor
19569360|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
19569361|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19569362|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19569363|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569364|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
19569365|NCT05016518|Propofol|propofol|mesh-list
19569366|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19569367|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569368|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569369|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19569370|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
19569371|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
19569372|NCT04978259|Remdesivir|remdesivir|mesh-list
19569373|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
19569374|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569375|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
19569376|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569377|NCT04975919|Decitabine|decitabine|mesh-list
19569378|NCT04975919|Venetoclax|venetoclax|mesh-list
19569379|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569380|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
19569381|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569382|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569383|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569384|NCT04970901|Gemcitabine|gemcitabine|mesh-list
19569385|NCT04970901|Lenalidomide|lenalidomide|mesh-list
19569386|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19569387|NCT04970901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569388|NCT04970901|Antimetabolites|antimetabolites|mesh-ancestor
19569389|NCT04970901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569390|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569391|NCT04970901|Antiviral Agents|antiviral agents|mesh-ancestor
19569392|NCT04970901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569393|NCT04970901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569394|NCT04970901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488862|NCT03651206|Niraparib|niraparib|mesh-list
19488863|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19488864|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488865|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488866|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488867|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
19488868|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19488869|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
19488870|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488871|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488872|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19488873|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19488874|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19488875|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19488876|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19488877|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
19488878|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488879|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488880|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
19488881|NCT03318861|Fludarabine|fludarabine|mesh-list
19488882|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488883|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
19488884|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488885|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19488886|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19488887|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
19488888|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488889|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488890|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19488891|NCT03119064|Irinotecan|irinotecan|mesh-list
19488892|NCT03119064|Temozolomide|temozolomide|mesh-list
19488893|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19488894|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19488895|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488896|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488897|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488898|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19488899|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
19488900|NCT03117933|Paclitaxel|paclitaxel|mesh-list
19488901|NCT03117933|Olaparib|olaparib|mesh-list
19488902|NCT03117933|Cediranib|cediranib|mesh-list
19488903|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19488904|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488905|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
19488906|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
19488907|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
19488908|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488909|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19488910|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488911|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19488912|NCT03107871|Valganciclovir|valganciclovir|mesh-list
19488913|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
19488914|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488915|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
19488916|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19488917|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
19488918|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488919|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488920|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19488921|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
19488922|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
19488923|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19488924|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
19488925|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488926|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488927|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19488928|NCT03084523|Hematinics|hematinics|mesh-ancestor
19488929|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19488930|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19488931|NCT03070301|Everolimus|everolimus|mesh-list
19488932|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488933|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19488934|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
19488935|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20024997|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20024998|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20024999|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20025000|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
20025001|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025002|NCT03241771|Naloxone|naloxone|mesh-list
20025003|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20025004|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025005|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
20025006|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025007|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
20025008|NCT03220776|Gabapentin|gabapentin|mesh-list
19488936|NCT03064113|Ipratropium|ipratropium|mesh-list
19488937|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19488938|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
19488939|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488940|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488941|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19488942|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
19488943|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19488944|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
19488945|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488946|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488947|NCT03049540|Tadalafil|tadalafil|mesh-list
19488948|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
19488949|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19488950|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19488951|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488952|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488953|NCT03049540|Urological Agents|urological agents|mesh-ancestor
19488954|NCT02940769|Methamphetamine|methamphetamine|mesh-list
19488955|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19488956|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488957|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
19488958|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
19488959|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488960|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
19488961|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19488962|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488963|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
19488964|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19488965|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19488966|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19488967|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19488968|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
19488969|NCT02938013|Velpatasvir|velpatasvir|mesh-list
19488970|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19488971|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
19488972|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488973|NCT02919683|Nivolumab|nivolumab|mesh-list
19488974|NCT02919683|Ipilimumab|ipilimumab|mesh-list
19488975|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488976|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488977|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19488978|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488979|NCT02901548|Durvalumab|durvalumab|mesh-list
19488980|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488981|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488982|NCT02890459|Denatonium|denatonium|mesh-list
19488983|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
19488984|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19488985|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
19488986|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19488987|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
19488988|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19488989|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
19488990|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19488991|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19488992|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19488993|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19488994|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19488995|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025009|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20025010|NCT03220776|Analgesics|analgesics|mesh-ancestor
19488996|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19488997|NCT02812667|Nivolumab|nivolumab|mesh-list
19488998|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19488999|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489000|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19489001|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744195|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19744196|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20025011|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
20025012|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025013|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744197|NCT03142893|Hormones|hormones|mesh-list
19744198|NCT03142893|Cosyntropin|cosyntropin|mesh-list
19744199|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19744200|NCT03142893|BB 1101|bb 1101|mesh-list
19744201|NCT03142893|Ganirelix|ganirelix|mesh-list
20025014|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
20025015|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20025016|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20025017|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20025018|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20025019|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20025020|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20025021|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025022|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025023|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
20025024|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
20025025|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025026|NCT03220776|Expectorants|expectorants|mesh-ancestor
20025027|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
20025028|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20025029|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
20025030|NCT03220776|Protective Agents|protective agents|mesh-ancestor
20025031|NCT03220776|Antidotes|antidotes|mesh-ancestor
20025032|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20025033|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
20025034|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20025035|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
20025036|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20025037|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025038|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20025039|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20025040|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025041|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
20025042|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
20025043|NCT03128359|Melphalan|melphalan|mesh-list
20025044|NCT03128359|Busulfan|busulfan|mesh-list
20025045|NCT03128359|Fludarabine|fludarabine|mesh-list
20025046|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
20025047|NCT03128359|Tacrolimus|tacrolimus|mesh-list
20025048|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025049|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
20025050|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025051|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025052|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025053|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
20025054|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025055|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025056|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20025057|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025058|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
20025059|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20025060|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025061|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025062|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20025063|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
19489002|NCT02797275|Albuterol|albuterol|mesh-list
19489003|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19489004|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
19489005|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489006|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489007|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19744202|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744203|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
19744204|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
20025064|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20576462|NCT02071537|Gemcitabine|gemcitabine|mesh-list
19489008|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
19489009|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
19489010|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19489011|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19489012|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19489013|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19489014|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
19489015|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489016|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489017|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
19489018|NCT02790138|Vedolizumab|vedolizumab|mesh-list
19489019|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19489020|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489021|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19489022|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19489023|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489024|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489025|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489026|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19489027|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19489028|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489029|NCT02783625|Bortezomib|bortezomib|mesh-list
19489030|NCT02783625|Romidepsin|romidepsin|mesh-list
19489031|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489032|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19489033|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19489034|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19489035|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489036|NCT02726997|Paclitaxel|paclitaxel|mesh-list
19489037|NCT02726997|Carboplatin|carboplatin|mesh-list
19489038|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19489039|NCT02726997|Durvalumab|durvalumab|mesh-list
19489040|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
19489041|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19489042|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
19489043|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19489044|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489045|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489046|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489047|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
19489048|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489049|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489050|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
19489051|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489052|NCT02723994|Leucovorin|leucovorin|mesh-list
19489053|NCT02723994|Cytarabine|cytarabine|mesh-list
19489054|NCT02723994|Dexamethasone|dexamethasone|mesh-list
19489055|NCT02723994|Prednisone|prednisone|mesh-list
19489056|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
19489057|NCT02723994|Doxorubicin|doxorubicin|mesh-list
19489058|NCT02723994|Methotrexate|methotrexate|mesh-list
19489059|NCT02723994|Vincristine|vincristine|mesh-list
19489060|NCT02723994|Asparaginase|asparaginase|mesh-list
19489061|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
19489062|NCT02723994|Pegaspargase|pegaspargase|mesh-list
19489063|NCT02723994|Thioguanine|thioguanine|mesh-list
19489064|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
19489065|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489066|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
19489067|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489068|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489069|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19489070|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
19489071|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489072|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489073|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19489074|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489075|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
19489076|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
19489077|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489078|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489079|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
19489080|NCT02723994|Hormones|hormones|mesh-ancestor
19489081|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489082|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20576463|NCT02071537|Chloroquine|chloroquine|mesh-list
19489083|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19489084|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19489085|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19489086|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489087|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19489088|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
19489089|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19489090|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19489091|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
19489092|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
19489093|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19489094|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19489095|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
19489096|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489097|NCT02723994|Antidotes|antidotes|mesh-ancestor
19489098|NCT02723994|Protective Agents|protective agents|mesh-ancestor
19489099|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
19489100|NCT02723994|Vitamins|vitamins|mesh-ancestor
19489101|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
19489102|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19489103|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489104|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489105|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744205|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744206|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744207|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744208|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
19744209|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749174|NCT05250973|Hormones|hormones|mesh-ancestor
19489112|NCT02669173|Bevacizumab|bevacizumab|mesh-list
19489113|NCT02669173|Capecitabine|capecitabine|mesh-list
19489114|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489115|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489116|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19489117|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19489118|NCT02669173|Growth Substances|growth substances|mesh-ancestor
19489119|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489120|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
19489121|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19489122|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
19489123|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489124|NCT02642315|Gabapentin|gabapentin|mesh-list
19489125|NCT02642315|Analgesics|analgesics|mesh-ancestor
19489126|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
19489127|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489128|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489129|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
19489130|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19489131|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19489132|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489133|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19489134|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19489135|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19489136|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489137|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292937|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292938|NCT04948333|Niacinamide|niacinamide|mesh-list
19489138|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
19489139|NCT02631447|Nivolumab|nivolumab|mesh-list
19489140|NCT02631447|Ipilimumab|ipilimumab|mesh-list
19489141|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489142|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489143|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19489144|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489145|NCT02586831|Exenatide|exenatide|mesh-list
19489146|NCT02586831|Aldesleukin|aldesleukin|mesh-list
19489147|NCT02586831|Adalimumab|adalimumab|mesh-list
19489148|NCT02586831|Interleukin-2|interleukin-2|mesh-list
19489149|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
19489150|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19489151|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489152|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489153|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489154|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489155|NCT02586831|Analgesics|analgesics|mesh-ancestor
19489156|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
19489157|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489158|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489159|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19489160|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19489161|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
19489162|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489163|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19489164|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19489165|NCT02586831|Incretins|incretins|mesh-ancestor
19489166|NCT02586831|Hormones|hormones|mesh-ancestor
19489167|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489168|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
19489169|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489170|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
19489171|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489172|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19489173|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489174|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489175|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
19489176|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489177|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489178|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19489179|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
19489180|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19489181|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
19489182|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489183|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489184|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19489185|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
19489186|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
19489187|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19489188|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
20025065|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025066|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
20025067|NCT03113487|Vaccines|vaccines|mesh-list
20025068|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
20025069|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025070|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025071|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025072|NCT03094884|Paclitaxel|paclitaxel|mesh-list
20025073|NCT03094884|Carboplatin|carboplatin|mesh-list
20025074|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025075|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025076|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025077|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025078|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
20025079|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489189|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489190|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489191|NCT02419417|Nivolumab|nivolumab|mesh-list
19489192|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025080|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
20025081|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20025082|NCT03047005|Naltrexone|naltrexone|mesh-list
19489193|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489194|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19489195|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489196|NCT02383251|Paclitaxel|paclitaxel|mesh-list
19489197|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19489198|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489199|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489200|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489201|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19489202|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489203|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
19489204|NCT02248701|Finasteride|finasteride|mesh-list
19489205|NCT02248701|Testosterone|testosterone|mesh-list
19489206|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
19489207|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
19489208|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19489209|NCT02248701|Androgens|androgens|mesh-ancestor
20025083|NCT03047005|Bupropion|bupropion|mesh-list
19489210|NCT02248701|Hormones|hormones|mesh-ancestor
19489211|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025084|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20025085|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19489212|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489213|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19489214|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489215|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
19489216|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19489217|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19489218|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489219|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489220|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
19489221|NCT02248701|Urological Agents|urological agents|mesh-ancestor
20025086|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025087|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
20025088|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025089|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20025090|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
20025091|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20025092|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20025093|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20025094|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20025095|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025096|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
20025097|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025098|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20025099|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20025100|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115496|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115497|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115498|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115499|NCT00005583|Doxorubicin|doxorubicin|mesh-list
20115500|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20115501|NCT00005583|Epirubicin|epirubicin|mesh-list
19489222|NCT02245672|Fluticasone|fluticasone|mesh-list
19489223|NCT02245672|Xhance|xhance|mesh-list
19489224|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19489225|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489226|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19489227|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
19489228|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489229|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489230|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20115502|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115503|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115504|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115505|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115506|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115507|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115508|NCT00005584|Prednisone|prednisone|mesh-list
20115509|NCT00005584|Epirubicin|epirubicin|mesh-list
20115510|NCT00005584|Bleomycin|bleomycin|mesh-list
20115511|NCT00005584|Vinblastine|vinblastine|mesh-list
20115512|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115513|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
20115514|NCT00005584|Hormones|hormones|mesh-ancestor
20115515|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115516|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115517|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115518|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115519|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115520|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115521|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115522|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115523|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115524|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115525|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115526|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115527|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115528|NCT00005585|Leucovorin|leucovorin|mesh-list
20115529|NCT00005585|Cytarabine|cytarabine|mesh-list
20115530|NCT00005585|Dexamethasone|dexamethasone|mesh-list
20115531|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
20115532|NCT00005585|Methotrexate|methotrexate|mesh-list
20115533|NCT00005585|Vincristine|vincristine|mesh-list
20115534|NCT00005585|Daunorubicin|daunorubicin|mesh-list
20115535|NCT00005585|Asparaginase|asparaginase|mesh-list
19489231|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
19489232|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
19489233|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19489234|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19489235|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19489236|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19489237|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
19489238|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489239|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025101|NCT03009240|Decitabine|decitabine|mesh-list
20025102|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19489240|NCT02129751|Bupropion|bupropion|mesh-list
19489241|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19489242|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
20025103|NCT03009240|Pevonedistat|pevonedistat|mesh-list
20025104|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19489243|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19489244|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19489245|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19489246|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19489247|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489248|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
20025105|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
20025106|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489249|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025107|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025108|NCT03002103|Gemcitabine|gemcitabine|mesh-list
20025109|NCT03002103|Paclitaxel|paclitaxel|mesh-list
20025110|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025111|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025112|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489250|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489251|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19489252|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19489253|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489254|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19489255|NCT02070705|Hematinics|hematinics|mesh-ancestor
19489256|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19489257|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19489258|NCT01979536|Cytarabine|cytarabine|mesh-list
19489259|NCT01979536|Dexamethasone|dexamethasone|mesh-list
19489260|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
19489261|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
19489262|NCT01979536|Ifosfamide|ifosfamide|mesh-list
19489263|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
19489264|NCT01979536|Doxorubicin|doxorubicin|mesh-list
20025113|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025114|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
19489265|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19489266|NCT01979536|Methotrexate|methotrexate|mesh-list
20115536|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
19489267|NCT01979536|Etoposide|etoposide|mesh-list
19489268|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
19489269|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19489270|NCT01979536|Crizotinib|crizotinib|mesh-list
19489271|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
19489272|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19489273|NCT01979536|Antibodies|antibodies|mesh-list
19489274|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
19489275|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19489276|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
19489277|NCT01979536|BB 1101|bb 1101|mesh-list
19489278|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489279|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
19489280|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489281|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489282|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19489283|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
19489284|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489285|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489286|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19489287|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489288|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
19489289|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
19489290|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489291|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489292|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
20025115|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025116|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025117|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
20025118|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
20025119|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025120|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025121|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025122|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
20025123|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025124|NCT02996825|Gemcitabine|gemcitabine|mesh-list
19489293|NCT01979536|Hormones|hormones|mesh-ancestor
19489294|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489295|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19489296|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
19489297|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489298|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19489299|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19489300|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19489301|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19489302|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
19489303|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19489304|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19489305|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
19489306|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
19489307|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19489308|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19489309|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19489310|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
19489311|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489312|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19489313|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
19489314|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489315|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489316|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
19489317|NCT01959633|Interferons|interferons|mesh-list
19489318|NCT01959633|Vemurafenib|vemurafenib|mesh-list
19489319|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489320|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
19489321|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489322|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19489323|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489324|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489325|NCT01936688|Etanercept|etanercept|mesh-list
19489326|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19489327|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20025125|NCT02996825|Maytansine|maytansine|mesh-list
20025126|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19489328|NCT01936688|Analgesics|analgesics|mesh-ancestor
19489329|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
19569395|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
19489330|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489331|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489332|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489333|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489334|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489335|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489336|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
20025127|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
20025128|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025129|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025130|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
20025131|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025132|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025133|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025134|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
20025135|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025136|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025137|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025138|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489337|NCT01861496|Cisplatin|cisplatin|mesh-list
19489338|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489339|NCT01826838|Dasatinib|dasatinib|mesh-list
19489340|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489341|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19489342|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489343|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489344|NCT01767675|Carboplatin|carboplatin|mesh-list
19489345|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744210|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744211|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744212|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
19744213|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744214|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025139|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20025140|NCT02944617|Micronutrients|micronutrients|mesh-list
20025141|NCT02944617|Trace Elements|trace elements|mesh-list
20025142|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569396|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569397|NCT04970901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19569398|NCT04970901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19569399|NCT04970901|Growth Substances|growth substances|mesh-ancestor
19569400|NCT04970901|Growth Inhibitors|growth inhibitors|mesh-ancestor
19569401|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569402|NCT04965090|Lazertinib|lazertinib|mesh-list
19569403|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19569404|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569405|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569406|NCT04934904|Ropivacaine|ropivacaine|mesh-list
19569407|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
19569408|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
19569409|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569410|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569411|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
19569412|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569413|NCT04915248|Dexamethasone|dexamethasone|mesh-list
19569414|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
19569415|NCT04915248|Bortezomib|bortezomib|mesh-list
19569416|NCT04915248|Daratumumab|daratumumab|mesh-list
19569417|NCT04915248|BB 1101|bb 1101|mesh-list
19569418|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19569419|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569420|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
19569421|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
19569422|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569423|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569424|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19569425|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
19569426|NCT04915248|Hormones|hormones|mesh-ancestor
19569427|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569428|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19569429|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025143|NCT02865135|Vaccines|vaccines|mesh-list
19569430|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
19569431|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569432|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489355|NCT00970866|Folic Acid|folic acid|mesh-list
19489356|NCT00970866|Micronutrients|micronutrients|mesh-list
19489357|NCT00970866|Trace Elements|trace elements|mesh-list
19489358|NCT00970866|Hematinics|hematinics|mesh-ancestor
20025144|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
20025145|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025146|NCT02859558|Tenofovir|tenofovir|mesh-list
20025147|NCT02859558|Emtricitabine|emtricitabine|mesh-list
20025148|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20025149|NCT02859558|Cobicistat|cobicistat|mesh-list
20025150|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20025151|NCT02859558|Elvitegravir|elvitegravir|mesh-list
20025152|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20025153|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
20025154|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025155|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20025156|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20025157|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025158|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025159|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20025160|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20025161|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19489359|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
19489360|NCT00970866|Vitamins|vitamins|mesh-ancestor
20025162|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20025163|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
20025164|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025165|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025166|NCT02632045|Fulvestrant|fulvestrant|mesh-list
20025167|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20025168|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025169|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20025170|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20025171|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
20025172|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025173|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025174|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
20576464|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20025175|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20025176|NCT02572791|Mupirocin|mupirocin|mesh-list
20025177|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20025178|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025179|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
20025180|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
20025181|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20025182|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20025183|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025184|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025185|NCT02481310|Cytarabine|cytarabine|mesh-list
20025186|NCT02481310|Prednisone|prednisone|mesh-list
20025187|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
20025188|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20025189|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20025190|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20025191|NCT02481310|Cortisone|cortisone|mesh-list
20025192|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
20025193|NCT02481310|Rituximab|rituximab|mesh-list
20025194|NCT02481310|Doxorubicin|doxorubicin|mesh-list
20025195|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20025196|NCT02481310|Methotrexate|methotrexate|mesh-list
20025197|NCT02481310|Etoposide|etoposide|mesh-list
20025198|NCT02481310|Vincristine|vincristine|mesh-list
20025199|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
20025200|NCT02481310|Ixazomib|ixazomib|mesh-list
20025201|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
20025202|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20025203|NCT02481310|Antibodies|antibodies|mesh-list
19489361|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489362|NCT00799396|Aspirin|aspirin|mesh-list
19489363|NCT00799396|Clopidogrel|clopidogrel|mesh-list
19489364|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20025204|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
20025205|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20025206|NCT02481310|Glycine|glycine|mesh-list
20025207|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025208|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
20025209|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489365|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489366|NCT00799396|Analgesics|analgesics|mesh-ancestor
19489367|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
19489368|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489369|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489370|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489371|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489372|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20025210|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025211|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025212|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
19489373|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19489374|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489375|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20025213|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025214|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025215|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20025216|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025217|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025218|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19489376|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19489377|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489378|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
19489379|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19489380|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19489381|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19489382|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
19489383|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489384|NCT00069238|Prednisone|prednisone|mesh-list
19489385|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
19489386|NCT00069238|Doxorubicin|doxorubicin|mesh-list
19489387|NCT00069238|Etoposide|etoposide|mesh-list
19489388|NCT00069238|Vincristine|vincristine|mesh-list
19489389|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
19489390|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489391|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
19489392|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489393|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489394|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19489395|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
19489396|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489397|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489398|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19489399|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19489400|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19489401|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19489402|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489403|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489404|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
19489405|NCT00069238|Hormones|hormones|mesh-ancestor
19489406|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489407|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19489408|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19489409|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489410|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489411|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
19489412|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489413|NCT03145467|Acetaminophen|acetaminophen|mesh-list
19489414|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
19489415|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489416|NCT03145467|Analgesics|analgesics|mesh-ancestor
19489417|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
19489418|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489419|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489420|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
19489421|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19489422|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19489423|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
19489424|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489425|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489426|NCT03145584|Bupivacaine|bupivacaine|mesh-list
19489427|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
19489428|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
19489429|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489430|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489431|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
19489432|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489433|NCT03145194|Ticagrelor|ticagrelor|mesh-list
19489434|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19489435|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19489436|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19489437|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19489438|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
19489439|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489440|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489441|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489442|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
19489443|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489444|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19489445|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489446|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489447|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
19489448|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489449|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489450|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19489451|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19489452|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489453|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
19489454|NCT03145025|Hormones|hormones|mesh-ancestor
19489455|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489456|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489457|NCT03144947|Docetaxel|docetaxel|mesh-list
19489458|NCT03144947|Trastuzumab|trastuzumab|mesh-list
19489459|NCT03144947|Pertuzumab|pertuzumab|mesh-list
19489460|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489461|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489462|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489463|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
19489464|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489465|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489466|NCT03144596|Tamsulosin|tamsulosin|mesh-list
19489467|NCT03144596|Alfuzosin|alfuzosin|mesh-list
19489468|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19489469|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19489470|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19489471|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
19489472|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489473|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489474|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489475|NCT03144596|Urological Agents|urological agents|mesh-ancestor
19489476|NCT03145012|Ranitidine|ranitidine|mesh-list
19489477|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19489478|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19489479|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489480|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19489481|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
19489482|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
19489483|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489484|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489485|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489486|NCT03144778|Durvalumab|durvalumab|mesh-list
19489487|NCT03144778|Ipilimumab|ipilimumab|mesh-list
19489488|NCT03144778|Tremelimumab|tremelimumab|mesh-list
19489489|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
19489490|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19489491|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
19489492|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489493|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489494|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
20025219|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025220|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489495|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489496|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20025221|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
20025222|NCT02481310|Hormones|hormones|mesh-ancestor
20115537|NCT00005585|Pegaspargase|pegaspargase|mesh-list
19489497|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489498|NCT03144843|Apatinib|apatinib|mesh-list
19489499|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489500|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19489501|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489502|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489503|NCT03144713|Terlipressin|terlipressin|mesh-list
19489504|NCT03144713|Midodrine|midodrine|mesh-list
19489505|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
19489506|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
19489507|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489508|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489509|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19489510|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19489511|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19489512|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19489513|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
19489514|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489515|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489516|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19489517|NCT03144856|Apatinib|apatinib|mesh-list
19489518|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489519|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19489520|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489521|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489522|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
19489523|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19489524|NCT03144882|Curcumin|curcumin|mesh-list
19489525|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19489526|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489527|NCT03144882|Analgesics|analgesics|mesh-ancestor
19489528|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
19489529|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489530|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489531|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489532|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489533|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489534|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489535|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489536|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
20025223|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025224|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20025225|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20025226|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
20025227|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20025228|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025229|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
20025230|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
20025231|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20025232|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20025233|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025234|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
20025235|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025236|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025237|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025238|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20025239|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
20025240|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
20025241|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
20025242|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025243|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
20025244|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025245|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025246|NCT02331134|Lenograstim|lenograstim|mesh-list
20025247|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20025248|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
20025249|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025250|NCT02205762|Cytarabine|cytarabine|mesh-list
20025251|NCT02205762|Prednisone|prednisone|mesh-list
20025252|NCT02205762|Indomethacin|indomethacin|mesh-list
20025253|NCT02205762|Methotrexate|methotrexate|mesh-list
20025254|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
20025255|NCT02205762|Vinblastine|vinblastine|mesh-list
20025256|NCT02205762|Cladribine|cladribine|mesh-list
20025257|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
20025258|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19489537|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489538|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489539|NCT03144453|Atropine|atropine|mesh-list
19489540|NCT03144453|Neostigmine|neostigmine|mesh-list
19489541|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19489542|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19489543|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19489544|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
19489545|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489546|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489547|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19489548|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
19489549|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
19489550|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
19489551|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19489552|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19489553|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
19489554|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489555|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489556|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19489557|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489558|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19489559|NCT03144401|Misoprostol|misoprostol|mesh-list
19489560|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19489561|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
19489562|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19489563|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489564|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19489565|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489566|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
19489567|NCT03144115|Oxytocin|oxytocin|mesh-list
19489568|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
19489569|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19489570|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489571|NCT03144128|Vitamin D|vitamin d|mesh-list
19489572|NCT03144128|Vitamins|vitamins|mesh-ancestor
19489573|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
19489574|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489575|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19489576|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
19489577|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489578|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489579|NCT03143946|Vitamins|vitamins|mesh-list
19489580|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
19489581|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489582|NCT03143933|Fentanyl|fentanyl|mesh-list
19489583|NCT03143933|Propofol|propofol|mesh-list
19489584|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19489585|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489586|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489587|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19489588|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
19489589|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
19489590|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19489591|NCT03143933|Narcotics|narcotics|mesh-ancestor
19489592|NCT03143933|Analgesics|analgesics|mesh-ancestor
19489593|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
19489594|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489595|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19489596|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19489597|NCT03143998|Grazoprevir|grazoprevir|mesh-list
19489598|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
19489599|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489600|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
19489601|NCT03143972|Remifentanil|remifentanil|mesh-list
19489602|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19489603|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489604|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489605|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489606|NCT03143972|Analgesics|analgesics|mesh-ancestor
19489607|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
19489608|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025259|NCT02205762|Antibodies|antibodies|mesh-list
20025260|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
19489609|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19489610|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19489611|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20025261|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19489612|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
19489613|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489614|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489615|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19489616|NCT03143972|Narcotics|narcotics|mesh-ancestor
19569433|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
19569434|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19569435|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19569436|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569437|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569438|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19569439|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19569440|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569441|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
19569442|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569443|NCT04907539|Denosumab|denosumab|mesh-list
19569444|NCT04907539|Nivolumab|nivolumab|mesh-list
19569445|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569446|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569447|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19569448|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569449|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19569450|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569451|NCT04891068|Azacitidine|azacitidine|mesh-list
19569452|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569453|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
19569454|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569455|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569456|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569457|NCT04887831|Gemcitabine|gemcitabine|mesh-list
19569458|NCT04887831|Carboplatin|carboplatin|mesh-list
19569459|NCT04887831|Avelumab|avelumab|mesh-list
19569460|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569461|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569462|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
19569463|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569464|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
19569465|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569466|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569467|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19569468|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
19569469|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569470|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569471|NCT04878432|Azacitidine|azacitidine|mesh-list
19569472|NCT04878432|Decitabine|decitabine|mesh-list
19569473|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569474|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
19569475|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569476|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569477|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569478|NCT04848753|Paclitaxel|paclitaxel|mesh-list
19569479|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19569480|NCT04848753|Cisplatin|cisplatin|mesh-list
19569481|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19569482|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569483|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
19569484|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
19569485|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744215|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
19489617|NCT03143530|Ropivacaine|ropivacaine|mesh-list
19489618|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
19489619|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
19489620|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489621|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489622|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
19489623|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489624|NCT03143738|Anesthetics|anesthetics|mesh-list
19489625|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489626|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489627|NCT03143452|Lidocaine|lidocaine|mesh-list
19489628|NCT03143452|Tetracaine|tetracaine|mesh-list
19489629|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19489630|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
19489631|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
19489632|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489633|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489634|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
19489635|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489636|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19489637|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19489638|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19489639|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19489640|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489641|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19489642|NCT03143465|Calcitonin|calcitonin|mesh-list
19489643|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
19489644|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
19489645|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19489646|NCT03143465|Katacalcin|katacalcin|mesh-list
19489647|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
19489648|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19489649|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20025262|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20025263|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
20025264|NCT02205762|Hormones|hormones|mesh-ancestor
20025265|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025266|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025267|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20025268|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025269|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20025270|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
20025271|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20025272|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025273|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
20025274|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025275|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
20025276|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025277|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20025278|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025279|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
20025280|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025281|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19489650|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489651|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489652|NCT03143465|Urological Agents|urological agents|mesh-ancestor
19489653|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19489654|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489655|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19489656|NCT03143491|Paclitaxel|paclitaxel|mesh-list
20025282|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
20025283|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025284|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025285|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025286|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025287|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
20025288|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20025289|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20025290|NCT02205762|Analgesics|analgesics|mesh-ancestor
20025291|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
20025292|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025293|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
20025294|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
20115538|NCT00005585|Thioguanine|thioguanine|mesh-list
19489657|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19489658|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489659|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
19489660|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
19489661|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
19489662|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489663|NCT03143244|Ketorolac|ketorolac|mesh-list
19489664|NCT03143244|Midazolam|midazolam|mesh-list
19489665|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
19489666|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19489667|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489668|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489669|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489670|NCT03143244|Analgesics|analgesics|mesh-ancestor
19489671|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
19489672|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489673|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19489674|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19744216|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744217|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19744218|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19744219|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19744220|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
19744221|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19744222|NCT03104283|Apatinib|apatinib|mesh-list
19744223|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744224|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744225|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744226|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744227|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
19744228|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19744229|NCT03086044|Velpatasvir|velpatasvir|mesh-list
19744230|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
19744231|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744232|NCT03084939|Capecitabine|capecitabine|mesh-list
19744233|NCT03084939|Trastuzumab|trastuzumab|mesh-list
19744234|NCT03084939|Lapatinib|lapatinib|mesh-list
19744235|NCT03084939|Maytansine|maytansine|mesh-list
19744236|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19744237|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744238|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
19744239|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744240|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744241|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744242|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744243|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744244|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744245|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744246|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744247|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744248|NCT03067571|Daratumumab|daratumumab|mesh-list
19744249|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744250|NCT03049306|Propranolol|propranolol|mesh-list
19744251|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19744252|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19744253|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
19744254|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744255|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744256|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744257|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19744258|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19744259|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
19744260|NCT03047928|Nivolumab|nivolumab|mesh-list
19744261|NCT03047928|Vaccines|vaccines|mesh-list
19744262|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
19744263|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744264|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744265|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744266|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19744267|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744268|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
19744269|NCT03006926|Lenvatinib|lenvatinib|mesh-list
20025295|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20025296|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
19489675|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19489676|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
19489677|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489678|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489679|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19489680|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19489681|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19489682|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19489683|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19489684|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
19489685|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
19489686|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
19489687|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
19489688|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19489689|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489690|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489691|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19489692|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489693|NCT03143036|Thalidomide|thalidomide|mesh-list
19489694|NCT03143036|Dexamethasone|dexamethasone|mesh-list
19489695|NCT03143036|Daratumumab|daratumumab|mesh-list
19489696|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489697|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
19489698|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
19489699|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489700|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489701|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489702|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
19489703|NCT03143036|Hormones|hormones|mesh-ancestor
19489704|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489705|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19489706|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489707|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489708|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
19489709|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
19489710|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19489711|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489712|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19489713|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19489714|NCT03143036|Growth Substances|growth substances|mesh-ancestor
19489715|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
19489716|NCT03143023|Fluorides|fluorides|mesh-list
19489717|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
19489718|NCT03143023|Protective Agents|protective agents|mesh-ancestor
19489719|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489720|NCT03142789|Cerivastatin|cerivastatin|mesh-list
19489721|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19489722|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19489723|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19489724|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
19489725|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489726|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489727|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19489728|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
19489729|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19489730|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489731|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489732|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489733|NCT03143010|Analgesics|analgesics|mesh-ancestor
19489734|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
19489735|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489736|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19489737|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19489738|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19489739|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
19489740|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489741|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489742|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19489743|NCT03142776|Clarithromycin|clarithromycin|mesh-list
19489744|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489745|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19489746|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489747|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489748|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19489749|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19489750|NCT03142880|Ropivacaine|ropivacaine|mesh-list
19489751|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
19489752|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
19489753|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489754|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489755|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
19489756|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489757|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
19489758|NCT03142646|Fludarabine|fludarabine|mesh-list
19489759|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489760|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
19489761|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489762|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489763|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19489764|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
19489765|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489766|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489767|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19489768|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
19489769|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19489770|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489771|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
19489772|NCT03142763|Choline|choline|mesh-list
19489773|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
19489774|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19489775|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
19489776|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489777|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489778|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19489779|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
19489780|NCT03142620|Vitamin D|vitamin d|mesh-list
19489781|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
19489782|NCT03142620|Amoxicillin|amoxicillin|mesh-list
19489783|NCT03142620|Clarithromycin|clarithromycin|mesh-list
19489784|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
19489785|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19489786|NCT03142620|Esomeprazole|esomeprazole|mesh-list
19489787|NCT03142620|Vitamins|vitamins|mesh-ancestor
19489788|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
19489789|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489790|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19489791|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19489792|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19489793|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489794|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19489795|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489796|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19489797|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489798|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489799|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19489800|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19489801|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19489802|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19489803|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
19489804|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19489805|NCT03142607|Metronidazole|metronidazole|mesh-list
19489806|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19489807|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489808|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
19489809|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
19489810|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19489811|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19489812|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19489813|NCT03142516|Leucovorin|leucovorin|mesh-list
19489814|NCT03142516|Folic Acid|folic acid|mesh-list
19489815|NCT03142516|Fluorouracil|fluorouracil|mesh-list
19489816|NCT03142516|Irinotecan|irinotecan|mesh-list
19489817|NCT03142516|Panitumumab|panitumumab|mesh-list
19489818|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
19489819|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
19489820|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489821|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19489822|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489823|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489824|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
19489825|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489826|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19489827|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19489828|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489829|NCT03142516|Antidotes|antidotes|mesh-ancestor
19489830|NCT03142516|Protective Agents|protective agents|mesh-ancestor
19489831|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
19489832|NCT03142516|Vitamins|vitamins|mesh-ancestor
19489833|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
19489834|NCT03142516|Hematinics|hematinics|mesh-ancestor
19489835|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19489836|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
19489837|NCT03142165|Promethazine|promethazine|mesh-list
19489838|NCT03142165|Famotidine|famotidine|mesh-list
19489839|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19489840|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19489841|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489842|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489843|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
19489844|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
19489845|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
19489846|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489847|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
19489848|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
19489849|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489850|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19489851|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
19489852|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
19489853|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489854|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489855|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19489856|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
19489857|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
19489858|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19489859|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19489860|NCT03142321|Vedolizumab|vedolizumab|mesh-list
19489861|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489862|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19489863|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19489864|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19489865|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489866|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489867|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
19489868|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489869|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19489870|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19489871|NCT03142139|Vaccines|vaccines|mesh-list
19489872|NCT03142139|Immunologic Factors|immunologic factors|mesh-ancestor
19489873|NCT03142139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489874|NCT03142360|Beraprost|beraprost|mesh-list
19489875|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19489876|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
19569486|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569487|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
19569488|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
19569489|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569490|NCT04827745|Blinatumomab|blinatumomab|mesh-list
19569491|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569492|NCT04811625|Aspirin|aspirin|mesh-list
19569493|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569494|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569495|NCT04811625|Analgesics|analgesics|mesh-ancestor
19569496|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
19569497|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569498|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569499|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569500|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569501|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19569502|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19569503|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569504|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19569505|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19569506|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569507|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
19569508|NCT04788615|Interferons|interferons|mesh-list
19569509|NCT04788615|Interferon-beta|interferon-beta|mesh-list
19569510|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
19569511|NCT04788615|Teriflunomide|teriflunomide|mesh-list
19569512|NCT04788615|Ofatumumab|ofatumumab|mesh-list
19569513|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
19489877|NCT03142542|Udenafil|udenafil|mesh-list
19489878|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19489879|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20025297|NCT02159495|Fludarabine|fludarabine|mesh-list
20025298|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
20025299|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025300|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
20025301|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489880|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489881|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489882|NCT03141827|Insulin|insulin|mesh-list
19489883|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19489884|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489885|NCT03141970|Prednisone|prednisone|mesh-list
19489886|NCT03141970|Prednisolone|prednisolone|mesh-list
19489887|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489888|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
19489889|NCT03141970|Hormones|hormones|mesh-ancestor
19489890|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489891|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489892|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19489893|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489894|NCT03141658|Ketamine|ketamine|mesh-list
19489895|NCT03141658|Analgesics|analgesics|mesh-ancestor
19489896|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
19489897|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025302|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025303|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025304|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
20025305|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025306|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025307|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20025308|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025309|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
20025310|NCT02157051|Vaccines|vaccines|mesh-list
20025311|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
20025312|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025313|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
20025314|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20025315|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
20025316|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025317|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
20025318|NCT02136901|Protective Agents|protective agents|mesh-ancestor
20025319|NCT02134301|Oritavancin|oritavancin|mesh-list
20025320|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20025321|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025322|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
20025323|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20025324|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
20025325|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025326|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
20025327|NCT02108496|Protective Agents|protective agents|mesh-ancestor
20025328|NCT02069730|Androgens|androgens|mesh-list
20025329|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
20025330|NCT02069730|Hormones|hormones|mesh-ancestor
20025331|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025332|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025333|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
20292939|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
20025334|NCT02057133|Tamoxifen|tamoxifen|mesh-list
20025335|NCT02057133|Trastuzumab|trastuzumab|mesh-list
20025336|NCT02057133|Pertuzumab|pertuzumab|mesh-list
20025337|NCT02057133|Everolimus|everolimus|mesh-list
20025338|NCT02057133|Letrozole|letrozole|mesh-list
20025339|NCT02057133|Fulvestrant|fulvestrant|mesh-list
20025340|NCT02057133|Anastrozole|anastrozole|mesh-list
20025341|NCT02057133|Exemestane|exemestane|mesh-list
20025342|NCT02057133|Loperamide|loperamide|mesh-list
20025343|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025344|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025345|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025346|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
20292940|NCT04948333|Vitamins|vitamins|mesh-ancestor
20292941|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
19489898|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489899|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20025347|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025348|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20292942|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489900|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19489901|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
19489902|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
19489903|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489904|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19489905|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19489906|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489907|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489908|NCT03141645|Ondansetron|ondansetron|mesh-list
19489909|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
19489910|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
19489911|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489912|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489913|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489914|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
19489915|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
19489916|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19489917|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
19489918|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489919|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489920|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19489921|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19489922|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489923|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19489924|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19489925|NCT03141918|Curcumin|curcumin|mesh-list
19489926|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19489927|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19489928|NCT03141918|Analgesics|analgesics|mesh-ancestor
19489929|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
19489930|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489931|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489932|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489933|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19489934|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489935|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489936|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489937|NCT03141632|Dulaglutide|dulaglutide|mesh-list
19489938|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19489939|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489940|NCT03141593|Vitamin D|vitamin d|mesh-list
19489941|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
19489942|NCT03141593|Vitamins|vitamins|mesh-list
19489943|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
19489944|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489945|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19489946|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19489947|NCT03141398|Pancrelipase|pancrelipase|mesh-list
19489948|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489949|NCT03141268|Lactulose|lactulose|mesh-list
19489950|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489951|NCT03141476|Cefuroxime|cefuroxime|mesh-list
19489952|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
19489953|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19489954|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489955|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
19489956|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
19489957|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19489958|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489959|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
19489960|NCT03141125|Ethanol|ethanol|mesh-list
19489961|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19489962|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19489963|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489964|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489965|NCT03140982|Propofol|propofol|mesh-list
19489966|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19489967|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19489968|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489969|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19489970|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
19489971|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
19489972|NCT03140956|Levodopa|levodopa|mesh-list
19489973|NCT03140956|Carbidopa|carbidopa|mesh-list
19489974|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19489975|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19489976|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
19744270|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744271|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744272|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744273|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744274|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744275|NCT02998528|Gemcitabine|gemcitabine|mesh-list
19744276|NCT02998528|Paclitaxel|paclitaxel|mesh-list
19744277|NCT02998528|Vinorelbine|vinorelbine|mesh-list
19744278|NCT02998528|Docetaxel|docetaxel|mesh-list
19744279|NCT02998528|Carboplatin|carboplatin|mesh-list
19744280|NCT02998528|Nivolumab|nivolumab|mesh-list
19744281|NCT02998528|Pemetrexed|pemetrexed|mesh-list
19744282|NCT02998528|Ipilimumab|ipilimumab|mesh-list
19744283|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744284|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744285|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744286|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744287|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744288|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744289|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744290|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
19744291|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
19744292|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744293|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744294|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744295|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
19744296|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744297|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744298|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20025349|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20025350|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025351|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489977|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19489978|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19489979|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489980|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19489981|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19489982|NCT03140943|Thalidomide|thalidomide|mesh-list
19489983|NCT03140943|Dexamethasone|dexamethasone|mesh-list
19489984|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19489985|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
19489986|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
19489987|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19489988|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19489989|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19489990|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
19489991|NCT03140943|Hormones|hormones|mesh-ancestor
19489992|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19489993|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19489994|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19489995|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19489996|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
19489997|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
19489998|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19489999|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490000|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19490001|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19490002|NCT03140943|Growth Substances|growth substances|mesh-ancestor
19490003|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
19490004|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
19490005|NCT03140553|Carboplatin|carboplatin|mesh-list
19490006|NCT03140553|Docetaxel|docetaxel|mesh-list
19490007|NCT03140553|Trastuzumab|trastuzumab|mesh-list
19490008|NCT03140553|Epirubicin|epirubicin|mesh-list
19490009|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19490010|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
19490011|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490012|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490013|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025352|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20292943|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
19490014|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
19490015|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744299|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19744300|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19744301|NCT02993926|Leuprolide|leuprolide|mesh-list
19490016|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490017|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19490018|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
19490019|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
19490020|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
19490021|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490022|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19490023|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19490024|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19490025|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490026|NCT03140826|Meropenem|meropenem|mesh-list
19490027|NCT03140826|Tazobactam|tazobactam|mesh-list
19490028|NCT03140826|Piperacillin|piperacillin|mesh-list
19490029|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19490030|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19490031|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490032|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19490033|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490034|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490035|NCT03140787|Lidocaine|lidocaine|mesh-list
19490036|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490037|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
19490038|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490039|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490040|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
19490041|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490042|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490043|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19490044|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19490045|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490046|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490047|NCT03140384|Misoprostol|misoprostol|mesh-list
19490048|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19490049|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
19490050|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19490051|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490052|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19490053|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490054|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
19490055|NCT03140449|Calcitriol|calcitriol|mesh-list
19490056|NCT03140449|Sirolimus|sirolimus|mesh-list
19490057|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19490058|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490059|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19490060|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490061|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
19490062|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19490063|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
19490064|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490065|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19490066|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19490067|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490068|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490069|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19490070|NCT03140449|Vitamins|vitamins|mesh-ancestor
19490071|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
19490072|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19490073|NCT03140709|Oxytocin|oxytocin|mesh-list
19490074|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
19490075|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19490076|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490077|NCT03140488|Oxytocin|oxytocin|mesh-list
19490078|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
19490079|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19490080|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490081|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19490082|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569514|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19569515|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
19569516|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569517|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
19569518|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025353|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
19569519|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
19569520|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115539|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
19490083|NCT03140358|Atropine|atropine|mesh-list
20025354|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025355|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19490084|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19490085|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490086|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19490087|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
19490088|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490089|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490090|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19490091|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
19490092|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
19490093|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
19490094|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19490095|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19490096|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
19490097|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490098|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490099|NCT03140293|Lidocaine|lidocaine|mesh-list
19490100|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
19490101|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490102|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
19490103|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490104|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490105|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
19490106|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490107|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490108|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19490109|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19490110|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490111|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490112|NCT03140332|Sorafenib|sorafenib|mesh-list
19490113|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490114|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19490115|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490116|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490117|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
19490118|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
19490119|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19490120|NCT03140397|Estrogens|estrogens|mesh-ancestor
19490121|NCT03140397|Hormones|hormones|mesh-ancestor
19490122|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490123|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490124|NCT03140176|Sunitinib|sunitinib|mesh-list
19490125|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490126|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19490127|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19490128|NCT03140176|Growth Substances|growth substances|mesh-ancestor
19490129|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490130|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
19490131|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19490132|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490133|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490134|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
19490135|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
19490136|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19490137|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
19490138|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490139|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490140|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19490141|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
19490142|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490143|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490144|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19490145|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490146|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19490147|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490148|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19490149|NCT03139708|Phenylephrine|phenylephrine|mesh-list
19490150|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
19490151|NCT03139708|Tropicamide|tropicamide|mesh-list
19490152|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19490153|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
19490154|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
19490155|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490156|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490157|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
19490158|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19490159|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
19490160|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
19490161|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19490162|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19490163|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19490164|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
19490165|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490166|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025356|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20025357|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20025358|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20025359|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20025360|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
20025361|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20025362|NCT02056236|Midazolam|midazolam|mesh-list
20025363|NCT02056236|Levetiracetam|levetiracetam|mesh-list
20025364|NCT02056236|Valproic Acid|valproic acid|mesh-list
20025365|NCT02056236|Lorazepam|lorazepam|mesh-list
20025366|NCT02056236|Thiopental|thiopental|mesh-list
20025367|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
20025368|NCT02056236|Propofol|propofol|mesh-list
20025369|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20025370|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576465|NCT02071537|Carboplatin|carboplatin|mesh-list
19490167|NCT03139708|Protective Agents|protective agents|mesh-ancestor
19490168|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19490169|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19490170|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19490171|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19490172|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
19490173|NCT03140033|Misoprostol|misoprostol|mesh-list
19490174|NCT03140033|Ranitidine|ranitidine|mesh-list
19744302|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19744303|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
19744304|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19744305|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744306|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744307|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744308|NCT02967640|Ketamine|ketamine|mesh-list
19744309|NCT02967640|Analgesics|analgesics|mesh-ancestor
19744310|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
19744311|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744312|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744313|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19744314|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19744315|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
19744316|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
19744317|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19744318|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19744319|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19744320|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744321|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744322|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
19744323|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744324|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19744325|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19744326|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
19744327|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744328|NCT02938442|Paclitaxel|paclitaxel|mesh-list
19744329|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19744330|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
19744331|NCT02938442|Doxorubicin|doxorubicin|mesh-list
19744332|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19744333|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
19744334|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744335|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744336|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19490175|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19744337|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025371|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025372|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19490176|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19490177|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
19490178|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19490179|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490180|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19490181|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490182|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
19490183|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19490184|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
19490185|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
19490186|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490187|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490188|NCT03139474|Hormones|hormones|mesh-list
19490189|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
19490190|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490191|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490192|NCT03139487|Dalteparin|dalteparin|mesh-list
19490193|NCT03139487|Tinzaparin|tinzaparin|mesh-list
19490194|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20025373|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
20025374|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
20025375|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20025376|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20025377|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20025378|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20292944|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20292945|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
20025379|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
20025380|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
20025381|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025382|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025383|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
20025384|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025385|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
20025386|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
20025387|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
20025388|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025389|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20025390|NCT02007044|Rituximab|rituximab|mesh-list
20025391|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20025392|NCT02007044|Antibodies|antibodies|mesh-list
20025393|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
20025394|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20025395|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
20025396|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025397|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025398|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490195|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
19490196|NCT03139487|Apixaban|apixaban|mesh-list
20576466|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490197|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20025399|NCT01962246|Capecitabine|capecitabine|mesh-list
20025400|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
20025401|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19490198|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
19490199|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19490200|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
19490201|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490202|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490203|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
19490204|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19490205|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19490206|NCT03139253|Amoxicillin|amoxicillin|mesh-list
19490207|NCT03139253|Clarithromycin|clarithromycin|mesh-list
19490208|NCT03139253|Levofloxacin|levofloxacin|mesh-list
19490209|NCT03139253|Ofloxacin|ofloxacin|mesh-list
19490210|NCT03139253|Tetracycline|tetracycline|mesh-list
19490211|NCT03139253|Tinidazole|tinidazole|mesh-list
19490212|NCT03139253|Furazolidone|furazolidone|mesh-list
19490213|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19490214|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490215|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19490216|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490217|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490218|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19490219|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19490220|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19490221|NCT03139253|Renal Agents|renal agents|mesh-ancestor
19490222|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19490223|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19490224|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490225|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19490226|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
19490227|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19490228|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19490229|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19490230|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19490231|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19490232|NCT03139591|Dexamethasone|dexamethasone|mesh-list
19490233|NCT03139591|Lidocaine|lidocaine|mesh-list
19490234|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19490235|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
19490236|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
19490237|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490238|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490239|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490240|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
19490241|NCT03139591|Hormones|hormones|mesh-ancestor
19490242|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490243|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19490244|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490245|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490246|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
19490247|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490248|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
19490249|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490250|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19490251|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19490252|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490253|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490254|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
19490255|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19490256|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025402|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
20025403|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490257|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
19490258|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
19490259|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
19490260|NCT03139422|Calcium|calcium|mesh-list
19490261|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19490262|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490263|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19490264|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19490265|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490266|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
19490267|NCT03139422|Coagulants|coagulants|mesh-ancestor
19490268|NCT03139513|Vemurafenib|vemurafenib|mesh-list
19490269|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490270|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19490271|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490272|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490273|NCT03139565|Vaccines|vaccines|mesh-list
19490274|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
19490275|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490276|NCT03139305|Glucagon|glucagon|mesh-list
19490277|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19490278|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490279|NCT03139305|Hormones|hormones|mesh-ancestor
19490280|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490281|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490282|NCT03139305|Incretins|incretins|mesh-ancestor
19490283|NCT03139500|Midazolam|midazolam|mesh-list
19490284|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20025404|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025405|NCT01810705|Asparaginase|asparaginase|mesh-list
20025406|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025407|NCT01568918|Tamsulosin|tamsulosin|mesh-list
20025408|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20025409|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20025410|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20025411|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
20025412|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025413|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025414|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025415|NCT01568918|Urological Agents|urological agents|mesh-ancestor
19490285|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19490286|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490287|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490288|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19490289|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19490290|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19490291|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19490292|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
19490293|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
19490294|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
19490295|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
19490296|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490297|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490298|NCT03139331|Irinotecan|irinotecan|mesh-list
19490299|NCT03139331|Temozolomide|temozolomide|mesh-list
19490300|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19490301|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19490302|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490303|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490304|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490305|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19490306|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
19490307|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19490308|NCT03138759|Probenecid|probenecid|mesh-list
19490309|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
19490310|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
19490311|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490312|NCT03138759|Renal Agents|renal agents|mesh-ancestor
19569521|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19569522|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19569523|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569524|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
19569525|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569526|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569527|NCT04788615|Analgesics|analgesics|mesh-ancestor
20025416|NCT01517243|Sirolimus|sirolimus|mesh-list
19569528|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
19569529|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569530|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19490313|NCT03138603|Metoprolol|metoprolol|mesh-list
19490314|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490315|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19490316|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
19490317|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
19490318|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490319|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490320|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19490321|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19490322|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19490323|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
19490324|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490325|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490326|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
19490327|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19490328|NCT03138681|Protective Agents|protective agents|mesh-ancestor
19490329|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490330|NCT03138668|Ropivacaine|ropivacaine|mesh-list
19490331|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490332|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
19490333|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490334|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490335|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
19490336|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490337|NCT03138785|Itraconazole|itraconazole|mesh-list
19490338|NCT03138785|Voriconazole|voriconazole|mesh-list
19490339|NCT03138785|Levofloxacin|levofloxacin|mesh-list
19490340|NCT03138785|Ofloxacin|ofloxacin|mesh-list
19490341|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
19490342|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490343|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19490344|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19490345|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490346|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025417|NCT01517243|Sunitinib|sunitinib|mesh-list
20025418|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025419|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20025420|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20025421|NCT01517243|Growth Substances|growth substances|mesh-ancestor
20025422|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025423|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
20025424|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025425|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025426|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025427|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20025428|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025429|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025430|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
20025431|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025432|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
20025433|NCT01269190|Proflavine|proflavine|mesh-list
20025434|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20025435|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025436|NCT00667121|Tamoxifen|tamoxifen|mesh-list
20025437|NCT00667121|Gabapentin|gabapentin|mesh-list
20025438|NCT00667121|Dexetimide|dexetimide|mesh-list
20025439|NCT00667121|Citalopram|citalopram|mesh-list
20025440|NCT00667121|Sertraline|sertraline|mesh-list
19490347|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19490348|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
19490349|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490350|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490351|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19490352|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20025441|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20025442|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490353|NCT03138785|Renal Agents|renal agents|mesh-ancestor
19490354|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19490355|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19490356|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19490357|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490358|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19490359|NCT03138616|Vitamin D|vitamin d|mesh-list
19490360|NCT03138616|Vitamins|vitamins|mesh-ancestor
19490361|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
19490362|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490363|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19490364|NCT03138499|Nivolumab|nivolumab|mesh-list
19490365|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19490366|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490367|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490368|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19490369|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490370|NCT03138447|Insulin|insulin|mesh-list
19490371|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19490372|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490373|NCT03138356|Metformin|metformin|mesh-list
19490374|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
19490375|NCT03138356|Saxagliptin|saxagliptin|mesh-list
19490376|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19490377|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490378|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19490379|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490380|NCT03138356|Incretins|incretins|mesh-ancestor
19490381|NCT03138356|Hormones|hormones|mesh-ancestor
19490382|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490383|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19490384|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
19490385|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490386|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19490387|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19490388|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490389|NCT03138031|Ethanol|ethanol|mesh-list
19490390|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19490391|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490392|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490393|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490394|NCT03137927|Vaccines|vaccines|mesh-list
19490395|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
19490396|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744338|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744339|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744340|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744341|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
19744342|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744343|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490403|NCT03137667|Vaccines|vaccines|mesh-list
19490404|NCT03137667|Immunologic Factors|immunologic factors|mesh-ancestor
19490405|NCT03137667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490406|NCT03137615|Anesthetics|anesthetics|mesh-list
19490407|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
19490408|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490409|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490410|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
19490411|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490412|NCT03137498|Ketorolac|ketorolac|mesh-list
19490413|NCT03137498|Lidocaine|lidocaine|mesh-list
19490414|NCT03137498|Prilocaine|prilocaine|mesh-list
19490415|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490416|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
19490417|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490418|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490419|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
19490420|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490421|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490422|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19490423|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19490424|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490425|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490426|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19490427|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20025443|NCT00667121|Analgesics|analgesics|mesh-ancestor
20025444|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
20025445|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025446|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025447|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
20025448|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20025449|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20025450|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20025451|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20025452|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20025453|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20025454|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025455|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
20025456|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20025457|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20025458|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20025459|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
20025460|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20025461|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
20025462|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20025463|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20025464|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
20025465|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
20025466|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20025467|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20025468|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
20025469|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20025470|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
20025471|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490428|NCT03137498|Analgesics|analgesics|mesh-ancestor
19490429|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19490430|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490431|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19490432|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490433|NCT03137160|Ixekizumab|ixekizumab|mesh-list
19490434|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
19490435|NCT03137316|Hormones|hormones|mesh-list
19490436|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
19490437|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025472|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20025473|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025474|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20025475|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20025476|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20025477|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20025478|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
20025479|NCT00641381|Carmustine|carmustine|mesh-list
20025480|NCT00641381|Etoposide|etoposide|mesh-list
20025481|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025482|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
20025483|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025484|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025485|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025486|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
19490438|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025487|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025488|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025489|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20025490|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025491|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025492|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20025493|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025494|NCT00544414|Leucovorin|leucovorin|mesh-list
20025495|NCT00544414|Gemcitabine|gemcitabine|mesh-list
20025496|NCT00544414|Docetaxel|docetaxel|mesh-list
20025497|NCT00544414|Fluorouracil|fluorouracil|mesh-list
20025498|NCT00544414|Calcium|calcium|mesh-list
20025499|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
19490439|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19490440|NCT03137134|Crizotinib|crizotinib|mesh-list
19490441|NCT03137134|Esomeprazole|esomeprazole|mesh-list
19490442|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19490443|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490444|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19490445|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490446|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490447|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490448|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19490449|NCT03137368|Tamoxifen|tamoxifen|mesh-list
19490450|NCT03137368|Exemestane|exemestane|mesh-list
19490451|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19490452|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
19490453|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490454|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490455|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19490456|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490457|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19490458|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19490459|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19490460|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19490461|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19490462|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490463|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490464|NCT03137290|Neostigmine|neostigmine|mesh-list
19490465|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19490466|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490467|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490468|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
19490469|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490470|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490471|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19490472|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
19490473|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490474|NCT03137186|Metformin|metformin|mesh-list
19490475|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19490476|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490477|NCT03137030|Acetaminophen|acetaminophen|mesh-list
19490478|NCT03137030|Hydrocodone|hydrocodone|mesh-list
19490479|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19490480|NCT03137030|Analgesics|analgesics|mesh-ancestor
19490481|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
19490482|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490483|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490484|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
19490485|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19490486|NCT03137030|Narcotics|narcotics|mesh-ancestor
20025500|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292946|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
19490487|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490488|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
19490489|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
19490490|NCT03137017|Acetaminophen|acetaminophen|mesh-list
19490491|NCT03137017|Hydrocodone|hydrocodone|mesh-list
19490492|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19490493|NCT03137017|Analgesics|analgesics|mesh-ancestor
19490494|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
19490495|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490496|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490497|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
19490498|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19490499|NCT03137017|Narcotics|narcotics|mesh-ancestor
19490500|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490501|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
19490502|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
19490503|NCT03137082|Guanfacine|guanfacine|mesh-list
19490504|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19490505|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19490506|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19490507|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19490508|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
19490509|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490510|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490511|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569531|NCT04768296|Topotecan|topotecan|mesh-list
19569532|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19569533|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19569534|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569535|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569536|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577766|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577767|NCT03941496|Azacitidine|azacitidine|mesh-list
19577768|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577769|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
19577770|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577771|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577772|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577773|NCT03913234|Trastuzumab|trastuzumab|mesh-list
19577774|NCT03913234|Letrozole|letrozole|mesh-list
19577775|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577776|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577777|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19577778|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19577779|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577780|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577781|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19577782|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
19577783|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577784|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577785|NCT03904199|Insulin|insulin|mesh-list
19577786|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19577787|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19577788|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577789|NCT03899467|Androgens|androgens|mesh-list
19577790|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
19577791|NCT03899467|Hormones|hormones|mesh-ancestor
19577792|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577793|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577794|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
19577795|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
19577796|NCT03894891|Docetaxel|docetaxel|mesh-list
19577797|NCT03894891|Nivolumab|nivolumab|mesh-list
19577798|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577799|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577800|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
19490512|NCT03137004|Docetaxel|docetaxel|mesh-list
19490513|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490514|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19490515|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19490516|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19490517|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490518|NCT03136666|Candesartan|candesartan|mesh-list
19490519|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
19490520|NCT03136666|Nifedipine|nifedipine|mesh-list
19490521|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19490522|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19490523|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19490524|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490525|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19490526|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490527|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19490528|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490529|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
19490530|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
19490531|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19490532|NCT03136705|Niacinamide|niacinamide|mesh-list
19490533|NCT03136705|Niacin|niacin|mesh-list
19490534|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
19490535|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
19490536|NCT03136705|Vitamins|vitamins|mesh-ancestor
19490537|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
19490538|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490539|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19490540|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
19490541|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490542|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19490543|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
19490544|NCT03136796|Meropenem|meropenem|mesh-list
19490545|NCT03136796|Piperacillin|piperacillin|mesh-list
19490546|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19490547|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490548|NCT03136510|Apixaban|apixaban|mesh-list
19490549|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19490550|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
19490551|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19490552|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
19490553|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490554|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490555|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
19490556|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19490557|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19490558|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19490559|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490560|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490561|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
19490562|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490563|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490564|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19490565|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490566|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
19490567|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19490568|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19490569|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490570|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
19490571|NCT03136445|Coagulants|coagulants|mesh-ancestor
19490572|NCT03136237|Cyclosporine|cyclosporine|mesh-list
19490573|NCT03136237|Digoxin|digoxin|mesh-list
19490574|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19490575|NCT03136237|Cyclosporins|cyclosporins|mesh-list
19490576|NCT03136237|Berotralstat|berotralstat|mesh-list
19490577|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490578|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490579|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19490580|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
19490581|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490582|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
19490583|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490584|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
19490585|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490586|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19490587|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19490588|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19490589|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
19490590|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20025501|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025502|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
20025503|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025504|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
20025505|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025506|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292947|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20292948|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292949|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025507|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025508|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
20025509|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025510|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025511|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025512|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
20025513|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20025514|NCT00544414|Antidotes|antidotes|mesh-ancestor
20025515|NCT00544414|Protective Agents|protective agents|mesh-ancestor
20025516|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
20025517|NCT00544414|Vitamins|vitamins|mesh-ancestor
20025518|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
20025519|NCT00534469|Cytarabine|cytarabine|mesh-list
20025520|NCT00534469|Aldesleukin|aldesleukin|mesh-list
20025521|NCT00534469|Etoposide|etoposide|mesh-list
20025522|NCT00534469|Idarubicin|idarubicin|mesh-list
20025523|NCT00534469|Busulfan|busulfan|mesh-list
20025524|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025525|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025526|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025527|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19490591|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19490592|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490593|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19490594|NCT03136237|Protective Agents|protective agents|mesh-ancestor
19490595|NCT03136406|Leucovorin|leucovorin|mesh-list
19490596|NCT03136406|Paclitaxel|paclitaxel|mesh-list
19490597|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
19490598|NCT03136406|Bevacizumab|bevacizumab|mesh-list
19490599|NCT03136406|Fluorouracil|fluorouracil|mesh-list
19490600|NCT03136406|Capecitabine|capecitabine|mesh-list
19490601|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
19490602|NCT03136406|Avelumab|avelumab|mesh-list
19490603|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19490604|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490605|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
19490606|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
19490607|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
19490608|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490609|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19490610|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
19490611|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490612|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490613|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19490614|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
19490615|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19490616|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490617|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19490618|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19490619|NCT03136406|Growth Substances|growth substances|mesh-ancestor
19744344|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19744345|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
19744346|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19744347|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744348|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19744349|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19744350|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744351|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19744352|NCT02932579|Acetaminophen|acetaminophen|mesh-list
19744353|NCT02932579|Ibuprofen|ibuprofen|mesh-list
19744354|NCT02932579|Oxycodone|oxycodone|mesh-list
19744355|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19744356|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19744357|NCT02932579|Analgesics|analgesics|mesh-ancestor
19744358|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
19744359|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744360|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744361|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744362|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744363|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19744364|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744365|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744366|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19744367|NCT02932579|Narcotics|narcotics|mesh-ancestor
20292950|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20292951|NCT04940390|Analgesics|analgesics|mesh-ancestor
19744368|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19744369|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
19744370|NCT02928224|Leucovorin|leucovorin|mesh-list
19744371|NCT02928224|Folic Acid|folic acid|mesh-list
19744372|NCT02928224|Fluorouracil|fluorouracil|mesh-list
19744373|NCT02928224|Irinotecan|irinotecan|mesh-list
19744374|NCT02928224|Cetuximab|cetuximab|mesh-list
19744375|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
19744376|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
19744377|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744378|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744379|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744380|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744381|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
19744382|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744383|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19744384|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19744385|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744386|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744387|NCT02928224|Antidotes|antidotes|mesh-ancestor
19744388|NCT02928224|Protective Agents|protective agents|mesh-ancestor
19744389|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
19744390|NCT02928224|Vitamins|vitamins|mesh-ancestor
19744391|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
19744392|NCT02928224|Hematinics|hematinics|mesh-ancestor
19744393|NCT02927067|Valganciclovir|valganciclovir|mesh-list
19744394|NCT02927067|Maribavir|maribavir|mesh-list
19744395|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
19744396|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744397|NCT02905799|Resveratrol|resveratrol|mesh-list
19744398|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
19744399|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744400|NCT02905799|Protective Agents|protective agents|mesh-ancestor
19744401|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490620|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
19490621|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
19490622|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19490623|NCT03136406|Antidotes|antidotes|mesh-ancestor
19490624|NCT03136406|Protective Agents|protective agents|mesh-ancestor
19490625|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
19490626|NCT03136406|Vitamins|vitamins|mesh-ancestor
19490627|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
19490628|NCT03135977|Etoposide|etoposide|mesh-list
19490629|NCT03135977|Apatinib|apatinib|mesh-list
19490630|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19490631|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490632|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025528|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025529|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025530|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025531|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
20025532|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
20025533|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025534|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025535|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
20025536|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025537|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
20025538|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025539|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20025540|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20025541|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20025542|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025543|NCT00534430|Cyclosporine|cyclosporine|mesh-list
20025544|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
20025545|NCT00534430|Etoposide|etoposide|mesh-list
19490633|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19490634|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490635|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490636|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19490637|NCT03136029|Antioxidants|antioxidants|mesh-list
19490638|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490639|NCT03136029|Protective Agents|protective agents|mesh-ancestor
19490640|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490641|NCT03135912|Terbinafine|terbinafine|mesh-list
19490642|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
19490643|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490644|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490645|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490646|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19490647|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
19490648|NCT03136003|Coagulants|coagulants|mesh-ancestor
19490649|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19490650|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
19490651|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490652|NCT03135795|Parecoxib|parecoxib|mesh-list
19490653|NCT03135795|Sufentanil|sufentanil|mesh-list
19490654|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
19490655|NCT03135795|Remifentanil|remifentanil|mesh-list
19490656|NCT03135795|Dsuvia|dsuvia|mesh-list
19490657|NCT03135795|Bromides|bromides|mesh-list
19490658|NCT03135795|Propofol|propofol|mesh-list
19490659|NCT03135795|Sevoflurane|sevoflurane|mesh-list
19490660|NCT03135795|Citric Acid|citric acid|mesh-list
19490661|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
19490662|NCT03135795|Rocuronium|rocuronium|mesh-list
19490663|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19490664|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490665|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490666|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19490667|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
19490668|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
19490669|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19490670|NCT03135795|Analgesics|analgesics|mesh-ancestor
19490671|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
19490672|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490673|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19490674|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19490675|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19490676|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
20025546|NCT00534430|Busulfan|busulfan|mesh-list
19490677|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490678|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490679|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
19490680|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19490681|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
19490682|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
19490683|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19490684|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19490685|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19490686|NCT03135795|Narcotics|narcotics|mesh-ancestor
19490687|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
19490688|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19490689|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19490690|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19490691|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19490692|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19490693|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19490694|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490695|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19490696|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19490697|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490698|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
19490699|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19490700|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
19490701|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490702|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490703|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19490704|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
19490705|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19490706|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
19490707|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490708|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490709|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19490710|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
19490711|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
19490712|NCT03135860|Protective Agents|protective agents|mesh-ancestor
19490713|NCT03136120|Bromides|bromides|mesh-list
19490714|NCT03136120|Ipratropium|ipratropium|mesh-list
19490715|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
19490716|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19490717|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
19490718|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490719|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490720|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19490721|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
19490722|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19490723|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
19744402|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744403|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19744404|NCT02897375|Carboplatin|carboplatin|mesh-list
19744405|NCT02897375|Palbociclib|palbociclib|mesh-list
19744406|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744407|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744408|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025547|NCT00534430|Cyclosporins|cyclosporins|mesh-list
20025548|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025549|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025550|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025551|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20025552|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025553|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025554|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025555|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
20025556|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025557|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
20025558|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025559|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
20025560|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025561|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20025562|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025563|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20025564|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
20025565|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20025566|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
20025567|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025568|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20025569|NCT00003927|Paclitaxel|paclitaxel|mesh-list
19490724|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025570|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
20025571|NCT00003927|Doxorubicin|doxorubicin|mesh-list
20025572|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20025573|NCT00003927|Amifostine|amifostine|mesh-list
20025574|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025575|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025576|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025577|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
19490725|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490726|NCT03135769|Avelumab|avelumab|mesh-list
19490727|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025578|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
20025579|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025580|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025581|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
20025582|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025583|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490728|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490729|NCT03135340|Anesthetics|anesthetics|mesh-list
19490730|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490731|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569537|NCT04739358|Tepotinib|tepotinib|mesh-list
19569538|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569539|NCT04735861|Bevacizumab|bevacizumab|mesh-list
19569540|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569541|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569542|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19569543|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19744409|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025584|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025585|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
20025586|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19744410|NCT02856113|Alogliptin|alogliptin|mesh-list
19744411|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19744412|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025587|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025588|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025589|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20025590|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025591|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20025592|NCT00003927|Protective Agents|protective agents|mesh-ancestor
20025593|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20025594|NCT02588261|Gefitinib|gefitinib|mesh-list
20025595|NCT02588261|Naquotinib|naquotinib|mesh-list
20025596|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025597|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025598|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025599|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025600|NCT02588339|Sirolimus|sirolimus|mesh-list
20025601|NCT02588339|Panobinostat|panobinostat|mesh-list
20025602|NCT02588339|Tacrolimus|tacrolimus|mesh-list
20025603|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025604|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
20025605|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025606|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20025607|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025608|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025609|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20025610|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025611|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025612|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025613|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
20025614|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20025615|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20025616|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
19744413|NCT02856113|Incretins|incretins|mesh-ancestor
19744414|NCT02856113|Hormones|hormones|mesh-ancestor
19744415|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744416|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19744417|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
19744418|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744419|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744420|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
19744421|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20025617|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025618|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
20025619|NCT02588612|Fludarabine|fludarabine|mesh-list
20025620|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025621|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
20025622|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025623|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025624|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025625|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
19490732|NCT03135171|Trastuzumab|trastuzumab|mesh-list
19490733|NCT03135171|Pertuzumab|pertuzumab|mesh-list
19490734|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490735|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490736|NCT03135184|Coal Tar|coal tar|mesh-list
19490737|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
19490738|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
19490739|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
19490740|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19490741|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490742|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19490743|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490744|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490745|NCT03135106|Itraconazole|itraconazole|mesh-list
19490746|NCT03135106|Fluconazole|fluconazole|mesh-list
19490747|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
19490748|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490749|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19490750|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19490751|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490752|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490753|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19490754|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
19490755|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490756|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490757|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19490758|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19490759|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19490760|NCT03134872|Carboplatin|carboplatin|mesh-list
19490761|NCT03134872|Pemetrexed|pemetrexed|mesh-list
19490762|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490763|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490764|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490765|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19490766|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19490767|NCT03134677|Bupivacaine|bupivacaine|mesh-list
19490768|NCT03134677|Sevoflurane|sevoflurane|mesh-list
19490769|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490770|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
19490771|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490772|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490773|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
19490774|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490775|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19490776|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19490777|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
19490778|NCT03134729|Ropivacaine|ropivacaine|mesh-list
19490779|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490780|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
19490781|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490782|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490783|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
19490784|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490785|NCT03134651|Propofol|propofol|mesh-list
19490786|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19490787|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490788|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490789|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19490790|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
19490791|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
19490792|NCT03134638|Carboplatin|carboplatin|mesh-list
19490793|NCT03134638|Fulvestrant|fulvestrant|mesh-list
19490794|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490795|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19490796|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19490797|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19490798|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
19490799|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490800|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490801|NCT03134547|Sevoflurane|sevoflurane|mesh-list
19490802|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19490803|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19490804|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
19490805|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
19490806|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490807|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490808|NCT03134443|Andrographolide|andrographolide|mesh-list
19490809|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19490810|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19490811|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19490812|NCT03134443|Analgesics|analgesics|mesh-ancestor
19490813|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
19490814|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490815|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025626|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025627|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025628|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20025629|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
20025630|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20025631|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
20025632|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025633|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
19490816|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19490817|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19490818|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19490819|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490820|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
19490821|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19490822|NCT03134612|Lidocaine|lidocaine|mesh-list
19490823|NCT03134612|Ondansetron|ondansetron|mesh-list
19490824|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490825|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
19490826|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490827|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490828|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
19490829|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490830|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19490831|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19490832|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19490833|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19490834|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490835|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
19490836|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
19490837|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490838|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
20025634|NCT02588872|Protective Agents|protective agents|mesh-ancestor
20025635|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
20025636|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20025637|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20025638|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490839|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
19490840|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19490841|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
19490842|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490843|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19490844|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19490845|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19490846|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19490847|NCT03134573|Interferons|interferons|mesh-list
19490848|NCT03134573|Interferon-beta|interferon-beta|mesh-list
19490849|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
19490850|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744422|NCT02810418|Paclitaxel|paclitaxel|mesh-list
20025639|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
19490851|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
19490852|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490853|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
19490854|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490855|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19490856|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
19490857|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490858|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490859|NCT03134417|Vitamin D|vitamin d|mesh-list
19490860|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
19490861|NCT03134417|Vitamins|vitamins|mesh-list
19490862|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
19490863|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490864|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19490865|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19490866|NCT03134378|Amoxicillin|amoxicillin|mesh-list
19490867|NCT03134378|Clarithromycin|clarithromycin|mesh-list
19490868|NCT03134378|Rabeprazole|rabeprazole|mesh-list
19490869|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19490870|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490871|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19490872|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490873|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490874|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19490875|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19490876|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19490877|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490878|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19490879|NCT03134846|Cetuximab|cetuximab|mesh-list
19490880|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490881|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490882|NCT03134339|Nicotine|nicotine|mesh-list
19490883|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19490884|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
19490885|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490886|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490887|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19490888|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19490889|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
19490890|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490891|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490892|NCT03134118|Nivolumab|nivolumab|mesh-list
19490893|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490894|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490895|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19490896|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490897|NCT03133975|Vitamin D|vitamin d|mesh-list
19490898|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
19490899|NCT03133975|Vitamins|vitamins|mesh-ancestor
19490900|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
19490901|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490902|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19490903|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19490904|NCT03133832|Praziquantel|praziquantel|mesh-list
19490905|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
19490906|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19490907|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19490908|NCT03133845|Fentanyl|fentanyl|mesh-list
19490909|NCT03133845|Midazolam|midazolam|mesh-list
19490910|NCT03133845|Morphine|morphine|mesh-list
19490911|NCT03133845|Anesthetics|anesthetics|mesh-list
19490912|NCT03133845|Propofol|propofol|mesh-list
20025640|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
20025641|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20025642|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
20025643|NCT02589626|Empagliflozin|empagliflozin|mesh-list
20025644|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20025645|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025646|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20025647|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025648|NCT02589639|Empagliflozin|empagliflozin|mesh-list
20025649|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19490913|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490914|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490915|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19490916|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19490917|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
19490918|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19490919|NCT03133845|Narcotics|narcotics|mesh-ancestor
19490920|NCT03133845|Analgesics|analgesics|mesh-ancestor
19490921|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
19490922|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490923|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19490924|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19490925|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19490926|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19490927|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
19490928|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
19490929|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490930|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490931|NCT03133897|Dexamethasone|dexamethasone|mesh-list
19490932|NCT03133897|Prednisone|prednisone|mesh-list
19490933|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19490934|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
19490935|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
19490936|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490937|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025650|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025651|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20025652|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025653|NCT02589665|Mirikizumab|mirikizumab|mesh-list
20025654|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20025655|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20025656|NCT02589665|Analgesics|analgesics|mesh-ancestor
19490938|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19490939|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
19490940|NCT03133897|Hormones|hormones|mesh-ancestor
19490941|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19490942|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19490943|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490944|NCT03133923|Vaccines|vaccines|mesh-list
19490945|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
19490946|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490947|NCT03134001|Analgesics|analgesics|mesh-list
19490948|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
19490949|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490950|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490951|NCT03133780|Midazolam|midazolam|mesh-list
19490952|NCT03133780|Ketamine|ketamine|mesh-list
19490953|NCT03133780|Analgesics|analgesics|mesh-ancestor
19490954|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
19490955|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19490956|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490957|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19490958|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19490959|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
19490960|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
19490961|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490962|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19490963|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19490964|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19490965|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490966|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19490967|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19490968|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19490969|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19490970|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19490971|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
19490972|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
19490973|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
19490974|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19490975|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569544|NCT04735861|Growth Substances|growth substances|mesh-ancestor
19569545|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569546|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
19569547|NCT04734210|Betamethasone|betamethasone|mesh-list
19569548|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
19569549|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19569550|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
19569551|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19569552|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20025657|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
19569553|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
19490976|NCT03133234|Osimertinib|osimertinib|mesh-list
19490977|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490978|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19490979|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490980|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490981|NCT03133546|Bevacizumab|bevacizumab|mesh-list
19490982|NCT03133546|Osimertinib|osimertinib|mesh-list
19490983|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19490984|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19490985|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19490986|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19490987|NCT03133546|Growth Substances|growth substances|mesh-ancestor
19490988|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490989|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
19490990|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19490991|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19490992|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19490993|NCT03133325|Lidocaine|lidocaine|mesh-list
19490994|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
19490995|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
19490996|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19490997|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19490998|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
19490999|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491000|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19491001|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19491002|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19491003|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19491004|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491005|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
19491006|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491007|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
19491008|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19491009|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
19491010|NCT03133312|Povidone|povidone|mesh-list
19491011|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19491012|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491013|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
19491014|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
19491015|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
19491016|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
19491017|NCT03133195|Vitamin D|vitamin d|mesh-list
19491018|NCT03133195|Teriparatide|teriparatide|mesh-list
19491019|NCT03133195|Calcium|calcium|mesh-list
19491020|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
19491021|NCT03133195|Vitamins|vitamins|mesh-ancestor
19491022|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
19491023|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491024|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19491025|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19491026|NCT03133299|Vitamin D|vitamin d|mesh-list
19491027|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
20292952|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
20292953|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20292954|NCT04940052|Trametinib|trametinib|mesh-list
20292955|NCT04940052|Dabrafenib|dabrafenib|mesh-list
20292956|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292957|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20292958|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292959|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292960|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
19491028|NCT03133299|Vitamins|vitamins|mesh-ancestor
19491029|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
19491030|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491031|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19491032|NCT03133299|Hormones|hormones|mesh-ancestor
19491033|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491034|NCT03132688|Propofol|propofol|mesh-list
19491035|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19491036|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491037|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025658|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491038|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19491039|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
19491040|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
20292961|NCT04938817|Lenvatinib|lenvatinib|mesh-list
19491041|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19491042|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19491043|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19491044|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19491045|NCT03132623|Andrographolide|andrographolide|mesh-list
19491046|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491047|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20025659|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025660|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20025661|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025662|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19491048|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491049|NCT03132623|Analgesics|analgesics|mesh-ancestor
19491050|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
19491051|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491052|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491053|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491054|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19491055|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19491056|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491057|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
19491058|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19491059|NCT03132714|Amoxicillin|amoxicillin|mesh-list
19491060|NCT03132714|Metronidazole|metronidazole|mesh-list
19491061|NCT03132714|Clarithromycin|clarithromycin|mesh-list
19491062|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491063|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491064|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19491065|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19491066|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19491067|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491068|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491069|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20025663|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20025664|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20025665|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20025666|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025667|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
20025668|NCT02589977|Regadenoson|regadenoson|mesh-list
20025669|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20025670|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20025671|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
20025672|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
20025673|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025674|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025675|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025676|NCT02590003|Paclitaxel|paclitaxel|mesh-list
20025677|NCT02590003|Carboplatin|carboplatin|mesh-list
20025678|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025679|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025680|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025681|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025682|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
20025683|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025684|NCT02590432|Linaclotide|linaclotide|mesh-list
20025685|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20025686|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
20025687|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025688|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20025689|NCT02590588|Idelalisib|idelalisib|mesh-list
20025690|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025691|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025692|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025693|NCT02591238|Melatonin|melatonin|mesh-list
20025694|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
20025695|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025696|NCT02591238|Protective Agents|protective agents|mesh-ancestor
20025697|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025698|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20025699|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
20025700|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20025701|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491070|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19491071|NCT03132610|Andrographolide|andrographolide|mesh-list
19491072|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491073|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19491074|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491075|NCT03132610|Analgesics|analgesics|mesh-ancestor
19491076|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
19491077|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491078|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491079|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491080|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19491081|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19491082|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491083|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
19491084|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19491085|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
19491086|NCT03132701|Analgesics|analgesics|mesh-ancestor
19491087|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
19491088|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491089|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491090|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
19491091|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491092|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19491093|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
20025702|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20025703|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115540|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115541|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
20115542|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292962|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20292963|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292964|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20292965|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292966|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292967|NCT04922424|Atorvastatin|atorvastatin|mesh-list
20292968|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20115543|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115544|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115545|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
20115546|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115547|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115548|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115549|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115550|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
20115551|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
20115552|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115553|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20115554|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
20115555|NCT00005585|Hormones|hormones|mesh-ancestor
20115556|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115557|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115558|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20115559|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
20115560|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20115561|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115562|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
20115563|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115564|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115565|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20115566|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20115567|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
20115568|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115569|NCT00005585|Antidotes|antidotes|mesh-ancestor
20115570|NCT00005585|Protective Agents|protective agents|mesh-ancestor
20115571|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
20115572|NCT00005585|Vitamins|vitamins|mesh-ancestor
20115573|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
20115574|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115575|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115576|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115577|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115578|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115579|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115580|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115581|NCT00005586|Leucovorin|leucovorin|mesh-list
19491094|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19491095|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19491096|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491097|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19491098|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
19491099|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19491100|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
19491101|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
19491102|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19491103|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
19491104|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491105|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491106|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19491107|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
19491108|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491109|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491110|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19491111|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19491112|NCT03132272|Autoantibodies|autoantibodies|mesh-list
19491113|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
19491114|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491115|NCT03132493|Nivolumab|nivolumab|mesh-list
19491116|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19491117|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491118|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19491119|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491120|NCT03132519|Remifentanil|remifentanil|mesh-list
19491121|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19491122|NCT03132519|Narcotics|narcotics|mesh-ancestor
19491123|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491124|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491125|NCT03132519|Analgesics|analgesics|mesh-ancestor
19491126|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
19491127|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491128|NCT03132233|Calcium|calcium|mesh-list
19491129|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19491130|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491131|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
19491132|NCT03132142|Capsaicin|capsaicin|mesh-list
19491133|NCT03132142|Menthol|menthol|mesh-list
19491134|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
19491135|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
19491136|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
19491137|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491138|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491139|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19491140|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491141|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19491142|NCT03132142|Protective Agents|protective agents|mesh-ancestor
19491143|NCT03132194|Dapsone|dapsone|mesh-list
19491144|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491145|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
19491146|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19491147|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19491148|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19491149|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491150|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491151|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
19491152|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491153|NCT03132311|Vaccines|vaccines|mesh-list
19491154|NCT03132311|Immunologic Factors|immunologic factors|mesh-ancestor
19491155|NCT03132311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491156|NCT03132376|Caseins|caseins|mesh-list
20025704|NCT02592434|Tofacitinib|tofacitinib|mesh-list
20025705|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025706|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491157|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
19491158|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
19744423|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744424|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744425|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
19491159|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491160|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
19491161|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19491162|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491163|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491164|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491165|NCT03132259|Analgesics|analgesics|mesh-ancestor
19491166|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
19491167|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491168|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19491169|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19491170|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19491171|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
19491172|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491173|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491174|NCT03132181|Empagliflozin|empagliflozin|mesh-list
19491175|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19491176|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491177|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19491178|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491179|NCT03132103|Vitamin D|vitamin d|mesh-list
19491180|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
19491181|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
19491182|NCT03132103|Vitamins|vitamins|mesh-list
19491183|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
19491184|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025707|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025708|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20025709|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
20025710|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025711|NCT02592629|Triamcinolone|triamcinolone|mesh-list
20025712|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19491185|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19491186|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19491187|NCT03132116|Gentamicins|gentamicins|mesh-list
19491188|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491189|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491190|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19491191|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491192|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491193|NCT03132168|Anesthetics|anesthetics|mesh-list
19491194|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491195|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491196|NCT03132025|Capecitabine|capecitabine|mesh-list
19491197|NCT03132025|Apatinib|apatinib|mesh-list
19491198|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19491199|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
19491200|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491201|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025713|NCT02592629|Lidocaine|lidocaine|mesh-list
19491202|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491203|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491204|NCT03132051|Triamcinolone|triamcinolone|mesh-list
19491205|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19491206|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19491207|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19491208|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491209|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
19491210|NCT03132051|Hormones|hormones|mesh-ancestor
19491211|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491212|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491213|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19491214|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
19491215|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491216|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491217|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
19491218|NCT03131908|GSK2636771|gsk2636771|mesh-list
19491219|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19491220|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491221|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491222|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491223|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491224|NCT03131700|Bevacizumab|bevacizumab|mesh-list
19491225|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025714|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
19491226|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491227|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19491228|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19491229|NCT03131700|Growth Substances|growth substances|mesh-ancestor
19491230|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491231|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
19569554|NCT04734210|Hormones|hormones|mesh-ancestor
19569555|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569556|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569557|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19569558|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
19569559|NCT04717700|Dexamethasone|dexamethasone|mesh-list
19569560|NCT04717700|Lenalidomide|lenalidomide|mesh-list
19569561|NCT04717700|Bortezomib|bortezomib|mesh-list
19569562|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569563|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
19569564|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
19569565|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569566|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569567|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19569568|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
19569569|NCT04717700|Hormones|hormones|mesh-ancestor
19569570|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569571|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19569572|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569573|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
19569574|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19569575|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19569576|NCT04717700|Growth Substances|growth substances|mesh-ancestor
19569577|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
19569578|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19569579|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19569580|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569581|NCT04686279|Tenofovir|tenofovir|mesh-list
19569582|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
19569583|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569584|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19569585|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19569586|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569587|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569588|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19569589|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19569590|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19569591|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
19569592|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
19569593|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569594|NCT04630730|Gemcitabine|gemcitabine|mesh-list
19569595|NCT04630730|Atezolizumab|atezolizumab|mesh-list
20025715|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
20025716|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
20025717|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20025718|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025719|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
20025720|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025721|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20025722|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20025723|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20025724|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20025725|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025726|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20025727|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
20025728|NCT02592629|Hormones|hormones|mesh-ancestor
20025729|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025730|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025731|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
20025732|NCT02592798|Abatacept|abatacept|mesh-list
20025733|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20025734|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025735|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025736|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025737|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
20025738|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025739|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491232|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
20025740|NCT02592876|Rituximab|rituximab|mesh-list
20025741|NCT02592876|Carboplatin|carboplatin|mesh-list
20025742|NCT02592876|Etoposide|etoposide|mesh-list
20025743|NCT02592876|Ifosfamide|ifosfamide|mesh-list
20025744|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20025745|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491233|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19491234|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19491235|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19491236|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19491237|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491238|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
19491239|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491240|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491241|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19491242|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491243|NCT03131843|Ethanol|ethanol|mesh-list
19491244|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19491245|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491246|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491247|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491248|NCT03131973|Leucovorin|leucovorin|mesh-list
19491249|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
19491250|NCT03131973|Methotrexate|methotrexate|mesh-list
19491251|NCT03131973|Digoxin|digoxin|mesh-list
19491252|NCT03131973|Midazolam|midazolam|mesh-list
19491253|NCT03131973|Caffeine|caffeine|mesh-list
19491254|NCT03131973|Omeprazole|omeprazole|mesh-list
19491255|NCT03131973|Pravastatin|pravastatin|mesh-list
19491256|NCT03131973|Montelukast|montelukast|mesh-list
19491257|NCT03131973|Branebrutinib|branebrutinib|mesh-list
19491258|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19491259|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
19491260|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19491261|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491262|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19491263|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
19491264|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491265|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491266|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
19491267|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491268|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19491269|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19491270|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
19491271|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491272|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19491273|NCT03131973|Antidotes|antidotes|mesh-ancestor
19491274|NCT03131973|Protective Agents|protective agents|mesh-ancestor
19491275|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
19491276|NCT03131973|Vitamins|vitamins|mesh-ancestor
19491277|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
19491278|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19491279|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19491280|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491281|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19491282|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19491283|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19491284|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19491285|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
19491286|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
19491287|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
19491288|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
19491289|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491290|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19491291|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491292|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19491293|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19491294|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19491295|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19491296|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19491297|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
19491298|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19491299|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
19491300|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19744426|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
19491301|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
20025746|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
19491302|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491303|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19491304|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19491305|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19491306|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19491307|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19491308|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19491309|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19491310|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19491311|NCT03131973|Analgesics|analgesics|mesh-ancestor
19491312|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
19491313|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491314|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19491315|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491316|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491317|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19491318|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491319|NCT03131882|Triamcinolone|triamcinolone|mesh-list
20025747|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025748|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025749|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025750|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025751|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20025752|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491320|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19491321|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19491322|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
19491323|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19491324|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491325|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
19491326|NCT03131882|Hormones|hormones|mesh-ancestor
19491327|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491328|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491329|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19491330|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
19491331|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491332|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491333|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19491334|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
19491335|NCT03131882|Protective Agents|protective agents|mesh-ancestor
19491336|NCT03131765|Poly I-C|poly i-c|mesh-list
19491337|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
19491338|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491339|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
19491340|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
19491341|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491342|NCT03131622|Coal Tar|coal tar|mesh-list
19491343|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
19491344|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
19491345|NCT03131583|Colchicine|colchicine|mesh-list
19491346|NCT03131583|Febuxostat|febuxostat|mesh-list
19491347|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
19491348|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491349|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
19491350|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
19491351|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
19491352|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491353|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491354|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
19491355|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19491356|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
19491357|NCT03131336|Coagulants|coagulants|mesh-ancestor
19491358|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
19491359|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19491360|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491361|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491362|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19744427|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744428|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744429|NCT02788981|Paclitaxel|paclitaxel|mesh-list
19744430|NCT02788981|Mifepristone|mifepristone|mesh-list
19744431|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744432|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491363|NCT03131375|Analgesics|analgesics|mesh-ancestor
19491364|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
19491365|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491366|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19491367|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19491368|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19491369|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
19491370|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491371|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491372|NCT03130933|Amoxicillin|amoxicillin|mesh-list
19491373|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491374|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491375|NCT03131050|Scopolamine|scopolamine|mesh-list
19491376|NCT03131050|Citalopram|citalopram|mesh-list
19491377|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19491378|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19491379|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19491380|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19744433|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744434|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744435|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744436|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744437|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19744438|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
19744439|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19744440|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744441|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19744442|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19744443|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19744444|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
19744445|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19744446|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19744447|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
19744448|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744449|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
19744450|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19744451|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19744452|NCT02788773|Durvalumab|durvalumab|mesh-list
19744453|NCT02788773|Tremelimumab|tremelimumab|mesh-list
19744454|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744455|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744456|NCT02782468|Azacitidine|azacitidine|mesh-list
19744457|NCT02782468|Pevonedistat|pevonedistat|mesh-list
19744458|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744459|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
19744460|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744461|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744462|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744463|NCT02781584|Firsocostat|firsocostat|mesh-list
19744464|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744465|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744466|NCT02772965|Methotrexate|methotrexate|mesh-list
19744467|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19744468|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
19744469|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19744470|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744471|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744472|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
19744473|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744474|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744475|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
19744476|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744477|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19744478|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744479|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
19744480|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744481|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19744482|NCT02767557|Gemcitabine|gemcitabine|mesh-list
20025753|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025754|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025755|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
20025756|NCT02593097|Metformin|metformin|mesh-list
20025757|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20115582|NCT00005586|Fluorouracil|fluorouracil|mesh-list
20025758|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025759|NCT02593305|Methamphetamine|methamphetamine|mesh-list
20025760|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20025761|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025762|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
20025763|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
20025764|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025765|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
19744483|NCT02767557|Paclitaxel|paclitaxel|mesh-list
19744484|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744485|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744486|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744487|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744488|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744489|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744490|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744491|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
19744492|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
19744493|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744494|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025766|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025767|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025768|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
20025769|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20025770|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20025771|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20025772|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19744495|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744496|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
19744497|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744498|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
19744499|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744500|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744501|NCT02714062|Topiramate|topiramate|mesh-list
19744502|NCT02714062|Phentermine|phentermine|mesh-list
19744503|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
19744504|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19744505|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744506|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19744507|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
19744508|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19744509|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
20025773|NCT02593396|Bupropion|bupropion|mesh-list
20025774|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20025775|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
20025776|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20025777|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20025778|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20025779|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20025780|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025781|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
20025782|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025783|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025784|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20025785|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20025786|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025787|NCT02593539|Nemiralisib|nemiralisib|mesh-list
20025788|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025789|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025790|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025791|NCT02593773|Interferons|interferons|mesh-list
20025792|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
20025793|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025794|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
20025795|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025796|NCT05372536|Cytarabine|cytarabine|mesh-list
20025797|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025798|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
20025799|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025800|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025801|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
20025802|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744510|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
19744511|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025803|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025804|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
20025805|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025806|NCT05372367|Rifampin|rifampin|mesh-list
20025807|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20025808|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
20025809|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20025810|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744512|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
19744513|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744514|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744515|NCT02689427|Paclitaxel|paclitaxel|mesh-list
19744516|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19744517|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744518|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744519|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744520|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025811|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
20025812|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20025813|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025814|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025815|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20025816|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20025817|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19744521|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744522|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744523|NCT02682004|Serotonin|serotonin|mesh-list
19744524|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19744525|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
19744526|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744527|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744528|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744529|NCT02656797|Amphotericin B|amphotericin b|mesh-list
19744530|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19744531|NCT02656797|Amebicides|amebicides|mesh-ancestor
19744532|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19744533|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19744534|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744535|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19744536|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
19744537|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
19744538|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744539|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
19744540|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744541|NCT02625441|Trastuzumab|trastuzumab|mesh-list
19744542|NCT02625441|Pertuzumab|pertuzumab|mesh-list
19744543|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744544|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744545|NCT02617407|Listerine|listerine|mesh-list
19744546|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
19744547|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
19744548|NCT02617407|Protective Agents|protective agents|mesh-ancestor
19744549|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744550|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19744551|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744552|NCT02616393|XL647|xl647|mesh-list
19744553|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744554|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744555|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744556|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744557|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
19744558|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744559|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744560|NCT02602288|Nicotine|nicotine|mesh-list
19744561|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19744562|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
19744563|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744564|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744565|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19744566|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19744567|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
19744568|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744569|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744570|NCT02593786|Nivolumab|nivolumab|mesh-list
19744571|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744572|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744573|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19744574|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744575|NCT02584478|Paclitaxel|paclitaxel|mesh-list
19744576|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19744577|NCT02584478|Carboplatin|carboplatin|mesh-list
19744578|NCT02584478|Doxorubicin|doxorubicin|mesh-list
19744579|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19744580|NCT02584478|Topotecan|topotecan|mesh-list
19744581|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744582|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744583|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744584|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744585|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744586|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744587|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744588|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025818|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20025819|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20025820|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20025821|NCT05372354|Dexamethasone|dexamethasone|mesh-list
20025822|NCT05372354|Trametinib|trametinib|mesh-list
20025823|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20025824|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
20025825|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
20025826|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744589|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19744590|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744591|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19744592|NCT02577523|Levodopa|levodopa|mesh-list
19744593|NCT02577523|Carbidopa|carbidopa|mesh-list
19744594|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19744595|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19744596|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19744597|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
19744598|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744599|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744600|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744601|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19744602|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749175|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749176|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749177|NCT05246670|Palmidrol|palmidrol|mesh-list
19749178|NCT05246670|Analgesics|analgesics|mesh-ancestor
19749179|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
19749180|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749181|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749182|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19749183|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19749184|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749185|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749186|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
19749187|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749188|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19749189|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19749190|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749191|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749192|NCT05246670|Hormones|hormones|mesh-ancestor
19749193|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749194|NCT05231460|Narcotics|narcotics|mesh-list
19749195|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19749196|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749197|NCT05231460|Analgesics|analgesics|mesh-ancestor
19749198|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
19749199|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025827|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744603|NCT02563002|Bevacizumab|bevacizumab|mesh-list
19744604|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
19744605|NCT02563002|Cetuximab|cetuximab|mesh-list
19744606|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744607|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744608|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19744609|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19744610|NCT02563002|Growth Substances|growth substances|mesh-ancestor
19744611|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744612|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
19744613|NCT02542657|Clarithromycin|clarithromycin|mesh-list
19744614|NCT02542657|Dexamethasone|dexamethasone|mesh-list
19744615|NCT02542657|Pomalidomide|pomalidomide|mesh-list
19744616|NCT02542657|Ixazomib|ixazomib|mesh-list
19744617|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744618|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
19744619|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
19744620|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744621|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744622|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744623|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
20292969|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20292970|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
20292971|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292972|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20292973|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20292974|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292975|NCT04914741|Prednisolone|prednisolone|mesh-list
20292976|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
20292977|NCT04914741|Rituximab|rituximab|mesh-list
20292978|NCT04914741|Doxorubicin|doxorubicin|mesh-list
20292979|NCT04914741|Vincristine|vincristine|mesh-list
20292980|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292981|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
20292982|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20292983|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292984|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20292985|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
19744624|NCT02542657|Hormones|hormones|mesh-ancestor
19744625|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744626|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744627|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744628|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744629|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19744630|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744631|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19744632|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744633|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19744634|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19744635|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
19744636|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19744637|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19744638|NCT02542657|Growth Substances|growth substances|mesh-ancestor
19744639|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
19744640|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
19744641|NCT02427958|Leuprolide|leuprolide|mesh-list
19744642|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19744643|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
19744644|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19744645|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744646|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744647|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744648|NCT02425826|Thalidomide|thalidomide|mesh-list
19744649|NCT02425826|Apremilast|apremilast|mesh-list
19744650|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19744651|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19744652|NCT02425826|Analgesics|analgesics|mesh-ancestor
19744653|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
19744654|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744655|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744656|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744657|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292986|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744658|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19744659|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19744660|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744661|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744662|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744663|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
19744664|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
19744665|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19744666|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744667|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19744668|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19744669|NCT02425826|Growth Substances|growth substances|mesh-ancestor
19744670|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
19744671|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744672|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
19744673|NCT02400567|Letrozole|letrozole|mesh-list
19744674|NCT02400567|Epirubicin|epirubicin|mesh-list
19744675|NCT02400567|Palbociclib|palbociclib|mesh-list
19744676|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744677|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
19744678|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744679|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744680|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19744681|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
19744682|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744683|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744684|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19744685|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19744686|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19744687|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025828|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20025829|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
20025830|NCT05372354|Hormones|hormones|mesh-ancestor
20025831|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025832|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20025833|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025834|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025835|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025836|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025837|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
20025838|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20025839|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025840|NCT05372224|Vitamins|vitamins|mesh-ancestor
20025841|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
20025842|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20025843|NCT05372133|Morphine|morphine|mesh-list
20025844|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20025845|NCT05372133|Narcotics|narcotics|mesh-ancestor
20025846|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20025847|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025848|NCT05372133|Analgesics|analgesics|mesh-ancestor
20025849|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
20025850|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025851|NCT05371964|Imetelstat|imetelstat|mesh-list
20292987|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20292988|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20292989|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20576467|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576468|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
20576469|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576470|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
20576471|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576472|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744688|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20025852|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
20025853|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025854|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025855|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025856|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
20025857|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
20025858|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20025859|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
20025860|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744689|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
19744690|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744691|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744692|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19744693|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19744694|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744695|NCT02384239|Tamoxifen|tamoxifen|mesh-list
19744696|NCT02384239|Fulvestrant|fulvestrant|mesh-list
19744697|NCT02384239|Palbociclib|palbociclib|mesh-list
19744698|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19744699|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
19744700|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19744701|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744702|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19744703|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744704|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19744705|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19744706|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19744707|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19744708|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744709|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744710|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744711|NCT02372409|Doxorubicin|doxorubicin|mesh-list
19744712|NCT02372409|Etoposide|etoposide|mesh-list
19744713|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
19744714|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744715|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744716|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19744717|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19744718|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744719|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744720|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744721|NCT02361801|Dobutamine|dobutamine|mesh-list
19744722|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19744723|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
19744724|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
19744725|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744726|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744727|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19744728|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19744729|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19744730|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
19744731|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744732|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744733|NCT02361801|Protective Agents|protective agents|mesh-ancestor
19744734|NCT02356705|Lidocaine|lidocaine|mesh-list
19744735|NCT02356705|Midazolam|midazolam|mesh-list
19744736|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19744737|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19744738|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19744739|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744740|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19744741|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19744742|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19744743|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19744744|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
19744745|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
19744746|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
19744747|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
19744748|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744749|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744750|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
19744751|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
19744752|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744753|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19744754|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19744755|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19744756|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19744757|NCT02353247|Norethindrone|norethindrone|mesh-list
19744758|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
19744759|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19744760|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20025861|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19744761|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19744762|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
19744763|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19744764|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744765|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19744766|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19744767|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
19744768|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744769|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744770|NCT02285959|Bevacizumab|bevacizumab|mesh-list
19744771|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744772|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744773|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19744774|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19744775|NCT02285959|Growth Substances|growth substances|mesh-ancestor
20025862|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20025863|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20025864|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20025865|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025866|NCT05371899|Chiauranib|chiauranib|mesh-list
20025867|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025868|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025869|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025870|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025871|NCT05371886|Midazolam|midazolam|mesh-list
20025872|NCT05371886|Morphine|morphine|mesh-list
20025873|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20025874|NCT05371886|Narcotics|narcotics|mesh-ancestor
20025875|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20025876|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744776|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744777|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
19744778|NCT02285140|Vancomycin|vancomycin|mesh-list
19744779|NCT02285140|Cefazolin|cefazolin|mesh-list
19744780|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19744781|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744782|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19744783|NCT02254941|Antibodies|antibodies|mesh-list
19744784|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
19744785|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19744786|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
19744787|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744788|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744789|NCT02229084|Paclitaxel|paclitaxel|mesh-list
19744790|NCT02229084|Docetaxel|docetaxel|mesh-list
19744791|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
19744792|NCT02229084|Doxorubicin|doxorubicin|mesh-list
19744793|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
19744794|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744795|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744796|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744797|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744798|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744799|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744800|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744801|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
19744802|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744803|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744804|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19744805|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
19744806|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19744807|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744808|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19744809|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19744810|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744811|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19744812|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
19744813|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744814|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
19744815|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744816|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744817|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19744818|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
19744819|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025877|NCT05371886|Analgesics|analgesics|mesh-ancestor
20025878|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
20025879|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744820|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744821|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19744822|NCT02098954|Gemcitabine|gemcitabine|mesh-list
19744823|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19744824|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744825|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
19744826|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744827|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744828|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
19744829|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744830|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744831|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744832|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
19744833|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744834|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744835|NCT02097225|Trametinib|trametinib|mesh-list
19744836|NCT02097225|Dabrafenib|dabrafenib|mesh-list
19744837|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744838|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744839|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744840|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744841|NCT02000622|Olaparib|olaparib|mesh-list
19744842|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19744843|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744844|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744845|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744846|NCT01933932|Docetaxel|docetaxel|mesh-list
19744847|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744848|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744849|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744850|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744851|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744852|NCT01927068|Paclitaxel|paclitaxel|mesh-list
19744853|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744854|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744855|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744856|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025880|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20025881|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20025882|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20025883|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20025884|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20025885|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20025886|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
20025887|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
20025888|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
20025889|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
20025890|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025891|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025892|NCT05371574|Clonidine|clonidine|mesh-list
20025893|NCT05371574|Analgesics|analgesics|mesh-ancestor
20025894|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
20025895|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20025896|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025897|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20025898|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
20025899|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
20025900|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20025901|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20025902|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20025903|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
20025904|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20025905|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025906|NCT05371340|Quercetin|quercetin|mesh-list
20025907|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
20025908|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025909|NCT05371340|Protective Agents|protective agents|mesh-ancestor
20025910|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025911|NCT05371301|Paclitaxel|paclitaxel|mesh-list
20025912|NCT05371301|Carboplatin|carboplatin|mesh-list
20025913|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025914|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744857|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744858|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025915|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744859|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19744860|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744861|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19744862|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744863|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744864|NCT01849146|Temozolomide|temozolomide|mesh-list
19744865|NCT01849146|Adavosertib|adavosertib|mesh-list
19744866|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19744867|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
19744868|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744869|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744870|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744871|NCT01837277|Efavirenz|efavirenz|mesh-list
19744872|NCT01837277|Dolutegravir|dolutegravir|mesh-list
19744873|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19744874|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19744875|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744876|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744877|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
19744878|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744879|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19744880|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19744881|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19744882|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19744883|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19744884|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19744885|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19744886|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19744887|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19744888|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19744889|NCT01813435|Aspirin|aspirin|mesh-list
19744890|NCT01813435|Clopidogrel|clopidogrel|mesh-list
19744891|NCT01813435|Ticagrelor|ticagrelor|mesh-list
19744892|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19744893|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19744894|NCT01813435|Analgesics|analgesics|mesh-ancestor
19744895|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
19744896|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744897|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744898|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744899|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744900|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19744901|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19744902|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744903|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19744904|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19744905|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744906|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
19744907|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19744908|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19744909|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19744910|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
19744911|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19744912|NCT01779050|Paclitaxel|paclitaxel|mesh-list
19744913|NCT01779050|Docetaxel|docetaxel|mesh-list
19744914|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
19744915|NCT01779050|Carboplatin|carboplatin|mesh-list
19744916|NCT01779050|Doxorubicin|doxorubicin|mesh-list
19744917|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19744918|NCT01779050|Fluorouracil|fluorouracil|mesh-list
19744919|NCT01779050|Trastuzumab|trastuzumab|mesh-list
19744920|NCT01779050|Epirubicin|epirubicin|mesh-list
19744921|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744922|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744923|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744924|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744925|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744926|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744927|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744928|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
19744929|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744930|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744931|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19744932|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
19744933|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19744934|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744935|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19744936|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19744937|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744938|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
19744939|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19744940|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744941|NCT01765218|Topiramate|topiramate|mesh-list
19744942|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
19744943|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19744944|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744945|NCT01745757|Paclitaxel|paclitaxel|mesh-list
19744946|NCT01745757|Bevacizumab|bevacizumab|mesh-list
19744947|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19744948|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744949|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
19744950|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
19744951|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744952|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744953|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19744954|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19744955|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19744956|NCT01745757|Growth Substances|growth substances|mesh-ancestor
19744957|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744958|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
19744959|NCT01729455|Belimumab|belimumab|mesh-list
19744960|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292990|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19744961|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
19744962|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744963|NCT01711554|Vitamin A|vitamin a|mesh-list
19744964|NCT01711554|Lenalidomide|lenalidomide|mesh-list
20025916|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025917|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
19744965|NCT01711554|Tretinoin|tretinoin|mesh-list
19744966|NCT01711554|Dinutuximab|dinutuximab|mesh-list
19744967|NCT01711554|Isotretinoin|isotretinoin|mesh-list
19744968|NCT01711554|Vitamins|vitamins|mesh-ancestor
20025918|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025919|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
20025920|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
20025921|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20025922|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
20025923|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025924|NCT05371288|Protective Agents|protective agents|mesh-ancestor
20025925|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744969|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
19744970|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744971|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
19744972|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20025926|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
20025927|NCT05371288|Vitamins|vitamins|mesh-ancestor
20025928|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
20025929|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
20025930|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20025931|NCT05371288|Expectorants|expectorants|mesh-ancestor
20025932|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
20025933|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20025934|NCT05371288|Antidotes|antidotes|mesh-ancestor
20025935|NCT05371275|Palbociclib|palbociclib|mesh-list
20025936|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025937|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025938|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025939|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025940|NCT05371223|Gemcitabine|gemcitabine|mesh-list
20025941|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20025942|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025943|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
20025944|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025945|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744973|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19744974|NCT01711554|Growth Substances|growth substances|mesh-ancestor
19744975|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
19744976|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19744977|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
19744978|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
20025946|NCT05371223|Antiviral Agents|antiviral agents|mesh-ancestor
20025947|NCT05371223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19744979|NCT01690299|Etanercept|etanercept|mesh-list
19744980|NCT01690299|Apremilast|apremilast|mesh-list
19744981|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19744982|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19744983|NCT01690299|Analgesics|analgesics|mesh-ancestor
19744984|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
19744985|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19744986|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19744987|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19744988|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19744989|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19744990|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19744991|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
19744992|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19744993|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19491381|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744994|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19744995|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19744996|NCT01659658|Thalidomide|thalidomide|mesh-list
19744997|NCT01659658|Dexamethasone|dexamethasone|mesh-list
19744998|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
19744999|NCT01659658|Melphalan|melphalan|mesh-list
19745000|NCT01659658|Lenalidomide|lenalidomide|mesh-list
20025948|NCT05371223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491382|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491383|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
19491384|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491385|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19491386|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
19491387|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19491388|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
19491389|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
19491390|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491391|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19491392|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19491393|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
19491394|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19491395|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
19491396|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491397|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
19491398|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19491399|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491400|NCT03131037|Valacyclovir|valacyclovir|mesh-list
19745001|NCT01659658|Ixazomib|ixazomib|mesh-list
19745002|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025949|NCT05371223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745003|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
19745004|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745005|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745006|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19745007|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
19745008|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745009|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745010|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19745011|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20025950|NCT05371223|Immunologic Factors|immunologic factors|mesh-ancestor
20025951|NCT05371223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025952|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20025953|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025954|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115583|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
20115584|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
20115585|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115586|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115587|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115588|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115589|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
20115590|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491401|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
20115591|NCT00005586|Antidotes|antidotes|mesh-ancestor
20115592|NCT00005586|Protective Agents|protective agents|mesh-ancestor
20115593|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
20115594|NCT00005586|Vitamins|vitamins|mesh-ancestor
20115595|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
20115596|NCT00005589|Cytarabine|cytarabine|mesh-list
20115597|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
20115598|NCT00005589|Melphalan|melphalan|mesh-list
20115599|NCT00005589|Carmustine|carmustine|mesh-list
20115600|NCT00005589|Rituximab|rituximab|mesh-list
20115601|NCT00005589|Etoposide|etoposide|mesh-list
20115602|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20292991|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20292992|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20292993|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292994|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20292995|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
20292996|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115603|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
20115604|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115605|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115606|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115607|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
20115608|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115609|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115610|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115611|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115612|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115613|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115614|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20292997|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
20292998|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292999|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
20293000|NCT04914741|Hormones|hormones|mesh-ancestor
19491402|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491403|NCT03131141|Lefamulin|lefamulin|mesh-list
19491404|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491405|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491406|NCT03130855|Carticaine|carticaine|mesh-list
19491407|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
19491408|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
19491409|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745012|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
20293001|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293002|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293003|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19745013|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
19745014|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745015|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19745016|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
19745017|NCT01659658|Hormones|hormones|mesh-ancestor
19745018|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745019|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745020|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19745021|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19745022|NCT01659658|Growth Substances|growth substances|mesh-ancestor
19745023|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
19745024|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
19745025|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745026|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745027|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
19745028|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745029|NCT01653925|Dutasteride|dutasteride|mesh-list
19745030|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19745031|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19745032|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745033|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745034|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
19745035|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745036|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745037|NCT01525329|Fluorouracil|fluorouracil|mesh-list
19745038|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
19745039|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745040|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19745041|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745042|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745043|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
19745044|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745045|NCT01482286|Metformin|metformin|mesh-list
19745046|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19745047|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745048|NCT01452152|Clopidogrel|clopidogrel|mesh-list
19745049|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19745050|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19745051|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19745052|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19745053|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19745054|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
19745055|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745056|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745057|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745058|NCT01420926|Bortezomib|bortezomib|mesh-list
19745059|NCT01420926|Decitabine|decitabine|mesh-list
19745060|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745061|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20025955|NCT05371132|Deferoxamine|deferoxamine|mesh-list
20025956|NCT05371132|Siderophores|siderophores|mesh-ancestor
20025957|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20025958|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
20025959|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
20025960|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025961|NCT05371093|Prednisone|prednisone|mesh-list
19491410|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491411|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
19491412|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491413|NCT03130842|Midazolam|midazolam|mesh-list
19491414|NCT03130842|Alprazolam|alprazolam|mesh-list
19491415|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19491416|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19491417|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491418|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491419|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19491420|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19491421|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19745062|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
20025962|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
19745063|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745064|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745065|NCT01386385|Paclitaxel|paclitaxel|mesh-list
19745066|NCT01386385|Carboplatin|carboplatin|mesh-list
19745067|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19745068|NCT01386385|Veliparib|veliparib|mesh-list
20293004|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20293005|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20293006|NCT04899193|Hormones|hormones|mesh-ancestor
20293007|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293008|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745069|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19745070|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745071|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745072|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745073|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745074|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745075|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19745076|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745077|NCT01375829|Sirolimus|sirolimus|mesh-list
19745078|NCT01375829|Epothilone B|epothilone b|mesh-list
19745079|NCT01375829|Epothilones|epothilones|mesh-list
19745080|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745081|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745082|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745083|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745084|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
19745085|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745086|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
19745087|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745088|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745089|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745090|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745091|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745092|NCT01364051|Cediranib|cediranib|mesh-list
19745093|NCT01364051|Maleic acid|maleic acid|mesh-list
19745094|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745095|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745096|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745097|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19745098|NCT01358877|Paclitaxel|paclitaxel|mesh-list
19745099|NCT01358877|Docetaxel|docetaxel|mesh-list
19745100|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
19745101|NCT01358877|Carboplatin|carboplatin|mesh-list
19745102|NCT01358877|Doxorubicin|doxorubicin|mesh-list
19745103|NCT01358877|Fluorouracil|fluorouracil|mesh-list
19745104|NCT01358877|Trastuzumab|trastuzumab|mesh-list
19745105|NCT01358877|Epirubicin|epirubicin|mesh-list
19745106|NCT01358877|Pertuzumab|pertuzumab|mesh-list
19745107|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19745108|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745109|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745110|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745111|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745112|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745113|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745114|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
19745115|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745116|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745117|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19745118|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
19745119|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19745120|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745121|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19745122|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19745123|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745124|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
19745125|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19745126|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293009|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19745127|NCT01253070|Cytarabine|cytarabine|mesh-list
19745128|NCT01253070|Sorafenib|sorafenib|mesh-list
19745129|NCT01253070|Daunorubicin|daunorubicin|mesh-list
19745130|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19745131|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
19745132|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745133|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745134|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
19745135|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745136|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745137|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
19745138|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745139|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19745140|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745141|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745142|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19745143|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19745144|NCT01232283|Apremilast|apremilast|mesh-list
19745145|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19745146|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19745147|NCT01232283|Analgesics|analgesics|mesh-ancestor
19745148|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
19745149|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745150|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745151|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745152|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745153|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19745154|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19745155|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745156|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745157|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
19745158|NCT01231516|Dolutegravir|dolutegravir|mesh-list
19745159|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19745160|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19745161|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
19745162|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745163|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19745164|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19745165|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745166|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745167|NCT01229943|Bevacizumab|bevacizumab|mesh-list
19745168|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19745169|NCT01229943|Everolimus|everolimus|mesh-list
19745170|NCT01229943|Octreotide|octreotide|mesh-list
19745171|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
19745172|NCT01229943|Antibodies|antibodies|mesh-list
19745173|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
19745174|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19745175|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
19745176|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745177|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19745178|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19745179|NCT01229943|Growth Substances|growth substances|mesh-ancestor
19745180|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745181|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
19745182|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
19745183|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745184|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19745185|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745186|NCT01194219|Apremilast|apremilast|mesh-list
19745187|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19745188|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19745189|NCT01194219|Analgesics|analgesics|mesh-ancestor
19745190|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
19745191|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745192|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745193|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745194|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745195|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19745196|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19745197|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745198|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745199|NCT01193842|Prednisone|prednisone|mesh-list
19745200|NCT01193842|Cortisone|cortisone|mesh-list
19745201|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
20025963|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20025964|NCT05371093|Rituximab|rituximab|mesh-list
19745202|NCT01193842|Rituximab|rituximab|mesh-list
19745203|NCT01193842|Doxorubicin|doxorubicin|mesh-list
19745204|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19745205|NCT01193842|Etoposide|etoposide|mesh-list
19745206|NCT01193842|Vincristine|vincristine|mesh-list
20025965|NCT05371093|Doxorubicin|doxorubicin|mesh-list
20025966|NCT05371093|Fludarabine|fludarabine|mesh-list
20025967|NCT05371093|Vincristine|vincristine|mesh-list
20025968|NCT05371093|Lenalidomide|lenalidomide|mesh-list
20025969|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025970|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
20025971|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20025972|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20025973|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20025974|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
20025975|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20025976|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025977|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19745207|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
19745208|NCT01193842|Vorinostat|vorinostat|mesh-list
19745209|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
19745210|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19745211|NCT01193842|Antibodies|antibodies|mesh-list
19745212|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
19745213|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19745214|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745215|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
19745216|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745217|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745218|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19745219|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
19745220|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745221|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745222|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19745223|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745224|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19745225|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19745226|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745227|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745228|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
19745229|NCT01193842|Hormones|hormones|mesh-ancestor
19745230|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745231|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745232|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19745233|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745234|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745235|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745236|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19745237|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
19745238|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
19745239|NCT01061840|Molgramostim|molgramostim|mesh-list
19745240|NCT01061840|Modafinil|modafinil|mesh-list
19745241|NCT01061840|Vaccines|vaccines|mesh-list
19745242|NCT01061840|Sargramostim|sargramostim|mesh-list
19745243|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
19745244|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745245|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745246|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19745247|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19745248|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19745249|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19745250|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745251|NCT01012817|Topotecan|topotecan|mesh-list
19745252|NCT01012817|Veliparib|veliparib|mesh-list
19745253|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19745254|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19745255|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745256|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745257|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20025978|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115615|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745258|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19745259|NCT00878163|Gemcitabine|gemcitabine|mesh-list
19745260|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19745261|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19745262|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
19745263|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745264|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745265|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
19745266|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745267|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745268|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20025979|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20025980|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20025981|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20025982|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20025983|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20025984|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
20025985|NCT05371093|Hormones|hormones|mesh-ancestor
20025986|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20025987|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20025988|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20025989|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
20025990|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
20025991|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745269|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
19745270|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745271|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20025992|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20025993|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20025994|NCT05371093|Growth Substances|growth substances|mesh-ancestor
20025995|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
20025996|NCT05371015|Ropivacaine|ropivacaine|mesh-list
20025997|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
20025998|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
20025999|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026000|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026001|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
20026002|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026003|NCT05370885|Vancomycin|vancomycin|mesh-list
20026004|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20026005|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026006|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
20026007|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20026008|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
20026009|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20026010|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20026011|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026012|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
20026013|NCT05370820|Coagulants|coagulants|mesh-ancestor
20026014|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20026015|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20026016|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026017|NCT05366777|Acetaminophen|acetaminophen|mesh-list
20026018|NCT05366777|Ibuprofen|ibuprofen|mesh-list
20026019|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026020|NCT05366777|Analgesics|analgesics|mesh-ancestor
20026021|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
20026022|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026023|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026024|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
20026025|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20026026|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026027|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026028|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20026029|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026030|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026031|NCT05365880|Lidocaine|lidocaine|mesh-list
19745272|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
19745273|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19745274|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19745275|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745276|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
19745277|NCT00740116|Coagulants|coagulants|mesh-ancestor
19745278|NCT00516724|Paclitaxel|paclitaxel|mesh-list
19745279|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19745280|NCT00516724|Carboplatin|carboplatin|mesh-list
19745281|NCT00516724|Olaparib|olaparib|mesh-list
19745282|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19745283|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19745284|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745285|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745286|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745287|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745288|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745289|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745290|NCT00470704|Trastuzumab|trastuzumab|mesh-list
19745291|NCT00470704|Lapatinib|lapatinib|mesh-list
19745292|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19745293|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745294|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19745295|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745296|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745297|NCT00142584|Metoprolol|metoprolol|mesh-list
19745298|NCT00142584|Nebivolol|nebivolol|mesh-list
19745299|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19745300|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19745301|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
19745302|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
19745303|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745304|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745305|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19745306|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19745307|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19745308|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
19745309|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745310|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745311|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
19745312|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19745313|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19745314|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19745315|NCT00107250|Paclitaxel|paclitaxel|mesh-list
19745316|NCT00107250|Carboplatin|carboplatin|mesh-list
19745317|NCT00107250|Capecitabine|capecitabine|mesh-list
19745318|NCT00107250|Cediranib|cediranib|mesh-list
19745319|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19745320|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745321|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745322|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745323|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745324|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745325|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19745326|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
19745327|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745328|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20026032|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
20026033|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
20026034|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745329|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
19745330|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19745331|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
19745332|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19745333|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745334|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19745335|NCT05285566|Lidocaine|lidocaine|mesh-list
19745336|NCT05285566|Bupivacaine|bupivacaine|mesh-list
19745337|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
19745338|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
19745339|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745340|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745341|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
20026035|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745342|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745343|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19745344|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19745345|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19745346|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19745347|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745348|NCT05285449|Cannabidiol|cannabidiol|mesh-list
19745349|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
19745350|NCT05285397|Liraglutide|liraglutide|mesh-list
19745351|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19745352|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745353|NCT05285397|Incretins|incretins|mesh-ancestor
19745354|NCT05285397|Hormones|hormones|mesh-ancestor
19745355|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745356|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
19745357|NCT05285384|Paraproteins|paraproteins|mesh-list
19745358|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
19745359|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745360|NCT05285293|Vitamin A|vitamin a|mesh-list
20026036|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
20026037|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576473|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745361|NCT05285293|Vitamins|vitamins|mesh-ancestor
19745362|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
19745363|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745364|NCT05285228|Fluorides|fluorides|mesh-list
19745365|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
19745366|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
19745367|NCT05285228|Protective Agents|protective agents|mesh-ancestor
19745368|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745369|NCT05285124|Melatonin|melatonin|mesh-list
19745370|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
19745371|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745372|NCT05285124|Protective Agents|protective agents|mesh-ancestor
19745373|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745374|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745375|NCT05285085|Atorvastatin|atorvastatin|mesh-list
19745376|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19745377|NCT05285085|Simvastatin|simvastatin|mesh-list
19745378|NCT05285085|Pravastatin|pravastatin|mesh-list
19745379|NCT05285085|Pitavastatin|pitavastatin|mesh-list
19745380|NCT05285085|Lovastatin|lovastatin|mesh-list
19745381|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19745382|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19745383|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
19745384|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745385|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19745386|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19745387|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745388|NCT05284994|Osimertinib|osimertinib|mesh-list
19745389|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745390|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19745391|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745392|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745393|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
19745394|NCT05284942|Prednisone|prednisone|mesh-list
19745395|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745396|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
19745397|NCT05284942|Hormones|hormones|mesh-ancestor
19745398|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745399|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745400|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745401|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745402|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745403|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19745404|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
19745405|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745406|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745407|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576474|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
20576475|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576476|NCT02071537|Amebicides|amebicides|mesh-ancestor
19745408|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745409|NCT05284851|Vaccines|vaccines|mesh-list
19745410|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
19745411|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745412|NCT05284812|Vaccines|vaccines|mesh-list
19745413|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
19745414|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745415|NCT05284734|Anesthetics|anesthetics|mesh-list
19745416|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745417|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745418|NCT05284643|Bevacizumab|bevacizumab|mesh-list
19745419|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19745420|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745421|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19745422|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19745423|NCT05284643|Growth Substances|growth substances|mesh-ancestor
19745424|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026038|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20026039|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20026040|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19745425|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
19745426|NCT05284552|Tinzaparin|tinzaparin|mesh-list
19745427|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19745428|NCT05284552|Dalteparin|dalteparin|mesh-list
19745429|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
19745430|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19745431|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19745432|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745433|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
19745434|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19745435|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745436|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745437|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19745438|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19745439|NCT05284448|Protective Agents|protective agents|mesh-ancestor
19745440|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745441|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
19745442|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19745443|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
19749215|NCT05212571|Ketamine|ketamine|mesh-list
19749216|NCT05212571|Esketamine|esketamine|mesh-list
19749217|NCT05212571|Analgesics|analgesics|mesh-ancestor
19749218|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
19749219|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749220|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749221|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19749222|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19749223|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
19749224|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
19749225|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19749226|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19749227|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19749228|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749229|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749230|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
19749231|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19749232|NCT05208047|Sunitinib|sunitinib|mesh-list
19749233|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749234|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749235|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749236|NCT05208047|Growth Substances|growth substances|mesh-ancestor
19749237|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749238|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749239|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749240|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293010|NCT04895748|Everolimus|everolimus|mesh-list
19749241|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749242|NCT05205486|Cefazolin|cefazolin|mesh-list
19745444|NCT05284409|Acetaminophen|acetaminophen|mesh-list
19745445|NCT05284409|Dexamethasone|dexamethasone|mesh-list
19745446|NCT05284409|Meperidine|meperidine|mesh-list
19745447|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745448|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
19745449|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
19745450|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745451|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745452|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19745453|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
19745454|NCT05284409|Hormones|hormones|mesh-ancestor
19745455|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745456|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745457|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745458|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19745459|NCT05284409|Analgesics|analgesics|mesh-ancestor
19745460|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
19745461|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
19745462|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19745463|NCT05284409|Narcotics|narcotics|mesh-ancestor
19745464|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745465|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19745466|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19745467|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745468|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19745469|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745470|NCT05284136|Prednisolone|prednisolone|mesh-list
19745471|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745472|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
19745473|NCT05284136|Hormones|hormones|mesh-ancestor
19745474|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745475|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745476|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745477|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745478|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
19745479|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
19745480|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
19745481|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745482|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745483|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745484|NCT05284019|Erenumab|erenumab|mesh-list
19745485|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20026041|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026042|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026043|NCT05365802|FAPI-46|fapi-46|mesh-list
20026044|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20026045|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026046|NCT05363007|Leucovorin|leucovorin|mesh-list
20026047|NCT05363007|Irinotecan|irinotecan|mesh-list
20026048|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20026049|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20026050|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026051|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026052|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026053|NCT05363007|Antidotes|antidotes|mesh-ancestor
20026054|NCT05363007|Protective Agents|protective agents|mesh-ancestor
20026055|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026056|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
20026057|NCT05363007|Vitamins|vitamins|mesh-ancestor
20026058|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
20026059|NCT05362994|Sirolimus|sirolimus|mesh-list
20026060|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20026061|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026062|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20026063|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026064|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
20026065|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026066|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
20026067|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026068|NCT05359835|Edetic Acid|edetic acid|mesh-list
20026069|NCT05359835|Calcium|calcium|mesh-list
20026070|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
20026071|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19745486|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20026072|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026073|NCT05359835|Antidotes|antidotes|mesh-ancestor
20026074|NCT05359835|Protective Agents|protective agents|mesh-ancestor
19745487|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19745488|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745489|NCT05284019|Analgesics|analgesics|mesh-ancestor
19745490|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
19745491|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745492|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745493|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19745494|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19745495|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19745496|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
19745497|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745498|NCT05283980|Bupivacaine|bupivacaine|mesh-list
19745499|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
19745500|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
19745501|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745502|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745503|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
19745504|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745505|NCT05283954|Ascorbic Acid|ascorbic acid|mesh-list
19745506|NCT05283954|Ivermectin|ivermectin|mesh-list
19745507|NCT05283954|Albendazole|albendazole|mesh-list
19745508|NCT05283954|Prednisolone|prednisolone|mesh-list
19745509|NCT05283954|Fluoxetine|fluoxetine|mesh-list
19745510|NCT05283954|Vitamins|vitamins|mesh-ancestor
19745511|NCT05283954|Micronutrients|micronutrients|mesh-ancestor
19745512|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745513|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745514|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
19745515|NCT05283954|Hormones|hormones|mesh-ancestor
19745516|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745517|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745518|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745519|NCT05283954|Protective Agents|protective agents|mesh-ancestor
19745520|NCT05283954|Antioxidants|antioxidants|mesh-ancestor
19745521|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745522|NCT05283954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19745523|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19745524|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026075|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
20026076|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
20026077|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026078|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19745525|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026079|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
20026080|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20026081|NCT05359731|Dexamethasone|dexamethasone|mesh-list
20026082|NCT05359731|Bupivacaine|bupivacaine|mesh-list
20026083|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026084|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
20026085|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
20026086|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026087|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026088|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026089|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
20026090|NCT05359731|Hormones|hormones|mesh-ancestor
20026091|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026092|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026093|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026094|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
20026095|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
20026096|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026097|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
20026098|NCT05343455|Doxycycline|doxycycline|mesh-list
20026099|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20026100|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026101|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
20026102|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19745526|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
19745527|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19745528|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
19745529|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20026103|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20026104|NCT05343429|Aspirin|aspirin|mesh-list
20026105|NCT05343429|Benzydamine|benzydamine|mesh-list
20026106|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19745530|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19745531|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19745532|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745533|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19745534|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745535|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
19745536|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
19745537|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19745538|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19745539|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745540|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745541|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745542|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
19745543|NCT05283850|Calcium|calcium|mesh-list
19745544|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19745545|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745546|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19745547|NCT05283720|Prednisone|prednisone|mesh-list
19745548|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
19745549|NCT05283720|Rituximab|rituximab|mesh-list
19745550|NCT05283720|Doxorubicin|doxorubicin|mesh-list
19745551|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19745552|NCT05283720|Lenalidomide|lenalidomide|mesh-list
19745553|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745554|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
19745555|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745556|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745557|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19745558|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
19745559|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745560|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745561|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19745562|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19745563|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745564|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19745565|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19745566|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745567|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745568|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
20293011|NCT04895748|Spartalizumab|spartalizumab|mesh-list
20293012|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293013|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293014|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
20293015|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293016|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20293017|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745569|NCT05283720|Hormones|hormones|mesh-ancestor
19745570|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745571|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745572|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19745573|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19745574|NCT05283720|Growth Substances|growth substances|mesh-ancestor
19745575|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
19745576|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19745577|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
19745578|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745579|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19745580|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
19745581|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745582|NCT05283551|Famciclovir|famciclovir|mesh-list
19745583|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
19745584|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745585|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19745586|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745587|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745588|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
19745589|NCT05283499|Analgesics|analgesics|mesh-list
19745590|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19745591|NCT05283499|Narcotics|narcotics|mesh-ancestor
20026107|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026108|NCT05343429|Analgesics|analgesics|mesh-ancestor
20026109|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
20026110|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026111|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026112|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745592|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745593|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745594|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
19745595|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745596|NCT05283421|Estrogens|estrogens|mesh-list
19745597|NCT05283421|Hormones|hormones|mesh-ancestor
19745598|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745599|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745600|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
19745601|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19745602|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
20026113|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026114|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20026115|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20026116|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026117|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20026118|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20026119|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026120|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
20026121|NCT05334108|Ecopipam|ecopipam|mesh-list
19745603|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745604|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19745605|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
19745606|NCT05265325|Hematinics|hematinics|mesh-ancestor
19745607|NCT05262205|Anesthetics|anesthetics|mesh-list
19745608|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745609|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745610|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
19745611|NCT05252884|Calcitriol|calcitriol|mesh-list
19745612|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
19745613|NCT05252884|Calcium|calcium|mesh-list
19745614|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19745615|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745616|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19745617|NCT05252884|Antacids|antacids|mesh-ancestor
19745618|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745619|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19745620|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19745621|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19745622|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19745623|NCT05252884|Vitamins|vitamins|mesh-ancestor
19745624|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
19745625|NCT05251376|Morphine|morphine|mesh-list
19745626|NCT05251376|Methadone|methadone|mesh-list
19745627|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19745628|NCT05251376|Narcotics|narcotics|mesh-ancestor
19745629|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745630|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745631|NCT05251376|Analgesics|analgesics|mesh-ancestor
19745632|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
19745633|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745634|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
19745635|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
19745636|NCT05233163|Empagliflozin|empagliflozin|mesh-list
19745637|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19745638|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026122|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20026123|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20026124|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745639|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19745640|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745641|NCT05220293|Betamethasone|betamethasone|mesh-list
19745642|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
19745643|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19745644|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
19745645|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19745646|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745647|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
19745648|NCT05220293|Hormones|hormones|mesh-ancestor
19745649|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745650|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745651|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19745652|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
19745653|NCT05216744|Doxycycline|doxycycline|mesh-list
19745654|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
19745655|NCT05216744|Cefixime|cefixime|mesh-list
19745656|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745657|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745658|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
19745659|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19745660|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19745661|NCT05206084|Sirolimus|sirolimus|mesh-list
19745662|NCT05206084|Everolimus|everolimus|mesh-list
19745663|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745664|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745665|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
19745666|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745667|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745668|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745669|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745670|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
19745671|NCT05183178|Ticagrelor|ticagrelor|mesh-list
19745672|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19745673|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19745674|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19745675|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19745676|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19745677|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
19745678|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745679|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745680|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745681|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19745682|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19745683|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
19745684|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745685|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745686|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745687|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19745688|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19745689|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745690|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
19749243|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19749244|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749245|NCT05201248|Prednisone|prednisone|mesh-list
19749246|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
19749247|NCT05201248|Rituximab|rituximab|mesh-list
19749248|NCT05201248|Doxorubicin|doxorubicin|mesh-list
19749249|NCT05201248|Vincristine|vincristine|mesh-list
19749250|NCT05201248|Lenalidomide|lenalidomide|mesh-list
19749251|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749252|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
19749253|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749254|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749255|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19749256|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
19749257|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749258|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749259|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19749260|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749261|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19749262|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19749263|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19749264|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749265|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026125|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026126|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20026127|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20026128|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
20026129|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026130|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026131|NCT05330754|Caffeine|caffeine|mesh-list
20026132|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20026133|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026134|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20026135|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026136|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749266|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
19749267|NCT05201248|Hormones|hormones|mesh-ancestor
19745691|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19745692|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
19745693|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745694|NCT05161351|Vitamin D|vitamin d|mesh-list
19745695|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
19745696|NCT05161351|Baclofen|baclofen|mesh-list
19745697|NCT05161351|Vitamins|vitamins|mesh-ancestor
19745698|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
19745699|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745700|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19491422|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19491423|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
19491424|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
19491425|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
20026137|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20026138|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20026139|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
20026140|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026141|NCT05323396|Metronidazole|metronidazole|mesh-list
20026142|NCT05323396|Albendazole|albendazole|mesh-list
20026143|NCT05323396|Praziquantel|praziquantel|mesh-list
20026144|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
20026145|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026146|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745701|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19745702|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20026147|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20026148|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
20026149|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
20026150|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20026151|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
20026152|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
19491426|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
19491427|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745703|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19745704|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745705|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19745706|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
19745707|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
19745708|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745709|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745710|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19745711|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19745712|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19745713|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491428|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745714|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745715|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19745716|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19745717|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745718|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
19745719|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745720|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19745721|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19745722|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19745723|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745724|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745725|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20026153|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
20026154|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491429|NCT03130829|Fucoidan|fucoidan|mesh-list
19745726|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19745727|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745728|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
19745729|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745730|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19745731|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19745732|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745733|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
19745734|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745735|NCT05141708|Talazoparib|talazoparib|mesh-list
19745736|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19745737|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745738|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745739|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745740|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
19745741|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19745742|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19745743|NCT05137496|Prednisolone|prednisolone|mesh-list
19745744|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
19745745|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19745746|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
19745747|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745748|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
19745749|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
19745750|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745751|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745752|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19745753|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
19745754|NCT05137496|Hormones|hormones|mesh-ancestor
19745755|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745756|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19745757|NCT05137496|Protective Agents|protective agents|mesh-ancestor
19745758|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745759|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745760|NCT05061563|Esomeprazole|esomeprazole|mesh-list
19745761|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19745762|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19745763|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19745764|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745765|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745766|NCT05053126|Pregabalin|pregabalin|mesh-list
19745767|NCT05053126|Oxycodone|oxycodone|mesh-list
19745768|NCT05053126|Analgesics|analgesics|mesh-ancestor
19745769|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
19745770|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745771|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745772|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
19745773|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19745774|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19745775|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745776|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19745777|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19745778|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19745779|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745780|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19745781|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19745782|NCT05053126|Narcotics|narcotics|mesh-ancestor
19745783|NCT05047952|Vortioxetine|vortioxetine|mesh-list
19745784|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
19745785|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19745786|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19745787|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19745788|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745789|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745790|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19745791|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19745792|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19745793|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745794|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745795|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
19745796|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19745797|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19745798|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19745799|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19745800|NCT05037123|Ketamine|ketamine|mesh-list
19745801|NCT05037123|Analgesics|analgesics|mesh-ancestor
19745802|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
19745803|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745804|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745805|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19745806|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19745807|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
19745808|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
19745809|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745810|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19745811|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19745812|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745813|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745814|NCT05030818|Aspirin|aspirin|mesh-list
19745815|NCT05030818|Ramipril|ramipril|mesh-list
19745816|NCT05030818|Atorvastatin|atorvastatin|mesh-list
19745817|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19745818|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19745819|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
19745820|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745821|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19745822|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19745823|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745824|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19745825|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19745826|NCT05030818|Analgesics|analgesics|mesh-ancestor
19745827|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
19745828|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745829|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293018|NCT04865237|Remdesivir|remdesivir|mesh-list
20293019|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
20293020|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026155|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026156|NCT05319873|Carboplatin|carboplatin|mesh-list
20026157|NCT05319873|Docetaxel|docetaxel|mesh-list
20026158|NCT05319873|Trastuzumab|trastuzumab|mesh-list
20026159|NCT05319873|Fulvestrant|fulvestrant|mesh-list
20026160|NCT05319873|Pertuzumab|pertuzumab|mesh-list
20026161|NCT05319873|Tucatinib|tucatinib|mesh-list
20026162|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20293021|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
20293022|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293023|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
20293024|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293025|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491430|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19745830|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19745831|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745832|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19745833|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19745834|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19745835|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19745836|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
19745837|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19745838|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19745839|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19745840|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19491431|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491432|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
19491433|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491434|NCT03130764|Durvalumab|durvalumab|mesh-list
19491435|NCT03130764|Tremelimumab|tremelimumab|mesh-list
19491436|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19491437|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491438|NCT03130504|Progesterone|progesterone|mesh-list
19491439|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19491440|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19491441|NCT03130504|Progestins|progestins|mesh-ancestor
19491442|NCT03130504|Hormones|hormones|mesh-ancestor
19569596|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
20026163|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20026164|NCT05319873|Antibodies|antibodies|mesh-list
20026165|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
20293026|NCT04833855|Omalizumab|omalizumab|mesh-list
20293027|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19745841|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19745842|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19745843|NCT04987892|Tamsulosin|tamsulosin|mesh-list
19745844|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19745845|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19745846|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19745847|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
19745848|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745849|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745850|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745851|NCT04987892|Urological Agents|urological agents|mesh-ancestor
19745852|NCT04977167|Antibodies|antibodies|mesh-list
19745853|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
19745854|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745855|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
19745856|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19745857|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745858|NCT04933721|Berotralstat|berotralstat|mesh-list
19745859|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745860|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745861|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19745862|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745863|NCT04857138|Atezolizumab|atezolizumab|mesh-list
19745864|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745865|NCT04849325|Sirolimus|sirolimus|mesh-list
19745866|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745867|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19745868|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745869|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745870|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
19745871|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745872|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
19745873|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745874|NCT04837768|Progesterone|progesterone|mesh-list
19745875|NCT04837768|Progestins|progestins|mesh-ancestor
19745876|NCT04837768|Hormones|hormones|mesh-ancestor
19745877|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745878|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745879|NCT04833426|Testosterone|testosterone|mesh-list
19745880|NCT04833426|Androgens|androgens|mesh-ancestor
19745881|NCT04833426|Hormones|hormones|mesh-ancestor
19745882|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745883|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745884|NCT04769388|Carboplatin|carboplatin|mesh-list
20026166|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20026167|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
20026168|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026169|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026170|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
20026171|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
20026172|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
20026173|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026174|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026175|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20026176|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20026177|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
20026178|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026179|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20026180|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026181|NCT05315271|Ketamine|ketamine|mesh-list
20026182|NCT05315271|Bupivacaine|bupivacaine|mesh-list
20026183|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
20026184|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
20576477|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19577801|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577802|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577803|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577804|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19577805|NCT03892785|Prednisone|prednisone|mesh-list
19577806|NCT03892785|Methotrexate|methotrexate|mesh-list
19577807|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577808|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
19577809|NCT03892785|Hormones|hormones|mesh-ancestor
19577810|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577811|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745885|NCT04769388|Pemetrexed|pemetrexed|mesh-list
19745886|NCT04769388|Osimertinib|osimertinib|mesh-list
19745887|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745888|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745889|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745890|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19745891|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19745892|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20026185|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026186|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026187|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
20026188|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026189|NCT05315271|Analgesics|analgesics|mesh-ancestor
20026190|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20026191|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20026192|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
20026193|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20026194|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20026195|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026196|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026197|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
20026198|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20026199|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20026200|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026201|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
20026202|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
20026203|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
20026204|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20026205|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026206|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
20026207|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
20026208|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20026209|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026210|NCT05289830|Citalopram|citalopram|mesh-list
20026211|NCT05289830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20026212|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20026213|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026214|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026215|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026216|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
20026217|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026218|NCT05289830|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20026219|NCT05289830|Antidepressive Agents|antidepressive agents|mesh-ancestor
20026220|NCT05289830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20026221|NCT05284747|Evolocumab|evolocumab|mesh-list
20026222|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20026223|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20026224|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
20026225|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026226|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20026227|NCT05259722|Alitretinoin|alitretinoin|mesh-list
20026228|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026229|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
20026230|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
20026231|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20026232|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026233|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
20026234|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
20026235|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20026236|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026237|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
20026238|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
20026239|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20026240|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026241|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
20026242|NCT05254002|Empagliflozin|empagliflozin|mesh-list
20026243|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20026244|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026245|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20026246|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026247|NCT05248139|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20026248|NCT05248139|Moxifloxacin|moxifloxacin|mesh-list
20026249|NCT05248139|Prednisolone|prednisolone|mesh-list
20026250|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20026251|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
20026252|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20026253|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
20026254|NCT05248139|Triamcinolone|triamcinolone|mesh-list
20026255|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20026256|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20026257|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20026258|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
20026259|NCT05248139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026260|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026261|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
20026262|NCT05248139|Hormones|hormones|mesh-ancestor
20026263|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026264|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026265|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026266|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026267|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
20026268|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
20026269|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026270|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026271|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20026272|NCT05248139|Protective Agents|protective agents|mesh-ancestor
20026273|NCT05248139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20026274|NCT05248139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20026275|NCT05248139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026276|NCT05248139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026277|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026278|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
20026279|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20026280|NCT05238142|Insulin|insulin|mesh-list
20026281|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20026282|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115616|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115617|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
20115618|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
20115619|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115620|NCT00005590|Levofloxacin|levofloxacin|mesh-list
20115621|NCT00005590|Ofloxacin|ofloxacin|mesh-list
20115622|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20115623|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115624|NCT00005590|Renal Agents|renal agents|mesh-ancestor
20115625|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20115626|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115627|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115628|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115629|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115630|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115631|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20115632|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20115633|NCT00005591|Gemcitabine|gemcitabine|mesh-list
20115634|NCT00005591|Cetuximab|cetuximab|mesh-list
20115635|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115636|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
20115637|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115638|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115639|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
20115640|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115641|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115642|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115643|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
20115644|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115645|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115646|NCT00005592|Rituximab|rituximab|mesh-list
20115647|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20115648|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115649|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115650|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
20115651|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115652|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115653|NCT00005593|Carboplatin|carboplatin|mesh-list
20115654|NCT00005593|Fludarabine|fludarabine|mesh-list
20115655|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
20115656|NCT00005593|Topotecan|topotecan|mesh-list
20115657|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115658|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115659|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
20293028|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20026283|NCT05213832|Isoflurane|isoflurane|mesh-list
20026284|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20026285|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
20026286|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
20026287|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026288|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026289|NCT05193994|Lamivudine|lamivudine|mesh-list
20026290|NCT05193994|Abacavir|abacavir|mesh-list
20026291|NCT05193994|Dolutegravir|dolutegravir|mesh-list
20026292|NCT05193994|Triumeq|triumeq|mesh-list
20026293|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20026294|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20026295|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026296|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026297|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
20026298|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026299|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20026300|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20026301|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20026302|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20026303|NCT05193591|Autoantibodies|autoantibodies|mesh-list
20026304|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
20026305|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026306|NCT05182151|Istradefylline|istradefylline|mesh-list
20026307|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20026308|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20026309|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20026310|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
20026311|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026312|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026313|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026314|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
20026315|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20026316|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026317|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20026318|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026319|NCT05157581|Methoxsalen|methoxsalen|mesh-list
20026320|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20026321|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
20026322|NCT05156710|Rituximab|rituximab|mesh-list
20026323|NCT05156710|Tacrolimus|tacrolimus|mesh-list
20026324|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
20026325|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20026326|NCT05156710|Antibodies|antibodies|mesh-list
20026327|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20026328|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
20026329|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20026330|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20026331|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026332|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
20026333|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026334|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026335|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026336|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20026337|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026338|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026339|NCT05151640|Nintedanib|nintedanib|mesh-list
20026340|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026341|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20026342|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026343|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026344|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20026345|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20026346|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20026347|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026348|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026349|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20026350|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026351|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026352|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
20026353|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026354|NCT05136690|Nicotine|nicotine|mesh-list
20026355|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20026356|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
20026357|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026358|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026359|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20026360|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20026361|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
20026362|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026363|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026364|NCT05119166|Niacinamide|niacinamide|mesh-list
20026365|NCT05119166|Azithromycin|azithromycin|mesh-list
20026366|NCT05119166|Vitamins|vitamins|mesh-ancestor
20026367|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
20026368|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026369|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20026370|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026371|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
20026372|NCT05113745|Reboxetine|reboxetine|mesh-list
20026373|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
20026374|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20026375|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20026376|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20026377|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026378|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026379|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
20026380|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026381|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026382|NCT05105074|Morphine|morphine|mesh-list
20026383|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20026384|NCT05105074|Narcotics|narcotics|mesh-ancestor
20026385|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026386|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026387|NCT05105074|Analgesics|analgesics|mesh-ancestor
20026388|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
20026389|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026390|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
20026391|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20026392|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026393|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026394|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026395|NCT05099055|Analgesics|analgesics|mesh-ancestor
20026396|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
20026397|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026398|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20026399|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20026400|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20026401|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20026402|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026403|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026404|NCT05086692|Interleukin-2|interleukin-2|mesh-list
20026405|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026406|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026407|NCT05086692|Analgesics|analgesics|mesh-ancestor
20026408|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
20026409|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026410|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026411|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
20026412|NCT05081193|Testosterone|testosterone|mesh-list
20026413|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
20026414|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
20026415|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20026416|NCT05081193|Androgens|androgens|mesh-ancestor
20026417|NCT05081193|Hormones|hormones|mesh-ancestor
20026418|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026419|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026420|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026421|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026422|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
20026423|NCT05071053|Ramucirumab|ramucirumab|mesh-list
20026424|NCT05071053|Maytansine|maytansine|mesh-list
20026425|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026426|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20026427|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
20026428|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293029|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20026429|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
20026430|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026431|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
20026432|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20026433|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20026434|NCT05068349|Protective Agents|protective agents|mesh-ancestor
20026435|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026436|NCT05047250|Gemcitabine|gemcitabine|mesh-list
20026437|NCT05047250|Paclitaxel|paclitaxel|mesh-list
20026438|NCT05047250|Carboplatin|carboplatin|mesh-list
20026439|NCT05047250|Pemetrexed|pemetrexed|mesh-list
20026440|NCT05047250|Atezolizumab|atezolizumab|mesh-list
20026441|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20026442|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026443|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
20026444|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
20026445|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
20026446|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026447|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20026448|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
20026449|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
20026450|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026451|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026452|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026453|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
20026454|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026455|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20026456|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20026457|NCT05047172|Aspirin|aspirin|mesh-list
20026458|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
20026459|NCT05047172|Clopidogrel|clopidogrel|mesh-list
20026460|NCT05047172|Ticagrelor|ticagrelor|mesh-list
20026461|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20026462|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026463|NCT05047172|Analgesics|analgesics|mesh-ancestor
20026464|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
20026465|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026466|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026467|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026468|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026469|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20026470|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20026471|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026472|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20026473|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20026474|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026475|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
20026476|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20026477|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20026478|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20026479|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
20026480|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026481|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20026482|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
20026483|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20026484|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
20026485|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
20026486|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20026487|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20026488|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026489|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
20026490|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20026491|NCT04997811|Valproic Acid|valproic acid|mesh-list
20026492|NCT04997811|Bezafibrate|bezafibrate|mesh-list
20026493|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
20026494|NCT04997811|Danazol|danazol|mesh-list
20026495|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
20026496|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026497|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026498|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
20026499|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026500|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026501|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
20026502|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20026503|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026504|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19569597|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026505|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20026506|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20026507|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20026508|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
20026509|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20026510|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20026511|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20026512|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20026513|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026514|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026515|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20026516|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
20026517|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026518|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20026519|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
20026520|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20026521|NCT04996719|Sirolimus|sirolimus|mesh-list
20026522|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20026523|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026524|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20026525|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026526|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
20026527|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026528|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
20026529|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026530|NCT04996602|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
20026531|NCT04996602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20026532|NCT04996602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026533|NCT04988308|Adalimumab|adalimumab|mesh-list
20026534|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026535|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026536|NCT04973605|Dexamethasone|dexamethasone|mesh-list
20026537|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026538|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
20026539|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
20026540|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026541|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026542|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026543|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
20026544|NCT04973605|Hormones|hormones|mesh-ancestor
20026545|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026546|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026547|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026548|NCT04961541|Vaccines|vaccines|mesh-list
20026549|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
20026550|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026551|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
20026552|NCT04947553|Bupropion|bupropion|mesh-list
20026553|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20026554|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
20026555|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20026556|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20026557|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20026558|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026559|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026560|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
20026561|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026562|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026563|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20026564|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20026565|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026566|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
20026567|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
20026568|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20026569|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20026570|NCT04945122|Atorvastatin|atorvastatin|mesh-list
20026571|NCT04945122|Pitavastatin|pitavastatin|mesh-list
20026572|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20026573|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20026574|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
20026575|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026576|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20026577|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20026578|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026579|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20026580|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20576478|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20026581|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026582|NCT04932382|Misoprostol|misoprostol|mesh-list
20026583|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20026584|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
20026585|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20026586|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026587|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20026588|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026589|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
20026590|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20026591|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20026592|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
20026593|NCT04921982|Propranolol|propranolol|mesh-list
20026594|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20026595|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20026596|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
20026597|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026598|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026599|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026600|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20026601|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20026602|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
20115660|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115661|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115662|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
20115663|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115664|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20115665|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115666|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115667|NCT00005596|Leucovorin|leucovorin|mesh-list
20115668|NCT00005596|Cytarabine|cytarabine|mesh-list
20115669|NCT00005596|Dexamethasone|dexamethasone|mesh-list
20115670|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
20115671|NCT00005596|Methotrexate|methotrexate|mesh-list
20115672|NCT00005596|Vincristine|vincristine|mesh-list
20115673|NCT00005596|Daunorubicin|daunorubicin|mesh-list
20115674|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
20115675|NCT00005596|Pegaspargase|pegaspargase|mesh-list
20115676|NCT00005596|Thioguanine|thioguanine|mesh-list
20115677|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
20115678|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115679|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
20115680|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115681|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115682|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115683|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
20115684|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115685|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115686|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115687|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115688|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
20115689|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
20115690|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115691|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20115692|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
20115693|NCT00005596|Hormones|hormones|mesh-ancestor
20115694|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115695|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115696|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20115697|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
20115698|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20115699|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115700|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
20115701|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115702|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115703|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20115704|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20115705|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
20115706|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115707|NCT00005596|Antidotes|antidotes|mesh-ancestor
20115708|NCT00005596|Protective Agents|protective agents|mesh-ancestor
20026608|NCT04882774|Treprostinil|treprostinil|mesh-list
20026609|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20026610|NCT04870034|Palbociclib|palbociclib|mesh-list
20026611|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026612|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20026613|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026614|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026615|NCT04865419|Voriconazole|voriconazole|mesh-list
20026616|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
20026617|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026618|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20026619|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20026620|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026621|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026622|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20026623|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
20026624|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026625|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026626|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20026627|NCT04853147|Dexamethasone|dexamethasone|mesh-list
20026628|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
20026629|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
20026630|NCT04853147|Aprepitant|aprepitant|mesh-list
20026631|NCT04853147|BB 1101|bb 1101|mesh-list
20026632|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026633|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
20026634|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
20026635|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026636|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026637|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026638|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
20026639|NCT04853147|Hormones|hormones|mesh-ancestor
20026640|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026641|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026642|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026643|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
20026644|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026645|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026646|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20026647|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026648|NCT04845035|Cytarabine|cytarabine|mesh-list
20026649|NCT04845035|Methotrexate|methotrexate|mesh-list
20026650|NCT04845035|Dasatinib|dasatinib|mesh-list
20026651|NCT04845035|Ponatinib|ponatinib|mesh-list
20026652|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20026653|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
20026654|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20026655|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026656|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20026657|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
20026658|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026659|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026660|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
20026661|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026662|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20026663|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026664|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
20026665|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026666|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20026667|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
20026668|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026669|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20026670|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20026671|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026672|NCT04833023|Olanzapine|olanzapine|mesh-list
20026673|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
20026674|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
20026675|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026676|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026677|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026678|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20026679|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20026680|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026681|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20026682|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20026683|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20026684|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026685|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026686|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026687|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
20026688|NCT04804735|Anesthetics|anesthetics|mesh-list
20026689|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026690|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026691|NCT04804553|Apremilast|apremilast|mesh-list
20026692|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20026693|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026694|NCT04804553|Analgesics|analgesics|mesh-ancestor
20026695|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
20026696|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026697|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026698|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026699|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026700|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20026701|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20026702|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026703|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026704|NCT04799249|Gemcitabine|gemcitabine|mesh-list
20026705|NCT04799249|Carboplatin|carboplatin|mesh-list
20026706|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026707|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20026708|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
20026709|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026710|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
20026711|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026712|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026713|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026714|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
20026715|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026716|NCT04798027|Vaccines|vaccines|mesh-list
20026717|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
20026718|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026719|NCT04762680|Vaccines|vaccines|mesh-list
20026720|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
20026721|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026722|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
20026723|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026724|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
20026725|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026726|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026727|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20026728|NCT04745351|Remdesivir|remdesivir|mesh-list
20026729|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
20026730|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026731|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
20026732|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026733|NCT04665570|Metformin|metformin|mesh-list
20026734|NCT04665570|Acarbose|acarbose|mesh-list
20026735|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20115709|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
20026736|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026737|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20026738|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026739|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026740|NCT04660344|Atezolizumab|atezolizumab|mesh-list
20026741|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026742|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
20026743|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026744|NCT04642365|Atezolizumab|atezolizumab|mesh-list
20026745|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026746|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
20026747|NCT04588311|Hematinics|hematinics|mesh-ancestor
20026748|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
20026749|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20026750|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
20026751|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20026752|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026753|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20026754|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026755|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026756|NCT04550260|Cisplatin|cisplatin|mesh-list
20026757|NCT04550260|Fluorouracil|fluorouracil|mesh-list
20026758|NCT04550260|Capecitabine|capecitabine|mesh-list
20026759|NCT04550260|Durvalumab|durvalumab|mesh-list
20026760|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026761|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
20026762|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026763|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20026764|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026765|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
20026766|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026767|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20026768|NCT04546633|Lumefantrine|lumefantrine|mesh-list
20026769|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
20026770|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20026771|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20026772|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026773|NCT04532372|Leflunomide|leflunomide|mesh-list
20026774|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026775|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026776|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026777|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
20026778|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026779|NCT04521231|Blinatumomab|blinatumomab|mesh-list
20026780|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026781|NCT04491877|Vaccines|vaccines|mesh-list
20026782|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
20026783|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026784|NCT04434092|Eculizumab|eculizumab|mesh-list
20026785|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20026786|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026787|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
20026788|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115710|NCT00005596|Vitamins|vitamins|mesh-ancestor
20115711|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
20115712|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115713|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115714|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115715|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115716|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115717|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115718|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115719|NCT00005597|Temozolomide|temozolomide|mesh-list
20115720|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115721|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
20115722|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115723|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115724|NCT00005598|Azacitidine|azacitidine|mesh-list
20115725|NCT00005598|Amifostine|amifostine|mesh-list
20115726|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115727|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
20115728|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115729|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745893|NCT04759248|Trastuzumab|trastuzumab|mesh-list
20115730|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115731|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20115732|NCT00005598|Protective Agents|protective agents|mesh-ancestor
20026789|NCT04432584|Eculizumab|eculizumab|mesh-list
20026790|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20026791|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026792|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
20026793|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026794|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20026795|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20026796|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026797|NCT04410991|Teriflunomide|teriflunomide|mesh-list
20026798|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20026799|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026800|NCT04410991|Analgesics|analgesics|mesh-ancestor
20026801|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
20026802|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026803|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026804|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026805|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026806|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026807|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
20026808|NCT04410978|Teriflunomide|teriflunomide|mesh-list
20026809|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20026810|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026811|NCT04410978|Analgesics|analgesics|mesh-ancestor
20026812|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
20026813|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026814|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026815|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026816|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026817|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026818|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
20026819|NCT04395196|Choline|choline|mesh-list
20026820|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
20026821|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20026822|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
20026823|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026824|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026825|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20026826|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
20026827|NCT04394624|Ramucirumab|ramucirumab|mesh-list
20026828|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026829|NCT04385368|Durvalumab|durvalumab|mesh-list
20026830|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20026831|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026832|NCT04375527|Nivolumab|nivolumab|mesh-list
20026833|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20026834|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026835|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20026836|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026837|NCT04372108|Ustekinumab|ustekinumab|mesh-list
20026838|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
20026839|NCT04276363|Nicotine|nicotine|mesh-list
20026840|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20026841|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
20026842|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026843|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026844|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20026845|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20026846|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
20026847|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026848|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026849|NCT04267809|Vitamin D|vitamin d|mesh-list
20026850|NCT04267809|Metformin|metformin|mesh-list
20026851|NCT04267809|Calcium|calcium|mesh-list
20026852|NCT04267809|Vitamins|vitamins|mesh-ancestor
20026853|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
20026854|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026855|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20026856|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20026857|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20026858|NCT04252742|Erenumab|erenumab|mesh-list
20026859|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20026860|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026861|NCT04252742|Analgesics|analgesics|mesh-ancestor
20026862|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
20026863|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026864|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026865|NCT04240002|Cytarabine|cytarabine|mesh-list
20026866|NCT04240002|Fludarabine|fludarabine|mesh-list
20026867|NCT04240002|Sargramostim|sargramostim|mesh-list
20026868|NCT04240002|Lenograstim|lenograstim|mesh-list
20026869|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026870|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20026871|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
20026872|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026873|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026874|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
20026875|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026876|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
20026877|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026878|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20026879|NCT04227366|Methotrexate|methotrexate|mesh-list
20026880|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20026881|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
20026882|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20026883|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026884|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20026885|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
20026886|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026887|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026888|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
20026889|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026890|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20026891|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20026892|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
20026893|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026894|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20026895|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
20026896|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20026897|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20026898|NCT04177433|Prednisolone|prednisolone|mesh-list
20026899|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
20026900|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20026901|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
20026902|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026903|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
20026904|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
20026905|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026906|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026907|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20026908|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
20026909|NCT04177433|Hormones|hormones|mesh-ancestor
20026910|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026911|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20026912|NCT04177433|Protective Agents|protective agents|mesh-ancestor
20026913|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026914|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026915|NCT04175613|Apremilast|apremilast|mesh-list
20026916|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20026917|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20026918|NCT04175613|Analgesics|analgesics|mesh-ancestor
20026919|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
20026920|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026921|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026922|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20026923|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20026924|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20026925|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20026926|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026927|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026928|NCT04158362|Paclitaxel|paclitaxel|mesh-list
20026929|NCT04158362|Capecitabine|capecitabine|mesh-list
20026930|NCT04158362|Letrozole|letrozole|mesh-list
20026931|NCT04158362|Fulvestrant|fulvestrant|mesh-list
20026932|NCT04158362|Anastrozole|anastrozole|mesh-list
20026933|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20026934|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026935|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
20026936|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
20026937|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
20026938|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026939|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20026940|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
20026941|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20026942|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20026943|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026944|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20026945|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
20026946|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20026947|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026948|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20026949|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20026950|NCT04143607|Gefitinib|gefitinib|mesh-list
20026951|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026952|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20026953|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20026954|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026955|NCT04142242|Vaccines|vaccines|mesh-list
20026956|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
20026957|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026958|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20026959|NCT04108858|Trastuzumab|trastuzumab|mesh-list
20026960|NCT04108858|Pertuzumab|pertuzumab|mesh-list
20026961|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20026962|NCT04108858|Antibodies|antibodies|mesh-list
20026963|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
20026964|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20026965|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
20026966|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026967|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026968|NCT04104139|Trifluridine|trifluridine|mesh-list
20026969|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
20026970|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026971|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
20026972|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20026973|NCT04082806|Trazodone|trazodone|mesh-list
20026974|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20026975|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20026976|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026977|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026978|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20026979|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20026980|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20026981|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20026982|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20026983|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20026984|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
20026985|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20026986|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
20026987|NCT04080739|Ropivacaine|ropivacaine|mesh-list
20026988|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
20026989|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
20026990|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20026991|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20026992|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
20026993|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20026994|NCT04075292|Rituximab|rituximab|mesh-list
20026995|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
20026996|NCT04075292|Chlorambucil|chlorambucil|mesh-list
20026997|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20026998|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20026999|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
20027000|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027001|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027002|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027003|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
20027004|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027005|NCT04075136|Triamcinolone|triamcinolone|mesh-list
20027006|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20027007|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20027008|NCT04075136|Ranibizumab|ranibizumab|mesh-list
20027009|NCT04075136|Verteporfin|verteporfin|mesh-list
20027010|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20027011|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027012|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027013|NCT04075136|Growth Substances|growth substances|mesh-ancestor
20027014|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027015|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027016|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027017|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027018|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
20027019|NCT04075136|Hormones|hormones|mesh-ancestor
20027020|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027021|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027022|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
20027023|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027024|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027025|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20027026|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
20027027|NCT04055649|Paclitaxel|paclitaxel|mesh-list
20027028|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20027029|NCT04055649|TIC10 compound|tic10 compound|mesh-list
20027030|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20027031|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027032|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027033|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027034|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027035|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027036|NCT04036435|BMS-986165|bms-986165|mesh-list
20027037|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
20027038|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20027039|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027040|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027041|NCT04025060|Caffeine|caffeine|mesh-list
20027042|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20027043|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027044|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20027045|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027046|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027047|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20027048|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20027049|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
20027050|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20027051|NCT04015180|Aflibercept|aflibercept|mesh-list
20027052|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027053|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027054|NCT04015180|Growth Substances|growth substances|mesh-ancestor
20027055|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027056|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027057|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027058|NCT04001881|Anesthetics|anesthetics|mesh-list
20027059|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20027060|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027061|NCT03997123|Paclitaxel|paclitaxel|mesh-list
20027062|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20027063|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027064|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027065|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027066|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027067|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027068|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
20027069|NCT03970252|Leucovorin|leucovorin|mesh-list
20027070|NCT03970252|Folic Acid|folic acid|mesh-list
20027071|NCT03970252|Fluorouracil|fluorouracil|mesh-list
20027072|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
20027073|NCT03970252|Nivolumab|nivolumab|mesh-list
20027074|NCT03970252|Irinotecan|irinotecan|mesh-list
20027075|NCT03970252|Camptothecin|camptothecin|mesh-list
20027076|NCT03970252|Calcium|calcium|mesh-list
20027077|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
20027078|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20027079|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027080|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20027081|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
20027082|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027083|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20027084|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027085|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027086|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
20027087|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027088|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20027089|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20027090|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20027091|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027092|NCT03970252|Antidotes|antidotes|mesh-ancestor
20027093|NCT03970252|Protective Agents|protective agents|mesh-ancestor
20027094|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
20027095|NCT03970252|Vitamins|vitamins|mesh-ancestor
20027096|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
20027097|NCT03970252|Hematinics|hematinics|mesh-ancestor
20027098|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20027099|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
20027100|NCT03959085|Leucovorin|leucovorin|mesh-list
20027101|NCT03959085|Folic Acid|folic acid|mesh-list
20027102|NCT03959085|Cytarabine|cytarabine|mesh-list
20027103|NCT03959085|Dexamethasone|dexamethasone|mesh-list
20027104|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
20027105|NCT03959085|Prednisolone|prednisolone|mesh-list
20027106|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20027107|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
20027108|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20027109|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
20027110|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
20027111|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20027112|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20027113|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20027114|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
20027115|NCT03959085|Doxorubicin|doxorubicin|mesh-list
20027116|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20027117|NCT03959085|Methotrexate|methotrexate|mesh-list
20027118|NCT03959085|Vincristine|vincristine|mesh-list
20027119|NCT03959085|Daunorubicin|daunorubicin|mesh-list
20027120|NCT03959085|Asparaginase|asparaginase|mesh-list
20027121|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
20027122|NCT03959085|Pegaspargase|pegaspargase|mesh-list
20027123|NCT03959085|Thioguanine|thioguanine|mesh-list
20027124|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20027125|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20027126|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
20027127|NCT03959085|BB 1101|bb 1101|mesh-list
20027128|NCT03959085|Calcium|calcium|mesh-list
20027129|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
20027130|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
20027131|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027132|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
20027133|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027134|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027135|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027136|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
20027137|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027138|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027139|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20027140|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027141|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
20027142|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
20027143|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027144|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027145|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
20027146|NCT03959085|Hormones|hormones|mesh-ancestor
20027147|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027148|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027149|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
20027150|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027151|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20027152|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20027153|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20027154|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20027155|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20027156|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20027157|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
20027158|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20027159|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20027160|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
20027161|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
20027162|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20027163|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20027164|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
20027165|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027166|NCT03959085|Antidotes|antidotes|mesh-ancestor
20027167|NCT03959085|Protective Agents|protective agents|mesh-ancestor
20027168|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
20027169|NCT03959085|Vitamins|vitamins|mesh-ancestor
20027170|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
20027171|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20027172|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027173|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027174|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027175|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20027176|NCT03959085|Hematinics|hematinics|mesh-ancestor
20027177|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027178|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
20027179|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027180|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027181|NCT03947385|Crizotinib|crizotinib|mesh-list
20027182|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027183|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20027184|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027185|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027186|NCT03940703|Osimertinib|osimertinib|mesh-list
20027187|NCT03940703|Tepotinib|tepotinib|mesh-list
20027188|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027189|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20027190|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027191|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027192|NCT03934541|Vaccines|vaccines|mesh-list
20027193|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
20027194|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027195|NCT03904251|Cytarabine|cytarabine|mesh-list
20027196|NCT03904251|Daunorubicin|daunorubicin|mesh-list
20027197|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
20027198|NCT03904251|Calicheamicins|calicheamicins|mesh-list
20027199|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20027200|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
20027201|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027202|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027203|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
20027204|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027205|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027206|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
20027207|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027208|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20027209|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20027210|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20027211|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027212|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115733|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115734|NCT00005599|Paclitaxel|paclitaxel|mesh-list
20115735|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
20115736|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115737|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115738|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115739|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115740|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115741|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115742|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20115743|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
20115744|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115745|NCT00005601|Cytarabine|cytarabine|mesh-list
20115746|NCT00005601|Dexamethasone|dexamethasone|mesh-list
20115747|NCT00005601|Rituximab|rituximab|mesh-list
20115748|NCT00005601|Sargramostim|sargramostim|mesh-list
20115749|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115750|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115751|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
20115752|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115753|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115754|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115755|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
20115756|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
20115757|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115758|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20115759|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
20115760|NCT00005601|Hormones|hormones|mesh-ancestor
20115761|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115762|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115763|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115764|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
20576479|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
20027213|NCT03903640|Nivolumab|nivolumab|mesh-list
20027214|NCT03903640|Ipilimumab|ipilimumab|mesh-list
20027215|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027216|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027217|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20027218|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027219|NCT03874936|Dexamethasone|dexamethasone|mesh-list
20027220|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20027221|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027222|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
20027223|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
20027224|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027225|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027226|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027227|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
20027228|NCT03874936|Hormones|hormones|mesh-ancestor
20027229|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027230|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027231|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027232|NCT03861767|Metformin|metformin|mesh-list
20027233|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20027234|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027235|NCT03834688|Rituximab|rituximab|mesh-list
20027236|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20027237|NCT03834688|Venetoclax|venetoclax|mesh-list
20027238|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027239|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027240|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
20027241|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027242|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027243|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027244|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
20027245|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027246|NCT03801304|Atezolizumab|atezolizumab|mesh-list
20027247|NCT03801304|Vinorelbine|vinorelbine|mesh-list
20027248|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027249|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20027250|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027251|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027252|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027253|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027254|NCT03782532|Prednisone|prednisone|mesh-list
20027255|NCT03782532|Prednisolone|prednisolone|mesh-list
20027256|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027257|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
20027258|NCT03782532|Hormones|hormones|mesh-ancestor
20027259|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027260|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027261|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027262|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027263|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
20027264|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20027265|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027266|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20027267|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20027268|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027269|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
20027270|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027271|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027272|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
20027273|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027274|NCT03769181|Cemiplimab|cemiplimab|mesh-list
20027275|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027276|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027277|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
20027278|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027279|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027280|NCT03708627|Bimatoprost|bimatoprost|mesh-list
20027281|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20027282|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
20027283|NCT03704298|Fludarabine|fludarabine|mesh-list
20027284|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027285|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
20027286|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027287|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027288|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027289|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
20027290|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027291|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027292|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20027293|NCT03657160|Vedolizumab|vedolizumab|mesh-list
20027294|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027295|NCT03651271|Nivolumab|nivolumab|mesh-list
20027296|NCT03651271|Ipilimumab|ipilimumab|mesh-list
20027297|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027298|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293030|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
20293031|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
20293032|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293033|NCT04822337|Dexamethasone|dexamethasone|mesh-list
20293034|NCT04822337|Lenalidomide|lenalidomide|mesh-list
20293035|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293036|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
20293037|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
20293038|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293039|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293040|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027299|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20027300|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027301|NCT03637764|Atezolizumab|atezolizumab|mesh-list
20027302|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027303|NCT03630705|Vaccines|vaccines|mesh-list
20027304|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
20027305|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293041|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
20293042|NCT04822337|Hormones|hormones|mesh-ancestor
20293043|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293044|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19745894|NCT04759248|Atezolizumab|atezolizumab|mesh-list
20027306|NCT03602157|Fludarabine|fludarabine|mesh-list
20027307|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20027308|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027309|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027310|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027311|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
20027312|NCT03560466|Prednisone|prednisone|mesh-list
20027313|NCT03560466|Prednisolone|prednisolone|mesh-list
20027314|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027315|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
20027316|NCT03560466|Hormones|hormones|mesh-ancestor
20027317|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027318|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027319|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027320|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027321|NCT03545035|Rituximab|rituximab|mesh-list
20027322|NCT03545035|Idelalisib|idelalisib|mesh-list
20027323|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027324|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027325|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
20027326|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027327|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027328|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027329|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027330|NCT03528941|Lamivudine|lamivudine|mesh-list
20027331|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20027332|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20027333|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027334|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027335|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
20027336|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027337|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20027338|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20027339|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20027340|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20027341|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027342|NCT03424005|Gemcitabine|gemcitabine|mesh-list
20027343|NCT03424005|Paclitaxel|paclitaxel|mesh-list
20027344|NCT03424005|Bevacizumab|bevacizumab|mesh-list
20027345|NCT03424005|Carboplatin|carboplatin|mesh-list
20027346|NCT03424005|Capecitabine|capecitabine|mesh-list
20027347|NCT03424005|Atezolizumab|atezolizumab|mesh-list
20027348|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20027349|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027350|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027351|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027352|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027353|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027354|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027355|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027356|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027357|NCT03424005|Growth Substances|growth substances|mesh-ancestor
20027358|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027359|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027360|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20027361|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
20027362|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
20027363|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027364|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027365|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027366|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
20027367|NCT03422861|Nabilone|nabilone|mesh-list
20027368|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
20027369|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
20027370|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027371|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027372|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027373|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20027374|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20027375|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20027376|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20027377|NCT03376698|Colchicine|colchicine|mesh-list
20027378|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
20027379|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027380|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027381|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027382|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027383|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027384|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027385|NCT03351244|BI 409306|bi 409306|mesh-list
20027386|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20027387|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027388|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027389|NCT03337698|Linagliptin|linagliptin|mesh-list
20027390|NCT03337698|Gemcitabine|gemcitabine|mesh-list
20027391|NCT03337698|Bevacizumab|bevacizumab|mesh-list
20027392|NCT03337698|Carboplatin|carboplatin|mesh-list
20027393|NCT03337698|Docetaxel|docetaxel|mesh-list
20027394|NCT03337698|Pemetrexed|pemetrexed|mesh-list
20027395|NCT03337698|Atezolizumab|atezolizumab|mesh-list
20027396|NCT03337698|Evolocumab|evolocumab|mesh-list
20027397|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027398|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027399|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027400|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027401|NCT03337698|Growth Substances|growth substances|mesh-ancestor
20027402|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027403|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027404|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20027405|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
20027406|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027407|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
20027408|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027409|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027410|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027411|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
20027412|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027413|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027414|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027415|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20027416|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20027417|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20027418|NCT03337698|Incretins|incretins|mesh-ancestor
20027419|NCT03337698|Hormones|hormones|mesh-ancestor
20027420|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027421|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20027422|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
20027423|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20027424|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20027425|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20027426|NCT03296813|Torsemide|torsemide|mesh-list
20027427|NCT03296813|Furosemide|furosemide|mesh-list
20027428|NCT03296813|Diuretics|diuretics|mesh-ancestor
20027429|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
20027430|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027431|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20027432|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20027433|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027434|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20027435|NCT03295734|Losartan|losartan|mesh-list
20027436|NCT03295734|Perindopril|perindopril|mesh-list
20027437|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20027438|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20027439|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20027440|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20027441|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027442|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20027443|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
20027444|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027445|NCT03292926|Dexamethasone|dexamethasone|mesh-list
20027446|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
20027447|NCT03292926|Bupivacaine|bupivacaine|mesh-list
20027448|NCT03292926|BB 1101|bb 1101|mesh-list
20027449|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027450|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
20027451|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
20027452|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027453|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027454|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027455|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
20027456|NCT03292926|Hormones|hormones|mesh-ancestor
20027457|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027458|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027459|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027460|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
20027461|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027462|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027463|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
20027464|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
20027465|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20027466|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
20027467|NCT03288974|Pomalidomide|pomalidomide|mesh-list
20027468|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
20027469|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027470|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027471|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027472|NCT03288974|Growth Substances|growth substances|mesh-ancestor
20027473|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027474|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027475|NCT03275285|Dexamethasone|dexamethasone|mesh-list
20027476|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027477|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
20027478|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
20027479|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027480|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027481|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027482|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
20027483|NCT03275285|Hormones|hormones|mesh-ancestor
20027484|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027485|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027486|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027487|NCT03271372|Avelumab|avelumab|mesh-list
20027488|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20027489|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027490|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027491|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
20027492|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027493|NCT03246750|Cisplatin|cisplatin|mesh-list
20027494|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027495|NCT03203642|XL647|xl647|mesh-list
19745895|NCT04759248|Vinorelbine|vinorelbine|mesh-list
20027496|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027497|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20027498|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027499|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027500|NCT03198351|Teriflunomide|teriflunomide|mesh-list
20027501|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20027502|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20027503|NCT03198351|Analgesics|analgesics|mesh-ancestor
20027504|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
20027505|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027506|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027507|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027508|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027509|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027510|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
20027511|NCT03192345|Cemiplimab|cemiplimab|mesh-list
20027512|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027513|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027514|NCT03119012|Aspirin|aspirin|mesh-list
20027515|NCT03119012|Clopidogrel|clopidogrel|mesh-list
20027516|NCT03119012|Ticagrelor|ticagrelor|mesh-list
20027517|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20027518|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20027519|NCT03119012|Analgesics|analgesics|mesh-ancestor
20027520|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
20027521|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027522|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027523|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027524|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027525|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20027526|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20027527|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027528|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20027529|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20027530|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027531|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
20027532|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20027533|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20027534|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20027535|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
20027536|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20027537|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
20027538|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
20027539|NCT03096782|Melphalan|melphalan|mesh-list
20027540|NCT03096782|Busulfan|busulfan|mesh-list
20027541|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
20027542|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20027543|NCT03096782|Rituximab|rituximab|mesh-list
20027544|NCT03096782|Fludarabine|fludarabine|mesh-list
20027545|NCT03096782|Clofarabine|clofarabine|mesh-list
20027546|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20027547|NCT03096782|Tacrolimus|tacrolimus|mesh-list
20027548|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
20027549|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20027550|NCT03096782|Antibodies|antibodies|mesh-list
20027551|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
20027552|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20027553|NCT03096782|Lenograstim|lenograstim|mesh-list
20027554|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027555|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
20027556|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027557|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027558|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027559|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
20027560|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027561|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027562|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20027563|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20027564|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
20027565|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20027566|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20027567|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027568|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20027569|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20027570|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
20027571|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20027572|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115765|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115766|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
20576480|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027573|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
20027574|NCT03069963|Antacids|antacids|mesh-ancestor
20027575|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027576|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027577|NCT03056001|Doxorubicin|doxorubicin|mesh-list
20027578|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
20027579|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20027580|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027581|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20027582|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20027583|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027584|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027585|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027586|NCT02982954|Nivolumab|nivolumab|mesh-list
20027587|NCT02982954|Ipilimumab|ipilimumab|mesh-list
20027588|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027589|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027590|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20027591|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027592|NCT02964078|Aldesleukin|aldesleukin|mesh-list
20027593|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
20027594|NCT02964078|Interleukin-2|interleukin-2|mesh-list
20027595|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027596|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027597|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20027598|NCT02964078|Analgesics|analgesics|mesh-ancestor
20027599|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
20027600|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027601|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027602|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20027603|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20027604|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
20027605|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027606|NCT02961257|Prednisone|prednisone|mesh-list
20027607|NCT02961257|Sargramostim|sargramostim|mesh-list
20027608|NCT02961257|Lenograstim|lenograstim|mesh-list
20027609|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027610|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
20027611|NCT02961257|Hormones|hormones|mesh-ancestor
20027612|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027613|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027614|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027615|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027616|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
20027617|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20027618|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
20027619|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027620|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027621|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
20027622|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027623|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027624|NCT02881242|Trametinib|trametinib|mesh-list
20027625|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027626|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20027627|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027628|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027629|NCT02825160|Iloprost|iloprost|mesh-list
20027630|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20027631|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
20027632|NCT02814916|Dalbavancin|dalbavancin|mesh-list
20027633|NCT02814916|Teicoplanin|teicoplanin|mesh-list
20027634|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20027635|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027636|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20027637|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027638|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20027639|NCT02791568|Hematinics|hematinics|mesh-ancestor
20027640|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20027641|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20027642|NCT02720445|Nicotine|nicotine|mesh-list
20027643|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20027644|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
20027645|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027646|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027647|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20027648|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20027649|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
20027650|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20027651|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027652|NCT02619682|Lenalidomide|lenalidomide|mesh-list
20027653|NCT02619682|Ixazomib|ixazomib|mesh-list
20027654|NCT02619682|Glycine|glycine|mesh-list
20027655|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
20027656|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027657|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027658|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027659|NCT02619682|Growth Substances|growth substances|mesh-ancestor
20027660|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027661|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027662|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027663|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
20027664|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027665|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
20027666|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20027667|NCT02454543|Androgens|androgens|mesh-list
20027668|NCT02454543|Hormones|hormones|mesh-ancestor
20027669|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027670|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027671|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20027672|NCT02429375|Mocetinostat|mocetinostat|mesh-list
20027673|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027674|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027675|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20027676|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027677|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027678|NCT02377492|Vasopressins|vasopressins|mesh-list
20027679|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
20027680|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
20027681|NCT02377492|Coagulants|coagulants|mesh-ancestor
20027682|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20027683|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20027684|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
20027685|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027686|NCT02377479|Letrozole|letrozole|mesh-list
20027687|NCT02377479|Clomiphene|clomiphene|mesh-list
20027688|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027689|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20027690|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20027691|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027692|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027693|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20027694|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
20027695|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027696|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027697|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20027698|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
20027699|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20027700|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20027701|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20027702|NCT02332577|Amoxicillin|amoxicillin|mesh-list
20027703|NCT02332577|Pristinamycin|pristinamycin|mesh-list
20027704|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20027705|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027706|NCT02162810|Prednisolone|prednisolone|mesh-list
20027707|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027708|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
20027709|NCT02162810|Hormones|hormones|mesh-ancestor
20027710|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027711|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745896|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19745897|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745898|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19745899|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19745900|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19745901|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19745902|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745903|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
20027712|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027713|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027714|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
20027715|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027716|NCT01997840|Dexamethasone|dexamethasone|mesh-list
20027717|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
20027718|NCT01997840|Pomalidomide|pomalidomide|mesh-list
20027719|NCT01997840|Ricolinostat|ricolinostat|mesh-list
20027720|NCT01997840|BB 1101|bb 1101|mesh-list
20027721|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027722|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
20027723|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
20027724|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027725|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027726|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027727|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
20027728|NCT01997840|Hormones|hormones|mesh-ancestor
20027729|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027730|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027731|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027732|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
20027733|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027734|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027735|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
20027736|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027737|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027738|NCT01997840|Growth Substances|growth substances|mesh-ancestor
20027739|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027740|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20027741|NCT01909453|Vemurafenib|vemurafenib|mesh-list
20027742|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027743|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20027744|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027745|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027746|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
20027747|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20027748|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
20027749|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027750|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
20027751|NCT01891396|Protective Agents|protective agents|mesh-ancestor
20027752|NCT01750567|Metformin|metformin|mesh-list
20027753|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20027754|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027755|NCT01589523|Cholic Acids|cholic acids|mesh-list
20027756|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
20027757|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027758|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20027759|NCT01525901|Mitogens|mitogens|mesh-list
20027760|NCT01525901|Mecasermin|mecasermin|mesh-list
20027761|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027762|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027763|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027764|NCT01525901|Growth Substances|growth substances|mesh-ancestor
20027765|NCT01354431|Nivolumab|nivolumab|mesh-list
20027766|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027767|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027768|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20027769|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027770|NCT00694850|Riociguat|riociguat|mesh-list
20027771|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
20027772|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027773|NCT02593903|Trimethoprim|trimethoprim|mesh-list
20027774|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20027775|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
20027776|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20027777|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027778|NCT02593903|Renal Agents|renal agents|mesh-ancestor
20027779|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
20027780|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20027781|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20027782|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20027783|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027784|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027785|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20027786|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20027787|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20027788|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20027789|NCT02594111|Colchicine|colchicine|mesh-list
20027790|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
20027791|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027792|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027793|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027794|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027795|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027796|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027797|NCT02594163|Rituximab|rituximab|mesh-list
20027798|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20027799|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20027800|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027801|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027802|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
20027803|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027804|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027805|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027806|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
20027807|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027808|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20027809|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20027810|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
20027811|NCT02595398|Triamcinolone|triamcinolone|mesh-list
20027812|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20027813|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20027814|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20027815|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027816|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
20027817|NCT02595398|Hormones|hormones|mesh-ancestor
20027818|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027819|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027820|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027821|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
20027822|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027823|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027824|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20027825|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027826|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20027827|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027828|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027829|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20027830|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20027831|NCT02595684|Tadalafil|tadalafil|mesh-list
20027832|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
20027833|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20027834|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20027835|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027836|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027837|NCT02595684|Urological Agents|urological agents|mesh-ancestor
20027838|NCT02595723|Megestrol|megestrol|mesh-list
20027839|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
20027840|NCT02595723|Phenytoin|phenytoin|mesh-list
20027841|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20027842|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20027843|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20027844|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
20027845|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20027846|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027847|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20027848|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20027849|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027850|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027851|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
20027852|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20027853|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
20027854|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20027855|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20027856|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20027857|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027858|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20027859|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20027860|NCT02595749|Oxytocin|oxytocin|mesh-list
20027861|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
20027862|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20027863|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115767|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115768|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115769|NCT00005602|Carboplatin|carboplatin|mesh-list
20115770|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115771|NCT00005603|Cytarabine|cytarabine|mesh-list
20115772|NCT00005603|Dexamethasone|dexamethasone|mesh-list
20115773|NCT00005603|Prednisone|prednisone|mesh-list
20115774|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
20115775|NCT00005603|Doxorubicin|doxorubicin|mesh-list
20115776|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20115777|NCT00005603|Methotrexate|methotrexate|mesh-list
20115778|NCT00005603|Vincristine|vincristine|mesh-list
20115779|NCT00005603|Daunorubicin|daunorubicin|mesh-list
20115780|NCT00005603|Asparaginase|asparaginase|mesh-list
20115781|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
20115782|NCT00005603|Thioguanine|thioguanine|mesh-list
20115783|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115784|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
20115785|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115786|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115787|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115788|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
20115789|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115790|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115791|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115792|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115793|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
20115794|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
20115795|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115796|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20115797|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
20115798|NCT00005603|Hormones|hormones|mesh-ancestor
20115799|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115800|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115801|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115802|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115803|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115804|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115805|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20115806|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
20115807|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20115808|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115809|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
20115810|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115811|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20115812|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20115813|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
20115814|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115815|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115816|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115817|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115818|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115819|NCT00005604|Aldesleukin|aldesleukin|mesh-list
20115820|NCT00005604|Interleukin-2|interleukin-2|mesh-list
20115821|NCT00005604|Interleukin-12|interleukin-12|mesh-list
20115822|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115823|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20115824|NCT00005604|Analgesics|analgesics|mesh-ancestor
20115825|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
20115826|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115827|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115828|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20115829|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20115830|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
20115831|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115832|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20115833|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
20115834|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20115835|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20115836|NCT00005604|Growth Substances|growth substances|mesh-ancestor
20115837|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
20115838|NCT00005607|Leucovorin|leucovorin|mesh-list
20115839|NCT00005607|Fluorouracil|fluorouracil|mesh-list
20115840|NCT00005607|Irinotecan|irinotecan|mesh-list
20115841|NCT00005607|Calcium|calcium|mesh-list
20115842|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
20115843|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20115844|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027864|NCT02596022|Ketamine|ketamine|mesh-list
20027865|NCT02596022|Analgesics|analgesics|mesh-ancestor
20027866|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
20027867|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027868|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027869|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20027870|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20027871|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
20027872|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
20027873|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20027874|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20027875|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20027876|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20027877|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027878|NCT02596451|Diclofenac|diclofenac|mesh-list
20027879|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20027880|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20027881|NCT02596451|Analgesics|analgesics|mesh-ancestor
20027882|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
20027883|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027884|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027885|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027886|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027887|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20027888|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027889|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027890|NCT02596620|Amoxicillin|amoxicillin|mesh-list
20027891|NCT02596620|Metronidazole|metronidazole|mesh-list
20027892|NCT02596620|Levofloxacin|levofloxacin|mesh-list
20027893|NCT02596620|Esomeprazole|esomeprazole|mesh-list
20027894|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20027895|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20027896|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20027897|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20027898|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20027899|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20027900|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20027901|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027902|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027903|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20027904|NCT02596620|Renal Agents|renal agents|mesh-ancestor
20027905|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20027906|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20027907|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027908|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20027909|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20027910|NCT02596711|Nicotine|nicotine|mesh-list
20027911|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
20027912|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20027913|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
20027914|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20027915|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027916|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20027917|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20027918|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
20027919|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20027920|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027921|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
20027922|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
20027923|NCT02596867|Propranolol|propranolol|mesh-list
20027924|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20027925|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20027926|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
20027927|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20027928|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027929|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027930|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20027931|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20027932|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
20027933|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
20027934|NCT02596945|Hematinics|hematinics|mesh-ancestor
20027935|NCT02596958|Bevacizumab|bevacizumab|mesh-list
20027936|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027937|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027938|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20027939|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20027940|NCT02596958|Growth Substances|growth substances|mesh-ancestor
20027941|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027942|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
20027943|NCT02596971|Prednisone|prednisone|mesh-list
20027944|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
20027945|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20027946|NCT02596971|Rituximab|rituximab|mesh-list
20027947|NCT02596971|Doxorubicin|doxorubicin|mesh-list
20027948|NCT02596971|Vincristine|vincristine|mesh-list
20027949|NCT02596971|Atezolizumab|atezolizumab|mesh-list
20027950|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
20027951|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20027952|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
20027953|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027954|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20027955|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20027956|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
20027957|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027958|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20027959|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20027960|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027961|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20027962|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20027963|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20027964|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20027965|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20027966|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
20027967|NCT02596971|Hormones|hormones|mesh-ancestor
20027968|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027969|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20027970|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20027971|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
20027972|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
20027973|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
20027974|NCT02597049|Metformin|metformin|mesh-list
20027975|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
20027976|NCT02597049|Empagliflozin|empagliflozin|mesh-list
20027977|NCT02597049|Canagliflozin|canagliflozin|mesh-list
20027978|NCT02597049|Dulaglutide|dulaglutide|mesh-list
20027979|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20027980|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20027981|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027982|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027983|NCT02597101|Metformin|metformin|mesh-list
20027984|NCT02597101|Saxagliptin|saxagliptin|mesh-list
20027985|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20027986|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027987|NCT02597101|Incretins|incretins|mesh-ancestor
20027988|NCT02597101|Hormones|hormones|mesh-ancestor
20027989|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20027990|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20027991|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
20027992|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745904|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20027993|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20027994|NCT02597478|Fentanyl|fentanyl|mesh-list
20027995|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20027996|NCT02597478|Narcotics|narcotics|mesh-ancestor
20027997|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20027998|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20027999|NCT02597478|Analgesics|analgesics|mesh-ancestor
20028000|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
20028001|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028002|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20028003|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20028004|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
20028005|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
20028006|NCT02597543|Regadenoson|regadenoson|mesh-list
20028007|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20028008|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20028009|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
20028010|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
20028011|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028012|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115845|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
20028013|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028014|NCT02597855|Aflibercept|aflibercept|mesh-list
20028015|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20028016|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20028017|NCT02597855|Growth Substances|growth substances|mesh-ancestor
20028018|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028019|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
20028020|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028021|NCT02597907|Aprepitant|aprepitant|mesh-list
20028022|NCT02597907|Palonosetron|palonosetron|mesh-list
20028023|NCT02597907|Ramosetron|ramosetron|mesh-list
20028024|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
20028025|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
20028026|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028027|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028028|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028029|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20028030|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028031|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028032|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20028033|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20028034|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
20028035|NCT02597933|Nintedanib|nintedanib|mesh-list
20028036|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028037|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20028038|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028039|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028040|NCT02597946|Paclitaxel|paclitaxel|mesh-list
20028041|NCT02597946|Afatinib|afatinib|mesh-list
20028042|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20028043|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028044|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
20028045|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
20028046|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
20028047|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028048|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20028049|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028050|NCT02598193|Pirfenidone|pirfenidone|mesh-list
20028051|NCT02598193|Nintedanib|nintedanib|mesh-list
20028052|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028053|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20028054|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028055|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028056|NCT02598193|Analgesics|analgesics|mesh-ancestor
20028057|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
20028058|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028059|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028060|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20028061|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20028062|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028063|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20028064|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
20028065|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20028066|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028067|NCT02599402|Nivolumab|nivolumab|mesh-list
20028068|NCT02599402|Ipilimumab|ipilimumab|mesh-list
20028069|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028070|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028071|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20028072|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028073|NCT02599649|Nivolumab|nivolumab|mesh-list
20028074|NCT02599649|Azacitidine|azacitidine|mesh-list
20028075|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028076|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028077|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20028078|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028079|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20028080|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
20028081|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028082|NCT02600325|Grazoprevir|grazoprevir|mesh-list
20028083|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
20028084|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028085|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
20028086|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20028087|NCT02600351|Ledipasvir|ledipasvir|mesh-list
20028088|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
20028089|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028090|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
20028091|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028092|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028093|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20028094|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20028095|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028096|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028097|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028098|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20028099|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20028100|NCT02600611|Vancomycin|vancomycin|mesh-list
20028101|NCT02600611|Iclaprim|iclaprim|mesh-list
20028102|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028103|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028104|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20028105|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028106|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028107|NCT02600715|Morphine|morphine|mesh-list
20028108|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20028109|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20028110|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20028111|NCT02600715|Narcotics|narcotics|mesh-ancestor
20028112|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028113|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028114|NCT02600715|Analgesics|analgesics|mesh-ancestor
20028115|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
20028116|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028117|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20028118|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20028119|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20028120|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028121|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
20028122|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028123|NCT02600767|Lumefantrine|lumefantrine|mesh-list
20028124|NCT02600767|Artemether|artemether|mesh-list
20028125|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20028126|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
20028127|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20028128|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20028129|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028130|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20028131|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028132|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028133|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
20028134|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028135|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
20028136|NCT02600871|Povidone|povidone|mesh-list
20028137|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
20028138|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
20028139|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20028140|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028141|NCT02601027|Acetaminophen|acetaminophen|mesh-list
20028142|NCT02601027|Oxycodone|oxycodone|mesh-list
20028143|NCT02601027|Hydromorphone|hydromorphone|mesh-list
20028144|NCT02601027|Ondansetron|ondansetron|mesh-list
20028145|NCT02601027|Bupivacaine|bupivacaine|mesh-list
20028146|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
20028147|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
20028148|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028149|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028150|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
20028151|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028152|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20028153|NCT02601027|Narcotics|narcotics|mesh-ancestor
20028154|NCT02601027|Analgesics|analgesics|mesh-ancestor
20028155|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
20028156|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
20028157|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028158|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
20028159|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
20028160|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20028161|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
20028162|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028163|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028164|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20028165|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20028166|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20028167|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20028168|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20028169|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
20028170|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
20028171|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20028172|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
20028173|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028174|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
20028175|NCT02601170|Protective Agents|protective agents|mesh-ancestor
20028176|NCT02601573|Ribavirin|ribavirin|mesh-list
20028177|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
20028178|NCT02601573|Grazoprevir|grazoprevir|mesh-list
20028179|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
20028180|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028181|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
20028182|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028183|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20028184|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
20028185|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028186|NCT02601833|Fluorides|fluorides|mesh-list
20028187|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
20028188|NCT02601833|Protective Agents|protective agents|mesh-ancestor
20028189|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028190|NCT02601976|Ribavirin|ribavirin|mesh-list
20028191|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20028192|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
20028193|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028194|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
20028195|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028196|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
20028197|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028198|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028199|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
20028200|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028201|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028202|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028203|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20028204|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20028205|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
20028206|NCT02603120|Tenofovir|tenofovir|mesh-list
20028207|NCT02603120|Emtricitabine|emtricitabine|mesh-list
20028208|NCT02603120|Lamivudine|lamivudine|mesh-list
20028209|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20028210|NCT02603120|Triumeq|triumeq|mesh-list
20028211|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
20028212|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028213|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20028214|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20028215|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028216|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028217|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028218|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028219|NCT02603393|Fluticasone|fluticasone|mesh-list
20028220|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
20028221|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20028222|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028223|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20028224|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
20028225|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028226|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028227|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20028228|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
20028229|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
20028230|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20028231|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
20028232|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20028233|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
20028234|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028235|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028236|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20028237|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20028238|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20028239|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
20028240|NCT02603419|Avelumab|avelumab|mesh-list
20028241|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20028242|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028243|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028244|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
20028245|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028246|NCT02603809|Lisinopril|lisinopril|mesh-list
20028247|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20028248|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
20028249|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028250|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028251|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20028252|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20028253|NCT02603809|Protective Agents|protective agents|mesh-ancestor
20028254|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028255|NCT02603926|Pregnanolone|pregnanolone|mesh-list
20028256|NCT02603926|Brexanolone|brexanolone|mesh-list
20028257|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
20028258|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028259|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028260|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
20028261|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028262|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028263|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
20028264|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
20028265|NCT02603952|Oseltamivir|oseltamivir|mesh-list
20028266|NCT02603952|MEDI8852|medi8852|mesh-list
20028267|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
20028268|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028269|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028270|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028271|NCT02604173|Budesonide|budesonide|mesh-list
20028272|NCT02604173|Acetazolamide|acetazolamide|mesh-list
20028273|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028274|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20028275|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
20028276|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028277|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028278|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20028279|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
20028280|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
20028281|NCT02604173|Hormones|hormones|mesh-ancestor
20576481|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20576482|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576483|NCT02071537|Analgesics|analgesics|mesh-ancestor
20576484|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
20028282|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028283|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
20028284|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20028285|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028286|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028287|NCT02604173|Diuretics|diuretics|mesh-ancestor
20028288|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
20028289|NCT02604199|Tenofovir|tenofovir|mesh-list
20028290|NCT02604199|Entecavir|entecavir|mesh-list
20028291|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
20028292|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20028293|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
20028294|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028295|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20028296|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20028297|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028298|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028299|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028300|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028301|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
20028302|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028303|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028304|NCT02604212|Tenofovir|tenofovir|mesh-list
20576485|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028305|NCT02604212|Entecavir|entecavir|mesh-list
20028306|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
20028307|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20028308|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
20028309|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028310|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20028311|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20028312|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028313|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028314|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028315|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028316|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
20028317|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028318|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028319|NCT02604342|Docetaxel|docetaxel|mesh-list
20028320|NCT02604342|Pemetrexed|pemetrexed|mesh-list
20028321|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028322|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
20028323|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
20028324|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
20028325|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028326|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028327|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20028328|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20028329|NCT02604550|Naproxen|naproxen|mesh-list
20028330|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20028331|NCT02604550|Ropivacaine|ropivacaine|mesh-list
20028332|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
20028333|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
20028334|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028335|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028336|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
20028337|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028338|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20028339|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20028340|NCT02604550|Analgesics|analgesics|mesh-ancestor
20028341|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028342|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20028343|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
20028344|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20028345|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028346|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028347|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20028348|NCT02604550|Narcotics|narcotics|mesh-ancestor
20028349|NCT02604589|Hydromorphone|hydromorphone|mesh-list
20028350|NCT02604589|Bupivacaine|bupivacaine|mesh-list
19745905|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745906|NCT04738643|Varenicline|varenicline|mesh-list
20028351|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
20028352|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
20028353|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028354|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028355|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
19745907|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19745908|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19745909|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
19745910|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745911|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745912|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745913|NCT04733183|Dacarbazine|dacarbazine|mesh-list
19745914|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19745915|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
19745916|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745917|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745918|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
19745919|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19745920|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745921|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19745922|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745923|NCT04707430|Progesterone|progesterone|mesh-list
19745924|NCT04707430|Progestins|progestins|mesh-ancestor
19745925|NCT04707430|Hormones|hormones|mesh-ancestor
20028356|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028357|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20028358|NCT02604589|Narcotics|narcotics|mesh-ancestor
20028359|NCT02604589|Analgesics|analgesics|mesh-ancestor
20028360|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
20028361|NCT02604810|Antibodies|antibodies|mesh-list
20028362|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
20028363|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20028364|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20028365|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
20028366|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
20028367|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028368|NCT02605122|Amoxicillin|amoxicillin|mesh-list
20028369|NCT02605122|Azithromycin|azithromycin|mesh-list
20028370|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
20028371|NCT02605122|Erythromycin|erythromycin|mesh-list
20028372|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
20028373|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20028374|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
20028375|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
20028376|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
20028377|NCT02605122|Ampicillin|ampicillin|mesh-list
20028378|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20028379|NCT02605122|Solithromycin|solithromycin|mesh-list
20028380|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
20028381|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028382|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028383|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028384|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20028385|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028386|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028387|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20028388|NCT02605174|Lasmiditan|lasmiditan|mesh-list
20028389|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20028390|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
20028391|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028392|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028393|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028394|NCT02605187|Acetaminophen|acetaminophen|mesh-list
20028395|NCT02605187|Ibuprofen|ibuprofen|mesh-list
20028396|NCT02605187|Morphine|morphine|mesh-list
20028397|NCT02605187|Gabapentin|gabapentin|mesh-list
20028398|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20028399|NCT02605187|Narcotics|narcotics|mesh-ancestor
20028400|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028401|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028402|NCT02605187|Analgesics|analgesics|mesh-ancestor
20028403|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
20028404|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028405|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20028406|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
20028407|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20028408|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028409|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20028410|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20028411|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028412|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028413|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
20028414|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20028415|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20028416|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20028417|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20028418|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20028419|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028420|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
20028421|NCT02605304|Ribavirin|ribavirin|mesh-list
20028422|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
20028423|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20028424|NCT02605304|Ledipasvir|ledipasvir|mesh-list
20028425|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
20028426|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028427|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
20028428|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028429|NCT02605395|Rabeprazole|rabeprazole|mesh-list
20028430|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20028431|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028432|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20028433|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028434|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028435|NCT02605642|Infliximab|infliximab|mesh-list
20028436|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
20028437|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028438|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20028439|NCT02605837|Budesonide|budesonide|mesh-list
20028440|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028441|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20028442|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
20028443|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028444|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028445|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20028446|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
20028447|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
20028448|NCT02605837|Hormones|hormones|mesh-ancestor
20028449|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115846|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115847|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115848|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115849|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115850|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
20115851|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20115852|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115853|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115854|NCT00005607|Antidotes|antidotes|mesh-ancestor
20115855|NCT00005607|Protective Agents|protective agents|mesh-ancestor
20115856|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
20115857|NCT00005607|Vitamins|vitamins|mesh-ancestor
20115858|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
20115859|NCT00005609|Rituximab|rituximab|mesh-list
20115860|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115861|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115862|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
20115863|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115864|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115865|NCT00005610|Sargramostim|sargramostim|mesh-list
20115866|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
20115867|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115868|NCT00005612|Paclitaxel|paclitaxel|mesh-list
20115869|NCT00005612|Etoposide|etoposide|mesh-list
20115870|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
20115871|NCT00005612|Carboplatin|carboplatin|mesh-list
20115872|NCT00005612|Topotecan|topotecan|mesh-list
20115873|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115874|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115875|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115876|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115877|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115878|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115879|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115880|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
20115881|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115882|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115883|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115884|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
20115885|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115886|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115887|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115888|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115889|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20115890|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
20115891|NCT00005613|Carmustine|carmustine|mesh-list
20115892|NCT00005613|Etoposide|etoposide|mesh-list
20115893|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115894|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
20115895|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115896|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115897|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20028450|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20028451|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
20028452|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028453|NCT02606253|Metolazone|metolazone|mesh-list
20028454|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
20028455|NCT02606253|Tolvaptan|tolvaptan|mesh-list
20028456|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20028457|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028458|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
20028459|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028460|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20028461|NCT02606253|Diuretics|diuretics|mesh-ancestor
20028462|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20028463|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20028464|NCT02606877|Pirfenidone|pirfenidone|mesh-list
20028465|NCT02606877|Nintedanib|nintedanib|mesh-list
20028466|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028467|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20028468|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028469|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028470|NCT02606877|Analgesics|analgesics|mesh-ancestor
20028471|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
20028472|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028473|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028474|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20028475|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20028476|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028477|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20028478|NCT02607254|Pregabalin|pregabalin|mesh-list
19491443|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491444|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491445|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19491446|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
19491447|NCT03130634|Silymarin|silymarin|mesh-list
19491448|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
19491449|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491450|NCT03130634|Protective Agents|protective agents|mesh-ancestor
19491451|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491452|NCT03130556|Rabeprazole|rabeprazole|mesh-list
19491453|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19491454|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491455|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19491456|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491457|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491458|NCT03130452|Amoxicillin|amoxicillin|mesh-list
19491459|NCT03130452|Metronidazole|metronidazole|mesh-list
19491460|NCT03130452|Clarithromycin|clarithromycin|mesh-list
19491461|NCT03130452|Lansoprazole|lansoprazole|mesh-list
19491462|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
19491463|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491464|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491465|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20028479|NCT02607254|Analgesics|analgesics|mesh-ancestor
20028480|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
20028481|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028482|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028483|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
20028484|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20028485|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20028486|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028487|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20028488|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20028489|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20028490|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028491|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20028492|NCT02607306|Insulin|insulin|mesh-list
20028493|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20028494|NCT02607306|Liraglutide|liraglutide|mesh-list
20028495|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
20028496|NCT02607306|Xultophy|xultophy|mesh-list
20028497|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20028498|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028499|NCT02607306|Incretins|incretins|mesh-ancestor
20028500|NCT02607306|Hormones|hormones|mesh-ancestor
20028501|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028502|NCT02607618|Vancomycin|vancomycin|mesh-list
20028503|NCT02607618|Iclaprim|iclaprim|mesh-list
20028504|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028505|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028506|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20028507|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028508|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028509|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
20028510|NCT02607735|Velpatasvir|velpatasvir|mesh-list
20028511|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
20028512|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028513|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
20028514|NCT02607800|Velpatasvir|velpatasvir|mesh-list
20028515|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
20028516|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028517|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20028518|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20028519|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028520|NCT02607865|Incretins|incretins|mesh-ancestor
20028521|NCT02607865|Hormones|hormones|mesh-ancestor
20028522|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028523|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20028524|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
20028525|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028526|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028527|NCT02608099|Apixaban|apixaban|mesh-list
20028528|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20028529|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
20028530|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20028531|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
20028532|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028533|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028534|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
20028535|NCT02608177|Linagliptin|linagliptin|mesh-list
20028536|NCT02608177|Glipizide|glipizide|mesh-list
20028537|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20028538|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028539|NCT02608177|Incretins|incretins|mesh-ancestor
20028540|NCT02608177|Hormones|hormones|mesh-ancestor
20028541|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028542|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20028543|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
20028544|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028545|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028546|NCT02608229|Gemcitabine|gemcitabine|mesh-list
20028547|NCT02608229|Paclitaxel|paclitaxel|mesh-list
20028548|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20028549|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20028550|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028551|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
20028552|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
20028553|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
20028554|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028555|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20028556|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
20028557|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
20028558|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028559|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028560|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20028561|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
20028562|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028563|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
20028564|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20028565|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
20028566|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028567|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
20028568|NCT02608489|Protective Agents|protective agents|mesh-ancestor
20028569|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
20028570|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20028571|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028572|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
20028573|NCT02609399|Oseltamivir|oseltamivir|mesh-list
20028574|NCT02609399|Peramivir|peramivir|mesh-list
20028575|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
20028576|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028577|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028578|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028579|NCT02609607|Bisacodyl|bisacodyl|mesh-list
20028580|NCT02609607|Cathartics|cathartics|mesh-ancestor
20028581|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028582|NCT02609607|Laxatives|laxatives|mesh-ancestor
20028583|NCT02609659|Ritonavir|ritonavir|mesh-list
20028584|NCT02609659|Ribavirin|ribavirin|mesh-list
20028585|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20028586|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20028587|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
20028588|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028589|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028590|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028591|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028592|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
20028593|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028594|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20028595|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20028596|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
20028597|NCT02609984|Atezolizumab|atezolizumab|mesh-list
20028598|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028599|NCT02610140|Vinorelbine|vinorelbine|mesh-list
20028600|NCT02610140|Maytansine|maytansine|mesh-list
20028601|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20028602|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028603|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
20028604|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
20028605|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
20028606|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028607|NCT02610231|Istradefylline|istradefylline|mesh-list
20028608|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20028609|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20293045|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293046|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
19491466|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20028610|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20028611|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
20028612|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028613|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028614|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028615|NCT02610777|Azacitidine|azacitidine|mesh-list
20028616|NCT02610777|Pevonedistat|pevonedistat|mesh-list
20028617|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20028618|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
20028619|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028620|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028621|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028622|NCT02610816|Fluticasone|fluticasone|mesh-list
20028623|NCT02610816|Xhance|xhance|mesh-list
20028624|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028625|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20028626|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
20028627|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028628|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028629|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20028630|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
20028631|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
20028632|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20028633|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
20028634|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
20028635|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20028636|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20028637|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028638|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
20028639|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028640|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028641|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20028642|NCT02611154|Testosterone|testosterone|mesh-list
20028643|NCT02611154|Androgens|androgens|mesh-ancestor
20028644|NCT02611154|Hormones|hormones|mesh-ancestor
20028645|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028646|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028647|NCT02611752|Buprenorphine|buprenorphine|mesh-list
20028648|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20028649|NCT02611752|Narcotics|narcotics|mesh-ancestor
20028650|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491467|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20028651|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028652|NCT02611752|Analgesics|analgesics|mesh-ancestor
20028653|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
20028654|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028655|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20028656|NCT02611765|Penicillins|penicillins|mesh-list
20028657|NCT02611765|Penicillin G|penicillin g|mesh-list
20028658|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20028659|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
20028660|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028661|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028662|NCT02611778|Ranibizumab|ranibizumab|mesh-list
20028663|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20028664|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20028665|NCT02611778|Growth Substances|growth substances|mesh-ancestor
20028666|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028667|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
20028668|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028669|NCT02611882|Edetic Acid|edetic acid|mesh-list
20028670|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
20028671|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
20028672|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
20028673|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028674|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
20028675|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20028676|NCT02612064|Fluorides|fluorides|mesh-list
20028677|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
20028678|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
20028679|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
20028680|NCT02612064|Protective Agents|protective agents|mesh-ancestor
20028681|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028682|NCT02612077|Bevacizumab|bevacizumab|mesh-list
20028683|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028684|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028685|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20028686|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20028687|NCT02612077|Growth Substances|growth substances|mesh-ancestor
20028688|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028689|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
20028690|NCT02612779|Dexamethasone|dexamethasone|mesh-list
20028691|NCT02612779|Nivolumab|nivolumab|mesh-list
20028692|NCT02612779|Pomalidomide|pomalidomide|mesh-list
20028693|NCT02612779|Elotuzumab|elotuzumab|mesh-list
20028694|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028695|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
20028696|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
20028697|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028698|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028699|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028700|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
20028701|NCT02612779|Hormones|hormones|mesh-ancestor
20028702|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028703|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20028704|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028705|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028706|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20028707|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028708|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
20028709|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20028710|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20028711|NCT02612779|Growth Substances|growth substances|mesh-ancestor
20028712|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
20028713|NCT02613117|Fluorides|fluorides|mesh-list
20028714|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
20028715|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
20028716|NCT02613117|Protective Agents|protective agents|mesh-ancestor
20028717|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028718|NCT02613169|Isoniazid|isoniazid|mesh-list
20028719|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
20028720|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028721|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028722|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20028723|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20028724|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
20028725|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028726|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20028727|NCT02613208|Paclitaxel|paclitaxel|mesh-list
20028728|NCT02613208|Bevacizumab|bevacizumab|mesh-list
20028729|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20028730|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028731|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
20028732|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
20028733|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
20028734|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028735|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028736|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20028737|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20028738|NCT02613208|Growth Substances|growth substances|mesh-ancestor
20028739|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028740|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
20028741|NCT02613221|Panitumumab|panitumumab|mesh-list
20028742|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028743|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028744|NCT02613403|Ribavirin|ribavirin|mesh-list
20028745|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
20028746|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
20028747|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028748|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
20028749|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028750|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
20028751|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
20028752|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028753|NCT02613572|Protective Agents|protective agents|mesh-ancestor
20028754|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028755|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
20028756|NCT02613572|Vitamins|vitamins|mesh-ancestor
20028757|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
20028758|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
20028759|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20028760|NCT02613871|Ledipasvir|ledipasvir|mesh-list
20028761|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
19745926|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19745927|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745928|NCT04679623|Midazolam|midazolam|mesh-list
19745929|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19745930|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19745931|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745932|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745933|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19745934|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19745935|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19745936|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19745937|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
19745938|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
19745939|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
19745940|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
19745941|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745942|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745943|NCT04673448|Niraparib|niraparib|mesh-list
19745944|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
19745945|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
19745946|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
19745947|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028762|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028763|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
19745948|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20028764|NCT02613897|Saxagliptin|saxagliptin|mesh-list
20028765|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20028766|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028767|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20028768|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028769|NCT02613897|Incretins|incretins|mesh-ancestor
20028770|NCT02613897|Hormones|hormones|mesh-ancestor
20028771|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028772|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20028773|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
20028774|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028775|NCT02613910|Acetaminophen|acetaminophen|mesh-list
20028776|NCT02613910|Cetirizine|cetirizine|mesh-list
20028777|NCT02613910|Prednisone|prednisone|mesh-list
20028778|NCT02613910|Prednisolone|prednisolone|mesh-list
20028779|NCT02613910|Ofatumumab|ofatumumab|mesh-list
20028780|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
20028781|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20028782|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20028783|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
20028784|NCT02613910|Hormones|hormones|mesh-ancestor
20028785|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028786|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028787|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20028788|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028789|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20028790|NCT02613910|Analgesics|analgesics|mesh-ancestor
20028791|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
20028792|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028793|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
20028794|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20028795|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20028796|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
20028797|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028798|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028799|NCT02614560|Fludarabine|fludarabine|mesh-list
20028800|NCT02614560|Melphalan|melphalan|mesh-list
20028801|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028802|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028803|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20028804|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
20028805|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028806|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20028807|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
20028808|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20028809|NCT02614703|Acetic Acid|acetic acid|mesh-list
20028810|NCT02614703|Retinol acetate|retinol acetate|mesh-list
20028811|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028812|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028813|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20028814|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
20028815|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028816|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20028817|NCT02614703|Protective Agents|protective agents|mesh-ancestor
20028818|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028819|NCT02614794|Capecitabine|capecitabine|mesh-list
20028820|NCT02614794|Trastuzumab|trastuzumab|mesh-list
20028821|NCT02614794|Tucatinib|tucatinib|mesh-list
20028822|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20028823|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
20028824|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028825|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028826|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20028827|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20028828|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115898|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
20115899|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115900|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115901|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115902|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115903|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115904|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115905|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115906|NCT00005614|Gemcitabine|gemcitabine|mesh-list
20115907|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115908|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
20115909|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028829|NCT02615470|Vaccines|vaccines|mesh-list
20028830|NCT02615470|Immunologic Factors|immunologic factors|mesh-ancestor
20028831|NCT02615470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028832|NCT02615535|Alprostadil|alprostadil|mesh-list
20028833|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20028834|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
20028835|NCT02615535|Urological Agents|urological agents|mesh-ancestor
20028836|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20028837|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028838|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028839|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
20028840|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028841|NCT02616250|Ivermectin|ivermectin|mesh-list
20028842|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20028843|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20028844|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028845|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20028846|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20028847|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20028848|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20028849|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
20028850|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028851|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028852|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028853|NCT02616523|Lidocaine|lidocaine|mesh-list
20028854|NCT02616523|Fentanyl|fentanyl|mesh-list
20028855|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
20028856|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
20028857|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
20028858|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028859|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028860|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
20028861|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028862|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20028863|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20028864|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20028865|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20028866|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028867|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20028868|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20028869|NCT02616523|Analgesics|analgesics|mesh-ancestor
20028870|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20028871|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20028872|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20028873|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
20028874|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028875|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20028876|NCT02616523|Narcotics|narcotics|mesh-ancestor
20028877|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20028878|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20028879|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
20028880|NCT02616601|Fluorouracil|fluorouracil|mesh-list
20028881|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
20028882|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028883|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20028884|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20028885|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20028886|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
20028887|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028888|NCT02616614|Clindamycin|clindamycin|mesh-list
20028889|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
20028890|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
20028891|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20028892|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028893|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028894|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20028895|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028896|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028897|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
20028898|NCT02616783|Lamivudine|lamivudine|mesh-list
20028899|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20028900|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20028901|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028902|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028903|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
20028904|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028905|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20028906|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20028907|NCT02617628|Naltrexone|naltrexone|mesh-list
20028908|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20028909|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20028910|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028911|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
20028912|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028913|NCT02617667|Cyclosporine|cyclosporine|mesh-list
20028914|NCT02617667|Cyclosporins|cyclosporins|mesh-list
20028915|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028916|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028917|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20028918|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
20028919|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028920|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
20028921|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028922|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
20028923|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20028924|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20028925|NCT02617784|Oseltamivir|oseltamivir|mesh-list
20028926|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
20028927|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028928|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20028929|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028930|NCT02617888|Bismuth|bismuth|mesh-list
20028931|NCT02617888|Antacids|antacids|mesh-ancestor
20028932|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028933|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028934|NCT02618187|Vancomycin|vancomycin|mesh-list
20028935|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20028936|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20028937|NCT02618343|Ondansetron|ondansetron|mesh-list
20028938|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
20028939|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
20028940|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028941|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028942|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20028943|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
20028944|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
20028945|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20028946|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
20028947|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028948|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028949|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20028950|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20028951|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028952|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20028953|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20028954|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
20028955|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20028956|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20028957|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028958|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
20028959|NCT02618382|Coagulants|coagulants|mesh-ancestor
20028960|NCT02618772|Midazolam|midazolam|mesh-list
20028961|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20028962|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20028963|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028964|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028965|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20028966|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20028967|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20028968|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20028969|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
20028970|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
20028971|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
20028972|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
20028973|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20028974|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20028975|NCT02619409|Bupivacaine|bupivacaine|mesh-list
20028976|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
20028977|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
20028978|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028979|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028980|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
20028981|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20028982|NCT02619617|Pasireotide|pasireotide|mesh-list
20028983|NCT02619617|Hormones|hormones|mesh-ancestor
20028984|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20028985|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028986|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
20028987|NCT02619799|Midazolam|midazolam|mesh-list
20028988|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20028989|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20028990|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20028991|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20028992|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20028993|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20028994|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20028995|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20028996|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
20028997|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
20028998|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
20028999|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
20029000|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029001|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029002|NCT02619799|Analgesics|analgesics|mesh-ancestor
20293047|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20293048|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20293049|NCT04822337|Growth Substances|growth substances|mesh-ancestor
20293050|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
20293051|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
20029003|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
20029004|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029005|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20029006|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
20029007|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20029008|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029009|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20029010|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
20029011|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20029012|NCT02620020|Fasinumab|fasinumab|mesh-list
20029013|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20029014|NCT02620020|Analgesics|analgesics|mesh-ancestor
20029015|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
20029016|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029017|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029018|NCT02620384|Metolazone|metolazone|mesh-list
20029019|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20029020|NCT02620384|Diuretics|diuretics|mesh-ancestor
20029021|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
20029022|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029023|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20029024|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029025|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029026|NCT02620683|Lidocaine|lidocaine|mesh-list
20029027|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
20029028|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
20029029|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029030|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029031|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
20029032|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029033|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20029034|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20029035|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20029036|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029037|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029038|NCT02620774|Tazobactam|tazobactam|mesh-list
20029039|NCT02620774|Ceftolozane|ceftolozane|mesh-list
20029040|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20029041|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20029042|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029043|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20029044|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029045|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491468|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576486|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029046|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20029047|NCT02620774|Renal Agents|renal agents|mesh-ancestor
20029048|NCT02620787|Tedizolid|tedizolid|mesh-list
20029049|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20029050|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029051|NCT02620878|Pancrelipase|pancrelipase|mesh-list
20029052|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029053|NCT02620904|Mifepristone|mifepristone|mesh-list
20029054|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20029055|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
20029056|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20029057|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029058|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20029059|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20029060|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20029061|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
20029062|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20029063|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20029064|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
20029065|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029066|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
20029067|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20029068|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20029069|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
20029070|NCT02621060|Antacids|antacids|mesh-ancestor
20029071|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029072|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029073|NCT02621619|Acetaminophen|acetaminophen|mesh-list
20029074|NCT02621619|Hydromorphone|hydromorphone|mesh-list
20029075|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20029076|NCT02621619|Analgesics|analgesics|mesh-ancestor
20029077|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
20029078|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029079|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029080|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
20029081|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20029082|NCT02621619|Narcotics|narcotics|mesh-ancestor
20029083|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029084|NCT02621931|Calcitonin|calcitonin|mesh-list
20029085|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20029086|NCT02621931|Katacalcin|katacalcin|mesh-list
20029087|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20029088|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029089|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20029090|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
20029091|NCT02622074|Paclitaxel|paclitaxel|mesh-list
20029092|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20029093|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
20029094|NCT02622074|Carboplatin|carboplatin|mesh-list
20029095|NCT02622074|Doxorubicin|doxorubicin|mesh-list
20029096|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
20029097|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20029098|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029099|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
20029100|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
20029101|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
20029102|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029103|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576487|NCT02071537|Filaricides|filaricides|mesh-ancestor
20576488|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
20029104|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
20029105|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029106|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029107|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20029108|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
20029109|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20029110|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20029111|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20029112|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20576489|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
20029113|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029114|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20576490|NCT02071589|Nifedipine|nifedipine|mesh-list
20029115|NCT02622113|Canagliflozin|canagliflozin|mesh-list
20029116|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029117|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029118|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20029119|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029120|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
20029121|NCT02622321|Coagulants|coagulants|mesh-ancestor
20029122|NCT02622724|Interferons|interferons|mesh-list
20029123|NCT02622724|Interferon-beta|interferon-beta|mesh-list
20029124|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
20029125|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029126|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
20029127|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029128|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
20029129|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029130|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20029131|NCT02623803|Lidocaine|lidocaine|mesh-list
20029132|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
20029133|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
20029134|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029135|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029136|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
20029137|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029138|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20029139|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20029140|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20029141|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029142|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293052|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20293053|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20293054|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293055|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20293056|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20293057|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293058|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293059|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293060|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20293061|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
20293062|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20293063|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293064|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20293065|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20293066|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20293067|NCT04807348|Metformin|metformin|mesh-list
20293068|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20293069|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293070|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
20293071|NCT04796779|Trace Elements|trace elements|mesh-ancestor
20293072|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
20293073|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293074|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
20293075|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20293076|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029143|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
20029144|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20029145|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20029146|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029147|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029148|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
20029149|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029150|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029151|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20029152|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029153|NCT02624050|Propofol|propofol|mesh-list
20029154|NCT02624050|Methohexital|methohexital|mesh-list
20029155|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20029156|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029157|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029158|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20029159|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
20029160|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
20029161|NCT02624180|Colchicine|colchicine|mesh-list
20029162|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
20029163|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029164|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
20029165|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
20029166|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
20029167|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029168|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029169|NCT02624492|Rituximab|rituximab|mesh-list
20029170|NCT02624492|BI 836826|bi 836826|mesh-list
20029171|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029172|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029173|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
20029174|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029175|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029176|NCT02624700|Pemetrexed|pemetrexed|mesh-list
20029177|NCT02624700|Sorafenib|sorafenib|mesh-list
20029178|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029179|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029180|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029181|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20029182|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20029183|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20029184|NCT02624843|Ethanol|ethanol|mesh-list
20029185|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
20029186|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20029187|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029188|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029189|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029190|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
20029191|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
20029192|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
20029193|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029194|NCT02624986|Rituximab|rituximab|mesh-list
20029195|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
20029196|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029197|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029198|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
20029199|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029200|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029201|NCT02625181|Promethazine|promethazine|mesh-list
20029202|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
20029203|NCT02625181|Meclizine|meclizine|mesh-list
20029204|NCT02625181|Dexamethasone|dexamethasone|mesh-list
20029205|NCT02625181|Fentanyl|fentanyl|mesh-list
20029206|NCT02625181|Sufentanil|sufentanil|mesh-list
20029207|NCT02625181|Scopolamine|scopolamine|mesh-list
20029208|NCT02625181|Oxymorphone|oxymorphone|mesh-list
20029209|NCT02625181|Meperidine|meperidine|mesh-list
20029210|NCT02625181|Droperidol|droperidol|mesh-list
20029211|NCT02625181|Ketamine|ketamine|mesh-list
20029212|NCT02625181|Morphine|morphine|mesh-list
20029213|NCT02625181|Remifentanil|remifentanil|mesh-list
20029214|NCT02625181|Oxycodone|oxycodone|mesh-list
20029215|NCT02625181|Methadone|methadone|mesh-list
20029216|NCT02625181|Hydromorphone|hydromorphone|mesh-list
20029217|NCT02625181|Hydrocodone|hydrocodone|mesh-list
20029218|NCT02625181|Alfentanil|alfentanil|mesh-list
20029219|NCT02625181|Haloperidol|haloperidol|mesh-list
20029220|NCT02625181|Ondansetron|ondansetron|mesh-list
20029221|NCT02625181|Aprepitant|aprepitant|mesh-list
20029222|NCT02625181|Palonosetron|palonosetron|mesh-list
20029223|NCT02625181|Metoclopramide|metoclopramide|mesh-list
20029224|NCT02625181|Granisetron|granisetron|mesh-list
20029225|NCT02625181|Ramosetron|ramosetron|mesh-list
20029226|NCT02625181|Tropisetron|tropisetron|mesh-list
20029227|NCT02625181|Dolasetron|dolasetron|mesh-list
20029228|NCT02625181|Anesthetics|anesthetics|mesh-list
20029229|NCT02625181|Propofol|propofol|mesh-list
20029230|NCT02625181|Sevoflurane|sevoflurane|mesh-list
20029231|NCT02625181|Desflurane|desflurane|mesh-list
20029232|NCT02625181|Isoflurane|isoflurane|mesh-list
20029233|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20029234|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029235|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
20029236|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
20029237|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029238|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029239|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029240|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
20029241|NCT02625181|Hormones|hormones|mesh-ancestor
20029242|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029243|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20029244|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029245|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029246|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20029247|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20029248|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
20029249|NCT02625181|Analgesics|analgesics|mesh-ancestor
20029250|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
20029251|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20029252|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20029253|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20029254|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029255|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029256|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20029257|NCT02625181|Narcotics|narcotics|mesh-ancestor
20029258|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20029259|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20029260|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20029261|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
20029262|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
20029263|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20029264|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
20029265|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20029266|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20029267|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20029268|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20029269|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
20029270|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
20029271|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20029272|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20029273|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
20029274|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20029275|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20029276|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20029277|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
20029278|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20029279|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
20029280|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20029281|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
20029282|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20029283|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
20029284|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
20029285|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20029286|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20029287|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
20029288|NCT02625207|Maraviroc|maraviroc|mesh-list
20029289|NCT02625207|Darunavir|darunavir|mesh-list
20029290|NCT02625207|Cobicistat|cobicistat|mesh-list
20029291|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20029292|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20029293|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029294|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20029295|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20029296|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
20029297|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029298|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20029299|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20029300|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20029301|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
20029302|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029303|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20029304|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20029305|NCT02625259|Lansoprazole|lansoprazole|mesh-list
20029306|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
20029307|NCT02625259|Serabelisib|serabelisib|mesh-list
20029308|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20029309|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029310|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20029311|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029312|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029313|NCT02625298|Pemetrexed|pemetrexed|mesh-list
20029314|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029315|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029316|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029317|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20029318|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20029319|NCT02625610|Leucovorin|leucovorin|mesh-list
20029320|NCT02625610|Fluorouracil|fluorouracil|mesh-list
20293077|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029321|NCT02625610|Capecitabine|capecitabine|mesh-list
20029322|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
20029323|NCT02625610|Avelumab|avelumab|mesh-list
20029324|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
20029325|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
20029326|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029327|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20029328|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029329|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20029330|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
20029331|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029332|NCT02625610|Antidotes|antidotes|mesh-ancestor
20029333|NCT02625610|Protective Agents|protective agents|mesh-ancestor
20029334|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
20029335|NCT02625610|Vitamins|vitamins|mesh-ancestor
20029336|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
20029337|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029338|NCT02625623|Paclitaxel|paclitaxel|mesh-list
20029339|NCT02625623|Irinotecan|irinotecan|mesh-list
20029340|NCT02625623|Avelumab|avelumab|mesh-list
20029341|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20029342|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029343|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
20029344|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
20029345|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
20029346|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029347|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20029348|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20029349|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029350|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029351|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
20029352|NCT02625909|Velpatasvir|velpatasvir|mesh-list
20029353|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
20029354|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029355|NCT02625974|Nifurtimox|nifurtimox|mesh-list
20029356|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20029357|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20029358|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20029359|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029360|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
20029361|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20029362|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029363|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029364|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
20029365|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029366|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
20029367|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
20029368|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20029369|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20029370|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029371|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029372|NCT02626182|Urological Agents|urological agents|mesh-ancestor
20115910|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115911|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
20115912|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115913|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115914|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115915|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
20115916|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115917|NCT00005615|Interferons|interferons|mesh-list
20115918|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
20115919|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115920|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
20029373|NCT02626611|Omalizumab|omalizumab|mesh-list
20029374|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20029375|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20029376|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
20029377|NCT02627144|Interferons|interferons|mesh-list
20029378|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
20029379|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
20029380|NCT02627144|Bevacizumab|bevacizumab|mesh-list
20029381|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029382|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029383|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20029384|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20029385|NCT02627144|Growth Substances|growth substances|mesh-ancestor
20029386|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029387|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
20029388|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
20029389|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029390|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
20029391|NCT02627677|Ponatinib|ponatinib|mesh-list
20029392|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029393|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20029394|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029395|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029396|NCT02628106|Alprostadil|alprostadil|mesh-list
20029397|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20029398|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
20029399|NCT02628106|Urological Agents|urological agents|mesh-ancestor
20029400|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20029401|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20029402|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
20029403|NCT02628600|Amikacin|amikacin|mesh-list
20029404|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20029405|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029406|NCT02628769|Solithromycin|solithromycin|mesh-list
20029407|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20029408|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029409|NCT02629094|Eplerenone|eplerenone|mesh-list
20029410|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20029411|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
20029412|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029413|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029414|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20029415|NCT02629094|Diuretics|diuretics|mesh-ancestor
20029416|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
20029417|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20029418|NCT02629354|Ibuprofen|ibuprofen|mesh-list
20029419|NCT02629354|Caffeine|caffeine|mesh-list
20029420|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20029421|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20029422|NCT02629354|Analgesics|analgesics|mesh-ancestor
20029423|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
20029424|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029425|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029426|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029427|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029428|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20029429|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029430|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029431|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20029432|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20029433|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20029434|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20029435|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
20029436|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029437|NCT02629822|Tenofovir|tenofovir|mesh-list
20029438|NCT02629822|Lamivudine|lamivudine|mesh-list
20029439|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
20029440|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029441|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20029442|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20029443|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029444|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029445|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20029446|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20029447|NCT02629861|Calcitonin|calcitonin|mesh-list
20029448|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20029449|NCT02629861|Katacalcin|katacalcin|mesh-list
20029450|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20029451|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029452|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20029453|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
20029454|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
20029455|NCT02629965|Olodaterol|olodaterol|mesh-list
20029456|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20029457|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
20029458|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029459|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029460|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20029461|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
20029462|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
20029463|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20029464|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
20029465|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029466|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029467|NCT02629991|Oxytocin|oxytocin|mesh-list
20029468|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
20029469|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20029470|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029471|NCT02630017|Methylphenidate|methylphenidate|mesh-list
20029472|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20029473|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029474|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20029475|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20029476|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029477|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029478|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
20029479|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029480|NCT02630030|Ixazomib|ixazomib|mesh-list
20029481|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029482|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
20029483|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029484|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029485|NCT02630186|Atezolizumab|atezolizumab|mesh-list
20029486|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029487|NCT02630316|Treprostinil|treprostinil|mesh-list
20029488|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20029489|NCT02630563|Cyclosporine|cyclosporine|mesh-list
20029490|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
20029491|NCT02630563|Cyclosporins|cyclosporins|mesh-list
20029492|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029493|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029494|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20029495|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
20029496|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029497|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
20029498|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029499|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
20029500|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029501|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20029502|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20029503|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745949|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029504|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20029505|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
20029506|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20029507|NCT02630693|Tamoxifen|tamoxifen|mesh-list
20029508|NCT02630693|Fulvestrant|fulvestrant|mesh-list
20029509|NCT02630693|Palbociclib|palbociclib|mesh-list
20029510|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20029511|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20029512|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
20029513|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029514|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029515|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20029516|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029517|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20029518|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20029519|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20029520|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20029521|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20029522|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029523|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029524|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20029525|NCT02630706|Metformin|metformin|mesh-list
20029526|NCT02630706|Glimepiride|glimepiride|mesh-list
20029527|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
20029528|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029529|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029530|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20029531|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20029532|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
20029533|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20029534|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029535|NCT02630719|Timolol|timolol|mesh-list
20029536|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20029537|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
20029538|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20029539|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20029540|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20029541|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
20029542|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029543|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029544|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029545|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20029546|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20029547|NCT02630966|Vedolizumab|vedolizumab|mesh-list
20029548|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029549|NCT02630992|Amoxicillin|amoxicillin|mesh-list
20029550|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
20029551|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
20029552|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20029553|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20029554|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029555|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20029556|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029557|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029558|NCT02631057|Warfarin|warfarin|mesh-list
20029559|NCT02631057|Dabigatran|dabigatran|mesh-list
20029560|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
20029561|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
20029562|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20029563|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
20029564|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029565|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029566|NCT02631525|Propofol|propofol|mesh-list
20029567|NCT02631525|Desflurane|desflurane|mesh-list
20029568|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20029569|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029570|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029571|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20029572|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
20029573|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
20029574|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20029575|NCT02631538|Rituximab|rituximab|mesh-list
20029576|NCT02631538|Belimumab|belimumab|mesh-list
20029577|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029578|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029579|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
20029580|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029581|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029582|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20029583|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
20029584|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20029585|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029586|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
20029587|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20029588|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20029589|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20029590|NCT02631551|Analgesics|analgesics|mesh-ancestor
20029591|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
20029592|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029593|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029594|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029595|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20029596|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20029597|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
20029598|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
20029599|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029600|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029601|NCT02631590|Gemcitabine|gemcitabine|mesh-list
20029602|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029603|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20029604|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
20029605|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029606|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
20029607|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029608|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029609|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20029610|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
20029611|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029612|NCT02631746|Nivolumab|nivolumab|mesh-list
20029613|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029614|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029615|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20029616|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029617|NCT02631772|Ribavirin|ribavirin|mesh-list
20029618|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
20029619|NCT02631772|Ledipasvir|ledipasvir|mesh-list
20029620|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
20029621|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029622|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
20029623|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029624|NCT02631876|Paclitaxel|paclitaxel|mesh-list
20029625|NCT02631876|Maytansine|maytansine|mesh-list
20029626|NCT02631876|Doxorubicin|doxorubicin|mesh-list
20029627|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20029628|NCT02631876|Topotecan|topotecan|mesh-list
20029629|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20029630|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029631|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
20029632|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
20029633|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
20029634|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029635|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20029636|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20029637|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20029638|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029639|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20029640|NCT02631954|Voriconazole|voriconazole|mesh-list
20029641|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
20029642|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029643|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20029644|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20029645|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029646|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029647|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20029648|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
20029649|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029650|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029651|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20029652|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20029653|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20029654|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
20029655|NCT02632747|Empagliflozin|empagliflozin|mesh-list
20029656|NCT02632747|Ramipril|ramipril|mesh-list
20029657|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20029658|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029659|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029660|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029661|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20029662|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
20029663|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029664|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20029665|NCT02632812|Naproxen|naproxen|mesh-list
20029666|NCT02632812|Rebamipide|rebamipide|mesh-list
20029667|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20029668|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20029669|NCT02632812|Analgesics|analgesics|mesh-ancestor
20029670|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
20029671|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029672|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029673|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029674|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029675|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
20029676|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20029677|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029678|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029679|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20029680|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029681|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
20029682|NCT02632812|Protective Agents|protective agents|mesh-ancestor
20029683|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20029684|NCT02633046|Hormones|hormones|mesh-ancestor
20029685|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029686|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029687|NCT02633371|Oxybutynin|oxybutynin|mesh-list
20029688|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
20029689|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
20029690|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029691|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029692|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20029693|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20029694|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
20029695|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029696|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029697|NCT02633371|Urological Agents|urological agents|mesh-ancestor
20029698|NCT02633488|Metformin|metformin|mesh-list
20029699|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029700|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029701|NCT02633800|Carboplatin|carboplatin|mesh-list
20029702|NCT02633800|Cetuximab|cetuximab|mesh-list
20029703|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029704|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029705|NCT02633956|Atorvastatin|atorvastatin|mesh-list
20029706|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20029707|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20029708|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
20029709|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029710|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20029711|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20029712|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029713|NCT02634073|Lamivudine|lamivudine|mesh-list
20029714|NCT02634073|Sorbitol|sorbitol|mesh-list
20029715|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20029716|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20029717|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029718|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029719|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
20029720|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029721|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20029722|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20029723|NCT02634073|Cathartics|cathartics|mesh-ancestor
20029724|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029725|NCT02634320|Aripiprazole|aripiprazole|mesh-list
20029726|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
20029727|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
20029728|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20029729|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20029730|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20029731|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029732|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029733|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
20029734|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
20029735|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029736|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029737|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20029738|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20029739|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
20029740|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20029741|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20029742|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20029743|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20029744|NCT02634333|Aflibercept|aflibercept|mesh-list
20029745|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
20029746|NCT02634333|Mitogens|mitogens|mesh-list
20029747|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20029748|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20029749|NCT02634333|Growth Substances|growth substances|mesh-ancestor
20029750|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029751|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
20029752|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029753|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
20029754|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029755|NCT02634346|Olanzapine|olanzapine|mesh-list
20029756|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
20029757|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
20029758|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029759|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029760|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029761|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20029762|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20029763|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029764|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20029765|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20029766|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20029767|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029768|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029769|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029770|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
20029771|NCT02634580|Ezetimibe|ezetimibe|mesh-list
20029772|NCT02634580|Evolocumab|evolocumab|mesh-list
20029773|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20029774|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20029775|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20029776|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
20029777|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029778|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20029779|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
20029780|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029781|NCT02634684|Amphetamine|amphetamine|mesh-list
20029782|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
20029783|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20029784|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029785|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
20029786|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
20029787|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029788|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
20029789|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029790|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029791|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
20029792|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20029793|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20029794|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029795|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20029796|NCT02634788|Buprenorphine|buprenorphine|mesh-list
20029797|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20029798|NCT02634788|Narcotics|narcotics|mesh-ancestor
20029799|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029800|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029801|NCT02634788|Analgesics|analgesics|mesh-ancestor
20029802|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
20029803|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029804|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20029805|NCT02634801|Methotrexate|methotrexate|mesh-list
20029806|NCT02634801|Ixekizumab|ixekizumab|mesh-list
20029807|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20029808|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
20029809|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20029810|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029811|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20029812|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
20029813|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029814|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029815|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
20029816|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029817|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20029818|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20029819|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
20029820|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20029821|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20029822|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20029823|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20029824|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029825|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20029826|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20029827|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029828|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029829|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
20029830|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029831|NCT02635204|Clobetasol|clobetasol|mesh-list
20029832|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029833|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
20029834|NCT02635204|Hormones|hormones|mesh-ancestor
20029835|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029836|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029837|NCT02635386|Metformin|metformin|mesh-list
20029838|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
20029839|NCT02635386|Exenatide|exenatide|mesh-list
20029840|NCT02635386|Topiramate|topiramate|mesh-list
20029841|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20029842|NCT02635386|Phentermine|phentermine|mesh-list
20029843|NCT02635386|Glucagon|glucagon|mesh-list
20029844|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20029845|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029846|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029847|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029848|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20029849|NCT02635386|Incretins|incretins|mesh-ancestor
20029850|NCT02635386|Hormones|hormones|mesh-ancestor
20029851|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029852|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
20029853|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029854|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20029855|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
20029856|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
20029857|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
20029858|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029859|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
20029860|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029861|NCT02635542|Cisatracurium|cisatracurium|mesh-list
20029862|NCT02635542|Succinylcholine|succinylcholine|mesh-list
20029863|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20029864|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20029865|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029866|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029867|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20029868|NCT02635724|Peramivir|peramivir|mesh-list
20029869|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
20029870|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029871|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029872|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029873|NCT02635828|Promethazine|promethazine|mesh-list
20029874|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
20029875|NCT02635828|Dexamethasone|dexamethasone|mesh-list
20029876|NCT02635828|Palonosetron|palonosetron|mesh-list
20029877|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029878|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
20029879|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
20029880|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029881|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029882|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029883|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
20029884|NCT02635828|Hormones|hormones|mesh-ancestor
20029885|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029886|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20029887|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029888|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20029889|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20029890|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
20029891|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029892|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029893|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
20029894|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
20029895|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20029896|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
20029897|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
20029898|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20029899|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20029900|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20029901|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029902|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
20029903|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
20029904|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
20029905|NCT02635984|Olanzapine|olanzapine|mesh-list
20029906|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
20029907|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
20029908|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20029909|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029910|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20029911|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20029912|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20029913|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029914|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20029915|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20029916|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20029917|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029918|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029919|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029920|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
20029921|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
20029922|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029923|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115921|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115922|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
20115923|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115924|NCT00005616|Antibodies|antibodies|mesh-list
20115925|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20115926|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
20115927|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115928|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
20115929|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115930|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
20115931|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115932|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
20115933|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115934|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115935|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115936|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
20029924|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
20029925|NCT02636725|Axitinib|axitinib|mesh-list
20029926|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20029927|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029928|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20029929|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029930|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029931|NCT02637037|Metformin|metformin|mesh-list
20029932|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
20029933|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20029934|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029935|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20029936|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029937|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
20029938|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20029939|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20029940|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
20029941|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
20029942|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029943|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029944|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20029945|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20029946|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20029947|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20029948|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20029949|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
20029950|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029951|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029952|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029953|NCT02637323|Triamcinolone|triamcinolone|mesh-list
20029954|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20029955|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20029956|NCT02637323|FX006|fx006|mesh-list
20029957|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20029958|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20029959|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
20029960|NCT02637323|Hormones|hormones|mesh-ancestor
20029961|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20029962|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029963|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20029964|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
20029965|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20029966|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029967|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
20029968|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
20029969|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029970|NCT02637895|Vortioxetine|vortioxetine|mesh-list
20029971|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
20029972|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20029973|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20029974|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20029975|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20029976|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029977|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20029978|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20029979|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20029980|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20029981|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20029982|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
20029983|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20029984|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20029985|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20029986|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20029987|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20029988|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
20029989|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
20029990|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20029991|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20029992|NCT02638012|Hemostatics|hemostatics|mesh-list
20029993|NCT02638012|Coagulants|coagulants|mesh-ancestor
20029994|NCT02638168|Methylphenidate|methylphenidate|mesh-list
20029995|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20029996|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20029997|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20029998|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20029999|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20030000|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030001|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
20030002|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030003|NCT02638259|GP2015|gp2015|mesh-list
20030004|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
20030005|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
20030006|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20030007|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
20030008|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030009|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20030010|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20030011|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20030012|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030013|NCT02638948|Methotrexate|methotrexate|mesh-list
20030014|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20030015|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
20030016|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20030017|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030018|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20030019|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
20030020|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030021|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030022|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
20030023|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030024|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20030025|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20030026|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
20030027|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030028|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20030029|NCT02639182|Axitinib|axitinib|mesh-list
20030030|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030031|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20030032|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030033|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030034|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
20030035|NCT02639247|Velpatasvir|velpatasvir|mesh-list
20030036|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
20030037|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030038|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
20030039|NCT02639338|Velpatasvir|velpatasvir|mesh-list
20030040|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
20030041|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030042|NCT02639429|Misoprostol|misoprostol|mesh-list
20030043|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20030044|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
20030045|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20030046|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030047|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20030048|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030049|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
20030050|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20030051|NCT02639637|Valsartan|valsartan|mesh-list
20030052|NCT02639637|Enalaprilat|enalaprilat|mesh-list
20030053|NCT02639637|Enalapril|enalapril|mesh-list
20030054|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20030055|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030056|NCT02639637|Incretins|incretins|mesh-ancestor
20030057|NCT02639637|Hormones|hormones|mesh-ancestor
20030058|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030059|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20030060|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
20030061|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030062|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030063|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20030064|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20030065|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20030066|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20030067|NCT02640053|Paclitaxel|paclitaxel|mesh-list
20030068|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20030069|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20030070|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030071|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
20030072|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
20030073|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
20030074|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030075|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
20030076|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
20030077|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030078|NCT02640404|Vaccines|vaccines|mesh-list
20030079|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
20030080|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030081|NCT02640755|Paclitaxel|paclitaxel|mesh-list
20030082|NCT02640755|Fulvestrant|fulvestrant|mesh-list
20030083|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20030084|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030085|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
20030086|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
20030087|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
20030088|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030089|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20030090|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20030091|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20030092|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20030093|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030094|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030095|NCT02641080|Aspirin|aspirin|mesh-list
20030096|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20030097|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030098|NCT02641080|Analgesics|analgesics|mesh-ancestor
20030099|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
20030100|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030101|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030102|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030103|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030104|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20030105|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20030106|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030107|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20030108|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20030109|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030110|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
20030111|NCT02641353|Thalidomide|thalidomide|mesh-list
20030112|NCT02641353|Apremilast|apremilast|mesh-list
20030113|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20030114|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030115|NCT02641353|Analgesics|analgesics|mesh-ancestor
20030116|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
20030117|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030118|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030119|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030120|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030121|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20030122|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20030123|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030124|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030125|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20030126|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
20030127|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
20030128|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20030129|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030130|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20030131|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20030132|NCT02641353|Growth Substances|growth substances|mesh-ancestor
20030133|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
20030134|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030135|NCT02641379|Ribavirin|ribavirin|mesh-list
20030136|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20030137|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
20030138|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030139|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
20030140|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030141|NCT02641522|Siltuximab|siltuximab|mesh-list
20030142|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030143|NCT02641561|Indomethacin|indomethacin|mesh-list
20030144|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20030145|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030146|NCT02641561|Analgesics|analgesics|mesh-ancestor
20030147|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
20030148|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030149|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030150|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030151|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030152|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
20030153|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
20030154|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20030155|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20030156|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030157|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030158|NCT02641691|Leucovorin|leucovorin|mesh-list
20030159|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
20030160|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
20030161|NCT02641691|Fluorouracil|fluorouracil|mesh-list
20030162|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
20030163|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
20030164|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
20030165|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030166|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20030167|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030168|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20030169|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
20030170|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030171|NCT02641691|Antidotes|antidotes|mesh-ancestor
20030172|NCT02641691|Protective Agents|protective agents|mesh-ancestor
20030173|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
20030174|NCT02641691|Vitamins|vitamins|mesh-ancestor
20030175|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
20030176|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
20030177|NCT02642159|Niacin|niacin|mesh-list
20030178|NCT02642159|Niacinamide|niacinamide|mesh-list
20030179|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20030180|NCT02642159|Ezetimibe|ezetimibe|mesh-list
20030181|NCT02642159|Fenofibrate|fenofibrate|mesh-list
20030182|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20030183|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20030184|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
20030185|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030186|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20030187|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
20030188|NCT02642159|Vitamins|vitamins|mesh-ancestor
20030189|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
20030190|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030191|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
20030192|NCT02642653|Lovastatin|lovastatin|mesh-list
20030193|NCT02642653|L 647318|l 647318|mesh-list
20030194|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
20030195|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20030196|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20030197|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
20030198|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030199|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20030200|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20030201|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030202|NCT02643251|Clonidine|clonidine|mesh-list
20030203|NCT02643251|Analgesics|analgesics|mesh-ancestor
20030204|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
20030205|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030206|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030207|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20030208|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
20030209|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
20030210|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20030211|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20030212|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20030213|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030214|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030215|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030216|NCT02643355|Clonidine|clonidine|mesh-list
20030217|NCT02643355|Olanzapine|olanzapine|mesh-list
20030218|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
20030219|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
20030220|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030221|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030222|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030223|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20030224|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20030225|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030226|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20030227|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20030228|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20030229|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20030230|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030231|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030232|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
20030233|NCT02643355|Analgesics|analgesics|mesh-ancestor
20030234|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
20030235|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20030236|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
20030237|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20030238|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20030239|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20030240|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030241|NCT02643394|Acetaminophen|acetaminophen|mesh-list
20030242|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030243|NCT02643394|Analgesics|analgesics|mesh-ancestor
20030244|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
20030245|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030246|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030247|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
20030248|NCT02643615|Propofol|propofol|mesh-list
20030249|NCT02643615|Desflurane|desflurane|mesh-list
20030250|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20030251|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030252|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030253|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20030254|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
20030255|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
20030256|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20030257|NCT02643862|Omalizumab|omalizumab|mesh-list
20030258|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20030259|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20030260|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
20030261|NCT02643979|Ketamine|ketamine|mesh-list
20030262|NCT02643979|Propofol|propofol|mesh-list
20030263|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20030264|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030265|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030266|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20030267|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
20030268|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
20030269|NCT02643979|Analgesics|analgesics|mesh-ancestor
20030270|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
20030271|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030272|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20030273|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20030274|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20030275|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030276|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115937|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115938|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115939|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115940|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
20115941|NCT00005623|Cyproterone|cyproterone|mesh-list
20115942|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
20115943|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
20115944|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115945|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115946|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115947|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20115948|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
20115949|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20115950|NCT00005624|Tacedinaline|tacedinaline|mesh-list
20115951|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20115952|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115953|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115954|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115955|NCT00005625|Trabectedin|trabectedin|mesh-list
20115956|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115957|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
20115958|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115959|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030277|NCT02645617|Imidacloprid|imidacloprid|mesh-list
20030278|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
20030279|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030280|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030281|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030282|NCT02646124|Naproxen|naproxen|mesh-list
20030283|NCT02646124|Diazepam|diazepam|mesh-list
20030284|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20030285|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030286|NCT02646124|Analgesics|analgesics|mesh-ancestor
20030287|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
20030288|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030289|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030290|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030291|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030292|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
20030293|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20030294|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030295|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030296|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20030297|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
20030298|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
20030299|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
20030300|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030301|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20030302|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030303|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20030304|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20030305|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20030306|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20030307|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20030308|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20030309|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
20030310|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
20030311|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
20030312|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
20030313|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030314|NCT02646332|Amoxicillin|amoxicillin|mesh-list
20030315|NCT02646332|Metronidazole|metronidazole|mesh-list
20030316|NCT02646332|Clarithromycin|clarithromycin|mesh-list
20030317|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
20030318|NCT02646332|Lansoprazole|lansoprazole|mesh-list
20030319|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20030320|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030321|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20030322|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20030323|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20030324|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030325|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030326|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20030327|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20030328|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20030329|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030330|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20030331|NCT02646449|Mirtazapine|mirtazapine|mesh-list
20030332|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
20030333|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20030334|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20030335|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
20030336|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
20030337|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030338|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030339|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030340|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20030341|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20030342|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030343|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20030344|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20030345|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20030346|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030347|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20030348|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20030349|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
20030350|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20030351|NCT02647203|Fluorides|fluorides|mesh-list
20030352|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
20030353|NCT02647203|Protective Agents|protective agents|mesh-ancestor
20030354|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030355|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20030356|NCT02647320|Firuglipel|firuglipel|mesh-list
20030357|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20030358|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030359|NCT02647320|Incretins|incretins|mesh-ancestor
20030360|NCT02647320|Hormones|hormones|mesh-ancestor
20030361|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030362|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20030363|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
20030364|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030365|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030366|NCT02647788|Acetaminophen|acetaminophen|mesh-list
20030367|NCT02647788|Ibuprofen|ibuprofen|mesh-list
20030368|NCT02647788|Codeine|codeine|mesh-list
20030369|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030370|NCT02647788|Analgesics|analgesics|mesh-ancestor
20030371|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
20030372|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030373|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030374|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
20030375|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20030376|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030377|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030378|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20030379|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030380|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030381|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20030382|NCT02647788|Narcotics|narcotics|mesh-ancestor
20030383|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030384|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
20030385|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
20030386|NCT02647866|KHK4083|khk4083|mesh-list
20030387|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
20030388|NCT02647944|Liraglutide|liraglutide|mesh-list
20030389|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20030390|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030391|NCT02647944|Incretins|incretins|mesh-ancestor
20030392|NCT02647944|Hormones|hormones|mesh-ancestor
20030393|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030394|NCT02648204|Dulaglutide|dulaglutide|mesh-list
20030395|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20030396|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030397|NCT02648217|Insulin|insulin|mesh-list
20030398|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20030399|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
20030400|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
20030401|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20030402|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
20030403|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20030404|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030405|NCT02649192|Vitamin D|vitamin d|mesh-list
20030406|NCT02649192|Vitamin A|vitamin a|mesh-list
20030407|NCT02649192|Vitamins|vitamins|mesh-ancestor
20030408|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
20030409|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030410|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20030411|NCT02649231|Ketamine|ketamine|mesh-list
20030412|NCT02649231|Analgesics|analgesics|mesh-ancestor
20030413|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
20030414|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030415|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030416|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20030417|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20030418|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
20030419|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
20030420|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030421|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20030422|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20030423|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030424|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030425|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
20030426|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20030427|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030428|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
20115960|NCT00005626|Irinotecan|irinotecan|mesh-list
20030429|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20030430|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20030431|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030432|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
20030433|NCT02650856|Coagulants|coagulants|mesh-ancestor
20030434|NCT02650921|Lidocaine|lidocaine|mesh-list
20030435|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030436|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
20030437|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030438|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030439|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
20030440|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030441|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20030442|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20030443|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20030444|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20030445|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030446|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
20030447|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20030448|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030449|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
20030450|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
20030451|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
20030452|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20030453|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20030454|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030455|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030456|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030457|NCT02651155|Lubiprostone|lubiprostone|mesh-list
20030458|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20030459|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20030460|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030461|NCT02651220|Adapalene|adapalene|mesh-list
20030462|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20030463|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20030464|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
20030465|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20030466|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030467|NCT02651220|Analgesics|analgesics|mesh-ancestor
20030468|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
20030469|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030470|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030471|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030472|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030473|NCT02651259|Vitamins|vitamins|mesh-list
20030474|NCT02651259|Pyridoxine|pyridoxine|mesh-list
20030475|NCT02651259|Pyridoxal|pyridoxal|mesh-list
20030476|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
20030477|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
20030478|NCT02651259|Isoniazid|isoniazid|mesh-list
20030479|NCT02651259|Rifapentine|rifapentine|mesh-list
20030480|NCT02651259|Rifamycins|rifamycins|mesh-list
20030481|NCT02651259|Hydrazine|hydrazine|mesh-list
20030482|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
20030483|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030484|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
20030485|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20030486|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030487|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20030488|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20030489|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
20030490|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030491|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20030492|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20030493|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
20030494|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030495|NCT02651272|Macitentan|macitentan|mesh-list
20030496|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20030497|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20030498|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030499|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20030500|NCT02651415|Perindopril|perindopril|mesh-list
20030501|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20030502|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
20030503|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030504|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030505|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20030506|NCT02651428|Taurolidine|taurolidine|mesh-list
20030507|NCT02651428|Heparin|heparin|mesh-list
20030508|NCT02651428|Calcium heparin|calcium heparin|mesh-list
20030509|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
20030510|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030511|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20030512|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20030513|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030514|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20030515|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030516|NCT02651584|Buprenorphine|buprenorphine|mesh-list
20030517|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20030518|NCT02651584|Narcotics|narcotics|mesh-ancestor
20030519|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030520|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030521|NCT02651584|Analgesics|analgesics|mesh-ancestor
20030522|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
20030523|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030524|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20030525|NCT02651688|Enclomiphene|enclomiphene|mesh-list
20030526|NCT02651688|Clomiphene|clomiphene|mesh-list
20030527|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
20030528|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20030529|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
20030530|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030531|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030532|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20030533|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
20030534|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20030535|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20030536|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20030537|NCT02651987|Lanreotide|lanreotide|mesh-list
20030538|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030539|NCT02652156|Bupivacaine|bupivacaine|mesh-list
20030540|NCT02652156|Ropivacaine|ropivacaine|mesh-list
20030541|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030542|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
20030543|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030544|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030545|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
20030546|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030547|NCT02652260|Tenofovir|tenofovir|mesh-list
20030548|NCT02652260|Lamivudine|lamivudine|mesh-list
20030549|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20030550|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
20030551|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030552|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20030553|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20030554|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030555|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030556|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20030557|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20030558|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
20030559|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20030560|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20030561|NCT02652390|Prednisolone|prednisolone|mesh-list
20030562|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
20030563|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20030564|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
20030565|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030566|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
20030567|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
20030568|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030569|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030570|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030571|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
20030572|NCT02652390|Hormones|hormones|mesh-ancestor
20030573|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030574|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20030575|NCT02652390|Protective Agents|protective agents|mesh-ancestor
20030576|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20030577|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030578|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20030579|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
20030580|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030581|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20030582|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20030583|NCT02653144|Dexamethasone|dexamethasone|mesh-list
20030584|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
20030585|NCT02653144|Ropivacaine|ropivacaine|mesh-list
20030586|NCT02653144|Anesthetics|anesthetics|mesh-list
20030587|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030588|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
20030589|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
20030590|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030591|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030592|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030593|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
20030594|NCT02653144|Hormones|hormones|mesh-ancestor
20030595|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030596|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20030597|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030598|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20030599|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030600|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030601|NCT02653144|Analgesics|analgesics|mesh-ancestor
20030602|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
20030603|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20030604|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20030605|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20030606|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030607|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030608|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030609|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030610|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20030611|NCT02653183|Laxatives|laxatives|mesh-ancestor
20030612|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030613|NCT02653300|Insulin|insulin|mesh-list
20030614|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20030615|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030616|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20030617|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20030618|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
20030619|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
20030620|NCT02653560|Citric Acid|citric acid|mesh-list
20030621|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
20030622|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
20030623|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20030624|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
20030625|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
20030626|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030627|NCT02653560|Diuretics|diuretics|mesh-ancestor
20030628|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
20030629|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030630|NCT02653560|Expectorants|expectorants|mesh-ancestor
20030631|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
20030632|NCT02653560|Cathartics|cathartics|mesh-ancestor
20030633|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030634|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
20030635|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20030636|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030637|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20030638|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20030639|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
20030640|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030641|NCT02653872|Itraconazole|itraconazole|mesh-list
20030642|NCT02653872|Verapamil|verapamil|mesh-list
20030643|NCT02653872|Diltiazem|diltiazem|mesh-list
20030644|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
20030645|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030646|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20030647|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20030648|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030649|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030650|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20030651|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
20030652|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030653|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030654|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20030655|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20030656|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20030657|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20030658|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20030659|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
20030660|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20030661|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20030662|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20030663|NCT02654054|Norethindrone|norethindrone|mesh-list
20030664|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
20030665|NCT02654054|Estradiol|estradiol|mesh-list
20030666|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20030667|NCT02654054|Estrogens|estrogens|mesh-ancestor
20030668|NCT02654054|Hormones|hormones|mesh-ancestor
20030669|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030670|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030671|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20030672|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
20030673|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20030674|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20030675|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20030676|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20030677|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20030678|NCT02654145|Omalizumab|omalizumab|mesh-list
20030679|NCT02654145|Albuterol|albuterol|mesh-list
20030680|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20030681|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
20030682|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030683|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030684|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20030685|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
20030686|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
20030687|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20030688|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20030689|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20030690|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20030691|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030692|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030693|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030694|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20030695|NCT02654483|Serlopitant|serlopitant|mesh-list
20030696|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20030697|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030698|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030699|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115961|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20115962|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115963|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115964|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115965|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115966|NCT00005627|Carboplatin|carboplatin|mesh-list
20115967|NCT00005627|Docetaxel|docetaxel|mesh-list
20115968|NCT00005627|Estramustine|estramustine|mesh-list
20115969|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115970|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115971|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115972|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115973|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115974|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115975|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
20115976|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115977|NCT00005630|Sargramostim|sargramostim|mesh-list
20115978|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
20115979|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115980|NCT00005631|Rituximab|rituximab|mesh-list
20115981|NCT00005631|Carboplatin|carboplatin|mesh-list
20115982|NCT00005631|Etoposide|etoposide|mesh-list
20115983|NCT00005631|Ifosfamide|ifosfamide|mesh-list
20115984|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115985|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115986|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
20115987|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030700|NCT02654860|Acetaminophen|acetaminophen|mesh-list
20030701|NCT02654860|Bupivacaine|bupivacaine|mesh-list
20030702|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030703|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
20030704|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030705|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030706|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
20030707|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030708|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030709|NCT02654860|Analgesics|analgesics|mesh-ancestor
20030710|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
20030711|NCT02655224|Relugolix|relugolix|mesh-list
20030712|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
20030713|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
20030714|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030715|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030716|NCT02655237|Leuprolide|leuprolide|mesh-list
20030717|NCT02655237|Relugolix|relugolix|mesh-list
20030718|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20030719|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
20030720|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20030721|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030722|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20030723|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030724|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
20030725|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
20030726|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030727|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
20030728|NCT02655354|Promethazine|promethazine|mesh-list
20030729|NCT02655354|Prazosin|prazosin|mesh-list
20030730|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20030731|NCT02655354|Mirtazapine|mirtazapine|mesh-list
20030732|NCT02655354|Trazodone|trazodone|mesh-list
20030733|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
20030734|NCT02655354|Sertraline|sertraline|mesh-list
20030735|NCT02655354|Fluoxetine|fluoxetine|mesh-list
20030736|NCT02655354|Paroxetine|paroxetine|mesh-list
20030737|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20030738|NCT02655354|Citalopram|citalopram|mesh-list
20030739|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20030740|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20030741|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20030742|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030743|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030744|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030745|NCT02655354|Analgesics|analgesics|mesh-ancestor
20030746|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
20030747|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030748|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
20030749|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20030750|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
20030751|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20030752|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
20030753|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20030754|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20030755|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20030756|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030757|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
20030758|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20030759|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20030760|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030761|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030762|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
20030763|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
20030764|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030765|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20030766|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
20030767|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
20030768|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20030769|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
20030770|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
20030771|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20030772|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20030773|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20030774|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20030775|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20030776|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030777|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20030778|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20030779|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20030780|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20030781|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20030782|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20030783|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20030784|NCT02655419|Metronidazole|metronidazole|mesh-list
20030785|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030786|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20030787|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20030788|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20030789|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
20030790|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
20030791|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20030792|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20030793|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030794|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
20030795|NCT02655653|Coagulants|coagulants|mesh-ancestor
20030796|NCT02655679|Ether|ether|mesh-list
20030797|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20030798|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
20030799|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
20030800|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030801|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030802|NCT02656069|Glucagon|glucagon|mesh-list
20030803|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20030804|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030805|NCT02656069|Hormones|hormones|mesh-ancestor
20030806|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030807|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030808|NCT02656069|Incretins|incretins|mesh-ancestor
20030809|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
20030810|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20030811|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20030812|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030813|NCT02656173|Tamsulosin|tamsulosin|mesh-list
19745950|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745951|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745952|NCT04669665|Ketamine|ketamine|mesh-list
19745953|NCT04669665|Analgesics|analgesics|mesh-ancestor
19745954|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
19745955|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19745956|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745957|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19745958|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19745959|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
19745960|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
20030814|NCT02656173|Mirabegron|mirabegron|mesh-list
20030815|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20030816|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20030817|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20030818|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030819|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030820|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030821|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030822|NCT02656173|Urological Agents|urological agents|mesh-ancestor
20030823|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20030824|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20030825|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20030826|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20030827|NCT02656329|Lugol's solution|lugol's solution|mesh-list
20030828|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030829|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030830|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030831|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20030832|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
20030833|NCT02656329|Coagulants|coagulants|mesh-ancestor
20030834|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
20030835|NCT02657031|Promethazine|promethazine|mesh-list
20030836|NCT02657031|Ketamine|ketamine|mesh-list
20030837|NCT02657031|Ondansetron|ondansetron|mesh-list
20030838|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
20030839|NCT02657031|Analgesics|analgesics|mesh-ancestor
20030840|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
20030841|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030842|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030843|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20030844|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20030845|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
20030846|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
20030847|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030848|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20030849|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20030850|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030851|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030852|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
20030853|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
20030854|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20030855|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
20030856|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
20030857|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20030858|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
20030859|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20030860|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20030861|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20030862|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20030863|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20030864|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20030865|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030866|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20030867|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
20030868|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
20030869|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20030870|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20030871|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
20030872|NCT02657252|Polidocanol|polidocanol|mesh-list
20030873|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20030874|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20030875|NCT02657369|Lenvatinib|lenvatinib|mesh-list
20030876|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030877|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20030878|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030879|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030880|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
20030881|NCT02657889|Niraparib|niraparib|mesh-list
20030882|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20030883|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030884|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20030885|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030886|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030887|NCT02657928|Letrozole|letrozole|mesh-list
20030888|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030889|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20030890|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20030891|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030892|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030893|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20030894|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
20030895|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20030896|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030897|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
20030898|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20030899|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030900|NCT02658084|Trastuzumab|trastuzumab|mesh-list
20030901|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20030902|NCT02658084|Vinorelbine|vinorelbine|mesh-list
20030903|NCT02658084|Maytansine|maytansine|mesh-list
20030904|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20030905|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030906|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20030907|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
20030908|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
20030909|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
20030910|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030911|NCT02658149|Ketorolac|ketorolac|mesh-list
20030912|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20030913|NCT02658149|Epinephrine|epinephrine|mesh-list
20030914|NCT02658149|Morphine|morphine|mesh-list
20030915|NCT02658149|Ropivacaine|ropivacaine|mesh-list
20030916|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20030917|NCT02658149|Narcotics|narcotics|mesh-ancestor
19745961|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19745962|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20030918|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030919|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030920|NCT02658149|Analgesics|analgesics|mesh-ancestor
20030921|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
20030922|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030923|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030924|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
20030925|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20030926|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20030927|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
19745963|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19745964|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19745965|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745966|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
19745967|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
20030928|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030929|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030930|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20030931|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20030932|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
20030933|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20030934|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
20030935|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
20030936|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
20030937|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20030938|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20030939|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20030940|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20030941|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20030942|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20030943|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20030944|NCT02658240|Epinephrine|epinephrine|mesh-list
20030945|NCT02658240|Ropivacaine|ropivacaine|mesh-list
20030946|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030947|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
19745968|NCT04665856|Carboplatin|carboplatin|mesh-list
19745969|NCT04665856|Etoposide|etoposide|mesh-list
19745970|NCT04665856|Atezolizumab|atezolizumab|mesh-list
19745971|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030948|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030949|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030950|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
20030951|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20030952|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20030953|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20030954|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
20030955|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20030956|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030957|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20030958|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20030959|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
20030960|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20030961|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
20030962|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
20030963|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
20030964|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20030965|NCT02658461|Trastuzumab|trastuzumab|mesh-list
20030966|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20030967|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030968|NCT02658487|Cytarabine|cytarabine|mesh-list
20030969|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20030970|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
20030971|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030972|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030973|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
20030974|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20030975|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20030976|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
20030977|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576491|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20576492|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576493|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030978|NCT02658734|Trastuzumab|trastuzumab|mesh-list
20576494|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20030979|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20030980|NCT02658734|Maytansine|maytansine|mesh-list
20030981|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20030982|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20030983|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20030984|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
20030985|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
20030986|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
20030987|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20030988|NCT02659501|Acetaminophen|acetaminophen|mesh-list
20030989|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20030990|NCT02659501|Epinephrine|epinephrine|mesh-list
20030991|NCT02659501|Diazepam|diazepam|mesh-list
20030992|NCT02659501|Morphine|morphine|mesh-list
20030993|NCT02659501|Hydrocodone|hydrocodone|mesh-list
20030994|NCT02659501|Bupivacaine|bupivacaine|mesh-list
20030995|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
20030996|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
20030997|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20030998|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20030999|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
20031000|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031001|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031002|NCT02659501|Narcotics|narcotics|mesh-ancestor
20031003|NCT02659501|Analgesics|analgesics|mesh-ancestor
20031004|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20031005|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
20031006|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20031007|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20031008|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
20031009|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031010|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745972|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19745973|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19745974|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19745975|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745976|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745977|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
19745978|NCT04660539|Azathioprine|azathioprine|mesh-list
19745979|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19745980|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19745981|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19745982|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
19745983|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19745984|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031011|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20031012|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20031013|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
20031014|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20031015|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
20031016|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
20031017|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
20031018|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20031019|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
20031020|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19745985|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19745986|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745987|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
20031021|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
20031022|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
20031023|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20031024|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20031025|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20031026|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20031027|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20031028|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20031029|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031030|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20576495|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031031|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
20031032|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
20031033|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
20031034|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20031035|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031036|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031037|NCT02659540|Nivolumab|nivolumab|mesh-list
20031038|NCT02659540|Ipilimumab|ipilimumab|mesh-list
20031039|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20031040|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031041|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20031042|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031043|NCT02659787|Buprenorphine|buprenorphine|mesh-list
20031044|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031045|NCT02659787|Narcotics|narcotics|mesh-ancestor
20031046|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031047|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031048|NCT02659787|Analgesics|analgesics|mesh-ancestor
20031049|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
20031050|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031051|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20031052|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
20031053|NCT02659943|Fludarabine|fludarabine|mesh-list
20031054|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20031055|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
20031056|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031057|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031058|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20031059|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
20031060|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031061|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031062|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20031063|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
20031064|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20031065|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20031066|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
20031067|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20031068|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20031069|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031070|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031071|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031072|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031073|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20031074|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031075|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
20031076|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
20031077|NCT02660229|Morphine|morphine|mesh-list
20031078|NCT02660229|Oxycodone|oxycodone|mesh-list
20031079|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031080|NCT02660229|Narcotics|narcotics|mesh-ancestor
20031081|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031082|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031083|NCT02660229|Analgesics|analgesics|mesh-ancestor
20031084|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
20031085|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031086|NCT02660242|Glucagon|glucagon|mesh-list
20031087|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20031088|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031089|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20031090|NCT02660242|Hormones|hormones|mesh-ancestor
20031091|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031092|NCT02660242|Incretins|incretins|mesh-ancestor
20031093|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
20031094|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20031095|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20031096|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
20031097|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20031098|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20031099|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031100|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031101|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031102|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031103|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20031104|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031105|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
20031106|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
20031107|NCT02660580|Adalimumab|adalimumab|mesh-list
20031108|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031109|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031110|NCT02660918|Bupivacaine|bupivacaine|mesh-list
20031111|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
20031112|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
20031113|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031114|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031115|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
20031116|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031117|NCT02660983|Donepezil|donepezil|mesh-list
20031118|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20031119|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031120|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031121|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031122|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031123|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031124|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
20031125|NCT02661061|Midazolam|midazolam|mesh-list
20031126|NCT02661061|Ketamine|ketamine|mesh-list
20031127|NCT02661061|Analgesics|analgesics|mesh-ancestor
20031128|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
20031129|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031130|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031131|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20031132|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031133|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
20031134|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
20031135|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031136|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20031137|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20031138|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031139|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031140|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20031141|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20031142|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20031143|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20031144|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031145|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
20031146|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
20031147|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
20031148|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
20031149|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031150|NCT02661178|Emodepside|emodepside|mesh-list
20031151|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20031152|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031153|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20031154|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20031155|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031156|NCT02661490|Vaccines|vaccines|mesh-list
20031157|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
20031158|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031159|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
20031160|NCT02661594|Amisulpride|amisulpride|mesh-list
20031161|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20031162|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031163|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20031164|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20031165|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031166|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031167|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031168|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031169|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20031170|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20031171|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031172|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031173|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20031174|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
20031175|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031176|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20031177|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
20031178|NCT02661815|Paclitaxel|paclitaxel|mesh-list
20031179|NCT02661815|Bevacizumab|bevacizumab|mesh-list
20031180|NCT02661815|Ricolinostat|ricolinostat|mesh-list
20031181|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20031182|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031183|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
20031184|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
20031185|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
20031186|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745988|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20031187|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20031188|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20031189|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20031190|NCT02661815|Growth Substances|growth substances|mesh-ancestor
20031191|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031192|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
20031193|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20031194|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031195|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
20031196|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031197|NCT02662036|Bupivacaine|bupivacaine|mesh-list
20031198|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
20031199|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
20031200|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031201|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031202|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
20031203|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031204|NCT02662556|Sufentanil|sufentanil|mesh-list
20031205|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031206|NCT02662556|Narcotics|narcotics|mesh-ancestor
20031207|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031208|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031209|NCT02662556|Analgesics|analgesics|mesh-ancestor
20031210|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
20031211|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031212|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20031213|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031214|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
20031215|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
20031216|NCT02662569|Atorvastatin|atorvastatin|mesh-list
20031217|NCT02662569|Evolocumab|evolocumab|mesh-list
20031218|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20031219|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20031220|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
20031221|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031222|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20031223|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20031224|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031225|NCT02662764|Sufentanil|sufentanil|mesh-list
20031226|NCT02662764|Dsuvia|dsuvia|mesh-list
20031227|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031228|NCT02662764|Narcotics|narcotics|mesh-ancestor
20031229|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031230|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031231|NCT02662764|Analgesics|analgesics|mesh-ancestor
20031232|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
20031233|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031234|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20031235|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031236|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
20031237|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
20031238|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20031239|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20031240|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20031241|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20031242|NCT02663674|Fluconazole|fluconazole|mesh-list
20031243|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
20031244|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031245|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19745989|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19745990|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
19745991|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745992|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19745993|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
19745994|NCT04656067|Ethamsylate|ethamsylate|mesh-list
19745995|NCT04656067|Oxytocin|oxytocin|mesh-list
19745996|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
20031246|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20031247|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031248|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031249|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20031250|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
20031251|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031252|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031253|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20031254|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20031255|NCT02663687|Complement C1s|complement c1s|mesh-list
20031256|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20031257|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20031258|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
20031259|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031260|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20031261|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20031262|NCT02663895|Treprostinil|treprostinil|mesh-list
20031263|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20031264|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
20031265|NCT02664220|Povidone|povidone|mesh-list
20031266|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
20031267|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
20031268|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20031269|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115988|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115989|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115990|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115991|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115992|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115993|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115994|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115995|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
20115996|NCT00005634|Vorinostat|vorinostat|mesh-list
20115997|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115998|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20115999|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116000|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116001|NCT00005635|Paclitaxel|paclitaxel|mesh-list
20116002|NCT00005635|Trastuzumab|trastuzumab|mesh-list
20116003|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116004|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116005|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116006|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116007|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116008|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19745997|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19745998|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19745999|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19746000|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19746001|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746002|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
19746003|NCT04656067|Coagulants|coagulants|mesh-ancestor
19746004|NCT04640168|Remdesivir|remdesivir|mesh-list
20116009|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20116010|NCT00005636|Pemetrexed|pemetrexed|mesh-list
20116011|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116012|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116013|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116014|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20116015|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116016|NCT00005637|Temozolomide|temozolomide|mesh-list
20116017|NCT00005637|Carmustine|carmustine|mesh-list
20116018|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116019|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
20116020|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116021|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116022|NCT00005638|Irinotecan|irinotecan|mesh-list
20116023|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116024|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20116025|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116026|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116027|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116028|NCT00005639|Azacitidine|azacitidine|mesh-list
19746005|NCT04640168|Dexamethasone|dexamethasone|mesh-list
19746006|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031270|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
20031271|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20031272|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20031273|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031274|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
20031275|NCT02664909|Coagulants|coagulants|mesh-ancestor
20031276|NCT02664922|Ketamine|ketamine|mesh-list
20031277|NCT02664922|Remifentanil|remifentanil|mesh-list
20031278|NCT02664922|Propofol|propofol|mesh-list
20031279|NCT02664922|Sevoflurane|sevoflurane|mesh-list
20031280|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20031281|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031282|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031283|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031284|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
20031285|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
20031286|NCT02664922|Analgesics|analgesics|mesh-ancestor
20031287|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
20031288|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031289|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20031290|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20031291|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20031292|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031293|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031294|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031295|NCT02664922|Narcotics|narcotics|mesh-ancestor
20031296|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20031297|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20031298|NCT02664961|Bevacizumab|bevacizumab|mesh-list
20031299|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20031300|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031301|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20031302|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20031303|NCT02664961|Growth Substances|growth substances|mesh-ancestor
20031304|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031305|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
20031306|NCT02665260|Cantharidin|cantharidin|mesh-list
20031307|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031308|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031309|NCT02665273|Bupivacaine|bupivacaine|mesh-list
19746007|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
19746008|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
19746009|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746010|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746011|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19746012|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
19746013|NCT04640168|Hormones|hormones|mesh-ancestor
19746014|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746015|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746016|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746017|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
19746018|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031310|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
20031311|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
20031312|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031313|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031314|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
20031315|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031316|NCT02665286|Naproxen|naproxen|mesh-list
20031317|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20031318|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20031319|NCT02665286|Orphenadrine|orphenadrine|mesh-list
20031320|NCT02665286|Methocarbamol|methocarbamol|mesh-list
20031321|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20031322|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20031323|NCT02665286|Analgesics|analgesics|mesh-ancestor
20031324|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
20031325|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031326|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031327|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031328|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
20031329|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19746019|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
19746020|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031330|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031331|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031332|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031333|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031334|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20031335|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20031336|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20031337|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20031338|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
20031339|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
20031340|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20031341|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
20031342|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20031343|NCT02665689|Ranibizumab|ranibizumab|mesh-list
20031344|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20031345|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20031346|NCT02665689|Growth Substances|growth substances|mesh-ancestor
20031347|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031348|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
20031349|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031350|NCT02665728|Laxatives|laxatives|mesh-list
20031351|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20031352|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
20031353|NCT02666352|Ruzasvir|ruzasvir|mesh-list
20031354|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
20031355|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031356|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20031357|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20031358|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
20031359|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031360|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20031361|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031362|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031363|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031364|NCT02666742|Aspirin|aspirin|mesh-list
20031365|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
20031366|NCT02666742|Edoxaban|edoxaban|mesh-list
20031367|NCT02666742|Dabigatran|dabigatran|mesh-list
20031368|NCT02666742|Anticoagulants|anticoagulants|mesh-list
20031369|NCT02666742|Coagulants|coagulants|mesh-list
20031370|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20031371|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20031372|NCT02666742|Analgesics|analgesics|mesh-ancestor
20031373|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
20031374|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031375|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031376|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031377|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031378|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20031379|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20031380|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031381|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20031382|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20031383|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031384|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
20031385|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20031386|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
20031387|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20031388|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
20031389|NCT02666846|Ibuprofen|ibuprofen|mesh-list
20031390|NCT02666846|Diclofenac|diclofenac|mesh-list
20031391|NCT02666846|Salicylates|salicylates|mesh-list
20031392|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
20031393|NCT02666846|Menthol|menthol|mesh-list
20031394|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20031395|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20031396|NCT02666846|Analgesics|analgesics|mesh-ancestor
20031397|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
20031398|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031399|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031400|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031401|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031402|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20031403|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031404|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031405|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
20031406|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
20031407|NCT02666950|Cytarabine|cytarabine|mesh-list
20031408|NCT02666950|Adavosertib|adavosertib|mesh-list
20031409|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20031410|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
20031411|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031412|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031413|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
20031414|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031415|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20031416|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
20031417|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031418|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031419|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20031420|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20031421|NCT02667704|Nintedanib|nintedanib|mesh-list
20031422|NCT02667704|Bosentan|bosentan|mesh-list
20031423|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031424|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20031425|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031426|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746021|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
19746022|NCT04608630|Denosumab|denosumab|mesh-list
19746023|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19746024|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746025|NCT04584112|Paclitaxel|paclitaxel|mesh-list
19746026|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19746027|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
20031427|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20031428|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20031429|NCT02668393|Docetaxel|docetaxel|mesh-list
20031430|NCT02668393|Nintedanib|nintedanib|mesh-list
20031431|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031432|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
20031433|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
20031434|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
20031435|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031436|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20031437|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031438|NCT02668432|Amiodarone|amiodarone|mesh-list
20031439|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20031440|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
20031441|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20031442|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20031443|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031444|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20031445|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20031446|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20031447|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031448|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20031449|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20031450|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20031451|NCT02668640|Adalimumab|adalimumab|mesh-list
20031452|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031453|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031454|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20031455|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20031456|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031457|NCT02669043|Ketamine|ketamine|mesh-list
20031458|NCT02669043|Analgesics|analgesics|mesh-ancestor
20031459|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
20031460|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031461|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031462|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20031463|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031464|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
20031465|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
20031466|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031467|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20031468|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20031469|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031470|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031471|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20031472|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20031473|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031474|NCT02669407|Lidocaine|lidocaine|mesh-list
19746028|NCT04584112|Carboplatin|carboplatin|mesh-list
20031475|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
20031476|NCT02669407|Anesthetics|anesthetics|mesh-list
20031477|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031478|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031479|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
20031480|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031481|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20031482|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20031483|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20031484|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20031485|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031486|NCT02669615|Melphalan|melphalan|mesh-list
20031487|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20031488|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
20031489|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031490|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031491|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20031492|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20031493|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
20031494|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031495|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20031496|NCT02669914|Durvalumab|durvalumab|mesh-list
20031497|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20031498|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031499|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
20031500|NCT02670343|Testosterone|testosterone|mesh-list
20031501|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
20031502|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
20031503|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20031504|NCT02670343|Androgens|androgens|mesh-ancestor
20031505|NCT02670343|Hormones|hormones|mesh-ancestor
20031506|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031507|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031508|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20031509|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031510|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
20031511|NCT02670538|Cariprazine|cariprazine|mesh-list
20031512|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20031513|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20031514|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031515|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031516|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031517|NCT02670551|Cariprazine|cariprazine|mesh-list
20031518|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20031519|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20031520|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031521|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031522|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031523|NCT02670915|Insulin|insulin|mesh-list
20031524|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20031525|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
20031526|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
20031527|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20031528|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031529|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031530|NCT02671266|Oxytocin|oxytocin|mesh-list
20031531|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
20031532|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20031533|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031534|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
20031535|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20031536|NCT02671500|Velpatasvir|velpatasvir|mesh-list
20031537|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
20031538|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031539|NCT02672111|Buprenorphine|buprenorphine|mesh-list
20031540|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031541|NCT02672111|Narcotics|narcotics|mesh-ancestor
20031542|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031543|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031544|NCT02672111|Analgesics|analgesics|mesh-ancestor
20031545|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
20031546|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031547|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19569598|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20031548|NCT02673138|Canagliflozin|canagliflozin|mesh-list
20031549|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20031550|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031551|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031552|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031553|NCT02673372|Ketamine|ketamine|mesh-list
20031554|NCT02673372|Morphine|morphine|mesh-list
20031555|NCT02673372|Analgesics|analgesics|mesh-ancestor
20031556|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
20031557|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031558|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031559|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20031560|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031561|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
20031562|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
20031563|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031564|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20031565|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20031566|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031567|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031568|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031569|NCT02673372|Narcotics|narcotics|mesh-ancestor
20031570|NCT02674399|Hylan|hylan|mesh-list
20031571|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
20031572|NCT02674399|Protective Agents|protective agents|mesh-ancestor
20031573|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031574|NCT02674412|Buspirone|buspirone|mesh-list
20031575|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20031576|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20031577|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031578|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031579|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031580|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20031581|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
20031582|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031583|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116029|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20116030|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116031|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
20116032|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116033|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116034|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116035|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20116036|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20116037|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116038|NCT00005641|Leucovorin|leucovorin|mesh-list
20116039|NCT00005641|Cyclosporine|cyclosporine|mesh-list
20116040|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
20116041|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
20116042|NCT00005641|Busulfan|busulfan|mesh-list
20116043|NCT00005641|Methotrexate|methotrexate|mesh-list
20116044|NCT00005641|Cyclosporins|cyclosporins|mesh-list
20116045|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20116046|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
20116047|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116048|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
20116049|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116050|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116051|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116052|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
20116053|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116054|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116055|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116056|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20116057|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
20116058|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20116059|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116060|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
20116061|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116062|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116063|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20116064|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116065|NCT00005641|Antidotes|antidotes|mesh-ancestor
20116066|NCT00005641|Protective Agents|protective agents|mesh-ancestor
20116067|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
19746029|NCT04584112|Doxorubicin|doxorubicin|mesh-list
20116068|NCT00005641|Vitamins|vitamins|mesh-ancestor
20031584|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20031585|NCT02674854|Latanoprost|latanoprost|mesh-list
20031586|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20031587|NCT02675907|Meloxicam|meloxicam|mesh-list
20031588|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20031589|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20031590|NCT02675907|Analgesics|analgesics|mesh-ancestor
20031591|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
20031592|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031593|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031594|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031595|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031596|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20031597|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20031598|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031599|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031600|NCT02676375|Bupropion|bupropion|mesh-list
20031601|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20031602|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
20031603|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031604|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20031605|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20031606|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20031607|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031608|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
20031609|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031610|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031611|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20031612|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20031613|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031614|NCT02676466|Losartan|losartan|mesh-list
20031615|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20031616|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20031617|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20031618|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20031619|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031620|NCT02676895|Vaccines|vaccines|mesh-list
20031621|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
20031622|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031623|NCT02677116|Doxorubicin|doxorubicin|mesh-list
20031624|NCT02677116|Irinotecan|irinotecan|mesh-list
20031625|NCT02677116|Vincristine|vincristine|mesh-list
20031626|NCT02677116|Ifosfamide|ifosfamide|mesh-list
20031627|NCT02677116|Olaratumab|olaratumab|mesh-list
20031628|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20031629|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031630|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20031631|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20031632|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031633|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031634|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20031635|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20031636|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
20031637|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
20031638|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
20031639|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20031640|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
20031641|NCT02677493|Vaccines|vaccines|mesh-list
20031642|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
20031643|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031644|NCT02677623|Mannitol|mannitol|mesh-list
20031645|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20031646|NCT02677623|Diuretics|diuretics|mesh-ancestor
20031647|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
20031648|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031649|NCT02677701|Azithromycin|azithromycin|mesh-list
20031650|NCT02677701|Tobramycin|tobramycin|mesh-list
20031651|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20031652|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031653|NCT02677844|Loperamide|loperamide|mesh-list
20031654|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
20031655|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20031656|NCT02678286|Meloxicam|meloxicam|mesh-list
20031657|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20031658|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20031659|NCT02678286|Analgesics|analgesics|mesh-ancestor
20031660|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
20031661|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031662|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031663|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031664|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031665|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20031666|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20031667|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031668|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031669|NCT02678416|Acetaminophen|acetaminophen|mesh-list
20031670|NCT02678416|Morphine|morphine|mesh-list
20031671|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031672|NCT02678416|Narcotics|narcotics|mesh-ancestor
20031673|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031674|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031675|NCT02678416|Analgesics|analgesics|mesh-ancestor
20031676|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
20031677|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031678|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20031679|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
20031680|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
20031681|NCT02679274|Testosterone|testosterone|mesh-list
20031682|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
20031683|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
20031684|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20031685|NCT02679274|Androgens|androgens|mesh-ancestor
20031686|NCT02679274|Hormones|hormones|mesh-ancestor
20031687|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031688|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031689|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20031690|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031691|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
20031692|NCT02679469|Nalmefene|nalmefene|mesh-list
20031693|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20031694|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031695|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
20031696|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031697|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
20031698|NCT02679573|Linezolid|linezolid|mesh-list
20031699|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20031700|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031701|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20031702|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20031703|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031704|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031705|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031706|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20031707|NCT02679755|Letrozole|letrozole|mesh-list
20031708|NCT02679755|Palbociclib|palbociclib|mesh-list
20031709|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031710|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20031711|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20031712|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031713|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031714|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20031715|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20031716|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031717|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031718|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20031719|NCT02679911|Amorolfine|amorolfine|mesh-list
20031720|NCT02679911|Ciclopirox|ciclopirox|mesh-list
20031721|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
20031722|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031723|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20031724|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20031725|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
20031726|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031727|NCT02680054|Insulin|insulin|mesh-list
20031728|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
20031729|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031730|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031731|NCT02680301|Triamcinolone|triamcinolone|mesh-list
20031732|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20031733|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20031734|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20031735|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031736|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
20031737|NCT02680301|Hormones|hormones|mesh-ancestor
20031738|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031739|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031740|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20031741|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
20031742|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031743|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031744|NCT02680314|Methotrexate|methotrexate|mesh-list
20031745|NCT02680314|Misoprostol|misoprostol|mesh-list
20031746|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20031747|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
20031748|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20031749|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031750|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20031751|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
20031752|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031753|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031754|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
20031755|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031756|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20031757|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20031758|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
20031759|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20031760|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20031761|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20031762|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20031763|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
20031764|NCT02680457|Insulin|insulin|mesh-list
20031765|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20031766|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
20031767|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031768|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031769|NCT02680756|Ferric maltol|ferric maltol|mesh-list
20031770|NCT02680756|Hematinics|hematinics|mesh-ancestor
20031771|NCT02680847|Naltrexone|naltrexone|mesh-list
20031772|NCT02680847|Oxycodone|oxycodone|mesh-list
20031773|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031774|NCT02680847|Narcotics|narcotics|mesh-ancestor
20031775|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031776|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031777|NCT02680847|Analgesics|analgesics|mesh-ancestor
20031778|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
20031779|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031780|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20031781|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20031782|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
20031783|NCT02681094|Saxagliptin|saxagliptin|mesh-list
20031784|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20031785|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031786|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031787|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031788|NCT02681094|Incretins|incretins|mesh-ancestor
20031789|NCT02681094|Hormones|hormones|mesh-ancestor
20031790|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031791|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20031792|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
20031793|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031794|NCT02681510|Nicotine|nicotine|mesh-list
20031795|NCT02681510|Varenicline|varenicline|mesh-list
20031796|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20031797|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
20031798|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031799|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031800|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20031801|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20031802|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031803|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031804|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031805|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20031806|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746030|NCT04584112|Atezolizumab|atezolizumab|mesh-list
20031807|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
20031808|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20031809|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20031810|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031811|NCT02682381|Teduglutide|teduglutide|mesh-list
20031812|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20031813|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20031814|NCT02682381|Protective Agents|protective agents|mesh-ancestor
19746031|NCT04584112|Molgramostim|molgramostim|mesh-list
19746032|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19746033|NCT04584112|Sargramostim|sargramostim|mesh-list
19746034|NCT04584112|Lenograstim|lenograstim|mesh-list
19746035|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20031815|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031816|NCT02682498|Bupivacaine|bupivacaine|mesh-list
20031817|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
20031818|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
20031819|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031820|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031821|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
20031822|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031823|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
20031824|NCT02682563|Gliclazide|gliclazide|mesh-list
20031825|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20031826|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031827|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031828|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031829|NCT02682602|Tacrine|tacrine|mesh-list
20031830|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20031831|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031832|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031833|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031834|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031835|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031836|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20031837|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
20031838|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031839|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
20031840|NCT02682784|Oxytocin|oxytocin|mesh-list
20031841|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
20031842|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20031843|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031844|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
20031845|NCT02683109|Olodaterol|olodaterol|mesh-list
20031846|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20031847|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
20031848|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031849|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031850|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20031851|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
20031852|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
20031853|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20031854|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031855|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031856|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031857|NCT02683161|Varenicline|varenicline|mesh-list
20031858|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20031859|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20031860|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031861|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031862|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031863|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031864|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20031865|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031866|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031867|NCT02683187|Incretins|incretins|mesh-ancestor
20031868|NCT02683187|Hormones|hormones|mesh-ancestor
20031869|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031870|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20031871|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
20031872|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031873|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746036|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746037|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
19746038|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
19746039|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
19746040|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746041|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20031874|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20031875|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20031876|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031877|NCT02683525|Incretins|incretins|mesh-ancestor
20031878|NCT02683525|Hormones|hormones|mesh-ancestor
20031879|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031880|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20031881|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
20031882|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20031883|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031884|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
20031885|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20031886|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
20031887|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031888|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031889|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20031890|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
20031891|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
20031892|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20031893|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
20031894|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031895|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031896|NCT02683707|Lidocaine|lidocaine|mesh-list
20031897|NCT02683707|Fentanyl|fentanyl|mesh-list
20031898|NCT02683707|Midazolam|midazolam|mesh-list
20031899|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
20031900|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
20031901|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031902|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031903|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
20031904|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031905|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20031906|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20031907|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20031908|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20031909|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031910|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031911|NCT02683707|Narcotics|narcotics|mesh-ancestor
20031912|NCT02683707|Analgesics|analgesics|mesh-ancestor
19746042|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
19746043|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746044|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746045|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19746046|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
20031913|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20031914|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031915|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
20031916|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20031917|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20031918|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20031919|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20031920|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
20031921|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
20031922|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031923|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
20031924|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20031925|NCT02683746|Incretins|incretins|mesh-ancestor
20031926|NCT02683746|Hormones|hormones|mesh-ancestor
20031927|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031928|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116069|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
20116070|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
20116071|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116072|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20116073|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20116074|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
19746047|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19746048|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19746049|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746050|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19746051|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746052|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19746053|NCT04572815|Interleukin-12|interleukin-12|mesh-list
19746054|NCT04572815|Ustekinumab|ustekinumab|mesh-list
20116075|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
20116076|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576496|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
19746055|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
19746056|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
19746057|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
19746058|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031929|NCT02683941|Lanreotide|lanreotide|mesh-list
20031930|NCT02683941|Somatostatin|somatostatin|mesh-list
20031931|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031932|NCT02683941|Hormones|hormones|mesh-ancestor
20031933|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031934|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031935|NCT02684136|Suvorexant|suvorexant|mesh-list
20031936|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20031937|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20031938|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031939|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031940|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20031941|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031942|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031943|NCT02684344|Tamsulosin|tamsulosin|mesh-list
20031944|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20031945|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20031946|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20031947|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
20031948|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20031949|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031950|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031951|NCT02684344|Urological Agents|urological agents|mesh-ancestor
20031952|NCT02684357|Ustekinumab|ustekinumab|mesh-list
20031953|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20031954|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
20031955|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
20031956|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031957|NCT02684370|Ustekinumab|ustekinumab|mesh-list
20031958|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20031959|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
20031960|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
20031961|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031962|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
20031963|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20031964|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031965|NCT02684942|Fentanyl|fentanyl|mesh-list
20031966|NCT02684942|Meperidine|meperidine|mesh-list
20031967|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20031968|NCT02684942|Narcotics|narcotics|mesh-ancestor
20031969|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20031970|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031971|NCT02684942|Analgesics|analgesics|mesh-ancestor
20031972|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
20031973|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20031974|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20031975|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20031976|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
20031977|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
20031978|NCT02685033|Dalbavancin|dalbavancin|mesh-list
19746059|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746060|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19746061|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19746062|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19746063|NCT04572815|Growth Substances|growth substances|mesh-ancestor
19746064|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746065|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746066|NCT04533737|Brodalumab|brodalumab|mesh-list
19746067|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746068|NCT04531943|Progesterone|progesterone|mesh-list
19746069|NCT04531943|Estrogens|estrogens|mesh-list
19746070|NCT04531943|Progestins|progestins|mesh-ancestor
19746071|NCT04531943|Hormones|hormones|mesh-ancestor
19746072|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746073|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746074|NCT04522323|Lenvatinib|lenvatinib|mesh-list
19746075|NCT04522323|Axitinib|axitinib|mesh-list
19746076|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746077|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20031979|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20031980|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20031981|NCT02685072|Progesterone|progesterone|mesh-list
20031982|NCT02685072|Progestins|progestins|mesh-ancestor
20031983|NCT02685072|Hormones|hormones|mesh-ancestor
20031984|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031985|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031986|NCT02685267|Prednisone|prednisone|mesh-list
20031987|NCT02685267|Docetaxel|docetaxel|mesh-list
20031988|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20031989|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
20031990|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
20031991|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
20031992|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20031993|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20031994|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
20031995|NCT02685267|Hormones|hormones|mesh-ancestor
20031996|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20031997|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20031998|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20031999|NCT02685436|Domperidone|domperidone|mesh-list
20032000|NCT02685436|Omeprazole|omeprazole|mesh-list
20032001|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20032002|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20032003|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20032004|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032005|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032006|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
20032007|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
20032008|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032009|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032010|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20032011|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
20032012|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032013|NCT02685826|Dexamethasone|dexamethasone|mesh-list
20032014|NCT02685826|Lenalidomide|lenalidomide|mesh-list
20032015|NCT02685826|Durvalumab|durvalumab|mesh-list
20032016|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032017|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
20032018|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
20032019|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032020|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032021|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20032022|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
20032023|NCT02685826|Hormones|hormones|mesh-ancestor
20032024|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032025|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20032026|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032027|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
20032028|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20032029|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20032030|NCT02685826|Growth Substances|growth substances|mesh-ancestor
20032031|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
20032032|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032033|NCT02686164|Lenvatinib|lenvatinib|mesh-list
20032034|NCT02686164|Midazolam|midazolam|mesh-list
20032035|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20032036|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20032037|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032038|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032039|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20032040|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20032041|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20032042|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20032043|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
20032044|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
20032045|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
20032046|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
20032047|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032048|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032049|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032050|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20032051|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032052|NCT02687451|Oxymorphone|oxymorphone|mesh-list
20032053|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20032054|NCT02687451|Narcotics|narcotics|mesh-ancestor
20032055|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032056|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032057|NCT02687451|Analgesics|analgesics|mesh-ancestor
20032058|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
20576497|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
20032059|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032060|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20032061|NCT02687815|Vitamin D|vitamin d|mesh-list
20032062|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
20032063|NCT02687815|Vitamins|vitamins|mesh-ancestor
20032064|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
20032065|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032066|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20032067|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20032068|NCT02688387|Ambrisentan|ambrisentan|mesh-list
20032069|NCT02688387|Tadalafil|tadalafil|mesh-list
20032070|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
20032071|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20032072|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20032073|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032074|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032075|NCT02688387|Urological Agents|urological agents|mesh-ancestor
20032076|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20032077|NCT02688556|Cyclosporine|cyclosporine|mesh-list
20032078|NCT02688556|Cyclosporins|cyclosporins|mesh-list
20032079|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032080|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032081|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032082|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
20032083|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032084|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
20032085|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032086|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032087|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032088|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20032089|NCT02688764|Calcium|calcium|mesh-list
20032090|NCT02688764|Calcium acetate|calcium acetate|mesh-list
20032091|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20032092|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032093|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
20032094|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
20032095|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032096|NCT02688829|Sirolimus|sirolimus|mesh-list
20032097|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20032098|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032099|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20032100|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032101|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
20032102|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032103|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
20032104|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032105|NCT02688842|Sirolimus|sirolimus|mesh-list
20032106|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20032107|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032108|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20032109|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032110|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
20032111|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032112|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
19746078|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032113|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032114|NCT02689063|Acetaminophen|acetaminophen|mesh-list
20032115|NCT02689063|Ibuprofen|ibuprofen|mesh-list
20032116|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032117|NCT02689063|Analgesics|analgesics|mesh-ancestor
20032118|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
19746079|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746080|NCT04487067|Bevacizumab|bevacizumab|mesh-list
19746081|NCT04487067|Atezolizumab|atezolizumab|mesh-list
19746082|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746083|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746084|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19746085|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19746086|NCT04487067|Growth Substances|growth substances|mesh-ancestor
20032119|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746087|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032120|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032121|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
20032122|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20032123|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032124|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032125|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20032126|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032127|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032128|NCT02689206|Glycine|glycine|mesh-list
20032129|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
20032130|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032131|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032132|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032133|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20032134|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032135|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032136|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
20032137|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
20032138|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
20032139|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
20032140|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20032141|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032142|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20032143|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20032144|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20032145|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20032146|NCT02690558|Gemcitabine|gemcitabine|mesh-list
20032147|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
20032148|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032149|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20032150|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
20032151|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032152|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
20032153|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032154|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032155|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032156|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
20032157|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032158|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032159|NCT02690714|Plasminogen|plasminogen|mesh-list
20032160|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20032161|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20032162|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032163|NCT02690727|Tenalisib|tenalisib|mesh-list
20032164|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
20032165|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032166|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032167|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
20032168|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032169|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032170|NCT02690974|Valsartan|valsartan|mesh-list
20032171|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20032172|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20032173|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20032174|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20032175|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032176|NCT02691416|Propofol|propofol|mesh-list
20032177|NCT02691416|Sevoflurane|sevoflurane|mesh-list
20032178|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20032179|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032180|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032181|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20032182|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
20032183|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
20032184|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20032185|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20032186|NCT02691468|Silicon|silicon|mesh-list
20032187|NCT02691468|Trace Elements|trace elements|mesh-ancestor
20032188|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
20032189|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032190|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20576498|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20032191|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20032192|NCT02691494|Norethindrone|norethindrone|mesh-list
20032193|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
20032194|NCT02691494|Estradiol|estradiol|mesh-list
20032195|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20032196|NCT02691494|Estrogens|estrogens|mesh-ancestor
20032197|NCT02691494|Hormones|hormones|mesh-ancestor
20032198|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032199|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032200|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20032201|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
20032202|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20032203|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20032204|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20032205|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20032206|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20032207|NCT02691507|Decanoic acid|decanoic acid|mesh-list
20032208|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
20032209|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032210|NCT02691572|Acetaminophen|acetaminophen|mesh-list
20032211|NCT02691572|Ketorolac|ketorolac|mesh-list
20032212|NCT02691572|Fentanyl|fentanyl|mesh-list
20032213|NCT02691572|Bupivacaine|bupivacaine|mesh-list
20032214|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
20032215|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
20032216|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032217|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032218|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
20032219|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032220|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20032221|NCT02691572|Narcotics|narcotics|mesh-ancestor
20032222|NCT02691572|Analgesics|analgesics|mesh-ancestor
20032223|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20032224|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20032225|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
20032226|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032227|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
20032228|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20032229|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032230|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032231|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20032232|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032233|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032234|NCT02691702|Melatonin|melatonin|mesh-list
20032235|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
20032236|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032237|NCT02691702|Protective Agents|protective agents|mesh-ancestor
20032238|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032239|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032240|NCT02691936|Estrogens|estrogens|mesh-list
20032241|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20032242|NCT02691936|Hormones|hormones|mesh-ancestor
20032243|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032244|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032245|NCT02692391|Indomethacin|indomethacin|mesh-list
20032246|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20032247|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032248|NCT02692391|Analgesics|analgesics|mesh-ancestor
20032249|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
20032250|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032251|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032252|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032253|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032254|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
20032255|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
20032256|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20032257|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20032258|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032259|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032260|NCT02692755|Letrozole|letrozole|mesh-list
20032261|NCT02692755|Fulvestrant|fulvestrant|mesh-list
20032262|NCT02692755|Palbociclib|palbociclib|mesh-list
20032263|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032264|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20032265|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20032266|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032267|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032268|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20032269|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20032270|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032271|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032272|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20032273|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20032274|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20116077|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20116078|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
20116079|NCT00005641|Hormones|hormones|mesh-ancestor
20116080|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116081|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20116082|NCT00005642|Semaxinib|semaxinib|mesh-list
20116083|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20116084|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20116085|NCT00005642|Growth Substances|growth substances|mesh-ancestor
20116086|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116087|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
20116088|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116089|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20116090|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116091|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116092|NCT00005643|Doxorubicin|doxorubicin|mesh-list
20116093|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20116094|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116095|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116096|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116097|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116098|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116099|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116100|NCT00005644|Gemcitabine|gemcitabine|mesh-list
20116101|NCT00005644|Paclitaxel|paclitaxel|mesh-list
20116102|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116103|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116104|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116105|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116106|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116107|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116108|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116109|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
20116110|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
20116111|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116112|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116113|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116114|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
20116115|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116116|NCT00005646|Paclitaxel|paclitaxel|mesh-list
20116117|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116118|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116119|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116120|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116121|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116122|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116123|NCT00005647|Paclitaxel|paclitaxel|mesh-list
20116124|NCT00005647|Semaxinib|semaxinib|mesh-list
20116125|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116126|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116127|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116128|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116129|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116130|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116131|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20116132|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20116133|NCT00005647|Growth Substances|growth substances|mesh-ancestor
20116134|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116135|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
20116136|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20116137|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116138|NCT00005648|Gemcitabine|gemcitabine|mesh-list
20116139|NCT00005648|Tipifarnib|tipifarnib|mesh-list
20116140|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116141|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
20116142|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116143|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032275|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20032276|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20032277|NCT02694328|Olanzapine|olanzapine|mesh-list
20032278|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
20032279|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
20032280|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032281|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032282|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20032283|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20032284|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20032285|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032286|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20032287|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20032288|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20032289|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032290|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032291|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032292|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
20032293|NCT02694523|Adalimumab|adalimumab|mesh-list
20032294|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20032295|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032296|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032297|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
20032298|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032299|NCT02694536|Gemcitabine|gemcitabine|mesh-list
20032300|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20032301|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20032302|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
20032303|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032304|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032305|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
20032306|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032307|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032308|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032309|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
20032310|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032311|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20032312|NCT02694601|Caffeine|caffeine|mesh-list
20032313|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20032314|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032315|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20032316|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032317|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032318|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20032319|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20032320|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
20032321|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032322|NCT02694718|Capecitabine|capecitabine|mesh-list
20032323|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
20032324|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20032325|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
20032326|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032327|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032328|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20032329|NCT02694978|Hematinics|hematinics|mesh-ancestor
20032330|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20032331|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20032332|NCT02695290|Afatinib|afatinib|mesh-list
20032333|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032334|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20032335|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032336|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032337|NCT02695446|Minocycline|minocycline|mesh-list
20032338|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20032339|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032340|NCT02695537|Cannabidiol|cannabidiol|mesh-list
20032341|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
20032342|NCT02695628|Misonidazole|misonidazole|mesh-list
20032343|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032344|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20032345|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20032346|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032347|NCT02695719|Lubiprostone|lubiprostone|mesh-list
20032348|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20032349|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032350|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032351|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20032352|NCT02696434|Naltrexone|naltrexone|mesh-list
20032353|NCT02696434|Buprenorphine|buprenorphine|mesh-list
20032354|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20032355|NCT02696434|Narcotics|narcotics|mesh-ancestor
20032356|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032357|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032358|NCT02696434|Analgesics|analgesics|mesh-ancestor
20032359|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
20032360|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032361|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20032362|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20032363|NCT02696785|Adalimumab|adalimumab|mesh-list
20032364|NCT02696785|Ixekizumab|ixekizumab|mesh-list
20032365|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032366|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032367|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032368|NCT02696798|Ixekizumab|ixekizumab|mesh-list
20032369|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032370|NCT02696850|Budesonide|budesonide|mesh-list
20032371|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032372|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20032373|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
20032374|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032375|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032376|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20032377|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
20032378|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
20032379|NCT02696850|Hormones|hormones|mesh-ancestor
20032380|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032381|NCT02697071|Ketamine|ketamine|mesh-list
20032382|NCT02697071|Analgesics|analgesics|mesh-ancestor
20032383|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
20032384|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032385|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032386|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20032387|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20032388|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
20032389|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
20032390|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032391|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20032392|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20032393|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032394|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032395|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
20032396|NCT02697188|Testosterone|testosterone|mesh-list
20032397|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
20032398|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
20032399|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20032400|NCT02697188|Androgens|androgens|mesh-ancestor
20032401|NCT02697188|Hormones|hormones|mesh-ancestor
20032402|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032403|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032404|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20032405|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032406|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
20032407|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
20032408|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20032409|NCT02697292|Antibodies|antibodies|mesh-list
20032410|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
20032411|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20032412|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
20032413|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032414|NCT02697617|Pioglitazone|pioglitazone|mesh-list
20032415|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20032416|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032417|NCT02697773|Tanezumab|tanezumab|mesh-list
20032418|NCT02697773|Analgesics|analgesics|mesh-ancestor
20032419|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
20032420|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032421|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032422|NCT02697916|Aspirin|aspirin|mesh-list
20032423|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20032424|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032425|NCT02697916|Analgesics|analgesics|mesh-ancestor
20032426|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
20032427|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032428|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032429|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032430|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032431|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20032432|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20032433|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032434|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20032435|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20032436|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032437|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
20032438|NCT02698215|Naltrexone|naltrexone|mesh-list
20032439|NCT02698215|Varenicline|varenicline|mesh-list
20032440|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20032441|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20032442|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032443|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
20032444|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032445|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20032446|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20032447|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
20032448|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032449|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032450|NCT02698410|Temozolomide|temozolomide|mesh-list
20032451|NCT02698410|Lanreotide|lanreotide|mesh-list
20032452|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20032453|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
20032454|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032455|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032456|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20032457|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032458|NCT02698475|Ustekinumab|ustekinumab|mesh-list
20032459|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032460|NCT02698566|Ranibizumab|ranibizumab|mesh-list
20032461|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20032462|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20032463|NCT02698566|Growth Substances|growth substances|mesh-ancestor
20032464|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032465|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
20032466|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032467|NCT02698735|Gentamicins|gentamicins|mesh-list
20032468|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20032469|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032470|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20032471|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032472|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032473|NCT02699099|Vitamin A|vitamin a|mesh-list
20032474|NCT02699099|Vaccines|vaccines|mesh-list
20032475|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
20032476|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032477|NCT02699099|Vitamins|vitamins|mesh-ancestor
20032478|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
20032479|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20032480|NCT02699125|Guanfacine|guanfacine|mesh-list
20032481|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20032482|NCT02699125|Diuretics|diuretics|mesh-ancestor
20032483|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
20032484|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032485|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20032486|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032487|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032488|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20032489|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20032490|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20032491|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
20032492|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032493|NCT02699450|Ranibizumab|ranibizumab|mesh-list
20032494|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20032495|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20032496|NCT02699450|Growth Substances|growth substances|mesh-ancestor
20032497|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032498|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20032499|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032500|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20032501|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20032502|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20032503|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032504|NCT02699892|Rituximab|rituximab|mesh-list
20032505|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032506|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032507|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
20032508|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032509|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032510|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
20032511|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20032512|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032513|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20032514|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032515|NCT02700412|Cannabidiol|cannabidiol|mesh-list
20032516|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
20032517|NCT02700815|Diclofenac|diclofenac|mesh-list
20032518|NCT02700815|Capsaicin|capsaicin|mesh-list
20032519|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20032520|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032521|NCT02700815|Analgesics|analgesics|mesh-ancestor
20032522|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
20032523|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032524|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032525|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032526|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032527|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20032528|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032529|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032530|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
20032531|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032532|NCT02701062|Warfarin|warfarin|mesh-list
20032533|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
20032534|NCT02701062|Dabigatran|dabigatran|mesh-list
20032535|NCT02701062|Apixaban|apixaban|mesh-list
20032536|NCT02701062|Anticoagulants|anticoagulants|mesh-list
20032537|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20032538|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
20032539|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20032540|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
20032541|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032542|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032543|NCT02701257|Glucagon|glucagon|mesh-list
20032544|NCT02701257|Pancrelipase|pancrelipase|mesh-list
20032545|NCT02701257|Pancreatin|pancreatin|mesh-list
20032546|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20032547|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20032548|NCT02701257|Hormones|hormones|mesh-ancestor
20032549|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032550|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032551|NCT02701257|Incretins|incretins|mesh-ancestor
20032552|NCT02701296|Epinephrine|epinephrine|mesh-list
20032553|NCT02701296|Ropivacaine|ropivacaine|mesh-list
20032554|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
20032555|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
20032556|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032557|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032558|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
20032559|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032560|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20032561|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20032562|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
20032563|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032564|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032565|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20032566|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20032567|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
20032568|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20032569|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
20032570|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
20032571|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
20032572|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20032573|NCT02701400|Durvalumab|durvalumab|mesh-list
20032574|NCT02701400|Ipilimumab|ipilimumab|mesh-list
20032575|NCT02701400|Tremelimumab|tremelimumab|mesh-list
20032576|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032577|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032578|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20032579|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032580|NCT02701582|Phenylephrine|phenylephrine|mesh-list
20032581|NCT02701582|Epinephrine|epinephrine|mesh-list
20032582|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
20032583|NCT02701582|Synephrine|synephrine|mesh-list
20032584|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20032585|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20032586|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
20032587|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032588|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032589|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032590|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20032591|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20032592|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
20032593|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032594|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20032595|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
20032596|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
20032597|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
20032598|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20032599|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20032600|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
20032601|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20032602|NCT02701582|Protective Agents|protective agents|mesh-ancestor
20116144|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
20116145|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116146|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116147|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116148|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
20116149|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116150|NCT00005649|Paclitaxel|paclitaxel|mesh-list
20116151|NCT00005649|Capecitabine|capecitabine|mesh-list
20116152|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116153|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116154|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116155|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116156|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116157|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116158|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116159|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
20116160|NCT00005652|Rituximab|rituximab|mesh-list
20116161|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20116162|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116163|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
20116164|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116165|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116166|NCT00005654|Metformin|metformin|mesh-list
20116167|NCT00005654|Clomiphene|clomiphene|mesh-list
20116168|NCT00005654|Enclomiphene|enclomiphene|mesh-list
20116169|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
20116170|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20116171|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116172|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20116173|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
20116174|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116175|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20116176|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
20116177|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20116178|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20116179|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20116180|NCT00005658|Glycine|glycine|mesh-list
20116181|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
20116182|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20116183|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116184|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116185|NCT00005663|Valacyclovir|valacyclovir|mesh-list
20116186|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
20116187|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116188|NCT00005665|Interferons|interferons|mesh-list
20116189|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
20116190|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116191|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
20116192|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116193|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
20116194|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120655|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120656|NCT00006384|Interferons|interferons|mesh-list
20120657|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
20032603|NCT02701764|Pregabalin|pregabalin|mesh-list
20032604|NCT02701764|Analgesics|analgesics|mesh-ancestor
20032605|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
20032606|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032607|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032608|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
20032609|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20032610|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032611|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032612|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20032613|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20032614|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20032615|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032616|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20032617|NCT02702011|Empagliflozin|empagliflozin|mesh-list
20032618|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20032619|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032620|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20032621|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032622|NCT02702388|Lenvatinib|lenvatinib|mesh-list
20032623|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032624|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20032625|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032626|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032627|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
20032628|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032629|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032630|NCT02703259|Acetaminophen|acetaminophen|mesh-list
20032631|NCT02703259|Celecoxib|celecoxib|mesh-list
20032632|NCT02703259|Gabapentin|gabapentin|mesh-list
20032633|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032634|NCT02703259|Analgesics|analgesics|mesh-ancestor
20032635|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
20032636|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032637|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032638|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
20032639|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20032640|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032641|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032642|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20032643|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20032644|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032645|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032646|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
20032647|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20032648|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20032649|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032650|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20032651|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20032652|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20032653|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032654|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
20032655|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
20032656|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20032657|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032658|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
20032659|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20032660|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032661|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
20032662|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20032663|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032664|NCT02703636|Rivastigmine|rivastigmine|mesh-list
20032665|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20032666|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032667|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032668|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
20032669|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032670|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032671|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20032672|NCT02703636|Protective Agents|protective agents|mesh-ancestor
20032673|NCT02703779|Plerixafor|plerixafor|mesh-list
20032674|NCT02703779|Bortezomib|bortezomib|mesh-list
20032675|NCT02703779|Lenograstim|lenograstim|mesh-list
20032676|NCT02703779|Sargramostim|sargramostim|mesh-list
20032677|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20032678|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
20032679|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032680|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032681|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20032682|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20032683|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
20032684|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032685|NCT02703909|Rocuronium|rocuronium|mesh-list
20032686|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20032687|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20032688|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20032689|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032690|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032691|NCT02703948|Lidocaine|lidocaine|mesh-list
20032692|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
20032693|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
20293078|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293079|NCT04772196|Vitamin D|vitamin d|mesh-list
20293080|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
20293081|NCT04772196|Vitamins|vitamins|mesh-ancestor
20032694|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032695|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032696|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
20032697|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032698|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20032699|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20032700|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20032701|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032702|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032703|NCT02704104|Hemostatics|hemostatics|mesh-list
20032704|NCT02704104|Coagulants|coagulants|mesh-ancestor
20032705|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20032706|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20032707|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20032708|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
20032709|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032710|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20032711|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20032712|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032713|NCT02705105|Nivolumab|nivolumab|mesh-list
20032714|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
20032715|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032716|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032717|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20032718|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032719|NCT02705352|Fluorouracil|fluorouracil|mesh-list
20032720|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
20032721|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032722|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20032723|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032724|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032725|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
20032726|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032727|NCT02705716|Fluorides|fluorides|mesh-list
20032728|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
20032729|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
20032730|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
20293082|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
20293083|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746088|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746089|NCT04465487|Cemiplimab|cemiplimab|mesh-list
19746090|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746091|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746092|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
19746093|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746094|NCT04419519|Venetoclax|venetoclax|mesh-list
19746095|NCT04419519|Antibodies|antibodies|mesh-list
19746096|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19746097|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
19746098|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746099|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746100|NCT04394117|Losartan|losartan|mesh-list
19746101|NCT04394117|Valsartan|valsartan|mesh-list
20032731|NCT02705716|Protective Agents|protective agents|mesh-ancestor
20293084|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20293085|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19746102|NCT04394117|Telmisartan|telmisartan|mesh-list
19746103|NCT04394117|Candesartan|candesartan|mesh-list
20032732|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032733|NCT02705807|Epoprostenol|epoprostenol|mesh-list
20032734|NCT02705807|Tezosentan|tezosentan|mesh-list
20032735|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20032736|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20032737|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
20032738|NCT02706249|Enoxaparin|enoxaparin|mesh-list
20032739|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
20032740|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20032741|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20032742|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032743|NCT02706483|Plecanatide|plecanatide|mesh-list
20032744|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20032745|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
20032746|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032747|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20032748|NCT02706873|Methotrexate|methotrexate|mesh-list
20032749|NCT02706873|Upadacitinib|upadacitinib|mesh-list
20032750|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20032751|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
20032752|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20032753|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032754|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20032755|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
20032756|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032757|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032758|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032759|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032760|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20032761|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032762|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
20032763|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032764|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20032765|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20032766|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20032767|NCT02706899|Azacitidine|azacitidine|mesh-list
20032768|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20032769|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
20032770|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032771|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032772|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032773|NCT02706951|Methotrexate|methotrexate|mesh-list
20032774|NCT02706951|Upadacitinib|upadacitinib|mesh-list
20032775|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20032776|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
19746104|NCT04394117|Olmesartan|olmesartan|mesh-list
19746105|NCT04394117|Irbesartan|irbesartan|mesh-list
19746106|NCT04394117|Eprosartan|eprosartan|mesh-list
19746107|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19746108|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19746109|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19746110|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746111|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19746112|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
19746113|NCT04393753|Avelumab|avelumab|mesh-list
19746114|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746115|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749268|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749269|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749270|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19749271|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749272|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19749273|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19749274|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749275|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749276|NCT05201248|Growth Substances|growth substances|mesh-ancestor
19749277|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749278|NCT05188677|Vaccines|vaccines|mesh-list
19749279|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
19749280|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032777|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576499|NCT02071615|Methylphenidate|methylphenidate|mesh-list
20032778|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032779|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20032780|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
20032781|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032782|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032783|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032784|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032785|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20032786|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20032787|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
20032788|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032789|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20032790|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20032791|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20032792|NCT02707523|Azithromycin|azithromycin|mesh-list
20032793|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20032794|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032795|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
20032796|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20032797|NCT02707601|Ledipasvir|ledipasvir|mesh-list
20032798|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20032799|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
20032800|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032801|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20032802|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20032803|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
20032804|NCT02707640|Pirfenidone|pirfenidone|mesh-list
20032805|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20032806|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
20032807|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032808|NCT02707640|Expectorants|expectorants|mesh-ancestor
20032809|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
20032810|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20032811|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
20032812|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032813|NCT02707640|Protective Agents|protective agents|mesh-ancestor
20032814|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032815|NCT02707640|Antidotes|antidotes|mesh-ancestor
20032816|NCT02707640|Analgesics|analgesics|mesh-ancestor
20032817|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
20032818|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032819|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20032820|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032821|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032822|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20032823|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032824|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20032825|NCT02707757|Hematinics|hematinics|mesh-ancestor
20032826|NCT02707861|Ibalizumab|ibalizumab|mesh-list
20032827|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20032828|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
20032829|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032830|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20032831|NCT02707952|Ritonavir|ritonavir|mesh-list
20032832|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20032833|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20032834|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
20032835|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032836|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032837|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20032838|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20032839|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
20032840|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032841|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20032842|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20032843|NCT02707965|Topiramate|topiramate|mesh-list
20032844|NCT02707965|Lamotrigine|lamotrigine|mesh-list
20032845|NCT02707965|Zonisamide|zonisamide|mesh-list
20032846|NCT02707965|Carbamazepine|carbamazepine|mesh-list
20032847|NCT02707965|Phenytoin|phenytoin|mesh-list
20032848|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
20032849|NCT02707965|Levetiracetam|levetiracetam|mesh-list
20032850|NCT02707965|Valproic Acid|valproic acid|mesh-list
20032851|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
20032852|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20032853|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032854|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
20032855|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20032856|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032857|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032858|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20032859|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20032860|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20032861|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032862|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20032863|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20032864|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
20032865|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20032866|NCT02707965|Analgesics|analgesics|mesh-ancestor
20032867|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
20032868|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032869|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20032870|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20032871|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032872|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
20032873|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032874|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20032875|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20032876|NCT02708238|Simethicone|simethicone|mesh-list
20032877|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
20032878|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032879|NCT02708238|Emollients|emollients|mesh-ancestor
20032880|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
20032881|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
20032882|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20032883|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032884|NCT02708355|Esomeprazole|esomeprazole|mesh-list
20032885|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20032886|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20032887|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20032888|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032889|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032890|NCT02708433|Lidocaine|lidocaine|mesh-list
20032891|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
20032892|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
20032893|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032894|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032895|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
20032896|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032897|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20032898|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20032899|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20032900|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032901|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032902|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
20032903|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20032904|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032905|NCT02709005|Monolaurin|monolaurin|mesh-list
20032906|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
20032907|NCT02709005|Protective Agents|protective agents|mesh-ancestor
20032908|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032909|NCT02709018|Losartan|losartan|mesh-list
20032910|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20032911|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20032912|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20032913|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20032914|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032915|NCT02709109|Ivacaftor|ivacaftor|mesh-list
20032916|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20032917|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032918|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032919|NCT02709486|Tanezumab|tanezumab|mesh-list
20032920|NCT02709486|Analgesics|analgesics|mesh-ancestor
20032921|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
20032922|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032923|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032924|NCT02709746|Vortioxetine|vortioxetine|mesh-list
20032925|NCT02709746|Fluoxetine|fluoxetine|mesh-list
20032926|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20032927|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20576500|NCT02071615|Caffeine|caffeine|mesh-list
20032928|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032929|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032930|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032931|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
20032932|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032933|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20032934|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
20032935|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20032936|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20032937|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20032938|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032939|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20032940|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20032941|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032942|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20032943|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20032944|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20032945|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20032946|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
20032947|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20032948|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20032949|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
20032950|NCT02709889|Dexamethasone|dexamethasone|mesh-list
20032951|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20032952|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
20032953|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
20032954|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032955|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032956|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20032957|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
20032958|NCT02709889|Hormones|hormones|mesh-ancestor
20032959|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032960|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20032961|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20032962|NCT02710045|Vaccines|vaccines|mesh-list
20032963|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
20032964|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032965|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20032966|NCT02710071|Nebivolol|nebivolol|mesh-list
20032967|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20032968|NCT02710071|Diuretics|diuretics|mesh-ancestor
20032969|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
20032970|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032971|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20032972|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20032973|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032974|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
20032975|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20032976|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20032977|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20032978|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
20032979|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20032980|NCT02710214|Estrogens|estrogens|mesh-list
20032981|NCT02710214|Hormones|hormones|mesh-ancestor
20032982|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20032983|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032984|NCT02710526|Buprenorphine|buprenorphine|mesh-list
20032985|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20032986|NCT02710526|Narcotics|narcotics|mesh-ancestor
20032987|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20032988|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20032989|NCT02710526|Analgesics|analgesics|mesh-ancestor
20032990|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
20032991|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20032992|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20032993|NCT02710630|Dabigatran|dabigatran|mesh-list
20032994|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
20032995|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20032996|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
20032997|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20032998|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20032999|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
20033000|NCT02710669|Propafenone|propafenone|mesh-list
20033001|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20033002|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20033003|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20033004|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033005|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116195|NCT00005668|Itraconazole|itraconazole|mesh-list
20116196|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
20116197|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116198|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20116199|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20116200|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116201|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116202|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20116203|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
20116204|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116205|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116206|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20116207|NCT00005673|Capravirine|capravirine|mesh-list
20116208|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20116209|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116210|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116211|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116212|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
20116213|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116214|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20116215|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20116216|NCT00005684|Heparin|heparin|mesh-list
20116217|NCT00005684|Warfarin|warfarin|mesh-list
20116218|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
20116219|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20116220|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20116221|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116222|NCT00005762|Ritonavir|ritonavir|mesh-list
20116223|NCT00005762|Nelfinavir|nelfinavir|mesh-list
20116224|NCT00005762|Indinavir|indinavir|mesh-list
20116225|NCT00005762|Saquinavir|saquinavir|mesh-list
20116226|NCT00005762|Amprenavir|amprenavir|mesh-list
20116227|NCT00005762|Efavirenz|efavirenz|mesh-list
20116228|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20116229|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20116230|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
20116231|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116232|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116233|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20116234|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20116235|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
20116236|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116237|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20116238|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20116239|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20116240|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116241|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20116242|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20116243|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20116244|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20116245|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20116246|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20116247|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
20116248|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20116249|NCT00005764|Lamivudine|lamivudine|mesh-list
20116250|NCT00005764|Zidovudine|zidovudine|mesh-list
20116251|NCT00005764|Abacavir|abacavir|mesh-list
20116252|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20116253|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20116254|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116255|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116256|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116257|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
20116258|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116259|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20116260|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20116261|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
20116262|NCT00005765|Nicotine|nicotine|mesh-list
20116263|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20033006|NCT02710890|Lacosamide|lacosamide|mesh-list
20033007|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
20033008|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20033009|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20033010|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033011|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033012|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
20033013|NCT02710981|Clomiphene|clomiphene|mesh-list
20033014|NCT02710981|Enclomiphene|enclomiphene|mesh-list
20033015|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
20033016|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033017|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
20033018|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20033019|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20033020|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033021|NCT02710981|Urological Agents|urological agents|mesh-ancestor
20033022|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20033023|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
20033024|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033025|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033026|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20033027|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
20033028|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20033029|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20033030|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20033031|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20033032|NCT02711306|Cathartics|cathartics|mesh-ancestor
20033033|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033034|NCT02711553|Gemcitabine|gemcitabine|mesh-list
20033035|NCT02711553|Ramucirumab|ramucirumab|mesh-list
20033036|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033037|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20033038|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
20033039|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033040|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
20033041|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033042|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033043|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033044|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
20033045|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033046|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20033047|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
20033048|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20033049|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033050|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033051|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
20033052|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033053|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033054|NCT02711995|Laxatives|laxatives|mesh-ancestor
20033055|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033056|NCT02712008|Aflibercept|aflibercept|mesh-list
20033057|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20033058|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20033059|NCT02712008|Growth Substances|growth substances|mesh-ancestor
20033060|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033061|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
20033062|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033063|NCT02712047|Fluticasone|fluticasone|mesh-list
20033064|NCT02712047|Xhance|xhance|mesh-list
20033065|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033066|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20033067|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
20033068|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033069|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033070|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20033071|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
20033072|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
20033073|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20033074|NCT02712788|Milrinone|milrinone|mesh-list
20033075|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20033076|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20033077|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
20033078|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20033079|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20033080|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033081|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033082|NCT02712788|Protective Agents|protective agents|mesh-ancestor
20033083|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033084|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20033085|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20033086|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033087|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20033088|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20033089|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033090|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033091|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
20033092|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033093|NCT02713178|Bupivacaine|bupivacaine|mesh-list
20033094|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
20033095|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
20033096|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033097|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033098|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
20033099|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033100|NCT02713204|Aflibercept|aflibercept|mesh-list
20033101|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20033102|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20033103|NCT02713204|Growth Substances|growth substances|mesh-ancestor
20033104|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033105|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
20033106|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033107|NCT02713230|Bupivacaine|bupivacaine|mesh-list
20033108|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
20033109|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
20033110|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033111|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033112|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
20033113|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033114|NCT02713490|Bupivacaine|bupivacaine|mesh-list
20033115|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
20033116|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
20033117|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033118|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033119|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
20033120|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033121|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
20033122|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033123|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033124|NCT02713698|Propofol|propofol|mesh-list
20033125|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20033126|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033127|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033128|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20033129|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
20033130|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
20033131|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
20033132|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20033133|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033134|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033135|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
20033136|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033137|NCT02714283|Azithromycin|azithromycin|mesh-list
20033138|NCT02714283|Erythromycin|erythromycin|mesh-list
20033139|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20033140|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033141|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033142|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20033143|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033144|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033145|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20033146|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20033147|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20033148|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033149|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033150|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033151|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033152|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20033153|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
20033154|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20033155|NCT02714504|Voriconazole|voriconazole|mesh-list
20033156|NCT02714504|Posaconazole|posaconazole|mesh-list
20033157|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
20033158|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033159|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20033160|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20033161|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033162|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033163|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20033164|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
20033165|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033166|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033167|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20033168|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20033169|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20033170|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20033171|NCT02714569|Atorvastatin|atorvastatin|mesh-list
20033172|NCT02714569|Simvastatin|simvastatin|mesh-list
20033173|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20033174|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20033175|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
20033176|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033177|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20033178|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20033179|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033180|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
20033181|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20033182|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033183|NCT02715700|Methadone|methadone|mesh-list
20033184|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20033185|NCT02715700|Narcotics|narcotics|mesh-ancestor
20033186|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033187|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033188|NCT02715700|Analgesics|analgesics|mesh-ancestor
20033189|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
20033190|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033191|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
20033192|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
20033193|NCT02715726|Atorvastatin|atorvastatin|mesh-list
20033194|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20033195|NCT02715726|Simvastatin|simvastatin|mesh-list
20033196|NCT02715726|Ezetimibe|ezetimibe|mesh-list
20033197|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20033198|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20033199|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20033200|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
20033201|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033202|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20033203|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20033204|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033205|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
20033206|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033207|NCT02715804|Gemcitabine|gemcitabine|mesh-list
20033208|NCT02715804|Paclitaxel|paclitaxel|mesh-list
20033209|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20033210|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033211|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
20033212|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
20033213|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
20033214|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033215|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20033216|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
20033217|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
20033218|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033219|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033220|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033221|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
20033222|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033223|NCT02716194|Factor VIII|factor viii|mesh-list
20033224|NCT02716194|Coagulants|coagulants|mesh-ancestor
20033225|NCT02716779|Interferons|interferons|mesh-list
20033226|NCT02716779|Ribavirin|ribavirin|mesh-list
20033227|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033228|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
20033229|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033230|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
20033231|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033232|NCT02716805|Melphalan|melphalan|mesh-list
20033233|NCT02716805|Durvalumab|durvalumab|mesh-list
20033234|NCT02716805|Tremelimumab|tremelimumab|mesh-list
20033235|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20033236|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
20033237|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033238|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033239|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20033240|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033241|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
20033242|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033243|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033244|NCT02716818|Dexamethasone|dexamethasone|mesh-list
20033245|NCT02716818|Prednisone|prednisone|mesh-list
20033246|NCT02716818|Prednisolone|prednisolone|mesh-list
20033247|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
20033248|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20033249|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20033250|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20033251|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
20033252|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033253|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
20033254|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
20033255|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033256|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033257|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033258|NCT02716818|Hormones|hormones|mesh-ancestor
20033259|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033260|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20033261|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033262|NCT02717195|Olanzapine|olanzapine|mesh-list
20033263|NCT02717195|Risperidone|risperidone|mesh-list
20033264|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20033265|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
20033266|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033267|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033268|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033269|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20033270|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20033271|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033272|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20033273|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20033274|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
20033275|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
20033276|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
20033277|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033278|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033279|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20033280|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20033281|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033282|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20033283|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20033284|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033285|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
20033286|NCT02717754|Oseltamivir|oseltamivir|mesh-list
20033287|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
20033288|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033289|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033290|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033291|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20033292|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20033293|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20033294|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033295|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033296|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
20033297|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033298|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033299|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20033300|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033301|NCT02718326|Aflibercept|aflibercept|mesh-list
20033302|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20033303|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20033304|NCT02718326|Growth Substances|growth substances|mesh-ancestor
20033305|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033306|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
20033307|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033308|NCT02718417|Paclitaxel|paclitaxel|mesh-list
20033309|NCT02718417|Carboplatin|carboplatin|mesh-list
20033310|NCT02718417|Avelumab|avelumab|mesh-list
20033311|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20033312|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20033313|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033314|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
20033315|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
20033316|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
20033317|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033318|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033319|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
20033320|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033321|NCT02718898|Ixekizumab|ixekizumab|mesh-list
20033322|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
20033323|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
20033324|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20033325|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033326|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20033327|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20033328|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033329|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033330|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033331|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20033332|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20033333|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20033334|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
20033335|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033336|NCT02720081|Albuterol|albuterol|mesh-list
20033337|NCT02720081|Montelukast|montelukast|mesh-list
20033338|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20033339|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
20033340|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20033341|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
20033342|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033343|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033344|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20033345|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20033346|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033347|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20033348|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
20033349|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033350|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
20033351|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20033352|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20033353|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20033354|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20033355|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
20033356|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033357|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20033358|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20033359|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033360|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033361|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
20033362|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033363|NCT02720198|Milnacipran|milnacipran|mesh-list
20033364|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20033365|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
20033366|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
20033367|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20033368|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20033369|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20033370|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033371|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033372|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20033373|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20116264|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
20576501|NCT02071615|Modafinil|modafinil|mesh-list
20033374|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033375|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033376|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033377|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20033378|NCT02720198|Analgesics|analgesics|mesh-ancestor
20033379|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
20033380|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033381|NCT02720484|Nivolumab|nivolumab|mesh-list
20033382|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033383|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033384|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20033385|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033386|NCT02720523|Upadacitinib|upadacitinib|mesh-list
20033387|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20293086|NCT04771741|Acetaminophen|acetaminophen|mesh-list
20033388|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20033389|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033390|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033391|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20033392|NCT02720536|Deferasirox|deferasirox|mesh-list
20033393|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20033394|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
20033395|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
20033396|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033397|NCT02721017|Fentanyl|fentanyl|mesh-list
20033398|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20033399|NCT02721017|Narcotics|narcotics|mesh-ancestor
20033400|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033401|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033402|NCT02721017|Analgesics|analgesics|mesh-ancestor
20033403|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
20033404|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033405|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20033406|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20033407|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
20033408|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
20033409|NCT02721641|Trastuzumab|trastuzumab|mesh-list
20033410|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033411|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116265|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116266|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116267|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20116268|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20116269|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
20116270|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20116271|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116272|NCT00005768|Estrogens|estrogens|mesh-list
20116273|NCT00005768|Hormones|hormones|mesh-ancestor
20116274|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116275|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116276|NCT00005769|Hormones|hormones|mesh-list
20116277|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116278|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120658|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120659|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
20120660|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120661|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
20120662|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120663|NCT00006385|Interferons|interferons|mesh-list
20120664|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
20120665|NCT00006385|Sargramostim|sargramostim|mesh-list
20120666|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
20120667|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120668|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
20120669|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120670|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
20120671|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120672|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20120673|NCT00006386|Carmustine|carmustine|mesh-list
20120674|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120675|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
20120676|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293087|NCT04771741|Ketorolac|ketorolac|mesh-list
20293088|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20033412|NCT02721875|Azacitidine|azacitidine|mesh-list
20033413|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20033414|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
20033415|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033416|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033417|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033418|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20033419|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
20033420|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033421|NCT02722044|Adalimumab|adalimumab|mesh-list
20033422|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033423|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20033424|NCT02722239|Metformin|metformin|mesh-list
20033425|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
20033426|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20033427|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033428|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20033429|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033430|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
20033431|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20033432|NCT02722278|Testosterone|testosterone|mesh-list
20033433|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
20033434|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
20033435|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20033436|NCT02722278|Androgens|androgens|mesh-ancestor
20033437|NCT02722278|Hormones|hormones|mesh-ancestor
20033438|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033439|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033440|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20033441|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033442|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
20033443|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
20033444|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20033445|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033446|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033447|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20033448|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20033449|NCT02722564|Ethanol|ethanol|mesh-list
20033450|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20033451|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033452|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033453|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033454|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
20033455|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20033456|NCT02722837|Velpatasvir|velpatasvir|mesh-list
20033457|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
20033458|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033459|NCT02722967|Aripiprazole|aripiprazole|mesh-list
20033460|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
20033461|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20033462|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20033463|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20033464|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033465|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033466|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
20033467|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
20033468|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033469|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033470|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20033471|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20033472|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
20033473|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20033474|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20033475|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20033476|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20033477|NCT02723006|Nivolumab|nivolumab|mesh-list
20033478|NCT02723006|Ipilimumab|ipilimumab|mesh-list
20033479|NCT02723006|Vedolizumab|vedolizumab|mesh-list
20033480|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033481|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033482|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20033483|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033484|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033485|NCT02723084|Ribavirin|ribavirin|mesh-list
20033486|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
20033487|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
20033488|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033489|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
20033490|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033491|NCT02723591|Tacrolimus|tacrolimus|mesh-list
20033492|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033493|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
20033494|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033495|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20033496|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033497|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033498|NCT02723630|Lenvatinib|lenvatinib|mesh-list
20033499|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033500|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20033501|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033502|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033503|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
20033504|NCT02723786|Azathioprine|azathioprine|mesh-list
20033505|NCT02723786|Tacrolimus|tacrolimus|mesh-list
20033506|NCT02723786|Basiliximab|basiliximab|mesh-list
20033507|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033508|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
20033509|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033510|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20033511|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033512|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033513|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20033514|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033515|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20033516|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
20293089|NCT04771741|Meloxicam|meloxicam|mesh-list
20293090|NCT04771741|Pregabalin|pregabalin|mesh-list
20293091|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
20293092|NCT04771741|Analgesics|analgesics|mesh-ancestor
20293093|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
20293094|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293095|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293096|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
20293097|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20293098|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293099|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293100|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20293101|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20293102|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20293103|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293104|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20293105|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20293106|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20293107|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293108|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20293109|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20293110|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293111|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
20293112|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20293113|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20293114|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
20293115|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20293116|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20293117|NCT04765059|Cisplatin|cisplatin|mesh-list
20293118|NCT04765059|Carboplatin|carboplatin|mesh-list
20293119|NCT04765059|Pemetrexed|pemetrexed|mesh-list
20293120|NCT04765059|Osimertinib|osimertinib|mesh-list
20293121|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293122|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293123|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293124|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20293125|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20293126|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293127|NCT04763759|Antibodies|antibodies|mesh-list
20033517|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20033518|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033519|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
20293128|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20293129|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
20116279|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
20293130|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033520|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20033521|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20033522|NCT02724020|Everolimus|everolimus|mesh-list
20033523|NCT02724020|Serabelisib|serabelisib|mesh-list
20033524|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033525|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033526|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
20033527|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033528|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033529|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033530|NCT02724033|Dexamethasone|dexamethasone|mesh-list
20033531|NCT02724033|Ondansetron|ondansetron|mesh-list
20033532|NCT02724033|Antiemetics|antiemetics|mesh-list
20033533|NCT02724033|Bupivacaine|bupivacaine|mesh-list
20033534|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033535|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
20033536|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033537|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033538|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033539|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
20033540|NCT02724033|Hormones|hormones|mesh-ancestor
20033541|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033542|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20033543|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033544|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033545|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
20033546|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
20033547|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033548|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
20033549|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
20033550|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
20033551|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20033552|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
20033553|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033554|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20033555|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20033556|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20033557|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20033558|NCT02724111|Rocuronium|rocuronium|mesh-list
20033559|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20033560|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20033561|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20033562|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033563|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033564|NCT02724423|Diazepam|diazepam|mesh-list
20033565|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20033566|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
20033567|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
20033568|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
20033569|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033570|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033571|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033572|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20033573|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033574|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20033575|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20033576|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20033577|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20033578|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20033579|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20033580|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
20033581|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
20033582|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
20033583|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
20033584|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033585|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033586|NCT02724592|Fluorides|fluorides|mesh-list
20033587|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
20033588|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
20033589|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
20033590|NCT02724592|Protective Agents|protective agents|mesh-ancestor
20033591|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033592|NCT02725008|Dexamethasone|dexamethasone|mesh-list
20033593|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033594|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
20033595|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
20033596|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033597|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033598|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033599|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
20033600|NCT02725008|Hormones|hormones|mesh-ancestor
20033601|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033602|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20033603|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033604|NCT02725268|Paclitaxel|paclitaxel|mesh-list
20033605|NCT02725268|Serabelisib|serabelisib|mesh-list
20033606|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20033607|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033608|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
20033609|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
20033610|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
20033611|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033612|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033613|NCT02725411|Celecoxib|celecoxib|mesh-list
20033614|NCT02725411|Tanezumab|tanezumab|mesh-list
20033615|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20033616|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20033617|NCT02725411|Analgesics|analgesics|mesh-ancestor
20033618|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
20033619|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033620|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033621|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033622|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20033623|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20033624|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20033625|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033626|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033627|NCT02725710|Gabapentin|gabapentin|mesh-list
20033628|NCT02725710|Analgesics|analgesics|mesh-ancestor
20033629|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
20033630|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033631|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033632|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
20033633|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20033634|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20033635|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033636|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20033637|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20033638|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20033639|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033640|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033641|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
20033642|NCT02725866|Ritonavir|ritonavir|mesh-list
20033643|NCT02725866|Ribavirin|ribavirin|mesh-list
20033644|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20033645|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20033646|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
20033647|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033648|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033649|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20033650|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20033651|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
20033652|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033653|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20033654|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20033655|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
20033656|NCT02726022|Ribavirin|ribavirin|mesh-list
20033657|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20033658|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
20033659|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033660|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
20033661|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033662|NCT02726113|Vitamin D|vitamin d|mesh-list
20033663|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
20033664|NCT02726113|Vitamins|vitamins|mesh-ancestor
20033665|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
20033666|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033667|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20033668|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20033669|NCT02726178|Ibuprofen|ibuprofen|mesh-list
20033670|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20033671|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20033672|NCT02726178|Analgesics|analgesics|mesh-ancestor
20033673|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
20033674|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033675|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033676|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033677|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20033678|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20033679|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033680|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033681|NCT02726620|Lidocaine|lidocaine|mesh-list
20033682|NCT02726620|Atropine|atropine|mesh-list
20033683|NCT02726620|Terlipressin|terlipressin|mesh-list
20033684|NCT02726620|Phenylephrine|phenylephrine|mesh-list
20033685|NCT02726620|Dobutamine|dobutamine|mesh-list
20033686|NCT02726620|Dopamine|dopamine|mesh-list
20033687|NCT02726620|Milrinone|milrinone|mesh-list
20033688|NCT02726620|Isoproterenol|isoproterenol|mesh-list
20033689|NCT02726620|Vasopressins|vasopressins|mesh-list
20033690|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
20033691|NCT02726620|Epinephrine|epinephrine|mesh-list
20033692|NCT02726620|Norepinephrine|norepinephrine|mesh-list
20033693|NCT02726620|Ephedrine|ephedrine|mesh-list
20033694|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
20033695|NCT02726620|Bupivacaine|bupivacaine|mesh-list
20033696|NCT02726620|Ropivacaine|ropivacaine|mesh-list
20033697|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
20033698|NCT02726620|Tetracaine|tetracaine|mesh-list
20033699|NCT02726620|Prilocaine|prilocaine|mesh-list
20033700|NCT02726620|Mepivacaine|mepivacaine|mesh-list
20033701|NCT02726620|Benzocaine|benzocaine|mesh-list
20033702|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
20033703|NCT02726620|Procaine|procaine|mesh-list
20033704|NCT02726620|Anesthetics|anesthetics|mesh-list
20033705|NCT02726620|Propofol|propofol|mesh-list
20033706|NCT02726620|Sevoflurane|sevoflurane|mesh-list
20033707|NCT02726620|Desflurane|desflurane|mesh-list
20033708|NCT02726620|Isoflurane|isoflurane|mesh-list
20033709|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20033710|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
20033711|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
20033712|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20033713|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033714|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
20033715|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033716|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20033717|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20033718|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20033719|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033720|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033721|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20033722|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20033723|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
20033724|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20033725|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20033726|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20033727|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20033728|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
20033729|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033730|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20033731|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20033732|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
20033733|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20033734|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
20033735|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
20033736|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
20033737|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20033738|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20033739|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
20033740|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20033741|NCT02726620|Protective Agents|protective agents|mesh-ancestor
20033742|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20033743|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
20033744|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20033745|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20033746|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
20033747|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
20033748|NCT02726620|Coagulants|coagulants|mesh-ancestor
20033749|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20033750|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
20033751|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20033752|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20033753|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20033754|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
20033755|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
20033756|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20033757|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20033758|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033759|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20033760|NCT02726789|Interferons|interferons|mesh-list
20033761|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
20033762|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
20033763|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20033764|NCT02726789|Entecavir|entecavir|mesh-list
20033765|NCT02726789|REP 2139|rep 2139|mesh-list
20033766|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033767|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
20033768|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033769|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
20033770|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033771|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
20033772|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20033773|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033774|NCT02727322|Renal Agents|renal agents|mesh-ancestor
20033775|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20033776|NCT02727660|Budesonide|budesonide|mesh-list
20033777|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
20033778|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033779|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20033780|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
20033781|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033782|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033783|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20033784|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
20033785|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
20033786|NCT02727660|Hormones|hormones|mesh-ancestor
20033787|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033788|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20033789|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20033790|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20033791|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
20033792|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033793|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033794|NCT02728089|Tazobactam|tazobactam|mesh-list
20033795|NCT02728089|Ceftolozane|ceftolozane|mesh-list
20033796|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20033797|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033798|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20033799|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033800|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033801|NCT02728102|Lenalidomide|lenalidomide|mesh-list
20033802|NCT02728102|Melphalan|melphalan|mesh-list
20033803|NCT02728102|Molgramostim|molgramostim|mesh-list
20033804|NCT02728102|Vaccines|vaccines|mesh-list
20033805|NCT02728102|Sargramostim|sargramostim|mesh-list
20033806|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
20033807|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033808|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20033809|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20293131|NCT04739592|Vitamin D|vitamin d|mesh-list
20033810|NCT02728102|Growth Substances|growth substances|mesh-ancestor
20033811|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
20033812|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033813|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20293132|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
20033814|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
20033815|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033816|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20033817|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20033818|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
20033819|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20033820|NCT02728206|Velpatasvir|velpatasvir|mesh-list
20033821|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
20033822|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033823|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
20033824|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033825|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033826|NCT02728895|Vedolizumab|vedolizumab|mesh-list
20033827|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033828|NCT02729025|Evolocumab|evolocumab|mesh-list
20033829|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20033830|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20033831|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
20033832|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033833|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20033834|NCT02729051|Albuterol|albuterol|mesh-list
20033835|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20033836|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
20033837|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033838|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033839|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20033840|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
20033841|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
20033842|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20033843|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20033844|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20033845|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20033846|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
20033847|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033848|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033849|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
20033850|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20033851|NCT02729545|Cyproterone|cyproterone|mesh-list
20033852|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20033853|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20033854|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20033855|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
20033856|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20033857|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033858|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20033859|NCT02729545|Estrogens|estrogens|mesh-ancestor
20033860|NCT02729545|Hormones|hormones|mesh-ancestor
20033861|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033862|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
20033863|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
20033864|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033865|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20033866|NCT02729896|Rituximab|rituximab|mesh-list
20033867|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
20033868|NCT02729896|Atezolizumab|atezolizumab|mesh-list
20033869|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033870|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033871|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
20033872|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033873|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20033874|NCT02729909|Lubiprostone|lubiprostone|mesh-list
20033875|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20033876|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033877|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033878|NCT02730195|Pioglitazone|pioglitazone|mesh-list
20033879|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20033880|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033881|NCT02730208|Ivacaftor|ivacaftor|mesh-list
20033882|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20033883|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20033884|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033885|NCT02730247|Paclitaxel|paclitaxel|mesh-list
20033886|NCT02730247|Ramucirumab|ramucirumab|mesh-list
20033887|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20033888|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033889|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
20033890|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
20033891|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
20033892|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033893|NCT02730351|Fluticasone|fluticasone|mesh-list
20033894|NCT02730351|Xhance|xhance|mesh-list
20033895|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20033896|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20033897|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
20033898|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20033899|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033900|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20033901|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
20033902|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
20033903|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20033904|NCT02730377|Liraglutide|liraglutide|mesh-list
20033905|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20033906|NCT02730377|Meglitinide|meglitinide|mesh-list
20033907|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20033908|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20033909|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
20033910|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20033911|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033912|NCT02730377|Incretins|incretins|mesh-ancestor
20033913|NCT02730377|Hormones|hormones|mesh-ancestor
20033914|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033915|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033916|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
20033917|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033918|NCT02730455|Natalizumab|natalizumab|mesh-list
20033919|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
20033920|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033921|NCT02730871|Timolol|timolol|mesh-list
20033922|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20033923|NCT02730871|Travoprost|travoprost|mesh-list
20033924|NCT02730871|Brinzolamide|brinzolamide|mesh-list
20033925|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20033926|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20033927|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
20033928|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20033929|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033930|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033931|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20033932|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20033933|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20033934|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20033935|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20033936|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20033937|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033938|NCT02730884|ON 01910|on 01910|mesh-list
20033939|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033940|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20033941|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033942|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033943|NCT02730962|Vancomycin|vancomycin|mesh-list
20033944|NCT02730962|Clindamycin|clindamycin|mesh-list
20033945|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
20033946|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
20033947|NCT02730962|Neomycin|neomycin|mesh-list
20033948|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20033949|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033950|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20033951|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033952|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033953|NCT02731131|Ribavirin|ribavirin|mesh-list
20033954|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20033955|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
20033956|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033957|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
20033958|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116280|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20116281|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
20116282|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116283|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116284|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20033959|NCT02731313|Trastuzumab|trastuzumab|mesh-list
20033960|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033961|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033962|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
20033963|NCT02731469|Hematinics|hematinics|mesh-ancestor
20033964|NCT02731638|Voriconazole|voriconazole|mesh-list
20033965|NCT02731638|Natamycin|natamycin|mesh-list
20033966|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
20033967|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20033968|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20033969|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20033970|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20033971|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033972|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20033973|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
20033974|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20033975|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033976|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20033977|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20033978|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20033979|NCT02731729|Nivolumab|nivolumab|mesh-list
20033980|NCT02731729|Ipilimumab|ipilimumab|mesh-list
20033981|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20033982|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20033983|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20033984|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033985|NCT02731820|Vitamin D|vitamin d|mesh-list
20033986|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
20033987|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
20033988|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
20033989|NCT02731820|Calcium|calcium|mesh-list
20033990|NCT02731820|Vitamins|vitamins|mesh-ancestor
20033991|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
20033992|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20033993|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20033994|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20033995|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20033996|NCT02731820|Antacids|antacids|mesh-ancestor
20033997|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20033998|NCT02731820|Diuretics|diuretics|mesh-ancestor
20033999|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
20034000|NCT02731820|Expectorants|expectorants|mesh-ancestor
20034001|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034002|NCT02731833|Fluorides|fluorides|mesh-list
20034003|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
20034004|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
20034005|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
20034006|NCT02731833|Protective Agents|protective agents|mesh-ancestor
20034007|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034008|NCT02732015|Dexamethasone|dexamethasone|mesh-list
20034009|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
20034010|NCT02732015|Doxorubicin|doxorubicin|mesh-list
20034011|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20034012|NCT02732015|Vincristine|vincristine|mesh-list
20034013|NCT02732015|Daunorubicin|daunorubicin|mesh-list
20034014|NCT02732015|Ifosfamide|ifosfamide|mesh-list
20034015|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
20034016|NCT02732015|Ondansetron|ondansetron|mesh-list
20034017|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
20034018|NCT02732015|Aprepitant|aprepitant|mesh-list
20034019|NCT02732015|BB 1101|bb 1101|mesh-list
20034020|NCT02732015|Rolapitant|rolapitant|mesh-list
20034021|NCT02732015|Mesna|mesna|mesh-list
20034022|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034023|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
20034024|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
20034025|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034026|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034027|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20034028|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
20034029|NCT02732015|Hormones|hormones|mesh-ancestor
20034030|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034031|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20034032|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034033|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
20034034|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034035|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034036|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20293133|NCT04739592|Alendronate|alendronate|mesh-list
20034037|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20034038|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20034039|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20034040|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
20034041|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
20034042|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
20034043|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
20034044|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
20034045|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20034046|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
20034047|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034048|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20034049|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20034050|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034051|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20034052|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20034053|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20034054|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
20034055|NCT02732015|Protective Agents|protective agents|mesh-ancestor
20034056|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20034057|NCT02732119|Everolimus|everolimus|mesh-list
20034058|NCT02732119|Exemestane|exemestane|mesh-list
20034059|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034060|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20034061|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
20034062|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034063|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20034064|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20034065|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034066|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034067|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20034068|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
20034069|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034070|NCT02732587|Saracatinib|saracatinib|mesh-list
20034071|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034072|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034073|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034074|NCT02732639|Interferons|interferons|mesh-list
20034075|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034076|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
20034077|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034078|NCT02732899|Sirolimus|sirolimus|mesh-list
20034079|NCT02732899|Aflibercept|aflibercept|mesh-list
20034080|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20034081|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034082|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20034083|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034084|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
20034085|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20034086|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
20034087|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034088|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20034089|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20034090|NCT02732899|Growth Substances|growth substances|mesh-ancestor
20034091|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
20034092|NCT02732912|Zopiclone|zopiclone|mesh-list
20034093|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20034094|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034095|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034096|NCT02732938|Gemcitabine|gemcitabine|mesh-list
20034097|NCT02732938|Paclitaxel|paclitaxel|mesh-list
20034098|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20034099|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034100|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
20034101|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
20034102|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
20034103|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034104|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20034105|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
20034106|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
20034107|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034108|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034109|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20034110|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
20034111|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034112|NCT02733588|Glucagon|glucagon|mesh-list
20034113|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20034114|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20034115|NCT02733588|Hormones|hormones|mesh-ancestor
20034116|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034117|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034118|NCT02733588|Incretins|incretins|mesh-ancestor
20034119|NCT02733757|Clonidine|clonidine|mesh-list
20034120|NCT02733757|Analgesics|analgesics|mesh-ancestor
20034121|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
20034122|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034123|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034124|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20034125|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
20034126|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
20034127|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20034128|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20034129|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20034130|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
20034131|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034132|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034133|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
20034134|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
20034135|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034136|NCT02734147|Protective Agents|protective agents|mesh-ancestor
20034137|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034138|NCT02734147|Vitamins|vitamins|mesh-ancestor
20034139|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
20034140|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
20034141|NCT02734238|Testosterone|testosterone|mesh-list
20034142|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
20034143|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
20034144|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20034145|NCT02734238|Androgens|androgens|mesh-ancestor
20034146|NCT02734238|Hormones|hormones|mesh-ancestor
20034147|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034148|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034149|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20034150|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034151|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
20034152|NCT02734355|Amlodipine|amlodipine|mesh-list
20293134|NCT04739592|Vitamins|vitamins|mesh-ancestor
20293135|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
20293136|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293137|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20034153|NCT02734355|Telmisartan|telmisartan|mesh-list
20034154|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20034155|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20034156|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20034157|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034158|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034159|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20034160|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034161|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
20034162|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20034163|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20034164|NCT02734862|Fluconazole|fluconazole|mesh-list
20034165|NCT02734862|Caspofungin|caspofungin|mesh-list
20034166|NCT02734862|Rezafungin|rezafungin|mesh-list
20034167|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
20034168|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034169|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20034170|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20034171|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034172|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034173|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20034174|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
20034175|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034176|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034177|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20034178|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20034179|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
20293138|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20293139|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
20293140|NCT04710277|Narcotics|narcotics|mesh-ancestor
20034180|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20034181|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
20034182|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034183|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034184|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20034185|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034186|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20034187|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
20034188|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034189|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034190|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20034191|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
20034192|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
20034193|NCT02734953|Protective Agents|protective agents|mesh-ancestor
20034194|NCT02735187|Vitamin D|vitamin d|mesh-list
20034195|NCT02735187|Vitamins|vitamins|mesh-ancestor
20034196|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
20034197|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034198|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20034199|NCT02735200|Vitamin D|vitamin d|mesh-list
20034200|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
20034201|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
20034202|NCT02735200|Vitamins|vitamins|mesh-list
20034203|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
20034204|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034205|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20034206|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20034207|NCT02735421|Adapalene|adapalene|mesh-list
20034208|NCT02735421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20034209|NCT02735421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20034210|NCT02735421|Analgesics|analgesics|mesh-ancestor
20034211|NCT02735421|Sensory System Agents|sensory system agents|mesh-ancestor
20034212|NCT02735421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034213|NCT02735421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034214|NCT02735421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034215|NCT02735421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034216|NCT02735421|Dermatologic Agents|dermatologic agents|mesh-ancestor
20034217|NCT02735577|Disulfiram|disulfiram|mesh-list
20034218|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20034219|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20034220|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034221|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034222|NCT02736175|Dexamethasone|dexamethasone|mesh-list
20034223|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034224|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
20034225|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
20034226|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034227|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034228|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20034229|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
20034230|NCT02736175|Hormones|hormones|mesh-ancestor
20034231|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034232|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20034233|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034234|NCT02736409|Budesonide|budesonide|mesh-list
20034235|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034236|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20034237|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
20034238|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034239|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034240|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20034241|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034242|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
20034243|NCT02736409|Hormones|hormones|mesh-ancestor
20034244|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034245|NCT02736474|Naltrexone|naltrexone|mesh-list
20034246|NCT02736474|Bupropion|bupropion|mesh-list
20034247|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20034248|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20034249|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034250|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
20034251|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034252|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20034253|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
20034254|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20034255|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20034256|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20034257|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034258|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034259|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
20034260|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034261|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20034262|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20034263|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034264|NCT02736578|Cetuximab|cetuximab|mesh-list
20034265|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034266|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034267|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20034268|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
20034269|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034270|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
20034271|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20034272|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20034273|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20034274|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034275|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034276|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
20034277|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034278|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034279|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20034280|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034281|NCT02737072|Durvalumab|durvalumab|mesh-list
20034282|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034283|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034284|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
20034285|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034286|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20034287|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034288|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034289|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
20034290|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034291|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034292|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20034293|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
20034294|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20034295|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
20034296|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034297|NCT02737358|Expectorants|expectorants|mesh-ancestor
20034298|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034299|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20034300|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
20034301|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034302|NCT02737358|Protective Agents|protective agents|mesh-ancestor
20034303|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034304|NCT02737358|Antidotes|antidotes|mesh-ancestor
20034305|NCT02737501|Crizotinib|crizotinib|mesh-list
20034306|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034307|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20034308|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034309|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034310|NCT02737826|Buprenorphine|buprenorphine|mesh-list
20034311|NCT02737826|Gabapentin|gabapentin|mesh-list
20034312|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20034313|NCT02737826|Narcotics|narcotics|mesh-ancestor
20034314|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034315|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034316|NCT02737826|Analgesics|analgesics|mesh-ancestor
20034317|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
20034318|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034319|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20034320|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
20034321|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20034322|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20034323|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20034324|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20034325|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20034326|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034327|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034328|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
20034329|NCT02737891|Metoprolol|metoprolol|mesh-list
20034330|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20034331|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20034332|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
20034333|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
20034334|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034335|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034336|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20034337|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20034338|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20034339|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
20034340|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034341|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034342|NCT02737930|Fluoxetine|fluoxetine|mesh-list
20034343|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20034344|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20034345|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034346|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034347|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034348|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
20034349|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034350|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20034351|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
20034352|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20034353|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20293141|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293142|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034354|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20034355|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034356|NCT02738008|Tenofovir|tenofovir|mesh-list
20034357|NCT02738008|Entecavir|entecavir|mesh-list
20034358|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
20034359|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20034360|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
20034361|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034362|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20034363|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20034364|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034365|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034366|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20034367|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20034368|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
20034369|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034370|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034371|NCT02738151|Insulin|insulin|mesh-list
20034372|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20034373|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
20034374|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20034375|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034376|NCT02738203|Lidocaine|lidocaine|mesh-list
20034377|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
20034378|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
20034379|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034380|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034381|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
20034382|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034383|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20034384|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20034385|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20034386|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034387|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034388|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
20034389|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
20034390|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034391|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20034392|NCT02738580|Hormones|hormones|mesh-ancestor
20034393|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034394|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034395|NCT02738879|Metformin|metformin|mesh-list
20034396|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
20034397|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20034398|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20034399|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034400|NCT02738879|Incretins|incretins|mesh-ancestor
20034401|NCT02738879|Hormones|hormones|mesh-ancestor
20034402|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034403|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20034404|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
20034405|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034406|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034407|NCT02739360|Idelalisib|idelalisib|mesh-list
20034408|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034409|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034410|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034411|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
20034412|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
20034413|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20034414|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034415|NCT02739698|Paclitaxel|paclitaxel|mesh-list
20034416|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20034417|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034418|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
20034419|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
20034420|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
20034421|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034422|NCT02739828|Adalimumab|adalimumab|mesh-list
20034423|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034424|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034425|NCT02739984|Evolocumab|evolocumab|mesh-list
20034426|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20034427|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20034428|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20034429|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
20034430|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034431|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20034432|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
20034433|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116285|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
20116286|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20116287|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
20116288|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116289|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20116290|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20116291|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
20116292|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
20116293|NCT00005773|Protective Agents|protective agents|mesh-ancestor
20116294|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20116295|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
20116296|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
20116297|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20116298|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20116299|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
20116300|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20116301|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
20116302|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116303|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116304|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20116305|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
20116306|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20116307|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
20116308|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116309|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20116310|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20116311|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
20116312|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
20116313|NCT00005776|Protective Agents|protective agents|mesh-ancestor
20116314|NCT00005777|Dexamethasone|dexamethasone|mesh-list
20116315|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20116316|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
20116317|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
20116318|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116319|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116320|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20116321|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
20116322|NCT00005777|Hormones|hormones|mesh-ancestor
20116323|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034434|NCT02739997|Metronidazole|metronidazole|mesh-list
20034435|NCT02739997|Tazobactam|tazobactam|mesh-list
20034436|NCT02739997|Ceftolozane|ceftolozane|mesh-list
20034437|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034438|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20034439|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20034440|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20034441|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20034442|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034443|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034444|NCT02740114|Oxycodone|oxycodone|mesh-list
20034445|NCT02740114|Bupivacaine|bupivacaine|mesh-list
20034446|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
20034447|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
20034448|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034449|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034450|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
20034451|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034452|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20034453|NCT02740114|Narcotics|narcotics|mesh-ancestor
20034454|NCT02740114|Analgesics|analgesics|mesh-ancestor
20034455|NCT02740543|Fluticasone|fluticasone|mesh-list
20034456|NCT02740543|Xhance|xhance|mesh-list
20034457|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034458|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20034459|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
20034460|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034461|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034462|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20034463|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034464|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
20034465|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20034466|NCT02740582|Tolcapone|tolcapone|mesh-list
20034467|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20034468|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20034469|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20034470|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034471|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034472|NCT02740660|Caffeine|caffeine|mesh-list
20034473|NCT02740660|Albuterol|albuterol|mesh-list
20034474|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20034475|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034476|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20034477|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034478|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034479|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20034480|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20034481|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
20034482|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034483|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20034484|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
20034485|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034486|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20034487|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034488|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
20034489|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20034490|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20034491|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20034492|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20034493|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
20034494|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
20034495|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034496|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034497|NCT02741076|Oxymorphone|oxymorphone|mesh-list
20034498|NCT02741076|Morphine|morphine|mesh-list
20034499|NCT02741076|Oxycodone|oxycodone|mesh-list
20034500|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
20034501|NCT02741076|Narcotics|narcotics|mesh-ancestor
20034502|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034503|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034504|NCT02741076|Analgesics|analgesics|mesh-ancestor
20034505|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
20034506|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034507|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20034508|NCT02741310|Sumatriptan|sumatriptan|mesh-list
20034509|NCT02741310|Erenumab|erenumab|mesh-list
20034510|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20034511|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20034512|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20034513|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
20034514|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034515|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034516|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034517|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20034518|NCT02741310|Analgesics|analgesics|mesh-ancestor
20034519|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
20034520|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034521|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20034522|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
20034523|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034524|NCT02741687|Insulin|insulin|mesh-list
20034525|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20034526|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
20034527|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20034528|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
20034529|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
20034530|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
20034531|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20034532|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034533|NCT02741687|Incretins|incretins|mesh-ancestor
20034534|NCT02741687|Hormones|hormones|mesh-ancestor
20034535|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034536|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20034537|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
20034538|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034539|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034540|NCT02741713|Lidocaine|lidocaine|mesh-list
20034541|NCT02741713|Clonidine|clonidine|mesh-list
20034542|NCT02741713|Epinephrine|epinephrine|mesh-list
20034543|NCT02741713|Racepinephrine|racepinephrine|mesh-list
20034544|NCT02741713|Bupivacaine|bupivacaine|mesh-list
20034545|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20034546|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
20034547|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
20034548|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
20034549|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034550|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034551|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
20034552|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034553|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20034554|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20034555|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20034556|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034557|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034558|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20034559|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20034560|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
20034561|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034562|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20034563|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20034564|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
20034565|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20034566|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034567|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
20034568|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
20034569|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20034570|NCT02741713|Analgesics|analgesics|mesh-ancestor
20034571|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20034572|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
20034573|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20034574|NCT02742519|Ivacaftor|ivacaftor|mesh-list
20034575|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20034576|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034577|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034578|NCT02742532|Oxytocin|oxytocin|mesh-list
20034579|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
20034580|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20034581|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034582|NCT02742649|Timolol|timolol|mesh-list
20034583|NCT02742649|Bimatoprost|bimatoprost|mesh-list
20034584|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20034585|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20034586|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20034587|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034588|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034589|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034590|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20034591|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20034592|NCT02742987|Clopidogrel|clopidogrel|mesh-list
20034593|NCT02742987|Ticagrelor|ticagrelor|mesh-list
20034594|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20034595|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20034596|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20034597|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20034598|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
20034599|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034600|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034601|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034602|NCT02743078|Bevacizumab|bevacizumab|mesh-list
20034603|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034604|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034605|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20034606|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20034607|NCT02743078|Growth Substances|growth substances|mesh-ancestor
20034608|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034609|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
20034610|NCT02743221|Trifluridine|trifluridine|mesh-list
20034611|NCT02743221|Bevacizumab|bevacizumab|mesh-list
20034612|NCT02743221|Capecitabine|capecitabine|mesh-list
20034613|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034614|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034615|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20034616|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20034617|NCT02743221|Growth Substances|growth substances|mesh-ancestor
20034618|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034619|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
20034620|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20034621|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
20034622|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034623|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
20034624|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034625|NCT02743377|Rolipram|rolipram|mesh-list
20034626|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
20034627|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20034628|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20034629|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20034630|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034631|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034632|NCT02743780|MGV354|mgv354|mesh-list
20034633|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
20034634|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034635|NCT02743949|Esomeprazole|esomeprazole|mesh-list
20034636|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20034637|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20034638|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20034639|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034640|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034641|NCT02744391|Levodopa|levodopa|mesh-list
20034642|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20034643|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20034644|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
20034645|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034646|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034647|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034648|NCT02744755|Adalimumab|adalimumab|mesh-list
20034649|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034650|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034651|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20034652|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034653|NCT02744898|Paclitaxel|paclitaxel|mesh-list
20034654|NCT02744898|Carboplatin|carboplatin|mesh-list
20034655|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20034656|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20034657|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034658|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
20034659|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
20034660|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
20034661|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034662|NCT02745080|Adalimumab|adalimumab|mesh-list
20034663|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034664|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034665|NCT02745353|Naloxegol|naloxegol|mesh-list
20034666|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20034667|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034668|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
20034669|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034670|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
20034671|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20034672|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20034673|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
20034674|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034675|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034676|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034677|NCT02746575|Metoprolol|metoprolol|mesh-list
20034678|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20034679|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20034680|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
20034681|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
20034682|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034683|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034684|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20034685|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20034686|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20034687|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
20034688|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034689|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034690|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20034691|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034692|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
20034693|NCT02746991|Hormones|hormones|mesh-ancestor
20034694|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034695|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034696|NCT02747004|Tamoxifen|tamoxifen|mesh-list
20034697|NCT02747004|Loperamide|loperamide|mesh-list
20034698|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
20034699|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20034700|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
20034701|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034702|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034703|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20034704|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034705|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20034706|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20034707|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20034708|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20034709|NCT02747043|Rituximab|rituximab|mesh-list
20034710|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034711|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034712|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
20034713|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034714|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034715|NCT02747186|Lidocaine|lidocaine|mesh-list
20034716|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
20034717|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
20034718|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034719|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034720|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
20034721|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034722|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20034723|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20034724|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20034725|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034726|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034727|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
20034728|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20034729|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20034730|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034731|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
20034732|NCT02747615|Coagulants|coagulants|mesh-ancestor
20034733|NCT02747628|Melatonin|melatonin|mesh-list
20034734|NCT02747628|Nicotine|nicotine|mesh-list
20034735|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20034736|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
20034737|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034738|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034739|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20034740|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20034741|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
20034742|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034743|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034744|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
20034745|NCT02747628|Protective Agents|protective agents|mesh-ancestor
20034746|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034747|NCT02747875|Fentanyl|fentanyl|mesh-list
20034748|NCT02747875|Methadone|methadone|mesh-list
20034749|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20034750|NCT02747875|Narcotics|narcotics|mesh-ancestor
20034751|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034752|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034753|NCT02747875|Analgesics|analgesics|mesh-ancestor
20034754|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
20034755|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034756|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20034757|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20034758|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
20034759|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
20034760|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
20034761|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034762|NCT02748070|Fluticasone|fluticasone|mesh-list
20034763|NCT02748070|Prednisone|prednisone|mesh-list
20034764|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034765|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
20034766|NCT02748070|Hormones|hormones|mesh-ancestor
20034767|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034768|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034769|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20034770|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034771|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20034772|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
20034773|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034774|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20034775|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034776|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
20034777|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20034778|NCT02748213|Docetaxel|docetaxel|mesh-list
20034779|NCT02748213|Capecitabine|capecitabine|mesh-list
20034780|NCT02748213|Trastuzumab|trastuzumab|mesh-list
20034781|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034782|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
20034783|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
20034784|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
20034785|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034786|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20034787|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
20034788|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034789|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20034790|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034791|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
20034792|NCT02748512|Hormones|hormones|mesh-ancestor
20034793|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034794|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034795|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
20034796|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20034797|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20034798|NCT02748785|Methotrexate|methotrexate|mesh-list
20034799|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20034800|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
20034801|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20034802|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034803|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20034804|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
20034805|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034806|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034807|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
20034808|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034809|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20034810|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20034811|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
20034812|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034813|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20034814|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20034815|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
20034816|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034817|NCT02748889|Carboplatin|carboplatin|mesh-list
20034818|NCT02748889|Etoposide|etoposide|mesh-list
20034819|NCT02748889|Atezolizumab|atezolizumab|mesh-list
20034820|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034821|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20034822|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20034823|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20034824|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034825|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034826|NCT02749370|Etanercept|etanercept|mesh-list
20034827|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20034828|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20034829|NCT02749370|Analgesics|analgesics|mesh-ancestor
20034830|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
20034831|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20034832|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034833|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034834|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034835|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20034836|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20034837|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
20034838|NCT02749721|Vortioxetine|vortioxetine|mesh-list
20034839|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
20034840|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20034841|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20034842|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20034843|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034844|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034845|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20034846|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20034847|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20034848|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034849|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034850|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
20034851|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20034852|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20034853|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20034854|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20034855|NCT02749799|Betamethasone|betamethasone|mesh-list
20034856|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
20034857|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20034858|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
20034859|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20034860|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034861|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
20034862|NCT02749799|Hormones|hormones|mesh-ancestor
20034863|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034864|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034865|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20034866|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
20034867|NCT02750306|Suvorexant|suvorexant|mesh-list
20034868|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20034869|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20034870|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20034871|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034872|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20034873|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034874|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034875|NCT02750332|Nitisinone|nitisinone|mesh-list
20034876|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034877|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034878|NCT02750345|Nitisinone|nitisinone|mesh-list
20034879|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034880|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034881|NCT02750410|Dulaglutide|dulaglutide|mesh-list
20034882|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20034883|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034884|NCT02750514|Nivolumab|nivolumab|mesh-list
20034885|NCT02750514|Ipilimumab|ipilimumab|mesh-list
20034886|NCT02750514|Dasatinib|dasatinib|mesh-list
20034887|NCT02750514|Linrodostat|linrodostat|mesh-list
20034888|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034889|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034890|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20034891|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034892|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20034893|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116324|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20116325|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116326|NCT00005779|Interleukin-12|interleukin-12|mesh-list
20116327|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20116328|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
20116329|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116330|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20116331|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20116332|NCT00005779|Growth Substances|growth substances|mesh-ancestor
20116333|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
20116334|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116335|NCT00005782|Sargramostim|sargramostim|mesh-list
20116336|NCT00005782|Lenograstim|lenograstim|mesh-list
20116337|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
20116338|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116339|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20116340|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
20116341|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116342|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
20116343|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
20116344|NCT00005787|Sargramostim|sargramostim|mesh-list
20116345|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20116346|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
20116347|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116348|NCT00005787|Hematinics|hematinics|mesh-ancestor
20116349|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20116350|NCT00005787|Protective Agents|protective agents|mesh-ancestor
20116351|NCT00005791|Fluorouracil|fluorouracil|mesh-list
20116352|NCT00005791|Irinotecan|irinotecan|mesh-list
20116353|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116354|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
20116355|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116356|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116357|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116358|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
20116359|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116360|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20116361|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116362|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116363|NCT00005792|Etoposide|etoposide|mesh-list
20116364|NCT00005792|Melphalan|melphalan|mesh-list
20116365|NCT00005792|Topotecan|topotecan|mesh-list
20116366|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
20034894|NCT02750709|Nitisinone|nitisinone|mesh-list
20034895|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034896|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034897|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
20034898|NCT02750761|Tedizolid|tedizolid|mesh-list
20034899|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
20034900|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20034901|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20034902|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20034903|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034904|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034905|NCT02750800|Adalimumab|adalimumab|mesh-list
20034906|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20034907|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034908|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
20034909|NCT02750930|Incretins|incretins|mesh-ancestor
20034910|NCT02750930|Hormones|hormones|mesh-ancestor
20034911|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20034912|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034913|NCT02750943|Fluorides|fluorides|mesh-list
20034914|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
20034915|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
20034916|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
20034917|NCT02750943|Protective Agents|protective agents|mesh-ancestor
20034918|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034919|NCT02751320|Citric Acid|citric acid|mesh-list
20034920|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
20034921|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
20034922|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20034923|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
20034924|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
20034925|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034926|NCT02751359|Cannabidiol|cannabidiol|mesh-list
20034927|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
20034928|NCT02751385|Nintedanib|nintedanib|mesh-list
20034929|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20034930|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20034931|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034932|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20034933|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034934|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034935|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20034936|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
20034937|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20034938|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034939|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20034940|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20034941|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20034942|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20034943|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20034944|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20034945|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20034946|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20034947|NCT02751450|Fluorides|fluorides|mesh-list
20034948|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
20034949|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
20034950|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
20034951|NCT02751450|Protective Agents|protective agents|mesh-ancestor
20034952|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034953|NCT02751931|Mirabegron|mirabegron|mesh-list
20034954|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20034955|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20034956|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20034957|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
20034958|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20034959|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034960|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034961|NCT02751931|Urological Agents|urological agents|mesh-ancestor
20034962|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
20034963|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20034964|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20034965|NCT02752256|Plasminogen|plasminogen|mesh-list
20034966|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20034967|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20034968|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20034969|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034970|NCT02752633|Allopurinol|allopurinol|mesh-list
20034971|NCT02752633|Febuxostat|febuxostat|mesh-list
20034972|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
20034973|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034974|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20034975|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
20034976|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20034977|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20034978|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
20034979|NCT02752633|Protective Agents|protective agents|mesh-ancestor
20034980|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034981|NCT02752958|Fluorides|fluorides|mesh-list
20034982|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
20034983|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
20034984|NCT02752958|Protective Agents|protective agents|mesh-ancestor
20034985|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034986|NCT02753075|Fluorides|fluorides|mesh-list
20034987|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
20034988|NCT02753075|Protective Agents|protective agents|mesh-ancestor
20034989|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20034990|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
20034991|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20034992|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20034993|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20034994|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
20034995|NCT02753816|Coagulants|coagulants|mesh-ancestor
20034996|NCT02753881|Doxorubicin|doxorubicin|mesh-list
20034997|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20034998|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20034999|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035000|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20035001|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20035002|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035003|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035004|NCT02753946|Tazobactam|tazobactam|mesh-list
20035005|NCT02753946|Piperacillin|piperacillin|mesh-list
20035006|NCT02753946|Fosfomycin|fosfomycin|mesh-list
20035007|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20035008|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20035009|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035010|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20035011|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035012|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035013|NCT02754518|Valsartan|valsartan|mesh-list
20035014|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20035015|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20035016|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20035017|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20035018|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035019|NCT02754570|Pilocarpine|pilocarpine|mesh-list
20035020|NCT02754570|Miotics|miotics|mesh-ancestor
20035021|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
20035022|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035023|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035024|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20035025|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20035026|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
20035027|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035028|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035029|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
20035030|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20035031|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
20035032|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
20035033|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035034|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035035|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20035036|NCT02755090|Analgesics|analgesics|mesh-ancestor
20035037|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
20035038|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035039|NCT02755116|Olanzapine|olanzapine|mesh-list
20035040|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
20035041|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
20035042|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035043|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035044|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20035045|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20035046|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20035047|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035048|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20035049|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20035050|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20035051|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20035052|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035053|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035054|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
20035055|NCT02755818|Heparin|heparin|mesh-list
20035056|NCT02755818|Calcium heparin|calcium heparin|mesh-list
20035057|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
20035058|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20035059|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20035060|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035061|NCT02756013|Paclitaxel|paclitaxel|mesh-list
20035062|NCT02756013|Carboplatin|carboplatin|mesh-list
20035063|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20035064|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035065|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
20035066|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
20035067|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
20035068|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035069|NCT02756364|Fulvestrant|fulvestrant|mesh-list
20035070|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20035071|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035072|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20035073|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20035074|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
20035075|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035076|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035077|NCT02756572|Cytarabine|cytarabine|mesh-list
20035078|NCT02756572|Cyclosporine|cyclosporine|mesh-list
20035079|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
20035080|NCT02756572|Sirolimus|sirolimus|mesh-list
20035081|NCT02756572|Fludarabine|fludarabine|mesh-list
20035082|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
20035083|NCT02756572|Melphalan|melphalan|mesh-list
20035084|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
20035085|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
20035086|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20035087|NCT02756572|Cladribine|cladribine|mesh-list
20035088|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
20035089|NCT02756572|Cyclosporins|cyclosporins|mesh-list
20035090|NCT02756572|Lenograstim|lenograstim|mesh-list
20035091|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035092|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20035093|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
20035094|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035095|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20035096|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
20035097|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035098|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
20035099|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035100|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20035101|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035102|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
20035103|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035104|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035105|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20035106|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20035107|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20035108|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
20035109|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20035110|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20035111|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
20035112|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20035113|NCT02756572|Analgesics|analgesics|mesh-ancestor
20035114|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
20035115|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035116|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20035117|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20035118|NCT02756624|Cetirizine|cetirizine|mesh-list
20035119|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20035120|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20035121|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20035122|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
20035123|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
20035124|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035125|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035126|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035127|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20035128|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20035129|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20035130|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035131|NCT02756832|Alogliptin|alogliptin|mesh-list
20035132|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035133|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035134|NCT02756832|Incretins|incretins|mesh-ancestor
20035135|NCT02756832|Hormones|hormones|mesh-ancestor
20035136|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035137|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20035138|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
20035139|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035140|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035141|NCT02757105|Ondansetron|ondansetron|mesh-list
20035142|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
20035143|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
20035144|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035145|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035146|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20035147|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
20035148|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035149|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20035150|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
20035151|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035152|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035153|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20035154|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20035155|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035156|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20035157|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20035158|NCT02757352|Ixekizumab|ixekizumab|mesh-list
20035159|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035160|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
20035161|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20035162|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035163|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035164|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20035165|NCT02757625|Analgesics|analgesics|mesh-ancestor
20035166|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
20035167|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035168|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20035169|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20035170|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20035171|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
20035172|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035173|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035174|NCT02757768|Tamsulosin|tamsulosin|mesh-list
20035175|NCT02757768|Mirabegron|mirabegron|mesh-list
20035176|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20035177|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20035178|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20035179|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
20035180|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035181|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035182|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035183|NCT02757768|Urological Agents|urological agents|mesh-ancestor
20035184|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20035185|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20035186|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20035187|NCT02758171|Empagliflozin|empagliflozin|mesh-list
20035188|NCT02758171|Linagliptin|linagliptin|mesh-list
20035189|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20035190|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035191|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035192|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035193|NCT02758171|Incretins|incretins|mesh-ancestor
20035194|NCT02758171|Hormones|hormones|mesh-ancestor
20035195|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035196|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20035197|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
20035198|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035199|NCT02759016|BI 836826|bi 836826|mesh-list
20035200|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035201|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035202|NCT02759120|Doxycycline|doxycycline|mesh-list
20035203|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20035204|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20035205|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
20035206|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
20035207|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20035208|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20035209|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20035210|NCT02759120|Renal Agents|renal agents|mesh-ancestor
20035211|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
20035212|NCT02759315|Ruzasvir|ruzasvir|mesh-list
20035213|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
20035214|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035215|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
20035216|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035217|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035218|NCT02760069|Ondansetron|ondansetron|mesh-list
20035219|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
20035220|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
20035221|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035222|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035223|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20035224|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
20035225|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035226|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20035227|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
20035228|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035229|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035230|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20035231|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20035232|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035233|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20035234|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20116367|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116368|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116369|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116370|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116371|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116372|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116373|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116374|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
20116375|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116376|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116377|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
20116378|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116379|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20116380|NCT00005793|Cytarabine|cytarabine|mesh-list
20116381|NCT00005793|Etoposide|etoposide|mesh-list
20116382|NCT00005793|Daunorubicin|daunorubicin|mesh-list
20116383|NCT00005793|Topotecan|topotecan|mesh-list
20116384|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116385|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116386|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116387|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116388|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116389|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116390|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116391|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
20035235|NCT02760407|Adalimumab|adalimumab|mesh-list
20035236|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035237|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035238|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
20035239|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20035240|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20035241|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20035242|NCT02760862|Mannitol|mannitol|mesh-list
20035243|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035244|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20035245|NCT02760862|Diuretics|diuretics|mesh-ancestor
20035246|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
20035247|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035248|NCT02761252|Montelukast|montelukast|mesh-list
20035249|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20035250|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
20035251|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20035252|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
20035253|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035254|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035255|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20035256|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20035257|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035258|NCT02761330|Ketamine|ketamine|mesh-list
20035259|NCT02761330|Analgesics|analgesics|mesh-ancestor
20035260|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
20035261|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035262|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035263|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20035264|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20035265|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
20035266|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
20035267|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035268|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20035269|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20035270|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035271|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035272|NCT02761629|Interferons|interferons|mesh-list
20035273|NCT02761629|Ribavirin|ribavirin|mesh-list
20035274|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
20035275|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
20035276|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20035277|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035278|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
20035279|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035280|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
20035281|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035282|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
20035283|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035284|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
20035285|NCT02761642|Hematinics|hematinics|mesh-ancestor
20035286|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
20035287|NCT02761915|Fludarabine|fludarabine|mesh-list
20035288|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20035289|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
20035290|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035291|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035292|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20035293|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
20035294|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035295|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035296|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20035297|NCT02761980|Acetaminophen|acetaminophen|mesh-list
20035298|NCT02761980|Ibuprofen|ibuprofen|mesh-list
20035299|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20035300|NCT02761980|Analgesics|analgesics|mesh-ancestor
20035301|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
20035302|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035303|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035304|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
20035305|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20035306|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035307|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035308|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20035309|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035310|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035311|NCT02762071|Bupivacaine|bupivacaine|mesh-list
20035312|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
20035313|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
20035314|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035315|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035316|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
20035317|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035318|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
20035319|NCT02762331|Vitamins|vitamins|mesh-ancestor
20035320|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
20035321|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035322|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
20035323|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035324|NCT02762331|Protective Agents|protective agents|mesh-ancestor
20035325|NCT02762370|Triamcinolone|triamcinolone|mesh-list
20035326|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20035327|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20035328|NCT02762370|FX006|fx006|mesh-list
20035329|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20035330|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035331|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
20035332|NCT02762370|Hormones|hormones|mesh-ancestor
20035333|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035334|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035335|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20035336|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
20035337|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035338|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035339|NCT02762513|Axitinib|axitinib|mesh-list
20035340|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035341|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20035342|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035343|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035344|NCT02762578|Insulin|insulin|mesh-list
20035345|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20035346|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
20035347|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
20035348|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20035349|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
20035350|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035351|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035352|NCT02762799|Lenograstim|lenograstim|mesh-list
20035353|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20035354|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
20035355|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035356|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20035357|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
20035358|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035359|NCT02763566|Letrozole|letrozole|mesh-list
20035360|NCT02763566|Fulvestrant|fulvestrant|mesh-list
20035361|NCT02763566|Anastrozole|anastrozole|mesh-list
20035362|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035363|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20035364|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20035365|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035366|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035367|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20035368|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
20035369|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035370|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035371|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20035372|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20035373|NCT02764333|Durvalumab|durvalumab|mesh-list
20035374|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035375|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035376|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20035377|NCT02764697|Hormones|hormones|mesh-ancestor
20035378|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035379|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035380|NCT02764762|Adalimumab|adalimumab|mesh-list
20035381|NCT02764762|Methotrexate|methotrexate|mesh-list
20035382|NCT02764762|Vedolizumab|vedolizumab|mesh-list
20035383|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20035384|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
20035385|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20035386|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035387|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20035388|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
20035389|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035390|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035391|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035392|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035393|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20035394|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20035395|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
20035396|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035397|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20035398|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035399|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20035400|NCT02765100|Minocycline|minocycline|mesh-list
20035401|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20035402|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035403|NCT02765165|Lomustine|lomustine|mesh-list
20035404|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20035405|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
20035406|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035407|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035408|NCT02765256|Promethazine|promethazine|mesh-list
20035409|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
20035410|NCT02765256|Vancomycin|vancomycin|mesh-list
20035411|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
20035412|NCT02765256|Neomycin|neomycin|mesh-list
20035413|NCT02765256|Fluconazole|fluconazole|mesh-list
20035414|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20035415|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20293143|NCT04710277|Analgesics|analgesics|mesh-ancestor
20293144|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
20293145|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293146|NCT04708782|Treprostinil|treprostinil|mesh-list
20293147|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20293148|NCT04703075|Rifapentine|rifapentine|mesh-list
20035416|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035417|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20035418|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20035419|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035420|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035421|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035422|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20035423|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20035424|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
20035425|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20035426|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20035427|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
20035428|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035429|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035430|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20035431|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20035432|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
20035433|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035434|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20035435|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
20035436|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
20035437|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035438|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20035439|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20035440|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20035441|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035442|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
20035443|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
20035444|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
20293149|NCT04703075|Rifampin|rifampin|mesh-list
20293150|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20293151|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
20293152|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20035445|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035446|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
20035447|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
20035448|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20035449|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20035450|NCT02765256|Laxatives|laxatives|mesh-ancestor
20035451|NCT02765490|Simeprevir|simeprevir|mesh-list
20035452|NCT02765490|Odalasvir|odalasvir|mesh-list
20035453|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
20035454|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035455|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
20035456|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035457|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035458|NCT02766023|Metronidazole|metronidazole|mesh-list
20035459|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035460|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20035461|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20035462|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20035463|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20035464|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035465|NCT02766517|Capsaicin|capsaicin|mesh-list
20035466|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
20035467|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035468|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
20035469|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035470|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035471|NCT02766608|Budesonide|budesonide|mesh-list
20035472|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
20035473|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20035474|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035475|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20035476|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
20035477|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035478|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035479|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20035480|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
20035481|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
20035482|NCT02766608|Hormones|hormones|mesh-ancestor
20035483|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035484|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20035485|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20035486|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20035487|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
20035488|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035489|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035490|NCT02766673|Albuterol|albuterol|mesh-list
20035491|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20035492|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
20035493|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035494|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035495|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20035496|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
20035497|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
20035498|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20035499|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20035500|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20035501|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20035502|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
20035503|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035504|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035505|NCT02766777|Lubiprostone|lubiprostone|mesh-list
20035506|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20035507|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20035508|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035509|NCT02767128|Citric Acid|citric acid|mesh-list
20035510|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
20035511|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
20035512|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20035513|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
20035514|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
20035515|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035516|NCT02767271|Luliconazole|luliconazole|mesh-list
20035517|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
20035518|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035519|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
20035520|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20035521|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20035522|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035523|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
20035524|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035525|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20035526|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035527|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
20035528|NCT02767492|Hormones|hormones|mesh-ancestor
20035529|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035530|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035531|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20035532|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
20035533|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
20035534|NCT02767765|Hematinics|hematinics|mesh-ancestor
20035535|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
20035536|NCT02767869|Antacids|antacids|mesh-ancestor
20035537|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035538|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20035539|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
20035540|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035541|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035542|NCT02767947|Luliconazole|luliconazole|mesh-list
20035543|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
20035544|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035545|NCT02768194|Fluorides|fluorides|mesh-list
20035546|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
20035547|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
20035548|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
20035549|NCT02768194|Protective Agents|protective agents|mesh-ancestor
20035550|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035551|NCT02768298|Enalapril|enalapril|mesh-list
20035552|NCT02768298|Enalaprilat|enalaprilat|mesh-list
20035553|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20035554|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20035555|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
20035556|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035557|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035558|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20035559|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20035560|NCT02768558|Nivolumab|nivolumab|mesh-list
20035561|NCT02768558|Etoposide|etoposide|mesh-list
20035562|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035563|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035564|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20035565|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035566|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20035567|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20035568|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20035569|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035570|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
20035571|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035572|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035573|NCT02769065|Donepezil|donepezil|mesh-list
20035574|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20035575|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035576|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035577|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
20035578|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035579|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035580|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
20035581|NCT02769247|Naproxen|naproxen|mesh-list
20035582|NCT02769247|Lidocaine|lidocaine|mesh-list
20035583|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
20035584|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
20035585|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035586|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035587|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
20035588|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035589|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20035590|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20035591|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20035592|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20035593|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116392|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
20035594|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20035595|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20035596|NCT02769247|Analgesics|analgesics|mesh-ancestor
20035597|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035598|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035599|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
20035600|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20035601|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035602|NCT02769481|Glimepiride|glimepiride|mesh-list
20035603|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
20035604|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20035605|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035606|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035607|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20035608|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
20035609|NCT02769624|Treprostinil|treprostinil|mesh-list
20035610|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20035611|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20035612|NCT02769702|Hormones|hormones|mesh-ancestor
20035613|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035614|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035615|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20035616|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035617|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20035618|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035619|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035620|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20035621|NCT02770248|Brinzolamide|brinzolamide|mesh-list
20035622|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20035623|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20035624|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20035625|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20035626|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
20035627|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035628|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035629|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035630|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20035631|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035632|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20035633|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20035634|NCT02770365|Estradiol|estradiol|mesh-list
20035635|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20035636|NCT02770365|Estrogens|estrogens|mesh-ancestor
20035637|NCT02770365|Hormones|hormones|mesh-ancestor
20035638|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035639|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035640|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20035641|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
20035642|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20035643|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20035644|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
20035645|NCT02770521|Treprostinil|treprostinil|mesh-list
20035646|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035647|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035648|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20035649|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
20035650|NCT02770612|Narcotics|narcotics|mesh-ancestor
20035651|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035652|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035653|NCT02770612|Analgesics|analgesics|mesh-ancestor
20035654|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
20035655|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116393|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116394|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116395|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
20116396|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116397|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20116398|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116399|NCT00005796|Vincristine|vincristine|mesh-list
20116400|NCT00005796|Lomustine|lomustine|mesh-list
20116401|NCT00005796|Procarbazine|procarbazine|mesh-list
20116402|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19746116|NCT04335890|Vaccines|vaccines|mesh-list
20116403|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116404|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
20035656|NCT02770820|Aldesleukin|aldesleukin|mesh-list
20035657|NCT02770820|Interleukin-2|interleukin-2|mesh-list
20035658|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035659|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20035660|NCT02770820|Analgesics|analgesics|mesh-ancestor
20035661|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
20035662|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035663|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035664|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20035665|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20035666|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
20035667|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035668|NCT02771093|Alogliptin|alogliptin|mesh-list
20035669|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035670|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035671|NCT02771093|Incretins|incretins|mesh-ancestor
20035672|NCT02771093|Hormones|hormones|mesh-ancestor
20035673|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035674|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20035675|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
20035676|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035677|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035678|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20035679|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20035680|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
20035681|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035682|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
20035683|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
20035684|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035685|NCT02772783|Insulin|insulin|mesh-list
20035686|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20035687|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035688|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035689|NCT02772978|Tolcapone|tolcapone|mesh-list
20035690|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20035691|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20035692|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20035693|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035694|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035695|NCT02773368|Insulin|insulin|mesh-list
20035696|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20035697|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
20035698|NCT02773368|Liraglutide|liraglutide|mesh-list
20035699|NCT02773368|Xultophy|xultophy|mesh-list
20035700|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035701|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035702|NCT02773368|Incretins|incretins|mesh-ancestor
20035703|NCT02773368|Hormones|hormones|mesh-ancestor
20035704|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035705|NCT02773758|Fluorides|fluorides|mesh-list
20035706|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
20035707|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
20035708|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
20035709|NCT02773758|Protective Agents|protective agents|mesh-ancestor
20035710|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035711|NCT02774226|Vitamins|vitamins|mesh-list
20035712|NCT02774226|Vitamin E|vitamin e|mesh-list
20035713|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
20035714|NCT02774226|Antioxidants|antioxidants|mesh-list
20035715|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
20035716|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035717|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035718|NCT02774226|Protective Agents|protective agents|mesh-ancestor
20035719|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
20035720|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20035721|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035722|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20035723|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035724|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035725|NCT02774343|Pioglitazone|pioglitazone|mesh-list
20035726|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035727|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035728|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20035729|NCT02774681|Trastuzumab|trastuzumab|mesh-list
20035730|NCT02774681|Palbociclib|palbociclib|mesh-list
20035731|NCT02774681|Antibodies|antibodies|mesh-list
20576502|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20035732|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
20035733|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20035734|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
20035735|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035736|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035737|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20035738|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035739|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035740|NCT02775240|Maribavir|maribavir|mesh-list
20035741|NCT02775240|Digoxin|digoxin|mesh-list
20035742|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
20035743|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20035744|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20035745|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035746|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035747|NCT02775240|Protective Agents|protective agents|mesh-ancestor
20035748|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035749|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
20035750|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
20035751|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20035752|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20035753|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035754|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
20035755|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035756|NCT02775617|Azithromycin|azithromycin|mesh-list
20035757|NCT02775617|Ivermectin|ivermectin|mesh-list
20035758|NCT02775617|Permethrin|permethrin|mesh-list
20035759|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20035760|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035761|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20035762|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035763|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035764|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
20035765|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
20035766|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20035767|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20035768|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035769|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035770|NCT02775903|Azacitidine|azacitidine|mesh-list
20035771|NCT02775903|Durvalumab|durvalumab|mesh-list
20035772|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20035773|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
20035774|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035775|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035776|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035777|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035778|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20035779|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
20035780|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20035781|NCT02776683|Bevacizumab|bevacizumab|mesh-list
20035782|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035783|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035784|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20035785|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20035786|NCT02776683|Growth Substances|growth substances|mesh-ancestor
20035787|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035788|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
20035789|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
20035790|NCT02777242|Testosterone|testosterone|mesh-list
20035791|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
20035792|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
20035793|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20035794|NCT02777242|Androgens|androgens|mesh-ancestor
20035795|NCT02777242|Hormones|hormones|mesh-ancestor
20035796|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035797|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035798|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20035799|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035800|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
20035801|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
20035802|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035803|NCT05350124|Vitamins|vitamins|mesh-list
20035804|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
20035805|NCT05350124|Vitamin E|vitamin e|mesh-list
20035806|NCT05350124|Tocopherols|tocopherols|mesh-list
20035807|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
20035808|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035809|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
20035810|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035811|NCT05350124|Protective Agents|protective agents|mesh-ancestor
20035812|NCT05350085|Midazolam|midazolam|mesh-list
20035813|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20035814|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20035815|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035816|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035817|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20035818|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20035819|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20035820|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20035821|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
20035822|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
20035823|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
20035824|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
20035825|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035826|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035827|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
20035828|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20035829|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20035830|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20035831|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035832|NCT05349929|Ibuprofen|ibuprofen|mesh-list
20035833|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20576503|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576504|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20576505|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20576506|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576507|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576508|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
20035834|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20035835|NCT05349929|Analgesics|analgesics|mesh-ancestor
20035836|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
20035837|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035838|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035839|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035840|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035841|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20035842|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035843|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035844|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20035845|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
20035846|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035847|NCT05349903|Protective Agents|protective agents|mesh-ancestor
20035848|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035849|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20035850|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20035851|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035852|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20035853|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
20035854|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20035855|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035856|NCT05349825|Losartan|losartan|mesh-list
20035857|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20035858|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20035859|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20035860|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20035861|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035862|NCT05349474|Metformin|metformin|mesh-list
20035863|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20035864|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035865|NCT05349396|Eszopiclone|eszopiclone|mesh-list
20035866|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20035867|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035868|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035869|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
20035870|NCT05349383|Antibodies|antibodies|mesh-list
20035871|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
20035872|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
20035873|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
20035874|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116405|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
20035875|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
20035876|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20035877|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20035878|NCT05349071|Prednisolone|prednisolone|mesh-list
20035879|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
20035880|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20035881|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
20035882|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035883|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
20035884|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
20035885|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035886|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035887|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20035888|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
20035889|NCT05349071|Hormones|hormones|mesh-ancestor
20035890|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20035891|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20035892|NCT05349071|Protective Agents|protective agents|mesh-ancestor
20035893|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20035894|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035895|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20035896|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035897|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035898|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
20035899|NCT05349045|Antibodies|antibodies|mesh-list
20035900|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
20035901|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035902|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20035903|NCT05349045|Growth Substances|growth substances|mesh-ancestor
20035904|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
20035905|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035906|NCT05349032|Curcumin|curcumin|mesh-list
20035907|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20035908|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20035909|NCT05349032|Analgesics|analgesics|mesh-ancestor
20035910|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
20035911|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035912|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035913|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035914|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035915|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035916|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035917|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035918|NCT05349006|Azathioprine|azathioprine|mesh-list
20035919|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
20035920|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035921|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20035922|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035923|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20035924|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
20035925|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035926|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20035927|NCT05348980|Phenylephrine|phenylephrine|mesh-list
20035928|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
20035929|NCT05348980|Synephrine|synephrine|mesh-list
20035930|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20035931|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
20035932|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
20035933|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20035934|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035935|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
20035936|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20035937|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
20035938|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
20035939|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20035940|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20035941|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20035942|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
20035943|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035944|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035945|NCT05348980|Protective Agents|protective agents|mesh-ancestor
20035946|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20035947|NCT05348824|Eusol|eusol|mesh-list
20035948|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
20035949|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20035950|NCT05348577|Docetaxel|docetaxel|mesh-list
20035951|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035952|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
20035953|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
20035954|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
20035955|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035956|NCT05348434|Ether|ether|mesh-list
20035957|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20035958|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
20035959|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
20035960|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20035961|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035962|NCT05348239|Copper|copper|mesh-list
20035963|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
20035964|NCT05348239|Trace Elements|trace elements|mesh-ancestor
20035965|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
20035966|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035967|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20035968|NCT05348239|Protective Agents|protective agents|mesh-ancestor
20035969|NCT05348213|Decitabine|decitabine|mesh-list
20035970|NCT05348213|Pomalidomide|pomalidomide|mesh-list
20035971|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
20035972|NCT05348213|Tofacitinib|tofacitinib|mesh-list
20035973|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20035974|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
20035975|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035976|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20035977|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20035978|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
20035979|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20035980|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20035981|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20035982|NCT05348213|Growth Substances|growth substances|mesh-ancestor
20035983|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
20035984|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20035985|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
20035986|NCT05348148|Cetirizine|cetirizine|mesh-list
20035987|NCT05348148|Phenylephrine|phenylephrine|mesh-list
20035988|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
20035989|NCT05348148|Levocetirizine|levocetirizine|mesh-list
20035990|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20035991|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
20035992|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20035993|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20035994|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20035995|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
20035996|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
20035997|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20035998|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20035999|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036000|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20036001|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036002|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036003|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
20036004|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
20036005|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036006|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
20036007|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20036008|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036009|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20036010|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
20036011|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20036012|NCT05348148|Protective Agents|protective agents|mesh-ancestor
20036013|NCT05347979|Dabigatran|dabigatran|mesh-list
20036014|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
20036015|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20036016|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
20036017|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036018|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036019|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
20036020|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
20036021|NCT05339581|Lenvatinib|lenvatinib|mesh-list
20036022|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036023|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036024|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20036025|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036026|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036027|NCT05337436|Calcium|calcium|mesh-list
20036028|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20036029|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116406|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116407|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116408|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116409|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
20116410|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
20116411|NCT00005797|Busulfan|busulfan|mesh-list
20116412|NCT00005797|Etoposide|etoposide|mesh-list
20116413|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116414|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
20116415|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116416|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116417|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116418|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
20116419|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116420|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116421|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116422|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116423|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116424|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116425|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116426|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
20116427|NCT00005798|Thiotepa|thiotepa|mesh-list
20116428|NCT00005798|Carboplatin|carboplatin|mesh-list
20116429|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116430|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
20116431|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116432|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116433|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116434|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
20116435|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293153|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293154|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
20293155|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20293156|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293157|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116436|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116437|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116438|NCT00005799|Cyclosporine|cyclosporine|mesh-list
20116439|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
20116440|NCT00005799|Fludarabine|fludarabine|mesh-list
20116441|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
20116442|NCT00005799|Cyclosporins|cyclosporins|mesh-list
20116443|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116444|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116445|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
20116446|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116447|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116448|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
20116449|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116450|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116451|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
20116452|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116453|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116454|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116455|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20116456|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116457|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20116458|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
20116459|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20116460|NCT00005800|Docetaxel|docetaxel|mesh-list
20116461|NCT00005800|Doxorubicin|doxorubicin|mesh-list
20116462|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20116463|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116464|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116465|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116466|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120677|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576509|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036030|NCT05334017|Cocaine|cocaine|mesh-list
20036031|NCT05334017|Xylometazoline|xylometazoline|mesh-list
20036032|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036033|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
20036034|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036035|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036036|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
20036037|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036038|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20036039|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20036040|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20036041|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036042|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036043|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
20036044|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036045|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
20036046|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036047|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20036048|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20036049|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036050|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036051|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036052|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036053|NCT05320718|Ropivacaine|ropivacaine|mesh-list
20036054|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036055|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
20036056|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036057|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036058|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
20036059|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036060|NCT05319353|Maribavir|maribavir|mesh-list
20036061|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
20036062|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036063|NCT05279937|Lidocaine|lidocaine|mesh-list
20036064|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20036065|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036066|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
20036067|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036068|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036069|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
20036070|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036071|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20036072|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20036073|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20036074|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036075|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036076|NCT05273359|Benralizumab|benralizumab|mesh-list
20036077|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036078|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036079|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20036080|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20036081|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
20036082|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036083|NCT05259527|Vitamin D|vitamin d|mesh-list
20036084|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
20036085|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
20036086|NCT05259527|Vitamins|vitamins|mesh-list
20036087|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
20036088|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036089|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20036090|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20036091|NCT05257590|Nivolumab|nivolumab|mesh-list
20036092|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036093|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036094|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20036095|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036096|NCT05256108|Oxycodone|oxycodone|mesh-list
20036097|NCT05256108|Tramadol|tramadol|mesh-list
20036098|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20036099|NCT05256108|Narcotics|narcotics|mesh-ancestor
20036100|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036101|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036102|NCT05256108|Analgesics|analgesics|mesh-ancestor
20036103|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
20036104|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036105|NCT05223231|Antibodies|antibodies|mesh-list
20036106|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
20036107|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
20036108|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036109|NCT05221021|Mirabegron|mirabegron|mesh-list
20036110|NCT05221021|Estradiol|estradiol|mesh-list
20036111|NCT05221021|Estrogens|estrogens|mesh-list
20036112|NCT05221021|Hormones|hormones|mesh-ancestor
20036113|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036114|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036115|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20036116|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20036117|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036118|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036119|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036120|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036121|NCT05221021|Urological Agents|urological agents|mesh-ancestor
20036122|NCT05215535|Liver Extracts|liver extracts|mesh-list
20036123|NCT05215535|Hematinics|hematinics|mesh-ancestor
20036124|NCT05201183|Fludarabine|fludarabine|mesh-list
20036125|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036126|NCT05195918|Pirfenidone|pirfenidone|mesh-list
20036127|NCT05195918|Nintedanib|nintedanib|mesh-list
20036128|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20036129|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036130|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20036131|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036132|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036133|NCT05195918|Analgesics|analgesics|mesh-ancestor
20036134|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
20036135|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036136|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036137|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20036138|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20036139|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036140|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20036141|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
20036142|NCT05195918|Protective Agents|protective agents|mesh-ancestor
20036143|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20036144|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20036145|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20036146|NCT05191446|Ethanol|ethanol|mesh-list
20036147|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20036148|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036149|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036150|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036151|NCT05180318|Ketamine|ketamine|mesh-list
20036152|NCT05180318|Esketamine|esketamine|mesh-list
20036153|NCT05180318|Analgesics|analgesics|mesh-ancestor
20036154|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
20036155|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036156|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036157|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20036158|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20036159|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
20036160|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
20036161|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036162|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20036163|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20036164|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036165|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036166|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
20036167|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20036168|NCT05177991|Bupivacaine|bupivacaine|mesh-list
20036169|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036170|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
20036171|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293158|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20036172|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036173|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
20036174|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116467|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116468|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116469|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116470|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116471|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116472|NCT00005802|Cytarabine|cytarabine|mesh-list
20116473|NCT00005802|Aldesleukin|aldesleukin|mesh-list
20116474|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
20116475|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20116476|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20116477|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20116478|NCT00005802|Methotrexate|methotrexate|mesh-list
20116479|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
20116480|NCT00005802|Fludarabine|fludarabine|mesh-list
20116481|NCT00005802|Etoposide|etoposide|mesh-list
20116482|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
20116483|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20116484|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
20116485|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20116486|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116487|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116488|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
20116489|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116490|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116491|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116492|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116493|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20116494|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116495|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
20116496|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116497|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116498|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116499|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116500|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116501|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
20116502|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116503|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20116504|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20116505|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20116506|NCT00005802|Analgesics|analgesics|mesh-ancestor
20116507|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
20116508|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116509|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
20116510|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116511|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
20116512|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116513|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116514|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116515|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
20116516|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116517|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116518|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116519|NCT00005806|Paclitaxel|paclitaxel|mesh-list
20116520|NCT00005806|Carboplatin|carboplatin|mesh-list
20116521|NCT00005806|Gefitinib|gefitinib|mesh-list
20116522|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116523|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116524|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116525|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116526|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116527|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116528|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20116529|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116530|NCT00005807|Epothilones|epothilones|mesh-list
20116531|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116532|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116533|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116534|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116535|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116536|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
20116537|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20116538|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116539|NCT00005810|Carboplatin|carboplatin|mesh-list
20116540|NCT00005810|Docetaxel|docetaxel|mesh-list
20036175|NCT05158153|Furosemide|furosemide|mesh-list
20036176|NCT05158153|Diuretics|diuretics|mesh-ancestor
20036177|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
20036178|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036179|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20036180|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036181|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036182|NCT05144854|Capecitabine|capecitabine|mesh-list
20036183|NCT05144854|Tegafur|tegafur|mesh-list
20036184|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
20036185|NCT05144854|Nivolumab|nivolumab|mesh-list
20036186|NCT05144854|Ipilimumab|ipilimumab|mesh-list
20036187|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20036188|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
20036189|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036190|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036191|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036192|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20036193|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
20036194|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20036195|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20036196|NCT05113901|Prednisolone|prednisolone|mesh-list
20036197|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
20036198|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20036199|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
20036200|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036201|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
20036202|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
20036203|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036204|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036205|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20036206|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
20036207|NCT05113901|Hormones|hormones|mesh-ancestor
20036208|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036209|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20036210|NCT05113901|Protective Agents|protective agents|mesh-ancestor
20036211|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20036212|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036213|NCT05103904|Lenvatinib|lenvatinib|mesh-list
20036214|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036215|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20036216|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036217|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036218|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
20036219|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20036220|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
20036221|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036222|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036223|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036224|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036225|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20036226|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
20036227|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036228|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036229|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20036230|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
20036231|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
20036232|NCT05101746|Protective Agents|protective agents|mesh-ancestor
20036233|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
20036234|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20036235|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20036236|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
20036237|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036238|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036239|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036240|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036241|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20036242|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
20036243|NCT05088369|Protective Agents|protective agents|mesh-ancestor
20036244|NCT05080322|Fluticasone|fluticasone|mesh-list
20036245|NCT05080322|Xhance|xhance|mesh-list
20036246|NCT05080322|Azelastine|azelastine|mesh-list
20036247|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036248|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20036249|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
20036250|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036251|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036252|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036253|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036254|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
20036255|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20036256|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20036257|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036258|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036259|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20036260|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20036261|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
20036262|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
20036263|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036264|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
20036265|NCT05063396|Anesthetics|anesthetics|mesh-list
20036266|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036267|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036268|NCT05063396|Narcotics|narcotics|mesh-ancestor
20036269|NCT05063396|Analgesics|analgesics|mesh-ancestor
20036270|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
20036271|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036272|NCT05062317|Leucovorin|leucovorin|mesh-list
20036273|NCT05062317|Bevacizumab|bevacizumab|mesh-list
20036274|NCT05062317|Fluorouracil|fluorouracil|mesh-list
20036275|NCT05062317|Capecitabine|capecitabine|mesh-list
20036276|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
20036277|NCT05062317|Irinotecan|irinotecan|mesh-list
20036278|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036279|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036280|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20036281|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20036282|NCT05062317|Growth Substances|growth substances|mesh-ancestor
20036283|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036284|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
20036285|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
20036286|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036287|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20036288|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20036289|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
20036290|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20036291|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20036292|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036293|NCT05062317|Antidotes|antidotes|mesh-ancestor
20036294|NCT05062317|Protective Agents|protective agents|mesh-ancestor
20036295|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
20036296|NCT05062317|Vitamins|vitamins|mesh-ancestor
20036297|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
20036298|NCT05055752|Aspirin|aspirin|mesh-list
20036299|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20036300|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20036301|NCT05055752|Analgesics|analgesics|mesh-ancestor
20036302|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
20036303|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036304|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036305|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036306|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20036307|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20036308|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20036309|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036310|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20036311|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20036312|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036313|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
20036314|NCT05051527|Silymarin|silymarin|mesh-list
20036315|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
20036316|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036317|NCT05051527|Protective Agents|protective agents|mesh-ancestor
20036318|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036319|NCT05045937|Vitamin D|vitamin d|mesh-list
20036320|NCT05045937|Vitamins|vitamins|mesh-list
20036321|NCT05045937|Ivermectin|ivermectin|mesh-list
20036322|NCT05045937|Remdesivir|remdesivir|mesh-list
20036323|NCT05045937|Ibuprofen|ibuprofen|mesh-list
20036324|NCT05045937|Budesonide|budesonide|mesh-list
20036325|NCT05045937|Melatonin|melatonin|mesh-list
20036326|NCT05045937|Albuterol|albuterol|mesh-list
20036327|NCT05045937|Quercetin|quercetin|mesh-list
20036328|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036329|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
20036330|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20036331|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20036332|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20036333|NCT05045937|Analgesics|analgesics|mesh-ancestor
20036334|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
20036335|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036336|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036337|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20036338|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036339|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20036340|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036341|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20036342|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
20036343|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036344|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036345|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
20036346|NCT05045937|Hormones|hormones|mesh-ancestor
20036347|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036348|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
20036349|NCT05045937|Protective Agents|protective agents|mesh-ancestor
20036350|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036351|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
20036352|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20036353|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20036354|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20036355|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036356|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036357|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036358|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20036359|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036360|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
20036361|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
20036362|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20036363|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036364|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036365|NCT05037032|Naltrexone|naltrexone|mesh-list
20036366|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20036367|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20036368|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036369|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
20036370|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036371|NCT05029726|Clonidine|clonidine|mesh-list
20036372|NCT05029726|Epinephrine|epinephrine|mesh-list
20036373|NCT05029726|Bupivacaine|bupivacaine|mesh-list
20036374|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036375|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
20036376|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036377|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036378|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
20036379|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036380|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20036381|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036382|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036383|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036384|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036385|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20036386|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20036387|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
20036388|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036389|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036390|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
20036391|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
20036392|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20036393|NCT05029726|Analgesics|analgesics|mesh-ancestor
20036394|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20036395|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
20036396|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20036397|NCT05029050|Clonidine|clonidine|mesh-list
20036398|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
20036399|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20036400|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036401|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036402|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20036403|NCT05029050|Analgesics|analgesics|mesh-ancestor
20036404|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
20036405|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036406|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20036407|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20036408|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036409|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036410|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036411|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036412|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20036413|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
20036414|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
20036415|NCT05006079|Morphine|morphine|mesh-list
20036416|NCT05006079|Alprazolam|alprazolam|mesh-list
20036417|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20036418|NCT05006079|Narcotics|narcotics|mesh-ancestor
20036419|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036420|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036421|NCT05006079|Analgesics|analgesics|mesh-ancestor
20036422|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
20036423|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036424|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20036425|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20036426|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20036427|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20036428|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
20036429|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
20036430|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036431|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036432|NCT04982237|Paclitaxel|paclitaxel|mesh-list
20036433|NCT04982237|Bevacizumab|bevacizumab|mesh-list
20036434|NCT04982237|Carboplatin|carboplatin|mesh-list
20036435|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20036436|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036437|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
20036438|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
20036439|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
20036440|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036441|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036442|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20036443|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20036444|NCT04982237|Growth Substances|growth substances|mesh-ancestor
20036445|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036446|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
20036447|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20036448|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20036449|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20036450|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036451|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036452|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036453|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036454|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20036455|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
20036456|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20036457|NCT04963296|Acetaminophen|acetaminophen|mesh-list
20036458|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
20036459|NCT04963296|Promethazine|promethazine|mesh-list
20036460|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
20036461|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
20036462|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20036463|NCT04963296|Analgesics|analgesics|mesh-ancestor
20036464|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
20036465|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036466|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036467|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
20036468|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036469|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
20036470|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
20036471|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20036472|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
20036473|NCT04963296|Hormones|hormones|mesh-ancestor
20036474|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036475|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20036476|NCT04963296|Protective Agents|protective agents|mesh-ancestor
20036477|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036478|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036479|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20036480|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20036481|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036482|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036483|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
20036484|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20036485|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
20036486|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
20036487|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036488|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036489|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20036490|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
20036491|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
20036492|NCT04958811|Bevacizumab|bevacizumab|mesh-list
20036493|NCT04958811|Atezolizumab|atezolizumab|mesh-list
20036494|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036495|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036496|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20036497|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20036498|NCT04958811|Growth Substances|growth substances|mesh-ancestor
20036499|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036500|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
20036501|NCT04949828|Pancrelipase|pancrelipase|mesh-list
20036502|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20036503|NCT04914897|Paclitaxel|paclitaxel|mesh-list
20036504|NCT04914897|Carboplatin|carboplatin|mesh-list
20036505|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
20036506|NCT04914897|Pemetrexed|pemetrexed|mesh-list
20036507|NCT04914897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20036508|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036509|NCT04914897|Tubulin Modulators|tubulin modulators|mesh-ancestor
20036510|NCT04914897|Antimitotic Agents|antimitotic agents|mesh-ancestor
20036511|NCT04914897|Mitosis Modulators|mitosis modulators|mesh-ancestor
20036512|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036513|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036514|NCT04914897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036515|NCT04914897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20036516|NCT04914897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20036517|NCT04911062|Epinephrine|epinephrine|mesh-list
20036518|NCT04911062|Bupivacaine|bupivacaine|mesh-list
20036519|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036520|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
20036521|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036522|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036523|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
20036524|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036525|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20036526|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036527|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036528|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036529|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036530|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20036531|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20036532|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
20036533|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036534|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036535|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
20036536|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
20036537|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20116541|NCT00005810|Estramustine|estramustine|mesh-list
20116542|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116543|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116544|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116545|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116546|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116547|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116548|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
20116549|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20116550|NCT00005811|Topotecan|topotecan|mesh-list
20116551|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20116552|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116553|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116554|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116555|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116556|NCT00005812|Temozolomide|temozolomide|mesh-list
20116557|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20036538|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
20036539|NCT04901169|Giapreza|giapreza|mesh-list
20036540|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
20036541|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20036542|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20036543|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
20036544|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036545|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036546|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
20036547|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20036548|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20036549|NCT04900220|Prednisolone|prednisolone|mesh-list
20036550|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
20036551|NCT04900220|Betamethasone|betamethasone|mesh-list
20036552|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20036553|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
20036554|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036555|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
20036556|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
20036557|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036558|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036559|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20036560|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
20036561|NCT04900220|Hormones|hormones|mesh-ancestor
20036562|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036563|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20036564|NCT04900220|Protective Agents|protective agents|mesh-ancestor
20036565|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20036566|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036567|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036568|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036569|NCT04887194|Nivolumab|nivolumab|mesh-list
20036570|NCT04887194|Digoxin|digoxin|mesh-list
20036571|NCT04887194|Midazolam|midazolam|mesh-list
20036572|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
20036573|NCT04887194|Warfarin|warfarin|mesh-list
20036574|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20036575|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036576|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036577|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20036578|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036579|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20036580|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20036581|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036582|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036583|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20036584|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20036585|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20036586|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20036587|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
20036588|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
20036589|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
20036590|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
20036591|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036592|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20036593|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20036594|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
20036595|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20036596|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20036597|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036598|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
20036599|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20036600|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20036601|NCT04887194|Protective Agents|protective agents|mesh-ancestor
20036602|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
20036603|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036604|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20036605|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20036606|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
20036607|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036608|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20036609|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036610|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746117|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
20036611|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
20036612|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036613|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036614|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20036615|NCT04863950|Lomustine|lomustine|mesh-list
20036616|NCT04863950|Imipramine|imipramine|mesh-list
20036617|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20036618|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
20036619|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036620|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036621|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20036622|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
20036623|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20293159|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20036624|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20036625|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20036626|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036627|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036628|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036629|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036630|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20036631|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
20036632|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036633|NCT04848220|APD791|apd791|mesh-list
20036634|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20036635|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20036636|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
20036637|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036638|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036639|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036640|NCT04840823|Enoxacin|enoxacin|mesh-list
20036641|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20036642|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036643|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20036644|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20036645|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036646|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036647|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036648|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20036649|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20036650|NCT04827056|Ethanol|ethanol|mesh-list
20036651|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
20036652|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20036653|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036654|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036655|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20036656|NCT04827056|Analgesics|analgesics|mesh-ancestor
20036657|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
20036658|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036659|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20036660|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20036661|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036662|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036663|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036664|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036665|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20036666|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036667|NCT04825522|Vancomycin|vancomycin|mesh-list
20036668|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20036669|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036670|NCT04817501|Edetic Acid|edetic acid|mesh-list
20036671|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
20036672|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20036673|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
20036674|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
20036675|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036676|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20036677|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036678|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
20036679|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20036680|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
20036681|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036682|NCT04792021|Expectorants|expectorants|mesh-ancestor
20036683|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036684|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20036685|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
20036686|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036687|NCT04792021|Protective Agents|protective agents|mesh-ancestor
20036688|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036689|NCT04792021|Antidotes|antidotes|mesh-ancestor
20036690|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20036691|NCT04776980|Hematinics|hematinics|mesh-ancestor
20576510|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20576511|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576512|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20036692|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20036693|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20036694|NCT04771299|Cariprazine|cariprazine|mesh-list
20036695|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20036696|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20036697|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036698|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036699|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20036700|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
20036701|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20036702|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
20036703|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036704|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
20036705|NCT04766918|Protective Agents|protective agents|mesh-ancestor
20036706|NCT04763226|Furosemide|furosemide|mesh-list
20036707|NCT04763226|Diuretics|diuretics|mesh-ancestor
20036708|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
20036709|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036710|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20036711|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036712|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036713|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
20036714|NCT04757675|Ketamine|ketamine|mesh-list
20036715|NCT04757675|Esketamine|esketamine|mesh-list
20036716|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20036717|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036718|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036719|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20036720|NCT04757675|Analgesics|analgesics|mesh-ancestor
20036721|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
20036722|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036723|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20036724|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20036725|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036726|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036727|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036728|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036729|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20036730|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20036731|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
20036732|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
20036733|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20036734|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20036735|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
20036736|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20036737|NCT04755712|Sufentanil|sufentanil|mesh-list
20036738|NCT04755712|Morphine|morphine|mesh-list
20036739|NCT04755712|Bupivacaine|bupivacaine|mesh-list
20036740|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036741|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
20036742|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036743|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036744|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
20036745|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036746|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20036747|NCT04755712|Narcotics|narcotics|mesh-ancestor
20036748|NCT04755712|Analgesics|analgesics|mesh-ancestor
20036749|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20036750|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20036751|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
20036752|NCT04752475|Furosemide|furosemide|mesh-list
20036753|NCT04752475|Diuretics|diuretics|mesh-ancestor
20036754|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
20036755|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036756|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20116558|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
20036757|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036758|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036759|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
20036760|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036761|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036762|NCT04751812|Narcotics|narcotics|mesh-ancestor
20036763|NCT04751812|Analgesics|analgesics|mesh-ancestor
20036764|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
20036765|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036766|NCT04739761|Trastuzumab|trastuzumab|mesh-list
20036767|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036768|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036769|NCT04733937|Caseins|caseins|mesh-list
20036770|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
20036771|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
20036772|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036773|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
20036774|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
20036775|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036776|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036777|NCT04705662|Lactulose|lactulose|mesh-list
20036778|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20036779|NCT04696029|Eflornithine|eflornithine|mesh-list
20036780|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036781|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20036782|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20036783|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20036784|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036785|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20036786|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036787|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036788|NCT04682366|Tamsulosin|tamsulosin|mesh-list
20036789|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20036790|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20036791|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20036792|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036793|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036794|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036795|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036796|NCT04682366|Urological Agents|urological agents|mesh-ancestor
20116559|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116560|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116561|NCT00005813|Antibodies|antibodies|mesh-list
20116562|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20116563|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
20116564|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116565|NCT00005814|Cetuximab|cetuximab|mesh-list
20116566|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116567|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20116568|NCT00005815|Thalidomide|thalidomide|mesh-list
20116569|NCT00005815|Temozolomide|temozolomide|mesh-list
20116570|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116571|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
20116572|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116573|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116574|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116575|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
20116576|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116577|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
20116578|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20116579|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116580|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20116581|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20116582|NCT00005815|Growth Substances|growth substances|mesh-ancestor
20116583|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
20116584|NCT00005818|Irinotecan|irinotecan|mesh-list
20116585|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20116586|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116587|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116588|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116589|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116590|NCT00005819|Paclitaxel|paclitaxel|mesh-list
20116591|NCT00005819|Fenretinide|fenretinide|mesh-list
20116592|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20036797|NCT04665089|Erythromycin|erythromycin|mesh-list
20036798|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
20036799|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20036800|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
20036801|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20036802|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20036803|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20036804|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20036805|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036806|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036807|NCT04654988|Prednisone|prednisone|mesh-list
20036808|NCT04654988|Azathioprine|azathioprine|mesh-list
20036809|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20036810|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
20036811|NCT04654988|Hormones|hormones|mesh-ancestor
20036812|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036813|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036814|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20036815|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036816|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
20036817|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036818|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20036819|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20036820|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
20036821|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20036822|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
20036823|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20036824|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036825|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036826|NCT04645823|Lidocaine|lidocaine|mesh-list
20036827|NCT04645823|Fentanyl|fentanyl|mesh-list
20036828|NCT04645823|Citric Acid|citric acid|mesh-list
20036829|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
20036830|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
20036831|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
20036832|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036833|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036834|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
20036835|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036836|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20036837|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20036838|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20036839|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036840|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036841|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20036842|NCT04645823|Narcotics|narcotics|mesh-ancestor
20036843|NCT04645823|Analgesics|analgesics|mesh-ancestor
20036844|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20036845|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20036846|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
20036847|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
20036848|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20036849|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
20036850|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
20036851|NCT04644068|Paclitaxel|paclitaxel|mesh-list
20036852|NCT04644068|Carboplatin|carboplatin|mesh-list
20036853|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20036854|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036855|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
20036856|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
20036857|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
20036858|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036859|NCT04640545|Axitinib|axitinib|mesh-list
20036860|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036861|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20036862|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036863|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036864|NCT04630808|Latanoprost|latanoprost|mesh-list
20036865|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20036866|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20036867|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
20036868|NCT04606901|Neostigmine|neostigmine|mesh-list
20036869|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20036870|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036871|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036872|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
20036873|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036874|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036875|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20036876|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
20036877|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036878|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20036879|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20036880|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20036881|NCT04606771|Osimertinib|osimertinib|mesh-list
20036882|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036883|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20036884|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036885|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036891|NCT04573946|Vitamin D|vitamin d|mesh-list
20036892|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
20036893|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
20036894|NCT04573946|Vitamins|vitamins|mesh-list
20036895|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
20036896|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036897|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20036898|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20036899|NCT04573751|Verapamil|verapamil|mesh-list
20036900|NCT04573751|Epinephrine|epinephrine|mesh-list
20036901|NCT04573751|Racepinephrine|racepinephrine|mesh-list
20036902|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
20036903|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20036904|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20036905|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036906|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036907|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036908|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036909|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20036910|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20036911|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
20036912|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036913|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20036914|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
20036915|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
20036916|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
20036917|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20036918|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20036919|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20036920|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036921|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20036922|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
20036923|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
20036924|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20036925|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036926|NCT04549428|Atezolizumab|atezolizumab|mesh-list
20036927|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036928|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20036929|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20036930|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20036931|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
20036932|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036933|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20036934|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20036935|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036936|NCT04532645|Olaparib|olaparib|mesh-list
20036937|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20036938|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036939|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036940|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036941|NCT04527900|Paclitaxel|paclitaxel|mesh-list
20036942|NCT04527900|Carboplatin|carboplatin|mesh-list
20036943|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20036944|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20036945|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
20036946|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20036947|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
20036948|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036949|NCT04520217|Imipramine|imipramine|mesh-list
20036950|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20036951|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
20036952|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20036953|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20036954|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20036955|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20036956|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036957|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
20036958|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036959|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036960|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20036961|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20036962|NCT04507022|Estradiol|estradiol|mesh-list
20036963|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20036964|NCT04507022|Progesterone|progesterone|mesh-list
20036965|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20036966|NCT04507022|Estrogens|estrogens|mesh-ancestor
20036967|NCT04507022|Hormones|hormones|mesh-ancestor
20036968|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20036969|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036970|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20036971|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
20036972|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20036973|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20036974|NCT04507022|Progestins|progestins|mesh-ancestor
20036975|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20036976|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20036977|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036978|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20036979|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
20036980|NCT04504175|Ketamine|ketamine|mesh-list
20036981|NCT04504175|Analgesics|analgesics|mesh-ancestor
20036982|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
20036983|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20036984|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20036985|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20036986|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20036987|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
20036988|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
20036989|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20036990|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20036991|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20036992|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20036993|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036994|NCT04497116|Gemcitabine|gemcitabine|mesh-list
20036995|NCT04497116|Talazoparib|talazoparib|mesh-list
20036996|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20036997|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
20036998|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20036999|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037000|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
20037001|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037002|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037003|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037004|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
20037005|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037006|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20037007|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
20037008|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20037009|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20037010|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037011|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
20037012|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037013|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037014|NCT04430959|Candesartan|candesartan|mesh-list
20037015|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20037016|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20037017|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20116593|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037018|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037019|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
20037020|NCT04421196|Analgesics|analgesics|mesh-list
20037021|NCT04421196|Narcotics|narcotics|mesh-ancestor
20037022|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20037023|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037024|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
20037025|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116594|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116595|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116596|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116597|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116598|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20116599|NCT00005819|Protective Agents|protective agents|mesh-ancestor
20116600|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116601|NCT00005822|Tamoxifen|tamoxifen|mesh-list
20116602|NCT00005822|Doxorubicin|doxorubicin|mesh-list
20116603|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20116604|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116605|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116606|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116607|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116608|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116609|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116610|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20116611|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
20116612|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116613|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116614|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20116615|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20116616|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20116617|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20116618|NCT00005823|Cytarabine|cytarabine|mesh-list
20116619|NCT00005823|Etoposide|etoposide|mesh-list
20116620|NCT00005823|Daunorubicin|daunorubicin|mesh-list
20116621|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
20116622|NCT00005823|Idarubicin|idarubicin|mesh-list
20116623|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
20116624|NCT00005823|Tretinoin|tretinoin|mesh-list
20116625|NCT00005823|Thioguanine|thioguanine|mesh-list
20116626|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116627|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116628|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116629|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116630|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116631|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116632|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116633|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
20116634|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
20116635|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116636|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116637|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
20116638|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116639|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116640|NCT00005823|Analgesics|analgesics|mesh-ancestor
20116641|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
20116642|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116643|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
20116644|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116645|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
20116646|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116647|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
20116648|NCT00005824|Busulfan|busulfan|mesh-list
20116649|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116650|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
20116651|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116652|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116653|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116654|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
20116655|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116656|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116657|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116658|NCT00005825|Vinorelbine|vinorelbine|mesh-list
20116659|NCT00005825|Mitomycins|mitomycins|mesh-list
20116660|NCT00005825|Mitomycin|mitomycin|mesh-list
20116661|NCT00005825|Tretinoin|tretinoin|mesh-list
20037026|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
20037027|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
20037028|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20037029|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20037030|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037031|NCT04372628|Ritonavir|ritonavir|mesh-list
20037032|NCT04372628|Lopinavir|lopinavir|mesh-list
20037033|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20037034|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20037035|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
20037036|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037037|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037038|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20037039|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20037040|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
20037041|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037042|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20037043|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20037044|NCT04367090|Docetaxel|docetaxel|mesh-list
20037045|NCT04367090|Trastuzumab|trastuzumab|mesh-list
20037046|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037047|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
20037048|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
20037049|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
20037050|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037051|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037052|NCT04344873|Abatacept|abatacept|mesh-list
20037053|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20037054|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037055|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037056|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037057|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
20037058|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037059|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037060|NCT04340856|Bisacodyl|bisacodyl|mesh-list
20037061|NCT04340856|Laxatives|laxatives|mesh-list
20037062|NCT04340856|Cathartics|cathartics|mesh-ancestor
20037063|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20037064|NCT04338022|Teriflunomide|teriflunomide|mesh-list
20037065|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037066|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037067|NCT04338022|Analgesics|analgesics|mesh-ancestor
20037068|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
20037069|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037070|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037071|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037072|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037073|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037074|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
20037075|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
20037076|NCT04336189|Piperaquine|piperaquine|mesh-list
20037077|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
20037078|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20037079|NCT04336189|Artenimol|artenimol|mesh-list
20037080|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
20037081|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20037082|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20037083|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037084|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20037085|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037086|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037087|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20037088|NCT04336189|Renal Agents|renal agents|mesh-ancestor
20037089|NCT04332497|Ibuprofen|ibuprofen|mesh-list
20037090|NCT04332497|Fentanyl|fentanyl|mesh-list
20037091|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20037092|NCT04332497|Narcotics|narcotics|mesh-ancestor
20037093|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20037094|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037095|NCT04332497|Analgesics|analgesics|mesh-ancestor
20037096|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
20037097|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037098|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20037099|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20037100|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
20037101|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
20037102|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037103|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037104|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037105|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037106|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20037107|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037108|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037109|NCT04311567|Methotrexate|methotrexate|mesh-list
20037110|NCT04311567|Tofacitinib|tofacitinib|mesh-list
20037111|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20037112|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
20037113|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20037114|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037115|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037116|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
20037117|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037118|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037119|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
20037120|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037121|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20037122|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037123|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
20037124|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037125|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20037126|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20037127|NCT04307953|Saracatinib|saracatinib|mesh-list
20037128|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037129|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037130|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037131|NCT04301843|Eflornithine|eflornithine|mesh-list
20037132|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037133|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20037134|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20037135|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20037136|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037137|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20037138|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037139|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037162|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
20037163|NCT04291001|Etonogestrel|etonogestrel|mesh-list
20037164|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20037165|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
20037166|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20037167|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037168|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20037169|NCT04260659|Lidocaine|lidocaine|mesh-list
20037170|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
20037171|NCT04260659|Fentanyl|fentanyl|mesh-list
20037172|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
20037173|NCT04260659|Ketamine|ketamine|mesh-list
20037174|NCT04260659|Remifentanil|remifentanil|mesh-list
20037175|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
20037176|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
20037177|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20037178|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037179|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
20037180|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037181|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20037182|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20037183|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20037184|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20037185|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037186|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20037187|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037188|NCT04260659|Analgesics|analgesics|mesh-ancestor
20037189|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20037190|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20037191|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20037192|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
20037193|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037194|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20037195|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20037196|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
20037197|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20037198|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20037199|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20037200|NCT04260659|Narcotics|narcotics|mesh-ancestor
20037201|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20037202|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
20037203|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20037204|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20037205|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
20037206|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20037207|NCT04259775|Insulin|insulin|mesh-list
20037208|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20037209|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037210|NCT04258397|Pirfenidone|pirfenidone|mesh-list
20037211|NCT04258397|Analgesics|analgesics|mesh-ancestor
20037212|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
20037213|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037214|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037215|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037216|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037217|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037218|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037219|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037220|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
20037221|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037222|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037223|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
20037224|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037225|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
20037226|NCT04231708|Yohimbine|yohimbine|mesh-list
20037227|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037228|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
20037229|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
20037230|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037231|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037232|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20037233|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20037234|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20037235|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
20037236|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037237|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037238|NCT04231708|Urological Agents|urological agents|mesh-ancestor
20037239|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
20037240|NCT04225078|Loperamide|loperamide|mesh-list
20037241|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
20037242|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20037243|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037244|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20037245|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20037246|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037247|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037248|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037249|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20037250|NCT04188665|Lectins|lectins|mesh-list
20037251|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
20037252|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
20037253|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037254|NCT04188665|Coagulants|coagulants|mesh-ancestor
20037255|NCT04186247|Azithromycin|azithromycin|mesh-list
20037256|NCT04186247|Metronidazole|metronidazole|mesh-list
20037257|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20037258|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037259|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20037260|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20037261|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
20037262|NCT04181515|Yohimbine|yohimbine|mesh-list
20037263|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037264|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
20037265|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
20037266|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037267|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037268|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20037269|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20037270|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20037271|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
20037272|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037273|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037274|NCT04181515|Urological Agents|urological agents|mesh-ancestor
20037275|NCT04181255|Poractant alfa|poractant alfa|mesh-list
20037276|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20037277|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
20037278|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
20037279|NCT04180969|Yohimbine|yohimbine|mesh-list
20037280|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037281|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
20037282|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
20037283|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037284|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037285|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20037286|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20037287|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20037288|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
20037289|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037290|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037291|NCT04180969|Urological Agents|urological agents|mesh-ancestor
20037300|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
20037301|NCT04164069|Leucovorin|leucovorin|mesh-list
20037302|NCT04164069|Folic Acid|folic acid|mesh-list
20037303|NCT04164069|Bevacizumab|bevacizumab|mesh-list
20037304|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20037305|NCT04164069|Fluorouracil|fluorouracil|mesh-list
20037306|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
20037307|NCT04164069|Dasatinib|dasatinib|mesh-list
20037308|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
20037309|NCT04164069|Antibodies|antibodies|mesh-list
20037310|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
20037311|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20037312|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
20037313|NCT04164069|Calcium|calcium|mesh-list
20037314|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
20037315|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037316|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20037317|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20037318|NCT04164069|Growth Substances|growth substances|mesh-ancestor
20037319|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037320|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
20037321|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
20037322|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20037323|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20037324|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
20037325|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037326|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037327|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037328|NCT04164069|Antidotes|antidotes|mesh-ancestor
20037329|NCT04164069|Protective Agents|protective agents|mesh-ancestor
20037330|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
20037331|NCT04164069|Vitamins|vitamins|mesh-ancestor
20037332|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
20037333|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20037334|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037335|NCT04164069|Hematinics|hematinics|mesh-ancestor
20037336|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20037337|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
20037338|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037339|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20037340|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20037341|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037342|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037343|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20037344|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20037345|NCT04129502|Carboplatin|carboplatin|mesh-list
20037346|NCT04129502|Pemetrexed|pemetrexed|mesh-list
20037347|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037348|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037349|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037350|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20037351|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20037352|NCT04101877|Bevacizumab|bevacizumab|mesh-list
20037353|NCT04101877|Aflibercept|aflibercept|mesh-list
20037354|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037355|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037356|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20037357|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20037358|NCT04101877|Growth Substances|growth substances|mesh-ancestor
20037359|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037360|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
20037361|NCT04079712|Nivolumab|nivolumab|mesh-list
20037362|NCT04079712|Ipilimumab|ipilimumab|mesh-list
20037363|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037364|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037365|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20037366|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037367|NCT04074161|Liraglutide|liraglutide|mesh-list
20037368|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20037369|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037370|NCT04074161|Incretins|incretins|mesh-ancestor
20037371|NCT04074161|Hormones|hormones|mesh-ancestor
20037372|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20037373|NCT04061330|Ketamine|ketamine|mesh-list
20037374|NCT04061330|Morphine|morphine|mesh-list
20037375|NCT04061330|Analgesics|analgesics|mesh-ancestor
20037376|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
20037377|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037378|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037379|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20037380|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20037381|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
20037382|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
20037383|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20037384|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20037385|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20037386|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037387|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037388|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20037389|NCT04061330|Narcotics|narcotics|mesh-ancestor
20037390|NCT04057898|Ibudilast|ibudilast|mesh-list
20037391|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20037392|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
20037393|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037394|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037395|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20037396|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
20037397|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20037398|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037399|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037400|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20037401|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
20037402|NCT04040790|Phenylephrine|phenylephrine|mesh-list
20037403|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
20037404|NCT04040790|Tropicamide|tropicamide|mesh-list
20037405|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20037406|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
20037407|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
20037408|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037409|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037410|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
20037411|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20037412|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
20037413|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
20037414|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20037415|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20037416|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20037417|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
20037418|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037419|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037420|NCT04040790|Protective Agents|protective agents|mesh-ancestor
20037421|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20037422|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20037423|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
20116662|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116663|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116664|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116665|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116666|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116667|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116668|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116669|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
20116670|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116671|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116672|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
20116673|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116674|NCT00005826|Rubitecan|rubitecan|mesh-list
20116675|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116676|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20116677|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116678|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116679|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116680|NCT00005827|Genistein|genistein|mesh-list
20116681|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20116682|NCT00005827|Protective Agents|protective agents|mesh-ancestor
20116683|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116684|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116685|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20116686|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116687|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116688|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
20116689|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20116690|NCT00005827|Estrogens|estrogens|mesh-ancestor
20116691|NCT00005827|Hormones|hormones|mesh-ancestor
20116692|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116693|NCT00005829|Gemcitabine|gemcitabine|mesh-list
20116694|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116695|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
20116696|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116697|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116698|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
20116699|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116700|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116701|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116702|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
20116703|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116704|NCT00005830|Doxorubicin|doxorubicin|mesh-list
20116705|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20116706|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116707|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116708|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116709|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116710|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116711|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116712|NCT00005831|Gemcitabine|gemcitabine|mesh-list
20116713|NCT00005831|Paclitaxel|paclitaxel|mesh-list
20116714|NCT00005831|Carboplatin|carboplatin|mesh-list
20037424|NCT04033354|Paclitaxel|paclitaxel|mesh-list
20037425|NCT04033354|Carboplatin|carboplatin|mesh-list
20037426|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20037427|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037428|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
20037429|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
20037430|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
20037431|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037432|NCT04028063|Doxorubicin|doxorubicin|mesh-list
20037433|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20037434|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037435|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20037436|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20037437|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037438|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037439|NCT04027894|Rifamycins|rifamycins|mesh-list
20037440|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
20037441|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20037442|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037443|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037444|NCT04026984|Rifamycins|rifamycins|mesh-list
20037445|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
20037446|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20037447|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037448|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037449|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
20037450|NCT04025216|Fludarabine|fludarabine|mesh-list
20037451|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037452|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
20037453|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037454|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037455|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20037456|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
20037457|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037458|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037459|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20037460|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
20037461|NCT04024761|Fludarabine|fludarabine|mesh-list
20037462|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037463|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
20037464|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037465|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037466|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20037467|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
20037468|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037469|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037470|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20037471|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
20037472|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20037473|NCT03923270|Durvalumab|durvalumab|mesh-list
20037474|NCT03923270|Olaparib|olaparib|mesh-list
20037475|NCT03923270|Tremelimumab|tremelimumab|mesh-list
20037476|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20037477|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037478|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037479|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20037480|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037481|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037482|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
20037483|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037484|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20037485|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20037486|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20037487|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037488|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037489|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20037490|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20037491|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037492|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
20037493|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037494|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
20037495|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20037496|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20037497|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037498|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
20037499|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037500|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037501|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
20037502|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20037503|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20037504|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037505|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
20037506|NCT03897621|Coagulants|coagulants|mesh-ancestor
20037507|NCT03897127|Cytarabine|cytarabine|mesh-list
20037508|NCT03897127|Daunorubicin|daunorubicin|mesh-list
20037509|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037510|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
20037511|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037512|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037513|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
20037514|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037515|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037516|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
20037517|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037518|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20037519|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20037520|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20037521|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037530|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
20037531|NCT03797196|Everolimus|everolimus|mesh-list
20037532|NCT03797196|Tacrolimus|tacrolimus|mesh-list
20037533|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037534|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
20037535|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037536|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20037537|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037538|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037539|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037540|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20037541|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20037542|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
20037543|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20037544|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037545|NCT03782415|Temozolomide|temozolomide|mesh-list
20037546|NCT03782415|Ibudilast|ibudilast|mesh-list
20037547|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20037548|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
20037549|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037550|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037551|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20037552|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
20037553|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037554|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037555|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20037556|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
20037557|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20037558|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037559|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20037560|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
20037561|NCT03773302|Gemcitabine|gemcitabine|mesh-list
20037562|NCT03773302|Infigratinib|infigratinib|mesh-list
20037563|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037564|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037565|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
20037566|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037567|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
20037568|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037569|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037570|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037571|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
20037572|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037573|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20037574|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20037575|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037576|NCT03743766|Nivolumab|nivolumab|mesh-list
20037577|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037578|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037579|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20037580|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037586|NCT03701763|Apremilast|apremilast|mesh-list
20037587|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037588|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037589|NCT03701763|Analgesics|analgesics|mesh-ancestor
20037590|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
20037591|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037592|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037593|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037594|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037595|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20037596|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20037597|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037598|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037599|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20037600|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037601|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037602|NCT03628716|Atezolizumab|atezolizumab|mesh-list
20037603|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037604|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
20037605|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20037606|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037607|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20037608|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037609|NCT03611738|Docetaxel|docetaxel|mesh-list
20037610|NCT03611738|Ceritinib|ceritinib|mesh-list
20037611|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037612|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
20037613|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
20037614|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
20037615|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037616|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20037617|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037618|NCT03598309|Curcumin|curcumin|mesh-list
20037619|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037620|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037621|NCT03598309|Analgesics|analgesics|mesh-ancestor
20037622|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
20037623|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037624|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037625|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037626|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037627|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037628|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037629|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037630|NCT03581409|Aspirin|aspirin|mesh-list
20037631|NCT03581409|Cilostazol|cilostazol|mesh-list
20037632|NCT03581409|Clopidogrel|clopidogrel|mesh-list
20037633|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20037634|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037635|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037636|NCT03581409|Analgesics|analgesics|mesh-ancestor
20037637|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
20037638|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037639|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037640|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037641|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037642|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20037643|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20037644|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037645|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20037646|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20037647|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037648|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
20037649|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20037650|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20037651|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20037652|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
20037653|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037654|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20037655|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
20037656|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20037657|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
20037658|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
20037659|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20037660|NCT03581409|Protective Agents|protective agents|mesh-ancestor
20037661|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20037662|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20037663|NCT03566667|Metoprolol|metoprolol|mesh-list
20037664|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20037665|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20037666|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
20037667|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
20037668|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037669|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037670|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20037671|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20037672|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20037673|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
20037674|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037675|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037676|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20037677|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20037678|NCT03556800|Estradiol|estradiol|mesh-list
20037679|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20037680|NCT03556800|Estrogens|estrogens|mesh-ancestor
20037681|NCT03556800|Hormones|hormones|mesh-ancestor
20037682|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20037683|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037684|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20037685|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
20037686|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20037687|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20037688|NCT03532217|Nivolumab|nivolumab|mesh-list
20037689|NCT03532217|Ipilimumab|ipilimumab|mesh-list
20037690|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037691|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037692|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20037693|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116715|NCT00005831|Trastuzumab|trastuzumab|mesh-list
20116716|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116717|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116718|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116719|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116720|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116721|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116722|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116723|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
20116724|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
20116725|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116726|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116727|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116728|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
20116729|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116730|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20116731|NCT00005832|Tipifarnib|tipifarnib|mesh-list
20116732|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116733|NCT00005833|Tipifarnib|tipifarnib|mesh-list
20116734|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116735|NCT00005834|Thalidomide|thalidomide|mesh-list
20116736|NCT00005834|Dexamethasone|dexamethasone|mesh-list
20116737|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
20116738|NCT00005834|Etoposide|etoposide|mesh-list
20116739|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116740|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
20116741|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037694|NCT03519256|Nivolumab|nivolumab|mesh-list
20037695|NCT03519256|Linrodostat|linrodostat|mesh-list
20037696|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037697|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037698|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20037699|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037700|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037701|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
20037702|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
20037703|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20037704|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
20037705|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037706|NCT03510741|Expectorants|expectorants|mesh-ancestor
20037707|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
20037708|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20037709|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
20037710|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037711|NCT03510741|Protective Agents|protective agents|mesh-ancestor
20037712|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749281|NCT05187182|Leucovorin|leucovorin|mesh-list
20037713|NCT03510741|Antidotes|antidotes|mesh-ancestor
20037714|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
20037715|NCT03503513|Gentamicins|gentamicins|mesh-list
20037716|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20037717|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037718|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20037719|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037720|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037721|NCT03492177|Selexipag|selexipag|mesh-list
20037722|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20037723|NCT03472495|Diltiazem|diltiazem|mesh-list
20037724|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20037725|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20037726|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20037727|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037728|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20037729|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037730|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
20037731|NCT03425643|Gemcitabine|gemcitabine|mesh-list
20037732|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
20037733|NCT03425643|Pemetrexed|pemetrexed|mesh-list
20037734|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037735|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037736|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
20037737|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037738|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
20037739|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037740|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037741|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037742|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
20037743|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037744|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037745|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20037746|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20037747|NCT03392376|Haloperidol|haloperidol|mesh-list
20037748|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
20037749|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
20037750|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
20037751|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293160|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20293161|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20293162|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20293163|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20308357|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308358|NCT00663897|Lansoprazole|lansoprazole|mesh-list
20037752|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037753|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20293164|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
20293165|NCT04701476|Tirapazamine|tirapazamine|mesh-list
20293166|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293167|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293168|NCT04699838|Carboplatin|carboplatin|mesh-list
20293169|NCT04699838|Etoposide|etoposide|mesh-list
20293170|NCT04699838|Durvalumab|durvalumab|mesh-list
20293171|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293172|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20293173|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19749282|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
20293174|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20293175|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037754|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20037755|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20037756|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20037757|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20037758|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20037759|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
20037760|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037761|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037762|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20037763|NCT03381183|Durvalumab|durvalumab|mesh-list
20037764|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037765|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037766|NCT03377699|Insulin|insulin|mesh-list
20037767|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20037768|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
20037769|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
20037770|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20037771|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037772|NCT03377023|Nivolumab|nivolumab|mesh-list
20037773|NCT03377023|Ipilimumab|ipilimumab|mesh-list
20037774|NCT03377023|Nintedanib|nintedanib|mesh-list
20037775|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037776|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037777|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20037778|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037779|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20037780|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037781|NCT03365687|Vitamin D|vitamin d|mesh-list
20037782|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
20037783|NCT03365687|Vitamins|vitamins|mesh-ancestor
20037784|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
20037785|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037786|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20037787|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20037788|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
20037789|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037790|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037791|NCT03275350|Naltrexone|naltrexone|mesh-list
20037792|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20037793|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20037794|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037795|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
20037796|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037797|NCT03272347|Tenofovir|tenofovir|mesh-list
20037798|NCT03272347|Lamivudine|lamivudine|mesh-list
20037799|NCT03272347|Islatravir|islatravir|mesh-list
20037800|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
20037801|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037802|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20037803|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20037804|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037805|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037806|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20037807|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20037808|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
20037809|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037810|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293176|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037811|NCT03250832|Bevacizumab|bevacizumab|mesh-list
20037812|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20308359|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
20037813|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037814|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20037815|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20037816|NCT03250832|Growth Substances|growth substances|mesh-ancestor
20037817|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037818|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
20037819|NCT03216967|Everolimus|everolimus|mesh-list
20037820|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037821|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037822|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
20037823|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037824|NCT03197194|Aspirin|aspirin|mesh-list
20037825|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20037826|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037827|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037828|NCT03197194|Analgesics|analgesics|mesh-ancestor
20037829|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
20037830|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037831|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037832|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037833|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037834|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20037835|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20037836|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037837|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20037838|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20037839|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037840|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
20037841|NCT03168880|Paclitaxel|paclitaxel|mesh-list
20037842|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20037843|NCT03168880|Carboplatin|carboplatin|mesh-list
20037844|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20037845|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037846|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
20037847|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
20037848|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
20037849|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037850|NCT03092895|Apatinib|apatinib|mesh-list
20037851|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037852|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20037853|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037854|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491469|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037855|NCT02984384|Aspirin|aspirin|mesh-list
20037856|NCT02984384|Heparin|heparin|mesh-list
20037857|NCT02984384|Enoxaparin|enoxaparin|mesh-list
19491470|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19491471|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19491472|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19491473|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491474|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19491475|NCT03130426|Insulin|insulin|mesh-list
19491476|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19491477|NCT03130426|Metformin|metformin|mesh-list
19491478|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
19491479|NCT03130426|Lixisenatide|lixisenatide|mesh-list
19491480|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19491481|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491482|NCT03130582|Etoposide|etoposide|mesh-list
19569599|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
20037858|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20037859|NCT02984384|Tinzaparin|tinzaparin|mesh-list
20037860|NCT02984384|Dalteparin|dalteparin|mesh-list
20037861|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20037862|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20037863|NCT02984384|Analgesics|analgesics|mesh-ancestor
20037864|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
20116742|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037865|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20037866|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037867|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20037868|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037869|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20037870|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20037871|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037872|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20037873|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20037874|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037875|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
20037876|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
20037877|NCT02977299|Aripiprazole|aripiprazole|mesh-list
20037878|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20037879|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
20037880|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20037881|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20037882|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20037883|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20037884|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037885|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
20037886|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
20037887|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20037888|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037889|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20037890|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20037891|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
20037892|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20037893|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20037894|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20037895|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20037896|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20037897|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20037898|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20037899|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20037900|NCT02932410|Macitentan|macitentan|mesh-list
20037901|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20037902|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20037903|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037904|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20037905|NCT02923466|Interferon-beta|interferon-beta|mesh-list
20037906|NCT02923466|Avelumab|avelumab|mesh-list
20037907|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037908|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037909|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
20037910|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037911|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
20037912|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037913|NCT02915198|Metformin|metformin|mesh-list
20037914|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20037915|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037916|NCT02853305|Gemcitabine|gemcitabine|mesh-list
20037917|NCT02853305|Carboplatin|carboplatin|mesh-list
20037918|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
20037919|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037920|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037921|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
20037922|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037923|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
20037924|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037925|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037926|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037927|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
20037928|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037929|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037930|NCT02850874|Gemcitabine|gemcitabine|mesh-list
20037931|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037932|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
20037933|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037934|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037935|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
20037936|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037937|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037938|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037939|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
20037940|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037941|NCT02827838|Durvalumab|durvalumab|mesh-list
20037942|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
20037943|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20037944|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
20037945|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037946|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037947|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
20037948|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037949|NCT02794337|Sorafenib|sorafenib|mesh-list
20037950|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037951|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20037952|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037953|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037954|NCT02773485|Gemcitabine|gemcitabine|mesh-list
20037955|NCT02773485|Cisplatin|cisplatin|mesh-list
20037956|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037957|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20037958|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
20037959|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037960|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
20037961|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20037962|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037963|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037964|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
20037965|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037966|NCT02759588|Bevacizumab|bevacizumab|mesh-list
20037967|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037968|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037969|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20037970|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20037971|NCT02759588|Growth Substances|growth substances|mesh-ancestor
20037972|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037973|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
20037974|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
20037975|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20037976|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116743|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116744|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
20116745|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116746|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116747|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116748|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20116749|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
20116750|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
20116751|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116752|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20116753|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
20116754|NCT00005834|Hormones|hormones|mesh-ancestor
20116755|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116756|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20116757|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116758|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116759|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116760|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116761|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
20116762|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20116763|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116764|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20116765|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20116766|NCT00005834|Growth Substances|growth substances|mesh-ancestor
20116767|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
20116768|NCT00005835|Melphalan|melphalan|mesh-list
20116769|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
20116770|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
20116771|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116772|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116773|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
20116774|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116775|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116776|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19491483|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20037977|NCT02721459|Vemurafenib|vemurafenib|mesh-list
20037978|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037979|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20037980|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20037981|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037982|NCT02652455|Aldesleukin|aldesleukin|mesh-list
20037983|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
20037984|NCT02652455|Nivolumab|nivolumab|mesh-list
20037985|NCT02652455|Fludarabine|fludarabine|mesh-list
20037986|NCT02652455|Interleukin-2|interleukin-2|mesh-list
20037987|NCT02652455|Antibodies|antibodies|mesh-list
20037988|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
20037989|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
20037990|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20037991|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
20037992|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20037993|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20037994|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20037995|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
20037996|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20037997|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20037998|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20037999|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038000|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20038001|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038002|NCT02652455|Analgesics|analgesics|mesh-ancestor
20038003|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
20038004|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038005|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20038006|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20038007|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
20038008|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038009|NCT02638701|Infliximab|infliximab|mesh-list
20038010|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20038011|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20038012|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038013|NCT02631733|Irinotecan|irinotecan|mesh-list
20038014|NCT02631733|Veliparib|veliparib|mesh-list
20038015|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20038016|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20038017|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20038018|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038019|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038020|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038021|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20038022|NCT02631733|Hematinics|hematinics|mesh-ancestor
20038023|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20038024|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20038025|NCT02611037|Gemcitabine|gemcitabine|mesh-list
20038026|NCT02611037|Methotrexate|methotrexate|mesh-list
20038027|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038028|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20038029|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
20038030|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038031|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
20038032|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038033|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038034|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038035|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
20038036|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038037|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20038038|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
20038039|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20038040|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
20038041|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20038042|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038043|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20576513|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20576514|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
20576515|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20576516|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20038044|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
20038045|NCT02590523|Vancomycin|vancomycin|mesh-list
20038046|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20038047|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038048|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20038049|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20038050|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038051|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038052|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038053|NCT02582125|Nivolumab|nivolumab|mesh-list
20038054|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038055|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038056|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20038057|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038058|NCT02440854|Afatinib|afatinib|mesh-list
20038059|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038060|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038061|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038062|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038063|NCT02344498|Tenofovir|tenofovir|mesh-list
20038064|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
20038065|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038066|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20038067|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20038068|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038069|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038070|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20038071|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20038072|NCT02278185|Leuprolide|leuprolide|mesh-list
20038073|NCT02278185|Goserelin|goserelin|mesh-list
20038074|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20038075|NCT02278185|Tryptophan|tryptophan|mesh-list
20038076|NCT02278185|Androgens|androgens|mesh-list
20038077|NCT02278185|Hormones|hormones|mesh-ancestor
20038078|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038079|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038080|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20038081|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
20038082|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20038083|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20038084|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038085|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
20038086|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20038087|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
20038088|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20038089|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20038090|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
20038091|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20038092|NCT02208375|Olaparib|olaparib|mesh-list
20038093|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20038094|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038095|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038096|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038097|NCT02154529|Trastuzumab|trastuzumab|mesh-list
20038098|NCT02154529|XL647|xl647|mesh-list
20038099|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038100|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038101|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038102|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038103|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038104|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20038105|NCT02154490|Nivolumab|nivolumab|mesh-list
20038106|NCT02154490|Ipilimumab|ipilimumab|mesh-list
20038107|NCT02154490|Durvalumab|durvalumab|mesh-list
20038108|NCT02154490|Rilotumumab|rilotumumab|mesh-list
20038109|NCT02154490|Docetaxel|docetaxel|mesh-list
20038110|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20038111|NCT02154490|Palbociclib|palbociclib|mesh-list
20038112|NCT02154490|Tremelimumab|tremelimumab|mesh-list
20038113|NCT02154490|Talazoparib|talazoparib|mesh-list
20038114|NCT02154490|Antibodies|antibodies|mesh-list
20038115|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
20038116|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20038117|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
20038118|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
20293177|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038119|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038120|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038121|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
20038122|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
20038123|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
20038124|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038125|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20038126|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20576517|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20576518|NCT02071641|Sunitinib|sunitinib|mesh-list
20576519|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576520|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20576521|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20576522|NCT02071641|Growth Substances|growth substances|mesh-ancestor
20038127|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038128|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20576523|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576524|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
20576525|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20576526|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576527|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038129|NCT02149277|Lenograstim|lenograstim|mesh-list
20038130|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20038131|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
20038132|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038133|NCT02143466|Durvalumab|durvalumab|mesh-list
20038134|NCT02143466|Osimertinib|osimertinib|mesh-list
20038135|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20038136|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038137|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038138|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
20038139|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038140|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038141|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038142|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038143|NCT02120807|Pemetrexed|pemetrexed|mesh-list
20038144|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
20038145|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038146|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038147|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038148|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20038149|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20038150|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038151|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
20038152|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038153|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038154|NCT02062489|Tamoxifen|tamoxifen|mesh-list
20038155|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20038156|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
20038157|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038158|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038159|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20038160|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038161|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20038162|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20038163|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20038164|NCT02060721|Macitentan|macitentan|mesh-list
20038165|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20038166|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20038167|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038168|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20038169|NCT01821781|Fludarabine|fludarabine|mesh-list
20038170|NCT01821781|Melphalan|melphalan|mesh-list
20038171|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
20038172|NCT01821781|Thiotepa|thiotepa|mesh-list
20038173|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038174|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038175|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038176|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
20038177|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038178|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20038179|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
20038180|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20038181|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20576528|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20038182|NCT01785420|Trastuzumab|trastuzumab|mesh-list
20038183|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038184|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038185|NCT01704859|Vitamin D|vitamin d|mesh-list
20038186|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
20038187|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
20038188|NCT01704859|Vitamins|vitamins|mesh-list
20038189|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
20038190|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038191|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20038192|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20038193|NCT01685814|Lenalidomide|lenalidomide|mesh-list
20038194|NCT01685814|Bortezomib|bortezomib|mesh-list
20576529|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576530|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576531|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576532|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20576533|NCT02071862|Paclitaxel|paclitaxel|mesh-list
20576534|NCT02071862|Docetaxel|docetaxel|mesh-list
20576535|NCT02071862|Everolimus|everolimus|mesh-list
20576536|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20576537|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576538|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
20576539|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
20576540|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
20576541|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038195|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
20038196|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038197|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038198|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038199|NCT01685814|Growth Substances|growth substances|mesh-ancestor
20038200|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038201|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038202|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
20038203|NCT01547468|Narcotics|narcotics|mesh-ancestor
20038204|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038205|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038206|NCT01547468|Analgesics|analgesics|mesh-ancestor
20038207|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
20038208|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038209|NCT01485861|Prednisone|prednisone|mesh-list
20038210|NCT01485861|Prednisolone|prednisolone|mesh-list
20038211|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038212|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
20038213|NCT01485861|Hormones|hormones|mesh-ancestor
20038214|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038215|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038216|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20038217|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038218|NCT01387763|Interferons|interferons|mesh-list
20038219|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
20038220|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
20038221|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20038222|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20038223|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
20038224|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038225|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
20038226|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038227|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
20038228|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038229|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
20038230|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038231|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038232|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20038233|NCT01349881|Eflornithine|eflornithine|mesh-list
20038234|NCT01349881|Sulindac|sulindac|mesh-list
20038235|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038236|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20038237|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20038238|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20038239|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038240|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20038241|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038242|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038243|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20038244|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038245|NCT01349881|Analgesics|analgesics|mesh-ancestor
20038246|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
20038247|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038248|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038249|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038250|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038251|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20038252|NCT01330446|Modafinil|modafinil|mesh-list
20038253|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20038254|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038255|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20038256|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20038257|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20038258|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038259|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
20038260|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20038261|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20038262|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038263|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20038264|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20038265|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
20038266|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20038267|NCT01295645|Cidofovir|cidofovir|mesh-list
20038268|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
20038269|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038270|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038271|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038272|NCT01283997|Minocycline|minocycline|mesh-list
20038273|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20038274|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038275|NCT01254864|Prednisone|prednisone|mesh-list
20038276|NCT01254864|Sunitinib|sunitinib|mesh-list
20038277|NCT01254864|Dasatinib|dasatinib|mesh-list
20038278|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
20038279|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038280|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
20038281|NCT01254864|Hormones|hormones|mesh-ancestor
20038282|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038283|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038284|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20038285|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038286|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038287|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038288|NCT01254864|Growth Substances|growth substances|mesh-ancestor
20038289|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038290|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038291|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038292|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038293|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20038294|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
20038295|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20038296|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
20038297|NCT01246869|Imidazole|imidazole|mesh-list
20038298|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038299|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038300|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
20038301|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
20038302|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038303|NCT01198067|Pomalidomide|pomalidomide|mesh-list
20038304|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
20038305|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038306|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038307|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038308|NCT01198067|Growth Substances|growth substances|mesh-ancestor
20038309|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038310|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038311|NCT01187199|Sirolimus|sirolimus|mesh-list
20038312|NCT01187199|Paclitaxel|paclitaxel|mesh-list
20038313|NCT01187199|Bevacizumab|bevacizumab|mesh-list
20038314|NCT01187199|Carboplatin|carboplatin|mesh-list
20038315|NCT01187199|Sorafenib|sorafenib|mesh-list
20038316|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20038317|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038318|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
20038319|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
20038320|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116777|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038321|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038322|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038323|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038324|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038325|NCT01187199|Growth Substances|growth substances|mesh-ancestor
20038326|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038327|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038328|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038329|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038330|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20038331|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038332|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20038333|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
20038334|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576542|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038335|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
20038336|NCT01176474|Nivolumab|nivolumab|mesh-list
20038337|NCT01176474|Ipilimumab|ipilimumab|mesh-list
20038338|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038339|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038340|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20038341|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038342|NCT01154920|Paclitaxel|paclitaxel|mesh-list
20038343|NCT01154920|Docetaxel|docetaxel|mesh-list
20038344|NCT01154920|Cisplatin|cisplatin|mesh-list
20038345|NCT01154920|Carboplatin|carboplatin|mesh-list
20038346|NCT01154920|Fluorouracil|fluorouracil|mesh-list
20038347|NCT01154920|Cetuximab|cetuximab|mesh-list
20038348|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20038349|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038350|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
20038351|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
20038352|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
20038353|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038354|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
20038355|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20038356|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038357|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
20038358|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038359|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038360|NCT01113476|Gemcitabine|gemcitabine|mesh-list
20038361|NCT01113476|Paclitaxel|paclitaxel|mesh-list
20038362|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20038363|NCT01113476|Bevacizumab|bevacizumab|mesh-list
20038364|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20038365|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038366|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
20038367|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
20038368|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
20038369|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038370|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038371|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038372|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038373|NCT01113476|Growth Substances|growth substances|mesh-ancestor
20038374|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038375|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038376|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20038377|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
20038378|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
20038379|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038380|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038381|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038382|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
20038383|NCT01015222|Paclitaxel|paclitaxel|mesh-list
20038384|NCT01015222|Bevacizumab|bevacizumab|mesh-list
20038385|NCT01015222|Dasatinib|dasatinib|mesh-list
20038386|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20038387|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038388|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
20038389|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
20038390|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
20038391|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116778|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
20576543|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
20038392|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038393|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038394|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038395|NCT01015222|Growth Substances|growth substances|mesh-ancestor
20038396|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038397|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038398|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038399|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038400|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
20038401|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
20038402|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038403|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
20038404|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038405|NCT00800514|Amantadine|amantadine|mesh-list
20038406|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20038407|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20038408|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
20038409|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038410|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
20038411|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038412|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038413|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038414|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038415|NCT00800514|Analgesics|analgesics|mesh-ancestor
20038416|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
20038417|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038418|NCT00788125|Carboplatin|carboplatin|mesh-list
20038419|NCT00788125|Etoposide|etoposide|mesh-list
20038420|NCT00788125|Ifosfamide|ifosfamide|mesh-list
20038421|NCT00788125|Dasatinib|dasatinib|mesh-list
20038422|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
20038423|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038424|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20038425|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20038426|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20038427|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038428|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038429|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20038430|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
20038431|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038432|NCT00745134|Curcumin|curcumin|mesh-list
20038433|NCT00745134|Capecitabine|capecitabine|mesh-list
20038434|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20038435|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
20038436|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038437|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038438|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20038439|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038440|NCT00745134|Analgesics|analgesics|mesh-ancestor
20038441|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
20038442|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038443|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038444|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038445|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038446|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038447|NCT00715442|Sunitinib|sunitinib|mesh-list
20038448|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038449|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038450|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038451|NCT00715442|Growth Substances|growth substances|mesh-ancestor
20038452|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038453|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038454|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038455|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038456|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038457|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
20038458|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
20038459|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038460|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
20038461|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038462|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
20038463|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
20038464|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038465|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
20038466|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038467|NCT00329043|Sunitinib|sunitinib|mesh-list
20038468|NCT00329043|Leuprolide|leuprolide|mesh-list
20038469|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038470|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038471|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038472|NCT00329043|Growth Substances|growth substances|mesh-ancestor
20038473|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038474|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038475|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038476|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038477|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038478|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20038479|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
20038480|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20038481|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20038482|NCT00200200|Bevacizumab|bevacizumab|mesh-list
20038483|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20038484|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038485|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038486|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038487|NCT00200200|Growth Substances|growth substances|mesh-ancestor
20038488|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038489|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038490|NCT00199862|Antibodies|antibodies|mesh-list
20038491|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
20038492|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116779|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116780|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116781|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20116782|NCT00005835|Protective Agents|protective agents|mesh-ancestor
20116783|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
20116784|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116785|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
20116786|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116787|NCT00005838|Paclitaxel|paclitaxel|mesh-list
20116788|NCT00005838|Vinorelbine|vinorelbine|mesh-list
20116789|NCT00005838|Carboplatin|carboplatin|mesh-list
20116790|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116791|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116792|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116793|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116794|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116795|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116796|NCT00005839|Capecitabine|capecitabine|mesh-list
20116797|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
20116798|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116799|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
20116800|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116801|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116802|NCT00005840|Paclitaxel|paclitaxel|mesh-list
20116803|NCT00005840|Cisplatin|cisplatin|mesh-list
20116804|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116805|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116806|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116807|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116808|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116809|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116810|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
20116811|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20116812|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
20116813|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116814|NCT00005842|Trastuzumab|trastuzumab|mesh-list
20116815|NCT00005842|Tipifarnib|tipifarnib|mesh-list
20116816|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20116817|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116818|NCT00005843|Tipifarnib|tipifarnib|mesh-list
20116819|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116820|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
20116821|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116822|NCT00005845|Tipifarnib|tipifarnib|mesh-list
20116823|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116824|NCT00005847|Interferons|interferons|mesh-list
20116825|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
20116826|NCT00005847|Paclitaxel|paclitaxel|mesh-list
20116827|NCT00005847|Vinorelbine|vinorelbine|mesh-list
20116828|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
20116829|NCT00005847|Estramustine|estramustine|mesh-list
20116830|NCT00005847|Isotretinoin|isotretinoin|mesh-list
20120678|NCT00006388|Tamoxifen|tamoxifen|mesh-list
20038493|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20038494|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038495|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038496|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038497|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20038498|NCT02777554|Thalidomide|thalidomide|mesh-list
20038499|NCT02777554|Apremilast|apremilast|mesh-list
20038500|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20038501|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038502|NCT02777554|Analgesics|analgesics|mesh-ancestor
20038503|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
20038504|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038505|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038506|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038507|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038508|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20038509|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20038510|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038511|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038512|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576544|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576545|NCT02071888|Dexamethasone|dexamethasone|mesh-list
20576546|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
20576547|NCT02071888|Pomalidomide|pomalidomide|mesh-list
20576548|NCT02071888|BB 1101|bb 1101|mesh-list
20576549|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576550|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
20576551|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
20576552|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576553|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576554|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576555|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
20576556|NCT02071888|Hormones|hormones|mesh-ancestor
20576557|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576558|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20576559|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576560|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
20576561|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038513|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
20038514|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
20038515|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20038516|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038517|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20038518|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20038519|NCT02777554|Growth Substances|growth substances|mesh-ancestor
20038520|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
20038521|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038522|NCT02777749|Bupivacaine|bupivacaine|mesh-list
20038523|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
20038524|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
20038525|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038526|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038527|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
20038528|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038529|NCT02777970|Acetaminophen|acetaminophen|mesh-list
20038530|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20038531|NCT02777970|Tramadol|tramadol|mesh-list
20038532|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038533|NCT02777970|Analgesics|analgesics|mesh-ancestor
20038534|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
20038535|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038536|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038537|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
20576562|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576563|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
20576564|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20576565|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20576566|NCT02071888|Growth Substances|growth substances|mesh-ancestor
20576567|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
20576568|NCT02071927|Azacitidine|azacitidine|mesh-list
20576569|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20038538|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20038539|NCT02777970|Narcotics|narcotics|mesh-ancestor
20576570|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
20576571|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038540|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038541|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20038542|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038543|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038544|NCT02778100|Phenylephrine|phenylephrine|mesh-list
20038545|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
20038546|NCT02778100|Glucagon|glucagon|mesh-list
20038547|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20038548|NCT02778100|Hormones|hormones|mesh-ancestor
20038549|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038550|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038551|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20038552|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20038553|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
20038554|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038555|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038556|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
20038557|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
20038558|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038559|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
20038560|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20038561|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
20038562|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20038563|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
20038564|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20038565|NCT02778100|Protective Agents|protective agents|mesh-ancestor
20038566|NCT02778113|Glucagon|glucagon|mesh-list
20038567|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20038568|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20038569|NCT02778113|Hormones|hormones|mesh-ancestor
20038570|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038571|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038572|NCT02778113|Incretins|incretins|mesh-ancestor
20038573|NCT02778867|Fluticasone|fluticasone|mesh-list
20038574|NCT02778867|Xhance|xhance|mesh-list
20038575|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038576|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20038577|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
20038578|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038579|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038580|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20038581|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
20038582|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
20038583|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20038584|NCT02778880|Fentanyl|fentanyl|mesh-list
20038585|NCT02778880|Ketamine|ketamine|mesh-list
20038586|NCT02778880|Analgesics|analgesics|mesh-ancestor
20038587|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
20038588|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038589|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038590|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20038591|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20038592|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
20038593|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
20038594|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038595|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20038596|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20038597|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038598|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038599|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20038600|NCT02778880|Narcotics|narcotics|mesh-ancestor
20038601|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20038602|NCT02779166|Celecoxib|celecoxib|mesh-list
20038603|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20038604|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038605|NCT02779166|Analgesics|analgesics|mesh-ancestor
20038606|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
20038607|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038608|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038609|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038610|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038611|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20038612|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20038613|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038614|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038615|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20038616|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20038617|NCT02780167|Abrocitinib|abrocitinib|mesh-list
20038618|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038619|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038620|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038621|NCT02780622|Oseltamivir|oseltamivir|mesh-list
20038622|NCT02780622|Warfarin|warfarin|mesh-list
20038623|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
20038624|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
20038625|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038626|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038627|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038628|NCT02780687|Afatinib|afatinib|mesh-list
20038629|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038630|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038631|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038632|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038633|NCT02780700|Capecitabine|capecitabine|mesh-list
20038634|NCT02780700|Nintedanib|nintedanib|mesh-list
20038635|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20038636|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
20038637|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038638|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038639|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038640|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038641|NCT02780869|Thrombin|thrombin|mesh-list
20038642|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
20038643|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
20038644|NCT02780869|Coagulants|coagulants|mesh-ancestor
20038645|NCT02781311|Finasteride|finasteride|mesh-list
20038646|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20038647|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20038648|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038649|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038650|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
20038651|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038652|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038653|NCT02781311|Urological Agents|urological agents|mesh-ancestor
20038654|NCT02781454|Mexiletine|mexiletine|mesh-list
20038655|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20038656|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20038657|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20038658|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20038659|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038660|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
20038661|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20038662|NCT02781558|Velpatasvir|velpatasvir|mesh-list
20038663|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
20038664|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038665|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
20038666|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20038667|NCT02781571|Velpatasvir|velpatasvir|mesh-list
20038668|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
20038669|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038670|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20038671|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038672|NCT02781649|Ribavirin|ribavirin|mesh-list
20038673|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
20038674|NCT02781649|Grazoprevir|grazoprevir|mesh-list
20038675|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
20038676|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
20038677|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038678|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
20038679|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038680|NCT02781818|Triamcinolone|triamcinolone|mesh-list
20038681|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20038682|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20038683|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20038684|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038685|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
20038686|NCT02781818|Hormones|hormones|mesh-ancestor
20038687|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038688|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038689|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038690|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
20038691|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038692|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038693|NCT02782169|Pregabalin|pregabalin|mesh-list
20038694|NCT02782169|Analgesics|analgesics|mesh-ancestor
20038695|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
20038696|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038697|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038698|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
20038699|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20038700|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20038701|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038702|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20038703|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20038704|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20038705|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038706|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20038707|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
20038708|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20038709|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
20038710|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038711|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
20038712|NCT02782676|Protective Agents|protective agents|mesh-ancestor
20038713|NCT02783170|Vaccines|vaccines|mesh-list
20038714|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
20038715|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038716|NCT02783443|Anesthetics|anesthetics|mesh-list
20038717|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038718|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038719|NCT02783599|Doxorubicin|doxorubicin|mesh-list
20038720|NCT02783599|Olaratumab|olaratumab|mesh-list
20038721|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20038722|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038723|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20038724|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20038725|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038726|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038727|NCT02783729|Zolpidem|zolpidem|mesh-list
20038728|NCT02783729|Lemborexant|lemborexant|mesh-list
20038729|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20038730|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20038731|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038732|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038733|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20038734|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
20038735|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
20038736|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038737|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038738|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20038739|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20038740|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20038741|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038742|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
20038743|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038744|NCT02785159|Tazarotene|tazarotene|mesh-list
20038745|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20038746|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
20038747|NCT02785172|Clobetasol|clobetasol|mesh-list
20038748|NCT02785172|Halobetasol|halobetasol|mesh-list
20038749|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20038750|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038751|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
20038752|NCT02785172|Hormones|hormones|mesh-ancestor
20116831|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20038753|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038754|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038755|NCT02785185|Clobetasol|clobetasol|mesh-list
20038756|NCT02785185|Halobetasol|halobetasol|mesh-list
20038757|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20038758|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038759|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
20038760|NCT02785185|Hormones|hormones|mesh-ancestor
20038761|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038762|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038763|NCT02785406|Suvorexant|suvorexant|mesh-list
20038764|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20038765|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20038766|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038767|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038768|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20038769|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038770|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038771|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
20038772|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20038773|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038774|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20038775|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20038776|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038777|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038778|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038779|NCT02785900|Azacitidine|azacitidine|mesh-list
20038780|NCT02785900|Decitabine|decitabine|mesh-list
20038781|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20038782|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
20038783|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038784|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038785|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038786|NCT02785939|Docetaxel|docetaxel|mesh-list
20038787|NCT02785939|Palbociclib|palbociclib|mesh-list
20038788|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038789|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
20038790|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
20038791|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
20038792|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038793|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038794|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038795|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
20038796|NCT02786719|Doxorubicin|doxorubicin|mesh-list
20038797|NCT02786719|Etoposide|etoposide|mesh-list
20038798|NCT02786719|Vincristine|vincristine|mesh-list
20038799|NCT02786719|Topotecan|topotecan|mesh-list
20038800|NCT02786719|Sargramostim|sargramostim|mesh-list
20038801|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038802|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
20038803|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038804|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038805|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20038806|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
20038807|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038808|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038809|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20038810|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20038811|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20038812|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20038813|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038814|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20038815|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
20038816|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
20038817|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
20038818|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20038819|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20038820|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20038821|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
20038822|NCT02787057|Vancomycin|vancomycin|mesh-list
20038823|NCT02787057|Ceftazidime|ceftazidime|mesh-list
20038824|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20038825|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038826|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20038827|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20038828|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038829|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038830|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038831|NCT02787083|Mirabegron|mirabegron|mesh-list
20038832|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20038833|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20038834|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20038835|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
20038836|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038837|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038838|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038839|NCT02787083|Urological Agents|urological agents|mesh-ancestor
20116832|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116833|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116834|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116835|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116836|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116837|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
20116838|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116839|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
20116840|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116841|NCT00005847|Analgesics|analgesics|mesh-ancestor
20116842|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
20116843|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116844|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20116845|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20116846|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116847|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116848|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116849|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
20116850|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20116851|NCT00005848|Tipifarnib|tipifarnib|mesh-list
20116852|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116853|NCT00005849|Paclitaxel|paclitaxel|mesh-list
20116854|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
20116855|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20116856|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116857|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116858|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116859|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116860|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116861|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20116862|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
20116863|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116864|NCT00005850|Gemcitabine|gemcitabine|mesh-list
20116865|NCT00005850|Fluoxetine|fluoxetine|mesh-list
20116866|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116867|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116868|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
20116869|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116870|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
20116871|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116872|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116873|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116874|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
20116875|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116876|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20116877|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20116878|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20116879|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20116880|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
20116881|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20116882|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
20116883|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20116884|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20116885|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20116886|NCT00005851|Cyclosporine|cyclosporine|mesh-list
20116887|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
20116888|NCT00005851|Fludarabine|fludarabine|mesh-list
20116889|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
20116890|NCT00005851|Cyclosporins|cyclosporins|mesh-list
20116891|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116892|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20116893|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
20120679|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20038840|NCT02787304|Volixibat|volixibat|mesh-list
20038841|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20038842|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20038843|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
20038844|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038845|NCT02788019|Ropivacaine|ropivacaine|mesh-list
20038846|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
20038847|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
20038848|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038849|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038850|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
20038851|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038852|NCT02788097|Progesterone|progesterone|mesh-list
20038853|NCT02788097|Progestins|progestins|mesh-ancestor
20038854|NCT02788097|Hormones|hormones|mesh-ancestor
20038855|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038856|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038857|NCT02788175|Vedolizumab|vedolizumab|mesh-list
20038858|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20038859|NCT02788279|Atezolizumab|atezolizumab|mesh-list
20038860|NCT02788279|Antibodies|antibodies|mesh-list
20038861|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
20038862|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038863|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038864|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20038865|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20038866|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20038867|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20038868|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038869|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
20038870|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038871|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038872|NCT02788474|Nintedanib|nintedanib|mesh-list
20038873|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038874|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20038875|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038876|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038877|NCT02788513|BI 425809|bi 425809|mesh-list
20038878|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
20038879|NCT02788656|Valsartan|valsartan|mesh-list
20038880|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
20038881|NCT02788656|Giapreza|giapreza|mesh-list
20038882|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
20038883|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20038884|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20038885|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20038886|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
20038887|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20038888|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038889|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
20038890|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20038891|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20038892|NCT02789033|Isosorbide|isosorbide|mesh-list
20038893|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20038894|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20038895|NCT02789033|Chitosan|chitosan|mesh-list
20038896|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20038897|NCT02789033|Diuretics|diuretics|mesh-ancestor
20038898|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
20038899|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038900|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
20038901|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20038902|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038903|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20038904|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20038905|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
20038906|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20038907|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
20038908|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
20038909|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
20038910|NCT02789033|Coagulants|coagulants|mesh-ancestor
20038911|NCT02789111|Alvimopan|alvimopan|mesh-list
20038912|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20038913|NCT02789410|Morphine|morphine|mesh-list
20038914|NCT02789410|Hydromorphone|hydromorphone|mesh-list
20038915|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20038916|NCT02789410|Narcotics|narcotics|mesh-ancestor
20120680|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
20038917|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20038918|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038919|NCT02789410|Analgesics|analgesics|mesh-ancestor
20038920|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
20038921|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038922|NCT02790736|Propranolol|propranolol|mesh-list
20038923|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20038924|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20038925|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
20038926|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038927|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038928|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038929|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20038930|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20038931|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
20038932|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
20038933|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20038934|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20038935|NCT02790788|Prednisolone|prednisolone|mesh-list
20038936|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
20038937|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
20038938|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20038939|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20038940|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
20038941|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038942|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
20038943|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
20038944|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038945|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038946|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20038947|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
20038948|NCT02790788|Hormones|hormones|mesh-ancestor
20038949|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038950|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20038951|NCT02790788|Protective Agents|protective agents|mesh-ancestor
20038952|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20038953|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20038954|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20038955|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
20038956|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20038957|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
20038958|NCT02791308|Tacrolimus|tacrolimus|mesh-list
20038959|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20038960|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20038961|NCT02791308|Analgesics|analgesics|mesh-ancestor
20038962|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
20038963|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20038964|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038965|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20038966|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20038967|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
20038968|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20038969|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
20038970|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20038971|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038972|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038973|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20038974|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20038975|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20038976|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038977|NCT02791490|Metformin|metformin|mesh-list
20038978|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20038979|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20293178|NCT04688658|Nivolumab|nivolumab|mesh-list
20038980|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038981|NCT02791490|Incretins|incretins|mesh-ancestor
20038982|NCT02791490|Hormones|hormones|mesh-ancestor
20038983|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20038984|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20038985|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
20038986|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20038987|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038988|NCT02791763|Glycine|glycine|mesh-list
20038989|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
20038990|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20038991|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038992|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038993|NCT02791906|Ascorbic Acid|ascorbic acid|mesh-list
20038994|NCT02791906|Vitamins|vitamins|mesh-ancestor
20038995|NCT02791906|Micronutrients|micronutrients|mesh-ancestor
20038996|NCT02791906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20038997|NCT02791906|Antioxidants|antioxidants|mesh-ancestor
20038998|NCT02791906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20038999|NCT02791906|Protective Agents|protective agents|mesh-ancestor
20039000|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
20039001|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20039002|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
20039003|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039004|NCT02791945|Expectorants|expectorants|mesh-ancestor
20039005|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039006|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20039007|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
20039008|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039009|NCT02791945|Protective Agents|protective agents|mesh-ancestor
20039010|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039011|NCT02791945|Antidotes|antidotes|mesh-ancestor
20039012|NCT02792062|Relugolix|relugolix|mesh-list
20039013|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
20039014|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
20039015|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039016|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039017|NCT02792192|Atezolizumab|atezolizumab|mesh-list
20039018|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039019|NCT02792218|Teriflunomide|teriflunomide|mesh-list
20039020|NCT02792218|Ofatumumab|ofatumumab|mesh-list
20039021|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20039022|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039023|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
20039024|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039025|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20039026|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039027|NCT02792218|Analgesics|analgesics|mesh-ancestor
20039028|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
20039029|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039030|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039031|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039032|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20039033|NCT02792231|Teriflunomide|teriflunomide|mesh-list
20039034|NCT02792231|Ofatumumab|ofatumumab|mesh-list
20039035|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20039036|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039037|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
20039038|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039039|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20039040|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039041|NCT02792231|Analgesics|analgesics|mesh-ancestor
20039042|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
20039043|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039044|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039045|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039046|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20039047|NCT02792517|Erenumab|erenumab|mesh-list
20039048|NCT02792517|Norgestimate|norgestimate|mesh-list
20039049|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
20039050|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
20039051|NCT02792517|Estradiol|estradiol|mesh-list
20039052|NCT02792517|Estrogens|estrogens|mesh-ancestor
20576572|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039053|NCT02792517|Hormones|hormones|mesh-ancestor
20039054|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293179|NCT04688658|Axitinib|axitinib|mesh-list
20039055|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039056|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20039057|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20039058|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20039059|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20039060|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039061|NCT02792517|Analgesics|analgesics|mesh-ancestor
20039062|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
20039063|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039064|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20039065|NCT02792699|Rituximab|rituximab|mesh-list
20039066|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20039067|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039068|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
20039069|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039070|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039071|NCT02792829|Lenvatinib|lenvatinib|mesh-list
20039072|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039073|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20039074|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039075|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039076|NCT02793128|Mitomycins|mitomycins|mesh-list
20039077|NCT02793128|Mitomycin|mitomycin|mesh-list
20039078|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20039079|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039080|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
20039081|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039082|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20039083|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039084|NCT02793154|Exenatide|exenatide|mesh-list
20039085|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
20039086|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039087|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039088|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20039089|NCT02793154|Incretins|incretins|mesh-ancestor
20039090|NCT02793154|Hormones|hormones|mesh-ancestor
20039091|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039092|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
20039093|NCT02793622|Piperaquine|piperaquine|mesh-list
20039094|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
20039095|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20039096|NCT02793622|Artenimol|artenimol|mesh-list
20039097|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
20039098|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20039099|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20039100|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039101|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20039102|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039103|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039104|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20039105|NCT02793622|Renal Agents|renal agents|mesh-ancestor
20039106|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20039107|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20039108|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
20039109|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20039110|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
20039111|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039112|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039113|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20039114|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
20039115|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039116|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039117|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20039118|NCT02793947|Epinephrine|epinephrine|mesh-list
20039119|NCT02793947|Morphine|morphine|mesh-list
20039120|NCT02793947|Ropivacaine|ropivacaine|mesh-list
20039121|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20039122|NCT02793947|Narcotics|narcotics|mesh-ancestor
20039123|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039124|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039125|NCT02793947|Analgesics|analgesics|mesh-ancestor
20039126|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
20039127|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039128|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
20039129|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
20039130|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20039131|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20039132|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
20039133|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039134|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039135|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20039136|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20039137|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
20039138|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039139|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039140|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
20039141|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
20039142|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20039143|NCT02794441|Dexamethasone|dexamethasone|mesh-list
20039144|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039145|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
20039146|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
20039147|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039148|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039149|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20039150|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
20039151|NCT02794441|Hormones|hormones|mesh-ancestor
20039152|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039153|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20039154|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039155|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20039156|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039157|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039158|NCT02794974|Anesthetics|anesthetics|mesh-list
20039159|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039160|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039161|NCT02795117|Ivermectin|ivermectin|mesh-list
20039162|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20039163|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039164|NCT02796144|Metformin|metformin|mesh-list
20039165|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039166|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039167|NCT02796352|Interleukin-2|interleukin-2|mesh-list
20039168|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039169|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039170|NCT02796352|Analgesics|analgesics|mesh-ancestor
20039171|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
20039172|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039173|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039174|NCT02796560|Travoprost|travoprost|mesh-list
20039175|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20039176|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20039177|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
20039178|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20039179|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
20039180|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039181|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039182|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039183|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039184|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20039185|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20039186|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20039187|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
20039188|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039189|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039190|NCT02796677|Bromides|bromides|mesh-list
20039191|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
20039192|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
20039193|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20039194|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
20039195|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039196|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039197|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039198|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039199|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20039200|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20039201|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20039202|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
20039203|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039204|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039205|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
20039206|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20039207|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
20039208|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
20039209|NCT02796755|Riluzole|riluzole|mesh-list
20039210|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
20039211|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20039212|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20039213|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039214|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039215|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039216|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20039217|NCT02796755|Protective Agents|protective agents|mesh-ancestor
20039218|NCT02797080|Interferons|interferons|mesh-list
20039219|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
20039220|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039221|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
20039222|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039223|NCT02797522|Acetaminophen|acetaminophen|mesh-list
20039224|NCT02797522|Tenofovir|tenofovir|mesh-list
20039225|NCT02797522|Entecavir|entecavir|mesh-list
20039226|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
20039227|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20039228|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
20039229|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039230|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20039231|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20039232|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039233|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039234|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20039235|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20039236|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039237|NCT02797522|Analgesics|analgesics|mesh-ancestor
20039238|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
20039239|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039240|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039241|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
20039242|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
20039243|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039244|NCT02797808|Sertraline|sertraline|mesh-list
20039245|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
20039246|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20039247|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20039248|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20039249|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576573|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039250|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039251|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039252|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
20039253|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039254|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20039255|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
20039256|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116894|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116895|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116896|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
20116897|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116898|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116899|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
20116900|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116901|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116902|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116903|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20116904|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20116905|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20116906|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
20116907|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20116908|NCT00005852|Cyclosporine|cyclosporine|mesh-list
20116909|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
20116910|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
20116911|NCT00005852|Cyclosporins|cyclosporins|mesh-list
20116912|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20116913|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
20116914|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116915|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
20116916|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576574|NCT02071966|Clopidogrel|clopidogrel|mesh-list
20039257|NCT02798835|Dexamethasone|dexamethasone|mesh-list
20039258|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
20039259|NCT02798835|Fentanyl|fentanyl|mesh-list
20039260|NCT02798835|Bupivacaine|bupivacaine|mesh-list
20039261|NCT02798835|Ropivacaine|ropivacaine|mesh-list
20039262|NCT02798835|BB 1101|bb 1101|mesh-list
20039263|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039264|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
20039265|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
20039266|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039267|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039268|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20039269|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
20039270|NCT02798835|Hormones|hormones|mesh-ancestor
20039271|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039272|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20039273|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039274|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
20039275|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039276|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039277|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
20039278|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
20039279|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039280|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
20039281|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20039282|NCT02798835|Narcotics|narcotics|mesh-ancestor
20039283|NCT02798835|Analgesics|analgesics|mesh-ancestor
20039284|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20039285|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20039286|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
20039287|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20039288|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20039289|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
20039290|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20039291|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20039292|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
20039293|NCT02799381|Levodopa|levodopa|mesh-list
20039294|NCT02799381|Carbidopa|carbidopa|mesh-list
20039295|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20039296|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
20039297|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20039298|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
20039299|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039300|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039301|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039302|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20039303|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039304|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20039305|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
20039306|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
20039307|NCT02799784|Albuterol|albuterol|mesh-list
20039308|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20039309|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
20039310|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039311|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039312|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039313|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039314|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
20039315|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20039316|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20039317|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20039318|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20039319|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
20039320|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039321|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039322|NCT02800148|Azelaic acid|azelaic acid|mesh-list
20039323|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039324|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
20039325|NCT02800642|Aflibercept|aflibercept|mesh-list
20039326|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20039327|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20039328|NCT02800642|Growth Substances|growth substances|mesh-ancestor
20039329|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039330|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
20039331|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039332|NCT02800928|Aticaprant|aticaprant|mesh-list
20039333|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20039334|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039335|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
20039336|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039337|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
20039338|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20039339|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039340|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20039341|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20039342|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039343|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039344|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039345|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20039346|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20039347|NCT02801617|Latanoprost|latanoprost|mesh-list
20039348|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20039349|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20039350|NCT02801669|Edoxaban|edoxaban|mesh-list
20039351|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20039352|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
20039353|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20039354|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
20039355|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039356|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039357|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
20039358|NCT02802111|Albuterol|albuterol|mesh-list
20039359|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20039360|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
20039361|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039362|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039363|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039364|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039365|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
20039366|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20039367|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20039368|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20039369|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20039370|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
20039371|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039372|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039373|NCT02802241|Peppermint oil|peppermint oil|mesh-list
20039374|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
20039375|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
20039376|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039377|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039378|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20039379|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
20039380|NCT02802345|Nintedanib|nintedanib|mesh-list
20039381|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
20039382|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
20039383|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20039384|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20039385|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039386|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039387|NCT02802345|Urological Agents|urological agents|mesh-ancestor
20039388|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039389|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20039390|NCT02802449|Vitamin D|vitamin d|mesh-list
20039391|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
20039392|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
20039393|NCT02802449|Calcifediol|calcifediol|mesh-list
20039394|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20039395|NCT02802449|Vitamins|vitamins|mesh-list
20039396|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
20039397|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039398|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20039399|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20039400|NCT02802501|Piperaquine|piperaquine|mesh-list
20039401|NCT02802501|Primaquine|primaquine|mesh-list
20039402|NCT02802501|Artenimol|artenimol|mesh-list
20039403|NCT02802501|Tafenoquine|tafenoquine|mesh-list
20039404|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
20039405|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20039406|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20039407|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039408|NCT02802514|Exenatide|exenatide|mesh-list
20039409|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
20039410|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20039411|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039412|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039413|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20039414|NCT02802514|Incretins|incretins|mesh-ancestor
20039415|NCT02802514|Hormones|hormones|mesh-ancestor
20039416|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039417|NCT02802735|Apremilast|apremilast|mesh-list
20039418|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20039419|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039420|NCT02802735|Analgesics|analgesics|mesh-ancestor
20039421|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
20039422|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039423|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039424|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039425|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039426|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20039427|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20039428|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039429|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039430|NCT02802865|Letrozole|letrozole|mesh-list
20039431|NCT02802865|Clomiphene|clomiphene|mesh-list
20039432|NCT02802865|Enclomiphene|enclomiphene|mesh-list
20039433|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
20039434|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039435|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039436|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20039437|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20039438|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039439|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20039440|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
20039441|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039442|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039443|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20039444|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
20039445|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20039446|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20039447|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20039448|NCT02803138|Ritonavir|ritonavir|mesh-list
20039449|NCT02803138|Ribavirin|ribavirin|mesh-list
20039450|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20039451|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20039452|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
20039453|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039454|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039455|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20039456|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20039457|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
20039458|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039459|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20039460|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20039461|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
20039462|NCT02803229|Amphetamine|amphetamine|mesh-list
20039463|NCT02803229|Adderall|adderall|mesh-list
20039464|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20039465|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039466|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
20039467|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
20039468|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039469|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
20039470|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039471|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039472|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
20039473|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20039474|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20039475|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20039476|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20039477|NCT02803749|Buspirone|buspirone|mesh-list
20039478|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20039479|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20039480|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039481|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039482|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20039483|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20039484|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
20039485|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039486|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039487|NCT02804399|Rifampin|rifampin|mesh-list
20039488|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20039489|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
20039490|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20039491|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039492|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
20039493|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20039494|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039495|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039496|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20039497|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20039498|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20039499|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20039500|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20039501|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20039502|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
20039503|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20039504|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
20039505|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039506|NCT02804594|Expectorants|expectorants|mesh-ancestor
20039507|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039508|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20039509|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
20039510|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039511|NCT02804594|Protective Agents|protective agents|mesh-ancestor
20039512|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039513|NCT02804594|Antidotes|antidotes|mesh-ancestor
20039514|NCT02805179|Temozolomide|temozolomide|mesh-list
20039515|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20039516|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
20039517|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039518|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039519|NCT02805660|Durvalumab|durvalumab|mesh-list
20039520|NCT02805660|Mocetinostat|mocetinostat|mesh-list
20039521|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20039522|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039523|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20039524|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039525|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039526|NCT02805907|Calcifediol|calcifediol|mesh-list
20039527|NCT02805907|Vitamins|vitamins|mesh-ancestor
20039528|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
20039529|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039530|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20039531|NCT02805972|Naloxone|naloxone|mesh-list
20039532|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20039533|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039534|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
20039535|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039536|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
20039537|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20039538|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20039539|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039540|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
20039541|NCT02806024|Coagulants|coagulants|mesh-ancestor
20576575|NCT02071966|Ticagrelor|ticagrelor|mesh-list
20576576|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20576577|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20576578|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20576579|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20039542|NCT02806232|Praziquantel|praziquantel|mesh-list
20039543|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
20039544|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20039545|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039546|NCT02806414|Ivermectin|ivermectin|mesh-list
20039547|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20039548|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039549|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20039550|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
20039551|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039552|NCT02806544|Tamoxifen|tamoxifen|mesh-list
20039553|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20039554|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
20039555|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039556|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039557|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20039558|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039559|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20039560|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20039561|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20039562|NCT02806869|Ibuprofen|ibuprofen|mesh-list
20039563|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20039564|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039565|NCT02806869|Analgesics|analgesics|mesh-ancestor
20039566|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
20039567|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039568|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039569|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039570|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039571|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20039572|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039573|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039574|NCT02806947|Sirolimus|sirolimus|mesh-list
20039575|NCT02806947|Prednisone|prednisone|mesh-list
20039576|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039577|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
20039578|NCT02806947|Hormones|hormones|mesh-ancestor
20039579|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039580|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039581|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20039582|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039583|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20039584|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039585|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20039586|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
20039587|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20039588|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
20039589|NCT02806973|Glucagon|glucagon|mesh-list
20039590|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20039591|NCT02806973|Hormones|hormones|mesh-ancestor
20039592|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039593|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039594|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
20039595|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
20039596|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20039597|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20039598|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
20039599|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039600|NCT02807623|Ibuprofen|ibuprofen|mesh-list
20039601|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20039602|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039603|NCT02807623|Analgesics|analgesics|mesh-ancestor
20039604|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
20039605|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039606|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039607|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039608|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039609|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20039610|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039611|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039612|NCT02807844|Spartalizumab|spartalizumab|mesh-list
20039613|NCT02807844|Sargramostim|sargramostim|mesh-list
20039614|NCT02807844|Immunologic Factors|immunologic factors|mesh-ancestor
20039615|NCT02807844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039616|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20039617|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039618|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039619|NCT02808052|Minocycline|minocycline|mesh-list
20039620|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20039621|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039622|NCT02808819|Benralizumab|benralizumab|mesh-list
20039623|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039624|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039625|NCT02808975|Adalimumab|adalimumab|mesh-list
20039626|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039627|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039628|NCT02809053|Rituximab|rituximab|mesh-list
20039629|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20039630|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039631|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
20039632|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039633|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039634|NCT02810392|Insulin|insulin|mesh-list
20039635|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20039636|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039637|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039638|NCT02810873|Copper|copper|mesh-list
20039639|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
20039640|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20039641|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20039642|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039643|NCT02810873|Trace Elements|trace elements|mesh-ancestor
20039644|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
20039645|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039646|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
20039647|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
20039648|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039649|NCT02810964|Sulforaphane|sulforaphane|mesh-list
20039650|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20039651|NCT02810964|Protective Agents|protective agents|mesh-ancestor
20039652|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039653|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116917|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116918|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116919|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
20116920|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116921|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116922|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116923|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116924|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
20116925|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116926|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116927|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20116928|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20116929|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
20116930|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
20116931|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116932|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20116933|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
20116934|NCT00005852|Hormones|hormones|mesh-ancestor
20116935|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20116936|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20116937|NCT00005852|Protective Agents|protective agents|mesh-ancestor
20116938|NCT00005853|Etanercept|etanercept|mesh-list
20116939|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20116940|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20116941|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20116942|NCT00005853|Analgesics|analgesics|mesh-ancestor
20116943|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
20116944|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20116945|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116946|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20116947|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116948|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20116949|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116950|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
20116951|NCT00005854|Cyclosporine|cyclosporine|mesh-list
20116952|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
20116953|NCT00005854|Methotrexate|methotrexate|mesh-list
20116954|NCT00005854|Cyclosporins|cyclosporins|mesh-list
20116955|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20116956|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
20116957|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116958|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20116959|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116960|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
20116961|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116962|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116963|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20116964|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20116965|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
20116966|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20116967|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20039654|NCT02812186|Rocuronium|rocuronium|mesh-list
20039655|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20039656|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20039657|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20039658|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039659|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039660|NCT02812238|Niacinamide|niacinamide|mesh-list
20039661|NCT02812238|Niacin|niacin|mesh-list
20039662|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
20039663|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
20039664|NCT02812238|Vitamins|vitamins|mesh-ancestor
20039665|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
20039666|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039667|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20039668|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
20039669|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039670|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20039671|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
20039672|NCT02812342|Tofacitinib|tofacitinib|mesh-list
20039673|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20039674|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039675|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039676|NCT02812771|Efinaconazole|efinaconazole|mesh-list
20039677|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
20039678|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039679|NCT02813070|Flutemetamol|flutemetamol|mesh-list
20039680|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20039681|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039682|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20039683|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20039684|NCT02813551|Torsemide|torsemide|mesh-list
20039685|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20039686|NCT02813551|Diuretics|diuretics|mesh-ancestor
20039687|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
20039688|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039689|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20039690|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20039691|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039692|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
20039693|NCT02813694|Lefamulin|lefamulin|mesh-list
20039694|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20039695|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039696|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20039697|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20039698|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039699|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039700|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039701|NCT02814175|Adalimumab|adalimumab|mesh-list
20039702|NCT02814175|Methotrexate|methotrexate|mesh-list
20039703|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20039704|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
20039705|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20039706|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039707|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20039708|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
20039709|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039710|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039711|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
20039712|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039713|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20039714|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20039715|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
20039716|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039717|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20039718|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039719|NCT02814279|Dipyrone|dipyrone|mesh-list
20039720|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
20039721|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20039722|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039723|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
20039724|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20039725|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039726|NCT02814279|Analgesics|analgesics|mesh-ancestor
19749283|NCT05187182|Nivolumab|nivolumab|mesh-list
20039727|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
20039728|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039729|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039730|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039731|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039732|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
20039733|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
20039734|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20039735|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
20039736|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20039737|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20039738|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039739|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20039740|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039741|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20039742|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039743|NCT02814643|Benralizumab|benralizumab|mesh-list
20039744|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039745|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039746|NCT02815644|Empagliflozin|empagliflozin|mesh-list
20039747|NCT02815644|Linagliptin|linagliptin|mesh-list
20039748|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20039749|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039750|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039751|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039752|NCT02815644|Incretins|incretins|mesh-ancestor
20039753|NCT02815644|Hormones|hormones|mesh-ancestor
20039754|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039755|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20039756|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
20039757|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039758|NCT02815709|Morphine|morphine|mesh-list
20039759|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20039760|NCT02815709|Narcotics|narcotics|mesh-ancestor
20039761|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039762|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039763|NCT02815709|Analgesics|analgesics|mesh-ancestor
20039764|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
20039765|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039766|NCT02816138|Nicotine|nicotine|mesh-list
20039767|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20039768|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
20039769|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039770|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039771|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20039772|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20039773|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
20039774|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039775|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039776|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
20039777|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
20039778|NCT02817555|Hematinics|hematinics|mesh-ancestor
20039779|NCT02817763|Dipyrone|dipyrone|mesh-list
20039780|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20039781|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039782|NCT02817763|Analgesics|analgesics|mesh-ancestor
20039783|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
20039784|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039785|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039786|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20039787|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039788|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
20039789|NCT02817828|Drospirenone|drospirenone|mesh-list
20039790|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20039791|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
20039792|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039793|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039794|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20039795|NCT02817828|Diuretics|diuretics|mesh-ancestor
20039796|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
20039797|NCT02817841|Drospirenone|drospirenone|mesh-list
20039798|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20039799|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
20039800|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039801|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039802|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20039803|NCT02817841|Diuretics|diuretics|mesh-ancestor
20039804|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
20039805|NCT02818036|Naltrexone|naltrexone|mesh-list
20039806|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20039807|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20039808|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039809|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
20039810|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039811|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
20039812|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20039813|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039814|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039815|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20039816|NCT02818569|Analgesics|analgesics|mesh-ancestor
20039817|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
20039818|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039819|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20039820|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20039821|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20039822|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
20039823|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20039824|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039825|NCT02818777|Cannabidiol|cannabidiol|mesh-list
20039826|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
20039827|NCT02818998|Aflibercept|aflibercept|mesh-list
20039828|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20039829|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20039830|NCT02818998|Growth Substances|growth substances|mesh-ancestor
20039831|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039832|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
20039833|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039834|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20039835|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20039836|NCT02819297|Laxatives|laxatives|mesh-list
20039837|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20039838|NCT02819310|Laxatives|laxatives|mesh-list
20039839|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20039840|NCT02819726|Rituximab|rituximab|mesh-list
20039841|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20039842|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039843|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
20039844|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039845|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20039846|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
20039847|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039848|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039849|NCT02820324|Morphine|morphine|mesh-list
20039850|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20039851|NCT02820324|Narcotics|narcotics|mesh-ancestor
20039852|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039853|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039854|NCT02820324|Analgesics|analgesics|mesh-ancestor
20039855|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
20039856|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039857|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20039858|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039859|NCT02821338|Lamotrigine|lamotrigine|mesh-list
20039860|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
20039861|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20039862|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20039863|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039864|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20039865|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039866|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20039867|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20039868|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039869|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20039870|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20039871|NCT02821416|Benralizumab|benralizumab|mesh-list
20039872|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20039873|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
20039874|NCT02821715|Flecainide|flecainide|mesh-list
20039875|NCT02821715|Modafinil|modafinil|mesh-list
20039876|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20039877|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039878|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20039879|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20039880|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20039881|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039882|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20039883|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20039884|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20039885|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20039886|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20039887|NCT02821819|Hormones|hormones|mesh-ancestor
20039888|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039889|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039890|NCT02821910|Metformin|metformin|mesh-list
20039891|NCT02821910|Empagliflozin|empagliflozin|mesh-list
20039892|NCT02821910|Linagliptin|linagliptin|mesh-list
20039893|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039894|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039895|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20039896|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039897|NCT02821910|Incretins|incretins|mesh-ancestor
20039898|NCT02821910|Hormones|hormones|mesh-ancestor
20039899|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039900|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20039901|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
20039902|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039903|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
20576580|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
20576581|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576582|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576583|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576584|NCT02072031|Sunitinib|sunitinib|mesh-list
20576585|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576586|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20039904|NCT02822222|Cathartics|cathartics|mesh-ancestor
20039905|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20039906|NCT02822794|Ribavirin|ribavirin|mesh-list
20039907|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
20039908|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20039909|NCT02822794|Velpatasvir|velpatasvir|mesh-list
20039910|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
20039911|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039912|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
20039913|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039914|NCT02822950|Ceftazidime|ceftazidime|mesh-list
20039915|NCT02822950|Avibactam|avibactam|mesh-list
20039916|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
20039917|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20039918|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039919|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20039920|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20039921|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039922|NCT02823080|Cetrorelix|cetrorelix|mesh-list
20039923|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20039924|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
20039925|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20039926|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039927|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
20039928|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039929|NCT02823431|Lidocaine|lidocaine|mesh-list
20576587|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20039930|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
20039931|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
20039932|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20039933|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039934|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
20039935|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20039936|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20039937|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20039938|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20039939|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20039940|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039941|NCT02823470|Ivacaftor|ivacaftor|mesh-list
20039942|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20039943|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20039944|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039945|NCT02824224|Tamoxifen|tamoxifen|mesh-list
20039946|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20039947|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
20039948|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20039949|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039950|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20039951|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20039952|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20039953|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20039954|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20039955|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20039956|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20039957|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
20039958|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20039959|NCT02825212|Ledipasvir|ledipasvir|mesh-list
20039960|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20039961|NCT02825212|Velpatasvir|velpatasvir|mesh-list
20039962|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
20039963|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20039964|NCT02825251|Insulin|insulin|mesh-list
20039965|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20039966|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
20039967|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
20039968|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20039969|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20039970|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20039971|NCT02825420|Trabectedin|trabectedin|mesh-list
20039972|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20039973|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
20039974|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20039975|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116968|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
20116969|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
20116970|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20116971|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20116972|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20116973|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
20116974|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116975|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20116976|NCT00005855|Carmustine|carmustine|mesh-list
20116977|NCT00005855|Efaproxiral|efaproxiral|mesh-list
20116978|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20116979|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
20116980|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116981|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116982|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
20116983|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
20116984|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116985|NCT00005857|Docetaxel|docetaxel|mesh-list
20116986|NCT00005857|Trastuzumab|trastuzumab|mesh-list
20116987|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116988|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
20116989|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
20116990|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
20116991|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20116992|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20116993|NCT00005858|Immunotoxins|immunotoxins|mesh-list
20116994|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
20576588|NCT02072031|Growth Substances|growth substances|mesh-ancestor
20039976|NCT02826603|Ustekinumab|ustekinumab|mesh-list
20039977|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
20039978|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
20039979|NCT02828358|Leucovorin|leucovorin|mesh-list
20576589|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576590|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
20576591|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20576592|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576593|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576594|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
20576595|NCT02072083|Ketamine|ketamine|mesh-list
20576596|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20576597|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576598|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576599|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576600|NCT02072083|Analgesics|analgesics|mesh-ancestor
20576601|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
20576602|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576603|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20576604|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20576605|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20576606|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
20576607|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576608|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576609|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20576610|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20039980|NCT02828358|Folic Acid|folic acid|mesh-list
20039981|NCT02828358|Cytarabine|cytarabine|mesh-list
20039982|NCT02828358|Dexamethasone|dexamethasone|mesh-list
20039983|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
20039984|NCT02828358|Prednisolone|prednisolone|mesh-list
20039985|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20039986|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
20039987|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20039988|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
20039989|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
20039990|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20039991|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20039992|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20039993|NCT02828358|Cortisone|cortisone|mesh-list
20039994|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
20039995|NCT02828358|Methotrexate|methotrexate|mesh-list
20039996|NCT02828358|Vincristine|vincristine|mesh-list
20039997|NCT02828358|Azacitidine|azacitidine|mesh-list
20039998|NCT02828358|Daunorubicin|daunorubicin|mesh-list
20039999|NCT02828358|Asparaginase|asparaginase|mesh-list
20040000|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
20040001|NCT02828358|Pegaspargase|pegaspargase|mesh-list
20040002|NCT02828358|Thioguanine|thioguanine|mesh-list
20040003|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20040004|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
20040005|NCT02828358|BB 1101|bb 1101|mesh-list
20040006|NCT02828358|Calcium|calcium|mesh-list
20040007|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
20040008|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
20040009|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20040010|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
20040011|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040012|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040013|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20040014|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
20040015|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040016|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040017|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20040018|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040019|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
20040020|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
20040021|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040022|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20040023|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
20040024|NCT02828358|Hormones|hormones|mesh-ancestor
20040025|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040026|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20040027|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
20040028|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040029|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20040030|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20040031|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20040032|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
20040033|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20040034|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20040035|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
20040036|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
20040037|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20040038|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20040039|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
20040040|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040041|NCT02828358|Antidotes|antidotes|mesh-ancestor
20040042|NCT02828358|Protective Agents|protective agents|mesh-ancestor
20040043|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
20040044|NCT02828358|Vitamins|vitamins|mesh-ancestor
20040045|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
20040046|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20040047|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
20040048|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
20040049|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
20040050|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20040051|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20040052|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20040053|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20040054|NCT02828358|Hematinics|hematinics|mesh-ancestor
20040055|NCT02829034|Ranolazine|ranolazine|mesh-list
20040056|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20040057|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040058|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040059|NCT02829775|Interferons|interferons|mesh-list
20040060|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
20040061|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
20040062|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20040063|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040064|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
20040065|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040066|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
20040067|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040068|NCT02829944|Ketorolac|ketorolac|mesh-list
20040069|NCT02829944|Ropivacaine|ropivacaine|mesh-list
20040070|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
20040071|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
20040072|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040073|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040074|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
20040075|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040076|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20040077|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040078|NCT02829944|Analgesics|analgesics|mesh-ancestor
20040079|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040080|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040081|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20040082|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040083|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040084|NCT02829983|Clarithromycin|clarithromycin|mesh-list
20040085|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20040086|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040087|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20040088|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040089|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040090|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20040091|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20040092|NCT02829996|Latanoprost|latanoprost|mesh-list
20040093|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20040094|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20040095|NCT02830776|Bimatoprost|bimatoprost|mesh-list
20040096|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20040097|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20040098|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20040099|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20040100|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20040101|NCT02831569|Loxoprofen|loxoprofen|mesh-list
20040102|NCT02831569|Methocarbamol|methocarbamol|mesh-list
20040103|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20040104|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040105|NCT02831569|Analgesics|analgesics|mesh-ancestor
20040106|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
20040107|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308360|NCT00663897|Mosapride|mosapride|mesh-list
20040108|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040109|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040110|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040111|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20040112|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20040113|NCT02831816|Ethanol|ethanol|mesh-list
20040114|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
20040115|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20040116|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20040117|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040118|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040119|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040120|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
20040121|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
20040122|NCT02831855|Methotrexate|methotrexate|mesh-list
20040123|NCT02831855|Tofacitinib|tofacitinib|mesh-list
20040124|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20040125|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
20040126|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20040127|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040128|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20040129|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
20040130|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040131|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040132|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
20040133|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040134|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20040135|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20040136|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
20040137|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040138|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20040139|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20040140|NCT02831998|Ethanol|ethanol|mesh-list
20040141|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
20040142|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20040143|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20040144|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040145|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040146|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040147|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
20040148|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
20040149|NCT02832037|BI 425809|bi 425809|mesh-list
20040150|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
20040151|NCT02832115|Lidocaine|lidocaine|mesh-list
20040152|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
20040153|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
20040154|NCT02832115|Anesthetics|anesthetics|mesh-list
20040155|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040156|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040157|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
20040158|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040159|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20040160|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20040161|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20040162|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040163|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040164|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
20040165|NCT02832375|Fluorides|fluorides|mesh-list
20040166|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
20040167|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
20040168|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
20040169|NCT02832375|Protective Agents|protective agents|mesh-ancestor
20040170|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040171|NCT02833350|Folic Acid|folic acid|mesh-list
20040172|NCT02833350|Adalimumab|adalimumab|mesh-list
20040173|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040174|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040175|NCT02833350|Hematinics|hematinics|mesh-ancestor
20040176|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
20040177|NCT02833350|Vitamins|vitamins|mesh-ancestor
20040178|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
20040179|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040180|NCT02833415|Empagliflozin|empagliflozin|mesh-list
20040181|NCT02833415|Glycerol|glycerol|mesh-list
20040182|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20040183|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040184|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20040185|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040186|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20040187|NCT02833415|Protective Agents|protective agents|mesh-ancestor
20040188|NCT02833844|Evolocumab|evolocumab|mesh-list
20040189|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20040190|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20040191|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
20040192|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040193|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20040194|NCT02833948|Aspirin|aspirin|mesh-list
20040195|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
20040196|NCT02833948|Clopidogrel|clopidogrel|mesh-list
20040197|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20040198|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20040199|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20040200|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20040201|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
20040202|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040203|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040204|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040205|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20040206|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
20040207|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20040208|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
20040209|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040210|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
20040211|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20040212|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040213|NCT02833948|Analgesics|analgesics|mesh-ancestor
20040214|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
20040215|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040216|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040217|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040218|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20040219|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20040220|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20040221|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
20040222|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20040223|NCT02834247|Nivolumab|nivolumab|mesh-list
20040224|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040225|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040226|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20040227|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040228|NCT02834390|Cytarabine|cytarabine|mesh-list
20040229|NCT02834390|Daunorubicin|daunorubicin|mesh-list
20040230|NCT02834390|Idarubicin|idarubicin|mesh-list
20040231|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20040232|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
20040233|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040234|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040235|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
20040236|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040237|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20040238|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
20040239|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040240|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20040241|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20040242|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20040243|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040244|NCT02834624|Poractant alfa|poractant alfa|mesh-list
20040245|NCT02834624|Calfactant|calfactant|mesh-list
20040246|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20040247|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
20040248|NCT02834663|Ranibizumab|ranibizumab|mesh-list
20040249|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20040250|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20040251|NCT02834663|Growth Substances|growth substances|mesh-ancestor
20040252|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040253|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
20040254|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040255|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
20040256|NCT02835339|Analgesics|analgesics|mesh-ancestor
20040257|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
20040258|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040259|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040260|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
20040261|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040262|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20040263|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
20040264|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20040265|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040266|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040267|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20040268|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
20040269|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20040270|NCT02835846|Estrogens|estrogens|mesh-list
20040271|NCT02835846|Hormones|hormones|mesh-ancestor
20040272|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040273|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040274|NCT02836496|Prednisone|prednisone|mesh-list
20040275|NCT02836496|Prednisolone|prednisolone|mesh-list
20040276|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040277|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
20040278|NCT02836496|Hormones|hormones|mesh-ancestor
20040279|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040280|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040281|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20040282|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040283|NCT02836652|Aspirin|aspirin|mesh-list
20040284|NCT02836652|Warfarin|warfarin|mesh-list
20040285|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20040286|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040287|NCT02836652|Analgesics|analgesics|mesh-ancestor
20040288|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
20040289|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040290|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040291|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040292|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040293|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20040294|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20040295|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040296|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20040297|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20040298|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040299|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
20040300|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
20040301|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
20040302|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20040303|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040304|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
20040305|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20040306|NCT02837237|Hormones|hormones|mesh-ancestor
20040307|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040308|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040309|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
20040310|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20040311|NCT02837237|Diuretics|diuretics|mesh-ancestor
20040312|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
20040313|NCT02837744|Hemostatics|hemostatics|mesh-list
20040314|NCT02837744|Coagulants|coagulants|mesh-ancestor
20040315|NCT02838134|Rocuronium|rocuronium|mesh-list
20040316|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20040317|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20040318|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20040319|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040320|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040321|NCT02838420|Crizotinib|crizotinib|mesh-list
20040322|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040323|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20040324|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040325|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040326|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
20040327|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040328|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040329|NCT02839200|Zolpidem|zolpidem|mesh-list
20040330|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20040331|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20040332|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040333|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040334|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20040335|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
20040336|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
20040337|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040338|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040339|NCT02839681|Maytansine|maytansine|mesh-list
20040340|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20040341|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040342|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
20040343|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
20040344|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
20040345|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040346|NCT02839772|Glycerol|glycerol|mesh-list
20040347|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20040348|NCT02839772|Protective Agents|protective agents|mesh-ancestor
20040349|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040350|NCT02839876|Acetaminophen|acetaminophen|mesh-list
20040351|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040352|NCT02839876|Analgesics|analgesics|mesh-ancestor
20040353|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
20040354|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040355|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040356|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
20040357|NCT02839889|Naloxegol|naloxegol|mesh-list
20040358|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20040359|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040360|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
20040361|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040362|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
20040363|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20040364|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20040365|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040366|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
20040367|NCT02840097|Coagulants|coagulants|mesh-ancestor
20040368|NCT02840461|Ivermectin|ivermectin|mesh-list
20040369|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20040370|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20116995|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20116996|NCT00005859|Tipifarnib|tipifarnib|mesh-list
20116997|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20116998|NCT00005860|Leucovorin|leucovorin|mesh-list
20116999|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
20117000|NCT00005860|Floxuridine|floxuridine|mesh-list
20117001|NCT00005860|Calcium|calcium|mesh-list
20117002|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
20117003|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20117004|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117005|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117006|NCT00005860|Antidotes|antidotes|mesh-ancestor
20117007|NCT00005860|Protective Agents|protective agents|mesh-ancestor
20117008|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
20117009|NCT00005860|Vitamins|vitamins|mesh-ancestor
20117010|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
20117011|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117012|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
20117013|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117014|NCT00005861|Doxorubicin|doxorubicin|mesh-list
20117015|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117016|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117017|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117018|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117019|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117020|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117021|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117022|NCT00005862|Semaxinib|semaxinib|mesh-list
20117023|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20117024|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20117025|NCT00005862|Growth Substances|growth substances|mesh-ancestor
20117026|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117027|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
20117028|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117029|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20117030|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117031|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117032|NCT00005863|Cytarabine|cytarabine|mesh-list
20117033|NCT00005863|Fludarabine|fludarabine|mesh-list
20117034|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
20117035|NCT00005863|Etoposide|etoposide|mesh-list
20117036|NCT00005863|Daunorubicin|daunorubicin|mesh-list
20040371|NCT02841033|Daratumumab|daratumumab|mesh-list
20040372|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040373|NCT02841241|Esmolol|esmolol|mesh-list
20040374|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20040375|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20040376|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20040377|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
20040378|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040379|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040380|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040381|NCT02842073|Naltrexone|naltrexone|mesh-list
20040382|NCT02842073|Bupropion|bupropion|mesh-list
20040383|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20040384|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20040385|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040386|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
20040387|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040388|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20040389|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
20040390|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20040391|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20040392|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20040393|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040394|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040395|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
20040396|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040397|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20040398|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20040399|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040400|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20040401|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20040402|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20040403|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20040404|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040405|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040406|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
20040407|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040408|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20040409|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20040410|NCT02844439|XL647|xl647|mesh-list
20040411|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040412|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20040413|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040414|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040415|NCT02844582|Prednisone|prednisone|mesh-list
20040416|NCT02844582|Cortisone|cortisone|mesh-list
20040417|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040418|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
20040419|NCT02844582|Hormones|hormones|mesh-ancestor
20040420|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040421|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040422|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20040423|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040424|NCT02845336|Celecoxib|celecoxib|mesh-list
20040425|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
20040426|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20040427|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040428|NCT02845336|Analgesics|analgesics|mesh-ancestor
20040429|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
20040430|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040431|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040432|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040433|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040434|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20040435|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20040436|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040437|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040438|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20040439|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20040440|NCT02845375|Neostigmine|neostigmine|mesh-list
20040441|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20040442|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040443|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040444|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
20040445|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040446|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040447|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20040448|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
20040449|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040450|NCT02845752|Bromides|bromides|mesh-list
20040451|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
20040452|NCT02845752|Olodaterol|olodaterol|mesh-list
20040453|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20040454|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
20040455|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040456|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040457|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20040458|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
20040459|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
20040460|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20040461|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
20040462|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040463|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040464|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
20040465|NCT02846233|Metformin|metformin|mesh-list
20040466|NCT02846233|Empagliflozin|empagliflozin|mesh-list
20040467|NCT02846233|Dulaglutide|dulaglutide|mesh-list
20040468|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20040469|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
20040470|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20040471|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040472|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040473|NCT02846233|Incretins|incretins|mesh-ancestor
20040474|NCT02846233|Hormones|hormones|mesh-ancestor
20040475|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040476|NCT02846792|Nivolumab|nivolumab|mesh-list
20040477|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040478|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040479|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20040480|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040481|NCT02847260|Treprostinil|treprostinil|mesh-list
20040482|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20040483|NCT02847494|Dexamethasone|dexamethasone|mesh-list
20040484|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
20040485|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20040486|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20040487|NCT02847494|Prednisolone|prednisolone|mesh-list
20040488|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
20040489|NCT02847494|Metoclopramide|metoclopramide|mesh-list
20040490|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20040491|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
20040492|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040493|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
20040494|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
20040495|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040496|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040497|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20040498|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
20040499|NCT02847494|Hormones|hormones|mesh-ancestor
20040500|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040501|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20040502|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040503|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20040504|NCT02847494|Protective Agents|protective agents|mesh-ancestor
20040505|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20040506|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20040507|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
20040508|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040509|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040510|NCT02848599|Morphine|morphine|mesh-list
20040511|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
20040512|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20040513|NCT02848599|Narcotics|narcotics|mesh-ancestor
20040514|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040515|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040516|NCT02848599|Analgesics|analgesics|mesh-ancestor
20040517|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
20040518|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040519|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
20040520|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
20040521|NCT02848651|Atezolizumab|atezolizumab|mesh-list
20040522|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040523|NCT02848729|Acetaminophen|acetaminophen|mesh-list
20040524|NCT02848729|Morphine|morphine|mesh-list
20040525|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20040526|NCT02848729|Narcotics|narcotics|mesh-ancestor
20040527|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040528|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040529|NCT02848729|Analgesics|analgesics|mesh-ancestor
20040530|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
20040531|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040532|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040533|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
20040534|NCT02848833|Empagliflozin|empagliflozin|mesh-list
20040535|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20040536|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040537|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20040538|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040539|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20040540|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20040541|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040542|NCT02849080|Incretins|incretins|mesh-ancestor
20040543|NCT02849080|Hormones|hormones|mesh-ancestor
20040544|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040545|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20040546|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
20040547|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040548|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040549|NCT02849184|Suvorexant|suvorexant|mesh-list
20040550|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20040551|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20040552|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040553|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040554|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20040555|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040556|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040557|NCT02849509|Vitamin K|vitamin k|mesh-list
20040558|NCT02849509|Dabigatran|dabigatran|mesh-list
20040559|NCT02849509|Vitamins|vitamins|mesh-ancestor
20040560|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
20040561|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040562|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
20040563|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20040564|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
20040565|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040566|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040567|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
20040568|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20040569|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20040570|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
20040571|NCT02849509|Coagulants|coagulants|mesh-ancestor
20040572|NCT02849678|Lidocaine|lidocaine|mesh-list
20040573|NCT02849678|Ropivacaine|ropivacaine|mesh-list
20040574|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
20040575|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
20040576|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040577|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040578|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
20040579|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040580|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20040581|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20040582|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20040583|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040584|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040585|NCT02849704|Pancrelipase|pancrelipase|mesh-list
20040586|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20040587|NCT02850276|Bromides|bromides|mesh-list
20040588|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20040589|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
20040590|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20040591|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040592|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040593|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
20117037|NCT00005863|Tretinoin|tretinoin|mesh-list
20040594|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040595|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040596|NCT02850601|Dexamethasone|dexamethasone|mesh-list
20040597|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040598|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
20040599|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
20040600|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040601|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040602|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20040603|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
20040604|NCT02850601|Hormones|hormones|mesh-ancestor
20040605|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040606|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20040607|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040608|NCT02850965|Adalimumab|adalimumab|mesh-list
20040609|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040610|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040611|NCT02851108|Primaquine|primaquine|mesh-list
20040612|NCT02851108|Phenothiazine|phenothiazine|mesh-list
20040613|NCT02851108|Methylene Blue|methylene blue|mesh-list
20040614|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
20040615|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20040616|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20040617|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040618|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040619|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040620|NCT02852005|Vaccines|vaccines|mesh-list
20040621|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
20040622|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040623|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
20040624|NCT02852265|Etonogestrel|etonogestrel|mesh-list
20040625|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20040626|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040627|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20040628|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20040629|NCT02852434|Lidocaine|lidocaine|mesh-list
20040630|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
20040631|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
20040632|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040633|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040634|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
20040635|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040636|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20040637|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20040638|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20040639|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040640|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040641|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
20040642|NCT02853123|Olodaterol|olodaterol|mesh-list
20040643|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20040644|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
20040645|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040646|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040647|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20040648|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
20040649|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
20040650|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20040651|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
20040652|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040653|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040654|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
20040655|NCT02853318|Bevacizumab|bevacizumab|mesh-list
20040656|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
20040657|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20040658|NCT02853318|Antibodies|antibodies|mesh-list
20040659|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
20040660|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20040661|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
20040662|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
20040663|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20040664|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
20040665|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040666|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040667|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20040668|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
20040669|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040670|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040671|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20040672|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20040673|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20040674|NCT02853318|Growth Substances|growth substances|mesh-ancestor
20040675|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
20040676|NCT02854527|Metformin|metformin|mesh-list
20040677|NCT02854527|Digoxin|digoxin|mesh-list
20040678|NCT02854527|Furosemide|furosemide|mesh-list
20040679|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20040680|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20040681|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040682|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20040683|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20040684|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
20040685|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040686|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20040687|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20040688|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040689|NCT02854527|Diuretics|diuretics|mesh-ancestor
20040690|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
20040691|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20040692|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040693|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20040694|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20040695|NCT02854527|Protective Agents|protective agents|mesh-ancestor
20040696|NCT02854631|Prednisolone|prednisolone|mesh-list
20040697|NCT02854631|Selonsertib|selonsertib|mesh-list
20040698|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040699|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
20040700|NCT02854631|Hormones|hormones|mesh-ancestor
20040701|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040702|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040703|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20040704|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040705|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20040706|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040707|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040708|NCT02854800|Varenicline|varenicline|mesh-list
20040709|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20040710|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20040711|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
20040712|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040713|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040714|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040715|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20040716|NCT02855086|Cetuximab|cetuximab|mesh-list
20040717|NCT02855086|Antibodies|antibodies|mesh-list
20040718|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
20040719|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20040720|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
20040721|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040722|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040723|NCT02855359|Prednisone|prednisone|mesh-list
20040724|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
20040725|NCT02855359|Rituximab|rituximab|mesh-list
20040726|NCT02855359|Doxorubicin|doxorubicin|mesh-list
20040727|NCT02855359|Vincristine|vincristine|mesh-list
20040728|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20040729|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
20040730|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040731|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040732|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20040733|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
20040734|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040735|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576611|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
20576612|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
20576613|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20576614|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20576615|NCT02072135|Bupivacaine|bupivacaine|mesh-list
20576616|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
20040736|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20576617|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
20040737|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20576618|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576619|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576620|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
20040738|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20040739|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20040740|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20040741|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040742|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040743|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
20040744|NCT02855359|Hormones|hormones|mesh-ancestor
20040745|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040746|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20040747|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20040748|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
20040749|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
20040750|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
20040751|NCT02856555|Firsocostat|firsocostat|mesh-list
20040752|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040753|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040754|NCT02856802|Sumatriptan|sumatriptan|mesh-list
20040755|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20040756|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20040757|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20040758|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
20040759|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040760|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040761|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117038|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117039|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117040|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
20117041|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117042|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117043|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
20117044|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117045|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117046|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117047|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117048|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117049|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
20117050|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117051|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117052|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
20117053|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117054|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
20117055|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117056|NCT00005865|Vinorelbine|vinorelbine|mesh-list
20117057|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117058|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117059|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117060|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117061|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117062|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117063|NCT00005866|Cyclosporine|cyclosporine|mesh-list
20117064|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
20117065|NCT00005866|Busulfan|busulfan|mesh-list
20117066|NCT00005866|Methotrexate|methotrexate|mesh-list
20117067|NCT00005866|Cyclosporins|cyclosporins|mesh-list
20117068|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117069|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
20117070|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117071|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117072|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117073|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
20117074|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117075|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117076|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117077|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20117078|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
20117079|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20117080|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117081|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
20117082|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117083|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040762|NCT02856880|Zinc|zinc|mesh-list
20040763|NCT02856880|Trace Elements|trace elements|mesh-ancestor
20040764|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
20040765|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040766|NCT02858076|Aflibercept|aflibercept|mesh-list
20040767|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
20040768|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20040769|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20040770|NCT02858076|Growth Substances|growth substances|mesh-ancestor
20040771|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040772|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
20040773|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040774|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
20040775|NCT02858180|Ledipasvir|ledipasvir|mesh-list
20040776|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
20040777|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040778|NCT02858401|Vesatolimod|vesatolimod|mesh-list
20040779|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
20040780|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040781|NCT02858713|Betamethasone|betamethasone|mesh-list
20040782|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
20040783|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20040784|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
20040785|NCT02858713|Calcipotriene|calcipotriene|mesh-list
20040786|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20040787|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040788|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
20040789|NCT02858713|Hormones|hormones|mesh-ancestor
20040790|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040791|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040792|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20040793|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
20040794|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
20040795|NCT02859142|Nicotine|nicotine|mesh-list
20040796|NCT02859142|Varenicline|varenicline|mesh-list
20040797|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20040798|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
20040799|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040800|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040801|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20040802|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20040803|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
20040804|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040805|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040806|NCT02859246|Guaifenesin|guaifenesin|mesh-list
20040807|NCT02859246|Expectorants|expectorants|mesh-ancestor
20040808|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
20040809|NCT02859324|Nivolumab|nivolumab|mesh-list
20040810|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040811|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040812|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20040813|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040814|NCT02859441|Ranibizumab|ranibizumab|mesh-list
20040815|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20040816|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20040817|NCT02859441|Growth Substances|growth substances|mesh-ancestor
20040818|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040819|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
20040820|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040821|NCT02859454|Avelumab|avelumab|mesh-list
20040822|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040823|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040824|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
20040825|NCT02860507|Neostigmine|neostigmine|mesh-list
20040826|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20040827|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040828|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040829|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
20040830|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040831|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040832|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20040833|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
20040834|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040835|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20040836|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20040837|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20040838|NCT02860546|Nivolumab|nivolumab|mesh-list
20040839|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040840|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040841|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20040842|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040843|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20040844|NCT02860845|Clindamycin|clindamycin|mesh-list
20040845|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
20040846|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
20040847|NCT02860845|Clotrimazole|clotrimazole|mesh-list
20040848|NCT02860845|Miconazole|miconazole|mesh-list
20040849|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
20040850|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040851|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20040852|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040853|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040854|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20040855|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20040856|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20040857|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20040858|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
20040859|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040860|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040861|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20040862|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20040863|NCT02861131|Neostigmine|neostigmine|mesh-list
20040864|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20040865|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040866|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040867|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
20040868|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040869|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040870|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20040871|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
20040872|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040873|NCT02861586|Vaccines|vaccines|mesh-list
20040874|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
20040875|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040876|NCT02861664|Fluorides|fluorides|mesh-list
20293180|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293181|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293182|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20293183|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293184|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293185|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293186|NCT04683939|Gemcitabine|gemcitabine|mesh-list
20293187|NCT04683939|Paclitaxel|paclitaxel|mesh-list
19746118|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040877|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
20040878|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
20040879|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
20040880|NCT02861664|Protective Agents|protective agents|mesh-ancestor
20040881|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040882|NCT02862106|Vaccines|vaccines|mesh-list
20040883|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
20040884|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040885|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
20040886|NCT02862535|Nivolumab|nivolumab|mesh-list
20040887|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293188|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19746119|NCT04256941|Letrozole|letrozole|mesh-list
19746120|NCT04256941|Fulvestrant|fulvestrant|mesh-list
19746121|NCT04256941|Palbociclib|palbociclib|mesh-list
19746122|NCT04256941|Anastrozole|anastrozole|mesh-list
19746123|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746124|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19746125|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19746126|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746127|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746128|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19746129|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
19746130|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746131|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040888|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040889|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20040890|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040891|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
20040892|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040893|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
20040894|NCT02862574|Methotrexate|methotrexate|mesh-list
20040895|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20040896|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
20040897|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20040898|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040899|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20040900|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
20040901|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040902|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040903|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
20040904|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040905|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20040906|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20040907|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
20040908|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040909|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20040910|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040911|NCT02862600|Perhexiline|perhexiline|mesh-list
20040912|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20040913|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20040914|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040915|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20040916|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040917|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
20040918|NCT02862730|Pancrelipase|pancrelipase|mesh-list
20040919|NCT02862730|Pancreatin|pancreatin|mesh-list
20040920|NCT02862730|Hormones|hormones|mesh-list
20040921|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040922|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040923|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20040924|NCT02862912|Fentanyl|fentanyl|mesh-list
20040925|NCT02862912|Bupivacaine|bupivacaine|mesh-list
20040926|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
20040927|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
20040928|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
20040929|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20040930|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040931|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
20040932|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040933|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20040934|NCT02862912|Narcotics|narcotics|mesh-ancestor
20040935|NCT02862912|Analgesics|analgesics|mesh-ancestor
20040936|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20040937|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20576621|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576622|NCT02072213|Tamsulosin|tamsulosin|mesh-list
20576623|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20576624|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20576625|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20576626|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
20576627|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576628|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576629|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576630|NCT02072213|Urological Agents|urological agents|mesh-ancestor
20576631|NCT02072278|Vortioxetine|vortioxetine|mesh-list
20576632|NCT02072278|Citalopram|citalopram|mesh-list
20576633|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20576634|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20576635|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576636|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576637|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576638|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
20576639|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576640|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20576641|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
20576642|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20576643|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20576644|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20576645|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576646|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20576647|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20576648|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20576649|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20040938|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
20040939|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
20040940|NCT02863263|Povidone|povidone|mesh-list
20040941|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
20040942|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
20040943|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20040944|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20040945|NCT02863328|Empagliflozin|empagliflozin|mesh-list
20040946|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20040947|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040948|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20293189|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293190|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
20293191|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293192|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
20293193|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040949|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040950|NCT02863354|Aflibercept|aflibercept|mesh-list
20040951|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20040952|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20040953|NCT02863354|Growth Substances|growth substances|mesh-ancestor
20040954|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040955|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
20040956|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040957|NCT02863419|Liraglutide|liraglutide|mesh-list
20040958|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20040959|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040960|NCT02863419|Incretins|incretins|mesh-ancestor
20040961|NCT02863419|Hormones|hormones|mesh-ancestor
20040962|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20040963|NCT02863575|Ibuprofen|ibuprofen|mesh-list
20040964|NCT02863575|Caffeine|caffeine|mesh-list
20040965|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20040966|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20040967|NCT02863575|Analgesics|analgesics|mesh-ancestor
20040968|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
20040969|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20040970|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20040971|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20040972|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20040973|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20040974|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20040975|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040976|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20040977|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20040978|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20040979|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20040980|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
20040981|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20040982|NCT02864316|Nivolumab|nivolumab|mesh-list
20040983|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040984|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040985|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20040986|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040987|NCT02864368|Temozolomide|temozolomide|mesh-list
20040988|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20040989|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
20040990|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040991|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040992|NCT02864381|Nivolumab|nivolumab|mesh-list
20040993|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20040994|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20040995|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20040996|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20040997|NCT02864394|Docetaxel|docetaxel|mesh-list
20040998|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
20040999|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041000|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
20041001|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
20041002|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
20041003|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041004|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041005|NCT02864706|Cyclosporine|cyclosporine|mesh-list
20041006|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
20041007|NCT02864706|Everolimus|everolimus|mesh-list
20041008|NCT02864706|Cyclosporins|cyclosporins|mesh-list
20041009|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041010|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041011|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041012|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
20041013|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041014|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
20041015|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041016|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041017|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041018|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20041019|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041020|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20041021|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20041022|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
20041023|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20041024|NCT02865499|Acarbose|acarbose|mesh-list
20041025|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20041026|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041027|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041028|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20041029|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041030|NCT02865590|Cimetidine|cimetidine|mesh-list
20041031|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20041032|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041033|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20041034|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
20041035|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
20041036|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041037|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041038|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041039|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20041040|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20041041|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041042|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20041043|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20041044|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041045|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
20041046|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041047|NCT02865811|Doxorubicin|doxorubicin|mesh-list
20041048|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20041049|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
20041050|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20041051|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041052|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20041053|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20041054|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041055|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041056|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041057|NCT02866175|Vitamin K|vitamin k|mesh-list
20041058|NCT02866175|Edoxaban|edoxaban|mesh-list
20041059|NCT02866175|Clopidogrel|clopidogrel|mesh-list
20041060|NCT02866175|Ticagrelor|ticagrelor|mesh-list
20576650|NCT02072291|Nifedipine|nifedipine|mesh-list
20576651|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20576652|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041061|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20041062|NCT02866175|Vitamins|vitamins|mesh-ancestor
20041063|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
20041064|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041065|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20041066|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20041067|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20041068|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20041069|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
20041070|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041071|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041072|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20041073|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20041074|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
20041075|NCT02866175|Coagulants|coagulants|mesh-ancestor
20041076|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20041077|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
20041078|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20041079|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
20041080|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041081|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
20041082|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
20041083|NCT02866643|Etonogestrel|etonogestrel|mesh-list
20041084|NCT02866643|Desogestrel|desogestrel|mesh-list
20041085|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20041086|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041087|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20041088|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20041089|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20041090|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20041091|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20041092|NCT02866643|Progestins|progestins|mesh-ancestor
20041093|NCT02866643|Hormones|hormones|mesh-ancestor
20041094|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20041095|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
20041096|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20041097|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20041098|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041099|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
20041100|NCT02867163|Coagulants|coagulants|mesh-ancestor
20041101|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
20041102|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20041103|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041104|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
20041105|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20041106|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
20041107|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041108|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
20041109|NCT02867605|Protective Agents|protective agents|mesh-ancestor
20041110|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20041111|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20041112|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
20041113|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20041114|NCT02868242|Ledipasvir|ledipasvir|mesh-list
20041115|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
20041116|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746132|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746133|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20041117|NCT02869438|Benralizumab|benralizumab|mesh-list
20041118|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20041119|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
20041120|NCT02869451|Bupropion|bupropion|mesh-list
20041121|NCT02869451|Nicotine|nicotine|mesh-list
20041122|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20041123|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
20041124|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041125|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041126|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20041127|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20041128|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
20041129|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041130|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041131|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20041132|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
20041133|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20041134|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20041135|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20041136|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19746134|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19746135|NCT04256421|Carboplatin|carboplatin|mesh-list
19746136|NCT04256421|Etoposide|etoposide|mesh-list
19746137|NCT04256421|Atezolizumab|atezolizumab|mesh-list
19746138|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746139|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20041137|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
20041138|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20041139|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20041140|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041141|NCT02869893|Secretin|secretin|mesh-list
20041142|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041143|NCT02869893|Hormones|hormones|mesh-ancestor
20041144|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20041145|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041146|NCT02870283|Carbamazepine|carbamazepine|mesh-list
20041147|NCT02870283|Valproic Acid|valproic acid|mesh-list
20041148|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20041149|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041150|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041151|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
20041152|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20041153|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041154|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041155|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
20041156|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
20041157|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041158|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041159|NCT02870283|Analgesics|analgesics|mesh-ancestor
20041160|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
20041161|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041162|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20041163|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041164|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20041165|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20041166|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20041167|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20041168|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20041169|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
20041170|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041171|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041172|NCT02870972|Berotralstat|berotralstat|mesh-list
20041173|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041174|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041175|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
20041176|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20041177|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
20041178|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041179|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041180|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20041181|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
20041182|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20041183|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
20041184|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041185|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041186|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20041187|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
20041188|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
20041189|NCT02871011|Protective Agents|protective agents|mesh-ancestor
20041190|NCT02871492|Acyclovir|acyclovir|mesh-list
20041191|NCT02871492|Pritelivir|pritelivir|mesh-list
20041192|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
20041193|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041194|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041195|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041196|NCT02871635|Adalimumab|adalimumab|mesh-list
20041197|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041198|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117084|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20117085|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20117086|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
20117087|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117088|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20117089|NCT00005867|Prednisolone|prednisolone|mesh-list
20117090|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
20117091|NCT00005867|Doxorubicin|doxorubicin|mesh-list
20117092|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117093|NCT00005867|Etoposide|etoposide|mesh-list
20117094|NCT00005867|Vincristine|vincristine|mesh-list
20117095|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
20117096|NCT00005867|Bleomycin|bleomycin|mesh-list
20117097|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117098|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
20117099|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117100|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308361|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20041199|NCT02872012|Lidocaine|lidocaine|mesh-list
20041200|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
20041201|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
20041202|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041203|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041204|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
20041205|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041206|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20041207|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20041208|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20041209|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041210|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041211|NCT02872311|Vaccines|vaccines|mesh-list
20041212|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
20041213|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041214|NCT02872857|Galantamine|galantamine|mesh-list
20041215|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20041216|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041217|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041218|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
20041219|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041220|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041221|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20041222|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
20041223|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041224|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
20041225|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
20041226|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20041227|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20041228|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20041229|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
20041230|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041231|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041232|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041233|NCT02873338|Cytarabine|cytarabine|mesh-list
20041234|NCT02873338|Idarubicin|idarubicin|mesh-list
20041235|NCT02873338|Heparin|heparin|mesh-list
20041236|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20041237|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
20041238|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041239|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041240|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
20041241|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041242|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041243|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
20041244|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041245|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
20041246|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20041247|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20041248|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20041249|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20041250|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20041251|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041252|NCT02873377|Nicotine|nicotine|mesh-list
20041253|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20041254|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
20041255|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041256|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041257|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20041258|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20041259|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
20041260|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041261|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041262|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
20041263|NCT02873689|Lansoprazole|lansoprazole|mesh-list
20041264|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20041265|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041266|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20041267|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041268|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041269|NCT02873702|Lansoprazole|lansoprazole|mesh-list
20041270|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
20041271|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20576653|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041272|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576654|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20576655|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041273|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20041274|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041275|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041276|NCT02873754|Bupropion|bupropion|mesh-list
20041277|NCT02873754|Nicotine|nicotine|mesh-list
20041278|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20041279|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
20041280|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041281|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041282|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20041283|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20041284|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
20041285|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041286|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041287|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20041288|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
20041289|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20041290|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20041291|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20041292|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041293|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
20041294|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20041295|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20041296|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041297|NCT02874092|Ticagrelor|ticagrelor|mesh-list
20041298|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20041299|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20041300|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20041301|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20041302|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
20041303|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041304|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041305|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041306|NCT02874794|Valsartan|valsartan|mesh-list
20041307|NCT02874794|Enalapril|enalapril|mesh-list
20041308|NCT02874794|Enalaprilat|enalaprilat|mesh-list
20041309|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20041310|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20041311|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20041312|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20041313|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041314|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20041315|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
20041316|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041317|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20041318|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20041319|NCT02874924|Sirolimus|sirolimus|mesh-list
20041320|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20041321|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041322|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20041323|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041324|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
20041325|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041326|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
20041327|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041328|NCT02875028|Vorapaxar|vorapaxar|mesh-list
20041329|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20041330|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
20041331|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
20041332|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041333|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576656|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
20576657|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
20576658|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576659|NCT02072317|Raltitrexed|raltitrexed|mesh-list
20576660|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576661|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
20576662|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576663|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041334|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576664|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20041335|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
20041336|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
20041337|NCT02875340|Risperidone|risperidone|mesh-list
20041338|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20041339|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
20041340|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041341|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041342|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041343|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20041344|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20041345|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041346|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20041347|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20041348|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
20041349|NCT02875366|Ivacaftor|ivacaftor|mesh-list
20041350|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20041351|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041352|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041353|NCT02875392|Fucoidan|fucoidan|mesh-list
20041354|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20041355|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041356|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
20041357|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041358|NCT02875613|Avelumab|avelumab|mesh-list
20041359|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041360|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041361|NCT02876601|Defibrotide|defibrotide|mesh-list
20041362|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20041363|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20041364|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041365|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20041366|NCT02876900|Asenapine|asenapine|mesh-list
20041367|NCT02876900|Maleic acid|maleic acid|mesh-list
20041368|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041369|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041370|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20041371|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20041372|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041373|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041374|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20041375|NCT02877082|Bortezomib|bortezomib|mesh-list
20041376|NCT02877082|Tacrolimus|tacrolimus|mesh-list
20041377|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
20041378|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20041379|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041380|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
20041381|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041382|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20041383|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041384|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041385|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041386|NCT02877095|Furosemide|furosemide|mesh-list
20041387|NCT02877095|Diuretics|diuretics|mesh-ancestor
20041388|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
20041389|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041390|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20041391|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041392|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041393|NCT02877485|Triamcinolone|triamcinolone|mesh-list
20041394|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20041395|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20041396|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20041397|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041398|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
20041399|NCT02877485|Hormones|hormones|mesh-ancestor
20041400|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20041401|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041402|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041403|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
20041404|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041405|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041406|NCT02877927|Linezolid|linezolid|mesh-list
20576665|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576666|NCT02072330|Amlodipine|amlodipine|mesh-list
20041407|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20041408|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041409|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20041410|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041411|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041412|NCT02878057|Apatinib|apatinib|mesh-list
20041413|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041414|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20041415|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041416|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041417|NCT02878382|Calcipotriene|calcipotriene|mesh-list
20041418|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041419|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
20041420|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041421|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041422|NCT02880228|Dexamethasone|dexamethasone|mesh-list
20041423|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
20041424|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
20041425|NCT02880228|Lenalidomide|lenalidomide|mesh-list
20041426|NCT02880228|Ichthammol|ichthammol|mesh-list
20041427|NCT02880228|BB 1101|bb 1101|mesh-list
20041428|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041429|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
20041430|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
20041431|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041432|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041433|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041434|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
20041435|NCT02880228|Hormones|hormones|mesh-ancestor
20041436|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20041437|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20041438|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041439|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041440|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
20041441|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20041442|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20041443|NCT02880228|Growth Substances|growth substances|mesh-ancestor
20041444|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
20041445|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
20041446|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041447|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041448|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041449|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
20041450|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041451|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041452|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20041453|NCT02880852|Belimumab|belimumab|mesh-list
20041454|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041455|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
20041456|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041457|NCT02880865|Vaccines|vaccines|mesh-list
20041458|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
20041459|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041460|NCT02881008|Entecavir|entecavir|mesh-list
20041461|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
20041462|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041463|NCT02881567|Daclizumab|daclizumab|mesh-list
20041464|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041465|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
20041466|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041467|NCT02881957|Vitamin D|vitamin d|mesh-list
20041468|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
20041469|NCT02881957|Vitamins|vitamins|mesh-ancestor
20041470|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
20041471|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041472|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20041473|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20041474|NCT02881996|Acetaminophen|acetaminophen|mesh-list
20041475|NCT02881996|Ketorolac|ketorolac|mesh-list
20041476|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041477|NCT02881996|Analgesics|analgesics|mesh-ancestor
20041478|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
20041479|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041480|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041481|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
20041482|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20041483|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041484|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041485|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20041486|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041487|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041488|NCT02882152|Morphine|morphine|mesh-list
20041489|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20041490|NCT02882152|Narcotics|narcotics|mesh-ancestor
20041491|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041492|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041493|NCT02882152|Analgesics|analgesics|mesh-ancestor
20041494|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
20041495|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041496|NCT02882633|Bupivacaine|bupivacaine|mesh-list
20041497|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
20041498|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
20041499|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041500|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041501|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
20041502|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041503|NCT02882711|Ketamine|ketamine|mesh-list
20041504|NCT02882711|Analgesics|analgesics|mesh-ancestor
20041505|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
20041506|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041507|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041508|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20041509|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20041510|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
20041511|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
20041512|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041513|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20041514|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20041515|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041516|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041517|NCT02882854|Guanfacine|guanfacine|mesh-list
20041518|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20041519|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20041520|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20041521|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20041522|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
20041523|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041524|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041525|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041526|NCT02883452|Infliximab|infliximab|mesh-list
20041527|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041528|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041529|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041530|NCT02884089|Metformin|metformin|mesh-list
20041531|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20041532|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041533|NCT02885012|Ambrisentan|ambrisentan|mesh-list
20041534|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20041535|NCT02885025|Fluticasone|fluticasone|mesh-list
20041536|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041537|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20041538|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
20041539|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041540|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041541|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20041542|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
20041543|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041544|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20041545|NCT02885181|Methotrexate|methotrexate|mesh-list
20041546|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20041547|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
20041548|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20041549|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041550|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20041551|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
20041552|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041553|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041554|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041555|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041556|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20041557|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041558|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
20041559|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041560|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20041561|NCT02885636|Albuterol|albuterol|mesh-list
20041562|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20041563|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
20041564|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041565|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041566|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20041567|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
20041568|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
20041569|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20041570|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20041571|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20041572|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20041573|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
20041574|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041575|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117101|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117102|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
20117103|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117104|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117105|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117106|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117107|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117108|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117109|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117110|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117111|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117112|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117113|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117114|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117115|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
20117116|NCT00005867|Hormones|hormones|mesh-ancestor
20117117|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117118|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20117119|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117120|NCT00005867|Analgesics|analgesics|mesh-ancestor
20117121|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
20117122|NCT00005868|Docetaxel|docetaxel|mesh-list
20117123|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117124|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117125|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117126|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117127|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117128|NCT00005869|Gemcitabine|gemcitabine|mesh-list
20117129|NCT00005869|Rubitecan|rubitecan|mesh-list
20117130|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117131|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
20117132|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117133|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117134|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
20117135|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117136|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117137|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117138|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
20117139|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117140|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117141|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117142|NCT00005870|Gemcitabine|gemcitabine|mesh-list
20117143|NCT00005870|Fluorouracil|fluorouracil|mesh-list
20117144|NCT00005870|Mitomycins|mitomycins|mesh-list
20117145|NCT00005870|Mitomycin|mitomycin|mesh-list
20117146|NCT00005870|Rubitecan|rubitecan|mesh-list
20117147|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117148|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
20117149|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117150|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117151|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
20117152|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117153|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117154|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117155|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
20117156|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117157|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117158|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
20117159|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20041576|NCT02886624|Grazoprevir|grazoprevir|mesh-list
20041577|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
20041578|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041579|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
20041580|NCT02886702|Tazarotene|tazarotene|mesh-list
20041581|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041582|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
20041583|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
20041584|NCT02886702|Vitamins|vitamins|mesh-ancestor
20041585|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
20041586|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041587|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
20041588|NCT02886715|Tazarotene|tazarotene|mesh-list
20041589|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041590|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
20041591|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
20041592|NCT02886715|Vitamins|vitamins|mesh-ancestor
20041593|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
20041594|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041595|NCT02887183|Valsartan|valsartan|mesh-list
20041596|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20041597|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20041598|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20041599|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20041600|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041601|NCT02887404|Analgesics|analgesics|mesh-list
20041602|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
20041603|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041604|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041605|NCT02888106|Tenofovir|tenofovir|mesh-list
20041606|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20041607|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
20041608|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
20041609|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041610|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20041611|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20041612|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041613|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041614|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20041615|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20041616|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041617|NCT02888665|Doxorubicin|doxorubicin|mesh-list
20041618|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20041619|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
20041620|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20041621|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041622|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20041623|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20041624|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041625|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041626|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041627|NCT02889393|Teduglutide|teduglutide|mesh-list
20041628|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041629|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20041630|NCT02889393|Protective Agents|protective agents|mesh-ancestor
20576667|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20041631|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041632|NCT02889510|Liraglutide|liraglutide|mesh-list
20041633|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20041634|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041635|NCT02889510|Incretins|incretins|mesh-ancestor
20041636|NCT02889510|Hormones|hormones|mesh-ancestor
20041637|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20041638|NCT02889562|Warfarin|warfarin|mesh-list
20041639|NCT02889562|Apixaban|apixaban|mesh-list
20041640|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
20041641|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20041642|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
20041643|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20041644|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
20041645|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041646|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041647|NCT02889796|Adalimumab|adalimumab|mesh-list
20041648|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041649|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041650|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
20041651|NCT02890992|Niacin|niacin|mesh-list
20041652|NCT02890992|Niacinamide|niacinamide|mesh-list
20041653|NCT02890992|Ezetimibe|ezetimibe|mesh-list
20041654|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
20041655|NCT02890992|Fenofibrate|fenofibrate|mesh-list
20041656|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20041657|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20041658|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
20041659|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041660|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20041661|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
20041662|NCT02890992|Vitamins|vitamins|mesh-ancestor
20041663|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
20041664|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041665|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
20041666|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20041667|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
20041668|NCT02891070|Coagulants|coagulants|mesh-ancestor
20041669|NCT02891174|Acetaminophen|acetaminophen|mesh-list
20041670|NCT02891174|Ibuprofen|ibuprofen|mesh-list
20041671|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041672|NCT02891174|Analgesics|analgesics|mesh-ancestor
20041673|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
20041674|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041675|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041676|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
20041677|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20041678|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041679|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041680|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20041681|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041682|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041683|NCT02891408|Fenofibrate|fenofibrate|mesh-list
20041684|NCT02891408|Firsocostat|firsocostat|mesh-list
20041685|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20041686|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
20041687|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041688|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20041689|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041690|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
20041691|NCT02891850|Tadalafil|tadalafil|mesh-list
20041692|NCT02891850|Riociguat|riociguat|mesh-list
20041693|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
20041694|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20041695|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20041696|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041697|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041698|NCT02891850|Urological Agents|urological agents|mesh-ancestor
20041699|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
20041700|NCT02891915|Amoxicillin|amoxicillin|mesh-list
20041701|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
20576668|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20576669|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20576670|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20576671|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576672|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041702|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
20041703|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20041704|NCT02891915|Cefdinir|cefdinir|mesh-list
20041705|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20041706|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041707|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20041708|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041709|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041710|NCT02892110|Varenicline|varenicline|mesh-list
20041711|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20041712|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20041713|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
20041714|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041715|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041716|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041717|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
20041718|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041719|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041720|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20041721|NCT02892409|Amoxicillin|amoxicillin|mesh-list
20041722|NCT02892409|Clarithromycin|clarithromycin|mesh-list
20041723|NCT02892409|Lansoprazole|lansoprazole|mesh-list
20041724|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
20041725|NCT02892409|Bismuth|bismuth|mesh-list
20041726|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20041727|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20041728|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20041729|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041730|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041731|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20041732|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20041733|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20041734|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041735|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20041736|NCT02892409|Antacids|antacids|mesh-ancestor
20041737|NCT02892734|Nivolumab|nivolumab|mesh-list
20041738|NCT02892734|Ipilimumab|ipilimumab|mesh-list
20041739|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041740|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041741|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20041742|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041743|NCT02895035|Ketorolac|ketorolac|mesh-list
20041744|NCT02895035|Phenylephrine|phenylephrine|mesh-list
20041745|NCT02895035|Epinephrine|epinephrine|mesh-list
20041746|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
20041747|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20041748|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20041749|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
20041750|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041751|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041752|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041753|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20041754|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20041755|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
20041756|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041757|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20041758|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
20041759|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
20041760|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
20041761|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20041762|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20041763|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041764|NCT02895035|Analgesics|analgesics|mesh-ancestor
20041765|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
20041766|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041767|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041768|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20041769|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041770|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20041771|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
20041772|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20041773|NCT02895035|Protective Agents|protective agents|mesh-ancestor
20041774|NCT02895945|Factor VIII|factor viii|mesh-list
20041775|NCT02895945|Coagulants|coagulants|mesh-ancestor
20041776|NCT02896296|Buprenorphine|buprenorphine|mesh-list
20041777|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20041778|NCT02896296|Narcotics|narcotics|mesh-ancestor
20041779|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041780|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041781|NCT02896296|Analgesics|analgesics|mesh-ancestor
20041782|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
20041783|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041784|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20041785|NCT02896400|Nicotine|nicotine|mesh-list
20041786|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20041787|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
20041788|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041789|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041790|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20041791|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20041792|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
20041793|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041794|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041795|NCT02896595|Anesthetics|anesthetics|mesh-list
20041796|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041797|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041798|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
20041799|NCT02896907|Vitamins|vitamins|mesh-list
20041800|NCT02896907|Leucovorin|leucovorin|mesh-list
20041801|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
20041802|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
20041803|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
20041804|NCT02896907|Fluorouracil|fluorouracil|mesh-list
20041805|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
20041806|NCT02896907|Irinotecan|irinotecan|mesh-list
20041807|NCT02896907|Camptothecin|camptothecin|mesh-list
20041808|NCT02896907|Calcium|calcium|mesh-list
20041809|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
20041810|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
20041811|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041812|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20041813|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20041814|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
20041815|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041816|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20041817|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041818|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20041819|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
20041820|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20041821|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20041822|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041823|NCT02896907|Antidotes|antidotes|mesh-ancestor
20041824|NCT02896907|Protective Agents|protective agents|mesh-ancestor
20041825|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
20041826|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
20041827|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20041828|NCT02897115|Adalimumab|adalimumab|mesh-list
20041829|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20041830|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20041831|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041832|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041833|NCT02897115|Analgesics|analgesics|mesh-ancestor
20041834|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
20041835|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041836|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041837|NCT02897349|Linagliptin|linagliptin|mesh-list
20041838|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20041839|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041840|NCT02897349|Incretins|incretins|mesh-ancestor
20041841|NCT02897349|Hormones|hormones|mesh-ancestor
20041842|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20041843|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20041844|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
20041845|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041846|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041847|NCT02898077|Paclitaxel|paclitaxel|mesh-list
20041848|NCT02898077|Ramucirumab|ramucirumab|mesh-list
20041849|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20041850|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041851|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
20041852|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
20041853|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
20041854|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041855|NCT02898116|Durvalumab|durvalumab|mesh-list
20041856|NCT02898116|Ensartinib|ensartinib|mesh-list
20041857|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041858|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041859|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20041860|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041861|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041862|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
20041863|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041864|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041865|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20041866|NCT02899156|Flumazenil|flumazenil|mesh-list
20041867|NCT02899156|Antidotes|antidotes|mesh-ancestor
20041868|NCT02899156|Protective Agents|protective agents|mesh-ancestor
20041869|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041870|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
20041871|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
20041872|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041873|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041874|NCT02899195|Durvalumab|durvalumab|mesh-list
20041875|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041876|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041877|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20041878|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041879|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
20041880|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
20041881|NCT02899988|Mirikizumab|mirikizumab|mesh-list
20041882|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20041883|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041884|NCT02899988|Analgesics|analgesics|mesh-ancestor
20041885|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
20041886|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041887|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041888|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041889|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041890|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20041891|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041892|NCT02900092|Ganaxolone|ganaxolone|mesh-list
20041893|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
20041894|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041895|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041896|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041897|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
20041898|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
20041899|NCT02900378|Valsartan|valsartan|mesh-list
20041900|NCT02900378|Enalapril|enalapril|mesh-list
20041901|NCT02900378|Enalaprilat|enalaprilat|mesh-list
20041902|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20041903|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20041904|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20041905|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20041906|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041907|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20041908|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
20041909|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041910|NCT02901054|Ondansetron|ondansetron|mesh-list
20041911|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
20041912|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
20041913|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041914|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041915|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20041916|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
20041917|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
20041918|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20041919|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
20041920|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041921|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041922|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20041923|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20041924|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041925|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20041926|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20041927|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
20041928|NCT02901249|Sertraline|sertraline|mesh-list
20041929|NCT02901249|Nortriptyline|nortriptyline|mesh-list
20041930|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
20041931|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20041932|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20041933|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20041934|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041935|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041936|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20041937|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
20041938|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041939|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041940|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
20041941|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20041942|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041943|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20041944|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20041945|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
20041946|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
20041947|NCT02901899|Guadecitabine|guadecitabine|mesh-list
20041948|NCT02901899|Azacitidine|azacitidine|mesh-list
20041949|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20041950|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20041951|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20041952|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
20041953|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041954|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041955|NCT02902081|Cannabidiol|cannabidiol|mesh-list
20041956|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
20041957|NCT02902172|Acetaminophen|acetaminophen|mesh-list
20041958|NCT02902172|Ibuprofen|ibuprofen|mesh-list
20041959|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041960|NCT02902172|Analgesics|analgesics|mesh-ancestor
20041961|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
20041962|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041963|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041964|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
20041965|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20041966|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041967|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041968|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20041969|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041970|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041971|NCT02902237|Thromboplastin|thromboplastin|mesh-list
20041972|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
20041973|NCT02902237|Coagulants|coagulants|mesh-ancestor
20041974|NCT02902770|Ketorolac|ketorolac|mesh-list
20041975|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20041976|NCT02902770|Lidocaine|lidocaine|mesh-list
20041977|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
20041978|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
20041979|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20041980|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041981|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
20041982|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20041983|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20041984|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20041985|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20041986|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20041987|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20041988|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20041989|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20041990|NCT02902770|Analgesics|analgesics|mesh-ancestor
20041991|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20041992|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20041993|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20041994|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20041995|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20041996|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
20041997|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20041998|NCT02902913|Ibuprofen|ibuprofen|mesh-list
20117160|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20041999|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20042000|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20042001|NCT02902913|Analgesics|analgesics|mesh-ancestor
20042002|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
20042003|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042004|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042005|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042006|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20042007|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20042008|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042009|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117161|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117162|NCT00005871|Fluorouracil|fluorouracil|mesh-list
20117163|NCT00005871|Rubitecan|rubitecan|mesh-list
20117164|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
20117165|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117166|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117167|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117168|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117169|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
20117170|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117171|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117172|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117173|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117174|NCT00005872|Rubitecan|rubitecan|mesh-list
20117175|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117176|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117177|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117178|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117179|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117180|NCT00005873|Rubitecan|rubitecan|mesh-list
20117181|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117182|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117183|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117184|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117185|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117186|NCT00005874|Rubitecan|rubitecan|mesh-list
20117187|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117188|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117189|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117190|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117191|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117192|NCT00005875|Rubitecan|rubitecan|mesh-list
20117193|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117194|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117195|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117196|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117197|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117198|NCT00005876|Rubitecan|rubitecan|mesh-list
20117199|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117200|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117201|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117202|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117203|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120681|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120682|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120683|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20120684|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120685|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20120686|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20120687|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20120688|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
20120689|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
20120690|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120691|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
20120692|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120693|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120694|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120695|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
20120696|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120697|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120698|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20042010|NCT02902965|Dexamethasone|dexamethasone|mesh-list
20042011|NCT02902965|Bortezomib|bortezomib|mesh-list
20042012|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042013|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
20042014|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
20042015|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042016|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042017|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042018|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
20042019|NCT02902965|Hormones|hormones|mesh-ancestor
20042020|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042021|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293194|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20293195|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
20042022|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042023|NCT02903030|Silicon|silicon|mesh-list
20042024|NCT02903030|Trace Elements|trace elements|mesh-ancestor
20042025|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
20042026|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042027|NCT02903121|Tamoxifen|tamoxifen|mesh-list
20042028|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20042029|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
20042030|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042031|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042032|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042033|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042034|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20042035|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20042036|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20042037|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20042038|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20042039|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20042040|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042041|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042042|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042043|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042044|NCT02903238|Analgesics|analgesics|mesh-ancestor
20042045|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
20042046|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042047|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
20042048|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042049|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
20042050|NCT02903368|Prednisone|prednisone|mesh-list
20042051|NCT02903368|Leuprolide|leuprolide|mesh-list
20042052|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
20042053|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042054|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
20042055|NCT02903368|Hormones|hormones|mesh-ancestor
20042056|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042057|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042058|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042059|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042060|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20042061|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
20042062|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20042063|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20042064|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042065|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042066|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
20042067|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20042068|NCT02903407|Midazolam|midazolam|mesh-list
20042069|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
20042070|NCT02903407|Propofol|propofol|mesh-list
20042071|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20042072|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042073|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042074|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042075|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
20042076|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
20042077|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20042078|NCT02903407|Analgesics|analgesics|mesh-ancestor
20042079|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
20042080|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042081|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20042082|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20042083|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20042084|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
20042085|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042086|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042087|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20042088|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20042089|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20042090|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042091|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
20042092|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
20042093|NCT02903446|Denosumab|denosumab|mesh-list
20042094|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20042095|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042096|NCT02903511|Metformin|metformin|mesh-list
20042097|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042098|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042099|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
20042100|NCT02903836|Nafithromycin|nafithromycin|mesh-list
20042101|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20042102|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20042103|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20042104|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20042105|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042106|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042107|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042108|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20042109|NCT02904096|Lidocaine|lidocaine|mesh-list
20042110|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
20042111|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
20042112|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042113|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042114|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
20042115|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042116|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20042117|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20042118|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20042119|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042120|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042121|NCT02904200|Silicon|silicon|mesh-list
20042122|NCT02904200|Trace Elements|trace elements|mesh-ancestor
20042123|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
20042124|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042125|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
20042126|NCT02904226|Nivolumab|nivolumab|mesh-list
20042127|NCT02904226|Ipilimumab|ipilimumab|mesh-list
20042128|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20042129|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042130|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20042131|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042132|NCT02904265|Acetazolamide|acetazolamide|mesh-list
20042133|NCT02904265|Diazepam|diazepam|mesh-list
20042134|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
20042135|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20042136|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042137|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042138|NCT02904265|Diuretics|diuretics|mesh-ancestor
20042139|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
20042140|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042141|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20042142|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
20042143|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
20042144|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042145|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042146|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20042147|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042148|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20042149|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20042150|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20042151|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20042152|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042153|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042154|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
20042155|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
20042156|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
20042157|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
20042158|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042159|NCT02904902|Adalimumab|adalimumab|mesh-list
20042160|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042161|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20042162|NCT02904915|Lidocaine|lidocaine|mesh-list
20042163|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
20042164|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
20042165|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042166|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042167|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
20042168|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042169|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20042170|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20042171|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20042172|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042173|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042174|NCT02904954|Durvalumab|durvalumab|mesh-list
20042175|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20042176|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20042177|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042178|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
20042179|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042180|NCT02905266|Nivolumab|nivolumab|mesh-list
20042181|NCT02905266|Ipilimumab|ipilimumab|mesh-list
20042182|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20042183|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042184|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20042185|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042186|NCT02905981|Citric Acid|citric acid|mesh-list
20042187|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
20042188|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
20042189|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20042190|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
20042191|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
20042192|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042193|NCT02906566|Vitamin A|vitamin a|mesh-list
20042194|NCT02906566|Vitamins|vitamins|mesh-ancestor
20042195|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
20042196|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042197|NCT02906579|Praliciguat|praliciguat|mesh-list
20042198|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20042199|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
20042200|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042201|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042202|NCT02906644|Nicotine|nicotine|mesh-list
20042203|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20042204|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
20042205|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042206|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042207|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20042208|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20042209|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042210|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042211|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042212|NCT02906709|Insulin|insulin|mesh-list
20042213|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042214|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042215|NCT02906917|Insulin|insulin|mesh-list
20042216|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20042217|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
20042218|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
20042219|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
20042220|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20042221|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042222|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042223|NCT02907177|Ponesimod|ponesimod|mesh-list
20042224|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20042225|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042226|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20042227|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
20042228|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042229|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20042230|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20042231|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20042232|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042233|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042234|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20042235|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042236|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042237|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042238|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042239|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20042240|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20042241|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20042242|NCT02907918|Trastuzumab|trastuzumab|mesh-list
20042243|NCT02907918|Letrozole|letrozole|mesh-list
20042244|NCT02907918|Palbociclib|palbociclib|mesh-list
20042245|NCT02907918|Goserelin|goserelin|mesh-list
20042246|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20042247|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042248|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20042249|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20042250|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042251|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042252|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20042253|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
20042254|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042255|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042256|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20042257|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042258|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
20042259|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
20042260|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20042261|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20042262|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042263|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042264|NCT02908490|Urological Agents|urological agents|mesh-ancestor
20042265|NCT02908529|Oxybutynin|oxybutynin|mesh-list
20042266|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20042267|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20042268|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20042269|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042270|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042271|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20042272|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042273|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042274|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
20042275|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
20042276|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042277|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20042278|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20042279|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042280|NCT02908529|Urological Agents|urological agents|mesh-ancestor
20042281|NCT02908620|Anesthetics|anesthetics|mesh-list
20042282|NCT02908620|Tetracaine|tetracaine|mesh-list
20042283|NCT02908620|Benzocaine|benzocaine|mesh-list
20042284|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042285|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042286|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
20042287|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
20042288|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042289|NCT02909140|Lidocaine|lidocaine|mesh-list
20042290|NCT02909140|Phenylephrine|phenylephrine|mesh-list
20042291|NCT02909140|Epinephrine|epinephrine|mesh-list
20042292|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
20042293|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
20042294|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
20042295|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
20042296|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042297|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042298|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
20042299|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042300|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20042301|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20042302|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20042303|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042304|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042305|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20042306|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20042307|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
20042308|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042309|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20042310|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20042311|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
20042312|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20042313|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
20042314|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
20042315|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
20042316|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20042317|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20042318|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
20042319|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20042320|NCT02909140|Protective Agents|protective agents|mesh-ancestor
20042321|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
20042322|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20042323|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20042324|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042325|NCT02909439|Neostigmine|neostigmine|mesh-list
20042326|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20042327|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042328|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042329|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042330|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042331|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042332|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20042333|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
20042334|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042335|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
20042336|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
20042337|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042338|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042339|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042340|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
20042341|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20042342|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042343|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042344|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
20042345|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20042346|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042347|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042348|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042349|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042350|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042351|NCT02909959|Sulforaphane|sulforaphane|mesh-list
20042352|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20042353|NCT02909959|Protective Agents|protective agents|mesh-ancestor
20042354|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042355|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042356|NCT02910011|Doxycycline|doxycycline|mesh-list
20042357|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20042358|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20042359|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
20042360|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20042361|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20042362|NCT02910063|Blinatumomab|blinatumomab|mesh-list
20042363|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042364|NCT02910167|Acetaminophen|acetaminophen|mesh-list
20042365|NCT02910167|Scopolamine|scopolamine|mesh-list
20042366|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20042367|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20042368|NCT02910167|Analgesics|analgesics|mesh-ancestor
20042369|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
20042370|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042371|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042372|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
20042373|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20042374|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
20042375|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
20042376|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042377|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
20042378|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20042379|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042380|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042381|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042382|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20042383|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
20042384|NCT02911116|Ustekinumab|ustekinumab|mesh-list
20042385|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
20042386|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
20042387|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20042388|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
20042389|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20042390|NCT02911285|Expectorants|expectorants|mesh-ancestor
20042391|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
20042392|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20042393|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
20042394|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042395|NCT02911285|Protective Agents|protective agents|mesh-ancestor
20042396|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042397|NCT02911285|Antidotes|antidotes|mesh-ancestor
20042398|NCT02911324|Nabilone|nabilone|mesh-list
20042399|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
20042400|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
20042401|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042402|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042403|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042404|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20042405|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20042406|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042407|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042408|NCT02911688|Vitamin E|vitamin e|mesh-list
20042409|NCT02911688|Tocopherols|tocopherols|mesh-list
20042410|NCT02911688|Tocotrienols|tocotrienols|mesh-list
20042411|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
20042412|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
20042413|NCT02911688|Vitamins|vitamins|mesh-ancestor
20042414|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
20042415|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042416|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
20042417|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042418|NCT02911688|Protective Agents|protective agents|mesh-ancestor
20042419|NCT02911818|Liraglutide|liraglutide|mesh-list
20042420|NCT02911818|Phentermine|phentermine|mesh-list
20042421|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042422|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042423|NCT02911818|Incretins|incretins|mesh-ancestor
20042424|NCT02911818|Hormones|hormones|mesh-ancestor
20042425|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042426|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20042427|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
20042428|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20042429|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
20042430|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
20042431|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042432|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
20042433|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042434|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042435|NCT02911844|Fulvestrant|fulvestrant|mesh-list
20042436|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042437|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042438|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20042439|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20042440|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
20042441|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042442|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042443|NCT02911948|Insulin|insulin|mesh-list
20042444|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20042445|NCT02911948|Liraglutide|liraglutide|mesh-list
20042446|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
20042447|NCT02911948|Xultophy|xultophy|mesh-list
20042448|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042449|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042450|NCT02911948|Incretins|incretins|mesh-ancestor
20042451|NCT02911948|Hormones|hormones|mesh-ancestor
20042452|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042453|NCT02912195|Lidocaine|lidocaine|mesh-list
20042454|NCT02912195|Morphine|morphine|mesh-list
20042455|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
20042456|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
20042457|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042458|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042459|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
20042460|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042461|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20042462|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20042463|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20042464|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042465|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042466|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20042467|NCT02912195|Narcotics|narcotics|mesh-ancestor
20042468|NCT02912195|Analgesics|analgesics|mesh-ancestor
20042469|NCT02912364|Carbamazepine|carbamazepine|mesh-list
20042470|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20042471|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
20042472|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
20042473|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20042474|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042475|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042476|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042477|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20042478|NCT02912364|Analgesics|analgesics|mesh-ancestor
20042479|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
20042480|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042481|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20042482|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042483|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042484|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20042485|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20042486|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20042487|NCT02912455|Canagliflozin|canagliflozin|mesh-list
20042488|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20042489|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042490|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042491|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042492|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
20042493|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042494|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
20042495|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20042496|NCT02912650|Acetaminophen|acetaminophen|mesh-list
20042497|NCT02912650|Ibuprofen|ibuprofen|mesh-list
20042498|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20042499|NCT02912650|Analgesics|analgesics|mesh-ancestor
20042500|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
20042501|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042502|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042503|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
20042504|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20042505|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042506|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20042507|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20042508|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042509|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042510|NCT02913326|Warfarin|warfarin|mesh-list
20042511|NCT02913326|Dabigatran|dabigatran|mesh-list
20042512|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
20042513|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
20042514|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20042515|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
20042516|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042517|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042518|NCT02913521|Diclofenac|diclofenac|mesh-list
20042519|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20042520|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20042521|NCT02913521|Analgesics|analgesics|mesh-ancestor
20042522|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
20042523|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042524|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042525|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042526|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20042527|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20042528|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042529|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042530|NCT02913924|Clonazepam|clonazepam|mesh-list
20042531|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
20042532|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
20042533|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
20042534|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042535|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042536|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042537|NCT02914119|Rocuronium|rocuronium|mesh-list
20042538|NCT02914119|Mivacurium|mivacurium|mesh-list
20042539|NCT02914119|Cisatracurium|cisatracurium|mesh-list
20042540|NCT02914119|Succinylcholine|succinylcholine|mesh-list
20042541|NCT02914119|Neostigmine|neostigmine|mesh-list
20042542|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20042543|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20042544|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20042545|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042546|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042547|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20042548|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042549|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042550|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042551|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042552|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20042553|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
20042554|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20117204|NCT00005877|Rubitecan|rubitecan|mesh-list
20117205|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117206|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20576673|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20576674|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576675|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
20576676|NCT02072330|Diuretics|diuretics|mesh-ancestor
20576677|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
20576678|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20117207|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117208|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117209|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117210|NCT00005878|Celecoxib|celecoxib|mesh-list
20117211|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20117212|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20117213|NCT00005878|Analgesics|analgesics|mesh-ancestor
20117214|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
20117215|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117216|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117217|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117218|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117219|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20117220|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20117221|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117222|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117223|NCT00005880|Budesonide|budesonide|mesh-list
20117224|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117225|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20117226|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
20117227|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117228|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117229|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20117230|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
20117231|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
20117232|NCT00005880|Hormones|hormones|mesh-ancestor
20117233|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117234|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
20117235|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117236|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117237|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20117238|NCT00005883|Protective Agents|protective agents|mesh-ancestor
20117239|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117240|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117241|NCT00005884|Eflornithine|eflornithine|mesh-list
20117242|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117243|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20117244|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20117245|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20117246|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117247|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20117248|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117249|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117250|NCT00005886|Tamoxifen|tamoxifen|mesh-list
20042555|NCT02914275|Vaccines|vaccines|mesh-list
20042556|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
20042557|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042558|NCT02914509|Travoprost|travoprost|mesh-list
20042559|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20042560|NCT02915159|Abatacept|abatacept|mesh-list
20042561|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20042562|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042563|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042564|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20042565|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
20042566|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042567|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20042568|NCT02915705|Vitamin D|vitamin d|mesh-list
20042569|NCT02915705|Vitamins|vitamins|mesh-ancestor
20042570|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
20042571|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042572|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20042573|NCT02915744|Gemcitabine|gemcitabine|mesh-list
20042574|NCT02915744|Paclitaxel|paclitaxel|mesh-list
20042575|NCT02915744|Vinorelbine|vinorelbine|mesh-list
20042576|NCT02915744|Docetaxel|docetaxel|mesh-list
20042577|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20042578|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
20042579|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20042580|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042581|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
20042582|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
20042583|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
20042584|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042585|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20042586|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
20042587|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
20042588|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20042589|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042590|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20042591|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
20042592|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042593|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20042594|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20042595|NCT02915835|Riociguat|riociguat|mesh-list
20042596|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
20042597|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042598|NCT02915978|Fentanyl|fentanyl|mesh-list
20042599|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20042600|NCT02915978|Narcotics|narcotics|mesh-ancestor
20042601|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042602|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042603|NCT02915978|Analgesics|analgesics|mesh-ancestor
20042604|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
20042605|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042606|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20042607|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042608|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
20042609|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
20042610|NCT02916407|Sevoflurane|sevoflurane|mesh-list
20042611|NCT02916407|Desflurane|desflurane|mesh-list
20042612|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20042613|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20042614|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
20042615|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
20042616|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042617|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042618|NCT02916433|Octreotide|octreotide|mesh-list
20042619|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042620|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042621|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042622|NCT02916693|Mirabegron|mirabegron|mesh-list
20042623|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20042624|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20042625|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20042626|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20042627|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042628|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042629|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042630|NCT02916693|Urological Agents|urological agents|mesh-ancestor
20042631|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20042632|NCT02916745|Trioxsalen|trioxsalen|mesh-list
20042633|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042634|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
20042635|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20042636|NCT02916927|Ketamine|ketamine|mesh-list
20042637|NCT02916927|Analgesics|analgesics|mesh-ancestor
20042638|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
20042639|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042640|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042641|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20042642|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042643|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
20042644|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
20042645|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042646|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20042647|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20042648|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042649|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042650|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20042651|NCT02917031|Saxagliptin|saxagliptin|mesh-list
20042652|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042653|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042654|NCT02917031|Incretins|incretins|mesh-ancestor
20042655|NCT02917031|Hormones|hormones|mesh-ancestor
20042656|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042657|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20042658|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
20042659|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042660|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042661|NCT02917122|Sertraline|sertraline|mesh-list
20042662|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
20042663|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042664|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20042665|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20042666|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042667|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042668|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042669|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
20042670|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042671|NCT02917941|Dexamethasone|dexamethasone|mesh-list
20042672|NCT02917941|Lenalidomide|lenalidomide|mesh-list
20042673|NCT02917941|Ixazomib|ixazomib|mesh-list
20042674|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042675|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
20042676|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
20042677|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042678|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042679|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042680|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
20042681|NCT02917941|Hormones|hormones|mesh-ancestor
20042682|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042683|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042684|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042685|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
20042686|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20042687|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20042688|NCT02917941|Growth Substances|growth substances|mesh-ancestor
20042689|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
20042690|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
20042691|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042692|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042693|NCT02918071|Benralizumab|benralizumab|mesh-list
20042694|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20042695|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
20042696|NCT02918097|Risperidone|risperidone|mesh-list
20042697|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
20042698|NCT02918097|Sertraline|sertraline|mesh-list
20042699|NCT02918097|Nortriptyline|nortriptyline|mesh-list
20042700|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20042701|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
20042702|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042703|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042704|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042705|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20042706|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20042707|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042708|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042709|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20042710|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
20042711|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
20042712|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20042713|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20042714|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042715|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042716|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
20042717|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20042718|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20042719|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
20042720|NCT02918266|Scopolamine|scopolamine|mesh-list
20042721|NCT02918266|Donepezil|donepezil|mesh-list
20042722|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20042723|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20042724|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042725|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042726|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042727|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042728|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042729|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
20042730|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20042731|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
20042732|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
20042733|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042734|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042735|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
20042736|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20042737|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20042738|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
20042739|NCT02918279|Liraglutide|liraglutide|mesh-list
20042740|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042741|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042742|NCT02918279|Incretins|incretins|mesh-ancestor
20042743|NCT02918279|Hormones|hormones|mesh-ancestor
20042744|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042745|NCT02918318|Esketamine|esketamine|mesh-list
20042746|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
20042747|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20042748|NCT02918357|Edetic Acid|edetic acid|mesh-list
20042749|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
20042750|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
20042751|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042752|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
20042753|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20042754|NCT02918617|Fluorides|fluorides|mesh-list
20042755|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
20042756|NCT02918617|Protective Agents|protective agents|mesh-ancestor
20042757|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042758|NCT02918630|Nicotine|nicotine|mesh-list
20042759|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20042760|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
20042761|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042762|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042763|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20293196|NCT04683939|Antiviral Agents|antiviral agents|mesh-ancestor
20293197|NCT04683939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293198|NCT04683939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293199|NCT04683939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293200|NCT04683939|Immunologic Factors|immunologic factors|mesh-ancestor
20293201|NCT04683939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293202|NCT04666961|Tamoxifen|tamoxifen|mesh-list
20293203|NCT04666961|Anastrozole|anastrozole|mesh-list
20293204|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20042764|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20042765|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
20042766|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042767|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042768|NCT02918721|Lidocaine|lidocaine|mesh-list
20042769|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
20042770|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
20042771|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
20042772|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042773|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042774|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
20042775|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042776|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20042777|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20042778|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20042779|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20042780|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042781|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20042782|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
20042783|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
20042784|NCT02918721|Protective Agents|protective agents|mesh-ancestor
20042785|NCT02918877|Propofol|propofol|mesh-list
20042786|NCT02918877|Sevoflurane|sevoflurane|mesh-list
20042787|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20042788|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042789|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042790|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042791|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
20042792|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
20042793|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20042794|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20042795|NCT02918968|Flutamide|flutamide|mesh-list
20042796|NCT02918968|Androgens|androgens|mesh-list
20042797|NCT02918968|Hormones|hormones|mesh-ancestor
20042798|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042799|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042800|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
20042801|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
20042802|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042803|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042804|NCT02919111|Edetic Acid|edetic acid|mesh-list
20042805|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
20042806|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
20042807|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042808|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
20042809|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20042810|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20042811|NCT02919761|Hormones|hormones|mesh-ancestor
20042812|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042813|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042814|NCT02920528|Ketamine|ketamine|mesh-list
20042815|NCT02920528|Analgesics|analgesics|mesh-ancestor
20042816|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
20042817|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042818|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042819|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20042820|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042821|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
20042822|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
20042823|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042824|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20042825|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20042826|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042827|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042828|NCT02920749|Anesthetics|anesthetics|mesh-list
20042829|NCT02920749|Propofol|propofol|mesh-list
20042830|NCT02920749|Sevoflurane|sevoflurane|mesh-list
20042831|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042832|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042833|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20042834|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042835|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
20042836|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20042837|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20042838|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20042839|NCT02920918|Canagliflozin|canagliflozin|mesh-list
20042840|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20042841|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042842|NCT02920918|Incretins|incretins|mesh-ancestor
20042843|NCT02920918|Hormones|hormones|mesh-ancestor
20042844|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042845|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20042846|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
20042847|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042848|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042849|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20042850|NCT02921061|Cytarabine|cytarabine|mesh-list
20042851|NCT02921061|Decitabine|decitabine|mesh-list
20042852|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
20042853|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
20042854|NCT02921061|Cladribine|cladribine|mesh-list
20042855|NCT02921061|Lenograstim|lenograstim|mesh-list
20042856|NCT02921061|Sargramostim|sargramostim|mesh-list
20042857|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20042858|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
20042859|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042860|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042861|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
20042862|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20042863|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20042864|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
20042865|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042866|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20042867|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042868|NCT02921061|Analgesics|analgesics|mesh-ancestor
20042869|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
20042870|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042871|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20042872|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20042873|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
20042874|NCT02921386|Testosterone|testosterone|mesh-list
20042875|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
20042876|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
20042877|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20042878|NCT02921386|Androgens|androgens|mesh-ancestor
20042879|NCT02921386|Hormones|hormones|mesh-ancestor
20042880|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042881|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042882|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20042883|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042884|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
20042885|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20042886|NCT02921750|Laxatives|laxatives|mesh-ancestor
20042887|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20042888|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
20042889|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20042890|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20042891|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042892|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
20042893|NCT02922582|Coagulants|coagulants|mesh-ancestor
20042894|NCT02922959|Naloxone|naloxone|mesh-list
20042895|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042896|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
20042897|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042898|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20042899|NCT02923115|Enoxaparin|enoxaparin|mesh-list
20042900|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
20042901|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20042902|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20042903|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042904|NCT02923895|Fluorides|fluorides|mesh-list
20042905|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
20042906|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
20042907|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
20042908|NCT02923895|Protective Agents|protective agents|mesh-ancestor
20042909|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042910|NCT02923921|Leucovorin|leucovorin|mesh-list
20042911|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
20042912|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042913|NCT02923921|Antidotes|antidotes|mesh-ancestor
20042914|NCT02923921|Protective Agents|protective agents|mesh-ancestor
20042915|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042916|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
20042917|NCT02923921|Vitamins|vitamins|mesh-ancestor
20042918|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
20042919|NCT02924350|Fluorides|fluorides|mesh-list
20042920|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
20042921|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
20042922|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
20042923|NCT02924350|Protective Agents|protective agents|mesh-ancestor
20042924|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042925|NCT02924688|Fluticasone|fluticasone|mesh-list
20042926|NCT02924688|Albuterol|albuterol|mesh-list
20042927|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20042928|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20042929|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20042930|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20042931|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
20042932|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042933|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042934|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20042935|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
20042936|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
20042937|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20042938|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20042939|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20042940|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20042941|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
20042942|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20042943|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042944|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
20042945|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20042946|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
20042947|NCT02924688|Hormones|hormones|mesh-ancestor
20042948|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042949|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
20042950|NCT02924883|Trastuzumab|trastuzumab|mesh-list
20042951|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20042952|NCT02924883|Atezolizumab|atezolizumab|mesh-list
20042953|NCT02924883|Maytansine|maytansine|mesh-list
20042954|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20042955|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20042956|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20042957|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
20042958|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
20042959|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
20042960|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042961|NCT02925117|Upadacitinib|upadacitinib|mesh-list
20042962|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20042963|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20042964|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20042965|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20042966|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117251|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20117252|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
20117253|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117254|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117255|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20117256|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117257|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20117258|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20117259|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20117260|NCT00005887|Efaproxiral|efaproxiral|mesh-list
20117261|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
20117262|NCT00005889|Glucagon|glucagon|mesh-list
20117263|NCT00005889|Glycerol|glycerol|mesh-list
20117264|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117265|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20117266|NCT00005889|Hormones|hormones|mesh-ancestor
20117267|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117268|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20117269|NCT00005889|Protective Agents|protective agents|mesh-ancestor
20117270|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20117271|NCT00005890|Hormones|hormones|mesh-ancestor
20117272|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117273|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117274|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
20117275|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117276|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
20117277|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117278|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117279|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117280|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
20117281|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117282|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117283|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117284|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
20117285|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20042967|NCT02925494|Norethindrone|norethindrone|mesh-list
20042968|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
20042969|NCT02925494|Estradiol|estradiol|mesh-list
20042970|NCT02925494|Estrogens|estrogens|mesh-ancestor
20042971|NCT02925494|Hormones|hormones|mesh-ancestor
20042972|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20042973|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042974|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20042975|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
20042976|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20042977|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20042978|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20042979|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20042980|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20042981|NCT02925611|Desflurane|desflurane|mesh-list
20042982|NCT02925611|Isoflurane|isoflurane|mesh-list
20042983|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20042984|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
20042985|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
20042986|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042987|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042988|NCT02925858|Ketamine|ketamine|mesh-list
20042989|NCT02925858|Analgesics|analgesics|mesh-ancestor
20042990|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
20042991|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20042992|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20042993|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20042994|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20042995|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
20042996|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
20042997|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20042998|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20042999|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20043000|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043001|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043002|NCT02925923|Clopidogrel|clopidogrel|mesh-list
20043003|NCT02925923|Ticagrelor|ticagrelor|mesh-list
20043004|NCT02925923|Eptifibatide|eptifibatide|mesh-list
20043005|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20043006|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20043007|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20043008|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20043009|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
20043010|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043011|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043012|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043013|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20043014|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20043015|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20043016|NCT02926573|Gabapentin|gabapentin|mesh-list
20043017|NCT02926573|Analgesics|analgesics|mesh-ancestor
20043018|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
20043019|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043020|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043021|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
20043022|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20043023|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20043024|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043025|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20043026|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20043027|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20043028|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043029|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043030|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
20043031|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20043032|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20043033|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043034|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20043035|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043036|NCT02926950|Metformin|metformin|mesh-list
20117286|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
20117287|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043037|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20043038|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20043039|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043040|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20043041|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043042|NCT02927223|Atropine|atropine|mesh-list
20043043|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20043044|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20043045|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20043046|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
20043047|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043048|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043049|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20043050|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
20043051|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
20043052|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
20043053|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20043054|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20043055|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
20043056|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043057|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043058|NCT02927301|Atezolizumab|atezolizumab|mesh-list
20043059|NCT02927301|Antibodies|antibodies|mesh-list
20043060|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20043061|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
20043062|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043063|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043064|NCT02927431|Oseltamivir|oseltamivir|mesh-list
20043065|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
20043066|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043067|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043068|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043069|NCT02927457|GSK2646264|gsk2646264|mesh-list
20043070|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20043071|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043072|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043073|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20043074|NCT02927834|Prednisone|prednisone|mesh-list
20043075|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043076|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
20043077|NCT02927834|Hormones|hormones|mesh-ancestor
20043078|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043079|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043080|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043081|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043082|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20043083|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043084|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20043085|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043086|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043087|NCT02927873|Vaccines|vaccines|mesh-list
20043088|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
20043089|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043090|NCT02927925|Daratumumab|daratumumab|mesh-list
20043091|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043092|NCT02928029|Dexamethasone|dexamethasone|mesh-list
20043093|NCT02928029|Bortezomib|bortezomib|mesh-list
20043094|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20043095|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043096|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
20043097|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
20043098|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043099|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043100|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043101|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
20043102|NCT02928029|Hormones|hormones|mesh-ancestor
20043103|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043104|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043105|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043106|NCT02929498|Azacitidine|azacitidine|mesh-list
20043107|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20043108|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
20043109|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043110|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043111|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043112|NCT02929667|Fluoxetine|fluoxetine|mesh-list
20043113|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20043114|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20043115|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043116|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043117|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043118|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
20043119|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043120|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20043121|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
20043122|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20043123|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20043124|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20043125|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043126|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20043127|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20043128|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
20043129|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
20043130|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
20043131|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20043132|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20043133|NCT02930005|Analgesics|analgesics|mesh-ancestor
20043134|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
20043135|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043136|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043137|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043138|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043139|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20043140|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043141|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043142|NCT02930343|Folic Acid|folic acid|mesh-list
20043143|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
20043144|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
20043145|NCT02930343|Prednisolone|prednisolone|mesh-list
20043146|NCT02930343|Methotrexate|methotrexate|mesh-list
20043147|NCT02930343|Leflunomide|leflunomide|mesh-list
20043148|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
20043149|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20043150|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
20043151|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20043152|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043153|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20043154|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
20043155|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043156|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043157|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
20043158|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043159|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20043160|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043161|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
20043162|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043163|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20043164|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043165|NCT02930343|Hormones|hormones|mesh-ancestor
20043166|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043167|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043168|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043169|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043170|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
20043171|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20043172|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20043173|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043174|NCT02930343|Hematinics|hematinics|mesh-ancestor
20043175|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
20043176|NCT02930343|Vitamins|vitamins|mesh-ancestor
20043177|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
20043178|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20043179|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20043180|NCT02930343|Analgesics|analgesics|mesh-ancestor
20043181|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
20043182|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20043183|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20043184|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20043185|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043186|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
20043187|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20043188|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20043189|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043190|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
20043191|NCT02930941|Coagulants|coagulants|mesh-ancestor
20043192|NCT02931045|Clopidogrel|clopidogrel|mesh-list
20043193|NCT02931045|Ticagrelor|ticagrelor|mesh-list
20043194|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20043195|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20043196|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20043197|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20043198|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
20043199|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043200|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043201|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043202|NCT02931253|Metformin|metformin|mesh-list
20043203|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20043204|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576679|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20576680|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20576681|NCT02072382|Metformin|metformin|mesh-list
20576682|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20576683|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576684|NCT02072408|Aflibercept|aflibercept|mesh-list
20576685|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20576686|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20576687|NCT02072408|Growth Substances|growth substances|mesh-ancestor
20576688|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576689|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
20043205|NCT02931539|Valganciclovir|valganciclovir|mesh-list
20043206|NCT02931539|Ganciclovir|ganciclovir|mesh-list
20043207|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20043208|NCT02931539|Cidofovir|cidofovir|mesh-list
20043209|NCT02931539|Foscarnet|foscarnet|mesh-list
20043210|NCT02931539|Maribavir|maribavir|mesh-list
20043211|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
20043212|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043213|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20043214|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043215|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043216|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20043217|NCT02931838|BMS-986165|bms-986165|mesh-list
20043218|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
20043219|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20043220|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043221|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043222|NCT02932267|Adapalene|adapalene|mesh-list
20043223|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20043224|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20043225|NCT02932267|Analgesics|analgesics|mesh-ancestor
20043226|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
20043227|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043228|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043229|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043230|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043231|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
20043232|NCT02932904|Vortioxetine|vortioxetine|mesh-list
20043233|NCT02932904|Paroxetine|paroxetine|mesh-list
20043234|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20043235|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20043236|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043237|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043238|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043239|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
20043240|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043241|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20043242|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
20043243|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20043244|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20043245|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20043246|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043247|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20043248|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20043249|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043250|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20043251|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20043252|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20043253|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20043254|NCT02933034|Manganese|manganese|mesh-list
20043255|NCT02933034|Trace Elements|trace elements|mesh-ancestor
20043256|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
20043257|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043258|NCT02933320|Rituximab|rituximab|mesh-list
20043259|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043260|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043261|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
20043262|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043263|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043264|NCT02933372|Varenicline|varenicline|mesh-list
20043265|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20043266|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20043267|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
20043268|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043269|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043270|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043271|NCT02934191|Acetaminophen|acetaminophen|mesh-list
20043272|NCT02934191|Celecoxib|celecoxib|mesh-list
20043273|NCT02934191|Oxycodone|oxycodone|mesh-list
20043274|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
20043275|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043276|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20043277|NCT02934191|Analgesics|analgesics|mesh-ancestor
20043278|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
20043279|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043280|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
20043281|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20043282|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043283|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043284|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20043285|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20043286|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043287|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043288|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20043289|NCT02934191|Narcotics|narcotics|mesh-ancestor
20043290|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043291|NCT02934191|Antacids|antacids|mesh-ancestor
20043292|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043293|NCT02934698|Ivacaftor|ivacaftor|mesh-list
20043294|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20043295|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043296|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043297|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
20043298|NCT02935699|Promethazine|promethazine|mesh-list
20043299|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20043300|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20043301|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043302|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043303|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
20043304|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
20043305|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
20043306|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043307|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
20043308|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
20043309|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043310|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20043311|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
20043312|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
20043313|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043314|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043315|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20043316|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
20043317|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
20043318|NCT02935738|Prednisolone|prednisolone|mesh-list
20043319|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043320|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
20043321|NCT02935738|Hormones|hormones|mesh-ancestor
20043322|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117288|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043323|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043324|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043325|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043326|NCT02935894|Ibuprofen|ibuprofen|mesh-list
20043327|NCT02935894|Pilocarpine|pilocarpine|mesh-list
20043328|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20043329|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20043330|NCT02935894|Analgesics|analgesics|mesh-ancestor
20043331|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
20043332|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043333|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043334|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043335|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043336|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20043337|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043338|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043339|NCT02935894|Miotics|miotics|mesh-ancestor
20043340|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
20043341|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20043342|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20043343|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
20043344|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043345|NCT02936037|Biotin|biotin|mesh-list
20043346|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
20043347|NCT02936037|Vitamins|vitamins|mesh-ancestor
20043348|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
20043349|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043350|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20043351|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20043352|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20043353|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043354|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
20043355|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117289|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117290|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
20117291|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117292|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117293|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117294|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
20117295|NCT00005893|Busulfan|busulfan|mesh-list
20117296|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20117297|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117298|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
20117299|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117300|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117301|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117302|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
20117303|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117304|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117305|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117306|NCT00005896|Lenograstim|lenograstim|mesh-list
20117307|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20117308|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
20117309|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117310|NCT00005898|Cyclosporine|cyclosporine|mesh-list
20117311|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
20117312|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
20117313|NCT00005898|Fludarabine|fludarabine|mesh-list
20117314|NCT00005898|Cyclosporins|cyclosporins|mesh-list
20117315|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20117316|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117317|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
20117318|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117319|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117320|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117321|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
20117322|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117323|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117324|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117325|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117326|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
20117327|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117328|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117329|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20117330|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117331|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
20043356|NCT02937116|Gemcitabine|gemcitabine|mesh-list
20043357|NCT02937116|Cisplatin|cisplatin|mesh-list
20043358|NCT02937116|Capecitabine|capecitabine|mesh-list
20043359|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
20043360|NCT02937116|Irinotecan|irinotecan|mesh-list
20043361|NCT02937116|Etoposide|etoposide|mesh-list
20043362|NCT02937116|Pemetrexed|pemetrexed|mesh-list
20043363|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043364|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20043365|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
20043366|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043367|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
20043368|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043369|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043370|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043371|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
20043372|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043373|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20043374|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20043375|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20043376|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20043377|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20043378|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20043379|NCT02937168|Reslizumab|reslizumab|mesh-list
20043380|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20043381|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20043382|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043383|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20043384|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
20043385|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20043386|NCT02937350|Calcifediol|calcifediol|mesh-list
20043387|NCT02937350|Vitamins|vitamins|mesh-ancestor
20043388|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
20043389|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043390|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20043391|NCT02937506|Fentanyl|fentanyl|mesh-list
20043392|NCT02937506|Midazolam|midazolam|mesh-list
20043393|NCT02937506|Propofol|propofol|mesh-list
20043394|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20043395|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043396|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043397|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20043398|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
20043399|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
20043400|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20043401|NCT02937506|Narcotics|narcotics|mesh-ancestor
20043402|NCT02937506|Analgesics|analgesics|mesh-ancestor
20043403|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
20043404|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043405|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20043406|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20043407|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20043408|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20043409|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
20043410|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
20043411|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043412|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043413|NCT02937558|Glucagon|glucagon|mesh-list
20043414|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20043415|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043416|NCT02937558|Hormones|hormones|mesh-ancestor
20043417|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043418|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043419|NCT02937558|Incretins|incretins|mesh-ancestor
20043420|NCT02937623|Calcium|calcium|mesh-list
20043421|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20043422|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043423|NCT02937636|Fluorides|fluorides|mesh-list
20043424|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
20043425|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
20043426|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
20043427|NCT02937636|Protective Agents|protective agents|mesh-ancestor
20043428|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576690|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043429|NCT02937701|Infliximab|infliximab|mesh-list
20043430|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20043431|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043432|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043433|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
20043434|NCT02937740|Testosterone|testosterone|mesh-list
20043435|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
20043436|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
20043437|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20043438|NCT02937740|Androgens|androgens|mesh-ancestor
20043439|NCT02937740|Hormones|hormones|mesh-ancestor
20043440|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043441|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043442|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043443|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043444|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
20043445|NCT02938494|Tazarotene|tazarotene|mesh-list
20043446|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
20043447|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
20043448|NCT02938520|Rilpivirine|rilpivirine|mesh-list
20043449|NCT02938520|Cabotegravir|cabotegravir|mesh-list
20043450|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20043451|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20043452|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043453|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043454|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
20043455|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043456|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20043457|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20043458|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20043459|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20043460|NCT02938585|Factor VIII|factor viii|mesh-list
20043461|NCT02938585|Coagulants|coagulants|mesh-ancestor
20043462|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20043463|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043464|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043465|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20043466|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20043467|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043468|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043469|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
20043470|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043471|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
20043472|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043473|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043474|NCT02939937|Phenytoin|phenytoin|mesh-list
20043475|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
20043476|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20043477|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20043478|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043479|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043480|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20043481|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20043482|NCT02940574|Oxytocin|oxytocin|mesh-list
20043483|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
20043484|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20043485|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043486|NCT02940691|Grazoprevir|grazoprevir|mesh-list
20043487|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
20043488|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043489|NCT02940730|Dalbavancin|dalbavancin|mesh-list
20043490|NCT02940730|Teicoplanin|teicoplanin|mesh-list
20043491|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20043492|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043493|NCT02940860|Iron|iron|mesh-list
20043494|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20043495|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20043496|NCT02940860|Trace Elements|trace elements|mesh-ancestor
20043497|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
20043498|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043499|NCT02940860|Hematinics|hematinics|mesh-ancestor
20043500|NCT02940886|Iron|iron|mesh-list
20043501|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20043502|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20043503|NCT02940886|Trace Elements|trace elements|mesh-ancestor
20043504|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
20043505|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043506|NCT02940886|Hematinics|hematinics|mesh-ancestor
20043507|NCT02941523|Carboplatin|carboplatin|mesh-list
20043508|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043509|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20043510|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20043511|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
20043512|NCT02941640|Hormones|hormones|mesh-ancestor
20043513|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043514|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043515|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043516|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043517|NCT02941692|Oxytocin|oxytocin|mesh-list
20043518|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
20043519|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20043520|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043521|NCT02942264|Temozolomide|temozolomide|mesh-list
20043522|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20043523|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
20043524|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043525|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043526|NCT02942407|Warfarin|warfarin|mesh-list
20043527|NCT02942407|Apixaban|apixaban|mesh-list
20043528|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
20043529|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20043530|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
20043531|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20043532|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
20043533|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043534|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043535|NCT02942485|Metronidazole|metronidazole|mesh-list
20043536|NCT02942485|Tinidazole|tinidazole|mesh-list
20043537|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043538|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20043539|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20043540|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20043541|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
20043542|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043543|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20043544|NCT02942576|Warfarin|warfarin|mesh-list
20043545|NCT02942576|Edoxaban|edoxaban|mesh-list
20043546|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
20043547|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
20043548|NCT02942576|Fluindione|fluindione|mesh-list
20043549|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
20043550|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20043551|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
20043552|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20043553|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
20043554|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043555|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043556|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
20043557|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20043558|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043559|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
20043560|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
20043561|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
20043562|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043563|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043564|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043565|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20043566|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20043567|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043568|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20043569|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20043570|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
20043571|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043572|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043573|NCT02943668|Deferasirox|deferasirox|mesh-list
20043574|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20043575|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
20043576|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
20043577|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043578|NCT02944461|Dapsone|dapsone|mesh-list
20043579|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043580|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
20043581|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20043582|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20043583|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20043584|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043585|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043586|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
20043587|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20043588|NCT02944565|Daratumumab|daratumumab|mesh-list
20293205|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
20293206|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293207|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293208|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043589|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043590|NCT02944656|Gabapentin|gabapentin|mesh-list
20043591|NCT02944656|Analgesics|analgesics|mesh-ancestor
20043592|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
20043593|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043594|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043595|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
20043596|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20043597|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20043598|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043599|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20043600|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20043601|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20043602|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043603|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043604|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
20043605|NCT02945150|Grazoprevir|grazoprevir|mesh-list
20043606|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
20043607|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043608|NCT02945410|Vitamin D|vitamin d|mesh-list
20043609|NCT02945410|Calcium|calcium|mesh-list
20043610|NCT02945410|Vitamins|vitamins|mesh-ancestor
20043611|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
20043612|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043613|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20043614|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20043615|NCT02946034|Ribavirin|ribavirin|mesh-list
20043616|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
20043617|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043618|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
20043619|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043620|NCT02946073|Buprenorphine|buprenorphine|mesh-list
20043621|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20043622|NCT02946073|Narcotics|narcotics|mesh-ancestor
20043623|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043624|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043625|NCT02946073|Analgesics|analgesics|mesh-ancestor
20043626|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
20043627|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043628|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20043629|NCT02946385|Vaccines|vaccines|mesh-list
20043630|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
20043631|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043632|NCT02946463|Eculizumab|eculizumab|mesh-list
20043633|NCT02946463|Ravulizumab|ravulizumab|mesh-list
20043634|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20043635|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043636|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
20043637|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043638|NCT02946489|Ketamine|ketamine|mesh-list
20043639|NCT02946489|Analgesics|analgesics|mesh-ancestor
20043640|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
20043641|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043642|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043643|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20043644|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20043645|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
20043646|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
20043647|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043648|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20043649|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20043650|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20117332|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
20043651|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043652|NCT02946580|Naloxegol|naloxegol|mesh-list
20043653|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20043654|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043655|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
20043656|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043657|NCT02946892|Carvedilol|carvedilol|mesh-list
20043658|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20043659|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20043660|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
20043661|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043662|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043663|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043664|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20043665|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
20043666|NCT02946892|Protective Agents|protective agents|mesh-ancestor
20043667|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20043668|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043669|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20043670|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
20043671|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20043672|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20043673|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
20043674|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
20043675|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043676|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
20043677|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20043678|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20043679|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20043680|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20043681|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
20043682|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043683|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043684|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043685|NCT02948777|Evolocumab|evolocumab|mesh-list
20043686|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20043687|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20043688|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
20043689|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043690|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20043691|NCT02949011|Oseltamivir|oseltamivir|mesh-list
20043692|NCT02949011|Baloxavir|baloxavir|mesh-list
20043693|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
20043694|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043695|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043696|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043697|NCT02949024|Triamcinolone|triamcinolone|mesh-list
20043698|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20043699|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20043700|NCT02949024|Aflibercept|aflibercept|mesh-list
20043701|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20043702|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043703|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
20043704|NCT02949024|Hormones|hormones|mesh-ancestor
20043705|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043706|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043707|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043708|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
20043709|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043710|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043711|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20576691|NCT02072486|Sorafenib|sorafenib|mesh-list
20043712|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20043713|NCT02949024|Growth Substances|growth substances|mesh-ancestor
20043714|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
20043715|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117333|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117334|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20117335|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
20117336|NCT00005898|Hormones|hormones|mesh-ancestor
20117337|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117338|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20117339|NCT00005898|Protective Agents|protective agents|mesh-ancestor
20117340|NCT00005912|Voriconazole|voriconazole|mesh-list
20043716|NCT02949271|Fentanyl|fentanyl|mesh-list
20043717|NCT02949271|Ropivacaine|ropivacaine|mesh-list
20043718|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
20043719|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
20043720|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043721|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043722|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
20043723|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043724|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20043725|NCT02949271|Narcotics|narcotics|mesh-ancestor
20043726|NCT02949271|Analgesics|analgesics|mesh-ancestor
20043727|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20043728|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20043729|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
20043730|NCT02949362|Teduglutide|teduglutide|mesh-list
20043731|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043732|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20043733|NCT02949362|Protective Agents|protective agents|mesh-ancestor
20043734|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043735|NCT02949674|Bupivacaine|bupivacaine|mesh-list
20043736|NCT02949674|Ropivacaine|ropivacaine|mesh-list
20576692|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576693|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20576694|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576695|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576696|NCT02072512|Fulvestrant|fulvestrant|mesh-list
20576697|NCT02072512|Anastrozole|anastrozole|mesh-list
20576698|NCT02072512|Goserelin|goserelin|mesh-list
20576699|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20576700|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576701|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20576702|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20576703|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
20576704|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576705|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576706|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20043737|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
20043738|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
20043739|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043740|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043741|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
20043742|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043743|NCT02949921|Lidocaine|lidocaine|mesh-list
20043744|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
20043745|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
20043746|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043747|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043748|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
20043749|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043750|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20043751|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20043752|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20043753|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043754|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043755|NCT02950467|Psilocybin|psilocybin|mesh-list
20043756|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
20043757|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
20043758|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043759|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20043760|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20043761|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
20043762|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043763|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043764|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20043765|NCT02950558|Ropivacaine|ropivacaine|mesh-list
20043766|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
20043767|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
20043768|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043769|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043770|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
20043771|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043772|NCT02951156|Gemcitabine|gemcitabine|mesh-list
20043773|NCT02951156|Rituximab|rituximab|mesh-list
20043774|NCT02951156|Avelumab|avelumab|mesh-list
20043775|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
20043776|NCT02951156|Azacitidine|azacitidine|mesh-list
20043777|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20043778|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043779|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043780|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
20043781|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043782|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043783|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20043784|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
20043785|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043786|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
20043787|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043788|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043789|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043790|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20043791|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
20043792|NCT02951182|Ivacaftor|ivacaftor|mesh-list
20043793|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20043794|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043795|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043796|NCT02951195|Ivacaftor|ivacaftor|mesh-list
20043797|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20043798|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043799|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043800|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
20043801|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20043802|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20043803|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20043804|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20043805|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
20043806|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043807|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043808|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043809|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
20043810|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
20043811|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
20043812|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043813|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043814|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
20043815|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043816|NCT02951429|Pirfenidone|pirfenidone|mesh-list
20043817|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
20043818|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
20043819|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20043820|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20043821|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043822|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043823|NCT02951429|Urological Agents|urological agents|mesh-ancestor
20043824|NCT02951429|Analgesics|analgesics|mesh-ancestor
20043825|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
20043826|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043827|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043828|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20043829|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20043830|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043831|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043832|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043833|NCT02951702|Vancomycin|vancomycin|mesh-list
20043834|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20043835|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043836|NCT02951819|Dexamethasone|dexamethasone|mesh-list
20043837|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
20043838|NCT02951819|Bortezomib|bortezomib|mesh-list
20043839|NCT02951819|Daratumumab|daratumumab|mesh-list
20043840|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043841|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
20576707|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20576708|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576709|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576710|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20576711|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
20576712|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576713|NCT02072720|Bevacizumab|bevacizumab|mesh-list
20576714|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043842|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043843|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043844|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20043845|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
20043846|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043847|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043848|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20043849|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043850|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
20043851|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
20043852|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043853|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043854|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
20043855|NCT02951819|Hormones|hormones|mesh-ancestor
20043856|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043857|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043858|NCT02951884|Bupivacaine|bupivacaine|mesh-list
20043859|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
20043860|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
20043861|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043862|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043863|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
20043864|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043865|NCT02952001|Triamcinolone|triamcinolone|mesh-list
20043866|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20043867|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20043868|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20043869|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043870|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
20043871|NCT02952001|Hormones|hormones|mesh-ancestor
20043872|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043873|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043874|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20043875|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
20043876|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043877|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043878|NCT02952586|Avelumab|avelumab|mesh-list
20043879|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043880|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043881|NCT02952820|Lemborexant|lemborexant|mesh-list
20043882|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20043883|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20043884|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043885|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20043886|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20043887|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20043888|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043889|NCT02952898|Diclofenac|diclofenac|mesh-list
20043890|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20043891|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20043892|NCT02952898|Analgesics|analgesics|mesh-ancestor
20043893|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
20043894|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043895|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043896|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043897|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20043898|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20043899|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043900|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043901|NCT02953314|Ivacaftor|ivacaftor|mesh-list
20043902|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20043903|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20043904|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043905|NCT02953548|Cannabidiol|cannabidiol|mesh-list
20043906|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
20043907|NCT02953561|Azacitidine|azacitidine|mesh-list
20043908|NCT02953561|Avelumab|avelumab|mesh-list
20043909|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20043910|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20043911|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
20043912|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043913|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043914|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043915|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043916|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
20043917|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043918|NCT02953678|Prednisone|prednisone|mesh-list
20043919|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
20043920|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20043921|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20043922|NCT02953678|Prednisolone|prednisolone|mesh-list
20043923|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
20043924|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20043925|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
20043926|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043927|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
20043928|NCT02953678|Hormones|hormones|mesh-ancestor
20043929|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043930|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043931|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043932|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043933|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
20043934|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
20043935|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043936|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043937|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20043938|NCT02953678|Protective Agents|protective agents|mesh-ancestor
20043939|NCT02953782|Cetuximab|cetuximab|mesh-list
20043940|NCT02953782|Magrolimab|magrolimab|mesh-list
20043941|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20043942|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043943|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20043944|NCT02953821|Hormones|hormones|mesh-ancestor
20043945|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043946|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043947|NCT02953860|Fulvestrant|fulvestrant|mesh-list
20043948|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20043949|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043950|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20043951|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20043952|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
20576715|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576716|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20576717|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20576718|NCT02072720|Growth Substances|growth substances|mesh-ancestor
20576719|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576720|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
20576721|NCT02072746|Zinc|zinc|mesh-list
20576722|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
20576723|NCT02072746|Trace Elements|trace elements|mesh-ancestor
20043953|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043954|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043955|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
20043956|NCT02953873|Prednisone|prednisone|mesh-list
20043957|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
20043958|NCT02953873|Tacrolimus|tacrolimus|mesh-list
20043959|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20043960|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
20043961|NCT02953873|Hormones|hormones|mesh-ancestor
20043962|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20043963|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043964|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293209|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293210|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20293211|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20293212|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20293213|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20293214|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20293215|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293216|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293217|NCT04658862|Gemcitabine|gemcitabine|mesh-list
20293218|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043965|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043966|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293219|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576724|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
20576725|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293220|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
20293221|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293222|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
20293223|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293224|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043967|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
20043968|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20043969|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20043970|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20043971|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20043972|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20043973|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
20043974|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20043975|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20043976|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
20043977|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
20043978|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20043979|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20043980|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20043981|NCT02953873|Protective Agents|protective agents|mesh-ancestor
20043982|NCT02953886|Fluorides|fluorides|mesh-list
20043983|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
20043984|NCT02953886|Protective Agents|protective agents|mesh-ancestor
20043985|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043986|NCT02953938|Ranibizumab|ranibizumab|mesh-list
20043987|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20043988|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20043989|NCT02953938|Growth Substances|growth substances|mesh-ancestor
20043990|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20043991|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
20043992|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043993|NCT02954172|Paclitaxel|paclitaxel|mesh-list
20043994|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20043995|NCT02954172|Bevacizumab|bevacizumab|mesh-list
20043996|NCT02954172|Carboplatin|carboplatin|mesh-list
20043997|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20043998|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20043999|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
20044000|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
20044001|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
20044002|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044003|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20044004|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20044005|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20044006|NCT02954172|Growth Substances|growth substances|mesh-ancestor
20044007|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044008|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
20044009|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
20044010|NCT02954198|Prednisone|prednisone|mesh-list
20044011|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
20044012|NCT02954198|Everolimus|everolimus|mesh-list
20044013|NCT02954198|Tacrolimus|tacrolimus|mesh-list
20044014|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044015|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
20044016|NCT02954198|Hormones|hormones|mesh-ancestor
20044017|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044018|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044019|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20044020|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044021|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20044022|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
20044023|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20044024|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044025|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044026|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20044027|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20044028|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
20044029|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20044030|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044031|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
20044032|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
20044033|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293225|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20044034|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044035|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20293226|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
20044036|NCT02954198|Protective Agents|protective agents|mesh-ancestor
20044037|NCT02954354|Oseltamivir|oseltamivir|mesh-list
20044038|NCT02954354|Baloxavir|baloxavir|mesh-list
20044039|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
20044040|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044041|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044042|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044043|NCT02954575|Factor VIII|factor viii|mesh-list
20044044|NCT02954575|Coagulants|coagulants|mesh-ancestor
20044045|NCT02954601|Insulin|insulin|mesh-list
20044046|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20044047|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044048|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044049|NCT02954653|Cytarabine|cytarabine|mesh-list
20044050|NCT02954653|Azacitidine|azacitidine|mesh-list
20044051|NCT02954653|Decitabine|decitabine|mesh-list
20044052|NCT02954653|Daunorubicin|daunorubicin|mesh-list
20044053|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20044054|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
20044055|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044056|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044057|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
20044058|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044059|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20044060|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
20044061|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044062|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044063|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20044064|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20044065|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20044066|NCT02954887|Cannabidiol|cannabidiol|mesh-list
20044067|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
20044068|NCT02955069|Spartalizumab|spartalizumab|mesh-list
20044069|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20044070|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044071|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044072|NCT02955147|Prednisone|prednisone|mesh-list
20044073|NCT02955147|Ustekinumab|ustekinumab|mesh-list
20044074|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044075|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
20576726|NCT02072746|Astringents|astringents|mesh-ancestor
20044076|NCT02955147|Hormones|hormones|mesh-ancestor
20044077|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044078|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044079|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20044080|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044081|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
20576727|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
20605614|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605615|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605616|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605617|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605618|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
20044082|NCT02955186|Saracatinib|saracatinib|mesh-list
20044083|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044084|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605619|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20605620|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605621|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
20605622|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605623|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20605624|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605625|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20605626|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20044085|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044086|NCT02955212|Upadacitinib|upadacitinib|mesh-list
20044087|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20044088|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20044089|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044090|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044091|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044092|NCT02955329|Nicotine|nicotine|mesh-list
20044093|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20044094|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
20044095|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044096|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044097|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20044098|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20044099|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
20044100|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044101|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044102|NCT02956044|Metformin|metformin|mesh-list
20044103|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20044104|NCT02956044|Glimepiride|glimepiride|mesh-list
20044105|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
20044106|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044107|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044108|NCT02956044|Incretins|incretins|mesh-ancestor
20044109|NCT02956044|Hormones|hormones|mesh-ancestor
20044110|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044111|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20044112|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
20044113|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044114|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044115|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20044116|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20044117|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
20044118|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
20044119|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
20044120|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
20044121|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044122|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
20044123|NCT02956057|Protective Agents|protective agents|mesh-ancestor
20044124|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044125|NCT02956057|Vitamins|vitamins|mesh-ancestor
20044126|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
20044127|NCT02956057|Cathartics|cathartics|mesh-ancestor
20044128|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044129|NCT02956070|Dexamethasone|dexamethasone|mesh-list
20044130|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
20044131|NCT02956070|BB 1101|bb 1101|mesh-list
20044132|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044133|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
20044134|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
20044135|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044136|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044137|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044138|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
20044139|NCT02956070|Hormones|hormones|mesh-ancestor
20044140|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044141|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20044142|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044143|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20044144|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044145|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044146|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
20044147|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20044148|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20044149|NCT02956122|Prednisolone|prednisolone|mesh-list
20044150|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
20044151|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20044152|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
20044153|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
20044154|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20044155|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044156|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
20044157|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
20044158|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044159|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044160|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044161|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
20044162|NCT02956122|Hormones|hormones|mesh-ancestor
20044163|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044164|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20044165|NCT02956122|Protective Agents|protective agents|mesh-ancestor
20044166|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20044167|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044168|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044169|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044170|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20044171|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20044172|NCT02956278|Allopurinol|allopurinol|mesh-list
20044173|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
20044174|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044175|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044176|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
20044177|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044178|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20044179|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
20044180|NCT02956278|Protective Agents|protective agents|mesh-ancestor
20044181|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044182|NCT02956616|Ketorolac|ketorolac|mesh-list
20044183|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20044184|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20044185|NCT02956616|Analgesics|analgesics|mesh-ancestor
20044186|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
20044187|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044188|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044189|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044190|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044191|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20576728|NCT02072785|Vincristine|vincristine|mesh-list
20576729|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20576730|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576731|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
20576732|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
20576733|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
20576734|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576735|NCT02072798|Cefuroxime|cefuroxime|mesh-list
20576736|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
20576737|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20576738|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576739|NCT02072811|Cytarabine|cytarabine|mesh-list
20576740|NCT02072811|Daunorubicin|daunorubicin|mesh-list
20576741|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
20576742|NCT02072811|Cladribine|cladribine|mesh-list
20576743|NCT02072811|Sargramostim|sargramostim|mesh-list
20576744|NCT02072811|Lenograstim|lenograstim|mesh-list
20576745|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576746|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
20576747|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576748|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576749|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
20576750|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576751|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576752|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
20576753|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576754|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20044192|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044193|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044194|NCT02956629|Ribavirin|ribavirin|mesh-list
20044195|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
20044196|NCT02956629|Ruzasvir|ruzasvir|mesh-list
20044197|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
20044198|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044199|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
20044200|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044201|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
20044202|NCT02956746|Antibodies|antibodies|mesh-list
20044203|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
20044204|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20044205|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20044206|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
20044207|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044208|NCT02956837|Vaccines|vaccines|mesh-list
20044209|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
20044210|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044211|NCT02957305|Misoprostol|misoprostol|mesh-list
20044212|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20044213|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
20044214|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20044215|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044216|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20044217|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576755|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20044218|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
20044219|NCT02957331|Propranolol|propranolol|mesh-list
20044220|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20044221|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20044222|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044223|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044224|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044225|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044226|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20044227|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20044228|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
20044229|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
20044230|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20044231|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
20044232|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044233|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
20044234|NCT02958267|Protective Agents|protective agents|mesh-ancestor
20044235|NCT02958345|Vaccines|vaccines|mesh-list
20044236|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
20044237|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044238|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20044239|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20044240|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20044241|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20044242|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044243|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044244|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044245|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20044246|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
20044247|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044248|NCT02958956|Pioglitazone|pioglitazone|mesh-list
20044249|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044250|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044251|NCT02958969|Apixaban|apixaban|mesh-list
20044252|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20044253|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
20044254|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20044255|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
20044256|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044257|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044258|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
20044259|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
20044260|NCT02959437|Azacitidine|azacitidine|mesh-list
20044261|NCT02959437|INCB057643|incb057643|mesh-list
20044262|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20044263|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044264|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20044265|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
20044266|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044267|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117341|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
20117342|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117343|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20117344|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20117345|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117346|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117347|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20117348|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
20117349|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117350|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117351|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20117352|NCT00005920|Caspofungin|caspofungin|mesh-list
20117353|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
20117354|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117355|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117356|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117357|NCT00005921|Caspofungin|caspofungin|mesh-list
20117358|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
20117359|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117360|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117361|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117362|NCT00005922|Triamcinolone|triamcinolone|mesh-list
20117363|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20044268|NCT02959840|Ondansetron|ondansetron|mesh-list
20044269|NCT02959840|Metoclopramide|metoclopramide|mesh-list
20044270|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
20044271|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
20044272|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044273|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044274|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044275|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
20044276|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
20044277|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20044278|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
20044279|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044280|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044281|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20044282|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20044283|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044284|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044285|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20044286|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20044287|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20044288|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
20044289|NCT02959853|Anastrozole|anastrozole|mesh-list
20044290|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20044291|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044292|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20044293|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20044294|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044295|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044296|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20044297|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
20044298|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044299|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044300|NCT02959892|Amphetamine|amphetamine|mesh-list
20044301|NCT02959892|Naxagolide|naxagolide|mesh-list
20044302|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20044303|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044304|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
20044305|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
20044306|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044307|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
20044308|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044309|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044310|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044311|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20044312|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20044313|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20044314|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20044315|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
20044316|NCT02959970|Dapsone|dapsone|mesh-list
20044317|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044318|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
20044319|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20044320|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20044321|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20044322|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044323|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044324|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
20044325|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20044326|NCT02959983|Eluxadoline|eluxadoline|mesh-list
20044327|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044328|NCT02959996|Bupivacaine|bupivacaine|mesh-list
20044329|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
20044330|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
20044331|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044332|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044333|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
20044334|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044335|NCT02960438|Quetmolimab|quetmolimab|mesh-list
20044336|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044337|NCT02960490|Quetmolimab|quetmolimab|mesh-list
20044338|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044339|NCT02960854|Nivolumab|nivolumab|mesh-list
20044340|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20044341|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044342|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20605627|NCT02233231|Varenicline|varenicline|mesh-list
20044343|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044344|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
20044345|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20044346|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044347|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20044348|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20044349|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044350|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044351|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044352|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20044353|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20044354|NCT02961764|Dalbavancin|dalbavancin|mesh-list
20044355|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20044356|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044357|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
20044358|NCT02961790|Oxybutynin|oxybutynin|mesh-list
20044359|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
20044360|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
20044361|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044362|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044363|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20044364|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20044365|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
20044366|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044367|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044368|NCT02961790|Urological Agents|urological agents|mesh-ancestor
20044369|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20044370|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044371|NCT02961790|Renal Agents|renal agents|mesh-ancestor
20044372|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
20044373|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
20044374|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
20044375|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20044376|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20044377|NCT02962284|Prednisolone|prednisolone|mesh-list
20044378|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
20044379|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
20044380|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20044381|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
20044382|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044383|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
20044384|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
20044385|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044386|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044387|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044388|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
20044389|NCT02962284|Hormones|hormones|mesh-ancestor
20044390|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044391|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20044392|NCT02962284|Protective Agents|protective agents|mesh-ancestor
20044393|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20044394|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044395|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20044396|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044397|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044398|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
20044399|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20044400|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20044401|NCT02962648|Hematinics|hematinics|mesh-ancestor
20044402|NCT02962739|Tenofovir|tenofovir|mesh-list
20044403|NCT02962739|Emtricitabine|emtricitabine|mesh-list
20044404|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
20044405|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044406|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20044407|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20044408|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044409|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044410|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20044411|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20044412|NCT02963701|Ibuprofen|ibuprofen|mesh-list
20044413|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
20044414|NCT02963701|Ephedrine|ephedrine|mesh-list
20605628|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20044415|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20044416|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20576756|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20576757|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576758|NCT02072811|Analgesics|analgesics|mesh-ancestor
20576759|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
20576760|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576761|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20576762|NCT02072967|Rituximab|rituximab|mesh-list
20044417|NCT02963701|Analgesics|analgesics|mesh-ancestor
20044418|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
20044419|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044420|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044421|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044422|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044423|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20044424|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044425|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044426|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20044427|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
20044428|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20044429|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
20044430|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
20044431|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20044432|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20044433|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
20044434|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044435|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044436|NCT02963922|Liraglutide|liraglutide|mesh-list
20044437|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044438|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044439|NCT02963922|Incretins|incretins|mesh-ancestor
20044440|NCT02963922|Hormones|hormones|mesh-ancestor
20044441|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044442|NCT02963935|Liraglutide|liraglutide|mesh-list
20044443|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044444|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044445|NCT02963935|Incretins|incretins|mesh-ancestor
20044446|NCT02963935|Hormones|hormones|mesh-ancestor
20044447|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044448|NCT02964247|Liraglutide|liraglutide|mesh-list
20044449|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044450|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044451|NCT02964247|Incretins|incretins|mesh-ancestor
20044452|NCT02964247|Hormones|hormones|mesh-ancestor
20044453|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044454|NCT02964416|Tramadol|tramadol|mesh-list
20044455|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20044456|NCT02964416|Narcotics|narcotics|mesh-ancestor
20044457|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044458|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044459|NCT02964416|Analgesics|analgesics|mesh-ancestor
20044460|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
20044461|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044462|NCT02965378|Docetaxel|docetaxel|mesh-list
20044463|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044464|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20044465|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20044466|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
20044467|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044468|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
20044469|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20044470|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
20044471|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044472|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
20044473|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20044474|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
20044475|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044476|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20044477|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
20044478|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20044479|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20044480|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044481|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
20044482|NCT02965924|Phenylephrine|phenylephrine|mesh-list
20044483|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
20044484|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20044485|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
20044486|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
20044487|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044488|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044489|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
20044490|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20044491|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
20044492|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
20044493|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20044494|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20044495|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20044496|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044497|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044498|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044499|NCT02965924|Protective Agents|protective agents|mesh-ancestor
20044500|NCT02966002|Aspirin|aspirin|mesh-list
20044501|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20044502|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20044503|NCT02966002|Analgesics|analgesics|mesh-ancestor
20044504|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
20044505|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044506|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044507|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044508|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044509|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20044510|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20044511|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044512|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20044513|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20044514|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044515|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
20044516|NCT02966275|Glucagon|glucagon|mesh-list
20044517|NCT02966275|Pancrelipase|pancrelipase|mesh-list
20044518|NCT02966275|Pancreatin|pancreatin|mesh-list
20044519|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20044520|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044521|NCT02966275|Hormones|hormones|mesh-ancestor
20044522|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044523|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044524|NCT02966275|Incretins|incretins|mesh-ancestor
20044525|NCT02966314|Omalizumab|omalizumab|mesh-list
20044526|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20044527|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20044528|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
20044529|NCT02966340|Prazosin|prazosin|mesh-list
20044530|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20044531|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20044532|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20044533|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20044534|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044535|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044536|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044537|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044538|NCT02967354|Tryptophan|tryptophan|mesh-list
20044539|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
20044540|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20044541|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
20044542|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044543|NCT02967679|Biotin|biotin|mesh-list
20044544|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
20044545|NCT02967679|Vitamins|vitamins|mesh-ancestor
20044546|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
20044547|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044548|NCT02968134|Posaconazole|posaconazole|mesh-list
20044549|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
20044550|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044551|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20044552|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20044553|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20044554|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20044555|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20044556|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044557|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044558|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20044559|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
20044560|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044561|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044562|NCT02968173|Palivizumab|palivizumab|mesh-list
20044563|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
20044564|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044565|NCT02968368|Ferric maltol|ferric maltol|mesh-list
20044566|NCT02968368|Hematinics|hematinics|mesh-ancestor
20044567|NCT02968576|Tenofovir|tenofovir|mesh-list
20044568|NCT02968576|Emtricitabine|emtricitabine|mesh-list
20044569|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20044570|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
20044571|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044572|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20044573|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20044574|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044575|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044576|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20044577|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20044578|NCT02968914|Benralizumab|benralizumab|mesh-list
20044579|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20044580|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
20044581|NCT02969018|PF-06700841|pf-06700841|mesh-list
20044582|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20044583|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044584|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044585|NCT02969187|Bupivacaine|bupivacaine|mesh-list
20044586|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
20044587|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
20044588|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044589|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044590|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
20044591|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044592|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
20044593|NCT02969317|Olodaterol|olodaterol|mesh-list
20044594|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20044595|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
20044596|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044597|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044598|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20044599|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
20044600|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
20044601|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20044602|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
20044603|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044604|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044605|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
20044606|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20044607|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20044608|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20044609|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20044610|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044611|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
20044612|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044613|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044614|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20044615|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117364|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20117365|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20117366|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117367|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
20117368|NCT00005922|Hormones|hormones|mesh-ancestor
20117369|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117370|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117371|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117372|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
20117373|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117374|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117375|NCT00005925|Muscimol|muscimol|mesh-list
20117376|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20117377|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
20117378|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
20117379|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120699|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20044616|NCT02969408|Albuterol|albuterol|mesh-list
20044617|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20044618|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
20044619|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044620|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044621|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20044622|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
20044623|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
20044624|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20044625|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20044626|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20044627|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20044628|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044629|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044630|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044631|NCT02969590|Leuprolide|leuprolide|mesh-list
20044632|NCT02969590|Norethindrone|norethindrone|mesh-list
20044633|NCT02969590|Estradiol|estradiol|mesh-list
20044634|NCT02969590|Estrogens|estrogens|mesh-list
20044635|NCT02969590|Progesterone|progesterone|mesh-list
20044636|NCT02969590|Progestins|progestins|mesh-list
20044637|NCT02969590|Hormones|hormones|mesh-ancestor
20044638|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044639|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044640|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20044641|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
20044642|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20044643|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20044644|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20044645|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
20044646|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20044647|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044648|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20044649|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20044650|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20044651|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
20044652|NCT02969655|Glycine|glycine|mesh-list
20044653|NCT02969655|Hematinics|hematinics|mesh-ancestor
20044654|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
20044655|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044656|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044657|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044658|NCT02969863|Pancrelipase|pancrelipase|mesh-list
20044659|NCT02969863|Pancreatin|pancreatin|mesh-list
20044660|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044661|NCT02969876|Vortioxetine|vortioxetine|mesh-list
20044662|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
20044663|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044664|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20044665|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20044666|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044667|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044668|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20044669|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20044670|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20044671|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044672|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044673|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
20044674|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20044675|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20044676|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20044677|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20044678|NCT02970032|Heparin|heparin|mesh-list
20044679|NCT02970032|Calcium heparin|calcium heparin|mesh-list
20044680|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
20044681|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20044682|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20044683|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044684|NCT02970162|Amifampridine|amifampridine|mesh-list
20044685|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20044686|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044687|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044688|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20044689|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20044690|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044691|NCT02970292|Pimavanserin|pimavanserin|mesh-list
20044692|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20044693|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20044694|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20044695|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20044696|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044697|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044698|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044699|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20044700|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20044701|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
20044702|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044703|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044704|NCT02970305|Pimavanserin|pimavanserin|mesh-list
20044705|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20044706|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20044707|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20044708|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20044709|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044710|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044711|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044712|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20044713|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20044714|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
20044715|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044716|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044717|NCT02970552|Progesterone|progesterone|mesh-list
20044718|NCT02970552|Progestins|progestins|mesh-ancestor
20044719|NCT02970552|Hormones|hormones|mesh-ancestor
20044720|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044721|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044722|NCT02970669|Valsartan|valsartan|mesh-list
20044723|NCT02970669|Enalapril|enalapril|mesh-list
20044724|NCT02970669|Enalaprilat|enalaprilat|mesh-list
20044725|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20044726|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20044727|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20044728|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20044729|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044730|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20044731|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
20044732|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044733|NCT02971007|Fluconazole|fluconazole|mesh-list
20044734|NCT02971007|Amphotericin B|amphotericin b|mesh-list
20044735|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20044736|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
20044737|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044738|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20044739|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20044740|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044741|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044742|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20044743|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
20044744|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044745|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044746|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20044747|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20044748|NCT02971007|Amebicides|amebicides|mesh-ancestor
20044749|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20044750|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20044751|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20044752|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
20044753|NCT02971228|Glucagon|glucagon|mesh-list
20044754|NCT02971228|Pancrelipase|pancrelipase|mesh-list
20044755|NCT02971228|Pancreatin|pancreatin|mesh-list
20044756|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20044757|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044758|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044759|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044760|NCT02971228|Hormones|hormones|mesh-ancestor
20044761|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044762|NCT02971228|Incretins|incretins|mesh-ancestor
20044763|NCT02971605|Psilocybin|psilocybin|mesh-list
20044764|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
20044765|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044766|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044767|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
20044768|NCT02972502|Promethazine|promethazine|mesh-list
20044769|NCT02972502|Haloperidol|haloperidol|mesh-list
20044770|NCT02972502|Metoclopramide|metoclopramide|mesh-list
20044771|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
20044772|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20044773|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20044774|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044775|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044776|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
20044777|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
20044778|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
20044779|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044780|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
20044781|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
20044782|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044783|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20044784|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
20044785|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
20044786|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044787|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044788|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20044789|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
20044790|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
20044791|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20044792|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20044793|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044794|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20044795|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
20044796|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20044797|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20044798|NCT02972554|Propranolol|propranolol|mesh-list
20044799|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20044800|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20044801|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044802|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044803|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044804|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044805|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20044806|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20044807|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
20044808|NCT02972632|Vortioxetine|vortioxetine|mesh-list
20044809|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
20044810|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044811|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20044812|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20044813|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044814|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044815|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20044816|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20044817|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20044818|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044819|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044820|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
20044821|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20044822|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20044823|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20044824|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20044825|NCT02973048|Bupivacaine|bupivacaine|mesh-list
20044826|NCT02973048|Prilocaine|prilocaine|mesh-list
20044827|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
20044828|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
20044829|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044830|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044831|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
20044832|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044833|NCT02973087|Factor VIII|factor viii|mesh-list
20044834|NCT02973087|Coagulants|coagulants|mesh-ancestor
20044835|NCT02973100|Dulaglutide|dulaglutide|mesh-list
20044836|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044837|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044838|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
20044839|NCT02973477|Glimepiride|glimepiride|mesh-list
20044840|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20044841|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044842|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044843|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044844|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20044845|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20044846|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
20044847|NCT02973503|Grazoprevir|grazoprevir|mesh-list
20044848|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
20044849|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044850|NCT02974010|Cycloserine|cycloserine|mesh-list
20044851|NCT02974010|Ketamine|ketamine|mesh-list
20044852|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20044853|NCT02974010|Analgesics|analgesics|mesh-ancestor
20044854|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
20044855|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044856|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044857|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20044858|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20044859|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
20044860|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
20044861|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20044862|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20044863|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20044864|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044865|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044866|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20044867|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044868|NCT02974010|Renal Agents|renal agents|mesh-ancestor
20044869|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20044870|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
20044871|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20044872|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
20044873|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20044874|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20044875|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20044876|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20044877|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20044878|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20044879|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044880|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20044881|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20044882|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
20044883|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20044884|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20044885|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
20044886|NCT02974114|Acetaminophen|acetaminophen|mesh-list
20044887|NCT02974114|Caffeine|caffeine|mesh-list
20044888|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20044889|NCT02974114|Analgesics|analgesics|mesh-ancestor
20044890|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
20044891|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044892|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044893|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
20044894|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20044895|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20044896|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044897|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044898|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20044899|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20044900|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
20044901|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044902|NCT02974868|PF-06700841|pf-06700841|mesh-list
20044903|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20044904|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044905|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044906|NCT02975206|Serlopitant|serlopitant|mesh-list
20044907|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20044908|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044909|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044910|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044911|NCT02975297|Exenatide|exenatide|mesh-list
20044912|NCT02975297|Nicotine|nicotine|mesh-list
20293227|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044913|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20044914|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
20044915|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044916|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044917|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20044918|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20044919|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
20044920|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044921|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044922|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20044923|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20044924|NCT02975297|Incretins|incretins|mesh-ancestor
20044925|NCT02975297|Hormones|hormones|mesh-ancestor
20044926|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20044927|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20044928|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
20044929|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20044930|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
20044931|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044932|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20044933|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
20044934|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20044935|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20044936|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20044937|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20044938|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
20044939|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20044940|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044941|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044942|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20044943|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20044944|NCT02976103|Analgesics|analgesics|mesh-list
20044945|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
20044946|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044947|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044948|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
20044949|NCT02977507|Hydroquinone|hydroquinone|mesh-list
20044950|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20044951|NCT02977507|Protective Agents|protective agents|mesh-ancestor
20044952|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044953|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
20044954|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
20044955|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044956|NCT02978157|Amoxicillin|amoxicillin|mesh-list
20044957|NCT02978157|Levofloxacin|levofloxacin|mesh-list
20044958|NCT02978157|Ofloxacin|ofloxacin|mesh-list
20044959|NCT02978157|Tetracycline|tetracycline|mesh-list
20044960|NCT02978157|Esomeprazole|esomeprazole|mesh-list
20044961|NCT02978157|Bismuth|bismuth|mesh-list
20293228|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
20293229|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20293230|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293231|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044962|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20044963|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20044964|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20044965|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20044966|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20044967|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044968|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044969|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20044970|NCT02978157|Renal Agents|renal agents|mesh-ancestor
20044971|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20044972|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20044973|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044974|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20044975|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20044976|NCT02978157|Antacids|antacids|mesh-ancestor
20044977|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20044978|NCT02978339|Curcumin|curcumin|mesh-list
20044979|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20044980|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20044981|NCT02978339|Analgesics|analgesics|mesh-ancestor
20576763|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20044982|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
20044983|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044984|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044985|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20044986|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20044987|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20044988|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044989|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044990|NCT02978417|Naltrexone|naltrexone|mesh-list
20044991|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20044992|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20044993|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20044994|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
20044995|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20044996|NCT02978508|Permethrin|permethrin|mesh-list
20044997|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20044998|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20044999|NCT02979197|Celecoxib|celecoxib|mesh-list
20045000|NCT02979197|Amlodipine|amlodipine|mesh-list
20045001|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20045002|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20045003|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20045004|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045005|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20045006|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045007|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
20045008|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20045009|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20045010|NCT02979197|Analgesics|analgesics|mesh-ancestor
20045011|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
20045012|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045013|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045014|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045015|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20045016|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20045017|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045018|NCT02979301|Tamoxifen|tamoxifen|mesh-list
20045019|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20045020|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
20045021|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045022|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045023|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20045024|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045025|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20045026|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20045027|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20045028|NCT02979431|Gontivimab|gontivimab|mesh-list
20045029|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
20045030|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045031|NCT02979522|Doxorubicin|doxorubicin|mesh-list
20045032|NCT02979522|Dacarbazine|dacarbazine|mesh-list
20045033|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20045034|NCT02979522|Vinblastine|vinblastine|mesh-list
20045035|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20045036|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045037|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20045038|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20045039|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045040|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045041|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20045042|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
20045043|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045044|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20045045|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
20045046|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
20045047|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
20045048|NCT02980042|Rituximab|rituximab|mesh-list
20045049|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
20045050|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045051|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045052|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
20045053|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045054|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045055|NCT02980133|Fluticasone|fluticasone|mesh-list
20045056|NCT02980133|Xhance|xhance|mesh-list
20045057|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20045058|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045059|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20045060|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
20045061|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045062|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045063|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20045064|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
20045065|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
20045066|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20045067|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20045068|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20045069|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20045070|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
20045071|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045072|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045073|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
20045074|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
20045075|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
20045076|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20045077|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
20045078|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20045079|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20045080|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045081|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20045082|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20045083|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045084|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045085|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045086|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045087|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20045088|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
20045089|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
20045090|NCT02980523|Protective Agents|protective agents|mesh-ancestor
20045091|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
20045092|NCT02980783|Lidocaine|lidocaine|mesh-list
20045093|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
20045094|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
20045095|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045096|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045097|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
20045098|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045099|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20045100|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20045101|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20045102|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20045103|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045104|NCT02980874|Triamcinolone|triamcinolone|mesh-list
20045105|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20045106|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20045107|NCT02980874|Aflibercept|aflibercept|mesh-list
20045108|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20045109|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045110|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
20045111|NCT02980874|Hormones|hormones|mesh-ancestor
20045112|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045113|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045114|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045115|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
20045116|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045117|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045118|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20045119|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20045120|NCT02980874|Growth Substances|growth substances|mesh-ancestor
20045121|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
20045122|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045123|NCT02981342|Gemcitabine|gemcitabine|mesh-list
20045124|NCT02981342|Capecitabine|capecitabine|mesh-list
20045125|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20045126|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
20045127|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045128|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045129|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
20045130|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045131|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045132|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045133|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
20045134|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117380|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117381|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117382|NCT00005926|Gemcitabine|gemcitabine|mesh-list
20117383|NCT00005926|Trastuzumab|trastuzumab|mesh-list
20117384|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117385|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
20117386|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117387|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117388|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
20117389|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117390|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117391|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117392|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
20117393|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117394|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20117395|NCT00005928|Ramipril|ramipril|mesh-list
20117396|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20117397|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
20117398|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117399|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117400|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20117401|NCT00005931|Semaxinib|semaxinib|mesh-list
20117402|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20117403|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20117404|NCT00005931|Growth Substances|growth substances|mesh-ancestor
20117405|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117406|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
20117407|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117408|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20117409|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117410|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117411|NCT00005934|Azacitidine|azacitidine|mesh-list
20117412|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117413|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
20117414|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117415|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117416|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117417|NCT00005935|Cyclosporine|cyclosporine|mesh-list
20117418|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
20117419|NCT00005935|Cyclosporins|cyclosporins|mesh-list
20117420|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117421|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117422|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117423|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
20117424|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117425|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
20117426|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117427|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117428|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117429|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20117430|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117431|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117432|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20117433|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
20117434|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20117435|NCT00005938|Exatecan|exatecan|mesh-list
20117436|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117437|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117438|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117439|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117440|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117441|NCT00005940|Iodine|iodine|mesh-list
20117442|NCT00005940|Cyclosporine|cyclosporine|mesh-list
20117443|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
20117444|NCT00005940|Busulfan|busulfan|mesh-list
20117445|NCT00005940|Methotrexate|methotrexate|mesh-list
20120700|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
20045135|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
20045136|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
20045137|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
20045138|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045139|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045140|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045141|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20045142|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
20045143|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045144|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045145|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20045146|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045147|NCT02982590|Warfarin|warfarin|mesh-list
20045148|NCT02982590|Apixaban|apixaban|mesh-list
20045149|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
20045150|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20045151|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
20045152|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20045153|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20045154|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045155|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045156|NCT02982772|Nicotine|nicotine|mesh-list
20045157|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20045158|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
20045159|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045160|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045161|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20045162|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20045163|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
20045164|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045165|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045166|NCT02983604|Fulvestrant|fulvestrant|mesh-list
20045167|NCT02983604|Exemestane|exemestane|mesh-list
20045168|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20045169|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045170|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20045171|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20045172|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
20045173|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045174|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045175|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20045176|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20045177|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045178|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045179|NCT02983981|Desoximetasone|desoximetasone|mesh-list
20045180|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045181|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
20045182|NCT02983981|Hormones|hormones|mesh-ancestor
20045183|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045184|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045185|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
20045186|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20045187|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045188|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20045189|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045190|NCT02984982|Anticoagulants|anticoagulants|mesh-list
20045191|NCT02984982|Atorvastatin|atorvastatin|mesh-list
20045192|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20045193|NCT02984982|Ezetimibe|ezetimibe|mesh-list
20045194|NCT02984982|Fenofibrate|fenofibrate|mesh-list
20045195|NCT02984982|Bezafibrate|bezafibrate|mesh-list
20045196|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20045197|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20045198|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
20045199|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045200|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20045201|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20045202|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045203|NCT02985021|Carboplatin|carboplatin|mesh-list
20045204|NCT02985021|Docetaxel|docetaxel|mesh-list
20045205|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045206|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
20045207|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
20045208|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
20045209|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045210|NCT02985879|Tilavonemab|tilavonemab|mesh-list
20045211|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
20045212|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20045213|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20045214|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20045215|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20045216|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045217|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045218|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
20045219|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045220|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20045221|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20045222|NCT02986139|Etanercept|etanercept|mesh-list
20045223|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20045224|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20045225|NCT02986139|Analgesics|analgesics|mesh-ancestor
20045226|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
20045227|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045228|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045229|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045230|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045231|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20045232|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045233|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
20045234|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
20045235|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
20045236|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
20045237|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045238|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045239|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20045240|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
20045241|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045242|NCT02988050|Lidocaine|lidocaine|mesh-list
20045243|NCT02988050|Epinephrine|epinephrine|mesh-list
20045244|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
20045245|NCT02988050|Remifentanil|remifentanil|mesh-list
20045246|NCT02988050|Bupivacaine|bupivacaine|mesh-list
20045247|NCT02988050|Propofol|propofol|mesh-list
20045248|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
20045249|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
20045250|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045251|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045252|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
20045253|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045254|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20045255|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20045256|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20045257|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20045258|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045259|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20045260|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20045261|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
20045262|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20045263|NCT02988050|Analgesics|analgesics|mesh-ancestor
20045264|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20045265|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20045266|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20045267|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
20045268|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045269|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20045270|NCT02988050|Narcotics|narcotics|mesh-ancestor
20045271|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20045272|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20045273|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
20045274|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20045275|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
20045276|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
20045277|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
20045278|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20045279|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20045280|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20293232|NCT04657562|Tacrolimus|tacrolimus|mesh-list
20293233|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293234|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
20293235|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293236|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20293237|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293238|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293239|NCT04646837|Paclitaxel|paclitaxel|mesh-list
20045281|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
20045282|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045283|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20045284|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045285|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20045286|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045287|NCT02988219|Epinephrine|epinephrine|mesh-list
20045288|NCT02988219|Fentanyl|fentanyl|mesh-list
20045289|NCT02988219|Bupivacaine|bupivacaine|mesh-list
20045290|NCT02988219|Anesthetics|anesthetics|mesh-list
20045291|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
20045292|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045293|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045294|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
20045295|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045296|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20045297|NCT02988219|Narcotics|narcotics|mesh-ancestor
20045298|NCT02988219|Analgesics|analgesics|mesh-ancestor
20045299|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20045300|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20045301|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
20045302|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20045303|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20045304|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
20045305|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045306|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045307|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20045308|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20045309|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
20045310|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20045311|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
20045312|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
20045313|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
20045314|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20045315|NCT02988349|Listerine|listerine|mesh-list
20045316|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
20045317|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
20045318|NCT02988349|Protective Agents|protective agents|mesh-ancestor
20045319|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045320|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20045321|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045322|NCT02988843|Bevacizumab|bevacizumab|mesh-list
20045323|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20045324|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045325|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045326|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20045327|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20045328|NCT02988843|Growth Substances|growth substances|mesh-ancestor
20045329|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045330|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
20045331|NCT02988882|Dexamethasone|dexamethasone|mesh-list
20045332|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045333|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
20045334|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
20045335|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045336|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045337|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20045338|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
20293240|NCT04646837|Carboplatin|carboplatin|mesh-list
20045339|NCT02988882|Hormones|hormones|mesh-ancestor
20045340|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045341|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20045342|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045343|NCT02988986|Tamoxifen|tamoxifen|mesh-list
20045344|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20045345|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
20045346|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045347|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045348|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20045349|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045350|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20045351|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20045352|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20045353|NCT02989389|Itraconazole|itraconazole|mesh-list
20045354|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
20045355|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045356|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20045357|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20045358|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045359|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045360|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20045361|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
20045362|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045363|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045364|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20045365|NCT02989493|Doxazosin|doxazosin|mesh-list
20045366|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20045367|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20045368|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20045369|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20045370|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
20045371|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045372|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045373|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045374|NCT02989649|Metformin|metformin|mesh-list
20045375|NCT02989649|Pioglitazone|pioglitazone|mesh-list
20045376|NCT02989649|Alogliptin|alogliptin|mesh-list
20045377|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20045378|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576764|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20576765|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576766|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
20576767|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576768|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20576769|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20576770|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
20576771|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576772|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
20576773|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20605629|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20045379|NCT02989649|Incretins|incretins|mesh-ancestor
20045380|NCT02989649|Hormones|hormones|mesh-ancestor
20045381|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045382|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20045383|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
20045384|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045385|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045386|NCT02989714|Nivolumab|nivolumab|mesh-list
20045387|NCT02989714|Interleukin-2|interleukin-2|mesh-list
20045388|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045389|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045390|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20045391|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045392|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20045393|NCT02989714|Analgesics|analgesics|mesh-ancestor
20045394|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
20045395|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045396|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045397|NCT02989727|Lamotrigine|lamotrigine|mesh-list
20045398|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
20120701|NCT00006391|Topotecan|topotecan|mesh-list
20045399|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20045400|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20045401|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045402|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20045403|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045404|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20045405|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20045406|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045407|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20045408|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20045409|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
20045410|NCT02990910|Narcotics|narcotics|mesh-ancestor
20045411|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045412|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045413|NCT02990910|Analgesics|analgesics|mesh-ancestor
20045414|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
20045415|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045416|NCT02991040|Lidocaine|lidocaine|mesh-list
20045417|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
20045418|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
20045419|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045420|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045421|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
20045422|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045423|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20045424|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20045425|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20045426|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20045427|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045428|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20045429|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20045430|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
20045431|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045432|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20045433|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045434|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20045435|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045436|NCT02991859|Fluticasone|fluticasone|mesh-list
20045437|NCT02991859|Xhance|xhance|mesh-list
20045438|NCT02991859|Budesonide|budesonide|mesh-list
20045439|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045440|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20045441|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
20045442|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045443|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045444|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20045445|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
20045446|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
20045447|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20045448|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
20045449|NCT02991859|Hormones|hormones|mesh-ancestor
20045450|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045451|NCT02992132|Pimavanserin|pimavanserin|mesh-list
20045452|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20045453|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20045454|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20045455|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20045456|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045457|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045458|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20045459|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20045460|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20045461|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
20045462|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045463|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045464|NCT02993224|Deferasirox|deferasirox|mesh-list
20045465|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20045466|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
20045467|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
20045468|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045469|NCT02993250|Simeprevir|simeprevir|mesh-list
20045470|NCT02993250|Odalasvir|odalasvir|mesh-list
20045471|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
20293241|NCT04646837|Durvalumab|durvalumab|mesh-list
20045472|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045473|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
20045474|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045475|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045476|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
20045477|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
20045478|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20045479|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045480|NCT02993302|Vitamins|vitamins|mesh-ancestor
20045481|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
20045482|NCT02993471|Vitamin K|vitamin k|mesh-list
20045483|NCT02993471|Midazolam|midazolam|mesh-list
20045484|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
20045485|NCT02993471|Caffeine|caffeine|mesh-list
20045486|NCT02993471|Ixekizumab|ixekizumab|mesh-list
20045487|NCT02993471|Omeprazole|omeprazole|mesh-list
20045488|NCT02993471|Warfarin|warfarin|mesh-list
20045489|NCT02993471|Vitamins|vitamins|mesh-ancestor
20045490|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
20045491|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045492|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20045493|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20045494|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045495|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20045496|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20045497|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20045498|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20045499|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
20045500|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
20045501|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
20045502|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
20045503|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045504|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045505|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
20045506|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20045507|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20045508|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20045509|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045510|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20045511|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20045512|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20045513|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20045514|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
20045515|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20045516|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20045517|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
20045518|NCT02993471|Coagulants|coagulants|mesh-ancestor
20045519|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
20045520|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
20045521|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20045522|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20045523|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
20045524|NCT02993783|Vedolizumab|vedolizumab|mesh-list
20045525|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20045526|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
20045527|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20045528|NCT02994056|Velpatasvir|velpatasvir|mesh-list
20045529|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
20045530|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045531|NCT02994394|Tolvaptan|tolvaptan|mesh-list
20045532|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20045533|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045534|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
20045535|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045536|NCT02994940|Acetaminophen|acetaminophen|mesh-list
20045537|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20045538|NCT02994940|Analgesics|analgesics|mesh-ancestor
20045539|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
20045540|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045541|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045542|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
20117446|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20117447|NCT00005940|Cyclosporins|cyclosporins|mesh-list
20117448|NCT00005940|Antibodies|antibodies|mesh-list
20117449|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
20117450|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20117451|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117452|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
20605630|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
20045543|NCT02995915|Bupropion|bupropion|mesh-list
20045544|NCT02995915|Nicotine|nicotine|mesh-list
20045545|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20045546|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
20045547|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045548|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045549|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20045550|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20045551|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
20045552|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045553|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045554|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20045555|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
20045556|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20045557|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20045558|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20045559|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20045560|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
20045561|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20045562|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20045563|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045564|NCT02996097|Triamcinolone|triamcinolone|mesh-list
20045565|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20045566|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20045567|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20045568|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045569|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
20045570|NCT02996097|Hormones|hormones|mesh-ancestor
20045571|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045572|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045573|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045574|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
20045575|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045576|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045577|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
20045578|NCT02996474|Decitabine|decitabine|mesh-list
20045579|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045580|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045581|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20045582|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
20045583|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045584|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045585|NCT02996500|Tofacitinib|tofacitinib|mesh-list
20045586|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20045587|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045588|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045589|NCT02996591|Dexamethasone|dexamethasone|mesh-list
20045590|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
20045591|NCT02996591|Midazolam|midazolam|mesh-list
20045592|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
20045593|NCT02996591|Ketamine|ketamine|mesh-list
20045594|NCT02996591|Bupivacaine|bupivacaine|mesh-list
20045595|NCT02996591|Mepivacaine|mepivacaine|mesh-list
20045596|NCT02996591|Anesthetics|anesthetics|mesh-list
20045597|NCT02996591|Propofol|propofol|mesh-list
20045598|NCT02996591|Sevoflurane|sevoflurane|mesh-list
20045599|NCT02996591|BB 1101|bb 1101|mesh-list
20045600|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045601|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
20045602|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
20045603|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045604|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045605|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20045606|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
20045607|NCT02996591|Hormones|hormones|mesh-ancestor
20045608|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045609|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20045610|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045611|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
20045612|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045613|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045614|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
20045615|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045616|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
20045617|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20045618|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20045619|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
20045620|NCT02996591|Analgesics|analgesics|mesh-ancestor
20045621|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20045622|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20045623|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20045624|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045625|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20045626|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20045627|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20045628|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20045629|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
20045630|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
20045631|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20045632|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20045633|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20045634|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20045635|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
20045636|NCT02996682|Ribavirin|ribavirin|mesh-list
20045637|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20045638|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
20045639|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045640|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
20045641|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045642|NCT02997163|Talazoparib|talazoparib|mesh-list
20045643|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20045644|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045645|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045646|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045647|NCT02997176|Talazoparib|talazoparib|mesh-list
20045648|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20045649|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045650|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045651|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045652|NCT02997722|Ketamine|ketamine|mesh-list
20045653|NCT02997722|Analgesics|analgesics|mesh-ancestor
20045654|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
20045655|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045656|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045657|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20045658|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20045659|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
20045660|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
20045661|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045662|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20045663|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20045664|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045665|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045666|NCT02998151|Minocycline|minocycline|mesh-list
20045667|NCT02998151|Acamprosate|acamprosate|mesh-list
20045668|NCT02998151|Baclofen|baclofen|mesh-list
20045669|NCT02998151|Lovastatin|lovastatin|mesh-list
20045670|NCT02998151|L 647318|l 647318|mesh-list
20045671|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
20045672|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20045673|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045674|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20045675|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045676|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20045677|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045678|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20045679|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
20045680|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
20045681|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045682|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045683|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20045684|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20045685|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
20045686|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20045687|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20045688|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045689|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20045690|NCT02998996|Endocine|endocine|mesh-list
20045691|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20045692|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
20045693|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045694|NCT02999100|Oxytocin|oxytocin|mesh-list
20045695|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
20045696|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20045697|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045698|NCT02999178|Nintedanib|nintedanib|mesh-list
20045699|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045700|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20045701|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045702|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045703|NCT02999672|Trastuzumab|trastuzumab|mesh-list
20045704|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20045705|NCT02999672|Maytansine|maytansine|mesh-list
20045706|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045707|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045708|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20045709|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
20045710|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
20045711|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
20045712|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045713|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20045714|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
20045715|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045716|NCT03000283|Conivaptan|conivaptan|mesh-list
20045717|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20045718|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045719|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
20045720|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045721|NCT03000309|Apremilast|apremilast|mesh-list
20045722|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20045723|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20045724|NCT03000309|Analgesics|analgesics|mesh-ancestor
20045725|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
20045726|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045727|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045728|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045729|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045730|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20045731|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20045732|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045733|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045734|NCT03000348|Cysteamine|cysteamine|mesh-list
20045735|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
20045736|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045737|NCT03000452|Durvalumab|durvalumab|mesh-list
20045738|NCT03000452|Daratumumab|daratumumab|mesh-list
20045739|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045740|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045741|NCT03000673|Heparin|heparin|mesh-list
20045742|NCT03000673|Enoxaparin|enoxaparin|mesh-list
20045743|NCT03000673|Calcium heparin|calcium heparin|mesh-list
20045744|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
20045745|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20045746|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20045747|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045748|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20045749|NCT03001076|Ezetimibe|ezetimibe|mesh-list
20045750|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20045751|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20045752|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
20045753|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045754|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20045755|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045756|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20045757|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045758|NCT03001219|Methotrexate|methotrexate|mesh-list
20045759|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20045760|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
20045761|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20045762|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045763|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20045764|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
20045765|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045766|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045767|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
20045768|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045769|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20045770|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045771|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
20045772|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045773|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20045774|NCT03001453|Epinephrine|epinephrine|mesh-list
20045775|NCT03001453|Bupivacaine|bupivacaine|mesh-list
20045776|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
20045777|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
20045778|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045779|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045780|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
20045781|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045782|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20045783|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20045784|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
20045785|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045786|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045787|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20045788|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20045789|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
20045790|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20045791|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
20045792|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
20045793|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
20045794|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20045795|NCT03001557|Lemborexant|lemborexant|mesh-list
20045796|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20045797|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045798|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045799|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20045800|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20045801|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045802|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045803|NCT03001843|Ketamine|ketamine|mesh-list
20045804|NCT03001843|Narcotics|narcotics|mesh-list
20045805|NCT03001843|Analgesics|analgesics|mesh-ancestor
20045806|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
20045807|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045808|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045809|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20045810|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20045811|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
20045812|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
20045813|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045814|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20045815|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20045816|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045817|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045818|NCT03002012|Fluconazole|fluconazole|mesh-list
20045819|NCT03002012|Sertraline|sertraline|mesh-list
20045820|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
20045821|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20045822|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20045823|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20045824|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20045825|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045826|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045827|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
20045828|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045829|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
20045830|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045831|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20045832|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20045833|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045834|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20045835|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
20045836|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045837|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20045838|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20045839|NCT03002038|Rituximab|rituximab|mesh-list
20045840|NCT03002038|Azathioprine|azathioprine|mesh-list
20045841|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045842|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045843|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
20045844|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045845|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045846|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
20045847|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045848|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20045849|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045850|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
20045851|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
20045852|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20045853|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045854|NCT03002506|Tazobactam|tazobactam|mesh-list
20045855|NCT03002506|Ceftolozane|ceftolozane|mesh-list
20045856|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20045857|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20045858|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20045859|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20045860|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045861|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045862|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20045863|NCT03002506|Renal Agents|renal agents|mesh-ancestor
20045864|NCT03002974|Triamcinolone|triamcinolone|mesh-list
20045865|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20045866|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20045867|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20045868|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20045869|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045870|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
20045871|NCT03002974|Hormones|hormones|mesh-ancestor
20045872|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045873|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045874|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045875|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
20045876|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045877|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045878|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045879|NCT03003000|Ibuprofen|ibuprofen|mesh-list
20045880|NCT03003000|Caffeine|caffeine|mesh-list
20045881|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20045882|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20045883|NCT03003000|Analgesics|analgesics|mesh-ancestor
20045884|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
20045885|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045886|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045887|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20045888|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045889|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20045890|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045891|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045892|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20045893|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20045894|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20045895|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20045896|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
20045897|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045898|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
20045899|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20045900|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
20045901|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045902|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
20045903|NCT03003130|Protective Agents|protective agents|mesh-ancestor
20045904|NCT03003390|Enoxaparin|enoxaparin|mesh-list
20045905|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
20045906|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20045907|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20045908|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045909|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
20045910|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
20045911|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20045912|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
20045913|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045914|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045915|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20045916|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
20045917|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045918|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045919|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20045920|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045921|NCT03003949|Estradiol|estradiol|mesh-list
20045922|NCT03003949|Progesterone|progesterone|mesh-list
20045923|NCT03003949|Estrogens|estrogens|mesh-ancestor
20045924|NCT03003949|Hormones|hormones|mesh-ancestor
20045925|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045926|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045927|NCT03003949|Progestins|progestins|mesh-ancestor
20045928|NCT03004469|Finasteride|finasteride|mesh-list
20045929|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20045930|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20045931|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045932|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045933|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
20045934|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045935|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045936|NCT03004469|Urological Agents|urological agents|mesh-ancestor
20045937|NCT03006341|Telmisartan|telmisartan|mesh-list
20045938|NCT03006341|Warfarin|warfarin|mesh-list
20045939|NCT03006341|Dabigatran|dabigatran|mesh-list
20045940|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
20045941|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20045942|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20045943|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20045944|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045945|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
20045946|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20045947|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
20045948|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045949|NCT03006393|Infliximab|infliximab|mesh-list
20045950|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
20045951|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20045952|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20045953|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
20045954|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20045955|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045956|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20045957|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045958|NCT03006562|Heparin|heparin|mesh-list
20045959|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
20045960|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20045961|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20045962|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045963|NCT03006848|Avelumab|avelumab|mesh-list
20045964|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045965|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045966|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
20045967|NCT03006887|Lenvatinib|lenvatinib|mesh-list
20045968|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20045969|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045970|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20045971|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20045972|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045973|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
20045974|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20045975|NCT03007225|Estrogens|estrogens|mesh-ancestor
20045976|NCT03007225|Hormones|hormones|mesh-ancestor
20045977|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20045978|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045979|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20045980|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20045981|NCT03007966|Clonidine|clonidine|mesh-list
20045982|NCT03007966|Epinephrine|epinephrine|mesh-list
20045983|NCT03007966|Bupivacaine|bupivacaine|mesh-list
20045984|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
20045985|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
20045986|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20045987|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20045988|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
20045989|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20045990|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20045991|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20045992|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
20045993|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20045994|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20045995|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20045996|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20045997|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
20045998|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20045999|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046000|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
20046001|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
20046002|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20046003|NCT03007966|Analgesics|analgesics|mesh-ancestor
20046004|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20046005|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
20046006|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20046007|NCT03008213|Palonosetron|palonosetron|mesh-list
20046008|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
20046009|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
20046010|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046011|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046012|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046013|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20046014|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20046015|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
20046016|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046017|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046018|NCT03008590|Naltrexone|naltrexone|mesh-list
20046019|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20046020|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20046021|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046022|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
20046023|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046024|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
20046025|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20046026|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
20046027|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046028|NCT03008889|Expectorants|expectorants|mesh-ancestor
20046029|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046030|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20046031|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
20046032|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046033|NCT03008889|Protective Agents|protective agents|mesh-ancestor
20046034|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046035|NCT03008889|Antidotes|antidotes|mesh-ancestor
20046036|NCT03008915|Aspirin|aspirin|mesh-list
20046037|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20046038|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
20046039|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20046040|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046041|NCT03008915|Analgesics|analgesics|mesh-ancestor
20046042|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
20046043|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046044|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046045|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046046|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046047|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20046048|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20046049|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046050|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20046051|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20046052|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046053|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
20046054|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20046055|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20046056|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046057|NCT03009162|Lasmiditan|lasmiditan|mesh-list
20046058|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20046059|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
20046060|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046061|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046062|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117453|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117454|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117455|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117456|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
20117457|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117458|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117459|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117460|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20117461|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
20117462|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20117463|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117464|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
20117465|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117466|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117467|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20117468|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20117469|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
20117470|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117471|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20117472|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20117473|NCT00005940|Trace Elements|trace elements|mesh-ancestor
20117474|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
20117475|NCT00005941|Cyclosporine|cyclosporine|mesh-list
20117476|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
20117477|NCT00005941|Fludarabine|fludarabine|mesh-list
20117478|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
20117479|NCT00005941|Cyclosporins|cyclosporins|mesh-list
20117480|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117481|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117482|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
20117483|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117484|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117485|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
20117486|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117487|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117488|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
20117489|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117490|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117491|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117492|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20117493|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117494|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20117495|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
20117496|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20117497|NCT00005942|Daunorubicin|daunorubicin|mesh-list
20117498|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117499|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117500|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117501|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117502|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20576774|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046063|NCT03009396|Clarithromycin|clarithromycin|mesh-list
20046064|NCT03009396|Rifabutin|rifabutin|mesh-list
20046065|NCT03009396|Clofazimine|clofazimine|mesh-list
20046066|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20046067|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046068|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20046069|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046070|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046071|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20046072|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20046073|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20046074|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
20046075|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046076|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
20046077|NCT03010631|Lubiprostone|lubiprostone|mesh-list
20046078|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20046079|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20046080|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046081|NCT03010683|Metformin|metformin|mesh-list
20046082|NCT03010683|Liraglutide|liraglutide|mesh-list
20046083|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20046084|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046085|NCT03010683|Incretins|incretins|mesh-ancestor
20046086|NCT03010683|Hormones|hormones|mesh-ancestor
20046087|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046088|NCT03011333|Epinephrine|epinephrine|mesh-list
20046089|NCT03011333|Bupivacaine|bupivacaine|mesh-list
20046090|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
20576775|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20576776|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20576777|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576778|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576779|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046091|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
20046092|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046093|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046094|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
20046095|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046096|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20046097|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20046098|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
20046099|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046100|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046101|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20046102|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20046103|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
20046104|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20046105|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046106|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
20046107|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
20046108|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20046109|NCT03011892|Triamcinolone|triamcinolone|mesh-list
20046110|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046111|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
20046112|NCT03011892|Hormones|hormones|mesh-ancestor
20046113|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046114|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046115|NCT03012061|Fluticasone|fluticasone|mesh-list
20046116|NCT03012061|Xhance|xhance|mesh-list
20046117|NCT03012061|Albuterol|albuterol|mesh-list
20046118|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046119|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20046120|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
20046121|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046122|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046123|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20046124|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046125|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
20046126|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20046127|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
20046128|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20046129|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20046130|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20046131|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20046132|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
20576780|NCT02073149|Iron|iron|mesh-list
20046133|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046134|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046135|NCT03012191|Gentamicins|gentamicins|mesh-list
20046136|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20046137|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046138|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20046139|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046140|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046141|NCT03012334|Alprazolam|alprazolam|mesh-list
20046142|NCT03012334|Lasmiditan|lasmiditan|mesh-list
20046143|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20046144|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046145|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046146|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20046147|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20046148|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20046149|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
20046150|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
20046151|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046152|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046153|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20046154|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
20046155|NCT03012477|Adavosertib|adavosertib|mesh-list
20046156|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046157|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046158|NCT03012594|Lanreotide|lanreotide|mesh-list
20046159|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046160|NCT03012828|Moxidectin|moxidectin|mesh-list
20046161|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
20046162|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20046163|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046164|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
20046165|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
20046166|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
19746140|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746141|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20046167|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20046168|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046169|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20046170|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046171|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20046172|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046173|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046174|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046175|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20046176|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046177|NCT03015220|Dulaglutide|dulaglutide|mesh-list
20046178|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20046179|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046180|NCT03015532|Bupivacaine|bupivacaine|mesh-list
20046181|NCT03015532|Ropivacaine|ropivacaine|mesh-list
20046182|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
20046183|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
20046184|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046185|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046186|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
20046187|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046188|NCT03015961|Bupivacaine|bupivacaine|mesh-list
20046189|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
20046190|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
20046191|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046192|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046193|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
20046194|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046195|NCT03016598|Oxytocin|oxytocin|mesh-list
20046196|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
20046197|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20046198|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046199|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
20046200|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
20046201|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
20046202|NCT03017235|Citric Acid|citric acid|mesh-list
19746142|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046203|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
20046204|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20046205|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
20046206|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
20046207|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046208|NCT03017235|Cathartics|cathartics|mesh-ancestor
20046209|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046210|NCT03017235|Antacids|antacids|mesh-ancestor
20046211|NCT03017508|Riluzole|riluzole|mesh-list
20046212|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
20046213|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20046214|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20046215|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046216|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046217|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046218|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20046219|NCT03017508|Protective Agents|protective agents|mesh-ancestor
20046220|NCT03017846|Cantharidin|cantharidin|mesh-list
20046221|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046222|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046223|NCT03018028|Liraglutide|liraglutide|mesh-list
20046224|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20046225|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046226|NCT03018028|Incretins|incretins|mesh-ancestor
20046227|NCT03018028|Hormones|hormones|mesh-ancestor
20046228|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046229|NCT03018106|Estrogens|estrogens|mesh-list
20046230|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20046231|NCT03018106|Hormones|hormones|mesh-ancestor
20046232|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046233|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046234|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
20046235|NCT03018223|Sirolimus|sirolimus|mesh-list
20046236|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
20046237|NCT03018223|Busulfan|busulfan|mesh-list
20046238|NCT03018223|Fludarabine|fludarabine|mesh-list
20046239|NCT03018223|Sargramostim|sargramostim|mesh-list
20046240|NCT03018223|Lenograstim|lenograstim|mesh-list
20046241|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20046242|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
20046243|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046244|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046245|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20046246|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
20046247|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046248|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046249|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20046250|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20046251|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20046252|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
20046253|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20046254|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046255|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046256|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
20046257|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20046258|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20046259|NCT03018249|Entinostat|entinostat|mesh-list
20046260|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
20046261|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20046262|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20046263|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20046264|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20046265|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
20046266|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20046267|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046268|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20046269|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20046270|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20046271|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046272|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046273|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046274|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046275|NCT03018340|Pimavanserin|pimavanserin|mesh-list
20046276|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20046277|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20046278|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20046279|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20046280|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046281|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046282|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20046283|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20046284|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20576781|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20576782|NCT02073149|Trace Elements|trace elements|mesh-ancestor
20576783|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
20576784|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576785|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20046285|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
20046286|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046287|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046288|NCT03018925|Golimumab|golimumab|mesh-list
20046289|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20046290|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046291|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20046292|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
20046293|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046294|NCT03018938|Insulin|insulin|mesh-list
20046295|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20046296|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20046297|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046298|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20046299|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20046300|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20046301|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
20046302|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046303|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20046304|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20046305|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046306|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20046307|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20046308|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20046309|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046310|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046311|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046312|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20046313|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20046314|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
20046315|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046316|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
20046317|NCT03019887|Haloperidol|haloperidol|mesh-list
20046318|NCT03019887|Olanzapine|olanzapine|mesh-list
20046319|NCT03019887|Risperidone|risperidone|mesh-list
20046320|NCT03019887|Aripiprazole|aripiprazole|mesh-list
20046321|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20046322|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20046323|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
20046324|NCT03019887|Perphenazine|perphenazine|mesh-list
20046325|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20046326|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
20046327|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046328|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046329|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046330|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20046331|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20046332|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046333|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20046334|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19491484|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491485|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19491486|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19491487|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491488|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491489|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
19491490|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19491491|NCT03130517|Antibodies|antibodies|mesh-list
19491492|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
19491493|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19491494|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
19491495|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491496|NCT03130348|Dexamethasone|dexamethasone|mesh-list
19491497|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
19491498|NCT03130348|Bortezomib|bortezomib|mesh-list
19491499|NCT03130348|Ichthammol|ichthammol|mesh-list
19491500|NCT03130348|BB 1101|bb 1101|mesh-list
20046335|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
20046336|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
20576786|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
19491501|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491502|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
20046337|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
20046338|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046339|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046340|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20046341|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20046342|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20046343|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
20046344|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
20046345|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20046346|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20046347|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20046348|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20046349|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20046350|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046351|NCT03019887|Analgesics|analgesics|mesh-ancestor
20046352|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
20046353|NCT03019939|Isavuconazole|isavuconazole|mesh-list
20046354|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
20046355|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046356|NCT03019965|Meropenem|meropenem|mesh-list
20046357|NCT03019965|Tazobactam|tazobactam|mesh-list
20046358|NCT03019965|Piperacillin|piperacillin|mesh-list
20046359|NCT03019965|Imipenem|imipenem|mesh-list
20046360|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20046361|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20046362|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046363|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20046364|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046365|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046366|NCT03020004|Ritonavir|ritonavir|mesh-list
20046367|NCT03020004|Ribavirin|ribavirin|mesh-list
20046368|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20046369|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20046370|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20046371|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046372|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046373|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046374|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20576787|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
20576788|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576789|NCT02073227|Metformin|metformin|mesh-list
20576790|NCT02073227|Canagliflozin|canagliflozin|mesh-list
20576791|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20576792|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576793|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20576794|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576795|NCT02073357|Anesthetics|anesthetics|mesh-list
20576796|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576797|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576798|NCT02073474|Nabiximols|nabiximols|mesh-list
20576799|NCT02073474|Analgesics|analgesics|mesh-ancestor
19491503|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
20046375|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20046376|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
20046377|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046378|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20046379|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20046380|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
20046381|NCT03020082|Ritonavir|ritonavir|mesh-list
20046382|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20046383|NCT03020082|Ribavirin|ribavirin|mesh-list
20046384|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20046385|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20046386|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046387|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046388|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046389|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20046390|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20046391|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
20046392|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046393|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20046394|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20046395|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
20576800|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
20046396|NCT03020095|Ritonavir|ritonavir|mesh-list
20046397|NCT03020095|Ribavirin|ribavirin|mesh-list
20046398|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20046399|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20046400|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046401|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046402|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046403|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20046404|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20046405|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
20046406|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046407|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20046408|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20046409|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
20046410|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20046411|NCT03020407|Dopamine|dopamine|mesh-list
20046412|NCT03020407|Epinephrine|epinephrine|mesh-list
20046413|NCT03020407|Norepinephrine|norepinephrine|mesh-list
20046414|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20046415|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046416|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20046417|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20046418|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
20046419|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046420|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046421|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046422|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20046423|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20046424|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
20046425|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046426|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20046427|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046428|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
20046429|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
20046430|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20046431|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
20046432|NCT03020407|Protective Agents|protective agents|mesh-ancestor
20046433|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
20046434|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046435|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
20046436|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046437|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046438|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20046439|NCT03020966|Acetaminophen|acetaminophen|mesh-list
20046440|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046441|NCT03020966|Analgesics|analgesics|mesh-ancestor
20046442|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
20046443|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046444|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046445|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
20046446|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
20046447|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20046448|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
20046449|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046450|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046451|NCT03021018|Lorazepam|lorazepam|mesh-list
20046452|NCT03021018|Brivaracetam|brivaracetam|mesh-list
20046453|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
20046454|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
20046455|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
20046456|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046457|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046458|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046459|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20046460|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046461|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20046462|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20046463|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20046464|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
20046465|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
20046466|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046467|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046468|NCT03021343|Colchicine|colchicine|mesh-list
20046469|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
20046470|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046471|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
20046472|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
20046473|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
20046474|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046475|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046476|NCT03021642|Tepotinib|tepotinib|mesh-list
20046477|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117503|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117504|NCT00005943|Aldesleukin|aldesleukin|mesh-list
20117505|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117506|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20117507|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20117508|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
20117509|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117510|NCT00005944|Leucovorin|leucovorin|mesh-list
20117511|NCT00005944|Fluorouracil|fluorouracil|mesh-list
20117512|NCT00005944|Mitomycins|mitomycins|mesh-list
20117513|NCT00005944|Mitomycin|mitomycin|mesh-list
20117514|NCT00005944|Calcium|calcium|mesh-list
20117515|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
20117516|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20117517|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117518|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
20117519|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117520|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117521|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117522|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117523|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
20117524|NCT00005944|Antidotes|antidotes|mesh-ancestor
20117525|NCT00005944|Protective Agents|protective agents|mesh-ancestor
20117526|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
20117527|NCT00005944|Vitamins|vitamins|mesh-ancestor
20117528|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
20117529|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117530|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
20117531|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20117532|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117533|NCT00005945|Cytarabine|cytarabine|mesh-list
20117534|NCT00005945|Dexamethasone|dexamethasone|mesh-list
20117535|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
20117536|NCT00005945|Doxorubicin|doxorubicin|mesh-list
20117537|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117538|NCT00005945|Methotrexate|methotrexate|mesh-list
20117539|NCT00005945|Vincristine|vincristine|mesh-list
20117540|NCT00005945|Daunorubicin|daunorubicin|mesh-list
20117541|NCT00005945|Asparaginase|asparaginase|mesh-list
20117542|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
20117543|NCT00005945|Pegaspargase|pegaspargase|mesh-list
20117544|NCT00005945|Thioguanine|thioguanine|mesh-list
20117545|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117546|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
20117547|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117548|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117549|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117550|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
20117551|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117552|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117553|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117554|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117555|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
20117556|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
20117557|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117558|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20117559|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
20117560|NCT00005945|Hormones|hormones|mesh-ancestor
20117561|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117562|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20117563|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20293242|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117564|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117565|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117566|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117567|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20117568|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
20046478|NCT03022526|Fentanyl|fentanyl|mesh-list
20046479|NCT03022526|Bupivacaine|bupivacaine|mesh-list
20046480|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
20046481|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
20046482|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046483|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046484|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
20046485|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046486|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20046487|NCT03022526|Narcotics|narcotics|mesh-ancestor
20046488|NCT03022526|Analgesics|analgesics|mesh-ancestor
20046489|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20046490|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20046491|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
20046492|NCT03022617|Apremilast|apremilast|mesh-list
20046493|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20046494|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046495|NCT03022617|Analgesics|analgesics|mesh-ancestor
20046496|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
20046497|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046498|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046499|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046500|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046501|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20046502|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20046503|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046504|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046505|NCT03022916|Efinaconazole|efinaconazole|mesh-list
20046506|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20046507|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
20046508|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046509|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
20046510|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20046511|NCT03022981|Velpatasvir|velpatasvir|mesh-list
20046512|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
20046513|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046514|NCT03023423|Atezolizumab|atezolizumab|mesh-list
20046515|NCT03023423|Daratumumab|daratumumab|mesh-list
20046516|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046517|NCT03023722|Maytansine|maytansine|mesh-list
20046518|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20046519|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046520|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
20046521|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
20046522|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
20046523|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046524|NCT03023878|Dexamethasone|dexamethasone|mesh-list
20046525|NCT03023878|Blinatumomab|blinatumomab|mesh-list
20046526|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046527|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
20046528|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
20046529|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046530|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046531|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046532|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
20046533|NCT03023878|Hormones|hormones|mesh-ancestor
20046534|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046535|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046536|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046537|NCT03023891|Prednisone|prednisone|mesh-list
20046538|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046539|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
20046540|NCT03023891|Hormones|hormones|mesh-ancestor
20046541|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046542|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046543|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046544|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046545|NCT03025945|Nepafenac|nepafenac|mesh-list
20046546|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20046547|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046548|NCT03025945|Analgesics|analgesics|mesh-ancestor
20046549|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
20046550|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046551|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046552|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046553|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046554|NCT03026088|Bisoprolol|bisoprolol|mesh-list
20046555|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20046556|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
20046557|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
20046558|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576801|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576802|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576803|NCT02073526|Adalimumab|adalimumab|mesh-list
20576804|NCT02073526|Infliximab|infliximab|mesh-list
20046559|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046560|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20046561|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20046562|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20046563|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
20046564|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046565|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046566|NCT03026166|Nivolumab|nivolumab|mesh-list
20046567|NCT03026166|Ipilimumab|ipilimumab|mesh-list
20046568|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20046569|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046570|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20046571|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046572|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20046573|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
20046574|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20046575|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20046576|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046577|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
20046578|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
20046579|NCT03026556|Apixaban|apixaban|mesh-list
20046580|NCT03026556|Dabigatran|dabigatran|mesh-list
20046581|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20046582|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
20046583|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20046584|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046585|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046586|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046587|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
20046588|NCT03026803|Capecitabine|capecitabine|mesh-list
20046589|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
20046590|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20046591|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
20046592|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046593|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046594|NCT03027557|Denosumab|denosumab|mesh-list
20046595|NCT03027557|Cinacalcet|cinacalcet|mesh-list
20046596|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20046597|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046598|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20046599|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20046600|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
20046601|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046602|NCT03027661|Bupivacaine|bupivacaine|mesh-list
20046603|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
20046604|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
20046605|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046606|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046607|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
20046608|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046609|NCT03028012|Dexamethasone|dexamethasone|mesh-list
20046610|NCT03028012|Ketorolac|ketorolac|mesh-list
20046611|NCT03028012|Lidocaine|lidocaine|mesh-list
20046612|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576805|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
20576806|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576807|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20576808|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
20576809|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576810|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576811|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
20576812|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046613|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
20046614|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
20046615|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046616|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576813|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
20046617|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046618|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
20046619|NCT03028012|Hormones|hormones|mesh-ancestor
20046620|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046621|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046622|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046623|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
20046624|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
20046625|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046626|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
20046627|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20046628|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20046629|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20046630|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20046631|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046632|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20046633|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046634|NCT03028012|Analgesics|analgesics|mesh-ancestor
20046635|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046636|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20046637|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046638|NCT03028025|Hemostatics|hemostatics|mesh-list
20046639|NCT03028025|Coagulants|coagulants|mesh-ancestor
20046640|NCT03028103|Repaglinide|repaglinide|mesh-list
20046641|NCT03028103|Fluconazole|fluconazole|mesh-list
20046642|NCT03028103|Omeprazole|omeprazole|mesh-list
20046643|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20046644|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046645|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20046646|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046647|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046648|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
20046649|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046650|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20046651|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20046652|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20046653|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
20046654|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046655|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046656|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20046657|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20046658|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20046659|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20046660|NCT03028129|Isoniazid|isoniazid|mesh-list
20046661|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046662|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
20046663|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20046664|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20046665|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
20046666|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046667|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20046668|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
20046669|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20046670|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
20046671|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046672|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046673|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20046674|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046675|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
20046676|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20046677|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
20046678|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046679|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046680|NCT03028467|Folic Acid|folic acid|mesh-list
20046681|NCT03028467|Methotrexate|methotrexate|mesh-list
20046682|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20046683|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
20046684|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20046685|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046686|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20046687|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
20046688|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046689|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046690|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
20046691|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046692|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20046693|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20046694|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
20046695|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046696|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20046697|NCT03028467|Hematinics|hematinics|mesh-ancestor
20046698|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
20046699|NCT03028467|Vitamins|vitamins|mesh-ancestor
20046700|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
20046701|NCT03028870|Naproxen|naproxen|mesh-list
20046702|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20046703|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046704|NCT03028870|Analgesics|analgesics|mesh-ancestor
20046705|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
20046706|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046707|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046708|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046709|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046710|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
20046711|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20046712|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046713|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046714|NCT03029091|Losartan|losartan|mesh-list
20046715|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20046716|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20046717|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20046718|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20576814|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20576815|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
20576816|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046719|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046720|NCT03029143|Vedolizumab|vedolizumab|mesh-list
20046721|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046722|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
20046723|NCT03029208|Hematinics|hematinics|mesh-ancestor
20046724|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
20046725|NCT03029247|Hematinics|hematinics|mesh-ancestor
20046726|NCT03029650|Scopolamine|scopolamine|mesh-list
20046727|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20046728|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20046729|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
20046730|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
20046731|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046732|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046733|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046734|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
20046735|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20046736|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
20046737|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046738|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046739|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20046740|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
20046741|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
20046742|NCT03029715|Remifentanil|remifentanil|mesh-list
20046743|NCT03029715|Propofol|propofol|mesh-list
20046744|NCT03029715|Desflurane|desflurane|mesh-list
20046745|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20046746|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046747|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046748|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20046749|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
20046750|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
20046751|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046752|NCT03029715|Analgesics|analgesics|mesh-ancestor
20046753|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
20046754|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046755|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20576817|NCT02073552|Protective Agents|protective agents|mesh-ancestor
20576818|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576819|NCT02073552|Vitamins|vitamins|mesh-ancestor
20576820|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
20576821|NCT02073552|Laxatives|laxatives|mesh-ancestor
20046756|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20046757|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20046758|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
20046759|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046760|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046761|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20046762|NCT03029715|Narcotics|narcotics|mesh-ancestor
20046763|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20046764|NCT03029780|Nivolumab|nivolumab|mesh-list
20046765|NCT03029780|Ipilimumab|ipilimumab|mesh-list
20046766|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20046767|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046768|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20046769|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046770|NCT03029819|Nicotine|nicotine|mesh-list
20046771|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20046772|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
20046773|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046774|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046775|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20046776|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20046777|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
20046778|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046779|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749284|NCT05187182|Trastuzumab|trastuzumab|mesh-list
20046780|NCT03030638|Olodaterol|olodaterol|mesh-list
20046781|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20046782|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
20046783|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046784|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046785|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20046786|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046787|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
20046788|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20046789|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20046790|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046791|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
20046792|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
20046793|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20046794|NCT03031496|Amiloride|amiloride|mesh-list
20046795|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
20046796|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20046797|NCT03031496|Diuretics|diuretics|mesh-ancestor
20046798|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
20046799|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046800|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20046801|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20046802|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046803|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20046804|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20046805|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20046806|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20046807|NCT03031795|Ketorolac|ketorolac|mesh-list
20046808|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20046809|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20046810|NCT03031795|Analgesics|analgesics|mesh-ancestor
20046811|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
20046812|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046813|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046814|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046815|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20046816|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20046817|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046818|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046819|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
20046820|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
20046821|NCT03031899|Coagulants|coagulants|mesh-ancestor
20046822|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
20046823|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046824|NCT03032380|Meropenem|meropenem|mesh-list
20046825|NCT03032380|Linezolid|linezolid|mesh-list
20046826|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20046827|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046828|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20046829|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046830|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576822|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046831|NCT03032965|Adenosine|adenosine|mesh-list
20046832|NCT03032965|Isoproterenol|isoproterenol|mesh-list
20046833|NCT03032965|Analgesics|analgesics|mesh-ancestor
20046834|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
20046835|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046836|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046837|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20046838|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
20046839|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20046840|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
20046841|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
20046842|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046843|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046844|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20046845|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20046846|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
20046847|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20046848|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
20046849|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20046850|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046851|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20046852|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
20046853|NCT03032965|Protective Agents|protective agents|mesh-ancestor
20046854|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20046855|NCT03033394|Penicillins|penicillins|mesh-list
20046856|NCT03033394|Lactams|lactams|mesh-list
20046857|NCT03033394|beta-Lactams|beta-lactams|mesh-list
20046858|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046859|NCT03033511|Dexamethasone|dexamethasone|mesh-list
20046860|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
20046861|NCT03033511|BB 1101|bb 1101|mesh-list
20046862|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
20046863|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046864|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
20046865|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
20576823|NCT02073669|Interferons|interferons|mesh-list
20576824|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
20576825|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576826|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
20576827|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576828|NCT02073734|Dexamethasone|dexamethasone|mesh-list
20576829|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576830|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
20576831|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
20576832|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576833|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046866|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046867|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046868|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046869|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
20046870|NCT03033511|Hormones|hormones|mesh-ancestor
20046871|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046872|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046873|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046874|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046875|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046876|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046877|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
20046878|NCT03033784|Oxytocin|oxytocin|mesh-list
20046879|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
20046880|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20046881|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046882|NCT03034135|Copper|copper|mesh-list
20046883|NCT03034135|Temozolomide|temozolomide|mesh-list
20046884|NCT03034135|Disulfiram|disulfiram|mesh-list
20046885|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20046886|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
20046887|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046888|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046889|NCT03034135|Trace Elements|trace elements|mesh-ancestor
20046890|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
20046891|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046892|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20046893|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20046894|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046895|NCT03034577|Neostigmine|neostigmine|mesh-list
20046896|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20576834|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576835|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
20046897|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046898|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046899|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
20046900|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046901|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046902|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20046903|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
20046904|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046905|NCT03034772|Timolol|timolol|mesh-list
20046906|NCT03034772|Dorzolamide|dorzolamide|mesh-list
20046907|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
20046908|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20046909|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20046910|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
20046911|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046912|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046913|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046914|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20046915|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20046916|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20046917|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20046918|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20046919|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046920|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20046921|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20046922|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
20046923|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046924|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046925|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20046926|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
20046927|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20046928|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20046929|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20046930|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
20046931|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046932|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046933|NCT03035032|Leuprolide|leuprolide|mesh-list
20046934|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20046935|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
20046936|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20046937|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046938|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046939|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046940|NCT03035708|Varenicline|varenicline|mesh-list
20046941|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20046942|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20046943|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
20046944|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046945|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046946|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117569|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20117570|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117571|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
20117572|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117573|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20117574|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20117575|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
20117576|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117577|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117578|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117579|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117580|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117581|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
20117582|NCT00005946|Etoposide|etoposide|mesh-list
20117583|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117584|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
20117585|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117586|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117587|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117588|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
20117589|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117590|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117591|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20576836|NCT02073734|Hormones|hormones|mesh-ancestor
20046947|NCT03035760|Oxfendazole|oxfendazole|mesh-list
20046948|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
20046949|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20046950|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20046951|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
20046952|NCT03035916|Anesthetics|anesthetics|mesh-list
20046953|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046954|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046955|NCT03035929|Dexamethasone|dexamethasone|mesh-list
20046956|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
20046957|NCT03035929|BB 1101|bb 1101|mesh-list
20046958|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046959|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
20046960|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
20046961|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046962|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046963|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046964|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
20046965|NCT03035929|Hormones|hormones|mesh-ancestor
20046966|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046967|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046968|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046969|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
20046970|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20046971|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046972|NCT03035942|Dexamethasone|dexamethasone|mesh-list
20046973|NCT03035942|Ondansetron|ondansetron|mesh-list
20046974|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20046975|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
20046976|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
20046977|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20046978|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20046979|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20046980|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
20046981|NCT03035942|Hormones|hormones|mesh-ancestor
20046982|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20046983|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20046984|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046985|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
20046986|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
20046987|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20046988|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
20046989|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20046990|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20046991|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20046992|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20046993|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20046994|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20046995|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20046996|NCT03035955|Azelaic acid|azelaic acid|mesh-list
20046997|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20046998|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
20046999|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
20047000|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20047001|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047002|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047003|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047004|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
20047005|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20047006|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047007|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047008|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047009|NCT03036163|Macozinone|macozinone|mesh-list
20047010|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
20047011|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20047012|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047013|NCT03036384|Sufentanil|sufentanil|mesh-list
20047014|NCT03036384|Morphine|morphine|mesh-list
20047015|NCT03036384|Prilocaine|prilocaine|mesh-list
20047016|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20047017|NCT03036384|Narcotics|narcotics|mesh-ancestor
20047018|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047019|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047020|NCT03036384|Analgesics|analgesics|mesh-ancestor
20047021|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
20047022|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047023|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20047024|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20047025|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
20047026|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
20047027|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
20047028|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
20047029|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20047030|NCT03036839|Ledipasvir|ledipasvir|mesh-list
20047031|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
20047032|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047033|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
20047034|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20047035|NCT03036852|Velpatasvir|velpatasvir|mesh-list
20047036|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
20047037|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047038|NCT03037580|Treprostinil|treprostinil|mesh-list
20047039|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20047040|NCT03038308|Ropinirole|ropinirole|mesh-list
20047041|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20047042|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20047043|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
20047044|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
20047045|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047046|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047047|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047048|NCT03038620|Liraglutide|liraglutide|mesh-list
20047049|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047050|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047051|NCT03038620|Incretins|incretins|mesh-ancestor
20047052|NCT03038620|Hormones|hormones|mesh-ancestor
20047053|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047054|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20047055|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20047056|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20047057|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047058|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047059|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047060|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047061|NCT03038867|Analgesics|analgesics|mesh-ancestor
20047062|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
20047063|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047064|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
20047065|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047066|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
20047067|NCT03038880|Ranibizumab|ranibizumab|mesh-list
20047068|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20047069|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20047070|NCT03038880|Growth Substances|growth substances|mesh-ancestor
20047071|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047072|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
20047073|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047074|NCT03039023|Choline|choline|mesh-list
20047075|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
20047076|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20047077|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
20047078|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047079|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047080|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20047081|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
20047082|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
20047083|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20047084|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
20047085|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047086|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047087|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047088|NCT03039192|Esketamine|esketamine|mesh-list
20047089|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
20047090|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047091|NCT03039543|Rocuronium|rocuronium|mesh-list
20047092|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20047093|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20047094|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20047095|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047096|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047097|NCT03040011|Dexamethasone|dexamethasone|mesh-list
20047098|NCT03040011|Bupivacaine|bupivacaine|mesh-list
20047099|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047100|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
20047101|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
20047102|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047103|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047104|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047105|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
20047106|NCT03040011|Hormones|hormones|mesh-ancestor
20047107|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047108|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20047109|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047110|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
20047111|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
20047112|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047113|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
20047114|NCT03040024|Ketamine|ketamine|mesh-list
20047115|NCT03040024|Analgesics|analgesics|mesh-ancestor
20047116|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
20047117|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047118|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047119|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20047120|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20047121|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
20047122|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
20047123|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047124|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20047125|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20047126|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047127|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047128|NCT03040362|Lasmiditan|lasmiditan|mesh-list
20047129|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20047130|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
20047131|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047132|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047133|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047134|NCT03040479|Lasmiditan|lasmiditan|mesh-list
20047135|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20047136|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
20047137|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047138|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047139|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047140|NCT03041181|Gemcitabine|gemcitabine|mesh-list
20047141|NCT03041181|Docetaxel|docetaxel|mesh-list
20047142|NCT03041181|Nivolumab|nivolumab|mesh-list
20047143|NCT03041181|Pemetrexed|pemetrexed|mesh-list
20047144|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20047145|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
20047146|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047147|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047148|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
20047149|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047150|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047151|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047152|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
20047153|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047154|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
20047155|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
20047156|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
20047157|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047158|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20047159|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20047160|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20047161|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20047162|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
20047163|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
20047164|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047165|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
20047166|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20047167|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047168|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047169|NCT03041792|Liraglutide|liraglutide|mesh-list
20047170|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047171|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047172|NCT03041792|Incretins|incretins|mesh-ancestor
20047173|NCT03041792|Hormones|hormones|mesh-ancestor
20047174|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047175|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20047176|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20047177|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20047178|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047179|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
20047180|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20047181|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047182|NCT03042910|Talazoparib|talazoparib|mesh-list
20047183|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20047184|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047185|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047186|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047187|NCT03043105|Thalidomide|thalidomide|mesh-list
20047188|NCT03043105|Prednisone|prednisone|mesh-list
20047189|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
20047190|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047191|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
20047192|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047193|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20047194|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20047195|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
20047196|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047197|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047198|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20047199|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047200|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
20047201|NCT03043105|Hormones|hormones|mesh-ancestor
20047202|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047203|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20047204|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
20047205|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20047206|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047207|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20047208|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20047209|NCT03043105|Growth Substances|growth substances|mesh-ancestor
20047210|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
20047211|NCT03043274|Cangrelor|cangrelor|mesh-list
20047212|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20047213|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20047214|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20047215|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20047216|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
20047217|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047218|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047219|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047220|NCT03043560|Ezogabine|ezogabine|mesh-list
20047221|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
20047222|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047223|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047224|NCT03043651|Treprostinil|treprostinil|mesh-list
20047225|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20047226|NCT03044418|Propofol|propofol|mesh-list
20047227|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
20047228|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047229|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047230|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20047231|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20047232|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
20047233|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
20047234|NCT03044730|Capecitabine|capecitabine|mesh-list
20047235|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047236|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047237|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20047238|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
20047239|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047240|NCT03044886|Vitamin D|vitamin d|mesh-list
20047241|NCT03044886|Vitamins|vitamins|mesh-ancestor
20047242|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
20047243|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047244|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20047245|NCT03045328|Venetoclax|venetoclax|mesh-list
20047246|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117592|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117593|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117594|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117595|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117596|NCT00005948|Interferons|interferons|mesh-list
20117597|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
20117598|NCT00005948|Aldesleukin|aldesleukin|mesh-list
20117599|NCT00005948|Busulfan|busulfan|mesh-list
20117600|NCT00005948|Sargramostim|sargramostim|mesh-list
20117601|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117602|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
20117603|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117604|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
20117605|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117606|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
20117607|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117608|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117609|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117610|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117611|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20117612|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20117613|NCT00005949|Aldesleukin|aldesleukin|mesh-list
20117614|NCT00005949|Interleukin-2|interleukin-2|mesh-list
20117615|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117616|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20117617|NCT00005949|Analgesics|analgesics|mesh-ancestor
20117618|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
20117619|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117620|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117621|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20117622|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20117623|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
20117624|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117625|NCT00005951|Irinotecan|irinotecan|mesh-list
20117626|NCT00005951|Temozolomide|temozolomide|mesh-list
20117627|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117628|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117629|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117630|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117631|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117632|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117633|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
20117634|NCT00005952|Temozolomide|temozolomide|mesh-list
20117635|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117636|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
20117637|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117638|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117639|NCT00005954|Temozolomide|temozolomide|mesh-list
20117640|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117641|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
20117642|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117643|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117644|NCT00005955|Temozolomide|temozolomide|mesh-list
20117645|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117646|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
20117647|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117648|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117649|NCT00005958|Gemcitabine|gemcitabine|mesh-list
20117650|NCT00005958|Docetaxel|docetaxel|mesh-list
20117651|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117652|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
20117653|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117654|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117655|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
20117656|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117657|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117658|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117659|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
20047247|NCT03045861|Cobicistat|cobicistat|mesh-list
20047248|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
20047249|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20047250|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20047251|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
20047252|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047253|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20047254|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20047255|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047256|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047257|NCT03046446|FX006|fx006|mesh-list
20047258|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047259|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
20047260|NCT03046446|Hormones|hormones|mesh-ancestor
20047261|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047262|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047263|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047264|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
20047265|NCT03047980|Sirolimus|sirolimus|mesh-list
20047266|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20047267|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047268|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20047269|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047270|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
20047271|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047272|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
20047273|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047274|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20047275|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
20047276|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
20047277|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047278|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20047279|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20047280|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20047281|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20047282|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20047283|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
20047284|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047285|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047286|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047287|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20047288|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20047289|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20047290|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047291|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047292|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20047293|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047294|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047295|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
20047296|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047297|NCT03048500|Metformin|metformin|mesh-list
20047298|NCT03048500|Nivolumab|nivolumab|mesh-list
20047299|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047300|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047301|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047302|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576837|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576838|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20576839|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576840|NCT02073773|Levodopa|levodopa|mesh-list
20576841|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20576842|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20576843|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
20576844|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576845|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576846|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576847|NCT02073838|Ribavirin|ribavirin|mesh-list
20576848|NCT02073838|Decitabine|decitabine|mesh-list
20576849|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
20576850|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576851|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
20047303|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20576852|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047304|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047305|NCT03048747|Tolvaptan|tolvaptan|mesh-list
20047306|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20047307|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047308|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
20047309|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047310|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20047311|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20047312|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
20047313|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047314|NCT03049488|Antacids|antacids|mesh-ancestor
20047315|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047316|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047317|NCT03050294|Desoximetasone|desoximetasone|mesh-list
20047318|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047319|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
20047320|NCT03050294|Hormones|hormones|mesh-ancestor
20047321|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576853|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576854|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576855|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047322|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047323|NCT03050307|Lansoprazole|lansoprazole|mesh-list
20047324|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
20047325|NCT03050307|Bismuth|bismuth|mesh-list
20047326|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20047327|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047328|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20047329|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047330|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047331|NCT03050307|Antacids|antacids|mesh-ancestor
20047332|NCT03050359|Lansoprazole|lansoprazole|mesh-list
20047333|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
20047334|NCT03050359|Bismuth|bismuth|mesh-list
20047335|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20047336|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047337|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20047338|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047339|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047340|NCT03050359|Antacids|antacids|mesh-ancestor
20047341|NCT03050450|Lenalidomide|lenalidomide|mesh-list
20047342|NCT03050450|Vorinostat|vorinostat|mesh-list
20047343|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
20047344|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047345|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20047346|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20047347|NCT03050450|Growth Substances|growth substances|mesh-ancestor
20047348|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20047349|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047350|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20047351|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047352|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047353|NCT03050619|Empagliflozin|empagliflozin|mesh-list
20047354|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20047355|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047356|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047357|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047358|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20047359|NCT03051100|Atorvastatin|atorvastatin|mesh-list
20047360|NCT03051100|Ezetimibe|ezetimibe|mesh-list
20047361|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20047362|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20047363|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
20047364|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047365|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20047366|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20047367|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047368|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047369|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047370|NCT03051256|Methadone|methadone|mesh-list
20047371|NCT03051256|D-methadone|d-methadone|mesh-list
20047372|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20047373|NCT03051256|Narcotics|narcotics|mesh-ancestor
20047374|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576856|NCT02073916|Paclitaxel|paclitaxel|mesh-list
20047375|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047376|NCT03051256|Analgesics|analgesics|mesh-ancestor
20047377|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
20047378|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047379|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
20047380|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
20047381|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20047382|NCT03051620|Alendronate|alendronate|mesh-list
20047383|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20047384|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047385|NCT03051646|Aspirin|aspirin|mesh-list
20047386|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20047387|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20047388|NCT03051646|Analgesics|analgesics|mesh-ancestor
20047389|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
20047390|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047391|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047392|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047393|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20047394|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20047395|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20047396|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047397|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20047398|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20047399|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047400|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
20047401|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
20047402|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047403|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047404|NCT03052322|Adalimumab|adalimumab|mesh-list
20047405|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047406|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20047407|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
20047408|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20047409|NCT03052517|Growth Substances|growth substances|mesh-ancestor
20047410|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047411|NCT03052725|Reslizumab|reslizumab|mesh-list
20047412|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20047413|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
20047414|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
20047415|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047416|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
20047417|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047418|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
20047419|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20047420|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20047421|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20047422|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047423|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047424|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
20047425|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047426|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047427|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20047428|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047429|NCT03052816|Hydromorphone|hydromorphone|mesh-list
20047430|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20047431|NCT03052816|Narcotics|narcotics|mesh-ancestor
20047432|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047433|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047434|NCT03052816|Analgesics|analgesics|mesh-ancestor
20047435|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
20047436|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047437|NCT03053050|Selonsertib|selonsertib|mesh-list
20047438|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20047439|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047440|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047441|NCT03053063|Selonsertib|selonsertib|mesh-list
20047442|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20047443|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047444|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047445|NCT03053401|Anesthetics|anesthetics|mesh-list
20047446|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
20047447|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047448|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047449|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
20047450|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047451|NCT03053427|Gabapentin|gabapentin|mesh-list
20047452|NCT03053427|Analgesics|analgesics|mesh-ancestor
20047453|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
20047454|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047455|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047456|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
20047457|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20047458|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20047459|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047460|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047461|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20047462|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20047463|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047464|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047465|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
20047466|NCT03054103|Midazolam|midazolam|mesh-list
20047467|NCT03054103|Ketamine|ketamine|mesh-list
20047468|NCT03054103|Analgesics|analgesics|mesh-ancestor
20047469|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
20047470|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047471|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047472|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20047473|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20047474|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
20047475|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
20047476|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047477|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20047478|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20047479|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047480|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047481|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20047482|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20047483|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20047484|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20047485|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047486|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
20047487|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
20047488|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20047489|NCT03054506|Laxatives|laxatives|mesh-ancestor
20047490|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047491|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
20047492|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
20047493|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
20047494|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047495|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047496|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
20047497|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047498|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
20047499|NCT03054805|Antacids|antacids|mesh-ancestor
20047500|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047501|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047502|NCT03054844|Lidocaine|lidocaine|mesh-list
20047503|NCT03054844|Midazolam|midazolam|mesh-list
20047504|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
20047505|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
20047506|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047507|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047508|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
20047509|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047510|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20047511|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20047512|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20047513|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047514|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047515|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20047516|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20047517|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20047518|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20047519|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047520|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20047521|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
20047522|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
20047523|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
20047524|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047525|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
20047526|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20047527|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047528|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047529|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20047530|NCT03054857|Analgesics|analgesics|mesh-ancestor
20047531|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
20047532|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047533|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20047534|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20047535|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20047536|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
20047537|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047538|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047539|NCT03054870|Xenon|xenon|mesh-list
20047540|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20047541|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
20047542|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
20047543|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047544|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047545|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
20047546|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20047547|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20047548|NCT03055221|Treprostinil|treprostinil|mesh-list
20047549|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20047550|NCT03055338|Risperidone|risperidone|mesh-list
20047551|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20047552|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
20047553|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047554|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047555|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047556|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20047557|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20047558|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047559|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047560|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20047561|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
20047562|NCT03055936|Levodopa|levodopa|mesh-list
20047563|NCT03055936|Carbidopa|carbidopa|mesh-list
20047564|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20047565|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20047566|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
20047567|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047568|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047569|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047570|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20047571|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047572|NCT03055988|Fluticasone|fluticasone|mesh-list
20047573|NCT03055988|Xhance|xhance|mesh-list
20047574|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
20047575|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20047576|NCT03055988|Olodaterol|olodaterol|mesh-list
20047577|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047578|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20047579|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
20047580|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047581|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047582|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20047583|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
20047584|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
20047585|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20047586|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
20047587|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20047588|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
20047589|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047590|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047591|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20047592|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20047593|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20047594|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
20047595|NCT03056040|Eculizumab|eculizumab|mesh-list
20047596|NCT03056040|Ravulizumab|ravulizumab|mesh-list
20047597|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20047598|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047599|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
20047600|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047601|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
20047602|NCT03056352|Promethazine|promethazine|mesh-list
20047603|NCT03056352|Metoclopramide|metoclopramide|mesh-list
20576857|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20576858|NCT02073916|Trastuzumab|trastuzumab|mesh-list
20576859|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20576860|NCT02073916|Lapatinib|lapatinib|mesh-list
20576861|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20576862|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576863|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
20047604|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20047605|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20047606|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047607|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047608|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
20047609|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
20047610|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
20047611|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047612|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
20047613|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
20047614|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047615|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20047616|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
20047617|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
20047618|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047619|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047620|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20047621|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
20047622|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
20047623|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20047624|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20047625|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
20047626|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
20047627|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047628|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047629|NCT03057132|Protective Agents|protective agents|mesh-list
20047630|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047631|NCT03057366|Paclitaxel|paclitaxel|mesh-list
20047632|NCT03057366|Docetaxel|docetaxel|mesh-list
20047633|NCT03057366|Carboplatin|carboplatin|mesh-list
20047634|NCT03057366|Pevonedistat|pevonedistat|mesh-list
20047635|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20047636|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047637|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
20047638|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
20047639|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
20047640|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047641|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047642|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
20047643|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047644|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047645|NCT03057704|Lidocaine|lidocaine|mesh-list
20047646|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
20047647|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
20047648|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047649|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047650|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
20047651|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047652|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20047653|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20047654|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20047655|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047656|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047657|NCT03057977|Empagliflozin|empagliflozin|mesh-list
20047658|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20047659|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047660|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047661|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047662|NCT03058692|Vaccines|vaccines|mesh-list
20047663|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
20047664|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047665|NCT03060447|Vesatolimod|vesatolimod|mesh-list
20047666|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
20047667|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047668|NCT03060486|Hybenx|hybenx|mesh-list
20047669|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
20047670|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
20047671|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047672|NCT03060512|Naloxegol|naloxegol|mesh-list
20047673|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20047674|NCT03060512|Laxatives|laxatives|mesh-ancestor
20047675|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047676|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20047677|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047678|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
20047679|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047680|NCT03061188|Nivolumab|nivolumab|mesh-list
20047681|NCT03061188|Veliparib|veliparib|mesh-list
20047682|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047683|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047684|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20047685|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047686|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20047687|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047688|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20047689|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047690|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047691|NCT03061214|Incretins|incretins|mesh-ancestor
20047692|NCT03061214|Hormones|hormones|mesh-ancestor
20047693|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047694|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20047695|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
20047696|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047697|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047698|NCT03061331|Ivacaftor|ivacaftor|mesh-list
20047699|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20047700|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047701|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047702|NCT03061812|Dexamethasone|dexamethasone|mesh-list
20047703|NCT03061812|Topotecan|topotecan|mesh-list
20047704|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047705|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
20047706|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
20047707|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047708|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047709|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20047710|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
20047711|NCT03061812|Hormones|hormones|mesh-ancestor
20047712|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047713|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20047714|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047715|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20047716|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20047717|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047718|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047719|NCT03062488|Acetaminophen|acetaminophen|mesh-list
20047720|NCT03062488|Fentanyl|fentanyl|mesh-list
20047721|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20047722|NCT03062488|Narcotics|narcotics|mesh-ancestor
20047723|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047724|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047725|NCT03062488|Analgesics|analgesics|mesh-ancestor
20047726|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
20047727|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047728|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20047729|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20047730|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
20047731|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
20047732|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20047733|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
20047734|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
20047735|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20047736|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047737|NCT03063086|Fluticasone|fluticasone|mesh-list
20047738|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20047739|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047740|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20047741|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
20047742|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047743|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047744|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20047745|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
20047746|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
20047747|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20047748|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20047749|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20047750|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20047751|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
20047752|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047753|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047754|NCT03063255|Anesthetics|anesthetics|mesh-list
20047755|NCT03063255|Mepivacaine|mepivacaine|mesh-list
20047756|NCT03063255|Rocuronium|rocuronium|mesh-list
20047757|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047758|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047759|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20047760|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20047761|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20047762|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047763|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
20047764|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
20047765|NCT03065179|Nivolumab|nivolumab|mesh-list
20047766|NCT03065179|Ipilimumab|ipilimumab|mesh-list
20047767|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047768|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047769|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20047770|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047771|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
20047772|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047773|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047774|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
20047775|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20047776|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047777|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047778|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20047779|NCT03065530|Analgesics|analgesics|mesh-ancestor
20047780|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
20047781|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047782|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20047783|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20047784|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20047785|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
20047786|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047787|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047788|NCT03066193|Palmidrol|palmidrol|mesh-list
20047789|NCT03066193|Dronabinol|dronabinol|mesh-list
20047790|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
20047791|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047792|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047793|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20047794|NCT03066193|Analgesics|analgesics|mesh-ancestor
20047795|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
20047796|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047797|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20047798|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20047799|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047800|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047801|NCT03066193|Hormones|hormones|mesh-ancestor
20047802|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047803|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20047804|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047805|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20047806|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
20047807|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047808|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20047809|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
20047810|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047811|NCT03066778|Carboplatin|carboplatin|mesh-list
20047812|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
20047813|NCT03066778|Etoposide|etoposide|mesh-list
20047814|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047815|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047816|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20047817|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20047818|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20047819|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047820|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047821|NCT03066804|Valsartan|valsartan|mesh-list
20047822|NCT03066804|Enalapril|enalapril|mesh-list
20047823|NCT03066804|Enalaprilat|enalaprilat|mesh-list
20047824|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20047825|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20047826|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20047827|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20047828|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047829|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20047830|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
20047831|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047832|NCT03066830|Metformin|metformin|mesh-list
20047833|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20047834|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047835|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047836|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20047837|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047838|NCT03066947|Interferons|interferons|mesh-list
20047839|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
20047840|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
20047841|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
20047842|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047843|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
20047844|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047845|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20047846|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20047847|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
20047848|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047849|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047850|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20047851|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
20047852|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047853|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20047854|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20047855|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
20047856|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047857|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20047858|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047859|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20047860|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047861|NCT03068312|Ivacaftor|ivacaftor|mesh-list
20047862|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20047863|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047864|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047865|NCT03068455|Nivolumab|nivolumab|mesh-list
20047866|NCT03068455|Ipilimumab|ipilimumab|mesh-list
20047867|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20047868|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047869|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20047870|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047871|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20047872|NCT03068754|Hormones|hormones|mesh-ancestor
20047873|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20047874|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047875|NCT03068767|Vitamin D|vitamin d|mesh-list
20047876|NCT03068767|Vitamins|vitamins|mesh-ancestor
20047877|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
20047878|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047879|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20047880|NCT03068897|Ibuprofen|ibuprofen|mesh-list
20047881|NCT03068897|Tizanidine|tizanidine|mesh-list
20047882|NCT03068897|Baclofen|baclofen|mesh-list
20047883|NCT03068897|Metaxalone|metaxalone|mesh-list
20047884|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20047885|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20047886|NCT03068897|Analgesics|analgesics|mesh-ancestor
20047887|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
20047888|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047889|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576864|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
20047890|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20047891|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20047892|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20047893|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047894|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047895|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20047896|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20047897|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20047898|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
20047899|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
20047900|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047901|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
20047902|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
20047903|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
20047904|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20047905|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20047906|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20047907|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
20047908|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
20047909|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
20047910|NCT03069313|Vitamins|vitamins|mesh-ancestor
20047911|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
20047912|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047913|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
20047914|NCT03069313|Hematinics|hematinics|mesh-ancestor
20047915|NCT03069352|Cytarabine|cytarabine|mesh-list
20047916|NCT03069352|Venetoclax|venetoclax|mesh-list
20047917|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20047918|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
20047919|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047920|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047921|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
20047922|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047923|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20047924|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
20047925|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047926|NCT03069482|Nicotine|nicotine|mesh-list
20047927|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20047928|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
20047929|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20047930|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047931|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20047932|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20047933|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
20047934|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047935|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047936|NCT03069677|Midazolam|midazolam|mesh-list
20047937|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20047938|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20047939|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20047940|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047941|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20047942|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20047943|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20047944|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20047945|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
20047946|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
20047947|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
20047948|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
20047949|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20047950|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047951|NCT03070171|Dabigatran|dabigatran|mesh-list
20047952|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
20047953|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20047954|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
20047955|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047956|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047957|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
20047958|NCT03070470|Ritonavir|ritonavir|mesh-list
20047959|NCT03070470|Lopinavir|lopinavir|mesh-list
20047960|NCT03070470|Chloroquine|chloroquine|mesh-list
20293243|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20047961|NCT03070470|Verapamil|verapamil|mesh-list
20047962|NCT03070470|Dofetilide|dofetilide|mesh-list
20047963|NCT03070470|Diltiazem|diltiazem|mesh-list
20047964|NCT03070470|Ranolazine|ranolazine|mesh-list
20047965|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20047966|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20047967|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
20047968|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20047969|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20047970|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20047971|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20047972|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
20047973|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20047974|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20047975|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20047976|NCT03070470|Amebicides|amebicides|mesh-ancestor
20047977|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20047978|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20047979|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
20047980|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20047981|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047982|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20047983|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20047984|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20047985|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20047986|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
20047987|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20047988|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20047989|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20047990|NCT03070483|Vitamin D|vitamin d|mesh-list
20047991|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
20047992|NCT03070483|Vitamins|vitamins|mesh-ancestor
20047993|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
20047994|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20047995|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20047996|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20047997|NCT03070548|Talazoparib|talazoparib|mesh-list
20047998|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20047999|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048000|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048001|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048002|NCT03070730|Atenolol|atenolol|mesh-list
20576865|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
20576866|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576867|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048003|NCT03070730|Droxidopa|droxidopa|mesh-list
20048004|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20048005|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20048006|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
20048007|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
20048008|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048009|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048010|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20048011|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20048012|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20048013|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048014|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048015|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048016|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20048017|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20048018|NCT03071094|Nivolumab|nivolumab|mesh-list
20048019|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048020|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048021|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20048022|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048023|NCT03071263|Spironolactone|spironolactone|mesh-list
20048024|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20048025|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
20048026|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048027|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048028|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20048029|NCT03071263|Diuretics|diuretics|mesh-ancestor
20048030|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
20048031|NCT03071276|Vidarabine|vidarabine|mesh-list
20048032|NCT03071276|Cytarabine|cytarabine|mesh-list
20048033|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
20048034|NCT03071276|Methotrexate|methotrexate|mesh-list
20048035|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
20048036|NCT03071276|Fludarabine|fludarabine|mesh-list
20048037|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20048038|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
20048039|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20048040|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048041|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20048042|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
20048043|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048044|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048045|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048046|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048047|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20048048|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20048049|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
20048050|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048051|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20048052|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
20048053|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048054|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048055|NCT03071744|Fentanyl|fentanyl|mesh-list
20048056|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20048057|NCT03071744|Narcotics|narcotics|mesh-ancestor
20048058|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048059|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048060|NCT03071744|Analgesics|analgesics|mesh-ancestor
20048061|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
20048062|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048063|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20048064|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20048065|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
20048066|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
20048067|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
20048068|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048069|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048070|NCT03072719|Fluorides|fluorides|mesh-list
20048071|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
20048072|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
20048073|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
20048074|NCT03072719|Protective Agents|protective agents|mesh-ancestor
20048075|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117660|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117661|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117662|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117663|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117664|NCT00005959|Prednisone|prednisone|mesh-list
20117665|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
20117666|NCT00005959|Rituximab|rituximab|mesh-list
20117667|NCT00005959|Doxorubicin|doxorubicin|mesh-list
20117668|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117669|NCT00005959|Vincristine|vincristine|mesh-list
20117670|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117671|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
20117672|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117673|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117674|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117675|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
20117676|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576868|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20576869|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576870|NCT02074137|Prednisone|prednisone|mesh-list
20576871|NCT02074137|Prednisolone|prednisolone|mesh-list
20117677|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117678|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117679|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20117680|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117681|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117682|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117683|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117684|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117685|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
20117686|NCT00005959|Hormones|hormones|mesh-ancestor
20117687|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117688|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20117689|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117690|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117691|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117692|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117693|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
20117694|NCT00005960|Docetaxel|docetaxel|mesh-list
20576872|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048076|NCT03073200|Etanercept|etanercept|mesh-list
20048077|NCT03073200|Ixekizumab|ixekizumab|mesh-list
20048078|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048079|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048080|NCT03073200|Analgesics|analgesics|mesh-ancestor
20048081|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
20048082|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048083|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048084|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048085|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048086|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048087|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20048088|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
20048089|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048090|NCT03073213|Ixekizumab|ixekizumab|mesh-list
20048091|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048092|NCT03073876|Donepezil|donepezil|mesh-list
20048093|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20048094|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048095|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048096|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
20048097|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048098|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048099|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
20048100|NCT03074162|Diclofenac|diclofenac|mesh-list
20048101|NCT03074162|Capsaicin|capsaicin|mesh-list
20048102|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048103|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048104|NCT03074162|Analgesics|analgesics|mesh-ancestor
20048105|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
20048106|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048107|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048108|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048109|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048110|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20048111|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048112|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048113|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
20048114|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048115|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
20048116|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20048117|NCT03074331|Velpatasvir|velpatasvir|mesh-list
20048118|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
20048119|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048120|NCT03074409|Oxytocin|oxytocin|mesh-list
20048121|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
20048122|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20048123|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048124|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
20048125|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20048126|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20048127|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20048128|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
20048129|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048130|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20048131|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20048132|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048133|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20048134|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20048135|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048136|NCT03075163|Ondansetron|ondansetron|mesh-list
20048137|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
20048138|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
20048139|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048140|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048141|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048142|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
20048143|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048144|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20048145|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
20048146|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048147|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048148|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20048149|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20048150|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048151|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20048152|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20048153|NCT03075267|Budesonide|budesonide|mesh-list
20048154|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
20048155|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
20048156|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048157|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20048158|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
20048159|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048160|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048161|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20048162|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
20048163|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
20048164|NCT03075267|Hormones|hormones|mesh-ancestor
20048165|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048166|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20048167|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20048168|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20048169|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048170|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048171|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048172|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20048173|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20048174|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20048175|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
20048176|NCT03075410|GSK656|gsk656|mesh-list
20048177|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20048178|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048179|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20048180|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048181|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048182|NCT03075553|Nivolumab|nivolumab|mesh-list
20048183|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048184|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048185|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20048186|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048187|NCT03075891|Doxycycline|doxycycline|mesh-list
20048188|NCT03075891|Ivermectin|ivermectin|mesh-list
20048189|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20048190|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048191|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
20048192|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20048193|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20048194|NCT03076970|Sumatriptan|sumatriptan|mesh-list
20048195|NCT03076970|Lasmiditan|lasmiditan|mesh-list
20048196|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20048197|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20048198|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20048199|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
20048200|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048201|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048202|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048203|NCT03077607|Itraconazole|itraconazole|mesh-list
20048204|NCT03077607|Rifampin|rifampin|mesh-list
20048205|NCT03077607|Talazoparib|talazoparib|mesh-list
20048206|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
20048207|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048208|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20048209|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20048210|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048211|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048212|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20048213|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
20048214|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048215|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048216|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20048217|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20048218|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
20048219|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20048220|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
20048221|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20048222|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20048223|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20048224|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20048225|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20048226|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20048227|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20048228|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20048229|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048230|NCT03077659|Paclitaxel|paclitaxel|mesh-list
20048231|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20048232|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048233|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
20048234|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
20048235|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
20048236|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048237|NCT03077711|Trimethoprim|trimethoprim|mesh-list
20048238|NCT03077711|Methenamine|methenamine|mesh-list
20048239|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
20048240|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
20048241|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20048242|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048243|NCT03077711|Renal Agents|renal agents|mesh-ancestor
20048244|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
20048245|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20048246|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20048247|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20048248|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048249|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048250|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20048251|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20048252|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20048253|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20048254|NCT03077919|Ropivacaine|ropivacaine|mesh-list
20048255|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
20048256|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
20048257|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048258|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048259|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
20048260|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048261|NCT03078075|Naltrexone|naltrexone|mesh-list
20048262|NCT03078075|Bupropion|bupropion|mesh-list
20048263|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20048264|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20048265|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048266|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
20048267|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048268|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20048269|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
20048270|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20048271|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20048272|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20048273|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048274|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048275|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
20048276|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048277|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20048278|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20048279|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048280|NCT03078556|Lamivudine|lamivudine|mesh-list
20048281|NCT03078556|Dolutegravir|dolutegravir|mesh-list
20048282|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20048283|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20048284|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048285|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048286|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
20048287|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048288|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20048289|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20048290|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20048291|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20048292|NCT03078907|Selexipag|selexipag|mesh-list
20048293|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20048294|NCT03078946|Midazolam|midazolam|mesh-list
20048295|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
20048296|NCT03078946|Morphine|morphine|mesh-list
20048297|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20293244|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
20293245|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
20048298|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048299|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048300|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048301|NCT03078946|Analgesics|analgesics|mesh-ancestor
20048302|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
20048303|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048304|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20048305|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20048306|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20048307|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048308|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048309|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048310|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20048311|NCT03078946|Narcotics|narcotics|mesh-ancestor
20048312|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20048313|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20048314|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20048315|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20048316|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20048317|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
20048318|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
20048319|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
20048320|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
20048321|NCT03080142|Bupivacaine|bupivacaine|mesh-list
20048322|NCT03080142|Ropivacaine|ropivacaine|mesh-list
20048323|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
20048324|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
20048325|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048326|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048327|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
20048328|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048329|NCT03080493|Acetaminophen|acetaminophen|mesh-list
20048330|NCT03080493|Ibuprofen|ibuprofen|mesh-list
20048331|NCT03080493|Gabapentin|gabapentin|mesh-list
20048332|NCT03080493|Codeine|codeine|mesh-list
20048333|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20048334|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048335|NCT03080493|Analgesics|analgesics|mesh-ancestor
20048336|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
20048337|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048338|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048339|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
20048340|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048341|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048342|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048343|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20048344|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048345|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048346|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
20048347|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20048348|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20048349|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048350|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20048351|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20048352|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20048353|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048354|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
20048355|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20048356|NCT03080493|Narcotics|narcotics|mesh-ancestor
20048357|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
20048358|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
20048359|NCT03080493|Laxatives|laxatives|mesh-ancestor
20048360|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048361|NCT03081117|Insulin|insulin|mesh-list
20048362|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20048363|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048364|NCT03082196|Fluorides|fluorides|mesh-list
20048365|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
20048366|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
20048367|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
20048368|NCT03082196|Protective Agents|protective agents|mesh-ancestor
20048369|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048370|NCT03083132|Modafinil|modafinil|mesh-list
20048371|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20048372|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048373|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20048374|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20048375|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20048376|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048377|NCT03083470|Paclitaxel|paclitaxel|mesh-list
20048378|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20048379|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048380|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20048381|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20048382|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20048383|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048384|NCT03083639|Esomeprazole|esomeprazole|mesh-list
20048385|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20048386|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048387|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20048388|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048389|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048390|NCT03083847|Chloroquine|chloroquine|mesh-list
20048391|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20048392|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
20048393|NCT03083847|Amebicides|amebicides|mesh-ancestor
20048394|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20048395|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20048396|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048397|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
20048398|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048399|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048400|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048401|NCT03083847|Analgesics|analgesics|mesh-ancestor
20048402|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
20048403|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048404|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048405|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048406|NCT03083847|Filaricides|filaricides|mesh-ancestor
20048407|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
20048408|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
20048409|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20048410|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048411|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048412|NCT03083990|Bevacizumab|bevacizumab|mesh-list
20048413|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048414|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048415|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20048416|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20048417|NCT03083990|Growth Substances|growth substances|mesh-ancestor
20048418|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048419|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20048420|NCT03084315|Nicotine|nicotine|mesh-list
20048421|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20048422|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
20048423|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048424|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048425|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20048426|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20048427|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
20048428|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048429|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048430|NCT03084796|Bromides|bromides|mesh-list
20048431|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
20048432|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20048433|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
20048434|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048435|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048436|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20048437|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
20048438|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
20048439|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20048440|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
20048441|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048442|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048443|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
20048444|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
20048445|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048446|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048447|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20048448|NCT03085914|Leucovorin|leucovorin|mesh-list
20048449|NCT03085914|Gemcitabine|gemcitabine|mesh-list
20048450|NCT03085914|Paclitaxel|paclitaxel|mesh-list
20048451|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20048452|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
20048453|NCT03085914|Carboplatin|carboplatin|mesh-list
20048454|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
20048455|NCT03085914|Fluorouracil|fluorouracil|mesh-list
20048456|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
20048457|NCT03085914|Pemetrexed|pemetrexed|mesh-list
20048458|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20048459|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048460|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
20048461|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
20048462|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
20048463|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048464|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20048465|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
20048466|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048467|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048468|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20048469|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
20048470|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20048471|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20048472|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
20048473|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
20048474|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048475|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048476|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048477|NCT03085914|Antidotes|antidotes|mesh-ancestor
20048478|NCT03085914|Protective Agents|protective agents|mesh-ancestor
20048479|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
20048480|NCT03085914|Vitamins|vitamins|mesh-ancestor
20048481|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
20048482|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20048483|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20048484|NCT03086213|Lidocaine|lidocaine|mesh-list
20048485|NCT03086213|Sufentanil|sufentanil|mesh-list
20048486|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
20048487|NCT03086213|Dsuvia|dsuvia|mesh-list
20048488|NCT03086213|Ropivacaine|ropivacaine|mesh-list
20048489|NCT03086213|Propofol|propofol|mesh-list
20048490|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
20048491|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
20048492|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048493|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048494|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
20048495|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048496|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20048497|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20048498|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20048499|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048500|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048501|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20048502|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20048503|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
20048504|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048505|NCT03086213|Analgesics|analgesics|mesh-ancestor
20048506|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20048507|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20048508|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20048509|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048510|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048511|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20048512|NCT03086213|Narcotics|narcotics|mesh-ancestor
20048513|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20048514|NCT03086343|Abatacept|abatacept|mesh-list
20048515|NCT03086343|Upadacitinib|upadacitinib|mesh-list
20048516|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20048517|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048518|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048519|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20048520|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
20048521|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048522|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048523|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20048524|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20048525|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048526|NCT03086356|Dabigatran|dabigatran|mesh-list
20048527|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
20048528|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20048529|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
20048530|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048531|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048532|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
20048533|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
20048534|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20048535|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
20048536|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048537|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048538|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20048539|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
20048540|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20048541|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20048542|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20048543|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048544|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048545|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117695|NCT00005960|Doxorubicin|doxorubicin|mesh-list
20117696|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117697|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117698|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
20117699|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117700|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117701|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117702|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
20117703|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117704|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117705|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117706|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117707|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117708|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117709|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117710|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117711|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117712|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117713|NCT00005961|Carmustine|carmustine|mesh-list
20117714|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20117715|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117716|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
20117717|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117718|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117719|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117720|NCT00005962|Cytarabine|cytarabine|mesh-list
20117721|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
20117722|NCT00005962|Topotecan|topotecan|mesh-list
20117723|NCT00005962|Daunorubicin|daunorubicin|mesh-list
20117724|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
20117725|NCT00005962|Sargramostim|sargramostim|mesh-list
20117726|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117727|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
20117728|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117729|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117730|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117731|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
20117732|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117733|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117734|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117735|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117736|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
20117737|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
20117738|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117739|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117740|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117741|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117742|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117743|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117744|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20117745|NCT00005963|Carboplatin|carboplatin|mesh-list
20117746|NCT00005963|Docetaxel|docetaxel|mesh-list
20117747|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117748|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117749|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117750|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117751|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117752|NCT00005964|Prednisone|prednisone|mesh-list
20048546|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
20048547|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048548|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048549|NCT03087604|Lidocaine|lidocaine|mesh-list
20048550|NCT03087604|Epinephrine|epinephrine|mesh-list
20048551|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
20048552|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
20048553|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048554|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048555|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
20048556|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048557|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20048558|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20048559|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20048560|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048561|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048562|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20048563|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20048564|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048565|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048566|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20048567|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20048568|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
20048569|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20048570|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
20048571|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
20048572|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
20048573|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20048574|NCT03087786|Nicotine|nicotine|mesh-list
20048575|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20048576|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
20048577|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048578|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048579|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20048580|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20048581|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
20048582|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048583|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048584|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
20048585|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20048586|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048587|NCT03088267|Amphetamine|amphetamine|mesh-list
20048588|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20048589|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048590|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
20048591|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
20048592|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048593|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
20048594|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048595|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048596|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048597|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20048598|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20048599|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048600|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20048601|NCT03088345|Vasopressins|vasopressins|mesh-list
20048602|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
20048603|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
20048604|NCT03088345|Coagulants|coagulants|mesh-ancestor
20048605|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20048606|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20048607|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
20048608|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048609|NCT03088800|Ibuprofen|ibuprofen|mesh-list
20048610|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048611|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048612|NCT03088800|Analgesics|analgesics|mesh-ancestor
20048613|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
20048614|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048615|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048616|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048617|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048618|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20048619|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117753|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
20048620|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048621|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
20048622|NCT03089216|Calcium|calcium|mesh-list
20048623|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20048624|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048625|NCT03089216|Antacids|antacids|mesh-ancestor
20048626|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048627|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048628|NCT03090620|Lorazepam|lorazepam|mesh-list
20048629|NCT03090620|Physostigmine|physostigmine|mesh-list
20048630|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
20048631|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
20048632|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
20048633|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048634|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048635|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048636|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20048637|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048638|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20048639|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20048640|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20048641|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
20048642|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
20048643|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048644|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048645|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20048646|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048647|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
20048648|NCT03090620|Miotics|miotics|mesh-ancestor
20048649|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
20048650|NCT03091348|Testosterone|testosterone|mesh-list
20048651|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
20048652|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
20048653|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20048654|NCT03091348|Androgens|androgens|mesh-ancestor
20048655|NCT03091348|Hormones|hormones|mesh-ancestor
20048656|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048657|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048658|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20048659|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048660|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
20048661|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20048662|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20048663|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20048664|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048665|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048666|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048667|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048668|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048669|NCT03091439|Dalbavancin|dalbavancin|mesh-list
20048670|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20048671|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048672|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
20048673|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048674|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048675|NCT03091673|Glucagon|glucagon|mesh-list
20048676|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20048677|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048678|NCT03091673|Hormones|hormones|mesh-ancestor
20048679|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048680|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048681|NCT03091673|Incretins|incretins|mesh-ancestor
20048682|NCT03091777|Metronidazole|metronidazole|mesh-list
20048683|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048684|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20048685|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20048686|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20048687|NCT03091920|Praliciguat|praliciguat|mesh-list
20048688|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20048689|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
20048690|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048691|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048692|NCT03092375|Ribavirin|ribavirin|mesh-list
19491504|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048693|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
20117754|NCT00005964|Doxorubicin|doxorubicin|mesh-list
20048694|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048695|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
20048696|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048697|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20048698|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048699|NCT03093207|Aspirin|aspirin|mesh-list
20048700|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048701|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048702|NCT03093207|Analgesics|analgesics|mesh-ancestor
20048703|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
20048704|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048705|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048706|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048707|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048708|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20048709|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20048710|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048711|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20048712|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20048713|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048714|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
20048715|NCT03093272|Prednisone|prednisone|mesh-list
20048716|NCT03093272|Docetaxel|docetaxel|mesh-list
20048717|NCT03093272|Leuprolide|leuprolide|mesh-list
20048718|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048719|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
20048720|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
20048721|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
20048722|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048723|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048724|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
20048725|NCT03093272|Hormones|hormones|mesh-ancestor
20048726|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048727|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048728|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20048729|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20048730|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
20048731|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20048732|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20048733|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048734|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20048735|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
20048736|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048737|NCT03093415|Grazoprevir|grazoprevir|mesh-list
20048738|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
20048739|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048740|NCT03093870|Capecitabine|capecitabine|mesh-list
20048741|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20048742|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
20048743|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048744|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048745|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20048746|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048747|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048748|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20048749|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
20048750|NCT03094637|Azacitidine|azacitidine|mesh-list
20048751|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048752|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048753|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20048754|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
20048755|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048756|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048757|NCT03095118|Daratumumab|daratumumab|mesh-list
20048758|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048759|NCT03095508|Menthol|menthol|mesh-list
20048760|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
20048761|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048762|NCT03095521|Menthol|menthol|mesh-list
20048763|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
20048764|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
20048765|NCT03095638|Dolutegravir|dolutegravir|mesh-list
19749285|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
20048766|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20048767|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20048768|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117755|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20048769|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048770|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20048771|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20048772|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
20048773|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048774|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
20048775|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20048776|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048777|NCT03096314|Vitamin D|vitamin d|mesh-list
20048778|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
20576873|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
20576874|NCT02074137|Hormones|hormones|mesh-ancestor
20576875|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576876|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576877|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20576878|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576879|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20576880|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20576881|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20576882|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576883|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576884|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20048779|NCT03096314|Vitamins|vitamins|mesh-ancestor
20048780|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
20048781|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048782|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20048783|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20048784|NCT03096353|Naloxone|naloxone|mesh-list
20048785|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20048786|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048787|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
20048788|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048789|NCT03096444|Lidocaine|lidocaine|mesh-list
20048790|NCT03096444|Ketamine|ketamine|mesh-list
20048791|NCT03096444|Amitriptyline|amitriptyline|mesh-list
20048792|NCT03096444|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20048793|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
20048794|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
20048795|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048796|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048797|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
20048798|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048799|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20048800|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20048801|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20048802|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048803|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048804|NCT03096444|Analgesics|analgesics|mesh-ancestor
20048805|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20048806|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20048807|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
20048808|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20048809|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20048810|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048811|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20048812|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
20048813|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20048814|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048815|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20048816|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20048817|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048818|NCT03096444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20048819|NCT03096444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20048820|NCT03096730|Sufentanil|sufentanil|mesh-list
20048821|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
20048822|NCT03096730|Remifentanil|remifentanil|mesh-list
20048823|NCT03096730|Dsuvia|dsuvia|mesh-list
20048824|NCT03096730|Nalmefene|nalmefene|mesh-list
20048825|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20048826|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048827|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048828|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048829|NCT03096730|Analgesics|analgesics|mesh-ancestor
20048830|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
20048831|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048832|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20048833|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20048834|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20048835|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
20048836|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048837|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048838|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20048839|NCT03096730|Narcotics|narcotics|mesh-ancestor
20048840|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20048841|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20048842|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
20048843|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
20048844|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20048845|NCT03096847|Letrozole|letrozole|mesh-list
20048846|NCT03096847|Goserelin|goserelin|mesh-list
20048847|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048848|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20048849|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20048850|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048851|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048852|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20048853|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
20048854|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048855|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048856|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20048857|NCT03097133|Esketamine|esketamine|mesh-list
20048858|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
20048859|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20048860|NCT03097315|Triamcinolone|triamcinolone|mesh-list
20048861|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20048862|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20048863|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20048864|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048865|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
20048866|NCT03097315|Hormones|hormones|mesh-ancestor
20048867|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048868|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048869|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20048870|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
20048871|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048872|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048873|NCT03097588|Palonosetron|palonosetron|mesh-list
20048874|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
20048875|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
20048876|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048877|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048878|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048879|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20048880|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20048881|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
20048882|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20048883|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048884|NCT03097783|Lidocaine|lidocaine|mesh-list
20048885|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
20048886|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
20048887|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048888|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048889|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
20048890|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048891|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20048892|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20048893|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20048894|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048895|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048896|NCT03097861|Lubiprostone|lubiprostone|mesh-list
20048897|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20048898|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048899|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048900|NCT03098030|Irinotecan|irinotecan|mesh-list
20048901|NCT03098030|Topotecan|topotecan|mesh-list
20048902|NCT03098030|Dinutuximab|dinutuximab|mesh-list
20048903|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20048904|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20048905|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048906|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048907|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048908|NCT03098420|Dexamethasone|dexamethasone|mesh-list
20048909|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
20048910|NCT03098420|Morphine|morphine|mesh-list
20048911|NCT03098420|Bupivacaine|bupivacaine|mesh-list
20048912|NCT03098420|Ropivacaine|ropivacaine|mesh-list
20048913|NCT03098420|BB 1101|bb 1101|mesh-list
20048914|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048915|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
20048916|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
20048917|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048918|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048919|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048920|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
20048921|NCT03098420|Hormones|hormones|mesh-ancestor
20048922|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20048923|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20048924|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048925|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
20048926|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048927|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048928|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
20048929|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
20048930|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20048931|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
20048932|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20048933|NCT03098420|Narcotics|narcotics|mesh-ancestor
20048934|NCT03098420|Analgesics|analgesics|mesh-ancestor
20048935|NCT03098550|Nivolumab|nivolumab|mesh-list
20048936|NCT03098550|Daratumumab|daratumumab|mesh-list
20048937|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048938|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048939|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20048940|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048941|NCT03098615|Efinaconazole|efinaconazole|mesh-list
20048942|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
20048943|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20048944|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
20048945|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20048946|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048947|NCT03099187|Pirfenidone|pirfenidone|mesh-list
20048948|NCT03099187|Analgesics|analgesics|mesh-ancestor
20048949|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
20048950|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048951|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048952|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048953|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048954|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20576885|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576886|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048955|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048956|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20048957|NCT03099538|Ixekizumab|ixekizumab|mesh-list
20048958|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117756|NCT00005964|Etoposide|etoposide|mesh-list
20117757|NCT00005964|Vincristine|vincristine|mesh-list
20117758|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117759|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
20117760|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117761|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117762|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117763|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
20117764|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117765|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117766|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117767|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117768|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117769|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117770|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117771|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117772|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
20117773|NCT00005964|Hormones|hormones|mesh-ancestor
20117774|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117775|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20048959|NCT03100058|Licogliflozin|licogliflozin|mesh-list
20048960|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20048961|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048962|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20048963|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048964|NCT03100123|Aspirin|aspirin|mesh-list
20048965|NCT03100123|Heparin|heparin|mesh-list
20048966|NCT03100123|Enoxaparin|enoxaparin|mesh-list
20048967|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20048968|NCT03100123|Tinzaparin|tinzaparin|mesh-list
20048969|NCT03100123|Dalteparin|dalteparin|mesh-list
20048970|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20048971|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20048972|NCT03100123|Analgesics|analgesics|mesh-ancestor
20048973|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
20048974|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20048975|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048976|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20048977|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20048978|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20048979|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20048980|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048981|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20048982|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20048983|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048984|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
20048985|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
20048986|NCT03100838|Nifedipine|nifedipine|mesh-list
20048987|NCT03100838|Omeprazole|omeprazole|mesh-list
20048988|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20048989|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20048990|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20048991|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20048992|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20048993|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20048994|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20048995|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20048996|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20048997|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
20048998|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
20048999|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20049000|NCT03101033|Betamethasone|betamethasone|mesh-list
20049001|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
20049002|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20049003|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
20049004|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20049005|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049006|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
20049007|NCT03101033|Hormones|hormones|mesh-ancestor
20049008|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049009|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049010|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20049011|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049012|NCT03101111|Vaccines|vaccines|mesh-list
20576887|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
20576888|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049013|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
20049014|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049015|NCT03101150|Vitamin D|vitamin d|mesh-list
20049016|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
20049017|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
20049018|NCT03101150|Vitamins|vitamins|mesh-list
20049019|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
20049020|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049021|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20049022|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20049023|NCT03101358|Paclitaxel|paclitaxel|mesh-list
20049024|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20049025|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20049026|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049027|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
20049028|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
20576889|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20576890|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20049029|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
20293246|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
20576891|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20576892|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576893|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576894|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20576895|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576896|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576897|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
20576898|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576899|NCT02074189|Gemcitabine|gemcitabine|mesh-list
20049030|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049031|NCT03101371|Iodine|iodine|mesh-list
20049032|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
20049033|NCT03101371|Povidone|povidone|mesh-list
20049034|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20049035|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049036|NCT03101371|Trace Elements|trace elements|mesh-ancestor
20049037|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
20049038|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049039|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
20049040|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
20049041|NCT03101462|Vaccines|vaccines|mesh-list
20049042|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
20049043|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049044|NCT03102190|Verapamil|verapamil|mesh-list
20049045|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049046|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20049047|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049048|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049049|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20049050|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049051|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
20049052|NCT03102645|Imipramine|imipramine|mesh-list
20049053|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20049054|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
20049055|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20049056|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20049057|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20049058|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049059|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049060|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
20049061|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049062|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049063|NCT03102710|Lidocaine|lidocaine|mesh-list
20049064|NCT03102710|Capsaicin|capsaicin|mesh-list
20049065|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049066|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
20049067|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049068|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049069|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
20049070|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049071|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049072|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049073|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049074|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049075|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049076|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
20049077|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049078|NCT03102736|Nitroprusside|nitroprusside|mesh-list
20049079|NCT03102736|Ketamine|ketamine|mesh-list
20049080|NCT03102736|Analgesics|analgesics|mesh-ancestor
20049081|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
20049082|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049083|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049084|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20049085|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20049086|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
20049087|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
20049088|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049089|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20049090|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20049091|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049092|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049093|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20049094|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
20049095|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20049096|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
20049097|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20049098|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20049099|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20049100|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049101|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049102|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
20049103|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049104|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049105|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20049106|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049107|NCT03102918|Cannabidiol|cannabidiol|mesh-list
20049108|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
20049109|NCT03103061|Regadenoson|regadenoson|mesh-list
20049110|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20049111|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20049112|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
20049113|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
20049114|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049115|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049116|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049117|NCT03103100|Lidocaine|lidocaine|mesh-list
20049118|NCT03103100|Bupivacaine|bupivacaine|mesh-list
20049119|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049120|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
20049121|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049122|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049123|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
20049124|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049125|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049126|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049127|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049128|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049129|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049130|NCT03103763|Warfarin|warfarin|mesh-list
20049131|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
20049132|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
20049133|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20049134|NCT03103906|Protective Agents|protective agents|mesh-ancestor
20049135|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049136|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049137|NCT03103919|Rotigotine|rotigotine|mesh-list
20049138|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
20049139|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
20049140|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049141|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049142|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049143|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
20049144|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20049145|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
20049146|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049147|NCT03104725|Expectorants|expectorants|mesh-ancestor
20049148|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049149|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20049150|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
20049151|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049152|NCT03104725|Protective Agents|protective agents|mesh-ancestor
20049153|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049154|NCT03104725|Antidotes|antidotes|mesh-ancestor
20049155|NCT03104738|Insulin|insulin|mesh-list
20049156|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049157|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049158|NCT03104816|Acetaminophen|acetaminophen|mesh-list
20049159|NCT03104816|Hydromorphone|hydromorphone|mesh-list
20049160|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20049161|NCT03104816|Analgesics|analgesics|mesh-ancestor
20049162|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
20049163|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049164|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049165|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
20049166|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20049167|NCT03104816|Narcotics|narcotics|mesh-ancestor
20049168|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049169|NCT03105479|Vancomycin|vancomycin|mesh-list
20049170|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20049171|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049172|NCT03105518|Acetaminophen|acetaminophen|mesh-list
20049173|NCT03105518|Fentanyl|fentanyl|mesh-list
20049174|NCT03105518|Oxycodone|oxycodone|mesh-list
20049175|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20049176|NCT03105518|Narcotics|narcotics|mesh-ancestor
20049177|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049178|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049179|NCT03105518|Analgesics|analgesics|mesh-ancestor
20049180|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
20049181|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049182|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20049183|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20049184|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
20049185|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
20049186|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20049187|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
20049188|NCT03106077|Maytansine|maytansine|mesh-list
20049189|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20049190|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049191|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
20049192|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
20049193|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
20049194|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049195|NCT03106753|Bupivacaine|bupivacaine|mesh-list
20049196|NCT03106753|Terbutaline|terbutaline|mesh-list
20049197|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049198|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
20049199|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049200|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049201|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
20049202|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049203|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20049204|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
20049205|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20049206|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049207|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
20049208|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
20049209|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20049210|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20049211|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20049212|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20049213|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
20049214|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049215|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049216|NCT03106870|Insulin|insulin|mesh-list
20049217|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20049218|NCT03106870|Metformin|metformin|mesh-list
20049219|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
20049220|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049221|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049222|NCT03107091|Terlipressin|terlipressin|mesh-list
20049223|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20049224|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20049225|NCT03107754|Lidocaine|lidocaine|mesh-list
20049226|NCT03107754|Anesthetics|anesthetics|mesh-list
20049227|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049228|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049229|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049230|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
20049231|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049232|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049233|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049234|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049235|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049236|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049237|NCT03107793|Ustekinumab|ustekinumab|mesh-list
20049238|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049239|NCT03108482|Celecoxib|celecoxib|mesh-list
20049240|NCT03108482|Tramadol|tramadol|mesh-list
20049241|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20049242|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20049243|NCT03108482|Analgesics|analgesics|mesh-ancestor
20049244|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
20049245|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049246|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049247|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049248|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20049249|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20049250|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20049251|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049252|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049253|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20049254|NCT03108482|Narcotics|narcotics|mesh-ancestor
20049255|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049256|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20049257|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049258|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049259|NCT03108521|Incretins|incretins|mesh-ancestor
20049260|NCT03108521|Hormones|hormones|mesh-ancestor
20049261|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049262|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20049263|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
20049264|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049265|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049266|NCT03109015|Sunitinib|sunitinib|mesh-list
20049267|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049268|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20049269|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20049270|NCT03109015|Growth Substances|growth substances|mesh-ancestor
20049271|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049272|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
20049273|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20049274|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049275|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049276|NCT03110003|Bupivacaine|bupivacaine|mesh-list
20049277|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049278|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
20049279|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049280|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049281|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
20049282|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049283|NCT03110029|Efinaconazole|efinaconazole|mesh-list
20049284|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
20049285|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049286|NCT03110562|Dexamethasone|dexamethasone|mesh-list
20049287|NCT03110562|Bortezomib|bortezomib|mesh-list
20049288|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049289|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
20049290|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
20049291|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049292|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049293|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049294|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
20049295|NCT03110562|Hormones|hormones|mesh-ancestor
20049296|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049297|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20049298|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049299|NCT03111108|Grazoprevir|grazoprevir|mesh-list
20049300|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
20049301|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049302|NCT03111316|Dinoprostone|dinoprostone|mesh-list
20049303|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
20049304|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20049305|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049306|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20049307|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20049308|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20049309|NCT03111381|Analgesics|analgesics|mesh-ancestor
20049310|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
20049311|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049312|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049313|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049314|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20049315|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20049316|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049317|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049318|NCT03111628|Omalizumab|omalizumab|mesh-list
20049319|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20049320|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20049321|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049322|NCT03112863|Vitamin A|vitamin a|mesh-list
20049323|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
20049324|NCT03112863|Vitamins|vitamins|mesh-ancestor
20049325|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
20049326|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049327|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
20049328|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049329|NCT03112863|Protective Agents|protective agents|mesh-ancestor
20049330|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20049331|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049332|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20049333|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
20049334|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20049335|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20049336|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049337|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20049338|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
20049339|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049340|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049341|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
20049342|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20049343|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
20049344|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049345|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049346|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
20049347|NCT03114969|Hormones|hormones|mesh-ancestor
20049348|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049349|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
20049350|NCT03114995|Tirofiban|tirofiban|mesh-list
20049351|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20049352|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20049353|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049354|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20049355|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20049356|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
20049357|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049358|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049359|NCT03115112|Incretins|incretins|mesh-ancestor
20049360|NCT03115112|Hormones|hormones|mesh-ancestor
20049361|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049362|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20049363|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
20049364|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049365|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117776|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117777|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117778|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117779|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117780|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
20117781|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117782|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20117783|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
20117784|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117785|NCT00005966|Interferons|interferons|mesh-list
20117786|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
20117787|NCT00005966|Thalidomide|thalidomide|mesh-list
20117788|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117789|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
20117790|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117791|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
20117792|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117793|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117794|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
20117795|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20117796|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20117797|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20117798|NCT00005966|Growth Substances|growth substances|mesh-ancestor
20117799|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
20117800|NCT00005967|Tipifarnib|tipifarnib|mesh-list
20117801|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117802|NCT00005968|Irofulven|irofulven|mesh-list
20117803|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117804|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
20049366|NCT03115177|Doxycycline|doxycycline|mesh-list
20049367|NCT03115177|Cefazolin|cefazolin|mesh-list
20049368|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20049369|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049370|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
20049371|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20049372|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20049373|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
20049374|NCT03115801|Nivolumab|nivolumab|mesh-list
20049375|NCT03115801|Atezolizumab|atezolizumab|mesh-list
20049376|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
20049377|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20049378|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049379|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20049380|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049381|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049382|NCT03115827|Carbidopa|carbidopa|mesh-list
20049383|NCT03115827|Droxidopa|droxidopa|mesh-list
20049384|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20049385|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20049386|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
20049387|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049388|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049389|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049390|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20049391|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049392|NCT03116152|Paclitaxel|paclitaxel|mesh-list
20049393|NCT03116152|Irinotecan|irinotecan|mesh-list
20049394|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20049395|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049396|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
20049397|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
20049398|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
20049399|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049400|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20049401|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20049402|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049403|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20049404|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
20049405|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049406|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049407|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049408|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049409|NCT03117140|Dexamethasone|dexamethasone|mesh-list
20049410|NCT03117140|Clonidine|clonidine|mesh-list
20049411|NCT03117140|Buprenorphine|buprenorphine|mesh-list
20049412|NCT03117140|Ropivacaine|ropivacaine|mesh-list
20049413|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049414|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
20049415|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
20049416|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049417|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049418|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049419|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
20049420|NCT03117140|Hormones|hormones|mesh-ancestor
20049421|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049422|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20049423|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049424|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049425|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
20049426|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049427|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
20049428|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20049429|NCT03117140|Narcotics|narcotics|mesh-ancestor
20049430|NCT03117140|Analgesics|analgesics|mesh-ancestor
20049431|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20049432|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20049433|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
20049434|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20049435|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20049436|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20049437|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
20049438|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049439|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049440|NCT03117361|Dexamethasone|dexamethasone|mesh-list
20049441|NCT03117361|Bortezomib|bortezomib|mesh-list
20049442|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049443|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
20049444|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
20049445|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049446|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049447|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049448|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
20049449|NCT03117361|Hormones|hormones|mesh-ancestor
20049450|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049451|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20049452|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049453|NCT03117517|Metformin|metformin|mesh-list
20049454|NCT03117517|Pioglitazone|pioglitazone|mesh-list
20049455|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049456|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049457|NCT03117634|Aflibercept|aflibercept|mesh-list
20049458|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20049459|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20049460|NCT03117634|Growth Substances|growth substances|mesh-ancestor
20049461|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049462|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
20049463|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049464|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
20049465|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20049466|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
20049467|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20049468|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049469|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20049470|NCT03118466|Cytarabine|cytarabine|mesh-list
20049471|NCT03118466|Etoposide|etoposide|mesh-list
20049472|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
20049473|NCT03118466|Lenalidomide|lenalidomide|mesh-list
20049474|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20049475|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049476|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20049477|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20049478|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049479|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049480|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20049481|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
20049482|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
20049483|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049484|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20049485|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
20049486|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049487|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20049488|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20049489|NCT03118466|Growth Substances|growth substances|mesh-ancestor
20049490|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
20049491|NCT03118466|Analgesics|analgesics|mesh-ancestor
20049492|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
20049493|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049494|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20049495|NCT03118739|Febuxostat|febuxostat|mesh-list
20049496|NCT03118739|Verinurad|verinurad|mesh-list
20049497|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
20049498|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20049499|NCT03118765|Bromides|bromides|mesh-list
20049500|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20049501|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
20049502|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20049503|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
20049504|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049505|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049506|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20049507|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049508|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
20049509|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20049510|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
20049511|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049512|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049513|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
20049514|NCT03118843|Velpatasvir|velpatasvir|mesh-list
20049515|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
20049516|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049517|NCT03118947|Pimavanserin|pimavanserin|mesh-list
20049518|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20049519|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20049520|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20049521|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20049522|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049523|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049524|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20049525|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20049526|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20049527|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
20049528|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049529|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049530|NCT03119168|Simethicone|simethicone|mesh-list
20049531|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
20049532|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049533|NCT03119168|Emollients|emollients|mesh-ancestor
20049534|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049535|NCT03119181|Lidocaine|lidocaine|mesh-list
20049536|NCT03119181|Epinephrine|epinephrine|mesh-list
20049537|NCT03119181|Racepinephrine|racepinephrine|mesh-list
20049538|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20049539|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
20049540|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049541|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
20049542|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049543|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049544|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
20049545|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049546|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049547|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049548|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049549|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049550|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049551|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20049552|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20049553|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
20049554|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049555|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20049556|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20049557|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
20049558|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20049559|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049560|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
20049561|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
20049562|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20049563|NCT03119610|Oxytocin|oxytocin|mesh-list
20049564|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
20049565|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20049566|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049567|NCT03119701|Interferons|interferons|mesh-list
20049568|NCT03119701|Interferon-beta|interferon-beta|mesh-list
20049569|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
20049570|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049571|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
20049572|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049573|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
20049574|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049575|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20049576|NCT03119831|Ethanol|ethanol|mesh-list
20049577|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
20049578|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20049579|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20049580|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049581|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049582|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049583|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
20049584|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049585|NCT03120351|Lidocaine|lidocaine|mesh-list
20049586|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049587|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
20049588|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049589|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049590|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
20049591|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049592|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049593|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049594|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049595|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049596|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049597|NCT03120520|Plecanatide|plecanatide|mesh-list
20049598|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20049599|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
20049600|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049601|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049602|NCT03121820|Memantine|memantine|mesh-list
20049603|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20049604|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20049605|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
20049606|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049607|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049608|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049609|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20049610|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20049611|NCT03122145|Capsaicin|capsaicin|mesh-list
20049612|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
20049613|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049614|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
20049615|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049616|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049617|NCT03122457|C 1027|c 1027|mesh-list
20049618|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20049619|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049620|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20049621|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049622|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
20049623|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20049624|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049625|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
20049626|NCT03122587|Vitamins|vitamins|mesh-ancestor
20049627|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
20049628|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049629|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20049630|NCT03122860|Lorecivivint|lorecivivint|mesh-list
20049631|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049632|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20049633|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
20049634|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20049635|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20049636|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
20049637|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20049638|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049639|NCT03123471|Apremilast|apremilast|mesh-list
20049640|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20049641|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20049642|NCT03123471|Analgesics|analgesics|mesh-ancestor
20049643|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
20049644|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049645|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049646|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049647|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20049648|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20049649|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20049650|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049651|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049652|NCT03123588|Anagrelide|anagrelide|mesh-list
20049653|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20049654|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20049655|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049656|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20049657|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20049658|NCT03123614|Prednisolone|prednisolone|mesh-list
20049659|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20049660|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
20049661|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20049662|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
20049663|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20049664|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
20049665|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049666|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
20049667|NCT03123614|Hormones|hormones|mesh-ancestor
20049668|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049669|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049670|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20049671|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049672|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
20049673|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
20049674|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049675|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049676|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20049677|NCT03123614|Protective Agents|protective agents|mesh-ancestor
20049678|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20049679|NCT03123848|Darunavir|darunavir|mesh-list
20049680|NCT03123848|Cobicistat|cobicistat|mesh-list
20049681|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20049682|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20049683|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
20049684|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049685|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049686|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20049687|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20049688|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
20049689|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049690|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20049691|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20049692|NCT03123861|Gabapentin|gabapentin|mesh-list
20049693|NCT03123861|Analgesics|analgesics|mesh-ancestor
20049694|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
20049695|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049696|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049697|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
20049698|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20049699|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20049700|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049701|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20049702|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20049703|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20049704|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049705|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293247|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293248|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293249|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
20049706|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
20049707|NCT03124121|Golimumab|golimumab|mesh-list
20049708|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20049709|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049710|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20049711|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
20049712|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049713|NCT03124199|Rifaximin|rifaximin|mesh-list
20049714|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20049715|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049716|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049717|NCT03124407|Capsaicin|capsaicin|mesh-list
20049718|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
20049719|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049720|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
20049721|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049722|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049723|NCT03125395|Ivacaftor|ivacaftor|mesh-list
20049724|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20049725|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049726|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491505|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749286|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293250|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049727|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20049728|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20049729|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049730|NCT03125941|Dexamethasone|dexamethasone|mesh-list
20049731|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049732|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
20049733|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
20049734|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049735|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049736|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049737|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
20049738|NCT03125941|Hormones|hormones|mesh-ancestor
20049739|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049740|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20049741|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117805|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117806|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117807|NCT00005969|Tretinoin|tretinoin|mesh-list
20117808|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117809|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
20117810|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117811|NCT00005970|Tamoxifen|tamoxifen|mesh-list
20117812|NCT00005970|Paclitaxel|paclitaxel|mesh-list
20117813|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
20117814|NCT00005970|Doxorubicin|doxorubicin|mesh-list
20117815|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117816|NCT00005970|Trastuzumab|trastuzumab|mesh-list
20117817|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20117818|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20117819|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20117820|NCT00005970|Antibodies|antibodies|mesh-list
20117821|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
20117822|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20117823|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20117824|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117825|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117826|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117827|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117828|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117829|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117830|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117831|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
20117832|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117833|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117834|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117835|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
20117836|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117837|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117838|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117839|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117840|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117841|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20117842|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
20117843|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117844|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20117845|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20117846|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20117847|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20117848|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20117849|NCT00005971|Alvocidib|alvocidib|mesh-list
20117850|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117851|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
20117852|NCT00005971|Growth Substances|growth substances|mesh-ancestor
20117853|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117854|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20117855|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117856|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117857|NCT00005972|Gemcitabine|gemcitabine|mesh-list
20117858|NCT00005972|Irinotecan|irinotecan|mesh-list
20117859|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117860|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
20117861|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117862|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117863|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
20049742|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20049743|NCT03126370|Emtricitabine|emtricitabine|mesh-list
20049744|NCT03126370|Tenofovir|tenofovir|mesh-list
20049745|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20049746|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
20049747|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20049748|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20049749|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049750|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049751|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
20049752|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049753|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20049754|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20049755|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20049756|NCT03126539|Sulforaphane|sulforaphane|mesh-list
20049757|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20049758|NCT03126539|Protective Agents|protective agents|mesh-ancestor
20049759|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049760|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049761|NCT03126682|Bupropion|bupropion|mesh-list
20049762|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20049763|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
20049764|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20049765|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20049766|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20049767|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049768|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049769|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
20049770|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049771|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049772|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20049773|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20049774|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049775|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20049776|NCT03126760|Hormones|hormones|mesh-ancestor
20049777|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049778|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049779|NCT03126786|Triamcinolone|triamcinolone|mesh-list
20049780|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20049781|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20049782|NCT03126786|Aflibercept|aflibercept|mesh-list
20049783|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20049784|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049785|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
20049786|NCT03126786|Hormones|hormones|mesh-ancestor
20049787|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049788|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049789|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20049790|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
20049791|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049792|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049793|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20049794|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20049795|NCT03126786|Growth Substances|growth substances|mesh-ancestor
20049796|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
20049797|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049798|NCT03127384|Lidocaine|lidocaine|mesh-list
20049799|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049800|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
20049801|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049802|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049803|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
20049804|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049805|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049806|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049807|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049808|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049809|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049810|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20049811|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049812|NCT03127943|Lidocaine|lidocaine|mesh-list
20049813|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049814|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
20049815|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049816|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049817|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
20049818|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049819|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049820|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20049821|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20049822|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049823|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049824|NCT03128008|Paclitaxel|paclitaxel|mesh-list
20049825|NCT03128008|Carboplatin|carboplatin|mesh-list
20049826|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20049827|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049828|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20049829|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20049830|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20049831|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049832|NCT03129100|Ixekizumab|ixekizumab|mesh-list
20049833|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049834|NCT03129945|Indomethacin|indomethacin|mesh-list
20049835|NCT03129945|Nifedipine|nifedipine|mesh-list
20049836|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20049837|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049838|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049839|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20049840|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049841|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
20049842|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
20049843|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20049844|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20049845|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20049846|NCT03129945|Analgesics|analgesics|mesh-ancestor
20049847|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
20049848|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049849|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20049850|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20049851|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
20049852|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20049853|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049854|NCT03130738|Miconazole|miconazole|mesh-list
20049855|NCT03130738|Clotrimazole|clotrimazole|mesh-list
20049856|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
20049857|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049858|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20049859|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20049860|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049861|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049862|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20049863|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
20049864|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049865|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049866|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20049867|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20049868|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20049869|NCT03131453|CNP520|cnp520|mesh-list
20049870|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049871|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049872|NCT03131479|Licogliflozin|licogliflozin|mesh-list
20049873|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20049874|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049875|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049876|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049877|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20049878|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
20049879|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049880|NCT03131687|Dulaglutide|dulaglutide|mesh-list
20049881|NCT03131687|Tirzepatide|tirzepatide|mesh-list
20049882|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049883|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049884|NCT03131687|Incretins|incretins|mesh-ancestor
20049885|NCT03131687|Hormones|hormones|mesh-ancestor
19491506|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049886|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20049887|NCT03131713|Acetaminophen|acetaminophen|mesh-list
20049888|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20049889|NCT03131713|Analgesics|analgesics|mesh-ancestor
20049890|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
20049891|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049892|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049893|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
20049894|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
20049895|NCT03131895|Lansoprazole|lansoprazole|mesh-list
20049896|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20049897|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049898|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20049899|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049900|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049901|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
20049902|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049903|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20049904|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049905|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049906|NCT03132571|Naltrexone|naltrexone|mesh-list
20049907|NCT03132571|Bupropion|bupropion|mesh-list
20049908|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20049909|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20049910|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049911|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
20049912|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049913|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20049914|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
20049915|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20049916|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20049917|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20049918|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049919|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049920|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
20049921|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20049922|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20049923|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20049924|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049925|NCT03133481|Ropivacaine|ropivacaine|mesh-list
20049926|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
20049927|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
20049928|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049929|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049930|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
20049931|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049932|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20049933|NCT03134183|Misoprostol|misoprostol|mesh-list
20049934|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20049935|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
20049936|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20049937|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049938|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20049939|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20049940|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
20049941|NCT03134703|Morphine|morphine|mesh-list
20049942|NCT03134703|Methadone|methadone|mesh-list
20049943|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20049944|NCT03134703|Narcotics|narcotics|mesh-ancestor
20049945|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20049946|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049947|NCT03134703|Analgesics|analgesics|mesh-ancestor
20049948|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
20049949|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20049950|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
20049951|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
20049952|NCT03135028|Cytarabine|cytarabine|mesh-list
20049953|NCT03135028|Daunorubicin|daunorubicin|mesh-list
20049954|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20049955|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
20049956|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049957|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20049958|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
20049959|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20049960|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20049961|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
20049962|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049963|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20049964|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20049965|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20049966|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049967|NCT03136068|Digoxin|digoxin|mesh-list
20049968|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20049969|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20049970|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20049971|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049972|NCT03136068|Protective Agents|protective agents|mesh-ancestor
20049973|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049974|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
20049975|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20049976|NCT03136107|Protective Agents|protective agents|mesh-ancestor
20049977|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049978|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
20049979|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
20049980|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20049981|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
20049982|NCT03136198|Diuretics|diuretics|mesh-list
20049983|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20049984|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
20049985|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049986|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20049987|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049988|NCT03136328|Edotreotide|edotreotide|mesh-list
20049989|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20049990|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049991|NCT03136484|Canagliflozin|canagliflozin|mesh-list
20049992|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20049993|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20049994|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20049995|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049996|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20049997|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
20049998|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20049999|NCT03137121|Olanzapine|olanzapine|mesh-list
20050000|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
20050001|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
20050002|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050003|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050004|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050005|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20050006|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20050007|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050008|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20050009|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20050010|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20050011|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050012|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050013|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050014|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
20050015|NCT03137303|Albuterol|albuterol|mesh-list
20050016|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20050017|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
20050018|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050019|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050020|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20050021|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050022|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
20050023|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20050024|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20050025|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20050026|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20050027|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
20050028|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050029|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050030|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
20050031|NCT03137784|Bromides|bromides|mesh-list
20050032|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
20050033|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20050034|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20050035|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20050036|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050037|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050038|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050039|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050040|NCT03137992|Bromides|bromides|mesh-list
20050041|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
20050042|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20050043|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
20050044|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050045|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050046|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20050047|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050048|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
20050049|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20050050|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050051|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050052|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050053|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
20050054|NCT03138655|Vedolizumab|vedolizumab|mesh-list
20050055|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050056|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
20050057|NCT03138967|Bromides|bromides|mesh-list
20050058|NCT03138967|Rocuronium|rocuronium|mesh-list
20576900|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576901|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576902|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
20576903|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576904|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
20576905|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576906|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576907|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576908|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
20050059|NCT03138967|Neostigmine|neostigmine|mesh-list
20050060|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
20050061|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20050062|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20050063|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20050064|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050065|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050066|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20050067|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050068|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050069|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050070|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050071|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20050072|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
20050073|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20050074|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20050075|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20050076|NCT03139240|Oxycodone|oxycodone|mesh-list
20050077|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20050078|NCT03139240|Narcotics|narcotics|mesh-ancestor
20050079|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050080|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050081|NCT03139240|Analgesics|analgesics|mesh-ancestor
20050082|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
20050083|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050084|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
20050085|NCT03139279|Propofol|propofol|mesh-list
20050086|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20050087|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050088|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050089|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20050090|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
20050091|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
20050092|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20050093|NCT03139279|Analgesics|analgesics|mesh-ancestor
20050094|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
20050095|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050096|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20293251|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293252|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050097|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20050098|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20050099|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
20050100|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050101|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050102|NCT03139604|Prednisone|prednisone|mesh-list
20050103|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
20050104|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20050105|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20050106|NCT03139604|Prednisolone|prednisolone|mesh-list
20050107|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
20050108|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20050109|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
19491507|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
20050110|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050111|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
20050112|NCT03139604|Hormones|hormones|mesh-ancestor
20050113|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050114|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050115|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20050116|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050117|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
20050118|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
20050119|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050120|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050121|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20050122|NCT03139604|Protective Agents|protective agents|mesh-ancestor
20050123|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
20050124|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20050125|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20050126|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050127|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
20050128|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117864|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117865|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117866|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117867|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
20117868|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117869|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117870|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117871|NCT00005974|Alvocidib|alvocidib|mesh-list
20117872|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117873|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
20117874|NCT00005974|Growth Substances|growth substances|mesh-ancestor
20117875|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117876|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20117877|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117878|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117879|NCT00005975|Megestrol|megestrol|mesh-list
20117880|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
20117881|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20117882|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20117883|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20117884|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
20117885|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20117886|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117887|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20117888|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20117889|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20117890|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117891|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
20117892|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20117893|NCT00005976|Carboplatin|carboplatin|mesh-list
20117894|NCT00005976|NSC 366140|nsc 366140|mesh-list
20117895|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117896|NCT00005977|Leucovorin|leucovorin|mesh-list
20117897|NCT00005977|Cytarabine|cytarabine|mesh-list
20117898|NCT00005977|Dexamethasone|dexamethasone|mesh-list
20117899|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
20117900|NCT00005977|Ifosfamide|ifosfamide|mesh-list
20117901|NCT00005977|Doxorubicin|doxorubicin|mesh-list
20117902|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117903|NCT00005977|Methotrexate|methotrexate|mesh-list
20117904|NCT00005977|Etoposide|etoposide|mesh-list
20117905|NCT00005977|Vincristine|vincristine|mesh-list
20117906|NCT00005977|Lenograstim|lenograstim|mesh-list
20050129|NCT03140631|Protamines|protamines|mesh-list
20050130|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
20050131|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050132|NCT03140631|Coagulants|coagulants|mesh-ancestor
20050133|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
20050134|NCT03140722|Hematinics|hematinics|mesh-ancestor
20050135|NCT03142451|Minocycline|minocycline|mesh-list
20050136|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20050137|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050138|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
20050139|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
20050140|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050141|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
20050142|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050143|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050144|NCT03143166|Telmisartan|telmisartan|mesh-list
20050145|NCT03143166|Dabigatran|dabigatran|mesh-list
20050146|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20050147|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20050148|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20050149|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050150|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
20050151|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20050152|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
20050153|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050154|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
20050155|NCT03143569|Heparin|heparin|mesh-list
20050156|NCT03143569|Calcium heparin|calcium heparin|mesh-list
20050157|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
20050158|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20050159|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20050160|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050161|NCT03144635|Grazoprevir|grazoprevir|mesh-list
20050162|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
20050163|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050164|NCT03144804|Lamivudine|lamivudine|mesh-list
20050165|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20050166|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20050167|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050168|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050169|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
20050170|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050171|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20050172|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20050173|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
20050174|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050175|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20050176|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050177|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050178|NCT03145207|Lidocaine|lidocaine|mesh-list
20050179|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050180|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
20050181|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050182|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050183|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
20050184|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050185|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20050186|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20050187|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20050188|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050189|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050190|NCT03145259|Diclofenac|diclofenac|mesh-list
20050191|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20050192|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20050193|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20050194|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20050195|NCT03145259|Analgesics|analgesics|mesh-ancestor
20050196|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
20050197|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050198|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050199|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050200|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20050201|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20050202|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050203|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050204|NCT03146403|Vaccines|vaccines|mesh-list
20050205|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
20050206|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050207|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
20050208|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
20050209|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050210|NCT03146806|Ketamine|ketamine|mesh-list
20050211|NCT03146806|Analgesics|analgesics|mesh-ancestor
20050212|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
20050213|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050214|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050215|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20050216|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20050217|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
20050218|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
20050219|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050220|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20050221|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20050222|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050223|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050224|NCT03147248|Infliximab|infliximab|mesh-list
20050225|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
20050226|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050227|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20050228|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
20050229|NCT03148236|Vitamins|vitamins|mesh-ancestor
20050230|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
20050231|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050232|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
20050233|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050234|NCT03148236|Protective Agents|protective agents|mesh-ancestor
20050235|NCT03149055|Isavuconazole|isavuconazole|mesh-list
20050236|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
20050237|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050238|NCT03149848|Rifabutin|rifabutin|mesh-list
20050239|NCT03149848|Cabotegravir|cabotegravir|mesh-list
20050240|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20050241|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050242|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20050243|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
20050244|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20050245|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20050246|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050247|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050248|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20050249|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20050250|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
20050251|NCT03149887|Bupivacaine|bupivacaine|mesh-list
20050252|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050253|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
20050254|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050255|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050256|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
20050257|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050258|NCT03149991|Ketamine|ketamine|mesh-list
20050259|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
20050260|NCT03149991|Analgesics|analgesics|mesh-ancestor
20050261|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
20050262|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050263|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050264|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20050265|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20050266|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
20050267|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
20050268|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050269|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20050270|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20050271|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050272|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050273|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
20050274|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
20050275|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
20050276|NCT03150056|Prednisone|prednisone|mesh-list
20050277|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050278|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
20050279|NCT03150056|Hormones|hormones|mesh-ancestor
20050280|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050281|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050282|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20050283|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050284|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
20050285|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20050286|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050287|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20050288|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20050289|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050290|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050291|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050292|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20050293|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20050294|NCT03150589|Ranibizumab|ranibizumab|mesh-list
20050295|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20050296|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20050297|NCT03150589|Growth Substances|growth substances|mesh-ancestor
20050298|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050299|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
20050300|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050301|NCT03150719|Ivacaftor|ivacaftor|mesh-list
20050302|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20050303|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050304|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050305|NCT03150875|Docetaxel|docetaxel|mesh-list
20050306|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050307|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
20050308|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
20050309|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
20050310|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050311|NCT03151434|Hydromorphone|hydromorphone|mesh-list
20050312|NCT03151434|Bupivacaine|bupivacaine|mesh-list
20050313|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050314|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
20050315|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050316|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050317|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
20050318|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050319|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20050320|NCT03151434|Narcotics|narcotics|mesh-ancestor
20050321|NCT03151434|Analgesics|analgesics|mesh-ancestor
20050322|NCT03151551|Adalimumab|adalimumab|mesh-list
20050323|NCT03151551|Ixekizumab|ixekizumab|mesh-list
20050324|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050325|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20050326|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
20050327|NCT03152019|Tacrolimus|tacrolimus|mesh-list
20050328|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050329|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
20050330|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050331|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20050332|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050333|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050334|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
20050335|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20050336|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050337|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050338|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050339|NCT03152552|Empagliflozin|empagliflozin|mesh-list
20050340|NCT03152552|Licogliflozin|licogliflozin|mesh-list
20050341|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20050342|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050343|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050344|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050345|NCT03152591|Licogliflozin|licogliflozin|mesh-list
20050346|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20050347|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050348|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050349|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050350|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
20050351|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746143|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050352|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
20050353|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
20050354|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20050355|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20050356|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050357|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050358|NCT03154476|Urological Agents|urological agents|mesh-ancestor
20050359|NCT03154658|Ropivacaine|ropivacaine|mesh-list
20050360|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050361|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
20050362|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050363|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050364|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
20050365|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050366|NCT03155178|Ethanol|ethanol|mesh-list
20050367|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
20050368|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20050369|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20050370|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050371|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491508|NCT03130348|Hormones|hormones|mesh-ancestor
20050372|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050373|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
20050374|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
20050375|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
20050376|NCT03157089|Afatinib|afatinib|mesh-list
20050377|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20050378|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050379|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20050380|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050381|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050382|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
20050383|NCT03157583|Glycerol|glycerol|mesh-list
20050384|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20050385|NCT03157583|Protective Agents|protective agents|mesh-ancestor
20050386|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050387|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
20050388|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20050389|NCT03158116|Aztreonam|aztreonam|mesh-list
20050390|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20050391|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050392|NCT03158220|Vaccines|vaccines|mesh-list
20050393|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
20050394|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050395|NCT03158272|Nivolumab|nivolumab|mesh-list
20050396|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20050397|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050398|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20050399|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050400|NCT03158311|Fluticasone|fluticasone|mesh-list
20050401|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
20050402|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20050403|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050404|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20050405|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
20050406|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050407|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050408|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20050409|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050410|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
20050411|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20050412|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
20050413|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20050414|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050415|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050416|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050417|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20050418|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20050419|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20050420|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
20050421|NCT03159143|Docetaxel|docetaxel|mesh-list
20050422|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
20050423|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050424|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
20050425|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
20050426|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
20050427|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117907|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
20117908|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117909|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
20117910|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117911|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20117912|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117913|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
20117914|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117915|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117916|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117917|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20117918|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
20117919|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
20117920|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20117921|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20117922|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
20117923|NCT00005977|Hormones|hormones|mesh-ancestor
20117924|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20117925|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20117926|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117927|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117928|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117929|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117930|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20117931|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
20117932|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20117933|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117934|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
20117935|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
20117936|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20117937|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20117938|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117939|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
20117940|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20117941|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20117942|NCT00005977|Antidotes|antidotes|mesh-ancestor
20117943|NCT00005977|Protective Agents|protective agents|mesh-ancestor
20117944|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
20117945|NCT00005977|Vitamins|vitamins|mesh-ancestor
20117946|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
20117947|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
20117948|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
20117949|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
20117950|NCT00005978|Carboplatin|carboplatin|mesh-list
20117951|NCT00005978|Etoposide|etoposide|mesh-list
20117952|NCT00005978|Melphalan|melphalan|mesh-list
20117953|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20117954|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117955|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20117956|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117957|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117958|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117959|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117960|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
20117961|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117962|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117963|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
20117964|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20117965|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20117966|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20117967|NCT00005979|Leucovorin|leucovorin|mesh-list
20117968|NCT00005979|Fluorouracil|fluorouracil|mesh-list
20117969|NCT00005979|Irinotecan|irinotecan|mesh-list
20117970|NCT00005979|Calcium|calcium|mesh-list
20117971|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
20117972|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20117973|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20117974|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
20117975|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117976|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20117977|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117978|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050428|NCT03159260|Allantoin|allantoin|mesh-list
20050429|NCT03159260|Dermatologic Agents|dermatologic agents|mesh-ancestor
20050430|NCT03160703|Fluorides|fluorides|mesh-list
20050431|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
20050432|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
20050433|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
20050434|NCT03160703|Protective Agents|protective agents|mesh-ancestor
20050435|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050436|NCT03160716|Lidocaine|lidocaine|mesh-list
20050437|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050438|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
20050439|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050440|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050441|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
20050442|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050443|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20050444|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20050445|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20050446|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050447|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050448|NCT03161158|Diuretics|diuretics|mesh-list
20050449|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
20050450|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050451|NCT03161405|Itraconazole|itraconazole|mesh-list
20050452|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050453|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050454|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
20050455|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050456|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20050457|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20050458|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20050459|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
20050460|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050461|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050462|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20050463|NCT03161938|Dexamethasone|dexamethasone|mesh-list
20050464|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050465|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
20050466|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
20050467|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050468|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050469|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050470|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
20050471|NCT03161938|Hormones|hormones|mesh-ancestor
20050472|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050473|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20050474|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050475|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
20050476|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
20050477|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20050478|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
20050479|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050480|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050481|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20050482|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050483|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20050484|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20050485|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20050486|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20050487|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050488|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050489|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20050490|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20050491|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20050492|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050493|NCT03163303|Nicotine|nicotine|mesh-list
20050494|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20050495|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
20050496|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050497|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050498|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20050499|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20050500|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050501|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050502|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050503|NCT03163472|Anesthetics|anesthetics|mesh-list
20050504|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
20050505|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050506|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050507|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
20050508|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050509|NCT03165981|Vaccines|vaccines|mesh-list
20050510|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20050511|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
20576909|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576910|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20576911|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20576912|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576913|NCT02074228|Methylphenidate|methylphenidate|mesh-list
20576914|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20576915|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050512|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050513|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
20050514|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050515|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050516|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
20050517|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20050518|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050519|NCT03167411|Exenatide|exenatide|mesh-list
20050520|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
20050521|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050522|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050523|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20050524|NCT03167411|Incretins|incretins|mesh-ancestor
20050525|NCT03167411|Hormones|hormones|mesh-ancestor
20050526|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050527|NCT03168022|Amitriptyline|amitriptyline|mesh-list
20050528|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
20050529|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20050530|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
20050531|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20050532|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20050533|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050534|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20050535|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050536|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20050537|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050538|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20050539|NCT03168022|Analgesics|analgesics|mesh-ancestor
20050540|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
20050541|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20050542|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20050543|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050544|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050545|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
20050546|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050547|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
20050548|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20050549|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050550|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050551|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050552|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
20050553|NCT03168308|Neostigmine|neostigmine|mesh-list
20050554|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20050555|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050556|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050557|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050558|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050559|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050560|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20050561|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
20050562|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050563|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20050564|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20050565|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20050566|NCT03168841|Efinaconazole|efinaconazole|mesh-list
20050567|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
20050568|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050569|NCT03168919|Temozolomide|temozolomide|mesh-list
20050570|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20050571|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
20050572|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050573|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050574|NCT03169244|Bupropion|bupropion|mesh-list
20050575|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20050576|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
20050577|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20050578|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20050579|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20050580|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050581|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050582|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
20050583|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050584|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050585|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20050586|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20050587|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050588|NCT03170219|Furosemide|furosemide|mesh-list
20050589|NCT03170219|Diuretics|diuretics|mesh-ancestor
20050590|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
20050591|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050592|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20050593|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050594|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050595|NCT03170271|Benralizumab|benralizumab|mesh-list
20050596|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20050597|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050598|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
20050599|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050600|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050601|NCT03170661|Rocuronium|rocuronium|mesh-list
20050602|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20050603|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20050604|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20050605|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050606|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050607|NCT03172325|Folic Acid|folic acid|mesh-list
20050608|NCT03172325|Prednisolone|prednisolone|mesh-list
20050609|NCT03172325|Adalimumab|adalimumab|mesh-list
20050610|NCT03172325|Methotrexate|methotrexate|mesh-list
20050611|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20050612|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
20050613|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20050614|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050615|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20050616|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
20050617|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050618|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050619|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
20050620|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050621|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20050622|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050623|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
20050624|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20050625|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20050626|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050627|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
20050628|NCT03172325|Hormones|hormones|mesh-ancestor
20050629|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050630|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20050631|NCT03172325|Hematinics|hematinics|mesh-ancestor
20050632|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
20050633|NCT03172325|Vitamins|vitamins|mesh-ancestor
20050634|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
20050635|NCT03172494|Insulin|insulin|mesh-list
20050636|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20050637|NCT03172494|Liraglutide|liraglutide|mesh-list
20050638|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
20050639|NCT03172494|Xultophy|xultophy|mesh-list
20050640|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050641|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050642|NCT03172494|Incretins|incretins|mesh-ancestor
20050643|NCT03172494|Hormones|hormones|mesh-ancestor
20050644|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050645|NCT03173170|Itraconazole|itraconazole|mesh-list
20050646|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
20050647|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050648|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20050649|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20050650|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050651|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050652|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20050653|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
20050654|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050655|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050656|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20050657|NCT03173560|Everolimus|everolimus|mesh-list
20050658|NCT03173560|Lenvatinib|lenvatinib|mesh-list
20050659|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050660|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050661|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
20050662|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050663|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20050664|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050665|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050666|NCT03174132|Lidocaine|lidocaine|mesh-list
20050667|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
20050668|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050669|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
20050670|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050671|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050672|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
20050673|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050674|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20050675|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20050676|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20050677|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050678|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050679|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20050680|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
20050681|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
20050682|NCT03174132|Protective Agents|protective agents|mesh-ancestor
20050683|NCT03174158|Nicotine|nicotine|mesh-list
20050684|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20050685|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
20050686|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050687|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050688|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20050689|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20050690|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050691|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050692|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050693|NCT03174366|Denosumab|denosumab|mesh-list
20050694|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20050695|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050696|NCT03175120|Insulin|insulin|mesh-list
20050697|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20050698|NCT03175120|Liraglutide|liraglutide|mesh-list
20050699|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
20050700|NCT03175120|Xultophy|xultophy|mesh-list
20050701|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050702|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050703|NCT03175120|Incretins|incretins|mesh-ancestor
20050704|NCT03175120|Hormones|hormones|mesh-ancestor
20050705|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050706|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
20050707|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20050708|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050709|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20050710|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050711|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050712|NCT03176238|Everolimus|everolimus|mesh-list
20050713|NCT03176238|Exemestane|exemestane|mesh-list
20050714|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050715|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050716|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
20050717|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050718|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20050719|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20050720|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050721|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050722|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20050723|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
20050724|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050725|NCT03176459|Bupivacaine|bupivacaine|mesh-list
20050726|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050727|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
20050728|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050729|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050730|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
20050731|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050732|NCT03176784|Nicotine|nicotine|mesh-list
20050733|NCT03176784|Varenicline|varenicline|mesh-list
20050734|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20050735|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
20050736|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050737|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050738|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20050739|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20050740|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050741|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050742|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050743|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
20050744|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20050745|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
20050746|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050747|NCT03177395|Expectorants|expectorants|mesh-ancestor
20050748|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050749|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20050750|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
20050751|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050752|NCT03177395|Protective Agents|protective agents|mesh-ancestor
20050753|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050754|NCT03177395|Antidotes|antidotes|mesh-ancestor
20117979|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
20117980|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20117981|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117982|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117983|NCT00005979|Antidotes|antidotes|mesh-ancestor
20117984|NCT00005979|Protective Agents|protective agents|mesh-ancestor
20117985|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
20117986|NCT00005979|Vitamins|vitamins|mesh-ancestor
20117987|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
20117988|NCT00005980|Doxorubicin|doxorubicin|mesh-list
20117989|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20117990|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20117991|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20117992|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20117993|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20117994|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20117995|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20117996|NCT00005981|Carmustine|carmustine|mesh-list
20117997|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20117998|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20117999|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
20118000|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118001|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118002|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118003|NCT00005984|Interferons|interferons|mesh-list
20118004|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
20118005|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
20118006|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118007|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
20118008|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118009|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118010|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118011|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
20576916|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20118012|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118013|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050755|NCT03177798|Icatibant|icatibant|mesh-list
20050756|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20050757|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20050758|NCT03177798|Analgesics|analgesics|mesh-ancestor
20050759|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
20050760|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050761|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050762|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050763|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20050764|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20050765|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20050766|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050767|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20050768|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050769|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
20050770|NCT03178851|Atezolizumab|atezolizumab|mesh-list
20050771|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20050772|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050773|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
20050774|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050775|NCT03178942|Permethrin|permethrin|mesh-list
20050776|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050777|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050778|NCT03179345|Pregabalin|pregabalin|mesh-list
20050779|NCT03179345|Gabapentin|gabapentin|mesh-list
20050780|NCT03179345|Analgesics|analgesics|mesh-ancestor
20050781|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
20050782|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050783|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050784|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
20050785|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20050786|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050787|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050788|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20050789|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20050790|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20050791|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050792|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20050793|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20050794|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20050795|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050796|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
20050797|NCT03179410|Avelumab|avelumab|mesh-list
20050798|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20050799|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050800|NCT03179787|Aripiprazole|aripiprazole|mesh-list
20050801|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
20050802|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20050803|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20050804|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20050805|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050806|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050807|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
20050808|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
20050809|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050810|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050811|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20050812|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20050813|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
20050814|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20293253|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293254|NCT04639986|Gemcitabine|gemcitabine|mesh-list
20293255|NCT04639986|Capecitabine|capecitabine|mesh-list
20293256|NCT04639986|Vinorelbine|vinorelbine|mesh-list
20293257|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20293258|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
20293259|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293260|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293261|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
20293262|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050815|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20293263|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050816|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20050817|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20050818|NCT03179891|Diazepam|diazepam|mesh-list
20050819|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20050820|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
20050821|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
20050822|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
20050823|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050824|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050825|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050826|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20050827|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050828|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20050829|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20050830|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20050831|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20050832|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20050833|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20050834|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
20050835|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
20050836|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
20050837|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
20050838|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050839|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050840|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
20050841|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20050842|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050843|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050844|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050845|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
20050846|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
20050847|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050848|NCT05365035|Cytarabine|cytarabine|mesh-list
20050849|NCT05365035|Azacitidine|azacitidine|mesh-list
20050850|NCT05365035|Venetoclax|venetoclax|mesh-list
20050851|NCT05365035|Cladribine|cladribine|mesh-list
20050852|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20050853|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
20050854|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050855|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050856|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
20050857|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20050858|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050859|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
20050860|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050861|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050862|NCT05364944|Octreotide|octreotide|mesh-list
20050863|NCT05364944|Lanreotide|lanreotide|mesh-list
20050864|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050865|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20050866|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050867|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20050868|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
20050869|NCT05364762|Tacrolimus|tacrolimus|mesh-list
20050870|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20050871|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
20050872|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050873|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20050874|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20050875|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
20050876|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050877|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050878|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20050879|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20050880|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050881|NCT05364645|Carboplatin|carboplatin|mesh-list
20050882|NCT05364645|Pemetrexed|pemetrexed|mesh-list
20050883|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050884|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050885|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050886|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20050887|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20050888|NCT05364619|Bismuth|bismuth|mesh-list
20050889|NCT05364619|Antacids|antacids|mesh-ancestor
20050890|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050891|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20050892|NCT05364567|Vitamin D|vitamin d|mesh-list
20050893|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
20050894|NCT05364567|Vitamins|vitamins|mesh-ancestor
20050895|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
20050896|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050897|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20050898|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20050899|NCT05364424|Rituximab|rituximab|mesh-list
20050900|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
20050901|NCT05364424|Carboplatin|carboplatin|mesh-list
20050902|NCT05364424|Etoposide|etoposide|mesh-list
20050903|NCT05364424|Ifosfamide|ifosfamide|mesh-list
20050904|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20050905|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050906|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
20050907|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050908|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20050909|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20050910|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20050911|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20050912|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20050913|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050914|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20050915|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
20050916|NCT05364385|Budesonide|budesonide|mesh-list
20050917|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20050918|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050919|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20050920|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
20050921|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050922|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050923|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20050924|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050925|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
20050926|NCT05364385|Hormones|hormones|mesh-ancestor
20050927|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050928|NCT05364216|Anesthetics|anesthetics|mesh-list
20050929|NCT05364216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050930|NCT05364216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050931|NCT05364190|Canagliflozin|canagliflozin|mesh-list
20050932|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20050933|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050934|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20050935|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050936|NCT05364099|Triamcinolone|triamcinolone|mesh-list
20050937|NCT05364099|Lidocaine|lidocaine|mesh-list
20050938|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
20050939|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
20293264|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293265|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
20293266|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293267|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20576917|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20050940|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20050941|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050942|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
20050943|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050944|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20050945|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20050946|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20050947|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20050948|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050949|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20050950|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
20050951|NCT05364099|Hormones|hormones|mesh-ancestor
20050952|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20050953|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20050954|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
20050955|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050956|NCT05364008|Protective Agents|protective agents|mesh-ancestor
20050957|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050958|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20050959|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20050960|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050961|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20050962|NCT05363917|Folic Acid|folic acid|mesh-list
20050963|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
20050964|NCT05363917|Hematinics|hematinics|mesh-ancestor
20050965|NCT05363917|Vitamins|vitamins|mesh-ancestor
20050966|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
20050967|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050968|NCT05363722|Bevacizumab|bevacizumab|mesh-list
20050969|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20050970|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20050971|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20050972|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20050973|NCT05363722|Growth Substances|growth substances|mesh-ancestor
20050974|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050975|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
20050976|NCT05363553|Caseins|caseins|mesh-list
20050977|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
20050978|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
20050979|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118014|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118015|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
20118016|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118017|NCT00005985|Cytarabine|cytarabine|mesh-list
20118018|NCT00005985|Dexamethasone|dexamethasone|mesh-list
20118019|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
20118020|NCT00005985|Carmustine|carmustine|mesh-list
20118021|NCT00005985|Etoposide|etoposide|mesh-list
20118022|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
20118023|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118024|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
20118025|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118026|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118027|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118028|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
20118029|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118030|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118031|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118032|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118033|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
20118034|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
20118035|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118036|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118037|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
20118038|NCT00005985|Hormones|hormones|mesh-ancestor
20118039|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118040|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20118041|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118042|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118043|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118044|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118045|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118046|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
20118047|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
20118048|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118049|NCT00005985|Analgesics|analgesics|mesh-ancestor
20118050|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
20118051|NCT00005986|Interferons|interferons|mesh-list
20118052|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
20118053|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
20118054|NCT00005986|Busulfan|busulfan|mesh-list
20118055|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118056|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
20118057|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118058|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118059|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118060|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
20118061|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118062|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118063|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118064|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
20118065|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118066|NCT00005987|Interferons|interferons|mesh-list
20118067|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
20118068|NCT00005987|Dexamethasone|dexamethasone|mesh-list
20118069|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
20118070|NCT00005987|Carmustine|carmustine|mesh-list
20118071|NCT00005987|Etoposide|etoposide|mesh-list
20118072|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
20118073|NCT00005987|Sargramostim|sargramostim|mesh-list
20050980|NCT05363501|Naloxone|naloxone|mesh-list
20050981|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20050982|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050983|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
20050984|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050985|NCT05362487|Bromides|bromides|mesh-list
20050986|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
20050987|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20050988|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
20050989|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20050990|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20050991|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20050992|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
20050993|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
20050994|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20050995|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
20050996|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20050997|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20050998|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
20050999|NCT05361486|Primaquine|primaquine|mesh-list
20051000|NCT05361486|Tafenoquine|tafenoquine|mesh-list
20051001|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
20051002|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20051003|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20051004|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051005|NCT05360628|Allopurinol|allopurinol|mesh-list
20051006|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
20051007|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051008|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051009|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
20051010|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051011|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20051012|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
20051013|NCT05360628|Protective Agents|protective agents|mesh-ancestor
20051014|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051015|NCT05359068|Valsartan|valsartan|mesh-list
20051016|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20051017|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20051018|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20051019|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051020|NCT05358626|Antibodies|antibodies|mesh-list
20051021|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
20051022|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
20051023|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051024|NCT05357911|Digoxin|digoxin|mesh-list
20051025|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20051026|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20051027|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051028|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051029|NCT05357911|Protective Agents|protective agents|mesh-ancestor
20051030|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051031|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
20051032|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20051033|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20051034|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051035|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
20051036|NCT05357079|Coagulants|coagulants|mesh-ancestor
20051037|NCT05353062|Epinephrine|epinephrine|mesh-list
20051038|NCT05353062|Hemostatics|hemostatics|mesh-list
20051039|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20051040|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20051041|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
20051042|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051043|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051044|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051045|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20051046|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20051047|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
20051048|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051049|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20051050|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
20051051|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
20051052|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
20051053|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20051054|NCT05353062|Coagulants|coagulants|mesh-ancestor
20051055|NCT05350696|Morphine|morphine|mesh-list
20051056|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20051057|NCT05350696|Narcotics|narcotics|mesh-ancestor
20051058|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051059|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051060|NCT05350696|Analgesics|analgesics|mesh-ancestor
20051061|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
20051062|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051063|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
20051064|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20051065|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051066|NCT05347082|Vitamins|vitamins|mesh-ancestor
20051067|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
20051068|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20051069|NCT05342584|Cytarabine|cytarabine|mesh-list
20051070|NCT05342584|Daunorubicin|daunorubicin|mesh-list
20051071|NCT05342584|Venetoclax|venetoclax|mesh-list
20051072|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051073|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
20051074|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051075|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051076|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
20051077|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051078|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051079|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
20051080|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051081|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20051082|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20051083|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20051084|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051085|NCT05341375|Anesthetics|anesthetics|mesh-list
20051086|NCT05341375|Esketamine|esketamine|mesh-list
20051087|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051088|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051089|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
20051090|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20051091|NCT05325099|Azacitidine|azacitidine|mesh-list
20051092|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051093|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
20051094|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051095|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051096|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051097|NCT05324852|Midazolam|midazolam|mesh-list
20051098|NCT05324852|Loxapine|loxapine|mesh-list
20051099|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20051100|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20051101|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051102|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051103|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20051104|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20051105|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20051106|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20051107|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
20051108|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
20051109|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
20051110|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
20051111|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051112|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051113|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20051114|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20051115|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
20051116|NCT05324384|Sirolimus|sirolimus|mesh-list
20051117|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20051118|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051119|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20051120|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051121|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
20051122|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051123|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
20051124|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051125|NCT05312268|Rasburicase|rasburicase|mesh-list
20051126|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
20051127|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051128|NCT05307874|Aldesleukin|aldesleukin|mesh-list
20051129|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051130|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20051131|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20051132|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
20051133|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051134|NCT05304468|Cisplatin|cisplatin|mesh-list
20051135|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051136|NCT05304455|Heparin|heparin|mesh-list
20051137|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20051138|NCT05304455|Tinzaparin|tinzaparin|mesh-list
20051139|NCT05304455|Dalteparin|dalteparin|mesh-list
20051140|NCT05304455|Dipyridamole|dipyridamole|mesh-list
20051141|NCT05304455|Apixaban|apixaban|mesh-list
20051142|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
20051143|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20051144|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20576918|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576919|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576920|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
20576921|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576922|NCT02074267|Gabapentin|gabapentin|mesh-list
20576923|NCT02074267|Analgesics|analgesics|mesh-ancestor
20576924|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
20576925|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576926|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576927|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
20576928|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20051145|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051146|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20051147|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
20051148|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20051149|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
20051150|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051151|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20051152|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20051153|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
20051154|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20051155|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051156|NCT05294341|Norethindrone|norethindrone|mesh-list
20051157|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
20051158|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20051159|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20051160|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20051161|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
20051162|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20051163|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051164|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20051165|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20051166|NCT05293509|Cyclosporine|cyclosporine|mesh-list
20051167|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
20051168|NCT05293509|Dexamethasone|dexamethasone|mesh-list
20051169|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
20051170|NCT05293509|Busulfan|busulfan|mesh-list
20051171|NCT05293509|Rituximab|rituximab|mesh-list
20051172|NCT05293509|Fludarabine|fludarabine|mesh-list
20051173|NCT05293509|Bortezomib|bortezomib|mesh-list
20051174|NCT05293509|Tacrolimus|tacrolimus|mesh-list
20051175|NCT05293509|Cyclosporins|cyclosporins|mesh-list
20051176|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
20051177|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051178|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
20051179|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051180|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051181|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20051182|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
20051183|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051184|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051185|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20051186|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051187|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20051188|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
20051189|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
20051190|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051191|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051192|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
20051193|NCT05293509|Hormones|hormones|mesh-ancestor
20051194|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051195|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20051196|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20051197|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051198|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
20051199|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051200|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
20051201|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20051202|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20051203|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
20051204|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20051205|NCT05281770|Erenumab|erenumab|mesh-list
20051206|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20051207|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051208|NCT05281770|Analgesics|analgesics|mesh-ancestor
20051209|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
20051210|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051211|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051212|NCT05273567|Guanfacine|guanfacine|mesh-list
20051213|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20051214|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20051215|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20051216|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20051217|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
20051218|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051219|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051220|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051221|NCT05267600|Prednisone|prednisone|mesh-list
20051222|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20051223|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
20051224|NCT05267600|Hormones|hormones|mesh-ancestor
20051225|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051226|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051227|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20051228|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051229|NCT05267054|Rituximab|rituximab|mesh-list
20051230|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051231|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051232|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
20051233|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051234|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118074|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118075|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
20118076|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118077|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118078|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118079|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
20118080|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118081|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118082|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118083|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118084|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
20118085|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
20118086|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118087|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118088|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
20118089|NCT00005987|Hormones|hormones|mesh-ancestor
20118090|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118091|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20118092|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118093|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118094|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118095|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118096|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
20118097|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118098|NCT00005987|Analgesics|analgesics|mesh-ancestor
20118099|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
20118100|NCT00005988|Leucovorin|leucovorin|mesh-list
20118101|NCT00005988|Cyclosporine|cyclosporine|mesh-list
20118102|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
20118103|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
20118104|NCT00005988|Methotrexate|methotrexate|mesh-list
20118105|NCT00005988|Cyclosporins|cyclosporins|mesh-list
20118106|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
20118107|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118108|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
20118109|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118110|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118111|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118112|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
20118113|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051235|NCT05243342|Daratumumab|daratumumab|mesh-list
20051236|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051237|NCT05216952|Misoprostol|misoprostol|mesh-list
20051238|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
20051239|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20051240|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
20051241|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20051242|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051243|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20051244|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051245|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
20051246|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20051247|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
20051248|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20051249|NCT05215925|Carboplatin|carboplatin|mesh-list
20051250|NCT05215925|Docetaxel|docetaxel|mesh-list
20051251|NCT05215925|Pemetrexed|pemetrexed|mesh-list
20051252|NCT05215925|Cetuximab|cetuximab|mesh-list
20051253|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051254|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
20051255|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
20051256|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
20051257|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051258|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051259|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20051260|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20051261|NCT05215925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051262|NCT05211323|Gemcitabine|gemcitabine|mesh-list
20051263|NCT05211323|Bevacizumab|bevacizumab|mesh-list
20051264|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20051265|NCT05211323|Cisplatin|cisplatin|mesh-list
20051266|NCT05211323|Atezolizumab|atezolizumab|mesh-list
20051267|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
20051268|NCT05211323|Antibodies|antibodies|mesh-list
20051269|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
20051270|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20051271|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
20051272|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051273|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20051274|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20051275|NCT05211323|Growth Substances|growth substances|mesh-ancestor
20051276|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051277|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
20051278|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
20051279|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051280|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
20051281|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051282|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
20051283|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051284|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051285|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051286|NCT05201859|Capecitabine|capecitabine|mesh-list
20051287|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051288|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
20051289|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051290|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051291|NCT05185583|Methylphenidate|methylphenidate|mesh-list
20051292|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20051293|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051294|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20051295|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20051296|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20051297|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051298|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
20051299|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051300|NCT05178043|Nivolumab|nivolumab|mesh-list
20051301|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051302|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051303|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20051304|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051305|NCT05171816|Olaparib|olaparib|mesh-list
20051306|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
20051307|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20051308|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051309|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051310|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051311|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20051312|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
20051313|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051314|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051315|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20051316|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
20051317|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051318|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051319|NCT05162027|Erenumab|erenumab|mesh-list
20051320|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20051321|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051322|NCT05162027|Analgesics|analgesics|mesh-ancestor
20051323|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
20051324|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051325|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051326|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
20051327|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
20051328|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051329|NCT05142228|Erenumab|erenumab|mesh-list
20051330|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20051331|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051332|NCT05142228|Analgesics|analgesics|mesh-ancestor
20051333|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
20051334|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051335|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051336|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
20051337|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
20051338|NCT05113004|Leflunomide|leflunomide|mesh-list
20051339|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20051340|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051341|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20051342|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
20051343|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20051344|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051345|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051346|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051347|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
20051348|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20051349|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20051350|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051351|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051352|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
20051353|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051354|NCT05110742|Vidarabine|vidarabine|mesh-list
20051355|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
20051356|NCT05110742|Fludarabine|fludarabine|mesh-list
20051357|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
20051358|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051359|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
20051360|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051361|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051362|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20051363|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
20051364|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051365|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051366|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20051367|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051368|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
20051369|NCT05110742|Antiviral Agents|antiviral agents|mesh-ancestor
20051370|NCT05110742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051371|NCT05093790|Aspirin|aspirin|mesh-list
20051372|NCT05093790|Ticagrelor|ticagrelor|mesh-list
20051373|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20051374|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20051375|NCT05093790|Analgesics|analgesics|mesh-ancestor
20051376|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
20051377|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051378|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051379|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20051380|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051381|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20051382|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20051383|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051384|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20051385|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20051386|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051387|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
20051388|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20051389|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20051390|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20051391|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
20051392|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051393|NCT05092373|Paclitaxel|paclitaxel|mesh-list
20051394|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20051395|NCT05092373|Atezolizumab|atezolizumab|mesh-list
20051396|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20051397|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20051398|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051399|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
20051400|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
20051401|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
20051402|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051403|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
20051404|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051405|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
20051406|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
20051407|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051408|NCT05083754|Temozolomide|temozolomide|mesh-list
20051409|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20051410|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
20051411|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051412|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051413|NCT05075993|Paclitaxel|paclitaxel|mesh-list
20051414|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20051415|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
20051416|NCT05075993|Bevacizumab|bevacizumab|mesh-list
20051417|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20051418|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051419|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
20051420|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
20051421|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
20051422|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051423|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051424|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
20051425|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051426|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051427|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20051428|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
20051429|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20051430|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051431|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20051432|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20051433|NCT05075993|Growth Substances|growth substances|mesh-ancestor
20051434|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
20051435|NCT05066061|Analgesics|analgesics|mesh-list
20051436|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
20051437|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
20051438|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051439|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051440|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20051441|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051442|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20051443|NCT05057949|Itraconazole|itraconazole|mesh-list
20051444|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20051445|NCT05057949|Rifampin|rifampin|mesh-list
20051446|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
20051447|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051448|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20051449|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20051450|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051451|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051452|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20051453|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
20051454|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051455|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051456|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20051457|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20051458|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
20051459|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20051460|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
20051461|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20051462|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20051463|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20051464|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20051465|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20051466|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20051467|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20051468|NCT05050136|Volixibat|volixibat|mesh-list
20051469|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20118114|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118115|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118116|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20118117|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
20118118|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20118119|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118120|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
20118121|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
20118122|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118123|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20118124|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20118125|NCT00005988|Antidotes|antidotes|mesh-ancestor
20118126|NCT00005988|Protective Agents|protective agents|mesh-ancestor
20118127|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
20118128|NCT00005988|Vitamins|vitamins|mesh-ancestor
20118129|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
20118130|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
20118131|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118132|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20118133|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118134|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
20118135|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
20118136|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118137|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118138|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
20118139|NCT00005988|Hormones|hormones|mesh-ancestor
20118140|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118141|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20118142|NCT00005989|Tipifarnib|tipifarnib|mesh-list
20118143|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118144|NCT00005990|Topotecan|topotecan|mesh-list
20118145|NCT00005990|Tipifarnib|tipifarnib|mesh-list
20118146|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20118147|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118148|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118149|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118150|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118151|NCT00005991|Gemcitabine|gemcitabine|mesh-list
20118152|NCT00005991|Doxorubicin|doxorubicin|mesh-list
20118153|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20118154|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118155|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
20118156|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118157|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118158|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
20118159|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118160|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051470|NCT05048238|Tofacitinib|tofacitinib|mesh-list
20051471|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20051472|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051473|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051474|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
19491509|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491510|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20051475|NCT05027308|Teduglutide|teduglutide|mesh-list
20051476|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051477|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20051478|NCT05027308|Protective Agents|protective agents|mesh-ancestor
20051479|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051480|NCT05024032|Tirzepatide|tirzepatide|mesh-list
20051481|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20051482|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051483|NCT05024032|Incretins|incretins|mesh-ancestor
20051484|NCT05024032|Hormones|hormones|mesh-ancestor
20051485|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051486|NCT05010954|Lansoprazole|lansoprazole|mesh-list
20051487|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
20051488|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20051489|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051490|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20051491|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051492|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051493|NCT04964934|Letrozole|letrozole|mesh-list
20051494|NCT04964934|Palbociclib|palbociclib|mesh-list
20051495|NCT04964934|Anastrozole|anastrozole|mesh-list
20051496|NCT04964934|Hormones|hormones|mesh-list
20051497|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20051498|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051499|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051500|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051501|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20051502|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20051503|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051504|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051505|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20051506|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
20051507|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20051508|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20051509|NCT04960215|Ubiquinone|ubiquinone|mesh-list
20051510|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
20051511|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
20051512|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051513|NCT04960215|Vitamins|vitamins|mesh-ancestor
20051514|NCT04949477|Acetaminophen|acetaminophen|mesh-list
20051515|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
20051516|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20051517|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051518|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051519|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20051520|NCT04949477|Analgesics|analgesics|mesh-ancestor
20051521|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
20051522|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051523|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20051524|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20051525|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20051526|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
20051527|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051528|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051529|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
20051530|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20051531|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20051532|NCT04944017|Ketamine|ketamine|mesh-list
20051533|NCT04944017|Analgesics|analgesics|mesh-ancestor
20051534|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
20051535|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051536|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051537|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20051538|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20051539|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
20051540|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
20051541|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051542|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20051543|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20051544|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051545|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051546|NCT04941261|Vaccines|vaccines|mesh-list
20051547|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
20051548|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051549|NCT04941170|Bupivacaine|bupivacaine|mesh-list
20051550|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
20051551|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
20051552|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051553|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051554|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
20051555|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051556|NCT04933344|Daptomycin|daptomycin|mesh-list
20051557|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20051558|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051559|NCT04916002|Cemiplimab|cemiplimab|mesh-list
20051560|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051561|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051562|NCT04874545|Propofol|propofol|mesh-list
20051563|NCT04874545|Sevoflurane|sevoflurane|mesh-list
20051564|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20293268|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
20293269|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293270|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
20293271|NCT04606381|Lazertinib|lazertinib|mesh-list
20293272|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293273|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293274|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293275|NCT04572451|Nivolumab|nivolumab|mesh-list
20293276|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293277|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293278|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20293279|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293280|NCT04549207|Denosumab|denosumab|mesh-list
20293281|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
20293282|NCT04549207|Pamidronate|pamidronate|mesh-list
20293283|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20293284|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293285|NCT04543591|Ravulizumab|ravulizumab|mesh-list
20051565|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051566|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051567|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20051568|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
20051569|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
20051570|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20051571|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20293286|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20293287|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293288|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
20293289|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293290|NCT04532463|Fluconazole|fluconazole|mesh-list
20293291|NCT04532463|Amphotericin B|amphotericin b|mesh-list
20293292|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20293293|NCT04532463|Flucytosine|flucytosine|mesh-list
20293294|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
20293295|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293296|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20293297|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20293298|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293299|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051572|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
20051573|NCT04873895|Axitinib|axitinib|mesh-list
20051574|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
20051575|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20051576|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20051577|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051578|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051579|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051580|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051581|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051582|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20051583|NCT04848688|Ivermectin|ivermectin|mesh-list
20051584|NCT04848688|Moxidectin|moxidectin|mesh-list
20051585|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20051586|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051587|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
20051588|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
20051589|NCT04830813|Chiauranib|chiauranib|mesh-list
20051590|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051591|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20051592|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051593|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051594|NCT04823156|Calcium|calcium|mesh-list
20051595|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20051596|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051597|NCT04789616|Maraviroc|maraviroc|mesh-list
20051598|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20051599|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20051600|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051601|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20051602|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20051603|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
20051604|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051605|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20051606|NCT04781673|Lidocaine|lidocaine|mesh-list
20051607|NCT04781673|Ketamine|ketamine|mesh-list
20051608|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
20051609|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
20051610|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051611|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051612|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
20051613|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051614|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20051615|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20051616|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20051617|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20051618|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051619|NCT04781673|Analgesics|analgesics|mesh-ancestor
20051620|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20051621|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20051622|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
20051623|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20051624|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20051625|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051626|NCT04776395|Dexamethasone|dexamethasone|mesh-list
20051627|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
20051628|NCT04776395|Ichthammol|ichthammol|mesh-list
20051629|NCT04776395|BB 1101|bb 1101|mesh-list
20051630|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20051631|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
20051632|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
20051633|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051634|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051635|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051636|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
20051637|NCT04776395|Hormones|hormones|mesh-ancestor
20051638|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051639|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20051640|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051641|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
20051642|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051643|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051644|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
20051645|NCT04774380|Carboplatin|carboplatin|mesh-list
20051646|NCT04774380|Etoposide|etoposide|mesh-list
20051647|NCT04774380|Durvalumab|durvalumab|mesh-list
20051648|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051649|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20051650|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20051651|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20051652|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051653|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051654|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051655|NCT04762979|Fulvestrant|fulvestrant|mesh-list
20051656|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20051657|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20051658|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051659|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20051660|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20051661|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
20051662|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051663|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051664|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20051665|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051666|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051667|NCT04756037|Relugolix|relugolix|mesh-list
20051668|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
20051669|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
20051670|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051671|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118161|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118162|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
20118163|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118164|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20118165|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118166|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118167|NCT00005993|Aldesleukin|aldesleukin|mesh-list
20118168|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118169|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20118170|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20118171|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
20118172|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118173|NCT00005994|Ondansetron|ondansetron|mesh-list
20118174|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
20118175|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
20118176|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118177|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118178|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118179|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
20118180|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
20118181|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20118182|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
20118183|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20118184|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118185|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20118186|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20118187|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20118188|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20118189|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20118190|NCT00005996|Gemcitabine|gemcitabine|mesh-list
20118191|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118192|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118193|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
20118194|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118195|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
20118196|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118197|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118198|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118199|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
20118200|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118201|NCT00005998|Cytarabine|cytarabine|mesh-list
20118202|NCT00005998|Dexamethasone|dexamethasone|mesh-list
20118203|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
20118204|NCT00005998|Carmustine|carmustine|mesh-list
20118205|NCT00005998|Etoposide|etoposide|mesh-list
20118206|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
20118207|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118208|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
20118209|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118210|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118211|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118212|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
20118213|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118214|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118215|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20051672|NCT04738942|Vedolizumab|vedolizumab|mesh-list
20051673|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051674|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20051675|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20051676|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
20051677|NCT04735926|Calcifediol|calcifediol|mesh-list
20051678|NCT04735926|Vitamins|vitamins|mesh-ancestor
20051679|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
20051680|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051681|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20051682|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
20051683|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20051684|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
20051685|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051686|NCT04732000|Expectorants|expectorants|mesh-ancestor
20051687|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
20051688|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20051689|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
20051690|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051691|NCT04732000|Protective Agents|protective agents|mesh-ancestor
20051692|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051693|NCT04732000|Antidotes|antidotes|mesh-ancestor
20051694|NCT04731363|Erythritol|erythritol|mesh-list
20051695|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
20051696|NCT04715646|Brivaracetam|brivaracetam|mesh-list
20051697|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
20051698|NCT04710368|Evolocumab|evolocumab|mesh-list
20051699|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20051700|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20051701|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
20051702|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051703|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20051704|NCT04708171|Anesthetics|anesthetics|mesh-list
20051705|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051706|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051707|NCT04704921|Ranibizumab|ranibizumab|mesh-list
20051708|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20051709|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20051710|NCT04704921|Growth Substances|growth substances|mesh-ancestor
20051711|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051712|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
20051713|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051714|NCT04695977|Nivolumab|nivolumab|mesh-list
20051715|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051716|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051717|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20051718|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051719|NCT04682574|Ascorbic Acid|ascorbic acid|mesh-list
20051720|NCT04682574|Vitamins|vitamins|mesh-ancestor
20051721|NCT04682574|Micronutrients|micronutrients|mesh-ancestor
20051722|NCT04682574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051723|NCT04682574|Antioxidants|antioxidants|mesh-ancestor
20051724|NCT04682574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051725|NCT04682574|Protective Agents|protective agents|mesh-ancestor
20051726|NCT04652440|Antibodies|antibodies|mesh-list
20051727|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20051728|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
20051729|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051730|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20051731|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20051732|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051733|NCT04624295|Aspirin|aspirin|mesh-list
20051734|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20051735|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20051736|NCT04624295|Analgesics|analgesics|mesh-ancestor
20051737|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
20051738|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051739|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051740|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20051741|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051742|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20051743|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20051744|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051745|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20576929|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20051746|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20051747|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051748|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
20051749|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20051750|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051751|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051752|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
20051753|NCT04598074|Narcotics|narcotics|mesh-ancestor
20051754|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051755|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051756|NCT04598074|Analgesics|analgesics|mesh-ancestor
20051757|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
20051758|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051759|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
20051760|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20051761|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051762|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20051763|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051764|NCT04593940|Remdesivir|remdesivir|mesh-list
20051765|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
20051766|NCT04593940|Abatacept|abatacept|mesh-list
20051767|NCT04593940|Infliximab|infliximab|mesh-list
20051768|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
20051769|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051770|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051771|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20051772|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051773|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051774|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051775|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
20051776|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051777|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
20051778|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
20051779|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051780|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20051781|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20051782|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20051783|NCT04589754|Ifosfamide|ifosfamide|mesh-list
20051784|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051785|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051786|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20051787|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
20051788|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
20051789|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20051790|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20051791|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20051792|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20051793|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051794|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
20051795|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051796|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051797|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20051798|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051799|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20051800|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20051801|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20051802|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20051803|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051804|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
20051805|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051806|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051807|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
20051808|NCT04546399|Leucovorin|leucovorin|mesh-list
20051809|NCT04546399|Folic Acid|folic acid|mesh-list
20051810|NCT04546399|Cytarabine|cytarabine|mesh-list
20051811|NCT04546399|Dexamethasone|dexamethasone|mesh-list
20051812|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
20051813|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
20051814|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20051815|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20051816|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20051817|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
20051818|NCT04546399|Methotrexate|methotrexate|mesh-list
20051819|NCT04546399|Nivolumab|nivolumab|mesh-list
20051820|NCT04546399|Etoposide|etoposide|mesh-list
20051821|NCT04546399|Vincristine|vincristine|mesh-list
20051822|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
20051823|NCT04546399|Asparaginase|asparaginase|mesh-list
20051824|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
20051825|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
20051826|NCT04546399|Pegaspargase|pegaspargase|mesh-list
20051827|NCT04546399|Thioguanine|thioguanine|mesh-list
20051828|NCT04546399|Blinatumomab|blinatumomab|mesh-list
20051829|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20051830|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
20051831|NCT04546399|Antibodies|antibodies|mesh-list
20051832|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
20051833|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20051834|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20051835|NCT04546399|BB 1101|bb 1101|mesh-list
20051836|NCT04546399|Calcium|calcium|mesh-list
20051837|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
20051838|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
20051839|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051840|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
20051841|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051842|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051843|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20051844|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
20051845|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051846|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051847|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20051848|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20051849|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
20051850|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
20051851|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051852|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20051853|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
20051854|NCT04546399|Hormones|hormones|mesh-ancestor
20051855|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20051856|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20051857|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
20051858|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051859|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20051860|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20051861|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20051862|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
20051863|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20051864|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051865|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
20051866|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
20051867|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20051868|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20051869|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20051870|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20051871|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20051872|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20051873|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
20051874|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051875|NCT04546399|Antidotes|antidotes|mesh-ancestor
20051876|NCT04546399|Protective Agents|protective agents|mesh-ancestor
20051877|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
20051878|NCT04546399|Vitamins|vitamins|mesh-ancestor
20051879|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
20051880|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
20051881|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
20051882|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
20051883|NCT04546399|Hematinics|hematinics|mesh-ancestor
20051884|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
20051885|NCT04535713|Gemcitabine|gemcitabine|mesh-list
20051886|NCT04535713|Docetaxel|docetaxel|mesh-list
20051887|NCT04535713|Doxorubicin|doxorubicin|mesh-list
20051888|NCT04535713|Nivolumab|nivolumab|mesh-list
20051889|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051890|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
20051891|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051892|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051893|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
20051894|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051895|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051896|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051897|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
20293300|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20051898|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051899|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
20051900|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
20051901|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
20051902|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20051903|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20051904|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20051905|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20051906|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20051907|NCT04534218|Aspirin|aspirin|mesh-list
20051908|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
20051909|NCT04534218|Capecitabine|capecitabine|mesh-list
20051910|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20051911|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
20051912|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051913|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20051914|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20051915|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
20051916|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051917|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051918|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20051919|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20051920|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
20051921|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20051922|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20051923|NCT04534218|Analgesics|analgesics|mesh-ancestor
20051924|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
20051925|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20051926|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20051927|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20051928|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20051929|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20051930|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20051931|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051932|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
20051933|NCT04527432|Antibodies|antibodies|mesh-list
20051934|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
20051935|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051936|NCT04524351|Phenserine|phenserine|mesh-list
20051937|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20051938|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051939|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051940|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
20051941|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051942|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051943|NCT04512066|Risperidone|risperidone|mesh-list
20051944|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20051945|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
20051946|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20051947|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051948|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051949|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20051950|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20051951|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051952|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20051953|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20051954|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
20051957|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
20051958|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20051959|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20051960|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20051961|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
20051962|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20051963|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051964|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20051965|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051966|NCT04473482|Ethanol|ethanol|mesh-list
20051967|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20051968|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20051969|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051970|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051971|NCT04450355|Nefopam|nefopam|mesh-list
20051972|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20051973|NCT04450355|Analgesics|analgesics|mesh-ancestor
20051974|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
20051975|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293301|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
20051976|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051977|NCT04436133|Vaccines|vaccines|mesh-list
20051978|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
20051979|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051980|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20051981|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20051982|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20051983|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20051984|NCT04426500|Bupivacaine|bupivacaine|mesh-list
20051985|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
20051986|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
20051987|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20051988|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20051989|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
20051990|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118216|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118217|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
20118218|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
20118219|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118220|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118221|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
20118222|NCT00005998|Hormones|hormones|mesh-ancestor
20118223|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118224|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20118225|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118226|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118227|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118228|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118229|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118230|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
20118231|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
20118232|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118233|NCT00005998|Analgesics|analgesics|mesh-ancestor
20118234|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
20118235|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
20118236|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118237|NCT00006000|Irinotecan|irinotecan|mesh-list
20118238|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118239|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20118240|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118241|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118242|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120702|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120703|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20120704|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120705|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120706|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120707|NCT00006394|Hormones|hormones|mesh-list
20120708|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120709|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120710|NCT00006396|Zidovudine|zidovudine|mesh-list
20120711|NCT00006396|Nevirapine|nevirapine|mesh-list
20120712|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
20120713|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120714|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20120715|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120716|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120717|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
20120718|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120719|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120720|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120721|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20120722|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20120723|NCT00006397|Ritonavir|ritonavir|mesh-list
20120724|NCT00006397|Indinavir|indinavir|mesh-list
20120725|NCT00006397|Stavudine|stavudine|mesh-list
20120726|NCT00006397|Didanosine|didanosine|mesh-list
20120727|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20120728|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20120729|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
20051996|NCT04384484|Gemcitabine|gemcitabine|mesh-list
20051997|NCT04384484|Rituximab|rituximab|mesh-list
20051998|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20051999|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
20052000|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052001|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052002|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
20052003|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491511|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491512|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
19491513|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491514|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491515|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
20052004|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052005|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052006|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
20052007|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052008|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
20052009|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052010|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052011|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052012|NCT04372433|Azacitidine|azacitidine|mesh-list
20052013|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052014|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
20052015|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052016|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052017|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052018|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
20052019|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
20052020|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20052021|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20052022|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052023|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052024|NCT04356716|Urological Agents|urological agents|mesh-ancestor
20052025|NCT04329494|Leucovorin|leucovorin|mesh-list
20052026|NCT04329494|Cisplatin|cisplatin|mesh-list
20052027|NCT04329494|Doxorubicin|doxorubicin|mesh-list
20052028|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20052029|NCT04329494|Fluorouracil|fluorouracil|mesh-list
20052030|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
20052031|NCT04329494|Irinotecan|irinotecan|mesh-list
20052032|NCT04329494|Daunorubicin|daunorubicin|mesh-list
20052033|NCT04329494|Mitomycins|mitomycins|mesh-list
20052034|NCT04329494|Mitomycin|mitomycin|mesh-list
20052035|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052036|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20052037|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20052038|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20052039|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052040|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052041|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
20052042|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052043|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052044|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
20052045|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052046|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20052047|NCT04329494|Antidotes|antidotes|mesh-ancestor
20052048|NCT04329494|Protective Agents|protective agents|mesh-ancestor
20052049|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
20052050|NCT04329494|Vitamins|vitamins|mesh-ancestor
20052051|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
20052052|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
20052053|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20052054|NCT04300309|Lumefantrine|lumefantrine|mesh-list
20052055|NCT04300309|Artemether|artemether|mesh-list
20052056|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
20052057|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20052058|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20052059|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052060|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20052061|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20052062|NCT04278781|Ivosidenib|ivosidenib|mesh-list
20052063|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052064|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052065|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052066|NCT04278755|Drospirenone|drospirenone|mesh-list
20052067|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20052068|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20052069|NCT04278755|Estradiol|estradiol|mesh-list
20052070|NCT04278755|Estrogens|estrogens|mesh-ancestor
20052071|NCT04278755|Hormones|hormones|mesh-ancestor
20052072|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052073|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052074|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20052075|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
20052076|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20052077|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20052078|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20052079|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20052080|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20052081|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20052082|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20052083|NCT04278755|Diuretics|diuretics|mesh-ancestor
20052084|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
20052085|NCT04275362|Cimetidine|cimetidine|mesh-list
20052086|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20052087|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052088|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20052089|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
20052090|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
20052091|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052092|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052093|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052094|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20052095|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20052096|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052097|NCT04246086|Lenalidomide|lenalidomide|mesh-list
20052098|NCT04246086|Obinutuzumab|obinutuzumab|mesh-list
20052099|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
20052100|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052101|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20052102|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20052103|NCT04246086|Growth Substances|growth substances|mesh-ancestor
20052104|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
20052105|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052106|NCT04246086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052107|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20052108|NCT04216017|Lidocaine|lidocaine|mesh-list
20052109|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
20052110|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
20052111|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20052112|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052113|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
20052114|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052115|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20052116|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20052117|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20052118|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20052119|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052120|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052121|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
20052122|NCT04216017|Hormones|hormones|mesh-ancestor
20052123|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052124|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052125|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
20052126|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
20052127|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052128|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
20052129|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052130|NCT04177108|Paclitaxel|paclitaxel|mesh-list
20052131|NCT04177108|Atezolizumab|atezolizumab|mesh-list
20052132|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20052133|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052134|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052135|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052136|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052137|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052138|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052139|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
20052140|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052141|NCT04165330|Nivolumab|nivolumab|mesh-list
20308362|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052142|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052143|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052144|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052145|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052146|NCT04157335|Benralizumab|benralizumab|mesh-list
20052147|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20052148|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
20052149|NCT04153760|Aspirin|aspirin|mesh-list
20052150|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20052151|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20052152|NCT04153760|Analgesics|analgesics|mesh-ancestor
20052153|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
20052154|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052155|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052156|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052157|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052158|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20052159|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20052160|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052161|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20052162|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20052163|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052164|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
20052165|NCT04146207|Prednisone|prednisone|mesh-list
20052166|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052167|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
20052168|NCT04146207|Hormones|hormones|mesh-ancestor
20052169|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052170|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052171|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20052172|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052173|NCT04131192|Gemcitabine|gemcitabine|mesh-list
20052174|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052175|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
20052176|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052177|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052178|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
20052179|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052180|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052181|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052182|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
20052183|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052184|NCT04127786|Vaccines|vaccines|mesh-list
20052185|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
20052186|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052187|NCT04121403|Rituximab|rituximab|mesh-list
20052188|NCT04121403|Cladribine|cladribine|mesh-list
20052189|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052190|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052191|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
20052192|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052193|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052194|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052195|NCT04088786|Irinotecan|irinotecan|mesh-list
20052196|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20052197|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20052198|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052199|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052200|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052201|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
20052202|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052203|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052204|NCT04023669|Gemcitabine|gemcitabine|mesh-list
20052205|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
20052206|NCT04023669|Lenograstim|lenograstim|mesh-list
20052207|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052208|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
20052209|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052210|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052211|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20052212|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
20052213|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052214|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052215|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20052216|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052217|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
20052218|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
20052219|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052220|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052221|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20052222|NCT04005352|Aflibercept|aflibercept|mesh-list
20052223|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20052224|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20052225|NCT04005352|Growth Substances|growth substances|mesh-ancestor
20052226|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052227|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
20052228|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052229|NCT04004208|Aflibercept|aflibercept|mesh-list
20052230|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20052231|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20052232|NCT04004208|Growth Substances|growth substances|mesh-ancestor
20052233|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052234|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
20052235|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052236|NCT03971734|Regadenoson|regadenoson|mesh-list
20052237|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20052238|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20052239|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
20052240|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
20052241|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052242|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052243|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052244|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
20052245|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576930|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20576931|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20576932|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20576933|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20576934|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576935|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576936|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
20576937|NCT02074280|Rifaximin|rifaximin|mesh-list
20576938|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20576939|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576940|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20576941|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20052246|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052247|NCT03906071|Docetaxel|docetaxel|mesh-list
20052248|NCT03906071|Nivolumab|nivolumab|mesh-list
20052249|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052250|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052251|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052252|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052253|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052254|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052255|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20118243|NCT00006001|Semaxinib|semaxinib|mesh-list
20118244|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20118245|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20118246|NCT00006001|Growth Substances|growth substances|mesh-ancestor
20118247|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118248|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
20118249|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118250|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118251|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118252|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118253|NCT00006002|Dexamethasone|dexamethasone|mesh-list
20118254|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118255|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
20118256|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
20118257|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118258|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118259|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118260|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
20118261|NCT00006002|Hormones|hormones|mesh-ancestor
20118262|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052256|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
20052257|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
20052258|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20052259|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
20052260|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052261|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
20052262|NCT03883074|Protective Agents|protective agents|mesh-ancestor
20052263|NCT03883074|Antacids|antacids|mesh-ancestor
20052264|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052265|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052266|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20052267|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
20052268|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052269|NCT03837509|Daratumumab|daratumumab|mesh-list
20052270|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052271|NCT03795350|Beclomethasone|beclomethasone|mesh-list
20052272|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
20052273|NCT03795350|Bromides|bromides|mesh-list
20052274|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
20052275|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20052276|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
20052277|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052278|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052279|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20052280|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
20052281|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20052282|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20052283|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20052284|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
20052285|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052286|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052287|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
20052288|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20052289|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20052290|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20052291|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
20052292|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052293|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
20052294|NCT03795350|Hormones|hormones|mesh-ancestor
20052295|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052296|NCT03794583|Treprostinil|treprostinil|mesh-list
20052297|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20052298|NCT03783403|Rituximab|rituximab|mesh-list
20052299|NCT03783403|Cetuximab|cetuximab|mesh-list
20052300|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052301|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052302|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
20052303|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052304|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052305|NCT03778996|Sirolimus|sirolimus|mesh-list
20052306|NCT03778996|Phenytoin|phenytoin|mesh-list
20052307|NCT03778996|Methoxsalen|methoxsalen|mesh-list
20052308|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
20052309|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20052310|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052311|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20052312|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052313|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
20052314|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052315|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
20052316|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052317|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
20052318|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20052319|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20052320|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20052321|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052322|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20052323|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20052324|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20052325|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
20052326|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052327|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
20052328|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20052329|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
20052330|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20052331|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
20052332|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052333|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052334|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
20052335|NCT03761095|Dacarbazine|dacarbazine|mesh-list
20052336|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20052337|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
20052338|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052339|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052340|NCT03742414|Fluticasone|fluticasone|mesh-list
20052341|NCT03742414|Xhance|xhance|mesh-list
20052342|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052343|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20052344|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
20052345|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052346|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052347|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20052348|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
20052349|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
20052350|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20052351|NCT03701282|Venetoclax|venetoclax|mesh-list
20052352|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
20052353|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052354|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052355|NCT03670836|Misoprostol|misoprostol|mesh-list
20052356|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20052357|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
20052358|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20052359|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052360|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20052361|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052362|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
20052363|NCT03655613|Nivolumab|nivolumab|mesh-list
20052364|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052365|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052366|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052367|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052368|NCT03653338|Rituximab|rituximab|mesh-list
20052369|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
20052370|NCT03653338|Fludarabine|fludarabine|mesh-list
20052371|NCT03653338|Thiotepa|thiotepa|mesh-list
20052372|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
20052373|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052374|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052375|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
20052376|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052377|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052378|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052379|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052380|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20052381|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
20052382|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20052383|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
20052384|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052385|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20052386|NCT03624062|Insulin|insulin|mesh-list
20052387|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20052388|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052389|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20052390|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
20052391|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052392|NCT03607656|Docetaxel|docetaxel|mesh-list
20052393|NCT03607656|Capecitabine|capecitabine|mesh-list
20052394|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
20052395|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052396|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052397|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052398|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052399|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293302|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293303|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293304|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20293305|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20576942|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20052400|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052401|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
20052402|NCT03598842|Metronidazole|metronidazole|mesh-list
20293306|NCT04532463|Amebicides|amebicides|mesh-ancestor
20293307|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20293308|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20293309|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20293310|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
20293311|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
20293312|NCT04526509|Fludarabine|fludarabine|mesh-list
20293313|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293314|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
20293315|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293316|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20293317|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20293318|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
20293319|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293320|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293321|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20293322|NCT04524000|Fulvestrant|fulvestrant|mesh-list
20293323|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293324|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293325|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20052403|NCT03598842|Ivermectin|ivermectin|mesh-list
20052404|NCT03598842|Albendazole|albendazole|mesh-list
20052405|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
20052406|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052407|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20052408|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20052409|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
20052410|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
20052411|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20052412|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052413|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052414|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052415|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052416|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052417|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20052418|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20052419|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
20052420|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052421|NCT03589768|Antacids|antacids|mesh-ancestor
20052422|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052423|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052424|NCT03580044|Aztreonam|aztreonam|mesh-list
20052425|NCT03580044|Avibactam|avibactam|mesh-list
20052426|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20052427|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052428|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20052429|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052430|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052431|NCT03579446|Oxymorphone|oxymorphone|mesh-list
20052432|NCT03579446|Morphine|morphine|mesh-list
20052433|NCT03579446|Oxycodone|oxycodone|mesh-list
20052434|NCT03579446|Hydromorphone|hydromorphone|mesh-list
20052435|NCT03579446|Hydrocodone|hydrocodone|mesh-list
20052436|NCT03579446|Levorphanol|levorphanol|mesh-list
20052437|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20052438|NCT03579446|Narcotics|narcotics|mesh-ancestor
20052439|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20052440|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052441|NCT03579446|Analgesics|analgesics|mesh-ancestor
20052442|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
20052443|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052444|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
20052445|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
20052446|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20052447|NCT03576612|Valacyclovir|valacyclovir|mesh-list
20052448|NCT03576612|Acyclovir|acyclovir|mesh-list
20052449|NCT03576612|Nivolumab|nivolumab|mesh-list
20052450|NCT03576612|Temozolomide|temozolomide|mesh-list
20052451|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052452|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052453|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052454|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052455|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20052456|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
20052457|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
20052458|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052459|NCT03568383|Pyridoxine|pyridoxine|mesh-list
20052460|NCT03568383|Pyridoxal|pyridoxal|mesh-list
20052461|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
20052462|NCT03568383|Isoniazid|isoniazid|mesh-list
20052463|NCT03568383|Vitamins|vitamins|mesh-ancestor
20052464|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
20052465|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052466|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
20052467|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
20052468|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20052469|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052470|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20052471|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20052472|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
20052473|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052474|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20052475|NCT03525028|Metformin|metformin|mesh-list
20052476|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20052477|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052478|NCT03523312|Capecitabine|capecitabine|mesh-list
20052479|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052480|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
20052481|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052482|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052483|NCT03505762|Prednisone|prednisone|mesh-list
20052484|NCT03505762|Cortisone|cortisone|mesh-list
20052485|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
20052486|NCT03505762|Rituximab|rituximab|mesh-list
20052487|NCT03505762|Doxorubicin|doxorubicin|mesh-list
20052488|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20052489|NCT03505762|Vincristine|vincristine|mesh-list
20052490|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20052491|NCT03505762|Antibodies|antibodies|mesh-list
20052492|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
20052493|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20052494|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052495|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
20052496|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052497|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052498|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20052499|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
20052500|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052501|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052502|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20052503|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20052504|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20052505|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20052506|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052507|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052508|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
20052509|NCT03505762|Hormones|hormones|mesh-ancestor
20052510|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052511|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20052512|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052513|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052514|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052515|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052516|NCT03503942|Metformin|metformin|mesh-list
20052517|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20052518|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052519|NCT03496623|Treprostinil|treprostinil|mesh-list
20052520|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20052521|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20052522|NCT03471663|Palbociclib|palbociclib|mesh-list
20052523|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052524|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20052525|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052526|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052527|NCT03459222|Nivolumab|nivolumab|mesh-list
20052528|NCT03459222|Ipilimumab|ipilimumab|mesh-list
20052529|NCT03459222|Linrodostat|linrodostat|mesh-list
20052530|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052531|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052532|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052533|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052534|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052535|NCT03458429|Sargramostim|sargramostim|mesh-list
20052536|NCT03458429|Lenograstim|lenograstim|mesh-list
20052537|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
20052538|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052539|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20052540|NCT03457142|Dexamethasone|dexamethasone|mesh-list
20052541|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
20052542|NCT03457142|Abatacept|abatacept|mesh-list
20052543|NCT03457142|Ixazomib|ixazomib|mesh-list
20052544|NCT03457142|Ichthammol|ichthammol|mesh-list
20052545|NCT03457142|BB 1101|bb 1101|mesh-list
20052546|NCT03457142|Glycine|glycine|mesh-list
20052547|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052548|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
20052549|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
20052550|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052551|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052552|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052553|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
20052554|NCT03457142|Hormones|hormones|mesh-ancestor
20052555|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052556|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20052557|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052558|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052559|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
20052560|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052561|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052562|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052563|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
20052564|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052565|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
20052566|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
20052567|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052568|NCT03447782|Naltrexone|naltrexone|mesh-list
20052569|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20052570|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20052571|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052572|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
20052573|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052574|NCT03440567|Rituximab|rituximab|mesh-list
20052575|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20052576|NCT03440567|Avelumab|avelumab|mesh-list
20052577|NCT03440567|Carboplatin|carboplatin|mesh-list
20052578|NCT03440567|Etoposide|etoposide|mesh-list
20052579|NCT03440567|Ifosfamide|ifosfamide|mesh-list
20052580|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
20052581|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
20052582|NCT03440567|Antibodies|antibodies|mesh-list
20052583|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
20052584|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20052585|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
20052586|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
20052587|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052588|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052589|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052590|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052591|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20052592|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20052593|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052594|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052595|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20052596|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
20052597|NCT03425331|Nivolumab|nivolumab|mesh-list
20052598|NCT03425331|Ipilimumab|ipilimumab|mesh-list
20052599|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052600|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052601|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052602|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052603|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
20052604|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
20052605|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052606|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20052607|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052608|NCT03410446|Ketamine|ketamine|mesh-list
20052609|NCT03410446|Analgesics|analgesics|mesh-ancestor
20052610|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
20052611|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052612|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052613|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20052614|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20052615|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
20052616|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
20052617|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20052618|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20052619|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20052620|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052621|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052622|NCT03409614|Cemiplimab|cemiplimab|mesh-list
20052623|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052624|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052625|NCT03381274|Osimertinib|osimertinib|mesh-list
20052626|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052627|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20052628|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052629|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052630|NCT03374839|Nivolumab|nivolumab|mesh-list
20052631|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052632|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052633|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052634|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052635|NCT03347929|Naproxen|naproxen|mesh-list
20052636|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20052637|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20052638|NCT03347929|Analgesics|analgesics|mesh-ancestor
20052639|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
20052640|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052641|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052642|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052643|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052644|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
20052645|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20052646|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052647|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052648|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
20052649|NCT03330028|Promethazine|promethazine|mesh-list
20052650|NCT03330028|Dexamethasone|dexamethasone|mesh-list
20052651|NCT03330028|Paclitaxel|paclitaxel|mesh-list
20052652|NCT03330028|Cisplatin|cisplatin|mesh-list
20052653|NCT03330028|Mitomycins|mitomycins|mesh-list
20052654|NCT03330028|Mitomycin|mitomycin|mesh-list
20576943|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20576944|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20576945|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576946|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20576947|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20576948|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052655|NCT03330028|Famotidine|famotidine|mesh-list
20052656|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052657|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052658|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052659|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052660|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052661|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052662|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052663|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
20052664|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
20052665|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052666|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052667|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052668|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
20052669|NCT03330028|Hormones|hormones|mesh-ancestor
20052670|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052671|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20052672|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20052673|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
20052674|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20052675|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052676|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20052677|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20052678|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20052679|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
20052680|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
20052681|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
20052682|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20052683|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
20052684|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
20052685|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052686|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20052687|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
20052688|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
20052689|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20052690|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20052691|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
20052692|NCT03325647|Testosterone|testosterone|mesh-list
20052693|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
20052694|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
20052695|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20052696|NCT03325647|Androgens|androgens|mesh-ancestor
20052697|NCT03325647|Hormones|hormones|mesh-ancestor
20052698|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052699|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052700|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20052701|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052702|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
20052703|NCT03324373|Everolimus|everolimus|mesh-list
20052704|NCT03324373|Lenvatinib|lenvatinib|mesh-list
20052705|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052706|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052707|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
20052708|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052709|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20052710|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052711|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052712|NCT03314935|Leucovorin|leucovorin|mesh-list
20052713|NCT03314935|Gemcitabine|gemcitabine|mesh-list
20052714|NCT03314935|Paclitaxel|paclitaxel|mesh-list
20052715|NCT03314935|Fluorouracil|fluorouracil|mesh-list
20052716|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
20052717|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052718|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052719|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052720|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052721|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052722|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052723|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052724|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
20052725|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
20052726|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20052727|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052728|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052729|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
20052730|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052731|NCT03314935|Antidotes|antidotes|mesh-ancestor
20052732|NCT03314935|Protective Agents|protective agents|mesh-ancestor
20052733|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
20052734|NCT03314935|Vitamins|vitamins|mesh-ancestor
20052735|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
19491516|NCT03130179|Nicotine|nicotine|mesh-list
19491517|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20118263|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20118264|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118265|NCT00006003|Semaxinib|semaxinib|mesh-list
20052736|NCT03282669|Morphine|morphine|mesh-list
20052737|NCT03282669|Hydromorphone|hydromorphone|mesh-list
20052738|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20052739|NCT03282669|Narcotics|narcotics|mesh-ancestor
20052740|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20052741|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052742|NCT03282669|Analgesics|analgesics|mesh-ancestor
20052743|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
20052744|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052745|NCT03281369|Leucovorin|leucovorin|mesh-list
20052746|NCT03281369|Linagliptin|linagliptin|mesh-list
20052747|NCT03281369|Paclitaxel|paclitaxel|mesh-list
20052748|NCT03281369|Fluorouracil|fluorouracil|mesh-list
20052749|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
20052750|NCT03281369|Atezolizumab|atezolizumab|mesh-list
20052751|NCT03281369|Ramucirumab|ramucirumab|mesh-list
20052752|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20052753|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052754|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052755|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052756|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052757|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052758|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052759|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
20052760|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052761|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20052762|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
20052763|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052764|NCT03281369|Antidotes|antidotes|mesh-ancestor
20052765|NCT03281369|Protective Agents|protective agents|mesh-ancestor
20052766|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
20052767|NCT03281369|Vitamins|vitamins|mesh-ancestor
20052768|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
20052769|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20052770|NCT03281369|Incretins|incretins|mesh-ancestor
20052771|NCT03281369|Hormones|hormones|mesh-ancestor
20052772|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052773|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20052774|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
20052775|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052776|NCT03247569|Edoxaban|edoxaban|mesh-list
20052777|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20052778|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
20052779|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20052780|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
20052781|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052782|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052783|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
20052784|NCT03238027|Durvalumab|durvalumab|mesh-list
20052785|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052786|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052787|NCT03200587|Avelumab|avelumab|mesh-list
20052788|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052789|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052805|NCT03138161|Nivolumab|nivolumab|mesh-list
20052806|NCT03138161|Ipilimumab|ipilimumab|mesh-list
20052807|NCT03138161|Trabectedin|trabectedin|mesh-list
20052808|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19491518|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
20052809|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052810|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052811|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052812|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20052813|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
20052814|NCT03087578|Mirabegron|mirabegron|mesh-list
20052815|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20052816|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20052817|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20052818|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
20052819|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052820|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052821|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052822|NCT03087578|Urological Agents|urological agents|mesh-ancestor
20052823|NCT03041311|Carboplatin|carboplatin|mesh-list
20052824|NCT03041311|Etoposide|etoposide|mesh-list
20052825|NCT03041311|Atezolizumab|atezolizumab|mesh-list
20052826|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052827|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052828|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20052829|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20052830|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052831|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052832|NCT03020914|Methamphetamine|methamphetamine|mesh-list
20052833|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20052834|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052835|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
20052836|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
20052837|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052838|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
20052839|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052840|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052841|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
20052842|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20052843|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20052844|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20052845|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20052846|NCT03001726|Docetaxel|docetaxel|mesh-list
20052847|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
20052848|NCT03001726|Tegafur|tegafur|mesh-list
20052849|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052850|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052851|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052852|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052853|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052854|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052855|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
20052856|NCT02967133|Paclitaxel|paclitaxel|mesh-list
20052857|NCT02967133|Nivolumab|nivolumab|mesh-list
20052858|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052859|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052860|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052861|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052862|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052863|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052864|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052865|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052866|NCT02935634|Nivolumab|nivolumab|mesh-list
20052867|NCT02935634|Ipilimumab|ipilimumab|mesh-list
20052868|NCT02935634|Rucaparib|rucaparib|mesh-list
20052869|NCT02935634|Linrodostat|linrodostat|mesh-list
20052870|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052871|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052872|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20052873|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052874|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20052875|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052876|NCT02925650|Phenserine|phenserine|mesh-list
20052877|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20052878|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052879|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052880|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
20052881|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20052882|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052883|NCT02849496|Atezolizumab|atezolizumab|mesh-list
20052884|NCT02849496|Olaparib|olaparib|mesh-list
20052885|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20052886|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20052887|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052888|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052889|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052890|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
20052891|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052892|NCT02849457|Vigabatrin|vigabatrin|mesh-list
20052893|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
20052894|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052895|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052896|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
20052897|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746144|NCT04203641|Doxorubicin|doxorubicin|mesh-list
19746145|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19746146|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746147|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746148|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19746149|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746150|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746151|NCT04203290|Bupivacaine|bupivacaine|mesh-list
19746152|NCT04203290|Sevoflurane|sevoflurane|mesh-list
19746153|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19746154|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
19746155|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20052898|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052899|NCT02844816|Atezolizumab|atezolizumab|mesh-list
20052900|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20052901|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052902|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
20052903|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052904|NCT02807558|Azacitidine|azacitidine|mesh-list
20052905|NCT02807558|Daratumumab|daratumumab|mesh-list
20052906|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20052907|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
20052908|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052909|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052910|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052911|NCT02792465|Fulvestrant|fulvestrant|mesh-list
20052912|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20052913|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052914|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20052915|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20052916|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
20052917|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052918|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052919|NCT02751255|Tretinoin|tretinoin|mesh-list
20052920|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052921|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
20052922|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
20052923|NCT02698891|Paclitaxel|paclitaxel|mesh-list
20052924|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20052925|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052926|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
20052927|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
20052928|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
20052929|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052930|NCT02651844|Mifepristone|mifepristone|mesh-list
20052931|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20052932|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
20052933|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20052934|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052935|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20052936|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20052937|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20052938|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
20052939|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20052940|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20052941|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
20052942|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052943|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
20052944|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20052945|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20052946|NCT02575794|Masoprocol|masoprocol|mesh-list
20052947|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
20052948|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052949|NCT02575794|Protective Agents|protective agents|mesh-ancestor
20052950|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052951|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20052952|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20052953|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20052954|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20052955|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20052956|NCT02575794|Analgesics|analgesics|mesh-ancestor
20052957|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
20052958|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052959|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052960|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20052961|NCT02419040|Lidocaine|lidocaine|mesh-list
20052962|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
20052963|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
20052964|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20052965|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293326|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20293327|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
20293328|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293329|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293330|NCT04520607|Lorecivivint|lorecivivint|mesh-list
20293331|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293332|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20293333|NCT04504734|Bucillamine|bucillamine|mesh-list
20052966|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
20052967|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052968|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20052969|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20052970|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20052971|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20052972|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052973|NCT02400476|Budesonide|budesonide|mesh-list
20052974|NCT02400476|Loperamide|loperamide|mesh-list
20052975|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
20052976|NCT02400476|Colestipol|colestipol|mesh-list
20052977|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20052978|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20052979|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
20052980|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20052981|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20052982|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20052983|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
20052984|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
20052985|NCT02400476|Hormones|hormones|mesh-ancestor
20052986|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20052987|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20052988|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20052989|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
20052990|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20052991|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20052992|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
20052993|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
20052994|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
20052995|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20052996|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20052997|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
20052998|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20052999|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20053000|NCT02283996|Prednisolone|prednisolone|mesh-list
20053001|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
20053002|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20053003|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
20053004|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053005|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
20053006|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
20053007|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053008|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053009|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053010|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
20053011|NCT02283996|Hormones|hormones|mesh-ancestor
20053012|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053013|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20053014|NCT02283996|Protective Agents|protective agents|mesh-ancestor
20053015|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053016|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053017|NCT02231749|Nivolumab|nivolumab|mesh-list
20053018|NCT02231749|Ipilimumab|ipilimumab|mesh-list
20053019|NCT02231749|Sunitinib|sunitinib|mesh-list
20053020|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053021|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491519|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053022|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20053023|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053024|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20053025|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20053026|NCT02231749|Growth Substances|growth substances|mesh-ancestor
20053027|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053028|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
20053029|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053030|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053031|NCT02199184|Prednisone|prednisone|mesh-list
20053032|NCT02199184|Cortisone|cortisone|mesh-list
20053033|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
20053034|NCT02199184|Rituximab|rituximab|mesh-list
20053035|NCT02199184|Doxorubicin|doxorubicin|mesh-list
20053036|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20053037|NCT02199184|Etoposide|etoposide|mesh-list
20053038|NCT02199184|Vincristine|vincristine|mesh-list
20053039|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
20053040|NCT02199184|Ofatumumab|ofatumumab|mesh-list
20053041|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
20053042|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20053043|NCT02199184|Antibodies|antibodies|mesh-list
20053044|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
20053045|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20053046|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20053047|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
20053048|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053049|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20053050|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20053051|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
20053052|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053053|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053054|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20053055|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20053056|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20053057|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20053058|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053059|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053060|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
20053061|NCT02199184|Hormones|hormones|mesh-ancestor
20053062|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053063|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053064|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20053065|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
20053066|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
20053067|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
20053068|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
20053069|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
20053070|NCT02108860|Abatacept|abatacept|mesh-list
20053071|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20053072|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053073|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053074|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20053075|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
20053076|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053077|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20053078|NCT02076217|Copper|copper|mesh-list
20053079|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20053080|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
20053081|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
20053082|NCT02076217|Etonogestrel|etonogestrel|mesh-list
20053083|NCT02076217|Desogestrel|desogestrel|mesh-list
20053084|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20053085|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053086|NCT02076217|Trace Elements|trace elements|mesh-ancestor
20053087|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
20053088|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20053089|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20053090|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20053091|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20053092|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20053093|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20053094|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053095|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053096|NCT02076217|Progestins|progestins|mesh-ancestor
20053097|NCT02076217|Hormones|hormones|mesh-ancestor
20053098|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053099|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
20053100|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
20053101|NCT02002130|Butyric Acid|butyric acid|mesh-list
20053102|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20053103|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
20053104|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053105|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
20053106|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053107|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053108|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
19746156|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746157|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
19746158|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746159|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19746160|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19746161|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
19746162|NCT04195945|Cytarabine|cytarabine|mesh-list
19746163|NCT04195945|Daunorubicin|daunorubicin|mesh-list
19746164|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
19746165|NCT04195945|Cladribine|cladribine|mesh-list
19746166|NCT04195945|Sargramostim|sargramostim|mesh-list
19746167|NCT04195945|Lenograstim|lenograstim|mesh-list
19746168|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19746169|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
19746170|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053109|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
20053110|NCT01969643|Trastuzumab|trastuzumab|mesh-list
20053111|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053112|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053113|NCT01786265|Prednisone|prednisone|mesh-list
20053114|NCT01786265|Cortisone|cortisone|mesh-list
20053115|NCT01786265|Leuprolide|leuprolide|mesh-list
20053116|NCT01786265|Goserelin|goserelin|mesh-list
20053117|NCT01786265|Flutamide|flutamide|mesh-list
20053118|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
20053119|NCT01786265|Bicalutamide|bicalutamide|mesh-list
20053120|NCT01786265|Nilutamide|nilutamide|mesh-list
20053121|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053122|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
20053123|NCT01786265|Hormones|hormones|mesh-ancestor
20053124|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053125|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053126|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053127|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053128|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20053129|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
20576949|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
20576950|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576951|NCT02074319|Methotrexate|methotrexate|mesh-list
20576952|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19491520|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053130|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20053131|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20053132|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053133|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053134|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
20053135|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20053136|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
20053137|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20053138|NCT01664910|Rituximab|rituximab|mesh-list
20053139|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20053140|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20576953|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
20053141|NCT01664910|Methotrexate|methotrexate|mesh-list
20053142|NCT01664910|Fludarabine|fludarabine|mesh-list
20053143|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
20053144|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20053145|NCT01664910|Antibodies|antibodies|mesh-list
20053146|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
20053147|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20053148|NCT01664910|Tacrolimus|tacrolimus|mesh-list
20053149|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
20053150|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20053151|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
20053152|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053153|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053154|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20053155|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20053156|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
20053157|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20053158|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20053159|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
20053160|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053161|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
20053162|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053163|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20053164|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20053165|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20053166|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20053167|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20053168|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
20053169|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20053170|NCT01658241|Panobinostat|panobinostat|mesh-list
20053171|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053172|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20053173|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053174|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053175|NCT01471106|Dasatinib|dasatinib|mesh-list
20053176|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053177|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053178|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053179|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053180|NCT01463670|Lenalidomide|lenalidomide|mesh-list
20053181|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
20053182|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053183|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20053184|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20053185|NCT01463670|Growth Substances|growth substances|mesh-ancestor
20053186|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
20053187|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053188|NCT01455051|Ofatumumab|ofatumumab|mesh-list
20053189|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053190|NCT01294020|Tacrolimus|tacrolimus|mesh-list
20053191|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20053192|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
20053193|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053194|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20053195|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053196|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053197|NCT00920816|Sorafenib|sorafenib|mesh-list
20053198|NCT00920816|Axitinib|axitinib|mesh-list
20053199|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053200|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053201|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053202|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118266|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20118267|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20118268|NCT00006003|Growth Substances|growth substances|mesh-ancestor
20118269|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118270|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
20118271|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118272|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118273|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118274|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118275|NCT00006004|Gemcitabine|gemcitabine|mesh-list
20118276|NCT00006004|Paclitaxel|paclitaxel|mesh-list
20118277|NCT00006004|Carboplatin|carboplatin|mesh-list
20118278|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118279|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053203|NCT00565851|Gemcitabine|gemcitabine|mesh-list
20053204|NCT00565851|Paclitaxel|paclitaxel|mesh-list
20053205|NCT00565851|Docetaxel|docetaxel|mesh-list
20053206|NCT00565851|Bevacizumab|bevacizumab|mesh-list
20053207|NCT00565851|Carboplatin|carboplatin|mesh-list
20053208|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20053209|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20053210|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
20053211|NCT00565851|Antibodies|antibodies|mesh-list
20053212|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
20053213|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20053214|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
20053215|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20053216|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053217|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
20053218|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
20053219|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
20053220|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053221|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20053222|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20053223|NCT00565851|Growth Substances|growth substances|mesh-ancestor
20053224|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053225|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
20053226|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
20053227|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20053228|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
20053229|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
20053230|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053231|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053232|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20053233|NCT00151398|Donepezil|donepezil|mesh-list
20053234|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20053235|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053236|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053237|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053238|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053239|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053240|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
20053241|NCT03181009|Omalizumab|omalizumab|mesh-list
20053242|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20053243|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20053244|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
20053245|NCT03181308|Nivolumab|nivolumab|mesh-list
20053246|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053247|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053248|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20053249|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053250|NCT03181451|Ferric maltol|ferric maltol|mesh-list
20053251|NCT03181451|Hematinics|hematinics|mesh-ancestor
20053252|NCT03181932|Vancomycin|vancomycin|mesh-list
20053253|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20053254|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053255|NCT03182920|Lasmiditan|lasmiditan|mesh-list
20053256|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20053257|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
20053258|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053259|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053260|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053261|NCT03183908|Vaccines|vaccines|mesh-list
20053262|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
20053263|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053264|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
20053265|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053266|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053267|NCT03184987|Albuterol|albuterol|mesh-list
20053268|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20053269|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
20053270|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053271|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053272|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20053273|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
20053274|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
20053275|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20053276|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20053277|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20053278|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20053279|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
20053280|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053281|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053282|NCT03185065|Amantadine|amantadine|mesh-list
20053283|NCT03185065|Methylphenidate|methylphenidate|mesh-list
20053284|NCT03185065|Modafinil|modafinil|mesh-list
20053285|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20053286|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053287|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20053288|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20053289|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20053290|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053291|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
20053292|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053293|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20053294|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20053295|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20053296|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20053297|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20053298|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
20053299|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053300|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20053301|NCT03185065|Analgesics|analgesics|mesh-ancestor
20053302|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
20053303|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053304|NCT03185546|Nicotine|nicotine|mesh-list
20053305|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20053306|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
20053307|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053308|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053309|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20053310|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20053311|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053312|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053313|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053314|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
20053315|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20053316|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20053317|NCT03186261|Fluorides|fluorides|mesh-list
20053318|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
20053319|NCT03186261|Protective Agents|protective agents|mesh-ancestor
20053320|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053321|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20053322|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053323|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
20053324|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
20053325|NCT03187197|Dabigatran|dabigatran|mesh-list
20053326|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
20053327|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20053328|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
20053329|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053330|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053331|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
20053332|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
20053333|NCT03187301|Apomorphine|apomorphine|mesh-list
20053334|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20053335|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053336|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20053337|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20053338|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053339|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053340|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053341|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053342|NCT03187301|Emetics|emetics|mesh-ancestor
20053343|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
20053344|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053345|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053346|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
20053347|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
20053348|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053349|NCT03187678|Selexipag|selexipag|mesh-list
20053350|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20053351|NCT03187730|Nicotine|nicotine|mesh-list
20053352|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20053353|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
20053354|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053355|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053356|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20053357|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20053358|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053359|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053360|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053361|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
20053362|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20053363|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
20053364|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053365|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20053366|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20053367|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
20053368|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053369|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053370|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20053371|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
20053372|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20053373|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
20053374|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053375|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053376|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20053377|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
20053378|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
20053379|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20053380|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053381|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053382|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053383|NCT03188185|Naltrexone|naltrexone|mesh-list
20053384|NCT03188185|Buprenorphine|buprenorphine|mesh-list
20053385|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20053386|NCT03188185|Narcotics|narcotics|mesh-ancestor
20053387|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20053388|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053389|NCT03188185|Analgesics|analgesics|mesh-ancestor
20053390|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
20053391|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053392|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20053393|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20053394|NCT03189446|Paclitaxel|paclitaxel|mesh-list
20053395|NCT03189446|Carboplatin|carboplatin|mesh-list
20053396|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20053397|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053398|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
20053399|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
20053400|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
20053401|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053402|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
20053403|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053404|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053405|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053406|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053407|NCT03189589|Nemiralisib|nemiralisib|mesh-list
20053408|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053409|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053410|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053411|NCT03190005|Clopidogrel|clopidogrel|mesh-list
20053412|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20053413|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20053414|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20053415|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20053416|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
20053417|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053418|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053419|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053420|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
20053421|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053422|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053423|NCT03191396|Liraglutide|liraglutide|mesh-list
20053424|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053425|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053426|NCT03191396|Incretins|incretins|mesh-ancestor
20053427|NCT03191396|Hormones|hormones|mesh-ancestor
20053428|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053429|NCT03192306|Ethanol|ethanol|mesh-list
20053430|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20053431|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053432|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20053433|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053434|NCT03192488|Cetirizine|cetirizine|mesh-list
20053435|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20053436|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20053437|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20053438|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
20053439|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
20053440|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053441|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053442|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053443|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20053444|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
20053445|NCT03192826|Dipivefrin|dipivefrin|mesh-list
20053446|NCT03192826|Brinzolamide|brinzolamide|mesh-list
20053447|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20053448|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20053449|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20053450|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20053451|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
20053452|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20576954|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20576955|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576956|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20576957|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
20576958|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576959|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576960|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
20576961|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053453|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053454|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053455|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20053456|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20053457|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20053458|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053459|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20053460|NCT03193047|Evolocumab|evolocumab|mesh-list
20053461|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20053462|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20053463|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
20053464|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053465|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20053466|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053467|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053468|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053469|NCT03194373|Carboplatin|carboplatin|mesh-list
20053470|NCT03194373|Palbociclib|palbociclib|mesh-list
20053471|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053472|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053473|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053474|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053475|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
20053476|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053477|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118280|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118281|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118282|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118283|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118284|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118285|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
20118286|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
20118287|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118288|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118289|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118290|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
20118291|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118292|NCT00006005|Thalidomide|thalidomide|mesh-list
20118293|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118294|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
20118295|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576962|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20053478|NCT03196349|Warfarin|warfarin|mesh-list
20053479|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
20053480|NCT03196349|Apixaban|apixaban|mesh-list
20053481|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
20053482|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20053483|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
20053484|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20053485|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
20053486|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053487|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053488|NCT03196505|Bupivacaine|bupivacaine|mesh-list
20053489|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
20053490|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
20053491|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20053492|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053493|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
20053494|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053495|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20053496|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20053497|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053498|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
20053499|NCT03197025|Aldesleukin|aldesleukin|mesh-list
20053500|NCT03197025|Interleukin-2|interleukin-2|mesh-list
20053501|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053502|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20053503|NCT03197025|Analgesics|analgesics|mesh-ancestor
20053504|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
20053505|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053506|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053507|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20053508|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20053509|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
20053510|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053511|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
20053512|NCT03197324|Digoxin|digoxin|mesh-list
20053513|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20053514|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20053515|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053516|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053517|NCT03197324|Protective Agents|protective agents|mesh-ancestor
20053518|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053519|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053520|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
20053521|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053522|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053523|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
20053524|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20053525|NCT03197883|Protective Agents|protective agents|mesh-ancestor
20053526|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053527|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
20053528|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20053529|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20053530|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
20053531|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
20053532|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20053533|NCT03198221|Citric Acid|citric acid|mesh-list
20053534|NCT03198221|Cathartics|cathartics|mesh-ancestor
20053535|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053536|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
20053537|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20053538|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
20053539|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
20053540|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053541|NCT03198221|Antacids|antacids|mesh-ancestor
20053542|NCT03198221|Laxatives|laxatives|mesh-ancestor
20053543|NCT03198507|Amoxicillin|amoxicillin|mesh-list
20053544|NCT03198507|Rifabutin|rifabutin|mesh-list
20053545|NCT03198507|Omeprazole|omeprazole|mesh-list
20053546|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20053547|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053548|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20576963|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20576964|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
20576965|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20576966|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20605631|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053549|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053550|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20053551|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576967|NCT02074605|Interferons|interferons|mesh-list
20576968|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
20576969|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576970|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
20576971|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576972|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
20576973|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053552|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053553|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20053554|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
20053555|NCT03198767|Licogliflozin|licogliflozin|mesh-list
20053556|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
20053557|NCT03198767|Psyllium|psyllium|mesh-list
20053558|NCT03198767|Calcium|calcium|mesh-list
20053559|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20053560|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053561|NCT03198767|Antacids|antacids|mesh-ancestor
20053562|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053563|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053564|NCT03198767|Cathartics|cathartics|mesh-ancestor
20053565|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20053566|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053567|NCT03198871|Acetaminophen|acetaminophen|mesh-list
20053568|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20053569|NCT03198871|Analgesics|analgesics|mesh-ancestor
20053570|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
20053571|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053572|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053573|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
20053574|NCT03198884|Darunavir|darunavir|mesh-list
20053575|NCT03198884|Dolutegravir|dolutegravir|mesh-list
20053576|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20053577|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20053578|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
20053579|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053580|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053581|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20053582|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20053583|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
20053584|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053585|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20053586|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20053587|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20053588|NCT03199911|Erythromycin|erythromycin|mesh-list
20053589|NCT03199911|Bacitracin|bacitracin|mesh-list
20053590|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053591|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053592|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20053593|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053594|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053595|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20053596|NCT03199963|Tamoxifen|tamoxifen|mesh-list
20053597|NCT03199963|Afimoxifene|afimoxifene|mesh-list
20053598|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20053599|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
20053600|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053601|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053602|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053603|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053604|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20053605|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20053606|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20053607|NCT03200860|Empagliflozin|empagliflozin|mesh-list
20053608|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20053609|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053610|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053611|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053612|NCT03201211|Vaccines|vaccines|mesh-list
20053613|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
20053614|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053615|NCT03201562|Tropicamide|tropicamide|mesh-list
20053616|NCT03201562|Aceclidine|aceclidine|mesh-list
20293334|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20576974|NCT02074800|Siltuximab|siltuximab|mesh-list
20576975|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20576976|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053617|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
20053618|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
20053619|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053620|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053621|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20053622|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20053623|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053624|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053625|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053626|NCT03201562|Miotics|miotics|mesh-ancestor
20053627|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20053628|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
20053629|NCT03202134|Anesthetics|anesthetics|mesh-list
20053630|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20053631|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053632|NCT03202134|Narcotics|narcotics|mesh-ancestor
20053633|NCT03202134|Analgesics|analgesics|mesh-ancestor
20053634|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
20053635|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053636|NCT03202511|Tenofovir|tenofovir|mesh-list
20053637|NCT03202511|Emtricitabine|emtricitabine|mesh-list
20053638|NCT03202511|Probenecid|probenecid|mesh-list
20053639|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
20053640|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053641|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20053642|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20053643|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053644|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053645|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20053646|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20053647|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
20053648|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
20053649|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20053650|NCT03202511|Renal Agents|renal agents|mesh-ancestor
20053651|NCT03202550|Oxycodone|oxycodone|mesh-list
20053652|NCT03202550|Lorazepam|lorazepam|mesh-list
20053653|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20053654|NCT03202550|Narcotics|narcotics|mesh-ancestor
20053655|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20053656|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053657|NCT03202550|Analgesics|analgesics|mesh-ancestor
20053658|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
20053659|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053660|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
20053661|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
20053662|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
20053663|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053664|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20053665|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20053666|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20053667|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20053668|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
20053669|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
20053670|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053671|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053672|NCT03203447|Triamcinolone|triamcinolone|mesh-list
20053673|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20053674|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20053675|NCT03203447|Bevacizumab|bevacizumab|mesh-list
20053676|NCT03203447|Ranibizumab|ranibizumab|mesh-list
20053677|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20053678|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053679|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053680|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20053681|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20053682|NCT03203447|Growth Substances|growth substances|mesh-ancestor
20053683|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053684|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
20053685|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053686|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
20053687|NCT03203447|Hormones|hormones|mesh-ancestor
20053688|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20576977|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
20053689|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20053690|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
20053691|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053692|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053693|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
20053694|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20053695|NCT03203681|Testosterone|testosterone|mesh-list
20053696|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
20053697|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
20053698|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053699|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053700|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
20053701|NCT03203681|Hormones|hormones|mesh-ancestor
20053702|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053703|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053704|NCT03203681|Androgens|androgens|mesh-ancestor
20053705|NCT03204279|Palonosetron|palonosetron|mesh-list
20053706|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
20053707|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
20053708|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053709|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053710|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053711|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20053712|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20053713|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
20053714|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053715|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053716|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
20053717|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053718|NCT03205150|Licogliflozin|licogliflozin|mesh-list
20053719|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20053720|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053721|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053722|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053723|NCT03205566|Lamivudine|lamivudine|mesh-list
20053724|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
20053725|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20053726|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20053727|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053728|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053729|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
20053730|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053731|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20053732|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20053733|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20053734|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20053735|NCT03206788|Losartan|losartan|mesh-list
20053736|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20053737|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20053738|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20053739|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20053740|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053741|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
20053742|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053743|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053744|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053745|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053746|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
20053747|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053748|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053749|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053750|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053751|NCT03207243|Fluticasone|fluticasone|mesh-list
20053752|NCT03207243|Xhance|xhance|mesh-list
20053753|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20053754|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053755|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20053756|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
20053757|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053758|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053759|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20053760|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
20053761|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
20053762|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20053763|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20053764|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20053765|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20053766|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
20053767|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053768|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053769|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20053770|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
20053771|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053772|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20053773|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
20053774|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20053775|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20053776|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20053777|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20053778|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053779|NCT03207750|Vaccines|vaccines|mesh-list
20053780|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20053781|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
20053782|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053783|NCT03208933|Pirfenidone|pirfenidone|mesh-list
20053784|NCT03208933|Analgesics|analgesics|mesh-ancestor
20053785|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
20053786|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053787|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053788|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20053789|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20053790|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053791|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20053792|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053793|NCT03209492|Leuprolide|leuprolide|mesh-list
20053794|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20053795|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
20053796|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20053797|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053798|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053799|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053800|NCT03209518|Leuprolide|leuprolide|mesh-list
20053801|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20053802|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
20053803|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20053804|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053805|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20053806|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053807|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
20053808|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
20053809|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
20053810|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20053811|NCT03209570|Protective Agents|protective agents|mesh-ancestor
20053812|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053813|NCT03210259|Adalimumab|adalimumab|mesh-list
20053814|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053815|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20053816|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20053817|NCT03210376|Neostigmine|neostigmine|mesh-list
20053818|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20053819|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053820|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053821|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053822|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053823|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053824|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20053825|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
20053826|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053827|NCT03211117|Docetaxel|docetaxel|mesh-list
20053828|NCT03211117|Doxorubicin|doxorubicin|mesh-list
20053829|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20053830|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
20053831|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053832|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
20053833|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
20053834|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
20053835|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053836|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20053837|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20053838|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20053839|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053840|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20053841|NCT03211156|Amoxicillin|amoxicillin|mesh-list
20053842|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20053843|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053844|NCT03211234|Ranibizumab|ranibizumab|mesh-list
20053845|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20053846|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20053847|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20053848|NCT03211234|Growth Substances|growth substances|mesh-ancestor
20053849|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053850|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
20053851|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118296|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
20118297|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20118298|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118299|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20118300|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20118301|NCT00006005|Growth Substances|growth substances|mesh-ancestor
20118302|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
20118303|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118304|NCT00006006|Interferons|interferons|mesh-list
20118305|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
20118306|NCT00006006|Thalidomide|thalidomide|mesh-list
20118307|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118308|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
20118309|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118310|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
20118311|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118312|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118313|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
20118314|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20118315|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20118316|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20118317|NCT00006006|Growth Substances|growth substances|mesh-ancestor
20118318|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
20118319|NCT00006007|Gemcitabine|gemcitabine|mesh-list
20118320|NCT00006007|Pemetrexed|pemetrexed|mesh-list
20118321|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118322|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
20118323|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118324|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118325|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
20118326|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118327|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118328|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118329|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
20118330|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118331|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20118332|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20118333|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
20118334|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118335|NCT00006009|Visilizumab|visilizumab|mesh-list
20293335|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20293336|NCT04504734|Analgesics|analgesics|mesh-ancestor
20293337|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
20293338|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293339|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293340|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293341|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20293342|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
20293343|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293344|NCT04504734|Protective Agents|protective agents|mesh-ancestor
20293345|NCT04500236|Anesthetics|anesthetics|mesh-list
20293346|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20118336|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
20118337|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118338|NCT00006010|Gemcitabine|gemcitabine|mesh-list
20118339|NCT00006010|Docetaxel|docetaxel|mesh-list
20118340|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118341|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
19491521|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20118342|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053852|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20053853|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20053854|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20053855|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053856|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053857|NCT03214367|Insulin|insulin|mesh-list
20053858|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20053859|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
20053860|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
20053861|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053862|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053863|NCT03214380|Insulin|insulin|mesh-list
20053864|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20053865|NCT03214380|Metformin|metformin|mesh-list
20053866|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
20053867|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
20053868|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20053869|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20053870|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053871|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053872|NCT03216226|Glucagon|glucagon|mesh-list
20053873|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053874|NCT03216226|Hormones|hormones|mesh-ancestor
20053875|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053876|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053877|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20053878|NCT03216902|Latanoprost|latanoprost|mesh-list
20053879|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20053880|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
20053881|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20053882|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
20053883|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053884|NCT03216954|Expectorants|expectorants|mesh-ancestor
20053885|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
20053886|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20053887|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
20053888|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053889|NCT03216954|Protective Agents|protective agents|mesh-ancestor
20053890|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053891|NCT03216954|Antidotes|antidotes|mesh-ancestor
20053892|NCT03218592|Tenofovir|tenofovir|mesh-list
20053893|NCT03218592|Emtricitabine|emtricitabine|mesh-list
20053894|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20053895|NCT03218592|Maraviroc|maraviroc|mesh-list
20053896|NCT03218592|Dolutegravir|dolutegravir|mesh-list
20053897|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
20053898|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053899|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20053900|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20053901|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576978|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576979|NCT02074878|Sunitinib|sunitinib|mesh-list
20576980|NCT02074878|Crizotinib|crizotinib|mesh-list
20576981|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20576982|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20576983|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20576984|NCT02074878|Growth Substances|growth substances|mesh-ancestor
20576985|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053902|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053903|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20053904|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20053905|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20053906|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20053907|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20053908|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20053909|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20053910|NCT03219294|Bromides|bromides|mesh-list
20053911|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
20053912|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
20053913|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20053914|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20053915|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20053916|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053917|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20576986|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
20053918|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20053919|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20053920|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053921|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053922|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053923|NCT03219723|Amoxicillin|amoxicillin|mesh-list
20053924|NCT03219723|Metronidazole|metronidazole|mesh-list
20053925|NCT03219723|Clarithromycin|clarithromycin|mesh-list
20053926|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20053927|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053928|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20053929|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20053930|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20053931|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053932|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053933|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20053934|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20053935|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
20053936|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20053937|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20053938|NCT03219866|Budesonide|budesonide|mesh-list
20053939|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
20053940|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20053941|NCT03219866|Ipratropium|ipratropium|mesh-list
20053942|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20053943|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20053944|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
20053945|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053946|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053947|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20053948|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
20053949|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
20053950|NCT03219866|Hormones|hormones|mesh-ancestor
20053951|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20053952|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
20053953|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20053954|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
20053955|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053956|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053957|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
20053958|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
20053959|NCT03220958|Promethazine|promethazine|mesh-list
20053960|NCT03220958|Metoclopramide|metoclopramide|mesh-list
20053961|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20053962|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20053963|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20053964|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20053965|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
20053966|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
20053967|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
20053968|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20053969|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
20053970|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
20053971|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20053972|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20053973|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
20053974|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
20053975|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20053976|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053977|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20053978|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
20053979|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
20053980|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20053981|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20053982|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
20053983|NCT03221764|Amiodarone|amiodarone|mesh-list
20053984|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20053985|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
20053986|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20053987|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20053988|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20053989|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20053990|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20053991|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20053992|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20053993|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20053994|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20053995|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20053996|NCT03222349|Diazepam|diazepam|mesh-list
20053997|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20053998|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
20053999|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
20054000|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
20054001|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054002|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054003|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20054004|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20054005|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054006|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20054007|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20054008|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20054009|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20054010|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20054011|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20054012|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
20054013|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
20054014|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
20054015|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
20054016|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054017|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054018|NCT03223272|Reserpine|reserpine|mesh-list
20054019|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20054020|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20054021|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20054022|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054023|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054024|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20054025|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20054026|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20054027|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054028|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054029|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054030|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054031|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
20054032|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20054033|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
20054034|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054035|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
20054036|NCT03223909|Protective Agents|protective agents|mesh-ancestor
20054037|NCT03224182|Apaziquone|apaziquone|mesh-list
20054038|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054039|NCT03224351|Ivacaftor|ivacaftor|mesh-list
20054040|NCT03224351|VX-659|vx-659|mesh-list
20054041|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20054042|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054043|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054044|NCT03224403|Acetaminophen|acetaminophen|mesh-list
20054045|NCT03224403|Ibuprofen|ibuprofen|mesh-list
20054046|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20054047|NCT03224403|Analgesics|analgesics|mesh-ancestor
20054048|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
20054049|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293347|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054050|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054051|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
20054052|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20054053|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054054|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20054055|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20054056|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054057|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054058|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20054059|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20054060|NCT03225313|Bupivacaine|bupivacaine|mesh-list
20054061|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20054062|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
20054063|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
20054064|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054065|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054066|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
20054067|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054068|NCT03226223|Methamphetamine|methamphetamine|mesh-list
20054069|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20054070|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054071|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
20054072|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
20054073|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054074|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
20054075|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054076|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054077|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054078|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20054079|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20054080|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054081|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20054082|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
20054083|NCT03226249|Doxorubicin|doxorubicin|mesh-list
20054084|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20054085|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
20054086|NCT03226249|Dacarbazine|dacarbazine|mesh-list
20054087|NCT03226249|Vinblastine|vinblastine|mesh-list
20054088|NCT03226249|Imidazole|imidazole|mesh-list
20054089|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20054090|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20054091|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054092|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20054093|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20054094|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054095|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054096|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20054097|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20054098|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
20054099|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20054100|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20054101|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
20054102|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
20054103|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
20054104|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
20054105|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
20054106|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054107|NCT03226275|Amlodipine|amlodipine|mesh-list
20054108|NCT03226275|Bisoprolol|bisoprolol|mesh-list
20054109|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20054110|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20054111|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054112|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054113|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20054114|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054115|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
20054116|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
20054117|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
20054118|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054119|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20054120|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20054121|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20054122|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054123|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054124|NCT03226457|Empagliflozin|empagliflozin|mesh-list
20054125|NCT03226457|Furosemide|furosemide|mesh-list
20054126|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20054127|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054128|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054129|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054130|NCT03226457|Diuretics|diuretics|mesh-ancestor
20054131|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
20054132|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20054133|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054134|NCT03226691|Plerixafor|plerixafor|mesh-list
20054135|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20054136|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20054137|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
20054138|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054139|NCT03226899|Colchicine|colchicine|mesh-list
20054140|NCT03226899|Allopurinol|allopurinol|mesh-list
20054141|NCT03226899|Febuxostat|febuxostat|mesh-list
20054142|NCT03226899|Lesinurad|lesinurad|mesh-list
20054143|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
20054144|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20054145|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
20054146|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
20054147|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
20054148|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054149|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054150|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
20054151|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054152|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20054153|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
20054154|NCT03226899|Protective Agents|protective agents|mesh-ancestor
20054155|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054156|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
20054157|NCT03226899|Renal Agents|renal agents|mesh-ancestor
20054158|NCT03228017|Aspirin|aspirin|mesh-list
20054159|NCT03228017|Atorvastatin|atorvastatin|mesh-list
20054160|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20054161|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20054162|NCT03228017|Analgesics|analgesics|mesh-ancestor
20054163|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
20054164|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054165|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054166|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054167|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20054168|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20054169|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20054170|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054171|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20054172|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20054173|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054174|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
20054175|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20054176|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20054177|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
20054178|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20054179|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20054180|NCT03228914|Phenylephrine|phenylephrine|mesh-list
20054181|NCT03228914|Epinephrine|epinephrine|mesh-list
20054182|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
20054183|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20054184|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20054185|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054186|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054187|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054188|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054189|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20054190|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20054191|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
20054192|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054193|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20054194|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
20054195|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
20054196|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
20054197|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20054198|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
20054199|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20054200|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20054201|NCT03228914|Protective Agents|protective agents|mesh-ancestor
20118343|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118344|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
20118345|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118346|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054202|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
20054203|NCT03229486|Neostigmine|neostigmine|mesh-list
20054204|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20054205|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054206|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054207|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
20054208|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054209|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054210|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20054211|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
20054212|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054213|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20054214|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20054215|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20054216|NCT03229759|Octenidine|octenidine|mesh-list
20054217|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054218|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20054219|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20054220|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054221|NCT03230864|Olanzapine|olanzapine|mesh-list
20054222|NCT03230864|Risperidone|risperidone|mesh-list
20054223|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20054224|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
20054225|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054226|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054227|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054228|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20054229|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20054230|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054231|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20054232|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20054233|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
20054234|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
20054235|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
20054236|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054237|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20054238|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20054239|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20054240|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054241|NCT03231228|Cefazolin|cefazolin|mesh-list
20054242|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20054243|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054244|NCT03231371|Adenosine|adenosine|mesh-list
20054245|NCT03231371|Analgesics|analgesics|mesh-ancestor
20054246|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
20054247|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054248|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054249|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20054250|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
20054251|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20054252|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
20054253|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
20054254|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054255|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054256|NCT03231709|Alogliptin|alogliptin|mesh-list
20054257|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054258|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054259|NCT03231709|Incretins|incretins|mesh-ancestor
20054260|NCT03231709|Hormones|hormones|mesh-ancestor
20054261|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054262|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20054263|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
20054264|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054265|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054266|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20054267|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
20054268|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20054269|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
20054270|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20054271|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054272|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20054273|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20054274|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054275|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
20054276|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20054277|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054278|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
20054279|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
20054280|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054281|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054282|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20054283|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
20054284|NCT03232749|Hormones|hormones|mesh-ancestor
20054285|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054286|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20054287|NCT03232749|Protective Agents|protective agents|mesh-ancestor
20054288|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
20054289|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054290|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054291|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20054292|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20054293|NCT03233438|Dalbavancin|dalbavancin|mesh-list
20054294|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20054295|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054296|NCT03233737|Anesthetics|anesthetics|mesh-list
20054297|NCT03233737|Tetracaine|tetracaine|mesh-list
20054298|NCT03233737|Benzocaine|benzocaine|mesh-list
20054299|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054300|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054301|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
20054302|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
20054303|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054304|NCT03234036|Ritonavir|ritonavir|mesh-list
20054305|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
20054306|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20054307|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20054308|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
20054309|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054310|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054311|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20054312|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20054313|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
20054314|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054315|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20054316|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20054317|NCT03234374|Bupivacaine|bupivacaine|mesh-list
20054318|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
20054319|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
20054320|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054321|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054322|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
20054323|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054324|NCT03235050|Liraglutide|liraglutide|mesh-list
20054325|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054326|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054327|NCT03235050|Incretins|incretins|mesh-ancestor
20054328|NCT03235050|Hormones|hormones|mesh-ancestor
20054329|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054330|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
20054331|NCT03235154|Velpatasvir|velpatasvir|mesh-list
20054332|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
20054333|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054334|NCT03236168|Ivermectin|ivermectin|mesh-list
20054335|NCT03236168|Permethrin|permethrin|mesh-list
20054336|NCT03236168|Malathion|malathion|mesh-list
20054337|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20054338|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054339|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054340|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054341|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20054342|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
20054343|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054344|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054345|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
20054346|NCT03236506|Grazoprevir|grazoprevir|mesh-list
20054347|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
20054348|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054349|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20054350|NCT03237065|Hematinics|hematinics|mesh-ancestor
20054351|NCT03237481|Bupivacaine|bupivacaine|mesh-list
20054352|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
20054353|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
20054354|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054355|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054356|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
20054357|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054358|NCT03238352|Listerine|listerine|mesh-list
20054359|NCT03238352|Fluorides|fluorides|mesh-list
20054360|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
20054361|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
20054362|NCT03238352|Protective Agents|protective agents|mesh-ancestor
20054363|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054364|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20054365|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054366|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20054367|NCT03238911|Hematinics|hematinics|mesh-ancestor
20054368|NCT03238924|Oxytocin|oxytocin|mesh-list
20054369|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
20054370|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20054371|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054372|NCT03239106|Apremilast|apremilast|mesh-list
20054373|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20054374|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20054375|NCT03239106|Analgesics|analgesics|mesh-ancestor
20054376|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
20054377|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054378|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054379|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054380|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20054381|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20054382|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20054383|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054384|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054385|NCT03239483|Dapivirine|dapivirine|mesh-list
20054386|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20054387|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20054388|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
20054389|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054390|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20054391|NCT03239522|Glycine|glycine|mesh-list
20054392|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
20054393|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054394|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054395|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054396|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20054397|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20054398|NCT03240081|Estradiol|estradiol|mesh-list
20054399|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20054400|NCT03240081|Estrogens|estrogens|mesh-ancestor
20054401|NCT03240081|Hormones|hormones|mesh-ancestor
20054402|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054403|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054404|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20054405|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
20054406|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20054407|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20054408|NCT03240133|Berotralstat|berotralstat|mesh-list
20054409|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054410|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054411|NCT03240575|Fluticasone|fluticasone|mesh-list
20054412|NCT03240575|Xhance|xhance|mesh-list
20054413|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
20054414|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20054415|NCT03240575|Olodaterol|olodaterol|mesh-list
20054416|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054417|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20054418|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
20054419|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054420|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054421|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20054422|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
20054423|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
20054424|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20054425|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
20054426|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20054427|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
20054428|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054429|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054430|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20054431|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20054432|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20054433|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054434|NCT03241030|Acetaminophen|acetaminophen|mesh-list
20054435|NCT03241030|Ibuprofen|ibuprofen|mesh-list
20054436|NCT03241030|Sucralfate|sucralfate|mesh-list
20054437|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20054438|NCT03241030|Analgesics|analgesics|mesh-ancestor
20054439|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
20054440|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054441|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054442|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
20054443|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20054444|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054445|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20054446|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20054447|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054448|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054449|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20054450|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20054451|NCT03241485|Morphine|morphine|mesh-list
20054452|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20054453|NCT03241485|Narcotics|narcotics|mesh-ancestor
20054454|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054455|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054456|NCT03241485|Analgesics|analgesics|mesh-ancestor
20054457|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
20054458|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054459|NCT03241810|Fulvestrant|fulvestrant|mesh-list
20054460|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20054461|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054462|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20054463|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20054464|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
20054465|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054466|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054467|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
20054468|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20054469|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054470|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20054471|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20054472|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054473|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054474|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054475|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20054476|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20054477|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054478|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054479|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054480|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
20054481|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20054482|NCT03242408|Testosterone|testosterone|mesh-list
20054483|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
20054484|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
20054485|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20054486|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054487|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
20054488|NCT03242408|Hormones|hormones|mesh-ancestor
20054489|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054490|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054491|NCT03242408|Androgens|androgens|mesh-ancestor
20054492|NCT03242434|Mannitol|mannitol|mesh-list
20054493|NCT03242434|Lactulose|lactulose|mesh-list
20054494|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20054495|NCT03242434|Diuretics|diuretics|mesh-ancestor
20054496|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
20054497|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054498|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20054499|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
20054500|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20054501|NCT03242590|Testosterone|testosterone|mesh-list
20054502|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
20054503|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
20054504|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20054505|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054506|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
20054507|NCT03242590|Hormones|hormones|mesh-ancestor
20054508|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054509|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054510|NCT03242590|Androgens|androgens|mesh-ancestor
20054511|NCT03242759|Pirfenidone|pirfenidone|mesh-list
20054512|NCT03242759|Nintedanib|nintedanib|mesh-list
20054513|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054514|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20054515|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054516|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054517|NCT03242759|Analgesics|analgesics|mesh-ancestor
20054518|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
20054519|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054520|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054521|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20054522|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20054523|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054524|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20054525|NCT03243630|Menthol|menthol|mesh-list
20054526|NCT03243630|Nicotine|nicotine|mesh-list
20054527|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20054528|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
20054529|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054530|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054531|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20054532|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20054533|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
20054534|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054535|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054536|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
20054537|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
20054538|NCT03244618|Fluorides|fluorides|mesh-list
20054539|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
20054540|NCT03244618|Protective Agents|protective agents|mesh-ancestor
20054541|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054542|NCT03245398|Mebendazole|mebendazole|mesh-list
20054543|NCT03245398|Piperazine|piperazine|mesh-list
20054544|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
20054545|NCT03245398|DMP 777|dmp 777|mesh-list
20054546|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
20054547|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
20054548|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20054549|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054550|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
20054551|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
20054552|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
20054553|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054554|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054555|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054556|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
20054557|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20054558|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
20054559|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054560|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
20054561|NCT03245463|Protective Agents|protective agents|mesh-ancestor
20118347|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118348|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
20118349|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118350|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118351|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118352|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118353|NCT00006012|Paclitaxel|paclitaxel|mesh-list
20118354|NCT00006012|Etoposide|etoposide|mesh-list
20118355|NCT00006012|Topotecan|topotecan|mesh-list
20118356|NCT00006012|Amifostine|amifostine|mesh-list
20118357|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118358|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118359|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118360|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118361|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118362|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118363|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118364|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118365|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054562|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
20054563|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20054564|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054565|NCT03245762|Oxytocin|oxytocin|mesh-list
20054566|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
20054567|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20054568|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054569|NCT03246152|Bevacizumab|bevacizumab|mesh-list
20054570|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20054571|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054572|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20054573|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20054574|NCT03246152|Growth Substances|growth substances|mesh-ancestor
20054575|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054576|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
20054577|NCT03246724|Midazolam|midazolam|mesh-list
20054578|NCT03246724|Triazolam|triazolam|mesh-list
20054579|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20054580|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20054581|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054582|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054583|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20054584|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20054585|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20054586|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20054587|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
20054588|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
20054589|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
20054590|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
20054591|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054592|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054593|NCT03247673|Bevacizumab|bevacizumab|mesh-list
20054594|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20054595|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054596|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20054597|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20054598|NCT03247673|Growth Substances|growth substances|mesh-ancestor
20054599|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054600|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
20054601|NCT03247738|Cangrelor|cangrelor|mesh-list
20054602|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20054603|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20054604|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20054605|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20054606|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
20054607|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054608|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054609|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054610|NCT03247790|Lasmiditan|lasmiditan|mesh-list
20054611|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20054612|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
20054613|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054614|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054615|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054616|NCT03248947|Buprenorphine|buprenorphine|mesh-list
20054617|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20054618|NCT03248947|Naloxone|naloxone|mesh-list
20054619|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20054620|NCT03248947|Narcotics|narcotics|mesh-ancestor
20054621|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054622|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054623|NCT03248947|Analgesics|analgesics|mesh-ancestor
20054624|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
20054625|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054626|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20054627|NCT03249272|Adenosine|adenosine|mesh-list
20054628|NCT03249272|Regadenoson|regadenoson|mesh-list
20054629|NCT03249272|Analgesics|analgesics|mesh-ancestor
20054630|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
20054631|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054632|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054633|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20054634|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
20054635|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20054636|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
20054637|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
20054638|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054639|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054640|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20054641|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20054642|NCT03249909|Laxatives|laxatives|mesh-ancestor
20054643|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20054644|NCT03249935|Azithromycin|azithromycin|mesh-list
20054645|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20054646|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054647|NCT03250182|Budesonide|budesonide|mesh-list
20054648|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
20054649|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
20054650|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054651|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20054652|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
20054653|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054654|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054655|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20054656|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
20054657|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
20054658|NCT03250182|Hormones|hormones|mesh-ancestor
20054659|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054660|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20054661|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20054662|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20054663|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054664|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054665|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054666|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20054667|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20054668|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20054669|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
20054670|NCT03251482|Apixaban|apixaban|mesh-list
20054671|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20054672|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
20054673|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20054674|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
20054675|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054676|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054677|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
20054678|NCT03251963|Enoxaparin|enoxaparin|mesh-list
20054679|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
20054680|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
20054681|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20054682|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20054683|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054684|NCT03252015|Lasmiditan|lasmiditan|mesh-list
20054685|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20054686|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
20054687|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054688|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054689|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054690|NCT03252353|Octreotide|octreotide|mesh-list
20054691|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20054692|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20054693|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054694|NCT03253094|Fluconazole|fluconazole|mesh-list
20054695|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
20054696|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
20054697|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054698|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20054699|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20054700|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054701|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054702|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20054703|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
20054704|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054705|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054706|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20054707|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20054708|NCT03254108|Tolvaptan|tolvaptan|mesh-list
20054709|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20120730|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054710|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054711|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
20054712|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054713|NCT03254134|Warfarin|warfarin|mesh-list
20054714|NCT03254134|Dabigatran|dabigatran|mesh-list
20054715|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
20054716|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
20054717|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20054718|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
20054719|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054720|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054721|NCT03254147|Warfarin|warfarin|mesh-list
20054722|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
20054723|NCT03254147|Dabigatran|dabigatran|mesh-list
20054724|NCT03254147|Apixaban|apixaban|mesh-list
20054725|NCT03254147|Edoxaban|edoxaban|mesh-list
20054726|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
20054727|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20054728|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
20054729|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20054730|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
20054731|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054732|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054733|NCT03254459|Morphine|morphine|mesh-list
20054734|NCT03254459|Oxycodone|oxycodone|mesh-list
20054735|NCT03254459|Buprenorphine|buprenorphine|mesh-list
20054736|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20054737|NCT03254459|Narcotics|narcotics|mesh-ancestor
20054738|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054739|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054740|NCT03254459|Analgesics|analgesics|mesh-ancestor
20054741|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
20054742|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054743|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20054744|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20054745|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
20054746|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20054747|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
20054748|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054749|NCT03255824|Fentanyl|fentanyl|mesh-list
20054750|NCT03255824|Midazolam|midazolam|mesh-list
20054751|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
20054752|NCT03255824|Propofol|propofol|mesh-list
20054753|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20054754|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054755|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054756|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20054757|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
20054758|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
20054759|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20054760|NCT03255824|Analgesics|analgesics|mesh-ancestor
20054761|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
20054762|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054763|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20054764|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20054765|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20054766|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054767|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054768|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054769|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20054770|NCT03255824|Narcotics|narcotics|mesh-ancestor
20054771|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20054772|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20054773|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20054774|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20054775|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
20054776|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
20054777|NCT03256136|Carboplatin|carboplatin|mesh-list
20054778|NCT03256136|Nivolumab|nivolumab|mesh-list
20054779|NCT03256136|Pemetrexed|pemetrexed|mesh-list
20054780|NCT03256136|Ipilimumab|ipilimumab|mesh-list
20054781|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054782|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20054783|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20054784|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054785|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054786|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20054787|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20054788|NCT03256162|Midazolam|midazolam|mesh-list
20054789|NCT03256162|Ketamine|ketamine|mesh-list
20054790|NCT03256162|Analgesics|analgesics|mesh-ancestor
20054791|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
20054792|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054793|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054794|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20054795|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20054796|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
20054797|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
20054798|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054799|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20054800|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20054801|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054802|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054803|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20054804|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20054805|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20054806|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20054807|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20054808|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
20054809|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
20054810|NCT03256253|Pregabalin|pregabalin|mesh-list
20054811|NCT03256253|Analgesics|analgesics|mesh-ancestor
20054812|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
20054813|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054814|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054815|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
20054816|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20054817|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054818|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054819|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20054820|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20054821|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20054822|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20054823|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20054824|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
20054825|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20054826|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20054827|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20054828|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
20054829|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054830|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054831|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054832|NCT03256695|Albuterol|albuterol|mesh-list
20054833|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20054834|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
20054835|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054836|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054837|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20054838|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
20054839|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
20054840|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20054841|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20054842|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20054843|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20054844|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054845|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054846|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054847|NCT03256799|Ivacaftor|ivacaftor|mesh-list
20054848|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20054849|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054850|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054851|NCT03257202|Clindamycin|clindamycin|mesh-list
20054852|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
20054853|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
20054854|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20054855|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20054856|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054857|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20054858|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054859|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054860|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
20054861|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20054862|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20054863|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054864|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20054865|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
20054866|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054867|NCT03257813|Timolol|timolol|mesh-list
20054868|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20054869|NCT03257813|Dorzolamide|dorzolamide|mesh-list
20054870|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20054871|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20054872|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
20054873|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054874|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054875|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054876|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20054877|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20054878|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20054879|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20054880|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20054881|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20054882|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054883|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
20054884|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
20054885|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054886|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054887|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054888|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
20054889|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
20054890|NCT03257995|Maleic acid|maleic acid|mesh-list
20054891|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054892|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054893|NCT03258645|Dabigatran|dabigatran|mesh-list
20054894|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
20054895|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20054896|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
20054897|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054898|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054899|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
20054900|NCT03258710|Tenofovir|tenofovir|mesh-list
20054901|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
20054902|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054903|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20054904|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20054905|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054906|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054907|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20054908|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20054909|NCT03258762|Leucovorin|leucovorin|mesh-list
20054910|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
20054911|NCT03258762|Calcium|calcium|mesh-list
20054912|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
20054913|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20054914|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054915|NCT03258762|Antidotes|antidotes|mesh-ancestor
20054916|NCT03258762|Protective Agents|protective agents|mesh-ancestor
20054917|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
20054918|NCT03258762|Vitamins|vitamins|mesh-ancestor
20054919|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
20054920|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
20054921|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20054922|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20054923|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054924|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20054925|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054926|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054927|NCT03259425|Nivolumab|nivolumab|mesh-list
20054928|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20054929|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20054930|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20054931|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054932|NCT03259490|Metformin|metformin|mesh-list
20054933|NCT03259490|Empagliflozin|empagliflozin|mesh-list
20054934|NCT03259490|Linagliptin|linagliptin|mesh-list
20054935|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054936|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054937|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20054938|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054939|NCT03259490|Incretins|incretins|mesh-ancestor
20054940|NCT03259490|Hormones|hormones|mesh-ancestor
20054941|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054942|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20054943|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
20054944|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054945|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
20054946|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
20054947|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054948|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054949|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054950|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
20054951|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
20054952|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
20054953|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20054954|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054955|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20054956|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20054957|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054958|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20054959|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20054960|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054961|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054962|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
20054963|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054964|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20054965|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
20054966|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054967|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
20054968|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20054969|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20054970|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20054971|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20054972|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054973|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20054974|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20054975|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054976|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20054977|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20054978|NCT03261336|Vitamin D|vitamin d|mesh-list
20054979|NCT03261336|Calcitriol|calcitriol|mesh-list
20054980|NCT03261336|Ketoconazole|ketoconazole|mesh-list
20054981|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
20054982|NCT03261336|Vitamins|vitamins|mesh-ancestor
20054983|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
20054984|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20054985|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20054986|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20054987|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20054988|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
20054989|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20054990|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20054991|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20293348|NCT04494425|Paclitaxel|paclitaxel|mesh-list
20293349|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20293350|NCT04494425|Capecitabine|capecitabine|mesh-list
20054992|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20054993|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20054994|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20054995|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
20054996|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20054997|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20054998|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20054999|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055000|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20118366|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118367|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20118368|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20293351|NCT04494425|Trastuzumab|trastuzumab|mesh-list
20293352|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20293353|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055001|NCT03261999|Leuprolide|leuprolide|mesh-list
20055002|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20055003|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
20055004|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20055005|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055006|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20055007|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055008|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20055009|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055010|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055011|NCT03262038|Ondansetron|ondansetron|mesh-list
20055012|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
20055013|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
20055014|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055015|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055016|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055017|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
20055018|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055019|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20055020|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
20055021|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055022|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055023|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20055024|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20055025|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055026|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20055027|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20055028|NCT03262233|Nicotine|nicotine|mesh-list
20055029|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20055030|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
20055031|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055032|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055033|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20055034|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20055035|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
20055036|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055037|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055038|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20055039|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20055040|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055041|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
20055042|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20055043|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055044|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20055045|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
20055046|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20055047|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055048|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055049|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055050|NCT03263442|Thiamine|thiamine|mesh-list
20055051|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
20055052|NCT03263442|Vitamins|vitamins|mesh-ancestor
20055053|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
20055054|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055055|NCT03264066|Atezolizumab|atezolizumab|mesh-list
20055056|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20055057|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055058|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
20055059|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055060|NCT03264157|Vaccines|vaccines|mesh-list
20055061|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
20055062|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055063|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20055064|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20055065|NCT03266419|Rocuronium|rocuronium|mesh-list
20055066|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20055067|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20055068|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20055069|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055070|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055071|NCT03267576|Metformin|metformin|mesh-list
20055072|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20055073|NCT03267576|Canagliflozin|canagliflozin|mesh-list
20055074|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20118369|NCT00006012|Protective Agents|protective agents|mesh-ancestor
20055075|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055076|NCT03267576|Incretins|incretins|mesh-ancestor
20055077|NCT03267576|Hormones|hormones|mesh-ancestor
20055078|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055079|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20055080|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
20055081|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055082|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055083|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20055084|NCT03267940|Atezolizumab|atezolizumab|mesh-list
20055085|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055086|NCT03268941|Metoclopramide|metoclopramide|mesh-list
20055087|NCT03268941|Maleic acid|maleic acid|mesh-list
20055088|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055089|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055090|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
20055091|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
20055092|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055093|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055094|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055095|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20055096|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20055097|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
20055098|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055099|NCT03269435|Metoclopramide|metoclopramide|mesh-list
20055100|NCT03269435|Bupivacaine|bupivacaine|mesh-list
20055101|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055102|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
20055103|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055104|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055105|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
20055106|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055107|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
20055108|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
20055109|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055110|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20055111|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20055112|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
20055113|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055114|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055115|NCT03269552|Rituximab|rituximab|mesh-list
20055116|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20055117|NCT03269552|Antibodies|antibodies|mesh-list
20055118|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
20055119|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20055120|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
20055121|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055122|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055123|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20055124|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20055125|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19491522|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19491523|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
19491524|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491525|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491526|NCT03130010|Nefopam|nefopam|mesh-list
19491527|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491528|NCT03130010|Analgesics|analgesics|mesh-ancestor
19491529|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
20055126|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20055127|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
20055128|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055129|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20055130|NCT03270332|Albuterol|albuterol|mesh-list
20055131|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20055132|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
20055133|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055134|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055135|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055136|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055137|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
20055138|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19491530|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055139|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20055140|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20055141|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20055142|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
20055143|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055144|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055145|NCT03270514|Bupivacaine|bupivacaine|mesh-list
20055146|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055147|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
20055148|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055149|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055150|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
20055151|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055152|NCT03270644|Propranolol|propranolol|mesh-list
20055153|NCT03270644|Lasmiditan|lasmiditan|mesh-list
20055154|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20055155|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20055156|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
20055157|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055158|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055159|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055160|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20055161|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20055162|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
20055163|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20055164|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
20055165|NCT03271528|Lacosamide|lacosamide|mesh-list
20055166|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
20055167|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20055168|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20055169|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055170|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055171|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
20055172|NCT03273153|Atezolizumab|atezolizumab|mesh-list
20055173|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055174|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055175|NCT03273257|Riociguat|riociguat|mesh-list
20055176|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
20055177|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055178|NCT03273387|Trimetazidine|trimetazidine|mesh-list
20055179|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
20055180|NCT03273946|Fluticasone|fluticasone|mesh-list
20055181|NCT03273946|Xhance|xhance|mesh-list
20055182|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20055183|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20055184|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
20055185|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055186|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055187|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055188|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055189|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055190|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20055191|NCT03274076|Tofacitinib|tofacitinib|mesh-list
20055192|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20055193|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055194|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055195|NCT03274453|Ketamine|ketamine|mesh-list
20055196|NCT03274453|Analgesics|analgesics|mesh-ancestor
20055197|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
20055198|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055199|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055200|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20055201|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20055202|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
20055203|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
20055204|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055205|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20055206|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20055207|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055208|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055209|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20055210|NCT03274466|Laxatives|laxatives|mesh-ancestor
20055211|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055212|NCT03274804|Maraviroc|maraviroc|mesh-list
20576987|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20055213|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
20055214|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055215|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055216|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20055217|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20055218|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055219|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20055220|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20055221|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
20055222|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055223|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20055224|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20055225|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055226|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
20055227|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
20055228|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20055229|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20055230|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055231|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055232|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055233|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20055234|NCT03276026|Neostigmine|neostigmine|mesh-list
20055235|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20055236|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055237|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055238|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
20055239|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055240|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055241|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20055242|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
20055243|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055244|NCT03276078|Bromides|bromides|mesh-list
20055245|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
20055246|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20055247|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
20055248|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055249|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055250|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055251|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055252|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20055253|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20055254|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20055255|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
20055256|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055257|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055258|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
20055259|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20055260|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
20055261|NCT03276975|Coagulants|coagulants|mesh-ancestor
20055262|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
20055263|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055264|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055265|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20055266|NCT03278106|Trifluridine|trifluridine|mesh-list
20055267|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
20055268|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055269|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
20055270|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055271|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20055272|NCT03278886|Naltrexone|naltrexone|mesh-list
20055273|NCT03278886|Nalmefene|nalmefene|mesh-list
20055274|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20055275|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20055276|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055277|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
20055278|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055279|NCT03279237|Leucovorin|leucovorin|mesh-list
20055280|NCT03279237|Paclitaxel|paclitaxel|mesh-list
20055281|NCT03279237|Carboplatin|carboplatin|mesh-list
20055282|NCT03279237|Fluorouracil|fluorouracil|mesh-list
20055283|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
20055284|NCT03279237|Irinotecan|irinotecan|mesh-list
20055285|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20055286|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055287|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
20055288|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
20055289|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
20055290|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055291|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
20055292|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20055293|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20055294|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
20055295|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055296|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20055297|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20055298|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055299|NCT03279237|Antidotes|antidotes|mesh-ancestor
20055300|NCT03279237|Protective Agents|protective agents|mesh-ancestor
20055301|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
20055302|NCT03279237|Vitamins|vitamins|mesh-ancestor
20055303|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
20055304|NCT03279731|Liraglutide|liraglutide|mesh-list
20055305|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055306|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055307|NCT03279731|Incretins|incretins|mesh-ancestor
20055308|NCT03279731|Hormones|hormones|mesh-ancestor
20055309|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055310|NCT03280537|Omalizumab|omalizumab|mesh-list
20055311|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20055312|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055313|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055314|NCT03280550|Omalizumab|omalizumab|mesh-list
20055315|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20055316|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055317|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055318|NCT03281200|Nintedanib|nintedanib|mesh-list
20055319|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
20055320|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
20055321|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055322|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055323|NCT03281304|Tofacitinib|tofacitinib|mesh-list
20055324|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20055325|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055326|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118370|NCT00006013|Semaxinib|semaxinib|mesh-list
20118371|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20118372|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20118373|NCT00006013|Growth Substances|growth substances|mesh-ancestor
20118374|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118375|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
20118376|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118377|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118378|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118379|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118380|NCT00006014|Semaxinib|semaxinib|mesh-list
20118381|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20118382|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20118383|NCT00006014|Growth Substances|growth substances|mesh-ancestor
20118384|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118385|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
20118386|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118387|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118388|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118389|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118390|NCT00006015|Leucovorin|leucovorin|mesh-list
20118391|NCT00006015|Fluorouracil|fluorouracil|mesh-list
20118392|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
20118393|NCT00006015|Trastuzumab|trastuzumab|mesh-list
20118394|NCT00006015|Calcium|calcium|mesh-list
20118395|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
20118396|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20118397|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118398|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
20118399|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118400|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118401|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118402|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118403|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
20118404|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20118405|NCT00006015|Antidotes|antidotes|mesh-ancestor
20118406|NCT00006015|Protective Agents|protective agents|mesh-ancestor
20118407|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
20118408|NCT00006015|Vitamins|vitamins|mesh-ancestor
20118409|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
20118410|NCT00006016|Thalidomide|thalidomide|mesh-list
20118411|NCT00006016|Doxorubicin|doxorubicin|mesh-list
20055327|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
20055328|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
20055329|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20055330|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20055331|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
20055332|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055333|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055334|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055335|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055336|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20055337|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055338|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
20055339|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055340|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20055341|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
20055342|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
20055343|NCT03282357|Protective Agents|protective agents|mesh-ancestor
20055344|NCT03282591|Serlopitant|serlopitant|mesh-list
20055345|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20055346|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055347|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055348|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055349|NCT03283436|Bupivacaine|bupivacaine|mesh-list
20055350|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055351|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
20055352|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055353|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055354|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
20055355|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055356|NCT03283696|Doxorubicin|doxorubicin|mesh-list
20055357|NCT03283696|Ifosfamide|ifosfamide|mesh-list
20055358|NCT03283696|Olaratumab|olaratumab|mesh-list
20055359|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20055360|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055361|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20055362|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20055363|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055364|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055365|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20055366|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
20055367|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
20055368|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055369|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055370|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
20055371|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
20055372|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055373|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
20055374|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055375|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055376|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
20055377|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055378|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055379|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
20055380|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20055381|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055382|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055383|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20055384|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055385|NCT03285646|Fasinumab|fasinumab|mesh-list
20055386|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20055387|NCT03285646|Analgesics|analgesics|mesh-ancestor
20055388|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
20055389|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055390|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055391|NCT03285984|Listerine|listerine|mesh-list
20055392|NCT03285984|Fluorides|fluorides|mesh-list
20055393|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
20055394|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
20055395|NCT03285984|Protective Agents|protective agents|mesh-ancestor
20055396|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055397|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20055398|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055399|NCT03286218|Alprazolam|alprazolam|mesh-list
20055400|NCT03286218|Lasmiditan|lasmiditan|mesh-list
20055401|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20055402|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055403|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055404|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20055405|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20055406|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20055407|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
20055408|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
20055409|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055410|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055411|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20055412|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
20055413|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
20055414|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055415|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055416|NCT03286829|Metoprolol|metoprolol|mesh-list
20055417|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20055418|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20055419|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
20055420|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
20055421|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055422|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055423|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20055424|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20055425|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20055426|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
20055427|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055428|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055429|NCT03287219|Methylene Blue|methylene blue|mesh-list
20055430|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055431|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055432|NCT03287310|Albuterol|albuterol|mesh-list
20055433|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20055434|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
20055435|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055436|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055437|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055438|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055439|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
20055440|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20055441|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20055442|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20055443|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20055444|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
20055445|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055446|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055447|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20055448|NCT03287635|Hormones|hormones|mesh-ancestor
20055449|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055450|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055451|NCT03287674|Vidarabine|vidarabine|mesh-list
20055452|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
20055453|NCT03287674|Nivolumab|nivolumab|mesh-list
20055454|NCT03287674|Fludarabine|fludarabine|mesh-list
20055455|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
20055456|NCT03287674|Ipilimumab|ipilimumab|mesh-list
20055457|NCT03287674|Interleukin-2|interleukin-2|mesh-list
20055458|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20055459|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
20055460|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055461|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20055462|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20055463|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
20055464|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055465|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055466|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20055467|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055468|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20055469|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20055470|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
20055471|NCT03287674|Antiviral Agents|antiviral agents|mesh-ancestor
20055472|NCT03287674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055473|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20055474|NCT03287674|Analgesics|analgesics|mesh-ancestor
20055475|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
20055476|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055477|NCT03287791|Azelaic acid|azelaic acid|mesh-list
20055478|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
20055479|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20055480|NCT03287791|Protective Agents|protective agents|mesh-ancestor
20055481|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055482|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055483|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055484|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
20055485|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
20055486|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055487|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055488|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055489|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
20055490|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
20055491|NCT03288987|Leucovorin|leucovorin|mesh-list
20055492|NCT03288987|Bevacizumab|bevacizumab|mesh-list
20055493|NCT03288987|Fluorouracil|fluorouracil|mesh-list
20055494|NCT03288987|Irinotecan|irinotecan|mesh-list
20055495|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055496|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055497|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20055498|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20055499|NCT03288987|Growth Substances|growth substances|mesh-ancestor
20055500|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055501|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
20055502|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
20055503|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055504|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20055505|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20055506|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
20055507|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20055508|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20055509|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055510|NCT03288987|Antidotes|antidotes|mesh-ancestor
20055511|NCT03288987|Protective Agents|protective agents|mesh-ancestor
20055512|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
20055513|NCT03288987|Vitamins|vitamins|mesh-ancestor
20055514|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
20055515|NCT03289208|Edaravone|edaravone|mesh-list
20055516|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20055517|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
20055518|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055519|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20055520|NCT03289208|Protective Agents|protective agents|mesh-ancestor
20055521|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055522|NCT03289234|Edaravone|edaravone|mesh-list
20055523|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20055524|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
20055525|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055526|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20055527|NCT03289234|Protective Agents|protective agents|mesh-ancestor
20055528|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055529|NCT03289533|Avelumab|avelumab|mesh-list
20055530|NCT03289533|Axitinib|axitinib|mesh-list
20055531|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055532|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055533|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20055534|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055535|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055536|NCT03289676|Nicotine|nicotine|mesh-list
20055537|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20055538|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
20055539|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055540|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055541|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20055542|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20055543|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
20055544|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055545|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055546|NCT03289858|Bupivacaine|bupivacaine|mesh-list
20055547|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055548|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
20055549|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055550|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055551|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
20055552|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055553|NCT03290027|Tazarotene|tazarotene|mesh-list
20055554|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055555|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
20055556|NCT03290378|Tramadol|tramadol|mesh-list
20055557|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20055558|NCT03290378|Narcotics|narcotics|mesh-ancestor
20055559|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055560|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055561|NCT03290378|Analgesics|analgesics|mesh-ancestor
20055562|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
20055563|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055564|NCT03291080|Tretinoin|tretinoin|mesh-list
20055565|NCT03291080|Isotretinoin|isotretinoin|mesh-list
20055566|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055567|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
20055568|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055569|NCT03291197|Bupivacaine|bupivacaine|mesh-list
20055570|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055571|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
20055572|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055573|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055574|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
20055575|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055576|NCT03291288|Tolbutamide|tolbutamide|mesh-list
20055577|NCT03291288|Midazolam|midazolam|mesh-list
20055578|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20055579|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20055580|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055581|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055582|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20055583|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20055584|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20055585|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20055586|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
20055587|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
20055588|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
20055589|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
20055590|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055591|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055592|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055593|NCT03292016|Apomorphine|apomorphine|mesh-list
20055594|NCT03292016|Emetics|emetics|mesh-ancestor
20055595|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055596|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
20055597|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055598|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055599|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
20055600|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
20055601|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055602|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055603|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
20055604|NCT03292640|Tazarotene|tazarotene|mesh-list
20055605|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055606|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
20055607|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
20055608|NCT03292640|Vitamins|vitamins|mesh-ancestor
20055609|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
20055610|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055611|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20055612|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20055613|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055614|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055615|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055616|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20055617|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20055618|NCT03293485|Imipenem|imipenem|mesh-list
20055619|NCT03293485|Relebactam|relebactam|mesh-list
20055620|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
20055621|NCT03293485|Cilastatin|cilastatin|mesh-list
20055622|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20055623|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055624|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
20055625|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055626|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055627|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20055628|NCT03293654|Bevacizumab|bevacizumab|mesh-list
20055629|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055630|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055631|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20055632|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20055633|NCT03293654|Growth Substances|growth substances|mesh-ancestor
20055634|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055635|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
20055636|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20055637|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20055638|NCT03294538|Estradiol|estradiol|mesh-list
20055639|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20055640|NCT03294538|Estrogens|estrogens|mesh-ancestor
20055641|NCT03294538|Hormones|hormones|mesh-ancestor
20055642|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055643|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055644|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20055645|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
20055646|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20055647|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20055648|NCT03295721|Bupivacaine|bupivacaine|mesh-list
20055649|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055650|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
20055651|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055652|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055653|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
20055654|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055655|NCT03296072|Listerine|listerine|mesh-list
20055656|NCT03296072|Fluorides|fluorides|mesh-list
20055657|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
20055658|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
20055659|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
20055660|NCT03296072|Protective Agents|protective agents|mesh-ancestor
20055661|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055662|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20055663|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055664|NCT03296163|Paclitaxel|paclitaxel|mesh-list
20055665|NCT03296163|Bevacizumab|bevacizumab|mesh-list
20055666|NCT03296163|Carboplatin|carboplatin|mesh-list
20055667|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20055668|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055669|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
20055670|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
20055671|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
20055672|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055673|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20055674|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20055675|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20055676|NCT03296163|Growth Substances|growth substances|mesh-ancestor
20055677|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055678|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
20055679|NCT03296345|Ketamine|ketamine|mesh-list
20055680|NCT03296345|Analgesics|analgesics|mesh-ancestor
20055681|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
20055682|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055683|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055684|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20055685|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20055686|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
20055687|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
20055688|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055689|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20055690|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20055691|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055692|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118412|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20118413|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20118414|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118415|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118416|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20055693|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20055694|NCT03296527|Hormones|hormones|mesh-ancestor
20055695|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055696|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055697|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
20055698|NCT03296800|Rifampin|rifampin|mesh-list
20055699|NCT03296800|Probenecid|probenecid|mesh-list
20055700|NCT03296800|Verapamil|verapamil|mesh-list
20055701|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20055702|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
20055703|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20055704|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055705|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
20055706|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20055707|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055708|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055709|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20055710|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20055711|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20055712|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20055713|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20055714|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20055715|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20055716|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20055717|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055718|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20055719|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055720|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
20055721|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
20055722|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
20055723|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20055724|NCT03296800|Renal Agents|renal agents|mesh-ancestor
20055725|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055726|NCT03297021|Ondansetron|ondansetron|mesh-list
20055727|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
20055728|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
20055729|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055730|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055731|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055732|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
20055733|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055734|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20055735|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
20055736|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055737|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055738|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20055739|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20055740|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055741|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20055742|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20055743|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20055744|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20055745|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20055746|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
20055747|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055748|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055749|NCT03297216|Progestins|progestins|mesh-ancestor
20055750|NCT03297216|Hormones|hormones|mesh-ancestor
20055751|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
20055752|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
20055753|NCT03297398|Androgens|androgens|mesh-list
20055754|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20055755|NCT03297398|Hormones|hormones|mesh-ancestor
20055756|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055757|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055758|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
20055759|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055760|NCT03297398|Protective Agents|protective agents|mesh-ancestor
20055761|NCT03297398|Vitamins|vitamins|mesh-ancestor
20055762|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
20055763|NCT03297398|Estrogens|estrogens|mesh-ancestor
20055764|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20055765|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055766|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
20055767|NCT03297944|Zolpidem|zolpidem|mesh-list
20055768|NCT03297944|Alprazolam|alprazolam|mesh-list
20055769|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20055770|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20055771|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055772|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055773|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20055774|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
20055775|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
20055776|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055777|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055778|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20055779|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20055780|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20055781|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
20055782|NCT03298113|Protective Agents|protective agents|mesh-list
20055783|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055784|NCT03298412|Blinatumomab|blinatumomab|mesh-list
20055785|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055786|NCT03299244|Cinacalcet|cinacalcet|mesh-list
20055787|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20055788|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055789|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20055790|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
20055791|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055792|NCT03300570|Dolcanatide|dolcanatide|mesh-list
20055793|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20055794|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
20055795|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055796|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055797|NCT03300674|Lidocaine|lidocaine|mesh-list
20055798|NCT03300674|Hydromorphone|hydromorphone|mesh-list
20055799|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055800|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
20055801|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055802|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055803|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
20055804|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055805|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20055806|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20055807|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20055808|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055809|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055810|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20055811|NCT03300674|Narcotics|narcotics|mesh-ancestor
20055812|NCT03300674|Analgesics|analgesics|mesh-ancestor
20055813|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20055814|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20055815|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20055816|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055817|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055818|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20055819|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055820|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055821|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
20055822|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055823|NCT03301649|Ivermectin|ivermectin|mesh-list
20055824|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20055825|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055826|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
20055827|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20055828|NCT03302559|Vitamin A|vitamin a|mesh-list
20055829|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
20055830|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
20055831|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20055832|NCT03302559|Protective Agents|protective agents|mesh-ancestor
20055833|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055834|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055835|NCT03302559|Vitamins|vitamins|mesh-ancestor
20055836|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
20055837|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
20055838|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055839|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20055840|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055841|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
20055842|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20055843|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055844|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055845|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
20055846|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055847|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055848|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20055849|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
20055850|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055851|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20055852|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
20055853|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055854|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20055855|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
20055856|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055857|NCT03303196|Pancrelipase|pancrelipase|mesh-list
20055858|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20055859|NCT03303794|Bupivacaine|bupivacaine|mesh-list
20055860|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055861|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
20055862|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055863|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055864|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
20055865|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055866|NCT03304054|Amifampridine|amifampridine|mesh-list
20055867|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20055868|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055869|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055870|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20055871|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055872|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055873|NCT03304626|Prednisone|prednisone|mesh-list
20055874|NCT03304626|Budesonide|budesonide|mesh-list
20055875|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20055876|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
20055877|NCT03304626|Hormones|hormones|mesh-ancestor
20055878|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20055879|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055880|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20055881|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055882|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20055883|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
20055884|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055885|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20055886|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
20055887|NCT03304873|Retapamulin|retapamulin|mesh-list
20055888|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20055889|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055890|NCT03305081|Copper|copper|mesh-list
20055891|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
20055892|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20055893|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
20055894|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20055895|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055896|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20055897|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20055898|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20055899|NCT03305081|Trace Elements|trace elements|mesh-ancestor
20055900|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
20055901|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
20055902|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20055903|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
20055904|NCT03305159|Povidone|povidone|mesh-list
20055905|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20055906|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055907|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
20055908|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20055909|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
20055910|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
20055911|NCT03305575|Bupivacaine|bupivacaine|mesh-list
20055912|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
20055913|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055914|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
20055915|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055916|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055917|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
20055918|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055919|NCT03305666|Bupivacaine|bupivacaine|mesh-list
20055920|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055921|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
20055922|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055923|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055924|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
20055925|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055926|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
20055927|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055928|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055929|NCT03306589|Molgramostim|molgramostim|mesh-list
20055930|NCT03306589|Sargramostim|sargramostim|mesh-list
20055931|NCT03306589|Cantharidin|cantharidin|mesh-list
20055932|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
20055933|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055934|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20055935|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055936|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055937|NCT03307005|Zolpidem|zolpidem|mesh-list
20055938|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20055939|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20055940|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055941|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055942|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20055943|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
20055944|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
20055945|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20055946|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055947|NCT03307174|Fentanyl|fentanyl|mesh-list
20055948|NCT03307174|Bupivacaine|bupivacaine|mesh-list
20055949|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
20055950|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
20055951|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20055952|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20055953|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
20055954|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20055955|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20055956|NCT03307174|Narcotics|narcotics|mesh-ancestor
20055957|NCT03307174|Analgesics|analgesics|mesh-ancestor
20055958|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20055959|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20055960|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
20055961|NCT03307252|Metformin|metformin|mesh-list
20055962|NCT03307252|Rifampin|rifampin|mesh-list
20055963|NCT03307252|Probenecid|probenecid|mesh-list
20055964|NCT03307252|Digoxin|digoxin|mesh-list
20055965|NCT03307252|Verapamil|verapamil|mesh-list
20055966|NCT03307252|Furosemide|furosemide|mesh-list
20055967|NCT03307252|Cimetidine|cimetidine|mesh-list
20055968|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20055969|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20055970|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491531|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569600|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569601|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
19569602|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569603|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055971|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20055972|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20055973|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
20055974|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20055975|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20055976|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20055977|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20055978|NCT03307252|Diuretics|diuretics|mesh-ancestor
20055979|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
20055980|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20055981|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20055982|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20055983|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
20055984|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20055985|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20055986|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
20055987|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20055988|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20055989|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20055990|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20055991|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20055992|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20055993|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20055994|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20055995|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20055996|NCT03307252|Protective Agents|protective agents|mesh-ancestor
20055997|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20055998|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20055999|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
20056000|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
20056001|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
20056002|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20056003|NCT03307252|Renal Agents|renal agents|mesh-ancestor
20056004|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20056005|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20056006|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20056007|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
20056008|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
20056009|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056010|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20056011|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20056012|NCT03308669|Topiramate|topiramate|mesh-list
20056013|NCT03308669|Lasmiditan|lasmiditan|mesh-list
20056014|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
20056015|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056016|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056017|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20056018|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
20056019|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056020|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056021|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
20056022|NCT03308942|Niraparib|niraparib|mesh-list
20056023|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056024|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056025|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20056026|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056027|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056028|NCT03309657|Tazobactam|tazobactam|mesh-list
20056029|NCT03309657|Ceftolozane|ceftolozane|mesh-list
20056030|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20056031|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20056032|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056033|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20056034|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056035|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056036|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20056037|NCT03309657|Renal Agents|renal agents|mesh-ancestor
20056038|NCT03309943|Propranolol|propranolol|mesh-list
20056039|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20056040|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20056041|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
20056042|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056043|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056044|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056045|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20056046|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20056047|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
20056048|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
20056049|NCT03310021|Apixaban|apixaban|mesh-list
20056050|NCT03310021|Edoxaban|edoxaban|mesh-list
20056051|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19491532|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20056052|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
20056053|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20056054|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
20056055|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056056|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056057|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
20056058|NCT03310268|Listerine|listerine|mesh-list
20056059|NCT03310268|Fluorides|fluorides|mesh-list
20056060|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
20056061|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
20056062|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
20056063|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
20056064|NCT03310268|Protective Agents|protective agents|mesh-ancestor
20056065|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056066|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20056067|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118417|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118418|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118419|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118420|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
20118421|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118422|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
20118423|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20118424|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118425|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20118426|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20118427|NCT00006016|Growth Substances|growth substances|mesh-ancestor
20118428|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
20118429|NCT00006018|Paclitaxel|paclitaxel|mesh-list
20118430|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118431|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118432|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118433|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118434|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118435|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118436|NCT00006019|Azacitidine|azacitidine|mesh-list
20118437|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20118438|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118439|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
20118440|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118441|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118442|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118443|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
20118444|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
20118445|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
20118446|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118447|NCT00006021|Protective Agents|protective agents|mesh-ancestor
20118448|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118449|NCT00006021|Vitamins|vitamins|mesh-ancestor
20118450|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
20118451|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118452|NCT00006022|Aldesleukin|aldesleukin|mesh-list
20118453|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
20118454|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118455|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20118456|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20118457|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
20118458|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118459|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20118460|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
20118461|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118462|NCT00006023|Capecitabine|capecitabine|mesh-list
20118463|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118464|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
20118465|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118466|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118467|NCT00006024|Temozolomide|temozolomide|mesh-list
20118468|NCT00006024|Lomustine|lomustine|mesh-list
20118469|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118470|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
20118471|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118472|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118473|NCT00006025|Irinotecan|irinotecan|mesh-list
20118474|NCT00006025|Temozolomide|temozolomide|mesh-list
20118475|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20118476|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19491533|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20056068|NCT03310411|Sumatriptan|sumatriptan|mesh-list
20056069|NCT03310411|Lasmiditan|lasmiditan|mesh-list
20056070|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20056071|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20056072|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20056073|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
20056074|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056075|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056076|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056077|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20056078|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20056079|NCT03310970|Lidocaine|lidocaine|mesh-list
20056080|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
20056081|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
20056082|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056083|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056084|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
20056085|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056086|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20056087|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20056088|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20056089|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056090|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056091|NCT03311646|Nicotine|nicotine|mesh-list
20056092|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20056093|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
20056094|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056095|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056096|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20056097|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20056098|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
20056099|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056100|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056101|NCT03311724|Tirzepatide|tirzepatide|mesh-list
20056102|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056103|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056104|NCT03311724|Incretins|incretins|mesh-ancestor
20056105|NCT03311724|Hormones|hormones|mesh-ancestor
20056106|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20056107|NCT03311841|Rifampin|rifampin|mesh-list
20056108|NCT03311841|Midazolam|midazolam|mesh-list
20056109|NCT03311841|Dabigatran|dabigatran|mesh-list
20056110|NCT03311841|Atorvastatin|atorvastatin|mesh-list
20056111|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20056112|NCT03311841|Pitavastatin|pitavastatin|mesh-list
20056113|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20056114|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20056115|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20056116|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
20056117|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056118|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20056119|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20056120|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056121|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20056122|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20056123|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056124|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056125|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20056126|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056127|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056128|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20056129|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
20056130|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
20056131|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
20056132|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
20056133|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056134|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
20056135|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20056136|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
20056137|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
20056138|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20056139|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
20056140|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20056141|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056142|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
20056143|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20056144|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20056145|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20056146|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20056147|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20056148|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20056149|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20056150|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
20056151|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20056152|NCT03312023|Ledipasvir|ledipasvir|mesh-list
20056153|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
20056154|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056155|NCT03312114|Avelumab|avelumab|mesh-list
20056156|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056157|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056158|NCT03312517|Suvorexant|suvorexant|mesh-list
20056159|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20056160|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20056161|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056162|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056163|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20056164|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056165|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056166|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20056167|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
20056168|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056169|NCT03313076|Vitamin D|vitamin d|mesh-list
20056170|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
20056171|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
20056172|NCT03313076|Vitamins|vitamins|mesh-list
20056173|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
20056174|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056175|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20056176|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20056177|NCT03314662|Vaccines|vaccines|mesh-list
20056178|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20056179|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
20056180|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056181|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20056182|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
20056183|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20056184|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
20056185|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20056186|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
20056187|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056188|NCT03315559|Nemiralisib|nemiralisib|mesh-list
20056189|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20056190|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056191|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056192|NCT03315780|Dulaglutide|dulaglutide|mesh-list
20056193|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056194|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056195|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20056196|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20056197|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20056198|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056199|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056200|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056201|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056202|NCT03315793|Analgesics|analgesics|mesh-ancestor
20056203|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
20056204|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056205|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
20056206|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056207|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
20056208|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
20056209|NCT03316131|Febuxostat|febuxostat|mesh-list
20056210|NCT03316131|Verinurad|verinurad|mesh-list
20056211|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20056212|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056213|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056214|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056215|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
20056216|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20056217|NCT03316378|Ropivacaine|ropivacaine|mesh-list
20056218|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
20056219|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
20056220|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056221|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056222|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
20056223|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056224|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
20056225|NCT03316976|Lansoprazole|lansoprazole|mesh-list
20056226|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20056227|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20056228|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20056229|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056230|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056231|NCT03318315|Vaccines|vaccines|mesh-list
20056232|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
20056233|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056234|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
20056235|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20056236|NCT03319277|Narcotics|narcotics|mesh-ancestor
20056237|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056238|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056239|NCT03319277|Analgesics|analgesics|mesh-ancestor
20056240|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
20056241|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056242|NCT03319719|Lidocaine|lidocaine|mesh-list
20056243|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
20056244|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
20056245|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
20056246|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056247|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056248|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
20056249|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056250|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20056251|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20056252|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20056253|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056254|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056255|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20056256|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
20056257|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
20056258|NCT03319719|Protective Agents|protective agents|mesh-ancestor
20056259|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
20056260|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20056261|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20056262|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
20056263|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056264|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
20056265|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056266|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056267|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056268|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056269|NCT03320057|Mifepristone|mifepristone|mesh-list
20056270|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20056271|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
20056272|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20056273|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056274|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20056275|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20056276|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20056277|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
20056278|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20056279|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20056280|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
20056281|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20056282|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
20056283|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20056284|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20056285|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
20056286|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20056287|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20056288|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20056289|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056290|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056291|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
20056292|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056293|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056294|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20056295|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056296|NCT03320941|Licogliflozin|licogliflozin|mesh-list
20056297|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20056298|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056299|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056300|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056301|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20056302|NCT03321006|Citalopram|citalopram|mesh-list
20056303|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20056304|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20056305|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056306|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056307|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056308|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
20056309|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056310|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20056311|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
20056312|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056313|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056314|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20056315|NCT03321006|Analgesics|analgesics|mesh-ancestor
20056316|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
20056317|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
20056318|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
20056319|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20056320|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056321|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056322|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
20056323|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056324|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056325|NCT03321396|Calcium|calcium|mesh-list
20056326|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20056327|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056328|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
20056329|NCT03322657|Neostigmine|neostigmine|mesh-list
20056330|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20056331|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056332|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056333|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
20056334|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056335|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056336|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20056337|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
20056338|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056339|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20056340|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20056341|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20056342|NCT03323164|Timolol|timolol|mesh-list
20056343|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20056344|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20056345|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20056346|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
20056347|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056348|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056349|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056350|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20056351|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20056352|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20056353|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20056354|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20056355|NCT03323801|Tretinoin|tretinoin|mesh-list
20056356|NCT03323801|Isotretinoin|isotretinoin|mesh-list
20056357|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056358|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
20056359|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
20056360|NCT03324451|Insulin|insulin|mesh-list
20056361|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056362|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056363|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20056364|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20056365|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20056366|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056367|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056368|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
20056369|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056370|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056371|NCT03325556|Pimavanserin|pimavanserin|mesh-list
20056372|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20056373|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20056374|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20056375|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056376|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056377|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056378|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056379|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20056380|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20056381|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
20056382|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056383|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056384|NCT03325816|Nivolumab|nivolumab|mesh-list
20056385|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20056386|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056387|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056388|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20056389|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056390|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20056391|NCT03326999|Bupivacaine|bupivacaine|mesh-list
20056392|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
20293354|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
20293355|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293356|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
20293357|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293358|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20293359|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
20293360|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293361|NCT04486833|Osimertinib|osimertinib|mesh-list
20293362|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293363|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293364|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293365|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293366|NCT04480918|Ketamine|ketamine|mesh-list
20293367|NCT04480918|Esketamine|esketamine|mesh-list
20293368|NCT04480918|Analgesics|analgesics|mesh-ancestor
20293369|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
20293370|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293371|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293372|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20293373|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20293374|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
20293375|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
20293376|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293377|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20293378|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20293379|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293380|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293381|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
20293382|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20293383|NCT04479579|Apixaban|apixaban|mesh-list
20293384|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20293385|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
20056393|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
20056394|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056395|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056396|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
20056397|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056398|NCT03327051|Omeprazole|omeprazole|mesh-list
20293386|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20056399|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20056400|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20056401|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20056402|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056403|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118477|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118478|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118479|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118480|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118481|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
20118482|NCT00006026|Rubitecan|rubitecan|mesh-list
20118483|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118484|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20118485|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118486|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118487|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118488|NCT00006027|Paclitaxel|paclitaxel|mesh-list
20118489|NCT00006027|Cisplatin|cisplatin|mesh-list
20118490|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118491|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118492|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118493|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118494|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118495|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118496|NCT00006028|Gemcitabine|gemcitabine|mesh-list
20118497|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118498|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118499|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
20118500|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118501|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
20118502|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118503|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118504|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118505|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
20118506|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118507|NCT00006029|Gemcitabine|gemcitabine|mesh-list
20118508|NCT00006029|Doxorubicin|doxorubicin|mesh-list
20118509|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20118510|NCT00006029|Vinorelbine|vinorelbine|mesh-list
20118511|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118512|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
20118513|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118514|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118515|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
20118516|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118517|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118518|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118519|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
20118520|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118521|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20118522|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118523|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118524|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118525|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118526|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118527|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118528|NCT00006030|Tamoxifen|tamoxifen|mesh-list
20118529|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20118530|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
20118531|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118532|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118533|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20118534|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118535|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20118536|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20118537|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20118538|NCT00006032|Etoposide|etoposide|mesh-list
20118539|NCT00006032|Topotecan|topotecan|mesh-list
20118540|NCT00006032|Ifosfamide|ifosfamide|mesh-list
20118541|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118542|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118543|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118544|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118545|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056404|NCT03328325|Vaccines|vaccines|mesh-list
20056405|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
20056406|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056407|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
20056408|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
20056409|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
20056410|NCT03328832|Thrombin|thrombin|mesh-list
20056411|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20056412|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20056413|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056414|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
20056415|NCT03328832|Coagulants|coagulants|mesh-ancestor
20056416|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20056417|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
20056418|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20056419|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
20056420|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056421|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
20056422|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
20056423|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056424|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20056425|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20056426|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056427|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056428|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056429|NCT03328897|Omalizumab|omalizumab|mesh-list
20056430|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20056431|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20056432|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
20056433|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
20056434|NCT03329196|Hematinics|hematinics|mesh-ancestor
20056435|NCT03329209|Vedolizumab|vedolizumab|mesh-list
20056436|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20056437|NCT03329573|Paroxetine|paroxetine|mesh-list
20056438|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20056439|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20056440|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056441|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056442|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056443|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
20056444|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056445|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20056446|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
20056447|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056448|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20056449|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20056450|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056451|NCT03329846|Nivolumab|nivolumab|mesh-list
20056452|NCT03329846|Linrodostat|linrodostat|mesh-list
20056453|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056454|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056455|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20056456|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056457|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056458|NCT03329911|Paclitaxel|paclitaxel|mesh-list
20056459|NCT03329911|Carboplatin|carboplatin|mesh-list
20056460|NCT03329911|Bevacizumab|bevacizumab|mesh-list
20056461|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20056462|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056463|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
20056464|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
20056465|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
20056466|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056467|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056468|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20056469|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20056470|NCT03329911|Growth Substances|growth substances|mesh-ancestor
20056471|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056472|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
20056473|NCT03329937|Niraparib|niraparib|mesh-list
20056474|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20056475|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056476|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056477|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056478|NCT03330236|Anesthetics|anesthetics|mesh-list
20293387|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
20056479|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056480|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056481|NCT03330457|Betrixaban|betrixaban|mesh-list
20056482|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20056483|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
20056484|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20056485|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
20056486|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056487|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056488|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
20056489|NCT03331315|Celecoxib|celecoxib|mesh-list
20056490|NCT03331315|Ketorolac|ketorolac|mesh-list
20056491|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20056492|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20056493|NCT03331315|Analgesics|analgesics|mesh-ancestor
20056494|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
20056495|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056496|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056497|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20056498|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20056499|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20056500|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20056501|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056502|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056503|NCT03331666|Evolocumab|evolocumab|mesh-list
20056504|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20056505|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20056506|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
20056507|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056508|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20056509|NCT03331835|Brodalumab|brodalumab|mesh-list
20056510|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
20056511|NCT03331965|Metoclopramide|metoclopramide|mesh-list
20056512|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
20056513|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
20056514|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056515|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056516|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20056517|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20056518|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20056519|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
20056520|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056521|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056522|NCT03332212|Empagliflozin|empagliflozin|mesh-list
20056523|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20576988|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576989|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569604|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20056524|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056525|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056526|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056527|NCT03332771|Metformin|metformin|mesh-list
20056528|NCT03332771|Glimepiride|glimepiride|mesh-list
20056529|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20056530|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056531|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056532|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20056533|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20056534|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
20056535|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20056536|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056537|NCT03333109|Erenumab|erenumab|mesh-list
20056538|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20056539|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056540|NCT03333109|Analgesics|analgesics|mesh-ancestor
20056541|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
20056542|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056543|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056544|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
20056545|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056546|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056547|NCT03334721|Gabapentin|gabapentin|mesh-list
20056548|NCT03334721|Analgesics|analgesics|mesh-ancestor
20056549|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
20056550|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056551|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056552|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
20056553|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20056554|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056555|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056556|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056557|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20056558|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20056559|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056560|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056561|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
20056562|NCT03334734|Isoniazid|isoniazid|mesh-list
20056563|NCT03334734|Macozinone|macozinone|mesh-list
20056564|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
20056565|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20056566|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056567|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20056568|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20056569|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
20056570|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056571|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20056572|NCT03334747|Lumefantrine|lumefantrine|mesh-list
20056573|NCT03334747|Artemether|artemether|mesh-list
20056574|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20056575|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
20056576|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20056577|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20056578|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056579|NCT03334903|Gabapentin|gabapentin|mesh-list
20056580|NCT03334903|Analgesics|analgesics|mesh-ancestor
20056581|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
20056582|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056583|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056584|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
20056585|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20056586|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056587|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056588|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056589|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20056590|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20056591|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056592|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056593|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
20056594|NCT03336450|Midazolam|midazolam|mesh-list
20056595|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20056596|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20056597|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056598|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056599|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20056600|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056601|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056602|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20056603|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
20056604|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
20056605|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
20056606|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
20056607|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056608|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056609|NCT03336502|Posaconazole|posaconazole|mesh-list
20056610|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
20056611|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056612|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20056613|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20056614|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20056615|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20056616|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20056617|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056618|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056619|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20056620|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
20056621|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293388|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056622|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056623|NCT03336645|Midazolam|midazolam|mesh-list
20056624|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20056625|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20056626|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056627|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056628|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20056629|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056630|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056631|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20056632|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
20056633|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
20056634|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
20056635|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
20056636|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056637|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056638|NCT03336853|Hybenx|hybenx|mesh-list
20056639|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
20056640|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
20056641|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576990|NCT02074891|Tenofovir|tenofovir|mesh-list
20576991|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
20576992|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20576993|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20576994|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20576995|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20576996|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20576997|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20576998|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20576999|NCT02075034|ON 01910|on 01910|mesh-list
20577000|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577001|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20577002|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577003|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056642|NCT03337152|Chloroquine|chloroquine|mesh-list
20056643|NCT03337152|Primaquine|primaquine|mesh-list
20056644|NCT03337152|Amebicides|amebicides|mesh-ancestor
20056645|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20056646|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20056647|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056648|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
20056649|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20056650|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20056651|NCT03337308|Ezetimibe|ezetimibe|mesh-list
20056652|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20056653|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20056654|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
20056655|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056656|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20056657|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056658|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056659|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056660|NCT03337477|Insulin|insulin|mesh-list
20056661|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20056662|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056663|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056664|NCT03337490|Ivermectin|ivermectin|mesh-list
20056665|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20056666|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056667|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
20056668|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056669|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056670|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
20056671|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056672|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056673|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
20056674|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
20056675|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
20056676|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056677|NCT03338400|Dexamethasone|dexamethasone|mesh-list
20056678|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20056679|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
20056680|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
20056681|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056682|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056683|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20056684|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
20056685|NCT03338400|Hormones|hormones|mesh-ancestor
20056686|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20056687|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20056688|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577004|NCT02075086|Bevacizumab|bevacizumab|mesh-list
20577005|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20577006|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056689|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
20056690|NCT03338569|Vitamins|vitamins|mesh-ancestor
20056691|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
20056692|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056693|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
20056694|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056695|NCT03338569|Protective Agents|protective agents|mesh-ancestor
20056696|NCT03338803|Linagliptin|linagliptin|mesh-list
20056697|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056698|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056699|NCT03338803|Incretins|incretins|mesh-ancestor
20056700|NCT03338803|Hormones|hormones|mesh-ancestor
20056701|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20056702|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20056703|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
20056704|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056705|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056706|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
20056707|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20056708|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056709|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056710|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056711|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20056712|NCT03338998|Siponimod|siponimod|mesh-list
20056713|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20056714|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056715|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20056716|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
20056717|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056718|NCT03339297|Defibrotide|defibrotide|mesh-list
20056719|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20056720|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20056721|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056722|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20056723|NCT03339453|Glucagon|glucagon|mesh-list
20056724|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20056725|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20056726|NCT03339453|Hormones|hormones|mesh-ancestor
20056727|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20056728|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056729|NCT03339453|Incretins|incretins|mesh-ancestor
20056730|NCT03339583|Zopiclone|zopiclone|mesh-list
20056731|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20056732|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056733|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056734|NCT03339726|Phenylephrine|phenylephrine|mesh-list
20056735|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
20056736|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20056737|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
20056738|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
20056739|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056740|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056741|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
20056742|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20056743|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
20056744|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
20056745|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20056746|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20056747|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20056748|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
20056749|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056750|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056751|NCT03339726|Protective Agents|protective agents|mesh-ancestor
20118546|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118547|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20577007|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20056752|NCT03340350|Minocycline|minocycline|mesh-list
20056753|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20056754|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056755|NCT03340961|Doxycycline|doxycycline|mesh-list
20056756|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20056757|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056758|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
20056759|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20056760|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20056761|NCT03341273|Azithromycin|azithromycin|mesh-list
20056762|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20056763|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056764|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
20056765|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056766|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056767|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
20056768|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056769|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056770|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
20056771|NCT03341910|Tazarotene|tazarotene|mesh-list
20056772|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
20056773|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
20056774|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
20056775|NCT03341910|Vitamins|vitamins|mesh-ancestor
20056776|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
20056777|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056778|NCT03342404|Luspatercept|luspatercept|mesh-list
20056779|NCT03342404|Hematinics|hematinics|mesh-ancestor
20056780|NCT03342690|Eplerenone|eplerenone|mesh-list
20056781|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20056782|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
20056783|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577008|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20577009|NCT02075086|Growth Substances|growth substances|mesh-ancestor
20056784|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056785|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20056786|NCT03342690|Diuretics|diuretics|mesh-ancestor
20056787|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
20056788|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20056789|NCT03342963|Aripiprazole|aripiprazole|mesh-list
20056790|NCT03342963|Sertraline|sertraline|mesh-list
20056791|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
20056792|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056793|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20056794|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056795|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056796|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577010|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577011|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
20577012|NCT02075112|Genistein|genistein|mesh-list
20577013|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577014|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20577015|NCT02075112|Protective Agents|protective agents|mesh-ancestor
20577016|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577017|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20577018|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577019|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577020|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
20577021|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20577022|NCT02075112|Estrogens|estrogens|mesh-ancestor
20577023|NCT02075112|Hormones|hormones|mesh-ancestor
20577024|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577025|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
20577026|NCT02075242|Tacrolimus|tacrolimus|mesh-list
20577027|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577028|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
20577029|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577030|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20577031|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577032|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056797|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
20056798|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
20056799|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056800|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056801|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20056802|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20056803|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
20056804|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20056805|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20056806|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20056807|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20056808|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20056809|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20056810|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056811|NCT03343067|Norethindrone|norethindrone|mesh-list
20056812|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
20056813|NCT03343067|Estradiol|estradiol|mesh-list
20056814|NCT03343067|Estrogens|estrogens|mesh-ancestor
20056815|NCT03343067|Hormones|hormones|mesh-ancestor
20056816|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20056817|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056818|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20056819|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
20056820|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20056821|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20056822|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20056823|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20056824|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20056825|NCT03343080|Lidocaine|lidocaine|mesh-list
20056826|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
20056827|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
20056828|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056829|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056830|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
20056831|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056832|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20056833|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20056834|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20056835|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20056836|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056837|NCT03343639|Serlopitant|serlopitant|mesh-list
20056838|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20056839|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056840|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056841|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056842|NCT03344172|Gemcitabine|gemcitabine|mesh-list
20056843|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
20056844|NCT03344172|Paclitaxel|paclitaxel|mesh-list
20056845|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20056846|NCT03344172|Avelumab|avelumab|mesh-list
20056847|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20056848|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056849|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
20056850|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
20056851|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
20056852|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056853|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20056854|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
20056855|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
20056856|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20056857|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056858|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20056859|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
20056860|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056861|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
20056862|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20056863|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20056864|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20056865|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056866|NCT03344510|Anesthetics|anesthetics|mesh-list
20056867|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056868|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056869|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20056870|NCT03344861|Trioxsalen|trioxsalen|mesh-list
20056871|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056872|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
20056873|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20056874|NCT03345407|Albuterol|albuterol|mesh-list
20056875|NCT03345407|Nemiralisib|nemiralisib|mesh-list
20056876|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20056877|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
20056878|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056879|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056880|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20056881|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
20056882|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
20056883|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20056884|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20056885|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20056886|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20056887|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
20056888|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056889|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056890|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20056891|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056892|NCT03345979|Aripiprazole|aripiprazole|mesh-list
20056893|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20056894|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
20056895|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
20056896|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20056897|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20056898|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20056899|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20056900|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056901|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
20056902|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
20056903|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056904|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056905|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20056906|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20056907|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
20056908|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20056909|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20056910|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20056911|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20056912|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
20056913|NCT03346057|Rocuronium|rocuronium|mesh-list
20056914|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
20056915|NCT03346057|Neostigmine|neostigmine|mesh-list
20056916|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20056917|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20056918|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20056919|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056920|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056921|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20056922|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056923|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056924|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
20056925|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056926|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20056927|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
20056928|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20056929|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20056930|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20056931|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20056932|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
20056933|NCT03346070|Rocuronium|rocuronium|mesh-list
20056934|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
20056935|NCT03346070|Neostigmine|neostigmine|mesh-list
20056936|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20056937|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20056938|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20056939|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20056940|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056941|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20056942|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056943|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056944|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
20056945|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056946|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20056947|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
20056948|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20056949|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20056950|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20056951|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20056952|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20056953|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
20056954|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056955|NCT03348683|Propranolol|propranolol|mesh-list
20056956|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20056957|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20056958|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
20056959|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20056960|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056961|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056962|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20056963|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20056964|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
20056965|NCT03349060|Abrocitinib|abrocitinib|mesh-list
20056966|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20056967|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20056968|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056969|NCT03349333|Folic Acid|folic acid|mesh-list
20056970|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
20056971|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
20056972|NCT03349333|Vitamins|vitamins|mesh-ancestor
20056973|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
20056974|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056975|NCT03349333|Hematinics|hematinics|mesh-ancestor
20056976|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
20056977|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20056978|NCT03349710|Nivolumab|nivolumab|mesh-list
20056979|NCT03349710|Cetuximab|cetuximab|mesh-list
20056980|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056981|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056982|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20056983|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056984|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20056985|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
20056986|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
20056987|NCT03351231|Nivolumab|nivolumab|mesh-list
20056988|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20056989|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20056990|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20056991|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056992|NCT03351478|Empagliflozin|empagliflozin|mesh-list
20056993|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20056994|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20056995|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20056996|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20056997|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20056998|NCT03351608|Atropine|atropine|mesh-list
20056999|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
20057000|NCT03351608|Neostigmine|neostigmine|mesh-list
20057001|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20057002|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20057003|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057004|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
20057005|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057006|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057007|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057008|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057009|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
20057010|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
20057011|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20057012|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20057013|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
20057014|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057015|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057016|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20057017|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057018|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20057019|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
20057020|NCT03351933|Antibodies|antibodies|mesh-list
20057021|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
20057022|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20057023|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20057024|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
20057025|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057026|NCT03352323|Phenylephrine|phenylephrine|mesh-list
20057027|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
20057028|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20057029|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057030|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057031|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057032|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057033|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057034|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
20057035|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
20057036|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057037|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
20057038|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20057039|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057040|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20057041|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
20057042|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20057043|NCT03352323|Protective Agents|protective agents|mesh-ancestor
20057044|NCT03352414|Alvimopan|alvimopan|mesh-list
20057045|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057046|NCT03353740|Edetic Acid|edetic acid|mesh-list
20057047|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
20057048|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
20057049|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057050|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
20057051|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20057052|NCT03354429|Ticagrelor|ticagrelor|mesh-list
20057053|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20057054|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20057055|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20057056|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20057057|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
20057058|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057059|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057060|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057061|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
20057062|NCT03354598|Probenecid|probenecid|mesh-list
20057063|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057064|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057065|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20057066|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20057067|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057068|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057069|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057070|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20057071|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20057072|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
20057073|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
20057074|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20057075|NCT03354598|Renal Agents|renal agents|mesh-ancestor
20057076|NCT03355326|Glycerol|glycerol|mesh-list
20057077|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20057078|NCT03355326|Protective Agents|protective agents|mesh-ancestor
20057079|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057080|NCT03355820|Antibodies|antibodies|mesh-list
20057081|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
20057082|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057083|NCT03357341|Albuterol|albuterol|mesh-list
20057084|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057085|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
20057086|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057087|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057088|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057089|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057090|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
20057091|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20057092|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20057093|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20057094|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057095|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057096|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057097|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057098|NCT03357393|Midazolam|midazolam|mesh-list
20057099|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
20057100|NCT03357393|Scopolamine|scopolamine|mesh-list
20057101|NCT03357393|Morphine|morphine|mesh-list
20057102|NCT03357393|Propofol|propofol|mesh-list
20057103|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20057104|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20057105|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057106|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057107|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20057108|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
20057109|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
20057110|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20057111|NCT03357393|Narcotics|narcotics|mesh-ancestor
20057112|NCT03357393|Analgesics|analgesics|mesh-ancestor
20057113|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
20057114|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057115|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20057116|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20057117|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20057118|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20057119|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
20057120|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
20057121|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057122|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057123|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20057124|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20057125|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
20057126|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
20057127|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
20057128|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057129|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
20057130|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
20057131|NCT03357614|Amoxicillin|amoxicillin|mesh-list
20057132|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
20057133|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
19746171|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746172|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
19746173|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746174|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746175|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
19746176|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746177|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19746178|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746179|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19746180|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057134|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
19746181|NCT04195945|Analgesics|analgesics|mesh-ancestor
20057135|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20057136|NCT03357614|Ertapenem|ertapenem|mesh-list
20057137|NCT03357614|Lactams|lactams|mesh-list
20057138|NCT03357614|Probenecid|probenecid|mesh-list
20057139|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057140|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057141|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20057142|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20057143|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057144|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057145|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057146|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20057147|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20057148|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20057149|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
20057150|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
20057151|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20057152|NCT03357614|Renal Agents|renal agents|mesh-ancestor
20118548|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118549|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
20118550|NCT00006033|Methotrexate|methotrexate|mesh-list
20118551|NCT00006033|Interleukin-2|interleukin-2|mesh-list
20118552|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20118553|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
20118554|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19746182|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
20118555|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118556|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118557|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
20118558|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118559|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057153|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
20057154|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
20057155|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
20057156|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057157|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
19746183|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746184|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19746185|NCT04195633|Cyclosporine|cyclosporine|mesh-list
20057158|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057159|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057160|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057161|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057162|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
20057163|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20057164|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
20057165|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057166|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057167|NCT03358472|Carboplatin|carboplatin|mesh-list
20057168|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
20057169|NCT03358472|Fluorouracil|fluorouracil|mesh-list
20057170|NCT03358472|Cetuximab|cetuximab|mesh-list
20057171|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057172|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057173|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
20057174|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057175|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20057176|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057177|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
20057178|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057179|NCT03358576|Amoxicillin|amoxicillin|mesh-list
20057180|NCT03358576|Metronidazole|metronidazole|mesh-list
20057181|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
20057182|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
20057183|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
20057184|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20057185|NCT03358576|Ertapenem|ertapenem|mesh-list
20057186|NCT03358576|Lactams|lactams|mesh-list
20057187|NCT03358576|Probenecid|probenecid|mesh-list
20057188|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057189|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057190|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20057191|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20057192|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20057193|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20057194|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057195|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057196|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057197|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20057198|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20057199|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20057200|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
20057201|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
20057202|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20057203|NCT03358576|Renal Agents|renal agents|mesh-ancestor
20057204|NCT03359395|Alfentanil|alfentanil|mesh-list
20057205|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20057206|NCT03359395|Narcotics|narcotics|mesh-ancestor
20057207|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057208|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057209|NCT03359395|Analgesics|analgesics|mesh-ancestor
20057210|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
20057211|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057212|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20057213|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
20057214|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
20057215|NCT03359473|GSK2881078|gsk2881078|mesh-list
20057216|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
20057217|NCT03359473|Hormones|hormones|mesh-ancestor
20057218|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057219|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057220|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20057221|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20057222|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057223|NCT03359590|Incretins|incretins|mesh-ancestor
20057224|NCT03359590|Hormones|hormones|mesh-ancestor
20057225|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057226|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20057227|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20057228|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057229|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057230|NCT03359850|Niraparib|niraparib|mesh-list
20057231|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20057232|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057233|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057234|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057235|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
20057236|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057237|NCT03361176|Triamcinolone|triamcinolone|mesh-list
20057238|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20057239|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20057240|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
20057241|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20057242|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057243|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
20057244|NCT03361176|Hormones|hormones|mesh-ancestor
20057245|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057246|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057247|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057248|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
20057249|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057250|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057251|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20057252|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057253|NCT03361605|Propofol|propofol|mesh-list
20057254|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20057255|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057256|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057257|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20057258|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
20057259|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
20057260|NCT03363776|Nivolumab|nivolumab|mesh-list
20057261|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057262|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057263|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20057264|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057265|NCT03363906|Dulaglutide|dulaglutide|mesh-list
20057266|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20057267|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20057268|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057269|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
20057270|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
20057271|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057272|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057273|NCT03364309|Ixekizumab|ixekizumab|mesh-list
20057274|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
20057275|NCT03364608|Albuterol|albuterol|mesh-list
20057276|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057277|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
20057278|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057279|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057280|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057281|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057282|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
20057283|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20057284|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20057285|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20057286|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057287|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057288|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057289|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057290|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
20057291|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20057292|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
20057293|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
20057294|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057295|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057296|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20057297|NCT03365011|Analgesics|analgesics|mesh-ancestor
20057298|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
20057299|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057300|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20057301|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057302|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
20057303|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057304|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057305|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20057306|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20057307|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057308|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057309|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057310|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20057311|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20057312|NCT03366298|Epinephrine|epinephrine|mesh-list
20057313|NCT03366298|Racepinephrine|racepinephrine|mesh-list
20057314|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
20057315|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20057316|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057317|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057318|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057319|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057320|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057321|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20057322|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057323|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
20057324|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057325|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057326|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057327|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
20057328|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
20057329|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20057330|NCT03367793|Metronidazole|metronidazole|mesh-list
20057331|NCT03367793|Methamphetamine|methamphetamine|mesh-list
20057332|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20057333|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057334|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
20057335|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
20057336|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057337|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
20057338|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057339|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057340|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057341|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20057342|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20057343|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20057344|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20057345|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057346|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057347|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20057348|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20057349|NCT03368235|Prednisolone|prednisolone|mesh-list
20057350|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057351|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
20057352|NCT03368235|Hormones|hormones|mesh-ancestor
20057353|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057354|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057355|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20057356|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057357|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
20057358|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20057359|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057360|NCT03368859|Leucovorin|leucovorin|mesh-list
20057361|NCT03368859|Bevacizumab|bevacizumab|mesh-list
20057362|NCT03368859|Fluorouracil|fluorouracil|mesh-list
20057363|NCT03368859|Irinotecan|irinotecan|mesh-list
20057364|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057365|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057366|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20057367|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20057368|NCT03368859|Growth Substances|growth substances|mesh-ancestor
20057369|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057370|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
20057371|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
20057372|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569605|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
20057373|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20057374|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057375|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
20057376|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20057377|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20057378|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057379|NCT03368859|Antidotes|antidotes|mesh-ancestor
20057380|NCT03368859|Protective Agents|protective agents|mesh-ancestor
20057381|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
20057382|NCT03368859|Vitamins|vitamins|mesh-ancestor
20057383|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
20057384|NCT03369704|Omalizumab|omalizumab|mesh-list
20057385|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20057386|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057387|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057388|NCT03369951|Minocycline|minocycline|mesh-list
20057389|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057390|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057391|NCT03370289|Vaccines|vaccines|mesh-list
20057392|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
20057393|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057394|NCT03370770|Osimertinib|osimertinib|mesh-list
20057395|NCT03370770|Afatinib|afatinib|mesh-list
20057396|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057397|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20057398|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057399|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057400|NCT03371381|Nivolumab|nivolumab|mesh-list
20057401|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057402|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057403|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20057404|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057405|NCT03371459|Albuterol|albuterol|mesh-list
20057406|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057407|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
20057408|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057409|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057410|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057411|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057412|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
20057413|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20057414|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20057415|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20057416|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057417|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057418|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057419|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057420|NCT03371836|Clobazam|clobazam|mesh-list
20057421|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
20057422|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20057423|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20057424|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057425|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057426|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20057427|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20057428|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
20057429|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
20057430|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057431|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057432|NCT03372083|Deferasirox|deferasirox|mesh-list
20057433|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20057434|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
20057435|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
20057436|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057437|NCT03372382|Acetaminophen|acetaminophen|mesh-list
20057438|NCT03372382|Ibuprofen|ibuprofen|mesh-list
20057439|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20057440|NCT03372382|Analgesics|analgesics|mesh-ancestor
20057441|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
20057442|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057443|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057444|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
20057445|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20057446|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057447|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20057448|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20057449|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057450|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057451|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20057452|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20057453|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20057454|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057455|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057456|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20057457|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20057458|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057459|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
20057460|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057461|NCT03373591|Bupivacaine|bupivacaine|mesh-list
20057462|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
20057463|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
20057464|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057465|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057466|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
20057467|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057468|NCT03374176|Amoxicillin|amoxicillin|mesh-list
20057469|NCT03374176|Metronidazole|metronidazole|mesh-list
20057470|NCT03374176|Clindamycin|clindamycin|mesh-list
20057471|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
20057472|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
20057473|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057474|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057475|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20057476|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20057477|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20057478|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057479|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057480|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
20057481|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20057482|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20057483|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
20057484|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057485|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20057486|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20057487|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057488|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057489|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
20057490|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057491|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057492|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
20057493|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20057494|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
20057495|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
20057496|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057497|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057498|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20057499|NCT03375294|Analgesics|analgesics|mesh-ancestor
20057500|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
20057501|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057502|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
20057503|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20057504|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20057505|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057506|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
20057507|NCT03376061|Coagulants|coagulants|mesh-ancestor
20057508|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
20057509|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057510|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
20057511|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057512|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057513|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057514|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057515|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
20057516|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20057517|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
20057518|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057519|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057520|NCT03377556|Talazoparib|talazoparib|mesh-list
20057521|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20057522|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057523|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118560|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
20057524|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118561|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118562|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20118563|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118564|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
20118565|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118566|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20118567|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20118568|NCT00006033|Analgesics|analgesics|mesh-ancestor
20118569|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
20118570|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118571|NCT00006034|Doxorubicin|doxorubicin|mesh-list
20118572|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20118573|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20118574|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20118575|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118576|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118577|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118578|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118579|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118580|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20118581|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
20118582|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118583|NCT00006035|Bleomycin|bleomycin|mesh-list
20118584|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20118585|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118586|NCT00006036|Lurtotecan|lurtotecan|mesh-list
20118587|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118588|NCT00006037|Fluorouracil|fluorouracil|mesh-list
20118589|NCT00006037|Irinotecan|irinotecan|mesh-list
20118590|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
20118591|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118592|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118593|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118594|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118595|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
20118596|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118597|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20118598|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118599|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118600|NCT00006038|Leucovorin|leucovorin|mesh-list
20118601|NCT00006038|Docetaxel|docetaxel|mesh-list
20118602|NCT00006038|Fluorouracil|fluorouracil|mesh-list
20118603|NCT00006038|Floxuridine|floxuridine|mesh-list
20118604|NCT00006038|Calcium|calcium|mesh-list
20118605|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
20118606|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118607|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118608|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118609|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118610|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118611|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20118612|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118613|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
20118614|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118615|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118616|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
20118617|NCT00006038|Antidotes|antidotes|mesh-ancestor
20118618|NCT00006038|Protective Agents|protective agents|mesh-ancestor
20118619|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
20118620|NCT00006038|Vitamins|vitamins|mesh-ancestor
20118621|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
20118622|NCT00006039|Interferons|interferons|mesh-list
20118623|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
20118624|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118625|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
20118626|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118627|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
20118628|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118629|NCT00006040|Etoposide|etoposide|mesh-list
20118630|NCT00006040|Antibodies|antibodies|mesh-list
20118631|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20118632|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
20118633|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118634|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118635|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118636|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118637|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20057525|NCT03378076|Triamcinolone|triamcinolone|mesh-list
20057526|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20057527|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20057528|NCT03378076|FX006|fx006|mesh-list
20057529|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20057530|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057531|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
20057532|NCT03378076|Hormones|hormones|mesh-ancestor
20057533|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057534|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057535|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057536|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
20057537|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057538|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057539|NCT03378635|Glucagon|glucagon|mesh-list
20057540|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057541|NCT03378635|Hormones|hormones|mesh-ancestor
20057542|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057543|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057544|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
20057545|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20057546|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057547|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057548|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20057549|NCT03378973|Analgesics|analgesics|mesh-ancestor
20057550|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
20057551|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057552|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20057553|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20057554|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057555|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057556|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057557|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057558|NCT03379506|Grazoprevir|grazoprevir|mesh-list
20057559|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
20057560|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057561|NCT03380026|Triamcinolone|triamcinolone|mesh-list
20057562|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20057563|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20057564|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
20057565|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20057566|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057567|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
20057568|NCT03380026|Hormones|hormones|mesh-ancestor
20057569|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057570|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057571|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057572|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
20057573|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057574|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057575|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
20057576|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20057577|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057578|NCT03380091|Vitamin D|vitamin d|mesh-list
20057579|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
20057580|NCT03380091|Metformin|metformin|mesh-list
20057581|NCT03380091|Vitamins|vitamins|mesh-ancestor
20057582|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
20057583|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057584|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20057585|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20057586|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20057587|NCT03380390|Phenylephrine|phenylephrine|mesh-list
20057588|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
20057589|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20057590|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057591|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057592|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057593|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057594|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057595|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
20057596|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
20057597|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057598|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
20057599|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20057600|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057601|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20057602|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
20057603|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20057604|NCT03380390|Protective Agents|protective agents|mesh-ancestor
20057605|NCT03380429|Albuterol|albuterol|mesh-list
20057606|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057607|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
20057608|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057609|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057610|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057611|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057612|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
20057613|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20057614|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20057615|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20057616|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057617|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057618|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057619|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057620|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
20057621|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20057622|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
20057623|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057624|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
20057625|NCT03381248|Protective Agents|protective agents|mesh-ancestor
20057626|NCT03381742|Clopidogrel|clopidogrel|mesh-list
20057627|NCT03381742|Ticagrelor|ticagrelor|mesh-list
20057628|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20057629|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20057630|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20057631|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20057632|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
20057633|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057634|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057635|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057636|NCT03382262|Triamcinolone|triamcinolone|mesh-list
20057637|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20057638|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20057639|NCT03382262|FX006|fx006|mesh-list
20057640|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20057641|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057642|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
20057643|NCT03382262|Hormones|hormones|mesh-ancestor
20057644|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057645|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057646|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057647|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
20057648|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057649|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057650|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20057651|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20057652|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
20057653|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057654|NCT03382418|Antacids|antacids|mesh-ancestor
20057655|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057656|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057657|NCT03382821|Dexamethasone|dexamethasone|mesh-list
20057658|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
20057659|NCT03382821|Triamcinolone|triamcinolone|mesh-list
20057660|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20057661|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20057662|NCT03382821|Lidocaine|lidocaine|mesh-list
20057663|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20057664|NCT03382821|BB 1101|bb 1101|mesh-list
20057665|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20057666|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057667|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
20057668|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
20293389|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293390|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
19746186|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
20057669|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057670|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057671|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057672|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
20057673|NCT03382821|Hormones|hormones|mesh-ancestor
20057674|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057675|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20057676|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057677|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
20057678|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057679|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057680|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
20057681|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
20057682|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057683|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
20057684|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20057685|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20057686|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20057687|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20057688|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057689|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
20057690|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
20057691|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057692|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057693|NCT03382912|Nivolumab|nivolumab|mesh-list
20057694|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057695|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057696|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20057697|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057698|NCT03383198|Bupivacaine|bupivacaine|mesh-list
20057699|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
20057700|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
20057701|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057702|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057703|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
20057704|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057705|NCT03383523|Praziquantel|praziquantel|mesh-list
20057706|NCT03383523|Emodepside|emodepside|mesh-list
20057707|NCT03383523|Toltrazuril|toltrazuril|mesh-list
20057708|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
20057709|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20057710|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057711|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
20057712|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20057713|NCT03383588|Epinephrine|epinephrine|mesh-list
20057714|NCT03383588|Fentanyl|fentanyl|mesh-list
20057715|NCT03383588|Morphine|morphine|mesh-list
20057716|NCT03383588|Bupivacaine|bupivacaine|mesh-list
20057717|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
20057718|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
20057719|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057720|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057721|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
20057722|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057723|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20057724|NCT03383588|Narcotics|narcotics|mesh-ancestor
20057725|NCT03383588|Analgesics|analgesics|mesh-ancestor
20057726|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20057727|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20057728|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
20057729|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20057730|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20057731|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
20057732|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057733|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057734|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20057735|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20057736|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
20057737|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20057738|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
20057739|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
20057740|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
20057741|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20057742|NCT03383614|Emodepside|emodepside|mesh-list
20057743|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20057744|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057745|NCT03383783|Listerine|listerine|mesh-list
20057746|NCT03383783|Fluorides|fluorides|mesh-list
20057747|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
20057748|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
20057749|NCT03383783|Protective Agents|protective agents|mesh-ancestor
20118638|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057750|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057751|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20057752|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057753|NCT03384316|Vaccines|vaccines|mesh-list
20057754|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
20057755|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057756|NCT03384329|Resveratrol|resveratrol|mesh-list
20057757|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
20057758|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057759|NCT03384329|Protective Agents|protective agents|mesh-ancestor
20057760|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057761|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057762|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20057763|NCT03384693|Defibrotide|defibrotide|mesh-list
20057764|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20057765|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20057766|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057767|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20057768|NCT03384940|Trastuzumab|trastuzumab|mesh-list
20057769|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057770|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057771|NCT03386032|Desonide|desonide|mesh-list
20057772|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057773|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20057774|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20057775|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057776|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20057777|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057778|NCT03386448|Scopolamine|scopolamine|mesh-list
20057779|NCT03386448|Naltrexone|naltrexone|mesh-list
20057780|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20057781|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20057782|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20057783|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057784|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
20057785|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057786|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20057787|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
20057788|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
20057789|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057790|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
20057791|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20057792|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
20057793|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057794|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057795|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20057796|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
20057797|NCT03386474|Aflibercept|aflibercept|mesh-list
20057798|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20057799|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20057800|NCT03386474|Growth Substances|growth substances|mesh-ancestor
20057801|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057802|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
20057803|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057804|NCT03387020|Everolimus|everolimus|mesh-list
20057805|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057806|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057807|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
20057808|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057809|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
20057810|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20057811|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20057812|NCT03387046|Prednisolone|prednisolone|mesh-list
20057813|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
20057814|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20057815|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
20057816|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057817|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
20057818|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
20577033|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20577034|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577035|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19746187|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
20057819|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577036|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
20057820|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057821|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057822|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
20057823|NCT03387046|Hormones|hormones|mesh-ancestor
20057824|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057825|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20057826|NCT03387046|Protective Agents|protective agents|mesh-ancestor
20057827|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20057828|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057829|NCT03387462|Tenofovir|tenofovir|mesh-list
20057830|NCT03387462|Emtricitabine|emtricitabine|mesh-list
20057831|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
20057832|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057833|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20057834|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20057835|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057836|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057837|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20057838|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20057839|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
20057840|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20057841|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057842|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20057843|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057844|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
20057845|NCT03388008|Prednisone|prednisone|mesh-list
20057846|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
20057847|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20057848|NCT03388008|Abatacept|abatacept|mesh-list
20057849|NCT03388008|Tacrolimus|tacrolimus|mesh-list
20057850|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
20057851|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293391|NCT04477772|Antibodies|antibodies|mesh-list
20293392|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20057852|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
20057853|NCT03388008|Hormones|hormones|mesh-ancestor
20057854|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20057855|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057856|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20057857|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057858|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20057859|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
20057860|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20057861|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20057862|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057863|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20057864|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20057865|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
20057866|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057867|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057868|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
20057869|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
20057870|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057871|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20057872|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20057873|NCT03388008|Protective Agents|protective agents|mesh-ancestor
20057874|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20057875|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20057876|NCT03388164|Dexetimide|dexetimide|mesh-list
20057877|NCT03388164|Citalopram|citalopram|mesh-list
20057878|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20057879|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20057880|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20057881|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057882|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057883|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
20057884|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057885|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20057886|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
20057887|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20057888|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20057889|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20057890|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
20293393|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
20057891|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
20057892|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057893|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20057894|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20057895|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
20057896|NCT03388268|Vancomycin|vancomycin|mesh-list
20057897|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20057898|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20057899|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
20057900|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057901|NCT03389555|Vitamins|vitamins|mesh-list
20057902|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
20057903|NCT03389555|Thiamine|thiamine|mesh-list
20057904|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
20057905|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
20057906|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057907|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057908|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
20057909|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057910|NCT03389555|Protective Agents|protective agents|mesh-ancestor
20057911|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
20057912|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20057913|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
20057914|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057915|NCT03390166|Vaccines|vaccines|mesh-list
20057916|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
20057917|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057918|NCT03390426|Anesthetics|anesthetics|mesh-list
20057919|NCT03390426|Mepivacaine|mepivacaine|mesh-list
20057920|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
20057921|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057922|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057923|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
20057924|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057925|NCT03391765|Tilavonemab|tilavonemab|mesh-list
20057926|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
20057927|NCT03393000|Vitamin A|vitamin a|mesh-list
20057928|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
20057929|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
20057930|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057931|NCT03393000|Protective Agents|protective agents|mesh-ancestor
20057932|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057933|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20057934|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057935|NCT03393000|Vitamins|vitamins|mesh-ancestor
20057936|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
20057937|NCT03393208|Metformin|metformin|mesh-list
20057938|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20057939|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057940|NCT03393494|Adapalene|adapalene|mesh-list
20057941|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20057942|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
20057943|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20057944|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20057945|NCT03393494|Analgesics|analgesics|mesh-ancestor
20057946|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
20057947|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057948|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057949|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20057950|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20057951|NCT03393754|Vaccines|vaccines|mesh-list
20057952|NCT03393754|Immunologic Factors|immunologic factors|mesh-ancestor
20057953|NCT03393754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057954|NCT03394885|Paclitaxel|paclitaxel|mesh-list
20057955|NCT03394885|Bevacizumab|bevacizumab|mesh-list
20057956|NCT03394885|Carboplatin|carboplatin|mesh-list
20057957|NCT03394885|Atezolizumab|atezolizumab|mesh-list
20057958|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20057959|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20057960|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
20057961|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
20057962|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
20057963|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057964|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20057965|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20057966|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20057967|NCT03394885|Growth Substances|growth substances|mesh-ancestor
20057968|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057969|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
20057970|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20057971|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20057972|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20057973|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20057974|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20057975|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20057976|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057977|NCT03395353|Analgesics|analgesics|mesh-ancestor
20057978|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
20057979|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057980|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
20057981|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20057982|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
20118639|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118640|NCT00006041|Vaccines|vaccines|mesh-list
20118641|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
20118642|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
20118643|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118644|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20118645|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
20118646|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
20118647|NCT00006042|Fludarabine|fludarabine|mesh-list
20118648|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
20118649|NCT00006042|Tacrolimus|tacrolimus|mesh-list
20118650|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118651|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
20118652|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118653|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118654|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118655|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
20118656|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118657|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118658|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118659|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118660|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
20118661|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20118662|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118663|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20118664|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20118665|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
20118666|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20118667|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118668|NCT00006043|Temozolomide|temozolomide|mesh-list
20118669|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118670|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
20118671|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118672|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118673|NCT00006044|Testosterone|testosterone|mesh-list
20118674|NCT00006044|Androgens|androgens|mesh-ancestor
20118675|NCT00006044|Hormones|hormones|mesh-ancestor
20118676|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118677|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118678|NCT00006045|Cytarabine|cytarabine|mesh-list
20118679|NCT00006045|Etoposide|etoposide|mesh-list
20118680|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
20118681|NCT00006045|Lintuzumab|lintuzumab|mesh-list
20118682|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118683|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118684|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118685|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118686|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118687|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118688|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118689|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
20118690|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
20118691|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118692|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118693|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
20118694|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118695|NCT00006045|Analgesics|analgesics|mesh-ancestor
20118696|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
20118697|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118698|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20118699|NCT00006047|Etoposide|etoposide|mesh-list
20118700|NCT00006047|Rubitecan|rubitecan|mesh-list
20057983|NCT03395808|Tramadol|tramadol|mesh-list
20057984|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20057985|NCT03395808|Narcotics|narcotics|mesh-ancestor
20057986|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057987|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057988|NCT03395808|Analgesics|analgesics|mesh-ancestor
20057989|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
20057990|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20057991|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
20057992|NCT03395886|Remifentanil|remifentanil|mesh-list
20057993|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20057994|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20057995|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20057996|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20057997|NCT03395886|Analgesics|analgesics|mesh-ancestor
20057998|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
20057999|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058000|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20058001|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20058002|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20058003|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20058004|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058005|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058006|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20058007|NCT03395886|Narcotics|narcotics|mesh-ancestor
20058008|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
20058009|NCT03395990|Procaine|procaine|mesh-list
20058010|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058011|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
20058012|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058013|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058014|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
20058015|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058016|NCT03396952|Aspirin|aspirin|mesh-list
20058017|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
20058018|NCT03396952|Ipilimumab|ipilimumab|mesh-list
20058019|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20058020|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058021|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20058022|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058023|NCT03396952|Analgesics|analgesics|mesh-ancestor
20058024|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
20058025|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058026|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058027|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058028|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058029|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20058030|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20058031|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058032|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20058033|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20058034|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058035|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
20058036|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20058037|NCT03397394|Rucaparib|rucaparib|mesh-list
20058038|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20058039|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058040|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058041|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058042|NCT03398278|Oxycodone|oxycodone|mesh-list
20058043|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20058044|NCT03398278|Narcotics|narcotics|mesh-ancestor
20058045|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058046|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058047|NCT03398278|Analgesics|analgesics|mesh-ancestor
20058048|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
20058049|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058050|NCT03398330|Oxycodone|oxycodone|mesh-list
20058051|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20058052|NCT03398330|Narcotics|narcotics|mesh-ancestor
20058053|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058054|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058055|NCT03398330|Analgesics|analgesics|mesh-ancestor
20058056|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
20058057|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058058|NCT03398421|Itraconazole|itraconazole|mesh-list
20058059|NCT03398421|Nemiralisib|nemiralisib|mesh-list
20058060|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
20058061|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058062|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20058063|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20058064|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058065|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058066|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20058067|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
20058068|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058069|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058070|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20058071|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20058072|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
20058073|NCT03400033|Hematinics|hematinics|mesh-ancestor
20058074|NCT03400475|Simvastatin|simvastatin|mesh-list
20058075|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20058076|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20058077|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
20058078|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058079|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20058080|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20058081|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058082|NCT03400852|Cosyntropin|cosyntropin|mesh-list
20058083|NCT03400852|Hormones|hormones|mesh-ancestor
20058084|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058085|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058086|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
20058087|NCT03401229|Benralizumab|benralizumab|mesh-list
20058088|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058089|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
20058090|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20058091|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20058092|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058093|NCT03401450|Bupivacaine|bupivacaine|mesh-list
20058094|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058095|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
20058096|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058097|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058098|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
20058099|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058100|NCT03402243|Menthol|menthol|mesh-list
20058101|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
20058102|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
20058103|NCT03403036|Brodalumab|brodalumab|mesh-list
20058104|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
20058105|NCT03403374|Evolocumab|evolocumab|mesh-list
20058106|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20058107|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20058108|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
20058109|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058110|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20058111|NCT03403504|Oxycodone|oxycodone|mesh-list
20058112|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20058113|NCT03403504|Narcotics|narcotics|mesh-ancestor
20058114|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058115|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058116|NCT03403504|Analgesics|analgesics|mesh-ancestor
20058117|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
20058118|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058119|NCT03403517|Dexamethasone|dexamethasone|mesh-list
20058120|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
20058121|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20058122|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20058123|NCT03403517|Prednisolone|prednisolone|mesh-list
20058124|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
20058125|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20058126|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
20058127|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058128|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
20058129|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
20058130|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058131|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058132|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058133|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
20058134|NCT03403517|Hormones|hormones|mesh-ancestor
20058135|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058136|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20058137|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058138|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20058139|NCT03403517|Protective Agents|protective agents|mesh-ancestor
20058140|NCT03403712|Dexamethasone|dexamethasone|mesh-list
20293394|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293395|NCT04446962|Lenalidomide|lenalidomide|mesh-list
20293396|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
20058141|NCT03403712|Palonosetron|palonosetron|mesh-list
20058142|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058143|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
20058144|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
20058145|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058146|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058147|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058148|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
20058149|NCT03403712|Hormones|hormones|mesh-ancestor
20058150|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058151|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20058152|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058153|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20058154|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20058155|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
20058156|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058157|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058158|NCT03404206|Ibuprofen|ibuprofen|mesh-list
20058159|NCT03404206|Naproxen|naproxen|mesh-list
20058160|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20058161|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058162|NCT03404206|Analgesics|analgesics|mesh-ancestor
20058163|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
20058164|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058165|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058166|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058167|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058168|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20058169|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058170|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058171|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
20058172|NCT03404648|Choline|choline|mesh-list
20058173|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
20058174|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20058175|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
20058176|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058177|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058178|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20058179|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
20058180|NCT03404843|Fasudil|fasudil|mesh-list
20058181|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20058182|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058183|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058184|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20058185|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058186|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
20058187|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20058188|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058189|NCT03405259|Fluorides|fluorides|mesh-list
20058190|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
20058191|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
20058192|NCT03405259|Protective Agents|protective agents|mesh-ancestor
20058193|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058194|NCT03405818|Tavaborole|tavaborole|mesh-list
20058195|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
20058196|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058197|NCT03406260|Lasmiditan|lasmiditan|mesh-list
20058198|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20058199|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
20058200|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293397|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293398|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20058201|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058202|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058203|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
20058204|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20058205|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058206|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
20058207|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20058208|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058209|NCT03407430|Pregabalin|pregabalin|mesh-list
20058210|NCT03407430|Analgesics|analgesics|mesh-ancestor
20058211|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
20058212|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058213|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058214|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
20058215|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20058216|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058217|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058218|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20058219|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20058220|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20058221|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058222|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20058223|NCT03407625|Misoprostol|misoprostol|mesh-list
20058224|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20058225|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
20058226|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20058227|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058228|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20058229|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058230|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
20058231|NCT03408483|Epinephrine|epinephrine|mesh-list
20058232|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
20058233|NCT03408483|Bupivacaine|bupivacaine|mesh-list
20058234|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058235|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
20058236|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058237|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058238|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
20058239|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058240|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20058241|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20058242|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
20058243|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058244|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058245|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20058246|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20058247|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
20058248|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20058249|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058250|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
20058251|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
20058252|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20058253|NCT03408483|Narcotics|narcotics|mesh-ancestor
20058254|NCT03408483|Analgesics|analgesics|mesh-ancestor
20058255|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
20058256|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
20058257|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
20058258|NCT03408639|Vitamins|vitamins|mesh-ancestor
20058259|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
20058260|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058261|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
20058262|NCT03408639|Hematinics|hematinics|mesh-ancestor
20058263|NCT03408730|Vaccines|vaccines|mesh-list
20058264|NCT03408730|Immunologic Factors|immunologic factors|mesh-ancestor
20058265|NCT03408730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058266|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
20058267|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20058268|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058269|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058270|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20058271|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058272|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20058273|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
20058274|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20058275|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058276|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
20058277|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
20058278|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20058279|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
20058280|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20058281|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
20058282|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058283|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058284|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
20058285|NCT03414359|Lidocaine|lidocaine|mesh-list
20058286|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
20058287|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058288|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
20058289|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058290|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058291|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
20058292|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058293|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20058294|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20058295|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20058296|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058297|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118701|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
20118702|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118703|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118704|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118705|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118706|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118707|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118708|NCT00006048|Gemcitabine|gemcitabine|mesh-list
20118709|NCT00006048|Gefitinib|gefitinib|mesh-list
20118710|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118711|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118712|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
20118713|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118714|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
20118715|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118716|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118717|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118718|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
20118719|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118720|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118721|NCT00006049|Paclitaxel|paclitaxel|mesh-list
20118722|NCT00006049|Carboplatin|carboplatin|mesh-list
20118723|NCT00006049|Gefitinib|gefitinib|mesh-list
20118724|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118725|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118726|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118727|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118728|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118729|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118730|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118731|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118732|NCT00006050|Leucovorin|leucovorin|mesh-list
20118733|NCT00006050|Fluorouracil|fluorouracil|mesh-list
20118734|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
20118735|NCT00006050|Calcium|calcium|mesh-list
20118736|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
20118737|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20118738|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118739|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
20118740|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118741|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118742|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118743|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118744|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
20118745|NCT00006050|Antidotes|antidotes|mesh-ancestor
20118746|NCT00006050|Protective Agents|protective agents|mesh-ancestor
20118747|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
20118748|NCT00006050|Vitamins|vitamins|mesh-ancestor
20118749|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
20118750|NCT00006051|Fluorouracil|fluorouracil|mesh-list
20118751|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118752|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
20118753|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118754|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118755|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118756|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
20118757|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058298|NCT03415178|Atorvastatin|atorvastatin|mesh-list
20058299|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20058300|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20058301|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20058302|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
20058303|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058304|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20058305|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20058306|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058307|NCT03415243|Acetaminophen|acetaminophen|mesh-list
20058308|NCT03415243|Phenylephrine|phenylephrine|mesh-list
20058309|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
20058310|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
20058311|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058312|NCT03415243|Analgesics|analgesics|mesh-ancestor
20058313|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
20058314|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058315|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058316|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
20058317|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20058318|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
20058319|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
20058320|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
20058321|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20058322|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
20058323|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058324|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20058325|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20058326|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20058327|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
20058328|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058329|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058330|NCT03415243|Protective Agents|protective agents|mesh-ancestor
20058331|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
20058332|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20058333|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20058334|NCT03415581|Oxycodone|oxycodone|mesh-list
20058335|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20058336|NCT03415581|Narcotics|narcotics|mesh-ancestor
20058337|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058338|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058339|NCT03415581|Analgesics|analgesics|mesh-ancestor
20058340|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
20058341|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058342|NCT03416127|Metformin|metformin|mesh-list
20058343|NCT03416127|Propolis|propolis|mesh-list
20058344|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20058345|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058346|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058347|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
20058348|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
20058349|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058350|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20058351|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058352|NCT03418571|Gontivimab|gontivimab|mesh-list
20058353|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
20058354|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058355|NCT03418714|Salvinorin A|salvinorin a|mesh-list
20058356|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
20058357|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058358|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20058359|NCT03419403|Temozolomide|temozolomide|mesh-list
20058360|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20058361|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20058362|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20058363|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
20058364|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058365|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058366|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20058367|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
20058368|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
20058369|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058370|NCT03421210|Nicotine|nicotine|mesh-list
20058371|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20058372|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
20058373|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058374|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058375|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20058376|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20058377|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
20058378|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058379|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058380|NCT03421379|Glucagon|glucagon|mesh-list
20058381|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20058382|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058383|NCT03421379|Hormones|hormones|mesh-ancestor
20058384|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058385|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058386|NCT03421379|Incretins|incretins|mesh-ancestor
20058387|NCT03421730|Budesonide|budesonide|mesh-list
20058388|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058389|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20058390|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
20058391|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058392|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058393|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20058394|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058395|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
20058396|NCT03421730|Hormones|hormones|mesh-ancestor
20058397|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058398|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
20058399|NCT03422159|Thiamine|thiamine|mesh-list
20058400|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
20058401|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20058402|NCT03422159|Vitamins|vitamins|mesh-ancestor
20058403|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
20058404|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058405|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058406|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
20058407|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058408|NCT03422159|Protective Agents|protective agents|mesh-ancestor
20058409|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
20058410|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
20058411|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058412|NCT03424044|Glucagon|glucagon|mesh-list
20058413|NCT03424044|Pancrelipase|pancrelipase|mesh-list
20058414|NCT03424044|Pancreatin|pancreatin|mesh-list
20058415|NCT03424044|Hormones|hormones|mesh-list
20058416|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058417|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058418|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058419|NCT03424239|Vitamin D|vitamin d|mesh-list
20058420|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
20058421|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
20058422|NCT03424239|Vitamins|vitamins|mesh-list
20058423|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
20058424|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058425|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20058426|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20058427|NCT03424681|Modafinil|modafinil|mesh-list
20058428|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20058429|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058430|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20058431|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20058432|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20058433|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058434|NCT03425097|Fexofenadine|fexofenadine|mesh-list
20058435|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20058436|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20058437|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20058438|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
20058439|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
20058440|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058441|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058442|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058443|NCT03425253|Lidocaine|lidocaine|mesh-list
20058444|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058445|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
20058446|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058447|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058448|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
20058449|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058450|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20058451|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20058452|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20058453|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058454|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058455|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
20058456|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20058457|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058458|NCT03425396|Renal Agents|renal agents|mesh-ancestor
20058459|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20058460|NCT03426228|Progesterone|progesterone|mesh-list
20058461|NCT03426228|Estrogens|estrogens|mesh-list
20058462|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058463|NCT03426228|Hormones|hormones|mesh-ancestor
20058464|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058465|NCT03426228|Progestins|progestins|mesh-ancestor
20058466|NCT03426995|Cantharidin|cantharidin|mesh-list
20058467|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058468|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058469|NCT03427619|Picibanil|picibanil|mesh-list
20058470|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058471|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
20058472|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
20058473|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058474|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058475|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058476|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
20058477|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
20058478|NCT03428230|Acetaminophen|acetaminophen|mesh-list
20058479|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
20058480|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20058481|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058482|NCT03428230|Analgesics|analgesics|mesh-ancestor
20058483|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
20058484|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058485|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058486|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
20058487|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058488|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
20058489|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058490|NCT03428360|Diazepam|diazepam|mesh-list
20577037|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20577038|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577039|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20577040|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20577041|NCT02075294|Entecavir|entecavir|mesh-list
20058491|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20058492|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
20058493|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
20058494|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
20058495|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058496|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058497|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058498|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20058499|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058500|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20058501|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20058502|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20058503|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20058504|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20058505|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20058506|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
20058507|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
20058508|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
20058509|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
20058510|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058511|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058512|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
20058513|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20058514|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058515|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058516|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
20577042|NCT02075294|Adefovir|adefovir|mesh-list
20058517|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058518|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058519|NCT03430050|Progesterone|progesterone|mesh-list
20058520|NCT03430050|Progestins|progestins|mesh-ancestor
20058521|NCT03430050|Hormones|hormones|mesh-ancestor
20058522|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058523|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058524|NCT03430856|Insulin|insulin|mesh-list
20058525|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20058526|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
20058527|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20058528|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058529|NCT03430986|Lidocaine|lidocaine|mesh-list
20058530|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058531|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
20058532|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058533|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058534|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
20058535|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058536|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20058537|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20058538|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20058539|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058540|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058541|NCT03431337|Amoxicillin|amoxicillin|mesh-list
20058542|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20058543|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058544|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20058545|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
20058546|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058547|NCT03432858|Vancomycin|vancomycin|mesh-list
20058548|NCT03432858|Cefazolin|cefazolin|mesh-list
20058549|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20058550|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058551|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
20058552|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20058553|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058554|NCT03433703|Lenvatinib|lenvatinib|mesh-list
20058555|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058556|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20058557|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058558|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058559|NCT03433755|Evolocumab|evolocumab|mesh-list
20058560|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20058561|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20058562|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
20058563|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058564|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20118758|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
20118759|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118760|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118761|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118762|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118763|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
20118764|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118765|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20118766|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118767|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118768|NCT00006054|Cyclosporine|cyclosporine|mesh-list
20118769|NCT00006054|Prednisone|prednisone|mesh-list
20118770|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
20118771|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
20118772|NCT00006054|Busulfan|busulfan|mesh-list
20118773|NCT00006054|Methotrexate|methotrexate|mesh-list
20118774|NCT00006054|Etoposide|etoposide|mesh-list
20118775|NCT00006054|Cyclosporins|cyclosporins|mesh-list
20118776|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20118777|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118778|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
20118779|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118780|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118781|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118782|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
20118783|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118784|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118785|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118786|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058565|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20058566|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20058567|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20058568|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058569|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
20058570|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20058571|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
20058572|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
20058573|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058574|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058575|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058576|NCT03435055|Analgesics|analgesics|mesh-ancestor
20058577|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
20058578|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058579|NCT03435614|Analgesics|analgesics|mesh-list
20058580|NCT03435614|Narcotics|narcotics|mesh-list
20058581|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058582|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058583|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
20058584|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058585|NCT03435692|Acetaminophen|acetaminophen|mesh-list
20058586|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
20058587|NCT03435692|Promethazine|promethazine|mesh-list
20058588|NCT03435692|Fentanyl|fentanyl|mesh-list
20058589|NCT03435692|Morphine|morphine|mesh-list
20058590|NCT03435692|Oxycodone|oxycodone|mesh-list
20058591|NCT03435692|Lorazepam|lorazepam|mesh-list
20058592|NCT03435692|Ondansetron|ondansetron|mesh-list
20058593|NCT03435692|Ropivacaine|ropivacaine|mesh-list
20058594|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20058595|NCT03435692|Narcotics|narcotics|mesh-ancestor
20058596|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058597|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058598|NCT03435692|Analgesics|analgesics|mesh-ancestor
20058599|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
20058600|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058601|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
20058602|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
20058603|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20058604|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20058605|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
20058606|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058607|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
20058608|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
20058609|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
20058610|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058611|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
20058612|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
20058613|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20058614|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
20058615|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058616|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058617|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20058618|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20058619|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20058620|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20058621|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20058622|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20058623|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20058624|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
20058625|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
20058626|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20058627|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
20058628|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
20058629|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
20058630|NCT03436420|Calcium|calcium|mesh-list
20058631|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20058632|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058633|NCT03437044|Clopidogrel|clopidogrel|mesh-list
20058634|NCT03437044|Ticagrelor|ticagrelor|mesh-list
20058635|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20058636|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20058637|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20058638|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20058639|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
20058640|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058641|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058642|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058643|NCT03437447|Praziquantel|praziquantel|mesh-list
20577043|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20058644|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
20058645|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20058646|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058647|NCT03437564|Vortioxetine|vortioxetine|mesh-list
20058648|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
20058649|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20058650|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20058651|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20058652|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058653|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058654|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20058655|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20058656|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058657|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058658|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058659|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
20058660|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20058661|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20058662|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20058663|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20058664|NCT03437577|Tacrolimus|tacrolimus|mesh-list
20058665|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20058666|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
20058667|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058668|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20058669|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058670|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058671|NCT03438006|Vaccines|vaccines|mesh-list
20058672|NCT03438006|Immunologic Factors|immunologic factors|mesh-ancestor
20058673|NCT03438006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058674|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
20058675|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20058676|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
20058677|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058678|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
20058679|NCT03438266|Protective Agents|protective agents|mesh-ancestor
20058680|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
20058681|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20058682|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058683|NCT03439072|Glucagon|glucagon|mesh-list
20058684|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20058685|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058686|NCT03439072|Hormones|hormones|mesh-ancestor
20058687|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058688|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058689|NCT03439072|Incretins|incretins|mesh-ancestor
20058690|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
20058691|NCT03439137|Hematinics|hematinics|mesh-ancestor
20058692|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20058693|NCT03440229|Laxatives|laxatives|mesh-ancestor
20058694|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058695|NCT03440411|Dexamethasone|dexamethasone|mesh-list
20058696|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
20058697|NCT03440411|Pomalidomide|pomalidomide|mesh-list
20058698|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20058699|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
20058700|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058701|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058702|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20058703|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
20058704|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577044|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
20577045|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577046|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20577047|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20577048|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058705|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058706|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20058707|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058708|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
20058709|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
20058710|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058711|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058712|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
20058713|NCT03440411|Hormones|hormones|mesh-ancestor
20058714|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058715|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20058716|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20058717|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20058718|NCT03440411|Growth Substances|growth substances|mesh-ancestor
20058719|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
20058720|NCT03440424|Lemborexant|lemborexant|mesh-list
20058721|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20058722|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058723|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058724|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20058725|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20058726|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058727|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058728|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
20058729|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20058730|NCT03441269|Ibuprofen|ibuprofen|mesh-list
20058731|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20058732|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058733|NCT03441269|Analgesics|analgesics|mesh-ancestor
20058734|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
20058735|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058736|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058737|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058738|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058739|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20058740|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058741|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058742|NCT03441581|Eluxadoline|eluxadoline|mesh-list
20058743|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20058744|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
20058745|NCT03441633|Apixaban|apixaban|mesh-list
20058746|NCT03441633|Dabigatran|dabigatran|mesh-list
20058747|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20058748|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
20058749|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20058750|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
20058751|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058752|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058753|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
20058754|NCT03441789|Betamethasone|betamethasone|mesh-list
20058755|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
20058756|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20058757|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
20058758|NCT03441789|Calcipotriene|calcipotriene|mesh-list
20058759|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20058760|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058761|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
20058762|NCT03441789|Hormones|hormones|mesh-ancestor
20058763|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20058764|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058765|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20058766|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058767|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
20058768|NCT03442569|Nivolumab|nivolumab|mesh-list
20058769|NCT03442569|Ipilimumab|ipilimumab|mesh-list
20058770|NCT03442569|Panitumumab|panitumumab|mesh-list
20058771|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20058772|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058773|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20118787|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
20058774|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058775|NCT03443063|Lemborexant|lemborexant|mesh-list
20058776|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20058777|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058778|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058779|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20058780|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20058781|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058782|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058783|NCT03444155|Folic Acid|folic acid|mesh-list
20058784|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
20058785|NCT03444155|Vitamins|vitamins|mesh-ancestor
20058786|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
20058787|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058788|NCT03444155|Hematinics|hematinics|mesh-ancestor
20058789|NCT03444584|Metformin|metformin|mesh-list
20058790|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20058791|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058792|NCT03444766|Nivolumab|nivolumab|mesh-list
20058793|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20058794|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058795|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20058796|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058797|NCT03445195|Imipenem|imipenem|mesh-list
20058798|NCT03445195|Sulbactam|sulbactam|mesh-list
20058799|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
20058800|NCT03445195|Cilastatin|cilastatin|mesh-list
20058801|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20058802|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058803|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
20058804|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058805|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058806|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20058807|NCT03445390|Acetaminophen|acetaminophen|mesh-list
20058808|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058809|NCT03445390|Analgesics|analgesics|mesh-ancestor
20058810|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
20058811|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058812|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058813|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
20058814|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20058815|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20058816|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058817|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20058818|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20058819|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058820|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058821|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
20058822|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058823|NCT03447249|Ivacaftor|ivacaftor|mesh-list
20058824|NCT03447249|VX-659|vx-659|mesh-list
20058825|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20058826|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20058827|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058828|NCT03447353|Acetaminophen|acetaminophen|mesh-list
20058829|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20058830|NCT03447353|Hydrocodone|hydrocodone|mesh-list
20058831|NCT03447353|Alprazolam|alprazolam|mesh-list
20058832|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058833|NCT03447353|Analgesics|analgesics|mesh-ancestor
20058834|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
20058835|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058836|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293399|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20293400|NCT04446962|Growth Substances|growth substances|mesh-ancestor
20293401|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
20293402|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308363|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20308364|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308365|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308366|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20058837|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
20308367|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
20058838|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20058839|NCT03447353|Narcotics|narcotics|mesh-ancestor
20058840|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058841|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
20058842|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058843|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20058844|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20058845|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20058846|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20058847|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
20058848|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
20058849|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058850|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058851|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20058852|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058853|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058854|NCT03447821|Rifamycins|rifamycins|mesh-list
20058855|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
20058856|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20058857|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058858|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058859|NCT03448068|Ketamine|ketamine|mesh-list
20058860|NCT03448068|Analgesics|analgesics|mesh-ancestor
20058861|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
20058862|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058863|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058864|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20058865|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20058866|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
20058867|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
20058868|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058869|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20058870|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20058871|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058872|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058873|NCT03448406|Empagliflozin|empagliflozin|mesh-list
20058874|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20058875|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058876|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20058877|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058878|NCT03448419|Empagliflozin|empagliflozin|mesh-list
20058879|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20058880|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058881|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20058882|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058883|NCT03448536|Acetaminophen|acetaminophen|mesh-list
20058884|NCT03448536|Naproxen|naproxen|mesh-list
20058885|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058886|NCT03448536|Analgesics|analgesics|mesh-ancestor
20058887|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
20058888|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058889|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058890|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
20058891|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20058892|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058893|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058894|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
20058895|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20058896|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058897|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058898|NCT03449433|Insulin|insulin|mesh-list
20058899|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20058900|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
20058901|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
20058902|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20058903|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
20058904|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20293403|NCT04403698|Alendronate|alendronate|mesh-list
20293404|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20293405|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293406|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
20293407|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293408|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058905|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058906|NCT03449446|Firsocostat|firsocostat|mesh-list
20058907|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293409|NCT04377204|Lidocaine|lidocaine|mesh-list
20293410|NCT04377204|Bupivacaine|bupivacaine|mesh-list
20608163|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058908|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118788|NCT00006054|Hormones|hormones|mesh-ancestor
20118789|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118790|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20118791|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20118792|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
20118793|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20118794|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118795|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
20118796|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
20118797|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118798|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20118799|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20118800|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118801|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118802|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118803|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
20118804|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118805|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20118806|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
20118807|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
20118808|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118809|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118810|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20118811|NCT00006054|Protective Agents|protective agents|mesh-ancestor
20118812|NCT00006055|Cyclosporine|cyclosporine|mesh-list
20118813|NCT00006055|Prednisone|prednisone|mesh-list
20118814|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
20118815|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
20118816|NCT00006055|Cyclosporins|cyclosporins|mesh-list
20118817|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20118818|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118819|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
20118820|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118821|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118822|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118823|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
20118824|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118825|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118826|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118827|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118828|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
20118829|NCT00006055|Hormones|hormones|mesh-ancestor
20118830|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20118831|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20118832|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118833|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
20118834|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118835|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
20118836|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20118837|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
20118838|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
20118839|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118840|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118841|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20118842|NCT00006055|Protective Agents|protective agents|mesh-ancestor
20118843|NCT00006056|Cyclosporine|cyclosporine|mesh-list
20118844|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
20118845|NCT00006056|Busulfan|busulfan|mesh-list
20118846|NCT00006056|Methotrexate|methotrexate|mesh-list
20118847|NCT00006056|Etoposide|etoposide|mesh-list
20118848|NCT00006056|Cyclosporins|cyclosporins|mesh-list
20118849|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20118850|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118851|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
20118852|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118853|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118854|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20118855|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
20118856|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118857|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118858|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20118859|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19746188|NCT04195633|Treosulfan|treosulfan|mesh-list
20058909|NCT03450083|Benralizumab|benralizumab|mesh-list
20058910|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20058911|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058912|NCT03451773|Gemcitabine|gemcitabine|mesh-list
20058913|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20058914|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
20058915|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058916|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058917|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
20058918|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058919|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058920|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20058921|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
20058922|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058923|NCT03452189|Vancomycin|vancomycin|mesh-list
20058924|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20058925|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058926|NCT03452527|Aflibercept|aflibercept|mesh-list
20058927|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
20058928|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20058929|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20058930|NCT03452527|Growth Substances|growth substances|mesh-ancestor
20058931|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058932|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
20058933|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20058934|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
20058935|NCT03453060|Thrombin|thrombin|mesh-list
20058936|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
20058937|NCT03453060|Coagulants|coagulants|mesh-ancestor
20058938|NCT03453151|Anesthetics|anesthetics|mesh-list
20058939|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
20058940|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20058941|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058942|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
20058943|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058944|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
20058945|NCT03454048|Piperaquine|piperaquine|mesh-list
20058946|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
20058947|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20058948|NCT03454048|Atovaquone|atovaquone|mesh-list
20058949|NCT03454048|Proguanil|proguanil|mesh-list
20058950|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20058951|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
20058952|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20058953|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20058954|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058955|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20058956|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058957|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058958|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20058959|NCT03454048|Renal Agents|renal agents|mesh-ancestor
20058960|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
20058961|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
20058962|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20058963|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
20058964|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058965|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058966|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20058967|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
20058968|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20058969|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
20058970|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058971|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20058972|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20058973|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
20058974|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
20058975|NCT03455218|Protective Agents|protective agents|mesh-ancestor
20058976|NCT03456960|Aspirin|aspirin|mesh-list
20058977|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20058978|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20058979|NCT03456960|Analgesics|analgesics|mesh-ancestor
20058980|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
20058981|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20058982|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20058983|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20058984|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20058985|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20058986|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20058987|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20058988|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20058989|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20058990|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20058991|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
20058992|NCT03457636|Doxycycline|doxycycline|mesh-list
20058993|NCT03457636|Adapalene|adapalene|mesh-list
20058994|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20058995|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20058996|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20058997|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20058998|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
20058999|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20059000|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20059001|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
20059002|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059003|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059004|NCT03457636|Analgesics|analgesics|mesh-ancestor
20059005|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
20059006|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059007|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059008|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059009|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059010|NCT03457727|Omeprazole|omeprazole|mesh-list
20059011|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20059012|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059013|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20059014|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059015|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059016|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20059017|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
20059018|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20059019|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20059020|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
20059021|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059022|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059023|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
20059024|NCT03459612|Promethazine|promethazine|mesh-list
20059025|NCT03459612|Lasmiditan|lasmiditan|mesh-list
20059026|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20059027|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20059028|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059029|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059030|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059031|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
20059032|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
20059033|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059034|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
20059035|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
20059036|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059037|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20059038|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
20059039|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
20059040|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059041|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059042|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20059043|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
20059044|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
20059045|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20059046|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
20059047|NCT03459794|Ivermectin|ivermectin|mesh-list
20059048|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20059049|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059050|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20059051|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059052|NCT03460990|Ivacaftor|ivacaftor|mesh-list
20059053|NCT03460990|VX-659|vx-659|mesh-list
20059054|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20059055|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20059056|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059057|NCT03462680|Niacin|niacin|mesh-list
20059058|NCT03462680|Vitamins|vitamins|mesh-ancestor
20059059|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
20059060|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746189|NCT04195633|Busulfan|busulfan|mesh-list
20059061|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
20059062|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20059063|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
20059064|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059065|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20059066|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
20059067|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
20059068|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20059069|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059070|NCT03463512|Racecadotril|racecadotril|mesh-list
20059071|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
20059072|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059073|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
20059074|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577049|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577050|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20577051|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20577052|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20577053|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059075|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059076|NCT03463889|Edetic Acid|edetic acid|mesh-list
20059077|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20059078|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20059079|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059080|NCT03463889|Anticoagulants|anticoagulants|mesh-ancestor
20059081|NCT03463889|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20059082|NCT03463889|Chelating Agents|chelating agents|mesh-ancestor
20059083|NCT03463889|Sequestering Agents|sequestering agents|mesh-ancestor
20059084|NCT03463915|Triamcinolone|triamcinolone|mesh-list
20059085|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20059086|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20059087|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20059088|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059089|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
20059090|NCT03463915|Hormones|hormones|mesh-ancestor
20059091|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059092|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059093|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20059094|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
20059095|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059096|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059097|NCT03464383|Citalopram|citalopram|mesh-list
20059098|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20059099|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20059100|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20059101|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059102|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059103|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
20059104|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059105|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20059106|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
20059107|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059108|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
20059109|NCT03465436|Lasmiditan|lasmiditan|mesh-list
20059110|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20059111|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059112|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20059113|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20059114|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059115|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059116|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059117|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059118|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20059119|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
20059120|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059121|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
20059122|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059123|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059124|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20059125|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20059126|NCT03467217|Losartan|losartan|mesh-list
20059127|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20059128|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20059129|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19746190|NCT04195633|Fludarabine|fludarabine|mesh-list
20059130|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20059131|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059132|NCT03467685|Anesthetics|anesthetics|mesh-list
20059133|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059134|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059135|NCT03467763|Metformin|metformin|mesh-list
20059136|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059137|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059138|NCT03467945|Metformin|metformin|mesh-list
20059139|NCT03467945|Gliclazide|gliclazide|mesh-list
20059140|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059141|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059142|NCT03467971|Metformin|metformin|mesh-list
20059143|NCT03467971|Gliclazide|gliclazide|mesh-list
20059144|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059145|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059146|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
20059147|NCT03468075|Gemcitabine|gemcitabine|mesh-list
20059148|NCT03468075|Vitamins|vitamins|mesh-ancestor
20059149|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
20059150|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059151|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20059152|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
20059153|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059154|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059155|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
20059156|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059157|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059158|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20059159|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
20059160|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
20059161|NCT03468075|Protective Agents|protective agents|mesh-ancestor
20059162|NCT03468543|Memantine|memantine|mesh-list
20059163|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20059164|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20059165|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
20059166|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059167|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059168|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059169|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20059170|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20059171|NCT03468920|Acetaminophen|acetaminophen|mesh-list
20059172|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059173|NCT03468920|Analgesics|analgesics|mesh-ancestor
20059174|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
20059175|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059176|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059177|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
20059178|NCT03468933|Plasminogen|plasminogen|mesh-list
20059179|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20059180|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20059181|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20059182|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059183|NCT03469336|Betamethasone|betamethasone|mesh-list
20059184|NCT03469336|Calcipotriene|calcipotriene|mesh-list
20059185|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059186|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
20059187|NCT03469336|Hormones|hormones|mesh-ancestor
20059188|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059189|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059190|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20059191|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
20059192|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
20059193|NCT03469349|Actovegin|actovegin|mesh-list
20059194|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20059195|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059196|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20059197|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059198|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
20059199|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059200|NCT03469349|Protective Agents|protective agents|mesh-ancestor
20059201|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20059202|NCT03471871|Lemborexant|lemborexant|mesh-list
20059203|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20059204|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059205|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059206|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20059207|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20059208|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059209|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059210|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
20059211|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059212|NCT03472326|GS-9131|gs-9131|mesh-list
20059213|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059214|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059215|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20059216|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20059217|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
20059218|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059219|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20059220|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20118860|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
20118861|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20118862|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118863|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
20118864|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
20118865|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118866|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20118867|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20118868|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118869|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20118870|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118871|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
20118872|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118873|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20118874|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
20118875|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118876|NCT00006063|Pancrelipase|pancrelipase|mesh-list
20118877|NCT00006063|Pancreatin|pancreatin|mesh-list
20118878|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118879|NCT00006066|Aldesleukin|aldesleukin|mesh-list
20118880|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118881|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20118882|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20118883|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
20118884|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118885|NCT00006070|Etanercept|etanercept|mesh-list
20118886|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20118887|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20118888|NCT00006070|Analgesics|analgesics|mesh-ancestor
20118889|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
20118890|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118891|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118892|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118893|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118894|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118895|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20118896|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
20118897|NCT00006072|Rituximab|rituximab|mesh-list
20118898|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20118899|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118900|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
20118901|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118902|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20118903|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
20118904|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20118905|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20118906|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118907|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
20118908|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
20118909|NCT00006077|Levodopa|levodopa|mesh-list
20059221|NCT03472469|Acetaminophen|acetaminophen|mesh-list
20059222|NCT03472469|Ketorolac|ketorolac|mesh-list
20059223|NCT03472469|Naproxen|naproxen|mesh-list
20059224|NCT03472469|Celecoxib|celecoxib|mesh-list
20059225|NCT03472469|Lidocaine|lidocaine|mesh-list
20059226|NCT03472469|Pregabalin|pregabalin|mesh-list
20059227|NCT03472469|Gabapentin|gabapentin|mesh-list
20059228|NCT03472469|Tramadol|tramadol|mesh-list
20059229|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059230|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
20059231|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059232|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059233|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
20059234|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059235|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20059236|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20059237|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20059238|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20059239|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059240|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059241|NCT03472469|Analgesics|analgesics|mesh-ancestor
20059242|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
20059243|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
20059244|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20059245|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20059246|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20059247|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059248|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059249|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20059250|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20059251|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059252|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
20059253|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20059254|NCT03472469|Narcotics|narcotics|mesh-ancestor
20059255|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059256|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059257|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059258|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20059259|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059260|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
20059261|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20059262|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
20059263|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059264|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
20059265|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059266|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
20059267|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059268|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
20059269|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059270|NCT03473665|Celecoxib|celecoxib|mesh-list
20059271|NCT03473665|Diclofenac|diclofenac|mesh-list
20059272|NCT03473665|Indomethacin|indomethacin|mesh-list
20059273|NCT03473665|Meloxicam|meloxicam|mesh-list
20059274|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059275|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059276|NCT03473665|Analgesics|analgesics|mesh-ancestor
20059277|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
20059278|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059279|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059280|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059281|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059282|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20059283|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20059284|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059285|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059286|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
20059287|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
20059288|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20059289|NCT03474081|Albuterol|albuterol|mesh-list
20059290|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
20059291|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20059292|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
20059293|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059294|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059295|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20059296|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
20059297|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
20059298|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20059299|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
20059300|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059301|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059302|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
20059303|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20059304|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20059305|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20059306|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20059307|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
20059308|NCT03476798|Bevacizumab|bevacizumab|mesh-list
20059309|NCT03476798|Rucaparib|rucaparib|mesh-list
20059310|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20059311|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059312|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20059313|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20059314|NCT03476798|Growth Substances|growth substances|mesh-ancestor
20059315|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059316|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
20059317|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20059318|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059319|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059320|NCT03478163|Clindamycin|clindamycin|mesh-list
20059321|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
20059322|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
20059323|NCT03478163|Cefazolin|cefazolin|mesh-list
20059324|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20059325|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059326|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20059327|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059328|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059329|NCT03478254|Vaccines|vaccines|mesh-list
20059330|NCT03478254|Immunologic Factors|immunologic factors|mesh-ancestor
20059331|NCT03478254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059332|NCT03478683|Budesonide|budesonide|mesh-list
20059333|NCT03478683|Albuterol|albuterol|mesh-list
20059334|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
20059335|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
20059336|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20059337|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059338|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20059339|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
20059340|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059341|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059342|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20059343|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
20059344|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
20059345|NCT03478683|Hormones|hormones|mesh-ancestor
20059346|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059347|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20059348|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20059349|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20059350|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
20059351|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059352|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059353|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
20059354|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20059355|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
20059356|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
20059357|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20059358|NCT03478696|Budesonide|budesonide|mesh-list
20059359|NCT03478696|Albuterol|albuterol|mesh-list
20059360|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
20059361|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
20059362|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20059363|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059364|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20059365|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
20059366|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059367|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059368|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20059369|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
20059370|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
20059371|NCT03478696|Hormones|hormones|mesh-ancestor
20059372|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059373|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20059374|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20059375|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20059376|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
20059377|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059378|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059379|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
20059380|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20059381|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
20059382|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
20059383|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20059384|NCT03478969|Insulin|insulin|mesh-list
20059385|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059386|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059387|NCT03478982|Alprazolam|alprazolam|mesh-list
20059388|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20059389|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059390|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059391|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20059392|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059393|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059394|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
20059395|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
20059396|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059397|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059398|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
20059399|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
20059400|NCT03479216|Bupivacaine|bupivacaine|mesh-list
20059401|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059402|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
20059403|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059404|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059405|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
20059406|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059407|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20059408|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059409|NCT03479216|Analgesics|analgesics|mesh-ancestor
20059410|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20059411|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20059412|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20059413|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
20059414|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059415|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059416|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20059417|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
20059418|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20059419|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20059420|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20059421|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
20059422|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20059423|NCT03480009|Oxycodone|oxycodone|mesh-list
20059424|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
20059425|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20059426|NCT03480009|Narcotics|narcotics|mesh-ancestor
20059427|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059428|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059429|NCT03480009|Analgesics|analgesics|mesh-ancestor
20059430|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
20059431|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059432|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
20059433|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
20059434|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20059435|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20059436|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059437|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059438|NCT03480022|Liraglutide|liraglutide|mesh-list
20059439|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059440|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059441|NCT03480022|Incretins|incretins|mesh-ancestor
20059442|NCT03480022|Hormones|hormones|mesh-ancestor
20059443|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059444|NCT03480243|Erythromycin|erythromycin|mesh-list
19491534|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059445|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
20059446|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20059447|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
20059448|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20059449|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059450|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059451|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20059452|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059453|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059454|NCT03480750|Carboplatin|carboplatin|mesh-list
20059455|NCT03480750|Doxorubicin|doxorubicin|mesh-list
20059456|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20059457|NCT03480750|Trientine|trientine|mesh-list
20059458|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059459|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20059460|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20059461|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20059462|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059463|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059464|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
20059465|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
20059466|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20059467|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
20059468|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059469|NCT03480932|Interferons|interferons|mesh-list
20059470|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
20059471|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
20059472|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20059473|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
20059474|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059475|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
20059476|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059477|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
20059478|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059479|NCT03481725|Coal Tar|coal tar|mesh-list
20059480|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
20059481|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
20059482|NCT03481816|Vaccines|vaccines|mesh-list
20059483|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
20059484|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059485|NCT03482011|Mirikizumab|mirikizumab|mesh-list
20059486|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059487|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059488|NCT03482011|Analgesics|analgesics|mesh-ancestor
20059489|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
20059490|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059491|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059492|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059493|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059494|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20059495|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059496|NCT03482583|Nicotine|nicotine|mesh-list
20059497|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20059498|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
20059499|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059500|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059501|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20059502|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20059503|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
20059504|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059505|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059506|NCT03482882|Pimavanserin|pimavanserin|mesh-list
20059507|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20059508|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20059509|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20059510|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059511|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059512|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059513|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059514|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20059515|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20059516|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
20059517|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059518|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059519|NCT03482973|Bupivacaine|bupivacaine|mesh-list
19491535|NCT03130218|Peppermint oil|peppermint oil|mesh-list
19491536|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
20059520|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059521|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
20059522|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059523|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059524|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
20059525|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059526|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20059527|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
20059528|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059529|NCT03485222|Empagliflozin|empagliflozin|mesh-list
20059530|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20059531|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059532|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059533|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059534|NCT03485976|Ixekizumab|ixekizumab|mesh-list
20059535|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
20059536|NCT03486392|Liraglutide|liraglutide|mesh-list
20059537|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059538|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059539|NCT03486392|Incretins|incretins|mesh-ancestor
20059540|NCT03486392|Hormones|hormones|mesh-ancestor
20059541|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059542|NCT03486834|Vaccines|vaccines|mesh-list
20059543|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
20059544|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059545|NCT03487276|Vilobelimab|vilobelimab|mesh-list
20059546|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20059547|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20059548|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
20059549|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059550|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20059551|NCT03487549|Cantharidin|cantharidin|mesh-list
20059552|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059553|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059554|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
20059555|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
20059556|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059557|NCT03488108|Minoxidil|minoxidil|mesh-list
20059558|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20059559|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
20059560|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
20059561|NCT03488225|Leucovorin|leucovorin|mesh-list
20059562|NCT03488225|Folic Acid|folic acid|mesh-list
20059563|NCT03488225|Cytarabine|cytarabine|mesh-list
20059564|NCT03488225|Dexamethasone|dexamethasone|mesh-list
20059565|NCT03488225|Prednisone|prednisone|mesh-list
20059566|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
20059567|NCT03488225|Cortisone|cortisone|mesh-list
20059568|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
20059569|NCT03488225|Rituximab|rituximab|mesh-list
20059570|NCT03488225|Doxorubicin|doxorubicin|mesh-list
20059571|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20059572|NCT03488225|Methotrexate|methotrexate|mesh-list
20059573|NCT03488225|Vincristine|vincristine|mesh-list
20059574|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
20059575|NCT03488225|Ofatumumab|ofatumumab|mesh-list
20059576|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20059577|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20059578|NCT03488225|Antibodies|antibodies|mesh-list
20059579|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
20059580|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20059581|NCT03488225|BB 1101|bb 1101|mesh-list
20059582|NCT03488225|Calcium|calcium|mesh-list
20059583|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
20059584|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577054|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577055|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577056|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20577057|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20577058|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20577059|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
20577060|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577061|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059585|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
20293411|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059586|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059587|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059588|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20059589|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
20059590|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059591|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059592|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20059593|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059594|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
20059595|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
20059596|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059597|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059598|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
20059599|NCT03488225|Hormones|hormones|mesh-ancestor
20059600|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059601|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20059602|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20059603|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20059604|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20059605|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059606|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20059607|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20059608|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20059609|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
20059610|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20059611|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20059612|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
20059613|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
20059614|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20059615|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20059616|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
20059617|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059618|NCT03488225|Antidotes|antidotes|mesh-ancestor
20059619|NCT03488225|Protective Agents|protective agents|mesh-ancestor
20059620|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
20059621|NCT03488225|Vitamins|vitamins|mesh-ancestor
20059622|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
20059623|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20059624|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
20059625|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
20059626|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
20059627|NCT03488225|Hematinics|hematinics|mesh-ancestor
20059628|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
20059629|NCT03489304|Zaleplon|zaleplon|mesh-list
20059630|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
20059631|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20059632|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059633|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059634|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
20059635|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
20059636|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059637|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059638|NCT03489551|Haloperidol|haloperidol|mesh-list
20059639|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
20059640|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
20059641|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059642|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059643|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059644|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20059645|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059646|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059647|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059648|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20059649|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
20059650|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059651|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059652|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20059653|NCT03489850|Ibudilast|ibudilast|mesh-list
20059654|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20059655|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
20059656|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059657|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059658|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20059659|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
20059660|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20059661|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059662|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059663|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20059664|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
20059665|NCT03489863|Ticagrelor|ticagrelor|mesh-list
20059666|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20059667|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20059668|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20059669|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20059670|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20059671|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
20059672|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059673|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059674|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059675|NCT03490942|Glucagon|glucagon|mesh-list
20059676|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20059677|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059678|NCT03490942|Hormones|hormones|mesh-ancestor
20059679|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059680|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059681|NCT03490942|Incretins|incretins|mesh-ancestor
20118910|NCT00006077|Domperidone|domperidone|mesh-list
20118911|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20118912|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20118913|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
20118914|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20118915|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118916|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118917|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
20118918|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
20118919|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20118920|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20118921|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20118922|NCT00006078|Lycopene|lycopene|mesh-list
20118923|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20118924|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
20118925|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118926|NCT00006078|Protective Agents|protective agents|mesh-ancestor
20118927|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118928|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20118929|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20118930|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118931|NCT00006079|Eflornithine|eflornithine|mesh-list
20118932|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118933|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20118934|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20118935|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20118936|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20118937|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20118938|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118939|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118940|NCT00006080|Fenretinide|fenretinide|mesh-list
20118941|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118942|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20118943|NCT00006080|Protective Agents|protective agents|mesh-ancestor
20118944|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118945|NCT00006081|Paclitaxel|paclitaxel|mesh-list
20118946|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
20118947|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118948|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577062|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20577063|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20577064|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
20577065|NCT02075619|Amlodipine|amlodipine|mesh-list
20577066|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20577067|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20577068|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20577069|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20118949|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118950|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118951|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118952|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118953|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20118954|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
20118955|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118956|NCT00006082|Rubitecan|rubitecan|mesh-list
20118957|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118958|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20577070|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059682|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20059683|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20059684|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20059685|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
20059686|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059687|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059688|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059689|NCT03492281|Urological Agents|urological agents|mesh-ancestor
20059690|NCT03493386|Glycine|glycine|mesh-list
20059691|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
20059692|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059693|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059694|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059695|NCT03493542|Vaccines|vaccines|mesh-list
20059696|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
20059697|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059698|NCT03493698|Midazolam|midazolam|mesh-list
20059699|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20059700|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20059701|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059702|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059703|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20059704|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059705|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059706|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20059707|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
20059708|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
20059709|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
20059710|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
20059711|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059712|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059713|NCT03493828|Bupivacaine|bupivacaine|mesh-list
20059714|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059715|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
20059716|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059717|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059718|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
20059719|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059720|NCT03494816|Axitinib|axitinib|mesh-list
20059721|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059722|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20059723|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059724|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059725|NCT03494985|Muramidase|muramidase|mesh-list
20059726|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059727|NCT03495102|Dulaglutide|dulaglutide|mesh-list
20059728|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059729|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059730|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
20059731|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059732|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059733|NCT03496324|Ibuprofen|ibuprofen|mesh-list
20059734|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059735|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059736|NCT03496324|Analgesics|analgesics|mesh-ancestor
20059737|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
20059738|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059739|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059740|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059741|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059742|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20059743|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491537|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
19491538|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491539|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491540|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491541|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
19491542|NCT03130153|Aspirin|aspirin|mesh-list
19491543|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
19491544|NCT03130153|Salicylates|salicylates|mesh-list
19491545|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19491546|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491547|NCT03130153|Analgesics|analgesics|mesh-ancestor
19746191|NCT04195633|Cyclosporins|cyclosporins|mesh-list
20059744|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059745|NCT03496467|Nepafenac|nepafenac|mesh-list
20059746|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059747|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059748|NCT03496467|Analgesics|analgesics|mesh-ancestor
20059749|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
20059750|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059751|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059752|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059753|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059754|NCT03496545|Acetaminophen|acetaminophen|mesh-list
20059755|NCT03496545|Bromocriptine|bromocriptine|mesh-list
20059756|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059757|NCT03496545|Analgesics|analgesics|mesh-ancestor
20059758|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
20059759|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059760|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059761|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
20059762|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20059763|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20059764|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
20059765|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059766|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
20059767|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
20059768|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059769|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059770|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20059771|NCT03496974|Antibodies|antibodies|mesh-list
20059772|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
20059773|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20059774|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
20059775|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059776|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059777|NCT03497039|Diclofenac|diclofenac|mesh-list
20059778|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059779|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059780|NCT03497039|Analgesics|analgesics|mesh-ancestor
20059781|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
20059782|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059783|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059784|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059785|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059786|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20059787|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059788|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059789|NCT03497429|Niraparib|niraparib|mesh-list
20059790|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20059791|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059792|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059793|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059794|NCT03497845|Vaccines|vaccines|mesh-list
20059795|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
20059796|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059797|NCT03498196|Avelumab|avelumab|mesh-list
20059798|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20059799|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059800|NCT03499353|Talazoparib|talazoparib|mesh-list
20059801|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20059802|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059803|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059804|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059805|NCT03499873|Nepafenac|nepafenac|mesh-list
20059806|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059807|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059808|NCT03499873|Analgesics|analgesics|mesh-ancestor
20059809|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
20059810|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059811|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059812|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059813|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059814|NCT03500211|Lidocaine|lidocaine|mesh-list
20059815|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059816|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
20059817|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059818|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059819|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
20059820|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059821|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20059822|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20059823|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20059824|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20059825|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059826|NCT03500289|Midazolam|midazolam|mesh-list
20059827|NCT03500289|Ketamine|ketamine|mesh-list
20059828|NCT03500289|Analgesics|analgesics|mesh-ancestor
20059829|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
20059830|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059831|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059832|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20059833|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20059834|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
20059835|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
20059836|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059837|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20059838|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20059839|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059840|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059841|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20059842|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20059843|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20059844|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059845|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059846|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
20059847|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
20059848|NCT03500302|Evolocumab|evolocumab|mesh-list
20059849|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20059850|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20059851|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
20059852|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059853|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20059854|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20059855|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20059856|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20059857|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059858|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
20059859|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059860|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059861|NCT03501277|Pioglitazone|pioglitazone|mesh-list
20059862|NCT03501277|Alogliptin|alogliptin|mesh-list
20059863|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20059864|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059865|NCT03501277|Incretins|incretins|mesh-ancestor
20059866|NCT03501277|Hormones|hormones|mesh-ancestor
20059867|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20059868|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20059869|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
20059870|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059871|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059872|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20059873|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
20059874|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059875|NCT03502616|Tofacitinib|tofacitinib|mesh-list
20059876|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20059877|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059878|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059879|NCT03502681|Avelumab|avelumab|mesh-list
20059880|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20059881|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059882|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
20059883|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20059884|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
20059885|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
20059886|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059887|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059888|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059889|NCT03502915|Analgesics|analgesics|mesh-ancestor
20059890|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
20059891|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059892|NCT03503292|Ondansetron|ondansetron|mesh-list
20059893|NCT03503292|Granisetron|granisetron|mesh-list
20059894|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
20059895|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
20059896|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059897|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059898|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20059899|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
20059900|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
20059901|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20059902|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
20059903|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059904|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059905|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20059906|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20059907|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059908|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20059909|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20059910|NCT03503578|Ketamine|ketamine|mesh-list
20059911|NCT03503578|Sevoflurane|sevoflurane|mesh-list
20059912|NCT03503578|Analgesics|analgesics|mesh-ancestor
20059913|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
20059914|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059915|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059916|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20059917|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20059918|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
20059919|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
20059920|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059921|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20059922|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20059923|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059924|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059925|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20059926|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20059927|NCT03506347|Vancomycin|vancomycin|mesh-list
20059928|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20059929|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20059930|NCT03506724|Labetalol|labetalol|mesh-list
20059931|NCT03506724|Nifedipine|nifedipine|mesh-list
20059932|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20059933|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20059934|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059935|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20059936|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059937|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
20059938|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
20059939|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20059940|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20059941|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20059942|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
20059943|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059944|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20059945|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
20059946|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
20059947|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059948|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20059949|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20059950|NCT03508830|Bupivacaine|bupivacaine|mesh-list
20059951|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
20059952|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
20059953|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20059954|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059955|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
20059956|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059957|NCT03509350|Vitamins|vitamins|mesh-list
20059958|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
20059959|NCT03509350|Thiamine|thiamine|mesh-list
20059960|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
20293412|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
20059961|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20577071|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20577072|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059962|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20059963|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20059964|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
20059965|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059966|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059967|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
20059968|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059969|NCT03509350|Protective Agents|protective agents|mesh-ancestor
20059970|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
20059971|NCT03509675|Ibuprofen|ibuprofen|mesh-list
20059972|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20059973|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20059974|NCT03509675|Analgesics|analgesics|mesh-ancestor
20059975|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
20059976|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20059977|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059978|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20059979|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20059980|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20059981|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059982|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059983|NCT03509766|Histamine|histamine|mesh-list
20059984|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
20059985|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
20059986|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20059987|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059988|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20059989|NCT03509883|Apixaban|apixaban|mesh-list
20059990|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20059991|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
20059992|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20059993|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
20059994|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20059995|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20059996|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
20118959|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20118960|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20118961|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118962|NCT00006083|Dalteparin|dalteparin|mesh-list
20118963|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
20118964|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20118965|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20118966|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118967|NCT00006084|Lintuzumab|lintuzumab|mesh-list
20118968|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20118969|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118970|NCT00006086|Carboplatin|carboplatin|mesh-list
20118971|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118972|NCT00006088|Vinorelbine|vinorelbine|mesh-list
20118973|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20118974|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118975|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20118976|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20118977|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20118978|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118979|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20118980|NCT00006089|Trastuzumab|trastuzumab|mesh-list
20118981|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20118982|NCT00006089|Antibodies|antibodies|mesh-list
20118983|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
20118984|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20118985|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
20118986|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118987|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118988|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
20118989|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118990|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
20118991|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118992|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
20118993|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20118994|NCT00006094|Fluorouracil|fluorouracil|mesh-list
20118995|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
20059997|NCT03510455|Infigratinib|infigratinib|mesh-list
20059998|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20059999|NCT03510481|Lumefantrine|lumefantrine|mesh-list
20060000|NCT03510481|Artemether|artemether|mesh-list
20060001|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
20060002|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20060003|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20060004|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060005|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
20060006|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20060007|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060008|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20060009|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20060010|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060011|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060012|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060013|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
20060014|NCT03510715|Niacin|niacin|mesh-list
20060015|NCT03510715|Niacinamide|niacinamide|mesh-list
20060016|NCT03510715|Atorvastatin|atorvastatin|mesh-list
20060017|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20060018|NCT03510715|Simvastatin|simvastatin|mesh-list
20060019|NCT03510715|Ezetimibe|ezetimibe|mesh-list
20060020|NCT03510715|Pravastatin|pravastatin|mesh-list
20060021|NCT03510715|Lovastatin|lovastatin|mesh-list
20060022|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
20060023|NCT03510715|Fenofibrate|fenofibrate|mesh-list
20060024|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20060025|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20060026|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
20060027|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060028|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20060029|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20060030|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060031|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
20060032|NCT03510715|Vitamins|vitamins|mesh-ancestor
20060033|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
20060034|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060035|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
20060036|NCT03510910|Acetaminophen|acetaminophen|mesh-list
20060037|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060038|NCT03510910|Analgesics|analgesics|mesh-ancestor
20060039|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
20060040|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060041|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060042|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
20060043|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20060044|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20060045|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20060046|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
20060047|NCT03511521|Insulin|insulin|mesh-list
20060048|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20060049|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
20060050|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
20060051|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
20060052|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
20060053|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060054|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060055|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20060056|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
20060057|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060058|NCT03512353|Dexamethasone|dexamethasone|mesh-list
20060059|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060060|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
20060061|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
20060062|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060063|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060064|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060065|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
20060066|NCT03512353|Hormones|hormones|mesh-ancestor
20060067|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20060068|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20060069|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060070|NCT03513757|Lidocaine|lidocaine|mesh-list
20060071|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
20060072|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
20060073|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
20060074|NCT03513757|Propofol|propofol|mesh-list
20060075|NCT03513757|Sevoflurane|sevoflurane|mesh-list
20060076|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
20060077|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
20060078|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060079|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060080|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
20060081|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060082|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20060083|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20060084|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20060085|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060086|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060087|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20060088|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20060089|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
20060090|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060091|NCT03513757|Analgesics|analgesics|mesh-ancestor
20060092|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20060093|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20060094|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20060095|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
20060096|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060097|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20060098|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20060099|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20060100|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20060101|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20060102|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
20060103|NCT03514277|Bupivacaine|bupivacaine|mesh-list
20060104|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
20060105|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
20060106|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060107|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060108|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
20060109|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060110|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
20060111|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060112|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060113|NCT03515941|Leucovorin|leucovorin|mesh-list
20060114|NCT03515941|Fluorouracil|fluorouracil|mesh-list
20060115|NCT03515941|Capecitabine|capecitabine|mesh-list
20060116|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
20060117|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
20060118|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060119|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20060120|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060121|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20060122|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
20060123|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060124|NCT03515941|Antidotes|antidotes|mesh-ancestor
20060125|NCT03515941|Protective Agents|protective agents|mesh-ancestor
20060126|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
20060127|NCT03515941|Vitamins|vitamins|mesh-ancestor
20060128|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
20060129|NCT03518125|Vaccines|vaccines|mesh-list
20060130|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
20060131|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060132|NCT03519204|Lidocaine|lidocaine|mesh-list
20060133|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
20060134|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
20060135|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060136|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060137|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
20060138|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060139|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20060140|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20060141|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20060142|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060143|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060144|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
20060145|NCT03519243|Hematinics|hematinics|mesh-ancestor
20060146|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
20060147|NCT03519516|Levofloxacin|levofloxacin|mesh-list
20060148|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20060149|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20060150|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20060151|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060152|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20060153|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20060154|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060155|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060156|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060157|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20060158|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20060159|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20060160|NCT03519516|Renal Agents|renal agents|mesh-ancestor
20060161|NCT03519854|Bromides|bromides|mesh-list
20060162|NCT03519854|Rocuronium|rocuronium|mesh-list
20060163|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
20060164|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20060165|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20060166|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20060167|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060168|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060169|NCT03519867|Bromides|bromides|mesh-list
20060170|NCT03519867|Rocuronium|rocuronium|mesh-list
20060171|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
20060172|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20060173|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20060174|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20060175|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060176|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060177|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
20060178|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
20060179|NCT03520348|Vitamins|vitamins|mesh-ancestor
20060180|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
20060181|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060182|NCT03520920|Rituximab|rituximab|mesh-list
20060183|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
20060184|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20060185|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060186|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
20060187|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060188|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060189|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20060190|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060191|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060192|NCT03521141|Nicotine|nicotine|mesh-list
20060193|NCT03521141|Varenicline|varenicline|mesh-list
20060194|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20060195|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
20060196|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060197|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060198|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20060199|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20060200|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
20060201|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060202|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060203|NCT03521193|Aspirin|aspirin|mesh-list
20060204|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060205|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060206|NCT03521193|Analgesics|analgesics|mesh-ancestor
20060207|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
20060208|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060209|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060210|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060211|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060212|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20060213|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20060214|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060215|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20060216|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20060217|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060218|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
20060219|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
20060220|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20060221|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
20060222|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060223|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
20060224|NCT03521505|Propofol|propofol|mesh-list
20060225|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20060226|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060227|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060228|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20060229|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
20060230|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
20060231|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060232|NCT03521505|Analgesics|analgesics|mesh-ancestor
20060233|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
20060234|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060235|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20060236|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20060237|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20060238|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
20060239|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060240|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060241|NCT03521635|Pramipexole|pramipexole|mesh-list
20060242|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
20060243|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060244|NCT03521635|Protective Agents|protective agents|mesh-ancestor
20060245|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060246|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20060247|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20060248|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
20060249|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
20060250|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060251|NCT03521791|Bromfenac|bromfenac|mesh-list
20060252|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060253|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060254|NCT03521791|Analgesics|analgesics|mesh-ancestor
20060255|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
20060256|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060257|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060258|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060259|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060260|NCT03521817|Ethanol|ethanol|mesh-list
20060261|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20060262|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060263|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060264|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060265|NCT03522441|Clindamycin|clindamycin|mesh-list
20060266|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
20060267|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
20060268|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20060269|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060270|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20060271|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060272|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060273|NCT03522506|Modafinil|modafinil|mesh-list
20060274|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20060275|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060276|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20060277|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20060278|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20060279|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060280|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20060281|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
20060282|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060283|NCT03523988|Acetaminophen|acetaminophen|mesh-list
20060284|NCT03523988|Ibuprofen|ibuprofen|mesh-list
20060285|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060286|NCT03523988|Analgesics|analgesics|mesh-ancestor
20060287|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
20060288|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060289|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060290|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
20060291|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060292|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060293|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060294|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20060295|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060296|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060297|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20060298|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20060299|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
20060300|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20060301|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
20060302|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060303|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
20060304|NCT03524157|Protective Agents|protective agents|mesh-ancestor
20060305|NCT03524339|Tamsulosin|tamsulosin|mesh-list
20060306|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20060307|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20060308|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20060309|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
20060310|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060311|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060312|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060313|NCT03524339|Urological Agents|urological agents|mesh-ancestor
20293413|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293414|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293415|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
20293416|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293417|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20293418|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20293419|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20293420|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293421|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293422|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20293423|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
20293424|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293425|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
20060314|NCT03525119|Vaccines|vaccines|mesh-list
20060315|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
20060316|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060317|NCT03525444|Ivacaftor|ivacaftor|mesh-list
20060318|NCT03525444|Elexacaftor|elexacaftor|mesh-list
20060319|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20060320|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060321|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060322|NCT03525548|Ivacaftor|ivacaftor|mesh-list
20060323|NCT03525548|Elexacaftor|elexacaftor|mesh-list
20060324|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20060325|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060326|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060327|NCT03525834|Everolimus|everolimus|mesh-list
20060328|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060329|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20060330|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
20060331|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060332|NCT03527173|Vaccines|vaccines|mesh-list
20060333|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
20060334|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060335|NCT03527745|Albendazole|albendazole|mesh-list
20060336|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
20060337|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20060338|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060339|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
20060340|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20060341|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20060342|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
20060343|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
20060344|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
20060345|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060346|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060347|NCT03528174|Pancrelipase|pancrelipase|mesh-list
20060348|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060349|NCT03528369|Capsaicin|capsaicin|mesh-list
20060350|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
20060351|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
20060352|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
20060353|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060354|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060355|NCT03528512|Fentanyl|fentanyl|mesh-list
20060356|NCT03528512|Midazolam|midazolam|mesh-list
20060357|NCT03528512|Ketamine|ketamine|mesh-list
20060358|NCT03528512|Analgesics|analgesics|mesh-ancestor
20060359|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
20060360|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060361|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060362|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20060363|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20060364|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
20060365|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
20060366|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060367|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20060368|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20060369|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060370|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060371|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20060372|NCT03528512|Narcotics|narcotics|mesh-ancestor
20060373|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20060374|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20060375|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20060376|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20060377|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20060378|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
20060379|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
20060380|NCT03528551|Factor VIII|factor viii|mesh-list
20060381|NCT03528551|Coagulants|coagulants|mesh-ancestor
20060382|NCT03528577|Albuterol|albuterol|mesh-list
20060383|NCT03528577|Procaterol|procaterol|mesh-list
20060384|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20060385|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
20060386|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060387|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060388|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20060389|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
20060390|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
20060391|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20060392|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20060393|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20060394|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20060395|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
20060396|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060397|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060398|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
20060399|NCT03530631|Adderall|adderall|mesh-list
20060400|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20060401|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060402|NCT03531840|Olaparib|olaparib|mesh-list
20060403|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20060404|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060405|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060406|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060407|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20060408|NCT03531905|Ezetimibe|ezetimibe|mesh-list
20060409|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20060410|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20060411|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
20060412|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060413|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20060414|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060415|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060416|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20118996|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
20118997|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20118998|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20118999|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119000|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119001|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
20119002|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119003|NCT00006095|Irinotecan|irinotecan|mesh-list
20119004|NCT00006095|Vincristine|vincristine|mesh-list
20119005|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20119006|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119007|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119008|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119009|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119010|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119011|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119012|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119013|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119014|NCT00006096|Cisplatin|cisplatin|mesh-list
20119015|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119016|NCT00006098|Bortezomib|bortezomib|mesh-list
20119017|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060417|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
20060418|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20060419|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060420|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
20060421|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
20060422|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
20060423|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
20060424|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
20060425|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060426|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20060427|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20060428|NCT03535194|Mirikizumab|mirikizumab|mesh-list
20060429|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060430|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060431|NCT03535194|Analgesics|analgesics|mesh-ancestor
20060432|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
20060433|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060434|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060435|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060436|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060437|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20060438|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060439|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20060440|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20060441|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20060442|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
20060443|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060444|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20060445|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
20060446|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060447|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060448|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20060449|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20060450|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060451|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
20060452|NCT03537274|Interferons|interferons|mesh-list
20060453|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
20060454|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
20060455|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20060456|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060457|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
20060458|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060459|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
20060460|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060461|NCT03537404|Ritonavir|ritonavir|mesh-list
20060462|NCT03537404|Tenofovir|tenofovir|mesh-list
20060463|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
20060464|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20060465|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20060466|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
20060467|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060468|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060469|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20060470|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20060471|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
20060472|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060473|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20060474|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20060475|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20060476|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20060477|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20060478|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20060479|NCT03537651|Ivacaftor|ivacaftor|mesh-list
20060480|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20060481|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060482|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060483|NCT03538431|Buspirone|buspirone|mesh-list
20060484|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20060485|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20060486|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060487|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060488|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20060489|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20060490|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
20060491|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060492|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060493|NCT03538808|Varenicline|varenicline|mesh-list
20060494|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20060495|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20060496|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
20060497|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060498|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060499|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060500|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
20060501|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20060502|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
20060503|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060504|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20060505|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20060506|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20060507|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060508|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
20060509|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20060510|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060511|NCT03540030|Acetaminophen|acetaminophen|mesh-list
20060512|NCT03540030|Celecoxib|celecoxib|mesh-list
20060513|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20060514|NCT03540030|Lidocaine|lidocaine|mesh-list
20060515|NCT03540030|Gabapentin|gabapentin|mesh-list
20060516|NCT03540030|Propofol|propofol|mesh-list
20060517|NCT03540030|Sevoflurane|sevoflurane|mesh-list
20060518|NCT03540030|Desflurane|desflurane|mesh-list
20060519|NCT03540030|Rocuronium|rocuronium|mesh-list
20060520|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
20060521|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
20060522|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
20060523|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060524|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060525|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
20060526|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060527|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20060528|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20060529|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20060530|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060531|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060532|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20060533|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20060534|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
20060535|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060536|NCT03540030|Analgesics|analgesics|mesh-ancestor
20060537|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
20060538|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20060539|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20060540|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060541|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577073|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
20577074|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20577075|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20060542|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060543|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20060544|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20060545|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060546|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
20060547|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20060548|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20060549|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20060550|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20060551|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20060552|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060553|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
20060554|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20060555|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20060556|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20060557|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20060558|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20060559|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
20060560|NCT03540160|Serlopitant|serlopitant|mesh-list
20060561|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20060562|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060563|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060564|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060565|NCT03541044|Nicotine|nicotine|mesh-list
20060566|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20060567|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
20060568|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060569|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060570|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20060571|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20060572|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
20060573|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060574|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060575|NCT03541356|Carbidopa|carbidopa|mesh-list
20060576|NCT03541356|Levodopa|levodopa|mesh-list
20060577|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20060578|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20060579|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20060580|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
20060581|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060582|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060583|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060584|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20060585|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060586|NCT03541941|Bupivacaine|bupivacaine|mesh-list
20060587|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
20060588|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
20060589|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060590|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060591|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
20060592|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060593|NCT03541980|Acetaminophen|acetaminophen|mesh-list
20060594|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060595|NCT03541980|Analgesics|analgesics|mesh-ancestor
20060596|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
20060597|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060598|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060599|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
20060600|NCT03543137|Nicotine|nicotine|mesh-list
20060601|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20060602|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
20060603|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060604|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060605|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20060606|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20060607|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
20060608|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060609|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060610|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20060611|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
20060612|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20060613|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060614|NCT03545503|Ketamine|ketamine|mesh-list
20060615|NCT03545503|Etomidate|etomidate|mesh-list
20060616|NCT03545503|Analgesics|analgesics|mesh-ancestor
20060617|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
20060618|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060619|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060620|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20060621|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20060622|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
20060623|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
20060624|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060625|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20060626|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20060627|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060628|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060629|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20060630|NCT03545893|Ibuprofen|ibuprofen|mesh-list
20060631|NCT03545893|Oxycodone|oxycodone|mesh-list
20060632|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060633|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060634|NCT03545893|Analgesics|analgesics|mesh-ancestor
20060635|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
20060636|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293426|NCT04369742|Calcium|calcium|mesh-list
20060637|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060638|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060639|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060640|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20060641|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060642|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060643|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20060644|NCT03545893|Narcotics|narcotics|mesh-ancestor
20060645|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060646|NCT03546621|Tenofovir|tenofovir|mesh-list
20060647|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
20060648|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060649|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19746192|NCT04195633|Lenograstim|lenograstim|mesh-list
20060650|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20060651|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060652|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060653|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20060654|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20060655|NCT03546816|Serlopitant|serlopitant|mesh-list
20060656|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20060657|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060658|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060659|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060660|NCT03547154|Interferons|interferons|mesh-list
20060661|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
20060662|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
20060663|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20060664|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060665|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
20060666|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060667|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
20060668|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060669|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20060670|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
20060671|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060672|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20060673|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20060674|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060675|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20060676|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
20060677|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060678|NCT03551730|Enoxaparin|enoxaparin|mesh-list
20060679|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
20060680|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
20060681|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20060682|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20060683|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060684|NCT03551743|Edoxaban|edoxaban|mesh-list
20060685|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20060686|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
20060687|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20060688|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
20060689|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060690|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060691|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
20060692|NCT03552523|Pancrelipase|pancrelipase|mesh-list
20060693|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060694|NCT03552549|Interferons|interferons|mesh-list
20060695|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
20060696|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
20060697|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20060698|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060699|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
20060700|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060701|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
20060702|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060703|NCT03553758|Ketamine|ketamine|mesh-list
20060704|NCT03553758|Analgesics|analgesics|mesh-ancestor
20060705|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
20060706|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119018|NCT00006100|Aldesleukin|aldesleukin|mesh-list
20060707|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060708|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20060709|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20060710|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
20060711|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
20060712|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060713|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20060714|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20060715|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060716|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060717|NCT03553940|Vaccines|vaccines|mesh-list
20060718|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
20060719|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060720|NCT03554005|Acetaminophen|acetaminophen|mesh-list
20060721|NCT03554005|Interferons|interferons|mesh-list
20060722|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
20060723|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
20060724|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20060725|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060726|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
20060727|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060728|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060729|NCT03554005|Analgesics|analgesics|mesh-ancestor
20060730|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
20060731|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060732|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060733|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
20060734|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
20060735|NCT03554018|Acetaminophen|acetaminophen|mesh-list
20060736|NCT03554018|Ibuprofen|ibuprofen|mesh-list
20060737|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060738|NCT03554018|Analgesics|analgesics|mesh-ancestor
20060739|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
20060740|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060741|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060742|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
20060743|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060744|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060745|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060746|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20060747|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060748|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060749|NCT03554486|Insulin|insulin|mesh-list
20060750|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20060751|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
20060752|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
20060753|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20060754|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060755|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119019|NCT00006100|Fludarabine|fludarabine|mesh-list
20119020|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
20119021|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119022|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119023|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
20119024|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119025|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119026|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
20119027|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119028|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119029|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119030|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
20119031|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119032|NCT00006103|Leucovorin|leucovorin|mesh-list
20119033|NCT00006103|Fluorouracil|fluorouracil|mesh-list
20119034|NCT00006103|Irinotecan|irinotecan|mesh-list
20119035|NCT00006103|Calcium|calcium|mesh-list
20119036|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
20119037|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20119038|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119039|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
20119040|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119041|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119042|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119043|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119044|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
20119045|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20060756|NCT03554772|Celecoxib|celecoxib|mesh-list
20060757|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20060758|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060759|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060760|NCT03554772|Analgesics|analgesics|mesh-ancestor
20060761|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
20060762|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060763|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060764|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060765|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060766|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20060767|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20060768|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060769|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060770|NCT03555305|Insulin|insulin|mesh-list
20060771|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20060772|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
20060773|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060774|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060775|NCT03555565|Metformin|metformin|mesh-list
20060776|NCT03555565|Alogliptin|alogliptin|mesh-list
20060777|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060778|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060779|NCT03555565|Incretins|incretins|mesh-ancestor
20060780|NCT03555565|Hormones|hormones|mesh-ancestor
20060781|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20060782|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20060783|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
20060784|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060785|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060786|NCT03555890|Cetirizine|cetirizine|mesh-list
20060787|NCT03555890|Levocetirizine|levocetirizine|mesh-list
20060788|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20060789|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20060790|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
20060791|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
20060792|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060793|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060794|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060795|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20060796|NCT03556761|Furosemide|furosemide|mesh-list
20060797|NCT03556761|Diuretics|diuretics|mesh-ancestor
20060798|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
20060799|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060800|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20060801|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060802|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060803|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
20060804|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20060805|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
20060806|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
20060807|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060808|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060809|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060810|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060811|NCT03557333|Analgesics|analgesics|mesh-ancestor
20060812|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
20060813|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060814|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
20060815|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060816|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060817|NCT03558555|Acetaminophen|acetaminophen|mesh-list
20060818|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060819|NCT03558555|Analgesics|analgesics|mesh-ancestor
20060820|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
20060821|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060822|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060823|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
20060824|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20060825|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
20060826|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060827|NCT03559062|Ivacaftor|ivacaftor|mesh-list
20060828|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20060829|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577076|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
20060830|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060831|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
20060832|NCT03559179|Narcotics|narcotics|mesh-ancestor
20060833|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060834|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060835|NCT03559179|Analgesics|analgesics|mesh-ancestor
20060836|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
20060837|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060838|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
20060839|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20060840|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
20060841|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20060842|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
20060843|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060844|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060845|NCT03560739|Ofatumumab|ofatumumab|mesh-list
20060846|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20060847|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060848|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
20060849|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060850|NCT03562377|Vaccines|vaccines|mesh-list
20060851|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
20060852|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060853|NCT03562481|Lidocaine|lidocaine|mesh-list
20060854|NCT03562481|Epinephrine|epinephrine|mesh-list
20060855|NCT03562481|Racepinephrine|racepinephrine|mesh-list
20060856|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
20060857|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
20060858|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
20060859|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060860|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060861|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
20060862|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060863|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20060864|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20060865|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20060866|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060867|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060868|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20060869|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20060870|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
20060871|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060872|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20060873|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20060874|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
20060875|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20060876|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
20060877|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
20060878|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
20060879|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20060880|NCT03562988|Vitamins|vitamins|mesh-list
20060881|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
20060882|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
20060883|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060884|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
20060885|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060886|NCT03562988|Protective Agents|protective agents|mesh-ancestor
20060887|NCT03565211|Progesterone|progesterone|mesh-list
20060888|NCT03565211|Progestins|progestins|mesh-ancestor
20060889|NCT03565211|Hormones|hormones|mesh-ancestor
20060890|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20060891|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060892|NCT03565666|Insulin|insulin|mesh-list
20060893|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20060894|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
20060895|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
20060896|NCT03565666|Pancrelipase|pancrelipase|mesh-list
20293427|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20060897|NCT03565666|Pancreatin|pancreatin|mesh-list
20060898|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060899|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060900|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060901|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20060902|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20060903|NCT03566485|Atezolizumab|atezolizumab|mesh-list
20060904|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060905|NCT03566810|Metformin|metformin|mesh-list
20060906|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20060907|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060908|NCT03566979|Naproxen|naproxen|mesh-list
20060909|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20060910|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20060911|NCT03566979|Analgesics|analgesics|mesh-ancestor
20060912|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
20060913|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060914|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060915|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060916|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060917|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
20060918|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20060919|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060920|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060921|NCT03567382|Tenofovir|tenofovir|mesh-list
20060922|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
20060923|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20060924|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20060925|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20060926|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060927|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060928|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20060929|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20060930|NCT03567616|Dexamethasone|dexamethasone|mesh-list
20060931|NCT03567616|Venetoclax|venetoclax|mesh-list
20060932|NCT03567616|Pomalidomide|pomalidomide|mesh-list
20060933|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20060934|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
20060935|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
20060936|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060937|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060938|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060939|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
20060940|NCT03567616|Hormones|hormones|mesh-ancestor
20060941|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20060942|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20060943|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060944|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
20060945|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20060946|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20060947|NCT03567616|Growth Substances|growth substances|mesh-ancestor
20060948|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
20060949|NCT03568500|Olanzapine|olanzapine|mesh-list
20060950|NCT03568500|Risperidone|risperidone|mesh-list
20060951|NCT03568500|Aripiprazole|aripiprazole|mesh-list
20060952|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20060953|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20060954|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
20060955|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060956|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491548|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
19491549|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491550|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060957|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20060958|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20060959|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20060960|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20060961|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20060962|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20060963|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
20060964|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
20060965|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
20060966|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060967|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20060968|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20060969|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19491551|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491552|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20060970|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060971|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
20060972|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
20060973|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20060974|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20060975|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20060976|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20060977|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
20060978|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20060979|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20060980|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
20060981|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20060982|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20060983|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060984|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
20060985|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20060986|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491553|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19491554|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19491555|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491556|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19491557|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19491558|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060987|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20060988|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20060989|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
20060990|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
20060991|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20060992|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20060993|NCT03570476|Olaparib|olaparib|mesh-list
20060994|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20060995|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20060996|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20060997|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20060998|NCT03570554|Acetaminophen|acetaminophen|mesh-list
20577077|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20577078|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20577079|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577080|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19746193|NCT04195633|Sargramostim|sargramostim|mesh-list
20060999|NCT03570554|Celecoxib|celecoxib|mesh-list
20061000|NCT03570554|Naproxen|naproxen|mesh-list
20061001|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061002|NCT03570554|Analgesics|analgesics|mesh-ancestor
20061003|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
20061004|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061005|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061006|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
20061007|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20061008|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061009|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061010|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20061011|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20061012|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061013|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061014|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
20061015|NCT03571516|Teduglutide|teduglutide|mesh-list
20061016|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20061017|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20061018|NCT03571516|Protective Agents|protective agents|mesh-ancestor
20061019|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061020|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20061021|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
20061022|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119046|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119047|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119048|NCT00006103|Antidotes|antidotes|mesh-ancestor
20119049|NCT00006103|Protective Agents|protective agents|mesh-ancestor
20119050|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
20119051|NCT00006103|Vitamins|vitamins|mesh-ancestor
20119052|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
20119053|NCT00006104|Docetaxel|docetaxel|mesh-list
20119054|NCT00006104|Trastuzumab|trastuzumab|mesh-list
20119055|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119056|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119057|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119058|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
20293428|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061023|NCT03571724|Menthol|menthol|mesh-list
20061024|NCT03571724|Nicotine|nicotine|mesh-list
20061025|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20061026|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
20061027|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061028|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061029|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20061030|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20061031|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
20061032|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061033|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061034|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
20061035|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061036|NCT03572478|Nivolumab|nivolumab|mesh-list
20061037|NCT03572478|Rucaparib|rucaparib|mesh-list
20061038|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20061039|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061040|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20061041|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061042|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20061043|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061044|NCT03572972|Warfarin|warfarin|mesh-list
20061045|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
20061046|NCT03572972|Dabigatran|dabigatran|mesh-list
20061047|NCT03572972|Apixaban|apixaban|mesh-list
20061048|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
20061049|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20061050|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
20061051|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20061052|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
20061053|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061054|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061055|NCT03573323|Ixekizumab|ixekizumab|mesh-list
20061056|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061057|NCT03573908|Linaclotide|linaclotide|mesh-list
20061058|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20061059|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
20061060|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061061|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20061062|NCT03574818|Gemcitabine|gemcitabine|mesh-list
20061063|NCT03574818|Necitumumab|necitumumab|mesh-list
20061064|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061065|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20061066|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
20061067|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061068|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
20061069|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061070|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061071|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061072|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
20061073|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061074|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20061075|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20061076|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20061077|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20061078|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
20061079|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061080|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061081|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061082|NCT03575702|Urological Agents|urological agents|mesh-ancestor
20061083|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
20061084|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20061085|NCT03575806|Estrogens|estrogens|mesh-ancestor
20061086|NCT03575806|Hormones|hormones|mesh-ancestor
20061087|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061088|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061089|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20061090|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061091|NCT03575871|Abrocitinib|abrocitinib|mesh-list
20061092|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20061093|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061094|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061095|NCT03576066|Tenofovir|tenofovir|mesh-list
20061096|NCT03576066|Entecavir|entecavir|mesh-list
20061097|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
20577081|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20061098|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061099|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20061100|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20061101|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061102|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061103|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20061104|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20061105|NCT03577171|Entecavir|entecavir|mesh-list
20061106|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
20061107|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061108|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
20061109|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20061110|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061111|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20061112|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20061113|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061114|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061115|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061116|NCT03577730|Caffeine|caffeine|mesh-list
20061117|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
20061118|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061119|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20061120|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061121|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20061122|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061123|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20061124|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20061125|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
20061126|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061127|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
20061128|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20061129|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
20061130|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20061131|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
20061132|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061133|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061134|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
20061135|NCT03579719|Itraconazole|itraconazole|mesh-list
20061136|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
20061137|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061138|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20061139|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20061140|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061141|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061142|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20061143|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
20061144|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061145|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061146|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20061147|NCT03579940|Lasmiditan|lasmiditan|mesh-list
20061148|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20061149|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
20061150|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061151|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061152|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061153|NCT03580343|Tofacitinib|tofacitinib|mesh-list
20061154|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20061155|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061156|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061157|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
20061158|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20061159|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
20061160|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061161|NCT03581084|Expectorants|expectorants|mesh-ancestor
20061162|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
20061163|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20061164|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
20061165|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061166|NCT03581084|Protective Agents|protective agents|mesh-ancestor
20061167|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061168|NCT03581084|Antidotes|antidotes|mesh-ancestor
20061169|NCT03582215|Salicylates|salicylates|mesh-list
20061170|NCT03582215|Avobenzone|avobenzone|mesh-list
20061171|NCT03582215|Oxybenzone|oxybenzone|mesh-list
20061172|NCT03582215|Homosalate|homosalate|mesh-list
20061173|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
20061174|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
20061175|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
20061176|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20061177|NCT03582215|Protective Agents|protective agents|mesh-ancestor
20061178|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061179|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061180|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20061181|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061182|NCT03582215|Analgesics|analgesics|mesh-ancestor
20061183|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
20061184|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061185|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061186|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061187|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20061188|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061189|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061190|NCT03582553|Naringenin|naringenin|mesh-list
20061191|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20061192|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20061193|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20061194|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
20061195|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061196|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061197|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20061198|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20061199|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20061200|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
20061201|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061202|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061203|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061204|NCT03583372|Urological Agents|urological agents|mesh-ancestor
20061205|NCT03583385|Metformin|metformin|mesh-list
20293429|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293430|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
20293431|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20061206|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20061207|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061208|NCT03584009|Venetoclax|venetoclax|mesh-list
20061209|NCT03584009|Fulvestrant|fulvestrant|mesh-list
20061210|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061211|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20061212|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20061213|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20061214|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
20061215|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061216|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061217|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
20061218|NCT03585504|Etonogestrel|etonogestrel|mesh-list
20061219|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20061220|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061221|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20061222|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20061223|NCT03585712|Norgestrel|norgestrel|mesh-list
20061224|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20061225|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20061226|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20061227|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
20061228|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20061229|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061230|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20061231|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20061232|NCT03586544|Albuterol|albuterol|mesh-list
20061233|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20061234|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
20061235|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061236|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061237|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20061238|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
20061239|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
20061240|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20061241|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20061242|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20061243|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20061244|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
20061245|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061246|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061247|NCT03586726|Rifampin|rifampin|mesh-list
20061248|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20061249|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
20061250|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20061251|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061252|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
20061253|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20061254|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061255|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061256|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20061257|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20061258|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20061259|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20061260|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20061261|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20061262|NCT03587207|Vaccines|vaccines|mesh-list
20061263|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
20061264|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061265|NCT03587428|Zinc|zinc|mesh-list
20061266|NCT03587428|Trace Elements|trace elements|mesh-ancestor
20061267|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
20061268|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061269|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20061270|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20061271|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20061272|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061273|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061274|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061275|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061276|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20061277|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
20061278|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20061279|NCT03588806|Oxycodone|oxycodone|mesh-list
20061280|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20061281|NCT03588806|Narcotics|narcotics|mesh-ancestor
20061282|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061283|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061284|NCT03588806|Analgesics|analgesics|mesh-ancestor
20061285|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
20061286|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061287|NCT03588910|Acetaminophen|acetaminophen|mesh-list
20061288|NCT03588910|Ibuprofen|ibuprofen|mesh-list
20061289|NCT03588910|Oxycodone|oxycodone|mesh-list
20061290|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061291|NCT03588910|Analgesics|analgesics|mesh-ancestor
20061292|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
20061293|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061294|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061295|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
20061296|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20061297|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061298|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061299|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20061300|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061301|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061302|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20061303|NCT03588910|Narcotics|narcotics|mesh-ancestor
20061304|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061305|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20061306|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
20061307|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061308|NCT03591068|Fluticasone|fluticasone|mesh-list
20061309|NCT03591068|Xhance|xhance|mesh-list
20061310|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061311|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20061312|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
20061313|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293432|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20061314|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061315|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20061316|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
20061317|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061318|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20061319|NCT03591146|Ropivacaine|ropivacaine|mesh-list
20061320|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
20061321|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
20061322|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061323|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061324|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
20061325|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061326|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20061327|NCT03591406|Hematinics|hematinics|mesh-ancestor
20061328|NCT03592121|Phenylephrine|phenylephrine|mesh-list
20061329|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20061330|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
20061331|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
20061332|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061333|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061334|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
20061335|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20061336|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
20061337|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
20061338|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20061339|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20061340|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20061341|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
20061342|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061343|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061344|NCT03592121|Protective Agents|protective agents|mesh-ancestor
20061345|NCT03593538|Metformin|metformin|mesh-list
20061346|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20061347|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061348|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
20061349|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20061350|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20061351|NCT03593902|Prednisolone|prednisolone|mesh-list
20061352|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
20061353|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
20061354|NCT03593902|Rituximab|rituximab|mesh-list
20061355|NCT03593902|Fludarabine|fludarabine|mesh-list
20061356|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
20061357|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20061358|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20061359|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
20061360|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061361|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
20061362|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061363|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061364|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20061365|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
20061366|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061367|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061368|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20061369|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20061370|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061371|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
20061372|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
20061373|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061374|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20061375|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
20061376|NCT03593902|Hormones|hormones|mesh-ancestor
20061377|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061378|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20061379|NCT03593902|Protective Agents|protective agents|mesh-ancestor
20061380|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20061381|NCT03594045|Apixaban|apixaban|mesh-list
20061382|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20061383|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
20061384|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20061385|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
20061386|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061387|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061388|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
20061389|NCT03595449|Lidocaine|lidocaine|mesh-list
20061390|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
20061391|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
20061392|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061393|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061394|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
20061395|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061396|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20061397|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20061398|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20061399|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061400|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061401|NCT03595579|Bupropion|bupropion|mesh-list
20061402|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20061403|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
20061404|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20061405|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20061406|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20061407|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061408|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061409|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
20061410|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061411|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061412|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20061413|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20061414|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061415|NCT03596723|Prednisolone|prednisolone|mesh-list
20061416|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20061417|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
20061418|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20061419|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
20061420|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20061421|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
20061422|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061423|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
20061424|NCT03596723|Hormones|hormones|mesh-ancestor
20061425|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061426|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061427|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20061428|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061429|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
20061430|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
20061431|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061432|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20061433|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20061434|NCT03596723|Protective Agents|protective agents|mesh-ancestor
20061435|NCT03597009|Nivolumab|nivolumab|mesh-list
20061436|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20061437|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20061438|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061439|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20061440|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061441|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
20061442|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
20061443|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
20061444|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
20061445|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061446|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
20061447|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20061448|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20061449|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061450|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20061451|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
20061452|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061453|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20061454|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
20119059|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119060|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20119061|NCT00006105|Gemcitabine|gemcitabine|mesh-list
20119062|NCT00006105|Amifostine|amifostine|mesh-list
20119063|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119064|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119065|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
20119066|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061455|NCT03597139|Cyclosporine|cyclosporine|mesh-list
20061456|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20061457|NCT03597139|Cyclosporins|cyclosporins|mesh-list
20061458|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061459|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061460|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061461|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
20061462|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061463|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
20061464|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061465|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061466|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061467|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20061468|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20061469|NCT03597347|Molgramostim|molgramostim|mesh-list
20061470|NCT03597347|Sargramostim|sargramostim|mesh-list
20061471|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061472|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
20061473|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061474|NCT03597529|Melatonin|melatonin|mesh-list
20061475|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
20061476|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061477|NCT03597529|Protective Agents|protective agents|mesh-ancestor
20061478|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061479|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061480|NCT03599089|Acetaminophen|acetaminophen|mesh-list
20061481|NCT03599089|Ketorolac|ketorolac|mesh-list
20061482|NCT03599089|Oxycodone|oxycodone|mesh-list
20061483|NCT03599089|Bupivacaine|bupivacaine|mesh-list
20061484|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
20061485|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
19491559|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
19491560|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491561|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
19491562|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
19491563|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
19491564|NCT03130114|Azithromycin|azithromycin|mesh-list
19491565|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491566|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061486|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061487|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061488|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
20061489|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061490|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061491|NCT03599089|Analgesics|analgesics|mesh-ancestor
20061492|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
20061493|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20061494|NCT03599089|Narcotics|narcotics|mesh-ancestor
20061495|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20061496|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061497|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061498|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20061499|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061500|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061501|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
20061502|NCT03599193|Tazarotene|tazarotene|mesh-list
20061503|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061504|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
20061505|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
20061506|NCT03599193|Vitamins|vitamins|mesh-ancestor
20061507|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
20061508|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061509|NCT03599362|Nivolumab|nivolumab|mesh-list
20061510|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20061511|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061512|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20061513|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061514|NCT03600376|Dantrolene|dantrolene|mesh-list
20061515|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20061516|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061517|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20293433|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061518|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293434|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061519|NCT03600428|Vaccines|vaccines|mesh-list
19491567|NCT03130270|Apatinib|apatinib|mesh-list
20061520|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
20061521|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061522|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20061523|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
20061524|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
20061525|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061526|NCT03604341|Dronabinol|dronabinol|mesh-list
20061527|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
20061528|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061529|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20061530|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061531|NCT03604341|Analgesics|analgesics|mesh-ancestor
20061532|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
20061533|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061534|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20061535|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20061536|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061537|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061538|NCT03604341|Hormones|hormones|mesh-ancestor
20061539|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061540|NCT03605212|Febuxostat|febuxostat|mesh-list
20061541|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
20061542|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061543|NCT03605914|Acetaminophen|acetaminophen|mesh-list
20061544|NCT03605914|Diclofenac|diclofenac|mesh-list
20061545|NCT03605914|Hydrocodone|hydrocodone|mesh-list
20061546|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061547|NCT03605914|Analgesics|analgesics|mesh-ancestor
20061548|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
20061549|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061550|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061551|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
20061552|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20061553|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061554|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061555|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20061556|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061557|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061558|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20061559|NCT03605914|Narcotics|narcotics|mesh-ancestor
20061560|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061561|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
20061562|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
20061563|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
20061564|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
20061565|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061566|NCT03607539|Pemetrexed|pemetrexed|mesh-list
20061567|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061568|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061569|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061570|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20061571|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20061572|NCT03608488|Vitamin D|vitamin d|mesh-list
20061573|NCT03608488|Vitamins|vitamins|mesh-ancestor
20061574|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
20061575|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061576|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20061577|NCT03608774|Azithromycin|azithromycin|mesh-list
20061578|NCT03608774|Doxycycline|doxycycline|mesh-list
20061579|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20061580|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061581|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
20061582|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20061583|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20061584|NCT03608839|Dexamethasone|dexamethasone|mesh-list
20061585|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
20061586|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20061587|NCT03608839|BB 1101|bb 1101|mesh-list
20061588|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061589|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
20061590|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
20061591|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061592|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061593|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20061594|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
20061595|NCT03608839|Hormones|hormones|mesh-ancestor
20061596|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061597|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20061598|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061599|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
20061600|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061601|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061602|NCT03610399|Primaquine|primaquine|mesh-list
20061603|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
20061604|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20061605|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20061606|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061607|NCT03610464|Amphetamine|amphetamine|mesh-list
20061608|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20061609|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061610|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
20061611|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
20061612|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061613|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
20061614|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061615|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061616|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
20061617|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20061618|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20061619|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061620|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20061621|NCT03610633|Oxytocin|oxytocin|mesh-list
20061622|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
20061623|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20061624|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061625|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
20061626|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20061627|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061628|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20061629|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20061630|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061631|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061632|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061633|NCT03614975|Vaccines|vaccines|mesh-list
20061634|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
20061635|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061636|NCT03615404|Molgramostim|molgramostim|mesh-list
20061637|NCT03615404|Sargramostim|sargramostim|mesh-list
20061638|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
20061639|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061640|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061641|NCT03615482|Vaccines|vaccines|mesh-list
20061642|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
20061643|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061644|NCT03615534|Niacin|niacin|mesh-list
20061645|NCT03615534|Fenofibrate|fenofibrate|mesh-list
20061646|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20061647|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
20293435|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061648|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061649|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20061650|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
20061651|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
20061652|NCT03615534|Vitamins|vitamins|mesh-ancestor
20061653|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
20061654|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061655|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20061656|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061657|NCT03615924|Ticagrelor|ticagrelor|mesh-list
20061658|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20061659|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20061660|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20061661|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20061662|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
20061663|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061664|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061665|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061666|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
20061667|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20061668|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061669|NCT03617861|Secretin|secretin|mesh-list
20061670|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20061671|NCT03617861|Hormones|hormones|mesh-ancestor
20119067|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
20061672|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061673|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061674|NCT03617913|Cisplatin|cisplatin|mesh-list
20061675|NCT03617913|Fluorouracil|fluorouracil|mesh-list
20061676|NCT03617913|Mitomycins|mitomycins|mesh-list
20061677|NCT03617913|Mitomycin|mitomycin|mesh-list
20061678|NCT03617913|Avelumab|avelumab|mesh-list
20061679|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20061680|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061681|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
20061682|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061683|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20061684|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061685|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
20061686|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061687|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20061688|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
20061689|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20061690|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061691|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20061692|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
20061693|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20061694|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061695|NCT03618823|Acetaminophen|acetaminophen|mesh-list
20061696|NCT03618823|Ibuprofen|ibuprofen|mesh-list
20061697|NCT03618823|Oxycodone|oxycodone|mesh-list
20061698|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061699|NCT03618823|Analgesics|analgesics|mesh-ancestor
20061700|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
20061701|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061702|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061703|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
20061704|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20061705|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061706|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061707|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20061708|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061709|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061710|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20061711|NCT03618823|Narcotics|narcotics|mesh-ancestor
20061712|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061713|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
20061714|NCT03619837|Velpatasvir|velpatasvir|mesh-list
20061715|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20061716|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
20061717|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491568|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491569|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491570|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491571|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491572|NCT03130101|Insulin|insulin|mesh-list
19491573|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19491574|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491575|NCT03129646|Paromomycin|paromomycin|mesh-list
19491576|NCT03129646|Miltefosine|miltefosine|mesh-list
19491577|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19491578|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19491579|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491580|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19491581|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19491582|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
19491583|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491584|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
19491585|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19491586|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
19491587|NCT03129594|Glucagon|glucagon|mesh-list
19491588|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19491589|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491590|NCT03129594|Hormones|hormones|mesh-ancestor
19746194|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061718|NCT03620162|Vaccines|vaccines|mesh-list
20061719|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
20061720|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061721|NCT03620708|Nicotine|nicotine|mesh-list
20061722|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19491591|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061723|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
20061724|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061725|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061726|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20061727|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20061728|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
20061729|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061730|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119068|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119069|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119070|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119071|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
20119072|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119073|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20119074|NCT00006105|Protective Agents|protective agents|mesh-ancestor
20119075|NCT00006106|Fluorouracil|fluorouracil|mesh-list
20119076|NCT00006106|Dl1520|dl1520|mesh-list
20119077|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119078|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
20119079|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119080|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119081|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119082|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
20119083|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119084|NCT00006107|Docetaxel|docetaxel|mesh-list
20119085|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119086|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119087|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119088|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119089|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119090|NCT00006108|Paclitaxel|paclitaxel|mesh-list
20119091|NCT00006108|Capecitabine|capecitabine|mesh-list
20119092|NCT00006108|Trastuzumab|trastuzumab|mesh-list
20119093|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119094|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119095|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119096|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119097|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119098|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119099|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119100|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
20119101|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20120731|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120732|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120733|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120734|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
20120735|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120736|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20120737|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20120738|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
20120739|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20120740|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120741|NCT00006398|Timolol|timolol|mesh-list
20120742|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20120743|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20120744|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
20120745|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120746|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120747|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120748|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20120749|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20120750|NCT00006399|Donepezil|donepezil|mesh-list
20120751|NCT00006399|Progesterone|progesterone|mesh-list
20120752|NCT00006399|Estrogens|estrogens|mesh-list
20120753|NCT00006399|Progestins|progestins|mesh-ancestor
20120754|NCT00006399|Hormones|hormones|mesh-ancestor
20120755|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120756|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120757|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20120758|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120759|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120760|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293436|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
20293437|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20293438|NCT04346654|Dexamethasone|dexamethasone|mesh-list
20061731|NCT03620890|Protamines|protamines|mesh-list
20061732|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
20061733|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061734|NCT03620890|Coagulants|coagulants|mesh-ancestor
20061735|NCT03621085|Ketamine|ketamine|mesh-list
20061736|NCT03621085|Analgesics|analgesics|mesh-ancestor
20061737|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
20061738|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061739|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061740|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20061741|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20061742|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
20061743|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
20061744|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061745|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20061746|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20061747|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061748|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061749|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20061750|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20061751|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
20061752|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20061753|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061754|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
20061755|NCT03624946|Antibodies|antibodies|mesh-list
20061756|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
20061757|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20061758|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20061759|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
20061760|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
20061761|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061762|NCT03626415|Abrocitinib|abrocitinib|mesh-list
20061763|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20061764|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061765|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061766|NCT03626714|Tacrolimus|tacrolimus|mesh-list
20061767|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061768|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
20061769|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061770|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20061771|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061772|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061773|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20061774|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20061775|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20061776|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061777|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061778|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20061779|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20061780|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20061781|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20061782|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
20061783|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061784|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061785|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20061786|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20061787|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
20061788|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20061789|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20061790|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
20061791|NCT03627767|Abrocitinib|abrocitinib|mesh-list
20061792|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20061793|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061794|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061795|NCT03628417|Bleomycin|bleomycin|mesh-list
20061796|NCT03628417|Calcium|calcium|mesh-list
20061797|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20061798|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061799|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20061800|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061801|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20061802|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
20061803|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061804|NCT03629054|Metformin|metformin|mesh-list
20061805|NCT03629054|Empagliflozin|empagliflozin|mesh-list
20061806|NCT03629054|Linagliptin|linagliptin|mesh-list
20061807|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20061808|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061809|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20061810|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061811|NCT03629054|Incretins|incretins|mesh-ancestor
20061812|NCT03629054|Hormones|hormones|mesh-ancestor
20061813|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061814|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20061815|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
20061816|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061817|NCT03629184|Oseltamivir|oseltamivir|mesh-list
20061818|NCT03629184|Baloxavir|baloxavir|mesh-list
20061819|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
20061820|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061821|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061822|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061823|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
20061824|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20061825|NCT03629249|Growth Substances|growth substances|mesh-ancestor
20061826|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061827|NCT03629925|Gemcitabine|gemcitabine|mesh-list
20061828|NCT03629925|Carboplatin|carboplatin|mesh-list
20061829|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061830|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20061831|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
20061832|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061833|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
20061834|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061835|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061836|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061837|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
20061838|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061839|NCT03630198|Lidocaine|lidocaine|mesh-list
20061840|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
20061841|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
20061842|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061843|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061844|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
20061845|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061846|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20061847|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20061848|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20061849|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061850|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061851|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
20061852|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20061853|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20061854|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061855|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
20061856|NCT03631355|Coagulants|coagulants|mesh-ancestor
20061857|NCT03631433|Acetaminophen|acetaminophen|mesh-list
20061858|NCT03631433|Ibuprofen|ibuprofen|mesh-list
20061859|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20061860|NCT03631433|Analgesics|analgesics|mesh-ancestor
20061861|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
20061862|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061863|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061864|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
20061865|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20061866|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20061867|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061868|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20061869|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061870|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061871|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
20061872|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20061873|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
20061874|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061875|NCT03632109|Gentamicins|gentamicins|mesh-list
20061876|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20061877|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20061878|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20061879|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119102|NCT00006111|Fluorouracil|fluorouracil|mesh-list
20061880|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061881|NCT03633331|Letrozole|letrozole|mesh-list
20061882|NCT03633331|Fulvestrant|fulvestrant|mesh-list
20061883|NCT03633331|Palbociclib|palbociclib|mesh-list
20061884|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061885|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20061886|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20061887|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061888|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061889|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20061890|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
20061891|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20061892|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061893|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20061894|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20061895|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20061896|NCT03633344|Silicon|silicon|mesh-list
20061897|NCT03633344|Trace Elements|trace elements|mesh-ancestor
20061898|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
20061899|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061900|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
20061901|NCT03633448|Guaifenesin|guaifenesin|mesh-list
20061902|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20061903|NCT03633448|Expectorants|expectorants|mesh-ancestor
20061904|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
20061905|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20061906|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20061907|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
20061908|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061909|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061910|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061911|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
20061912|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20061913|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
20061914|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
20061915|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061916|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
20061917|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20061918|NCT03633487|Guaifenesin|guaifenesin|mesh-list
20061919|NCT03633487|Expectorants|expectorants|mesh-ancestor
20061920|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
20061921|NCT03633526|Ivacaftor|ivacaftor|mesh-list
20061922|NCT03633526|VX-659|vx-659|mesh-list
20061923|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20061924|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061925|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061926|NCT03634800|Nivolumab|nivolumab|mesh-list
20061927|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20061928|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061929|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20061930|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061931|NCT03635957|Folic Acid|folic acid|mesh-list
20061932|NCT03635957|Methotrexate|methotrexate|mesh-list
20061933|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20061934|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
20061935|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20061936|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061937|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20061938|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
20061939|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061940|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061941|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061942|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061943|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20061944|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20061945|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
20061946|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20061947|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20061948|NCT03635957|Hematinics|hematinics|mesh-ancestor
20061949|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
20061950|NCT03635957|Vitamins|vitamins|mesh-ancestor
20061951|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
20061952|NCT03636061|Varenicline|varenicline|mesh-list
20061953|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20061954|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20061955|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
20061956|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061957|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061958|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061959|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20061960|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20061961|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
20061962|NCT03638635|Bupivacaine|bupivacaine|mesh-list
20061963|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
20061964|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
20061965|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20061966|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061967|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
20061968|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20061969|NCT03638908|Fluoxetine|fluoxetine|mesh-list
20061970|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20061971|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20061972|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061973|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061974|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061975|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
20061976|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061977|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20061978|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
20061979|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20061980|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20061981|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20061982|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20061983|NCT03639675|Aflibercept|aflibercept|mesh-list
20061984|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20061985|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20061986|NCT03639675|Growth Substances|growth substances|mesh-ancestor
20061987|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061988|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
20061989|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20061990|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20061991|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20061992|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20061993|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20061994|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20061995|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
20061996|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20061997|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20061998|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20061999|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062000|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
20062001|NCT03639779|Antidotes|antidotes|mesh-ancestor
20062002|NCT03639779|Protective Agents|protective agents|mesh-ancestor
20062003|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062004|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
20062005|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062006|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
20062007|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062008|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062009|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
20062010|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
20062011|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
20062012|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20062013|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062014|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
20062015|NCT03641508|Dexamethasone|dexamethasone|mesh-list
20062016|NCT03641508|Triamcinolone|triamcinolone|mesh-list
20062017|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062018|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
20062019|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
20062020|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062021|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062022|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20062023|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
20062024|NCT03641508|Hormones|hormones|mesh-ancestor
20062025|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20062026|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20062027|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062028|NCT03642262|Guaifenesin|guaifenesin|mesh-list
20062029|NCT03642262|Expectorants|expectorants|mesh-ancestor
20062030|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062031|NCT03642457|Bupivacaine|bupivacaine|mesh-list
20062032|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062033|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
20062034|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062035|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062036|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
20062037|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062038|NCT03642717|Empagliflozin|empagliflozin|mesh-list
20062039|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20062040|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062041|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20062042|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062043|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
20062044|NCT03642873|Hydrocodone|hydrocodone|mesh-list
20062045|NCT03642873|Guaifenesin|guaifenesin|mesh-list
20062046|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20062047|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20062048|NCT03642873|Narcotics|narcotics|mesh-ancestor
20062049|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062050|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062051|NCT03642873|Analgesics|analgesics|mesh-ancestor
20062052|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
20062053|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062054|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
20062055|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062056|NCT03642873|Expectorants|expectorants|mesh-ancestor
20062057|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20062058|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20062059|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062060|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062061|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062062|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
20062063|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20062064|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
20062065|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
20062066|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
20062067|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20119103|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119104|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
20119105|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119106|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119107|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119108|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
20119109|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119110|NCT00006112|Leucovorin|leucovorin|mesh-list
20119111|NCT00006112|Fluorouracil|fluorouracil|mesh-list
20119112|NCT00006112|Mitomycins|mitomycins|mesh-list
20119113|NCT00006112|Mitomycin|mitomycin|mesh-list
20119114|NCT00006112|Calcium|calcium|mesh-list
20119115|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
20119116|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20119117|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119118|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
20119119|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119120|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119121|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119122|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119123|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
20119124|NCT00006112|Antidotes|antidotes|mesh-ancestor
20119125|NCT00006112|Protective Agents|protective agents|mesh-ancestor
20119126|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
20119127|NCT00006112|Vitamins|vitamins|mesh-ancestor
20119128|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
20119129|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119130|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
20119131|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119132|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119133|NCT00006113|Interferons|interferons|mesh-list
20119134|NCT00006113|Aldesleukin|aldesleukin|mesh-list
20119135|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
20119136|NCT00006113|Interleukin-4|interleukin-4|mesh-list
20119137|NCT00006113|Sargramostim|sargramostim|mesh-list
20119138|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119139|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
20119140|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062068|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
20062069|NCT03643575|Guaifenesin|guaifenesin|mesh-list
20062070|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20062071|NCT03643575|Expectorants|expectorants|mesh-ancestor
20062072|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062073|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20062074|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20062075|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062076|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062077|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062078|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062079|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
20062080|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20062081|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
20062082|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
20062083|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062084|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
20062085|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20062086|NCT03643952|Daptomycin|daptomycin|mesh-list
20062087|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062088|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062089|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
20062090|NCT03644095|Guaifenesin|guaifenesin|mesh-list
20062091|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20062092|NCT03644095|Expectorants|expectorants|mesh-ancestor
20062093|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062094|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20062095|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20062096|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062097|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062098|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062099|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062100|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
20062101|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20062102|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
20062103|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
20062104|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062105|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
20062106|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20062107|NCT03644108|Guaifenesin|guaifenesin|mesh-list
20062108|NCT03644108|Expectorants|expectorants|mesh-ancestor
20062109|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062110|NCT03644212|Vitamin D|vitamin d|mesh-list
20062111|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
20062112|NCT03644212|Vitamins|vitamins|mesh-list
20062113|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
20062114|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062115|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20062116|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20062117|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
20062118|NCT03647709|Narcotics|narcotics|mesh-ancestor
20062119|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062120|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062121|NCT03647709|Analgesics|analgesics|mesh-ancestor
20062122|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
20062123|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062124|NCT03649477|Carbetocin|carbetocin|mesh-list
20062125|NCT03649477|Oxytocin|oxytocin|mesh-list
20062126|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
20062127|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20062128|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062129|NCT03649750|Guaifenesin|guaifenesin|mesh-list
20062130|NCT03649750|Expectorants|expectorants|mesh-ancestor
20062131|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062132|NCT03650387|Lidocaine|lidocaine|mesh-list
20062133|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062134|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
20062135|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062136|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062137|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
20062138|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062139|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20062140|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20062141|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20062142|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062143|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062144|NCT03652610|Vaccines|vaccines|mesh-list
20062145|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
20062146|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062147|NCT03652818|Acetaminophen|acetaminophen|mesh-list
20062148|NCT03652818|Pregabalin|pregabalin|mesh-list
20062149|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062150|NCT03652818|Analgesics|analgesics|mesh-ancestor
20062151|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
20062152|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062153|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062154|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
20062155|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
20062156|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20062157|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062158|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062159|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20062160|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20062161|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20062162|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062163|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20062164|NCT03653416|Bupivacaine|bupivacaine|mesh-list
20062165|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062166|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
20062167|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062168|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062169|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
20062170|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062171|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
20062172|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20062173|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20062174|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062175|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
20062176|NCT03653429|Coagulants|coagulants|mesh-ancestor
20062177|NCT03654326|Naproxen|naproxen|mesh-list
20062178|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20062179|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062180|NCT03654326|Analgesics|analgesics|mesh-ancestor
20062181|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
20062182|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062183|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062184|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062185|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062186|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
20062187|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20062188|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062189|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062190|NCT03654417|Lidocaine|lidocaine|mesh-list
20062191|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062192|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
20062193|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062194|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062195|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
20062196|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062197|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20062198|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20062199|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20062200|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062201|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062202|NCT03655080|Paclitaxel|paclitaxel|mesh-list
20062203|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20062204|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20062205|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062206|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
20062207|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
20062208|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
20062209|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062210|NCT03655301|Metformin|metformin|mesh-list
20062211|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20062212|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062213|NCT03655444|Nivolumab|nivolumab|mesh-list
20062214|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20062215|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062216|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20062217|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062218|NCT03657095|Beraprost|beraprost|mesh-list
20062219|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20062220|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
20062221|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
20062222|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062223|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062224|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20062225|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20062226|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062227|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062228|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062229|NCT03657407|Glycerol|glycerol|mesh-list
20062230|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20062231|NCT03657407|Protective Agents|protective agents|mesh-ancestor
20062232|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062233|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20062234|NCT03658876|Hematinics|hematinics|mesh-ancestor
20062235|NCT03661346|Labetalol|labetalol|mesh-list
20062236|NCT03661346|Esmolol|esmolol|mesh-list
20062237|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20062238|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20062239|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20062240|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062241|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062242|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062243|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062244|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20062245|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
20062246|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
20062247|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062248|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20062249|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20062250|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
20062251|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20062252|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
20062253|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062254|NCT03661983|Aripiprazole|aripiprazole|mesh-list
20062255|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
20062256|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20062257|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20062258|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20062259|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062260|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062261|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
20062262|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
20062263|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062264|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062265|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20062266|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20062267|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
20062268|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20062269|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20062270|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20062271|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20062272|NCT03662074|Gemcitabine|gemcitabine|mesh-list
20062273|NCT03662074|Nivolumab|nivolumab|mesh-list
20062274|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20062275|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
20062276|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062277|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062278|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
20062279|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062280|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062281|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20062282|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
20062283|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062284|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20062285|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20062286|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
20062287|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20062288|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062289|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20062290|NCT03662789|Hematinics|hematinics|mesh-ancestor
20062291|NCT03663101|Lidocaine|lidocaine|mesh-list
20062292|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
20062293|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20062294|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20062295|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062296|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
20062297|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062298|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062299|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
20062300|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062301|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20062302|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20062303|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20062304|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062305|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062306|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20062307|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062308|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062309|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20062310|NCT03663283|Bupivacaine|bupivacaine|mesh-list
20062311|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062312|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
20062313|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062314|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062315|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
20062316|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062317|NCT03663582|Teduglutide|teduglutide|mesh-list
20062318|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20062319|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20062320|NCT03663582|Protective Agents|protective agents|mesh-ancestor
20062321|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062322|NCT03664544|Edaravone|edaravone|mesh-list
20062323|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20062324|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
20062325|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062326|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20062327|NCT03664544|Protective Agents|protective agents|mesh-ancestor
20062328|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062329|NCT03665155|Daratumumab|daratumumab|mesh-list
20062330|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062331|NCT03666663|Lidocaine|lidocaine|mesh-list
20062332|NCT03666663|Bupivacaine|bupivacaine|mesh-list
20062333|NCT03666663|Ropivacaine|ropivacaine|mesh-list
20062334|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062335|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
20062336|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062337|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062338|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
20062339|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062340|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20062341|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20062342|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20062343|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062344|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062345|NCT03667053|Glucagon|glucagon|mesh-list
20062346|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20062347|NCT03667053|Hormones|hormones|mesh-ancestor
20062348|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20062349|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062350|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
20062351|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20062352|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20062353|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
20062354|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062355|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20062356|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20062357|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062358|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062359|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20062360|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
20062361|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062362|NCT03669081|Ketorolac|ketorolac|mesh-list
20062363|NCT03669081|Pregabalin|pregabalin|mesh-list
20062364|NCT03669081|Analgesics|analgesics|mesh-ancestor
20062365|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
20062366|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119141|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
20062367|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062368|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
20062369|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20062370|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062371|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062372|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20062373|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20062374|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20062375|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062376|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20062377|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20062378|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062379|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062380|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062381|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20062382|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062383|NCT03669861|Abatacept|abatacept|mesh-list
20062384|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20062385|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062386|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062387|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20062388|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
20062389|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062390|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062391|NCT03670030|Sirolimus|sirolimus|mesh-list
20062392|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062393|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062394|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20062395|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062396|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
20062397|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20062398|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
20062399|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062400|NCT03670160|Clonidine|clonidine|mesh-list
20062401|NCT03670160|Phenobarbital|phenobarbital|mesh-list
20062402|NCT03670160|Analgesics|analgesics|mesh-ancestor
20062403|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
20062404|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062405|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062406|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20062407|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
20062408|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
20062409|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20062410|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20062411|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20062412|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062413|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062414|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062415|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
20062416|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20062417|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062418|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20062419|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20062420|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
20062421|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
20062422|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20062423|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20062424|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20119142|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119143|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119144|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119145|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20119146|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119147|NCT00006114|Vinorelbine|vinorelbine|mesh-list
20119148|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
20119149|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119150|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119151|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119152|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119153|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119154|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119155|NCT00006114|Analgesics|analgesics|mesh-ancestor
20119156|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
20293439|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062425|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
20062426|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
20062427|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20062428|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062429|NCT03670810|Lasmiditan|lasmiditan|mesh-list
20062430|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20062431|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
20062432|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062433|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062434|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062435|NCT03672006|Heparin|heparin|mesh-list
20062436|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20062437|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
20062438|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20062439|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20062440|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293440|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
20062441|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20062442|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20062443|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
20062444|NCT03673670|Olodaterol|olodaterol|mesh-list
20062445|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20062446|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
20062447|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062448|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062449|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20062450|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062451|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
20062452|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20062453|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062454|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062455|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062456|NCT03674177|Vaccines|vaccines|mesh-list
20062457|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
20062458|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062459|NCT03674970|Nicotine|nicotine|mesh-list
20062460|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20062461|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
20062462|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062463|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062464|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20062465|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20062466|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062467|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062468|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062469|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20062470|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20062471|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062472|NCT03675581|Nintedanib|nintedanib|mesh-list
20062473|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20062474|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20062475|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062476|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20062477|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062478|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062479|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20062480|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
20062481|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20062482|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062483|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20062484|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20062485|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20062486|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20062487|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20062488|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20062489|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20062490|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20062491|NCT03676725|Lidocaine|lidocaine|mesh-list
20062492|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062493|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
20062494|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062495|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746195|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
20062496|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
20062497|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062498|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20062499|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20062500|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20062501|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062502|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062503|NCT03677401|Serlopitant|serlopitant|mesh-list
20062504|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20062505|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062506|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062507|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062508|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
20062509|NCT03678870|Narcotics|narcotics|mesh-ancestor
20062510|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062511|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062512|NCT03678870|Analgesics|analgesics|mesh-ancestor
20062513|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
20062514|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062515|NCT03679975|Riluzole|riluzole|mesh-list
20062516|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
20062517|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20062518|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20062519|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062520|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062521|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062522|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20062523|NCT03679975|Protective Agents|protective agents|mesh-ancestor
20062524|NCT03680521|Nivolumab|nivolumab|mesh-list
20062525|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20062526|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062527|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20062528|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062529|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
20062530|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20062531|NCT03681093|Growth Substances|growth substances|mesh-ancestor
20062532|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062533|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
20062534|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20062535|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062536|NCT03682302|Bupivacaine|bupivacaine|mesh-list
20062537|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062538|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
20062539|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062540|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062541|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
20062542|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062543|NCT03682705|Upadacitinib|upadacitinib|mesh-list
20062544|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20062545|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20062546|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062547|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062548|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062549|NCT03684044|Baloxavir|baloxavir|mesh-list
20062550|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
20062551|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062552|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062553|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062554|NCT03684265|Meloxicam|meloxicam|mesh-list
20062555|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20062556|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062557|NCT03684265|Analgesics|analgesics|mesh-ancestor
20062558|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
20062559|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062560|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062561|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062562|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062563|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20062564|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20062565|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062566|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062567|NCT03684642|Metformin|metformin|mesh-list
20062568|NCT03684642|Dulaglutide|dulaglutide|mesh-list
20062569|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
20062570|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20062571|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062572|NCT03685344|Durvalumab|durvalumab|mesh-list
20062573|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20062574|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20062575|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20062576|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062577|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
20062578|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062579|NCT03685396|Hemostatics|hemostatics|mesh-list
20062580|NCT03685396|Coagulants|coagulants|mesh-ancestor
20062581|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20062582|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20062583|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062584|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20062585|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20062586|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20062587|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062588|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062589|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062590|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062591|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062592|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20062593|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062594|NCT03687827|Insulin|insulin|mesh-list
20062595|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20062596|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
20062597|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20062598|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062599|NCT03691779|Ivacaftor|ivacaftor|mesh-list
20062600|NCT03691779|Elexacaftor|elexacaftor|mesh-list
20062601|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20062602|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062603|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062604|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20062605|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20062606|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062607|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
20062608|NCT03691948|Narcotics|narcotics|mesh-ancestor
20062609|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062610|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062611|NCT03691948|Analgesics|analgesics|mesh-ancestor
20062612|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
20062613|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062614|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
20062615|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20062616|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
20062617|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062618|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062619|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20062620|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062621|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
20062622|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20062623|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062624|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062625|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062626|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
20062627|NCT03693950|Hematinics|hematinics|mesh-ancestor
20062628|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
20062629|NCT03693989|Difluprednate|difluprednate|mesh-list
20062630|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
20062631|NCT03693989|Hormones|hormones|mesh-ancestor
20062632|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20062633|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062634|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062635|NCT03695094|Lamotrigine|lamotrigine|mesh-list
20062636|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
20062637|NCT03695094|Levetiracetam|levetiracetam|mesh-list
20062638|NCT03695094|Brivaracetam|brivaracetam|mesh-list
20062639|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
20062640|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
20062641|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20062642|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062643|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062644|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20062645|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062646|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20062647|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20062648|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062649|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20062650|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20062651|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20062652|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20062653|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20062654|NCT03695367|Acetaminophen|acetaminophen|mesh-list
20062655|NCT03695367|Ibuprofen|ibuprofen|mesh-list
20062656|NCT03695367|Ketorolac|ketorolac|mesh-list
20062657|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062658|NCT03695367|Analgesics|analgesics|mesh-ancestor
20062659|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
20062660|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062661|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062662|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
20062663|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20062664|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062665|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062666|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20062667|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062668|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119157|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119158|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119159|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119160|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119161|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119162|NCT00006115|Leucovorin|leucovorin|mesh-list
20119163|NCT00006115|Fluorouracil|fluorouracil|mesh-list
20119164|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
20119165|NCT00006115|Irinotecan|irinotecan|mesh-list
20119166|NCT00006115|Calcium|calcium|mesh-list
20119167|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
20119168|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20119169|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119170|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
20119171|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119172|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119173|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119174|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119175|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
20119176|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20119177|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119178|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119179|NCT00006115|Antidotes|antidotes|mesh-ancestor
20119180|NCT00006115|Protective Agents|protective agents|mesh-ancestor
20119181|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
20119182|NCT00006115|Vitamins|vitamins|mesh-ancestor
20119183|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
20119184|NCT00006116|Gemcitabine|gemcitabine|mesh-list
20119185|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119186|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119187|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
20119188|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119189|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
20119190|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119191|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119192|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119193|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
20119194|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119195|NCT00006117|Gemcitabine|gemcitabine|mesh-list
20119196|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
20119197|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119198|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
20119199|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119200|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119201|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
20119202|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119203|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119204|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119205|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
20119206|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119207|NCT00006118|Gemcitabine|gemcitabine|mesh-list
20119208|NCT00006118|Paclitaxel|paclitaxel|mesh-list
20293441|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
20062669|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
20062670|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
20062671|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062672|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062673|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20062674|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20062675|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20062676|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20062677|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062678|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062679|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062680|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
20062681|NCT03696758|Metoprolol|metoprolol|mesh-list
20062682|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
20062683|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
20062684|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20062685|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20062686|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062687|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062688|NCT03696758|Urological Agents|urological agents|mesh-ancestor
20062689|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20062690|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20062691|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
20062692|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
20062693|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062694|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062695|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20062696|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20062697|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20062698|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062699|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062700|NCT03697252|Xanomeline|xanomeline|mesh-list
20062701|NCT03697252|Trospium chloride|trospium chloride|mesh-list
20062702|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
20062703|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
20062704|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062705|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062706|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20062707|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20062708|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062709|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062710|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062711|NCT03697252|Urological Agents|urological agents|mesh-ancestor
20062712|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20062713|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20062714|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20062715|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20062716|NCT03697993|Levofloxacin|levofloxacin|mesh-list
20062717|NCT03697993|Ofloxacin|ofloxacin|mesh-list
20062718|NCT03697993|Fosfomycin|fosfomycin|mesh-list
20062719|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20062720|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062721|NCT03697993|Renal Agents|renal agents|mesh-ancestor
20062722|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062723|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20062724|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20062725|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062726|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062727|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062728|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20062729|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20062730|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
20062731|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20062732|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062733|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20062734|NCT03700892|Protective Agents|protective agents|mesh-ancestor
20062735|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062736|NCT03701061|Vaccines|vaccines|mesh-list
20062737|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
20062738|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062739|NCT03701074|Acetaminophen|acetaminophen|mesh-list
20062740|NCT03701074|Ibuprofen|ibuprofen|mesh-list
20062741|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062742|NCT03701074|Analgesics|analgesics|mesh-ancestor
20062743|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
20062744|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062745|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062746|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
20062747|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20062748|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062749|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062750|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20062751|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062752|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062753|NCT03704376|Clonidine|clonidine|mesh-list
20062754|NCT03704376|Ropivacaine|ropivacaine|mesh-list
20062755|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062756|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
20062757|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062758|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062759|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
20062760|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062761|NCT03704376|Analgesics|analgesics|mesh-ancestor
20062762|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20062763|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
20062764|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
20062765|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20062766|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20062767|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20062768|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062769|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062770|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062771|NCT03704467|Carboplatin|carboplatin|mesh-list
20062772|NCT03704467|Avelumab|avelumab|mesh-list
20062773|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062774|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20062775|NCT03705273|Dexamethasone|dexamethasone|mesh-list
20062776|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
20062777|NCT03705273|BB 1101|bb 1101|mesh-list
20062778|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062779|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
20062780|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
20062781|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062782|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062783|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20062784|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
20062785|NCT03705273|Hormones|hormones|mesh-ancestor
20062786|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20062787|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20062788|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062789|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
20062790|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062791|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062792|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
20062793|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062794|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
20062795|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20062796|NCT03706313|Bupivacaine|bupivacaine|mesh-list
20062797|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062798|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
20062799|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062800|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062801|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
20062802|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062803|NCT03708211|Esomeprazole|esomeprazole|mesh-list
20062804|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20062805|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20062806|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20062807|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062808|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062809|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
20062810|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
20062811|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20062812|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20062813|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
20062814|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062815|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062816|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062817|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062818|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20062819|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062820|NCT03710161|Vitamin D|vitamin d|mesh-list
20062821|NCT03710161|Vitamins|vitamins|mesh-ancestor
20062822|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
20062823|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062824|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20062825|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
20062826|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062827|NCT03710590|Nicotine|nicotine|mesh-list
20062828|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20062829|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
20062830|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062831|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062832|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20062833|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20062834|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062835|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062836|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062837|NCT03710889|Abaloparatide|abaloparatide|mesh-list
20062838|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20062839|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062840|NCT03711578|Tenalisib|tenalisib|mesh-list
20062841|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
20062842|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062843|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062844|NCT03712280|Rifaximin|rifaximin|mesh-list
20062845|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
20062846|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062847|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062848|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20062849|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20062850|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
20062851|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062852|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062853|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20062854|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20062855|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20062856|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062857|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062858|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20062859|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062860|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062861|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062862|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062863|NCT03712917|Topiramate|topiramate|mesh-list
20062864|NCT03712917|Flunarizine|flunarizine|mesh-list
20062865|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
20062866|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20062867|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062868|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20062869|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20062870|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062871|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20062872|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20062873|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
20062874|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
20062875|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062876|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
20062877|NCT03714022|Abatacept|abatacept|mesh-list
20062878|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20062879|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062880|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062881|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20062882|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
20062883|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062884|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062885|NCT03714672|Diclofenac|diclofenac|mesh-list
20062886|NCT03714672|Tramadol|tramadol|mesh-list
20062887|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20062888|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062889|NCT03714672|Analgesics|analgesics|mesh-ancestor
20062890|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
20062891|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062892|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062893|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20062894|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20062895|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20062896|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062897|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062898|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20062899|NCT03714672|Narcotics|narcotics|mesh-ancestor
20062900|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062901|NCT03714919|Acetaminophen|acetaminophen|mesh-list
20062902|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
20062903|NCT03714919|Ketamine|ketamine|mesh-list
20062904|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
20062905|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20062906|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062907|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062908|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20062909|NCT03714919|Analgesics|analgesics|mesh-ancestor
20062910|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
20062911|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062912|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20062913|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20062914|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20062915|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
20062916|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062917|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062918|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20062919|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20062920|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
20062921|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
20062922|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20062923|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20062924|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
20062925|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
20062926|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
20062927|NCT03716024|Linezolid|linezolid|mesh-list
20062928|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062929|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062930|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20062931|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062932|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062933|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
20062934|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
20062935|NCT03716076|Carbetocin|carbetocin|mesh-list
20062936|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
20062937|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20062938|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062939|NCT03717012|Nintedanib|nintedanib|mesh-list
20062940|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062941|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20062942|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062943|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062944|NCT03717051|Nicotine|nicotine|mesh-list
20062945|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20062946|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
20062947|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062948|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062949|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20062950|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20062951|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
20062952|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20062953|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062954|NCT03717064|Pitavastatin|pitavastatin|mesh-list
20062955|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20062956|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20062957|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20062958|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
20062959|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062960|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062961|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20062962|NCT03717155|Gemcitabine|gemcitabine|mesh-list
20062963|NCT03717155|Carboplatin|carboplatin|mesh-list
20062964|NCT03717155|Cetuximab|cetuximab|mesh-list
20062965|NCT03717155|Avelumab|avelumab|mesh-list
20062966|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20062967|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577082|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
20062968|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
20062969|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062970|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
20062971|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062972|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062973|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20062974|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
20062975|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062976|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20062977|NCT03717506|Clindamycin|clindamycin|mesh-list
20062978|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
20062979|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
20062980|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20062981|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062982|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20062983|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20062984|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062985|NCT03719586|Remdesivir|remdesivir|mesh-list
20062986|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
20062987|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20062988|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
20062989|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20062990|NCT03720119|Lidocaine|lidocaine|mesh-list
20062991|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
20062992|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
20062993|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20062994|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20062995|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
20062996|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20062997|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20062998|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20062999|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20063000|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063001|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063002|NCT03720470|Abrocitinib|abrocitinib|mesh-list
20063003|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20063004|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063005|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063006|NCT03720847|Estradiol|estradiol|mesh-list
20063007|NCT03720847|Progesterone|progesterone|mesh-list
20063008|NCT03720847|Estrogens|estrogens|mesh-ancestor
20063009|NCT03720847|Hormones|hormones|mesh-ancestor
20063010|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063011|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063012|NCT03720847|Progestins|progestins|mesh-ancestor
20063013|NCT03721172|Apremilast|apremilast|mesh-list
20063014|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063015|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063016|NCT03721172|Analgesics|analgesics|mesh-ancestor
20063017|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
20063018|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063019|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063020|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063021|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063022|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20063023|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20063024|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063025|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119209|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119210|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119211|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119212|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119213|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119214|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119215|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119216|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
20119217|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
20119218|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119219|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119220|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119221|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
20119222|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119223|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
20119224|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063026|NCT03722238|Ibuprofen|ibuprofen|mesh-list
20063027|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063028|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063029|NCT03722238|Analgesics|analgesics|mesh-ancestor
20063030|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
20063031|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063032|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063033|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063034|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063035|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20063036|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063037|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063038|NCT03722524|Amlodipine|amlodipine|mesh-list
20063039|NCT03722524|Perindopril|perindopril|mesh-list
20063040|NCT03722524|Indapamide|indapamide|mesh-list
20063041|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
20063042|NCT03722524|Diuretics|diuretics|mesh-list
20063043|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20063044|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20063045|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20063046|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063047|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063048|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20063049|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063050|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
20063051|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
20063052|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
20063053|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063054|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20063055|NCT03722576|Calcium|calcium|mesh-list
20063056|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20063057|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063058|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
20063059|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20063060|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063061|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20063062|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
20063063|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063064|NCT03746002|Metolazone|metolazone|mesh-list
20063065|NCT03746002|Furosemide|furosemide|mesh-list
20063066|NCT03746002|Diuretics|diuretics|mesh-ancestor
20063067|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
20063068|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063069|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20063070|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063071|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063072|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20063073|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20063074|NCT03789292|Adalimumab|adalimumab|mesh-list
20063075|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063076|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063077|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
20063078|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
20063079|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
20063080|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063081|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063082|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
20063083|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063084|NCT03828422|Calcium|calcium|mesh-list
20063085|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20063086|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063087|NCT03829618|Lidocaine|lidocaine|mesh-list
20063088|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
20063089|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
20063090|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063091|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063092|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
20063093|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063094|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20063095|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20063096|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20063097|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063098|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063099|NCT03830333|Metronidazole|metronidazole|mesh-list
20063100|NCT03830333|Meropenem|meropenem|mesh-list
20063101|NCT03830333|Tazobactam|tazobactam|mesh-list
20063102|NCT03830333|Ceftolozane|ceftolozane|mesh-list
20063103|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20063104|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063105|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20063106|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20063107|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063108|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20063109|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063110|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063111|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20063112|NCT03830333|Renal Agents|renal agents|mesh-ancestor
20063113|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
20063114|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
20063115|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063116|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
20063117|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20063118|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063119|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
20063120|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063121|NCT03862755|Heparin|heparin|mesh-list
20063122|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20063123|NCT03862755|Tinzaparin|tinzaparin|mesh-list
20063124|NCT03862755|Dalteparin|dalteparin|mesh-list
20063125|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
20063126|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20063127|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20063128|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063129|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
20063130|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20063131|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063132|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20063133|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063134|NCT03885596|Acetaminophen|acetaminophen|mesh-list
20063135|NCT03885596|Celecoxib|celecoxib|mesh-list
20063136|NCT03885596|Ketorolac|ketorolac|mesh-list
20063137|NCT03885596|Lidocaine|lidocaine|mesh-list
20063138|NCT03885596|Fentanyl|fentanyl|mesh-list
20063139|NCT03885596|Bupivacaine|bupivacaine|mesh-list
20063140|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
20063141|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
20063142|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063143|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063144|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
20063145|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063146|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20063147|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20063148|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20063149|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063150|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063151|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20063152|NCT03885596|Narcotics|narcotics|mesh-ancestor
20063153|NCT03885596|Analgesics|analgesics|mesh-ancestor
20063154|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20063155|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20063156|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
20063157|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063158|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
20063159|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063160|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063161|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063162|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20063163|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20063164|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063165|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20063166|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20063167|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20063168|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
20063169|NCT03889158|Vaccines|vaccines|mesh-list
20063170|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
20063171|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063172|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
20063173|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063174|NCT03889158|Protective Agents|protective agents|mesh-ancestor
20063175|NCT03889158|Vitamins|vitamins|mesh-ancestor
20063176|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
20063177|NCT03897348|Lacosamide|lacosamide|mesh-list
20063178|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
20063179|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20063180|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20063181|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063182|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063183|NCT03907033|Bupivacaine|bupivacaine|mesh-list
20063184|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
20063185|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
20063186|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063187|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063188|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
20063189|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063190|NCT03920215|Varenicline|varenicline|mesh-list
20063191|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20063192|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20063193|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063194|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063195|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063196|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063197|NCT03921151|Mirtazapine|mirtazapine|mesh-list
20063198|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
20063199|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063200|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20063201|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
20063202|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
20063203|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063204|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063205|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063206|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20063207|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063208|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063209|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20063210|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20063211|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20063212|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
20063213|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20063214|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20063215|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
20063216|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20063217|NCT03927911|Bupivacaine|bupivacaine|mesh-list
20063218|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
20063219|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
20063220|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063221|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063222|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
20063223|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063224|NCT03938857|Fentanyl|fentanyl|mesh-list
20063225|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
20063226|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20063227|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063228|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063229|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063230|NCT03938857|Analgesics|analgesics|mesh-ancestor
20063231|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
20063232|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063233|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20063234|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20063235|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20063236|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
20063237|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063238|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063239|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20063240|NCT03938857|Narcotics|narcotics|mesh-ancestor
20063241|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20063242|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20063243|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
20063244|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
20063245|NCT03945981|Lamivudine|lamivudine|mesh-list
20063246|NCT03945981|Dolutegravir|dolutegravir|mesh-list
20063247|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20063248|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20063249|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063250|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063251|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
20063252|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063253|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20063254|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20063255|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20063256|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20063257|NCT03954834|Tirzepatide|tirzepatide|mesh-list
20063258|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20063259|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063260|NCT03954834|Incretins|incretins|mesh-ancestor
20063261|NCT03954834|Hormones|hormones|mesh-ancestor
20063262|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063263|NCT03958071|Pirfenidone|pirfenidone|mesh-list
20063264|NCT03958071|Nintedanib|nintedanib|mesh-list
20063265|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063266|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20063267|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063268|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063269|NCT03958071|Analgesics|analgesics|mesh-ancestor
20063270|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
20063271|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063272|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063273|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063274|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063275|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063276|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063277|NCT03968159|Pimavanserin|pimavanserin|mesh-list
20063278|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20063279|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20063280|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20063281|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063282|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063283|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063284|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063285|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20063286|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20063287|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
20063288|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063289|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063290|NCT03970824|Adalimumab|adalimumab|mesh-list
20063291|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063292|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063293|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
20063294|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20063295|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20063296|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
20063297|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063298|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063299|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063300|NCT03979807|Bromides|bromides|mesh-list
20063301|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
20063302|NCT03979807|Olodaterol|olodaterol|mesh-list
20063303|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20063304|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
20063305|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063306|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063307|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20063308|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063309|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
20063310|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20063311|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063312|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063313|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063314|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
20063315|NCT03982069|Vaccines|vaccines|mesh-list
20063316|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
20063317|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063318|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
20063319|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
20063320|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063321|NCT04011592|Ketamine|ketamine|mesh-list
20063322|NCT04011592|Analgesics|analgesics|mesh-ancestor
20063323|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
20063324|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063325|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063326|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20063327|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20063328|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
20063329|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
20063330|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063331|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20063332|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20063333|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063334|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063335|NCT04032327|Bupivacaine|bupivacaine|mesh-list
20063336|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
20063337|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
20063338|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063339|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063340|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
20063341|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063342|NCT04036292|Varenicline|varenicline|mesh-list
20063343|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20063344|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20063345|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063346|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063347|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063348|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063349|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
20063350|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20063351|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063352|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20063353|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20063354|NCT04052204|Avelumab|avelumab|mesh-list
20063355|NCT04052204|Talazoparib|talazoparib|mesh-list
20063356|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20063357|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063358|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20063359|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063360|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119225|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
20119226|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119227|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119228|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119229|NCT00006120|Paclitaxel|paclitaxel|mesh-list
20119230|NCT00006120|Docetaxel|docetaxel|mesh-list
20119231|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119232|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119233|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119234|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119235|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119236|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119237|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
20119238|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119239|NCT00006122|Cytarabine|cytarabine|mesh-list
20119240|NCT00006122|Etoposide|etoposide|mesh-list
20119241|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
20119242|NCT00006122|Idarubicin|idarubicin|mesh-list
20119243|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
20119244|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119245|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119246|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119247|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119248|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119249|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119250|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119251|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
20119252|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
20119253|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119254|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119255|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
20119256|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119257|NCT00006122|Analgesics|analgesics|mesh-ancestor
20119258|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
20119259|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119260|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119261|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20119262|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
20119263|NCT00006123|Thiotepa|thiotepa|mesh-list
20063361|NCT04067011|Doxycycline|doxycycline|mesh-list
20063362|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
20063363|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20063364|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063365|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
20063366|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20063367|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063368|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20063369|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20063370|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063371|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063372|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063373|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20063374|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20063375|NCT04085341|Sunitinib|sunitinib|mesh-list
20063376|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063377|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20063378|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20063379|NCT04085341|Growth Substances|growth substances|mesh-ancestor
20063380|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063381|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
20063382|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20063383|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063384|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063385|NCT04094870|Sertraline|sertraline|mesh-list
20063386|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
20063387|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063388|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20063389|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20063390|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063391|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063392|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063393|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
20063394|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063395|NCT04103515|Cimetidine|cimetidine|mesh-list
20063396|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20063397|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063398|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20063399|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
20063400|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
20063401|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063402|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063403|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063404|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20063405|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20063406|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063407|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
20063408|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20063409|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
20063410|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063411|NCT04123405|Expectorants|expectorants|mesh-ancestor
20063412|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063413|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20063414|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
20063415|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063416|NCT04123405|Protective Agents|protective agents|mesh-ancestor
20063417|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063418|NCT04123405|Antidotes|antidotes|mesh-ancestor
20063419|NCT04138758|Bromides|bromides|mesh-list
20063420|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
20063421|NCT04138758|Olodaterol|olodaterol|mesh-list
20063422|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20063423|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
20063424|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063425|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063426|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20063427|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063428|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
20063429|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20063430|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063431|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063432|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063433|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
20063434|NCT04147715|Dolutegravir|dolutegravir|mesh-list
20063435|NCT04147715|Midazolam|midazolam|mesh-list
20063436|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20063437|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20063438|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063439|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063440|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20063441|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063442|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063443|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20063444|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
20063445|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
20063446|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
20063447|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
20063448|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063449|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063450|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20063451|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20063452|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063453|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20063454|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20063455|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
20063456|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063457|NCT04160091|FX006|fx006|mesh-list
20063458|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063459|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
20063460|NCT04160091|Hormones|hormones|mesh-ancestor
20063461|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063462|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063463|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063464|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
20063465|NCT04164758|Pimavanserin|pimavanserin|mesh-list
20063466|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20063467|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
20063468|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063469|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20063470|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063471|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063472|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063473|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20063474|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20063475|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20063476|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20063477|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
20063478|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063479|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063480|NCT04165031|Docetaxel|docetaxel|mesh-list
20063481|NCT04165031|Cetuximab|cetuximab|mesh-list
20063482|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20063483|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063484|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20063485|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20063486|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20063487|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063488|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20063489|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20063490|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063491|NCT04171414|Adalimumab|adalimumab|mesh-list
20063492|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063493|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063494|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
20063495|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20063496|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063497|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20063498|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20063499|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063500|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063501|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063502|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
20063503|NCT04184297|Olodaterol|olodaterol|mesh-list
20063504|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20063505|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
20063506|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063507|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063508|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20063509|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063510|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
20063511|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20063512|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063513|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063514|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063515|NCT04189848|Dulaglutide|dulaglutide|mesh-list
20063516|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20063517|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063518|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
20063519|NCT04211909|Velpatasvir|velpatasvir|mesh-list
20063520|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
20063521|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063522|NCT04218110|Ethanol|ethanol|mesh-list
20063523|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
20063524|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20063525|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20063526|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063527|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063528|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063529|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
20063530|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
20063531|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20063532|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20063533|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
20063534|NCT04223843|Olodaterol|olodaterol|mesh-list
20063535|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20063536|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
20063537|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063538|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063539|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20063540|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063541|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
20063542|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20063543|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063544|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063545|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063546|NCT04229303|Voriconazole|voriconazole|mesh-list
20063547|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
20063548|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063549|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20063550|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20063551|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063552|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063553|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20063554|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
20063555|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063556|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063557|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20063558|NCT04256603|Gabapentin|gabapentin|mesh-list
20063559|NCT04256603|Analgesics|analgesics|mesh-ancestor
20063560|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
20063561|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063562|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063563|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
20063564|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20063565|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063566|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063567|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063568|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20063569|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20063570|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063571|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063572|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
20063573|NCT04290494|Plasminogen|plasminogen|mesh-list
20063574|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20063575|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20063576|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063577|NCT04303156|Islatravir|islatravir|mesh-list
20063578|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
20063579|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063580|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063581|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063582|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20063583|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20063584|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20063585|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20063586|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20063587|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20063588|NCT04323852|Vitamin D|vitamin d|mesh-list
20063589|NCT04323852|Vitamins|vitamins|mesh-ancestor
20063590|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
20063591|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063592|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20063593|NCT04327843|Haloperidol|haloperidol|mesh-list
20063594|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
20063595|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
20063596|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
20063597|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063598|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063599|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063600|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20063601|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063602|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063603|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063604|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20063605|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
20063606|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063607|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063608|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20063609|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
20063610|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
20063611|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20063612|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063613|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063614|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063615|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063616|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063617|NCT04347954|Iodine|iodine|mesh-list
20063618|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
20063619|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
20063620|NCT04347954|Povidone|povidone|mesh-list
20063621|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20063622|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063623|NCT04347954|Trace Elements|trace elements|mesh-ancestor
20063624|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
20063625|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063626|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
20063627|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
20063628|NCT04358068|Azithromycin|azithromycin|mesh-list
20063629|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
20063630|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20063631|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063632|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
20063633|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20063634|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063635|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063636|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063637|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063638|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
20063639|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20063640|NCT04373421|Benzydamine|benzydamine|mesh-list
20063641|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20063642|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063643|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
20063644|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
20577083|NCT02075749|Triamcinolone|triamcinolone|mesh-list
20577084|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20063645|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063646|NCT04398732|Etanercept|etanercept|mesh-list
20063647|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063648|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063649|NCT04398732|Analgesics|analgesics|mesh-ancestor
20063650|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
20063651|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063652|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063653|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063654|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063655|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063656|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063657|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
20063658|NCT04401293|Heparin|heparin|mesh-list
20063659|NCT04401293|Enoxaparin|enoxaparin|mesh-list
20063660|NCT04401293|Calcium heparin|calcium heparin|mesh-list
20063661|NCT04401293|Dalteparin|dalteparin|mesh-list
20063662|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
20577085|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20293442|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293443|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063663|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
20063664|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20063665|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20063666|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063667|NCT04420572|Betamethasone|betamethasone|mesh-list
20063668|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063669|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
20063670|NCT04420572|Hormones|hormones|mesh-ancestor
20063671|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063672|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063673|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20063674|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063675|NCT04428411|Etanercept|etanercept|mesh-list
20063676|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063677|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063678|NCT04428411|Analgesics|analgesics|mesh-ancestor
20063679|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
20063680|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063681|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063682|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063683|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063684|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063685|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063686|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
20063687|NCT04495283|Acetaminophen|acetaminophen|mesh-list
20063688|NCT04495283|Pregabalin|pregabalin|mesh-list
20063689|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063690|NCT04495283|Analgesics|analgesics|mesh-ancestor
20063691|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
20063692|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063693|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063694|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
20063695|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
20063696|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20063697|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063698|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063699|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20063700|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20063701|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063702|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063703|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063704|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
20063705|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063706|NCT04501640|Mirabegron|mirabegron|mesh-list
20063707|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20063708|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20063709|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20063710|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
20063711|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063712|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063713|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063714|NCT04501640|Urological Agents|urological agents|mesh-ancestor
20063715|NCT04501952|Remdesivir|remdesivir|mesh-list
20063716|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
20063717|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063718|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
20063719|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063720|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
20063721|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20063722|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
20063723|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20063724|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
20063725|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063726|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063727|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
20063728|NCT04507763|Etanercept|etanercept|mesh-list
20063729|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063730|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063731|NCT04507763|Analgesics|analgesics|mesh-ancestor
20063732|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
20063733|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063734|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063735|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063736|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063737|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20577086|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20577087|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577088|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
20577089|NCT02075749|Hormones|hormones|mesh-ancestor
20577090|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577091|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063738|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063739|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
20063740|NCT04854707|Menotropins|menotropins|mesh-list
20063741|NCT04854707|Hormones|hormones|mesh-list
20063742|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20063743|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063744|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063745|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20063746|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
20063747|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20119264|NCT00006123|Carmustine|carmustine|mesh-list
20119265|NCT00006123|Carboplatin|carboplatin|mesh-list
20119266|NCT00006123|Trastuzumab|trastuzumab|mesh-list
20119267|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119268|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
20119269|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119270|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119271|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20119272|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
20119273|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119274|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119275|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20119276|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20119277|NCT00006124|Celecoxib|celecoxib|mesh-list
20119278|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20119279|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20119280|NCT00006124|Analgesics|analgesics|mesh-ancestor
20119281|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
20119282|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119283|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119284|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20119285|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119286|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20119287|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20119288|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119289|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119290|NCT00006125|Doxorubicin|doxorubicin|mesh-list
20119291|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20119292|NCT00006125|Topotecan|topotecan|mesh-list
20119293|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119294|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119295|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119296|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119297|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119298|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119299|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20119300|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
20119301|NCT00006126|Busulfan|busulfan|mesh-list
20119302|NCT00006126|Fludarabine|fludarabine|mesh-list
20119303|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
20119304|NCT00006126|Etoposide|etoposide|mesh-list
20119305|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119306|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
20119307|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119308|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119309|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20119310|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
20119311|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119312|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119313|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20119314|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119315|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
20119316|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119317|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119318|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119319|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063748|NCT04926233|Bromides|bromides|mesh-list
20063749|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
20063750|NCT04926233|Olodaterol|olodaterol|mesh-list
20063751|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20063752|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
20063753|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063754|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063755|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20063756|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063757|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
20063758|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20063759|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063760|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063761|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063762|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
20063763|NCT04943159|Afamelanotide|afamelanotide|mesh-list
20063764|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20063765|NCT04525157|Afamelanotide|afamelanotide|mesh-list
20063766|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
20063767|NCT04523831|Doxycycline|doxycycline|mesh-list
20063768|NCT04523831|Ivermectin|ivermectin|mesh-list
20063769|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20063770|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063771|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
20063772|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20063773|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063774|NCT04511520|Trimetazidine|trimetazidine|mesh-list
20063775|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
20063776|NCT04507776|Etanercept|etanercept|mesh-list
20063777|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063778|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063779|NCT04507776|Analgesics|analgesics|mesh-ancestor
20063780|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
20063781|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063782|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063783|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063784|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063785|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063786|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063787|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
20063788|NCT04495374|Pregabalin|pregabalin|mesh-list
20063789|NCT04495374|Analgesics|analgesics|mesh-ancestor
20063790|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
20063791|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063792|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063793|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
20063794|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20063795|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063796|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063797|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20063798|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20063799|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20063800|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063801|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20063802|NCT04495712|Spironolactone|spironolactone|mesh-list
20063803|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20063804|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
20063805|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063806|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063807|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20063808|NCT04495712|Diuretics|diuretics|mesh-ancestor
20063809|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
20063810|NCT04490499|Vaccines|vaccines|mesh-list
20063811|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
20063812|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063813|NCT04490239|Heparin|heparin|mesh-list
20063814|NCT04490239|Calcium heparin|calcium heparin|mesh-list
20063815|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
20063816|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20063817|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20063818|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063819|NCT04467424|Lidocaine|lidocaine|mesh-list
20063820|NCT04467424|Ketamine|ketamine|mesh-list
20063821|NCT04467424|Propofol|propofol|mesh-list
20063822|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
20063823|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
20063824|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20119320|NCT00006127|Amifostine|amifostine|mesh-list
20063825|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063826|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
20063827|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063828|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20063829|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20063830|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20063831|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20063832|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063833|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20063834|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20063835|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
20063836|NCT04467424|Analgesics|analgesics|mesh-ancestor
20063837|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20063838|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20063839|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20063840|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063841|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
20063842|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063843|NCT04448561|Morphine|morphine|mesh-list
20063844|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20063845|NCT04448561|Narcotics|narcotics|mesh-ancestor
20063846|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063847|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063848|NCT04448561|Analgesics|analgesics|mesh-ancestor
20063849|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
20063850|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063851|NCT04459585|Dabigatran|dabigatran|mesh-list
20063852|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
20063853|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20063854|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
20063855|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063856|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063857|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
20063858|NCT04456634|Lumefantrine|lumefantrine|mesh-list
20063859|NCT04456634|Artemether|artemether|mesh-list
20063860|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20063861|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
20063862|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20063863|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063864|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063865|NCT04439214|Nivolumab|nivolumab|mesh-list
20063866|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20063867|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063868|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20063869|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063870|NCT04428502|Etanercept|etanercept|mesh-list
20063871|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063872|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063873|NCT04428502|Analgesics|analgesics|mesh-ancestor
20063874|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
20063875|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063876|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063877|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063878|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063879|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063880|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063881|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
20063882|NCT04428424|Etanercept|etanercept|mesh-list
20063883|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063884|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063885|NCT04428424|Analgesics|analgesics|mesh-ancestor
20063886|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
20063887|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063888|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063889|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063890|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063891|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063892|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063893|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
20063894|NCT04428359|Vitamin D|vitamin d|mesh-list
20063895|NCT04428359|Vitamins|vitamins|mesh-ancestor
20063896|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
20577092|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20063897|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063898|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20063899|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
20063900|NCT04410159|Listerine|listerine|mesh-list
20063901|NCT04410159|Povidone|povidone|mesh-list
20063902|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
20063903|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
20063904|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20063905|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063906|NCT04425850|Ivermectin|ivermectin|mesh-list
20063907|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063908|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063909|NCT04425863|Aspirin|aspirin|mesh-list
20063910|NCT04425863|Ivermectin|ivermectin|mesh-list
20063911|NCT04425863|Dexamethasone|dexamethasone|mesh-list
20063912|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
20063913|NCT04425863|Enoxaparin|enoxaparin|mesh-list
20063914|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20063915|NCT04425863|BB 1101|bb 1101|mesh-list
20063916|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063917|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
20063918|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
20063919|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063920|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063921|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063922|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
20063923|NCT04425863|Hormones|hormones|mesh-ancestor
20063924|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20063925|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20063926|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20063927|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
20063928|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20063929|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063930|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063931|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063932|NCT04425863|Analgesics|analgesics|mesh-ancestor
20063933|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
20063934|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063935|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20063936|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20063937|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20063938|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20063939|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
20063940|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
20063941|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063942|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063943|NCT04425746|Afamelanotide|afamelanotide|mesh-list
20063944|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
20063945|NCT04422561|Ivermectin|ivermectin|mesh-list
20063946|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063947|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063948|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
20063949|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20063950|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20063951|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
20063952|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063953|NCT04407507|Ivermectin|ivermectin|mesh-list
20063954|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20063955|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063956|NCT04406194|Favipiravir|favipiravir|mesh-list
20063957|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
20063958|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063959|NCT04403399|Varenicline|varenicline|mesh-list
20063960|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20063961|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20063962|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
20063963|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20063964|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20063965|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063966|NCT04400682|Favipiravir|favipiravir|mesh-list
20063967|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
20063968|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063969|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
20063970|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20063971|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20063972|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
20063973|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
20063974|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063975|NCT04399122|Acetaminophen|acetaminophen|mesh-list
20063976|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20063977|NCT04399122|Oxycodone|oxycodone|mesh-list
20063978|NCT04399122|Codeine|codeine|mesh-list
20063979|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20063980|NCT04399122|Analgesics|analgesics|mesh-ancestor
20063981|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
20063982|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20063983|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20063984|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
20063985|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20063986|NCT04399122|Narcotics|narcotics|mesh-ancestor
20063987|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20063988|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
20063989|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
20063990|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20063991|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20063992|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20063993|NCT04397445|Ranitidine|ranitidine|mesh-list
20063994|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20063995|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20063996|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20063997|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20063998|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
20063999|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
20064000|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064001|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064002|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064003|NCT04396639|Factor VIII|factor viii|mesh-list
20064004|NCT04396639|Coagulants|coagulants|mesh-ancestor
20064005|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
20064006|NCT04393493|Furosemide|furosemide|mesh-list
20064007|NCT04393493|Spironolactone|spironolactone|mesh-list
20064008|NCT04393493|Diuretics|diuretics|mesh-ancestor
20064009|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
20064010|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064011|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20064012|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064013|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064014|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20064015|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
20064016|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064017|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20293444|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20293445|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
20293446|NCT04346654|Hormones|hormones|mesh-ancestor
20293447|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293448|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293449|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293450|NCT04346628|Favipiravir|favipiravir|mesh-list
20293451|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
20293452|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293453|NCT04340843|Decitabine|decitabine|mesh-list
20293454|NCT04340843|Azacitidine|azacitidine|mesh-list
20293455|NCT04340843|Belinostat|belinostat|mesh-list
20293456|NCT04340843|Guadecitabine|guadecitabine|mesh-list
20293457|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577093|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
20577094|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064018|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20064019|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20064020|NCT04392362|Adenosine|adenosine|mesh-list
20064021|NCT04392362|Analgesics|analgesics|mesh-ancestor
20064022|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
20064023|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064024|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064025|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20064026|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
20064027|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20064028|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
20064029|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
20064030|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064031|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064032|NCT04392141|Colchicine|colchicine|mesh-list
20064033|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
20293458|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
20577095|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064034|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20293459|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064035|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
20064036|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
20064037|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
20064038|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064039|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064040|NCT04391842|Diclofenac|diclofenac|mesh-list
20064041|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20064042|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20064043|NCT04391842|Analgesics|analgesics|mesh-ancestor
20064044|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
20064045|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064046|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064047|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064048|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064049|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20064050|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064051|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064052|NCT04390022|Ivermectin|ivermectin|mesh-list
20064053|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064054|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064055|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
20064056|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064057|NCT04374500|Verapamil|verapamil|mesh-list
20064058|NCT04374500|Nitroprusside|nitroprusside|mesh-list
20064059|NCT04374500|Acetylcholine|acetylcholine|mesh-list
20064060|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
20064061|NCT04374500|Bradykinin|bradykinin|mesh-list
20064062|NCT04374500|Substance P|substance p|mesh-list
20064063|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20064064|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20064065|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064066|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064067|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20064068|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064069|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20064070|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20064071|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20064072|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
20064073|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119321|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20119322|NCT00006127|Protective Agents|protective agents|mesh-ancestor
20119323|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119324|NCT00006129|Testosterone|testosterone|mesh-list
20119325|NCT00006129|Androgens|androgens|mesh-ancestor
20119326|NCT00006129|Hormones|hormones|mesh-ancestor
20119327|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119328|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119329|NCT00006131|Valacyclovir|valacyclovir|mesh-list
20119330|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
20119331|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119332|NCT00006132|Acyclovir|acyclovir|mesh-list
20119333|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
20119334|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119335|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20119336|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20119337|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20119338|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20119339|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
20119340|NCT00006133|Norethindrone|norethindrone|mesh-list
20119341|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
20119342|NCT00006133|Estradiol|estradiol|mesh-list
20119343|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20119344|NCT00006133|Estrogens|estrogens|mesh-ancestor
20119345|NCT00006133|Hormones|hormones|mesh-ancestor
20119346|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119347|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119348|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20119349|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
20119350|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20119351|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20119352|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20119353|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20119354|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20119355|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20119356|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20119357|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064074|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
20064075|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
20064076|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
20064077|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064078|NCT04370548|Clindamycin|clindamycin|mesh-list
20064079|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
20064080|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
20064081|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064082|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064083|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20064084|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064085|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064086|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20064087|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
20064088|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064089|NCT04358991|Ceftazidime|ceftazidime|mesh-list
20064090|NCT04358991|Avibactam|avibactam|mesh-list
20064091|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
20064092|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064093|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064094|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20064095|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064096|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064097|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064098|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
20064099|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064100|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064101|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064102|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064103|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064104|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491592|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064105|NCT04352660|Mitomycins|mitomycins|mesh-list
20064106|NCT04352660|Mitomycin|mitomycin|mesh-list
20064107|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20064108|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064109|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
20064110|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064111|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20064112|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064113|NCT04349917|Methylphenidate|methylphenidate|mesh-list
20064114|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20064115|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064116|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20064117|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20064118|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064119|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064120|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
20064121|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064122|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
20064123|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064124|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064125|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
20064126|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064127|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064128|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064129|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064130|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064131|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064132|NCT04343222|Bromfenac|bromfenac|mesh-list
20064133|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
20064134|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20064135|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20064136|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20064137|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20064138|NCT04343222|Analgesics|analgesics|mesh-ancestor
20064139|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
20064140|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064141|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064142|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064143|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064144|NCT04343092|Ivermectin|ivermectin|mesh-list
20064145|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064146|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064147|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
20064148|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20064149|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20064150|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064151|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064152|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20064153|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20064154|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20064155|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064156|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064157|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064158|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
20064159|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20064160|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
20064161|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20064162|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20064163|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064164|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20064165|NCT04342130|Morphine|morphine|mesh-list
20064166|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20064167|NCT04342130|Narcotics|narcotics|mesh-ancestor
20064168|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064169|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064170|NCT04342130|Analgesics|analgesics|mesh-ancestor
20064171|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
20064172|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064173|NCT04340557|Losartan|losartan|mesh-list
20064174|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20064175|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20064176|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20064177|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20064178|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064179|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20064180|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
20064181|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064182|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064183|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
20064184|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20064185|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20064186|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064187|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
20064188|NCT04338074|Coagulants|coagulants|mesh-ancestor
20064189|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
20064190|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20064191|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064192|NCT04335552|Azithromycin|azithromycin|mesh-list
20064193|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064194|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064195|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064196|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
20064197|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064198|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064199|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064200|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064201|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064202|NCT04334876|Antibodies|antibodies|mesh-list
20064203|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
20064204|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
20064205|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064206|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064207|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
20064208|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064209|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064210|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064211|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064212|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064213|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064214|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
19746196|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746197|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746198|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20064215|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
20064216|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064217|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064218|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746199|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
19746200|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746201|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746202|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19746203|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19746204|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746205|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
19746206|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064219|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064220|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064221|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064222|NCT04322968|Ketorolac|ketorolac|mesh-list
19746207|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746208|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19746209|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19746210|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19746211|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
19746212|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746213|NCT04180371|Nivolumab|nivolumab|mesh-list
19746214|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746215|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746216|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19746217|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746218|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
20064223|NCT04322968|Ketamine|ketamine|mesh-list
20064224|NCT04322968|Analgesics|analgesics|mesh-ancestor
20064225|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
20064226|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064227|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064228|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20064229|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20064230|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
20064231|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
20064232|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064233|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20064234|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20064235|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064236|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064237|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20064238|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20064239|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064240|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064241|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20064242|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064243|NCT04332107|Azithromycin|azithromycin|mesh-list
20064244|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064245|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064246|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
20064247|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20064248|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20064249|NCT04323592|Prednisolone|prednisolone|mesh-list
20064250|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
20064251|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20064252|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
20064253|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064254|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
20064255|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
20064256|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064257|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064258|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19746219|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20064259|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
20064260|NCT04323592|Hormones|hormones|mesh-ancestor
20064261|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064262|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20064263|NCT04323592|Protective Agents|protective agents|mesh-ancestor
20064264|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20064265|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064266|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064267|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
20064268|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064269|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064270|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064271|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064272|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064273|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064274|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064275|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
20064276|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064277|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064278|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064279|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064280|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064281|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064282|NCT04322526|Naltrexone|naltrexone|mesh-list
20064283|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20064284|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20064285|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064286|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
20064287|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064288|NCT04322682|Colchicine|colchicine|mesh-list
20064289|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
20064290|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064291|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
20064292|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
20064293|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
20064294|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064295|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064296|NCT04322396|Azithromycin|azithromycin|mesh-list
20064297|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064298|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064299|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064300|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
20064301|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064302|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064303|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064304|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064305|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064306|NCT04318535|Griseofulvin|griseofulvin|mesh-list
20064307|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
20064308|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064309|NCT04314037|Praziquantel|praziquantel|mesh-list
20064310|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
20064311|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064312|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064313|NCT04310085|Lumefantrine|lumefantrine|mesh-list
20064314|NCT04310085|Artemether|artemether|mesh-list
20064315|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20064316|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
20064317|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064318|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064319|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064320|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
20064321|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
20064322|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20064323|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20064324|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064325|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064326|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064327|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064328|NCT04307940|Acetaminophen|acetaminophen|mesh-list
20064329|NCT04307940|Naproxen|naproxen|mesh-list
20064330|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20064331|NCT04307940|Hydrocodone|hydrocodone|mesh-list
20064332|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20064333|NCT04307940|Analgesics|analgesics|mesh-ancestor
20064334|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
20064335|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064336|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064337|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
20064338|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20064339|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064340|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064341|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
20064342|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20064343|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064344|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064345|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20064346|NCT04307940|Narcotics|narcotics|mesh-ancestor
20064347|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064348|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
19746220|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746221|NCT04125550|Propofol|propofol|mesh-list
19746222|NCT04125550|Sevoflurane|sevoflurane|mesh-list
19746223|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19746224|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746225|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746226|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19746227|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
19746228|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
19746229|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19746230|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19746231|NCT04123561|Dexamethasone|dexamethasone|mesh-list
19746232|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
19746233|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19746234|NCT04123561|BB 1101|bb 1101|mesh-list
19746235|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064349|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
20064350|NCT04297631|Tobramycin|tobramycin|mesh-list
20064351|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064352|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064353|NCT04297241|Isosorbide|isosorbide|mesh-list
20064354|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20064355|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20064356|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20064357|NCT04297241|Diuretics|diuretics|mesh-ancestor
20064358|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
20064359|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064360|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
20064361|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20064362|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064363|NCT04292535|Insulin|insulin|mesh-list
20064364|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20064365|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
19491593|NCT03129594|Incretins|incretins|mesh-ancestor
20577096|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
20064366|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
20064367|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20064368|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20064369|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064370|NCT04292171|Gabapentin|gabapentin|mesh-list
20064371|NCT04292171|Analgesics|analgesics|mesh-ancestor
20064372|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
19491594|NCT03129867|Ticagrelor|ticagrelor|mesh-list
19491595|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19491596|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19491597|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19491598|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19491599|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
19491600|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491601|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491602|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491603|NCT03129698|Apatinib|apatinib|mesh-list
19491604|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491605|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491606|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491607|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491608|NCT03129347|Nalmefene|nalmefene|mesh-list
19491609|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19491610|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491611|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
19491612|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491613|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
19491614|NCT03129490|Apixaban|apixaban|mesh-list
19491615|NCT03129490|Edoxaban|edoxaban|mesh-list
19491616|NCT03129490|Dabigatran|dabigatran|mesh-list
20064373|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064374|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064375|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
20577097|NCT02075970|Hematinics|hematinics|mesh-ancestor
19746236|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
19746237|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
20064376|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20577098|NCT02076191|Decitabine|decitabine|mesh-list
20064377|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20064378|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064379|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20064380|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20064381|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20064382|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064383|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064384|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
19746238|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746239|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746240|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20064385|NCT04292899|Remdesivir|remdesivir|mesh-list
20064386|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
20064387|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064388|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
20064389|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064390|NCT04292730|Remdesivir|remdesivir|mesh-list
20064391|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
20064392|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064393|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
20064394|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064395|NCT04290676|Dexamethasone|dexamethasone|mesh-list
20064396|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
20064397|NCT04290676|BB 1101|bb 1101|mesh-list
20064398|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064399|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
20064400|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
20064401|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064402|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064403|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20064404|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
20064405|NCT04290676|Hormones|hormones|mesh-ancestor
20064406|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064407|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20064408|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064409|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
20064410|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064411|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064412|NCT04290039|Atropine|atropine|mesh-list
20064413|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20064414|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20064415|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20064416|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20064417|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20064418|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
20064419|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064420|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064421|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20064422|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
20064423|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
20064424|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
20064425|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20064426|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20064427|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
20064428|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064429|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064430|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
20064431|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20064432|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064433|NCT04284930|Bupivacaine|bupivacaine|mesh-list
20064434|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
20064435|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
20064436|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064437|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064438|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
20064439|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746241|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
20064440|NCT04283773|Antibodies|antibodies|mesh-list
20064441|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
20064442|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20064443|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
20064444|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064445|NCT04277936|Levetiracetam|levetiracetam|mesh-list
20064446|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
20064447|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
20064448|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20064449|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
20064450|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
20064451|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064452|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064453|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
20064454|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064455|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20119358|NCT00006135|Acyclovir|acyclovir|mesh-list
20119359|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
20119360|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119361|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
20119362|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
20119363|NCT00006136|Hematinics|hematinics|mesh-ancestor
20119364|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119365|NCT00006137|Enalapril|enalapril|mesh-list
20119366|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20119367|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
20119368|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119369|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119370|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20119371|NCT00006144|Ritonavir|ritonavir|mesh-list
20119372|NCT00006144|Lopinavir|lopinavir|mesh-list
20119373|NCT00006144|Emtricitabine|emtricitabine|mesh-list
20119374|NCT00006144|Stavudine|stavudine|mesh-list
20119375|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20119376|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20119377|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
20119378|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119379|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119380|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119381|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119382|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
20119383|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119384|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20119385|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20119386|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20119387|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119388|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
20119389|NCT00006145|Valganciclovir|valganciclovir|mesh-list
20119390|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
20119391|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119392|NCT00006152|Ritonavir|ritonavir|mesh-list
20119393|NCT00006152|Amprenavir|amprenavir|mesh-list
20119394|NCT00006152|Abacavir|abacavir|mesh-list
20119395|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20119396|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20119397|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
20119398|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119399|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119400|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119401|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119402|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
20119403|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119404|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20119405|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20119406|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20119407|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119408|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20119409|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
20119410|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20119411|NCT00006154|Ritonavir|ritonavir|mesh-list
20119412|NCT00006154|Indinavir|indinavir|mesh-list
20119413|NCT00006154|Aldesleukin|aldesleukin|mesh-list
20119414|NCT00006154|Abacavir|abacavir|mesh-list
20119415|NCT00006154|Stavudine|stavudine|mesh-list
20119416|NCT00006154|Didanosine|didanosine|mesh-list
20119417|NCT00006154|Efavirenz|efavirenz|mesh-list
20119418|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20119419|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20119420|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
20064456|NCT04272775|Dexamethasone|dexamethasone|mesh-list
20064457|NCT04272775|Lenalidomide|lenalidomide|mesh-list
20064458|NCT04272775|Ixazomib|ixazomib|mesh-list
20064459|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064460|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
20064461|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
20064462|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064463|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064464|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20064465|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
20064466|NCT04272775|Hormones|hormones|mesh-ancestor
20064467|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064468|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20064469|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064470|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
20064471|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20064472|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20064473|NCT04272775|Growth Substances|growth substances|mesh-ancestor
20064474|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
20064475|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
20064476|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064477|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064478|NCT04267770|Insulin|insulin|mesh-list
20064479|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20064480|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20064481|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064482|NCT04249336|Listerine|listerine|mesh-list
20064483|NCT04249336|Calcium|calcium|mesh-list
20064484|NCT04249336|Fluorides|fluorides|mesh-list
20064485|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
20064486|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20064487|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064488|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
20064489|NCT04249336|Protective Agents|protective agents|mesh-ancestor
20064490|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20064491|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064492|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
20064493|NCT04249310|Olodaterol|olodaterol|mesh-list
20064494|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20064495|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
20064496|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064497|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064498|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20064499|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
20064500|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
20064501|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20064502|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
20064503|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064504|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064505|NCT04238650|Bevacizumab|bevacizumab|mesh-list
20064506|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20064507|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064508|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20064509|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20064510|NCT04238650|Growth Substances|growth substances|mesh-ancestor
20064511|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064512|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746242|NCT04123561|Hormones|hormones|mesh-ancestor
19746243|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064513|NCT04238663|Bevacizumab|bevacizumab|mesh-list
20064514|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20064515|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064516|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20064517|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20064518|NCT04238663|Growth Substances|growth substances|mesh-ancestor
20064519|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064520|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
20064521|NCT04203225|Lidocaine|lidocaine|mesh-list
20064522|NCT04203225|Epinephrine|epinephrine|mesh-list
20064523|NCT04203225|Tetracaine|tetracaine|mesh-list
20064524|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
20064525|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
20064526|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064527|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064528|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
20064529|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064530|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20064531|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20064532|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20064533|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064534|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064535|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20064536|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20064537|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
20064538|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064539|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20064540|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20064541|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
20064542|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20064543|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
20064544|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
20064545|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
20064546|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20064547|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
20064548|NCT04222699|Mupirocin|mupirocin|mesh-list
20064549|NCT04222699|Calcium|calcium|mesh-list
20064550|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20064551|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064552|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20064553|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064554|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
20064555|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064556|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20064557|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064558|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064559|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
20064560|NCT04218799|Mupirocin|mupirocin|mesh-list
19746244|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20064561|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20064562|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064563|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
20064564|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064565|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20064566|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064567|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064568|NCT04204057|Tenalisib|tenalisib|mesh-list
20064569|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
20064570|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064571|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064572|NCT04207840|Epinephrine|epinephrine|mesh-list
20064573|NCT04207840|Racepinephrine|racepinephrine|mesh-list
20064574|NCT04207840|Albuterol|albuterol|mesh-list
20064575|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
20064576|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20064577|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20064578|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
20064579|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064580|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064581|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064582|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20064583|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20064584|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
20064585|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064586|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20064587|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
20064588|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
20064589|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
20064590|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20064591|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
20064592|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20064593|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20064594|NCT04198948|Gliclazide|gliclazide|mesh-list
20064595|NCT04198948|Omeprazole|omeprazole|mesh-list
20064596|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20064597|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20064598|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20064599|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064600|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064601|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20064602|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064603|NCT04204200|Vitamins|vitamins|mesh-list
20064604|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
20064605|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
20064606|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064607|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
20064608|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064609|NCT04204200|Protective Agents|protective agents|mesh-ancestor
20064610|NCT04194151|Propofol|propofol|mesh-list
20064611|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20064612|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064613|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064614|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20064615|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
20064616|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
20064617|NCT04186806|Muramidase|muramidase|mesh-list
20064618|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064619|NCT04184999|Dexamethasone|dexamethasone|mesh-list
20064620|NCT04184999|Prednisolone|prednisolone|mesh-list
20064621|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20064622|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
20064623|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20064624|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
20064625|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20064626|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
20064627|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064628|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
20064629|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
20064630|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064631|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064632|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20064633|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
20064634|NCT04184999|Hormones|hormones|mesh-ancestor
20119421|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064635|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293460|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293461|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293462|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20293463|NCT04329039|Somatostatin|somatostatin|mesh-list
20064636|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20064637|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064638|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20064639|NCT04184999|Protective Agents|protective agents|mesh-ancestor
20064640|NCT04184271|Fluorides|fluorides|mesh-list
20064641|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
20064642|NCT04184271|Protective Agents|protective agents|mesh-ancestor
20064643|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064644|NCT04179461|Vitamin D|vitamin d|mesh-list
20064645|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
20064646|NCT04179461|Fluticasone|fluticasone|mesh-list
20064647|NCT04179461|Xhance|xhance|mesh-list
20064648|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
20064649|NCT04179461|Cetirizine|cetirizine|mesh-list
20064650|NCT04179461|Loratadine|loratadine|mesh-list
20064651|NCT04179461|Azithromycin|azithromycin|mesh-list
20064652|NCT04179461|Budesonide|budesonide|mesh-list
20064653|NCT04179461|Beclomethasone|beclomethasone|mesh-list
20064654|NCT04179461|Emollients|emollients|mesh-list
20064655|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
20064656|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
20064657|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20064658|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20064659|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
20064660|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20064661|NCT04179461|Vitamins|vitamins|mesh-ancestor
20064662|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
20064663|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064664|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20064665|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064666|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20064667|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
20064668|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064669|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20064670|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
20064671|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
20064672|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20064673|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20064674|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
20064675|NCT04179461|Hormones|hormones|mesh-ancestor
20064676|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064677|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064678|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064679|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20064680|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20064681|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20064682|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
20064683|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064684|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064685|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
20064686|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20064687|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
20064688|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20064689|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
20064690|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
20064691|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
20064692|NCT04179474|Erenumab|erenumab|mesh-list
20064693|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20064694|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293464|NCT04329039|Hormones|hormones|mesh-ancestor
20064695|NCT04179474|Analgesics|analgesics|mesh-ancestor
20064696|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
20064697|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064698|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064699|NCT04177862|Fentanyl|fentanyl|mesh-list
20064700|NCT04177862|Sufentanil|sufentanil|mesh-list
20064701|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20064702|NCT04177862|Narcotics|narcotics|mesh-ancestor
20064703|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064704|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064705|NCT04177862|Analgesics|analgesics|mesh-ancestor
20064706|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
20064707|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064708|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20064709|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20064710|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
20064711|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
20064712|NCT04175262|Sunitinib|sunitinib|mesh-list
20064713|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064714|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20064715|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20064716|NCT04175262|Growth Substances|growth substances|mesh-ancestor
20064717|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064718|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
20064719|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20064720|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064721|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064722|NCT04173429|Nadroparin|nadroparin|mesh-list
20064723|NCT04173429|Warfarin|warfarin|mesh-list
20064724|NCT04173429|Calcium|calcium|mesh-list
20064725|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20064726|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064727|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
20064728|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20064729|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20064730|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064731|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20064732|NCT04169061|Hormones|hormones|mesh-ancestor
20064733|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064734|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064735|NCT04157738|Insulin|insulin|mesh-list
20064736|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20064737|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
20577099|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577100|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
20577101|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577102|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064738|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
20064739|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20064740|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064741|NCT04156646|Esomeprazole|esomeprazole|mesh-list
20064742|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20064743|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20064744|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20064745|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064746|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064747|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
20064748|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20293465|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293466|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293467|NCT04321668|Hylan|hylan|mesh-list
20293468|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
20293469|NCT04321668|Protective Agents|protective agents|mesh-ancestor
20293470|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293471|NCT04311502|Pyridoxine|pyridoxine|mesh-list
20293472|NCT04311502|Pyridoxal|pyridoxal|mesh-list
20293473|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
20293474|NCT04311502|Rifampin|rifampin|mesh-list
20293475|NCT04311502|Rifapentine|rifapentine|mesh-list
20293476|NCT04311502|Clofazimine|clofazimine|mesh-list
20293477|NCT04311502|Isoniazid|isoniazid|mesh-list
20293478|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
20293479|NCT04311502|Ethambutol|ethambutol|mesh-list
20064749|NCT04169113|Narcotics|narcotics|mesh-ancestor
20064750|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064751|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293480|NCT04311502|Vitamins|vitamins|mesh-ancestor
20293481|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
20064752|NCT04169113|Analgesics|analgesics|mesh-ancestor
20064753|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
20064754|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064755|NCT04160975|Vaccines|vaccines|mesh-list
20064756|NCT04160975|Immunologic Factors|immunologic factors|mesh-ancestor
20064757|NCT04160975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064758|NCT04167189|Lidocaine|lidocaine|mesh-list
20064759|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
20064760|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
20064761|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064762|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064763|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
20064764|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064765|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20064766|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20064767|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20064768|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064769|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064770|NCT04162795|Loratadine|loratadine|mesh-list
20064771|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
20064772|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
20064773|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20064774|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20064775|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20064776|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
20064777|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
20064778|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064779|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064780|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064781|NCT04161144|Sirolimus|sirolimus|mesh-list
20064782|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064783|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064784|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20064785|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064786|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
20064787|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20064788|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
20064789|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064790|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20064791|NCT04150861|Hormones|hormones|mesh-ancestor
20064792|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20064793|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119422|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119423|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119424|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119425|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
20119426|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119427|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20119428|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20119429|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119430|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20119431|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119432|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20119433|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20119434|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20119435|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20119436|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20119437|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
20119438|NCT00006155|Carboplatin|carboplatin|mesh-list
20119439|NCT00006155|Semaxinib|semaxinib|mesh-list
20119440|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119441|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20119442|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20119443|NCT00006155|Growth Substances|growth substances|mesh-ancestor
20119444|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119445|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
20119446|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20119447|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119448|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119449|NCT00006157|Desipramine|desipramine|mesh-list
20119450|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20119451|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
20064794|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20064795|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064796|NCT04150224|Macozinone|macozinone|mesh-list
20064797|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
20064798|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064799|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064800|NCT04149405|Diphosphonates|diphosphonates|mesh-list
20064801|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20064802|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064803|NCT04141930|Baloxavir|baloxavir|mesh-list
20064804|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
20064805|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064806|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064807|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064808|NCT04139018|Timolol|timolol|mesh-list
20064809|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20064810|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20064811|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
20064812|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064813|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064814|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064815|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20064816|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20064817|NCT04131556|Maribavir|maribavir|mesh-list
20064818|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
20064819|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064820|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
20064821|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20064822|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064823|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20064824|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20064825|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064826|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064827|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
20064828|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064829|NCT04137627|Melatonin|melatonin|mesh-list
20064830|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
20064831|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064832|NCT04137627|Protective Agents|protective agents|mesh-ancestor
20064833|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064834|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064835|NCT04136145|Belimumab|belimumab|mesh-list
20064836|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20064837|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
20064838|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064839|NCT04132336|Naproxen|naproxen|mesh-list
20064840|NCT04132336|Caffeine|caffeine|mesh-list
20064841|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20064842|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064843|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20064844|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119452|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19491617|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20064845|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064846|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20064847|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20064848|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
20064849|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064850|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20064851|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20064852|NCT04132336|Analgesics|analgesics|mesh-ancestor
20064853|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
20064854|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064855|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064856|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064857|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
20064858|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20064859|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20064860|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20064861|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20064862|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
20064863|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20064864|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064865|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20064866|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20064867|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20064868|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20064869|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20064870|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20064871|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20064872|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20064873|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
20064874|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064875|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064876|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20064877|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20064878|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064879|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064880|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064881|NCT04123665|Fluorides|fluorides|mesh-list
20064882|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
20064883|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
20064884|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
20064885|NCT04123665|Protective Agents|protective agents|mesh-ancestor
20064886|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064887|NCT04121078|Rifampin|rifampin|mesh-list
20064888|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20064889|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
20064890|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20064891|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064892|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
20064893|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20064894|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064895|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064896|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20064897|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20064898|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20064899|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20064900|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20064901|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20064902|NCT04117607|Rezafungin|rezafungin|mesh-list
20064903|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
20064904|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20064905|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
20064906|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20064907|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
20064908|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064909|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
20577103|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491618|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
20064910|NCT04115358|Protective Agents|protective agents|mesh-ancestor
20064911|NCT04114058|Bupivacaine|bupivacaine|mesh-list
20064912|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
20064913|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
20064914|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064915|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064916|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
20064917|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064918|NCT04112160|Ketorolac|ketorolac|mesh-list
20064919|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20064920|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20064921|NCT04112160|Analgesics|analgesics|mesh-ancestor
20064922|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
20064923|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064924|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064925|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20064926|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20064927|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20064928|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20064929|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064930|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
20064931|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
20064932|NCT04112069|Pancrelipase|pancrelipase|mesh-list
20064933|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20064934|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064935|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20064936|NCT04105972|Ivacaftor|ivacaftor|mesh-list
20064937|NCT04105972|Elexacaftor|elexacaftor|mesh-list
20064938|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20064939|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064940|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064941|NCT04102956|Kallikreins|kallikreins|mesh-list
20064942|NCT04102956|Coagulants|coagulants|mesh-ancestor
20064943|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
20064944|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
20064945|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20064946|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064947|NCT04102345|Zolpidem|zolpidem|mesh-list
20064948|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20064949|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20064950|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20064951|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064952|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20064953|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
20064954|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
20064955|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064956|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064957|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20064958|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20064959|NCT04089982|Varenicline|varenicline|mesh-list
20064960|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20064961|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20064962|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
20064963|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064964|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064965|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064966|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
20064967|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20064968|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20064969|NCT04098575|Empagliflozin|empagliflozin|mesh-list
20064970|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20064971|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064972|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20064973|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064974|NCT04094883|Vaccines|vaccines|mesh-list
20064975|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
20064976|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064977|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20064978|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20064979|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20064980|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20064981|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064982|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
20064983|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064984|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064985|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20064986|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20064987|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
20064988|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20064989|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
20064990|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064991|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
20064992|NCT04081610|Protective Agents|protective agents|mesh-ancestor
20064993|NCT04081324|Lasmiditan|lasmiditan|mesh-list
20064994|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20064995|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
20064996|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20064997|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20064998|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20064999|NCT04076787|Sunitinib|sunitinib|mesh-list
20065000|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065001|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20065002|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20065003|NCT04076787|Growth Substances|growth substances|mesh-ancestor
20065004|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065005|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
20065006|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20065007|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065008|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065009|NCT04042324|Heparin|heparin|mesh-list
20065010|NCT04042324|Calcium heparin|calcium heparin|mesh-list
20065011|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
20065012|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065013|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20065014|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20065015|NCT04070287|Antibodies|antibodies|mesh-list
20065016|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
20065017|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
20065018|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119453|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119454|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119455|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20119456|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20119457|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20119458|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
20119459|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119460|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119461|NCT00006158|Testosterone|testosterone|mesh-list
20119462|NCT00006158|Androgens|androgens|mesh-ancestor
20119463|NCT00006158|Hormones|hormones|mesh-ancestor
20119464|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119465|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491619|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19491620|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
19491621|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119466|NCT00006167|Oxandrolone|oxandrolone|mesh-list
20119467|NCT00006167|Androgens|androgens|mesh-ancestor
20119468|NCT00006167|Hormones|hormones|mesh-ancestor
20119469|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119470|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119471|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
20119472|NCT00006168|Methotrexate|methotrexate|mesh-list
20119473|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20119474|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
20065019|NCT04050722|Listerine|listerine|mesh-list
20065020|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
20065021|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
20065022|NCT04050722|Protective Agents|protective agents|mesh-ancestor
20065023|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065024|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20065025|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065026|NCT04069221|Cobicistat|cobicistat|mesh-list
20065027|NCT04069221|Artefenomel|artefenomel|mesh-list
20065028|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20065029|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20065030|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
20065031|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065032|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20065033|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20065034|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065035|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065036|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
20065037|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20065038|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20065039|NCT04066647|Dexamethasone|dexamethasone|mesh-list
20065040|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20065041|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
20065042|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
20065043|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065044|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065045|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065046|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
20065047|NCT04066647|Hormones|hormones|mesh-ancestor
20065048|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065049|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20065050|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065051|NCT04066426|Acetaminophen|acetaminophen|mesh-list
20065052|NCT04066426|Dexamethasone|dexamethasone|mesh-list
20065053|NCT04066426|Naproxen|naproxen|mesh-list
20065054|NCT04066426|Codeine|codeine|mesh-list
20065055|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20065056|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
20065057|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
20065058|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065059|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065060|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065061|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
20065062|NCT04066426|Hormones|hormones|mesh-ancestor
20065063|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065064|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20065065|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065066|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20065067|NCT04066426|Analgesics|analgesics|mesh-ancestor
20065068|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
20065069|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
20065070|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20065071|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20065072|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
20065073|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20065074|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065075|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065076|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20065077|NCT04066426|Narcotics|narcotics|mesh-ancestor
20065078|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065079|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
20065080|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
20065081|NCT04060654|Buprenorphine|buprenorphine|mesh-list
20065082|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20065083|NCT04060654|Narcotics|narcotics|mesh-ancestor
20065084|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065085|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065086|NCT04060654|Analgesics|analgesics|mesh-ancestor
20065087|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
20065088|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065089|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20293482|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065090|NCT04058353|Ivacaftor|ivacaftor|mesh-list
20065091|NCT04058353|Elexacaftor|elexacaftor|mesh-list
20065092|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20065093|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293483|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
20065094|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065095|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
20065096|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20065097|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065098|NCT04051684|Ropivacaine|ropivacaine|mesh-list
20065099|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
20065100|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
20065101|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065102|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065103|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
20065104|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065105|NCT04045964|Nicotine|nicotine|mesh-list
20065106|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20065107|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
20065108|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065109|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065110|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20065111|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20065112|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
20065113|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065114|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065115|NCT04054193|Dexamethasone|dexamethasone|mesh-list
20065116|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
20065117|NCT04054193|Aprepitant|aprepitant|mesh-list
20065118|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
20065119|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20065120|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
20065121|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
20065122|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065123|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065124|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065125|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
20065126|NCT04054193|Hormones|hormones|mesh-ancestor
20065127|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065128|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20065129|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065130|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20065131|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065132|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065133|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20065134|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
20065135|NCT04053270|Afamelanotide|afamelanotide|mesh-list
20065136|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
20065137|NCT04049552|Sirolimus|sirolimus|mesh-list
20065138|NCT04049552|Petrolatum|petrolatum|mesh-list
20065139|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20065140|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065141|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20065142|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065143|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
20065144|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20065145|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
20065146|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065147|NCT04049552|Emollients|emollients|mesh-ancestor
20065148|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
20065149|NCT04050865|Dexamethasone|dexamethasone|mesh-list
20065150|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20065151|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
20065152|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
20065153|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065154|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293484|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20293485|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
20293486|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20293487|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293488|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
20293489|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20293490|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065155|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065156|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
20065157|NCT04050865|Hormones|hormones|mesh-ancestor
20065158|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065159|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293491|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293492|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20293493|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20293494|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20065160|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065161|NCT04050371|Tenofovir|tenofovir|mesh-list
20065162|NCT04050371|Emtricitabine|emtricitabine|mesh-list
20065163|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
20065164|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065165|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20065166|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20065167|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065168|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065169|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20065170|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20065171|NCT04048681|Cocaine|cocaine|mesh-list
20065172|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
20065173|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
20065174|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065175|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065176|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
20065177|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065178|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20065179|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20065180|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20065181|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20065182|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065183|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
20065184|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065185|NCT04041453|Ivermectin|ivermectin|mesh-list
20065186|NCT04041453|Albendazole|albendazole|mesh-list
20065187|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20065188|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065189|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
20065190|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
20065191|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20065192|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20065193|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
20065194|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
20065195|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
20065196|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065197|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065198|NCT04041219|Tacrolimus|tacrolimus|mesh-list
20065199|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20065200|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
20065201|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065202|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20065203|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065204|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065205|NCT04039867|Gemcitabine|gemcitabine|mesh-list
20065206|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
20065207|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20065208|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
20065209|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065210|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065211|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
20065212|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065213|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065214|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20065215|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
20065216|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065217|NCT04039412|Levofloxacin|levofloxacin|mesh-list
20065218|NCT04039412|Ofloxacin|ofloxacin|mesh-list
20293495|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20293496|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20293497|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20293498|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20293499|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20293500|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
20065219|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20065220|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065221|NCT04039412|Renal Agents|renal agents|mesh-ancestor
20065222|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20065223|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20065224|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20065225|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065226|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065227|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065228|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20065229|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20065230|NCT04036110|Vitamins|vitamins|mesh-list
20065231|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
20065232|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
20065233|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065234|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
20065235|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065236|NCT04036110|Protective Agents|protective agents|mesh-ancestor
20065237|NCT04024501|Verinurad|verinurad|mesh-list
20065238|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
20065239|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20065240|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
20065241|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20065242|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
20065243|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065244|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065245|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
20065246|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065247|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
20065248|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20065249|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
20065250|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065251|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065252|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
20065253|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065254|NCT04031885|Paclitaxel|paclitaxel|mesh-list
20065255|NCT04031885|Docetaxel|docetaxel|mesh-list
20065256|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20065257|NCT04031885|Capecitabine|capecitabine|mesh-list
20065258|NCT04031885|Fulvestrant|fulvestrant|mesh-list
20065259|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20065260|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065261|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
20065262|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
20065263|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
20065264|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065265|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20065266|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
20065267|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20065268|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20065269|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20065270|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
20065271|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065272|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065273|NCT04029584|Rifampin|rifampin|mesh-list
20065274|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20065275|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
20065276|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20065277|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065278|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
20065279|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20065280|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065281|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065282|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20065283|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20065284|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20065285|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20065286|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20065287|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20065288|NCT04028960|Insulin|insulin|mesh-list
20065289|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20065290|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20065291|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293501|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20065292|NCT04023695|Lidocaine|lidocaine|mesh-list
20065293|NCT04023695|Epinephrine|epinephrine|mesh-list
20065294|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
20065295|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
20065296|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065297|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065298|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
20065299|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065300|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20065301|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20065302|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20065303|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20065304|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065305|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20065306|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20065307|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
20065308|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065309|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20065310|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20065311|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
20065312|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20065313|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
20065314|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
20065315|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
20065316|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20065317|NCT04018664|Nalbuphine|nalbuphine|mesh-list
20065318|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20065319|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20065320|NCT04018664|Narcotics|narcotics|mesh-ancestor
20065321|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065322|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065323|NCT04018664|Analgesics|analgesics|mesh-ancestor
20065324|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
20065325|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065326|NCT04027803|Eculizumab|eculizumab|mesh-list
20065327|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20065328|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20065329|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
20065330|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065331|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
20065332|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20065333|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065334|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
20119475|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20119476|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119477|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119478|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
20119479|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119480|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119481|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
20119482|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119483|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20119484|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119485|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
20119486|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119487|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119488|NCT00006174|Letrozole|letrozole|mesh-list
20119489|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119490|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20119491|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20119492|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119493|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119494|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20119495|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
20119496|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119497|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119498|NCT00006180|Alendronate|alendronate|mesh-list
20119499|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20119500|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119501|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
20119502|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20119503|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119504|NCT00006190|Lamivudine|lamivudine|mesh-list
20119505|NCT00006190|Efavirenz|efavirenz|mesh-list
20119506|NCT00006190|Stavudine|stavudine|mesh-list
20119507|NCT00006190|Nelfinavir|nelfinavir|mesh-list
20119508|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20119509|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20065335|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
20065336|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20065337|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
20065338|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065339|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065340|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20065341|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
20065342|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
20065343|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20065344|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
20065345|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065346|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065347|NCT04009577|Lemborexant|lemborexant|mesh-list
20065348|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20065349|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065350|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065351|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20065352|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20065353|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065354|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065355|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
20065356|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
20065357|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065358|NCT03995680|Mebendazole|mebendazole|mesh-list
20065359|NCT03995680|Piperazine|piperazine|mesh-list
20065360|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
20065361|NCT03995680|DMP 777|dmp 777|mesh-list
20065362|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
20065363|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
20065364|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20065365|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065366|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
20065367|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
20065368|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
20065369|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065370|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065371|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065372|NCT04005404|Ropivacaine|ropivacaine|mesh-list
20065373|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
20065374|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
20065375|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065376|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065377|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
20065378|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065379|NCT03993288|Iron|iron|mesh-list
20065380|NCT03993288|Trace Elements|trace elements|mesh-ancestor
20065381|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
20065382|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065383|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
20065384|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20065385|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065386|NCT03978832|Risperidone|risperidone|mesh-list
20065387|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20065388|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
20065389|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065390|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065391|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293502|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20065392|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20065393|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20065394|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293503|NCT04296890|Maytansine|maytansine|mesh-list
19491622|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491623|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
19491624|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
19491625|NCT03129555|Apixaban|apixaban|mesh-list
19491626|NCT03129555|Edoxaban|edoxaban|mesh-list
19491627|NCT03129555|Dabigatran|dabigatran|mesh-list
19491628|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19491629|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
19491630|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19491631|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
19491632|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577104|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
19491633|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491634|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
19491635|NCT03129542|Midodrine|midodrine|mesh-list
19491636|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
19491637|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
19491638|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065395|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20065396|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20065397|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
20065398|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20065399|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
20065400|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
20065401|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
20065402|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20065403|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065404|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20065405|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20065406|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20065407|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20065408|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20065409|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20065410|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20065411|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065412|NCT04004481|Morphine|morphine|mesh-list
20065413|NCT04004481|Tramadol|tramadol|mesh-list
20065414|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20065415|NCT04004481|Narcotics|narcotics|mesh-ancestor
20065416|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065417|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065418|NCT04004481|Analgesics|analgesics|mesh-ancestor
20065419|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
20065420|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065421|NCT03997851|Acetaminophen|acetaminophen|mesh-list
20065422|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20065423|NCT03997851|Analgesics|analgesics|mesh-ancestor
20065424|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
20065425|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065426|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065427|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
20065428|NCT03996694|Oxycodone|oxycodone|mesh-list
20065429|NCT03996694|Buprenorphine|buprenorphine|mesh-list
20065430|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20065431|NCT03996694|Narcotics|narcotics|mesh-ancestor
20065432|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065433|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065434|NCT03996694|Analgesics|analgesics|mesh-ancestor
20065435|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
20065436|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065437|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20065438|NCT03988907|Midazolam|midazolam|mesh-list
20065439|NCT03988907|Risdiplam|risdiplam|mesh-list
20065440|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20065441|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20065442|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065443|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065444|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20065445|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20065446|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20065447|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20065448|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
20065449|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
20065450|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
20065451|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
20065452|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065453|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065454|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20065455|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065456|NCT03988088|Lasmiditan|lasmiditan|mesh-list
20065457|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20065458|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
20065459|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065460|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065461|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065462|NCT03980522|Rilonacept|rilonacept|mesh-list
20065463|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20065464|NCT03999684|Tretinoin|tretinoin|mesh-list
20065465|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065466|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
20065467|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
20065468|NCT03993392|Buprenorphine|buprenorphine|mesh-list
20065469|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20065470|NCT03993392|Narcotics|narcotics|mesh-ancestor
20065471|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065472|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065473|NCT03993392|Analgesics|analgesics|mesh-ancestor
20065474|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
20065475|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065476|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20065477|NCT03989427|Listerine|listerine|mesh-list
20065478|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
20065479|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
20065480|NCT03989427|Protective Agents|protective agents|mesh-ancestor
20065481|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065482|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20065483|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065484|NCT03981822|Cantharidin|cantharidin|mesh-list
20065485|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065486|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065487|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
20065488|NCT03992482|Antibodies|antibodies|mesh-list
20065489|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
20065490|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20065491|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20065492|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
20065493|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065494|NCT03993119|Anticoagulants|anticoagulants|mesh-list
20065495|NCT03988803|Memantine|memantine|mesh-list
20065496|NCT03988803|BI 425809|bi 425809|mesh-list
20065497|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20065498|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20065499|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
20065500|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065501|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065502|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065503|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20065504|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20065505|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
20065506|NCT03987191|Insulin|insulin|mesh-list
20065507|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
20065508|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20065509|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20065510|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065511|NCT03988842|Heparin|heparin|mesh-list
20065512|NCT03988842|Calcium heparin|calcium heparin|mesh-list
20065513|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20065514|NCT03988842|Plasminogen|plasminogen|mesh-list
20065515|NCT03988842|Apixaban|apixaban|mesh-list
20065516|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
20065517|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20065518|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20065519|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065520|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20065521|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
20065522|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20065523|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
20065524|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065525|NCT03981861|Metformin|metformin|mesh-list
20065526|NCT03981861|Spironolactone|spironolactone|mesh-list
20065527|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20065528|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065529|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20065530|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
20065531|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065532|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20065533|NCT03981861|Diuretics|diuretics|mesh-ancestor
20065534|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
20065535|NCT03987074|Firsocostat|firsocostat|mesh-list
20065536|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065537|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065538|NCT03979820|Phenelzine|phenelzine|mesh-list
20065539|NCT03979820|Tyramine|tyramine|mesh-list
20293504|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20293505|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065540|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
20065541|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20065542|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20065543|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065544|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065545|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
20065546|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
20065547|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065548|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065549|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20065550|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20065551|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20065552|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
20065553|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065554|NCT03972137|Nicotine|nicotine|mesh-list
20065555|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20065556|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
20065557|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065558|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065559|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20065560|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20065561|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
20065562|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065563|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065564|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
20065565|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
20065566|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065567|NCT03984838|Dolutegravir|dolutegravir|mesh-list
20065568|NCT03984838|Rilpivirine|rilpivirine|mesh-list
20065569|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20065570|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20065571|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065572|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065573|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20065574|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20065575|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
20065576|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065577|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20065578|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20065579|NCT03983941|Ropivacaine|ropivacaine|mesh-list
20065580|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
20577105|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20577106|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
20577107|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577108|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577109|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
20577110|NCT02076373|Hematinics|hematinics|mesh-ancestor
20608164|NCT02244762|Analgesics|analgesics|mesh-ancestor
20065581|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
20065582|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065583|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065584|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
20065585|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065586|NCT03976752|Tenofovir|tenofovir|mesh-list
20065587|NCT03976752|Emtricitabine|emtricitabine|mesh-list
20065588|NCT03976752|Cobicistat|cobicistat|mesh-list
20065589|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20065590|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20065591|NCT03976752|Elvitegravir|elvitegravir|mesh-list
20065592|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
20065593|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065594|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20065595|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20065596|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065597|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065598|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20065599|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20065600|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20065601|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20065602|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20065603|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20065604|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20065605|NCT03976466|Calcium|calcium|mesh-list
20065606|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20065607|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065608|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065609|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
20065610|NCT03979066|Atezolizumab|atezolizumab|mesh-list
20065611|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065612|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
20065613|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20065614|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065615|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20065616|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
20065617|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065618|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
20065619|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065620|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
20065621|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20065622|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
20065623|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065624|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
20065625|NCT03967444|Protective Agents|protective agents|mesh-ancestor
20065626|NCT03966365|Timolol|timolol|mesh-list
20065627|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20065628|NCT03966365|Dorzolamide|dorzolamide|mesh-list
20065629|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20065630|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20065631|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
20065632|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065633|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065634|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065635|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20065636|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20065637|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20065638|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20065639|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20065640|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20065641|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065642|NCT03965351|Probenecid|probenecid|mesh-list
20065643|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
20065644|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
20065645|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20065646|NCT03965351|Renal Agents|renal agents|mesh-ancestor
20065647|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
20065648|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20065649|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
20065650|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065651|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065652|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20065653|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
20065654|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
20065655|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20065656|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
20065657|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065658|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119510|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119511|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119512|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
20119513|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119514|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119515|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119516|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20119517|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20119518|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20119519|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20119520|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20119521|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20119522|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
20119523|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20119524|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20119525|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
20119526|NCT00006195|Olanzapine|olanzapine|mesh-list
20119527|NCT00006195|Risperidone|risperidone|mesh-list
20119528|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20119529|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
20119530|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119531|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119532|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119533|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20119534|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20119535|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20119536|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20119537|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20065659|NCT03965052|Travoprost|travoprost|mesh-list
20065660|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20065661|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20065662|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20065663|NCT03965039|Fluorides|fluorides|mesh-list
20065664|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
20065665|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
20065666|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
20065667|NCT03965039|Protective Agents|protective agents|mesh-ancestor
20065668|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065669|NCT03963401|PF-06700841|pf-06700841|mesh-list
20065670|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20065671|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065672|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065673|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
20065674|NCT03962634|Tetracaine|tetracaine|mesh-list
20065675|NCT03962634|Carticaine|carticaine|mesh-list
20065676|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
20065677|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
20065678|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065679|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065680|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
20065681|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065682|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20065683|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20065684|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19491639|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491640|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19491641|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19491642|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20065685|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065686|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065687|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
20065688|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
20065689|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
20065690|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20065691|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
20065692|NCT03962738|Lasmiditan|lasmiditan|mesh-list
20065693|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20065694|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
20065695|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065696|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065697|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065698|NCT03946124|Fesoterodine|fesoterodine|mesh-list
20065699|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20065700|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20065701|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
20065702|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065703|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065704|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065705|NCT03946124|Urological Agents|urological agents|mesh-ancestor
20065706|NCT03961308|Vedolizumab|vedolizumab|mesh-list
20065707|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065708|NCT03961295|Vedolizumab|vedolizumab|mesh-list
20065709|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065710|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20065711|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20065712|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20065713|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20065714|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065715|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
20065716|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065717|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065718|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20065719|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065720|NCT03954444|Phenylephrine|phenylephrine|mesh-list
20065721|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
20065722|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20065723|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20065724|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
20065725|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065726|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065727|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065728|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
20065729|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
20065730|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065731|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
20065732|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20065733|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
20065734|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20065735|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
20065736|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20065737|NCT03954444|Protective Agents|protective agents|mesh-ancestor
20065738|NCT03953820|Diazepam|diazepam|mesh-list
20065739|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20065740|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
20065741|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
20065742|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
20065743|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065744|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065745|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065746|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20065747|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065748|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20065749|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20065750|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20065751|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20065752|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19491643|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20065753|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20065754|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
20065755|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
20065756|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
20065757|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
20065758|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065759|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065760|NCT03961100|Entrectinib|entrectinib|mesh-list
20065761|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20065762|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065763|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065764|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20065765|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
20065766|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065767|NCT03960658|Ketamine|ketamine|mesh-list
20065768|NCT03960658|Analgesics|analgesics|mesh-ancestor
20065769|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
20065770|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065771|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065772|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20065773|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20065774|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
20065775|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
20065776|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065777|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20065778|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20065779|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065780|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065781|NCT03959332|Baloxavir|baloxavir|mesh-list
20065782|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
20065783|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065784|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065785|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065786|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
20065787|NCT03958656|Fludarabine|fludarabine|mesh-list
20065788|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20065789|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
20065790|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065791|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20065792|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20065793|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
20065794|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065795|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065796|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20065797|NCT03951805|Insulin|insulin|mesh-list
20065798|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20065799|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
20065800|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20065801|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065802|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20065803|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
20065804|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065805|NCT03949621|Vedolizumab|vedolizumab|mesh-list
20065806|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065807|NCT03949244|Latanoprost|latanoprost|mesh-list
20065808|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20065809|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20065810|NCT03948581|Vedolizumab|vedolizumab|mesh-list
20065811|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20065812|NCT03948386|Bupivacaine|bupivacaine|mesh-list
20065813|NCT03948386|Mepivacaine|mepivacaine|mesh-list
20065814|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
20065815|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
20065816|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065817|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065818|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
20065819|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065820|NCT03943095|Fluorides|fluorides|mesh-list
20065821|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
20065822|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
20065823|NCT03943095|Protective Agents|protective agents|mesh-ancestor
20065824|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065825|NCT03942042|Ixekizumab|ixekizumab|mesh-list
20065826|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
20065827|NCT03923530|Eplerenone|eplerenone|mesh-list
20065828|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20065829|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
20065830|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065831|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065832|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20065833|NCT03923530|Diuretics|diuretics|mesh-ancestor
20065834|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
20065835|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20065836|NCT03914417|Imiquimod|imiquimod|mesh-list
20065837|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20065838|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
20065839|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065840|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065841|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
20065842|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
20065843|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20065844|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
20065845|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065846|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065847|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20065848|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
20065849|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
20065850|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20065851|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
20065852|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065853|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065854|NCT03936387|Ropivacaine|ropivacaine|mesh-list
20065855|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
20065856|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
20065857|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065858|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065859|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
20065860|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065861|NCT03935399|Oxytocin|oxytocin|mesh-list
20293506|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
20293507|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293508|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
20065862|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
20065863|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20065864|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065865|NCT03928327|Itraconazole|itraconazole|mesh-list
20065866|NCT03928327|Rifampin|rifampin|mesh-list
20065867|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
20065868|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065869|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20065870|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20065871|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065872|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065873|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20065874|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
20308368|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119538|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
20577111|NCT02076386|Dolutegravir|dolutegravir|mesh-list
20577112|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20577113|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20577114|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577115|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577116|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20577117|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20577118|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
20577119|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577120|NCT02076451|DS-8273a|ds-8273a|mesh-list
20577121|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20577122|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577123|NCT02076477|Docetaxel|docetaxel|mesh-list
20065875|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065876|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065877|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20065878|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20065879|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
20065880|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20065881|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
20065882|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20065883|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20065884|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20065885|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20065886|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20065887|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20065888|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20065889|NCT03933774|Tretinoin|tretinoin|mesh-list
20065890|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065891|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
20065892|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
20065893|NCT03933618|Anastrozole|anastrozole|mesh-list
20065894|NCT03933618|Clomiphene|clomiphene|mesh-list
20065895|NCT03933618|Enclomiphene|enclomiphene|mesh-list
20293509|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065896|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
20065897|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065898|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20065899|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065900|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20065901|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20065902|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065903|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20065904|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
20065905|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20065906|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065907|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20065908|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
20065909|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20065910|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20293510|NCT04276259|Naltrexone|naltrexone|mesh-list
20293511|NCT04276259|Buprenorphine|buprenorphine|mesh-list
20293512|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20293513|NCT04276259|Narcotics|narcotics|mesh-ancestor
20293514|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293515|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293516|NCT04276259|Analgesics|analgesics|mesh-ancestor
20293517|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
20293518|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293519|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20293520|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20293521|NCT04272242|Pyridoxine|pyridoxine|mesh-list
20293522|NCT04272242|Pyridoxal|pyridoxal|mesh-list
20293523|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
20293524|NCT04272242|Isoniazid|isoniazid|mesh-list
20293525|NCT04272242|Rifapentine|rifapentine|mesh-list
20293526|NCT04272242|Dolutegravir|dolutegravir|mesh-list
20293527|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20293528|NCT04272242|Vitamins|vitamins|mesh-ancestor
20293529|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
20293530|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293531|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
20293532|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
20577124|NCT02076477|Pemetrexed|pemetrexed|mesh-list
20577125|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065911|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20065912|NCT03927105|Nivolumab|nivolumab|mesh-list
20065913|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20065914|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065915|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20065916|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065917|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
20065918|NCT03923933|Bumetanide|bumetanide|mesh-list
20065919|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20065920|NCT03923933|Diuretics|diuretics|mesh-ancestor
20065921|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
20065922|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065923|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20065924|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20065925|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065926|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20065927|NCT03909295|Valsartan|valsartan|mesh-list
20065928|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20065929|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20065930|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20065931|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20065932|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065933|NCT03930264|Azathioprine|azathioprine|mesh-list
20065934|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
20065935|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065936|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20065937|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065938|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20065939|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
20065940|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065941|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20065942|NCT03929367|Oxytocin|oxytocin|mesh-list
20065943|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
20065944|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20065945|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065946|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20065947|NCT03928522|Vancomycin|vancomycin|mesh-list
20065948|NCT03928522|Tobramycin|tobramycin|mesh-list
20065949|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065950|NCT03910439|Avelumab|avelumab|mesh-list
20065951|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20065952|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20065953|NCT03927950|Citalopram|citalopram|mesh-list
20065954|NCT03927950|Bupropion|bupropion|mesh-list
20065955|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20065956|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20065957|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20065958|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065959|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20065960|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
20065961|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065962|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20065963|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
20065964|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20065965|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20065966|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
20065967|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20065968|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20065969|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20065970|NCT03927781|Pregabalin|pregabalin|mesh-list
20065971|NCT03927781|Analgesics|analgesics|mesh-ancestor
20065972|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
20065973|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065974|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065975|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
20065976|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20065977|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20065978|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20065979|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20065980|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20065981|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20293533|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20065982|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065983|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20065984|NCT03895307|Anesthetics|anesthetics|mesh-list
20065985|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
20065986|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065987|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20065988|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
20065989|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20065990|NCT03905642|Amikacin|amikacin|mesh-list
20065991|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20065992|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20065993|NCT03892889|Aripiprazole|aripiprazole|mesh-list
20065994|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
20065995|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20065996|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20065997|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20065998|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20065999|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066000|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
20066001|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
20066002|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066003|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066004|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20066005|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20066006|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
20066007|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20066008|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20066009|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20066010|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20066011|NCT03921723|Dolutegravir|dolutegravir|mesh-list
20066012|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20066013|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20066014|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066015|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066016|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20066017|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20066018|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
20066019|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066020|NCT03921190|Anesthetics|anesthetics|mesh-list
20066021|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066022|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066023|NCT03920865|Risdiplam|risdiplam|mesh-list
20066024|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20066025|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066026|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066027|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20066028|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20066029|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20066030|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066031|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066032|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20066033|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20066034|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20066035|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20066036|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
20066037|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066038|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066039|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20066040|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20066041|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
20066042|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20066043|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20066044|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
20066045|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
20066046|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
20066047|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066048|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066049|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066050|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
20066051|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
20119539|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
20119540|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
20119541|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119542|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066052|NCT03911843|Vitamin D|vitamin d|mesh-list
20066053|NCT03911843|Vitamins|vitamins|mesh-ancestor
20066054|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
20066055|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066056|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20066057|NCT03896633|Brinzolamide|brinzolamide|mesh-list
20066058|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20066059|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066060|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066061|NCT03894813|Metronidazole|metronidazole|mesh-list
20066062|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066063|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20293534|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066064|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20066065|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20066066|NCT03906448|Temozolomide|temozolomide|mesh-list
20066067|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20066068|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
20066069|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066070|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066071|NCT03909763|Danazol|danazol|mesh-list
20066072|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20066073|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
20066074|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066075|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066076|NCT03903822|PF-06700841|pf-06700841|mesh-list
20066077|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20066078|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066079|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066080|NCT03905096|Donepezil|donepezil|mesh-list
20066081|NCT03905096|BI 425809|bi 425809|mesh-list
20066082|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20066083|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066084|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066085|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
20066086|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066087|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066088|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
20066089|NCT03894969|Vaccines|vaccines|mesh-list
20066090|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
20066091|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066092|NCT03892707|Folic Acid|folic acid|mesh-list
20066093|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
20293535|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20293536|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20293537|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
20293538|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293539|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20293540|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20293541|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20293542|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293543|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20066094|NCT03892707|Celecoxib|celecoxib|mesh-list
20066095|NCT03892707|Etoricoxib|etoricoxib|mesh-list
20066096|NCT03892707|Meloxicam|meloxicam|mesh-list
20066097|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20066098|NCT03892707|Nimesulide|nimesulide|mesh-list
20066099|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20066100|NCT03892707|Benphothiamine|benphothiamine|mesh-list
20066101|NCT03892707|Vitamins|vitamins|mesh-ancestor
20066102|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
20293544|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
20293545|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20293546|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
20293547|NCT04267926|Ubiquinone|ubiquinone|mesh-list
20293548|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
20066103|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066104|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066105|NCT03892707|Analgesics|analgesics|mesh-ancestor
20066106|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
20577126|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
20066107|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066108|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066109|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20293549|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066110|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20066111|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066112|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066113|NCT03892707|Hematinics|hematinics|mesh-ancestor
20066114|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20066115|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
20066116|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
20066117|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
20066118|NCT03889444|Dexamethasone|dexamethasone|mesh-list
20066119|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066120|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
20066121|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
20066122|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066123|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066124|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066125|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
20066126|NCT03889444|Hormones|hormones|mesh-ancestor
20066127|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066128|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20066129|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066130|NCT03888755|Icatibant|icatibant|mesh-list
20066131|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20066132|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066133|NCT03888755|Analgesics|analgesics|mesh-ancestor
20066134|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
20066135|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066136|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066137|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066138|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066139|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20066140|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20066141|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066142|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20066143|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20066144|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
20066145|NCT03888365|Treprostinil|treprostinil|mesh-list
20066146|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20066147|NCT03887442|Paclitaxel|paclitaxel|mesh-list
20066148|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20066149|NCT03887442|Cetuximab|cetuximab|mesh-list
20066150|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20066151|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066152|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
20066153|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
20066154|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
20066155|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066156|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20066157|NCT03873987|Oritavancin|oritavancin|mesh-list
20066158|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20066159|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066160|NCT03887299|Disinfectants|disinfectants|mesh-list
20066161|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066162|NCT03886701|Isoniazid|isoniazid|mesh-list
20066163|NCT03886701|Rifapentine|rifapentine|mesh-list
20066164|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
20066165|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20066166|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066167|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20066168|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20293550|NCT04243278|Aspirin|aspirin|mesh-list
20293551|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20293552|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20293553|NCT04243278|Analgesics|analgesics|mesh-ancestor
20293554|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
20293555|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293556|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066169|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
20066170|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066171|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20066172|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20066173|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
20066174|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20066175|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
20066176|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066177|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
20066178|NCT03885154|Valproic Acid|valproic acid|mesh-list
20066179|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
20066180|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066181|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066182|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
20066183|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066184|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066185|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
20066186|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20066187|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066188|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20066189|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20066190|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
20066191|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
20066192|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066193|NCT03885154|Analgesics|analgesics|mesh-ancestor
20066194|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
20066195|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066196|NCT03883386|Loratadine|loratadine|mesh-list
20066197|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
20066198|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066199|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20066200|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20066201|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20066202|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
20066203|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
20066204|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066205|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066206|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066207|NCT03882424|Bevacizumab|bevacizumab|mesh-list
20066208|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20066209|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066210|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20066211|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20066212|NCT03882424|Growth Substances|growth substances|mesh-ancestor
20066213|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066214|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
20066215|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
20066216|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20066217|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
20066218|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066219|NCT03881163|Expectorants|expectorants|mesh-ancestor
20066220|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
20066221|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20066222|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
20066223|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066224|NCT03881163|Protective Agents|protective agents|mesh-ancestor
20066225|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066226|NCT03881163|Antidotes|antidotes|mesh-ancestor
20066227|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
20066228|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20066229|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20066230|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20066231|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
20066232|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066233|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066234|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066235|NCT03848871|Betamethasone|betamethasone|mesh-list
20066236|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
20066237|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20066238|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
20066239|NCT03848871|Calcipotriene|calcipotriene|mesh-list
20066240|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20066241|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066242|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
20066243|NCT03848871|Hormones|hormones|mesh-ancestor
20119543|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20066244|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066245|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066246|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20066247|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
20066248|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066249|NCT03848403|Ixekizumab|ixekizumab|mesh-list
20066250|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066251|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20066252|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20066253|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
20066254|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066255|NCT03879603|Antacids|antacids|mesh-ancestor
20066256|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066257|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066258|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
20066259|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20066260|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066261|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066262|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066263|NCT03866434|Anagrelide|anagrelide|mesh-list
20066264|NCT03866434|Omeprazole|omeprazole|mesh-list
20066265|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20066266|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066267|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20066268|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066269|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293557|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293558|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20293559|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20293560|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20293561|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293562|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20293563|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20293564|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293565|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
20293566|NCT04243122|Aspirin|aspirin|mesh-list
20066270|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20066271|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20066272|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20066273|NCT03855059|Dexamethasone|dexamethasone|mesh-list
20066274|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
20066275|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20066276|NCT03855059|BB 1101|bb 1101|mesh-list
20066277|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066278|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
20066279|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
20066280|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066281|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066282|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066283|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
20066284|NCT03855059|Hormones|hormones|mesh-ancestor
20066285|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066286|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293567|NCT04243122|Apixaban|apixaban|mesh-list
20293568|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20293569|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20293570|NCT04243122|Analgesics|analgesics|mesh-ancestor
20293571|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
20293572|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293573|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293574|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293575|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066287|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066288|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
20066289|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066290|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066291|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
20066292|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20066293|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20066294|NCT03852537|Prednisolone|prednisolone|mesh-list
20066295|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
20066296|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20066297|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
20293576|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20066298|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066299|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
20066300|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
20066301|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066302|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066303|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066304|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
20066305|NCT03852537|Hormones|hormones|mesh-ancestor
20066306|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066307|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20066308|NCT03852537|Protective Agents|protective agents|mesh-ancestor
20066309|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20066310|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066311|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
20066312|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
20066313|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066314|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20066315|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
20066316|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066317|NCT03873116|Berotralstat|berotralstat|mesh-list
20066318|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066319|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066320|NCT03872843|Ibuprofen|ibuprofen|mesh-list
20066321|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20066322|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066323|NCT03872843|Analgesics|analgesics|mesh-ancestor
20066324|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
20066325|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066326|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066327|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066328|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066329|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20066330|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066331|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066332|NCT03861338|Buprenorphine|buprenorphine|mesh-list
20066333|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20066334|NCT03861338|Narcotics|narcotics|mesh-ancestor
20066335|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066336|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066337|NCT03861338|Analgesics|analgesics|mesh-ancestor
20066338|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
20066339|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066340|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20119544|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20119545|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20119546|NCT00006196|Vitamin D|vitamin d|mesh-list
20119547|NCT00006196|Vitamins|vitamins|mesh-ancestor
20119548|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
20119549|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119550|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20119551|NCT00006198|Thalidomide|thalidomide|mesh-list
20119552|NCT00006198|Doxorubicin|doxorubicin|mesh-list
20119553|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119554|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119555|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119556|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119557|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119558|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119559|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119560|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
20119561|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119562|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
20119563|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20119564|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119565|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20119566|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20119567|NCT00006198|Growth Substances|growth substances|mesh-ancestor
20119568|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
20119569|NCT00006199|Topotecan|topotecan|mesh-list
20119570|NCT00006199|Tipifarnib|tipifarnib|mesh-list
20119571|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20119572|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119573|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119574|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119575|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119576|NCT00006200|Thalidomide|thalidomide|mesh-list
20066341|NCT03848416|Ixekizumab|ixekizumab|mesh-list
20066342|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066343|NCT03853551|Osimertinib|osimertinib|mesh-list
20066344|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066345|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20066346|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066347|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066348|NCT03869450|Lidocaine|lidocaine|mesh-list
20066349|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
20066350|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066351|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
20066352|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066353|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066354|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
20066355|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066356|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20066357|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20066358|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20066359|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20066360|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066361|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20066362|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
20066363|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
20066364|NCT03869450|Protective Agents|protective agents|mesh-ancestor
20066365|NCT03859960|Insulin|insulin|mesh-list
20066366|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20066367|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066368|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066369|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
20066370|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20066371|NCT03868059|Testosterone|testosterone|mesh-list
20066372|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
20066373|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
20066374|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20066375|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066376|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
20066377|NCT03868059|Hormones|hormones|mesh-ancestor
20066378|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066379|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066380|NCT03868059|Androgens|androgens|mesh-ancestor
20066381|NCT03865407|Allopurinol|allopurinol|mesh-list
20066382|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
20066383|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066384|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066385|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
20066386|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066387|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20066388|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
20066389|NCT03865407|Protective Agents|protective agents|mesh-ancestor
20066390|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066391|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20066392|NCT03857230|Hormones|hormones|mesh-ancestor
20066393|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066394|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066395|NCT03847610|Penicillins|penicillins|mesh-list
20066396|NCT03847610|Penicillin V|penicillin v|mesh-list
20066397|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20066398|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066399|NCT03850093|Bisoprolol|bisoprolol|mesh-list
20066400|NCT03850093|Gabapentin|gabapentin|mesh-list
20066401|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066402|NCT03850093|Analgesics|analgesics|mesh-ancestor
20066403|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
20066404|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066405|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
20066406|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20066407|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20066408|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066409|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20066410|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20066411|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20066412|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066413|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066414|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
20066415|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20066416|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
20066417|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
20066418|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20066419|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20066420|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20066421|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
20066422|NCT03847389|Clobetasol|clobetasol|mesh-list
20066423|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066424|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
20066425|NCT03847389|Hormones|hormones|mesh-ancestor
20066426|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066427|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066428|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20066429|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066430|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
20066431|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20066432|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20066433|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20066434|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20066435|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066436|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
20066437|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066438|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066439|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20066440|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066441|NCT03857750|Rocuronium|rocuronium|mesh-list
20066442|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20066443|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20066444|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20066445|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066446|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066447|NCT03860753|Pioglitazone|pioglitazone|mesh-list
20066448|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066449|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066450|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20066451|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20066452|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
20066453|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20066454|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20066455|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066456|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
20066457|NCT03856164|Coagulants|coagulants|mesh-ancestor
20066458|NCT03849690|Esomeprazole|esomeprazole|mesh-list
20066459|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20066460|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066461|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20066462|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066463|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066464|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20066465|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20066466|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
20066467|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
20066468|NCT03840811|Cefixime|cefixime|mesh-list
20066469|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20066470|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066471|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20066472|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20066473|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066474|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066475|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066476|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20066477|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20066478|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
20066479|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20066480|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20066481|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066482|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
20066483|NCT03825939|Coagulants|coagulants|mesh-ancestor
20066484|NCT03841331|Serlopitant|serlopitant|mesh-list
20066485|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20066486|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066487|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066488|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066489|NCT03840278|Pancrelipase|pancrelipase|mesh-list
20293577|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20066490|NCT03840278|Pancreatin|pancreatin|mesh-list
20066491|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066492|NCT03839355|Warfarin|warfarin|mesh-list
20066493|NCT03839355|Apixaban|apixaban|mesh-list
20066494|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
20066495|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20066496|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
20066497|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20066498|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
20066499|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066500|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066501|NCT03838874|Bupivacaine|bupivacaine|mesh-list
20066502|NCT03838874|Mepivacaine|mepivacaine|mesh-list
20066503|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066504|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
20066505|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066506|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066507|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
20066508|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066509|NCT03822078|Denosumab|denosumab|mesh-list
20066510|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20066511|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066512|NCT03811951|Insulin|insulin|mesh-list
20066513|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066514|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066515|NCT03810235|Lidocaine|lidocaine|mesh-list
20066516|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066517|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
20066518|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066519|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066520|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
20066521|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066522|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20066523|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20066524|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20066525|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20066526|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066527|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
20066528|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20066529|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20066530|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066531|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
20066532|NCT03806556|Coagulants|coagulants|mesh-ancestor
20066533|NCT03836664|Timolol|timolol|mesh-list
20066534|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20066535|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20066536|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20066537|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20066538|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
20066539|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066540|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066541|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066542|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20066543|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20066544|NCT03823391|Adalimumab|adalimumab|mesh-list
20066545|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066546|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066547|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
20066548|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20577127|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
20577128|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
20577129|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066549|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20066550|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066551|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20066552|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20066553|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066554|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066555|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066556|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20066557|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
20066558|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20066559|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066560|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20066561|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20066562|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20066563|NCT03836729|Tenofovir|tenofovir|mesh-list
20066564|NCT03836729|Emtricitabine|emtricitabine|mesh-list
20066565|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
20066566|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066567|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20066568|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20066569|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066570|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066571|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20066572|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20066573|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20066574|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
20066575|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066576|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
20066577|NCT03801148|Lansoprazole|lansoprazole|mesh-list
20066578|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20066579|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066580|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20066581|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066582|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119577|NCT00006200|Dacarbazine|dacarbazine|mesh-list
20119578|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119579|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
20119580|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119581|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
20119582|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20119583|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119584|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20119585|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20119586|NCT00006200|Growth Substances|growth substances|mesh-ancestor
20119587|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
20119588|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119589|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20119590|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
20119591|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119592|NCT00006203|Naltrexone|naltrexone|mesh-list
20119593|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20119594|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20119595|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119596|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
20119597|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119598|NCT00006204|Naltrexone|naltrexone|mesh-list
20119599|NCT00006204|Fluoxetine|fluoxetine|mesh-list
20119600|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20119601|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20119602|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119603|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
20119604|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119605|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20119606|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20119607|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20119608|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119609|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119610|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
20119611|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20119612|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
20119613|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20119614|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20119615|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20119616|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119617|NCT00006205|Topiramate|topiramate|mesh-list
20119618|NCT00006205|Ondansetron|ondansetron|mesh-list
20119619|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
20119620|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
20119621|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119622|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119623|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20119624|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
20119625|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
20119626|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20119627|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
20119628|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577130|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577131|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20066583|NCT03831854|Lamotrigine|lamotrigine|mesh-list
20066584|NCT03831854|Ketamine|ketamine|mesh-list
20066585|NCT03831854|Analgesics|analgesics|mesh-ancestor
20066586|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
20066587|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066588|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066589|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20066590|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20066591|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
20066592|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
20066593|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066594|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20066595|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20066596|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066597|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066598|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
20066599|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20066600|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20066601|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20066602|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20066603|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20066604|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20066605|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20066606|NCT03824912|Ketoconazole|ketoconazole|mesh-list
20066607|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
20066608|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066609|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20066610|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20066611|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066612|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066613|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20066614|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
20066615|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066616|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066617|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20066618|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
20066619|NCT03822884|Hematinics|hematinics|mesh-ancestor
20066620|NCT03806270|Midazolam|midazolam|mesh-list
20066621|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
20066622|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20066623|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20066624|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066625|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066626|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20066627|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20066628|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20066629|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20066630|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
20066631|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
20066632|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
20066633|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
20066634|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066635|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066636|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
20066637|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066638|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20066639|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
20066640|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
20066641|NCT03830892|Nicotine|nicotine|mesh-list
20066642|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20066643|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
20066644|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066645|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066646|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20066647|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20066648|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
20066649|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066650|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066651|NCT03823378|Upadacitinib|upadacitinib|mesh-list
20066652|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20066653|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20066654|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066655|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066656|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066657|NCT03830281|Insulin|insulin|mesh-list
20066658|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20066659|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
20066660|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066661|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066662|NCT03818815|Amoxicillin|amoxicillin|mesh-list
20066663|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
20066664|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
20066665|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20066666|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20066667|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066668|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20066669|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066670|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066671|NCT03828539|Topiramate|topiramate|mesh-list
20066672|NCT03828539|Erenumab|erenumab|mesh-list
20066673|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20066674|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
20066675|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066676|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066677|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20066678|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066679|NCT03828539|Analgesics|analgesics|mesh-ancestor
20066680|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
20066681|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066682|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
20066683|NCT03824704|Nivolumab|nivolumab|mesh-list
20066684|NCT03824704|Rucaparib|rucaparib|mesh-list
20066685|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20066686|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066687|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20066688|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066689|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20066690|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066691|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
20066692|NCT03827473|Prednisone|prednisone|mesh-list
20066693|NCT03827473|Cortisone|cortisone|mesh-list
20066694|NCT03827473|Docetaxel|docetaxel|mesh-list
20066695|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
20066696|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
20066697|NCT03827473|Hormones|hormones|mesh-list
20066698|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20066699|NCT03827473|Androgens|androgens|mesh-list
20066700|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
20066701|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066702|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
20066703|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
20066704|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
20066705|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066706|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066707|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
20066708|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066709|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066710|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20066711|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20066712|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066713|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
20066714|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20066715|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
20066716|NCT03827473|Protective Agents|protective agents|mesh-ancestor
20066717|NCT03827473|Vitamins|vitamins|mesh-ancestor
20066718|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
20066719|NCT03827473|Estrogens|estrogens|mesh-ancestor
20066720|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
20066721|NCT03812328|Enoxaparin|enoxaparin|mesh-list
20066722|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
20066723|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20066724|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20066725|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066726|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20066727|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20066728|NCT03822182|Dexamethasone|dexamethasone|mesh-list
20066729|NCT03822182|Bupivacaine|bupivacaine|mesh-list
20066730|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066731|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
20066732|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
20066733|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066734|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066735|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066736|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
20066737|NCT03822182|Hormones|hormones|mesh-ancestor
20066738|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066739|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20066740|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066741|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066742|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
20066743|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066744|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
20066745|NCT03822416|Nicotine|nicotine|mesh-list
20066746|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20066747|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
20066748|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066749|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066750|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20066751|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20066752|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
20066753|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066754|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066755|NCT03806231|Dinoprostone|dinoprostone|mesh-list
20066756|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
20066757|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20066758|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066759|NCT03822377|Ticagrelor|ticagrelor|mesh-list
20066760|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20066761|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20066762|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20066763|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20066764|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
20066765|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066766|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066767|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066768|NCT03820388|Propofol|propofol|mesh-list
20066769|NCT03820388|Etomidate|etomidate|mesh-list
20066770|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20066771|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066772|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066773|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20066774|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
20066775|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
20066776|NCT03809182|Fentanyl|fentanyl|mesh-list
20066777|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
20066778|NCT03809182|Morphine|morphine|mesh-list
20066779|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20066780|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066781|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066782|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066783|NCT03809182|Analgesics|analgesics|mesh-ancestor
20066784|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
20066785|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066786|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20066787|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20066788|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20066789|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
20066790|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066791|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066792|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20066793|NCT03809182|Narcotics|narcotics|mesh-ancestor
20066794|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20066795|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20066796|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
20066797|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
20066798|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
20066799|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066800|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066801|NCT03805672|Enoxaparin|enoxaparin|mesh-list
20066802|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
20066803|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
20066804|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20066805|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20066806|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066807|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20066808|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20066809|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066810|NCT03802994|Vaccines|vaccines|mesh-list
20066811|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20066812|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
20066813|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066814|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20066815|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20066816|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
20066817|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066818|NCT03807245|Antacids|antacids|mesh-ancestor
20066819|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066820|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066821|NCT03802916|Deferiprone|deferiprone|mesh-list
20066822|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20066823|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
20066824|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
20066825|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066826|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
20066827|NCT03805386|Narcotics|narcotics|mesh-ancestor
20066828|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066829|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066830|NCT03805386|Analgesics|analgesics|mesh-ancestor
20066831|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
20066832|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066833|NCT03803475|Edetic Acid|edetic acid|mesh-list
20066834|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
20066835|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
20066836|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066837|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
20066838|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20066839|NCT03802227|Oxycodone|oxycodone|mesh-list
20066840|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20066841|NCT03802227|Narcotics|narcotics|mesh-ancestor
20066842|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293578|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293579|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20293580|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20293581|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293582|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
20293583|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20293584|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
20293585|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20293586|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
20293587|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
20293588|NCT04234217|Niacin|niacin|mesh-list
20293589|NCT04234217|Niacinamide|niacinamide|mesh-list
20293590|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
20293591|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20293592|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
20293593|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293594|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20293595|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
20066843|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293596|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
20066844|NCT03802227|Analgesics|analgesics|mesh-ancestor
20066845|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
20066846|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066847|NCT03802864|Bupivacaine|bupivacaine|mesh-list
20066848|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066849|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
20066850|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066851|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066852|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
20066853|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066854|NCT03801265|Ropivacaine|ropivacaine|mesh-list
20066855|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066856|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
20066857|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293597|NCT04234217|Vitamins|vitamins|mesh-ancestor
20066858|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293598|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
20066859|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
20066860|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066861|NCT03801928|Infliximab|infliximab|mesh-list
20066862|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066863|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066864|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066865|NCT03800173|Galidesivir|galidesivir|mesh-list
20066866|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
20066867|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066868|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
20066869|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20066870|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066871|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066872|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066873|NCT03799783|Analgesics|analgesics|mesh-ancestor
20066874|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
20066875|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066876|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20066877|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20066878|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20066879|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
20066880|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066881|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066882|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
20066883|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
20066884|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20066885|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20066886|NCT03797872|Prednisolone|prednisolone|mesh-list
20066887|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
20066888|NCT03797872|Triamcinolone|triamcinolone|mesh-list
20066889|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20066890|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20066891|NCT03797872|Methotrexate|methotrexate|mesh-list
20066892|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20066893|NCT03797872|Leflunomide|leflunomide|mesh-list
20066894|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20066895|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
20066896|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20066897|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
20066898|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20066899|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066900|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20066901|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
20066902|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066903|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20066904|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066905|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066906|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20066907|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20066908|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
20066909|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066910|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20066911|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066912|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
20066913|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
20066914|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066915|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066916|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
20066917|NCT03797872|Hormones|hormones|mesh-ancestor
20066918|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20066919|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20066920|NCT03797872|Protective Agents|protective agents|mesh-ancestor
20066921|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20066922|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20066923|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20066924|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066925|NCT03797872|Analgesics|analgesics|mesh-ancestor
20066926|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
20066927|NCT03799484|Lidocaine|lidocaine|mesh-list
20066928|NCT03799484|Prilocaine|prilocaine|mesh-list
20066929|NCT03799484|Petrolatum|petrolatum|mesh-list
20066930|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
20066931|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20066932|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20066933|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066934|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
20066935|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066936|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066937|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
20066938|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066939|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20066940|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20066941|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20066942|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20066943|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066944|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20066945|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
20066946|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20066947|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20066948|NCT03799484|Emollients|emollients|mesh-ancestor
20066949|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
20066950|NCT03796728|Lidocaine|lidocaine|mesh-list
20066951|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
20066952|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
20066953|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066954|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066955|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
20066956|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066957|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20066958|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20066959|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20066960|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20066961|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066962|NCT03796260|Entrectinib|entrectinib|mesh-list
20066963|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20066964|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066965|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066966|NCT03780959|Etanercept|etanercept|mesh-list
20066967|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20066968|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066969|NCT03780959|Analgesics|analgesics|mesh-ancestor
20066970|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
20066971|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066972|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066973|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20066974|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20066975|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20066976|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20066977|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
20066978|NCT03796182|Metformin|metformin|mesh-list
20066979|NCT03796182|Abrocitinib|abrocitinib|mesh-list
20066980|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20066981|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066982|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20066983|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066984|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066985|NCT03796013|Entrectinib|entrectinib|mesh-list
20066986|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20066987|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20066988|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20066989|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
20066990|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20066991|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20066992|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20066993|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20066994|NCT03793751|Analgesics|analgesics|mesh-ancestor
20066995|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
20066996|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20066997|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20066998|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20066999|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20067000|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067001|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067002|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067003|NCT03793556|Omeprazole|omeprazole|mesh-list
20067004|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20067005|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067006|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20067007|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067008|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067009|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20067010|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20067011|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20067012|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20067013|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20067014|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20067015|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20067016|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067017|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067018|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067019|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119629|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119630|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20119631|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20119632|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20119633|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20119634|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20119635|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
20119636|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20119637|NCT00006206|Naltrexone|naltrexone|mesh-list
20119638|NCT00006206|Acamprosate|acamprosate|mesh-list
20119639|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20119640|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20119641|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119642|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
20119643|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119644|NCT00006208|Emtricitabine|emtricitabine|mesh-list
20119645|NCT00006208|Efavirenz|efavirenz|mesh-list
20119646|NCT00006208|Stavudine|stavudine|mesh-list
20119647|NCT00006208|Didanosine|didanosine|mesh-list
20119648|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
20119649|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119650|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20119651|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119652|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119653|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119654|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119655|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119656|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20119657|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20119658|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20119659|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20119660|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20119661|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20119662|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
20119663|NCT00006211|Nelfinavir|nelfinavir|mesh-list
20119664|NCT00006211|Capravirine|capravirine|mesh-list
20119665|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20119666|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20119667|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
20119668|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119669|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119670|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119671|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20119672|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
20119673|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119674|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20119675|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119676|NCT00006212|Vinblastine|vinblastine|mesh-list
20119677|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119678|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20293599|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293600|NCT04230252|Acetaminophen|acetaminophen|mesh-list
20293601|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20293602|NCT04230252|Analgesics|analgesics|mesh-ancestor
20293603|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
20293604|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293605|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293606|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
20293607|NCT04230031|Daratumumab|daratumumab|mesh-list
20577132|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119679|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
20577133|NCT02076529|Ramosetron|ramosetron|mesh-list
20293608|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067020|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
20067021|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
20067022|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
20067023|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067024|NCT03792672|Ketamine|ketamine|mesh-list
20067025|NCT03792672|Analgesics|analgesics|mesh-ancestor
20067026|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
20067027|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067028|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067029|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20067030|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20067031|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
20067032|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
20067033|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067034|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20067035|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20067036|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067037|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067038|NCT03792191|Fentanyl|fentanyl|mesh-list
20067039|NCT03792191|Bupivacaine|bupivacaine|mesh-list
20067040|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
20067041|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
20067042|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067043|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067044|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
20067045|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067046|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20067047|NCT03792191|Narcotics|narcotics|mesh-ancestor
20067048|NCT03792191|Analgesics|analgesics|mesh-ancestor
20067049|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20067050|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20067051|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
20067052|NCT03789175|Niacinamide|niacinamide|mesh-list
20067053|NCT03789175|Niacin|niacin|mesh-list
20067054|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
20067055|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
20067056|NCT03789175|Vitamins|vitamins|mesh-ancestor
20067057|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
20067058|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067059|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20067060|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
20067061|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067062|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20067063|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
20067064|NCT03783702|Acetaminophen|acetaminophen|mesh-list
20067065|NCT03783702|Ibuprofen|ibuprofen|mesh-list
20067066|NCT03783702|Oxycodone|oxycodone|mesh-list
20067067|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20067068|NCT03783702|Analgesics|analgesics|mesh-ancestor
20067069|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
20067070|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067071|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067072|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
20067073|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20067074|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067075|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20067076|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20067077|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067078|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067079|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20067080|NCT03783702|Narcotics|narcotics|mesh-ancestor
20067081|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067082|NCT03781479|Amifampridine|amifampridine|mesh-list
20067083|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20067084|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067085|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067086|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20067087|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20067088|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067089|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
20067090|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
20067091|NCT03783039|Coagulants|coagulants|mesh-ancestor
20067092|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20067093|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
20067094|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20067095|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
20067096|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067097|NCT03783130|Antacids|antacids|mesh-ancestor
20067098|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067099|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067100|NCT03773796|Nabilone|nabilone|mesh-list
20067101|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
20067102|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
20067103|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067104|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067105|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067106|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20067107|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20067108|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067109|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067110|NCT03782233|Bromides|bromides|mesh-list
20067111|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20067112|NCT03782233|Rocuronium|rocuronium|mesh-list
20067113|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
20067114|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20067115|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20067116|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20067117|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067118|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067119|NCT03781375|Etanercept|etanercept|mesh-list
20067120|NCT03781375|Methotrexate|methotrexate|mesh-list
20067121|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20067122|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
20067123|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20067124|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067125|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20067126|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
20067127|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067128|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067129|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
20067130|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067131|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20067132|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067133|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
20067134|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20067135|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20067136|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20067137|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20067138|NCT03781375|Analgesics|analgesics|mesh-ancestor
20067139|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
20067140|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067141|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067142|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067143|NCT03780010|Paclitaxel|paclitaxel|mesh-list
20067144|NCT03780010|Carboplatin|carboplatin|mesh-list
20067145|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20067146|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067147|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
20067148|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
20067149|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
20067150|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067151|NCT03774576|Itraconazole|itraconazole|mesh-list
20067152|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
20067153|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067154|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20067155|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20067156|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067157|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067158|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20067159|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
20067160|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067161|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067162|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20067163|NCT03772041|Tolvaptan|tolvaptan|mesh-list
20067164|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20067165|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067166|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
20119680|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293609|NCT04213404|Spartalizumab|spartalizumab|mesh-list
20067167|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067168|NCT03774745|Mifepristone|mifepristone|mesh-list
20067169|NCT03774745|Progesterone|progesterone|mesh-list
20067170|NCT03774745|Progestins|progestins|mesh-ancestor
20067171|NCT03774745|Hormones|hormones|mesh-ancestor
20067172|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067173|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067174|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20067175|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
20067176|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20067177|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20067178|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20067179|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20067180|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
20067181|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20067182|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20067183|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
20067184|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
20067185|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20067186|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20067187|NCT03771560|Leucovorin|leucovorin|mesh-list
20067188|NCT03771560|Folic Acid|folic acid|mesh-list
20067189|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
20067190|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067191|NCT03771560|Antidotes|antidotes|mesh-ancestor
20067192|NCT03771560|Protective Agents|protective agents|mesh-ancestor
20067193|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
20067194|NCT03771560|Vitamins|vitamins|mesh-ancestor
20067195|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
20067196|NCT03771560|Hematinics|hematinics|mesh-ancestor
20067197|NCT03770091|Allantoin|allantoin|mesh-list
20067198|NCT03770091|Dermatologic Agents|dermatologic agents|mesh-ancestor
20067199|NCT03769896|Nabilone|nabilone|mesh-list
20067200|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
20067201|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
20067202|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067203|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067204|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067205|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20067206|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20067207|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067208|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067209|NCT03768726|Ziprasidone|ziprasidone|mesh-list
20067210|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20067211|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
20067212|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067213|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067214|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067215|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20067216|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20067217|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067218|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067219|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20067220|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
20067221|NCT03767738|Aflibercept|aflibercept|mesh-list
20067222|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20067223|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20067224|NCT03767738|Growth Substances|growth substances|mesh-ancestor
20067225|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067226|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
20067227|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067228|NCT03767062|Topiramate|topiramate|mesh-list
20067229|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
20067230|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20067231|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067232|NCT03765502|Glucagon|glucagon|mesh-list
20293610|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20067233|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20067234|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067235|NCT03765502|Hormones|hormones|mesh-ancestor
20067236|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067237|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067238|NCT03765502|Incretins|incretins|mesh-ancestor
20067239|NCT03765138|Pramipexole|pramipexole|mesh-list
20067240|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
20067241|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067242|NCT03765138|Protective Agents|protective agents|mesh-ancestor
20067243|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067244|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20067245|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20067246|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
20067247|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
20067248|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067249|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
20067250|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
20067251|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067252|NCT03763929|Protective Agents|protective agents|mesh-ancestor
20067253|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067254|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20067255|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067256|NCT03763175|Lovastatin|lovastatin|mesh-list
20067257|NCT03763175|L 647318|l 647318|mesh-list
20067258|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
20067259|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20067260|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20067261|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
20293611|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293612|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293613|NCT04200417|Mitomycins|mitomycins|mesh-list
20293614|NCT04200417|Mitomycin|mitomycin|mesh-list
20293615|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
20293616|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20293617|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293618|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
20293619|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293620|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20293621|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293622|NCT04199117|Nicotine|nicotine|mesh-list
20293623|NCT04199117|Varenicline|varenicline|mesh-list
20293624|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20293625|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
20293626|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293627|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293628|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20293629|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20293630|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293631|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293632|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293633|NCT04196257|Paclitaxel|paclitaxel|mesh-list
20293634|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20293635|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293636|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
20293637|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293638|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
20293639|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293640|NCT04188873|Varenicline|varenicline|mesh-list
20293641|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293642|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293643|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293644|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20293645|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20293646|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293647|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
20293648|NCT04176783|Narcotics|narcotics|mesh-ancestor
20293649|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293650|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293651|NCT04176783|Analgesics|analgesics|mesh-ancestor
20067262|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067263|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20067264|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20067265|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067266|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
20293652|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
20293653|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293654|NCT04176172|Nicotine|nicotine|mesh-list
20067267|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20067268|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067269|NCT03760250|Imiquimod|imiquimod|mesh-list
20067270|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20293655|NCT04176172|Varenicline|varenicline|mesh-list
20293656|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20067271|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
20119681|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
20067272|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067273|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067274|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
20067275|NCT03759600|Niraparib|niraparib|mesh-list
20067276|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20067277|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067278|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067279|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067280|NCT03758365|Triamcinolone|triamcinolone|mesh-list
20067281|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20067282|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20067283|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
20067284|NCT03758365|Betamethasone|betamethasone|mesh-list
20067285|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
20067286|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20067287|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
20067288|NCT03758365|Clobetasol|clobetasol|mesh-list
20067289|NCT03758365|Desonide|desonide|mesh-list
20067290|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
20067291|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20067292|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20067293|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067294|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
20067295|NCT03758365|Hormones|hormones|mesh-ancestor
20067296|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067297|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067298|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067299|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
20067300|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067301|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067302|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20067303|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
20067304|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
20067305|NCT03757234|Levofloxacin|levofloxacin|mesh-list
20067306|NCT03757234|Ofloxacin|ofloxacin|mesh-list
20067307|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20067308|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067309|NCT03757234|Renal Agents|renal agents|mesh-ancestor
20067310|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067311|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20067312|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20067313|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067314|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067315|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067316|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20067317|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20067318|NCT03756883|Fluticasone|fluticasone|mesh-list
20067319|NCT03756883|Xhance|xhance|mesh-list
20067320|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20067321|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20067322|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067323|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20067324|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
20067325|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067326|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067327|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20067328|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
20067329|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
20067330|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20067331|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20067332|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20067333|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20067334|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067335|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067336|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067337|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
20067338|NCT03756883|Hormones|hormones|mesh-ancestor
20067339|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067340|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
20067341|NCT03756129|Ketamine|ketamine|mesh-list
20067342|NCT03756129|Analgesics|analgesics|mesh-ancestor
20067343|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
20067344|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067345|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067346|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20067347|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20067348|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
20067349|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
20067350|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067351|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20067352|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20067353|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067354|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067355|NCT03756038|Lorazepam|lorazepam|mesh-list
20067356|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
20067357|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
20067358|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
20067359|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067360|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067361|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067362|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20067363|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067364|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20067365|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20067366|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067367|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
20067368|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
20067369|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067370|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119682|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119683|NCT00006214|Flutamide|flutamide|mesh-list
20119684|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
20119685|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
20119686|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119687|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119688|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20119689|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119690|NCT00006215|Docetaxel|docetaxel|mesh-list
20119691|NCT00006215|Vinorelbine|vinorelbine|mesh-list
20119692|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119693|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119694|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119695|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119696|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119697|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119698|NCT00006216|Ganciclovir|ganciclovir|mesh-list
20119699|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20119700|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
20119701|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119702|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20119703|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119704|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119705|NCT00006219|Clarithromycin|clarithromycin|mesh-list
20119706|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20119707|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20119708|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119709|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20119710|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119711|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119712|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20119713|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20119714|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20119715|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
20119716|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119717|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
20119718|NCT00006220|Tretinoin|tretinoin|mesh-list
20119719|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119720|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
20119721|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
20119722|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
20119723|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20119724|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
20119725|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119726|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20119727|NCT00006223|Protective Agents|protective agents|mesh-ancestor
20119728|NCT00006224|Gemcitabine|gemcitabine|mesh-list
20119729|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577134|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
20577135|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
20067371|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
20067372|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20067373|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
20067374|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20067375|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067376|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20067377|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20067378|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20067379|NCT03753113|Minoxidil|minoxidil|mesh-list
20067380|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20067381|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
20067382|NCT03751657|Insulin|insulin|mesh-list
20067383|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20067384|NCT03751657|Metformin|metformin|mesh-list
20067385|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
20067386|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20067387|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20067388|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067389|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
20067390|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067391|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067392|NCT03747497|Linezolid|linezolid|mesh-list
20067393|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067394|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067395|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20067396|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067397|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067398|NCT03743038|Minocycline|minocycline|mesh-list
20067399|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067400|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067401|NCT03742154|Varenicline|varenicline|mesh-list
20067402|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20067403|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20067404|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
20067405|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067406|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067407|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067408|NCT03740659|Levofloxacin|levofloxacin|mesh-list
20067409|NCT03740659|Ofloxacin|ofloxacin|mesh-list
20067410|NCT03740659|Dexamethasone|dexamethasone|mesh-list
20067411|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
20067412|NCT03740659|BB 1101|bb 1101|mesh-list
20067413|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067414|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
20067415|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
20067416|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067417|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067418|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067419|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
20067420|NCT03740659|Hormones|hormones|mesh-ancestor
20067421|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067422|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20067423|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067424|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
20067425|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067426|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067427|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20067428|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067429|NCT03740659|Renal Agents|renal agents|mesh-ancestor
20067430|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067431|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20067432|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20293657|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
20293658|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293659|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293660|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20293661|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20293662|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293663|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293664|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293665|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
20293666|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20293667|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20067433|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20119730|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
20293668|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20067434|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20067435|NCT03739528|Levofloxacin|levofloxacin|mesh-list
20067436|NCT03739528|Ofloxacin|ofloxacin|mesh-list
20067437|NCT03739528|Tobramycin|tobramycin|mesh-list
20067438|NCT03739528|Dexamethasone|dexamethasone|mesh-list
20067439|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
20067440|NCT03739528|BB 1101|bb 1101|mesh-list
20067441|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067442|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
20067443|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
20067444|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067445|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067446|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067447|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
20293669|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293670|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293671|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293672|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293673|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293674|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20577136|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067448|NCT03739528|Hormones|hormones|mesh-ancestor
20067449|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067450|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20067451|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067452|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
20067453|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067454|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067455|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20067456|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067457|NCT03739528|Renal Agents|renal agents|mesh-ancestor
20067458|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067459|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20067460|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20067461|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20067462|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20067463|NCT03738865|Glucagon|glucagon|mesh-list
20067464|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20067465|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067466|NCT03738865|Hormones|hormones|mesh-ancestor
20067467|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067468|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067469|NCT03738865|Incretins|incretins|mesh-ancestor
20067470|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20577137|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577138|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20577139|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20577140|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
20577141|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577142|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577143|NCT02076594|Docetaxel|docetaxel|mesh-list
20067471|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20067472|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20067473|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20067474|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067475|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
20067476|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067477|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067478|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20067479|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067480|NCT03736785|Insulin|insulin|mesh-list
20067481|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20577144|NCT02076594|Capecitabine|capecitabine|mesh-list
20577145|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
20577146|NCT02076594|Epirubicin|epirubicin|mesh-list
20577147|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067482|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067483|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
20067484|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
20067485|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067486|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
20067487|NCT03734601|Tacrolimus|tacrolimus|mesh-list
20067488|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20293675|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067489|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067490|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
20067491|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067492|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20067493|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067494|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067495|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20067496|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067497|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20067498|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
20067499|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067500|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067501|NCT03733899|Anesthetics|anesthetics|mesh-list
20067502|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067503|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067504|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
20067505|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
20067506|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20067507|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20067508|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067509|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067510|NCT03733470|Urological Agents|urological agents|mesh-ancestor
20067511|NCT03732248|Sirolimus|sirolimus|mesh-list
20067512|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067513|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067514|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20067515|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067516|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
20067517|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067518|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
20067519|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067520|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20067521|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
20067522|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067523|NCT03730961|Furosemide|furosemide|mesh-list
20067524|NCT03730961|Diuretics|diuretics|mesh-ancestor
20067525|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
20067526|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067527|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20067528|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20067529|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067530|NCT03730116|Bisoprolol|bisoprolol|mesh-list
20067531|NCT03730116|Perindopril|perindopril|mesh-list
20067532|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20067533|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
20067534|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
20067535|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067536|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067537|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20067538|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20067539|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20067540|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067541|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067542|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067543|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20067544|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
20067545|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067546|NCT03726996|Desipramine|desipramine|mesh-list
20067547|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20067548|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
20067549|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067550|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067551|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067552|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20067553|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20067554|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20067555|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067556|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067557|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067558|NCT03725085|Guaifenesin|guaifenesin|mesh-list
20067559|NCT03725085|Expectorants|expectorants|mesh-ancestor
20067560|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
20067561|NCT03724981|Dulaglutide|dulaglutide|mesh-list
20067562|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20067563|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067564|NCT03724968|Nivolumab|nivolumab|mesh-list
20067565|NCT03724968|Ipilimumab|ipilimumab|mesh-list
20067566|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20067567|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067568|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20067569|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067570|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
20067571|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20067572|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067573|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067574|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067575|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20067576|NCT03723980|Propolis|propolis|mesh-list
20067577|NCT03723980|Calcium|calcium|mesh-list
20067578|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20067579|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067580|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067581|NCT03723447|Dexamethasone|dexamethasone|mesh-list
20067582|NCT03723447|Epinephrine|epinephrine|mesh-list
20067583|NCT03723447|Bupivacaine|bupivacaine|mesh-list
20067584|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067585|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
20067586|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
20067587|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067588|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067589|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067590|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
20067591|NCT03723447|Hormones|hormones|mesh-ancestor
20067592|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067593|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20067594|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067595|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
20067596|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
20067597|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067598|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
20067599|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20067600|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20067601|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067602|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067603|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067604|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20067605|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20067606|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20067607|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
20067608|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
20067609|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
20067610|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20067611|NCT03718143|Adavosertib|adavosertib|mesh-list
20067612|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067613|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067614|NCT03709576|Azacitidine|azacitidine|mesh-list
20067615|NCT03709576|Pevonedistat|pevonedistat|mesh-list
20067616|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20067617|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
20067618|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067619|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067620|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067621|NCT03701295|Azacitidine|azacitidine|mesh-list
20067622|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20067623|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
20067624|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067625|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067626|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067627|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
20067628|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20067629|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20067630|NCT03694821|Prednisolone|prednisolone|mesh-list
20067631|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
20067632|NCT03694821|Ketorolac|ketorolac|mesh-list
20067633|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20293676|NCT04149210|Fluorometholone|fluorometholone|mesh-list
20067634|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20067635|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
20067636|NCT03694821|Hylan|hylan|mesh-list
20067637|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067638|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
20067639|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
20067640|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067641|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067642|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067643|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
20067644|NCT03694821|Hormones|hormones|mesh-ancestor
20067645|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067646|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20067647|NCT03694821|Protective Agents|protective agents|mesh-ancestor
20067648|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20067649|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067650|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20067651|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20067652|NCT03694821|Analgesics|analgesics|mesh-ancestor
20067653|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
20067654|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20067655|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20067656|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067657|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067658|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
20067659|NCT03682367|Gabapentin|gabapentin|mesh-list
20067660|NCT03682367|Analgesics|analgesics|mesh-ancestor
20067661|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
20067662|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067663|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067664|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
20067665|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20067666|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20067667|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067668|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067669|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20067670|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20067671|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067672|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067673|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
20067674|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
20067675|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20067676|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
20067677|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067678|NCT03680911|Expectorants|expectorants|mesh-ancestor
20067679|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
20067680|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20067681|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
20067682|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067683|NCT03680911|Protective Agents|protective agents|mesh-ancestor
20067684|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067685|NCT03680911|Antidotes|antidotes|mesh-ancestor
20067686|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20067687|NCT03656692|Hormones|hormones|mesh-ancestor
20067688|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067689|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119731|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119732|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119733|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
20119734|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119735|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119736|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119737|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
20119738|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119739|NCT00006226|Thalidomide|thalidomide|mesh-list
20119740|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119741|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
20119742|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067690|NCT03643159|Aripiprazole|aripiprazole|mesh-list
20067691|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
20067692|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
20067693|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067694|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20067695|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067696|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067697|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
20067698|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
20067699|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067700|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067701|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20067702|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20067703|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
20067704|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20067705|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20067706|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20067707|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20067708|NCT03630120|Sorafenib|sorafenib|mesh-list
20067709|NCT03630120|Lenvatinib|lenvatinib|mesh-list
20067710|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067711|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20067712|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067713|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067714|NCT03615144|Fludarabine|fludarabine|mesh-list
20067715|NCT03615144|Melphalan|melphalan|mesh-list
20067716|NCT03615144|Thiotepa|thiotepa|mesh-list
20067717|NCT03615144|Clofarabine|clofarabine|mesh-list
20067718|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
20067719|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20067720|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067721|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20067722|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
20067723|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067724|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067725|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
20067726|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067727|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20067728|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
20067729|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20067730|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
20067731|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067732|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
20067733|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20067734|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20067735|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067736|NCT03598140|Urological Agents|urological agents|mesh-ancestor
20067737|NCT03591458|Amitriptyline|amitriptyline|mesh-list
20067738|NCT03591458|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20067739|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20067740|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
20067741|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20067742|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20067743|NCT03591458|Analgesics|analgesics|mesh-ancestor
20067744|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
20067745|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067746|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067747|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20067748|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20067749|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20067750|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067751|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067752|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067753|NCT03591458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20067754|NCT03591458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20067755|NCT03591458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067756|NCT03590743|Apixaban|apixaban|mesh-list
20067757|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20067758|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
20067759|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20067760|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
20067761|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067762|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067763|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
20067764|NCT03580382|Trametinib|trametinib|mesh-list
20067765|NCT03580382|Antibodies|antibodies|mesh-list
20067766|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
20067767|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067768|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067769|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20067770|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067771|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067772|NCT03565328|Niacinamide|niacinamide|mesh-list
20067773|NCT03565328|Niacin|niacin|mesh-list
20067774|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
20067775|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
20067776|NCT03565328|Vitamins|vitamins|mesh-ancestor
20067777|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
20067778|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067779|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20067780|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
20067781|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067782|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20067783|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
20067784|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
20067785|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
20067786|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067787|NCT03538015|Carvedilol|carvedilol|mesh-list
20067788|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20067789|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20067790|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
20067791|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067792|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067793|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067794|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20067795|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
20067796|NCT03538015|Protective Agents|protective agents|mesh-ancestor
20067797|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20067798|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20067799|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20067800|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
20067801|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20067802|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20067803|NCT03509207|Vorinostat|vorinostat|mesh-list
20067804|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067805|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20067806|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067807|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067808|NCT03490916|Acetazolamide|acetazolamide|mesh-list
20067809|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
20067810|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20067811|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067812|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067813|NCT03490916|Diuretics|diuretics|mesh-ancestor
20067814|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
20067815|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067816|NCT03477903|Metoclopramide|metoclopramide|mesh-list
20067817|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
20067818|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
20067819|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067820|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067821|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067822|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20067823|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20067824|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
20067825|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067826|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067827|NCT03469258|Pancrelipase|pancrelipase|mesh-list
20067828|NCT03469258|Pancreatin|pancreatin|mesh-list
20067829|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067830|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
20067831|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20067832|NCT03465891|Atezolizumab|atezolizumab|mesh-list
20067833|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067834|NCT03465735|Heparin|heparin|mesh-list
20067835|NCT03465735|Enoxaparin|enoxaparin|mesh-list
20067836|NCT03465735|Dalteparin|dalteparin|mesh-list
20067837|NCT03465735|Warfarin|warfarin|mesh-list
20067838|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
20067839|NCT03465735|Dabigatran|dabigatran|mesh-list
20067840|NCT03465735|Apixaban|apixaban|mesh-list
20067841|NCT03465735|Edoxaban|edoxaban|mesh-list
20067842|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
20067843|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20067844|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20067845|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067846|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20067847|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
20067848|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20293677|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
20293678|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20293679|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20293680|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293681|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
20293682|NCT04149210|Hormones|hormones|mesh-ancestor
20293683|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293684|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293685|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20293686|NCT04141644|Ipilimumab|ipilimumab|mesh-list
20293687|NCT04141644|Osimertinib|osimertinib|mesh-list
20293688|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293689|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293690|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20293691|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293692|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293693|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293694|NCT04140266|Tenofovir|tenofovir|mesh-list
20293695|NCT04140266|Emtricitabine|emtricitabine|mesh-list
20293696|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20293697|NCT04140266|Dapivirine|dapivirine|mesh-list
20293698|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
20293699|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293700|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20293701|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20293702|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293703|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293704|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20293705|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20293706|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
20293707|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293708|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293709|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293710|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293711|NCT04115644|Triamcinolone|triamcinolone|mesh-list
20293712|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20067849|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
20067850|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067851|NCT03457818|Denosumab|denosumab|mesh-list
20067852|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20293713|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20293714|NCT04115644|Ketorolac|ketorolac|mesh-list
20293715|NCT04115644|Bupivacaine|bupivacaine|mesh-list
20293716|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20293717|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
20293718|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
20293719|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293720|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293721|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
20293722|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293723|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293724|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
20293725|NCT04115644|Hormones|hormones|mesh-ancestor
20293726|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293727|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293728|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
20293729|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293730|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293731|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20293732|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20293733|NCT04115644|Analgesics|analgesics|mesh-ancestor
20293734|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20067853|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067854|NCT03455556|Atezolizumab|atezolizumab|mesh-list
20067855|NCT03455556|Maytansine|maytansine|mesh-list
20067856|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20293735|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20293736|NCT04109729|Nivolumab|nivolumab|mesh-list
20293737|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293738|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293739|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20293740|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293741|NCT04096170|Lidocaine|lidocaine|mesh-list
20293742|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
20293743|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
20293744|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293745|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293746|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
20293747|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293748|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20293749|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20293750|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20293751|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293752|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293753|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
20293754|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293755|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293756|NCT04051320|Leuprolide|leuprolide|mesh-list
20293757|NCT04051320|Estradiol|estradiol|mesh-list
20293758|NCT04051320|Progesterone|progesterone|mesh-list
20293759|NCT04051320|Estrogens|estrogens|mesh-ancestor
20293760|NCT04051320|Hormones|hormones|mesh-ancestor
20293761|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293762|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293763|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20293764|NCT04051320|Progestins|progestins|mesh-ancestor
20293765|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20293766|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
20293767|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293768|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293769|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
20293770|NCT04036929|Estrogens|estrogens|mesh-list
20067857|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067858|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
20067859|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067860|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20293771|NCT04036929|Hormones|hormones|mesh-ancestor
20293772|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293773|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293774|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20293775|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20293776|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
20293777|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20293778|NCT04032626|Lenalidomide|lenalidomide|mesh-list
20293779|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
20293780|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293781|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20293782|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20293783|NCT04032626|Growth Substances|growth substances|mesh-ancestor
20293784|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
20293785|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293786|NCT04022980|Nivolumab|nivolumab|mesh-list
20293787|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293788|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293789|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20293790|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308369|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308370|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20308371|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20308372|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308373|NCT00663949|Captopril|captopril|mesh-list
20308374|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
20308375|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308376|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308377|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067861|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
20067862|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20067863|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
20067864|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067865|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
20293791|NCT04005859|Lidocaine|lidocaine|mesh-list
20293792|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
20293793|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
20293794|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293795|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293796|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
20293797|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293798|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20293799|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20293800|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20293801|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293802|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293803|NCT04001829|Paclitaxel|paclitaxel|mesh-list
20293804|NCT04001829|Docetaxel|docetaxel|mesh-list
20293805|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20293806|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20293807|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293808|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20293809|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
20293810|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20293811|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293812|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
20293813|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20293814|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20293815|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20293816|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20293817|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293818|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293819|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
20067866|NCT03447639|Povidone|povidone|mesh-list
20067867|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
20067868|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
20067869|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20067870|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067871|NCT03426137|Ketorolac|ketorolac|mesh-list
20067872|NCT03426137|Oxycodone|oxycodone|mesh-list
20067873|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20293820|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293821|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293822|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20293823|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293824|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
20293825|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20293826|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293827|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
20293828|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293829|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293830|NCT03975829|Trametinib|trametinib|mesh-list
20293831|NCT03975829|Dabrafenib|dabrafenib|mesh-list
20293832|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293833|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293834|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293835|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293836|NCT03974152|Nicotine|nicotine|mesh-list
20293837|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20293838|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
20293839|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067874|NCT03426137|Narcotics|narcotics|mesh-ancestor
20067875|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067876|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067877|NCT03426137|Analgesics|analgesics|mesh-ancestor
20067878|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
20067879|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067880|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20067881|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20067882|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20293840|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293841|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20293842|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20293843|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293844|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293845|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293846|NCT03969901|Relebactam|relebactam|mesh-list
20067883|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20067884|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20067885|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067886|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067887|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
20067888|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20067889|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20067890|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067891|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
20067892|NCT03425799|Coagulants|coagulants|mesh-ancestor
20067893|NCT03382925|Triamcinolone|triamcinolone|mesh-list
20067894|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20067895|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20067896|NCT03382925|Lidocaine|lidocaine|mesh-list
20067897|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20067898|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
20067899|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
20293847|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20293848|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293849|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293850|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20293851|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293852|NCT03959488|Palivizumab|palivizumab|mesh-list
20293853|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
20067900|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20067901|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067902|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
20067903|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293854|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293855|NCT03948568|Tamoxifen|tamoxifen|mesh-list
20293856|NCT03948568|Letrozole|letrozole|mesh-list
20293857|NCT03948568|Anastrozole|anastrozole|mesh-list
20293858|NCT03948568|Exemestane|exemestane|mesh-list
20293859|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293860|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20293861|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20293862|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293863|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293864|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20293865|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
20293866|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20293867|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293868|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20293869|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20293870|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20293871|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20293872|NCT03933904|Sirolimus|sirolimus|mesh-list
20293873|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20067904|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20067905|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20067906|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20067907|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20067908|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20067909|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067910|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
20067911|NCT03382925|Hormones|hormones|mesh-ancestor
20067912|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067913|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067914|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
20067915|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067916|NCT03370536|Ibutilide|ibutilide|mesh-list
20067917|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20067918|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
20067919|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20067920|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20067921|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
20067922|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293874|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293875|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20293876|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293877|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
20293878|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293879|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
20293880|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293881|NCT03927989|Nicotine|nicotine|mesh-list
20067923|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067924|NCT03360903|Caffeine|caffeine|mesh-list
20293882|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20293883|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
20293884|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293885|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293886|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20293887|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20293888|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293889|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293890|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293891|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
20293892|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293893|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293894|NCT03917472|Aflibercept|aflibercept|mesh-list
20293895|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20293896|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20293897|NCT03917472|Growth Substances|growth substances|mesh-ancestor
20293898|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293899|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
20293900|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293901|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
20293902|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20067925|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20067926|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067927|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20067928|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067929|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293903|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20293904|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20293905|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293906|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293907|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293908|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293909|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293910|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20293911|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293912|NCT03893617|Propranolol|propranolol|mesh-list
20293913|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20293914|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20293915|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
20293916|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293917|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293918|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293919|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20293920|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20293921|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
20293922|NCT03879135|Factor VIII|factor viii|mesh-list
20293923|NCT03879135|Coagulants|coagulants|mesh-ancestor
20293924|NCT03875664|Bupivacaine|bupivacaine|mesh-list
20293925|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
20293926|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
20293927|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20293928|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293929|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
20293930|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20293931|NCT03874715|Insulin|insulin|mesh-list
20293932|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20293933|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
20293934|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
20293935|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
20293936|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20293937|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20293938|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293939|NCT03870919|Palbociclib|palbociclib|mesh-list
20293940|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293941|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293942|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067930|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20067931|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20067932|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
20067933|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20067934|NCT03359174|Tretinoin|tretinoin|mesh-list
20067935|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293943|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293944|NCT03854929|Azithromycin|azithromycin|mesh-list
20293945|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
20293946|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20293947|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20293948|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20293949|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20293950|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293951|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293952|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293953|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20293954|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20293955|NCT03851614|Durvalumab|durvalumab|mesh-list
20293956|NCT03851614|Olaparib|olaparib|mesh-list
20067936|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
20067937|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
20067938|NCT03348904|Gemcitabine|gemcitabine|mesh-list
20067939|NCT03348904|Paclitaxel|paclitaxel|mesh-list
20293957|NCT03851614|Cediranib|cediranib|mesh-list
20293958|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293959|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293960|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20293961|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293962|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293963|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293964|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
20293965|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20577148|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
20577149|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
20577150|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
20577151|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577152|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577153|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
20577154|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20577155|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20577156|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20577157|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577158|NCT02076659|Methotrexate|methotrexate|mesh-list
20577159|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20577160|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
20577161|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20577162|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577163|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577164|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
20577165|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577166|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577167|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
20577168|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577169|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20577170|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577171|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
20577172|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20577173|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20577174|NCT02076685|Isoniazid|isoniazid|mesh-list
20577175|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
20577176|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20577177|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577178|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20577179|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20577180|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
20577181|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577182|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20577183|NCT02076750|Vitamin D|vitamin d|mesh-list
20577184|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
20577185|NCT02076750|Vitamins|vitamins|mesh-ancestor
20577186|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
20577187|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577188|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20067940|NCT03348904|Carboplatin|carboplatin|mesh-list
20067941|NCT03348904|Nivolumab|nivolumab|mesh-list
20067942|NCT03348904|Pemetrexed|pemetrexed|mesh-list
20067943|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20067944|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067945|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
20067946|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
20067947|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
20067948|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293966|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20293967|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20293968|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293969|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293970|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
20293971|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293972|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293973|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20293974|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308378|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20308379|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20308380|NCT00663949|Protective Agents|protective agents|mesh-ancestor
20308381|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308382|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308383|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20308384|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
20308385|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20308386|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
20308387|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20308388|NCT00664001|Antioxidants|antioxidants|mesh-list
20308389|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308390|NCT00664001|Protective Agents|protective agents|mesh-ancestor
20308391|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308392|NCT00664014|Tolvaptan|tolvaptan|mesh-list
20308393|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20308394|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308395|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
20308396|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308397|NCT00664040|Aspirin|aspirin|mesh-list
20308398|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308399|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308400|NCT00664040|Analgesics|analgesics|mesh-ancestor
20308401|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
20308402|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308403|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308404|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308405|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308406|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20308407|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20308408|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308409|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20308410|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308411|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308412|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
20308413|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20308414|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20308415|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
20308416|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067949|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20067950|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
20067951|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
20308417|NCT00664144|Rasburicase|rasburicase|mesh-list
20308418|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
20308419|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308420|NCT00664170|Docetaxel|docetaxel|mesh-list
20308421|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308422|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
20308423|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
20308424|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
20308425|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308426|NCT00664196|Hormones|hormones|mesh-list
20308427|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308428|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067952|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20067953|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20067954|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067955|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
20067956|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067957|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20067958|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20067959|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20308429|NCT00664222|Furosemide|furosemide|mesh-list
20067960|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20293975|NCT03824483|Venetoclax|venetoclax|mesh-list
20293976|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
20293977|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
20293978|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20293979|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20293980|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20293981|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293982|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293983|NCT03823768|Tacrolimus|tacrolimus|mesh-list
20293984|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20293985|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
20293986|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293987|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20293988|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20293989|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293990|NCT03812588|Citalopram|citalopram|mesh-list
20293991|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20293992|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20293993|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20293994|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20293995|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20293996|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
20293997|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20293998|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20293999|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
20294000|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20294001|NCT03809988|Letrozole|letrozole|mesh-list
20294002|NCT03809988|Fulvestrant|fulvestrant|mesh-list
20294003|NCT03809988|Palbociclib|palbociclib|mesh-list
20294004|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294005|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20294006|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20294007|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294008|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294009|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20294010|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
20294011|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294012|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294013|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294014|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20294015|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20294016|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
20294017|NCT03809884|Diuretics|diuretics|mesh-ancestor
20294018|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
20294019|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294020|NCT03809884|Expectorants|expectorants|mesh-ancestor
20294021|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
20294022|NCT03773107|Dexamethasone|dexamethasone|mesh-list
20294023|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294024|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
20294025|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
20294026|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294027|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294028|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20294029|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
20294030|NCT03773107|Hormones|hormones|mesh-ancestor
20294031|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294032|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294033|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294034|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
20294035|NCT03760718|Procaine|procaine|mesh-list
20294036|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
20294037|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
20294038|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294039|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294040|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
20294041|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294042|NCT03737253|Menotropins|menotropins|mesh-list
20294043|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20294044|NCT03737253|Hormones|hormones|mesh-ancestor
20294045|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294046|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294047|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20294048|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
20294049|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20294050|NCT03724994|Gemcitabine|gemcitabine|mesh-list
20294051|NCT03724994|Paclitaxel|paclitaxel|mesh-list
20294052|NCT03724994|Fluorouracil|fluorouracil|mesh-list
20294053|NCT03724994|Folfirinox|folfirinox|mesh-list
20294054|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20294055|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294056|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294057|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
20294058|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294059|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294060|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294061|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
20294062|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
20294063|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294064|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294065|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294066|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
20294067|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294068|NCT03709758|Cytarabine|cytarabine|mesh-list
20294069|NCT03709758|Daunorubicin|daunorubicin|mesh-list
20294070|NCT03709758|Venetoclax|venetoclax|mesh-list
20294071|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294072|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
20294073|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294074|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294075|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
20294076|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294077|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294078|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
20294079|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294080|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20294081|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20294082|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20294083|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294084|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20294085|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
20294086|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294087|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
20294088|NCT03695510|Afatinib|afatinib|mesh-list
20294089|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294090|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294091|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20294092|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294093|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294094|NCT03673527|Tacrolimus|tacrolimus|mesh-list
20294095|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294096|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
20294097|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294098|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20294099|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294100|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294101|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
20294102|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20294103|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294104|NCT03663504|Metronidazole|metronidazole|mesh-list
20294105|NCT03663504|Neomycin|neomycin|mesh-list
20294106|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294107|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20294108|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20294109|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20577189|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20067961|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
20067962|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20067963|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
20067964|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
20067965|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20067966|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
20067967|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20067968|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20067969|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20067970|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
20067971|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294110|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20294111|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308430|NCT00664222|Spironolactone|spironolactone|mesh-list
20294112|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294113|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
20294114|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294115|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294116|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
20294117|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20294118|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20294119|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20294120|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294121|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294122|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
20294123|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294124|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294125|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20294126|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294127|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20294128|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294129|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294130|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294131|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20294132|NCT03633058|Ketamine|ketamine|mesh-list
20294133|NCT03633058|Analgesics|analgesics|mesh-ancestor
20294134|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
20294135|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294136|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294137|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20294138|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20577190|NCT02076815|Anagrelide|anagrelide|mesh-list
20577191|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20577192|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20577193|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577194|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20577195|NCT02076828|Zinc|zinc|mesh-list
20577196|NCT02076828|Glycine|glycine|mesh-list
20577197|NCT02076828|Trace Elements|trace elements|mesh-ancestor
20577198|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
20577199|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577200|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
20577201|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577202|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577203|NCT02076841|Interferons|interferons|mesh-list
20577204|NCT02076841|Interferon-beta|interferon-beta|mesh-list
20577205|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
20577206|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577207|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
20577208|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577209|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
20577210|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577211|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20577212|NCT02076893|Ibuprofen|ibuprofen|mesh-list
20577213|NCT02076893|Gabapentin|gabapentin|mesh-list
20577214|NCT02076893|Tramadol|tramadol|mesh-list
20067972|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067973|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20067974|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20067975|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
20067976|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
20067977|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20067978|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067979|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
20067980|NCT03342638|Hormones|hormones|mesh-ancestor
20067981|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20067982|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20067983|NCT03342638|Protective Agents|protective agents|mesh-ancestor
20067984|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20067985|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20067986|NCT03342157|Sennosides|sennosides|mesh-list
20067987|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
20067988|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20067989|NCT03342157|Laxatives|laxatives|mesh-ancestor
20067990|NCT03339401|Brincidofovir|brincidofovir|mesh-list
20577215|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20577216|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20067991|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
20067992|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294139|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
20294140|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
20294141|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294142|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20294143|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20294144|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294145|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294146|NCT03613181|Paclitaxel|paclitaxel|mesh-list
20294147|NCT03613181|Capecitabine|capecitabine|mesh-list
20294148|NCT03613181|Methotrexate|methotrexate|mesh-list
20067993|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20067994|NCT03333746|Nivolumab|nivolumab|mesh-list
20067995|NCT03333746|Lenalidomide|lenalidomide|mesh-list
20067996|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20067997|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20067998|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20067999|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068000|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
20068001|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068002|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20068003|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20068004|NCT03333746|Growth Substances|growth substances|mesh-ancestor
20068005|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
20294149|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20294150|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294151|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294152|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
20294153|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294154|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294155|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294156|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
20294157|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20294158|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
20294159|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20294160|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294161|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
20294162|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294163|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20294164|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294165|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
20294166|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294167|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20294168|NCT03593655|Tenofovir|tenofovir|mesh-list
20294169|NCT03593655|Emtricitabine|emtricitabine|mesh-list
20294170|NCT03593655|Dapivirine|dapivirine|mesh-list
20294171|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
20294172|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294173|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20294174|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20294175|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294176|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294177|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20294178|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20294179|NCT03562871|Carboplatin|carboplatin|mesh-list
20294180|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
20294181|NCT03562871|Pemetrexed|pemetrexed|mesh-list
20294182|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294183|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294184|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294185|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294186|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20294187|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20294188|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
20294189|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294190|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
20294191|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294192|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294193|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294194|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
20294195|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294196|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294197|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20068006|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
19491644|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
20294198|NCT03521102|Acetaminophen|acetaminophen|mesh-list
20294199|NCT03521102|Hydromorphone|hydromorphone|mesh-list
20294200|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20294201|NCT03521102|Analgesics|analgesics|mesh-ancestor
20294202|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
20068007|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20068008|NCT03325114|Diuretics|diuretics|mesh-ancestor
20068009|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
20294203|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294204|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294205|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
20294206|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20294207|NCT03521102|Narcotics|narcotics|mesh-ancestor
20294208|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294209|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20294210|NCT03497676|Rilpivirine|rilpivirine|mesh-list
20294211|NCT03497676|Cabotegravir|cabotegravir|mesh-list
20294212|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
20294213|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294214|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20294215|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20294216|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294217|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294218|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20294219|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20294220|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20294221|NCT03484923|Spartalizumab|spartalizumab|mesh-list
20294222|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20294223|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294224|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294225|NCT03405090|Fentanyl|fentanyl|mesh-list
20294226|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
20294227|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20294228|NCT03405090|Narcotics|narcotics|mesh-ancestor
20294229|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294230|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294231|NCT03405090|Analgesics|analgesics|mesh-ancestor
20294232|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
20294233|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294234|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20294235|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20294236|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
20294237|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
20294238|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
20294239|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20294240|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
20308431|NCT00664222|Diuretics|diuretics|mesh-ancestor
20308432|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
20308433|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308434|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20308435|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20308436|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308437|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20308438|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
20308439|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308440|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20068010|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068011|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20068012|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20068013|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068014|NCT03305055|Fentanyl|fentanyl|mesh-list
20068015|NCT03305055|Ketamine|ketamine|mesh-list
20068016|NCT03305055|Analgesics|analgesics|mesh-ancestor
20068017|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
20068018|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068019|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068020|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20068021|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20068022|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
20068023|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
20068024|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068025|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20068026|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20308441|NCT00664248|Clindamycin|clindamycin|mesh-list
20294241|NCT03364868|Insulin|insulin|mesh-list
20294242|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20294243|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294244|NCT03364686|Biotin|biotin|mesh-list
20294245|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
20294246|NCT03364686|Vitamins|vitamins|mesh-ancestor
20294247|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
20294248|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294249|NCT03361306|Elotuzumab|elotuzumab|mesh-list
20294250|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294251|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
20294252|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20294253|NCT03341962|Calcium|calcium|mesh-list
20294254|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20294255|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294256|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20294257|NCT03333408|Clindamycin|clindamycin|mesh-list
20294258|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
20294259|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
20294260|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20294261|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294262|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20294263|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294264|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294265|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20294266|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
20294267|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20294268|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20294269|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20294270|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294271|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294272|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
20294273|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294274|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294275|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20294276|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294277|NCT03326791|Aspirin|aspirin|mesh-list
20294278|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20294279|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20294280|NCT03326791|Analgesics|analgesics|mesh-ancestor
20294281|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
20294282|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294283|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294284|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294285|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294286|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20294287|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20294288|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294289|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20294290|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20294291|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294292|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
20294293|NCT03289741|Octreotide|octreotide|mesh-list
20294294|NCT03289741|Lanreotide|lanreotide|mesh-list
20294295|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20294296|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294297|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294298|NCT03287947|Nintedanib|nintedanib|mesh-list
20294299|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294300|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20294301|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294302|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068027|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068028|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068029|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20068030|NCT03305055|Narcotics|narcotics|mesh-ancestor
20068031|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20068032|NCT03302247|Gemcitabine|gemcitabine|mesh-list
20068033|NCT03302247|Nivolumab|nivolumab|mesh-list
20068034|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20068035|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
20294303|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
20294304|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20577217|NCT02076893|Analgesics|analgesics|mesh-ancestor
20577218|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
20068036|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294305|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294306|NCT03287089|Renal Agents|renal agents|mesh-ancestor
20294307|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20294308|NCT03259867|Nivolumab|nivolumab|mesh-list
20294309|NCT03259867|Tirapazamine|tirapazamine|mesh-list
20294310|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294311|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294312|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20294313|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294314|NCT03255915|Tenofovir|tenofovir|mesh-list
20294315|NCT03255915|Emtricitabine|emtricitabine|mesh-list
20294316|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
20294317|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294318|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20294319|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20294320|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294321|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294322|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20294323|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20294324|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20294325|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
20294326|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294327|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
20294328|NCT03195374|Narcotics|narcotics|mesh-ancestor
20294329|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294330|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294331|NCT03195374|Analgesics|analgesics|mesh-ancestor
20294332|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
20294333|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294334|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
20294335|NCT03193216|Antacids|antacids|mesh-ancestor
20294336|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294337|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20294338|NCT03188068|Sirolimus|sirolimus|mesh-list
20294339|NCT03188068|Prednisolone|prednisolone|mesh-list
20294340|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20294341|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068037|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068038|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
20068039|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068040|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068041|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068042|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
20068043|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068044|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20068045|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20068046|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
20294342|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20294343|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294344|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
20294345|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294346|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
20294347|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294348|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294349|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
20294350|NCT03188068|Hormones|hormones|mesh-ancestor
20294351|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068047|NCT03277183|Hematinics|hematinics|mesh-ancestor
20068048|NCT03248141|Factor VIII|factor viii|mesh-list
20068049|NCT03248141|Coagulants|coagulants|mesh-ancestor
20068050|NCT03251326|Propranolol|propranolol|mesh-list
20068051|NCT03251326|Nabilone|nabilone|mesh-list
20294352|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294353|NCT03181789|Interleukin-12|interleukin-12|mesh-list
20294354|NCT03181789|Vaccines|vaccines|mesh-list
20294355|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
20294356|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294357|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20294358|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20294359|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20294360|NCT03181789|Growth Substances|growth substances|mesh-ancestor
20068052|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20068053|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20294361|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
20294362|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068054|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
20068055|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068056|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068057|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068058|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20068059|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20068060|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
20068061|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
20068062|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
20068063|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068064|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068065|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20068066|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068067|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068068|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068069|NCT03219372|Pravastatin|pravastatin|mesh-list
20068070|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20068071|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20068072|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
20068073|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068074|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20068075|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20068076|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068077|NCT03217175|Glucagon|glucagon|mesh-list
20068078|NCT03217175|Pancrelipase|pancrelipase|mesh-list
20068079|NCT03217175|Pancreatin|pancreatin|mesh-list
20068080|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068081|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068082|NCT03217175|Hormones|hormones|mesh-ancestor
20068083|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068084|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20068085|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20068086|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068087|NCT03232892|Trametinib|trametinib|mesh-list
20068088|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294363|NCT03143985|Pomalidomide|pomalidomide|mesh-list
20294364|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
20294365|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294366|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20294367|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20294368|NCT03143985|Growth Substances|growth substances|mesh-ancestor
20294369|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
20294370|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294371|NCT03141359|Paclitaxel|paclitaxel|mesh-list
20294372|NCT03141359|Etoposide|etoposide|mesh-list
20068089|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068090|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068091|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068092|NCT03169530|Ethanol|ethanol|mesh-list
20068093|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20068094|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068095|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294373|NCT03141359|Carboplatin|carboplatin|mesh-list
20294374|NCT03141359|Durvalumab|durvalumab|mesh-list
20294375|NCT03141359|Cisplatin|cisplatin|mesh-list
20294376|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20294377|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294378|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294379|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
20294380|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294381|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294382|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20294383|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20294384|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294385|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294386|NCT03133221|Idelalisib|idelalisib|mesh-list
20294387|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294388|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294389|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294390|NCT03117816|Interferons|interferons|mesh-list
20294391|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
20294392|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
20068096|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294393|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068097|NCT03189433|Dantrolene|dantrolene|mesh-list
20294394|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
20294395|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294396|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
20294397|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294398|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
20294399|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20294400|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20294401|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20294402|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294403|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294404|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
20294405|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294406|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294407|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20294408|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294409|NCT03100786|Dexamethasone|dexamethasone|mesh-list
20294410|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294411|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
20294412|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
20294413|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294414|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294415|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20294416|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
20294417|NCT03100786|Hormones|hormones|mesh-ancestor
20294418|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294419|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294420|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294421|NCT03051516|Vaccines|vaccines|mesh-list
20294422|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
20294423|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294424|NCT03034200|TIC10 compound|tic10 compound|mesh-list
20294425|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294426|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
20068098|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20068099|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068100|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20068101|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068102|NCT03172026|Maraviroc|maraviroc|mesh-list
20068103|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20068104|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20068105|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294427|NCT03015974|Prednisone|prednisone|mesh-list
20294428|NCT03015974|Prednisolone|prednisolone|mesh-list
20294429|NCT03015974|Deflazacort|deflazacort|mesh-list
20294430|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
20294431|NCT03015974|Dipyridamole|dipyridamole|mesh-list
20294432|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20294433|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20294434|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294435|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
20294436|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294437|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294438|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294439|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
20068106|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20068107|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20068108|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
20068109|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068110|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20068111|NCT03161964|Propranolol|propranolol|mesh-list
20068112|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20068113|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20068114|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
20068115|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068116|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068117|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068118|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20068119|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20068120|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
20294440|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294441|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294442|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20294443|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294444|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
20068121|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20294445|NCT03015974|Hormones|hormones|mesh-ancestor
20308442|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
20294446|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294447|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294448|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20294449|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20294450|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
20294451|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20294452|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294453|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294454|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
20294455|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20294456|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20294457|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
20294458|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
20294459|NCT03013504|Docetaxel|docetaxel|mesh-list
20294460|NCT03013504|Trastuzumab|trastuzumab|mesh-list
20294461|NCT03013504|Epirubicin|epirubicin|mesh-list
20294462|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294463|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
20294464|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294465|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294466|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294467|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
20294468|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294469|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294470|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20294471|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294472|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
20294473|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294474|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294475|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20294476|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20294477|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20294478|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294479|NCT02974049|Ivermectin|ivermectin|mesh-list
20294480|NCT02974049|Albendazole|albendazole|mesh-list
20294481|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
20294482|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20294483|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294484|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
20294485|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
20294486|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20294487|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20294488|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294489|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
20294490|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294491|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294492|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294493|NCT02974049|Filaricides|filaricides|mesh-ancestor
20294494|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
20294495|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20294496|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294497|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20294498|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20294499|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20294500|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
20294501|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294502|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294503|NCT02937766|Progestins|progestins|mesh-ancestor
20294504|NCT02937766|Hormones|hormones|mesh-ancestor
20294505|NCT02927938|Cytarabine|cytarabine|mesh-list
20294506|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294507|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
20294508|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294509|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294510|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
20294511|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577219|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577220|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577221|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294512|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294513|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
20294514|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294515|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
20294516|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20294517|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20294518|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294519|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
20294520|NCT02918201|Coagulants|coagulants|mesh-ancestor
20294521|NCT02883400|Spironolactone|spironolactone|mesh-list
20294522|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20294523|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
20294524|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294525|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294526|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20294527|NCT02883400|Diuretics|diuretics|mesh-ancestor
20294528|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
20294529|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
20294530|NCT02869217|Fludarabine|fludarabine|mesh-list
20294531|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294532|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
20294533|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294534|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294535|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294536|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
20294537|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294538|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294539|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20294540|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
20294541|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20294542|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294543|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294544|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20294545|NCT02856594|Analgesics|analgesics|mesh-ancestor
20294546|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
20294547|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294548|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20294549|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20294550|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20294551|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
20294552|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294553|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308443|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
20308444|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20308445|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308446|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308447|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20308448|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308449|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308450|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308942|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20308943|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
20308944|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20308945|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308946|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20308947|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
20308948|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308949|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308950|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308951|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308952|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20308953|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308954|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
20308955|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308956|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20308957|NCT00666393|Fentanyl|fentanyl|mesh-list
20308958|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20308959|NCT00666393|Narcotics|narcotics|mesh-ancestor
20308960|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20308961|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308962|NCT00666393|Analgesics|analgesics|mesh-ancestor
20308963|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
20308964|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308965|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20308966|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20308967|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
20308968|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
20308969|NCT00666484|Prednisolone|prednisolone|mesh-list
20308970|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
20308971|NCT00666484|Doxorubicin|doxorubicin|mesh-list
20068122|NCT03150160|Travoprost|travoprost|mesh-list
20068123|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20068124|NCT03150160|Brinzolamide|brinzolamide|mesh-list
20294554|NCT02823574|Nivolumab|nivolumab|mesh-list
20294555|NCT02823574|Ipilimumab|ipilimumab|mesh-list
20294556|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294557|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294558|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20294559|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294560|NCT02807636|Gemcitabine|gemcitabine|mesh-list
20294561|NCT02807636|Carboplatin|carboplatin|mesh-list
20294562|NCT02807636|Atezolizumab|atezolizumab|mesh-list
20294563|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294564|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294565|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
20294566|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294567|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
20294568|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294569|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294570|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294571|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
20294572|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294573|NCT02799134|Ascorbic Acid|ascorbic acid|mesh-list
20294574|NCT02799134|Dexamethasone|dexamethasone|mesh-list
20294575|NCT02799134|Vitamins|vitamins|mesh-ancestor
20294576|NCT02799134|Micronutrients|micronutrients|mesh-ancestor
20294577|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294578|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294579|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
20294580|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
20294581|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294582|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20294583|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
20294584|NCT02799134|Hormones|hormones|mesh-ancestor
20294585|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294586|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294587|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294588|NCT02799134|Antioxidants|antioxidants|mesh-ancestor
20294589|NCT02799134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294590|NCT02799134|Protective Agents|protective agents|mesh-ancestor
20294591|NCT02792413|Denosumab|denosumab|mesh-list
20294592|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20577222|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20577223|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20577224|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577225|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577226|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
20577227|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20577228|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20577229|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577230|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068125|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20068126|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20577231|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20577232|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20577233|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577234|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
20577235|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20577236|NCT02076893|Narcotics|narcotics|mesh-ancestor
20577237|NCT02076945|Lidocaine|lidocaine|mesh-list
20577238|NCT02076945|Bupivacaine|bupivacaine|mesh-list
20577239|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
20577240|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
20577241|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577242|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577243|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
20577244|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577245|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20577246|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20068127|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20068128|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20068129|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20068130|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
20068131|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294593|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308451|NCT00664287|Niacin|niacin|mesh-list
20577247|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20068132|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068133|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068134|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20068135|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068136|NCT03109418|Ketamine|ketamine|mesh-list
20068137|NCT03109418|Analgesics|analgesics|mesh-ancestor
20068138|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
20068139|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068140|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068141|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20068142|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20068143|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
20068144|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
20068145|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068146|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20068147|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20068148|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068149|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068150|NCT03120676|Atezolizumab|atezolizumab|mesh-list
20294594|NCT02773212|Amphetamine|amphetamine|mesh-list
20294595|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
20294596|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20294597|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294598|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
20294599|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
20294600|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294601|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
20294602|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294603|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294604|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
20294605|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20294606|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20294607|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294608|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20294609|NCT02757872|Vitamin D|vitamin d|mesh-list
20294610|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
20294611|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
20294612|NCT02757872|Vitamins|vitamins|mesh-list
20294613|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
20294614|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294615|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20294616|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20294617|NCT02746796|Capecitabine|capecitabine|mesh-list
20294618|NCT02746796|Tegafur|tegafur|mesh-list
20294619|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
20294620|NCT02746796|Nivolumab|nivolumab|mesh-list
20294621|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294622|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
20294623|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294624|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294625|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294626|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20294627|NCT02744976|Metformin|metformin|mesh-list
20294628|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20294629|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294630|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
20294631|NCT02743819|Ipilimumab|ipilimumab|mesh-list
20294632|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294633|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294634|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20294635|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294636|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
20294637|NCT02719392|Minocycline|minocycline|mesh-list
20294638|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20294639|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
20294640|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294641|NCT02719392|Expectorants|expectorants|mesh-ancestor
20294642|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
20294643|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20294644|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
20294645|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294646|NCT02719392|Protective Agents|protective agents|mesh-ancestor
20294647|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068151|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119743|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
20294648|NCT02719392|Antidotes|antidotes|mesh-ancestor
20294649|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20294650|NCT02697448|Propofol|propofol|mesh-list
20294651|NCT02697448|Sevoflurane|sevoflurane|mesh-list
20294652|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20294653|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294654|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294655|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20294656|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
20294657|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
20294658|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20294659|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20294660|NCT02685709|Octreotide|octreotide|mesh-list
20294661|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20294662|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294663|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294664|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
20294665|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
20294666|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
20294667|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20294668|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294669|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
20294670|NCT02684851|Coagulants|coagulants|mesh-ancestor
20294671|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
20294672|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20294673|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294674|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20294675|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294676|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
20294677|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294678|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294679|NCT02632409|Nivolumab|nivolumab|mesh-list
20294680|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294681|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068152|NCT03109873|Metformin|metformin|mesh-list
20068153|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20068154|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068155|NCT03113071|Decitabine|decitabine|mesh-list
20068156|NCT03113071|Digoxin|digoxin|mesh-list
20068157|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20068158|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
20068159|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294682|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20294683|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294684|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
20294685|NCT02619253|Vorinostat|vorinostat|mesh-list
20294686|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294687|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294688|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20294689|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294690|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294691|NCT02612194|Crizotinib|crizotinib|mesh-list
20294692|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294693|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20294694|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294695|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294696|NCT02586207|Cisplatin|cisplatin|mesh-list
20294697|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
20294698|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294699|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294700|NCT02584933|Ceritinib|ceritinib|mesh-list
20294701|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294702|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20294703|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294704|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294705|NCT02571725|Olaparib|olaparib|mesh-list
20294706|NCT02571725|Tremelimumab|tremelimumab|mesh-list
20294707|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20294708|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294709|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294710|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294711|NCT02546934|Gemcitabine|gemcitabine|mesh-list
20068160|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294712|NCT02546934|Cisplatin|cisplatin|mesh-list
20294713|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068161|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068162|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20068163|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20068164|NCT03113071|Protective Agents|protective agents|mesh-ancestor
20068165|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068166|NCT03110900|Lorazepam|lorazepam|mesh-list
20068167|NCT03110900|Haloperidol|haloperidol|mesh-list
20068168|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
20068169|NCT03110900|Loxapine|loxapine|mesh-list
20294714|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294715|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
20294716|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294717|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
20294718|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294719|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294720|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294721|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
20294722|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294723|NCT02531516|Bicalutamide|bicalutamide|mesh-list
20294724|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
20294725|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
20294726|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294727|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294728|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294729|NCT02519777|Maraviroc|maraviroc|mesh-list
20294730|NCT02519777|Dolutegravir|dolutegravir|mesh-list
20294731|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20068170|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
20068171|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
20068172|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068173|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068174|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068175|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20068176|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068177|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068178|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068179|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20068180|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
20294732|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20294733|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294734|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20294735|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20294736|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
20294737|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294738|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20294739|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20294740|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20294741|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294742|NCT02503774|Durvalumab|durvalumab|mesh-list
20294743|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294744|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294745|NCT02496585|Prednisone|prednisone|mesh-list
20294746|NCT02496585|Nintedanib|nintedanib|mesh-list
20294747|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20294748|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
20294749|NCT02496585|Hormones|hormones|mesh-ancestor
20294750|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294751|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294752|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294753|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294754|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20294755|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294756|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294757|NCT02484443|Dinutuximab|dinutuximab|mesh-list
20294758|NCT02484443|Sargramostim|sargramostim|mesh-list
20294759|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
20294760|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068181|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068182|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068183|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20068184|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
20068185|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20294761|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068186|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20068187|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
20068188|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
20068189|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
20068190|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20068191|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20068192|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20068193|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20068194|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294762|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
20294763|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294764|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
20294765|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294766|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294767|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294768|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
20294769|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294770|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294771|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20294772|NCT02395666|Eflornithine|eflornithine|mesh-list
20294773|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294774|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20294775|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20294776|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20294777|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294778|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20294779|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294780|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294781|NCT02357810|Topotecan|topotecan|mesh-list
20294782|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20294783|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20294784|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294785|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294786|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294787|NCT02343549|Bevacizumab|bevacizumab|mesh-list
20294788|NCT02343549|Temozolomide|temozolomide|mesh-list
20294789|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294790|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294791|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20294792|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20294793|NCT02343549|Growth Substances|growth substances|mesh-ancestor
20294794|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294795|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
20294796|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294797|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
20294798|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294799|NCT02329847|Nivolumab|nivolumab|mesh-list
20294800|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20294801|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294802|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20294803|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294804|NCT02328105|Paclitaxel|paclitaxel|mesh-list
20294805|NCT02328105|Carboplatin|carboplatin|mesh-list
20294806|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20294807|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20294808|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294809|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294810|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
20294811|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294812|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294813|NCT02327195|Methylphenidate|methylphenidate|mesh-list
20294814|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20294815|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294816|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20294817|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20294818|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294819|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294820|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
20294821|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294822|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
20294823|NCT02326311|Dasatinib|dasatinib|mesh-list
20294824|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491645|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068195|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
20068196|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294825|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20294826|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294827|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294828|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20294829|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
20294830|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
20577248|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577249|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577250|NCT02077010|Milrinone|milrinone|mesh-list
20577251|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20577252|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20577253|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
20577254|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20577255|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20577256|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577257|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068197|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068198|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20068199|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068200|NCT03065933|Clonidine|clonidine|mesh-list
20068201|NCT03065933|Analgesics|analgesics|mesh-ancestor
20068202|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
20068203|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068204|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577258|NCT02077010|Protective Agents|protective agents|mesh-ancestor
20577259|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577260|NCT02077231|Vitamins|vitamins|mesh-list
20577261|NCT02077231|Vitamin A|vitamin a|mesh-list
20577262|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
20577263|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
20577264|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577265|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
20577266|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577267|NCT02077231|Protective Agents|protective agents|mesh-ancestor
20577268|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20577269|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577270|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20577271|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20577272|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20577273|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
20577274|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577275|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20577276|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20577277|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577278|NCT02077309|Linagliptin|linagliptin|mesh-list
20577279|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20577280|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577281|NCT02077309|Incretins|incretins|mesh-ancestor
20577282|NCT02077309|Hormones|hormones|mesh-ancestor
20577283|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577284|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20577285|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
20577286|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577287|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577288|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
20577289|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
20577290|NCT02077322|Coagulants|coagulants|mesh-ancestor
20577291|NCT02077348|Hormones|hormones|mesh-list
20577292|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577293|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577294|NCT02077400|Cefazolin|cefazolin|mesh-list
20577295|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20577296|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577297|NCT02077478|Remifentanil|remifentanil|mesh-list
20577298|NCT02077478|Propofol|propofol|mesh-list
20577299|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20577300|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577301|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308452|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20068205|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20294831|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294832|NCT02265367|Milnacipran|milnacipran|mesh-list
20294833|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
20294834|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20294835|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20294836|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294837|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294838|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294839|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294840|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
20294841|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20294842|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20294843|NCT02265367|Analgesics|analgesics|mesh-ancestor
20294844|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
20294845|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294846|NCT02188264|Cyclosporine|cyclosporine|mesh-list
20294847|NCT02188264|Cyclosporins|cyclosporins|mesh-list
20294848|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294849|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294850|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294851|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
20294852|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294853|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
20294854|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294855|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
20294856|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294857|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20294858|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
20294859|NCT02161783|Fludarabine|fludarabine|mesh-list
20294860|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294861|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
20294862|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294863|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20294864|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294865|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
20294866|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294867|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294868|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20294869|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
20294870|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
20294871|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20294872|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294873|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294874|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
20294875|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20294876|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294877|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294878|NCT02122562|Ketamine|ketamine|mesh-list
20294879|NCT02122562|Analgesics|analgesics|mesh-ancestor
20294880|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
20294881|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294882|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294883|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20294884|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20294885|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
20294886|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
20294887|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294888|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20294889|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20294890|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294891|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294892|NCT02098876|Everolimus|everolimus|mesh-list
20294893|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294894|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294895|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
20294896|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294897|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
20294898|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20294899|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20294900|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20294901|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294902|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294903|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
20294904|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294905|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294906|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20294907|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294908|NCT01999569|Letrozole|letrozole|mesh-list
20294909|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294910|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20294911|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20294912|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294913|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294914|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20294915|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
20294916|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294917|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294918|NCT01959464|Progesterone|progesterone|mesh-list
20294919|NCT01959464|Progestins|progestins|mesh-ancestor
20294920|NCT01959464|Hormones|hormones|mesh-ancestor
20294921|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294922|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294923|NCT01921166|Leuprolide|leuprolide|mesh-list
20294924|NCT01921166|Clomiphene|clomiphene|mesh-list
20294925|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20294926|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
20294927|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20294928|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294929|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20294930|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294931|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20294932|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
20294933|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20294934|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20294935|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20308453|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
20308454|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308455|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20308456|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308457|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
20308458|NCT00664287|Vitamins|vitamins|mesh-ancestor
20308459|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
20308460|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308461|NCT00664313|Linezolid|linezolid|mesh-list
20308462|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308463|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308464|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20308465|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308466|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308467|NCT00664417|Vaccines|vaccines|mesh-list
20308468|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
20308469|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308470|NCT00664469|Atorvastatin|atorvastatin|mesh-list
20308471|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20068206|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
20068207|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
20068208|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20068209|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20308472|NCT00664469|Simvastatin|simvastatin|mesh-list
20308473|NCT00664469|Ezetimibe|ezetimibe|mesh-list
20308474|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20308475|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20308476|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
20308477|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068210|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20068211|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
20068212|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068213|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068214|NCT03070002|Denosumab|denosumab|mesh-list
20068215|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20068216|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068217|NCT03050398|Letrozole|letrozole|mesh-list
20068218|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308478|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20294936|NCT01879085|Gemcitabine|gemcitabine|mesh-list
20294937|NCT01879085|Docetaxel|docetaxel|mesh-list
20294938|NCT01879085|Vorinostat|vorinostat|mesh-list
20294939|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20294940|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
20068219|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20068220|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20068221|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068222|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068223|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20068224|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
20068225|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068226|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068227|NCT03042780|Folfirinox|folfirinox|mesh-list
20068228|NCT03042780|Sargramostim|sargramostim|mesh-list
20068229|NCT03042780|Lenograstim|lenograstim|mesh-list
20068230|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
20068231|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068232|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20068233|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068234|NCT03029832|Atezolizumab|atezolizumab|mesh-list
20068235|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068236|NCT03031340|Pregabalin|pregabalin|mesh-list
20068237|NCT03031340|Analgesics|analgesics|mesh-ancestor
20068238|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
20068239|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068240|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068241|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
20068242|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20068243|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20068244|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068245|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20068246|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20068247|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068248|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068249|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068250|NCT03007719|Fluorides|fluorides|mesh-list
20068251|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
20068252|NCT03007719|Protective Agents|protective agents|mesh-ancestor
20294941|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294942|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294943|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
20294944|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20294945|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294946|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20294947|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
20294948|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294949|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294950|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
20068253|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068254|NCT03010423|Nicorandil|nicorandil|mesh-list
20068255|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20068256|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20068257|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
20068258|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
20068259|NCT03010423|Vitamins|vitamins|mesh-ancestor
20068260|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
20068261|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068262|NCT02985801|Pancrelipase|pancrelipase|mesh-list
20068263|NCT02985801|Pancreatin|pancreatin|mesh-list
20068264|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068265|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
20068266|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20068267|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20294951|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294952|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20294953|NCT01845441|Fentanyl|fentanyl|mesh-list
20294954|NCT01845441|Midazolam|midazolam|mesh-list
20294955|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
20068268|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20068269|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20294956|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20068270|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068271|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
20294957|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20294958|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20294959|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20294960|NCT01845441|Analgesics|analgesics|mesh-ancestor
20294961|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
20294962|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20294963|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20294964|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20294965|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20294966|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
20294967|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294968|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294969|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20294970|NCT01845441|Narcotics|narcotics|mesh-ancestor
20294971|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20294972|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20294973|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
20294974|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
20294975|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20294976|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20294977|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20294978|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
19491646|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491647|NCT03129256|Apatinib|apatinib|mesh-list
19491648|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491649|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491650|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491651|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491652|NCT03129074|Capecitabine|capecitabine|mesh-list
19491653|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19491654|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
19491655|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491656|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491657|NCT03129022|Anesthetics|anesthetics|mesh-list
20068272|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20294979|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
20294980|NCT01821833|Paclitaxel|paclitaxel|mesh-list
20294981|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20294982|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294983|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
20294984|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
20294985|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
20294986|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294987|NCT01505608|Irinotecan|irinotecan|mesh-list
20294988|NCT01505608|Temozolomide|temozolomide|mesh-list
20294989|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20294990|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20294991|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20294992|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20294993|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20294994|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20294995|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
20294996|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20294997|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20294998|NCT01227616|Hematinics|hematinics|mesh-ancestor
20294999|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20295000|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20295001|NCT01192698|Interferons|interferons|mesh-list
20295002|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295003|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
20295004|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295005|NCT01188096|Poly ICLC|poly iclc|mesh-list
20068273|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068274|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20068275|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068276|NCT02994251|Gemcitabine|gemcitabine|mesh-list
20068277|NCT02994251|Doxorubicin|doxorubicin|mesh-list
20068278|NCT02994251|Mitomycins|mitomycins|mesh-list
20068279|NCT02994251|Mitomycin|mitomycin|mesh-list
20068280|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068281|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20068282|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
20068283|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068284|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
20068285|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068286|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295006|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
20068287|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068288|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
20295007|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
20295008|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295009|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20295010|NCT01114217|Hematinics|hematinics|mesh-ancestor
20295011|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20295012|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20295013|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20295014|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20295015|NCT01114204|Hematinics|hematinics|mesh-ancestor
20295016|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20295017|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20295018|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20295019|NCT01114139|Hematinics|hematinics|mesh-ancestor
20295020|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20295021|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20295022|NCT01059071|Eflornithine|eflornithine|mesh-list
20295023|NCT01059071|Etoposide|etoposide|mesh-list
20295024|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295025|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295026|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20295027|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20295028|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295029|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295030|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20295031|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20295032|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20295033|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295034|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20295035|NCT00934700|Xenon|xenon|mesh-list
20295036|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20295037|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
20295038|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
20295039|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295040|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295041|NCT00785291|Paclitaxel|paclitaxel|mesh-list
20295042|NCT00785291|Epothilones|epothilones|mesh-list
20577302|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20577303|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
20577304|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
20577305|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20577306|NCT02077478|Narcotics|narcotics|mesh-ancestor
20577307|NCT02077478|Analgesics|analgesics|mesh-ancestor
20577308|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
20577309|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577310|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
20068289|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068290|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20068291|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20068292|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20577311|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
20577312|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20577313|NCT02077556|Prednisolone|prednisolone|mesh-list
20577314|NCT02077556|Everolimus|everolimus|mesh-list
20577315|NCT02077556|Tacrolimus|tacrolimus|mesh-list
20577316|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577317|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
20577318|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577319|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20577320|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577321|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577322|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577323|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20577324|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20577325|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
20577326|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20577327|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577328|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577329|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
20577330|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
20577331|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068293|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
20068294|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20068295|NCT02971839|Ivacaftor|ivacaftor|mesh-list
20068296|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20577332|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295043|NCT00785291|Epothilone B|epothilone b|mesh-list
20295044|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20295045|NCT00785291|Bevacizumab|bevacizumab|mesh-list
20295046|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20295047|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
20295048|NCT00785291|Antibodies|antibodies|mesh-list
20295049|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
20295050|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20295051|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
20295052|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295053|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295054|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295055|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20295056|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295057|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295058|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20295059|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20295060|NCT00785291|Growth Substances|growth substances|mesh-ancestor
20295061|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295062|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
20295063|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
20295064|NCT00782288|Digitoxin|digitoxin|mesh-list
20295065|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20295066|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20295067|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295068|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295069|NCT00782288|Protective Agents|protective agents|mesh-ancestor
20295070|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295071|NCT00771654|Phentermine|phentermine|mesh-list
20295072|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20295073|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295074|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
20295075|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20295076|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
20295077|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
20295078|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295079|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
20295080|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295081|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295082|NCT00770809|Paclitaxel|paclitaxel|mesh-list
20295083|NCT00770809|Trastuzumab|trastuzumab|mesh-list
20295084|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20295085|NCT00770809|Lapatinib|lapatinib|mesh-list
20295086|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20295087|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20295088|NCT00770809|Antibodies|antibodies|mesh-list
20295089|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
20295090|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20295091|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295092|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295093|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295094|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
20295095|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295096|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295097|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
20295098|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295099|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295100|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295101|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
20295102|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
20295103|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295104|NCT00765310|Protective Agents|protective agents|mesh-ancestor
20295105|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295106|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
20295107|NCT00765310|Vitamins|vitamins|mesh-ancestor
20295108|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
20295109|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
20295110|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
20295111|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295112|NCT00764270|Protective Agents|protective agents|mesh-ancestor
20295113|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295114|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
20295115|NCT00764270|Vitamins|vitamins|mesh-ancestor
20295116|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
20295117|NCT00621751|Carbamazepine|carbamazepine|mesh-list
20295118|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
20295119|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
20295120|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20295121|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295122|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295123|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20295124|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20295125|NCT00621751|Analgesics|analgesics|mesh-ancestor
20068297|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20068298|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068299|NCT02985840|Dexamethasone|dexamethasone|mesh-list
20068300|NCT02985840|Ondansetron|ondansetron|mesh-list
20068301|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20068302|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
20068303|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
20068304|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068305|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068306|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068307|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
20068308|NCT02985840|Hormones|hormones|mesh-ancestor
20068309|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068310|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20295126|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
20295127|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295128|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20295129|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20295130|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295131|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20295132|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20295133|NCT00605215|Interferons|interferons|mesh-list
20295134|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
20295135|NCT00605215|Interferon-beta|interferon-beta|mesh-list
20295136|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295137|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
20295138|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295139|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20295140|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
20295141|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295142|NCT00302744|Niacin|niacin|mesh-list
20295143|NCT00302744|Psilocybin|psilocybin|mesh-list
20295144|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20295145|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
20295146|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295147|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20295148|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
20295149|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
20295150|NCT00302744|Vitamins|vitamins|mesh-ancestor
20295151|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
20295152|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295153|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
20295154|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20295155|NCT00290511|Vidarabine|vidarabine|mesh-list
20295156|NCT00290511|Dexamethasone|dexamethasone|mesh-list
20295157|NCT00290511|Rituximab|rituximab|mesh-list
20295158|NCT00290511|Fludarabine|fludarabine|mesh-list
20068311|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068312|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
20068313|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
20295159|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
20295160|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
20295161|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20295162|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068314|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20068315|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
20068316|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068317|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068318|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20068319|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068320|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068321|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20295163|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
20295164|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295165|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20295166|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20295167|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
20295168|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
20295169|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068322|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20295170|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295171|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
20295172|NCT00290511|Hormones|hormones|mesh-ancestor
20295173|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295174|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20295175|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20068323|NCT02974803|Trametinib|trametinib|mesh-list
20068324|NCT02974803|Dabrafenib|dabrafenib|mesh-list
20068325|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068326|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068327|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295176|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
20295177|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295178|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295179|NCT00290511|Antiviral Agents|antiviral agents|mesh-ancestor
20295180|NCT00290511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295181|NCT00290511|Analgesics|analgesics|mesh-ancestor
20295182|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
20295183|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20295184|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20295185|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295186|NCT00265798|Sorafenib|sorafenib|mesh-list
20295187|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295188|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295189|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295190|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295191|NCT00255216|Policosanol|policosanol|mesh-list
20295192|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20295193|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20295194|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
20295195|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295196|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20295197|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20295198|NCT00248703|Docetaxel|docetaxel|mesh-list
20295199|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295200|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295201|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
20295202|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295203|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295204|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20295205|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
20295206|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
20295207|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295208|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295209|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20295210|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20295211|NCT00195091|Growth Substances|growth substances|mesh-ancestor
20295212|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295213|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
20295214|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295215|NCT00005780|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20295216|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
20295217|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295218|NCT00611143|Atorvastatin|atorvastatin|mesh-list
20295219|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20295220|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20295221|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
20295222|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295223|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20295224|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20295225|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295226|NCT00611169|Tirofiban|tirofiban|mesh-list
20295227|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20295228|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20295229|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295230|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20295231|NCT00611195|Remifentanil|remifentanil|mesh-list
20295232|NCT00611195|Propofol|propofol|mesh-list
20295233|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20295234|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068328|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068329|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
20068330|NCT02974686|Everolimus|everolimus|mesh-list
20068331|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068332|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068333|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
20068334|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295235|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295236|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20295237|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
20295238|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
20295239|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20295240|NCT00611195|Narcotics|narcotics|mesh-ancestor
20295241|NCT00611195|Analgesics|analgesics|mesh-ancestor
20295242|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
20295243|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295244|NCT00611286|Sirolimus|sirolimus|mesh-list
20295245|NCT00611286|Paclitaxel|paclitaxel|mesh-list
20295246|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20295247|NCT00611286|Everolimus|everolimus|mesh-list
20068335|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20068336|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20068337|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
20068338|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20068339|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068340|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068341|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068342|NCT02956005|Tacrolimus|tacrolimus|mesh-list
20068343|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068344|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
20068345|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068346|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20068347|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295248|NCT00611286|Clopidogrel|clopidogrel|mesh-list
20295249|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
20295250|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295251|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295252|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295253|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
20295254|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295255|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295256|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295257|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
20295258|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295259|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20295260|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20295261|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20295262|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
20295263|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295264|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20295265|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295266|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20295267|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
20295268|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20295269|NCT00611416|Caffeine|caffeine|mesh-list
20295270|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20295271|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295272|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20068348|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068349|NCT02966184|Albuterol|albuterol|mesh-list
20068350|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20068351|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
20068352|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295273|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295274|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295275|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20295276|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20295277|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
20295278|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295279|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
20295280|NCT00611416|Protective Agents|protective agents|mesh-ancestor
20295281|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20295282|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20295283|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295284|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20295285|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
20295286|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20295287|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295288|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20068353|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295289|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
20295290|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20295291|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295292|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295293|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295294|NCT00611507|Fluorouracil|fluorouracil|mesh-list
20295295|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
20295296|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
20295297|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295298|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295299|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295300|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295301|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
20295302|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295303|NCT00611572|Flumazenil|flumazenil|mesh-list
20295304|NCT00611572|Antidotes|antidotes|mesh-ancestor
20295305|NCT00611572|Protective Agents|protective agents|mesh-ancestor
20295306|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295307|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
20295308|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
20295309|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295310|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308479|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20308480|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308481|NCT00664586|Masoprocol|masoprocol|mesh-list
20308482|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
20308483|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308484|NCT00664586|Protective Agents|protective agents|mesh-ancestor
20308485|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308486|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20308487|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308488|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308489|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308490|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308491|NCT00664586|Analgesics|analgesics|mesh-ancestor
20308492|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
20308493|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308494|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308495|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308496|NCT00664599|Rituximab|rituximab|mesh-list
20308497|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20308498|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308499|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
20308500|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308501|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308502|NCT00664677|Masoprocol|masoprocol|mesh-list
20308503|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
20308504|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308505|NCT00664677|Protective Agents|protective agents|mesh-ancestor
20308506|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308507|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20308508|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308509|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308510|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20068354|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20068355|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
20068356|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
20068357|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20068358|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20068359|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20068360|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20068361|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
20068362|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068363|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068364|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20068365|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20068366|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20068367|NCT02954159|Vedolizumab|vedolizumab|mesh-list
20068368|NCT02954159|Tacrolimus|tacrolimus|mesh-list
20068369|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068370|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
20068371|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068372|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20068373|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295311|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20295312|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
20295313|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295314|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20295315|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
20295316|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295317|NCT00611650|Protective Agents|protective agents|mesh-ancestor
20295318|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295319|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20295320|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20295321|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068374|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068375|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068376|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
20068377|NCT02947022|Zinc|zinc|mesh-list
20068378|NCT02947022|Edetic Acid|edetic acid|mesh-list
20068379|NCT02947022|Calcium|calcium|mesh-list
20068380|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
20068381|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20068382|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295322|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20295323|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20295324|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
20295325|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295326|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20295327|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20295328|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20068383|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20295329|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20295330|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295331|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295332|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295333|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20295334|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
20295335|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20295336|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
20295337|NCT00611689|Vatalanib|vatalanib|mesh-list
20295338|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295339|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295340|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295341|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295342|NCT00611728|Irinotecan|irinotecan|mesh-list
20068384|NCT02947022|Trace Elements|trace elements|mesh-ancestor
20068385|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
20068386|NCT02947022|Antidotes|antidotes|mesh-ancestor
20068387|NCT02947022|Protective Agents|protective agents|mesh-ancestor
20068388|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
20068389|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
20068390|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068391|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20068392|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
20068393|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20068394|NCT02936999|Vitamin D|vitamin d|mesh-list
20068395|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
20068396|NCT02936999|Vitamins|vitamins|mesh-ancestor
20068397|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
20295343|NCT00611728|Sunitinib|sunitinib|mesh-list
20295344|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20295345|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20295346|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295347|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295348|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295349|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20295350|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20295351|NCT00611728|Growth Substances|growth substances|mesh-ancestor
20295352|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295353|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
20295354|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295355|NCT00611741|Furosemide|furosemide|mesh-list
20295356|NCT00611741|Diuretics|diuretics|mesh-ancestor
20295357|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
20295358|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068398|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068399|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20068400|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20068401|NCT02950480|Zafirlukast|zafirlukast|mesh-list
20068402|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20068403|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
20068404|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20068405|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
20068406|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068407|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068408|NCT02936206|Tamoxifen|tamoxifen|mesh-list
20068409|NCT02936206|Fulvestrant|fulvestrant|mesh-list
20068410|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20068411|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
20068412|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068413|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068414|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20068415|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068416|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20068417|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20068418|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20068419|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20068420|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
20068421|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
20068422|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068423|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068424|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068425|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
20068426|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
20068427|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
20068428|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20068429|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20068430|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068431|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
20068432|NCT02908516|Coagulants|coagulants|mesh-ancestor
20068433|NCT02920450|Paclitaxel|paclitaxel|mesh-list
20068434|NCT02920450|Carboplatin|carboplatin|mesh-list
20068435|NCT02920450|Gedatolisib|gedatolisib|mesh-list
20068436|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20068437|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068438|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
20068439|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
20068440|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
20068441|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068442|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068443|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068444|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20068445|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20068446|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
20068447|NCT02920177|Hormones|hormones|mesh-ancestor
20068448|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068449|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068450|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068451|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
20068452|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20068453|NCT02926638|Rilotumumab|rilotumumab|mesh-list
20068454|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20068455|NCT02926638|Antibodies|antibodies|mesh-list
20068456|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
20068457|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20068458|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
20068459|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068460|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068461|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068462|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068463|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068464|NCT02920242|Rifaximin|rifaximin|mesh-list
20068465|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20068466|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068467|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068468|NCT02892500|Betamethasone|betamethasone|mesh-list
20068469|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
20068470|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20068471|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
20295359|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20295360|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20295361|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068472|NCT02892500|Bupivacaine|bupivacaine|mesh-list
20068473|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20068474|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
20068475|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
20068476|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068477|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068478|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
20068479|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068480|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20068481|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
20068482|NCT02892500|Hormones|hormones|mesh-ancestor
20068483|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068484|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20068485|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
20068486|NCT02899728|Cisplatin|cisplatin|mesh-list
20068487|NCT02899728|Carboplatin|carboplatin|mesh-list
20068488|NCT02899728|Etoposide|etoposide|mesh-list
20068489|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
20068490|NCT02899728|Olaparib|olaparib|mesh-list
20068491|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
20068492|NCT02899728|Cediranib|cediranib|mesh-list
20295362|NCT00611754|Fluorouracil|fluorouracil|mesh-list
20295363|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
20295364|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
20295365|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295366|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295367|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295368|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295369|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
20295370|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295371|NCT00611793|Bevacizumab|bevacizumab|mesh-list
20295372|NCT00611793|Vatalanib|vatalanib|mesh-list
20295373|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20295374|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295375|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20295376|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20295377|NCT00611793|Growth Substances|growth substances|mesh-ancestor
20068493|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20068494|NCT02899728|Maleic acid|maleic acid|mesh-list
20068495|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068496|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20068497|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20068498|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20068499|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295378|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295379|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
20295380|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295381|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295382|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295383|NCT00611819|Interferons|interferons|mesh-list
20295384|NCT00611819|Ribavirin|ribavirin|mesh-list
20295385|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20295386|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
20295387|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295388|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
20295389|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295390|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
20295391|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295392|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
20295393|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295394|NCT00611845|Aprotinin|aprotinin|mesh-list
20295395|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
20295396|NCT00611845|Coagulants|coagulants|mesh-ancestor
20295397|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20295398|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20295399|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
20295400|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295401|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295402|NCT00611871|Propranolol|propranolol|mesh-list
20295403|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20295404|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20068500|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295405|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
20295406|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295407|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295408|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295409|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20295410|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20295411|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
20295412|NCT00611910|Sirolimus|sirolimus|mesh-list
20295413|NCT00611910|Paclitaxel|paclitaxel|mesh-list
20295414|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295415|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577333|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
20577334|NCT02077556|Hormones|hormones|mesh-ancestor
20577335|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577336|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20577337|NCT02077556|Protective Agents|protective agents|mesh-ancestor
20577338|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20577339|NCT02077634|Prednisone|prednisone|mesh-list
20577340|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
20577341|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577342|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
20577343|NCT02077634|Hormones|hormones|mesh-ancestor
20577344|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577345|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577346|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20577347|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577348|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20577349|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577350|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577351|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
20577352|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20577353|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
20577354|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20577355|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577356|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577357|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20577358|NCT02077712|Analgesics|analgesics|mesh-ancestor
20577359|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
20577360|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577361|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20577362|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20577363|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20577364|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
20577365|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577366|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577367|NCT02077751|Biotin|biotin|mesh-list
20577368|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
20577369|NCT02077751|Vitamins|vitamins|mesh-ancestor
20577370|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
20577371|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577372|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20577373|NCT02077777|Mesalamine|mesalamine|mesh-list
20577374|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20577375|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20577376|NCT02077777|Analgesics|analgesics|mesh-ancestor
20068501|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
20068502|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
20068503|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
20068504|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
20068505|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
20068506|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068507|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
20068508|NCT02875067|Lenalidomide|lenalidomide|mesh-list
20068509|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20068510|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068511|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
20295416|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295417|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
20577377|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
20577378|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577379|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068512|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068513|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20068514|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20068515|NCT02875067|Growth Substances|growth substances|mesh-ancestor
20068516|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
20068517|NCT02868892|Pemetrexed|pemetrexed|mesh-list
20068518|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068519|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068520|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068521|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20068522|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20068523|NCT02828124|Nivolumab|nivolumab|mesh-list
20068524|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20068525|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295418|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295419|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295420|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20295421|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295422|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20295423|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
20295424|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295425|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
20295426|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295427|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20295428|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20295429|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20295430|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20295431|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295432|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
20295433|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295434|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295435|NCT00611962|Paclitaxel|paclitaxel|mesh-list
20295436|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
20295437|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295438|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295439|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295440|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
20295441|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295442|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295443|NCT00612079|Sertindole|sertindole|mesh-list
20295444|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20295445|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20295446|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295447|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295448|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20295449|NCT00612144|Metformin|metformin|mesh-list
20295450|NCT00612144|Glimepiride|glimepiride|mesh-list
20295451|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20295452|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295453|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20295454|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295455|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
20295456|NCT00612157|Eszopiclone|eszopiclone|mesh-list
20295457|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20295458|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295459|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295460|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20295461|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20295462|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
20295463|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295464|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295465|NCT00612261|Triamcinolone|triamcinolone|mesh-list
20295466|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20295467|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20295468|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20295469|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20295470|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
20295471|NCT00612261|Hormones|hormones|mesh-ancestor
20295472|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295473|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295474|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295475|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
20295476|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295477|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295478|NCT00612274|Sirolimus|sirolimus|mesh-list
20295479|NCT00612274|Methotrexate|methotrexate|mesh-list
20295480|NCT00612274|Tacrolimus|tacrolimus|mesh-list
20295481|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20295482|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
20295483|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20295484|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295485|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295486|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
20295487|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295488|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295489|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
20295490|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295491|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20295492|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295493|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
20295494|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20295495|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20295496|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20068526|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20068527|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068528|NCT02826551|Bupivacaine|bupivacaine|mesh-list
20068529|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
20068530|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
20295497|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20295498|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295499|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20295500|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
20295501|NCT00612287|Buprenorphine|buprenorphine|mesh-list
20295502|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20295503|NCT00612287|Narcotics|narcotics|mesh-ancestor
20295504|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295505|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295506|NCT00612287|Analgesics|analgesics|mesh-ancestor
20295507|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
20295508|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295509|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20295510|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
20295511|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20295512|NCT00612469|Listerine|listerine|mesh-list
20295513|NCT00612469|Vancomycin|vancomycin|mesh-list
20295514|NCT00612469|Fluorides|fluorides|mesh-list
20295515|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
20295516|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
20295517|NCT00612469|Protective Agents|protective agents|mesh-ancestor
20295518|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295519|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20295520|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295521|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
20295522|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
20295523|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20295524|NCT00612495|Fluorouracil|fluorouracil|mesh-list
20295525|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
20295526|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
20295527|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295528|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295529|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295530|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295531|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
20295532|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295533|NCT00612521|Adenosine|adenosine|mesh-list
20295534|NCT00612521|Analgesics|analgesics|mesh-ancestor
20295535|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
20295536|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295537|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068531|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068532|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068533|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
20068534|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068535|NCT02819804|Nivolumab|nivolumab|mesh-list
20068536|NCT02819804|Dasatinib|dasatinib|mesh-list
20068537|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20295538|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20295539|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
20068538|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068539|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20068540|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068541|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068542|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068543|NCT02806960|Glucagon|glucagon|mesh-list
20068544|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295540|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20295541|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
20295542|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
20295543|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295544|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295545|NCT00612547|Artesunate|artesunate|mesh-list
20295546|NCT00612547|Amodiaquine|amodiaquine|mesh-list
20295547|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
20295548|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20295549|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20295550|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295551|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295552|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
20295553|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
20295554|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20295555|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
20295556|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
20295557|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
20295558|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20295559|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295560|NCT00612612|Rituximab|rituximab|mesh-list
20295561|NCT00612612|Fludarabine|fludarabine|mesh-list
20295562|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
20295563|NCT00612612|Obatoclax|obatoclax|mesh-list
20295564|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20295565|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295566|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
20295567|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295568|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20295569|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295570|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
20295571|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295572|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295573|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295574|NCT00612625|Glucagon|glucagon|mesh-list
20295575|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20295576|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295577|NCT00612625|Hormones|hormones|mesh-ancestor
20295578|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295579|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295580|NCT00612625|Incretins|incretins|mesh-ancestor
20295581|NCT00612638|Irinotecan|irinotecan|mesh-list
20295582|NCT00612638|Temozolomide|temozolomide|mesh-list
20295583|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20295584|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20295585|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20295586|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295587|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295588|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295589|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20295590|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
20295591|NCT00612651|Temozolomide|temozolomide|mesh-list
20295592|NCT00612651|Lonafarnib|lonafarnib|mesh-list
20295593|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20295594|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
20295595|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295596|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295597|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295598|NCT00612755|Ribavirin|ribavirin|mesh-list
20295599|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20295600|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
20295601|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295602|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
20295603|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068545|NCT02806960|Hormones|hormones|mesh-ancestor
20295604|NCT00612794|Exenatide|exenatide|mesh-list
20295605|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20295606|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295607|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20295608|NCT00612794|Incretins|incretins|mesh-ancestor
20295609|NCT00612794|Hormones|hormones|mesh-ancestor
20295610|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295611|NCT00612859|Levetiracetam|levetiracetam|mesh-list
20295612|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
20295613|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
20295614|NCT00612898|Lamivudine|lamivudine|mesh-list
20295615|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20295616|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20295617|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295618|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295619|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
20295620|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295621|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20295622|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20295623|NCT00612950|Glucagon|glucagon|mesh-list
20295624|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20295625|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20295626|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295627|NCT00612950|Hormones|hormones|mesh-ancestor
20295628|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295629|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295630|NCT00612950|Incretins|incretins|mesh-ancestor
20295631|NCT00612989|Temozolomide|temozolomide|mesh-list
20295632|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20295633|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20295634|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
20295635|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295636|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295637|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295638|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
20295639|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
20295640|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295641|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295642|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295643|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295644|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
20295645|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20295646|NCT00613067|Citalopram|citalopram|mesh-list
20295647|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20295648|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20295649|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20295650|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295651|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295652|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
20295653|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295654|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20295655|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
20295656|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20295657|NCT00613093|Temozolomide|temozolomide|mesh-list
20295658|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20295659|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20295660|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
20068546|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068547|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068548|NCT02815397|Metformin|metformin|mesh-list
20068549|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20068550|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068551|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
20068552|NCT02802592|Hematinics|hematinics|mesh-ancestor
20295661|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295662|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295663|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295664|NCT00613132|Everolimus|everolimus|mesh-list
20295665|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
20295666|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
20295667|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295668|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295669|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
20068553|NCT02774148|Acetaminophen|acetaminophen|mesh-list
20068554|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068555|NCT02774148|Analgesics|analgesics|mesh-ancestor
20068556|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
20295670|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295671|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295672|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295673|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295674|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
20295675|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20295676|NCT00613145|Capecitabine|capecitabine|mesh-list
20295677|NCT00613145|Sorafenib|sorafenib|mesh-list
20295678|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295679|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
20295680|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295681|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295682|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295683|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295684|NCT00613223|Etoposide|etoposide|mesh-list
20295685|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
20295686|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295687|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295688|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20295689|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20295690|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295691|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295692|NCT00613249|Dapivirine|dapivirine|mesh-list
20295693|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20295694|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20295695|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
20295696|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295697|NCT00613288|Testosterone|testosterone|mesh-list
20295698|NCT00613288|Androgens|androgens|mesh-ancestor
20295699|NCT00613288|Hormones|hormones|mesh-ancestor
20295700|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295701|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295702|NCT00613392|Antioxidants|antioxidants|mesh-list
20295703|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295704|NCT00613392|Protective Agents|protective agents|mesh-ancestor
20295705|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295706|NCT00613457|Cytarabine|cytarabine|mesh-list
20295707|NCT00613457|Dexamethasone|dexamethasone|mesh-list
20295708|NCT00613457|Prednisone|prednisone|mesh-list
20295709|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
20295710|NCT00613457|Ifosfamide|ifosfamide|mesh-list
20295711|NCT00613457|Doxorubicin|doxorubicin|mesh-list
20295712|NCT00613457|Methotrexate|methotrexate|mesh-list
20295713|NCT00613457|Etoposide|etoposide|mesh-list
20295714|NCT00613457|Vincristine|vincristine|mesh-list
20295715|NCT00613457|Daunorubicin|daunorubicin|mesh-list
20068557|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068558|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068559|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
20068560|NCT02773576|Risperidone|risperidone|mesh-list
20068561|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20068562|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
20068563|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068564|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068565|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068566|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20068567|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068568|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068569|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068570|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20068571|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
20068572|NCT02730793|Aztreonam|aztreonam|mesh-list
20068573|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20068574|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068575|NCT02744352|Ropivacaine|ropivacaine|mesh-list
20068576|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
20068577|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
20068578|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295716|NCT00613457|Asparaginase|asparaginase|mesh-list
20068579|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295717|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
20295718|NCT00613457|Thioguanine|thioguanine|mesh-list
20295719|NCT00613457|Vindesine|vindesine|mesh-list
20295720|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068580|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
20068581|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068582|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
20295721|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
20295722|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068583|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20295723|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20295724|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20295725|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
20295726|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295727|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295728|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20295729|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20295730|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
20295731|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
20295732|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295733|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295734|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
20295735|NCT00613457|Hormones|hormones|mesh-ancestor
20295736|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295737|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20295738|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20295739|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20295740|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20295741|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295742|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20295743|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
20295744|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20295745|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295746|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
20295747|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
20295748|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20295749|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20295750|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20295751|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
20295752|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295753|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295754|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
20295755|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295756|NCT00613470|Citalopram|citalopram|mesh-list
20295757|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20295758|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20295759|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20295760|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295761|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295762|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
20295763|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295764|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20295765|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
20295766|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20295767|NCT00613496|Irbesartan|irbesartan|mesh-list
20295768|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20295769|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20295770|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20295771|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308511|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308512|NCT00664677|Analgesics|analgesics|mesh-ancestor
20068584|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
20068585|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
20068586|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068587|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068588|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068589|NCT02757521|Analgesics|analgesics|mesh-ancestor
20295772|NCT00613561|Fludarabine|fludarabine|mesh-list
20295773|NCT00613561|Busulfan|busulfan|mesh-list
20295774|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20295775|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295776|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295777|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295778|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
20295779|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295780|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
20295781|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20295782|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20295783|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20295784|NCT00613600|Cathartics|cathartics|mesh-ancestor
20295785|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295786|NCT00613613|Fenofibrate|fenofibrate|mesh-list
20295787|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20295788|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
20295789|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295790|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20295791|NCT00613665|Vaccines|vaccines|mesh-list
20295792|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
20295793|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295794|NCT00613717|Vitamin D|vitamin d|mesh-list
20295795|NCT00613717|Vitamins|vitamins|mesh-list
20295796|NCT00613717|Folic Acid|folic acid|mesh-list
20295797|NCT00613717|Vitamin A|vitamin a|mesh-list
20295798|NCT00613717|Iron|iron|mesh-list
20295799|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
20295800|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
20295801|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
20295802|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295803|NCT00613717|Trace Elements|trace elements|mesh-ancestor
20068590|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
20068591|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068592|NCT02758132|Denosumab|denosumab|mesh-list
20068593|NCT02758132|Prednisone|prednisone|mesh-list
20068594|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20295804|NCT00613717|Hematinics|hematinics|mesh-ancestor
20295805|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
20295806|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295807|NCT00613717|Protective Agents|protective agents|mesh-ancestor
20295808|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20295809|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295810|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20295811|NCT00613743|Morphine|morphine|mesh-list
20295812|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20295813|NCT00613743|Narcotics|narcotics|mesh-ancestor
20295814|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295815|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295816|NCT00613743|Analgesics|analgesics|mesh-ancestor
20295817|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
20295818|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295819|NCT00613769|Metronidazole|metronidazole|mesh-list
20295820|NCT00613769|Trimethoprim|trimethoprim|mesh-list
20295821|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
20295822|NCT00613769|Cefuroxime|cefuroxime|mesh-list
20295823|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
20295824|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20295825|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295826|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20295827|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20295828|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20295829|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20295830|NCT00613769|Renal Agents|renal agents|mesh-ancestor
19491658|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491659|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491660|NCT03129009|Anesthetics|anesthetics|mesh-list
20068595|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
20068596|NCT02758132|Hormones|hormones|mesh-ancestor
20068597|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068598|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295831|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
20295832|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20295833|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491661|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295834|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295835|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20295836|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20295837|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20295838|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
20295839|NCT00613782|Testosterone|testosterone|mesh-list
20295840|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
20295841|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
20295842|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20295843|NCT00613782|Androgens|androgens|mesh-ancestor
20295844|NCT00613782|Hormones|hormones|mesh-ancestor
20295845|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20295846|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295847|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20295848|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295849|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
20295850|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
20295851|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20295852|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
20295853|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295854|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295855|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20295856|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
20295857|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20295858|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
20295859|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295860|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295861|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20295862|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
20295863|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
20295864|NCT00613808|Protective Agents|protective agents|mesh-ancestor
20295865|NCT00613847|Trastuzumab|trastuzumab|mesh-list
20295866|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
20295867|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20577380|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577381|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20577382|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
20577383|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20577384|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577385|NCT02077803|Metformin|metformin|mesh-list
20577386|NCT02077803|Canagliflozin|canagliflozin|mesh-list
20577387|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20577388|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577389|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20577390|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605632|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605633|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605634|NCT02233244|Midazolam|midazolam|mesh-list
20605635|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20605636|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20068599|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20068600|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068601|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20068602|NCT02734940|Lidocaine|lidocaine|mesh-list
20068603|NCT02734940|Fentanyl|fentanyl|mesh-list
20068604|NCT02734940|Ketamine|ketamine|mesh-list
20068605|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
20068606|NCT02734940|Morphine|morphine|mesh-list
20068607|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
20068608|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
20068609|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068610|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068611|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
20068612|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068613|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20068614|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20068615|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20068616|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20068617|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068618|NCT02734940|Analgesics|analgesics|mesh-ancestor
20068619|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20068620|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20295868|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068621|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
20295869|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295870|NCT00613964|Diuretics|diuretics|mesh-list
20308972|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20295871|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20295872|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
20295873|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295874|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20295875|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295876|NCT00614029|Sumatriptan|sumatriptan|mesh-list
20295877|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20295878|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20295879|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20295880|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
20295881|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295882|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295883|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295884|NCT00614159|Ketamine|ketamine|mesh-list
20295885|NCT00614159|Propofol|propofol|mesh-list
20068622|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20068623|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20068624|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068625|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20068626|NCT02734940|Narcotics|narcotics|mesh-ancestor
20068627|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20068628|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20068629|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068630|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20068631|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20068632|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20068633|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
20068634|NCT02749617|Apixaban|apixaban|mesh-list
20068635|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20068636|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
20068637|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20068638|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
20068639|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068640|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068641|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
20068642|NCT02749227|Pasireotide|pasireotide|mesh-list
20068643|NCT02749227|Hormones|hormones|mesh-ancestor
20295886|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20295887|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295888|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295889|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20295890|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
20295891|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
20295892|NCT00614159|Analgesics|analgesics|mesh-ancestor
20295893|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
20295894|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295895|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20295896|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20295897|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20295898|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295899|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295900|NCT00614328|Naltrexone|naltrexone|mesh-list
20295901|NCT00614328|Baclofen|baclofen|mesh-list
20295902|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20295903|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20068644|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068645|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068646|NCT02746263|Acetaminophen|acetaminophen|mesh-list
20068647|NCT02746263|Morphine|morphine|mesh-list
20068648|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20068649|NCT02746263|Narcotics|narcotics|mesh-ancestor
20068650|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068651|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068652|NCT02746263|Analgesics|analgesics|mesh-ancestor
20068653|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
20068654|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068655|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068656|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
20068657|NCT02721277|SMOFlipid|smoflipid|mesh-list
20068658|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20308973|NCT00666484|Etoposide|etoposide|mesh-list
20068659|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20068660|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20068661|NCT02732327|Vancomycin|vancomycin|mesh-list
20068662|NCT02732327|Meropenem|meropenem|mesh-list
20068663|NCT02732327|Tazobactam|tazobactam|mesh-list
19491662|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491663|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
19491664|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19491665|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19491666|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491667|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
19491668|NCT03128866|Coagulants|coagulants|mesh-ancestor
19491669|NCT03128736|Esomeprazole|esomeprazole|mesh-list
19491670|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
19491671|NCT03128736|Lansoprazole|lansoprazole|mesh-list
20068664|NCT02732327|Linezolid|linezolid|mesh-list
20068665|NCT02732327|Piperacillin|piperacillin|mesh-list
20068666|NCT02732327|Cefepime|cefepime|mesh-list
20068667|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20068668|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20068669|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068670|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20068671|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068672|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068673|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20068674|NCT02726399|Capecitabine|capecitabine|mesh-list
20068675|NCT02726399|Trastuzumab|trastuzumab|mesh-list
20068676|NCT02726399|Ramucirumab|ramucirumab|mesh-list
20068677|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068678|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20068679|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
20068680|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068681|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20068682|NCT02720510|Dexamethasone|dexamethasone|mesh-list
20068683|NCT02720510|Lenalidomide|lenalidomide|mesh-list
20068684|NCT02720510|Bortezomib|bortezomib|mesh-list
20068685|NCT02720510|Panobinostat|panobinostat|mesh-list
20068686|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20068687|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
20068688|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
20068689|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068690|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068691|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20068692|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
20068693|NCT02720510|Hormones|hormones|mesh-ancestor
20068694|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068695|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20068696|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068697|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
20068698|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20068699|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20068700|NCT02720510|Growth Substances|growth substances|mesh-ancestor
20068701|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
20068702|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20068703|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068704|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068705|NCT02717949|Ribavirin|ribavirin|mesh-list
20068706|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
20068707|NCT02717949|Ledipasvir|ledipasvir|mesh-list
20068708|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
20068709|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068710|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
20068711|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068712|NCT02717130|Aripiprazole|aripiprazole|mesh-list
20068713|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
20068714|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068715|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20068716|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068717|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068718|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068719|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
20068720|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
20068721|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068722|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068723|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20068724|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20068725|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
19491672|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20068726|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20295904|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295905|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
20295906|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20295907|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20295908|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20295909|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20295910|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
20295911|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
20295912|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20295913|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295914|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20295915|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
20295916|NCT00614471|Entecavir|entecavir|mesh-list
20295917|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
20295918|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295919|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
20295920|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295921|NCT00614536|Rabeprazole|rabeprazole|mesh-list
20295922|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20295923|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20295924|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20295925|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295926|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295927|NCT00614588|Anesthetics|anesthetics|mesh-list
20295928|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20295929|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295930|NCT00614653|Bevacizumab|bevacizumab|mesh-list
20295931|NCT00614653|Capecitabine|capecitabine|mesh-list
20295932|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20295933|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20295934|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295935|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20295936|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20295937|NCT00614653|Growth Substances|growth substances|mesh-ancestor
20295938|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295939|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
20295940|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295941|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
20295942|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295943|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295944|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295945|NCT00614666|Nikkomycin|nikkomycin|mesh-list
20295946|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
20295947|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295948|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295949|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295950|NCT00614679|Tigecycline|tigecycline|mesh-list
20295951|NCT00614679|Heparin|heparin|mesh-list
20295952|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
20295953|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20295954|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20295955|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295956|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20295957|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295958|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20295959|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295960|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
20295961|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20295962|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
20295963|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295964|NCT00614757|Expectorants|expectorants|mesh-ancestor
20295965|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
20295966|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20295967|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
20295968|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295969|NCT00614757|Protective Agents|protective agents|mesh-ancestor
20295970|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295971|NCT00614757|Antidotes|antidotes|mesh-ancestor
20295972|NCT00614809|Gefitinib|gefitinib|mesh-list
20295973|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295974|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20295975|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295976|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295977|NCT00614835|Gemcitabine|gemcitabine|mesh-list
20295978|NCT00614835|Docetaxel|docetaxel|mesh-list
20295979|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20295980|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
20295981|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295982|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295983|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
20295984|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20295985|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295986|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20295987|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
20295988|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20295989|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20295990|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20295991|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
20295992|NCT00614965|Irinotecan|irinotecan|mesh-list
20295993|NCT00614965|Pemetrexed|pemetrexed|mesh-list
20295994|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20295995|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20295996|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20295997|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20295998|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20295999|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20296000|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20296001|NCT00614978|Temozolomide|temozolomide|mesh-list
20296002|NCT00614978|Lapatinib|lapatinib|mesh-list
20296003|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20296004|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
20296005|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296006|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296007|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296008|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296009|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
20068727|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20068728|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20068729|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20119744|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20296010|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20296011|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20296012|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296013|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296014|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296015|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
20296016|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296017|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
20296018|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20296019|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20296020|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296021|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
20296022|NCT00615147|Coagulants|coagulants|mesh-ancestor
20296023|NCT00615160|Dacarbazine|dacarbazine|mesh-list
20296024|NCT00615160|Vatalanib|vatalanib|mesh-list
20296025|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20296026|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
20296027|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296028|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296029|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296030|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296031|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
20296032|NCT00615173|Azathioprine|azathioprine|mesh-list
20296033|NCT00615173|Tacrolimus|tacrolimus|mesh-list
20296034|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296035|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
20296036|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296037|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119745|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119746|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20119747|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20119748|NCT00006226|Growth Substances|growth substances|mesh-ancestor
20119749|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
20119750|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119751|NCT00006228|Aldesleukin|aldesleukin|mesh-list
20119752|NCT00006228|Trastuzumab|trastuzumab|mesh-list
20296038|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20296039|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
20296040|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068730|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
20068731|NCT02709083|Dasatinib|dasatinib|mesh-list
20068732|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068733|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068734|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068735|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068736|NCT02693171|Dinutuximab|dinutuximab|mesh-list
20068737|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068738|NCT02696226|Aspirin|aspirin|mesh-list
20068739|NCT02696226|Warfarin|warfarin|mesh-list
20068740|NCT02696226|Clopidogrel|clopidogrel|mesh-list
20068741|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20068742|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068743|NCT02696226|Analgesics|analgesics|mesh-ancestor
20068744|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
20068745|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068746|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068747|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20068748|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20068749|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20068750|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20068751|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068752|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20068753|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20068754|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068755|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
20068756|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20068757|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20068758|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20068759|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
20068760|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068761|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
20068762|NCT02706691|Infigratinib|infigratinib|mesh-list
20068763|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068764|NCT02708849|Lamotrigine|lamotrigine|mesh-list
20068765|NCT02708849|Ketamine|ketamine|mesh-list
20068766|NCT02708849|Analgesics|analgesics|mesh-ancestor
20068767|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
20068768|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068769|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068770|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20068771|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20068772|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
20068773|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
20068774|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068775|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20068776|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20068777|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068778|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068779|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
20068780|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20068781|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20068782|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20068783|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20068784|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068785|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068786|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20068787|NCT02693717|Pemetrexed|pemetrexed|mesh-list
20068788|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068789|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068790|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068791|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20068792|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20068793|NCT02693002|Norethindrone|norethindrone|mesh-list
20068794|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
20068795|NCT02693002|Estradiol|estradiol|mesh-list
20068796|NCT02693002|Estrogens|estrogens|mesh-ancestor
20068797|NCT02693002|Hormones|hormones|mesh-ancestor
20068798|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20068799|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068800|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20068801|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
20296041|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296042|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20296043|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20296044|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296045|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
20068802|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20068803|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20068804|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20068805|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20068806|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20068807|NCT02689518|Aflibercept|aflibercept|mesh-list
20068808|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20068809|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20068810|NCT02689518|Growth Substances|growth substances|mesh-ancestor
20068811|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068812|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
20068813|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068814|NCT02687165|Cycloserine|cycloserine|mesh-list
20068815|NCT02687165|Milnacipran|milnacipran|mesh-list
20068816|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
19491673|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491674|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19491675|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068817|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20068818|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068819|NCT02687165|Renal Agents|renal agents|mesh-ancestor
20068820|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20068821|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
20068822|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20068823|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
20068824|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119753|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20296046|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296047|NCT00615186|Temozolomide|temozolomide|mesh-list
20296048|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20296049|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
20296050|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296051|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491676|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491677|NCT03128879|Venetoclax|venetoclax|mesh-list
19491678|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569606|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569607|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19569608|NCT04622839|Acetaminophen|acetaminophen|mesh-list
19569609|NCT04622839|Ibuprofen|ibuprofen|mesh-list
19569610|NCT04622839|Diclofenac|diclofenac|mesh-list
19569611|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569612|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569613|NCT04622839|Analgesics|analgesics|mesh-ancestor
19569614|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
19569615|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569616|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569617|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569618|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569619|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19569620|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569621|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569622|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
19569623|NCT04594551|Vaccines|vaccines|mesh-list
19569624|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
20296052|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
20296053|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
20296054|NCT00615212|Midazolam|midazolam|mesh-list
20296055|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20296056|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20296057|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296058|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296059|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20296060|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20296061|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20296062|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20296063|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
20296064|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
20296065|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
20296066|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
19569625|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20068825|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20068826|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20068827|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296067|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296068|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296069|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20296070|NCT00615212|Analgesics|analgesics|mesh-ancestor
20296071|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
20296072|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296073|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20296074|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296075|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296076|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296077|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20296078|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296079|NCT00615303|Simethicone|simethicone|mesh-list
20296080|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
20296081|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296082|NCT00615303|Emollients|emollients|mesh-ancestor
20296083|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
20296084|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
20296085|NCT00615368|Hematinics|hematinics|mesh-ancestor
20296086|NCT00615381|Insulin|insulin|mesh-list
20296087|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20296088|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20296089|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296090|NCT00615446|Gemcitabine|gemcitabine|mesh-list
20296091|NCT00615446|Sunitinib|sunitinib|mesh-list
20296092|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296093|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
20296094|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296095|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296096|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
20296097|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296098|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296099|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296100|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
20296101|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296102|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20068828|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068829|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068830|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068831|NCT02687165|Analgesics|analgesics|mesh-ancestor
20068832|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
20068833|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068834|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
20068835|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20296103|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20296104|NCT00615446|Growth Substances|growth substances|mesh-ancestor
20296105|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
20296106|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296107|NCT00615524|Exemestane|exemestane|mesh-list
20296108|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296109|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20296110|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20296111|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296112|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296113|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20296114|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
20296115|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20296116|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308513|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
20308514|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308515|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308516|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308517|NCT00664690|Celecoxib|celecoxib|mesh-list
20308518|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308519|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308520|NCT00664690|Analgesics|analgesics|mesh-ancestor
20068836|NCT02679560|Bupivacaine|bupivacaine|mesh-list
20068837|NCT02679560|Ropivacaine|ropivacaine|mesh-list
20068838|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
20068839|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
20308521|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
20308522|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296117|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
20296118|NCT00615602|Docetaxel|docetaxel|mesh-list
20296119|NCT00615602|Trastuzumab|trastuzumab|mesh-list
20296120|NCT00615602|Epirubicin|epirubicin|mesh-list
20296121|NCT00615602|Fluorouracil|fluorouracil|mesh-list
20296122|NCT00615602|Mitogens|mitogens|mesh-list
20296123|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296124|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
20296125|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296126|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296127|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20296128|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
20296129|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296130|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296131|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20296132|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296133|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
20296134|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
20296135|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20296136|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20296137|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20296138|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20068840|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068841|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068842|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
20068843|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068844|NCT02674204|Atorvastatin|atorvastatin|mesh-list
20068845|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20068846|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20296139|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296140|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
20296141|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296142|NCT00615615|Levetiracetam|levetiracetam|mesh-list
20296143|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
20296144|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
20296145|NCT00615667|Tacrolimus|tacrolimus|mesh-list
20296146|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068847|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
20068848|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068849|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20296147|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
20296148|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296149|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20296150|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296151|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296152|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20296153|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20296154|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20296155|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296156|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296157|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
20296158|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296159|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296160|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296161|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20296162|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296163|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296164|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068850|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20068851|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068852|NCT02671461|Aspirin|aspirin|mesh-list
20068853|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20068854|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068855|NCT02671461|Analgesics|analgesics|mesh-ancestor
20068856|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
20068857|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068858|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068859|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20068860|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20068861|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20068862|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20296165|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296166|NCT00615797|Penicillins|penicillins|mesh-list
20296167|NCT00615797|Penicillin V|penicillin v|mesh-list
20296168|NCT00615797|Haloperidol|haloperidol|mesh-list
20296169|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
20296170|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
20296171|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20296172|NCT00615797|Antibodies|antibodies|mesh-list
20296173|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
20296174|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20296175|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
20296176|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296177|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
20296178|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
20296179|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296180|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296181|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20296182|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20296183|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296184|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20296185|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20296186|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
20296187|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296188|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296189|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20296190|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20296191|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296192|NCT00615810|Efavirenz|efavirenz|mesh-list
20296193|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20296194|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20296195|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20296196|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296197|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296198|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
20296199|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296200|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20068863|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068864|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20068865|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20068866|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068867|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
20068868|NCT02663752|Deferasirox|deferasirox|mesh-list
20068869|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20068870|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
20068871|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
20068872|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068873|NCT02658357|Risperidone|risperidone|mesh-list
20068874|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20296201|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20296202|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20296203|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20296204|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20296205|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20296206|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296207|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296208|NCT00615823|Atorvastatin|atorvastatin|mesh-list
20296209|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20296210|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20296211|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
20296212|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296213|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20296214|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20296215|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296216|NCT00615875|Naproxen|naproxen|mesh-list
20296217|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20296218|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296219|NCT00615875|Analgesics|analgesics|mesh-ancestor
20296220|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
20296221|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296222|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296223|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296224|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296225|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
20068875|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
20577391|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
20068876|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296226|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20296227|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296228|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296229|NCT00616005|Irinotecan|irinotecan|mesh-list
20296230|NCT00616005|Temozolomide|temozolomide|mesh-list
20296231|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20296232|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20296233|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296234|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296235|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296236|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20068877|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068878|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296237|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
20296238|NCT00616031|Paclitaxel|paclitaxel|mesh-list
20296239|NCT00616031|Carboplatin|carboplatin|mesh-list
20296240|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
20296241|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20296242|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296243|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296244|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20296245|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20296246|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296247|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
20296248|NCT00616044|Anesthetics|anesthetics|mesh-list
20296249|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296250|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296251|NCT00616070|Difluprednate|difluprednate|mesh-list
20296252|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
20296253|NCT00616070|Hormones|hormones|mesh-ancestor
20296254|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20296255|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296256|NCT00616187|Interferons|interferons|mesh-list
20296257|NCT00616187|Interferon-beta|interferon-beta|mesh-list
20296258|NCT00616187|Atorvastatin|atorvastatin|mesh-list
20296259|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296260|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
20296261|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296262|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20296263|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20296264|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
20296265|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296266|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20296267|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20296268|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296269|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
20296270|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296271|NCT00616213|Lenograstim|lenograstim|mesh-list
20296272|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20296273|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
20296274|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296275|NCT00616382|Indomethacin|indomethacin|mesh-list
20068879|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20068880|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20068881|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068882|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068883|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20068884|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
20068885|NCT02658877|Omalizumab|omalizumab|mesh-list
20068886|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20068887|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20068888|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
20068889|NCT02654639|Bevacizumab|bevacizumab|mesh-list
20068890|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20068891|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068892|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20068893|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20068894|NCT02654639|Growth Substances|growth substances|mesh-ancestor
20068895|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068896|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
20068897|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
20068898|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068899|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
20296276|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
20296277|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20068900|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068901|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068902|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20068903|NCT02634606|Tocotrienols|tocotrienols|mesh-list
20068904|NCT02634606|Vitamin E|vitamin e|mesh-list
20068905|NCT02634606|Tocopherols|tocopherols|mesh-list
20068906|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
20068907|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068908|NCT02634606|Protective Agents|protective agents|mesh-ancestor
20068909|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068910|NCT02634606|Vitamins|vitamins|mesh-ancestor
20068911|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
20068912|NCT02634827|Decitabine|decitabine|mesh-list
20068913|NCT02634827|Midostaurin|midostaurin|mesh-list
20068914|NCT02634827|Staurosporine|staurosporine|mesh-list
20068915|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20068916|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
20068917|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068918|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068919|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068920|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20068921|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20068922|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20068923|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068924|NCT02638129|Naltrexone|naltrexone|mesh-list
20068925|NCT02638129|Bupropion|bupropion|mesh-list
20068926|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20068927|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20068928|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068929|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
20068930|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068931|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20068932|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
20068933|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20068934|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20068935|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20068936|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20068937|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068938|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
20068939|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20068940|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20068941|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20068942|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068943|NCT02623959|Doxycycline|doxycycline|mesh-list
20068944|NCT02623959|Fentanyl|fentanyl|mesh-list
20068945|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20068946|NCT02623959|Narcotics|narcotics|mesh-ancestor
20068947|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068948|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068949|NCT02623959|Analgesics|analgesics|mesh-ancestor
20068950|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
20068951|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068952|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20068953|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20068954|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
20068955|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
20068956|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20068957|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068958|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
20068959|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20068960|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20068961|NCT02631148|Melatonin|melatonin|mesh-list
20068962|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
20068963|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068964|NCT02631148|Protective Agents|protective agents|mesh-ancestor
20068965|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068966|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20068967|NCT02630472|Quinine|quinine|mesh-list
20068968|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
20068969|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20068970|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20068971|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068972|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20308974|NCT00666484|Vincristine|vincristine|mesh-list
20068973|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296278|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296279|NCT00616382|Analgesics|analgesics|mesh-ancestor
20296280|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
20296281|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296282|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296283|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296284|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296285|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
20296286|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
20296287|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20296288|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20296289|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296290|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296291|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20296292|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20296293|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20296294|NCT00616382|Protective Agents|protective agents|mesh-ancestor
20296295|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
20296296|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20296297|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
20296298|NCT00616408|Octreotide|octreotide|mesh-list
20296299|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296300|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20296301|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068974|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20068975|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068976|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20068977|NCT02630472|Analgesics|analgesics|mesh-ancestor
20068978|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
20068979|NCT02626520|Gemcitabine|gemcitabine|mesh-list
20068980|NCT02626520|Paclitaxel|paclitaxel|mesh-list
20068981|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20068982|NCT02626520|Fluorouracil|fluorouracil|mesh-list
20068983|NCT02626520|Irinotecan|irinotecan|mesh-list
20068984|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20068985|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20068986|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
20068987|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
20068988|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
20068989|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20068990|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296302|NCT00616460|Bivalirudin|bivalirudin|mesh-list
20296303|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
20296304|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20296305|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
20296306|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296307|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296308|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
20296309|NCT00616499|Gefitinib|gefitinib|mesh-list
20296310|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296311|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296312|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296313|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296314|NCT00616538|Fluticasone|fluticasone|mesh-list
20296315|NCT00616538|Xhance|xhance|mesh-list
20296316|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296317|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20296318|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
20296319|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20068991|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
20068992|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
20068993|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20068994|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20068995|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20068996|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
20068997|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20068998|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20068999|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20069000|NCT02614898|Eculizumab|eculizumab|mesh-list
20069001|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20069002|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296320|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296321|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20069003|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
20296322|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
20296323|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
20296324|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20296325|NCT00616551|Octreotide|octreotide|mesh-list
20296326|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296327|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20296328|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296329|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
20296330|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
20296331|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20296332|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20296333|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20069004|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069005|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
20069006|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20069007|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069008|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20069009|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069010|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20069011|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
20069012|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20069013|NCT02619812|Antibodies|antibodies|mesh-list
20069014|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
20069015|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069016|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20296334|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296335|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20296336|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20296337|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
20296338|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20296339|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296340|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296341|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20296342|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296343|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20296344|NCT00616720|Interferons|interferons|mesh-list
20296345|NCT00616720|Aldesleukin|aldesleukin|mesh-list
20296346|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
20296347|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296348|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
20296349|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296350|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296351|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296352|NCT00616746|Ethanol|ethanol|mesh-list
20296353|NCT00616746|Nicotine|nicotine|mesh-list
20296354|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20296355|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
20296356|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296357|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296358|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20296359|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20296360|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
20296361|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069017|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20069018|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
20296362|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296363|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20296364|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296365|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296366|NCT00616785|Irinotecan|irinotecan|mesh-list
20296367|NCT00616785|Etoposide|etoposide|mesh-list
20296368|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069019|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069020|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20069021|NCT02614586|Ondansetron|ondansetron|mesh-list
20069022|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
20069023|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
20069024|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069025|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069026|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069027|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
20069028|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069029|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20069030|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
20296369|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20296370|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20296371|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296372|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296373|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20296374|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20296375|NCT00616850|Lidocaine|lidocaine|mesh-list
20296376|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
20296377|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
20296378|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577392|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20577393|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577394|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
20577395|NCT02077933|Everolimus|everolimus|mesh-list
20577396|NCT02077933|Exemestane|exemestane|mesh-list
20577397|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577398|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577399|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
20577400|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577401|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20577402|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20577403|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577404|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577405|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20577406|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
20577407|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577408|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20577409|NCT02077946|Liraglutide|liraglutide|mesh-list
20577410|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20577411|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577412|NCT02077946|Incretins|incretins|mesh-ancestor
20577413|NCT02077946|Hormones|hormones|mesh-ancestor
20577414|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577415|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20577416|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
20577417|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577418|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577419|NCT02077959|Lenalidomide|lenalidomide|mesh-list
20577420|NCT02077959|Pidilizumab|pidilizumab|mesh-list
20577421|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
20577422|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069031|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069032|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069033|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20069034|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20069035|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069036|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20069037|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20069038|NCT02606279|Valsartan|valsartan|mesh-list
20069039|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20069040|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20069041|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20069042|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069043|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
20069044|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20069045|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
20069046|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069047|NCT02605824|Expectorants|expectorants|mesh-ancestor
20069048|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
20577423|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20577424|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20577425|NCT02077959|Growth Substances|growth substances|mesh-ancestor
19491679|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
20069049|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20069050|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
20296379|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577426|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
20069051|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296380|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
20296381|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296382|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20296383|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20296384|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20296385|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296386|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296387|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
20296388|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
20296389|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20296390|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20296391|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296392|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296393|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20296394|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20296395|NCT00616876|Lactulose|lactulose|mesh-list
20296396|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296397|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20296398|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
20296399|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20296400|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20296401|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20296402|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296403|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296404|NCT00616915|Bupropion|bupropion|mesh-list
20296405|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20296406|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
20296407|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20296408|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20296409|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20296410|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296411|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296412|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
20296413|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296414|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296415|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20296416|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20296417|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296418|NCT00616993|Difluprednate|difluprednate|mesh-list
20296419|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
20296420|NCT00616993|Hormones|hormones|mesh-ancestor
20296421|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20296422|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296423|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20296424|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20296425|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20296426|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296427|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296428|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296429|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296430|NCT00617045|Analgesics|analgesics|mesh-ancestor
20296431|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
20296432|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069052|NCT02605824|Protective Agents|protective agents|mesh-ancestor
20069053|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069054|NCT02605824|Antidotes|antidotes|mesh-ancestor
20069055|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
20069056|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
20069057|NCT02598622|Vitamins|vitamins|mesh-ancestor
20069058|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
20069059|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069060|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
20069061|NCT02589145|Pyridoxine|pyridoxine|mesh-list
20069062|NCT02589145|Gemcitabine|gemcitabine|mesh-list
20069063|NCT02589145|Dexamethasone|dexamethasone|mesh-list
20069064|NCT02589145|Rituximab|rituximab|mesh-list
20069065|NCT02589145|Lenalidomide|lenalidomide|mesh-list
20069066|NCT02589145|Melphalan|melphalan|mesh-list
20069067|NCT02589145|Busulfan|busulfan|mesh-list
20069068|NCT02589145|Vorinostat|vorinostat|mesh-list
20069069|NCT02589145|Enoxaparin|enoxaparin|mesh-list
20069070|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20296433|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
20296434|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20296435|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
20296436|NCT00617253|Sunitinib|sunitinib|mesh-list
20296437|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296438|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20296439|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20296440|NCT00617253|Growth Substances|growth substances|mesh-ancestor
20296441|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069071|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069072|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
20069073|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069074|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296442|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
20296443|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296444|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296445|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296446|NCT00617370|Paclitaxel|paclitaxel|mesh-list
20296447|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
20296448|NCT00617370|Epirubicin|epirubicin|mesh-list
20296449|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20296450|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296451|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296452|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
20296453|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
20296454|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296455|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296456|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
20296457|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296458|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296459|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20296460|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
20296461|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20296462|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20296463|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20296464|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20296465|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296466|NCT00617448|Anesthetics|anesthetics|mesh-list
20296467|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296468|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296469|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
20296470|NCT00617474|Hematinics|hematinics|mesh-ancestor
20296471|NCT00617500|Hormones|hormones|mesh-list
20296472|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20296473|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296474|NCT00617513|Prucalopride|prucalopride|mesh-list
20296475|NCT00617513|Laxatives|laxatives|mesh-ancestor
20296476|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296477|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20296478|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20296479|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
20296480|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296481|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296482|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296483|NCT00617565|Insulin|insulin|mesh-list
20577427|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569626|NCT04594551|Antibodies|antibodies|mesh-list
20296484|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20296485|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
20296486|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
20296487|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20296488|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308523|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308524|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308525|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069075|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069076|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
20069077|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
20069078|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069079|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069080|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
20069081|NCT02589145|Hormones|hormones|mesh-ancestor
20069082|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069083|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069084|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296489|NCT00617643|Nevirapine|nevirapine|mesh-list
20296490|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20296491|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20296492|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296493|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296494|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
20296495|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296496|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296497|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296498|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20296499|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20296500|NCT00617656|Gemcitabine|gemcitabine|mesh-list
20296501|NCT00617656|Cisplatin|cisplatin|mesh-list
20296502|NCT00617656|Docetaxel|docetaxel|mesh-list
20296503|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296504|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296505|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
20296506|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296507|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
20296508|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296509|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296510|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296511|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
20296512|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296513|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296514|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
20296515|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
20296516|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
20296517|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20296518|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20296519|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
20296520|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296521|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296522|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296523|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
20296524|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20296525|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20296526|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
20296527|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296528|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296529|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296530|NCT00617760|Vaccines|vaccines|mesh-list
20296531|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20296532|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
20296533|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296534|NCT00617799|Aldesleukin|aldesleukin|mesh-list
20296535|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296536|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296537|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296538|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
20296539|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296540|NCT00617877|Losartan|losartan|mesh-list
20296541|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20069085|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
20069086|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296542|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20296543|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20296544|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20296545|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20296546|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296547|NCT00617877|Diuretics|diuretics|mesh-ancestor
20296548|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
20296549|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296550|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20577428|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20577429|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
20577430|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069087|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
20069088|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069089|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069090|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069091|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20069092|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20577431|NCT02078063|Mepivacaine|mepivacaine|mesh-list
20296551|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296552|NCT00617955|Aprotinin|aprotinin|mesh-list
20296553|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296554|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
20296555|NCT00617955|Coagulants|coagulants|mesh-ancestor
20296556|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20296557|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20296558|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
20296559|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296560|NCT00617968|Docetaxel|docetaxel|mesh-list
20296561|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296562|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296563|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
20296564|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
20296565|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296566|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
20296567|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
20296568|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20296569|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20296570|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296571|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296572|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20296573|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20296574|NCT00618059|Pilocarpine|pilocarpine|mesh-list
20296575|NCT00618059|Miotics|miotics|mesh-ancestor
20296576|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
20069093|NCT02589145|Growth Substances|growth substances|mesh-ancestor
20069094|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
20069095|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069096|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
20069097|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20069098|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
20069099|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20069100|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20069101|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20069102|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
20069103|NCT02589145|Vitamins|vitamins|mesh-ancestor
20069104|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
20069105|NCT02582749|Bicalutamide|bicalutamide|mesh-list
20296577|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296578|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577432|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
20577433|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
20577434|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577435|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577436|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
20577437|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577438|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
20577439|NCT02078089|Morphine|morphine|mesh-list
20577440|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20577441|NCT02078089|Narcotics|narcotics|mesh-ancestor
20577442|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577443|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577444|NCT02078089|Analgesics|analgesics|mesh-ancestor
20577445|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
20577446|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577447|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
20577448|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20069106|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20069107|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
20069108|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
20069109|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069110|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069111|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069112|NCT02593682|Suvorexant|suvorexant|mesh-list
20069113|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20296579|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20577449|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20069114|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20296580|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20296581|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
20296582|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296583|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296584|NCT00618111|Granisetron|granisetron|mesh-list
20296585|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
20296586|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
20069115|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069116|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069117|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20069118|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069119|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069120|NCT02587650|Ceritinib|ceritinib|mesh-list
20069121|NCT02587650|Entrectinib|entrectinib|mesh-list
20069122|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069123|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20069124|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069125|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069126|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
20069127|NCT02569957|Topotecan|topotecan|mesh-list
20069128|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20069129|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20069130|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20069131|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069132|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069133|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069134|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
20069135|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069136|NCT02569957|Expectorants|expectorants|mesh-ancestor
20069137|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
20069138|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20069139|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
20069140|NCT02569957|Protective Agents|protective agents|mesh-ancestor
20296587|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296588|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296589|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296590|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20296591|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
20296592|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296593|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296594|NCT00618124|Capecitabine|capecitabine|mesh-list
20296595|NCT00618124|Sunitinib|sunitinib|mesh-list
20296596|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296597|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
20296598|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296599|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296600|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20296601|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20296602|NCT00618124|Growth Substances|growth substances|mesh-ancestor
20296603|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069141|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069142|NCT02569957|Antidotes|antidotes|mesh-ancestor
20069143|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
20069144|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
20069145|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069146|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069147|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20296604|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
20296605|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296606|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296607|NCT00618163|Meloxicam|meloxicam|mesh-list
20296608|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20296609|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296610|NCT00618163|Analgesics|analgesics|mesh-ancestor
20296611|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
20296612|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296613|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296614|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296615|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296616|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20296617|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20296618|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069148|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
20069149|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
20296619|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296620|NCT00618176|Lamivudine|lamivudine|mesh-list
20296621|NCT00618176|Zidovudine|zidovudine|mesh-list
20296622|NCT00618176|Nevirapine|nevirapine|mesh-list
20296623|NCT00618176|Stavudine|stavudine|mesh-list
20296624|NCT00618176|Didanosine|didanosine|mesh-list
20296625|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20296626|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20296627|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296628|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296629|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
20296630|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296631|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296632|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296633|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
20296634|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20296635|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20296636|NCT00618202|Balsalazide|balsalazide|mesh-list
20296637|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20296638|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296639|NCT00618202|Analgesics|analgesics|mesh-ancestor
20296640|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
20296641|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296642|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296643|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296644|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296645|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296646|NCT00618228|Balsalazide|balsalazide|mesh-list
20296647|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20069150|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069151|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069152|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296648|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296649|NCT00618228|Analgesics|analgesics|mesh-ancestor
20296650|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
20296651|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296652|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296653|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069153|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20069154|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
20069155|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20069156|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20069157|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20069158|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069159|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296654|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296655|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296656|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
20296657|NCT00618241|Lamotrigine|lamotrigine|mesh-list
20296658|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20296659|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20296660|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
20296661|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296662|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20296663|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20296664|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296665|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296666|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
20296667|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20296668|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296669|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20296670|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296671|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20296672|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20296673|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296674|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20296675|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20296676|NCT00618254|Granisetron|granisetron|mesh-list
20069160|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
20069161|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069162|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20069163|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20296677|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
20296678|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
20308975|NCT00666484|Procarbazine|procarbazine|mesh-list
20296679|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296680|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296681|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20296682|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20296683|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
20069164|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069165|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
20069166|NCT02549716|Acetaminophen|acetaminophen|mesh-list
20069167|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20069168|NCT02549716|Analgesics|analgesics|mesh-ancestor
20069169|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
20069170|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069171|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069172|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
20069173|NCT02531308|Metformin|metformin|mesh-list
20296684|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296685|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296686|NCT00618280|Nicotine|nicotine|mesh-list
20296687|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20296688|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
20296689|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296690|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296691|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20296692|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20296693|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
20296694|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296695|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296696|NCT00618345|Everolimus|everolimus|mesh-list
20069174|NCT02531308|Prednisone|prednisone|mesh-list
20069175|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
20069176|NCT02531308|Rituximab|rituximab|mesh-list
20069177|NCT02531308|Doxorubicin|doxorubicin|mesh-list
20069178|NCT02531308|Vincristine|vincristine|mesh-list
20069179|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069180|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
20069181|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069182|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069183|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069184|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
20069185|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069186|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069187|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20069188|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20069189|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20069190|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20069191|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20069192|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20069193|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296697|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296698|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296699|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
20296700|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296701|NCT00618358|Thrombin|thrombin|mesh-list
20296702|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
20296703|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
20296704|NCT00618358|Coagulants|coagulants|mesh-ancestor
20296705|NCT00618384|Sorafenib|sorafenib|mesh-list
20296706|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296707|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296708|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296709|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296710|NCT00618397|Ketamine|ketamine|mesh-list
20296711|NCT00618397|Analgesics|analgesics|mesh-ancestor
20296712|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
20296713|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296714|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296715|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20069194|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069195|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
20296716|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20069196|NCT02531308|Hormones|hormones|mesh-ancestor
20119754|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296717|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
20296718|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
20296719|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296720|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20296721|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20296722|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296723|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296724|NCT00618423|Ketamine|ketamine|mesh-list
20296725|NCT00618423|Analgesics|analgesics|mesh-ancestor
20296726|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
20296727|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296728|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296729|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20296730|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20296731|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
20296732|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
20296733|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296734|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20296735|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20296736|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296737|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296738|NCT00618501|Leucovorin|leucovorin|mesh-list
20296739|NCT00618501|Cytarabine|cytarabine|mesh-list
20296740|NCT00618501|Prednisolone|prednisolone|mesh-list
20296741|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
20296742|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20296743|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20296744|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20296745|NCT00618501|Methotrexate|methotrexate|mesh-list
20296746|NCT00618501|Etoposide|etoposide|mesh-list
20296747|NCT00618501|Vincristine|vincristine|mesh-list
20296748|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
20296749|NCT00618501|Daunorubicin|daunorubicin|mesh-list
20296750|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
20296751|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296752|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20296753|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
20296754|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20296755|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296756|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
20296757|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296758|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296759|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
20296760|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296761|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20296762|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296763|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
20296764|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296765|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20296766|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20296767|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20296768|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20296769|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
20296770|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296771|NCT00618501|Antidotes|antidotes|mesh-ancestor
20296772|NCT00618501|Protective Agents|protective agents|mesh-ancestor
20296773|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
20296774|NCT00618501|Vitamins|vitamins|mesh-ancestor
20296775|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
20296776|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296777|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
20296778|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
20296779|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296780|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
20296781|NCT00618501|Hormones|hormones|mesh-ancestor
20296782|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20296783|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20296784|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296785|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20296786|NCT00618527|Interferons|interferons|mesh-list
20296787|NCT00618527|Interferon-beta|interferon-beta|mesh-list
20296788|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
20296789|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
20296790|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296791|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
20296792|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296793|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20296794|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20296795|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
20296796|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20296797|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296798|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296799|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
20296800|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296801|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20296802|NCT00618579|Warfarin|warfarin|mesh-list
20296803|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
20296804|NCT00618631|Carfentanil|carfentanil|mesh-list
20296805|NCT00618631|Nicotine|nicotine|mesh-list
20296806|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20296807|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
20296808|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296809|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296810|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20069197|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069198|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069199|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069200|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296811|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20296812|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
20296813|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20296814|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296815|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20296816|NCT00618631|Narcotics|narcotics|mesh-ancestor
20296817|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20296818|NCT00618631|Analgesics|analgesics|mesh-ancestor
20296819|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
20296820|NCT00618644|Ranibizumab|ranibizumab|mesh-list
20296821|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20296822|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20296823|NCT00618644|Growth Substances|growth substances|mesh-ancestor
20296824|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296825|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
20296826|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296827|NCT00618657|Paclitaxel|paclitaxel|mesh-list
20296828|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20296829|NCT00618657|Bevacizumab|bevacizumab|mesh-list
20296830|NCT00618657|Carboplatin|carboplatin|mesh-list
20296831|NCT00618657|Trastuzumab|trastuzumab|mesh-list
20296832|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20296833|NCT00618657|Antibodies|antibodies|mesh-list
20296834|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
20296835|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20296836|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20296837|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296838|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
20296839|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
20296840|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
20296841|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296842|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20296843|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20296844|NCT00618657|Growth Substances|growth substances|mesh-ancestor
20296845|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296846|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
19491680|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069201|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069202|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
20069203|NCT02534038|Quinidine|quinidine|mesh-list
20069204|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
20069205|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
20069206|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
20069207|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20069208|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20069209|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069210|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069211|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069212|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20069213|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20069214|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
20069215|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20069216|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
20069217|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20296847|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
20296848|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20296849|NCT00618696|Antibodies|antibodies|mesh-list
20296850|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
20296851|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20296852|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
20296853|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296854|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296855|NCT00618852|Furosemide|furosemide|mesh-list
20296856|NCT00618852|Diuretics|diuretics|mesh-ancestor
20296857|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
20296858|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296859|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20296860|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20296861|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296862|NCT00618969|Busulfan|busulfan|mesh-list
20296863|NCT00618969|Melphalan|melphalan|mesh-list
20296864|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
20296865|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296866|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296867|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
20296868|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296869|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20296870|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296871|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20296872|NCT00619021|Gemcitabine|gemcitabine|mesh-list
20296873|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296874|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
20296875|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296876|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296877|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
20296878|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296879|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296880|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296881|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
20296882|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296883|NCT00619034|Diclofenac|diclofenac|mesh-list
20296884|NCT00619034|Dorzolamide|dorzolamide|mesh-list
20296885|NCT00619034|Latanoprost|latanoprost|mesh-list
20296886|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20296887|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20296888|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296889|NCT00619034|Analgesics|analgesics|mesh-ancestor
20296890|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
20296891|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296892|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296893|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20296894|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296895|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20296896|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296897|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296898|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20296899|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20296900|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20296901|NCT00619203|Acetaminophen|acetaminophen|mesh-list
20296902|NCT00619203|Glycerol|glycerol|mesh-list
20296903|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20296904|NCT00619203|Analgesics|analgesics|mesh-ancestor
20296905|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
20296906|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20296907|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296908|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
20577450|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19491681|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
20069218|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20069219|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069220|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069221|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20069222|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20069223|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
20069224|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20069225|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20296909|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20296910|NCT00619203|Protective Agents|protective agents|mesh-ancestor
20577451|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577452|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20069226|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577453|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20577454|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
20577455|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
20577456|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577457|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
20577458|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577459|NCT02078167|Policosanol|policosanol|mesh-list
20577460|NCT02078167|Red yeast rice|red yeast rice|mesh-list
20577461|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20577462|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20577463|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
20577464|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577465|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20577466|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20577467|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20577468|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577469|NCT02078232|Pancrelipase|pancrelipase|mesh-list
20577470|NCT02078232|Pancreatin|pancreatin|mesh-list
20577471|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20577472|NCT02078323|Linaclotide|linaclotide|mesh-list
20577473|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20577474|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
20069227|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20069228|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20069229|NCT02520726|Sertraline|sertraline|mesh-list
20069230|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
20069231|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20069232|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20069233|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20069234|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20069235|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069236|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069237|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
20069238|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069239|NCT02518750|Cytarabine|cytarabine|mesh-list
20069240|NCT02518750|Dexamethasone|dexamethasone|mesh-list
20069241|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
20069242|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
20069243|NCT02518750|Methotrexate|methotrexate|mesh-list
20069244|NCT02518750|Etoposide|etoposide|mesh-list
20069245|NCT02518750|Vincristine|vincristine|mesh-list
20069246|NCT02518750|Bortezomib|bortezomib|mesh-list
20069247|NCT02518750|Asparaginase|asparaginase|mesh-list
20069248|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
20069249|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
20069250|NCT02518750|Clofarabine|clofarabine|mesh-list
20069251|NCT02518750|Panobinostat|panobinostat|mesh-list
20069252|NCT02518750|Pegaspargase|pegaspargase|mesh-list
20069253|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069254|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
20069255|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069256|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069257|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069258|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
20069259|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069260|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069261|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20069262|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069263|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
20069264|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
20069265|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069266|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069267|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
20069268|NCT02518750|Hormones|hormones|mesh-ancestor
20069269|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069270|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069271|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20069272|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
20069273|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20069274|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069275|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
20069276|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20296911|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
20296912|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20296913|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296914|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20296915|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
20296916|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20296917|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296918|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296919|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296920|NCT00619268|Interferons|interferons|mesh-list
20296921|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
20296922|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
20296923|NCT00619268|Sirolimus|sirolimus|mesh-list
20296924|NCT00619268|Bevacizumab|bevacizumab|mesh-list
20296925|NCT00619268|Sunitinib|sunitinib|mesh-list
20296926|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20296927|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296928|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20296929|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20296930|NCT00619268|Growth Substances|growth substances|mesh-ancestor
20296931|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296932|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
20296933|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
20296934|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296935|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
20296936|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296937|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296938|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296939|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20296940|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20296941|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
20296942|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296943|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20296944|NCT00619333|Hormones|hormones|mesh-ancestor
20296945|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20296946|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296947|NCT00619346|Pafuramidine|pafuramidine|mesh-list
20296948|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20296949|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20296950|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20296951|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296952|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
20296953|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
20296954|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296955|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296956|NCT00619398|Tacrolimus|tacrolimus|mesh-list
20296957|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296958|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
20296959|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296960|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20296961|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296962|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296963|NCT00619424|Pemetrexed|pemetrexed|mesh-list
20296964|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20296965|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296966|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20296967|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296968|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20296969|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20296970|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20296971|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
20296972|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20296973|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296974|NCT00619541|Fluorouracil|fluorouracil|mesh-list
20296975|NCT00619541|Sorafenib|sorafenib|mesh-list
20296976|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
20296977|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20296978|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20296979|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296980|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20296981|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
20296982|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577475|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577476|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20577477|NCT02078336|Atropine|atropine|mesh-list
20296983|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20069277|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069278|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20069279|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20069280|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069281|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20069282|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20069283|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
20069284|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20296984|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308526|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20308527|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308528|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308529|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308530|NCT00664703|Methylphenidate|methylphenidate|mesh-list
20308531|NCT00664703|Lobeline|lobeline|mesh-list
20308532|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20308533|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308534|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20308535|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20308536|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20308537|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308538|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
20308539|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308540|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20308541|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
20308542|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308543|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20069285|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
20069286|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069287|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
20069288|NCT02518750|Analgesics|analgesics|mesh-ancestor
20069289|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
20069290|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20069291|NCT02515851|Bupivacaine|bupivacaine|mesh-list
20069292|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
20069293|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
20069294|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069295|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069296|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
20069297|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069298|NCT02506985|Warfarin|warfarin|mesh-list
20069299|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
20069300|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
20069301|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20069302|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
20069303|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20069304|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069305|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069306|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069307|NCT02514252|Fentanyl|fentanyl|mesh-list
20069308|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20069309|NCT02514252|Narcotics|narcotics|mesh-ancestor
20308544|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20308545|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
20308546|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
20308547|NCT00664781|Rucaparib|rucaparib|mesh-list
20308548|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20308549|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308550|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308551|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308552|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20308553|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308554|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20308555|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308556|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308557|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308558|NCT00664833|Urological Agents|urological agents|mesh-ancestor
20308559|NCT00664846|Aspirin|aspirin|mesh-list
20308560|NCT00664846|Clopidogrel|clopidogrel|mesh-list
20308561|NCT00664846|Atorvastatin|atorvastatin|mesh-list
20308562|NCT00664846|Simvastatin|simvastatin|mesh-list
20069310|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069311|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308563|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20296985|NCT00619671|Rituximab|rituximab|mesh-list
20296986|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20296987|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20296988|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
20296989|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20296990|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20296991|NCT00619697|Insulin|insulin|mesh-list
20296992|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20296993|NCT00619697|Metformin|metformin|mesh-list
20296994|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
20296995|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
20296996|NCT00619697|Glimepiride|glimepiride|mesh-list
20296997|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
20296998|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20296999|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20297000|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297001|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20297002|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297003|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
20297004|NCT00619710|Meropenem|meropenem|mesh-list
20297005|NCT00619710|Imipenem|imipenem|mesh-list
20297006|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
20297007|NCT00619710|Cilastatin|cilastatin|mesh-list
20297008|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20297009|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297010|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
20297011|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297012|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297013|NCT00619840|Methylphenidate|methylphenidate|mesh-list
20297014|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20297015|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297016|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20297017|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20297018|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20297019|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297020|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
20297021|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297022|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20297023|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
20297024|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297025|NCT00619931|APD791|apd791|mesh-list
20297026|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20297027|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20297028|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
20297029|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297030|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297031|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297032|NCT00619944|Ritonavir|ritonavir|mesh-list
20297033|NCT00619944|Lopinavir|lopinavir|mesh-list
20297034|NCT00619944|Lumefantrine|lumefantrine|mesh-list
20297035|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20297036|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20297037|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20297038|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069312|NCT02514252|Analgesics|analgesics|mesh-ancestor
20069313|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
20069314|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297039|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297040|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297041|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20297042|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20297043|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
20297044|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297045|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20297046|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297047|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
20297048|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20069315|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20069316|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20069317|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
20069318|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
19491682|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069319|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
20069320|NCT02501759|Antidotes|antidotes|mesh-ancestor
20297049|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20297050|NCT00619996|Docetaxel|docetaxel|mesh-list
20297051|NCT00619996|Sorafenib|sorafenib|mesh-list
20297052|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297053|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
20297054|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
20297055|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
20297056|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297057|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297058|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297059|NCT00620100|Docetaxel|docetaxel|mesh-list
20297060|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297061|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
20297062|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
20297063|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
20297064|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297065|NCT00620165|Levetiracetam|levetiracetam|mesh-list
20297066|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
20297067|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
20297068|NCT00620178|Losartan|losartan|mesh-list
20297069|NCT00620178|Candesartan|candesartan|mesh-list
20297070|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
20297071|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20297072|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20297073|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20297074|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20297075|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297076|NCT00620204|Atorvastatin|atorvastatin|mesh-list
20297077|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20297078|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20297079|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
20297080|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297081|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20297082|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20297083|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297084|NCT00620269|Irinotecan|irinotecan|mesh-list
20297085|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20297086|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297087|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20297088|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20297089|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297090|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297091|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297092|NCT00620295|Gemcitabine|gemcitabine|mesh-list
20297093|NCT00620295|Bortezomib|bortezomib|mesh-list
20297094|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20297095|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
20297096|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297097|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297098|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
20297099|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297100|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297101|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297102|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
20297103|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297104|NCT00620347|Sunitinib|sunitinib|mesh-list
20297105|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297106|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20297107|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20297108|NCT00620347|Growth Substances|growth substances|mesh-ancestor
20297109|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297110|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
20297111|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297112|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297113|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297114|NCT00620438|Efavirenz|efavirenz|mesh-list
20297115|NCT00620438|Nevirapine|nevirapine|mesh-list
20297116|NCT00620438|Rifampin|rifampin|mesh-list
20297117|NCT00620438|Lumefantrine|lumefantrine|mesh-list
20297118|NCT00620438|Artemether|artemether|mesh-list
20297119|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20297120|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20297121|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20297122|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297123|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297124|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
20297125|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297126|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20297127|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297128|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20297129|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20297130|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20297131|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20297132|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20297133|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20297134|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20297135|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
20297136|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20297137|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
20297138|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20297139|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20297140|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20297141|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
20297142|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20297143|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20297144|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
20297145|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
20297146|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
20297147|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297148|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297149|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
20069321|NCT02501759|Protective Agents|protective agents|mesh-ancestor
20069322|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069323|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
20069324|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
20069325|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069326|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20069327|NCT02487277|Gemcitabine|gemcitabine|mesh-list
20069328|NCT02487277|Paclitaxel|paclitaxel|mesh-list
20069329|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069330|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069331|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
20297150|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297151|NCT00620490|Ropivacaine|ropivacaine|mesh-list
20297152|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
20297153|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
20297154|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297155|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297156|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
20297157|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297158|NCT00620581|Paroxetine|paroxetine|mesh-list
20297159|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20297160|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20297161|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20297162|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297163|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297164|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
20297165|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297166|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20297167|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
20297168|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297169|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20297170|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297171|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297172|NCT00620594|Dactolisib|dactolisib|mesh-list
20297173|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297174|NCT00620620|Zaleplon|zaleplon|mesh-list
20297175|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
20297176|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20297177|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297178|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297179|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
20297180|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
20297181|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297182|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297183|NCT00620646|Aspirin|aspirin|mesh-list
20297184|NCT00620646|Cilostazol|cilostazol|mesh-list
20297185|NCT00620646|Clopidogrel|clopidogrel|mesh-list
20069332|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069333|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
20297186|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20297187|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20297188|NCT00620646|Analgesics|analgesics|mesh-ancestor
20297189|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
20297190|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069334|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069335|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069336|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
20069337|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
20069338|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069339|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069340|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069341|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
20069342|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069343|NCT02499887|Prednisone|prednisone|mesh-list
20069344|NCT02499887|Albuterol|albuterol|mesh-list
20069345|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069346|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
20297191|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297192|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20297193|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20297194|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20297195|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20297196|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297197|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20297198|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20297199|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297200|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
20069347|NCT02499887|Hormones|hormones|mesh-ancestor
20069348|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069349|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069350|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069351|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069352|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20297201|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20297202|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20297203|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20297204|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
20297205|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297206|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20297207|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
20297208|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20297209|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
20297210|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
20297211|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20297212|NCT00620646|Protective Agents|protective agents|mesh-ancestor
20297213|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20297214|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20297215|NCT00620724|Nifedipine|nifedipine|mesh-list
20297216|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20297217|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20297218|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297219|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20297220|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297221|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
20297222|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
20297223|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20297224|NCT00620789|Dexetimide|dexetimide|mesh-list
20297225|NCT00620789|Citalopram|citalopram|mesh-list
20297226|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
20297227|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20297228|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20297229|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20297230|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297231|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297232|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
20297233|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297234|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20297235|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297236|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20297237|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20069353|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
20069354|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297238|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
20069355|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20297239|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
20297240|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069356|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
20069357|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
20069358|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20297241|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20297242|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20297243|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
20297244|NCT00620802|Clopidogrel|clopidogrel|mesh-list
20297245|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20297246|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20297247|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20297248|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20297249|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
20297250|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297251|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297252|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297253|NCT00620867|Ibuprofen|ibuprofen|mesh-list
20297254|NCT00620867|Celecoxib|celecoxib|mesh-list
20297255|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20297256|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20297257|NCT00620867|Analgesics|analgesics|mesh-ancestor
20297258|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
20297259|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297260|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297261|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20297262|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20297263|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20297264|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297265|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297266|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20297267|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
20297268|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20297269|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20297270|NCT00620919|Secretin|secretin|mesh-list
20297271|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20297272|NCT00620919|Hormones|hormones|mesh-ancestor
20069359|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20069360|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20069361|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20069362|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
20069363|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297273|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297274|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297275|NCT00620971|Gemcitabine|gemcitabine|mesh-list
20297276|NCT00620971|Bevacizumab|bevacizumab|mesh-list
20297277|NCT00620971|Cisplatin|cisplatin|mesh-list
20297278|NCT00620971|Docetaxel|docetaxel|mesh-list
20297279|NCT00620971|Vinorelbine|vinorelbine|mesh-list
20297280|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20297281|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297282|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20297283|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20297284|NCT00620971|Growth Substances|growth substances|mesh-ancestor
20297285|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297286|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
20297287|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20297288|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
20297289|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297290|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
20297291|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297292|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297293|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297294|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
20297295|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
20297296|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
20297297|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
20297298|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20297299|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
20297300|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
20297301|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
20297302|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297303|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297304|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
20297305|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297306|NCT00621036|Methotrexate|methotrexate|mesh-list
20297307|NCT00621036|Thiotepa|thiotepa|mesh-list
20297308|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
20297309|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20297310|NCT00621036|Antibodies|antibodies|mesh-list
20297311|NCT00621036|Sargramostim|sargramostim|mesh-list
20297312|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20297313|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20297314|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
20297315|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20297316|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069364|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069365|NCT02504099|Ritonavir|ritonavir|mesh-list
20069366|NCT02504099|Ribavirin|ribavirin|mesh-list
20297317|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20297318|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
20297319|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297320|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297321|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
20297322|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297323|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20297324|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297325|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
20297326|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20297327|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20297328|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20297329|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
20297330|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20297331|NCT00621101|Sirolimus|sirolimus|mesh-list
20297332|NCT00621101|Ezetimibe|ezetimibe|mesh-list
20297333|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20297334|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297335|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20297336|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297337|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
20297338|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297339|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
20297340|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297341|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20297342|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20297343|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
20297344|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297345|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20069367|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20069368|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20297346|NCT00621166|Ritonavir|ritonavir|mesh-list
20297347|NCT00621166|Lopinavir|lopinavir|mesh-list
20297348|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20297349|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20297350|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
20297351|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297352|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297353|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20297354|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20297355|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
20297356|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297357|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20297358|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297359|NCT00621218|Tretinoin|tretinoin|mesh-list
20297360|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297361|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
20069369|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069370|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069371|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069372|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20069373|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20069374|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
20069375|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069376|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20069377|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20069378|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
20069379|NCT02500901|Niraparib|niraparib|mesh-list
20069380|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20297362|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069381|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297363|NCT00621283|Secretin|secretin|mesh-list
20297364|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20297365|NCT00621283|Hormones|hormones|mesh-ancestor
20297366|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297367|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297368|NCT00621361|Etoposide|etoposide|mesh-list
20297369|NCT00621361|Cediranib|cediranib|mesh-list
20297370|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297371|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20297372|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20297373|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20297374|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577478|NCT02078336|Midazolam|midazolam|mesh-list
20577479|NCT02078336|Droperidol|droperidol|mesh-list
20577480|NCT02078336|Lorazepam|lorazepam|mesh-list
20577481|NCT02078336|Biperiden|biperiden|mesh-list
20577482|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20577483|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20577484|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577485|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577486|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20577487|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20577488|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20577489|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20577490|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
20577491|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
20577492|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
20577493|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
20577494|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577495|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577496|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20577497|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20577498|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
20577499|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577500|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20577501|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
20069382|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577502|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
20577503|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
20069383|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069384|NCT02496039|Quinidine|quinidine|mesh-list
20069385|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
20069386|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
20069387|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
20069388|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20069389|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20069390|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069391|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069392|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069393|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20069394|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20069395|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
20069396|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20069397|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
20069398|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20069399|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20069400|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069401|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577504|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20577505|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20577506|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
20577507|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
20577508|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
20577509|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20577510|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20577511|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20577512|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20577513|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20577514|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20577515|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
20577516|NCT02078388|Doxorubicin|doxorubicin|mesh-list
20577517|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20577518|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297375|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577519|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20577520|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20577521|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297376|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297377|NCT00621387|Ofloxacin|ofloxacin|mesh-list
20297378|NCT00621387|Roxithromycin|roxithromycin|mesh-list
20297379|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20297380|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297381|NCT00621387|Renal Agents|renal agents|mesh-ancestor
20297382|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20297383|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20297384|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20297385|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297386|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297387|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297388|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20297389|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297390|NCT00621400|Dexamethasone|dexamethasone|mesh-list
20297391|NCT00621400|Lenalidomide|lenalidomide|mesh-list
20297392|NCT00621400|Melphalan|melphalan|mesh-list
19491683|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491684|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19491685|NCT03128528|Empagliflozin|empagliflozin|mesh-list
19491686|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19491687|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491688|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19491689|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491690|NCT03128242|Oxytocin|oxytocin|mesh-list
19491691|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
20069402|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20069403|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20297393|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20297394|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
20297395|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
20297396|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297397|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297398|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20297399|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
20297400|NCT00621400|Hormones|hormones|mesh-ancestor
20297401|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297402|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20297403|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297404|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
20297405|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20297406|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20069404|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
20069405|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20069406|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20069407|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20069408|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20069409|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20069410|NCT02492295|Propofol|propofol|mesh-list
20069411|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20069412|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069413|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069414|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20069415|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
20297407|NCT00621400|Growth Substances|growth substances|mesh-ancestor
20297408|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
20297409|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20297410|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
20297411|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297412|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20297413|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297414|NCT00621452|Aldesleukin|aldesleukin|mesh-list
20297415|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
20297416|NCT00621452|Interleukin-2|interleukin-2|mesh-list
20297417|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297418|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
20297419|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297420|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20297421|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20297422|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
20297423|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297424|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297425|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20297426|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20297427|NCT00621452|Analgesics|analgesics|mesh-ancestor
20297428|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
20297429|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297430|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20297431|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20297432|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
20297433|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297434|NCT00621478|Diazepam|diazepam|mesh-list
20297435|NCT00621478|Lorazepam|lorazepam|mesh-list
20297436|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
20297437|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
20297438|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
20297439|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297440|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297441|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20297442|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20297443|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297444|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20297445|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297446|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297447|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
20297448|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
20297449|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297450|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297451|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20297452|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19491692|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19491693|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491694|NCT03128216|Bupivacaine|bupivacaine|mesh-list
19491695|NCT03128216|Ropivacaine|ropivacaine|mesh-list
19491696|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
19491697|NCT03128216|Anesthetics|anesthetics|mesh-list
19491698|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069416|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
20069417|NCT02473445|Cysteamine|cysteamine|mesh-list
20069418|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
20069419|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069420|NCT02491411|Dexamethasone|dexamethasone|mesh-list
20069421|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
20069422|NCT02491411|Ichthammol|ichthammol|mesh-list
20069423|NCT02491411|BB 1101|bb 1101|mesh-list
20069424|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069425|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
20069426|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
20069427|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069428|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069429|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069430|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
20069431|NCT02491411|Hormones|hormones|mesh-ancestor
20069432|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069433|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069434|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069435|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069436|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069437|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069438|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069439|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20069440|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20069441|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20069442|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20069443|NCT02468583|Triamcinolone|triamcinolone|mesh-list
20069444|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20069445|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20069446|NCT02468583|FX006|fx006|mesh-list
20069447|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20069448|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069449|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
20069450|NCT02468583|Hormones|hormones|mesh-ancestor
20069451|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069452|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069453|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069454|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
20069455|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297453|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20297454|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20297455|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
20297456|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
20297457|NCT00621491|Warfarin|warfarin|mesh-list
20297458|NCT00621491|Anticoagulants|anticoagulants|mesh-list
20297459|NCT00621556|Secretin|secretin|mesh-list
20297460|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20297461|NCT00621556|Hormones|hormones|mesh-ancestor
20297462|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297463|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297464|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20297465|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
20297466|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297467|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20297468|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297469|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297470|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297471|NCT00621673|Factor VIII|factor viii|mesh-list
20297472|NCT00621673|Coagulants|coagulants|mesh-ancestor
20297473|NCT00621699|Ezetimibe|ezetimibe|mesh-list
20297474|NCT00621699|Tacrolimus|tacrolimus|mesh-list
20297475|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297476|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
20297477|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297478|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20297479|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297480|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069456|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069457|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20069458|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297481|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20297482|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20297483|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
20297484|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20297485|NCT00621725|Cediranib|cediranib|mesh-list
20297486|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297487|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297488|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297489|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308564|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308565|NCT00664846|Analgesics|analgesics|mesh-ancestor
20069459|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20069460|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069461|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069462|NCT02469415|Azacitidine|azacitidine|mesh-list
20069463|NCT02469415|Decitabine|decitabine|mesh-list
20069464|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069465|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
20069466|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069467|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069468|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069469|NCT02434146|Phenylephrine|phenylephrine|mesh-list
20069470|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
20069471|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20069472|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
20069473|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
20069474|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308566|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
20308567|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308568|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308569|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308570|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308571|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20308572|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20308573|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308574|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20308575|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308576|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308577|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
20308578|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20308579|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20308580|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
20308581|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20069475|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308582|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20308583|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20069476|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
20297490|NCT00621790|Fenoldopam|fenoldopam|mesh-list
20297491|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20297492|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
20297493|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
20297494|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
20297495|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297496|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297497|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297498|NCT00621816|Nitroprusside|nitroprusside|mesh-list
20297499|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20297500|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
20297501|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20297502|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297503|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
20297504|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20297505|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297506|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20297507|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297508|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
20297509|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20297510|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297511|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
20297512|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
20297513|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
20297514|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297515|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069477|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20069478|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
20069479|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
20069480|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20069481|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20069482|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20069483|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
20069484|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069485|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069486|NCT02434146|Protective Agents|protective agents|mesh-ancestor
20069487|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
20069488|NCT02447887|Ixazomib|ixazomib|mesh-list
20069489|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069490|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069491|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069492|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069493|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
20069494|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119755|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20119756|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20297516|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
20297517|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297518|NCT00621998|Olanzapine|olanzapine|mesh-list
20297519|NCT00621998|Risperidone|risperidone|mesh-list
20297520|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20297521|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
20297522|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297523|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297524|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297525|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20297526|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297527|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297528|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297529|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20297530|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
20297531|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
20297532|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
20297533|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297534|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20297535|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20297536|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20297537|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20297538|NCT00622011|Risperidone|risperidone|mesh-list
20297539|NCT00622011|Zotepine|zotepine|mesh-list
20297540|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20297541|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
20297542|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119757|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
20297543|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297544|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297545|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20297546|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297547|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297548|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20069495|NCT02439970|Valganciclovir|valganciclovir|mesh-list
20069496|NCT02439970|Brincidofovir|brincidofovir|mesh-list
20069497|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
20069498|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069499|NCT02439957|Valganciclovir|valganciclovir|mesh-list
20069500|NCT02439957|Brincidofovir|brincidofovir|mesh-list
20069501|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
20069502|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069503|NCT02436265|Dexamethasone|dexamethasone|mesh-list
20069504|NCT02436265|Ropivacaine|ropivacaine|mesh-list
20069505|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069506|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
20069507|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
20297549|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20297550|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
20297551|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
20297552|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20297553|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20297554|NCT00622115|Enoxaparin|enoxaparin|mesh-list
20297555|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
20297556|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20297557|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19746245|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746246|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
19746247|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746248|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746249|NCT04106856|Losartan|losartan|mesh-list
19746250|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19746251|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19746252|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19746253|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19746254|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746255|NCT04098744|Artesunate|artesunate|mesh-list
19746256|NCT04098744|Artemisinins|artemisinins|mesh-list
19746257|NCT04098744|Artemisinin|artemisinin|mesh-list
19491699|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491700|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
20297558|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297559|NCT00622141|Saquinavir|saquinavir|mesh-list
20297560|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20297561|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20297562|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
20297563|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297564|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297565|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20297566|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20297567|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
20297568|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069508|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069509|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069510|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069511|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
20069512|NCT02436265|Hormones|hormones|mesh-ancestor
20069513|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069514|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069515|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069516|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
20069517|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
20069518|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069519|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
20069520|NCT02429583|Vaccines|vaccines|mesh-list
20069521|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
20069522|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069523|NCT02417870|Aldesleukin|aldesleukin|mesh-list
20069524|NCT02417870|Interleukin-2|interleukin-2|mesh-list
20069525|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069526|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20069527|NCT02417870|Analgesics|analgesics|mesh-ancestor
20069528|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
20069529|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069530|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069531|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20069532|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20069533|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
20069534|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069535|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20069536|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069537|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069538|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
20069539|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069540|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20069541|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069542|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069543|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
20297569|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20297570|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297571|NCT00622206|Ritonavir|ritonavir|mesh-list
20297572|NCT00622206|Saquinavir|saquinavir|mesh-list
20069544|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069545|NCT02413047|Methotrexate|methotrexate|mesh-list
20069546|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
20069547|NCT02413047|Azathioprine|azathioprine|mesh-list
20069548|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20069549|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
20069550|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20069551|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069552|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069553|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
20297573|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20297574|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20297575|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
20297576|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069554|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069555|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069556|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069557|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069558|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20297577|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297578|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20297579|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20297580|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
20297581|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297582|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20297583|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297584|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20297585|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
20297586|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297587|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20297588|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297589|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297590|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297591|NCT00622258|Everolimus|everolimus|mesh-list
20297592|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297593|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297594|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
20297595|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297596|NCT00622349|Gemcitabine|gemcitabine|mesh-list
20297597|NCT00622349|Cisplatin|cisplatin|mesh-list
20297598|NCT00622349|Docetaxel|docetaxel|mesh-list
20297599|NCT00622349|Ifosfamide|ifosfamide|mesh-list
20297600|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
20297601|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297602|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20297603|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
20069559|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069560|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
20069561|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069562|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20069563|NCT02422303|Ketamine|ketamine|mesh-list
20297604|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069564|NCT02422303|Analgesics|analgesics|mesh-ancestor
20297605|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
20297606|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297607|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297608|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297609|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
20297610|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297611|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
20297612|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
20297613|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
20297614|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20297615|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
20297616|NCT00622375|Mesalamine|mesalamine|mesh-list
20297617|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20297618|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20297619|NCT00622375|Analgesics|analgesics|mesh-ancestor
20297620|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
20297621|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297622|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297623|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069565|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
20069566|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069567|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069568|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20069569|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20069570|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
20069571|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
20297624|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20297625|NCT00622414|Aflibercept|aflibercept|mesh-list
20297626|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
20069572|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069573|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20069574|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20069575|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069576|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069577|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20069578|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069579|NCT02410551|Vidarabine|vidarabine|mesh-list
20069580|NCT02410551|Fludarabine|fludarabine|mesh-list
20069581|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
20069582|NCT02410551|Busulfan|busulfan|mesh-list
20297627|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20297628|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20297629|NCT00622414|Growth Substances|growth substances|mesh-ancestor
20297630|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297631|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
20297632|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297633|NCT00622479|Sorafenib|sorafenib|mesh-list
20297634|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297635|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297636|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297637|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297638|NCT00622570|Pentobarbital|pentobarbital|mesh-list
20577522|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069583|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577523|NCT02078440|Bromocriptine|bromocriptine|mesh-list
20069584|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069585|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
20069586|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069587|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069588|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
20069589|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069590|NCT02410551|Antiviral Agents|antiviral agents|mesh-ancestor
20069591|NCT02410551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069592|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
20069593|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069594|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20069595|NCT02411643|Calcipotriene|calcipotriene|mesh-list
20069596|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069597|NCT02409355|Gemcitabine|gemcitabine|mesh-list
20069598|NCT02409355|Carboplatin|carboplatin|mesh-list
20297639|NCT00622570|Thiopental|thiopental|mesh-list
20297640|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
20577524|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20577525|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20577526|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
20577527|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577528|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577529|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
20577530|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
20577531|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577532|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577533|NCT02078583|Fentanyl|fentanyl|mesh-list
20577534|NCT02078583|Remifentanil|remifentanil|mesh-list
20577535|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20577536|NCT02078583|Narcotics|narcotics|mesh-ancestor
20577537|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577538|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577539|NCT02078583|Analgesics|analgesics|mesh-ancestor
20069599|NCT02409355|Atezolizumab|atezolizumab|mesh-list
20069600|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069601|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069602|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
20069603|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069604|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
20069605|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069606|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069607|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069608|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
20297641|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20297642|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069609|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069610|NCT02392377|Leucovorin|leucovorin|mesh-list
20069611|NCT02392377|Paclitaxel|paclitaxel|mesh-list
20069612|NCT02392377|Carboplatin|carboplatin|mesh-list
20069613|NCT02392377|Fluorouracil|fluorouracil|mesh-list
20297643|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297644|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20297645|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
20297646|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
20297647|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
20297648|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
20297649|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297650|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297651|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20577540|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
20577541|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577542|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20577543|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20577544|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
20577545|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
20577546|NCT02078596|Valproic Acid|valproic acid|mesh-list
20577547|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
20577548|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577549|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577550|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
20577551|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069614|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
20069615|NCT02392377|Calcium|calcium|mesh-list
20069616|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
20069617|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069618|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069619|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
20069620|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069621|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
20297652|NCT00622622|Gemcitabine|gemcitabine|mesh-list
20069622|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069623|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20297653|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20297654|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
20297655|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297656|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297657|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
20297658|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297659|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297660|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297661|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
20297662|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297663|NCT00622648|Enoxaparin|enoxaparin|mesh-list
20297664|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
20297665|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20069624|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069625|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
20069626|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069627|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069628|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
20069629|NCT02392377|Antidotes|antidotes|mesh-ancestor
20297666|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20297667|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297668|NCT00622674|Cetuximab|cetuximab|mesh-list
20297669|NCT00622674|Bortezomib|bortezomib|mesh-list
20297670|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20297671|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297672|NCT00622687|Iloprost|iloprost|mesh-list
20297673|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20297674|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
20297675|NCT00622752|Nicotine|nicotine|mesh-list
20297676|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20297677|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
20297678|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297679|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577552|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577553|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
20577554|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20577555|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577556|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20577557|NCT02078609|Midostaurin|midostaurin|mesh-list
20577558|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577559|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20577560|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577561|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577562|NCT02078648|Poly I-C|poly i-c|mesh-list
20577563|NCT02078648|Bevacizumab|bevacizumab|mesh-list
20577564|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20577565|NCT02078648|Poly ICLC|poly iclc|mesh-list
20577566|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20577567|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577568|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20577569|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20577570|NCT02078648|Growth Substances|growth substances|mesh-ancestor
20577571|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577572|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
20577573|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
20577574|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
20577575|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
20577576|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577577|NCT02078648|Laxatives|laxatives|mesh-ancestor
20577578|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069630|NCT02392377|Protective Agents|protective agents|mesh-ancestor
20069631|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
20069632|NCT02392377|Vitamins|vitamins|mesh-ancestor
20069633|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
20069634|NCT02394665|Temozolomide|temozolomide|mesh-list
20069635|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069636|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
20069637|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069638|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069639|NCT02389712|Lamotrigine|lamotrigine|mesh-list
20069640|NCT02389712|Fluoxetine|fluoxetine|mesh-list
20069641|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20297680|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20577579|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20577580|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20577581|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20069642|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20297681|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20297682|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
20297683|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297684|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297685|NCT00622817|Epinephrine|epinephrine|mesh-list
20297686|NCT00622817|Xylometazoline|xylometazoline|mesh-list
20297687|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20297688|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20297689|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
20297690|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297691|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297692|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297693|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20297694|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20297695|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
20297696|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297697|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20297698|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
20297699|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
20297700|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
20297701|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20297702|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
20297703|NCT00622830|Darapladib|darapladib|mesh-list
20297704|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20297705|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297706|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297707|NCT00622843|Vaccines|vaccines|mesh-list
20297708|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20297709|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
20297710|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297711|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
20297712|NCT00622934|Hematinics|hematinics|mesh-ancestor
20297713|NCT00623064|Gemcitabine|gemcitabine|mesh-list
20297714|NCT00623064|Lapatinib|lapatinib|mesh-list
20297715|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297716|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20297717|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
20297718|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297719|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
20297720|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297721|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297722|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297723|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
20297724|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297725|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297726|NCT00623077|Etoposide|etoposide|mesh-list
20297727|NCT00623077|Melphalan|melphalan|mesh-list
20297728|NCT00623077|Busulfan|busulfan|mesh-list
20297729|NCT00623077|Ifosfamide|ifosfamide|mesh-list
20297730|NCT00623077|Thiotepa|thiotepa|mesh-list
20297731|NCT00623077|Sargramostim|sargramostim|mesh-list
20297732|NCT00623077|Mesna|mesna|mesh-list
20297733|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20297734|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297735|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20297736|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20297737|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297738|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297739|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
20297740|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297741|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20297742|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
20069643|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20069644|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069645|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069646|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
20069647|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069648|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20069649|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
20069650|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20069651|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20069652|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20069653|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297743|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20297744|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19491701|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491702|NCT03128398|Domperidone|domperidone|mesh-list
19491703|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
19491704|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
19491705|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491706|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491707|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491708|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19491709|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
19491710|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491711|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069654|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
20069655|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20069656|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20297745|NCT00623077|Protective Agents|protective agents|mesh-ancestor
20297746|NCT00623116|Testosterone|testosterone|mesh-list
20297747|NCT00623116|Estrogens|estrogens|mesh-list
20297748|NCT00623116|Androgens|androgens|mesh-ancestor
20297749|NCT00623116|Hormones|hormones|mesh-ancestor
20297750|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297751|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297752|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
20297753|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
20297754|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20297755|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
20069657|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20069658|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20069659|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069660|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20069661|NCT02390362|Rituximab|rituximab|mesh-list
20069662|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20069663|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069664|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
20069665|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069666|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069667|NCT02383433|Gemcitabine|gemcitabine|mesh-list
20069668|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069669|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
20069670|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069671|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297756|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20297757|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20297758|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297759|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20297760|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297761|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297762|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20297763|NCT00623155|Renal Agents|renal agents|mesh-ancestor
20297764|NCT00623168|Ribavirin|ribavirin|mesh-list
20297765|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
20297766|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297767|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
20297768|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297769|NCT00623207|Atropine|atropine|mesh-list
20069672|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
20069673|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069674|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069675|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069676|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
20069677|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069678|NCT02382588|Ganciclovir|ganciclovir|mesh-list
20069679|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
20069680|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069681|NCT02379390|Prednisone|prednisone|mesh-list
20069682|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
20069683|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069684|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
20069685|NCT02379390|Hormones|hormones|mesh-ancestor
20069686|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069687|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297770|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20297771|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20297772|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19491712|NCT03128346|Aspirin|aspirin|mesh-list
20297773|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
20297774|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297775|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297776|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20297777|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
20297778|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
20297779|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
20297780|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20297781|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20297782|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
20297783|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297784|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297785|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
20297786|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20297787|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
20297788|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
20297789|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297790|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297791|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20297792|NCT00623220|Analgesics|analgesics|mesh-ancestor
20297793|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
20297794|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297795|NCT00623285|Pregabalin|pregabalin|mesh-list
20297796|NCT00623285|Analgesics|analgesics|mesh-ancestor
20069688|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069689|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069690|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20069691|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069692|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069693|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
20069694|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20069695|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20069696|NCT02373865|Glimepiride|glimepiride|mesh-list
20069697|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20069698|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297797|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
20297798|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297799|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297800|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
20297801|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20297802|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20297803|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297804|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20297805|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20297806|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297807|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297808|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297809|NCT00623376|Dronabinol|dronabinol|mesh-list
20297810|NCT00623376|Nabilone|nabilone|mesh-list
20297811|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
20297812|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
20297813|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297814|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297815|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20297816|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19491713|NCT03128346|Acetaminophen|acetaminophen|mesh-list
19491714|NCT03128346|Fentanyl|fentanyl|mesh-list
19491715|NCT03128346|Hydromorphone|hydromorphone|mesh-list
19491716|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20069699|NCT02373865|Incretins|incretins|mesh-ancestor
20069700|NCT02373865|Hormones|hormones|mesh-ancestor
20069701|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069702|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20069703|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069704|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069705|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069706|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20069707|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069708|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
20297817|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19491717|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491718|NCT03128346|Analgesics|analgesics|mesh-ancestor
19491719|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
19491720|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491721|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491722|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491723|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20297818|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297819|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297820|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
20297821|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20297822|NCT00623376|Analgesics|analgesics|mesh-ancestor
20297823|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
20297824|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20297825|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20297826|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297827|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297828|NCT00623376|Hormones|hormones|mesh-ancestor
20297829|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297830|NCT00623402|Interferons|interferons|mesh-list
20297831|NCT00623402|Sorafenib|sorafenib|mesh-list
20297832|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297833|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
20297834|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297835|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20297836|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069709|NCT02369744|Tamsulosin|tamsulosin|mesh-list
20069710|NCT02369744|Silodosin|silodosin|mesh-list
20069711|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20069712|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20069713|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20069714|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
20069715|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069716|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069717|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069718|NCT02369744|Urological Agents|urological agents|mesh-ancestor
20069719|NCT02379585|Paclitaxel|paclitaxel|mesh-list
20069720|NCT02379585|Docetaxel|docetaxel|mesh-list
20069721|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
20069722|NCT02379585|Doxorubicin|doxorubicin|mesh-list
20069723|NCT02379585|Trastuzumab|trastuzumab|mesh-list
20069724|NCT02379585|Pertuzumab|pertuzumab|mesh-list
20069725|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069726|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069727|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
20069728|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
20297837|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297838|NCT00623415|Flupirtine|flupirtine|mesh-list
20297839|NCT00623415|Analgesics|analgesics|mesh-ancestor
20297840|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
20297841|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297842|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297843|NCT00623558|Docetaxel|docetaxel|mesh-list
20297844|NCT00623558|Cetuximab|cetuximab|mesh-list
20297845|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297846|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
20297847|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
20297848|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
20297849|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297850|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20297851|NCT00623688|Imidacloprid|imidacloprid|mesh-list
20297852|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
20297853|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297854|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297855|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297856|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
20297857|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20297858|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20297859|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20297860|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308584|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20308585|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20308586|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
20308587|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308588|NCT00664898|Bortezomib|bortezomib|mesh-list
19491724|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20297861|NCT00623857|Vitamins|vitamins|mesh-list
20297862|NCT00623857|Zinc|zinc|mesh-list
20297863|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
20297864|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297865|NCT00623857|Trace Elements|trace elements|mesh-ancestor
20297866|NCT00623987|Warfarin|warfarin|mesh-list
20297867|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
20297868|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20297869|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20297870|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20297871|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297872|NCT00624026|Memantine|memantine|mesh-list
20297873|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20297874|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20297875|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
20297876|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297877|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297878|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297879|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20297880|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19491725|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19491726|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491727|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19491728|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19491729|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297881|NCT00624039|Pilocarpine|pilocarpine|mesh-list
20297882|NCT00624039|Miotics|miotics|mesh-ancestor
20297883|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
20297884|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297885|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297886|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20297887|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20069729|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
20069730|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069731|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069732|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
20069733|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069734|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069735|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069736|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
20069737|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20069738|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20069739|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20069740|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20069741|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069742|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20069743|NCT02370888|Lenalidomide|lenalidomide|mesh-list
20069744|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
20069745|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069746|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20069747|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20069748|NCT02370888|Growth Substances|growth substances|mesh-ancestor
20069749|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
20069750|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069751|NCT02367170|Midazolam|midazolam|mesh-list
20069752|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20069753|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20069754|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069755|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297888|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
20297889|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297890|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297891|NCT00624078|Antivenins|antivenins|mesh-list
20297892|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
20297893|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297894|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20297895|NCT00624130|Dacuronium|dacuronium|mesh-list
20297896|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20297897|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297898|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20297899|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20069756|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20297900|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20297901|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297902|NCT00624143|Voriconazole|voriconazole|mesh-list
20297903|NCT00624143|Amphotericin B|amphotericin b|mesh-list
20297904|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20297905|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
20297906|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297907|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20297908|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20297909|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297910|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297911|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20297912|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
20297913|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297914|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297915|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20297916|NCT00624143|Amebicides|amebicides|mesh-ancestor
20297917|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20297918|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20297919|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20297920|NCT00624182|Gemcitabine|gemcitabine|mesh-list
20297921|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20297922|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
20297923|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297924|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069757|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20069758|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20069759|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20297925|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
20297926|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20069760|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
20069761|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
20069762|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
20069763|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
20069764|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069765|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069766|NCT02365233|Insulin|insulin|mesh-list
20069767|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20069768|NCT02365233|Pioglitazone|pioglitazone|mesh-list
20069769|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20069770|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
20069771|NCT02365233|Saxagliptin|saxagliptin|mesh-list
20069772|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20069773|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20069774|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069775|NCT02365233|Incretins|incretins|mesh-ancestor
20069776|NCT02365233|Hormones|hormones|mesh-ancestor
20069777|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069778|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069779|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069780|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069781|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
20069782|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069783|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
20069784|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069785|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20069786|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069787|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
20069788|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069789|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069790|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20069791|NCT02353468|Dexamethasone|dexamethasone|mesh-list
20069792|NCT02353468|Lenalidomide|lenalidomide|mesh-list
20069793|NCT02353468|Bortezomib|bortezomib|mesh-list
20069794|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069795|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
20069796|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
20069797|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069798|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069799|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069800|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
20069801|NCT02353468|Hormones|hormones|mesh-ancestor
20069802|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069803|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069804|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069805|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
20069806|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20297927|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297928|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20297929|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
20297930|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297931|NCT00624208|Droperidol|droperidol|mesh-list
20297932|NCT00624208|Ondansetron|ondansetron|mesh-list
20297933|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
20297934|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
20297935|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297936|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297937|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069807|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20069808|NCT02353468|Growth Substances|growth substances|mesh-ancestor
20069809|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
20069810|NCT02360059|Metformin|metformin|mesh-list
20069811|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20069812|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069813|NCT02345460|Leucovorin|leucovorin|mesh-list
20069814|NCT02345460|Fluorouracil|fluorouracil|mesh-list
20069815|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
20069816|NCT02345460|Irinotecan|irinotecan|mesh-list
20069817|NCT02345460|Calcium|calcium|mesh-list
20069818|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
20069819|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20069820|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069821|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
20069822|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069823|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069824|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069825|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069826|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
20069827|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20297938|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
20297939|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
20297940|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19746258|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
19746259|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19746260|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19746261|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746262|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746263|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
19746264|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
19746265|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19746266|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
19746267|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
19746268|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19746269|NCT04090190|Oxybutynin|oxybutynin|mesh-list
19746270|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19746271|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19746272|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
19746273|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746274|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577582|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069828|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19746275|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746276|NCT04090190|Urological Agents|urological agents|mesh-ancestor
19746277|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
19746278|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
20297941|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
20297942|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297943|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297944|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20297945|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297946|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297947|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297948|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20297949|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20297950|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20297951|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20297952|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
20297953|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
20297954|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
20297955|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20297956|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19746279|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069829|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069830|NCT02345460|Antidotes|antidotes|mesh-ancestor
20069831|NCT02345460|Protective Agents|protective agents|mesh-ancestor
20069832|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
20069833|NCT02345460|Vitamins|vitamins|mesh-ancestor
20069834|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
20069835|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
20069836|NCT02351063|Diuretics|diuretics|mesh-list
20069837|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20069838|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20069839|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20069840|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
20069841|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069842|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069843|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
20069844|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069845|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20069846|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
20069847|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069848|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20069849|NCT02345772|Docetaxel|docetaxel|mesh-list
20069850|NCT02345772|Trastuzumab|trastuzumab|mesh-list
20069851|NCT02345772|Fulvestrant|fulvestrant|mesh-list
20069852|NCT02345772|Pertuzumab|pertuzumab|mesh-list
20069853|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069854|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
20069855|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069856|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
20069857|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069858|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20069859|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069860|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20069861|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20069862|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
20069863|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069864|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069865|NCT02353572|Dexamethasone|dexamethasone|mesh-list
20069866|NCT02353572|Bortezomib|bortezomib|mesh-list
20069867|NCT02353572|Melphalan|melphalan|mesh-list
20069868|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069869|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
20069870|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
20069871|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069872|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069873|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20069874|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
20069875|NCT02353572|Hormones|hormones|mesh-ancestor
20069876|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069877|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20069878|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069879|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20069880|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
20069881|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069882|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20069883|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069884|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
20069885|NCT02343263|Bupivacaine|bupivacaine|mesh-list
20069886|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20069887|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
20069888|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
20069889|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20069890|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069891|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
20069892|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069893|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
20069894|NCT02343263|Coagulants|coagulants|mesh-ancestor
20069895|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20069896|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069897|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069898|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
20577583|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577584|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20577585|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577586|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577587|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
20577588|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577589|NCT02078869|Progesterone|progesterone|mesh-list
20577590|NCT02078869|Progestins|progestins|mesh-ancestor
20069899|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069900|NCT02341495|Vitamin D|vitamin d|mesh-list
20069901|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
20069902|NCT02341495|Azacitidine|azacitidine|mesh-list
20069903|NCT02341495|Deferasirox|deferasirox|mesh-list
20069904|NCT02341495|Vitamins|vitamins|mesh-ancestor
20069905|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
20069906|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069907|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20069908|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069909|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
20069910|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069911|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069912|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069913|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20069914|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20069915|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
20069916|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
20069917|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
20069918|NCT02318901|Trastuzumab|trastuzumab|mesh-list
20069919|NCT02318901|Cetuximab|cetuximab|mesh-list
20069920|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20069921|NCT02318901|Maytansine|maytansine|mesh-list
20069922|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20069923|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069924|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069925|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
20069926|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069927|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
20069928|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069929|NCT02317276|Triamcinolone|triamcinolone|mesh-list
20069930|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20069931|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20069932|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20069933|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20069934|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
20069935|NCT02317276|Hormones|hormones|mesh-ancestor
20069936|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20069937|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069938|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20069939|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
20069940|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20069941|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069942|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
20069943|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
20069944|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
20069945|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20069946|NCT02299206|Protective Agents|protective agents|mesh-ancestor
20069947|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069948|NCT02302859|Nicotine|nicotine|mesh-list
20069949|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20069950|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
20069951|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20069952|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069953|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20069954|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20069955|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
20577591|NCT02078869|Hormones|hormones|mesh-ancestor
20577592|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297957|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20297958|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20297959|NCT00624273|Urological Agents|urological agents|mesh-ancestor
20297960|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
20297961|NCT00624312|Hematinics|hematinics|mesh-ancestor
20297962|NCT00624325|Interferons|interferons|mesh-list
20297963|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
20297964|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
20297965|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20297966|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
20297967|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20297968|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
20297969|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297970|NCT00624364|Metformin|metformin|mesh-list
20297971|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
20297972|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
20297973|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20297974|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297975|NCT00624429|Budesonide|budesonide|mesh-list
20297976|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20297977|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20297978|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
20297979|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297980|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297981|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20297982|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
20297983|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
20297984|NCT00624429|Hormones|hormones|mesh-ancestor
20297985|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20297986|NCT00624455|Gabapentin|gabapentin|mesh-list
20297987|NCT00624455|Analgesics|analgesics|mesh-ancestor
20297988|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
20297989|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20297990|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20297991|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
20297992|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20297993|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20297994|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20297995|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20297996|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20297997|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20297998|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20297999|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298000|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
20069956|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069957|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069958|NCT02297230|Paclitaxel|paclitaxel|mesh-list
20069959|NCT02297230|Capecitabine|capecitabine|mesh-list
20069960|NCT02297230|Trastuzumab|trastuzumab|mesh-list
20069961|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069962|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069963|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
20069964|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069965|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
20069966|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069967|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069968|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
20298001|NCT00624481|Teriparatide|teriparatide|mesh-list
20298002|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20298003|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298004|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20298005|NCT00624546|Lansoprazole|lansoprazole|mesh-list
20298006|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
20298007|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298008|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298009|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298010|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298011|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298012|NCT00624663|Rivastigmine|rivastigmine|mesh-list
20298013|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20298014|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298015|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298016|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
20577593|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298017|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577594|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
20069969|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20298018|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298019|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20298020|NCT00624663|Protective Agents|protective agents|mesh-ancestor
20298021|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
20298022|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
20298023|NCT00624676|Salicylates|salicylates|mesh-list
20298024|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20298025|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
20298026|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298027|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
19491730|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
19491731|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19491732|NCT03128346|Narcotics|narcotics|mesh-ancestor
19491733|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491734|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20298028|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
20298029|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20298030|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20298031|NCT00624676|Analgesics|analgesics|mesh-ancestor
20298032|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
20298033|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298034|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298035|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298036|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298037|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20298038|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298039|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298040|NCT00624702|Maleic acid|maleic acid|mesh-list
20298041|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298042|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069970|NCT02284906|Pioglitazone|pioglitazone|mesh-list
20069971|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20069972|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069973|NCT02282332|Ticagrelor|ticagrelor|mesh-list
20069974|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20069975|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20069976|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20069977|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20069978|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
20298043|NCT00624741|Pergolide|pergolide|mesh-list
20298044|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
20298045|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
20298046|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298047|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298048|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069979|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20069980|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069981|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20069982|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20069983|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20069984|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069985|NCT02276560|Gemcitabine|gemcitabine|mesh-list
20069986|NCT02276560|Paclitaxel|paclitaxel|mesh-list
20069987|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20069988|NCT02276560|Cisplatin|cisplatin|mesh-list
20069989|NCT02276560|Pemetrexed|pemetrexed|mesh-list
20069990|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20069991|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20069992|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
20069993|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
20069994|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
20069995|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20069996|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20069997|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
20069998|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
20069999|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070000|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070001|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070002|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
20070003|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298049|NCT00624754|Budesonide|budesonide|mesh-list
20070004|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20070005|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20070006|NCT02280252|Paclitaxel|paclitaxel|mesh-list
20298050|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
20298051|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298052|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20298053|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
20070007|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070008|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070009|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070010|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070011|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070012|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298054|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298055|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298056|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20298057|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
20070013|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
20070014|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
20070015|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20298058|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
20298059|NCT00624754|Hormones|hormones|mesh-ancestor
20298060|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20298061|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20298062|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20298063|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20298064|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
20577595|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20577596|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20577597|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20577598|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577599|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577600|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
20577601|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577602|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577603|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20577604|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577605|NCT02078973|Tolvaptan|tolvaptan|mesh-list
20577606|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20070016|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
20070017|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070018|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070019|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20070020|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
20070021|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
20070022|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20070023|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
20070024|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070025|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070026|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20577607|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577608|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
20577609|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577610|NCT02079064|Propofol|propofol|mesh-list
20577611|NCT02079064|Desflurane|desflurane|mesh-list
20577612|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20577613|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070027|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20070028|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20070029|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
20070030|NCT02273752|Everolimus|everolimus|mesh-list
20070031|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577614|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577615|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20577616|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
20577617|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
20577618|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20577619|NCT02079181|Fluorides|fluorides|mesh-list
20577620|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
20577621|NCT02079181|Protective Agents|protective agents|mesh-ancestor
20577622|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577623|NCT02079194|Aspirin|aspirin|mesh-list
20070032|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070033|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
20070034|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298065|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298066|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298067|NCT00624767|Insulin|insulin|mesh-list
20298068|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20298069|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
20298070|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20298071|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298072|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
20298073|NCT00624871|Ibuprofen|ibuprofen|mesh-list
20298074|NCT00624871|Vitamins|vitamins|mesh-ancestor
20298075|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
20298076|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298077|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20298078|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20298079|NCT00624871|Analgesics|analgesics|mesh-ancestor
20298080|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
20298081|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298082|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298083|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298084|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20298085|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298086|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298087|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
20298088|NCT00624871|Protective Agents|protective agents|mesh-ancestor
20298089|NCT00624936|Bortezomib|bortezomib|mesh-list
20298090|NCT00624936|Azacitidine|azacitidine|mesh-list
20298091|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298092|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298093|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
20298094|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298095|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298096|NCT00625014|Haloperidol|haloperidol|mesh-list
20298097|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
20298098|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
20298099|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
20298100|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298101|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298102|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298103|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20298104|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20298105|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298106|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298107|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20298108|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
20298109|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298110|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298111|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20298112|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
20298113|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
20298114|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20298115|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20298116|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298117|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298118|NCT00625079|Urological Agents|urological agents|mesh-ancestor
20298119|NCT00625092|Leucovorin|leucovorin|mesh-list
20298120|NCT00625092|Fluorouracil|fluorouracil|mesh-list
20298121|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
20298122|NCT00625092|Calcium|calcium|mesh-list
20298123|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
20298124|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20298125|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298126|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
20298127|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298128|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298129|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298130|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298131|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
20298132|NCT00625092|Antidotes|antidotes|mesh-ancestor
20298133|NCT00625092|Protective Agents|protective agents|mesh-ancestor
20298134|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
20298135|NCT00625092|Vitamins|vitamins|mesh-ancestor
20298136|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
20298137|NCT00625170|Haloperidol|haloperidol|mesh-list
20298138|NCT00625170|Olanzapine|olanzapine|mesh-list
20298139|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
20298140|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
20298141|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
20298142|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298143|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298144|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298145|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20298146|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20298147|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298148|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298149|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20298150|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20298151|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298152|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298153|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298154|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
20298155|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20298156|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
20298157|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20298158|NCT00625196|Fluticasone|fluticasone|mesh-list
20298159|NCT00625196|Xhance|xhance|mesh-list
20298160|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298161|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20298162|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
20298163|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298164|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298165|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20298166|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
20298167|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
20298168|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20298169|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20298170|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
20298171|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20298172|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20298173|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20298174|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
20298175|NCT00625209|Protein C|protein c|mesh-list
20298176|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298177|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
20298178|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20298179|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20298180|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298181|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298182|NCT00625248|Anticoagulants|anticoagulants|mesh-list
20298183|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20298184|NCT00625274|Esomeprazole|esomeprazole|mesh-list
20298185|NCT00625274|Pantoprazole|pantoprazole|mesh-list
20298186|NCT00625274|Lansoprazole|lansoprazole|mesh-list
20298187|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
20298188|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298189|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298190|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298191|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298192|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298193|NCT00625339|Lamivudine|lamivudine|mesh-list
20298194|NCT00625339|Entecavir|entecavir|mesh-list
20298195|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20298196|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20298197|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298198|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298199|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
20298200|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298201|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20298202|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20298203|NCT00625352|Gemcitabine|gemcitabine|mesh-list
20070035|NCT02271594|Insulin|insulin|mesh-list
20070036|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070037|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070038|NCT02263365|Loperamide|loperamide|mesh-list
20070039|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
20070040|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20070041|NCT02266797|Dexamethasone|dexamethasone|mesh-list
20070042|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070043|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
20070044|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
20070045|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070046|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298204|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298205|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
20070047|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298206|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298207|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298208|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
20298209|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298210|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298211|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298212|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
20298213|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298214|NCT00625378|Sorafenib|sorafenib|mesh-list
20298215|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298216|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20298217|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298218|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298219|NCT00625430|Vidarabine|vidarabine|mesh-list
20298220|NCT00625430|Fludarabine|fludarabine|mesh-list
20298221|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
20298222|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298223|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298224|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
20298225|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298226|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298227|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
20298228|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298229|NCT00625430|Antiviral Agents|antiviral agents|mesh-ancestor
20298230|NCT00625430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298231|NCT00625456|Molgramostim|molgramostim|mesh-list
20298232|NCT00625456|Sargramostim|sargramostim|mesh-list
20298233|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
20298234|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298235|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298236|NCT00625469|Bosentan|bosentan|mesh-list
20298237|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20298238|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20070048|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
20070049|NCT02266797|Hormones|hormones|mesh-ancestor
20070050|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070051|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20070052|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070053|NCT02253394|Ambrisentan|ambrisentan|mesh-list
20070054|NCT02253394|Spironolactone|spironolactone|mesh-list
20298239|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298240|NCT00625495|Esomeprazole|esomeprazole|mesh-list
20298241|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298242|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20070055|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20070056|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
20070057|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070058|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070059|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20070060|NCT02253394|Diuretics|diuretics|mesh-ancestor
20070061|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
20070062|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20070063|NCT02241551|Gemcitabine|gemcitabine|mesh-list
20070064|NCT02241551|Paclitaxel|paclitaxel|mesh-list
20070065|NCT02241551|Fluorouracil|fluorouracil|mesh-list
20070066|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
20070067|NCT02241551|Irinotecan|irinotecan|mesh-list
20070068|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070069|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070070|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070071|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070072|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070073|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070074|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070075|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
20070076|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
20070077|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070078|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070079|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070080|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
20070081|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070082|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20070083|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20070084|NCT02232880|Abatacept|abatacept|mesh-list
20298243|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298244|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298245|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298246|NCT00625547|Levodopa|levodopa|mesh-list
20070085|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20070086|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070087|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070088|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070089|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
20070090|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070091|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20070092|NCT02239627|Clonidine|clonidine|mesh-list
20070093|NCT02239627|Analgesics|analgesics|mesh-ancestor
20070094|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
20070095|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070096|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070097|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20070098|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
20070099|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
20070100|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20070101|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20070102|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20070103|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20070104|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070105|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070106|NCT02244944|Ezetimibe|ezetimibe|mesh-list
20070107|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20070108|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20070109|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
20070110|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070111|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20070112|NCT02241187|Cetuximab|cetuximab|mesh-list
20070113|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20070114|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070115|NCT02239926|Ranolazine|ranolazine|mesh-list
20070116|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20070117|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070118|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119758|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119759|NCT00006229|Paclitaxel|paclitaxel|mesh-list
20119760|NCT00006229|Carboplatin|carboplatin|mesh-list
20119761|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119762|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119763|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119764|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119765|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119766|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119767|NCT00006230|Rubitecan|rubitecan|mesh-list
20119768|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119769|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20119770|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119771|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119772|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120761|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120762|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
20120763|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
20120764|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20120765|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
20120766|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120767|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120768|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20120769|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
20120770|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20120771|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
20120772|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120773|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120774|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20120775|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
20120776|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
20120777|NCT00006401|Protective Agents|protective agents|mesh-ancestor
20120778|NCT00006412|Fenofibrate|fenofibrate|mesh-list
20120779|NCT00006412|Pravastatin|pravastatin|mesh-list
20120780|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20120781|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
20120782|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120783|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20120784|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20298247|NCT00625547|Cabergoline|cabergoline|mesh-list
20298248|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20298249|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20298250|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
20298251|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298252|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298253|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298254|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
20298255|NCT00625560|Lamivudine|lamivudine|mesh-list
20070119|NCT02234011|Ketamine|ketamine|mesh-list
20070120|NCT02234011|Analgesics|analgesics|mesh-ancestor
20070121|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
20070122|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070123|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070124|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20070125|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20070126|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
20070127|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
20070128|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070129|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20070130|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20070131|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070132|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070133|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
20070134|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20070135|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20070136|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070137|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
20070138|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
20070139|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070140|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
20070141|NCT02224599|Imiquimod|imiquimod|mesh-list
20070142|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070143|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
20070144|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070145|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20070146|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20070147|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
20070148|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070149|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070150|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20070151|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20070152|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
20070153|NCT02200328|Metronidazole|metronidazole|mesh-list
20070154|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070155|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20070156|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20070157|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20070158|NCT02181790|Acitretin|acitretin|mesh-list
20070159|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
20070160|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
20070161|NCT02177266|Colchicine|colchicine|mesh-list
20070162|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
20070163|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20070164|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070165|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070166|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070167|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070168|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070169|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20070170|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20070171|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070172|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20070173|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20070174|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070175|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070176|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
20070177|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070178|NCT02177773|Octreotide|octreotide|mesh-list
20070179|NCT02177773|Edotreotide|edotreotide|mesh-list
20070180|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20070181|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20070182|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070183|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20070184|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298256|NCT00625560|Entecavir|entecavir|mesh-list
20298257|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20298258|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20298259|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298260|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298261|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
20298262|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298263|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20298264|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20298265|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20298266|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298267|NCT00625677|Vaccines|vaccines|mesh-list
20298268|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
20298269|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308589|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308590|NCT00664963|Sirolimus|sirolimus|mesh-list
20070185|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
20070186|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
20070187|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20070188|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20070189|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070190|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070191|NCT02162979|Urological Agents|urological agents|mesh-ancestor
20070192|NCT02169830|Topiramate|topiramate|mesh-list
20070193|NCT02169830|Nortriptyline|nortriptyline|mesh-list
20070194|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
20070195|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070196|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070197|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20070198|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
20070199|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20070200|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20070201|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20070202|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070203|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070204|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
20070205|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070206|NCT02159040|Azacitidine|azacitidine|mesh-list
20070207|NCT02159040|Deferasirox|deferasirox|mesh-list
20070208|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070209|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
20070210|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070211|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070212|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070213|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20070214|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
20070215|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
20070216|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
20070217|NCT02168270|Temozolomide|temozolomide|mesh-list
20070218|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20070219|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
20070220|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070221|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070222|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
20070223|NCT02168270|Protective Agents|protective agents|mesh-ancestor
20070224|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070225|NCT02168270|Vitamins|vitamins|mesh-ancestor
20070226|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
20070227|NCT02157116|Docetaxel|docetaxel|mesh-list
20070228|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070229|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070230|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070231|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070232|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070233|NCT02152670|Raclopride|raclopride|mesh-list
20070234|NCT02152670|Methylphenidate|methylphenidate|mesh-list
20070235|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
20070236|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20070237|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070238|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20070239|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20070240|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070241|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308591|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308592|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298270|NCT00625781|Insulin|insulin|mesh-list
20298271|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20298272|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
20298273|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20298274|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298275|NCT00625794|Nicotine|nicotine|mesh-list
20298276|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20298277|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
20298278|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298279|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298280|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20298281|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20298282|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
20298283|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298284|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298285|NCT00625859|Bupropion|bupropion|mesh-list
20298286|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20298287|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
20298288|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298289|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20298290|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20298291|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298292|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298293|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
20298294|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298295|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298296|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20298297|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20298298|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298299|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
20298300|NCT00625898|Bevacizumab|bevacizumab|mesh-list
20298301|NCT00625898|Carboplatin|carboplatin|mesh-list
20298302|NCT00625898|Docetaxel|docetaxel|mesh-list
20298303|NCT00625898|Fluorouracil|fluorouracil|mesh-list
20298304|NCT00625898|Trastuzumab|trastuzumab|mesh-list
20298305|NCT00625898|Epirubicin|epirubicin|mesh-list
20298306|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298307|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
20298308|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298309|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298310|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20298311|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
20298312|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298313|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298314|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20298315|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20298316|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20070242|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
20070243|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070244|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20070245|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20070246|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070247|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20070248|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20070249|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070250|NCT02137096|Carboplatin|carboplatin|mesh-list
20070251|NCT02137096|Etoposide|etoposide|mesh-list
20070252|NCT02137096|Ifosfamide|ifosfamide|mesh-list
20070253|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
20070254|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070255|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070256|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20070257|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20070258|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070259|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070260|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20070261|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
20070262|NCT02147834|Ranolazine|ranolazine|mesh-list
20070263|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20070264|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070265|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070266|NCT02144155|Oxytocin|oxytocin|mesh-list
20070267|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
20070268|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20070269|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298317|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19491735|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19491736|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
19491737|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
19491738|NCT03128203|Oxytocin|oxytocin|mesh-list
19491739|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
20070270|NCT02140788|Metformin|metformin|mesh-list
20070271|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070272|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070273|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
20070274|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20070275|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
20070276|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
20070277|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070278|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070279|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20070280|NCT02145169|Analgesics|analgesics|mesh-ancestor
20070281|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
20070282|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070283|NCT02130622|Promethazine|promethazine|mesh-list
20070284|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
20070285|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
20070286|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
20070287|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20070288|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
20070289|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
20070290|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070291|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070292|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070293|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20070294|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20070295|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20070296|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070297|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
20070298|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
20070299|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
20070300|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070301|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
20070302|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
20070303|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20070304|NCT02133534|Atorvastatin|atorvastatin|mesh-list
20070305|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20070306|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20070307|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
20070308|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070309|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20070310|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20070311|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070312|NCT02134912|Pemetrexed|pemetrexed|mesh-list
20070313|NCT02134912|Crizotinib|crizotinib|mesh-list
20070314|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070315|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070316|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070317|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20070318|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20070319|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20070320|NCT02131155|Afatinib|afatinib|mesh-list
20070321|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070322|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20070323|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070324|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070325|NCT02117050|Interferons|interferons|mesh-list
20070326|NCT02117050|Interferon-beta|interferon-beta|mesh-list
20070327|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
20070328|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070329|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
20070330|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070331|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
20070332|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070333|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20070334|NCT02110069|Sirolimus|sirolimus|mesh-list
20070335|NCT02110069|Vincristine|vincristine|mesh-list
20070336|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070337|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070338|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070339|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070340|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070341|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070342|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20070343|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070344|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20070345|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
20070346|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070347|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
20070348|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070349|NCT02105116|Cytarabine|cytarabine|mesh-list
20070350|NCT02105116|Fludarabine|fludarabine|mesh-list
20070351|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
20070352|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070353|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070354|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
20070355|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070356|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070357|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
20070358|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070359|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
20070360|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070361|NCT02094352|Ketamine|ketamine|mesh-list
20070362|NCT02094352|Analgesics|analgesics|mesh-ancestor
20070363|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
20070364|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070365|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070366|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20070367|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20070368|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
20070369|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
20070370|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070371|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20070372|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20070373|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070374|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070375|NCT02096042|Azacitidine|azacitidine|mesh-list
20070376|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20070377|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070378|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
20070379|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070380|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070381|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070382|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20070383|NCT02088957|Phenytoin|phenytoin|mesh-list
20070384|NCT02088957|Brivaracetam|brivaracetam|mesh-list
20070385|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20070386|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
20070387|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20070388|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20070389|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070390|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070391|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20070392|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20070393|NCT02075411|Bupivacaine|bupivacaine|mesh-list
20070394|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
20070395|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
20070396|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070397|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070398|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
20070399|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070400|NCT02074904|Topiramate|topiramate|mesh-list
20070401|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
20070402|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070403|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070404|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
20070405|NCT02081183|Prednisone|prednisone|mesh-list
20070406|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
20070407|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070408|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
20070409|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070410|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20070411|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20070412|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
20070413|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491740|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19491741|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491742|NCT03127800|Morphine|morphine|mesh-list
19491743|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19491744|NCT03127800|Narcotics|narcotics|mesh-ancestor
19491745|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491746|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298318|NCT00625898|Growth Substances|growth substances|mesh-ancestor
20298319|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
20298320|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
20298321|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
20298322|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
20298323|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
20298324|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298325|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20298326|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20298327|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20298328|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298329|NCT00625911|Ketamine|ketamine|mesh-list
20298330|NCT00625911|Morphine|morphine|mesh-list
20298331|NCT00625911|Analgesics|analgesics|mesh-ancestor
20298332|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
20298333|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298334|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298335|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20298336|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20298337|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
20298338|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
20577624|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20577625|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20577626|NCT02079194|Analgesics|analgesics|mesh-ancestor
20577627|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
20577628|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577629|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577630|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577631|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20577632|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20577633|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20577634|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577635|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20577636|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20577637|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577638|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
20577639|NCT02079220|Capecitabine|capecitabine|mesh-list
20577640|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
20577641|NCT02079220|Aflibercept|aflibercept|mesh-list
20577642|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577643|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
20577644|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577645|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577646|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20577647|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20577648|NCT02079220|Growth Substances|growth substances|mesh-ancestor
20577649|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577650|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
20577651|NCT02079298|Fluconazole|fluconazole|mesh-list
20577652|NCT02079298|Ibuprofen|ibuprofen|mesh-list
20577653|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20577654|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20577655|NCT02079298|Analgesics|analgesics|mesh-ancestor
20577656|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
20577657|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577658|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577659|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070414|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070415|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20070416|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070417|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
20070418|NCT02081183|Hormones|hormones|mesh-ancestor
20070419|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070420|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20070421|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19491747|NCT03127800|Analgesics|analgesics|mesh-ancestor
20298339|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298340|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20298341|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20298342|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298343|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298344|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20298345|NCT00625911|Narcotics|narcotics|mesh-ancestor
20298346|NCT00625937|Docetaxel|docetaxel|mesh-list
20298347|NCT00625937|Tegafur|tegafur|mesh-list
20298348|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298349|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
20298350|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20298351|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20298352|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298353|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298354|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
20298355|NCT00626015|Temozolomide|temozolomide|mesh-list
20298356|NCT00626015|Daclizumab|daclizumab|mesh-list
20070422|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20070423|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
20070424|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20070425|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070426|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070427|NCT02075021|Paclitaxel|paclitaxel|mesh-list
20070428|NCT02075021|Lenalidomide|lenalidomide|mesh-list
20070429|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070430|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070431|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070432|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070433|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070434|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070435|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
20070436|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070437|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20070438|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20070439|NCT02075021|Growth Substances|growth substances|mesh-ancestor
20070440|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
20298357|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20298358|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
20298359|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298360|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298361|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298362|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
20298363|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298364|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20298365|NCT00626080|Insulin|insulin|mesh-list
20298366|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20298367|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
20298368|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
20298369|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
20298370|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
20298371|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20298372|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298373|NCT00626158|Gemcitabine|gemcitabine|mesh-list
20298374|NCT00626158|Capecitabine|capecitabine|mesh-list
20298375|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298376|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
20577660|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20070441|NCT02057237|Mitotane|mitotane|mesh-list
20070442|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20070443|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070444|NCT02058537|Bethanechol|bethanechol|mesh-list
20070445|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20070446|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
20070447|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070448|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070449|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20070450|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20070451|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
20070452|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070453|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070454|NCT02038153|Lenalidomide|lenalidomide|mesh-list
20298377|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298378|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298379|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
20070455|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
20298380|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298381|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298382|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298383|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
20298384|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298385|NCT00626223|Folic Acid|folic acid|mesh-list
20298386|NCT00626223|Hematinics|hematinics|mesh-ancestor
20298387|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
20298388|NCT00626223|Vitamins|vitamins|mesh-ancestor
20298389|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
20298390|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298391|NCT00626262|Esomeprazole|esomeprazole|mesh-list
20298392|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298393|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298394|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298395|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298396|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298397|NCT00626288|Mesalamine|mesalamine|mesh-list
20298398|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20298399|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20298400|NCT00626288|Analgesics|analgesics|mesh-ancestor
20298401|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
20298402|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298403|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298404|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298405|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298406|NCT00626483|Basiliximab|basiliximab|mesh-list
20298407|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298408|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
20298409|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298410|NCT00626509|Sunitinib|sunitinib|mesh-list
20298411|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070456|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070457|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20070458|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20070459|NCT02038153|Growth Substances|growth substances|mesh-ancestor
20070460|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
20070461|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298412|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20070462|NCT02044302|Morphine|morphine|mesh-list
20070463|NCT02044302|Narcotics|narcotics|mesh-list
20070464|NCT02044302|Analgesics|analgesics|mesh-list
20070465|NCT02044302|Bupivacaine|bupivacaine|mesh-list
20070466|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
20070467|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
20070468|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
20070469|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070470|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070471|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
20070472|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070473|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20070474|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20070475|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070476|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070477|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
20070478|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070479|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20298413|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20298414|NCT00626509|Growth Substances|growth substances|mesh-ancestor
20298415|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298416|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
20298417|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20298418|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298419|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298420|NCT00626535|Esomeprazole|esomeprazole|mesh-list
20298421|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298422|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298423|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298424|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298425|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298426|NCT00626600|Oxycodone|oxycodone|mesh-list
20298427|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20298428|NCT00626600|Narcotics|narcotics|mesh-ancestor
20298429|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298430|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298431|NCT00626600|Analgesics|analgesics|mesh-ancestor
20070480|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070481|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070482|NCT02048904|Incretins|incretins|mesh-ancestor
20070483|NCT02048904|Hormones|hormones|mesh-ancestor
20070484|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070485|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20070486|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
20070487|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070488|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070489|NCT02044822|Rituximab|rituximab|mesh-list
20070490|NCT02044822|Idelalisib|idelalisib|mesh-list
20070491|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20298432|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
20298433|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298434|NCT00626613|Risperidone|risperidone|mesh-list
20298435|NCT00626613|Galantamine|galantamine|mesh-list
20298436|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20298437|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
20298438|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298439|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298440|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298441|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20298442|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20298443|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298444|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298445|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20298446|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
20298447|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20298448|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298449|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
20298450|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20298451|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
20298452|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298453|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
20298454|NCT00626665|Tadalafil|tadalafil|mesh-list
20298455|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
20298456|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20298457|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20298458|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298459|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298460|NCT00626665|Urological Agents|urological agents|mesh-ancestor
20298461|NCT00626678|Prednisone|prednisone|mesh-list
20070492|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070493|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
20070494|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070495|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20070496|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070497|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070498|NCT02043860|Melphalan|melphalan|mesh-list
20070499|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
20070500|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070501|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20070502|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
20070503|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070504|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070505|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20070506|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070507|NCT02030015|Miglustat|miglustat|mesh-list
20070508|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070509|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070510|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20070511|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20070512|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
20070513|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070514|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20070515|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070516|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070517|NCT02015663|Tobramycin|tobramycin|mesh-list
20070518|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20070519|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070520|NCT02029846|Metformin|metformin|mesh-list
20070521|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20070522|NCT02029846|Incretins|incretins|mesh-list
20070523|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070524|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070525|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
20298462|NCT00626678|Azathioprine|azathioprine|mesh-list
20298463|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298464|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
20298465|NCT00626678|Hormones|hormones|mesh-ancestor
20298466|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20298467|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298468|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20298469|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298470|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
20298471|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298472|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298473|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298474|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
20298475|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298476|NCT00626717|Riboflavin|riboflavin|mesh-list
20298477|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
20298478|NCT00626717|Vitamins|vitamins|mesh-ancestor
20298479|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
20298480|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298481|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20298482|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
20298483|NCT00626769|Genistein|genistein|mesh-list
20298484|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20298485|NCT00626769|Protective Agents|protective agents|mesh-ancestor
20298486|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298487|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298488|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20298489|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298490|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298491|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
20070526|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070527|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070528|NCT02029846|Hormones|hormones|mesh-ancestor
20070529|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070530|NCT02027272|Dexamethasone|dexamethasone|mesh-list
20070531|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
20070532|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070533|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
20070534|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
20070535|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070536|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070537|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20070538|NCT02027272|Hormones|hormones|mesh-ancestor
20070539|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070540|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20070541|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070542|NCT02017379|Erythromycin|erythromycin|mesh-list
20070543|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
20070544|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20070545|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
20070546|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20070547|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070548|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20070549|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20070550|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070551|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070552|NCT02008370|Bupivacaine|bupivacaine|mesh-list
20070553|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
20070554|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
20070555|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070556|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070557|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
20070558|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070559|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20070560|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070561|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070562|NCT02015910|Incretins|incretins|mesh-ancestor
20070563|NCT02015910|Hormones|hormones|mesh-ancestor
20070564|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070565|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20070566|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
20070567|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070568|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298492|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20298493|NCT00626769|Estrogens|estrogens|mesh-ancestor
20298494|NCT00626769|Hormones|hormones|mesh-ancestor
20070569|NCT01986751|Clonidine|clonidine|mesh-list
20070570|NCT01986751|Ropivacaine|ropivacaine|mesh-list
20298495|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20298496|NCT00626834|Vigabatrin|vigabatrin|mesh-list
20298497|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
20298498|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298499|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298500|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
20298501|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298502|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298503|NCT00626977|Clonidine|clonidine|mesh-list
20298504|NCT00626977|Ropivacaine|ropivacaine|mesh-list
20298505|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
20298506|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
20298507|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298508|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298509|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
20298510|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298511|NCT00626977|Analgesics|analgesics|mesh-ancestor
20298512|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20298513|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
20298514|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
20298515|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20070571|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
20070572|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
20070573|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070574|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070575|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
20070576|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070577|NCT01986751|Analgesics|analgesics|mesh-ancestor
20070578|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20070579|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
20070580|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
20070581|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20070582|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20070583|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20070584|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
20070585|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070586|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070587|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
20070588|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070589|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
20070590|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20070591|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20070592|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070593|NCT01996852|Urological Agents|urological agents|mesh-ancestor
20070594|NCT01997567|Ropivacaine|ropivacaine|mesh-list
20070595|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
20070596|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
20070597|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070598|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070599|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
20070600|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070601|NCT01977729|Sertraline|sertraline|mesh-list
20070602|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
20070603|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20070604|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20070605|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20070606|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070607|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070608|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070609|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
20070610|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070611|NCT01973062|Rituximab|rituximab|mesh-list
20070612|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20070613|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20070614|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070615|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
20070616|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070617|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20070618|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20070619|NCT01984268|Hormones|hormones|mesh-ancestor
20119773|NCT00006232|Dexamethasone|dexamethasone|mesh-list
20298516|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20298517|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20298518|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
20298519|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298520|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298521|NCT00626990|Temozolomide|temozolomide|mesh-list
20298522|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20298523|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
20298524|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298525|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298526|NCT00627003|Cabergoline|cabergoline|mesh-list
20070620|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070621|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070622|NCT01974284|Ethanol|ethanol|mesh-list
20070623|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20070624|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070625|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070626|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119774|NCT00006232|Doxorubicin|doxorubicin|mesh-list
20119775|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20119776|NCT00006232|Vincristine|vincristine|mesh-list
20119777|NCT00006232|Idarubicin|idarubicin|mesh-list
20119778|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20119779|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
20119780|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
20119781|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119782|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119783|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20119784|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
20119785|NCT00006232|Hormones|hormones|mesh-ancestor
20119786|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119787|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20119788|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119789|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119790|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119791|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119792|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119793|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119794|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119795|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119796|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119797|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119798|NCT00006233|Cyclosporine|cyclosporine|mesh-list
20119799|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
20119800|NCT00006233|Fludarabine|fludarabine|mesh-list
20119801|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
20119802|NCT00006233|Cyclosporins|cyclosporins|mesh-list
20119803|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119804|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119805|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
20119806|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119807|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119808|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
20119809|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119810|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119811|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
20119812|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119813|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
20119814|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119815|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20119816|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119817|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20119818|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
20119819|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20119820|NCT00006235|Carboplatin|carboplatin|mesh-list
20119821|NCT00006235|Doxorubicin|doxorubicin|mesh-list
20119822|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20119823|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119824|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119825|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119826|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119827|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119828|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298527|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20298528|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20119829|NCT00006239|Tretinoin|tretinoin|mesh-list
20119830|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20070627|NCT01971853|Analgesics|analgesics|mesh-list
20070628|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
20070629|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070630|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070631|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
20070632|NCT01980875|Idelalisib|idelalisib|mesh-list
20070633|NCT01980875|Chlorambucil|chlorambucil|mesh-list
20070634|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20070635|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070636|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070637|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070638|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20070639|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
20070640|NCT01980342|Efavirenz|efavirenz|mesh-list
20070641|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19746280|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
20070642|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20070643|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070644|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070645|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
20070646|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070647|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20070648|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20070649|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20070650|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20070651|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20070652|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20070653|NCT01978535|Iron|iron|mesh-list
20070654|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20070655|NCT01978535|Trace Elements|trace elements|mesh-ancestor
20070656|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
20070657|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070658|NCT01978535|Hematinics|hematinics|mesh-ancestor
20070659|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20070660|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070661|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070662|NCT01970462|Incretins|incretins|mesh-ancestor
20070663|NCT01970462|Hormones|hormones|mesh-ancestor
20070664|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070665|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20070666|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
20070667|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070668|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070669|NCT01969565|Dexamethasone|dexamethasone|mesh-list
20070670|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070671|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
20070672|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
20070673|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070674|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070675|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20070676|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
20070677|NCT01969565|Hormones|hormones|mesh-ancestor
20070678|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070679|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20070680|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070681|NCT01962974|Golimumab|golimumab|mesh-list
20070682|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20070683|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070684|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070685|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
20070686|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070687|NCT01951378|Albuterol|albuterol|mesh-list
20070688|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20070689|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
20070690|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070691|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070692|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20070693|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
20070694|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
20070695|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20070696|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20070697|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19746281|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20298529|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
20298530|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
20298531|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298532|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298533|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298534|NCT00627081|Remifentanil|remifentanil|mesh-list
20298535|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20298536|NCT00627081|Narcotics|narcotics|mesh-ancestor
20298537|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298538|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298539|NCT00627081|Analgesics|analgesics|mesh-ancestor
20298540|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
20298541|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298542|NCT00627133|Levetiracetam|levetiracetam|mesh-list
20298543|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
20298544|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
20298545|NCT00627354|Prednisone|prednisone|mesh-list
20298546|NCT00627354|Etoposide|etoposide|mesh-list
20298547|NCT00627354|Vinorelbine|vinorelbine|mesh-list
20298548|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
20298549|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070698|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20070699|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
20070700|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070701|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070702|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20070703|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20070704|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20070705|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
20070706|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20070707|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070708|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20070709|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20070710|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20070711|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20070712|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20070713|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20070714|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20070715|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20070716|NCT01935947|Gemcitabine|gemcitabine|mesh-list
20070717|NCT01935947|Azacitidine|azacitidine|mesh-list
20070718|NCT01935947|Docetaxel|docetaxel|mesh-list
20070719|NCT01935947|Irinotecan|irinotecan|mesh-list
20070720|NCT01935947|Pemetrexed|pemetrexed|mesh-list
20070721|NCT01935947|Camptothecin|camptothecin|mesh-list
20070722|NCT01935947|Entinostat|entinostat|mesh-list
20070723|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20070724|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070725|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
20070726|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070727|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070728|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
20070729|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070730|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070731|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070732|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
20070733|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070734|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070735|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070736|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070737|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20070738|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20070739|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20070740|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20070741|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070742|NCT01938716|Gemcitabine|gemcitabine|mesh-list
20070743|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070744|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
20070745|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070746|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070747|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
20070748|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070749|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298550|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
20298551|NCT00627354|Hormones|hormones|mesh-ancestor
20577661|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20577662|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070750|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070751|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
20070752|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070753|NCT01936974|Gemcitabine|gemcitabine|mesh-list
20070754|NCT01936974|Bevacizumab|bevacizumab|mesh-list
20070755|NCT01936974|Carboplatin|carboplatin|mesh-list
20070756|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
20070757|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20070758|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070759|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20070760|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20070761|NCT01936974|Growth Substances|growth substances|mesh-ancestor
20070762|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070763|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
20070764|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070765|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
20070766|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070767|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
20070768|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070769|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070770|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070771|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
20070772|NCT01938833|Paclitaxel|paclitaxel|mesh-list
20070773|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20070774|NCT01938833|Romidepsin|romidepsin|mesh-list
20070775|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070776|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070777|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070778|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070779|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070780|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070781|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20070782|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20070783|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20070784|NCT01928082|Estradiol|estradiol|mesh-list
20070785|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20070786|NCT01928082|Estrogens|estrogens|mesh-ancestor
20070787|NCT01928082|Hormones|hormones|mesh-ancestor
20070788|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20070789|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070790|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20070791|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
20070792|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20070793|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20070794|NCT01928615|Trastuzumab|trastuzumab|mesh-list
20070795|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20070796|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20070797|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070798|NCT01910389|Tadalafil|tadalafil|mesh-list
20070799|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
20070800|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20070801|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20070802|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070803|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070804|NCT01910389|Urological Agents|urological agents|mesh-ancestor
20070805|NCT01916590|Bupivacaine|bupivacaine|mesh-list
20070806|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
20070807|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
20070808|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070809|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070810|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
20070811|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070812|NCT01913327|Risperidone|risperidone|mesh-list
20070813|NCT01913327|Aripiprazole|aripiprazole|mesh-list
20070814|NCT01913327|Modafinil|modafinil|mesh-list
20070815|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20070816|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
20070817|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070818|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070819|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070820|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20070821|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20070822|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20070823|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20070824|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20070825|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
20298552|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20298553|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298554|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20298555|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298556|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20298557|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20298558|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20298559|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298560|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298561|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
20298562|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
20298563|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
20298564|NCT00627354|Analgesics|analgesics|mesh-ancestor
20298565|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
20070826|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
20070827|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
20070828|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20070829|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20070830|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20070831|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20070832|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20070833|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20070834|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20070835|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20070836|NCT01901224|Metformin|metformin|mesh-list
20070837|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070838|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070839|NCT01910441|Metformin|metformin|mesh-list
20070840|NCT01910441|Glimepiride|glimepiride|mesh-list
20070841|NCT01910441|Vildagliptin|vildagliptin|mesh-list
20070842|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070843|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070844|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20070845|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070846|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
20070847|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20070848|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
20070849|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070850|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070851|NCT01902966|Propranolol|propranolol|mesh-list
20070852|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20070853|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20070854|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
20070855|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070856|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070857|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070858|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20070859|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20070860|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
20070861|NCT01901679|Celecoxib|celecoxib|mesh-list
20070862|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20070863|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20070864|NCT01901679|Analgesics|analgesics|mesh-ancestor
20070865|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
20070866|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577663|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577664|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
20577665|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577666|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20577667|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20577668|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20577669|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
20577670|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577671|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20577672|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20577673|NCT02079337|Rocuronium|rocuronium|mesh-list
20577674|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20577675|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19491748|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
19491749|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491750|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20577676|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20577677|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577678|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577679|NCT02079350|Polygeline|polygeline|mesh-list
20577680|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
20577681|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
20577682|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20577683|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20577684|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
20577685|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577686|NCT02079506|Candesartan|candesartan|mesh-list
20577687|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20577688|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20577689|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20577690|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
20577691|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577692|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20577693|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20577694|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577695|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20577696|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20577697|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20605637|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605638|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605639|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20605640|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20605641|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605642|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20605643|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
20605644|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
20605645|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
20605646|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
20605647|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605648|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605649|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
20605650|NCT02233322|Hematinics|hematinics|mesh-ancestor
20605651|NCT02233387|Imidazole|imidazole|mesh-list
20605652|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605653|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605654|NCT02233400|Acetaminophen|acetaminophen|mesh-list
20605655|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20605656|NCT02233400|Analgesics|analgesics|mesh-ancestor
20605657|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
20605658|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605659|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605660|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
20605661|NCT02233439|Galactogogues|galactogogues|mesh-list
20070867|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070868|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20070869|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20605662|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605663|NCT02233452|Ketamine|ketamine|mesh-list
20605664|NCT02233452|Methadone|methadone|mesh-list
20605665|NCT02233452|Analgesics|analgesics|mesh-ancestor
20605666|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
20605667|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070870|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20070871|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20070872|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070873|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070874|NCT01900730|Valproic Acid|valproic acid|mesh-list
20070875|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
20070876|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070877|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070878|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
20070879|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20070880|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070881|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
20070882|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20070883|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605668|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605669|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19491751|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19491752|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070884|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298566|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298567|NCT00627432|Gemcitabine|gemcitabine|mesh-list
20298568|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
20298569|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298570|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
20298571|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298572|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298573|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
20298574|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298575|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070885|NCT01877564|Metformin|metformin|mesh-list
20070886|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20070887|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070888|NCT01890694|Tolvaptan|tolvaptan|mesh-list
20070889|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20070890|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070891|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
20070892|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070893|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
20070894|NCT01890577|Hematinics|hematinics|mesh-ancestor
20070895|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
20070896|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20070897|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
20070898|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070899|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
20070900|NCT01895959|Protective Agents|protective agents|mesh-ancestor
20070901|NCT01889420|Everolimus|everolimus|mesh-list
20070902|NCT01889420|Pomalidomide|pomalidomide|mesh-list
20070903|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070904|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070905|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
20070906|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070907|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20070908|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20070909|NCT01889420|Growth Substances|growth substances|mesh-ancestor
20070910|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
20070911|NCT01881984|Glycerol|glycerol|mesh-list
20070912|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20070913|NCT01881984|Protective Agents|protective agents|mesh-ancestor
20070914|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070915|NCT01893359|Riboflavin|riboflavin|mesh-list
20070916|NCT01893359|Dextrans|dextrans|mesh-list
20070917|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20070918|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20070919|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
20070920|NCT01893359|Vitamins|vitamins|mesh-ancestor
20070921|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
20070922|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070923|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20070924|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
20070925|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
20070926|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
20070927|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
20070928|NCT01887288|Capecitabine|capecitabine|mesh-list
20070929|NCT01887288|Digoxin|digoxin|mesh-list
20070930|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070931|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
20070932|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070933|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070934|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20070935|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20070936|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070937|NCT01887288|Protective Agents|protective agents|mesh-ancestor
20070938|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070939|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
20070940|NCT01878786|Everolimus|everolimus|mesh-list
20070941|NCT01878786|Tacrolimus|tacrolimus|mesh-list
20070942|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070943|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
20070944|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577698|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20070945|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20070946|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070947|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070948|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577699|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
20070949|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20070950|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20070951|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
20070952|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20070953|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070954|NCT01861717|Lanreotide|lanreotide|mesh-list
20070955|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070956|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
20070957|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
20070958|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
20070959|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070960|NCT01860040|Gemcitabine|gemcitabine|mesh-list
20070961|NCT01860040|Pemetrexed|pemetrexed|mesh-list
20070962|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070963|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070964|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
20070965|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070966|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
20070967|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070968|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070969|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070970|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
20070971|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070972|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20070973|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20070974|NCT01851174|Gemcitabine|gemcitabine|mesh-list
20070975|NCT01851174|Paclitaxel|paclitaxel|mesh-list
20070976|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20070977|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20070978|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
20070979|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
20070980|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
20070981|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20070982|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20070983|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
20070984|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
20070985|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20070986|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20070987|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20070988|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
20070989|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070990|NCT01846182|Pregabalin|pregabalin|mesh-list
20070991|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20070992|NCT01846182|Analgesics|analgesics|mesh-ancestor
20070993|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
20070994|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20070995|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20070996|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
20070997|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20070998|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20070999|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071000|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20071001|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20071002|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20071003|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071004|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20071005|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20071006|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20071007|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071008|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
20071009|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
20071010|NCT01844206|Morphine|morphine|mesh-list
20071011|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20071012|NCT01844206|Narcotics|narcotics|mesh-ancestor
20071013|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071014|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071015|NCT01844206|Analgesics|analgesics|mesh-ancestor
20071016|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
20071017|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071018|NCT01856322|Sulindac|sulindac|mesh-list
20071019|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071020|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071021|NCT01856322|Analgesics|analgesics|mesh-ancestor
20298576|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298577|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
20298578|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298579|NCT00627471|Insulin|insulin|mesh-list
20071022|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
20071023|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071024|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071025|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071026|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071027|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071028|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20071029|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071030|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071031|NCT01853176|Bupivacaine|bupivacaine|mesh-list
20071032|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
20071033|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
20071034|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071035|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071036|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
20071037|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071038|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20071039|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071040|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20071041|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071042|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071043|NCT01856361|Ramipril|ramipril|mesh-list
20071044|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20071045|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
20071046|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071047|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071048|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20071049|NCT01853982|Tazobactam|tazobactam|mesh-list
20071050|NCT01853982|Piperacillin|piperacillin|mesh-list
20071051|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20071052|NCT01853982|Ceftolozane|ceftolozane|mesh-list
20071053|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20071054|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20071055|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071056|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20071057|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071058|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071059|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20071060|NCT01853982|Renal Agents|renal agents|mesh-ancestor
20071061|NCT01841931|Buprenorphine|buprenorphine|mesh-list
20071062|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20071063|NCT01841931|Naloxone|naloxone|mesh-list
20071064|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20071065|NCT01841931|Narcotics|narcotics|mesh-ancestor
20071066|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071067|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071068|NCT01841931|Analgesics|analgesics|mesh-ancestor
20071069|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
20071070|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071071|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20071072|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20071073|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
20071074|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071075|NCT01821963|Interferons|interferons|mesh-list
20071076|NCT01821963|Ribavirin|ribavirin|mesh-list
20071077|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
20071078|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
20071079|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20071080|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071081|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
20071082|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071083|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
20071084|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071085|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
20071086|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071087|NCT01821898|Budesonide|budesonide|mesh-list
20071088|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071089|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20298580|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20298581|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
20298582|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20298583|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298584|NCT00627536|Mitogens|mitogens|mesh-list
20298585|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
20298586|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298587|NCT00627575|Lamotrigine|lamotrigine|mesh-list
20298588|NCT00627575|Phenytoin|phenytoin|mesh-list
20298589|NCT00627575|Atorvastatin|atorvastatin|mesh-list
20298590|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20298591|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20298592|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
20298593|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298594|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20298595|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20298596|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298597|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
20298598|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20298599|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298600|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20298601|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298602|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20298603|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20298604|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298605|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298606|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19491753|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19491754|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
19491755|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19491756|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
19491757|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
19491758|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491759|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491760|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491761|NCT03127371|Analgesics|analgesics|mesh-ancestor
19491762|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
19491763|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491764|NCT03127449|Aflutinib|aflutinib|mesh-list
20298607|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20298608|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20298609|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20298610|NCT00627653|Fenofibrate|fenofibrate|mesh-list
20298611|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20298612|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
20298613|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298614|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20298615|NCT00627666|Leucovorin|leucovorin|mesh-list
20298616|NCT00627666|Methotrexate|methotrexate|mesh-list
20298617|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
20298618|NCT00627666|Fludarabine|fludarabine|mesh-list
20298619|NCT00627666|Busulfan|busulfan|mesh-list
20298620|NCT00627666|Calcium|calcium|mesh-list
20298621|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20298622|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
20298623|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20298624|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298625|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20298626|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
20298627|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20298628|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298629|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
20298630|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298631|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298632|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
20298633|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298634|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20298635|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298636|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
20298637|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298638|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20298639|NCT00627666|Antidotes|antidotes|mesh-ancestor
20298640|NCT00627666|Protective Agents|protective agents|mesh-ancestor
20298641|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
20298642|NCT00627666|Vitamins|vitamins|mesh-ancestor
20298643|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
20298644|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
20577700|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491765|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20298645|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20298646|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20298647|NCT00627692|Prucalopride|prucalopride|mesh-list
20298648|NCT00627692|Laxatives|laxatives|mesh-ancestor
20298649|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298650|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20298651|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20298652|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
20298653|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298654|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298655|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298656|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
20298657|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20298658|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20298659|NCT00627731|Prednisolone|prednisolone|mesh-list
20298660|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
19491766|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491767|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298661|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20298662|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
20298663|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20298664|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
20298665|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
20298666|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298667|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298668|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298669|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
20298670|NCT00627731|Hormones|hormones|mesh-ancestor
20298671|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20298672|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20298673|NCT00627731|Protective Agents|protective agents|mesh-ancestor
20298674|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20298675|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298676|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20298677|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20298678|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298679|NCT00627744|Incretins|incretins|mesh-ancestor
20298680|NCT00627744|Hormones|hormones|mesh-ancestor
20298681|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20298682|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20298683|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
20298684|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298685|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308593|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19491768|NCT03127631|Aspirin|aspirin|mesh-list
19491769|NCT03127631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19491770|NCT03127631|Atorvastatin|atorvastatin|mesh-list
19491771|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19491772|NCT03127631|Simvastatin|simvastatin|mesh-list
19491773|NCT03127631|Pravastatin|pravastatin|mesh-list
19569627|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
20308594|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308595|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
20308596|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071090|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
20071091|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071092|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071093|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20071094|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
20071095|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
20071096|NCT01821898|Hormones|hormones|mesh-ancestor
20071097|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071098|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
20071099|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071100|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
20071101|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20071102|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308597|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
20308598|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308599|NCT00665041|Quinagolide|quinagolide|mesh-list
20308600|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
20308601|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
20298686|NCT00627796|Lanreotide|lanreotide|mesh-list
20298687|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298688|NCT00627809|Streptokinase|streptokinase|mesh-list
20298689|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19491774|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20071103|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071104|NCT01830790|Urological Agents|urological agents|mesh-ancestor
19491775|NCT03127631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19491776|NCT03127631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491777|NCT03127631|Analgesics|analgesics|mesh-ancestor
19491778|NCT03127631|Sensory System Agents|sensory system agents|mesh-ancestor
19491779|NCT03127631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491780|NCT03127631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746282|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298690|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20298691|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298692|NCT00627835|Cisplatin|cisplatin|mesh-list
20298693|NCT00627835|Sorafenib|sorafenib|mesh-list
20298694|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298695|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20298696|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298697|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298698|NCT00627848|Rivastigmine|rivastigmine|mesh-list
20298699|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20298700|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298701|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298702|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
20298703|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298704|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298705|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20298706|NCT00627848|Protective Agents|protective agents|mesh-ancestor
20298707|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20298708|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
20298709|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298710|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298711|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298712|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20298713|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20298714|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298715|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298716|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20298717|NCT00627900|Sirolimus|sirolimus|mesh-list
20298718|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20298719|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298720|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20298721|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298722|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
20298723|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746283|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746284|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746285|NCT04040439|Analgesics|analgesics|mesh-ancestor
20071105|NCT01829477|Glimepiride|glimepiride|mesh-list
20577701|NCT02079558|Oxytocin|oxytocin|mesh-list
20577702|NCT02079558|Carbetocin|carbetocin|mesh-list
20577703|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
20577704|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20577705|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577706|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20577707|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
20577708|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577709|NCT02079727|Celecoxib|celecoxib|mesh-list
20577710|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20577711|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071106|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20071107|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20071108|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071109|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071110|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
20071111|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20071112|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20071113|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20071114|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577712|NCT02079727|Analgesics|analgesics|mesh-ancestor
20071115|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071116|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071117|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071118|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
20071119|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20071120|NCT01821859|Bevacizumab|bevacizumab|mesh-list
20071121|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20071122|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20071123|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071124|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20071125|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20071126|NCT01821859|Growth Substances|growth substances|mesh-ancestor
20071127|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071128|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
20071129|NCT01810302|Nicardipine|nicardipine|mesh-list
20071130|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20071131|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20071132|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071133|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071134|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20071135|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071136|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
20071137|NCT01804166|Golimumab|golimumab|mesh-list
20071138|NCT01804166|Infliximab|infliximab|mesh-list
20071139|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
20071140|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071141|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071142|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20071143|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071144|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071145|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
20071146|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071147|NCT01783015|Etanercept|etanercept|mesh-list
20071148|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071149|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071150|NCT01783015|Analgesics|analgesics|mesh-ancestor
20071151|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
20071152|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071153|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071154|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071155|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071156|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071157|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071158|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
20071159|NCT01800162|Methotrexate|methotrexate|mesh-list
20071160|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20071161|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
20071162|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071163|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071164|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20071165|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
20071166|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071167|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071168|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
20071169|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071170|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20071171|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071172|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
20071173|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071174|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20071175|NCT01797380|Citalopram|citalopram|mesh-list
20071176|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20071177|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20071178|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071179|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071180|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071181|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
20071182|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071183|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20071184|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
19746286|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
19491781|NCT03127631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491782|NCT03127631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491783|NCT03127631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19491784|NCT03127631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19491785|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491786|NCT03127631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19491787|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491788|NCT03127631|Antipyretics|antipyretics|mesh-ancestor
19491789|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19491790|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19491791|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
19491792|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19491793|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19491794|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
20577713|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
20577714|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577715|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491795|NCT03127137|Triamcinolone|triamcinolone|mesh-list
19491796|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20298724|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
20071185|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20071186|NCT01781026|Vemurafenib|vemurafenib|mesh-list
20071187|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071188|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20071189|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071190|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071191|NCT01788475|Dexamethasone|dexamethasone|mesh-list
20071192|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
20071193|NCT01788475|BB 1101|bb 1101|mesh-list
20071194|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071195|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
20071196|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
20071197|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071198|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071199|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071200|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
20071201|NCT01788475|Hormones|hormones|mesh-ancestor
20298725|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298726|NCT00627913|Anesthetics|anesthetics|mesh-list
20298727|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298728|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298729|NCT00627952|Amlodipine|amlodipine|mesh-list
20298730|NCT00627952|Manidipine|manidipine|mesh-list
20298731|NCT00627952|Delapril|delapril|mesh-list
20298732|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20298733|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20298734|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298735|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298736|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20298737|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298738|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
20298739|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20298740|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
20298741|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298742|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
20071202|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071203|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20071204|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071205|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
20071206|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071207|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071208|NCT01784991|Morphine|morphine|mesh-list
20071209|NCT01784991|Hydromorphone|hydromorphone|mesh-list
20071210|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20298743|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298744|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
20298745|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20298746|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20071211|NCT01784991|Narcotics|narcotics|mesh-ancestor
20071212|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071213|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071214|NCT01784991|Analgesics|analgesics|mesh-ancestor
19491797|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19491798|NCT03127137|Lidocaine|lidocaine|mesh-list
19491799|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19491800|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
20298747|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298748|NCT00627965|Urological Agents|urological agents|mesh-ancestor
20298749|NCT00627991|Valsartan|valsartan|mesh-list
20298750|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20298751|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20298752|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20298753|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298754|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
20298755|NCT00628043|Hematinics|hematinics|mesh-ancestor
20298756|NCT00628056|Perhexiline|perhexiline|mesh-list
20298757|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20071215|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
20071216|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071217|NCT01777854|Omeprazole|omeprazole|mesh-list
20071218|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20071219|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071220|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20071221|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071222|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071223|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20071224|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20071225|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298758|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298759|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298760|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20298761|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298762|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
20298763|NCT00628121|Cetrorelix|cetrorelix|mesh-list
20298764|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20298765|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
19491801|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
20298766|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20298767|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298768|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
20298769|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071226|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20071227|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20298770|NCT00628160|Terlipressin|terlipressin|mesh-list
20298771|NCT00628160|Dopamine|dopamine|mesh-list
20298772|NCT00628160|Norepinephrine|norepinephrine|mesh-list
20298773|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
20298774|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20298775|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20298776|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298777|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298778|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298779|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
20298780|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
20298781|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298782|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20298783|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20298784|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20298785|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
20298786|NCT00628160|Protective Agents|protective agents|mesh-ancestor
20298787|NCT00628225|Bupropion|bupropion|mesh-list
20298788|NCT00628225|Nicotine|nicotine|mesh-list
20298789|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20071228|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071229|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071230|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
20071231|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071232|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
20071233|NCT01772719|Simvastatin|simvastatin|mesh-list
20071234|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20071235|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20071236|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
20071237|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071238|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20071239|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20298790|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
20298791|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298792|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298793|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20298794|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20577716|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577717|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20577718|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20577719|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20577720|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577721|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577722|NCT02079961|Micronutrients|micronutrients|mesh-list
20577723|NCT02079961|Trace Elements|trace elements|mesh-list
20577724|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577725|NCT02079974|Pravastatin|pravastatin|mesh-list
20577726|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20577727|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20577728|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
20577729|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577730|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20577731|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20577732|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577733|NCT02080026|Chloroquine|chloroquine|mesh-list
20577734|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20577735|NCT02080026|Atovaquone|atovaquone|mesh-list
20577736|NCT02080026|Proguanil|proguanil|mesh-list
20577737|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20577738|NCT02080026|Vaccines|vaccines|mesh-list
20577739|NCT02080026|Amebicides|amebicides|mesh-ancestor
20071240|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577740|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20577741|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20577742|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577743|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
20577744|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20577745|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20577746|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20577747|NCT02080026|Analgesics|analgesics|mesh-ancestor
20577748|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
20577749|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577750|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577751|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20577752|NCT02080026|Filaricides|filaricides|mesh-ancestor
20577753|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
20577754|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
20577755|NCT02080026|Immunologic Factors|immunologic factors|mesh-ancestor
20577756|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577757|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577758|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
20577759|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20577760|NCT02080078|Theophylline|theophylline|mesh-list
20577761|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577762|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20577763|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577764|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577765|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20577766|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
20577767|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577768|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577769|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20577770|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
20577771|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20577772|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
20577773|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20577774|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20577775|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
20577776|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577777|NCT02080104|Oxytocin|oxytocin|mesh-list
20577778|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
20577779|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20577780|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577781|NCT02080169|Fentanyl|fentanyl|mesh-list
20577782|NCT02080169|Midazolam|midazolam|mesh-list
20577783|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
20577784|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20071241|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20577785|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071242|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298795|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
20298796|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298797|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298798|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20298799|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
20298800|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298801|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20298802|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20298803|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298804|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
20298805|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20298806|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20298807|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298808|NCT00628238|Rituximab|rituximab|mesh-list
20298809|NCT00628238|Lenalidomide|lenalidomide|mesh-list
20298810|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20298811|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298812|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
20298813|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298814|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298815|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20298816|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20298817|NCT00628238|Growth Substances|growth substances|mesh-ancestor
20298818|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
20298819|NCT00628290|Cannabidiol|cannabidiol|mesh-list
20298820|NCT00628290|Amisulpride|amisulpride|mesh-list
20298821|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
20298822|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20298823|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20298824|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298825|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298826|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298827|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20298828|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
20298829|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298830|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298831|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20298832|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
20298833|NCT00628316|Caffeine|caffeine|mesh-list
20298834|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20298835|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298836|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20298837|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298838|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298839|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20577786|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577787|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20577788|NCT02080169|Analgesics|analgesics|mesh-ancestor
20577789|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
20577790|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577791|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20577792|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20577793|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20577794|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
20577795|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577796|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577797|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20577798|NCT02080169|Narcotics|narcotics|mesh-ancestor
20577799|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20577800|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20298840|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20298841|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
20298842|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298843|NCT00628342|Esomeprazole|esomeprazole|mesh-list
20298844|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298845|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298846|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298847|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298848|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298849|NCT00628459|Micronutrients|micronutrients|mesh-list
20298850|NCT00628459|Trace Elements|trace elements|mesh-list
20577801|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
20577802|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
20577803|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20298851|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298852|NCT00628550|Vasopressins|vasopressins|mesh-list
20298853|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
20298854|NCT00628550|Epinephrine|epinephrine|mesh-list
20298855|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20298856|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20298857|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
20298858|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298859|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298860|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298861|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20298862|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20298863|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
20298864|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298865|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20298866|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
20298867|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
20298868|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
20298869|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20298870|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
20298871|NCT00628550|Coagulants|coagulants|mesh-ancestor
20298872|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20298873|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
20298874|NCT00628576|Heparin|heparin|mesh-list
20298875|NCT00628576|Calcium heparin|calcium heparin|mesh-list
20071243|NCT01764997|Adalimumab|adalimumab|mesh-list
20298876|NCT00628576|Tinzaparin|tinzaparin|mesh-list
20577804|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20071244|NCT01764997|Etanercept|etanercept|mesh-list
20071245|NCT01764997|Methotrexate|methotrexate|mesh-list
20071246|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20071247|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
20071248|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071249|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071250|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20071251|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
20071252|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071253|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071254|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
20071255|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298877|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20298878|NCT00628576|Dalteparin|dalteparin|mesh-list
20298879|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
20298880|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20298881|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20298882|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298883|NCT00628667|Esomeprazole|esomeprazole|mesh-list
20298884|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298885|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298886|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298887|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298888|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298889|NCT00628680|Heparin|heparin|mesh-list
20298890|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
20298891|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20298892|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20298893|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491802|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491803|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491804|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
19491805|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491806|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19491807|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19491808|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19491809|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19491810|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491811|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491812|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
19491813|NCT03127137|Hormones|hormones|mesh-ancestor
19491814|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491815|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19491816|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
19491817|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298894|NCT00628706|Dronabinol|dronabinol|mesh-list
20298895|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
20298896|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298897|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298898|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20298899|NCT00628706|Analgesics|analgesics|mesh-ancestor
20298900|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
20298901|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298902|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20298903|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20298904|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298905|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298906|NCT00628706|Hormones|hormones|mesh-ancestor
20298907|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20298908|NCT00628719|Amphotericin B|amphotericin b|mesh-list
20298909|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20298910|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20298911|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
20298912|NCT00628719|Amebicides|amebicides|mesh-ancestor
20298913|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20298914|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20298915|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298916|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20298917|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
20298918|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20298919|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298920|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
20298921|NCT00628732|Topotecan|topotecan|mesh-list
20298922|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298923|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
20298924|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298925|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298926|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20298927|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
20298928|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298929|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298930|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20298931|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20577805|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20577806|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
20577807|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
20071256|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20071257|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071258|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
20298932|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20298933|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298934|NCT00628810|Leucovorin|leucovorin|mesh-list
20298935|NCT00628810|Bevacizumab|bevacizumab|mesh-list
20298936|NCT00628810|Fluorouracil|fluorouracil|mesh-list
20298937|NCT00628810|Irinotecan|irinotecan|mesh-list
20298938|NCT00628810|Calcium|calcium|mesh-list
20298939|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
20298940|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20298941|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20298942|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20298943|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20298944|NCT00628810|Growth Substances|growth substances|mesh-ancestor
20298945|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298946|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
20298947|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20298948|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
20071259|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20298949|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577808|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
20577809|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20577810|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
20298950|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20298951|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20298952|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
20298953|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20298954|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20577811|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577812|NCT02080182|Expectorants|expectorants|mesh-ancestor
20577813|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
20577814|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20577815|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
20577816|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577817|NCT02080182|Protective Agents|protective agents|mesh-ancestor
20071260|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20071261|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071262|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071263|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071264|NCT01764997|Analgesics|analgesics|mesh-ancestor
20298955|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298956|NCT00628810|Antidotes|antidotes|mesh-ancestor
20298957|NCT00628810|Protective Agents|protective agents|mesh-ancestor
20298958|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
20298959|NCT00628810|Vitamins|vitamins|mesh-ancestor
20298960|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
20298961|NCT00628914|Dexetimide|dexetimide|mesh-list
20298962|NCT00628914|Eszopiclone|eszopiclone|mesh-list
20298963|NCT00628914|Citalopram|citalopram|mesh-list
20298964|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20298965|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20071265|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
20071266|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071267|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298966|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20298967|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298968|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20298969|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
20298970|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298971|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20298972|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
20298973|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20298974|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20071268|NCT01769443|Bortezomib|bortezomib|mesh-list
20071269|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071270|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20071271|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20071272|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20298975|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20298976|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
20577818|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071273|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20298977|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
20071274|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20071275|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071276|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071277|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
20071278|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071279|NCT01749826|Morphine|morphine|mesh-list
20071280|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20071281|NCT01749826|Narcotics|narcotics|mesh-ancestor
20298978|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20298979|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20298980|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20298981|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
20298982|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20298983|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20298984|NCT00628953|Esomeprazole|esomeprazole|mesh-list
20298985|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20298986|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20298987|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20298988|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20298989|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298990|NCT00629031|Paromomycin|paromomycin|mesh-list
20298991|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20298992|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20298993|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20298994|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20298995|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
20577819|NCT02080182|Antidotes|antidotes|mesh-ancestor
20577820|NCT02080234|Gemcitabine|gemcitabine|mesh-list
20577821|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
20577822|NCT02080234|Asparaginase|asparaginase|mesh-list
20577823|NCT02080234|Pegaspargase|pegaspargase|mesh-list
20071282|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071283|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071284|NCT01749826|Analgesics|analgesics|mesh-ancestor
20071285|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
20071286|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071287|NCT01756586|Dexamethasone|dexamethasone|mesh-list
20071288|NCT01756586|Bupivacaine|bupivacaine|mesh-list
20071289|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071290|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
20071291|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
20071292|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071293|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071294|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20577824|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20577825|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
20071295|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
20071296|NCT01756586|Hormones|hormones|mesh-ancestor
20071297|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20577826|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577827|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577828|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
20577829|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577830|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577831|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577832|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
20577833|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577834|NCT02080377|Glyburide|glyburide|mesh-list
20577835|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20577836|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577837|NCT02080416|Nelfinavir|nelfinavir|mesh-list
20577838|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20577839|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20577840|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
20577841|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577842|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577843|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20577844|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20577845|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
20577846|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577847|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
20577848|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20298996|NCT00629135|Metronidazole|metronidazole|mesh-list
20298997|NCT00629135|Tazobactam|tazobactam|mesh-list
20577849|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20071298|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20577850|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20298998|NCT00629135|Piperacillin|piperacillin|mesh-list
20298999|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20299000|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20299001|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299002|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20299003|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20299004|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299005|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299006|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299007|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20299008|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20299009|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20299010|NCT00629148|Capecitabine|capecitabine|mesh-list
20299011|NCT00629148|Vinorelbine|vinorelbine|mesh-list
20299012|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20299013|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
20299014|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299015|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299016|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20299017|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
20299018|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
20299019|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
20299020|NCT00629187|Temozolomide|temozolomide|mesh-list
20299021|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20299022|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
20299023|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299024|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299025|NCT00629200|Interferons|interferons|mesh-list
20299026|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
20299027|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
20299028|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20299029|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299030|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
20299031|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299032|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
20299033|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299034|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20299035|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20299036|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
20299037|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20299038|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
20299039|NCT00629213|Acarbose|acarbose|mesh-list
20299040|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20299041|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299042|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299043|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20299044|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299045|NCT00629226|Cetuximab|cetuximab|mesh-list
20299046|NCT00629226|Bortezomib|bortezomib|mesh-list
20299047|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299048|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20299049|NCT00629252|Risperidone|risperidone|mesh-list
20299050|NCT00629252|Sertindole|sertindole|mesh-list
20299051|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20071299|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071300|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
20071301|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
20071302|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071303|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
20119831|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119832|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
20119833|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
20119834|NCT00006240|Dexamethasone|dexamethasone|mesh-list
20119835|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20119836|NCT00006240|Sargramostim|sargramostim|mesh-list
20119837|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20119838|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
20119839|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
20119840|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119841|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119842|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20119843|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
20299052|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
20299053|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299054|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119844|NCT00006240|Hormones|hormones|mesh-ancestor
20299055|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299056|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20299057|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20299058|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299059|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299060|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20299061|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
20299062|NCT00629278|Tamoxifen|tamoxifen|mesh-list
20299063|NCT00629278|Docetaxel|docetaxel|mesh-list
20299064|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
20299065|NCT00629278|Doxorubicin|doxorubicin|mesh-list
20299066|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20299067|NCT00629278|Fluorouracil|fluorouracil|mesh-list
20299068|NCT00629278|Trastuzumab|trastuzumab|mesh-list
20299069|NCT00629278|Epirubicin|epirubicin|mesh-list
20299070|NCT00629278|Hormones|hormones|mesh-list
20299071|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19491818|NCT03127319|Docetaxel|docetaxel|mesh-list
19491819|NCT03127319|Apatinib|apatinib|mesh-list
19491820|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491821|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
19491822|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
20299072|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299073|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
20299074|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
20299075|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
20299076|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299077|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299078|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
20299079|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491823|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
19491824|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491825|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491826|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491827|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19491828|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19491829|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19491830|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19491831|NCT03127189|Rilpivirine|rilpivirine|mesh-list
19491832|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19491833|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19491834|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491835|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491836|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
19491837|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19491838|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20299080|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299081|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20299082|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
20299083|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20299084|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20299085|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20299086|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20299087|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299088|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
20299089|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20299090|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20299091|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299092|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20299093|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
20299094|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20299095|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20299096|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20299097|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20299098|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20299099|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
20299100|NCT00629304|Antithrombins|antithrombins|mesh-list
20299101|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20299102|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
20299103|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299104|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299105|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
20299106|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20299107|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20299108|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20299109|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
20299110|NCT00629343|Temozolomide|temozolomide|mesh-list
20299111|NCT00629343|Azacitidine|azacitidine|mesh-list
20299112|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20299113|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
20299114|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299115|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299116|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20299117|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
20299118|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299119|NCT00629382|Polymyxins|polymyxins|mesh-list
20299120|NCT00629382|Polymyxin B|polymyxin b|mesh-list
20299121|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20299122|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299123|NCT00629447|Tinzaparin|tinzaparin|mesh-list
20299124|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
20299125|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20299126|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20299127|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299128|NCT00629473|Dexamethasone|dexamethasone|mesh-list
20299129|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
20299130|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20299131|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
20299132|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
20299133|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299134|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071304|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
20071305|NCT01754987|Sorafenib|sorafenib|mesh-list
20071306|NCT01754987|Vitamins|vitamins|mesh-ancestor
20071307|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
20071308|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071309|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071310|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20071311|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071312|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071313|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
20299135|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299136|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
20299137|NCT00629473|Hormones|hormones|mesh-ancestor
20299138|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299139|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20299140|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299141|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
20299142|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299143|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308602|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308603|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308604|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308605|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20308606|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308607|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20308608|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308609|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308610|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308611|NCT00665054|Urological Agents|urological agents|mesh-ancestor
20308612|NCT00665093|Insulin|insulin|mesh-list
20308613|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20308614|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
20308615|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
20308616|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
20308617|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20308618|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20308619|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308620|NCT00665119|Remifentanil|remifentanil|mesh-list
20308621|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20308622|NCT00665119|Narcotics|narcotics|mesh-ancestor
20308623|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20308624|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308625|NCT00665119|Analgesics|analgesics|mesh-ancestor
20308626|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
20308627|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308628|NCT00665314|Plerixafor|plerixafor|mesh-list
20308629|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20308630|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20071314|NCT01754987|Protective Agents|protective agents|mesh-ancestor
20071315|NCT01756560|Bupivacaine|bupivacaine|mesh-list
20071316|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
20071317|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
20071318|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071319|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071320|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
20071321|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071322|NCT01756573|Bupivacaine|bupivacaine|mesh-list
20071323|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
20071324|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
20071325|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071326|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071327|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
20071328|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071329|NCT01745913|Fludarabine|fludarabine|mesh-list
20299144|NCT00629512|Esomeprazole|esomeprazole|mesh-list
20299145|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20299146|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299147|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20299148|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299149|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299150|NCT00629564|Esomeprazole|esomeprazole|mesh-list
20299151|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20299152|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299153|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20299154|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299155|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299156|NCT00629616|Fulvestrant|fulvestrant|mesh-list
20071330|NCT01745913|Melphalan|melphalan|mesh-list
20299157|NCT00629616|Anastrozole|anastrozole|mesh-list
20299158|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20299159|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299160|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20299161|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20299162|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
20299163|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299164|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299165|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20299166|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20299167|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299168|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299169|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
20299170|NCT00629642|Oxybutynin|oxybutynin|mesh-list
20299171|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20299172|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20299173|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
20299174|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299175|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299176|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299177|NCT00629642|Urological Agents|urological agents|mesh-ancestor
20299178|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
20299179|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
19491839|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19491840|NCT03127124|Leucovorin|leucovorin|mesh-list
19491841|NCT03127124|Fluorouracil|fluorouracil|mesh-list
19491842|NCT03127124|Bevacizumab|bevacizumab|mesh-list
19491843|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
19491844|NCT03127124|Calcium|calcium|mesh-list
19491845|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
19491846|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19491847|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491848|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
19491849|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577851|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
20577852|NCT02080494|Coagulants|coagulants|mesh-ancestor
20577853|NCT02080624|Sirolimus|sirolimus|mesh-list
20577854|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20577855|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577856|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20071331|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
20071332|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577857|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491850|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19491851|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491852|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577858|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
20577859|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19491853|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
19491854|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19491855|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19491856|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19491857|NCT03127124|Growth Substances|growth substances|mesh-ancestor
19491858|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
19491859|NCT03127124|Antidotes|antidotes|mesh-ancestor
20299180|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299181|NCT00629681|Pregabalin|pregabalin|mesh-list
20299182|NCT00629681|Analgesics|analgesics|mesh-ancestor
20299183|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
20299184|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299185|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299186|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
20299187|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20299188|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299189|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299190|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20299191|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20299192|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20299193|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299194|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299195|NCT00629720|Alfuzosin|alfuzosin|mesh-list
20299196|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20299197|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20299198|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20299199|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
20299200|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299201|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299202|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299203|NCT00629720|Urological Agents|urological agents|mesh-ancestor
20299204|NCT00629811|Mitogens|mitogens|mesh-list
20299205|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
20299206|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299207|NCT00629824|Interferons|interferons|mesh-list
20299208|NCT00629824|Ribavirin|ribavirin|mesh-list
20299209|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
20299210|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20299211|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299212|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
20299213|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299214|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
20071333|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071334|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071335|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
20071336|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071337|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20299215|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299216|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
20299217|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071338|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
20071339|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20071340|NCT01752023|Gemcitabine|gemcitabine|mesh-list
20071341|NCT01752023|Itraconazole|itraconazole|mesh-list
20071342|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20071343|NCT01752023|Cisplatin|cisplatin|mesh-list
20071344|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071345|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20071346|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
20071347|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071348|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
20071349|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071350|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071351|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071352|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
20071353|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071354|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
20071355|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20071356|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20299218|NCT00629837|Factor VIII|factor viii|mesh-list
20299219|NCT00629837|Coagulants|coagulants|mesh-ancestor
20299220|NCT00629863|Fluorouracil|fluorouracil|mesh-list
19491860|NCT03127124|Protective Agents|protective agents|mesh-ancestor
20071357|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19491861|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
20299221|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299222|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
20299223|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299224|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20299225|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299226|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
20299227|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299228|NCT00629889|Pregabalin|pregabalin|mesh-list
20299229|NCT00629889|Levetiracetam|levetiracetam|mesh-list
20299230|NCT00629889|Analgesics|analgesics|mesh-ancestor
20299231|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
20299232|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299233|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299234|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
20299235|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20299236|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299237|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299238|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20299239|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20299240|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19491862|NCT03127124|Vitamins|vitamins|mesh-ancestor
19491863|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
20071358|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
20071359|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071360|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20071361|NCT01740154|Sunitinib|sunitinib|mesh-list
20071362|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491864|NCT03127046|Aceclofenac|aceclofenac|mesh-list
19491865|NCT03127046|Diclofenac|diclofenac|mesh-list
19491866|NCT03127046|Esomeprazole|esomeprazole|mesh-list
19491867|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19491868|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491869|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19491870|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491871|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299241|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299242|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299243|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
20299244|NCT00629928|Esomeprazole|esomeprazole|mesh-list
20299245|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20299246|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071363|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20071364|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20071365|NCT01740154|Growth Substances|growth substances|mesh-ancestor
20071366|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071367|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
19491872|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071368|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20071369|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071370|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071371|NCT01748162|Fluticasone|fluticasone|mesh-list
20071372|NCT01748162|Prednisolone|prednisolone|mesh-list
20071373|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071374|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20071375|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
20071376|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071377|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071378|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20071379|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
20071380|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
20071381|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20071382|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
20071383|NCT01748162|Hormones|hormones|mesh-ancestor
20071384|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071385|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20071386|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071387|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20071388|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20071389|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071390|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20071391|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20071392|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299247|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20071393|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071394|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
20071395|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071396|NCT01732926|Rituximab|rituximab|mesh-list
20071397|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20071398|NCT01732926|Idelalisib|idelalisib|mesh-list
20071399|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20071400|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071401|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
20071402|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071403|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071404|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20299248|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491873|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19491874|NCT03127046|Analgesics|analgesics|mesh-ancestor
19491875|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
19491876|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19491877|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491878|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19491879|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491880|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19491881|NCT03126877|Mitomycins|mitomycins|mesh-list
19491882|NCT03126877|Mitomycin|mitomycin|mesh-list
19491883|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20299249|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299250|NCT00629967|Interferons|interferons|mesh-list
20299251|NCT00629967|Ribavirin|ribavirin|mesh-list
20299252|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
20299253|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
20299254|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20299255|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299256|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
20299257|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299258|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
20299259|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299260|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
20299261|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299262|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
20299263|NCT00630019|Levofloxacin|levofloxacin|mesh-list
20299264|NCT00630019|Ofloxacin|ofloxacin|mesh-list
20299265|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20299266|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20299267|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20299268|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20299269|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299270|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20299271|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20299272|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299273|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299274|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299275|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20299276|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
20299277|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20299278|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299279|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20299280|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20299281|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20299282|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20299283|NCT00630019|Renal Agents|renal agents|mesh-ancestor
20071405|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
20071406|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071407|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299284|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20299285|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20299286|NCT00630045|Capecitabine|capecitabine|mesh-list
20299287|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
20299288|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20299289|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
20071408|NCT01732913|Rituximab|rituximab|mesh-list
20071409|NCT01732913|Idelalisib|idelalisib|mesh-list
20071410|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20071411|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071412|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
19491884|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071413|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299290|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299291|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299292|NCT00630084|Interferons|interferons|mesh-list
20299293|NCT00630084|Ribavirin|ribavirin|mesh-list
20299294|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
20299295|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
20299296|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20299297|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299298|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
20299299|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299300|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
20299301|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299302|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
20299303|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299304|NCT00630097|Modafinil|modafinil|mesh-list
20299305|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20299306|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299307|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20299308|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20299309|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20299310|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299311|NCT00630110|Docetaxel|docetaxel|mesh-list
20299312|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299313|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
20299314|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
20299315|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
20299316|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299317|NCT00630149|Pemetrexed|pemetrexed|mesh-list
20299318|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299319|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299320|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299321|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20299322|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20299323|NCT00630175|Zolpidem|zolpidem|mesh-list
20299324|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20299325|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20299326|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299327|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299328|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20299329|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
20299330|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
20299331|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299332|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299333|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
20299334|NCT00630214|Vitamin D|vitamin d|mesh-list
20299335|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
20299336|NCT00630214|Vitamins|vitamins|mesh-list
20299337|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
20299338|NCT00630214|Calcium|calcium|mesh-list
20299339|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
20299340|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299341|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20299342|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20299343|NCT00630214|Antacids|antacids|mesh-ancestor
20299344|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071414|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071415|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071416|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071417|NCT01716052|Ibuprofen|ibuprofen|mesh-list
20299345|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299346|NCT00630357|Levetiracetam|levetiracetam|mesh-list
20299347|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
20299348|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
20299349|NCT00630370|ATI 7505|ati 7505|mesh-list
20299350|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20299351|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20071418|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071419|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071420|NCT01716052|Analgesics|analgesics|mesh-ancestor
20071421|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
20071422|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071423|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299352|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
20299353|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308631|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
20299354|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299355|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299356|NCT00630383|Histamine|histamine|mesh-list
20299357|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
20299358|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
20299359|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299360|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299361|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299362|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20299363|NCT00630435|Estrogens|estrogens|mesh-ancestor
20299364|NCT00630435|Hormones|hormones|mesh-ancestor
20299365|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299366|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299367|NCT00630474|Xylometazoline|xylometazoline|mesh-list
20299368|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
20299369|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20577860|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
20577861|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577862|NCT02080715|Tolcapone|tolcapone|mesh-list
20577863|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20577864|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20577865|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20577866|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577867|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577868|NCT02080728|Ropivacaine|ropivacaine|mesh-list
20577869|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
20577870|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
20577871|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577872|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577873|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
20577874|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577875|NCT02080845|Theobromine|theobromine|mesh-list
20577876|NCT02080845|Caffeine|caffeine|mesh-list
20577877|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20577878|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577879|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20577880|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577881|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577882|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20577883|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20577884|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
20577885|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577886|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20577887|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
20577888|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577889|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20577890|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
20577891|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
20577892|NCT02080858|Apixaban|apixaban|mesh-list
20577893|NCT02080858|Ticagrelor|ticagrelor|mesh-list
20071424|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071425|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071426|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20071427|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071428|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071429|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20071430|NCT01718444|Clomiphene|clomiphene|mesh-list
20071431|NCT01718444|Enclomiphene|enclomiphene|mesh-list
20071432|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
20071433|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
20299370|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
20299371|NCT00630500|Memantine|memantine|mesh-list
20299372|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20299373|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20299374|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
20299375|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299376|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299377|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299378|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19746287|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071434|NCT01718444|Progestins|progestins|mesh-list
20299379|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20299380|NCT00630513|Ampicillin|ampicillin|mesh-list
20299381|NCT00630513|Ertapenem|ertapenem|mesh-list
20299382|NCT00630513|Sulbactam|sulbactam|mesh-list
20299383|NCT00630513|Sultamicillin|sultamicillin|mesh-list
20299384|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20299385|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299386|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20299387|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299388|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299389|NCT00630630|Levetiracetam|levetiracetam|mesh-list
20299390|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
20299391|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
20299392|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
20071435|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20071436|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
20071437|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071438|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071439|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20071440|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
20071441|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071442|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20071443|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20071444|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20071445|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20071446|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20071447|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
20071448|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20071449|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20299393|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
20299394|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299395|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299396|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
20299397|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20299398|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299399|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20299400|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20299401|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299402|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299403|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
20299404|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299405|NCT00630695|Lanreotide|lanreotide|mesh-list
20299406|NCT00630695|Somatostatin|somatostatin|mesh-list
20299407|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299408|NCT00630695|Hormones|hormones|mesh-ancestor
20299409|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299410|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299411|NCT00630708|Losartan|losartan|mesh-list
20299412|NCT00630708|Benazepril|benazepril|mesh-list
20299413|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20299414|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20299415|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20299416|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20299417|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299418|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20299419|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
20299420|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299421|NCT00630851|Donepezil|donepezil|mesh-list
20299422|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20299423|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299424|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299425|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
20299426|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299427|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299428|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
20299429|NCT00630890|Capecitabine|capecitabine|mesh-list
20299430|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20299431|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
20299432|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299433|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299434|NCT00630903|Methoxsalen|methoxsalen|mesh-list
20299435|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20299436|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
20299437|NCT00630929|Ibuprofen|ibuprofen|mesh-list
20071450|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20071451|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20071452|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071453|NCT01718444|Hormones|hormones|mesh-ancestor
20071454|NCT01712854|Budesonide|budesonide|mesh-list
20071455|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20071456|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071457|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20071458|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
20071459|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071460|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071461|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20071462|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
20299438|NCT00630929|Celecoxib|celecoxib|mesh-list
20071463|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
20071464|NCT01712854|Hormones|hormones|mesh-ancestor
20071465|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071466|NCT01717482|Metformin|metformin|mesh-list
20071467|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20071468|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071469|NCT01702896|Interleukin-2|interleukin-2|mesh-list
20071470|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071471|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071472|NCT01702896|Analgesics|analgesics|mesh-ancestor
20071473|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
20071474|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071475|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071476|NCT01709136|Sirolimus|sirolimus|mesh-list
20071477|NCT01709136|Tacrolimus|tacrolimus|mesh-list
20071478|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071479|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
20071480|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071481|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20071482|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071483|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071484|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20071485|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071486|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20071487|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071488|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
20071489|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
20071490|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20071491|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
20071492|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071493|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071494|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20071495|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
20071496|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
20071497|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20071498|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
20071499|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071500|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071501|NCT01705106|Celecoxib|celecoxib|mesh-list
20071502|NCT01705106|Capecitabine|capecitabine|mesh-list
20071503|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20071504|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
20071505|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071506|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071507|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071508|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071509|NCT01705106|Analgesics|analgesics|mesh-ancestor
20071510|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
20071511|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071512|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071513|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071514|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071515|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20071516|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20071517|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071518|NCT01702909|Interleukin-2|interleukin-2|mesh-list
20071519|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071520|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071521|NCT01702909|Analgesics|analgesics|mesh-ancestor
20299439|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20299440|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20299441|NCT00630929|Analgesics|analgesics|mesh-ancestor
20299442|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
20299443|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299444|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299445|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20299446|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299447|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20299448|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299449|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299450|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20299451|NCT00630942|Minocycline|minocycline|mesh-list
20299452|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20299453|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299454|NCT00630968|Levetiracetam|levetiracetam|mesh-list
20299455|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
20299456|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
20299457|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20299458|NCT00630981|Citalopram|citalopram|mesh-list
20299459|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20299460|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20299461|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299462|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299463|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299464|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
20299465|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299466|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20299467|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
20299468|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299469|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20299470|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20299471|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299472|NCT00631033|Metformin|metformin|mesh-list
20299473|NCT00631033|Diazoxide|diazoxide|mesh-list
20299474|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20071522|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
20071523|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071524|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071525|NCT01701622|Febuxostat|febuxostat|mesh-list
20071526|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
20299475|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299476|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20299477|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
20299478|NCT00631085|Tocopherols|tocopherols|mesh-list
20299479|NCT00631085|Vitamin E|vitamin e|mesh-list
20299480|NCT00631085|Tocotrienols|tocotrienols|mesh-list
20299481|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
20299482|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
20299483|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
20299484|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299485|NCT00631085|Protective Agents|protective agents|mesh-ancestor
20299486|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299487|NCT00631085|Vitamins|vitamins|mesh-ancestor
20299488|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
20299489|NCT00631124|Drospirenone|drospirenone|mesh-list
20299490|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20299491|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20299492|NCT00631124|Estradiol|estradiol|mesh-list
20299493|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20299494|NCT00631124|Estrogens|estrogens|mesh-ancestor
20299495|NCT00631124|Hormones|hormones|mesh-ancestor
20299496|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299497|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299498|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20299499|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
20071527|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071528|NCT01697800|Tadalafil|tadalafil|mesh-list
20071529|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
20071530|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20071531|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20071532|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071533|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071534|NCT01697800|Urological Agents|urological agents|mesh-ancestor
20071535|NCT01692691|Dacarbazine|dacarbazine|mesh-list
20299500|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071536|NCT01692691|Carmustine|carmustine|mesh-list
20071537|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20071538|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
20299501|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20299502|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20299503|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
20299504|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20299505|NCT00631124|Diuretics|diuretics|mesh-ancestor
20299506|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
20299507|NCT00631150|Levetiracetam|levetiracetam|mesh-list
20299508|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
20299509|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
20299510|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
20299511|NCT00631202|Hematinics|hematinics|mesh-ancestor
20299512|NCT00631228|Everolimus|everolimus|mesh-list
20299513|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299514|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299515|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
20071539|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071540|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071541|NCT01691079|Bromides|bromides|mesh-list
20071542|NCT01691079|Ipratropium|ipratropium|mesh-list
20071543|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
20071544|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20071545|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
20071546|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071547|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071548|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20071549|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
20071550|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20071551|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
20071552|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071553|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299516|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308632|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308633|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
20071554|NCT01689974|Ipilimumab|ipilimumab|mesh-list
20071555|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20071556|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071557|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20071558|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071559|NCT01663285|Gemcitabine|gemcitabine|mesh-list
20071560|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071561|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20071562|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
20071563|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308634|NCT00665327|Levofloxacin|levofloxacin|mesh-list
20308635|NCT00665327|Ofloxacin|ofloxacin|mesh-list
20308636|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20308637|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308638|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308639|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20308640|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20308641|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308642|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308643|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308644|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20308645|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
20308646|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20308647|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308648|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20308649|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20308650|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20308651|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20308652|NCT00665327|Renal Agents|renal agents|mesh-ancestor
20308653|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20308654|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20308655|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20308656|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308657|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20308658|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308659|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308660|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308661|NCT00665340|Urological Agents|urological agents|mesh-ancestor
20299517|NCT00631501|Doxycycline|doxycycline|mesh-list
20299518|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20299519|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299520|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
20299521|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20299522|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20299523|NCT00631514|Acetaminophen|acetaminophen|mesh-list
20299524|NCT00631514|Ibuprofen|ibuprofen|mesh-list
20299525|NCT00631514|Piroxicam|piroxicam|mesh-list
20299526|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20299527|NCT00631514|Analgesics|analgesics|mesh-ancestor
20299528|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
19491885|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
19491886|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19491887|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19491888|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491889|NCT03126864|Vidarabine|vidarabine|mesh-list
20299529|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299530|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299531|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
20299532|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20299533|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20299534|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299535|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20299536|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299537|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299538|NCT00631527|Sunitinib|sunitinib|mesh-list
20299539|NCT00631527|Leuprolide|leuprolide|mesh-list
20299540|NCT00631527|Goserelin|goserelin|mesh-list
20299541|NCT00631527|Bicalutamide|bicalutamide|mesh-list
20299542|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299543|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20299544|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20299545|NCT00631527|Growth Substances|growth substances|mesh-ancestor
20577894|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20577895|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19491890|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
19746288|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19746289|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19746290|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19746291|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
19746292|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071564|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
20071565|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071566|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071567|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071568|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
19746293|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746294|NCT04038255|Nicotine|nicotine|mesh-list
19746295|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19746296|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
19746297|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746298|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746299|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20071569|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071570|NCT01683864|Cisplatin|cisplatin|mesh-list
20071571|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071572|NCT01673061|Lidocaine|lidocaine|mesh-list
20071573|NCT01673061|Epinephrine|epinephrine|mesh-list
20071574|NCT01673061|Norflurane|norflurane|mesh-list
20071575|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
20071576|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
20071577|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071578|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071579|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
20071580|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071581|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20071582|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20071583|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20071584|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299546|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299547|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
20299548|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19491891|NCT03126864|Fludarabine|fludarabine|mesh-list
19491892|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
19491893|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299549|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299550|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299551|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20299552|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
20299553|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20299554|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20299555|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
20299556|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
20299557|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299558|NCT00631579|Rasburicase|rasburicase|mesh-list
20299559|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
20299560|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299561|NCT00631592|Dolutegravir|dolutegravir|mesh-list
20299562|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20299563|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20299564|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299565|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299566|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20299567|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20299568|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
20299569|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299570|NCT00631618|Sunitinib|sunitinib|mesh-list
20299571|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299572|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20299573|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20071585|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071586|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20071587|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20071588|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
20071589|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071590|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20071591|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20071592|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
20071593|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20071594|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
20071595|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
20071596|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
20071597|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20071598|NCT01675960|Gabapentin|gabapentin|mesh-list
20071599|NCT01675960|Analgesics|analgesics|mesh-ancestor
20071600|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
20071601|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071602|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071603|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
20299574|NCT00631618|Growth Substances|growth substances|mesh-ancestor
20299575|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299576|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
20299577|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20299578|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299579|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299580|NCT00631631|Mifamurtide|mifamurtide|mesh-list
20299581|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20299582|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
20299583|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299584|NCT00631722|Haloperidol|haloperidol|mesh-list
20071604|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20071605|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20071606|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071607|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20071608|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20071609|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20071610|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071611|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071612|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
20071613|NCT01668147|Ritonavir|ritonavir|mesh-list
20071614|NCT01668147|Efavirenz|efavirenz|mesh-list
20071615|NCT01668147|Loperamide|loperamide|mesh-list
20299585|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
20299586|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
20299587|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
20071616|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
20071617|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20071618|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20071619|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
20299588|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299589|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299590|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299591|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20299592|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20299593|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299594|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299595|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20299596|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
20299597|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299598|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299599|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20299600|NCT00631813|Prucalopride|prucalopride|mesh-list
20299601|NCT00631813|Laxatives|laxatives|mesh-ancestor
20071620|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071621|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071622|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20071623|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20071624|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
20071625|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071626|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20071627|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20071628|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20071629|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20071630|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20071631|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20071632|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20071633|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20071634|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20071635|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071636|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20071637|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
20071638|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071639|NCT01662102|Rituximab|rituximab|mesh-list
20071640|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20071641|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071642|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
20071643|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071644|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299602|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19491894|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
19491895|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491896|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19491897|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19491898|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
19491899|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299603|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20299604|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20299605|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
20299606|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299607|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299608|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299609|NCT00631943|Pregabalin|pregabalin|mesh-list
20299610|NCT00631943|Analgesics|analgesics|mesh-ancestor
20299611|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
20299612|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299613|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299614|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
20071645|NCT01659554|Cisplatin|cisplatin|mesh-list
20071646|NCT01659554|Doxorubicin|doxorubicin|mesh-list
20071647|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20071648|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071649|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20071650|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20299615|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20299616|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299617|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299618|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20299619|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20299620|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20299621|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299622|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299623|NCT00631995|Vaccines|vaccines|mesh-list
20071651|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19491900|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491901|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19491902|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19491903|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
19491904|NCT03126864|Antiviral Agents|antiviral agents|mesh-ancestor
20071652|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071653|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071654|NCT01658813|Interferons|interferons|mesh-list
20071655|NCT01658813|Fluorouracil|fluorouracil|mesh-list
20071656|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
20071657|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299624|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
20299625|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299626|NCT00632073|Maleic acid|maleic acid|mesh-list
20299627|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299628|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299629|NCT00632086|Aspirin|aspirin|mesh-list
20299630|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20299631|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20299632|NCT00632086|Analgesics|analgesics|mesh-ancestor
20299633|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
20299634|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299635|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299636|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20299637|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746300|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19746301|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
19746302|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746303|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746304|NCT04028050|Carboplatin|carboplatin|mesh-list
19746305|NCT04028050|Etoposide|etoposide|mesh-list
19746306|NCT04028050|Atezolizumab|atezolizumab|mesh-list
19746307|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746308|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19746309|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746310|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19746311|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746312|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746313|NCT03976375|Docetaxel|docetaxel|mesh-list
19746314|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
19746315|NCT03976375|Lenvatinib|lenvatinib|mesh-list
19746316|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746317|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
19746318|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
19746319|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
20299638|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20299639|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20299640|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299641|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20299642|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20299643|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299644|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
20299645|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
20299646|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20299647|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299648|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299649|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20299650|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299651|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20299652|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
20299653|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299654|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20299655|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299656|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299657|NCT00632268|Leucovorin|leucovorin|mesh-list
20299658|NCT00632268|Everolimus|everolimus|mesh-list
19491905|NCT03126864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071658|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20071659|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071660|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071661|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
20071662|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071663|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
20071664|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299659|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299660|NCT00632268|Antidotes|antidotes|mesh-ancestor
20299661|NCT00632268|Protective Agents|protective agents|mesh-ancestor
20299662|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299663|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
20299664|NCT00632268|Vitamins|vitamins|mesh-ancestor
20071665|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20071666|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
20071667|NCT01649505|Coagulants|coagulants|mesh-ancestor
20071668|NCT01642732|Everolimus|everolimus|mesh-list
20071669|NCT01642732|Leuprolide|leuprolide|mesh-list
20071670|NCT01642732|Bicalutamide|bicalutamide|mesh-list
20299665|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
20299666|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299667|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
20299668|NCT00632333|Fluorouracil|fluorouracil|mesh-list
20299669|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299670|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
20299671|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299672|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20299673|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299674|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
20299675|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299676|NCT00632385|Eletriptan|eletriptan|mesh-list
20299677|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20299678|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
20299679|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299680|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299681|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299682|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
20299683|NCT00632476|Vitamins|vitamins|mesh-ancestor
20299684|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
20299685|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299686|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
20299687|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299688|NCT00632476|Protective Agents|protective agents|mesh-ancestor
20299689|NCT00632554|Prednisolone|prednisolone|mesh-list
20299690|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20299691|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
20299692|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20299693|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
20299694|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20299695|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
20299696|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20299697|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
20299698|NCT00632554|Hormones|hormones|mesh-ancestor
20299699|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299700|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299701|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20299702|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577896|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20071671|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071672|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071673|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
20071674|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071675|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20071676|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
20071677|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071678|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20071679|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
20071680|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
20071681|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071682|NCT01645709|Verapamil|verapamil|mesh-list
20071683|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20071684|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20071685|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071686|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071687|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20071688|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071689|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
20071690|NCT01648270|Buprenorphine|buprenorphine|mesh-list
20071691|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20071692|NCT01648270|Narcotics|narcotics|mesh-ancestor
20071693|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071694|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299703|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
20299704|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
20299705|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299706|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299707|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20299708|NCT00632554|Protective Agents|protective agents|mesh-ancestor
20299709|NCT00632580|Ropivacaine|ropivacaine|mesh-list
20299710|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
20299711|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
20299712|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299713|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299714|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
20299715|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299716|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
20299717|NCT00632606|Metoclopramide|metoclopramide|mesh-list
20299718|NCT00632606|Analgesics|analgesics|mesh-ancestor
20299719|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
20299720|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299721|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299722|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
20299723|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299724|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20299725|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
20299726|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20299727|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299728|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299729|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20299730|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
20299731|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20299732|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
20299733|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
20299734|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299735|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20299736|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20299737|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
20299738|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299739|NCT00632645|Olanzapine|olanzapine|mesh-list
20299740|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
20299741|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
20299742|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
20299743|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
20299744|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299745|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299746|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299747|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20299748|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20299749|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299750|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299751|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20299752|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20299753|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299754|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299755|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071695|NCT01648270|Analgesics|analgesics|mesh-ancestor
20071696|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
20071697|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299756|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
20299757|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20299758|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
20299759|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20299760|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
20299761|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
20299762|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20299763|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299764|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299765|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20071698|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20071699|NCT01633814|Estradiol|estradiol|mesh-list
20071700|NCT01633814|Estrogens|estrogens|mesh-ancestor
20071701|NCT01633814|Hormones|hormones|mesh-ancestor
20071702|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071703|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071704|NCT01636466|Everolimus|everolimus|mesh-list
20071705|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308662|NCT00665418|Sevoflurane|sevoflurane|mesh-list
20071706|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071707|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
20071708|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071709|NCT01629329|Aspirin|aspirin|mesh-list
20299766|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20577897|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20577898|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
20577899|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577900|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577901|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577902|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20577903|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
20577904|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20577905|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
20577906|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577907|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
20577908|NCT02081027|Riluzole|riluzole|mesh-list
20577909|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
20577910|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20577911|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20577912|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577913|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577914|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577915|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20577916|NCT02081027|Protective Agents|protective agents|mesh-ancestor
20577917|NCT02081144|Nicotine|nicotine|mesh-list
20577918|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20577919|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
20577920|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577921|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577922|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20577923|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20577924|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
20577925|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577926|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577927|NCT02081287|Inositol|inositol|mesh-list
20577928|NCT02081287|Lamotrigine|lamotrigine|mesh-list
20577929|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
20577930|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20577931|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577932|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577933|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20577934|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577935|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20577936|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20577937|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577938|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20577939|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20577940|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
20577941|NCT02081287|Vitamins|vitamins|mesh-ancestor
20577942|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
20577943|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
20577944|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20577945|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
20577946|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577947|NCT02081339|Ranibizumab|ranibizumab|mesh-list
20577948|NCT02081339|Aflibercept|aflibercept|mesh-list
20577949|NCT02081339|Verteporfin|verteporfin|mesh-list
20577950|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20577951|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20577952|NCT02081339|Growth Substances|growth substances|mesh-ancestor
20577953|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577954|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
20577955|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577956|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20577957|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
20605670|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20071710|NCT01629329|Acetaminophen|acetaminophen|mesh-list
20071711|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
20071712|NCT01629329|Caffeine|caffeine|mesh-list
20071713|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071714|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071715|NCT01629329|Analgesics|analgesics|mesh-ancestor
20071716|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
20605671|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
20605672|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
20605673|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071717|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071718|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071719|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071720|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071721|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20071722|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20071723|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071724|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20071725|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20071726|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071727|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
20071728|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20071729|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20071730|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20071731|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20071732|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
20071733|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071734|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
20071735|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
20071736|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071737|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20071738|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20071739|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071740|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20071741|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20071742|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
20071743|NCT01632020|Metformin|metformin|mesh-list
20071744|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20071745|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071746|NCT01608906|Heparin|heparin|mesh-list
20071747|NCT01608906|Calcium heparin|calcium heparin|mesh-list
20071748|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
20071749|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20071750|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20071751|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071752|NCT01621737|Oxytocin|oxytocin|mesh-list
20071753|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
20071754|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071755|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071756|NCT01614067|Ganirelix|ganirelix|mesh-list
20071757|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
20071758|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071759|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071760|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20071761|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20071762|NCT01607320|Clomiphene|clomiphene|mesh-list
20071763|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
20071764|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20071765|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
20071766|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071767|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071768|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20071769|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
20071770|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071771|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20071772|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20071773|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20071774|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20071775|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
20071776|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20071777|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20071778|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20071779|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071780|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20071781|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20071782|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20071783|NCT01609231|Irinotecan|irinotecan|mesh-list
20071784|NCT01609231|Cetuximab|cetuximab|mesh-list
20071785|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20299767|NCT00632697|Protective Agents|protective agents|mesh-ancestor
20299768|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299769|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
20299770|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20299771|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
20299772|NCT00632723|Gefitinib|gefitinib|mesh-list
20299773|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299774|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20299775|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299776|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299777|NCT00632762|Amantadine|amantadine|mesh-list
20299778|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20299779|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20299780|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
20299781|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299782|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
20299783|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299784|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299785|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299786|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20299787|NCT00632762|Analgesics|analgesics|mesh-ancestor
20299788|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
20299789|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299790|NCT00632840|Atorvastatin|atorvastatin|mesh-list
20299791|NCT00632840|Fenofibrate|fenofibrate|mesh-list
20299792|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20299793|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20299794|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
20299795|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299796|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20299797|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20299798|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299799|NCT00632853|Carboplatin|carboplatin|mesh-list
20299800|NCT00632853|Etoposide|etoposide|mesh-list
20299801|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299802|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20299803|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20299804|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20071786|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20071787|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071788|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071789|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071790|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20071791|NCT01602198|Rivastigmine|rivastigmine|mesh-list
20299805|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299806|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299807|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
20299808|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
20299809|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20299810|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20299811|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299812|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299813|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299814|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299815|NCT00633035|Esomeprazole|esomeprazole|mesh-list
20299816|NCT00633035|Famotidine|famotidine|mesh-list
20299817|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20299818|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299819|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20299820|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299821|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746320|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746321|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746322|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19746323|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746324|NCT03954782|Nintedanib|nintedanib|mesh-list
19746325|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071792|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20071793|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071794|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071795|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
20299822|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20299823|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
20299824|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
20299825|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299826|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299827|NCT00633269|Olaparib|olaparib|mesh-list
20299828|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20299829|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299830|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299831|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299832|NCT00633282|Pioglitazone|pioglitazone|mesh-list
20299833|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20299834|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20299835|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308663|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20308664|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20308665|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
20308666|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
20308667|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20308668|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308669|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20308670|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308671|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20308672|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308673|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308674|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308675|NCT00665496|Urological Agents|urological agents|mesh-ancestor
20308676|NCT00665522|Fentanyl|fentanyl|mesh-list
20308677|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20308678|NCT00665522|Narcotics|narcotics|mesh-ancestor
20308679|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20308680|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308681|NCT00665522|Analgesics|analgesics|mesh-ancestor
20308682|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
20308683|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308684|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20308685|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20308686|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
20308687|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
20308688|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20308689|NCT00665600|Albuterol|albuterol|mesh-list
20308690|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20308691|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
20308692|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308693|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308694|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20308695|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
20308696|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
20308697|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20308698|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20308699|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20308700|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20308701|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
20308702|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308703|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308704|NCT00665639|Caspofungin|caspofungin|mesh-list
20308705|NCT00665639|Micafungin|micafungin|mesh-list
20308706|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
20308707|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308708|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308709|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308710|NCT00665678|Paroxetine|paroxetine|mesh-list
20308711|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20308712|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20071796|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071797|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071798|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20071799|NCT01602198|Protective Agents|protective agents|mesh-ancestor
20071800|NCT01606150|Lidocaine|lidocaine|mesh-list
20071801|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
20071802|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
20071803|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071804|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071805|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
20071806|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071807|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20308713|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299836|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20299837|NCT00633347|Cetrorelix|cetrorelix|mesh-list
20299838|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20299839|NCT00633347|Hormones|hormones|mesh-ancestor
20299840|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20299841|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299842|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20299843|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
20299844|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20299845|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
20299846|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
20299847|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20299848|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
20299849|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20299850|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20299851|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299852|NCT00633373|Cyclosporine|cyclosporine|mesh-list
20299853|NCT00633373|Cyclosporins|cyclosporins|mesh-list
20299854|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299855|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299856|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299857|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
20299858|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299859|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
20299860|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299861|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
20299862|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299863|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20299864|NCT00633386|Celecoxib|celecoxib|mesh-list
20299865|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20299866|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20299867|NCT00633386|Analgesics|analgesics|mesh-ancestor
20299868|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
20299869|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299870|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299871|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20299872|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299873|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20299874|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20299875|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299876|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299877|NCT00633412|Esomeprazole|esomeprazole|mesh-list
20299878|NCT00633412|Ranitidine|ranitidine|mesh-list
20299879|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20299880|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20299881|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299882|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20299883|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299884|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299885|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20299886|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
20299887|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
20299888|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299889|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299890|NCT00633425|Glimepiride|glimepiride|mesh-list
20299891|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20299892|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20299893|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299894|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20299895|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
20299896|NCT00633438|Celecoxib|celecoxib|mesh-list
20299897|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20299898|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071808|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20071809|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20299899|NCT00633438|Analgesics|analgesics|mesh-ancestor
20299900|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
20071810|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071811|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071812|NCT01605370|Metoprolol|metoprolol|mesh-list
20071813|NCT01605370|Nebivolol|nebivolol|mesh-list
20071814|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20071815|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20299901|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577958|NCT02081391|Tapentadol|tapentadol|mesh-list
20299902|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299903|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20299904|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20299905|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20299906|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20299907|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299908|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299909|NCT00633490|Apatinib|apatinib|mesh-list
20299910|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299911|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20299912|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299913|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299914|NCT00633542|Interferons|interferons|mesh-list
20299915|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
20071816|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
20071817|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
20071818|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299916|NCT00633542|Thalidomide|thalidomide|mesh-list
20299917|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299918|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
20299919|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20299920|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
20299921|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299922|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071819|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071820|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20299923|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
20299924|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20299925|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20299926|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20299927|NCT00633542|Growth Substances|growth substances|mesh-ancestor
20299928|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
20299929|NCT00633568|Cisplatin|cisplatin|mesh-list
20299930|NCT00633568|Docetaxel|docetaxel|mesh-list
20299931|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20299932|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
20299933|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
20299934|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
20299935|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299936|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
20299937|NCT00633581|Vitamins|vitamins|mesh-ancestor
20299938|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
20299939|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299940|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
20299941|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299942|NCT00633581|Protective Agents|protective agents|mesh-ancestor
20299943|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20299944|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20299945|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
20299946|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
20071821|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20071822|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19491906|NCT03126578|Midazolam|midazolam|mesh-list
19491907|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19491908|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19491909|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491910|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491911|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19491912|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19491913|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20071823|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
20071824|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071825|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071826|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
20071827|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20071828|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20071829|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20071830|NCT01605617|Fesoterodine|fesoterodine|mesh-list
20071831|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20071832|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20071833|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
20071834|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299947|NCT00633672|Esomeprazole|esomeprazole|mesh-list
20299948|NCT00633672|Ranitidine|ranitidine|mesh-list
20299949|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20299950|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20071835|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071836|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071837|NCT01605617|Urological Agents|urological agents|mesh-ancestor
20071838|NCT01606709|Leuprolide|leuprolide|mesh-list
20071839|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20071840|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
20071841|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20071842|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071843|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20071844|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071845|NCT01603121|Lisofylline|lisofylline|mesh-list
20071846|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20071847|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
20071848|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071849|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20071850|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20071851|NCT01603121|Analgesics|analgesics|mesh-ancestor
20071852|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
20071853|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071854|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071855|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20071856|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20071857|NCT01602016|Leucovorin|leucovorin|mesh-list
20071858|NCT01602016|Folic Acid|folic acid|mesh-list
20071859|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
20071860|NCT01602016|Antidotes|antidotes|mesh-ancestor
20071861|NCT01602016|Protective Agents|protective agents|mesh-ancestor
20071862|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071863|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
20071864|NCT01602016|Vitamins|vitamins|mesh-ancestor
20071865|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
20299951|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20299952|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20299953|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299954|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299955|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20299956|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
20299957|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
20299958|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20071866|NCT01602016|Hematinics|hematinics|mesh-ancestor
20071867|NCT01603394|Pregabalin|pregabalin|mesh-list
20071868|NCT01603394|Analgesics|analgesics|mesh-ancestor
20071869|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
20071870|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071871|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071872|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
20071873|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20071874|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071875|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071876|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20299959|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299960|NCT00633685|Fluoxetine|fluoxetine|mesh-list
20299961|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20299962|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20299963|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20299964|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299965|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299966|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
20071877|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20299967|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299968|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20299969|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
20299970|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299971|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20299972|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20299973|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20299974|NCT00633698|Niacin|niacin|mesh-list
20299975|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
20299976|NCT00633698|Niacinamide|niacinamide|mesh-list
20299977|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20071878|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20071879|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20299978|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
20299979|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071880|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20299980|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20299981|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
20299982|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
20299983|NCT00633698|Vitamins|vitamins|mesh-ancestor
20299984|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
20299985|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299986|NCT00633763|Fallypride|fallypride|mesh-list
20299987|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20299988|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20299989|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
20299990|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20299991|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20299992|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299993|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
20299994|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20299995|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
20299996|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20299997|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20299998|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20299999|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
20300000|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20300001|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20300002|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20300003|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
20300004|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300005|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071881|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20071882|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071883|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20071884|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071885|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071886|NCT01598025|Fludarabine|fludarabine|mesh-list
20071887|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
20071888|NCT01598025|Melphalan|melphalan|mesh-list
20071889|NCT01598025|Thiotepa|thiotepa|mesh-list
20071890|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20071891|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071892|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20071893|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
20071894|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071895|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300006|NCT00633802|Risperidone|risperidone|mesh-list
20300007|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20300008|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
20300009|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300010|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300011|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300012|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20300013|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300014|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300015|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300016|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20300017|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
20300018|NCT00633958|Alovudine|alovudine|mesh-list
20300019|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
20300020|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300021|NCT00634062|Lamotrigine|lamotrigine|mesh-list
20300022|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
20300023|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20300024|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20300025|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300026|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20300027|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746326|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20071896|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
20071897|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071898|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20071899|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
20071900|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20071901|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
20071902|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
20071903|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300028|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20300029|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300030|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300031|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300032|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20300033|NCT00634140|Ezetimibe|ezetimibe|mesh-list
20300034|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20300035|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20300036|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
20300037|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300038|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20300039|NCT00634192|Tobramycin|tobramycin|mesh-list
20300040|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20300041|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300042|NCT00634205|Doxorubicin|doxorubicin|mesh-list
20300043|NCT00634205|Valproic Acid|valproic acid|mesh-list
20300044|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20300045|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300046|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20300047|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20300048|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300049|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300050|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
20300051|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
20300052|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300053|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577959|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20577960|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20577961|NCT02081391|Narcotics|narcotics|mesh-ancestor
20577962|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20577963|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20577964|NCT02081391|Analgesics|analgesics|mesh-ancestor
20577965|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
20577966|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20577967|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20577968|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20577969|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20577970|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577971|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
20577972|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20577973|NCT02081404|Esomeprazole|esomeprazole|mesh-list
20577974|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20577975|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20577976|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20577977|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071904|NCT01587963|Protective Agents|protective agents|mesh-ancestor
20071905|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071906|NCT01587963|Vitamins|vitamins|mesh-ancestor
20071907|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
20071908|NCT01591096|Plasminogen|plasminogen|mesh-list
20577978|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577979|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20577980|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19746327|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746328|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746329|NCT03922997|Atezolizumab|atezolizumab|mesh-list
19746330|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20071909|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20071910|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20577981|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577982|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20577983|NCT02081495|Doxorubicin|doxorubicin|mesh-list
20577984|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20577985|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20577986|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20577987|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20577988|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577989|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20577990|NCT02081560|Colistin|colistin|mesh-list
20577991|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20071911|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20071912|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071913|NCT01576575|Rifampin|rifampin|mesh-list
20071914|NCT01576575|Ketoconazole|ketoconazole|mesh-list
20071915|NCT01576575|Buprenorphine|buprenorphine|mesh-list
20071916|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20300054|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
20300055|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300056|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300057|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300058|NCT00634231|Valacyclovir|valacyclovir|mesh-list
20300059|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
20300060|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300061|NCT00634309|Candesartan|candesartan|mesh-list
20300062|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20300063|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20300064|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20300065|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300066|NCT00634348|Aripiprazole|aripiprazole|mesh-list
20300067|NCT00634348|Ziprasidone|ziprasidone|mesh-list
20300068|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
20300069|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300070|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20300071|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300072|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071917|NCT01576575|Narcotics|narcotics|mesh-ancestor
20071918|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071919|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300073|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300074|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
20300075|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
20300076|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300077|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300078|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20300079|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20300080|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
20300081|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20300082|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20071920|NCT01576575|Analgesics|analgesics|mesh-ancestor
20071921|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
20300083|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20300084|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20300085|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20300086|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20300087|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20300088|NCT00634400|Candesartan|candesartan|mesh-list
20300089|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20300090|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20300091|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20300092|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300093|NCT00634413|Budesonide|budesonide|mesh-list
20300094|NCT00634413|Theophylline|theophylline|mesh-list
20300095|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20300096|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20300097|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
19491914|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20071922|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300098|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300099|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300100|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20300101|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
20300102|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
20300103|NCT00634413|Hormones|hormones|mesh-ancestor
20300104|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300105|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20300106|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300107|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300108|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
20300109|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20300110|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20300111|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
20300112|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300113|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20071923|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20071924|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20071925|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
20071926|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20071927|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20071928|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
19491915|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
20300114|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20300115|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20300116|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20300117|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300118|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
20300119|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300120|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300121|NCT00634491|Acetazolamide|acetazolamide|mesh-list
20300122|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
20300123|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20300124|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300125|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300126|NCT00634491|Diuretics|diuretics|mesh-ancestor
20300127|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
20300128|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300129|NCT00634556|Levodopa|levodopa|mesh-list
20300130|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20300131|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20300132|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20300133|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
20300134|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300135|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300136|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300137|NCT00634595|Paclitaxel|paclitaxel|mesh-list
20300138|NCT00634595|Cisplatin|cisplatin|mesh-list
20300139|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20300140|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300141|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
20300142|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
20300143|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
20300144|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300145|NCT00634634|Sorafenib|sorafenib|mesh-list
20300146|NCT00634634|Letrozole|letrozole|mesh-list
20300147|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300148|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20300149|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300150|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300151|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20300152|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20300153|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20300154|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300155|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300156|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300157|NCT00634686|Vitamin D|vitamin d|mesh-list
20300158|NCT00634686|Calcium|calcium|mesh-list
20300159|NCT00634686|Vitamins|vitamins|mesh-ancestor
20300160|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
20300161|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300162|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20300163|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20300164|NCT00634712|Candesartan|candesartan|mesh-list
20300165|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20300166|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20300167|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20300168|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300169|NCT00634725|Gemcitabine|gemcitabine|mesh-list
20300170|NCT00634725|Capecitabine|capecitabine|mesh-list
20300171|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20300172|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20300173|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
20300174|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300175|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300176|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
20300177|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300178|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20577992|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20577993|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
20577994|NCT02081755|Everolimus|everolimus|mesh-list
20577995|NCT02081755|Azathioprine|azathioprine|mesh-list
20577996|NCT02081755|Tacrolimus|tacrolimus|mesh-list
20577997|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20577998|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
20577999|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578000|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20578001|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578002|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578003|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300179|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300180|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
20300181|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300182|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20300183|NCT00634790|Alprazolam|alprazolam|mesh-list
20300184|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20300185|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300186|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300187|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20300188|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300189|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300190|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
20300191|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
20300192|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300193|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300194|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
20300195|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20300196|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300197|NCT00634894|Letrozole|letrozole|mesh-list
20300198|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300199|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20300200|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20300201|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300202|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300203|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20300204|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300205|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300206|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300207|NCT00634959|Maraviroc|maraviroc|mesh-list
20300208|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20300209|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20300210|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300211|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20300212|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20071929|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20071930|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20071931|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071932|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20071933|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20071934|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20300213|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
20300214|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300215|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20300216|NCT00634985|Eletriptan|eletriptan|mesh-list
20300217|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20300218|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
20300219|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300220|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300221|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300222|NCT00634998|Ascorbic Acid|ascorbic acid|mesh-list
20300223|NCT00634998|Vitamins|vitamins|mesh-ancestor
20300224|NCT00634998|Micronutrients|micronutrients|mesh-ancestor
20300225|NCT00634998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300226|NCT00634998|Antioxidants|antioxidants|mesh-ancestor
20300227|NCT00634998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300228|NCT00634998|Protective Agents|protective agents|mesh-ancestor
20300229|NCT00635037|Bupivacaine|bupivacaine|mesh-list
20300230|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
20300231|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
20300232|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300233|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300234|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
20300235|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300236|NCT00635076|Alprazolam|alprazolam|mesh-list
20300237|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20300238|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300239|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300240|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20300241|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20071935|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20071936|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20071937|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20071938|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
20071939|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20071940|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20071941|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20071942|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
20071943|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300242|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300243|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
20578004|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20578005|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20578006|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
20578007|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578008|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578009|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
20578010|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20578011|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578012|NCT02081885|Chitosan|chitosan|mesh-list
20578013|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20578014|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20578015|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
20578016|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578017|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20578018|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
20578019|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
20578020|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
20578021|NCT02081885|Coagulants|coagulants|mesh-ancestor
20578022|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
20578023|NCT02082054|Atropine|atropine|mesh-list
20578024|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
20578025|NCT02082054|Ephedrine|ephedrine|mesh-list
20578026|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20578027|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20578028|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20578029|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
20578030|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578031|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578032|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20578033|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
20578034|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
20578035|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
20578036|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20578037|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20578038|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
20578039|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578040|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578041|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
20578042|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20578043|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20578044|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
20578045|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
20578046|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
20578047|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
20578048|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20578049|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
20578050|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
20578051|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19491916|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
19491917|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
20071944|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20578052|NCT02082067|Ketorolac|ketorolac|mesh-list
20578053|NCT02082067|Morphine|morphine|mesh-list
20578054|NCT02082067|Anesthetics|anesthetics|mesh-list
20578055|NCT02082067|Ropivacaine|ropivacaine|mesh-list
20578056|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
20578057|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
20578058|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20071945|NCT01583647|Niacin|niacin|mesh-list
20071946|NCT01583647|Niacinamide|niacinamide|mesh-list
20578059|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491918|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
19491919|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491920|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578060|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20578061|NCT02082067|Narcotics|narcotics|mesh-ancestor
20578062|NCT02082067|Analgesics|analgesics|mesh-ancestor
20578063|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
20300244|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
20300245|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300246|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300247|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20300248|NCT00635258|Ganirelix|ganirelix|mesh-list
20300249|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300250|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300251|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
20300252|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20300253|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
20300254|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20300255|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20300256|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20300257|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300258|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300259|NCT00635284|Sirolimus|sirolimus|mesh-list
20300260|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20300261|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300262|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20300263|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300264|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
20071947|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
20071948|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20071949|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
20071950|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071951|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20071952|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
20071953|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
20071954|NCT01583647|Vitamins|vitamins|mesh-ancestor
20071955|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
20071956|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071957|NCT01575028|Bupivacaine|bupivacaine|mesh-list
20071958|NCT01575028|Ropivacaine|ropivacaine|mesh-list
20071959|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
20071960|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
20071961|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300265|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300266|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
20300267|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300268|NCT00635310|Liver Extracts|liver extracts|mesh-list
20300269|NCT00635310|Hematinics|hematinics|mesh-ancestor
20300270|NCT00635323|Capecitabine|capecitabine|mesh-list
20300271|NCT00635323|Irinotecan|irinotecan|mesh-list
20300272|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20300273|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
20300274|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300275|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300276|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20300277|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20300278|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308714|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308715|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308716|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
20308717|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308718|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20308719|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
20308720|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20308721|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20308722|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20308723|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308724|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
20578064|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071962|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071963|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
20071964|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20071965|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
20071966|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
20071967|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20071968|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
20308725|NCT00665717|Pravastatin|pravastatin|mesh-list
20308726|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20308727|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20308728|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
20071969|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071970|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300279|NCT00635401|Varenicline|varenicline|mesh-list
20300280|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20300281|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20300282|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
20300283|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300284|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300285|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300286|NCT00635414|Esomeprazole|esomeprazole|mesh-list
20300287|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20300288|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20300289|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20300290|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300291|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300292|NCT00635531|Alprazolam|alprazolam|mesh-list
20300293|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20300294|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300295|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300296|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20300297|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300298|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300299|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
20300300|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
20300301|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300302|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300303|NCT00635557|Carboplatin|carboplatin|mesh-list
20300304|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300305|NCT00635713|Fulvestrant|fulvestrant|mesh-list
20300306|NCT00635713|Anastrozole|anastrozole|mesh-list
20300307|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20300308|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300309|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20300310|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20300311|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300312|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300313|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300314|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20300315|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20300316|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300317|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300318|NCT00635726|Gemcitabine|gemcitabine|mesh-list
20300319|NCT00635726|Cisplatin|cisplatin|mesh-list
20300320|NCT00635726|Doxorubicin|doxorubicin|mesh-list
20300321|NCT00635726|Methotrexate|methotrexate|mesh-list
20300322|NCT00635726|Vinblastine|vinblastine|mesh-list
20300323|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300324|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20300325|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
20300326|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300327|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
20300328|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300329|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300330|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300331|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
20300332|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300333|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20300334|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20300335|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20300336|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20300337|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
20300338|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20300339|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
20300340|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20300341|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300342|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20300343|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20300344|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
20300345|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
20300346|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
20300347|NCT00635791|Sorafenib|sorafenib|mesh-list
20300348|NCT00635791|Vorinostat|vorinostat|mesh-list
20300349|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300350|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20300351|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300352|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300353|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20071971|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300354|NCT00635856|Gefitinib|gefitinib|mesh-list
20300355|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300356|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20300357|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300358|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300359|NCT00635921|Ziprasidone|ziprasidone|mesh-list
20300360|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20300361|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
20300362|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300363|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300364|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300365|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20300366|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300367|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300368|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300369|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20300370|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
20300371|NCT00635960|Hormones|hormones|mesh-list
20300372|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20071972|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
20071973|NCT01570634|Loperamide|loperamide|mesh-list
20071974|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
20071975|NCT01570634|Calcium|calcium|mesh-list
20071976|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20071977|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071978|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20071979|NCT01566370|Zonisamide|zonisamide|mesh-list
20071980|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
20071981|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20071982|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20071983|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071984|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20071985|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300373|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300374|NCT00635973|Gefitinib|gefitinib|mesh-list
20300375|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300376|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20300377|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300378|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300379|NCT00635986|Fentanyl|fentanyl|mesh-list
20300380|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20300381|NCT00635986|Narcotics|narcotics|mesh-ancestor
20300382|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300383|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300384|NCT00635986|Analgesics|analgesics|mesh-ancestor
20300385|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
20300386|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300387|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20300388|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20300389|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
20300390|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
20300391|NCT00636038|Beta Carotene|beta carotene|mesh-list
20300392|NCT00636038|Carotenoids|carotenoids|mesh-list
20300393|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
20300394|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300395|NCT00636038|Protective Agents|protective agents|mesh-ancestor
20300396|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300397|NCT00636038|Provitamins|provitamins|mesh-ancestor
20300398|NCT00636038|Vitamins|vitamins|mesh-ancestor
20300399|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
20300400|NCT00636064|Parecoxib|parecoxib|mesh-list
20300401|NCT00636064|Valdecoxib|valdecoxib|mesh-list
20300402|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20300403|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20300404|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300405|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300406|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20300407|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20300408|NCT00636064|Analgesics|analgesics|mesh-ancestor
20300409|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
20300410|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300411|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300412|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20071986|NCT01561989|Vitamin D|vitamin d|mesh-list
20300413|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300414|NCT00636116|Antivenins|antivenins|mesh-list
20300415|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
20300416|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300417|NCT00636142|Infliximab|infliximab|mesh-list
20300418|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
20300419|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20300420|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300421|NCT00636246|Sertraline|sertraline|mesh-list
20300422|NCT00636246|Reboxetine|reboxetine|mesh-list
20300423|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
20300424|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300425|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20300426|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20300427|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20300428|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20071987|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
20071988|NCT01561989|Vaccines|vaccines|mesh-list
20071989|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
20071990|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20071991|NCT01561989|Vitamins|vitamins|mesh-ancestor
20071992|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
20071993|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20071994|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20071995|NCT01560507|Bupropion|bupropion|mesh-list
20071996|NCT01560507|Nicotine|nicotine|mesh-list
20071997|NCT01560507|Varenicline|varenicline|mesh-list
20071998|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20071999|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
20072000|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300429|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300430|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
20300431|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300432|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20300433|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
20300434|NCT00636259|Bicalutamide|bicalutamide|mesh-list
20300435|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
20300436|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300437|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300438|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300439|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300440|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20300441|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
20300442|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300443|NCT00636298|Bevacizumab|bevacizumab|mesh-list
20300444|NCT00636298|Cetuximab|cetuximab|mesh-list
20300445|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20300446|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300447|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20300448|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20300449|NCT00636298|Growth Substances|growth substances|mesh-ancestor
20300450|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300451|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
20300452|NCT00636311|Gemcitabine|gemcitabine|mesh-list
20300453|NCT00636311|Bortezomib|bortezomib|mesh-list
20300454|NCT00636311|Vinorelbine|vinorelbine|mesh-list
20300455|NCT00636311|Ifosfamide|ifosfamide|mesh-list
20300456|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20300457|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
20300458|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300459|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300460|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
20300461|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300462|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300463|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300464|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
20300465|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300466|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20300467|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
20300468|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
20300469|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20300470|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20300471|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
20072001|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072002|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20300472|NCT00636415|Morphine|morphine|mesh-list
20072003|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20072004|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
20300473|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20300474|NCT00636415|Narcotics|narcotics|mesh-ancestor
20300475|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300476|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300477|NCT00636415|Analgesics|analgesics|mesh-ancestor
20300478|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
20300479|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300480|NCT00636428|Midazolam|midazolam|mesh-list
20300481|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20300482|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20300483|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300484|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300485|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20300486|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300487|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300488|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20300489|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
20300490|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
20300491|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
20300492|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
20300493|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300494|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300495|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20300496|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20300497|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
20300498|NCT00636493|Hormones|hormones|mesh-ancestor
20300499|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300500|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300501|NCT00636519|Antitoxins|antitoxins|mesh-list
20072005|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072006|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072007|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20072008|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
20072009|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20072010|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20072011|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20072012|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072013|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
20072014|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20072015|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20072016|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300502|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
20300503|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
20300504|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300505|NCT00636545|Oblimersen|oblimersen|mesh-list
20300506|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300507|NCT00636584|Nitroprusside|nitroprusside|mesh-list
20300508|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20300509|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
20578065|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20578066|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578067|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578068|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578069|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20578070|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578071|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578072|NCT02082236|Sufentanil|sufentanil|mesh-list
20578073|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20578074|NCT02082236|Narcotics|narcotics|mesh-ancestor
20578075|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578076|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578077|NCT02082236|Analgesics|analgesics|mesh-ancestor
20578078|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
20578079|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578080|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20578081|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20578082|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
20578083|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
20578084|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
20578085|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
20578086|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578087|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578088|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578089|NCT02082405|Dexamethasone|dexamethasone|mesh-list
20072017|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
20300510|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20300511|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300512|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
20300513|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20300514|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300515|NCT00636766|Metformin|metformin|mesh-list
20300516|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
20300517|NCT00636766|Rimonabant|rimonabant|mesh-list
20300518|NCT00636766|Atorvastatin|atorvastatin|mesh-list
20300519|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20300520|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300521|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20300522|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20300523|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
20300524|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300525|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20300526|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20300527|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300528|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20300529|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20300530|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20300531|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300532|NCT00636766|Hormones|hormones|mesh-ancestor
20300533|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300534|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20300535|NCT00636831|Cefazolin|cefazolin|mesh-list
20300536|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300537|NCT00636870|Fexofenadine|fexofenadine|mesh-list
20300538|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20300539|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20300540|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20300541|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
20300542|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
20300543|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300544|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300545|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300546|NCT00636883|Gemcitabine|gemcitabine|mesh-list
20300547|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
20300548|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20300549|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
20300550|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300551|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300552|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
20300553|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300554|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300555|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300556|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
20300557|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300558|NCT00636896|Olanzapine|olanzapine|mesh-list
20300559|NCT00636896|Modafinil|modafinil|mesh-list
20300560|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
20300561|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
20300562|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300563|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300564|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20300565|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20300566|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20300567|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300568|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300569|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20300570|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20300571|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20300572|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300573|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300574|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
20300575|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20300576|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20300577|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20300578|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20300579|NCT00636909|Cyclosporine|cyclosporine|mesh-list
20300580|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
20300581|NCT00636909|Methotrexate|methotrexate|mesh-list
20300582|NCT00636909|Fludarabine|fludarabine|mesh-list
20300583|NCT00636909|Cyclosporins|cyclosporins|mesh-list
20300584|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300585|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
20300586|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300587|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300588|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20300589|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
20300590|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300591|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300592|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20300593|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20300594|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
20300595|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20300596|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20300597|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
20300598|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
20300599|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300600|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20300601|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20300602|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
20300603|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300604|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20300605|NCT00636922|Everolimus|everolimus|mesh-list
20300606|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300607|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300608|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
20300609|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300610|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20300611|NCT00636935|Clindamycin|clindamycin|mesh-list
20300612|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
20300613|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
20300614|NCT00636935|Dapsone|dapsone|mesh-list
20300615|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20300616|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20300617|NCT00636935|Primaquine|primaquine|mesh-list
20300618|NCT00636935|Trimethoprim|trimethoprim|mesh-list
20300619|NCT00636935|Atovaquone|atovaquone|mesh-list
20300620|NCT00636935|Pentamidine|pentamidine|mesh-list
20300621|NCT00636935|Prednisone|prednisone|mesh-list
20300622|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20300623|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
20300624|NCT00636935|Hormones|hormones|mesh-ancestor
20072018|NCT01555489|Vitamins|vitamins|mesh-ancestor
20072019|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
20072020|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072021|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
20072022|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072023|NCT01555489|Protective Agents|protective agents|mesh-ancestor
20119845|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119846|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20119847|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300625|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300626|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300627|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20300628|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300629|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300630|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
20300631|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20300632|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300633|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300634|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
20300635|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20300636|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20300637|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20300638|NCT00636935|Renal Agents|renal agents|mesh-ancestor
20300639|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20300640|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20300641|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20300642|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20300643|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
20300644|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
20300645|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20300646|NCT00636974|Anesthetics|anesthetics|mesh-list
20300647|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20300648|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300649|NCT00637026|Gefitinib|gefitinib|mesh-list
20300650|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119848|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
20300651|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20300652|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300653|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300654|NCT00637065|Bosentan|bosentan|mesh-list
20300655|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20300656|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20300657|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300658|NCT00637078|Amlodipine|amlodipine|mesh-list
20300659|NCT00637078|Spironolactone|spironolactone|mesh-list
20300660|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20072024|NCT01549977|Febuxostat|febuxostat|mesh-list
20072025|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
20072026|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072027|NCT01558492|Paclitaxel|paclitaxel|mesh-list
20072028|NCT01558492|Carboplatin|carboplatin|mesh-list
20072029|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20072030|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072031|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
20072032|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
20072033|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
20072034|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072035|NCT01555073|Celecoxib|celecoxib|mesh-list
20300661|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20300662|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20300663|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300664|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20300665|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300666|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
20300667|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20300668|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300669|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072036|NCT01555073|Pregabalin|pregabalin|mesh-list
20072037|NCT01555073|Analgesics|analgesics|mesh-ancestor
20072038|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
20072039|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072040|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072041|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
20072042|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20072043|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072044|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072045|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20072046|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20072047|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20072048|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072049|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20300670|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20300671|NCT00637078|Diuretics|diuretics|mesh-ancestor
20300672|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
20300673|NCT00637091|Irinotecan|irinotecan|mesh-list
20300674|NCT00637091|Cetuximab|cetuximab|mesh-list
20300675|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20300676|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20300677|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300678|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300679|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300680|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20300681|NCT00637104|Chromium|chromium|mesh-list
20300682|NCT00637104|Trace Elements|trace elements|mesh-ancestor
20300683|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
20300684|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300685|NCT00637117|Interferons|interferons|mesh-list
20300686|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
20300687|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300688|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
20300689|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300690|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
20300691|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300692|NCT00637143|Cyclosporine|cyclosporine|mesh-list
20300693|NCT00637143|Tacrolimus|tacrolimus|mesh-list
20300694|NCT00637143|Cyclosporins|cyclosporins|mesh-list
20300695|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300696|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
20072050|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20072051|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20300697|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300698|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20300699|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300700|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300701|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
20300702|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300703|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
20300704|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300705|NCT00637182|Anastrozole|anastrozole|mesh-list
20300706|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20300707|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300708|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20300709|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20300710|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300711|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300712|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20300713|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300714|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300715|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300716|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
20300717|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
20072052|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20072053|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072054|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20072055|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20072056|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072057|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20072058|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20072059|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20072060|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
20072061|NCT01550510|Irinotecan|irinotecan|mesh-list
20072062|NCT01550510|Camptothecin|camptothecin|mesh-list
20072063|NCT01550510|Vitamins|vitamins|mesh-ancestor
20072064|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
20072065|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072066|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20072067|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20072068|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072069|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072070|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300718|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20300719|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20300720|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20300721|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300722|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20300723|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20300724|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
20300725|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20300726|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20300727|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
20300728|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300729|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300730|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300731|NCT00637325|Trastuzumab|trastuzumab|mesh-list
20300732|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20300733|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308729|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308730|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20308731|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20308732|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308733|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308734|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20308735|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20308736|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
20308737|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20308738|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20308739|NCT00665743|Naproxen|naproxen|mesh-list
20308740|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308741|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308742|NCT00665743|Analgesics|analgesics|mesh-ancestor
20308743|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
20308744|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308745|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072071|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
20578090|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
20578091|NCT02082405|Bortezomib|bortezomib|mesh-list
20578092|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20578093|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
20578094|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578095|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578096|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20578097|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
20578098|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578099|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578100|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20578101|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578102|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
20578103|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
20578104|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578105|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578106|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
20578107|NCT02082405|Hormones|hormones|mesh-ancestor
20578108|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578109|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20578110|NCT02082418|Caseins|caseins|mesh-list
20578111|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
20578112|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
20578113|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578114|NCT02082496|Liraglutide|liraglutide|mesh-list
20578115|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19746331|NCT03899428|Sorafenib|sorafenib|mesh-list
19746332|NCT03899428|Durvalumab|durvalumab|mesh-list
19746333|NCT03899428|Lenvatinib|lenvatinib|mesh-list
20578116|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578117|NCT02082496|Incretins|incretins|mesh-ancestor
20578118|NCT02082496|Hormones|hormones|mesh-ancestor
20578119|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578120|NCT02082613|Polidocanol|polidocanol|mesh-list
20578121|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20578122|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20578123|NCT02082652|Etonogestrel|etonogestrel|mesh-list
20578124|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20578125|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
20578126|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20578127|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578128|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20578129|NCT02082665|Dabrafenib|dabrafenib|mesh-list
20578130|NCT02082665|Midazolam|midazolam|mesh-list
20578131|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20578132|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20578133|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20578134|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578135|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578136|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20578137|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20578138|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20578139|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20578140|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
20578141|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
20578142|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
20578143|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
20578144|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578145|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578146|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20578147|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20578148|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
20578149|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20578150|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20578151|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578152|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578153|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20072072|NCT01550510|Protective Agents|protective agents|mesh-ancestor
20072073|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20072074|NCT01547728|Antithrombins|antithrombins|mesh-list
20072075|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
20072076|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20072077|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
20072078|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578154|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
19746334|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578155|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
20300734|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
20300735|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20300736|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300737|NCT00637403|Megestrol|megestrol|mesh-list
20300738|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
20300739|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20300740|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20300741|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20300742|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
20300743|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20300744|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300745|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20300746|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20300747|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20300748|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300749|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
20300750|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20300751|NCT00637442|Galantamine|galantamine|mesh-list
20300752|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20300753|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300754|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300755|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
20300756|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300757|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300758|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20300759|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
20300760|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300761|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
20300762|NCT00637455|Fexofenadine|fexofenadine|mesh-list
20300763|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20300764|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20300765|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20300766|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
20300767|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
20300768|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300769|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300770|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300771|NCT00637468|Aspirin|aspirin|mesh-list
20300772|NCT00637468|Heparin|heparin|mesh-list
20300773|NCT00637468|Acetazolamide|acetazolamide|mesh-list
20300774|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20300775|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
20300776|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20300777|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20300778|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300779|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20300780|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20300781|NCT00637468|Analgesics|analgesics|mesh-ancestor
20300782|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
20300783|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300784|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300785|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20300786|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300787|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20300788|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20300789|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300790|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
20300791|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
20300792|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20300793|NCT00637468|Diuretics|diuretics|mesh-ancestor
20300794|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
20300795|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20072079|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072080|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
20072081|NCT01548651|Saxagliptin|saxagliptin|mesh-list
20072082|NCT01548651|Incretins|incretins|mesh-ancestor
20072083|NCT01548651|Hormones|hormones|mesh-ancestor
20072084|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072085|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072086|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20072087|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
20072088|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300796|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
20300797|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300798|NCT00637481|Atorvastatin|atorvastatin|mesh-list
20300799|NCT00637481|Calcium|calcium|mesh-list
20300800|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20300801|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300802|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20300803|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20300804|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
20300805|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300806|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20300807|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20300808|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300809|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
20300810|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20300811|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20300812|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20300813|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20300814|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300815|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
20300816|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300817|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300818|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20300819|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300820|NCT00637559|Esomeprazole|esomeprazole|mesh-list
20300821|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20300822|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20300823|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20300824|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300825|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300826|NCT00637585|Fexofenadine|fexofenadine|mesh-list
20300827|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20300828|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20300829|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20300830|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
20300831|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
20300832|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300833|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300834|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300835|NCT00637611|Fexofenadine|fexofenadine|mesh-list
20300836|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20300837|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20300838|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20300839|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
20300840|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
20300841|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300842|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300843|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300844|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
20072089|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072090|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20072091|NCT01545648|Denosumab|denosumab|mesh-list
20072092|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20072093|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072094|NCT01546883|Dabigatran|dabigatran|mesh-list
20072095|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
20072096|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20072097|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
20072098|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300845|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20072099|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072100|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
20300846|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
20300847|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300848|NCT00637624|Expectorants|expectorants|mesh-ancestor
20300849|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
20300850|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20300851|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
20300852|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072101|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20072102|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
20072103|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072104|NCT01536015|Rotigotine|rotigotine|mesh-list
20578156|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20578157|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578158|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578159|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578160|NCT02083055|Analgesics|analgesics|mesh-ancestor
20578161|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
20578162|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578163|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20578164|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20578165|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20578166|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20578167|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578168|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578169|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
20578170|NCT02083068|Vaccines|vaccines|mesh-list
20578171|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
20578172|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605674|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20605675|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20605676|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605677|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605678|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20605679|NCT02233452|Narcotics|narcotics|mesh-ancestor
20605680|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
20605681|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605682|NCT02233504|Deferasirox|deferasirox|mesh-list
20605683|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20605684|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
20605685|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
20605686|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605687|NCT02233556|Memantine|memantine|mesh-list
20605688|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20605689|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20605690|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
20605691|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605692|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605693|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605694|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20605695|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20072105|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
20072106|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
20072107|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072108|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072109|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072110|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20072111|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20072112|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072113|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
20072114|NCT01533753|Gabapentin|gabapentin|mesh-list
20072115|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20072116|NCT01533753|Analgesics|analgesics|mesh-ancestor
20072117|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
20072118|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072119|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072120|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
20072121|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20072122|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20072123|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072124|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20072125|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20072126|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20072127|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072128|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072129|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
20072130|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20072131|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20072132|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072133|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20072134|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
20072135|NCT01534143|Sirolimus|sirolimus|mesh-list
20072136|NCT01534143|Fludarabine|fludarabine|mesh-list
20072137|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
20300853|NCT00637624|Protective Agents|protective agents|mesh-ancestor
20300854|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300855|NCT00637624|Antidotes|antidotes|mesh-ancestor
20300856|NCT00637637|Ritonavir|ritonavir|mesh-list
20300857|NCT00637637|Indinavir|indinavir|mesh-list
20300858|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20300859|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20300860|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
20300861|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300862|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300863|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20300864|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20300865|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
20300866|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300867|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20300868|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20072138|NCT01534143|Bortezomib|bortezomib|mesh-list
20072139|NCT01534143|Busulfan|busulfan|mesh-list
20072140|NCT01534143|Tacrolimus|tacrolimus|mesh-list
20072141|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
20072142|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20300869|NCT00637663|Lamivudine|lamivudine|mesh-list
20300870|NCT00637663|Entecavir|entecavir|mesh-list
20300871|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20300872|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20300873|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300874|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300875|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
20300876|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300877|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20300878|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20300879|NCT00637715|Alfuzosin|alfuzosin|mesh-list
20300880|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20300881|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20300882|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20300883|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
20300884|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300885|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300886|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300887|NCT00637715|Urological Agents|urological agents|mesh-ancestor
20300888|NCT00637767|Melphalan|melphalan|mesh-list
20300889|NCT00637767|Antibodies|antibodies|mesh-list
20300890|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20300891|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
20300892|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300893|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20300894|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
20300895|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300896|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300897|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20300898|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300899|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
20300900|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20300901|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20300902|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
20300903|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300904|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300905|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300906|NCT00637819|Leflunomide|leflunomide|mesh-list
20300907|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300908|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300909|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20300910|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
20300911|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300912|NCT00637845|Esomeprazole|esomeprazole|mesh-list
20300913|NCT00637845|Lansoprazole|lansoprazole|mesh-list
20300914|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
20300915|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20072143|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
20072144|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072145|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072146|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
20300916|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578173|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
20072147|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300917|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20300918|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300919|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300920|NCT00637858|Lycopene|lycopene|mesh-list
20300921|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20300922|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
20300923|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300924|NCT00637858|Protective Agents|protective agents|mesh-ancestor
20300925|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300926|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20300927|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20300928|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300929|NCT00637871|Tamoxifen|tamoxifen|mesh-list
20300930|NCT00637871|Bicalutamide|bicalutamide|mesh-list
20300931|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20300932|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
20300933|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20300934|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300935|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20300936|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300937|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20300938|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20300939|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20300940|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
20300941|NCT00637884|Fexofenadine|fexofenadine|mesh-list
20300942|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20300943|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20300944|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20300945|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
20300946|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
20300947|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20300948|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300949|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300950|NCT00637897|Paclitaxel|paclitaxel|mesh-list
20300951|NCT00637897|Docetaxel|docetaxel|mesh-list
20300952|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20300953|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20300954|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300955|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
20300956|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
20072148|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072149|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
20072150|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072151|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20072152|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072153|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072154|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072155|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20072156|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
20300957|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
20300958|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300959|NCT00637910|Docetaxel|docetaxel|mesh-list
20300960|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20300961|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300962|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
20300963|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
20300964|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
20300965|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072157|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
20072158|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20072159|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20072160|NCT01530880|Acetaminophen|acetaminophen|mesh-list
20072161|NCT01530880|Ibuprofen|ibuprofen|mesh-list
20300966|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20300967|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300968|NCT00637949|Rofecoxib|rofecoxib|mesh-list
20300969|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
20300970|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20300971|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20072162|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20300972|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20300973|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20300974|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20072163|NCT01530880|Analgesics|analgesics|mesh-ancestor
20300975|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20300976|NCT00637949|Analgesics|analgesics|mesh-ancestor
20300977|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
20300978|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300979|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300980|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20300981|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20300982|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
20300983|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20300984|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
20300985|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300986|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20072164|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
20072165|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072166|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072167|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
20072168|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20300987|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20300988|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
20300989|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20300990|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
20300991|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20300992|NCT00637962|Protective Agents|protective agents|mesh-ancestor
20300993|NCT00637975|Pregabalin|pregabalin|mesh-list
20300994|NCT00637975|Oxycodone|oxycodone|mesh-list
20300995|NCT00637975|Analgesics|analgesics|mesh-ancestor
20300996|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
20300997|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20300998|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20300999|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
20072169|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20072170|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072171|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20072172|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301000|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20301001|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301002|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301003|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20301004|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20301005|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20301006|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20301007|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20301008|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20301009|NCT00637975|Narcotics|narcotics|mesh-ancestor
20301010|NCT00637988|Aspirin|aspirin|mesh-list
20301011|NCT00637988|Rofecoxib|rofecoxib|mesh-list
20301012|NCT00637988|Esomeprazole|esomeprazole|mesh-list
20301013|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301014|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301015|NCT00637988|Analgesics|analgesics|mesh-ancestor
20301016|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
20301017|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301018|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072173|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072174|NCT01527942|Acetaminophen|acetaminophen|mesh-list
20072175|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20072176|NCT01527942|Analgesics|analgesics|mesh-ancestor
20072177|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
20072178|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072179|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072180|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
20072181|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
20072182|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
20072183|NCT01532635|Tacrolimus|tacrolimus|mesh-list
20072184|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072185|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
20072186|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301019|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301020|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301021|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20301022|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20301023|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072187|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301024|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20072188|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20578174|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20578175|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578176|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
20578177|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20578178|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578179|NCT02083276|Renal Agents|renal agents|mesh-ancestor
20578180|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072189|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
20072190|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072191|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072192|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20072193|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20072194|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072195|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20072196|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20072197|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
20072198|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072199|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072200|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
20072201|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072202|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
20072203|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072204|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072205|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20072206|NCT01526408|Famciclovir|famciclovir|mesh-list
20072207|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
20072208|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072209|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20072210|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072211|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072212|NCT01525927|Cisplatin|cisplatin|mesh-list
20072213|NCT01525927|Carboplatin|carboplatin|mesh-list
20072214|NCT01525927|Etoposide|etoposide|mesh-list
20072215|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072216|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20072217|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20072218|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20072219|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072220|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072221|NCT01507233|Morphine|morphine|mesh-list
20072222|NCT01507233|Bupivacaine|bupivacaine|mesh-list
20072223|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
20072224|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
20072225|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072226|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072227|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
20072228|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072229|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20072230|NCT01507233|Narcotics|narcotics|mesh-ancestor
20072231|NCT01507233|Analgesics|analgesics|mesh-ancestor
20072232|NCT01500772|Ribavirin|ribavirin|mesh-list
20072233|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20072234|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
20072235|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072236|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
20072237|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072238|NCT01517763|Immunoconjugates|immunoconjugates|mesh-list
20072239|NCT01517763|Immunologic Factors|immunologic factors|mesh-ancestor
20072240|NCT01517763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072241|NCT01507584|Bimatoprost|bimatoprost|mesh-list
20072242|NCT01507584|Brinzolamide|brinzolamide|mesh-list
20072243|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20072244|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20072245|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072246|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072247|NCT01510756|Sorafenib|sorafenib|mesh-list
20072248|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072249|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20072250|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072251|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072252|NCT01500109|Acetaminophen|acetaminophen|mesh-list
20301025|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20578181|NCT02083315|Morphine|morphine|mesh-list
20072253|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301026|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301027|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
20301028|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20301029|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20301030|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20301031|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20301032|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
20301033|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20301034|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20301035|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20301036|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301037|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301038|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
20301039|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301040|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301041|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20301042|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301043|NCT00638079|Megestrol|megestrol|mesh-list
20301044|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
20301045|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20301046|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20301047|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20301048|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
20301049|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20301050|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301051|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20301052|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20301053|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20301054|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301055|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
20301056|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20301057|NCT00638118|Fexofenadine|fexofenadine|mesh-list
20301058|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20301059|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20301060|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20301061|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
20301062|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
20301063|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301064|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301065|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301066|NCT00638131|Bosentan|bosentan|mesh-list
20301067|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20301068|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20301069|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301070|NCT00638209|Insulin|insulin|mesh-list
20301071|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20301072|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20301073|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301074|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
20301075|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20301076|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20301077|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301078|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
20301079|NCT00638300|Calcium|calcium|mesh-list
20301080|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20301081|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301082|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20301083|NCT00638326|Clopidogrel|clopidogrel|mesh-list
20301084|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20301085|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20301086|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20301087|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20301088|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
20301089|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301090|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301091|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301092|NCT00638391|Anastrozole|anastrozole|mesh-list
20301093|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20301094|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301095|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20301096|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20578182|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20301097|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301098|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301099|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20301100|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
20301101|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301102|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301103|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20301104|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20301105|NCT00638482|Diuretics|diuretics|mesh-ancestor
20301106|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
20301107|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301108|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20301109|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301110|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301111|NCT00638534|Telithromycin|telithromycin|mesh-list
20301112|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20301113|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301114|NCT00638560|Vitamins|vitamins|mesh-list
20301115|NCT00638560|Ascorbic Acid|ascorbic acid|mesh-list
20301116|NCT00638560|Vitamin E|vitamin e|mesh-list
20301117|NCT00638560|Antioxidants|antioxidants|mesh-list
20301118|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
20301119|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301120|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301121|NCT00638560|Protective Agents|protective agents|mesh-ancestor
20301122|NCT00638612|Valacyclovir|valacyclovir|mesh-list
20301123|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
20301124|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301125|NCT00638638|Abciximab|abciximab|mesh-list
20301126|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
20301127|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20301128|NCT00638677|Sorbitol|sorbitol|mesh-list
20301129|NCT00638677|Cathartics|cathartics|mesh-ancestor
20301130|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20301131|NCT00638729|Clonidine|clonidine|mesh-list
20301132|NCT00638729|Midazolam|midazolam|mesh-list
20301133|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20301134|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20301135|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20301136|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301137|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20301138|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20301139|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20301140|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20301141|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
20301142|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
20301143|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
20301144|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
20301145|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301146|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301147|NCT00638729|Analgesics|analgesics|mesh-ancestor
20301148|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
20301149|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301150|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20301151|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
20301152|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
20301153|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20301154|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20301155|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20301156|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
20301157|NCT00638742|Latanoprost|latanoprost|mesh-list
20301158|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20301159|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20301160|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
20301161|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20301162|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20301163|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301164|NCT00638807|Celecoxib|celecoxib|mesh-list
20301165|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301166|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301167|NCT00638807|Analgesics|analgesics|mesh-ancestor
20301168|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
20301169|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301170|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746335|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19746336|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746337|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746338|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746339|NCT03885713|Adalimumab|adalimumab|mesh-list
19746340|NCT03885713|Golimumab|golimumab|mesh-list
19746341|NCT03885713|Infliximab|infliximab|mesh-list
19746342|NCT03885713|Ustekinumab|ustekinumab|mesh-list
19746343|NCT03885713|Vedolizumab|vedolizumab|mesh-list
19746344|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746345|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746346|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746347|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19746348|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19746349|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746350|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
19746351|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746352|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
19746353|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746354|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301171|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301172|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301173|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20301174|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20301175|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301176|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301177|NCT00638833|Memantine|memantine|mesh-list
20301178|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20301179|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20301180|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
20301181|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301182|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301183|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301184|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20301185|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20301186|NCT00638859|Telithromycin|telithromycin|mesh-list
20301187|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20301188|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301189|NCT00638976|Eptifibatide|eptifibatide|mesh-list
20301190|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20301191|NCT00639015|Phenylephrine|phenylephrine|mesh-list
20301192|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
20301193|NCT00639015|Norepinephrine|norepinephrine|mesh-list
20301194|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20301195|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
20301196|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
20301197|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301198|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301199|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
20301200|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20301201|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
20301202|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301203|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20301204|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20301205|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20301206|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
20301207|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301208|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301209|NCT00639015|Protective Agents|protective agents|mesh-ancestor
20301210|NCT00639119|Ropinirole|ropinirole|mesh-list
20301211|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20301212|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20301213|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
19746355|NCT03862716|Insulin|insulin|mesh-list
19746356|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19746357|NCT03862716|Metformin|metformin|mesh-list
20072254|NCT01500109|Analgesics|analgesics|mesh-ancestor
20072255|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
20072256|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072257|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072258|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
20072259|NCT01509053|Aripiprazole|aripiprazole|mesh-list
20072260|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
20072261|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20072262|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20072263|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20301214|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
20301215|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301216|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301217|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308746|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308747|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308748|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
20308749|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308750|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308751|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308752|NCT00665756|Mitomycins|mitomycins|mesh-list
20308753|NCT00665756|Mitomycin|mitomycin|mesh-list
20308754|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20308755|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308756|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
20308757|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308758|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20308759|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308760|NCT00665808|Insulin|insulin|mesh-list
20308761|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20308762|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
20308763|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
20308764|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
20308765|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
20308766|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20308767|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308768|NCT00665834|Atorvastatin|atorvastatin|mesh-list
20308769|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20072264|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072265|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072266|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
20072267|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
20072268|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072269|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308770|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20308771|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20308772|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
20308773|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308774|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20308775|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20308776|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308777|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20072270|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20072271|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20578183|NCT02083315|Narcotics|narcotics|mesh-ancestor
20578184|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072272|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
20072273|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20072274|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20072275|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20072276|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20072277|NCT01495988|Bevacizumab|bevacizumab|mesh-list
20072278|NCT01495988|Vemurafenib|vemurafenib|mesh-list
20072279|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20072280|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578185|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578186|NCT02083315|Analgesics|analgesics|mesh-ancestor
20072281|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072282|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072283|NCT01495988|Growth Substances|growth substances|mesh-ancestor
20578187|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
20578188|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578189|NCT02083328|Mannitol|mannitol|mesh-list
20578190|NCT02083328|Caffeine|caffeine|mesh-list
20578191|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20578192|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578193|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20578194|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578195|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578196|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20578197|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20578198|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
20578199|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578200|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20578201|NCT02083328|Diuretics|diuretics|mesh-ancestor
20578202|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
20578203|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
20301218|NCT00639249|SA 4503|sa 4503|mesh-list
20301219|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
20301220|NCT00639262|Temozolomide|temozolomide|mesh-list
20301221|NCT00639262|Sorafenib|sorafenib|mesh-list
20072284|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072285|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
20072286|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20072287|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072288|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072289|NCT01483872|Tigecycline|tigecycline|mesh-list
20072290|NCT01483872|Heparin|heparin|mesh-list
20072291|NCT01483872|Calcium heparin|calcium heparin|mesh-list
20072292|NCT01483872|Anticoagulants|anticoagulants|mesh-list
20072293|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072294|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20072295|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20072296|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072297|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301222|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20301223|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
20301224|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301225|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301226|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20301227|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301228|NCT00639327|Irinotecan|irinotecan|mesh-list
20301229|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20301230|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20301231|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301232|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301233|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301234|NCT00639366|Trastuzumab|trastuzumab|mesh-list
20301235|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20301236|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301237|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
20301238|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20301239|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301240|NCT00639483|Celecoxib|celecoxib|mesh-list
20301241|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301242|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301243|NCT00639483|Analgesics|analgesics|mesh-ancestor
20301244|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
20301245|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301246|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301247|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301248|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301249|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20301250|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20301251|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301252|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301253|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
20301254|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20301255|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
20301256|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301257|NCT00639496|Expectorants|expectorants|mesh-ancestor
20301258|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301259|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20301260|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
20301261|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301262|NCT00639496|Protective Agents|protective agents|mesh-ancestor
20301263|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301264|NCT00639496|Antidotes|antidotes|mesh-ancestor
20301265|NCT00639522|Paclitaxel|paclitaxel|mesh-list
20301266|NCT00639522|Capecitabine|capecitabine|mesh-list
20301267|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20301268|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301269|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
20301270|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
20301271|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
20301272|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301273|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20301274|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
20301275|NCT00639574|Nefopam|nefopam|mesh-list
20072298|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20072299|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301276|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301277|NCT00639574|Analgesics|analgesics|mesh-ancestor
20301278|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
20301279|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301280|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301281|NCT00639587|Cetirizine|cetirizine|mesh-list
20301282|NCT00639587|Ketotifen|ketotifen|mesh-list
20301283|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20301284|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20301285|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20301286|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
20301287|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
20301288|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301289|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072300|NCT01487499|Cisplatin|cisplatin|mesh-list
20072301|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072302|NCT01478113|Amphetamine|amphetamine|mesh-list
20072303|NCT01478113|Adderall|adderall|mesh-list
20072304|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
20301290|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301291|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
20301292|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
20301293|NCT00639691|Omalizumab|omalizumab|mesh-list
20301294|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20301295|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20578204|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20578205|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578206|NCT02083510|Colchicine|colchicine|mesh-list
20578207|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
20578208|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578209|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
20578210|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
20578211|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
20578212|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578213|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072305|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20072306|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072307|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
20072308|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
20072309|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072310|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
20072311|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578214|NCT02083536|Docetaxel|docetaxel|mesh-list
20578215|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578216|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
20578217|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
20578218|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
20578219|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578220|NCT02083575|Vitamins|vitamins|mesh-list
20578221|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
20578222|NCT02083575|Deferiprone|deferiprone|mesh-list
20578223|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
20578224|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578225|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
20578226|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578227|NCT02083575|Protective Agents|protective agents|mesh-ancestor
20578228|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20578229|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
20578230|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
20578231|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
20578232|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20301296|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
20578233|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20578234|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20578235|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
20578236|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578237|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20578238|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20578239|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578240|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578241|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578242|NCT02083640|Palbociclib|palbociclib|mesh-list
20578243|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578244|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20578245|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301297|NCT00639743|Tenecteplase|tenecteplase|mesh-list
20072312|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578246|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578247|NCT02083692|Metformin|metformin|mesh-list
20301298|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20301299|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20301300|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301301|NCT00639756|Allopurinol|allopurinol|mesh-list
20301302|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
20301303|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301304|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301305|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
20301306|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301307|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20301308|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
20072313|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
20072314|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20072315|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20072316|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072317|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20072318|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
20072319|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20072320|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20072321|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20072322|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072323|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301309|NCT00639756|Protective Agents|protective agents|mesh-ancestor
20301310|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301311|NCT00639873|Doxycycline|doxycycline|mesh-list
20301312|NCT00639873|Artesunate|artesunate|mesh-list
20301313|NCT00639873|Quinine|quinine|mesh-list
20301314|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072324|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
20072325|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072326|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301315|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301316|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
20301317|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20301318|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20301319|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301320|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
20301321|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
20301322|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20301323|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
20301324|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20301325|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301326|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20301327|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301328|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301329|NCT00639873|Analgesics|analgesics|mesh-ancestor
20301330|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
20301331|NCT00639925|Gemcitabine|gemcitabine|mesh-list
20301332|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20301333|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
20301334|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301335|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301336|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
20301337|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301338|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301339|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20301340|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
20301341|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301342|NCT00639938|Nevirapine|nevirapine|mesh-list
20301343|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
20301344|NCT00639938|Antibodies|antibodies|mesh-list
20301345|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
20301346|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20301347|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20301348|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
20301349|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301350|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20301351|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20301352|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301353|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301354|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
20301355|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301356|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20301357|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20301358|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20308778|NCT00665873|Amoxicillin|amoxicillin|mesh-list
20301359|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20301360|NCT00640003|Baclofen|baclofen|mesh-list
20301361|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20301362|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301363|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20301364|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301365|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20301366|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
20301367|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
20301368|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301369|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301370|NCT00640029|Meloxicam|meloxicam|mesh-list
20072327|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20072328|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072329|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20072330|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072331|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
20072332|NCT01473732|Everolimus|everolimus|mesh-list
20072333|NCT01473732|Tacrolimus|tacrolimus|mesh-list
20072334|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072335|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
20072336|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072337|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20072338|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072339|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301371|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301372|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301373|NCT00640029|Analgesics|analgesics|mesh-ancestor
20301374|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
20301375|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301376|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301377|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301378|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301379|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20301380|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20301381|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072340|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072341|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20072342|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20072343|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
20072344|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072345|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072346|NCT01472692|Febuxostat|febuxostat|mesh-list
20072347|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
20072348|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072349|NCT01465230|Lenalidomide|lenalidomide|mesh-list
20301382|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301383|NCT00640081|Leucovorin|leucovorin|mesh-list
20301384|NCT00640081|Fluorouracil|fluorouracil|mesh-list
20301385|NCT00640081|Capecitabine|capecitabine|mesh-list
20301386|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
20301387|NCT00640081|Cetuximab|cetuximab|mesh-list
20301388|NCT00640081|Calcium|calcium|mesh-list
20301389|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
20301390|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20301391|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301392|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
20301393|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301394|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20301395|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301396|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20301397|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
20072350|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
20301398|NCT00640081|Antidotes|antidotes|mesh-ancestor
20301399|NCT00640081|Protective Agents|protective agents|mesh-ancestor
20301400|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
20301401|NCT00640081|Vitamins|vitamins|mesh-ancestor
20301402|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
20301403|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20301404|NCT00640094|Melatonin|melatonin|mesh-list
20301405|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
20301406|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301407|NCT00640094|Protective Agents|protective agents|mesh-ancestor
20301408|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301409|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072351|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072352|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072353|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072354|NCT01465230|Growth Substances|growth substances|mesh-ancestor
20072355|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
20072356|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072357|NCT01464723|Ranibizumab|ranibizumab|mesh-list
20301410|NCT00640159|Selegiline|selegiline|mesh-list
20301411|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
20301412|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20301413|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20301414|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20301415|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20301416|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301417|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301418|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20072358|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072359|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072360|NCT01464723|Growth Substances|growth substances|mesh-ancestor
20301419|NCT00640159|Protective Agents|protective agents|mesh-ancestor
20301420|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301421|NCT00640198|Memantine|memantine|mesh-list
20301422|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20301423|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20301424|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
20301425|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301426|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301427|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301428|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20072361|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072362|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
20072363|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072364|NCT01446250|Ribavirin|ribavirin|mesh-list
20072365|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20072366|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
20072367|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301429|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20301430|NCT00640237|Calcifediol|calcifediol|mesh-list
20301431|NCT00640237|Vitamins|vitamins|mesh-ancestor
20301432|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
20301433|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301434|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20301435|NCT00640263|Ritonavir|ritonavir|mesh-list
20301436|NCT00640263|Lopinavir|lopinavir|mesh-list
20301437|NCT00640263|Lamivudine|lamivudine|mesh-list
20301438|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20072368|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
20072369|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301439|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20301440|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
20301441|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301442|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301443|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20301444|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20301445|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
20301446|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301447|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20301448|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20301449|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20301450|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20301451|NCT00640276|Pitavastatin|pitavastatin|mesh-list
20301452|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20301453|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20301454|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20301455|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
20301456|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301457|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301458|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20301459|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20301460|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20301461|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20301462|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301463|NCT00640432|Celecoxib|celecoxib|mesh-list
20301464|NCT00640432|Diclofenac|diclofenac|mesh-list
20072370|NCT01457053|Torsemide|torsemide|mesh-list
20072371|NCT01457053|Furosemide|furosemide|mesh-list
20072372|NCT01457053|Bumetanide|bumetanide|mesh-list
20301465|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301466|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301467|NCT00640432|Analgesics|analgesics|mesh-ancestor
20301468|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
20301469|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301470|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301471|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301472|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301473|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20301474|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20301475|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301476|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301477|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
20301478|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
20301479|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20301480|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20301481|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301482|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301483|NCT00640458|Urological Agents|urological agents|mesh-ancestor
20301484|NCT00640471|Cetuximab|cetuximab|mesh-list
20301485|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20301486|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301487|NCT00640549|Atorvastatin|atorvastatin|mesh-list
20301488|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20301489|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20301490|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
20301491|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301492|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20301493|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20301494|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301495|NCT00640575|Triamcinolone|triamcinolone|mesh-list
20301496|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20301497|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20301498|NCT00640575|Lidocaine|lidocaine|mesh-list
20301499|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20301500|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
20301501|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
20301502|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20301503|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301504|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
20301505|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301506|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20301507|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20072373|NCT01457053|Diuretics|diuretics|mesh-list
19491921|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
20072374|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20301508|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20301509|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301510|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301511|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301512|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
20301513|NCT00640575|Hormones|hormones|mesh-ancestor
20301514|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578248|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19491922|NCT03126656|Testosterone|testosterone|mesh-list
20072375|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
20072376|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072377|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072378|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072379|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20072380|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20072381|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
20072382|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072383|NCT01451723|Protective Agents|protective agents|mesh-ancestor
20072384|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072385|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20072386|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20072387|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072388|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20072389|NCT01440595|Ribavirin|ribavirin|mesh-list
20072390|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20072391|NCT01440595|Grazoprevir|grazoprevir|mesh-list
20301515|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072392|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
20072393|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072394|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
20072395|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072396|NCT01443923|Interferons|interferons|mesh-list
20072397|NCT01443923|Ribavirin|ribavirin|mesh-list
20072398|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
20301516|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
20301517|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301518|NCT00640588|Adefovir|adefovir|mesh-list
20301519|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20301520|NCT00640588|Telbivudine|telbivudine|mesh-list
20072399|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
20072400|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20072401|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072402|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
20072403|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072404|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
20072405|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072406|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
20072407|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072408|NCT01439347|Vincristine|vincristine|mesh-list
20072409|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20072410|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301521|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
20301522|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301523|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20301524|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20301525|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301526|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301527|NCT00640627|Celecoxib|celecoxib|mesh-list
20301528|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301529|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301530|NCT00640627|Analgesics|analgesics|mesh-ancestor
20301531|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
20301532|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301533|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301534|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301535|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301536|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20301537|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20072411|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
20072412|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
20072413|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
20072414|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072415|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
20301538|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301539|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301540|NCT00640640|Bevacizumab|bevacizumab|mesh-list
20301541|NCT00640640|Ranibizumab|ranibizumab|mesh-list
20301542|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20301543|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301544|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20301545|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20301546|NCT00640640|Growth Substances|growth substances|mesh-ancestor
20301547|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301548|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
20301549|NCT00640679|Clopidogrel|clopidogrel|mesh-list
20301550|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20301551|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20301552|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20072416|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20072417|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072418|NCT01434745|Simvastatin|simvastatin|mesh-list
20072419|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20072420|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20072421|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
20072422|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072423|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20072424|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20301553|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20578249|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072425|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301554|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
20301555|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301556|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301557|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301558|NCT00640705|Diclofenac|diclofenac|mesh-list
20301559|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301560|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301561|NCT00640705|Analgesics|analgesics|mesh-ancestor
20301562|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
20301563|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301564|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301565|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301566|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301567|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20301568|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301569|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301570|NCT00640744|Atorvastatin|atorvastatin|mesh-list
20301571|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20301572|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20301573|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
20301574|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301575|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20301576|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20301577|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19491923|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
19491924|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
19491925|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19491926|NCT03126656|Androgens|androgens|mesh-ancestor
19491927|NCT03126656|Hormones|hormones|mesh-ancestor
19491928|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19491929|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491930|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19491931|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19491932|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
19491933|NCT03126721|Midazolam|midazolam|mesh-list
20072426|NCT01415986|Temoporfin|temoporfin|mesh-list
20301578|NCT00640796|Aldesleukin|aldesleukin|mesh-list
20301579|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
20301580|NCT00640796|Fludarabine|fludarabine|mesh-list
20301581|NCT00640796|Interleukin-2|interleukin-2|mesh-list
20301582|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20301583|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
20301584|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301585|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301586|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20301587|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
20301588|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301589|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301590|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20301591|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301592|NCT00640796|Analgesics|analgesics|mesh-ancestor
20301593|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
20301594|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301595|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20301596|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20301597|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
20301598|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301599|NCT00640809|Ibuprofen|ibuprofen|mesh-list
20301600|NCT00640809|Celecoxib|celecoxib|mesh-list
20301601|NCT00640809|Omeprazole|omeprazole|mesh-list
20072427|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072428|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20072429|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
20072430|NCT01410799|Hormones|hormones|mesh-list
20072431|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20072432|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072433|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072434|NCT01426113|Timolol|timolol|mesh-list
20072435|NCT01426113|Bimatoprost|bimatoprost|mesh-list
20072436|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20072437|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20072438|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20072439|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20072440|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
20301602|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20072441|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072442|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301603|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301604|NCT00640809|Analgesics|analgesics|mesh-ancestor
20301605|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
20301606|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301607|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301608|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301609|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301610|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20301611|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301612|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301613|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20301614|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20072443|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072444|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20072445|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20301615|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20301616|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20301617|NCT00640861|Vaccines|vaccines|mesh-list
20301618|NCT00640861|Sargramostim|sargramostim|mesh-list
20301619|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
20301620|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
20301621|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301622|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20301623|NCT00640887|Ritonavir|ritonavir|mesh-list
20301624|NCT00640887|Lopinavir|lopinavir|mesh-list
20301625|NCT00640887|Nevirapine|nevirapine|mesh-list
20301626|NCT00640887|Efavirenz|efavirenz|mesh-list
20301627|NCT00640887|Rifabutin|rifabutin|mesh-list
20301628|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20301629|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20301630|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
20301631|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578250|NCT02083874|Cannabidiol|cannabidiol|mesh-list
20578251|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
20578252|NCT02083991|Prednisolone|prednisolone|mesh-list
20578253|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
20578254|NCT02083991|Basiliximab|basiliximab|mesh-list
20578255|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578256|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
20578257|NCT02083991|Hormones|hormones|mesh-ancestor
20578258|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578259|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578260|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20578261|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578262|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
20578263|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20578264|NCT02084043|Amikacin|amikacin|mesh-list
20578265|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578266|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578267|NCT02084225|Lidocaine|lidocaine|mesh-list
20578268|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
20578269|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
20578270|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578271|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578272|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
20578273|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578274|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20578275|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20578276|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20578277|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578278|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578279|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20072446|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
20072447|NCT01420965|Antibodies|antibodies|mesh-list
20072448|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
20072449|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072450|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
20072451|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072452|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072453|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20578280|NCT02084303|Hematinics|hematinics|mesh-ancestor
20301632|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301633|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20308779|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
20578281|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20301634|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20301635|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
20301636|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301637|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20301638|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20301639|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20301640|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20301641|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20301642|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20301643|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20301644|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20301645|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20301646|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20301647|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20301648|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
20308780|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
20308781|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20308782|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308783|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
20308784|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308785|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308786|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20308787|NCT00665951|Ritonavir|ritonavir|mesh-list
20308788|NCT00665951|Lopinavir|lopinavir|mesh-list
20308789|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20308790|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20308791|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
20308792|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308793|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308794|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20308795|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20308796|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
20308797|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578282|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20578283|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20578284|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
20578285|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20578286|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20578287|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578288|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
20578289|NCT02084342|Coagulants|coagulants|mesh-ancestor
20578290|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20578291|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
20578292|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578293|NCT02084355|Fentanyl|fentanyl|mesh-list
20578294|NCT02084355|Oxycodone|oxycodone|mesh-list
20578295|NCT02084355|Hydromorphone|hydromorphone|mesh-list
20578296|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20578297|NCT02084355|Narcotics|narcotics|mesh-ancestor
20578298|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578299|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578300|NCT02084355|Analgesics|analgesics|mesh-ancestor
20578301|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
20578302|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578303|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20578304|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20578305|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
20578306|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
20578307|NCT02084368|Bupivacaine|bupivacaine|mesh-list
20072454|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
20072455|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072456|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072457|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20578308|NCT02084368|Ropivacaine|ropivacaine|mesh-list
20578309|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
20578310|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
20578311|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578312|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072458|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
20072459|NCT01406860|Promethazine|promethazine|mesh-list
20072460|NCT01406860|Droperidol|droperidol|mesh-list
20072461|NCT01406860|Metoclopramide|metoclopramide|mesh-list
20072462|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20072463|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20072464|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20301649|NCT00640939|Diclofenac|diclofenac|mesh-list
20301650|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20301651|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20301652|NCT00640939|Analgesics|analgesics|mesh-ancestor
20301653|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
20301654|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301655|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301656|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301657|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301658|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20301659|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301660|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301661|NCT00640952|Acamprosate|acamprosate|mesh-list
20301662|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20301663|NCT00640991|Insulin|insulin|mesh-list
20301664|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
20301665|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
20301666|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20301667|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072465|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072466|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
20072467|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
20072468|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
20301668|NCT00641004|Esomeprazole|esomeprazole|mesh-list
20301669|NCT00641004|Rebamipide|rebamipide|mesh-list
20301670|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20301671|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20301672|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20301673|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301674|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301675|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
20301676|NCT00641004|Protective Agents|protective agents|mesh-ancestor
20301677|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301678|NCT00641030|Melphalan|melphalan|mesh-list
20301679|NCT00641030|Clofarabine|clofarabine|mesh-list
20301680|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20301681|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
20301682|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301683|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301684|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20301685|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20301686|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
20301687|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301688|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20301689|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
20301690|NCT00641082|Adefovir|adefovir|mesh-list
20301691|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20301692|NCT00641082|Clevudine|clevudine|mesh-list
20301693|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
20301694|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301695|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20301696|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20072469|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072470|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
20072471|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
20072472|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20072473|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20072474|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
20072475|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
20072476|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072477|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072478|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20072479|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
20072480|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
20072481|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20072482|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20072483|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
20072484|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20072485|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20072486|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20072487|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20072488|NCT01401049|Lidocaine|lidocaine|mesh-list
20072489|NCT01401049|Propofol|propofol|mesh-list
20072490|NCT01401049|Fospropofol|fospropofol|mesh-list
20072491|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
20301697|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301698|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301699|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
20301700|NCT00641095|Rituximab|rituximab|mesh-list
20301701|NCT00641095|Fludarabine|fludarabine|mesh-list
20301702|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20301703|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
20301704|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301705|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20301706|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20301707|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
20301708|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301709|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301710|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20301711|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20301712|NCT00641160|Vinorelbine|vinorelbine|mesh-list
20301713|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20301714|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301715|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
20301716|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
20301717|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
20301718|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301719|NCT00641173|Paroxetine|paroxetine|mesh-list
20301720|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20301721|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20301722|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301723|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301724|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301725|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
20301726|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301727|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20072492|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
20072493|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20301728|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
20301729|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20301730|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20301731|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20301732|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301733|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
20301734|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20301735|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20301736|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
20301737|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
20301738|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20301739|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301740|NCT00641212|Budesonide|budesonide|mesh-list
20301741|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301742|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301743|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
20301744|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301745|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301746|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301747|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301748|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
20301749|NCT00641212|Hormones|hormones|mesh-ancestor
20301750|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301751|NCT00641264|Omeprazole|omeprazole|mesh-list
20301752|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20301753|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20301754|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20301755|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301756|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301757|NCT00641329|Clonidine|clonidine|mesh-list
20301758|NCT00641329|Analgesics|analgesics|mesh-ancestor
20301759|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
20301760|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301761|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072494|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072495|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
20072496|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072497|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20072498|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20072499|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20072500|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072501|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301762|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20301763|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
20301764|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
20301765|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20301766|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20301767|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20301768|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
20301769|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301770|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301771|NCT00641407|Insulin|insulin|mesh-list
20301772|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20301773|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
20301774|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20301775|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301776|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
20301777|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20301778|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20301779|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301780|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20301781|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20301782|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
20301783|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20301784|NCT00641446|Budesonide|budesonide|mesh-list
20301785|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301786|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301787|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
20301788|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301789|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301790|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301791|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301792|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
20301793|NCT00641446|Hormones|hormones|mesh-ancestor
20301794|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301795|NCT00641472|Budesonide|budesonide|mesh-list
20301796|NCT00641472|Montelukast|montelukast|mesh-list
20301797|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301798|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301799|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
20301800|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301801|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301802|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301803|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301804|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
20301805|NCT00641472|Hormones|hormones|mesh-ancestor
20301806|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301807|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20301808|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
20301809|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20301810|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20301811|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301812|NCT00641537|Cladribine|cladribine|mesh-list
20301813|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301814|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20301815|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
20301816|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301817|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
20301818|NCT00641589|Hematinics|hematinics|mesh-ancestor
20301819|NCT00641602|Esomeprazole|esomeprazole|mesh-list
20301820|NCT00641602|Lansoprazole|lansoprazole|mesh-list
20301821|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
20301822|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20301823|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20301824|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20301825|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301826|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301827|NCT00641654|Interferons|interferons|mesh-list
20301828|NCT00641654|Ribavirin|ribavirin|mesh-list
20301829|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
20578313|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
20578314|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578315|NCT02084420|Pantoprazole|pantoprazole|mesh-list
20578316|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20578317|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578318|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20301830|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
20301831|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20301832|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20301833|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
20301834|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20301835|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
20301836|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301837|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
20072502|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20072503|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20072504|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
20072505|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
20301838|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301839|NCT00641680|Fluticasone|fluticasone|mesh-list
20301840|NCT00641680|Xhance|xhance|mesh-list
20301841|NCT00641680|Budesonide|budesonide|mesh-list
20301842|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301843|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301844|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
20301845|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301846|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301847|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301848|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301849|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20301850|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20301851|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
20301852|NCT00641680|Hormones|hormones|mesh-ancestor
20301853|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301854|NCT00641693|Budesonide|budesonide|mesh-list
20301855|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301856|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301857|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
20301858|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301859|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301860|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301861|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
20072506|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
20072507|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20072508|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20072509|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072510|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072511|NCT01409031|Urological Agents|urological agents|mesh-ancestor
20072512|NCT01402531|Bevacizumab|bevacizumab|mesh-list
20072513|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20072514|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072515|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072516|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072517|NCT01402531|Growth Substances|growth substances|mesh-ancestor
20072518|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072519|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
20072520|NCT01397552|Dexamethasone|dexamethasone|mesh-list
20301862|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
20301863|NCT00641693|Hormones|hormones|mesh-ancestor
20301864|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301865|NCT00641758|Pycnogenols|pycnogenols|mesh-list
20301866|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20301867|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
20301868|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301869|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
20301870|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301871|NCT00641758|Protective Agents|protective agents|mesh-ancestor
20301872|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20301873|NCT00641810|Caffeine|caffeine|mesh-list
20301874|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20301875|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301876|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20301877|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301878|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301879|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20301880|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20301881|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
20072521|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
20072522|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20072523|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20301882|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578319|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072524|NCT01397552|Prednisolone|prednisolone|mesh-list
20301883|NCT00641914|Budesonide|budesonide|mesh-list
20301884|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301885|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301886|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
20301887|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072525|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
20072526|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20072527|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
20072528|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20072529|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
20072530|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
20072531|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072532|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072533|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20072534|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
20072535|NCT01397552|Hormones|hormones|mesh-ancestor
20072536|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072537|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20072538|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072539|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20072540|NCT01397552|Protective Agents|protective agents|mesh-ancestor
20072541|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20072542|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
20072543|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072544|NCT01397695|Bevacizumab|bevacizumab|mesh-list
20072545|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20301888|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301889|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301890|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301891|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
20301892|NCT00641914|Hormones|hormones|mesh-ancestor
20301893|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301894|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
20301895|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20301896|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
20301897|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20301898|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301899|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301900|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
20301901|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20301902|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20301903|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301904|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20301905|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20301906|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301907|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301908|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20301909|NCT00641979|Budesonide|budesonide|mesh-list
20301910|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301911|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301912|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
20301913|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301914|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301915|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301916|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301917|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
20301918|NCT00641979|Hormones|hormones|mesh-ancestor
20301919|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301920|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
20301921|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20301922|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20301923|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301924|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301925|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
20072546|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072547|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072548|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072549|NCT01397695|Growth Substances|growth substances|mesh-ancestor
20072550|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072551|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
20072552|NCT01390181|Losartan|losartan|mesh-list
20072553|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20072554|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20119849|NCT00006241|Lenograstim|lenograstim|mesh-list
20301926|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301927|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301928|NCT00642096|Metoprolol|metoprolol|mesh-list
20301929|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20301930|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20301931|NCT00642096|Diuretics|diuretics|mesh-ancestor
20301932|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
20072555|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20072556|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20072557|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072558|NCT01394211|Anastrozole|anastrozole|mesh-list
20072559|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20072560|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072561|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20301933|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301934|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20301935|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20301936|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301937|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20301938|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
20301939|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
20301940|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301941|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20072562|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20072563|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072564|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072565|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20072566|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
20072567|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301942|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20301943|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20301944|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
20301945|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301946|NCT00642122|Budesonide|budesonide|mesh-list
20301947|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301948|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301949|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
20301950|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301951|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301952|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301953|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301954|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
20301955|NCT00642122|Hormones|hormones|mesh-ancestor
20301956|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301957|NCT00642135|Phenylephrine|phenylephrine|mesh-list
20301958|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
20301959|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20301960|NCT00642135|Tropicamide|tropicamide|mesh-list
20301961|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20301962|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
20301963|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
20301964|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301965|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301966|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
20301967|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20301968|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
20301969|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301970|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20301971|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20301972|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20301973|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
20301974|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20301975|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20301976|NCT00642135|Protective Agents|protective agents|mesh-ancestor
20072568|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072569|NCT01377441|Ibuprofen|ibuprofen|mesh-list
20072570|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20072571|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20072572|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20072573|NCT01377441|Analgesics|analgesics|mesh-ancestor
20072574|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
20072575|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072576|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301977|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20301978|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20301979|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20301980|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
20301981|NCT00642161|Budesonide|budesonide|mesh-list
20301982|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301983|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301984|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
20301985|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20301986|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301987|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301988|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
20301989|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
20301990|NCT00642161|Hormones|hormones|mesh-ancestor
20301991|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20301992|NCT00642187|Budesonide|budesonide|mesh-list
20301993|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20301994|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20301995|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
20301996|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072577|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072578|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20072579|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20301997|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20301998|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20301999|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
20302000|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
20072580|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119850|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20119851|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
20119852|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302001|NCT00642187|Hormones|hormones|mesh-ancestor
20302002|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302003|NCT00642226|Triamcinolone|triamcinolone|mesh-list
20302004|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302005|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
20302006|NCT00642226|Hormones|hormones|mesh-ancestor
20302007|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302008|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119853|NCT00006243|Sargramostim|sargramostim|mesh-list
20119854|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
20119855|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
20119856|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119857|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20119858|NCT00006245|Paclitaxel|paclitaxel|mesh-list
20119859|NCT00006245|Alvocidib|alvocidib|mesh-list
20119860|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119861|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119862|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119863|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119864|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
20302009|NCT00642252|Fluorides|fluorides|mesh-list
20302010|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
20302011|NCT00642252|Protective Agents|protective agents|mesh-ancestor
20302012|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302013|NCT00642291|Emtricitabine|emtricitabine|mesh-list
20302014|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
20302015|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302016|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20302017|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20302018|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302019|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302020|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20302021|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20302022|NCT00642330|Ibuprofen|ibuprofen|mesh-list
20302023|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20302024|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20302025|NCT00642330|Analgesics|analgesics|mesh-ancestor
20302026|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
20302027|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302028|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302029|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302030|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119865|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119866|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
20302031|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20302032|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302033|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072581|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
20072582|NCT01383447|Entinostat|entinostat|mesh-list
20072583|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20072584|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072585|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20302034|NCT00642395|Bortezomib|bortezomib|mesh-list
20302035|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302036|NCT00642408|Micronutrients|micronutrients|mesh-list
20302037|NCT00642408|Trace Elements|trace elements|mesh-list
20302038|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302039|NCT00642421|Octreotide|octreotide|mesh-list
20302040|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20072586|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072587|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302041|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20302042|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302043|NCT00642434|Metoprolol|metoprolol|mesh-list
20302044|NCT00642434|Carvedilol|carvedilol|mesh-list
20302045|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20302046|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20302047|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
20302048|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
20302049|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072588|NCT01372618|Pasireotide|pasireotide|mesh-list
20302050|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302051|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20302052|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20302053|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20302054|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
20302055|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302056|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302057|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
20302058|NCT00642434|Protective Agents|protective agents|mesh-ancestor
20302059|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20302060|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20302061|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20302062|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
20302063|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20302064|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20302065|NCT00642499|Dronabinol|dronabinol|mesh-list
20302066|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
20302067|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302068|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302069|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578320|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578321|NCT02084433|Anesthetics|anesthetics|mesh-list
20578322|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578323|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578324|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
20578325|NCT02084446|Prednisone|prednisone|mesh-list
20578326|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
20578327|NCT02084446|Everolimus|everolimus|mesh-list
20578328|NCT02084446|Tacrolimus|tacrolimus|mesh-list
20578329|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
20578330|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20578331|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578332|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
20578333|NCT02084446|Hormones|hormones|mesh-ancestor
20578334|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578335|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578336|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20578337|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578338|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20578339|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
20578340|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20578341|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072589|NCT01372618|Hormones|hormones|mesh-ancestor
20072590|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302070|NCT00642499|Analgesics|analgesics|mesh-ancestor
20302071|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
20578342|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072591|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072592|NCT01385280|Exemestane|exemestane|mesh-list
20072593|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20072594|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20072595|NCT01385280|Estradiol|estradiol|mesh-list
20072596|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20072597|NCT01385280|Estrogens|estrogens|mesh-ancestor
20072598|NCT01385280|Hormones|hormones|mesh-ancestor
20072599|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072600|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072601|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20072602|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
20072603|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20072604|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20302072|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302073|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20302074|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20302075|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302076|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302077|NCT00642499|Hormones|hormones|mesh-ancestor
20302078|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302079|NCT00642512|Dronabinol|dronabinol|mesh-list
20302080|NCT00642512|Ondansetron|ondansetron|mesh-list
20302081|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
20302082|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
20302083|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302084|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302085|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20302086|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
20302087|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
20302088|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302089|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
20302090|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302091|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302092|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302093|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302094|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302095|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302096|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20302097|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
20302098|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20302099|NCT00642512|Analgesics|analgesics|mesh-ancestor
20302100|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
20302101|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20302102|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20302103|NCT00642512|Hormones|hormones|mesh-ancestor
20302104|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302105|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
20302106|NCT00642551|Vitamin K|vitamin k|mesh-list
20302107|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
20302108|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20302109|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20302110|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302111|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
20302112|NCT00642551|Coagulants|coagulants|mesh-ancestor
20302113|NCT00642551|Vitamins|vitamins|mesh-ancestor
20302114|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
20302115|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302116|NCT00642577|Leucovorin|leucovorin|mesh-list
20302117|NCT00642577|Bevacizumab|bevacizumab|mesh-list
20302118|NCT00642577|Fluorouracil|fluorouracil|mesh-list
20578343|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20578344|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20578345|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
20578346|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578347|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578348|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
20578349|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
20578350|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578351|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578352|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20578353|NCT02084446|Protective Agents|protective agents|mesh-ancestor
20578354|NCT02084472|Petrolatum|petrolatum|mesh-list
20302119|NCT00642577|Irinotecan|irinotecan|mesh-list
20302120|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20578355|NCT02084472|Mineral Oil|mineral oil|mesh-list
20578356|NCT02084472|Glycerol|glycerol|mesh-list
20302121|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302122|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20302123|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20302124|NCT00642577|Growth Substances|growth substances|mesh-ancestor
20302125|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302126|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
20302127|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
20072605|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072606|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20072607|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20072608|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072609|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072610|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20072611|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
20072612|NCT01379274|Lenalidomide|lenalidomide|mesh-list
20072613|NCT01379274|Azacitidine|azacitidine|mesh-list
20072614|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
20072615|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072616|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072617|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072618|NCT01379274|Growth Substances|growth substances|mesh-ancestor
20072619|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
20072620|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072621|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072622|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
20072623|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072624|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072625|NCT01379469|Carbamazepine|carbamazepine|mesh-list
20302128|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302129|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20302130|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302131|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
20302132|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20302133|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302134|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302135|NCT00642577|Antidotes|antidotes|mesh-ancestor
20302136|NCT00642577|Protective Agents|protective agents|mesh-ancestor
20302137|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
20302138|NCT00642577|Vitamins|vitamins|mesh-ancestor
20302139|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
20308798|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20308799|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20308800|NCT00665977|Triamcinolone|triamcinolone|mesh-list
20308801|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20308802|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20072626|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
20072627|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
20308803|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20308804|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308805|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
20308806|NCT00665977|Hormones|hormones|mesh-ancestor
20072628|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20072629|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072630|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072631|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20072632|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20072633|NCT01379469|Analgesics|analgesics|mesh-ancestor
20072634|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
20072635|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308807|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308808|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308809|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308810|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
20308811|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308812|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308813|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
20308814|NCT00665990|Bevacizumab|bevacizumab|mesh-list
20308815|NCT00665990|Sorafenib|sorafenib|mesh-list
20308816|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308817|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
20308818|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072636|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20308819|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308820|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20302140|NCT00642655|Rituximab|rituximab|mesh-list
20302141|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20302142|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302143|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
20302144|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302145|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302146|NCT00642681|Insulin|insulin|mesh-list
20302147|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20302148|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302149|NCT00642733|Gemcitabine|gemcitabine|mesh-list
20302150|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20302151|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20302152|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
20302153|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302154|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302155|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
20302156|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302157|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302158|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302159|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
20302160|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302161|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20302162|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20302163|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20302164|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302165|NCT00642798|Incretins|incretins|mesh-ancestor
20302166|NCT00642798|Hormones|hormones|mesh-ancestor
20302167|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302168|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20302169|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
20302170|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302171|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302172|NCT00642824|Bevacizumab|bevacizumab|mesh-list
20302173|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20302174|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302175|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20302176|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20302177|NCT00642824|Growth Substances|growth substances|mesh-ancestor
20302178|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302179|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
20302180|NCT00642837|Acetaminophen|acetaminophen|mesh-list
20302181|NCT00642837|Tramadol|tramadol|mesh-list
20302182|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20302183|NCT00642837|Analgesics|analgesics|mesh-ancestor
20302184|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
20302185|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302186|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302187|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
20302188|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20302189|NCT00642837|Narcotics|narcotics|mesh-ancestor
20302190|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302191|NCT00642863|Vitamin D|vitamin d|mesh-list
20072637|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072638|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072639|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20302192|NCT00642863|Vitamins|vitamins|mesh-list
20302193|NCT00642863|Vitamin A|vitamin a|mesh-list
20302194|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
20302195|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
20578357|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20072640|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20072641|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
20072642|NCT01369641|Cisplatin|cisplatin|mesh-list
20072643|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072644|NCT01369641|Antidotes|antidotes|mesh-ancestor
20072645|NCT01369641|Protective Agents|protective agents|mesh-ancestor
20072646|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072647|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
20072648|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072649|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
20072650|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072651|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578358|NCT02084472|Protective Agents|protective agents|mesh-ancestor
20072652|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
20302196|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302197|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
20302198|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302199|NCT00642863|Protective Agents|protective agents|mesh-ancestor
20302200|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20302201|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302202|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20302203|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
20302204|NCT00642915|Glimepiride|glimepiride|mesh-list
20302205|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20302206|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302207|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20302208|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302209|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
20302210|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
20302211|NCT00642967|Hematinics|hematinics|mesh-ancestor
20302212|NCT00642980|Clindamycin|clindamycin|mesh-list
20302213|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
20302214|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
20302215|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302216|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302217|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20302218|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302219|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302220|NCT00643071|Tacrolimus|tacrolimus|mesh-list
20302221|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302222|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
20302223|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302224|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20302225|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302226|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072653|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
20072654|NCT01359254|Vidarabine|vidarabine|mesh-list
20072655|NCT01359254|Fludarabine|fludarabine|mesh-list
20072656|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
20072657|NCT01359254|Melphalan|melphalan|mesh-list
20072658|NCT01359254|Busulfan|busulfan|mesh-list
20072659|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20072660|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072661|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072662|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
20072663|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072664|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072665|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
20072666|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302227|NCT00643136|Pregabalin|pregabalin|mesh-list
20302228|NCT00643136|Analgesics|analgesics|mesh-ancestor
20302229|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
20302230|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302231|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302232|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
20302233|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20302234|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20302235|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302236|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20302237|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20302238|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302239|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302240|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302241|NCT00643149|Amoxicillin|amoxicillin|mesh-list
20302242|NCT00643149|Azithromycin|azithromycin|mesh-list
20302243|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302244|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302245|NCT00643227|Azithromycin|azithromycin|mesh-list
20302246|NCT00643227|Clarithromycin|clarithromycin|mesh-list
20302247|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302248|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302249|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20302250|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302251|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302252|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20302253|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302254|NCT00643240|Antibodies|antibodies|mesh-list
20072667|NCT01359254|Antiviral Agents|antiviral agents|mesh-ancestor
20302255|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20302256|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
20302257|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072668|NCT01359254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302258|NCT00643292|Amoxicillin|amoxicillin|mesh-list
20302259|NCT00643292|Azithromycin|azithromycin|mesh-list
20302260|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
20302261|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
20302262|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20302263|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302264|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302265|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20302266|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302267|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302268|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
20302269|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20302270|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
20302271|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
20302272|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302273|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302274|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20072669|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20072670|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
20072671|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20072672|NCT01347632|Metronidazole|metronidazole|mesh-list
20072673|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072674|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072675|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20072676|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20072677|NCT01350232|Cytarabine|cytarabine|mesh-list
20072678|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
20072679|NCT01350232|Rituximab|rituximab|mesh-list
20072680|NCT01350232|Fludarabine|fludarabine|mesh-list
20072681|NCT01350232|Bortezomib|bortezomib|mesh-list
20072682|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302275|NCT00643357|Analgesics|analgesics|mesh-ancestor
20302276|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
20302277|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302278|NCT00643409|Azithromycin|azithromycin|mesh-list
20302279|NCT00643409|Levofloxacin|levofloxacin|mesh-list
20302280|NCT00643409|Ofloxacin|ofloxacin|mesh-list
20578359|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578360|NCT02084472|Emollients|emollients|mesh-ancestor
20578361|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
20578362|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
20578363|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20578364|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20578365|NCT02084563|Cytarabine|cytarabine|mesh-list
20578366|NCT02084563|Decitabine|decitabine|mesh-list
20578367|NCT02084563|Daunorubicin|daunorubicin|mesh-list
20578368|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20578369|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
20578370|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578371|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578372|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
20578373|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578374|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20578375|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
20578376|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578377|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578378|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20578379|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20072683|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
20072684|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072685|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072686|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20072687|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
20072688|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072689|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072690|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20072691|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20072692|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20302281|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578380|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20578381|NCT02084576|Ketorolac|ketorolac|mesh-list
20578382|NCT02084576|Nepafenac|nepafenac|mesh-list
20578383|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20072693|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
20072694|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
20302282|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302283|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20302284|NCT00643409|Renal Agents|renal agents|mesh-ancestor
20302285|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20302286|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302287|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302288|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302289|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302290|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20302291|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302292|NCT00643500|Levetiracetam|levetiracetam|mesh-list
20302293|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
20302294|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
20302295|NCT00643539|Azithromycin|azithromycin|mesh-list
20302296|NCT00643539|Amoxicillin|amoxicillin|mesh-list
20302297|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302298|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302299|NCT00643643|Maraviroc|maraviroc|mesh-list
20302300|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20302301|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20302302|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302303|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20302304|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20302305|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
20302306|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302307|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20302308|NCT00643734|Azithromycin|azithromycin|mesh-list
20302309|NCT00643734|Levofloxacin|levofloxacin|mesh-list
20302310|NCT00643734|Ofloxacin|ofloxacin|mesh-list
20302311|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302312|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302313|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20302314|NCT00643734|Renal Agents|renal agents|mesh-ancestor
20302315|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20302316|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302317|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302318|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302319|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302320|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20302321|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302322|NCT00643799|Celecoxib|celecoxib|mesh-list
20302323|NCT00643799|Naproxen|naproxen|mesh-list
20302324|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20302325|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20302326|NCT00643799|Analgesics|analgesics|mesh-ancestor
20302327|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
20302328|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302329|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302330|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302331|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302332|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20302333|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20302334|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302335|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302336|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
20302337|NCT00643825|Temozolomide|temozolomide|mesh-list
20302338|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20302339|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
20302340|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302341|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302342|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
20302343|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302344|NCT00644020|Fluorouracil|fluorouracil|mesh-list
20302345|NCT00644020|Mitomycins|mitomycins|mesh-list
20302346|NCT00644020|Mitomycin|mitomycin|mesh-list
20302347|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
20302348|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302349|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20302350|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302351|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302352|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
20302353|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302354|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20302355|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
20302356|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20302357|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302358|NCT00644033|Frovatriptan|frovatriptan|mesh-list
20302359|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20302360|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
20302361|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302362|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302363|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072695|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302364|NCT00644085|Aspirin|aspirin|mesh-list
20302365|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20302366|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20302367|NCT00644085|Analgesics|analgesics|mesh-ancestor
20302368|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
20302369|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302370|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302371|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302372|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302373|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20302374|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20302375|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302376|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20302377|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20302378|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302379|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
20302380|NCT00644111|Hydromorphone|hydromorphone|mesh-list
20302381|NCT00644111|Bupivacaine|bupivacaine|mesh-list
20302382|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
20302383|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
20302384|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302385|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302386|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
20302387|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302388|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20302389|NCT00644111|Narcotics|narcotics|mesh-ancestor
20302390|NCT00644111|Analgesics|analgesics|mesh-ancestor
20302391|NCT00644124|Aflibercept|aflibercept|mesh-list
20302392|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20302393|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20302394|NCT00644124|Growth Substances|growth substances|mesh-ancestor
20302395|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302396|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
20302397|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302398|NCT00644137|Pregabalin|pregabalin|mesh-list
20302399|NCT00644137|Analgesics|analgesics|mesh-ancestor
20302400|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
20072696|NCT01352416|Ranolazine|ranolazine|mesh-list
20072697|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20072698|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072699|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072700|NCT01350258|Vidarabine|vidarabine|mesh-list
20072701|NCT01350258|Fludarabine|fludarabine|mesh-list
20072702|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
20302401|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302402|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302403|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
20302404|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20302405|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20302406|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302407|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20302408|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20302409|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302410|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302411|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302412|NCT00644176|Azithromycin|azithromycin|mesh-list
20302413|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302414|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302415|NCT00644215|Mitomycins|mitomycins|mesh-list
20302416|NCT00644215|Mitomycin|mitomycin|mesh-list
20302417|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20302418|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302419|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
20302420|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746358|NCT03862716|Liraglutide|liraglutide|mesh-list
19746359|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
20072703|NCT01350258|Melphalan|melphalan|mesh-list
20072704|NCT01350258|Thiotepa|thiotepa|mesh-list
20072705|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072706|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072707|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
20072708|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072709|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072710|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
20072711|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072712|NCT01350258|Antiviral Agents|antiviral agents|mesh-ancestor
20072713|NCT01350258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072714|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20072715|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
20072716|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20072717|NCT01349595|Bortezomib|bortezomib|mesh-list
20072718|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072719|NCT01340573|Interferons|interferons|mesh-list
20072720|NCT01340573|Ribavirin|ribavirin|mesh-list
20302421|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20302422|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302423|NCT00644293|Azithromycin|azithromycin|mesh-list
20302424|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302425|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302426|NCT00644306|Thalidomide|thalidomide|mesh-list
20302427|NCT00644306|Prednisone|prednisone|mesh-list
20302428|NCT00644306|Melphalan|melphalan|mesh-list
20302429|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302430|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
20302431|NCT00644306|Hormones|hormones|mesh-ancestor
20302432|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302433|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302434|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20302435|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302436|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20302437|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
20302438|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302439|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20302440|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302441|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
20302442|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
20302443|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072721|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20072722|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072723|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
20072724|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072725|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
20072726|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072727|NCT01335997|Niacin|niacin|mesh-list
20302444|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302445|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20302446|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20302447|NCT00644306|Growth Substances|growth substances|mesh-ancestor
20302448|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
20302449|NCT00644319|Ibuprofen|ibuprofen|mesh-list
20302450|NCT00644319|Morphine|morphine|mesh-list
20302451|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20072728|NCT01335997|Niacinamide|niacinamide|mesh-list
20072729|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
20072730|NCT01335997|Simvastatin|simvastatin|mesh-list
20072731|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20072732|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20302452|NCT00644319|Narcotics|narcotics|mesh-ancestor
20302453|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302454|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302455|NCT00644319|Analgesics|analgesics|mesh-ancestor
20302456|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
20302457|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302458|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20302459|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20302460|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302461|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072733|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
20072734|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072735|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20072736|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20072737|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302462|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20302463|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072738|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
20072739|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
20072740|NCT01335997|Vitamins|vitamins|mesh-ancestor
20072741|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
20072742|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072743|NCT01340885|Rivastigmine|rivastigmine|mesh-list
20072744|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20308821|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
20578384|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578385|NCT02084576|Analgesics|analgesics|mesh-ancestor
20578386|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
20578387|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578388|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578389|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578390|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578391|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20578392|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578393|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578394|NCT02084589|Fentanyl|fentanyl|mesh-list
20578395|NCT02084589|Ropivacaine|ropivacaine|mesh-list
20578396|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
20578397|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
20578398|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578399|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578400|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
20578401|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578402|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20578403|NCT02084589|Narcotics|narcotics|mesh-ancestor
20578404|NCT02084589|Analgesics|analgesics|mesh-ancestor
20578405|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20578406|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20578407|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
20578408|NCT02084602|Artesunate|artesunate|mesh-list
20578409|NCT02084602|Mefloquine|mefloquine|mesh-list
20578410|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
20578411|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20578412|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20578413|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578414|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578415|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
20578416|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
20578417|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20578418|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
20578419|NCT02084615|Aspirin|aspirin|mesh-list
20578420|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20578421|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578422|NCT02084615|Analgesics|analgesics|mesh-ancestor
20578423|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
20578424|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578425|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578426|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578427|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578428|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20578429|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20578430|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578431|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20578432|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20578433|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578434|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
20578435|NCT02084654|Exenatide|exenatide|mesh-list
20578436|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20578437|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578438|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20578439|NCT02084654|Incretins|incretins|mesh-ancestor
20578440|NCT02084654|Hormones|hormones|mesh-ancestor
20578441|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072745|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20072746|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20072747|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20072748|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072749|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
20072750|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072751|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072752|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20072753|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578442|NCT02084719|Antibodies|antibodies|mesh-list
20578443|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
20578444|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578445|NCT02084732|Sorafenib|sorafenib|mesh-list
20302464|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302465|NCT00644371|Rituximab|rituximab|mesh-list
20302466|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20302467|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302468|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
20302469|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302470|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302471|NCT00644384|Acitretin|acitretin|mesh-list
20302472|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
20302473|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308822|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308823|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308824|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20308825|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20308826|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072754|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
20072755|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20072756|NCT01340885|Protective Agents|protective agents|mesh-ancestor
20072757|NCT01326923|Cetuximab|cetuximab|mesh-list
20072758|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20072759|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072760|NCT01332799|Allopurinol|allopurinol|mesh-list
20072761|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
20308827|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20308828|NCT00665990|Growth Substances|growth substances|mesh-ancestor
20308829|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20308830|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20308831|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308976|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308977|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
20308978|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308979|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308980|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20308981|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
20308982|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308983|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308984|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20308985|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20308986|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20308987|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20308988|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308989|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20308990|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
20308991|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
20308992|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
20308993|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308994|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
20308995|NCT00666484|Hormones|hormones|mesh-ancestor
20308996|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308997|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20308998|NCT00666575|Gabapentin|gabapentin|mesh-list
20308999|NCT00666575|Analgesics|analgesics|mesh-ancestor
20309000|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
20309001|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309002|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309003|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
20309004|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20309005|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20309006|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309007|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309008|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20309009|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20309010|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309011|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309012|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
20309013|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
20309014|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578446|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072762|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072763|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072764|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
20072765|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072766|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20578447|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20302474|NCT00644449|Azithromycin|azithromycin|mesh-list
20302475|NCT00644449|Levofloxacin|levofloxacin|mesh-list
20302476|NCT00644449|Ofloxacin|ofloxacin|mesh-list
20072767|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
20072768|NCT01332799|Protective Agents|protective agents|mesh-ancestor
20072769|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072770|NCT01329549|Carboplatin|carboplatin|mesh-list
20072771|NCT01329549|Nintedanib|nintedanib|mesh-list
20302477|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302478|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302479|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20302480|NCT00644449|Renal Agents|renal agents|mesh-ancestor
20302481|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20302482|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302483|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302484|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302485|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302486|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20302487|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302488|NCT00644475|Candesartan|candesartan|mesh-list
20302489|NCT00644475|Imidapril|imidapril|mesh-list
20302490|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20302491|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20302492|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20302493|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302494|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20302495|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
20302496|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302497|NCT00644540|Vaccines|vaccines|mesh-list
20302498|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
20302499|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072772|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302500|NCT00644553|Amoxicillin|amoxicillin|mesh-list
20302501|NCT00644553|Clarithromycin|clarithromycin|mesh-list
20302502|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
20302503|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20302504|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302505|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302506|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20302507|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302508|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302509|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20302510|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302511|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20302512|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
20302513|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
20302514|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20302515|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20302516|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302517|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302518|NCT00644605|Urological Agents|urological agents|mesh-ancestor
20302519|NCT00644618|Gemcitabine|gemcitabine|mesh-list
20302520|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20302521|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
20302522|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302523|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302524|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
20302525|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302526|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302527|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302528|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
20302529|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302530|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
20302531|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
20302532|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20072773|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20072774|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302533|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20302534|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302535|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302536|NCT00644631|Urological Agents|urological agents|mesh-ancestor
20578448|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072775|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605696|NCT02233582|Ibuprofen|ibuprofen|mesh-list
20072776|NCT01326845|Deferasirox|deferasirox|mesh-list
20072777|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20072778|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
20072779|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
20072780|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072781|NCT01320683|Leucovorin|leucovorin|mesh-list
20072782|NCT01320683|Bevacizumab|bevacizumab|mesh-list
20072783|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20072784|NCT01320683|Fluorouracil|fluorouracil|mesh-list
20072785|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
20072786|NCT01320683|Irinotecan|irinotecan|mesh-list
20302537|NCT00644670|Atorvastatin|atorvastatin|mesh-list
20302538|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20302539|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20302540|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
20302541|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302542|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20302543|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20302544|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302545|NCT00644696|Cefixime|cefixime|mesh-list
20302546|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
20302547|NCT00644696|Irinotecan|irinotecan|mesh-list
20302548|NCT00644696|Bortezomib|bortezomib|mesh-list
20302549|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20302550|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302551|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302552|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302553|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302554|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302555|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302556|NCT00644709|Atorvastatin|atorvastatin|mesh-list
20302557|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20302558|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20302559|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
20302560|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302561|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20302562|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20302563|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302564|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
20302565|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
20302566|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
20302567|NCT00644735|Esomeprazole|esomeprazole|mesh-list
20302568|NCT00644735|Lansoprazole|lansoprazole|mesh-list
20302569|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
20302570|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20302571|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20302572|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20302573|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302574|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302575|NCT00644748|Gabapentin|gabapentin|mesh-list
20302576|NCT00644748|Analgesics|analgesics|mesh-ancestor
20302577|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
20302578|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302579|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302580|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
20302581|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20302582|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302583|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302584|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302585|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20302586|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20302587|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302588|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302589|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
20302590|NCT00644761|Adefovir|adefovir|mesh-list
20302591|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20302592|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
20302593|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302594|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20302595|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20302596|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302597|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302598|NCT00644774|Azithromycin|azithromycin|mesh-list
20072787|NCT01320683|Antibodies|antibodies|mesh-list
20302599|NCT00644774|Cefdinir|cefdinir|mesh-list
20072788|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
20302600|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302601|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302602|NCT00644800|Ziprasidone|ziprasidone|mesh-list
20302603|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302604|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
20302605|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302606|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302607|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302608|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302609|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302610|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302611|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20072789|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20072790|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
20072791|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072792|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20072793|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072794|NCT01320683|Growth Substances|growth substances|mesh-ancestor
20072795|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072796|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
20302612|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20302613|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
20302614|NCT00644891|Amoxicillin|amoxicillin|mesh-list
20302615|NCT00644891|Cefdinir|cefdinir|mesh-list
20302616|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302617|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302618|NCT00644904|Vitamin D|vitamin d|mesh-list
20302619|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
20302620|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
20302621|NCT00644904|Vitamins|vitamins|mesh-list
20302622|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
20302623|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302624|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20302625|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20302626|NCT00644943|Amoxicillin|amoxicillin|mesh-list
20302627|NCT00644943|Cefdinir|cefdinir|mesh-list
20302628|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302629|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302630|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
20302631|NCT00644956|Tadalafil|tadalafil|mesh-list
20302632|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
20302633|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20302634|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20302635|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302636|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302637|NCT00644956|Urological Agents|urological agents|mesh-ancestor
20302638|NCT00644982|Sertraline|sertraline|mesh-list
20302639|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20302640|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
20302641|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302642|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20302643|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20302644|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20302645|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302646|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302647|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
20302648|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302649|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20302650|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20302651|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
20302652|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
20302653|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20072797|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
20072798|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
20072799|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072800|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072801|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072802|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20072803|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20072804|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072805|NCT01320683|Antidotes|antidotes|mesh-ancestor
20302654|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20302655|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302656|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746360|NCT03862716|Xultophy|xultophy|mesh-list
19746361|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20302657|NCT00645034|Urological Agents|urological agents|mesh-ancestor
20302658|NCT00645060|Antibodies|antibodies|mesh-list
20302659|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20302660|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
20302661|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302662|NCT00645073|Levofloxacin|levofloxacin|mesh-list
20302663|NCT00645073|Ofloxacin|ofloxacin|mesh-list
20302664|NCT00645073|Cefdinir|cefdinir|mesh-list
20302665|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20302666|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302667|NCT00645073|Renal Agents|renal agents|mesh-ancestor
20302668|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302669|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20302670|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302671|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302672|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578449|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605697|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20605698|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20072806|NCT01320683|Protective Agents|protective agents|mesh-ancestor
20072807|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
20072808|NCT01320683|Vitamins|vitamins|mesh-ancestor
20072809|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
20072810|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
20072811|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
20072812|NCT01313273|Lanreotide|lanreotide|mesh-list
20072813|NCT01313273|Androgens|androgens|mesh-list
20072814|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20072815|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20072816|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
20072817|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
20072818|NCT01313273|Hormones|hormones|mesh-ancestor
20072819|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072820|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072821|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
20072822|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605699|NCT02233582|Analgesics|analgesics|mesh-ancestor
20605700|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
20605701|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605702|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605703|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20605704|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20605705|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20605706|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605707|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605708|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20605709|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20605710|NCT02233621|Estradiol|estradiol|mesh-list
20605711|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20605712|NCT02233621|Estrogens|estrogens|mesh-ancestor
20605713|NCT02233621|Hormones|hormones|mesh-ancestor
20605714|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605715|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605716|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20605717|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
20605718|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20605719|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20605720|NCT02233777|Pregabalin|pregabalin|mesh-list
20605721|NCT02233777|Analgesics|analgesics|mesh-ancestor
20605722|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
20605723|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605724|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302673|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302674|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20302675|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302676|NCT00645086|Clarithromycin|clarithromycin|mesh-list
20302677|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20605725|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
20605726|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20605727|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605728|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072823|NCT01313273|Protective Agents|protective agents|mesh-ancestor
20072824|NCT01313273|Vitamins|vitamins|mesh-ancestor
20302678|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302679|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20302680|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302681|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302682|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20302683|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302684|NCT00645112|Azithromycin|azithromycin|mesh-list
20302685|NCT00645112|Cefdinir|cefdinir|mesh-list
20302686|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302687|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302688|NCT00645125|Amoxicillin|amoxicillin|mesh-list
20302689|NCT00645125|Cefdinir|cefdinir|mesh-list
20302690|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302691|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302692|NCT00645138|Anesthetics|anesthetics|mesh-list
20302693|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302694|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302695|NCT00645151|Atorvastatin|atorvastatin|mesh-list
20302696|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20302697|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20302698|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
20302699|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302700|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20302701|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20302702|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302703|NCT00645190|Galantamine|galantamine|mesh-list
20302704|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20302705|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302706|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302707|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
20302708|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302709|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302710|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20302711|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
20302712|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302713|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
20302714|NCT00645203|Cefdinir|cefdinir|mesh-list
20072825|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
20072826|NCT01313273|Estrogens|estrogens|mesh-ancestor
20072827|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20072828|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072829|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
20072830|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
20072831|NCT01321008|Prednisone|prednisone|mesh-list
20072832|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
20302715|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302716|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302717|NCT00645229|Ziprasidone|ziprasidone|mesh-list
20302718|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302719|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
20302720|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302721|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302722|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302723|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302724|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302725|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302726|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302727|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20302728|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
20302729|NCT00645242|Fluconazole|fluconazole|mesh-list
20302730|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
20302731|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302732|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20302733|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302734|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302735|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302736|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20302737|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
20302738|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302739|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302740|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20302741|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20302742|NCT00645255|Sibutramine|sibutramine|mesh-list
20302743|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
20072833|NCT01321008|Doxorubicin|doxorubicin|mesh-list
20072834|NCT01321008|Vincristine|vincristine|mesh-list
20072835|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302744|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302745|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
20302746|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20302747|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
20302748|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
20302749|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20302750|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20302751|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302752|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302753|NCT00645268|Urological Agents|urological agents|mesh-ancestor
20302754|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20302755|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20302756|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20302757|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
20302758|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302759|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072836|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
20072837|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072838|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072839|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20072840|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
20072841|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072842|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072843|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20072844|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20302760|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302761|NCT00645281|Urological Agents|urological agents|mesh-ancestor
20578450|NCT02084784|Methylene Blue|methylene blue|mesh-list
20578451|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578452|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578453|NCT02084875|Tofacitinib|tofacitinib|mesh-list
20072845|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20072846|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20072847|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302762|NCT00645294|Adefovir|adefovir|mesh-list
20302763|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20302764|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
20302765|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302766|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20302767|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20302768|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302769|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302770|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20302771|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302772|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302773|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302774|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302775|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302776|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20072848|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20072849|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
20072850|NCT01321008|Hormones|hormones|mesh-ancestor
20072851|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302777|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302778|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
20302779|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302780|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302781|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20302782|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20302783|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
20302784|NCT00645320|Ziprasidone|ziprasidone|mesh-list
20302785|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302786|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
20302787|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302788|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302789|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302790|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302791|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302792|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302793|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302794|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20302795|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
20302796|NCT00645372|Risperidone|risperidone|mesh-list
20072852|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20072853|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20072854|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20072855|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20072856|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20302797|NCT00645372|Ziprasidone|ziprasidone|mesh-list
20302798|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302799|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
20302800|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302801|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302802|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302803|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302804|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302805|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302806|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302807|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20302808|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
20302809|NCT00645398|Pregabalin|pregabalin|mesh-list
20302810|NCT00645398|Analgesics|analgesics|mesh-ancestor
20302811|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
20302812|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302813|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302814|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
20302815|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20302816|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20302817|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302818|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20302819|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20302820|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302821|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302822|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302823|NCT00645424|Atorvastatin|atorvastatin|mesh-list
20302824|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20302825|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20302826|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
20302827|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072857|NCT01310803|Valrubicin|valrubicin|mesh-list
20072858|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072859|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20072860|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20072861|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072862|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072863|NCT01309581|Ketamine|ketamine|mesh-list
20302828|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20302829|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20072864|NCT01309581|Methohexital|methohexital|mesh-list
20072865|NCT01309581|Analgesics|analgesics|mesh-ancestor
20072866|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
20072867|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072868|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072869|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20072870|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20302830|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302831|NCT00645437|Levofloxacin|levofloxacin|mesh-list
20302832|NCT00645437|Ofloxacin|ofloxacin|mesh-list
20302833|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20302834|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302835|NCT00645437|Renal Agents|renal agents|mesh-ancestor
20302836|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302837|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20302838|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302839|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302840|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302841|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072871|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
20072872|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
20072873|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20072874|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20072875|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20072876|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072877|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302842|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20302843|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302844|NCT00645502|Risperidone|risperidone|mesh-list
20302845|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302846|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
20302847|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302848|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302849|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302850|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302851|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302852|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302853|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302854|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20302855|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
20302856|NCT00645515|Risperidone|risperidone|mesh-list
20302857|NCT00645515|Ziprasidone|ziprasidone|mesh-list
20302858|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20302859|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
20302860|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302861|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302862|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302863|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20302864|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302865|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302866|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302867|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20302868|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
20302869|NCT00645554|Galantamine|galantamine|mesh-list
20302870|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20302871|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302872|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302873|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
20302874|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302875|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302876|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20302877|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
20302878|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302879|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
20302880|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
20302881|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20302882|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20302883|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302884|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302885|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20302886|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20302887|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20302888|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20302889|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302890|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20302891|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
20302892|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20302893|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
20302894|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20302895|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20302896|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302897|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20302898|NCT00645606|Rituximab|rituximab|mesh-list
20302899|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20302900|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302901|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
20302902|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302903|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302904|NCT00645632|Doxorubicin|doxorubicin|mesh-list
20302905|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20302906|NCT00645632|Methotrexate|methotrexate|mesh-list
20302907|NCT00645632|Ifosfamide|ifosfamide|mesh-list
20302908|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302909|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20302910|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20302911|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302912|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302913|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302914|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19746362|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072878|NCT01315873|Bortezomib|bortezomib|mesh-list
20072879|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20072880|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072881|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20072882|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
20072883|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072884|NCT01313923|Sirolimus|sirolimus|mesh-list
20072885|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20072886|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072887|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20072888|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072889|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
20072890|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072891|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
20072892|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072893|NCT01313416|Gemcitabine|gemcitabine|mesh-list
20072894|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072895|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
20072896|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072897|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072898|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
20072899|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072900|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072901|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072902|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
20072903|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072904|NCT01303003|Dexamethasone|dexamethasone|mesh-list
20072905|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20072906|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
20072907|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
20072908|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20072909|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072910|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20072911|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
20072912|NCT01303003|Hormones|hormones|mesh-ancestor
20072913|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20072914|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20072915|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072916|NCT01302444|Tadalafil|tadalafil|mesh-list
20072917|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
20072918|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20072919|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20072920|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072921|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072922|NCT01302444|Urological Agents|urological agents|mesh-ancestor
20072923|NCT01301963|Plerixafor|plerixafor|mesh-list
20072924|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20072925|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20072926|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
20072927|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20072928|NCT01292070|Histamine|histamine|mesh-list
20072929|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
20072930|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
20072931|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20072932|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072933|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072934|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
20072935|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072936|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
20072937|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072938|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20072939|NCT01290718|Capecitabine|capecitabine|mesh-list
20072940|NCT01290718|Trastuzumab|trastuzumab|mesh-list
20072941|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072942|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
20072943|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072944|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072945|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20072946|NCT01293123|Tenofovir|tenofovir|mesh-list
20072947|NCT01293123|Emtricitabine|emtricitabine|mesh-list
20072948|NCT01293123|Efavirenz|efavirenz|mesh-list
20072949|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
20072950|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
20072951|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119867|NCT00006245|Growth Substances|growth substances|mesh-ancestor
20302915|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
20302916|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20302917|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302918|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20302919|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
20302920|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
20302921|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20302922|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20302923|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
20302924|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302925|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20302926|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20302927|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
20302928|NCT00645658|Testosterone|testosterone|mesh-list
20302929|NCT00645658|Androgens|androgens|mesh-ancestor
20302930|NCT00645658|Hormones|hormones|mesh-ancestor
20302931|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20302932|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302933|NCT00645723|Colistin|colistin|mesh-list
20072952|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20072953|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20072954|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072955|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072956|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20072957|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20072958|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20072959|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20072960|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20072961|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20072962|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20302934|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20302935|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20302936|NCT00645801|Lubiprostone|lubiprostone|mesh-list
20302937|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20302938|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20302939|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302940|NCT00645814|Adalimumab|adalimumab|mesh-list
20302941|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302942|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302943|NCT00645866|Docetaxel|docetaxel|mesh-list
20302944|NCT00645866|Capecitabine|capecitabine|mesh-list
20302945|NCT00645866|Epirubicin|epirubicin|mesh-list
20302946|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20302947|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
20302948|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
20302949|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
20302950|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302951|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20302952|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
20302953|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20302954|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20302955|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20302956|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20302957|NCT00645879|Citric Acid|citric acid|mesh-list
20302958|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
20302959|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
20302960|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20302961|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
20302962|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
20302963|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302964|NCT00645892|Adalimumab|adalimumab|mesh-list
20302965|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302966|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302967|NCT00645905|Adalimumab|adalimumab|mesh-list
20302968|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302969|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20302970|NCT00645918|Clopidogrel|clopidogrel|mesh-list
20302971|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20302972|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20302973|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20302974|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20302975|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
20302976|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578454|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20308832|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
20302977|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20302978|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302979|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20302980|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20302981|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302982|NCT00646009|Fluticasone|fluticasone|mesh-list
20302983|NCT00646009|Budesonide|budesonide|mesh-list
20302984|NCT00646009|Albuterol|albuterol|mesh-list
20302985|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
20302986|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20302987|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20302988|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20302989|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20302990|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
20302991|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20302992|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20302993|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20302994|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
20072963|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20072964|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20302995|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20302996|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20302997|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
20302998|NCT00646009|Hormones|hormones|mesh-ancestor
20302999|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303000|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20303001|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20072965|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20072966|NCT01280643|Leucovorin|leucovorin|mesh-list
20072967|NCT01280643|Bevacizumab|bevacizumab|mesh-list
20072968|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20072969|NCT01280643|Cetuximab|cetuximab|mesh-list
20072970|NCT01280643|Fluorouracil|fluorouracil|mesh-list
20072971|NCT01280643|Capecitabine|capecitabine|mesh-list
20072972|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
20072973|NCT01280643|Irinotecan|irinotecan|mesh-list
20072974|NCT01280643|Antibodies|antibodies|mesh-list
20072975|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
20072976|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20303002|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20303003|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303004|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303005|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303006|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
20303007|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20303008|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
20303009|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
20303010|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20303011|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303012|NCT00646035|Vitamins|vitamins|mesh-ancestor
20303013|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
20303014|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20303015|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20303016|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
20303017|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
20303018|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303019|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303020|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20303021|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20303022|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
20303023|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303024|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303025|NCT00646087|Ketamine|ketamine|mesh-list
20303026|NCT00646087|Analgesics|analgesics|mesh-ancestor
20303027|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
20303028|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303029|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303030|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20303031|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20303032|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
20072977|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
20072978|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20072979|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20303033|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
20072980|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20072981|NCT01280643|Growth Substances|growth substances|mesh-ancestor
20578455|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578456|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578457|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
20578458|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578459|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578460|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20578461|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20578462|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578463|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578464|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578465|NCT02085005|Capecitabine|capecitabine|mesh-list
20578466|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
20578467|NCT02085005|Aflibercept|aflibercept|mesh-list
20578468|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20578469|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
20578470|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578471|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578472|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20578473|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20578474|NCT02085005|Growth Substances|growth substances|mesh-ancestor
20578475|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578476|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
20578477|NCT02085018|Omeprazole|omeprazole|mesh-list
20578478|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20578479|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20072982|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20072983|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
20072984|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
20072985|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
20072986|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20072987|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072988|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20072989|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20072990|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20072991|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20072992|NCT01280643|Antidotes|antidotes|mesh-ancestor
20072993|NCT01280643|Protective Agents|protective agents|mesh-ancestor
20578480|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20578481|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578482|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578483|NCT02085109|Theobromine|theobromine|mesh-list
20578484|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20578485|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
20578486|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578487|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578488|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20578489|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
20578490|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
20578491|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
20578492|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
20578493|NCT02085239|Lidocaine|lidocaine|mesh-list
20578494|NCT02085239|Ropivacaine|ropivacaine|mesh-list
20578495|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
20578496|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
20578497|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578498|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578499|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
20072994|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
20072995|NCT01280643|Vitamins|vitamins|mesh-ancestor
20072996|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
20072997|NCT01281124|Azacitidine|azacitidine|mesh-list
20072998|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20072999|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
20073000|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073001|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073002|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073003|NCT01272141|Everolimus|everolimus|mesh-list
20073004|NCT01272141|Lapatinib|lapatinib|mesh-list
20073005|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073006|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073007|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
20073008|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073009|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20073010|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073011|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303034|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303035|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20073012|NCT01282216|Vaccines|vaccines|mesh-list
20073013|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20073014|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
20073015|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073016|NCT01284504|Celecoxib|celecoxib|mesh-list
20073017|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20073018|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20073019|NCT01284504|Analgesics|analgesics|mesh-ancestor
20073020|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
20073021|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073022|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073023|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073024|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073025|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20073026|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20303036|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20303037|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303038|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303039|NCT00646126|Artesunate|artesunate|mesh-list
20303040|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
20303041|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
20073027|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073028|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073029|NCT01269034|Insulin|insulin|mesh-list
20073030|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20073031|NCT01269034|Exenatide|exenatide|mesh-list
20303042|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
20303043|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20303044|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20303045|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303046|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303047|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
20303048|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
20303049|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20073032|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
20073033|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
20073034|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
20073035|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20073036|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073037|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20303050|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
20303051|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20303052|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303053|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303054|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20073038|NCT01269034|Incretins|incretins|mesh-ancestor
20073039|NCT01269034|Hormones|hormones|mesh-ancestor
20073040|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073041|NCT01274533|Lenalidomide|lenalidomide|mesh-list
20073042|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
20073043|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073044|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20303055|NCT00646126|Renal Agents|renal agents|mesh-ancestor
20303056|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
20303057|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303058|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303059|NCT00646152|Poly ICLC|poly iclc|mesh-list
20073045|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20303060|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
20303061|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
20303062|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308833|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20308834|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20308835|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20308836|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308837|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308838|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20073046|NCT01274533|Growth Substances|growth substances|mesh-ancestor
20073047|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
20073048|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303063|NCT00646178|Adalimumab|adalimumab|mesh-list
20303064|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303065|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303066|NCT00646191|Adalimumab|adalimumab|mesh-list
20303067|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303068|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303069|NCT00646204|Memantine|memantine|mesh-list
20303070|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20303071|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20303072|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
20303073|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303074|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303075|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303076|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20303077|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20303078|NCT00646230|Fenretinide|fenretinide|mesh-list
20303079|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303080|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20303081|NCT00646230|Protective Agents|protective agents|mesh-ancestor
20303082|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303083|NCT00646321|Budesonide|budesonide|mesh-list
20303084|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
20073049|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
20073050|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
20073051|NCT01279616|Busulfan|busulfan|mesh-list
20073052|NCT01279616|Rituximab|rituximab|mesh-list
20073053|NCT01279616|Fludarabine|fludarabine|mesh-list
20073054|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
20073055|NCT01279616|Tacrolimus|tacrolimus|mesh-list
20073056|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
20073057|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073058|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
20073059|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073060|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073061|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20073062|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
20303085|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19746363|NCT03862716|Incretins|incretins|mesh-ancestor
19746364|NCT03862716|Hormones|hormones|mesh-ancestor
20073063|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073064|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073065|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20073066|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20073067|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073068|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
20073069|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20073070|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073071|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20073072|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20073073|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
20073074|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20073075|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073076|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20073077|NCT01276054|Methylene Blue|methylene blue|mesh-list
20073078|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20073079|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073080|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073081|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20073082|NCT01264965|Acetaminophen|acetaminophen|mesh-list
20073083|NCT01264965|Oxycodone|oxycodone|mesh-list
20073084|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746365|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746366|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
19746367|NCT03862170|Cefazolin|cefazolin|mesh-list
19746368|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746369|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746370|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746371|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19746372|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746373|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746374|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073085|NCT01264965|Analgesics|analgesics|mesh-ancestor
20073086|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
20073087|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073088|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073089|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
20303086|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746375|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19746376|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19746377|NCT03844997|Palbociclib|palbociclib|mesh-list
19746378|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746379|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19746380|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303087|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20303088|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
20303089|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303090|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303091|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20303092|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
20303093|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
20303094|NCT00646321|Hormones|hormones|mesh-ancestor
20303095|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303096|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20303097|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20303098|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20303099|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303100|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303101|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303102|NCT00646386|Adalimumab|adalimumab|mesh-list
20303103|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303104|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303105|NCT00646425|Basiliximab|basiliximab|mesh-list
20303106|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303107|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
20303108|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303109|NCT00646503|Telbivudine|telbivudine|mesh-list
20303110|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
20303111|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303112|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20303113|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303114|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303115|NCT00646516|Budesonide|budesonide|mesh-list
20303116|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
20303117|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20303118|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303119|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20303120|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
20303121|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303122|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303123|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20303124|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
20303125|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
20303126|NCT00646516|Hormones|hormones|mesh-ancestor
20303127|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303128|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20073090|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20073091|NCT01264965|Narcotics|narcotics|mesh-ancestor
20073092|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20073093|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
20073094|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20303129|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20303130|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20303131|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303132|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303133|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303134|NCT00646529|Budesonide|budesonide|mesh-list
20303135|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
20073095|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20073096|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
20073097|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
20073098|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20073099|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073100|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
20073101|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073102|NCT01273064|Interferons|interferons|mesh-list
20073103|NCT01273064|Ribavirin|ribavirin|mesh-list
20073104|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073105|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
20073106|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303136|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20073107|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
20303137|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303138|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20303139|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
20303140|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303141|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303142|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20303143|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
20303144|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
20303145|NCT00646529|Hormones|hormones|mesh-ancestor
20303146|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303147|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20303148|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20303149|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20303150|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303151|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303152|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303153|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20578500|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578501|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20578502|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20578503|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20578504|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578505|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578506|NCT02085291|Norepinephrine|norepinephrine|mesh-list
20578507|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20578508|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20578509|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
20578510|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578511|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578512|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578513|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
20578514|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
20578515|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578516|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20578517|NCT02085304|Temozolomide|temozolomide|mesh-list
20578518|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20578519|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
20578520|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578521|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578522|NCT02085317|Nitroprusside|nitroprusside|mesh-list
20578523|NCT02085317|Acetylcholine|acetylcholine|mesh-list
20578524|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20578525|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
20578526|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20578527|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578528|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20578529|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
20578530|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578531|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578532|NCT02085408|Cytarabine|cytarabine|mesh-list
20578533|NCT02085408|Decitabine|decitabine|mesh-list
20578534|NCT02085408|Clofarabine|clofarabine|mesh-list
20578535|NCT02085408|Azacitidine|azacitidine|mesh-list
20578536|NCT02085408|Daunorubicin|daunorubicin|mesh-list
20578537|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20578538|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
20578539|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578540|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578541|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
20578542|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578543|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20578544|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
20073108|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073109|NCT01274559|Niacin|niacin|mesh-list
20073110|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20073111|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
20073112|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073113|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20073114|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
20073115|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
20073116|NCT01274559|Vitamins|vitamins|mesh-ancestor
20073117|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
20073118|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303154|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20303155|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303156|NCT00646594|Fluticasone|fluticasone|mesh-list
20303157|NCT00646594|Budesonide|budesonide|mesh-list
20073119|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
20073120|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20073121|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20073122|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20073123|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073124|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
20073125|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19491934|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19491935|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19491936|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19491937|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19491938|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19491939|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19491940|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19491941|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20303158|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
20303159|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20303160|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20303161|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20303162|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303163|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20303164|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
20303165|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303166|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303167|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20303168|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
20303169|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
20303170|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20303171|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
20303172|NCT00646594|Hormones|hormones|mesh-ancestor
20303173|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303174|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20303175|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20303176|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20303177|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303178|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303179|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303180|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
20303181|NCT00646607|Leucovorin|leucovorin|mesh-list
20303182|NCT00646607|Fluorouracil|fluorouracil|mesh-list
20303183|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
20303184|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
20303185|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
20303186|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303187|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20303188|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303189|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303190|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
20303191|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303192|NCT00646607|Antidotes|antidotes|mesh-ancestor
20303193|NCT00646607|Protective Agents|protective agents|mesh-ancestor
20303194|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
20303195|NCT00646607|Vitamins|vitamins|mesh-ancestor
20303196|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
20303197|NCT00646620|Fluticasone|fluticasone|mesh-list
20303198|NCT00646620|Budesonide|budesonide|mesh-list
20303199|NCT00646620|Albuterol|albuterol|mesh-list
20303200|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
20303201|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20303202|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20303203|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20303204|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303205|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20303206|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
20303207|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578545|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073126|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073127|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20073128|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073129|NCT01267825|Bupivacaine|bupivacaine|mesh-list
20073130|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
20303208|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303209|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20303210|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
20303211|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
20303212|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20303213|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
20303214|NCT00646620|Hormones|hormones|mesh-ancestor
20303215|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303216|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20303217|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20303218|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20303219|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303220|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303221|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303222|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
20303223|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20303224|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
20303225|NCT00646659|Carboplatin|carboplatin|mesh-list
20303226|NCT00646659|Docetaxel|docetaxel|mesh-list
20303227|NCT00646659|Fluorouracil|fluorouracil|mesh-list
20303228|NCT00646659|Cetuximab|cetuximab|mesh-list
20303229|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303230|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
20303231|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
20073131|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
20073132|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20073133|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073134|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
20303232|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
20303233|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303234|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
20303235|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20303236|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303237|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
20303238|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303239|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20303240|NCT00646711|Valproic Acid|valproic acid|mesh-list
20303241|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
20303242|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303243|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303244|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
20303245|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578546|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578547|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20578548|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20578549|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20578550|NCT02085538|Palbociclib|palbociclib|mesh-list
20578551|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578552|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20578553|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578554|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578555|NCT02085577|Acetaminophen|acetaminophen|mesh-list
20578556|NCT02085577|Sufentanil|sufentanil|mesh-list
20578557|NCT02085577|Ketamine|ketamine|mesh-list
20578558|NCT02085577|Morphine|morphine|mesh-list
20578559|NCT02085577|Dsuvia|dsuvia|mesh-list
20578560|NCT02085577|Ondansetron|ondansetron|mesh-list
20578561|NCT02085577|Analgesics|analgesics|mesh-ancestor
20578562|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
20578563|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578564|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578565|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20578566|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20578567|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
20578568|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
20578569|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578570|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20578571|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20578572|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578573|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073135|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073136|NCT01259284|Atorvastatin|atorvastatin|mesh-list
20073137|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20073138|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20073139|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
20578574|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20073140|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073141|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20073142|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20073143|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073144|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
20073145|NCT01263028|Vitamin D|vitamin d|mesh-list
20073146|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20073147|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073148|NCT01263028|Vitamins|vitamins|mesh-ancestor
20073149|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
20073150|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20073151|NCT01253668|Antibodies|antibodies|mesh-list
20073152|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20073153|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
20073154|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073155|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
20073156|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20073157|NCT01259024|Estrogens|estrogens|mesh-ancestor
20073158|NCT01259024|Hormones|hormones|mesh-ancestor
20073159|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073160|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073161|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073162|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073163|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
20073164|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073165|NCT01246011|Warfarin|warfarin|mesh-list
20073166|NCT01246011|Argatroban|argatroban|mesh-list
20073167|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
20073168|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
20073169|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20073170|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
20073171|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073172|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073173|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20073174|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
20073175|NCT01244620|Tadalafil|tadalafil|mesh-list
20073176|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
20073177|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
20073178|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20073179|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20073180|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073181|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073182|NCT01244620|Urological Agents|urological agents|mesh-ancestor
20073183|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20073184|NCT01240304|Gemcitabine|gemcitabine|mesh-list
20073185|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073186|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
20073187|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073188|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073189|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
20073190|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073191|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073192|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073193|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
20073194|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073195|NCT01230788|Rituximab|rituximab|mesh-list
20073196|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20073197|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073198|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
20073199|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073200|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073201|NCT01231750|Capsaicin|capsaicin|mesh-list
20073202|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
20073203|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073204|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
20073205|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073206|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073207|NCT01230307|Vitamin D|vitamin d|mesh-list
20073208|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
20073209|NCT01230307|Vitamins|vitamins|mesh-ancestor
20073210|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
20073211|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073212|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20073213|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20073214|NCT01222871|Triamcinolone|triamcinolone|mesh-list
20073215|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073216|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
20073217|NCT01222871|Hormones|hormones|mesh-ancestor
20073218|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303246|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303247|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
20303248|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303249|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303250|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303251|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
20303252|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20303253|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303254|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20303255|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
20303256|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20303257|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303258|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303259|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303260|NCT00646750|Rituximab|rituximab|mesh-list
20303261|NCT00646750|Melphalan|melphalan|mesh-list
20303262|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20303263|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303264|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
20303265|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303266|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303267|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20303268|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
20303269|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303270|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20303271|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303272|NCT00646802|Progesterone|progesterone|mesh-list
20303273|NCT00646802|Progestins|progestins|mesh-ancestor
20303274|NCT00646802|Hormones|hormones|mesh-ancestor
20303275|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303276|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303277|NCT00646815|Hormones|hormones|mesh-list
20303278|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303279|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303280|NCT00646841|Doxazosin|doxazosin|mesh-list
20303281|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303282|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20303283|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20303284|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20303285|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303286|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303287|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303288|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303289|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
20303290|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
20303291|NCT00646854|Doxorubicin|doxorubicin|mesh-list
20303292|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20303293|NCT00646854|Vincristine|vincristine|mesh-list
20303294|NCT00646854|Lenograstim|lenograstim|mesh-list
20303295|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303296|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
20303297|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303298|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303299|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20303300|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
20303301|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303302|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303303|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20303304|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20303305|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20303306|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20303307|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20303308|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20303309|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303310|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20073219|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073220|NCT01219673|Minocycline|minocycline|mesh-list
20073221|NCT01219673|Modafinil|modafinil|mesh-list
20073222|NCT01219673|Bupropion|bupropion|mesh-list
20303311|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
20303312|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
20303313|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
20303314|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20303315|NCT00646880|Propiverine|propiverine|mesh-list
20303316|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20303317|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20303318|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
20303319|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303320|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578575|NCT02085577|Narcotics|narcotics|mesh-ancestor
20578576|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578577|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
20578578|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
20578579|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
20578580|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578581|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
20578582|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
20578583|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20578584|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
20578585|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20578586|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20578587|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20578588|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20578589|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20578590|NCT02085590|Vaccines|vaccines|mesh-list
20578591|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
20578592|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
20578593|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578594|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20578595|NCT02085603|Saracatinib|saracatinib|mesh-list
20578596|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578597|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578598|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578599|NCT02085655|Gemcitabine|gemcitabine|mesh-list
20578600|NCT02085655|Thalidomide|thalidomide|mesh-list
20578601|NCT02085655|Dexamethasone|dexamethasone|mesh-list
20578602|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
20578603|NCT02085655|Methotrexate|methotrexate|mesh-list
20578604|NCT02085655|Pegaspargase|pegaspargase|mesh-list
20578605|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578606|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
20578607|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
20578608|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578609|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578610|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578611|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
20578612|NCT02085655|Hormones|hormones|mesh-ancestor
20578613|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578614|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20578615|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578616|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20578617|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
20578618|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578619|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
20578620|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578621|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578622|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20578623|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
20578624|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20578625|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
20073223|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20073224|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
20073225|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20073226|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20073227|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20073228|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20073229|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578626|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20578627|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
20578628|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20578629|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578630|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20578631|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
20578632|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578633|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20303321|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303322|NCT00646880|Urological Agents|urological agents|mesh-ancestor
20303323|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
20303324|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
20303325|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303326|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
20073230|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
20073231|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303327|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20303328|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303329|NCT00646932|Vitamins|vitamins|mesh-ancestor
20303330|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
20303331|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20303332|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
20303333|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20303334|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
20578634|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20578635|NCT02085655|Growth Substances|growth substances|mesh-ancestor
20578636|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
20578637|NCT02085824|Enoxaparin|enoxaparin|mesh-list
20578638|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
20578639|NCT02085824|Dabigatran|dabigatran|mesh-list
20578640|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20578641|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
20578642|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20578643|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
20578644|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578645|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578646|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
20578647|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20578648|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20578649|NCT02085902|Ropivacaine|ropivacaine|mesh-list
20578650|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
20578651|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
20578652|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578653|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578654|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
20578655|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578656|NCT02085967|Itraconazole|itraconazole|mesh-list
20578657|NCT02085967|Rifampin|rifampin|mesh-list
20578658|NCT02085967|Midazolam|midazolam|mesh-list
20073232|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073233|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20073234|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20073235|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073236|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20073237|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073238|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20073239|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20073240|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20073241|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20073242|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20073243|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20073244|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20073245|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20073246|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073247|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073248|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073249|NCT01223001|Analgesics|analgesics|mesh-ancestor
20073250|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
20073251|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073252|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
20303335|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
20578659|NCT02085967|Bupropion|bupropion|mesh-list
20578660|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20578661|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20303336|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303337|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303338|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20303339|NCT00646945|Analgesics|analgesics|mesh-ancestor
20303340|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
20303341|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303342|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20073253|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20073254|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
20073255|NCT01217060|Dexamethasone|dexamethasone|mesh-list
20073256|NCT01217060|Docetaxel|docetaxel|mesh-list
20073257|NCT01217060|Fluorouracil|fluorouracil|mesh-list
20303343|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
20303344|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303345|NCT00647023|Metformin|metformin|mesh-list
20303346|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20303347|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303348|NCT00647049|Cytarabine|cytarabine|mesh-list
20303349|NCT00647049|Rituximab|rituximab|mesh-list
20303350|NCT00647049|Methotrexate|methotrexate|mesh-list
20303351|NCT00647049|Thiotepa|thiotepa|mesh-list
20303352|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20303353|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303354|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
20303355|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303356|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303357|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20303358|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
20303359|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20303360|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20303361|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
20303362|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303363|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
20303364|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303365|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20303366|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303367|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20303368|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
20303369|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303370|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20303371|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
20303372|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20303373|NCT00647101|Latanoprost|latanoprost|mesh-list
20303374|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20303375|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20303376|NCT00647127|Fentanyl|fentanyl|mesh-list
20303377|NCT00647127|Buprenorphine|buprenorphine|mesh-list
20303378|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20303379|NCT00647127|Narcotics|narcotics|mesh-ancestor
20303380|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303381|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303382|NCT00647127|Analgesics|analgesics|mesh-ancestor
20303383|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
20303384|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303385|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20303386|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20303387|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
20303388|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
20303389|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20303390|NCT00647140|Levodopa|levodopa|mesh-list
20303391|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
20303392|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303393|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073258|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073259|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
20073260|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
20073261|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073262|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073263|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20073264|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
20073265|NCT01217060|Hormones|hormones|mesh-ancestor
20073266|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073267|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073268|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303394|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073269|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
20073270|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
20073271|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
20073272|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073273|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
20073274|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073275|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073276|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
20073277|NCT01206101|Liraglutide|liraglutide|mesh-list
20073278|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20073279|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303395|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20303396|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20303397|NCT00647166|Azathioprine|azathioprine|mesh-list
20303398|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
20303399|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303400|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20303401|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303402|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303403|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
20073280|NCT01206101|Incretins|incretins|mesh-ancestor
20073281|NCT01206101|Hormones|hormones|mesh-ancestor
20073282|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073283|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
20073284|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20073285|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20073286|NCT01216631|Prednisolone|prednisolone|mesh-list
20073287|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
20073288|NCT01216631|Infliximab|infliximab|mesh-list
20073289|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20073290|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
20073291|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073292|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
20073293|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
20073294|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073295|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073296|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20073297|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
20073298|NCT01216631|Hormones|hormones|mesh-ancestor
20073299|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073300|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20073301|NCT01216631|Protective Agents|protective agents|mesh-ancestor
20073302|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073303|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073304|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073305|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073306|NCT01211756|Oxytocin|oxytocin|mesh-list
20073307|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
20073308|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20303404|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303405|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303406|NCT00647192|Eplerenone|eplerenone|mesh-list
20303407|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20303408|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
20303409|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303410|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303411|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20303412|NCT00647192|Diuretics|diuretics|mesh-ancestor
20303413|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
20303414|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20073309|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073310|NCT01209520|Paclitaxel|paclitaxel|mesh-list
20073311|NCT01209520|Vinorelbine|vinorelbine|mesh-list
20073312|NCT01209520|Docetaxel|docetaxel|mesh-list
20073313|NCT01209520|Cisplatin|cisplatin|mesh-list
20073314|NCT01209520|Carboplatin|carboplatin|mesh-list
20073315|NCT01209520|Pemetrexed|pemetrexed|mesh-list
20073316|NCT01209520|Azacitidine|azacitidine|mesh-list
20073317|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20073318|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073319|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
20073320|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
20073321|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
20073322|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073323|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073324|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20073325|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20073326|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20303415|NCT00647218|Paclitaxel|paclitaxel|mesh-list
20303416|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20303417|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303418|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
20303419|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
20303420|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
20303421|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303422|NCT00647244|Tenofovir|tenofovir|mesh-list
20303423|NCT00647244|Abacavir|abacavir|mesh-list
20303424|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
20303425|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303426|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20303427|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20303428|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303429|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303430|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20303431|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20303432|NCT00647257|Losartan|losartan|mesh-list
20303433|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303434|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303435|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20303436|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20303437|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303438|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
20303439|NCT00647465|Vaccines|vaccines|mesh-list
20303440|NCT00647465|Immunologic Factors|immunologic factors|mesh-ancestor
20303441|NCT00647465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303442|NCT00647491|Adalimumab|adalimumab|mesh-list
20303443|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303444|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303445|NCT00647530|Fluorouracil|fluorouracil|mesh-list
20303446|NCT00647530|Capecitabine|capecitabine|mesh-list
20303447|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
20303448|NCT00647530|Panitumumab|panitumumab|mesh-list
20303449|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
20303450|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303451|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20303452|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578662|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578663|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578664|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20578665|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20578666|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20578667|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20578668|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
20578669|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
20303453|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303454|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
20303455|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303456|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20303457|NCT00647543|Atorvastatin|atorvastatin|mesh-list
20303458|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20303459|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20303460|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
20303461|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303462|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20303463|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20303464|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303465|NCT00647608|Propranolol|propranolol|mesh-list
20303466|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20303467|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20303468|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303469|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303470|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303471|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303472|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303473|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303474|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
20303475|NCT00647621|Phenytoin|phenytoin|mesh-list
20303476|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
20303477|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20303478|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20303479|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303480|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303481|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20303482|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20303483|NCT00647634|Alprazolam|alprazolam|mesh-list
20578670|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
20578671|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
20578672|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578673|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578674|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20578675|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
20578676|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20578677|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20578678|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578679|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
20578680|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20578681|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20578682|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578683|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
20578684|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578685|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20578686|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20578687|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
20578688|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578689|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20578690|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20578691|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
20578692|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578693|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
20578694|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20578695|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20578696|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20578697|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20578698|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20578699|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20578700|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20578701|NCT02086019|Aspirin|aspirin|mesh-list
20578702|NCT02086019|Ramipril|ramipril|mesh-list
20578703|NCT02086019|Bisoprolol|bisoprolol|mesh-list
20578704|NCT02086019|Heparin|heparin|mesh-list
20578705|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20578706|NCT02086019|Tinzaparin|tinzaparin|mesh-list
20578707|NCT02086019|Dalteparin|dalteparin|mesh-list
20578708|NCT02086019|Clopidogrel|clopidogrel|mesh-list
20578709|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20578710|NCT02086019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20578711|NCT02086019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578712|NCT02086019|Analgesics|analgesics|mesh-ancestor
20578713|NCT02086019|Sensory System Agents|sensory system agents|mesh-ancestor
20578714|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578715|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578716|NCT02086019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578717|NCT02086019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578718|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20578719|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20578720|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578721|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20578722|NCT02086019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20578723|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578724|NCT02086019|Antipyretics|antipyretics|mesh-ancestor
20073327|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
20119868|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119869|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20119870|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119871|NCT00006246|Busulfan|busulfan|mesh-list
20119872|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
20119873|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119874|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119875|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
20119876|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119877|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20303484|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20303485|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303486|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303487|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20303488|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303489|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303490|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
20303491|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
20303492|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303493|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303494|NCT00647647|Terbinafine|terbinafine|mesh-list
20303495|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
20303496|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303497|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303498|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303499|NCT00647660|Nadolol|nadolol|mesh-list
20303500|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
20303501|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20303502|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20303503|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303504|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303505|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303506|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303507|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303508|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303509|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
20303510|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
20303511|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303512|NCT00647660|Diuretics|diuretics|mesh-ancestor
20303513|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
20303514|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20303515|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303516|NCT00647673|Verapamil|verapamil|mesh-list
20303517|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303518|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20303519|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303520|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303521|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20303522|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303523|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
20303524|NCT00647686|Fentanyl|fentanyl|mesh-list
20303525|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20303526|NCT00647686|Narcotics|narcotics|mesh-ancestor
20303527|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303528|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303529|NCT00647686|Analgesics|analgesics|mesh-ancestor
20303530|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
20303531|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303532|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20303533|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20303534|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
20303535|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
20303536|NCT00647712|Valproic Acid|valproic acid|mesh-list
20303537|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
20303538|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303539|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303540|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
20303541|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303542|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303543|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
20303544|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303545|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303546|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303547|NCT00647738|Baclofen|baclofen|mesh-list
20303548|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20303549|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303550|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20303551|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303552|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20303553|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
20303554|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
20303555|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303556|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303557|NCT00647751|Lamotrigine|lamotrigine|mesh-list
20578725|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20303558|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
20303559|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20303560|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303561|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303562|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20303563|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073328|NCT01207726|Azacitidine|azacitidine|mesh-list
20073329|NCT01207726|Entinostat|entinostat|mesh-list
20073330|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20073331|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073332|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
20073333|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073334|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073335|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073336|NCT01206296|Gemcitabine|gemcitabine|mesh-list
20073337|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073338|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
20073339|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073340|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073341|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
20073342|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073343|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073344|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073345|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
20073346|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303564|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20303565|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303566|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303567|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303568|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20308839|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20308840|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308841|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308842|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073347|NCT01207102|Paclitaxel|paclitaxel|mesh-list
20073348|NCT01207102|Carboplatin|carboplatin|mesh-list
20308843|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20308844|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
20308845|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20308846|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308847|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20308848|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20073349|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20073350|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20073351|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073352|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
20073353|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
20073354|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
20073355|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073356|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
20073357|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20073358|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073359|NCT01202110|Propranolol|propranolol|mesh-list
20308849|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20308850|NCT00666055|Ritonavir|ritonavir|mesh-list
20308851|NCT00666055|Lopinavir|lopinavir|mesh-list
20308852|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20308853|NCT00666055|Tenofovir|tenofovir|mesh-list
20073360|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20073361|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20073362|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
20073363|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073364|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073365|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073366|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20073367|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20073368|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
20073369|NCT01206439|Nebivolol|nebivolol|mesh-list
20073370|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20073371|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
20073372|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19491942|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
20308854|NCT00666055|Lamivudine|lamivudine|mesh-list
19491943|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
20073373|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20073374|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20073375|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
20073376|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073377|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073378|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073379|NCT01200602|Megestrol|megestrol|mesh-list
20073380|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
20073381|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20073382|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20073383|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20303569|NCT00647777|Olanzapine|olanzapine|mesh-list
20303570|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
20303571|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
20303572|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303573|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303574|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20303575|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20303576|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303577|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303578|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303579|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20303580|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20303581|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303582|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303583|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303584|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
20303585|NCT00647816|Propranolol|propranolol|mesh-list
20303586|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20303587|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20303588|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303589|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303590|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303591|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578726|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20578727|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20578728|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
20578729|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578730|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
20578731|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
20578732|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20578733|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20578734|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20578735|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
20578736|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
20578737|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
20578738|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20578739|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20073384|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
20073385|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20073386|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073387|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20073388|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20073389|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073390|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073391|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
20073392|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20073393|NCT01198548|Vitamin D|vitamin d|mesh-list
20073394|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
20578740|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20578741|NCT02086032|Estradiol|estradiol|mesh-list
20578742|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20578743|NCT02086032|Estrogens|estrogens|mesh-list
20578744|NCT02086032|Progesterone|progesterone|mesh-list
20578745|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
19746381|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073395|NCT01198548|Leucovorin|leucovorin|mesh-list
20073396|NCT01198548|Bevacizumab|bevacizumab|mesh-list
20073397|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20073398|NCT01198548|Fluorouracil|fluorouracil|mesh-list
20073399|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
20073400|NCT01198548|Antibodies|antibodies|mesh-list
20073401|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
20073402|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20073403|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
20578746|NCT02086032|Hormones|hormones|mesh-ancestor
20303592|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303593|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303594|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
20303595|NCT00647829|Valdecoxib|valdecoxib|mesh-list
20303596|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20303597|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20303598|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303599|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303600|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20303601|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20303602|NCT00647829|Analgesics|analgesics|mesh-ancestor
20303603|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
20303604|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303605|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303606|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303607|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303608|NCT00647842|Fentanyl|fentanyl|mesh-list
20303609|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20303610|NCT00647842|Narcotics|narcotics|mesh-ancestor
20303611|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303612|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303613|NCT00647842|Analgesics|analgesics|mesh-ancestor
20303614|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
20303615|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303616|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20303617|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20303618|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
20303619|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
20303620|NCT00647868|Testosterone|testosterone|mesh-list
20303621|NCT00647868|Androgens|androgens|mesh-ancestor
20303622|NCT00647868|Hormones|hormones|mesh-ancestor
20303623|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303624|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303625|NCT00647881|Paroxetine|paroxetine|mesh-list
20303626|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20303627|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20303628|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303629|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303630|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303631|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
20303632|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303633|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20303634|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
20303635|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303636|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20303637|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20303638|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303639|NCT00647894|Alprazolam|alprazolam|mesh-list
20303640|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20303641|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303642|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303643|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20303644|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303645|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303646|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
20303647|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
20303648|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303649|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303650|NCT00647907|Voriconazole|voriconazole|mesh-list
20303651|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
20303652|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303653|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20303654|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20303655|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303656|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303657|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20303658|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
20303659|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303660|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303661|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20578747|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746382|NCT03825302|Mannitol|mannitol|mesh-list
20303662|NCT00647920|Adalimumab|adalimumab|mesh-list
20303663|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303664|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303665|NCT00647946|Tenofovir|tenofovir|mesh-list
20303666|NCT00647946|Abacavir|abacavir|mesh-list
20303667|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
20303668|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303669|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20303670|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20303671|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303672|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303673|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20303674|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20303675|NCT00647959|Doxycycline|doxycycline|mesh-list
20303676|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20303677|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303678|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
20303679|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20303680|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20303681|NCT00647972|Olanzapine|olanzapine|mesh-list
20303682|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
20303683|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
20303684|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303685|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303686|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20303687|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20303688|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303689|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303690|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303691|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20303692|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20303693|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303694|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303695|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303696|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
20303697|NCT00647985|Fexofenadine|fexofenadine|mesh-list
20303698|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20303699|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20303700|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20303701|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
20303702|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
20303703|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303704|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303705|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303706|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20303707|NCT00648011|Quinapril|quinapril|mesh-list
20303708|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303709|NCT00648011|Diuretics|diuretics|mesh-ancestor
20303710|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
20303711|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303712|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20303713|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303714|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303715|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20303716|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
20303717|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303718|NCT00648024|Anagrelide|anagrelide|mesh-list
20303719|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20303720|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20303721|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303722|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20303723|NCT00648050|Verapamil|verapamil|mesh-list
20303724|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303725|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20303726|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303727|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303728|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20303729|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303730|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
20303731|NCT00648063|Letrozole|letrozole|mesh-list
20303732|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303733|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20303734|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20303735|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303736|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303737|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20303738|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
20303739|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303740|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303741|NCT00648076|Valproic Acid|valproic acid|mesh-list
20303742|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
20303743|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073404|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303744|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303745|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
20303746|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303747|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303748|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
20303749|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20303750|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303751|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303752|NCT00648128|Clarithromycin|clarithromycin|mesh-list
20303753|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20303754|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303755|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20303756|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303757|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303758|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20303759|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20303760|NCT00648141|Celecoxib|celecoxib|mesh-list
20073405|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20073406|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20073407|NCT01198548|Growth Substances|growth substances|mesh-ancestor
20073408|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073409|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
20073410|NCT01198548|Vitamins|vitamins|mesh-ancestor
20073411|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
20303761|NCT00648141|Diclofenac|diclofenac|mesh-list
20303762|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20303763|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20303764|NCT00648141|Analgesics|analgesics|mesh-ancestor
20303765|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
20303766|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303767|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303768|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303769|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303770|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20303771|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20303772|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303773|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303774|NCT00648154|Letrozole|letrozole|mesh-list
20303775|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303776|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20303777|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20303778|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303779|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303780|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20303781|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
20303782|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303783|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303784|NCT00648180|Doxycycline|doxycycline|mesh-list
20303785|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20303786|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20303787|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
20303788|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20303789|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20303790|NCT00648193|Paroxetine|paroxetine|mesh-list
20303791|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20303792|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20303793|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303794|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303795|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303796|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
20303797|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308855|NCT00666055|Zidovudine|zidovudine|mesh-list
20578748|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578749|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20073412|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
20073413|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20073414|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20073415|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
20073416|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073417|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073418|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073419|NCT01198548|Antidotes|antidotes|mesh-ancestor
20073420|NCT01198548|Protective Agents|protective agents|mesh-ancestor
20073421|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
20073422|NCT01194908|Tamoxifen|tamoxifen|mesh-list
20073423|NCT01194908|Decitabine|decitabine|mesh-list
20073424|NCT01194908|Panobinostat|panobinostat|mesh-list
20073425|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073426|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
20073427|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073428|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073429|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073430|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20073431|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
20073432|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073433|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073434|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073435|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20073436|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20073437|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20073438|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20073439|NCT01194856|Ritonavir|ritonavir|mesh-list
20073440|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20073441|NCT01194856|Efavirenz|efavirenz|mesh-list
20073442|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20073443|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20073444|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
20073445|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073446|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073447|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20073448|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20073449|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
20073450|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073451|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20073452|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20073453|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20073454|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20073455|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20073456|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20073457|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20073458|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20073459|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20073460|NCT01194427|Tamoxifen|tamoxifen|mesh-list
20073461|NCT01194427|Vorinostat|vorinostat|mesh-list
20073462|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20073463|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
20073464|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073465|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073466|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073467|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073468|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20073469|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20073470|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20073471|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20073472|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073473|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073474|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20073475|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073476|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20073477|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073478|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073479|NCT01182610|Paclitaxel|paclitaxel|mesh-list
20073480|NCT01182610|Carboplatin|carboplatin|mesh-list
20303798|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20303799|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
20303800|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303801|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20303802|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20303803|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303804|NCT00648219|Olmesartan|olmesartan|mesh-list
20303805|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20303806|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303807|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20303808|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20303809|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303810|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20303811|NCT00648258|Naproxen|naproxen|mesh-list
20303812|NCT00648258|Valdecoxib|valdecoxib|mesh-list
20303813|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20303814|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20303815|NCT00648258|Analgesics|analgesics|mesh-ancestor
20303816|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
20303817|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303818|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303819|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303820|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578750|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
20578751|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20578752|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20578753|NCT02086032|Progestins|progestins|mesh-ancestor
20578754|NCT02086097|Ibuprofen|ibuprofen|mesh-list
20578755|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20578756|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20578757|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578758|NCT02086097|Analgesics|analgesics|mesh-ancestor
20578759|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
20303821|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
20303822|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20303823|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303824|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303825|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20303826|NCT00648271|Metoprolol|metoprolol|mesh-list
20303827|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303828|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303829|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
20303830|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
20303831|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303832|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303833|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20303834|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20303835|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20303836|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303837|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303838|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303839|NCT00648297|Nadolol|nadolol|mesh-list
20303840|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
20303841|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20303842|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20303843|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303844|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303845|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303846|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303847|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303848|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303849|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
20303850|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
20303851|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303852|NCT00648297|Diuretics|diuretics|mesh-ancestor
20303853|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
20303854|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20303855|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303856|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20578760|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073481|NCT01182610|Fluorouracil|fluorouracil|mesh-list
20073482|NCT01182610|Panitumumab|panitumumab|mesh-list
20073483|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20073484|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073485|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
20303857|NCT00648310|Estrogens|estrogens|mesh-list
20303858|NCT00648310|Hormones|hormones|mesh-ancestor
20303859|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20303860|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303861|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20303862|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20303863|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
20303864|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303865|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303866|NCT00648310|Urological Agents|urological agents|mesh-ancestor
20303867|NCT00648323|Doxazosin|doxazosin|mesh-list
20303868|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20303869|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20303870|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20303871|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20303872|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303873|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303874|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303875|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303876|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
20303877|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
20303878|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303879|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20303880|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20303881|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303882|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
20303883|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303884|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20303885|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303886|NCT00648349|Rabeprazole|rabeprazole|mesh-list
20303887|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20303888|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20303889|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20303890|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303891|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303892|NCT00648362|Glimepiride|glimepiride|mesh-list
20303893|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303894|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20073486|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
20073487|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
20073488|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073489|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
20073490|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073491|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073492|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
20073493|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073494|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20073495|NCT01189071|Darifenacin|darifenacin|mesh-list
20073496|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20073497|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20073498|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
20073499|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073500|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073501|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073502|NCT01189071|Urological Agents|urological agents|mesh-ancestor
20073503|NCT01183416|Tretinoin|tretinoin|mesh-list
20073504|NCT01183416|Isotretinoin|isotretinoin|mesh-list
20073505|NCT01183416|Antibodies|antibodies|mesh-list
20073506|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20073507|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
20073508|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073509|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073510|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
20073511|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073512|NCT01183221|Oxytocin|oxytocin|mesh-list
20073513|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
20073514|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20073515|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308856|NCT00666055|Emtricitabine|emtricitabine|mesh-list
20303895|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303896|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20303897|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
20303898|NCT00648388|Cilostazol|cilostazol|mesh-list
20303899|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20303900|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
20303901|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303902|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303903|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20303904|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
20303905|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20303906|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20303907|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303908|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20303909|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
20303910|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20303911|NCT00648388|Protective Agents|protective agents|mesh-ancestor
20303912|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20303913|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20303914|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303915|NCT00648401|Verapamil|verapamil|mesh-list
20073516|NCT01190306|Riboflavin|riboflavin|mesh-list
20073517|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
20073518|NCT01190306|Vitamins|vitamins|mesh-ancestor
20073519|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
20073520|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073521|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20073522|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073523|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20073524|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
20073525|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20073526|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20073527|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
20073528|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073529|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073530|NCT01181921|Galantamine|galantamine|mesh-list
20073531|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20073532|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073533|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073534|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
20073535|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073536|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073537|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20073538|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
20073539|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073540|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
20073541|NCT01188798|Methotrexate|methotrexate|mesh-list
20303916|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20303917|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20303918|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20303919|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303920|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20303921|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303922|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
20303923|NCT00648414|Fentanyl|fentanyl|mesh-list
20303924|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20303925|NCT00648414|Narcotics|narcotics|mesh-ancestor
20303926|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20303927|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303928|NCT00648414|Analgesics|analgesics|mesh-ancestor
20303929|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
20303930|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303931|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20303932|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20303933|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
20303934|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
20303935|NCT00648427|Paroxetine|paroxetine|mesh-list
20303936|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20303937|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20303938|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20073542|NCT01188798|Pentostatin|pentostatin|mesh-list
20073543|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20073544|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
20073545|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20308857|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
20303939|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303940|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303941|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
20303942|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303943|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20303944|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
20303945|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20303946|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20303947|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20303948|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20303949|NCT00648440|Midodrine|midodrine|mesh-list
20303950|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
20303951|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
20303952|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303953|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303954|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20303955|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20303956|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20303957|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20303958|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
20303959|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303960|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303961|NCT00648453|Clopidogrel|clopidogrel|mesh-list
20303962|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20303963|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20303964|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20303965|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20303966|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
20303967|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303968|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303969|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303970|NCT00648466|Sumatriptan|sumatriptan|mesh-list
20303971|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20303972|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20303973|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20303974|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
20303975|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20303976|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20303977|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303978|NCT00648492|Metformin|metformin|mesh-list
20303979|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20303980|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303981|NCT00648505|Metformin|metformin|mesh-list
20303982|NCT00648505|Glipizide|glipizide|mesh-list
20303983|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20303984|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303985|NCT00648518|Metformin|metformin|mesh-list
20303986|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20303987|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303988|NCT00648531|Balsalazide|balsalazide|mesh-list
20303989|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20303990|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20303991|NCT00648531|Analgesics|analgesics|mesh-ancestor
20303992|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
20303993|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20303994|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20303995|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20303996|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303997|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578761|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073546|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073547|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073548|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
20073549|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073550|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073551|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073552|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073553|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20073554|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073555|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
20073556|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20303998|NCT00648544|Pravastatin|pravastatin|mesh-list
20303999|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20304000|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20304001|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
20304002|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304003|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20304004|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20304005|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304006|NCT00648570|Dexetimide|dexetimide|mesh-list
20304007|NCT00648570|Citalopram|citalopram|mesh-list
20304008|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20304009|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20304010|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304011|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304012|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304013|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
20304014|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304015|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20304016|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
20304017|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304018|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20304019|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20304020|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
20304021|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
20304022|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304023|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20304024|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20304025|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
20304026|NCT00648583|Ondansetron|ondansetron|mesh-list
20304027|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
20304028|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
20304029|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304030|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304031|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304032|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
20073557|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20073558|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20073559|NCT01183884|Tretinoin|tretinoin|mesh-list
20073560|NCT01183884|Isotretinoin|isotretinoin|mesh-list
20073561|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20304033|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
20304034|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20304035|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
20304036|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304037|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304038|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20304039|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304040|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304041|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304042|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20304043|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
20304044|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
20304045|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20304046|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20304047|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304048|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304049|NCT00648596|Urological Agents|urological agents|mesh-ancestor
20304050|NCT00648622|Carvedilol|carvedilol|mesh-list
20304051|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20304052|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20304053|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
19491944|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
20073562|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
20073563|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073564|NCT01183429|Tretinoin|tretinoin|mesh-list
20073565|NCT01183429|Isotretinoin|isotretinoin|mesh-list
20073566|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073567|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
20073568|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073569|NCT01166178|Vitamin D|vitamin d|mesh-list
20073570|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
20304054|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304055|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304056|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073571|NCT01166178|Calcium|calcium|mesh-list
20073572|NCT01166178|Vitamins|vitamins|mesh-ancestor
20304057|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304058|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
20304059|NCT00648622|Protective Agents|protective agents|mesh-ancestor
20304060|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20304061|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304062|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20304063|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
20304064|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20304065|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20304066|NCT00648661|Dexetimide|dexetimide|mesh-list
20304067|NCT00648661|Citalopram|citalopram|mesh-list
20304068|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20304069|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20304070|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304071|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304072|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304073|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
20304074|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304075|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20304076|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
20304077|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304078|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20304079|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20304080|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
20304081|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
20304082|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304083|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20304084|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20304085|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
20304086|NCT00648713|Terbinafine|terbinafine|mesh-list
20304087|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
20304088|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304089|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304090|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304091|NCT00648726|Azithromycin|azithromycin|mesh-list
20304092|NCT00648726|Erythromycin|erythromycin|mesh-list
20304093|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
20304094|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20304095|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
20578762|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578763|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578764|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20578765|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578766|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578767|NCT02086188|Mirabegron|mirabegron|mesh-list
20578768|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20578769|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20578770|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20578771|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
20578772|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578773|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578774|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578775|NCT02086188|Urological Agents|urological agents|mesh-ancestor
20578776|NCT02086227|Glucagon|glucagon|mesh-list
20578777|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20578778|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578779|NCT02086227|Hormones|hormones|mesh-ancestor
20578780|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578781|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578782|NCT02086227|Incretins|incretins|mesh-ancestor
20073573|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
20073574|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073575|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20073576|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20073577|NCT01169753|Modafinil|modafinil|mesh-list
20073578|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20073579|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073580|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20073581|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20073582|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20073583|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304096|NCT00648726|Cefuroxime|cefuroxime|mesh-list
20578783|NCT02086253|BQ 788|bq 788|mesh-list
20073584|NCT01169610|Varenicline|varenicline|mesh-list
20073585|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20073586|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20073587|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
20073588|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073589|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304097|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
20304098|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304099|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304100|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304101|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20304102|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304103|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304104|NCT00648765|Anagrelide|anagrelide|mesh-list
20304105|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20304106|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20304107|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304108|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20304109|NCT00648778|Loxapine|loxapine|mesh-list
20304110|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20304111|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304112|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304113|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304114|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304115|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20304116|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
20304117|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304118|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304119|NCT00648791|Finasteride|finasteride|mesh-list
20304120|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20304121|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20304122|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304123|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304124|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
20304125|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304126|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304127|NCT00648791|Urological Agents|urological agents|mesh-ancestor
20304128|NCT00648804|Ondansetron|ondansetron|mesh-list
20304129|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
20304130|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
20304131|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304132|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304133|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304134|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
20304135|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073590|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073591|NCT01163084|Leuprolide|leuprolide|mesh-list
20073592|NCT01163084|Goserelin|goserelin|mesh-list
20073593|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20073594|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
20073595|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20073596|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073597|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073598|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073599|NCT01166724|Sirolimus|sirolimus|mesh-list
20073600|NCT01166724|Tacrolimus|tacrolimus|mesh-list
20073601|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073602|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
20073603|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073604|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20073605|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073606|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073607|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20073608|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073609|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20073610|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073611|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
20073612|NCT01157533|Vancomycin|vancomycin|mesh-list
20073613|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20073614|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073615|NCT01162304|Oxycodone|oxycodone|mesh-list
20073616|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20073617|NCT01162304|Narcotics|narcotics|mesh-ancestor
20073618|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20073619|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073620|NCT01162304|Analgesics|analgesics|mesh-ancestor
20073621|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
20073622|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304136|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20304137|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
20304138|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304139|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304140|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20073623|NCT01151904|Timolol|timolol|mesh-list
20073624|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19491945|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
19491946|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304141|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304142|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304143|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304144|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20073625|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20073626|NCT01151904|Latanoprost|latanoprost|mesh-list
20073627|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20073628|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20073629|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20304145|NCT00648817|Tenofovir|tenofovir|mesh-list
20304146|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
20304147|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304148|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20304149|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20304150|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304151|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304152|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20304153|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20304154|NCT00648830|Clarithromycin|clarithromycin|mesh-list
20304155|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304156|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304157|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20304158|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304159|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304160|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20304161|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20304162|NCT00648843|Oxybutynin|oxybutynin|mesh-list
20304163|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
20304164|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
20304165|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304166|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304167|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20304168|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20304169|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
20304170|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304171|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304172|NCT00648843|Urological Agents|urological agents|mesh-ancestor
20304173|NCT00648856|Sertraline|sertraline|mesh-list
20304174|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
20304175|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304176|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20304177|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20073630|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
20073631|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073632|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073633|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073634|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20073635|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20073636|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20073637|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20073638|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20073639|NCT01155518|Clomiphene|clomiphene|mesh-list
20073640|NCT01155518|Testosterone|testosterone|mesh-list
19491947|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073641|NCT01155518|Androgens|androgens|mesh-ancestor
20304178|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20073642|NCT01155518|Hormones|hormones|mesh-ancestor
20304179|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304180|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304181|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
20304182|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304183|NCT00648869|Metformin|metformin|mesh-list
20304184|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304185|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304186|NCT00648921|Olanzapine|olanzapine|mesh-list
20304187|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
20304188|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
20304189|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073643|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073644|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073645|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20073646|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
20073647|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20073648|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
20073649|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20073650|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20073651|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20304190|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304191|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304192|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20304193|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304194|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304195|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304196|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20304197|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20304198|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304199|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304200|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073652|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
20073653|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073654|NCT01147393|Epratuzumab|epratuzumab|mesh-list
20304201|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
20304202|NCT00648934|Topiramate|topiramate|mesh-list
20304203|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
20304204|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304205|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304206|NCT00648947|Clopidogrel|clopidogrel|mesh-list
20304207|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20304208|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20304209|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20304210|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20304211|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
20304212|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304213|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304214|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304215|NCT00648960|Clarithromycin|clarithromycin|mesh-list
20304216|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304217|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304218|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20304219|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304220|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304221|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20304222|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20304223|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
20304224|NCT00648973|Promethazine|promethazine|mesh-list
20304225|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
20304226|NCT00648973|Ephedrine|ephedrine|mesh-list
20304227|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20304228|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20304229|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304230|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304231|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
20304232|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
20304233|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
20304234|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304235|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
20304236|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
20304237|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304238|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20304239|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
20073655|NCT01147393|Veltuzumab|veltuzumab|mesh-list
20304240|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
20304241|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304242|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304243|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20304244|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
20304245|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
20304246|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20304247|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20304248|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
20304249|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
20304250|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20304251|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20304252|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
20304253|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
20304254|NCT00648986|Tazarotene|tazarotene|mesh-list
20304255|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
20304256|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
20304257|NCT00648999|Ritonavir|ritonavir|mesh-list
20304258|NCT00648999|Lopinavir|lopinavir|mesh-list
20304259|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20304260|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20304261|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304262|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304263|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304264|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20304265|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20304266|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
20304267|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304268|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20304269|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20304270|NCT00649012|Pioglitazone|pioglitazone|mesh-list
20304271|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304272|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304273|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20304274|NCT00649038|Benazepril|benazepril|mesh-list
20304275|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304276|NCT00649038|Diuretics|diuretics|mesh-ancestor
20304277|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304278|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304279|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304280|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304281|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304282|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20304283|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304284|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304285|NCT00649051|Metolazone|metolazone|mesh-list
20304286|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304287|NCT00649051|Diuretics|diuretics|mesh-ancestor
20578784|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20578785|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20578786|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578787|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20578788|NCT02086279|Hormones|hormones|mesh-list
20578789|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578790|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578791|NCT02086292|Lidocaine|lidocaine|mesh-list
20578792|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
20578793|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
20578794|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578795|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578796|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
20578797|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578798|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20578799|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20073656|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
20073657|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20073658|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073659|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
20073660|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
20073661|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073662|NCT01147042|Interferons|interferons|mesh-list
20073663|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
20073664|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073665|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
20304288|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304289|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304290|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304291|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304292|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304293|NCT00649064|Ziprasidone|ziprasidone|mesh-list
20304294|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20304295|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
20304296|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304297|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304298|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304299|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20304300|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304301|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304302|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304303|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20304304|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
20304305|NCT00649077|Meloxicam|meloxicam|mesh-list
20304306|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20304307|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20304308|NCT00649077|Analgesics|analgesics|mesh-ancestor
20304309|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
20304310|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304311|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304312|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304313|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304314|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20304315|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20304316|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304317|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304318|NCT00649090|Exemestane|exemestane|mesh-list
20304319|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20304320|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20304321|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20304322|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304323|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304324|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20304325|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
20304326|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304327|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304328|NCT00649103|Quinapril|quinapril|mesh-list
20073666|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073667|NCT01139996|Clonidine|clonidine|mesh-list
20073668|NCT01139996|Analgesics|analgesics|mesh-ancestor
20073669|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
20073670|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073671|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073672|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20073673|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
20073674|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
20073675|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20073676|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20073677|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20073678|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20073679|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304329|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20304330|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304331|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304332|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304333|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304334|NCT00649116|Metoprolol|metoprolol|mesh-list
20304335|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20304336|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304337|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
20304338|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
20304339|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304340|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304341|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20304342|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20304343|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20304344|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
19746383|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
20073680|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073681|NCT01142128|Esomeprazole|esomeprazole|mesh-list
20073682|NCT01142128|Pancrelipase|pancrelipase|mesh-list
20073683|NCT01142128|Pancreatin|pancreatin|mesh-list
20073684|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20073685|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20073686|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20073687|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073688|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304345|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304346|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304347|NCT00649129|Oxybutynin|oxybutynin|mesh-list
20304348|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
20304349|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
20304350|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304351|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304352|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20304353|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20304354|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
20304355|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304356|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304357|NCT00649129|Urological Agents|urological agents|mesh-ancestor
20304358|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
20304359|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304360|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304361|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20304362|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20304363|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304364|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304365|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20304366|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20304367|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20304368|NCT00649168|Bromocriptine|bromocriptine|mesh-list
20304369|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20304370|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20304371|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
20304372|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304373|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304374|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
20304375|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
20304376|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304377|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304378|NCT00649181|Metolazone|metolazone|mesh-list
20304379|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304380|NCT00649181|Diuretics|diuretics|mesh-ancestor
20304381|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304382|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304383|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20073689|NCT01131884|Alendronate|alendronate|mesh-list
20073690|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20073691|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073692|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20073693|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
20073694|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20073695|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20073696|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20073697|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20073698|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073699|NCT01126879|Genistein|genistein|mesh-list
20073700|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20073701|NCT01126879|Protective Agents|protective agents|mesh-ancestor
20073702|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073703|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073704|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20073705|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073706|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073707|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
20073708|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20073709|NCT01126879|Estrogens|estrogens|mesh-ancestor
20073710|NCT01126879|Hormones|hormones|mesh-ancestor
20073711|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073712|NCT01139125|Cysteamine|cysteamine|mesh-list
20073713|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
20073714|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073715|NCT01133639|Ketorolac|ketorolac|mesh-list
20304384|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304385|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304386|NCT00649194|Rabeprazole|rabeprazole|mesh-list
20304387|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20304388|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304389|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20304390|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304391|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304392|NCT00649207|Veliparib|veliparib|mesh-list
20304393|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20304394|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304395|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304396|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20304397|NCT00649233|Metoprolol|metoprolol|mesh-list
20304398|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20304399|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304400|NCT00649233|Diuretics|diuretics|mesh-ancestor
20304401|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304402|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304403|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304404|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304405|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304406|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20304407|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
20304408|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
20304409|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304410|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20304411|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20304412|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20304413|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
20304414|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308858|NCT00666055|Maraviroc|maraviroc|mesh-list
20308859|NCT00666055|Efavirenz|efavirenz|mesh-list
20308860|NCT00666055|Etravirine|etravirine|mesh-list
20308861|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20308862|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20308863|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
20308864|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308865|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308866|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20308867|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20308868|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
20308869|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073716|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20073717|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20073718|NCT01133639|Analgesics|analgesics|mesh-ancestor
20073719|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
20073720|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073721|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073722|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073723|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073724|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20073725|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073726|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073727|NCT01126801|Estradiol|estradiol|mesh-list
20073728|NCT01126801|Estrogens|estrogens|mesh-ancestor
20073729|NCT01126801|Hormones|hormones|mesh-ancestor
20073730|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073731|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073732|NCT01126957|Fentanyl|fentanyl|mesh-list
20073733|NCT01126957|Ketamine|ketamine|mesh-list
20073734|NCT01126957|Propofol|propofol|mesh-list
20073735|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20073736|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20073737|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073738|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20073739|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
20073740|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
20073741|NCT01126957|Analgesics|analgesics|mesh-ancestor
20073742|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
20308870|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20578800|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20073743|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073744|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20073745|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20073746|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20073747|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073748|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073749|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20073750|NCT01126957|Narcotics|narcotics|mesh-ancestor
20073751|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20073752|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
20073753|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073754|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073755|NCT01122511|Dexamethasone|dexamethasone|mesh-list
20073756|NCT01122511|Ranibizumab|ranibizumab|mesh-list
20073757|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073758|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
20073759|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
20073760|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073761|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073762|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20073763|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
20073764|NCT01122511|Hormones|hormones|mesh-ancestor
20073765|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073766|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073767|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073768|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20073769|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20073770|NCT01122511|Growth Substances|growth substances|mesh-ancestor
20073771|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
20073772|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
20073773|NCT01118013|Methotrexate|methotrexate|mesh-list
20073774|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
20073775|NCT01118013|Fludarabine|fludarabine|mesh-list
20073776|NCT01118013|Busulfan|busulfan|mesh-list
20073777|NCT01118013|Tacrolimus|tacrolimus|mesh-list
20073778|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20073779|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20073780|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
20073781|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20073782|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073783|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20073784|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
20073785|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073786|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073787|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073788|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073789|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20073790|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073791|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
20073792|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073793|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20073794|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20073795|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20073796|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20073797|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
20073798|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20073799|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073800|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
20073801|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20073802|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20073803|NCT01122381|Ethosuximide|ethosuximide|mesh-list
20073804|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
20073805|NCT01116232|Sirolimus|sirolimus|mesh-list
20073806|NCT01116232|Rituximab|rituximab|mesh-list
20073807|NCT01116232|Tacrolimus|tacrolimus|mesh-list
20073808|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20073809|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20073810|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073811|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
20073812|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073813|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073814|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073815|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20073816|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073817|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073818|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304415|NCT00649259|Oxybutynin|oxybutynin|mesh-list
20304416|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
20304417|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
20304418|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304419|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073819|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073820|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20073821|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
20073822|NCT01108666|Nelfinavir|nelfinavir|mesh-list
20073823|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20073824|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20073825|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
20073826|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073827|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073828|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20073829|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20073830|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
20304420|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20304421|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20304422|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
20304423|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304424|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304425|NCT00649259|Urological Agents|urological agents|mesh-ancestor
20304426|NCT00649272|Oxybutynin|oxybutynin|mesh-list
20304427|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
20304428|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
20304429|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304430|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304431|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20304432|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20304433|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
20304434|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304435|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304436|NCT00649272|Urological Agents|urological agents|mesh-ancestor
20304437|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
20304438|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20304439|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304440|NCT00649285|Renal Agents|renal agents|mesh-ancestor
20304441|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304442|NCT00649311|Losartan|losartan|mesh-list
20304443|NCT00649311|Eplerenone|eplerenone|mesh-list
20304444|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20304445|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304446|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20304447|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20304448|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304449|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20304450|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
20304451|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304452|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304453|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20578801|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578802|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605729|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605730|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20605731|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20605732|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605733|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605734|NCT02233790|Clopidogrel|clopidogrel|mesh-list
20073831|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073832|NCT01115244|Dapsone|dapsone|mesh-list
20073833|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073834|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
20073835|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20073836|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20073837|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20304454|NCT00649311|Diuretics|diuretics|mesh-ancestor
20304455|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304456|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20304457|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20605735|NCT02233790|Ticagrelor|ticagrelor|mesh-list
20605736|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20605737|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20304458|NCT00649324|Diuretics|diuretics|mesh-ancestor
20073838|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304459|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304460|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304461|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304462|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304463|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304464|NCT00649350|Metformin|metformin|mesh-list
20304465|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20073839|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073840|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
20073841|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20073842|NCT01106534|Aspirin|aspirin|mesh-list
20073843|NCT01106534|Everolimus|everolimus|mesh-list
20073844|NCT01106534|Clopidogrel|clopidogrel|mesh-list
20073845|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20073846|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20073847|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20073848|NCT01106534|Analgesics|analgesics|mesh-ancestor
20073849|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
20073850|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073851|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073852|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073853|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073854|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20304466|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304467|NCT00649363|Ondansetron|ondansetron|mesh-list
20304468|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
20304469|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
20304470|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304471|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304472|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304473|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
20304474|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
20304475|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20304476|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
20304477|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304478|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304479|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20304480|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20578803|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
20578804|NCT02086409|Vitamin D|vitamin d|mesh-list
20578805|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
20578806|NCT02086409|Vitamins|vitamins|mesh-list
20578807|NCT02086409|Calcium|calcium|mesh-list
20578808|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
20578809|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578810|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20578811|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20578812|NCT02086474|Bupivacaine|bupivacaine|mesh-list
20578813|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
20578814|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
20073855|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20073856|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073857|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20073858|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20073859|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073860|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
20073861|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073862|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073863|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
20073864|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20073865|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20073866|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20073867|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
20073868|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073869|NCT01100658|Methylphenidate|methylphenidate|mesh-list
20073870|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20073871|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073872|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20073873|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20073874|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304481|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304482|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304483|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20578815|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
20578816|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304484|NCT00649376|Fexofenadine|fexofenadine|mesh-list
20073875|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073876|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
20073877|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073878|NCT01103180|Citalopram|citalopram|mesh-list
20073879|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20073880|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20073881|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304485|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20304486|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20304487|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20304488|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
20304489|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
20304490|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304491|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304492|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304493|NCT00649402|Amlodipine|amlodipine|mesh-list
20304494|NCT00649402|Benazepril|benazepril|mesh-list
20304495|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304496|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20304497|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304498|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304499|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20304500|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304501|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
20304502|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20304503|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304504|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304505|NCT00649415|Valdecoxib|valdecoxib|mesh-list
20304506|NCT00649415|Piroxicam|piroxicam|mesh-list
20304507|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20304508|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20304509|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304510|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304511|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20304512|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20304513|NCT00649415|Analgesics|analgesics|mesh-ancestor
20304514|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
20304515|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304516|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073882|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073883|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073884|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
20073885|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073886|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20073887|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
20073888|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20073889|NCT01090141|Micafungin|micafungin|mesh-list
20073890|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
20073891|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073892|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20073893|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
20073894|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073895|NCT01094561|Secretin|secretin|mesh-list
20073896|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20073897|NCT01094561|Hormones|hormones|mesh-ancestor
20073898|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073899|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073900|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20073901|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
20073902|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073903|NCT01078844|Memantine|memantine|mesh-list
20073904|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20073905|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20073906|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
20073907|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073908|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073909|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073910|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20073911|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20304517|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304518|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304519|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20304520|NCT00649441|Quinapril|quinapril|mesh-list
20304521|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304522|NCT00649441|Diuretics|diuretics|mesh-ancestor
20304523|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304524|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304525|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304526|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304527|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304528|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20304529|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304530|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073912|NCT01085643|Lubiprostone|lubiprostone|mesh-list
20073913|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20073914|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20073915|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073916|NCT01080768|Amlodipine|amlodipine|mesh-list
20304531|NCT00649454|Metformin|metformin|mesh-list
20304532|NCT00649454|Glipizide|glipizide|mesh-list
20304533|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304534|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304535|NCT00649467|Topiramate|topiramate|mesh-list
20304536|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
20304537|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304538|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304539|NCT00649480|Balsalazide|balsalazide|mesh-list
20304540|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20304541|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20304542|NCT00649480|Analgesics|analgesics|mesh-ancestor
20304543|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
20304544|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304545|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304546|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304547|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304548|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304549|NCT00649493|Rabeprazole|rabeprazole|mesh-list
20304550|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20304551|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20073917|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20073918|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20073919|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20073920|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073921|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20304552|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20304553|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304554|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304555|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
20304556|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20304557|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304558|NCT00649506|Renal Agents|renal agents|mesh-ancestor
20304559|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304560|NCT00649519|Amlodipine|amlodipine|mesh-list
20304561|NCT00649519|Benazepril|benazepril|mesh-list
20304562|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304563|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20304564|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304565|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304566|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20304567|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304568|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
20304569|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20304570|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304571|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304572|NCT00649532|Ondansetron|ondansetron|mesh-list
20304573|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
20304574|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
20304575|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304576|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304577|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304578|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
20304579|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
20304580|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20304581|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
20304582|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308871|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20304583|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304584|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20304585|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304586|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304587|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304588|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20304589|NCT00649545|Adalimumab|adalimumab|mesh-list
20304590|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304591|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304592|NCT00649558|Pioglitazone|pioglitazone|mesh-list
20304593|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304594|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304595|NCT00649571|Doxycycline|doxycycline|mesh-list
20304596|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304597|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304598|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
20304599|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20304600|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20304601|NCT00649584|Gemcitabine|gemcitabine|mesh-list
20304602|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20304603|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20304604|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
20304605|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304606|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20304607|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
20304608|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304609|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304610|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20304611|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
20304612|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304613|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20304614|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20304615|NCT00649597|Benazepril|benazepril|mesh-list
20304616|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304617|NCT00649597|Diuretics|diuretics|mesh-ancestor
20304618|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304619|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304620|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304621|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304622|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304623|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20304624|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304625|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304626|NCT00649610|Diclofenac|diclofenac|mesh-list
20304627|NCT00649610|Valdecoxib|valdecoxib|mesh-list
20304628|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20304629|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578817|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578818|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
20578819|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578820|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20578821|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
20578822|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
20578823|NCT02086474|Protective Agents|protective agents|mesh-ancestor
20578824|NCT02086526|Metformin|metformin|mesh-list
20578825|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20578826|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578827|NCT02086656|Bevacizumab|bevacizumab|mesh-list
20578828|NCT02086656|Capecitabine|capecitabine|mesh-list
20578829|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
20578830|NCT02086656|Irinotecan|irinotecan|mesh-list
20578831|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20073922|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073923|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
20073924|NCT01074502|Apremilast|apremilast|mesh-list
20073925|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20073926|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20073927|NCT01074502|Analgesics|analgesics|mesh-ancestor
20073928|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
20073929|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073930|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073931|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073932|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578832|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578833|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20578834|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20073933|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20073934|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20073935|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073936|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073937|NCT01074437|Prednisolone|prednisolone|mesh-list
20073938|NCT01074437|Propranolol|propranolol|mesh-list
20073939|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304630|NCT00649610|Analgesics|analgesics|mesh-ancestor
20304631|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
20304632|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304633|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304634|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304635|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304636|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20304637|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304638|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304639|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20304640|NCT00649623|Olmesartan|olmesartan|mesh-list
20304641|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20304642|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304643|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20304644|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20304645|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304646|NCT00649636|Fluoxetine|fluoxetine|mesh-list
20304647|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20304648|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20304649|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578835|NCT02086656|Growth Substances|growth substances|mesh-ancestor
20073940|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
20073941|NCT01074437|Hormones|hormones|mesh-ancestor
20073942|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20073943|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073944|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20073945|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20073946|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20073947|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20073948|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
20073949|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20073950|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073951|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20073952|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20073953|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
20073954|NCT01072526|Cyclosporine|cyclosporine|mesh-list
20073955|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
20073956|NCT01072526|Cyclosporins|cyclosporins|mesh-list
20073957|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578836|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578837|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
20073958|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073959|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20073960|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
20073961|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073962|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
20073963|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073964|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
20073965|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20073966|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20073967|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20073968|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20073969|NCT01071993|Atorvastatin|atorvastatin|mesh-list
20073970|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20073971|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20073972|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
20073973|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073974|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20073975|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20073976|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073977|NCT01065051|Riociguat|riociguat|mesh-list
20073978|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
20073979|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073980|NCT01058642|Pregabalin|pregabalin|mesh-list
20073981|NCT01058642|Analgesics|analgesics|mesh-ancestor
20073982|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
20304650|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304651|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304652|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
20304653|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304654|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20304655|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
20304656|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20073983|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20073984|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20073985|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
20073986|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20073987|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304657|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20304658|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20304659|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304660|NCT00649649|Quinapril|quinapril|mesh-list
20304661|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20304662|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304663|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304664|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304665|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304666|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
20304667|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304668|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304669|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20304670|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20304671|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304672|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304673|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20304674|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20304675|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20304676|NCT00649675|Meloxicam|meloxicam|mesh-list
20304677|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20304678|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20304679|NCT00649675|Analgesics|analgesics|mesh-ancestor
20304680|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
20304681|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304682|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304683|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20073988|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20073989|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20073990|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20073991|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20073992|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20073993|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20119878|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119879|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20119880|NCT00006247|Semaxinib|semaxinib|mesh-list
20119881|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20119882|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20119883|NCT00006247|Growth Substances|growth substances|mesh-ancestor
20119884|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119885|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
20119886|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119887|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20119888|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119889|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119890|NCT00006248|Paclitaxel|paclitaxel|mesh-list
20119891|NCT00006248|Fluorouracil|fluorouracil|mesh-list
20119892|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119893|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119894|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119895|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119896|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119897|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119898|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
20119899|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119900|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119901|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
20119902|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119903|NCT00006249|Interferons|interferons|mesh-list
20119904|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
20304684|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304685|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20304686|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20304687|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304688|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304689|NCT00649688|Metoprolol|metoprolol|mesh-list
20304690|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20304691|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304692|NCT00649688|Diuretics|diuretics|mesh-ancestor
20304693|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
20304694|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304695|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304696|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304697|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304698|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20304699|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
20304700|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
20304701|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304702|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20304703|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20304704|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20304705|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
20304706|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304707|NCT00649714|Zonisamide|zonisamide|mesh-list
20304708|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
20073994|NCT01065818|Telbivudine|telbivudine|mesh-list
20073995|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
20073996|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20073997|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20073998|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20073999|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074000|NCT01051921|Interferons|interferons|mesh-list
20074001|NCT01051921|Ribavirin|ribavirin|mesh-list
20074002|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074003|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
20074004|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074005|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
20074006|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074007|NCT01048125|Nitroprusside|nitroprusside|mesh-list
20074008|NCT01048125|Phenylephrine|phenylephrine|mesh-list
20074009|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
20074010|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20074011|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
20074012|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
20074013|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074014|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074015|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
20074016|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20074017|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
20074018|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
20074019|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20074020|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20074021|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20074022|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
20074023|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074024|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074025|NCT01048125|Protective Agents|protective agents|mesh-ancestor
20074026|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20074027|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
20074028|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20074029|NCT01058369|Deferasirox|deferasirox|mesh-list
20074030|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20074031|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
20074032|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
20074033|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074034|NCT01048723|Everolimus|everolimus|mesh-list
20074035|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074036|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074037|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
20074038|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074039|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
20304709|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20304710|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304711|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304712|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20074040|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20074041|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074042|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20074043|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
20074044|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20074045|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074046|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074047|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074048|NCT01038752|Suramin|suramin|mesh-list
20074049|NCT01038752|Carboplatin|carboplatin|mesh-list
20074050|NCT01038752|Docetaxel|docetaxel|mesh-list
20074051|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074052|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
20074053|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
20074054|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074055|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074056|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
20074057|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
20074058|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20074059|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074060|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20074061|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20074062|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20074063|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20074064|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20074065|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20074066|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074067|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074068|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074069|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
20074070|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20074071|NCT01045694|Triamcinolone|triamcinolone|mesh-list
20074072|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20074073|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20074074|NCT01045694|Lidocaine|lidocaine|mesh-list
20074075|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
20074076|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20074077|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20074078|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20074079|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
20074080|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
20074081|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074082|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074083|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
20074084|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074085|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20074086|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20074087|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20074088|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20074089|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074090|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20074091|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
20074092|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074093|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20074094|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074095|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
20074096|NCT01045694|Hormones|hormones|mesh-ancestor
20074097|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074098|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074099|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
20074100|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074101|NCT01035944|Chitosan|chitosan|mesh-list
20074102|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20074103|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20074104|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
20074105|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074106|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20074107|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
20074108|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
20074109|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
20304713|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304714|NCT00649727|Oxybutynin|oxybutynin|mesh-list
20578838|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20578839|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
20578840|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578841|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20578842|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20578843|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578844|NCT02086747|Acetaminophen|acetaminophen|mesh-list
20578845|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20578846|NCT02086747|Analgesics|analgesics|mesh-ancestor
20578847|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
20074110|NCT01035944|Coagulants|coagulants|mesh-ancestor
20074111|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
20074112|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074113|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20074114|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074115|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074116|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20578848|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578849|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578850|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
20578851|NCT02086825|Rifaximin|rifaximin|mesh-list
20578852|NCT02086825|Lactulose|lactulose|mesh-list
20578853|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20578854|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578855|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578856|NCT02086838|Dextrans|dextrans|mesh-list
20578857|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
20578858|NCT02086838|Hematinics|hematinics|mesh-list
20578859|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
20578860|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
20578861|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
20578862|NCT02086903|Clopidogrel|clopidogrel|mesh-list
20578863|NCT02086903|Ticagrelor|ticagrelor|mesh-list
20578864|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20578865|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20578866|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20578867|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20578868|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
20578869|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578870|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578871|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578872|NCT02086929|Trazodone|trazodone|mesh-list
20578873|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20074117|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20074118|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20074119|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20074120|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074121|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578874|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20578875|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20578876|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578877|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578878|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578879|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578880|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20578881|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
20578882|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20578883|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20578884|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20578885|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578886|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20074122|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074123|NCT01035073|Analgesics|analgesics|mesh-ancestor
20304715|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
20304716|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
20304717|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304718|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304719|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20304720|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20304721|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
20304722|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304723|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304724|NCT00649727|Urological Agents|urological agents|mesh-ancestor
20304725|NCT00649740|Topiramate|topiramate|mesh-list
20304726|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
20074124|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
20074125|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074126|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
20074127|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20074128|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
20074129|NCT01031550|Propofol|propofol|mesh-list
20074130|NCT01031550|Isoflurane|isoflurane|mesh-list
20074131|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20074132|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074133|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074134|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20074135|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
20074136|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
20074137|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20074138|NCT01025271|Daptomycin|daptomycin|mesh-list
20074139|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20074140|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304727|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304728|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304729|NCT00649779|Albuterol|albuterol|mesh-list
20304730|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20304731|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
20304732|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074141|NCT01022398|Vitamin D|vitamin d|mesh-list
20074142|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
20074143|NCT01022398|Vitamins|vitamins|mesh-ancestor
20074144|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
20074145|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074146|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20074147|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20074148|NCT01019980|Acetaminophen|acetaminophen|mesh-list
20074149|NCT01019980|Diclofenac|diclofenac|mesh-list
20074150|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20074151|NCT01019980|Analgesics|analgesics|mesh-ancestor
20074152|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
20074153|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074154|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074155|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
20074156|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20074157|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074158|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074159|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20074160|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074161|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074162|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
20074163|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20074164|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20074165|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
20074166|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074167|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20074168|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20074169|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
20074170|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20074171|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074172|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20074173|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20074174|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20074175|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074176|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
20074177|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074178|NCT01020903|Aprepitant|aprepitant|mesh-list
20074179|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
20074180|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
20074181|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074182|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074183|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20074184|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20074185|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074186|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074187|NCT01023620|Pioglitazone|pioglitazone|mesh-list
20074188|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20074189|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074190|NCT01018810|Interleukin-23|interleukin-23|mesh-list
20304733|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304734|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20304735|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
20304736|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
20304737|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20304738|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20304739|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20304740|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20304741|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
20304742|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304743|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304744|NCT00649805|Verapamil|verapamil|mesh-list
20304745|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20074191|NCT01018810|Antibodies|antibodies|mesh-list
20074192|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
20074193|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
20074194|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074195|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20304746|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20304747|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304748|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304749|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20304750|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304751|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
20304752|NCT00649818|Lorazepam|lorazepam|mesh-list
20304753|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
20304754|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
20304755|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
20304756|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304757|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304758|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20304759|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20304760|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304761|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20304762|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304763|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304764|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
20304765|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
20304766|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304767|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304768|NCT00649831|Amoxicillin|amoxicillin|mesh-list
20304769|NCT00649831|Azithromycin|azithromycin|mesh-list
20304770|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304771|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304772|NCT00649844|Ziprasidone|ziprasidone|mesh-list
20304773|NCT00649844|Clozapine|clozapine|mesh-list
20304774|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20304775|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
20304776|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304777|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304778|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304779|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20304780|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20578887|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
20074196|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20074197|NCT01018810|Growth Substances|growth substances|mesh-ancestor
20074198|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
20074199|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074200|NCT01016561|Cisplatin|cisplatin|mesh-list
20074201|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074202|NCT01016847|Montelukast|montelukast|mesh-list
20074203|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20074204|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
20074205|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20074206|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
20074207|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074208|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074209|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20074210|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20304781|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304782|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304783|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20304784|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
20304785|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
20304786|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
20074211|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074212|NCT01014767|Leucovorin|leucovorin|mesh-list
20074213|NCT01014767|Dactinomycin|dactinomycin|mesh-list
20074214|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
20074215|NCT01014767|Temozolomide|temozolomide|mesh-list
20074216|NCT01014767|Cisplatin|cisplatin|mesh-list
20074217|NCT01014767|Carboplatin|carboplatin|mesh-list
20074218|NCT01014767|Doxorubicin|doxorubicin|mesh-list
20074219|NCT01014767|Methotrexate|methotrexate|mesh-list
20074220|NCT01014767|Irinotecan|irinotecan|mesh-list
20074221|NCT01014767|Etoposide|etoposide|mesh-list
20074222|NCT01014767|Vincristine|vincristine|mesh-list
20074223|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074224|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
20074225|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074226|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074227|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20074228|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
20074229|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074230|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074231|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20074232|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20074233|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20074234|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20074235|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074236|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20074237|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
20074238|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20074239|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20074240|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
20074241|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
20074242|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20074243|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20074244|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20074245|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20074246|NCT01014767|Antidotes|antidotes|mesh-ancestor
20074247|NCT01014767|Protective Agents|protective agents|mesh-ancestor
20074248|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
20074249|NCT01014767|Vitamins|vitamins|mesh-ancestor
20074250|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
20074251|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
20074252|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
20074253|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074254|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20074255|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074256|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20074257|NCT01013701|Fluticasone|fluticasone|mesh-list
20074258|NCT01013701|Xhance|xhance|mesh-list
20074259|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074260|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20074261|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
20074262|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074263|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074264|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20074265|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
20074266|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20074267|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20074268|NCT01009931|Dexamethasone|dexamethasone|mesh-list
20074269|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
20074270|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
20074271|NCT01009931|Choline|choline|mesh-list
20074272|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20074273|NCT01009931|BB 1101|bb 1101|mesh-list
20074274|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074275|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
20074276|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
20074277|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074278|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304787|NCT00649857|Cetirizine|cetirizine|mesh-list
20304788|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20074279|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20074280|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
20074281|NCT01009931|Hormones|hormones|mesh-ancestor
20074282|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304789|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20304790|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20304791|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
20304792|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
20304793|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304794|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304795|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304796|NCT00649870|Valacyclovir|valacyclovir|mesh-list
20304797|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
20304798|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304799|NCT00649883|Vaccines|vaccines|mesh-list
20304800|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
20304801|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304802|NCT00649896|Estradiol|estradiol|mesh-list
20304803|NCT00649896|Estrogens|estrogens|mesh-ancestor
20304804|NCT00649896|Hormones|hormones|mesh-ancestor
20074283|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20074284|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074285|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
20074286|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074287|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074288|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
20074289|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20074290|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
20074291|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20074292|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
20074293|NCT01009931|Analgesics|analgesics|mesh-ancestor
20074294|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
20074295|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20074296|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20074297|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074298|NCT01006018|Pioglitazone|pioglitazone|mesh-list
20074299|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20074300|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304805|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304806|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304807|NCT00649922|Adalimumab|adalimumab|mesh-list
20304808|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304809|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304810|NCT00649935|Azithromycin|azithromycin|mesh-list
20304811|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304812|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304813|NCT00649948|Metformin|metformin|mesh-list
20304814|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304815|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304816|NCT00649974|Valacyclovir|valacyclovir|mesh-list
20074301|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074302|NCT01006018|Incretins|incretins|mesh-ancestor
20304817|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
20304818|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20304819|NCT00649987|Albuterol|albuterol|mesh-list
20304820|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20304821|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
20304822|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304823|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304824|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20304825|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
20304826|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
20304827|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20304828|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20304829|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20304830|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20304831|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
20304832|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304833|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304834|NCT00650000|Modafinil|modafinil|mesh-list
20304835|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20304836|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304837|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20304838|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20304839|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20074303|NCT01006018|Hormones|hormones|mesh-ancestor
20074304|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304840|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074305|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20304841|NCT00650013|Midodrine|midodrine|mesh-list
20304842|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
20074306|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
20074307|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074308|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074309|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
20074310|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20074311|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304843|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
20304844|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304845|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304846|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20304847|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20304848|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20304849|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20304850|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
20304851|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304852|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304853|NCT00650026|Adalimumab|adalimumab|mesh-list
20074312|NCT01005914|Cytarabine|cytarabine|mesh-list
20074313|NCT01005914|Dexamethasone|dexamethasone|mesh-list
20074314|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
20074315|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20074316|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20074317|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
20074318|NCT01005914|Doxorubicin|doxorubicin|mesh-list
20074319|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20074320|NCT01005914|Methotrexate|methotrexate|mesh-list
20074321|NCT01005914|Vincristine|vincristine|mesh-list
20074322|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
20074323|NCT01005914|Asparaginase|asparaginase|mesh-list
20074324|NCT01005914|Pegaspargase|pegaspargase|mesh-list
20074325|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074326|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
20074327|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074328|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074329|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20074330|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
20074331|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074332|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074333|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20074334|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074335|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
20074336|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
20074337|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074338|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20074339|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
20074340|NCT01005914|Hormones|hormones|mesh-ancestor
20074341|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074342|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20074343|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20074344|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20074345|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20074346|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074347|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20074348|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
20074349|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20074350|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20074351|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
20074352|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
20074353|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20074354|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20074355|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
20074356|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074357|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20074358|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
20074359|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
20074360|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074361|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20074362|NCT01005914|Protective Agents|protective agents|mesh-ancestor
20074363|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20074364|NCT00996333|Gemcitabine|gemcitabine|mesh-list
20074365|NCT00996333|Capecitabine|capecitabine|mesh-list
20074366|NCT00996333|Docetaxel|docetaxel|mesh-list
20074367|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20074368|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
20074369|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074370|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074371|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
20074372|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074373|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074374|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074375|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
20074376|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074377|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
20074378|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
20074379|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074380|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
20074381|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
20074382|NCT00998738|Calcium|calcium|mesh-list
20074383|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20074384|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074385|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20074386|NCT00998738|Analgesics|analgesics|mesh-ancestor
20074387|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
20074388|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074389|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
20074390|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074391|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20074392|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
20074393|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20074394|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20074395|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074396|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
20074397|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20074398|NCT00996502|Prednisone|prednisone|mesh-list
20074399|NCT00996502|Bevacizumab|bevacizumab|mesh-list
20074400|NCT00996502|Docetaxel|docetaxel|mesh-list
20074401|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20074402|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20074403|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074404|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20074405|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20074406|NCT00996502|Growth Substances|growth substances|mesh-ancestor
20074407|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074408|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
20074409|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
20074410|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
20074411|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074412|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074413|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074414|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
20074415|NCT00996502|Hormones|hormones|mesh-ancestor
20074416|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074417|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20074418|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20074419|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074420|NCT00997386|Melphalan|melphalan|mesh-list
20074421|NCT00997386|Busulfan|busulfan|mesh-list
20074422|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
20074423|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20074424|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
20074425|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074426|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074427|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20074428|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074429|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
20074430|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074431|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20074432|NCT00985738|Dutasteride|dutasteride|mesh-list
20074433|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20074434|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20074435|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074436|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074437|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
20074438|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074439|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074440|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20074441|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20074442|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20304854|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304855|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304856|NCT00650039|Valdecoxib|valdecoxib|mesh-list
20304857|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20304858|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20304859|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304860|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304861|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20304862|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20304863|NCT00650039|Analgesics|analgesics|mesh-ancestor
20304864|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
20304865|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304866|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304867|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20304868|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304869|NCT00650052|Zonisamide|zonisamide|mesh-list
20304870|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
20074443|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
20074444|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074445|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20074446|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20074447|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074448|NCT00989937|Oxytocin|oxytocin|mesh-list
20074449|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
20074450|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20074451|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074452|NCT00986947|Rituximab|rituximab|mesh-list
20074453|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20074454|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074455|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
20074456|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074457|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074458|NCT00982995|Palonosetron|palonosetron|mesh-list
20074459|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
20074460|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
20074461|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074462|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074463|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20074464|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20074465|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20074466|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
20074467|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074468|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074469|NCT00984490|Metformin|metformin|mesh-list
20074470|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20074471|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074472|NCT00986310|Fluoxetine|fluoxetine|mesh-list
20074473|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20074474|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20074475|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20074476|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074477|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074478|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
20074479|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074480|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20074481|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
20074482|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20074483|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20074484|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20074485|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074486|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20074487|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20074488|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074489|NCT00983645|Cyclosporine|cyclosporine|mesh-list
20074490|NCT00983645|Tacrolimus|tacrolimus|mesh-list
20074491|NCT00983645|Cyclosporins|cyclosporins|mesh-list
20074492|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074493|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
20074494|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074495|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20074496|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074497|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074498|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
20304871|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20074499|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074500|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
20304872|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304873|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304874|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20304875|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304876|NCT00650065|Cetirizine|cetirizine|mesh-list
20304877|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20304878|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20304879|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20074501|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074502|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20074503|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20074504|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20074505|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
20074506|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074507|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20074508|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20074509|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074510|NCT00979550|Imiquimod|imiquimod|mesh-list
19491995|NCT03126708|Paclitaxel|paclitaxel|mesh-list
19491996|NCT03126708|Cetuximab|cetuximab|mesh-list
19491997|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19491998|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074511|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20304880|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
20304881|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
20304882|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304883|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304884|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304885|NCT00650117|Fentanyl|fentanyl|mesh-list
20304886|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20304887|NCT00650117|Narcotics|narcotics|mesh-ancestor
20304888|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304889|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304890|NCT00650117|Analgesics|analgesics|mesh-ancestor
20304891|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
20304892|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304893|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20304894|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20304895|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
20074512|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
20074513|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074514|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074515|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
20074516|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
20074517|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20074518|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074519|NCT00981370|Deferasirox|deferasirox|mesh-list
20074520|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20074521|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
20074522|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
20074523|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074524|NCT00975611|Amantadine|amantadine|mesh-list
20074525|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20074526|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20074527|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
20074528|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074529|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
20074530|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074531|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074532|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074533|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20074534|NCT00975611|Analgesics|analgesics|mesh-ancestor
20074535|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
20074536|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074537|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20074538|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20074539|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20074540|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
20074541|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074542|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20304896|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
19491999|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
20304897|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20304898|NCT00650143|Lenograstim|lenograstim|mesh-list
20304899|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304900|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304901|NCT00650143|Incretins|incretins|mesh-ancestor
20304902|NCT00650143|Hormones|hormones|mesh-ancestor
20304903|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20304904|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20304905|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
20304906|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304907|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304908|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19746384|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20074543|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20074544|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074545|NCT00979810|Alovudine|alovudine|mesh-list
20074546|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
20074547|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074548|NCT00974922|Vitamin D|vitamin d|mesh-list
20074549|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
20074550|NCT00974922|Vitamins|vitamins|mesh-ancestor
20074551|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
20074552|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074553|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20074554|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20074555|NCT00976339|Vitamin D|vitamin d|mesh-list
20074556|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
20074557|NCT00976339|Vitamins|vitamins|mesh-ancestor
20074558|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
20074559|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074560|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20074561|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20074562|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20074563|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20074564|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
20074565|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074566|NCT00957827|Cephalexin|cephalexin|mesh-list
20074567|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20074568|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074569|NCT00953329|Alefacept|alefacept|mesh-list
20074570|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
20074571|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
20074572|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074573|NCT00965055|Atorvastatin|atorvastatin|mesh-list
20074574|NCT00965055|Ezetimibe|ezetimibe|mesh-list
20074575|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20074576|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20074577|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
20074578|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074579|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20074580|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20074581|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074582|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
20074583|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
20074584|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074585|NCT00962429|Protective Agents|protective agents|mesh-ancestor
20074586|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074587|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
20074588|NCT00962429|Vitamins|vitamins|mesh-ancestor
20074589|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
20074590|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20074591|NCT00966654|Incretins|incretins|mesh-ancestor
20074592|NCT00966654|Hormones|hormones|mesh-ancestor
20074593|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074594|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074595|NCT00954187|Pregabalin|pregabalin|mesh-list
20074596|NCT00954187|Gabapentin|gabapentin|mesh-list
20074597|NCT00954187|Analgesics|analgesics|mesh-ancestor
20074598|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
20074599|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074600|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074601|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
20074602|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20074603|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20074604|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304909|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
19746385|NCT03825302|Diuretics|diuretics|mesh-ancestor
20304910|NCT00650156|Adalimumab|adalimumab|mesh-list
20304911|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578888|NCT02086942|Dexamethasone|dexamethasone|mesh-list
20578889|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
20578890|NCT02086942|Bortezomib|bortezomib|mesh-list
20578891|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074605|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20074606|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20074607|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20074608|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074609|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20578892|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
20578893|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578894|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20578895|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20578896|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
20074610|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20074611|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20074612|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074613|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
20074614|NCT00953615|Thalidomide|thalidomide|mesh-list
20074615|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074616|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
20074617|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074618|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
20074619|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20074620|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074621|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20074622|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20074623|NCT00953615|Growth Substances|growth substances|mesh-ancestor
20074624|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
20074625|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074626|NCT00947284|Nalbuphine|nalbuphine|mesh-list
20074627|NCT00947284|Naloxone|naloxone|mesh-list
20074628|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20074629|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074630|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
20074631|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074632|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20074633|NCT00947284|Narcotics|narcotics|mesh-ancestor
20074634|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074635|NCT00947284|Analgesics|analgesics|mesh-ancestor
20074636|NCT00957034|Testosterone|testosterone|mesh-list
20074637|NCT00957034|Androgens|androgens|mesh-ancestor
20074638|NCT00957034|Hormones|hormones|mesh-ancestor
20074639|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074640|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074641|NCT00949988|Rituximab|rituximab|mesh-list
20074642|NCT00949988|Dasatinib|dasatinib|mesh-list
20074643|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20074644|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074645|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
20074646|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074647|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074648|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20074649|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074650|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074651|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
20074652|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20074653|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
20074654|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074655|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074656|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20074657|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
20074658|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20074659|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
20074660|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304912|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20304913|NCT00650169|Clopidogrel|clopidogrel|mesh-list
20304914|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20304915|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20304916|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20304917|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20304918|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
20578897|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304919|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304920|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304921|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304922|NCT00650182|Fentanyl|fentanyl|mesh-list
20304923|NCT00650182|Naltrexone|naltrexone|mesh-list
20304924|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20304925|NCT00650182|Narcotics|narcotics|mesh-ancestor
20304926|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304927|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304928|NCT00650182|Analgesics|analgesics|mesh-ancestor
20304929|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
20304930|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20304931|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20304932|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20304933|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
20304934|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
20304935|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20304936|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20304937|NCT00650195|Metolazone|metolazone|mesh-list
20304938|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20304939|NCT00650195|Diuretics|diuretics|mesh-ancestor
20304940|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
20074661|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074662|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20074663|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
20074664|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
20074665|NCT00948194|Protective Agents|protective agents|mesh-ancestor
20074666|NCT00946985|Risperidone|risperidone|mesh-list
20074667|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20074668|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20074669|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
20074670|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074671|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074672|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074673|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20074674|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20074675|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074676|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20074677|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20074678|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
20074679|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20074680|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20074681|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20074682|NCT00950690|Latanoprost|latanoprost|mesh-list
20074683|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20074684|NCT00941928|Vidarabine|vidarabine|mesh-list
20074685|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
20074686|NCT00941928|Fludarabine|fludarabine|mesh-list
20074687|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
20074688|NCT00941928|Interleukin-2|interleukin-2|mesh-list
20074689|NCT00941928|Epratuzumab|epratuzumab|mesh-list
20074690|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074691|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
20074692|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074693|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074694|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20074695|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
20074696|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074697|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074698|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20074699|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20074700|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
20074701|NCT00941928|Antiviral Agents|antiviral agents|mesh-ancestor
20074702|NCT00941928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074703|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20074704|NCT00941928|Analgesics|analgesics|mesh-ancestor
20074705|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
20074706|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074707|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20074708|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
20074709|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074710|NCT00947791|Midazolam|midazolam|mesh-list
20074711|NCT00947791|Ketamine|ketamine|mesh-list
20304941|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074712|NCT00947791|Analgesics|analgesics|mesh-ancestor
20074713|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
20304942|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20304943|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304944|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074714|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074715|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304945|NCT00650208|Lamotrigine|lamotrigine|mesh-list
20304946|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
20304947|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20074716|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20074717|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20074718|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
20074719|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
20074720|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074721|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20074722|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20074723|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074724|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074725|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20304948|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20304949|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304950|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20304951|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304952|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20074726|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20074727|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20074728|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20074729|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304953|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304954|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304955|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304956|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20304957|NCT00650221|Pravastatin|pravastatin|mesh-list
20304958|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20304959|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20304960|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
20304961|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304962|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20304963|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20304964|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20304965|NCT00650234|Metformin|metformin|mesh-list
20304966|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304967|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304968|NCT00650247|Sumatriptan|sumatriptan|mesh-list
20304969|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20304970|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20304971|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20304972|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
20304973|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20304974|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304975|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304976|NCT00650273|Azithromycin|azithromycin|mesh-list
20304977|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20304978|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074730|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
20074731|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
20304979|NCT00650286|Modafinil|modafinil|mesh-list
20304980|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20304981|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304982|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20304983|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20304984|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20304985|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304986|NCT00650299|Alprazolam|alprazolam|mesh-list
20304987|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20304988|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20304989|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20304990|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20304991|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20304992|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20304993|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
20304994|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
20304995|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074732|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20304996|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20304997|NCT00650312|Metformin|metformin|mesh-list
20304998|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20304999|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305000|NCT00650325|Sertraline|sertraline|mesh-list
20305001|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
20305002|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305003|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20305004|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20305005|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305006|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305007|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305008|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
20305009|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305010|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20305011|NCT00650338|Latanoprost|latanoprost|mesh-list
20305012|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20305013|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
20305014|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305015|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305016|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20305017|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20305018|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305019|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305020|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305021|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20305022|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20305023|NCT00650364|Midodrine|midodrine|mesh-list
20305024|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
20305025|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
20305026|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305027|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305028|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20305029|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20305030|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20305031|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305032|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305033|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305034|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305035|NCT00650377|Finasteride|finasteride|mesh-list
20305036|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20305037|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20305038|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305039|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305040|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
20305041|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305042|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305043|NCT00650377|Urological Agents|urological agents|mesh-ancestor
20305044|NCT00650390|Adalimumab|adalimumab|mesh-list
20305045|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305046|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305047|NCT00650403|Paroxetine|paroxetine|mesh-list
20305048|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20305049|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20305050|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305051|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305052|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305053|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
20305054|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305055|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20305056|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
20305057|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305058|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20305059|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20305060|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305061|NCT00650416|Carvedilol|carvedilol|mesh-list
20305062|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20305063|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20305064|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305065|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305066|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305067|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074733|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20074734|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074735|NCT00947011|Incretins|incretins|mesh-ancestor
20074736|NCT00947011|Hormones|hormones|mesh-ancestor
20074737|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074738|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20074739|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
20074740|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074741|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074742|NCT00936598|Zolpidem|zolpidem|mesh-list
20074743|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20074744|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20305068|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305069|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
20305070|NCT00650416|Protective Agents|protective agents|mesh-ancestor
20305071|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20305072|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305073|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20305074|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
20305075|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20305076|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20305077|NCT00650429|Ziprasidone|ziprasidone|mesh-list
20305078|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20305079|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
20305080|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305081|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305082|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305083|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20305084|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305085|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074745|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305086|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305087|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20305088|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
20305089|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20305090|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20305091|NCT00650442|Estradiol|estradiol|mesh-list
20305092|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20305093|NCT00650442|Estrogens|estrogens|mesh-ancestor
20305094|NCT00650442|Hormones|hormones|mesh-ancestor
20305095|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305096|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305097|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20305098|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
20305099|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20305100|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20305101|NCT00650455|Naproxen|naproxen|mesh-list
20305102|NCT00650455|Valdecoxib|valdecoxib|mesh-list
20305103|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305104|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305105|NCT00650455|Analgesics|analgesics|mesh-ancestor
20305106|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
20305107|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305108|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305109|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305110|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305111|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
20305112|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20305113|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305114|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305115|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305116|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
20305117|NCT00650468|Prednisone|prednisone|mesh-list
20305118|NCT00650468|Tacrolimus|tacrolimus|mesh-list
20305119|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305120|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
20305121|NCT00650468|Hormones|hormones|mesh-ancestor
20305122|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305123|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305124|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20305125|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305126|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20305127|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
20305128|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20305129|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305130|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305131|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20305132|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20305133|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
20074746|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074747|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20305134|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305135|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305136|NCT00650481|Oxybutynin|oxybutynin|mesh-list
20305137|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
20305138|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
20305139|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305140|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305141|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20305142|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20305143|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
20305144|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305145|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305146|NCT00650481|Urological Agents|urological agents|mesh-ancestor
20305147|NCT00650494|Valacyclovir|valacyclovir|mesh-list
20305148|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
20305149|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305150|NCT00650520|Bromocriptine|bromocriptine|mesh-list
20305151|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20305152|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20305153|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
20305154|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305155|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305156|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
20305157|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
20305158|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305159|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305160|NCT00650533|Glimepiride|glimepiride|mesh-list
20305161|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20305162|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20305163|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074748|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
20074749|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
20074750|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305164|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20305165|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
20305166|NCT00650598|Diclofenac|diclofenac|mesh-list
20305167|NCT00650598|Valdecoxib|valdecoxib|mesh-list
20305168|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305169|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305170|NCT00650598|Analgesics|analgesics|mesh-ancestor
20305171|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
20305172|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305173|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305174|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305175|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305176|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20305177|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305178|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305179|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305180|NCT00650611|Ziprasidone|ziprasidone|mesh-list
20305181|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20305182|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
20074751|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074752|NCT00920309|Sirolimus|sirolimus|mesh-list
20074753|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20074754|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074755|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20074756|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074757|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
20074758|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074759|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
20074760|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074761|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
20074762|NCT00934791|Sirolimus|sirolimus|mesh-list
20074763|NCT00934791|Prednisone|prednisone|mesh-list
20074764|NCT00934791|Tacrolimus|tacrolimus|mesh-list
20074765|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305183|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305184|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305185|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305186|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20305187|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305188|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305189|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305190|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20305191|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
20305192|NCT00650624|Valdecoxib|valdecoxib|mesh-list
20305193|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305194|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20305195|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305196|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305197|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305198|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305199|NCT00650624|Analgesics|analgesics|mesh-ancestor
20305200|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
20305201|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305202|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305203|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305204|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074766|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
20074767|NCT00934791|Hormones|hormones|mesh-ancestor
20074768|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074769|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074770|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20074771|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074772|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074773|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
20074774|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20074775|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305205|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
20305206|NCT00650637|Lamivudine|lamivudine|mesh-list
20305207|NCT00650637|Zidovudine|zidovudine|mesh-list
20305208|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20305209|NCT00650637|Nelfinavir|nelfinavir|mesh-list
20305210|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
20305211|NCT00650637|Loperamide|loperamide|mesh-list
20305212|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
20305213|NCT00650637|Calcium|calcium|mesh-list
20305214|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20305215|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305216|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20305217|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20305218|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20305219|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305220|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305221|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
20305222|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305223|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20305224|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20305225|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
20305226|NCT00650637|Antacids|antacids|mesh-ancestor
20305227|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578898|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578899|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20578900|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20578901|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
20074776|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074777|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20074778|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20578902|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
20578903|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578904|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578905|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
20074779|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
20074780|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20074781|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074782|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
20074783|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20074784|NCT00932152|Bevacizumab|bevacizumab|mesh-list
20074785|NCT00932152|Fulvestrant|fulvestrant|mesh-list
20305228|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20305229|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20578906|NCT02086942|Hormones|hormones|mesh-ancestor
20578907|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20578908|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20578909|NCT02086994|Misoprostol|misoprostol|mesh-list
20578910|NCT02086994|Carbetocin|carbetocin|mesh-list
20578911|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20578912|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
20578913|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20578914|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578915|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20578916|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20578917|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
20578918|NCT02087007|Cilostazol|cilostazol|mesh-list
20578919|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20578920|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
20578921|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578922|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578923|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20578924|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
20578925|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20578926|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20578927|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578928|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20578929|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
20578930|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20305230|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
20308872|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20308873|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20308874|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
20578931|NCT02087007|Protective Agents|protective agents|mesh-ancestor
20578932|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20578933|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20578934|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20578935|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20578936|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578937|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
20578938|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20074786|NCT00932152|Anastrozole|anastrozole|mesh-list
20074787|NCT00932152|Analgesics|analgesics|mesh-list
20074788|NCT00932152|Antiemetics|antiemetics|mesh-list
20074789|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20074790|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074791|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20074792|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20074793|NCT00932152|Growth Substances|growth substances|mesh-ancestor
20074794|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074795|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
20074796|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578939|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20578940|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
20578941|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578942|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578943|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578944|NCT02087098|Urological Agents|urological agents|mesh-ancestor
20578945|NCT02087111|Interferons|interferons|mesh-list
20578946|NCT02087111|Ribavirin|ribavirin|mesh-list
20578947|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
20578948|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
20578949|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20578950|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20578951|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
20578952|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20578953|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
20578954|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578955|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
20578956|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578957|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
20578958|NCT02087202|Ketamine|ketamine|mesh-list
20578959|NCT02087202|Analgesics|analgesics|mesh-ancestor
20578960|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
20578961|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20578962|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578963|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20578964|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20074797|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20578965|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
20074798|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20074799|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20074800|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
20074801|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074802|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20074803|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20074804|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074805|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305231|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20305232|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20305233|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
20305234|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305235|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20305236|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20305237|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305238|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305239|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305240|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305241|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20305242|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20074806|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
20074807|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074808|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
20305243|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
20305244|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305245|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305246|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20305247|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20305248|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
20305249|NCT00650871|Casopitant|casopitant|mesh-list
20305250|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
20305251|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
20305252|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305253|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305254|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20305255|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20305256|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305257|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305258|NCT00650897|Citalopram|citalopram|mesh-list
20305259|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20305260|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20305261|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305262|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305263|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305264|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
20305265|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305266|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20305267|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
20305268|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305269|NCT00650910|Lapatinib|lapatinib|mesh-list
20305270|NCT00650910|Digoxin|digoxin|mesh-list
20305271|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305272|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20305273|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305274|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305275|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20305276|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20305277|NCT00650910|Protective Agents|protective agents|mesh-ancestor
20305278|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305279|NCT00650923|Temozolomide|temozolomide|mesh-list
20305280|NCT00650923|Aflibercept|aflibercept|mesh-list
20305281|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
20305282|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20305283|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
20305284|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305285|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305286|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20305287|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20305288|NCT00650923|Growth Substances|growth substances|mesh-ancestor
20305289|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074809|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20074810|NCT00924807|Sorafenib|sorafenib|mesh-list
20305290|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
20305291|NCT00651066|Ritonavir|ritonavir|mesh-list
20305292|NCT00651066|Lopinavir|lopinavir|mesh-list
20305293|NCT00651066|Rifabutin|rifabutin|mesh-list
20305294|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20305295|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20305296|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
20074811|NCT00924807|Leuprolide|leuprolide|mesh-list
20074812|NCT00924807|Bicalutamide|bicalutamide|mesh-list
20074813|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074814|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20074815|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074816|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074817|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20578966|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
20578967|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20578968|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20578969|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20578970|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20578971|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578972|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20074818|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
20074819|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20074820|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074821|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20074822|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
20074823|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
20074824|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074825|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
20074826|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20074827|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
20074828|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074829|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074830|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20074831|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
20074832|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074833|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074834|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20119905|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119906|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
20119907|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119908|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
20119909|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119910|NCT00006250|Dexamethasone|dexamethasone|mesh-list
20119911|NCT00006250|Fludarabine|fludarabine|mesh-list
20119912|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
20119913|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
20119914|NCT00006250|Chlorambucil|chlorambucil|mesh-list
20578973|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
20578974|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20578975|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578976|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20578977|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
20578978|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20578979|NCT02087215|Boron|boron|mesh-list
20578980|NCT02087215|Trace Elements|trace elements|mesh-ancestor
20578981|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
20578982|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578983|NCT02087332|Torsemide|torsemide|mesh-list
20578984|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20578985|NCT02087332|Diuretics|diuretics|mesh-ancestor
20578986|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
20578987|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578988|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20578989|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20578990|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578991|NCT02087384|Vaccines|vaccines|mesh-list
20578992|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
20578993|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20578994|NCT02087462|Vitamins|vitamins|mesh-list
20578995|NCT02087462|Thiamine|thiamine|mesh-list
20578996|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
20305297|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305298|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20578997|NCT02087462|Diclofenac|diclofenac|mesh-list
20578998|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
20074835|NCT00926575|Beclomethasone|beclomethasone|mesh-list
20074836|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074837|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
20074838|NCT00926575|Hormones|hormones|mesh-ancestor
20074839|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074840|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305299|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20305300|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20305301|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
20305302|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305303|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20305304|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20305305|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305306|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20305307|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
20305308|NCT00651105|Vildagliptin|vildagliptin|mesh-list
20305309|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20305310|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305311|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20305312|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
20305313|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305314|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305315|NCT00651131|Daptomycin|daptomycin|mesh-list
20305316|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305317|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305318|NCT00651209|Tenofovir|tenofovir|mesh-list
20305319|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
20305320|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305321|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20305322|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20305323|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305324|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305325|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492000|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
20074841|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20074842|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
20074843|NCT00911053|Melatonin|melatonin|mesh-list
20074844|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
20074845|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074846|NCT00911053|Protective Agents|protective agents|mesh-ancestor
20074847|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074848|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20074849|NCT00918463|Dasatinib|dasatinib|mesh-list
20074850|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074851|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20074852|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074853|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074854|NCT00913692|Glycine|glycine|mesh-list
20074855|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
20074856|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074857|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074858|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074859|NCT00918645|Calcium|calcium|mesh-list
20305326|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19492001|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074860|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20074861|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074862|NCT00907218|Varenicline|varenicline|mesh-list
20074863|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20074864|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20074865|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
20074866|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074867|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074868|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074869|NCT00906035|Aspirin|aspirin|mesh-list
20074870|NCT00906035|Dipyridamole|dipyridamole|mesh-list
20074871|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305327|NCT00651235|Losartan|losartan|mesh-list
20305328|NCT00651235|Propranolol|propranolol|mesh-list
20305329|NCT00651235|Atenolol|atenolol|mesh-list
20305330|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20305331|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305332|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20305333|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20305334|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305335|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20305336|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20305337|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305338|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305339|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305340|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
20305341|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
20305342|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
20305343|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305344|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20074872|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20074873|NCT00906035|Analgesics|analgesics|mesh-ancestor
20305345|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20305346|NCT00651287|Quinapril|quinapril|mesh-list
20305347|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305348|NCT00651287|Diuretics|diuretics|mesh-ancestor
20305349|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
20305350|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305351|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20305352|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305353|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305354|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20074874|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
20074875|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074876|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074877|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074878|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074879|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20074880|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20074881|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074882|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20074883|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20074884|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074885|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
20074886|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20074887|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
20074888|NCT00904423|Vitamin D|vitamin d|mesh-list
20074889|NCT00904423|Vitamins|vitamins|mesh-ancestor
20074890|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
20074891|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074892|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20074893|NCT00903396|Palonosetron|palonosetron|mesh-list
20074894|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
20074895|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
20074896|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074897|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074898|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20074899|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20074900|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20074901|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
20074902|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492002|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492003|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19492004|NCT03126695|Ticagrelor|ticagrelor|mesh-list
19492005|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19492006|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20074903|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074904|NCT00894790|Celecoxib|celecoxib|mesh-list
20074905|NCT00894790|Diclofenac|diclofenac|mesh-list
20074906|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20074907|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20074908|NCT00894790|Analgesics|analgesics|mesh-ancestor
20074909|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
20074910|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074911|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074912|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074913|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074914|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20074915|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20074916|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074917|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305355|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
20074918|NCT00902668|Lovastatin|lovastatin|mesh-list
20074919|NCT00902668|L 647318|l 647318|mesh-list
20074920|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
20305356|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305357|NCT00651300|Parecoxib|parecoxib|mesh-list
20305358|NCT00651300|Valdecoxib|valdecoxib|mesh-list
20305359|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305360|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20305361|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305362|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305363|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305364|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305365|NCT00651300|Analgesics|analgesics|mesh-ancestor
20305366|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
20305367|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305368|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305369|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305370|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305371|NCT00651326|Docetaxel|docetaxel|mesh-list
20305372|NCT00651326|Leuprolide|leuprolide|mesh-list
20305373|NCT00651326|Goserelin|goserelin|mesh-list
20305374|NCT00651326|Bicalutamide|bicalutamide|mesh-list
20305375|NCT00651326|Flutamide|flutamide|mesh-list
20305376|NCT00651326|Buserelin|buserelin|mesh-list
20305377|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305378|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20305379|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20305380|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074921|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20074922|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20074923|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
20074924|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074925|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20074926|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20074927|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074928|NCT00881205|Rivastigmine|rivastigmine|mesh-list
20074929|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20074930|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305381|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305382|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20305383|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
20305384|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20305385|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305386|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20305387|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
20305388|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
20305389|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305390|NCT00651352|Nicotine|nicotine|mesh-list
20305391|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20305392|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
20305393|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305394|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074931|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074932|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
20074933|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20074934|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305395|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20305396|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20305397|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
20305398|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305399|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305400|NCT00651443|Galiximab|galiximab|mesh-list
20305401|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305402|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305403|NCT00651456|Bevacizumab|bevacizumab|mesh-list
20305404|NCT00651456|Cisplatin|cisplatin|mesh-list
20305405|NCT00651456|Pemetrexed|pemetrexed|mesh-list
20305406|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20305407|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305408|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20305409|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20074935|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20074936|NCT00881205|Protective Agents|protective agents|mesh-ancestor
20074937|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
20305410|NCT00651456|Growth Substances|growth substances|mesh-ancestor
20074938|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20305411|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305412|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
20305413|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305414|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305415|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20305416|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20305417|NCT00651547|Budesonide|budesonide|mesh-list
20305418|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
20305419|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305420|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20305421|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
20305422|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305423|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305424|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20305425|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
20305426|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
20305427|NCT00651547|Hormones|hormones|mesh-ancestor
20305428|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305429|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20305430|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20305431|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20074939|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
20074940|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20074941|NCT00896025|Expectorants|expectorants|mesh-ancestor
20074942|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
20074943|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20074944|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
20074945|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074946|NCT00896025|Protective Agents|protective agents|mesh-ancestor
20074947|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305432|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305433|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305434|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305435|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
20305436|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
20305437|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20305438|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20305439|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305440|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305441|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20305442|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20305443|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305444|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305445|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305446|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20305447|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20305448|NCT00651599|Drospirenone|drospirenone|mesh-list
20305449|NCT00651599|Estradiol|estradiol|mesh-list
20305450|NCT00651599|Estrogens|estrogens|mesh-ancestor
20305451|NCT00651599|Hormones|hormones|mesh-ancestor
20305452|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305453|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305454|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20305455|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
20305456|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20305457|NCT00651599|Diuretics|diuretics|mesh-ancestor
20305458|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
20305459|NCT00651612|Timolol|timolol|mesh-list
20305460|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20305461|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20305462|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20305463|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20305464|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20305465|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305466|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305467|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305468|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305469|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20305470|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20074948|NCT00896025|Antidotes|antidotes|mesh-ancestor
20074949|NCT00903006|Dasatinib|dasatinib|mesh-list
20074950|NCT00903006|Fulvestrant|fulvestrant|mesh-list
20074951|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074952|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20074953|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305471|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20305472|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20305473|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305474|NCT00651651|Budesonide|budesonide|mesh-list
20305475|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
20305476|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305477|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20305478|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
20305479|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074954|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074955|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20074956|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20074957|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20074958|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
20074959|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074960|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074961|NCT00887315|Cisplatin|cisplatin|mesh-list
20074962|NCT00887315|Docetaxel|docetaxel|mesh-list
20074963|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074964|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
20074965|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
20074966|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
20074967|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074968|NCT00891904|Cetuximab|cetuximab|mesh-list
20578999|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579000|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20579001|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579002|NCT02087462|Analgesics|analgesics|mesh-ancestor
20579003|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
20579004|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579005|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579006|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579007|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20579008|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579009|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579010|NCT02087475|Fluorouracil|fluorouracil|mesh-list
20579011|NCT02087475|Irinotecan|irinotecan|mesh-list
20579012|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
20579013|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579014|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20579015|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579016|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20579017|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
20074969|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20074970|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20074971|NCT00889421|Apremilast|apremilast|mesh-list
20074972|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20074973|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20074974|NCT00889421|Analgesics|analgesics|mesh-ancestor
20074975|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
20074976|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20074977|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074978|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20074979|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20074980|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20074981|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20074982|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074983|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20074984|NCT00875394|Metformin|metformin|mesh-list
20074985|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20074986|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20074987|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20074988|NCT00875394|Incretins|incretins|mesh-ancestor
20074989|NCT00875394|Hormones|hormones|mesh-ancestor
20074990|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20074991|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20074992|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
20074993|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074994|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579018|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579019|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20579020|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20579021|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20074995|NCT00882310|Gemcitabine|gemcitabine|mesh-list
20074996|NCT00882310|Capecitabine|capecitabine|mesh-list
20074997|NCT00882310|Docetaxel|docetaxel|mesh-list
20074998|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20074999|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
20075000|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075001|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075002|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
20075003|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075004|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075005|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075006|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
20075007|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075008|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20075009|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075010|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075011|NCT00880542|Sorafenib|sorafenib|mesh-list
20075012|NCT00880542|Ifosfamide|ifosfamide|mesh-list
20075013|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075014|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075015|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075016|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075017|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20305480|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305481|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20305482|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
20305483|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
20305484|NCT00651651|Hormones|hormones|mesh-ancestor
20305485|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305486|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20305487|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20305488|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305489|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305490|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305491|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305492|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
20305493|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20305494|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20305495|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20305496|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305497|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305498|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
20305499|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305500|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305501|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20305502|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305503|NCT00651703|Imiquimod|imiquimod|mesh-list
20305504|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20305505|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
20305506|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305507|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305508|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
20305509|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
20305510|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20305511|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20305512|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20305513|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305514|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305515|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
20305516|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305517|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305518|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20305519|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305520|NCT00651768|Budesonide|budesonide|mesh-list
20305521|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
20305522|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20305523|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579022|NCT02087488|Eszopiclone|eszopiclone|mesh-list
20579023|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20075018|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
20075019|NCT00879619|Prednisone|prednisone|mesh-list
20075020|NCT00879619|Cortisone|cortisone|mesh-list
20075021|NCT00879619|Docetaxel|docetaxel|mesh-list
20075022|NCT00879619|Sunitinib|sunitinib|mesh-list
20075023|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075024|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
20305524|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20305525|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
20305526|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305527|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305528|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20305529|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
20305530|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
20305531|NCT00651768|Hormones|hormones|mesh-ancestor
20305532|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305533|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20305534|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20305535|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305536|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305537|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305538|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305539|NCT00651781|Bortezomib|bortezomib|mesh-list
20305540|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305541|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20305542|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20305543|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20305544|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305545|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20305546|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
20305547|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20305548|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20305549|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20305550|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20305551|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20305552|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20305553|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20305554|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20305555|NCT00651859|Bimatoprost|bimatoprost|mesh-list
20305556|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20305557|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20305558|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305559|NCT00651885|Treprostinil|treprostinil|mesh-list
20305560|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305561|NCT00651911|Rasburicase|rasburicase|mesh-list
20305562|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
20305563|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305564|NCT00651976|Letrozole|letrozole|mesh-list
20305565|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305566|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20305567|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20305568|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305569|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075025|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075026|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075027|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075028|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20075029|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
20075030|NCT00879619|Hormones|hormones|mesh-ancestor
20305570|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20305571|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
20305572|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305573|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305574|NCT00652002|Budesonide|budesonide|mesh-list
20305575|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
20305576|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305577|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20305578|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
20305579|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305580|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305581|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20305582|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
20305583|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
20305584|NCT00652002|Hormones|hormones|mesh-ancestor
20305585|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305586|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20305587|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20119915|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305588|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305589|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305590|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305591|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305592|NCT00652041|Thalidomide|thalidomide|mesh-list
20305593|NCT00652041|Bortezomib|bortezomib|mesh-list
20305594|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305595|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20305596|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
20305597|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305598|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
20305599|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305600|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305601|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20305602|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20305603|NCT00652041|Growth Substances|growth substances|mesh-ancestor
20305604|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
20305605|NCT00652106|Timolol|timolol|mesh-list
20305606|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20305607|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20305608|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20305609|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20305610|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20305611|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305612|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305613|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305614|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305615|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20305616|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305617|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20305618|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20305619|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305620|NCT00652119|Paclitaxel|paclitaxel|mesh-list
20305621|NCT00652119|Bevacizumab|bevacizumab|mesh-list
20305622|NCT00652119|Carboplatin|carboplatin|mesh-list
20305623|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20305624|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305625|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
20305626|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
20305627|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
20305628|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305629|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20305630|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20305631|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20305632|NCT00652119|Growth Substances|growth substances|mesh-ancestor
20305633|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305634|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
20305635|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
20305636|NCT00652132|Antidotes|antidotes|mesh-ancestor
20305637|NCT00652132|Protective Agents|protective agents|mesh-ancestor
20305638|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305639|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
20305640|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305641|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
20305642|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305643|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305644|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
20305645|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
20305646|NCT00652171|Lamotrigine|lamotrigine|mesh-list
20305647|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
20305648|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20305649|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305650|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305651|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20305652|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305653|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20305654|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305655|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305656|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305657|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20305658|NCT00652184|Valacyclovir|valacyclovir|mesh-list
19492007|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20305659|NCT00652184|Sorivudine|sorivudine|mesh-list
20305660|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
20305661|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305662|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305663|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305664|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20305665|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
20305666|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20305667|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20305668|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305669|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305670|NCT00652262|Urological Agents|urological agents|mesh-ancestor
20305671|NCT00652288|Insulin|insulin|mesh-list
20305672|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20305673|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
20305674|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
20305675|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
20305676|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20305677|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
20305678|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
20305679|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20305680|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305681|NCT00652379|Octreotide|octreotide|mesh-list
20305682|NCT00652379|Lanreotide|lanreotide|mesh-list
20305683|NCT00652379|Somatostatin|somatostatin|mesh-list
20305684|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20305685|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20305686|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305687|NCT00652379|Hormones|hormones|mesh-ancestor
20305688|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305689|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305690|NCT00652392|Budesonide|budesonide|mesh-list
20305691|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
20305692|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305693|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20305694|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
20305695|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305696|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305697|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20305698|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
20305699|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
20305700|NCT00652392|Hormones|hormones|mesh-ancestor
20305701|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305702|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20305703|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20305704|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305705|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305706|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305707|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305708|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20305709|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20305710|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20579024|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579025|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579026|NCT02087527|Dexamethasone|dexamethasone|mesh-list
20579027|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579028|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
20579029|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
20579030|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579031|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579032|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579033|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
20579034|NCT02087527|Hormones|hormones|mesh-ancestor
20579035|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579036|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20579037|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579038|NCT02087540|Telmisartan|telmisartan|mesh-list
20579039|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20579040|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20579041|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20579042|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
20579043|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579044|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20579045|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20579046|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579047|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20579048|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20305711|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305712|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20305713|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20305714|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20305715|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305716|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305717|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305718|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305719|NCT00652496|Bimatoprost|bimatoprost|mesh-list
20305720|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20305721|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20305722|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305723|NCT00652600|Propranolol|propranolol|mesh-list
20305724|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20305725|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20305726|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305727|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305728|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305729|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305730|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20305731|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305732|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
20305733|NCT00652639|Clonazepam|clonazepam|mesh-list
20305734|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
20305735|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
20305736|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
20305737|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075031|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075032|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075033|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20305738|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305739|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305740|NCT00652652|Furosemide|furosemide|mesh-list
20305741|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20075034|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20075035|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20075036|NCT00879619|Growth Substances|growth substances|mesh-ancestor
20075037|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
20075038|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075039|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075040|NCT00874939|Donepezil|donepezil|mesh-list
20075041|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20075042|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075043|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075044|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075045|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305742|NCT00652652|Diuretics|diuretics|mesh-ancestor
20305743|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
20305744|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305745|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20305746|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20305747|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305748|NCT00652665|Leflunomide|leflunomide|mesh-list
20305749|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305750|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305751|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20305752|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
20075046|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305753|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308875|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20308876|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20308877|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20308878|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20308879|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20308880|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20308881|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20308882|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20308883|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20308884|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20308885|NCT00666068|Hormones|hormones|mesh-list
20308886|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20075047|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
20075048|NCT00877071|Doxorubicin|doxorubicin|mesh-list
20075049|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20075050|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075051|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20075052|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20075053|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075054|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075055|NCT00878969|Valsartan|valsartan|mesh-list
20075056|NCT00878969|Ramipril|ramipril|mesh-list
20075057|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20075058|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305754|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
20305755|NCT00652691|Carboplatin|carboplatin|mesh-list
20305756|NCT00652691|Topotecan|topotecan|mesh-list
20305757|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20305758|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
20305759|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305760|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305761|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20305762|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
20305763|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305764|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305765|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20305766|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20305767|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20305768|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305769|NCT00652704|Doxycycline|doxycycline|mesh-list
20305770|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305771|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305772|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
20305773|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20305774|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20305775|NCT00652730|Buspirone|buspirone|mesh-list
20305776|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20305777|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305778|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305779|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305780|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305781|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20305782|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
20305783|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305784|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305785|NCT00652782|Rolofylline|rolofylline|mesh-list
20305786|NCT00652782|Diuretics|diuretics|mesh-ancestor
20305787|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
20075059|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20075060|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20075061|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075062|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
20305788|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305789|NCT00652795|Doxycycline|doxycycline|mesh-list
20305790|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305791|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305792|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
20305793|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20305794|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20305795|NCT00652808|Naproxen|naproxen|mesh-list
20579049|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20579050|NCT02087566|Linezolid|linezolid|mesh-list
20075063|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075064|NCT00869414|Insulin|insulin|mesh-list
20075065|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20305796|NCT00652808|Valdecoxib|valdecoxib|mesh-list
20579051|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20579052|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579053|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20579054|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579055|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579056|NCT02087579|Olanzapine|olanzapine|mesh-list
20579057|NCT02087579|Risperidone|risperidone|mesh-list
20579058|NCT02087579|Aripiprazole|aripiprazole|mesh-list
19492008|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20305797|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305798|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305799|NCT00652808|Analgesics|analgesics|mesh-ancestor
20579059|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20305800|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
20305801|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305802|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305803|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305804|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305805|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
20305806|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20305807|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305808|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305809|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305810|NCT00652821|Tramadol|tramadol|mesh-list
20305811|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20305812|NCT00652821|Narcotics|narcotics|mesh-ancestor
20305813|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305814|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305815|NCT00652821|Analgesics|analgesics|mesh-ancestor
20305816|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
20305817|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305818|NCT00652860|Doxorubicin|doxorubicin|mesh-list
20305819|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20305820|NCT00652860|Ifosfamide|ifosfamide|mesh-list
20305821|NCT00652860|Molgramostim|molgramostim|mesh-list
20305822|NCT00652860|Mitomycins|mitomycins|mesh-list
20305823|NCT00652860|Mitomycin|mitomycin|mesh-list
20305824|NCT00652860|Sargramostim|sargramostim|mesh-list
20305825|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305826|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20305827|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20305828|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20305829|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305830|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305831|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20305832|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
20305833|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
20305834|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305835|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20305836|NCT00652873|Cabergoline|cabergoline|mesh-list
20305837|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20305838|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20305839|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
20305840|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
20305841|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305842|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305843|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305844|NCT00652886|Oxandrolone|oxandrolone|mesh-list
20305845|NCT00652886|Androgens|androgens|mesh-ancestor
20305846|NCT00652886|Hormones|hormones|mesh-ancestor
20305847|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305848|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305849|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
20305850|NCT00652912|Clonazepam|clonazepam|mesh-list
20305851|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
20305852|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
20305853|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
20305854|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305855|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305856|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305857|NCT00652925|Celecoxib|celecoxib|mesh-list
20305858|NCT00652925|Naproxen|naproxen|mesh-list
20305859|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305860|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305861|NCT00652925|Analgesics|analgesics|mesh-ancestor
20305862|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
20305863|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305864|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305865|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305866|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492009|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
20305867|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305868|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20305869|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305870|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305871|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
20305872|NCT00653003|Leflunomide|leflunomide|mesh-list
19746386|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
20305873|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305874|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305875|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20305876|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
20305877|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305878|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20305879|NCT00653016|Norelgestromin|norelgestromin|mesh-list
20305880|NCT00653016|Estradiol|estradiol|mesh-list
20305881|NCT00653016|Estrogens|estrogens|mesh-ancestor
20305882|NCT00653016|Hormones|hormones|mesh-ancestor
20305883|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20305884|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305885|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20305886|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
20305887|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20305888|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20305889|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20305890|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20305891|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20305892|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
20305893|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305894|NCT00653055|Cabergoline|cabergoline|mesh-list
20305895|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20305896|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20305897|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
20305898|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
20305899|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305900|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305901|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075066|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
20075067|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20075068|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075069|NCT00863512|Gemcitabine|gemcitabine|mesh-list
20075070|NCT00863512|Docetaxel|docetaxel|mesh-list
20075071|NCT00863512|Pemetrexed|pemetrexed|mesh-list
20075072|NCT00863512|Vinorelbine|vinorelbine|mesh-list
20075073|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20305902|NCT00653120|Propranolol|propranolol|mesh-list
20305903|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20305904|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20305905|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
20305906|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305907|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305908|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305909|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20305910|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20305911|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
20305912|NCT00653172|Streptogramin A|streptogramin a|mesh-list
20305913|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305914|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305915|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
20305916|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20305917|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305918|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
20305919|NCT00653250|Celecoxib|celecoxib|mesh-list
20305920|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305921|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305922|NCT00653250|Analgesics|analgesics|mesh-ancestor
20305923|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
20305924|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305925|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305926|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305927|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305928|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305929|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20075074|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20075075|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
20075076|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075077|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
20075078|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075079|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075080|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075081|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
20075082|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075083|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
20305930|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075084|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
20305931|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305932|NCT00653302|Metformin|metformin|mesh-list
20305933|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
20305934|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20305935|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305936|NCT00653315|Tramadol|tramadol|mesh-list
20305937|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20305938|NCT00653315|Narcotics|narcotics|mesh-ancestor
20305939|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579060|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20579061|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20579062|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
20579063|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579064|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579065|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579066|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20579067|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20579068|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579069|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20579070|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20579071|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
20579072|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
20579073|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
20579074|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579075|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579076|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20579077|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20075085|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075086|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20075087|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20075088|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20075089|NCT00868998|Gemcitabine|gemcitabine|mesh-list
20075090|NCT00868998|Capecitabine|capecitabine|mesh-list
20075091|NCT00868998|Docetaxel|docetaxel|mesh-list
20075092|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20075093|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
20075094|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579078|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579079|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
20579080|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
20579081|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20579082|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20579083|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20579084|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20075095|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075096|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
20075097|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075098|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075099|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075100|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
20075101|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075102|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
20075103|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075104|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075105|NCT00869258|Gemcitabine|gemcitabine|mesh-list
20075106|NCT00869258|Capecitabine|capecitabine|mesh-list
20075107|NCT00869258|Docetaxel|docetaxel|mesh-list
20075108|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20579085|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20579086|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
20579087|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20579088|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20579089|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20579090|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579091|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579092|NCT02087683|Vitamin D|vitamin d|mesh-list
20579093|NCT02087683|Vitamins|vitamins|mesh-ancestor
20075109|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
20075110|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075111|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075112|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
20075113|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305940|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579094|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
20579095|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075114|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075115|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075116|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
20075117|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075118|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
20075119|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075120|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075121|NCT00853229|Pregabalin|pregabalin|mesh-list
20579096|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579097|NCT02087722|Melatonin|melatonin|mesh-list
20579098|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
20579099|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579100|NCT02087722|Protective Agents|protective agents|mesh-ancestor
20579101|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579102|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579103|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
20579104|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20579105|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
20579106|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20579107|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
20579108|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579109|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
20579110|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
20579111|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579112|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579113|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579114|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
20579115|NCT02087813|Hormones|hormones|mesh-ancestor
20579116|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075122|NCT00853229|Analgesics|analgesics|mesh-ancestor
20075123|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
20075124|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075125|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075126|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
20075127|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20075128|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075129|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579117|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20579118|NCT02087813|Protective Agents|protective agents|mesh-ancestor
20579119|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20579120|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579121|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579122|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579123|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20579124|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20579125|NCT02088008|Valsartan|valsartan|mesh-list
20579126|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20579127|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20579128|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20579129|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579130|NCT02088060|Cannabidiol|cannabidiol|mesh-list
20579131|NCT02088060|Olanzapine|olanzapine|mesh-list
20579132|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
20579133|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
20579134|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579135|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579136|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579137|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20579138|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20579139|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579140|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20579141|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20579142|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20579143|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579144|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579145|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579146|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
20579147|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
20605738|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20605739|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20605740|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
20605741|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119916|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
20075130|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20075131|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20075132|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20579148|NCT02088398|Ricolinostat|ricolinostat|mesh-list
20579149|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579150|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20579151|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579152|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579153|NCT02088411|Diclofenac|diclofenac|mesh-list
20579154|NCT02088411|Wobenzym|wobenzym|mesh-list
20579155|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20579156|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579157|NCT02088411|Analgesics|analgesics|mesh-ancestor
20579158|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
20579159|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579160|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579161|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579162|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579163|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20579164|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579165|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579166|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20075133|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075134|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20075135|NCT00860158|Dasatinib|dasatinib|mesh-list
20075136|NCT00860158|Leuprolide|leuprolide|mesh-list
20075137|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075138|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075139|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075140|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075141|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20075142|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
20075143|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20075144|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075145|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20075146|NCT00843986|Conivaptan|conivaptan|mesh-list
20579167|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
20579168|NCT02088424|Insulin|insulin|mesh-list
20579169|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579170|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579171|NCT02088450|Nitrendipine|nitrendipine|mesh-list
20579172|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20579173|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20579174|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579175|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075147|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20075148|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075149|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
20075150|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075151|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
20075152|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20075153|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20075154|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20075155|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579176|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579177|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579178|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
20579179|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
20579180|NCT02088502|Theophylline|theophylline|mesh-list
20579181|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20579182|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
20579183|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579184|NCT02088502|Expectorants|expectorants|mesh-ancestor
20579185|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
20579186|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20579187|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
20579188|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579189|NCT02088502|Protective Agents|protective agents|mesh-ancestor
20579190|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579191|NCT02088502|Antidotes|antidotes|mesh-ancestor
20579192|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20579193|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
20579194|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579195|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20579196|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20579197|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579198|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
20579199|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20579200|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20579201|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
20579202|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579203|NCT02088515|Docetaxel|docetaxel|mesh-list
20579204|NCT02088515|Nedaplatin|nedaplatin|mesh-list
20579205|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579206|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
20579207|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
20579208|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
20579209|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579210|NCT02088528|Mitomycins|mitomycins|mesh-list
20579211|NCT02088528|Mitomycin|mitomycin|mesh-list
20579212|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20579213|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579214|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
20579215|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579216|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20579217|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579218|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
20579219|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20579220|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579221|NCT02088671|Propofol|propofol|mesh-list
20579222|NCT02088671|Desflurane|desflurane|mesh-list
20579223|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20579224|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579225|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579226|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20579227|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
20579228|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
20075156|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579229|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20579230|NCT02088684|Fulvestrant|fulvestrant|mesh-list
20579231|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20579232|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579233|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20579234|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20579235|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
20579236|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579237|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579238|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
20579239|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
20579240|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
20579241|NCT02088866|Lidocaine|lidocaine|mesh-list
20579242|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
20579243|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
20579244|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579245|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579246|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
20579247|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579248|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20579249|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20579250|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20579251|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579252|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579253|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
20579254|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20579255|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
20579256|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579257|NCT02088918|Metformin|metformin|mesh-list
20579258|NCT02088918|Nateglinide|nateglinide|mesh-list
20579259|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579260|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579261|NCT02088944|Infliximab|infliximab|mesh-list
20579262|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
20579263|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579264|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579265|NCT02088970|Riboflavin|riboflavin|mesh-list
20579266|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20579267|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579268|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
20579269|NCT02088970|Vitamins|vitamins|mesh-ancestor
20579270|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
20579271|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579272|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20579273|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
20579274|NCT02088983|Choline|choline|mesh-list
20579275|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20579276|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
20579277|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20579278|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
20579279|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579280|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579281|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20579282|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
20075157|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075158|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579283|NCT02089048|Auranofin|auranofin|mesh-list
20579284|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579285|NCT02089061|Atorvastatin|atorvastatin|mesh-list
20579286|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20579287|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20579288|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20579289|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
20579290|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579291|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20075159|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075160|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20075161|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075162|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
20075163|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20075164|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075165|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
20075166|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20075167|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
20075168|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075169|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
20075170|NCT00852241|Protective Agents|protective agents|mesh-ancestor
20075171|NCT00851552|Rituximab|rituximab|mesh-list
20075172|NCT00851552|Doxorubicin|doxorubicin|mesh-list
20075173|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20075174|NCT00851552|Bortezomib|bortezomib|mesh-list
20075175|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075176|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075177|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
20075178|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579292|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20579293|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579294|NCT02089126|Glimepiride|glimepiride|mesh-list
20579295|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20579296|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579297|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579298|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20579299|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
20579300|NCT02089178|Remifentanil|remifentanil|mesh-list
20579301|NCT02089178|Anesthetics|anesthetics|mesh-list
20579302|NCT02089178|Propofol|propofol|mesh-list
20579303|NCT02089178|Sevoflurane|sevoflurane|mesh-list
20579304|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579305|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579306|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20579307|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20075179|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075180|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20075181|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20075182|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20075183|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075184|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075185|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
20075186|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20075187|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20075188|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20579308|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
20075189|NCT00850720|Vasopressins|vasopressins|mesh-list
20075190|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075191|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
20075192|NCT00850720|Coagulants|coagulants|mesh-ancestor
20579309|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20579310|NCT02089178|Narcotics|narcotics|mesh-ancestor
20075193|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20579311|NCT02089178|Analgesics|analgesics|mesh-ancestor
20579312|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
20579313|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579314|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20075194|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20075195|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
20075196|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20075197|NCT00851591|Psyllium|psyllium|mesh-list
20075198|NCT00851591|Cathartics|cathartics|mesh-ancestor
20579315|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20579316|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
20579317|NCT02089204|Fluorides|fluorides|mesh-list
20579318|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
20579319|NCT02089204|Protective Agents|protective agents|mesh-ancestor
20579320|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579321|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
20579322|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579323|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
20579324|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579325|NCT02089256|Liraglutide|liraglutide|mesh-list
20579326|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579327|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579328|NCT02089256|Incretins|incretins|mesh-ancestor
20579329|NCT02089256|Hormones|hormones|mesh-ancestor
20579330|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579331|NCT02089295|Oxycodone|oxycodone|mesh-list
20579332|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20579333|NCT02089295|Narcotics|narcotics|mesh-ancestor
20579334|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579335|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579336|NCT02089295|Analgesics|analgesics|mesh-ancestor
20579337|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
20579338|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579339|NCT02089308|Nicotine|nicotine|mesh-list
20579340|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20579341|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
20579342|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075199|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075200|NCT00843310|Dexamethasone|dexamethasone|mesh-list
20579343|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579344|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20579345|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20579346|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
20579347|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579348|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579349|NCT02089386|Tamoxifen|tamoxifen|mesh-list
20579350|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20579351|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
20579352|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579353|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579354|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20579355|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579356|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20579357|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20579358|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579359|NCT02089399|Olmesartan|olmesartan|mesh-list
20579360|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20579361|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20579362|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20579363|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
20579364|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579365|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20579366|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20579367|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579368|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20579369|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20579370|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20579371|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20579372|NCT02089438|Vildagliptin|vildagliptin|mesh-list
20579373|NCT02089438|Saxagliptin|saxagliptin|mesh-list
20579374|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579375|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579376|NCT02089438|Incretins|incretins|mesh-ancestor
20579377|NCT02089438|Hormones|hormones|mesh-ancestor
20579378|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075201|NCT00843310|Lenalidomide|lenalidomide|mesh-list
20075202|NCT00843310|Melphalan|melphalan|mesh-list
20579379|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20579380|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
20579381|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305941|NCT00653315|Analgesics|analgesics|mesh-ancestor
20305942|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
20305943|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305944|NCT00653341|Insulin|insulin|mesh-list
20305945|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20305946|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
20579382|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579383|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
20579384|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579385|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579386|NCT02089503|Ranibizumab|ranibizumab|mesh-list
20579387|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20579388|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20579389|NCT02089503|Growth Substances|growth substances|mesh-ancestor
20579390|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579391|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
20579392|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579393|NCT02089529|Ibuprofen|ibuprofen|mesh-list
20579394|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20579395|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579396|NCT02089529|Analgesics|analgesics|mesh-ancestor
20579397|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
20579398|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579399|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579400|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579401|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579402|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20579403|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579404|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579405|NCT02089542|Methylene Blue|methylene blue|mesh-list
20579406|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579407|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579408|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20579409|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20579410|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579411|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20579412|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579413|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579414|NCT02089633|BCT-100|bct-100|mesh-list
20579415|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579416|NCT02089763|BCT-100|bct-100|mesh-list
20579417|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605742|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605743|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605744|NCT02233816|Vaccines|vaccines|mesh-list
20605745|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
20605746|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605747|NCT02233881|Ipratropium|ipratropium|mesh-list
20605748|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605749|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
20605750|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605751|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075203|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20075204|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
20075205|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
20075206|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075207|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075208|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075209|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
20075210|NCT00843310|Hormones|hormones|mesh-ancestor
20075211|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075212|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20075213|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075214|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
20075215|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20075216|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20075217|NCT00843310|Growth Substances|growth substances|mesh-ancestor
20075218|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
20075219|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20075220|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
20305947|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
20075221|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075222|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20075223|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075224|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20075225|NCT00847002|Laxatives|laxatives|mesh-ancestor
20075226|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075227|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20075228|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
20075229|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
20075230|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075231|NCT00843830|Vaccines|vaccines|mesh-list
20075232|NCT00843830|Immunologic Factors|immunologic factors|mesh-ancestor
20075233|NCT00843830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075234|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20075235|NCT00835679|Cetuximab|cetuximab|mesh-list
20075236|NCT00835679|Dasatinib|dasatinib|mesh-list
20075237|NCT00835679|Antibodies|antibodies|mesh-list
20075238|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
20075239|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20075240|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
20075241|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075242|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075243|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20579418|NCT02089841|Lumefantrine|lumefantrine|mesh-list
20579419|NCT02089841|Artemether|artemether|mesh-list
20579420|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20579421|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
20579422|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20579423|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20579424|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579425|NCT02089854|Toremifene|toremifene|mesh-list
20579426|NCT02089854|Anastrozole|anastrozole|mesh-list
20579427|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20579428|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579429|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20579430|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20579431|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579432|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579433|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20579434|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
20579435|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579436|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579437|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20579438|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20579439|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579440|NCT02089867|Ezetimibe|ezetimibe|mesh-list
20579441|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20579442|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20579443|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
20579444|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579445|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20579446|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
20579447|NCT02089932|Bupivacaine|bupivacaine|mesh-list
20579448|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
20579449|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
20579450|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579451|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579452|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
20579453|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579454|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20579455|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579456|NCT02089932|Analgesics|analgesics|mesh-ancestor
20579457|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20579458|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20579459|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20579460|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
20075244|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075245|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075246|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20075247|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075248|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075249|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579461|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605752|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20579462|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579463|NCT02090036|Lumefantrine|lumefantrine|mesh-list
20579464|NCT02090036|Artemether|artemether|mesh-list
20579465|NCT02090036|Primaquine|primaquine|mesh-list
20579466|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20579467|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
20579468|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20579469|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20579470|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579471|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20579472|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579473|NCT02090153|Leucovorin|leucovorin|mesh-list
20579474|NCT02090153|Tegafur|tegafur|mesh-list
20579475|NCT02090153|Antidotes|antidotes|mesh-ancestor
20579476|NCT02090153|Protective Agents|protective agents|mesh-ancestor
20579477|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579478|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
20579479|NCT02090153|Vitamins|vitamins|mesh-ancestor
20579480|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
20579481|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20579482|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
20579483|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579484|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579485|NCT02090244|Teriparatide|teriparatide|mesh-list
20579486|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579487|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579488|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579489|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
20579490|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075250|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075251|NCT00832520|Mirtazapine|mirtazapine|mesh-list
20075252|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
20075253|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20579491|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
20579492|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579493|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579494|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20579495|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
20579496|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579497|NCT02090322|Bevacizumab|bevacizumab|mesh-list
20579498|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20579499|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579500|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20579501|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20579502|NCT02090322|Growth Substances|growth substances|mesh-ancestor
20579503|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579504|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
20579505|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20579506|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
20579507|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20579508|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
20579509|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579510|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
20579511|NCT02090400|Calcium|calcium|mesh-list
20579512|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579513|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579514|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20579515|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20579516|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
20579517|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579518|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579519|NCT02090439|Silodosin|silodosin|mesh-list
20579520|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20579521|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20579522|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20579523|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
20579524|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579525|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579526|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579527|NCT02090439|Urological Agents|urological agents|mesh-ancestor
20579528|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
20579529|NCT02090504|Oxazepam|oxazepam|mesh-list
20579530|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20579531|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20579532|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
20579533|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
20579534|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579535|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579536|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20075254|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20075255|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
20075256|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
20579537|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20579538|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20579539|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20579540|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
20579541|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
20579542|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579543|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075257|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075258|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075259|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075260|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20075261|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20075262|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075263|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20075264|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20075265|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20075266|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
20075267|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20075268|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20075269|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
20075270|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20075271|NCT00833859|Gemcitabine|gemcitabine|mesh-list
20305948|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
20579544|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
20579545|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
20579546|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20579547|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
20579548|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20579549|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
20579550|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579551|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579552|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
20579553|NCT02090673|Exenatide|exenatide|mesh-list
20579554|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579555|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579556|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20579557|NCT02090673|Incretins|incretins|mesh-ancestor
20579558|NCT02090673|Hormones|hormones|mesh-ancestor
20579559|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579560|NCT02090738|Amoxicillin|amoxicillin|mesh-list
20579561|NCT02090738|Clarithromycin|clarithromycin|mesh-list
20579562|NCT02090738|Acetazolamide|acetazolamide|mesh-list
20579563|NCT02090738|Esomeprazole|esomeprazole|mesh-list
20579564|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20579565|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579566|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20579567|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579568|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20579569|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579570|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579571|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20579572|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20579573|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20305949|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
20305950|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20305951|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305952|NCT00653354|Valdecoxib|valdecoxib|mesh-list
20305953|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20305954|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20305955|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305956|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305957|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20305958|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20305959|NCT00653354|Analgesics|analgesics|mesh-ancestor
20305960|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
20579574|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
20579575|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20579576|NCT02090738|Diuretics|diuretics|mesh-ancestor
20579577|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
20579578|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579579|NCT02090790|Dexamethasone|dexamethasone|mesh-list
20579580|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
20579581|NCT02090790|BB 1101|bb 1101|mesh-list
20579582|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579583|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
20579584|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
20579585|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579586|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579587|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579588|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
20579589|NCT02090790|Hormones|hormones|mesh-ancestor
20579590|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579591|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20579592|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579593|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
20579594|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579595|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579596|NCT02090829|Oxytocin|oxytocin|mesh-list
20579597|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
20579598|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20579599|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579600|NCT02090920|Nifedipine|nifedipine|mesh-list
20579601|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20579602|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579603|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579604|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579605|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579606|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
20579607|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
20579608|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20579609|NCT02090933|Celecoxib|celecoxib|mesh-list
20579610|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20579611|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579612|NCT02090933|Analgesics|analgesics|mesh-ancestor
20579613|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
20579614|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579615|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579616|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579617|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579618|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20579619|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20579620|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579621|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579622|NCT02091063|Ricolinostat|ricolinostat|mesh-list
20579623|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579624|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20579625|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579626|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579627|NCT02091180|Mannitol|mannitol|mesh-list
20579628|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20579629|NCT02091180|Diuretics|diuretics|mesh-ancestor
20579630|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
20579631|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579632|NCT02091219|Vitamin D|vitamin d|mesh-list
20579633|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
20579634|NCT02091219|Calcifediol|calcifediol|mesh-list
20579635|NCT02091219|Vitamins|vitamins|mesh-ancestor
20579636|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
20579637|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579638|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579639|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579640|NCT02091297|Acetaminophen|acetaminophen|mesh-list
20579641|NCT02091297|Morphine|morphine|mesh-list
20579642|NCT02091297|Ropivacaine|ropivacaine|mesh-list
20579643|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20579644|NCT02091297|Narcotics|narcotics|mesh-ancestor
20579645|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579646|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579647|NCT02091297|Analgesics|analgesics|mesh-ancestor
20579648|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
20579649|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579650|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
20305961|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20305962|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305963|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20305964|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20305965|NCT00653380|Doxycycline|doxycycline|mesh-list
20305966|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20305967|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20305968|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
20305969|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20579651|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
20579652|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579653|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
20579654|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
20579655|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20579656|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579657|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20579658|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20579659|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579660|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579661|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579662|NCT02091336|Metformin|metformin|mesh-list
20579663|NCT02091336|Glyburide|glyburide|mesh-list
20579664|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579665|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579666|NCT02091388|Risperidone|risperidone|mesh-list
20579667|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20579668|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
20579669|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579670|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579671|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579672|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20579673|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20579674|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075272|NCT00833859|Capecitabine|capecitabine|mesh-list
20075273|NCT00833859|Docetaxel|docetaxel|mesh-list
20579675|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20579676|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20579677|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
20579678|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
20579679|NCT02091401|Analgesics|analgesics|mesh-ancestor
20579680|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
20579681|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579682|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579683|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
20579684|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579685|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20579686|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
20579687|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20579688|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579689|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579690|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579691|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
20579692|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20579693|NCT02091492|Teriparatide|teriparatide|mesh-list
20579694|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579695|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579696|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579697|NCT02091505|Ranibizumab|ranibizumab|mesh-list
20579698|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20579699|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20579700|NCT02091505|Growth Substances|growth substances|mesh-ancestor
20579701|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579702|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
20579703|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605753|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605754|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20075274|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20075275|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
20075276|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075277|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075278|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
20075279|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075280|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075281|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20305970|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20579704|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
20579705|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20579706|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
20579707|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579708|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
20579709|NCT02091674|Protective Agents|protective agents|mesh-ancestor
20579710|NCT02091817|Oxytocin|oxytocin|mesh-list
20579711|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
20579712|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20579713|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579714|NCT02091830|Acetaminophen|acetaminophen|mesh-list
20579715|NCT02091830|Cortisone|cortisone|mesh-list
20579716|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20579717|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20579718|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579719|NCT02091830|Analgesics|analgesics|mesh-ancestor
20579720|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
20579721|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579722|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579723|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
20579724|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579725|NCT02091908|Lactitol|lactitol|mesh-list
20075282|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
20075283|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075284|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
20075285|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075286|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075287|NCT00840827|Cyclosporine|cyclosporine|mesh-list
20075288|NCT00840827|Lenalidomide|lenalidomide|mesh-list
20075289|NCT00840827|Cyclosporins|cyclosporins|mesh-list
20075290|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075291|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075292|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075293|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
20075294|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075295|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
20579726|NCT02091908|Vaccines|vaccines|mesh-list
20579727|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
20579728|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579729|NCT02091908|Cathartics|cathartics|mesh-ancestor
20579730|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579731|NCT02091973|Everolimus|everolimus|mesh-list
20579732|NCT02091973|Tacrolimus|tacrolimus|mesh-list
20579733|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20579734|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
20579735|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579736|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20579737|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579738|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579739|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579740|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20579741|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
20579742|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20579743|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579744|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579745|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579746|NCT02092012|Analgesics|analgesics|mesh-ancestor
20579747|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
20579748|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579749|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20579750|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20579751|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20579752|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
20579753|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579754|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579755|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20579756|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579757|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20579758|NCT02092038|Temozolomide|temozolomide|mesh-list
20579759|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20579760|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
20579761|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579762|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579763|NCT02092142|Vaccines|vaccines|mesh-list
20075296|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075297|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
20579764|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
20579765|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579766|NCT02092363|Paclitaxel|paclitaxel|mesh-list
20579767|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20579768|NCT02092363|Carboplatin|carboplatin|mesh-list
20579769|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20579770|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20579771|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579772|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
20579773|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
20579774|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
20579775|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579776|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
20075298|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075299|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20075300|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20075301|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20075302|NCT00840827|Growth Substances|growth substances|mesh-ancestor
20579777|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579778|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
20579779|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579780|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075303|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
20075304|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492010|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075305|NCT00832572|Ranolazine|ranolazine|mesh-list
20075306|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20075307|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075308|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075309|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20075310|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20075311|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075312|NCT00832624|Incretins|incretins|mesh-ancestor
20075313|NCT00832624|Hormones|hormones|mesh-ancestor
20075314|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075315|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20075316|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
20075317|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075318|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075319|NCT00832299|Leucovorin|leucovorin|mesh-list
20075320|NCT00832299|Fluorouracil|fluorouracil|mesh-list
20075321|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
20075322|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
20075323|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075324|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20075325|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075326|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075327|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
20075328|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075329|NCT00832299|Antidotes|antidotes|mesh-ancestor
20075330|NCT00832299|Protective Agents|protective agents|mesh-ancestor
20075331|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
20579781|NCT02092376|Vitamins|vitamins|mesh-ancestor
20579782|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
20579783|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579784|NCT02092428|Adenosine|adenosine|mesh-list
20579785|NCT02092428|Regadenoson|regadenoson|mesh-list
20579786|NCT02092428|Analgesics|analgesics|mesh-ancestor
20579787|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
20579788|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579789|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579790|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20579791|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
20579792|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20579793|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
20579794|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
20579795|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579796|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075332|NCT00832299|Vitamins|vitamins|mesh-ancestor
20075333|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
20579797|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20579798|NCT02092506|Amoxicillin|amoxicillin|mesh-list
20579799|NCT02092506|Metronidazole|metronidazole|mesh-list
20579800|NCT02092506|Clarithromycin|clarithromycin|mesh-list
20579801|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20579802|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20579803|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579804|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20579805|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20579806|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20579807|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579808|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579809|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20579810|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20579811|NCT02092532|Aflibercept|aflibercept|mesh-list
20579812|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20579813|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20579814|NCT02092532|Growth Substances|growth substances|mesh-ancestor
20579815|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579816|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
20579817|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579818|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
20579819|NCT02092558|Cephalosporins|cephalosporins|mesh-list
20579820|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20579821|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579822|NCT02092558|Renal Agents|renal agents|mesh-ancestor
20579823|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20579824|NCT02092597|Exenatide|exenatide|mesh-list
20579825|NCT02092597|Linagliptin|linagliptin|mesh-list
20579826|NCT02092597|Gliclazide|gliclazide|mesh-list
20579827|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579828|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579829|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20579830|NCT02092597|Incretins|incretins|mesh-ancestor
20579831|NCT02092597|Hormones|hormones|mesh-ancestor
20579832|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579833|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20579834|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
20579835|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579836|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579837|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
20579838|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20579839|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579840|NCT02092701|Vitamins|vitamins|mesh-ancestor
20579841|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
20579842|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20579843|NCT02092766|Artesunate|artesunate|mesh-list
20579844|NCT02092766|Quinine|quinine|mesh-list
20579845|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
20579846|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20579847|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20579848|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579849|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579850|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
20579851|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
20579852|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20075334|NCT00836355|Minocycline|minocycline|mesh-list
20579853|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
20579854|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20075335|NCT00836355|Enoxaparin|enoxaparin|mesh-list
20579855|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579856|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20579857|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579858|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20579859|NCT02092766|Analgesics|analgesics|mesh-ancestor
20579860|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
20579861|NCT02092818|Riociguat|riociguat|mesh-list
20579862|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
20579863|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579864|NCT02092896|Liraglutide|liraglutide|mesh-list
20579865|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20579866|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579867|NCT02092896|Incretins|incretins|mesh-ancestor
20579868|NCT02092896|Hormones|hormones|mesh-ancestor
20579869|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579870|NCT02092974|Citalopram|citalopram|mesh-list
20579871|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20579872|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20579873|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20579874|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579875|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579876|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
20579877|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579878|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20075336|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
20075337|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20075338|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20075339|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075340|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20075341|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075342|NCT00816777|Irinotecan|irinotecan|mesh-list
20075343|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20075344|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20579879|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
20579880|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20579881|NCT02093000|Bevacizumab|bevacizumab|mesh-list
20579882|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20579883|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579884|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20579885|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20579886|NCT02093000|Growth Substances|growth substances|mesh-ancestor
20579887|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579888|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
20579889|NCT02093091|Vitremer|vitremer|mesh-list
20579890|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
20579891|NCT02093091|Protective Agents|protective agents|mesh-ancestor
20579892|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579893|NCT02093143|Remifentanil|remifentanil|mesh-list
20579894|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20579895|NCT02093143|Narcotics|narcotics|mesh-ancestor
20579896|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20579897|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579898|NCT02093143|Analgesics|analgesics|mesh-ancestor
20579899|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
20579900|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579901|NCT02093195|Bosentan|bosentan|mesh-list
20579902|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20579903|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20579904|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
20075345|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075346|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075347|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075348|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
20075349|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20075350|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
20075351|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075352|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075353|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20075354|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
20075355|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20075356|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
20579905|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20075357|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305971|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
20579906|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20579907|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579908|NCT02093299|Clopidogrel|clopidogrel|mesh-list
20579909|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20579910|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20579911|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20579912|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20579913|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
20579914|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579915|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579916|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579917|NCT02093403|Decitabine|decitabine|mesh-list
20579918|NCT02093403|Azacitidine|azacitidine|mesh-list
20579919|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20579920|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
20579921|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579922|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075358|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075359|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20075360|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
20075361|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
20075362|NCT00823095|Protective Agents|protective agents|mesh-ancestor
20075363|NCT00827567|Everolimus|everolimus|mesh-list
20075364|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075365|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075366|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
20075367|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075368|NCT00815633|Alefacept|alefacept|mesh-list
20075369|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
20075370|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
20075371|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075372|NCT00825227|Modafinil|modafinil|mesh-list
20075373|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20075374|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075375|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20075376|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20579923|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605755|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
20605756|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605757|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605758|NCT02233894|Ipratropium|ipratropium|mesh-list
20605759|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605760|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
20605761|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605762|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605763|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605764|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605765|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20605766|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
20605767|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605768|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605769|NCT02233907|Oxitropium|oxitropium|mesh-list
20605770|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
20605771|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
20605772|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605773|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605774|NCT02233920|Oxitropium|oxitropium|mesh-list
20605775|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
20605776|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
20605777|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605778|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605779|NCT02233972|Midazolam|midazolam|mesh-list
20605780|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20605781|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20605782|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605783|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605784|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20605785|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20605786|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605787|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20605788|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
20605789|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
20605790|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
20605791|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
20579924|NCT02093533|Eculizumab|eculizumab|mesh-list
20579925|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20579926|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20579927|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
20579928|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579929|NCT02093585|Tenofovir|tenofovir|mesh-list
20579930|NCT02093585|Abacavir|abacavir|mesh-list
20579931|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
20579932|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579933|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20579934|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20579935|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579936|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579937|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20579938|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20579939|NCT02093598|Sirolimus|sirolimus|mesh-list
20579940|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20579941|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579942|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20579943|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579944|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
20579945|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20579946|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
20579947|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579948|NCT02093728|Itraconazole|itraconazole|mesh-list
20579949|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20579950|NCT02093728|Fluconazole|fluconazole|mesh-list
20579951|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
20579952|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20579953|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20579954|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20579955|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579956|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579957|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20579958|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
20579959|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579960|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579961|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20579962|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20579963|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20579964|NCT02093741|Factor VIII|factor viii|mesh-list
20579965|NCT02093741|Coagulants|coagulants|mesh-ancestor
20579966|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20579967|NCT02093845|Everolimus|everolimus|mesh-list
20579968|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579969|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20579970|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
20579971|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579972|NCT02093910|Dexamethasone|dexamethasone|mesh-list
20579973|NCT02093910|Bortezomib|bortezomib|mesh-list
20579974|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20579975|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
20579976|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
20579977|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20579978|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579979|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20579980|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
20579981|NCT02093910|Hormones|hormones|mesh-ancestor
20579982|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20579983|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20579984|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20579985|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20579986|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20579987|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579988|NCT02094053|Donepezil|donepezil|mesh-list
20579989|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20579990|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20579991|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579992|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
20579993|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20579994|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20579995|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
20075377|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20075378|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20579996|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
20579997|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20579998|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20579999|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580000|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
20580001|NCT02094066|Coagulants|coagulants|mesh-ancestor
20580002|NCT02094157|Heparin|heparin|mesh-list
20580003|NCT02094157|Calcium heparin|calcium heparin|mesh-list
20580004|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20580005|NCT02094157|Tinzaparin|tinzaparin|mesh-list
20580006|NCT02094157|Dalteparin|dalteparin|mesh-list
20580007|NCT02094157|Warfarin|warfarin|mesh-list
20580008|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
20580009|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20580010|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20580011|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580012|NCT02094196|Ethanol|ethanol|mesh-list
20580013|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20580014|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075379|NCT00822679|Eszopiclone|eszopiclone|mesh-list
20075380|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20580015|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580016|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580017|NCT02094222|Glycerol|glycerol|mesh-list
20580018|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20580019|NCT02094222|Protective Agents|protective agents|mesh-ancestor
20580020|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580021|NCT02094274|Fluticasone|fluticasone|mesh-list
20580022|NCT02094274|Xhance|xhance|mesh-list
20580023|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20580024|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580025|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20580026|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
20580027|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580028|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580029|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20580030|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
20580031|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
20580032|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20580033|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20580034|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20580035|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20580036|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
20580037|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580038|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580039|NCT02094287|Dimethindene|dimethindene|mesh-list
20580040|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
20580041|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
20580042|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20580043|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
20580044|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
20580045|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580046|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580047|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580048|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20580049|NCT02094313|Atorvastatin|atorvastatin|mesh-list
20580050|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
20580051|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20580052|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
20580053|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580054|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20580055|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20075381|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075382|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075383|NCT00809458|Vitamin E|vitamin e|mesh-list
20075384|NCT00809458|Tocopherols|tocopherols|mesh-list
20075385|NCT00809458|Tocotrienols|tocotrienols|mesh-list
20075386|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
20075387|NCT00809458|Vitamins|vitamins|mesh-ancestor
20075388|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
20075389|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075390|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
20075391|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075392|NCT00809458|Protective Agents|protective agents|mesh-ancestor
20580056|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580057|NCT02094339|Analgesics|analgesics|mesh-list
20580058|NCT02094339|Ropivacaine|ropivacaine|mesh-list
20580059|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
20580060|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
20580061|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580062|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580063|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
20580064|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580065|NCT02094378|Esketamine|esketamine|mesh-list
20580066|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
20580067|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20580068|NCT02094391|Ipilimumab|ipilimumab|mesh-list
20580069|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20580070|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580071|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20580072|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580073|NCT02094469|Cilostazol|cilostazol|mesh-list
20580074|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20580075|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
20580076|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580077|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580078|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20580079|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
20580080|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20580081|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20580082|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580083|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580084|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
20580085|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20580086|NCT02094469|Protective Agents|protective agents|mesh-ancestor
20580087|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20580088|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20580089|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580090|NCT02094599|Dronabinol|dronabinol|mesh-list
20580091|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
20580092|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580093|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20580094|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580095|NCT02094599|Analgesics|analgesics|mesh-ancestor
20580096|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
20580097|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580098|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20580099|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20580100|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580101|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580102|NCT02094599|Hormones|hormones|mesh-ancestor
20580103|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20580104|NCT02094651|Valproic Acid|valproic acid|mesh-list
20580105|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
20580106|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580107|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580108|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
20580109|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580110|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580111|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
20580112|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20580113|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580114|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20580115|NCT02094703|Levofloxacin|levofloxacin|mesh-list
20580116|NCT02094703|Ofloxacin|ofloxacin|mesh-list
20580117|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
20580118|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20580119|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580120|NCT02094703|Renal Agents|renal agents|mesh-ancestor
20580121|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580122|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20580123|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20580124|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580125|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580126|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580127|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20580128|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20580129|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20580130|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20580131|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
20580132|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580133|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580134|NCT02094703|Urological Agents|urological agents|mesh-ancestor
20580135|NCT02094807|Acetaminophen|acetaminophen|mesh-list
20580136|NCT02094807|Diclofenac|diclofenac|mesh-list
19492011|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492012|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075393|NCT00807365|Hormones|hormones|mesh-list
20075394|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20075395|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075396|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075397|NCT00814333|Thrombin|thrombin|mesh-list
20075398|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
20075399|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
20075400|NCT00814333|Coagulants|coagulants|mesh-ancestor
20075401|NCT00809341|Prednisone|prednisone|mesh-list
20075402|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
20075403|NCT00809341|Ifosfamide|ifosfamide|mesh-list
20075404|NCT00809341|Rituximab|rituximab|mesh-list
20075405|NCT00809341|Carboplatin|carboplatin|mesh-list
20075406|NCT00809341|Doxorubicin|doxorubicin|mesh-list
20075407|NCT00809341|Etoposide|etoposide|mesh-list
20075408|NCT00809341|Vincristine|vincristine|mesh-list
20075409|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075410|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
19492013|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
19492014|NCT03126591|Olaratumab|olaratumab|mesh-list
19492015|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20580137|NCT02094807|Oxycodone|oxycodone|mesh-list
20580138|NCT02094807|Tramadol|tramadol|mesh-list
20580139|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580140|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580141|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580142|NCT02094807|Analgesics|analgesics|mesh-ancestor
20580143|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
20580144|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580145|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
20580146|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20580147|NCT02094807|Narcotics|narcotics|mesh-ancestor
20075411|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075412|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075413|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20075414|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
20075415|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075416|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075417|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20580148|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20580149|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580150|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580151|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20580152|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580153|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580154|NCT02094833|Vaccines|vaccines|mesh-list
20075418|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075419|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20075420|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20075421|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20075422|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075423|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20075424|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
20075425|NCT00809341|Hormones|hormones|mesh-ancestor
20119917|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
20580155|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
20580156|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580157|NCT02094924|Candesartan|candesartan|mesh-list
20075426|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075427|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20075428|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20075429|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
20075430|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075431|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075432|NCT00803283|Morphine|morphine|mesh-list
20075433|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20075434|NCT00803283|Narcotics|narcotics|mesh-ancestor
20075435|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075436|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075437|NCT00803283|Analgesics|analgesics|mesh-ancestor
20075438|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
20075439|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075440|NCT00811590|Everolimus|everolimus|mesh-list
20075441|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075442|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075443|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
20075444|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075445|NCT00808899|Sirolimus|sirolimus|mesh-list
20075446|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
20580158|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
20580159|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20580160|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20580161|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20305972|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
20305973|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305974|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20305975|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20305976|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305977|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20305978|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305979|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305980|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305981|NCT00653406|Risperidone|risperidone|mesh-list
20305982|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20305983|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
20305984|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20305985|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20305986|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492016|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075447|NCT00808899|Doxorubicin|doxorubicin|mesh-list
20075448|NCT00808899|Irinotecan|irinotecan|mesh-list
20305987|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20305988|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305989|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305990|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305991|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20305992|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
20305993|NCT00653419|Buspirone|buspirone|mesh-list
20580162|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580163|NCT02094963|Clopidogrel|clopidogrel|mesh-list
20580164|NCT02094963|Ticagrelor|ticagrelor|mesh-list
19492017|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
20075449|NCT00808899|Etoposide|etoposide|mesh-list
20580165|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580166|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20580167|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20580168|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20580169|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
20580170|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580171|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580172|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580173|NCT02095054|Cetuximab|cetuximab|mesh-list
20580174|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20580175|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580176|NCT02095119|Gemcitabine|gemcitabine|mesh-list
20580177|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
20580178|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580179|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20580180|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
20580181|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580182|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
20580183|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580184|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580185|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20580186|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
20580187|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580188|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20580189|NCT02095132|Irinotecan|irinotecan|mesh-list
20580190|NCT02095132|Camptothecin|camptothecin|mesh-list
20580191|NCT02095132|Adavosertib|adavosertib|mesh-list
20580192|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20580193|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20580194|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580195|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580196|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580197|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20605792|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605793|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605794|NCT02234037|Decitabine|decitabine|mesh-list
20605795|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20605796|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
20605797|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605798|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605799|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605800|NCT02234050|Trabectedin|trabectedin|mesh-list
20605801|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20605802|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
20605803|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605804|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605805|NCT02234193|Lidocaine|lidocaine|mesh-list
20605806|NCT02234193|Epinephrine|epinephrine|mesh-list
20605807|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
20605808|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
20605809|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605810|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605811|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
20605812|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605813|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20605814|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20605815|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20605816|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605817|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605818|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20605819|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20605820|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
20605821|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605822|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20605823|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20605824|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
20605825|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20605826|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
20605827|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
20605828|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
20605829|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19492018|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20075450|NCT00808899|Topotecan|topotecan|mesh-list
20580198|NCT02095314|Vaccines|vaccines|mesh-list
20580199|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
20580200|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580201|NCT02095366|Sufentanil|sufentanil|mesh-list
20580202|NCT02095366|Morphine|morphine|mesh-list
20580203|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20580204|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20580205|NCT02095366|Narcotics|narcotics|mesh-ancestor
20580206|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580207|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580208|NCT02095366|Analgesics|analgesics|mesh-ancestor
20580209|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
20580210|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580211|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20580212|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20580213|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
20075451|NCT00808899|Tretinoin|tretinoin|mesh-list
20075452|NCT00808899|Isotretinoin|isotretinoin|mesh-list
20075453|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075454|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
20075455|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075456|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075457|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20075458|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
20075459|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075460|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075461|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20075462|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20075463|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20075464|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20075465|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075466|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20075467|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20075468|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20075469|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075470|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
20075471|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
20075472|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
20075473|NCT00808769|Omeprazole|omeprazole|mesh-list
20075474|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
20075475|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20075476|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075477|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20075478|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075479|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075480|NCT00803179|Hormones|hormones|mesh-list
20075481|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075482|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075483|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
20075484|NCT00801931|Melphalan|melphalan|mesh-list
20075485|NCT00801931|Busulfan|busulfan|mesh-list
20075486|NCT00801931|Thiotepa|thiotepa|mesh-list
20075487|NCT00801931|Fludarabine|fludarabine|mesh-list
20580214|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
20580215|NCT02095405|Caffeine|caffeine|mesh-list
20580216|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20580217|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580218|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20580219|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580220|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580221|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20580222|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20075488|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
20075489|NCT00801931|Phenytoin|phenytoin|mesh-list
20075490|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
20075491|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
20305994|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20305995|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20305996|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20305997|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20305998|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20305999|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20306000|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
20306001|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580223|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
20075492|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20580224|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580225|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
20580226|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20580227|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580228|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20580229|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
20580230|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580231|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580232|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075493|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075494|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
20075495|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075496|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075497|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20580233|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580234|NCT02095509|Enoxaparin|enoxaparin|mesh-list
20580235|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
20580236|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20580237|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20580238|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580239|NCT02095522|Colchicine|colchicine|mesh-list
20580240|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
20580241|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580242|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
20580243|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
20580244|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
20580245|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580246|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580247|NCT02095548|Lorecivivint|lorecivivint|mesh-list
20580248|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20075498|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
20075499|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075500|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075501|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20075502|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075503|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
20075504|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20075505|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20075506|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075507|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20075508|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20075509|NCT00793520|Milnacipran|milnacipran|mesh-list
20075510|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
20075511|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20075512|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20075513|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20580249|NCT02095574|Venetoclax|venetoclax|mesh-list
20580250|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580251|NCT02095665|Acetaminophen|acetaminophen|mesh-list
20580252|NCT02095665|Tamsulosin|tamsulosin|mesh-list
20580253|NCT02095665|Mirabegron|mirabegron|mesh-list
20580254|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20580255|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20075514|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075515|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075516|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075517|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20075518|NCT00793520|Analgesics|analgesics|mesh-ancestor
20075519|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
20075520|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075521|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
20075522|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20075523|NCT00795236|Melatonin|melatonin|mesh-list
20075524|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
20075525|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075526|NCT00795236|Protective Agents|protective agents|mesh-ancestor
20075527|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075528|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075529|NCT00799773|Rituximab|rituximab|mesh-list
20075530|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075531|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075532|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
20075533|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580256|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20075534|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075535|NCT00790452|Aspirin|aspirin|mesh-list
20075536|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20580257|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
20580258|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580259|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580260|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580261|NCT02095665|Urological Agents|urological agents|mesh-ancestor
20580262|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580263|NCT02095665|Analgesics|analgesics|mesh-ancestor
20580264|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
20580265|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580266|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
20580267|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20580268|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20580269|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20580270|NCT02095704|Acetaminophen|acetaminophen|mesh-list
20580271|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580272|NCT02095704|Analgesics|analgesics|mesh-ancestor
20580273|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
20580274|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580275|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580276|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
20580277|NCT02095717|Curcumin|curcumin|mesh-list
20580278|NCT02095717|Docetaxel|docetaxel|mesh-list
20580279|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580280|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
20580281|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
20580282|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
20580283|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075537|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20075538|NCT00790452|Analgesics|analgesics|mesh-ancestor
20075539|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
20075540|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075541|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075542|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20075543|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075544|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20075545|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20075546|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075547|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580284|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20580285|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580286|NCT02095717|Analgesics|analgesics|mesh-ancestor
20580287|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
20580288|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580289|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580290|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580291|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580292|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580293|NCT02095730|Vitamins|vitamins|mesh-list
20580294|NCT02095730|Riboflavin|riboflavin|mesh-list
20580295|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
20580296|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
20580297|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580298|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20580299|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
20580300|NCT02095782|Paclitaxel|paclitaxel|mesh-list
20580301|NCT02095782|Carboplatin|carboplatin|mesh-list
20580302|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20580303|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20580304|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580305|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
20580306|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
20580307|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
20580308|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580309|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20580310|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580311|NCT02095834|Dexamethasone|dexamethasone|mesh-list
20580312|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
20075548|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20075549|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075550|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
20075551|NCT00795665|Bevacizumab|bevacizumab|mesh-list
20580313|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20580314|NCT02095834|Ichthammol|ichthammol|mesh-list
20580315|NCT02095834|BB 1101|bb 1101|mesh-list
20075552|NCT00795665|Carmustine|carmustine|mesh-list
20075553|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075554|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075555|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20075556|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20075557|NCT00795665|Growth Substances|growth substances|mesh-ancestor
20075558|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075559|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
20075560|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20075561|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
20075562|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075563|NCT00787917|Omalizumab|omalizumab|mesh-list
20075564|NCT00787917|Itraconazole|itraconazole|mesh-list
20075565|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
20075566|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075567|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20075568|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20075569|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075570|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075571|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20075572|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
20075573|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075574|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075575|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20075576|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20580316|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580317|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
20580318|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
20580319|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580320|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580321|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20580322|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
20580323|NCT02095834|Hormones|hormones|mesh-ancestor
20075577|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20075578|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
20075579|NCT00798590|Glucagon|glucagon|mesh-list
20075580|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20075581|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075582|NCT00798590|Hormones|hormones|mesh-ancestor
20075583|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20580324|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20580325|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20580326|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580327|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20580328|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
20075584|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075585|NCT00798590|Incretins|incretins|mesh-ancestor
20075586|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
20075587|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
20075588|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
20075589|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20075590|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20075591|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075592|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075593|NCT00796510|Urological Agents|urological agents|mesh-ancestor
20075594|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20075595|NCT00796861|Sunitinib|sunitinib|mesh-list
20075596|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075597|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20075598|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20075599|NCT00796861|Growth Substances|growth substances|mesh-ancestor
20075600|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075601|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
20075602|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075603|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075604|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580329|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580330|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
20580331|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580332|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20580333|NCT02095847|Proflavine|proflavine|mesh-list
20580334|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20580335|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580336|NCT02095886|BMS-955176|bms-955176|mesh-list
20580337|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20580338|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20580339|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
20580340|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075605|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
20075606|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075607|NCT00791076|Hormones|hormones|mesh-ancestor
20075608|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075609|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075610|NCT00790478|Melatonin|melatonin|mesh-list
20075611|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
20075612|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075613|NCT00790478|Protective Agents|protective agents|mesh-ancestor
20075614|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580341|NCT02095899|Rufinamide|rufinamide|mesh-list
20580342|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
20580343|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20580344|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20580345|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20580346|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580347|NCT02095938|Amisulpride|amisulpride|mesh-list
20580348|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20075615|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075616|NCT00796107|Letrozole|letrozole|mesh-list
20075617|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075618|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20075619|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20075620|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075621|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075622|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20075623|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
20075624|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075625|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075626|NCT00791336|Nelfinavir|nelfinavir|mesh-list
20075627|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20075628|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20075629|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
20580349|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20580350|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580351|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580352|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20580353|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20580354|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
20580355|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580356|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580357|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20580358|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
20580359|NCT02095990|Hydroquinone|hydroquinone|mesh-list
20580360|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
20580361|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580362|NCT02095990|Protective Agents|protective agents|mesh-ancestor
20580363|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580364|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20580365|NCT02096055|Idarubicin|idarubicin|mesh-list
20580366|NCT02096055|Cladribine|cladribine|mesh-list
20580367|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
20075630|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075631|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075632|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20580368|NCT02096055|Guadecitabine|guadecitabine|mesh-list
20075633|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20075634|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
20075635|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075636|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
20075637|NCT00786682|Docetaxel|docetaxel|mesh-list
20075638|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075639|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
20075640|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075641|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075642|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075643|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
20075644|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20075645|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20075646|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075647|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075648|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075649|NCT00791843|Hormones|hormones|mesh-list
20075650|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20075651|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075652|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075653|NCT00774306|Phenytoin|phenytoin|mesh-list
20075654|NCT00774306|Levetiracetam|levetiracetam|mesh-list
20075655|NCT00774306|Valproic Acid|valproic acid|mesh-list
20075656|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
20580369|NCT02096055|Azacitidine|azacitidine|mesh-list
20580370|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20580371|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580372|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20580373|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20580374|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580375|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580376|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20580377|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
20075657|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
20075658|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075659|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075660|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
20075661|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075662|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580378|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580379|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20580380|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
20580381|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
20580382|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20075663|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
20075664|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20075665|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580383|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580384|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580385|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580386|NCT02096068|Analgesics|analgesics|mesh-ancestor
20580387|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
20580388|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580389|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20580390|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20580391|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20580392|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
20580393|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580394|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580395|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
20580396|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20580397|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580398|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
20580399|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
20580400|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20580401|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580402|NCT02096133|Vitamins|vitamins|mesh-ancestor
20580403|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
20580404|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20580405|NCT02096224|Sevoflurane|sevoflurane|mesh-list
20580406|NCT02096224|Desflurane|desflurane|mesh-list
20580407|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580408|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20075666|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20075667|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20580409|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
20580410|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
20580411|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580412|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580413|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
20580414|NCT02096250|Edetic Acid|edetic acid|mesh-list
20580415|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
20580416|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20580417|NCT02096250|Trace Elements|trace elements|mesh-ancestor
20580418|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
20580419|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580420|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20580421|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
20580422|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
20580423|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580424|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
20580425|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20580426|NCT02096250|Hematinics|hematinics|mesh-ancestor
20580427|NCT02096289|Thioridazine|thioridazine|mesh-list
20580428|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20580429|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20580430|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580431|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580432|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20580433|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20580434|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
20580435|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580436|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580437|NCT02096315|Murepavadin|murepavadin|mesh-list
20580438|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580439|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580440|NCT02096328|Murepavadin|murepavadin|mesh-list
20580441|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580442|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580443|NCT02096380|Cisplatin|cisplatin|mesh-list
20580444|NCT02096380|Docetaxel|docetaxel|mesh-list
20580445|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580446|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
20580447|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
20580448|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
20580449|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580450|NCT02096419|Clopidogrel|clopidogrel|mesh-list
20580451|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580452|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20580453|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20580454|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20580455|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
20580456|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580457|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580458|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580459|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
20580460|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20580461|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20580462|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20580463|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580464|NCT02096536|Vancomycin|vancomycin|mesh-list
20580465|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580466|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075668|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20075669|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075670|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20075671|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20075672|NCT00771602|Rituximab|rituximab|mesh-list
20075673|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
20075674|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075675|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580467|NCT02096601|Levodopa|levodopa|mesh-list
20580468|NCT02096601|Carbidopa|carbidopa|mesh-list
20580469|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20580470|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20580471|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
20580472|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580473|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580474|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580475|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20580476|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075676|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
20075677|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580477|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
20580478|NCT02096614|Fludarabine|fludarabine|mesh-list
20580479|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20580480|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
20580481|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580482|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580483|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20580484|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
20580485|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580486|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580487|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20580488|NCT02096913|Ibuprofen|ibuprofen|mesh-list
20580489|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20580490|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580491|NCT02096913|Analgesics|analgesics|mesh-ancestor
20580492|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
20580493|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580494|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580495|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580496|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580497|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20580498|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580499|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580500|NCT02096926|Ibuprofen|ibuprofen|mesh-list
20580501|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20580502|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580503|NCT02096926|Analgesics|analgesics|mesh-ancestor
20580504|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
20580505|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580506|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580507|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580508|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580509|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20580510|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580511|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580512|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
20580513|NCT02096965|Tolvaptan|tolvaptan|mesh-list
20580514|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20580515|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580516|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
20580517|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580518|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20580519|NCT02097004|Entecavir|entecavir|mesh-list
20580520|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
20580521|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580522|NCT02097017|Lidocaine|lidocaine|mesh-list
20580523|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
20580524|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
20580525|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580526|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580527|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
20580528|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580529|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20580530|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20580531|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20580532|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20580533|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580534|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
20580535|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580536|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580537|NCT02097069|Folic Acid|folic acid|mesh-list
20580538|NCT02097069|Inositol|inositol|mesh-list
20580539|NCT02097069|Hematinics|hematinics|mesh-ancestor
20580540|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
20580541|NCT02097069|Vitamins|vitamins|mesh-ancestor
20580542|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
20580543|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580544|NCT02097082|Paclitaxel|paclitaxel|mesh-list
20580545|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20580546|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580547|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
20075678|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580548|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
20580549|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
20580550|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605830|NCT02234349|Pancrelipase|pancrelipase|mesh-list
20605831|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605832|NCT02234440|Metformin|metformin|mesh-list
20605833|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20605834|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605835|NCT02234466|Dexamethasone|dexamethasone|mesh-list
20075679|NCT00779038|Fentanyl|fentanyl|mesh-list
20075680|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20075681|NCT00779038|Narcotics|narcotics|mesh-ancestor
20075682|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075683|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075684|NCT00779038|Analgesics|analgesics|mesh-ancestor
20075685|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
20075686|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075687|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20075688|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20075689|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
20075690|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
20605836|NCT02234466|Ondansetron|ondansetron|mesh-list
20605837|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20605838|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
20605839|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
20605840|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605841|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605842|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20605843|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
20605844|NCT02234466|Hormones|hormones|mesh-ancestor
20605845|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605846|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20075691|NCT00780455|Interferons|interferons|mesh-list
20075692|NCT00780455|Interferon-beta|interferon-beta|mesh-list
20075693|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
20075694|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075695|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
20075696|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075697|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
20075698|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075699|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20075700|NCT00771316|Meropenem|meropenem|mesh-list
20075701|NCT00771316|Ertapenem|ertapenem|mesh-list
20075702|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20075703|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075704|NCT00780481|Bradykinin|bradykinin|mesh-list
20605847|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605848|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
20605849|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
20605850|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20605851|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
20605852|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605853|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605854|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20605855|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20605856|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605857|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20605858|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20605859|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20605860|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20605861|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605862|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
20605863|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605864|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605865|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20605866|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605867|NCT02234544|Vitamin D|vitamin d|mesh-list
20605868|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
20605869|NCT02234544|Ezetimibe|ezetimibe|mesh-list
20605870|NCT02234544|Vitamins|vitamins|mesh-ancestor
20605871|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
20605872|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075705|NCT00780481|Kininogens|kininogens|mesh-list
20075706|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
20075707|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20075708|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
20605873|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20605874|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20580551|NCT02097147|Paroxetine|paroxetine|mesh-list
20580552|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20580553|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20580554|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20580555|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20580556|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580557|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580558|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
20580559|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580560|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20580561|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
20580562|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20580563|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20580564|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20580565|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580566|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20580567|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20580568|NCT02097160|Vitamin D|vitamin d|mesh-list
20580569|NCT02097160|Vitamins|vitamins|mesh-ancestor
20580570|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
20580571|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580572|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20580573|NCT02097173|Methotrexate|methotrexate|mesh-list
20580574|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20580575|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
20580576|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20580577|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580578|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20580579|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
20580580|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580581|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580582|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
20580583|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580584|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20580585|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20580586|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
20580587|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580588|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20580589|NCT02097264|Adalimumab|adalimumab|mesh-list
20580590|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580591|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580592|NCT02097316|Insulin|insulin|mesh-list
20580593|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20580594|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580595|NCT02097329|Palbociclib|palbociclib|mesh-list
20580596|NCT02097329|Rabeprazole|rabeprazole|mesh-list
20580597|NCT02097329|Famotidine|famotidine|mesh-list
20580598|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
20580599|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
20580600|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20580601|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
20580602|NCT02097329|Antacids|antacids|mesh-list
20580603|NCT02097329|TEMPO|tempo|mesh-list
20580604|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580605|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20580606|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580607|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580608|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075709|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580609|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20580610|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20580611|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
20580612|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
20580613|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580614|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580615|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
20580616|NCT02097329|Protective Agents|protective agents|mesh-ancestor
20580617|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20580618|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
20580619|NCT02097342|Linagliptin|linagliptin|mesh-list
20580620|NCT02097342|Voglibose|voglibose|mesh-list
20580621|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20580622|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580623|NCT02097342|Incretins|incretins|mesh-ancestor
20580624|NCT02097342|Hormones|hormones|mesh-ancestor
20605875|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20075710|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075711|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20075712|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
20075713|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20075714|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075715|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20580625|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20580626|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20580627|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
20580628|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580629|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580630|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20580631|NCT02097381|Ritonavir|ritonavir|mesh-list
20580632|NCT02097381|Lopinavir|lopinavir|mesh-list
20580633|NCT02097381|Darunavir|darunavir|mesh-list
20580634|NCT02097381|Tenofovir|tenofovir|mesh-list
20580635|NCT02097381|Emtricitabine|emtricitabine|mesh-list
20580636|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20580637|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20580638|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
20580639|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580640|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580641|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20580642|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20580643|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
20580644|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580645|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20580646|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20580647|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20580648|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20580649|NCT02097394|Pancreatin|pancreatin|mesh-list
20580650|NCT02097394|Pancrelipase|pancrelipase|mesh-list
20580651|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20580652|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
20580653|NCT02097407|Propofol|propofol|mesh-list
20580654|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20306002|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306003|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306004|NCT00653445|Ezetimibe|ezetimibe|mesh-list
20306005|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306006|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20580655|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580656|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580657|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20580658|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
20580659|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
20580660|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20580661|NCT02097407|Analgesics|analgesics|mesh-ancestor
20075716|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20306007|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
20306008|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306009|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306010|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306011|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306012|NCT00653458|Ondansetron|ondansetron|mesh-list
20306013|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
20306014|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
20306015|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306016|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306017|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20306018|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
20075717|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075718|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075719|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
20075720|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580662|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
20580663|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075721|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
20075722|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20075723|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20075724|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
20075725|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20075726|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075727|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20075728|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20075729|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20075730|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20075731|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306019|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
20306020|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20075732|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20580664|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20580665|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20580666|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20580667|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
20580668|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580669|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580670|NCT02097459|Tamoxifen|tamoxifen|mesh-list
20580671|NCT02097459|Toremifene|toremifene|mesh-list
20580672|NCT02097459|Anastrozole|anastrozole|mesh-list
20580673|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20580674|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
20580675|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20580676|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580677|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20580678|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580679|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20580680|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20580681|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20580682|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20580683|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20580684|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580685|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580686|NCT02097511|Metoprolol|metoprolol|mesh-list
20580687|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
20580688|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20580689|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20580690|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
20580691|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
20580692|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580693|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580694|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20580695|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20580696|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20580697|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
20580698|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580699|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580700|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20580701|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20580702|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580703|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20075733|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20075734|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075735|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580704|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
20580705|NCT02097589|Atorvastatin|atorvastatin|mesh-list
20580706|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20580707|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
20580708|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580709|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20580710|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20580711|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
20580712|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580713|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20075736|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075737|NCT00755261|Bevacizumab|bevacizumab|mesh-list
20075738|NCT00755261|Doxorubicin|doxorubicin|mesh-list
20306021|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
20580714|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20580715|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580716|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
20580717|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20580718|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20580719|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580720|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
20580721|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
20580722|NCT02097810|Entrectinib|entrectinib|mesh-list
20580723|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20580724|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580725|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580726|NCT02097953|Rifampin|rifampin|mesh-list
20580727|NCT02097953|Daptomycin|daptomycin|mesh-list
20580728|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20580729|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
20580730|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580731|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580732|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
20075739|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075740|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075741|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20075742|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20075743|NCT00755261|Growth Substances|growth substances|mesh-ancestor
20075744|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075745|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
20075746|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20075747|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20075748|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20075749|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075750|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075751|NCT00766636|Gemcitabine|gemcitabine|mesh-list
20075752|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20075753|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20075754|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
20075755|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075756|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075757|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
20075758|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580733|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20580734|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580735|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580736|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20580737|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20075759|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075760|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20075761|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
20075762|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075763|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075764|NCT00768248|Ropivacaine|ropivacaine|mesh-list
20075765|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
20075766|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
20075767|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075768|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075769|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
20075770|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075771|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
20075772|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
20075773|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20075774|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20075775|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580738|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20580739|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20580740|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20580741|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20580742|NCT02097966|Ribavirin|ribavirin|mesh-list
20580743|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
20580744|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
20580745|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580746|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
20580747|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580748|NCT02098148|Xenon|xenon|mesh-list
20075776|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075777|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580749|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20580750|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
20580751|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
20580752|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580753|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580754|NCT02098317|Vitamin D|vitamin d|mesh-list
20075778|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075779|NCT00764699|Mecasermin|mecasermin|mesh-list
20075780|NCT00764699|Growth Substances|growth substances|mesh-ancestor
20075781|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075782|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
20075783|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20580755|NCT02098317|Vitamins|vitamins|mesh-ancestor
20580756|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
20580757|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580758|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20580759|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
20580760|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20580761|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20580762|NCT02098330|Prednisolone|prednisolone|mesh-list
20580763|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
20580764|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20580765|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
20580766|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580767|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
20580768|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
20580769|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580770|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580771|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20580772|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
20580773|NCT02098330|Hormones|hormones|mesh-ancestor
20580774|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20580775|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20580776|NCT02098330|Protective Agents|protective agents|mesh-ancestor
20580777|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20580778|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580779|NCT02098343|Carboplatin|carboplatin|mesh-list
20580780|NCT02098343|Doxorubicin|doxorubicin|mesh-list
20580781|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20580782|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580783|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20580784|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20580785|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20580786|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580787|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580788|NCT02098421|Oxytocin|oxytocin|mesh-list
20580789|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
20580790|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20580791|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580792|NCT02098460|Cilostazol|cilostazol|mesh-list
20580793|NCT02098460|Atorvastatin|atorvastatin|mesh-list
20580794|NCT02098460|Probucol|probucol|mesh-list
20580795|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20580796|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20580797|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
20580798|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580799|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20580800|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20580801|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580802|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20580803|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
20580804|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580805|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580806|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20580807|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
20580808|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20580809|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20580810|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580811|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
20580812|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20580813|NCT02098460|Protective Agents|protective agents|mesh-ancestor
20075784|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20580814|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20580815|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20580816|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
20580817|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
20075785|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
20580818|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
20580819|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20580820|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075786|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075787|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580821|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20580822|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20580823|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580824|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580825|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580826|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
20580827|NCT02098499|Promethazine|promethazine|mesh-list
20580828|NCT02098499|Haloperidol|haloperidol|mesh-list
20580829|NCT02098499|Metoclopramide|metoclopramide|mesh-list
20580830|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
20580831|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20580832|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20580833|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20580834|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580835|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
20580836|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
20580837|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
20580838|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580839|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
20580840|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
20580841|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075788|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075789|NCT00759577|Urological Agents|urological agents|mesh-ancestor
20075790|NCT00763009|Dipyridamole|dipyridamole|mesh-list
20075791|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20075792|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075793|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075794|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20075795|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
20075796|NCT00760461|Domperidone|domperidone|mesh-list
20075797|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
20580842|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20580843|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
20580844|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
20580845|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075798|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
20075799|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075800|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075801|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20075802|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20075803|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
20075804|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075805|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075806|NCT00749658|Bupropion|bupropion|mesh-list
20075807|NCT00749658|Varenicline|varenicline|mesh-list
20075808|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20075809|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
20075810|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20075811|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20075812|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20075813|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075814|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075815|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
20075816|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075817|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075818|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20075819|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20075820|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075821|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20075822|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20075823|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075824|NCT00754793|Dexetimide|dexetimide|mesh-list
20075825|NCT00754793|Citalopram|citalopram|mesh-list
20075826|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20075827|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20580846|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580847|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20580848|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
20580849|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
20580850|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20075828|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075829|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075830|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075831|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
20075832|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580851|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20580852|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20580853|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20580854|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
20580855|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20580856|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20580857|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20580858|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20580859|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580860|NCT02098590|Chloroquine|chloroquine|mesh-list
20075833|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20075834|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
20075835|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20075836|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20075837|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20075838|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
20075839|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
20075840|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075841|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20075842|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20580861|NCT02098590|Atovaquone|atovaquone|mesh-list
20580862|NCT02098590|Proguanil|proguanil|mesh-list
20580863|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20580864|NCT02098590|Vaccines|vaccines|mesh-list
20580865|NCT02098590|Amebicides|amebicides|mesh-ancestor
20580866|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20580867|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20580868|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580869|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
19492019|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492020|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075843|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075844|NCT00754052|Donepezil|donepezil|mesh-list
20075845|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20075846|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075847|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492021|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492022|NCT03126422|Analgesics|analgesics|mesh-ancestor
19492023|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
19492024|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492025|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20075848|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
20580870|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580871|NCT02098590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580872|NCT02098590|Immunologic Factors|immunologic factors|mesh-ancestor
20580873|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580874|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580875|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
20580876|NCT02098616|Asunaprevir|asunaprevir|mesh-list
20580877|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
20580878|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580879|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580880|NCT02098629|Milrinone|milrinone|mesh-list
20580881|NCT02098629|Esmolol|esmolol|mesh-list
20580882|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20580883|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20580884|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20580885|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
20580886|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580887|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580888|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580889|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20580890|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20580891|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
20580892|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20580893|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20075849|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580894|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580895|NCT02098629|Protective Agents|protective agents|mesh-ancestor
20580896|NCT02098785|Caffeine|caffeine|mesh-list
20580897|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
20580898|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580899|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20580900|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580901|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20580902|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580903|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20580904|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20580905|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
20580906|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605876|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605877|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
20605878|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605879|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605880|NCT02234739|Voriconazole|voriconazole|mesh-list
20605881|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
20605882|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605883|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20605884|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20605885|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605886|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605887|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20605888|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
20605889|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20605890|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605891|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20605892|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
20605893|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20605894|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
20605895|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20605896|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
20605897|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605898|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605899|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
20605900|NCT02234869|Interferons|interferons|mesh-list
20605901|NCT02234869|Interferon-beta|interferon-beta|mesh-list
20605902|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
20605903|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
20605904|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605905|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
20605906|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605907|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
20605908|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605909|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20605910|NCT02234882|Fostemsavir|fostemsavir|mesh-list
20605911|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20605912|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20605913|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20605914|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
20605915|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605916|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20605917|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20605918|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20605919|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20605920|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20605921|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
20605922|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20605923|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20605924|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20605925|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
20075850|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075851|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
20075852|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20605926|NCT02234921|Imiquimod|imiquimod|mesh-list
20605927|NCT02234921|Vaccines|vaccines|mesh-list
20605928|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
20605929|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605930|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20605931|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20605932|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20605933|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
20605934|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605935|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20580907|NCT02098824|Methylphenidate|methylphenidate|mesh-list
20580908|NCT02098824|Galantamine|galantamine|mesh-list
20580909|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20075853|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075854|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075855|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075856|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075857|NCT00752986|Fulvestrant|fulvestrant|mesh-list
20580910|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580911|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20580912|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20580913|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20580914|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580915|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
20580916|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580917|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20580918|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580919|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
20580920|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20580921|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
20580922|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580923|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
20580924|NCT02098837|Dolutegravir|dolutegravir|mesh-list
20580925|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20580926|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20580927|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580928|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580929|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20580930|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20580931|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
20580932|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20580933|NCT02098889|Scopolamine|scopolamine|mesh-list
20580934|NCT02098889|Bromides|bromides|mesh-list
20580935|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20580936|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
20580937|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20580938|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
20580939|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
20580940|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580941|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580942|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20580943|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
20580944|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20580945|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
20580946|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580947|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580948|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20580949|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
20580950|NCT02098915|Metoclopramide|metoclopramide|mesh-list
20580951|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
20580952|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
20580953|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580954|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580955|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20580956|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20580957|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20580958|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
20580959|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20580960|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580961|NCT02098980|Vitamin D|vitamin d|mesh-list
20580962|NCT02098980|Vitamins|vitamins|mesh-ancestor
20580963|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
20580964|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580965|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20580966|NCT02099123|Atorvastatin|atorvastatin|mesh-list
20580967|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20580968|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20580969|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
20580970|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580971|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20580972|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20580973|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20580974|NCT02099136|Celecoxib|celecoxib|mesh-list
20580975|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20580976|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20075858|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20580977|NCT02099136|Analgesics|analgesics|mesh-ancestor
20580978|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
20580979|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20580980|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20580981|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20580982|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20580983|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20580984|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20580985|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075859|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075860|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20075861|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20075862|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
20075863|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075864|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075865|NCT00746239|Dexetimide|dexetimide|mesh-list
20075866|NCT00746239|Citalopram|citalopram|mesh-list
20075867|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20075868|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20075869|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20075870|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580986|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20580987|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20580988|NCT02099240|Amoxicillin|amoxicillin|mesh-list
20580989|NCT02099240|Azithromycin|azithromycin|mesh-list
20580990|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
20580991|NCT02099240|Vancomycin|vancomycin|mesh-list
20580992|NCT02099240|Clarithromycin|clarithromycin|mesh-list
20580993|NCT02099240|Doxycycline|doxycycline|mesh-list
20580994|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
20580995|NCT02099240|Levofloxacin|levofloxacin|mesh-list
20580996|NCT02099240|Ofloxacin|ofloxacin|mesh-list
20580997|NCT02099240|Minocycline|minocycline|mesh-list
20580998|NCT02099240|Rifampin|rifampin|mesh-list
20580999|NCT02099240|Clindamycin|clindamycin|mesh-list
20581000|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
20581001|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
20581002|NCT02099240|Gentamicins|gentamicins|mesh-list
20581003|NCT02099240|Isoniazid|isoniazid|mesh-list
20581004|NCT02099240|Meropenem|meropenem|mesh-list
20581005|NCT02099240|Tazobactam|tazobactam|mesh-list
20581006|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
20581007|NCT02099240|Linezolid|linezolid|mesh-list
20581008|NCT02099240|Cycloserine|cycloserine|mesh-list
20581009|NCT02099240|Piperacillin|piperacillin|mesh-list
20581010|NCT02099240|Metronidazole|metronidazole|mesh-list
20581011|NCT02099240|Imipenem|imipenem|mesh-list
20581012|NCT02099240|Penicillins|penicillins|mesh-list
20581013|NCT02099240|Erythromycin|erythromycin|mesh-list
20581014|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
20581015|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20075871|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075872|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
20075873|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075874|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20075875|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
20075876|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20075877|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20075878|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20581016|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
20581017|NCT02099240|Amikacin|amikacin|mesh-list
20581018|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
20581019|NCT02099240|Ceftazidime|ceftazidime|mesh-list
20581020|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20581021|NCT02099240|Colistin|colistin|mesh-list
20581022|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
20581023|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
20581024|NCT02099240|Ampicillin|ampicillin|mesh-list
20581025|NCT02099240|Rifabutin|rifabutin|mesh-list
20581026|NCT02099240|Mupirocin|mupirocin|mesh-list
20581027|NCT02099240|Fosfomycin|fosfomycin|mesh-list
20581028|NCT02099240|Rifapentine|rifapentine|mesh-list
20581029|NCT02099240|Cefuroxime|cefuroxime|mesh-list
20581030|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
20581031|NCT02099240|Cefepime|cefepime|mesh-list
20581032|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20581033|NCT02099240|Paromomycin|paromomycin|mesh-list
20581034|NCT02099240|Polymyxins|polymyxins|mesh-list
20581035|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
20581036|NCT02099240|Aztreonam|aztreonam|mesh-list
20581037|NCT02099240|Neomycin|neomycin|mesh-list
20581038|NCT02099240|Bacitracin|bacitracin|mesh-list
20581039|NCT02099240|Sulbactam|sulbactam|mesh-list
20581040|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
20581041|NCT02099240|Cefotaxime|cefotaxime|mesh-list
20581042|NCT02099240|Cefoxitin|cefoxitin|mesh-list
20075879|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
20581043|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
20581044|NCT02099240|Cefixime|cefixime|mesh-list
20581045|NCT02099240|Polymyxin B|polymyxin b|mesh-list
20581046|NCT02099240|Cefdinir|cefdinir|mesh-list
20581047|NCT02099240|Penicillin G|penicillin g|mesh-list
20581048|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20581049|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
20581050|NCT02099240|Cloxacillin|cloxacillin|mesh-list
20581051|NCT02099240|Norfloxacin|norfloxacin|mesh-list
20581052|NCT02099240|Cefprozil|cefprozil|mesh-list
20581053|NCT02099240|Cephalosporins|cephalosporins|mesh-list
20581054|NCT02099240|Oxacillin|oxacillin|mesh-list
20581055|NCT02099240|Streptomycin|streptomycin|mesh-list
20581056|NCT02099240|Nafcillin|nafcillin|mesh-list
20581057|NCT02099240|Ticarcillin|ticarcillin|mesh-list
20581058|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
20581059|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
20581060|NCT02099240|Sultamicillin|sultamicillin|mesh-list
20581061|NCT02099240|Penicillin V|penicillin v|mesh-list
20581062|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
20581063|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
20581064|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
20581065|NCT02099240|Kanamycin|kanamycin|mesh-list
20581066|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
20581067|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
20581068|NCT02099240|Cefoperazone|cefoperazone|mesh-list
20581069|NCT02099240|Lincomycin|lincomycin|mesh-list
20581070|NCT02099240|Cefotetan|cefotetan|mesh-list
20581071|NCT02099240|Dirithromycin|dirithromycin|mesh-list
20581072|NCT02099240|Demeclocycline|demeclocycline|mesh-list
20581073|NCT02099240|Ethionamide|ethionamide|mesh-list
20581074|NCT02099240|Capreomycin|capreomycin|mesh-list
20581075|NCT02099240|Mafenide|mafenide|mesh-list
20581076|NCT02099240|Cefaclor|cefaclor|mesh-list
20581077|NCT02099240|Ceftibuten|ceftibuten|mesh-list
20581078|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
20581079|NCT02099240|Tobramycin|tobramycin|mesh-list
20581080|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
20581081|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
20581082|NCT02099240|Netilmicin|netilmicin|mesh-list
20581083|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
20581084|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
20581085|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
20581086|NCT02099240|Virginiamycin|virginiamycin|mesh-list
20581087|NCT02099240|Enoxacin|enoxacin|mesh-list
20581088|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20581089|NCT02099240|Methicillin|methicillin|mesh-list
20581090|NCT02099240|Bacampicillin|bacampicillin|mesh-list
20581091|NCT02099240|Carbenicillin|carbenicillin|mesh-list
20581092|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
20581093|NCT02099240|Mezlocillin|mezlocillin|mesh-list
20581094|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
20581095|NCT02099240|Cefamandole|cefamandole|mesh-list
20581096|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
20581097|NCT02099240|Cefonicid|cefonicid|mesh-list
20581098|NCT02099240|Cefmetazole|cefmetazole|mesh-list
20581099|NCT02099240|Loracarbef|loracarbef|mesh-list
20581100|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
20581101|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
20581102|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
20581103|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
20581104|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
20581105|NCT02099240|Methacycline|methacycline|mesh-list
20581106|NCT02099240|Tetracycline|tetracycline|mesh-list
20581107|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
20581108|NCT02099240|Dalfopristin|dalfopristin|mesh-list
20581109|NCT02099240|Novobiocin|novobiocin|mesh-list
20581110|NCT02099240|Spectinomycin|spectinomycin|mesh-list
20581111|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20581112|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
20581113|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
20581114|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20581115|NCT02099240|Methenamine|methenamine|mesh-list
20581116|NCT02099240|Sulperazone|sulperazone|mesh-list
20581117|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
20581118|NCT02099240|Cinoxacin|cinoxacin|mesh-list
20581119|NCT02099240|Trimethoprim|trimethoprim|mesh-list
20581120|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
20581121|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
20581122|NCT02099240|Procaine|procaine|mesh-list
20581123|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20581124|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20581125|NCT02099240|Cilastatin|cilastatin|mesh-list
20581126|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581127|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
20581128|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20075880|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
20075881|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075882|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20581129|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20581130|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581131|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581132|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581133|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20581134|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
20581135|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581136|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581137|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20581138|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20581139|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20581140|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20581141|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20581142|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20581143|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
20581144|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20581145|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20581146|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20581147|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20581148|NCT02099240|Renal Agents|renal agents|mesh-ancestor
20581149|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
20581150|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20581151|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20581152|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20581153|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20581154|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20581155|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20581156|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20581157|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20581158|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20581159|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
20581160|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20581161|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20581162|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20581163|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20581164|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581165|NCT02099240|Analgesics|analgesics|mesh-ancestor
20581166|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
20581167|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581168|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581169|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20581170|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20581171|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
20581172|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20581173|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20581174|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
20581175|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
20581176|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
20581177|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581178|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20581179|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20581180|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20581181|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20581182|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
20581183|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
20581184|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20581185|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581186|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581187|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581188|NCT02099253|Analgesics|analgesics|mesh-ancestor
20581189|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
20581190|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581191|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20581192|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20581193|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20581194|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20581195|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581196|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075883|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20581197|NCT02099292|Rituximab|rituximab|mesh-list
20581198|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20581199|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581200|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
20581201|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581202|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20581203|NCT02099331|Melatonin|melatonin|mesh-list
20581204|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
20581205|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581206|NCT02099331|Protective Agents|protective agents|mesh-ancestor
20581207|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581208|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581209|NCT02099357|Vitamin D|vitamin d|mesh-list
20581210|NCT02099357|Vitamins|vitamins|mesh-ancestor
20581211|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
20581212|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581213|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20581214|NCT02099396|Gemcitabine|gemcitabine|mesh-list
20581215|NCT02099396|Docetaxel|docetaxel|mesh-list
20581216|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20581217|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
20581218|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581219|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581220|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
20581221|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581222|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581223|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20581224|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
20581225|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581226|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
20581227|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
20581228|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
20581229|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
20581230|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20581231|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20581232|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
20581233|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581234|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20581235|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20581236|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581237|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581238|NCT02099604|Vitamin D|vitamin d|mesh-list
20581239|NCT02099604|Interferons|interferons|mesh-list
20581240|NCT02099604|Ribavirin|ribavirin|mesh-list
20581241|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
20581242|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
20581243|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20581244|NCT02099604|Vitamins|vitamins|mesh-ancestor
20581245|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
20581246|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581247|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20581248|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581249|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
20581250|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581251|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
20581252|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581253|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
20581254|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
20581255|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20581256|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20581257|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
20581258|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581259|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581260|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581261|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
20581262|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
20581263|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581264|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
20581265|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20581266|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
20581267|NCT02099695|Oxybutynin|oxybutynin|mesh-list
20581268|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
20581269|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
20581270|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581271|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581272|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20075884|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075885|NCT00754013|Donepezil|donepezil|mesh-list
20075886|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20075887|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075888|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075889|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075890|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075891|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075892|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
20075893|NCT00751933|Vaccines|vaccines|mesh-list
20075894|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
20075895|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075896|NCT00746603|Simvastatin|simvastatin|mesh-list
20075897|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20075898|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20075899|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
20075900|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581273|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20581274|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
20581275|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581276|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581277|NCT02099695|Urological Agents|urological agents|mesh-ancestor
20581278|NCT02099825|Cycloserine|cycloserine|mesh-list
20581279|NCT02099825|Mifepristone|mifepristone|mesh-list
20581280|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20581281|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
20581282|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581283|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581284|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20075901|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20075902|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20075903|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075904|NCT00736385|Metformin|metformin|mesh-list
20075905|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20075906|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075907|NCT00738972|Valsartan|valsartan|mesh-list
20581285|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20581286|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20581287|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
20581288|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20581289|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20581290|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
20581291|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581292|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
20581293|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20581294|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20581295|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20581296|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581297|NCT02099825|Renal Agents|renal agents|mesh-ancestor
20581298|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20581299|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
20581300|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20581301|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
20581302|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581303|NCT02099877|Fentanyl|fentanyl|mesh-list
20581304|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20581305|NCT02099877|Narcotics|narcotics|mesh-ancestor
20581306|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581307|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581308|NCT02099877|Analgesics|analgesics|mesh-ancestor
20581309|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
20581310|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581311|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20581312|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20581313|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
20581314|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
20581315|NCT02099890|Curcumin|curcumin|mesh-list
20581316|NCT02099890|Antioxidants|antioxidants|mesh-list
20581317|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20581318|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581319|NCT02099890|Analgesics|analgesics|mesh-ancestor
20581320|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
20581321|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581322|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581323|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581324|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20581325|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581326|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581327|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581328|NCT02099890|Protective Agents|protective agents|mesh-ancestor
20581329|NCT02099916|Menotropins|menotropins|mesh-list
20581330|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581331|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20581332|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
20581333|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581334|NCT02099955|Vitamin D|vitamin d|mesh-list
20581335|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
20581336|NCT02099955|Vitamins|vitamins|mesh-ancestor
20581337|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
20581338|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581339|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20581340|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20581341|NCT02099981|Pimagedine|pimagedine|mesh-list
20581342|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581343|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581344|NCT02100046|Ethosuximide|ethosuximide|mesh-list
20581345|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
20581346|NCT02100176|Dopamine|dopamine|mesh-list
20581347|NCT02100176|Rotigotine|rotigotine|mesh-list
20581348|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
20581349|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
20581350|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581351|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581352|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581353|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20581354|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
20581355|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
20581356|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581357|NCT02100176|Protective Agents|protective agents|mesh-ancestor
20581358|NCT02100202|Turmeric extract|turmeric extract|mesh-list
20581359|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
20581360|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581361|NCT02100202|Protective Agents|protective agents|mesh-ancestor
20581362|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581363|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
20581364|NCT02100267|Miotics|miotics|mesh-ancestor
20581365|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
20581366|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581367|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581368|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20581369|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20581370|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
20581371|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20581372|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20581373|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
20581374|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581375|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581376|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
20581377|NCT02100293|Analgesics|analgesics|mesh-ancestor
20581378|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
20581379|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581380|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581381|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
20581382|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581383|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20581384|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
20581385|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20581386|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581387|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581388|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20581389|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
20581390|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581391|NCT02100423|Vitamin D|vitamin d|mesh-list
20581392|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
20581393|NCT02100423|Curcumin|curcumin|mesh-list
20581394|NCT02100423|Vitamins|vitamins|mesh-ancestor
20581395|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
20581396|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581397|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20581398|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20581399|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20581400|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581401|NCT02100423|Analgesics|analgesics|mesh-ancestor
20581402|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
20581403|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581404|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581405|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20581406|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581407|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581408|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581409|NCT02100462|Aspirin|aspirin|mesh-list
20581410|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20581411|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
20581412|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20581413|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581414|NCT02100462|Analgesics|analgesics|mesh-ancestor
20581415|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
20581416|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581417|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581418|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581419|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20581420|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20581421|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20581422|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581423|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20581424|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20581425|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581426|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
20581427|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20581428|NCT02100462|Diuretics|diuretics|mesh-ancestor
20581429|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
20581430|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20581431|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581432|NCT02100488|Insulin|insulin|mesh-list
20581433|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20581434|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20581435|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581436|NCT02100553|Itraconazole|itraconazole|mesh-list
20581437|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20581438|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
20581439|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581440|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20581441|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20581442|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581443|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581444|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20581445|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
20581446|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581447|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581448|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20605936|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20605937|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20605938|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
20605939|NCT02235012|Ketamine|ketamine|mesh-list
20605940|NCT02235012|Analgesics|analgesics|mesh-ancestor
20605941|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
20605942|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605943|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605944|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20605945|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20605946|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
20605947|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
20605948|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605949|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20605950|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20605951|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20605952|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605953|NCT02235194|Chromium|chromium|mesh-list
20605954|NCT02235194|Picolinic acid|picolinic acid|mesh-list
20605955|NCT02235194|Trace Elements|trace elements|mesh-ancestor
20605956|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
20605957|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581449|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
20581450|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
20581451|NCT02100605|Ephedrine|ephedrine|mesh-list
20581452|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20581453|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
20581454|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20581455|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581456|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
20581457|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
20581458|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581459|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
20581460|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581461|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581462|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20581463|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20581464|NCT02100761|Voriconazole|voriconazole|mesh-list
20581465|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
20581466|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581467|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20581468|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20581469|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581470|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581471|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20581472|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
20581473|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581474|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581475|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20581476|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20581477|NCT02100787|Laxatives|laxatives|mesh-ancestor
20581478|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20581479|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
20581480|NCT02100852|Chlorambucil|chlorambucil|mesh-list
20581481|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20581482|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581483|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20581484|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
20581485|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581486|NCT02100917|Trastuzumab|trastuzumab|mesh-list
20581487|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20581488|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581489|NCT02101047|Phenylephrine|phenylephrine|mesh-list
20581490|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
20581491|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20581492|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
20581493|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
20581494|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581495|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581496|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
20581497|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20581498|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
20581499|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
20581500|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20581501|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20581502|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20581503|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
20581504|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581505|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581506|NCT02101047|Protective Agents|protective agents|mesh-ancestor
20581507|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20581508|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20581509|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20075908|NCT00738972|Simvastatin|simvastatin|mesh-list
20075909|NCT00738972|Ezetimibe|ezetimibe|mesh-list
20581510|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
20581511|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581512|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20581513|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20581514|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581515|NCT02101138|Pramipexole|pramipexole|mesh-list
20581516|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
20581517|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075910|NCT00738972|Pravastatin|pravastatin|mesh-list
20075911|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20075912|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20581518|NCT02101138|Protective Agents|protective agents|mesh-ancestor
20581519|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581520|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20581521|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20581522|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
20581523|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
20581524|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581525|NCT02101151|Vitamin D|vitamin d|mesh-list
20581526|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
20581527|NCT02101151|Vitamins|vitamins|mesh-ancestor
20581528|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
20581529|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581530|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20581531|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20581532|NCT02101164|Denosumab|denosumab|mesh-list
20581533|NCT02101164|Pamidronate|pamidronate|mesh-list
20581534|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20581535|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581536|NCT02101203|Buspirone|buspirone|mesh-list
20581537|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20581538|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20581539|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581540|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581541|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20581542|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20581543|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
20581544|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581545|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581546|NCT02101216|Abacavir|abacavir|mesh-list
20581547|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
20581548|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20581549|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20075913|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
20075914|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075915|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20075916|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20075917|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075918|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20075919|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20075920|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20075921|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20075922|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581550|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581551|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581552|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
20581553|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581554|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20581555|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20581556|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
20581557|NCT02101229|Insulin|insulin|mesh-list
20581558|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20581559|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20581560|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581561|NCT02101255|Fluorides|fluorides|mesh-list
20581562|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
20581563|NCT02101255|Protective Agents|protective agents|mesh-ancestor
20581564|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581565|NCT02101476|Acetaminophen|acetaminophen|mesh-list
20581566|NCT02101476|Oxycodone|oxycodone|mesh-list
20581567|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581568|NCT02101476|Analgesics|analgesics|mesh-ancestor
20581569|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
20075923|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20075924|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075925|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075926|NCT00739882|Antibodies|antibodies|mesh-list
20075927|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20075928|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
20075929|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581570|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581571|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581572|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
20581573|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20581574|NCT02101476|Narcotics|narcotics|mesh-ancestor
20581575|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581576|NCT02101567|Oxytocin|oxytocin|mesh-list
20581577|NCT02101567|Carbetocin|carbetocin|mesh-list
20581578|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
20581579|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581580|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581581|NCT02101606|Tenecteplase|tenecteplase|mesh-list
20581582|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20581583|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20581584|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581585|NCT02101632|Petrolatum|petrolatum|mesh-list
20581586|NCT02101632|Emollients|emollients|mesh-ancestor
20581587|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
20581588|NCT02101710|Isosorbide|isosorbide|mesh-list
20581589|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20581590|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20581591|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20581592|NCT02101710|Diuretics|diuretics|mesh-ancestor
20581593|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
20581594|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581595|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
20581596|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20581597|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581598|NCT02101840|Oxycodone|oxycodone|mesh-list
20581599|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20581600|NCT02101840|Narcotics|narcotics|mesh-ancestor
20581601|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581602|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581603|NCT02101840|Analgesics|analgesics|mesh-ancestor
20581604|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
20581605|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581606|NCT02101892|Amitriptyline|amitriptyline|mesh-list
20581607|NCT02101892|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20581608|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20581609|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
20581610|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20581611|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581612|NCT02101892|Analgesics|analgesics|mesh-ancestor
20581613|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
20581614|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581615|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581616|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20581617|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20581618|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581619|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581620|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
20581621|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581622|NCT02101892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20581623|NCT02101892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20581624|NCT02101892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581625|NCT02101905|Lapatinib|lapatinib|mesh-list
20581626|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581627|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20581628|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581629|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581630|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20581631|NCT02101931|Levulinic acid|levulinic acid|mesh-list
20581632|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20581633|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
20581634|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581635|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581636|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20581637|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20581638|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20581639|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
20581640|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581641|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581642|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20581643|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20581644|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
20581645|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581646|NCT02102139|Propofol|propofol|mesh-list
20581647|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20581648|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581649|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581650|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20581651|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
20581652|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
20581653|NCT02102152|Tobramycin|tobramycin|mesh-list
20581654|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20581655|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581656|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
20581657|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
20581658|NCT02102295|Fluorides|fluorides|mesh-list
20581659|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
20581660|NCT02102295|Protective Agents|protective agents|mesh-ancestor
20581661|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581662|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
20075930|NCT00731770|Fluticasone|fluticasone|mesh-list
20075931|NCT00731770|Xhance|xhance|mesh-list
20075932|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20075933|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20075934|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20075935|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20075936|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
20075937|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075938|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075939|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20075940|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
20075941|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
20075942|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20075943|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20581663|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581664|NCT02102295|Vitamins|vitamins|mesh-ancestor
20581665|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
20581666|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581667|NCT02102321|Albendazole|albendazole|mesh-list
20581668|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
20581669|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20581670|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581671|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
20581672|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20581673|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20581674|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
20581675|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
20581676|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
20581677|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581678|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581679|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20581680|NCT02102373|Laxatives|laxatives|mesh-ancestor
20075944|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20075945|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20075946|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
20075947|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075948|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581681|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20581682|NCT02102438|Paclitaxel|paclitaxel|mesh-list
20581683|NCT02102438|Carboplatin|carboplatin|mesh-list
20581684|NCT02102438|Trastuzumab|trastuzumab|mesh-list
20581685|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20581686|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581687|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
20581688|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
20581689|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
20581690|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581691|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20581692|NCT02102516|Ketorolac|ketorolac|mesh-list
20581693|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20581694|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20581695|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581696|NCT02102516|Analgesics|analgesics|mesh-ancestor
20581697|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
20581698|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075949|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
20075950|NCT00731770|Hormones|hormones|mesh-ancestor
20581699|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581700|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581701|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075951|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20075952|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
20581702|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20581703|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581704|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605958|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20605959|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
20605960|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
20605961|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605962|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
20605963|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20605964|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605965|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
20605966|NCT02235246|Analgesics|analgesics|mesh-ancestor
20605967|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
20605968|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20605969|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605970|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
20605971|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20605972|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20605973|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
20605974|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20605975|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20605976|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605977|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605978|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
20605979|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20605980|NCT02235324|Leucovorin|leucovorin|mesh-list
20605981|NCT02235324|Fluorouracil|fluorouracil|mesh-list
20605982|NCT02235324|Aflibercept|aflibercept|mesh-list
20605983|NCT02235324|Calcium|calcium|mesh-list
20605984|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
20605985|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
20605986|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20605987|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20605988|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
20605989|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20605990|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20605991|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20605992|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20605993|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
20605994|NCT02235324|Antidotes|antidotes|mesh-ancestor
20605995|NCT02235324|Protective Agents|protective agents|mesh-ancestor
20605996|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
20605997|NCT02235324|Vitamins|vitamins|mesh-ancestor
20605998|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
20605999|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20606000|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20606001|NCT02235324|Growth Substances|growth substances|mesh-ancestor
20606002|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
20606003|NCT02235337|Riboflavin|riboflavin|mesh-list
20606004|NCT02235337|Vitamins|vitamins|mesh-ancestor
20606005|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
20606006|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606007|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
20606008|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20606009|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
20606010|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20606011|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20606012|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20606013|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606014|NCT02235402|Lacidipine|lacidipine|mesh-list
20606015|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
20606016|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20606017|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20606018|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606019|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606020|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606021|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606022|NCT02235402|Diuretics|diuretics|mesh-ancestor
20606023|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
20075953|NCT00729365|Ramipril|ramipril|mesh-list
20606024|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20606025|NCT02235415|Lacidipine|lacidipine|mesh-list
20581705|NCT02102555|Acetaminophen|acetaminophen|mesh-list
20581706|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581707|NCT02102555|Analgesics|analgesics|mesh-ancestor
20581708|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
20581709|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581710|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581711|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
20581712|NCT02102594|Bortezomib|bortezomib|mesh-list
20581713|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581714|NCT02102620|Lidocaine|lidocaine|mesh-list
20581715|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
20581716|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
20581717|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581718|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581719|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
20581720|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581721|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20581722|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20581723|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20581724|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581725|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581726|NCT02102633|Dabigatran|dabigatran|mesh-list
20581727|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
20581728|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20581729|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
20581730|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581731|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581732|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
20581733|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20581734|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
20581735|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20581736|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
20581737|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581738|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581739|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20581740|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20581741|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581742|NCT02102672|Trimetazidine|trimetazidine|mesh-list
20581743|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
20581744|NCT02102698|Ecopipam|ecopipam|mesh-list
20581745|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20581746|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20581747|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581748|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581749|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20581750|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20581751|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
20581752|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581753|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581754|NCT02102711|Vitamin A|vitamin a|mesh-list
20581755|NCT02102711|Vitamins|vitamins|mesh-ancestor
20581756|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
20581757|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581758|NCT02102776|Mitomycins|mitomycins|mesh-list
20581759|NCT02102776|Mitomycin|mitomycin|mesh-list
20581760|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20581761|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581762|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
20581763|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581764|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20581765|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581766|NCT02102789|Leucovorin|leucovorin|mesh-list
20581767|NCT02102789|Dexamethasone|dexamethasone|mesh-list
20581768|NCT02102789|Fluorouracil|fluorouracil|mesh-list
20581769|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
20581770|NCT02102789|Floxuridine|floxuridine|mesh-list
20581771|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581772|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
20581773|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
20581774|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581775|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581776|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20581777|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
20581778|NCT02102789|Hormones|hormones|mesh-ancestor
20581779|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581780|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20581781|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581782|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581783|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
20581784|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20581785|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20581786|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
20581787|NCT02102789|Antidotes|antidotes|mesh-ancestor
20581788|NCT02102789|Protective Agents|protective agents|mesh-ancestor
20581789|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
20581790|NCT02102789|Vitamins|vitamins|mesh-ancestor
20581791|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
20581792|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20581793|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
20581794|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581795|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20581796|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
20581797|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581798|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581799|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20581800|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20581801|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581802|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
20581803|NCT02102815|Dexamethasone|dexamethasone|mesh-list
20581804|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581805|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
20581806|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
20581807|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581808|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581809|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20581810|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
20581811|NCT02102815|Hormones|hormones|mesh-ancestor
20581812|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581813|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20581814|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581815|NCT02102828|Aspirin|aspirin|mesh-list
20581816|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20581817|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581818|NCT02102828|Analgesics|analgesics|mesh-ancestor
20075954|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20075955|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
20075956|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075957|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075958|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20075959|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
20075960|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20075961|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20075962|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20075963|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581819|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
20581820|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581821|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581822|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581823|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20581824|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20581825|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20581826|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581827|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20581828|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20581829|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581830|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
20581831|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
20581832|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20581833|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
20581834|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581835|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20581836|NCT02102971|Liver Extracts|liver extracts|mesh-list
20581837|NCT02102971|Hematinics|hematinics|mesh-ancestor
20581838|NCT02103023|Imiquimod|imiquimod|mesh-list
20581839|NCT02103023|Vaccines|vaccines|mesh-list
20581840|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
20581841|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581842|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20581843|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581844|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
20581845|NCT02103049|Ezetimibe|ezetimibe|mesh-list
20581846|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20581847|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20581848|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
20581849|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581850|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20581851|NCT02103166|Scopolamine|scopolamine|mesh-list
20581852|NCT02103166|Bromides|bromides|mesh-list
20581853|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
20581854|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20581855|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
20581856|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
20581857|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581858|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581859|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20581860|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
20581861|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20581862|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
20581863|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581864|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581865|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20581866|NCT02103192|Antioxidants|antioxidants|mesh-list
20581867|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581868|NCT02103192|Protective Agents|protective agents|mesh-ancestor
20581869|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581870|NCT02103205|Iron|iron|mesh-list
20581871|NCT02103205|Lactoferrin|lactoferrin|mesh-list
20581872|NCT02103205|Trace Elements|trace elements|mesh-ancestor
20581873|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
20581874|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581875|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20581876|NCT02103244|Carboplatin|carboplatin|mesh-list
20581877|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581878|NCT02103335|Dexamethasone|dexamethasone|mesh-list
20581879|NCT02103335|Pomalidomide|pomalidomide|mesh-list
20581880|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581881|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
20581882|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
20581883|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581884|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581885|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20581886|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
20581887|NCT02103335|Hormones|hormones|mesh-ancestor
20581888|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581889|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20075964|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20075965|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075966|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20075967|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075968|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20075969|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20075970|NCT00726180|Trastuzumab|trastuzumab|mesh-list
20581890|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581891|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
20581892|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20581893|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20581894|NCT02103335|Growth Substances|growth substances|mesh-ancestor
20581895|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
20581896|NCT02103361|Ustekinumab|ustekinumab|mesh-list
20581897|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
20581898|NCT02103374|Terbutaline|terbutaline|mesh-list
20581899|NCT02103374|Ipratropium|ipratropium|mesh-list
20581900|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20581901|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
20581902|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581903|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581904|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20581905|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
20581906|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20581907|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
20075971|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075972|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581908|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581909|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581910|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
20581911|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
20581912|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581913|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20581914|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20581915|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20075973|NCT00724282|Eszopiclone|eszopiclone|mesh-list
20075974|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20075975|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20075976|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075977|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
20581916|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
20581917|NCT02103465|Rotigotine|rotigotine|mesh-list
20581918|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
20581919|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
20581920|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20581921|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581922|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581923|NCT02103556|Mineral Oil|mineral oil|mesh-list
20581924|NCT02103556|Emollients|emollients|mesh-ancestor
20581925|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
20581926|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20581927|NCT02103569|Norethindrone|norethindrone|mesh-list
20581928|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
20581929|NCT02103569|Estradiol|estradiol|mesh-list
20581930|NCT02103569|Asunaprevir|asunaprevir|mesh-list
20581931|NCT02103569|Estrogens|estrogens|mesh-ancestor
20075978|NCT00728845|Paclitaxel|paclitaxel|mesh-list
20075979|NCT00728845|Bevacizumab|bevacizumab|mesh-list
20075980|NCT00728845|Carboplatin|carboplatin|mesh-list
20075981|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20075982|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20075983|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
20581932|NCT02103569|Hormones|hormones|mesh-ancestor
20581933|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581934|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581935|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20581936|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
20581937|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581938|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20581939|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20581940|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20581941|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20581942|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
20581943|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20581944|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581945|NCT02103647|Pregabalin|pregabalin|mesh-list
20581946|NCT02103647|Analgesics|analgesics|mesh-ancestor
20581947|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
20581948|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581949|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581950|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
20581951|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20581952|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581953|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581954|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20581955|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20581956|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20581957|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581958|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20581959|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20581960|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
20581961|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
20581962|NCT02103660|Progestins|progestins|mesh-list
20581963|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20581964|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581965|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20581966|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20581967|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20581968|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20581969|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20581970|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20075984|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
20075985|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
20075986|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581971|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20581972|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20581973|NCT02103660|Hormones|hormones|mesh-ancestor
20581974|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20581975|NCT02103686|Pregabalin|pregabalin|mesh-list
20581976|NCT02103686|Analgesics|analgesics|mesh-ancestor
20581977|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
20581978|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581979|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581980|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
20581981|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20581982|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20581983|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20581984|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20581985|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20581986|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20075987|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20075988|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20075989|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20075990|NCT00728845|Growth Substances|growth substances|mesh-ancestor
20075991|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20075992|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
20075993|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
20075994|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20075995|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20075996|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20075997|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20075998|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20075999|NCT00726830|Morphine|morphine|mesh-list
20076000|NCT00726830|Oxycodone|oxycodone|mesh-list
20076001|NCT00726830|Methadone|methadone|mesh-list
20076002|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20076003|NCT00726830|Narcotics|narcotics|mesh-ancestor
20076004|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076005|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076006|NCT00726830|Analgesics|analgesics|mesh-ancestor
20076007|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
20076008|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076009|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
20076010|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
20076011|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
20076012|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076013|NCT00729560|Flutamide|flutamide|mesh-list
20581987|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20581988|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20581989|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
20581990|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20581991|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20581992|NCT02103725|Analgesics|analgesics|mesh-ancestor
20581993|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
20581994|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20581995|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20581996|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20581997|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20581998|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
20581999|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582000|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
20582001|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20582002|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582003|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582004|NCT02103738|Ranibizumab|ranibizumab|mesh-list
20582005|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20582006|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20582007|NCT02103738|Growth Substances|growth substances|mesh-ancestor
20582008|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582009|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
20582010|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076014|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
20076015|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
20076016|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076017|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076018|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076019|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076020|NCT00716807|Nalbuphine|nalbuphine|mesh-list
20076021|NCT00716807|Naloxone|naloxone|mesh-list
20582011|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20582012|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
20582013|NCT02103764|Desogestrel|desogestrel|mesh-list
20582014|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20582015|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20582016|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20582017|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
20582018|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20582019|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582020|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20582021|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20582022|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20582023|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20582024|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582025|NCT02103764|Progestins|progestins|mesh-ancestor
20582026|NCT02103764|Hormones|hormones|mesh-ancestor
20582027|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582028|NCT02103777|Caffeine|caffeine|mesh-list
20582029|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
20076022|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20076023|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076024|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
20076025|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076026|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20582030|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582031|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20582032|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582033|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20582034|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582035|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20582036|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20582037|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
20582038|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582039|NCT02103881|Ketamine|ketamine|mesh-list
20582040|NCT02103881|Haloperidol|haloperidol|mesh-list
20582041|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
20582042|NCT02103881|Analgesics|analgesics|mesh-ancestor
20582043|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
20582044|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582045|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582046|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20582047|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20582048|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
20582049|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
20582050|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582051|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20582052|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20582053|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582054|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582055|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
20582056|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
20582057|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582058|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20582059|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20582060|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20582061|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20582062|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
20582063|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20582064|NCT02103998|Iodine|iodine|mesh-list
20582065|NCT02103998|Hormones|hormones|mesh-list
20582066|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582067|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582068|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20582069|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582070|NCT02103998|Trace Elements|trace elements|mesh-ancestor
20582071|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
20582072|NCT02104011|Propranolol|propranolol|mesh-list
20582073|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20582074|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20582075|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
20582076|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582077|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076027|NCT00716807|Narcotics|narcotics|mesh-ancestor
20582078|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582079|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582080|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20582081|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
20606026|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20606027|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20606028|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606029|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606030|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606031|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607964|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607965|NCT02244190|Ritonavir|ritonavir|mesh-list
20607966|NCT02244190|Tipranavir|tipranavir|mesh-list
20607967|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20607968|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20607969|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
20607970|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607971|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607972|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20607973|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20607974|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
20607975|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607976|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20607977|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20607978|NCT02244216|Fenoterol|fenoterol|mesh-list
20607979|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20607980|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
20607981|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607982|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607983|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20607984|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607985|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
20607986|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
20607987|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20607988|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20607989|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20607990|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20607991|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607992|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607993|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607994|NCT02244229|Tamsulosin|tamsulosin|mesh-list
20607995|NCT02244229|Finasteride|finasteride|mesh-list
20607996|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20607997|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20607998|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20607999|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608000|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608001|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608002|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608003|NCT02244229|Urological Agents|urological agents|mesh-ancestor
20608004|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20608005|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20608006|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608007|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
20608008|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608009|NCT02244242|Tamsulosin|tamsulosin|mesh-list
20608010|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608011|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608012|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608013|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608014|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608015|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608016|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608017|NCT02244242|Urological Agents|urological agents|mesh-ancestor
20608018|NCT02244255|Tamsulosin|tamsulosin|mesh-list
20608019|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608020|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608021|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608022|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608023|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608024|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582082|NCT02104128|Bupropion|bupropion|mesh-list
20582083|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20582084|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
20582085|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20582086|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20582087|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20582088|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582089|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582090|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
20582091|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582092|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582093|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20582094|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20582095|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582096|NCT02104193|Simvastatin|simvastatin|mesh-list
20582097|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20582098|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20582099|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
20582100|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582101|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20582102|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20582103|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582104|NCT02104284|Mannitol|mannitol|mesh-list
20582105|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
20582106|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20582107|NCT02104284|Diuretics|diuretics|mesh-ancestor
20582108|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
20582109|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582110|NCT02104284|Miotics|miotics|mesh-ancestor
20582111|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
20582112|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582113|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20582114|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20582115|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
20582116|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20582117|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20582118|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
20582119|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582120|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582121|NCT02104297|Remifentanil|remifentanil|mesh-list
20582122|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20582123|NCT02104297|Narcotics|narcotics|mesh-ancestor
20582124|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582125|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582126|NCT02104297|Analgesics|analgesics|mesh-ancestor
20582127|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
20582128|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582129|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20582130|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582131|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
20582132|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582133|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582134|NCT02104323|Endostatins|endostatins|mesh-list
20582135|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582136|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20076028|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076029|NCT00716807|Analgesics|analgesics|mesh-ancestor
20076030|NCT00714948|Gemcitabine|gemcitabine|mesh-list
20076031|NCT00714948|Sorafenib|sorafenib|mesh-list
20076032|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582137|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20582138|NCT02104323|Growth Substances|growth substances|mesh-ancestor
20582139|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582140|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
20582141|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
20582142|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20582143|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
20582144|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20582145|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582146|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20582147|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20582148|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20076033|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076034|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
20582149|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
20582150|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20582151|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20582152|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582153|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20582154|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20582155|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582156|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582157|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582158|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20582159|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
20582160|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20582161|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582162|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20582163|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20582164|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20582165|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
20582166|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
20582167|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20582168|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20582169|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582170|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582171|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20582172|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20582173|NCT02104674|Montelukast|montelukast|mesh-list
20582174|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20582175|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
20582176|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20582177|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
20582178|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582179|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582180|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20582181|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20582182|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582183|NCT02104700|Tenofovir|tenofovir|mesh-list
20582184|NCT02104700|Emtricitabine|emtricitabine|mesh-list
20582185|NCT02104700|Rilpivirine|rilpivirine|mesh-list
20582186|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
20582187|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582188|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20582189|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20582190|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582191|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582192|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20582193|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20582194|NCT02104778|Dexamethasone|dexamethasone|mesh-list
20582195|NCT02104778|Epinephrine|epinephrine|mesh-list
20582196|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582197|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
20582198|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
20582199|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582200|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582201|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582202|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
20582203|NCT02104778|Hormones|hormones|mesh-ancestor
20582204|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582205|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20582206|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582207|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20582208|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20582209|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
20582210|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582211|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582212|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20582213|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20582214|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20076035|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076036|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
20076037|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582215|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
20582216|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
20076038|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582217|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
20582218|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20582219|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20582220|NCT02104843|Asunaprevir|asunaprevir|mesh-list
20582221|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20582222|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20582223|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
20582224|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582225|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20582226|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20582227|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582228|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
20582229|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
20582230|NCT02104986|Cisplatin|cisplatin|mesh-list
20582231|NCT02104986|Ifosfamide|ifosfamide|mesh-list
20582232|NCT02104986|Bleomycin|bleomycin|mesh-list
20582233|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582234|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20582235|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
20582236|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582237|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20582238|NCT02105077|Anesthetics|anesthetics|mesh-list
20582239|NCT02105077|Xenon|xenon|mesh-list
20076039|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076040|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
20076041|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076042|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20076043|NCT00720343|Choline|choline|mesh-list
20076044|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
20076045|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20076046|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
20076047|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076048|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076049|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20076050|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
20076051|NCT00719914|Eptifibatide|eptifibatide|mesh-list
20076052|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20076053|NCT00718640|Dexamethasone|dexamethasone|mesh-list
20076054|NCT00718640|Bortezomib|bortezomib|mesh-list
20076055|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076056|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
20076057|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
20076058|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076059|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076060|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076061|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
20076062|NCT00718640|Hormones|hormones|mesh-ancestor
20076063|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076064|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076065|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076066|NCT00720083|Cisplatin|cisplatin|mesh-list
20306022|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582240|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582241|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582242|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20582243|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
20582244|NCT02105090|Anesthetics|anesthetics|mesh-list
20582245|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
20582246|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582247|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076067|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582248|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582249|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
20582250|NCT02105103|Insulin|insulin|mesh-list
20582251|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20582252|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582253|NCT02105155|Tacrolimus|tacrolimus|mesh-list
20582254|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582255|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
20582256|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582257|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20582258|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582259|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582260|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
20582261|NCT02105311|Travoprost|travoprost|mesh-list
20582262|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20582263|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20582264|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582265|NCT02105350|Gemcitabine|gemcitabine|mesh-list
20582266|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
20582267|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20582268|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
20582269|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582270|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582271|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
20582272|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582273|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582274|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582275|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
20582276|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582277|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
20582278|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
20582279|NCT02105610|Sevoflurane|sevoflurane|mesh-list
20582280|NCT02105610|Desflurane|desflurane|mesh-list
20582281|NCT02105610|Isoflurane|isoflurane|mesh-list
20582282|NCT02105610|Anesthetics|anesthetics|mesh-list
20582283|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
20582284|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20582285|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20076068|NCT00717275|Temozolomide|temozolomide|mesh-list
20582286|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
20582287|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582288|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582289|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20582290|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20582291|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20582292|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
20582293|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582294|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20582295|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20582296|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582297|NCT02105675|Docetaxel|docetaxel|mesh-list
20582298|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582299|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
20582300|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
20582301|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
20582302|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582303|NCT02105714|Formaldehyde|formaldehyde|mesh-list
20582304|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
20582305|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582306|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20582307|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20582308|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582309|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20582310|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582311|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
20076069|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20076070|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
20076071|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076072|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076073|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
20582312|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582313|NCT02105870|Abciximab|abciximab|mesh-list
20582314|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
20582315|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20606032|NCT02235428|Bromides|bromides|mesh-list
20606033|NCT02235428|Albuterol|albuterol|mesh-list
20606034|NCT02235428|Ipratropium|ipratropium|mesh-list
20606035|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
20582316|NCT02106104|Glimepiride|glimepiride|mesh-list
20582317|NCT02106104|Linagliptin|linagliptin|mesh-list
20582318|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582319|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20582320|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582321|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582322|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
20582323|NCT02106104|Incretins|incretins|mesh-ancestor
20582324|NCT02106104|Hormones|hormones|mesh-ancestor
20582325|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582326|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20582327|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
20582328|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582329|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582330|NCT02106130|Rebamipide|rebamipide|mesh-list
20582331|NCT02106130|Mosapride|mosapride|mesh-list
20582332|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582333|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20582334|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582335|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
20582336|NCT02106130|Protective Agents|protective agents|mesh-ancestor
20582337|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582338|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582339|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20582340|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
20582341|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582342|NCT02106182|Silodosin|silodosin|mesh-list
20582343|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20582344|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20582345|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20582346|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
20582347|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582348|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582349|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582350|NCT02106182|Urological Agents|urological agents|mesh-ancestor
20582351|NCT02106286|Bisoprolol|bisoprolol|mesh-list
20582352|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20582353|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
20582354|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
20582355|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582356|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582357|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20582358|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20582359|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20582360|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
20076074|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20076075|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20076076|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20076077|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076078|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076079|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
20076080|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076081|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076082|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20076083|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076084|NCT00706797|Etanercept|etanercept|mesh-list
20076085|NCT00706797|Methotrexate|methotrexate|mesh-list
20076086|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20076087|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
20076088|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20076089|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076090|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076091|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
20076092|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582361|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582362|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582363|NCT02106364|Insulin|insulin|mesh-list
20582364|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20582365|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
20582366|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20582367|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582368|NCT02106468|Prednisone|prednisone|mesh-list
20582369|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582370|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
20582371|NCT02106468|Hormones|hormones|mesh-ancestor
20582372|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582373|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582374|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20582375|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582376|NCT02106481|Ropivacaine|ropivacaine|mesh-list
20582377|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
20582378|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
20582379|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582380|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582381|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
20582382|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582383|NCT02106507|Everolimus|everolimus|mesh-list
20582384|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582385|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582386|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
20582387|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582388|NCT02106520|Bevacizumab|bevacizumab|mesh-list
20582389|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20582390|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582391|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20582392|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20582393|NCT02106520|Growth Substances|growth substances|mesh-ancestor
20582394|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582395|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
20582396|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20582397|NCT02106559|Trioxsalen|trioxsalen|mesh-list
20582398|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582399|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
20582400|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20582401|NCT02106637|Varenicline|varenicline|mesh-list
20582402|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20582403|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20582404|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
20582405|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582406|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582407|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582408|NCT02106650|Leucovorin|leucovorin|mesh-list
20582409|NCT02106650|Folic Acid|folic acid|mesh-list
20582410|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
20582411|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
20582412|NCT02106650|Vitamins|vitamins|mesh-ancestor
20582413|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
20582414|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582415|NCT02106650|Antidotes|antidotes|mesh-ancestor
20582416|NCT02106650|Protective Agents|protective agents|mesh-ancestor
20582417|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
20582418|NCT02106650|Hematinics|hematinics|mesh-ancestor
20582419|NCT02106767|Rifampin|rifampin|mesh-list
20582420|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20582421|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20582422|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20582423|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
20582424|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582425|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20582426|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20582427|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582428|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20582429|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
20582430|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20582431|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582432|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
20582433|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20582434|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20582435|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20582436|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20582437|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20582438|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20582439|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20582440|NCT02106793|Mitomycins|mitomycins|mesh-list
20582441|NCT02106793|Mitomycin|mitomycin|mesh-list
20582442|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20582443|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582444|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
20582445|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582446|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20582447|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582448|NCT02106806|Zinc|zinc|mesh-list
20582449|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
20582450|NCT02106806|Trace Elements|trace elements|mesh-ancestor
20582451|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
20582452|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582453|NCT02106806|Astringents|astringents|mesh-ancestor
20582454|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
20582455|NCT02106845|Digoxin|digoxin|mesh-list
20582456|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20582457|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20582458|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20582459|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
20582460|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582461|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20582462|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20582463|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582464|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582465|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20582466|NCT02106845|Protective Agents|protective agents|mesh-ancestor
20582467|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582468|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
20582469|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
20582470|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20582471|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20582472|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582473|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582474|NCT02106871|Urological Agents|urological agents|mesh-ancestor
20582475|NCT02106988|Dexamethasone|dexamethasone|mesh-list
20582476|NCT02106988|Carboplatin|carboplatin|mesh-list
20582477|NCT02106988|Etoposide|etoposide|mesh-list
20582478|NCT02106988|Ifosfamide|ifosfamide|mesh-list
20582479|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
20582480|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582481|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
20582482|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
20582483|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582484|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582485|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582486|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
20582487|NCT02106988|Hormones|hormones|mesh-ancestor
20582488|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582489|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20582490|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582491|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20582492|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20582493|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20582494|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582495|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582496|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20582497|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
20582498|NCT02107079|Melatonin|melatonin|mesh-list
20582499|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
20582500|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582501|NCT02107079|Protective Agents|protective agents|mesh-ancestor
20582502|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582503|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582504|NCT02107118|Complement Factor H|complement factor h|mesh-list
20582505|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20582506|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582507|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
20582508|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582509|NCT02107144|Trimetazidine|trimetazidine|mesh-list
20582510|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
20582511|NCT02107170|Remifentanil|remifentanil|mesh-list
20582512|NCT02107170|Propofol|propofol|mesh-list
20582513|NCT02107170|Sevoflurane|sevoflurane|mesh-list
20582514|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20582515|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582516|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582517|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20582518|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
20582519|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
20582520|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20582521|NCT02107170|Narcotics|narcotics|mesh-ancestor
20582522|NCT02107170|Analgesics|analgesics|mesh-ancestor
20582523|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
20582524|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582525|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20582526|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20582527|NCT02107235|ON 01910|on 01910|mesh-list
20582528|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582529|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20582530|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582531|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582532|NCT02107365|Interferons|interferons|mesh-list
20582533|NCT02107365|Ribavirin|ribavirin|mesh-list
20582534|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
20582535|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
20582536|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20582537|NCT02107365|Asunaprevir|asunaprevir|mesh-list
20582538|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582539|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
20582540|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582541|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
20582542|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582543|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
20582544|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582545|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
20582546|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582547|NCT02107378|Paclitaxel|paclitaxel|mesh-list
20582548|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20582549|NCT02107378|Doxorubicin|doxorubicin|mesh-list
20582550|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20582551|NCT02107378|Topotecan|topotecan|mesh-list
20582552|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20582553|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582554|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20582555|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20582556|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
20582557|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582558|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20582559|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20582560|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20582561|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076093|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076094|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
20076095|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582562|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20582563|NCT02107391|Leuprolide|leuprolide|mesh-list
20582564|NCT02107391|Goserelin|goserelin|mesh-list
20582565|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20582566|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
20582567|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20582568|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582569|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20582570|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582571|NCT02107690|Lidocaine|lidocaine|mesh-list
20582572|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
20582573|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
20582574|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582575|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582576|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
20582577|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582578|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582579|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20076096|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20582580|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20582581|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582582|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582583|NCT02107716|Lidocaine|lidocaine|mesh-list
20582584|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
20582585|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
20582586|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582587|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582588|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
20582589|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582590|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582591|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20582592|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20582593|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582594|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606036|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606037|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
20606038|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606039|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606040|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606041|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606042|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
20606043|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606044|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20606045|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20606046|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20606047|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606048|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606049|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606050|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606051|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606052|NCT02235480|Tazarotene|tazarotene|mesh-list
20606053|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
20606054|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
20606055|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20606056|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20606057|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20606058|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606059|NCT02235532|Fluorides|fluorides|mesh-list
20606060|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
20606061|NCT02235532|Protective Agents|protective agents|mesh-ancestor
20606062|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606063|NCT02235558|Verapamil|verapamil|mesh-list
20606064|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20606065|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20606066|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606067|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606068|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606069|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606070|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
20606071|NCT02235584|Dexamethasone|dexamethasone|mesh-list
20606072|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606073|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
20606074|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
20606075|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606076|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606077|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20606078|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
20606079|NCT02235584|Hormones|hormones|mesh-ancestor
20606080|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606081|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20606082|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606083|NCT02235662|Tenofovir|tenofovir|mesh-list
20606084|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
20606085|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
20076097|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076098|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
20076099|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076100|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20076101|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20076102|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20076103|NCT00706797|Analgesics|analgesics|mesh-ancestor
20606086|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606087|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20606088|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20606089|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606090|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582595|NCT02107729|Lidocaine|lidocaine|mesh-list
20582596|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
20582597|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
20582598|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582599|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582600|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
20582601|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582602|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582603|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20582604|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20582605|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582606|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582607|NCT02107742|Lidocaine|lidocaine|mesh-list
20582608|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
20582609|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
20582610|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582611|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582612|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
20582613|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582614|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582615|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20582616|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20582617|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582618|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582619|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20582620|NCT02107755|Ipilimumab|ipilimumab|mesh-list
20582621|NCT02107755|Antibodies|antibodies|mesh-list
20582622|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
20582623|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20582624|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
20582625|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582626|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582627|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20582628|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582629|NCT02107807|Lactitol|lactitol|mesh-list
20582630|NCT02107807|Vaccines|vaccines|mesh-list
20582631|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
20582632|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582633|NCT02107807|Cathartics|cathartics|mesh-ancestor
20582634|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582635|NCT02107924|Vancomycin|vancomycin|mesh-list
20582636|NCT02107924|Tobramycin|tobramycin|mesh-list
20582637|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20582638|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582639|NCT02107950|Gemcitabine|gemcitabine|mesh-list
20582640|NCT02107950|Carboplatin|carboplatin|mesh-list
20582641|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582642|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20582643|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
20582644|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582645|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
20582646|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582647|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582648|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582649|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
20582650|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582651|NCT02108002|Vorinostat|vorinostat|mesh-list
20582652|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582653|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20582654|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582655|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582656|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
20582657|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20582658|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20582659|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20582660|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582661|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582662|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
20582663|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582664|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582665|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20582666|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582667|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20582668|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20582669|NCT02108301|Cyclosporine|cyclosporine|mesh-list
20582670|NCT02108301|Tacrolimus|tacrolimus|mesh-list
20582671|NCT02108301|Cyclosporins|cyclosporins|mesh-list
20076104|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
20076105|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076106|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076107|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076108|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20582672|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582673|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
20582674|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076109|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
20076110|NCT00713596|Coagulants|coagulants|mesh-ancestor
20076111|NCT00703885|Alprazolam|alprazolam|mesh-list
20076112|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20582675|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20582676|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582677|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582678|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
20582679|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582680|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
20582681|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20582682|NCT02108353|Melatonin|melatonin|mesh-list
20076113|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076114|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076115|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20076116|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20582683|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
20582684|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582685|NCT02108353|Protective Agents|protective agents|mesh-ancestor
20582686|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582687|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582688|NCT02108366|Oseltamivir|oseltamivir|mesh-list
20582689|NCT02108366|Celecoxib|celecoxib|mesh-list
20582690|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20582691|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20582692|NCT02108366|Analgesics|analgesics|mesh-ancestor
20582693|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
20582694|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582695|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582696|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582697|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20582698|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20582699|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20582700|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582701|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582702|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
20582703|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582704|NCT02108483|Dapsone|dapsone|mesh-list
20582705|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582706|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
20582707|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20582708|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20582709|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20582710|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582711|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582712|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
20582713|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20582714|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
20582715|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20582716|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20582717|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582718|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20582719|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20582720|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
20582721|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20582722|NCT02108548|Naproxen|naproxen|mesh-list
20582723|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20582724|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20582725|NCT02108548|Analgesics|analgesics|mesh-ancestor
19492026|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20076117|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20582726|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
20076118|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
20582727|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582728|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582729|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582730|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20582731|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
20582732|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20582733|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582734|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582735|NCT02108626|Nicotine|nicotine|mesh-list
20582736|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20582737|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
20582738|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582739|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582740|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20582741|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20582742|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
20582743|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582744|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582745|NCT02108639|Asunaprevir|asunaprevir|mesh-list
20582746|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
20582747|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582748|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582749|NCT02108743|Albuterol|albuterol|mesh-list
20582750|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20076119|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
20076120|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076121|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076122|NCT00713258|Alendronate|alendronate|mesh-list
20076123|NCT00713258|Hormones|hormones|mesh-list
20076124|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
20076125|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076126|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076127|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20582751|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
20582752|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582753|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582754|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20582755|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
20582756|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
20582757|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20582758|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20582759|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20582760|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20582761|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
20582762|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582763|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582764|NCT02108756|Pantoprazole|pantoprazole|mesh-list
20582765|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20582766|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582767|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20582768|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582769|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582770|NCT02108795|Remifentanil|remifentanil|mesh-list
20582771|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20582772|NCT02108795|Narcotics|narcotics|mesh-ancestor
20582773|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582774|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582775|NCT02108795|Analgesics|analgesics|mesh-ancestor
20582776|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
20076128|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20076129|NCT00707161|Cisplatin|cisplatin|mesh-list
20076130|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076131|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
20582777|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582778|NCT02108808|Clopidogrel|clopidogrel|mesh-list
20582779|NCT02108808|Ticagrelor|ticagrelor|mesh-list
20582780|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20582781|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20582782|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20582783|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20582784|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20076132|NCT00704496|Ephedrine|ephedrine|mesh-list
20076133|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20582785|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
20582786|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582787|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582788|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582789|NCT02108847|Ropivacaine|ropivacaine|mesh-list
20582790|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
20582791|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
20582792|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582793|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582794|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
20582795|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582796|NCT02108886|Montelukast|montelukast|mesh-list
20582797|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20582798|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
20582799|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20582800|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
20582801|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582802|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582803|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20582804|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20582805|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582806|NCT02108990|Acetaminophen|acetaminophen|mesh-list
20582807|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20582808|NCT02108990|Analgesics|analgesics|mesh-ancestor
20582809|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
20582810|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582811|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582812|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
20582813|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
20582814|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582815|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
20582816|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20582817|NCT02109289|Etanercept|etanercept|mesh-list
20582818|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20582819|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20582820|NCT02109289|Analgesics|analgesics|mesh-ancestor
20582821|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
20582822|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582823|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582824|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582825|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20582826|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582827|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582828|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
20582829|NCT02109315|Ascorbic Acid|ascorbic acid|mesh-list
20582830|NCT02109315|Liraglutide|liraglutide|mesh-list
20582831|NCT02109315|Vitamins|vitamins|mesh-ancestor
20582832|NCT02109315|Micronutrients|micronutrients|mesh-ancestor
20582833|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582834|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20582835|NCT02109315|Incretins|incretins|mesh-ancestor
20582836|NCT02109315|Hormones|hormones|mesh-ancestor
20582837|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582838|NCT02109315|Antioxidants|antioxidants|mesh-ancestor
20582839|NCT02109315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582840|NCT02109315|Protective Agents|protective agents|mesh-ancestor
20582841|NCT02109328|Paclitaxel|paclitaxel|mesh-list
20582842|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20582843|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582844|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
20582845|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
20582846|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
20582847|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582848|NCT02109341|Paclitaxel|paclitaxel|mesh-list
20582849|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20582850|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20582851|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582852|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
20582853|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
20582854|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
20582855|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582856|NCT02109354|Vaccines|vaccines|mesh-list
20582857|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
20582858|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582859|NCT02109510|Lidocaine|lidocaine|mesh-list
20582860|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
20582861|NCT02109510|Ketamine|ketamine|mesh-list
20582862|NCT02109510|Anesthetics|anesthetics|mesh-list
20582863|NCT02109510|Propofol|propofol|mesh-list
20582864|NCT02109510|Sevoflurane|sevoflurane|mesh-list
20582865|NCT02109510|Rocuronium|rocuronium|mesh-list
20582866|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
20582867|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582868|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582869|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
20582870|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582871|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20582872|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20582873|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20582874|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20582875|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582876|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20582877|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20582878|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
20582879|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20582880|NCT02109510|Analgesics|analgesics|mesh-ancestor
20582881|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20582882|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20582883|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20582884|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
20582885|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582886|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20582887|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20582888|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20582889|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20582890|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20582891|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20582892|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20582893|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20606091|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20606092|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20606093|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20606094|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
20606095|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606096|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606097|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20606098|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20606099|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20606100|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
20606101|NCT02235805|Cathartics|cathartics|mesh-ancestor
20606102|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20606103|NCT02235909|Losartan|losartan|mesh-list
20606104|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20606105|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20606106|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20606107|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20606108|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20606109|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606110|NCT02235948|Folic Acid|folic acid|mesh-list
20606111|NCT02235948|Hematinics|hematinics|mesh-ancestor
20606112|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
20606113|NCT02235948|Vitamins|vitamins|mesh-ancestor
20606114|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
20606115|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606116|NCT02235961|Liraglutide|liraglutide|mesh-list
20606117|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20606118|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606119|NCT02235961|Incretins|incretins|mesh-ancestor
20606120|NCT02235961|Hormones|hormones|mesh-ancestor
20606121|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606122|NCT02236013|Cytarabine|cytarabine|mesh-list
20606123|NCT02236013|Daunorubicin|daunorubicin|mesh-list
20606124|NCT02236013|Idarubicin|idarubicin|mesh-list
20606125|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076134|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
20076135|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076136|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076137|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20076138|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
20076139|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
20606126|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
20076140|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20076141|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20076142|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
20076143|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
20076144|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076145|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076146|NCT00708916|Apremilast|apremilast|mesh-list
20076147|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20076148|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20076149|NCT00708916|Analgesics|analgesics|mesh-ancestor
20076150|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
20582894|NCT02109614|Niacin|niacin|mesh-list
20582895|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20582896|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
20582897|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582898|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20582899|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
20582900|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
20582901|NCT02109614|Vitamins|vitamins|mesh-ancestor
20582902|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
20582903|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582904|NCT02109627|Cytarabine|cytarabine|mesh-list
20582905|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20582906|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
20582907|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582908|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582909|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
20582910|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076151|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076152|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076153|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076154|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076155|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20076156|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20582911|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582912|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
20582913|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582914|NCT02109666|Abatacept|abatacept|mesh-list
20582915|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20582916|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582917|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582918|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582919|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
20582920|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582921|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20582922|NCT02109679|Metformin|metformin|mesh-list
20582923|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20582924|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582925|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
20582926|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20582927|NCT02109718|Petrolatum|petrolatum|mesh-list
20582928|NCT02109718|Emollients|emollients|mesh-ancestor
20582929|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
20582930|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20582931|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20582932|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20582933|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20582934|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
20582935|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20582936|NCT02109783|Caffeine|caffeine|mesh-list
20582937|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20582938|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582939|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20582940|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076157|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076158|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076159|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20076160|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20076161|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076162|NCT00699842|Lenalidomide|lenalidomide|mesh-list
20076163|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
20582941|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582942|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20582943|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20582944|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
20076164|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076165|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20076166|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20582945|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20582946|NCT02109861|Dexamethasone|dexamethasone|mesh-list
20582947|NCT02109861|Bortezomib|bortezomib|mesh-list
20582948|NCT02109861|Melphalan|melphalan|mesh-list
20582949|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20582950|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
20582951|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
20582952|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582953|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582954|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20582955|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
20582956|NCT02109861|Hormones|hormones|mesh-ancestor
20582957|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582958|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20582959|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582960|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20582961|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
20582962|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582963|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20582964|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582965|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
20582966|NCT02109900|Progesterone|progesterone|mesh-list
20582967|NCT02109900|Progestins|progestins|mesh-ancestor
20582968|NCT02109900|Hormones|hormones|mesh-ancestor
20582969|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582970|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582971|NCT02109913|Everolimus|everolimus|mesh-list
20582972|NCT02109913|Exemestane|exemestane|mesh-list
20582973|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20582974|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20582975|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
20582976|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582977|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20582978|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20582979|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20582980|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20582981|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20582982|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
20582983|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20582984|NCT02109965|Midazolam|midazolam|mesh-list
20582985|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
20582986|NCT02109965|Propofol|propofol|mesh-list
20582987|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20582988|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20582989|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20582990|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20582991|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
20582992|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
20582993|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20582994|NCT02109965|Analgesics|analgesics|mesh-ancestor
20582995|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
20582996|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20582997|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20582998|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20582999|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20583000|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
20583001|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583002|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583003|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20583004|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20583005|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20583006|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583007|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
20583008|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
20583009|NCT02110082|Cetuximab|cetuximab|mesh-list
20583010|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20583011|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583012|NCT02110134|Hydroquinone|hydroquinone|mesh-list
20583013|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
20583014|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076167|NCT00699842|Growth Substances|growth substances|mesh-ancestor
20583015|NCT02110134|Protective Agents|protective agents|mesh-ancestor
20583016|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583017|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20583018|NCT02110303|Ticagrelor|ticagrelor|mesh-list
20583019|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20583020|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20583021|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20583022|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20583023|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
20583024|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583025|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076168|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
20076169|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076170|NCT00702962|Carboplatin|carboplatin|mesh-list
20076171|NCT00702962|Etoposide|etoposide|mesh-list
20076172|NCT00702962|Vorinostat|vorinostat|mesh-list
20076173|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076174|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20076175|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20076176|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20076177|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076178|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076179|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20583026|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583027|NCT02110316|Voriconazole|voriconazole|mesh-list
20583028|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
20583029|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583030|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20583031|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20583032|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583033|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583034|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20583035|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
20583036|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583037|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583038|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20583039|NCT02110355|Trametinib|trametinib|mesh-list
20583040|NCT02110355|Dabrafenib|dabrafenib|mesh-list
20583041|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583042|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20583043|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583044|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583045|NCT02110394|Rituximab|rituximab|mesh-list
20583046|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20583047|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20583048|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583049|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
20583050|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583051|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583052|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20583053|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
20583054|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076180|NCT00703534|Lesogaberan|lesogaberan|mesh-list
20076181|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076182|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20076183|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
20076184|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
20076185|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076186|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076187|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076188|NCT00698009|Vidarabine|vidarabine|mesh-list
20076189|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
20076190|NCT00698009|Fludarabine|fludarabine|mesh-list
20076191|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
20076192|NCT00698009|Interleukin-2|interleukin-2|mesh-list
20076193|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076194|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
20076195|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076196|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076197|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20076198|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
20076199|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306023|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583055|NCT02110459|Murepavadin|murepavadin|mesh-list
20583056|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20583057|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583058|NCT02110524|Paclitaxel|paclitaxel|mesh-list
20076200|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076201|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20076202|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076203|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
20076204|NCT00698009|Antiviral Agents|antiviral agents|mesh-ancestor
20076205|NCT00698009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076206|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20076207|NCT00698009|Analgesics|analgesics|mesh-ancestor
20076208|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
20076209|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076210|NCT00703339|Treprostinil|treprostinil|mesh-list
20076211|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20076212|NCT00691444|Melatonin|melatonin|mesh-list
20076213|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
20076214|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583059|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20583060|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583061|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
20583062|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
20583063|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
20583064|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583065|NCT02110537|Flecainide|flecainide|mesh-list
20583066|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20583067|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20583068|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20583069|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583070|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583071|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
20583072|NCT02110654|Montelukast|montelukast|mesh-list
20583073|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20583074|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
20583075|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20583076|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
20583077|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583078|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583079|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20583080|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20583081|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583082|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076215|NCT00691444|Protective Agents|protective agents|mesh-ancestor
20076216|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076217|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20119918|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20119919|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583083|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
20583084|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20583085|NCT02110719|Acetaminophen|acetaminophen|mesh-list
20583086|NCT02110719|Dexamethasone|dexamethasone|mesh-list
20583087|NCT02110719|Ibuprofen|ibuprofen|mesh-list
20583088|NCT02110719|Celecoxib|celecoxib|mesh-list
20583089|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20583090|NCT02110719|Oxycodone|oxycodone|mesh-list
20583091|NCT02110719|Gabapentin|gabapentin|mesh-list
20583092|NCT02110719|Hydromorphone|hydromorphone|mesh-list
20583093|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583094|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
20583095|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
20583096|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583097|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583098|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583099|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
20583100|NCT02110719|Hormones|hormones|mesh-ancestor
20583101|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583102|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20583103|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583104|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20583105|NCT02110719|Analgesics|analgesics|mesh-ancestor
20119920|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20119921|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
20583106|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
20583107|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
20119922|NCT00006250|Hormones|hormones|mesh-ancestor
20583108|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20583109|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583110|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20583111|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583112|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583113|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20583114|NCT02110719|Narcotics|narcotics|mesh-ancestor
20583115|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583116|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
20583117|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20583118|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20583119|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583120|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20583121|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20583122|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583123|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
20583124|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20583125|NCT02110745|Propofol|propofol|mesh-list
20583126|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20583127|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583128|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583129|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20583130|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
20583131|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
20583132|NCT02110784|Piperaquine|piperaquine|mesh-list
20583133|NCT02110784|Artenimol|artenimol|mesh-list
20583134|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
20583135|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20583136|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20583137|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583138|NCT02110810|Indomethacin|indomethacin|mesh-list
20583139|NCT02110810|Glycerol|glycerol|mesh-list
20583140|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20583141|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20583142|NCT02110810|Analgesics|analgesics|mesh-ancestor
20583143|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
20583144|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583145|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583146|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583147|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583148|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
20583149|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
20583150|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20583151|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20583152|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583153|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583154|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20583155|NCT02110810|Protective Agents|protective agents|mesh-ancestor
20583156|NCT02110953|Irinotecan|irinotecan|mesh-list
20583157|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20583158|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20583159|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583160|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583161|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583162|NCT02110966|Tramadol|tramadol|mesh-list
20583163|NCT02110966|Mepivacaine|mepivacaine|mesh-list
20583164|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20583165|NCT02110966|Narcotics|narcotics|mesh-ancestor
20583166|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583167|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583168|NCT02110966|Analgesics|analgesics|mesh-ancestor
20583169|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
20583170|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583171|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
20583172|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
20583173|NCT02110992|Docetaxel|docetaxel|mesh-list
20583174|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583175|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
20583176|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
20583177|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
20583178|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583179|NCT02111044|Octreotide|octreotide|mesh-list
20583180|NCT02111044|Somatostatin|somatostatin|mesh-list
20583181|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583182|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20583183|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583184|NCT02111044|Hormones|hormones|mesh-ancestor
20583185|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583186|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583187|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
20583188|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20076218|NCT00691652|Rituximab|rituximab|mesh-list
20076219|NCT00691652|Clofarabine|clofarabine|mesh-list
20076220|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20076221|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076222|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
20076223|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076224|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076225|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076226|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
20076227|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583189|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20583190|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
20583191|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
20583192|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583193|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583194|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
20583195|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20583196|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
20583197|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
20583198|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20583199|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
20583200|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583201|NCT02111265|Sufentanil|sufentanil|mesh-list
20583202|NCT02111265|Remifentanil|remifentanil|mesh-list
20583203|NCT02111265|Cisatracurium|cisatracurium|mesh-list
20583204|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20583205|NCT02111265|Narcotics|narcotics|mesh-ancestor
20583206|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583207|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076228|NCT00686972|Glucagon|glucagon|mesh-list
20076229|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20076230|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583208|NCT02111265|Analgesics|analgesics|mesh-ancestor
20583209|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
20583210|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583211|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20583212|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20583213|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
20583214|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
20583215|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20583216|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20583217|NCT02111317|Verapamil|verapamil|mesh-list
20583218|NCT02111317|Peficitinib|peficitinib|mesh-list
20583219|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20583220|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20583221|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583222|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583223|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20583224|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583225|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
20583226|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583227|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583228|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
20606127|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606128|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606129|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
20606130|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606131|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20606132|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
20606133|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606134|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20606135|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20606136|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20606137|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606138|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
20606139|NCT02236026|ST 1435|st 1435|mesh-list
20606140|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20076231|NCT00686972|Hormones|hormones|mesh-ancestor
20076232|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606141|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606142|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20583229|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
20583230|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20583231|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583232|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583233|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20076233|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076234|NCT00686972|Incretins|incretins|mesh-ancestor
20076235|NCT00693017|Zonisamide|zonisamide|mesh-list
20076236|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
20076237|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20076238|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076239|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076240|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20583234|NCT02111421|Analgesics|analgesics|mesh-ancestor
20583235|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
20583236|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583237|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20583238|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20583239|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20583240|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
20583241|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583242|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583243|NCT02111434|Testosterone|testosterone|mesh-list
20583244|NCT02111434|Androgens|androgens|mesh-ancestor
20583245|NCT02111434|Hormones|hormones|mesh-ancestor
20583246|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583247|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583248|NCT02111473|Testosterone|testosterone|mesh-list
20583249|NCT02111473|Androgens|androgens|mesh-ancestor
20583250|NCT02111473|Hormones|hormones|mesh-ancestor
20583251|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583252|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583253|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
20583254|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20583255|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20583256|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
20583257|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583258|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583259|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583260|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
20583261|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20583262|NCT02111590|Antibodies|antibodies|mesh-list
20583263|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
20583264|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583265|NCT02111629|Fluconazole|fluconazole|mesh-list
20583266|NCT02111629|Secnidazole|secnidazole|mesh-list
20076241|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076242|NCT00691574|Melatonin|melatonin|mesh-list
20076243|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
20076244|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076245|NCT00691574|Protective Agents|protective agents|mesh-ancestor
20076246|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076247|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583267|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
20583268|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583269|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20583270|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20583271|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583272|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583273|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20583274|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
20583275|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583276|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583277|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20583278|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20076248|NCT00692094|Melatonin|melatonin|mesh-list
20076249|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
20076250|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076251|NCT00692094|Protective Agents|protective agents|mesh-ancestor
20076252|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076253|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076254|NCT00692003|Zonisamide|zonisamide|mesh-list
20583279|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20076255|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
20076256|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20076257|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583280|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20583281|NCT02111707|Indomethacin|indomethacin|mesh-list
20583282|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20583283|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20583284|NCT02111707|Analgesics|analgesics|mesh-ancestor
20583285|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
20583286|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583287|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583288|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583289|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583290|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
20583291|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
20583292|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20583293|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20583294|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583295|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583296|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20583297|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20583298|NCT02111941|Vaccines|vaccines|mesh-list
20583299|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
20583300|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583301|NCT02112006|Bupivacaine|bupivacaine|mesh-list
20583302|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
20583303|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
20583304|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583305|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583306|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
20583307|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583308|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
20583309|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583310|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20583311|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
20583312|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20583313|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583314|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
20583315|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583316|NCT02112097|Etanercept|etanercept|mesh-list
20583317|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20583318|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20583319|NCT02112097|Analgesics|analgesics|mesh-ancestor
20583320|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
20583321|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583322|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583323|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583324|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583325|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076258|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076259|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20076260|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076261|NCT00678288|Interferons|interferons|mesh-list
20076262|NCT00678288|Sorafenib|sorafenib|mesh-list
20076263|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076264|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
20076265|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076266|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20583326|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583327|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
20583328|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
20583329|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20583330|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20583331|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583332|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
20583333|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
20583334|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583335|NCT02112175|Lenalidomide|lenalidomide|mesh-list
20583336|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
20583337|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583338|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20076267|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076268|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583339|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20076269|NCT00676026|Zolpidem|zolpidem|mesh-list
20076270|NCT00676026|Fluoxetine|fluoxetine|mesh-list
20076271|NCT00676026|Progesterone|progesterone|mesh-list
20076272|NCT00676026|Progestins|progestins|mesh-ancestor
20076273|NCT00676026|Hormones|hormones|mesh-ancestor
20076274|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076275|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583340|NCT02112175|Growth Substances|growth substances|mesh-ancestor
20583341|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
20583342|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583343|NCT02112214|Bismuth|bismuth|mesh-list
20583344|NCT02112214|Antacids|antacids|mesh-ancestor
20583345|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583346|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583347|NCT02112292|Dronabinol|dronabinol|mesh-list
20583348|NCT02112292|Cannabidiol|cannabidiol|mesh-list
20583349|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
20076276|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20076277|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20076278|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076279|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076280|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076281|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
20076282|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20076283|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
20076284|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20076285|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20076286|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20076287|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583350|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
20076288|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20583351|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583352|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583353|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20583354|NCT02112292|Analgesics|analgesics|mesh-ancestor
20583355|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
20583356|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583357|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20583358|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20583359|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583360|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583361|NCT02112292|Hormones|hormones|mesh-ancestor
20583362|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583363|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
20583364|NCT02112305|Analgesics|analgesics|mesh-ancestor
20076289|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20076290|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306024|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20306025|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20583365|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
20583366|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583367|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583368|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
20583369|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583370|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20583371|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
20583372|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20583373|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583374|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583375|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20583376|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
20583377|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20583378|NCT02112422|Dexamethasone|dexamethasone|mesh-list
20583379|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
20583380|NCT02112422|BB 1101|bb 1101|mesh-list
20583381|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583382|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
20583383|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
20583384|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583385|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583386|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583387|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
20583388|NCT02112422|Hormones|hormones|mesh-ancestor
20583389|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583390|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20583391|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583392|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
20583393|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583394|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583395|NCT02112487|Macitentan|macitentan|mesh-list
20583396|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20583397|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20583398|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583399|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20583400|NCT02112552|Paclitaxel|paclitaxel|mesh-list
20583401|NCT02112552|Carboplatin|carboplatin|mesh-list
20583402|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20583403|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583404|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
20583405|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
20583406|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
20583407|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583408|NCT02112578|Meclizine|meclizine|mesh-list
20583409|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
20583410|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
20583411|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
20583412|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583413|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583414|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583415|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20583416|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
20583417|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
20583418|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583419|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583420|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20583421|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20583422|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583423|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583424|NCT02112630|Interferons|interferons|mesh-list
20583425|NCT02112630|Ribavirin|ribavirin|mesh-list
20583426|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
20583427|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
20583428|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20583429|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20583430|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20583431|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583432|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
20583433|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583434|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
20583435|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583436|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
20583437|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583438|NCT02112643|Selenium|selenium|mesh-list
20583439|NCT02112643|Selenic Acid|selenic acid|mesh-list
20583440|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
19492027|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19492028|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492029|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492030|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492031|NCT03126461|Nivolumab|nivolumab|mesh-list
19492032|NCT03126461|Ipilimumab|ipilimumab|mesh-list
19492033|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19492034|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492035|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19492036|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492037|NCT03126188|Sertraline|sertraline|mesh-list
19492038|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20583441|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583442|NCT02112643|Protective Agents|protective agents|mesh-ancestor
20583443|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583444|NCT02112643|Trace Elements|trace elements|mesh-ancestor
20583445|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
20583446|NCT02112695|Diprenorphine|diprenorphine|mesh-list
20583447|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20583448|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583449|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
20583450|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583451|NCT02112721|Vitamin D|vitamin d|mesh-list
20583452|NCT02112721|Vitamins|vitamins|mesh-ancestor
20583453|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
19492039|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
19492040|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19492041|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19492042|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19492043|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19492044|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492045|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492046|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
19492047|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492048|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19492049|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19492050|NCT03126123|Acetic Acid|acetic acid|mesh-list
19492051|NCT03126123|Retinol acetate|retinol acetate|mesh-list
19492052|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19492053|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492054|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19492055|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
19492056|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492057|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19492058|NCT03126123|Protective Agents|protective agents|mesh-ancestor
19492059|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492060|NCT03126084|Acetaminophen|acetaminophen|mesh-list
19492061|NCT03126084|Tramadol|tramadol|mesh-list
19492062|NCT03126084|Bupivacaine|bupivacaine|mesh-list
20583454|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583455|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20583456|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20583457|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
20583458|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583459|NCT02112864|Dexamethasone|dexamethasone|mesh-list
20583460|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583461|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
20583462|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
20583463|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583464|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583465|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583466|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
20583467|NCT02112864|Hormones|hormones|mesh-ancestor
20583468|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583469|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20583470|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583471|NCT02112903|Vortioxetine|vortioxetine|mesh-list
20583472|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
20583473|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583474|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20583475|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20583476|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583477|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583478|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20583479|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20583480|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583481|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076291|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20076292|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
20076293|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
20306026|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583482|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583483|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
20583484|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20583485|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20583486|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20583487|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20583488|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
20583489|NCT02112916|Leucovorin|leucovorin|mesh-list
20583490|NCT02112916|Folic Acid|folic acid|mesh-list
20583491|NCT02112916|Cytarabine|cytarabine|mesh-list
20583492|NCT02112916|Dexamethasone|dexamethasone|mesh-list
20583493|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
20583494|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
20583495|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20583496|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20583497|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20583498|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
20583499|NCT02112916|Ifosfamide|ifosfamide|mesh-list
20583500|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
20583501|NCT02112916|Doxorubicin|doxorubicin|mesh-list
20583502|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20583503|NCT02112916|Methotrexate|methotrexate|mesh-list
20583504|NCT02112916|Etoposide|etoposide|mesh-list
20583505|NCT02112916|Vincristine|vincristine|mesh-list
20583506|NCT02112916|Bortezomib|bortezomib|mesh-list
20583507|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
20583508|NCT02112916|Daunorubicin|daunorubicin|mesh-list
20583509|NCT02112916|Asparaginase|asparaginase|mesh-list
20583510|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
20583511|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
20583512|NCT02112916|Pegaspargase|pegaspargase|mesh-list
20583513|NCT02112916|Thioguanine|thioguanine|mesh-list
20076294|NCT00689052|Pramipexole|pramipexole|mesh-list
20076295|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
20076296|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076297|NCT00689052|Protective Agents|protective agents|mesh-ancestor
20076298|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076299|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20076300|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20076301|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
20076302|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
20076303|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076304|NCT00678574|Fluoxetine|fluoxetine|mesh-list
20076305|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20076306|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20076307|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076308|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076309|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076310|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
20076311|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076312|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20076313|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
20076314|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20076315|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20076316|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20076317|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076318|NCT00683917|Leuprolide|leuprolide|mesh-list
20076319|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20076320|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
20076321|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20076322|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076323|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076324|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076325|NCT00688935|Melatonin|melatonin|mesh-list
20076326|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
20076327|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076328|NCT00688935|Protective Agents|protective agents|mesh-ancestor
20583514|NCT02112916|BB 1101|bb 1101|mesh-list
20583515|NCT02112916|Calcium|calcium|mesh-list
20583516|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
20583517|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
20583518|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306027|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583519|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
20583520|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583521|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583522|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20583523|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
20583524|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583525|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583526|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20583527|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583528|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
20583529|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
20583530|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583531|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583532|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
20583533|NCT02112916|Hormones|hormones|mesh-ancestor
20583534|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583535|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076329|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076330|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583536|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
20583537|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583538|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20076331|NCT00685880|Betamethasone|betamethasone|mesh-list
20076332|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
20076333|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076334|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
20076335|NCT00685880|Hormones|hormones|mesh-ancestor
20076336|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076337|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076338|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20076339|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
20076340|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20076341|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
20583539|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20583540|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20583541|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20583542|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20583543|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20583544|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
20583545|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20583546|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20583547|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
20583548|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
20583549|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20583550|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20583551|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20583552|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
20583553|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583554|NCT02112916|Antidotes|antidotes|mesh-ancestor
20583555|NCT02112916|Protective Agents|protective agents|mesh-ancestor
20583556|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
20583557|NCT02112916|Vitamins|vitamins|mesh-ancestor
20583558|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
20583559|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
20583560|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
20583561|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
20583562|NCT02112916|Hematinics|hematinics|mesh-ancestor
20583563|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
20583564|NCT02112929|Xenon|xenon|mesh-list
20583565|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20583566|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
20583567|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
20583568|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583569|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583570|NCT02112981|Sirolimus|sirolimus|mesh-list
20583571|NCT02112981|Everolimus|everolimus|mesh-list
20583572|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583573|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583574|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
20583575|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583576|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20583577|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583578|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20583579|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
20606143|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20606144|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076342|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076343|NCT00681044|Melphalan|melphalan|mesh-list
20606145|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606146|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606147|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20583580|NCT02113072|Beclomethasone|beclomethasone|mesh-list
20583581|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583582|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
20583583|NCT02113072|Hormones|hormones|mesh-ancestor
20583584|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583585|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583586|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20583587|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
20583588|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
20583589|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
20583590|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
20583591|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583592|NCT02113150|Ketamine|ketamine|mesh-list
20583593|NCT02113150|Remifentanil|remifentanil|mesh-list
20583594|NCT02113150|Analgesics|analgesics|mesh-ancestor
20583595|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
20583596|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583597|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583598|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20583599|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20583600|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
20583601|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
20583602|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583603|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20583604|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20583605|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583606|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583607|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20583608|NCT02113150|Narcotics|narcotics|mesh-ancestor
20583609|NCT02113176|Minocycline|minocycline|mesh-list
20583610|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20583611|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583612|NCT02113202|Bevacizumab|bevacizumab|mesh-list
20583613|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20583614|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583615|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20583616|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20583617|NCT02113202|Growth Substances|growth substances|mesh-ancestor
20583618|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583619|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
20583620|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
20583621|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583622|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
20583623|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20583624|NCT02113319|Dasatinib|dasatinib|mesh-list
20583625|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583626|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20583627|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583628|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076344|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
20076345|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076346|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20076347|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
20076348|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076349|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076350|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20076351|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583629|NCT02113332|Liraglutide|liraglutide|mesh-list
20583630|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20583631|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583632|NCT02113332|Incretins|incretins|mesh-ancestor
20583633|NCT02113332|Hormones|hormones|mesh-ancestor
20583634|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583635|NCT02113397|Tobramycin|tobramycin|mesh-list
20583636|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20583637|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583638|NCT02113540|Atorvastatin|atorvastatin|mesh-list
20583639|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20583640|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20583641|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
20583642|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583643|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20583644|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20583645|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583646|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20583647|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
20583648|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20583649|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
20583650|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20583651|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583652|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20583653|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20583654|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583655|NCT02113566|Acetaminophen|acetaminophen|mesh-list
20583656|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20583657|NCT02113566|Analgesics|analgesics|mesh-ancestor
20583658|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
20583659|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583660|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583661|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
20583662|NCT02113631|Interferons|interferons|mesh-list
20583663|NCT02113631|Ribavirin|ribavirin|mesh-list
20583664|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
20583665|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
20583666|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20583667|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583668|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
20076352|NCT00684255|Fludarabine|fludarabine|mesh-list
20076353|NCT00684255|Busulfan|busulfan|mesh-list
20076354|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
20076355|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076356|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076357|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076358|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
20076359|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076360|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
20076361|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20076362|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20076363|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20583669|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583670|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
20583671|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583672|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
20583673|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583674|NCT02113657|Ipilimumab|ipilimumab|mesh-list
20583675|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20583676|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583677|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20583678|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583679|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20583680|NCT02113735|Hormones|hormones|mesh-ancestor
20583681|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583682|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583683|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
20583684|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20583685|NCT02113800|Everolimus|everolimus|mesh-list
20583686|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583687|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583688|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
20583689|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583690|NCT02113813|Naquotinib|naquotinib|mesh-list
20583691|NCT02113813|Midazolam|midazolam|mesh-list
20583692|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20583693|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20583694|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583695|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583696|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20583697|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20076364|NCT00683787|Docetaxel|docetaxel|mesh-list
20076365|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076366|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
20076367|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
20076368|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
20076369|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076370|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
20076371|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20076372|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076373|NCT00678041|Renal Agents|renal agents|mesh-ancestor
20076374|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20076375|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20076376|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
20583698|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583699|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20583700|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
20583701|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
20583702|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
20583703|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
20583704|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583705|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583706|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583707|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20583708|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583709|NCT02113891|Eculizumab|eculizumab|mesh-list
20583710|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20583711|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583712|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
20583713|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583714|NCT02113904|Adalimumab|adalimumab|mesh-list
20583715|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583716|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583717|NCT02113943|Citalopram|citalopram|mesh-list
20583718|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20583719|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20583720|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583721|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583722|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583723|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
20583724|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583725|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20583726|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
20583727|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583728|NCT02114021|Betamethasone|betamethasone|mesh-list
20583729|NCT02114021|Lidocaine|lidocaine|mesh-list
20583730|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
20583731|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
20583732|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583733|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583734|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
20583735|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583736|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20583737|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20583738|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20583739|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583740|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583741|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583742|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
20583743|NCT02114021|Hormones|hormones|mesh-ancestor
20583744|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583745|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20583746|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
20583747|NCT02114073|Cyclosporine|cyclosporine|mesh-list
20583748|NCT02114073|Betamethasone|betamethasone|mesh-list
20583749|NCT02114073|Cyclosporins|cyclosporins|mesh-list
20583750|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583751|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583752|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583753|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
20583754|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583755|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
20583756|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583757|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
20583758|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583759|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20583760|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583761|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
20583762|NCT02114073|Hormones|hormones|mesh-ancestor
20583763|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583764|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20583765|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
20583766|NCT02114099|Atorvastatin|atorvastatin|mesh-list
20583767|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20583768|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20583769|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
20606148|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
20583770|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583771|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20583772|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20583773|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583774|NCT02114333|Vaccines|vaccines|mesh-list
20583775|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
20583776|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583777|NCT02114346|Atorvastatin|atorvastatin|mesh-list
20583778|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20583779|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20583780|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
20583781|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583782|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20583783|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19492063|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
19492064|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
19492065|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492066|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492067|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
20076377|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583784|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583785|NCT02114359|Cisplatin|cisplatin|mesh-list
20583786|NCT02114359|Fluorouracil|fluorouracil|mesh-list
20583787|NCT02114359|Capecitabine|capecitabine|mesh-list
20583788|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
20583789|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583790|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
20583791|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583792|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20583793|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583794|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
20583795|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583796|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
20583797|NCT02114463|Analgesics|analgesics|mesh-list
20583798|NCT02114463|Ropivacaine|ropivacaine|mesh-list
20583799|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
20583800|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
20583801|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583802|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583803|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
20583804|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583805|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20583806|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20583807|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583808|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583809|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20583810|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583811|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583812|NCT02114476|Progestins|progestins|mesh-list
20583813|NCT02114476|Hormones|hormones|mesh-ancestor
20583814|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583815|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583816|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
20583817|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20583818|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076378|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20076379|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20076380|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076381|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076382|NCT00669461|Lubiprostone|lubiprostone|mesh-list
20076383|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20076384|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076385|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076386|NCT00673309|Insulin|insulin|mesh-list
20076387|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20076388|NCT00673309|Itraconazole|itraconazole|mesh-list
20076389|NCT00673309|Propranolol|propranolol|mesh-list
20076390|NCT00673309|Hormones|hormones|mesh-list
20076391|NCT00673309|Oxandrolone|oxandrolone|mesh-list
20076392|NCT00673309|Nandrolone|nandrolone|mesh-list
20076393|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20076394|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076395|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076396|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076397|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20076398|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20076399|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
20076400|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076401|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20076402|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20583819|NCT02114502|Pyridoxine|pyridoxine|mesh-list
20583820|NCT02114502|Gemcitabine|gemcitabine|mesh-list
20583821|NCT02114502|Dexamethasone|dexamethasone|mesh-list
20583822|NCT02114502|Melphalan|melphalan|mesh-list
20076403|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
20076404|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
20076405|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076406|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20076407|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20076408|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076409|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20076410|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
20583823|NCT02114502|Busulfan|busulfan|mesh-list
20583824|NCT02114502|Vorinostat|vorinostat|mesh-list
20583825|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583826|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
20583827|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
20583828|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076411|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20076412|NCT00673309|Androgens|androgens|mesh-ancestor
20076413|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
20076414|NCT00673595|Varenicline|varenicline|mesh-list
20076415|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20076416|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20583829|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076417|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
20076418|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076419|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076420|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076421|NCT00673361|Temozolomide|temozolomide|mesh-list
20076422|NCT00673361|Sorafenib|sorafenib|mesh-list
20076423|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20076424|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
20076425|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076426|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076427|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20076428|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583830|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20583831|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
20583832|NCT02114502|Hormones|hormones|mesh-ancestor
20583833|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583834|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20583835|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076429|NCT00668785|Ranibizumab|ranibizumab|mesh-list
20076430|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20076431|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20076432|NCT00668785|Growth Substances|growth substances|mesh-ancestor
20076433|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076434|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
20076435|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076436|NCT00673179|Leucovorin|leucovorin|mesh-list
20076437|NCT00673179|Gemcitabine|gemcitabine|mesh-list
20076438|NCT00673179|Doxorubicin|doxorubicin|mesh-list
20076439|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20076440|NCT00673179|Methotrexate|methotrexate|mesh-list
20076441|NCT00673179|Ifosfamide|ifosfamide|mesh-list
20076442|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
20076443|NCT00673179|Razoxane|razoxane|mesh-list
20076444|NCT00673179|Sargramostim|sargramostim|mesh-list
20076445|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076446|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076447|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
20076448|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076449|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
20076450|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076451|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076452|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076453|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
20076454|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076455|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20076456|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20076457|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20076458|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20076459|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
20076460|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20076461|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
20076462|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20583836|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20583837|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
20583838|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583839|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
20583840|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583841|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583842|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583843|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
20583844|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20583845|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
20583846|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20583847|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20583848|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
20583849|NCT02114502|Vitamins|vitamins|mesh-ancestor
20583850|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
20583851|NCT02114528|Amiodarone|amiodarone|mesh-list
20583852|NCT02114528|Sotalol|sotalol|mesh-list
20583853|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20583854|NCT02114528|Mexiletine|mexiletine|mesh-list
20583855|NCT02114528|Procainamide|procainamide|mesh-list
20583856|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
20583857|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20583858|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583859|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583860|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20583861|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20583862|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20583863|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583864|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20583865|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20583866|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20583867|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20583868|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20583869|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
20583870|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583871|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076463|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076464|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20076465|NCT00673179|Antidotes|antidotes|mesh-ancestor
20076466|NCT00673179|Protective Agents|protective agents|mesh-ancestor
20076467|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
20076468|NCT00673179|Vitamins|vitamins|mesh-ancestor
20076469|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
20076470|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20076471|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
20076472|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20076473|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
20076474|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
20076475|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20076476|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
20583872|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
20583873|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
20583874|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583875|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20583876|NCT02114645|Leuprolide|leuprolide|mesh-list
20583877|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20583878|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20583879|NCT02114645|Estradiol|estradiol|mesh-list
20583880|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20583881|NCT02114645|Progesterone|progesterone|mesh-list
20583882|NCT02114645|Estrogens|estrogens|mesh-ancestor
20583883|NCT02114645|Hormones|hormones|mesh-ancestor
20583884|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583885|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583886|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20583887|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
20583888|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20583889|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20583890|NCT02114645|Progestins|progestins|mesh-ancestor
20076477|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20583891|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20583892|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
20583893|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20583894|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583895|NCT02114658|Sorafenib|sorafenib|mesh-list
20583896|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583897|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20583898|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583899|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583900|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
20583901|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20583902|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20583903|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20583904|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20583905|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583906|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583907|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583908|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20583909|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20583910|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20583911|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20583912|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20583913|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
20583914|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583915|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20076478|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20076479|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20076480|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583916|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20583917|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606149|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606150|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606151|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20606152|NCT02236052|Vaccines|vaccines|mesh-list
20606153|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
20606154|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606155|NCT02236065|Lenograstim|lenograstim|mesh-list
20606156|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20606157|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
20606158|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606159|NCT02236078|Isoniazid|isoniazid|mesh-list
20606160|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
20606161|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20606162|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606163|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20606164|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20606165|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
20606166|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076481|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076482|NCT00660348|Morphine|morphine|mesh-list
20076483|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20076484|NCT00660348|Narcotics|narcotics|mesh-ancestor
20076485|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076486|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076487|NCT00660348|Analgesics|analgesics|mesh-ancestor
20606167|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20606168|NCT02236169|Bromides|bromides|mesh-list
20606169|NCT02236169|Norflurane|norflurane|mesh-list
20606170|NCT02236169|Ipratropium|ipratropium|mesh-list
20606171|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
20076488|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
20076489|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076490|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
20076491|NCT00664066|Hematinics|hematinics|mesh-ancestor
20076492|NCT00667017|Immunotoxins|immunotoxins|mesh-list
20076493|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
20076494|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076495|NCT00665444|Aripiprazole|aripiprazole|mesh-list
20076496|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
20076497|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20076498|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20606172|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606173|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
20076499|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20606174|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076500|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583918|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
20583919|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583920|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
20583921|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20583922|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20583923|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20583924|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583925|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
20583926|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20583927|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583928|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20583929|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583930|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
20583931|NCT02114775|Hormones|hormones|mesh-list
20583932|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20583933|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583934|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
20583935|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20583936|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20583937|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583938|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583939|NCT02114775|Urological Agents|urological agents|mesh-ancestor
20583940|NCT02115035|Vemurafenib|vemurafenib|mesh-list
20076501|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076502|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
20076503|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
20076504|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076505|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076506|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20076507|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20076508|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
20076509|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20076510|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20076511|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20583941|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583942|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20583943|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583944|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583945|NCT02115087|Morphine|morphine|mesh-list
20583946|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20583947|NCT02115087|Narcotics|narcotics|mesh-ancestor
20583948|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20583949|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583950|NCT02115087|Analgesics|analgesics|mesh-ancestor
20583951|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
20583952|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20583953|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
20583954|NCT02115152|Fluorouracil|fluorouracil|mesh-list
20583955|NCT02115152|Capecitabine|capecitabine|mesh-list
20583956|NCT02115152|Epirubicin|epirubicin|mesh-list
20583957|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583958|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
20583959|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583960|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583961|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20583962|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
20076512|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20076513|NCT00656916|Fluticasone|fluticasone|mesh-list
20076514|NCT00656916|Xhance|xhance|mesh-list
20076515|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20583963|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583964|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583965|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20583966|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
20076516|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20076517|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
20076518|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076519|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076520|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20076521|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
20583967|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20583968|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20583969|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20583970|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20583971|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583972|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
20583973|NCT02115204|Docetaxel|docetaxel|mesh-list
20583974|NCT02115204|Fluorouracil|fluorouracil|mesh-list
20583975|NCT02115204|Methotrexate|methotrexate|mesh-list
20583976|NCT02115204|Epirubicin|epirubicin|mesh-list
20583977|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20583978|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
20076522|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
20076523|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20076524|NCT00660595|Risperidone|risperidone|mesh-list
20583979|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20583980|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20583981|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20583982|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
20583983|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20583984|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20583985|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20583986|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
20583987|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
20583988|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
20583989|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
20583990|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20583991|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20583992|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
20583993|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20583994|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
20583995|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20583996|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20583997|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20583998|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20583999|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20584000|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20584001|NCT02115243|Ipilimumab|ipilimumab|mesh-list
20584002|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20584003|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584004|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20584005|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584006|NCT02115360|Calcitonin|calcitonin|mesh-list
20584007|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
20076525|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20076526|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20076527|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
20076528|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076529|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076530|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076531|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20076532|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20076533|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076534|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20076535|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20076536|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
20076537|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
20076538|NCT00661466|Bupivacaine|bupivacaine|mesh-list
20076539|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
20076540|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
20076541|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076542|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584008|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20584009|NCT02115360|Fentanyl|fentanyl|mesh-list
20584010|NCT02115360|Katacalcin|katacalcin|mesh-list
20584011|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584012|NCT02115360|Narcotics|narcotics|mesh-ancestor
20584013|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584014|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584015|NCT02115360|Analgesics|analgesics|mesh-ancestor
20584016|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
20584017|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584018|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20076543|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
20584019|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20584020|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
20584021|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
20584022|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20584023|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20584024|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
20584025|NCT02115464|Metformin|metformin|mesh-list
20584026|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20584027|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584028|NCT02115490|Diphosphonates|diphosphonates|mesh-list
20584029|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20584030|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584031|NCT02115529|Nabilone|nabilone|mesh-list
20584032|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
20076544|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584033|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
20584034|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584035|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584036|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20584037|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584038|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584039|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584040|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584041|NCT02115594|Fulvestrant|fulvestrant|mesh-list
20584042|NCT02115594|Entinostat|entinostat|mesh-list
20584043|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20584044|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584045|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20584046|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20584047|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
20584048|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584049|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584050|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20584051|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584052|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584053|NCT02115659|Triptolide|triptolide|mesh-list
20584054|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20584055|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584056|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20584057|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
20584058|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20584059|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20584060|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
20584061|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20584062|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
20584063|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584064|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584065|NCT02115724|Vitamins|vitamins|mesh-list
20584066|NCT02115724|Vitamin E|vitamin e|mesh-list
20584067|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
20584068|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
20584069|NCT02115724|Antioxidants|antioxidants|mesh-list
20584070|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
20584071|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584072|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584073|NCT02115724|Protective Agents|protective agents|mesh-ancestor
20584074|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
20584075|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
20076545|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20076546|NCT00646282|Vitamins|vitamins|mesh-ancestor
20076547|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
20076548|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076549|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20076550|NCT00657553|Bortezomib|bortezomib|mesh-list
20076551|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584076|NCT02115763|Caffeine|caffeine|mesh-list
20584077|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20584078|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584079|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20584080|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584081|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584082|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20584083|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20306028|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584084|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
20076552|NCT00655057|Citalopram|citalopram|mesh-list
20076553|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20584085|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584086|NCT02115776|Amoxicillin|amoxicillin|mesh-list
20584087|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
20584088|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
20584089|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
20584090|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584091|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584092|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20584093|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
20584094|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20584095|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584096|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584097|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
20584098|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20584099|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584100|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492068|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492069|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492070|NCT03126084|Analgesics|analgesics|mesh-ancestor
19492071|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
19492072|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584101|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20584102|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20584103|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
20584104|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20584105|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
20584106|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20584107|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
20584108|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20584109|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
20584110|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584111|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584112|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
20584113|NCT02116231|Cisplatin|cisplatin|mesh-list
20584114|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584115|NCT02116257|Propacetamol|propacetamol|mesh-list
20584116|NCT02116257|Analgesics|analgesics|mesh-ancestor
20584117|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
20584118|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584119|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584120|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20584121|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20584122|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076554|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20076555|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076556|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076557|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076558|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
20076559|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076560|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20076561|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
20076562|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20076563|NCT00648895|Metoprolol|metoprolol|mesh-list
20584123|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20584124|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
20584125|NCT02116348|Mitogens|mitogens|mesh-list
20584126|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
20584127|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584128|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20584129|NCT02116348|Protective Agents|protective agents|mesh-ancestor
19492073|NCT03126084|Narcotics|narcotics|mesh-ancestor
20584130|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584131|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
20584132|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
20584133|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
20584134|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584135|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584136|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584137|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
20584138|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584139|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584140|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606175|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606176|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606177|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606178|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606179|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606180|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606181|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606182|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
20606183|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606184|NCT02236182|Bromides|bromides|mesh-list
20606185|NCT02236182|Ipratropium|ipratropium|mesh-list
20606186|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
20606187|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606188|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
20606189|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606190|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606191|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606192|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606193|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606194|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606195|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606196|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606197|NCT02236260|Lidocaine|lidocaine|mesh-list
20606198|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
20606199|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
20606200|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606201|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606202|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
20606203|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606204|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20606205|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20606206|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20606207|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606208|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606209|NCT02236403|Metronidazole|metronidazole|mesh-list
20606210|NCT02236403|Ivermectin|ivermectin|mesh-list
20076564|NCT00648895|Nebivolol|nebivolol|mesh-list
20076565|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20076566|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20606211|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606212|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20606213|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20606214|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20606215|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20606216|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076567|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
20076568|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
20076569|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076570|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076571|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20076572|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20076573|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20606217|NCT02236715|Ipratropium|ipratropium|mesh-list
20606218|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606219|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
19492074|NCT03126214|Warfarin|warfarin|mesh-list
20584141|NCT02116465|Levodopa|levodopa|mesh-list
20584142|NCT02116465|Carbidopa|carbidopa|mesh-list
20584143|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20584144|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20584145|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20584146|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
20584147|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584148|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584149|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584150|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20584151|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584152|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20584153|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
20584154|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
20584155|NCT02116556|Rifaximin|rifaximin|mesh-list
20584156|NCT02116556|Prednisone|prednisone|mesh-list
20584157|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20584158|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
20584159|NCT02116556|Hormones|hormones|mesh-ancestor
20584160|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584161|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584162|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20584163|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584164|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584165|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584166|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20584167|NCT02116569|Daratumumab|daratumumab|mesh-list
20584168|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584169|NCT02116712|Saracatinib|saracatinib|mesh-list
20584170|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584171|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584172|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584173|NCT02116790|Naproxen|naproxen|mesh-list
20076574|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
20076575|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076576|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076577|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
20076578|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20076579|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20076580|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20076581|NCT00647426|Carboplatin|carboplatin|mesh-list
20076582|NCT00647426|Docetaxel|docetaxel|mesh-list
20584174|NCT02116790|Levodopa|levodopa|mesh-list
20584175|NCT02116790|Carbidopa|carbidopa|mesh-list
20584176|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20584177|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20584178|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20584179|NCT02116790|Analgesics|analgesics|mesh-ancestor
20584180|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
20584181|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584182|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584183|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20584184|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20584185|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
20584186|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20584187|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584188|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584189|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20584190|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20584191|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
20584192|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584193|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19492075|NCT03126214|Anticoagulants|anticoagulants|mesh-list
19492076|NCT03125980|Capecitabine|capecitabine|mesh-list
19492077|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
19492078|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492079|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
20076583|NCT00647426|Sorafenib|sorafenib|mesh-list
20584194|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20584195|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
20584196|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
20584197|NCT02116842|Fentanyl|fentanyl|mesh-list
20584198|NCT02116842|Bupivacaine|bupivacaine|mesh-list
20584199|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
20584200|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
20584201|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584202|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584203|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
20584204|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584205|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584206|NCT02116842|Narcotics|narcotics|mesh-ancestor
20584207|NCT02116842|Analgesics|analgesics|mesh-ancestor
20584208|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20584209|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20584210|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
20584211|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
20584212|NCT02116868|Nicardipine|nicardipine|mesh-list
20584213|NCT02116868|Urapidil|urapidil|mesh-list
20584214|NCT02116868|Remifentanil|remifentanil|mesh-list
20584215|NCT02116868|Esmolol|esmolol|mesh-list
20584216|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584217|NCT02116868|Narcotics|narcotics|mesh-ancestor
20584218|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584219|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584220|NCT02116868|Analgesics|analgesics|mesh-ancestor
20584221|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
20584222|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584223|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20584224|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20584225|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20584226|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
20584227|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584228|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584229|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20584230|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20584231|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20584232|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
20584233|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20584234|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
20584235|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20584236|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20584237|NCT02116959|Carboplatin|carboplatin|mesh-list
20584238|NCT02116959|Etoposide|etoposide|mesh-list
20584239|NCT02116959|Vincristine|vincristine|mesh-list
20584240|NCT02116959|Melphalan|melphalan|mesh-list
20584241|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584242|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20584243|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20584244|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20584245|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584246|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584247|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
20584248|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
20584249|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
20584250|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20584251|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
20584252|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20584253|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20584254|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
20584255|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584256|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
20584257|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20584258|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20076584|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076585|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
20584259|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584260|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
20584261|NCT02117128|Coagulants|coagulants|mesh-ancestor
20584262|NCT02117141|Hydrocodone|hydrocodone|mesh-list
20584263|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584264|NCT02117141|Narcotics|narcotics|mesh-ancestor
20584265|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584266|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584267|NCT02117141|Analgesics|analgesics|mesh-ancestor
20584268|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
20584269|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584270|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
20584271|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
20584272|NCT02117167|Pemetrexed|pemetrexed|mesh-list
20584273|NCT02117167|Durvalumab|durvalumab|mesh-list
20584274|NCT02117167|Olaparib|olaparib|mesh-list
20584275|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584276|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584277|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584278|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20584279|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20584280|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20584281|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20584282|NCT02117219|Azacitidine|azacitidine|mesh-list
20584283|NCT02117219|Durvalumab|durvalumab|mesh-list
20584284|NCT02117219|Tremelimumab|tremelimumab|mesh-list
20584285|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20584286|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
20584287|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584288|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584289|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584290|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20584291|NCT02117362|Ipilimumab|ipilimumab|mesh-list
20584292|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20584293|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584294|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20584295|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584296|NCT02117401|Midazolam|midazolam|mesh-list
20584297|NCT02117401|Ketamine|ketamine|mesh-list
20584298|NCT02117401|Remifentanil|remifentanil|mesh-list
20584299|NCT02117401|Propofol|propofol|mesh-list
20584300|NCT02117401|Mivacurium|mivacurium|mesh-list
20584301|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20584302|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584303|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584304|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20584305|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
20584306|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
20584307|NCT02117401|Analgesics|analgesics|mesh-ancestor
20584308|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
20584309|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584310|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20584311|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20584312|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20584313|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584314|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584315|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20584316|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584317|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584318|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584319|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
20584320|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
20584321|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20076586|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
20076587|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
20076588|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076589|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20076590|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076591|NCT00637806|Megestrol|megestrol|mesh-list
20076592|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
20076593|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20584322|NCT02117401|Narcotics|narcotics|mesh-ancestor
20076594|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20076595|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20584323|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20584324|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20584325|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20584326|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20584327|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20584328|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20584329|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
20584330|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584331|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20584332|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20584333|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584334|NCT02117466|Cetuximab|cetuximab|mesh-list
20584335|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20584336|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584337|NCT02117583|Oxycodone|oxycodone|mesh-list
20584338|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584339|NCT02117583|Narcotics|narcotics|mesh-ancestor
20584340|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584341|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584342|NCT02117583|Analgesics|analgesics|mesh-ancestor
20584343|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
20584344|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584345|NCT02117596|Sirolimus|sirolimus|mesh-list
20584346|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584347|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584348|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20584349|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584350|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
20584351|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20584352|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
20584353|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584354|NCT02117622|Insulin|insulin|mesh-list
20584355|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20584356|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584357|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
20584358|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20584359|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
20584360|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584361|NCT02117700|Expectorants|expectorants|mesh-ancestor
20584362|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
20584363|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20584364|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
20584365|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584366|NCT02117700|Protective Agents|protective agents|mesh-ancestor
20584367|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584368|NCT02117700|Antidotes|antidotes|mesh-ancestor
20584369|NCT02117726|Midazolam|midazolam|mesh-list
20584370|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
20584371|NCT02117726|Propofol|propofol|mesh-list
20584372|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20584373|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584374|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584375|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20584376|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
20584377|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
20584378|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20584379|NCT02117726|Analgesics|analgesics|mesh-ancestor
20584380|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
20584381|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076596|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
20076597|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20076598|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076599|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20584382|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20584383|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20584384|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20584385|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
20584386|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584387|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584388|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20584389|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584390|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584391|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584392|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
20584393|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
20584394|NCT02117739|Dapsone|dapsone|mesh-list
20584395|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584396|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
20584397|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20076600|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20584398|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20584399|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20584400|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584401|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584402|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
20584403|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584404|NCT02117752|Dapsone|dapsone|mesh-list
20584405|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584406|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
20584407|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20584408|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20584409|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20584410|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584411|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584412|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
20584413|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584414|NCT02117765|Ustekinumab|ustekinumab|mesh-list
20584415|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
20584416|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
20584417|NCT02117830|Enclomiphene|enclomiphene|mesh-list
20584418|NCT02117830|Clomiphene|clomiphene|mesh-list
20584419|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
20584420|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584421|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584422|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20584423|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20584424|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584425|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584426|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584427|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20584428|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584429|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20584430|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
20584431|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584432|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20584433|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
20584434|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20584435|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20584436|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
20584437|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584438|NCT02117869|Furocoumarins|furocoumarins|mesh-list
20076601|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076602|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076603|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
20076604|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20076605|NCT00652457|Memantine|memantine|mesh-list
20584439|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
20584440|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20584441|NCT02117986|Colistin|colistin|mesh-list
20584442|NCT02117986|Polymyxins|polymyxins|mesh-list
20584443|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584444|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584445|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20584446|NCT02118051|Progesterone|progesterone|mesh-list
20584447|NCT02118051|Ganirelix|ganirelix|mesh-list
20584448|NCT02118051|Progestins|progestins|mesh-ancestor
20584449|NCT02118051|Hormones|hormones|mesh-ancestor
20584450|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584451|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584452|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
20584453|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20584454|NCT02118064|Irinotecan|irinotecan|mesh-list
20584455|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20584456|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20584457|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584458|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584459|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584460|NCT02118090|Chloroquine|chloroquine|mesh-list
20584461|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20584462|NCT02118090|Amebicides|amebicides|mesh-ancestor
20584463|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20076606|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20076607|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20076608|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
20076609|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076610|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076611|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076612|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20076613|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20076614|NCT00642603|Bevacizumab|bevacizumab|mesh-list
20076615|NCT00642603|Capecitabine|capecitabine|mesh-list
20584464|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20584465|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584466|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
20584467|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20584468|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20584469|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20584470|NCT02118090|Analgesics|analgesics|mesh-ancestor
20584471|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
20584472|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584473|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584474|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20584475|NCT02118090|Filaricides|filaricides|mesh-ancestor
20584476|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
20584477|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
20584478|NCT02118142|Betaine|betaine|mesh-list
20584479|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20584480|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
20584481|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20584482|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
20584483|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584484|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20606220|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606221|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606222|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606223|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606224|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606225|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606226|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606227|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606228|NCT02236728|Pramipexole|pramipexole|mesh-list
20606229|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
20606230|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606231|NCT02236728|Protective Agents|protective agents|mesh-ancestor
20606232|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606233|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20606234|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20606235|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
20606236|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
20076616|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
20606237|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606238|NCT02236741|Pramipexole|pramipexole|mesh-list
20584485|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
20584486|NCT02118285|Fludarabine|fludarabine|mesh-list
20584487|NCT02118285|Interleukin-2|interleukin-2|mesh-list
20584488|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20584489|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
20584490|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584491|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20584492|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20584493|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
20584494|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584495|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584496|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20584497|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20584498|NCT02118285|Analgesics|analgesics|mesh-ancestor
20584499|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
20584500|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584501|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
20584502|NCT02118311|Fludarabine|fludarabine|mesh-list
20584503|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20584504|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
20584505|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584506|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20584507|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20584508|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
20584509|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584510|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584511|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20584512|NCT02118376|Exenatide|exenatide|mesh-list
20584513|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20584514|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584515|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20584516|NCT02118376|Incretins|incretins|mesh-ancestor
20584517|NCT02118376|Hormones|hormones|mesh-ancestor
20584518|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584519|NCT02118467|Phenylephrine|phenylephrine|mesh-list
20584520|NCT02118467|Vasopressins|vasopressins|mesh-list
20584521|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
20584522|NCT02118467|Epinephrine|epinephrine|mesh-list
20584523|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
20584524|NCT02118467|Norepinephrine|norepinephrine|mesh-list
20584525|NCT02118467|Synephrine|synephrine|mesh-list
20584526|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20584527|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20584528|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
20584529|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584530|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584531|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584532|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20584533|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20584534|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
20584535|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584536|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20584537|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
20584538|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
20584539|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
20584540|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20584541|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20584542|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
20584543|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20584544|NCT02118467|Protective Agents|protective agents|mesh-ancestor
20584545|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
20584546|NCT02118467|Coagulants|coagulants|mesh-ancestor
20584547|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20584548|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
20584549|NCT02118532|Paclitaxel|paclitaxel|mesh-list
20584550|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20584551|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584552|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
20584553|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
20584554|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
20584555|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584556|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
20584557|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584558|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20584559|NCT02118675|Protective Agents|protective agents|mesh-ancestor
20584560|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584561|NCT02118688|Risperidone|risperidone|mesh-list
20584562|NCT02118688|Trazodone|trazodone|mesh-list
20584563|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20584564|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
20584565|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584566|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584567|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584568|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20584569|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584570|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746387|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746388|NCT03825302|Miotics|miotics|mesh-ancestor
19746389|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
19746390|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746391|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19746392|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19746393|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
19746394|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19746395|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19746396|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
19746397|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584571|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584572|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20584573|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
20584574|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584575|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20584576|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20584577|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20584578|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20584579|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
20584580|NCT02118727|Memantine|memantine|mesh-list
20584581|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20584582|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20584583|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
20584584|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584585|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584586|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584587|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20584588|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20584589|NCT02118753|Eplerenone|eplerenone|mesh-list
20584590|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20584591|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
20584592|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584593|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584594|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20584595|NCT02118753|Diuretics|diuretics|mesh-ancestor
20584596|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
20076617|NCT00642603|Irinotecan|irinotecan|mesh-list
20584597|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20584598|NCT02118844|Rocuronium|rocuronium|mesh-list
20584599|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20584600|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20584601|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20584602|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584603|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584604|NCT02118870|Aspirin|aspirin|mesh-list
20584605|NCT02118870|Clopidogrel|clopidogrel|mesh-list
20076618|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20306029|NCT00653510|Insulin|insulin|mesh-list
20584606|NCT02118870|Ticagrelor|ticagrelor|mesh-list
20584607|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20584608|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20584609|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20584610|NCT02118870|Analgesics|analgesics|mesh-ancestor
20584611|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
20584612|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584613|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584614|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20584615|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20584616|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20584617|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20584618|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584619|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20584620|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20584621|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584622|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
20584623|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20584624|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20584625|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20584626|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
20076619|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076620|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20076621|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20076622|NCT00642603|Growth Substances|growth substances|mesh-ancestor
20076623|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076624|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
20584627|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584628|NCT02118909|Itraconazole|itraconazole|mesh-list
20584629|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
20584630|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
20584631|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584632|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20584633|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20584634|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584635|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584636|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20584637|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
20584638|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584639|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584640|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20584641|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584642|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20584643|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20584644|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584645|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20584646|NCT02118987|Omalizumab|omalizumab|mesh-list
20584647|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20584648|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20584649|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
20584650|NCT02119000|Bisacodyl|bisacodyl|mesh-list
20584651|NCT02119000|Cathartics|cathartics|mesh-ancestor
20584652|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20584653|NCT02119000|Laxatives|laxatives|mesh-ancestor
20584654|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20584655|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20584656|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
20076625|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076626|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
20076627|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076628|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20306030|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20584657|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584658|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584659|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20584660|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20584661|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584662|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584663|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584664|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
20584665|NCT02119117|Vitamins|vitamins|mesh-ancestor
20584666|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
20306031|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20584667|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584668|NCT02119143|Vitamins|vitamins|mesh-list
20584669|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
20584670|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584671|NCT02119234|Beclomethasone|beclomethasone|mesh-list
20584672|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
20584673|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
20584674|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20584675|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
20584676|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584677|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584678|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20584679|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
20584680|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20584681|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20584682|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20584683|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
20584684|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584685|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584686|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20584687|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20584688|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20584689|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
20584690|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20584691|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
20584692|NCT02119234|Hormones|hormones|mesh-ancestor
20584693|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584694|NCT02119273|Prednisone|prednisone|mesh-list
20584695|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20584696|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
20584697|NCT02119273|Hormones|hormones|mesh-ancestor
20584698|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584699|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584700|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20584701|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584702|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20584703|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20584704|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
20584705|NCT02119416|Caffeine|caffeine|mesh-list
20584706|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20076629|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20076630|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076631|NCT00629798|Fludarabine|fludarabine|mesh-list
20076632|NCT00629798|Melphalan|melphalan|mesh-list
20076633|NCT00629798|Busulfan|busulfan|mesh-list
20076634|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20076635|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076636|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076637|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076638|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
20584707|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584708|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20584709|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584710|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584711|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20584712|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20584713|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
20584714|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584715|NCT02119520|Atorvastatin|atorvastatin|mesh-list
20584716|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20584717|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20584718|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
20584719|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584720|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20584721|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20584722|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584723|NCT02119806|Fentanyl|fentanyl|mesh-list
20584724|NCT02119806|Midazolam|midazolam|mesh-list
20584725|NCT02119806|Propofol|propofol|mesh-list
20584726|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20584727|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076639|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584728|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584729|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20584730|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
20584731|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
20584732|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584733|NCT02119806|Narcotics|narcotics|mesh-ancestor
20584734|NCT02119806|Analgesics|analgesics|mesh-ancestor
20584735|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
20584736|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584737|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20584738|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584739|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584740|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584741|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
20584742|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
20584743|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584744|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584745|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20584746|NCT02119884|Octreotide|octreotide|mesh-list
20076640|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20076641|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
20076642|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20076643|NCT00637728|Megestrol|megestrol|mesh-list
20076644|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
20076645|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20076646|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20584747|NCT02119884|Terlipressin|terlipressin|mesh-list
20584748|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19492080|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492081|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492082|NCT03126097|Drospirenone|drospirenone|mesh-list
19492083|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19492084|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19492085|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20584749|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20584750|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584751|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20584752|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20606239|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
20076647|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20076648|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
20076649|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20076650|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606240|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606241|NCT02236741|Protective Agents|protective agents|mesh-ancestor
20606242|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606243|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20606244|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20606245|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
20606246|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
20606247|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606248|NCT02236793|Becaplermin|becaplermin|mesh-list
20606249|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
20606250|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20606251|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20606252|NCT02236793|Growth Substances|growth substances|mesh-ancestor
20606253|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606254|NCT02236936|Cetuximab|cetuximab|mesh-list
20076651|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20076652|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20076653|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076654|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606255|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606256|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20606257|NCT02236962|Pioglitazone|pioglitazone|mesh-list
20606258|NCT02236962|Ephedrine|ephedrine|mesh-list
20606259|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20606260|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606261|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20606262|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
20606263|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
20606264|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076655|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
20606265|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20606266|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606267|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584753|NCT02120066|Plasminogen|plasminogen|mesh-list
20584754|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20584755|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20584756|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20584757|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584758|NCT02120092|Clopidogrel|clopidogrel|mesh-list
20584759|NCT02120092|Ticagrelor|ticagrelor|mesh-list
20584760|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20584761|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20584762|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20584763|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20584764|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
20584765|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584766|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584767|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584768|NCT02120118|Docetaxel|docetaxel|mesh-list
20584769|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584770|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
20584771|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
20584772|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
20584773|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584774|NCT02120196|Rifaximin|rifaximin|mesh-list
20584775|NCT02120196|Norfloxacin|norfloxacin|mesh-list
20584776|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584777|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584778|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20584779|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20584780|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20584781|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584782|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584783|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584784|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20584785|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20584786|NCT02120274|Vitamin D|vitamin d|mesh-list
20584787|NCT02120274|Vitamins|vitamins|mesh-list
20584788|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
20584789|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
20584790|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
20584791|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584792|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20584793|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
20584794|NCT02120274|Hematinics|hematinics|mesh-ancestor
20584795|NCT02120339|Carvedilol|carvedilol|mesh-list
20584796|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20584797|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20584798|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
20584799|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584800|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584801|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584802|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20584803|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
20584804|NCT02120339|Protective Agents|protective agents|mesh-ancestor
20584805|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20584806|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20584807|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20076656|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20076657|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
20076658|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20076659|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076660|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
20584808|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
20584809|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20584810|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20584811|NCT02120404|Esmolol|esmolol|mesh-list
20584812|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20584813|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20584814|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20584815|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
20584816|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584817|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584818|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584819|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
20076661|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20076662|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
20584820|NCT02120547|Liver Extracts|liver extracts|mesh-list
20584821|NCT02120547|Hematinics|hematinics|mesh-ancestor
20584822|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20584823|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584824|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20584825|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20584826|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
20584827|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584828|NCT02120599|Folic Acid|folic acid|mesh-list
20584829|NCT02120599|Hematinics|hematinics|mesh-ancestor
20584830|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
20584831|NCT02120599|Vitamins|vitamins|mesh-ancestor
20584832|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
20584833|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584834|NCT02120612|Naloxone|naloxone|mesh-list
20584835|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20584836|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584837|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
20584838|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584839|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
20584840|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
20076663|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076664|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
20076665|NCT00642382|Protective Agents|protective agents|mesh-ancestor
20076666|NCT00637416|Lansoprazole|lansoprazole|mesh-list
20584841|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20584842|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584843|NCT02120651|Hemostatics|hemostatics|mesh-list
20584844|NCT02120651|Coagulants|coagulants|mesh-ancestor
20584845|NCT02120677|Itraconazole|itraconazole|mesh-list
20584846|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
20584847|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584848|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20584849|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20584850|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584851|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584852|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20584853|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
20584854|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584855|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584856|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20584857|NCT02120703|Pregabalin|pregabalin|mesh-list
20584858|NCT02120703|Gabapentin|gabapentin|mesh-list
20584859|NCT02120703|Analgesics|analgesics|mesh-ancestor
20584860|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
20584861|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584862|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584863|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
20584864|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20584865|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20584866|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584867|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20584868|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584869|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584870|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584871|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584872|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20584873|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20584874|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584875|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
20584876|NCT02120859|Paclitaxel|paclitaxel|mesh-list
20584877|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20584878|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584879|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
20584880|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
20584881|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
20584882|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584883|NCT02120872|Simvastatin|simvastatin|mesh-list
20584884|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20584885|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20584886|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
20584887|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076667|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
20076668|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20584888|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20584889|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20584890|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584891|NCT02120911|Trastuzumab|trastuzumab|mesh-list
20584892|NCT02120911|Pertuzumab|pertuzumab|mesh-list
20584893|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20584894|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584895|NCT02121119|Lidocaine|lidocaine|mesh-list
20584896|NCT02121119|Bupivacaine|bupivacaine|mesh-list
20584897|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
20584898|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
20584899|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584900|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076669|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076670|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20076671|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20584901|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
20584902|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584903|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20584904|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20584905|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20584906|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20584907|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584908|NCT02121197|Dexamethasone|dexamethasone|mesh-list
20584909|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20584910|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
20584911|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
20584912|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584913|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584914|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20584915|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
20584916|NCT02121197|Hormones|hormones|mesh-ancestor
20584917|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20584918|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20584919|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584920|NCT02121288|Clopidogrel|clopidogrel|mesh-list
20584921|NCT02121288|Ticagrelor|ticagrelor|mesh-list
20584922|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20584923|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20584924|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20584925|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20584926|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
20584927|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584928|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584929|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584930|NCT02121353|Ranibizumab|ranibizumab|mesh-list
20076672|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076673|NCT00638222|Carvedilol|carvedilol|mesh-list
20076674|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20076675|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20076676|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
20076677|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076678|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076679|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076680|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20076681|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
20584931|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20584932|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20584933|NCT02121353|Growth Substances|growth substances|mesh-ancestor
20584934|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584935|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
20584936|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584937|NCT02121366|Ethanol|ethanol|mesh-list
20584938|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20584939|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584940|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584941|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584942|NCT02121444|Interferons|interferons|mesh-list
20584943|NCT02121444|Interferon-beta|interferon-beta|mesh-list
20584944|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
20584945|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20584946|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
20076682|NCT00638222|Protective Agents|protective agents|mesh-ancestor
20076683|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20584947|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20584948|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
20584949|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746398|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746399|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20076684|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20584950|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20584951|NCT02121457|Selenium|selenium|mesh-list
20584952|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
20584953|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584954|NCT02121457|Protective Agents|protective agents|mesh-ancestor
20584955|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584956|NCT02121457|Trace Elements|trace elements|mesh-ancestor
20584957|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
20584958|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
20584959|NCT02121613|Tamsulosin|tamsulosin|mesh-list
20584960|NCT02121613|Urological Agents|urological agents|mesh-ancestor
20584961|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20584962|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20584963|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20584964|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
20584965|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584966|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584967|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606268|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606269|NCT02237027|Tenofovir|tenofovir|mesh-list
20606270|NCT02237027|Emtricitabine|emtricitabine|mesh-list
20076685|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20076686|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
20076687|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20076688|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20076689|NCT00634322|Leucovorin|leucovorin|mesh-list
20076690|NCT00634322|Antidotes|antidotes|mesh-ancestor
20076691|NCT00634322|Protective Agents|protective agents|mesh-ancestor
20076692|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606271|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20606272|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
20606273|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606274|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20606275|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20606276|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606277|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606278|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20606279|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20606280|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20606281|NCT02237053|Octreotide|octreotide|mesh-list
20606282|NCT02237053|Glucagon|glucagon|mesh-list
20606283|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606284|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20606285|NCT02237053|Hormones|hormones|mesh-ancestor
20606286|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606287|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20606288|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606289|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
20606290|NCT02237079|Estrogens|estrogens|mesh-list
20606291|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20606292|NCT02237079|Hormones|hormones|mesh-ancestor
20606293|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606294|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606295|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20606296|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20606297|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
20606298|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20608025|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608026|NCT02244255|Urological Agents|urological agents|mesh-ancestor
20608027|NCT02244268|Tamsulosin|tamsulosin|mesh-list
20076693|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
20076694|NCT00634322|Vitamins|vitamins|mesh-ancestor
20076695|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
20076696|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
20076697|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
20076698|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076699|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
20076700|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076701|NCT00631137|Testosterone|testosterone|mesh-list
20076702|NCT00631137|Androgens|androgens|mesh-ancestor
20076703|NCT00631137|Hormones|hormones|mesh-ancestor
20076704|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076705|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076706|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20076707|NCT00634972|Ketorolac|ketorolac|mesh-list
20076708|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20076709|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20076710|NCT00634972|Analgesics|analgesics|mesh-ancestor
20584968|NCT02121782|Vaccines|vaccines|mesh-list
20584969|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
20584970|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584971|NCT02121951|Lidocaine|lidocaine|mesh-list
20584972|NCT02121951|Fentanyl|fentanyl|mesh-list
20584973|NCT02121951|Midazolam|midazolam|mesh-list
20584974|NCT02121951|Anesthetics|anesthetics|mesh-list
20584975|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
20584976|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
20584977|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20584978|NCT02121951|Narcotics|narcotics|mesh-ancestor
20584979|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20584980|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20584981|NCT02121951|Analgesics|analgesics|mesh-ancestor
20584982|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
20584983|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20584984|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20584985|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20584986|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
20584987|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20584988|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20584989|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20584990|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20584991|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
20584992|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
20584993|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20584994|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20584995|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20584996|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20584997|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20584998|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20584999|NCT02121990|Paclitaxel|paclitaxel|mesh-list
20585000|NCT02121990|Bevacizumab|bevacizumab|mesh-list
20585001|NCT02121990|Olaparib|olaparib|mesh-list
20585002|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20585003|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585004|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
20585005|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
20585006|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
20585007|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585008|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20076711|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
19746400|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
19746401|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
19746402|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19746403|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19746404|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19746405|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
19746406|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19746407|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076712|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076713|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076714|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076715|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585009|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20585010|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20585011|NCT02121990|Growth Substances|growth substances|mesh-ancestor
20076716|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20076717|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076718|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076719|NCT00633061|Enoxaparin|enoxaparin|mesh-list
20076720|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
20076721|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20076722|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20076723|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076724|NCT00626444|Ascorbic Acid|ascorbic acid|mesh-list
20076725|NCT00626444|Vitamins|vitamins|mesh-ancestor
20076726|NCT00626444|Micronutrients|micronutrients|mesh-ancestor
20076727|NCT00626444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076728|NCT00626444|Antioxidants|antioxidants|mesh-ancestor
20076729|NCT00626444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076730|NCT00626444|Protective Agents|protective agents|mesh-ancestor
20076731|NCT00634010|Morphine|morphine|mesh-list
20076732|NCT00634010|Methadone|methadone|mesh-list
20076733|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20076734|NCT00634010|Narcotics|narcotics|mesh-ancestor
20076735|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076736|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076737|NCT00634010|Analgesics|analgesics|mesh-ancestor
20076738|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
20076739|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076740|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
20076741|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
20076742|NCT00623974|Teriparatide|teriparatide|mesh-list
20076743|NCT00623974|Calcitriol|calcitriol|mesh-list
20076744|NCT00623974|Calcium|calcium|mesh-list
20076745|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
20076746|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20076747|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076748|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20076749|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20585012|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585013|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20585014|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20585015|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585016|NCT02122003|Sorafenib|sorafenib|mesh-list
20585017|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585018|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20585019|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585020|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585021|NCT02122055|Fentanyl|fentanyl|mesh-list
20585022|NCT02122055|Midazolam|midazolam|mesh-list
20585023|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
20585024|NCT02122055|Propofol|propofol|mesh-list
20585025|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20585026|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585027|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585028|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20585029|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
20585030|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
20585031|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20585032|NCT02122055|Analgesics|analgesics|mesh-ancestor
20585033|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
20585034|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585035|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20585036|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20585037|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20585038|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20585039|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585040|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585041|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20585042|NCT02122055|Narcotics|narcotics|mesh-ancestor
20076750|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306032|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585043|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20585044|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20585045|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20585046|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20585047|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
20585048|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
20585049|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
20585050|NCT02122081|Methotrexate|methotrexate|mesh-list
20585051|NCT02122081|Tacrolimus|tacrolimus|mesh-list
20585052|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
20585053|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20585054|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
20585055|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585056|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
20585057|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585058|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585059|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20585060|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
20585061|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585062|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585063|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20585064|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20585065|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
20585066|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20585067|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076751|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076752|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20076753|NCT00623974|Vitamins|vitamins|mesh-ancestor
20076754|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
20076755|NCT00624650|Phenylephrine|phenylephrine|mesh-list
20585068|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
20585069|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
20585070|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585071|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20585072|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20585073|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20076756|NCT00624650|Dobutamine|dobutamine|mesh-list
20076757|NCT00624650|Furosemide|furosemide|mesh-list
20076758|NCT00624650|Vasopressins|vasopressins|mesh-list
20585074|NCT02122172|Afatinib|afatinib|mesh-list
20585075|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585076|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20585077|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585078|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585079|NCT02122211|Betaine|betaine|mesh-list
20585080|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20585081|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
20585082|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20585083|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
20585084|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585085|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20585086|NCT02122393|Sertraline|sertraline|mesh-list
20585087|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
20585088|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20585089|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20585090|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20585091|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20585092|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585093|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585094|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
20585095|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585096|NCT02122484|Colchicine|colchicine|mesh-list
20585097|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
20585098|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585099|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
20585100|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
20585101|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
20585102|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585103|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585104|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
20585105|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20585106|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585107|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585108|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20076759|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
20076760|NCT00624650|Epinephrine|epinephrine|mesh-list
20585109|NCT02122510|Analgesics|analgesics|mesh-ancestor
20585110|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
20585111|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585112|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20585113|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20585114|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19746408|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19746409|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19746410|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19746411|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746412|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746413|NCT03675139|Progestins|progestins|mesh-ancestor
20076761|NCT00624650|Racepinephrine|racepinephrine|mesh-list
20076762|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
20076763|NCT00624650|Norepinephrine|norepinephrine|mesh-list
20076764|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20076765|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
20076766|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20076767|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20076768|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19746414|NCT03675139|Hormones|hormones|mesh-ancestor
19746415|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746416|NCT03537599|Daratumumab|daratumumab|mesh-list
19746417|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746418|NCT03537508|Vaccines|vaccines|mesh-list
19746419|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
19746420|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746421|NCT03464097|Ozanimod|ozanimod|mesh-list
20585115|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
20585116|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585117|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585118|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20585119|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20585120|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20585121|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20585122|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585123|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585124|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20585125|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20585126|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585127|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
20585128|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585129|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
20585130|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20585131|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
20585132|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585133|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
20076769|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076770|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585134|NCT02122601|Protective Agents|protective agents|mesh-ancestor
20585135|NCT02122627|Vitamin D|vitamin d|mesh-list
20585136|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
20585137|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
20585138|NCT02122627|Vitamins|vitamins|mesh-list
20076771|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746422|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20076772|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20076773|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20076774|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
20076775|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076776|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20076777|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
20076778|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
20076779|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
20076780|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20076781|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
20076782|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20076783|NCT00624650|Protective Agents|protective agents|mesh-ancestor
20076784|NCT00624650|Diuretics|diuretics|mesh-ancestor
20076785|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
20076786|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20585139|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
20585140|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585141|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20585142|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20585143|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
20585144|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20585145|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20585146|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585147|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
20585148|NCT02122679|Coagulants|coagulants|mesh-ancestor
20585149|NCT02122692|Itraconazole|itraconazole|mesh-list
20585150|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20585151|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
20585152|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585153|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20585154|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20585155|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585156|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585157|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20585158|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
20585159|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585160|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585161|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20585162|NCT02122705|Remifentanil|remifentanil|mesh-list
20585163|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20585164|NCT02122705|Narcotics|narcotics|mesh-ancestor
20585165|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585166|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585167|NCT02122705|Analgesics|analgesics|mesh-ancestor
20585168|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
20585169|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585170|NCT02122731|Amiloride|amiloride|mesh-list
20585171|NCT02122731|Diuretics|diuretics|mesh-ancestor
20585172|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
20585173|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585174|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20585175|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20585176|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20585177|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585178|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20585179|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20585180|NCT02122809|Chiauranib|chiauranib|mesh-list
20585181|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585182|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20585183|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585184|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585185|NCT02122939|Citalopram|citalopram|mesh-list
20585186|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20585187|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20585188|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20585189|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585190|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585191|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
20585192|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585193|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20585194|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
20585195|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20585196|NCT02123004|Clopidogrel|clopidogrel|mesh-list
20585197|NCT02123004|Ticagrelor|ticagrelor|mesh-list
20585198|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20585199|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20585200|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20585201|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20585202|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
20585203|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606299|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
20076787|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076788|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
20076789|NCT00624650|Coagulants|coagulants|mesh-ancestor
20076790|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20076791|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19746423|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076792|NCT00626561|Paclitaxel|paclitaxel|mesh-list
20585204|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585205|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585206|NCT02123056|Metoprolol|metoprolol|mesh-list
20585207|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20585208|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20585209|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
20585210|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
20585211|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585212|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585213|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20585214|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20585215|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20585216|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
20585217|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585218|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585219|NCT02123069|Nitroprusside|nitroprusside|mesh-list
20585220|NCT02123069|Phenylephrine|phenylephrine|mesh-list
20585221|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
20585222|NCT02123069|Norepinephrine|norepinephrine|mesh-list
20585223|NCT02123069|Acetylcholine|acetylcholine|mesh-list
20585224|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20585225|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
20585226|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
20585227|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585228|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585229|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
20585230|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20585231|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
20585232|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
20585233|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20585234|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20076793|NCT00626561|Bevacizumab|bevacizumab|mesh-list
20076794|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20076795|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076796|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
20076797|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
20076798|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
20076799|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076800|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20076801|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20076802|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20076803|NCT00626561|Growth Substances|growth substances|mesh-ancestor
20076804|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076805|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
20076806|NCT00613730|Gemcitabine|gemcitabine|mesh-list
20585235|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20585236|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
20585237|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585238|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585239|NCT02123069|Protective Agents|protective agents|mesh-ancestor
20585240|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20585241|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
20585242|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20585243|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20585244|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
20076807|NCT00613730|Panitumumab|panitumumab|mesh-list
20076808|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076809|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
20076810|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076811|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076812|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
20076813|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076814|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076815|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076816|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
20076817|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585245|NCT02123108|Basiliximab|basiliximab|mesh-list
20585246|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585247|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
20585248|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585249|NCT02123121|Resveratrol|resveratrol|mesh-list
20585250|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
20585251|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076818|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20585252|NCT02123121|Protective Agents|protective agents|mesh-ancestor
20585253|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585254|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585255|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20585256|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
20585257|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20585258|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585259|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
20585260|NCT02123355|Remifentanil|remifentanil|mesh-list
20585261|NCT02123355|Sevoflurane|sevoflurane|mesh-list
20585262|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
20585263|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
20585264|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585265|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585266|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20585267|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20585268|NCT02123355|Analgesics|analgesics|mesh-ancestor
20585269|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
20585270|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585271|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20585272|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20585273|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20585274|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
20585275|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585276|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585277|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20585278|NCT02123355|Narcotics|narcotics|mesh-ancestor
20585279|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20585280|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20585281|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
20585282|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20585283|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20585284|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20585285|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20585286|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20585287|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
20585288|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
20585289|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20585290|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
20585291|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585292|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
20585293|NCT02123368|Protective Agents|protective agents|mesh-ancestor
20585294|NCT02123381|Cetuximab|cetuximab|mesh-list
20585295|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20585296|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585297|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20585298|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
20585299|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585300|NCT02123498|Omeprazole|omeprazole|mesh-list
20585301|NCT02123498|Pantoprazole|pantoprazole|mesh-list
20585302|NCT02123498|Ranitidine|ranitidine|mesh-list
20585303|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20585304|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20585305|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20585306|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20585307|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585308|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585309|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20585310|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
20076819|NCT00625586|Gemcitabine|gemcitabine|mesh-list
20076820|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076821|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
20306033|NCT00653549|Torsemide|torsemide|mesh-list
20585311|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
20585312|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585313|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585314|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
20585315|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20585316|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
20585317|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20585318|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
20585319|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585320|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585321|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
20606300|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
20606301|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20606302|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606303|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606304|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20606305|NCT02237209|Vaccines|vaccines|mesh-list
20606306|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
20606307|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076822|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076823|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076824|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
20076825|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076826|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076827|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20606308|NCT02237261|Prednisone|prednisone|mesh-list
20606309|NCT02237261|Bortezomib|bortezomib|mesh-list
20606310|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20606311|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606312|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
20606313|NCT02237261|Hormones|hormones|mesh-ancestor
20606314|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606315|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606316|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20606317|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606318|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20606319|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
20606320|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606321|NCT02237326|Acetic Acid|acetic acid|mesh-list
20606322|NCT02237326|Retinol acetate|retinol acetate|mesh-list
20606323|NCT02237326|Lugol's solution|lugol's solution|mesh-list
20606324|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20606325|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606326|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20606327|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
20606328|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606329|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20606330|NCT02237326|Protective Agents|protective agents|mesh-ancestor
20606331|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606332|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
20606333|NCT02237326|Coagulants|coagulants|mesh-ancestor
20606334|NCT02237339|Allopurinol|allopurinol|mesh-list
20606335|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
20606336|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606337|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606338|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
20606339|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20606340|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20606341|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
20606342|NCT02237339|Protective Agents|protective agents|mesh-ancestor
20606343|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606344|NCT02237365|Aspirin|aspirin|mesh-list
20606345|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20606346|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20606347|NCT02237365|Analgesics|analgesics|mesh-ancestor
20606348|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
20606349|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606350|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606351|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606352|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20606353|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20606354|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20606355|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076828|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
20606356|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20076829|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076830|NCT00625703|Linezolid|linezolid|mesh-list
20076831|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20076832|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20076833|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20076834|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076835|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076836|NCT00625742|Ibuprofen|ibuprofen|mesh-list
20076837|NCT00625742|Atenolol|atenolol|mesh-list
20076838|NCT00625742|Melatonin|melatonin|mesh-list
20585322|NCT02123563|Listerine|listerine|mesh-list
20585323|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20585324|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585325|NCT02123589|Fentanyl|fentanyl|mesh-list
20585326|NCT02123589|Midazolam|midazolam|mesh-list
20585327|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20585328|NCT02123589|Narcotics|narcotics|mesh-ancestor
20585329|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585330|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585331|NCT02123589|Analgesics|analgesics|mesh-ancestor
20585332|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
20585333|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585334|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20585335|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20585336|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
20585337|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
20585338|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20585339|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20585340|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20585341|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20585342|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
20585343|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
20585344|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585345|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585346|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
20585347|NCT02123615|Antibodies|antibodies|mesh-list
20076839|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20076840|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20076841|NCT00625742|Analgesics|analgesics|mesh-ancestor
20076842|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
20076843|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076844|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076845|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076846|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076847|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20585348|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
20585349|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20585350|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20585351|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
20585352|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
20585353|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076848|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076849|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076850|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
20076851|NCT00625742|Protective Agents|protective agents|mesh-ancestor
20076852|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585354|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20585355|NCT02123628|Doxycycline|doxycycline|mesh-list
20585356|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
20585357|NCT02123628|Levofloxacin|levofloxacin|mesh-list
20585358|NCT02123628|Rifampin|rifampin|mesh-list
20076853|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20076854|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20076855|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
20076856|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
20076857|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20076858|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20076859|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20076860|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
20076861|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076862|NCT00619242|Sorafenib|sorafenib|mesh-list
20585359|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
20076863|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076864|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20076865|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585360|NCT02123628|Linezolid|linezolid|mesh-list
20585361|NCT02123628|Cefepime|cefepime|mesh-list
20585362|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20076866|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585363|NCT02123628|Cefotaxime|cefotaxime|mesh-list
20585364|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
20585365|NCT02123628|Trimethoprim|trimethoprim|mesh-list
20585366|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
20585367|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585368|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20585369|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
20076867|NCT00616577|Ropivacaine|ropivacaine|mesh-list
20076868|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
20076869|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
20076870|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076871|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585370|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
20585371|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20585372|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20585373|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20585374|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20585375|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585376|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585377|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585378|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20585379|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20585380|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20585381|NCT02123628|Renal Agents|renal agents|mesh-ancestor
20585382|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
20585383|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20585384|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20585385|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20585386|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20585387|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20585388|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20585389|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20585390|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20585391|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20585392|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20585393|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20585394|NCT02123654|Asunaprevir|asunaprevir|mesh-list
20585395|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
20585396|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585397|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585398|NCT02123979|Rotigotine|rotigotine|mesh-list
20585399|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
20585400|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
20585401|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585402|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585403|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585404|NCT02124005|Bupivacaine|bupivacaine|mesh-list
20585405|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
20585406|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
20585407|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585408|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585409|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
20585410|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585411|NCT02124070|Hormones|hormones|mesh-list
20585412|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585413|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585414|NCT02124148|Leucovorin|leucovorin|mesh-list
20585415|NCT02124148|Fluorouracil|fluorouracil|mesh-list
20585416|NCT02124148|Pemetrexed|pemetrexed|mesh-list
20585417|NCT02124148|Cetuximab|cetuximab|mesh-list
20585418|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076872|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
20076873|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076874|NCT00616759|Propofol|propofol|mesh-list
20076875|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20076876|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076877|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585419|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
20585420|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076878|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20585421|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20585422|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585423|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
20585424|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585425|NCT02124148|Antidotes|antidotes|mesh-ancestor
20585426|NCT02124148|Protective Agents|protective agents|mesh-ancestor
20585427|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
20585428|NCT02124148|Vitamins|vitamins|mesh-ancestor
20585429|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
20585430|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585431|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20585432|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20585433|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20076879|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
20585434|NCT02124174|Azacitidine|azacitidine|mesh-list
20585435|NCT02124174|Valproic Acid|valproic acid|mesh-list
20585436|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20585437|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
20585438|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585439|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585440|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585441|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
20585442|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
20585443|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585444|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585445|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
20585446|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20585447|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585448|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20585449|NCT02124200|Nicotine|nicotine|mesh-list
20585450|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20585451|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
20585452|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585453|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585454|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20585455|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20585456|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
20585457|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076880|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
20076881|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
20076882|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20076883|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076884|NCT00616343|Zonisamide|zonisamide|mesh-list
20076885|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
20076886|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20076887|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076888|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076889|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20076890|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076891|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
20076892|NCT00612677|Pemetrexed|pemetrexed|mesh-list
20076893|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076894|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076895|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076896|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20076897|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20076898|NCT00616603|Dexamethasone|dexamethasone|mesh-list
20076899|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
20076900|NCT00616603|Ropivacaine|ropivacaine|mesh-list
20076901|NCT00616603|BB 1101|bb 1101|mesh-list
20076902|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076903|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
20076904|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
20076905|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076906|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076907|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076908|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
20076909|NCT00616603|Hormones|hormones|mesh-ancestor
20076910|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076911|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076912|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076913|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
20076914|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076915|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076916|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
20076917|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
20585458|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585459|NCT02124226|Methotrexate|methotrexate|mesh-list
20585460|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20585461|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
20585462|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20585463|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585464|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20585465|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
20585466|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585467|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585468|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
20585469|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585470|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20585471|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585472|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
20585473|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585474|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20585475|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
20585476|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
20585477|NCT02124317|Paclitaxel|paclitaxel|mesh-list
20585478|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20585479|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20585480|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585481|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
20585482|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
20585483|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
20585484|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585485|NCT02124330|Bentonite|bentonite|mesh-list
20585486|NCT02124330|Antidotes|antidotes|mesh-ancestor
20585487|NCT02124330|Protective Agents|protective agents|mesh-ancestor
20585488|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585489|NCT02124369|Gemcitabine|gemcitabine|mesh-list
20585490|NCT02124369|Paclitaxel|paclitaxel|mesh-list
20585491|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20585492|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20585493|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585494|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
20585495|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
20585496|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
20585497|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585498|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20585499|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
20585500|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
20585501|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585502|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585503|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585504|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
20585505|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585506|NCT02124421|Paclitaxel|paclitaxel|mesh-list
20585507|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20585508|NCT02124421|Carboplatin|carboplatin|mesh-list
20585509|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20585510|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585511|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
20585512|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
20585513|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
20585514|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585515|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
20076918|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585516|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20585517|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
20585518|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585519|NCT02124525|Expectorants|expectorants|mesh-ancestor
20585520|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
20585521|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20585522|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
20585523|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585524|NCT02124525|Protective Agents|protective agents|mesh-ancestor
20585525|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585526|NCT02124525|Antidotes|antidotes|mesh-ancestor
20585527|NCT02124642|Folic Acid|folic acid|mesh-list
20585528|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
20585529|NCT02124642|Hematinics|hematinics|mesh-ancestor
20585530|NCT02124642|Vitamins|vitamins|mesh-ancestor
20585531|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
20585532|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585533|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
20585534|NCT02124655|Listerine|listerine|mesh-list
20076919|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
20585535|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20585536|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585537|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
20585538|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
20076920|NCT00610532|Probenecid|probenecid|mesh-list
20076921|NCT00610532|Phenytoin|phenytoin|mesh-list
20076922|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
20076923|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20076924|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20076925|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20076926|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076927|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20076928|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20585539|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
20585540|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20585541|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20585542|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585543|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585544|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585545|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585546|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20585547|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20585548|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
20585549|NCT02124850|Nivolumab|nivolumab|mesh-list
20585550|NCT02124850|Cetuximab|cetuximab|mesh-list
20585551|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20585552|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585553|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20585554|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585555|NCT02124954|Digoxin|digoxin|mesh-list
20585556|NCT02124954|Midazolam|midazolam|mesh-list
20585557|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20585558|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20585559|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585560|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585561|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20585562|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20585563|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20585564|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20585565|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
20585566|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
20585567|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
20585568|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
20585569|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585570|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585571|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20585572|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20585573|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585574|NCT02124954|Protective Agents|protective agents|mesh-ancestor
20585575|NCT02125084|Everolimus|everolimus|mesh-list
20585576|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585577|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585578|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
20585579|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585580|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20585581|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
20585582|NCT02125188|Coagulants|coagulants|mesh-ancestor
20585583|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20585584|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
20585585|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585586|NCT02125201|Fentanyl|fentanyl|mesh-list
20585587|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20585588|NCT02125201|Narcotics|narcotics|mesh-ancestor
20585589|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585590|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585591|NCT02125201|Analgesics|analgesics|mesh-ancestor
20585592|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
20585593|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585594|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20585595|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20585596|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
20585597|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
20585598|NCT02125227|Metformin|metformin|mesh-list
20585599|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20585600|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20585601|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585602|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20585603|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20585604|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
20585605|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585606|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20585607|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20585608|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585609|NCT02125305|Metformin|metformin|mesh-list
20585610|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20585611|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585612|NCT02125318|Anagrelide|anagrelide|mesh-list
20585613|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20585614|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20585615|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585616|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20606357|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20606358|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606359|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
20606360|NCT02237443|Bromides|bromides|mesh-list
20606361|NCT02237443|Rocuronium|rocuronium|mesh-list
20606362|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
20606363|NCT02237443|Succinylcholine|succinylcholine|mesh-list
20606364|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
20606365|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20606366|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20606367|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20606368|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606369|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076929|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
20076930|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
20076931|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20076932|NCT00610532|Renal Agents|renal agents|mesh-ancestor
20606370|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20606371|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20606372|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606373|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606374|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606375|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606376|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
20606377|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20076933|NCT00609765|Dexamethasone|dexamethasone|mesh-list
20076934|NCT00609765|Bevacizumab|bevacizumab|mesh-list
20606378|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606379|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606380|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20606381|NCT02237495|Analgesics|analgesics|mesh-ancestor
20606382|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
20606383|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606384|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20606385|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20606386|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20606387|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606388|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606389|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606390|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
20606391|NCT02237534|Calcium|calcium|mesh-list
20606392|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606393|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606394|NCT02237534|Antacids|antacids|mesh-ancestor
20606395|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606396|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20606397|NCT02237560|Camphor|camphor|mesh-list
20606398|NCT02237560|Salicylates|salicylates|mesh-list
20606399|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
20606400|NCT02237560|Menthol|menthol|mesh-list
20606401|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20606402|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606403|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
20606404|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
20076935|NCT00609765|Doxorubicin|doxorubicin|mesh-list
20076936|NCT00609765|Fluorouracil|fluorouracil|mesh-list
20606405|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20606406|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20585617|NCT02125344|Paclitaxel|paclitaxel|mesh-list
20585618|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
20585619|NCT02125344|Carboplatin|carboplatin|mesh-list
20585620|NCT02125344|Doxorubicin|doxorubicin|mesh-list
20585621|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20585622|NCT02125344|Trastuzumab|trastuzumab|mesh-list
20585623|NCT02125344|Epirubicin|epirubicin|mesh-list
20585624|NCT02125344|Pertuzumab|pertuzumab|mesh-list
20585625|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20585626|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585627|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
20585628|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
20585629|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
20585630|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585631|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585632|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
20585633|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585634|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585635|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20585636|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
20585637|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20585638|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20585639|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20585640|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20585641|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585642|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20585643|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
20585644|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585645|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20585646|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585647|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585648|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
20585649|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585650|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585651|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20585652|NCT02125409|Aspirin|aspirin|mesh-list
20585653|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20585654|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20585655|NCT02125409|Analgesics|analgesics|mesh-ancestor
20585656|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
20585657|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585658|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585659|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20585660|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585661|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20585662|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20585663|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585664|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20585665|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20585666|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585667|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
20585668|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
20585669|NCT02125500|Ledipasvir|ledipasvir|mesh-list
20585670|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
20585671|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585672|NCT02125513|Paclitaxel|paclitaxel|mesh-list
20585673|NCT02125513|Carboplatin|carboplatin|mesh-list
20585674|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20585675|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585676|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
20585677|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
20585678|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
20585679|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585680|NCT02125565|Lidocaine|lidocaine|mesh-list
20585681|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
20585682|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
20585683|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585684|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585685|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
20585686|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585687|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20585688|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20585689|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20585690|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606407|NCT02237560|Analgesics|analgesics|mesh-ancestor
20585691|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585692|NCT02125578|Interferons|interferons|mesh-list
20585693|NCT02125578|Interferon-beta|interferon-beta|mesh-list
20585694|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
20585695|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585696|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
20585697|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585698|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
20585699|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585700|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20585701|NCT02125617|Prednisolone|prednisolone|mesh-list
20585702|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20585703|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
20585704|NCT02125617|Hormones|hormones|mesh-ancestor
20585705|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585706|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585707|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20585708|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585709|NCT02125630|Hormones|hormones|mesh-list
20585710|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585711|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585712|NCT02125643|Caffeine|caffeine|mesh-list
20585713|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20585714|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585715|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20585716|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585717|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585718|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20585719|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20585720|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
20585721|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585722|NCT02125682|Atorvastatin|atorvastatin|mesh-list
20585723|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20585724|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20076937|NCT00609765|Streptozocin|streptozocin|mesh-list
20076938|NCT00609765|Ondansetron|ondansetron|mesh-list
20076939|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20585725|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
20585726|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585727|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20585728|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20585729|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585730|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20585731|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20585732|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585733|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
20076940|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20076941|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20076942|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20076943|NCT00609765|Growth Substances|growth substances|mesh-ancestor
20076944|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076945|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
20076946|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076947|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
20076948|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
20076949|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20076950|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20076951|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
20076952|NCT00609765|Hormones|hormones|mesh-ancestor
20076953|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076954|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20076955|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20076956|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20076957|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20076958|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076959|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076960|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
20076961|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20076962|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20076963|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
20076964|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
20306034|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20585734|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20585735|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585736|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20076965|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
20076966|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20076967|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
20076968|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20076969|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20076970|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20076971|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20076972|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20076973|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20076974|NCT00608465|Ramipril|ramipril|mesh-list
20076975|NCT00608465|Eplerenone|eplerenone|mesh-list
20076976|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20076977|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
20076978|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20076979|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20076980|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20076981|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20076982|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
20076983|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076984|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076985|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20076986|NCT00608465|Diuretics|diuretics|mesh-ancestor
20076987|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
20076988|NCT00608777|Betamethasone|betamethasone|mesh-list
20076989|NCT00608777|Calcipotriene|calcipotriene|mesh-list
20076990|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20076991|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
20076992|NCT00608777|Hormones|hormones|mesh-ancestor
20076993|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20076994|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20076995|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20076996|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
20076997|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
20076998|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20076999|NCT00601848|Trioxsalen|trioxsalen|mesh-list
20077000|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077001|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077002|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20077003|NCT00607477|Minoxidil|minoxidil|mesh-list
20077004|NCT00607477|Hydralazine|hydralazine|mesh-list
20077005|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20077006|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
20077007|NCT00595920|Vaccines|vaccines|mesh-list
20077008|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
20077009|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077010|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
20077011|NCT00596947|Prednisone|prednisone|mesh-list
20077012|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
20077013|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20077014|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20585737|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20585738|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585739|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077015|NCT00596947|Prednisolone|prednisolone|mesh-list
20077016|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
20077017|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20585740|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492086|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20585741|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
20585742|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20585743|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20585744|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585745|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
20585746|NCT02125890|Coagulants|coagulants|mesh-ancestor
20585747|NCT02125903|Ropivacaine|ropivacaine|mesh-list
20585748|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
20585749|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
20585750|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585751|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585752|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
20585753|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585754|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
20585755|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20585756|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20585757|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
20585758|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585759|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585760|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585761|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
20585762|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
20585763|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585764|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
20585765|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20585766|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
20585767|NCT02126020|Infliximab|infliximab|mesh-list
20585768|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
20585769|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20585770|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585771|NCT02126137|Ezetimibe|ezetimibe|mesh-list
20585772|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20585773|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20585774|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
20585775|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585776|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20585777|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
20585778|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20585779|NCT02126267|Azithromycin|azithromycin|mesh-list
20585780|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20585781|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585782|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
20585783|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
20585784|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20585785|NCT02126293|Zinc|zinc|mesh-list
20585786|NCT02126293|Trace Elements|trace elements|mesh-ancestor
20585787|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
20585788|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585789|NCT02126332|Acetaminophen|acetaminophen|mesh-list
20585790|NCT02126332|Sufentanil|sufentanil|mesh-list
20585791|NCT02126332|Nefopam|nefopam|mesh-list
20585792|NCT02126332|Tramadol|tramadol|mesh-list
20585793|NCT02126332|Ropivacaine|ropivacaine|mesh-list
20585794|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
20585795|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
20585796|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20077018|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
20077019|NCT00596947|Tacrolimus|tacrolimus|mesh-list
20077020|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
20077021|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20077022|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077023|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
20077024|NCT00596947|Hormones|hormones|mesh-ancestor
20585797|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585798|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
20585799|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077025|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077026|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585800|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20585801|NCT02126332|Analgesics|analgesics|mesh-ancestor
20585802|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
20585803|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20585804|NCT02126332|Narcotics|narcotics|mesh-ancestor
20585805|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20585806|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20077027|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20585807|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
20585808|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20585809|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20585810|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20585811|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
20585812|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585813|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20585814|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20585815|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585816|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20077028|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077029|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077030|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
20077031|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20077032|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077033|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077034|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20077035|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20077036|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
20077037|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077038|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077039|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
20077040|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
20077041|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077042|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077043|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20077044|NCT00596947|Protective Agents|protective agents|mesh-ancestor
20119923|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20119924|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20119925|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119926|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119927|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
20119928|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119929|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585817|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
20585818|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585819|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20585820|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20585821|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
20585822|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585823|NCT02126462|Antacids|antacids|mesh-ancestor
20585824|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585825|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20585826|NCT02126527|Sirolimus|sirolimus|mesh-list
20585827|NCT02126527|Auranofin|auranofin|mesh-list
20585828|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20585829|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585830|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20585831|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585832|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
20585833|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585834|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
20585835|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585836|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585837|NCT02126579|Poly ICLC|poly iclc|mesh-list
20585838|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
20585839|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
20585840|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585841|NCT02126644|Glycolic acid|glycolic acid|mesh-list
20585842|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
20585843|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
20585844|NCT02126657|Glycolic acid|glycolic acid|mesh-list
20585845|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
20585846|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
20585847|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
20585848|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
20585849|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20119930|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
20119931|NCT00006250|Analgesics|analgesics|mesh-ancestor
20119932|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
20119933|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20119934|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20119935|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119936|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20119937|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
20119938|NCT00006251|Cyclosporine|cyclosporine|mesh-list
20119939|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
20585850|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20585851|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585852|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585853|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077045|NCT00584012|Docetaxel|docetaxel|mesh-list
20077046|NCT00584012|Lovastatin|lovastatin|mesh-list
20077047|NCT00584012|L 647318|l 647318|mesh-list
20077048|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
20077049|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077050|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077051|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
20077052|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
20077053|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077054|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20077055|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20077056|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
20077057|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20077058|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20077059|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585854|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20585855|NCT02126761|Vaccines|vaccines|mesh-list
20585856|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
20585857|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606408|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
20606409|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606410|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606411|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606412|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20606413|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20606414|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606415|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606416|NCT02237651|Anesthetics|anesthetics|mesh-list
20606417|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606418|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606419|NCT02237690|Doxorubicin|doxorubicin|mesh-list
20606420|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20606421|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20606422|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606423|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20606424|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20606425|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606426|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606427|NCT02237729|Adalimumab|adalimumab|mesh-list
20606428|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606429|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20606430|NCT02237755|Citric Acid|citric acid|mesh-list
20606431|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
20606432|NCT02237755|Clomiphene|clomiphene|mesh-list
20077060|NCT00599131|Docetaxel|docetaxel|mesh-list
20077061|NCT00599131|Fluorouracil|fluorouracil|mesh-list
20077062|NCT00599131|Cetuximab|cetuximab|mesh-list
20077063|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077064|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077065|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
20077066|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
20077067|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077068|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
20606433|NCT02237755|Enclomiphene|enclomiphene|mesh-list
20606434|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
20606435|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
20606436|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20077069|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077070|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077071|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
20077072|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077073|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077074|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
20077075|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
20077076|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077077|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
20077078|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077079|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077080|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
20077081|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077082|NCT00589550|Interferons|interferons|mesh-list
20077083|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
20077084|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
20077085|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20077086|NCT00589550|Sorafenib|sorafenib|mesh-list
20606437|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
20077087|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077088|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
20077089|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077090|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077091|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077092|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585858|NCT02126917|Ethanol|ethanol|mesh-list
20585859|NCT02126917|Hydrocodone|hydrocodone|mesh-list
20585860|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20585861|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585862|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585863|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585864|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20585865|NCT02126917|Narcotics|narcotics|mesh-ancestor
20585866|NCT02126917|Analgesics|analgesics|mesh-ancestor
20585867|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
20585868|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20585869|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
20585870|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
20585871|NCT02126943|Macitentan|macitentan|mesh-list
20585872|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20585873|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20585874|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585875|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20585876|NCT02126956|Ponesimod|ponesimod|mesh-list
20585877|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20585878|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585879|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585880|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
20585881|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585882|NCT02126995|Metadoxine|metadoxine|mesh-list
20585883|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20585884|NCT02127034|Digoxin|digoxin|mesh-list
20585885|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
20585886|NCT02127034|Mirabegron|mirabegron|mesh-list
20585887|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20585888|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20585889|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585890|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585891|NCT02127034|Protective Agents|protective agents|mesh-ancestor
20585892|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585893|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20585894|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20585895|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
20585896|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20585897|NCT02127034|Urological Agents|urological agents|mesh-ancestor
20585898|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20585899|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20585900|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20585901|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
20585902|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20585903|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20585904|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585905|NCT02127047|Incretins|incretins|mesh-ancestor
20585906|NCT02127047|Hormones|hormones|mesh-ancestor
20585907|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585908|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20585909|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
20585910|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585911|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585912|NCT02127060|Ascorbic Acid|ascorbic acid|mesh-list
20585913|NCT02127060|Vitamins|vitamins|mesh-ancestor
20585914|NCT02127060|Micronutrients|micronutrients|mesh-ancestor
20585915|NCT02127060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585916|NCT02127060|Antioxidants|antioxidants|mesh-ancestor
20585917|NCT02127060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585918|NCT02127060|Protective Agents|protective agents|mesh-ancestor
20585919|NCT02127073|Oxytocin|oxytocin|mesh-list
20585920|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
20585921|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20585922|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585923|NCT02127138|Sirolimus|sirolimus|mesh-list
20585924|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20585925|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585926|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20077093|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
20585927|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585928|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
20585929|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20585930|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
20585931|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585932|NCT02127151|Talazoparib|talazoparib|mesh-list
20585933|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20585934|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585935|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585936|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585937|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20585938|NCT02127164|Eusol|eusol|mesh-list
20585939|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
20585940|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585941|NCT02127190|CXA-10|cxa-10|mesh-list
20585942|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20585943|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20585944|NCT02127320|Ezetimibe|ezetimibe|mesh-list
20077094|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077095|NCT00577772|Rifaximin|rifaximin|mesh-list
20077096|NCT00577772|Lactulose|lactulose|mesh-list
20077097|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077098|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077099|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077100|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20077101|NCT00592007|Fulvestrant|fulvestrant|mesh-list
20077102|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077103|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077104|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077105|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077106|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20077107|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20077108|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20077109|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
20077110|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077111|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077112|NCT00595582|Curcumin|curcumin|mesh-list
20077113|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20077114|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20077115|NCT00595582|Analgesics|analgesics|mesh-ancestor
20077116|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
20077117|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077118|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077119|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077120|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077121|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077122|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077123|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077124|NCT00588146|Interferons|interferons|mesh-list
20077125|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
20077126|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
20077127|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20077128|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077129|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
20585945|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20585946|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20585947|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
20585948|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585949|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20585950|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20585951|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20585952|NCT02127437|Lanreotide|lanreotide|mesh-list
20585953|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585954|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20585955|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20585956|NCT02127489|Bupivacaine|bupivacaine|mesh-list
20585957|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
20585958|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
20585959|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20585960|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585961|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
20585962|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077130|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585963|NCT02127541|Exenatide|exenatide|mesh-list
20585964|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20585965|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077131|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
20077132|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585966|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20585967|NCT02127541|Incretins|incretins|mesh-ancestor
20585968|NCT02127541|Hormones|hormones|mesh-ancestor
20585969|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585970|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
20585971|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20585972|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20585973|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20585974|NCT02127593|Norgestimate|norgestimate|mesh-list
20585975|NCT02127593|Norgestrel|norgestrel|mesh-list
20585976|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20585977|NCT02127593|Estradiol|estradiol|mesh-list
20585978|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20585979|NCT02127593|Estrogens|estrogens|mesh-ancestor
20585980|NCT02127593|Hormones|hormones|mesh-ancestor
20585981|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20585982|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585983|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20585984|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
20585985|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20585986|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20585987|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20585988|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20585989|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20585990|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20585991|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20585992|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20585993|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20585994|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077133|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20077134|NCT00590538|Genistein|genistein|mesh-list
20077135|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077136|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20077137|NCT00590538|Protective Agents|protective agents|mesh-ancestor
20077138|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20585995|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20585996|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20585997|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20585998|NCT02127684|Ranibizumab|ranibizumab|mesh-list
20585999|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20586000|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20586001|NCT02127684|Growth Substances|growth substances|mesh-ancestor
20586002|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586003|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
20586004|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586005|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
20586006|NCT02127697|Albuterol|albuterol|mesh-list
20586007|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20586008|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
20586009|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586010|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586011|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20586012|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
20586013|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
20586014|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20586015|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20586016|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20586017|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20586018|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
20586019|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20077139|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20586020|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586021|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20586022|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20586023|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20586024|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
20586025|NCT02127736|Amitriptyline|amitriptyline|mesh-list
20586026|NCT02127736|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20586027|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20586028|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
20586029|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20586030|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586031|NCT02127736|Analgesics|analgesics|mesh-ancestor
20586032|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
20586033|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586034|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586035|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20586036|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20586037|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20586038|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586039|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
20586040|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586041|NCT02127736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20586042|NCT02127736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20586043|NCT02127736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586044|NCT02127749|Metronidazole|metronidazole|mesh-list
20586045|NCT02127749|Vancomycin|vancomycin|mesh-list
20586046|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
20586047|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586048|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20586049|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20586050|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20586051|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20586052|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586053|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586054|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586055|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586056|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20586057|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20586058|NCT02127775|Lesinurad|lesinurad|mesh-list
20586059|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
20586060|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586061|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
20586062|NCT02127775|Renal Agents|renal agents|mesh-ancestor
20077140|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077141|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077142|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
20077143|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20586063|NCT02127788|Micafungin|micafungin|mesh-list
20586064|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
20586065|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586066|NCT02127840|Epinephrine|epinephrine|mesh-list
20586067|NCT02127840|Racepinephrine|racepinephrine|mesh-list
20586068|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
20586069|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20586070|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20586071|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
20586072|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586073|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586074|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586075|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20586076|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20586077|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
20586078|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586079|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20586080|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
20586081|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
20586082|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
20586083|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20586084|NCT02127853|Gabapentin|gabapentin|mesh-list
20586085|NCT02127853|Analgesics|analgesics|mesh-ancestor
20077144|NCT00590538|Estrogens|estrogens|mesh-ancestor
20077145|NCT00590538|Hormones|hormones|mesh-ancestor
20119940|NCT00006251|Fludarabine|fludarabine|mesh-list
20586086|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
20586087|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586088|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586089|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
20586090|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20586091|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20586092|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586093|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20586094|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20586095|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20586096|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586097|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586098|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
20586099|NCT02127866|Beclomethasone|beclomethasone|mesh-list
20586100|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
20586101|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
20586102|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20586103|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
20586104|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586105|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586106|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20586107|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
20586108|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20586109|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20586110|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20586111|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
20586112|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586113|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586114|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20306035|NCT00653549|Diuretics|diuretics|mesh-ancestor
20306036|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
20586115|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20586116|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20586117|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
20586118|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20586119|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
20586120|NCT02127866|Hormones|hormones|mesh-ancestor
20586121|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077146|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077147|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
20077148|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077149|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077150|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077151|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077152|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
20077153|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
20077154|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20077155|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077156|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077157|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
20077158|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20077159|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20077160|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077161|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
20077162|NCT00586716|Antibodies|antibodies|mesh-list
20077163|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
20077164|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20077165|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20077166|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
20077167|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077168|NCT00588471|Simvastatin|simvastatin|mesh-list
20077169|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20077170|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20077171|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
20077172|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077173|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20077174|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20077175|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077176|NCT00590135|Atorvastatin|atorvastatin|mesh-list
20077177|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20077178|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20077179|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
20077180|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077181|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20077182|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20077183|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077184|NCT00582036|Insulin|insulin|mesh-list
20586122|NCT02127918|Clobazam|clobazam|mesh-list
20586123|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
20586124|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20586125|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20586126|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586127|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586128|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20586129|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20586130|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
20586131|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
20586132|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586133|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586134|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20586135|NCT02127996|Incretins|incretins|mesh-ancestor
20586136|NCT02127996|Hormones|hormones|mesh-ancestor
20586137|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586138|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077185|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20077186|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20077187|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077188|NCT00585585|Betahistine|betahistine|mesh-list
20077189|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
20077190|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
20077191|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
20077192|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20077193|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586139|NCT02128022|Glyburide|glyburide|mesh-list
20586140|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20586141|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586142|NCT02128061|Rituximab|rituximab|mesh-list
20586143|NCT02128061|Lenalidomide|lenalidomide|mesh-list
20586144|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20586145|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586146|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
20586147|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586148|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586149|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20586150|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20586151|NCT02128061|Growth Substances|growth substances|mesh-ancestor
20586152|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
20586153|NCT02128100|Leucovorin|leucovorin|mesh-list
20586154|NCT02128100|Fluorouracil|fluorouracil|mesh-list
20586155|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
20586156|NCT02128100|Irinotecan|irinotecan|mesh-list
20586157|NCT02128100|Folfirinox|folfirinox|mesh-list
20586158|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
20586159|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586160|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586161|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586162|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586163|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
20586164|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586165|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20586166|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586167|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586168|NCT02128100|Antidotes|antidotes|mesh-ancestor
20586169|NCT02128100|Protective Agents|protective agents|mesh-ancestor
20586170|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
20586171|NCT02128100|Vitamins|vitamins|mesh-ancestor
20586172|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
20586173|NCT02128126|Vaccines|vaccines|mesh-list
20586174|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
20586175|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586176|NCT02128178|Enoxaparin|enoxaparin|mesh-list
20586177|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
20586178|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
20586179|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20586180|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20586181|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586182|NCT02128191|Ibuprofen|ibuprofen|mesh-list
20586183|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20077194|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077195|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20586184|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586185|NCT02128191|Analgesics|analgesics|mesh-ancestor
20586186|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
20586187|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586188|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586189|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20586190|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586191|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20586192|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586193|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586194|NCT02128204|Lidocaine|lidocaine|mesh-list
20077196|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
20077197|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077198|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077199|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077200|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077201|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
20077202|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077203|NCT00579254|Amlodipine|amlodipine|mesh-list
20077204|NCT00579254|Atorvastatin|atorvastatin|mesh-list
20077205|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20077206|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20077207|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
20077208|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077209|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20077210|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20077211|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077212|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20077213|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20077214|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20077215|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20077216|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077217|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
20077218|NCT00585611|Atorvastatin|atorvastatin|mesh-list
20077219|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20077220|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20077221|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
20077222|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077223|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20077224|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20077225|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077226|NCT00572260|Daptomycin|daptomycin|mesh-list
20077227|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077228|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077229|NCT00571194|Pravastatin|pravastatin|mesh-list
20077230|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20077231|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20077232|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
20077233|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077234|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20077235|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20077236|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077237|NCT00584935|Rituximab|rituximab|mesh-list
20077238|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077239|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077240|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
20077241|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077242|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077243|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
20077244|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20077245|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20077246|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077247|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20077248|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077249|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20077250|NCT00573391|Thalidomide|thalidomide|mesh-list
20077251|NCT00573391|Dexamethasone|dexamethasone|mesh-list
20077252|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
20077253|NCT00573391|Melphalan|melphalan|mesh-list
20077254|NCT00573391|Bortezomib|bortezomib|mesh-list
20077255|NCT00573391|BB 1101|bb 1101|mesh-list
20586195|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
20586196|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
20586197|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586198|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586199|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
20586200|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586201|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20586202|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20586203|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20077256|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077257|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
20077258|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
20077259|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077260|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077261|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077262|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
20077263|NCT00573391|Hormones|hormones|mesh-ancestor
20586204|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20586205|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586206|NCT02128243|Leucovorin|leucovorin|mesh-list
20586207|NCT02128243|Cisplatin|cisplatin|mesh-list
20586208|NCT02128243|Docetaxel|docetaxel|mesh-list
20586209|NCT02128243|Fluorouracil|fluorouracil|mesh-list
20586210|NCT02128243|Capecitabine|capecitabine|mesh-list
20586211|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
20586212|NCT02128243|Epirubicin|epirubicin|mesh-list
20586213|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
20586214|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586215|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077264|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077265|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20077266|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077267|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
20077268|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077269|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077270|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20077271|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
20077272|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20077273|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077274|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
20077275|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
20077276|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077277|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077278|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20077279|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20077280|NCT00573391|Growth Substances|growth substances|mesh-ancestor
20077281|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
20077282|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20077283|NCT00570258|Fulvestrant|fulvestrant|mesh-list
20077284|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077285|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077286|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077287|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077288|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20077289|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20077290|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20077291|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
20586216|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
20586217|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
20586218|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586219|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
20586220|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586221|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586222|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
20586223|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586224|NCT02128243|Antidotes|antidotes|mesh-ancestor
20586225|NCT02128243|Protective Agents|protective agents|mesh-ancestor
20586226|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
20586227|NCT02128243|Vitamins|vitamins|mesh-ancestor
20586228|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
20586229|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20586230|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20586231|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586232|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746424|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746425|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
19746426|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746427|NCT03440385|Ozanimod|ozanimod|mesh-list
19746428|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19746429|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746430|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586233|NCT02128282|Gemcitabine|gemcitabine|mesh-list
20586234|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586235|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586236|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
20586237|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586238|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
20586239|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586240|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586241|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586242|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
20586243|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586244|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
20586245|NCT02128308|Levofloxacin|levofloxacin|mesh-list
20586246|NCT02128308|Ofloxacin|ofloxacin|mesh-list
20586247|NCT02128308|Cycloserine|cycloserine|mesh-list
20586248|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
20586249|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20586250|NCT02128308|Streptomycin|streptomycin|mesh-list
20586251|NCT02128308|Kanamycin|kanamycin|mesh-list
20586252|NCT02128308|Prothionamide|prothionamide|mesh-list
20586253|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20586254|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20586255|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586256|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20586257|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586258|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586259|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586260|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586261|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20586262|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
20586263|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20586264|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586265|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20586266|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20586267|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20586268|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20586269|NCT02128308|Renal Agents|renal agents|mesh-ancestor
20586270|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20586271|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20586272|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20586273|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
20586274|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
20586275|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20586276|NCT02128321|Repaglinide|repaglinide|mesh-list
20586277|NCT02128321|Isavuconazole|isavuconazole|mesh-list
20586278|NCT02128321|Caffeine|caffeine|mesh-list
20586279|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20586280|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586281|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20586282|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586283|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586284|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20586285|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20586286|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
20586287|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586288|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20586289|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
20586290|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586291|NCT02128334|Leuprolide|leuprolide|mesh-list
20586292|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20586293|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
20586294|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20586295|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586296|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20586297|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586298|NCT02128360|Letrozole|letrozole|mesh-list
20586299|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586300|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20586301|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20586302|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586303|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586304|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20586305|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
20586306|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586307|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606438|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
20606439|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606440|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20606441|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20606442|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606443|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606444|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20606445|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
20606446|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606447|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20606448|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20606449|NCT02237768|Dirithromycin|dirithromycin|mesh-list
20606450|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20606451|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606452|NCT02237807|Dirithromycin|dirithromycin|mesh-list
20606453|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20606454|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077292|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077293|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077294|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
20077295|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077296|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
20077297|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077298|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077299|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20077300|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
20077301|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077302|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
20077303|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077304|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077305|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20077306|NCT00574080|Cytarabine|cytarabine|mesh-list
20077307|NCT00574080|Thalidomide|thalidomide|mesh-list
20077308|NCT00574080|Dexamethasone|dexamethasone|mesh-list
20077309|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
20077310|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
20077311|NCT00574080|Melphalan|melphalan|mesh-list
20077312|NCT00574080|Carmustine|carmustine|mesh-list
20077313|NCT00574080|Cisplatin|cisplatin|mesh-list
20077314|NCT00574080|Etoposide|etoposide|mesh-list
20077315|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
20077316|NCT00574080|Doxorubicin|doxorubicin|mesh-list
20077317|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20077318|NCT00574080|Bortezomib|bortezomib|mesh-list
20077319|NCT00574080|BB 1101|bb 1101|mesh-list
20077320|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077321|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
20077322|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077323|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077324|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20077325|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
20077326|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077327|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077328|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20077329|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077330|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
20077331|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
20077332|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077333|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077334|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
20606455|NCT02237820|Dexamethasone|dexamethasone|mesh-list
20586308|NCT02128425|Leucovorin|leucovorin|mesh-list
20586309|NCT02128425|Fluorouracil|fluorouracil|mesh-list
20586310|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
20586311|NCT02128425|Irinotecan|irinotecan|mesh-list
20586312|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
20586313|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
20586314|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586315|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586316|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586317|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586318|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
20586319|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586320|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20586321|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586322|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586323|NCT02128425|Antidotes|antidotes|mesh-ancestor
20586324|NCT02128425|Protective Agents|protective agents|mesh-ancestor
20586325|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
20586326|NCT02128425|Vitamins|vitamins|mesh-ancestor
20586327|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
20077335|NCT00574080|Hormones|hormones|mesh-ancestor
20077336|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077337|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20077338|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
20077339|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077340|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20077341|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20077342|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586328|NCT02128451|Fentanyl|fentanyl|mesh-list
20586329|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20586330|NCT02128451|Narcotics|narcotics|mesh-ancestor
20586331|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586332|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586333|NCT02128451|Analgesics|analgesics|mesh-ancestor
20586334|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
20586335|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586336|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20586337|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20586338|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
20586339|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
20586340|NCT02128633|Listerine|listerine|mesh-list
20586341|NCT02128633|Fluorides|fluorides|mesh-list
20586342|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
20586343|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
20586344|NCT02128633|Protective Agents|protective agents|mesh-ancestor
20586345|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586346|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20586347|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586348|NCT02128646|Ketorolac|ketorolac|mesh-list
20586349|NCT02128646|Bupivacaine|bupivacaine|mesh-list
20586350|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
20586351|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
20586352|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586353|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586354|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
20586355|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586356|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20586357|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586358|NCT02128646|Analgesics|analgesics|mesh-ancestor
20586359|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20586360|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586361|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20586362|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077343|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077344|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
20077345|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
20077346|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077347|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20077348|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
20077349|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20586363|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586364|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
20586365|NCT02128685|Progestins|progestins|mesh-ancestor
20586366|NCT02128685|Hormones|hormones|mesh-ancestor
20586367|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586368|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586369|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
20586370|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20586371|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
20586372|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20586373|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
20586374|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586375|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586376|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
20586377|NCT02128893|Isavuconazole|isavuconazole|mesh-list
20586378|NCT02128893|Esomeprazole|esomeprazole|mesh-list
20586379|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20586380|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20586381|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20586382|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586383|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586384|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
20586385|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586386|NCT02128906|Docetaxel|docetaxel|mesh-list
20586387|NCT02128906|Cetuximab|cetuximab|mesh-list
20077350|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20077351|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20077352|NCT00574080|Growth Substances|growth substances|mesh-ancestor
20077353|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
20077354|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
20077355|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077356|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
20077357|NCT00558558|Hormones|hormones|mesh-ancestor
20077358|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077359|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077360|NCT00577356|Docetaxel|docetaxel|mesh-list
20077361|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077362|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077363|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
20077364|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
20077365|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077366|NCT00573937|Morphine|morphine|mesh-list
20077367|NCT00573937|Methadone|methadone|mesh-list
20077368|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20077369|NCT00573937|Narcotics|narcotics|mesh-ancestor
20077370|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20077371|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077372|NCT00573937|Analgesics|analgesics|mesh-ancestor
20077373|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
20077374|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077375|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
20077376|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
20077377|NCT00571922|Acamprosate|acamprosate|mesh-list
20077378|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20077379|NCT00569868|Bortezomib|bortezomib|mesh-list
20077380|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077381|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
20077382|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20077383|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077384|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20077385|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
20077386|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077387|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077388|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077389|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077390|NCT00570531|Paclitaxel|paclitaxel|mesh-list
20077391|NCT00570531|Bevacizumab|bevacizumab|mesh-list
20077392|NCT00570531|Fluorouracil|fluorouracil|mesh-list
20077393|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20077394|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077395|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077396|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
20077397|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
20077398|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077399|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077400|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20077401|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20077402|NCT00570531|Growth Substances|growth substances|mesh-ancestor
20077403|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077404|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
20077405|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
20077406|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586388|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586389|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
20586390|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
20586391|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
20586392|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586393|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077407|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077408|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
20077409|NCT00561912|Interferons|interferons|mesh-list
20077410|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
20077411|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
20077412|NCT00561912|Decitabine|decitabine|mesh-list
20077413|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077414|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
20077415|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077416|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
20077417|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077418|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077419|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
20586394|NCT02128945|Fludarabine|fludarabine|mesh-list
20586395|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586396|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
20586397|NCT02128971|Trace Elements|trace elements|mesh-ancestor
20586398|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
20586399|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586400|NCT02128984|Antioxidants|antioxidants|mesh-list
20586401|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586402|NCT02128984|Protective Agents|protective agents|mesh-ancestor
20586403|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077420|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077421|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077422|NCT00561795|Paclitaxel|paclitaxel|mesh-list
20077423|NCT00561795|Carboplatin|carboplatin|mesh-list
20077424|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20077425|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077426|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077427|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
20077428|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
20077429|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077430|NCT00564876|Dasatinib|dasatinib|mesh-list
20077431|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077432|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077433|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077434|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077435|NCT00558870|Morphine|morphine|mesh-list
20077436|NCT00558870|Methadone|methadone|mesh-list
20077437|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20077438|NCT00558870|Narcotics|narcotics|mesh-ancestor
20077439|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20077440|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077441|NCT00558870|Analgesics|analgesics|mesh-ancestor
20077442|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
20077443|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077444|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
20077445|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
20077446|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
20077447|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
20077448|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20077449|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077450|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077451|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20077452|NCT00521924|Cyclosporine|cyclosporine|mesh-list
20077453|NCT00521924|Chloroquine|chloroquine|mesh-list
20077454|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
20077455|NCT00521924|Methotrexate|methotrexate|mesh-list
20586404|NCT02129088|Esketamine|esketamine|mesh-list
20077456|NCT00521924|Infliximab|infliximab|mesh-list
20077457|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
20586405|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
20077458|NCT00521924|Cyclosporins|cyclosporins|mesh-list
20077459|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20077460|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
20077461|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077462|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077463|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077464|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
20077465|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077466|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077467|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077468|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077469|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20077470|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077471|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
20077472|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20077473|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
20077474|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077475|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20077476|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077477|NCT00521924|Amebicides|amebicides|mesh-ancestor
20077478|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20077479|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20077480|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
20077481|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20077482|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20077483|NCT00521924|Analgesics|analgesics|mesh-ancestor
20077484|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
20077485|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077486|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077487|NCT00548886|Epinephrine|epinephrine|mesh-list
20077488|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20077489|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20077490|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20077491|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586406|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20586407|NCT02129101|Azacitidine|azacitidine|mesh-list
20586408|NCT02129101|Decitabine|decitabine|mesh-list
20586409|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586410|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
20586411|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586412|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586413|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077492|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077493|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077494|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20077495|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20077496|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
20077497|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077498|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20077499|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
20077500|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
20077501|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
20077502|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20077503|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
20077504|NCT00539838|Prednisone|prednisone|mesh-list
20077505|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
20077506|NCT00539838|Methotrexate|methotrexate|mesh-list
20077507|NCT00539838|Azathioprine|azathioprine|mesh-list
20077508|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20077509|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
20077510|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077511|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
20077512|NCT00539838|Hormones|hormones|mesh-ancestor
20077513|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077514|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586414|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20586415|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20586416|NCT02129114|Estradiol|estradiol|mesh-list
20586417|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20586418|NCT02129114|Estrogens|estrogens|mesh-ancestor
20586419|NCT02129114|Hormones|hormones|mesh-ancestor
20586420|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586421|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077515|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20586422|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20586423|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
20586424|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20586425|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20586426|NCT02129127|Paclitaxel|paclitaxel|mesh-list
20586427|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20586428|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586429|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
20586430|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
20586431|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
20586432|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586433|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
20586434|NCT02129166|Dasatinib|dasatinib|mesh-list
20586435|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586436|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20586437|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586438|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586439|NCT02129179|Glucagon|glucagon|mesh-list
20586440|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20586441|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20586442|NCT02129179|Hormones|hormones|mesh-ancestor
20586443|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586444|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586445|NCT02129179|Incretins|incretins|mesh-ancestor
20586446|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
20586447|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20586448|NCT02129231|Simvastatin|simvastatin|mesh-list
20586449|NCT02129231|Ezetimibe|ezetimibe|mesh-list
20586450|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20586451|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20586452|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20586453|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
20586454|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586455|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20586456|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20586457|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586458|NCT02129231|Antacids|antacids|mesh-ancestor
20586459|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20586460|NCT02129257|Leucovorin|leucovorin|mesh-list
20586461|NCT02129257|Folic Acid|folic acid|mesh-list
20586462|NCT02129257|Fluorouracil|fluorouracil|mesh-list
20586463|NCT02129257|Irinotecan|irinotecan|mesh-list
20586464|NCT02129257|Aflibercept|aflibercept|mesh-list
20586465|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
20586466|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
20586467|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586468|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586469|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586470|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586471|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
20077516|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077517|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20077518|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
20077519|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077520|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586472|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586473|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20586474|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586475|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586476|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20586477|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20586478|NCT02129257|Growth Substances|growth substances|mesh-ancestor
20586479|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
20586480|NCT02129257|Antidotes|antidotes|mesh-ancestor
20586481|NCT02129257|Protective Agents|protective agents|mesh-ancestor
20586482|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
20586483|NCT02129257|Vitamins|vitamins|mesh-ancestor
20586484|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
20077521|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
20077522|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077523|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077524|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077525|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20586485|NCT02129257|Hematinics|hematinics|mesh-ancestor
20586486|NCT02129270|Lidocaine|lidocaine|mesh-list
20586487|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
20586488|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
20586489|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586490|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586491|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
20586492|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586493|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20586494|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20586495|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20586496|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20586497|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586498|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
20586499|NCT02129322|Sorafenib|sorafenib|mesh-list
20586500|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586501|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20586502|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586503|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586504|NCT02129400|Anesthetics|anesthetics|mesh-list
20586505|NCT02129400|Xenon|xenon|mesh-list
20586506|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20077526|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
20586507|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586508|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20586509|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
20586510|NCT02129582|Methotrexate|methotrexate|mesh-list
20586511|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
20586512|NCT02129582|Fludarabine|fludarabine|mesh-list
20586513|NCT02129582|Busulfan|busulfan|mesh-list
20586514|NCT02129582|Tacrolimus|tacrolimus|mesh-list
20586515|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
20586516|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20586517|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
20586518|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20586519|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
20586520|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077527|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077528|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20077529|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20077530|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20077531|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
20077532|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077533|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077534|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
20077535|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
20077536|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077537|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077538|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20077539|NCT00539838|Protective Agents|protective agents|mesh-ancestor
20077540|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20077541|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20077542|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20077543|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20077544|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077545|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
20077546|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20077547|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077548|NCT00542542|Fentanyl|fentanyl|mesh-list
20077549|NCT00542542|Midazolam|midazolam|mesh-list
20077550|NCT00542542|Propofol|propofol|mesh-list
20077551|NCT00542542|Ropivacaine|ropivacaine|mesh-list
20077552|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20077553|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20077554|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077555|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20077556|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
20077557|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
20077558|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20077559|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
20077560|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077561|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20077562|NCT00542542|Narcotics|narcotics|mesh-ancestor
20077563|NCT00542542|Analgesics|analgesics|mesh-ancestor
20077564|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20077565|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20077566|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20077567|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20077568|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
20077569|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
20077570|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586521|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586522|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586523|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
20586524|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586525|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586526|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077571|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077572|NCT00547300|Metoprolol|metoprolol|mesh-list
20077573|NCT00547300|Nebivolol|nebivolol|mesh-list
20077574|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20077575|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20077576|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
20077577|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
20077578|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077579|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077580|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20077581|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20077582|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20077583|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
20077584|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20077585|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077586|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
20077587|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20077588|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20077589|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20077590|NCT00539617|Leucovorin|leucovorin|mesh-list
20077591|NCT00539617|Fluorouracil|fluorouracil|mesh-list
20077592|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
20077593|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20077594|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
20077595|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077596|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077597|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077598|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077599|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
20077600|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077601|NCT00539617|Antidotes|antidotes|mesh-ancestor
20077602|NCT00539617|Protective Agents|protective agents|mesh-ancestor
20077603|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
20586527|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586528|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20586529|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586530|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
20586531|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586532|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20586533|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20586534|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
20586535|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20586536|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20586537|NCT02129595|Resveratrol|resveratrol|mesh-list
20586538|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
20586539|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586540|NCT02129595|Protective Agents|protective agents|mesh-ancestor
20586541|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586542|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077604|NCT00539617|Vitamins|vitamins|mesh-ancestor
20077605|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
20077606|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077607|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077608|NCT00546455|Fenretinide|fenretinide|mesh-list
20077609|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077610|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20077611|NCT00546455|Protective Agents|protective agents|mesh-ancestor
20077612|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077613|NCT00538980|Dasatinib|dasatinib|mesh-list
20077614|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077615|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077616|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077617|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077618|NCT00535262|Selegiline|selegiline|mesh-list
20077619|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
20077620|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20077621|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20077622|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20119941|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
20586543|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20586544|NCT02129621|Spironolactone|spironolactone|mesh-list
20586545|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20586546|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
20586547|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586548|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586549|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20586550|NCT02129621|Diuretics|diuretics|mesh-ancestor
20586551|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
20586552|NCT02129634|Paclitaxel|paclitaxel|mesh-list
20586553|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20586554|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586555|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
20586556|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20586557|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20586558|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586559|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20586560|NCT02129673|Latanoprost|latanoprost|mesh-list
20586561|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20586562|NCT02129699|Denosumab|denosumab|mesh-list
20586563|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20586564|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586565|NCT02129764|Prednisone|prednisone|mesh-list
20586566|NCT02129764|Allopurinol|allopurinol|mesh-list
20586567|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20586568|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
20586569|NCT02129764|Hormones|hormones|mesh-ancestor
20077623|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20077624|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077625|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077626|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20077627|NCT00535262|Protective Agents|protective agents|mesh-ancestor
20077628|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077629|NCT00536978|Cytarabine|cytarabine|mesh-list
20077630|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
20077631|NCT00536978|Melphalan|melphalan|mesh-list
20077632|NCT00536978|Carmustine|carmustine|mesh-list
20077633|NCT00536978|Rituximab|rituximab|mesh-list
20077634|NCT00536978|Methotrexate|methotrexate|mesh-list
20077635|NCT00536978|Fludarabine|fludarabine|mesh-list
20077636|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
20077637|NCT00536978|Etoposide|etoposide|mesh-list
20077638|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
20077639|NCT00536978|Tacrolimus|tacrolimus|mesh-list
20077640|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586570|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586571|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586572|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20586573|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586574|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
20586575|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586576|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586577|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
20586578|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586579|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20077641|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
20077642|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077643|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586580|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
20586581|NCT02129764|Protective Agents|protective agents|mesh-ancestor
20586582|NCT02129829|Tenofovir|tenofovir|mesh-list
20586583|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
20586584|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077644|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20077645|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
20077646|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077647|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586585|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20077648|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20077649|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20119942|NCT00006251|Cyclosporins|cyclosporins|mesh-list
20077650|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20077651|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
20077652|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077653|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077654|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
20586586|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20586587|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586588|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586589|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20586590|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20586591|NCT02129933|Bevacizumab|bevacizumab|mesh-list
20586592|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20586593|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586594|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20586595|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20586596|NCT02129933|Growth Substances|growth substances|mesh-ancestor
20586597|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586598|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
20586599|NCT02129985|Metformin|metformin|mesh-list
20586600|NCT02129985|Exenatide|exenatide|mesh-list
20586601|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20586602|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586603|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20586604|NCT02129985|Incretins|incretins|mesh-ancestor
20586605|NCT02129985|Hormones|hormones|mesh-ancestor
20586606|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606456|NCT02237820|Prednisone|prednisone|mesh-list
20606457|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606458|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
20606459|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
20606460|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606461|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606462|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077655|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077656|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077657|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20077658|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20077659|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
20077660|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077661|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20077662|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20077663|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20606463|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
20606464|NCT02237820|Hormones|hormones|mesh-ancestor
20606465|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606466|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20606467|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606468|NCT02237859|Vancomycin|vancomycin|mesh-list
20606469|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077664|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20077665|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20077666|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20077667|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077668|NCT00529282|Vancomycin|vancomycin|mesh-list
20077669|NCT00529282|Cefepime|cefepime|mesh-list
20077670|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
20077671|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20077672|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20077673|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077674|NCT00524134|Carvedilol|carvedilol|mesh-list
20077675|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20606470|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606471|NCT02237924|Endostar protein|endostar protein|mesh-list
20606472|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20606473|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20586607|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20586608|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20586609|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586610|NCT02130167|Atropine|atropine|mesh-list
20586611|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20586612|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20586613|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20586614|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
20586615|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586616|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077676|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20077677|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
20077678|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20077679|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077680|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586617|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20586618|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
20586619|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
20586620|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
20586621|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20586622|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20586623|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20586624|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20586625|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586626|NCT02130323|Imiquimod|imiquimod|mesh-list
20586627|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20077681|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20077682|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
20077683|NCT00524134|Protective Agents|protective agents|mesh-ancestor
20077684|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20077685|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20077686|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20077687|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
20077688|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20077689|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20077690|NCT00517699|Cytarabine|cytarabine|mesh-list
20077691|NCT00517699|Rituximab|rituximab|mesh-list
20077692|NCT00517699|Methotrexate|methotrexate|mesh-list
20077693|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077694|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077695|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
20077696|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077697|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077698|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20077699|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
20077700|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077701|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077702|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
20077703|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077704|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077705|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077706|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20077707|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077708|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20077709|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
20077710|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077711|NCT00528437|Carboplatin|carboplatin|mesh-list
20077712|NCT00528437|Temozolomide|temozolomide|mesh-list
20077713|NCT00528437|Thiotepa|thiotepa|mesh-list
20077714|NCT00528437|Tretinoin|tretinoin|mesh-list
20077715|NCT00528437|Isotretinoin|isotretinoin|mesh-list
20077716|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077717|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20077718|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
20077719|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077720|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20077721|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077722|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
20077723|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077724|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
20077725|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077726|NCT00527982|Celecoxib|celecoxib|mesh-list
20077727|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20586628|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
20586629|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586630|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586631|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
20586632|NCT02130414|Cyclosporine|cyclosporine|mesh-list
20586633|NCT02130414|Cyclosporins|cyclosporins|mesh-list
20586634|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586635|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586636|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586637|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
20586638|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586639|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
20586640|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586641|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
20586642|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586643|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20586644|NCT02130440|Resveratrol|resveratrol|mesh-list
20586645|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
20586646|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586647|NCT02130440|Protective Agents|protective agents|mesh-ancestor
20586648|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586649|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586650|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20586651|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
20586652|NCT02130466|Trametinib|trametinib|mesh-list
20586653|NCT02130466|Dabrafenib|dabrafenib|mesh-list
20586654|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20586655|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586656|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20586657|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586658|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586659|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20586660|NCT02130661|Itraconazole|itraconazole|mesh-list
20586661|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
20586662|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586663|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20077728|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20077729|NCT00527982|Analgesics|analgesics|mesh-ancestor
20077730|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
20077731|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077732|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077733|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077734|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077735|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20077736|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20077737|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077738|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077739|NCT00524459|Docetaxel|docetaxel|mesh-list
20077740|NCT00524459|Doxorubicin|doxorubicin|mesh-list
20077741|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20077742|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077743|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077744|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
20077745|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
20077746|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077747|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20077748|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20077749|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20077750|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077751|NCT00517361|Bevacizumab|bevacizumab|mesh-list
20077752|NCT00517361|Carboplatin|carboplatin|mesh-list
20077753|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077754|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077755|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20077756|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20077757|NCT00517361|Growth Substances|growth substances|mesh-ancestor
20077758|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077759|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
20077760|NCT00523939|Cytarabine|cytarabine|mesh-list
20077761|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077762|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
20077763|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077764|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077765|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
20077766|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077767|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586664|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20586665|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586666|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586667|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20586668|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
20586669|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586670|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586671|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20586672|NCT02130700|Seviteronel|seviteronel|mesh-list
20586673|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586674|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20586675|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606474|NCT02237924|Growth Substances|growth substances|mesh-ancestor
20077768|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
20077769|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077770|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
20077771|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077772|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077773|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077774|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077775|NCT00523809|Vidarabine|vidarabine|mesh-list
20077776|NCT00523809|Bevacizumab|bevacizumab|mesh-list
20077777|NCT00523809|Fludarabine|fludarabine|mesh-list
20077778|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
20077779|NCT00523809|Melphalan|melphalan|mesh-list
20077780|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
20077781|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20077782|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077783|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077784|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20077785|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20077786|NCT00523809|Growth Substances|growth substances|mesh-ancestor
20077787|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077788|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
20077789|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077790|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
20077791|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077792|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077793|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
20077794|NCT00523809|Antiviral Agents|antiviral agents|mesh-ancestor
20077795|NCT00523809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077796|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20077797|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
20077798|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20077799|NCT00522301|Sorafenib|sorafenib|mesh-list
20077800|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077801|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077802|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077803|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077804|NCT00517192|Ritonavir|ritonavir|mesh-list
20077805|NCT00517192|Darunavir|darunavir|mesh-list
20077806|NCT00517192|Tipranavir|tipranavir|mesh-list
20077807|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20077808|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20077809|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
20077810|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077811|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077812|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20077813|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20077814|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
20077815|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077816|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20077817|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20077818|NCT00503581|Megestrol|megestrol|mesh-list
20077819|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
20077820|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20077821|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20077822|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20077823|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
20077824|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077825|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077826|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20077827|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20077828|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20077829|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586676|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586677|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
20586678|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20586679|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586680|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20586681|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586682|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586683|NCT02130739|Fentanyl|fentanyl|mesh-list
20586684|NCT02130739|Propofol|propofol|mesh-list
20586685|NCT02130739|Ropivacaine|ropivacaine|mesh-list
20586686|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
20586687|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586688|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586689|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20586690|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20586691|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
20586692|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
20586693|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
20586694|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077830|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
20077831|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20077832|NCT00509600|Etanercept|etanercept|mesh-list
20077833|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20077834|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20077835|NCT00509600|Analgesics|analgesics|mesh-ancestor
20077836|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
20077837|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077838|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077839|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077840|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077841|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20077842|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077843|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
20077844|NCT00515112|Testosterone|testosterone|mesh-list
20077845|NCT00515112|Androgens|androgens|mesh-ancestor
20077846|NCT00515112|Hormones|hormones|mesh-ancestor
20077847|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20077848|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586695|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20586696|NCT02130739|Narcotics|narcotics|mesh-ancestor
20586697|NCT02130739|Analgesics|analgesics|mesh-ancestor
20586698|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20586699|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20586700|NCT02130804|Salicylates|salicylates|mesh-list
20586701|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20586702|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586703|NCT02130804|Analgesics|analgesics|mesh-ancestor
20586704|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
20586705|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586706|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586707|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077849|NCT00508872|Leucovorin|leucovorin|mesh-list
20077850|NCT00508872|Bevacizumab|bevacizumab|mesh-list
20077851|NCT00508872|Fluorouracil|fluorouracil|mesh-list
20077852|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
20077853|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20077854|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077855|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20077856|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20077857|NCT00508872|Growth Substances|growth substances|mesh-ancestor
20077858|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077859|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
20077860|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
20077861|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077862|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077863|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077864|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
20077865|NCT00508872|Antidotes|antidotes|mesh-ancestor
20077866|NCT00508872|Protective Agents|protective agents|mesh-ancestor
20077867|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
20077868|NCT00508872|Vitamins|vitamins|mesh-ancestor
20077869|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
20077870|NCT00506064|Melatonin|melatonin|mesh-list
20586708|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586709|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20077871|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
20119943|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586710|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586711|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586712|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
20586713|NCT02130817|Dexamethasone|dexamethasone|mesh-list
20586714|NCT02130817|Prednisone|prednisone|mesh-list
20586715|NCT02130817|Abatacept|abatacept|mesh-list
20586716|NCT02130817|Tacrolimus|tacrolimus|mesh-list
20586717|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
20586718|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20586719|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
20586720|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20586721|NCT02130817|Antibodies|antibodies|mesh-list
20586722|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
20586723|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
20586724|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20077872|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077873|NCT00506064|Protective Agents|protective agents|mesh-ancestor
20077874|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077875|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20077876|NCT00503880|Cytarabine|cytarabine|mesh-list
20077877|NCT00503880|Clofarabine|clofarabine|mesh-list
20077878|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20077879|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
20077880|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077881|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077882|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
20077883|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077884|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077885|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
20077886|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119944|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119945|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
20119946|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119947|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119948|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
20119949|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119950|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119951|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
20119952|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20119953|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
20119954|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119955|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20119956|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20119957|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20119958|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
20119959|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20119960|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
20119961|NCT00006252|Fludarabine|fludarabine|mesh-list
20119962|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
20119963|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119964|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
20119965|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119966|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20119967|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20119968|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
20119969|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119970|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119971|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20119972|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20119973|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
20119974|NCT00006257|Paclitaxel|paclitaxel|mesh-list
20119975|NCT00006257|Semaxinib|semaxinib|mesh-list
20119976|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20119977|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119978|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
20119979|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
20119980|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
20119981|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20119982|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20119983|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20119984|NCT00006257|Growth Substances|growth substances|mesh-ancestor
20119985|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20119986|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
20586725|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20586726|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
20586727|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
19746431|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
19746432|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586728|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586729|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586730|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20586731|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
20586732|NCT02130817|Hormones|hormones|mesh-ancestor
20586733|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586734|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20586735|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586736|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586737|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586738|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586739|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
20586740|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20077887|NCT00501228|Lenograstim|lenograstim|mesh-list
20077888|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20077889|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
20077890|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077891|NCT00496782|Maraviroc|maraviroc|mesh-list
20077892|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20077893|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20077894|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077895|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20077896|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20077897|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
20077898|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077899|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20077900|NCT00506909|Oxytocin|oxytocin|mesh-list
20077901|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
20077902|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20077903|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077904|NCT00487578|Naratriptan|naratriptan|mesh-list
20077905|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20077906|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20077907|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20077908|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
20077909|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20077910|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077911|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077912|NCT00503009|Fluticasone|fluticasone|mesh-list
20077913|NCT00503009|Xhance|xhance|mesh-list
20077914|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20077915|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077916|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20077917|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
20077918|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077919|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077920|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20077921|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
20077922|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20077923|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20077924|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20077925|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20077926|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20077927|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
20077928|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20077929|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077930|NCT00500045|Niacin|niacin|mesh-list
20077931|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
20077932|NCT00500045|Niacinamide|niacinamide|mesh-list
20077933|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20077934|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
20077935|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077936|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20077937|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
20077938|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
20077939|NCT00500045|Vitamins|vitamins|mesh-ancestor
20077940|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
20077941|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077942|NCT00499590|Ranibizumab|ranibizumab|mesh-list
20077943|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20077944|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20586741|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20077945|NCT00499590|Growth Substances|growth substances|mesh-ancestor
20586742|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20586743|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
20586744|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20586745|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077946|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077947|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
20077948|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077949|NCT00501345|Aspirin|aspirin|mesh-list
20077950|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20077951|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20077952|NCT00501345|Analgesics|analgesics|mesh-ancestor
20077953|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
20077954|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20077955|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077956|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20077957|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077958|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20077959|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20077960|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077961|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20077962|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20077963|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077964|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
20077965|NCT00496756|Sorafenib|sorafenib|mesh-list
20077966|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077967|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077968|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077969|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077970|NCT00495716|Acyclovir|acyclovir|mesh-list
20077971|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
20077972|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20077973|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
20077974|NCT00500890|Carboplatin|carboplatin|mesh-list
20077975|NCT00500890|Etoposide|etoposide|mesh-list
20077976|NCT00500890|Vincristine|vincristine|mesh-list
20077977|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20077978|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
20077979|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20077980|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20077981|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20077982|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
20077983|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077984|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077985|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20077986|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20077987|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20077988|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20077989|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077990|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
20077991|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20077992|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
20077993|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20077994|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20077995|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20077996|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20077997|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20077998|NCT00493025|Paclitaxel|paclitaxel|mesh-list
20077999|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20078000|NCT00493025|Cisplatin|cisplatin|mesh-list
20078001|NCT00493025|Gefitinib|gefitinib|mesh-list
20078002|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078003|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078004|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078005|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078006|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078007|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078008|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20078009|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586746|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20078010|NCT00491400|Atorvastatin|atorvastatin|mesh-list
19492087|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20078011|NCT00491400|Fenofibrate|fenofibrate|mesh-list
20078012|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20586747|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586748|NCT02130830|Lidocaine|lidocaine|mesh-list
20078013|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20586749|NCT02130830|Prilocaine|prilocaine|mesh-list
20586750|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
20586751|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
20586752|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586753|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586754|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
20586755|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586756|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20586757|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20586758|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20586759|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20586760|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586761|NCT02130869|Cytarabine|cytarabine|mesh-list
20586762|NCT02130869|Aldesleukin|aldesleukin|mesh-list
20586763|NCT02130869|Carboplatin|carboplatin|mesh-list
20586764|NCT02130869|Etoposide|etoposide|mesh-list
20586765|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
20586766|NCT02130869|Melphalan|melphalan|mesh-list
20078014|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
20078015|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078016|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20078017|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20078018|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078019|NCT00490776|Panobinostat|panobinostat|mesh-list
20078020|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078021|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20078022|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078023|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078024|NCT00487162|Insulin|insulin|mesh-list
20078025|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20078026|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078027|NCT00491387|Metoprolol|metoprolol|mesh-list
20078028|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20078029|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20078030|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
20078031|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
20078032|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078033|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078034|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20078035|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20078036|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20078037|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078038|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119987|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20586767|NCT02130869|Busulfan|busulfan|mesh-list
20586768|NCT02130869|Interleukin-2|interleukin-2|mesh-list
20586769|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20586770|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
20586771|NCT02130869|Sargramostim|sargramostim|mesh-list
20586772|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586773|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20586774|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20586775|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586776|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586777|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586778|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586779|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
20586780|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
20586781|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586782|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586783|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
20586784|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586785|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20586786|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
20586787|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20586788|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586789|NCT02130869|Analgesics|analgesics|mesh-ancestor
20586790|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
20586791|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586792|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20586793|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20586794|NCT02130973|Denosumab|denosumab|mesh-list
20586795|NCT02130973|Teriparatide|teriparatide|mesh-list
20586796|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20586797|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586798|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20586799|NCT02131012|Celecoxib|celecoxib|mesh-list
20586800|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20586801|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586802|NCT02131012|Analgesics|analgesics|mesh-ancestor
20586803|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
20586804|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586805|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586806|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20586807|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586808|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20586809|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20586810|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586811|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586812|NCT02131220|Tirofiban|tirofiban|mesh-list
20586813|NCT02131220|Saruplase|saruplase|mesh-list
20586814|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20586815|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20586816|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586817|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20078039|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078040|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
20078041|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078042|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
20078043|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
20078044|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20078045|NCT00483119|Antibodies|antibodies|mesh-list
20078046|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
20078047|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20078048|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078049|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
20078050|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078051|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078052|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20078053|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
20078054|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078055|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078056|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20078057|NCT00487461|Simvastatin|simvastatin|mesh-list
20078058|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20078059|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20078060|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
20078061|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078062|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20078063|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20078064|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078065|NCT00484718|Celecoxib|celecoxib|mesh-list
20078066|NCT00484718|Oxycodone|oxycodone|mesh-list
20078067|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20078068|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20078069|NCT00484718|Analgesics|analgesics|mesh-ancestor
20078070|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
20078071|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078072|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078073|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078074|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078075|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20078076|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20078077|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078078|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078079|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20078080|NCT00484718|Narcotics|narcotics|mesh-ancestor
20078081|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078082|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20078083|NCT00470067|Carboplatin|carboplatin|mesh-list
20078084|NCT00470067|Doxorubicin|doxorubicin|mesh-list
20078085|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20078086|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078087|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078088|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20078089|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20078090|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078091|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078092|NCT00476827|Gemcitabine|gemcitabine|mesh-list
20586818|NCT02131246|Insulin|insulin|mesh-list
20586819|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20586820|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
20586821|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
20586822|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20586823|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20586824|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586825|NCT02131298|Itraconazole|itraconazole|mesh-list
20586826|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20586827|NCT02131298|Palbociclib|palbociclib|mesh-list
20586828|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586829|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20586830|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586831|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586832|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
20586833|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078093|NCT00476827|Paclitaxel|paclitaxel|mesh-list
20078094|NCT00476827|Vinorelbine|vinorelbine|mesh-list
20078095|NCT00476827|Docetaxel|docetaxel|mesh-list
20078096|NCT00476827|Bevacizumab|bevacizumab|mesh-list
20078097|NCT00476827|Irinotecan|irinotecan|mesh-list
20078098|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078099|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078100|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078101|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078102|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078103|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078104|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078105|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20078106|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20078107|NCT00476827|Growth Substances|growth substances|mesh-ancestor
20078108|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078109|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
20078110|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078111|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
20078112|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
20078113|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078114|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078115|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078116|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
20078117|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20078118|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20078119|NCT00475657|Pemetrexed|pemetrexed|mesh-list
20078120|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078121|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078122|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078123|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20078124|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20078125|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20078126|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20078127|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
20078128|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078129|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
20078130|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
20078131|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20078132|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20078133|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078134|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078135|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20078136|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20078137|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
20078138|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078139|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
20078140|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20078141|NCT00459121|Paclitaxel|paclitaxel|mesh-list
20078142|NCT00459121|Carboplatin|carboplatin|mesh-list
20078143|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078144|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078145|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078146|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078147|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078148|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078149|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
20078150|NCT00450333|Hematinics|hematinics|mesh-ancestor
20586834|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20078151|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
20586835|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20586836|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20586837|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
20586838|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586839|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078152|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20078153|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078154|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078155|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20078156|NCT00455143|Analgesics|analgesics|mesh-ancestor
20078157|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
20078158|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078159|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20078160|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20078161|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20078162|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078163|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078164|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078165|NCT00456989|Docetaxel|docetaxel|mesh-list
20078166|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078167|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078168|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078169|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078170|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078171|NCT00448682|Leucovorin|leucovorin|mesh-list
20078172|NCT00448682|Docetaxel|docetaxel|mesh-list
20078173|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
20078174|NCT00448682|Floxuridine|floxuridine|mesh-list
20078175|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
20078176|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078177|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078178|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078179|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078180|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078181|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078182|NCT00448682|Antidotes|antidotes|mesh-ancestor
20078183|NCT00448682|Protective Agents|protective agents|mesh-ancestor
20078184|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
20078185|NCT00448682|Vitamins|vitamins|mesh-ancestor
20078186|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
20078187|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078188|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
20078189|NCT00454571|Leuprolide|leuprolide|mesh-list
20078190|NCT00454571|Goserelin|goserelin|mesh-list
20078191|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20078192|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
20078193|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20078194|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078195|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20078196|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078197|NCT00452361|Cyclosporine|cyclosporine|mesh-list
20078198|NCT00452361|Sirolimus|sirolimus|mesh-list
20078199|NCT00452361|Tacrolimus|tacrolimus|mesh-list
20078200|NCT00452361|Cyclosporins|cyclosporins|mesh-list
20078201|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20078202|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078203|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
20078204|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078205|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078206|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078207|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
20078208|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078209|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
20078210|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078211|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20078212|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078213|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078214|NCT00447421|Pemetrexed|pemetrexed|mesh-list
20078215|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078216|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078217|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078218|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20078219|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20078220|NCT00441272|Pioglitazone|pioglitazone|mesh-list
20078221|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20078222|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586840|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20586841|NCT02131350|Ranibizumab|ranibizumab|mesh-list
20078223|NCT00440271|Ritonavir|ritonavir|mesh-list
20078224|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
20078225|NCT00440271|Maraviroc|maraviroc|mesh-list
20078226|NCT00440271|Tipranavir|tipranavir|mesh-list
20078227|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
20078228|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20586842|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20586843|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20586844|NCT02131350|Growth Substances|growth substances|mesh-ancestor
20586845|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586846|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
20586847|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586848|NCT02131480|Doxorubicin|doxorubicin|mesh-list
20586849|NCT02131480|Trabectedin|trabectedin|mesh-list
20586850|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20586851|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586852|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20586853|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586854|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586855|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586856|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20586857|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
20586858|NCT02131506|Lapatinib|lapatinib|mesh-list
20586859|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20586860|NCT02131506|Doxorubicin|doxorubicin|mesh-list
20586861|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586862|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20586863|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586864|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586865|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20586866|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20586867|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586868|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20586869|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
20586870|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20586871|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20586872|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20586873|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586874|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586875|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
20078229|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20078230|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20078231|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
20078232|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078233|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078234|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20586876|NCT02131688|Analgesics|analgesics|mesh-ancestor
20586877|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
20586878|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586879|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586880|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586881|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20586882|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20586883|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586884|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586885|NCT02131818|Amoxicillin|amoxicillin|mesh-list
20586886|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20586887|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606475|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606476|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
20606477|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606478|NCT02237937|Amitriptyline|amitriptyline|mesh-list
20606479|NCT02237937|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20606480|NCT02237937|Citalopram|citalopram|mesh-list
20606481|NCT02237937|Paroxetine|paroxetine|mesh-list
20606482|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20078235|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20078236|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
20078237|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606483|NCT02237937|Sertraline|sertraline|mesh-list
19492088|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
19492089|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606484|NCT02237937|Nortriptyline|nortriptyline|mesh-list
20078238|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20078239|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20078240|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20078241|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20586888|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
20586889|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20586890|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586891|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
20586892|NCT02131948|Insulin|insulin|mesh-list
20586893|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
20078242|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20078243|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20078244|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20078245|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20078246|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20078247|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078248|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
20078249|NCT00429026|Melphalan|melphalan|mesh-list
20078250|NCT00429026|Fludarabine|fludarabine|mesh-list
20078251|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078252|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
20078253|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078254|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078255|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20078256|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
20078257|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078258|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078259|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20078260|NCT00428207|Insulin|insulin|mesh-list
20078261|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20078262|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
20078263|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
20078264|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20078265|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
20078266|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20078267|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078268|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20078269|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078270|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
20078271|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078272|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078273|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20078274|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
20078275|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20078276|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078277|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078278|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078279|NCT00430027|Capecitabine|capecitabine|mesh-list
20078280|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
20078281|NCT00430027|Cetuximab|cetuximab|mesh-list
20078282|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078283|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
20078284|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078285|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078286|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078287|NCT00429858|Gemcitabine|gemcitabine|mesh-list
20586894|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20586895|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586896|NCT02132000|Tamoxifen|tamoxifen|mesh-list
20586897|NCT02132000|Toremifene|toremifene|mesh-list
20586898|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20586899|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
20586900|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586901|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586902|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20586903|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586904|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20586905|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20586906|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20586907|NCT02132026|Denosumab|denosumab|mesh-list
20586908|NCT02132026|Alendronate|alendronate|mesh-list
20586909|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20586910|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586911|NCT02132091|Vitamins|vitamins|mesh-list
20586912|NCT02132091|Ascorbic Acid|ascorbic acid|mesh-list
20586913|NCT02132091|Vitamin E|vitamin e|mesh-list
20586914|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
20586915|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586916|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
20586917|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586918|NCT02132091|Protective Agents|protective agents|mesh-ancestor
20586919|NCT02132104|Hormones|hormones|mesh-list
20586920|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586921|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586922|NCT02132234|Adalimumab|adalimumab|mesh-list
20586923|NCT02132234|Etanercept|etanercept|mesh-list
20586924|NCT02132234|Infliximab|infliximab|mesh-list
20586925|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
20586926|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20586927|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078288|NCT00429858|Tegafur|tegafur|mesh-list
20078289|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078290|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
20078291|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586928|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
20586929|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20586930|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20586931|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586932|NCT02132234|Analgesics|analgesics|mesh-ancestor
20586933|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
20586934|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586935|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586936|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586937|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
20586938|NCT02132260|Naftifine|naftifine|mesh-list
20586939|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
20586940|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586941|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20586942|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
20586943|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20586944|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20586945|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20586946|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586947|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586948|NCT02132390|Toremifene|toremifene|mesh-list
20586949|NCT02132390|Goserelin|goserelin|mesh-list
20586950|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20586951|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586952|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20586953|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20586954|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
20586955|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20586956|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586957|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20586958|NCT02132403|Gemcitabine|gemcitabine|mesh-list
20586959|NCT02132403|Milk fat globule|milk fat globule|mesh-list
20586960|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20586961|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
20586962|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586963|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20586964|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
20586965|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20586966|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586967|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20586968|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
20586969|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586970|NCT02132416|Acetaminophen|acetaminophen|mesh-list
20586971|NCT02132416|Ibuprofen|ibuprofen|mesh-list
20586972|NCT02132416|Diclofenac|diclofenac|mesh-list
20586973|NCT02132416|Morphine|morphine|mesh-list
20586974|NCT02132416|Oxycodone|oxycodone|mesh-list
20586975|NCT02132416|Tramadol|tramadol|mesh-list
20586976|NCT02132416|Anesthetics|anesthetics|mesh-list
20586977|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20586978|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586979|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20586980|NCT02132416|Narcotics|narcotics|mesh-ancestor
20586981|NCT02132416|Analgesics|analgesics|mesh-ancestor
20586982|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
20586983|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20586984|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20586985|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20586986|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078292|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078293|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
20078294|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078295|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078296|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078297|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
20078298|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586987|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20586988|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20586989|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20586990|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20586991|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
20586992|NCT02132442|Vitamin D|vitamin d|mesh-list
20586993|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
20586994|NCT02132442|Vitamins|vitamins|mesh-ancestor
20586995|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
20586996|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20586997|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20586998|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20586999|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
20587000|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20587001|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587002|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
20587003|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20587004|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20587005|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
20587006|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587007|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20587008|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
20587009|NCT02132689|Heparin|heparin|mesh-list
20587010|NCT02132689|Calcium heparin|calcium heparin|mesh-list
20587011|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20587012|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587013|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
20587014|NCT02132897|Carbamazepine|carbamazepine|mesh-list
20587015|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
20587016|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
20587017|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587018|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587019|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587020|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587021|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20587022|NCT02132897|Analgesics|analgesics|mesh-ancestor
20078299|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
20078300|NCT00425438|Prednisolone|prednisolone|mesh-list
20587023|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
20587024|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587025|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20587026|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20587027|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587028|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20587029|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20587030|NCT02133014|Fluorouracil|fluorouracil|mesh-list
20078301|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
20078302|NCT00425438|Azathioprine|azathioprine|mesh-list
20587031|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
20587032|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587033|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20587034|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587035|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587036|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
20587037|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587038|NCT02133053|Beclomethasone|beclomethasone|mesh-list
20587039|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587040|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
20078303|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078304|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
20078305|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078306|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078307|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20078308|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
20078309|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078310|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078311|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20078312|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078313|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20078314|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
20078315|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20078316|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078317|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078318|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078319|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
20587041|NCT02133053|Hormones|hormones|mesh-ancestor
20587042|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587043|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587044|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20587045|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
20587046|NCT02133079|Vaccines|vaccines|mesh-list
20587047|NCT02133079|Immunologic Factors|immunologic factors|mesh-ancestor
20587048|NCT02133079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587049|NCT02133105|Simendan|simendan|mesh-list
20078320|NCT00425438|Hormones|hormones|mesh-ancestor
20078321|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078322|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20078323|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
20587050|NCT02133105|Dobutamine|dobutamine|mesh-list
20587051|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20587052|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
20587053|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20587054|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20078324|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078325|NCT00421954|Ziprasidone|ziprasidone|mesh-list
20078326|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20078327|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
20078328|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078329|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078330|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078331|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20078332|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20078333|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078334|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20078335|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20587055|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587056|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587057|NCT02133105|Protective Agents|protective agents|mesh-ancestor
20587058|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587059|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
20587060|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
20587061|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587062|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20587063|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20587064|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587065|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587066|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587067|NCT02133118|Pioglitazone|pioglitazone|mesh-list
20587068|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20587069|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587070|NCT02133287|Sirolimus|sirolimus|mesh-list
20587071|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
20587072|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587073|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587074|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078336|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
20078337|NCT00422942|Rituximab|rituximab|mesh-list
20587075|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587076|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
20587077|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587078|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
20587079|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587080|NCT02133326|Acetaminophen|acetaminophen|mesh-list
20587081|NCT02133326|Ibuprofen|ibuprofen|mesh-list
20587082|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20587083|NCT02133326|Analgesics|analgesics|mesh-ancestor
20587084|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
20587085|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587086|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587087|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
20587088|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20587089|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587090|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587091|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20587092|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587093|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587094|NCT02133378|Hemostatics|hemostatics|mesh-list
20587095|NCT02133378|Coagulants|coagulants|mesh-ancestor
20587096|NCT02133404|Cinacalcet|cinacalcet|mesh-list
20587097|NCT02133404|ASP7991|asp7991|mesh-list
20587098|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20078338|NCT00422942|Methotrexate|methotrexate|mesh-list
20078339|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078340|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078341|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
20078342|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078343|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078344|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20078345|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
20078346|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20078347|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078348|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
20078349|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078350|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
20078351|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078352|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20078353|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078354|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20078355|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
20078356|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20078357|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078358|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078359|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20078360|NCT00409344|Analgesics|analgesics|mesh-ancestor
20078361|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
20078362|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078363|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20078364|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20078365|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587099|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587100|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20587101|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
20587102|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587103|NCT02133469|Vaccines|vaccines|mesh-list
20587104|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20587105|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
20587106|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587107|NCT02133612|Paclitaxel|paclitaxel|mesh-list
20587108|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20587109|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20587110|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587111|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
20587112|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
20587113|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
20587114|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587115|NCT02133625|Pioglitazone|pioglitazone|mesh-list
20587116|NCT02133625|Carboplatin|carboplatin|mesh-list
20587117|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587118|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20587119|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587120|NCT02133638|Propofol|propofol|mesh-list
20078366|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078367|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078368|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078369|NCT00414453|Lidocaine|lidocaine|mesh-list
20078370|NCT00414453|Oxycodone|oxycodone|mesh-list
20078371|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
20078372|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
20078373|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078374|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587121|NCT02133638|Sevoflurane|sevoflurane|mesh-list
20587122|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20587123|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587124|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587125|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20587126|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
20587127|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
20587128|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20587129|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20587130|NCT02133677|Temozolomide|temozolomide|mesh-list
20587131|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20587132|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
20587133|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587134|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606485|NCT02237937|Trimipramine|trimipramine|mesh-list
20606486|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20606487|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20606488|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606489|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606490|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606491|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
20606492|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606493|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20606494|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
20606495|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20606496|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606497|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20606498|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20606499|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606500|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20606501|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20606502|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20606503|NCT02237937|Analgesics|analgesics|mesh-ancestor
20606504|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
20606505|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20606506|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606507|NCT02237937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20606508|NCT02237937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20606509|NCT02237937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078375|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
20078376|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078377|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20606510|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20606511|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606512|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
20606513|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606514|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606515|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606516|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
20078378|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20078379|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20078380|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078381|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078382|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20078383|NCT00414453|Narcotics|narcotics|mesh-ancestor
20078384|NCT00414453|Analgesics|analgesics|mesh-ancestor
20078385|NCT00417248|Etoposide|etoposide|mesh-list
20078386|NCT00417248|Sorafenib|sorafenib|mesh-list
20078387|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078388|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078389|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20078390|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20606517|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20587135|NCT02133755|Bromocriptine|bromocriptine|mesh-list
20587136|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20587137|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20587138|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20587139|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587140|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587141|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
20587142|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
20587143|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587144|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587145|NCT02133820|Analgesics|analgesics|mesh-list
20587146|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
20587147|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587148|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587149|NCT02133885|Minocycline|minocycline|mesh-list
20587150|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587151|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587152|NCT02133911|Ranolazine|ranolazine|mesh-list
20587153|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20587154|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20587155|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587156|NCT02133924|Prednisone|prednisone|mesh-list
20587157|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
20587158|NCT02133924|Natalizumab|natalizumab|mesh-list
20587159|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587160|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
20587161|NCT02133924|Hormones|hormones|mesh-ancestor
20587162|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587163|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587164|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20587165|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587166|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
20587167|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
20587168|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587169|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587170|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20587171|NCT02133924|Protective Agents|protective agents|mesh-ancestor
20587172|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
20587173|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20587174|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
20587175|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587176|NCT02133989|Ticlopidine|ticlopidine|mesh-list
20587177|NCT02133989|Clopidogrel|clopidogrel|mesh-list
20587178|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20587179|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20587180|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20587181|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20587182|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
20587183|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587184|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587185|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587186|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20587187|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20587188|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20587189|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20587190|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587191|NCT02134002|Disulfiram|disulfiram|mesh-list
20587192|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20587193|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20587194|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587195|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587196|NCT02134067|Paclitaxel|paclitaxel|mesh-list
20587197|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20587198|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587199|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
20587200|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
20587201|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078391|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078392|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078393|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20078394|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
20078395|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20587202|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587203|NCT02134093|Midazolam|midazolam|mesh-list
20587204|NCT02134093|Sufentanil|sufentanil|mesh-list
20587205|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
20587206|NCT02134093|Remifentanil|remifentanil|mesh-list
20587207|NCT02134093|Anesthetics|anesthetics|mesh-list
20587208|NCT02134093|Propofol|propofol|mesh-list
20587209|NCT02134093|Etomidate|etomidate|mesh-list
20587210|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
20587211|NCT02134093|Rocuronium|rocuronium|mesh-list
20587212|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587213|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587214|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20587215|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20587216|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
20587217|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20587218|NCT02134093|Analgesics|analgesics|mesh-ancestor
20587219|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
20587220|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587221|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20587222|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20587223|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587224|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587225|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587226|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587227|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20587228|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20587229|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587230|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587231|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
20587232|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
20587233|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20587234|NCT02134093|Narcotics|narcotics|mesh-ancestor
20587235|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20587236|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20587237|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20587238|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20587239|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20587240|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
20587241|NCT02134106|Polymyxins|polymyxins|mesh-list
20587242|NCT02134106|Doripenem|doripenem|mesh-list
20587243|NCT02134106|Polymyxin B|polymyxin b|mesh-list
20587244|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587245|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587246|NCT02134249|Cabergoline|cabergoline|mesh-list
20587247|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20587248|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20078396|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20587249|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
20587250|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
20587251|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587252|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587253|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587254|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
20587255|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20587256|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587257|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
20587258|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587259|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587260|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20587261|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
20587262|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587263|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587264|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20587265|NCT02134288|Everolimus|everolimus|mesh-list
20587266|NCT02134288|Abatacept|abatacept|mesh-list
20587267|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587268|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587269|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
20587270|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587271|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20587272|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587273|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587274|NCT02134327|Midazolam|midazolam|mesh-list
20587275|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
20587276|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20587277|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587278|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587279|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20587280|NCT02134327|Analgesics|analgesics|mesh-ancestor
20587281|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
20587282|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587283|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20587284|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20587285|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587286|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587287|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078397|NCT00418145|Prednisolone|prednisolone|mesh-list
20078398|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
20078399|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20587288|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587289|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20587290|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20587291|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587292|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587293|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20587294|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
20587295|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
20587296|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
20587297|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
20587298|NCT02134366|Lorazepam|lorazepam|mesh-list
20587299|NCT02134366|Clonazepam|clonazepam|mesh-list
20587300|NCT02134366|Clobazam|clobazam|mesh-list
20587301|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
20587302|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
20587303|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
20587304|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587305|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587306|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587307|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20078400|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
20078401|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078402|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
20078403|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
20078404|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078405|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078406|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20078407|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
20078408|NCT00418145|Hormones|hormones|mesh-ancestor
20078409|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078410|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20078411|NCT00418145|Protective Agents|protective agents|mesh-ancestor
20078412|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20078413|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078414|NCT00409331|Amifostine|amifostine|mesh-list
20078415|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20078416|NCT00409331|Protective Agents|protective agents|mesh-ancestor
20078417|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078418|NCT00391430|Sertraline|sertraline|mesh-list
20078419|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
20078420|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20078421|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20078422|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20078423|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078424|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078425|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078426|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
20078427|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078428|NCT00384293|Niacin|niacin|mesh-list
20078429|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20078430|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
20078431|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078432|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20078433|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
20078434|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
20078435|NCT00384293|Vitamins|vitamins|mesh-ancestor
20078436|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
20078437|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078438|NCT00374543|Ziprasidone|ziprasidone|mesh-list
20078439|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20078440|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
20078441|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20119988|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587308|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587309|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20587310|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587311|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587312|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
20587313|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
20587314|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587315|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587316|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20587317|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
20587318|NCT02134379|Clotrimazole|clotrimazole|mesh-list
20587319|NCT02134379|Miconazole|miconazole|mesh-list
20587320|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20587321|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587322|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
20587323|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20587324|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20078442|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078443|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078444|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20078445|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20078446|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078447|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20078448|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20078449|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
20078450|NCT00377455|Bosentan|bosentan|mesh-list
20078451|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20078452|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20078453|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078454|NCT00369265|Lansoprazole|lansoprazole|mesh-list
20078455|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
20078456|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20078457|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20078458|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20078459|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078460|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078461|NCT00364689|Rifaximin|rifaximin|mesh-list
20078462|NCT00364689|Lactulose|lactulose|mesh-list
20078463|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20078464|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078465|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20078466|NCT00352118|Docetaxel|docetaxel|mesh-list
20078467|NCT00352118|Fluorouracil|fluorouracil|mesh-list
20078468|NCT00352118|Lenograstim|lenograstim|mesh-list
20078469|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078470|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078471|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078472|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078473|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078474|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
20078475|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078476|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078477|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
20078478|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078479|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20078480|NCT00368654|Methotrexate|methotrexate|mesh-list
20078481|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20078482|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
20078483|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20078484|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078485|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078486|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
20078487|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078488|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078489|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
20078490|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078491|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20078492|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078493|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
20078494|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078495|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20587325|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587326|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587327|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20587328|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
20587329|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587330|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587331|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20587332|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20587333|NCT02134405|Esomeprazole|esomeprazole|mesh-list
20587334|NCT02134405|Rebamipide|rebamipide|mesh-list
20587335|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20587336|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587337|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20587338|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587339|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587340|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
20587341|NCT02134405|Protective Agents|protective agents|mesh-ancestor
20587342|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587343|NCT02134457|Ranibizumab|ranibizumab|mesh-list
20587344|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20587345|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20587346|NCT02134457|Growth Substances|growth substances|mesh-ancestor
20587347|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587348|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
20587349|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587350|NCT02134470|Testosterone|testosterone|mesh-list
20587351|NCT02134470|Androgens|androgens|mesh-ancestor
20587352|NCT02134470|Hormones|hormones|mesh-ancestor
20587353|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587354|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587355|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
20587356|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20587357|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587358|NCT02134626|Simvastatin|simvastatin|mesh-list
20587359|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20587360|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20587361|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
20587362|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587363|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20587364|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20587365|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587366|NCT02134639|Edotreotide|edotreotide|mesh-list
20587367|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20587368|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587369|NCT02134717|Maraviroc|maraviroc|mesh-list
20587370|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20587371|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20587372|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587373|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20587374|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20587375|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
20587376|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587377|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20587378|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20587379|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587380|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20587381|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587382|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587383|NCT02134899|Everolimus|everolimus|mesh-list
20587384|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20587385|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587386|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587387|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
20587388|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587389|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587390|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587391|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20587392|NCT02134938|Cathartics|cathartics|mesh-ancestor
20587393|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587394|NCT02134964|Dapansutrile|dapansutrile|mesh-list
20587395|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587396|NCT02134990|Docetaxel|docetaxel|mesh-list
20587397|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587398|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
20587399|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
20587400|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
20587401|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587402|NCT02135029|Atorvastatin|atorvastatin|mesh-list
20587403|NCT02135029|Bococizumab|bococizumab|mesh-list
20587404|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20587405|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20587406|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
20587407|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587408|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20587409|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20587410|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587411|NCT02135055|Midazolam|midazolam|mesh-list
20587412|NCT02135055|Morphine|morphine|mesh-list
20587413|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20587414|NCT02135055|Narcotics|narcotics|mesh-ancestor
20587415|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587416|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587417|NCT02135055|Analgesics|analgesics|mesh-ancestor
20587418|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
20587419|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587420|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20587421|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20078496|NCT00356421|Insulin|insulin|mesh-list
20078497|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20078498|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
20078499|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20078500|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078501|NCT00356187|Propranolol|propranolol|mesh-list
20078502|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20078503|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20078504|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078505|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078506|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078507|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078508|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20078509|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20078510|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
20078511|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
20078512|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078513|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
20078514|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078515|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078516|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20078517|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20078518|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
20078519|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078520|NCT00319839|Paclitaxel|paclitaxel|mesh-list
20587422|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20587423|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587424|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587425|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20587426|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
20587427|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
20587428|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
20587429|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
20587430|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587431|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587432|NCT02135120|Morphine|morphine|mesh-list
20587433|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587434|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587435|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20587436|NCT02135120|Narcotics|narcotics|mesh-ancestor
20587437|NCT02135120|Analgesics|analgesics|mesh-ancestor
20078521|NCT00319839|Cetuximab|cetuximab|mesh-list
20078522|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20587438|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
20587439|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587440|NCT02135133|Ofatumumab|ofatumumab|mesh-list
20587441|NCT02135133|Idelalisib|idelalisib|mesh-list
20587442|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587443|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306037|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587444|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587445|NCT02135224|Fentanyl|fentanyl|mesh-list
20587446|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20587447|NCT02135224|Narcotics|narcotics|mesh-ancestor
20078523|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078524|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078525|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078526|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078527|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
20587448|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078528|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078529|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078530|NCT00344019|Atorvastatin|atorvastatin|mesh-list
20078531|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20078532|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20078533|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
20078534|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078535|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20078536|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20078537|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587449|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587450|NCT02135224|Analgesics|analgesics|mesh-ancestor
20587451|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
20587452|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587453|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20587454|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20587455|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
20587456|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
20587457|NCT02135263|Enalapril|enalapril|mesh-list
20587458|NCT02135263|Methylphenidate|methylphenidate|mesh-list
20587459|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20587460|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587461|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20587462|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20587463|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20587464|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587465|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
20587466|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587467|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20587468|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
20587469|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587470|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20587471|NCT02135315|Antihypertensive Agents|antihypertensive agents|mesh-list
20587472|NCT02135315|Labetalol|labetalol|mesh-list
20587473|NCT02135315|Nicardipine|nicardipine|mesh-list
20587474|NCT02135315|Isosorbide|isosorbide|mesh-list
20587475|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20587476|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20587477|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20587478|NCT02135315|Diuretics|diuretics|mesh-ancestor
20587479|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
20587480|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587481|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
20587482|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20587483|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587484|NCT02135315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20587485|NCT02135315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20587486|NCT02135315|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587487|NCT02135315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587488|NCT02135315|Sympathomimetics|sympathomimetics|mesh-ancestor
20587489|NCT02135315|Autonomic Agents|autonomic agents|mesh-ancestor
20587490|NCT02135315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587491|NCT02135315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20587492|NCT02135315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20587493|NCT02135315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20587494|NCT02135315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078538|NCT00338455|Dobutamine|dobutamine|mesh-list
20587495|NCT02135315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606518|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20606519|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20606520|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606521|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606522|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606523|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
20606524|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
20078539|NCT00338455|Milrinone|milrinone|mesh-list
20606525|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20587496|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
20587497|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20587498|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20587499|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20587500|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20587501|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078540|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20078541|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20078542|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
20078543|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
20078544|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078545|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078546|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20078547|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20078548|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20078549|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078550|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078551|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078552|NCT00338455|Protective Agents|protective agents|mesh-ancestor
20078553|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
20078554|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20078555|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
20078556|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20078557|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20078558|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078559|NCT00329108|Olanzapine|olanzapine|mesh-list
20078560|NCT00329108|Ziprasidone|ziprasidone|mesh-list
20078561|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
20078562|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
20078563|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078564|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078565|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20078566|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20078567|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20078568|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078569|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587502|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587503|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
20587504|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587505|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587506|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20587507|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587508|NCT02135354|Azithromycin|azithromycin|mesh-list
20587509|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587510|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587511|NCT02135393|Folic Acid|folic acid|mesh-list
20587512|NCT02135393|Hematinics|hematinics|mesh-ancestor
20078570|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20587513|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
20587514|NCT02135393|Vitamins|vitamins|mesh-ancestor
20587515|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
20587516|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587517|NCT02135419|Fluorouracil|fluorouracil|mesh-list
20587518|NCT02135419|Imiquimod|imiquimod|mesh-list
20587519|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
20587520|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587521|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20587522|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587523|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587524|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
20587525|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587526|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20587527|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
20078571|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20587528|NCT02135510|Palonosetron|palonosetron|mesh-list
20587529|NCT02135510|Metoclopramide|metoclopramide|mesh-list
20587530|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
20587531|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
20587532|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587533|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587534|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587535|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20587536|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20587537|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
20587538|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587539|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587540|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20587541|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20587542|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
20587543|NCT02135588|Plasminogen|plasminogen|mesh-list
20587544|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20587545|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20587546|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20587547|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587548|NCT02135627|Epinephrine|epinephrine|mesh-list
20587549|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20587550|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587551|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587552|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587553|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587554|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587555|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20587556|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20587557|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
20587558|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587559|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20587560|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
20587561|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
20587562|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
20587563|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20587564|NCT02135640|Denosumab|denosumab|mesh-list
20587565|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20587566|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587567|NCT02135770|Heparin|heparin|mesh-list
20587568|NCT02135770|Calcium heparin|calcium heparin|mesh-list
20587569|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
20587570|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20587571|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20587572|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587573|NCT02135822|Gemcitabine|gemcitabine|mesh-list
20587574|NCT02135822|Paclitaxel|paclitaxel|mesh-list
20587575|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20587576|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20587577|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587578|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
20587579|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
20587580|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
20587581|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587582|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20587583|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
20587584|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
20587585|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587586|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587587|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587588|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
20587589|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587590|NCT02135874|Cytarabine|cytarabine|mesh-list
20587591|NCT02135874|Dexamethasone|dexamethasone|mesh-list
20587592|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
20587593|NCT02135874|Rituximab|rituximab|mesh-list
20587594|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20587595|NCT02135874|Vincristine|vincristine|mesh-list
20587596|NCT02135874|Sorafenib|sorafenib|mesh-list
20587597|NCT02135874|Idarubicin|idarubicin|mesh-list
20587598|NCT02135874|Clofarabine|clofarabine|mesh-list
20587599|NCT02135874|Antibodies|antibodies|mesh-list
20587600|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
20587601|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20587602|NCT02135874|BB 1101|bb 1101|mesh-list
20587603|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
20078572|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078573|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078574|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078575|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
20078576|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20078577|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20078578|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
20078579|NCT00325572|Ascorbic Acid|ascorbic acid|mesh-list
20078580|NCT00325572|Vitamins|vitamins|mesh-ancestor
20078581|NCT00325572|Micronutrients|micronutrients|mesh-ancestor
20078582|NCT00325572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078583|NCT00325572|Antioxidants|antioxidants|mesh-ancestor
20078584|NCT00325572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078585|NCT00325572|Protective Agents|protective agents|mesh-ancestor
20078586|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
20078587|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20078588|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078589|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20078590|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20078591|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20078592|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
20078593|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078594|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078595|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078596|NCT00323635|Urological Agents|urological agents|mesh-ancestor
20078597|NCT00329732|Lidocaine|lidocaine|mesh-list
20078598|NCT00329732|Bupivacaine|bupivacaine|mesh-list
20078599|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
20078600|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
20587604|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587605|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078601|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078602|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587606|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587607|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587608|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
20587609|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
20587610|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587611|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587612|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
20587613|NCT02135874|Hormones|hormones|mesh-ancestor
20587614|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587615|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20587616|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
20587617|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587618|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587619|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20587620|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
20587621|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
20587622|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587623|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587624|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20587625|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
20587626|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
20587627|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
20587628|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20587629|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20587630|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20587631|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20587632|NCT02135887|Leucovorin|leucovorin|mesh-list
20587633|NCT02135887|Folic Acid|folic acid|mesh-list
20587634|NCT02135887|Fluorouracil|fluorouracil|mesh-list
20587635|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
20587636|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
20587637|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
20587638|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587639|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20587640|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587641|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587642|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
20587643|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587644|NCT02135887|Antidotes|antidotes|mesh-ancestor
20587645|NCT02135887|Protective Agents|protective agents|mesh-ancestor
20587646|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
20587647|NCT02135887|Vitamins|vitamins|mesh-ancestor
20587648|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
20078603|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
20078604|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078605|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20078606|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20078607|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20078608|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078609|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078610|NCT00314353|Bevacizumab|bevacizumab|mesh-list
20078611|NCT00314353|Capecitabine|capecitabine|mesh-list
20078612|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
20078613|NCT00314353|Irinotecan|irinotecan|mesh-list
20078614|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078615|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078616|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20078617|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20078618|NCT00314353|Growth Substances|growth substances|mesh-ancestor
20078619|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078620|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
20078621|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078622|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
20078623|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078624|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20078625|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20078626|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20119989|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
20119990|NCT00006258|Methotrexate|methotrexate|mesh-list
20119991|NCT00006258|Etoposide|etoposide|mesh-list
20119992|NCT00006258|Vincristine|vincristine|mesh-list
20119993|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20119994|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
20587649|NCT02135887|Hematinics|hematinics|mesh-ancestor
20587650|NCT02135913|Vitamin D|vitamin d|mesh-list
20587651|NCT02135913|Vitamins|vitamins|mesh-ancestor
20119995|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587652|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
20587653|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606526|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
20587654|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20587655|NCT02135965|Caffeine|caffeine|mesh-list
20587656|NCT02135965|Albuterol|albuterol|mesh-list
20587657|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20587658|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587659|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20587660|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587661|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587662|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20587663|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20587664|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
20587665|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587666|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20587667|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
20587668|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587669|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20587670|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
20587671|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
20587672|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20587673|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20587674|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20587675|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587676|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587677|NCT02136030|Amphotericin B|amphotericin b|mesh-list
20587678|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20587679|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20587680|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
20587681|NCT02136030|Amebicides|amebicides|mesh-ancestor
20587682|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20078627|NCT00314327|Risperidone|risperidone|mesh-list
20078628|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20078629|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
20078630|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078631|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078632|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078633|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20078634|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587683|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20587684|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587685|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587686|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
20587687|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20587688|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587689|NCT02136147|Guanfacine|guanfacine|mesh-list
20587690|NCT02136147|Methylphenidate|methylphenidate|mesh-list
20587691|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20587692|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20587693|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20587694|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587695|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20587696|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20078635|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078636|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20078637|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20078638|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
20078639|NCT00308113|Ubiquinone|ubiquinone|mesh-list
20078640|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
20078641|NCT00308113|Prednisone|prednisone|mesh-list
20078642|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078643|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
20078644|NCT00308113|Hormones|hormones|mesh-ancestor
20078645|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078646|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078647|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20078648|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078649|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
20078650|NCT00308113|Vitamins|vitamins|mesh-ancestor
20587697|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078651|NCT00305643|Celecoxib|celecoxib|mesh-list
20587698|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587699|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
20587700|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587701|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20587702|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587703|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20587704|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20078652|NCT00305643|Capecitabine|capecitabine|mesh-list
20078653|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078654|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
20587705|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20587706|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587707|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20078655|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078656|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078657|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20078658|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20078659|NCT00305643|Analgesics|analgesics|mesh-ancestor
20078660|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
20587708|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
20587709|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
20587710|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20587711|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20587712|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587713|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587714|NCT02136329|Urological Agents|urological agents|mesh-ancestor
20587715|NCT02136511|Rituximab|rituximab|mesh-list
20587716|NCT02136511|Idelalisib|idelalisib|mesh-list
20078661|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078662|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587717|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20587718|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587719|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
20587720|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587721|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587722|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587723|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587724|NCT02136589|Diclofenac|diclofenac|mesh-list
20587725|NCT02136589|Travoprost|travoprost|mesh-list
20587726|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20587727|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20587728|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20587729|NCT02136589|Analgesics|analgesics|mesh-ancestor
20587730|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
20587731|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587732|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587733|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587734|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587735|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20587736|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587737|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587738|NCT02136641|Fentanyl|fentanyl|mesh-list
20587739|NCT02136641|Midazolam|midazolam|mesh-list
20587740|NCT02136641|Ketamine|ketamine|mesh-list
20587741|NCT02136641|Analgesics|analgesics|mesh-ancestor
20587742|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
20587743|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587744|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587745|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20587746|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20587747|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
20587748|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
20587749|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587750|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20587751|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20587752|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587753|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587754|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20587755|NCT02136641|Narcotics|narcotics|mesh-ancestor
20587756|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20587757|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20078663|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078664|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078665|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20587758|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20587759|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587760|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587761|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
20078666|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20078667|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078668|NCT00298740|Insulin|insulin|mesh-list
20078669|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20078670|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078671|NCT00301080|Cycloserine|cycloserine|mesh-list
20078672|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20078673|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078674|NCT00301080|Renal Agents|renal agents|mesh-ancestor
20078675|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20078676|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
20078677|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587762|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
20587763|NCT02136693|Psyllium|psyllium|mesh-list
20587764|NCT02136693|Cathartics|cathartics|mesh-ancestor
20587765|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587766|NCT02136771|Vitamin D|vitamin d|mesh-list
20587767|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
20587768|NCT02136771|Vitamins|vitamins|mesh-ancestor
20587769|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
20587770|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587771|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20587772|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20587773|NCT02136784|Morphine|morphine|mesh-list
20078678|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
20078679|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078680|NCT00299195|Sulindac|sulindac|mesh-list
20078681|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20078682|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20078683|NCT00299195|Analgesics|analgesics|mesh-ancestor
20078684|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
20078685|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078686|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078687|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078688|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078689|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078690|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20078691|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078692|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078693|NCT00290407|Rituximab|rituximab|mesh-list
20078694|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078695|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587774|NCT02136784|Oxycodone|oxycodone|mesh-list
20587775|NCT02136784|Buprenorphine|buprenorphine|mesh-list
20587776|NCT02136784|Hydromorphone|hydromorphone|mesh-list
20587777|NCT02136784|Hydrocodone|hydrocodone|mesh-list
20587778|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20587779|NCT02136784|Narcotics|narcotics|mesh-ancestor
20587780|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587781|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587782|NCT02136784|Analgesics|analgesics|mesh-ancestor
20587783|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
20587784|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587785|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20587786|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
20587787|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
20587788|NCT02136823|Isradipine|isradipine|mesh-list
20587789|NCT02136823|Riluzole|riluzole|mesh-list
20587790|NCT02136823|Memantine|memantine|mesh-list
20587791|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20587792|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20587793|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
20587794|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587795|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587796|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587797|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20587798|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20587799|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
20587800|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20078696|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
20587801|NCT02136823|Protective Agents|protective agents|mesh-ancestor
20078697|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587802|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20587803|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20587804|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20587805|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20587806|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
20587807|NCT02136875|Fluticasone|fluticasone|mesh-list
20587808|NCT02136875|Xhance|xhance|mesh-list
20587809|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20587810|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587811|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20587812|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
20587813|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587814|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587815|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20587816|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
20587817|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
20587818|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20587819|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20587820|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20587821|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20587822|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
20587823|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587824|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587825|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
20587826|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20078698|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078699|NCT00268463|Capecitabine|capecitabine|mesh-list
20587827|NCT02136888|Ponesimod|ponesimod|mesh-list
20587828|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587829|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587830|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20587831|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20587832|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587833|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587834|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587835|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20587836|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
20587837|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20587838|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587839|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20587840|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20587841|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20587842|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20587843|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078700|NCT00268463|Floxuridine|floxuridine|mesh-list
20078701|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
20078702|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078703|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
20078704|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078705|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078706|NCT00276419|Diclofenac|diclofenac|mesh-list
20078707|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20587844|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
20606527|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606528|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606529|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606530|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606531|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20606532|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20606533|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20606534|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606535|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078708|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20078709|NCT00276419|Analgesics|analgesics|mesh-ancestor
20606536|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606537|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
20606538|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606539|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606540|NCT02238132|Ipratropium|ipratropium|mesh-list
20606541|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606542|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
20606543|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606544|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606545|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606546|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
20078710|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
20587845|NCT02136979|Propofol|propofol|mesh-list
20587846|NCT02136979|Sevoflurane|sevoflurane|mesh-list
20587847|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20587848|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587849|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587850|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20587851|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
20587852|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
20587853|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20587854|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20587855|NCT02136992|Pirfenidone|pirfenidone|mesh-list
20587856|NCT02136992|Analgesics|analgesics|mesh-ancestor
20587857|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
20587858|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587859|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587860|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20587861|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20587862|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587863|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587864|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587865|NCT02137083|Docetaxel|docetaxel|mesh-list
20587866|NCT02137083|Fulvestrant|fulvestrant|mesh-list
20587867|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587868|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
20587869|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
20587870|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
20587871|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587872|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20587873|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20587874|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20587875|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
20078711|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078712|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078713|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078714|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078715|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20078716|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078717|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078718|NCT00279409|Aripiprazole|aripiprazole|mesh-list
20078719|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
20078720|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20078721|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20078722|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20078723|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078724|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078725|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
20078726|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
20078727|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078728|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078729|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20078730|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19492090|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492091|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19492092|NCT03126097|Estrogens|estrogens|mesh-ancestor
19492093|NCT03126097|Hormones|hormones|mesh-ancestor
20078731|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
20078732|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20078733|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20078734|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20587876|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492094|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492095|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19492096|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
20587877|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587878|NCT02137109|Natalizumab|natalizumab|mesh-list
20587879|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
20587880|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587881|NCT02137161|Tobramycin|tobramycin|mesh-list
20587882|NCT02137161|Dexamethasone|dexamethasone|mesh-list
20587883|NCT02137161|Bromfenac|bromfenac|mesh-list
20587884|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20587885|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587886|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
20587887|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
20587888|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587889|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587890|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587891|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
20587892|NCT02137161|Hormones|hormones|mesh-ancestor
20587893|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587894|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20587895|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587896|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20587897|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587898|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587899|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20587900|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20587901|NCT02137161|Analgesics|analgesics|mesh-ancestor
20587902|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
20587903|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587904|NCT02137213|Naloxone|naloxone|mesh-list
20587905|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20587906|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587907|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
20587908|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587909|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
20587910|NCT02137239|Prednisone|prednisone|mesh-list
20587911|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
20587912|NCT02137239|Everolimus|everolimus|mesh-list
20587913|NCT02137239|Abatacept|abatacept|mesh-list
20587914|NCT02137239|Tacrolimus|tacrolimus|mesh-list
20587915|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
20587916|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587917|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
20587918|NCT02137239|Hormones|hormones|mesh-ancestor
20587919|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587920|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587921|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20587922|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587923|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20587924|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
20587925|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20078735|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20078736|NCT00281879|Cytarabine|cytarabine|mesh-list
20078737|NCT00281879|Cyclosporine|cyclosporine|mesh-list
20078738|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
20078739|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
20587926|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078740|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
20078741|NCT00281879|Melphalan|melphalan|mesh-list
20078742|NCT00281879|Busulfan|busulfan|mesh-list
20078743|NCT00281879|Carmustine|carmustine|mesh-list
20078744|NCT00281879|Methotrexate|methotrexate|mesh-list
20078745|NCT00281879|Fludarabine|fludarabine|mesh-list
20078746|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
20078747|NCT00281879|Etoposide|etoposide|mesh-list
20078748|NCT00281879|Tacrolimus|tacrolimus|mesh-list
20078749|NCT00281879|Cyclosporins|cyclosporins|mesh-list
20078750|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20078751|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078752|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
20078753|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078754|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078755|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20078756|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
20078757|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078758|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078759|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20078760|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20078761|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
20078762|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20078763|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078764|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
20078765|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
20078766|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078767|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20587927|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078768|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20078769|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078770|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20587928|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20587929|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20587930|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
20587931|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20587932|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20587933|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
20587934|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
20587935|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587936|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587937|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20587938|NCT02137239|Protective Agents|protective agents|mesh-ancestor
20587939|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20587940|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20587941|NCT02137265|Clomiphene|clomiphene|mesh-list
20587942|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20587943|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
20587944|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078771|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20078772|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
20078773|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078774|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20078775|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
20078776|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078777|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20078778|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
20078779|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20078780|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078781|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
20078782|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
20078783|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078784|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20078785|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
20587945|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587946|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20587947|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
20078786|NCT00281879|Hormones|hormones|mesh-ancestor
20078787|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078788|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20078789|NCT00281879|Protective Agents|protective agents|mesh-ancestor
20078790|NCT00271011|Irinotecan|irinotecan|mesh-list
20078791|NCT00271011|Cetuximab|cetuximab|mesh-list
20078792|NCT00271011|Mitomycins|mitomycins|mesh-list
20078793|NCT00271011|Mitomycin|mitomycin|mesh-list
20078794|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20078795|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20078796|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078797|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078798|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078799|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078800|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078801|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
20078802|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20078803|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20587948|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20587949|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20587950|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20587951|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
20587952|NCT02137278|Levodopa|levodopa|mesh-list
20587953|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
20587954|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
20587955|NCT02137278|Diuretics|diuretics|mesh-list
20587956|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587957|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
20587958|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587959|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
20587960|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20587961|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587962|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20587963|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20587964|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20587965|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20587966|NCT02137356|Capecitabine|capecitabine|mesh-list
20587967|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20587968|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
20587969|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587970|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587971|NCT02137395|Dexamethasone|dexamethasone|mesh-list
20078804|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
20078805|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078806|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20587972|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20587973|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
20587974|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
20587975|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20587976|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587977|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20587978|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
20078807|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
20078808|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078809|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078810|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20078811|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20078812|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078813|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078814|NCT00256295|Gemcitabine|gemcitabine|mesh-list
20587979|NCT02137395|Hormones|hormones|mesh-ancestor
20587980|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20587981|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20587982|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20587983|NCT02137421|Resveratrol|resveratrol|mesh-list
20587984|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
20587985|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20587986|NCT02137421|Protective Agents|protective agents|mesh-ancestor
20587987|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587988|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20587989|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20587990|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
20587991|NCT02137434|Calcium|calcium|mesh-list
20587992|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20587993|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20587994|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20587995|NCT02137525|Fentanyl|fentanyl|mesh-list
20587996|NCT02137525|Morphine|morphine|mesh-list
20587997|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20587998|NCT02137525|Narcotics|narcotics|mesh-ancestor
20587999|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588000|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588001|NCT02137525|Analgesics|analgesics|mesh-ancestor
20588002|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
20588003|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588004|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20588005|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20588006|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
20588007|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
20588008|NCT02137616|Olanzapine|olanzapine|mesh-list
20588009|NCT02137616|Risperidone|risperidone|mesh-list
20588010|NCT02137616|Aripiprazole|aripiprazole|mesh-list
20588011|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20588012|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20588013|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
20588014|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588015|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588016|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588017|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20588018|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588019|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588020|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20588021|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20078815|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
20078816|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078817|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
20588022|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
20588023|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
20588024|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
20588025|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588026|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20588027|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20588028|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20588029|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588030|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
20588031|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
20588032|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20078818|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078819|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078820|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
20588033|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20588034|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20588035|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20588036|NCT02137629|Azacitidine|azacitidine|mesh-list
20588037|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20588038|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
20588039|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588040|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588041|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588042|NCT02137668|Vancomycin|vancomycin|mesh-list
20588043|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588044|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588045|NCT02137681|Rituximab|rituximab|mesh-list
20588046|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20588047|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588048|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
20588049|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588050|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20588051|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20588052|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20588053|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588054|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588055|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
20588056|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588057|NCT02137733|Carvedilol|carvedilol|mesh-list
20588058|NCT02137733|Bisoprolol|bisoprolol|mesh-list
20588059|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20588060|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20588061|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588062|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588063|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588064|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588065|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20588066|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
20588067|NCT02137733|Protective Agents|protective agents|mesh-ancestor
20588068|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20588069|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588070|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20588071|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
20588072|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20588073|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20588074|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
20588075|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
20588076|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588077|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20588078|NCT02137759|Temozolomide|temozolomide|mesh-list
20588079|NCT02137759|Belinostat|belinostat|mesh-list
20588080|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20588081|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
20588082|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588083|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588084|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20588085|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588086|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
20588087|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20588088|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588089|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588090|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20588091|NCT02137863|Analgesics|analgesics|mesh-ancestor
20588092|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
20588093|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588094|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20588095|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20588096|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20588097|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588098|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078821|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078822|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078823|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588099|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588100|NCT02137928|Carboplatin|carboplatin|mesh-list
20588101|NCT02137928|Etoposide|etoposide|mesh-list
20588102|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
20588103|NCT02137928|Vincristine|vincristine|mesh-list
20078824|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
20078825|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078826|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
20078827|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078828|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20078829|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078830|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078831|NCT00268450|Gemcitabine|gemcitabine|mesh-list
20078832|NCT00268450|Paclitaxel|paclitaxel|mesh-list
20078833|NCT00268450|Bevacizumab|bevacizumab|mesh-list
20078834|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078835|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078836|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078837|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078838|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078839|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078840|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078841|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20078842|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20078843|NCT00268450|Growth Substances|growth substances|mesh-ancestor
20078844|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078845|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20078846|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20078847|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
20078848|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
20078849|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078850|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078851|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078852|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
20078853|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
20078854|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
20078855|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078856|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078857|NCT00250718|Levofloxacin|levofloxacin|mesh-list
20078858|NCT00250718|Ofloxacin|ofloxacin|mesh-list
20078859|NCT00250718|Dexamethasone|dexamethasone|mesh-list
20078860|NCT00250718|Rituximab|rituximab|mesh-list
20078861|NCT00250718|Etoposide|etoposide|mesh-list
20078862|NCT00250718|Vincristine|vincristine|mesh-list
20078863|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20078864|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078865|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
20078866|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078867|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20078868|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078869|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
20078870|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
20078871|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078872|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20078873|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
20078874|NCT00250718|Hormones|hormones|mesh-ancestor
20078875|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078876|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20078877|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588104|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078878|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20078879|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20078880|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078881|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078882|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078883|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078884|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078885|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20078886|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20078887|NCT00250718|Renal Agents|renal agents|mesh-ancestor
20078888|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588105|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588106|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20588107|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20588108|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588109|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588110|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
20588111|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
20588112|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
20588113|NCT02137954|Lidocaine|lidocaine|mesh-list
20588114|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
20588115|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
20588116|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588117|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588118|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
20588119|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078889|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20078890|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20078891|NCT00218036|Dexetimide|dexetimide|mesh-list
20078892|NCT00218036|Modafinil|modafinil|mesh-list
20078893|NCT00218036|Citalopram|citalopram|mesh-list
20078894|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20588120|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20588121|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20588122|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20588123|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588124|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588125|NCT02137993|Olanzapine|olanzapine|mesh-list
20588126|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
20588127|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
20588128|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588129|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588130|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20588131|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20588132|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588133|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588134|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20588135|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20588136|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20588137|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588138|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588139|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588140|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
20588141|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20588142|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
20588143|NCT02138019|Coagulants|coagulants|mesh-ancestor
20588144|NCT02138045|Liraglutide|liraglutide|mesh-list
20588145|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20588146|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588147|NCT02138045|Incretins|incretins|mesh-ancestor
20588148|NCT02138045|Hormones|hormones|mesh-ancestor
20588149|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588150|NCT02138058|Topiramate|topiramate|mesh-list
20588151|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
20588152|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20588153|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588154|NCT02138084|Ritonavir|ritonavir|mesh-list
20588155|NCT02138084|Fostemsavir|fostemsavir|mesh-list
20588156|NCT02138084|Rifabutin|rifabutin|mesh-list
20588157|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20588158|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20588159|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
20588160|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588161|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588162|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20588163|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20588164|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
20588165|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588166|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20588167|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20588168|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588169|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20588170|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
20588171|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20588172|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20588173|NCT02138292|Trametinib|trametinib|mesh-list
20588174|NCT02138292|Digoxin|digoxin|mesh-list
20588175|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588176|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588177|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078895|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20606547|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20588178|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588179|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20588180|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20588181|NCT02138292|Protective Agents|protective agents|mesh-ancestor
20588182|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588183|NCT02138357|Buprenorphine|buprenorphine|mesh-list
20588184|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20588185|NCT02138357|Narcotics|narcotics|mesh-ancestor
20588186|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588187|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588188|NCT02138357|Analgesics|analgesics|mesh-ancestor
20588189|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
20588190|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588191|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20588192|NCT02138383|Gemcitabine|gemcitabine|mesh-list
20588193|NCT02138383|Paclitaxel|paclitaxel|mesh-list
20588194|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20588195|NCT02138383|Androgens|androgens|mesh-list
20588196|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588197|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588198|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
20588199|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
20588200|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
20588201|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588202|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20588203|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
20588204|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
20588205|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588206|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588207|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078896|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20078897|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078898|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078899|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
20078900|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078901|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20078902|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
20078903|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20078904|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20078905|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20078906|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
20078907|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
20078908|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20078909|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20078910|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20078911|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
20588208|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
20588209|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078912|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20078913|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20078914|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20078915|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20078916|NCT00240227|Prazosin|prazosin|mesh-list
20078917|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20078918|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20078919|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20078920|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20078921|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078922|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078923|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078924|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078925|NCT00206375|Hormones|hormones|mesh-list
20119996|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20588210|NCT02138383|Hormones|hormones|mesh-ancestor
20606548|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
20588211|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588212|NCT02138396|Fentanyl|fentanyl|mesh-list
20588213|NCT02138396|Naltrexone|naltrexone|mesh-list
20588214|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20588215|NCT02138396|Narcotics|narcotics|mesh-ancestor
20588216|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078926|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078927|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078928|NCT00229931|Triamcinolone|triamcinolone|mesh-list
20078929|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20078930|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20078931|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20078932|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20078933|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
20078934|NCT00229931|Hormones|hormones|mesh-ancestor
20078935|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20078936|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078937|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20078938|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
20078939|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078940|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078941|NCT00209131|Tamsulosin|tamsulosin|mesh-list
20078942|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20078943|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20078944|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20078945|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
20078946|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078947|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078948|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078949|NCT00209131|Urological Agents|urological agents|mesh-ancestor
20078950|NCT00233090|Modafinil|modafinil|mesh-list
20588217|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588218|NCT02138396|Analgesics|analgesics|mesh-ancestor
20588219|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
20078951|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20588220|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588221|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20588222|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20588223|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
20588224|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
20588225|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20588226|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20588227|NCT02138409|Fentanyl|fentanyl|mesh-list
20588228|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20588229|NCT02138409|Narcotics|narcotics|mesh-ancestor
20588230|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588231|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588232|NCT02138409|Analgesics|analgesics|mesh-ancestor
20588233|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
20588234|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588235|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20588236|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20588237|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
20588238|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
20588239|NCT02138500|PF-06372865|pf-06372865|mesh-list
20588240|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
20078952|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588241|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
20588242|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588243|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078953|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20078954|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20078955|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20078956|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078957|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
20078958|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20078959|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20078960|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078961|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20078962|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20078963|NCT00205049|Protective Agents|protective agents|mesh-ancestor
20078964|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078965|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
20078966|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20078967|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
20078968|NCT00209027|Aripiprazole|aripiprazole|mesh-list
20078969|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
20078970|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20078971|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20078972|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588244|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588245|NCT02138539|Hydroquinone|hydroquinone|mesh-list
20588246|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
20588247|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588248|NCT02138539|Protective Agents|protective agents|mesh-ancestor
20588249|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588250|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20588251|NCT02138552|Octenidine|octenidine|mesh-list
20588252|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588253|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20588254|NCT02138617|Leucovorin|leucovorin|mesh-list
20588255|NCT02138617|Bevacizumab|bevacizumab|mesh-list
20588256|NCT02138617|Fluorouracil|fluorouracil|mesh-list
20588257|NCT02138617|Irinotecan|irinotecan|mesh-list
20588258|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
20588259|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20588260|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588261|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20588262|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20588263|NCT02138617|Growth Substances|growth substances|mesh-ancestor
20588264|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588265|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
20588266|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
20588267|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588268|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20588269|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588270|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
20588271|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20588272|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20588273|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588274|NCT02138617|Antidotes|antidotes|mesh-ancestor
20588275|NCT02138617|Protective Agents|protective agents|mesh-ancestor
20588276|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
20588277|NCT02138617|Vitamins|vitamins|mesh-ancestor
20588278|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
20078973|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20078974|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20078975|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
20078976|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
20078977|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588279|NCT02138630|Capsaicin|capsaicin|mesh-list
20588280|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
20588281|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
20588282|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
20588283|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588284|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606549|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606550|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606551|NCT02238145|Ipratropium|ipratropium|mesh-list
20606552|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606553|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
20606554|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606555|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606556|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606557|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
20588285|NCT02138708|Adenosine|adenosine|mesh-list
20588286|NCT02138708|Acetylcholine|acetylcholine|mesh-list
20588287|NCT02138708|Analgesics|analgesics|mesh-ancestor
20588288|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
20588289|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588290|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588291|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20588292|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
20588293|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20588294|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
20588295|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
20588296|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20078978|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078979|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20078980|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20078981|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
20078982|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20078983|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20078984|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20078985|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20078986|NCT00182637|Bortezomib|bortezomib|mesh-list
20078987|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078988|NCT00176488|Vinorelbine|vinorelbine|mesh-list
20588297|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588298|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20588299|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
20588300|NCT02138773|Tamsulosin|tamsulosin|mesh-list
20588301|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20588302|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20588303|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20588304|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588305|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588306|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20078989|NCT00176488|Epirubicin|epirubicin|mesh-list
20078990|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20078991|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20078992|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
20078993|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
20078994|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
20078995|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588307|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588308|NCT02138773|Urological Agents|urological agents|mesh-ancestor
20588309|NCT02138799|Rifampin|rifampin|mesh-list
20588310|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20588311|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
20588312|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588313|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588314|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
20588315|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20588316|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588317|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588318|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20588319|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20588320|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20588321|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20588322|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20588323|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20588324|NCT02138812|Paclitaxel|paclitaxel|mesh-list
20588325|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588326|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588327|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20588328|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20588329|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20588330|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588331|NCT02138929|Everolimus|everolimus|mesh-list
20588332|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588333|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588334|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
20588335|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588336|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20588337|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
20588338|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588339|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20588340|NCT02139098|Amitriptyline|amitriptyline|mesh-list
20588341|NCT02139098|Zolpidem|zolpidem|mesh-list
20588342|NCT02139098|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20588343|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20588344|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20588345|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588346|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588347|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20588348|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
20588349|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
20078996|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20078997|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20078998|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20078999|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079000|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
20079001|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20079002|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079003|NCT00183963|Tamoxifen|tamoxifen|mesh-list
20079004|NCT00183963|Fulvestrant|fulvestrant|mesh-list
20079005|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20079006|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
20079007|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079008|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079009|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20079010|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079011|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20079012|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20079013|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20079014|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20079015|NCT00162773|Omalizumab|omalizumab|mesh-list
20079016|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20079017|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20079018|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
20079019|NCT00176631|Docetaxel|docetaxel|mesh-list
20079020|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079021|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079022|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079023|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079024|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079025|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
20079026|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20079027|NCT00177970|Antibodies|antibodies|mesh-list
20588350|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588351|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588352|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20588353|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
20588354|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20079028|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
20079029|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
20079030|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20079031|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
20079032|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079033|NCT00177866|Celecoxib|celecoxib|mesh-list
20079034|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20079035|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20079036|NCT00177866|Analgesics|analgesics|mesh-ancestor
20079037|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
20079038|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079039|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079040|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079041|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079042|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20079043|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20079044|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079045|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079046|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
20588355|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20588356|NCT02139098|Analgesics|analgesics|mesh-ancestor
20588357|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
20588358|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588359|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20079047|NCT00165503|Pemetrexed|pemetrexed|mesh-list
20079048|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588360|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20588361|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588362|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588363|NCT02139098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20588364|NCT02139098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588365|NCT02139241|Ramosetron|ramosetron|mesh-list
20588366|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
20588367|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
20588368|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588369|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588370|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20588371|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20588372|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
20588373|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588374|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588375|NCT02139267|Vaccines|vaccines|mesh-list
20588376|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
20588377|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588378|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
20588379|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20588380|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588381|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588382|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
20588383|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588384|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588385|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20588386|NCT02139579|Bevacizumab|bevacizumab|mesh-list
20588387|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20079049|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079050|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079051|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20588388|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588389|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20079052|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20079053|NCT00165503|Antidotes|antidotes|mesh-ancestor
20079054|NCT00165503|Protective Agents|protective agents|mesh-ancestor
20079055|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079056|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
20079057|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
20079058|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20079059|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588390|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20588391|NCT02139579|Growth Substances|growth substances|mesh-ancestor
20588392|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588393|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
20588394|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20588395|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20588396|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20588397|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
20588398|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
20588399|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
20588400|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588401|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
20588402|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20588403|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20588404|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20588405|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588406|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079060|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
20079061|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
20079062|NCT00160563|Levocetirizine|levocetirizine|mesh-list
20079063|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20079064|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20079065|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
20079066|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
20079067|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079068|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079069|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079070|NCT00142519|Morphine|morphine|mesh-list
20079071|NCT00142519|Methadone|methadone|mesh-list
20588407|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20588408|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492097|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20079072|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20588409|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20588410|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588411|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588412|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20588413|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20588414|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
20588415|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588416|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588417|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20588418|NCT02139761|Analgesics|analgesics|mesh-ancestor
20588419|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
20588420|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588421|NCT02139852|Capsaicin|capsaicin|mesh-list
20588422|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
20588423|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
20588424|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
20588425|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588426|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588427|NCT02139904|Vinorelbine|vinorelbine|mesh-list
20588428|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079073|NCT00142519|Narcotics|narcotics|mesh-ancestor
20079074|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20079075|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079076|NCT00142519|Analgesics|analgesics|mesh-ancestor
20079077|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
20079078|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079079|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
20079080|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
20079081|NCT00145704|Vitamin D|vitamin d|mesh-list
20079082|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
20079083|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
20079084|NCT00145704|Diphosphonates|diphosphonates|mesh-list
20079085|NCT00145704|Vitamins|vitamins|mesh-list
20079086|NCT00145704|Calcium|calcium|mesh-list
20079087|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
20079088|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079089|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20079090|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20079091|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20079092|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20079093|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079094|NCT00113386|Docetaxel|docetaxel|mesh-list
20079095|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079096|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079097|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079098|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079099|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079100|NCT00138151|Interferons|interferons|mesh-list
20079101|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
20079102|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
20588429|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588430|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079103|NCT00138151|Paclitaxel|paclitaxel|mesh-list
20079104|NCT00138151|Isotretinoin|isotretinoin|mesh-list
20079105|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079106|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079107|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079108|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079109|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079110|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079111|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
20079112|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079113|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
20079114|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079115|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
20079116|NCT00129974|Gemcitabine|gemcitabine|mesh-list
20588431|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
20588432|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
20588433|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588434|NCT02139930|Nicotine|nicotine|mesh-list
20079117|NCT00129974|Pemetrexed|pemetrexed|mesh-list
20079118|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20079119|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
20588435|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20588436|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
20588437|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588438|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588439|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20588440|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20588441|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
20588442|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588443|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079120|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079121|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079122|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
20079123|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079124|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079125|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079126|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
20079127|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079128|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20079129|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20079130|NCT00126659|Sorafenib|sorafenib|mesh-list
20079131|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079132|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588444|NCT02140047|Vaccines|vaccines|mesh-list
20588445|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
20588446|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588447|NCT02140073|Domperidone|domperidone|mesh-list
20588448|NCT02140073|Omeprazole|omeprazole|mesh-list
20588449|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20588450|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20588451|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20588452|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588453|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588454|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
20588455|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
20588456|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588457|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588458|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20588459|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
20588460|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588461|NCT02140151|Ranibizumab|ranibizumab|mesh-list
20588462|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20588463|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20079133|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079134|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079135|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
20079136|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
20079137|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20079138|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20079139|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079140|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079141|NCT00133679|Urological Agents|urological agents|mesh-ancestor
20079142|NCT00113399|Paclitaxel|paclitaxel|mesh-list
20079143|NCT00113399|Docetaxel|docetaxel|mesh-list
20079144|NCT00113399|Fluorouracil|fluorouracil|mesh-list
20079145|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588464|NCT02140151|Growth Substances|growth substances|mesh-ancestor
20588465|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588466|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
20588467|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588468|NCT02140242|Daunorubicin|daunorubicin|mesh-list
20588469|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20588470|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588471|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20588472|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20588473|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588474|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588475|NCT02140255|Ritonavir|ritonavir|mesh-list
20588476|NCT02140255|Lopinavir|lopinavir|mesh-list
20588477|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
20588478|NCT02140255|Nevirapine|nevirapine|mesh-list
20588479|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20079146|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079147|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079148|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079149|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079150|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588480|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20588481|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20588482|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
20588483|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588484|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588485|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20588486|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20588487|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
20588488|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588489|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20588490|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20588491|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20588492|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20588493|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20588494|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20588495|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20588496|NCT02140268|Midazolam|midazolam|mesh-list
20588497|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20588498|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20588499|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588500|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588501|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20588502|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588503|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20079151|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
20079152|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20079153|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079154|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
20079155|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588504|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20588505|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
20588506|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
20588507|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
20588508|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
20588509|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588510|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588511|NCT02140281|Cefadroxil|cefadroxil|mesh-list
20079156|NCT00118053|Carboplatin|carboplatin|mesh-list
20079157|NCT00118053|Docetaxel|docetaxel|mesh-list
20079158|NCT00118053|Trastuzumab|trastuzumab|mesh-list
20079159|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079160|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079161|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079162|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
20588512|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588513|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588514|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20588515|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588516|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588517|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588518|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606558|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20079163|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079164|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20079165|NCT00107614|Rituximab|rituximab|mesh-list
20079166|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20079167|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606559|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606560|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606561|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606562|NCT02238158|Ipratropium|ipratropium|mesh-list
20606563|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606564|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
20606565|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606566|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606567|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606568|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606569|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606570|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606571|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606572|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606573|NCT02238171|Ipratropium|ipratropium|mesh-list
20079168|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
20588519|NCT02140437|Fulvestrant|fulvestrant|mesh-list
20588520|NCT02140437|Anastrozole|anastrozole|mesh-list
20588521|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20588522|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588523|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20588524|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20588525|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
20588526|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588527|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588528|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20588529|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20588530|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588531|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588532|NCT02140450|Timolol|timolol|mesh-list
20588533|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20588534|NCT02140450|Mannitol|mannitol|mesh-list
20588535|NCT02140450|Acetazolamide|acetazolamide|mesh-list
20588536|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20588537|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20588538|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588539|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588540|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588541|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588542|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20588543|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20588544|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20588545|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20588546|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20588547|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20588548|NCT02140450|Diuretics|diuretics|mesh-ancestor
20588549|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
20588550|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
20588551|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20588552|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588553|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20588554|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20079169|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079170|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079171|NCT00107315|Bevacizumab|bevacizumab|mesh-list
20079172|NCT00107315|Capecitabine|capecitabine|mesh-list
20079173|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20079174|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079175|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20079176|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20079177|NCT00107315|Growth Substances|growth substances|mesh-ancestor
20079178|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079179|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
20079180|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20079181|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
20079182|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079183|NCT00108433|Vancomycin|vancomycin|mesh-list
20588555|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20079184|NCT00108433|Cefazolin|cefazolin|mesh-list
20079185|NCT00108433|Linezolid|linezolid|mesh-list
20079186|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20079187|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079188|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20079189|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079190|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079191|NCT00113919|Busulfan|busulfan|mesh-list
20079192|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
20079193|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079194|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079195|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
20079196|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079197|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20079198|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079199|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20079200|NCT00108342|Nicotine|nicotine|mesh-list
20079201|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20079202|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
20588556|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
20588557|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588558|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20588559|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20588560|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588561|NCT02140515|Hormones|hormones|mesh-list
20588562|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20588563|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588564|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588565|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20588566|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
20588567|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
20588568|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20588569|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20588570|NCT02140632|Prednisolone|prednisolone|mesh-list
20588571|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
20588572|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20588573|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
20588574|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20588575|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
20588576|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
20588577|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588578|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588579|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20588580|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
20588581|NCT02140632|Hormones|hormones|mesh-ancestor
20588582|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588583|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20588584|NCT02140632|Protective Agents|protective agents|mesh-ancestor
20588585|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20588586|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588587|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
20588588|NCT02140736|Hematinics|hematinics|mesh-ancestor
20588589|NCT02140801|Clopidogrel|clopidogrel|mesh-list
20588590|NCT02140801|Ticagrelor|ticagrelor|mesh-list
20588591|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20588592|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20588593|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20588594|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20588595|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
20588596|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588597|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588598|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588599|NCT02140814|Niacinamide|niacinamide|mesh-list
20588600|NCT02140814|Niacin|niacin|mesh-list
20588601|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
20588602|NCT02140814|Vitamins|vitamins|mesh-ancestor
20588603|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
20588604|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588605|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
20588606|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20588607|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
20588608|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588609|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20588610|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
20588611|NCT02140840|Trametinib|trametinib|mesh-list
20588612|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588613|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588614|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588615|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588616|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
20588617|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20588618|NCT02140983|Liraglutide|liraglutide|mesh-list
20588619|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20588620|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588621|NCT02140983|Incretins|incretins|mesh-ancestor
20588622|NCT02140983|Hormones|hormones|mesh-ancestor
20079203|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079204|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079205|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20079206|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20079207|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
20079208|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588623|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588624|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20588625|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
20079209|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079210|NCT00100828|Irinotecan|irinotecan|mesh-list
20079211|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20588626|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588627|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
20588628|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
20588629|NCT02141035|Vitamins|vitamins|mesh-ancestor
20588630|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
20588631|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588632|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
20588633|NCT02141087|Pirfenidone|pirfenidone|mesh-list
20588634|NCT02141087|Analgesics|analgesics|mesh-ancestor
20588635|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
20588636|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079212|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079213|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079214|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079215|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079216|NCT00104728|Gefitinib|gefitinib|mesh-list
20079217|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079218|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20079219|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588637|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588638|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20588639|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20588640|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20588641|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20588642|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588643|NCT02141100|Thioguanine|thioguanine|mesh-list
20588644|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20588645|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
20588646|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588647|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079220|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079221|NCT00089414|Drospirenone|drospirenone|mesh-list
20079222|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20079223|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20079224|NCT00089414|Estradiol|estradiol|mesh-list
20079225|NCT00089414|Progesterone|progesterone|mesh-list
20079226|NCT00089414|Estrogens|estrogens|mesh-ancestor
20588648|NCT02141113|Guanfacine|guanfacine|mesh-list
20588649|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20588650|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20588651|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20588652|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20588653|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588654|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588655|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588656|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588657|NCT02141139|Ibuprofen|ibuprofen|mesh-list
20588658|NCT02141139|Ketorolac|ketorolac|mesh-list
20588659|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20079227|NCT00089414|Hormones|hormones|mesh-ancestor
20079228|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079229|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079230|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20079231|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
20079232|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20079233|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20079234|NCT00089414|Progestins|progestins|mesh-ancestor
20079235|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20079236|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20079237|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20079238|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
20079239|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20588660|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20588661|NCT02141139|Analgesics|analgesics|mesh-ancestor
20588662|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
20588663|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588664|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588665|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20588666|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20588667|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20079240|NCT00089414|Diuretics|diuretics|mesh-ancestor
20588668|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588669|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588670|NCT02141178|Bupivacaine|bupivacaine|mesh-list
20588671|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
20588672|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
20588673|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588674|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588675|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
20588676|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588677|NCT02141321|Alprostadil|alprostadil|mesh-list
20588678|NCT02141321|Misoprostol|misoprostol|mesh-list
20588679|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20588680|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
20588681|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20588682|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588683|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20588684|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20588685|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
20588686|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20588687|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
20588688|NCT02141321|Urological Agents|urological agents|mesh-ancestor
20588689|NCT02141347|Durvalumab|durvalumab|mesh-list
20588690|NCT02141347|Tremelimumab|tremelimumab|mesh-list
20588691|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20588692|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588693|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
20588694|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20588695|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588696|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588697|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20588698|NCT02141412|Analgesics|analgesics|mesh-ancestor
20588699|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
20588700|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588701|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20588702|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20588703|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20588704|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588705|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588706|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588707|NCT02141425|Peficitinib|peficitinib|mesh-list
20588708|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588709|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588710|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588711|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
20588712|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588713|NCT02141477|Decitabine|decitabine|mesh-list
20588714|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
20588715|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20588716|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
20588717|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588718|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588719|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588720|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588721|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20588722|NCT02141698|Esomeprazole|esomeprazole|mesh-list
20588723|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20588724|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20079241|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
20079242|NCT00083915|Thalidomide|thalidomide|mesh-list
20079243|NCT00083915|Dexamethasone|dexamethasone|mesh-list
20079244|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
20079245|NCT00083915|Melphalan|melphalan|mesh-list
20079246|NCT00083915|Cisplatin|cisplatin|mesh-list
20079247|NCT00083915|Doxorubicin|doxorubicin|mesh-list
20079248|NCT00083915|Etoposide|etoposide|mesh-list
20079249|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20079250|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079251|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
20079252|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079253|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079254|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20079255|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
20079256|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079257|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588725|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20588726|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079258|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20079259|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079260|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
20079261|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
20588727|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588728|NCT02141737|Lidocaine|lidocaine|mesh-list
20588729|NCT02141737|Fentanyl|fentanyl|mesh-list
20079262|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079263|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20588730|NCT02141737|Midazolam|midazolam|mesh-list
20588731|NCT02141737|Etomidate|etomidate|mesh-list
20588732|NCT02141737|Rocuronium|rocuronium|mesh-list
20588733|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
20588734|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
20588735|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588736|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588737|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
20588738|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588739|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20588740|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20588741|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20588742|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588743|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588744|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20588745|NCT02141737|Narcotics|narcotics|mesh-ancestor
20588746|NCT02141737|Analgesics|analgesics|mesh-ancestor
20588747|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20588748|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20588749|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
20588750|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20588751|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20588752|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588753|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20588754|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
20588755|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
20588756|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588757|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20588758|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20588759|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20588760|NCT02141958|Fenretinide|fenretinide|mesh-list
20588761|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588762|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20588763|NCT02141958|Protective Agents|protective agents|mesh-ancestor
20588764|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588765|NCT02142010|Paclitaxel|paclitaxel|mesh-list
20588766|NCT02142010|Cisplatin|cisplatin|mesh-list
20588767|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588768|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588769|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
20588770|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
20588771|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
20588772|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588773|NCT02142036|Trastuzumab|trastuzumab|mesh-list
20588774|NCT02142036|Cetuximab|cetuximab|mesh-list
20588775|NCT02142036|Panitumumab|panitumumab|mesh-list
20588776|NCT02142036|Everolimus|everolimus|mesh-list
20588777|NCT02142036|Sunitinib|sunitinib|mesh-list
20588778|NCT02142036|Dasatinib|dasatinib|mesh-list
20588779|NCT02142036|Lapatinib|lapatinib|mesh-list
20588780|NCT02142036|Gefitinib|gefitinib|mesh-list
20588781|NCT02142036|Afatinib|afatinib|mesh-list
20588782|NCT02142036|Vemurafenib|vemurafenib|mesh-list
20588783|NCT02142036|Dabrafenib|dabrafenib|mesh-list
20588784|NCT02142036|Crizotinib|crizotinib|mesh-list
20588785|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20588786|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588787|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588788|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
20588789|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588790|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588791|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588792|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588793|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20079264|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
20079265|NCT00083915|Hormones|hormones|mesh-ancestor
20119997|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20588794|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20588795|NCT02142036|Growth Substances|growth substances|mesh-ancestor
20588796|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
20588797|NCT02142075|Daptomycin|daptomycin|mesh-list
20588798|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588799|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588800|NCT02142140|Methylphenidate|methylphenidate|mesh-list
20588801|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20588802|NCT02142140|Adderall|adderall|mesh-list
20588803|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
20588804|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
20588805|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20588806|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588807|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20588808|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20079266|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079267|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20079268|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20079269|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20588809|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588810|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588811|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
20588812|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588813|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20588814|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606574|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606575|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
20606576|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606577|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606578|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606579|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606580|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606581|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606582|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606583|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606584|NCT02238184|Ipratropium|ipratropium|mesh-list
20606585|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606586|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
20606587|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606588|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606589|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606590|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606591|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606592|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606593|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606594|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606595|NCT02238197|Ipratropium|ipratropium|mesh-list
20606596|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606597|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
20606598|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606599|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606600|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606601|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606602|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606603|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606604|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606605|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606606|NCT02238210|Ipratropium|ipratropium|mesh-list
20606607|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606608|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
20606609|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606610|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606611|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606612|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606613|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20606614|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
20606615|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606616|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606617|NCT02238223|Epinastine|epinastine|mesh-list
20606618|NCT02238223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20606619|NCT02238223|Histamine Antagonists|histamine antagonists|mesh-ancestor
20606620|NCT02238223|Histamine Agents|histamine agents|mesh-ancestor
20606621|NCT02238223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606622|NCT02238223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606623|NCT02238223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606624|NCT02238236|Epinastine|epinastine|mesh-list
20588815|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
20588816|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20588817|NCT02142192|Natalizumab|natalizumab|mesh-list
20588818|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
20588819|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588820|NCT02142205|Natalizumab|natalizumab|mesh-list
20588821|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
20588822|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588823|NCT02142218|Nivolumab|nivolumab|mesh-list
20588824|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20588825|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588826|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20588827|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588828|NCT02142296|Aflibercept|aflibercept|mesh-list
20588829|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20588830|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20588831|NCT02142296|Growth Substances|growth substances|mesh-ancestor
20588832|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588833|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
20588834|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588835|NCT02142309|Pioglitazone|pioglitazone|mesh-list
20588836|NCT02142309|Glimepiride|glimepiride|mesh-list
20588837|NCT02142309|Vildagliptin|vildagliptin|mesh-list
20588838|NCT02142309|Canagliflozin|canagliflozin|mesh-list
20588839|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20588840|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588841|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20588842|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588843|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
20588844|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20588845|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
20588846|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588847|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588848|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20588849|NCT02142335|Rituximab|rituximab|mesh-list
20588850|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20588851|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588852|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
20588853|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588854|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20588855|NCT02142530|Belinostat|belinostat|mesh-list
20588856|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079270|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079271|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079272|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079273|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
20079274|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20079275|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079276|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20079277|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20079278|NCT00083915|Growth Substances|growth substances|mesh-ancestor
20079279|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
20079280|NCT00090870|Interferons|interferons|mesh-list
20079281|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
20079282|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
20079283|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20079284|NCT00090870|Thalidomide|thalidomide|mesh-list
20079285|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588857|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20588858|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588859|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588860|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
20588861|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
20588862|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
20588863|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20588864|NCT02142543|Protective Agents|protective agents|mesh-ancestor
20588865|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588866|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20588867|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
20588868|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20588869|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20588870|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588871|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20079286|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
20079287|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588872|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588873|NCT02142569|Tocotrienols|tocotrienols|mesh-list
20079288|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
20079289|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079290|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20588874|NCT02142569|Vitamin E|vitamin e|mesh-list
20588875|NCT02142569|Tocopherols|tocopherols|mesh-list
20588876|NCT02142569|Red yeast rice|red yeast rice|mesh-list
20588877|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
20588878|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588879|NCT02142569|Protective Agents|protective agents|mesh-ancestor
20588880|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588881|NCT02142569|Vitamins|vitamins|mesh-ancestor
20588882|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
20588883|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20588884|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20588885|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20588886|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
20588887|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588888|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20588889|NCT02142595|Midazolam|midazolam|mesh-list
20588890|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
20588891|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20588892|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588893|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588894|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20588895|NCT02142595|Analgesics|analgesics|mesh-ancestor
20588896|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
20588897|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588898|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20588899|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20588900|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20588901|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
20588902|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20588903|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588904|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20588905|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20588906|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20588907|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20588908|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20588909|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
20588910|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
20588911|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
20588912|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
20588913|NCT02142634|Budesonide|budesonide|mesh-list
20588914|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20588915|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20588916|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
20588917|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588918|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588919|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20588920|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
20588921|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
20588922|NCT02142634|Hormones|hormones|mesh-ancestor
20588923|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588924|NCT02142751|Meropenem|meropenem|mesh-list
20588925|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
20588926|NCT02142751|Fosfomycin|fosfomycin|mesh-list
20588927|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20588928|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588929|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20588930|NCT02142777|Equol|equol|mesh-list
20588931|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
20588932|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20588933|NCT02142777|Estrogens|estrogens|mesh-ancestor
20588934|NCT02142777|Hormones|hormones|mesh-ancestor
20588935|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588936|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588937|NCT02142790|Paclitaxel|paclitaxel|mesh-list
20588938|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20588939|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079291|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
20079292|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20588940|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079293|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20588941|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
20588942|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
20588943|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588944|NCT02142829|Bupivacaine|bupivacaine|mesh-list
20588945|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
20588946|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
20588947|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20588948|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588949|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
20588950|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20588951|NCT02142868|Letrozole|letrozole|mesh-list
20588952|NCT02142868|Palbociclib|palbociclib|mesh-list
20588953|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588954|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20588955|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20588956|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588957|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588958|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20588959|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
20588960|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20588961|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588962|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588963|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
20588964|NCT02142920|Gedatolisib|gedatolisib|mesh-list
20588965|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588966|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588967|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588968|NCT02143050|Metformin|metformin|mesh-list
20588969|NCT02143050|Trametinib|trametinib|mesh-list
20588970|NCT02143050|Dabrafenib|dabrafenib|mesh-list
20588971|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20588972|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588973|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588974|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20588975|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588976|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588977|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
20588978|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20588979|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20588980|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20588981|NCT02143219|Leucovorin|leucovorin|mesh-list
20588982|NCT02143219|Folic Acid|folic acid|mesh-list
20588983|NCT02143219|Irinotecan|irinotecan|mesh-list
20588984|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
20588985|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
20588986|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20588987|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20588988|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20588989|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079294|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20079295|NCT00090870|Growth Substances|growth substances|mesh-ancestor
20588990|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20588991|NCT02143219|Antidotes|antidotes|mesh-ancestor
20588992|NCT02143219|Protective Agents|protective agents|mesh-ancestor
20588993|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20588994|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
20588995|NCT02143219|Vitamins|vitamins|mesh-ancestor
20588996|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
20588997|NCT02143219|Hematinics|hematinics|mesh-ancestor
20588998|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20588999|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589000|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589001|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20589002|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589003|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589004|NCT02143362|Remifentanil|remifentanil|mesh-list
20589005|NCT02143362|Anesthetics|anesthetics|mesh-list
20589006|NCT02143362|Propofol|propofol|mesh-list
20589007|NCT02143362|Cisatracurium|cisatracurium|mesh-list
20589008|NCT02143362|Atracurium|atracurium|mesh-list
20079296|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
20589009|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589010|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589011|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20589012|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20589013|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
20589014|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20589015|NCT02143362|Narcotics|narcotics|mesh-ancestor
20589016|NCT02143362|Analgesics|analgesics|mesh-ancestor
20589017|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
20589018|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589019|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20589020|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20589021|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20589022|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20589023|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20589024|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
20589025|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589026|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589027|NCT02143440|Insulin|insulin|mesh-list
20589028|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20589029|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589030|NCT02143479|Tacrolimus|tacrolimus|mesh-list
20589031|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20589032|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
20589033|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589034|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20589035|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589036|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589037|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20589038|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
20589039|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20589040|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
20589041|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589042|NCT02143518|Antacids|antacids|mesh-ancestor
20079297|NCT00088972|Celecoxib|celecoxib|mesh-list
20079298|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20079299|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20079300|NCT00088972|Analgesics|analgesics|mesh-ancestor
20079301|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
20079302|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079303|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079304|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079305|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079306|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20079307|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20079308|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079309|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079310|NCT00088829|Paclitaxel|paclitaxel|mesh-list
20079311|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20079312|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079313|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079314|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079315|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079316|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079317|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079318|NCT00089128|Gemcitabine|gemcitabine|mesh-list
20079319|NCT00089128|Irinotecan|irinotecan|mesh-list
20079320|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20079321|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
20079322|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079323|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079324|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
20079325|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079326|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079327|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079328|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
20079329|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079330|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20079331|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079332|NCT00075608|Melphalan|melphalan|mesh-list
20079333|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
20079334|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079335|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20079336|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
20079337|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079338|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079339|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20079340|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079341|NCT00074724|Dobutamine|dobutamine|mesh-list
20079342|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20079343|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
20079344|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
20589043|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589044|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589045|NCT02143531|Haloperidol|haloperidol|mesh-list
20589046|NCT02143531|Ondansetron|ondansetron|mesh-list
20589047|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
20589048|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
20589049|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
20589050|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589051|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589052|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589053|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
20589054|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
20589055|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20079345|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079346|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079347|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20589056|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
20589057|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589058|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589059|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20589060|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20589061|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589062|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589063|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20589064|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20589065|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
20589066|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20589067|NCT02143570|Darifenacin|darifenacin|mesh-list
20589068|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20589069|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20589070|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
20589071|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589072|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589073|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589074|NCT02143570|Urological Agents|urological agents|mesh-ancestor
20589075|NCT02143622|Cetuximab|cetuximab|mesh-list
20589076|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20589077|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589078|NCT02143687|Sevoflurane|sevoflurane|mesh-list
20589079|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20589080|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20589081|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
20079348|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20079349|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20079350|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
20079351|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079352|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079353|NCT00074724|Protective Agents|protective agents|mesh-ancestor
20079354|NCT00085631|Cisplatin|cisplatin|mesh-list
20079355|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079356|NCT00062751|Sirolimus|sirolimus|mesh-list
20589082|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
20589083|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589084|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606625|NCT02238236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20606626|NCT02238236|Histamine Antagonists|histamine antagonists|mesh-ancestor
20606627|NCT02238236|Histamine Agents|histamine agents|mesh-ancestor
20606628|NCT02238236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606629|NCT02238236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606630|NCT02238236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606631|NCT02238249|Epinastine|epinastine|mesh-list
20606632|NCT02238249|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20606633|NCT02238249|Histamine Antagonists|histamine antagonists|mesh-ancestor
20606634|NCT02238249|Histamine Agents|histamine agents|mesh-ancestor
20606635|NCT02238249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606636|NCT02238249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606637|NCT02238249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606638|NCT02238262|Telmisartan|telmisartan|mesh-list
20606639|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20606640|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20606641|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20079357|NCT00062751|Letrozole|letrozole|mesh-list
20079358|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606642|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606643|NCT02238275|Telmisartan|telmisartan|mesh-list
20606644|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20079359|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20079360|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20079361|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079362|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079363|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20589085|NCT02143765|Acarbose|acarbose|mesh-list
20589086|NCT02143765|Mitiglinide|mitiglinide|mesh-list
20589087|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20589088|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589089|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589090|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20589091|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589092|NCT02143804|Molgramostim|molgramostim|mesh-list
20589093|NCT02143804|Sargramostim|sargramostim|mesh-list
20589094|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
20589095|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589096|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589097|NCT02143934|Chloroquine|chloroquine|mesh-list
20589098|NCT02143934|Lumefantrine|lumefantrine|mesh-list
20589099|NCT02143934|Artemether|artemether|mesh-list
20589100|NCT02143934|Primaquine|primaquine|mesh-list
20589101|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20589102|NCT02143934|Amebicides|amebicides|mesh-ancestor
20589103|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20589104|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20589105|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589106|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
20589107|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20589108|NCT02144025|Cyclosporine|cyclosporine|mesh-list
20589109|NCT02144025|Cyclosporins|cyclosporins|mesh-list
20589110|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589111|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589112|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20589113|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
20589114|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589115|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
20589116|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589117|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
20589118|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20589119|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20589120|NCT02144064|Heparin|heparin|mesh-list
20589121|NCT02144064|Calcium heparin|calcium heparin|mesh-list
20589122|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
20589123|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20589124|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20589125|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589126|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
20589127|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20589128|NCT02144194|Docetaxel|docetaxel|mesh-list
20589129|NCT02144194|Vinorelbine|vinorelbine|mesh-list
20589130|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589131|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
20589132|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
20589133|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
20589134|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589135|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20589136|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
20589137|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20589138|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20589139|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20589140|NCT02144246|Norgestimate|norgestimate|mesh-list
20589141|NCT02144246|Norgestrel|norgestrel|mesh-list
20589142|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20589143|NCT02144246|Estradiol|estradiol|mesh-list
20589144|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20589145|NCT02144246|Estrogens|estrogens|mesh-ancestor
20589146|NCT02144246|Hormones|hormones|mesh-ancestor
20589147|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589148|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589149|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20589150|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
20589151|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589152|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20589153|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20589154|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20589155|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20589156|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589157|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589158|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20589159|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20589160|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589161|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589162|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589163|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20589164|NCT02144376|Psyllium|psyllium|mesh-list
20589165|NCT02144376|Cathartics|cathartics|mesh-ancestor
20589166|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589167|NCT02144389|Praziquantel|praziquantel|mesh-list
20079364|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
20079365|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079366|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079367|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20079368|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079369|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20079370|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
20589168|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
20589169|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20589170|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589171|NCT02144415|Amphetamine|amphetamine|mesh-list
20589172|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20589173|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
20589174|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20589175|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589176|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
20589177|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
20589178|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589179|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
20589180|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589181|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589182|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
20589183|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20589184|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20589185|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589186|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20589187|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
20589188|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20589189|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589190|NCT02144623|Valproic Acid|valproic acid|mesh-list
20589191|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
20589192|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589193|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589194|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
20589195|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746433|NCT03434730|Cyclosporine|cyclosporine|mesh-list
19746434|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
19746435|NCT03434730|Lenograstim|lenograstim|mesh-list
19746436|NCT03434730|Cyclosporins|cyclosporins|mesh-list
19746437|NCT03434730|Sargramostim|sargramostim|mesh-list
20079371|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079372|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
20079373|NCT00066807|Tamoxifen|tamoxifen|mesh-list
20079374|NCT00066807|Epirubicin|epirubicin|mesh-list
20079375|NCT00066807|Exemestane|exemestane|mesh-list
20079376|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20589196|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589197|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
19746438|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19746439|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
19746440|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746441|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746442|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079377|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20589198|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20589199|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589200|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589201|NCT02144662|Ranibizumab|ranibizumab|mesh-list
20589202|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20589203|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20589204|NCT02144662|Growth Substances|growth substances|mesh-ancestor
20589205|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746443|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746444|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
20079378|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079379|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746445|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746446|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746447|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746448|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19746449|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19746450|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589206|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
20589207|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589208|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20589209|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
20589210|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589211|NCT02144753|Psyllium|psyllium|mesh-list
20589212|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
20589213|NCT02144753|Cathartics|cathartics|mesh-ancestor
20589214|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589215|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
20589216|NCT02144766|Ropivacaine|ropivacaine|mesh-list
20589217|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
20589218|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
20589219|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589220|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589221|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
20589222|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079380|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079381|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079382|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079383|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20079384|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
20079385|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079386|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079387|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20079388|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20589223|NCT02144792|Verapamil|verapamil|mesh-list
20589224|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20589225|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20589226|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589227|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589228|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20589229|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589230|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
20589231|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20589232|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
20589233|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20589234|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
20589235|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589236|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589237|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20589238|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20589239|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589240|NCT02144922|Pitavastatin|pitavastatin|mesh-list
20589241|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20589242|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20589243|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20589244|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
20589245|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079389|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20119998|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
20589246|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589247|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20589248|NCT02145065|Paclitaxel|paclitaxel|mesh-list
20589249|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20589250|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589251|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
20589252|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
20589253|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
20589254|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589255|NCT02145091|Psilocybin|psilocybin|mesh-list
20589256|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
20589257|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
19746451|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20589258|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746452|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
20589259|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589260|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20589261|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
20589262|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589263|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589264|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20589265|NCT02145104|Valsartan|valsartan|mesh-list
20589266|NCT02145104|Cilnidipine|cilnidipine|mesh-list
20589267|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19492098|NCT03126097|Diuretics|diuretics|mesh-ancestor
19492099|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
19492100|NCT03126071|Bevacizumab|bevacizumab|mesh-list
19492101|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
19492102|NCT03126071|Irinotecan|irinotecan|mesh-list
19492103|NCT03126071|Raltitrexed|raltitrexed|mesh-list
19492104|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19492105|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492106|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19492107|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19492108|NCT03126071|Growth Substances|growth substances|mesh-ancestor
20589268|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20589269|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20589270|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589271|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20589272|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589273|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20589274|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589275|NCT02145195|Vitamin D|vitamin d|mesh-list
20589276|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
20589277|NCT02145195|Vitamins|vitamins|mesh-ancestor
20079390|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20079391|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20079392|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20079393|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
20079394|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20079395|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
20079396|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589278|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
20589279|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589280|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20589281|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20589282|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
20589283|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20589284|NCT02145338|Trimethoprim|trimethoprim|mesh-list
20589285|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
20589286|NCT02145338|Cephalexin|cephalexin|mesh-list
20589287|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20589288|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589289|NCT02145338|Renal Agents|renal agents|mesh-ancestor
20589290|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
20079397|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20079398|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
20589291|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20589292|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20589293|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20589294|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589295|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589296|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20589297|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20589298|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20589299|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589300|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
20589301|NCT02145520|Analgesics|analgesics|mesh-ancestor
20589302|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
20589303|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746453|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746454|NCT03418779|Prednisolone|prednisolone|mesh-list
19746455|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
19746456|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19746457|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
19746458|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492109|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492110|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746459|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20589304|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589305|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
20589306|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589307|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20589308|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
20589309|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20589310|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589311|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589312|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20589313|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
20589314|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589315|NCT02145546|Amiodarone|amiodarone|mesh-list
20079399|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
20079400|NCT00058188|Calcium|calcium|mesh-list
20079401|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20079402|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079403|NCT00058188|Vitamins|vitamins|mesh-ancestor
20079404|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
20079405|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20079406|NCT00014560|Antibodies|antibodies|mesh-list
20079407|NCT00014560|Sargramostim|sargramostim|mesh-list
20079408|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20079409|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
20079410|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079411|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
20079412|NCT00038142|Doxorubicin|doxorubicin|mesh-list
20079413|NCT00038142|Vincristine|vincristine|mesh-list
20079414|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
20079415|NCT00038142|Razoxane|razoxane|mesh-list
20079416|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079417|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
20079418|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079419|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079420|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20079421|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
20079422|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079423|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079424|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20079425|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20079426|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20079427|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079428|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079429|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079430|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079431|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079432|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079433|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20079434|NCT00038142|Protective Agents|protective agents|mesh-ancestor
20079435|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
20079436|NCT00020722|Ifosfamide|ifosfamide|mesh-list
20079437|NCT00020722|Thiotepa|thiotepa|mesh-list
20079438|NCT00020722|Carboplatin|carboplatin|mesh-list
20079439|NCT00020722|Etoposide|etoposide|mesh-list
20079440|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
20079441|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079442|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
20079443|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079444|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079445|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20079446|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
20079447|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079448|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079449|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20079450|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079451|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20079452|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079453|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079454|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20079455|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20079456|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
20079457|NCT00006478|Sargramostim|sargramostim|mesh-list
20079458|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20079459|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
20079460|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079461|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20079462|NCT00019747|Thalidomide|thalidomide|mesh-list
20079463|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079464|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
20079465|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589316|NCT02145546|Sotalol|sotalol|mesh-list
20589317|NCT02145546|Propafenone|propafenone|mesh-list
20589318|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20589319|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
20589320|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20589321|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589322|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589323|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20589324|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20589325|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20589326|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589327|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20589328|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20589329|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20589330|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20589331|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20589332|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
20589333|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079466|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
20079467|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20079468|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589334|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589335|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
20589336|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
20589337|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589338|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20589339|NCT02145559|Metformin|metformin|mesh-list
20589340|NCT02145559|Sirolimus|sirolimus|mesh-list
20589341|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20589342|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589343|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589344|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589345|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20079469|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20079470|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20079471|NCT00019747|Growth Substances|growth substances|mesh-ancestor
20079472|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
20079473|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079474|NCT00006916|Bleomycin|bleomycin|mesh-list
20079475|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20079476|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079477|NCT00003726|Lepirudin|lepirudin|mesh-list
20079478|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
20079479|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20079480|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
20079481|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079482|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079483|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
20079484|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079485|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20079486|NCT04051996|Decitabine|decitabine|mesh-list
20079487|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20079488|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
20079489|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079490|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079491|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589346|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589347|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
20589348|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20589349|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
20589350|NCT02145585|Anesthetics|anesthetics|mesh-list
20589351|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589352|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589353|NCT02145598|Lenalidomide|lenalidomide|mesh-list
20589354|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
20589355|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589356|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20589357|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20589358|NCT02145598|Growth Substances|growth substances|mesh-ancestor
20589359|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
20589360|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589361|NCT02145611|Vildagliptin|vildagliptin|mesh-list
20589362|NCT02145611|Glyburide|glyburide|mesh-list
20589363|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20079492|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20079493|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079494|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
20079495|NCT02126878|Hormones|hormones|mesh-ancestor
20079496|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079497|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079498|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079499|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
20079500|NCT02595996|Propranolol|propranolol|mesh-list
20079501|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20079502|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20079503|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20079504|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589364|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589365|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20589366|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
20589367|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589368|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606645|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20606646|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20606647|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606648|NCT02238288|Acetaminophen|acetaminophen|mesh-list
20606649|NCT02238288|Lidocaine|lidocaine|mesh-list
20606650|NCT02238288|Epinephrine|epinephrine|mesh-list
20606651|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
20606652|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
20606653|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
20606654|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606655|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606656|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
20606657|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606658|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20606659|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20606660|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20606661|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606662|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606663|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20606664|NCT02238288|Analgesics|analgesics|mesh-ancestor
20606665|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
20606666|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20606667|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20606668|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606669|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606670|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20606671|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606672|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
20606673|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606674|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606675|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
20606676|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
20606677|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20606678|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20606679|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20606680|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
20606681|NCT02238288|Coagulants|coagulants|mesh-ancestor
20606682|NCT02238314|Ritonavir|ritonavir|mesh-list
20606683|NCT02238314|Tipranavir|tipranavir|mesh-list
20606684|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20606685|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20606686|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20606687|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
20606688|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606689|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606690|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20606691|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20606692|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
20606693|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606694|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20606695|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20606696|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20606697|NCT02238340|Ketoprofen|ketoprofen|mesh-list
20606698|NCT02238340|Morphine|morphine|mesh-list
20606699|NCT02238340|Oxycodone|oxycodone|mesh-list
20606700|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20606701|NCT02238340|Narcotics|narcotics|mesh-ancestor
20079505|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589369|NCT02145624|Vaccines|vaccines|mesh-list
20589370|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
20589371|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589372|NCT02145637|Afatinib|afatinib|mesh-list
20589373|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589374|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20589375|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589376|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589377|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
20589378|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20589379|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20079506|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079507|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20079508|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20589380|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20589381|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589382|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589383|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
20589384|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589385|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589386|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20589387|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589388|NCT02145715|Thalidomide|thalidomide|mesh-list
20589389|NCT02145715|Dexamethasone|dexamethasone|mesh-list
20589390|NCT02145715|Bortezomib|bortezomib|mesh-list
20589391|NCT02145715|Panobinostat|panobinostat|mesh-list
20589392|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20589393|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
20589394|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
20589395|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589396|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589397|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589398|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
20589399|NCT02145715|Hormones|hormones|mesh-ancestor
20589400|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589401|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20589402|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589403|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20589404|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
20589405|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
20589406|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589407|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589408|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20589409|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20589410|NCT02145715|Growth Substances|growth substances|mesh-ancestor
20589411|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
20589412|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20589413|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589414|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079509|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
20079510|NCT02009384|Ipilimumab|ipilimumab|mesh-list
20079511|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20589415|NCT02145767|Progesterone|progesterone|mesh-list
20589416|NCT02145767|Progestins|progestins|mesh-ancestor
20589417|NCT02145767|Hormones|hormones|mesh-ancestor
20589418|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589419|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589420|NCT02145832|Fluconazole|fluconazole|mesh-list
20589421|NCT02145832|Micafungin|micafungin|mesh-list
20589422|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
20589423|NCT02145832|Clotrimazole|clotrimazole|mesh-list
20589424|NCT02145832|Miconazole|miconazole|mesh-list
20589425|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589426|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20589427|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20589428|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589429|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589430|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20589431|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
20589432|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589433|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589434|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20589435|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20079512|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589436|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20589437|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20589438|NCT02145884|Timolol|timolol|mesh-list
20589439|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20589440|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20589441|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
20589442|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589443|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589444|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589445|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20589446|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20589447|NCT02145910|Vemurafenib|vemurafenib|mesh-list
20589448|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079513|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20079514|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079515|NCT04558125|Heparin|heparin|mesh-list
20589449|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20589450|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589451|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589452|NCT02145949|Tryptophan|tryptophan|mesh-list
20589453|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20589454|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
20589455|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589456|NCT02145975|Fentanyl|fentanyl|mesh-list
20589457|NCT02145975|Morphine|morphine|mesh-list
20589458|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
20589459|NCT02145975|Narcotics|narcotics|mesh-ancestor
20589460|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589461|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589462|NCT02145975|Analgesics|analgesics|mesh-ancestor
20589463|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
20589464|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589465|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20589466|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20589467|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
20589468|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
20589469|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20589470|NCT02146118|Silybin|silybin|mesh-list
20589471|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589472|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20589473|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589474|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589475|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20589476|NCT02146118|Protective Agents|protective agents|mesh-ancestor
20589477|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589478|NCT02146209|Metronidazole|metronidazole|mesh-list
20589479|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589480|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589481|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20589482|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20589483|NCT02146222|Docetaxel|docetaxel|mesh-list
20589484|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589485|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
20589486|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
20589487|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
20589488|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589489|NCT02146261|Quetmolimab|quetmolimab|mesh-list
20589490|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20589491|NCT02146300|Xylometazoline|xylometazoline|mesh-list
20589492|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
20589493|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20589494|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
20589495|NCT02146391|Enclomiphene|enclomiphene|mesh-list
20589496|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20589497|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
20589498|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589499|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589500|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20589501|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
20589502|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589503|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20589504|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20079516|NCT04558125|Calcium heparin|calcium heparin|mesh-list
20079517|NCT04558125|Enoxaparin|enoxaparin|mesh-list
20589505|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
20589506|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20589507|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20589508|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589509|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
20589510|NCT02146456|Coagulants|coagulants|mesh-ancestor
20589511|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
20589512|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20589513|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589514|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589515|NCT02146547|Aripiprazole|aripiprazole|mesh-list
20589516|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20589517|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
20589518|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589519|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20589520|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20589521|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589522|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589523|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
20589524|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
20589525|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589526|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589527|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20589528|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20589529|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
20589530|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20589531|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20589532|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20589533|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20589534|NCT02146638|Fentanyl|fentanyl|mesh-list
20589535|NCT02146638|Morphine|morphine|mesh-list
20589536|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20589537|NCT02146638|Narcotics|narcotics|mesh-ancestor
20589538|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589539|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589540|NCT02146638|Analgesics|analgesics|mesh-ancestor
20589541|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
20589542|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589543|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20079518|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20079519|NCT04558125|Tinzaparin|tinzaparin|mesh-list
20079520|NCT04558125|Dalteparin|dalteparin|mesh-list
20079521|NCT04558125|Tenecteplase|tenecteplase|mesh-list
20079522|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
20079523|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
20079524|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079525|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20079526|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079527|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
20079528|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
20079529|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20079530|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20079531|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079532|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079533|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079534|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079535|NCT00521885|Enoxaparin|enoxaparin|mesh-list
20079536|NCT00521885|Fondaparinux|fondaparinux|mesh-list
20079537|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
20079538|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079539|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20079540|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079541|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20079542|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
20079543|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20079544|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
20589544|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20589545|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
20589546|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
20589547|NCT02146651|Insulin|insulin|mesh-list
20079545|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589548|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20079546|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
20589549|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
20589550|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20079547|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20589551|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079548|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20079549|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589552|NCT02146703|Gemcitabine|gemcitabine|mesh-list
20589553|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20589554|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
20589555|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589556|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589557|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
20589558|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589559|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589560|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20589561|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
20589562|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589563|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
20589564|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589565|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20589566|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589567|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589568|NCT02146911|Bupropion|bupropion|mesh-list
20589569|NCT02146911|Varenicline|varenicline|mesh-list
20589570|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20589571|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
20589572|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589573|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20589574|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20589575|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589576|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589577|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
20589578|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589579|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589580|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20589581|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20589582|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589583|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20589584|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20589585|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
20589586|NCT02146937|Bicalutamide|bicalutamide|mesh-list
20589587|NCT02146937|Finasteride|finasteride|mesh-list
20589588|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
20589589|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
20589590|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079550|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
20079551|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079552|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079553|NCT00479167|Bortezomib|bortezomib|mesh-list
20079554|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
20079555|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20119999|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120000|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120001|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20120002|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20120003|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
20120004|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20120005|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120006|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
20589591|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589592|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589593|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20120007|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
20120008|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120009|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20589594|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20589595|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589596|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589597|NCT02146937|Urological Agents|urological agents|mesh-ancestor
20589598|NCT02146976|Propofol|propofol|mesh-list
20589599|NCT02146976|Sevoflurane|sevoflurane|mesh-list
20589600|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20589601|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589602|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589603|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20589604|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
20079556|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
20079557|NCT02212574|Lomustine|lomustine|mesh-list
20589605|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
20589606|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20589607|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20589608|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20589609|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
20589610|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
20589611|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
20589612|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20589613|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589614|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20589615|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
20589616|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
20589617|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589618|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589619|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589620|NCT02147015|Hormones|hormones|mesh-ancestor
20589621|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589622|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20589623|NCT02147015|Protective Agents|protective agents|mesh-ancestor
20589624|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589625|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589626|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20589627|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20589628|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
20589629|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589630|NCT02147041|Protective Agents|protective agents|mesh-ancestor
20079558|NCT02212574|Vincristine|vincristine|mesh-list
20079559|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079560|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
20589631|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589632|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20589633|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20589634|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589635|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20589636|NCT02147054|Rocuronium|rocuronium|mesh-list
20589637|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20589638|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20589639|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20589640|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589641|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606702|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606703|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606704|NCT02238340|Analgesics|analgesics|mesh-ancestor
20606705|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
20606706|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606707|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20606708|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20606709|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606710|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20606711|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20606712|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606713|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606714|NCT02238353|Fluticasone|fluticasone|mesh-list
20606715|NCT02238353|Azelastine|azelastine|mesh-list
20606716|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606717|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20606718|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
20606719|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079561|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079562|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079563|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20079564|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
20079565|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079566|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079567|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20079568|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079569|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
20079570|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079571|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079572|NCT04422210|Carboplatin|carboplatin|mesh-list
20079573|NCT04422210|Etoposide|etoposide|mesh-list
20606720|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589642|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20589643|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589644|NCT02147262|Doxycycline|doxycycline|mesh-list
20589645|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589646|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589647|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
20589648|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20589649|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20589650|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20589651|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20589652|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20079574|NCT04422210|Atezolizumab|atezolizumab|mesh-list
20079575|NCT04422210|Venetoclax|venetoclax|mesh-list
20079576|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079577|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079578|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20079579|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079580|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079581|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079582|NCT04298918|Trastuzumab|trastuzumab|mesh-list
20079583|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20079584|NCT04298918|Venetoclax|venetoclax|mesh-list
20079585|NCT04298918|Maytansine|maytansine|mesh-list
20079586|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20079587|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079588|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079589|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
20589653|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589654|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589655|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589656|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20589657|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20589658|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20589659|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
20589660|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589661|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589662|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20589663|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20589664|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
20589665|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20589666|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20589667|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
20589668|NCT02147535|Methylphenidate|methylphenidate|mesh-list
20589669|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20589670|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589671|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20589672|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20589673|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20079590|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
20079591|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
20079592|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079593|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
20079594|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20079595|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079596|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
20079597|NCT00955929|Alprostadil|alprostadil|mesh-list
20079598|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
20079599|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20079600|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20079601|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589674|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589675|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
20589676|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589677|NCT02147548|Lorazepam|lorazepam|mesh-list
20589678|NCT02147548|Etifoxine|etifoxine|mesh-list
20589679|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
20589680|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
20589681|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
20589682|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589683|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589684|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589685|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20120010|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20589686|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20079602|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079603|NCT00955929|Urological Agents|urological agents|mesh-ancestor
20079604|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20589687|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20589688|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20079605|NCT00402883|Folic Acid|folic acid|mesh-list
20079606|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
20079607|NCT00402883|Hydroxocobalamin|hydroxocobalamin|mesh-list
20079608|NCT00402883|Bevacizumab|bevacizumab|mesh-list
20079609|NCT00402883|Carboplatin|carboplatin|mesh-list
20079610|NCT00402883|Pemetrexed|pemetrexed|mesh-list
20079611|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20079612|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079613|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20079614|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20079615|NCT00402883|Growth Substances|growth substances|mesh-ancestor
20079616|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079617|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
20079618|NCT00402883|Vitamins|vitamins|mesh-ancestor
20079619|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
20079620|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079621|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079622|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20079623|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20079624|NCT00402883|Hematinics|hematinics|mesh-ancestor
20079625|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
20079626|NCT02934503|Carboplatin|carboplatin|mesh-list
20079627|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
20079628|NCT02934503|Etoposide|etoposide|mesh-list
20079629|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079630|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20079631|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079632|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20079633|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079634|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079635|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079636|NCT02137252|Naltrexone|naltrexone|mesh-list
20079637|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20079638|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20079639|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079640|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
20589689|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589690|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
20589691|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
20589692|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589693|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589694|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
20589695|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20079641|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079642|NCT01294670|Etoposide|etoposide|mesh-list
20079643|NCT01294670|Vorinostat|vorinostat|mesh-list
20079644|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20079645|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079646|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20079647|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20079648|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079649|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079650|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20079651|NCT03095287|Factor VIII|factor viii|mesh-list
20079652|NCT03095287|Coagulants|coagulants|mesh-ancestor
20079653|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20079654|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079655|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
20079656|NCT00000105|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20589696|NCT02147678|Remifentanil|remifentanil|mesh-list
20589697|NCT02147678|Propofol|propofol|mesh-list
20589698|NCT02147678|Etomidate|etomidate|mesh-list
20589699|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
20589700|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589701|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589702|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20079657|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20079658|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
20589703|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20589704|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
20589705|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20079659|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079660|NCT00000114|Vitamins|vitamins|mesh-list
20079661|NCT00000114|Vitamin E|vitamin e|mesh-list
20079662|NCT00000114|Vitamin A|vitamin a|mesh-list
20079663|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
20079664|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079665|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
20079666|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079667|NCT00000114|Protective Agents|protective agents|mesh-ancestor
20589706|NCT02147678|Narcotics|narcotics|mesh-ancestor
20589707|NCT02147678|Analgesics|analgesics|mesh-ancestor
20589708|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
20589709|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589710|NCT02147730|Anesthetics|anesthetics|mesh-list
20589711|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589712|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589713|NCT02147808|Midazolam|midazolam|mesh-list
20589714|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20589715|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20589716|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589717|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589718|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20589719|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20589720|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20589721|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20589722|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
20589723|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
20589724|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
20589725|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
20589726|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589727|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589728|NCT02147873|Azacitidine|azacitidine|mesh-list
20589729|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20589730|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
20589731|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589732|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589733|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589734|NCT02147925|Metformin|metformin|mesh-list
20589735|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
20589736|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20589737|NCT02147925|Liraglutide|liraglutide|mesh-list
20589738|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20079668|NCT00000115|Acetazolamide|acetazolamide|mesh-list
20079669|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
20079670|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20079671|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079672|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079673|NCT00000115|Diuretics|diuretics|mesh-ancestor
20079674|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
20589739|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589740|NCT02147925|Incretins|incretins|mesh-ancestor
20589741|NCT02147925|Hormones|hormones|mesh-ancestor
20589742|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589743|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20589744|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
20589745|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589746|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589747|NCT02147938|Tacrolimus|tacrolimus|mesh-list
20589748|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20589749|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
20589750|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589751|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20589752|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589753|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589754|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20589755|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20589756|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589757|NCT02147964|Ketoconazole|ketoconazole|mesh-list
20589758|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
20079675|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079676|NCT00000116|Vitamin A|vitamin a|mesh-list
20079677|NCT00000116|Vitamins|vitamins|mesh-ancestor
20079678|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
20589759|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20079679|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079680|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
20589760|NCT02147964|Testosterone|testosterone|mesh-list
20079681|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20079682|NCT00000117|Antibodies|antibodies|mesh-list
20589761|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
20589762|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
20589763|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20589764|NCT02147964|Dutasteride|dutasteride|mesh-list
20589765|NCT02147964|Acyline|acyline|mesh-list
20589766|NCT02147964|Androgens|androgens|mesh-ancestor
20589767|NCT02147964|Hormones|hormones|mesh-ancestor
20079683|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
20079684|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079685|NCT00000119|Heparin|heparin|mesh-list
20079686|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
20079687|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079688|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20589768|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589769|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589770|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20589771|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589772|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
20589773|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
20589774|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589775|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20589776|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20589777|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589778|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589779|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20589780|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
20589781|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20589782|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20589783|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589784|NCT02148016|Levofloxacin|levofloxacin|mesh-list
20589785|NCT02148016|Ofloxacin|ofloxacin|mesh-list
20589786|NCT02148016|Betamethasone|betamethasone|mesh-list
20589787|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20589788|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589789|NCT02148016|Renal Agents|renal agents|mesh-ancestor
20589790|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589791|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20589792|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20589793|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589794|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589795|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589796|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20589797|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20589798|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20589799|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
20589800|NCT02148016|Hormones|hormones|mesh-ancestor
20589801|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589802|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589803|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20589804|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20589805|NCT02148094|Tenofovir|tenofovir|mesh-list
20589806|NCT02148094|Emtricitabine|emtricitabine|mesh-list
20589807|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20589808|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
20589809|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589810|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20589811|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20079689|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589812|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589813|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589814|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20589815|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20589816|NCT02148120|Beclomethasone|beclomethasone|mesh-list
20589817|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
20589818|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20589819|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
20589820|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589821|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589822|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20079690|NCT00000120|Erythromycin|erythromycin|mesh-list
20079691|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
20589823|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
20589824|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20589825|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20589826|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20589827|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
20079692|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20079693|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
20079694|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
20589828|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589829|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589830|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20589831|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
20589832|NCT02148120|Hormones|hormones|mesh-ancestor
20589833|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589834|NCT02148328|Vaccines|vaccines|mesh-list
20589835|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
20589836|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589837|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
20589838|NCT02148367|Hematinics|hematinics|mesh-ancestor
20589839|NCT02148380|Carboplatin|carboplatin|mesh-list
20589840|NCT02148380|Pemetrexed|pemetrexed|mesh-list
20589841|NCT02148380|Gefitinib|gefitinib|mesh-list
20589842|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589843|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589844|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589845|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20589846|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20589847|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20589848|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20589849|NCT02148393|Estradiol|estradiol|mesh-list
20589850|NCT02148393|Progesterone|progesterone|mesh-list
20589851|NCT02148393|Estrogens|estrogens|mesh-ancestor
20589852|NCT02148393|Hormones|hormones|mesh-ancestor
20589853|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589854|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589855|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589856|NCT02148393|Progestins|progestins|mesh-ancestor
20589857|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
20589858|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20589859|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20589860|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589861|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20589862|NCT02148432|Analgesics|analgesics|mesh-ancestor
20589863|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
20589864|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589865|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20589866|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20589867|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20589868|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
20589869|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589870|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589871|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
20589872|NCT02148549|Irinotecan|irinotecan|mesh-list
20589873|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589874|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20589875|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20589876|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589877|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589878|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20589879|NCT02148601|Vancomycin|vancomycin|mesh-list
20589880|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589881|NCT02148640|Infliximab|infliximab|mesh-list
20589882|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
20589883|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589884|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20589885|NCT02148783|Methylphenidate|methylphenidate|mesh-list
20589886|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20589887|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589888|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20589889|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20079695|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589890|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589891|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079696|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589892|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
20589893|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20589894|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
20589895|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20589896|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20589897|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079697|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20079698|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20079699|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079700|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079701|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20079702|NCT00000122|Fluorouracil|fluorouracil|mesh-list
20079703|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
20079704|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079705|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20079706|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079707|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20079708|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
20079709|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079710|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20079711|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
20079712|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20079713|NCT00000123|Protective Agents|protective agents|mesh-ancestor
20079714|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079715|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20079716|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079717|NCT00000132|Betaxolol|betaxolol|mesh-list
20079718|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20079719|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
20079720|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
20079721|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079722|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079723|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20079724|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20079725|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20079726|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
20079727|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079728|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079729|NCT00000138|Acyclovir|acyclovir|mesh-list
20079730|NCT00000138|Prednisolone|prednisolone|mesh-list
20079731|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20079732|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
20079733|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20079734|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
20079735|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20079736|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
20079737|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079738|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
20079739|NCT00000138|Hormones|hormones|mesh-ancestor
20079740|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079741|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079742|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20079743|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079744|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
20079745|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
20079746|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079747|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20079748|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20589898|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20589899|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589900|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20589901|NCT02148861|Insulin|insulin|mesh-list
20589902|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20589903|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20589904|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606721|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20606722|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606723|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
20606724|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20606725|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20606726|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606727|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606728|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20606729|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20606730|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
20606731|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
20606732|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606733|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20606734|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
20606735|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20606736|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
20606737|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606738|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606739|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20606740|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20606741|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606742|NCT02238392|Adenosine|adenosine|mesh-list
20606743|NCT02238392|Analgesics|analgesics|mesh-ancestor
20606744|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
20606745|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606746|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606747|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20606748|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
20606749|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20606750|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
20606751|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
20606752|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606753|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606754|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
20606755|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606756|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606757|NCT02238418|Vitamins|vitamins|mesh-ancestor
20606758|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
20606759|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20606760|NCT02238431|Leuprolide|leuprolide|mesh-list
20606761|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20606762|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
20606763|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20606764|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606765|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20606766|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606767|NCT02238444|Aspirin|aspirin|mesh-list
20606768|NCT02238444|Heparin|heparin|mesh-list
20606769|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20606770|NCT02238444|Tinzaparin|tinzaparin|mesh-list
20606771|NCT02238444|Dalteparin|dalteparin|mesh-list
20606772|NCT02238444|Dipyridamole|dipyridamole|mesh-list
20606773|NCT02238444|Warfarin|warfarin|mesh-list
20606774|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20606775|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20606776|NCT02238444|Analgesics|analgesics|mesh-ancestor
20606777|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
20606778|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606779|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606780|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20606781|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20606782|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20606783|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20606784|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606785|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20606786|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20606787|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079749|NCT00000138|Protective Agents|protective agents|mesh-ancestor
20079750|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
20079751|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079752|NCT00000139|Acyclovir|acyclovir|mesh-list
20606788|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
20606789|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
20079753|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
20589905|NCT02148913|Melphalan|melphalan|mesh-list
20589906|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20589907|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20589908|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
20079754|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20079755|NCT00000145|Zinc|zinc|mesh-list
20079756|NCT00000145|Antioxidants|antioxidants|mesh-list
20079757|NCT00000145|Trace Elements|trace elements|mesh-ancestor
20589909|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589910|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589911|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20589912|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20589913|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
20589914|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589915|NCT02148978|Saxagliptin|saxagliptin|mesh-list
20589916|NCT02148978|Incretins|incretins|mesh-ancestor
20589917|NCT02148978|Hormones|hormones|mesh-ancestor
20589918|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589919|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589920|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20589921|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
20589922|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589923|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589924|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20589925|NCT02149095|Treprostinil|treprostinil|mesh-list
20589926|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20589927|NCT02149212|Aminaftone|aminaftone|mesh-list
20589928|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
20589929|NCT02149212|Coagulants|coagulants|mesh-ancestor
20589930|NCT02149225|Poly I-C|poly i-c|mesh-list
20589931|NCT02149225|Molgramostim|molgramostim|mesh-list
20589932|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20589933|NCT02149225|Vaccines|vaccines|mesh-list
20589934|NCT02149225|Sargramostim|sargramostim|mesh-list
20589935|NCT02149225|Poly ICLC|poly iclc|mesh-list
20589936|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
20589937|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589938|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589939|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
20589940|NCT02149225|Laxatives|laxatives|mesh-ancestor
20589941|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20589942|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
20589943|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589944|NCT02149329|Meropenem|meropenem|mesh-list
20589945|NCT02149329|Imipenem|imipenem|mesh-list
20589946|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
20589947|NCT02149329|Cilastatin|cilastatin|mesh-list
20589948|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20589949|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20589950|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
20589951|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589952|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589953|NCT02149407|Glycerol|glycerol|mesh-list
20589954|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20589955|NCT02149407|Protective Agents|protective agents|mesh-ancestor
20589956|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589957|NCT02149433|Prednisone|prednisone|mesh-list
20589958|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20589959|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
20589960|NCT02149433|Hormones|hormones|mesh-ancestor
20589961|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20589962|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589963|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20589964|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20589965|NCT02149459|Metformin|metformin|mesh-list
20589966|NCT02149459|Biguanides|biguanides|mesh-list
20589967|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20589968|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589969|NCT02149628|Propofol|propofol|mesh-list
20589970|NCT02149628|Desflurane|desflurane|mesh-list
20589971|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20589972|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20079758|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
20079759|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589973|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120011|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20589974|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20589975|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
20589976|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
20079760|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079761|NCT00000145|Protective Agents|protective agents|mesh-ancestor
20079762|NCT00000146|Prednisone|prednisone|mesh-list
20079763|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
20589977|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20589978|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
20589979|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20589980|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
20589981|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589982|NCT02149758|Etoricoxib|etoricoxib|mesh-list
20589983|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20589984|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20589985|NCT02149758|Analgesics|analgesics|mesh-ancestor
20589986|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
20589987|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20589988|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589989|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20589990|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20589991|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20589992|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20589993|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20589994|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20589995|NCT02149823|Oxytocin|oxytocin|mesh-list
20589996|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
20589997|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20589998|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20589999|NCT02149888|Tenofovir|tenofovir|mesh-list
20590000|NCT02149888|Emtricitabine|emtricitabine|mesh-list
20590001|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
20590002|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590003|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20590004|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20590005|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590006|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590007|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19746460|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19746461|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
19746462|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746463|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746464|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19746465|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746466|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
19746467|NCT03418779|Hormones|hormones|mesh-ancestor
19746468|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746469|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746470|NCT03388138|Ketotifen|ketotifen|mesh-list
20079764|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20590008|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20590009|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
20590010|NCT02149901|Ephedrine|ephedrine|mesh-list
20590011|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20590012|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
20590013|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590014|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590015|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20590016|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
20590017|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
20590018|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20590019|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20590020|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
20590021|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
20590022|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590023|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590024|NCT02149914|Rabeprazole|rabeprazole|mesh-list
20590025|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20590026|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20590027|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590028|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590029|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590030|NCT02149927|Sevoflurane|sevoflurane|mesh-list
20590031|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20590032|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20590033|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
20590034|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
20590035|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590036|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590037|NCT02149953|Glycine|glycine|mesh-list
20590038|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
20590039|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590040|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590041|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590042|NCT02149992|Inositol|inositol|mesh-list
20590043|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
20590044|NCT02149992|Vitamins|vitamins|mesh-ancestor
20590045|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
20590046|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590047|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
20590048|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20590049|NCT02150031|Lidocaine|lidocaine|mesh-list
20079765|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20079766|NCT00000146|Prednisolone|prednisolone|mesh-list
20079767|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
20079768|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20079769|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
20079770|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079771|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
20590050|NCT02150031|Epinephrine|epinephrine|mesh-list
20590051|NCT02150031|Racepinephrine|racepinephrine|mesh-list
20590052|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
20590053|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
20590054|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
20590055|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590056|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590057|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
20590058|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590059|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20590060|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20590061|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20590062|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590063|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590064|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20590065|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590066|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
20590067|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
20590068|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20590069|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20590070|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
20590071|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590072|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20590073|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20590074|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
20590075|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20590076|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
20590077|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
20590078|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
20590079|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20590080|NCT02150122|Vitamin D|vitamin d|mesh-list
20590081|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
20590082|NCT02150122|Vitamins|vitamins|mesh-ancestor
20590083|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
20590084|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590085|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20590086|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20590087|NCT02150161|Lidocaine|lidocaine|mesh-list
20590088|NCT02150161|Fentanyl|fentanyl|mesh-list
20590089|NCT02150161|Ketamine|ketamine|mesh-list
20590090|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
20590091|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
20590092|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590093|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590094|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
20590095|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590096|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20590097|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20590098|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20590099|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590100|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079772|NCT00000146|Hormones|hormones|mesh-ancestor
20590101|NCT02150161|Analgesics|analgesics|mesh-ancestor
20590102|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19746471|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
20079773|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079774|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079775|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20079776|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079777|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
20079778|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
20079779|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079780|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590103|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20590104|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
20590105|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20590106|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20590107|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590108|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590109|NCT02150161|Narcotics|narcotics|mesh-ancestor
20590110|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20590111|NCT02150291|Folic Acid|folic acid|mesh-list
20079781|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20079782|NCT00000146|Protective Agents|protective agents|mesh-ancestor
20079783|NCT00000147|Prednisone|prednisone|mesh-list
20079784|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
20079785|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20079786|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20079787|NCT00000147|Prednisolone|prednisolone|mesh-list
20079788|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
20079789|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20079790|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
20079791|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079792|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
20079793|NCT00000147|Hormones|hormones|mesh-ancestor
20079794|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079795|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079796|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20079797|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079798|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
20079799|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
20079800|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079801|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20079802|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20079803|NCT00000147|Protective Agents|protective agents|mesh-ancestor
20079804|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20079805|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20079806|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
20079807|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079808|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079809|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079810|NCT00000151|Aspirin|aspirin|mesh-list
20079811|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20079812|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20079813|NCT00000151|Analgesics|analgesics|mesh-ancestor
20079814|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
20079815|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079816|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079817|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079818|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079819|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079820|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20079821|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079822|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20079823|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20079824|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079825|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
20079826|NCT00000152|Aspirin|aspirin|mesh-list
20079827|NCT00000152|Beta Carotene|beta carotene|mesh-list
20079828|NCT00000152|Carotenoids|carotenoids|mesh-list
20079829|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20079830|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20079831|NCT00000152|Analgesics|analgesics|mesh-ancestor
20590112|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
20590113|NCT02150291|Hematinics|hematinics|mesh-ancestor
20590114|NCT02150291|Vitamins|vitamins|mesh-ancestor
20590115|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
20590116|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590117|NCT02150317|Sorafenib|sorafenib|mesh-list
20590118|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
20590119|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590120|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20590121|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590122|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590123|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20590124|NCT02150317|Estrogens|estrogens|mesh-ancestor
20590125|NCT02150317|Hormones|hormones|mesh-ancestor
20590126|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590127|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590128|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20590129|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20590130|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20590131|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
20590132|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590133|NCT02150447|Lansoprazole|lansoprazole|mesh-list
20590134|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20590135|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20590136|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590137|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590138|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590139|NCT02150473|Adalimumab|adalimumab|mesh-list
20590140|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590141|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20606790|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20606791|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
20606792|NCT02238457|Losartan|losartan|mesh-list
20606793|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20606794|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20606795|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20606796|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20606797|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606798|NCT02238470|Warfarin|warfarin|mesh-list
20606799|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
20606800|NCT02238470|Dabigatran|dabigatran|mesh-list
20606801|NCT02238470|Apixaban|apixaban|mesh-list
20606802|NCT02238470|Anticoagulants|anticoagulants|mesh-list
20606803|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20606804|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
20606805|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20606806|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
20606807|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606808|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606809|NCT02238496|Sirolimus|sirolimus|mesh-list
20606810|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20606811|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606812|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20606813|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606814|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
20606815|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20606816|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
20606817|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606818|NCT02238509|Trastuzumab|trastuzumab|mesh-list
20606819|NCT02238509|Lapatinib|lapatinib|mesh-list
20606820|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20606821|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606822|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20606823|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606824|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606825|NCT02238535|Iloprost|iloprost|mesh-list
20606826|NCT02238535|Warfarin|warfarin|mesh-list
20606827|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
20606828|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20606829|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
20606830|NCT02238548|Vaccines|vaccines|mesh-list
20606831|NCT02238548|Immunologic Factors|immunologic factors|mesh-ancestor
20606832|NCT02238548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606833|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
20606834|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20606835|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20606836|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606837|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
20079832|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
20079833|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079834|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079835|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079836|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079837|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079838|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20079839|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079840|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20079841|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20079842|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590142|NCT02150616|Sevoflurane|sevoflurane|mesh-list
20590143|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20590144|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20590145|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
20590146|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
20590147|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590148|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590149|NCT02150707|Liraglutide|liraglutide|mesh-list
20590150|NCT02150707|Exenatide|exenatide|mesh-list
20590151|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20590152|NCT02150707|Glucagon|glucagon|mesh-list
20590153|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20590154|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20590155|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590156|NCT02150707|Incretins|incretins|mesh-ancestor
20590157|NCT02150707|Hormones|hormones|mesh-ancestor
20590158|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590159|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20590160|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590161|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
20590162|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590163|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590164|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
20590165|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20590166|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20590167|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20590168|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590169|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
20590170|NCT02150720|Coagulants|coagulants|mesh-ancestor
20590171|NCT02150928|Asparaginase|asparaginase|mesh-list
20590172|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590173|NCT02150993|Ritonavir|ritonavir|mesh-list
20590174|NCT02150993|Lopinavir|lopinavir|mesh-list
20590175|NCT02150993|Tenofovir|tenofovir|mesh-list
20590176|NCT02150993|Lamivudine|lamivudine|mesh-list
20590177|NCT02150993|Zidovudine|zidovudine|mesh-list
20590178|NCT02150993|Emtricitabine|emtricitabine|mesh-list
20590179|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
20590180|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20079843|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
20079844|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
20079845|NCT00000152|Protective Agents|protective agents|mesh-ancestor
20079846|NCT00000152|Provitamins|provitamins|mesh-ancestor
20079847|NCT00000152|Vitamins|vitamins|mesh-ancestor
20590181|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20590182|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20590183|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
20590184|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590185|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590186|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20590187|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20590188|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
20590189|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590190|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20590191|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20590192|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20590193|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20590194|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
20590195|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20590196|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20590197|NCT02151084|Gemcitabine|gemcitabine|mesh-list
20079848|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
20079849|NCT00000157|Aspirin|aspirin|mesh-list
20590198|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079850|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20590199|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20590200|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
20590201|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590202|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
20590203|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590204|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590205|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590206|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
20590207|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590208|NCT02151201|Vaccines|vaccines|mesh-list
20590209|NCT02151201|Immunologic Factors|immunologic factors|mesh-ancestor
20590210|NCT02151201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079851|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20079852|NCT00000157|Analgesics|analgesics|mesh-ancestor
20079853|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
20079854|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079855|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590211|NCT02151240|Acyclovir|acyclovir|mesh-list
20590212|NCT02151240|Foscarnet|foscarnet|mesh-list
20590213|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20590214|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
20590215|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590216|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20590217|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20590218|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590219|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590220|NCT02151279|Chitosan|chitosan|mesh-list
20590221|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20590222|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20590223|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
20590224|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590225|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20590226|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
20590227|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
20590228|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
20590229|NCT02151279|Coagulants|coagulants|mesh-ancestor
20590230|NCT02151305|Remifentanil|remifentanil|mesh-list
20590231|NCT02151305|Propofol|propofol|mesh-list
20590232|NCT02151305|Sevoflurane|sevoflurane|mesh-list
20590233|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20590234|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590235|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590236|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20590237|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
20590238|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
20590239|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590240|NCT02151305|Narcotics|narcotics|mesh-ancestor
20590241|NCT02151305|Analgesics|analgesics|mesh-ancestor
20590242|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
20590243|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590244|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20590245|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20590246|NCT02151344|Vaccines|vaccines|mesh-list
20590247|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
20590248|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590249|NCT02151604|Xenon|xenon|mesh-list
20590250|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20590251|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
20590252|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
20590253|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590254|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590255|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
20590256|NCT02151630|Salicylates|salicylates|mesh-list
20590257|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590258|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
20590259|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
20590260|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
20590261|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20590262|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590263|NCT02151630|Analgesics|analgesics|mesh-ancestor
20590264|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
20590265|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079856|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079857|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079858|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079859|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20590266|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590267|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590268|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590269|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20590270|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590271|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590272|NCT02151695|Aflibercept|aflibercept|mesh-list
20590273|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20590274|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20590275|NCT02151695|Growth Substances|growth substances|mesh-ancestor
20590276|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590277|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
20590278|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590279|NCT02151721|Gefitinib|gefitinib|mesh-list
20079860|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079861|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20079862|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20079863|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079864|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
20079865|NCT00000160|Xenon|xenon|mesh-list
20079866|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20079867|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
20079868|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
20079869|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20079870|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079871|NCT00000161|Aspirin|aspirin|mesh-list
20079872|NCT00000161|Vitamins|vitamins|mesh-list
20079873|NCT00000161|Ascorbic Acid|ascorbic acid|mesh-list
20079874|NCT00000161|Vitamin E|vitamin e|mesh-list
20079875|NCT00000161|Beta Carotene|beta carotene|mesh-list
20079876|NCT00000161|Carotenoids|carotenoids|mesh-list
20590280|NCT02151721|Vorinostat|vorinostat|mesh-list
20590281|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590282|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20590283|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590284|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590285|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20590286|NCT02151812|Paclitaxel|paclitaxel|mesh-list
20590287|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20590288|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20590289|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590290|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20590291|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20590292|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20590293|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590294|NCT02151916|Fluorides|fluorides|mesh-list
20590295|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
20590296|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
20590297|NCT02151916|Protective Agents|protective agents|mesh-ancestor
20590298|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079877|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
20079878|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079879|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20079880|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20079881|NCT00000161|Analgesics|analgesics|mesh-ancestor
20079882|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
20079883|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079884|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079885|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20079886|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20079887|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20079888|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079889|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20079890|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20079891|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590299|NCT02151929|Everolimus|everolimus|mesh-list
20590300|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590301|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590302|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
20590303|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590304|NCT02151968|Anesthetics|anesthetics|mesh-list
20590305|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
20590306|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590307|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590308|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
20590309|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590310|NCT02152059|Nintedanib|nintedanib|mesh-list
20590311|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079892|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
20590312|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20590313|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590314|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590315|NCT02152176|Morphine|morphine|mesh-list
20590316|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590317|NCT02152176|Narcotics|narcotics|mesh-ancestor
20590318|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590319|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590320|NCT02152176|Analgesics|analgesics|mesh-ancestor
20590321|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
20590322|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590323|NCT02152228|Teriparatide|teriparatide|mesh-list
20590324|NCT02152228|Hormones|hormones|mesh-list
20590325|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
20590326|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590327|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590328|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20590329|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20590330|NCT02152306|Amlodipine|amlodipine|mesh-list
20590331|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590332|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20590333|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590334|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590335|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20590336|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590337|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
20606838|NCT02238639|Coagulants|coagulants|mesh-ancestor
20608028|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608029|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608030|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608031|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608032|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608033|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608034|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608035|NCT02244268|Urological Agents|urological agents|mesh-ancestor
20608036|NCT02244281|Tamsulosin|tamsulosin|mesh-list
20608037|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20079893|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
20079894|NCT00000161|Protective Agents|protective agents|mesh-ancestor
20079895|NCT00000161|Provitamins|provitamins|mesh-ancestor
20079896|NCT00000170|Atropine|atropine|mesh-list
20608038|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608039|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608040|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608041|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608042|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608043|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608044|NCT02244281|Urological Agents|urological agents|mesh-ancestor
20608045|NCT02244294|Tamsulosin|tamsulosin|mesh-list
20079897|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20079898|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20079899|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20079900|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
20079901|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608046|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608047|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608048|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608049|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608050|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608051|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608052|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608053|NCT02244294|Urological Agents|urological agents|mesh-ancestor
20608054|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
20079902|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079903|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20079904|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
20079905|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
20079906|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
20079907|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20079908|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20079909|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
20079910|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079911|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590338|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
20590339|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20590340|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20590341|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590342|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20590343|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20590344|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079912|NCT00000171|Melatonin|melatonin|mesh-list
20079913|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
20079914|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079915|NCT00000171|Protective Agents|protective agents|mesh-ancestor
20590345|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590346|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590347|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20590348|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
20590349|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20590350|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590351|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20590352|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20590353|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20590354|NCT02152358|Acyclovir|acyclovir|mesh-list
20590355|NCT02152358|Ganciclovir|ganciclovir|mesh-list
20590356|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20590357|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
20590358|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590359|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20590360|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590361|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590362|NCT02152410|Morphine|morphine|mesh-list
20590363|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590364|NCT02152410|Narcotics|narcotics|mesh-ancestor
20590365|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590366|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590367|NCT02152410|Analgesics|analgesics|mesh-ancestor
20590368|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
20590369|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590370|NCT02152423|Enoxaparin|enoxaparin|mesh-list
20590371|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
20590372|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20590373|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20590374|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590375|NCT02152475|Curcumin|curcumin|mesh-list
20590376|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20590377|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590378|NCT02152475|Analgesics|analgesics|mesh-ancestor
20590379|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
20590380|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590381|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590382|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590383|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590384|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590385|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590386|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590387|NCT02152514|Sufentanil|sufentanil|mesh-list
20590388|NCT02152514|Morphine|morphine|mesh-list
20590389|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590390|NCT02152514|Narcotics|narcotics|mesh-ancestor
20590391|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590392|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590393|NCT02152514|Analgesics|analgesics|mesh-ancestor
20590394|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
20590395|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590396|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20079916|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079917|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20079918|NCT00000172|Galantamine|galantamine|mesh-list
20079919|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20079920|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079921|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079922|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
20079923|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079924|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079925|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20079926|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
20590397|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20590398|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
20590399|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
20590400|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
20590401|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20590402|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590403|NCT02152579|Isosorbide|isosorbide|mesh-list
20590404|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20590405|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20590406|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20590407|NCT02152579|Diuretics|diuretics|mesh-ancestor
20590408|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
20590409|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590410|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
20590411|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20590412|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590413|NCT02152709|Vaccines|vaccines|mesh-list
20590414|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
20590415|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590416|NCT02152787|Propofol|propofol|mesh-list
20590417|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20590418|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590419|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590420|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20590421|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
20590422|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
20590423|NCT02152800|Valacyclovir|valacyclovir|mesh-list
20590424|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
20590425|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590426|NCT02152865|Lupeol|lupeol|mesh-list
20590427|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590428|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
20590429|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20590430|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20590431|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590432|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
20590433|NCT02152917|Coagulants|coagulants|mesh-ancestor
20590434|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20590435|NCT02152943|Trastuzumab|trastuzumab|mesh-list
20079927|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079928|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
20079929|NCT00000173|Vitamin E|vitamin e|mesh-list
20079930|NCT00000173|Donepezil|donepezil|mesh-list
20590436|NCT02152943|Everolimus|everolimus|mesh-list
20590437|NCT02152943|Letrozole|letrozole|mesh-list
20590438|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20590439|NCT02152943|Antibodies|antibodies|mesh-list
20590440|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
20590441|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20590442|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
20590443|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590444|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590445|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590446|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20590447|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20590448|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590449|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590450|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20590451|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
20590452|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590453|NCT02152969|Amlodipine|amlodipine|mesh-list
20590454|NCT02152969|Telmisartan|telmisartan|mesh-list
20590455|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
20590456|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590457|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20590458|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590459|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590460|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20590461|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590462|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
20590463|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20590464|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20590465|NCT02152969|Diuretics|diuretics|mesh-ancestor
20079931|NCT00000173|Vitamins|vitamins|mesh-ancestor
20079932|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
20590466|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
20590467|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20590468|NCT02153060|Dexamethasone|dexamethasone|mesh-list
20590469|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
20590470|NCT02153060|BB 1101|bb 1101|mesh-list
20590471|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590472|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
20590473|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
20590474|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590475|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590476|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590477|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
20590478|NCT02153060|Hormones|hormones|mesh-ancestor
20590479|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590480|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20590481|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590482|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
20590483|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590484|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079933|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079934|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20079935|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079936|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079937|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
20079938|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079939|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
20079940|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
20079941|NCT00000173|Protective Agents|protective agents|mesh-ancestor
20079942|NCT00000174|Rivastigmine|rivastigmine|mesh-list
20079943|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20079944|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20079945|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079946|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
20079947|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079948|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079949|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20079950|NCT00000174|Protective Agents|protective agents|mesh-ancestor
20079951|NCT00000175|Testosterone|testosterone|mesh-list
20079952|NCT00000175|Estrogens|estrogens|mesh-list
20079953|NCT00000175|Androgens|androgens|mesh-ancestor
20079954|NCT00000175|Hormones|hormones|mesh-ancestor
20079955|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079956|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079957|NCT00000176|Progesterone|progesterone|mesh-list
20079958|NCT00000176|Estrogens|estrogens|mesh-list
20079959|NCT00000176|Progestins|progestins|mesh-ancestor
20079960|NCT00000176|Hormones|hormones|mesh-ancestor
20079961|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20079962|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079963|NCT00000177|Estrogens|estrogens|mesh-list
20079964|NCT00000177|Hormones|hormones|mesh-ancestor
20590485|NCT02153125|Eplerenone|eplerenone|mesh-list
20590486|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20590487|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
20590488|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590489|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590490|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19492111|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19492112|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19492113|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492114|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492115|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492116|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
19492117|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19492118|NCT03125772|Paclitaxel|paclitaxel|mesh-list
20079965|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492119|NCT03125772|Everolimus|everolimus|mesh-list
20079966|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079967|NCT00000178|Prednisone|prednisone|mesh-list
20079968|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20079969|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
20079970|NCT00000178|Hormones|hormones|mesh-ancestor
20079971|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590491|NCT02153125|Diuretics|diuretics|mesh-ancestor
20590492|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
20590493|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590494|NCT02153177|Acetaminophen|acetaminophen|mesh-list
20079972|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590495|NCT02153177|Ibuprofen|ibuprofen|mesh-list
20079973|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20079974|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20079975|NCT00000179|Haloperidol|haloperidol|mesh-list
20079976|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
20079977|NCT00000179|Trazodone|trazodone|mesh-list
20079978|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
20079979|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
20079980|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20079981|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20079982|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20079983|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20079984|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20079985|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20079986|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20079987|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20079988|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
20079989|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20079990|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20079991|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20079992|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20079993|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20079994|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20079995|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20079996|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
20079997|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20079998|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
20079999|NCT00000187|Ritanserin|ritanserin|mesh-list
20080000|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20080001|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
20080002|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080003|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080004|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080005|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20080006|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080007|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080008|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080009|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20080010|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20080011|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080012|NCT00000188|Selegiline|selegiline|mesh-list
20080013|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080014|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080015|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20080016|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20080017|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20080018|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080019|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080020|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20080021|NCT00000188|Protective Agents|protective agents|mesh-ancestor
20080022|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080023|NCT00000189|Gepirone|gepirone|mesh-list
20080024|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080025|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080026|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20080027|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080028|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080029|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080030|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20080031|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
20080032|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080033|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120012|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120013|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120014|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
20120015|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
20120016|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120017|NCT00006260|Etoposide|etoposide|mesh-list
20120018|NCT00006260|Ifosfamide|ifosfamide|mesh-list
20120019|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120020|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120021|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20590496|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20590497|NCT02153177|Hydrocodone|hydrocodone|mesh-list
20590498|NCT02153177|Oxycodone|oxycodone|mesh-list
20590499|NCT02153177|Omeprazole|omeprazole|mesh-list
20080034|NCT00000191|Carbamazepine|carbamazepine|mesh-list
20080035|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
20080036|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
20080037|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080038|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080039|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080040|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080041|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080042|NCT00000191|Analgesics|analgesics|mesh-ancestor
20080043|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
20080044|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080045|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20080046|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080047|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080048|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20080049|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20080050|NCT00000192|Lamotrigine|lamotrigine|mesh-list
20080051|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
20080052|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20080053|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080054|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080055|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20080056|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080057|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20590500|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590501|NCT02153177|Analgesics|analgesics|mesh-ancestor
20590502|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
20590503|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590504|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590505|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
20590506|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20590507|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590508|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590509|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20590510|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590511|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590512|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20590513|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590514|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20590515|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590516|NCT02153177|Narcotics|narcotics|mesh-ancestor
20590517|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590518|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
20590519|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
20590520|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20590521|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590522|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
20590523|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20590524|NCT02153281|Phenelzine|phenelzine|mesh-list
20590525|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
20590526|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20590527|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20590528|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590529|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590530|NCT02153424|Apixaban|apixaban|mesh-list
20590531|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20590532|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
20590533|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20590534|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
20590535|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590536|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590537|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
20590538|NCT02153437|Sotalol|sotalol|mesh-list
20590539|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20590540|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20590541|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
20590542|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590543|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590544|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590545|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20590546|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
20590547|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
20590548|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080058|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080059|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080060|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20590549|NCT02153450|Metformin|metformin|mesh-list
20590550|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20590551|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590552|NCT02153541|Antipyrine|antipyrine|mesh-list
20590553|NCT02153541|Benzocaine|benzocaine|mesh-list
20590554|NCT02153541|Mineral Oil|mineral oil|mesh-list
20590555|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
20080061|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19746472|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746473|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19746474|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
19746475|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
19746476|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746477|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746478|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746479|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19746480|NCT03351348|Bupivacaine|bupivacaine|mesh-list
19746481|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
20590556|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
20590557|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590558|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590559|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
20590560|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590561|NCT02153541|Emollients|emollients|mesh-ancestor
20590562|NCT02153541|Dermatologic Agents|dermatologic agents|mesh-ancestor
20590563|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20590564|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590565|NCT02153541|Analgesics|analgesics|mesh-ancestor
20590566|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590567|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590568|NCT02153567|Citalopram|citalopram|mesh-list
20590569|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20590570|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20590571|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590572|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590573|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590574|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
20590575|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590576|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20590577|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
20590578|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20590579|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
20590580|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20590581|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20590582|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20590583|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590584|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
20590585|NCT02153593|Coagulants|coagulants|mesh-ancestor
20590586|NCT02153606|Glycerol|glycerol|mesh-list
20590587|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20590588|NCT02153606|Protective Agents|protective agents|mesh-ancestor
20590589|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590590|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
20590591|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20590592|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590593|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
20590594|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
20590595|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20590596|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20590597|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20590598|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590599|NCT02153866|Vaccines|vaccines|mesh-list
20590600|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
20590601|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590602|NCT02153879|Niacin|niacin|mesh-list
20590603|NCT02153879|Fenofibrate|fenofibrate|mesh-list
20590604|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20590605|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
20590606|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080062|NCT00000194|Cycloserine|cycloserine|mesh-list
20590607|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20590608|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
20590609|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
20590610|NCT02153879|Vitamins|vitamins|mesh-ancestor
19492120|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19492121|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492122|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
19492123|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
19492124|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
19492125|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492126|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492127|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
19492128|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492129|NCT03125694|Pioglitazone|pioglitazone|mesh-list
19492130|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19492131|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19492132|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492133|NCT03125694|Incretins|incretins|mesh-ancestor
20590611|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
20590612|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080063|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20080064|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20080065|NCT00000194|Renal Agents|renal agents|mesh-ancestor
20080066|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20080067|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
20080068|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20080069|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
20080070|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080071|NCT00000195|Naltrexone|naltrexone|mesh-list
20080072|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20080073|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080074|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080075|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
20080076|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080077|NCT00000196|Naltrexone|naltrexone|mesh-list
20080078|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20590613|NCT02153944|Propranolol|propranolol|mesh-list
20590614|NCT02153944|Methylphenidate|methylphenidate|mesh-list
20590615|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20590616|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590617|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20590618|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20590619|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590620|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590621|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
20590622|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590623|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20590624|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20590625|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
20590626|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20590627|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590628|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
20590629|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
20590630|NCT02154074|Isoflurane|isoflurane|mesh-list
20590631|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
20590632|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590633|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590634|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20590635|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590636|NCT02154074|Analgesics|analgesics|mesh-ancestor
20590637|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
20590638|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590639|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20590640|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20590641|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20590642|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
20590643|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590644|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590645|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20590646|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
20080079|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080080|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080081|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
20080082|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080083|NCT00000197|Propranolol|propranolol|mesh-list
20080084|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20080085|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20080086|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080087|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080088|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590647|NCT02154217|Timolol|timolol|mesh-list
20590648|NCT02154217|Bimatoprost|bimatoprost|mesh-list
20590649|NCT02154217|Latanoprost|latanoprost|mesh-list
20590650|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20590651|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20590652|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
20590653|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590654|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590655|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590656|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20590657|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590658|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20590659|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20590660|NCT02154230|Calcium|calcium|mesh-list
20590661|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20590662|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590663|NCT02154269|Lenograstim|lenograstim|mesh-list
20590664|NCT02154269|Sargramostim|sargramostim|mesh-list
20590665|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20590666|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
20590667|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590668|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
20590669|NCT02154334|Phenylephrine|phenylephrine|mesh-list
20590670|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
20590671|NCT02154334|Esketamine|esketamine|mesh-list
20590672|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590673|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
20590674|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20590675|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
20590676|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20590677|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20590678|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20590679|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
20590680|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590681|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590682|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590683|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
20590684|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
20080089|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080090|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20080091|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590685|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590686|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
20590687|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20590688|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
20590689|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20590690|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
20080092|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
20080093|NCT00000198|Piracetam|piracetam|mesh-list
20080094|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20080095|NCT00000198|Protective Agents|protective agents|mesh-ancestor
20080096|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080097|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
20080098|NCT00000199|Piracetam|piracetam|mesh-list
20080099|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20080100|NCT00000199|Protective Agents|protective agents|mesh-ancestor
20080101|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080102|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
20590691|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20590692|NCT02154334|Protective Agents|protective agents|mesh-ancestor
20590693|NCT02154360|Aprepitant|aprepitant|mesh-list
20590694|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
20590695|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
20590696|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590697|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590698|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590699|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20590700|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590701|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080103|NCT00000200|Methadone|methadone|mesh-list
20080104|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080105|NCT00000200|Narcotics|narcotics|mesh-ancestor
20590702|NCT02154438|Ketamine|ketamine|mesh-list
20590703|NCT02154438|Analgesics|analgesics|mesh-ancestor
20590704|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
20606839|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
20590705|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590706|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590707|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20080106|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080107|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080108|NCT00000200|Analgesics|analgesics|mesh-ancestor
20080109|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
20080110|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080111|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
20080112|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
20080113|NCT00000201|Selegiline|selegiline|mesh-list
20080114|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080115|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080116|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20080117|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20080118|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20590708|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20590709|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
20590710|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
20590711|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590712|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20080119|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080120|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080121|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20590713|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20590714|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590715|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590716|NCT02154464|Acetaminophen|acetaminophen|mesh-list
20590717|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590718|NCT02154464|Analgesics|analgesics|mesh-ancestor
20590719|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
20590720|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590721|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590722|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
20590723|NCT02154503|Minoxidil|minoxidil|mesh-list
20590724|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590725|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
20590726|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
20590727|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20590728|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20590729|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590730|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
20590731|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
20590732|NCT02154646|Gemcitabine|gemcitabine|mesh-list
20080122|NCT00000201|Protective Agents|protective agents|mesh-ancestor
20080123|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080124|NCT00000202|Buprenorphine|buprenorphine|mesh-list
20080125|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080126|NCT00000202|Narcotics|narcotics|mesh-ancestor
20080127|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080128|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080129|NCT00000202|Analgesics|analgesics|mesh-ancestor
20080130|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
20590733|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20590734|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
20590735|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590736|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590737|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
20590738|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590739|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590740|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590741|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
20590742|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590743|NCT02154737|Gemcitabine|gemcitabine|mesh-list
20590744|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20080131|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080132|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20590745|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20590746|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
20590747|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590748|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590749|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
20590750|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20080133|NCT00000203|Buprenorphine|buprenorphine|mesh-list
20590751|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590752|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590753|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
20590754|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590755|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20590756|NCT02154776|Letrozole|letrozole|mesh-list
20080134|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080135|NCT00000203|Narcotics|narcotics|mesh-ancestor
20080136|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080137|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080138|NCT00000203|Analgesics|analgesics|mesh-ancestor
20080139|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
20080140|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080141|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080142|NCT00000204|Buprenorphine|buprenorphine|mesh-list
20590757|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20080143|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080144|NCT00000204|Narcotics|narcotics|mesh-ancestor
20080145|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080146|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080147|NCT00000204|Analgesics|analgesics|mesh-ancestor
20080148|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
20080149|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080150|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080151|NCT00000205|Buprenorphine|buprenorphine|mesh-list
20080152|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080153|NCT00000205|Narcotics|narcotics|mesh-ancestor
20080154|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080155|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080156|NCT00000205|Analgesics|analgesics|mesh-ancestor
20080157|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
20590758|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20590759|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20590760|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590761|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590762|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20590763|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
20590764|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590765|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590766|NCT02154789|Polidocanol|polidocanol|mesh-list
20590767|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20590768|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20590769|NCT02154854|Tacrolimus|tacrolimus|mesh-list
20590770|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590771|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
20590772|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590773|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20590774|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590775|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590776|NCT02154932|Misoprostol|misoprostol|mesh-list
20590777|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20590778|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
20590779|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20590780|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590781|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20590782|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20590783|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
20590784|NCT02155023|Insulin|insulin|mesh-list
20590785|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20590786|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20590787|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590788|NCT02155049|Bimatoprost|bimatoprost|mesh-list
20590789|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20590790|NCT02155088|Gemcitabine|gemcitabine|mesh-list
20590791|NCT02155088|Paclitaxel|paclitaxel|mesh-list
20590792|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20590793|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590794|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20590795|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20590796|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20590797|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590798|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20590799|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
20080158|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080159|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080160|NCT00000206|Buprenorphine|buprenorphine|mesh-list
20590800|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
20590801|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590802|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590803|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590804|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
20590805|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590806|NCT02155166|Ibuprofen|ibuprofen|mesh-list
20590807|NCT02155166|Lidocaine|lidocaine|mesh-list
20590808|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
20590809|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
20590810|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590811|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590812|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
20590813|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590814|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20590815|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20590816|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20590817|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590818|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590819|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20590820|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590821|NCT02155166|Analgesics|analgesics|mesh-ancestor
20590822|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590823|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590824|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20590825|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590826|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
20590827|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20590828|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590829|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20590830|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20590831|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590832|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590833|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590834|NCT02155374|Insulin|insulin|mesh-list
20590835|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20590836|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
20590837|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
20590838|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20590839|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590840|NCT02155439|Triamcinolone|triamcinolone|mesh-list
20590841|NCT02155439|Fluorouracil|fluorouracil|mesh-list
20590842|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
20590843|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590844|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20590845|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590846|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590847|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
20590848|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590849|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590850|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
20590851|NCT02155439|Hormones|hormones|mesh-ancestor
20590852|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590853|NCT02155504|Itraconazole|itraconazole|mesh-list
20590854|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
20590855|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590856|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20590857|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20590858|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590859|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590860|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20590861|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
20590862|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590863|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590864|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20590865|NCT02155517|Propofol|propofol|mesh-list
20590866|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20590867|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590868|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590869|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20590870|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
20590871|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
20590872|NCT02155530|Atorvastatin|atorvastatin|mesh-list
20590873|NCT02155530|Pravastatin|pravastatin|mesh-list
20590874|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20590875|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20590876|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
20590877|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590878|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20590879|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20590880|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590881|NCT02155634|Lenalidomide|lenalidomide|mesh-list
20590882|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
20590883|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590884|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20590885|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20590886|NCT02155634|Growth Substances|growth substances|mesh-ancestor
20590887|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
20590888|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590889|NCT02155777|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20590890|NCT02155777|Norinyl|norinyl|mesh-list
20590891|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20590892|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20590893|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20590894|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
20590895|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20590896|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590897|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20590898|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20590899|NCT02155777|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20590900|NCT02155777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20590901|NCT02155803|Hormones|hormones|mesh-list
20590902|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20590903|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20590904|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
20590905|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20590906|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590907|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20590908|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606840|NCT02238704|Iron|iron|mesh-list
20606841|NCT02238704|Folic Acid|folic acid|mesh-list
20606842|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
20080161|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080162|NCT00000206|Narcotics|narcotics|mesh-ancestor
20080163|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080164|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080165|NCT00000206|Analgesics|analgesics|mesh-ancestor
20080166|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
20080167|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080168|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080169|NCT00000207|Buprenorphine|buprenorphine|mesh-list
20080170|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080171|NCT00000207|Narcotics|narcotics|mesh-ancestor
20080172|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080173|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080174|NCT00000207|Analgesics|analgesics|mesh-ancestor
20080175|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
20080176|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080177|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080178|NCT00000208|Buprenorphine|buprenorphine|mesh-list
20606843|NCT02238704|Calcium|calcium|mesh-list
20606844|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606845|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606846|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20606847|NCT02238704|Trace Elements|trace elements|mesh-ancestor
20606848|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
20606849|NCT02238704|Hematinics|hematinics|mesh-ancestor
20606850|NCT02238704|Vitamins|vitamins|mesh-ancestor
20606851|NCT02238717|Pregabalin|pregabalin|mesh-list
20606852|NCT02238717|PF-06372865|pf-06372865|mesh-list
20606853|NCT02238717|Analgesics|analgesics|mesh-ancestor
20606854|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
20606855|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606856|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606857|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
20606858|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20606859|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20608055|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
19492134|NCT03125694|Hormones|hormones|mesh-ancestor
20080179|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590909|NCT02156336|Ranolazine|ranolazine|mesh-list
20590910|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20590911|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20590912|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590913|NCT02156375|Ustekinumab|ustekinumab|mesh-list
20590914|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
20590915|NCT02156570|Ribavirin|ribavirin|mesh-list
20590916|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
20590917|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
20590918|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590919|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
20590920|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20590921|NCT02156596|Ketoprofen|ketoprofen|mesh-list
20590922|NCT02156596|Morphine|morphine|mesh-list
20590923|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20590924|NCT02156596|Narcotics|narcotics|mesh-ancestor
20590925|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590926|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590927|NCT02156596|Analgesics|analgesics|mesh-ancestor
20590928|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
20590929|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20590930|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20590931|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20590932|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20590933|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590934|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20590935|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590936|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590937|NCT02156661|Oxytocin|oxytocin|mesh-list
20590938|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
20590939|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20590940|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590941|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
20590942|NCT02156726|Fludarabine|fludarabine|mesh-list
20590943|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590944|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
20590945|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590946|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590947|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20590948|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
20590949|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590950|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590951|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20590952|NCT02156739|Edetic Acid|edetic acid|mesh-list
20590953|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
20590954|NCT02156739|Antidotes|antidotes|mesh-ancestor
20590955|NCT02156739|Protective Agents|protective agents|mesh-ancestor
20590956|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080180|NCT00000208|Narcotics|narcotics|mesh-ancestor
20080181|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590957|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
20590958|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
20590959|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590960|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20590961|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
20590962|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20590963|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
20590964|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
20590965|NCT02156843|Vitamins|vitamins|mesh-ancestor
20590966|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
20590967|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590968|NCT02156960|Denosumab|denosumab|mesh-list
20590969|NCT02156960|Teriparatide|teriparatide|mesh-list
20590970|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20590971|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590972|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20590973|NCT02156999|Vitamin D|vitamin d|mesh-list
20590974|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
20590975|NCT02156999|Vitamins|vitamins|mesh-ancestor
20590976|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
19746482|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
19746483|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20590977|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590978|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20590979|NCT02157012|Tofacitinib|tofacitinib|mesh-list
20590980|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20590981|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20590982|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20590983|NCT02157077|Aflibercept|aflibercept|mesh-list
20590984|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20590985|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20590986|NCT02157077|Growth Substances|growth substances|mesh-ancestor
20590987|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590988|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
20590989|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590990|NCT02157181|Rituximab|rituximab|mesh-list
20590991|NCT02157181|Cladribine|cladribine|mesh-list
20590992|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20590993|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20590994|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
20590995|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20590996|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20590997|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20590998|NCT02157207|Vitamins|vitamins|mesh-list
20590999|NCT02157207|Vitamin E|vitamin e|mesh-list
20591000|NCT02157207|Antioxidants|antioxidants|mesh-list
20591001|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
20591002|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591003|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591004|NCT02157207|Protective Agents|protective agents|mesh-ancestor
20591005|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
20591006|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20591007|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
20591008|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20591009|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
20591010|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591011|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591012|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
20591013|NCT02157311|Tenofovir|tenofovir|mesh-list
20591014|NCT02157311|Lamivudine|lamivudine|mesh-list
20591015|NCT02157311|Emtricitabine|emtricitabine|mesh-list
20591016|NCT02157311|Efavirenz|efavirenz|mesh-list
20591017|NCT02157311|Lopinavir|lopinavir|mesh-list
20591018|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20591019|NCT02157311|Darunavir|darunavir|mesh-list
20591020|NCT02157311|Abacavir|abacavir|mesh-list
20591021|NCT02157311|Rilpivirine|rilpivirine|mesh-list
20591022|NCT02157311|Etravirine|etravirine|mesh-list
20591023|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
20591024|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591025|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20591026|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20591027|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591028|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591029|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20591030|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20591031|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20591032|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20591033|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20591034|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20591035|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20591036|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20591037|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20080182|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080183|NCT00000208|Analgesics|analgesics|mesh-ancestor
20080184|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
20080185|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080186|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080187|NCT00000209|Buprenorphine|buprenorphine|mesh-list
20080188|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080189|NCT00000209|Narcotics|narcotics|mesh-ancestor
20080190|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080191|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080192|NCT00000209|Analgesics|analgesics|mesh-ancestor
20080193|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
20080194|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080195|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080196|NCT00000210|Buprenorphine|buprenorphine|mesh-list
20080197|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080198|NCT00000210|Narcotics|narcotics|mesh-ancestor
20080199|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591038|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20591039|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
20591040|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20591041|NCT02157337|Atorvastatin|atorvastatin|mesh-list
20591042|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20591043|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20591044|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
20591045|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591046|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20591047|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20591048|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591049|NCT02157415|Polihexanide|polihexanide|mesh-list
20591050|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
20591051|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591052|NCT02157428|Flumazenil|flumazenil|mesh-list
20591053|NCT02157428|Antidotes|antidotes|mesh-ancestor
20591054|NCT02157428|Protective Agents|protective agents|mesh-ancestor
20591055|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591056|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
20591057|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
20591058|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080200|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080201|NCT00000210|Analgesics|analgesics|mesh-ancestor
20080202|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
20080203|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080204|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080205|NCT00000211|Buprenorphine|buprenorphine|mesh-list
20080206|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20591059|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591060|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
20591061|NCT02157467|BMS-955176|bms-955176|mesh-list
20591062|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20591063|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20591064|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591065|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20591066|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20591067|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591068|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591069|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591070|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20591071|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
20591072|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591073|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591074|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20591075|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20591076|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20591077|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20591078|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20591079|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
20591080|NCT02157558|Fexofenadine|fexofenadine|mesh-list
20591081|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20591082|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20591083|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20080207|NCT00000211|Narcotics|narcotics|mesh-ancestor
20080208|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080209|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080210|NCT00000211|Analgesics|analgesics|mesh-ancestor
20080211|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
20080212|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080213|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080214|NCT00000212|Desipramine|desipramine|mesh-list
20080215|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20080216|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080217|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080218|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080219|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080220|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20080221|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080222|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080223|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080224|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080225|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080226|NCT00000213|Fluoxetine|fluoxetine|mesh-list
20080227|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20080228|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080229|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20591084|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
20591085|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
20591086|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591087|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591088|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591089|NCT02157571|Levofloxacin|levofloxacin|mesh-list
20591090|NCT02157571|Ofloxacin|ofloxacin|mesh-list
20591091|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
20591092|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
20591093|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20591094|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591095|NCT02157571|Renal Agents|renal agents|mesh-ancestor
20591096|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20591097|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20591098|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20591099|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591100|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591101|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591102|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20591103|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20591104|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20606860|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606861|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20606862|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20606863|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20606864|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606865|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20606866|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
20606867|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
20606868|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606869|NCT02238808|Estradiol|estradiol|mesh-list
20606870|NCT02238808|Estrogens|estrogens|mesh-list
20606871|NCT02238808|Hormones|hormones|mesh-ancestor
20606872|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606873|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606874|NCT02238860|Tenofovir|tenofovir|mesh-list
20606875|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
20606876|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606877|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20606878|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20606879|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606880|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606881|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20606882|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20606883|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
20606884|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20606885|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
20606886|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606887|NCT02239107|Expectorants|expectorants|mesh-ancestor
20606888|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
20606889|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20606890|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
20606891|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606892|NCT02239107|Protective Agents|protective agents|mesh-ancestor
20606893|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606894|NCT02239107|Antidotes|antidotes|mesh-ancestor
20606895|NCT02239276|Stiripentol|stiripentol|mesh-list
20606896|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
20606897|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
20606898|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
20606899|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20606900|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606901|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606902|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20606903|NCT02239445|Analgesics|analgesics|mesh-ancestor
20080230|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080231|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080232|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
20080233|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080234|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20080235|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080236|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20606904|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
19746484|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606905|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080237|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20080238|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20080239|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080240|NCT00000214|Buprenorphine|buprenorphine|mesh-list
20080241|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20591105|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
20591106|NCT02157649|Codeine|codeine|mesh-list
20591107|NCT02157649|Guaifenesin|guaifenesin|mesh-list
20591108|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20080242|NCT00000214|Narcotics|narcotics|mesh-ancestor
20080243|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080244|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080245|NCT00000214|Analgesics|analgesics|mesh-ancestor
20080246|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
20080247|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080248|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080249|NCT00000215|Pergolide|pergolide|mesh-list
20080250|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
20080251|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
20080252|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591109|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20591110|NCT02157649|Narcotics|narcotics|mesh-ancestor
20591111|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591112|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591113|NCT02157649|Analgesics|analgesics|mesh-ancestor
20591114|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
20591115|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591116|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
20591117|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
20591118|NCT02157649|Expectorants|expectorants|mesh-ancestor
20591119|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20591120|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20591121|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20591122|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591123|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591124|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
20591125|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20591126|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
20591127|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
20591128|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
20591129|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20591130|NCT02157792|Gemcitabine|gemcitabine|mesh-list
20591131|NCT02157792|Carboplatin|carboplatin|mesh-list
20591132|NCT02157792|Irinotecan|irinotecan|mesh-list
20591133|NCT02157792|Etoposide|etoposide|mesh-list
19746485|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
20080253|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080254|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746486|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746487|NCT03289039|Fulvestrant|fulvestrant|mesh-list
19746488|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746489|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20080255|NCT00000216|Buprenorphine|buprenorphine|mesh-list
20080256|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080257|NCT00000216|Narcotics|narcotics|mesh-ancestor
20080258|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080259|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080260|NCT00000216|Analgesics|analgesics|mesh-ancestor
20080261|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
20080262|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080263|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080264|NCT00000217|Carbamazepine|carbamazepine|mesh-list
20080265|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
20080266|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
20080267|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080268|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591134|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746490|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19746491|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20080269|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080270|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20591135|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20591136|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
20591137|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746492|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
20591138|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
20591139|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591140|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591141|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591142|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
20080271|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080272|NCT00000217|Analgesics|analgesics|mesh-ancestor
20080273|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
20080274|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080275|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20080276|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080277|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080278|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20080279|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20080280|NCT00000218|Carbamazepine|carbamazepine|mesh-list
20080281|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
20080282|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
20080283|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080284|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080285|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080286|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080287|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080288|NCT00000218|Analgesics|analgesics|mesh-ancestor
20591143|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591144|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20591145|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20591146|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20591147|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20591148|NCT02157818|Midazolam|midazolam|mesh-list
20591149|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
20591150|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20591151|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591152|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591153|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591154|NCT02157818|Analgesics|analgesics|mesh-ancestor
20591155|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
20591156|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591157|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20591158|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20591159|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20591160|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080289|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
20080290|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591161|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591162|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591163|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20591164|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20591165|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20591166|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20591167|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20591168|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
20591169|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
20591170|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
20591171|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
20591172|NCT02158013|Diltiazem|diltiazem|mesh-list
20591173|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20591174|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20591175|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20591176|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591177|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20591178|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591179|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
20591180|NCT02158052|Tacrolimus|tacrolimus|mesh-list
20591181|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20591182|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591183|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
20591184|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591185|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20591186|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591187|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591188|NCT02158078|Insulin|insulin|mesh-list
20591189|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20591190|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080291|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20591191|NCT02158117|Naloxone|naloxone|mesh-list
20591192|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20591193|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591194|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
20591195|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591196|NCT02158143|Vitamin D|vitamin d|mesh-list
20591197|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
20591198|NCT02158143|Vitamins|vitamins|mesh-ancestor
20591199|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
20591200|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591201|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20591202|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20591203|NCT02158182|Rifaximin|rifaximin|mesh-list
20591204|NCT02158182|Lactulose|lactulose|mesh-list
20591205|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
20591206|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20591207|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591208|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591209|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20591210|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20591211|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080292|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080293|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080294|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20080295|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20080296|NCT00000219|Buprenorphine|buprenorphine|mesh-list
20080297|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080298|NCT00000219|Narcotics|narcotics|mesh-ancestor
20080299|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080300|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080301|NCT00000219|Analgesics|analgesics|mesh-ancestor
20080302|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
20080303|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080304|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080305|NCT00000220|Buprenorphine|buprenorphine|mesh-list
20080306|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080307|NCT00000220|Narcotics|narcotics|mesh-ancestor
20080308|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080309|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080310|NCT00000220|Analgesics|analgesics|mesh-ancestor
20080311|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
20080312|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080313|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080314|NCT00000221|Buprenorphine|buprenorphine|mesh-list
20080315|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080316|NCT00000221|Narcotics|narcotics|mesh-ancestor
20080317|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080318|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080319|NCT00000221|Analgesics|analgesics|mesh-ancestor
20080320|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
20080321|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080322|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080323|NCT00000222|Buprenorphine|buprenorphine|mesh-list
20080324|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080325|NCT00000222|Narcotics|narcotics|mesh-ancestor
20080326|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080327|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080328|NCT00000222|Analgesics|analgesics|mesh-ancestor
20080329|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
20080330|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080331|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080332|NCT00000223|Buprenorphine|buprenorphine|mesh-list
20080333|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080334|NCT00000223|Narcotics|narcotics|mesh-ancestor
20080335|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080336|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080337|NCT00000223|Analgesics|analgesics|mesh-ancestor
20080338|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
20080339|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080340|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080341|NCT00000224|Buprenorphine|buprenorphine|mesh-list
20080342|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20591212|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080343|NCT00000224|Narcotics|narcotics|mesh-ancestor
20080344|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080345|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080346|NCT00000224|Analgesics|analgesics|mesh-ancestor
20080347|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
20080348|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591213|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591214|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
20080349|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080350|NCT00000225|Buprenorphine|buprenorphine|mesh-list
20080351|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080352|NCT00000225|Narcotics|narcotics|mesh-ancestor
20080353|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080354|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080355|NCT00000225|Analgesics|analgesics|mesh-ancestor
20080356|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
20080357|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080358|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20591215|NCT02158221|Growth Substances|growth substances|mesh-ancestor
20080359|NCT00000226|Buprenorphine|buprenorphine|mesh-list
20080360|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080361|NCT00000226|Narcotics|narcotics|mesh-ancestor
20080362|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080363|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080364|NCT00000226|Analgesics|analgesics|mesh-ancestor
20080365|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
20080366|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080367|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080368|NCT00000227|Buprenorphine|buprenorphine|mesh-list
20080369|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080370|NCT00000227|Narcotics|narcotics|mesh-ancestor
20080371|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080372|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080373|NCT00000227|Analgesics|analgesics|mesh-ancestor
20080374|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
20080375|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080376|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080377|NCT00000228|Buprenorphine|buprenorphine|mesh-list
20080378|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080379|NCT00000228|Narcotics|narcotics|mesh-ancestor
20080380|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080381|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080382|NCT00000228|Analgesics|analgesics|mesh-ancestor
20080383|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
20080384|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080385|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080386|NCT00000229|Buprenorphine|buprenorphine|mesh-list
20080387|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080388|NCT00000229|Narcotics|narcotics|mesh-ancestor
20080389|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080390|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080391|NCT00000229|Analgesics|analgesics|mesh-ancestor
20080392|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
20080393|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080394|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080395|NCT00000230|Buprenorphine|buprenorphine|mesh-list
20591216|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591217|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
20591218|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591219|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591220|NCT02158286|Acetaminophen|acetaminophen|mesh-list
20591221|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591222|NCT02158286|Analgesics|analgesics|mesh-ancestor
20591223|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
20080396|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080397|NCT00000230|Narcotics|narcotics|mesh-ancestor
20080398|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591224|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591225|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591226|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
20591227|NCT02158481|Carotenoids|carotenoids|mesh-list
20591228|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
20591229|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591230|NCT02158481|Protective Agents|protective agents|mesh-ancestor
20591231|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591232|NCT02158585|Lamotrigine|lamotrigine|mesh-list
20591233|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
20591234|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20591235|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20591236|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591237|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20591238|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591239|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20591240|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20591241|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591242|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20591243|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20591244|NCT02158598|Vitamin D|vitamin d|mesh-list
20591245|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
20591246|NCT02158598|Vitamins|vitamins|mesh-list
20591247|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
20591248|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591249|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20591250|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20591251|NCT02158624|Ranibizumab|ranibizumab|mesh-list
20591252|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20591253|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20591254|NCT02158624|Growth Substances|growth substances|mesh-ancestor
20591255|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591256|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
20591257|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591258|NCT02158689|Letrozole|letrozole|mesh-list
20591259|NCT02158689|Menotropins|menotropins|mesh-list
20591260|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591261|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20591262|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20591263|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591264|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591265|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20591266|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
20591267|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591268|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591269|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20591270|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
20591271|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591272|NCT02158702|Dexamethasone|dexamethasone|mesh-list
20591273|NCT02158702|Pomalidomide|pomalidomide|mesh-list
20591274|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591275|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
20591276|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
20591277|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591278|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591279|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591280|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
20591281|NCT02158702|Hormones|hormones|mesh-ancestor
20591282|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591283|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20591284|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591285|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
20591286|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20591287|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20591288|NCT02158702|Growth Substances|growth substances|mesh-ancestor
20591289|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
20591290|NCT02158845|Leuprolide|leuprolide|mesh-list
20591291|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
20591292|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20591293|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
20591294|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591295|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591296|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20591297|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591298|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20591299|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
20080399|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080400|NCT00000230|Analgesics|analgesics|mesh-ancestor
20080401|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
20080402|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080403|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080404|NCT00000231|Buprenorphine|buprenorphine|mesh-list
20080405|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080406|NCT00000231|Narcotics|narcotics|mesh-ancestor
20080407|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080408|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080409|NCT00000231|Analgesics|analgesics|mesh-ancestor
20080410|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
20080411|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080412|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080413|NCT00000232|Buprenorphine|buprenorphine|mesh-list
20080414|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080415|NCT00000232|Narcotics|narcotics|mesh-ancestor
20080416|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080417|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080418|NCT00000232|Analgesics|analgesics|mesh-ancestor
20080419|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
20080420|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080421|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080422|NCT00000233|Buprenorphine|buprenorphine|mesh-list
20080423|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080424|NCT00000233|Narcotics|narcotics|mesh-ancestor
20080425|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080426|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080427|NCT00000233|Analgesics|analgesics|mesh-ancestor
20080428|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
20591300|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20591301|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20591302|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20591303|NCT02158910|Donepezil|donepezil|mesh-list
20591304|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20591305|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591306|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591307|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591308|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591309|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591310|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
20591311|NCT02159027|Maraviroc|maraviroc|mesh-list
20591312|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20591313|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20591314|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591315|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20591316|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20591317|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
20591318|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591319|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20591320|NCT02159066|Infigratinib|infigratinib|mesh-list
20591321|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591322|NCT02159131|Cabotegravir|cabotegravir|mesh-list
20591323|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
20591324|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20591325|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
20591326|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591327|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591328|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20080429|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080430|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080431|NCT00000234|Buprenorphine|buprenorphine|mesh-list
20080432|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080433|NCT00000234|Narcotics|narcotics|mesh-ancestor
20591329|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20591330|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20591331|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20591332|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20591333|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591334|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591335|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20591336|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20591337|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
20080434|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080435|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080436|NCT00000234|Analgesics|analgesics|mesh-ancestor
20080437|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
20591338|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591339|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
20591340|NCT02159196|Albuterol|albuterol|mesh-list
20591341|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20591342|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
20591343|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591344|NCT02159196|Expectorants|expectorants|mesh-ancestor
20591345|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
20591346|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20591347|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
20591348|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591349|NCT02159196|Protective Agents|protective agents|mesh-ancestor
20591350|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591351|NCT02159196|Antidotes|antidotes|mesh-ancestor
20591352|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20591353|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
20591354|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591355|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20591356|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
20591357|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591358|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20591359|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20591360|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20591361|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
20591362|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591363|NCT02159248|Gemcitabine|gemcitabine|mesh-list
20591364|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
20591365|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20591366|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
20591367|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591368|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591369|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
20591370|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591371|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591372|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591373|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
20591374|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591375|NCT02159248|Analgesics|analgesics|mesh-ancestor
20591376|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
20591377|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591378|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20591379|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591380|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591381|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591382|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20591383|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20591384|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20591385|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
20591386|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
20591387|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591388|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20080438|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080439|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080440|NCT00000235|Buprenorphine|buprenorphine|mesh-list
20080441|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080442|NCT00000235|Narcotics|narcotics|mesh-ancestor
20080443|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080444|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080445|NCT00000235|Analgesics|analgesics|mesh-ancestor
20591389|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
20080446|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
20591390|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591391|NCT02159287|Heparin|heparin|mesh-list
20591392|NCT02159287|Calcium heparin|calcium heparin|mesh-list
20591393|NCT02159287|Enoxaparin|enoxaparin|mesh-list
20591394|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
20591395|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
20591396|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20591397|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20591398|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591399|NCT02159313|Riociguat|riociguat|mesh-list
20591400|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
20591401|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591402|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20591403|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20591404|NCT02159326|Riociguat|riociguat|mesh-list
20591405|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
20591406|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591407|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20591408|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
20591409|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591410|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591411|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20591412|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20591413|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20591414|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20591415|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20591416|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20591417|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20591418|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20606906|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20606907|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20606908|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20606909|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606910|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606911|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606912|NCT02239458|Saxagliptin|saxagliptin|mesh-list
20606913|NCT02239458|Incretins|incretins|mesh-ancestor
20606914|NCT02239458|Hormones|hormones|mesh-ancestor
20606915|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20606916|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606917|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20606918|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
20606919|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606920|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606921|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20606922|NCT02239484|Tadalafil|tadalafil|mesh-list
20606923|NCT02239484|Tamsulosin|tamsulosin|mesh-list
20606924|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
20606925|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20606926|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20606927|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606928|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606929|NCT02239484|Urological Agents|urological agents|mesh-ancestor
20606930|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20606931|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20606932|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20606933|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606934|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606935|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606936|NCT02239523|Denosumab|denosumab|mesh-list
20080447|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080448|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080449|NCT00000236|Buprenorphine|buprenorphine|mesh-list
20080450|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20080451|NCT00000236|Naloxone|naloxone|mesh-list
20080452|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20606937|NCT02239523|Teriparatide|teriparatide|mesh-list
20606938|NCT02239523|Diphosphonates|diphosphonates|mesh-list
20606939|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20606940|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606941|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20080453|NCT00000236|Narcotics|narcotics|mesh-ancestor
20080454|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591419|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20591420|NCT02159573|Natalizumab|natalizumab|mesh-list
20591421|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
20080455|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080456|NCT00000236|Analgesics|analgesics|mesh-ancestor
20080457|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
20080458|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080459|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080460|NCT00000237|Buprenorphine|buprenorphine|mesh-list
20080461|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080462|NCT00000237|Narcotics|narcotics|mesh-ancestor
20080463|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080464|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080465|NCT00000237|Analgesics|analgesics|mesh-ancestor
20080466|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
20080467|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080468|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080469|NCT00000238|Buprenorphine|buprenorphine|mesh-list
20080470|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080471|NCT00000238|Narcotics|narcotics|mesh-ancestor
20080472|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080473|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080474|NCT00000238|Analgesics|analgesics|mesh-ancestor
20591422|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591423|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
20591424|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591425|NCT02159599|Ritonavir|ritonavir|mesh-list
20591426|NCT02159599|Darunavir|darunavir|mesh-list
20591427|NCT02159599|Tenofovir|tenofovir|mesh-list
20591428|NCT02159599|Lamivudine|lamivudine|mesh-list
20591429|NCT02159599|Emtricitabine|emtricitabine|mesh-list
20591430|NCT02159599|Abacavir|abacavir|mesh-list
20591431|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20591432|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20591433|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
20591434|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591435|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591436|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20591437|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20591438|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
20591439|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591440|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20591441|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20591442|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20591443|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20591444|NCT02159651|Tacrolimus|tacrolimus|mesh-list
20591445|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591446|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
20591447|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591448|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20591449|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591450|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591451|NCT02159690|Prednisone|prednisone|mesh-list
20591452|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
20591453|NCT02159690|Dutasteride|dutasteride|mesh-list
20591454|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591455|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
20591456|NCT02159690|Hormones|hormones|mesh-ancestor
20591457|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591458|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591459|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20591460|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591461|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20591462|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591463|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591464|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
20591465|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20591466|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20591467|NCT02159820|Paclitaxel|paclitaxel|mesh-list
20591468|NCT02159820|Carboplatin|carboplatin|mesh-list
20591469|NCT02159820|Decitabine|decitabine|mesh-list
20591470|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20591471|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591472|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
20080475|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
20591473|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
20591474|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
20591475|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591476|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20591477|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
20591478|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591479|NCT02159911|Misoprostol|misoprostol|mesh-list
20591480|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20591481|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
20591482|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20080476|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080477|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080478|NCT00000239|Buprenorphine|buprenorphine|mesh-list
19749287|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20080479|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080480|NCT00000239|Narcotics|narcotics|mesh-ancestor
20591483|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591484|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20591485|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591486|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
20591487|NCT02160028|Anesthetics|anesthetics|mesh-list
20591488|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591489|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591490|NCT02160054|Tacrolimus|tacrolimus|mesh-list
20591491|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591492|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
20591493|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591494|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20591495|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591496|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591497|NCT02160080|Interferons|interferons|mesh-list
20591498|NCT02160080|Ribavirin|ribavirin|mesh-list
20591499|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
20591500|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591501|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
20591502|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591503|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
20591504|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591505|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
20591506|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591507|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
20591508|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20591509|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20591510|NCT02160132|Prednisolone|prednisolone|mesh-list
20591511|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
20591512|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20591513|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
20591514|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591515|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
20591516|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
20591517|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591518|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591519|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591520|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
20591521|NCT02160132|Hormones|hormones|mesh-ancestor
20591522|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591523|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20591524|NCT02160132|Protective Agents|protective agents|mesh-ancestor
20591525|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20591526|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591527|NCT02160158|Fesoterodine|fesoterodine|mesh-list
20591528|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20591529|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20591530|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591531|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591532|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591533|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591534|NCT02160158|Urological Agents|urological agents|mesh-ancestor
20591535|NCT02160184|Pancrelipase|pancrelipase|mesh-list
20591536|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591537|NCT02160223|Neostigmine|neostigmine|mesh-list
20591538|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20591539|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591540|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591541|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591542|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591543|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591544|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20591545|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
20591546|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591547|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20591548|NCT02160236|Tenoxicam|tenoxicam|mesh-list
20591549|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20591550|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591551|NCT02160236|Analgesics|analgesics|mesh-ancestor
20591552|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
20591553|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591554|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591555|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591556|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591557|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20591558|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591559|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591560|NCT02160275|Insulin|insulin|mesh-list
20591561|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20591562|NCT02160275|Pancrelipase|pancrelipase|mesh-list
20591563|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20591564|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080481|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080482|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080483|NCT00000239|Analgesics|analgesics|mesh-ancestor
20080484|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
20080485|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080486|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080487|NCT00000240|Buprenorphine|buprenorphine|mesh-list
20080488|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080489|NCT00000240|Narcotics|narcotics|mesh-ancestor
20080490|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080491|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080492|NCT00000240|Analgesics|analgesics|mesh-ancestor
20080493|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
20080494|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591565|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591566|NCT02160301|Acetaminophen|acetaminophen|mesh-list
20591567|NCT02160301|Dexamethasone|dexamethasone|mesh-list
20591568|NCT02160301|Celecoxib|celecoxib|mesh-list
20591569|NCT02160301|Oxycodone|oxycodone|mesh-list
20591570|NCT02160301|Gabapentin|gabapentin|mesh-list
20591571|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591572|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
20591573|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
20591574|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591575|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591576|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591577|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
20591578|NCT02160301|Hormones|hormones|mesh-ancestor
20591579|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591580|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20591581|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591582|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591583|NCT02160301|Analgesics|analgesics|mesh-ancestor
20591584|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
20591585|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
20591586|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20591587|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591588|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20591589|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20591590|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591591|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591592|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20591593|NCT02160301|Narcotics|narcotics|mesh-ancestor
20591594|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591595|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
20591596|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20591597|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20591598|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20591599|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20591600|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20591601|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591602|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
20591603|NCT02160353|Prednisolone|prednisolone|mesh-list
20591604|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
20591605|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591606|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
20591607|NCT02160353|Hormones|hormones|mesh-ancestor
20591608|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591609|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591610|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20591611|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591612|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20591613|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591614|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080495|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080496|NCT00000241|Flupenthixol|flupenthixol|mesh-list
20591615|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
20591616|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20591617|NCT02160548|Atropine|atropine|mesh-list
20591618|NCT02160548|Albuterol|albuterol|mesh-list
20591619|NCT02160548|Pralidoxime|pralidoxime|mesh-list
20591620|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20591621|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
20591622|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591623|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591624|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20591625|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
20591626|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
20591627|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591628|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20591629|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20591630|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20591631|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
20591632|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591633|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591634|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20591635|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20591636|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
20591637|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
20591638|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20591639|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20591640|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591641|NCT02160548|Antidotes|antidotes|mesh-ancestor
20591642|NCT02160548|Protective Agents|protective agents|mesh-ancestor
20591643|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
20591644|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
20591645|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
20591646|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20591647|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20591648|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591649|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
20591650|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
20591651|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
20591652|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20591653|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20591654|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591655|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
20591656|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
20591657|NCT02160704|Enclomiphene|enclomiphene|mesh-list
20080497|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20080498|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20080499|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080500|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080501|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080502|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080503|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20080504|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
20080505|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080506|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591658|NCT02160704|Clomiphene|clomiphene|mesh-list
20591659|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
20591660|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20591661|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
20591662|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591663|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591664|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20591665|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
20591666|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591667|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20591668|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20591669|NCT02160743|Metformin|metformin|mesh-list
20591670|NCT02160743|Atorvastatin|atorvastatin|mesh-list
20591671|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20591672|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591673|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20591674|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20591675|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
20591676|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591677|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20591678|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20591679|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591680|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20591681|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20591682|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591683|NCT02161055|Insulin|insulin|mesh-list
20591684|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20591685|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20591686|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591687|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
20591688|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20591689|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20591690|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20591691|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20591692|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591693|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591694|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591695|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591696|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20591697|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591698|NCT02161237|Tacrolimus|tacrolimus|mesh-list
20591699|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591700|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
20591701|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591702|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20080507|NCT00000242|Carbamazepine|carbamazepine|mesh-list
20080508|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
20080509|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
20080510|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080511|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080512|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080513|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080514|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080515|NCT00000242|Analgesics|analgesics|mesh-ancestor
20080516|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
20080517|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080518|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20080519|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080520|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080521|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20080522|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20080523|NCT00000243|Buprenorphine|buprenorphine|mesh-list
20080524|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080525|NCT00000243|Narcotics|narcotics|mesh-ancestor
20080526|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080527|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080528|NCT00000243|Analgesics|analgesics|mesh-ancestor
20080529|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
20591703|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591704|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606942|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20606943|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
20606944|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
20606945|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606946|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20606947|NCT02239614|Antacids|antacids|mesh-ancestor
20606948|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606949|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20606950|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20606951|NCT02239731|Doxycycline|doxycycline|mesh-list
20080530|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080531|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20080532|NCT00000244|Dynorphins|dynorphins|mesh-list
20606952|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606953|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
20606954|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20606955|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20080533|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080534|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080535|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080536|NCT00000245|Desipramine|desipramine|mesh-list
20080537|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20080538|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080539|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080540|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080541|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080542|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20080543|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20606956|NCT02239835|Ritonavir|ritonavir|mesh-list
20606957|NCT02239835|Saquinavir|saquinavir|mesh-list
20606958|NCT02239835|Tipranavir|tipranavir|mesh-list
20591705|NCT02161354|Buprenorphine|buprenorphine|mesh-list
20591706|NCT02161354|Naloxone|naloxone|mesh-list
20591707|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20591708|NCT02161354|Narcotics|narcotics|mesh-ancestor
19746493|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746494|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746495|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
19746496|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20080544|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080545|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080546|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746497|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20080547|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080548|NCT00000246|Flumazenil|flumazenil|mesh-list
20591709|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591710|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591711|NCT02161354|Analgesics|analgesics|mesh-ancestor
20591712|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
20591713|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591714|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20591715|NCT02161367|Simethicone|simethicone|mesh-list
20591716|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
20591717|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591718|NCT02161367|Emollients|emollients|mesh-ancestor
20591719|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
20591720|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20591721|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20591722|NCT02161614|Estradiol|estradiol|mesh-list
20591723|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20591724|NCT02161614|Estrogens|estrogens|mesh-ancestor
20591725|NCT02161614|Hormones|hormones|mesh-ancestor
20080549|NCT00000246|Antidotes|antidotes|mesh-ancestor
20591726|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591727|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591728|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20591729|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
20591730|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591731|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20591732|NCT02161653|Pyridoxine|pyridoxine|mesh-list
20591733|NCT02161653|Prednisone|prednisone|mesh-list
20591734|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
20591735|NCT02161653|Metadoxine|metadoxine|mesh-list
20591736|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591737|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
20591738|NCT02161653|Hormones|hormones|mesh-ancestor
20591739|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591740|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591741|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20591742|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591743|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20591744|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591745|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591746|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20591747|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20591748|NCT02161653|Protective Agents|protective agents|mesh-ancestor
20591749|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
20591750|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20591751|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
20591752|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20591753|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
20591754|NCT02161653|Vitamins|vitamins|mesh-ancestor
20591755|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
20591756|NCT02161679|Carboplatin|carboplatin|mesh-list
20591757|NCT02161679|Camptothecin|camptothecin|mesh-list
20591758|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
20591759|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591760|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20591761|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20591762|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20591763|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591764|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591765|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
20591766|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591767|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
20591768|NCT02161692|Carboplatin|carboplatin|mesh-list
20591769|NCT02161692|Etoposide|etoposide|mesh-list
20591770|NCT02161692|Bleomycin|bleomycin|mesh-list
20591771|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20591772|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
20591773|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591774|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591775|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20591776|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
20591777|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591778|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591779|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20591780|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20591781|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20591782|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20591783|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591784|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20591785|NCT02161770|Osimertinib|osimertinib|mesh-list
20591786|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591787|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20591788|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591789|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591790|NCT02161822|Simvastatin|simvastatin|mesh-list
20591791|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20591792|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20591793|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
20080550|NCT00000246|Protective Agents|protective agents|mesh-ancestor
20080551|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080552|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
20080553|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
20080554|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591794|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120022|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20591795|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20591796|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20591797|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591798|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
20591799|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
20591800|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591801|NCT02161952|Pirfenidone|pirfenidone|mesh-list
20591802|NCT02161952|Analgesics|analgesics|mesh-ancestor
20591803|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
20591804|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591805|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591806|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20591807|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591808|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591809|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591810|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591811|NCT02161965|Warfarin|warfarin|mesh-list
20591812|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
20591813|NCT02161965|Fluindione|fluindione|mesh-list
20591814|NCT02161965|Phenindione|phenindione|mesh-list
20591815|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
20591816|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20591817|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
20591818|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20591819|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
20591820|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591821|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591822|NCT02161991|Aprepitant|aprepitant|mesh-list
20591823|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
20591824|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
20591825|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591826|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591827|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20591828|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20591829|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591830|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591831|NCT02162121|Ketorolac|ketorolac|mesh-list
20591832|NCT02162121|Buprenorphine|buprenorphine|mesh-list
20591833|NCT02162121|Anesthetics|anesthetics|mesh-list
20591834|NCT02162121|Ropivacaine|ropivacaine|mesh-list
20591835|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
20591836|NCT02162121|Mepivacaine|mepivacaine|mesh-list
20591837|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
20591838|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591839|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591840|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
20591841|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591842|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20591843|NCT02162121|Narcotics|narcotics|mesh-ancestor
20591844|NCT02162121|Analgesics|analgesics|mesh-ancestor
19746498|NCT03226301|Venetoclax|venetoclax|mesh-list
20591845|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20591846|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20591847|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591848|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591849|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591850|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20591851|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591852|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080555|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080556|NCT00000248|Pergolide|pergolide|mesh-list
20080557|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
20591853|NCT02162134|Cefuroxime|cefuroxime|mesh-list
20591854|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
20591855|NCT02162134|Ketorolac|ketorolac|mesh-list
20591856|NCT02162134|Midazolam|midazolam|mesh-list
20591857|NCT02162134|Propofol|propofol|mesh-list
20591858|NCT02162134|Sevoflurane|sevoflurane|mesh-list
20591859|NCT02162134|Atracurium|atracurium|mesh-list
20591860|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20591861|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20591862|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591863|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20591864|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
20591865|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
20591866|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20591867|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20591868|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20591869|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20591870|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
20080558|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
20080559|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080560|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080561|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080562|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
20080563|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080564|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
20080565|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
20080566|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080567|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080568|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080569|NCT00000249|Analgesics|analgesics|mesh-ancestor
20080570|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
20080571|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080572|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
20080573|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080574|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
20080575|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
20080576|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080577|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080578|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080579|NCT00000250|Analgesics|analgesics|mesh-ancestor
20080580|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
20080581|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080582|NCT00000251|Isoflurane|isoflurane|mesh-list
20080583|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20591871|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
20591872|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591873|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591874|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20591875|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20591876|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20591877|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20591878|NCT02162134|Analgesics|analgesics|mesh-ancestor
20591879|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
20591880|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591881|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20080584|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
20080585|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
20080586|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080587|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080588|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
20080589|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080590|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
20080591|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
20080592|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080593|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080594|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080595|NCT00000252|Analgesics|analgesics|mesh-ancestor
20080596|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
20120023|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591882|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591883|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20591884|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080597|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080598|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
20080599|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20591885|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20591886|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20591887|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20591888|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20591889|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20591890|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20591891|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20591892|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591893|NCT02162251|Donepezil|donepezil|mesh-list
20591894|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20591895|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591896|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591897|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591898|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591899|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591900|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
20591901|NCT02162264|Donepezil|donepezil|mesh-list
20591902|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20591903|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591904|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591905|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
20591906|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591907|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591908|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
20591909|NCT02162303|Colchicine|colchicine|mesh-list
20591910|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
20591911|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20591912|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
20591913|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
20591914|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
20591915|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591916|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591917|NCT02162381|Methylphenidate|methylphenidate|mesh-list
20591918|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20591919|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591920|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20591921|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20591922|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20591923|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591924|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
20591925|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591926|NCT02162407|Insulin|insulin|mesh-list
20591927|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20591928|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
20591929|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20591930|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591931|NCT02162485|Fluticasone|fluticasone|mesh-list
20591932|NCT02162485|Xhance|xhance|mesh-list
20591933|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20080600|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
20080601|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
20080602|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080603|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080604|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080605|NCT00000253|Analgesics|analgesics|mesh-ancestor
20591934|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20591935|NCT02162485|Charcoal|charcoal|mesh-list
20080606|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
20591936|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591937|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20591938|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
20591939|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591940|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591941|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20591942|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
20591943|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
20591944|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20591945|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20591946|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20591947|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20080607|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080608|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
20080609|NCT00000254|Isoflurane|isoflurane|mesh-list
20080610|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080611|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
20080612|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
20080613|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080614|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080615|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080616|NCT00000254|Analgesics|analgesics|mesh-ancestor
20080617|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
20591948|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
20591949|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20591950|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591951|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
20591952|NCT02162485|Hormones|hormones|mesh-ancestor
20591953|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591954|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
20591955|NCT02162485|Antidotes|antidotes|mesh-ancestor
20591956|NCT02162485|Protective Agents|protective agents|mesh-ancestor
20591957|NCT02162537|Bevacizumab|bevacizumab|mesh-list
20591958|NCT02162537|Pemetrexed|pemetrexed|mesh-list
20591959|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20591960|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20591961|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20591962|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20591963|NCT02162537|Growth Substances|growth substances|mesh-ancestor
20591964|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591965|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
20591966|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20591967|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20591968|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20591969|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20591970|NCT02162550|Exenatide|exenatide|mesh-list
20591971|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20591972|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591973|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20591974|NCT02162550|Incretins|incretins|mesh-ancestor
20591975|NCT02162550|Hormones|hormones|mesh-ancestor
20591976|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591977|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
20591978|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20591979|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
20591980|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591981|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
20591982|NCT02162693|Protective Agents|protective agents|mesh-ancestor
20591983|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20591984|NCT02162784|Budesonide|budesonide|mesh-list
20591985|NCT02162784|Albuterol|albuterol|mesh-list
20591986|NCT02162784|Procaterol|procaterol|mesh-list
20591987|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20591988|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20591989|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
20591990|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20591991|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20591992|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20591993|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
20591994|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
20591995|NCT02162784|Hormones|hormones|mesh-ancestor
20591996|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20591997|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
20591998|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20591999|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20592000|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20592001|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20592002|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
20592003|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080618|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080619|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
20080620|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080621|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
20080622|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
20080623|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080624|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080625|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080626|NCT00000255|Analgesics|analgesics|mesh-ancestor
20080627|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
20080628|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080629|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
20592004|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592005|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
20592006|NCT02162797|Zinc|zinc|mesh-list
20592007|NCT02162797|Trace Elements|trace elements|mesh-ancestor
20592008|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
20592009|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080630|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080631|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
20080632|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
20080633|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080634|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080635|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080636|NCT00000256|Analgesics|analgesics|mesh-ancestor
20080637|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
20080638|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080639|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
20080640|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080641|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
20080642|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
20592010|NCT02162849|Nicotine|nicotine|mesh-list
20592011|NCT02162849|Varenicline|varenicline|mesh-list
20592012|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20592013|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
20592014|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592015|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592016|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20592017|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20592018|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
20592019|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592020|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592021|NCT02162875|Praziquantel|praziquantel|mesh-list
20592022|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
20592023|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20592024|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592025|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20592026|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20592027|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
20592028|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592029|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592030|NCT02162966|Colistin|colistin|mesh-list
20592031|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20592032|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592033|NCT02163070|Vitamins|vitamins|mesh-list
20592034|NCT02163070|Vitamin E|vitamin e|mesh-list
20592035|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
20592036|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592037|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
20592038|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592039|NCT02163070|Protective Agents|protective agents|mesh-ancestor
20606959|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20606960|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20606961|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
20606962|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20606963|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606964|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20606965|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20606966|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
20606967|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606968|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20080643|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080644|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592040|NCT02163161|Abrocitinib|abrocitinib|mesh-list
20592041|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20592042|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592043|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592044|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
20592045|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20592046|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592047|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592048|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592049|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20592050|NCT02163174|Protective Agents|protective agents|mesh-ancestor
20592051|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592052|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
20592053|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20080645|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080646|NCT00000257|Analgesics|analgesics|mesh-ancestor
20080647|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
20080648|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080649|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
20080650|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080651|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
20080652|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
20080653|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080654|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080655|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080656|NCT00000258|Analgesics|analgesics|mesh-ancestor
20592054|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
20592055|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
20080657|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
20080658|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080659|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
20080660|NCT00000259|Sevoflurane|sevoflurane|mesh-list
20080661|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20080662|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20592056|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20592057|NCT02163213|Antibodies|antibodies|mesh-list
20592058|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
20592059|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592060|NCT02163291|Paclitaxel|paclitaxel|mesh-list
20592061|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20592062|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592063|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20592064|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20592065|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20080663|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
20080664|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
20592066|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592067|NCT02163330|Acetazolamide|acetazolamide|mesh-list
20592068|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
20592069|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20080665|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592070|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592071|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592072|NCT02163330|Diuretics|diuretics|mesh-ancestor
20592073|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
20592074|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592075|NCT02163616|Misoprostol|misoprostol|mesh-list
20592076|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20592077|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
20592078|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20592079|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592080|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20592081|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592082|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
20592083|NCT02163655|Furosemide|furosemide|mesh-list
20592084|NCT02163655|Diuretics|diuretics|mesh-ancestor
20592085|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
20592086|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592087|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20592088|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20592089|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592090|NCT02163707|Psilocybin|psilocybin|mesh-list
20592091|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
20592092|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592093|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20592094|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20592095|NCT02163720|Doxorubicin|doxorubicin|mesh-list
20592096|NCT02163720|Trabectedin|trabectedin|mesh-list
20592097|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20592098|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592099|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20592100|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20592101|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592102|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592103|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20592104|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
20592105|NCT02163954|Clopidogrel|clopidogrel|mesh-list
20592106|NCT02163954|Ticagrelor|ticagrelor|mesh-list
20592107|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592108|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20592109|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20592110|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20592111|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
20592112|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592113|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592114|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592115|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
20592116|NCT02163980|Ropivacaine|ropivacaine|mesh-list
20592117|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20592118|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592119|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592120|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592121|NCT02163980|Analgesics|analgesics|mesh-ancestor
20592122|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
20592123|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592124|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20592125|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20592126|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20592127|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
20592128|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592129|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592130|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
20592131|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
20592132|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20592133|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20592134|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20592135|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592136|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
20592137|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592138|NCT02164032|Insulin|insulin|mesh-list
20592139|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20592140|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20592141|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592142|NCT02164045|Fostemsavir|fostemsavir|mesh-list
20592143|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20592144|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20592145|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
20592146|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592147|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20592148|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20592149|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592150|NCT02164097|Heparin|heparin|mesh-list
20592151|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
20592152|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20592153|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20592154|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592155|NCT02164110|Vaccines|vaccines|mesh-list
20592156|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
20592157|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592158|NCT02164214|Etanercept|etanercept|mesh-list
20592159|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20592160|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592161|NCT02164214|Analgesics|analgesics|mesh-ancestor
20592162|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
20592163|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592164|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592165|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20592166|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20592167|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592168|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20592169|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
20592170|NCT02164253|Deferiprone|deferiprone|mesh-list
20592171|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20592172|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
20592173|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
20592174|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592175|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
20592176|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20592177|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592178|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
20592179|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20592180|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592181|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592182|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592183|NCT02164448|Analgesics|analgesics|mesh-ancestor
20592184|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
20592185|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592186|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20592187|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20592188|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20592189|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
20592190|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592191|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592192|NCT02164552|Vitamin D|vitamin d|mesh-list
20592193|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
20592194|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
20592195|NCT02164552|Vitamins|vitamins|mesh-list
20592196|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
20592197|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592198|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20592199|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20592200|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
20592201|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20592202|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20592203|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592204|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
20592205|NCT02164565|Coagulants|coagulants|mesh-ancestor
20592206|NCT02164578|Aspirin|aspirin|mesh-list
20592207|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
20592208|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20592209|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592210|NCT02164578|Analgesics|analgesics|mesh-ancestor
20592211|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
20592212|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592213|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592214|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20080666|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080667|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592215|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20592216|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20592217|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20592218|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592219|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592220|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20592221|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592222|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
20592223|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20592224|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
20592225|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20592226|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
20592227|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
20592228|NCT02164604|Ranibizumab|ranibizumab|mesh-list
20592229|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20592230|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20592231|NCT02164604|Growth Substances|growth substances|mesh-ancestor
20592232|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592233|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
20592234|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592235|NCT02164734|Remifentanil|remifentanil|mesh-list
20592236|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20592237|NCT02164734|Narcotics|narcotics|mesh-ancestor
20592238|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592239|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592240|NCT02164734|Analgesics|analgesics|mesh-ancestor
20592241|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
20592242|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592243|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
20592244|NCT02164773|Analgesics|analgesics|mesh-ancestor
20592245|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
20592246|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592247|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592248|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
20592249|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592250|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20592251|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
20592252|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20592253|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20592254|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592255|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20080668|NCT00000259|Analgesics|analgesics|mesh-ancestor
20080669|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
20080670|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592256|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
20592257|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20592258|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
20592259|NCT02164812|Efavirenz|efavirenz|mesh-list
20592260|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20592261|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592262|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20592263|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20592264|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592265|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592266|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592267|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20592268|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20592269|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
20592270|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20592271|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20592272|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20080671|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
20080672|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080673|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
20080674|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
20080675|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080676|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080677|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080678|NCT00000260|Analgesics|analgesics|mesh-ancestor
20080679|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
20080680|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080681|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
20080682|NCT00000261|Sevoflurane|sevoflurane|mesh-list
20080683|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20080684|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080685|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
20080686|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
20080687|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080688|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080689|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080690|NCT00000261|Analgesics|analgesics|mesh-ancestor
20080691|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
20080692|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080693|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
20080694|NCT00000262|Sevoflurane|sevoflurane|mesh-list
20080695|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20080696|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080697|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
20592273|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20592274|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20592275|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20592276|NCT02164825|Morphine|morphine|mesh-list
20592277|NCT02164825|Ropivacaine|ropivacaine|mesh-list
20592278|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20080698|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
20592279|NCT02164825|Narcotics|narcotics|mesh-ancestor
20592280|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592281|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592282|NCT02164825|Analgesics|analgesics|mesh-ancestor
20592283|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
20592284|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592285|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
20592286|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
20592287|NCT02164838|Axitinib|axitinib|mesh-list
20592288|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592289|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20592290|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592291|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592292|NCT02164890|Micafungin|micafungin|mesh-list
20592293|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
20592294|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20606969|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20606970|NCT02239900|Ipilimumab|ipilimumab|mesh-list
20606971|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20606972|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20606973|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20606974|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606975|NCT02239913|Topiramate|topiramate|mesh-list
20606976|NCT02239913|Phentermine|phentermine|mesh-list
20606977|NCT02239913|Cocaine|cocaine|mesh-list
20606978|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
20606979|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20606980|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20606981|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
20606982|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
20606983|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20606984|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
20606985|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20606986|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20606987|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20606988|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20606989|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20606990|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20606991|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
20606992|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20606993|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20606994|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
20606995|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20606996|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
20606997|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
20606998|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
20606999|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20607000|NCT02239952|Sunitinib|sunitinib|mesh-list
20607001|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607002|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20607003|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607004|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607005|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20607006|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20607007|NCT02239952|Growth Substances|growth substances|mesh-ancestor
20607008|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607009|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
20607010|NCT02240017|Gemcitabine|gemcitabine|mesh-list
20607011|NCT02240017|Carboplatin|carboplatin|mesh-list
20607012|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607013|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20607014|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
20607015|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607016|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
20607017|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607018|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607019|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20592295|NCT02165007|Sirolimus|sirolimus|mesh-list
20592296|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20592297|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592298|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20592299|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592300|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
20592301|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20592302|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
20592303|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592304|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
20592305|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20592306|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
20592307|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592308|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
20592309|NCT02165020|Protective Agents|protective agents|mesh-ancestor
20592310|NCT02165033|Budesonide|budesonide|mesh-list
20592311|NCT02165033|Procaterol|procaterol|mesh-list
20592312|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20592313|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20592314|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
20592315|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592316|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592317|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20592318|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
20592319|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
20592320|NCT02165033|Hormones|hormones|mesh-ancestor
20592321|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592322|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
20592323|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20592324|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20592325|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20592326|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
20592327|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592328|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592329|NCT02165046|Budesonide|budesonide|mesh-list
20592330|NCT02165046|Procaterol|procaterol|mesh-list
20592331|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20592332|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20592333|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
20592334|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592335|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592336|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20592337|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
20592338|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
20592339|NCT02165046|Hormones|hormones|mesh-ancestor
20592340|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592341|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
20592342|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20592343|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20592344|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20592345|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
20592346|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592347|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592348|NCT02165098|Cariprazine|cariprazine|mesh-list
20592349|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20592350|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20592351|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592352|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592353|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20592354|NCT02165189|Ribavirin|ribavirin|mesh-list
20592355|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
20592356|NCT02165189|Simeprevir|simeprevir|mesh-list
20592357|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
20592358|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592359|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
20592360|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592361|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
20592362|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592363|NCT02165215|Etrolizumab|etrolizumab|mesh-list
20592364|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592365|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
20592366|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592367|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
20592368|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20592369|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20592370|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592371|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20592372|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20592373|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592374|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592375|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592376|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20592377|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
20592378|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20592379|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592380|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20592381|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20592382|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20592383|NCT02165449|Ketamine|ketamine|mesh-list
20592384|NCT02165449|Analgesics|analgesics|mesh-ancestor
20592385|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
20592386|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592387|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592388|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20592389|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20592390|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
20592391|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
20592392|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592393|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20592394|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20592395|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592396|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592397|NCT02165475|Loperamide|loperamide|mesh-list
20592398|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
20592399|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592400|NCT02165566|Insulin|insulin|mesh-list
20592401|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20592402|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
20592403|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20592404|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592405|NCT02165644|Nimodipine|nimodipine|mesh-list
20592406|NCT02165644|Acetazolamide|acetazolamide|mesh-list
20592407|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
20592408|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20592409|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592410|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592411|NCT02165644|Diuretics|diuretics|mesh-ancestor
20592412|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
20592413|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592414|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20592415|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20592416|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20592417|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20592418|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
20592419|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
20592420|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592421|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592422|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
20592423|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20592424|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592425|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
20592426|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20592427|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
20592428|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592429|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
20592430|NCT02165917|Protective Agents|protective agents|mesh-ancestor
20592431|NCT02165930|Naltrexone|naltrexone|mesh-list
20592432|NCT02165930|Oxycodone|oxycodone|mesh-list
20592433|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20592434|NCT02165930|Narcotics|narcotics|mesh-ancestor
20592435|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592436|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592437|NCT02165930|Analgesics|analgesics|mesh-ancestor
20592438|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
20592439|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592440|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20592441|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20592442|NCT02166229|Valproic Acid|valproic acid|mesh-list
20592443|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
20592444|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592445|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592446|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
19746499|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746500|NCT03199924|Diclofenac|diclofenac|mesh-list
19746501|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19746502|NCT03199924|Lidocaine|lidocaine|mesh-list
20080699|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080700|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080701|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080702|NCT00000262|Analgesics|analgesics|mesh-ancestor
20080703|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
19746503|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
19746504|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
19746505|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
19746506|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746507|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746508|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
19746509|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080704|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080705|NCT00000263|Ethanol|ethanol|mesh-list
20080706|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
20080707|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20592447|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746510|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19746511|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19746512|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19746513|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19746514|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746515|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19746516|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746517|NCT03199924|Analgesics|analgesics|mesh-ancestor
19746518|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746519|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19746520|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592448|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592449|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
20592450|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20592451|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592452|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20592453|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20592454|NCT02166359|Icodextrin|icodextrin|mesh-list
20592455|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
20592456|NCT02166450|Nystatin|nystatin|mesh-list
20592457|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20592458|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592459|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
20592460|NCT02166450|Ionophores|ionophores|mesh-ancestor
20592461|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20592462|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592463|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
20592464|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20592465|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
20592466|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592467|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
20592468|NCT02166554|Protective Agents|protective agents|mesh-ancestor
20607020|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
20607021|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607022|NCT02240043|Hormones|hormones|mesh-list
20607023|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20607024|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607025|NCT02240160|Nabiximols|nabiximols|mesh-list
20607026|NCT02240160|Analgesics|analgesics|mesh-ancestor
20607027|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
20607028|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607029|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607030|NCT02240173|Haloperidol|haloperidol|mesh-list
20607031|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
20607032|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
20607033|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
20607034|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607035|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607036|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607037|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20607038|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19746521|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
20080708|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20080709|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592469|NCT02166593|Atorvastatin|atorvastatin|mesh-list
20592470|NCT02166593|Pravastatin|pravastatin|mesh-list
20592471|NCT02166593|Fenofibrate|fenofibrate|mesh-list
20592472|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20592473|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20592474|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
20592475|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592476|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20592477|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20592478|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592479|NCT02166632|Bupivacaine|bupivacaine|mesh-list
20592480|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
20592481|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
20592482|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592483|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592484|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
20592485|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592486|NCT02166671|Vaccines|vaccines|mesh-list
20592487|NCT02166671|Immunologic Factors|immunologic factors|mesh-ancestor
20592488|NCT02166671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592489|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20592490|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20592491|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20592492|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
20592493|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592494|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20592495|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20592496|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592497|NCT02166853|Midazolam|midazolam|mesh-list
20592498|NCT02166853|Sevoflurane|sevoflurane|mesh-list
20592499|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20592500|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20592501|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592502|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592503|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20592504|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20592505|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20592506|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20592507|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
20592508|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
20592509|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
20592510|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
20592511|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592512|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592513|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592514|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20592515|NCT02166905|Poly I-C|poly i-c|mesh-list
20592516|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20592517|NCT02166905|Poly ICLC|poly iclc|mesh-list
20592518|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
20592519|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
20592520|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592521|NCT02166905|Laxatives|laxatives|mesh-ancestor
20080710|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080711|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080712|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
20080713|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
20080714|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080715|NCT00000263|Analgesics|analgesics|mesh-ancestor
20592522|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592523|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
20592524|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592525|NCT02166944|Tamoxifen|tamoxifen|mesh-list
20592526|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20592527|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
20592528|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592529|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592530|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20080716|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
20080717|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080718|NCT00000264|Ethanol|ethanol|mesh-list
20080719|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
20080720|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20080721|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20080722|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080723|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080724|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20080725|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
20080726|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
20592531|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592532|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20592533|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20592534|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20592535|NCT02167061|Metformin|metformin|mesh-list
20592536|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20592537|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592538|NCT02167165|Digoxin|digoxin|mesh-list
20592539|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20592540|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20592541|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592542|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592543|NCT02167165|Protective Agents|protective agents|mesh-ancestor
20592544|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592545|NCT02167178|Polygeline|polygeline|mesh-list
20592546|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
20592547|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
20592548|NCT02167321|Leucovorin|leucovorin|mesh-list
20592549|NCT02167321|Fluorouracil|fluorouracil|mesh-list
20592550|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
20592551|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
20592552|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592553|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20592554|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592555|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20592556|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
20592557|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592558|NCT02167321|Antidotes|antidotes|mesh-ancestor
20592559|NCT02167321|Protective Agents|protective agents|mesh-ancestor
20592560|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
20592561|NCT02167321|Vitamins|vitamins|mesh-ancestor
20592562|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
20592563|NCT02167425|Methadone|methadone|mesh-list
20592564|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20592565|NCT02167425|Narcotics|narcotics|mesh-ancestor
20592566|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592567|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592568|NCT02167425|Analgesics|analgesics|mesh-ancestor
20592569|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
20592570|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592571|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
20592572|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
20592573|NCT02167464|Coal Tar|coal tar|mesh-list
20592574|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20592575|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
20592576|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
20592577|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
20592578|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592579|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592580|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20592581|NCT02167464|Diuretics|diuretics|mesh-ancestor
20592582|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
20592583|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
20592584|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
20592585|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
20080727|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592586|NCT02167620|Metformin|metformin|mesh-list
20080728|NCT00000264|Analgesics|analgesics|mesh-ancestor
20592587|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20592588|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592589|NCT02167633|Pantoprazole|pantoprazole|mesh-list
20592590|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20592591|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
20592592|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20592593|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592594|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592595|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592596|NCT02167633|Hormones|hormones|mesh-ancestor
20592597|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592598|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080729|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
20080730|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080731|NCT00000266|Flupenthixol|flupenthixol|mesh-list
20080732|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20080733|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20080734|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080735|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080736|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592599|NCT02167685|Brincidofovir|brincidofovir|mesh-list
20592600|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
20592601|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592602|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
20592603|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20592604|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20592605|NCT02167698|Prednisolone|prednisolone|mesh-list
20592606|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
20592607|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20592608|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
20592609|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20592610|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
20592611|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
20592612|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592613|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592614|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592615|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
20592616|NCT02167698|Hormones|hormones|mesh-ancestor
20592617|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592618|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20080737|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080738|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20080739|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
20080740|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080741|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592619|NCT02167698|Protective Agents|protective agents|mesh-ancestor
20592620|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20592621|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592622|NCT02167854|Trastuzumab|trastuzumab|mesh-list
20592623|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20592624|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592625|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
20592626|NCT02167958|Fludarabine|fludarabine|mesh-list
20592627|NCT02167958|Tacrolimus|tacrolimus|mesh-list
20592628|NCT02167958|Sargramostim|sargramostim|mesh-list
20592629|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20592630|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
20592631|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592632|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20592633|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20592634|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
20592635|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592636|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592637|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20080742|NCT00000267|Risperidone|risperidone|mesh-list
20080743|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20080744|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
20080745|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080746|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080747|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080748|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20080749|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20592638|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20592639|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592640|NCT02168010|Neurotropin|neurotropin|mesh-list
20592641|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20592642|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
20592643|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592644|NCT02168010|Analgesics|analgesics|mesh-ancestor
20592645|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
20592646|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592647|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
20592648|NCT02168075|Mannitol|mannitol|mesh-list
20592649|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20592650|NCT02168075|Diuretics|diuretics|mesh-ancestor
20592651|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
20592652|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592653|NCT02168127|Methylphenidate|methylphenidate|mesh-list
20592654|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20592655|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592656|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20592657|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20592658|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20592659|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592660|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
20592661|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607039|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607040|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080750|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080751|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080752|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20080753|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
20080754|NCT00000268|Bupropion|bupropion|mesh-list
20080755|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20080756|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
20607041|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20607042|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
20607043|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607044|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607045|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20607046|NCT02240199|Lidocaine|lidocaine|mesh-list
20607047|NCT02240199|Pregabalin|pregabalin|mesh-list
20607048|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
20607049|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
20607050|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607051|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607052|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
20607053|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746522|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19746523|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19746524|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
19746525|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20080757|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080758|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20080759|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080760|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080761|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080762|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
20080763|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080764|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080765|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20080766|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20080767|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080768|NCT00000269|Pergolide|pergolide|mesh-list
20080769|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
20080770|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
20080771|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080772|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080773|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080774|NCT00000270|Cocaine|cocaine|mesh-list
20080775|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
20080776|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
20080777|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080778|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080779|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
20080780|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080781|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20080782|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20080783|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080784|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19746526|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
20592662|NCT02168205|Pomalidomide|pomalidomide|mesh-list
20592663|NCT02168205|Caffeine|caffeine|mesh-list
20592664|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20592665|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592666|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20592667|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592668|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592669|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20592670|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20592671|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
20592672|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592673|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
20592674|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20592675|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20592676|NCT02168205|Growth Substances|growth substances|mesh-ancestor
20592677|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
20592678|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592679|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
20592680|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20592681|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
20592682|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592683|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
20592684|NCT02168426|Protective Agents|protective agents|mesh-ancestor
20592685|NCT02168543|Alendronate|alendronate|mesh-list
20592686|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20592687|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592688|NCT02168569|Artesunate|artesunate|mesh-list
20592689|NCT02168569|Lumefantrine|lumefantrine|mesh-list
20592690|NCT02168569|Artemether|artemether|mesh-list
20592691|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20592692|NCT02168569|Amodiaquine|amodiaquine|mesh-list
20592693|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
20592694|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20592695|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20592696|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592697|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20080785|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080786|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
20080787|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080788|NCT00000271|Desipramine|desipramine|mesh-list
20080789|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20080790|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080791|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080792|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080793|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080794|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20080795|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080796|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080797|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080798|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080799|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080800|NCT00000273|Fentanyl|fentanyl|mesh-list
20080801|NCT00000273|Morphine|morphine|mesh-list
20592698|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
20592699|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
20592700|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20592701|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
20592702|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
20592703|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20592704|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20592705|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592706|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
20592707|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592708|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592709|NCT02168751|Propofol|propofol|mesh-list
20592710|NCT02168751|Sevoflurane|sevoflurane|mesh-list
20592711|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20592712|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592713|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592714|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20592715|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
20080802|NCT00000273|Oxycodone|oxycodone|mesh-list
20080803|NCT00000273|Buprenorphine|buprenorphine|mesh-list
20080804|NCT00000273|Methadone|methadone|mesh-list
20592716|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
20592717|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592718|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20592719|NCT02168881|Misoprostol|misoprostol|mesh-list
20592720|NCT02168881|Dinoprostone|dinoprostone|mesh-list
20592721|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20592722|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
20592723|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20592724|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592725|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20592726|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592727|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
20592728|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
20592729|NCT02168907|Rituximab|rituximab|mesh-list
20592730|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20592731|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20592732|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592733|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
20592734|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592735|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20592736|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20592737|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
20592738|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592739|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
20592740|NCT02168907|Protective Agents|protective agents|mesh-ancestor
20592741|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
20592742|NCT02168907|Vitamins|vitamins|mesh-ancestor
20592743|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
20592744|NCT02168959|Bupivacaine|bupivacaine|mesh-list
20592745|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
20592746|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
20592747|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592748|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592749|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
20592750|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592751|NCT02169063|Listerine|listerine|mesh-list
20592752|NCT02169063|Fluorides|fluorides|mesh-list
20592753|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
20592754|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
20592755|NCT02169063|Protective Agents|protective agents|mesh-ancestor
20592756|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592757|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20592758|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592759|NCT02169089|Spironolactone|spironolactone|mesh-list
20592760|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20592761|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
20592762|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592763|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592764|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20592765|NCT02169089|Diuretics|diuretics|mesh-ancestor
20592766|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
20592767|NCT02169154|Diclofenac|diclofenac|mesh-list
20592768|NCT02169154|Menthol|menthol|mesh-list
20592769|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20592770|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592771|NCT02169154|Analgesics|analgesics|mesh-ancestor
20592772|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
20592773|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592774|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592775|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20592776|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20080805|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20592777|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20592778|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080806|NCT00000273|Narcotics|narcotics|mesh-ancestor
20592779|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592780|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
20592781|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
20592782|NCT02169167|Octenidine|octenidine|mesh-list
20592783|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592784|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20592785|NCT02169544|Abatacept|abatacept|mesh-list
20592786|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20592787|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592788|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592789|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20592790|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
20592791|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592792|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20592793|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
20592794|NCT02169570|Vitamin D|vitamin d|mesh-list
20592795|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
20592796|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
20592797|NCT02169570|Vitamins|vitamins|mesh-list
20592798|NCT02169570|Calcium|calcium|mesh-list
20592799|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
20592800|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592801|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20592802|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20592803|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20592804|NCT02169596|Ticagrelor|ticagrelor|mesh-list
20592805|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592806|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20592807|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20592808|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20592809|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
20592810|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592811|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592812|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592813|NCT02169609|Interleukin-2|interleukin-2|mesh-list
20592814|NCT02169609|Dinutuximab|dinutuximab|mesh-list
20592815|NCT02169609|Isotretinoin|isotretinoin|mesh-list
20592816|NCT02169609|Sargramostim|sargramostim|mesh-list
20592817|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592818|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592819|NCT02169609|Analgesics|analgesics|mesh-ancestor
20592820|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
20592821|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592822|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080807|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080808|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080809|NCT00000273|Analgesics|analgesics|mesh-ancestor
20080810|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
20080811|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080812|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20080813|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20080814|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
20080815|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
20080816|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20592823|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
20592824|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
20592825|NCT02169648|Ranibizumab|ranibizumab|mesh-list
20592826|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20592827|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20592828|NCT02169648|Growth Substances|growth substances|mesh-ancestor
20592829|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592830|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
20592831|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592832|NCT02169713|Tamsulosin|tamsulosin|mesh-list
20592833|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
20592834|NCT02169713|Mirabegron|mirabegron|mesh-list
20592835|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20592836|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20592837|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20592838|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
20592839|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592840|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592841|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592842|NCT02169713|Urological Agents|urological agents|mesh-ancestor
20592843|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20080817|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
20080818|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
20592844|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20592845|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
20592846|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20592847|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20592848|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20592849|NCT02169752|Ambrisentan|ambrisentan|mesh-list
20592850|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20592851|NCT02169804|Enclomiphene|enclomiphene|mesh-list
20592852|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20592853|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
20592854|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592855|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592856|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20592857|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
20592858|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20592859|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20592860|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20592861|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
20592862|NCT02169843|Sevoflurane|sevoflurane|mesh-list
20592863|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20592864|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592865|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080819|NCT00000274|Flupenthixol|flupenthixol|mesh-list
20080820|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20080821|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20080822|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080823|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080824|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592866|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592867|NCT02169843|Analgesics|analgesics|mesh-ancestor
20592868|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
20592869|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592870|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20592871|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20592872|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20592873|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
20592874|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592875|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592876|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592877|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20592878|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
20592879|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
20592880|NCT02169856|Cefuroxime|cefuroxime|mesh-list
20592881|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
20592882|NCT02169856|Ketorolac|ketorolac|mesh-list
20592883|NCT02169856|Midazolam|midazolam|mesh-list
20592884|NCT02169856|Propofol|propofol|mesh-list
20592885|NCT02169856|Sevoflurane|sevoflurane|mesh-list
20592886|NCT02169856|Atracurium|atracurium|mesh-list
20592887|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20592888|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20592889|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592890|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20592891|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
20592892|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
20592893|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20592894|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20592895|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20592896|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20592897|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
20592898|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
20592899|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20592900|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592901|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20592902|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20592903|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20592904|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20592905|NCT02169856|Analgesics|analgesics|mesh-ancestor
20592906|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
20592907|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592908|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20592909|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20592910|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20592911|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592912|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20592913|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592914|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20080825|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080826|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20080827|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
20080828|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080829|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080830|NCT00000275|Flupenthixol|flupenthixol|mesh-list
20080831|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20592915|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20592916|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20592917|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20592918|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20592919|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
20592920|NCT02169882|Rifampin|rifampin|mesh-list
20592921|NCT02169882|Dexamethasone|dexamethasone|mesh-list
20592922|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20592923|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
20592924|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
20592925|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20592926|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592927|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20592928|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
20592929|NCT02169882|Hormones|hormones|mesh-ancestor
20592930|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592931|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20592932|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592933|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20592934|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
20592935|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20592936|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592937|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
20592938|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20080832|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20080833|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080834|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080835|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080836|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080837|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20080838|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
20080839|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080840|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080841|NCT00000276|Bupropion|bupropion|mesh-list
20080842|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20080843|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080844|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080845|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20080846|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20592939|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592940|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592941|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20592942|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20592943|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20592944|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20592945|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20592946|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20592947|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
20080847|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080848|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080849|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
20080850|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080851|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080852|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20080853|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20080854|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080855|NCT00000277|Mazindol|mazindol|mesh-list
20592948|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592949|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607054|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20607055|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20607056|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20607057|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607058|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607059|NCT02240199|Analgesics|analgesics|mesh-ancestor
20607060|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
20607061|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20607062|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20607063|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20607064|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20607065|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20607066|NCT02240212|Paclitaxel|paclitaxel|mesh-list
20607067|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20607068|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607069|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
20607070|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
20607071|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
20607072|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607073|NCT02240238|Gemcitabine|gemcitabine|mesh-list
19746527|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19746528|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746529|NCT03171025|Nivolumab|nivolumab|mesh-list
19746530|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746531|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746532|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19746533|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746534|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
19746535|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746536|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
19746537|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746538|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746539|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19746540|NCT03140423|Mupirocin|mupirocin|mesh-list
19746541|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746542|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607074|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20607075|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
20607076|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607077|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607078|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
20607079|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607080|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607081|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607082|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
20607083|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607084|NCT02240433|Sorafenib|sorafenib|mesh-list
20607085|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607086|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20607087|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607088|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607089|NCT02240459|Fesoterodine|fesoterodine|mesh-list
20607090|NCT02240459|Oxybutynin|oxybutynin|mesh-list
20607091|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20607092|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20607093|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
20607094|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607095|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607096|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607097|NCT02240459|Urological Agents|urological agents|mesh-ancestor
20607098|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
20607099|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
20607100|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608056|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
20608057|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608058|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608059|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608060|NCT02244320|Tamsulosin|tamsulosin|mesh-list
20608061|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608062|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19746543|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20080856|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20080857|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080858|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20080859|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080860|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080861|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080862|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080863|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080864|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20080865|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
20080866|NCT00000278|Disulfiram|disulfiram|mesh-list
20080867|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20080868|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20080869|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080870|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080871|NCT00000279|Clonidine|clonidine|mesh-list
20080872|NCT00000279|Analgesics|analgesics|mesh-ancestor
20080873|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
20080874|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080875|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080876|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20080877|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
20080878|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
20080879|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20080880|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20080881|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20080882|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080883|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080884|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080885|NCT00000280|Nimodipine|nimodipine|mesh-list
20080886|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20080887|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20080888|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080889|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080890|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20080891|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080892|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
20592950|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20592951|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20592952|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20592953|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
20592954|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20592955|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592956|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20592957|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20592958|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20592959|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20592960|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20592961|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20592962|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20592963|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20592964|NCT02170090|Gemcitabine|gemcitabine|mesh-list
20080893|NCT00000281|Amantadine|amantadine|mesh-list
20080894|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20080895|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20592965|NCT02170090|Capecitabine|capecitabine|mesh-list
20592966|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20592967|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20592968|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
20592969|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592970|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
20592971|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20592972|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592973|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20592974|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
20592975|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592976|NCT02170116|Dabigatran|dabigatran|mesh-list
20592977|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
20592978|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20592979|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
20592980|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20592981|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592982|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
20592983|NCT02170246|Telmisartan|telmisartan|mesh-list
20592984|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20592985|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20592986|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20592987|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20592988|NCT02170324|Exenatide|exenatide|mesh-list
20592989|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20592990|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20592991|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20592992|NCT02170324|Incretins|incretins|mesh-ancestor
20592993|NCT02170324|Hormones|hormones|mesh-ancestor
20592994|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20592995|NCT02170402|Factor VIII|factor viii|mesh-list
20592996|NCT02170402|Coagulants|coagulants|mesh-ancestor
20592997|NCT02170415|Pregabalin|pregabalin|mesh-list
20592998|NCT02170415|Anesthetics|anesthetics|mesh-list
20592999|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
20593000|NCT02170415|Analgesics|analgesics|mesh-ancestor
20593001|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
20593002|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593003|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593004|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
20593005|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20080896|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
20080897|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20080898|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
20080899|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080900|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080901|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080902|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20080903|NCT00000281|Analgesics|analgesics|mesh-ancestor
20080904|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
20080905|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080906|NCT00000282|Pemoline|pemoline|mesh-list
20080907|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20080908|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080909|NCT00000285|Phenytoin|phenytoin|mesh-list
20080910|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
20080911|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20080912|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20080913|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080914|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080915|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20593006|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20593007|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593008|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20593009|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20593010|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20593011|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20593012|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20593013|NCT02170571|Dabigatran|dabigatran|mesh-list
20593014|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
20593015|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593016|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593017|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593018|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593019|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
20593020|NCT02170584|Dabigatran|dabigatran|mesh-list
20593021|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
20593022|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593023|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593024|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593025|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593026|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
20593027|NCT02170597|Dabigatran|dabigatran|mesh-list
20593028|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
20593029|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593030|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593031|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593032|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593033|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
20593034|NCT02170610|Pantoprazole|pantoprazole|mesh-list
20593035|NCT02170610|Dabigatran|dabigatran|mesh-list
20593036|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593037|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593038|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20593039|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593040|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593041|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
20593042|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593043|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
20080916|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20080917|NCT00000286|Nefazodone|nefazodone|mesh-list
20080918|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20593044|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
20593045|NCT02170623|Pantoprazole|pantoprazole|mesh-list
20593046|NCT02170623|Dabigatran|dabigatran|mesh-list
20593047|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593048|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593049|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20593050|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593051|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593052|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
20593053|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593054|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593055|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
20593056|NCT02170636|Pantoprazole|pantoprazole|mesh-list
20593057|NCT02170636|Dabigatran|dabigatran|mesh-list
20593058|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593059|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593060|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20593061|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593062|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593063|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
20593064|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593065|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593066|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
20593067|NCT02170675|Ketoconazole|ketoconazole|mesh-list
20593068|NCT02170675|Dabigatran|dabigatran|mesh-list
20593069|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
20593070|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593071|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593072|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593073|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593074|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
20593075|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
20593076|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20593077|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20593078|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593079|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20593080|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
20593081|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20593082|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593083|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20593084|NCT02170701|Dabigatran|dabigatran|mesh-list
20593085|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
20593086|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593087|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593088|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593089|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593090|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
20593091|NCT02170740|Pantoprazole|pantoprazole|mesh-list
20593092|NCT02170740|Dabigatran|dabigatran|mesh-list
20593093|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593094|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593095|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20593096|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593097|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593098|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
20593099|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593100|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593101|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
20593102|NCT02170766|Pantoprazole|pantoprazole|mesh-list
20593103|NCT02170766|Dabigatran|dabigatran|mesh-list
20593104|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593105|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593106|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20080919|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080920|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080921|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080922|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080923|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593107|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607101|NCT02240537|Sargramostim|sargramostim|mesh-list
20607102|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
20607103|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607104|NCT02240602|Oxycodone|oxycodone|mesh-list
20607105|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20607106|NCT02240602|Narcotics|narcotics|mesh-ancestor
20607107|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607108|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607109|NCT02240602|Analgesics|analgesics|mesh-ancestor
20593108|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593109|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
20593110|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593111|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593112|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
20593113|NCT02170792|Ranitidine|ranitidine|mesh-list
20593114|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20593115|NCT02170792|Dabigatran|dabigatran|mesh-list
20593116|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593117|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593118|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20593119|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
20593120|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
20593121|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593122|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593123|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593124|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
20593125|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593126|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593127|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593128|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
20593129|NCT02170805|Pantoprazole|pantoprazole|mesh-list
20593130|NCT02170805|Dabigatran|dabigatran|mesh-list
20593131|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593132|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593133|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20593134|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593135|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593136|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
20593137|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593138|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593139|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
20593140|NCT02170831|Dabigatran|dabigatran|mesh-list
20593141|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
20593142|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593143|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593144|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593145|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593146|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
20593147|NCT02170844|Dabigatran|dabigatran|mesh-list
20593148|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
20593149|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593150|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593151|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593152|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593153|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
20593154|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
20593155|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20593156|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
20593157|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593158|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
20593159|NCT02170857|Protective Agents|protective agents|mesh-ancestor
20593160|NCT02170896|Pantoprazole|pantoprazole|mesh-list
20593161|NCT02170896|Dabigatran|dabigatran|mesh-list
20593162|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593163|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593164|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20593165|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593166|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593167|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
20593168|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593169|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593170|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
20593171|NCT02170909|Dabigatran|dabigatran|mesh-list
20593172|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
20593173|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593174|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593175|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593176|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593177|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
20593178|NCT02170922|Dabigatran|dabigatran|mesh-list
20593179|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
20593180|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593181|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593182|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593183|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593184|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
20593185|NCT02170935|Dabigatran|dabigatran|mesh-list
20593186|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
20593187|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593188|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593189|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593190|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593191|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
20593192|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
20593193|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20593194|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20593195|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593196|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20593197|NCT02170948|Analgesics|analgesics|mesh-ancestor
20593198|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
20593199|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593200|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20593201|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20593202|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20593203|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
20593204|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593205|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593206|NCT02170974|Dabigatran|dabigatran|mesh-list
20593207|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
20593208|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593209|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593210|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593211|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593212|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
20593213|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
20593214|NCT02170987|Dabigatran|dabigatran|mesh-list
20593215|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20593216|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20593217|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20593218|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20593219|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593220|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593221|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593222|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
20593223|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593224|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593225|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
20593226|NCT02171000|Dabigatran|dabigatran|mesh-list
20593227|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
20593228|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593229|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593230|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593231|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593232|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
20593233|NCT02171013|Dabigatran|dabigatran|mesh-list
20593234|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
20593235|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593236|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
20080924|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20593237|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593238|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593239|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
20593240|NCT02171026|Amiodarone|amiodarone|mesh-list
20593241|NCT02171026|Dabigatran|dabigatran|mesh-list
20593242|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
20593243|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593244|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593245|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593246|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593247|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
20593248|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20593249|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
20593250|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20593251|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20593252|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20593253|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20593254|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593255|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20593256|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20593257|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20593258|NCT02171039|Dabigatran|dabigatran|mesh-list
20593259|NCT02171039|Atorvastatin|atorvastatin|mesh-list
20593260|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20593261|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20593262|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
20593263|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593264|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20593265|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20593266|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593267|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
20593268|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593269|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593270|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
20593271|NCT02171052|Digoxin|digoxin|mesh-list
20593272|NCT02171052|Dabigatran|dabigatran|mesh-list
20593273|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
20593274|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593275|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593276|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593277|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593278|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
20593279|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20593280|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20593281|NCT02171052|Protective Agents|protective agents|mesh-ancestor
20593282|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593283|NCT02171156|Nintedanib|nintedanib|mesh-list
20593284|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593285|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593286|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593287|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593288|NCT02171182|Capsaicin|capsaicin|mesh-list
20593289|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
20593290|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
20593291|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
20593292|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593293|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593294|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20593295|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
20593296|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20593297|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
20593298|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593299|NCT02171221|DFP-11207|dfp-11207|mesh-list
20593300|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20593301|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
20593302|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593303|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593304|NCT02171299|Ropivacaine|ropivacaine|mesh-list
20593305|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
20593306|NCT02171299|Anesthetics|anesthetics|mesh-list
20593307|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20593308|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593309|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
20593310|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593311|NCT02171325|Irinotecan|irinotecan|mesh-list
20593312|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20593313|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20593314|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593315|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593316|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593317|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20593318|NCT02171338|Azithromycin|azithromycin|mesh-list
20593319|NCT02171338|Clarithromycin|clarithromycin|mesh-list
20593320|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
20593321|NCT02171338|Tazobactam|tazobactam|mesh-list
20593322|NCT02171338|Piperacillin|piperacillin|mesh-list
20593323|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20593324|NCT02171338|Penicillin G|penicillin g|mesh-list
20593325|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20593326|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20593327|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593328|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593329|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20593330|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593331|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20593332|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20080925|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080926|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20593333|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492135|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492136|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20593334|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20593335|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20593336|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
20593337|NCT02171390|Testosterone|testosterone|mesh-list
20593338|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
20593339|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
20593340|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20593341|NCT02171390|Androgens|androgens|mesh-ancestor
20593342|NCT02171390|Hormones|hormones|mesh-ancestor
20593343|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20593344|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593345|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20593346|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593347|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
20593348|NCT02171416|Rilonacept|rilonacept|mesh-list
19492137|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
19492138|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492139|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593349|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20593350|NCT02171442|Dabigatran|dabigatran|mesh-list
20593351|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
20593352|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593353|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593354|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593355|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593356|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
20593357|NCT02171455|Dabigatran|dabigatran|mesh-list
20593358|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
20593359|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593360|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593361|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593362|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593363|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
20593364|NCT02171468|Dabigatran|dabigatran|mesh-list
20593365|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
20593366|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593367|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593368|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593369|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593370|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
20593371|NCT02171481|Dabigatran|dabigatran|mesh-list
19492140|NCT03125746|Exemestane|exemestane|mesh-list
19492141|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492142|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19492143|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19492144|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492145|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492146|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20593372|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
20593373|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593374|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593375|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593376|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593377|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
20593378|NCT02171494|Warfarin|warfarin|mesh-list
20593379|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
20593380|NCT02171507|Diclofenac|diclofenac|mesh-list
20593381|NCT02171507|Dabigatran|dabigatran|mesh-list
20593382|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20593383|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20593384|NCT02171507|Analgesics|analgesics|mesh-ancestor
20593385|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
20593386|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593387|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593388|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20593389|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20593390|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20593391|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593392|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593393|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
20593394|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593395|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593396|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
20593397|NCT02171520|Dabigatran|dabigatran|mesh-list
20593398|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
20593399|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593400|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593401|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593402|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593403|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
20593404|NCT02171533|Verapamil|verapamil|mesh-list
20593405|NCT02171533|Dabigatran|dabigatran|mesh-list
20593406|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
20593407|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593408|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593409|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593410|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593411|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
20593412|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20593413|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20593414|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20593415|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20593416|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593417|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
20593418|NCT02171546|Fexofenadine|fexofenadine|mesh-list
20593419|NCT02171546|Quinidine|quinidine|mesh-list
20593420|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
20593421|NCT02171546|Dabigatran|dabigatran|mesh-list
20593422|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
20593423|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593424|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593425|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593426|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492147|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
19492148|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20593427|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
20593428|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20593429|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20593430|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20593431|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
19492149|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492150|NCT03125616|Vaccines|vaccines|mesh-list
19492151|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
19492152|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492153|NCT03125486|Belimumab|belimumab|mesh-list
19492154|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492155|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
19492156|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492157|NCT03125473|Vaccines|vaccines|mesh-list
20080927|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20080928|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20593432|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
20593433|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593434|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593435|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19492158|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
19746544|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593436|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20593437|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
20593438|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20593439|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
20593440|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20593441|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20593442|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746545|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746546|NCT03101722|Huperzine A|huperzine a|mesh-list
20593443|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20593444|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593445|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593446|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20593447|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20593448|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20593449|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20593450|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593451|NCT02171559|Enoxaparin|enoxaparin|mesh-list
20593452|NCT02171559|Dabigatran|dabigatran|mesh-list
20593453|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
20593454|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20593455|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20080929|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
20593456|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593457|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
20593458|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593459|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593460|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593461|NCT02171572|Dabigatran|dabigatran|mesh-list
20593462|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
20593463|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593464|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593465|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593466|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593467|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
20593468|NCT02171585|Clarithromycin|clarithromycin|mesh-list
20593469|NCT02171585|Dabigatran|dabigatran|mesh-list
20593470|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20593471|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20593472|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20593473|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593474|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593475|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20593476|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593477|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
20593478|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593479|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593480|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
20593481|NCT02171598|Dabigatran|dabigatran|mesh-list
20593482|NCT02171598|Clopidogrel|clopidogrel|mesh-list
20593483|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20593484|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20593485|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20593486|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20593487|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
20593488|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593489|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593490|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593491|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
20593492|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593493|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593494|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593495|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
20593496|NCT02171624|Quinidine|quinidine|mesh-list
20593497|NCT02171624|Dabigatran|dabigatran|mesh-list
20593498|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
20593499|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20593500|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593501|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593502|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593503|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
20593504|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20593505|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20593506|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
20593507|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593508|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593509|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20593510|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
20593511|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20593512|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20593513|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20593514|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20593515|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593516|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593517|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20593518|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20593519|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20593520|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20593521|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593522|NCT02171637|Afatinib|afatinib|mesh-list
20593523|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593524|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593525|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593526|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607110|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
20607111|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607112|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
20607113|NCT02240641|Lacidipine|lacidipine|mesh-list
20607114|NCT02240641|Diuretics|diuretics|mesh-list
20607115|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20607116|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20607117|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20607118|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
20607119|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
20607120|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607121|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20607122|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607123|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607124|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607125|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
20607126|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20607127|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607128|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20607129|NCT02240719|Everolimus|everolimus|mesh-list
20607130|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20607131|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607132|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607133|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
20607134|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607135|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20607136|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
20607137|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607138|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20607139|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
20607140|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607141|NCT02240927|Enoxaparin|enoxaparin|mesh-list
20607142|NCT02240927|Warfarin|warfarin|mesh-list
20607143|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
20607144|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
20607145|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20607146|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20607147|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607148|NCT02240953|Warfarin|warfarin|mesh-list
20607149|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
20607150|NCT02241005|Allantoin|allantoin|mesh-list
20607151|NCT02241005|Dermatologic Agents|dermatologic agents|mesh-ancestor
20607152|NCT02241018|Antibodies|antibodies|mesh-list
20607153|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20607154|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20607155|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
20607156|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607157|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607158|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607159|NCT02241031|Oprelvekin|oprelvekin|mesh-list
20607160|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607161|NCT02241083|Dopamine|dopamine|mesh-list
20607162|NCT02241083|Norepinephrine|norepinephrine|mesh-list
20607163|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20593527|NCT02171650|Afatinib|afatinib|mesh-list
20593528|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593529|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593530|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593531|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593532|NCT02171663|Afatinib|afatinib|mesh-list
20593533|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593534|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593535|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593536|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593537|NCT02171676|Docetaxel|docetaxel|mesh-list
20593538|NCT02171676|Afatinib|afatinib|mesh-list
20593539|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593540|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
20593541|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
20593542|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
20593543|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593544|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593545|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593546|NCT02171689|Afatinib|afatinib|mesh-list
20593547|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593548|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593549|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593550|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593551|NCT02171702|Afatinib|afatinib|mesh-list
20593552|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593553|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593554|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593555|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593556|NCT02171715|Afatinib|afatinib|mesh-list
20593557|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593558|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593559|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593560|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593561|NCT02171728|Afatinib|afatinib|mesh-list
20593562|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607164|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20080930|NCT00000289|Ondansetron|ondansetron|mesh-list
20080931|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
20080932|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
20080933|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080934|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080935|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20080936|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
20080937|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
20080938|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20080939|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
20080940|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080941|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080942|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20080943|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20080944|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080945|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20080946|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20080947|NCT00000290|Cocaine|cocaine|mesh-list
20593563|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593564|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593565|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593566|NCT02171741|Docetaxel|docetaxel|mesh-list
20593567|NCT02171741|Afatinib|afatinib|mesh-list
20593568|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593569|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
20593570|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
20593571|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
20593572|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593573|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593574|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593575|NCT02171754|Ritonavir|ritonavir|mesh-list
20593576|NCT02171754|Afatinib|afatinib|mesh-list
20593577|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20593578|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20593579|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593580|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593581|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593582|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20593583|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20593584|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
20593585|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20593586|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20593587|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593588|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593589|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593590|NCT02171767|Afatinib|afatinib|mesh-list
20080948|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
20080949|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
20080950|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20080951|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080952|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
20593591|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593592|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20593593|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20080953|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080954|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20080955|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20080956|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080957|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20080958|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080959|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
20080960|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080961|NCT00000291|Labetalol|labetalol|mesh-list
20080962|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20080963|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20080964|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607165|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
20080965|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080966|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080967|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080968|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19746547|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
19746548|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593594|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593595|NCT02171780|Olodaterol|olodaterol|mesh-list
20593596|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593597|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
20593598|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593599|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593600|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593601|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593602|NCT02171793|Olodaterol|olodaterol|mesh-list
20593603|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593604|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
20593605|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593606|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593607|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593608|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593609|NCT02171806|Olodaterol|olodaterol|mesh-list
20593610|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593611|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
20593612|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593613|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593614|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593615|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593616|NCT02171832|Olodaterol|olodaterol|mesh-list
20593617|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593618|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
20593619|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593620|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593621|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593622|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593623|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
20593624|NCT02171910|Doxapram|doxapram|mesh-list
19749288|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20080969|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
20080970|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
20593625|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20593626|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593627|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593628|NCT02171975|Anesthetics|anesthetics|mesh-list
20593629|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20593630|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593631|NCT02171988|Propranolol|propranolol|mesh-list
20593632|NCT02171988|Bisoprolol|bisoprolol|mesh-list
20593633|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20593634|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20593635|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20593636|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
20593637|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593638|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593639|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593640|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20593641|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20593642|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
20080971|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080972|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20080973|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20080974|NCT00000292|Cocaine|cocaine|mesh-list
20593643|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
20593644|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
20593645|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593646|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20593647|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20593648|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593649|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593650|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20593651|NCT02172001|Hematinics|hematinics|mesh-ancestor
20593652|NCT02172014|Fentanyl|fentanyl|mesh-list
20593653|NCT02172014|Midazolam|midazolam|mesh-list
20593654|NCT02172014|Citric Acid|citric acid|mesh-list
19746549|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746550|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
19746551|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080975|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
20080976|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
20080977|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20593655|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
20593656|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20593657|NCT02172014|Narcotics|narcotics|mesh-ancestor
20593658|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20593659|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593660|NCT02172014|Analgesics|analgesics|mesh-ancestor
20593661|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
20593662|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593663|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20080978|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080979|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
20080980|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080981|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20593664|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20593665|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
20593666|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
20593667|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20593668|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20593669|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20593670|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20593671|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
20593672|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
20593673|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080982|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20080983|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080984|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20593674|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593675|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
20593676|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20593677|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
20593678|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
20593679|NCT02172105|Olodaterol|olodaterol|mesh-list
20593680|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593681|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
20593682|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593683|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593684|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593685|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593686|NCT02172131|Olodaterol|olodaterol|mesh-list
20593687|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593688|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
20593689|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593690|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593691|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593692|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593693|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
20593694|NCT02172144|Olodaterol|olodaterol|mesh-list
20593695|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20593696|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20593697|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20593698|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20593699|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593700|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593701|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593702|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593703|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593704|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
20593705|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593706|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593707|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593708|NCT02172157|Olodaterol|olodaterol|mesh-list
20593709|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593710|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
20593711|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593712|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593713|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593714|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593715|NCT02172170|Empagliflozin|empagliflozin|mesh-list
20593716|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593717|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593718|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20593719|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593720|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20593721|NCT02172196|Empagliflozin|empagliflozin|mesh-list
20593722|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20593723|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593724|NCT02172196|Incretins|incretins|mesh-ancestor
20593725|NCT02172196|Hormones|hormones|mesh-ancestor
20080985|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20080986|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
20080987|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080988|NCT00000293|Nefazodone|nefazodone|mesh-list
20080989|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20593726|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20593727|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20593728|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593729|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593730|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593731|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593732|NCT02172209|Empagliflozin|empagliflozin|mesh-list
20593733|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593734|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593735|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20593736|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593737|NCT02172222|Linagliptin|linagliptin|mesh-list
20593738|NCT02172222|Empagliflozin|empagliflozin|mesh-list
20593739|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20593740|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593741|NCT02172222|Incretins|incretins|mesh-ancestor
20593742|NCT02172222|Hormones|hormones|mesh-ancestor
19746552|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746553|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19746554|NCT03101722|Protective Agents|protective agents|mesh-ancestor
19746555|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
19746556|NCT03088852|Cathartics|cathartics|mesh-ancestor
19746557|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19746558|NCT03067610|Paclitaxel|paclitaxel|mesh-list
19746559|NCT03067610|Cisplatin|cisplatin|mesh-list
19746560|NCT03067610|Carboplatin|carboplatin|mesh-list
19746561|NCT03067610|Cetuximab|cetuximab|mesh-list
19746562|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20080990|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20080991|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20308887|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20593743|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20593744|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20593745|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
20593746|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746563|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746564|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19746565|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
20593747|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593748|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593749|NCT02172235|Pioglitazone|pioglitazone|mesh-list
20593750|NCT02172235|Empagliflozin|empagliflozin|mesh-list
20593751|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19746566|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
20593752|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593753|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593754|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593755|NCT02172248|Metformin|metformin|mesh-list
20593756|NCT02172248|Empagliflozin|empagliflozin|mesh-list
20593757|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20080992|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593758|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593759|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593760|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593761|NCT02172261|Glimepiride|glimepiride|mesh-list
20593762|NCT02172261|Empagliflozin|empagliflozin|mesh-list
20593763|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20593764|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20593765|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593766|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20593767|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
20593768|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593769|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593770|NCT02172274|Empagliflozin|empagliflozin|mesh-list
20593771|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20593772|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593773|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20593774|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593775|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
20593776|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20593777|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593778|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
20593779|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20080993|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20080994|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20080995|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20080996|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
20080997|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20593780|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593781|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593782|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593783|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
20080998|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20080999|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081000|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
20593784|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593785|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593786|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593787|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593788|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20593789|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20120024|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120025|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120026|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
20120027|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
20120028|NCT00006261|Docetaxel|docetaxel|mesh-list
20120029|NCT00006261|Doxorubicin|doxorubicin|mesh-list
20120030|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20120031|NCT00006261|Fludarabine|fludarabine|mesh-list
20120032|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
20120033|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120034|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
20120035|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120036|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120037|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120038|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
20120039|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120040|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120041|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20120042|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
20120043|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
20120044|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120045|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20120046|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120047|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120048|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120049|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120050|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
20120051|NCT00006263|Carboplatin|carboplatin|mesh-list
20593790|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20120052|NCT00006263|Temozolomide|temozolomide|mesh-list
20120053|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20593791|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
20593792|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
20593793|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593794|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
20593795|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593796|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593797|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593798|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593799|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
20593800|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593801|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593802|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593803|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593804|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
20593805|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593806|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
20593807|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593808|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081001|NCT00000294|Carvedilol|carvedilol|mesh-list
20081002|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20081003|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20081004|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081005|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081006|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081007|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081008|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20081009|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
20081010|NCT00000294|Protective Agents|protective agents|mesh-ancestor
20081011|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20081012|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081013|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20593809|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593810|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593811|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
20593812|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593813|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593814|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081014|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
20081015|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20081016|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20081017|NCT00000295|Progesterone|progesterone|mesh-list
20081018|NCT00000295|Progestins|progestins|mesh-ancestor
20081019|NCT00000295|Hormones|hormones|mesh-ancestor
20081020|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081021|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081022|NCT00000297|Labetalol|labetalol|mesh-list
20593815|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593816|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
20593817|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593818|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
20593819|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593820|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593821|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593822|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593823|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
20593824|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593825|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593826|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593827|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593828|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
20593829|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593830|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
20593831|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593832|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593833|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593834|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593835|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
20593836|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20081023|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20081024|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20081025|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
20593837|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593838|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593839|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593840|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
20593841|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593842|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
20593843|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593844|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593845|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593846|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593847|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
20593848|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593849|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593850|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593851|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593852|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
20593853|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593854|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
20593855|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593856|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593857|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593858|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593859|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
20593860|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593861|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593862|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593863|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593864|NCT02172404|Ipratropium|ipratropium|mesh-list
20593865|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593866|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
20593867|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593868|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593869|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593870|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593871|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593872|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593873|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593874|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593875|NCT02172417|Ranitidine|ranitidine|mesh-list
20593876|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20593877|NCT02172417|Cimetidine|cimetidine|mesh-list
20593878|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
20593879|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593880|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
20593881|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593882|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593883|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593884|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593885|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
20593886|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593887|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593888|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593889|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593890|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20593891|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20593892|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20593893|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
20593894|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
20593895|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20593896|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20593897|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20593898|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
20593899|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593900|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
20593901|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081026|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081027|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081028|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593902|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593903|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593904|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593905|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
20593906|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593907|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593908|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593909|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593910|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
20593911|NCT02172443|Ipratropium|ipratropium|mesh-list
20593912|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20081029|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20081030|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
20081031|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
20081032|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081033|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20081034|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20081035|NCT00000298|Buprenorphine|buprenorphine|mesh-list
20081036|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20081037|NCT00000298|Naloxone|naloxone|mesh-list
20081038|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081039|NCT00000298|Narcotics|narcotics|mesh-ancestor
20081040|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081041|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081042|NCT00000298|Analgesics|analgesics|mesh-ancestor
20081043|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
20081044|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081045|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081046|NCT00000299|Buprenorphine|buprenorphine|mesh-list
20081047|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081048|NCT00000299|Narcotics|narcotics|mesh-ancestor
20081049|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081050|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081051|NCT00000299|Analgesics|analgesics|mesh-ancestor
20081052|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
20081053|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081054|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081055|NCT00000301|Amantadine|amantadine|mesh-list
20081056|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20081057|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20081058|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
20081059|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20081060|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
20081061|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081062|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081063|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081064|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20081065|NCT00000301|Analgesics|analgesics|mesh-ancestor
20081066|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
20081067|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081068|NCT00000302|Buprenorphine|buprenorphine|mesh-list
20081069|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081070|NCT00000302|Narcotics|narcotics|mesh-ancestor
20081071|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081072|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081073|NCT00000302|Analgesics|analgesics|mesh-ancestor
20081074|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
20081075|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081076|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20593913|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
20593914|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593915|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593916|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593917|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593918|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
20593919|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593920|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593921|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593922|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593923|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
20081077|NCT00000303|Baclofen|baclofen|mesh-list
20081078|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20593924|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593925|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
20593926|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593927|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593928|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593929|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593930|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
20593931|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593932|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
20081079|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081080|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20081081|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081082|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20081083|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
20081084|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
20081085|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593933|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593934|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593935|NCT02172469|Bromides|bromides|mesh-list
20593936|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
20593937|NCT02172469|Ipratropium|ipratropium|mesh-list
20593938|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593939|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
20593940|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593941|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593942|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593943|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593944|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
20593945|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593946|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593947|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593948|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593949|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
20593950|NCT02172482|Bromides|bromides|mesh-list
20593951|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
20593952|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593953|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
20593954|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593955|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593956|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593957|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593958|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
20593959|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593960|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593961|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593962|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593963|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
20593964|NCT02172495|Bromides|bromides|mesh-list
20593965|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
20593966|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593967|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
20593968|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593969|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593970|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593971|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593972|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
20593973|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593974|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593975|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593976|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593977|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
20593978|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
20593979|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20081086|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081087|NCT00000304|Amphetamine|amphetamine|mesh-list
20081088|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
20081089|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20081090|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081091|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
20081092|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
20081093|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081094|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
20593980|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
20593981|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593982|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593983|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593984|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593985|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
20593986|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20593987|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
20593988|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20593989|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20593990|NCT02172521|Bromides|bromides|mesh-list
20593991|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
20593992|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20593993|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
20593994|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20593995|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20593996|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20593997|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
20593998|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
20593999|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594000|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594001|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594002|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594003|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
20594004|NCT02172534|Bromides|bromides|mesh-list
20594005|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
20594006|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594007|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
20594008|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594009|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594010|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594011|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594012|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
20594013|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594014|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594015|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594016|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594017|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
20594018|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
20594019|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594020|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
20594021|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081095|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081096|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081097|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081098|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20594022|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594023|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594024|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594025|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
20594026|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594027|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594028|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594029|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594030|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
20594031|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594032|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
20594033|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594034|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594035|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594036|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594037|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
20594038|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594039|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594040|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594041|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594042|NCT02172573|Pramipexole|pramipexole|mesh-list
20594043|NCT02172573|Bromocriptine|bromocriptine|mesh-list
20594044|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
20594045|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594046|NCT02172573|Protective Agents|protective agents|mesh-ancestor
20594047|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594048|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20594049|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20594050|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
20594051|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
20081099|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081100|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081101|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20081102|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
20081103|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20081104|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081105|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20594052|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594053|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
20594054|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594055|NCT02172586|Losartan|losartan|mesh-list
20594056|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20594057|NCT02172586|Telmisartan|telmisartan|mesh-list
20594058|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20594059|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20594060|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20594061|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20594062|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594063|NCT02172586|Diuretics|diuretics|mesh-ancestor
20594064|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
20594065|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594066|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20594067|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594068|NCT02172729|Lidocaine|lidocaine|mesh-list
20594069|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
20594070|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
20594071|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594072|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081106|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081107|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081108|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081109|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
20081110|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081111|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
20594073|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
20594074|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594075|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20594076|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20594077|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20594078|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594079|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594080|NCT02172768|Micafungin|micafungin|mesh-list
20594081|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
20594082|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594083|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
20594084|NCT02172781|Ipratropium|ipratropium|mesh-list
20594085|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594086|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
20594087|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594088|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081112|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20081113|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081114|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20081115|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081116|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081117|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081118|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
20081119|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081120|NCT00000307|Naltrexone|naltrexone|mesh-list
20081121|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20081122|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081123|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081124|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
20081125|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081126|NCT00000308|Amphetamine|amphetamine|mesh-list
20081127|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
20081128|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20081129|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081130|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
20081131|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
20081132|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081133|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
20081134|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081135|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081136|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081137|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20081138|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081139|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081140|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20081141|NCT00000309|Risperidone|risperidone|mesh-list
20081142|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081143|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
20081144|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081145|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594089|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594090|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594091|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
20594092|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594093|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594094|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594095|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594096|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
20594097|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20594098|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594099|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
20594100|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594101|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594102|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594103|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594104|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
20594105|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594106|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594107|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594108|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594109|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20594110|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20594111|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20594112|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594113|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
20594114|NCT02172807|Oxitropium|oxitropium|mesh-list
20594115|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594116|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
20594117|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594118|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594119|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594120|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594121|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
20594122|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594123|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594124|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594125|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594126|NCT02172846|Paclitaxel|paclitaxel|mesh-list
20594127|NCT02172846|Carboplatin|carboplatin|mesh-list
20594128|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20594129|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594130|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
20594131|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
20594132|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
20594133|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081146|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081147|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20594134|NCT02172976|Gemcitabine|gemcitabine|mesh-list
20594135|NCT02172976|Fluorouracil|fluorouracil|mesh-list
20594136|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
20594137|NCT02172976|Irinotecan|irinotecan|mesh-list
20594138|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20594139|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
20594140|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594141|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594142|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
20594143|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594144|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594145|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20594146|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
20594147|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594148|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20594149|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20594150|NCT02173093|Aldesleukin|aldesleukin|mesh-list
20594151|NCT02173093|Interleukin-2|interleukin-2|mesh-list
20594152|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594153|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20594154|NCT02173093|Analgesics|analgesics|mesh-ancestor
20594155|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
20594156|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594157|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594158|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20594159|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20594160|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
20594161|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20081148|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081149|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081150|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081151|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081152|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
20081153|NCT00000310|Risperidone|risperidone|mesh-list
20081154|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081155|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
20081156|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594162|NCT02173106|Cyclosporine|cyclosporine|mesh-list
20081157|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594163|NCT02173106|Cyclosporins|cyclosporins|mesh-list
20594164|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594165|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594166|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20594167|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
20594168|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081158|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081159|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081160|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081161|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081162|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081163|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081164|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
20081165|NCT00000311|Buprenorphine|buprenorphine|mesh-list
20081166|NCT00000311|Methadone|methadone|mesh-list
20081167|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081168|NCT00000311|Narcotics|narcotics|mesh-ancestor
20081169|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081170|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081171|NCT00000311|Analgesics|analgesics|mesh-ancestor
20081172|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
20081173|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081174|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081175|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
20081176|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
20081177|NCT00000313|Fenfluramine|fenfluramine|mesh-list
20081178|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081179|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081180|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081181|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081182|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081183|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
20081184|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081185|NCT00000315|Cocaine|cocaine|mesh-list
20081186|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
20081187|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
20081188|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081189|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081190|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
20081191|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081192|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20081193|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20081194|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081195|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081196|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081197|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
20081198|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081199|NCT00000316|Cocaine|cocaine|mesh-list
20081200|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
20081201|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
20081202|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081203|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081204|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
20081205|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081206|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20081207|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20594169|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
20594170|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594171|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
20594172|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20594173|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20607166|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607167|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607168|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607169|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
20607170|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
20607171|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607172|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20607173|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20607174|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
20607175|NCT02241083|Protective Agents|protective agents|mesh-ancestor
20607176|NCT02241096|Lidocaine|lidocaine|mesh-list
20607177|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
20607178|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
20081208|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081209|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607179|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746567|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746568|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746569|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20594174|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
20594175|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
20594176|NCT02173132|Vitamins|vitamins|mesh-ancestor
20594177|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
20594178|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594179|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
20594180|NCT02173145|Azithromycin|azithromycin|mesh-list
20594181|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594182|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594183|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
20594184|NCT02173262|Sargramostim|sargramostim|mesh-list
20594185|NCT02173262|Lenograstim|lenograstim|mesh-list
20594186|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
20594187|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594188|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594189|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594190|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20594191|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20594192|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594193|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594194|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594195|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20594196|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20594197|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20594198|NCT02173288|Furosemide|furosemide|mesh-list
20594199|NCT02173288|Spironolactone|spironolactone|mesh-list
20594200|NCT02173288|Tolvaptan|tolvaptan|mesh-list
20594201|NCT02173288|Midodrine|midodrine|mesh-list
20594202|NCT02173288|Diuretics|diuretics|mesh-ancestor
20594203|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
20594204|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594205|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20594206|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594207|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594208|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20594209|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
20594210|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594211|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20594212|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20594213|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
20594214|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
20594215|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594216|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20594217|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20594218|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20594219|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20594220|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594221|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594222|NCT02173418|Ropivacaine|ropivacaine|mesh-list
20594223|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
20594224|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
20594225|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594226|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594227|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
20594228|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594229|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20594230|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20594231|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594232|NCT02173457|Incretins|incretins|mesh-ancestor
20594233|NCT02173457|Hormones|hormones|mesh-ancestor
20594234|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594235|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20594236|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
20594237|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594238|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594239|NCT02173639|Metformin|metformin|mesh-list
20594240|NCT02173639|Linagliptin|linagliptin|mesh-list
20594241|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20594242|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594243|NCT02173639|Incretins|incretins|mesh-ancestor
20594244|NCT02173639|Hormones|hormones|mesh-ancestor
20594245|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594246|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20594247|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
20594248|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594249|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594250|NCT02173652|Linagliptin|linagliptin|mesh-list
20594251|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20594252|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594253|NCT02173652|Incretins|incretins|mesh-ancestor
20594254|NCT02173652|Hormones|hormones|mesh-ancestor
20594255|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594256|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20594257|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
20594258|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594259|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594260|NCT02173665|Linagliptin|linagliptin|mesh-list
20594261|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20594262|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594263|NCT02173665|Incretins|incretins|mesh-ancestor
20594264|NCT02173665|Hormones|hormones|mesh-ancestor
20594265|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594266|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20594267|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
20594268|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594269|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594270|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
20594271|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20594272|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594273|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
20594274|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594275|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594276|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594277|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594278|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
20594279|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594280|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594281|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594282|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594283|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20594284|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20594285|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20594286|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594287|NCT02173717|Rifampin|rifampin|mesh-list
20594288|NCT02173717|Dabigatran|dabigatran|mesh-list
20594289|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
20594290|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20594291|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
20594292|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594293|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594294|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
20594295|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20594296|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
20594297|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594298|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594299|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
20594300|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20594301|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20594302|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20594303|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20594304|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20594305|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20594306|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20594307|NCT02173730|Pantoprazole|pantoprazole|mesh-list
20594308|NCT02173730|Dabigatran|dabigatran|mesh-list
20594309|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20120054|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20081210|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081211|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
20081212|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081213|NCT00000317|Risperidone|risperidone|mesh-list
20081214|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081215|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
20081216|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081217|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081218|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081219|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081220|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081221|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081222|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081223|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081224|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
20081225|NCT00000318|Buprenorphine|buprenorphine|mesh-list
20081226|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081227|NCT00000318|Narcotics|narcotics|mesh-ancestor
20081228|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081229|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081230|NCT00000318|Analgesics|analgesics|mesh-ancestor
20594310|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20594311|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20594312|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594313|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594314|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
20594315|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20594316|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
20594317|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
20594318|NCT02173756|Morphine|morphine|mesh-list
20594319|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20594320|NCT02173756|Narcotics|narcotics|mesh-ancestor
20594321|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594322|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594323|NCT02173756|Analgesics|analgesics|mesh-ancestor
20594324|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
20594325|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594326|NCT02173782|Fenoterol|fenoterol|mesh-list
20594327|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20081231|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
20081232|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081233|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081234|NCT00000319|Buprenorphine|buprenorphine|mesh-list
20081235|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081236|NCT00000319|Narcotics|narcotics|mesh-ancestor
20081237|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081238|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081239|NCT00000319|Analgesics|analgesics|mesh-ancestor
20081240|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
20081241|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081242|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081243|NCT00000320|Buprenorphine|buprenorphine|mesh-list
20081244|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081245|NCT00000320|Narcotics|narcotics|mesh-ancestor
20081246|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594328|NCT02173782|Ipratropium|ipratropium|mesh-list
20594329|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594330|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
20594331|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594332|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594333|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594334|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594335|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
20594336|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
20594337|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20594338|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20594339|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20594340|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20594341|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594342|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594343|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594344|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594345|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594346|NCT02173795|Fenoterol|fenoterol|mesh-list
20594347|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20594348|NCT02173795|Ipratropium|ipratropium|mesh-list
20594349|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594350|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
20594351|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594352|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594353|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594354|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594355|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
20594356|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
20594357|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20594358|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20594359|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20594360|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20594361|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594362|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594363|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594364|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594365|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594366|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
20594367|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
20594368|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20594369|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
20594370|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20594371|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594372|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20594373|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20594374|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20594375|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20594376|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20594377|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20594378|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20594379|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594380|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594381|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594382|NCT02173873|Aflibercept|aflibercept|mesh-list
20594383|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20594384|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20594385|NCT02173873|Growth Substances|growth substances|mesh-ancestor
20594386|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594387|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
20594388|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594389|NCT02173886|Bupropion|bupropion|mesh-list
20594390|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20594391|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
20594392|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20594393|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20594394|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20594395|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594396|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594397|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
20594398|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081247|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081248|NCT00000320|Analgesics|analgesics|mesh-ancestor
20081249|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
20081250|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081251|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081252|NCT00000321|Desipramine|desipramine|mesh-list
20081253|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20081254|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081255|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081256|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081257|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081258|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20081259|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20594399|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594400|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20594401|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20594402|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594403|NCT02173912|Amlodipine|amlodipine|mesh-list
20594404|NCT02173912|Candesartan|candesartan|mesh-list
20594405|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
20594406|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20594407|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20594408|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081260|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081261|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081262|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081263|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081264|NCT00000324|Tryptophan|tryptophan|mesh-list
20081265|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20081266|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081267|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081268|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20081269|NCT00000325|Hormones|hormones|mesh-ancestor
20081270|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081271|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081272|NCT00000326|Heroin|heroin|mesh-list
20081273|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081274|NCT00000326|Narcotics|narcotics|mesh-ancestor
20081275|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081276|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081277|NCT00000326|Analgesics|analgesics|mesh-ancestor
20081278|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
20081279|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081280|NCT00000327|Heroin|heroin|mesh-list
20081281|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081282|NCT00000327|Narcotics|narcotics|mesh-ancestor
20081283|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081284|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081285|NCT00000327|Analgesics|analgesics|mesh-ancestor
20594409|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594410|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20594411|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594412|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
20594413|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20594414|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20594415|NCT02173951|Deferiprone|deferiprone|mesh-list
20594416|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20594417|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
20594418|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
20594419|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594420|NCT02173964|Pinaverium|pinaverium|mesh-list
20594421|NCT02173964|Bromides|bromides|mesh-list
20594422|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
20594423|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20594424|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594425|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594426|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20594427|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594428|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
20594429|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
20594430|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594431|NCT02173990|Aflibercept|aflibercept|mesh-list
20594432|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20594433|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20594434|NCT02173990|Growth Substances|growth substances|mesh-ancestor
20594435|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594436|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20594437|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594438|NCT02174068|Acetaminophen|acetaminophen|mesh-list
20594439|NCT02174068|Nefopam|nefopam|mesh-list
20594440|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20594441|NCT02174068|Analgesics|analgesics|mesh-ancestor
20594442|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
20594443|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594444|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594445|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
20594446|NCT02174094|Clobazam|clobazam|mesh-list
20594447|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
20594448|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20594449|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20594450|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594451|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594452|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20594453|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20594454|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
20594455|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
20594456|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594457|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594458|NCT02174120|Propofol|propofol|mesh-list
20594459|NCT02174120|Etomidate|etomidate|mesh-list
20081286|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
20081287|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081288|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
20081289|NCT00000328|Narcotics|narcotics|mesh-ancestor
20081290|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081291|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081292|NCT00000328|Analgesics|analgesics|mesh-ancestor
20081293|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
20081294|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081295|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
20081296|NCT00000329|Narcotics|narcotics|mesh-ancestor
20081297|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081298|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081299|NCT00000329|Analgesics|analgesics|mesh-ancestor
20081300|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
20594460|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20594461|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594462|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594463|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20594464|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
20594465|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
20594466|NCT02174172|Interferons|interferons|mesh-list
20594467|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
20594468|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
20594469|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20594470|NCT02174172|Bevacizumab|bevacizumab|mesh-list
20594471|NCT02174172|Ipilimumab|ipilimumab|mesh-list
20594472|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
20594473|NCT02174172|Atezolizumab|atezolizumab|mesh-list
20594474|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20594475|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594476|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20594477|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20594478|NCT02174172|Growth Substances|growth substances|mesh-ancestor
20594479|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594480|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
20594481|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
20594482|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594483|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20594484|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594485|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
20594486|NCT02174211|Ranibizumab|ranibizumab|mesh-list
20594487|NCT02174211|Aflibercept|aflibercept|mesh-list
20594488|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20594489|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20594490|NCT02174211|Growth Substances|growth substances|mesh-ancestor
20081301|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081302|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
20081303|NCT00000330|Narcotics|narcotics|mesh-ancestor
20081304|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081305|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081306|NCT00000330|Analgesics|analgesics|mesh-ancestor
20081307|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
20081308|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594491|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594492|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
20594493|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594494|NCT02174250|Rifampin|rifampin|mesh-list
20594495|NCT02174250|Istradefylline|istradefylline|mesh-list
20594496|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20594497|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
20594498|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594499|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594500|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
20594501|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20594502|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594503|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594504|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20594505|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20594506|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20594507|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20594508|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20594509|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20594510|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20594511|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20594512|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20081309|NCT00000332|Nimodipine|nimodipine|mesh-list
20081310|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20081311|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20081312|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081313|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081314|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20081315|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081316|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
20081317|NCT00000333|Benztropine|benztropine|mesh-list
20081318|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20081319|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20081320|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
20081321|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
20594513|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
20081322|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594514|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594515|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594516|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
20594517|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
20594518|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
20594519|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594520|NCT02174328|Aspirin|aspirin|mesh-list
20594521|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20594522|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20081323|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594523|NCT02174328|Analgesics|analgesics|mesh-ancestor
20594524|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
20594525|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594526|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594527|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20594528|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20594529|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20594530|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20594531|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594532|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20594533|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20594534|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081324|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20081325|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20081326|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
20081327|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081328|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081329|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20081330|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081331|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081332|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
20081333|NCT00000334|Buprenorphine|buprenorphine|mesh-list
20081334|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081335|NCT00000334|Narcotics|narcotics|mesh-ancestor
20081336|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081337|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081338|NCT00000334|Analgesics|analgesics|mesh-ancestor
20081339|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
20081340|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081341|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081342|NCT00000335|Morphine|morphine|mesh-list
20594535|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
20594536|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
20594537|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594538|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20594539|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594540|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594541|NCT02174575|Sevoflurane|sevoflurane|mesh-list
20594542|NCT02174575|Desflurane|desflurane|mesh-list
20594543|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20594544|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20594545|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
20594546|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
20081343|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081344|NCT00000335|Narcotics|narcotics|mesh-ancestor
20081345|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081346|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081347|NCT00000335|Analgesics|analgesics|mesh-ancestor
20081348|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
20081349|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081350|NCT00000336|Selegiline|selegiline|mesh-list
20594547|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594548|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594549|NCT02174588|Midazolam|midazolam|mesh-list
20594550|NCT02174588|Propofol|propofol|mesh-list
20594551|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20594552|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594553|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594554|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20594555|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
20594556|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
20594557|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20594558|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20594559|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081351|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081352|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081353|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20081354|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20081355|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20081356|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081357|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081358|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20081359|NCT00000336|Protective Agents|protective agents|mesh-ancestor
20081360|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081361|NCT00000337|Selegiline|selegiline|mesh-list
20081362|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081363|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081364|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20081365|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20081366|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20081367|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081368|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081369|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20081370|NCT00000337|Protective Agents|protective agents|mesh-ancestor
20594560|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20594561|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
20594562|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
20594563|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594564|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594565|NCT02174666|Vitamin D|vitamin d|mesh-list
20594566|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
20594567|NCT02174666|Vitamins|vitamins|mesh-list
20594568|NCT02174666|Genistein|genistein|mesh-list
20594569|NCT02174666|Biochanin A|biochanin a|mesh-list
20594570|NCT02174666|Daidzein|daidzein|mesh-list
20594571|NCT02174666|Formononetin|formononetin|mesh-list
20594572|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
20594573|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594574|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20594575|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20594576|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20594577|NCT02174666|Protective Agents|protective agents|mesh-ancestor
20594578|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594579|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20594580|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594581|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594582|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
20081371|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081372|NCT00000338|Lisuride|lisuride|mesh-list
20081373|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20594583|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20594584|NCT02174666|Estrogens|estrogens|mesh-ancestor
20594585|NCT02174666|Hormones|hormones|mesh-ancestor
20594586|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20607180|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607181|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
20607182|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607183|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20607184|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20081374|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20081375|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20081376|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
20081377|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081378|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081379|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081380|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
20607185|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20594587|NCT02174718|Vitamin D|vitamin d|mesh-list
20594588|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
20594589|NCT02174718|Vitamins|vitamins|mesh-ancestor
20594590|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
20594591|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594592|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20594593|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20594594|NCT02174757|Doxycycline|doxycycline|mesh-list
20594595|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594596|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594597|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
20594598|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20594599|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20594600|NCT02174887|Gemcitabine|gemcitabine|mesh-list
20594601|NCT02174887|Paclitaxel|paclitaxel|mesh-list
20594602|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20594603|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594604|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
20594605|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
20594606|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
20594607|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594608|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20594609|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
20594610|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
20594611|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594612|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746570|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746571|NCT03015090|Theophylline|theophylline|mesh-list
19746572|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19746573|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
19746574|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746575|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746576|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19746577|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594613|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20594614|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
20594615|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594616|NCT02174900|Lumefantrine|lumefantrine|mesh-list
20594617|NCT02174900|Artemether|artemether|mesh-list
20594618|NCT02174900|Primaquine|primaquine|mesh-list
19746578|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19746579|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746580|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746581|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
19746582|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19746583|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19746584|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
19746585|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746586|NCT03000374|Leucovorin|leucovorin|mesh-list
19746587|NCT03000374|Fluorouracil|fluorouracil|mesh-list
19746588|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
19746589|NCT03000374|Panitumumab|panitumumab|mesh-list
20081381|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
20081382|NCT00000339|Risperidone|risperidone|mesh-list
20594619|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20594620|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
20594621|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20594622|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20594623|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594624|NCT02174939|Cilostazol|cilostazol|mesh-list
20594625|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594626|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
20081383|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081384|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
20081385|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081386|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081387|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081388|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081389|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081390|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594627|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594628|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081391|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19746590|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
20594629|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594630|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594631|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20594632|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20594633|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594634|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20594635|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
20594636|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20594637|NCT02174939|Protective Agents|protective agents|mesh-ancestor
20081392|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081393|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
20081394|NCT00000340|Pemoline|pemoline|mesh-list
20081395|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20081396|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081397|NCT00000341|Buprenorphine|buprenorphine|mesh-list
20081398|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081399|NCT00000341|Narcotics|narcotics|mesh-ancestor
20081400|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594638|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20594639|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20594640|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594641|NCT02175017|Nivolumab|nivolumab|mesh-list
20594642|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20594643|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594644|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20594645|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594646|NCT02175030|Copper|copper|mesh-list
20594647|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
20081401|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081402|NCT00000341|Analgesics|analgesics|mesh-ancestor
20081403|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
20081404|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081405|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081406|NCT00000342|Risperidone|risperidone|mesh-list
20081407|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081408|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
20081409|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081410|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081411|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081412|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081413|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081414|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081415|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081416|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081417|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
20081418|NCT00000344|Buprenorphine|buprenorphine|mesh-list
20081419|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20081420|NCT00000344|Naloxone|naloxone|mesh-list
20081421|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081422|NCT00000344|Narcotics|narcotics|mesh-ancestor
20081423|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081424|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081425|NCT00000344|Analgesics|analgesics|mesh-ancestor
20081426|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
20081427|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081428|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081429|NCT00000345|Lofexidine|lofexidine|mesh-list
20081430|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20081431|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081432|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081433|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
20081434|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081435|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20081436|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20081437|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20081438|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081439|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081440|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081441|NCT00000347|Risperidone|risperidone|mesh-list
20081442|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081443|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
20081444|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081445|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081446|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081447|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081448|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081449|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081450|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20594648|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20594649|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
20594650|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20594651|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594652|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20594653|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20594654|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20594655|NCT02175030|Trace Elements|trace elements|mesh-ancestor
20594656|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
20594657|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20594658|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20594659|NCT02175069|Ropivacaine|ropivacaine|mesh-list
20594660|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
20594661|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
20594662|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594663|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594664|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
20594665|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594666|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
20594667|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594668|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
20594669|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594670|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594671|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594672|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594673|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
20594674|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594675|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594676|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594677|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594678|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20594679|NCT02175355|Telmisartan|telmisartan|mesh-list
20594680|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20594681|NCT02175355|Diuretics|diuretics|mesh-ancestor
20594682|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
20594683|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594684|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20594685|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594686|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594687|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20594688|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20594689|NCT02175381|Gemcitabine|gemcitabine|mesh-list
20594690|NCT02175381|Carboplatin|carboplatin|mesh-list
20594691|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594692|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20594693|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
20594694|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594695|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
20594696|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594697|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594698|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20594699|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
20594700|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594701|NCT02175394|Linagliptin|linagliptin|mesh-list
20594702|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20594703|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20594704|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20594705|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594706|NCT02175394|Incretins|incretins|mesh-ancestor
20594707|NCT02175394|Hormones|hormones|mesh-ancestor
20594708|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594709|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20081451|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081452|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
20081453|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
20081454|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
20081455|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
20081456|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081457|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081458|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081459|NCT00000349|Flupenthixol|flupenthixol|mesh-list
20594710|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
20081460|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20594711|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594712|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594713|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20594714|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
20594715|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20594716|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20594717|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20594718|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20594719|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20594720|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20594721|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20594722|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20594723|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20594724|NCT02175407|Itraconazole|itraconazole|mesh-list
20594725|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
20594726|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594727|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20594728|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20594729|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594730|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594731|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20081461|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081462|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081463|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081464|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081465|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081466|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081467|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
20081468|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081469|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081470|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
20081471|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
20081472|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
20081473|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20081474|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20081475|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081476|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081477|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081478|NCT00000353|Buprenorphine|buprenorphine|mesh-list
20081479|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20081480|NCT00000353|Naloxone|naloxone|mesh-list
20081481|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081482|NCT00000353|Narcotics|narcotics|mesh-ancestor
20081483|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081484|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081485|NCT00000353|Analgesics|analgesics|mesh-ancestor
20081486|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
20081487|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081488|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081489|NCT00000354|Lofexidine|lofexidine|mesh-list
20081490|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20081491|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081492|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081493|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
20081494|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081495|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20081496|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20081497|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20081498|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594732|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
20594733|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594734|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594735|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20594736|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
20594737|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
20594738|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594739|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20081499|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081500|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081501|NCT00000355|Buprenorphine|buprenorphine|mesh-list
20594740|NCT02175446|Bevacizumab|bevacizumab|mesh-list
20594741|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20081502|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081503|NCT00000355|Narcotics|narcotics|mesh-ancestor
20081504|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081505|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081506|NCT00000355|Analgesics|analgesics|mesh-ancestor
20081507|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
20081508|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081509|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081510|NCT00000357|Buprenorphine|buprenorphine|mesh-list
20081511|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20081512|NCT00000357|Narcotics|narcotics|mesh-ancestor
20081513|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081514|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081515|NCT00000357|Analgesics|analgesics|mesh-ancestor
20081516|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
20081517|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081518|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081519|NCT00000358|Lofexidine|lofexidine|mesh-list
20081520|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20081521|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081522|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081523|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
20081524|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081525|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20081526|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20081527|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20081528|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081529|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081530|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081531|NCT00000361|Methotrexate|methotrexate|mesh-list
20081532|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20081533|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
20081534|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20081535|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081536|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20081537|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
20081538|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081539|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594742|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594743|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20594744|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20594745|NCT02175446|Growth Substances|growth substances|mesh-ancestor
20594746|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594747|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
20594748|NCT02175485|Fexofenadine|fexofenadine|mesh-list
20594749|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20594750|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20594751|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20594752|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
20594753|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
20594754|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594755|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594756|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594757|NCT02175589|Colchicine|colchicine|mesh-list
20594758|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
20594759|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20594760|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
20594761|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
20594762|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
20594763|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594764|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594765|NCT02175602|Citalopram|citalopram|mesh-list
20594766|NCT02175602|Sertraline|sertraline|mesh-list
20594767|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20594768|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20594769|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594770|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594771|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594772|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
20594773|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594774|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20594775|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
20594776|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20594777|NCT02175680|Leronlimab|leronlimab|mesh-list
20594778|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20594779|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20594780|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594781|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20594782|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20594783|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
20594784|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594785|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
20594786|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20594787|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594788|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20594789|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594790|NCT02175888|Iron|iron|mesh-list
20594791|NCT02175888|Trace Elements|trace elements|mesh-ancestor
20594792|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
20594793|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594794|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20594795|NCT02175901|Amoxicillin|amoxicillin|mesh-list
20594796|NCT02175901|Metronidazole|metronidazole|mesh-list
20594797|NCT02175901|Clarithromycin|clarithromycin|mesh-list
20594798|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20594799|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
20594800|NCT02175901|Lansoprazole|lansoprazole|mesh-list
20594801|NCT02175901|Bismuth|bismuth|mesh-list
20594802|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20594803|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594804|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594805|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
20594806|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20594807|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20594808|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20594809|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594810|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20594811|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20594812|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20594813|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20594814|NCT02175901|Antacids|antacids|mesh-ancestor
20594815|NCT02175901|Diuretics|diuretics|mesh-ancestor
20594816|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
20594817|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594818|NCT02175901|Expectorants|expectorants|mesh-ancestor
20594819|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594820|NCT02175914|Erythromycin|erythromycin|mesh-list
20594821|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
20594822|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20594823|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
20594824|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594825|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594826|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20594827|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20594828|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594829|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594830|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20594831|NCT02175927|Amoxicillin|amoxicillin|mesh-list
20594832|NCT02175927|Metronidazole|metronidazole|mesh-list
20594833|NCT02175927|Tetracycline|tetracycline|mesh-list
20594834|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20594835|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
20594836|NCT02175927|Lansoprazole|lansoprazole|mesh-list
20594837|NCT02175927|Bismuth|bismuth|mesh-list
20594838|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20594839|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594840|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20081540|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
20081541|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081542|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20081543|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20081544|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
20081545|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20081546|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20081547|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
20081548|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20081549|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
20081550|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081551|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081552|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081553|NCT00000368|Paroxetine|paroxetine|mesh-list
20081554|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081555|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081556|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081557|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081558|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081559|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
20081560|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081561|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20081562|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081563|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081564|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20081565|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20081566|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081567|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
20081568|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081569|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081570|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081571|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081572|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
20081573|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081574|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081575|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081576|NCT00000372|Cycloserine|cycloserine|mesh-list
20081577|NCT00000372|Clozapine|clozapine|mesh-list
20081578|NCT00000372|Glycine|glycine|mesh-list
20081579|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20081580|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20081581|NCT00000372|Renal Agents|renal agents|mesh-ancestor
20081582|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20081583|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
20081584|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20081585|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
20081586|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081587|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081588|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
20081589|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081590|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081591|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081592|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20120055|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
20594841|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
20594842|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20594843|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20594844|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20594845|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20594846|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594847|NCT02175927|Antacids|antacids|mesh-ancestor
20594848|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20594849|NCT02175927|Diuretics|diuretics|mesh-ancestor
20594850|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
20594851|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594852|NCT02175927|Expectorants|expectorants|mesh-ancestor
20594853|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594854|NCT02176044|Nitroprusside|nitroprusside|mesh-list
20594855|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20594856|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
20594857|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20594858|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594859|NCT02176057|Azithromycin|azithromycin|mesh-list
20594860|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594861|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594862|NCT02176122|Meropenem|meropenem|mesh-list
20594863|NCT02176122|Tazobactam|tazobactam|mesh-list
20594864|NCT02176122|Piperacillin|piperacillin|mesh-list
20594865|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20594866|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20594867|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20594868|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20594869|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20594870|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594871|NCT02176135|Auranofin|auranofin|mesh-list
20594872|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20081593|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081594|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081595|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
20594873|NCT02176161|Metformin|metformin|mesh-list
20594874|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20594875|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594876|NCT02176187|Fenoterol|fenoterol|mesh-list
20594877|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20594878|NCT02176187|Ipratropium|ipratropium|mesh-list
20594879|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594880|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
20594881|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594882|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594883|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594884|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594885|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
20594886|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
20594887|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20594888|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20594889|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20594890|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20081596|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
20081597|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
20081598|NCT00000373|Olanzapine|olanzapine|mesh-list
20081599|NCT00000373|Fluoxetine|fluoxetine|mesh-list
20081600|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
20081601|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
20081602|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081603|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081604|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20081605|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081606|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081607|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081608|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081609|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081610|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081611|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081612|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081613|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081614|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
20081615|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20081616|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081617|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20081618|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20594891|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594892|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594893|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594894|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594895|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594896|NCT02176200|Fenoterol|fenoterol|mesh-list
20594897|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20594898|NCT02176200|Ipratropium|ipratropium|mesh-list
20594899|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20594900|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
20594901|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594902|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594903|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20594904|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
20594905|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
20594906|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
20594907|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20594908|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20594909|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20594910|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20594911|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594912|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20594913|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594914|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20594915|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
20594916|NCT02176213|Dexamethasone|dexamethasone|mesh-list
20594917|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
20594918|NCT02176213|Pomalidomide|pomalidomide|mesh-list
20594919|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20594920|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
20594921|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594922|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20594923|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20594924|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
20594925|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594926|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594927|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20594928|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20594929|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
20594930|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
20594931|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594932|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20594933|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
20594934|NCT02176213|Hormones|hormones|mesh-ancestor
20081619|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081620|NCT00000374|Olanzapine|olanzapine|mesh-list
20081621|NCT00000374|Risperidone|risperidone|mesh-list
20081622|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081623|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
20081624|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081625|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081626|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081627|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081628|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081629|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081630|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081631|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20081632|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
20081633|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
20081634|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
20081635|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081636|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20081637|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081638|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081639|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081640|NCT00000375|Nortriptyline|nortriptyline|mesh-list
20081641|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081642|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081643|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081644|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081645|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20081646|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20081647|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081648|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081649|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
20594935|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594936|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20594937|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20594938|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20594939|NCT02176213|Growth Substances|growth substances|mesh-ancestor
20594940|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
20594941|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20594942|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
20594943|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20594944|NCT02176304|Prednisolone|prednisolone|mesh-list
20594945|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
20081650|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081651|NCT00000376|Desipramine|desipramine|mesh-list
20081652|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20081653|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081654|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081655|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081656|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081657|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20081658|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081659|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081660|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081661|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081662|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081663|NCT00000377|Nortriptyline|nortriptyline|mesh-list
20081664|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20081665|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081666|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081667|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20081668|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081669|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081670|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081671|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081672|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081673|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081674|NCT00000379|Fluoxetine|fluoxetine|mesh-list
20081675|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081676|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081677|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081678|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081679|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081680|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
20081681|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081682|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20081683|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081684|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081685|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20081686|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20081687|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081688|NCT00000381|Fluoxetine|fluoxetine|mesh-list
20081689|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081690|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081691|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081692|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081693|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081694|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
20081695|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081696|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20081697|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081698|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081699|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20081700|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20081701|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081702|NCT00000384|Sertraline|sertraline|mesh-list
20081703|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081704|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081705|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20594946|NCT02176304|Lidocaine|lidocaine|mesh-list
20594947|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20594948|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
20594949|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
20594950|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
20594951|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20594952|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594953|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
20594954|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20594955|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20594956|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20594957|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20594958|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594959|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594960|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20594961|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
20594962|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
20594963|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20594964|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
20594965|NCT02176304|Hormones|hormones|mesh-ancestor
20594966|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20594967|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20594968|NCT02176304|Protective Agents|protective agents|mesh-ancestor
20594969|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20594970|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20081706|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081707|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081708|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081709|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081710|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
20081711|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081712|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
20081713|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081714|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081715|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081716|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081717|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
20081718|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081719|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081720|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081721|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
20081722|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20081723|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081724|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081725|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081726|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081727|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081728|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081729|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081730|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081731|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081732|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
20081733|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20081734|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081735|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20081736|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20081737|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081738|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20081739|NCT00000390|Imipramine|imipramine|mesh-list
20081740|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20081741|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081742|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081743|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20081744|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081745|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081746|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081747|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081748|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081749|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081750|NCT00000395|Folic Acid|folic acid|mesh-list
20081751|NCT00000395|Leucovorin|leucovorin|mesh-list
20081752|NCT00000395|Methotrexate|methotrexate|mesh-list
20081753|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
20594971|NCT02176369|Vinorelbine|vinorelbine|mesh-list
20594972|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20594973|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20594974|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
20594975|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
20594976|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
20594977|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594978|NCT02176460|Colchicine|colchicine|mesh-list
20594979|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
20594980|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20594981|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
20594982|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
20594983|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
20594984|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594985|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607186|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607187|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607188|NCT02241148|Acetaminophen|acetaminophen|mesh-list
20607189|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20607190|NCT02241148|Analgesics|analgesics|mesh-ancestor
20607191|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
20607192|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607193|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607194|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
20607195|NCT02241161|Bacteriocins|bacteriocins|mesh-list
20607196|NCT02241161|Antioxidants|antioxidants|mesh-list
20607197|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607198|NCT02241161|Protective Agents|protective agents|mesh-ancestor
20607199|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607200|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20607201|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607202|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20607203|NCT02241174|Eusol|eusol|mesh-list
20607204|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
20607205|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607206|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
20607207|NCT02241200|Hematinics|hematinics|mesh-ancestor
20607208|NCT02241278|Ketamine|ketamine|mesh-list
20607209|NCT02241278|Analgesics|analgesics|mesh-ancestor
20607210|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
20607211|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607212|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607213|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20607214|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20607215|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
20607216|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
20607217|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607218|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20607219|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20607220|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607221|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607222|NCT02241356|Methamphetamine|methamphetamine|mesh-list
20607223|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20607224|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607225|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
20607226|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
20607227|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607228|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
20607229|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607230|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607231|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607232|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20607233|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081754|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20081755|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
20081756|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20081757|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081758|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20081759|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
20081760|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081761|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20081762|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
20081763|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607234|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607235|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20607236|NCT02241421|Amoxicillin|amoxicillin|mesh-list
20594986|NCT02176499|Telmisartan|telmisartan|mesh-list
20594987|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20594988|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20594989|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20594990|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20594991|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20594992|NCT02176512|Telmisartan|telmisartan|mesh-list
20594993|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20594994|NCT02176512|Diuretics|diuretics|mesh-ancestor
20081764|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20081765|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20081766|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
20081767|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20081768|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20081769|NCT00000395|Hematinics|hematinics|mesh-ancestor
20081770|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
20081771|NCT00000395|Vitamins|vitamins|mesh-ancestor
20081772|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
20081773|NCT00000395|Antidotes|antidotes|mesh-ancestor
20081774|NCT00000395|Protective Agents|protective agents|mesh-ancestor
20081775|NCT00000399|Hormones|hormones|mesh-list
20081776|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081777|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081778|NCT00000400|Alendronate|alendronate|mesh-list
20081779|NCT00000400|Teriparatide|teriparatide|mesh-list
20081780|NCT00000400|Hormones|hormones|mesh-list
20081781|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
20081782|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081783|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081784|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20081785|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20120056|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120057|NCT00006264|Zidovudine|zidovudine|mesh-list
20120058|NCT00006264|Aldesleukin|aldesleukin|mesh-list
20120059|NCT00006264|Ganciclovir|ganciclovir|mesh-list
20120060|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20120061|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
20120062|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120063|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20120064|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120065|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120066|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
20120067|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120068|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120069|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120070|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120071|NCT00006265|Cytarabine|cytarabine|mesh-list
20120072|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
20120073|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120074|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
20081786|NCT00000402|Calcium|calcium|mesh-list
20081787|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20081788|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081789|NCT00000403|Doxycycline|doxycycline|mesh-list
20081790|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20081791|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20081792|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
20081793|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20081794|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20081795|NCT00000412|Alendronate|alendronate|mesh-list
20081796|NCT00000412|Calcitriol|calcitriol|mesh-list
20081797|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20081798|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081799|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20594995|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
20594996|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20594997|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20594998|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20594999|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595000|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595001|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595002|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
20595003|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
20595004|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595005|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595006|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20595007|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595008|NCT02176681|Vildagliptin|vildagliptin|mesh-list
20081800|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20081801|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081802|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081803|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20081804|NCT00000412|Vitamins|vitamins|mesh-ancestor
20081805|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
20081806|NCT00000415|Calcium|calcium|mesh-list
20081807|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20081808|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081809|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20081810|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20081811|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20081812|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
20081813|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20081814|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081815|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20081816|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20081817|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20081818|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20081819|NCT00000419|Estrogens|estrogens|mesh-ancestor
20081820|NCT00000419|Hormones|hormones|mesh-ancestor
20081821|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081822|NCT00000420|Norinyl|norinyl|mesh-list
20081823|NCT00000420|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20081824|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20081825|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20081826|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20081827|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
20081828|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20081829|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081830|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20081831|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20081832|NCT00000420|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20081833|NCT00000420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20081834|NCT00000421|Prednisone|prednisone|mesh-list
20081835|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20081836|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
20081837|NCT00000421|Hormones|hormones|mesh-ancestor
20081838|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081839|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081840|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20081841|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20081842|NCT00000425|Acetaminophen|acetaminophen|mesh-list
20595009|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20595010|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595011|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20595012|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595013|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595014|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595015|NCT02176720|Fluorides|fluorides|mesh-list
20595016|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20595017|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
20595018|NCT02176720|Protective Agents|protective agents|mesh-ancestor
20595019|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595020|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
20595021|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595022|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595023|NCT02176733|Cyclosporine|cyclosporine|mesh-list
20595024|NCT02176733|Cyclosporins|cyclosporins|mesh-list
20595025|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595026|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595027|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20595028|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
20595029|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595030|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
20595031|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595032|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
20595033|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595034|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20595035|NCT02176759|Citric Acid|citric acid|mesh-list
20081843|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20081844|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20081845|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20081846|NCT00000425|Analgesics|analgesics|mesh-ancestor
20081847|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
20081848|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081849|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081850|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
20081851|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20081852|NCT00000426|Calcium|calcium|mesh-list
20081853|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20081854|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081855|NCT00000427|Alendronate|alendronate|mesh-list
20081856|NCT00000427|Hormones|hormones|mesh-list
20081857|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
20081858|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081859|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081860|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20081861|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20081862|NCT00000428|Amitriptyline|amitriptyline|mesh-list
20081863|NCT00000428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20081864|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20081865|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081866|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081867|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20081868|NCT00000428|Analgesics|analgesics|mesh-ancestor
20081869|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
20081870|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081871|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081872|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20081873|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081874|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081875|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081876|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
20081877|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081878|NCT00000428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20081879|NCT00000428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081880|NCT00000428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081881|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
20081882|NCT00000429|Calcium|calcium|mesh-list
20081883|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20081884|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081885|NCT00000429|Antacids|antacids|mesh-ancestor
20081886|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595036|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
20595037|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
20595038|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20595039|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
20595040|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
20595041|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595042|NCT02176850|Telmisartan|telmisartan|mesh-list
20595043|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595044|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595045|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595046|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595047|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20595048|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
20595049|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595050|NCT02177071|Methotrexate|methotrexate|mesh-list
20595051|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
20595052|NCT02177071|Azathioprine|azathioprine|mesh-list
20081887|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20081888|NCT00000430|Alendronate|alendronate|mesh-list
20081889|NCT00000430|Estrogens|estrogens|mesh-list
20081890|NCT00000430|Progestins|progestins|mesh-list
20081891|NCT00000430|Hormones|hormones|mesh-ancestor
20081892|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20081893|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081894|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20081895|NCT00000437|Naltrexone|naltrexone|mesh-list
20081896|NCT00000437|Nicotine|nicotine|mesh-list
20595053|NCT02177071|Infliximab|infliximab|mesh-list
20595054|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20595055|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
20595056|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20595057|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595058|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20595059|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
20595060|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595061|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595062|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
20595063|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595064|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20595065|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20595066|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
20595067|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595068|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20595069|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20595070|NCT02177175|Carvedilol|carvedilol|mesh-list
20595071|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20595072|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20081897|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20081898|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
20081899|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081900|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081901|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20081902|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20081903|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
20081904|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081905|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081906|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20081907|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20595073|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595074|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595075|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595076|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595077|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595078|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
20595079|NCT02177175|Protective Agents|protective agents|mesh-ancestor
20595080|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20595081|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595082|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20595083|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
20595084|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20595085|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20595086|NCT02177253|Bromides|bromides|mesh-list
20595087|NCT02177253|Albuterol|albuterol|mesh-list
20595088|NCT02177253|Ipratropium|ipratropium|mesh-list
20595089|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
20081908|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
20595090|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20595091|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
20595092|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595093|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595094|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20595095|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595096|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
20595097|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20595098|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20595099|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20595100|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20595101|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595102|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595103|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081909|NCT00000438|Naltrexone|naltrexone|mesh-list
20081910|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20081911|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081912|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081913|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
20081914|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081915|NCT00000439|Valproic Acid|valproic acid|mesh-list
20081916|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
20081917|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20081918|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081919|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
20081920|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081921|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081922|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
20081923|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081924|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081925|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081926|NCT00000440|Naltrexone|naltrexone|mesh-list
20081927|NCT00000440|Sertraline|sertraline|mesh-list
20081928|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20081929|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081930|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081931|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
20081932|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081933|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
20081934|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081935|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20081936|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20081937|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081938|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081939|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081940|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
20081941|NCT00000441|Carbamazepine|carbamazepine|mesh-list
20081942|NCT00000441|Lorazepam|lorazepam|mesh-list
20081943|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
20081944|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
20081945|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
20081946|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081947|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081948|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20081949|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20081950|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081951|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20081952|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081953|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081954|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
20081955|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
20081956|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081957|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081958|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
20081959|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20081960|NCT00000441|Analgesics|analgesics|mesh-ancestor
20081961|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
20081962|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20081963|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20081964|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20081965|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20081966|NCT00000442|Naltrexone|naltrexone|mesh-list
20081967|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20081968|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20081969|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081970|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
20081971|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081972|NCT00000443|Ondansetron|ondansetron|mesh-list
20081973|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
20081974|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
20081975|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081976|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081977|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20081978|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
20081979|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
20081980|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20081981|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
20081982|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081983|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081984|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20595104|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20595105|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595106|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20595107|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
20595108|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20595109|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
20595110|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595111|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595112|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20595113|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595114|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
20595115|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20595116|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595117|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595118|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595119|NCT02177318|Bromides|bromides|mesh-list
20595120|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
20595121|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20595122|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
20081985|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20081986|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20081987|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20081988|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20081989|NCT00000444|Nicotine|nicotine|mesh-list
20081990|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20081991|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
20081992|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20081993|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20081994|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20081995|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20081996|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
20081997|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20081998|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20081999|NCT00000445|Naltrexone|naltrexone|mesh-list
20306038|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20306039|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306040|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306041|NCT00653562|Zolpidem|zolpidem|mesh-list
20306042|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20306043|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20306044|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306045|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306046|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20595123|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082000|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082001|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082002|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082003|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
20082004|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082005|NCT00000446|Sertraline|sertraline|mesh-list
20082006|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
20082007|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082008|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20082009|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082010|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082011|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595124|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595125|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20595126|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595127|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
20595128|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20595129|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595130|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595131|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082012|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082013|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
20082014|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082015|NCT00000447|Naltrexone|naltrexone|mesh-list
20082016|NCT00000447|Nicotine|nicotine|mesh-list
20082017|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20082018|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
20082019|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082020|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082021|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20082022|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20082023|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
20082024|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082025|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082026|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082027|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082028|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
20082029|NCT00000448|Naltrexone|naltrexone|mesh-list
20082030|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082031|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082032|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082033|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
20082034|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082035|NCT00000449|Naltrexone|naltrexone|mesh-list
20082036|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082037|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082038|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082039|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
20082040|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082041|NCT00000450|Naltrexone|naltrexone|mesh-list
20082042|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082043|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082044|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082045|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
20082046|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082047|NCT00000451|Naltrexone|naltrexone|mesh-list
20082048|NCT00000451|Sertraline|sertraline|mesh-list
20082049|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082050|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082051|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082052|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
20082053|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082054|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
20082055|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082056|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20082057|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082058|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082059|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082060|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082061|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
20082062|NCT00000452|Naltrexone|naltrexone|mesh-list
20082063|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082064|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082065|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082066|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
20082067|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082068|NCT00000454|Nicotine|nicotine|mesh-list
20082069|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20082070|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
20082071|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082072|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595132|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
20595133|NCT02177331|Lacidipine|lacidipine|mesh-list
20595134|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595135|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20082073|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20595136|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607237|NCT02241421|Vancomycin|vancomycin|mesh-list
20082074|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20082075|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595137|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595138|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20595139|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595140|NCT02177344|Bromides|bromides|mesh-list
20595141|NCT02177344|Ipratropium|ipratropium|mesh-list
20595142|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
20595143|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20595144|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
19746591|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746592|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19746593|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746594|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746595|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
20082076|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082077|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082078|NCT00000455|Naltrexone|naltrexone|mesh-list
20082079|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082080|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082081|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082082|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
20082083|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082084|NCT00000456|Naltrexone|naltrexone|mesh-list
20082085|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20082086|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20082087|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082088|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
20082089|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082090|NCT00000457|Bupropion|bupropion|mesh-list
20082091|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20082092|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
20082093|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082094|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20082095|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082096|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082097|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082098|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
20082099|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082100|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082101|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20082102|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20082103|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082104|NCT00000458|Sertraline|sertraline|mesh-list
20082105|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
20082106|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082107|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20082108|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082109|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082110|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082111|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082112|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
20082113|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082114|NCT00000461|Niacin|niacin|mesh-list
20082115|NCT00000461|Pravastatin|pravastatin|mesh-list
20082116|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
20082117|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
20082118|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082119|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
20082120|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082121|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082122|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082123|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
20082124|NCT00000461|Vitamins|vitamins|mesh-ancestor
20082125|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
20082126|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082127|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082128|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082129|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082130|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20082131|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20082132|NCT00000463|Warfarin|warfarin|mesh-list
20082133|NCT00000463|Lovastatin|lovastatin|mesh-list
20082134|NCT00000463|L 647318|l 647318|mesh-list
20595145|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746596|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746597|NCT03000374|Antidotes|antidotes|mesh-ancestor
19746598|NCT03000374|Protective Agents|protective agents|mesh-ancestor
19746599|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
19746600|NCT03000374|Vitamins|vitamins|mesh-ancestor
20082135|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
20082136|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
20082137|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
20082138|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082139|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082140|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
20082141|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082142|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082143|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082144|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082145|NCT00000464|Quinidine|quinidine|mesh-list
20082146|NCT00000464|Amiodarone|amiodarone|mesh-list
20082147|NCT00000464|Sotalol|sotalol|mesh-list
20082148|NCT00000464|Propafenone|propafenone|mesh-list
20082149|NCT00000464|Mexiletine|mexiletine|mesh-list
20082150|NCT00000464|Procainamide|procainamide|mesh-list
20082151|NCT00000464|Imipramine|imipramine|mesh-list
20082152|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082153|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082154|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20082155|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082156|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082157|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20082158|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20082159|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20082160|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082161|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20082162|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20082163|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20082164|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082165|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082166|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082167|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082168|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082169|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
20082170|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
20082171|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082172|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20082173|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
20082174|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082175|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20082176|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082177|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20082178|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
20082179|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20082180|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20082181|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20082182|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20082183|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20082184|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
20082185|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20082186|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20082187|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
20082188|NCT00000466|Progesterone|progesterone|mesh-list
20082189|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20082190|NCT00000466|Estrogens|estrogens|mesh-list
20082191|NCT00000466|Progestins|progestins|mesh-ancestor
20082192|NCT00000466|Hormones|hormones|mesh-ancestor
20082193|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082194|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082195|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20306047|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
19746601|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
19746602|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746603|NCT02994836|Adalimumab|adalimumab|mesh-list
19746604|NCT02994836|Infliximab|infliximab|mesh-list
19746605|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19746606|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746607|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595146|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595147|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20082196|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20082197|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20082198|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
20082199|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20082200|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20082201|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20082202|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20082203|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20082204|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20082205|NCT00000468|Plasminogen|plasminogen|mesh-list
20082206|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20082207|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082208|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082209|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082210|NCT00000469|Aspirin|aspirin|mesh-list
20082211|NCT00000469|Lovastatin|lovastatin|mesh-list
20082212|NCT00000469|L 647318|l 647318|mesh-list
20082213|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
20082214|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082215|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082216|NCT00000469|Analgesics|analgesics|mesh-ancestor
20082217|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
20082218|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082219|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082220|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082221|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082222|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082223|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082224|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082225|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20082226|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082227|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082228|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
20082229|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082230|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082231|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
20082232|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082233|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082234|NCT00000472|Heparin|heparin|mesh-list
20082235|NCT00000472|Plasminogen|plasminogen|mesh-list
20082236|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20082237|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
20082238|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082239|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082240|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082241|NCT00000477|Lovastatin|lovastatin|mesh-list
20082242|NCT00000477|L 647318|l 647318|mesh-list
20082243|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
20082244|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082245|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20595148|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595149|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20595150|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595151|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082246|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
20082247|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082248|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082249|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082250|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082251|NCT00000478|Atenolol|atenolol|mesh-list
20082252|NCT00000478|Diltiazem|diltiazem|mesh-list
20595152|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595153|NCT02177357|Pramipexole|pramipexole|mesh-list
20595154|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
20082253|NCT00000478|Nifedipine|nifedipine|mesh-list
20595155|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595156|NCT02177357|Protective Agents|protective agents|mesh-ancestor
20595157|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595158|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20595159|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20595160|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
20595161|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
20595162|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595163|NCT02177370|Fenoterol|fenoterol|mesh-list
20595164|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20595165|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
20595166|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595167|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595168|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20595169|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595170|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
20082254|NCT00000478|Isosorbide|isosorbide|mesh-list
20082255|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20082256|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20082257|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20082258|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082259|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082260|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20082261|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082262|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082263|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
20082264|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20082265|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082266|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082267|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
20082268|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
20082269|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082270|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20082271|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082272|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082273|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082274|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082275|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20082276|NCT00000478|Diuretics|diuretics|mesh-ancestor
20082277|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082278|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20082279|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20082280|NCT00000482|Niacin|niacin|mesh-list
20082281|NCT00000482|Clofibrate|clofibrate|mesh-list
20082282|NCT00000482|Estrogens|estrogens|mesh-list
20082283|NCT00000482|Hormones|hormones|mesh-ancestor
20082284|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082285|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082286|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082287|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
20082288|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082289|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082290|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082291|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
20082292|NCT00000482|Vitamins|vitamins|mesh-ancestor
20082293|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
20082294|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082295|NCT00000483|Niacin|niacin|mesh-list
20082296|NCT00000483|Clofibrate|clofibrate|mesh-list
20082297|NCT00000483|Estrogens|estrogens|mesh-list
20082298|NCT00000483|Hormones|hormones|mesh-ancestor
20082299|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082300|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082301|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082302|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
20082303|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082304|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082305|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082306|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
20082307|NCT00000483|Vitamins|vitamins|mesh-ancestor
20082308|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
20082309|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20595171|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
20082310|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
20082311|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082312|NCT00000484|Diuretics|diuretics|mesh-ancestor
20595172|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20595173|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20595174|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20595175|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20595176|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595177|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595178|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595179|NCT02177396|Valsartan|valsartan|mesh-list
20595180|NCT02177396|Telmisartan|telmisartan|mesh-list
20595181|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595182|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595183|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595184|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595185|NCT02177409|Amlodipine|amlodipine|mesh-list
20595186|NCT02177409|Telmisartan|telmisartan|mesh-list
20595187|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595188|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20595189|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595190|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595191|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20595192|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595193|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
20595194|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20082313|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082314|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082315|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20082316|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082317|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082318|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
20082319|NCT00000485|Diuretics|diuretics|mesh-list
20082320|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082321|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082322|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
20082323|NCT00000487|Diuretics|diuretics|mesh-list
20082324|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082325|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082326|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
20082327|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082328|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082329|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
20082330|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082331|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082332|NCT00000491|Aspirin|aspirin|mesh-list
20082333|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082334|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082335|NCT00000491|Analgesics|analgesics|mesh-ancestor
20082336|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
20082337|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082338|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082339|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082340|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082341|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082342|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082343|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082344|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20082345|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082346|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082347|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
20082348|NCT00000492|Propranolol|propranolol|mesh-list
20082349|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082350|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082351|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082352|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082353|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082354|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082355|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082356|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082357|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082358|NCT00000493|Propranolol|propranolol|mesh-list
20082359|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082360|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082361|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082362|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306048|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
20595195|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595196|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20595197|NCT02177422|Telmisartan|telmisartan|mesh-list
20082363|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082364|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082365|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082366|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082367|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082368|NCT00000494|Indomethacin|indomethacin|mesh-list
20595198|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595199|NCT02177422|Diuretics|diuretics|mesh-ancestor
20595200|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
20595201|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595202|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20595203|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595204|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082369|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082370|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082371|NCT00000494|Analgesics|analgesics|mesh-ancestor
20082372|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
20082373|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082374|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082375|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082376|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082377|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
20082378|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
20082379|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20082380|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082381|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082382|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082383|NCT00000496|Aspirin|aspirin|mesh-list
20082384|NCT00000496|Dipyridamole|dipyridamole|mesh-list
20082385|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082386|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082387|NCT00000496|Analgesics|analgesics|mesh-ancestor
20595205|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595206|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595207|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20595208|NCT02177435|Telmisartan|telmisartan|mesh-list
20082388|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
20082389|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082390|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082391|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082392|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082393|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082394|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082395|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082396|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20082397|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082398|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082399|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
20082400|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20082401|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082402|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
20082403|NCT00000499|Metoprolol|metoprolol|mesh-list
20082404|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
20082405|NCT00000499|Hydralazine|hydralazine|mesh-list
20082406|NCT00000499|Reserpine|reserpine|mesh-list
20082407|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082408|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082409|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
20082410|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
20082411|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082412|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082413|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20082414|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082415|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082416|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082417|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082418|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082419|NCT00000499|Diuretics|diuretics|mesh-ancestor
20082420|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082421|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20082422|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082423|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082424|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20082425|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20082426|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20082427|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082428|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20082429|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082430|NCT00000500|Aspirin|aspirin|mesh-list
20082431|NCT00000500|Carotenoids|carotenoids|mesh-list
20082432|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082433|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082434|NCT00000500|Analgesics|analgesics|mesh-ancestor
20082435|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
20595209|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20595210|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595211|NCT02177435|Diuretics|diuretics|mesh-ancestor
20595212|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
20595213|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595214|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20595215|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595216|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595217|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20082436|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082437|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082438|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082439|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082440|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082441|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082442|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082443|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20082444|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082445|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082446|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
20082447|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
20082448|NCT00000500|Protective Agents|protective agents|mesh-ancestor
20120075|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120076|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120077|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
20120078|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120079|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120080|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
20120081|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120082|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20120083|NCT00006267|Rubitecan|rubitecan|mesh-list
20120084|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120085|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20120086|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120087|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120088|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120089|NCT00006269|Irinotecan|irinotecan|mesh-list
20120090|NCT00006269|Octreotide|octreotide|mesh-list
20306049|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306050|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306051|NCT00653588|Atorvastatin|atorvastatin|mesh-list
20306052|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306053|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306054|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306055|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
20306056|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306057|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306058|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306059|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306060|NCT00653614|Drospirenone|drospirenone|mesh-list
20306061|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20595218|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595219|NCT02177448|Enalapril|enalapril|mesh-list
20306062|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
20595220|NCT02177448|Enalaprilat|enalaprilat|mesh-list
20595221|NCT02177448|Telmisartan|telmisartan|mesh-list
20595222|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20595223|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595224|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595225|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595226|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082449|NCT00000503|Streptokinase|streptokinase|mesh-list
20082450|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
20595227|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595228|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20082451|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082452|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082453|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082454|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082455|NCT00000504|Flecainide|flecainide|mesh-list
20082456|NCT00000504|Moricizine|moricizine|mesh-list
20595229|NCT02177461|Telmisartan|telmisartan|mesh-list
20595230|NCT02177461|Clonidine|clonidine|mesh-list
20595231|NCT02177461|Enalapril|enalapril|mesh-list
20595232|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595233|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595234|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595235|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595236|NCT02177461|Analgesics|analgesics|mesh-ancestor
20595237|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
20595238|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595239|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595240|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
20595241|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
20595242|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20595243|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20595244|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20595245|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595246|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595247|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20595248|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595249|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595250|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20595251|NCT02177487|Telmisartan|telmisartan|mesh-list
20082457|NCT00000504|Encainide|encainide|mesh-list
20082458|NCT00000504|Imipramine|imipramine|mesh-list
20082459|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082460|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20082461|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20082462|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595252|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20595253|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595254|NCT02177487|Diuretics|diuretics|mesh-ancestor
20595255|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
20595256|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595257|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20595258|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595259|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595260|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595261|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595262|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20595263|NCT02177500|Telmisartan|telmisartan|mesh-list
20595264|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20595265|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595266|NCT02177500|Diuretics|diuretics|mesh-ancestor
20595267|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
20595268|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595269|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20595270|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595271|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595272|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595273|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595274|NCT02177539|Phenylephrine|phenylephrine|mesh-list
20595275|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
20595276|NCT02177539|Tropicamide|tropicamide|mesh-list
20595277|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
20595278|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20595279|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
20595280|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
20595281|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595282|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595283|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
20595284|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20595285|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
20595286|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595287|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20595288|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20595289|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20595290|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595291|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595292|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595293|NCT02177539|Protective Agents|protective agents|mesh-ancestor
20595294|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20595295|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20595296|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595297|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
20595298|NCT02177552|Carboplatin|carboplatin|mesh-list
20595299|NCT02177552|Docetaxel|docetaxel|mesh-list
20595300|NCT02177552|Capecitabine|capecitabine|mesh-list
20595301|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
20595302|NCT02177552|Epirubicin|epirubicin|mesh-list
20595303|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20082463|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082464|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20082465|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
20082466|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082467|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20082468|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082469|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082470|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082471|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082472|NCT00000505|Plasminogen|plasminogen|mesh-list
20082473|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20082474|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20595304|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
20595305|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
20595306|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
20595307|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595308|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20595309|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
20595310|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20595311|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20082475|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595312|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20595313|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595314|NCT02177578|Temozolomide|temozolomide|mesh-list
20595315|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20595316|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
20595317|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595318|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595319|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
20595320|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595321|NCT02177734|Vaccines|vaccines|mesh-list
20595322|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
20595323|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595324|NCT02177760|Sirolimus|sirolimus|mesh-list
20595325|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20082476|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082477|NCT00000506|Phentermine|phentermine|mesh-list
20082478|NCT00000506|Fenfluramine|fenfluramine|mesh-list
20082479|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20082480|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082481|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
20082482|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20082483|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
20082484|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
20082485|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082486|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082487|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082488|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082489|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20082490|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082491|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082492|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
20082493|NCT00000507|Streptokinase|streptokinase|mesh-list
20082494|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20595326|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595327|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20595328|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595329|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
20595330|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20595331|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
20595332|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595333|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
20595334|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595335|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20595336|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595337|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595338|NCT02177851|Iron|iron|mesh-list
20595339|NCT02177851|Trace Elements|trace elements|mesh-ancestor
20595340|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
20595341|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595342|NCT02177955|Midazolam|midazolam|mesh-list
20595343|NCT02177955|Diazepam|diazepam|mesh-list
20595344|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20595345|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20595346|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595347|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595348|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20595349|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20595350|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20595351|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20595352|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
20595353|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
20595354|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
20595355|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
20595356|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595357|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595358|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
20595359|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
20595360|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
20595361|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595362|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20082495|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595363|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20595364|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20595365|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
20595366|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20595367|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595368|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20607238|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20607239|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607240|NCT02241460|Lidocaine|lidocaine|mesh-list
20607241|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
20607242|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
20607243|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607244|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607245|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
20607246|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607247|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20607248|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20607249|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20607250|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607251|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082496|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082497|NCT00000510|Aspirin|aspirin|mesh-list
20082498|NCT00000510|Dipyridamole|dipyridamole|mesh-list
20082499|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082500|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082501|NCT00000510|Analgesics|analgesics|mesh-ancestor
20082502|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
20607252|NCT02241499|Fluorouracil|fluorouracil|mesh-list
20607253|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
20607254|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
20607255|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607256|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20607257|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607258|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607259|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
20607260|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607261|NCT02241564|Sirolimus|sirolimus|mesh-list
20607262|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20607263|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607264|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607265|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20607266|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607267|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20607268|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607269|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
20607270|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607271|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
20607272|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607273|NCT02241590|Entecavir|entecavir|mesh-list
20607274|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
20607275|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607276|NCT02241616|Entecavir|entecavir|mesh-list
20607277|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
20607278|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607279|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
20607280|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20607281|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607282|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20607283|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20607284|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607285|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607286|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607287|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
20607288|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20607289|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
20607290|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607291|NCT02241876|Expectorants|expectorants|mesh-ancestor
20607292|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607293|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20607294|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
20607295|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607296|NCT02241876|Protective Agents|protective agents|mesh-ancestor
20607297|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607298|NCT02241876|Antidotes|antidotes|mesh-ancestor
20607299|NCT02241941|Daptomycin|daptomycin|mesh-list
20607300|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20607301|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607302|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20082503|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082504|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082505|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595369|NCT02178124|Donepezil|donepezil|mesh-list
20595370|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20595371|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595372|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595373|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595374|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595375|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595376|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
20595377|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
20595378|NCT02178137|Astringents|astringents|mesh-ancestor
20595379|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595380|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
20595381|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
20595382|NCT02178150|Antacids|antacids|mesh-ancestor
20595383|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595384|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20595385|NCT02178254|Fosfomycin|fosfomycin|mesh-list
20595386|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20595387|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595388|NCT02178293|Ketoprofen|ketoprofen|mesh-list
20595389|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
20595390|NCT02178293|Benzydamine|benzydamine|mesh-list
20595391|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19492159|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492160|NCT03125187|Heparin|heparin|mesh-list
19492161|NCT03125187|Calcium heparin|calcium heparin|mesh-list
19492162|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
19492163|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19492164|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595392|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569628|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595393|NCT02178293|Analgesics|analgesics|mesh-ancestor
19492165|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082506|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082507|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20595394|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
20595395|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595396|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595397|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595398|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595399|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595400|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082508|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082509|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082510|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20082511|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082512|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082513|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
20082514|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20082515|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082516|NCT00000512|Niacin|niacin|mesh-list
20082517|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
20082518|NCT00000512|Lovastatin|lovastatin|mesh-list
20595401|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595402|NCT02178306|Telmisartan|telmisartan|mesh-list
20595403|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19492166|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19492167|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
19492168|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569629|NCT04593680|Tenofovir|tenofovir|mesh-list
20082519|NCT00000512|L 647318|l 647318|mesh-list
20082520|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
20082521|NCT00000512|Colestipol|colestipol|mesh-list
20082522|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082523|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
20082524|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082525|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082526|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082527|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
20082528|NCT00000512|Vitamins|vitamins|mesh-ancestor
20082529|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
20082530|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595404|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20595405|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20595406|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595407|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20595408|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595409|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20595410|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595411|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595412|NCT02178449|Dexamethasone|dexamethasone|mesh-list
20595413|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
20595414|NCT02178449|Ropivacaine|ropivacaine|mesh-list
20595415|NCT02178449|BB 1101|bb 1101|mesh-list
20595416|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595417|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
20082531|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082532|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082533|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082534|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
20082535|NCT00000513|Atenolol|atenolol|mesh-list
20082536|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
20082537|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082538|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082539|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
20595418|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
20595419|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595420|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595421|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20595422|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
20595423|NCT02178449|Hormones|hormones|mesh-ancestor
20595424|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20595425|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20595426|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595427|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
20082540|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
20082541|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082542|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082543|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20082544|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082545|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082546|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082547|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082548|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082549|NCT00000513|Diuretics|diuretics|mesh-ancestor
20082550|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082551|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20082552|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082553|NCT00000514|Atenolol|atenolol|mesh-list
20082554|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
20082555|NCT00000514|Reserpine|reserpine|mesh-list
20082556|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082557|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082558|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
20082559|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
20082560|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082561|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082562|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20082563|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082564|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082565|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082566|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082567|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595428|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
20082568|NCT00000514|Diuretics|diuretics|mesh-ancestor
20082569|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082570|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20082571|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082572|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20082573|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20082574|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20082575|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082576|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20082577|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082578|NCT00000516|Enalapril|enalapril|mesh-list
20082579|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20082580|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595429|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595430|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
20595431|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
19746608|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746609|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19746610|NCT02985957|Prednisone|prednisone|mesh-list
19746611|NCT02985957|Nivolumab|nivolumab|mesh-list
19746612|NCT02985957|Ipilimumab|ipilimumab|mesh-list
19746613|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746614|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
19746615|NCT02985957|Hormones|hormones|mesh-ancestor
19746616|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082581|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082582|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082583|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082584|NCT00000517|Warfarin|warfarin|mesh-list
20082585|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
20082586|NCT00000518|Quinidine|quinidine|mesh-list
20082587|NCT00000518|Sotalol|sotalol|mesh-list
20082588|NCT00000518|Mexiletine|mexiletine|mesh-list
20082589|NCT00000518|Procainamide|procainamide|mesh-list
20082590|NCT00000518|Imipramine|imipramine|mesh-list
20082591|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20595432|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746617|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746618|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746619|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20082592|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20595433|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595434|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
20595435|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20595436|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595437|NCT02178488|Vitamins|vitamins|mesh-ancestor
20595438|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
20595439|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20595440|NCT02178644|Capecitabine|capecitabine|mesh-list
20595441|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20595442|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
20595443|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595444|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595445|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
20595446|NCT02178683|Tacrolimus|tacrolimus|mesh-list
20595447|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20595448|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
20595449|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595450|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20595451|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595452|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595453|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20595454|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595455|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20595456|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
20595457|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20595458|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595459|NCT02178761|Chromium|chromium|mesh-list
20595460|NCT02178761|Everolimus|everolimus|mesh-list
20595461|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595462|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746620|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20082593|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082594|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082595|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595463|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
20595464|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595465|NCT02178761|Trace Elements|trace elements|mesh-ancestor
20595466|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
20595467|NCT02178813|Minocycline|minocycline|mesh-list
20595468|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20595469|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595470|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20595471|NCT02179008|Latanoprost|latanoprost|mesh-list
20595472|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20595473|NCT02179034|Menthol|menthol|mesh-list
20595474|NCT02179034|Nicotine|nicotine|mesh-list
20595475|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20595476|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
20595477|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595478|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595479|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20595480|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20595481|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
20082596|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082597|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082598|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
20082599|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
20082600|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082601|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20082602|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
20082603|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20082604|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20082605|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082606|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082607|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20082608|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
20082609|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20595482|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595483|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595484|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
20595485|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
20595486|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
20595487|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20595488|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20595489|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082610|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20082611|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20082612|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082613|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20082614|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20082615|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
20082616|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20082617|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20595490|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595491|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595492|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595493|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595494|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20595495|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595496|NCT02179255|Hormones|hormones|mesh-list
20595497|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20595498|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20595499|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082618|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20595500|NCT02179268|Sertraline|sertraline|mesh-list
20595501|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20595502|NCT02179268|Citalopram|citalopram|mesh-list
20082619|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20082620|NCT00000520|Aspirin|aspirin|mesh-list
20082621|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
20595503|NCT02179268|Reboxetine|reboxetine|mesh-list
20595504|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
20595505|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20595506|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20595507|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20082622|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20082623|NCT00000520|Antibodies|antibodies|mesh-list
20082624|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
20595508|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595509|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082625|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20595510|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595511|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
20595512|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595513|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20595514|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20595515|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20595516|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595517|NCT02179294|Meperidine|meperidine|mesh-list
20595518|NCT02179294|Remifentanil|remifentanil|mesh-list
20595519|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20595520|NCT02179294|Narcotics|narcotics|mesh-ancestor
20595521|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595522|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595523|NCT02179294|Analgesics|analgesics|mesh-ancestor
20595524|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
20595525|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595526|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20595527|NCT02179528|Etoposide|etoposide|mesh-list
20595528|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20595529|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595530|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20595531|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20595532|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595533|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595534|NCT02179567|Bevacizumab|bevacizumab|mesh-list
20595535|NCT02179567|Docetaxel|docetaxel|mesh-list
20595536|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20595537|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595538|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20595539|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20595540|NCT02179567|Growth Substances|growth substances|mesh-ancestor
20595541|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595542|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
20595543|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
20595544|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
20595545|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
20595546|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595547|NCT02179645|Celecoxib|celecoxib|mesh-list
20595548|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20595549|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082626|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082627|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082628|NCT00000520|Analgesics|analgesics|mesh-ancestor
20082629|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
20082630|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082631|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082632|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082633|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082634|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082635|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082636|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082637|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20082638|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082639|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082640|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
20082641|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
20082642|NCT00000522|Acebutolol|acebutolol|mesh-list
20082643|NCT00000522|Amlodipine|amlodipine|mesh-list
20595550|NCT02179645|Analgesics|analgesics|mesh-ancestor
20595551|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
20595552|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595553|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595554|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595555|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595556|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20595557|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595558|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595559|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082644|NCT00000522|Enalapril|enalapril|mesh-list
20082645|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
20082646|NCT00000522|Doxazosin|doxazosin|mesh-list
20595560|NCT02179658|Vancomycin|vancomycin|mesh-list
20595561|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
20595562|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20595563|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595564|NCT02179775|Propranolol|propranolol|mesh-list
20595565|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20595566|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20595567|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595568|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595569|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595570|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595571|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20595572|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595573|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
20595574|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
20595575|NCT02179814|Promethazine|promethazine|mesh-list
20595576|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20595577|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20595578|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595579|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595580|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
20595581|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
20595582|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
20595583|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595584|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
20595585|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
20595586|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20595587|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20595588|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
20595589|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
20082647|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082648|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20082649|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082650|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082651|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20082652|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082653|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082654|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20306063|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306064|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306065|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20306066|NCT00653614|Diuretics|diuretics|mesh-ancestor
20306067|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
20306068|NCT00653744|Atorvastatin|atorvastatin|mesh-list
20306069|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20595590|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595591|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595592|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20595593|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
20595594|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
20607303|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20607304|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20607305|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20607306|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20607307|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608063|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608064|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608065|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608066|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608067|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608068|NCT02244320|Urological Agents|urological agents|mesh-ancestor
20608069|NCT02244437|Acetaminophen|acetaminophen|mesh-list
20608070|NCT02244437|Ibuprofen|ibuprofen|mesh-list
20608071|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20608072|NCT02244437|Analgesics|analgesics|mesh-ancestor
20608073|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
20608074|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608075|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608076|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
20608077|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20608078|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608079|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608080|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20608081|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608082|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608083|NCT02244489|Capecitabine|capecitabine|mesh-list
20608084|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
20608085|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
20608086|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20608087|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
20608088|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608089|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608090|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20608091|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608092|NCT02244502|Paclitaxel|paclitaxel|mesh-list
20608093|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20608094|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608095|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
20608096|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
20608097|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
20608098|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608099|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
20608100|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20608101|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608102|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608103|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20608104|NCT02244515|Analgesics|analgesics|mesh-ancestor
20608105|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
20608106|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608107|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20608108|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20608109|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20608110|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608111|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608112|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608113|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
20608114|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
20608115|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20608116|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20608117|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608118|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608119|NCT02244528|Urological Agents|urological agents|mesh-ancestor
20608120|NCT02244567|Metformin|metformin|mesh-list
20608121|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608122|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20608123|NCT02244632|Bevacizumab|bevacizumab|mesh-list
20608124|NCT02244632|Fluorouracil|fluorouracil|mesh-list
20608125|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
20608126|NCT02244632|Irinotecan|irinotecan|mesh-list
20595595|NCT02179931|Flupenthixol|flupenthixol|mesh-list
20595596|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20595597|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20595598|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20595599|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595600|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595601|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20595602|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20595603|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
20595604|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595605|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595606|NCT02179970|Plerixafor|plerixafor|mesh-list
20595607|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20595608|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20595609|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
20595610|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595611|NCT02179996|Vaccines|vaccines|mesh-list
20595612|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
20595613|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595614|NCT02180048|Caffeine|caffeine|mesh-list
20595615|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20595616|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595617|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20595618|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595619|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595620|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20595621|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20595622|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
20595623|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595624|NCT02180087|Ketoprofen|ketoprofen|mesh-list
20082655|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
20082656|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082657|NCT00000522|Diuretics|diuretics|mesh-ancestor
20082658|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082659|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20082660|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20082661|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20082662|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082663|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082664|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082665|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082666|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
20082667|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
20082668|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082669|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20082670|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082671|NCT00000524|Cyclosporine|cyclosporine|mesh-list
20082672|NCT00000524|Prednisone|prednisone|mesh-list
20082673|NCT00000524|Cyclosporins|cyclosporins|mesh-list
20082674|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082675|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
20082676|NCT00000524|Hormones|hormones|mesh-ancestor
20082677|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082678|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082679|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20082680|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595625|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20082681|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082682|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082683|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20595626|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082684|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
20082685|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
20595627|NCT02180087|Analgesics|analgesics|mesh-ancestor
20595628|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
20082686|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20082687|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
20082688|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082689|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20082690|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20082691|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
20082692|NCT00000525|Triamterene|triamterene|mesh-list
20082693|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082694|NCT00000525|Diuretics|diuretics|mesh-ancestor
20595629|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595630|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595631|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595632|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595633|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595634|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595635|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595636|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20595637|NCT02180204|Tenecteplase|tenecteplase|mesh-list
20595638|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20595639|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595640|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595641|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
20595642|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20595643|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595644|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595645|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
20595646|NCT02180321|Coagulants|coagulants|mesh-ancestor
20595647|NCT02180334|Acetaminophen|acetaminophen|mesh-list
20595648|NCT02180334|Linagliptin|linagliptin|mesh-list
20595649|NCT02180334|Mosapride|mosapride|mesh-list
20595650|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595651|NCT02180334|Analgesics|analgesics|mesh-ancestor
20595652|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
20595653|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595654|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595655|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
20595656|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595657|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20595658|NCT02180334|Incretins|incretins|mesh-ancestor
20595659|NCT02180334|Hormones|hormones|mesh-ancestor
20082695|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082696|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082697|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20082698|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082699|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082700|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20082701|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20082702|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20082703|NCT00000526|Flecainide|flecainide|mesh-list
20082704|NCT00000526|Moricizine|moricizine|mesh-list
20082705|NCT00000526|Encainide|encainide|mesh-list
20082706|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082707|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20082708|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20595660|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20595661|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20595662|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595663|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595664|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20595665|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20595666|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
20595667|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595668|NCT02180425|Adapalene|adapalene|mesh-list
20595669|NCT02180425|Tretinoin|tretinoin|mesh-list
20595670|NCT02180425|Isotretinoin|isotretinoin|mesh-list
20595671|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
20595672|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20595673|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595674|NCT02180425|Analgesics|analgesics|mesh-ancestor
20595675|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
20595676|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082709|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595677|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595678|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595679|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607308|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
20595680|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595681|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
20595682|NCT02180503|Linagliptin|linagliptin|mesh-list
20595683|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20595684|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595685|NCT02180503|Incretins|incretins|mesh-ancestor
20595686|NCT02180503|Hormones|hormones|mesh-ancestor
20595687|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20595688|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20595689|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595690|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595691|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595692|NCT02180516|Meloxicam|meloxicam|mesh-list
20595693|NCT02180516|Etodolac|etodolac|mesh-list
20595694|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20595695|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20082710|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082711|NCT00000527|Aspirin|aspirin|mesh-list
20082712|NCT00000527|Dipyridamole|dipyridamole|mesh-list
20082713|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20595696|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595697|NCT02180516|Analgesics|analgesics|mesh-ancestor
20595698|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
20595699|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595700|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595701|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595702|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20595703|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595704|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595705|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595706|NCT02180529|Methylphenidate|methylphenidate|mesh-list
20595707|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20595708|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082714|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20082715|NCT00000527|Analgesics|analgesics|mesh-ancestor
20082716|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
20082717|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082718|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082719|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082720|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20082721|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082722|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082723|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082724|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20082725|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20082726|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082727|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
20595709|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20595710|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20595711|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595712|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595713|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
20595714|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595715|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
20595716|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595717|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
20595718|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20595719|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595720|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595721|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595722|NCT02180737|Analgesics|analgesics|mesh-ancestor
20595723|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
20595724|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595725|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20595726|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20595727|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20595728|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595729|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595730|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595731|NCT02180789|Tamsulosin|tamsulosin|mesh-list
20595732|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20595733|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20595734|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20595735|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595736|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595737|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595738|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595739|NCT02180789|Urological Agents|urological agents|mesh-ancestor
20595740|NCT02180880|Pregabalin|pregabalin|mesh-list
20595741|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
20595742|NCT02180880|Analgesics|analgesics|mesh-ancestor
20595743|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
20595744|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595745|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595746|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
20595747|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20595748|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20595749|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082728|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20082729|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082730|NCT00000529|Tamoxifen|tamoxifen|mesh-list
20082731|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20082732|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
20082733|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082734|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082735|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20082736|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20082737|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20082738|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20595750|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20595751|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20595752|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20595753|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595754|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20595755|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20595756|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20595757|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20595758|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20595759|NCT02180997|Tamsulosin|tamsulosin|mesh-list
20595760|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
20595761|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20595762|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20595763|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20595764|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595765|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595766|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595767|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595768|NCT02180997|Urological Agents|urological agents|mesh-ancestor
20595769|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20595770|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20595771|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595772|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
20595773|NCT02181023|Bromides|bromides|mesh-list
20595774|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
20595775|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20595776|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20595777|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20595778|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
20595779|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595780|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595781|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595782|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
20595783|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20595784|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595785|NCT02181205|Bupivacaine|bupivacaine|mesh-list
20595786|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
20595787|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
19746621|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19746622|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746623|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19746624|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746625|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746626|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
19746627|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746628|NCT02916771|Dexamethasone|dexamethasone|mesh-list
19746629|NCT02916771|Lenalidomide|lenalidomide|mesh-list
19746630|NCT02916771|Ixazomib|ixazomib|mesh-list
19746631|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746632|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
20082739|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20595788|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20595789|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595790|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
20595791|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595792|NCT02181218|Gemcitabine|gemcitabine|mesh-list
20595793|NCT02181218|Dexamethasone|dexamethasone|mesh-list
20082740|NCT00000530|Nifedipine|nifedipine|mesh-list
20082741|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20082742|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082743|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082744|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20082745|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082746|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082747|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
20082748|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20082749|NCT00000531|Amiodarone|amiodarone|mesh-list
20082750|NCT00000531|Sotalol|sotalol|mesh-list
20082751|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20595794|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
20595795|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
20595796|NCT02181218|Romidepsin|romidepsin|mesh-list
20595797|NCT02181218|BB 1101|bb 1101|mesh-list
20595798|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595799|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
20595800|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
20595801|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082752|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082753|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20082754|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082755|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082756|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20082757|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20082758|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20082759|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595802|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595803|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20595804|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
20595805|NCT02181218|Hormones|hormones|mesh-ancestor
20607309|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746633|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
19746634|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595806|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20595807|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20595808|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595809|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595810|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595811|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595812|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20595813|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
20595814|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
20595815|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595816|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20595817|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
20595818|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20595819|NCT02181309|Meloxicam|meloxicam|mesh-list
20595820|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20595821|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595822|NCT02181309|Analgesics|analgesics|mesh-ancestor
20595823|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
20595824|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595825|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595826|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595827|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595828|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20595829|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595830|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595831|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595832|NCT02181322|Meloxicam|meloxicam|mesh-list
20595833|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20595834|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595835|NCT02181322|Analgesics|analgesics|mesh-ancestor
20082760|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20082761|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20082762|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20082763|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20082764|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082765|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082766|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082767|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082768|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
20082769|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
20082770|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082771|NCT00000534|Calcium|calcium|mesh-list
20082772|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20595836|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
20595837|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595838|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082773|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082774|NCT00000539|Vitamins|vitamins|mesh-list
20082775|NCT00000539|Vitamin E|vitamin e|mesh-list
20082776|NCT00000539|Beta Carotene|beta carotene|mesh-list
20082777|NCT00000539|Warfarin|warfarin|mesh-list
20082778|NCT00000539|Pravastatin|pravastatin|mesh-list
20082779|NCT00000539|Carotenoids|carotenoids|mesh-list
20082780|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
20595839|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595840|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595841|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20595842|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595843|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595844|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595845|NCT02181335|Budesonide|budesonide|mesh-list
20595846|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595847|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20595848|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
20595849|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595850|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595851|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20595852|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
20595853|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
20595854|NCT02181335|Hormones|hormones|mesh-ancestor
20595855|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492169|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
20082781|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082782|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
20595856|NCT02181348|Vitamin E|vitamin e|mesh-list
20595857|NCT02181348|Vitamins|vitamins|mesh-ancestor
20595858|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
20595859|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595860|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
20595861|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595862|NCT02181348|Protective Agents|protective agents|mesh-ancestor
20595863|NCT02181361|Aspirin|aspirin|mesh-list
20595864|NCT02181361|Hirudins|hirudins|mesh-list
20595865|NCT02181361|Warfarin|warfarin|mesh-list
20595866|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20595867|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595868|NCT02181361|Analgesics|analgesics|mesh-ancestor
20595869|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
20595870|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595871|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595872|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595873|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595874|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20595875|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595876|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595877|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20595878|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595879|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595880|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
20595881|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
20595882|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
20595883|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20595884|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
20595885|NCT02181478|Cyclosporine|cyclosporine|mesh-list
20595886|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
20595887|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
20595888|NCT02181478|Fludarabine|fludarabine|mesh-list
20595889|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
20595890|NCT02181478|Cyclosporins|cyclosporins|mesh-list
20595891|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20595892|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
20595893|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595894|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595895|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20595896|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
20595897|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595898|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20595899|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20595900|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20595901|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
20595902|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595903|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
20595904|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595905|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
20595906|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20595907|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20595908|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20595909|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
20595910|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20595911|NCT02181543|Clonidine|clonidine|mesh-list
20082783|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
20082784|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082785|NCT00000539|Protective Agents|protective agents|mesh-ancestor
20082786|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082787|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
20082788|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082789|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082790|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082791|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082792|NCT00000539|Provitamins|provitamins|mesh-ancestor
20595912|NCT02181543|Analgesics|analgesics|mesh-ancestor
20595913|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
20595914|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595915|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082793|NCT00000541|Vitamins|vitamins|mesh-list
20082794|NCT00000541|Folic Acid|folic acid|mesh-list
20082795|NCT00000541|Vitamin E|vitamin e|mesh-list
20082796|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
20595916|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20595917|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
20595918|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
20595919|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20595920|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20595921|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20595922|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
20595923|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20595924|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595925|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
20595926|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20595927|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607310|NCT02242214|Misoprostol|misoprostol|mesh-list
20607311|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20607312|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
20607313|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20607314|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607315|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20607316|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607317|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
20607318|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20607319|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20607320|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
20607321|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607322|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607323|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20607324|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607325|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20607326|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20607327|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20607328|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607329|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607330|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607331|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
20607332|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
20607333|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20607334|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
20607335|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607336|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607337|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20607338|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607339|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20607340|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20607341|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20607342|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607343|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607344|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607345|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
20607346|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20607347|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
20607348|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
20607349|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20607350|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20607351|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
20607352|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607353|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607354|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20607355|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
20082797|NCT00000541|Hydroxocobalamin|hydroxocobalamin|mesh-list
20082798|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
20082799|NCT00000541|Pyridoxal|pyridoxal|mesh-list
20082800|NCT00000541|Pyridoxine|pyridoxine|mesh-list
20082801|NCT00000541|Beta Carotene|beta carotene|mesh-list
20607356|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
20607357|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20607358|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
20607359|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607360|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607361|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20607362|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20607363|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20607364|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607365|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
20607366|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20607367|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
20082802|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
20082803|NCT00000541|Carotenoids|carotenoids|mesh-list
20595928|NCT02181920|Dipyrone|dipyrone|mesh-list
20595929|NCT02181920|Diclofenac|diclofenac|mesh-list
20595930|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20595931|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20595932|NCT02181920|Analgesics|analgesics|mesh-ancestor
20595933|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
20595934|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20595935|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595936|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20595937|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20595938|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20595939|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595940|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595941|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
20595942|NCT02181933|Lamivudine|lamivudine|mesh-list
20595943|NCT02181933|Zidovudine|zidovudine|mesh-list
20595944|NCT02181933|Nevirapine|nevirapine|mesh-list
20595945|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20595946|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20082804|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
20595947|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595948|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595949|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
20595950|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595951|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20595952|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20595953|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
20595954|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20595955|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20595956|NCT02181946|Fluconazole|fluconazole|mesh-list
20595957|NCT02181946|Nevirapine|nevirapine|mesh-list
20595958|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
20595959|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20595960|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20595961|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20595962|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20595963|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595964|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20595965|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
20595966|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20595967|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20595968|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20595969|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20595970|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20595971|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20595972|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
20595973|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20595974|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20595975|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20595976|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20595977|NCT02181985|Heparin|heparin|mesh-list
20595978|NCT02181985|Enoxaparin|enoxaparin|mesh-list
20082805|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082806|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
20595979|NCT02181985|Tenecteplase|tenecteplase|mesh-list
20595980|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20595981|NCT02181985|Abciximab|abciximab|mesh-list
20595982|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
20595983|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20595984|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595985|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20595986|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20595987|NCT02181998|Heparin|heparin|mesh-list
20595988|NCT02181998|Enoxaparin|enoxaparin|mesh-list
20595989|NCT02181998|Tenecteplase|tenecteplase|mesh-list
20595990|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
20595991|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20082807|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082808|NCT00000541|Protective Agents|protective agents|mesh-ancestor
20082809|NCT00000541|Hematinics|hematinics|mesh-ancestor
20082810|NCT00000541|Provitamins|provitamins|mesh-ancestor
20082811|NCT00000542|Amlodipine|amlodipine|mesh-list
20595992|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595993|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082812|NCT00000542|Lisinopril|lisinopril|mesh-list
20595994|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20595995|NCT02182011|Tenecteplase|tenecteplase|mesh-list
20595996|NCT02182011|Streptokinase|streptokinase|mesh-list
20595997|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20595998|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20595999|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596000|NCT02182024|Dabigatran|dabigatran|mesh-list
20596001|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
20596002|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20596003|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596004|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596005|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596006|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
20596007|NCT02182050|Nintedanib|nintedanib|mesh-list
20596008|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596009|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596010|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596011|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596012|NCT02182063|Nintedanib|nintedanib|mesh-list
20596013|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596014|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596015|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596016|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596017|NCT02182076|Nintedanib|nintedanib|mesh-list
20596018|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596019|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596020|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596021|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596022|NCT02182102|Pemetrexed|pemetrexed|mesh-list
20596023|NCT02182102|Nintedanib|nintedanib|mesh-list
20596024|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596025|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596026|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596027|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20596028|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20596029|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596030|NCT02182128|Nintedanib|nintedanib|mesh-list
20596031|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596032|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596033|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596034|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596035|NCT02182141|Nintedanib|nintedanib|mesh-list
20596036|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596037|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596038|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596039|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596040|NCT02182154|Nintedanib|nintedanib|mesh-list
20596041|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596042|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596043|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596044|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596045|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
20596046|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20596047|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
20596048|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596049|NCT02182167|Expectorants|expectorants|mesh-ancestor
20596050|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596051|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20596052|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
20596053|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596054|NCT02182167|Protective Agents|protective agents|mesh-ancestor
20596055|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596056|NCT02182167|Antidotes|antidotes|mesh-ancestor
20596057|NCT02182193|Nintedanib|nintedanib|mesh-list
20596058|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596059|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596060|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596061|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596062|NCT02182206|Nintedanib|nintedanib|mesh-list
20596063|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596064|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596065|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082813|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
20082814|NCT00000542|Doxazosin|doxazosin|mesh-list
20082815|NCT00000542|Pravastatin|pravastatin|mesh-list
20082816|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20082817|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082818|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20082819|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20596066|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596067|NCT02182219|Nintedanib|nintedanib|mesh-list
20596068|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596069|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596070|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596071|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596072|NCT02182232|Paclitaxel|paclitaxel|mesh-list
20596073|NCT02182232|Carboplatin|carboplatin|mesh-list
20596074|NCT02182232|Nintedanib|nintedanib|mesh-list
20596075|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20596076|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596077|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
20596078|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
20596079|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
20596080|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596081|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596082|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596083|NCT02182245|Paclitaxel|paclitaxel|mesh-list
20596084|NCT02182245|Carboplatin|carboplatin|mesh-list
20596085|NCT02182245|Nintedanib|nintedanib|mesh-list
20596086|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20596087|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596088|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
20596089|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
20596090|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
20596091|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596092|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20306070|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306071|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306072|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
20082820|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306073|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306074|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306075|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306076|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306077|NCT00653757|Leuprolide|leuprolide|mesh-list
20596093|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596094|NCT02182258|Nintedanib|nintedanib|mesh-list
20596095|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596096|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20596097|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596098|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596099|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
20596100|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20596101|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596102|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20596103|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20596104|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596105|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596106|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596107|NCT02182336|Vitamin K|vitamin k|mesh-list
20596108|NCT02182336|Digoxin|digoxin|mesh-list
20596109|NCT02182336|Midazolam|midazolam|mesh-list
20596110|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
20596111|NCT02182336|Caffeine|caffeine|mesh-list
20596112|NCT02182336|Omeprazole|omeprazole|mesh-list
20596113|NCT02182336|Warfarin|warfarin|mesh-list
20596114|NCT02182336|Vitamins|vitamins|mesh-ancestor
20596115|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
20596116|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596117|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20596118|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20596119|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20596120|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20596121|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20596122|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20596123|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20596124|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
20596125|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
20596126|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
20596127|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
20596128|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596129|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596130|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
20596131|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20596132|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19492170|NCT03124680|Narcotics|narcotics|mesh-ancestor
19492171|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492172|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492173|NCT03124680|Analgesics|analgesics|mesh-ancestor
19492174|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
19492175|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492176|NCT03124524|Dienogest|dienogest|mesh-list
19492177|NCT03124524|Drospirenone|drospirenone|mesh-list
19492178|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19492179|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19492180|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19492181|NCT03124524|Estradiol|estradiol|mesh-list
19492182|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20596133|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20596134|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596135|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20082821|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20082822|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082823|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082824|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082825|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20596136|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20596137|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20596138|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20596139|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
20596140|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082826|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
20082827|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082828|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082829|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082830|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
20082831|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20082832|NCT00000542|Protective Agents|protective agents|mesh-ancestor
20082833|NCT00000542|Diuretics|diuretics|mesh-ancestor
20082834|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
20082835|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20596141|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20596142|NCT02182336|Protective Agents|protective agents|mesh-ancestor
20596143|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20596144|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20596145|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
20596146|NCT02182336|Coagulants|coagulants|mesh-ancestor
20596147|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
20596148|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596149|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20596150|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20596151|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
20596152|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20596153|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20596154|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
20596155|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596156|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20596157|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20596158|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596159|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596160|NCT02182401|Tolbutamide|tolbutamide|mesh-list
20596161|NCT02182401|Midazolam|midazolam|mesh-list
20596162|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20596163|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20596164|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20596165|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596166|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20082836|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20082837|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20596167|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20596168|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20596169|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20596170|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
20596171|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
20596172|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
20596173|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
20082838|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082839|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
20082840|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082841|NCT00000543|Calcium|calcium|mesh-list
20082842|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20082843|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082844|NCT00000547|Enalapril|enalapril|mesh-list
20082845|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20082846|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
20082847|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082848|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082849|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20082850|NCT00000549|Hormones|hormones|mesh-list
20596174|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596175|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082851|NCT00000549|Estrogens|estrogens|mesh-list
20596176|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596177|NCT02182453|Empagliflozin|empagliflozin|mesh-list
20082852|NCT00000549|Progestins|progestins|mesh-list
20082853|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082854|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596178|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20596179|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596180|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596181|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596182|NCT02182479|Fenoterol|fenoterol|mesh-list
20596183|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20596184|NCT02182479|Ipratropium|ipratropium|mesh-list
20596185|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20596186|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
20596187|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596188|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596189|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20596190|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596191|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
20596192|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
20596193|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596194|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20596195|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20596196|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20596197|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
20596198|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596199|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596200|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20596201|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
20596202|NCT02182505|Fenoterol|fenoterol|mesh-list
20596203|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20596204|NCT02182505|Ipratropium|ipratropium|mesh-list
20596205|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20596206|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
20596207|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596208|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596209|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20596210|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596211|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
20596212|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
20596213|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596214|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20596215|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20596216|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20596217|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492183|NCT03124524|Estrogens|estrogens|mesh-ancestor
20082855|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
20082856|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20082857|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082858|NCT00000553|Niacin|niacin|mesh-list
20082859|NCT00000553|Simvastatin|simvastatin|mesh-list
20082860|NCT00000553|Antioxidants|antioxidants|mesh-list
20082861|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20082862|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20082863|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
20082864|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082865|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20082866|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20082867|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082868|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
20082869|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
20082870|NCT00000553|Vitamins|vitamins|mesh-ancestor
20082871|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
20082872|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082873|NCT00000553|Protective Agents|protective agents|mesh-ancestor
20082874|NCT00000554|Dobutamine|dobutamine|mesh-list
20082875|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20082876|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
20082877|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
20082878|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082879|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082880|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20082881|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20082882|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20082883|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
20596218|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596219|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082884|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082885|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082886|NCT00000554|Protective Agents|protective agents|mesh-ancestor
20082887|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
20082888|NCT00000555|Vitamin E|vitamin e|mesh-list
20082889|NCT00000555|Hormones|hormones|mesh-list
20082890|NCT00000555|Progesterone|progesterone|mesh-list
20082891|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20082892|NCT00000555|Estrogens|estrogens|mesh-list
20596220|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20596221|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
20596222|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
20596223|NCT02182518|Ephedrine|ephedrine|mesh-list
20596224|NCT02182518|Epinastine|epinastine|mesh-list
20596225|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20596226|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
20596227|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596228|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596229|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20596230|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
20082893|NCT00000555|Vitamins|vitamins|mesh-ancestor
20082894|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
20082895|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082896|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082897|NCT00000555|Progestins|progestins|mesh-ancestor
20082898|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
20082899|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596231|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
20596232|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20596233|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20596234|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
20596235|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
20596236|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596237|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596238|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20596239|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
20596240|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
20596241|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
20596242|NCT02182531|Ephedrine|ephedrine|mesh-list
20596243|NCT02182531|Epinastine|epinastine|mesh-list
20596244|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20596245|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
20596246|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596247|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596248|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20596249|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596250|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
20596251|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20596252|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20596253|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
20596254|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
20596255|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596256|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596257|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20596258|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
20596259|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
20596260|NCT02182544|Ketotifen|ketotifen|mesh-list
20596261|NCT02182544|Epinastine|epinastine|mesh-list
20596262|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
20596263|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
20596264|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20596265|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
20596266|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
20596267|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596268|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596269|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596270|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20596271|NCT02182557|Ketotifen|ketotifen|mesh-list
20596272|NCT02182557|Epinastine|epinastine|mesh-list
20596273|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
20596274|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
20596275|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20082900|NCT00000555|Protective Agents|protective agents|mesh-ancestor
20082901|NCT00000556|Quinidine|quinidine|mesh-list
20596276|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
20596277|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
20596278|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596279|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596280|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596281|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20596282|NCT02182570|Epinastine|epinastine|mesh-list
20596283|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20596284|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
20596285|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
20596286|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596287|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596288|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596289|NCT02182583|Oxitropium|oxitropium|mesh-list
20596290|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
20596291|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
20596292|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596293|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082902|NCT00000556|Digoxin|digoxin|mesh-list
20082903|NCT00000556|Amiodarone|amiodarone|mesh-list
20082904|NCT00000556|Verapamil|verapamil|mesh-list
20082905|NCT00000556|Sotalol|sotalol|mesh-list
20082906|NCT00000556|Flecainide|flecainide|mesh-list
20082907|NCT00000556|Propafenone|propafenone|mesh-list
20082908|NCT00000556|Procainamide|procainamide|mesh-list
20082909|NCT00000556|Moricizine|moricizine|mesh-list
20082910|NCT00000556|Disopyramide|disopyramide|mesh-list
20082911|NCT00000556|Diltiazem|diltiazem|mesh-list
20082912|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20082913|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
20082914|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20082915|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20082916|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082917|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082918|NCT00000556|Protective Agents|protective agents|mesh-ancestor
20596294|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
20596295|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20596296|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596297|NCT02182622|Prednisone|prednisone|mesh-list
20596298|NCT02182622|Docetaxel|docetaxel|mesh-list
20596299|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20082919|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082920|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
20596300|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
20596301|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
20596302|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
20082921|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20082922|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20082923|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20082924|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20082925|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20082926|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20082927|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20082928|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20082929|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20596303|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596304|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596305|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
20596306|NCT02182622|Hormones|hormones|mesh-ancestor
20596307|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596308|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596309|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20596310|NCT02182635|Oxitropium|oxitropium|mesh-list
20596311|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
20596312|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
20082930|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20082931|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20596313|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596314|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596315|NCT02182648|Propofol|propofol|mesh-list
20596316|NCT02182648|Etomidate|etomidate|mesh-list
20596317|NCT02182648|Sevoflurane|sevoflurane|mesh-list
20082932|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082933|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082934|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
20082935|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
20082936|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082937|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20082938|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20082939|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
20082940|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20082941|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20082942|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20082943|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20082944|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20596318|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20596319|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20596320|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596321|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20596322|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
20596323|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
20596324|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20596325|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20596326|NCT02182661|Oxitropium|oxitropium|mesh-list
20596327|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
20596328|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
20596329|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596330|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596331|NCT02182700|Bromides|bromides|mesh-list
20596332|NCT02182700|Albuterol|albuterol|mesh-list
20596333|NCT02182700|Ipratropium|ipratropium|mesh-list
20596334|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
20596335|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20596336|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
20596337|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596338|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596339|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20596340|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
20082945|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
20082946|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20082947|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20082948|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082949|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
20082950|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20082951|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
20082952|NCT00000559|Hormones|hormones|mesh-list
20082953|NCT00000559|Estradiol|estradiol|mesh-list
20082954|NCT00000559|Estrogens|estrogens|mesh-list
20082955|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082956|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082957|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20082958|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
20082959|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596341|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
20596342|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596343|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20596344|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20596345|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19746635|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746636|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19746637|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
19746638|NCT02916771|Hormones|hormones|mesh-ancestor
19746639|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746640|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746641|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746642|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
19746643|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19746644|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19746645|NCT02916771|Growth Substances|growth substances|mesh-ancestor
20082960|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20082961|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20596346|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
20596347|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746646|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746647|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596348|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596349|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20596350|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
20596351|NCT02182713|Bromides|bromides|mesh-list
20596352|NCT02182713|Albuterol|albuterol|mesh-list
20596353|NCT02182713|Ipratropium|ipratropium|mesh-list
20596354|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
20596355|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20596356|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
20596357|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596358|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596359|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20596360|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596361|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
20596362|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596363|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20596364|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20596365|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20596366|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
20596367|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596368|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596369|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20596370|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
20596371|NCT02182739|Meloxicam|meloxicam|mesh-list
20596372|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596373|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596374|NCT02182739|Analgesics|analgesics|mesh-ancestor
20596375|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
20596376|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596377|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596378|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082962|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20082963|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20082964|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20082965|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20082966|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20082967|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
20082968|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20082969|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082970|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082971|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082972|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20082973|NCT00000563|Dexamethasone|dexamethasone|mesh-list
20082974|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082975|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
20082976|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
20596379|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596380|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19746648|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746649|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746650|NCT02831673|Tenofovir|tenofovir|mesh-list
19746651|NCT02831673|Lamivudine|lamivudine|mesh-list
19746652|NCT02831673|Emtricitabine|emtricitabine|mesh-list
19746653|NCT02831673|Dolutegravir|dolutegravir|mesh-list
19746654|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
20082977|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082978|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596381|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596382|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20082979|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19492184|NCT03124524|Hormones|hormones|mesh-ancestor
19746655|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596383|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596384|NCT02182752|Tramadol|tramadol|mesh-list
20596385|NCT02182752|Ropivacaine|ropivacaine|mesh-list
20596386|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
20596387|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
20596388|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20596389|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596390|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
20596391|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596392|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20596393|NCT02182752|Narcotics|narcotics|mesh-ancestor
20596394|NCT02182752|Analgesics|analgesics|mesh-ancestor
20596395|NCT02182765|Nevirapine|nevirapine|mesh-list
20596396|NCT02182765|Abacavir|abacavir|mesh-list
20596397|NCT02182765|Amprenavir|amprenavir|mesh-list
20596398|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20596399|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20596400|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596401|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596402|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
20596403|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596404|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20082980|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
20082981|NCT00000563|Hormones|hormones|mesh-ancestor
20082982|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20082983|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20082984|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20082985|NCT00000568|Ipratropium|ipratropium|mesh-list
20082986|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20082987|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
20082988|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20082989|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20082990|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20082991|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
20082992|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20082993|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
20082994|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20082995|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20082996|NCT00000569|Triamcinolone|triamcinolone|mesh-list
20082997|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20082998|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
20082999|NCT00000569|Hormones|hormones|mesh-ancestor
20083000|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083001|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596405|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20596406|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20596407|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20596408|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20596409|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
20596410|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20596411|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20596412|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20596413|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596414|NCT02182778|Gemcitabine|gemcitabine|mesh-list
20596415|NCT02182778|Cisplatin|cisplatin|mesh-list
20596416|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596417|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20596418|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
20596419|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596420|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
20596421|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746656|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20596422|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596423|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20596424|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
20596425|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596426|NCT02182791|Nevirapine|nevirapine|mesh-list
20596427|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20596428|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20596429|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746657|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083002|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20596430|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596431|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
20596432|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596433|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20596434|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20596435|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20596436|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20596437|NCT02182856|Bromides|bromides|mesh-list
20596438|NCT02182856|Albuterol|albuterol|mesh-list
20596439|NCT02182856|Ipratropium|ipratropium|mesh-list
20596440|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
20596441|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20596442|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
20596443|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596444|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596445|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20596446|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596447|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
20083003|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
20083004|NCT00000574|Ibuprofen|ibuprofen|mesh-list
20083005|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20083006|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20083007|NCT00000574|Analgesics|analgesics|mesh-ancestor
20083008|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
20083009|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083010|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083011|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083012|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20083013|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20083014|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083015|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083016|NCT00000576|Beclomethasone|beclomethasone|mesh-list
20083017|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083018|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
20083019|NCT00000576|Hormones|hormones|mesh-ancestor
20083020|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083021|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083022|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20083023|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
20083024|NCT00000577|Colchicine|colchicine|mesh-list
20083025|NCT00000577|Albuterol|albuterol|mesh-list
20596448|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596449|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20083026|NCT00000577|Hormones|hormones|mesh-list
20083027|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
20083028|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
20083029|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083030|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083031|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20083032|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
20083033|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083034|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20083035|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
20083036|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
20083037|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20083038|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20083039|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20596450|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20596451|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20596452|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
20596453|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596454|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596455|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20596456|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
20596457|NCT02182960|Ibuprofen|ibuprofen|mesh-list
20596458|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19746658|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746659|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746660|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19746661|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19746662|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19746663|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20083040|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20083041|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596459|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596460|NCT02182960|Analgesics|analgesics|mesh-ancestor
20596461|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
20596462|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596463|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596464|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596465|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596466|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596467|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596468|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596469|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20596470|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
20596471|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596472|NCT02183012|Ibuprofen|ibuprofen|mesh-list
20596473|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596474|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596475|NCT02183012|Analgesics|analgesics|mesh-ancestor
20596476|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
20596477|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596478|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596479|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596480|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596481|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596482|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596483|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596484|NCT02183025|Meloxicam|meloxicam|mesh-list
20596485|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
20596486|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596487|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596488|NCT02183025|Analgesics|analgesics|mesh-ancestor
20596489|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
20596490|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596491|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596492|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596493|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596494|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596495|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596496|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596497|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596498|NCT02183038|Naproxen|naproxen|mesh-list
20596499|NCT02183038|Meloxicam|meloxicam|mesh-list
20596500|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596501|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596502|NCT02183038|Analgesics|analgesics|mesh-ancestor
20596503|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
20596504|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596505|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596506|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596507|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596508|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
20596509|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596510|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596511|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596512|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596513|NCT02183051|Ibuprofen|ibuprofen|mesh-list
20596514|NCT02183051|Meloxicam|meloxicam|mesh-list
20596515|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596516|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596517|NCT02183051|Analgesics|analgesics|mesh-ancestor
20596518|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
20596519|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596520|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596521|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596522|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596523|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596524|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596525|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596526|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596527|NCT02183064|Meloxicam|meloxicam|mesh-list
20596528|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596529|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20083042|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
20083043|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20083044|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
20596530|NCT02183064|Analgesics|analgesics|mesh-ancestor
20596531|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
20596532|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596533|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083045|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
20083046|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
20596534|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596535|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596536|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596537|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596538|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596539|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596540|NCT02183077|Meloxicam|meloxicam|mesh-list
20596541|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596542|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596543|NCT02183077|Analgesics|analgesics|mesh-ancestor
20596544|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
20596545|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596546|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596547|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596548|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596549|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596550|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596551|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596552|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596553|NCT02183090|Meloxicam|meloxicam|mesh-list
20596554|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596555|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596556|NCT02183090|Analgesics|analgesics|mesh-ancestor
20596557|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
20596558|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596559|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596560|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596561|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596562|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596563|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596564|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596565|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083047|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083048|NCT00000578|Beclomethasone|beclomethasone|mesh-list
20083049|NCT00000578|Theophylline|theophylline|mesh-list
20083050|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083051|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
20083052|NCT00000578|Hormones|hormones|mesh-ancestor
20083053|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083054|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596566|NCT02183103|Meloxicam|meloxicam|mesh-list
20596567|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596568|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596569|NCT02183103|Analgesics|analgesics|mesh-ancestor
20596570|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
20083055|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19746664|NCT02800941|Warfarin|warfarin|mesh-list
20083056|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596571|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596572|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596573|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596574|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596575|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596576|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596577|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596578|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596579|NCT02183116|Meloxicam|meloxicam|mesh-list
20596580|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596581|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596582|NCT02183116|Analgesics|analgesics|mesh-ancestor
20596583|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
20596584|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596585|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596586|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596587|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596588|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20083057|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20083058|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
19746665|NCT02800941|Anticoagulants|anticoagulants|mesh-list
20596589|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596590|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596591|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596592|NCT02183129|Diclofenac|diclofenac|mesh-list
20596593|NCT02183129|Meloxicam|meloxicam|mesh-list
20596594|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596595|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596596|NCT02183129|Analgesics|analgesics|mesh-ancestor
20596597|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
20596598|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596599|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596600|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596601|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596602|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596603|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596604|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746666|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
19746667|NCT02800941|Fluindione|fluindione|mesh-list
19746668|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
20083059|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596605|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596606|NCT02183142|Meloxicam|meloxicam|mesh-list
20596607|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596608|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596609|NCT02183142|Analgesics|analgesics|mesh-ancestor
20596610|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
20596611|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596612|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596613|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596614|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596615|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596616|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596617|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596618|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596619|NCT02183155|Indomethacin|indomethacin|mesh-list
20596620|NCT02183155|Meloxicam|meloxicam|mesh-list
20596621|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596622|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596623|NCT02183155|Analgesics|analgesics|mesh-ancestor
20596624|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
20596625|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596626|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596627|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596628|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596629|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
20596630|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
20596631|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596632|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19746669|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20083060|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20083061|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083062|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596633|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596634|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083063|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
20083064|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20083065|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20083066|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
20083067|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596635|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20596636|NCT02183168|Indomethacin|indomethacin|mesh-list
20596637|NCT02183168|Meloxicam|meloxicam|mesh-list
20596638|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596639|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20083068|NCT00000579|Ketoconazole|ketoconazole|mesh-list
19746670|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596640|NCT02183168|Analgesics|analgesics|mesh-ancestor
20596641|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
20596642|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596643|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596644|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596645|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596646|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
20596647|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
20596648|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20596649|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596650|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596651|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596652|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20607368|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607369|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607370|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20607371|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607372|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
20607373|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20607374|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
20607375|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607376|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607377|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
20607378|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20607379|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
20083069|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
20083070|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20083071|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20083072|NCT00000579|Prednisolone|prednisolone|mesh-list
20083073|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
20083074|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20083075|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
20083076|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083077|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
20083078|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
20083079|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083080|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083081|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20083082|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
20083083|NCT00000579|Hormones|hormones|mesh-ancestor
20083084|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083085|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20607380|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596653|NCT02183181|Meloxicam|meloxicam|mesh-list
20596654|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596655|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596656|NCT02183181|Analgesics|analgesics|mesh-ancestor
20596657|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
20596658|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596659|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596660|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596661|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596662|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20083086|NCT00000579|Protective Agents|protective agents|mesh-ancestor
20083087|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20083088|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083089|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
20083090|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083091|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20083092|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20596663|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596664|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596665|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596666|NCT02183194|Paclitaxel|paclitaxel|mesh-list
20596667|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20596668|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596669|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
20596670|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
20596671|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
20596672|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596673|NCT02183220|Aspirin|aspirin|mesh-list
20596674|NCT02183220|Dipyrone|dipyrone|mesh-list
20596675|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20596676|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596677|NCT02183220|Analgesics|analgesics|mesh-ancestor
20596678|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
20596679|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596680|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596681|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20596682|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20596683|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20596684|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20596685|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596686|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20596687|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20596688|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596689|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
20596690|NCT02183246|Porfiromycin|porfiromycin|mesh-list
20596691|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20596692|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596693|NCT02183272|Ketamine|ketamine|mesh-list
20596694|NCT02183272|Analgesics|analgesics|mesh-ancestor
20596695|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
20596696|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596697|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596698|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20596699|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20596700|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
20596701|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
20596702|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20596703|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20596704|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20596705|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596706|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596707|NCT02183298|Linagliptin|linagliptin|mesh-list
20596708|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596709|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596710|NCT02183298|Incretins|incretins|mesh-ancestor
20596711|NCT02183298|Hormones|hormones|mesh-ancestor
20596712|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596713|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596714|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596715|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596716|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596717|NCT02183311|Linagliptin|linagliptin|mesh-list
20596718|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596719|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596720|NCT02183311|Incretins|incretins|mesh-ancestor
20596721|NCT02183311|Hormones|hormones|mesh-ancestor
20596722|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596723|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596724|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596725|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596726|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596727|NCT02183324|Linagliptin|linagliptin|mesh-list
20596728|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596729|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596730|NCT02183324|Incretins|incretins|mesh-ancestor
20596731|NCT02183324|Hormones|hormones|mesh-ancestor
20596732|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596733|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596734|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596735|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596736|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596737|NCT02183337|Pioglitazone|pioglitazone|mesh-list
20596738|NCT02183337|Linagliptin|linagliptin|mesh-list
20596739|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596740|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596741|NCT02183337|Incretins|incretins|mesh-ancestor
20596742|NCT02183337|Hormones|hormones|mesh-ancestor
20596743|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596744|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596745|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596746|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083093|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083094|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083095|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20083096|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
20083097|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20083098|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
20596747|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596748|NCT02183350|Linagliptin|linagliptin|mesh-list
20596749|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596750|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083099|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20083100|NCT00000580|Antibodies|antibodies|mesh-list
20083101|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
20083102|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20596751|NCT02183350|Incretins|incretins|mesh-ancestor
20596752|NCT02183350|Hormones|hormones|mesh-ancestor
20596753|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596754|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596755|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596756|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596757|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596758|NCT02183363|Linagliptin|linagliptin|mesh-list
20596759|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596760|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596761|NCT02183363|Incretins|incretins|mesh-ancestor
20596762|NCT02183363|Hormones|hormones|mesh-ancestor
20596763|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596764|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596765|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596766|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083103|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
20083104|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083105|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
20083106|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20083107|NCT00000584|Antibodies|antibodies|mesh-list
20083108|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
20083109|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083110|NCT00000585|Penicillins|penicillins|mesh-list
20083111|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083112|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083113|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
20083114|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083115|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
20083116|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083117|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596767|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596768|NCT02183376|Linagliptin|linagliptin|mesh-list
20596769|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596770|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596771|NCT02183376|Incretins|incretins|mesh-ancestor
20596772|NCT02183376|Hormones|hormones|mesh-ancestor
20596773|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596774|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596775|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596776|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596777|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596778|NCT02183389|Linagliptin|linagliptin|mesh-list
20596779|NCT02183389|Warfarin|warfarin|mesh-list
20596780|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
20596781|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596782|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596783|NCT02183389|Incretins|incretins|mesh-ancestor
20596784|NCT02183389|Hormones|hormones|mesh-ancestor
20596785|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596786|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596787|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596788|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596789|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596790|NCT02183402|Linagliptin|linagliptin|mesh-list
20596791|NCT02183402|Digoxin|digoxin|mesh-list
20596792|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20596793|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20596794|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596795|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596796|NCT02183402|Protective Agents|protective agents|mesh-ancestor
20596797|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596798|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596799|NCT02183402|Incretins|incretins|mesh-ancestor
20596800|NCT02183402|Hormones|hormones|mesh-ancestor
20596801|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596802|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596803|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596804|NCT02183415|Linagliptin|linagliptin|mesh-list
20596805|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596806|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596807|NCT02183415|Incretins|incretins|mesh-ancestor
20596808|NCT02183415|Hormones|hormones|mesh-ancestor
20596809|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596810|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596811|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596812|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596813|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596814|NCT02183428|Glyburide|glyburide|mesh-list
20596815|NCT02183428|Linagliptin|linagliptin|mesh-list
20596816|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596817|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596818|NCT02183428|Incretins|incretins|mesh-ancestor
20596819|NCT02183428|Hormones|hormones|mesh-ancestor
20596820|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596821|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596822|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596823|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596824|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596825|NCT02183441|Linagliptin|linagliptin|mesh-list
20596826|NCT02183441|Ritonavir|ritonavir|mesh-list
20596827|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20596828|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20596829|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596830|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596831|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596832|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20596833|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083118|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20306078|NCT00653757|Goserelin|goserelin|mesh-list
20596834|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
20596835|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596836|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20596837|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20596838|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596839|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596840|NCT02183441|Incretins|incretins|mesh-ancestor
20596841|NCT02183441|Hormones|hormones|mesh-ancestor
20596842|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596843|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596844|NCT02183467|Linagliptin|linagliptin|mesh-list
20596845|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
20596846|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20596847|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596848|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20596849|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20596850|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596851|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596852|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20596853|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596854|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596855|NCT02183467|Incretins|incretins|mesh-ancestor
20596856|NCT02183467|Hormones|hormones|mesh-ancestor
20596857|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596858|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596859|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596860|NCT02183480|Linagliptin|linagliptin|mesh-list
20596861|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596862|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596863|NCT02183480|Incretins|incretins|mesh-ancestor
20596864|NCT02183480|Hormones|hormones|mesh-ancestor
20596865|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596866|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596867|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596868|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596869|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596870|NCT02183493|Linagliptin|linagliptin|mesh-list
20596871|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596872|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596873|NCT02183493|Incretins|incretins|mesh-ancestor
20596874|NCT02183493|Hormones|hormones|mesh-ancestor
20596875|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596876|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596877|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596878|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596879|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596880|NCT02183506|Metformin|metformin|mesh-list
20596881|NCT02183506|Linagliptin|linagliptin|mesh-list
20596882|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596883|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596884|NCT02183506|Incretins|incretins|mesh-ancestor
20596885|NCT02183506|Hormones|hormones|mesh-ancestor
20596886|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596887|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596888|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596889|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596890|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596891|NCT02183532|Linagliptin|linagliptin|mesh-list
20596892|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596893|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596894|NCT02183532|Incretins|incretins|mesh-ancestor
20596895|NCT02183532|Hormones|hormones|mesh-ancestor
20596896|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596897|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596898|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596899|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596900|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596901|NCT02183571|Metformin|metformin|mesh-list
20596902|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596903|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596904|NCT02183584|Linagliptin|linagliptin|mesh-list
20083119|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
20083120|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20083121|NCT00000590|Antibodies|antibodies|mesh-list
20083122|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
20083123|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083124|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
20083125|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20596905|NCT02183584|Rifampin|rifampin|mesh-list
20083126|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20083127|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
20083128|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083129|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20083130|NCT00000595|Deferoxamine|deferoxamine|mesh-list
20596906|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596907|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596908|NCT02183584|Incretins|incretins|mesh-ancestor
20596909|NCT02183584|Hormones|hormones|mesh-ancestor
20596910|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596911|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596912|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596913|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596914|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083131|NCT00000595|Siderophores|siderophores|mesh-ancestor
20083132|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20596915|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20596916|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
20596917|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20596918|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20596919|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
20596920|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20596921|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20596922|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20596923|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20596924|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20596925|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20596926|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20596927|NCT02183610|Linagliptin|linagliptin|mesh-list
20596928|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20596929|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596930|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596931|NCT02183610|Incretins|incretins|mesh-ancestor
20596932|NCT02183610|Hormones|hormones|mesh-ancestor
20596933|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596934|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596935|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596936|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596937|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596938|NCT02183623|Linagliptin|linagliptin|mesh-list
20596939|NCT02183623|Simvastatin|simvastatin|mesh-list
20596940|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20596941|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20596942|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
20596943|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596944|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20596945|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20596946|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596947|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596948|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596949|NCT02183623|Incretins|incretins|mesh-ancestor
20596950|NCT02183623|Hormones|hormones|mesh-ancestor
20083133|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
20083134|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
20083135|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083136|NCT00000596|Dapsone|dapsone|mesh-list
20083137|NCT00000596|Prednisone|prednisone|mesh-list
20083138|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
20083139|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20083140|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
20083141|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083142|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20083143|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20083144|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
20596951|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596952|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596953|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596954|NCT02183636|Pioglitazone|pioglitazone|mesh-list
20596955|NCT02183636|Linagliptin|linagliptin|mesh-list
20596956|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20596957|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596958|NCT02183636|Incretins|incretins|mesh-ancestor
20596959|NCT02183636|Hormones|hormones|mesh-ancestor
20596960|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20596961|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20596962|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
20596963|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596964|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596965|NCT02183649|Carbetapentane|carbetapentane|mesh-list
20596966|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
20596967|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
20596968|NCT02183688|Acetaminophen|acetaminophen|mesh-list
20596969|NCT02183688|Caffeine|caffeine|mesh-list
20596970|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20596971|NCT02183688|Analgesics|analgesics|mesh-ancestor
20596972|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
20596973|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20596974|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596975|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
20596976|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20596977|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20596978|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20596979|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596980|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20596981|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20596982|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
20596983|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20596984|NCT02183701|Losartan|losartan|mesh-list
20596985|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20596986|NCT02183701|Telmisartan|telmisartan|mesh-list
20596987|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20596988|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20596989|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20596990|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20596991|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20596992|NCT02183701|Diuretics|diuretics|mesh-ancestor
20596993|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
20596994|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20596995|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20596996|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20083145|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083146|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083147|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20083148|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083149|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
20083150|NCT00000596|Hormones|hormones|mesh-ancestor
20083151|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083152|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20083153|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083154|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
20083155|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083156|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20083157|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20083158|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083159|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
20083160|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083161|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
20083162|NCT00000597|Nandrolone|nandrolone|mesh-list
20083163|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
20083164|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20083165|NCT00000597|Androgens|androgens|mesh-ancestor
20083166|NCT00000597|Hormones|hormones|mesh-ancestor
20596997|NCT02183779|Fluconazole|fluconazole|mesh-list
20596998|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
20596999|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597000|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20597001|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20597002|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597003|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597004|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20597005|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
20597006|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597007|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597008|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20597009|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20597010|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
20597011|NCT02183805|Carboplatin|carboplatin|mesh-list
20597012|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20597013|NCT02183805|Paclitaxel|paclitaxel|mesh-list
20597014|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20083167|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083168|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083169|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
20083170|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20083171|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
19492185|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597015|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
19569630|NCT04593680|Emtricitabine|emtricitabine|mesh-list
20597016|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597017|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597018|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20597019|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
20597020|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597021|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597022|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20597023|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20597024|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
20597025|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
20597026|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
20597027|NCT02183870|Crizotinib|crizotinib|mesh-list
20597028|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597029|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20597030|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597031|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597032|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20597033|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597034|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597035|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
20597036|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597037|NCT02183948|Oxytocin|oxytocin|mesh-list
20597038|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
20597039|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20597040|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597041|NCT02184052|Meloxicam|meloxicam|mesh-list
20597042|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20597043|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597044|NCT02184052|Analgesics|analgesics|mesh-ancestor
20597045|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
20597046|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597047|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597048|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597049|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597050|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20597051|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20597052|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597053|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083172|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20083173|NCT00000599|Niacin|niacin|mesh-list
20083174|NCT00000599|Colestipol|colestipol|mesh-list
20083175|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20083176|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
20083177|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083178|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20083179|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
20083180|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
20083181|NCT00000599|Vitamins|vitamins|mesh-ancestor
20083182|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
20597054|NCT02184065|Meloxicam|meloxicam|mesh-list
20597055|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20597056|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597057|NCT02184065|Analgesics|analgesics|mesh-ancestor
20597058|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
20597059|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597060|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597061|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597062|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597063|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20597064|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20597065|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597066|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597067|NCT02184078|Nevirapine|nevirapine|mesh-list
20083183|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083184|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
20083185|NCT00000600|Vitamins|vitamins|mesh-list
20083186|NCT00000600|Ascorbic Acid|ascorbic acid|mesh-list
20083187|NCT00000600|Vitamin E|vitamin e|mesh-list
20083188|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
20083189|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083190|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
20083191|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083192|NCT00000600|Protective Agents|protective agents|mesh-ancestor
20083193|NCT00000601|Hormones|hormones|mesh-list
20083194|NCT00000601|Progesterone|progesterone|mesh-list
20083195|NCT00000601|Estrogens|estrogens|mesh-list
20083196|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083197|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083198|NCT00000601|Progestins|progestins|mesh-ancestor
20083199|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
20083200|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083201|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
20083202|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083203|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083204|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120091|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20120092|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120093|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120094|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120095|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120096|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20120097|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20120098|NCT00006270|Cosyntropin|cosyntropin|mesh-list
20120099|NCT00006270|Metyrapone|metyrapone|mesh-list
20120100|NCT00006270|Hormones|hormones|mesh-ancestor
20120101|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597068|NCT02184078|Rifabutin|rifabutin|mesh-list
20597069|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20597070|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597071|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597072|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597073|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
20597074|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597075|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597076|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597077|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20597078|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20597079|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597080|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20597081|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
20597082|NCT02184091|Nevirapine|nevirapine|mesh-list
20597083|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20597084|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597085|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597086|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597087|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
20597088|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597089|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597090|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597091|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20597092|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20597093|NCT02184104|Caffeine|caffeine|mesh-list
20597094|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20597095|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597096|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20597097|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597098|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597099|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20597100|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20597101|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
20597102|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597103|NCT02184117|Adenosine|adenosine|mesh-list
20597104|NCT02184117|Analgesics|analgesics|mesh-ancestor
20597105|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
20597106|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597107|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597108|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20597109|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
20597110|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20597111|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
20597112|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
20597113|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597114|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597115|NCT02184247|Theophylline|theophylline|mesh-list
19746671|NCT02359994|Hemostatics|hemostatics|mesh-list
20120102|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120103|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
19746672|NCT02359994|Coagulants|coagulants|mesh-ancestor
20597116|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20597117|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
20597118|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597119|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597120|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20597121|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
20597122|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20597123|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597124|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597125|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
20597126|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20597127|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20597128|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
20597129|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597130|NCT02184260|Dipyrone|dipyrone|mesh-list
20597131|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20083205|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20083206|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
20083207|NCT00000605|Hormones|hormones|mesh-list
20083208|NCT00000605|Estrogens|estrogens|mesh-list
20083209|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083210|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083211|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20083212|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20083213|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20597132|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597133|NCT02184260|Analgesics|analgesics|mesh-ancestor
20597134|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
20597135|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597136|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597137|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597138|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20083214|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
20083215|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20083216|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20083217|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20083218|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20083219|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20083220|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597139|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
20597140|NCT02184273|Dipyrone|dipyrone|mesh-list
20597141|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20597142|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597143|NCT02184273|Analgesics|analgesics|mesh-ancestor
20597144|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
20597145|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597146|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597147|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597148|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597149|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
20597150|NCT02184286|Nevirapine|nevirapine|mesh-list
20597151|NCT02184286|Saquinavir|saquinavir|mesh-list
20597152|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20597153|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597154|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597155|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597156|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
20597157|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597158|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597159|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597160|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20597161|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20597162|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20597163|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20597164|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
20597165|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20597166|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20597167|NCT02184299|Nevirapine|nevirapine|mesh-list
20597168|NCT02184299|Prednisone|prednisone|mesh-list
20597169|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083221|NCT00000609|Amiodarone|amiodarone|mesh-list
20083222|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20083223|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
20083224|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20083225|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20083226|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083227|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20083228|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20083229|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083230|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083231|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20083232|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20083233|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20083234|NCT00000611|Vitamin D|vitamin d|mesh-list
20083235|NCT00000611|Calcium|calcium|mesh-list
20597170|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
20597171|NCT02184299|Hormones|hormones|mesh-ancestor
20597172|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597173|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597174|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20597175|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597176|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20597177|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597178|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597179|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597180|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
20597181|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597182|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597183|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597184|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20597185|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20597186|NCT02184312|Nevirapine|nevirapine|mesh-list
20597187|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20597188|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597189|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597190|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597191|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
20597192|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597193|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597194|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597195|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20597196|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20597197|NCT02184351|Clotrimazole|clotrimazole|mesh-list
20597198|NCT02184351|Miconazole|miconazole|mesh-list
20597199|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20597200|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597201|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
20597202|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20597203|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20597204|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597205|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597206|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20597207|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
20597208|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597209|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597210|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20597211|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20597212|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20597213|NCT02184364|Estrogens|estrogens|mesh-ancestor
20597214|NCT02184364|Hormones|hormones|mesh-ancestor
20597215|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597216|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597217|NCT02184429|PF-06669571|pf-06669571|mesh-list
20597218|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
20597219|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
20597220|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597221|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597222|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597223|NCT02184533|Selenious Acid|selenious acid|mesh-list
20597224|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
20597225|NCT02184533|Trace Elements|trace elements|mesh-ancestor
20597226|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
20597227|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597228|NCT02184559|Ropivacaine|ropivacaine|mesh-list
20597229|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
20597230|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
20597231|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597232|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597233|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
20597234|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083236|NCT00000611|Hormones|hormones|mesh-list
20083237|NCT00000611|Estrogens|estrogens|mesh-list
20083238|NCT00000611|Progestins|progestins|mesh-list
20083239|NCT00000611|Vitamins|vitamins|mesh-ancestor
20083240|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
20083241|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083242|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20083243|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20083244|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083245|NCT00000612|Estrogens|estrogens|mesh-list
20083246|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20083247|NCT00000612|Hormones|hormones|mesh-ancestor
20083248|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083249|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597235|NCT02184637|Lumefantrine|lumefantrine|mesh-list
20597236|NCT02184637|Artemether|artemether|mesh-list
20083250|NCT00000613|Genistein|genistein|mesh-list
20597237|NCT02184637|Piperaquine|piperaquine|mesh-list
20597238|NCT02184637|Artenimol|artenimol|mesh-list
20597239|NCT02184637|Tafenoquine|tafenoquine|mesh-list
20597240|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20597241|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
20597242|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20597243|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20597244|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607381|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607382|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20607383|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607384|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
20607385|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20607386|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
20607387|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607388|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083251|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20083252|NCT00000613|Protective Agents|protective agents|mesh-ancestor
20083253|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083254|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607389|NCT02242292|Scopolamine|scopolamine|mesh-list
20607390|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20083255|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20083256|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083257|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083258|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
20083259|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20083260|NCT00000613|Estrogens|estrogens|mesh-ancestor
20083261|NCT00000613|Hormones|hormones|mesh-ancestor
20083262|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083263|NCT00000614|Warfarin|warfarin|mesh-list
20083264|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
20083265|NCT00000617|Azithromycin|azithromycin|mesh-list
20083266|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083267|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083268|NCT00000621|Tretinoin|tretinoin|mesh-list
20083269|NCT00000621|Isotretinoin|isotretinoin|mesh-list
20083270|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083271|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
20083272|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
20083273|NCT00000623|Decitabine|decitabine|mesh-list
20083274|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
20083275|NCT00000623|Deferiprone|deferiprone|mesh-list
20083276|NCT00000623|Deferoxamine|deferoxamine|mesh-list
20083277|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20083278|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
20083279|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083280|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083281|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083282|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
20083283|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20083284|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20083285|NCT00000623|Urological Agents|urological agents|mesh-ancestor
20083286|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20083287|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
20083288|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
20083289|NCT00000623|Siderophores|siderophores|mesh-ancestor
20083290|NCT00000625|Zidovudine|zidovudine|mesh-list
20083291|NCT00000625|Didanosine|didanosine|mesh-list
20083292|NCT00000625|Zalcitabine|zalcitabine|mesh-list
20083293|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
20083294|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083295|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083296|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083297|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083298|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
20083299|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083300|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083301|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083302|NCT00000626|Doxorubicin|doxorubicin|mesh-list
20083303|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20083304|NCT00000626|Bleomycin|bleomycin|mesh-list
20083305|NCT00000626|Dacarbazine|dacarbazine|mesh-list
20083306|NCT00000626|Vinblastine|vinblastine|mesh-list
20083307|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20607391|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20083308|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083309|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20083310|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20597245|NCT02184819|Riboflavin|riboflavin|mesh-list
20597246|NCT02184819|Simendan|simendan|mesh-list
20597247|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
20597248|NCT02184819|Vitamins|vitamins|mesh-ancestor
20597249|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
20597250|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597251|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20597252|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
20597253|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20597254|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
20597255|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20597256|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20597257|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597258|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597259|NCT02184819|Protective Agents|protective agents|mesh-ancestor
20597260|NCT02184832|Metformin|metformin|mesh-list
20597261|NCT02184832|Tryptophan|tryptophan|mesh-list
20597262|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20597263|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597264|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20597265|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
20597266|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20597267|NCT02184858|Lisinopril|lisinopril|mesh-list
20597268|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20597269|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
20597270|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597271|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597272|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20597273|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20597274|NCT02184858|Protective Agents|protective agents|mesh-ancestor
20597275|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597276|NCT02184897|Lenograstim|lenograstim|mesh-list
20597277|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20597278|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
20597279|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597280|NCT02184910|Gastrins|gastrins|mesh-list
20597281|NCT02184910|Hormones|hormones|mesh-ancestor
20597282|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597283|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597284|NCT02184975|Hemostatics|hemostatics|mesh-list
20597285|NCT02184975|Coagulants|coagulants|mesh-ancestor
20597286|NCT02185066|Metformin|metformin|mesh-list
20597287|NCT02185066|Atorvastatin|atorvastatin|mesh-list
20597288|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20597289|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597290|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20597291|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20083311|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083312|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083313|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20083314|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
20083315|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20083316|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
20083317|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
20083318|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
20083319|NCT00000627|Fluconazole|fluconazole|mesh-list
20083320|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
20083321|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083322|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20083323|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083324|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083325|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083326|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20083327|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
20083328|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083329|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083330|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20083331|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20597292|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
20597293|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597294|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20597295|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20597296|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569631|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
20597297|NCT02185118|Sevoflurane|sevoflurane|mesh-list
20597298|NCT02185118|Isoflurane|isoflurane|mesh-list
20597299|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20597300|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20597301|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
20597302|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
20597303|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597304|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597305|NCT02185196|Vitamin D|vitamin d|mesh-list
20597306|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
20597307|NCT02185196|Vitamins|vitamins|mesh-ancestor
20597308|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
20597309|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597310|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20083332|NCT00000628|Zidovudine|zidovudine|mesh-list
20597311|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597312|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
20597313|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597314|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597315|NCT02185222|Vitamins|vitamins|mesh-ancestor
20597316|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
20597317|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20597318|NCT02185261|Interferons|interferons|mesh-list
20597319|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
20597320|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
20597321|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597322|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
20597323|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597324|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
20597325|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597326|NCT02185300|Dolutegravir|dolutegravir|mesh-list
20597327|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20597328|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20597329|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597330|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597331|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597332|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597333|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
20597334|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597335|NCT02185326|Hormones|hormones|mesh-list
20597336|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597337|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597338|NCT02185352|Cisplatin|cisplatin|mesh-list
20597339|NCT02185352|Etoposide|etoposide|mesh-list
20597340|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597341|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20597342|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20597343|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20597344|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597345|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083333|NCT00000628|L-697661|l-697661|mesh-list
20597346|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
20597347|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20597348|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597349|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597350|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597351|NCT02185430|Analgesics|analgesics|mesh-ancestor
20597352|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
20597353|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597354|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20597355|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20597356|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20597357|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
20597358|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597359|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597360|NCT02185456|Metronidazole|metronidazole|mesh-list
20597361|NCT02185456|Miconazole|miconazole|mesh-list
20597362|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597363|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597364|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083334|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
20083335|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083336|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083337|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597365|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20597366|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
20597367|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20597368|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20597369|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597370|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597371|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20597372|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
20597373|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597374|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597375|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20597376|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20597377|NCT02185547|Sertraline|sertraline|mesh-list
20597378|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
20597379|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20597380|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20597381|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20597382|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597383|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597384|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20083338|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083339|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
20083340|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083341|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083342|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083343|NCT00000629|Zidovudine|zidovudine|mesh-list
20083344|NCT00000629|Valproic Acid|valproic acid|mesh-list
20083345|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
20083346|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083347|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083348|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083349|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083350|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
20083351|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083352|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083353|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083354|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
20083355|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
20083356|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20083357|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083358|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
20083359|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20083360|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20083361|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20083362|NCT00000633|Vaccines|vaccines|mesh-list
20083363|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
20083364|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083365|NCT00000634|Nevirapine|nevirapine|mesh-list
20083366|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083367|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083368|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597385|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
20597386|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597387|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
20597388|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20597389|NCT02185651|Miglustat|miglustat|mesh-list
20597390|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597391|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597392|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597393|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597394|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
20597395|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597396|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20597397|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20597398|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083369|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083370|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
20083371|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083372|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083373|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083374|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20083375|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20083376|NCT00000635|Trifluridine|trifluridine|mesh-list
20083377|NCT00000635|Polymyxins|polymyxins|mesh-list
20083378|NCT00000635|Bacitracin|bacitracin|mesh-list
20083379|NCT00000635|Polymyxin B|polymyxin b|mesh-list
20083380|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
20083381|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083382|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
20083383|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083384|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597399|NCT02185690|Carboplatin|carboplatin|mesh-list
20597400|NCT02185690|Pemetrexed|pemetrexed|mesh-list
20597401|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597402|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597403|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597404|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20597405|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597406|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
20597407|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
20083385|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20083386|NCT00000636|Pyridoxine|pyridoxine|mesh-list
20083387|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
20083388|NCT00000636|Rifampin|rifampin|mesh-list
20083389|NCT00000636|Isoniazid|isoniazid|mesh-list
20083390|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
20083391|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20083392|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
20083393|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083394|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083395|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
20083396|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083397|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083398|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083399|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20083400|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20083401|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20083402|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20083403|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20083404|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20083405|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20083406|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20083407|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
20083408|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20083409|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
20083410|NCT00000636|Vitamins|vitamins|mesh-ancestor
20083411|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
20083412|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083413|NCT00000637|Zidovudine|zidovudine|mesh-list
20083414|NCT00000637|Didanosine|didanosine|mesh-list
20597408|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
20597409|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597410|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597411|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
20597412|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083415|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
20083416|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083417|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083418|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083419|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083420|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
20597413|NCT02185768|Idarubicin|idarubicin|mesh-list
20597414|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20597415|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597416|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20597417|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20597418|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597419|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597420|NCT02185833|Dirithromycin|dirithromycin|mesh-list
20597421|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597422|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597423|NCT02185846|Dirithromycin|dirithromycin|mesh-list
20597424|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597425|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597426|NCT02185859|Lidocaine|lidocaine|mesh-list
20597427|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
20597428|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
20597429|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
20597430|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597431|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597432|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
20597433|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597434|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20597435|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20597436|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20597437|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597438|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597439|NCT02185859|Analgesics|analgesics|mesh-ancestor
20597440|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
20597441|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20597442|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597443|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
20597444|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20597445|NCT02185898|Menthol|menthol|mesh-list
20597446|NCT02185898|Nicotine|nicotine|mesh-list
20597447|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20597448|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
20597449|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597450|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597451|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20597452|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20597453|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
20597454|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597455|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597456|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
20597457|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
20597458|NCT02185924|Parecoxib|parecoxib|mesh-list
20597459|NCT02185924|Ropivacaine|ropivacaine|mesh-list
20597460|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
20597461|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
20597462|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597463|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597464|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
20597465|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597466|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20597467|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20597468|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597469|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597470|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20597471|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597472|NCT02185924|Analgesics|analgesics|mesh-ancestor
20597473|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597474|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597475|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20597476|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20597477|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20597478|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
20597479|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597480|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20597481|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20597482|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597483|NCT02186028|Vitamin D|vitamin d|mesh-list
20597484|NCT02186028|Vitamins|vitamins|mesh-ancestor
20597485|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
20597486|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597487|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20597488|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
20597489|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597490|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597491|NCT02186106|Vitamins|vitamins|mesh-ancestor
20597492|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
20597493|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20597494|NCT02186119|Ranibizumab|ranibizumab|mesh-list
20597495|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20597496|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20597497|NCT02186119|Growth Substances|growth substances|mesh-ancestor
20597498|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597499|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
20597500|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597501|NCT02186132|Atropine|atropine|mesh-list
20597502|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20597503|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20597504|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20597505|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
20597506|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597507|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597508|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20597509|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
20597510|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
20597511|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
20597512|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20597513|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20597514|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
20597515|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597516|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597517|NCT02186145|Metronidazole|metronidazole|mesh-list
20597518|NCT02186145|Nystatin|nystatin|mesh-list
20597519|NCT02186145|Dexamethasone|dexamethasone|mesh-list
20597520|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597521|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
20597522|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
20597523|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597524|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597525|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20597526|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
20597527|NCT02186145|Hormones|hormones|mesh-ancestor
20597528|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597529|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20597530|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597531|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597532|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597533|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20597534|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20597535|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
20597536|NCT02186145|Ionophores|ionophores|mesh-ancestor
20597537|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597538|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597539|NCT02186158|Ascorbic Acid|ascorbic acid|mesh-list
20597540|NCT02186158|Vitamins|vitamins|mesh-ancestor
20597541|NCT02186158|Micronutrients|micronutrients|mesh-ancestor
20597542|NCT02186158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597543|NCT02186158|Antioxidants|antioxidants|mesh-ancestor
20597544|NCT02186158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597545|NCT02186158|Protective Agents|protective agents|mesh-ancestor
20597546|NCT02186249|Nivolumab|nivolumab|mesh-list
20597547|NCT02186249|Ipilimumab|ipilimumab|mesh-list
20597548|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20597549|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597550|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20597551|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597552|NCT02186275|Vitamin D|vitamin d|mesh-list
20597553|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
20597554|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
20597555|NCT02186275|Vitamins|vitamins|mesh-list
20597556|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
20597557|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597558|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20597559|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597560|NCT02186366|Buspirone|buspirone|mesh-list
20597561|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20597562|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20597563|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597564|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597565|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20597566|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20597567|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
20597568|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597569|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607392|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
20607393|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
20607394|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607395|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607396|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607397|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
20607398|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20607399|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
20607400|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607401|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607402|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20607403|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
20607404|NCT02242318|Valsartan|valsartan|mesh-list
20607405|NCT02242318|Telmisartan|telmisartan|mesh-list
20607406|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607407|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607408|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607409|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607410|NCT02242331|Telmisartan|telmisartan|mesh-list
20607411|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607412|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607413|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607414|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607415|NCT02242344|Telmisartan|telmisartan|mesh-list
20607416|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607417|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607418|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607419|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607420|NCT02242357|Telmisartan|telmisartan|mesh-list
20607421|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607422|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607423|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607424|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607425|NCT02242370|Telmisartan|telmisartan|mesh-list
20607426|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607427|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607428|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607429|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607430|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20607431|NCT02242383|Telmisartan|telmisartan|mesh-list
20607432|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607433|NCT02242383|Diuretics|diuretics|mesh-ancestor
20607434|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
20607435|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607436|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20607437|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607438|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607439|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607440|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607441|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20607442|NCT02242396|Telmisartan|telmisartan|mesh-list
20607443|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20607444|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607445|NCT02242396|Diuretics|diuretics|mesh-ancestor
20607446|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
20607447|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607448|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20607449|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607450|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607451|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597570|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20597571|NCT02186457|Polymyxins|polymyxins|mesh-list
20597572|NCT02186457|Polymyxin B|polymyxin b|mesh-list
20597573|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597574|NCT02186483|Metformin|metformin|mesh-list
20597575|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20597576|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20597577|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597578|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20597579|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20597580|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
20597581|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597582|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20597583|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20597584|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597585|NCT02186496|Amlodipine|amlodipine|mesh-list
20597586|NCT02186496|Candesartan|candesartan|mesh-list
20597587|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20597588|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20597589|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597590|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597591|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597592|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597593|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
20597594|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597595|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20597596|NCT02186535|Vitamin D|vitamin d|mesh-list
20597597|NCT02186535|Calcium|calcium|mesh-list
20597598|NCT02186535|Vitamins|vitamins|mesh-ancestor
20597599|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
20597600|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597601|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597602|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20597603|NCT02186574|Tenofovir|tenofovir|mesh-list
20597604|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
20597605|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597606|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20597607|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20597608|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597609|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597610|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597611|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597612|NCT02186600|Vitamin D|vitamin d|mesh-list
20597613|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
20597614|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
20597615|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
20597616|NCT02186600|Calcium|calcium|mesh-list
20597617|NCT02186600|Vitamins|vitamins|mesh-ancestor
20597618|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
20597619|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597620|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20597621|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20597622|NCT02186600|Antacids|antacids|mesh-ancestor
20597623|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597624|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20597625|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20597626|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597627|NCT02186769|Risperidone|risperidone|mesh-list
20597628|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20597629|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
20597630|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597631|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597632|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597633|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20597634|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20597635|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597636|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20597637|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20597638|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
20597639|NCT02186782|Citric Acid|citric acid|mesh-list
20597640|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
20597641|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20597642|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20597643|NCT02186782|Clomiphene|clomiphene|mesh-list
20597644|NCT02186782|Enclomiphene|enclomiphene|mesh-list
20597645|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
20597646|NCT02186782|Estradiol|estradiol|mesh-list
20597647|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20083421|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083422|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083423|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083424|NCT00000638|Pyridoxine|pyridoxine|mesh-list
20083425|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
20083426|NCT00000638|Rifampin|rifampin|mesh-list
20083427|NCT00000638|Isoniazid|isoniazid|mesh-list
20083428|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
20083429|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20597648|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
20597649|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20597650|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
20597651|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
20597652|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597653|NCT02186782|Estrogens|estrogens|mesh-ancestor
20597654|NCT02186782|Hormones|hormones|mesh-ancestor
20597655|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597656|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597657|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20597658|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
20597659|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20597660|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20597661|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20597662|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
20597663|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20597664|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
20597665|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20597666|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20597667|NCT02186886|Golimumab|golimumab|mesh-list
20597668|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20597669|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597670|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20597671|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
20597672|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597673|NCT02186899|Anesthetics|anesthetics|mesh-list
20083430|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
20083431|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083432|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083433|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
20083434|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083435|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083436|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083437|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20083438|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20083439|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20083440|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20597674|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597675|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597676|NCT02186951|Amoxicillin|amoxicillin|mesh-list
20597677|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
20597678|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
20597679|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597680|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597681|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597682|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597683|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20597684|NCT02186990|Propofol|propofol|mesh-list
20597685|NCT02186990|Etomidate|etomidate|mesh-list
20597686|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20597687|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597688|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597689|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20597690|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
20597691|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
20597692|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
20597693|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20597694|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597695|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597696|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597697|NCT02187068|Analgesics|analgesics|mesh-ancestor
20083441|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20083442|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20083443|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20083444|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20083445|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
20083446|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20083447|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
20083448|NCT00000638|Vitamins|vitamins|mesh-ancestor
20083449|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
20083450|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492186|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492187|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19492188|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
19492189|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19746673|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20083451|NCT00000639|Itraconazole|itraconazole|mesh-list
20083452|NCT00000639|Fluconazole|fluconazole|mesh-list
20083453|NCT00000639|Amphotericin B|amphotericin b|mesh-list
20597698|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
20597699|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597700|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20597701|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20597702|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20597703|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
20597704|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597705|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597706|NCT02187081|Sorafenib|sorafenib|mesh-list
20597707|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597708|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20597709|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597710|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597711|NCT02187107|Darunavir|darunavir|mesh-list
20597712|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20597713|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20597714|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
20597715|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597716|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597717|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20597718|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20597719|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
20597720|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597721|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
20597722|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20597723|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20597724|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597725|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
20597726|NCT02187120|Coagulants|coagulants|mesh-ancestor
20597727|NCT02187133|Rituximab|rituximab|mesh-list
20597728|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20597729|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20597730|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597731|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
20597732|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597733|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597734|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20597735|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
20597736|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597737|NCT02187211|Minocycline|minocycline|mesh-list
20597738|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597739|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597740|NCT02187250|Metformin|metformin|mesh-list
20597741|NCT02187250|Liraglutide|liraglutide|mesh-list
20597742|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20597743|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597744|NCT02187250|Incretins|incretins|mesh-ancestor
20597745|NCT02187250|Hormones|hormones|mesh-ancestor
20597746|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597747|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
20597748|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597749|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597750|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
20597751|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597752|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597753|NCT02187315|Cisplatin|cisplatin|mesh-list
20597754|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597755|NCT02187354|Blinatumomab|blinatumomab|mesh-list
20083454|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20083455|NCT00000639|Flucytosine|flucytosine|mesh-list
20083456|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
20083457|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083458|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20083459|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083460|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083461|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083462|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20083463|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
20083464|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083465|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083466|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20083467|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20083468|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20597756|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597757|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
20597758|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20597759|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
20597760|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597761|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597762|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20597763|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
20597764|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597765|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597766|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20597767|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20597768|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597769|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597770|NCT02187445|Budesonide|budesonide|mesh-list
20597771|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597772|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20083469|NCT00000639|Amebicides|amebicides|mesh-ancestor
20083470|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083471|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20083472|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083473|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
20083474|NCT00000640|Clindamycin|clindamycin|mesh-list
20083475|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
20083476|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
20083477|NCT00000640|Dapsone|dapsone|mesh-list
20597773|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
20597774|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597775|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597776|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20597777|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
20597778|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
20597779|NCT02187445|Hormones|hormones|mesh-ancestor
20597780|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597781|NCT02187484|Telmisartan|telmisartan|mesh-list
20597782|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20597783|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597784|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20597785|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597786|NCT02187497|Telmisartan|telmisartan|mesh-list
20597787|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20597788|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597789|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20597790|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597791|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20597792|NCT02187523|Telmisartan|telmisartan|mesh-list
20597793|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20597794|NCT02187523|Diuretics|diuretics|mesh-ancestor
20597795|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
20597796|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597797|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20597798|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597799|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597800|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597801|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20597802|NCT02187536|Telmisartan|telmisartan|mesh-list
20597803|NCT02187536|Simvastatin|simvastatin|mesh-list
20597804|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20597805|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20597806|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
20597807|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597808|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20597809|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20597810|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597811|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20597812|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597813|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20597814|NCT02187562|Aspirin|aspirin|mesh-list
20597815|NCT02187562|Meloxicam|meloxicam|mesh-list
20597816|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20597817|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597818|NCT02187562|Analgesics|analgesics|mesh-ancestor
20083478|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20083479|NCT00000640|Primaquine|primaquine|mesh-list
20083480|NCT00000640|Trimethoprim|trimethoprim|mesh-list
20597819|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
20597820|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597821|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597822|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597823|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597824|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20597825|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20597826|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597827|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20597828|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20597829|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597830|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
20597831|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20597832|NCT02187588|Ibuprofen|ibuprofen|mesh-list
20597833|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20597834|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597835|NCT02187588|Analgesics|analgesics|mesh-ancestor
20597836|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
20597837|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597838|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597839|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597840|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597841|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20597842|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597843|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597844|NCT02187614|Acetaminophen|acetaminophen|mesh-list
20597845|NCT02187614|Diclofenac|diclofenac|mesh-list
20597846|NCT02187614|Morphine|morphine|mesh-list
20597847|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20597848|NCT02187614|Narcotics|narcotics|mesh-ancestor
20597849|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20083481|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
20083482|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083483|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083484|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20083485|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083486|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597850|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597851|NCT02187614|Analgesics|analgesics|mesh-ancestor
20597852|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
20597853|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597854|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20597855|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
20597856|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20597857|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597858|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597859|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20597860|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597861|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597862|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20597863|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20597864|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20597865|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597866|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597867|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
20597868|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597869|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597870|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20597871|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597872|NCT02187705|Telmisartan|telmisartan|mesh-list
20597873|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20597874|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597875|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20597876|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597877|NCT02187718|Anesthetics|anesthetics|mesh-list
20597878|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20597879|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597880|NCT02187822|Taxane|taxane|mesh-list
20597881|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597882|NCT02187874|Oxytocin|oxytocin|mesh-list
20597883|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
20597884|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20597885|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597886|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
20597887|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
20597888|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20597889|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597890|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20597891|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
20597892|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597893|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597894|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597895|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597896|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20597897|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20597898|NCT02187900|Protective Agents|protective agents|mesh-ancestor
20083487|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
20083488|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083489|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20083490|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20083491|NCT00000640|Renal Agents|renal agents|mesh-ancestor
20083492|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20083493|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20083494|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19746674|NCT02359097|Hematinics|hematinics|mesh-ancestor
20083495|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083496|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
20083497|NCT00000641|Azithromycin|azithromycin|mesh-list
20083498|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
20083499|NCT00000641|Rifampin|rifampin|mesh-list
20083500|NCT00000641|Amikacin|amikacin|mesh-list
20083501|NCT00000641|Ethambutol|ethambutol|mesh-list
20083502|NCT00000641|Clofazimine|clofazimine|mesh-list
20083503|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083504|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083505|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20083506|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20083507|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083508|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083509|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083510|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20083511|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083512|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20083513|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
20083514|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
20083515|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083516|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20083517|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20083518|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20597899|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597900|NCT02188121|Losartan|losartan|mesh-list
20597901|NCT02188121|Simvastatin|simvastatin|mesh-list
20597902|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20597903|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20597904|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
20597905|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597906|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20597907|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20597908|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597909|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20597910|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19492190|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19492191|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19492192|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19492193|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20083519|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20083520|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20083521|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20083522|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083523|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
19492194|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
19492195|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19492196|NCT03124524|Diuretics|diuretics|mesh-ancestor
19492197|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
19492198|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19492199|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19492200|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492201|NCT03124420|Amoxicillin|amoxicillin|mesh-list
19492202|NCT03124420|Clarithromycin|clarithromycin|mesh-list
19492203|NCT03124420|Lansoprazole|lansoprazole|mesh-list
19492204|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
19492205|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19492206|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492207|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19492208|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492209|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492210|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19492211|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19492212|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19492213|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19492214|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19492215|NCT03124082|Lidocaine|lidocaine|mesh-list
19492216|NCT03124082|Clonidine|clonidine|mesh-list
19492217|NCT03124082|Ketamine|ketamine|mesh-list
19492218|NCT03124082|Remifentanil|remifentanil|mesh-list
19492219|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
19492220|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
19492221|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492222|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492223|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
19492224|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492225|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19492226|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19492227|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19492228|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19492229|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492230|NCT03124082|Analgesics|analgesics|mesh-ancestor
19492231|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20083524|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
20083525|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083526|NCT00000643|Leucovorin|leucovorin|mesh-list
20083527|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
20083528|NCT00000643|Calcium|calcium|mesh-list
20083529|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
20083530|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20083531|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083532|NCT00000643|Antidotes|antidotes|mesh-ancestor
20083533|NCT00000643|Protective Agents|protective agents|mesh-ancestor
20083534|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
20083535|NCT00000643|Vitamins|vitamins|mesh-ancestor
20597911|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20597912|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20597913|NCT02188173|Dexamethasone|dexamethasone|mesh-list
20597914|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597915|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
20597916|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
20597917|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597918|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597919|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20597920|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
20597921|NCT02188173|Hormones|hormones|mesh-ancestor
20597922|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597923|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20597924|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597925|NCT02188186|Metformin|metformin|mesh-list
20597926|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20597927|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20597928|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597929|NCT02188186|Incretins|incretins|mesh-ancestor
20597930|NCT02188186|Hormones|hormones|mesh-ancestor
20597931|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597932|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20597933|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
20597934|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597935|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597936|NCT02188225|Fluoxetine|fluoxetine|mesh-list
20597937|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20597938|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20597939|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597940|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597941|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597942|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
20597943|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597944|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20597945|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
20597946|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20597947|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20597948|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20597949|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597950|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
20597951|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20597952|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20597953|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20597954|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20597955|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20597956|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597957|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
20597958|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20597959|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597960|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20597961|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597962|NCT02188368|Clarithromycin|clarithromycin|mesh-list
20597963|NCT02188368|Dexamethasone|dexamethasone|mesh-list
20597964|NCT02188368|Prednisone|prednisone|mesh-list
20597965|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
20597966|NCT02188368|Bortezomib|bortezomib|mesh-list
20597967|NCT02188368|Pomalidomide|pomalidomide|mesh-list
20597968|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20597969|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
20597970|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20597971|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20597972|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20597973|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
20597974|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20597975|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20597976|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20597977|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20597978|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
20597979|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
20597980|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20597981|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20597982|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
20597983|NCT02188368|Hormones|hormones|mesh-ancestor
20597984|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20597985|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20597986|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20597987|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20597988|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20597989|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20597990|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20597991|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20597992|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20597993|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20597994|NCT02188368|Growth Substances|growth substances|mesh-ancestor
20597995|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
20597996|NCT02188394|Bupivacaine|bupivacaine|mesh-list
20597997|NCT02188394|Anesthetics|anesthetics|mesh-list
20597998|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
20597999|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598000|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598001|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
20598002|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598003|NCT02188407|Propofol|propofol|mesh-list
20598004|NCT02188407|Sevoflurane|sevoflurane|mesh-list
20598005|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20598006|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598007|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598008|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20598009|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
20598010|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
20598011|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20598012|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20598013|NCT02188472|Trimethoprim|trimethoprim|mesh-list
20598014|NCT02188472|Penicillins|penicillins|mesh-list
20083536|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
20083537|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
20083538|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083539|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20083540|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083541|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20083542|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083543|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083544|NCT00000644|Clarithromycin|clarithromycin|mesh-list
20083545|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083546|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083547|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20083548|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083549|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598015|NCT02188472|Penicillin V|penicillin v|mesh-list
20598016|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20598017|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598018|NCT02188472|Renal Agents|renal agents|mesh-ancestor
20598019|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
20598020|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20598021|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20598022|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20598023|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598024|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598025|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20598026|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20598027|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20598028|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20598029|NCT02188511|Nicotine|nicotine|mesh-list
20598030|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20598031|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
20598032|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598033|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598034|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20598035|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20598036|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
20598037|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598038|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598039|NCT02188537|Nelfinavir|nelfinavir|mesh-list
20598040|NCT02188537|Dexamethasone|dexamethasone|mesh-list
20598041|NCT02188537|Bortezomib|bortezomib|mesh-list
20598042|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598043|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
20598044|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
20598045|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083550|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20598046|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598047|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598048|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
20598049|NCT02188537|Hormones|hormones|mesh-ancestor
20598050|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598051|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598052|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598053|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20598054|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20598055|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
20598056|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598057|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598058|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598059|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598060|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
20598061|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598062|NCT02188550|Everolimus|everolimus|mesh-list
20598063|NCT02188550|Letrozole|letrozole|mesh-list
20598064|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598065|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20598066|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
20598067|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598068|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20598069|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20598070|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598071|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598072|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20598073|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
20598074|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598075|NCT02188615|Vinorelbine|vinorelbine|mesh-list
20598076|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083551|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083552|NCT00000645|Hypericin|hypericin|mesh-list
20083553|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
20598077|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20598078|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
20598079|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
20598080|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
20598081|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598082|NCT02188654|Metformin|metformin|mesh-list
20598083|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20598084|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598085|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
20598086|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20598087|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
20598088|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598089|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
20598090|NCT02188771|Protective Agents|protective agents|mesh-ancestor
20598091|NCT02188810|Vaccines|vaccines|mesh-list
20598092|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
20598093|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598094|NCT02188888|Esmolol|esmolol|mesh-list
20598095|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20598096|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20598097|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20598098|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
20598099|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598100|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598101|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598102|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
20598103|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
20598104|NCT02188953|Calcium|calcium|mesh-list
20598105|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20598106|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598107|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20598108|NCT02188953|Antacids|antacids|mesh-ancestor
20598109|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598110|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598111|NCT02189304|Budesonide|budesonide|mesh-list
20598112|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
20083554|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20598113|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
20598114|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20083555|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083556|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
20083557|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083558|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083559|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083560|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20083561|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
20083562|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083563|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
20083564|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20083565|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083566|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083567|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20083568|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20083569|NCT00000646|Protective Agents|protective agents|mesh-ancestor
20083570|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083571|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
20083572|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20083573|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
20083574|NCT00000647|Interferons|interferons|mesh-list
20598115|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598116|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20598117|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
20598118|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306079|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20306080|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
20598119|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598120|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20598121|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598122|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
20598123|NCT02189304|Hormones|hormones|mesh-ancestor
20598124|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598125|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20598126|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20598127|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20598128|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
20598129|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598130|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598131|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20598132|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20598133|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20598134|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
20598135|NCT02189343|Thalidomide|thalidomide|mesh-list
20598136|NCT02189343|Dexamethasone|dexamethasone|mesh-list
20598137|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
20598138|NCT02189343|Pomalidomide|pomalidomide|mesh-list
20598139|NCT02189343|Ricolinostat|ricolinostat|mesh-list
20598140|NCT02189343|BB 1101|bb 1101|mesh-list
20598141|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598142|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
20083575|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
20083576|NCT00000647|Zidovudine|zidovudine|mesh-list
20083577|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
20083578|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083579|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
20083580|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306081|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20598143|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
20598144|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598145|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598146|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598147|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
20598148|NCT02189343|Hormones|hormones|mesh-ancestor
20598149|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598150|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598151|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598152|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
20598153|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598154|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598155|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
20598156|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20598157|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20598158|NCT02189343|Growth Substances|growth substances|mesh-ancestor
20598159|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
20598160|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20598161|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
20598162|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083581|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
20598163|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598164|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20598165|NCT02189395|Insulin|insulin|mesh-list
20598166|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
20598167|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20598168|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20598169|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598170|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
20598171|NCT02189577|Bromides|bromides|mesh-list
20598172|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
20598173|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20598174|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20598175|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20598176|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
20598177|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598178|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598179|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598180|NCT02189655|Bupivacaine|bupivacaine|mesh-list
20598181|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
20598182|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
20598183|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598184|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598185|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
20598186|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598187|NCT02189681|Anesthetics|anesthetics|mesh-list
20598188|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598189|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607452|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607453|NCT02242409|Gemcitabine|gemcitabine|mesh-list
20607454|NCT02242409|Paclitaxel|paclitaxel|mesh-list
20607455|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20607456|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20607457|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607458|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
20607459|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
20607460|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
20607461|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607462|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20607463|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
20607464|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
20607465|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607466|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607467|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607468|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
20607469|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607470|NCT02242474|Adalimumab|adalimumab|mesh-list
20607471|NCT02242474|Etanercept|etanercept|mesh-list
20607472|NCT02242474|Golimumab|golimumab|mesh-list
20607473|NCT02242474|Infliximab|infliximab|mesh-list
20607474|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
20607475|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20607476|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20607477|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607478|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
20607479|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607480|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20598190|NCT02189694|Hormones|hormones|mesh-list
20598191|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598192|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598193|NCT02189720|Amifampridine|amifampridine|mesh-list
20598194|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20598195|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598196|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598197|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20598198|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598199|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598200|NCT02189772|Metadoxine|metadoxine|mesh-list
20598201|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20598202|NCT02190149|Factor VIII|factor viii|mesh-list
20598203|NCT02190149|Coagulants|coagulants|mesh-ancestor
20598204|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
20598205|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
20598206|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598207|NCT02190318|Losartan|losartan|mesh-list
20598208|NCT02190318|Spironolactone|spironolactone|mesh-list
20598209|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20598210|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20598211|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20598212|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20598213|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598214|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20598215|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
20598216|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598217|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598218|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20598219|NCT02190318|Diuretics|diuretics|mesh-ancestor
20598220|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
20598221|NCT02190357|Rifaximin|rifaximin|mesh-list
20598222|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20598223|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598224|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598225|NCT02190526|Mesalamine|mesalamine|mesh-list
20598226|NCT02190526|Amitriptyline|amitriptyline|mesh-list
20598227|NCT02190526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20598228|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20598229|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20598230|NCT02190526|Analgesics|analgesics|mesh-ancestor
20598231|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
20598232|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598233|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598234|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598235|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20598236|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20598237|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
20598238|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20598239|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20598240|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20598241|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598242|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598243|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
20598244|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598245|NCT02190526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20598246|NCT02190526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20598247|NCT02190526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598248|NCT02190695|Carboplatin|carboplatin|mesh-list
20598249|NCT02190695|Decitabine|decitabine|mesh-list
20598250|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
20598251|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598252|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20598253|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
20598254|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598255|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598256|NCT02190708|Midazolam|midazolam|mesh-list
20598257|NCT02190708|Omeprazole|omeprazole|mesh-list
20598258|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20598259|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20598260|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20598261|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598262|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598263|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20598264|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20598265|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20598266|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20598267|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
20598268|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
20598269|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
20598270|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
20598271|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598272|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598273|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20598274|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598275|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598276|NCT02190760|Dexamethasone|dexamethasone|mesh-list
20598277|NCT02190760|Bupivacaine|bupivacaine|mesh-list
20598278|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598279|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
20598280|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
20598281|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598282|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598283|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598284|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
20598285|NCT02190760|Hormones|hormones|mesh-ancestor
20598286|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598287|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598288|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598289|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
20598290|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
20598291|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598292|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
20598293|NCT02190838|Metformin|metformin|mesh-list
20598294|NCT02190838|Dacarbazine|dacarbazine|mesh-list
20598295|NCT02190838|Melatonin|melatonin|mesh-list
20598296|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20598297|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598298|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
20598299|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598300|NCT02190838|Protective Agents|protective agents|mesh-ancestor
20598301|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598302|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20598303|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
20598304|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598305|NCT02190994|Prednisone|prednisone|mesh-list
20598306|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
20598307|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598308|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
20598309|NCT02190994|Hormones|hormones|mesh-ancestor
20598310|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598311|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598312|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598313|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598314|NCT02191007|Calcitriol|calcitriol|mesh-list
20598315|NCT02191007|Betamethasone|betamethasone|mesh-list
20598316|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
20598317|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20598318|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
20598319|NCT02191007|Calcipotriene|calcipotriene|mesh-list
20598320|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20598321|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598322|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
20598323|NCT02191007|Hormones|hormones|mesh-ancestor
20598324|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598325|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598326|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20598327|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598328|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
20598329|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20598330|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20598331|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598332|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598333|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20598334|NCT02191007|Vitamins|vitamins|mesh-ancestor
20598335|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
20598336|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20598337|NCT02191020|Acitretin|acitretin|mesh-list
20598338|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
20083582|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083583|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
20083584|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083585|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083586|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083587|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083588|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083589|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083590|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
20083591|NCT00000648|Penicillins|penicillins|mesh-list
20083592|NCT00000648|Penicillin G|penicillin g|mesh-list
20083593|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20083594|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
20083595|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083596|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598339|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
20598340|NCT02191059|Docetaxel|docetaxel|mesh-list
20598341|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598342|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
20598343|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
20598344|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
20598345|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598346|NCT02191072|Omalizumab|omalizumab|mesh-list
20598347|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20598348|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20598349|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598350|NCT02191124|Mirtazapine|mirtazapine|mesh-list
20083597|NCT00000649|Zidovudine|zidovudine|mesh-list
20083598|NCT00000649|Nevirapine|nevirapine|mesh-list
20083599|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
20083600|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083601|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083602|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083603|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083604|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
20083605|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083606|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598351|NCT02191124|Paroxetine|paroxetine|mesh-list
20598352|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20598353|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20598354|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598355|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598356|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598357|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
20598358|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598359|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20598360|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
20598361|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20598362|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20598363|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20598364|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598365|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20598366|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
20598367|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
20598368|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20598369|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20598370|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598371|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19746675|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19746676|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20083607|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598372|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20598373|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20598374|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
20083608|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20083609|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20083610|NCT00000650|Ditiocarb|ditiocarb|mesh-list
20083611|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20083612|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
20083613|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083614|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
20083615|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598375|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20083616|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
20598376|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20598377|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20598378|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
20598379|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
20598380|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598381|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20598382|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20598383|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598384|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598385|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598386|NCT02191189|Nevirapine|nevirapine|mesh-list
20598387|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598388|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598389|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598390|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598391|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
20598392|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598393|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598394|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598395|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598396|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20598397|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20598398|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598399|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598400|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598401|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
20598402|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598403|NCT02191215|Nevirapine|nevirapine|mesh-list
20598404|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598405|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598406|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598407|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598408|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
20598409|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598410|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598411|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598412|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598413|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20598414|NCT02191228|Linagliptin|linagliptin|mesh-list
20598415|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20598416|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598417|NCT02191228|Incretins|incretins|mesh-ancestor
20598418|NCT02191228|Hormones|hormones|mesh-ancestor
20598419|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598420|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20598421|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
20598422|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598423|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598424|NCT02191280|Quercetin|quercetin|mesh-list
20598425|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
20598426|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083617|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
20083618|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083619|NCT00000651|Zidovudine|zidovudine|mesh-list
20083620|NCT00000651|Zalcitabine|zalcitabine|mesh-list
20083621|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
20083622|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083623|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083624|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083625|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083626|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
20083627|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083628|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083629|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083630|NCT00000652|Zidovudine|zidovudine|mesh-list
20083631|NCT00000652|Didanosine|didanosine|mesh-list
20083632|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
20083633|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083634|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083635|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083636|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083637|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
20598427|NCT02191280|Protective Agents|protective agents|mesh-ancestor
20598428|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598429|NCT02191293|Nevirapine|nevirapine|mesh-list
20083638|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083639|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083640|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083641|NCT00000653|Zalcitabine|zalcitabine|mesh-list
20083642|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
20083643|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083644|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598430|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598431|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598432|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598433|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598434|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
20598435|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598436|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598437|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598438|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598439|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20607481|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20607482|NCT02242474|Analgesics|analgesics|mesh-ancestor
20607483|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
20607484|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607485|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607486|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607487|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
20607488|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20607489|NCT02242513|Lidocaine|lidocaine|mesh-list
20607490|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
20607491|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
20607492|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607493|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607494|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
20607495|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607496|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20607497|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20607498|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20607499|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607500|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607501|NCT02242591|Ropivacaine|ropivacaine|mesh-list
20607502|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
20607503|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
20607504|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607505|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607506|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
20607507|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607508|NCT02242656|Opium|opium|mesh-list
20607509|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20607510|NCT02242656|Narcotics|narcotics|mesh-ancestor
20607511|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607512|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607513|NCT02242656|Analgesics|analgesics|mesh-ancestor
20607514|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
20607515|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607516|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
20607517|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607518|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
20607519|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607520|NCT02242695|Clotrimazole|clotrimazole|mesh-list
20607521|NCT02242695|Dequalinium|dequalinium|mesh-list
20607522|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20607523|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607524|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
20598440|NCT02191319|Nevirapine|nevirapine|mesh-list
20598441|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598442|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598443|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598444|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598445|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
20598446|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598447|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598448|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598449|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598450|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20598451|NCT02191332|Nevirapine|nevirapine|mesh-list
20598452|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598453|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598454|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598455|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598456|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
20598457|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598458|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598459|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598460|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598461|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20598462|NCT02191371|Propofol|propofol|mesh-list
20598463|NCT02191371|Desflurane|desflurane|mesh-list
20598464|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20598465|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598466|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598467|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20598468|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
20598469|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
20598470|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20598471|NCT02191423|Oxytocin|oxytocin|mesh-list
20598472|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
20598473|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20598474|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598475|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20598476|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20598477|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598478|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20598479|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598480|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598481|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
20598482|NCT02191566|Tegafur|tegafur|mesh-list
20598483|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598484|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20598485|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
20598486|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598487|NCT02191657|Deferiprone|deferiprone|mesh-list
20598488|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20598489|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
20598490|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
20598491|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598492|NCT02191670|Tenecteplase|tenecteplase|mesh-list
20598493|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20598494|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20598495|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598496|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
20598497|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
20598498|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598499|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20598500|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20598501|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598502|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598503|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598504|NCT02191748|Triamcinolone|triamcinolone|mesh-list
20598505|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598506|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
20598507|NCT02191748|Hormones|hormones|mesh-ancestor
20598508|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598509|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598510|NCT02191826|Tolcapone|tolcapone|mesh-list
20598511|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20598512|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20083645|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083646|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083647|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
20083648|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083649|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083650|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083651|NCT00000654|Fialuridine|fialuridine|mesh-list
20083652|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
20083653|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083654|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083655|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083656|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083657|NCT00000655|Trimethoprim|trimethoprim|mesh-list
20083658|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20083659|NCT00000655|Atovaquone|atovaquone|mesh-list
20598513|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20598514|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598515|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598516|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20598517|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
20598518|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20598519|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20598520|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
20598521|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598522|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598523|NCT02191891|Afatinib|afatinib|mesh-list
20598524|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598525|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20598526|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598527|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598528|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
20598529|NCT02191930|Doxorubicin|doxorubicin|mesh-list
20598530|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20598531|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20598532|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20598533|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
20598534|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598535|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20598536|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20598537|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
20598538|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598539|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598540|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20598541|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20598542|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20598543|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20598544|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598545|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20598546|NCT02191943|Fluorides|fluorides|mesh-list
20598547|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
20598548|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
20598549|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
20598550|NCT02191943|Protective Agents|protective agents|mesh-ancestor
20598551|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598552|NCT02192060|Triclosan|triclosan|mesh-list
20598553|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20598554|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598555|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20598556|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20598557|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
20598558|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598559|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20598560|NCT02192203|Diclofenac|diclofenac|mesh-list
20598561|NCT02192203|Menthol|menthol|mesh-list
20598562|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20598563|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20598564|NCT02192203|Analgesics|analgesics|mesh-ancestor
20598565|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
20598566|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598567|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083660|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
20083661|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20598568|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083662|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083663|NCT00000655|Renal Agents|renal agents|mesh-ancestor
20083664|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
20083665|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083666|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20083667|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20083668|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083669|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083670|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20083671|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20083672|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083673|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083674|NCT00000656|Zidovudine|zidovudine|mesh-list
20083675|NCT00000656|Didanosine|didanosine|mesh-list
20083676|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
20598569|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20598570|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20598571|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598572|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598573|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
20598574|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
20598575|NCT02192229|Vitamin D|vitamin d|mesh-list
20598576|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
20598577|NCT02192229|Vitamins|vitamins|mesh-ancestor
20598578|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
20598579|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598580|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20598581|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20598582|NCT02192320|Dexamethasone|dexamethasone|mesh-list
20598583|NCT02192320|Atorvastatin|atorvastatin|mesh-list
20598584|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598585|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
20598586|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
20598587|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598588|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598589|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598590|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
20598591|NCT02192320|Hormones|hormones|mesh-ancestor
20598592|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598593|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598594|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598595|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20598596|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20598597|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
20598598|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598599|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20598600|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20598601|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598602|NCT02192411|Lidocaine|lidocaine|mesh-list
20598603|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
20598604|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
20083677|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083678|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083679|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083680|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083681|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
20083682|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083683|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598605|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598606|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083684|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598607|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
20598608|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598609|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20598610|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20598611|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20598612|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598613|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598614|NCT02192424|Insulin|insulin|mesh-list
20598615|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20598616|NCT02192424|Metformin|metformin|mesh-list
20083685|NCT00000657|Zidovudine|zidovudine|mesh-list
20598617|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
20083686|NCT00000657|Didanosine|didanosine|mesh-list
20083687|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
20083688|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083689|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083690|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083691|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083692|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
20083693|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083694|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083695|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598618|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
20598619|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20598620|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598621|NCT02192450|Insulin|insulin|mesh-list
20598622|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20598623|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
20598624|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
20598625|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20083696|NCT00000658|Leucovorin|leucovorin|mesh-list
20083697|NCT00000658|Cytarabine|cytarabine|mesh-list
20083698|NCT00000658|Dexamethasone|dexamethasone|mesh-list
20083699|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
20083700|NCT00000658|Doxorubicin|doxorubicin|mesh-list
20083701|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20083702|NCT00000658|Methotrexate|methotrexate|mesh-list
20083703|NCT00000658|Vincristine|vincristine|mesh-list
20083704|NCT00000658|Bleomycin|bleomycin|mesh-list
20083705|NCT00000658|Allopurinol|allopurinol|mesh-list
20083706|NCT00000658|Sargramostim|sargramostim|mesh-list
20083707|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
20083708|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20083709|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
20083710|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083711|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20598626|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20598627|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598628|NCT02192463|Nevirapine|nevirapine|mesh-list
20598629|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598630|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598631|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598632|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598633|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
20598634|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598635|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598636|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598637|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598638|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20598639|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20598640|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20598641|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20598642|NCT02192632|Analgesics|analgesics|mesh-ancestor
20598643|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
20598644|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598645|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598646|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598647|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20598648|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
20598649|NCT02192697|Naquotinib|naquotinib|mesh-list
20598650|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598651|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20598652|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598653|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598654|NCT02192710|Midazolam|midazolam|mesh-list
20598655|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20598656|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20598657|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598658|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598659|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20598660|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20598661|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20598662|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20083712|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20598663|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
20083713|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
20083714|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083715|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598664|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
20598665|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
20598666|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
20598667|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598668|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598669|NCT02192723|Olanzapine|olanzapine|mesh-list
20598670|NCT02192723|Risperidone|risperidone|mesh-list
20598671|NCT02192723|Aripiprazole|aripiprazole|mesh-list
20598672|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20083716|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20083717|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083718|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
20083719|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
20083720|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083721|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20083722|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
20598673|NCT02192723|Ziprasidone|ziprasidone|mesh-list
20598674|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
20598675|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20598676|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
20598677|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598678|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598679|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598680|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20598681|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598682|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20598683|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20598684|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
20598685|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
20598686|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
20598687|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598688|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598689|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20598690|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20598691|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598692|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
20598693|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
20598694|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20598695|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20598696|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20598697|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20598698|NCT02192827|Dexamethasone|dexamethasone|mesh-list
20598699|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
20598700|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20598701|NCT02192827|BB 1101|bb 1101|mesh-list
20598702|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598703|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
20598704|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
20598705|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598706|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598707|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598708|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
20598709|NCT02192827|Hormones|hormones|mesh-ancestor
20598710|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598711|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598712|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598713|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
20598714|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598715|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598716|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20598717|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20598718|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598719|NCT02192853|Incretins|incretins|mesh-ancestor
20598720|NCT02192853|Hormones|hormones|mesh-ancestor
20598721|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598722|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20598723|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
20598724|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598725|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083723|NCT00000658|Hormones|hormones|mesh-ancestor
20083724|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598726|NCT02192944|Chloroquine|chloroquine|mesh-list
20598727|NCT02192944|Piperaquine|piperaquine|mesh-list
20598728|NCT02192944|Artenimol|artenimol|mesh-list
20598729|NCT02192944|Amebicides|amebicides|mesh-ancestor
20598730|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20598731|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20598732|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598733|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
20598734|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607525|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20607526|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20607527|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607528|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607529|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20607530|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
20607531|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20607532|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607533|NCT02242734|Hydrocodone|hydrocodone|mesh-list
20607534|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20607535|NCT02242734|Narcotics|narcotics|mesh-ancestor
20607536|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607537|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607538|NCT02242734|Analgesics|analgesics|mesh-ancestor
20607539|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
20607540|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607541|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
20607542|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607543|NCT02242799|Artesunate|artesunate|mesh-list
20607544|NCT02242799|Lumefantrine|lumefantrine|mesh-list
20607545|NCT02242799|Artemether|artemether|mesh-list
20607546|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20083725|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20083726|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20083727|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20607547|NCT02242799|Amodiaquine|amodiaquine|mesh-list
20607548|NCT02242799|Dolutegravir|dolutegravir|mesh-list
20607549|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
20607550|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20607551|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20607552|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607553|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607554|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
20607555|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
20083728|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20083729|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083730|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20083731|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
20083732|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20083733|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20083734|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
20083735|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
20607556|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20607557|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
20607558|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20607559|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20607560|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607561|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607562|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20607563|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20607564|NCT02242812|Metoprolol|metoprolol|mesh-list
20607565|NCT02242812|Telmisartan|telmisartan|mesh-list
20607566|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607567|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607568|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607569|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083736|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20083737|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083738|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
20083739|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083740|NCT00000658|Antidotes|antidotes|mesh-ancestor
20083741|NCT00000658|Protective Agents|protective agents|mesh-ancestor
20083742|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
20607570|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20607571|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
20607572|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
20083743|NCT00000658|Vitamins|vitamins|mesh-ancestor
20083744|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
20083745|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20083746|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
20598735|NCT02193022|Miltefosine|miltefosine|mesh-list
20598736|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
20598737|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598738|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083747|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
20083748|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
20083749|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
20083750|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20083751|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
20083752|NCT00000659|Zidovudine|zidovudine|mesh-list
20083753|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
20083754|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083755|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083756|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083757|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083758|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
20083759|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083760|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083761|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083762|NCT00000660|Etoposide|etoposide|mesh-list
20598739|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20598740|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20598741|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20598742|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20598743|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598744|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20598745|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
20598746|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598747|NCT02193256|Prazosin|prazosin|mesh-list
20598748|NCT02193256|Varenicline|varenicline|mesh-list
20598749|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20598750|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20598751|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
20598752|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598753|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598754|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598755|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20598756|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20598757|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20598758|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20598759|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
20598760|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20598761|NCT02193269|Minocycline|minocycline|mesh-list
20598762|NCT02193269|Tetracycline|tetracycline|mesh-list
20598763|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598764|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20598765|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598766|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598767|NCT02193308|Amlodipine|amlodipine|mesh-list
20598768|NCT02193308|Telmisartan|telmisartan|mesh-list
20598769|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20598770|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20598771|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20598772|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598773|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598774|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20598775|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598776|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
20598777|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20598778|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20598779|NCT02193334|Mitogens|mitogens|mesh-list
20598780|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
20598781|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598782|NCT02193568|Anesthetics|anesthetics|mesh-list
20598783|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598784|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083763|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20083764|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083765|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20598785|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
20598786|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598787|NCT02193620|Nalbuphine|nalbuphine|mesh-list
20598788|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20598789|NCT02193620|Narcotics|narcotics|mesh-ancestor
20598790|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598791|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598792|NCT02193620|Analgesics|analgesics|mesh-ancestor
20598793|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
20598794|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598795|NCT02193633|Paclitaxel|paclitaxel|mesh-list
20598796|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20598797|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20598798|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598799|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
20598800|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
20598801|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
20598802|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598803|NCT02193698|Dexamethasone|dexamethasone|mesh-list
20598804|NCT02193698|Lenalidomide|lenalidomide|mesh-list
20598805|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20598806|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
20598807|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
20598808|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598809|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598810|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598811|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
20598812|NCT02193698|Hormones|hormones|mesh-ancestor
20598813|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20598814|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598815|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598816|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
20598817|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20598818|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20598819|NCT02193698|Growth Substances|growth substances|mesh-ancestor
20598820|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
20598821|NCT02193893|Coal Tar|coal tar|mesh-list
20598822|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
20598823|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
20598824|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20598825|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20598826|NCT02194049|Etoposide|etoposide|mesh-list
20598827|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
20598828|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598829|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20598830|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20598831|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20598832|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598833|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598834|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
20598835|NCT02194075|Methylphenidate|methylphenidate|mesh-list
20598836|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20598837|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598838|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20598839|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20598840|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598841|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598842|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
20598843|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598844|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20598845|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20598846|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20083766|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20083767|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083768|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083769|NCT00000661|Zidovudine|zidovudine|mesh-list
20083770|NCT00000661|Oxazepam|oxazepam|mesh-list
20083771|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
20083772|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083773|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083774|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598847|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20083775|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598848|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20598849|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
20598850|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20598851|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
20598852|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20598853|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20598854|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598855|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20598856|NCT02194153|Tenecteplase|tenecteplase|mesh-list
20598857|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20598858|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20598859|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598860|NCT02194166|Paclitaxel|paclitaxel|mesh-list
20598861|NCT02194166|Docetaxel|docetaxel|mesh-list
20598862|NCT02194166|Trastuzumab|trastuzumab|mesh-list
20598863|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20598864|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598865|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
20598866|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
20598867|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
20598868|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598869|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20598870|NCT02194179|Nevirapine|nevirapine|mesh-list
20598871|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598872|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598873|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598874|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598875|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
20598876|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598877|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598878|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598879|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598880|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20598881|NCT02194192|Ephedrine|ephedrine|mesh-list
20598882|NCT02194192|Ondansetron|ondansetron|mesh-list
20598883|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
20598884|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
20598885|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598886|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598887|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598888|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
20598889|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
20598890|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20598891|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
20598892|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20598893|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598894|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20598895|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20598896|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598897|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20598898|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20598899|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20598900|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
20598901|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20598902|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
20598903|NCT02194218|Nevirapine|nevirapine|mesh-list
20598904|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20598905|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20598906|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598907|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598908|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
20598909|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598910|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20598911|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598912|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20598913|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20598914|NCT02194231|Trabectedin|trabectedin|mesh-list
20598915|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20598916|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
20598917|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598918|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598919|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20598920|NCT02194257|Ambroxol|ambroxol|mesh-list
20598921|NCT02194257|Expectorants|expectorants|mesh-ancestor
20598922|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598923|NCT02194270|Ambroxol|ambroxol|mesh-list
20598924|NCT02194270|Expectorants|expectorants|mesh-ancestor
20598925|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598926|NCT02194283|Ambroxol|ambroxol|mesh-list
20598927|NCT02194283|Expectorants|expectorants|mesh-ancestor
20598928|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598929|NCT02194296|Ambroxol|ambroxol|mesh-list
20598930|NCT02194296|Expectorants|expectorants|mesh-ancestor
20598931|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598932|NCT02194309|Amlodipine|amlodipine|mesh-list
20598933|NCT02194309|Telmisartan|telmisartan|mesh-list
20598934|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20598935|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20598936|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20598937|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598938|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20598939|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598940|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
20598941|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20598942|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20598943|NCT02194374|Vidarabine|vidarabine|mesh-list
20598944|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
20598945|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20598946|NCT02194374|Rituximab|rituximab|mesh-list
20083776|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
20083777|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083778|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083779|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20598947|NCT02194374|Fludarabine|fludarabine|mesh-list
20598948|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
20598949|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20083780|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20083781|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20598950|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
20598951|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598952|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20598953|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20598954|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
20598955|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598956|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598957|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20598958|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20598959|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20598960|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
20598961|NCT02194374|Antiviral Agents|antiviral agents|mesh-ancestor
20598962|NCT02194374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598963|NCT02194452|Octreotide|octreotide|mesh-list
20598964|NCT02194452|Edotreotide|edotreotide|mesh-list
20598965|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20598966|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20598967|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598968|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20598969|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598970|NCT02194491|AS2471907|as2471907|mesh-list
20598971|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20598972|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598973|NCT02194556|Gemcitabine|gemcitabine|mesh-list
20598974|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20598975|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
20598976|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598977|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20598978|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
20598979|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20598980|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20598981|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20598982|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
20598983|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607573|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607574|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607575|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20607576|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20607577|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20607578|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
20607579|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607580|NCT02242825|Telmisartan|telmisartan|mesh-list
20607581|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20607582|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607583|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607584|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607585|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607586|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20607587|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607588|NCT02242825|Diuretics|diuretics|mesh-ancestor
20607589|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
20607590|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607591|NCT02242838|Telmisartan|telmisartan|mesh-list
20607592|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607593|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607594|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607595|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607596|NCT02242851|Telmisartan|telmisartan|mesh-list
20607597|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607598|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607599|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20083782|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598984|NCT02194686|Cilostazol|cilostazol|mesh-list
20598985|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20598986|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
20598987|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20598988|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20598989|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20598990|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
20598991|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20598992|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20598993|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20598994|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20598995|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
20598996|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20598997|NCT02194686|Protective Agents|protective agents|mesh-ancestor
20598998|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20598999|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20599000|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599001|NCT02194764|Naltrexone|naltrexone|mesh-list
20599002|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20599003|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20599004|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599005|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
20599006|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599007|NCT02194829|Gemcitabine|gemcitabine|mesh-list
20599008|NCT02194829|Paclitaxel|paclitaxel|mesh-list
20599009|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20599010|NCT02194829|Adavosertib|adavosertib|mesh-list
20599011|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20599012|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599013|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20599014|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
20599015|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20599016|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599017|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20599018|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
20599019|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
20599020|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599021|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599022|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20599023|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
20599024|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599025|NCT02194855|Rocuronium|rocuronium|mesh-list
20599026|NCT02194855|Cisatracurium|cisatracurium|mesh-list
20599027|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20599028|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20599029|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20599030|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599031|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599032|NCT02194881|Ivacaftor|ivacaftor|mesh-list
20599033|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20599034|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20599035|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599036|NCT02194894|Acetaminophen|acetaminophen|mesh-list
20599037|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599038|NCT02194894|Analgesics|analgesics|mesh-ancestor
20599039|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
20599040|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599041|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599042|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
20599043|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
20599044|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20599045|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599046|NCT02195089|Vaccines|vaccines|mesh-list
20599047|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
20599048|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599049|NCT02195115|Amitriptyline|amitriptyline|mesh-list
20599050|NCT02195115|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20599051|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20599052|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
20599053|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20599054|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599055|NCT02195115|Analgesics|analgesics|mesh-ancestor
20599056|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
20599057|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599058|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599059|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20599060|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20599061|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20083783|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20083784|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20083785|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20083786|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
20083787|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
20599062|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599063|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
20599064|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599065|NCT02195115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20599066|NCT02195115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20599067|NCT02195115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599068|NCT02195180|Leucovorin|leucovorin|mesh-list
20599069|NCT02195180|Gemcitabine|gemcitabine|mesh-list
20599070|NCT02195180|Fluorouracil|fluorouracil|mesh-list
20599071|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
20599072|NCT02195180|Asparaginase|asparaginase|mesh-list
20599073|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20599074|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
20599075|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599076|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599077|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
20599078|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599079|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599080|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20599081|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
20599082|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599083|NCT02195180|Antidotes|antidotes|mesh-ancestor
20599084|NCT02195180|Protective Agents|protective agents|mesh-ancestor
20599085|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
20083788|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20083789|NCT00000662|Zidovudine|zidovudine|mesh-list
20083790|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
20083791|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492232|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20599086|NCT02195180|Vitamins|vitamins|mesh-ancestor
20599087|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
20599088|NCT02195271|Melatonin|melatonin|mesh-list
20599089|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
20599090|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599091|NCT02195271|Protective Agents|protective agents|mesh-ancestor
20083792|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083793|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083794|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083795|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
20083796|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083797|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083798|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20599092|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492233|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
19746677|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
20599093|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599094|NCT02195336|Paclitaxel|paclitaxel|mesh-list
20599095|NCT02195336|Bevacizumab|bevacizumab|mesh-list
20599096|NCT02195336|Carboplatin|carboplatin|mesh-list
20599097|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20599098|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599099|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
20599100|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
20599101|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
20599102|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599103|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20599104|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20599105|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20599106|NCT02195336|Growth Substances|growth substances|mesh-ancestor
20599107|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599108|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
20599109|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20599110|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20599111|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
20599112|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599113|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599114|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20599115|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
20083799|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
20083800|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
20083801|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083802|NCT00000664|Zidovudine|zidovudine|mesh-list
20083803|NCT00000664|Interleukin-2|interleukin-2|mesh-list
20083804|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083805|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20083806|NCT00000664|Analgesics|analgesics|mesh-ancestor
20083807|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
20083808|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083809|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083810|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
20083811|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083812|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083813|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083814|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083815|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
20083816|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083817|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083818|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083819|NCT00000665|Ganciclovir|ganciclovir|mesh-list
20083820|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20083821|NCT00000665|Foscarnet|foscarnet|mesh-list
20083822|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20083823|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
20083824|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083825|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083826|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599116|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
20599117|NCT02195375|Hormones|hormones|mesh-ancestor
20599118|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599119|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
20599120|NCT02195466|Ritonavir|ritonavir|mesh-list
20599121|NCT02195466|Tipranavir|tipranavir|mesh-list
20599122|NCT02195466|Fluconazole|fluconazole|mesh-list
20599123|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20599124|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20599125|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
20599126|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599127|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599128|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20599129|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20599130|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
20599131|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599132|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20599133|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20599134|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
20599135|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20599136|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20599137|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
20599138|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599139|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599140|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20599141|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20599142|NCT02195492|Hylan|hylan|mesh-list
20599143|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
20599144|NCT02195492|Protective Agents|protective agents|mesh-ancestor
20599145|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599146|NCT02195544|Hylan|hylan|mesh-list
20599147|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
20599148|NCT02195544|Protective Agents|protective agents|mesh-ancestor
20599149|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599150|NCT02195557|Hylan|hylan|mesh-list
20599151|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
20599152|NCT02195557|Protective Agents|protective agents|mesh-ancestor
20599153|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599154|NCT02195635|Octreotide|octreotide|mesh-list
20599155|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20599156|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20599157|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599158|NCT02195661|Melatonin|melatonin|mesh-list
20599159|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
20599160|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
20083827|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083828|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083829|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
20083830|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
20599161|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599162|NCT02195661|Protective Agents|protective agents|mesh-ancestor
20599163|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599164|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599165|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20599166|NCT02195791|Pioglitazone|pioglitazone|mesh-list
20599167|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599168|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599169|NCT02195804|Ranitidine|ranitidine|mesh-list
20599170|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20599171|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20599172|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20599173|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20599174|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
20599175|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
20599176|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599177|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599178|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599179|NCT02195817|Nalmefene|nalmefene|mesh-list
20599180|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20599181|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599182|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
20599183|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599184|NCT02195908|Antiemetics|antiemetics|mesh-list
20599185|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
20599186|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599187|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599188|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20599189|NCT02195973|Paclitaxel|paclitaxel|mesh-list
20599190|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20599191|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599192|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
20599193|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
20599194|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
20599195|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599196|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
20599197|NCT02196142|Mannitol|mannitol|mesh-list
20083831|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083832|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599198|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20599199|NCT02196142|Diuretics|diuretics|mesh-ancestor
20599200|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
20599201|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599202|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20599203|NCT02196155|Cortisone|cortisone|mesh-list
20599204|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
20599205|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20599206|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20599207|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20599208|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20599209|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599210|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
20599211|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599212|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599213|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20599214|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20599215|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599216|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
20599217|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20599218|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
20599219|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599220|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599221|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20599222|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
20599223|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
20599224|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20599225|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
20599226|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599227|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599228|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20599229|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
20599230|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599231|NCT02196285|Vaccines|vaccines|mesh-list
20599232|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
20599233|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607600|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607601|NCT02242864|Telmisartan|telmisartan|mesh-list
20607602|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20607603|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607604|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607605|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607606|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607607|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20607608|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607609|NCT02242864|Diuretics|diuretics|mesh-ancestor
20607610|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
20083833|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083834|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20083835|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607611|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607612|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20607613|NCT02242877|Telmisartan|telmisartan|mesh-list
20607614|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607615|NCT02242877|Diuretics|diuretics|mesh-ancestor
20607616|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
20607617|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607618|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20607619|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607620|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607621|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607622|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607623|NCT02242929|Imiquimod|imiquimod|mesh-list
20607624|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20607625|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
20607626|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607627|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607628|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
20607629|NCT02242955|Diazepam|diazepam|mesh-list
20607630|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20607631|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
20607632|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
20607633|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
20607634|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599234|NCT02196441|Bupivacaine|bupivacaine|mesh-list
20599235|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
20599236|NCT02196441|Tetracaine|tetracaine|mesh-list
20599237|NCT02196441|Anesthetics|anesthetics|mesh-list
20599238|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599239|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599240|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
20083836|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083837|NCT00000668|Ganciclovir|ganciclovir|mesh-list
20083838|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20083839|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
20083840|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083841|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083842|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083843|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599241|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599242|NCT02196493|Azithromycin|azithromycin|mesh-list
20599243|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599244|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599245|NCT02196662|Mesalamine|mesalamine|mesh-list
20599246|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20599247|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599248|NCT02196662|Analgesics|analgesics|mesh-ancestor
20599249|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
20599250|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599251|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599252|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20599253|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20599254|NCT02196740|Metronidazole|metronidazole|mesh-list
20599255|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
20599256|NCT02196740|Clindamycin|clindamycin|mesh-list
20599257|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
20599258|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
20599259|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
20599260|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599261|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599262|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20599263|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599264|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20599265|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20599266|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599267|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599268|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599269|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20599270|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20599271|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20599272|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20599273|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20599274|NCT02196805|Probucol|probucol|mesh-list
20599275|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20599276|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20599277|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
20599278|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599279|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20599280|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
20599281|NCT02196805|Protective Agents|protective agents|mesh-ancestor
20599282|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599283|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20599284|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20599285|NCT02197000|Protective Agents|protective agents|mesh-ancestor
20599286|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599287|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599288|NCT02197026|Hylan|hylan|mesh-list
20599289|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
20599290|NCT02197026|Protective Agents|protective agents|mesh-ancestor
20599291|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599292|NCT02197039|Esomeprazole|esomeprazole|mesh-list
20599293|NCT02197039|Pantoprazole|pantoprazole|mesh-list
20599294|NCT02197039|Hemostatics|hemostatics|mesh-list
20599295|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20599296|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20599297|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20599298|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599299|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599300|NCT02197039|Coagulants|coagulants|mesh-ancestor
20599301|NCT02197143|Esomeprazole|esomeprazole|mesh-list
20599302|NCT02197143|Ranitidine|ranitidine|mesh-list
20599303|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20599304|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20599305|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20599306|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20599307|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599308|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599309|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20599310|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
20599311|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
20599312|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599313|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599314|NCT02197156|Acetaminophen|acetaminophen|mesh-list
20599315|NCT02197156|Hydrocodone|hydrocodone|mesh-list
20599316|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599317|NCT02197156|Analgesics|analgesics|mesh-ancestor
20599318|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
20599319|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599320|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599321|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
20599322|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20599323|NCT02197156|Narcotics|narcotics|mesh-ancestor
20599324|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599325|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
20599326|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
20599327|NCT02197169|Interferons|interferons|mesh-list
20599328|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
20599329|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599330|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
20599331|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599332|NCT02197182|Copper|copper|mesh-list
20599333|NCT02197182|Metronidazole|metronidazole|mesh-list
20599334|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599335|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599336|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20599337|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599338|NCT02197182|Trace Elements|trace elements|mesh-ancestor
20599339|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
20599340|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599341|NCT02197260|Amoxicillin|amoxicillin|mesh-list
20599342|NCT02197260|Metronidazole|metronidazole|mesh-list
20599343|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599344|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599345|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20599346|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599347|NCT02197286|Vitamin D|vitamin d|mesh-list
20599348|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
20599349|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
20599350|NCT02197286|Vitamins|vitamins|mesh-list
20599351|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
20599352|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599353|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20599354|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20599355|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
20599356|NCT02197403|Propofol|propofol|mesh-list
20599357|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20599358|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599359|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599360|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20083844|NCT00000669|Didanosine|didanosine|mesh-list
20083845|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
20083846|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083847|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083848|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083849|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599361|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
20599362|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
20599363|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599364|NCT02197403|Analgesics|analgesics|mesh-ancestor
20599365|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
20599366|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599367|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20599368|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20599369|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20599370|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
20599371|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599372|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599373|NCT02197442|Valsartan|valsartan|mesh-list
20599374|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20599375|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20599376|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20599377|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599378|NCT02197494|Valsartan|valsartan|mesh-list
20599379|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20599380|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20599381|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20599382|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599383|NCT02197598|Nalmefene|nalmefene|mesh-list
20599384|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20599385|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599386|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
20083850|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
20083851|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083852|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083853|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083854|NCT00000670|Zidovudine|zidovudine|mesh-list
20083855|NCT00000670|Probenecid|probenecid|mesh-list
20083856|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
20083857|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083858|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083859|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20599387|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20083860|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083861|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
20083862|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083863|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083864|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083865|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
20599388|NCT02197637|Vinorelbine|vinorelbine|mesh-list
20599389|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20599390|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599391|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
20599392|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
20083866|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
20083867|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20083868|NCT00000670|Renal Agents|renal agents|mesh-ancestor
20083869|NCT00000671|Zidovudine|zidovudine|mesh-list
20083870|NCT00000671|Didanosine|didanosine|mesh-list
20083871|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
20083872|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083873|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083874|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083875|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083876|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
20599393|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
20599394|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599395|NCT02197650|Asparaginase|asparaginase|mesh-list
20599396|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599397|NCT02197676|Guadecitabine|guadecitabine|mesh-list
20599398|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599399|NCT02197702|Vitamin D|vitamin d|mesh-list
20599400|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
20599401|NCT02197702|Vitamins|vitamins|mesh-ancestor
20599402|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
20599403|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599404|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20599405|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20599406|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
20599407|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20599408|NCT02197741|Narcotics|narcotics|mesh-ancestor
20599409|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599410|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599411|NCT02197741|Analgesics|analgesics|mesh-ancestor
20599412|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
20599413|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599414|NCT02197884|Clarithromycin|clarithromycin|mesh-list
20599415|NCT02197884|Itraconazole|itraconazole|mesh-list
20599416|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599417|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599418|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20599419|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083877|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083878|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20599420|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599421|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20599422|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20599423|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
20599424|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20599425|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20599426|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
20599427|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599428|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599429|NCT02197988|Fentanyl|fentanyl|mesh-list
20599430|NCT02197988|Bupivacaine|bupivacaine|mesh-list
20599431|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
20599432|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
20599433|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20083879|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083880|NCT00000672|Didanosine|didanosine|mesh-list
20083881|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
20083882|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083883|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083884|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083885|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083886|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
20599434|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599435|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
20599436|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599437|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20599438|NCT02197988|Narcotics|narcotics|mesh-ancestor
20599439|NCT02197988|Analgesics|analgesics|mesh-ancestor
20599440|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20599441|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20599442|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
20599443|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20599444|NCT02198001|Amoxicillin|amoxicillin|mesh-list
20599445|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
20599446|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
20083887|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083888|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083889|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083890|NCT00000673|Ganciclovir|ganciclovir|mesh-list
20083891|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20599447|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20599448|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599449|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20599450|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599451|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599452|NCT02198027|Bupivacaine|bupivacaine|mesh-list
20599453|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
20599454|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
20599455|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599456|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083892|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
20083893|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083894|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083895|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083896|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083897|NCT00000674|Leucovorin|leucovorin|mesh-list
20083898|NCT00000674|Clindamycin|clindamycin|mesh-list
20083899|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
20083900|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
20083901|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
20083902|NCT00000674|Calcium|calcium|mesh-list
20083903|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
20083904|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20083905|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599457|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
20599458|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607635|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607636|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607637|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20607638|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607639|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20607640|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20607641|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20607642|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20607643|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20083906|NCT00000674|Antidotes|antidotes|mesh-ancestor
20083907|NCT00000674|Protective Agents|protective agents|mesh-ancestor
20083908|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
20083909|NCT00000674|Vitamins|vitamins|mesh-ancestor
20083910|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
20083911|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20083912|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083913|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20083914|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083915|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083916|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
20083917|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20083918|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599459|NCT02198170|Ketoconazole|ketoconazole|mesh-list
20599460|NCT02198170|Lenvatinib|lenvatinib|mesh-list
20599461|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
20599462|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599463|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20599464|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20599465|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599466|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599467|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20599468|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
20599469|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599470|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599471|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20083919|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20083920|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
20083921|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
20083922|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083923|NCT00000676|Fluconazole|fluconazole|mesh-list
20083924|NCT00000676|Clotrimazole|clotrimazole|mesh-list
20083925|NCT00000676|Miconazole|miconazole|mesh-list
20083926|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
20083927|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083928|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20083929|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20083930|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083931|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083932|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20083933|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
20083934|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083935|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20083936|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20083937|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20599472|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599473|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20599474|NCT02198209|Liraglutide|liraglutide|mesh-list
20599475|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599476|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599477|NCT02198209|Incretins|incretins|mesh-ancestor
20599478|NCT02198209|Hormones|hormones|mesh-ancestor
20599479|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599480|NCT02198248|Prednisolone|prednisolone|mesh-list
20599481|NCT02198248|Rituximab|rituximab|mesh-list
20599482|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
20599483|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20599484|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599485|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
20599486|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599487|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20599488|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20083938|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20083939|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20083940|NCT00000677|Sch 39304|sch 39304|mesh-list
20083941|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
20083942|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083943|NCT00000678|Zidovudine|zidovudine|mesh-list
20083944|NCT00000678|Zalcitabine|zalcitabine|mesh-list
20083945|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
20083946|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083947|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083948|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20599489|NCT02198248|Hormones|hormones|mesh-ancestor
20599490|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20083949|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083950|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
20083951|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083952|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083953|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20599491|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20599492|NCT02198261|Minoxidil|minoxidil|mesh-list
20599493|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20599494|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
20599495|NCT02198300|Clopidogrel|clopidogrel|mesh-list
20599496|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20599497|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20599498|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20599499|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20599500|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
20599501|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599502|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599503|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599504|NCT02198378|Acetaminophen|acetaminophen|mesh-list
20599505|NCT02198378|Morphine|morphine|mesh-list
20599506|NCT02198378|Entonox|entonox|mesh-list
20599507|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20599508|NCT02198378|Narcotics|narcotics|mesh-ancestor
20599509|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599510|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599511|NCT02198378|Analgesics|analgesics|mesh-ancestor
20599512|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
20599513|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599514|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599515|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
20599516|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20599517|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
20599518|NCT02198404|Propofol|propofol|mesh-list
20083954|NCT00000679|Zidovudine|zidovudine|mesh-list
20599519|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20599520|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599521|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599522|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20599523|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
20599524|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
20599525|NCT02198417|Metformin|metformin|mesh-list
20599526|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599527|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599528|NCT02198443|Ritonavir|ritonavir|mesh-list
20083955|NCT00000679|Zalcitabine|zalcitabine|mesh-list
20599529|NCT02198443|Lopinavir|lopinavir|mesh-list
20599530|NCT02198443|Tenofovir|tenofovir|mesh-list
20599531|NCT02198443|Emtricitabine|emtricitabine|mesh-list
20599532|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20599533|NCT02198443|Cobicistat|cobicistat|mesh-list
20599534|NCT02198443|Elvitegravir|elvitegravir|mesh-list
20599535|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20599536|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20599537|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
20599538|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599539|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599540|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20599541|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20599542|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
20599543|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599544|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20599545|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20599546|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20599547|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20599548|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20599549|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20599550|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20599551|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
20599552|NCT02198482|Cytarabine|cytarabine|mesh-list
20599553|NCT02198482|Daunorubicin|daunorubicin|mesh-list
20599554|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
20599555|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20599556|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
20599557|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599558|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599559|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
20599560|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599561|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20599562|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
20599563|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599564|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20599565|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20599566|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20599567|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599568|NCT02198482|Analgesics|analgesics|mesh-ancestor
20599569|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
20599570|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599571|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20599572|NCT02198495|Hematinics|hematinics|mesh-ancestor
20599573|NCT02198508|Deferasirox|deferasirox|mesh-list
20599574|NCT02198508|Deferiprone|deferiprone|mesh-list
20599575|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20599576|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
20599577|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
20599578|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599579|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
20599580|NCT02198547|Ropivacaine|ropivacaine|mesh-list
20599581|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
20599582|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
20599583|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599584|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599585|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
20599586|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599587|NCT02198547|Analgesics|analgesics|mesh-ancestor
20599588|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20599589|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
20599590|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20599591|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20599592|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599593|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20599594|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
20599595|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20599596|NCT02198807|Piperaquine|piperaquine|mesh-list
20599597|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
20599598|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
20599599|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20599600|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599601|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599602|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599603|NCT02198820|Anesthetics|anesthetics|mesh-list
20599604|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599605|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599606|NCT02198846|Insulin|insulin|mesh-list
20599607|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599608|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599609|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
20599610|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
20599611|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20599612|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599613|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599614|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
20599615|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20083956|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
20083957|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083958|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083959|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083960|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083961|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
20083962|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083963|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083964|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083965|NCT00000680|Zidovudine|zidovudine|mesh-list
20083966|NCT00000680|Aldesleukin|aldesleukin|mesh-list
20083967|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
20083968|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083969|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083970|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083971|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083972|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
20083973|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083974|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083975|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20083976|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083977|NCT00000681|Zidovudine|zidovudine|mesh-list
20083978|NCT00000681|Doxorubicin|doxorubicin|mesh-list
20083979|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20083980|NCT00000681|Bleomycin|bleomycin|mesh-list
20083981|NCT00000681|Vincristine|vincristine|mesh-list
20083982|NCT00000681|Sargramostim|sargramostim|mesh-list
20083983|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20083984|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20083985|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20083986|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20599616|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20083987|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20083988|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20083989|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20083990|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
20083991|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
20083992|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
20083993|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
20083994|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20083995|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20083996|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
20083997|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20083998|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20083999|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084000|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
20084001|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084002|NCT00000682|Zidovudine|zidovudine|mesh-list
20084003|NCT00000682|Zalcitabine|zalcitabine|mesh-list
20084004|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
20084005|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084006|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084007|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084008|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084009|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
20084010|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084011|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084012|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084013|NCT00000684|Dextrans|dextrans|mesh-list
20599617|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599618|NCT02198924|Celecoxib|celecoxib|mesh-list
20599619|NCT02198924|Parecoxib|parecoxib|mesh-list
20599620|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20599621|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599622|NCT02198924|Analgesics|analgesics|mesh-ancestor
20599623|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
20599624|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599625|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599626|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20599627|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20599628|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20599629|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20599630|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599631|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599632|NCT02199171|Carboplatin|carboplatin|mesh-list
20599633|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599634|NCT02199223|Panitumumab|panitumumab|mesh-list
20599635|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20599636|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599637|NCT02199327|Interferons|interferons|mesh-list
20599638|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
20599639|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
20599640|NCT02199327|Mitomycins|mitomycins|mesh-list
20599641|NCT02199327|Mitomycin|mitomycin|mesh-list
20599642|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599643|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
20599644|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599645|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
20599646|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599647|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20599648|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
20599649|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599650|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20599651|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599652|NCT02199379|Lenvatinib|lenvatinib|mesh-list
20599653|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599654|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20599655|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599656|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599657|NCT02199392|Lenvatinib|lenvatinib|mesh-list
20599658|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599659|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20599660|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084014|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
20599661|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599662|NCT02199418|Paclitaxel|paclitaxel|mesh-list
20599663|NCT02199418|Cisplatin|cisplatin|mesh-list
20599664|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20084015|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
20084016|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
20084017|NCT00000685|Zidovudine|zidovudine|mesh-list
20084018|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
20599665|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599666|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
20599667|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
20599668|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
20599669|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599670|NCT02199431|Itraconazole|itraconazole|mesh-list
20599671|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
20599672|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599673|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20599674|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20599675|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599676|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599677|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20084019|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084020|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084021|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084022|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084023|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
20084024|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084025|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084026|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20599678|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
20599679|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599680|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599681|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20599682|NCT02199444|Sevelamer|sevelamer|mesh-list
20599683|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
20599684|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
20599685|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599686|NCT02199522|Propofol|propofol|mesh-list
20599687|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20599688|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599689|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599690|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20599691|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
20599692|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
20599693|NCT02199613|Darunavir|darunavir|mesh-list
20599694|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20599695|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20599696|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
20599697|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599698|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599699|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20599700|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20599701|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
20599702|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607644|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20607645|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
20607646|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
20607647|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
20607648|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
20607649|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607650|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607651|NCT02243098|Digoxin|digoxin|mesh-list
20607652|NCT02243098|Atorvastatin|atorvastatin|mesh-list
20084027|NCT00000686|Stavudine|stavudine|mesh-list
20084028|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
20607653|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20607654|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20607655|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
20607656|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607657|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20607658|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20607659|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607660|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20607661|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20607662|NCT02243098|Protective Agents|protective agents|mesh-ancestor
20607663|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607664|NCT02243124|Dexamethasone|dexamethasone|mesh-list
20084029|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599703|NCT02199678|Ketamine|ketamine|mesh-list
20599704|NCT02199678|Analgesics|analgesics|mesh-ancestor
20084030|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084031|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084032|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084033|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
20084034|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084035|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084036|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084037|NCT00000687|Interferons|interferons|mesh-list
20084038|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
20084039|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
20599705|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
20599706|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599707|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599708|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20599709|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20599710|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
20599711|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
20599712|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599713|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20599714|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20599715|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599716|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599717|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
20599718|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20599719|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20599720|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
20599721|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599722|NCT02199951|Piperaquine|piperaquine|mesh-list
20599723|NCT02199951|Artenimol|artenimol|mesh-list
20599724|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
20599725|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20599726|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599727|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599728|NCT02200094|Telmisartan|telmisartan|mesh-list
20599729|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20599730|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20599731|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20599732|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599733|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
20599734|NCT02200146|Prednisone|prednisone|mesh-list
20599735|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20599736|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
20599737|NCT02200146|Hormones|hormones|mesh-ancestor
20599738|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599739|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599740|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20599741|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599742|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
20599743|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20599744|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599745|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599746|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599747|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599748|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20599749|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
20599750|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20599751|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599752|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599753|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599754|NCT02200159|Analgesics|analgesics|mesh-ancestor
20599755|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
20599756|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599757|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20599758|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20599759|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20599760|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
20084040|NCT00000687|Zidovudine|zidovudine|mesh-list
20599761|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599762|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599763|NCT02200172|Melatonin|melatonin|mesh-list
20599764|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
20599765|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599766|NCT02200172|Protective Agents|protective agents|mesh-ancestor
20599767|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599768|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599769|NCT02200185|Morphine|morphine|mesh-list
20599770|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20599771|NCT02200185|Narcotics|narcotics|mesh-ancestor
20599772|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599773|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599774|NCT02200185|Analgesics|analgesics|mesh-ancestor
20599775|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
20599776|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599777|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
20599778|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20599779|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
20599780|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599781|NCT02200237|Antacids|antacids|mesh-ancestor
20599782|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599783|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20599784|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
20599785|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20599786|NCT02200354|Bevacizumab|bevacizumab|mesh-list
20599787|NCT02200354|Pemetrexed|pemetrexed|mesh-list
20599788|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20599789|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599790|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20599791|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20599792|NCT02200354|Growth Substances|growth substances|mesh-ancestor
20599793|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599794|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
20599795|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599796|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084041|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084042|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
20084043|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084044|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
20084045|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084046|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
20084047|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084048|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084049|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084050|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084051|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084052|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084053|NCT00000688|Ganciclovir|ganciclovir|mesh-list
20084054|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20084055|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
20084056|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084057|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084058|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084059|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084060|NCT00000689|Leucovorin|leucovorin|mesh-list
20084061|NCT00000689|Cytarabine|cytarabine|mesh-list
20084062|NCT00000689|Dexamethasone|dexamethasone|mesh-list
20084063|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
20084064|NCT00000689|Doxorubicin|doxorubicin|mesh-list
20084065|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20599797|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20599798|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20599799|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20599800|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20599801|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20599802|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20599803|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599804|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20084066|NCT00000689|Methotrexate|methotrexate|mesh-list
20084067|NCT00000689|Vincristine|vincristine|mesh-list
20084068|NCT00000689|Bleomycin|bleomycin|mesh-list
20084069|NCT00000689|Sargramostim|sargramostim|mesh-list
20084070|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
20084071|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20084072|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
20084073|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084074|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20084075|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20084076|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
20084077|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084078|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084079|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20084080|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20084081|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
20084082|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
20084083|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084084|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20084085|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
20084086|NCT00000689|Hormones|hormones|mesh-ancestor
20084087|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084088|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20084089|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20084090|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20084091|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20084092|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084093|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20084094|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
20084095|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20084096|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20084097|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
20084098|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
20084099|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084100|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084101|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
20084102|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084103|NCT00000689|Antidotes|antidotes|mesh-ancestor
20084104|NCT00000689|Protective Agents|protective agents|mesh-ancestor
20084105|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
20084106|NCT00000689|Vitamins|vitamins|mesh-ancestor
20084107|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
20084108|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20084109|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
20084110|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
20084111|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
20084112|NCT00000690|Dextrans|dextrans|mesh-list
20599805|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599806|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
20599807|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20599808|NCT02200562|Ipilimumab|ipilimumab|mesh-list
20599809|NCT02200562|Dabrafenib|dabrafenib|mesh-list
20599810|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20599811|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599812|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20599813|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599814|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20599815|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599816|NCT02200575|Telmisartan|telmisartan|mesh-list
20599817|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20599818|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20599819|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20599820|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599821|NCT02200640|Losartan|losartan|mesh-list
20599822|NCT02200640|Telmisartan|telmisartan|mesh-list
20599823|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20599824|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20599825|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20599826|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20599827|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599828|NCT02200653|Losartan|losartan|mesh-list
20599829|NCT02200653|Telmisartan|telmisartan|mesh-list
20599830|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20599831|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20599832|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20084113|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
20084114|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
20599833|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20599834|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599835|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
20084115|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
20084116|NCT00000691|Foscarnet|foscarnet|mesh-list
20084117|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20084118|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
20084119|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084120|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084121|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084122|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599836|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20599837|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
20599838|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599839|NCT02200757|Topotecan|topotecan|mesh-list
20599840|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20599841|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20599842|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599843|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599844|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599845|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20599846|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20599847|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
20599848|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599849|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599850|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599851|NCT02200848|Rituximab|rituximab|mesh-list
20599852|NCT02200848|Lenalidomide|lenalidomide|mesh-list
20599853|NCT02200848|Glutarimide|glutarimide|mesh-list
20599854|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20599855|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599856|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
20599857|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084123|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084124|NCT00000692|Miglustat|miglustat|mesh-list
20084125|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084126|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084127|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084128|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084129|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
20599858|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20599859|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20599860|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20599861|NCT02200848|Growth Substances|growth substances|mesh-ancestor
20599862|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
20599863|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20599864|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599865|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599866|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
20599867|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20599868|NCT02200991|Lixisenatide|lixisenatide|mesh-list
20599869|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599870|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599871|NCT02200991|Incretins|incretins|mesh-ancestor
20084130|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084131|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20084132|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599872|NCT02200991|Hormones|hormones|mesh-ancestor
20599873|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20599874|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20599875|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
20599876|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084133|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084134|NCT00000693|Zidovudine|zidovudine|mesh-list
20084135|NCT00000693|Acyclovir|acyclovir|mesh-list
20084136|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
20084137|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084138|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084139|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084140|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084141|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
20084142|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084143|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084144|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084145|NCT00000694|Interferons|interferons|mesh-list
20599877|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599878|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
20599879|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599880|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599881|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20599882|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599883|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20599884|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
20599885|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599886|NCT02201043|Thalidomide|thalidomide|mesh-list
20599887|NCT02201043|Tolnaftate|tolnaftate|mesh-list
20084146|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
20599888|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20599889|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
20599890|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599891|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
20599892|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599893|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599894|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20599895|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20599896|NCT02201043|Growth Substances|growth substances|mesh-ancestor
20599897|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
20599898|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599899|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
20599900|NCT02201082|Amikacin|amikacin|mesh-list
20599901|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599902|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599903|NCT02201121|Phenylephrine|phenylephrine|mesh-list
20599904|NCT02201121|Dopamine|dopamine|mesh-list
20599905|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
20599906|NCT02201121|Ephedrine|ephedrine|mesh-list
20599907|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20599908|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
20599909|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
20599910|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599911|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599912|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
20599913|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20599914|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
20599915|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
20599916|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20599917|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20599918|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20599919|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
20599920|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599921|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599922|NCT02201121|Protective Agents|protective agents|mesh-ancestor
20599923|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20599924|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
20599925|NCT02201134|Sevoflurane|sevoflurane|mesh-list
20599926|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20599927|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20599928|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
20599929|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
20599930|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20599931|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599932|NCT02201199|Insulin|insulin|mesh-list
20599933|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20599934|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
20599935|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599936|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599937|NCT02201225|Micronutrients|micronutrients|mesh-list
20599938|NCT02201225|Trace Elements|trace elements|mesh-list
20599939|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599940|NCT02201238|Diclofenac|diclofenac|mesh-list
20599941|NCT02201238|Menthol|menthol|mesh-list
20599942|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20599943|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20599944|NCT02201238|Analgesics|analgesics|mesh-ancestor
20599945|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
20599946|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20599947|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599948|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20599949|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20599950|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20599951|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599952|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599953|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
20599954|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
20599955|NCT02201316|Mosapride|mosapride|mesh-list
20599956|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599957|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20599958|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20599959|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
20599960|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20599961|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599962|NCT02201342|Udenafil|udenafil|mesh-list
20599963|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20599964|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20599965|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599966|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607665|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20607666|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
20607667|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
20607668|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607669|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607670|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607671|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
20607672|NCT02243124|Hormones|hormones|mesh-ancestor
20084147|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
20084148|NCT00000694|Zidovudine|zidovudine|mesh-list
20084149|NCT00000694|Sargramostim|sargramostim|mesh-list
20084150|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084151|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
20084152|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084153|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
20084154|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084155|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
20084156|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084157|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20607673|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20607674|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20607675|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607676|NCT02243137|Aspirin|aspirin|mesh-list
20607677|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
20607678|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20607679|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20607680|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20607681|NCT02243137|Analgesics|analgesics|mesh-ancestor
20607682|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
20607683|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607684|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607685|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20607686|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607687|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20607688|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20607689|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607690|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20607691|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20607692|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607693|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
20607694|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
20607695|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20607696|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084158|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084159|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084160|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084161|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084162|NCT00000695|Interferons|interferons|mesh-list
20084163|NCT00000695|Zidovudine|zidovudine|mesh-list
20084164|NCT00000695|Interferon-beta|interferon-beta|mesh-list
20084165|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
20084166|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084167|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
20084168|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084169|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
20084170|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084171|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084172|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084173|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084174|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084175|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084176|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
20084177|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084178|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20607697|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607698|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20607699|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20607700|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607701|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607702|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084179|NCT00000696|Interferons|interferons|mesh-list
20084180|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
20084181|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
20599967|NCT02201381|Metformin|metformin|mesh-list
20599968|NCT02201381|Doxycycline|doxycycline|mesh-list
20599969|NCT02201381|Mebendazole|mebendazole|mesh-list
20599970|NCT02201381|Atorvastatin|atorvastatin|mesh-list
20599971|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20599972|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20599973|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20599974|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20599975|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
20599976|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20599977|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20599978|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20599979|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20599980|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20599981|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599982|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
20599983|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20599984|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20599985|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
20599986|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
20599987|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
20599988|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
20599989|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
20084182|NCT00000696|Zidovudine|zidovudine|mesh-list
20084183|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084184|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
20084185|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599990|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599991|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20599992|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
20599993|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20599994|NCT02201459|Interferons|interferons|mesh-list
20599995|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
20599996|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
20599997|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20599998|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20599999|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
20600000|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600001|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
20600002|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600003|NCT02201563|Minocycline|minocycline|mesh-list
20600004|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600005|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600006|NCT02201576|Bortezomib|bortezomib|mesh-list
20600007|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
20600008|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20600009|NCT02201576|Antibodies|antibodies|mesh-list
20600010|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
20600011|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20600012|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600013|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
20600014|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600015|NCT02201602|Gliclazide|gliclazide|mesh-list
20600016|NCT02201602|Glyburide|glyburide|mesh-list
20600017|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20600018|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600019|NCT02201641|Calcium|calcium|mesh-list
20600020|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600021|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600022|NCT02201667|Aspirin|aspirin|mesh-list
20600023|NCT02201667|Clopidogrel|clopidogrel|mesh-list
20600024|NCT02201667|Ticagrelor|ticagrelor|mesh-list
20600025|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20600026|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20600027|NCT02201667|Analgesics|analgesics|mesh-ancestor
20600028|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
20600029|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600030|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600031|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600032|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600033|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20600034|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20600035|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600036|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20600037|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20600038|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600039|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
20600040|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20600041|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20600042|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20600043|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
20600044|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600045|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20600046|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
20600047|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600048|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
20600049|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600050|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20600051|NCT02201914|Clomiphene|clomiphene|mesh-list
20600052|NCT02201914|Enclomiphene|enclomiphene|mesh-list
20600053|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
20600054|NCT02201914|Cetrorelix|cetrorelix|mesh-list
20600055|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20600056|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
20600057|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20600058|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600059|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20084186|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
20084187|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600060|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
20600061|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20084188|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
20084189|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084190|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084191|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600062|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20600063|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20600064|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
20084192|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084193|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084194|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084195|NCT00000697|Foscarnet|foscarnet|mesh-list
20084196|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20084197|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
20084198|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084199|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084200|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084201|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600065|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20600066|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
20600067|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20600068|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20600069|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600070|NCT02201992|Crizotinib|crizotinib|mesh-list
20600071|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600072|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20600073|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600074|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600075|NCT02202005|Nevirapine|nevirapine|mesh-list
20600076|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20600077|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600078|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600079|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600080|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
20600081|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600082|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20600083|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20600084|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20084202|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084203|NCT00000698|Ganciclovir|ganciclovir|mesh-list
20084204|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20084205|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
20084206|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084207|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084208|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084209|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084210|NCT00000699|Ribavirin|ribavirin|mesh-list
20084211|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
20084212|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
20084213|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084214|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
20084215|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084216|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20084217|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
20084218|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600085|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20600086|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20600087|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20600088|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20600089|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600090|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600091|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20600092|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600093|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600094|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
20600095|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600096|NCT02202200|Palbociclib|palbociclib|mesh-list
20600097|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600098|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20600099|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600100|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600101|NCT02202239|Fentanyl|fentanyl|mesh-list
20084219|NCT00000700|Zidovudine|zidovudine|mesh-list
20084220|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
20084221|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084222|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084223|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084224|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084225|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
20084226|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084227|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084228|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084229|NCT00000701|Zidovudine|zidovudine|mesh-list
20084230|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
20084231|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084232|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084233|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084234|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600102|NCT02202239|Midazolam|midazolam|mesh-list
20600103|NCT02202239|Remifentanil|remifentanil|mesh-list
20600104|NCT02202239|Propofol|propofol|mesh-list
20600105|NCT02202239|Etomidate|etomidate|mesh-list
20600106|NCT02202239|Sevoflurane|sevoflurane|mesh-list
20600107|NCT02202239|Cisatracurium|cisatracurium|mesh-list
20600108|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20600109|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600110|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600111|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20600112|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
20600113|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
20600114|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20600115|NCT02202239|Narcotics|narcotics|mesh-ancestor
20600116|NCT02202239|Analgesics|analgesics|mesh-ancestor
20600117|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
20600118|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600119|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20084235|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
20084236|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600120|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20600121|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20600122|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20600123|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
20600124|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
20600125|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600126|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600127|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20600128|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20600129|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20600130|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20600131|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
20600132|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20600133|NCT02202304|Thymol|thymol|mesh-list
20600134|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20600135|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600136|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
20600137|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
20600138|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
20600139|NCT02202473|Lamivudine|lamivudine|mesh-list
20600140|NCT02202473|Oxymatrine|oxymatrine|mesh-list
20600141|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20600142|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600143|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600144|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600145|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
20600146|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600147|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20600148|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20600149|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20600150|NCT02202512|Naproxen|naproxen|mesh-list
20600151|NCT02202512|Cimetidine|cimetidine|mesh-list
20600152|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20600153|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20600154|NCT02202512|Analgesics|analgesics|mesh-ancestor
20600155|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
20600156|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600157|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600158|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600159|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600160|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
20600161|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20600162|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600163|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600164|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20600165|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20600166|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20600167|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
20600168|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
20600169|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600170|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20600171|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20600172|NCT02202525|Telmisartan|telmisartan|mesh-list
20600173|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600174|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20084237|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084238|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20600175|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20600176|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600177|NCT02202564|Ganciclovir|ganciclovir|mesh-list
20600178|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20600179|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
20600180|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084239|NCT00000702|Zidovudine|zidovudine|mesh-list
20084240|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
20084241|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084242|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084243|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084244|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084245|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
20084246|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600181|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600182|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600183|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600184|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
20084247|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20600185|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
20600186|NCT02202577|Povidone|povidone|mesh-list
20600187|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20600188|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600189|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
20600190|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
20600191|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
20600192|NCT02202603|Teriparatide|teriparatide|mesh-list
20600193|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600194|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600195|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20600196|NCT02202707|Gabapentin|gabapentin|mesh-list
20600197|NCT02202707|Analgesics|analgesics|mesh-ancestor
20600198|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
20600199|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600200|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600201|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
20600202|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20600203|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20600204|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600205|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20600206|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20600207|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20600208|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600209|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600210|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
20600211|NCT02202720|Sevoflurane|sevoflurane|mesh-list
20600212|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20600213|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20600214|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
20600215|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
20600216|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600217|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600218|NCT02202889|Calcium|calcium|mesh-list
20600219|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600220|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600221|NCT02202967|Misoprostol|misoprostol|mesh-list
20600222|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20600223|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
20600224|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20600225|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600226|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20600227|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20084248|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084249|NCT00000703|Leucovorin|leucovorin|mesh-list
20084250|NCT00000703|Cytarabine|cytarabine|mesh-list
20084251|NCT00000703|Zidovudine|zidovudine|mesh-list
20084252|NCT00000703|Dexamethasone|dexamethasone|mesh-list
20084253|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
20084254|NCT00000703|Doxorubicin|doxorubicin|mesh-list
20084255|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20084256|NCT00000703|Methotrexate|methotrexate|mesh-list
20084257|NCT00000703|Vincristine|vincristine|mesh-list
20084258|NCT00000703|Bleomycin|bleomycin|mesh-list
20084259|NCT00000703|Allopurinol|allopurinol|mesh-list
20084260|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
20084261|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20084262|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
20084263|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084264|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20084265|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20084266|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
20084267|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084268|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084269|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20084270|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20084271|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
20084272|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
20084273|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084274|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20084275|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
20084276|NCT00000703|Hormones|hormones|mesh-ancestor
20084277|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084278|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20084279|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20600228|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
20084280|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20084281|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20600229|NCT02202993|Mibefradil|mibefradil|mesh-list
20600230|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600231|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20600232|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600233|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600234|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600235|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600236|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
20600237|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20600238|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20600239|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607703|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20607704|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
20607705|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20607706|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607707|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20607708|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20607709|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20607710|NCT02243254|Ibuprofen|ibuprofen|mesh-list
20607711|NCT02243254|Remifentanil|remifentanil|mesh-list
20607712|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20607713|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20607714|NCT02243254|Analgesics|analgesics|mesh-ancestor
20607715|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
20607716|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084282|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607717|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607718|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20607719|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607720|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20607721|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607722|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607723|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20607724|NCT02243254|Narcotics|narcotics|mesh-ancestor
20607725|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607726|NCT02243358|Gemcitabine|gemcitabine|mesh-list
20607727|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20607728|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
20600240|NCT02203097|Propofol|propofol|mesh-list
20600241|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20600242|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600243|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600244|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20600245|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
20600246|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
20600247|NCT02203175|Fentanyl|fentanyl|mesh-list
20600248|NCT02203175|Propofol|propofol|mesh-list
20600249|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20600250|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600251|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600252|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20600253|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
20600254|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
20600255|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20600256|NCT02203175|Narcotics|narcotics|mesh-ancestor
20600257|NCT02203175|Analgesics|analgesics|mesh-ancestor
20600258|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
20084283|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20084284|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
20600259|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600260|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20600261|NCT02203227|Turmeric extract|turmeric extract|mesh-list
20600262|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
20600263|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600264|NCT02203227|Protective Agents|protective agents|mesh-ancestor
20600265|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600266|NCT02203253|Thalidomide|thalidomide|mesh-list
20600267|NCT02203253|Dexamethasone|dexamethasone|mesh-list
20600268|NCT02203253|Palonosetron|palonosetron|mesh-list
20600269|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600270|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
20600271|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
20600272|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600273|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600274|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20600275|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
20600276|NCT02203253|Hormones|hormones|mesh-ancestor
20600277|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20600278|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20600279|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600280|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600281|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
20600282|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
20600283|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600284|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600285|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20600286|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20600287|NCT02203253|Growth Substances|growth substances|mesh-ancestor
20600288|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
20600289|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20600290|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20600291|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
20600292|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600293|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600294|NCT02203396|Cyclosporine|cyclosporine|mesh-list
20600295|NCT02203396|Levamisole|levamisole|mesh-list
20600296|NCT02203396|Cyclosporins|cyclosporins|mesh-list
20600297|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
20600298|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600299|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600300|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600301|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
20084285|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20084286|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20084287|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
20084288|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
20084289|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084290|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600302|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600303|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
20600304|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600305|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
20600306|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600307|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20600308|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20600309|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
20600310|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
20600311|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20600312|NCT02203422|Cyclosporine|cyclosporine|mesh-list
20600313|NCT02203422|Cyclosporins|cyclosporins|mesh-list
20600314|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600315|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084291|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
20084292|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084293|NCT00000703|Antidotes|antidotes|mesh-ancestor
20084294|NCT00000703|Protective Agents|protective agents|mesh-ancestor
20084295|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
20084296|NCT00000703|Vitamins|vitamins|mesh-ancestor
20084297|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
20600316|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600317|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
20600318|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084298|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20600319|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
20600320|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600321|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
20600322|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600323|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20600324|NCT02203461|Ritonavir|ritonavir|mesh-list
20600325|NCT02203461|Lopinavir|lopinavir|mesh-list
20600326|NCT02203461|Darunavir|darunavir|mesh-list
20600327|NCT02203461|Tenofovir|tenofovir|mesh-list
20084299|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
20084300|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
20084301|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
20084302|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084303|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084304|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084305|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
20084306|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20084307|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
20084308|NCT00000704|Zalcitabine|zalcitabine|mesh-list
20084309|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
20084310|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084311|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084312|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084313|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084314|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
20600328|NCT02203461|Emtricitabine|emtricitabine|mesh-list
20600329|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20600330|NCT02203461|Cobicistat|cobicistat|mesh-list
20600331|NCT02203461|Elvitegravir|elvitegravir|mesh-list
20600332|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20600333|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20600334|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
20600335|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600336|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600337|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20600338|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20600339|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
20600340|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600341|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20600342|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20600343|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20600344|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600345|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20600346|NCT02203500|Telmisartan|telmisartan|mesh-list
20600347|NCT02203500|Lacidipine|lacidipine|mesh-list
20600348|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600349|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20600350|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20600351|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600352|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20600353|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600354|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600355|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600356|NCT02203552|Minocycline|minocycline|mesh-list
20600357|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600358|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600359|NCT02203604|Aldesleukin|aldesleukin|mesh-list
20600360|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20600361|NCT02203604|Ipilimumab|ipilimumab|mesh-list
20600362|NCT02203604|Interleukin-2|interleukin-2|mesh-list
20600363|NCT02203604|Antibodies|antibodies|mesh-list
20600364|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
20600365|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20600366|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
20600367|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600368|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600369|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20600370|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600371|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20600372|NCT02203604|Analgesics|analgesics|mesh-ancestor
20600373|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
20600374|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600375|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20600376|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20600377|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
20600378|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600379|NCT02203643|Dexamethasone|dexamethasone|mesh-list
20600380|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
20600381|NCT02203643|Lenalidomide|lenalidomide|mesh-list
20600382|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600383|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
20600384|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600385|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600386|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20600387|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
20600388|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600389|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600390|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20600391|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600392|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
20600393|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
20600394|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600395|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20600396|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
20600397|NCT02203643|Hormones|hormones|mesh-ancestor
20600398|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20600399|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20600400|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20600401|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20600402|NCT02203643|Growth Substances|growth substances|mesh-ancestor
20600403|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
20600404|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
20600405|NCT02203656|Testosterone|testosterone|mesh-list
20600406|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
20600407|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
20600408|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20600409|NCT02203656|Androgens|androgens|mesh-ancestor
20600410|NCT02203656|Hormones|hormones|mesh-ancestor
20600411|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20600412|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600413|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20600414|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600415|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
20600416|NCT02203760|Gemcitabine|gemcitabine|mesh-list
20600417|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20600418|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
20600419|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600420|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600421|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
20600422|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600423|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600424|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600425|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
20600426|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084315|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084316|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084317|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084318|NCT00000705|Zidovudine|zidovudine|mesh-list
20084319|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
20084320|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600427|NCT02203773|Posaconazole|posaconazole|mesh-list
20600428|NCT02203773|Azacitidine|azacitidine|mesh-list
20600429|NCT02203773|Decitabine|decitabine|mesh-list
20600430|NCT02203773|Venetoclax|venetoclax|mesh-list
20600431|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20600432|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
20600433|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600434|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600435|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600436|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
20600437|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600438|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20600439|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20600440|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20600441|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20600442|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20600443|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20600444|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
20600445|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20600446|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600447|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
20600448|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600449|NCT02204020|Azacitidine|azacitidine|mesh-list
20600450|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20600451|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
20600452|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600453|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600454|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600455|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20600456|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20084321|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084322|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084323|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084324|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
20084325|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084326|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084327|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084328|NCT00000706|Zidovudine|zidovudine|mesh-list
20084329|NCT00000706|Quinine|quinine|mesh-list
20306082|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600457|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600458|NCT02204254|Doxycycline|doxycycline|mesh-list
20600459|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600460|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600461|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
20600462|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20600463|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20600464|NCT02204397|Ustekinumab|ustekinumab|mesh-list
20600465|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
20600466|NCT02204475|Interferons|interferons|mesh-list
20600467|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20600468|NCT02204475|Grazoprevir|grazoprevir|mesh-list
20600469|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600470|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
20600471|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600472|NCT02204501|Midazolam|midazolam|mesh-list
20600473|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20600474|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20600475|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600476|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600477|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20600478|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20600479|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20600480|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20600481|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
20600482|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
20600483|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
20600484|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
20600485|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600486|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600487|NCT02204527|Vitamin D|vitamin d|mesh-list
20600488|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
20600489|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
20600490|NCT02204527|Vitamins|vitamins|mesh-list
20600491|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
20600492|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600493|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20600494|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600495|NCT02204553|Panobinostat|panobinostat|mesh-list
20600496|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600497|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20600498|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600499|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600500|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
20600501|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
20600502|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600503|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20600504|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600505|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600506|NCT02204683|Aflibercept|aflibercept|mesh-list
20600507|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20600508|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20600509|NCT02204683|Growth Substances|growth substances|mesh-ancestor
20084330|NCT00000706|Probenecid|probenecid|mesh-list
20600510|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600511|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
20600512|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600513|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
20600514|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600515|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20600516|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746678|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746679|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
19746680|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746681|NCT02188745|Letrozole|letrozole|mesh-list
19746682|NCT02188745|Anastrozole|anastrozole|mesh-list
19746683|NCT02188745|Exemestane|exemestane|mesh-list
19746684|NCT02188745|Estradiol|estradiol|mesh-list
19746685|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19746686|NCT02188745|Estrogens|estrogens|mesh-ancestor
19746687|NCT02188745|Hormones|hormones|mesh-ancestor
19746688|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746689|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600517|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746690|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746691|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19746692|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600518|NCT02204839|Insulin|insulin|mesh-list
20600519|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
20600520|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
20600521|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20600522|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600523|NCT02204852|Iloprost|iloprost|mesh-list
20600524|NCT02204852|Eptifibatide|eptifibatide|mesh-list
20600525|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20600526|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
20600527|NCT02204878|Parecoxib|parecoxib|mesh-list
20600528|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20084331|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
20084332|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084333|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084334|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600529|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20600530|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084335|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600531|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600532|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20600533|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20600534|NCT02204878|Analgesics|analgesics|mesh-ancestor
20600535|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
20600536|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600537|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600538|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600539|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607729|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607730|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607731|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
20607732|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607733|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600540|NCT02205034|Oxytocin|oxytocin|mesh-list
20600541|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
20600542|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20600543|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600544|NCT02205112|Levofloxacin|levofloxacin|mesh-list
20600545|NCT02205112|Ofloxacin|ofloxacin|mesh-list
20600546|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20600547|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600548|NCT02205112|Renal Agents|renal agents|mesh-ancestor
20600549|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600550|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20600551|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20600552|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600553|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600554|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600555|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20600556|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20600557|NCT02205151|Amlodipine|amlodipine|mesh-list
20600558|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600559|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20600560|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600561|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600562|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600563|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600564|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
20600565|NCT02205164|Aprepitant|aprepitant|mesh-list
20600566|NCT02205164|Palonosetron|palonosetron|mesh-list
20600567|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
20600568|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
20600569|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600570|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600571|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20600572|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20600573|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600574|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600575|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20600576|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20600577|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
20600578|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20600579|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20600580|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20600581|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
20600582|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084336|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
20084337|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084338|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20600583|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20600584|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20600585|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600586|NCT02205242|Azithromycin|azithromycin|mesh-list
20600587|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600588|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600589|NCT02205255|Azithromycin|azithromycin|mesh-list
20600590|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600591|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600592|NCT02205398|Cetuximab|cetuximab|mesh-list
20600593|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20600594|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600595|NCT02205489|Cetirizine|cetirizine|mesh-list
20600596|NCT02205489|Acyclovir|acyclovir|mesh-list
20600597|NCT02205489|Ibuprofen|ibuprofen|mesh-list
20600598|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
20600599|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20600600|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20600601|NCT02205489|Prednisolone|prednisolone|mesh-list
20600602|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
20600603|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
20600604|NCT02205489|Esomeprazole|esomeprazole|mesh-list
20084339|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084340|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
20084341|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084342|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084343|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20600605|NCT02205489|Ranitidine|ranitidine|mesh-list
20084344|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600606|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20600607|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
20600608|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20600609|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20600610|NCT02205489|Analgesics|analgesics|mesh-ancestor
20084345|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20084346|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084347|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20084348|NCT00000706|Analgesics|analgesics|mesh-ancestor
20084349|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
20084350|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
20084351|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
20084352|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20084353|NCT00000706|Renal Agents|renal agents|mesh-ancestor
20084354|NCT00000707|Pentamidine|pentamidine|mesh-list
20084355|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
20084356|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084357|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084358|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084359|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20084360|NCT00000708|Fluconazole|fluconazole|mesh-list
20084361|NCT00000708|Amphotericin B|amphotericin b|mesh-list
20084362|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20084363|NCT00000708|Flucytosine|flucytosine|mesh-list
20084364|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
20084365|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084366|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20084367|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084368|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084369|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084370|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20084371|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
20084372|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084373|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084374|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20084375|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20084376|NCT00000708|Amebicides|amebicides|mesh-ancestor
20084377|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20600611|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
20600612|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600613|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600614|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600615|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600616|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20600617|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600618|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084378|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20600619|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
20600620|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
20600621|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20600622|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
20600623|NCT02205489|Hormones|hormones|mesh-ancestor
20600624|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20600625|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20600626|NCT02205489|Protective Agents|protective agents|mesh-ancestor
20600627|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20600628|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600629|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20600630|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20600631|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20600632|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
20600633|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600634|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20600635|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20600636|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20600637|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
20600638|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
20600639|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600640|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20600641|NCT02205502|Lidocaine|lidocaine|mesh-list
20600642|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
20600643|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
20600644|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600645|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600646|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
20600647|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600648|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20600649|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20600650|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20600651|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600652|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600653|NCT02205515|Everolimus|everolimus|mesh-list
20600654|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600655|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600656|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
20600657|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600658|NCT02205541|Eculizumab|eculizumab|mesh-list
20600659|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20600660|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600661|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
20600662|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600663|NCT02205554|Tramadol|tramadol|mesh-list
20600664|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20600665|NCT02205554|Narcotics|narcotics|mesh-ancestor
20600666|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600667|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600668|NCT02205554|Analgesics|analgesics|mesh-ancestor
20600669|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
20600670|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600671|NCT02205580|Sufentanil|sufentanil|mesh-list
20600672|NCT02205580|Dsuvia|dsuvia|mesh-list
20600673|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20600674|NCT02205580|Narcotics|narcotics|mesh-ancestor
20600675|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600676|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600677|NCT02205580|Analgesics|analgesics|mesh-ancestor
20600678|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
20600679|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600680|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20600681|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20600682|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
20600683|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
20600684|NCT02205619|Glycine|glycine|mesh-list
20600685|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
20600686|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600687|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600688|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600689|NCT02205775|Atorvastatin|atorvastatin|mesh-list
20600690|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20600691|NCT02205775|Ezetimibe|ezetimibe|mesh-list
20600692|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20600693|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20600694|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
20600695|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600696|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20600697|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20600698|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600699|NCT02205879|Pregabalin|pregabalin|mesh-list
20600700|NCT02205879|Analgesics|analgesics|mesh-ancestor
20600701|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
20600702|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600703|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600704|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
20600705|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20600706|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600707|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600708|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600709|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20600710|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20600711|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600712|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20600713|NCT02205892|Lupeol|lupeol|mesh-list
20600714|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600715|NCT02205931|Topiramate|topiramate|mesh-list
20600716|NCT02205931|Lamotrigine|lamotrigine|mesh-list
20600717|NCT02205931|Zonisamide|zonisamide|mesh-list
20600718|NCT02205931|Carbamazepine|carbamazepine|mesh-list
20600719|NCT02205931|Phenytoin|phenytoin|mesh-list
20600720|NCT02205931|Rufinamide|rufinamide|mesh-list
20600721|NCT02205931|Levetiracetam|levetiracetam|mesh-list
20600722|NCT02205931|Valproic Acid|valproic acid|mesh-list
20600723|NCT02205931|Clonazepam|clonazepam|mesh-list
20600724|NCT02205931|Vigabatrin|vigabatrin|mesh-list
20600725|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
20600726|NCT02205931|Clobazam|clobazam|mesh-list
20600727|NCT02205931|Ethosuximide|ethosuximide|mesh-list
20600728|NCT02205931|Stiripentol|stiripentol|mesh-list
20600729|NCT02205931|Nitrazepam|nitrazepam|mesh-list
20600730|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20600731|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600732|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
20600733|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20600734|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600735|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600736|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600737|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20600738|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20600739|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600740|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20600741|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20600742|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600743|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
20600744|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600745|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
20600746|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20600747|NCT02205931|Analgesics|analgesics|mesh-ancestor
20600748|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
20600749|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600750|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20600751|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20600752|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20600753|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20600754|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
20600755|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20600756|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20600757|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
20600758|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20600759|NCT02205996|Insulin|insulin|mesh-list
20600760|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20600761|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20600762|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600763|NCT02206022|Remifentanil|remifentanil|mesh-list
20600764|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20600765|NCT02206022|Narcotics|narcotics|mesh-ancestor
20600766|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20600767|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600768|NCT02206022|Analgesics|analgesics|mesh-ancestor
20600769|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
20600770|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600771|NCT02206035|Methotrexate|methotrexate|mesh-list
20600772|NCT02206035|Tacrolimus|tacrolimus|mesh-list
20600773|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20600774|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
20600775|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20600776|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600777|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20600778|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
20600779|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600780|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600781|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
20600782|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600783|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20600784|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600785|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
20600786|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600787|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600788|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20600789|NCT02206048|Proflavine|proflavine|mesh-list
20600790|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20600791|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600792|NCT02206165|Amlodipine|amlodipine|mesh-list
20600793|NCT02206165|Candesartan|candesartan|mesh-list
20600794|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
20600795|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600796|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20600797|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20600798|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600799|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20600800|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600801|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
20600802|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20600803|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20600804|NCT02206178|Acetaminophen|acetaminophen|mesh-list
20600805|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
20084379|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084380|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
20120104|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120105|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120106|NCT00006275|Calcitriol|calcitriol|mesh-list
20120107|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20120108|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120109|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20120110|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20120111|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120112|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20120113|NCT00006275|Vitamins|vitamins|mesh-ancestor
20120114|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
20120115|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20120116|NCT00006276|Paclitaxel|paclitaxel|mesh-list
20120117|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120118|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600806|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20600807|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20600808|NCT02206178|Analgesics|analgesics|mesh-ancestor
20600809|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
20600810|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600811|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600812|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
20600813|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
20600814|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600815|NCT02206178|Expectorants|expectorants|mesh-ancestor
20600816|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
20600817|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20600818|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
20600819|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600820|NCT02206178|Protective Agents|protective agents|mesh-ancestor
20600821|NCT02206178|Antidotes|antidotes|mesh-ancestor
20600822|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
20600823|NCT02206204|Selexipag|selexipag|mesh-list
20600824|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20600825|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20600826|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600827|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20600828|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120119|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
20600829|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600830|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600831|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600832|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20600833|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
20600834|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20600835|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600836|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20600837|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20600838|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20600839|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600840|NCT02206295|Selexipag|selexipag|mesh-list
20600841|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600842|NCT02206308|Antibodies|antibodies|mesh-list
20600843|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20600844|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
20600845|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600846|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
20600847|NCT02206425|Dexamethasone|dexamethasone|mesh-list
20600848|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
20600849|NCT02206425|Prednisone|prednisone|mesh-list
20600850|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
20600851|NCT02206425|Melphalan|melphalan|mesh-list
20600852|NCT02206425|Doxorubicin|doxorubicin|mesh-list
20600853|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20600854|NCT02206425|Lenalidomide|lenalidomide|mesh-list
20600855|NCT02206425|Pomalidomide|pomalidomide|mesh-list
20600856|NCT02206425|BB 1101|bb 1101|mesh-list
20600857|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600858|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
20600859|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600860|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600861|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20600862|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
20600863|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600864|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600865|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20600866|NCT02206425|Vitamins|vitamins|mesh-ancestor
20600867|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
20600868|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600869|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
20600870|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
20600871|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600872|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20600873|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
20600874|NCT02206425|Hormones|hormones|mesh-ancestor
20600875|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084381|NCT00000709|Zidovudine|zidovudine|mesh-list
20084382|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
20084383|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084384|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084385|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084386|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084387|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
20084388|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084389|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084390|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20600876|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20600877|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
20600878|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600879|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20600880|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20600881|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20600882|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20600883|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20600884|NCT02206425|Growth Substances|growth substances|mesh-ancestor
20600885|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
20600886|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
20600887|NCT02206425|Protective Agents|protective agents|mesh-ancestor
20600888|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20600889|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20084391|NCT00000710|Didanosine|didanosine|mesh-list
20600890|NCT02206477|Protective Agents|protective agents|mesh-ancestor
20600891|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600892|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20600893|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
20600894|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600895|NCT02206490|Naltrexone|naltrexone|mesh-list
20600896|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
20600897|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20600898|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20600899|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600900|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
20600901|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600902|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
20600903|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
20600904|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20600905|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20600906|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600907|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600908|NCT02206503|Dexamethasone|dexamethasone|mesh-list
20600909|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
20600910|NCT02206503|Lenalidomide|lenalidomide|mesh-list
20600911|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600912|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
20600913|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600914|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600915|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20600916|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
20600917|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600918|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600919|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20600920|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600921|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
20600922|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
20600923|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600924|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20600925|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
20600926|NCT02206503|Hormones|hormones|mesh-ancestor
20600927|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20600928|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20600929|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20600930|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20600931|NCT02206503|Growth Substances|growth substances|mesh-ancestor
20600932|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
20607734|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607735|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
20607736|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607737|NCT02243436|Cytarabine|cytarabine|mesh-list
20607738|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
20607739|NCT02243436|Etoposide|etoposide|mesh-list
20607740|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20607741|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607742|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20607743|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20607744|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20607745|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607746|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607747|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20607748|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
20607749|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
20607750|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607751|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600933|NCT02206555|Tenofovir|tenofovir|mesh-list
20600934|NCT02206555|Emtricitabine|emtricitabine|mesh-list
20600935|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20600936|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
20600937|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600938|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20600939|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600940|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600941|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600942|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084392|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
20084393|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600943|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084394|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084395|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20600944|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
20600945|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
20600946|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20600947|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600948|NCT02206646|Tenecteplase|tenecteplase|mesh-list
20600949|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20600950|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20600951|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600952|NCT02206659|Telmisartan|telmisartan|mesh-list
20600953|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20600954|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20600955|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20600956|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600957|NCT02206711|BMS-955176|bms-955176|mesh-list
20600958|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20600959|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20600960|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
20600961|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600962|NCT02206737|Nicotine|nicotine|mesh-list
20600963|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20600964|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
20600965|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20600966|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600967|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20600968|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20600969|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
20600970|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20600971|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600972|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20600973|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
20600974|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20600975|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20600976|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600977|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600978|NCT02206789|Cyclosporine|cyclosporine|mesh-list
20600979|NCT02206789|Prednisolone|prednisolone|mesh-list
20600980|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20600981|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
20600982|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20600983|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
20600984|NCT02206789|Cyclosporins|cyclosporins|mesh-list
20600985|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20600986|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
20600987|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20600988|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20600989|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20600990|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
20600991|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20600992|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
20600993|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20600994|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
20600995|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20600996|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20600997|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20600998|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
20600999|NCT02206789|Hormones|hormones|mesh-ancestor
20601000|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20601001|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20601002|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601003|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
20601004|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
20601005|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601006|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20601007|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20601008|NCT02206789|Protective Agents|protective agents|mesh-ancestor
20601009|NCT02206802|Minoxidil|minoxidil|mesh-list
20601010|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20601011|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
20084396|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084397|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
20084398|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084399|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084400|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084401|NCT00000711|Zidovudine|zidovudine|mesh-list
20084402|NCT00000711|Sargramostim|sargramostim|mesh-list
20084403|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
20084404|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084405|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084406|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601012|NCT02206815|Aspirin|aspirin|mesh-list
20601013|NCT02206815|Warfarin|warfarin|mesh-list
20601014|NCT02206815|Clopidogrel|clopidogrel|mesh-list
20601015|NCT02206815|Ticagrelor|ticagrelor|mesh-list
20601016|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20601017|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601018|NCT02206815|Analgesics|analgesics|mesh-ancestor
20601019|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
20601020|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601021|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601022|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601023|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601024|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20601025|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20601026|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601027|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20601028|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20601029|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601030|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
20601031|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20601032|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20601033|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20601034|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
20601035|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601036|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
20601037|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
20601038|NCT02206854|Analgesics|analgesics|mesh-ancestor
20601039|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
20601040|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601041|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601042|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20601043|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601044|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601045|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601046|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20601047|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601048|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601049|NCT02206867|Adalimumab|adalimumab|mesh-list
20601050|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601051|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601052|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
20601053|NCT02206932|Simeprevir|simeprevir|mesh-list
20601054|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
20601055|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601056|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
20601057|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601058|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601059|NCT02207010|Adavosertib|adavosertib|mesh-list
20601060|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601061|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601062|NCT02207335|Gemcitabine|gemcitabine|mesh-list
20601063|NCT02207335|Carboplatin|carboplatin|mesh-list
20601064|NCT02207335|Capecitabine|capecitabine|mesh-list
20601065|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601066|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20601067|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
20601068|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601069|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
20601070|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084407|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601071|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601072|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20601073|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
20601074|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601075|NCT02207348|Liraglutide|liraglutide|mesh-list
20601076|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20601077|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601078|NCT02207348|Incretins|incretins|mesh-ancestor
20601079|NCT02207348|Hormones|hormones|mesh-ancestor
20601080|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20601081|NCT02207361|Paclitaxel|paclitaxel|mesh-list
20601082|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20601083|NCT02207361|Carboplatin|carboplatin|mesh-list
20601084|NCT02207361|Epirubicin|epirubicin|mesh-list
20601085|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20601086|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601087|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
20601088|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
20601089|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
20601090|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601091|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20601092|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20601093|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20601094|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084408|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
20084409|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084410|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084411|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084412|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
20084413|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084414|NCT00000712|Zidovudine|zidovudine|mesh-list
20084415|NCT00000712|Acyclovir|acyclovir|mesh-list
20084416|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
20084417|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601095|NCT02207387|Rasagiline|rasagiline|mesh-list
20601096|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20601097|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601098|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601099|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20601100|NCT02207387|Protective Agents|protective agents|mesh-ancestor
20601101|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601102|NCT02207426|Tobramycin|tobramycin|mesh-list
20601103|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601104|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601105|NCT02207439|Nelfinavir|nelfinavir|mesh-list
20601106|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20601107|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20601108|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
20601109|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601110|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601111|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601112|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20601113|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
20601114|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601115|NCT02207452|Albuterol|albuterol|mesh-list
20601116|NCT02207452|Ipratropium|ipratropium|mesh-list
20601117|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20601118|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
20084418|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20607752|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
20084419|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084420|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084421|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
20084422|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084423|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084424|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084425|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20084426|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
20084427|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084428|NCT00000714|Leucovorin|leucovorin|mesh-list
20084429|NCT00000714|Trimetrexate|trimetrexate|mesh-list
20084430|NCT00000714|Calcium|calcium|mesh-list
20084431|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
20084432|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20084433|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084434|NCT00000714|Antidotes|antidotes|mesh-ancestor
20084435|NCT00000714|Protective Agents|protective agents|mesh-ancestor
20084436|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
20084437|NCT00000714|Vitamins|vitamins|mesh-ancestor
20084438|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
20084439|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
20084440|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084441|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20084442|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
20084443|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084444|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084445|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084446|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084447|NCT00000715|Trimethoprim|trimethoprim|mesh-list
20084448|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20084449|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
20084450|NCT00000715|Pentamidine|pentamidine|mesh-list
20084451|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20084452|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084453|NCT00000715|Renal Agents|renal agents|mesh-ancestor
20084454|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
20084455|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084456|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084457|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084458|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084459|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084460|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20084461|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20084462|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084463|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
20084464|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20084465|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084466|NCT00000716|Zidovudine|zidovudine|mesh-list
20084467|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
20084468|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084469|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084470|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084471|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084472|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
20084473|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084474|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084475|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084476|NCT00000717|Clindamycin|clindamycin|mesh-list
20084477|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
20084478|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
20601119|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601120|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601121|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20601122|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
20601123|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
20601124|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20601125|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20601126|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20601127|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20601128|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
20601129|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607753|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607754|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20084479|NCT00000717|Primaquine|primaquine|mesh-list
20084480|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20607755|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
20607756|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
20607757|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607758|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607759|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
20607760|NCT02243436|Hormones|hormones|mesh-ancestor
20607761|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20607762|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20607763|NCT02243436|Protective Agents|protective agents|mesh-ancestor
20607764|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20607765|NCT02243553|Vitamin K|vitamin k|mesh-list
20607766|NCT02243553|Ritonavir|ritonavir|mesh-list
20607767|NCT02243553|Tipranavir|tipranavir|mesh-list
20607768|NCT02243553|Digoxin|digoxin|mesh-list
20607769|NCT02243553|Midazolam|midazolam|mesh-list
20607770|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
20607771|NCT02243553|Caffeine|caffeine|mesh-list
20607772|NCT02243553|Omeprazole|omeprazole|mesh-list
20607773|NCT02243553|Warfarin|warfarin|mesh-list
20607774|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20607775|NCT02243553|Vitamins|vitamins|mesh-ancestor
20607776|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
20607777|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607778|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20607779|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20607780|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607781|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20607782|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20607783|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20607784|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20607785|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
20607786|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
20607787|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
20607788|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
20607789|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607790|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607791|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20607792|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20607793|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
20607794|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607795|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20607796|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20607797|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
20607798|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607799|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20607800|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20607801|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
20607802|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20607803|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607804|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20607805|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20607806|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20607807|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20084481|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084482|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20084483|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084484|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084485|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
20601130|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601131|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20601132|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
20601133|NCT02207660|Fluorouracil|fluorouracil|mesh-list
20601134|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601135|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
20601136|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601137|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20084486|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20601138|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20601139|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
20084487|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084488|NCT00000718|Zidovudine|zidovudine|mesh-list
20084489|NCT00000718|Zalcitabine|zalcitabine|mesh-list
20084490|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
20084491|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084492|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084493|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084494|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084495|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
20084496|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084497|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084498|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084499|NCT00000719|Zidovudine|zidovudine|mesh-list
20084500|NCT00000719|Zalcitabine|zalcitabine|mesh-list
20084501|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
20084502|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084503|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084504|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084505|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084506|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
20084507|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084508|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084509|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084510|NCT00000720|Zidovudine|zidovudine|mesh-list
20084511|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
20084512|NCT00000720|Antibodies|antibodies|mesh-list
20084513|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
20084514|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084515|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084516|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084517|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084518|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
20084519|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084520|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084521|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20601140|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601141|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
20601142|NCT02207699|Benzonatate|benzonatate|mesh-list
20601143|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601144|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601145|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20601146|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20084522|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
20084523|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084524|NCT00000722|Pentamidine|pentamidine|mesh-list
20084525|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
20084526|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084527|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20601147|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084528|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084529|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20601148|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084530|NCT00000723|Leucovorin|leucovorin|mesh-list
20084531|NCT00000723|Zidovudine|zidovudine|mesh-list
20084532|NCT00000723|Dexamethasone|dexamethasone|mesh-list
20084533|NCT00000723|Methotrexate|methotrexate|mesh-list
20084534|NCT00000723|Calcium|calcium|mesh-list
20084535|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
20084536|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20084537|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
20084538|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
20084539|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084540|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084541|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20084542|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
20084543|NCT00000723|Hormones|hormones|mesh-ancestor
20084544|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084545|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20084546|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084547|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20084548|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20084549|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
20084550|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20084551|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20084552|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
20084553|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084554|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
20084555|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084556|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084557|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20084558|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
20084559|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20084560|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084561|NCT00000723|Antidotes|antidotes|mesh-ancestor
20084562|NCT00000723|Protective Agents|protective agents|mesh-ancestor
20084563|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
20084564|NCT00000723|Vitamins|vitamins|mesh-ancestor
20084565|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
20084566|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084567|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
19746693|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601149|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601150|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
20601151|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
20601152|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
20601153|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
20084568|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084569|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601154|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
20601155|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601156|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601157|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
20601158|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084570|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084571|NCT00000724|Leucovorin|leucovorin|mesh-list
20084572|NCT00000724|Trimetrexate|trimetrexate|mesh-list
20084573|NCT00000724|Calcium|calcium|mesh-list
20084574|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
20084575|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20084576|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084577|NCT00000724|Antidotes|antidotes|mesh-ancestor
20084578|NCT00000724|Protective Agents|protective agents|mesh-ancestor
20084579|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
20084580|NCT00000724|Vitamins|vitamins|mesh-ancestor
20084581|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
20084582|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
20084583|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306083|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20306084|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306085|NCT00653822|Alefacept|alefacept|mesh-list
20306086|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
20306087|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
20084584|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20084585|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
20084586|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084587|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084588|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084589|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084590|NCT00000725|Interferons|interferons|mesh-list
20084591|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
20084592|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
20084593|NCT00000725|Zidovudine|zidovudine|mesh-list
20084594|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084595|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
20084596|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084597|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
20084598|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084599|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
20084600|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084601|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084602|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084603|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084604|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084605|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084606|NCT00000726|Foscarnet|foscarnet|mesh-list
20084607|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20601159|NCT02207920|Vaccines|vaccines|mesh-list
20601160|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
20601161|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601162|NCT02207959|Proflavine|proflavine|mesh-list
20601163|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20601164|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601165|NCT02208128|Bevacizumab|bevacizumab|mesh-list
20601166|NCT02208128|Sunitinib|sunitinib|mesh-list
20601167|NCT02208128|Everolimus|everolimus|mesh-list
20084608|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
20084609|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084610|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084611|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084612|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084613|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084614|NCT00000727|Zidovudine|zidovudine|mesh-list
20084615|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
20084616|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
20084617|NCT00000727|Trimethoprim|trimethoprim|mesh-list
20084618|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
20084619|NCT00000727|Pentamidine|pentamidine|mesh-list
20084620|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20084621|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
20084622|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084623|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084624|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084625|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084626|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
20084627|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084628|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084629|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084630|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
20084631|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084632|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084633|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084634|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20084635|NCT00000727|Renal Agents|renal agents|mesh-ancestor
20084636|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20084637|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20084638|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084639|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
20084640|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20084641|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084642|NCT00000728|Zidovudine|zidovudine|mesh-list
20084643|NCT00000728|Aldesleukin|aldesleukin|mesh-list
20084644|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
20084645|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084646|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084647|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601168|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20601169|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601170|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20601171|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20601172|NCT02208128|Growth Substances|growth substances|mesh-ancestor
20601173|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601174|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
20601175|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20601176|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
20601177|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20084648|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084649|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
20084650|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084651|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084652|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084653|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084654|NCT00000729|Foscarnet|foscarnet|mesh-list
20084655|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20084656|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
20084657|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492234|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19492235|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19492236|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492237|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19492238|NCT03124082|Narcotics|narcotics|mesh-ancestor
19492239|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19492240|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
19492241|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
19492242|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19492243|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19492244|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19492245|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492246|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
20084658|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084659|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084660|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492247|NCT03123913|Testosterone|testosterone|mesh-list
19746694|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20084661|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084662|NCT00000730|Leucovorin|leucovorin|mesh-list
20084663|NCT00000730|Trimethoprim|trimethoprim|mesh-list
20084664|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20084665|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
20084666|NCT00000730|Pentamidine|pentamidine|mesh-list
20084667|NCT00000730|Trimetrexate|trimetrexate|mesh-list
20084668|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
20084669|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
20084670|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084671|NCT00000730|Antidotes|antidotes|mesh-ancestor
20084672|NCT00000730|Protective Agents|protective agents|mesh-ancestor
20084673|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
20084674|NCT00000730|Vitamins|vitamins|mesh-ancestor
20084675|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
20084676|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20084677|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
20084678|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
20084679|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084680|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20084681|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
20084682|NCT00000730|Hormones|hormones|mesh-ancestor
20084683|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084684|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20084685|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084686|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20084687|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084688|NCT00000730|Renal Agents|renal agents|mesh-ancestor
20084689|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
20084690|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084691|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084692|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084693|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084694|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084695|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20084696|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20120120|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
20084697|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084698|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
20084699|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20084700|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084701|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20084702|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
20601178|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601179|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601180|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
20084703|NCT00000731|Acetaminophen|acetaminophen|mesh-list
20084704|NCT00000731|Zidovudine|zidovudine|mesh-list
20084705|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20084706|NCT00000731|Analgesics|analgesics|mesh-ancestor
20601181|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20601182|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20601183|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601184|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
20601185|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
20601186|NCT02208245|Ropivacaine|ropivacaine|mesh-list
20601187|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
20601188|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
20084707|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
20084708|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084709|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084710|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
20084711|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
20084712|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084713|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084714|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084715|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084716|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
20084717|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084718|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084719|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084720|NCT00000732|Zidovudine|zidovudine|mesh-list
20084721|NCT00000732|Trimethoprim|trimethoprim|mesh-list
20084722|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
20084723|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20084724|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
20084725|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084726|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084727|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084728|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084729|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
20084730|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084731|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084732|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120121|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
19492248|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
20084733|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20084734|NCT00000732|Renal Agents|renal agents|mesh-ancestor
20084735|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
20084736|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084737|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084738|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084739|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20084740|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20084741|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084742|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084743|NCT00000733|Ribavirin|ribavirin|mesh-list
20084744|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
20084745|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084746|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
20084747|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084748|NCT00000734|Zidovudine|zidovudine|mesh-list
20084749|NCT00000734|Trimethoprim|trimethoprim|mesh-list
20084750|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
20084751|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20084752|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
20084753|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084754|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084755|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084756|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084757|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
20084758|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084759|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084760|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084761|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20084762|NCT00000734|Renal Agents|renal agents|mesh-ancestor
20084763|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
20084764|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084765|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084766|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084767|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20084768|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20084769|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084770|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084771|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20084772|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
20084773|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084774|NCT00000736|Zidovudine|zidovudine|mesh-list
20084775|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
20084776|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084777|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084778|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084779|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084780|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
20084781|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084782|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084783|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084784|NCT00000737|Megestrol|megestrol|mesh-list
20084785|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
20084786|NCT00000737|Dronabinol|dronabinol|mesh-list
20084787|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
20084788|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084789|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20084790|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20084791|NCT00000737|Analgesics|analgesics|mesh-ancestor
20084792|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
20084793|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084794|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20084795|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20084796|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20084797|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084798|NCT00000737|Hormones|hormones|mesh-ancestor
20084799|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084800|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20084801|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20084802|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20084803|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
20084804|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20084805|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20084806|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20084807|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20084808|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084809|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
20084810|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20084811|NCT00000738|Zidovudine|zidovudine|mesh-list
20084812|NCT00000738|Nimodipine|nimodipine|mesh-list
20084813|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
20084814|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084815|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084816|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084817|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084818|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
20084819|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601189|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601190|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084820|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084821|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084822|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20084823|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20084824|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20084825|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20084826|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084827|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
20084828|NCT00000739|Dapsone|dapsone|mesh-list
20084829|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084830|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
20084831|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084832|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084833|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084834|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084835|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084836|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
20084837|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084838|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
20084839|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20084840|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20084841|NCT00000741|Prednisolone|prednisolone|mesh-list
20084842|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
20084843|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20084844|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
20084845|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20084846|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
20084847|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
20084848|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084849|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084850|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20084851|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
20084852|NCT00000741|Hormones|hormones|mesh-ancestor
20084853|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084854|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20084855|NCT00000741|Protective Agents|protective agents|mesh-ancestor
20084856|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20084857|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084858|NCT00000742|Zidovudine|zidovudine|mesh-list
20084859|NCT00000742|Didanosine|didanosine|mesh-list
20084860|NCT00000742|Atevirdine|atevirdine|mesh-list
20084861|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
20084862|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084863|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084864|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084865|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084866|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
20084867|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084868|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601191|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
20601192|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601193|NCT02208427|Isoniazid|isoniazid|mesh-list
20601194|NCT02208427|Rifapentine|rifapentine|mesh-list
20601195|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
20601196|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601197|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601198|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20601199|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20601200|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
20084869|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084870|NCT00000743|Zidovudine|zidovudine|mesh-list
20601201|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601202|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20084871|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
20084872|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084873|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084874|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084875|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084876|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
20084877|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084878|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084879|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084880|NCT00000744|Fluconazole|fluconazole|mesh-list
20084881|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
20084882|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084883|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20084884|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084885|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084886|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084887|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20084888|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
20084889|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084890|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084891|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20084892|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20084893|NCT00000745|Vaccines|vaccines|mesh-list
20084894|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
20084895|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084896|NCT00000747|Nevirapine|nevirapine|mesh-list
20084897|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084898|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084899|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084900|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084901|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
20084902|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084903|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084904|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084905|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20084906|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20084907|NCT00000748|Trimethoprim|trimethoprim|mesh-list
20084908|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20084909|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
20084910|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20084911|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084912|NCT00000748|Renal Agents|renal agents|mesh-ancestor
20084913|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
20084914|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20084915|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20084916|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20084917|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084918|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084919|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20084920|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20084921|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20084922|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084923|NCT00000750|Zidovudine|zidovudine|mesh-list
20084924|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
20084925|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084926|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084927|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084928|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084929|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
20084930|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084931|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084932|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084933|NCT00000751|Zidovudine|zidovudine|mesh-list
20084934|NCT00000751|Immune Sera|immune sera|mesh-list
20084935|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
20084936|NCT00000751|Antibodies|antibodies|mesh-list
20084937|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
20084938|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084939|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084940|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492249|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
19492250|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19492251|NCT03123913|Androgens|androgens|mesh-ancestor
19492252|NCT03123913|Hormones|hormones|mesh-ancestor
19492253|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492254|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492255|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19492256|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492257|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
19492258|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
19492259|NCT03123770|Docetaxel|docetaxel|mesh-list
19492260|NCT03123770|Doxorubicin|doxorubicin|mesh-list
19492261|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19492262|NCT03123770|Epirubicin|epirubicin|mesh-list
19492263|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492264|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
19492265|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492266|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492267|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19492268|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
19492269|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492270|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492271|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19492272|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
19492273|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
19492274|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
19492275|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19492276|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19492277|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19492278|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492279|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
19492280|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
19492281|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
19492282|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492283|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
19492284|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19492285|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492286|NCT03123744|Palbociclib|palbociclib|mesh-list
19492287|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492288|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19492289|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492290|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492291|NCT03123718|Methotrexate|methotrexate|mesh-list
19492292|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19492293|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
19492294|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19492295|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492296|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492297|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
19492298|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492299|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492300|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
19492301|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492302|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19492303|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492304|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
19492305|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492306|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492307|NCT03123406|Cinacalcet|cinacalcet|mesh-list
19492308|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19492309|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492310|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19492311|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
19492312|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492313|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19492314|NCT03123484|Gefitinib|gefitinib|mesh-list
19492315|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492316|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19492317|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492318|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492319|NCT03123289|Gallium citrate|gallium citrate|mesh-list
20084941|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084942|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
20084943|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084944|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084945|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084946|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
20084947|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084948|NCT00000752|Cefuroxime|cefuroxime|mesh-list
20084949|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
20084950|NCT00000752|Beclomethasone|beclomethasone|mesh-list
20084951|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
20084952|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
20084953|NCT00000752|Ephedrine|ephedrine|mesh-list
19746695|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
20084954|NCT00000752|Guaifenesin|guaifenesin|mesh-list
20601203|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20601204|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
20601205|NCT02208492|Levetiracetam|levetiracetam|mesh-list
20601206|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
20601207|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
20601208|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
20601209|NCT02208505|Remifentanil|remifentanil|mesh-list
20601210|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601211|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601212|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084955|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20084956|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20084957|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
20084958|NCT00000752|Hormones|hormones|mesh-ancestor
20084959|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20084960|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20084961|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20084962|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
20084963|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20084964|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
20084965|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20084966|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
20084967|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20084968|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20084969|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
20084970|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
20084971|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20084972|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084973|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20084974|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084975|NCT00000752|Expectorants|expectorants|mesh-ancestor
20084976|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20084977|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20084978|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
20084979|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20084980|NCT00000753|Zidovudine|zidovudine|mesh-list
20084981|NCT00000753|Didanosine|didanosine|mesh-list
20084982|NCT00000753|Zalcitabine|zalcitabine|mesh-list
20084983|NCT00000753|Atevirdine|atevirdine|mesh-list
20084984|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
20084985|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20084986|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20084987|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20084988|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20084989|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
20084990|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20084991|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20084992|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20084993|NCT00000754|Interferons|interferons|mesh-list
20084994|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
20084995|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
20084996|NCT00000754|Zidovudine|zidovudine|mesh-list
20084997|NCT00000754|Zalcitabine|zalcitabine|mesh-list
20084998|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20084999|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
20085000|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085001|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
20085002|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085003|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
20085004|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085005|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085006|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085007|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085008|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085009|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085010|NCT00000755|Zidovudine|zidovudine|mesh-list
20085011|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
20085012|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085013|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085014|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085015|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085016|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
20085017|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085018|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085019|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085020|NCT00000758|Fluorouracil|fluorouracil|mesh-list
20085021|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
20085022|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085023|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20085024|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085025|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20085026|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
20085027|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085028|NCT00000760|Zidovudine|zidovudine|mesh-list
20085029|NCT00000760|Didanosine|didanosine|mesh-list
20085030|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
20085031|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085032|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085033|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085034|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085035|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
20085036|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085037|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085038|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085039|NCT00000761|Interferons|interferons|mesh-list
20085040|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
20085041|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085042|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
20085043|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085044|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
20085045|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20085046|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085047|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20085048|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20085049|NCT00000763|Growth Substances|growth substances|mesh-ancestor
20085050|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085051|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
20085052|NCT00000764|Interferons|interferons|mesh-list
20085053|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
20085054|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
20085055|NCT00000764|Isotretinoin|isotretinoin|mesh-list
20085056|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085057|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
20085058|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085059|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
20085060|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085061|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
20085062|NCT00000765|Zidovudine|zidovudine|mesh-list
20085063|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
20085064|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085065|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085066|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085067|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085068|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
20085069|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085070|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085071|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085072|NCT00000766|Ganciclovir|ganciclovir|mesh-list
20085073|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20085074|NCT00000766|Foscarnet|foscarnet|mesh-list
20085075|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20085076|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
20085077|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085078|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085079|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085080|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085081|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085082|NCT00000767|Vaccines|vaccines|mesh-list
20085083|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
20085084|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085085|NCT00000768|Ganciclovir|ganciclovir|mesh-list
20085086|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20085087|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
20085088|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085089|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085090|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085091|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085092|NCT00000769|Interleukin-4|interleukin-4|mesh-list
20085093|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20085094|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
20085095|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085096|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085097|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20085098|NCT00000770|Zidovudine|zidovudine|mesh-list
20085099|NCT00000770|Nevirapine|nevirapine|mesh-list
20085100|NCT00000770|Didanosine|didanosine|mesh-list
20085101|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
20085102|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085103|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085104|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085105|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085106|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
20085107|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085108|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085109|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085110|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20085111|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20085112|NCT00000771|Paromomycin|paromomycin|mesh-list
20085113|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085114|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085115|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085116|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085117|NCT00000772|Ribavirin|ribavirin|mesh-list
20085118|NCT00000772|Didanosine|didanosine|mesh-list
20085119|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
20085120|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085121|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
19492320|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492321|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19492322|NCT03123445|Gemcitabine|gemcitabine|mesh-list
20085122|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085123|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19746696|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20085124|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085125|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085126|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085127|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085128|NCT00000773|Atovaquone|atovaquone|mesh-list
20085129|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085130|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
20085131|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085132|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085133|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746697|NCT02032823|Olaparib|olaparib|mesh-list
20085134|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085135|NCT00000776|Fluconazole|fluconazole|mesh-list
20085136|NCT00000776|Amphotericin B|amphotericin b|mesh-list
20085137|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20085138|NCT00000776|Flucytosine|flucytosine|mesh-list
20085139|NCT00000776|Dexamethasone|dexamethasone|mesh-list
20085140|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20085141|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
20085142|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
20085143|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20085144|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085145|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20085146|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
20085147|NCT00000776|Hormones|hormones|mesh-ancestor
20085148|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20085149|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20085150|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085151|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
20085152|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085153|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20085154|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085155|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085156|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085157|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20085158|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
20085159|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20085160|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20085161|NCT00000776|Amebicides|amebicides|mesh-ancestor
20085162|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085163|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085164|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085165|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
20601213|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601214|NCT02208505|Analgesics|analgesics|mesh-ancestor
20601215|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
20601216|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601217|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20601218|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20601219|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20601220|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
20601221|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601222|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601223|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20601224|NCT02208505|Narcotics|narcotics|mesh-ancestor
20607808|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20601225|NCT02208583|Prednisone|prednisone|mesh-list
20601226|NCT02208583|Cisplatin|cisplatin|mesh-list
20085166|NCT00000778|Pyridoxine|pyridoxine|mesh-list
20085167|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
20085168|NCT00000778|Levofloxacin|levofloxacin|mesh-list
20085169|NCT00000778|Ofloxacin|ofloxacin|mesh-list
20085170|NCT00000778|Isoniazid|isoniazid|mesh-list
20085171|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20085172|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085173|NCT00000778|Renal Agents|renal agents|mesh-ancestor
20085174|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085175|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20085176|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19492323|NCT03123445|Endostar protein|endostar protein|mesh-list
19492324|NCT03123445|Endostatins|endostatins|mesh-list
19492325|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492326|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492327|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
19492328|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492329|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
20085177|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492330|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492331|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492332|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492333|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
19492334|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492335|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19492336|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20085178|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085179|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085180|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19492337|NCT03123445|Growth Substances|growth substances|mesh-ancestor
19492338|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
20085181|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085182|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
20085183|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20085184|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20601227|NCT02208583|Docetaxel|docetaxel|mesh-list
20601228|NCT02208583|Etoposide|etoposide|mesh-list
20601229|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
20601230|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601231|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
20601232|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
20601233|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
20085185|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
20601234|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085186|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20085187|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
20085188|NCT00000778|Vitamins|vitamins|mesh-ancestor
20085189|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
20085190|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085191|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20085192|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20085193|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
20085194|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085195|NCT00000779|Antacids|antacids|mesh-ancestor
20085196|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085197|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20085198|NCT00000781|Zidovudine|zidovudine|mesh-list
20085199|NCT00000781|Nevirapine|nevirapine|mesh-list
20085200|NCT00000781|Didanosine|didanosine|mesh-list
20085201|NCT00000781|Zalcitabine|zalcitabine|mesh-list
20085202|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
20085203|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085204|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085205|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085206|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085207|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
20085208|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085209|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085210|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085211|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20085212|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20085213|NCT00000782|Vaccines|vaccines|mesh-list
20085214|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
20085215|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085216|NCT00000788|Fluconazole|fluconazole|mesh-list
20085217|NCT00000788|Methadone|methadone|mesh-list
20085218|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20085219|NCT00000788|Narcotics|narcotics|mesh-ancestor
20085220|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20085221|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085222|NCT00000788|Analgesics|analgesics|mesh-ancestor
20085223|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
20085224|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20085225|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
20085226|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
20085227|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
20085228|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085229|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20085230|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085231|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085232|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085233|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20085234|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
20085235|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20085236|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20085237|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20085238|NCT00000789|Zidovudine|zidovudine|mesh-list
20085239|NCT00000789|Stavudine|stavudine|mesh-list
20085240|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
20085241|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085242|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085243|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085244|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085245|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
20085246|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085247|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085248|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085249|NCT00000790|Thalidomide|thalidomide|mesh-list
20085250|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20085251|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
20601235|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601236|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
20601237|NCT02208583|Hormones|hormones|mesh-ancestor
20601238|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20601239|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601240|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20085252|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085253|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
20085254|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085255|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085256|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20085257|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20085258|NCT00000790|Growth Substances|growth substances|mesh-ancestor
20085259|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
20085260|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085261|NCT00000791|Zidovudine|zidovudine|mesh-list
20085262|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
20601241|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20601242|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20601243|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20601244|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601245|NCT02208596|Pentazocine|pentazocine|mesh-list
20601246|NCT02208596|Propofol|propofol|mesh-list
20601247|NCT02208596|Etomidate|etomidate|mesh-list
20601248|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601249|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601250|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601251|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20085263|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085264|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085265|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085266|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085267|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
20085268|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085269|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085270|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085271|NCT00000792|Hypericin|hypericin|mesh-list
20085272|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
20085273|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20085274|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085275|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
20085276|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085277|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085278|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085279|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20085280|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
20085281|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085282|NCT00000793|Mexiletine|mexiletine|mesh-list
20085283|NCT00000793|Amitriptyline|amitriptyline|mesh-list
20085284|NCT00000793|Benztropine|benztropine|mesh-list
20085285|NCT00000793|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20085286|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20085287|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
20085288|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20085289|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20085290|NCT00000793|Analgesics|analgesics|mesh-ancestor
20085291|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
20085292|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20085293|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085294|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20085295|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20085296|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20085297|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085298|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
20085299|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20085300|NCT00000793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20085301|NCT00000793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20085302|NCT00000793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20085303|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20085304|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20085305|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20085306|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20085307|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20085308|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
20085309|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
20085310|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20085311|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20085312|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
20085313|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20085314|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
20085315|NCT00000794|Leucovorin|leucovorin|mesh-list
20085316|NCT00000794|Clarithromycin|clarithromycin|mesh-list
20085317|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
20085318|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
20085319|NCT00000794|Atovaquone|atovaquone|mesh-list
20085320|NCT00000794|Calcium|calcium|mesh-list
20085321|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
20085322|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20085323|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085324|NCT00000794|Antidotes|antidotes|mesh-ancestor
20085325|NCT00000794|Protective Agents|protective agents|mesh-ancestor
20085326|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
20085327|NCT00000794|Vitamins|vitamins|mesh-ancestor
20085328|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
20085329|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085330|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085331|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20085332|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085333|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085334|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20085335|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085336|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
20085337|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085338|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085339|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20085340|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
20085341|NCT00000796|Pyridoxine|pyridoxine|mesh-list
20085342|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
20085343|NCT00000796|Levofloxacin|levofloxacin|mesh-list
20085344|NCT00000796|Cycloserine|cycloserine|mesh-list
20085345|NCT00000796|Rifampin|rifampin|mesh-list
20085346|NCT00000796|Isoniazid|isoniazid|mesh-list
20085347|NCT00000796|Amikacin|amikacin|mesh-list
20085348|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
20085349|NCT00000796|Ethambutol|ethambutol|mesh-list
20085350|NCT00000796|Clofazimine|clofazimine|mesh-list
20085351|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20085352|NCT00000796|Streptomycin|streptomycin|mesh-list
20085353|NCT00000796|Ethionamide|ethionamide|mesh-list
20085354|NCT00000796|Capreomycin|capreomycin|mesh-list
20085355|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20085356|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085357|NCT00000796|Renal Agents|renal agents|mesh-ancestor
20085358|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085359|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20085360|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20085361|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085362|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085363|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085364|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20085365|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085366|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20085367|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
20085368|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
20085369|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085370|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20085371|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20085372|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20085373|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20085374|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20085375|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20085376|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20085377|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20085378|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
20085379|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20085380|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
20085381|NCT00000796|Vitamins|vitamins|mesh-ancestor
20085382|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
20085383|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601252|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
20601253|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
20601254|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20601255|NCT02208596|Narcotics|narcotics|mesh-ancestor
20601256|NCT02208596|Analgesics|analgesics|mesh-ancestor
20601257|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
20601258|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601259|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20601260|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20601261|NCT02208778|Remifentanil|remifentanil|mesh-list
20601262|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20601263|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20601264|NCT02208778|Narcotics|narcotics|mesh-ancestor
20601265|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601266|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601267|NCT02208778|Analgesics|analgesics|mesh-ancestor
20601268|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
20601269|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601270|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20601271|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20601272|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20601273|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601274|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601275|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
20601276|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20601277|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
20601278|NCT02208791|Sirolimus|sirolimus|mesh-list
20601279|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601280|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601281|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20085384|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20085385|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20085386|NCT00000799|Cidofovir|cidofovir|mesh-list
20085387|NCT00000799|Probenecid|probenecid|mesh-list
20085388|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
20085389|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
20085390|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20085391|NCT00000799|Renal Agents|renal agents|mesh-ancestor
20085392|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
20085393|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085394|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085395|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085396|NCT00000800|Zidovudine|zidovudine|mesh-list
20085397|NCT00000800|Methadone|methadone|mesh-list
20085398|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
20085399|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085400|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085401|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085402|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085403|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
20085404|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085405|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085406|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085407|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20085408|NCT00000800|Narcotics|narcotics|mesh-ancestor
20085409|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20085410|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085411|NCT00000800|Analgesics|analgesics|mesh-ancestor
20085412|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
20085413|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20085414|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
20085415|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
20085416|NCT00000801|Cytarabine|cytarabine|mesh-list
20085417|NCT00000801|Dexamethasone|dexamethasone|mesh-list
20085418|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
20085419|NCT00000801|Doxorubicin|doxorubicin|mesh-list
20085420|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20085421|NCT00000801|Vincristine|vincristine|mesh-list
20085422|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20085423|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
20085424|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085425|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20085426|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20085427|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
20085428|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085429|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085430|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20085431|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20085432|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
20085433|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
20085434|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20085435|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20085436|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
20085437|NCT00000801|Hormones|hormones|mesh-ancestor
20085438|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20085439|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20085440|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20085441|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20085442|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20085443|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085444|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20085445|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
20085446|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
20085447|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085448|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20085449|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
20085450|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
20085451|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
20085452|NCT00000802|Dapsone|dapsone|mesh-list
20085453|NCT00000802|Atovaquone|atovaquone|mesh-list
20085454|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085455|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
20085456|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085457|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085458|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20085459|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085460|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085461|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
20085462|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085463|NCT00000803|Zidovudine|zidovudine|mesh-list
20085464|NCT00000803|Didanosine|didanosine|mesh-list
20085465|NCT00000803|Delavirdine|delavirdine|mesh-list
20085466|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
20085467|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085468|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085469|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085470|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085471|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
20085472|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085473|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085474|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085475|NCT00000804|Indinavir|indinavir|mesh-list
20085476|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20085477|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20085478|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
20085479|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085480|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085481|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085482|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085483|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
20085484|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085485|NCT00000805|Ganciclovir|ganciclovir|mesh-list
20085486|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20085487|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
20085488|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085489|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085490|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085491|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085492|NCT00000807|Etoposide|etoposide|mesh-list
20085493|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20085494|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085495|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20085496|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20085497|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085498|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085499|NCT00000808|Nevirapine|nevirapine|mesh-list
20085500|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085501|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085502|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085503|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085504|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
20085505|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085506|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085507|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085508|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20085509|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20085510|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20085511|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20085512|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
20085513|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085514|NCT00000809|Antacids|antacids|mesh-ancestor
20085515|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085516|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20120122|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120123|NCT00006279|Nevirapine|nevirapine|mesh-list
20085517|NCT00000810|Zidovudine|zidovudine|mesh-list
20085518|NCT00000810|Didanosine|didanosine|mesh-list
20085519|NCT00000810|Delavirdine|delavirdine|mesh-list
20085520|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
20085521|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085522|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085523|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085524|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085525|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
20085526|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085527|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085528|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085529|NCT00000811|Azithromycin|azithromycin|mesh-list
20085530|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20085531|NCT00000811|Trimethoprim|trimethoprim|mesh-list
20085532|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
20085533|NCT00000811|Atovaquone|atovaquone|mesh-list
20085534|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085535|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085536|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20085537|NCT00000811|Renal Agents|renal agents|mesh-ancestor
20085538|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
20085539|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085540|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085541|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20085542|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085543|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085544|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20085545|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20085546|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085547|NCT00000812|Thalidomide|thalidomide|mesh-list
20085548|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20085549|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
20085550|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085551|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
20085552|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085553|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085554|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20085555|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20085556|NCT00000812|Growth Substances|growth substances|mesh-ancestor
20085557|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
20085558|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085559|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
20085560|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20085561|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
20085562|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085563|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20085564|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085565|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
20085566|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085567|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
20085568|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20085569|NCT00000813|Protective Agents|protective agents|mesh-ancestor
20085570|NCT00000814|Zidovudine|zidovudine|mesh-list
20085571|NCT00000814|Nevirapine|nevirapine|mesh-list
20085572|NCT00000814|Didanosine|didanosine|mesh-list
20085573|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
20085574|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085575|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085576|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085577|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085578|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
20085579|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085580|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085581|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085582|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20085583|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20085584|NCT00000816|Trimethoprim|trimethoprim|mesh-list
20085585|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20085586|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
20085587|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20085588|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085589|NCT00000816|Renal Agents|renal agents|mesh-ancestor
20085590|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
20085591|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085592|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085593|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20085594|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085595|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085596|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20085597|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20085598|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085599|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085600|NCT00000817|Amitriptyline|amitriptyline|mesh-list
20085601|NCT00000817|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20085602|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20085603|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
20085604|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20085605|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20085606|NCT00000817|Analgesics|analgesics|mesh-ancestor
20085607|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
20085608|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20085609|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085610|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20085611|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20085612|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20085613|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085614|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
20085615|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20085616|NCT00000817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20085617|NCT00000817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20085618|NCT00000817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20085619|NCT00000818|Zidovudine|zidovudine|mesh-list
20085620|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
20085621|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085622|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085623|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085624|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085625|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
20085626|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085627|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085628|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085629|NCT00000819|Prednisone|prednisone|mesh-list
20085630|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20085631|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
20085632|NCT00000819|Hormones|hormones|mesh-ancestor
20085633|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20085634|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085635|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20085636|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085637|NCT00000820|Aldesleukin|aldesleukin|mesh-list
20085638|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085639|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085640|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085641|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
20085642|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085643|NCT00000821|Aldesleukin|aldesleukin|mesh-list
20085644|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085645|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085646|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085647|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
20085648|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085649|NCT00000822|Ritonavir|ritonavir|mesh-list
20085650|NCT00000822|Stavudine|stavudine|mesh-list
20085651|NCT00000822|Didanosine|didanosine|mesh-list
20085652|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20085653|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20085654|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
20085655|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085656|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085657|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085658|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085659|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
20085660|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085661|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20085662|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085663|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
20085664|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085665|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085666|NCT00000823|Zidovudine|zidovudine|mesh-list
20085667|NCT00000823|Didanosine|didanosine|mesh-list
20085668|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
20120124|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085669|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085670|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085671|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085672|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085673|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
20085674|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085675|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085676|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085677|NCT00000825|Aldesleukin|aldesleukin|mesh-list
20085678|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085679|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085680|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085681|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
20085682|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085683|NCT00000826|Clarithromycin|clarithromycin|mesh-list
20085684|NCT00000826|Dapsone|dapsone|mesh-list
20085685|NCT00000826|Rifabutin|rifabutin|mesh-list
20085686|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20085687|NCT00000826|Fluconazole|fluconazole|mesh-list
20085688|NCT00000826|Trimethoprim|trimethoprim|mesh-list
20085689|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
20085690|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20085691|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085692|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20085693|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085694|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085695|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20085696|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085697|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
20085698|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20085699|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20085700|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
20120125|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601282|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601283|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
20601284|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20601285|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
20601286|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601287|NCT02208882|Midazolam|midazolam|mesh-list
20601288|NCT02208882|BMS-986120|bms-986120|mesh-list
20601289|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20601290|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601291|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601292|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601293|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20601294|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20601295|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20601296|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20601297|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
20601298|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
20601299|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
20601300|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
20601301|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601302|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601303|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20601304|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20085701|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20085702|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085703|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20085704|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20085705|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20085706|NCT00000826|Renal Agents|renal agents|mesh-ancestor
20085707|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
20085708|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20085709|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20085710|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20085711|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20085712|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20085713|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
20085714|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20085715|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
20085716|NCT00000827|Immune Sera|immune sera|mesh-list
20085717|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
20085718|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085719|NCT00000829|Vaccines|vaccines|mesh-list
20085720|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20085721|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
20085722|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085723|NCT00000831|Lamivudine|lamivudine|mesh-list
20085724|NCT00000831|Zidovudine|zidovudine|mesh-list
20085725|NCT00000831|Stavudine|stavudine|mesh-list
20085726|NCT00000831|Didanosine|didanosine|mesh-list
20085727|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085728|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085729|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085730|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085731|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
20085732|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085733|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085734|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085735|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
20085736|NCT00000833|Ribavirin|ribavirin|mesh-list
20085737|NCT00000833|Didanosine|didanosine|mesh-list
20085738|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
20085739|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085740|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
20085741|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085742|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085743|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085744|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085745|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085746|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085747|NCT00000834|Lamivudine|lamivudine|mesh-list
20085748|NCT00000834|Zidovudine|zidovudine|mesh-list
20085749|NCT00000834|Methotrexate|methotrexate|mesh-list
20085750|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20085751|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
20085752|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20085753|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085754|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20085755|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
20085756|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085757|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085758|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20085759|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085760|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20085761|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20085762|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
20085763|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20085764|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085765|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085766|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
20085767|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085768|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085769|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120126|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120127|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120128|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
20120129|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120130|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120131|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120132|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20120133|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20120134|NCT00006280|Tobramycin|tobramycin|mesh-list
20120135|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20120136|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120137|NCT00006286|Fluoxetine|fluoxetine|mesh-list
20120138|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20085770|NCT00000838|Lamivudine|lamivudine|mesh-list
20085771|NCT00000838|Zidovudine|zidovudine|mesh-list
20085772|NCT00000838|Stavudine|stavudine|mesh-list
20085773|NCT00000838|Didanosine|didanosine|mesh-list
20601305|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
20601306|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20601307|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
20601308|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20601309|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601310|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20601311|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20085774|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085775|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085776|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085777|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085778|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
20085779|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085780|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085781|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085782|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
20085783|NCT00000839|Didanosine|didanosine|mesh-list
20085784|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
20085785|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085786|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085787|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085788|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085789|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
20085790|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085791|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085792|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085793|NCT00000841|Lamivudine|lamivudine|mesh-list
20085794|NCT00000841|Zidovudine|zidovudine|mesh-list
20085795|NCT00000841|Stavudine|stavudine|mesh-list
20085796|NCT00000841|Indinavir|indinavir|mesh-list
20085797|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085798|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085799|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085800|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085801|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
20085802|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085803|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085804|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085805|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
20085806|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20085807|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20085808|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
20085809|NCT00000842|Mitogens|mitogens|mesh-list
20085810|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
20085811|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085812|NCT00000843|Adefovir|adefovir|mesh-list
20601312|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085813|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20085814|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
20085815|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085816|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085817|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085818|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085819|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085820|NCT00000844|Interferons|interferons|mesh-list
20085821|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
20085822|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085823|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
20085824|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085825|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
20085826|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085827|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
20085828|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20085829|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
20085830|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085831|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20085832|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085833|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
20085834|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085835|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
20085836|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20085837|NCT00000847|Protective Agents|protective agents|mesh-ancestor
20085838|NCT00000848|Indinavir|indinavir|mesh-list
20085839|NCT00000848|Saquinavir|saquinavir|mesh-list
20085840|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20085841|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20085842|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
20085843|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085844|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085845|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085846|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085847|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
20085848|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085849|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20085850|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085851|NCT00000849|Aldesleukin|aldesleukin|mesh-list
20085852|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20085853|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085854|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085855|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
20085856|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085857|NCT00000850|Indinavir|indinavir|mesh-list
20085858|NCT00000850|Sargramostim|sargramostim|mesh-list
20085859|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
20085860|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085861|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20085862|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20085863|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
20085864|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085865|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085866|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085867|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085868|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
20085869|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085870|NCT00000851|Stavudine|stavudine|mesh-list
20085871|NCT00000851|Didanosine|didanosine|mesh-list
20085872|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
20085873|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085874|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085875|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085876|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085877|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
20085878|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085879|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085880|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085881|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
20085882|NCT00000854|Nandrolone|nandrolone|mesh-list
20085883|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
20085884|NCT00000854|Androgens|androgens|mesh-ancestor
20085885|NCT00000854|Hormones|hormones|mesh-ancestor
20085886|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20085887|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085888|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
20085889|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20085890|NCT00000855|Zidovudine|zidovudine|mesh-list
20085891|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
20085892|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085893|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085894|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085895|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085896|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
20085897|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085898|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085899|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085900|NCT00000856|Ganciclovir|ganciclovir|mesh-list
20085901|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20085902|NCT00000856|Foscarnet|foscarnet|mesh-list
20085903|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20085904|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
20085905|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085906|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085907|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085908|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085909|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085910|NCT00000857|Interleukin-12|interleukin-12|mesh-list
20601313|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20601314|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20601315|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
20601316|NCT02209025|Theobromine|theobromine|mesh-list
20601317|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20601318|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
20601319|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601320|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601321|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20085911|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20085912|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
20085913|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085914|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20085915|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20085916|NCT00000857|Growth Substances|growth substances|mesh-ancestor
20085917|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
20085918|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607809|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
20085919|NCT00000859|Ritonavir|ritonavir|mesh-list
20085920|NCT00000859|Nelfinavir|nelfinavir|mesh-list
20085921|NCT00000859|Indinavir|indinavir|mesh-list
20085922|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20607810|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20085923|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20085924|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
20085925|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085926|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085927|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085928|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085929|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
20085930|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085931|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20085932|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20085933|NCT00000861|Indinavir|indinavir|mesh-list
20085934|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20085935|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20085936|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
20085937|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085938|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085939|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085940|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085941|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
20085942|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085943|NCT00000862|Zidovudine|zidovudine|mesh-list
20085944|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
20085945|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085946|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085947|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085948|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085949|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
20085950|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085951|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085952|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085953|NCT00000864|Zidovudine|zidovudine|mesh-list
20085954|NCT00000864|Abacavir|abacavir|mesh-list
20085955|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
20085956|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085957|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085958|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085959|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085960|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
20085961|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085962|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085963|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085964|NCT00000865|Lamivudine|lamivudine|mesh-list
20085965|NCT00000865|Zidovudine|zidovudine|mesh-list
20085966|NCT00000865|Abacavir|abacavir|mesh-list
20085967|NCT00000865|Stavudine|stavudine|mesh-list
20085968|NCT00000865|Didanosine|didanosine|mesh-list
20085969|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085970|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085971|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085972|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085973|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
20085974|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20085975|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20085976|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20085977|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
20085978|NCT00000867|Memantine|memantine|mesh-list
20085979|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20085980|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20085981|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
20085982|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20085983|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085984|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607811|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20085985|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20085986|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20085987|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20085988|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20085989|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
20085990|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20085991|NCT00000868|Antacids|antacids|mesh-ancestor
20085992|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085993|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20085994|NCT00000869|Nevirapine|nevirapine|mesh-list
20085995|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20085996|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20085997|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20085998|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20085999|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
20086000|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086001|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086002|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086003|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086004|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086005|NCT00000870|Lamivudine|lamivudine|mesh-list
20086006|NCT00000870|Zidovudine|zidovudine|mesh-list
20086007|NCT00000870|Stavudine|stavudine|mesh-list
20086008|NCT00000870|Didanosine|didanosine|mesh-list
20086009|NCT00000870|Aldesleukin|aldesleukin|mesh-list
20086010|NCT00000870|Indinavir|indinavir|mesh-list
20086011|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086012|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086013|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086014|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086015|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
20086016|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086017|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086018|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086019|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
20086020|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086021|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086022|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086023|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086024|NCT00000872|Lamivudine|lamivudine|mesh-list
20086025|NCT00000872|Zidovudine|zidovudine|mesh-list
20086026|NCT00000872|Nevirapine|nevirapine|mesh-list
20086027|NCT00000872|Abacavir|abacavir|mesh-list
20086028|NCT00000872|Stavudine|stavudine|mesh-list
20086029|NCT00000872|Nelfinavir|nelfinavir|mesh-list
20086030|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086031|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086032|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086033|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086034|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
20086035|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086036|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086037|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086038|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
20086039|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086040|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086041|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086042|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086043|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086044|NCT00000875|Acetaminophen|acetaminophen|mesh-list
20086045|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
20086046|NCT00000875|Promethazine|promethazine|mesh-list
20086047|NCT00000875|Lamivudine|lamivudine|mesh-list
20086048|NCT00000875|Zidovudine|zidovudine|mesh-list
20306088|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086049|NCT00000875|Aldesleukin|aldesleukin|mesh-list
20086050|NCT00000875|Indinavir|indinavir|mesh-list
20086051|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20086052|NCT00000875|Analgesics|analgesics|mesh-ancestor
20086053|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
20086054|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20086055|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086056|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
20086057|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086058|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086059|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086060|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086061|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
20086062|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086063|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086064|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086065|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
20086066|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086067|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20086068|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20086069|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20086070|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
20086071|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
20086072|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
20086073|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
20086074|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19492339|NCT03123276|Gemcitabine|gemcitabine|mesh-list
19492340|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
19492341|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492342|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
19492343|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492344|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492345|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
19492346|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492347|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492348|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20086075|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19492349|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
20086076|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
20086077|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
20086078|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20086079|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20086080|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
20086081|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
20086082|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086083|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086084|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086085|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
20086086|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
20086087|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086088|NCT00000877|Indinavir|indinavir|mesh-list
20086089|NCT00000877|Rifabutin|rifabutin|mesh-list
20086090|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086091|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086092|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086093|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086094|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086095|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086096|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086097|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
20086098|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086099|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086100|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20086101|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
20086102|NCT00000878|Lamivudine|lamivudine|mesh-list
20086103|NCT00000878|Zidovudine|zidovudine|mesh-list
20086104|NCT00000878|Stavudine|stavudine|mesh-list
20601322|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
20601323|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
20601324|NCT02209155|Verapamil|verapamil|mesh-list
20601325|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20601326|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20601327|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20601328|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601329|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20601330|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086105|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086106|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601331|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
20601332|NCT02209350|Aspirin|aspirin|mesh-list
20601333|NCT02209350|Clopidogrel|clopidogrel|mesh-list
20601334|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20601335|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601336|NCT02209350|Analgesics|analgesics|mesh-ancestor
20601337|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
20601338|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601339|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601340|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601341|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601342|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20601343|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20601344|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601345|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20601346|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20086107|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086108|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086109|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
20086110|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086111|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086112|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086113|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
20086114|NCT00000880|Cyclosporine|cyclosporine|mesh-list
20086115|NCT00000880|Cyclosporins|cyclosporins|mesh-list
20086116|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086117|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086118|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20086119|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
20086120|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601347|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601348|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
20601349|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20607812|NCT02243553|Protective Agents|protective agents|mesh-ancestor
20086121|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
20086122|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492350|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086123|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
20086124|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20086125|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20086126|NCT00000881|Cidofovir|cidofovir|mesh-list
20086127|NCT00000881|Probenecid|probenecid|mesh-list
20086128|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
20086129|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
20086130|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20086131|NCT00000881|Renal Agents|renal agents|mesh-ancestor
20086132|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
20086133|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086134|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086135|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086136|NCT00000882|Lamivudine|lamivudine|mesh-list
20086137|NCT00000882|Zidovudine|zidovudine|mesh-list
20086138|NCT00000882|Stavudine|stavudine|mesh-list
20086139|NCT00000882|Delavirdine|delavirdine|mesh-list
20086140|NCT00000882|Indinavir|indinavir|mesh-list
20086141|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086142|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086143|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086144|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086145|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
20086146|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086147|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086148|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086149|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
20086150|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086151|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086152|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086153|NCT00000883|Azithromycin|azithromycin|mesh-list
20086154|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086155|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086156|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
20086157|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20086158|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
20086159|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086160|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20086161|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086162|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
20086163|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086164|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
20086165|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20086166|NCT00000884|Protective Agents|protective agents|mesh-ancestor
20086167|NCT00000885|Lamivudine|lamivudine|mesh-list
20086168|NCT00000885|Zidovudine|zidovudine|mesh-list
20086169|NCT00000885|Efavirenz|efavirenz|mesh-list
20086170|NCT00000885|Abacavir|abacavir|mesh-list
20086171|NCT00000885|Stavudine|stavudine|mesh-list
20086172|NCT00000885|Didanosine|didanosine|mesh-list
20086173|NCT00000885|Adefovir|adefovir|mesh-list
20086174|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20086175|NCT00000885|Nelfinavir|nelfinavir|mesh-list
20086176|NCT00000885|Indinavir|indinavir|mesh-list
19492351|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20086177|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086178|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086179|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086180|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086181|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
20086182|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086183|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086184|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086185|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
20086186|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086187|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086188|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086189|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086190|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086191|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19492352|NCT03123016|Apremilast|apremilast|mesh-list
20086192|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086193|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086194|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086195|NCT00000887|Lamivudine|lamivudine|mesh-list
20086196|NCT00000887|Zidovudine|zidovudine|mesh-list
20086197|NCT00000887|Nelfinavir|nelfinavir|mesh-list
20086198|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086199|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086200|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086201|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086202|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
20086203|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492353|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19492354|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492355|NCT03123016|Analgesics|analgesics|mesh-ancestor
19492356|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
19492357|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492358|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492359|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492360|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492361|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19492362|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19492363|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492364|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492365|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
19492366|NCT03123107|Vitamins|vitamins|mesh-ancestor
19492367|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
19492368|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492369|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
19492370|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492371|NCT03123107|Protective Agents|protective agents|mesh-ancestor
20086204|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086205|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086206|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
20086207|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086208|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086209|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086210|NCT00000888|Ritonavir|ritonavir|mesh-list
20086211|NCT00000888|Lamivudine|lamivudine|mesh-list
20086212|NCT00000888|Zidovudine|zidovudine|mesh-list
20086213|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086214|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086215|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
19569632|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569633|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19569634|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19569635|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569636|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569637|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086216|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086217|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086218|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086219|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086220|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
20086221|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086222|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086223|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086224|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086225|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086226|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
20086227|NCT00000889|Aldesleukin|aldesleukin|mesh-list
20086228|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086229|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086230|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086231|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
20086232|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086233|NCT00000891|Ritonavir|ritonavir|mesh-list
20086234|NCT00000891|Saquinavir|saquinavir|mesh-list
20601350|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19749537|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601351|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20601352|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
20601353|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601354|NCT02209428|Temozolomide|temozolomide|mesh-list
20601355|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20601356|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
20601357|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601358|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086235|NCT00000891|Lamivudine|lamivudine|mesh-list
20086236|NCT00000891|Zidovudine|zidovudine|mesh-list
20086237|NCT00000891|Stavudine|stavudine|mesh-list
20086238|NCT00000891|Didanosine|didanosine|mesh-list
20086239|NCT00000891|Delavirdine|delavirdine|mesh-list
20086240|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086241|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086242|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086243|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086244|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086245|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086246|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086247|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
20086248|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086249|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086250|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20306089|NCT00653848|Docetaxel|docetaxel|mesh-list
20086251|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086252|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086253|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
20086254|NCT00000892|Ritonavir|ritonavir|mesh-list
20086255|NCT00000892|Nelfinavir|nelfinavir|mesh-list
20086256|NCT00000892|Saquinavir|saquinavir|mesh-list
20086257|NCT00000892|Delavirdine|delavirdine|mesh-list
20086258|NCT00000892|Adefovir|adefovir|mesh-list
20086259|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20086260|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086261|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086262|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086263|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086264|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086265|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086266|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086267|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
20086268|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086269|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086270|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086271|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086272|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086273|NCT00000893|Efavirenz|efavirenz|mesh-list
20086274|NCT00000893|Nelfinavir|nelfinavir|mesh-list
20086275|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086276|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086277|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086278|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086279|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
20086280|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086281|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086282|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086283|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20306090|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492372|NCT03122938|Lactoferrin|lactoferrin|mesh-list
19492373|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086284|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086285|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086286|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086287|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086288|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086289|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086290|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086291|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086292|NCT00000894|Ganciclovir|ganciclovir|mesh-list
20086293|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20086294|NCT00000894|Cidofovir|cidofovir|mesh-list
20086295|NCT00000894|Probenecid|probenecid|mesh-list
20086296|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
20086297|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086298|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086299|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086300|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086301|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
20086302|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
20086303|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20086304|NCT00000894|Renal Agents|renal agents|mesh-ancestor
20086305|NCT00000895|Azithromycin|azithromycin|mesh-list
19492374|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
19492375|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19492376|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19492377|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492378|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
19492379|NCT03122782|Coagulants|coagulants|mesh-ancestor
19492380|NCT03122561|Acetaminophen|acetaminophen|mesh-list
19492381|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492382|NCT03122561|Analgesics|analgesics|mesh-ancestor
19492383|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
20086306|NCT00000895|Nevirapine|nevirapine|mesh-list
19492384|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492385|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086307|NCT00000895|Nelfinavir|nelfinavir|mesh-list
20086308|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086309|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086310|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086311|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086312|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086313|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086314|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
20086315|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086316|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086317|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086318|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086319|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086320|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086321|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086322|NCT00000896|Lamivudine|lamivudine|mesh-list
20086323|NCT00000896|Zidovudine|zidovudine|mesh-list
20086324|NCT00000896|Nevirapine|nevirapine|mesh-list
20086325|NCT00000896|Stavudine|stavudine|mesh-list
20086326|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20086327|NCT00000896|Indinavir|indinavir|mesh-list
20086328|NCT00000896|Interleukin-12|interleukin-12|mesh-list
20086329|NCT00000896|Sargramostim|sargramostim|mesh-list
20086330|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086331|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086332|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086333|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086334|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
20086335|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086336|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086337|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086338|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
20086339|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
20086340|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086341|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086342|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086343|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086344|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086345|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086346|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086347|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20086348|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20086349|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20086350|NCT00000896|Growth Substances|growth substances|mesh-ancestor
20086351|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
20086352|NCT00000897|Zidovudine|zidovudine|mesh-list
20086353|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
20086354|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086355|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086356|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086357|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086358|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
20086359|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086360|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086361|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086362|NCT00000898|Ritonavir|ritonavir|mesh-list
20086363|NCT00000898|Nelfinavir|nelfinavir|mesh-list
20086364|NCT00000898|Saquinavir|saquinavir|mesh-list
20086365|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086366|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086367|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086368|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086369|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086370|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086371|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086372|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
20086373|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086374|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086375|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086376|NCT00000899|Lamivudine|lamivudine|mesh-list
20086377|NCT00000899|Stavudine|stavudine|mesh-list
20086378|NCT00000899|Nelfinavir|nelfinavir|mesh-list
20086379|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
20086380|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20086381|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
20086382|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086383|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20086384|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20086385|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
20086386|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086387|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086388|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20086389|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086390|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086391|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086392|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
20086393|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086394|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086395|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086396|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
20306091|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
20086397|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086398|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086399|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086400|NCT00000901|Lamivudine|lamivudine|mesh-list
20086401|NCT00000901|Stavudine|stavudine|mesh-list
20086402|NCT00000901|Indinavir|indinavir|mesh-list
20086403|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086404|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086405|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086406|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086407|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
20086408|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086409|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086410|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086411|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
20086412|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086413|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086414|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086415|NCT00000902|Ritonavir|ritonavir|mesh-list
20086416|NCT00000902|Nelfinavir|nelfinavir|mesh-list
20086417|NCT00000902|Lamivudine|lamivudine|mesh-list
20086418|NCT00000902|Zidovudine|zidovudine|mesh-list
20086419|NCT00000902|Nevirapine|nevirapine|mesh-list
20086420|NCT00000902|Stavudine|stavudine|mesh-list
20086421|NCT00000902|Didanosine|didanosine|mesh-list
20086422|NCT00000902|Zalcitabine|zalcitabine|mesh-list
20086423|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086424|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086425|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086426|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086427|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492386|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
19492387|NCT03122509|Durvalumab|durvalumab|mesh-list
20086428|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086429|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086430|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
20086431|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086432|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086433|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086434|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086435|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086436|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
20086437|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086438|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086439|NCT00000903|Lamivudine|lamivudine|mesh-list
20086440|NCT00000903|Zidovudine|zidovudine|mesh-list
20086441|NCT00000903|Efavirenz|efavirenz|mesh-list
20086442|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19492388|NCT03122509|Tremelimumab|tremelimumab|mesh-list
19749538|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
20086443|NCT00000903|Nelfinavir|nelfinavir|mesh-list
20086444|NCT00000903|Indinavir|indinavir|mesh-list
20086445|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086446|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086447|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086448|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086449|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
20086450|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086451|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492389|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19492390|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492391|NCT03122639|Atorvastatin|atorvastatin|mesh-list
19492392|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19492393|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19492394|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
19492395|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492396|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19492397|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19492398|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492399|NCT03122652|Teriflunomide|teriflunomide|mesh-list
19492400|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19492401|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492402|NCT03122652|Analgesics|analgesics|mesh-ancestor
19492403|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
19492404|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492405|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492406|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492407|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492408|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492409|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
19492410|NCT03122730|Epoprostenol|epoprostenol|mesh-list
19492411|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19492412|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19492413|NCT03122613|Curcumin|curcumin|mesh-list
19492414|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19492415|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492416|NCT03122613|Analgesics|analgesics|mesh-ancestor
19492417|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
19492418|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492419|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492420|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492421|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492422|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492423|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492424|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492425|NCT03122756|Dexamethasone|dexamethasone|mesh-list
19492426|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492427|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
19492428|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
19492429|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492430|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086452|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086453|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
20086454|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086455|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086456|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086457|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086458|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086459|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086460|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086461|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086462|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086463|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
20086464|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20086465|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
20086466|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086467|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20086468|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086469|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
20086470|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086471|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
20086472|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20086473|NCT00000904|Protective Agents|protective agents|mesh-ancestor
20306092|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
20086474|NCT00000906|Ritonavir|ritonavir|mesh-list
20086475|NCT00000906|Saquinavir|saquinavir|mesh-list
20086476|NCT00000906|Methadone|methadone|mesh-list
20086477|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086478|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086479|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086480|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086481|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086482|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086483|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086484|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
20086485|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749539|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
20306093|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
20086486|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086487|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086488|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20086489|NCT00000906|Narcotics|narcotics|mesh-ancestor
20086490|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20086491|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086492|NCT00000906|Analgesics|analgesics|mesh-ancestor
20086493|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
20086494|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20086495|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
20086496|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
20086497|NCT00000909|Aldesleukin|aldesleukin|mesh-list
19492431|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20086498|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086499|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086500|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086501|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
20086502|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120139|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20120140|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20120141|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086503|NCT00000912|Efavirenz|efavirenz|mesh-list
20086504|NCT00000912|Abacavir|abacavir|mesh-list
20086505|NCT00000912|Adefovir|adefovir|mesh-list
20086506|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20086507|NCT00000912|Nelfinavir|nelfinavir|mesh-list
20086508|NCT00000912|Indinavir|indinavir|mesh-list
20086509|NCT00000912|Saquinavir|saquinavir|mesh-list
20086510|NCT00000912|Amprenavir|amprenavir|mesh-list
20086511|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086512|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086513|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086514|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086515|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
20086516|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086517|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086518|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086519|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086520|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086521|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086522|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086523|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086524|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086525|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086526|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086527|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086528|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086529|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20086530|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
20086531|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086532|NCT00000913|Ritonavir|ritonavir|mesh-list
20086533|NCT00000913|Nelfinavir|nelfinavir|mesh-list
20086534|NCT00000913|Saquinavir|saquinavir|mesh-list
20086535|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086536|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086537|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086538|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086539|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086540|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086541|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086542|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
20601359|NCT02209441|Sorafenib|sorafenib|mesh-list
20601360|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601361|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20601362|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601363|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601364|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
20601365|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
20601366|NCT02209636|Vitamins|vitamins|mesh-ancestor
20601367|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
20601368|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601369|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
20601370|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601371|NCT02209636|Protective Agents|protective agents|mesh-ancestor
20601372|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
20601373|NCT02209649|Telmisartan|telmisartan|mesh-list
20601374|NCT02209649|Lacidipine|lacidipine|mesh-list
20601375|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20086543|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086544|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086545|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086546|NCT00000914|Ritonavir|ritonavir|mesh-list
20086547|NCT00000914|Nelfinavir|nelfinavir|mesh-list
20086548|NCT00000914|Indinavir|indinavir|mesh-list
20086549|NCT00000914|Efavirenz|efavirenz|mesh-list
20086550|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086551|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086552|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086553|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492432|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
19492433|NCT03122756|Hormones|hormones|mesh-ancestor
19492434|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492435|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19492436|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492437|NCT03122678|Thiamine|thiamine|mesh-list
19492438|NCT03122678|Vitamins|vitamins|mesh-ancestor
19492439|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
19492440|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492441|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
19492442|NCT03122665|Nefopam|nefopam|mesh-list
19492443|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492444|NCT03122665|Analgesics|analgesics|mesh-ancestor
19492445|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
19492446|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492447|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492448|NCT03122444|Imipramine|imipramine|mesh-list
19492449|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19492450|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
20086554|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086555|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086556|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086557|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
20086558|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492451|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19492452|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19492453|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19492454|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20086559|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086560|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086561|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086562|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086563|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086564|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086565|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086566|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086567|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086568|NCT00000916|Lamivudine|lamivudine|mesh-list
20086569|NCT00000916|Zidovudine|zidovudine|mesh-list
20086570|NCT00000916|Stavudine|stavudine|mesh-list
20086571|NCT00000916|Didanosine|didanosine|mesh-list
20086572|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20086573|NCT00000916|Indinavir|indinavir|mesh-list
20086574|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
20086575|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086576|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086577|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086578|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086579|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
20086580|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086581|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086582|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086583|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
20086584|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086585|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
20086586|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086587|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086588|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086589|NCT00000918|Ritonavir|ritonavir|mesh-list
20086590|NCT00000918|Indinavir|indinavir|mesh-list
20086591|NCT00000918|Saquinavir|saquinavir|mesh-list
20086592|NCT00000918|Amprenavir|amprenavir|mesh-list
20086593|NCT00000918|Lamivudine|lamivudine|mesh-list
20086594|NCT00000918|Zidovudine|zidovudine|mesh-list
20086595|NCT00000918|Stavudine|stavudine|mesh-list
20086596|NCT00000918|Didanosine|didanosine|mesh-list
20086597|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20086598|NCT00000918|Efavirenz|efavirenz|mesh-list
20086599|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086600|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086601|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086602|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086603|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086604|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086605|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086606|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
20086607|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086608|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086609|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086610|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086611|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086612|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
20086613|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086614|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086615|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086616|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086617|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086618|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20086619|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
20086620|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086621|NCT00000919|Ritonavir|ritonavir|mesh-list
20086622|NCT00000919|Nelfinavir|nelfinavir|mesh-list
20086623|NCT00000919|Indinavir|indinavir|mesh-list
20086624|NCT00000919|Amprenavir|amprenavir|mesh-list
20086625|NCT00000919|Lamivudine|lamivudine|mesh-list
20086626|NCT00000919|Zidovudine|zidovudine|mesh-list
20086627|NCT00000919|Abacavir|abacavir|mesh-list
20086628|NCT00000919|Stavudine|stavudine|mesh-list
20086629|NCT00000919|Didanosine|didanosine|mesh-list
20086630|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20086631|NCT00000919|Efavirenz|efavirenz|mesh-list
20086632|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
20086633|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086634|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086635|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086636|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086637|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086638|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086639|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19569638|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086640|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
20086641|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086642|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086643|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086644|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086645|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086646|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
20086647|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19569639|NCT04591808|Perindopril|perindopril|mesh-list
20086648|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086649|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086650|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086651|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086652|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086653|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
20086654|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20086655|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
20086656|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086657|NCT00000920|Ritonavir|ritonavir|mesh-list
19569640|NCT04591808|Atorvastatin|atorvastatin|mesh-list
20086658|NCT00000920|Saquinavir|saquinavir|mesh-list
20086659|NCT00000920|Lamivudine|lamivudine|mesh-list
20086660|NCT00000920|Zidovudine|zidovudine|mesh-list
20086661|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086662|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086663|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086664|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086665|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086666|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086667|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086668|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
20086669|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086670|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086671|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086672|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086673|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086674|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
20086675|NCT00000921|Prednisone|prednisone|mesh-list
20086676|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20086677|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
20086678|NCT00000921|Hormones|hormones|mesh-ancestor
20086679|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20086680|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086681|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20086682|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086683|NCT00000922|Lamivudine|lamivudine|mesh-list
20086684|NCT00000922|Efavirenz|efavirenz|mesh-list
20086685|NCT00000922|Nevirapine|nevirapine|mesh-list
20086686|NCT00000922|Abacavir|abacavir|mesh-list
20086687|NCT00000922|Stavudine|stavudine|mesh-list
20086688|NCT00000922|Didanosine|didanosine|mesh-list
20086689|NCT00000922|Nelfinavir|nelfinavir|mesh-list
20086690|NCT00000922|Indinavir|indinavir|mesh-list
20086691|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086692|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086693|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601376|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20601377|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20601378|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086694|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086695|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
20086696|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601379|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20601380|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20601381|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20601382|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086697|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086698|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086699|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086700|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086701|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086702|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086703|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086704|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086705|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
20086706|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086707|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086708|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086709|NCT00000923|Lamivudine|lamivudine|mesh-list
20086710|NCT00000923|Zidovudine|zidovudine|mesh-list
20086711|NCT00000923|Stavudine|stavudine|mesh-list
20086712|NCT00000923|Didanosine|didanosine|mesh-list
20086713|NCT00000923|Aldesleukin|aldesleukin|mesh-list
20086714|NCT00000923|Indinavir|indinavir|mesh-list
20086715|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086716|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086717|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086718|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086719|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
20086720|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086721|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086722|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086723|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
20086724|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086725|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086726|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086727|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086728|NCT00000924|Ritonavir|ritonavir|mesh-list
20086729|NCT00000924|Nelfinavir|nelfinavir|mesh-list
20086730|NCT00000924|Nevirapine|nevirapine|mesh-list
20086731|NCT00000924|Stavudine|stavudine|mesh-list
20086732|NCT00000924|Didanosine|didanosine|mesh-list
20086733|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086734|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086735|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086736|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086737|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086738|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086739|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086740|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
20086741|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086742|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086743|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086744|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086745|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086746|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086747|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086748|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
20086749|NCT00000926|Nonoxynol|nonoxynol|mesh-list
20086750|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20086751|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20086752|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086753|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20086754|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
20086755|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20086756|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20086757|NCT00000929|Nonoxynol|nonoxynol|mesh-list
20086758|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20086759|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20086760|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086761|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20086762|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
20086763|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20086764|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20086765|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
20086766|NCT00000935|Antibodies|antibodies|mesh-list
20086767|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
20086768|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20086769|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20086770|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
20086771|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086772|NCT00000936|Cyclosporine|cyclosporine|mesh-list
20601383|NCT02209701|Porfiromycin|porfiromycin|mesh-list
20601384|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20601385|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601386|NCT02209740|Tenofovir|tenofovir|mesh-list
20086773|NCT00000936|Cyclosporins|cyclosporins|mesh-list
20086774|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086775|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086776|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20086777|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
20086778|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086779|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
20086780|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086781|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
20086782|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20086783|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20086784|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20086785|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086786|NCT00000938|Doxycycline|doxycycline|mesh-list
20086787|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
20086788|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086789|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086790|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
20086791|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20086792|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20601387|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
20601388|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601389|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20601390|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601391|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601392|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601393|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601394|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20601395|NCT02209831|Pantoprazole|pantoprazole|mesh-list
20601396|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20601397|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20601398|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20601399|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601400|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601401|NCT02209909|Aspirin|aspirin|mesh-list
20601402|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20601403|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601404|NCT02209909|Analgesics|analgesics|mesh-ancestor
20601405|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
20086793|NCT00000939|Efavirenz|efavirenz|mesh-list
20086794|NCT00000939|Stavudine|stavudine|mesh-list
20086795|NCT00000939|Didanosine|didanosine|mesh-list
20086796|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
20086797|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086798|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086799|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086800|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086801|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
20086802|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086803|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086804|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086805|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086806|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20086807|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086808|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086809|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086810|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
20086811|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
20086812|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086813|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086814|NCT00000940|Ritonavir|ritonavir|mesh-list
20086815|NCT00000940|Amprenavir|amprenavir|mesh-list
20086816|NCT00000940|Lamivudine|lamivudine|mesh-list
20086817|NCT00000940|Abacavir|abacavir|mesh-list
20086818|NCT00000940|Stavudine|stavudine|mesh-list
20086819|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086820|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086821|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086822|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086823|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086824|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086825|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086826|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
19492455|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492456|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492457|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492458|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492459|NCT03122769|Metformin|metformin|mesh-list
19492460|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19492461|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492462|NCT03122353|Calcitriol|calcitriol|mesh-list
19492463|NCT03122353|Betamethasone|betamethasone|mesh-list
19492464|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
19492465|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19492466|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
19492467|NCT03122353|Calcipotriene|calcipotriene|mesh-list
19492468|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19492469|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20086827|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086828|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086829|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086830|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086831|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086832|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
20086833|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20086834|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
20086835|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086836|NCT00000941|Ritonavir|ritonavir|mesh-list
20086837|NCT00000941|Nelfinavir|nelfinavir|mesh-list
20086838|NCT00000941|Saquinavir|saquinavir|mesh-list
20086839|NCT00000941|Atorvastatin|atorvastatin|mesh-list
20086840|NCT00000941|Simvastatin|simvastatin|mesh-list
20086841|NCT00000941|Pravastatin|pravastatin|mesh-list
19492470|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
19492471|NCT03122353|Hormones|hormones|mesh-ancestor
19492472|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492473|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492474|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19492475|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
19492476|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
19492477|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19492478|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19492479|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19492480|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492481|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19492482|NCT03122353|Vitamins|vitamins|mesh-ancestor
19492483|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
20086842|NCT00000941|Calcium|calcium|mesh-list
20086843|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20086844|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086845|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20086846|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20086847|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
20086848|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086849|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20086850|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20086851|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086852|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086853|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086854|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
19492484|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19492485|NCT03122197|Letrozole|letrozole|mesh-list
20086855|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086856|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086857|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
20086858|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086859|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086860|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086861|NCT00000942|Nevirapine|nevirapine|mesh-list
20086862|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086863|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086864|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086865|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086866|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
20086867|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086868|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086869|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20601406|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601407|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601408|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601409|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601410|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20601411|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20601412|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086870|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086871|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086872|NCT00000943|Vaccines|vaccines|mesh-list
20086873|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
20086874|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086875|NCT00000944|Lamivudine|lamivudine|mesh-list
20086876|NCT00000944|Zidovudine|zidovudine|mesh-list
20086877|NCT00000944|Indinavir|indinavir|mesh-list
20086878|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086879|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086880|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086881|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086882|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
20086883|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086884|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086885|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086886|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
20086887|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20601413|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20601414|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20086888|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086889|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086890|NCT00000945|Cidofovir|cidofovir|mesh-list
20086891|NCT00000945|Probenecid|probenecid|mesh-list
20086892|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
20086893|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
20086894|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20086895|NCT00000945|Renal Agents|renal agents|mesh-ancestor
20086896|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
20086897|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086898|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086899|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086900|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
20086901|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20086902|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
20086903|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086904|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20086905|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086906|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
20086907|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086908|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
20086909|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20086910|NCT00000946|Protective Agents|protective agents|mesh-ancestor
20086911|NCT00000947|Azithromycin|azithromycin|mesh-list
20086912|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086913|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086914|NCT00000948|Aldesleukin|aldesleukin|mesh-list
20086915|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086916|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086917|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086918|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
20086919|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086920|NCT00000949|Aldesleukin|aldesleukin|mesh-list
20086921|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086922|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086923|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086924|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
20086925|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086926|NCT00000950|Pyridoxine|pyridoxine|mesh-list
20086927|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
20086928|NCT00000950|Rifampin|rifampin|mesh-list
20086929|NCT00000950|Isoniazid|isoniazid|mesh-list
20086930|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
20086931|NCT00000950|Ethambutol|ethambutol|mesh-list
20086932|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20086933|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
20086934|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20086935|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086936|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
20086937|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086938|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086939|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086940|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20601415|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086941|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20086942|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20601416|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
20601417|NCT02209974|Fluticasone|fluticasone|mesh-list
20601418|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601419|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20601420|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
20601421|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601422|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601423|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20601424|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
20086943|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20601425|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
20601426|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20601427|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20601428|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
20601429|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601430|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
20601431|NCT02210104|Ipilimumab|ipilimumab|mesh-list
20601432|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20601433|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
20601434|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601435|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601436|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20601437|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
20601438|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601439|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601440|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20601441|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20601442|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20601443|NCT02210117|Bevacizumab|bevacizumab|mesh-list
20601444|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20601445|NCT02210117|Nivolumab|nivolumab|mesh-list
20601446|NCT02210117|Ipilimumab|ipilimumab|mesh-list
20601447|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
20601448|NCT02210117|Antibodies|antibodies|mesh-list
20601449|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
20601450|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20601451|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
20601452|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601453|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20601454|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20086944|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20086945|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20086946|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20086947|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20086948|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
20086949|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20086950|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
20086951|NCT00000950|Vitamins|vitamins|mesh-ancestor
20086952|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
20086953|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086954|NCT00000951|Fluconazole|fluconazole|mesh-list
20086955|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
20086956|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086957|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20086958|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086959|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086960|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086961|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19492486|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492487|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20601455|NCT02210117|Growth Substances|growth substances|mesh-ancestor
20601456|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086962|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
20086963|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20086964|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20086965|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20086966|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20086967|NCT00000952|Ritonavir|ritonavir|mesh-list
20086968|NCT00000952|Lamivudine|lamivudine|mesh-list
20086969|NCT00000952|Zidovudine|zidovudine|mesh-list
20086970|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20086971|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20086972|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
20086973|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086974|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086975|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20086976|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20086977|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
20086978|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086979|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20086980|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20086981|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20086982|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20086983|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
20086984|NCT00000953|Acyclovir|acyclovir|mesh-list
20601457|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
20601458|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
20601459|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20601460|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607813|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20607814|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20607815|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
20607816|NCT02243553|Coagulants|coagulants|mesh-ancestor
20607817|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
20607818|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
20607819|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20607820|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20607821|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20607822|NCT02243566|Telmisartan|telmisartan|mesh-list
20607823|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20607824|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20607825|NCT02243566|Diuretics|diuretics|mesh-ancestor
20607826|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
20607827|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607828|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20086985|NCT00000953|Sorivudine|sorivudine|mesh-list
20086986|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
20086987|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20086988|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20086989|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086990|NCT00000954|Didanosine|didanosine|mesh-list
20086991|NCT00000954|Zalcitabine|zalcitabine|mesh-list
20086992|NCT00000954|Doxorubicin|doxorubicin|mesh-list
20086993|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20086994|NCT00000954|Bleomycin|bleomycin|mesh-list
19746698|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19746699|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746700|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746701|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746702|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
19746703|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19746704|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20601461|NCT02210156|Micronutrients|micronutrients|mesh-list
19746705|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20086995|NCT00000954|Vincristine|vincristine|mesh-list
20601462|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601463|NCT02210169|Vancomycin|vancomycin|mesh-list
20601464|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601465|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601466|NCT02210182|Pentamidine|pentamidine|mesh-list
20601467|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
20601468|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601469|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20086996|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20086997|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20086998|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20086999|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20087000|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087001|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087002|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20087003|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
20087004|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
20087005|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
20087006|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
20087007|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087008|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087009|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
20087010|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087011|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087012|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19492488|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19492489|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492490|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492491|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19492492|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
19492493|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492494|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492495|NCT03122262|Tenofovir|tenofovir|mesh-list
19492496|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19492497|NCT03122262|Dolutegravir|dolutegravir|mesh-list
19492498|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19492499|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
19492500|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492501|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19492502|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492503|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492504|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492505|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19746706|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
19746707|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
20087013|NCT00000959|Pyridoxine|pyridoxine|mesh-list
20087014|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
20087015|NCT00000959|Isoniazid|isoniazid|mesh-list
20087016|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
20087017|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087018|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087019|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20087020|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20087021|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
20087022|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087023|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20087024|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
20087025|NCT00000959|Vitamins|vitamins|mesh-ancestor
20087026|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
20087027|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087028|NCT00000960|Zidovudine|zidovudine|mesh-list
20087029|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
20087030|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087031|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087032|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087033|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087034|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
20087035|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087036|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087037|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087038|NCT00000961|Zidovudine|zidovudine|mesh-list
20087039|NCT00000961|Immune Sera|immune sera|mesh-list
20087040|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
20087041|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087042|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087043|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087044|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087045|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
20087046|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087047|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087048|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087049|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
20087050|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087051|NCT00000962|Nevirapine|nevirapine|mesh-list
20087052|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087053|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087054|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087055|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087056|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
20087057|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087058|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087059|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087060|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20087061|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20087062|NCT00000963|Didanosine|didanosine|mesh-list
20087063|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
20087064|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087065|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087066|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087067|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087068|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
20087069|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087070|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087071|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087072|NCT00000964|Foscarnet|foscarnet|mesh-list
20087073|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20087074|NCT00000964|Ranitidine|ranitidine|mesh-list
20087075|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20087076|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20087077|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20087078|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20087079|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
20087080|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
20087081|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20087082|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087083|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087084|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
20087085|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087086|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087087|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087088|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087089|NCT00000965|Zidovudine|zidovudine|mesh-list
20087090|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
20087091|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087092|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087093|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087094|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087095|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
20087096|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087097|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087098|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087099|NCT00000966|Leucovorin|leucovorin|mesh-list
20087100|NCT00000966|Azithromycin|azithromycin|mesh-list
20087101|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
20087102|NCT00000966|Calcium|calcium|mesh-list
20087103|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
20087104|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20087105|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087106|NCT00000966|Antidotes|antidotes|mesh-ancestor
20087107|NCT00000966|Protective Agents|protective agents|mesh-ancestor
20087108|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
20087109|NCT00000966|Vitamins|vitamins|mesh-ancestor
20087110|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
20087111|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19492506|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087112|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087113|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
20087114|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087115|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087116|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20087117|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087118|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087119|NCT00000967|Interferons|interferons|mesh-list
20087120|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
20087121|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
20087122|NCT00000967|Zidovudine|zidovudine|mesh-list
20087123|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087124|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
20087125|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087126|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
20087127|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087128|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
20087129|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087130|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087131|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087132|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087133|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087134|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087135|NCT00000969|Didanosine|didanosine|mesh-list
20087136|NCT00000969|Zalcitabine|zalcitabine|mesh-list
20087137|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
20601470|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20601471|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20601472|NCT02210260|Heroin|heroin|mesh-list
20601473|NCT02210260|Bupivacaine|bupivacaine|mesh-list
20601474|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
20601475|NCT02210260|Anesthetics|anesthetics|mesh-list
20601476|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601477|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601478|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
20601479|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601480|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20601481|NCT02210260|Narcotics|narcotics|mesh-ancestor
20601482|NCT02210260|Analgesics|analgesics|mesh-ancestor
20087138|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087139|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087140|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087141|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087142|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
20087143|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087144|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087145|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087146|NCT00000970|Ganciclovir|ganciclovir|mesh-list
20087147|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20087148|NCT00000970|Foscarnet|foscarnet|mesh-list
20087149|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20087150|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
20087151|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087152|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087153|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087154|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087155|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087156|NCT00000971|Zidovudine|zidovudine|mesh-list
20087157|NCT00000971|Didanosine|didanosine|mesh-list
20087158|NCT00000971|Clarithromycin|clarithromycin|mesh-list
20087159|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
20087160|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087161|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087162|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087163|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087164|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
20087165|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087166|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087167|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087168|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087169|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20087170|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087171|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087172|NCT00000973|Leucovorin|leucovorin|mesh-list
20087173|NCT00000973|Zidovudine|zidovudine|mesh-list
20087174|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
20087175|NCT00000973|Calcium|calcium|mesh-list
20087176|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
20087177|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20087178|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087179|NCT00000973|Antidotes|antidotes|mesh-ancestor
20087180|NCT00000973|Protective Agents|protective agents|mesh-ancestor
20087181|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
20087182|NCT00000973|Vitamins|vitamins|mesh-ancestor
20087183|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
20087184|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
20087185|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601483|NCT02210325|Azithromycin|azithromycin|mesh-list
20601484|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
20601485|NCT02210325|Solithromycin|solithromycin|mesh-list
20601486|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601487|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601488|NCT02210364|Capecitabine|capecitabine|mesh-list
20601489|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20601490|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
20601491|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601492|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601493|NCT02210598|Oxytocin|oxytocin|mesh-list
20601494|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
20601495|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20601496|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601497|NCT02210663|Veliparib|veliparib|mesh-list
20601498|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20601499|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601500|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601501|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601502|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20601503|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20601504|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20601505|NCT02210702|Norethindrone|norethindrone|mesh-list
20601506|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
20601507|NCT02210702|Estradiol|estradiol|mesh-list
20601508|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20601509|NCT02210702|Estrogens|estrogens|mesh-ancestor
20087186|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20601510|NCT02210702|Hormones|hormones|mesh-ancestor
20601511|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20087187|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087188|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087189|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
20087190|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087191|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087192|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087193|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
20087194|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087195|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087196|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20087197|NCT00000974|Pentamidine|pentamidine|mesh-list
20087198|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
20087199|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601512|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601513|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20601514|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
20601515|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20601516|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20601517|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20601518|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20087200|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087201|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087202|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20087203|NCT00000975|Itraconazole|itraconazole|mesh-list
20087204|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
20087205|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087206|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20087207|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087208|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087209|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087210|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20087211|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
20087212|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20087213|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087214|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087215|NCT00000976|Zidovudine|zidovudine|mesh-list
20087216|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
20087217|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
20601519|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20601520|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
20601521|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20601522|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601523|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
20601524|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601525|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20601526|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20601527|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087218|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087219|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087220|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087221|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087222|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
20087223|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087224|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087225|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087226|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
20087227|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087228|NCT00000978|Zidovudine|zidovudine|mesh-list
20087229|NCT00000978|Zalcitabine|zalcitabine|mesh-list
20087230|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
20087231|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087232|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087233|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087234|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087235|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
20087236|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087237|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087238|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19492507|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20087239|NCT00000979|Zidovudine|zidovudine|mesh-list
20087240|NCT00000979|Didanosine|didanosine|mesh-list
20087241|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
20087242|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087243|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087244|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087245|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087246|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
20087247|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087248|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087249|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087250|NCT00000980|Spiramycin|spiramycin|mesh-list
20087251|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087252|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087253|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
20087254|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087255|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087256|NCT00000981|Fiacitabine|fiacitabine|mesh-list
20087257|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087258|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
20087259|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087260|NCT00000982|Zidovudine|zidovudine|mesh-list
20087261|NCT00000982|Didanosine|didanosine|mesh-list
20087262|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
19492508|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20087263|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087264|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087265|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087266|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087267|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
20087268|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087269|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087270|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087271|NCT00000983|Zidovudine|zidovudine|mesh-list
20087272|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
20087273|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087274|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087275|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087276|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087277|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
20087278|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087279|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087280|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087281|NCT00000985|Acyclovir|acyclovir|mesh-list
20087282|NCT00000985|Foscarnet|foscarnet|mesh-list
20087283|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20087284|NCT00000985|Vidarabine|vidarabine|mesh-list
20087285|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
20087286|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087287|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087288|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087289|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087290|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087291|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
20087292|NCT00000986|Zidovudine|zidovudine|mesh-list
20087293|NCT00000986|Aldesleukin|aldesleukin|mesh-list
20087294|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
20087295|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087296|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087297|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087298|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087299|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
20087300|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087301|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087302|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087303|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087304|NCT00000987|Zidovudine|zidovudine|mesh-list
20087305|NCT00000987|Doxorubicin|doxorubicin|mesh-list
20087306|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20087307|NCT00000987|Bleomycin|bleomycin|mesh-list
20087308|NCT00000987|Vincristine|vincristine|mesh-list
20087309|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20087310|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087311|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20087312|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20087313|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087314|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087315|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20087316|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
20087317|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
20087318|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
20087319|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
20087320|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087321|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087322|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
20087323|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087324|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087325|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087326|NCT00000988|Stavudine|stavudine|mesh-list
20087327|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
20087328|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087329|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087330|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087331|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087332|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
20087333|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087334|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087335|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087336|NCT00000989|Zidovudine|zidovudine|mesh-list
20087337|NCT00000989|Ganciclovir|ganciclovir|mesh-list
20087338|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20087339|NCT00000989|Sargramostim|sargramostim|mesh-list
20087340|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
19492509|NCT03122158|Citalopram|citalopram|mesh-list
20601528|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601529|NCT02210728|Methylphenidate|methylphenidate|mesh-list
20601530|NCT02210728|Amphetamine|amphetamine|mesh-list
20601531|NCT02210728|Adderall|adderall|mesh-list
20601532|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
20601533|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20601534|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601535|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20601536|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20601537|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20601538|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601539|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
20601540|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601541|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
20601542|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
20601543|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20087341|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087342|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087343|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087344|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601544|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
20601545|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20601546|NCT02210754|Menthol|menthol|mesh-list
20601547|NCT02210754|Nicotine|nicotine|mesh-list
20601548|NCT02210754|Glycerol|glycerol|mesh-list
20087345|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
20087346|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087347|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087348|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087349|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
20087350|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087351|NCT00000990|Zidovudine|zidovudine|mesh-list
20087352|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
20087353|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087354|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087355|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087356|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087357|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
20601549|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20601550|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
20601551|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601552|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601553|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20601554|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20601555|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
20601556|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20087358|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087359|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087360|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087361|NCT00000991|Zidovudine|zidovudine|mesh-list
20087362|NCT00000991|Trimethoprim|trimethoprim|mesh-list
20087363|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
20087364|NCT00000991|Dapsone|dapsone|mesh-list
20087365|NCT00000991|Pentamidine|pentamidine|mesh-list
20087366|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20087367|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
20087368|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087369|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087370|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087371|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087372|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
20087373|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087374|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087375|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087376|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20087377|NCT00000991|Renal Agents|renal agents|mesh-ancestor
20087378|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
20087379|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087380|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087381|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20087382|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20087383|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20087384|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087385|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
20087386|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087387|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
20087388|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20087389|NCT00000992|Itraconazole|itraconazole|mesh-list
20087390|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
20087391|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087392|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20087393|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087394|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087395|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087396|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20087397|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
20087398|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20087399|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087400|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087401|NCT00000993|Zidovudine|zidovudine|mesh-list
20087402|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
20087403|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087404|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19492510|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19492511|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19492512|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19492513|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492514|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492515|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
19492516|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492517|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19492518|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
19492519|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19492520|NCT03121963|Acetaminophen|acetaminophen|mesh-list
19492521|NCT03121963|Celecoxib|celecoxib|mesh-list
19492522|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19492523|NCT03121963|Oxycodone|oxycodone|mesh-list
19492524|NCT03121963|Gabapentin|gabapentin|mesh-list
19492525|NCT03121963|Hydrocodone|hydrocodone|mesh-list
19492526|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492527|NCT03121963|Analgesics|analgesics|mesh-ancestor
19492528|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
19492529|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492530|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492531|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
19492532|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19492533|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492534|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492535|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19492536|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19492537|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492538|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492539|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19492540|NCT03121963|Narcotics|narcotics|mesh-ancestor
19492541|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492542|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
19492543|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19492544|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19492545|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19492546|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19492547|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19492548|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492549|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
19492550|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
19492551|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
19492552|NCT03122132|Ritonavir|ritonavir|mesh-list
19492553|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19492554|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19492555|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
19492556|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492557|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492558|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492559|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19492560|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
19492561|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492562|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19492563|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19492564|NCT03122002|Aspirin|aspirin|mesh-list
19492565|NCT03122002|Clopidogrel|clopidogrel|mesh-list
19492566|NCT03122002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19492567|NCT03122002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492568|NCT03122002|Analgesics|analgesics|mesh-ancestor
20087405|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087406|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087407|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
20087408|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087409|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087410|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087411|NCT00000994|Zidovudine|zidovudine|mesh-list
20087412|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
20087413|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087414|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087415|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087416|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087417|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
20087418|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087419|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087420|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087421|NCT00000995|Zidovudine|zidovudine|mesh-list
20601557|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601558|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
20601559|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
20601560|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20601561|NCT02210754|Protective Agents|protective agents|mesh-ancestor
20601562|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
20601563|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20601564|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
20601565|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20601566|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
20601567|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601568|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601569|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
20601570|NCT02210858|Tipifarnib|tipifarnib|mesh-list
20601571|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087422|NCT00000995|Ganciclovir|ganciclovir|mesh-list
20601572|NCT02210884|Vitamin D|vitamin d|mesh-list
20087423|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20087424|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
20087425|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087426|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087427|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087428|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087429|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
20087430|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087431|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087432|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087433|NCT00000996|Doxorubicin|doxorubicin|mesh-list
20087434|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20087435|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20087436|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087437|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20087438|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20087439|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087440|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087441|NCT00000997|Zalcitabine|zalcitabine|mesh-list
20087442|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
20087443|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087444|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087445|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087446|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087447|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
20087448|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087449|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087450|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087451|NCT00000998|Leucovorin|leucovorin|mesh-list
20087452|NCT00000998|Trimetrexate|trimetrexate|mesh-list
20087453|NCT00000998|Calcium|calcium|mesh-list
20087454|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
20601573|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
20601574|NCT02210884|Vitamins|vitamins|mesh-list
20601575|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
20601576|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601577|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20601578|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20601579|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
20601580|NCT02210949|Hematinics|hematinics|mesh-ancestor
20601581|NCT02211066|Clopidogrel|clopidogrel|mesh-list
20601582|NCT02211066|Ticagrelor|ticagrelor|mesh-list
20087455|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20087456|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087457|NCT00000998|Antidotes|antidotes|mesh-ancestor
20087458|NCT00000998|Protective Agents|protective agents|mesh-ancestor
20087459|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
20087460|NCT00000998|Vitamins|vitamins|mesh-ancestor
20087461|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
20087462|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
20087463|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087464|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20087465|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
20087466|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087467|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087468|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20087469|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087470|NCT00000999|Zidovudine|zidovudine|mesh-list
20087471|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
20087472|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087473|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087474|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087475|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087476|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
19492569|NCT03122002|Sensory System Agents|sensory system agents|mesh-ancestor
19492570|NCT03122002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20087477|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087478|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087479|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087480|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20087481|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
20087482|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087483|NCT00001001|Zidovudine|zidovudine|mesh-list
20087484|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
20087485|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087486|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087487|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087488|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087489|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
20087490|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492571|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087491|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087492|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087493|NCT00001002|Zidovudine|zidovudine|mesh-list
20087494|NCT00001002|Foscarnet|foscarnet|mesh-list
20087495|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20087496|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
20087497|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087498|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087499|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087500|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087501|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
20087502|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087503|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087504|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087505|NCT00001003|Zidovudine|zidovudine|mesh-list
20087506|NCT00001003|Pentamidine|pentamidine|mesh-list
20087507|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
20087508|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087509|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087510|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087511|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087512|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
20087513|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087514|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087515|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087516|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
20087517|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087518|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087519|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20087520|NCT00001004|Interferons|interferons|mesh-list
20087521|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
20087522|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087523|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
20087524|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087525|NCT00001005|Zidovudine|zidovudine|mesh-list
20087526|NCT00001005|Aldesleukin|aldesleukin|mesh-list
20087527|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
20087528|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087529|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087530|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087531|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087532|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
20087533|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087534|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087535|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087536|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087537|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20087538|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20087539|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
20087540|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087541|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087542|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20087543|NCT00001006|Protective Agents|protective agents|mesh-ancestor
20087544|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087545|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087546|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120142|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601583|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20601584|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20601585|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20601586|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20601587|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
20601588|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601589|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601590|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601591|NCT02211079|Tolbutamide|tolbutamide|mesh-list
20601592|NCT02211079|Midazolam|midazolam|mesh-list
20601593|NCT02211079|Caffeine|caffeine|mesh-list
20087547|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087548|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
20087549|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087550|NCT00001007|Zidovudine|zidovudine|mesh-list
20087551|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
20087552|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087553|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087554|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087555|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087556|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
20087557|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087558|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601594|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20087559|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087560|NCT00001008|Zidovudine|zidovudine|mesh-list
20087561|NCT00001008|Methadone|methadone|mesh-list
20087562|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
20087563|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087564|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087565|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087566|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087567|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
20087568|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087569|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087570|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087571|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20087572|NCT00001008|Narcotics|narcotics|mesh-ancestor
20087573|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20087574|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087575|NCT00001008|Analgesics|analgesics|mesh-ancestor
20087576|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
20087577|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20087578|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
20087579|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
20087580|NCT00001009|Dextrans|dextrans|mesh-list
20087581|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
20087582|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
20087583|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
20087584|NCT00001010|Zidovudine|zidovudine|mesh-list
20087585|NCT00001010|Acyclovir|acyclovir|mesh-list
20087586|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
20087587|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087588|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087589|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087590|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087591|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
20087592|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087593|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087594|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120143|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
20120144|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120145|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20087595|NCT00001011|Zidovudine|zidovudine|mesh-list
20087596|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
20087597|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087598|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087599|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087600|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087601|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
20087602|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087603|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087604|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087605|NCT00001013|Leucovorin|leucovorin|mesh-list
20087606|NCT00001013|Trimethoprim|trimethoprim|mesh-list
20087607|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20087608|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
20087609|NCT00001013|Pentamidine|pentamidine|mesh-list
20087610|NCT00001013|Trimetrexate|trimetrexate|mesh-list
20087611|NCT00001013|Calcium|calcium|mesh-list
20087612|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
20087613|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20087614|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087615|NCT00001013|Antidotes|antidotes|mesh-ancestor
20087616|NCT00001013|Protective Agents|protective agents|mesh-ancestor
20087617|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
20601595|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601596|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601597|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601598|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20601599|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20601600|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20601601|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20601602|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
20601603|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
20601604|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
20601605|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
20601606|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601607|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601608|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20601609|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20087618|NCT00001013|Vitamins|vitamins|mesh-ancestor
20087619|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
20087620|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20087621|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492572|NCT03122002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20087622|NCT00001013|Renal Agents|renal agents|mesh-ancestor
20087623|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
20087624|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087625|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087626|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19492573|NCT03122002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492574|NCT03122002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19492575|NCT03122002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19492576|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492577|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19492578|NCT03122002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19492579|NCT03122002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492580|NCT03122002|Antipyretics|antipyretics|mesh-ancestor
19492581|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19492582|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19492583|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19492584|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
19492585|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492586|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19492587|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19492588|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492589|NCT03122041|Incretins|incretins|mesh-ancestor
19492590|NCT03122041|Hormones|hormones|mesh-ancestor
19492591|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492592|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19492593|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
19492594|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492595|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492596|NCT03121846|Apatinib|apatinib|mesh-list
19492597|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492598|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19492599|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492600|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492601|NCT03122314|Acetaminophen|acetaminophen|mesh-list
19492602|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19492603|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492604|NCT03122314|Analgesics|analgesics|mesh-ancestor
19492605|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
19492606|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492607|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492608|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
19492609|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19492610|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492611|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492612|NCT03122067|Oxytocin|oxytocin|mesh-list
19492613|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
19492614|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19492615|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492616|NCT03121833|Endostar protein|endostar protein|mesh-list
19492617|NCT03121833|Endostatins|endostatins|mesh-list
20087627|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087628|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087629|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20087630|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20601610|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601611|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20601612|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20601613|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
20601614|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20601615|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
20601616|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601617|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601618|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601619|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601620|NCT02211118|Analgesics|analgesics|mesh-ancestor
20601621|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
20601622|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20087631|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087632|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
20087633|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20087634|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087635|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20087636|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
20087637|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087638|NCT00001014|Leucovorin|leucovorin|mesh-list
20087639|NCT00001014|Trimethoprim|trimethoprim|mesh-list
20087640|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20087641|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
20087642|NCT00001014|Trimetrexate|trimetrexate|mesh-list
20087643|NCT00001014|Calcium|calcium|mesh-list
20087644|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
20087645|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20087646|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087647|NCT00001014|Antidotes|antidotes|mesh-ancestor
20087648|NCT00001014|Protective Agents|protective agents|mesh-ancestor
20087649|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
20087650|NCT00001014|Vitamins|vitamins|mesh-ancestor
20087651|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
19492618|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20087652|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20087653|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087654|NCT00001014|Renal Agents|renal agents|mesh-ancestor
20087655|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
20087656|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087657|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20601623|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20601624|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20601625|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20601626|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
20601627|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20087658|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20087659|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087660|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087661|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20601628|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601629|NCT02211222|Lenvatinib|lenvatinib|mesh-list
20601630|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601631|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20601632|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087662|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20601633|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601634|NCT02211326|Warfarin|warfarin|mesh-list
20601635|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
20601636|NCT02211391|Caseins|caseins|mesh-list
20601637|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
20601638|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
20601639|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601640|NCT02211417|Mineral Oil|mineral oil|mesh-list
20601641|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
20601642|NCT02211417|Emollients|emollients|mesh-ancestor
20601643|NCT02211443|Cetuximab|cetuximab|mesh-list
20601644|NCT02211443|Antibodies|antibodies|mesh-list
20601645|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20601646|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
20601647|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601648|NCT02211443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20601649|NCT02211443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601650|NCT02211482|Lamivudine|lamivudine|mesh-list
20601651|NCT02211482|Dolutegravir|dolutegravir|mesh-list
20601652|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20601653|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601654|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601655|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601656|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
20601657|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087663|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087664|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087665|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
20087666|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20087667|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
20087668|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087669|NCT00001015|Ribavirin|ribavirin|mesh-list
20087670|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
20087671|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087672|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
20601658|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492619|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19492620|NCT03121833|Growth Substances|growth substances|mesh-ancestor
19492621|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492622|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
19492623|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492624|NCT03121807|Leucovorin|leucovorin|mesh-list
19492625|NCT03121807|Fluorouracil|fluorouracil|mesh-list
19492626|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
19492627|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
19492628|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492629|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492630|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492631|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492632|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
19492633|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492634|NCT03121807|Antidotes|antidotes|mesh-ancestor
19492635|NCT03121807|Protective Agents|protective agents|mesh-ancestor
19492636|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
19492637|NCT03121807|Vitamins|vitamins|mesh-ancestor
19492638|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
19492639|NCT03121521|Melatonin|melatonin|mesh-list
19492640|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
19492641|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601659|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19492642|NCT03121521|Protective Agents|protective agents|mesh-ancestor
20087673|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087674|NCT00001016|Leucovorin|leucovorin|mesh-list
20087675|NCT00001016|Trimetrexate|trimetrexate|mesh-list
20087676|NCT00001016|Calcium|calcium|mesh-list
20087677|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
20087678|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20087679|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087680|NCT00001016|Antidotes|antidotes|mesh-ancestor
20087681|NCT00001016|Protective Agents|protective agents|mesh-ancestor
20087682|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
20087683|NCT00001016|Vitamins|vitamins|mesh-ancestor
20087684|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
20087685|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
20087686|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087687|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20087688|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
20087689|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087690|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087691|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20087692|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087693|NCT00001017|Fluconazole|fluconazole|mesh-list
20087694|NCT00001017|Amphotericin B|amphotericin b|mesh-list
20087695|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20087696|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
20087697|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087698|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20087699|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087700|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087701|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087702|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20087703|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
20087704|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20087705|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087706|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20087707|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20087708|NCT00001017|Amebicides|amebicides|mesh-ancestor
20087709|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087710|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087711|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087712|NCT00001022|Zidovudine|zidovudine|mesh-list
20087713|NCT00001022|Didanosine|didanosine|mesh-list
20087714|NCT00001022|Zalcitabine|zalcitabine|mesh-list
20087715|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
20087716|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087717|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087718|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087719|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087720|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
20087721|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087722|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087723|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087724|NCT00001023|Azithromycin|azithromycin|mesh-list
20087725|NCT00001023|Clarithromycin|clarithromycin|mesh-list
20087726|NCT00001023|Rifabutin|rifabutin|mesh-list
20087727|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087728|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087729|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20087730|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087731|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087732|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087733|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087734|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20087735|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
20087736|NCT00001024|Zidovudine|zidovudine|mesh-list
20087737|NCT00001024|Didanosine|didanosine|mesh-list
20087738|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
20087739|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087740|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087741|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087742|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087743|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
20087744|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087745|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087746|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087747|NCT00001025|Zidovudine|zidovudine|mesh-list
20087748|NCT00001025|Didanosine|didanosine|mesh-list
20087749|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
20087750|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087751|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087752|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087753|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087754|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
20087755|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087756|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087757|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087758|NCT00001027|Pentamidine|pentamidine|mesh-list
20087759|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
20601660|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20601661|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20601662|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
20601663|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20601664|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
20601665|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601666|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
20601667|NCT02211521|Protective Agents|protective agents|mesh-ancestor
20601668|NCT02211625|Oxycodone|oxycodone|mesh-list
20601669|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20601670|NCT02211625|Narcotics|narcotics|mesh-ancestor
20601671|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601672|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601673|NCT02211625|Analgesics|analgesics|mesh-ancestor
20601674|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
20601675|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601676|NCT02211690|Tenofovir|tenofovir|mesh-list
20601677|NCT02211690|Emtricitabine|emtricitabine|mesh-list
20601678|NCT02211690|Dolutegravir|dolutegravir|mesh-list
20601679|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
20601680|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601681|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20601682|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601683|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492643|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492644|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492645|NCT03121716|Gemcitabine|gemcitabine|mesh-list
19492646|NCT03121716|Cisplatin|cisplatin|mesh-list
19492647|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492648|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
19492649|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492650|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492651|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
19492652|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492653|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492654|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492655|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
19492656|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492657|NCT03121664|Itraconazole|itraconazole|mesh-list
19492658|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
19492659|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492660|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19492661|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19492662|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492663|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492664|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19492665|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
19492666|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492667|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492668|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19492669|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19492670|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19492671|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19492672|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19492673|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492674|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20087760|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087761|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087762|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087763|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20087764|NCT00001028|Dapsone|dapsone|mesh-list
20087765|NCT00001028|Pentamidine|pentamidine|mesh-list
20087766|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087767|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
20087768|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20087769|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20087770|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20087771|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087772|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492675|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492676|NCT03121573|Analgesics|analgesics|mesh-ancestor
19492677|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
19492678|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492679|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
20087773|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
20087774|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087775|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
20087776|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20087777|NCT00001029|Zidovudine|zidovudine|mesh-list
20601684|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601685|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601686|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20601687|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20601688|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20601689|NCT02211729|Azithromycin|azithromycin|mesh-list
20601690|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
20601691|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
20087778|NCT00001029|Didanosine|didanosine|mesh-list
20087779|NCT00001029|Zalcitabine|zalcitabine|mesh-list
20087780|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
20087781|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087782|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087783|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087784|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087785|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
20087786|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087787|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087788|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087789|NCT00001030|Clarithromycin|clarithromycin|mesh-list
20087790|NCT00001030|Rifabutin|rifabutin|mesh-list
20087791|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087792|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087793|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19492680|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20087794|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120146|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
20087795|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087796|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087797|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087798|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20087799|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
20087800|NCT00001032|Zidovudine|zidovudine|mesh-list
20087801|NCT00001032|Zalcitabine|zalcitabine|mesh-list
20087802|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
20087803|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087804|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087805|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087806|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087807|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
20087808|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087809|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087810|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087811|NCT00001033|Pyridoxine|pyridoxine|mesh-list
20087812|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
20087813|NCT00001033|Levofloxacin|levofloxacin|mesh-list
20087814|NCT00001033|Rifampin|rifampin|mesh-list
20087815|NCT00001033|Isoniazid|isoniazid|mesh-list
20087816|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
20087817|NCT00001033|Ethambutol|ethambutol|mesh-list
20087818|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20087819|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087820|NCT00001033|Renal Agents|renal agents|mesh-ancestor
20087821|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087822|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20087823|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20087824|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087825|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087826|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087827|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20087828|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087829|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20087830|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
20087831|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
20087832|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087833|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20087834|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20087835|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20087836|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20087837|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20087838|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20087839|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20087840|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20087841|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
20087842|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20087843|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
20087844|NCT00001033|Vitamins|vitamins|mesh-ancestor
20087845|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
20087846|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087847|NCT00001034|Ganciclovir|ganciclovir|mesh-list
20601692|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20601693|NCT02211729|Amodiaquine|amodiaquine|mesh-list
20601694|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601695|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601696|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
20601697|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20601698|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20601699|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20601700|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601701|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601702|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20601703|NCT02211729|Renal Agents|renal agents|mesh-ancestor
20601704|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
20601705|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20601706|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087848|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20087849|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
20087850|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087851|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087852|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087853|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087854|NCT00001035|Interferons|interferons|mesh-list
20087855|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
20087856|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
20087857|NCT00001035|Zidovudine|zidovudine|mesh-list
20087858|NCT00001035|Didanosine|didanosine|mesh-list
20087859|NCT00001035|Zalcitabine|zalcitabine|mesh-list
20087860|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087861|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
20087862|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087863|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
20087864|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087865|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
20087866|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087867|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087868|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492681|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
20087869|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601707|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20601708|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607829|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20607830|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607831|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20607832|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20607833|NCT02243618|Rebamipide|rebamipide|mesh-list
20607834|NCT02243618|Polaprezinc|polaprezinc|mesh-list
20607835|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20607836|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607837|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
20607838|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607839|NCT02243618|Protective Agents|protective agents|mesh-ancestor
20607840|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607841|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607842|NCT02243631|Probenecid|probenecid|mesh-list
20607843|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
20087870|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087871|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087872|NCT00001036|Zidovudine|zidovudine|mesh-list
20087873|NCT00001036|Interleukin-2|interleukin-2|mesh-list
20087874|NCT00001036|Thymalfasin|thymalfasin|mesh-list
20087875|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087876|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20087877|NCT00001036|Analgesics|analgesics|mesh-ancestor
19492682|NCT03121417|Nivolumab|nivolumab|mesh-list
19492683|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19492684|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492685|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19492686|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492687|NCT03121313|Tegafur|tegafur|mesh-list
19492688|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492689|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
19492690|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492691|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492692|NCT03121352|Paclitaxel|paclitaxel|mesh-list
19492693|NCT03121352|Carboplatin|carboplatin|mesh-list
19492694|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
19492695|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19492696|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492697|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
19492698|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
19492699|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
19492700|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492701|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19492702|NCT03121599|Alovudine|alovudine|mesh-list
19492703|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
19492704|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492705|NCT03121690|Prednisone|prednisone|mesh-list
19492706|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492707|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
19492708|NCT03121690|Hormones|hormones|mesh-ancestor
19492709|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492710|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492711|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19492712|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492713|NCT03121547|Tramadol|tramadol|mesh-list
19492714|NCT03121547|Tapentadol|tapentadol|mesh-list
19492715|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492716|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19492717|NCT03121547|Narcotics|narcotics|mesh-ancestor
19492718|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492719|NCT03121547|Analgesics|analgesics|mesh-ancestor
19492720|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
19492721|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492722|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19492723|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19492724|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19492725|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492726|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492727|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492728|NCT03121339|Vaccines|vaccines|mesh-list
19492729|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
19492730|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492731|NCT03121261|Clonidine|clonidine|mesh-list
19492732|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
20087878|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
20087879|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20087880|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087881|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
20087882|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087883|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087884|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492733|NCT03121261|Analgesics|analgesics|mesh-ancestor
20087885|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087886|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
20087887|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087888|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087889|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087890|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20087891|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
20087892|NCT00001038|Valacyclovir|valacyclovir|mesh-list
20087893|NCT00001038|Acyclovir|acyclovir|mesh-list
20087894|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
20087895|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087896|NCT00001039|Clarithromycin|clarithromycin|mesh-list
20087897|NCT00001039|Ethambutol|ethambutol|mesh-list
20087898|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087899|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087900|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20087901|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087902|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087903|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087904|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20601709|NCT02211833|Pemetrexed|pemetrexed|mesh-list
20601710|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601711|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601712|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601713|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20601714|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601715|NCT02211846|Mirabegron|mirabegron|mesh-list
20601716|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20601717|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20601718|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20087905|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
20087906|NCT00001040|Zidovudine|zidovudine|mesh-list
20087907|NCT00001040|Zalcitabine|zalcitabine|mesh-list
20087908|NCT00001040|Saquinavir|saquinavir|mesh-list
20087909|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
20087910|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087911|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087912|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087913|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087914|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
20087915|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087916|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087917|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20601719|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
20087918|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20087919|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20087920|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
20087921|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087922|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087923|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20087924|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20087925|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
20087926|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20087927|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
20087928|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087929|NCT00001042|Antacids|antacids|mesh-ancestor
20087930|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087931|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20087932|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20087933|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20087934|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
20087935|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087936|NCT00001044|Antacids|antacids|mesh-ancestor
20087937|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087938|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20087939|NCT00001045|Zidovudine|zidovudine|mesh-list
20087940|NCT00001045|Nevirapine|nevirapine|mesh-list
20087941|NCT00001045|Didanosine|didanosine|mesh-list
20087942|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
20087943|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087944|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087945|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087946|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087947|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
20087948|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087949|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087950|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087951|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20087952|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20087953|NCT00001047|Clarithromycin|clarithromycin|mesh-list
20087954|NCT00001047|Ethambutol|ethambutol|mesh-list
20087955|NCT00001047|Rifabutin|rifabutin|mesh-list
20087956|NCT00001047|Clofazimine|clofazimine|mesh-list
20087957|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20087958|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087959|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20087960|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087961|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087962|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20087963|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20087964|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
20087965|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20087966|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20087967|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
20087968|NCT00001048|Cytarabine|cytarabine|mesh-list
20087969|NCT00001048|Zidovudine|zidovudine|mesh-list
20087970|NCT00001048|Didanosine|didanosine|mesh-list
20087971|NCT00001048|Zalcitabine|zalcitabine|mesh-list
20087972|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20087973|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
20087974|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087975|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20087976|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
20087977|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087978|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20087979|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
20087980|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20087981|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087982|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087983|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087984|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087985|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087986|NCT00001049|Zidovudine|zidovudine|mesh-list
20087987|NCT00001049|Didanosine|didanosine|mesh-list
20087988|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
20087989|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20087990|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20087991|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20087992|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20087993|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
20087994|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20087995|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20087996|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20087997|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20087998|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20087999|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
20088000|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088001|NCT00001052|Antacids|antacids|mesh-ancestor
20088002|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088003|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20088004|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20088005|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20088006|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
20088007|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088008|NCT00001053|Antacids|antacids|mesh-ancestor
20088009|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088010|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20088011|NCT00001054|Valacyclovir|valacyclovir|mesh-list
20088012|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
20088013|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492734|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
20088014|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
20088015|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20088016|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
20088017|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088018|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20088019|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088020|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
20088021|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088022|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
20088023|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20088024|NCT00001055|Protective Agents|protective agents|mesh-ancestor
20088025|NCT00001057|Zidovudine|zidovudine|mesh-list
20088026|NCT00001057|Didanosine|didanosine|mesh-list
20088027|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
20088028|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088029|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088030|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088031|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088032|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
20088033|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088034|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088035|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088036|NCT00001058|Ritonavir|ritonavir|mesh-list
20088037|NCT00001058|Indinavir|indinavir|mesh-list
20088038|NCT00001058|Clarithromycin|clarithromycin|mesh-list
20088039|NCT00001058|Ethambutol|ethambutol|mesh-list
20601720|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601721|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601722|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601723|NCT02211846|Urological Agents|urological agents|mesh-ancestor
20601724|NCT02211911|Bisacodyl|bisacodyl|mesh-list
20601725|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
20601726|NCT02211911|Cathartics|cathartics|mesh-ancestor
20601727|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20601728|NCT02211911|Laxatives|laxatives|mesh-ancestor
20601729|NCT02211950|Acarbose|acarbose|mesh-list
20088040|NCT00001058|Rifabutin|rifabutin|mesh-list
20088041|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088042|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088043|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088044|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088045|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088046|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088047|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088048|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
20088049|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088050|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088051|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088052|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20088053|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20088054|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
20088055|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20088056|NCT00001059|Doxorubicin|doxorubicin|mesh-list
20088057|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20088058|NCT00001059|Bleomycin|bleomycin|mesh-list
20088059|NCT00001059|Vincristine|vincristine|mesh-list
20088060|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20088061|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088062|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19492735|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492736|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492737|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19492738|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
19492739|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
20088063|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20088064|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088065|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088066|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20088067|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
20088068|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
20088069|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
20088070|NCT00001061|Ganciclovir|ganciclovir|mesh-list
20088071|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20088072|NCT00001061|Foscarnet|foscarnet|mesh-list
20088073|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20088074|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
20088075|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088076|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088077|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088078|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088079|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088080|NCT00001062|Ganciclovir|ganciclovir|mesh-list
20088081|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20088082|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
20088083|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088084|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088085|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088086|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088087|NCT00001063|Zidovudine|zidovudine|mesh-list
20088088|NCT00001063|Stavudine|stavudine|mesh-list
20088089|NCT00001063|Didanosine|didanosine|mesh-list
20088090|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
20088091|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088092|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088093|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088094|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088095|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
20088096|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088097|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088098|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088099|NCT00001065|Amphotericin B|amphotericin b|mesh-list
20088100|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20088101|NCT00001065|Amebicides|amebicides|mesh-ancestor
20088102|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20088103|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20088104|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088105|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20088106|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
20088107|NCT00001066|Lamivudine|lamivudine|mesh-list
20088108|NCT00001066|Zidovudine|zidovudine|mesh-list
20601730|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20601731|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088109|NCT00001066|Didanosine|didanosine|mesh-list
20601732|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601733|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20601734|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601735|NCT02211976|Bisacodyl|bisacodyl|mesh-list
20601736|NCT02211976|Cathartics|cathartics|mesh-ancestor
20601737|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20601738|NCT02211976|Laxatives|laxatives|mesh-ancestor
20601739|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
20088110|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088111|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088112|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088113|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088114|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
20088115|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088116|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088117|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088118|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
20088119|NCT00001067|Lamivudine|lamivudine|mesh-list
20088120|NCT00001067|Zidovudine|zidovudine|mesh-list
20088121|NCT00001067|Stavudine|stavudine|mesh-list
20088122|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088123|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088124|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088125|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088126|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
20088127|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088128|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088129|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088130|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
20088131|NCT00001068|Lamivudine|lamivudine|mesh-list
20088132|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088133|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088134|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088135|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088136|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
20088137|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088138|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088139|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088140|NCT00001070|Ascorbic Acid|ascorbic acid|mesh-list
20088141|NCT00001070|Vitamins|vitamins|mesh-ancestor
20088142|NCT00001070|Micronutrients|micronutrients|mesh-ancestor
20088143|NCT00001070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088144|NCT00001070|Antioxidants|antioxidants|mesh-ancestor
20088145|NCT00001070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088146|NCT00001070|Protective Agents|protective agents|mesh-ancestor
20088147|NCT00001071|Lenograstim|lenograstim|mesh-list
20088148|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20088149|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
20088150|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088151|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
20088152|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20088153|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
20088154|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088155|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20088156|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088157|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
20088158|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088159|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
20088160|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20088161|NCT00001072|Protective Agents|protective agents|mesh-ancestor
20088162|NCT00001073|Isotretinoin|isotretinoin|mesh-list
20088163|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
20088164|NCT00001074|Didanosine|didanosine|mesh-list
20088165|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
20088166|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088167|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
20088168|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088169|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088170|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088171|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
20088172|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088173|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
20088174|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088175|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088176|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088177|NCT00001075|Ritonavir|ritonavir|mesh-list
20088178|NCT00001075|Lamivudine|lamivudine|mesh-list
20088179|NCT00001075|Zidovudine|zidovudine|mesh-list
20088180|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088181|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088182|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088183|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492740|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19492741|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19492742|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19492743|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492744|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492745|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492746|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
19492747|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
19492748|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569641|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19569642|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19569643|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
19569644|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569645|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19569646|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19569647|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569648|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19569649|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
19569650|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19569651|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
19569652|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19569653|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19569654|NCT04590417|Estradiol|estradiol|mesh-list
19569655|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19569656|NCT04590417|Cyproterone|cyproterone|mesh-list
19569657|NCT04590417|Estrogens|estrogens|mesh-ancestor
19569658|NCT04590417|Hormones|hormones|mesh-ancestor
19569659|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569660|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088184|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088185|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088186|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088187|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
20088188|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088189|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088190|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088191|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088192|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088193|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
20088194|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
20088195|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20088196|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
20088197|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088198|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20088199|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088200|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
20088201|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088202|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
20088203|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20088204|NCT00001076|Protective Agents|protective agents|mesh-ancestor
20088205|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
20088206|NCT00001079|Megestrol|megestrol|mesh-list
20088207|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
20088208|NCT00001079|Testosterone|testosterone|mesh-list
20088209|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
20088210|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
20088211|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20088212|NCT00001079|Androgens|androgens|mesh-ancestor
20088213|NCT00001079|Hormones|hormones|mesh-ancestor
20088214|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088215|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088216|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20088217|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088218|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
20088219|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20088220|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20088221|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20088222|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
20088223|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20088224|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20088225|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20088226|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
20088227|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20088228|NCT00001080|Lamivudine|lamivudine|mesh-list
20088229|NCT00001080|Vaccines|vaccines|mesh-list
20088230|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20088231|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
20601740|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20601741|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20601742|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601743|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
20601744|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601745|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601746|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
20601747|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20601748|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20601749|NCT02212210|Prednisolone|prednisolone|mesh-list
20601750|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
20601751|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20601752|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
20601753|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20088232|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088233|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088234|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088235|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088236|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088237|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
20088238|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088239|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088240|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19492749|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
20088241|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
20088242|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20088243|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088244|NCT00001082|Adefovir|adefovir|mesh-list
20088245|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20088246|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
20088247|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088248|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088249|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088250|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088251|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088252|NCT00001083|Ritonavir|ritonavir|mesh-list
20088253|NCT00001083|Indinavir|indinavir|mesh-list
20088254|NCT00001083|Lamivudine|lamivudine|mesh-list
20088255|NCT00001083|Zidovudine|zidovudine|mesh-list
20088256|NCT00001083|Nevirapine|nevirapine|mesh-list
20088257|NCT00001083|Stavudine|stavudine|mesh-list
20088258|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088259|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088260|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088261|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088262|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088263|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088264|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088265|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
20088266|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088267|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088268|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088269|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088270|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088271|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
20088272|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088273|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088274|NCT00001084|Lamivudine|lamivudine|mesh-list
20088275|NCT00001084|Zidovudine|zidovudine|mesh-list
20088276|NCT00001084|Stavudine|stavudine|mesh-list
20088277|NCT00001084|Indinavir|indinavir|mesh-list
20601754|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
20601755|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
20601756|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601757|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601758|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20601759|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
20601760|NCT02212210|Hormones|hormones|mesh-ancestor
20601761|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20601762|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20601763|NCT02212210|Protective Agents|protective agents|mesh-ancestor
20601764|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20601765|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601766|NCT02212223|Vitamin D|vitamin d|mesh-list
20088278|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088279|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088280|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088281|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088282|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
20088283|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088284|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088285|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088286|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
20088287|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088288|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088289|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088290|NCT00001085|Lamivudine|lamivudine|mesh-list
20088291|NCT00001085|Zidovudine|zidovudine|mesh-list
19492750|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20088292|NCT00001085|Amprenavir|amprenavir|mesh-list
20088293|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088294|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088295|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088296|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088297|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
20088298|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088299|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088300|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088301|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
20088302|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20088303|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
20088304|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20088305|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088306|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088307|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088308|NCT00001086|Efavirenz|efavirenz|mesh-list
20088309|NCT00001086|Abacavir|abacavir|mesh-list
20088310|NCT00001086|Indinavir|indinavir|mesh-list
20088311|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088312|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088313|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088314|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088315|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
20088316|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088317|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20088318|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088319|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20088320|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20088321|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088322|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088323|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088324|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088325|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20601767|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
20601768|NCT02212223|Vitamins|vitamins|mesh-ancestor
20601769|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
20601770|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601771|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20601772|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20601773|NCT02212340|Remifentanil|remifentanil|mesh-list
20601774|NCT02212340|Desflurane|desflurane|mesh-list
20601775|NCT02212340|Propofol|propofol|mesh-list
20601776|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20601777|NCT02212340|Narcotics|narcotics|mesh-ancestor
20601778|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601779|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601780|NCT02212340|Analgesics|analgesics|mesh-ancestor
20601781|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
20601782|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601783|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20088326|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088327|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088328|NCT00001087|Ritonavir|ritonavir|mesh-list
20088329|NCT00001087|Nelfinavir|nelfinavir|mesh-list
20088330|NCT00001087|Saquinavir|saquinavir|mesh-list
20088331|NCT00001087|Lamivudine|lamivudine|mesh-list
20088332|NCT00001087|Zidovudine|zidovudine|mesh-list
20088333|NCT00001087|Stavudine|stavudine|mesh-list
20088334|NCT00001087|Didanosine|didanosine|mesh-list
20088335|NCT00001087|Zalcitabine|zalcitabine|mesh-list
20088336|NCT00001087|Efavirenz|efavirenz|mesh-list
20088337|NCT00001087|Adefovir|adefovir|mesh-list
20088338|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20088339|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088340|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088341|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088342|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088343|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088344|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088345|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088346|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
20088347|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088348|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088349|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088350|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088351|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088352|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
20088353|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20088354|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20120147|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19492751|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
19492752|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492753|NCT03121222|Expectorants|expectorants|mesh-ancestor
19492754|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
19492755|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19492756|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
19492757|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492758|NCT03121222|Protective Agents|protective agents|mesh-ancestor
19492759|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492760|NCT03121222|Antidotes|antidotes|mesh-ancestor
19492761|NCT03121014|Methotrexate|methotrexate|mesh-list
19492762|NCT03121014|Fludarabine|fludarabine|mesh-list
19492763|NCT03121014|Busulfan|busulfan|mesh-list
19492764|NCT03121014|Tacrolimus|tacrolimus|mesh-list
19492765|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
19492766|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19492767|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
19492768|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19492769|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492770|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19492771|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
19492772|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492773|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492774|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
19492775|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492776|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19492777|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492778|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
19492779|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19492780|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492781|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19492782|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
19492783|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19492784|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19492785|NCT03120962|Famciclovir|famciclovir|mesh-list
19492786|NCT03120962|Oxycodone|oxycodone|mesh-list
19492787|NCT03120962|Gabapentin|gabapentin|mesh-list
19492788|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19492789|NCT03120962|Narcotics|narcotics|mesh-ancestor
19492790|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492791|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492792|NCT03120962|Analgesics|analgesics|mesh-ancestor
19492793|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
19492794|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601784|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
20601785|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
20601786|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601787|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20601788|NCT02212392|Meropenem|meropenem|mesh-list
20601789|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601790|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601791|NCT02212431|Cysteamine|cysteamine|mesh-list
20601792|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
20601793|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601794|NCT02212535|Plerixafor|plerixafor|mesh-list
20601795|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20601796|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088355|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20088356|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088357|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20601797|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
20601798|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601799|NCT02212561|Vidarabine|vidarabine|mesh-list
20601800|NCT02212561|Cytarabine|cytarabine|mesh-list
20601801|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
20601802|NCT02212561|Methotrexate|methotrexate|mesh-list
20601803|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
20601804|NCT02212561|Fludarabine|fludarabine|mesh-list
20601805|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20601806|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
20601807|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20088358|NCT00001088|Bupivacaine|bupivacaine|mesh-list
20088359|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
20601808|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088360|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
20601809|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20088361|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20088362|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088363|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
20088364|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20088365|NCT00001090|Sargramostim|sargramostim|mesh-list
20088366|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
20088367|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088368|NCT00001091|Ritonavir|ritonavir|mesh-list
20088369|NCT00001091|Nelfinavir|nelfinavir|mesh-list
20088370|NCT00001091|Lamivudine|lamivudine|mesh-list
20088371|NCT00001091|Nevirapine|nevirapine|mesh-list
20088372|NCT00001091|Stavudine|stavudine|mesh-list
20088373|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088374|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088375|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088376|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088377|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088378|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088379|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088380|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
20088381|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088382|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088383|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088384|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088385|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088386|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088387|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088388|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
20088389|NCT00001094|Lamivudine|lamivudine|mesh-list
20088390|NCT00001094|Zidovudine|zidovudine|mesh-list
20088391|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20088392|NCT00001094|Delavirdine|delavirdine|mesh-list
20088393|NCT00001094|Nelfinavir|nelfinavir|mesh-list
20088394|NCT00001094|Saquinavir|saquinavir|mesh-list
20088395|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088396|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088397|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088398|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088399|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
20088400|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088401|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088402|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088403|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
20088404|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088405|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088406|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088407|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088408|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088409|NCT00001095|Lamivudine|lamivudine|mesh-list
20088410|NCT00001095|Zidovudine|zidovudine|mesh-list
20088411|NCT00001095|Nevirapine|nevirapine|mesh-list
20088412|NCT00001095|Stavudine|stavudine|mesh-list
20088413|NCT00001095|Indinavir|indinavir|mesh-list
20088414|NCT00001095|Amprenavir|amprenavir|mesh-list
20088415|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088416|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088417|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088418|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088419|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
20088420|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088421|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088422|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088423|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
20088424|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20601810|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
20601811|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601812|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601813|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
20601814|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601815|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20601816|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20601817|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
20601818|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601819|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601820|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
20601821|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601822|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601823|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
20601824|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
20601825|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601826|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601827|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601828|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
20601829|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
20601830|NCT02212639|Digoxin|digoxin|mesh-list
20601831|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20601832|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20601833|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601834|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601835|NCT02212639|Protective Agents|protective agents|mesh-ancestor
20601836|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601837|NCT02212652|Vitamin D|vitamin d|mesh-list
20601838|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
20601839|NCT02212652|Vitamins|vitamins|mesh-list
20601840|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
20601841|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601842|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20601843|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20601844|NCT02212756|Metformin|metformin|mesh-list
20601845|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20601846|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601847|NCT02212769|Losartan|losartan|mesh-list
20601848|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20601849|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20601850|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20601851|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20601852|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601853|NCT02212782|Linagliptin|linagliptin|mesh-list
20601854|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20601855|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601856|NCT02212782|Incretins|incretins|mesh-ancestor
20088425|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20601857|NCT02212782|Hormones|hormones|mesh-ancestor
20088426|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088427|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088428|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088429|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20088430|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
20088431|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20088432|NCT00001100|Ganciclovir|ganciclovir|mesh-list
20088433|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20088434|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
20088435|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088436|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088437|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088438|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088439|NCT00001101|Doxycycline|doxycycline|mesh-list
20088440|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
20088441|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20088442|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088443|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
20088444|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20088445|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20088446|NCT00001104|Zidovudine|zidovudine|mesh-list
20088447|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
20088448|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088449|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088450|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088451|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088452|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
20088453|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088454|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088455|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088456|NCT00001105|Antibodies|antibodies|mesh-list
20088457|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20088458|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
20088459|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088460|NCT00001106|Zidovudine|zidovudine|mesh-list
20088461|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
20088462|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088463|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088464|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088465|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088466|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
20088467|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088468|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088469|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088470|NCT00001107|Fluconazole|fluconazole|mesh-list
20088471|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20088472|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
20088473|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607844|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
20607845|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607846|NCT02243631|Renal Agents|renal agents|mesh-ancestor
20607847|NCT02243644|Albendazole|albendazole|mesh-list
20607848|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
20607849|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20607850|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607851|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
20607852|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20607853|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20607854|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
20607855|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
20607856|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
20088474|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20088475|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088476|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088477|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088478|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20088479|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
20601858|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20601859|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20601860|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
20601861|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088480|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088481|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088482|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20088483|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20088484|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20088485|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20088486|NCT00001108|Ritonavir|ritonavir|mesh-list
20088487|NCT00001108|Nelfinavir|nelfinavir|mesh-list
20088488|NCT00001108|Saquinavir|saquinavir|mesh-list
20088489|NCT00001108|Lamivudine|lamivudine|mesh-list
20088490|NCT00001108|Nevirapine|nevirapine|mesh-list
20088491|NCT00001108|Stavudine|stavudine|mesh-list
20088492|NCT00001108|Didanosine|didanosine|mesh-list
20601862|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601863|NCT02212795|Levofloxacin|levofloxacin|mesh-list
20601864|NCT02212795|Ofloxacin|ofloxacin|mesh-list
20601865|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
20601866|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20601867|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492795|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
20088493|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088494|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20601868|NCT02212795|Renal Agents|renal agents|mesh-ancestor
20601869|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601870|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20601871|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20601872|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601873|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601874|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20601875|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20601876|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20601877|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601878|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
20601879|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20601880|NCT02212821|Erythromycin|erythromycin|mesh-list
20601881|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
20601882|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20601883|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
20601884|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20601885|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601886|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19492796|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19492797|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19492798|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19492799|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19492800|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19492801|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492802|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492803|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
19492804|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
19492805|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492806|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492807|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492808|NCT03120936|Tenofovir|tenofovir|mesh-list
19492809|NCT03120936|Emtricitabine|emtricitabine|mesh-list
19492810|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
19492811|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492812|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19492813|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492814|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492815|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492816|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492817|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19492818|NCT03121079|Interferons|interferons|mesh-list
19492819|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
19492820|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19492821|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
19492822|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492823|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
19492824|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492825|NCT03120923|Triamcinolone|triamcinolone|mesh-list
19492826|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19492827|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19492828|NCT03120923|Lidocaine|lidocaine|mesh-list
19492829|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19492830|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
19492831|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
19492832|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492833|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492834|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
19492835|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492836|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19492837|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19492838|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19492839|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20088495|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088496|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088497|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088498|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088499|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088500|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
20601887|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20601888|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601889|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601890|NCT02212990|Acetaminophen|acetaminophen|mesh-list
20601891|NCT02212990|Ibuprofen|ibuprofen|mesh-list
20601892|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601893|NCT02212990|Analgesics|analgesics|mesh-ancestor
20601894|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
20601895|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601896|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601897|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
20601898|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20601899|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20601900|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601901|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20601902|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601903|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601904|NCT02213029|Oxytocin|oxytocin|mesh-list
20601905|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
20601906|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20601907|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088501|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601908|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
20601909|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20601910|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
20601911|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20601912|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601913|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20601914|NCT02213107|Dutasteride|dutasteride|mesh-list
20601915|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20088502|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20601916|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20601917|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088503|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088504|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088505|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088506|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088507|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088508|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
20088509|NCT00001111|Zidovudine|zidovudine|mesh-list
20088510|NCT00001111|Nevirapine|nevirapine|mesh-list
20088511|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
20088512|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088513|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088514|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088515|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088516|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
20088517|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088518|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088519|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088520|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088521|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20601918|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601919|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
20601920|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20601921|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601922|NCT02213146|Insulin|insulin|mesh-list
20601923|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
20601924|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20601925|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20088522|NCT00001112|Interferons|interferons|mesh-list
20088523|NCT00001112|Zidovudine|zidovudine|mesh-list
20088524|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
20088525|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088526|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
20088527|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088528|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
20088529|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088530|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088531|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088532|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088533|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088534|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088535|NCT00001113|Interferons|interferons|mesh-list
20088536|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
20088537|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
20088538|NCT00001113|Zidovudine|zidovudine|mesh-list
20088539|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088540|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
20088541|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088542|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
20088543|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088544|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
20088545|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088546|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088547|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088548|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088549|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088550|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120148|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20120149|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20120150|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120151|NCT00006291|Aldesleukin|aldesleukin|mesh-list
20120152|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120153|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120154|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120155|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
20120156|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120157|NCT00006292|Infliximab|infliximab|mesh-list
20120158|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
20120159|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20088551|NCT00001114|Interferons|interferons|mesh-list
20088552|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
20088553|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
20088554|NCT00001114|Didanosine|didanosine|mesh-list
20088555|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088556|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
20088557|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088558|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
20088559|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492840|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088560|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
20088561|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309015|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492841|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19492842|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
19492843|NCT03120923|Hormones|hormones|mesh-ancestor
19492844|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492845|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492846|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
19492847|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492848|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19492849|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492850|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19492851|NCT03120728|Etonogestrel|etonogestrel|mesh-list
19492852|NCT03120728|NuvaRing|nuvaring|mesh-list
19492853|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
19492854|NCT03120728|Estradiol|estradiol|mesh-list
19492855|NCT03120728|Estrogens|estrogens|mesh-ancestor
19492856|NCT03120728|Hormones|hormones|mesh-ancestor
19492857|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492858|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492859|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19492860|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19492861|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19492862|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19492863|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19492864|NCT03120442|Fentanyl|fentanyl|mesh-list
19492865|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
19492866|NCT03120442|Propofol|propofol|mesh-list
19492867|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19492868|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492869|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492870|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19492871|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
19492872|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
19492873|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492874|NCT03120442|Analgesics|analgesics|mesh-ancestor
19492875|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
19492876|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492877|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19492878|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19492879|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19492880|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492881|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492882|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492883|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19492884|NCT03120442|Narcotics|narcotics|mesh-ancestor
19492885|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20088562|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20309016|NCT00666627|Alendronate|alendronate|mesh-list
19492886|NCT03120468|Topiramate|topiramate|mesh-list
19492887|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
20120160|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20088563|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088564|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088565|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088566|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088567|NCT00001115|Acyclovir|acyclovir|mesh-list
20088568|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
20088569|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088570|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
20088571|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20088572|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20088573|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088574|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492888|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19492889|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
20088575|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088576|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
20088577|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088578|NCT00001119|Ritonavir|ritonavir|mesh-list
20088579|NCT00001119|Indinavir|indinavir|mesh-list
20088580|NCT00001119|Amprenavir|amprenavir|mesh-list
20088581|NCT00001119|Lamivudine|lamivudine|mesh-list
20088582|NCT00001119|Zidovudine|zidovudine|mesh-list
20088583|NCT00001119|Abacavir|abacavir|mesh-list
20088584|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20601926|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601927|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
20601928|NCT02213159|Morphine|morphine|mesh-list
20601929|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601930|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601931|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601932|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20601933|NCT02213159|Analgesics|analgesics|mesh-ancestor
20601934|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
20601935|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20601936|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20601937|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20088585|NCT00001119|Efavirenz|efavirenz|mesh-list
20088586|NCT00001119|Vaccines|vaccines|mesh-list
20088587|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
20088588|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088589|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088590|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088591|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088592|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088593|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088594|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088595|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088596|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
20088597|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088598|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088599|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088600|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088601|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088602|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
20088603|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20601938|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20088604|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20601939|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
20601940|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20601941|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601942|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20601943|NCT02213159|Narcotics|narcotics|mesh-ancestor
20601944|NCT02213211|Lumefantrine|lumefantrine|mesh-list
20601945|NCT02213211|Artemether|artemether|mesh-list
20601946|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20601947|NCT02213211|Artemisinins|artemisinins|mesh-list
20088605|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20088606|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088607|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088608|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20088609|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
20088610|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20088611|NCT00001122|Efavirenz|efavirenz|mesh-list
20088612|NCT00001122|Stavudine|stavudine|mesh-list
20088613|NCT00001122|Didanosine|didanosine|mesh-list
20088614|NCT00001122|Nelfinavir|nelfinavir|mesh-list
20088615|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20120161|NCT00006294|Amlodipine|amlodipine|mesh-list
20601948|NCT02213211|Artemisinin|artemisinin|mesh-list
20088616|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088617|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088618|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088619|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
20088620|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088621|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20088622|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088623|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20601949|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
20601950|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20601951|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20601952|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601953|NCT02213224|Amlodipine|amlodipine|mesh-list
20601954|NCT02213224|Telmisartan|telmisartan|mesh-list
20601955|NCT02213224|Perindopril|perindopril|mesh-list
20601956|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20601957|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20601958|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20601959|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601960|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20088624|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20088625|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088626|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088627|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
20088628|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088629|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088630|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088631|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088632|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088633|NCT00001123|Ribavirin|ribavirin|mesh-list
20088634|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
20088635|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088636|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
20088637|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088638|NCT00001126|Cidofovir|cidofovir|mesh-list
20088639|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
20088640|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088641|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088642|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088643|NCT00001128|Azithromycin|azithromycin|mesh-list
20088644|NCT00001128|Paromomycin|paromomycin|mesh-list
20088645|NCT00001128|Interleukin-12|interleukin-12|mesh-list
20088646|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20088647|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088648|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20088649|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
20088650|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088651|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20088652|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20088653|NCT00001128|Growth Substances|growth substances|mesh-ancestor
20601961|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601962|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
20601963|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20601964|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20601965|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20601966|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
20601967|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601968|NCT02213302|Midazolam|midazolam|mesh-list
20088654|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
20088655|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088656|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19492890|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19492891|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492892|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
19492893|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492894|NCT03120468|Expectorants|expectorants|mesh-ancestor
19492895|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
19492896|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19492897|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
19492898|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492899|NCT03120468|Protective Agents|protective agents|mesh-ancestor
19492900|NCT03120468|Antidotes|antidotes|mesh-ancestor
19492901|NCT03120715|Heparin|heparin|mesh-list
19492902|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19492903|NCT03120715|Tinzaparin|tinzaparin|mesh-list
19492904|NCT03120715|Dalteparin|dalteparin|mesh-list
19492905|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19492906|NCT03120715|Progesterone|progesterone|mesh-list
19492907|NCT03120715|Estrogens|estrogens|mesh-list
19492908|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
19492909|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19492910|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19492911|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492912|NCT03120715|Progestins|progestins|mesh-ancestor
19492913|NCT03120715|Hormones|hormones|mesh-ancestor
19492914|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19492915|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492916|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19492917|NCT03120533|Treprostinil|treprostinil|mesh-list
20088657|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20601969|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20601970|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20601971|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20601972|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601973|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20601974|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20601975|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20088658|NCT00001131|Aldesleukin|aldesleukin|mesh-list
20088659|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088660|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088661|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088662|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
20088663|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088664|NCT00001132|Abacavir|abacavir|mesh-list
20088665|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088666|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088667|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088668|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088669|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
20088670|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088671|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088672|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088673|NCT00001133|Ritonavir|ritonavir|mesh-list
20088674|NCT00001133|Indinavir|indinavir|mesh-list
20088675|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20088676|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20088677|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088678|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088679|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088680|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088681|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088682|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
20088683|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088684|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088685|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088686|NCT00001135|Nevirapine|nevirapine|mesh-list
20088687|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088688|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088689|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088690|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088691|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
20088692|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088693|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088694|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088695|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20088696|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20088697|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20088698|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20088699|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20088700|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
20088701|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20088702|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
20088703|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088704|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20088705|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20088706|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
20088707|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601976|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20601977|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
20601978|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
20601979|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
20601980|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
20088708|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088709|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20088710|NCT00001165|Doxorubicin|doxorubicin|mesh-list
20088711|NCT00001165|Streptozocin|streptozocin|mesh-list
20088712|NCT00001165|Fluorouracil|fluorouracil|mesh-list
20088713|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20088714|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088715|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20601981|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20088716|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20088717|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601982|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601983|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
20601984|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20601985|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20601986|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
20601987|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20601988|NCT02213328|Tenofovir|tenofovir|mesh-list
20601989|NCT02213328|Emtricitabine|emtricitabine|mesh-list
20601990|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20601991|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
20601992|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20601993|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20601994|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20601995|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20601996|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20601997|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088718|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088719|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
20088720|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20088721|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20088722|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
20601998|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20601999|NCT02213419|Ethanol|ethanol|mesh-list
20602000|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20602001|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602002|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602003|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602004|NCT02213432|Vaccines|vaccines|mesh-list
20602005|NCT02213432|Immunologic Factors|immunologic factors|mesh-ancestor
20602006|NCT02213432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088723|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088724|NCT00001180|Hormones|hormones|mesh-list
20088725|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20088726|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20088727|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088728|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088729|NCT00001181|Testolactone|testolactone|mesh-list
20088730|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20088731|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088732|NCT00001190|Deslorelin|deslorelin|mesh-list
20088733|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088734|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088735|NCT00001191|Omeprazole|omeprazole|mesh-list
20088736|NCT00001191|Pantoprazole|pantoprazole|mesh-list
20088737|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20088738|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20088739|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20088740|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088741|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088742|NCT00001193|Melphalan|melphalan|mesh-list
20088743|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20088744|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
20088745|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088746|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088747|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20088748|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20088749|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
20088750|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088751|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
20088752|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088753|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
20088754|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088755|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088756|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088757|NCT00001202|Testolactone|testolactone|mesh-list
20088758|NCT00001202|Spironolactone|spironolactone|mesh-list
20088759|NCT00001202|Deslorelin|deslorelin|mesh-list
20088760|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20088761|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
20088762|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088763|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088764|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20088765|NCT00001202|Diuretics|diuretics|mesh-ancestor
20088766|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
20088767|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602007|NCT02213497|Paclitaxel|paclitaxel|mesh-list
20602008|NCT02213497|Carboplatin|carboplatin|mesh-list
20602009|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20602010|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20602011|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602012|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
20602013|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
20602014|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
20602015|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088768|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088769|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20088770|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088771|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
20088772|NCT00001209|Ifosfamide|ifosfamide|mesh-list
20088773|NCT00001209|Vincristine|vincristine|mesh-list
20088774|NCT00001209|Doxorubicin|doxorubicin|mesh-list
20088775|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20088776|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20088777|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
20088778|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088779|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20088780|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20088781|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
20088782|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088783|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088784|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20088785|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20088786|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20088787|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
20088788|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
20088789|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20088790|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20088791|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20088792|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088793|NCT00001212|Cyclosporine|cyclosporine|mesh-list
20088794|NCT00001212|Prednisone|prednisone|mesh-list
20088795|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
20088796|NCT00001212|Cyclosporins|cyclosporins|mesh-list
20088797|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20088798|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
20088799|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088800|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20088801|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20088802|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
20088803|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088804|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088805|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20088806|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20088807|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
20088808|NCT00001212|Hormones|hormones|mesh-ancestor
20088809|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088810|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20088811|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088812|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
20088813|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088814|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
20088815|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20088816|NCT00001221|Hormones|hormones|mesh-list
20088817|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088818|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088819|NCT00001228|Interferons|interferons|mesh-list
20088820|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088821|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
20088822|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088823|NCT00001237|Molgramostim|molgramostim|mesh-list
20088824|NCT00001237|Sargramostim|sargramostim|mesh-list
20088825|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
20088826|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088827|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088828|NCT00001249|Antibodies|antibodies|mesh-list
20088829|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
20088830|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088831|NCT00001251|Mafosfamide|mafosfamide|mesh-list
20088832|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20088833|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
20088834|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088835|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088836|NCT00001256|Prednisone|prednisone|mesh-list
20088837|NCT00001256|Methotrexate|methotrexate|mesh-list
20088838|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20088839|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
20088840|NCT00001256|Hormones|hormones|mesh-ancestor
20088841|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088842|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088843|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20088844|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088845|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20088846|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
20088847|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20088848|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20088849|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
20088850|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088851|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
20088852|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088853|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20088854|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20088855|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
20088856|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20088857|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120162|NCT00006294|Lisinopril|lisinopril|mesh-list
20120163|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
20120164|NCT00006294|Doxazosin|doxazosin|mesh-list
20120165|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20120166|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20120167|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20120168|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120169|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20120170|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120171|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
20120172|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20088858|NCT00001259|Leuprolide|leuprolide|mesh-list
20088859|NCT00001259|Estradiol|estradiol|mesh-list
20088860|NCT00001259|Progesterone|progesterone|mesh-list
20088861|NCT00001259|Estrogens|estrogens|mesh-ancestor
20088862|NCT00001259|Hormones|hormones|mesh-ancestor
20088863|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088864|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088865|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20088866|NCT00001259|Progestins|progestins|mesh-ancestor
20088867|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20088868|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
20088869|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20088870|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088871|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
20088872|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20088873|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20088874|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
20088875|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088876|NCT00001266|Suramin|suramin|mesh-list
20088877|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
20088878|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
20088879|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20088880|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088881|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088882|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20088883|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20088884|NCT00001267|Zidovudine|zidovudine|mesh-list
20088885|NCT00001267|Didanosine|didanosine|mesh-list
20088886|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
20088887|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088888|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088889|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088890|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088891|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
20088892|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088893|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088894|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088895|NCT00001280|Itraconazole|itraconazole|mesh-list
20088896|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
20088897|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088898|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20088899|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20088900|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088901|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088902|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20088903|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
20088904|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20088905|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088906|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20088907|NCT00001282|Zidovudine|zidovudine|mesh-list
20088908|NCT00001282|Interleukin-2|interleukin-2|mesh-list
20088909|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088910|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20088911|NCT00001282|Analgesics|analgesics|mesh-ancestor
20088912|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
20088913|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20088914|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088915|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
20088916|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088917|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20088918|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088919|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088920|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
20088921|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088922|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20088923|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20088924|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
20088925|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20088926|NCT00001287|Antibodies|antibodies|mesh-list
20088927|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
20088928|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20088929|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
20088930|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088931|NCT00001296|Interferons|interferons|mesh-list
20088932|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
20088933|NCT00001296|Melphalan|melphalan|mesh-list
20088934|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088935|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
20088936|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088937|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20088938|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
20088939|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088940|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20088941|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20088942|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
20088943|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088944|NCT00001300|Doxorubicin|doxorubicin|mesh-list
20088945|NCT00001300|Ifosfamide|ifosfamide|mesh-list
20088946|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20088947|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088948|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20088949|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20088950|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088951|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088952|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20088953|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
20088954|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
20088955|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20088956|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
20088957|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20088958|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120173|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
20088959|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20088960|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
20088961|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20088962|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
20088963|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088964|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20088965|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20088966|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
20088967|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
20088968|NCT00001303|Protective Agents|protective agents|mesh-ancestor
20088969|NCT00001307|Capsaicin|capsaicin|mesh-list
20088970|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
20088971|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
20088972|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
20088973|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20088974|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20088975|NCT00001311|Heparin|heparin|mesh-list
20088976|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
20088977|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20088978|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20088979|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20088980|NCT00001317|Interferons|interferons|mesh-list
20088981|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
20088982|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088983|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
20088984|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088985|NCT00001318|Interferons|interferons|mesh-list
20088986|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
20088987|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20088988|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
20088989|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088990|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20088991|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20088992|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602016|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20607857|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607858|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607859|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
20607860|NCT02243735|Trace Elements|trace elements|mesh-ancestor
20607861|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
20607862|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608127|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608128|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608129|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20608130|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20608131|NCT02244632|Growth Substances|growth substances|mesh-ancestor
20608132|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608133|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
20608134|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
20608135|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608136|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20608137|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608138|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
20608139|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20608140|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20608141|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608142|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
20608143|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20608144|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20608145|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602017|NCT02213588|Antioxidants|antioxidants|mesh-list
20602018|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602019|NCT02213588|Protective Agents|protective agents|mesh-ancestor
20602020|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602021|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
20602022|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
20602023|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20088993|NCT00001328|Ganciclovir|ganciclovir|mesh-list
20088994|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20088995|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
20088996|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20088997|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20088998|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20088999|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089000|NCT00001332|Cisplatin|cisplatin|mesh-list
20089001|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089002|NCT00001333|Topotecan|topotecan|mesh-list
20089003|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20089004|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20089005|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089006|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089007|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089008|NCT00001335|Topotecan|topotecan|mesh-list
20089009|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20089010|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20089011|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089012|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089013|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089014|NCT00001339|Doxorubicin|doxorubicin|mesh-list
20089015|NCT00001339|Etoposide|etoposide|mesh-list
20089016|NCT00001339|Vincristine|vincristine|mesh-list
20089017|NCT00001339|Mitotane|mitotane|mesh-list
20089018|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20089019|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089020|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20089021|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20089022|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089023|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089024|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089025|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089026|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089027|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089028|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20089029|NCT00001341|Raltitrexed|raltitrexed|mesh-list
20089030|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089031|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
20089032|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089033|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089034|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20089035|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089036|NCT00001343|Oxandrolone|oxandrolone|mesh-list
20089037|NCT00001343|Androgens|androgens|mesh-ancestor
20089038|NCT00001343|Hormones|hormones|mesh-ancestor
20089039|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089040|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089041|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
20089042|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
20089043|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
20089044|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
20089045|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20089046|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20089047|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602024|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602025|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602026|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
20602027|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20602028|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602029|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602030|NCT02213627|Menotropins|menotropins|mesh-list
20602031|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20602032|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
20089048|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089049|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089050|NCT00001354|Zidovudine|zidovudine|mesh-list
20089051|NCT00001354|Interleukin-2|interleukin-2|mesh-list
20089052|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089053|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089054|NCT00001354|Analgesics|analgesics|mesh-ancestor
20089055|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
20089056|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089057|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089058|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
20089059|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089060|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20089061|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20089062|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089063|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
20089064|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089065|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20089066|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089067|NCT00001357|Interleukin-2|interleukin-2|mesh-list
20089068|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089069|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089070|NCT00001357|Analgesics|analgesics|mesh-ancestor
20089071|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
20089072|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089073|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089074|NCT00001359|Penicillins|penicillins|mesh-list
20089075|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089076|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089077|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
20089078|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
20089079|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
20089080|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20089081|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20089082|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20089083|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089084|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089085|NCT00001378|Fenretinide|fenretinide|mesh-list
20089086|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089087|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20089088|NCT00001378|Protective Agents|protective agents|mesh-ancestor
20089089|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089090|NCT00001381|Suramin|suramin|mesh-list
20089091|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
20089092|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
20089093|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20089094|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089095|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089096|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20089097|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20089098|NCT00001383|Paclitaxel|paclitaxel|mesh-list
20089099|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089100|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089101|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089102|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089103|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089104|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089105|NCT00001384|Paclitaxel|paclitaxel|mesh-list
20089106|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
20089107|NCT00001384|Doxorubicin|doxorubicin|mesh-list
20089108|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20089109|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089110|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089111|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089112|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089113|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089114|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089115|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089116|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
20089117|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089118|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089119|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20089120|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
20089121|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20089122|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20089123|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20089124|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20089125|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089126|NCT00001387|Paclitaxel|paclitaxel|mesh-list
20089127|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089128|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089129|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089130|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089131|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089132|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089133|NCT00001407|Interferons|interferons|mesh-list
20089134|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
20089135|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089136|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
20089137|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089138|NCT00001409|Interleukin-2|interleukin-2|mesh-list
20089139|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089140|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089141|NCT00001409|Analgesics|analgesics|mesh-ancestor
20089142|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
20089143|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089144|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120174|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120175|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20120176|NCT00006294|Protective Agents|protective agents|mesh-ancestor
20120177|NCT00006294|Diuretics|diuretics|mesh-ancestor
20120178|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
20089145|NCT00001421|Methimazole|methimazole|mesh-list
20089146|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
20089147|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
20089148|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089149|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089150|NCT00001422|Fludarabine|fludarabine|mesh-list
20089151|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089152|NCT00001426|Paclitaxel|paclitaxel|mesh-list
20089153|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
20089154|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089155|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089156|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089157|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089158|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089159|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089160|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089161|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
20089162|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089163|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089164|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20089165|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
20089166|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20089167|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
20089168|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089169|NCT00001428|Fluorouracil|fluorouracil|mesh-list
20089170|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
20089171|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089172|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089173|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089174|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089175|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
20089176|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089177|NCT00001431|Gemcitabine|gemcitabine|mesh-list
20089178|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089179|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
20089180|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089181|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089182|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
20089183|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089184|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089185|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089186|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
20089187|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089188|NCT00001436|Tamoxifen|tamoxifen|mesh-list
20089189|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20089190|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
20089191|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089192|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089193|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20089194|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089195|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20089196|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20089197|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20089198|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
20089199|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20089200|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089201|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089202|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20089203|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20089204|NCT00001437|Protective Agents|protective agents|mesh-ancestor
20089205|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089206|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
20089207|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20089208|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
20089209|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
20089210|NCT00001438|Tretinoin|tretinoin|mesh-list
20089211|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089212|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
20089213|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089214|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
20089215|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089216|NCT00001440|Interleukin-2|interleukin-2|mesh-list
20089217|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089218|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089219|NCT00001440|Analgesics|analgesics|mesh-ancestor
20089220|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
20089221|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089222|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089223|NCT00001442|Paclitaxel|paclitaxel|mesh-list
20089224|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089225|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089226|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089227|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089228|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089229|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089230|NCT00001443|Indinavir|indinavir|mesh-list
20089231|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20089232|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20089233|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
20089234|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089235|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089236|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20089237|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089238|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
20089239|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089240|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20089241|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089242|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20089243|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089244|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089245|NCT00001446|Thalidomide|thalidomide|mesh-list
20089246|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089247|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
20089248|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089249|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
20089250|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089251|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089252|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20089253|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20089254|NCT00001446|Growth Substances|growth substances|mesh-ancestor
20089255|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
20089256|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089257|NCT00001449|Leucovorin|leucovorin|mesh-list
20089258|NCT00001449|Gemcitabine|gemcitabine|mesh-list
20089259|NCT00001449|Floxuridine|floxuridine|mesh-list
20089260|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089261|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
20089262|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089263|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089264|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
20089265|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089266|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089267|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089268|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
20089269|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089270|NCT00001449|Antidotes|antidotes|mesh-ancestor
20089271|NCT00001449|Protective Agents|protective agents|mesh-ancestor
20089272|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
20089273|NCT00001449|Vitamins|vitamins|mesh-ancestor
20089274|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
20089275|NCT00001450|Paclitaxel|paclitaxel|mesh-list
20089276|NCT00001450|Cisplatin|cisplatin|mesh-list
20089277|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089278|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089279|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089280|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089281|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089282|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089283|NCT00001457|Lamivudine|lamivudine|mesh-list
20089284|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20089285|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20089286|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089287|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089288|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
20089289|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089290|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20089291|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089292|NCT00001474|Interleukin-2|interleukin-2|mesh-list
20089293|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089294|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089295|NCT00001474|Analgesics|analgesics|mesh-ancestor
20089296|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
20089297|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089298|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089299|NCT00001475|Thalidomide|thalidomide|mesh-list
20089300|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089301|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
20089302|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089303|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
20089304|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089305|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089306|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20089307|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20089308|NCT00001475|Growth Substances|growth substances|mesh-ancestor
20089309|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
20089310|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089311|NCT00001482|Lamotrigine|lamotrigine|mesh-list
20089312|NCT00001482|Gabapentin|gabapentin|mesh-list
20089313|NCT00001482|Analgesics|analgesics|mesh-ancestor
20089314|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
20089315|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089316|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089317|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
20089318|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20089319|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20089320|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20089321|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20089322|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20089323|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20089324|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20089325|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089326|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
20089327|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20089328|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20089329|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20089330|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20089331|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20089332|NCT00001483|Sertraline|sertraline|mesh-list
20089333|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20089334|NCT00001483|Bupropion|bupropion|mesh-list
20089335|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
20089336|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20089337|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20089338|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20089339|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20089340|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089341|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20089342|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
20089343|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089344|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20089345|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20089346|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20089347|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
20089348|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20089349|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20089350|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089351|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20089352|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20089353|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
20089354|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089355|NCT00001495|Irinotecan|irinotecan|mesh-list
20089356|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20089357|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20089358|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089359|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089360|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089361|NCT00001498|Leucovorin|leucovorin|mesh-list
20089362|NCT00001498|Paclitaxel|paclitaxel|mesh-list
20089363|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
20089364|NCT00001498|Doxorubicin|doxorubicin|mesh-list
20089365|NCT00001498|Fluorouracil|fluorouracil|mesh-list
20089366|NCT00001498|Methotrexate|methotrexate|mesh-list
20089367|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089368|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089369|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089370|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089371|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089372|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089373|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089374|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
20089375|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089376|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089377|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20089378|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
20089379|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20089380|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20089381|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20089382|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20089383|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089384|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
20089385|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089386|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20089387|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
20089388|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20089389|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089390|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20089391|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20089392|NCT00001498|Antidotes|antidotes|mesh-ancestor
20089393|NCT00001498|Protective Agents|protective agents|mesh-ancestor
20089394|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
20089395|NCT00001498|Vitamins|vitamins|mesh-ancestor
20089396|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
20089397|NCT00001499|Paclitaxel|paclitaxel|mesh-list
20089398|NCT00001499|Cisplatin|cisplatin|mesh-list
20089399|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089400|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089401|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089402|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089403|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089404|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089405|NCT00001502|Carboplatin|carboplatin|mesh-list
20089406|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089407|NCT00001504|Tretinoin|tretinoin|mesh-list
20089408|NCT00001504|Alitretinoin|alitretinoin|mesh-list
20089409|NCT00001504|Isotretinoin|isotretinoin|mesh-list
20089410|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089411|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
20089412|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089413|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20089414|NCT00001507|Antibodies|antibodies|mesh-list
20089415|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
20089416|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20089417|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
20089418|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089419|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089420|NCT00001509|Tretinoin|tretinoin|mesh-list
20089421|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089422|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
20089423|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089424|NCT00001520|Neostigmine|neostigmine|mesh-list
20089425|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20089426|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120179|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20089427|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089428|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
20089429|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20089430|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089431|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20089432|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
20089433|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089434|NCT00001524|Thalidomide|thalidomide|mesh-list
20089435|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089436|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
20089437|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089438|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
20089439|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089440|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089441|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20089442|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20089443|NCT00001524|Growth Substances|growth substances|mesh-ancestor
20089444|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
20089445|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089446|NCT00001526|Daclizumab|daclizumab|mesh-list
20089447|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089448|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
20089449|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089450|NCT00001533|Cyclosporine|cyclosporine|mesh-list
20089451|NCT00001533|Cyclosporins|cyclosporins|mesh-list
20089452|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089453|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089454|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089455|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
20089456|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089457|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
20089458|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089459|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089460|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089461|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20089462|NCT00001534|Losartan|losartan|mesh-list
20089463|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20089464|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20089465|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20089466|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20089467|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089468|NCT00001535|Interleukin-2|interleukin-2|mesh-list
20089469|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089470|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089471|NCT00001535|Analgesics|analgesics|mesh-ancestor
20089472|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
20089473|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089474|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089475|NCT00001542|Fluconazole|fluconazole|mesh-list
20089476|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
20089477|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089478|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20089479|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20089480|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089481|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089482|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20089483|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
20089484|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089485|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089486|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20089487|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20120180|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20120181|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20120182|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20120183|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
20120184|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120185|NCT00006299|Celecoxib|celecoxib|mesh-list
20120186|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20120187|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20120188|NCT00006299|Analgesics|analgesics|mesh-ancestor
20120189|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
20120190|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120191|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120192|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20120193|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120194|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20120195|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20120196|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120197|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120198|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
20120199|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120200|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
20089488|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
20089489|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20089490|NCT00001561|Antibodies|antibodies|mesh-list
20089491|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20089492|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
20089493|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089494|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20089495|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089496|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
20089497|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089498|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
20089499|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089500|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
20089501|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20089502|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
20089503|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089504|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
20089505|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089506|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20089507|NCT00001569|Paclitaxel|paclitaxel|mesh-list
20089508|NCT00001569|Cisplatin|cisplatin|mesh-list
20089509|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089510|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089511|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089512|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089513|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089514|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089515|NCT00001570|Vinblastine|vinblastine|mesh-list
20089516|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089517|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089518|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089519|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089520|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089521|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089522|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
20089523|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20089524|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
20089525|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089526|NCT00001576|Leucovorin|leucovorin|mesh-list
20089527|NCT00001576|Melphalan|melphalan|mesh-list
20089528|NCT00001576|Floxuridine|floxuridine|mesh-list
20089529|NCT00001576|Antidotes|antidotes|mesh-ancestor
20089530|NCT00001576|Protective Agents|protective agents|mesh-ancestor
20089531|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089532|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
19492918|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19492919|NCT03120403|Morphine|morphine|mesh-list
19492920|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19492921|NCT03120403|Narcotics|narcotics|mesh-ancestor
19492922|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492923|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492924|NCT03120403|Analgesics|analgesics|mesh-ancestor
19492925|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
19492926|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492927|NCT03120494|Tenofovir|tenofovir|mesh-list
19492928|NCT03120494|Emtricitabine|emtricitabine|mesh-list
20089533|NCT00001576|Vitamins|vitamins|mesh-ancestor
20089534|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
20089535|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20089536|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
20089537|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089538|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089539|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20089540|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19492929|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
20089541|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
20089542|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089543|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
20089544|NCT00001577|Melphalan|melphalan|mesh-list
20089545|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20089546|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
20089547|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089548|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089549|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20089550|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089551|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
20089552|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089553|NCT00001579|Leucovorin|leucovorin|mesh-list
20089554|NCT00001579|Fluorouracil|fluorouracil|mesh-list
20089555|NCT00001579|Eniluracil|eniluracil|mesh-list
20089556|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
20089557|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089558|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089559|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089560|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089561|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
20089562|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089563|NCT00001579|Antidotes|antidotes|mesh-ancestor
20089564|NCT00001579|Protective Agents|protective agents|mesh-ancestor
20089565|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
20089566|NCT00001579|Vitamins|vitamins|mesh-ancestor
20089567|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
20089568|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089569|NCT00001587|Melphalan|melphalan|mesh-list
20089570|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20089571|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
20089572|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089573|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089574|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20089575|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089576|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
20089577|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089578|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20089579|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20089580|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
20089581|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089582|NCT00001599|Thalidomide|thalidomide|mesh-list
20089583|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089584|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
20089585|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089586|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
20089587|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089588|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089589|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20089590|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20089591|NCT00001599|Growth Substances|growth substances|mesh-ancestor
20089592|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
20089593|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089594|NCT00001624|Insulin|insulin|mesh-list
20089595|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20089596|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089597|NCT00001626|Cyclosporine|cyclosporine|mesh-list
20089598|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
20089599|NCT00001626|Cyclosporins|cyclosporins|mesh-list
20089600|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20089601|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089602|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
20089603|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089604|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089605|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20089606|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
20089607|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089608|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089609|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20089610|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089611|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
20089612|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089613|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089614|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20089615|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
20089616|NCT00001628|Giapreza|giapreza|mesh-list
20089617|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
19492930|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089618|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
20089619|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20089620|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20089621|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
20089622|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089623|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089624|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20089625|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
20089626|NCT00001629|Giapreza|giapreza|mesh-list
20089627|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
20089628|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
20089629|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20089630|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20089631|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
19492931|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19492932|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19492933|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492934|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492935|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492936|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089632|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089633|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492937|NCT03120637|Methylene Blue|methylene blue|mesh-list
20089634|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20089635|NCT00001644|Lamivudine|lamivudine|mesh-list
20089636|NCT00001644|Zidovudine|zidovudine|mesh-list
20089637|NCT00001644|Nevirapine|nevirapine|mesh-list
20089638|NCT00001644|Indinavir|indinavir|mesh-list
20089639|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20089640|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20089641|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089642|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089643|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
20089644|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089645|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20089646|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089647|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
20089648|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20089649|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20089650|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20089651|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20089652|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
20089653|NCT00001646|Voriconazole|voriconazole|mesh-list
20089654|NCT00001646|Amphotericin B|amphotericin b|mesh-list
20089655|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20089656|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
20089657|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089658|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20089659|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20089660|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089661|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089662|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20089663|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
20089664|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089665|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089666|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20089667|NCT00001646|Amebicides|amebicides|mesh-ancestor
20089668|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20089669|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20089670|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089671|NCT00001649|Valacyclovir|valacyclovir|mesh-list
20089672|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
20089673|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089674|NCT00001658|Amoxicillin|amoxicillin|mesh-list
20089675|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089676|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089677|NCT00001666|Methamphetamine|methamphetamine|mesh-list
20089678|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20089679|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089680|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
20089681|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
20089682|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089683|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
20089684|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20089685|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089686|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
20089687|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20089688|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20089689|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20089690|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20089691|NCT00001669|Mecasermin|mecasermin|mesh-list
20089692|NCT00001669|Growth Substances|growth substances|mesh-ancestor
20089693|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089694|NCT00001676|Fludarabine|fludarabine|mesh-list
20089695|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089696|NCT00001677|Methotrexate|methotrexate|mesh-list
20089697|NCT00001677|Fludarabine|fludarabine|mesh-list
20089698|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20089699|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
20089700|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20089701|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089702|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20089703|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
20089704|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089705|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089706|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089707|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089708|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20089709|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089710|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
20089711|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089712|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20089713|NCT00001680|Thalidomide|thalidomide|mesh-list
20089714|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089715|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
20089716|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089717|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
20089718|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089719|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089720|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20089721|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20089722|NCT00001680|Growth Substances|growth substances|mesh-ancestor
20089723|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
20089724|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089725|NCT00001688|Ritonavir|ritonavir|mesh-list
20089726|NCT00001688|Nevirapine|nevirapine|mesh-list
20089727|NCT00001688|Stavudine|stavudine|mesh-list
20089728|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20089729|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20089730|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
20089731|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089732|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089733|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20089734|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089735|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
20089736|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089737|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20089738|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20089739|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20089740|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20089741|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20089742|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20089743|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
20089744|NCT00001689|Vincristine|vincristine|mesh-list
20089745|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089746|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089747|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
20089748|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
20089749|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
20089750|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089751|NCT00001693|Celecoxib|celecoxib|mesh-list
20089752|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20089753|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089754|NCT00001693|Analgesics|analgesics|mesh-ancestor
20089755|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
19746708|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492938|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089756|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089757|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602033|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20602034|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602035|NCT02213653|Iron|iron|mesh-list
20602036|NCT02213653|Trace Elements|trace elements|mesh-ancestor
20602037|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
20602038|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602039|NCT02213718|Sufentanil|sufentanil|mesh-list
20602040|NCT02213718|Propofol|propofol|mesh-list
20602041|NCT02213718|Desflurane|desflurane|mesh-list
20602042|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20602043|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602044|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089758|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20089759|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089760|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20089761|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20089762|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089763|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602045|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20602046|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
20602047|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
20602048|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20602049|NCT02213718|Narcotics|narcotics|mesh-ancestor
20602050|NCT02213718|Analgesics|analgesics|mesh-ancestor
20120201|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120202|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20120203|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
20120204|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20120205|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
20120206|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20120207|NCT00006324|Estradiol|estradiol|mesh-list
20602051|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
20602052|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602053|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20602054|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20120208|NCT00006324|Estrogens|estrogens|mesh-ancestor
20120209|NCT00006324|Hormones|hormones|mesh-ancestor
20120210|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120211|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120212|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20120213|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
20120214|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20120215|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20120216|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20120217|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20120218|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20120219|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20120220|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20120221|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120222|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19492939|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492940|NCT03120663|Amoxicillin|amoxicillin|mesh-list
20089764|NCT00001696|Genistein|genistein|mesh-list
20089765|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20089766|NCT00001696|Protective Agents|protective agents|mesh-ancestor
20089767|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089768|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089769|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20089770|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089771|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089772|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
20089773|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20089774|NCT00001696|Estrogens|estrogens|mesh-ancestor
20089775|NCT00001696|Hormones|hormones|mesh-ancestor
20089776|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089777|NCT00001698|Ketorolac|ketorolac|mesh-list
20089778|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20089779|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089780|NCT00001698|Analgesics|analgesics|mesh-ancestor
20089781|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
20089782|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089783|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089784|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20089785|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089786|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20089787|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089788|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089789|NCT00001713|Heparin|heparin|mesh-list
20089790|NCT00001713|Plasminogen|plasminogen|mesh-list
20089791|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20089792|NCT00001713|Warfarin|warfarin|mesh-list
20089793|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
20089794|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20089795|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20089796|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089797|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
20089798|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
20089799|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20089800|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
20089801|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602055|NCT02213744|Gemcitabine|gemcitabine|mesh-list
20602056|NCT02213744|Capecitabine|capecitabine|mesh-list
20602057|NCT02213744|Trastuzumab|trastuzumab|mesh-list
20602058|NCT02213744|Vinorelbine|vinorelbine|mesh-list
20089802|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089803|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20602059|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20602060|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
20602061|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602062|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602063|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
20602064|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602065|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602066|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602067|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
20602068|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602069|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602070|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20089804|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
20602071|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
20602072|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
20602073|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
20602074|NCT02213757|Estrogens|estrogens|mesh-list
20602075|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20602076|NCT02213757|Hormones|hormones|mesh-ancestor
20089805|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20089806|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
20089807|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089808|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602077|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602078|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602079|NCT02213783|Imipenem|imipenem|mesh-list
20602080|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602081|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602082|NCT02213796|Meropenem|meropenem|mesh-list
20602083|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602084|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602085|NCT02213848|Calcium|calcium|mesh-list
20602086|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20602087|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602088|NCT02213887|Pantoprazole|pantoprazole|mesh-list
20602089|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20602090|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20089809|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20089810|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
20089811|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
20089812|NCT00001716|Protective Agents|protective agents|mesh-ancestor
20089813|NCT00001720|Alendronate|alendronate|mesh-list
20089814|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20089815|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089816|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
20089817|NCT00001724|Analgesics|analgesics|mesh-ancestor
20089818|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
20089819|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20089820|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089821|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20089822|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20089823|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20089824|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089825|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20089826|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089827|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089828|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
20089829|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
20089830|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
20089831|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20089832|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20089833|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20089834|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089835|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089836|NCT00001728|Alendronate|alendronate|mesh-list
20089837|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20089838|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089839|NCT00001729|Ribavirin|ribavirin|mesh-list
20089840|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
20089841|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089842|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
20089843|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089844|NCT00001731|Cyclosporine|cyclosporine|mesh-list
20089845|NCT00001731|Cyclosporins|cyclosporins|mesh-list
20089846|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089847|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089848|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089849|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
20089850|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089851|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
20089852|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089853|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089854|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089855|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20089856|NCT00001736|Cysteamine|cysteamine|mesh-list
20089857|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
20089858|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089859|NCT00001737|Cyclosporine|cyclosporine|mesh-list
20089860|NCT00001737|Cyclosporins|cyclosporins|mesh-list
20089861|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089862|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089863|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089864|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
20089865|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089866|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
20089867|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089868|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089869|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089870|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20089871|NCT00001741|Losartan|losartan|mesh-list
20089872|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20089873|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20089874|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20089875|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20089876|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089877|NCT00001749|Cyclosporine|cyclosporine|mesh-list
20089878|NCT00001749|Cyclosporins|cyclosporins|mesh-list
20089879|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20089880|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089881|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089882|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20089883|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
20089884|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089885|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
20089886|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602091|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20602092|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089887|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
20089888|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20089889|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20089890|NCT00001752|Estrogens|estrogens|mesh-list
20089891|NCT00001752|Hormones|hormones|mesh-ancestor
20089892|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089893|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089894|NCT00001757|Voriconazole|voriconazole|mesh-list
20089895|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
20602093|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602094|NCT02213913|Prednisone|prednisone|mesh-list
20602095|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
20602096|NCT02213913|Rituximab|rituximab|mesh-list
19492941|NCT03120663|Clindamycin|clindamycin|mesh-list
19492942|NCT03120663|Meropenem|meropenem|mesh-list
20089896|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602097|NCT02213913|Doxorubicin|doxorubicin|mesh-list
20602098|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19492943|NCT03120663|Tazobactam|tazobactam|mesh-list
20602099|NCT02213913|Etoposide|etoposide|mesh-list
20089897|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20089898|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20089899|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089900|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089901|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20089902|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
20089903|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20089904|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089905|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20089906|NCT00001758|Efavirenz|efavirenz|mesh-list
20089907|NCT00001758|Abacavir|abacavir|mesh-list
20602100|NCT02213913|Vincristine|vincristine|mesh-list
20602101|NCT02213913|Lenalidomide|lenalidomide|mesh-list
20602102|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
20602103|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602104|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
20602105|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602106|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20602107|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20602108|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
20602109|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602110|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602111|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20602112|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602113|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602114|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20602115|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20602116|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089908|NCT00001758|Amprenavir|amprenavir|mesh-list
20089909|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20089910|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20602117|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602118|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
20602119|NCT02213913|Hormones|hormones|mesh-ancestor
20602120|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602121|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20089911|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089912|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089913|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
20089914|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089915|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20602122|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20602123|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
20602124|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
20602125|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
20602126|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20089916|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20089917|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20089918|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20089919|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20089920|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20089921|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20089922|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089923|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20089924|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
20089925|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089926|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20089927|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19492944|NCT03120663|Piperacillin|piperacillin|mesh-list
20602127|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20602128|NCT02213913|Growth Substances|growth substances|mesh-ancestor
20602129|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
20602130|NCT02214004|Trastuzumab|trastuzumab|mesh-list
20602131|NCT02214004|Letrozole|letrozole|mesh-list
20602132|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602133|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602134|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20089928|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
20089929|NCT00001763|Interleukin-12|interleukin-12|mesh-list
19492945|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
20089930|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20089931|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
20089932|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089933|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20089934|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20089935|NCT00001763|Growth Substances|growth substances|mesh-ancestor
20089936|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
20089937|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089938|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
20089939|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20089940|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20089941|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20089942|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
20089943|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089944|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089945|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089946|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089947|NCT00001766|Ritonavir|ritonavir|mesh-list
20089948|NCT00001766|Nelfinavir|nelfinavir|mesh-list
20089949|NCT00001766|Amprenavir|amprenavir|mesh-list
20089950|NCT00001766|Abacavir|abacavir|mesh-list
20089951|NCT00001766|Efavirenz|efavirenz|mesh-list
20089952|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20089953|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20089954|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
20089955|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20089956|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089957|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20089958|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20089959|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
20089960|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20089961|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20089962|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20089963|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20089964|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20089965|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20089966|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20089967|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20089968|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20089969|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20089970|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20089971|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
20089972|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20089973|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
20089974|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20089975|NCT00001768|Antibodies|antibodies|mesh-list
20089976|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
19492946|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
19492947|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20089977|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20089978|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
20089979|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746709|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
20602135|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20602136|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602137|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602138|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20602139|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
20602140|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602141|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602142|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20602143|NCT02214368|Propofol|propofol|mesh-list
20602144|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20602145|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602146|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602147|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20602148|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
20602149|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
20602150|NCT02214381|Paclitaxel|paclitaxel|mesh-list
20602151|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
20602152|NCT02214381|Doxorubicin|doxorubicin|mesh-list
20602153|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20602154|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602155|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
20602156|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
20602157|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
20602158|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602159|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602160|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
20602161|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602162|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20602163|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20602164|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
20602165|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20602166|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602167|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20602168|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20602169|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602170|NCT02214433|Pantoprazole|pantoprazole|mesh-list
20602171|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20602172|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20602173|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602174|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20602175|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602176|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602177|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20602178|NCT02214498|Enalapril|enalapril|mesh-list
19492948|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20602179|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602180|NCT02214498|Diuretics|diuretics|mesh-ancestor
20602181|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
20602182|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602183|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20602184|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602185|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602186|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20602187|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
20602188|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602189|NCT02214563|Vitamin D|vitamin d|mesh-list
20602190|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
20602191|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
20602192|NCT02214563|Vitamins|vitamins|mesh-list
20602193|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
20602194|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602195|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20602196|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20602197|NCT02214602|Doxorubicin|doxorubicin|mesh-list
20602198|NCT02214602|Epirubicin|epirubicin|mesh-list
20602199|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602200|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602201|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20602202|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20602203|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602204|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602205|NCT02214680|Timolol|timolol|mesh-list
20602206|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20602207|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
20602208|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20602209|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20602210|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
20602211|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602212|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602213|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602214|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20602215|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602216|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20602217|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20602218|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20602219|NCT02214706|Sirolimus|sirolimus|mesh-list
20602220|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602221|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602222|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602223|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602224|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
20602225|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602226|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
20602227|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602228|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
20602229|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602230|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602231|NCT02214810|Bupivacaine|bupivacaine|mesh-list
20602232|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
20089980|NCT00001777|Sertraline|sertraline|mesh-list
20089981|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
20089982|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20089983|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20089984|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20089985|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20089986|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089987|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20089988|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
20120223|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20602233|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
20089989|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20089990|NCT00001784|Mexiletine|mexiletine|mesh-list
20089991|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20089992|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20089993|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20602234|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492949|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19492950|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492951|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20602235|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602236|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
20602237|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602238|NCT02214966|Telmisartan|telmisartan|mesh-list
20602239|NCT02214966|Ramipril|ramipril|mesh-list
20602240|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602241|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20602242|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20602243|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602244|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20602245|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
20602246|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602247|NCT02214979|Telmisartan|telmisartan|mesh-list
20602248|NCT02214979|Ramipril|ramipril|mesh-list
20602249|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602250|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20602251|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20602252|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602253|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20089994|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20089995|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20089996|NCT00001785|Interferons|interferons|mesh-list
20089997|NCT00001785|Interferon-beta|interferon-beta|mesh-list
20089998|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
20089999|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090000|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
20090001|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090002|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
20090003|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090004|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090005|NCT00001790|Micafungin|micafungin|mesh-list
20090006|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
20090007|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090008|NCT00001805|Rituximab|rituximab|mesh-list
20090009|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20090010|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090011|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
19746710|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
20090012|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090013|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746711|NCT01904136|Melphalan|melphalan|mesh-list
20090014|NCT00001810|Voriconazole|voriconazole|mesh-list
20090015|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
20120224|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
20090016|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090017|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20090018|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20090019|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090020|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090021|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20090022|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
20090023|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090024|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090025|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20090026|NCT00001812|Nystatin|nystatin|mesh-list
20090027|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090028|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090029|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
20090030|NCT00001812|Ionophores|ionophores|mesh-ancestor
20090031|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20090032|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090033|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
20090034|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090035|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
20090036|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090037|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090038|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090039|NCT00001827|Aldesleukin|aldesleukin|mesh-list
20090040|NCT00001827|Sargramostim|sargramostim|mesh-list
20090041|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
20090042|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
20090043|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090044|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090045|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090046|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090047|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
20090048|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090049|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090050|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
20090051|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090052|NCT00001839|Cyclosporine|cyclosporine|mesh-list
20090053|NCT00001839|Cyclosporins|cyclosporins|mesh-list
20090054|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20090055|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090056|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090057|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090058|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
20090059|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090060|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
20090061|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19492952|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090062|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
20090063|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090064|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20090065|NCT00001842|Dexamethasone|dexamethasone|mesh-list
20090066|NCT00001842|Sargramostim|sargramostim|mesh-list
20090067|NCT00001842|Lenograstim|lenograstim|mesh-list
20090068|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090069|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
19492953|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090070|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
20090071|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090072|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090073|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20090074|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
20090075|NCT00001842|Hormones|hormones|mesh-ancestor
20090076|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090077|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20090078|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090079|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
20090080|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090081|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20090082|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20090083|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
20090084|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090085|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090086|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20090087|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20090088|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20090089|NCT00001854|Ribavirin|ribavirin|mesh-list
20090090|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
20090091|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090092|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
20090093|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090094|NCT00001860|Octreotide|octreotide|mesh-list
20090095|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602254|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
20602255|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602256|NCT02214992|Telmisartan|telmisartan|mesh-list
20602257|NCT02214992|Ramipril|ramipril|mesh-list
20602258|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20090096|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20090097|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090098|NCT00001862|Etanercept|etanercept|mesh-list
20090099|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20602259|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20602260|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20602261|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602262|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20602263|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
20602264|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602265|NCT02215005|Telmisartan|telmisartan|mesh-list
20602266|NCT02215005|Ramipril|ramipril|mesh-list
20602267|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602268|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19746712|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
20090100|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090101|NCT00001862|Analgesics|analgesics|mesh-ancestor
20090102|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
20090103|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309017|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
20090104|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090105|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090106|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090107|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20090108|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090109|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
20120225|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120226|NCT00006326|Ritonavir|ritonavir|mesh-list
20120227|NCT00006326|Indinavir|indinavir|mesh-list
20120228|NCT00006326|Delavirdine|delavirdine|mesh-list
20120229|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20120230|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20120231|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
20120232|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120233|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120234|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120235|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120236|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
20120237|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120238|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20120239|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20120240|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20120241|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120242|NCT00006330|Digoxin|digoxin|mesh-list
20120243|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20120244|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20120245|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120246|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120247|NCT00006330|Protective Agents|protective agents|mesh-ancestor
20120248|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120249|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20120250|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
20120251|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
20120252|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120253|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120254|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20120255|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20120256|NCT00006332|Growth Substances|growth substances|mesh-ancestor
20120257|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120258|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
20120259|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120260|NCT00006337|Levodopa|levodopa|mesh-list
20120261|NCT00006337|Istradefylline|istradefylline|mesh-list
20120262|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20120263|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20120264|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
20120265|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120266|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120267|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120268|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20120269|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20120270|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20120271|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
20120272|NCT00006339|Ritonavir|ritonavir|mesh-list
20120273|NCT00006339|Indinavir|indinavir|mesh-list
20120274|NCT00006339|Stavudine|stavudine|mesh-list
20120275|NCT00006339|Didanosine|didanosine|mesh-list
20090110|NCT00001863|Leflunomide|leflunomide|mesh-list
20090111|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090112|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090113|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090114|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
20090115|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602269|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20602270|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602271|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20602272|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
20602273|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090116|NCT00001864|Atropine|atropine|mesh-list
20090117|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20090118|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20090119|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20090120|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
20090121|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090122|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090123|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20090124|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
20090125|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
20090126|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
20090127|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20090128|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20090129|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
20090130|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090131|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602274|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20602275|NCT02215044|Gemcitabine|gemcitabine|mesh-list
20602276|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20602277|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
20602278|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602279|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602280|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
20602281|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090132|NCT00001865|Daclizumab|daclizumab|mesh-list
20090133|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090134|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
20090135|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090136|NCT00001870|Acetylcholine|acetylcholine|mesh-list
20090137|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
20090138|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20090139|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
20090140|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090141|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602282|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602283|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602284|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
20602285|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602286|NCT02215057|Lidocaine|lidocaine|mesh-list
20602287|NCT02215057|Anesthetics|anesthetics|mesh-list
20090142|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090143|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
20090144|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20602288|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
20602289|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602290|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602291|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
20602292|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602293|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20090145|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090146|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090147|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20090148|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20090149|NCT00001877|Protective Agents|protective agents|mesh-ancestor
20090150|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090151|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
20090152|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20090153|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
20090154|NCT00001889|Dobutamine|dobutamine|mesh-list
20090155|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20090156|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
20090157|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
20090158|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090159|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090160|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20090161|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20090162|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20090163|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
20090164|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607863|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
20090165|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090166|NCT00001889|Protective Agents|protective agents|mesh-ancestor
20090167|NCT00001890|Estrogens|estrogens|mesh-list
20090168|NCT00001890|Hormones|hormones|mesh-ancestor
20090169|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090170|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090171|NCT00001891|Dobutamine|dobutamine|mesh-list
20090172|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20090173|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
20090174|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
20090175|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090176|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090177|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20090178|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20090179|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20090180|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
20090181|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090182|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090183|NCT00001891|Protective Agents|protective agents|mesh-ancestor
20090184|NCT00001893|Etanercept|etanercept|mesh-list
20090185|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20090186|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090187|NCT00001893|Analgesics|analgesics|mesh-ancestor
20090188|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
20090189|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090190|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090191|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090192|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090193|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20090194|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090195|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
20090196|NCT00001901|Etanercept|etanercept|mesh-list
20090197|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20090198|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090199|NCT00001901|Analgesics|analgesics|mesh-ancestor
20602294|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20602295|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20602296|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602297|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602298|NCT02215096|GSK2636771|gsk2636771|mesh-list
20090200|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
20602299|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090201|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120276|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
20602300|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20602301|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608146|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
20602302|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607864|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20607865|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607866|NCT02243800|Vitamins|vitamins|mesh-ancestor
20607867|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
20607868|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20607869|NCT02243813|Psilocybin|psilocybin|mesh-list
20607870|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
20607871|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607872|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20607873|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
20607874|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20607875|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
20607876|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
20090202|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090203|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090204|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090205|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20090206|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090207|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
20090208|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
20090209|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20090210|NCT00001903|Antibodies|antibodies|mesh-list
20090211|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
20090212|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090213|NCT00001905|Interferons|interferons|mesh-list
20602303|NCT02215148|Tolvaptan|tolvaptan|mesh-list
20602304|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20602305|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602306|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
20602307|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602308|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20602309|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20602310|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20602311|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
20090214|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
20602312|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602313|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20602314|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20602315|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602316|NCT02215213|Vitamin D|vitamin d|mesh-list
20602317|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
20602318|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
20602319|NCT02215213|Vitamins|vitamins|mesh-list
20602320|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
20602321|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090215|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090216|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
20090217|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090218|NCT00001906|Interleukin-12|interleukin-12|mesh-list
20602322|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20602323|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20602324|NCT02215330|Eplerenone|eplerenone|mesh-list
20602325|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20602326|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
20602327|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090219|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20090220|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090221|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
20090222|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090223|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20090224|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20090225|NCT00001906|Growth Substances|growth substances|mesh-ancestor
20090226|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
20090227|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090228|NCT00001906|Antacids|antacids|mesh-ancestor
20090229|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090230|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20090231|NCT00001911|Interleukin-12|interleukin-12|mesh-list
20090232|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090233|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
20090234|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090235|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20090236|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20090237|NCT00001911|Growth Substances|growth substances|mesh-ancestor
20090238|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
20090239|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090240|NCT00001929|Eliprodil|eliprodil|mesh-list
20090241|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20090242|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20090243|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090244|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602328|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602329|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20602330|NCT02215330|Diuretics|diuretics|mesh-ancestor
20602331|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
20602332|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602333|NCT02215382|Atropine|atropine|mesh-list
20602334|NCT02215382|Neostigmine|neostigmine|mesh-list
20602335|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20090245|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090246|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20090247|NCT00001929|Protective Agents|protective agents|mesh-ancestor
20090248|NCT00001930|Amantadine|amantadine|mesh-list
20090249|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20090250|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20090251|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
20090252|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090253|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
20090254|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090255|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090256|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090257|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090258|NCT00001930|Analgesics|analgesics|mesh-ancestor
20090259|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
20090260|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090261|NCT00001933|Nefiracetam|nefiracetam|mesh-list
20090262|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20090263|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20090264|NCT00001933|Protective Agents|protective agents|mesh-ancestor
20090265|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090266|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
20090267|NCT00001934|Daclizumab|daclizumab|mesh-list
20090268|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090269|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
20090270|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090271|NCT00001937|Fluconazole|fluconazole|mesh-list
20090272|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
20090273|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090274|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19492954|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19492955|NCT03120273|Lansoprazole|lansoprazole|mesh-list
19492956|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
19492957|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19492958|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19492959|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19492960|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19492961|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492962|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
19492963|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19492964|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492965|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492966|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492967|NCT03120247|Analgesics|analgesics|mesh-ancestor
19492968|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
19492969|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492970|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19492971|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19492972|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19492973|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492974|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492975|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19492976|NCT03120234|Fentanyl|fentanyl|mesh-list
19492977|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
19492978|NCT03120234|Ketamine|ketamine|mesh-list
19492979|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19492980|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19492981|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19492982|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19492983|NCT03120234|Analgesics|analgesics|mesh-ancestor
19492984|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
19492985|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19492986|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19492987|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19492988|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19492989|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
19492990|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19492991|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090275|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20090276|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090277|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090278|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20090279|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
20090280|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090281|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090282|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20090283|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20090284|NCT00001940|Voriconazole|voriconazole|mesh-list
20090285|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
20090286|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090287|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20090288|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20090289|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090290|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090291|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20090292|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
20090293|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090294|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090295|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20090296|NCT00001944|Vinorelbine|vinorelbine|mesh-list
20602336|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20602337|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20602338|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
20602339|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602340|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602341|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20602342|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
20602343|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
20602344|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
20602345|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20602346|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20602347|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
20602348|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602349|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602350|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20602351|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090297|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20090298|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090299|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
20090300|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
20090301|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
20602352|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20602353|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20120277|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20602354|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
20602355|NCT02215395|Estradiol|estradiol|mesh-list
20602356|NCT02215395|Estrogens|estrogens|mesh-ancestor
20602357|NCT02215395|Hormones|hormones|mesh-ancestor
20602358|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602359|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090302|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090303|NCT00001954|Etanercept|etanercept|mesh-list
20090304|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20090305|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090306|NCT00001954|Analgesics|analgesics|mesh-ancestor
20090307|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
20090308|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090309|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090310|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090311|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090312|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20090313|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090314|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
20090315|NCT00001955|Celecoxib|celecoxib|mesh-list
20090316|NCT00001955|Etanercept|etanercept|mesh-list
20090317|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20090318|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090319|NCT00001955|Analgesics|analgesics|mesh-ancestor
20602360|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20602361|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20602362|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20602363|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20090320|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
20090321|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090322|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090323|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090324|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090325|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20090326|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20090327|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090328|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090329|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20090330|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090331|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
20090332|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
20090333|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090334|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
20090335|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090336|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090337|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090338|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
20090339|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20090340|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
20090341|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090342|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090343|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20090344|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
20090345|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20090346|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
20090347|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090348|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090349|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20090350|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
20090351|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
20090352|NCT00001963|Protective Agents|protective agents|mesh-ancestor
20090353|NCT00001964|Cyclosporine|cyclosporine|mesh-list
20090354|NCT00001964|Cyclosporins|cyclosporins|mesh-list
20090355|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090356|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090357|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090358|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
20090359|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090360|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
20090361|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090362|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
20090363|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090364|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20090365|NCT00001965|Cyclosporine|cyclosporine|mesh-list
20090366|NCT00001965|Cyclosporins|cyclosporins|mesh-list
20090367|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090368|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090369|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20090370|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
20090371|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090372|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
20090373|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090374|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602364|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20602365|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
20602366|NCT02215434|Testosterone|testosterone|mesh-list
20602367|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
20090375|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20090376|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20090377|NCT00001968|Ritonavir|ritonavir|mesh-list
19492992|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20090378|NCT00001968|Amprenavir|amprenavir|mesh-list
20090379|NCT00001968|Lamivudine|lamivudine|mesh-list
20090380|NCT00001968|Abacavir|abacavir|mesh-list
20602368|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
20602369|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20602370|NCT02215434|Androgens|androgens|mesh-ancestor
20602371|NCT02215434|Hormones|hormones|mesh-ancestor
20607877|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20090381|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20090382|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20090383|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
20090384|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090385|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090386|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19492993|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20090387|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090388|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
20090389|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090390|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20090391|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20090392|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090393|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090394|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20090395|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
20090396|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090397|NCT00001989|Zidovudine|zidovudine|mesh-list
19492994|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
19492995|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
19492996|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19492997|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19492998|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19492999|NCT03120234|Narcotics|narcotics|mesh-ancestor
19493000|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19493001|NCT03119857|Docetaxel|docetaxel|mesh-list
19493002|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
19493003|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493004|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19493005|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19493006|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19493007|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493008|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19493009|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493010|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493011|NCT03120182|Aspirin|aspirin|mesh-list
19493012|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19493013|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493014|NCT03120182|Analgesics|analgesics|mesh-ancestor
19493015|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
19493016|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493017|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493018|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493019|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493020|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19493021|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19493022|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493023|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19493024|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19493025|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493026|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
19493027|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
19493028|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19493029|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19493030|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493031|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
19493032|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090398|NCT00001989|Trichosanthin|trichosanthin|mesh-list
19493033|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493034|NCT03119532|Metronidazole|metronidazole|mesh-list
19493035|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493036|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493037|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19493038|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19493039|NCT03119623|Valsartan|valsartan|mesh-list
19493040|NCT03119623|Enalapril|enalapril|mesh-list
19493041|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19493042|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19493043|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19493044|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493045|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19493046|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
19493047|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569661|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19569662|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
19569663|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19569664|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19569665|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
19569666|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
19569667|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090399|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
20090400|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090401|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090402|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090403|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569668|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19569677|NCT04545554|Vitamin D|vitamin d|mesh-list
19569678|NCT04545554|Calcium|calcium|mesh-list
19569679|NCT04545554|Vitamins|vitamins|mesh-ancestor
19569680|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
19569681|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569682|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19569683|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19569684|NCT04537208|Vaccines|vaccines|mesh-list
19569685|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
19569686|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569687|NCT04477759|Atezolizumab|atezolizumab|mesh-list
19569688|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569689|NCT04466618|Heparin|heparin|mesh-list
19569690|NCT04466618|Calcium heparin|calcium heparin|mesh-list
19569691|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19569692|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
19569693|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19569694|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19569695|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569696|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19569697|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19569698|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19569699|NCT04461587|Pirfenidone|pirfenidone|mesh-list
19569700|NCT04461587|Analgesics|analgesics|mesh-ancestor
19569701|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
19569702|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569703|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569704|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19569705|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19569706|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569707|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569708|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569709|NCT04457089|Simvastatin|simvastatin|mesh-list
19569710|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19569711|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19569712|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
19569713|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569714|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19493048|NCT03119454|Betamethasone|betamethasone|mesh-list
19493049|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
19493050|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493051|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
19493052|NCT03119454|Hormones|hormones|mesh-ancestor
19493053|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493054|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493055|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19493056|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
19493057|NCT03119636|Levodopa|levodopa|mesh-list
19493058|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19493059|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19493060|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
19493061|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493062|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493063|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493064|NCT03119714|Pemirolast|pemirolast|mesh-list
19493065|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
19493066|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
19493067|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577812|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20090404|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
20090405|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090406|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090407|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090408|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20090409|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
20090410|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20090411|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090412|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20090413|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090414|NCT00001990|Atovaquone|atovaquone|mesh-list
20090415|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090416|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
20090417|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090418|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090419|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090420|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090421|NCT00001991|Atovaquone|atovaquone|mesh-list
20090422|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090423|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
20090424|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090425|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090426|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090427|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090428|NCT00001993|Miglustat|miglustat|mesh-list
20090429|NCT00001993|Zidovudine|zidovudine|mesh-list
20090430|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
20090431|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090432|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090433|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090434|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090435|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
20090436|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090437|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090438|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090439|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20090440|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20090441|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090442|NCT00001994|Atovaquone|atovaquone|mesh-list
20090443|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090444|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
20090445|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090446|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090447|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090448|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090449|NCT00001995|Rifabutin|rifabutin|mesh-list
20090450|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090451|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090452|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20090453|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
20120278|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20120279|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
20120280|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309018|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
20090454|NCT00001996|Atovaquone|atovaquone|mesh-list
20090455|NCT00001996|Pentamidine|pentamidine|mesh-list
20090456|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090457|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
20090458|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090459|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090460|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090461|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493068|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493069|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493070|NCT03119428|Nivolumab|nivolumab|mesh-list
19493071|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19493072|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493073|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19493074|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493075|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
19493076|NCT03119116|Apixaban|apixaban|mesh-list
19493077|NCT03119116|Dabigatran|dabigatran|mesh-list
19493078|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19493079|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
19493080|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19493081|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
19493082|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493083|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493084|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
19493085|NCT03119077|Itraconazole|itraconazole|mesh-list
19493086|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
19493087|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493088|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19493089|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19493090|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493091|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493092|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19493093|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
19493094|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493095|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493096|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19493097|NCT03119194|Opicapone|opicapone|mesh-list
19493098|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19493099|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493100|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493101|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19493102|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20090462|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
20090463|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20090464|NCT00001997|Zidovudine|zidovudine|mesh-list
20090465|NCT00001997|Didanosine|didanosine|mesh-list
20090466|NCT00001997|Interleukin-2|interleukin-2|mesh-list
20090467|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090468|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090469|NCT00001997|Analgesics|analgesics|mesh-ancestor
19493103|NCT03119038|Ketorolac|ketorolac|mesh-list
19493104|NCT03119038|Clonidine|clonidine|mesh-list
19493105|NCT03119038|Epinephrine|epinephrine|mesh-list
19493106|NCT03119038|Bupivacaine|bupivacaine|mesh-list
19493107|NCT03119038|Ropivacaine|ropivacaine|mesh-list
19493108|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
19493109|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
19493110|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493111|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493112|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
19493113|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493114|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19493115|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19493116|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
19493117|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493118|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493119|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19493120|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19493121|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
19493122|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20090470|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
20090471|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090472|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090473|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
19493123|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
19493124|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
19493125|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
19493126|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19493127|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19493128|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090474|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090475|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090476|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090477|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493129|NCT03119038|Analgesics|analgesics|mesh-ancestor
19493130|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493131|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493132|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19493133|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493134|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19493135|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
19493136|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19493137|NCT03119324|Nimesulide|nimesulide|mesh-list
19493138|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19493139|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493140|NCT03119324|Analgesics|analgesics|mesh-ancestor
19493141|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
19493142|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493143|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493144|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493145|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493146|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19493147|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493148|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493149|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19493150|NCT03118830|Cetrorelix|cetrorelix|mesh-list
19493151|NCT03118830|Hormones|hormones|mesh-list
19493152|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19493153|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493154|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493155|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
19493156|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19493157|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
19493158|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19493159|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19493160|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19493161|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493162|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19493163|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
19493164|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
19493165|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
19493166|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
19493167|NCT03118492|Melphalan|melphalan|mesh-list
19493168|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
19493169|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19493170|NCT03118492|Fludarabine|fludarabine|mesh-list
19493171|NCT03118492|Tacrolimus|tacrolimus|mesh-list
19493172|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19493173|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
19493174|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493175|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493176|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19493177|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
19493178|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493179|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493180|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19493181|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19493182|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493183|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19493184|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19493185|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
19493186|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493187|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493188|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
19493189|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19493190|NCT03118674|Ledipasvir|ledipasvir|mesh-list
19493191|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
19493192|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493193|NCT03118713|Metformin|metformin|mesh-list
19493194|NCT03118713|Glimepiride|glimepiride|mesh-list
20090478|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
20090479|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090480|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090481|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090482|NCT00001998|Nystatin|nystatin|mesh-list
20090483|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090484|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090485|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
19493195|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
19493196|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19493197|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493198|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19493199|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19493200|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
19493201|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19493202|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493203|NCT03118479|Anastrozole|anastrozole|mesh-list
19493204|NCT03118479|Testosterone|testosterone|mesh-list
19493205|NCT03118479|Androgens|androgens|mesh-ancestor
19493206|NCT03118479|Hormones|hormones|mesh-ancestor
19493207|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493208|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493209|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19493210|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493211|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19493212|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19493213|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493214|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493215|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19493216|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
19493217|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
19493218|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19493219|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19493220|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
19493221|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19493222|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
19493223|NCT03118232|Povidone|povidone|mesh-list
19493224|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19493225|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493226|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
19493227|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
19493228|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
19493229|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
19493230|NCT03118336|Empagliflozin|empagliflozin|mesh-list
19493231|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19493232|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493233|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19493234|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493235|NCT03118167|Antioxidants|antioxidants|mesh-list
19493236|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493237|NCT03118167|Protective Agents|protective agents|mesh-ancestor
19493238|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493239|NCT03118037|Zaleplon|zaleplon|mesh-list
19493240|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
19493241|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19493242|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493243|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493244|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
19493245|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
19493246|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493247|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493248|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
19493249|NCT03118076|Ropivacaine|ropivacaine|mesh-list
19493250|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19493251|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493252|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493253|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493254|NCT03118076|Analgesics|analgesics|mesh-ancestor
19493255|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
19493256|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493257|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19493258|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20090486|NCT00001998|Ionophores|ionophores|mesh-ancestor
20090487|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19493259|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19493260|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
19493261|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493262|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493263|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
19493264|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
19493265|NCT03118128|Metformin|metformin|mesh-list
19493266|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19493267|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569715|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19569716|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569717|NCT04416737|Insulin|insulin|mesh-list
19569718|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19569719|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569720|NCT04409860|Paclitaxel|paclitaxel|mesh-list
19569721|NCT04409860|Cisplatin|cisplatin|mesh-list
19569722|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19569723|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569724|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
19569725|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
19569726|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
19569727|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569728|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
19569729|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569730|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
19569731|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569732|NCT04363801|Capecitabine|capecitabine|mesh-list
19569733|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
19569734|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20090488|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090489|NCT00001999|Ganciclovir|ganciclovir|mesh-list
20090490|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20090491|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
20090492|NCT00001999|Antibodies|antibodies|mesh-list
20090493|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
20090494|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090495|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090496|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090497|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090498|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
20090499|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569735|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
19569736|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569737|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569738|NCT04349306|Rasburicase|rasburicase|mesh-list
19569739|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
19569740|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569741|NCT04345913|Halichondrin B|halichondrin b|mesh-list
19569742|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
19569743|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
19569744|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
19569745|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569746|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569747|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
19569748|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
19569749|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19569750|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19569751|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569752|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569753|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569754|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569755|NCT04292223|Pimavanserin|pimavanserin|mesh-list
19569756|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19569757|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19569758|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19569759|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19569760|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569761|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569762|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19569763|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20090500|NCT00002000|Valacyclovir|valacyclovir|mesh-list
19569764|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19569765|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
19569766|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569767|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569768|NCT04229615|Apatinib|apatinib|mesh-list
19493268|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
19493269|NCT03117790|Morphine|morphine|mesh-list
19493270|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19493271|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493272|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493273|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493274|NCT03117790|Analgesics|analgesics|mesh-ancestor
19493275|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
19493276|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493277|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19493278|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19493279|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19493280|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
19493281|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493282|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493283|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19493284|NCT03117790|Narcotics|narcotics|mesh-ancestor
19493285|NCT03117894|Acetaminophen|acetaminophen|mesh-list
19493286|NCT03117894|Etoricoxib|etoricoxib|mesh-list
19493287|NCT03117894|Morphine|morphine|mesh-list
19493288|NCT03117894|Remifentanil|remifentanil|mesh-list
19493289|NCT03117894|Ondansetron|ondansetron|mesh-list
19493290|NCT03117894|Propofol|propofol|mesh-list
19493291|NCT03117894|Ropivacaine|ropivacaine|mesh-list
19493292|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19493293|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493294|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493295|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19493296|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
19493297|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
19493298|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19493299|NCT03117894|Narcotics|narcotics|mesh-ancestor
19493300|NCT03117894|Analgesics|analgesics|mesh-ancestor
19493301|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
19493302|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493303|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
19493304|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493305|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
19493306|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
19493307|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
19493308|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19493309|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
19493310|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
19493311|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19493312|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
19493313|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493314|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493315|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19493316|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19493317|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19493318|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19493319|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19493320|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493321|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493322|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19493323|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19493324|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493325|NCT03117660|Vitamin A|vitamin a|mesh-list
19493326|NCT03117660|Vitamins|vitamins|mesh-ancestor
19493327|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
19493328|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493329|NCT03117972|Leucovorin|leucovorin|mesh-list
19493330|NCT03117972|Bevacizumab|bevacizumab|mesh-list
19493331|NCT03117972|Fluorouracil|fluorouracil|mesh-list
19493332|NCT03117972|Capecitabine|capecitabine|mesh-list
19493333|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
19493334|NCT03117972|Irinotecan|irinotecan|mesh-list
19493335|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
19493336|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19493337|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493338|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19493339|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19493340|NCT03117972|Growth Substances|growth substances|mesh-ancestor
19493341|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493342|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
20607878|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493343|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
19493344|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493345|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19493346|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19493347|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
19493348|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19493349|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19493350|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493351|NCT03117972|Antidotes|antidotes|mesh-ancestor
19493352|NCT03117972|Protective Agents|protective agents|mesh-ancestor
19493353|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
19493354|NCT03117972|Vitamins|vitamins|mesh-ancestor
19493355|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
19493356|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
19493357|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19493358|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
19493359|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493360|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493361|NCT03117855|Capecitabine|capecitabine|mesh-list
19493362|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19493363|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
19493364|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493365|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493366|NCT03117998|Volagidemab|volagidemab|mesh-list
19493367|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19493368|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493369|NCT03117595|Fentanyl|fentanyl|mesh-list
19493370|NCT03117595|Morphine|morphine|mesh-list
19493371|NCT03117595|Bupivacaine|bupivacaine|mesh-list
20090501|NCT00002000|Acyclovir|acyclovir|mesh-list
20090502|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
20090503|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090504|NCT00002001|Zidovudine|zidovudine|mesh-list
20090505|NCT00002001|Didanosine|didanosine|mesh-list
20090506|NCT00002001|Zalcitabine|zalcitabine|mesh-list
20090507|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
19493372|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
19493373|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
19493374|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493375|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493376|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
20090508|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090509|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090510|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090511|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090512|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
20090513|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090514|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090515|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090516|NCT00002002|Leucovorin|leucovorin|mesh-list
20090517|NCT00002002|Trimethoprim|trimethoprim|mesh-list
20090518|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
20090519|NCT00002002|Calcium|calcium|mesh-list
20090520|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
20090521|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20090522|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493377|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493378|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19493379|NCT03117595|Narcotics|narcotics|mesh-ancestor
19493380|NCT03117595|Analgesics|analgesics|mesh-ancestor
19493381|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20090523|NCT00002002|Antidotes|antidotes|mesh-ancestor
20090524|NCT00002002|Protective Agents|protective agents|mesh-ancestor
19493382|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19493383|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
19493384|NCT03117335|Endostatins|endostatins|mesh-list
19493385|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493386|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19493387|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19493388|NCT03117335|Growth Substances|growth substances|mesh-ancestor
19493389|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493390|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
19493391|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
19493392|NCT03117439|Clotrimazole|clotrimazole|mesh-list
19493393|NCT03117439|Miconazole|miconazole|mesh-list
20090525|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
20090526|NCT00002002|Vitamins|vitamins|mesh-ancestor
20090527|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
19493394|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090528|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20090529|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090530|NCT00002002|Renal Agents|renal agents|mesh-ancestor
20090531|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
19493395|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19493396|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19493397|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19493398|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493399|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493400|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19493401|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
19493402|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493403|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493404|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19493405|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19493406|NCT03117530|Minocycline|minocycline|mesh-list
19493407|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493408|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493409|NCT03117725|Melatonin|melatonin|mesh-list
19493410|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
19493411|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493412|NCT03117725|Protective Agents|protective agents|mesh-ancestor
19493413|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493414|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493415|NCT03117257|Cisplatin|cisplatin|mesh-list
19493416|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493417|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
19493418|NCT03117192|Astringents|astringents|mesh-ancestor
19493419|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493420|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
20090532|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090533|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090534|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20090535|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090536|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090537|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20090538|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20090539|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20090540|NCT00002003|Etoposide|etoposide|mesh-list
20090541|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
19493421|NCT03117166|Lidocaine|lidocaine|mesh-list
19493422|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
20602372|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493423|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
19493424|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493425|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493426|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
19493427|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493428|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19493429|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19493430|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19493431|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19493432|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493433|NCT03116971|Etoposide|etoposide|mesh-list
19493434|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493435|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19493436|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20090542|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20090543|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090544|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20090545|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20090546|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090547|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090548|NCT00002003|Analgesics|analgesics|mesh-ancestor
20090549|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
20090550|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090551|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090552|NCT00002006|Zidovudine|zidovudine|mesh-list
20090553|NCT00002006|Sargramostim|sargramostim|mesh-list
20090554|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
20090555|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493437|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19493438|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493439|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090556|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090557|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19493440|NCT03116945|Gallium citrate|gallium citrate|mesh-list
19493441|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493442|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19493443|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
19493444|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19493445|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493446|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493447|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493448|NCT03117023|Analgesics|analgesics|mesh-ancestor
19493449|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
19493450|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493451|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19493452|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20090558|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090559|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
20090560|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090561|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090562|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090563|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
20090564|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090565|NCT00002007|Zidovudine|zidovudine|mesh-list
20090566|NCT00002007|Sargramostim|sargramostim|mesh-list
20090567|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
20090568|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090569|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090570|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090571|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090572|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
20090573|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090574|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090575|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090576|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
19493453|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19493454|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
19493455|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493456|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493457|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
19493458|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493459|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
19493460|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
19493461|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
19493462|NCT03116893|Itraconazole|itraconazole|mesh-list
19493463|NCT03116893|Rifampin|rifampin|mesh-list
19493464|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
20090577|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090578|NCT00002008|Sargramostim|sargramostim|mesh-list
19493465|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493466|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19493467|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19493468|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493469|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493470|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19493471|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
19493472|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493473|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493474|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19493475|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19493476|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
19493477|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493478|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
19493479|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19493480|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19493481|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19493482|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19493483|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19493484|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19493485|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19493486|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19493487|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
20090579|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
20090580|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090581|NCT00002009|Sargramostim|sargramostim|mesh-list
19493488|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19493489|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19493490|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
19493491|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493492|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
19493493|NCT03116776|Protective Agents|protective agents|mesh-ancestor
19493494|NCT03116737|Benzocaine|benzocaine|mesh-list
19493495|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19493496|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
19493497|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
19493498|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493499|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493500|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
19493501|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493502|NCT03116659|Doxycycline|doxycycline|mesh-list
20090582|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
20090583|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090584|NCT00002010|Fluconazole|fluconazole|mesh-list
20090585|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
19493503|NCT03116659|Imiquimod|imiquimod|mesh-list
19493504|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493505|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493506|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
19493507|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19493508|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19493509|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19493510|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
19493511|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493512|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493513|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
19493514|NCT03116672|Diclofenac|diclofenac|mesh-list
19493515|NCT03116672|Ketorolac|ketorolac|mesh-list
19493516|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19493517|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493518|NCT03116672|Analgesics|analgesics|mesh-ancestor
19493519|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
19493520|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493521|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493522|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493523|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493524|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19493525|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493526|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493527|NCT03116490|Anesthetics|anesthetics|mesh-list
19493528|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493529|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493530|NCT03116542|Alovudine|alovudine|mesh-list
19493531|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
19493532|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493533|NCT03116347|Immunoglobulins|immunoglobulins|mesh-list
19493534|NCT03116347|Antibodies|antibodies|mesh-list
19493535|NCT03116347|gamma-Globulins|gamma-globulins|mesh-list
19493536|NCT03116347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19493537|NCT03116347|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19493538|NCT03116347|Immunoglobulin G|immunoglobulin g|mesh-list
19493539|NCT03116347|Immunologic Factors|immunologic factors|mesh-ancestor
19493540|NCT03116347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493541|NCT03116555|Irinotecan|irinotecan|mesh-list
19493542|NCT03116555|Apatinib|apatinib|mesh-list
19493543|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19493544|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19493545|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493546|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493547|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493548|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19569769|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569770|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19569771|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569772|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569773|NCT04210349|Vaccines|vaccines|mesh-list
19569774|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
19569775|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090586|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569776|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19569777|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569778|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569779|NCT04177693|Letrozole|letrozole|mesh-list
19493549|NCT03116516|Amlodipine|amlodipine|mesh-list
19493550|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19493551|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19493552|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19493553|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19493554|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493555|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19493556|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493557|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
19493558|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19493559|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19493560|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
19493561|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19493562|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19493563|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493564|NCT03116269|Aspirin|aspirin|mesh-list
19493565|NCT03116269|Cilostazol|cilostazol|mesh-list
19493566|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19493567|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493568|NCT03116269|Analgesics|analgesics|mesh-ancestor
19493569|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
19493570|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493571|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493572|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493573|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493574|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19493575|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19493576|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493577|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19493578|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19493579|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493580|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
19493581|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19493582|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
19493583|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19493584|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
19493585|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
19493586|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19493587|NCT03116269|Protective Agents|protective agents|mesh-ancestor
19493588|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19493589|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19493590|NCT03116126|Guanfacine|guanfacine|mesh-list
19493591|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19493592|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19493593|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19493594|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19493595|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
19493596|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493597|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090587|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20090588|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20090589|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090590|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090591|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20090592|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
20090593|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493598|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493599|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19493600|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
19493601|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19493602|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19493603|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19493604|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493605|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
19493606|NCT03116087|Testosterone|testosterone|mesh-list
19493607|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
19493608|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
19493609|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19493610|NCT03116087|Androgens|androgens|mesh-ancestor
19493611|NCT03116087|Hormones|hormones|mesh-ancestor
19493612|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090594|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493613|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493614|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19493615|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493616|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
19493617|NCT03116308|Opicapone|opicapone|mesh-list
19493618|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19493619|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493620|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493621|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19493622|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19493623|NCT03116282|Ethanol|ethanol|mesh-list
19493624|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19493625|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602373|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602374|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19493626|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493627|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493628|NCT03116295|Opicapone|opicapone|mesh-list
19493629|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19493630|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493631|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493632|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19493633|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19493634|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
19493635|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19493636|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493637|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
19493638|NCT03115697|Rifaximin|rifaximin|mesh-list
19493639|NCT03115697|Lactulose|lactulose|mesh-list
19493640|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493641|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493642|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19493643|NCT03115736|Tenofovir|tenofovir|mesh-list
19493644|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
19493645|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493646|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19493647|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19493648|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493649|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493650|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19493651|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19493652|NCT03115775|Vitamin D|vitamin d|mesh-list
19493653|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
19493654|NCT03115775|Vitamins|vitamins|mesh-list
19493655|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
19493656|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493657|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19493658|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19493659|NCT03115489|Ketamine|ketamine|mesh-list
19493660|NCT03115489|Propofol|propofol|mesh-list
19493661|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19493662|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493663|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493664|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19493665|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
19493666|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
19493667|NCT03115489|Analgesics|analgesics|mesh-ancestor
19493668|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
19493669|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493670|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19493671|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19493672|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19493673|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493674|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493675|NCT03115762|Bevacizumab|bevacizumab|mesh-list
19493676|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19493677|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493678|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19493679|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19493680|NCT03115762|Growth Substances|growth substances|mesh-ancestor
19493681|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602375|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602376|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
20602377|NCT02215447|Paclitaxel|paclitaxel|mesh-list
20602378|NCT02215447|Carboplatin|carboplatin|mesh-list
19493682|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
19493683|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19493684|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
19493685|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19493686|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
19493687|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19493688|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493689|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19493690|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19493691|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493692|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19493693|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19493694|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493695|NCT03115619|Pirfenidone|pirfenidone|mesh-list
19493696|NCT03115619|Analgesics|analgesics|mesh-ancestor
19493697|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
19493698|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493699|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090595|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20090596|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20090597|NCT00002011|Methoxsalen|methoxsalen|mesh-list
20090598|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20090599|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
20090600|NCT00002012|Interferons|interferons|mesh-list
20090601|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
20090602|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090603|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
19493700|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19493701|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19493702|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493703|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493704|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493705|NCT03115567|Triamcinolone|triamcinolone|mesh-list
19493706|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493707|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
19493708|NCT03115567|Hormones|hormones|mesh-ancestor
19493709|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493710|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493711|NCT03115255|Ranibizumab|ranibizumab|mesh-list
19493712|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19493713|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19493714|NCT03115255|Growth Substances|growth substances|mesh-ancestor
19493715|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493716|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
19493717|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746713|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19746714|NCT01904136|Fludarabine|fludarabine|mesh-list
19746715|NCT01904136|Tacrolimus|tacrolimus|mesh-list
19746716|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746717|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
19746718|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746719|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746720|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19746721|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
20090604|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090605|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
20090606|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090607|NCT00002013|Zidovudine|zidovudine|mesh-list
20090608|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
20090609|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090610|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19746722|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746723|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746724|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20090611|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090612|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090613|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
20090614|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090615|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090616|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090617|NCT00002014|Zidovudine|zidovudine|mesh-list
20090618|NCT00002014|Didanosine|didanosine|mesh-list
20090619|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
20090620|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090621|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090622|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090623|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090624|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
20090625|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090626|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090627|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090628|NCT00002015|Ganciclovir|ganciclovir|mesh-list
20090629|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20090630|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
20090631|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090632|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090633|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090634|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746725|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19746726|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090635|NCT00002017|Interleukin-2|interleukin-2|mesh-list
20090636|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090637|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20090638|NCT00002017|Analgesics|analgesics|mesh-ancestor
20090639|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
20090640|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20090641|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090642|NCT00002018|Interferons|interferons|mesh-list
20090643|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
20090644|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090645|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
20090646|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090647|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
20090648|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090649|NCT00002019|Amphotericin B|amphotericin b|mesh-list
20090650|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20090651|NCT00002019|Amebicides|amebicides|mesh-ancestor
20090652|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090653|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090654|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090655|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090656|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
20090657|NCT00002020|Zidovudine|zidovudine|mesh-list
20090658|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
20090659|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090660|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090661|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090662|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090663|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
20090664|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090665|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090666|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090667|NCT00002021|Foscarnet|foscarnet|mesh-list
19493751|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
19493752|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19493753|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19493754|NCT03115034|Melatonin|melatonin|mesh-list
19493755|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
19493756|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493757|NCT03115034|Protective Agents|protective agents|mesh-ancestor
19493758|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493759|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493760|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19493761|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493762|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493763|NCT03115073|Clotrimazole|clotrimazole|mesh-list
19493764|NCT03115073|Miconazole|miconazole|mesh-list
19493765|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19493766|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493767|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
19493768|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19493769|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19493770|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493771|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493772|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19493773|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
19493774|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090668|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20090669|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
20090670|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493775|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493776|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19493777|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19493778|NCT03115151|Fentanyl|fentanyl|mesh-list
19493779|NCT03115151|Hydromorphone|hydromorphone|mesh-list
19493780|NCT03115151|Bupivacaine|bupivacaine|mesh-list
19493781|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
20090671|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090672|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090673|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090674|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090675|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
20090676|NCT00002022|Hematinics|hematinics|mesh-ancestor
20090677|NCT00002023|Zidovudine|zidovudine|mesh-list
20090678|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
20090679|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090680|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090681|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090682|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493782|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
19493783|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19493784|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493785|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
19493786|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493787|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19493788|NCT03115151|Narcotics|narcotics|mesh-ancestor
19493789|NCT03115151|Analgesics|analgesics|mesh-ancestor
19493790|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19493791|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19493792|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
19493793|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19493794|NCT03115099|Liraglutide|liraglutide|mesh-list
19493795|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19493796|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493797|NCT03115099|Incretins|incretins|mesh-ancestor
19493798|NCT03115099|Hormones|hormones|mesh-ancestor
19493799|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493800|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19493801|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
19493802|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493803|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493804|NCT03114813|Carvedilol|carvedilol|mesh-list
19493805|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19493806|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19493807|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
19493808|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493809|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493810|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493811|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19493812|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
19493813|NCT03114813|Protective Agents|protective agents|mesh-ancestor
19493814|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19493815|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19493816|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19493817|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
19493818|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19493819|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19569780|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19569781|NCT04177693|Clomiphene|clomiphene|mesh-list
19569782|NCT04177693|Enclomiphene|enclomiphene|mesh-list
19569783|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
19569784|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569785|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569786|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19569787|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19569788|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569789|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19569790|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
19569791|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569792|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569793|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19569794|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
19569795|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20090683|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
19493820|NCT03114527|Everolimus|everolimus|mesh-list
19493821|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090684|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090685|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090686|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090687|NCT00002024|Ganciclovir|ganciclovir|mesh-list
20602379|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20602380|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602381|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
20602382|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
20602383|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
20602384|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602385|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
20602386|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20602387|NCT02215460|Azithromycin|azithromycin|mesh-list
20602388|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19493822|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19493823|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
19493824|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493825|NCT03114371|Oxytocin|oxytocin|mesh-list
19493826|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
19493827|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19493828|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493829|NCT03114280|Carboplatin|carboplatin|mesh-list
20602389|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602390|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
20090688|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20090689|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
20090690|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090691|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090692|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493830|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493831|NCT03114228|Midostaurin|midostaurin|mesh-list
19493832|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493833|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19493834|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493835|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493836|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19493837|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19493838|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
19493839|NCT03114085|Capecitabine|capecitabine|mesh-list
19493840|NCT03114085|Apatinib|apatinib|mesh-list
19493841|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19493842|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
19493843|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493844|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493845|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19493846|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493847|NCT03114072|Methamphetamine|methamphetamine|mesh-list
19493848|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19493849|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493850|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
19493851|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
19493852|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493853|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
19493854|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493855|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493856|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19493857|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19493858|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19493859|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19493860|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19493861|NCT03114215|Biotin|biotin|mesh-list
19493862|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
19493863|NCT03114215|Vitamins|vitamins|mesh-ancestor
19493864|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
19493865|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493866|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19493867|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
19493868|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19493869|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
19493870|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493871|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
20090693|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602391|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602392|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493872|NCT03114020|Protective Agents|protective agents|mesh-ancestor
19493873|NCT03113851|Molgramostim|molgramostim|mesh-list
19493874|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493875|NCT03113773|Aldesleukin|aldesleukin|mesh-list
19493876|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493877|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19493878|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19493879|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
19493880|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493881|NCT03113448|Capsaicin|capsaicin|mesh-list
19493882|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
19493883|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19493884|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
19493885|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493886|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493887|NCT03113500|Prednisone|prednisone|mesh-list
19493888|NCT03113500|Cortisone|cortisone|mesh-list
19493889|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
19493890|NCT03113500|Doxorubicin|doxorubicin|mesh-list
19493891|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19493892|NCT03113500|Etoposide|etoposide|mesh-list
19493893|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
19493894|NCT03113500|Daunorubicin|daunorubicin|mesh-list
19493895|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19493896|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
20090694|NCT00002025|Ganciclovir|ganciclovir|mesh-list
20090695|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20090696|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
20090697|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090698|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090699|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090700|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090701|NCT00002026|Acyclovir|acyclovir|mesh-list
20090702|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
20090703|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090704|NCT00002027|Diclazuril|diclazuril|mesh-list
20090705|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
20090706|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090707|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090708|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090709|NCT00002028|Didanosine|didanosine|mesh-list
20090710|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
20090711|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090712|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090713|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090714|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090715|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
20090716|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090717|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090718|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090719|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20090720|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20090721|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20090722|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20090723|NCT00002030|Pentamidine|pentamidine|mesh-list
20090724|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
20090725|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090726|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090727|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090728|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20090729|NCT00002032|Rifabutin|rifabutin|mesh-list
20090730|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090731|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493897|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19493898|NCT03113500|Antibodies|antibodies|mesh-list
19493899|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
19493900|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19493901|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
19493902|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19493903|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
19493904|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090732|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19493905|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19493906|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20090733|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
19493907|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
19493908|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493909|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20090734|NCT00002033|Zidovudine|zidovudine|mesh-list
20090735|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
20090736|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090737|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090738|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090739|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090740|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
20090741|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493910|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19493911|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19493912|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19493913|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19493914|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493915|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19493916|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
19493917|NCT03113500|Hormones|hormones|mesh-ancestor
19493918|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19493919|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19493920|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19493921|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
19493922|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
19493923|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
20090742|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090743|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090744|NCT00002034|Zidovudine|zidovudine|mesh-list
20090745|NCT00002034|Ganciclovir|ganciclovir|mesh-list
20090746|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20090747|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
20090748|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090749|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090750|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090751|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090752|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
20090753|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090754|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090755|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090756|NCT00002035|Zidovudine|zidovudine|mesh-list
20602393|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
19493924|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
19493925|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
19493926|NCT03113695|Lenalidomide|lenalidomide|mesh-list
19493927|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
19493928|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
19493929|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493930|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19493931|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19493932|NCT03113695|Growth Substances|growth substances|mesh-ancestor
19493933|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
19493934|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19493935|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19493936|NCT03113396|Baclofen|baclofen|mesh-list
19493937|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19493938|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493939|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19493940|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19493941|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19493942|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
19493943|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
19493944|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493945|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493946|NCT03113708|Heparin|heparin|mesh-list
19493947|NCT03113708|Calcium heparin|calcium heparin|mesh-list
19493948|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
19493949|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19493950|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19493951|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493952|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
19493953|NCT03113617|Bombesin|bombesin|mesh-list
19493954|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493955|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19493956|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493957|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19493958|NCT03113344|Amoxicillin|amoxicillin|mesh-list
19493959|NCT03113344|Azithromycin|azithromycin|mesh-list
19493960|NCT03113344|Meropenem|meropenem|mesh-list
20602394|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19493961|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
19493962|NCT03113344|Imipenem|imipenem|mesh-list
20090757|NCT00002035|Didanosine|didanosine|mesh-list
19493963|NCT03113344|Penicillins|penicillins|mesh-list
19493964|NCT03113344|Erythromycin|erythromycin|mesh-list
20090758|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
20090759|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090760|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090761|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090762|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19493965|NCT03113344|Ceftazidime|ceftazidime|mesh-list
19493966|NCT03113344|Ampicillin|ampicillin|mesh-list
19493967|NCT03113344|Cephalosporins|cephalosporins|mesh-list
19493968|NCT03113344|Acyclovir|acyclovir|mesh-list
19493969|NCT03113344|Ganciclovir|ganciclovir|mesh-list
19493970|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
19493971|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19493972|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493973|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090763|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
20090764|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090765|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090766|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090767|NCT00002036|Immune Sera|immune sera|mesh-list
20090768|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
20090769|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493974|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493975|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19493976|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19493977|NCT03113123|Tenofovir|tenofovir|mesh-list
19493978|NCT03113123|Emtricitabine|emtricitabine|mesh-list
19493979|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19493980|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
19493981|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19493982|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19493983|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19493984|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090770|NCT00002037|Trifluridine|trifluridine|mesh-list
20090771|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
20090772|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090773|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
20090774|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090775|NCT00002038|Fluconazole|fluconazole|mesh-list
20090776|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
20090777|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090778|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20090779|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20090780|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090781|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090782|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20090783|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
20090784|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090785|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090786|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20090787|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20090788|NCT00002039|Foscarnet|foscarnet|mesh-list
20090789|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20090790|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
20090791|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090792|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19493985|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493986|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090793|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19493987|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19493988|NCT03113084|Heparin|heparin|mesh-list
19493989|NCT03113084|Calcium heparin|calcium heparin|mesh-list
19493990|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
19493991|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19493992|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19493993|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19493994|NCT03113266|Antibodies|antibodies|mesh-list
19493995|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19493996|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
19493997|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19493998|NCT03113019|Vaccines|vaccines|mesh-list
19493999|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
19494000|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494001|NCT03113110|Empagliflozin|empagliflozin|mesh-list
20090794|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494002|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19494003|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494004|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19494005|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569796|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19569797|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19569798|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
19569799|NCT04177693|Protective Agents|protective agents|mesh-ancestor
19569800|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19569801|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19569802|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19569803|NCT04142086|Vaccines|vaccines|mesh-list
19569804|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
19569805|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569806|NCT04137887|Vaccines|vaccines|mesh-list
19569807|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
19569808|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569809|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
20090795|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090796|NCT00002040|Fluconazole|fluconazole|mesh-list
20090797|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
20090798|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090799|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20090800|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19569810|NCT04109482|Fludarabine|fludarabine|mesh-list
19569811|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19569812|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
19569813|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569814|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569815|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19569816|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
19569817|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569818|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569819|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19569820|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
19569821|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19569822|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19569823|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569824|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19569825|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090801|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090802|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090803|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20090804|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
20602395|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19569826|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19577813|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577814|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19577815|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
20602396|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602397|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
20602398|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602399|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
19577816|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19577817|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577818|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
19577819|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577820|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577821|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577822|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19577823|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577824|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
19577825|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577826|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19577827|NCT03889743|Dexamethasone|dexamethasone|mesh-list
19577828|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577829|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
19577830|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
19577831|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577832|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577833|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494006|NCT03113162|Cytarabine|cytarabine|mesh-list
19494007|NCT03113162|Etoposide|etoposide|mesh-list
19494008|NCT03113162|Melphalan|melphalan|mesh-list
19494009|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19494010|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494011|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19494012|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19494013|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494014|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494015|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19494016|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
19494017|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
19494018|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494019|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19494020|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
19494021|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494022|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19494023|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
19494024|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19494025|NCT03112889|Valproic Acid|valproic acid|mesh-list
19494026|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
19494027|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494028|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494029|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
19494030|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494031|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494032|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
20090805|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20090806|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090807|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20090808|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20090809|NCT00002041|Amphotericin B|amphotericin b|mesh-list
20090810|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20090811|NCT00002041|Amebicides|amebicides|mesh-ancestor
20090812|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090813|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090814|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090815|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090816|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
20090817|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
20090818|NCT00002042|Hematinics|hematinics|mesh-ancestor
20090819|NCT00002043|Dapsone|dapsone|mesh-list
20090820|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090821|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
20090822|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20602400|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20602401|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20602402|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
19494033|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19494034|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494035|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19494036|NCT03112707|Aspirin|aspirin|mesh-list
19494037|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19494038|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20602403|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
20602404|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494039|NCT03112707|Analgesics|analgesics|mesh-ancestor
19494040|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
19494041|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494042|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494043|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494044|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494045|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19494046|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19494047|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494048|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19494049|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19494050|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494051|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
19494052|NCT03112642|Anesthetics|anesthetics|mesh-list
19494053|NCT03112642|Bupivacaine|bupivacaine|mesh-list
19494054|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
19494055|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494056|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494057|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
20090823|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19494058|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494059|NCT03112577|Fluticasone|fluticasone|mesh-list
19494060|NCT03112577|Xhance|xhance|mesh-list
19494061|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494062|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19494063|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
19494064|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494065|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494066|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19494067|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
19494068|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
19494069|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19494070|NCT03112538|Insulin|insulin|mesh-list
19494071|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19494072|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19494073|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494074|NCT03112785|Cimetidine|cimetidine|mesh-list
19494075|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19494076|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494077|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19494078|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
19494079|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
19494080|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494081|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494082|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494083|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19494084|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19494085|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494086|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
19494087|NCT03112551|Analgesics|analgesics|mesh-ancestor
19494088|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
19494089|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494090|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494091|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
19494092|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494093|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19494094|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
19494095|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19494096|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494097|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494098|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19494099|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
19494100|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19494101|NCT03112564|Fentanyl|fentanyl|mesh-list
19494102|NCT03112564|Sevoflurane|sevoflurane|mesh-list
19494103|NCT03112564|Rocuronium|rocuronium|mesh-list
19494104|NCT03112564|Cisatracurium|cisatracurium|mesh-list
19494105|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19494106|NCT03112564|Narcotics|narcotics|mesh-ancestor
19494107|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494108|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494109|NCT03112564|Analgesics|analgesics|mesh-ancestor
19494110|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
19494111|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494112|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19494113|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19494114|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
19494115|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
19494116|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20090824|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20090825|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494117|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19494118|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19494119|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19494120|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19494121|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
19494122|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19494123|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
19494124|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19494125|NCT03112148|Tofacitinib|tofacitinib|mesh-list
19494126|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19494127|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494128|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494129|NCT03112187|Iron|iron|mesh-list
19494130|NCT03112187|Trace Elements|trace elements|mesh-ancestor
19494131|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
19494132|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494133|NCT03112135|Epinephrine|epinephrine|mesh-list
19494134|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
19494135|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19494136|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19494137|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494138|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494139|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494140|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494141|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19494142|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19494143|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
19494144|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494145|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19494146|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
19494147|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
19494148|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
19494149|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19494150|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19494151|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19494152|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
19494153|NCT03112135|Coagulants|coagulants|mesh-ancestor
19494154|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
19494155|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494156|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
19494157|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
19494158|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
19494159|NCT03112382|Vitamins|vitamins|mesh-list
19494160|NCT03112382|Vitamin A|vitamin a|mesh-list
19494161|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
19494162|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
19494163|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494164|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
19494165|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494166|NCT03112382|Protective Agents|protective agents|mesh-ancestor
19494167|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19494168|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494169|NCT03112226|Estradiol|estradiol|mesh-list
19494170|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
19494171|NCT03112226|Estrogens|estrogens|mesh-ancestor
19494172|NCT03112226|Hormones|hormones|mesh-ancestor
19494173|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19494174|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494175|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
19494176|NCT03112005|Mydriatics|mydriatics|mesh-list
19494177|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
19494178|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494179|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494180|NCT03111966|Grazoprevir|grazoprevir|mesh-list
19494181|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
19494182|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494183|NCT03112031|Tamoxifen|tamoxifen|mesh-list
19494184|NCT03112031|Fluconazole|fluconazole|mesh-list
19494185|NCT03112031|Amphotericin B|amphotericin b|mesh-list
19494186|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19494187|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20090826|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494188|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
19494189|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19494190|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494191|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19494192|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494193|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20090827|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
20090828|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090829|NCT00002044|Zidovudine|zidovudine|mesh-list
20090830|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
20090831|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090832|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090833|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090834|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090835|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
20090836|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090837|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090838|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19494194|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19494195|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19494196|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
19494197|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494198|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19494199|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19494200|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494201|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494202|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19494203|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19494204|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19494205|NCT03112031|Amebicides|amebicides|mesh-ancestor
19494206|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19494207|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19494208|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19494209|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
19494210|NCT03111901|Interleukin-2|interleukin-2|mesh-list
19494211|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19494212|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494213|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19494214|NCT03111901|Analgesics|analgesics|mesh-ancestor
19494215|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
19494216|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494217|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494218|NCT03111797|Morphine|morphine|mesh-list
19494219|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19494220|NCT03111797|Narcotics|narcotics|mesh-ancestor
20090839|NCT00002045|Zidovudine|zidovudine|mesh-list
20090840|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
20090841|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090842|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090843|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090844|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494221|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494222|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494223|NCT03111797|Analgesics|analgesics|mesh-ancestor
19494224|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
19494225|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494226|NCT03111810|Prednisolone|prednisolone|mesh-list
20090845|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
20090846|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090847|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090848|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090849|NCT00002046|Zidovudine|zidovudine|mesh-list
20090850|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
20090851|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090852|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090853|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090854|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090855|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
20090856|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090857|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090858|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090859|NCT00002047|Zidovudine|zidovudine|mesh-list
20090860|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
20090861|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090862|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090863|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090864|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090865|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
20090866|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090867|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19494227|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20090868|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090869|NCT00002048|Zidovudine|zidovudine|mesh-list
20090870|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
20090871|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090872|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090873|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090874|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090875|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
20090876|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494228|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
19494229|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19494230|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
19494231|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19494232|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
19494233|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494234|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
19494235|NCT03111810|Hormones|hormones|mesh-ancestor
19494236|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19494237|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494238|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19494239|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494240|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
19494241|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
19494242|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494243|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494244|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19494245|NCT03111810|Protective Agents|protective agents|mesh-ancestor
19494246|NCT03111537|Nicotine|nicotine|mesh-list
19494247|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19494248|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
19494249|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494250|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494251|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19494252|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20090877|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090878|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20090879|NCT00002049|Thymopentin|thymopentin|mesh-list
20090880|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090881|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
20090882|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090883|NCT00002050|Thymopentin|thymopentin|mesh-list
20090884|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090885|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
20090886|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090887|NCT00002051|Thymopentin|thymopentin|mesh-list
20090888|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090889|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
20090890|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090891|NCT00002052|Amoxicillin|amoxicillin|mesh-list
20090892|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
20090893|NCT00002052|Ampicillin|ampicillin|mesh-list
20090894|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090895|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090896|NCT00002053|Pentamidine|pentamidine|mesh-list
20090897|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
20090898|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090899|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090900|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090901|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20090902|NCT00002054|Pentamidine|pentamidine|mesh-list
20090903|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
20090904|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090905|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090906|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090907|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20090908|NCT00002055|Pentamidine|pentamidine|mesh-list
20090909|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
19494253|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
19494254|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494255|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494256|NCT03111511|Drospirenone|drospirenone|mesh-list
20090910|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494257|NCT03111511|Midazolam|midazolam|mesh-list
19494258|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20090911|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090912|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090913|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20090914|NCT00002056|Pentamidine|pentamidine|mesh-list
20090915|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
19494259|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19494260|NCT03111511|Betadex|betadex|mesh-list
19494261|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19494262|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19494263|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494264|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494265|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19494266|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19494267|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19494268|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19494269|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
19494270|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
19494271|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
19494272|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
19494273|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494274|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494275|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19494276|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19494277|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19494278|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
19494279|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19494280|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19494281|NCT03111511|Estrogens|estrogens|mesh-ancestor
19494282|NCT03111511|Hormones|hormones|mesh-ancestor
19494283|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19494284|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19494285|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
19494286|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19494287|NCT03111511|Diuretics|diuretics|mesh-ancestor
19494288|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
19494289|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
19494290|NCT03111485|Levodopa|levodopa|mesh-list
19494291|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19494292|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19494293|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19494294|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
19494295|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494296|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494297|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494298|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19494299|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
19494300|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
19494301|NCT03111342|Lidocaine|lidocaine|mesh-list
19494302|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
19494303|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
19494304|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494305|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494306|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
19494307|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494308|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19494309|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19494310|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19494311|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494312|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494313|NCT03111420|Clopidogrel|clopidogrel|mesh-list
19494314|NCT03111420|Ticagrelor|ticagrelor|mesh-list
19494315|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19494316|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19494317|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19494318|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19494319|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19494320|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
19494321|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494322|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494323|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090916|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090917|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090918|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090919|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20090920|NCT00002057|Nystatin|nystatin|mesh-list
20090921|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090922|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090923|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
20090924|NCT00002057|Ionophores|ionophores|mesh-ancestor
20090925|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20090926|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090927|NCT00002058|Clofazimine|clofazimine|mesh-list
20090928|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090929|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
20090930|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090931|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090932|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
20090933|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090934|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
20090935|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090936|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
20090937|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090938|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
20090939|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090940|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
20090941|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090942|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
20090943|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090944|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
20090945|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090946|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
19494324|NCT03111433|Ubiquinone|ubiquinone|mesh-list
19494325|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
19494326|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494327|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
19494328|NCT03111433|Vitamins|vitamins|mesh-ancestor
19494329|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19494330|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19494331|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494332|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494333|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19494334|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
19494335|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19494336|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494337|NCT03111446|Anesthetics|anesthetics|mesh-list
19494338|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494339|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494340|NCT03111186|Acetaminophen|acetaminophen|mesh-list
19494341|NCT03111186|Ibuprofen|ibuprofen|mesh-list
19494342|NCT03111186|Oxycodone|oxycodone|mesh-list
19494343|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19494344|NCT03111186|Analgesics|analgesics|mesh-ancestor
19494345|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
19494346|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494347|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494348|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
19494349|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19494350|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494351|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494352|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19494353|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494354|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494355|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19494356|NCT03111186|Narcotics|narcotics|mesh-ancestor
19494357|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494358|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
19494359|NCT03111121|Neostigmine|neostigmine|mesh-list
19494360|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19494361|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494362|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494363|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
19494364|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20090947|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494365|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090948|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
20090949|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090950|NCT00002062|Spiramycin|spiramycin|mesh-list
19494366|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19494367|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
19494368|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494369|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19494370|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19494371|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19494372|NCT03110952|Vaccines|vaccines|mesh-list
19494373|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
19494374|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494375|NCT03111069|Doxorubicin|doxorubicin|mesh-list
19494376|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19494377|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19494378|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494379|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19494380|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19494381|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494382|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494383|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19746727|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19746728|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19746729|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
19746730|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746731|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746732|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19746733|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19746734|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19746735|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746736|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746737|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19746738|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19746739|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19746740|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
19746741|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746742|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746743|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19746744|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19746745|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
19746746|NCT01310010|Dasatinib|dasatinib|mesh-list
19746747|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746748|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19746749|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746750|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746751|NCT00719888|Cyclosporine|cyclosporine|mesh-list
19746752|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
19746753|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
19746754|NCT00719888|Thiotepa|thiotepa|mesh-list
19746755|NCT00719888|Fludarabine|fludarabine|mesh-list
19746756|NCT00719888|Cyclosporins|cyclosporins|mesh-list
19746757|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746758|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
19746759|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090951|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090952|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090953|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
20090954|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090955|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090956|NCT00002063|Zidovudine|zidovudine|mesh-list
20090957|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
20090958|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090959|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20090960|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20090961|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090962|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
20090963|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20090964|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20090965|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19494384|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19746760|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746761|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19746762|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
19494385|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
19494386|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494387|NCT03110757|Antacids|antacids|mesh-ancestor
19494388|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090966|NCT00002064|Clindamycin|clindamycin|mesh-list
20090967|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
19494389|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494390|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
19494391|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19494392|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19494393|NCT03110848|Prednisolone|prednisolone|mesh-list
19494394|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
19494395|NCT03110848|Atorvastatin|atorvastatin|mesh-list
19494396|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19494397|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
19494398|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
19494399|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19494400|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19494401|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
19494402|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494403|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19494404|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19494405|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494406|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494407|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
19494408|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
19494409|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494410|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494411|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494412|NCT03110848|Hormones|hormones|mesh-ancestor
19494413|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19494414|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19494415|NCT03110848|Protective Agents|protective agents|mesh-ancestor
19494416|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19494417|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494418|NCT03110653|Remifentanil|remifentanil|mesh-list
19494419|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19494420|NCT03110653|Narcotics|narcotics|mesh-ancestor
19494421|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494422|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494423|NCT03110653|Analgesics|analgesics|mesh-ancestor
19494424|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
19494425|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494426|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
19494427|NCT03110640|Fludarabine|fludarabine|mesh-list
19494428|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19494429|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
19494430|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494431|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494432|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19494433|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
19494434|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494435|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494436|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19494437|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
19494438|NCT03110341|Hematinics|hematinics|mesh-ancestor
19494439|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
19494440|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19494441|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
19494442|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494443|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
19494444|NCT03110679|Protective Agents|protective agents|mesh-ancestor
19494445|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
19494446|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19494447|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494448|NCT03110510|Leucovorin|leucovorin|mesh-list
19494449|NCT03110510|Fluorouracil|fluorouracil|mesh-list
19494450|NCT03110510|Irinotecan|irinotecan|mesh-list
19494451|NCT03110510|Calcium|calcium|mesh-list
19494452|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
19494453|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19494454|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494455|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
19494456|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494457|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19494458|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494459|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19494460|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
19494461|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19494462|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19494463|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494464|NCT03110510|Antidotes|antidotes|mesh-ancestor
19494465|NCT03110510|Protective Agents|protective agents|mesh-ancestor
19494466|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
19494467|NCT03110510|Vitamins|vitamins|mesh-ancestor
19494468|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
19494469|NCT03110484|Pemetrexed|pemetrexed|mesh-list
19494470|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19494471|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494472|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494473|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494474|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19494475|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19494476|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19494477|NCT03110094|Adalimumab|adalimumab|mesh-list
19494478|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494479|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494480|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
19494481|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19494482|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
19494483|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494484|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494485|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
19494486|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
19494487|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494488|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19494489|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19494490|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19494491|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494492|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494493|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494494|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494495|NCT03110172|Analgesics|analgesics|mesh-ancestor
19494496|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
19494497|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494498|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
19494499|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19494500|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
19494501|NCT03109886|Maleic acid|maleic acid|mesh-list
19494502|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494503|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494504|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
19494505|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19494506|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19494507|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19494508|NCT03110198|Mesalamine|mesalamine|mesh-list
19494509|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20090968|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
19494510|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19494511|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19494512|NCT03110198|Analgesics|analgesics|mesh-ancestor
19494513|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
19494514|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494515|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494516|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494517|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19494518|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19494519|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
19494520|NCT03109977|Pertuzumab|pertuzumab|mesh-list
19494521|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19494522|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494523|NCT03110055|Grazoprevir|grazoprevir|mesh-list
19494524|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
19494525|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494526|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
19494527|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19494528|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494529|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494530|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19494531|NCT03109990|Analgesics|analgesics|mesh-ancestor
19494532|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
19494533|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494534|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19494535|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19494536|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19494537|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494538|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569827|NCT04088188|Gemcitabine|gemcitabine|mesh-list
19494539|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494540|NCT03109847|Metformin|metformin|mesh-list
19494541|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19494542|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494543|NCT03109691|Dexamethasone|dexamethasone|mesh-list
20090969|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
20090970|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20090971|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746763|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746764|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746765|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19494544|NCT03109691|Bupivacaine|bupivacaine|mesh-list
19494545|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494546|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
19494547|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
19494548|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494549|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494550|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494551|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
19494552|NCT03109691|Hormones|hormones|mesh-ancestor
19494553|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746766|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746767|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
19746768|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746769|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746770|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19746771|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19746772|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19746773|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
19746774|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746775|NCT00503035|Celecoxib|celecoxib|mesh-list
19746776|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19746777|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746778|NCT00503035|Analgesics|analgesics|mesh-ancestor
19746779|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
19746780|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746781|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746782|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746783|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19746784|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19746785|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19494554|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19494555|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494556|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
19494557|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
19494558|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494559|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
19494560|NCT03109730|Tenofovir|tenofovir|mesh-list
19494561|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19494562|NCT03109730|Entecavir|entecavir|mesh-list
19494563|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
19494564|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494565|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19494566|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19494567|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494568|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494569|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19494570|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19746786|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746787|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746788|NCT00378482|Tremelimumab|tremelimumab|mesh-list
19746789|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494571|NCT03109756|Gaboxadol|gaboxadol|mesh-list
19494572|NCT03109756|Analgesics|analgesics|mesh-ancestor
19494573|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
19494574|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494575|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494576|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
19494577|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
19494578|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
19494579|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494580|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494581|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19494582|NCT03109795|Clonidine|clonidine|mesh-list
19746790|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
19746791|NCT00303849|Carboplatin|carboplatin|mesh-list
19494583|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19494584|NCT03109795|Diuretics|diuretics|mesh-ancestor
19494585|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
19494586|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494587|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19494588|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494589|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494590|NCT03109795|Analgesics|analgesics|mesh-ancestor
19494591|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
19494592|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494593|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
19494594|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
19494595|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19494596|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19494597|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19494598|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494599|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746792|NCT00303849|Etoposide|etoposide|mesh-list
19746793|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
19746794|NCT00303849|Melphalan|melphalan|mesh-list
19569828|NCT04088188|Cisplatin|cisplatin|mesh-list
19569829|NCT04088188|Ivosidenib|ivosidenib|mesh-list
19569830|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569831|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19569832|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
19569833|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569834|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
19569835|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569836|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569837|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19569838|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
19569839|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569840|NCT04075513|Insulin|insulin|mesh-list
19746795|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
19746796|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
19746797|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19746798|NCT00303849|Mannitol|mannitol|mesh-list
19746799|NCT00303849|Antidotes|antidotes|mesh-list
19746800|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746801|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19746802|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746803|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19746804|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746805|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746806|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19746807|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
20090972|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19569841|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19569842|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
19569843|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
19569844|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19569845|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569846|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
19569847|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19569848|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19569849|NCT04074187|Prednisolone|prednisolone|mesh-list
19569850|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
19569851|NCT04074187|Rituximab|rituximab|mesh-list
19569852|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19569853|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
19569854|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19569855|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569856|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569857|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
19569858|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569859|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569860|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569861|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
19569862|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
19569863|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569864|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19569865|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
19746808|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19569866|NCT04074187|Hormones|hormones|mesh-ancestor
19569867|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746809|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19494600|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
19494601|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494602|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494603|NCT03109600|Vaccines|vaccines|mesh-list
19494604|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19494605|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
20090973|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090974|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090975|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
20090976|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20090977|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20090978|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20090979|NCT00002065|Disulfiram|disulfiram|mesh-list
20090980|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20090981|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20090982|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20090983|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20090984|NCT00002066|Thymopentin|thymopentin|mesh-list
20090985|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20090986|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
20090987|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090988|NCT00002067|Megestrol|megestrol|mesh-list
20090989|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
20090990|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20090991|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20090992|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20090993|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
20090994|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20090995|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20090996|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20090997|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20090998|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20090999|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091000|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
20091001|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20091002|NCT00002068|Fluconazole|fluconazole|mesh-list
20091003|NCT00002068|Amphotericin B|amphotericin b|mesh-list
19494606|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494607|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
19494608|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19494609|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19494610|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494611|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
19494612|NCT03109652|Coagulants|coagulants|mesh-ancestor
19494613|NCT03109392|Lidocaine|lidocaine|mesh-list
19494614|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19494615|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
19494616|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494617|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494618|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
19494619|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494620|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19494621|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19494622|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19494623|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494624|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494625|NCT03109379|Trospium chloride|trospium chloride|mesh-list
19494626|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
19494627|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
19494628|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494629|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494630|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19494631|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19494632|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
19494633|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494634|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494635|NCT03109379|Urological Agents|urological agents|mesh-ancestor
19494636|NCT03109080|Olaparib|olaparib|mesh-list
19494637|NCT03109080|Adenosine|adenosine|mesh-list
19494638|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19494639|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569868|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20091004|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20602405|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494640|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494641|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494642|NCT03109080|Analgesics|analgesics|mesh-ancestor
19494643|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
19494644|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494645|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494646|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19494647|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
19494648|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19494649|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
19494650|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
19494651|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494652|NCT03109158|Cetuximab|cetuximab|mesh-list
19494653|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19494654|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494655|NCT03109119|Propofol|propofol|mesh-list
19494656|NCT03109119|Sevoflurane|sevoflurane|mesh-list
19494657|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19494658|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494659|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494660|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19494661|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
19494662|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
19494663|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19494664|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19494665|NCT03109314|Donepezil|donepezil|mesh-list
19494666|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19494667|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494668|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494669|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
19494670|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494671|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494672|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
19494673|NCT03108846|Citalopram|citalopram|mesh-list
19494674|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19494675|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19494676|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494677|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494678|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494679|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
19494680|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494681|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19494682|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
19494683|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19494684|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
19494685|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19494686|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494687|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494688|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746810|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
19746811|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746812|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20091005|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
19494689|NCT03108937|Analgesics|analgesics|mesh-ancestor
19494690|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
19494691|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494692|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19494693|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19494694|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19494695|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494696|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494697|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494698|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19494699|NCT03108833|Saruplase|saruplase|mesh-list
19494700|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19494701|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19494702|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494703|NCT03108963|Metformin|metformin|mesh-list
19494704|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19494705|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091006|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746813|NCT00303849|Diuretics|diuretics|mesh-ancestor
20091007|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20602406|NCT02215538|Methylphenidate|methylphenidate|mesh-list
20091008|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19494706|NCT03108989|Neostigmine|neostigmine|mesh-list
19494707|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19494708|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494709|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494710|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
19494711|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494712|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602407|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20602408|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602409|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20602410|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20602411|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602412|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091009|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091010|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091011|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091012|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091013|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091014|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091015|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20091016|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20091017|NCT00002068|Amebicides|amebicides|mesh-ancestor
20091018|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20091019|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20091020|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091021|NCT00002069|Ditiocarb|ditiocarb|mesh-list
20091022|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091023|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
20091024|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091025|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
20091026|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091027|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
19494713|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19494714|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
19494715|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494716|NCT03108872|Anticoagulants|anticoagulants|mesh-list
20091028|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
20091029|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091030|NCT00002070|Ganciclovir|ganciclovir|mesh-list
20091031|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20091032|NCT00002070|Sargramostim|sargramostim|mesh-list
20091033|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
20091034|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091035|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
20091036|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091037|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091038|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091039|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091040|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
20091041|NCT00002071|Hematinics|hematinics|mesh-ancestor
20091042|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
20091043|NCT00002072|Hematinics|hematinics|mesh-ancestor
20091044|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
19494717|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19494718|NCT03108690|Meropenem|meropenem|mesh-list
19494719|NCT03108690|Tazobactam|tazobactam|mesh-list
19494720|NCT03108690|Piperacillin|piperacillin|mesh-list
19494721|NCT03108690|Ampicillin|ampicillin|mesh-list
19494722|NCT03108690|Cefuroxime|cefuroxime|mesh-list
19494723|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19494724|NCT03108690|Lactams|lactams|mesh-list
19494725|NCT03108690|beta-Lactams|beta-lactams|mesh-list
19494726|NCT03108690|Penicillin G|penicillin g|mesh-list
19494727|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
19494728|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19494729|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494730|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
19494731|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19494732|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494733|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494734|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
20091045|NCT00002073|Hematinics|hematinics|mesh-ancestor
20091046|NCT00002074|Fluconazole|fluconazole|mesh-list
19494735|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19494736|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19494737|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494738|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
19494739|NCT03108807|Coagulants|coagulants|mesh-ancestor
19494740|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19494741|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
19494742|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19494743|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19494744|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494745|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091047|NCT00002074|Amphotericin B|amphotericin b|mesh-list
20091048|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20091049|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
20091050|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091051|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20091052|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19494746|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20091053|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091054|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746814|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
19746815|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
19746816|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746817|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
19746818|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
19494747|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19494748|NCT03108313|Fluorides|fluorides|mesh-list
20091055|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091056|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091057|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091058|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091059|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20091060|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20091061|NCT00002074|Amebicides|amebicides|mesh-ancestor
20091062|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20091063|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20091064|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091065|NCT00002075|Fluconazole|fluconazole|mesh-list
20091066|NCT00002075|Amphotericin B|amphotericin b|mesh-list
20091067|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20091068|NCT00002075|Flucytosine|flucytosine|mesh-list
20602413|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
19494749|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
19494750|NCT03108313|Protective Agents|protective agents|mesh-ancestor
19494751|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494752|NCT03108625|Vortioxetine|vortioxetine|mesh-list
19494753|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
19494754|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19494755|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19494756|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19494757|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746819|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
19746820|NCT00303849|Protective Agents|protective agents|mesh-ancestor
19746821|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
19746822|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
19746823|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19494758|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494759|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19494760|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19494761|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19494762|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494763|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494764|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
19494765|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19494766|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19494767|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19494768|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19494769|NCT03108300|Doxorubicin|doxorubicin|mesh-list
19494770|NCT03108300|Propranolol|propranolol|mesh-list
19494771|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19494772|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494773|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19746824|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746825|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
20091069|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
20602414|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602415|NCT02215720|Sirolimus|sirolimus|mesh-list
19494774|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19494775|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494776|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494777|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19494778|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19494779|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494780|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494781|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494782|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19494783|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19494784|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
19494785|NCT03108326|Infliximab|infliximab|mesh-list
19494786|NCT03108326|Ustekinumab|ustekinumab|mesh-list
19494787|NCT03108326|Vedolizumab|vedolizumab|mesh-list
19494788|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494789|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
19494790|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494791|NCT03108365|Hemostatics|hemostatics|mesh-list
19494792|NCT03108365|Chitosan|chitosan|mesh-list
19494793|NCT03108365|Coagulants|coagulants|mesh-ancestor
19494794|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19494795|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19494796|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
19494797|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494798|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19494799|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
19494800|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
19494801|NCT03108248|Doxorubicin|doxorubicin|mesh-list
19494802|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
19494803|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19494804|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19494805|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494806|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19494807|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19494808|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494809|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494810|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
19494811|NCT03108248|Coagulants|coagulants|mesh-ancestor
19494812|NCT03108287|Amoxicillin|amoxicillin|mesh-list
19494813|NCT03108287|Clarithromycin|clarithromycin|mesh-list
19494814|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19746826|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
19746827|NCT00161044|Galantamine|galantamine|mesh-list
19746828|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19746829|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746830|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746831|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
19746832|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19746833|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746834|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19746835|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
19746836|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746837|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
19746838|NCT03833323|Treprostinil|treprostinil|mesh-list
19746839|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19746840|NCT03829579|Esketamine|esketamine|mesh-list
19746841|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
19746842|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19746843|NCT03828162|Anticoagulants|anticoagulants|mesh-list
19749289|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749290|NCT05187182|Antidotes|antidotes|mesh-ancestor
19749291|NCT05187182|Protective Agents|protective agents|mesh-ancestor
19749292|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749293|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
19749294|NCT05187182|Vitamins|vitamins|mesh-ancestor
19749295|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
19749296|NCT05185999|Icodextrin|icodextrin|mesh-list
19749297|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
19749298|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19749299|NCT05181735|Luspatercept|luspatercept|mesh-list
19749300|NCT05181735|Hematinics|hematinics|mesh-ancestor
19494815|NCT03108287|Rabeprazole|rabeprazole|mesh-list
19749301|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19494816|NCT03108287|Bismuth|bismuth|mesh-list
19494817|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19494818|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749302|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
19749303|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749304|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19746844|NCT03819413|Antibodies|antibodies|mesh-list
19746845|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
19746846|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
19746847|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494819|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19494820|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494821|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494822|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19494823|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19746848|NCT03819452|Vitamin D|vitamin d|mesh-list
19746849|NCT03819452|Vitamins|vitamins|mesh-ancestor
19746850|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
19746851|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746852|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19746853|NCT03815422|Anesthetics|anesthetics|mesh-list
19746854|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746855|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494824|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19494825|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494826|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19494827|NCT03108287|Antacids|antacids|mesh-ancestor
19494828|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
19494829|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19494830|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494831|NCT03108274|Fexofenadine|fexofenadine|mesh-list
19494832|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
19494833|NCT03108274|Midazolam|midazolam|mesh-list
19494834|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19494835|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19494836|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494837|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746856|NCT03811366|Prednisone|prednisone|mesh-list
19746857|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19746858|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
19746859|NCT03811366|Hormones|hormones|mesh-ancestor
19746860|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746861|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746862|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19746863|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746864|NCT03806543|Vancomycin|vancomycin|mesh-list
19746865|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746866|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746867|NCT03804099|Aflibercept|aflibercept|mesh-list
19746868|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19494838|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20602416|NCT02215720|Cetuximab|cetuximab|mesh-list
19749305|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
20602417|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602418|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602419|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602420|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602421|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602422|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
20602423|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602424|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
20602425|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602426|NCT02215733|Telmisartan|telmisartan|mesh-list
20602427|NCT02215733|Diuretics|diuretics|mesh-list
20602428|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20602429|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602430|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20602431|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20602432|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602433|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
20602434|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602435|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20602436|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
20602437|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602438|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20602439|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20602440|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19494839|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19494840|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19494841|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19494842|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
19494843|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
19494844|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
19494845|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
19494846|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494847|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494848|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19494849|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494850|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19494851|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
19494852|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19494853|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746869|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19746870|NCT03804099|Growth Substances|growth substances|mesh-ancestor
19746871|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746872|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746873|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749306|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749307|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749308|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19749309|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19749310|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19749311|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
19749312|NCT05144529|Nivolumab|nivolumab|mesh-list
19749313|NCT05144529|Ipilimumab|ipilimumab|mesh-list
19749314|NCT05144529|Evolocumab|evolocumab|mesh-list
19749315|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749316|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749317|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19749318|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749319|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19749320|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19494854|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494855|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19494856|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19494857|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19494858|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
19494859|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
19494860|NCT03107858|Dopamine|dopamine|mesh-list
20091070|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091071|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20091072|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091073|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494861|NCT03107858|Norepinephrine|norepinephrine|mesh-list
19494862|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19494863|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19494864|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494865|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494866|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494867|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494868|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
19494869|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
19494870|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494871|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19494872|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19494873|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
19494874|NCT03107858|Protective Agents|protective agents|mesh-ancestor
19569869|NCT04074187|Protective Agents|protective agents|mesh-ancestor
19569870|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19569871|NCT04017546|Venetoclax|venetoclax|mesh-list
19569872|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569873|NCT04007991|Ecopipam|ecopipam|mesh-list
19569874|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19569875|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19569876|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569877|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749321|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
19749322|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19749323|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
19569878|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19569879|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19569880|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
19746874|NCT03797547|Aflibercept|aflibercept|mesh-list
19746875|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19746876|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19746877|NCT03797547|Growth Substances|growth substances|mesh-ancestor
19746878|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746879|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746880|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746881|NCT03793400|Bevacizumab|bevacizumab|mesh-list
19746882|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746883|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746884|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19746885|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19746886|NCT03793400|Growth Substances|growth substances|mesh-ancestor
19746887|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746888|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
19746889|NCT03792334|Anesthetics|anesthetics|mesh-list
19746890|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746891|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746892|NCT03789968|Tenofovir|tenofovir|mesh-list
19746893|NCT03789968|Emtricitabine|emtricitabine|mesh-list
19746894|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19746895|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
20091074|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091075|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091076|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091077|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091078|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091079|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20091080|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20091081|NCT00002075|Amebicides|amebicides|mesh-ancestor
20091082|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20091083|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20091084|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091085|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
20091086|NCT00002076|Fluconazole|fluconazole|mesh-list
20091087|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
20602441|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602442|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602443|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602444|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091088|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091089|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19494875|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
19494876|NCT03107962|Antibodies|antibodies|mesh-list
19494877|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
19494878|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
19494879|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091090|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091091|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091092|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091093|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20602445|NCT02215798|Analgesics|analgesics|mesh-ancestor
19494880|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19494881|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19494882|NCT03107884|Metformin|metformin|mesh-list
19494883|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19494884|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494885|NCT03107923|Dobutamine|dobutamine|mesh-list
19494886|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19494887|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
19494888|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
19494889|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494890|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494891|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19494892|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19494893|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19494894|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494895|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494896|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494897|NCT03107923|Protective Agents|protective agents|mesh-ancestor
19494898|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19494899|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19746896|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494900|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19494901|NCT03107702|Melatonin|melatonin|mesh-list
19494902|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
19494903|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494904|NCT03107702|Protective Agents|protective agents|mesh-ancestor
19494905|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494906|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494907|NCT03107481|Acetaminophen|acetaminophen|mesh-list
20091094|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091095|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091096|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091097|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20091098|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19494908|NCT03107481|Hydromorphone|hydromorphone|mesh-list
19494909|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19494910|NCT03107481|Analgesics|analgesics|mesh-ancestor
19494911|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
19494912|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746897|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19746898|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19746899|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746900|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746901|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19746902|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19749324|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19749325|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19749326|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19749327|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19749328|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749329|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
19749330|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749331|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749332|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19749333|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749334|NCT05137067|Cisplatin|cisplatin|mesh-list
19749335|NCT05137067|Docetaxel|docetaxel|mesh-list
19494913|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494914|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
20091099|NCT00002077|Fluconazole|fluconazole|mesh-list
20091100|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
20091101|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091102|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19494915|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19749336|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
19749337|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749338|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
19749339|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
19749340|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749341|NCT05136677|Carboplatin|carboplatin|mesh-list
19494916|NCT03107481|Narcotics|narcotics|mesh-ancestor
19494917|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494918|NCT03107429|Acetazolamide|acetazolamide|mesh-list
19494919|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
19494920|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19494921|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19494922|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494923|NCT03107429|Diuretics|diuretics|mesh-ancestor
19494924|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
19494925|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494926|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19494927|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19494928|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494929|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
19494930|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19494931|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494932|NCT03107247|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
19494933|NCT03107247|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19494934|NCT03107247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494935|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19494936|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19494937|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19494938|NCT03107338|Analgesics|analgesics|mesh-ancestor
19749342|NCT05136677|Nivolumab|nivolumab|mesh-list
19494939|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
19494940|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494941|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494942|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494943|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20091103|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091104|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091105|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091106|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091107|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
19746903|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19746904|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19746905|NCT03767712|Antibodies|antibodies|mesh-list
19746906|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
19746907|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
19746908|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746909|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
19746910|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
19746911|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746912|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
19746913|NCT03760562|Hormones|hormones|mesh-ancestor
19746914|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19746915|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749343|NCT05136677|Pemetrexed|pemetrexed|mesh-list
19749344|NCT05136677|Ipilimumab|ipilimumab|mesh-list
19749345|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749346|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19494944|NCT03107507|Levetiracetam|levetiracetam|mesh-list
19494945|NCT03107507|Phenobarbital|phenobarbital|mesh-list
19494946|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
19494947|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
19749347|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19749348|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749349|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749350|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19749351|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19749352|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
19749353|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749354|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749355|NCT05119855|Vaccines|vaccines|mesh-list
19749356|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
19494948|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19494949|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19494950|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494951|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19494952|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19494953|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494954|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494955|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
19494956|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
19494957|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19494958|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19494959|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19494960|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
19749357|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749358|NCT05112952|Lazertinib|lazertinib|mesh-list
19749359|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749360|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749361|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749362|NCT05096169|Citric Acid|citric acid|mesh-list
19494961|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
20091108|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091109|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091110|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20091111|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19749363|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
20091112|NCT00002078|Interferons|interferons|mesh-list
20091113|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
20091114|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091115|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
20091116|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494962|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19494963|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
19749364|NCT05096169|Clomiphene|clomiphene|mesh-list
19494964|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
19494965|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602446|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
20602447|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602448|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
20602449|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20602450|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
19494966|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494967|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19494968|NCT03107078|Hormones|hormones|mesh-ancestor
19494969|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602451|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20602452|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
19494970|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20602453|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602454|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
20602455|NCT02215876|Doxorubicin|doxorubicin|mesh-list
20602456|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602457|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
20602458|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602459|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494971|NCT03107078|Protective Agents|protective agents|mesh-ancestor
19494972|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
19494973|NCT03106948|Penicillamine|penicillamine|mesh-list
19494974|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
19494975|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494976|NCT03106948|Protective Agents|protective agents|mesh-ancestor
19494977|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494978|NCT03106948|Vitamins|vitamins|mesh-ancestor
19494979|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
19494980|NCT03106948|Antidotes|antidotes|mesh-ancestor
19494981|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
19494982|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
19494983|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19494984|NCT03107169|Vancomycin|vancomycin|mesh-list
19494985|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19494986|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19494987|NCT03106831|Norepinephrine|norepinephrine|mesh-list
19494988|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19494989|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19494990|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
19494991|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19494992|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19494993|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19494994|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
19494995|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
19494996|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19494997|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19494998|NCT03106740|Minocycline|minocycline|mesh-list
19494999|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19495000|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495001|NCT03106597|Amlodipine|amlodipine|mesh-list
19495002|NCT03106597|Manidipine|manidipine|mesh-list
19495003|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19495004|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19495005|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495006|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495007|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19495008|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495009|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
19495010|NCT03106818|Ketorolac|ketorolac|mesh-list
19495011|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
19495012|NCT03106818|Bupivacaine|bupivacaine|mesh-list
19495013|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
19495014|NCT03106818|Anesthetics|anesthetics|mesh-list
19495015|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495016|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495017|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
19495018|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495019|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746916|NCT03751397|Cystatins|cystatins|mesh-list
20602460|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19495020|NCT03106818|Analgesics|analgesics|mesh-ancestor
19495021|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19495022|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19495023|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749365|NCT05096169|Enclomiphene|enclomiphene|mesh-list
19746917|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19746918|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
19746919|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746920|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746921|NCT03748095|Tazobactam|tazobactam|mesh-list
19746922|NCT03748095|Piperacillin|piperacillin|mesh-list
19746923|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746924|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746925|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19746926|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746927|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746928|NCT03744546|Tilavonemab|tilavonemab|mesh-list
19746929|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
19746930|NCT03738683|Tazobactam|tazobactam|mesh-list
19746931|NCT03738683|Piperacillin|piperacillin|mesh-list
19746932|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19746933|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746934|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746935|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19746936|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19746937|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749366|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
19749367|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
19749368|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20602461|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
20607879|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19749369|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
19749370|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
19749371|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749372|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19495024|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19495025|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495026|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495027|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19495028|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
19495029|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19495030|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495031|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19495032|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
19749373|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
19749374|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749375|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749376|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19749377|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
19749378|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19749379|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19749380|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19749381|NCT05085054|Osimertinib|osimertinib|mesh-list
19749382|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749383|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749384|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091117|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
19495033|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19495034|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
19495035|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19495036|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
19495037|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495038|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19495039|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19495040|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
19495041|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495042|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495043|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19495044|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
19495045|NCT03106623|Mirabegron|mirabegron|mesh-list
19495046|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19495047|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19495048|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
19495049|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495050|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495051|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495052|NCT03106623|Urological Agents|urological agents|mesh-ancestor
19495053|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19495054|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19495055|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19495056|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
19495057|NCT03106610|Nivolumab|nivolumab|mesh-list
19495058|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495059|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495060|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19495061|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495062|NCT03106571|Methamphetamine|methamphetamine|mesh-list
19495063|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19495064|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495065|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
19495066|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
19495067|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495068|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
19495069|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495070|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495071|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
19495072|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19495073|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19495074|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495075|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19495076|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19495077|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19495078|NCT03106545|Bupivacaine|bupivacaine|mesh-list
19495079|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495080|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
19495081|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495082|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495083|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
19495084|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495085|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
19495086|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19746938|NCT03738553|Trastuzumab|trastuzumab|mesh-list
19746939|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19746940|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19746941|NCT05142319|Vaccines|vaccines|mesh-list
19746942|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
19746943|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495087|NCT03106454|Norethindrone|norethindrone|mesh-list
19495088|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
19495089|NCT03106454|Estradiol|estradiol|mesh-list
19495090|NCT03106454|Estrogens|estrogens|mesh-ancestor
19746944|NCT05142085|Mineral Oil|mineral oil|mesh-list
19746945|NCT05142085|Emollients|emollients|mesh-ancestor
19746946|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
19746947|NCT05141968|Vitamin D|vitamin d|mesh-list
19746948|NCT05141968|Vitamins|vitamins|mesh-ancestor
19746949|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
19746950|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746951|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19746952|NCT05141877|Anesthetics|anesthetics|mesh-list
19746953|NCT05141877|Propofol|propofol|mesh-list
19495091|NCT03106454|Hormones|hormones|mesh-ancestor
19495092|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19495093|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495094|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19495095|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
19495096|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19495097|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19495098|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19495099|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19495100|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19495101|NCT03106454|Trace Elements|trace elements|mesh-ancestor
19495102|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
19495103|NCT03106363|Ethanol|ethanol|mesh-list
19495104|NCT03106363|Dronabinol|dronabinol|mesh-list
19495105|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19495106|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495107|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495108|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495109|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
19495110|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19495111|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746954|NCT05141877|Sevoflurane|sevoflurane|mesh-list
19746955|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746956|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495112|NCT03106363|Analgesics|analgesics|mesh-ancestor
19495113|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
19495114|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495115|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19495116|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19495117|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495118|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495119|NCT03106363|Hormones|hormones|mesh-ancestor
19495120|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19495121|NCT03106519|Bupivacaine|bupivacaine|mesh-list
19495122|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495123|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
19495124|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495125|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495126|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
19495127|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495128|NCT03106389|Misoprostol|misoprostol|mesh-list
19495129|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19495130|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
19495131|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19495132|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495133|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19495134|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19495135|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
19495136|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19495137|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19495138|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495139|NCT03106402|Bromfenac|bromfenac|mesh-list
19495140|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19495141|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19495142|NCT03106402|Analgesics|analgesics|mesh-ancestor
19495143|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
19495144|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495145|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746957|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19746958|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19746959|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
19746960|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19746961|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19746962|NCT05141864|Lidocaine|lidocaine|mesh-list
19746963|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
19746964|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
19746965|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19746966|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746967|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
19746968|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746969|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19746970|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19746971|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19746972|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602462|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602463|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602464|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20602465|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602466|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20602467|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20602468|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602469|NCT02215993|Ticagrelor|ticagrelor|mesh-list
20602470|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20607880|NCT02243826|Analgesics|analgesics|mesh-ancestor
19495146|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19495147|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569881|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569882|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569883|NCT04003818|Teicoplanin|teicoplanin|mesh-list
19569884|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19569885|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569886|NCT03958799|Vaccines|vaccines|mesh-list
19569887|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
19569888|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569889|NCT03951142|Losartan|losartan|mesh-list
19569890|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19569891|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20091118|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091119|NCT00002079|Miglustat|miglustat|mesh-list
20091120|NCT00002079|Zidovudine|zidovudine|mesh-list
20091121|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
20091122|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569892|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19569893|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19569894|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569895|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
19569896|NCT03945591|Bortezomib|bortezomib|mesh-list
19569897|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19569898|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
19746973|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091123|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091124|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091125|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091126|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
20091127|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091128|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091129|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091130|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20091131|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20091132|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091133|NCT00002080|Rifabutin|rifabutin|mesh-list
20091134|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19749385|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749386|NCT05083169|Dexamethasone|dexamethasone|mesh-list
20091135|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091136|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19569899|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569900|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569901|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19569902|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
19569903|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569904|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569905|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19569906|NCT03943875|Vaccines|vaccines|mesh-list
19569907|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
19569908|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569909|NCT03930446|Ethanol|ethanol|mesh-list
19569910|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19569911|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19569912|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19569913|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569914|NCT03916601|Insulin|insulin|mesh-list
19569915|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19569916|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
20091137|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
20091138|NCT00002081|Zidovudine|zidovudine|mesh-list
20091139|NCT00002081|Zalcitabine|zalcitabine|mesh-list
20091140|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
20091141|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091142|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091143|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091144|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091145|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
20091146|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091147|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091148|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19569917|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
19569918|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20091149|NCT00002082|Azithromycin|azithromycin|mesh-list
19495148|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19495149|NCT03106298|Hematinics|hematinics|mesh-ancestor
19495150|NCT03106324|Lenalidomide|lenalidomide|mesh-list
19495151|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
20602471|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19495152|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495153|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19495154|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19495155|NCT03106324|Growth Substances|growth substances|mesh-ancestor
19495156|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
19495157|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495158|NCT03105830|Acetaminophen|acetaminophen|mesh-list
19495159|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19495160|NCT03105830|Analgesics|analgesics|mesh-ancestor
19495161|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
19495162|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495163|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495164|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
19495165|NCT03105986|Probenecid|probenecid|mesh-list
19495166|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
19495167|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
19495168|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19495169|NCT03105986|Renal Agents|renal agents|mesh-ancestor
19495170|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
19495171|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19495172|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495173|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
19495174|NCT03105661|Atenolol|atenolol|mesh-list
19495175|NCT03105661|Labetalol|labetalol|mesh-list
19746974|NCT05141474|Aldesleukin|aldesleukin|mesh-list
19746975|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
19746976|NCT05141474|Fludarabine|fludarabine|mesh-list
19746977|NCT05141474|Interleukin-2|interleukin-2|mesh-list
19746978|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19746979|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
19746980|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746981|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20091150|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091151|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091152|NCT00002084|Valacyclovir|valacyclovir|mesh-list
20091153|NCT00002084|Acyclovir|acyclovir|mesh-list
20091154|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
20091155|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091156|NCT00002085|Azithromycin|azithromycin|mesh-list
20091157|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091158|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091159|NCT00002086|Interferons|interferons|mesh-list
20091160|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
20091161|NCT00002086|Zidovudine|zidovudine|mesh-list
20091162|NCT00002086|Zalcitabine|zalcitabine|mesh-list
20091163|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091164|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
20091165|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091166|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
20091167|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091168|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
20091169|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091170|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091171|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091172|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091173|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091174|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091175|NCT00002089|Azithromycin|azithromycin|mesh-list
20091176|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091177|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091178|NCT00002090|Azithromycin|azithromycin|mesh-list
20091179|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091180|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091181|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
19495176|NCT03105661|Nifedipine|nifedipine|mesh-list
19495177|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19495178|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495179|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495180|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19495181|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19746982|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20091182|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20091183|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495182|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
19495183|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
19495184|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19495185|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19495186|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19495187|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
19495188|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
19495189|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495190|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19495191|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19495192|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19495193|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
19495194|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495195|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
19495196|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19495197|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19495198|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
19495199|NCT03105791|Narcotics|narcotics|mesh-ancestor
19495200|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495201|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495202|NCT03105791|Analgesics|analgesics|mesh-ancestor
19495203|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
19495204|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495205|NCT03105674|Anesthetics|anesthetics|mesh-list
19495206|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
19495207|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495208|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495209|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
19495210|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495211|NCT03105765|Ketamine|ketamine|mesh-list
19495212|NCT03105765|Analgesics|analgesics|mesh-ancestor
19495213|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
19495214|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495215|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495216|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20091184|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091185|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20091186|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20091187|NCT00002091|Protective Agents|protective agents|mesh-ancestor
20091188|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091189|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
20091190|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20091191|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
20091192|NCT00002092|Cimetidine|cimetidine|mesh-list
20091193|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20091194|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20091195|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20091196|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
20091197|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
20091198|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20091199|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495217|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19495218|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
19495219|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
19495220|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495221|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19495222|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19495223|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495224|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495225|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
19495226|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19495227|NCT03105505|Permethrin|permethrin|mesh-list
19495228|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19495229|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495230|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495231|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19746983|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
19746984|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19746985|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091200|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091201|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20602472|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19495232|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746986|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19746987|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19746988|NCT05141474|Analgesics|analgesics|mesh-ancestor
19746989|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
19746990|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19746991|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19746992|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19746993|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
19746994|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746995|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19746996|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
19746997|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19746998|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19746999|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747000|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747001|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747002|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19747003|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19747004|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
19495233|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19495234|NCT03105193|Lidocaine|lidocaine|mesh-list
19495235|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495236|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
19495237|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495238|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495239|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
19495240|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495241|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19495242|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19495243|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19495244|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495245|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495246|NCT03105310|Interferons|interferons|mesh-list
19495247|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
19495248|NCT03105310|Ezetimibe|ezetimibe|mesh-list
19495249|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495250|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
19495251|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495252|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
19495253|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495254|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20091202|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091203|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495255|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19495256|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
19495257|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495258|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19495259|NCT03105583|Vitamins|vitamins|mesh-list
19495260|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
19495261|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495262|NCT03105180|Mannitol|mannitol|mesh-list
19495263|NCT03105180|Sorbitol|sorbitol|mesh-list
19495264|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19495265|NCT03105180|Diuretics|diuretics|mesh-ancestor
19495266|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
19495267|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495268|NCT03105180|Cathartics|cathartics|mesh-ancestor
19495269|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19495270|NCT03105115|Fentanyl|fentanyl|mesh-list
19495271|NCT03105115|Bupivacaine|bupivacaine|mesh-list
19495272|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495273|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
19495274|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495275|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495276|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
19495277|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495278|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19495279|NCT03105115|Narcotics|narcotics|mesh-ancestor
19495280|NCT03105115|Analgesics|analgesics|mesh-ancestor
19495281|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19495282|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19495283|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
20091204|NCT00002093|Doxorubicin|doxorubicin|mesh-list
19495284|NCT03105349|Ribavirin|ribavirin|mesh-list
19495285|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
19495286|NCT03105349|Grazoprevir|grazoprevir|mesh-list
19495287|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
19747005|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495288|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495289|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
19495290|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495291|NCT03105245|Thiopental|thiopental|mesh-list
19495292|NCT03105245|Anesthetics|anesthetics|mesh-list
19495293|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495294|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495295|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
19495296|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19495297|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19495298|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
19747006|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
19747007|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747008|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747009|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
20091205|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19495299|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
19495300|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
19495301|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495302|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091206|NCT00002093|Daunorubicin|daunorubicin|mesh-list
20091207|NCT00002093|Bleomycin|bleomycin|mesh-list
20091208|NCT00002093|Vincristine|vincristine|mesh-list
20091209|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20091210|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091211|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20091212|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20091213|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091214|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091215|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20091216|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
20091217|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
20091218|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
20091219|NCT00002094|Atevirdine|atevirdine|mesh-list
20091220|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091221|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091222|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091223|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091224|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
20091225|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091226|NCT00002095|Ganciclovir|ganciclovir|mesh-list
20091227|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20091228|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
20091229|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495314|NCT03105375|Omeprazole|omeprazole|mesh-list
19495315|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19495316|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19495317|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19495318|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495319|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495320|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19495321|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20091230|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091231|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091232|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120281|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120282|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120283|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120284|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
20120285|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495322|NCT03105466|Tacrolimus|tacrolimus|mesh-list
19495323|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747010|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120286|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20120287|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20120288|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120289|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
20120290|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120291|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
20120292|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20602473|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19495324|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
19495325|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120293|NCT00006340|Ganciclovir|ganciclovir|mesh-list
20091233|NCT00002096|Zidovudine|zidovudine|mesh-list
20091234|NCT00002096|Didanosine|didanosine|mesh-list
20091235|NCT00002096|Ganciclovir|ganciclovir|mesh-list
20091236|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20091237|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
20091238|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091239|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091240|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091241|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091242|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
20091243|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091244|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091245|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091246|NCT00002097|Nystatin|nystatin|mesh-list
20091247|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091248|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091249|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
20091250|NCT00002097|Ionophores|ionophores|mesh-ancestor
19495326|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19495327|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495328|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495329|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19495330|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19495331|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19495332|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495333|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
20091251|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20091252|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091253|NCT00002098|Didanosine|didanosine|mesh-list
20091254|NCT00002098|Lentinan|lentinan|mesh-list
20091255|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
19495334|NCT03105466|Hormones|hormones|mesh-ancestor
19495335|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19495339|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
19495340|NCT05378061|Growth Substances|growth substances|mesh-ancestor
19495341|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495342|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
19495343|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495344|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495345|NCT05377905|Doxorubicin|doxorubicin|mesh-list
19495346|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19495347|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19495348|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495349|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19747011|NCT05114460|Naloxone|naloxone|mesh-list
19747012|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19747013|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747014|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
19747015|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747016|NCT05089175|Aspirin|aspirin|mesh-list
19747017|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19747018|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747019|NCT05089175|Analgesics|analgesics|mesh-ancestor
20091256|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091257|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091258|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747020|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
20091259|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091260|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
19495350|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19495351|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495352|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569919|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19569920|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747021|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747022|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747023|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747024|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747025|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19747026|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19747027|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569921|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19569922|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19569923|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569924|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19569925|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569926|NCT03903016|Insulin|insulin|mesh-list
19569927|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19569928|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
19569929|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19569930|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569931|NCT03892642|Avelumab|avelumab|mesh-list
19569932|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569933|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569934|NCT03891355|Dexamethasone|dexamethasone|mesh-list
20091261|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091262|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091263|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19747028|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19747029|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19747030|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091264|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091265|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
20091266|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091267|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091268|NCT00002099|Didanosine|didanosine|mesh-list
20091269|NCT00002099|Lentinan|lentinan|mesh-list
20091270|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
20091271|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091272|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19569935|NCT03891355|Lenalidomide|lenalidomide|mesh-list
19569936|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19569937|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
19569938|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
19569939|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569940|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569941|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20091273|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747031|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
19747032|NCT05066997|Dexamethasone|dexamethasone|mesh-list
19747033|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
19747034|NCT05066997|BB 1101|bb 1101|mesh-list
19747035|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747036|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
19747037|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
19747038|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20091274|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091275|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
20091276|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091277|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091278|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091279|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19495353|NCT05377619|Buspirone|buspirone|mesh-list
19495354|NCT05377619|Prucalopride|prucalopride|mesh-list
19495355|NCT05377619|Laxatives|laxatives|mesh-ancestor
19495356|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19495357|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19495358|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19495359|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
19495360|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495361|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495362|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495363|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20091280|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
20091281|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091282|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495364|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19495365|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495366|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19495367|NCT05377606|Temazepam|temazepam|mesh-list
19495368|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19495369|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495370|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495371|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19495372|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19495373|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19495374|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
19747039|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747040|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747041|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
19747042|NCT05066997|Hormones|hormones|mesh-ancestor
20091283|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
20091284|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
20091285|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20091286|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20091287|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091288|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
20091289|NCT00002101|Clarithromycin|clarithromycin|mesh-list
20091290|NCT00002101|Ethambutol|ethambutol|mesh-list
20091291|NCT00002101|Rifabutin|rifabutin|mesh-list
20091292|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091293|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091294|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20091295|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091296|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091297|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20091298|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091299|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
20091300|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20091301|NCT00002102|Leucovorin|leucovorin|mesh-list
20091302|NCT00002102|Trimetrexate|trimetrexate|mesh-list
20091303|NCT00002102|Calcium|calcium|mesh-list
20091304|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
20091305|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20091306|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091307|NCT00002102|Antidotes|antidotes|mesh-ancestor
19747043|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747044|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747045|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495375|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
20091308|NCT00002102|Protective Agents|protective agents|mesh-ancestor
20091309|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
20091310|NCT00002102|Vitamins|vitamins|mesh-ancestor
20091311|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
20091312|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
20091313|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495376|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495377|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495378|NCT05377424|Istradefylline|istradefylline|mesh-list
19495379|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
19495380|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19747046|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
19747047|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747048|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747049|NCT05064449|Itraconazole|itraconazole|mesh-list
19747050|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
19747051|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
19747052|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747053|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19747054|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19747055|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747056|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747057|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19747058|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
19747059|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747060|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747061|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19747062|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19747063|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747064|NCT05064449|Analgesics|analgesics|mesh-ancestor
19747065|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
19749387|NCT05083169|Bortezomib|bortezomib|mesh-list
20091314|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20091315|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
20091316|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495381|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19495382|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
19495383|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495384|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495385|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495386|NCT05377333|Dulaglutide|dulaglutide|mesh-list
19495387|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19495388|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495389|NCT05377255|Naloxone|naloxone|mesh-list
19495390|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19495391|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495392|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
19495393|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495394|NCT05377242|Curcumin|curcumin|mesh-list
19495395|NCT05377242|Resveratrol|resveratrol|mesh-list
19495396|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19495397|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19495398|NCT05377242|Analgesics|analgesics|mesh-ancestor
19495399|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
19495400|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495401|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495402|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19495403|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19495404|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495405|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495406|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495407|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
19495408|NCT05377242|Protective Agents|protective agents|mesh-ancestor
19495409|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19495410|NCT05377034|Bevacizumab|bevacizumab|mesh-list
19495411|NCT05377034|Atezolizumab|atezolizumab|mesh-list
19495412|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495413|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495414|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19495415|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19495416|NCT05377034|Growth Substances|growth substances|mesh-ancestor
19495417|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495418|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
19495419|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
19495420|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495421|NCT05376904|Ropivacaine|ropivacaine|mesh-list
19495422|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
19747066|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747067|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747068|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747069|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19747070|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19747071|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747072|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747073|NCT05046639|Lidocaine|lidocaine|mesh-list
19747074|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
19747075|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
19747076|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495423|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
19495424|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495425|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495426|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
19495427|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495428|NCT05376878|Copper|copper|mesh-list
19495429|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19495430|NCT05376878|Trastuzumab|trastuzumab|mesh-list
19747077|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747078|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
19747079|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747080|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19747081|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19747082|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19747083|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19747084|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747085|NCT05045066|Vitamin D|vitamin d|mesh-list
19747086|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
19747087|NCT05045066|Vitamins|vitamins|mesh-ancestor
19747088|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
19747089|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091317|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495431|NCT05376878|Camptothecin|camptothecin|mesh-list
19495432|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19495433|NCT05376878|Antibodies|antibodies|mesh-list
19495434|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
19495435|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19495436|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
19495437|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
19495438|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091318|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20091319|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091320|NCT00002103|Leucovorin|leucovorin|mesh-list
20091321|NCT00002103|Trimetrexate|trimetrexate|mesh-list
20091322|NCT00002103|Calcium|calcium|mesh-list
20091323|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
20091324|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20091325|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091326|NCT00002103|Antidotes|antidotes|mesh-ancestor
20602474|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19495439|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495440|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495441|NCT05376878|Trace Elements|trace elements|mesh-ancestor
19495442|NCT05376878|Micronutrients|micronutrients|mesh-ancestor
19495443|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19495444|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19495445|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19495446|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495447|NCT05376865|Vitamin D|vitamin d|mesh-list
19495448|NCT05376865|Vitamins|vitamins|mesh-ancestor
19495449|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
19495450|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495451|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20091327|NCT00002103|Protective Agents|protective agents|mesh-ancestor
20091328|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
20091329|NCT00002103|Vitamins|vitamins|mesh-ancestor
20091330|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
20091331|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
20091332|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091333|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20091334|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
19747090|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20091335|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602475|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
19495452|NCT05376852|Decitabine|decitabine|mesh-list
20091336|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495453|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19495454|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
19747091|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19747092|NCT05033639|Melatonin|melatonin|mesh-list
19747093|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
19747094|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747095|NCT05033639|Protective Agents|protective agents|mesh-ancestor
19747096|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747097|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747098|NCT04970355|Erenumab|erenumab|mesh-list
19747099|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19747100|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747101|NCT04970355|Analgesics|analgesics|mesh-ancestor
19747102|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
19747103|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747104|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747105|NCT04963283|Nivolumab|nivolumab|mesh-list
19747106|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747107|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747108|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19747109|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747110|NCT04912921|Palmidrol|palmidrol|mesh-list
19747111|NCT04912921|Analgesics|analgesics|mesh-ancestor
19747112|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
19747113|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747114|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747115|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19747116|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747117|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747118|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19495455|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495456|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495457|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495458|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
19495459|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19495460|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495461|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495462|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19495463|NCT05376761|Analgesics|analgesics|mesh-ancestor
19495464|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
19495465|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495466|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19495467|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19747119|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
19747120|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747121|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19747122|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19747123|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747124|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747125|NCT04912921|Hormones|hormones|mesh-ancestor
19747126|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747127|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
19747128|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19747129|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747130|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19747131|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747132|NCT04870138|Azithromycin|azithromycin|mesh-list
19747133|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
19747134|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
19747135|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19747136|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747137|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19747138|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19747139|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747140|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747141|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747142|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19747143|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19747144|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
19747145|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19749388|NCT05083169|Daratumumab|daratumumab|mesh-list
19747146|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747147|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19747148|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749389|NCT05083169|Pomalidomide|pomalidomide|mesh-list
19749390|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749391|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
19495468|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19495469|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
19495470|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495471|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495472|NCT05376722|Prednisone|prednisone|mesh-list
19495473|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19495474|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
19495475|NCT05376722|Hormones|hormones|mesh-ancestor
19495476|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19495477|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495478|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19495479|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495480|NCT05376670|Gentamicins|gentamicins|mesh-list
19495481|NCT05376670|Tobramycin|tobramycin|mesh-list
19495482|NCT05376670|Amikacin|amikacin|mesh-list
19495483|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19495484|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495485|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19495486|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495487|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091337|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20091338|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091339|NCT00002104|Thalidomide|thalidomide|mesh-list
19495488|NCT05376579|Siponimod|siponimod|mesh-list
19495489|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19495490|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495491|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19495492|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
19495493|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495494|NCT05376553|Docetaxel|docetaxel|mesh-list
19495495|NCT05376553|Cemiplimab|cemiplimab|mesh-list
19495496|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495497|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
19495498|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
19495499|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
19495500|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495501|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495502|NCT05376319|Rituximab|rituximab|mesh-list
19495503|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
19495504|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495505|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495506|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
19495507|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749392|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
19749393|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749394|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749395|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19749396|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
19749397|NCT05083169|Hormones|hormones|mesh-ancestor
19749398|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749399|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749400|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749401|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
19749402|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749403|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749404|NCT05083169|Growth Substances|growth substances|mesh-ancestor
19749405|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749406|NCT05082688|Vaccines|vaccines|mesh-list
19749407|NCT05082688|Immunologic Factors|immunologic factors|mesh-ancestor
19749408|NCT05082688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749409|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
19749410|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749411|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091340|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19495508|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19569942|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
19569943|NCT03891355|Hormones|hormones|mesh-ancestor
19749412|NCT05071664|Golimumab|golimumab|mesh-list
19749413|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20091341|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
20091342|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091343|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
20091344|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091345|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091346|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20091347|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20091348|NCT00002104|Growth Substances|growth substances|mesh-ancestor
20091349|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
20091350|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091351|NCT00002105|Doxorubicin|doxorubicin|mesh-list
20091352|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20091353|NCT00002105|Bleomycin|bleomycin|mesh-list
20091354|NCT00002105|Vincristine|vincristine|mesh-list
20091355|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20091356|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091357|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20091358|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20091359|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091360|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091361|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20091362|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
19495509|NCT05376228|Vancomycin|vancomycin|mesh-list
19495510|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19495511|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495512|NCT05376202|Cetuximab|cetuximab|mesh-list
19495513|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495514|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495515|NCT05376189|Vitamin D|vitamin d|mesh-list
19495516|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
19495517|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
19495518|NCT05376189|Vitamins|vitamins|mesh-list
19495519|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
19495520|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091363|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
20091364|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
20091365|NCT00002106|Ranitidine|ranitidine|mesh-list
20091366|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20091367|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20091368|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20091369|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20091370|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
20091371|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
20091372|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20091373|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091374|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495521|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19495522|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19495523|NCT05375994|Adagrasib|adagrasib|mesh-list
19495524|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495525|NCT05375942|Infliximab|infliximab|mesh-list
19495526|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
19495527|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19495528|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19495529|NCT05375929|Abrocitinib|abrocitinib|mesh-list
19495530|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19495531|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495532|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495533|NCT05375916|Hydromorphone|hydromorphone|mesh-list
19495534|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19495535|NCT05375916|Narcotics|narcotics|mesh-ancestor
19495536|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495537|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495538|NCT05375916|Analgesics|analgesics|mesh-ancestor
20091375|NCT00002107|Aldesleukin|aldesleukin|mesh-list
19495539|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
19495540|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495541|NCT05375786|Vaccines|vaccines|mesh-list
20091376|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091377|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19495542|NCT05375786|Immunologic Factors|immunologic factors|mesh-ancestor
19495543|NCT05375786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495544|NCT05375747|Propofol|propofol|mesh-list
19495545|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19495546|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495547|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091378|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091379|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
20091380|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091381|NCT00002108|Lamivudine|lamivudine|mesh-list
20091382|NCT00002108|Zidovudine|zidovudine|mesh-list
20091383|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091384|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091385|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495548|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19495549|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
19495550|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
19495551|NCT05375630|Vitamin K|vitamin k|mesh-list
19495552|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
19747149|NCT04729296|Golimumab|golimumab|mesh-list
19747150|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19747151|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747152|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747153|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
19747154|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747155|NCT04686786|PF-06372865|pf-06372865|mesh-list
19747156|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
19747157|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
19747158|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747159|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747160|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747161|NCT04649060|Dexamethasone|dexamethasone|mesh-list
19747162|NCT04649060|Melphalan|melphalan|mesh-list
19747163|NCT04649060|Daratumumab|daratumumab|mesh-list
19747164|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747165|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
19747166|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
19747167|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747168|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495553|NCT05375630|Vitamins|vitamins|mesh-ancestor
20091386|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091387|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
20091388|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091389|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091390|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091391|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
19495554|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
19495555|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495556|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19495557|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19747169|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747170|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
19747171|NCT04649060|Hormones|hormones|mesh-ancestor
19747172|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747173|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747174|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747175|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747176|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
19749414|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602476|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602477|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602478|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602479|NCT02216045|Ribavirin|ribavirin|mesh-list
20602480|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20602481|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
20602482|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
20602483|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495558|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495559|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
19495560|NCT05375630|Coagulants|coagulants|mesh-ancestor
19495561|NCT05375305|Morphine|morphine|mesh-list
19495562|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19495563|NCT05375305|Narcotics|narcotics|mesh-ancestor
19495564|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495565|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091392|NCT00002109|Zidovudine|zidovudine|mesh-list
20091393|NCT00002109|Stavudine|stavudine|mesh-list
19495566|NCT05375305|Analgesics|analgesics|mesh-ancestor
20602484|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
19747177|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747178|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19747179|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747180|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
19495567|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
19495568|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495569|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
19495570|NCT05375240|Propranolol|propranolol|mesh-list
19495571|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19495572|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19495573|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19495574|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495575|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495576|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495577|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19495578|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19495579|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
19495580|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19495581|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495582|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
19495583|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19495584|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495585|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495586|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20091394|NCT00002109|Didanosine|didanosine|mesh-list
20091395|NCT00002109|Zalcitabine|zalcitabine|mesh-list
20091396|NCT00002109|Thymopentin|thymopentin|mesh-list
20091397|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
20091398|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091399|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091400|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091401|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091402|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
20091403|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091404|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091405|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091406|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091407|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
20091408|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091409|NCT00002110|Zidovudine|zidovudine|mesh-list
20091410|NCT00002110|Cysteamine|cysteamine|mesh-list
20091411|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
20091412|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091413|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091414|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091415|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495587|NCT05375188|Analgesics|analgesics|mesh-ancestor
19495588|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
19495589|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20091416|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
20091417|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091418|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091419|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091420|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
20091421|NCT00002111|Saquinavir|saquinavir|mesh-list
20602485|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602486|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
20602487|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602488|NCT02216058|Sirolimus|sirolimus|mesh-list
20602489|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602490|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091422|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091423|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091424|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
20091425|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091426|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091427|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091428|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091429|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
20091430|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091431|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20091432|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091433|NCT00002112|Fluconazole|fluconazole|mesh-list
20091434|NCT00002112|Nystatin|nystatin|mesh-list
20091435|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
20091436|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091437|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20091438|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091439|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091440|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747181|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
19747182|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19747183|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19747184|NCT04628338|Interferons|interferons|mesh-list
19747185|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
20091441|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091442|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091443|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19495590|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19495591|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19495592|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19495593|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
19495594|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495595|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495596|NCT05374954|Vaccines|vaccines|mesh-list
19495597|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
19495598|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091444|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091445|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20091446|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20091447|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19569944|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569945|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19569946|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569947|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
19747186|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747187|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
19747188|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747189|NCT04566328|Dexamethasone|dexamethasone|mesh-list
19747190|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
19747191|NCT04566328|Lenalidomide|lenalidomide|mesh-list
19747192|NCT04566328|Bortezomib|bortezomib|mesh-list
19747193|NCT04566328|Daratumumab|daratumumab|mesh-list
19747194|NCT04566328|Ichthammol|ichthammol|mesh-list
19747195|NCT04566328|BB 1101|bb 1101|mesh-list
19747196|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19747197|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747198|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
19747199|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
19747200|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747201|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747202|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747203|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
19747204|NCT04566328|Hormones|hormones|mesh-ancestor
19747205|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747206|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20091448|NCT00002112|Ionophores|ionophores|mesh-ancestor
19569948|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19569949|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19569950|NCT03891355|Growth Substances|growth substances|mesh-ancestor
19569951|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
19569952|NCT03861702|Irinotecan|irinotecan|mesh-list
19569953|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19569954|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19569955|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569956|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569957|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091449|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20091450|NCT00002113|Fluconazole|fluconazole|mesh-list
19569958|NCT03822507|Cinacalcet|cinacalcet|mesh-list
19569959|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19569960|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569961|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20091451|NCT00002113|Flucytosine|flucytosine|mesh-list
20091452|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
20091453|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091454|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19747207|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747208|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
19569962|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
19747209|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495599|NCT05374603|Durvalumab|durvalumab|mesh-list
19495600|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495601|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495602|NCT05374564|Flutemetamol|flutemetamol|mesh-list
19495603|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19495604|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495605|NCT05374525|Cabotegravir|cabotegravir|mesh-list
19495606|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19495607|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19495608|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495609|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747210|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747211|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
19747212|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19747213|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19747214|NCT04566328|Growth Substances|growth substances|mesh-ancestor
19747215|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
19747216|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747217|NCT04558190|Ubiquinone|ubiquinone|mesh-list
19747218|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19747219|NCT04558190|Albuterol|albuterol|mesh-list
19747220|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19747221|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
19747222|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747223|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747224|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19747225|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
19747226|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
19747227|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19747228|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19747229|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19747230|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19747231|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
19495610|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19495611|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19495612|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
19495613|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495614|NCT05374499|Epinephrine|epinephrine|mesh-list
19495615|NCT05374499|Bupivacaine|bupivacaine|mesh-list
19495616|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495617|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
19495618|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495619|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747232|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747233|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747234|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19747235|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19747236|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19747237|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
19747238|NCT04551365|Chitosan|chitosan|mesh-list
19747239|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19747240|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19747241|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
19747242|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747243|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19495620|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
19495621|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747244|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
20091455|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19747245|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
19747246|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
19747247|NCT04551365|Coagulants|coagulants|mesh-ancestor
19747248|NCT04535089|Lidocaine|lidocaine|mesh-list
20091456|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091457|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091458|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091459|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091460|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091461|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091462|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19495622|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19747249|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
19495623|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19495624|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
19747250|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
20091463|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20091464|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
20091465|NCT00002115|Adefovir|adefovir|mesh-list
20091466|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
19495625|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495626|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495627|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19495628|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19495629|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
20091467|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091468|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091469|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091470|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091471|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091472|NCT00002116|Cidofovir|cidofovir|mesh-list
20091473|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
19495630|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19747251|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
19747252|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747253|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747254|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
19747255|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747256|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19747257|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19747258|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19747259|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19747260|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747261|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19747262|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747263|NCT04535089|Analgesics|analgesics|mesh-ancestor
19747264|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19747265|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19495631|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
19495632|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
19495633|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
19495634|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19495635|NCT05374356|Morphine|morphine|mesh-list
19495636|NCT05374356|Bupivacaine|bupivacaine|mesh-list
19495637|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495638|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
19495639|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495640|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495641|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
19495642|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495643|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19495644|NCT05374356|Narcotics|narcotics|mesh-ancestor
19495645|NCT05374356|Analgesics|analgesics|mesh-ancestor
19495646|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
19495647|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19495648|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495649|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19495650|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495651|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19495652|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495653|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747266|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19747267|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
19747268|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747269|NCT04462471|Vemurafenib|vemurafenib|mesh-list
19747270|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747271|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19747272|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747273|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747274|NCT04444869|Cisplatin|cisplatin|mesh-list
19747275|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747276|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
19747277|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19747278|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19495654|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
19495655|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19495656|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495657|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
19495658|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19495659|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495660|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
19495661|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19495662|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495663|NCT05372991|Atropine|atropine|mesh-list
19495664|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19495665|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19495666|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19495667|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
19495668|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495669|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495670|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19747279|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
19747280|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495671|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
19495672|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
19747281|NCT04392505|Durvalumab|durvalumab|mesh-list
19747282|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747283|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747284|NCT04329325|Dexamethasone|dexamethasone|mesh-list
19747285|NCT04329325|Methotrexate|methotrexate|mesh-list
19747286|NCT04329325|Dasatinib|dasatinib|mesh-list
19747287|NCT04329325|Blinatumomab|blinatumomab|mesh-list
19747288|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602491|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602492|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602493|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
19747289|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
20091474|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091475|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091476|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091477|NCT00002117|Zidovudine|zidovudine|mesh-list
20091478|NCT00002117|Zalcitabine|zalcitabine|mesh-list
19747290|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
19747291|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747292|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747293|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747294|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
19747295|NCT04329325|Hormones|hormones|mesh-ancestor
19747296|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747297|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747298|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747299|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19747300|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
19747301|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19495673|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
19495674|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19495675|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19495676|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
19495677|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495678|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495679|NCT05371600|Midazolam|midazolam|mesh-list
19495680|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19747302|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747303|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
19747304|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747305|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747306|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091479|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
20091480|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091481|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091482|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091483|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091484|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
20091485|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091486|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19747307|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19747308|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747309|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
19747310|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747311|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747312|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19495681|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19495682|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747313|NCT04308694|Methadone|methadone|mesh-list
19747314|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19747315|NCT04308694|Narcotics|narcotics|mesh-ancestor
19747316|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747317|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747318|NCT04308694|Analgesics|analgesics|mesh-ancestor
19747319|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
19747320|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747321|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
19747322|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
19747323|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19747324|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
19747325|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19747326|NCT04223765|Fludarabine|fludarabine|mesh-list
19747327|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747328|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
19747329|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747330|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747331|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747332|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
19747333|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747334|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747335|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19747336|NCT04216524|Cytarabine|cytarabine|mesh-list
19747337|NCT04216524|Dexamethasone|dexamethasone|mesh-list
19747338|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
20091487|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091488|NCT00002118|Zalcitabine|zalcitabine|mesh-list
20091489|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
19747339|NCT04216524|Prednisone|prednisone|mesh-list
19747340|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
19747341|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19747342|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19747343|NCT04216524|Prednisolone|prednisolone|mesh-list
19747344|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
19747345|NCT04216524|Cortisone|cortisone|mesh-list
19747346|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
19747347|NCT04216524|Rituximab|rituximab|mesh-list
19747348|NCT04216524|Doxorubicin|doxorubicin|mesh-list
19747349|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19747350|NCT04216524|Methotrexate|methotrexate|mesh-list
19747351|NCT04216524|Vincristine|vincristine|mesh-list
19495683|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091490|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091491|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091492|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091493|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091494|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
20091495|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091496|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091497|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091498|NCT00002120|Leucovorin|leucovorin|mesh-list
20091499|NCT00002120|Trimethoprim|trimethoprim|mesh-list
20602494|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19495684|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19495685|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19747352|NCT04216524|Daunorubicin|daunorubicin|mesh-list
19747353|NCT04216524|Venetoclax|venetoclax|mesh-list
19747354|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
19747355|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19747356|NCT04216524|Antibodies|antibodies|mesh-list
19747357|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
19747358|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19747359|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19747360|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
19747361|NCT04216524|BB 1101|bb 1101|mesh-list
19747362|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19495686|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19495687|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19495688|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
19495689|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
19495690|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
19495691|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
19495692|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577834|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
19747363|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
19747364|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747365|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747366|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747367|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
19749415|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20091500|NCT00002120|Dapsone|dapsone|mesh-list
19747368|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747369|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747370|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19747371|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747372|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
19747373|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
19747374|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747375|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747376|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
19747377|NCT04216524|Hormones|hormones|mesh-ancestor
19747378|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747379|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19495693|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495694|NCT05369676|Ritonavir|ritonavir|mesh-list
19495695|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19495696|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19495697|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
19495698|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747380|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
19747381|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747382|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19747383|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19747384|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19747385|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19747386|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
19747387|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19747388|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747389|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
19747390|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747391|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19747392|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747393|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
19747394|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747395|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19747396|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
19747397|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
19747398|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
19747399|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19747400|NCT04216524|Protective Agents|protective agents|mesh-ancestor
19747401|NCT04187196|Propofol|propofol|mesh-list
19747402|NCT04187196|Methohexital|methohexital|mesh-list
19747403|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19747404|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747405|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747406|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19747407|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
19747408|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
19747409|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
19747410|NCT04109885|Promethazine|promethazine|mesh-list
19747411|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
19747412|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19747413|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19747414|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747415|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747416|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
19747417|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
19747418|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
19747419|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20091501|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
20091502|NCT00002120|Trimetrexate|trimetrexate|mesh-list
20091503|NCT00002120|Calcium|calcium|mesh-list
20091504|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
20091505|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20091506|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091507|NCT00002120|Antidotes|antidotes|mesh-ancestor
20091508|NCT00002120|Protective Agents|protective agents|mesh-ancestor
20091509|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
20091510|NCT00002120|Vitamins|vitamins|mesh-ancestor
19495699|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495700|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19495701|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19495702|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
19495703|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747420|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
20091511|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
20091512|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19495704|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19495705|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19495706|NCT05368012|Dexamethasone|dexamethasone|mesh-list
19495707|NCT05368012|Bupivacaine|bupivacaine|mesh-list
19495708|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19495709|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
19495710|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
19495711|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495712|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495713|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19495714|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
19495715|NCT05368012|Hormones|hormones|mesh-ancestor
19495716|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19495717|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19495718|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495719|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495720|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
19495721|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747421|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
19747422|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747423|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19747424|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
19747425|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
19747426|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747427|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747428|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19495722|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
19747429|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
19747430|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747431|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19747432|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19747433|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19747434|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19747435|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
19747436|NCT04089553|Durvalumab|durvalumab|mesh-list
19747437|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602495|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
20602496|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602497|NCT02216149|Capecitabine|capecitabine|mesh-list
20602498|NCT02216149|Tegafur|tegafur|mesh-list
20602499|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
20602500|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20602501|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
19747438|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747439|NCT04078737|Aspirin|aspirin|mesh-list
19747440|NCT04078737|Clopidogrel|clopidogrel|mesh-list
19747441|NCT04078737|Ticagrelor|ticagrelor|mesh-list
19747442|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19747443|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747444|NCT04078737|Analgesics|analgesics|mesh-ancestor
19747445|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
19747446|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747447|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747448|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747449|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747450|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19747451|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19747452|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747453|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19747454|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19747455|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747456|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
19747457|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19747458|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19747459|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19747460|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
19747461|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747462|NCT04058197|Deferoxamine|deferoxamine|mesh-list
19747463|NCT04058197|Siderophores|siderophores|mesh-ancestor
19747464|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19747465|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
20602502|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602503|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747466|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
19747467|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747468|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19747469|NCT03999411|Nicotine|nicotine|mesh-list
19747470|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
19747471|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747472|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19495731|NCT05363631|Selenium|selenium|mesh-list
19495732|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
19495733|NCT05363631|Axitinib|axitinib|mesh-list
19495734|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495735|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495736|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19495737|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495738|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495739|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
19495740|NCT05363631|Protective Agents|protective agents|mesh-ancestor
19495741|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495742|NCT05363631|Trace Elements|trace elements|mesh-ancestor
19495743|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
19495744|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19495745|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
19495746|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495747|NCT05361330|Fluoxetine|fluoxetine|mesh-list
19495748|NCT05361330|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19495749|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19495750|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495751|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747473|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
19747474|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747475|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495752|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495753|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
20602504|NCT02216227|Iodine|iodine|mesh-list
19495754|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747476|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19747477|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19747478|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
19747479|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747480|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747481|NCT03958981|Castor Oil|castor oil|mesh-list
19747482|NCT03958981|Cathartics|cathartics|mesh-ancestor
19747483|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747484|NCT03937635|Dexamethasone|dexamethasone|mesh-list
19747485|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
19747486|NCT03937635|Lenalidomide|lenalidomide|mesh-list
19747487|NCT03937635|Daratumumab|daratumumab|mesh-list
19747488|NCT03937635|Ichthammol|ichthammol|mesh-list
19747489|NCT03937635|BB 1101|bb 1101|mesh-list
19747490|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747491|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
19747492|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
19747493|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747494|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747495|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747496|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
19747497|NCT03937635|Hormones|hormones|mesh-ancestor
19747498|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747499|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747500|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747501|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
19747502|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19747503|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19747504|NCT03937635|Growth Substances|growth substances|mesh-ancestor
19747505|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
19747506|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
19747507|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747508|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747509|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747510|NCT03892369|Ethanol|ethanol|mesh-list
20602505|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
20602506|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20602507|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
20602508|NCT02216227|Vancomycin|vancomycin|mesh-list
20602509|NCT02216227|Cefazolin|cefazolin|mesh-list
20602510|NCT02216227|Mupirocin|mupirocin|mesh-list
20602511|NCT02216227|Povidone|povidone|mesh-list
20602512|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20602513|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747511|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19747512|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747513|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747514|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747515|NCT03878589|Oxytocin|oxytocin|mesh-list
19747516|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
19747517|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19747518|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749416|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
19495755|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19495756|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
19495757|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19495758|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19495759|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19495760|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495761|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
19495762|NCT05353439|Topotecan|topotecan|mesh-list
19495763|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495764|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495765|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19495766|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19495767|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495768|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569963|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19569964|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19749417|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749418|NCT05069831|Abrocitinib|abrocitinib|mesh-list
19749419|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749420|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749421|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749422|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
19749423|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749424|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749428|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
19749429|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602514|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
20602515|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
19569965|NCT03802487|Charcoal|charcoal|mesh-list
19569966|NCT03802487|Antidotes|antidotes|mesh-ancestor
19569967|NCT03802487|Protective Agents|protective agents|mesh-ancestor
19569968|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569969|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19569970|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569971|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19569972|NCT03800836|Paclitaxel|paclitaxel|mesh-list
19569973|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19569974|NCT03800836|Atezolizumab|atezolizumab|mesh-list
19569975|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19569976|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19569977|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
19569978|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
19569979|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
19569980|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569981|NCT03798080|Insulin|insulin|mesh-list
19569982|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19569983|NCT03798080|Metformin|metformin|mesh-list
19569984|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
19569985|NCT03798080|Lixisenatide|lixisenatide|mesh-list
19569986|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19495769|NCT05350917|Maleic acid|maleic acid|mesh-list
19495770|NCT05350917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495771|NCT05350917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495772|NCT05338866|Capecitabine|capecitabine|mesh-list
19495773|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19495774|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
19495775|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495776|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495777|NCT05337137|Bevacizumab|bevacizumab|mesh-list
19495778|NCT05337137|Nivolumab|nivolumab|mesh-list
19495779|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495780|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495781|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19495782|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19495783|NCT05337137|Growth Substances|growth substances|mesh-ancestor
19495784|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495785|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
19495786|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19495787|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747519|NCT03803605|Vorinostat|vorinostat|mesh-list
19747520|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747521|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19747522|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747523|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747524|NCT03774394|Clopidogrel|clopidogrel|mesh-list
19747525|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19747526|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19747527|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19747528|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19747529|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
19747530|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747531|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747532|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747533|NCT03770728|Metformin|metformin|mesh-list
19747534|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
19747535|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19747536|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747537|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19747538|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
19747539|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747540|NCT03737110|Rilonacept|rilonacept|mesh-list
19747541|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747542|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
19747543|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19747544|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747545|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
19747546|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747547|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747548|NCT03524235|Rituximab|rituximab|mesh-list
19747549|NCT03524235|Fludarabine|fludarabine|mesh-list
19747550|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19747551|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495788|NCT05335109|Xenon|xenon|mesh-list
19495789|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19495790|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
19495791|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
19495792|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495793|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495794|NCT05331807|Vitamin D|vitamin d|mesh-list
19495795|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
19495796|NCT05331807|Vitamins|vitamins|mesh-list
19495797|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
19495798|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495799|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19495800|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19495801|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19495802|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495803|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495804|NCT05318105|Diuretics|diuretics|mesh-list
19495805|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19495806|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
19747552|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747553|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
19495807|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747554|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747555|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747556|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747557|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20091513|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19495808|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495809|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091514|NCT00002120|Renal Agents|renal agents|mesh-ancestor
20091515|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
20091516|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20091517|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20091518|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19495815|NCT05317416|Lenalidomide|lenalidomide|mesh-list
19495816|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
19495817|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495818|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19495819|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19495820|NCT05317416|Growth Substances|growth substances|mesh-ancestor
19495821|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
19495822|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495823|NCT05315947|Brivaracetam|brivaracetam|mesh-list
19495824|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
19495825|NCT05314127|Fluorouracil|fluorouracil|mesh-list
19495826|NCT05314127|Imiquimod|imiquimod|mesh-list
19495827|NCT05314127|Tazarotene|tazarotene|mesh-list
19495828|NCT05314127|Petrolatum|petrolatum|mesh-list
19495829|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
19495830|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495831|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20091519|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091520|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091521|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20091522|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20091523|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091524|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
20091525|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091526|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
20091527|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20091528|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
20091529|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091530|NCT00002122|Azithromycin|azithromycin|mesh-list
20091531|NCT00002122|Rifabutin|rifabutin|mesh-list
20091532|NCT00002122|Fluconazole|fluconazole|mesh-list
20091533|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091534|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091535|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
20091536|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20091537|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091538|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091539|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091540|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091541|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091542|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091543|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495832|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495833|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19495834|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
19495835|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495836|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19495837|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
19495838|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
19495839|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
19495840|NCT05314127|Emollients|emollients|mesh-ancestor
19495841|NCT05312255|Propranolol|propranolol|mesh-list
19495842|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20602516|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602517|NCT02216227|Trace Elements|trace elements|mesh-ancestor
19495843|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
20091544|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20602518|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
20602519|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602520|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
19495844|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
19495845|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19569987|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495846|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495847|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495848|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19747558|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
19747559|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
19747560|NCT03514901|Nivolumab|nivolumab|mesh-list
19747561|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747562|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747563|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19747564|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747565|NCT03471624|Tenofovir|tenofovir|mesh-list
19747566|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
19747567|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747568|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19747569|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747570|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747571|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747572|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19495849|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19495850|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
19495851|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
19747573|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19747574|NCT03462966|Rifaximin|rifaximin|mesh-list
19747575|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19747576|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747577|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747578|NCT03462251|Paclitaxel|paclitaxel|mesh-list
19747579|NCT03462251|Bevacizumab|bevacizumab|mesh-list
19747580|NCT03462251|Capecitabine|capecitabine|mesh-list
19747581|NCT03462251|Fulvestrant|fulvestrant|mesh-list
19747582|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19747583|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19747584|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495852|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495853|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495874|NCT05302804|Menthol|menthol|mesh-list
19495875|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
19495876|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747585|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19747586|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19747587|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19747588|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747589|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747590|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19747591|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19747592|NCT03462251|Growth Substances|growth substances|mesh-ancestor
19747593|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747594|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
19747595|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747596|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
19747597|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747598|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19747599|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19747600|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
19747601|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747602|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19747603|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747604|NCT03369197|Anesthetics|anesthetics|mesh-list
19747605|NCT03369197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747606|NCT03369197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747607|NCT03338647|Doxorubicin|doxorubicin|mesh-list
19747608|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19747609|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747610|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20091545|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20091546|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20091547|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
20091548|NCT00002123|Didanosine|didanosine|mesh-list
20091549|NCT00002123|Delavirdine|delavirdine|mesh-list
20091550|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
20091551|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091552|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091553|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747611|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19747612|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747613|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747614|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
19747615|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747616|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747617|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
19747618|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19747619|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747620|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
19495895|NCT05297565|Nivolumab|nivolumab|mesh-list
19495896|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495897|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495898|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19747621|NCT03220477|Guadecitabine|guadecitabine|mesh-list
19747622|NCT03220477|Mocetinostat|mocetinostat|mesh-list
19747623|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747624|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747625|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19747626|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747627|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747628|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
19747629|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747630|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747631|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19747632|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20091554|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19569988|NCT03794336|Aspirin|aspirin|mesh-list
19747633|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747634|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19747635|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
19747636|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747637|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
19747638|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747639|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747640|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747641|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19747642|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
19747643|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747644|NCT02894398|Letrozole|letrozole|mesh-list
19747645|NCT02894398|Fulvestrant|fulvestrant|mesh-list
19747646|NCT02894398|Palbociclib|palbociclib|mesh-list
19747647|NCT02894398|Anastrozole|anastrozole|mesh-list
19747648|NCT02894398|Exemestane|exemestane|mesh-list
19747649|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747650|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19747651|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19747652|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747653|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747654|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19747655|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
19747656|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747657|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747658|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747659|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19747660|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19747661|NCT02852057|Timolol|timolol|mesh-list
19747662|NCT02852057|Dorzolamide|dorzolamide|mesh-list
19747663|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19495899|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495900|NCT05296798|Paclitaxel|paclitaxel|mesh-list
19495901|NCT05296798|Docetaxel|docetaxel|mesh-list
19495902|NCT05296798|Trastuzumab|trastuzumab|mesh-list
19495903|NCT05296798|Pertuzumab|pertuzumab|mesh-list
19495904|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19495905|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495906|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
19495907|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
19495908|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
19495909|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495910|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495911|NCT05296603|Lenvatinib|lenvatinib|mesh-list
20091555|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
20091556|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091557|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091558|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091559|NCT00002124|Lamivudine|lamivudine|mesh-list
20091560|NCT00002124|Zidovudine|zidovudine|mesh-list
20091561|NCT00002124|Delavirdine|delavirdine|mesh-list
20091562|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091563|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19495912|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747664|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19747665|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
19747666|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747667|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747668|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747669|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19747670|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19747671|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747672|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19747673|NCT02734537|Cisplatin|cisplatin|mesh-list
19747674|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747675|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19747676|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19747677|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747678|NCT02710734|Doxorubicin|doxorubicin|mesh-list
19747679|NCT02710734|Methotrexate|methotrexate|mesh-list
19747680|NCT02710734|Mitomycins|mitomycins|mesh-list
19747681|NCT02710734|Mitomycin|mitomycin|mesh-list
20602521|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
19495913|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19747682|NCT02710734|Vinblastine|vinblastine|mesh-list
19747683|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091564|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747684|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19747685|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19747686|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19747687|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747688|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747689|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19747690|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
19747691|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19747692|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747693|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747694|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
19747695|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747696|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19747697|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747698|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
19747699|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747700|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19747701|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
19747702|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19495914|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495915|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495916|NCT05286996|Anesthetics|anesthetics|mesh-list
19495917|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
19495918|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747703|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19747704|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
19747705|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19747706|NCT02611024|Irinotecan|irinotecan|mesh-list
19495919|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495920|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
19495921|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747707|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19747708|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19747709|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091565|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091566|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
20091567|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091568|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091569|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091570|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
20091571|NCT00002125|Foscarnet|foscarnet|mesh-list
20602522|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20602523|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602524|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602525|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20602526|NCT02216266|Physostigmine|physostigmine|mesh-list
20602527|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20602528|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747710|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495922|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19495923|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19495924|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495925|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19495926|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19495927|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19495928|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091572|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20602529|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602530|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
20602531|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747711|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747712|NCT02564796|Iron|iron|mesh-list
19747713|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
19747714|NCT02564796|Trace Elements|trace elements|mesh-ancestor
19747715|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
19747716|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747717|NCT02564796|Hematinics|hematinics|mesh-ancestor
19747718|NCT02562716|Gemcitabine|gemcitabine|mesh-list
19747719|NCT02562716|Paclitaxel|paclitaxel|mesh-list
19747720|NCT02562716|Camptothecin|camptothecin|mesh-list
19747721|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19747722|NCT02562716|Fluorouracil|fluorouracil|mesh-list
19747723|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
19747724|NCT02562716|Irinotecan|irinotecan|mesh-list
19747725|NCT02562716|Pancrelipase|pancrelipase|mesh-list
19747726|NCT02562716|Pancreatin|pancreatin|mesh-list
19747727|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19747728|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747729|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
19747730|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
19747731|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
19747732|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747733|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747734|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
19747735|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
19747736|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747737|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602532|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602533|NCT02216266|Miotics|miotics|mesh-ancestor
20091573|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
20091574|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747738|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747739|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
19747740|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747741|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19747742|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19747743|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747744|NCT02558010|Morphine|morphine|mesh-list
19747745|NCT02558010|Methadone|methadone|mesh-list
19747746|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19747747|NCT02558010|Narcotics|narcotics|mesh-ancestor
19747748|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747749|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091575|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091576|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091577|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091578|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091579|NCT00002126|Lenograstim|lenograstim|mesh-list
20091580|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091581|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
20091582|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091583|NCT00002127|Thalidomide|thalidomide|mesh-list
20091584|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20091585|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
20091586|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091587|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
20091588|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091589|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091590|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20091591|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20091592|NCT00002127|Growth Substances|growth substances|mesh-ancestor
20091593|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
20091594|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091595|NCT00002128|Adefovir|adefovir|mesh-list
20091596|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20091597|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
20091598|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091599|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19747750|NCT02558010|Analgesics|analgesics|mesh-ancestor
19747751|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
19747752|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747753|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
20091600|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20602534|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
19747754|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
19747755|NCT02502006|Celecoxib|celecoxib|mesh-list
19747756|NCT02502006|Naproxen|naproxen|mesh-list
20091601|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747757|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19747758|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747759|NCT02502006|Analgesics|analgesics|mesh-ancestor
19747760|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
19747761|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747762|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747763|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747764|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747765|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19747766|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19747767|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747768|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747769|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
19747770|NCT02481245|Bezafibrate|bezafibrate|mesh-list
19747771|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19747772|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
19747773|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747774|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19747775|NCT02477384|Propranolol|propranolol|mesh-list
19747776|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19747777|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19747778|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
19747779|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19747780|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747781|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747782|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19495929|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
19495930|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495931|NCT05285982|Nintedanib|nintedanib|mesh-list
19495932|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495933|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19495934|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747783|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19747784|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
19747785|NCT02427724|Lidocaine|lidocaine|mesh-list
19495935|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495936|NCT05285813|Acetaminophen|acetaminophen|mesh-list
19495937|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
19495938|NCT05285813|Promethazine|promethazine|mesh-list
19495939|NCT05285813|Dexamethasone|dexamethasone|mesh-list
19495940|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19495941|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
19495942|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
19495943|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495944|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495945|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19495946|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
19495947|NCT05285813|Hormones|hormones|mesh-ancestor
19495948|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19495949|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19495950|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495951|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747786|NCT02427724|Tetracaine|tetracaine|mesh-list
20091602|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091603|NCT00002129|Vesnarinone|vesnarinone|mesh-list
20091604|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091605|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
20602535|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602536|NCT02216331|Rifampin|rifampin|mesh-list
20602537|NCT02216331|Rifapentine|rifapentine|mesh-list
20091606|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091607|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091608|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
20091609|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091610|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20602538|NCT02216331|Bedaquiline|bedaquiline|mesh-list
19495952|NCT05285813|Analgesics|analgesics|mesh-ancestor
19495953|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
20091611|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20091612|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091613|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091614|NCT00002129|Protective Agents|protective agents|mesh-ancestor
20602539|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19495954|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
19495955|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20602540|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
20091615|NCT00002130|Vesnarinone|vesnarinone|mesh-list
20091616|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091617|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
20091618|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091619|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091620|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
20091621|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091622|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20091623|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20091624|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091625|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091626|NCT00002130|Protective Agents|protective agents|mesh-ancestor
20091627|NCT00002131|Vesnarinone|vesnarinone|mesh-list
20091628|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091629|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
19747787|NCT02427724|Prilocaine|prilocaine|mesh-list
19747788|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
19747789|NCT02427724|Anesthetics|anesthetics|mesh-list
19747790|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19747791|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747792|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
19747793|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747794|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19747795|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19747796|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19747797|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19747798|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747799|NCT02393794|Nivolumab|nivolumab|mesh-list
19747800|NCT02393794|Romidepsin|romidepsin|mesh-list
19747801|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19747802|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747803|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747804|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19747805|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747806|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19747807|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747808|NCT02047513|Gemcitabine|gemcitabine|mesh-list
19747809|NCT02047513|Paclitaxel|paclitaxel|mesh-list
19747810|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19747811|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19747812|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747813|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
19747814|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
19747815|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
19747816|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747817|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747818|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
19747819|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
19747820|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747821|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747822|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747823|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
19747824|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747825|NCT02043847|Melphalan|melphalan|mesh-list
19747826|NCT02043847|Lenograstim|lenograstim|mesh-list
19747827|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20091630|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091631|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091632|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
20091633|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091634|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20091635|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20091636|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091637|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495956|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19495957|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19495958|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
19495959|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
19495960|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19495961|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
19495962|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
19495963|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19495964|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19495965|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19495966|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
20091638|NCT00002131|Protective Agents|protective agents|mesh-ancestor
20091639|NCT00002132|Itraconazole|itraconazole|mesh-list
20091640|NCT00002132|Fluconazole|fluconazole|mesh-list
20091641|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
20091642|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091643|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20091644|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19495967|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
19495968|NCT05283382|Cannabidiol|cannabidiol|mesh-list
19495969|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
19495970|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
19747828|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
19747829|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747830|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747831|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
19747832|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747833|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747834|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19747835|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747836|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
19747837|NCT01976286|Salicylates|salicylates|mesh-list
19747838|NCT01976286|Glycolic acid|glycolic acid|mesh-list
19747839|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747840|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
19747841|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
19747842|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
19747843|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19747844|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19747845|NCT01976286|Analgesics|analgesics|mesh-ancestor
19747846|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
19747847|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747848|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747849|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747850|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747851|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19747852|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747853|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749430|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
19749431|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749432|NCT05050097|Lenalidomide|lenalidomide|mesh-list
19749433|NCT05050097|Pomalidomide|pomalidomide|mesh-list
19749434|NCT05050097|Daratumumab|daratumumab|mesh-list
19749435|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
19749436|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749437|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749438|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749439|NCT05050097|Growth Substances|growth substances|mesh-ancestor
19749440|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749441|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749526|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19749527|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749528|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091645|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19495971|NCT05279742|Valsartan|valsartan|mesh-list
19495972|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19495973|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19495974|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19495975|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19569989|NCT03794336|Metformin|metformin|mesh-list
19569990|NCT03794336|Alogliptin|alogliptin|mesh-list
19569991|NCT03794336|Acarbose|acarbose|mesh-list
19569992|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19749529|NCT04944134|Vaccines|vaccines|mesh-list
19749530|NCT04944134|Immunologic Factors|immunologic factors|mesh-ancestor
19747854|NCT01775644|Bevacizumab|bevacizumab|mesh-list
19747855|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747856|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747857|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19747858|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19747859|NCT01775644|Growth Substances|growth substances|mesh-ancestor
19747860|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747861|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
19747862|NCT01472081|Nivolumab|nivolumab|mesh-list
19747863|NCT01472081|Ipilimumab|ipilimumab|mesh-list
19747864|NCT01472081|Sunitinib|sunitinib|mesh-list
19747865|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747866|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747867|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19747868|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747869|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19747870|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19747871|NCT01472081|Growth Substances|growth substances|mesh-ancestor
19747872|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747873|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
19747874|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19747875|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747876|NCT01367002|Paclitaxel|paclitaxel|mesh-list
19747877|NCT01367002|Carboplatin|carboplatin|mesh-list
19747878|NCT01367002|Trastuzumab|trastuzumab|mesh-list
19747879|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19747880|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747881|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
19747882|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
19747883|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
19747884|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747885|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19747886|NCT01309672|Prednisone|prednisone|mesh-list
19747887|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
19747888|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747889|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
19747890|NCT01309672|Hormones|hormones|mesh-ancestor
19747891|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747892|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747893|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747894|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747895|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091646|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091647|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091648|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091649|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091650|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091651|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20091652|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20091653|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20091654|NCT00002133|Itraconazole|itraconazole|mesh-list
20091655|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
20091656|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091657|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20091658|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19747896|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747897|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747898|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
19747899|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19747900|NCT01131169|Vidarabine|vidarabine|mesh-list
19747901|NCT01131169|Fludarabine|fludarabine|mesh-list
19747902|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
19747903|NCT01131169|Melphalan|melphalan|mesh-list
19747904|NCT01131169|Busulfan|busulfan|mesh-list
19747905|NCT01131169|Lenograstim|lenograstim|mesh-list
19747906|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747907|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747908|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
19747909|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747910|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747911|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
19747912|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747913|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
20091659|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091660|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091661|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091662|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091663|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091664|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091665|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20091666|NCT00002134|Ganciclovir|ganciclovir|mesh-list
20091667|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20091668|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
20091669|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091670|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091671|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091672|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091673|NCT00002135|Ganciclovir|ganciclovir|mesh-list
20091674|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19747914|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747915|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747916|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
19747917|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19747918|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19747919|NCT00882505|Vitamin D|vitamin d|mesh-list
19747920|NCT00882505|Vitamins|vitamins|mesh-ancestor
19747921|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
19747922|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747923|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19747924|NCT00871013|Thalidomide|thalidomide|mesh-list
19747925|NCT00871013|Dexamethasone|dexamethasone|mesh-list
19747926|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
19747927|NCT00871013|Melphalan|melphalan|mesh-list
19747928|NCT00871013|Doxorubicin|doxorubicin|mesh-list
19747929|NCT00871013|Etoposide|etoposide|mesh-list
19747930|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19747931|NCT00871013|Bortezomib|bortezomib|mesh-list
19747932|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747933|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
20091675|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
20091676|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091677|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091678|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091679|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091680|NCT00002139|Azithromycin|azithromycin|mesh-list
20091681|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091682|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091683|NCT00002140|Azithromycin|azithromycin|mesh-list
19495976|NCT05271331|Anesthetics|anesthetics|mesh-list
19495977|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
19495978|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20091684|NCT00002140|Clarithromycin|clarithromycin|mesh-list
20091685|NCT00002140|Ethambutol|ethambutol|mesh-list
20091686|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091687|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091688|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20091689|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091690|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091691|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20091692|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091693|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
20091694|NCT00002141|Abacavir|abacavir|mesh-list
20091695|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19495979|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495980|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
19495981|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19495982|NCT05268744|Micronutrients|micronutrients|mesh-list
19495983|NCT05268744|Trace Elements|trace elements|mesh-list
19495984|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19495985|NCT05266846|Bevacizumab|bevacizumab|mesh-list
19495986|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
19495987|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19495988|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19495989|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19495990|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19495991|NCT05266846|Growth Substances|growth substances|mesh-ancestor
19747934|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747935|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20091696|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091697|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091698|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091699|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
20091700|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747936|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747937|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
19747938|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747939|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747940|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19747941|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747942|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
19747943|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
19747944|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747945|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747946|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
19747947|NCT00871013|Hormones|hormones|mesh-ancestor
19747948|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19747949|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19747950|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19747951|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19747952|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19747953|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19747954|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19747955|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
19747956|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19747957|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747958|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19747959|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19747960|NCT00871013|Growth Substances|growth substances|mesh-ancestor
19747961|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
19747962|NCT00774345|Lenalidomide|lenalidomide|mesh-list
20091701|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091702|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091703|NCT00002142|Cidofovir|cidofovir|mesh-list
20091704|NCT00002142|Probenecid|probenecid|mesh-list
20091705|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
20091706|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
20091707|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20091708|NCT00002142|Renal Agents|renal agents|mesh-ancestor
20091709|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
20091710|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091711|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091712|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091713|NCT00002143|Acitretin|acitretin|mesh-list
19495992|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747963|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
19747964|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747965|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749442|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
20091714|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
20091715|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19495993|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
19495994|NCT05263206|Loratadine|loratadine|mesh-list
19495995|NCT05263206|Fexofenadine|fexofenadine|mesh-list
19495996|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
19495997|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
19495998|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19495999|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19496000|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19496001|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
19496002|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
19496003|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496004|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496005|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496006|NCT05261464|Metoprolol|metoprolol|mesh-list
19496007|NCT05261464|Diltiazem|diltiazem|mesh-list
20091716|NCT00002144|Foscarnet|foscarnet|mesh-list
19496008|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20091717|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20091718|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
20091719|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091720|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19496009|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19496010|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
20091721|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19496011|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
19496012|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496013|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496014|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19496015|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19496016|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19496017|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
19496018|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496019|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496020|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19496021|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496022|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19496023|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
19747966|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19747967|NCT00774345|Growth Substances|growth substances|mesh-ancestor
19747968|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
19747969|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747970|NCT00735657|Iodine|iodine|mesh-list
19747971|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19747972|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19747973|NCT00735657|Trace Elements|trace elements|mesh-ancestor
19747974|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
19747975|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747976|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
19747977|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
19747978|NCT00258427|Busulfan|busulfan|mesh-list
19747979|NCT00258427|Fludarabine|fludarabine|mesh-list
19747980|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
19747981|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19496024|NCT05259696|Pembrolizumab|pembrolizumab|mesh-list
19496025|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496026|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496027|NCT05253651|Leucovorin|leucovorin|mesh-list
20091722|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091723|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091724|NCT00002145|Foscarnet|foscarnet|mesh-list
19496028|NCT05253651|Bevacizumab|bevacizumab|mesh-list
19496029|NCT05253651|Trastuzumab|trastuzumab|mesh-list
19496030|NCT05253651|Cetuximab|cetuximab|mesh-list
19496031|NCT05253651|Fluorouracil|fluorouracil|mesh-list
19496032|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
19496033|NCT05253651|Tucatinib|tucatinib|mesh-list
19496034|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
19496035|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496036|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496037|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19496038|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19496039|NCT05253651|Growth Substances|growth substances|mesh-ancestor
19496040|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496041|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
20091725|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20091726|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
20091727|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091728|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19747982|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19747983|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
19747984|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19747985|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19747986|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19747987|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
19747988|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19747989|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19747990|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19747991|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19747992|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
19747993|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19747994|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
19747995|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
19747996|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19747997|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19747998|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
19747999|NCT00258427|Hormones|hormones|mesh-ancestor
20091729|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091730|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496042|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
19496043|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748000|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748001|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19748002|NCT00258427|Protective Agents|protective agents|mesh-ancestor
19748003|NCT00250341|Beclomethasone|beclomethasone|mesh-list
19748004|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19496044|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496045|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496046|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
19496047|NCT05253651|Antidotes|antidotes|mesh-ancestor
19496048|NCT05253651|Protective Agents|protective agents|mesh-ancestor
19496049|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
19496050|NCT05253651|Vitamins|vitamins|mesh-ancestor
19496051|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
19496052|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19496053|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496054|NCT05249426|Cetuximab|cetuximab|mesh-list
19496055|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748005|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748006|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
19748007|NCT00250341|Hormones|hormones|mesh-ancestor
19748008|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748009|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748010|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19748011|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
19748012|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19748013|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
19748014|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748015|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
20091731|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091732|NCT00002146|Foscarnet|foscarnet|mesh-list
20091733|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20091734|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
20091735|NCT00002146|Analgesics|analgesics|mesh-ancestor
20091736|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
20091737|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748016|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
19748017|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19748018|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748019|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748020|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748021|NCT03723538|Analgesics|analgesics|mesh-ancestor
19748022|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
19748023|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748024|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19748025|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19748026|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19496056|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496057|NCT05245071|Maytansine|maytansine|mesh-list
19748027|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
19748028|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748029|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748030|NCT00000102|Nifedipine|nifedipine|mesh-list
20091738|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091739|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
20091740|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20091741|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20091742|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
20091743|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20091744|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20091745|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091746|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20091747|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
20091748|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19748031|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19748032|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748033|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748034|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748035|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748036|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
19748037|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
19749443|NCT05005299|Fludarabine|fludarabine|mesh-list
19496058|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19496059|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091749|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
20091750|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091751|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091752|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091753|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091754|NCT00002147|Doxorubicin|doxorubicin|mesh-list
19748038|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19748039|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
19748040|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19748041|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19748042|NCT00000134|Ganciclovir|ganciclovir|mesh-list
19748043|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19748044|NCT00000134|Foscarnet|foscarnet|mesh-list
19748045|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
19748046|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748047|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19748048|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748049|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748050|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19748051|NCT00000136|Ganciclovir|ganciclovir|mesh-list
19748052|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19748053|NCT00000136|Foscarnet|foscarnet|mesh-list
19748054|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
19748055|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748056|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19748057|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748058|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748059|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091755|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20091756|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20091757|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748060|NCT00000142|Cidofovir|cidofovir|mesh-list
19748061|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
19748062|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091758|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20091759|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20091760|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091761|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091762|NCT00002148|OPC 14117|opc 14117|mesh-list
20091763|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20091764|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
20091765|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091766|NCT00002148|Protective Agents|protective agents|mesh-ancestor
20091767|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091768|NCT00002149|Amoxicillin|amoxicillin|mesh-list
20091769|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
20091770|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
20091771|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
20091772|NCT00002149|Ephedrine|ephedrine|mesh-list
20091773|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091774|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602541|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19748063|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748064|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748065|NCT00000143|Ganciclovir|ganciclovir|mesh-list
19748066|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19748067|NCT00000143|Cidofovir|cidofovir|mesh-list
20091775|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20091776|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091777|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091778|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20091779|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
20091780|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20091781|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091782|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20091783|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
20602542|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748068|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
19748069|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748070|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19748071|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748072|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748073|NCT00000371|Cycloserine|cycloserine|mesh-list
20091784|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
19749444|NCT05005299|Venetoclax|venetoclax|mesh-list
20602543|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
19748074|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19748075|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748076|NCT00000371|Renal Agents|renal agents|mesh-ancestor
19748077|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19748078|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
19748079|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19748080|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
19748081|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748082|NCT00000378|Sertraline|sertraline|mesh-list
19748083|NCT00000378|Nortriptyline|nortriptyline|mesh-list
19748084|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
19748085|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748086|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19748087|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19496060|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496061|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496062|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
19496063|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496064|NCT05244993|Paclitaxel|paclitaxel|mesh-list
19496065|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19496066|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496067|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496068|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496069|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19496070|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496071|NCT05239741|Leucovorin|leucovorin|mesh-list
19748088|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748089|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748090|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748091|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
19748092|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748093|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19748094|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19748095|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
19748096|NCT00000479|Aspirin|aspirin|mesh-list
19748097|NCT00000479|Vitamin E|vitamin e|mesh-list
19496072|NCT05239741|Bevacizumab|bevacizumab|mesh-list
19496073|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
19496074|NCT05239741|Cetuximab|cetuximab|mesh-list
19496075|NCT05239741|Fluorouracil|fluorouracil|mesh-list
19496076|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
19496077|NCT05239741|Irinotecan|irinotecan|mesh-list
19496078|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20091785|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20091786|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20091787|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
20091788|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
20091789|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20091790|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
20091791|NCT00002154|Selegiline|selegiline|mesh-list
19496079|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496080|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19496081|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19496082|NCT05239741|Growth Substances|growth substances|mesh-ancestor
19496083|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496084|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
19496085|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
19496086|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496087|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496088|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20091792|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
20091793|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20091794|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20602544|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19496089|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
19496090|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19748098|NCT00000479|Vitamins|vitamins|mesh-ancestor
19748099|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
19748100|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748101|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19748102|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748103|NCT00000479|Analgesics|analgesics|mesh-ancestor
19748104|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
19496091|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748105|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20091795|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19748106|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748107|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748108|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19748109|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19748110|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748111|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19748112|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19748113|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748114|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
19748115|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
19748116|NCT00000479|Protective Agents|protective agents|mesh-ancestor
19748117|NCT00000575|Nedocromil|nedocromil|mesh-list
19496092|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748118|NCT00000575|Budesonide|budesonide|mesh-list
19748119|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748120|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19748121|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
19496093|NCT05239741|Antidotes|antidotes|mesh-ancestor
19496094|NCT05239741|Protective Agents|protective agents|mesh-ancestor
19496095|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
19496096|NCT05239741|Vitamins|vitamins|mesh-ancestor
19496097|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
19496098|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
19496099|NCT05232825|Promethazine|promethazine|mesh-list
19496100|NCT05232825|Dexamethasone|dexamethasone|mesh-list
19496101|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
19496102|NCT05232825|Desloratadine|desloratadine|mesh-list
19496103|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
19496104|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19496105|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
19496106|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
19496107|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496108|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496109|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19496110|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
19496111|NCT05232825|Hormones|hormones|mesh-ancestor
19496112|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496113|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19496114|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496115|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19496116|NCT05232825|Protective Agents|protective agents|mesh-ancestor
19496117|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19496118|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19496119|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19496120|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
19496121|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
19496122|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
19496123|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19496124|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
19496125|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
19496126|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496127|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496128|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19496129|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
19496130|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
19496131|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
19496132|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19496133|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
19496134|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19577835|NCT03889743|Hormones|hormones|mesh-ancestor
19748122|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20091796|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20091797|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091798|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091799|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20091800|NCT00002154|Protective Agents|protective agents|mesh-ancestor
20091801|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091802|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
20091803|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
20091804|NCT00002154|Vitamins|vitamins|mesh-ancestor
20091805|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
20091806|NCT00002155|Lamivudine|lamivudine|mesh-list
20091807|NCT00002155|Zidovudine|zidovudine|mesh-list
20091808|NCT00002155|Indinavir|indinavir|mesh-list
20091809|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091810|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19748123|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748124|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19748125|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
19748126|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
19748127|NCT00000575|Hormones|hormones|mesh-ancestor
19748128|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748129|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19748130|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
19748131|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19748132|NCT00000620|Insulin|insulin|mesh-list
19748133|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19748134|NCT00000620|Metformin|metformin|mesh-list
19748135|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
19748136|NCT00000620|Pioglitazone|pioglitazone|mesh-list
19748137|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
19748138|NCT00000620|Glimepiride|glimepiride|mesh-list
19748139|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
19748140|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
19496146|NCT05218499|Doxorubicin|doxorubicin|mesh-list
19496147|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19496148|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748141|NCT00000620|Acarbose|acarbose|mesh-list
19748142|NCT00000620|Repaglinide|repaglinide|mesh-list
19748143|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19748144|NCT00000620|Metoprolol|metoprolol|mesh-list
19748145|NCT00000620|Felodipine|felodipine|mesh-list
19748146|NCT00000620|Amlodipine|amlodipine|mesh-list
19748147|NCT00000620|Valsartan|valsartan|mesh-list
19748148|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19748149|NCT00000620|Carvedilol|carvedilol|mesh-list
19748150|NCT00000620|Candesartan|candesartan|mesh-list
19748151|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
19748152|NCT00000620|Lisinopril|lisinopril|mesh-list
19748153|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
19748154|NCT00000620|Diltiazem|diltiazem|mesh-list
19748155|NCT00000620|Benazepril|benazepril|mesh-list
19748156|NCT00000620|Hydralazine|hydralazine|mesh-list
19748157|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
19748158|NCT00000620|Reserpine|reserpine|mesh-list
19496149|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19496150|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496151|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496152|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496153|NCT05211947|BI 425809|bi 425809|mesh-list
19496154|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
19496155|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
19496156|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
19496157|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091811|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091812|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091813|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
20091814|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091815|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091816|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091817|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
19748159|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
20091818|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19748160|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
19748161|NCT00000620|Triamterene|triamterene|mesh-list
19748162|NCT00000620|Furosemide|furosemide|mesh-list
19748163|NCT00000620|Simvastatin|simvastatin|mesh-list
19748164|NCT00000620|Fenofibrate|fenofibrate|mesh-list
19748165|NCT00000620|Terazosin|terazosin|mesh-list
19748166|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748167|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19748168|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748169|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748170|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748171|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
19748172|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19748173|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19748174|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
19748175|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19748176|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19748177|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748178|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19748179|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19748180|NCT00000620|Diuretics|diuretics|mesh-ancestor
19748181|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
20091819|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091820|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
20091821|NCT00002156|Ganciclovir|ganciclovir|mesh-list
20091822|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20091823|NCT00002156|Fomivirsen|fomivirsen|mesh-list
19496171|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
19496172|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496173|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748182|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19748183|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19748184|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748185|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
19748186|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
19748187|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
19748188|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748189|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19748190|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19748191|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19748192|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
20091824|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
20091825|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496174|NCT05170204|Durvalumab|durvalumab|mesh-list
19496175|NCT05170204|Pralsetinib|pralsetinib|mesh-list
19496176|NCT05170204|Entrectinib|entrectinib|mesh-list
19496177|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496178|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496179|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19496180|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496181|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496182|NCT05164367|Atropine|atropine|mesh-list
19496183|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19496184|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19496185|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20091826|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091827|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091828|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496186|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
19496187|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496188|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496189|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19496190|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
19496191|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
19496192|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
19496193|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19496194|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19496195|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
19496196|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20091829|NCT00002157|Thalidomide|thalidomide|mesh-list
20091830|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20091831|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
20091832|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091833|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
20091834|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091835|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091836|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19496197|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496198|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19496199|NCT05164081|Clindamycin|clindamycin|mesh-list
19496200|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
19496201|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
19496202|NCT05164081|Gentamicins|gentamicins|mesh-list
20091837|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20091838|NCT00002157|Growth Substances|growth substances|mesh-ancestor
20602545|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496203|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19496204|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496205|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
19496206|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19496207|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496208|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496209|NCT05153915|Tacrolimus|tacrolimus|mesh-list
19496210|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496211|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
19496212|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496213|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19496214|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496215|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496216|NCT05152628|Tacrolimus|tacrolimus|mesh-list
19496217|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496218|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
19496219|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496220|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20602546|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602547|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20602548|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20602549|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20602550|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20602551|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20602552|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20602553|NCT02216383|Oxytocin|oxytocin|mesh-list
19496221|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496222|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748193|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748194|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19748195|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
19748196|NCT00000620|Protective Agents|protective agents|mesh-ancestor
19748197|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19748198|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19748199|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19748200|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
19748201|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19748202|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19748203|NCT00000620|Urological Agents|urological agents|mesh-ancestor
19748204|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19748205|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748206|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748207|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748208|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19748209|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19748210|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19748211|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19748212|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19748213|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19748214|NCT00001151|Calcitriol|calcitriol|mesh-list
19748215|NCT00001151|Vitamins|vitamins|mesh-ancestor
19748216|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
19748217|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748218|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19748219|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748220|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19748221|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748222|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748223|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19748224|NCT00001213|Cysteamine|cysteamine|mesh-list
19748225|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19748226|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748227|NCT00001262|Copper|copper|mesh-list
20091839|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
20602554|NCT02216383|Carbetocin|carbetocin|mesh-list
20602555|NCT02216383|Syntometrine|syntometrine|mesh-list
19496223|NCT05152147|Fluorouracil|fluorouracil|mesh-list
19496224|NCT05152147|Capecitabine|capecitabine|mesh-list
19748228|NCT00001262|Trace Elements|trace elements|mesh-ancestor
19748229|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
19748230|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748231|NCT00001304|Vitamin D|vitamin d|mesh-list
19748232|NCT00001304|Calcitriol|calcitriol|mesh-list
19748233|NCT00001304|Calcium|calcium|mesh-list
19748234|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
19748235|NCT00001304|Hormones|hormones|mesh-list
19748236|NCT00001304|Vitamins|vitamins|mesh-ancestor
19748237|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
19748238|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748239|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748240|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19748241|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748242|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19748243|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748244|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748245|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19748246|NCT00001566|Indinavir|indinavir|mesh-list
19748247|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19496225|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
19496226|NCT05152147|Trastuzumab|trastuzumab|mesh-list
19496227|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496228|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
19496229|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496230|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20091840|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20091841|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
20091842|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20091843|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091844|NCT00002159|Itraconazole|itraconazole|mesh-list
20091845|NCT00002159|Amphotericin B|amphotericin b|mesh-list
20091846|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20091847|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
19748248|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19748249|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
19748250|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748251|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748252|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748253|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19748254|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
19748255|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748256|NCT00001575|Edetic Acid|edetic acid|mesh-list
19748257|NCT00001575|Calcium|calcium|mesh-list
20091848|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091849|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20091850|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091851|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091852|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091853|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20091854|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
20091855|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20091856|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091857|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20091858|NCT00002159|Amebicides|amebicides|mesh-ancestor
20091859|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20091860|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20091861|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091862|NCT00002160|Ziconotide|ziconotide|mesh-list
20602556|NCT02216383|Ergonovine|ergonovine|mesh-list
20602557|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
20602558|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20602559|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602560|NCT02216409|Magrolimab|magrolimab|mesh-list
20602561|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602562|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602563|NCT02216487|Irinotecan|irinotecan|mesh-list
19496231|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496232|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
19496233|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496234|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569993|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569994|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19748258|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
19748259|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20091863|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20091864|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748260|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748261|NCT00001575|Antidotes|antidotes|mesh-ancestor
19748262|NCT00001575|Protective Agents|protective agents|mesh-ancestor
19748263|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
19748264|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
19748265|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748266|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20091865|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091866|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19496237|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
19496238|NCT05145309|Cathartics|cathartics|mesh-ancestor
19496239|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19496240|NCT05144243|Azacitidine|azacitidine|mesh-list
19496241|NCT05144243|Venetoclax|venetoclax|mesh-list
19496242|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496243|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
19496244|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496245|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496246|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496247|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
19496248|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19496249|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496250|NCT05135845|Spartalizumab|spartalizumab|mesh-list
19496251|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19496252|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496253|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496254|NCT05133804|Methylphenidate|methylphenidate|mesh-list
19496255|NCT05133804|Reboxetine|reboxetine|mesh-list
19496256|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19496257|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496258|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19496259|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19496260|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496261|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496262|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
19496263|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496264|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
20091867|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091868|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20091869|NCT00002160|Protective Agents|protective agents|mesh-ancestor
20091870|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20091871|NCT00002160|Analgesics|analgesics|mesh-ancestor
20091872|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
20091873|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20091874|NCT00002161|Adefovir|adefovir|mesh-list
20091875|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20091876|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
20091877|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091878|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091879|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091880|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091881|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091882|NCT00002162|Lamivudine|lamivudine|mesh-list
20091883|NCT00002162|Zidovudine|zidovudine|mesh-list
20091884|NCT00002162|Stavudine|stavudine|mesh-list
20091885|NCT00002162|Didanosine|didanosine|mesh-list
20091886|NCT00002162|Zalcitabine|zalcitabine|mesh-list
20091887|NCT00002162|Saquinavir|saquinavir|mesh-list
20091888|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20602564|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20602565|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496265|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748267|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
19748268|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19748269|NCT00001586|Vidarabine|vidarabine|mesh-list
19748270|NCT00001586|Rituximab|rituximab|mesh-list
19748271|NCT00001586|Fludarabine|fludarabine|mesh-list
19748272|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
19748273|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496266|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20091889|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20602566|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496267|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
19748274|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496268|NCT05132582|Trastuzumab|trastuzumab|mesh-list
19496269|NCT05132582|Pertuzumab|pertuzumab|mesh-list
19496270|NCT05132582|Tucatinib|tucatinib|mesh-list
19496271|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496272|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496273|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19496274|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496275|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496276|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19496277|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496278|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
19496279|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496280|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496281|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19496282|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19496283|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19496284|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496285|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496286|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496287|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496288|NCT05115123|Analgesics|analgesics|mesh-ancestor
19496289|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
19496290|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496291|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
19496292|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496293|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
20091890|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602567|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602568|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602569|NCT02216513|Deferoxamine|deferoxamine|mesh-list
20602570|NCT02216513|Siderophores|siderophores|mesh-ancestor
20602571|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20091891|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091892|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
20091893|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091894|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091895|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091896|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
20091897|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091898|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091899|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
19496304|NCT05103332|Amlodipine|amlodipine|mesh-list
19496305|NCT05103332|Olmesartan|olmesartan|mesh-list
19496306|NCT05103332|Indapamide|indapamide|mesh-list
19496307|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19496308|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19496309|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496310|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496311|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19496312|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496313|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
19496314|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19496315|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19496316|NCT05103332|Diuretics|diuretics|mesh-ancestor
19496317|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
20602572|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
20602573|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
20602574|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602575|NCT02216552|Resveratrol|resveratrol|mesh-list
20602576|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
19496318|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19496319|NCT05092451|Vidarabine|vidarabine|mesh-list
19496320|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
19496321|NCT05092451|Fludarabine|fludarabine|mesh-list
19496322|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
19496323|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496324|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
19496325|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496326|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19496327|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19496328|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
19496329|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748275|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
20607881|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
19496330|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496331|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19496332|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496333|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
19496334|NCT05092451|Antiviral Agents|antiviral agents|mesh-ancestor
19496335|NCT05092451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496336|NCT05079074|Fulvestrant|fulvestrant|mesh-list
19496337|NCT05079074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19496338|NCT05079074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19496339|NCT05079074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19496340|NCT05079074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496341|NCT05079074|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19496342|NCT05079074|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19496343|NCT05079074|Hormone Antagonists|hormone antagonists|mesh-ancestor
19496344|NCT05079074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496345|NCT05079074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496346|NCT05079074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496347|NCT05079074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496348|NCT05076149|Ivacaftor|ivacaftor|mesh-list
19496349|NCT05076149|Elexacaftor|elexacaftor|mesh-list
19496350|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19496351|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496352|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496353|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
19496354|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496355|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748276|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748277|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748278|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19748279|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
19748280|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748281|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748282|NCT00001586|Antiviral Agents|antiviral agents|mesh-ancestor
19748283|NCT00001586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748284|NCT00001596|Pirfenidone|pirfenidone|mesh-list
19748285|NCT00001596|Analgesics|analgesics|mesh-ancestor
19496356|NCT05069597|Pancrelipase|pancrelipase|mesh-list
19496357|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19496358|NCT05067387|Dronabinol|dronabinol|mesh-list
19496359|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
19496360|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496361|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496362|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19496363|NCT05067387|Analgesics|analgesics|mesh-ancestor
19496364|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
19496365|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496366|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19496367|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19496368|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496369|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496370|NCT05067387|Hormones|hormones|mesh-ancestor
19496371|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496372|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19496373|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19496374|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
19496375|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496376|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496377|NCT05044611|Amiloride|amiloride|mesh-list
19496378|NCT05044611|Diuretics|diuretics|mesh-ancestor
19496379|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
19496380|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748286|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
19748287|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748288|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748289|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19748290|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748291|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602577|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602578|NCT02216552|Protective Agents|protective agents|mesh-ancestor
20602579|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602580|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602581|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20602582|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19748292|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748293|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602583|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20602584|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20602585|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602586|NCT02216617|Docetaxel|docetaxel|mesh-list
20602587|NCT02216617|Afatinib|afatinib|mesh-list
20602588|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748294|NCT00001656|Olanzapine|olanzapine|mesh-list
20091900|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20091901|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20091902|NCT00002163|Abacavir|abacavir|mesh-list
20091903|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091904|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091905|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748295|NCT00001656|Clozapine|clozapine|mesh-list
19748296|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
19748297|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
19748298|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748299|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748300|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19748301|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19748302|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748303|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748304|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748305|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19748306|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19748307|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748308|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748309|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748310|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
19748311|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19748312|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
19748313|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
19748314|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
19748315|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19748316|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
19748317|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748318|NCT00001723|Orlistat|orlistat|mesh-list
19748319|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748320|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748321|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19748322|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20091906|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091907|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
20091908|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091909|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091910|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091911|NCT00002164|Nelfinavir|nelfinavir|mesh-list
20091912|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091913|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091914|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
19748323|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
20091915|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091916|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091917|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748324|NCT00001832|Fludarabine|fludarabine|mesh-list
19748325|NCT00001832|Interleukin-2|interleukin-2|mesh-list
19748326|NCT00001832|Sargramostim|sargramostim|mesh-list
19748327|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748328|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
19748329|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748330|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748331|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19748332|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
19748333|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748334|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748335|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19748336|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748337|NCT00001832|Analgesics|analgesics|mesh-ancestor
19748338|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
20091918|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091919|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
20602589|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
19748339|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748340|NCT00001849|Edetic Acid|edetic acid|mesh-list
19748341|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
19748342|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748343|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748344|NCT00001849|Antidotes|antidotes|mesh-ancestor
19748345|NCT00001849|Protective Agents|protective agents|mesh-ancestor
19748346|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
19748347|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
19748348|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19748349|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
19748350|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19748351|NCT00001880|Cyclosporine|cyclosporine|mesh-list
19748352|NCT00001880|Methotrexate|methotrexate|mesh-list
19748353|NCT00001880|Cyclosporins|cyclosporins|mesh-list
19748354|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19748355|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
19748356|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19748357|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748358|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19748359|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
19748360|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748361|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748362|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
19748363|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748364|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20091920|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091921|NCT00002165|Nelfinavir|nelfinavir|mesh-list
20091922|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091923|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091924|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
19748365|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748366|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
19748367|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748368|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19748369|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
19748370|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748371|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19748372|NCT00001941|Daclizumab|daclizumab|mesh-list
19748373|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748374|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
19748375|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748376|NCT00001959|Pirfenidone|pirfenidone|mesh-list
19748377|NCT00001959|Analgesics|analgesics|mesh-ancestor
19748378|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
19748379|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748380|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748381|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19748382|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748383|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748384|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748385|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748386|NCT00001962|Daclizumab|daclizumab|mesh-list
19748387|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748388|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
19748389|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748390|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
19748391|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748392|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748393|NCT00002525|Leucovorin|leucovorin|mesh-list
19748394|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
19748395|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19748396|NCT00002525|Fluorouracil|fluorouracil|mesh-list
19748397|NCT00002525|Calcium|calcium|mesh-list
19748398|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
19496381|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19496382|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19496383|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496384|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496385|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19496386|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19496387|NCT05043090|Durvalumab|durvalumab|mesh-list
19496388|NCT05043090|Sunitinib|sunitinib|mesh-list
19496389|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496390|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748399|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748400|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091925|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748401|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
19748402|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602590|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
20602591|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
20602592|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602593|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20602594|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602595|NCT02216656|Cinacalcet|cinacalcet|mesh-list
20602596|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748403|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19748404|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748405|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748406|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
19748407|NCT00002525|Antidotes|antidotes|mesh-ancestor
19748408|NCT00002525|Protective Agents|protective agents|mesh-ancestor
19748409|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
20091926|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091927|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091928|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091929|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
20091930|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091931|NCT00002166|Nevirapine|nevirapine|mesh-list
20091932|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20091933|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091934|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091935|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091936|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
20091937|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091938|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091939|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091940|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20091941|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20091942|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
20091943|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20091944|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
20091945|NCT00002168|Lamivudine|lamivudine|mesh-list
20091946|NCT00002168|Zidovudine|zidovudine|mesh-list
20091947|NCT00002168|Stavudine|stavudine|mesh-list
20091948|NCT00002168|Didanosine|didanosine|mesh-list
20091949|NCT00002168|Indinavir|indinavir|mesh-list
20091950|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19748410|NCT00002525|Vitamins|vitamins|mesh-ancestor
19748411|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
19748412|NCT00002558|Paclitaxel|paclitaxel|mesh-list
19748413|NCT00002558|Etoposide|etoposide|mesh-list
19748414|NCT00002558|Carboplatin|carboplatin|mesh-list
19748415|NCT00002558|Ifosfamide|ifosfamide|mesh-list
19748416|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748417|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748418|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
19748419|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
19748420|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748421|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091951|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20091952|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748422|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19748423|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748424|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748425|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20091953|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602597|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091954|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
20091955|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091956|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748426|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
19748427|NCT00002597|Leuprolide|leuprolide|mesh-list
19748428|NCT00002597|Goserelin|goserelin|mesh-list
19748429|NCT00002597|Flutamide|flutamide|mesh-list
19496391|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19496392|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19496393|NCT05043090|Growth Substances|growth substances|mesh-ancestor
19496394|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748430|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19748431|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
19748432|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19748433|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748434|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19748435|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748436|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
19748437|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
19748438|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748439|NCT00002601|Doxorubicin|doxorubicin|mesh-list
20091957|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091958|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
20091959|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091960|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091961|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
20091962|NCT00002169|Nelfinavir|nelfinavir|mesh-list
20091963|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091964|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091965|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
20091966|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091967|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091968|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091969|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091970|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
20091971|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091972|NCT00002170|Nelfinavir|nelfinavir|mesh-list
20091973|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091974|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091975|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
20091976|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091977|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091978|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091979|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20091980|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
20091981|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091982|NCT00002171|Nelfinavir|nelfinavir|mesh-list
20091983|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20091984|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20091985|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
20091986|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20091987|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091988|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20091989|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19496395|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
19496396|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19496397|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496398|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496399|NCT05037487|Dronabinol|dronabinol|mesh-list
19496400|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
19496401|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496402|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496403|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19496404|NCT05037487|Analgesics|analgesics|mesh-ancestor
19496405|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
19496406|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496407|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19496408|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19496409|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496410|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496411|NCT05037487|Hormones|hormones|mesh-ancestor
19496412|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748440|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19748441|NCT00002601|Melphalan|melphalan|mesh-list
20091990|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
19748442|NCT00002601|Ifosfamide|ifosfamide|mesh-list
19748443|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748444|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19748445|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19748446|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748447|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748448|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748449|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
19748450|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748451|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19748452|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
19748453|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19748454|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748455|NCT00002651|Goserelin|goserelin|mesh-list
19748456|NCT00002651|Bicalutamide|bicalutamide|mesh-list
19748457|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19748458|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748459|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
19748460|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
19748461|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748462|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748463|NCT00002766|Cytarabine|cytarabine|mesh-list
19748464|NCT00002766|Dactinomycin|dactinomycin|mesh-list
19748465|NCT00002766|Prednisone|prednisone|mesh-list
19748466|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
19748467|NCT00002766|Carmustine|carmustine|mesh-list
19748468|NCT00002766|Doxorubicin|doxorubicin|mesh-list
19748469|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19748470|NCT00002766|Methotrexate|methotrexate|mesh-list
19748471|NCT00002766|Etoposide|etoposide|mesh-list
19748472|NCT00002766|Vincristine|vincristine|mesh-list
19748473|NCT00002766|Daunorubicin|daunorubicin|mesh-list
19748474|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
19748475|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
19748476|NCT00002766|Pegaspargase|pegaspargase|mesh-list
19748477|NCT00002766|Sargramostim|sargramostim|mesh-list
19748478|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748479|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
19748480|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748481|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748482|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19748483|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
19748484|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20091991|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091992|NCT00002174|Thalidomide|thalidomide|mesh-list
20091993|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20091994|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
20091995|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20091996|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
20091997|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20091998|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20091999|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20092000|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20092001|NCT00002174|Growth Substances|growth substances|mesh-ancestor
20092002|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
19496413|NCT05033080|Ivacaftor|ivacaftor|mesh-list
19496414|NCT05033080|Elexacaftor|elexacaftor|mesh-list
19496415|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19496416|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496417|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496418|NCT05028075|Cobalt|cobalt|mesh-list
19496419|NCT05028075|Trace Elements|trace elements|mesh-ancestor
19496420|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
19496421|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496422|NCT05027516|Azithromycin|azithromycin|mesh-list
19496423|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
19496424|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19496425|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496426|NCT05024734|Gemcitabine|gemcitabine|mesh-list
19496427|NCT05024734|Docetaxel|docetaxel|mesh-list
19496428|NCT05024734|Epirubicin|epirubicin|mesh-list
19496429|NCT05024734|Mitomycins|mitomycins|mesh-list
19496430|NCT05024734|Mitomycin|mitomycin|mesh-list
19496431|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496432|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
19569995|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748485|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748486|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19748487|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19496433|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496434|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496435|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
19496436|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496437|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496438|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748488|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19748489|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748490|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748491|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748492|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
19748493|NCT00002766|Hormones|hormones|mesh-ancestor
19748494|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748495|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19748496|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19748497|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
19748498|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19748499|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19748500|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
19748501|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
19748502|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19748503|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19748504|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748505|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
19748506|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748507|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
19748508|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
20092003|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092004|NCT00002176|Stavudine|stavudine|mesh-list
20092005|NCT00002176|Didanosine|didanosine|mesh-list
20092006|NCT00002176|Nelfinavir|nelfinavir|mesh-list
19748509|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748510|NCT00002766|Analgesics|analgesics|mesh-ancestor
19748511|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
20092007|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
20092008|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092009|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
20092010|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092011|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748512|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748513|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19748514|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19748515|NCT00002842|Leucovorin|leucovorin|mesh-list
19496439|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
19496440|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496441|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496442|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496443|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748516|NCT00002842|Fluorouracil|fluorouracil|mesh-list
19748517|NCT00002842|Floxuridine|floxuridine|mesh-list
19748518|NCT00002842|Calcium|calcium|mesh-list
19748519|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
19748520|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748521|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748522|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
19748523|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748524|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19748525|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748526|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748527|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
19748528|NCT00002842|Antidotes|antidotes|mesh-ancestor
19748529|NCT00002842|Protective Agents|protective agents|mesh-ancestor
19748530|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
19748531|NCT00002842|Vitamins|vitamins|mesh-ancestor
19748532|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
19748533|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
19748534|NCT00002850|Ofloxacin|ofloxacin|mesh-list
19748535|NCT00002850|Trimethoprim|trimethoprim|mesh-list
19748536|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
19748537|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092012|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20602598|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19748538|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496444|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19748539|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19748540|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20092013|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
19748541|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748542|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748543|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748544|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19748545|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19748546|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19748547|NCT00002850|Renal Agents|renal agents|mesh-ancestor
19748548|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
19748549|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19748550|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19748551|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19748552|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19748553|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19748554|NCT05384938|Benralizumab|benralizumab|mesh-list
19748555|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19748556|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
19748557|NCT05384847|Hormones|hormones|mesh-list
19748558|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748559|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748560|NCT05384821|Irinotecan|irinotecan|mesh-list
19748561|NCT05384821|Etoposide|etoposide|mesh-list
19748562|NCT05384821|Vincristine|vincristine|mesh-list
19748563|NCT05384821|Temozolomide|temozolomide|mesh-list
19748564|NCT05384821|Tretinoin|tretinoin|mesh-list
19748565|NCT05384821|Isotretinoin|isotretinoin|mesh-list
19748566|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19748567|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748568|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748569|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748570|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748571|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748572|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19748573|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
19748574|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
19748575|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748576|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19748577|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
19748578|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
19748579|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
19749445|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749446|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
19749447|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749448|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749449|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19496445|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19496446|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496447|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
19749450|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
19749451|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749452|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749453|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19749454|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19749455|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19749456|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19749457|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19749458|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749459|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749460|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
19496448|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19496449|NCT05022758|Warfarin|warfarin|mesh-list
19496450|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
19496451|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
19496452|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19496453|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
19496454|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19496455|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
19496456|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496457|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496458|NCT05020860|Paclitaxel|paclitaxel|mesh-list
19496459|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
19496460|NCT05020860|Carboplatin|carboplatin|mesh-list
19496461|NCT05020860|Doxorubicin|doxorubicin|mesh-list
19496462|NCT05020860|Trastuzumab|trastuzumab|mesh-list
19496463|NCT05020860|Pertuzumab|pertuzumab|mesh-list
19748580|NCT05384756|Sirolimus|sirolimus|mesh-list
19748581|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19748582|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
19748583|NCT05384756|Antibodies|antibodies|mesh-list
19748584|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
19748585|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19748586|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
19748587|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748588|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748589|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19748590|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748591|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20092014|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092015|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
20092016|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748592|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
19748593|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748594|NCT05384743|Rituximab|rituximab|mesh-list
19748595|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748596|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748597|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
19748598|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748599|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748600|NCT05384691|Luspatercept|luspatercept|mesh-list
19748601|NCT05384691|Hematinics|hematinics|mesh-ancestor
19748602|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19748603|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
19748604|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748605|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748606|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20092017|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092018|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092019|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092020|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092021|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092022|NCT00002177|Stavudine|stavudine|mesh-list
20092023|NCT00002177|Didanosine|didanosine|mesh-list
20092024|NCT00002177|Nelfinavir|nelfinavir|mesh-list
20092025|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
20092026|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092027|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
20092028|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092029|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092030|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092031|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
19496464|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19496465|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092032|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092033|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
20092034|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496466|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
20092035|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092036|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092037|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092038|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092039|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092040|NCT00002178|Ritonavir|ritonavir|mesh-list
20092041|NCT00002178|Nelfinavir|nelfinavir|mesh-list
20092042|NCT00002178|Saquinavir|saquinavir|mesh-list
19496467|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496468|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
19496469|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496470|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496471|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
19496472|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496473|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19496474|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19496475|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
19496476|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19496477|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19496478|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19496479|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748607|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
19748608|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20092043|NCT00002178|Delavirdine|delavirdine|mesh-list
20092044|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092045|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092046|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092047|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092048|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496480|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496481|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19569996|NCT03794336|Analgesics|analgesics|mesh-ancestor
19748609|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748610|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19748611|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
19748612|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19748613|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748614|NCT05384574|Vitamins|vitamins|mesh-ancestor
19748615|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
19748616|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19748617|NCT05384496|Nivolumab|nivolumab|mesh-list
19748618|NCT05384496|Ipilimumab|ipilimumab|mesh-list
19748619|NCT05384496|Axitinib|axitinib|mesh-list
19748620|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748621|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748622|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19748623|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748624|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19748625|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748626|NCT05384483|Cariprazine|cariprazine|mesh-list
19748627|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19748628|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748629|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748630|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748631|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748632|NCT05384366|Paclitaxel|paclitaxel|mesh-list
19748633|NCT05384366|Carboplatin|carboplatin|mesh-list
19748634|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748635|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748636|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
19748637|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
19748638|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748639|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748640|NCT05384210|Gabapentin|gabapentin|mesh-list
19748641|NCT05384210|Milnacipran|milnacipran|mesh-list
19748642|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
19748643|NCT05384210|Analgesics|analgesics|mesh-ancestor
19748644|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
19748645|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748646|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19569997|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
19569998|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19569999|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570000|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570001|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19570002|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19570003|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570004|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19570005|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19570006|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570007|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
19570008|NCT03794336|Incretins|incretins|mesh-ancestor
19570009|NCT03794336|Hormones|hormones|mesh-ancestor
19570010|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570011|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19570012|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
19570013|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19570014|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19570015|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19570016|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570017|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570018|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570019|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
19570020|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570021|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570022|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
19570023|NCT03767543|Lixisenatide|lixisenatide|mesh-list
19570024|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20092049|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748647|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
19748648|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19748649|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748650|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748651|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748652|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19748653|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19748654|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748655|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748656|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
19748657|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19748658|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19748659|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496482|NCT05020184|Cimetidine|cimetidine|mesh-list
19496483|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19496484|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19496485|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19496486|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
20092050|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092051|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
20092052|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092053|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20092054|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092055|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092056|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092057|NCT00002179|Lamivudine|lamivudine|mesh-list
20092058|NCT00002179|Zidovudine|zidovudine|mesh-list
20092059|NCT00002179|Indinavir|indinavir|mesh-list
20092060|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092061|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19496487|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
19496488|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496489|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496490|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496491|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19496492|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19496493|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496494|NCT05019716|Cisplatin|cisplatin|mesh-list
19496495|NCT05019716|Etoposide|etoposide|mesh-list
19496496|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
19496497|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
19496498|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496499|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19496500|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19496501|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496502|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496503|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496504|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
19496505|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
19496506|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496507|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496508|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748660|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748661|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
19748662|NCT05384119|Palbociclib|palbociclib|mesh-list
19748663|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19748664|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748665|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19748666|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748667|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748668|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19748669|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19748670|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
19748671|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20092062|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092063|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092064|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
20092065|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092066|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092067|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092068|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
19496509|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
19496510|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19748672|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748673|NCT05384015|Carboplatin|carboplatin|mesh-list
19748674|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
19748675|NCT05384015|Etoposide|etoposide|mesh-list
19748676|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
19748677|NCT05384015|Lenvatinib|lenvatinib|mesh-list
19748678|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748679|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748680|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748681|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19748682|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748683|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748684|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748685|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19748686|NCT05383820|Ketorolac|ketorolac|mesh-list
19748687|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20092069|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092070|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19748688|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748689|NCT05383820|Analgesics|analgesics|mesh-ancestor
19748690|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
19748691|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748692|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748693|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748694|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19748695|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19748696|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748697|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748698|NCT05383742|Rifampin|rifampin|mesh-list
19748699|NCT05383742|Isoniazid|isoniazid|mesh-list
19496511|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
19496512|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19496513|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19748700|NCT05383742|Linezolid|linezolid|mesh-list
19748701|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
19748702|NCT05383742|Ethambutol|ethambutol|mesh-list
19748703|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19748704|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
19748705|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19748706|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092071|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092072|NCT00002180|Tenofovir|tenofovir|mesh-list
19496514|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496515|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
19496516|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496517|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496518|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19496519|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
19496520|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
19496521|NCT05012566|Protective Agents|protective agents|mesh-ancestor
19496522|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19496523|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496524|NCT05008224|Prednisone|prednisone|mesh-list
19496525|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
19496526|NCT05008224|Dacarbazine|dacarbazine|mesh-list
20092073|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
20092074|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092075|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092076|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092077|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092078|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092079|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092080|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092081|NCT00002181|Cidofovir|cidofovir|mesh-list
20092082|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
20092083|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092084|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092085|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602599|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
19496527|NCT05008224|Doxorubicin|doxorubicin|mesh-list
19496528|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
19496529|NCT05008224|Etoposide|etoposide|mesh-list
19496530|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
19748707|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
19496531|NCT05008224|Vincristine|vincristine|mesh-list
19496532|NCT05008224|Bleomycin|bleomycin|mesh-list
19496533|NCT05008224|Vinblastine|vinblastine|mesh-list
19748708|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19496534|NCT05008224|Procarbazine|procarbazine|mesh-list
19748709|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748710|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496535|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496536|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
19496537|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496538|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19496539|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19496540|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
19496541|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496542|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496543|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19496544|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19496545|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19496546|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496547|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748711|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19748712|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19748713|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19748714|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19748715|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19748716|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19748717|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19748718|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19748719|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
19748720|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19748721|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19748722|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
19748723|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748724|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748725|NCT05383625|Vaccines|vaccines|mesh-list
19748726|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
19748727|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748728|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19748729|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19748730|NCT05383560|Vaccines|vaccines|mesh-list
19748731|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
19748732|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748733|NCT05383547|Bortezomib|bortezomib|mesh-list
19748734|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748735|NCT05383534|Propofol|propofol|mesh-list
19748736|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19748737|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748738|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748739|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19748740|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
19748741|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
19748742|NCT05383521|Tinidazole|tinidazole|mesh-list
19748743|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
19748744|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748745|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19748746|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748747|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19748748|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19748749|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19748750|NCT05383495|Midazolam|midazolam|mesh-list
19748751|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
19748752|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
20092086|NCT00002182|Megestrol|megestrol|mesh-list
19748753|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19748754|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748755|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748756|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748757|NCT05383495|Analgesics|analgesics|mesh-ancestor
19748758|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
19748759|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748760|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19748761|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19748762|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19748763|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
20092087|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
20092088|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20092089|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19496548|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748764|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748765|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748766|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19748767|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19748768|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748769|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748770|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19748771|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
19748772|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
19748773|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
19748774|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
19748775|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19748776|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19748777|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
19748778|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748779|NCT05383352|Leucovorin|leucovorin|mesh-list
19748780|NCT05383352|Folic Acid|folic acid|mesh-list
19748781|NCT05383352|Fluorouracil|fluorouracil|mesh-list
19748782|NCT05383352|Irinotecan|irinotecan|mesh-list
19748783|NCT05383352|Camptothecin|camptothecin|mesh-list
19748784|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
19748785|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
19748786|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748787|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19748788|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748789|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19748790|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
19748791|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748792|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19748793|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19748794|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748795|NCT05383352|Antidotes|antidotes|mesh-ancestor
19748796|NCT05383352|Protective Agents|protective agents|mesh-ancestor
19748797|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
19748798|NCT05383352|Vitamins|vitamins|mesh-ancestor
19748799|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
19748800|NCT05383352|Hematinics|hematinics|mesh-ancestor
19748801|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748802|NCT05383313|Midazolam|midazolam|mesh-list
19748803|NCT05383313|Ketamine|ketamine|mesh-list
19748804|NCT05383313|Psilocybin|psilocybin|mesh-list
19748805|NCT05383313|Analgesics|analgesics|mesh-ancestor
19748806|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
19748807|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748808|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092090|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20092091|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
20092092|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20092093|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092094|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20092095|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20092096|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19748809|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19748810|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19748811|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
19748812|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
19748813|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748814|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19748815|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19748816|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748817|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748818|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19748819|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19748820|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19748821|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748822|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748823|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
19748824|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
19748825|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
19748826|NCT05383300|Oxytocin|oxytocin|mesh-list
19748827|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
19748828|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19748829|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749461|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749462|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19749463|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19749464|NCT04988295|Carboplatin|carboplatin|mesh-list
19749465|NCT04988295|Pemetrexed|pemetrexed|mesh-list
19749466|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19749467|NCT04988295|Lazertinib|lazertinib|mesh-list
19748830|NCT05383209|Aflibercept|aflibercept|mesh-list
19748831|NCT05383209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19748832|NCT05383209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19748833|NCT05383209|Growth Substances|growth substances|mesh-ancestor
19748834|NCT05383209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748835|NCT05383209|Growth Inhibitors|growth inhibitors|mesh-ancestor
19748836|NCT05383209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748837|NCT05383196|Paclitaxel|paclitaxel|mesh-list
19748838|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19748839|NCT05383196|Onvansertib|onvansertib|mesh-list
19748840|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748841|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748842|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
19748843|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
19748844|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748845|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748846|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19748847|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748848|NCT05383183|Choline|choline|mesh-list
19748849|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
19748850|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19748851|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
19748852|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748853|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19748854|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20092097|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092098|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
20092099|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20092100|NCT00002183|Lamivudine|lamivudine|mesh-list
20092101|NCT00002183|Zidovudine|zidovudine|mesh-list
20092102|NCT00002183|Abacavir|abacavir|mesh-list
20092103|NCT00002183|Amprenavir|amprenavir|mesh-list
20092104|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092105|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092106|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092107|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092108|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
20092109|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092110|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748855|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
19748856|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
20092111|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092112|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
20092113|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19496549|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19496550|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
19496551|NCT05008224|Hormones|hormones|mesh-ancestor
19496552|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496553|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19496554|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19496555|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496556|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496557|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
19496558|NCT05007106|Gemcitabine|gemcitabine|mesh-list
19496559|NCT05007106|Docetaxel|docetaxel|mesh-list
19496560|NCT05007106|Bevacizumab|bevacizumab|mesh-list
19496561|NCT05007106|Carboplatin|carboplatin|mesh-list
19496562|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
19496563|NCT05007106|Fluorouracil|fluorouracil|mesh-list
19496564|NCT05007106|Capecitabine|capecitabine|mesh-list
19496565|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
19496566|NCT05007106|Lenvatinib|lenvatinib|mesh-list
19496567|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092114|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092115|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19496568|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496569|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
20092116|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092117|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092118|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
19496570|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
19748857|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748858|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748859|NCT05379803|Aflutinib|aflutinib|mesh-list
20092119|NCT00002184|Lamivudine|lamivudine|mesh-list
20092120|NCT00002184|Zidovudine|zidovudine|mesh-list
19496571|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092121|NCT00002184|Stavudine|stavudine|mesh-list
20092122|NCT00002184|Adefovir|adefovir|mesh-list
20092123|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19496572|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496573|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19496574|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19496575|NCT05007106|Growth Substances|growth substances|mesh-ancestor
19496576|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496577|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
19496578|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496579|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
19496580|NCT05007106|Antiviral Agents|antiviral agents|mesh-ancestor
19496581|NCT05007106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496582|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496583|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496584|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
19496585|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19496586|NCT05004350|Fluorouracil|fluorouracil|mesh-list
19496587|NCT05004350|Irinotecan|irinotecan|mesh-list
19496588|NCT05004350|Cetuximab|cetuximab|mesh-list
19496589|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
19496590|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496591|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496592|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496593|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496594|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
19496595|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496596|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19496597|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496598|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496599|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496600|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
19496601|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
19496602|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496603|NCT04998604|Omalizumab|omalizumab|mesh-list
19496604|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19496605|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19496606|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
19496607|NCT04996004|Doxorubicin|doxorubicin|mesh-list
19496608|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19496609|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496610|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19496611|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496612|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496613|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496614|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19496615|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19496616|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19496617|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496618|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496619|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19496620|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496621|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496622|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
19496623|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496624|NCT04993677|Carboplatin|carboplatin|mesh-list
19496625|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
19496626|NCT04993677|Pemetrexed|pemetrexed|mesh-list
19496627|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496628|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496629|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496630|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496631|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19496632|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19496633|NCT04990037|Folfirinox|folfirinox|mesh-list
19496634|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496635|NCT04978493|Ustekinumab|ustekinumab|mesh-list
19496636|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
19496637|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
19496638|NCT04972968|Hormones|hormones|mesh-ancestor
20092124|NCT00002184|Nelfinavir|nelfinavir|mesh-list
20092125|NCT00002184|Saquinavir|saquinavir|mesh-list
20092126|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092127|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092128|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092129|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092130|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
20092131|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496639|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496640|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496641|NCT04971785|Firsocostat|firsocostat|mesh-list
19496642|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496643|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496644|NCT04966676|Nivolumab|nivolumab|mesh-list
19496645|NCT04966676|Ipilimumab|ipilimumab|mesh-list
19496646|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496647|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496648|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19496649|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496650|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
19496651|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496652|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496653|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
19496654|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
19496655|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496656|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19496657|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748860|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19748861|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092132|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092133|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092134|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
19496663|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19496664|NCT04934228|Clonidine|clonidine|mesh-list
19496665|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19496666|NCT04934228|Diuretics|diuretics|mesh-ancestor
19496667|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
19496668|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496669|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19496670|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496671|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496672|NCT04934228|Analgesics|analgesics|mesh-ancestor
19496673|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
19496674|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496675|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
19496676|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
19496677|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19496678|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19496679|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19496680|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
19496681|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20092135|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092136|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092137|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092138|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20092139|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092140|NCT00002185|Nelfinavir|nelfinavir|mesh-list
20092141|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092142|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092143|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092144|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092145|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092146|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092147|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092148|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
20092149|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092150|NCT00002186|Acyclovir|acyclovir|mesh-list
20092151|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
20092152|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092153|NCT00002187|Fomivirsen|fomivirsen|mesh-list
20092154|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
20092155|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092156|NCT00002188|Alitretinoin|alitretinoin|mesh-list
20092157|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092158|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
20092159|NCT00002189|Paclitaxel|paclitaxel|mesh-list
20092160|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20092161|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092162|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
20092163|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
20092164|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
19496682|NCT04933942|Lomustine|lomustine|mesh-list
19496683|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19496684|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
19496685|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496686|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496687|NCT04930458|Listerine|listerine|mesh-list
19496688|NCT04930458|Calcium|calcium|mesh-list
19496689|NCT04930458|Fluorides|fluorides|mesh-list
19496690|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
19496691|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
19496692|NCT04930458|Caseins|caseins|mesh-list
19496693|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19496694|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496695|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
19496696|NCT04930458|Protective Agents|protective agents|mesh-ancestor
19496697|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19496698|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092165|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496699|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
19496700|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
19496701|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496702|NCT04926818|Ofatumumab|ofatumumab|mesh-list
19496703|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19496704|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19496705|NCT04926818|Siponimod|siponimod|mesh-list
19496706|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496707|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
19496708|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496709|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19496710|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496711|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496712|NCT04926324|Niraparib|niraparib|mesh-list
19496713|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19496714|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496715|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496716|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496717|NCT04917588|Lidocaine|lidocaine|mesh-list
19496718|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
19496719|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
19496720|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602600|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602601|NCT02216669|Imidazole|imidazole|mesh-list
20602602|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602603|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607882|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20607883|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19496721|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496722|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
19496723|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496724|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19496725|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19496726|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19496727|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19496728|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496729|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20092166|NCT00002190|Lamivudine|lamivudine|mesh-list
20092167|NCT00002190|Zidovudine|zidovudine|mesh-list
20092168|NCT00002190|Saquinavir|saquinavir|mesh-list
20092169|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092170|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092171|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092172|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092173|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
20092174|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092175|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092176|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092177|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
20092178|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092179|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092180|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092181|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20607884|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19496730|NCT04915729|Tenecteplase|tenecteplase|mesh-list
19496731|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19496732|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19496733|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496734|NCT04906395|Tamoxifen|tamoxifen|mesh-list
19496735|NCT04906395|Letrozole|letrozole|mesh-list
19496736|NCT04906395|Anastrozole|anastrozole|mesh-list
19496737|NCT04906395|Exemestane|exemestane|mesh-list
19496738|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496739|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19496740|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19496741|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496742|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496743|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19496744|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
19496745|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496746|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496747|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19496748|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19496749|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19496750|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19496751|NCT04898348|Vancomycin|vancomycin|mesh-list
19496752|NCT04898348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19496753|NCT04898348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496754|NCT04883645|Imiquimod|imiquimod|mesh-list
19496755|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19496756|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
19496757|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496758|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496759|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
19496760|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
19496761|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
19496762|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570025|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570026|NCT03761134|Metformin|metformin|mesh-list
19570027|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19570028|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570029|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570030|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19570031|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570032|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
19570033|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570034|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570035|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19570036|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19570037|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570038|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570039|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570040|NCT03743636|Niacinamide|niacinamide|mesh-list
19570041|NCT03743636|Niacin|niacin|mesh-list
19570042|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
20092182|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092183|NCT00002191|Albendazole|albendazole|mesh-list
20092184|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
19570043|NCT03743636|Resveratrol|resveratrol|mesh-list
19570044|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
19570045|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570046|NCT03743636|Protective Agents|protective agents|mesh-ancestor
19570047|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570048|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570049|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19570050|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
19570051|NCT03743636|Vitamins|vitamins|mesh-ancestor
19570052|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
19570053|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19570054|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
19570055|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19570056|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
19570057|NCT03739554|Venetoclax|venetoclax|mesh-list
19570058|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570059|NCT03719768|Avelumab|avelumab|mesh-list
19570060|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570061|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570062|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
19496763|NCT04860830|BI 425809|bi 425809|mesh-list
19496764|NCT04860830|Nootropic Agents|nootropic agents|mesh-ancestor
19496765|NCT04860518|Dexamethasone|dexamethasone|mesh-list
19496766|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20092185|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20092186|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092187|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
20092188|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20092189|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20092190|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
20092191|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
20092192|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
20092193|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092194|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092195|NCT00002192|Azithromycin|azithromycin|mesh-list
20092196|NCT00002192|Clarithromycin|clarithromycin|mesh-list
20092197|NCT00002192|Ethambutol|ethambutol|mesh-list
20092198|NCT00002192|Rifapentine|rifapentine|mesh-list
20092199|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092200|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092201|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20092202|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092203|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092204|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20602604|NCT02216747|Prednisone|prednisone|mesh-list
20602605|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602606|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
20602607|NCT02216747|Hormones|hormones|mesh-ancestor
20602608|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602609|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092205|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19496767|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
19496768|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
19496769|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496770|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496771|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19496772|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
19496773|NCT04860518|Hormones|hormones|mesh-ancestor
19496774|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496775|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19496776|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496777|NCT04859296|Dronabinol|dronabinol|mesh-list
19496778|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
19496779|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496780|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496781|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19496782|NCT04859296|Analgesics|analgesics|mesh-ancestor
19496783|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
19496784|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496785|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19496786|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19496787|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496788|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496789|NCT04859296|Hormones|hormones|mesh-ancestor
19496790|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19496791|NCT04856215|Antibodies|antibodies|mesh-list
20092206|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092207|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092208|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
20092209|NCT00002193|Amprenavir|amprenavir|mesh-list
20092210|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092211|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092212|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092213|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092214|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092215|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092216|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092217|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092218|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092219|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092220|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092221|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
19496792|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19496793|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
20092222|NCT00002194|Clarithromycin|clarithromycin|mesh-list
20092223|NCT00002194|Erythromycin|erythromycin|mesh-list
19496794|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496795|NCT04852679|Lanreotide|lanreotide|mesh-list
19496796|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496797|NCT04843761|Remdesivir|remdesivir|mesh-list
19496798|NCT04843761|Phentolamine|phentolamine|mesh-list
19496799|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
19496800|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
19496801|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496802|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
19496803|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092224|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
20092225|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20092226|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
20602610|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20092227|NCT00002194|Nevirapine|nevirapine|mesh-list
20092228|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092229|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496804|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19496805|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19496806|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
20092230|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20092231|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092232|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092233|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20092234|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092235|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092236|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092237|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
20092238|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092239|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092240|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20092241|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092242|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20092243|NCT00002195|Lamivudine|lamivudine|mesh-list
20092244|NCT00002195|Zidovudine|zidovudine|mesh-list
19496807|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496808|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496809|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19496810|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19496811|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
19496812|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19496813|NCT04843761|Protective Agents|protective agents|mesh-ancestor
19496814|NCT04842045|Midazolam|midazolam|mesh-list
19496815|NCT04842045|Psilocybin|psilocybin|mesh-list
19496816|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20092245|NCT00002195|Amprenavir|amprenavir|mesh-list
20092246|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092247|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092248|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092249|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496817|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19496818|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19496819|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496820|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19496821|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19496822|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496823|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19496824|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
19496825|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
19496826|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
19496827|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
20092250|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
20092251|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092252|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092253|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20602611|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602612|NCT02216786|Everolimus|everolimus|mesh-list
20602613|NCT02216786|Fulvestrant|fulvestrant|mesh-list
20602614|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602615|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602616|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
19496828|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496829|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602617|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496830|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
19496831|NCT04840199|Letermovir|letermovir|mesh-list
19496832|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19496833|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496834|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496835|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496836|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
19496837|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496838|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
19496839|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19496840|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
19496841|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496842|NCT04832009|Protective Agents|protective agents|mesh-ancestor
19496843|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496844|NCT04832009|Vitamins|vitamins|mesh-ancestor
19496845|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
19496846|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19496847|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19496848|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19496849|NCT04827576|Docetaxel|docetaxel|mesh-list
19496850|NCT04827576|Magrolimab|magrolimab|mesh-list
19496851|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496852|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496853|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496854|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
19496855|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496856|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496857|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
19496858|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496859|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496860|NCT04823468|Cisplatin|cisplatin|mesh-list
19496861|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496862|NCT04823442|Bisoprolol|bisoprolol|mesh-list
19496863|NCT04823442|Mirabegron|mirabegron|mesh-list
19496864|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19496865|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19496866|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19496867|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
19496868|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496869|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602618|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602619|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20602620|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19496870|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496871|NCT04823442|Urological Agents|urological agents|mesh-ancestor
19496872|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19496873|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
19496874|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
19496875|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496876|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19496877|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19496878|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19496879|NCT04820309|Xanomeline|xanomeline|mesh-list
19496880|NCT04820309|Trospium chloride|trospium chloride|mesh-list
19496881|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
19496882|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
19496883|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496884|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496885|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19496886|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19496887|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
19496888|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496889|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496890|NCT04820309|Urological Agents|urological agents|mesh-ancestor
19496891|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19496892|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496893|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19496894|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19496895|NCT04791553|Cenobamate|cenobamate|mesh-list
19496896|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
19496897|NCT04791514|Treprostinil|treprostinil|mesh-list
19496898|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19496899|NCT04785820|Nivolumab|nivolumab|mesh-list
19496900|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496901|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602621|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
19496902|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19496903|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496904|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
19496905|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496906|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19496907|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19496908|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496909|NCT04778410|Cytarabine|cytarabine|mesh-list
19496910|NCT04778410|Etoposide|etoposide|mesh-list
19496911|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
19496912|NCT04778410|Azacitidine|azacitidine|mesh-list
19496913|NCT04778410|Venetoclax|venetoclax|mesh-list
19496914|NCT04778410|Cc-486|cc-486|mesh-list
19496915|NCT04778410|Magrolimab|magrolimab|mesh-list
19496916|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19496917|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496918|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19496919|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19496920|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496921|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496922|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496923|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
19496924|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
19496925|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19496926|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496927|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
19496928|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496929|NCT04778410|Analgesics|analgesics|mesh-ancestor
19496930|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
19496931|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496932|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19496933|NCT04762498|Methotrexate|methotrexate|mesh-list
19496934|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19496935|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
19496936|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19496937|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496938|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19496939|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
19496940|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496941|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496942|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
19496943|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496944|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19496945|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19496946|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
19496947|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19496948|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19496949|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19496950|NCT04750954|Peposertib|peposertib|mesh-list
19496951|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496952|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19496953|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19496954|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496955|NCT04738123|Xanomeline|xanomeline|mesh-list
19496956|NCT04738123|Trospium chloride|trospium chloride|mesh-list
19496957|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
19496958|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
19496959|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19496960|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496961|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19496962|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19496963|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
19496964|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496965|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496966|NCT04738123|Urological Agents|urological agents|mesh-ancestor
19496967|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19496968|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496969|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19496970|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19496971|NCT04736173|Paclitaxel|paclitaxel|mesh-list
19496972|NCT04736173|Carboplatin|carboplatin|mesh-list
19496973|NCT04736173|Pemetrexed|pemetrexed|mesh-list
19496974|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19496975|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19496976|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
19496977|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
19496978|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
19496979|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496980|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19496981|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19496982|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19570063|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570064|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570065|NCT03699319|Leucovorin|leucovorin|mesh-list
19570066|NCT03699319|Folic Acid|folic acid|mesh-list
19570067|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
19570068|NCT03699319|Irinotecan|irinotecan|mesh-list
19570069|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
19570070|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570071|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570072|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19570073|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19570074|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570075|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570076|NCT03699319|Antidotes|antidotes|mesh-ancestor
19570077|NCT03699319|Protective Agents|protective agents|mesh-ancestor
19570078|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
19570079|NCT03699319|Vitamins|vitamins|mesh-ancestor
19570080|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
19570081|NCT03699319|Hematinics|hematinics|mesh-ancestor
19570082|NCT03681158|Valproic Acid|valproic acid|mesh-list
19570083|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
19570084|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570085|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570086|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
19570087|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570088|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570089|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
19570090|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19570091|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19570092|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19570093|NCT03670056|Nivolumab|nivolumab|mesh-list
19570094|NCT03670056|Ipilimumab|ipilimumab|mesh-list
19570095|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570096|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570097|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19570098|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570099|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
19570100|NCT03666000|Fludarabine|fludarabine|mesh-list
19570101|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570102|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
19570103|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602622|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602623|NCT02216799|Insulin|insulin|mesh-list
19570104|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20602624|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20092254|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
20092255|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092256|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092257|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092258|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092259|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092260|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
20120294|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20120295|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
20120296|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
20120297|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120298|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120299|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120300|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120301|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120302|NCT00006343|Interferons|interferons|mesh-list
19570105|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19570106|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
19570107|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570108|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570109|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19570110|NCT03664882|Fexofenadine|fexofenadine|mesh-list
19570111|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19570112|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19570113|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20120303|NCT00006343|Cytarabine|cytarabine|mesh-list
19496983|NCT04727138|Midazolam|midazolam|mesh-list
19496984|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19496985|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19496986|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19496987|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19496988|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19496989|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19496990|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19496991|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19496992|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
19496993|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
19496994|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
19496995|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
19496996|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19496997|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19496998|NCT04720326|Tacrolimus|tacrolimus|mesh-list
19496999|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497000|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
19497001|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497002|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19497003|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497004|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497005|NCT04718727|Olanzapine|olanzapine|mesh-list
19497006|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
19497007|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
19497008|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497009|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497010|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19497011|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19497012|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19497013|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497014|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19497015|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19497016|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19497017|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497018|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497019|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497020|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
19497021|NCT04704661|Trastuzumab|trastuzumab|mesh-list
19497022|NCT04704661|Camptothecin|camptothecin|mesh-list
19497023|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
19497024|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497025|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497026|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497027|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19497028|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19497029|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497030|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497031|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
19497032|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497033|NCT04675931|Artesunate|artesunate|mesh-list
19497034|NCT04675931|Lumefantrine|lumefantrine|mesh-list
19497035|NCT04675931|Artemether|artemether|mesh-list
19497036|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19497037|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
19497038|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19497039|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19497040|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497041|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497042|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
19497043|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
19497044|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19497045|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
19497046|NCT04674254|Bevacizumab|bevacizumab|mesh-list
19497047|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497048|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497049|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497050|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19497051|NCT04674254|Growth Substances|growth substances|mesh-ancestor
19497052|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497053|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
19497054|NCT04670471|Remifentanil|remifentanil|mesh-list
19497055|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19497056|NCT04670471|Narcotics|narcotics|mesh-ancestor
19497057|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497058|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497059|NCT04670471|Analgesics|analgesics|mesh-ancestor
19497060|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
19497061|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497062|NCT04669197|Gemcitabine|gemcitabine|mesh-list
19497063|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
19497064|NCT04669197|Paclitaxel|paclitaxel|mesh-list
19497065|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19497066|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497067|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497068|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497069|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497070|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497071|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497072|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497073|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
19497074|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
19497075|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497076|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497077|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497078|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
19497079|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497080|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
19497081|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19497082|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19497083|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497084|NCT04660812|Bevacizumab|bevacizumab|mesh-list
19497085|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497086|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497087|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497088|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19497089|NCT04660812|Growth Substances|growth substances|mesh-ancestor
19497090|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497091|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
19497092|NCT04659174|Xanomeline|xanomeline|mesh-list
19497093|NCT04659174|Trospium chloride|trospium chloride|mesh-list
19497094|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
19497095|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
19497096|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497097|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497098|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19497099|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20092261|NCT00002197|Abacavir|abacavir|mesh-list
20092262|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20602625|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
19497100|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
20092263|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092264|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092265|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092266|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
20092267|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497101|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497102|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497103|NCT04659174|Urological Agents|urological agents|mesh-ancestor
19497104|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19497105|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19497106|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19497107|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19497108|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
19497109|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497110|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497111|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
19497112|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497113|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497114|NCT04657289|Ranibizumab|ranibizumab|mesh-list
19497115|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497116|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19748862|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092268|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092269|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092270|NCT00002198|Abacavir|abacavir|mesh-list
20092271|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092272|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092273|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092274|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497117|NCT04657289|Growth Substances|growth substances|mesh-ancestor
19497118|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497119|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
19497120|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497121|NCT04654052|Clopidogrel|clopidogrel|mesh-list
19497122|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19497123|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19497124|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19497125|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19497126|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
19497127|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497128|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497129|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497130|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20092275|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
20602626|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20602627|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602628|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
20602629|NCT02216877|Antacids|antacids|mesh-ancestor
20602630|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602631|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19497131|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
19497132|NCT04644016|Cyclosporine|cyclosporine|mesh-list
19497133|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
19497134|NCT04644016|Fludarabine|fludarabine|mesh-list
19497135|NCT04644016|Busulfan|busulfan|mesh-list
19497136|NCT04644016|Clofarabine|clofarabine|mesh-list
19497137|NCT04644016|Cyclosporins|cyclosporins|mesh-list
19497138|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497139|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497140|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
19497141|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497142|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497143|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
19497144|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497145|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497146|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
19497147|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497148|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
19497149|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497150|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19497151|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19497152|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19497153|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
19497154|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19497155|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
19497156|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19497157|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19497158|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19497159|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19497160|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19497161|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497162|NCT04636671|Dexamethasone|dexamethasone|mesh-list
19497163|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
19497164|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19497165|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19497166|NCT04636671|Prednisolone|prednisolone|mesh-list
19497167|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
19497168|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19497169|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
19497170|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19497171|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
19497172|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
19497173|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497174|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497175|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19497176|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
19497177|NCT04636671|Hormones|hormones|mesh-ancestor
19497178|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19497179|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19497180|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497181|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19497182|NCT04636671|Protective Agents|protective agents|mesh-ancestor
19497183|NCT04632589|Losartan|losartan|mesh-list
20092276|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092277|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20602632|NCT02216994|Mineral Oil|mineral oil|mesh-list
19497184|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19497185|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19497186|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19497187|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19497188|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497201|NCT04603183|Paclitaxel|paclitaxel|mesh-list
19497202|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19497203|NCT04603183|Letrozole|letrozole|mesh-list
19497204|NCT04603183|Fulvestrant|fulvestrant|mesh-list
19497205|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497206|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497207|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497208|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497209|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497210|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497211|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19497212|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19497213|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497214|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19497215|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
19497216|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19497217|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497218|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19497219|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19497220|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
19497221|NCT04591626|Dulaglutide|dulaglutide|mesh-list
19497222|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19497223|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497224|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
19497225|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19497226|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
19497227|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19497228|NCT04585841|Cannabidiol|cannabidiol|mesh-list
19497229|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
19497230|NCT04581447|Metformin|metformin|mesh-list
19497231|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19497232|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570114|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
19570115|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
19570116|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570117|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570118|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570119|NCT03653507|Capecitabine|capecitabine|mesh-list
19570120|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
19570121|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19570122|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
19570123|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570124|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570125|NCT03630809|Vaccines|vaccines|mesh-list
19570126|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
19570127|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570128|NCT03589326|Cytarabine|cytarabine|mesh-list
19570129|NCT03589326|Dexamethasone|dexamethasone|mesh-list
19570130|NCT03589326|Prednisone|prednisone|mesh-list
19570131|NCT03589326|Methotrexate|methotrexate|mesh-list
19570132|NCT03589326|Vincristine|vincristine|mesh-list
19570133|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
19570134|NCT03589326|Ponatinib|ponatinib|mesh-list
19570135|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570136|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
19570137|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
19570138|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570139|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570140|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19570141|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
20092278|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19497239|NCT04574479|Morphine|morphine|mesh-list
19497240|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19497241|NCT04574479|Narcotics|narcotics|mesh-ancestor
19497242|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497243|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497244|NCT04574479|Analgesics|analgesics|mesh-ancestor
19497245|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
19497246|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497247|NCT04569032|Prednisone|prednisone|mesh-list
19497248|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
19497249|NCT04569032|Doxorubicin|doxorubicin|mesh-list
19497250|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19497251|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497252|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
19497253|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497254|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497255|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19497256|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
19497257|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602633|NCT02216994|Lactulose|lactulose|mesh-list
20602634|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602635|NCT02216994|Emollients|emollients|mesh-ancestor
20602636|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602637|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
20602638|NCT02217007|Acamprosate|acamprosate|mesh-list
20602639|NCT02217007|Calcium|calcium|mesh-list
20602640|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20602641|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602642|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20602643|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20602644|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
19497258|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497259|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19497260|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20092279|NCT00002199|Lamivudine|lamivudine|mesh-list
20092280|NCT00002199|Zidovudine|zidovudine|mesh-list
19497261|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19497262|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19497263|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497264|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19497265|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
19497266|NCT04569032|Hormones|hormones|mesh-ancestor
19497267|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19497268|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19497269|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497270|NCT04551040|Terazosin|terazosin|mesh-list
19497271|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19497272|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19497273|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19497274|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
19497275|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497276|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497277|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497278|NCT04551040|Urological Agents|urological agents|mesh-ancestor
19497279|NCT04550494|Talazoparib|talazoparib|mesh-list
19497280|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19497281|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497282|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497283|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497284|NCT04546425|Vaccines|vaccines|mesh-list
19497285|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19497286|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
19497287|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497288|NCT04542837|Lenvatinib|lenvatinib|mesh-list
19497289|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092281|NCT00002199|Abacavir|abacavir|mesh-list
19570142|NCT03589326|Hormones|hormones|mesh-ancestor
20092282|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20602645|NCT02217020|Irinotecan|irinotecan|mesh-list
19497290|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19497291|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497292|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497302|NCT04531462|Empagliflozin|empagliflozin|mesh-list
19497303|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19497304|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497305|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19497306|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497307|NCT04520048|Acetylcholine|acetylcholine|mesh-list
19497308|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
19497309|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19497310|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
19497311|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497312|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497313|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497314|NCT04512430|Bevacizumab|bevacizumab|mesh-list
19497315|NCT04512430|Carboplatin|carboplatin|mesh-list
19497316|NCT04512430|Pemetrexed|pemetrexed|mesh-list
19497317|NCT04512430|Atezolizumab|atezolizumab|mesh-list
19497318|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497319|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497320|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497321|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19497322|NCT04512430|Growth Substances|growth substances|mesh-ancestor
19497323|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497324|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
19497325|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497326|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497327|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19497328|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19497329|NCT04503551|Ranibizumab|ranibizumab|mesh-list
19497330|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497331|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19497332|NCT04503551|Growth Substances|growth substances|mesh-ancestor
19497333|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497334|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
19497335|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497336|NCT04499924|Paclitaxel|paclitaxel|mesh-list
19497337|NCT04499924|Trastuzumab|trastuzumab|mesh-list
19497338|NCT04499924|Ramucirumab|ramucirumab|mesh-list
19497339|NCT04499924|Tucatinib|tucatinib|mesh-list
19497340|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497341|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497342|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497343|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497344|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497345|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497346|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497347|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19497348|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497349|NCT04495868|Lidocaine|lidocaine|mesh-list
19497350|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
19497351|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
19497352|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497353|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497354|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
19497355|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20092283|NCT00002199|Indinavir|indinavir|mesh-list
20092284|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092285|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092286|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092287|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092288|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
20092289|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092290|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19497356|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19497357|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19497358|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19497359|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497360|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497361|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
19497362|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497363|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19497364|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497365|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497366|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
19497367|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19497368|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497369|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19497370|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
19497371|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19497372|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497373|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19497374|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497395|NCT04474366|Ropivacaine|ropivacaine|mesh-list
19497396|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
19497397|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
19497398|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497399|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497400|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
19497401|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497402|NCT04472611|Colchicine|colchicine|mesh-list
19497403|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19497404|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19497405|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19497406|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
19497407|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497408|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19497409|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19497410|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497411|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
19497412|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497413|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497414|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497415|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497416|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497417|NCT04463693|Etonogestrel|etonogestrel|mesh-list
19497418|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19497419|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
19497420|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19497421|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497422|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19497423|NCT04449861|Durvalumab|durvalumab|mesh-list
19497424|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497425|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497426|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
19497427|NCT04438213|Metolazone|metolazone|mesh-list
20092291|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092292|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
20092293|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092294|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19497428|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19497429|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497430|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19497431|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497432|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19497433|NCT04438213|Diuretics|diuretics|mesh-ancestor
19497434|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
19497435|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19497436|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497437|NCT04434664|Metoprolol|metoprolol|mesh-list
19497438|NCT04434664|Amlodipine|amlodipine|mesh-list
19497439|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19497440|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19497441|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497442|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497443|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19497444|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497445|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
19497446|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19497447|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
19497448|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
19497449|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497450|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19497451|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19497452|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19497453|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
19497454|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497455|NCT04433494|Tamoxifen|tamoxifen|mesh-list
20092295|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092296|NCT00002200|Abacavir|abacavir|mesh-list
20092297|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092298|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092299|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092300|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092301|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
20092302|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092303|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092304|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092305|NCT00002201|Ritonavir|ritonavir|mesh-list
20092306|NCT00002201|Nelfinavir|nelfinavir|mesh-list
20092307|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092308|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092309|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092310|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092311|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092312|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19497456|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19497457|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
19497458|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20092313|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092314|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
20092315|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497459|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497460|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19497461|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497462|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19497463|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20602646|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602647|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20602648|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20602649|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608147|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497464|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19497465|NCT04431453|Remdesivir|remdesivir|mesh-list
19497466|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
19497467|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497468|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
20092316|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20092317|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19497469|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497470|NCT04423211|Leuprolide|leuprolide|mesh-list
19497471|NCT04423211|Goserelin|goserelin|mesh-list
19497472|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19497473|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
19497474|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19497475|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497476|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19497477|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497478|NCT04417517|Azacitidine|azacitidine|mesh-list
19497479|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497480|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
19497481|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497482|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497483|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497484|NCT04411836|Primaquine|primaquine|mesh-list
19497485|NCT04411836|Tafenoquine|tafenoquine|mesh-list
20092318|NCT00002202|Indinavir|indinavir|mesh-list
20092319|NCT00002202|Amprenavir|amprenavir|mesh-list
20092320|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092321|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092322|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
19497486|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
19497487|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19497488|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19497489|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497490|NCT04406857|Capecitabine|capecitabine|mesh-list
19497491|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
20092323|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092324|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092325|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092326|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092327|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
20092328|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092329|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092330|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092331|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092332|NCT00002203|Lamivudine|lamivudine|mesh-list
20092333|NCT00002203|Zidovudine|zidovudine|mesh-list
20092334|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20092335|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092336|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092337|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092338|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092339|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
20092340|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092341|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19497492|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497493|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
19497494|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497495|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497496|NCT04404283|Rituximab|rituximab|mesh-list
19497497|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19497498|NCT04404283|Lenalidomide|lenalidomide|mesh-list
19497499|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497500|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497501|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
19497502|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497503|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497504|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497505|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19497506|NCT04404283|Growth Substances|growth substances|mesh-ancestor
19497507|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19748863|NCT05376111|Azacitidine|azacitidine|mesh-list
19748864|NCT05376111|Venetoclax|venetoclax|mesh-list
19748865|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19748866|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
19748867|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748868|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748869|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497515|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
19497516|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19497517|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
19497518|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497519|NCT04381897|Expectorants|expectorants|mesh-ancestor
19497520|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
20092342|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092343|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
19497521|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19497522|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
19497523|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497524|NCT04381897|Protective Agents|protective agents|mesh-ancestor
19497525|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497526|NCT04381897|Antidotes|antidotes|mesh-ancestor
19570143|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570144|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19570145|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570146|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19570147|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
19570148|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19570149|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19570150|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
19570151|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570152|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
19570153|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570154|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19570155|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570156|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
19570157|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570158|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19570159|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
19570160|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570161|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19570162|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
19570163|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
19570164|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
19570165|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19570166|NCT03583658|Ambroxol|ambroxol|mesh-list
19570167|NCT03583658|Expectorants|expectorants|mesh-ancestor
19570168|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
19570169|NCT03555968|Dronabinol|dronabinol|mesh-list
19570170|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
19570171|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570172|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19570173|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19570174|NCT03555968|Analgesics|analgesics|mesh-ancestor
19570175|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
19570176|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570177|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19570178|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19570179|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570180|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570181|NCT03555968|Hormones|hormones|mesh-ancestor
19570182|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570183|NCT03529123|Insulin|insulin|mesh-list
19570184|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19570185|NCT03529123|Metformin|metformin|mesh-list
19570186|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
19570187|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
19570188|NCT03529123|Lixisenatide|lixisenatide|mesh-list
19570189|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570190|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577836|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577837|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577838|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577839|NCT03873337|Nicotine|nicotine|mesh-list
19577840|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19577841|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
19577842|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577843|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577844|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19577845|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19577846|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
19577847|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577848|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577849|NCT03863587|Ramucirumab|ramucirumab|mesh-list
19577850|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577851|NCT03861988|Ketamine|ketamine|mesh-list
19577852|NCT03861988|Analgesics|analgesics|mesh-ancestor
19497527|NCT04368364|Morphine|morphine|mesh-list
19497528|NCT04368364|Bupivacaine|bupivacaine|mesh-list
19497529|NCT04368364|Ropivacaine|ropivacaine|mesh-list
19497530|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
19497531|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
19497532|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497533|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497534|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
19497535|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497536|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19497537|NCT04368364|Narcotics|narcotics|mesh-ancestor
19497538|NCT04368364|Analgesics|analgesics|mesh-ancestor
19497539|NCT04353661|Azithromycin|azithromycin|mesh-list
19497540|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19497541|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497542|NCT04348292|Sirolimus|sirolimus|mesh-list
19497543|NCT04348292|Durvalumab|durvalumab|mesh-list
19497544|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
19497545|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19497546|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
19497547|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19497548|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497549|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19497550|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497551|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
19497552|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497553|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
19497554|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497555|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497556|NCT04323566|Rituximab|rituximab|mesh-list
19497557|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497558|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497559|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
19497560|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497561|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497562|NCT04323436|Spartalizumab|spartalizumab|mesh-list
19497563|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19497564|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497565|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497566|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
19497567|NCT04319328|Cefazolin|cefazolin|mesh-list
19497568|NCT04319328|Ceftazidime|ceftazidime|mesh-list
19497569|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19497570|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497571|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19497572|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19497573|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497574|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497575|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497576|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19497577|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19497578|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
19497579|NCT04318678|Rituximab|rituximab|mesh-list
19497580|NCT04318678|Fludarabine|fludarabine|mesh-list
19497581|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497582|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
19497583|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497584|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497585|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19497586|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
19497587|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497588|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497589|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19497590|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497591|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
19497592|NCT04305054|Lenvatinib|lenvatinib|mesh-list
19497593|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20092344|NCT00002205|Abacavir|abacavir|mesh-list
20092345|NCT00002205|Amprenavir|amprenavir|mesh-list
20092346|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19497594|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497595|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19497596|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497597|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497598|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
20120304|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
19497599|NCT04303000|Naloxone|naloxone|mesh-list
19497600|NCT04303000|Narcotics|narcotics|mesh-ancestor
19497601|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497602|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497603|NCT04303000|Analgesics|analgesics|mesh-ancestor
19497604|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
19497605|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497606|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19497607|NCT04302870|Memantine|memantine|mesh-list
19497608|NCT04302870|Trazodone|trazodone|mesh-list
19497609|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19497610|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19497611|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19497612|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
19497613|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497614|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497615|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497616|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19497617|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19497618|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19497619|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19497620|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497621|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19497622|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19497623|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19497624|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497625|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
19497626|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19497627|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
19497628|NCT04299113|Vinorelbine|vinorelbine|mesh-list
19497629|NCT04299113|Mocetinostat|mocetinostat|mesh-list
19497630|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497631|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497632|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497633|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497634|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497635|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497636|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19497637|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497638|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
19497639|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19497640|NCT04285567|Rituximab|rituximab|mesh-list
19497641|NCT04285567|Fludarabine|fludarabine|mesh-list
19497642|NCT04285567|Venetoclax|venetoclax|mesh-list
19497643|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
19497644|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497645|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
19497646|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497647|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497648|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19497649|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
19497650|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497651|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497652|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19497653|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497654|NCT04284774|Tipifarnib|tipifarnib|mesh-list
19497655|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602650|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497656|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
19497657|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19497658|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19497659|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19497660|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497661|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497662|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
19497663|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497664|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497665|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19497666|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497667|NCT04274426|Gemcitabine|gemcitabine|mesh-list
19497668|NCT04274426|Paclitaxel|paclitaxel|mesh-list
19497669|NCT04274426|Maytansine|maytansine|mesh-list
19497670|NCT04274426|Carboplatin|carboplatin|mesh-list
19497671|NCT04274426|Doxorubicin|doxorubicin|mesh-list
19497672|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19497673|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497674|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497675|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497676|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497677|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497678|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497679|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497680|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
19497681|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
19497682|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497683|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497684|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497685|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
19497686|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497687|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19497688|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19497689|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19497690|NCT04250155|Atezolizumab|atezolizumab|mesh-list
19497691|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497692|NCT04249401|Warfarin|warfarin|mesh-list
19497693|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
19497694|NCT04249401|Dabigatran|dabigatran|mesh-list
19497695|NCT04249401|Apixaban|apixaban|mesh-list
19497696|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
19497697|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19497698|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
19497699|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19497700|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
19497701|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497702|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497703|NCT04245865|Leucovorin|leucovorin|mesh-list
19497704|NCT04245865|Tocotrienols|tocotrienols|mesh-list
19497705|NCT04245865|Vitamin E|vitamin e|mesh-list
19497706|NCT04245865|Tocopherols|tocopherols|mesh-list
19497707|NCT04245865|Bevacizumab|bevacizumab|mesh-list
19497708|NCT04245865|Fluorouracil|fluorouracil|mesh-list
19497709|NCT04245865|Capecitabine|capecitabine|mesh-list
19497710|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
19497711|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
19497712|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497713|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497714|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497715|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19497716|NCT04245865|Growth Substances|growth substances|mesh-ancestor
19497717|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497718|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
19497719|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
19497720|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497721|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497722|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497723|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
19497724|NCT04245865|Antidotes|antidotes|mesh-ancestor
19497725|NCT04245865|Protective Agents|protective agents|mesh-ancestor
19497726|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
19497727|NCT04245865|Vitamins|vitamins|mesh-ancestor
19497728|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
19497729|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
19497730|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19497731|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497732|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19497733|NCT04230148|Triclabendazole|triclabendazole|mesh-list
19497734|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19497735|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
19497736|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19497737|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497738|NCT04227678|Heparin|heparin|mesh-list
19497739|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
19497740|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19497741|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19497742|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497743|NCT04222972|Gemcitabine|gemcitabine|mesh-list
19497744|NCT04222972|Paclitaxel|paclitaxel|mesh-list
19497745|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19497746|NCT04222972|Carboplatin|carboplatin|mesh-list
19497747|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
19497748|NCT04222972|Pemetrexed|pemetrexed|mesh-list
19497749|NCT04222972|Pralsetinib|pralsetinib|mesh-list
19497750|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497751|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497752|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497753|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497754|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497755|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497756|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497757|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
19497758|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
19497759|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497760|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497761|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19497762|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
19497763|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497764|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497765|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19497766|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19497767|NCT04221880|Lidocaine|lidocaine|mesh-list
19497768|NCT04221880|Bupivacaine|bupivacaine|mesh-list
20092347|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092348|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092349|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092350|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
20092351|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092352|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092353|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092354|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092355|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092356|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092357|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092358|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19497769|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19497770|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
19497771|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
19497772|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497773|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497774|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
19497775|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497776|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19497777|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19497778|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19497779|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497780|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497781|NCT04219449|Protein C|protein c|mesh-list
19497782|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
19497783|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19497784|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19497785|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497786|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
19497787|NCT04201457|Trametinib|trametinib|mesh-list
19497788|NCT04201457|Dabrafenib|dabrafenib|mesh-list
19497789|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19497790|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
20092359|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092360|NCT00002206|Adefovir|adefovir|mesh-list
20602651|NCT02217163|Dexamethasone|dexamethasone|mesh-list
19497791|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19497792|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19497793|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19497794|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497795|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497796|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497797|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497798|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19497799|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19497800|NCT04201457|Protective Agents|protective agents|mesh-ancestor
19497801|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497802|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19497803|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
19497804|NCT04199221|Vaccines|vaccines|mesh-list
19497805|NCT04199221|Immunologic Factors|immunologic factors|mesh-ancestor
19497806|NCT04199221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497807|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19497808|NCT04197687|Trastuzumab|trastuzumab|mesh-list
19497809|NCT04197687|Pertuzumab|pertuzumab|mesh-list
19497810|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19497811|NCT04197687|Maytansine|maytansine|mesh-list
19497812|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19497813|NCT04197687|Vaccines|vaccines|mesh-list
19497814|NCT04197687|Antibodies|antibodies|mesh-list
19497815|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
19497816|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19497817|NCT04197687|Sargramostim|sargramostim|mesh-list
19497818|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
19497819|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
19497820|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497821|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497822|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497823|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497824|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497825|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497826|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497827|NCT04195555|Ivosidenib|ivosidenib|mesh-list
19497828|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497829|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497830|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497831|NCT04191304|Benralizumab|benralizumab|mesh-list
19497832|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19497833|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19497834|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
19497835|NCT04189588|Promethazine|promethazine|mesh-list
19497836|NCT04189588|Cetirizine|cetirizine|mesh-list
19497837|NCT04189588|Paclitaxel|paclitaxel|mesh-list
19497838|NCT04189588|Rituximab|rituximab|mesh-list
19497839|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497840|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497841|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497842|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497843|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497844|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497845|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497846|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
19497847|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497848|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497849|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19497850|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19497851|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19497852|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
19497853|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
19497854|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
19497855|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497856|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
19497857|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
19497858|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19497859|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19497860|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
19497861|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
19497862|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497863|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19497864|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
19497865|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
19497866|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19497867|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
19497868|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497869|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497870|NCT04181008|Amiloride|amiloride|mesh-list
19497871|NCT04181008|Diuretics|diuretics|mesh-ancestor
19497872|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
20092361|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19497873|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497874|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19497875|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19497876|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497877|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497878|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19497879|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19497880|NCT04180397|Furosemide|furosemide|mesh-list
19497881|NCT04180397|Diuretics|diuretics|mesh-ancestor
19497882|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
19497883|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497884|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19497885|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19497886|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497887|NCT04175470|Tocotrienols|tocotrienols|mesh-list
19497888|NCT04175470|Vitamin E|vitamin e|mesh-list
19497889|NCT04175470|Tocopherols|tocopherols|mesh-list
19497890|NCT04175470|Bevacizumab|bevacizumab|mesh-list
19497891|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497892|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497893|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19497894|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19497895|NCT04175470|Growth Substances|growth substances|mesh-ancestor
19497896|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497897|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
19497898|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
19497899|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497900|NCT04175470|Protective Agents|protective agents|mesh-ancestor
19497901|NCT04175470|Vitamins|vitamins|mesh-ancestor
20092362|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
19497902|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
19497903|NCT04168931|Trastuzumab|trastuzumab|mesh-list
19497904|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497905|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570191|NCT03514732|Melatonin|melatonin|mesh-list
19570192|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
19570193|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570194|NCT03514732|Protective Agents|protective agents|mesh-ancestor
19570195|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570196|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19570197|NCT03498313|Estradiol|estradiol|mesh-list
19570198|NCT03498313|Progesterone|progesterone|mesh-list
19570199|NCT03498313|Estrogens|estrogens|mesh-ancestor
19570200|NCT03498313|Hormones|hormones|mesh-ancestor
19570201|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570202|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570203|NCT03498313|Progestins|progestins|mesh-ancestor
19570204|NCT03492099|Buprenorphine|buprenorphine|mesh-list
19570205|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19570206|NCT03492099|Narcotics|narcotics|mesh-ancestor
19570207|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19570208|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570209|NCT03492099|Analgesics|analgesics|mesh-ancestor
19570210|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
19570211|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570212|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19570213|NCT03485547|Venetoclax|venetoclax|mesh-list
19570214|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570215|NCT03481959|Methylphenidate|methylphenidate|mesh-list
19570216|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19570217|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570218|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19570219|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19570220|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19570221|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570222|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
19570223|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570224|NCT03479502|Doxycycline|doxycycline|mesh-list
19570225|NCT03479502|Prednisone|prednisone|mesh-list
19570226|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
20092363|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570227|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19570228|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19497906|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
19497907|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19497908|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
19497909|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497910|NCT04165096|Acetaminophen|acetaminophen|mesh-list
19497911|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
19497912|NCT04165096|Promethazine|promethazine|mesh-list
19497913|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
19497914|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497915|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497916|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19497917|NCT04165096|Analgesics|analgesics|mesh-ancestor
19497918|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
19497919|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497920|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497921|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
19497922|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19497923|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19497924|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20092364|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092365|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092366|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497925|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
19497926|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
19497927|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
19497928|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
19497929|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19497930|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19497931|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
19497932|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
19497933|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19497934|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497935|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19497936|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
19497937|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
19497938|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
19497939|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497940|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497941|NCT04165070|Paclitaxel|paclitaxel|mesh-list
19497942|NCT04165070|Carboplatin|carboplatin|mesh-list
19497943|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
19497944|NCT04165070|Pemetrexed|pemetrexed|mesh-list
20092367|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092368|NCT00002208|Lamivudine|lamivudine|mesh-list
20092369|NCT00002208|Zidovudine|zidovudine|mesh-list
20092370|NCT00002208|Stavudine|stavudine|mesh-list
20092371|NCT00002208|Indinavir|indinavir|mesh-list
20092372|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092373|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19497945|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19497946|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497947|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
19497948|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
19497949|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
19497950|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497951|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497952|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497953|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19497954|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19497955|NCT04150562|Avelumab|avelumab|mesh-list
19497956|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19497957|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497958|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19497959|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
19497960|NCT04146038|Azacitidine|azacitidine|mesh-list
19497961|NCT04146038|Decitabine|decitabine|mesh-list
19497962|NCT04146038|Venetoclax|venetoclax|mesh-list
19497963|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19497964|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
19497965|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19497966|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497967|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092374|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19497968|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19497969|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19497970|NCT04146038|Analgesics|analgesics|mesh-ancestor
19497971|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
19497972|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497973|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497974|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19497975|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497976|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19497977|NCT04125836|Octreotide|octreotide|mesh-list
19497978|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19497979|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19497980|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497981|NCT04115748|Adalimumab|adalimumab|mesh-list
19497982|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19497983|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19497984|NCT04113018|Dexamethasone|dexamethasone|mesh-list
19497985|NCT04113018|Lenalidomide|lenalidomide|mesh-list
19497986|NCT04113018|Daratumumab|daratumumab|mesh-list
19497987|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19497988|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
19497989|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
19497990|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19497991|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19497992|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19497993|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
19497994|NCT04113018|Hormones|hormones|mesh-ancestor
20092375|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092376|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
20092377|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092378|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092379|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092380|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
20092381|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092382|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092383|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
19497995|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19497996|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19497997|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19497998|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
19497999|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19498000|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19498001|NCT04113018|Growth Substances|growth substances|mesh-ancestor
19498002|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
19498011|NCT04087408|Hormones|hormones|mesh-list
19498012|NCT04087408|Progesterone|progesterone|mesh-list
19498013|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498014|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498015|NCT04087408|Progestins|progestins|mesh-ancestor
19498016|NCT04084951|Nivolumab|nivolumab|mesh-list
19498017|NCT04084951|Ipilimumab|ipilimumab|mesh-list
19498018|NCT04084951|Atezolizumab|atezolizumab|mesh-list
19498019|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498020|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498021|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19498022|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498023|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19498024|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498025|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19498026|NCT04076462|Octreotide|octreotide|mesh-list
19498027|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20092384|NCT00002210|Delavirdine|delavirdine|mesh-list
20092385|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092386|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20602652|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
20602653|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602654|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
19498028|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19498029|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498030|NCT04076059|Androgens|androgens|mesh-list
19498031|NCT04076059|Hormones|hormones|mesh-ancestor
19498032|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498033|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498034|NCT04059172|Ibuprofen|ibuprofen|mesh-list
19498035|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19498036|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19498037|NCT04059172|Analgesics|analgesics|mesh-ancestor
19498038|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
19498039|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498040|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498041|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498042|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19498043|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19498044|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498045|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498067|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
19498068|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19498069|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19498070|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498071|NCT04025775|Insulin|insulin|mesh-list
19498072|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19498073|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498074|NCT04025372|Bicalutamide|bicalutamide|mesh-list
19498075|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
19498076|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
19498077|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498078|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498079|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498080|NCT04022876|Carboplatin|carboplatin|mesh-list
19498081|NCT04022876|Pemetrexed|pemetrexed|mesh-list
19498082|NCT04022876|Topotecan|topotecan|mesh-list
19498083|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498084|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498085|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498086|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19498087|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498088|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19498089|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19498090|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
19498091|NCT04021550|Telmisartan|telmisartan|mesh-list
19498092|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19498093|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19498094|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19498095|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498096|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
20092387|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092388|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498097|NCT04021550|Protective Agents|protective agents|mesh-ancestor
19498098|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498099|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
19498100|NCT04021550|Vitamins|vitamins|mesh-ancestor
19498101|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
19498102|NCT04016805|Venetoclax|venetoclax|mesh-list
19498103|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
20092389|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
19498104|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498105|NCT04014790|KRN 7000|krn 7000|mesh-list
19498106|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19498107|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
19498108|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498109|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498110|NCT04009343|Lumefantrine|lumefantrine|mesh-list
19498111|NCT04009343|Artemether|artemether|mesh-list
19498112|NCT04009343|Piperaquine|piperaquine|mesh-list
19498113|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19498114|NCT04009343|Artenimol|artenimol|mesh-list
19498115|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
19498116|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19498117|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19498118|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498119|NCT03994731|Acetaminophen|acetaminophen|mesh-list
19498120|NCT03994731|Folic Acid|folic acid|mesh-list
19498121|NCT03994731|Fexofenadine|fexofenadine|mesh-list
19498122|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
19498123|NCT03994731|Methotrexate|methotrexate|mesh-list
19498124|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19498125|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
19498126|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19498127|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498128|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498129|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
19498130|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498131|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498132|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
19498133|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498134|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19498135|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498136|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
19498137|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19498138|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498139|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19498140|NCT03994731|Analgesics|analgesics|mesh-ancestor
19498141|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
19498142|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498143|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
19498144|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498145|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
19498146|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
19498147|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19498148|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
19498149|NCT03994731|Hormones|hormones|mesh-ancestor
19498150|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498151|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19498152|NCT03994731|Protective Agents|protective agents|mesh-ancestor
19498153|NCT03994731|Hematinics|hematinics|mesh-ancestor
19498154|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
19498155|NCT03994731|Vitamins|vitamins|mesh-ancestor
19498156|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
19498157|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19498158|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19498159|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19498160|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
19498161|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
19498162|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498163|NCT03991013|Dolutegravir|dolutegravir|mesh-list
19498164|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19498165|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19498166|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498167|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498168|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19498169|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19498170|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
19498171|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498172|NCT03976258|Naltrexone|naltrexone|mesh-list
19498173|NCT03976258|Buprenorphine|buprenorphine|mesh-list
19498174|NCT03976258|Methadone|methadone|mesh-list
19498175|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19498176|NCT03976258|Heroin|heroin|mesh-list
19498177|NCT03976258|Naloxone|naloxone|mesh-list
19498178|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19498179|NCT03976258|Narcotics|narcotics|mesh-ancestor
19498180|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19498181|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498182|NCT03976258|Analgesics|analgesics|mesh-ancestor
19498183|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
19498184|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498185|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19498186|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19498187|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
19498188|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
19498189|NCT03975647|Tucatinib|tucatinib|mesh-list
19498190|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498191|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498192|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498193|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498194|NCT03971708|Lidocaine|lidocaine|mesh-list
19498195|NCT03971708|Ropivacaine|ropivacaine|mesh-list
19498196|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
19498197|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
19498198|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19498199|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498200|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
19498201|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498202|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19498203|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19498204|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19498205|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19498206|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570229|NCT03479502|Prednisolone|prednisolone|mesh-list
19570230|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
19570231|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19570232|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
19570233|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570234|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
19570235|NCT03479502|Hormones|hormones|mesh-ancestor
19570236|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570237|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570238|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19570239|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570240|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
19570241|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
19570242|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570243|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19570244|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19570245|NCT03479502|Protective Agents|protective agents|mesh-ancestor
19570246|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570247|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570248|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
19570249|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19570250|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19570251|NCT03462069|Empagliflozin|empagliflozin|mesh-list
19570252|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19570253|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19570254|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570255|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570256|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570257|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
19570258|NCT03462017|Acetylcholine|acetylcholine|mesh-list
19570259|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
19570260|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19570261|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19570262|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570263|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570264|NCT03462017|Urological Agents|urological agents|mesh-ancestor
19570265|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19570266|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
19570267|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570268|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570269|NCT03436498|Insulin|insulin|mesh-list
19570270|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19570271|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
19570272|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
19570273|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19570274|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570275|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570276|NCT03435952|Doxycycline|doxycycline|mesh-list
19570277|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
19498207|NCT03966014|Amoxicillin|amoxicillin|mesh-list
19498208|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19498209|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498210|NCT03965728|Methotrexate|methotrexate|mesh-list
19498211|NCT03965728|Midazolam|midazolam|mesh-list
19498212|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19498213|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
19498214|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19498215|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498216|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498217|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
19498218|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498219|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498220|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
19498221|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498222|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19498223|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498224|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
20092390|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092391|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092392|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092393|NCT00002211|Stavudine|stavudine|mesh-list
20092394|NCT00002211|Didanosine|didanosine|mesh-list
20092395|NCT00002211|Delavirdine|delavirdine|mesh-list
20092396|NCT00002211|Nelfinavir|nelfinavir|mesh-list
20092397|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
20092398|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092399|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19498225|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19498226|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498227|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19498228|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19498229|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19498230|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19498231|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19498232|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19498233|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19498234|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
19498235|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
19498236|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
19498237|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
19498238|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498239|NCT03963895|Thrombin|thrombin|mesh-list
19498240|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
19498241|NCT03963895|Coagulants|coagulants|mesh-ancestor
19498242|NCT03956446|Doxycycline|doxycycline|mesh-list
19498243|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092400|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092401|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092402|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
20092403|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092404|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092405|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092406|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092407|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092408|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092409|NCT00002212|Bexarotene|bexarotene|mesh-list
20092410|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092411|NCT00002213|Efavirenz|efavirenz|mesh-list
20092412|NCT00002213|Abacavir|abacavir|mesh-list
20092413|NCT00002213|Amprenavir|amprenavir|mesh-list
20092414|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092415|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092416|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092417|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092418|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
20092419|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092420|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092421|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092422|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20092423|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20092424|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092425|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20092426|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19498244|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498245|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
19498246|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20092427|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19498247|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19498248|NCT03955172|Everolimus|everolimus|mesh-list
19498249|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498250|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498251|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
19498252|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498253|NCT03954613|Memantine|memantine|mesh-list
19498254|NCT03954613|Donepezil|donepezil|mesh-list
19498255|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19498256|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498257|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498258|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
19498259|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498260|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498261|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
19498262|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19498263|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19498264|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
19498265|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19498266|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19498267|NCT03946800|Durvalumab|durvalumab|mesh-list
19498268|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20092428|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092429|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092430|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092431|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092432|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092433|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092434|NCT00002214|Capravirine|capravirine|mesh-list
20092435|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092436|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092437|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092438|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498269|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498270|NCT03934307|Irbesartan|irbesartan|mesh-list
19498271|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19498272|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19498273|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19498274|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498275|NCT03932201|Factor VIII|factor viii|mesh-list
19498276|NCT03932201|Coagulants|coagulants|mesh-ancestor
19498277|NCT03924635|Budesonide|budesonide|mesh-list
19498278|NCT03924635|Albuterol|albuterol|mesh-list
19498279|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
19498280|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19498281|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498282|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19498283|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
19498284|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498285|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498286|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19498287|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
19498288|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
19498289|NCT03924635|Hormones|hormones|mesh-ancestor
19498290|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498291|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19498292|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19498293|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19498294|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
19498295|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498296|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498297|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
19498298|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19498299|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
19498300|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19498301|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498302|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
19498303|NCT03914300|Nivolumab|nivolumab|mesh-list
19498304|NCT03914300|Ipilimumab|ipilimumab|mesh-list
19498305|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498306|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498307|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19498308|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498309|NCT03909165|Atropine|atropine|mesh-list
19498310|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
19498311|NCT03909165|Neostigmine|neostigmine|mesh-list
19498312|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19498313|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19498314|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19498315|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
19498316|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498317|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498318|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19498319|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
19498320|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
19498321|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
19498322|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19498323|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19498324|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
19498325|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498326|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498327|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19498328|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498329|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20092439|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
20092440|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092441|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092442|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092443|NCT00002215|Nelfinavir|nelfinavir|mesh-list
20092444|NCT00002215|Emivirine|emivirine|mesh-list
20092445|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092446|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092447|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092448|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092449|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092450|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092451|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092452|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
20092453|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092454|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092455|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092456|NCT00002216|Lamivudine|lamivudine|mesh-list
20092457|NCT00002216|Zidovudine|zidovudine|mesh-list
20092458|NCT00002216|Abacavir|abacavir|mesh-list
20092459|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20092460|NCT00002216|Nelfinavir|nelfinavir|mesh-list
19498330|NCT03906721|Oxycodone|oxycodone|mesh-list
20092461|NCT00002216|Amprenavir|amprenavir|mesh-list
20092462|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092463|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092464|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092465|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498331|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19498332|NCT03906721|Narcotics|narcotics|mesh-ancestor
19498333|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19498334|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498335|NCT03906721|Analgesics|analgesics|mesh-ancestor
19498336|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
19498337|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498338|NCT03905811|Terazosin|terazosin|mesh-list
19498339|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19498340|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19498341|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19498342|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
20092466|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
20092467|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092468|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092469|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092470|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
20092471|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19498343|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498344|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498345|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498346|NCT03905811|Urological Agents|urological agents|mesh-ancestor
19498347|NCT03889275|Durvalumab|durvalumab|mesh-list
19498348|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498349|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498350|NCT03878368|Sulforaphane|sulforaphane|mesh-list
20092472|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092473|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
19498351|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20120305|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
19498352|NCT03878368|Protective Agents|protective agents|mesh-ancestor
19498353|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498354|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498355|NCT03870399|Tamoxifen|tamoxifen|mesh-list
19498356|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19498357|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
19498358|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498359|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498360|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19498361|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498362|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19498363|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19498364|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19498365|NCT03867201|Erenumab|erenumab|mesh-list
19498366|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19498367|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498368|NCT03867201|Analgesics|analgesics|mesh-ancestor
19498369|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
19498370|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498371|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498372|NCT03850782|Bimatoprost|bimatoprost|mesh-list
19498373|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19498374|NCT03822351|Durvalumab|durvalumab|mesh-list
19498375|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19498376|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498377|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498378|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
19498379|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498380|NCT03818061|Bevacizumab|bevacizumab|mesh-list
19498381|NCT03818061|Atezolizumab|atezolizumab|mesh-list
19498382|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498383|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498384|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19498385|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19498386|NCT03818061|Growth Substances|growth substances|mesh-ancestor
19498387|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498388|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
19498389|NCT03807843|Vaccines|vaccines|mesh-list
19498390|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
19498391|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498392|NCT03801902|Durvalumab|durvalumab|mesh-list
19498393|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
19498394|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19498395|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
19498396|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498397|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498398|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
19498399|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498400|NCT03801525|Venetoclax|venetoclax|mesh-list
19498401|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498402|NCT03785678|Tenecteplase|tenecteplase|mesh-list
19498403|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19498404|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19498405|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498406|NCT03783026|Apremilast|apremilast|mesh-list
19498407|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19498408|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19498409|NCT03783026|Analgesics|analgesics|mesh-ancestor
19498410|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
19498411|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498412|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498413|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498414|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20092474|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092475|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092476|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092477|NCT00002217|Lamivudine|lamivudine|mesh-list
20092478|NCT00002217|Zidovudine|zidovudine|mesh-list
20092479|NCT00002217|Abacavir|abacavir|mesh-list
19498415|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20092480|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19498416|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19498417|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498418|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498419|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
19498420|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19498421|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
19498422|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498423|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498424|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
19498425|NCT03747432|Propofol|propofol|mesh-list
19498426|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19498427|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19498428|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092481|NCT00002217|Amprenavir|amprenavir|mesh-list
20092482|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092483|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092484|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092485|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092486|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
20092487|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092488|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092489|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092490|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
20092491|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092492|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092493|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092494|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19498429|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19498430|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
19498431|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
19498432|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19498433|NCT03747432|Analgesics|analgesics|mesh-ancestor
19498434|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
19498435|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498436|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19498437|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19498438|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19498439|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
19498440|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498441|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498442|NCT03734744|Vitamin D|vitamin d|mesh-list
19498443|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
19498444|NCT03734744|Vitamins|vitamins|mesh-ancestor
19498445|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
19498446|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498447|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19498448|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19498449|NCT03725059|Paclitaxel|paclitaxel|mesh-list
19498450|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
19498451|NCT03725059|Doxorubicin|doxorubicin|mesh-list
19498452|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
19498453|NCT03725059|Epirubicin|epirubicin|mesh-list
20092495|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20602655|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748870|NCT05372315|Dexamethasone|dexamethasone|mesh-list
20602656|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20092496|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092497|NCT00002219|Nelfinavir|nelfinavir|mesh-list
20092498|NCT00002219|Adefovir|adefovir|mesh-list
20092499|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20092500|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092501|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092502|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092503|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092504|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092505|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092506|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092507|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
20092508|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092509|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092510|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092511|NCT00002220|Efavirenz|efavirenz|mesh-list
20092512|NCT00002220|Adefovir|adefovir|mesh-list
20092513|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20092514|NCT00002220|Indinavir|indinavir|mesh-list
20092515|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19498454|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498455|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498456|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498457|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498458|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498459|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092516|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498460|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498461|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
19498462|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498463|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19498464|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19498465|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
19498466|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19498467|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19498468|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19498469|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19498470|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498471|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498472|NCT03711448|Prednisone|prednisone|mesh-list
19498473|NCT03711448|Ustekinumab|ustekinumab|mesh-list
19498474|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498475|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
19498476|NCT03711448|Hormones|hormones|mesh-ancestor
19498477|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498478|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498479|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19498480|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498481|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19498482|NCT03682068|Gemcitabine|gemcitabine|mesh-list
19498483|NCT03682068|Carboplatin|carboplatin|mesh-list
19498484|NCT03682068|Durvalumab|durvalumab|mesh-list
19498485|NCT03682068|Tremelimumab|tremelimumab|mesh-list
19498486|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498487|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498488|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
19498489|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498490|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
20092517|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498491|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498492|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498493|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498494|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
19498495|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498496|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570278|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570279|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570280|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570281|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570282|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
19570283|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19570284|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19570285|NCT03421652|Nivolumab|nivolumab|mesh-list
19570286|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570287|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570288|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19570289|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570290|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19570291|NCT03414723|Ramipril|ramipril|mesh-list
19570292|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19570293|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
19570294|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570295|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570296|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19570297|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20092518|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570298|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570299|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570300|NCT03409276|Vaccines|vaccines|mesh-list
19570301|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
19570302|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570303|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
19570304|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570305|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570306|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
19570307|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20092519|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
20092520|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092521|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092522|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092523|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20092524|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20092525|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092526|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20092527|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092528|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092529|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092530|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092531|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092532|NCT00002222|Valganciclovir|valganciclovir|mesh-list
20092533|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
20092534|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498497|NCT03659136|Everolimus|everolimus|mesh-list
19498498|NCT03659136|Exemestane|exemestane|mesh-list
19498499|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498500|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498501|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
19498502|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498503|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19498504|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19498505|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498506|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498507|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19498508|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
19498509|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498510|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19498511|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
19498512|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498513|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
19498514|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
19498515|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498516|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19498517|NCT03576716|Calcifediol|calcifediol|mesh-list
19498518|NCT03576716|Vitamins|vitamins|mesh-ancestor
19498519|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
19498520|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498521|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19498522|NCT03572049|Itraconazole|itraconazole|mesh-list
19498523|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19498524|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
19498525|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498526|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19498527|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19498528|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498529|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498530|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19498531|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
19498532|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498533|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498534|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19498535|NCT03539744|Dexamethasone|dexamethasone|mesh-list
19498536|NCT03539744|Venetoclax|venetoclax|mesh-list
19498537|NCT03539744|Pomalidomide|pomalidomide|mesh-list
19498538|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498539|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
20602657|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20602658|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
20608148|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498540|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
19498541|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19498542|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498543|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19498544|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
19498545|NCT03539744|Hormones|hormones|mesh-ancestor
19498546|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498547|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19498548|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498549|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
19498550|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20092535|NCT00002223|Ritonavir|ritonavir|mesh-list
20092536|NCT00002223|Indinavir|indinavir|mesh-list
20092537|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092538|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092539|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092540|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092541|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092542|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092543|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19498551|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19498552|NCT03539744|Growth Substances|growth substances|mesh-ancestor
19498553|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
19498554|NCT03526250|Palbociclib|palbociclib|mesh-list
19498555|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570308|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20092544|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
20092545|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092546|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19498556|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498557|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498558|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498559|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
19498560|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
19498561|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498562|NCT03521154|Osimertinib|osimertinib|mesh-list
19498563|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092547|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092548|NCT00002225|Efavirenz|efavirenz|mesh-list
20092549|NCT00002225|Stavudine|stavudine|mesh-list
19498564|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498565|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498566|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498567|NCT03519971|Paclitaxel|paclitaxel|mesh-list
19498568|NCT03519971|Etoposide|etoposide|mesh-list
19498569|NCT03519971|Cisplatin|cisplatin|mesh-list
19498570|NCT03519971|Carboplatin|carboplatin|mesh-list
19498571|NCT03519971|Pemetrexed|pemetrexed|mesh-list
19498572|NCT03519971|Durvalumab|durvalumab|mesh-list
19498573|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498574|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498575|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498576|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498577|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498578|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498579|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19498580|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19498581|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498582|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19498583|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092550|NCT00002225|Didanosine|didanosine|mesh-list
20092551|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092552|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092553|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092554|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092555|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
20092556|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092557|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092558|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092559|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20092560|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20092561|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20602659|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498584|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498585|NCT03485209|Carboplatin|carboplatin|mesh-list
19498586|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
19498587|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
19498588|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498589|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498590|NCT03473756|Atezolizumab|atezolizumab|mesh-list
19498591|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498592|NCT03456076|Gemcitabine|gemcitabine|mesh-list
19498593|NCT03456076|Carboplatin|carboplatin|mesh-list
19498594|NCT03456076|Pemetrexed|pemetrexed|mesh-list
19498595|NCT03456076|Vinorelbine|vinorelbine|mesh-list
19498596|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498597|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498598|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
19498599|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498600|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
19498601|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498602|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498603|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498604|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
19498605|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498606|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19498607|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498608|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498609|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498610|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498611|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498612|NCT03456063|Gemcitabine|gemcitabine|mesh-list
19498613|NCT03456063|Paclitaxel|paclitaxel|mesh-list
19498614|NCT03456063|Carboplatin|carboplatin|mesh-list
19498615|NCT03456063|Pemetrexed|pemetrexed|mesh-list
19498616|NCT03456063|Atezolizumab|atezolizumab|mesh-list
19498617|NCT03456063|Antibodies|antibodies|mesh-list
19498618|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498619|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498620|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498621|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498622|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498623|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498624|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
19498625|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498626|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498627|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
19498628|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
19498629|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498630|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498631|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20092562|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20092563|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
20092564|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092565|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092566|NCT00002226|Semaxinib|semaxinib|mesh-list
20092567|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20092568|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20092569|NCT00002226|Growth Substances|growth substances|mesh-ancestor
20092570|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092571|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
20092572|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092573|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20092574|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092575|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092576|NCT00002227|Lamivudine|lamivudine|mesh-list
20092577|NCT00002227|Efavirenz|efavirenz|mesh-list
20092578|NCT00002227|Stavudine|stavudine|mesh-list
20092579|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19498632|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19498633|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498634|NCT03440372|Ozanimod|ozanimod|mesh-list
19498635|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19498636|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498637|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498638|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
19498639|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498640|NCT03436862|Nivolumab|nivolumab|mesh-list
19498641|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498642|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498643|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19498644|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498645|NCT03406715|Nivolumab|nivolumab|mesh-list
19498646|NCT03406715|Ipilimumab|ipilimumab|mesh-list
19498647|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498648|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498649|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19498650|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498651|NCT03379051|Lenalidomide|lenalidomide|mesh-list
19498652|NCT03379051|Venetoclax|venetoclax|mesh-list
19498653|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
19498654|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498655|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19498656|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19498657|NCT03379051|Growth Substances|growth substances|mesh-ancestor
19498658|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
19498659|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498660|NCT03367819|Cemiplimab|cemiplimab|mesh-list
19498661|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498662|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498663|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
19498664|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498665|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498666|NCT03343197|Ivosidenib|ivosidenib|mesh-list
19498667|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498668|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498669|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498670|NCT03328026|Interferons|interferons|mesh-list
20092580|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092581|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498671|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
19498672|NCT03328026|Vaccines|vaccines|mesh-list
19498673|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498674|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
19498675|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498676|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19498677|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19498678|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
19498679|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498680|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498681|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19498682|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
19498683|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498684|NCT03313180|Nintedanib|nintedanib|mesh-list
19498685|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498686|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498687|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498688|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498689|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
19498690|NCT03290612|Vitamins|vitamins|mesh-ancestor
19498691|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
19498692|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498693|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
19498694|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498695|NCT03290612|Protective Agents|protective agents|mesh-ancestor
19498696|NCT03269669|Prednisone|prednisone|mesh-list
19498697|NCT03269669|Cortisone|cortisone|mesh-list
19498698|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
19498699|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19498700|NCT03269669|Doxorubicin|doxorubicin|mesh-list
19498701|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19498702|NCT03269669|Vincristine|vincristine|mesh-list
19498703|NCT03269669|Lenalidomide|lenalidomide|mesh-list
19498704|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
19498705|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498706|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
19498707|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498708|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19498709|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19498710|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
19498711|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498712|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498713|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19498714|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19498715|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19498716|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19498717|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498718|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498719|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
19498720|NCT03269669|Hormones|hormones|mesh-ancestor
19498721|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498722|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19498723|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498724|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498725|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498726|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498727|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19498728|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19498729|NCT03269669|Growth Substances|growth substances|mesh-ancestor
19498730|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
19498731|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498732|NCT03213652|Ensartinib|ensartinib|mesh-list
19498733|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498734|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498735|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498736|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498737|NCT03191786|Gemcitabine|gemcitabine|mesh-list
19498738|NCT03191786|Atezolizumab|atezolizumab|mesh-list
19498739|NCT03191786|Vinorelbine|vinorelbine|mesh-list
19498740|NCT03191786|Antibodies|antibodies|mesh-list
19498741|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19498742|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
19498743|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498744|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498745|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
19498746|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498747|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498748|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
19498749|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498750|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498751|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498752|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498753|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498754|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498755|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498756|NCT03180502|Temozolomide|temozolomide|mesh-list
19498757|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19498758|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
19498759|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498760|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092582|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092583|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
20092584|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092585|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092586|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092587|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092588|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092589|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19498761|NCT03177746|Tadalafil|tadalafil|mesh-list
19498762|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
19498763|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19498764|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19498765|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498766|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498767|NCT03177746|Urological Agents|urological agents|mesh-ancestor
19498768|NCT03173248|Azacitidine|azacitidine|mesh-list
19498769|NCT03173248|Ivosidenib|ivosidenib|mesh-list
19498770|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498771|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
19498772|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498773|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498774|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092590|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20092591|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092592|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20092593|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
20092594|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
20092595|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20092596|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20602660|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602661|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20602662|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19498775|NCT03125902|Paclitaxel|paclitaxel|mesh-list
19498776|NCT03125902|Atezolizumab|atezolizumab|mesh-list
19498777|NCT03125902|Antibodies|antibodies|mesh-list
19498778|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19498779|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498780|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498781|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498782|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498783|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498784|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498785|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
19498786|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498787|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
19498788|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
19498789|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498790|NCT03079011|Letrozole|letrozole|mesh-list
19498791|NCT03079011|Fulvestrant|fulvestrant|mesh-list
20602663|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
19498792|NCT03079011|Palbociclib|palbociclib|mesh-list
19498793|NCT03079011|Anastrozole|anastrozole|mesh-list
20602664|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
20602665|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602666|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602667|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
20602668|NCT02217163|Hormones|hormones|mesh-ancestor
19498794|NCT03079011|Exemestane|exemestane|mesh-list
19498795|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19498796|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498797|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19498798|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498799|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498800|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19498801|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
19498802|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498803|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498804|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602669|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602670|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602671|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
20602672|NCT02217189|Astringents|astringents|mesh-ancestor
20602673|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602674|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602675|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20602676|NCT02217202|Laxatives|laxatives|mesh-ancestor
20602677|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20092597|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092598|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20602678|NCT02217267|Lidocaine|lidocaine|mesh-list
20602679|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
20602680|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
20602681|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602682|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602683|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
20602684|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602685|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20602686|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20602687|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20602688|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602689|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498805|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19498806|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498807|NCT03077620|Suvorexant|suvorexant|mesh-list
19498808|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19498809|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19498810|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19498811|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498812|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19498813|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19498814|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498815|NCT03056755|Letrozole|letrozole|mesh-list
19498816|NCT03056755|Fulvestrant|fulvestrant|mesh-list
19498817|NCT03056755|Leuprolide|leuprolide|mesh-list
19498818|NCT03056755|Goserelin|goserelin|mesh-list
19498819|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498820|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19498821|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20092599|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092600|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
20092601|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092602|NCT00002229|Saquinavir|saquinavir|mesh-list
20092603|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092604|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092605|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092606|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498822|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498823|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498824|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19498825|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
19498826|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498827|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498828|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19498829|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19498830|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19498831|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
19498832|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20092607|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498833|NCT03043313|Trastuzumab|trastuzumab|mesh-list
19498834|NCT03043313|Tucatinib|tucatinib|mesh-list
19498835|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498836|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498837|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498838|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498839|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498840|NCT03038100|Paclitaxel|paclitaxel|mesh-list
19498841|NCT03038100|Bevacizumab|bevacizumab|mesh-list
19498842|NCT03038100|Carboplatin|carboplatin|mesh-list
19498843|NCT03038100|Atezolizumab|atezolizumab|mesh-list
19498844|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19498845|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19498846|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498847|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498848|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498849|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498850|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498851|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19498852|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19498853|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19498854|NCT03038100|Growth Substances|growth substances|mesh-ancestor
19498855|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498856|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
19498857|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
19498858|NCT03037385|Pralsetinib|pralsetinib|mesh-list
19498859|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498860|NCT03012529|Riboflavin|riboflavin|mesh-list
19498861|NCT03012529|Rifampin|rifampin|mesh-list
19498862|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19498863|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
19498864|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19498865|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498866|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
19498867|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498868|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498869|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498870|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19498871|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19498872|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19498873|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19498874|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19498875|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19498876|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
19498877|NCT03012529|Vitamins|vitamins|mesh-ancestor
19498878|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
20092608|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092609|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092610|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
20092611|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092612|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20092613|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092614|NCT00002230|Efavirenz|efavirenz|mesh-list
19498879|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498880|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19498881|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
19498882|NCT02980276|Metformin|metformin|mesh-list
19498883|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19498884|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092615|NCT00002230|Stavudine|stavudine|mesh-list
20092616|NCT00002230|Didanosine|didanosine|mesh-list
19498885|NCT02974257|Thiamine|thiamine|mesh-list
19498886|NCT02974257|Vitamins|vitamins|mesh-ancestor
19498887|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
19498888|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498889|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
19498890|NCT02951052|Rilpivirine|rilpivirine|mesh-list
19498891|NCT02951052|Cabotegravir|cabotegravir|mesh-list
20092617|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
20092618|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092619|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092620|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092621|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498892|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092622|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
19498893|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19498894|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092623|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092624|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092625|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092626|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20092627|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19498895|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498896|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
19498897|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092628|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092629|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19498898|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19498899|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19498900|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19498901|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19498902|NCT02871843|Temozolomide|temozolomide|mesh-list
19498903|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19498904|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
19498905|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498906|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498907|NCT02848131|Dasatinib|dasatinib|mesh-list
19498908|NCT02848131|Quercetin|quercetin|mesh-list
19498909|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498910|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498911|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498912|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498913|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
19498914|NCT02848131|Protective Agents|protective agents|mesh-ancestor
19498915|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570309|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19570310|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570311|NCT03391193|Vaccines|vaccines|mesh-list
19570312|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
19570313|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570314|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19570315|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19570316|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19570317|NCT03387657|Diuretics|diuretics|mesh-ancestor
19570318|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
19570319|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570320|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19570321|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19570322|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570323|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19570324|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570325|NCT03345784|Cisplatin|cisplatin|mesh-list
19570326|NCT03345784|Adavosertib|adavosertib|mesh-list
19570327|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570328|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570329|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570330|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19570331|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19570332|NCT03332303|Estradiol|estradiol|mesh-list
19570333|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19570334|NCT03332303|Estrogens|estrogens|mesh-ancestor
19570335|NCT03332303|Hormones|hormones|mesh-ancestor
20092630|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092631|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
20092632|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
20092633|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092634|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092635|NCT00002233|Lamivudine|lamivudine|mesh-list
20092636|NCT00002233|Abacavir|abacavir|mesh-list
20092637|NCT00002233|Indinavir|indinavir|mesh-list
20092638|NCT00002233|Amprenavir|amprenavir|mesh-list
20092639|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092640|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092641|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570336|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570337|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748871|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
19748872|NCT05372315|BB 1101|bb 1101|mesh-list
19748873|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602690|NCT02217319|Sevoflurane|sevoflurane|mesh-list
19498916|NCT02825940|Gemcitabine|gemcitabine|mesh-list
19498917|NCT02825940|Atezolizumab|atezolizumab|mesh-list
19498918|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498919|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19498920|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
19498921|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498922|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
19498923|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498924|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498925|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19498926|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
19498927|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498928|NCT02813785|Docetaxel|docetaxel|mesh-list
19498929|NCT02813785|Atezolizumab|atezolizumab|mesh-list
19498930|NCT02813785|Antibodies|antibodies|mesh-list
19498931|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
19498932|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498933|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498934|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
19498935|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
19498936|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
19498937|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498938|NCT02801097|Irinotecan|irinotecan|mesh-list
19498939|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19498940|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19498941|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498942|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498943|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498944|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19498945|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19498946|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
19498947|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498948|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498949|NCT02764541|Tamoxifen|tamoxifen|mesh-list
19498950|NCT02764541|Letrozole|letrozole|mesh-list
19498951|NCT02764541|Palbociclib|palbociclib|mesh-list
19498952|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19498953|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19498954|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19498955|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498956|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498957|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19498958|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
19498959|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498960|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498961|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19498962|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19498963|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19498964|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19498965|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19498966|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
19498967|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19498968|NCT02759380|Estrogens|estrogens|mesh-ancestor
19498969|NCT02759380|Hormones|hormones|mesh-ancestor
19498970|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19498971|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498972|NCT02724410|Amoxicillin|amoxicillin|mesh-list
19498973|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
19498974|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
19498975|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19498976|NCT02724410|Ertapenem|ertapenem|mesh-list
19498977|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19498978|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19498979|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19498980|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19498981|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498982|NCT02721537|Niacinamide|niacinamide|mesh-list
19498983|NCT02721537|Niacin|niacin|mesh-list
19498984|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
19498985|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
19498986|NCT02721537|Vitamins|vitamins|mesh-ancestor
19498987|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
20608149|NCT02244710|Clopidogrel|clopidogrel|mesh-list
19498988|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092642|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498989|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19498990|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
19498991|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19498992|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19498993|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
19498994|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
19498995|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19498996|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
19498997|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19498998|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
19498999|NCT02708706|Protective Agents|protective agents|mesh-ancestor
19499000|NCT02708680|Atezolizumab|atezolizumab|mesh-list
19499001|NCT02708680|Entinostat|entinostat|mesh-list
19499002|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499003|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19499004|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499005|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499006|NCT02672475|Paclitaxel|paclitaxel|mesh-list
19499007|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19499008|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499009|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499010|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499011|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499012|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499013|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499014|NCT02632708|Cytarabine|cytarabine|mesh-list
19499015|NCT02632708|Etoposide|etoposide|mesh-list
19499016|NCT02632708|Daunorubicin|daunorubicin|mesh-list
19499017|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
19499018|NCT02632708|Idarubicin|idarubicin|mesh-list
19499019|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499020|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499021|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499022|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499023|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499024|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499025|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499026|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
19499027|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
19499028|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499029|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499030|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
19499031|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499032|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499033|NCT02632708|Analgesics|analgesics|mesh-ancestor
19499034|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
19499035|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499036|NCT02620046|Vedolizumab|vedolizumab|mesh-list
19499037|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19499038|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
19499039|NCT02612311|Chlorambucil|chlorambucil|mesh-list
19499040|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499041|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499042|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499043|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
19499044|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499045|NCT02608268|Decitabine|decitabine|mesh-list
19499046|NCT02608268|Spartalizumab|spartalizumab|mesh-list
19499047|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499048|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
19499049|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499050|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499051|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499052|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19499053|NCT02598583|Ravulizumab|ravulizumab|mesh-list
19499054|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19499055|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499056|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
19499057|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499058|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19499059|NCT02536794|Durvalumab|durvalumab|mesh-list
19499060|NCT02536794|Ipilimumab|ipilimumab|mesh-list
19499061|NCT02536794|Tremelimumab|tremelimumab|mesh-list
19499062|NCT02536794|Antibodies|antibodies|mesh-list
19499063|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
19499064|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19499065|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
19499066|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499067|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499068|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19499069|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499070|NCT02506517|Afatinib|afatinib|mesh-list
19499071|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499072|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19499073|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499074|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499075|NCT02500407|Atezolizumab|atezolizumab|mesh-list
19499076|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499077|NCT02489903|Gemcitabine|gemcitabine|mesh-list
19499078|NCT02489903|Paclitaxel|paclitaxel|mesh-list
19499079|NCT02489903|Etoposide|etoposide|mesh-list
19499080|NCT02489903|Vinorelbine|vinorelbine|mesh-list
19499081|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19499082|NCT02489903|Carboplatin|carboplatin|mesh-list
19499083|NCT02489903|Irinotecan|irinotecan|mesh-list
20092643|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
20092644|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092645|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092646|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092647|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092648|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092649|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
19499084|NCT02489903|Pemetrexed|pemetrexed|mesh-list
19499085|NCT02489903|Taxane|taxane|mesh-list
19499086|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499087|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499088|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499089|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499090|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499091|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499092|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499093|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
19499094|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
19499095|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499096|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499097|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499098|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
19499099|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499100|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19499101|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499102|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499103|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19499104|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19499105|NCT02489006|Olaparib|olaparib|mesh-list
19499106|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19499107|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499108|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499109|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499110|NCT02428270|Trametinib|trametinib|mesh-list
19499111|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499112|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19499113|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499114|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499115|NCT02428205|Propranolol|propranolol|mesh-list
19499116|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19499117|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19499118|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19499119|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499120|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499121|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499122|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19499123|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19499124|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
19499125|NCT02402842|Docetaxel|docetaxel|mesh-list
20092650|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092651|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092652|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092653|NCT00002234|Lamivudine|lamivudine|mesh-list
20092654|NCT00002234|Efavirenz|efavirenz|mesh-list
20092655|NCT00002234|Didanosine|didanosine|mesh-list
19499126|NCT02402842|Fluorouracil|fluorouracil|mesh-list
19499127|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092656|NCT00002234|Adefovir|adefovir|mesh-list
19499128|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499129|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499130|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499131|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499132|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
19499133|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499134|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499135|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
19499136|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499137|NCT02399943|Panitumumab|panitumumab|mesh-list
19499138|NCT02399943|Trametinib|trametinib|mesh-list
19499139|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499140|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499141|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19499142|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499143|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499144|NCT02398656|Tenecteplase|tenecteplase|mesh-list
19499145|NCT02398656|Clopidogrel|clopidogrel|mesh-list
20092657|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20092658|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092659|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19499146|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19499147|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19499148|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19499149|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19499150|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
19499151|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499152|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499153|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499154|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19499155|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19499156|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
19499157|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19499158|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
19499159|NCT02375295|Trimethoprim|trimethoprim|mesh-list
19499160|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092660|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092661|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092662|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
20092663|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092664|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092665|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19499161|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499162|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499163|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499164|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499165|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499166|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499167|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19499168|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19499169|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19499170|NCT02375295|Renal Agents|renal agents|mesh-ancestor
19499171|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
19499172|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19499173|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19499174|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19499175|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19499176|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19499177|NCT02327455|Dobutamine|dobutamine|mesh-list
19499178|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19499179|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
19499180|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
19499181|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499182|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499183|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19499184|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19499185|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19499186|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
19499187|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499188|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499189|NCT02327455|Protective Agents|protective agents|mesh-ancestor
19499190|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
19499191|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19499192|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499193|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499194|NCT02124187|Nicotine|nicotine|mesh-list
19499195|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19499196|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
19499197|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499198|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499199|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19499200|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19499201|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
19499202|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499203|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499204|NCT02096354|Irinotecan|irinotecan|mesh-list
19499205|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499206|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19499207|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499208|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499209|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499210|NCT02074839|Ivosidenib|ivosidenib|mesh-list
19499211|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499212|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499213|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499214|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
19499215|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19499216|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19499217|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499218|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
20092666|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092667|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092668|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20092669|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19499219|NCT02074436|Coagulants|coagulants|mesh-ancestor
19499220|NCT02073994|Ivosidenib|ivosidenib|mesh-list
19499221|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499222|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499223|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499224|NCT02053909|Aspirin|aspirin|mesh-list
19499225|NCT02053909|Ticagrelor|ticagrelor|mesh-list
19499226|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19499227|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19499228|NCT02053909|Analgesics|analgesics|mesh-ancestor
19499229|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
19499230|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499231|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499232|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499233|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499234|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19499235|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19499236|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499237|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20092670|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092671|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20602691|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20602692|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20602693|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
20602694|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
19499238|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19499239|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499240|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
19499241|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19499242|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19499243|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20602695|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602696|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602697|NCT02217514|Midazolam|midazolam|mesh-list
19499244|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
19499245|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602698|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20602699|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20602700|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20092672|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
20092673|NCT00002235|Efavirenz|efavirenz|mesh-list
20092674|NCT00002235|Nelfinavir|nelfinavir|mesh-list
20092675|NCT00002235|Indinavir|indinavir|mesh-list
20092676|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19499246|NCT02002819|Levetiracetam|levetiracetam|mesh-list
19499247|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
19499248|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
19499249|NCT01979796|Nicotine|nicotine|mesh-list
19499250|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19499251|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
19499252|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499253|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499254|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19499255|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19499256|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
19499257|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499258|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499259|NCT01936857|Buprenorphine|buprenorphine|mesh-list
19499260|NCT01936857|Methadone|methadone|mesh-list
19499261|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19499262|NCT01936857|Naloxone|naloxone|mesh-list
19499263|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19499264|NCT01936857|Narcotics|narcotics|mesh-ancestor
19499265|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19499266|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499267|NCT01936857|Analgesics|analgesics|mesh-ancestor
19499268|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
19499269|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499270|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19499271|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
19499272|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
19499273|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
19499274|NCT01903330|Bevacizumab|bevacizumab|mesh-list
19499275|NCT01903330|Sargramostim|sargramostim|mesh-list
19499276|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499277|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
19499278|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499279|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499280|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499281|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
19499282|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499283|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499284|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20092677|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092678|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092679|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092680|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
20092681|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092682|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092683|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092684|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20092685|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20092686|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092687|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20092688|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092689|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092690|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092691|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092692|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092693|NCT00002236|Zidovudine|zidovudine|mesh-list
19499285|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499286|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19499287|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19499288|NCT01903330|Growth Substances|growth substances|mesh-ancestor
19499289|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
19499290|NCT01878617|Gemcitabine|gemcitabine|mesh-list
19499291|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
19499292|NCT01878617|Vincristine|vincristine|mesh-list
19499293|NCT01878617|Pemetrexed|pemetrexed|mesh-list
19499294|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499295|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
19499296|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499297|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499298|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499299|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
20092694|NCT00002236|Delavirdine|delavirdine|mesh-list
20092695|NCT00002236|Indinavir|indinavir|mesh-list
20092696|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
19499300|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499301|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499302|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19499303|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499304|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
19499305|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
19499306|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499307|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499308|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499309|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499310|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499311|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499312|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19499313|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19499314|NCT01856192|Prednisone|prednisone|mesh-list
19499315|NCT01856192|Cortisone|cortisone|mesh-list
19499316|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
19499317|NCT01856192|Rituximab|rituximab|mesh-list
19499318|NCT01856192|Doxorubicin|doxorubicin|mesh-list
19499319|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19499320|NCT01856192|Vincristine|vincristine|mesh-list
19499321|NCT01856192|Lenalidomide|lenalidomide|mesh-list
19499322|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19499323|NCT01856192|Antibodies|antibodies|mesh-list
19499324|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
19499325|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19499326|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499327|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
19499328|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499329|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499330|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499331|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
19499332|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499333|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499334|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19499335|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499336|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499337|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499338|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499339|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499340|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
19499341|NCT01856192|Hormones|hormones|mesh-ancestor
19499342|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19499343|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19499344|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20092697|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092698|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092699|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092700|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092701|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
20092702|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092703|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20602701|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602702|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20602703|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20602704|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20602705|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20602706|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
20602707|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
20602708|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
20602709|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
20602710|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602711|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499345|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499346|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
20602712|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
20602713|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19499347|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499348|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19499349|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20092704|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20602714|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499350|NCT01856192|Growth Substances|growth substances|mesh-ancestor
19499351|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
19499352|NCT01853826|Afatinib|afatinib|mesh-list
19499353|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499354|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19499355|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499356|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499357|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
19499358|NCT01735461|Calcium|calcium|mesh-list
19499359|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19499360|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499361|NCT01735461|Antacids|antacids|mesh-ancestor
19499362|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748874|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
20092705|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092706|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092707|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092708|NCT00002238|Interferons|interferons|mesh-list
20092709|NCT00002238|Zidovudine|zidovudine|mesh-list
20092710|NCT00002238|Interferon-beta|interferon-beta|mesh-list
20092711|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
20092712|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092713|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
20092714|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092715|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
20092716|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092717|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092718|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092719|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092720|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092721|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092722|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
20092723|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092724|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20092725|NCT00002239|Ritonavir|ritonavir|mesh-list
20092726|NCT00002239|Amprenavir|amprenavir|mesh-list
20092727|NCT00002239|Abacavir|abacavir|mesh-list
20092728|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
19748875|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
19748876|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748877|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748878|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19748879|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
19748880|NCT05372315|Hormones|hormones|mesh-ancestor
20092729|NCT00002239|Efavirenz|efavirenz|mesh-list
19499363|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20092730|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092731|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092732|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092733|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499364|NCT01731444|Phenylephrine|phenylephrine|mesh-list
19499365|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
19499366|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19499367|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
19499368|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
19499369|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499370|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499371|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
19499372|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19499373|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
19499374|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
19499375|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19499376|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19499377|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19499378|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
19499379|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499380|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499381|NCT01731444|Protective Agents|protective agents|mesh-ancestor
19499382|NCT01715285|Prednisone|prednisone|mesh-list
19499383|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
19499384|NCT01715285|Androgens|androgens|mesh-list
19499385|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499386|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
19499387|NCT01715285|Hormones|hormones|mesh-ancestor
20092734|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499388|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19499389|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092735|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092736|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092737|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
19499390|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19499391|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499392|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19499393|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499394|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499395|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
19499396|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19570338|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19570339|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
19570340|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19570341|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19570342|NCT03312907|Rituximab|rituximab|mesh-list
19570343|NCT03312907|Belimumab|belimumab|mesh-list
19570344|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19570345|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570346|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570347|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
19570348|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570349|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570350|NCT03180034|Vaccines|vaccines|mesh-list
19570351|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
19570352|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570353|NCT03148756|Dalbavancin|dalbavancin|mesh-list
19570354|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570355|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570356|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
19570357|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19570358|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
19570359|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570360|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570361|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19570362|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
19570363|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19570364|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
19570365|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570366|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570367|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19570368|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
19570369|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
19570370|NCT03079102|Protective Agents|protective agents|mesh-ancestor
19570371|NCT03031821|Metformin|metformin|mesh-list
19570372|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20092738|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092739|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20092740|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20092741|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092742|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092743|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20092744|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20092745|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20092746|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092747|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20092748|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20092749|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20092750|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092751|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092752|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092753|NCT00002241|Ritonavir|ritonavir|mesh-list
20092754|NCT00002241|Indinavir|indinavir|mesh-list
20092755|NCT00002241|Lamivudine|lamivudine|mesh-list
20092756|NCT00002241|Stavudine|stavudine|mesh-list
20092757|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092758|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092759|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092760|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092761|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092762|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092763|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092764|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
20092765|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092766|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19570373|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570374|NCT03026062|Durvalumab|durvalumab|mesh-list
19570375|NCT03026062|Ipilimumab|ipilimumab|mesh-list
20602715|NCT02217553|Vitamins|vitamins|mesh-ancestor
20602716|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
20602717|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20602718|NCT02217631|Prednisolone|prednisolone|mesh-list
20602719|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20602720|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
19499397|NCT01646814|Aspirin|aspirin|mesh-list
20092767|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20602721|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19499398|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19499399|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19499400|NCT01646814|Analgesics|analgesics|mesh-ancestor
19499401|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
19499402|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499403|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499404|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499405|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499406|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19499407|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19499408|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499409|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19499410|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19499411|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499412|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
19499413|NCT01613118|Irbesartan|irbesartan|mesh-list
19499414|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19499415|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19499416|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19499417|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499418|NCT01595841|Sirolimus|sirolimus|mesh-list
19499419|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19499420|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499421|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499422|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499423|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
19499424|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499425|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
19499426|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499427|NCT01554046|Methylphenidate|methylphenidate|mesh-list
19499428|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19499429|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499430|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19499431|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19499432|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19499433|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499434|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
19499435|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499436|NCT01506986|Metronidazole|metronidazole|mesh-list
19499437|NCT01506986|Clarithromycin|clarithromycin|mesh-list
19499438|NCT01506986|Lansoprazole|lansoprazole|mesh-list
19499439|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
19499440|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092768|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092769|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092770|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
20092771|NCT00002243|Calanolide A|calanolide a|mesh-list
20092772|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092773|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092774|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
20092775|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499441|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19499442|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19499443|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19499444|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19499445|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499446|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092776|NCT00002245|Lamivudine|lamivudine|mesh-list
20092777|NCT00002245|Abacavir|abacavir|mesh-list
20092778|NCT00002245|Amprenavir|amprenavir|mesh-list
20092779|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092780|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092781|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092782|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602722|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
19499447|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19499448|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20602723|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20602724|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
19499449|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19499450|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19499451|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19499452|NCT01295944|Bevacizumab|bevacizumab|mesh-list
19499453|NCT01295944|Carboplatin|carboplatin|mesh-list
19499454|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499455|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499456|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19499457|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19499458|NCT01295944|Growth Substances|growth substances|mesh-ancestor
19499459|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499460|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
19499461|NCT01285557|Cisplatin|cisplatin|mesh-list
19499462|NCT01285557|Fluorouracil|fluorouracil|mesh-list
19499463|NCT01285557|Tegafur|tegafur|mesh-list
19499464|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499465|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
20092783|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
20092784|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092785|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19499466|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499467|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499468|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499469|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
19499470|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499471|NCT01228331|Cytarabine|cytarabine|mesh-list
19499472|NCT01228331|Dexamethasone|dexamethasone|mesh-list
19499473|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
19499474|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
19499475|NCT01228331|Doxorubicin|doxorubicin|mesh-list
19499476|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19499477|NCT01228331|Methotrexate|methotrexate|mesh-list
19499478|NCT01228331|Etoposide|etoposide|mesh-list
19499479|NCT01228331|Vincristine|vincristine|mesh-list
19499480|NCT01228331|Daunorubicin|daunorubicin|mesh-list
19499481|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
19499482|NCT01228331|Clofarabine|clofarabine|mesh-list
19499483|NCT01228331|Pegaspargase|pegaspargase|mesh-list
19499484|NCT01228331|Thioguanine|thioguanine|mesh-list
20092786|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092787|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20602725|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602726|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
20602727|NCT02217631|Hormones|hormones|mesh-ancestor
20602728|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602729|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602730|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602731|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602732|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
20602733|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
19499485|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
19499486|NCT01228331|Amsacrine|amsacrine|mesh-list
19499487|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499488|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
19499489|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499490|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499491|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499492|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
19499493|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499494|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499495|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19499496|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499497|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
19499498|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
20092788|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
20092789|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092790|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20092791|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20092792|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
20092793|NCT00002247|Ganciclovir|ganciclovir|mesh-list
20092794|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20092795|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
20092796|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499499|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499500|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19499501|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
19499502|NCT01228331|Hormones|hormones|mesh-ancestor
19499503|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19499504|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19499505|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499506|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499507|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499508|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499509|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19499510|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
19499511|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19499512|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499513|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
19499514|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
19499515|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19499516|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19499517|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499518|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
19499519|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499520|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499521|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499522|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499523|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19499524|NCT01228331|Protective Agents|protective agents|mesh-ancestor
19499525|NCT01171937|Risperidone|risperidone|mesh-list
19499526|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19499527|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
19499528|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20092797|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092798|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092799|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092800|NCT00002249|Levofloxacin|levofloxacin|mesh-list
20092801|NCT00002249|Ofloxacin|ofloxacin|mesh-list
20092802|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20092803|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092804|NCT00002249|Renal Agents|renal agents|mesh-ancestor
20092805|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092806|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20092807|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20092808|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092809|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092810|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092811|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20092812|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19499529|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499530|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499531|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19499532|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19499533|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19499534|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19499535|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19499536|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
19748881|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19748882|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602734|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602735|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602736|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20602737|NCT02217631|Protective Agents|protective agents|mesh-ancestor
20602738|NCT02217670|Metformin|metformin|mesh-list
20602739|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20602740|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602741|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
20602742|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20602743|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
20602744|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602745|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602746|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20602747|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
20602748|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20602749|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
20602750|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748883|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499540|NCT00977691|Sirolimus|sirolimus|mesh-list
19499541|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
19499542|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
19499543|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499544|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
19499545|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499546|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499547|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20092813|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
20092814|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
20092815|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092816|NCT00002251|Ganciclovir|ganciclovir|mesh-list
20092817|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20092818|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
20092819|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499548|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
19499549|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499550|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499551|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19499552|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19499553|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499554|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499555|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
19499556|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499557|NCT00964002|Efavirenz|efavirenz|mesh-list
20602751|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20092820|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092821|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092822|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092823|NCT00002252|Octreotide|octreotide|mesh-list
20602752|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19499558|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19499559|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19499560|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499561|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499562|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
19499563|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499564|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19499565|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19499566|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19499567|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19748884|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
19748885|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092824|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602753|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
19499568|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20092825|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20092826|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092827|NCT00002253|Octreotide|octreotide|mesh-list
20092828|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20092829|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19499569|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19499570|NCT00887783|Vinorelbine|vinorelbine|mesh-list
19499571|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499572|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499573|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499574|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499575|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499576|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092830|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092831|NCT00002254|Alovudine|alovudine|mesh-list
20092832|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
20092833|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092834|NCT00002255|Zidovudine|zidovudine|mesh-list
20092835|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
20092836|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
19499577|NCT00790218|Adenosine|adenosine|mesh-list
19499578|NCT00790218|Analgesics|analgesics|mesh-ancestor
19499579|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
19499580|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499581|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499582|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19499583|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
19499584|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19499585|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
19499586|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
19499587|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20092837|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092838|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19499588|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499589|NCT00583778|Ipratropium|ipratropium|mesh-list
19499590|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19499591|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
19499592|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499593|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499594|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19499595|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
19499596|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19499597|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
19499598|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499599|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499600|NCT00485693|Epinephrine|epinephrine|mesh-list
19499601|NCT00485693|Bupivacaine|bupivacaine|mesh-list
19499602|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
19499603|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
19499604|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19499605|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499606|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
19499607|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499608|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19499609|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19499610|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20092839|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092840|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092841|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
20092842|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499611|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499612|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499613|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19499614|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19499615|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
19499616|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19499617|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
19499618|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
19499619|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
19499620|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19499621|NCT00432094|Paclitaxel|paclitaxel|mesh-list
20092843|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092844|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19499622|NCT00432094|Etoposide|etoposide|mesh-list
20092845|NCT00002255|Hematinics|hematinics|mesh-ancestor
20092846|NCT00002256|Zalcitabine|zalcitabine|mesh-list
19499623|NCT00432094|Carboplatin|carboplatin|mesh-list
19499624|NCT00432094|Ifosfamide|ifosfamide|mesh-list
19499625|NCT00432094|Thiotepa|thiotepa|mesh-list
19499626|NCT00432094|Mesna|mesna|mesh-list
19499627|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499628|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499629|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499630|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499631|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499632|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499633|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499634|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499635|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499636|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
19499637|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499638|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499639|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
19499640|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19499641|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499642|NCT00432094|Protective Agents|protective agents|mesh-ancestor
19499643|NCT00416351|Clofarabine|clofarabine|mesh-list
19499644|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499645|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
19499646|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499647|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499648|NCT00352027|Prednisone|prednisone|mesh-list
19499649|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
19499650|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
19499651|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
19499652|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19499653|NCT00352027|Doxorubicin|doxorubicin|mesh-list
19499654|NCT00352027|Etoposide|etoposide|mesh-list
19499655|NCT00352027|Vincristine|vincristine|mesh-list
19499656|NCT00352027|Bleomycin|bleomycin|mesh-list
19499657|NCT00352027|Vinblastine|vinblastine|mesh-list
19499658|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499659|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
19499660|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499661|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499662|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499663|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
19499664|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499665|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499666|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19499667|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499668|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499669|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499670|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499671|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499672|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
19499673|NCT00352027|Hormones|hormones|mesh-ancestor
19499674|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19499675|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19499676|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499677|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499678|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499679|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499680|NCT00334815|Bevacizumab|bevacizumab|mesh-list
19499681|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19499682|NCT00334815|Cisplatin|cisplatin|mesh-list
19499683|NCT00334815|Docetaxel|docetaxel|mesh-list
19499684|NCT00334815|Etoposide|etoposide|mesh-list
19499685|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
19499686|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
19499687|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
19499688|NCT00334815|Antibodies|antibodies|mesh-list
19499689|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
19499690|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19499691|NCT00334815|Lenograstim|lenograstim|mesh-list
19499692|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
19499693|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499694|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19499695|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20092847|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
19499696|NCT00334815|Growth Substances|growth substances|mesh-ancestor
19499697|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499698|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
19499699|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
19499700|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
19499701|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
19499702|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
19499703|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499704|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19499705|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19499706|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499707|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499708|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19499709|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
19499710|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19499711|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
19499712|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19499713|NCT00072358|Irinotecan|irinotecan|mesh-list
19499714|NCT00072358|Temozolomide|temozolomide|mesh-list
19499715|NCT00072358|Molgramostim|molgramostim|mesh-list
19499716|NCT00072358|Isotretinoin|isotretinoin|mesh-list
19499717|NCT00072358|Antibodies|antibodies|mesh-list
19499718|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
19499719|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19499720|NCT00072358|Sargramostim|sargramostim|mesh-list
19499721|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
20602754|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
19499722|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
19499723|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499724|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499725|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19499726|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19499727|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499728|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499729|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499730|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
19499731|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
19499732|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19499733|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499734|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
19499735|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19499736|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
19499737|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499738|NCT03104959|Expectorants|expectorants|mesh-ancestor
19499739|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
19499740|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19499741|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
19499742|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499743|NCT03104959|Protective Agents|protective agents|mesh-ancestor
19499744|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499745|NCT03104959|Antidotes|antidotes|mesh-ancestor
19499746|NCT03104998|Ubiquinone|ubiquinone|mesh-list
19499747|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
20092848|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092849|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092850|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092851|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092852|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
19499748|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
19499749|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499750|NCT03104998|Vitamins|vitamins|mesh-ancestor
19499751|NCT03104790|Vaccines|vaccines|mesh-list
19499752|NCT03104790|Immunologic Factors|immunologic factors|mesh-ancestor
19499753|NCT03104790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499754|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19499755|NCT03104855|Calcifediol|calcifediol|mesh-list
19499756|NCT03104855|Vitamins|vitamins|mesh-ancestor
19499757|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
19499758|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499759|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19499760|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19499761|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20092853|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092854|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092855|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092856|NCT00002257|Ganciclovir|ganciclovir|mesh-list
20092857|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20092858|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
19499762|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499763|NCT03104634|Bromides|bromides|mesh-list
19499764|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
20092859|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499765|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20092860|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092861|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092862|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602755|NCT02217683|Protective Agents|protective agents|mesh-ancestor
20602756|NCT02217709|Phenelzine|phenelzine|mesh-list
20602757|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
20602758|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20602759|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20602760|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602761|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602762|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20602763|NCT02217722|Amoxicillin|amoxicillin|mesh-list
20602764|NCT02217722|Metronidazole|metronidazole|mesh-list
20602765|NCT02217722|Doxycycline|doxycycline|mesh-list
20602766|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602767|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20602768|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20602769|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
20602770|NCT02217787|PF-06372865|pf-06372865|mesh-list
20602771|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
20602772|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
20602773|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602774|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602775|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602776|NCT02217826|Octreotide|octreotide|mesh-list
19499766|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
19499767|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499768|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499769|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19499770|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
19499771|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19499772|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19499773|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19499774|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19499775|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20092863|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
20092864|NCT00002259|Analgesics|analgesics|mesh-ancestor
20092865|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
20092866|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20092867|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092868|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092869|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20092870|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20092871|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092872|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092873|NCT00002260|Alovudine|alovudine|mesh-list
19499776|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499777|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
19499778|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19499779|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602777|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602778|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602779|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602780|NCT02217839|Octreotide|octreotide|mesh-list
20602781|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602782|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602783|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602784|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20602785|NCT02217852|Captopril|captopril|mesh-list
20602786|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
20602787|NCT02217852|Nitrendipine|nitrendipine|mesh-list
20602788|NCT02217852|Diuretics|diuretics|mesh-ancestor
20602789|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
20602790|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602791|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20602792|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602793|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499780|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499781|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499782|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
19499783|NCT03104426|Hematinics|hematinics|mesh-ancestor
19499784|NCT03104439|Nivolumab|nivolumab|mesh-list
19499785|NCT03104439|Ipilimumab|ipilimumab|mesh-list
19499786|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499787|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499788|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19499789|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602794|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19499790|NCT03104335|Apatinib|apatinib|mesh-list
19499791|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499792|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19499793|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602795|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
20602796|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602797|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19499794|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499795|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
19499796|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19499797|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
19499798|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19499799|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499800|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19499801|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19499802|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19499803|NCT03104140|Ketamine|ketamine|mesh-list
19499804|NCT03104140|Thiopental|thiopental|mesh-list
19499805|NCT03104140|Analgesics|analgesics|mesh-ancestor
19499806|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
19499807|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499808|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499809|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19499810|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19499811|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
19499812|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
19499813|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19499814|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19499815|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19499816|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499817|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499818|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
19499819|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19499820|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
19499821|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
19499822|NCT03104010|Hormones|hormones|mesh-list
19499823|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19499824|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499825|NCT03103893|Sirolimus|sirolimus|mesh-list
19499826|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19499827|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499828|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19499829|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499830|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
19499831|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499832|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
19499833|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499834|NCT03104036|Mesalamine|mesalamine|mesh-list
19499835|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19499836|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19499837|NCT03104036|Analgesics|analgesics|mesh-ancestor
19499838|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
19499839|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499840|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499841|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499842|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570376|NCT03026062|Tremelimumab|tremelimumab|mesh-list
19570377|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
19570378|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19570379|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
20092874|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
20092875|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570380|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570381|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092876|NCT00002261|Vaccines|vaccines|mesh-list
19499843|NCT03103867|Insulin|insulin|mesh-list
19499844|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19499845|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499846|NCT03103685|Clopidogrel|clopidogrel|mesh-list
19499847|NCT03103685|Ticagrelor|ticagrelor|mesh-list
19499848|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19499849|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19499850|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19499851|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19499852|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19499853|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
19499854|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499855|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092877|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
20092878|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092879|NCT00002263|Zidovudine|zidovudine|mesh-list
20092880|NCT00002263|Sargramostim|sargramostim|mesh-list
20092881|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
20092882|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092883|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092884|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092885|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092886|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
20092887|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092888|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092889|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092890|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
20092891|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092892|NCT00002265|Zalcitabine|zalcitabine|mesh-list
20092893|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
20092894|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092895|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092896|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19499856|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499857|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
19499858|NCT03103555|Bortezomib|bortezomib|mesh-list
19499859|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499860|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
19499861|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499862|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499863|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19499864|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
19499865|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499866|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499867|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19499868|NCT03103412|Tofacitinib|tofacitinib|mesh-list
19499869|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19499870|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499871|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499872|NCT03103568|Tolbutamide|tolbutamide|mesh-list
19499873|NCT03103568|Metoprolol|metoprolol|mesh-list
19499874|NCT03103568|Furosemide|furosemide|mesh-list
19499875|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
19499876|NCT03103568|Nitisinone|nitisinone|mesh-list
19499877|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19499878|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19499879|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
19499880|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
19499881|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499882|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499883|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19499884|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19499885|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19499886|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
19499887|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499888|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499889|NCT03103568|Diuretics|diuretics|mesh-ancestor
19499890|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
19499891|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19499892|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19499893|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20092897|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499894|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499895|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19499896|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19499897|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19499898|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
20092898|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
20092899|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092900|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19499899|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499900|NCT03103646|Itraconazole|itraconazole|mesh-list
19499901|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19499902|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
19499903|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499904|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19499905|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19499906|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499907|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499908|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19499909|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
19499910|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602798|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20602799|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
20602800|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
20602801|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602802|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602803|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20602804|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20602805|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499911|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499912|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19499913|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
19499914|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19499915|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19499916|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
19499917|NCT03103399|Levodopa|levodopa|mesh-list
19499918|NCT03103399|Carbidopa|carbidopa|mesh-list
19499919|NCT03103399|Entacapone|entacapone|mesh-list
19499920|NCT03103399|Benserazide|benserazide|mesh-list
19499921|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
19499922|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
19499923|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19499924|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19499925|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
19499926|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499927|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499928|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499929|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499930|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19499931|NCT03103334|Methotrexate|methotrexate|mesh-list
19499932|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19499933|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
19499934|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19499935|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499936|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19499937|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
19499938|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499939|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19499940|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602806|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602807|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602808|NCT02217956|Bevacizumab|bevacizumab|mesh-list
20602809|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19499941|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092901|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092902|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20092903|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20092904|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
20092905|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092906|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092907|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19499942|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19499943|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19499944|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
19499945|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20092908|NCT00002266|Protective Agents|protective agents|mesh-ancestor
19499946|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19499947|NCT03103152|Aspirin|aspirin|mesh-list
19499948|NCT03103152|Vitamin D|vitamin d|mesh-list
19499949|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
19499950|NCT03103152|Vitamins|vitamins|mesh-list
19499951|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
19499952|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499953|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19499954|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19499955|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19499956|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19499957|NCT03103152|Analgesics|analgesics|mesh-ancestor
19499958|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
19499959|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499960|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499961|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499962|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19499963|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19499964|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499965|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19499966|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19499967|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499968|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
19499969|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19499970|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19499971|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19499972|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19499973|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499974|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
19499975|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19499976|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499977|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
19499978|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19499979|NCT03103009|Pasireotide|pasireotide|mesh-list
19499980|NCT03103009|Hormones|hormones|mesh-ancestor
19499981|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19499982|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499983|NCT03103022|Acetaminophen|acetaminophen|mesh-list
19499984|NCT03103022|Ibuprofen|ibuprofen|mesh-list
20092909|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092910|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092911|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092912|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092913|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
20092914|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092915|NCT00002267|Rifabutin|rifabutin|mesh-list
20092916|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20092917|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092918|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20092919|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
19499985|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20608150|NCT02244710|Ticagrelor|ticagrelor|mesh-list
20608151|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20608152|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20608153|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20608154|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20608155|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
20608156|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608157|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499986|NCT03103022|Analgesics|analgesics|mesh-ancestor
19499987|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
19499988|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19499989|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19499990|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
19499991|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19499992|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19499993|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19499994|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19499995|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19499996|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19499997|NCT03102658|Micafungin|micafungin|mesh-list
19499998|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
19499999|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500000|NCT03102801|Insulin|insulin|mesh-list
19500001|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19500002|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19500003|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500004|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
19500005|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19500006|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500007|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
20092920|NCT00002269|Zidovudine|zidovudine|mesh-list
20092921|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20092922|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
20092923|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602810|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602811|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20602812|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20602813|NCT02217956|Growth Substances|growth substances|mesh-ancestor
19500008|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20092924|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19500009|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500010|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500011|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500012|NCT03102359|Analgesics|analgesics|mesh-ancestor
19500013|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
19500014|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500015|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19500016|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19500017|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19500018|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
19500019|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500020|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500021|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19500022|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
19500023|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19500024|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19500025|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500026|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500027|NCT03102398|Urological Agents|urological agents|mesh-ancestor
19500028|NCT03101995|Gemcitabine|gemcitabine|mesh-list
19500029|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19500030|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
19500031|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500032|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500033|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
19500034|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500035|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500036|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500037|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
19500038|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500039|NCT03102242|Atezolizumab|atezolizumab|mesh-list
19500040|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500041|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19500042|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19500043|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500044|NCT03102320|Gemcitabine|gemcitabine|mesh-list
19500045|NCT03102320|Maytansine|maytansine|mesh-list
19500046|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500047|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20092925|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19500048|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
19570382|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
20092926|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092927|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
20092928|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092929|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092930|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092931|NCT00002270|Interferons|interferons|mesh-list
20092932|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
20092933|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
20092934|NCT00002270|Zidovudine|zidovudine|mesh-list
20092935|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20092936|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
20092937|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500049|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500050|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
19500051|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500052|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500053|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500054|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
19500055|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500056|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19500057|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
19500058|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
19500059|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
19570383|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570384|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19570385|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570386|NCT02966756|Venetoclax|venetoclax|mesh-list
19570387|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570388|NCT02964013|Carboplatin|carboplatin|mesh-list
19570389|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
19570390|NCT02964013|Etoposide|etoposide|mesh-list
19570391|NCT02964013|Pemetrexed|pemetrexed|mesh-list
19570392|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570393|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570394|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19570395|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19570396|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19570397|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570398|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092938|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
20092939|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092940|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
20092941|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092942|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092943|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092944|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092945|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092946|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092947|NCT00002271|Alovudine|alovudine|mesh-list
20092948|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
20092949|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092950|NCT00002272|Foscarnet|foscarnet|mesh-list
20092951|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20092952|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
20092953|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092954|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092955|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092956|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092957|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092958|NCT00002273|Ganciclovir|ganciclovir|mesh-list
20092959|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20092960|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
20092961|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092962|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092963|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092964|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092965|NCT00002274|Didanosine|didanosine|mesh-list
20092966|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
20092967|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092968|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092969|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19570399|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20092970|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570400|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092971|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
20092972|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092973|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092974|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092975|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20092976|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20092977|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20092978|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20092979|NCT00002276|Zidovudine|zidovudine|mesh-list
20092980|NCT00002276|Ibuprofen|ibuprofen|mesh-list
20092981|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20092982|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20092983|NCT00002276|Analgesics|analgesics|mesh-ancestor
20092984|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
20092985|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20092986|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20092987|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20092988|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20092989|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19500060|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
19500061|NCT03102021|Hematinics|hematinics|mesh-ancestor
19500062|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19500063|NCT03101930|Liraglutide|liraglutide|mesh-list
19500064|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19500065|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500066|NCT03101930|Incretins|incretins|mesh-ancestor
19500067|NCT03101930|Hormones|hormones|mesh-ancestor
19500068|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500069|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19500070|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
19500071|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500072|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500073|NCT03101800|Azathioprine|azathioprine|mesh-list
19500074|NCT03101800|Allopurinol|allopurinol|mesh-list
19500075|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
19500076|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500077|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500078|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
19500079|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500080|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19500081|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
19500082|NCT03101800|Protective Agents|protective agents|mesh-ancestor
19500083|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500084|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19500085|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500086|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500087|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
19500088|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19500089|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
19500090|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20092990|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20092991|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20092992|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
19500091|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
19500092|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500093|NCT03101423|Interleukin-2|interleukin-2|mesh-list
19500094|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500095|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500096|NCT03101423|Analgesics|analgesics|mesh-ancestor
19500097|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
19500098|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500099|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500100|NCT03101579|Folic Acid|folic acid|mesh-list
19500101|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
19500102|NCT03101579|Hydroxocobalamin|hydroxocobalamin|mesh-list
20092993|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20092994|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20092995|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
20092996|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20092997|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20092998|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20092999|NCT00002277|Fluconazole|fluconazole|mesh-list
20093000|NCT00002277|Amphotericin B|amphotericin b|mesh-list
20093001|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19500103|NCT03101579|Dexamethasone|dexamethasone|mesh-list
19500104|NCT03101579|Pemetrexed|pemetrexed|mesh-list
19500105|NCT03101579|Vitamins|vitamins|mesh-ancestor
20093002|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
20093003|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093004|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19500106|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
19500107|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500108|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500109|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
19500110|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
19500111|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500112|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500113|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
19500114|NCT03101579|Hormones|hormones|mesh-ancestor
19500115|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500116|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19500117|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500118|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500119|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500120|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19500121|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093005|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093006|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093007|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093008|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093009|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093010|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093011|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093012|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093013|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093014|NCT00002277|Amebicides|amebicides|mesh-ancestor
19500122|NCT03101579|Hematinics|hematinics|mesh-ancestor
19500123|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
19500124|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
19500125|NCT03101709|Fludarabine|fludarabine|mesh-list
19500126|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500127|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
19500128|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500129|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500130|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19500131|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
19500132|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500133|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500134|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19500139|NCT03101501|Mitomycins|mitomycins|mesh-list
19500140|NCT03101501|Mitomycin|mitomycin|mesh-list
19500141|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19500142|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500143|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
19500144|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500145|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19500146|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500147|NCT03101319|Vitamin D|vitamin d|mesh-list
19500148|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
19500149|NCT03101319|Vitamins|vitamins|mesh-ancestor
19500150|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
19500151|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500152|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19500153|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19500154|NCT03101280|Atezolizumab|atezolizumab|mesh-list
19500155|NCT03101280|Rucaparib|rucaparib|mesh-list
19500156|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500157|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19500158|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500159|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093015|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093016|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093017|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093018|NCT00002278|Diclazuril|diclazuril|mesh-list
20093019|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
19500160|NCT03101644|Darunavir|darunavir|mesh-list
19500161|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19500162|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19500163|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
19500164|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500165|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500166|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19500167|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19500168|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
19500169|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500170|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19500171|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19500172|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500173|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
19500174|NCT03100955|Cisplatin|cisplatin|mesh-list
19500175|NCT03100955|Etoposide|etoposide|mesh-list
19500176|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
19500177|NCT03100955|Apatinib|apatinib|mesh-list
19500178|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500179|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19500180|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19500181|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19500182|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500183|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500184|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19500185|NCT03101137|Dexamethasone|dexamethasone|mesh-list
19500186|NCT03101137|Bupivacaine|bupivacaine|mesh-list
19500187|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500188|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
19500189|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
19500190|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500191|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500192|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500193|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
19500194|NCT03101137|Hormones|hormones|mesh-ancestor
19500195|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500196|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19500197|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500198|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
19500199|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
19500200|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500201|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
19500202|NCT03101085|Equol|equol|mesh-list
19500203|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
19500204|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19500205|NCT03101085|Estrogens|estrogens|mesh-ancestor
19500206|NCT03101085|Hormones|hormones|mesh-ancestor
20093020|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093021|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093022|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093023|NCT00002279|Zalcitabine|zalcitabine|mesh-list
20093024|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
20093025|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093026|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093027|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093028|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093029|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
20093030|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500207|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500208|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500209|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
19500210|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19500211|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19500212|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500213|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
19500214|NCT03101124|Coagulants|coagulants|mesh-ancestor
19500215|NCT03101254|Vemurafenib|vemurafenib|mesh-list
20093031|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19500216|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500217|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19500218|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500219|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500220|NCT03100994|Bupivacaine|bupivacaine|mesh-list
19500221|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
20093032|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093033|NCT00002280|Didanosine|didanosine|mesh-list
19500222|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
19500223|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20093034|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
19500224|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500225|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
19500226|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500227|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
19500228|NCT03100877|Melphalan|melphalan|mesh-list
19500229|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
19500230|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19500231|NCT03100877|Lenalidomide|lenalidomide|mesh-list
19500232|NCT03100877|Lenograstim|lenograstim|mesh-list
19500233|NCT03100877|Mitogens|mitogens|mesh-list
19500234|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500235|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
19500236|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500237|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500238|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19500239|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
19500240|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500241|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500242|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19500243|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19500244|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19500245|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19500246|NCT03100877|Growth Substances|growth substances|mesh-ancestor
20093035|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093036|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19500247|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
19500248|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
19500249|NCT03100604|Sevoflurane|sevoflurane|mesh-list
19500250|NCT03100604|Desflurane|desflurane|mesh-list
19500251|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19500252|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19500253|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
19500254|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
19500255|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500256|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500257|NCT03100513|Lactulose|lactulose|mesh-list
19500258|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500259|NCT03100734|Etanercept|etanercept|mesh-list
19500260|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19500261|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500262|NCT03100734|Analgesics|analgesics|mesh-ancestor
19500263|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
19500264|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500265|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500266|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500267|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500268|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500269|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500270|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
19500271|NCT03100565|Lidocaine|lidocaine|mesh-list
19500272|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
19500273|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
19500274|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500275|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500276|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
19500277|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500278|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19500279|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19500280|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19500281|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19500282|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500283|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
19500284|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19500285|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500286|NCT03100253|Adalimumab|adalimumab|mesh-list
19500287|NCT03100253|Etanercept|etanercept|mesh-list
19500288|NCT03100253|Golimumab|golimumab|mesh-list
19500289|NCT03100253|Infliximab|infliximab|mesh-list
19500290|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
19500291|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500292|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500293|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
19500294|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500295|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19500296|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500297|NCT03100253|Analgesics|analgesics|mesh-ancestor
19500298|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
20602814|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602815|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
20602816|NCT02218021|Oxycodone|oxycodone|mesh-list
20602817|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20602818|NCT02218021|Narcotics|narcotics|mesh-ancestor
20602819|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602820|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602821|NCT02218021|Analgesics|analgesics|mesh-ancestor
20602822|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
20602823|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602824|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
19500299|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20093037|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093038|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093039|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
20093040|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500300|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500301|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500302|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
19500303|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19570401|NCT02932618|Factor VIII|factor viii|mesh-list
19570402|NCT02932618|Coagulants|coagulants|mesh-ancestor
19570403|NCT02916316|Doxorubicin|doxorubicin|mesh-list
19570404|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19570405|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19570406|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570407|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19570408|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19570409|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570410|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570411|NCT02759419|Riociguat|riociguat|mesh-list
19570412|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
19570413|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570414|NCT02699840|Vaccines|vaccines|mesh-list
19570415|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
19570416|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570417|NCT02626455|Prednisone|prednisone|mesh-list
19570418|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
19570419|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19570420|NCT02626455|Rituximab|rituximab|mesh-list
19570421|NCT02626455|Doxorubicin|doxorubicin|mesh-list
19570422|NCT02626455|Vincristine|vincristine|mesh-list
19570423|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570424|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
19570425|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570426|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570427|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19570428|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
19570429|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570430|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570431|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20093041|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093042|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19570432|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20602825|NCT02218034|Tazarotene|tazarotene|mesh-list
19570433|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20093043|NCT00002281|Zidovudine|zidovudine|mesh-list
20093044|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
20093045|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
20093046|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093047|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093048|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19500304|NCT03100318|Dotinurad|dotinurad|mesh-list
19500305|NCT03100318|Benzbromarone|benzbromarone|mesh-list
19500306|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
19500307|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
19500308|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500309|NCT03100318|Renal Agents|renal agents|mesh-ancestor
19500310|NCT03100422|Armin|armin|mesh-list
19500311|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19500312|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500313|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500314|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
19500315|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500316|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500317|NCT03100019|Resveratrol|resveratrol|mesh-list
19500318|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
19500319|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500320|NCT03100019|Protective Agents|protective agents|mesh-ancestor
19500321|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500322|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500323|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19500324|NCT03100071|Apixaban|apixaban|mesh-list
19500325|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19500326|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
19500327|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19500328|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
19500329|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500330|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500331|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
19500332|NCT03100006|Nivolumab|nivolumab|mesh-list
19500333|NCT03100006|Oregovomab|oregovomab|mesh-list
19500334|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19500335|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500336|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19500337|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500338|NCT03099720|Ropivacaine|ropivacaine|mesh-list
19500339|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
19500340|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
19500341|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500342|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500343|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
19500344|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500345|NCT03099759|Vitamin D|vitamin d|mesh-list
20093049|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093050|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
20093051|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093052|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093053|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093054|NCT00002281|Hematinics|hematinics|mesh-ancestor
20093055|NCT00002282|Fluconazole|fluconazole|mesh-list
20093056|NCT00002282|Clotrimazole|clotrimazole|mesh-list
20093057|NCT00002282|Miconazole|miconazole|mesh-list
20093058|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
20093059|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093060|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093061|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093062|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093063|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093064|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093065|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093066|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093067|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093068|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093069|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093070|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20093071|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093072|NCT00002283|Trimethoprim|trimethoprim|mesh-list
20093073|NCT00002283|Dapsone|dapsone|mesh-list
20093074|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
20093075|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20093076|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500346|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
19500347|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
19500348|NCT03099759|Vitamins|vitamins|mesh-ancestor
19500349|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
19500350|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500351|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19500352|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19500353|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
19500354|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
20093077|NCT00002283|Renal Agents|renal agents|mesh-ancestor
20093078|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
20093079|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093080|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093081|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20093082|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093083|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093084|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20093085|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19500355|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500356|NCT03099824|Protective Agents|protective agents|mesh-ancestor
19500357|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500358|NCT03099785|Rifamycins|rifamycins|mesh-list
19500359|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
19500360|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19500361|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500362|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500363|NCT03099590|Puerarin|puerarin|mesh-list
19500364|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
19500365|NCT03099616|Propofol|propofol|mesh-list
19500366|NCT03099616|Desflurane|desflurane|mesh-list
19500367|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19500368|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500369|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500370|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19500371|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
19500372|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
19500373|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19500374|NCT03099382|Docetaxel|docetaxel|mesh-list
19500375|NCT03099382|Irinotecan|irinotecan|mesh-list
19500376|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500377|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
19500378|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
19500379|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
19500380|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500381|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19500382|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19500383|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500384|NCT03099278|Ezetimibe|ezetimibe|mesh-list
19500385|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19500386|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19500387|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
19500388|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500389|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19500390|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
19500391|NCT03099122|Prednisone|prednisone|mesh-list
19500392|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
19500393|NCT03099122|Tacrolimus|tacrolimus|mesh-list
19500394|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
19500395|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19500396|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
19500397|NCT03099122|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19500398|NCT03099122|Antibodies|antibodies|mesh-list
19500399|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500400|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
19500401|NCT03099122|Hormones|hormones|mesh-ancestor
19500402|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500403|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500404|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19500405|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500406|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602826|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602827|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
20602828|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
20602829|NCT02218034|Vitamins|vitamins|mesh-ancestor
20602830|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
20602831|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500407|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
19500408|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19500409|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500410|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602832|NCT02218047|Interferons|interferons|mesh-list
19500411|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20602833|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
20602834|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
20602835|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602836|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
20602837|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500412|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19500413|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
19500414|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19500415|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500416|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
19500417|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
19500418|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500419|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500420|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19500421|NCT03099122|Protective Agents|protective agents|mesh-ancestor
19500422|NCT03099408|Metronidazole|metronidazole|mesh-list
19500423|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500424|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19500425|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19500426|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093086|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093087|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
20093088|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093089|NCT00002284|Zidovudine|zidovudine|mesh-list
20093090|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
20093091|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093092|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093093|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093094|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093095|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
20093096|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093097|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093098|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093099|NCT00002285|Zidovudine|zidovudine|mesh-list
20093100|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
20093101|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093102|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20602838|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
20602839|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500446|NCT03099213|Ramipril|ramipril|mesh-list
19500447|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19500448|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
19500449|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500450|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500451|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19500452|NCT03098875|Remifentanil|remifentanil|mesh-list
19500453|NCT03098875|Propofol|propofol|mesh-list
19500454|NCT03098875|Sevoflurane|sevoflurane|mesh-list
19500455|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19500456|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500457|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500458|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19500459|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
19500460|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
19500461|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19500462|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19500463|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19500464|NCT03098875|Narcotics|narcotics|mesh-ancestor
19500465|NCT03098875|Analgesics|analgesics|mesh-ancestor
19500466|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
19500467|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500468|NCT03099031|Tinzaparin|tinzaparin|mesh-list
19500469|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19500470|NCT03099031|Dalteparin|dalteparin|mesh-list
19500471|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
20602840|NCT02218177|Ranibizumab|ranibizumab|mesh-list
19748886|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748887|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20602841|NCT02218177|Aflibercept|aflibercept|mesh-list
20602842|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19500472|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19500473|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19500474|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500475|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19500476|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19500477|NCT03098823|Prednisone|prednisone|mesh-list
19500478|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500479|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
20602843|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20602844|NCT02218177|Growth Substances|growth substances|mesh-ancestor
20602845|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500480|NCT03098823|Hormones|hormones|mesh-ancestor
19500481|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500482|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500483|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19500484|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500485|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
19500486|NCT03098810|Astringents|astringents|mesh-ancestor
19500487|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500488|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
19500489|NCT03098680|Verapamil|verapamil|mesh-list
19500490|NCT03098680|Nicardipine|nicardipine|mesh-list
19500491|NCT03098680|Phentolamine|phentolamine|mesh-list
19500492|NCT03098680|Phenylephrine|phenylephrine|mesh-list
19500493|NCT03098680|Dobutamine|dobutamine|mesh-list
19500494|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
19500495|NCT03098680|Albuterol|albuterol|mesh-list
20602846|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
20602847|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602848|NCT02218359|Amikacin|amikacin|mesh-list
20602849|NCT02218359|Fosfomycin|fosfomycin|mesh-list
20602850|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20602851|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20602852|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602853|NCT02218398|Albuterol|albuterol|mesh-list
20602854|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20602855|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
19500496|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19500497|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
19500498|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500499|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500500|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19500501|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
19500502|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
19500503|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19500504|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19500505|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19500506|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19500507|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
19500508|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500509|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500510|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19500511|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
19500512|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
19500513|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19500514|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
19500515|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19500516|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20602856|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602857|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602858|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20602859|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
20602860|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
20602861|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20602862|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20602863|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20602864|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20602865|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
19500517|NCT03098680|Protective Agents|protective agents|mesh-ancestor
20093103|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093104|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093105|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
20093106|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602866|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602867|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607885|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607886|NCT02243852|Hormones|hormones|mesh-list
20607887|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093107|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093108|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19500518|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20093109|NCT00002286|Zidovudine|zidovudine|mesh-list
20602868|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
20602869|NCT02218476|Vitamins|vitamins|mesh-ancestor
20602870|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
20602871|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602872|NCT02218606|Prednisone|prednisone|mesh-list
20602873|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
20602874|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602875|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
20602876|NCT02218606|Hormones|hormones|mesh-ancestor
20602877|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602878|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602879|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602880|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602881|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20602882|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20602883|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602884|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
20602885|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20602886|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
20602887|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
20602888|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20602889|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20602890|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500519|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19500520|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19500521|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19500522|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
19500523|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19500524|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20093110|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
20093111|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093112|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093113|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093114|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093115|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
20093116|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093117|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093118|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093119|NCT00002287|Zidovudine|zidovudine|mesh-list
20093120|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
20093121|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093122|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093123|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093124|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500525|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19500526|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19500527|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19500528|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500529|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500530|NCT03098407|Buprenorphine|buprenorphine|mesh-list
19500531|NCT03098407|Methadone|methadone|mesh-list
19500532|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20093125|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
20093126|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093127|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093128|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093129|NCT00002288|Zidovudine|zidovudine|mesh-list
20093130|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
19500533|NCT03098407|Narcotics|narcotics|mesh-ancestor
19500534|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500535|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500536|NCT03098407|Analgesics|analgesics|mesh-ancestor
19500537|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
19500538|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500539|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19500540|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
19500541|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
19500542|NCT03098589|Lenalidomide|lenalidomide|mesh-list
19500543|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
19500544|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500545|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19500546|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20602891|NCT02218645|Brotizolam|brotizolam|mesh-list
20602892|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19500547|NCT03098589|Growth Substances|growth substances|mesh-ancestor
19500548|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
19500549|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570434|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19570435|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19570436|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570437|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570438|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
19570439|NCT02626455|Hormones|hormones|mesh-ancestor
19570440|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570441|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19570442|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19570443|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
19570444|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
19570445|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
19570446|NCT02584426|Cefazolin|cefazolin|mesh-list
19570447|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570448|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570449|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
19570450|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570451|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570452|NCT02480803|Levodopa|levodopa|mesh-list
19570453|NCT02480803|Carbidopa|carbidopa|mesh-list
19570454|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19570455|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19570456|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19570457|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
19570458|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570459|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570460|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570461|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19570462|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570463|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19570464|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
19570465|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
19570466|NCT02415153|Pomalidomide|pomalidomide|mesh-list
19570467|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
19570468|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570469|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19570470|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19570471|NCT02415153|Growth Substances|growth substances|mesh-ancestor
19570472|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
19570473|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093131|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093132|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093133|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093134|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093135|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
20093136|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093137|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093138|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093139|NCT00002289|Thymopentin|thymopentin|mesh-list
20093140|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093141|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
20093142|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093143|NCT00002290|Zidovudine|zidovudine|mesh-list
20093144|NCT00002290|Acyclovir|acyclovir|mesh-list
20093145|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
20093146|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093147|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093148|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093149|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093150|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
20093151|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093152|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093153|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093154|NCT00002291|Pentamidine|pentamidine|mesh-list
20093155|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
20093156|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093157|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093158|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19570474|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
19570475|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20093159|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20093160|NCT00002292|Pentamidine|pentamidine|mesh-list
20093161|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
19570476|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500550|NCT03098368|Rotigotine|rotigotine|mesh-list
19500551|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
19500552|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
19500553|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500554|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093162|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093163|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093164|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093165|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20093166|NCT00002293|Nystatin|nystatin|mesh-list
20093167|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093168|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093169|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
20602893|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602894|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602895|NCT02218658|Brotizolam|brotizolam|mesh-list
20602896|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20602897|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602898|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093170|NCT00002293|Ionophores|ionophores|mesh-ancestor
20093171|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20093172|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602899|NCT02218671|Brotizolam|brotizolam|mesh-list
19500555|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500556|NCT03098355|Interleukin-2|interleukin-2|mesh-list
19500557|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500558|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500559|NCT03098355|Analgesics|analgesics|mesh-ancestor
19500560|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
19500561|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500562|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500563|NCT03098342|Amorolfine|amorolfine|mesh-list
19500564|NCT03098342|Methylene Blue|methylene blue|mesh-list
19500565|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500566|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500567|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
19500568|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500569|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
19500570|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19500571|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19500572|NCT03098225|Prednisolone|prednisolone|mesh-list
19500573|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
19500574|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19500575|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
19500576|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500577|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
19500578|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
19500579|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500580|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500581|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500582|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
19500583|NCT03098225|Hormones|hormones|mesh-ancestor
19500584|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500585|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19500586|NCT03098225|Protective Agents|protective agents|mesh-ancestor
19500587|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19500588|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500589|NCT03098160|Ipilimumab|ipilimumab|mesh-list
19500590|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20093173|NCT00002294|Fluconazole|fluconazole|mesh-list
20093174|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
20093175|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093176|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093177|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093178|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093179|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093180|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093181|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093182|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093183|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093184|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20602900|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19500591|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500592|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20602901|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500593|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500594|NCT03098199|Menotropins|menotropins|mesh-list
19500595|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500596|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19500597|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
19500598|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19500599|NCT03098121|Grazoprevir|grazoprevir|mesh-list
19500600|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
19500601|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500602|NCT03097939|Nivolumab|nivolumab|mesh-list
19500603|NCT03097939|Ipilimumab|ipilimumab|mesh-list
19500604|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19500605|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500606|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19500607|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500608|NCT03097848|Sorafenib|sorafenib|mesh-list
19500609|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500610|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19500611|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500612|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500613|NCT03097900|Caffeine|caffeine|mesh-list
19500614|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
19500615|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500616|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19500617|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500618|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19500619|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500620|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19500621|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19500622|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
19500623|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500624|NCT03097835|Anesthetics|anesthetics|mesh-list
19500625|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500626|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500627|NCT03097601|Sunitinib|sunitinib|mesh-list
19500628|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500629|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19500630|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19500631|NCT03097601|Growth Substances|growth substances|mesh-ancestor
19500632|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500633|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
19500634|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19500635|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500636|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093185|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093186|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
20093187|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093188|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
20093189|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093190|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
20093191|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093192|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
20093193|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093194|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
20093195|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093196|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
20093197|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093198|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
20093199|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093200|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
20093201|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093202|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
20093203|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093204|NCT00002298|Ribavirin|ribavirin|mesh-list
20093205|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
20093206|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093207|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
20093208|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093209|NCT00002299|Interferons|interferons|mesh-list
20093210|NCT00002299|Interferon-beta|interferon-beta|mesh-list
20093211|NCT00002299|Ganciclovir|ganciclovir|mesh-list
20093212|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19500637|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
20093213|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
19500638|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19500639|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
19500640|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500641|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500642|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19500643|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
19500644|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
19500645|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19500646|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
19500647|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500648|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500649|NCT03097445|Nicotine|nicotine|mesh-list
19500650|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19500651|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
19500652|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20093214|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093215|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
20093216|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093217|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
20093218|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093219|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093220|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093221|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093222|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093223|NCT00002300|Megestrol|megestrol|mesh-list
20093224|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
20093225|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20093226|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20093227|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20093228|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
20602902|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602903|NCT02218684|Telmisartan|telmisartan|mesh-list
20602904|NCT02218684|Lacidipine|lacidipine|mesh-list
20602905|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20602906|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20602907|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20602908|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602909|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20602910|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20602911|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20602912|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602913|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20602914|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
20602915|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093229|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20602916|NCT02218762|Fluticasone|fluticasone|mesh-list
20602917|NCT02218762|Xhance|xhance|mesh-list
20602918|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20602919|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20602920|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602921|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20602922|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
20093230|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093231|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20093232|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20093233|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20093234|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500653|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500654|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20093235|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
20093236|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20120306|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120307|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
20120308|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120309|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120310|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
20120311|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120312|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120313|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
20120314|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120315|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20120316|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120317|NCT00006345|Dexamethasone|dexamethasone|mesh-list
20120318|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
20120319|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20120320|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
20120321|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
20120322|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120323|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120324|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20120325|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
20120326|NCT00006345|Hormones|hormones|mesh-ancestor
20120327|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120328|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20120329|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120330|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20120331|NCT00006347|Antibodies|antibodies|mesh-list
20120332|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
20120333|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20120334|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
20120335|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120336|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120337|NCT00006348|Ondansetron|ondansetron|mesh-list
20120338|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
20120339|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
20120340|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120341|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120342|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20120343|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
20120344|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
20120345|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20120346|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
20120347|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120348|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120349|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20120350|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20120351|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20120352|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20120353|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20120354|NCT00006349|Vitamin E|vitamin e|mesh-list
20120355|NCT00006349|Donepezil|donepezil|mesh-list
20120356|NCT00006349|Vitamins|vitamins|mesh-ancestor
20120357|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
20120358|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120359|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20120360|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120361|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120362|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
20120363|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120364|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
20120365|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
20120366|NCT00006349|Protective Agents|protective agents|mesh-ancestor
20120367|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
20120368|NCT00006350|Tacrolimus|tacrolimus|mesh-list
19500655|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20120369|NCT00006350|Daclizumab|daclizumab|mesh-list
20120370|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120371|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
20120372|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120373|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19500656|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
19500657|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120374|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120375|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120376|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20093237|NCT00002301|Foscarnet|foscarnet|mesh-list
19500658|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500659|NCT03097406|Imidacloprid|imidacloprid|mesh-list
19500660|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
19500661|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500662|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500663|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500664|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19500665|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
19500666|NCT03097120|Estrogens|estrogens|mesh-list
19500667|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19500668|NCT03097120|Hormones|hormones|mesh-ancestor
19500669|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500670|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500671|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19500672|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19500673|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19500674|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
19500675|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19500676|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19500677|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19500678|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19500679|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19500680|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093238|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20093239|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
20093240|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093241|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093242|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093243|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093244|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093245|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
20093246|NCT00002302|Hematinics|hematinics|mesh-ancestor
20093247|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
20093248|NCT00002303|Hematinics|hematinics|mesh-ancestor
20093249|NCT00002304|Fluconazole|fluconazole|mesh-list
20093250|NCT00002304|Ketoconazole|ketoconazole|mesh-list
20093251|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
20093252|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093253|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093254|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093255|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093256|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093257|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093258|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093259|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093260|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093261|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093262|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093263|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093264|NCT00002305|Fluconazole|fluconazole|mesh-list
20093265|NCT00002305|Amphotericin B|amphotericin b|mesh-list
20093266|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20093267|NCT00002305|Flucytosine|flucytosine|mesh-list
20093268|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
20093269|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093270|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093271|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093272|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093273|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093274|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093275|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093276|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093277|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093278|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093279|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093280|NCT00002305|Amebicides|amebicides|mesh-ancestor
20093281|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093282|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093283|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093284|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
19500681|NCT03097068|Ranibizumab|ranibizumab|mesh-list
19500682|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19500683|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19500684|NCT03097068|Growth Substances|growth substances|mesh-ancestor
19500685|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500686|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
20093285|NCT00002306|Fluconazole|fluconazole|mesh-list
20093286|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
20093287|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093288|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093289|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093290|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093291|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093292|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093293|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093294|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500687|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500688|NCT03097211|Levodopa|levodopa|mesh-list
20093295|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093296|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093297|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093298|NCT00002307|Zidovudine|zidovudine|mesh-list
20093299|NCT00002307|Stavudine|stavudine|mesh-list
20093300|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
20093301|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093302|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093303|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093304|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093305|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
20093306|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093307|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093308|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093309|NCT00002308|Stavudine|stavudine|mesh-list
20093310|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
20093311|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093312|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093313|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093314|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093315|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
20093316|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093317|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093318|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093319|NCT00002309|Azithromycin|azithromycin|mesh-list
20093320|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093321|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093322|NCT00002311|Wobenzym|wobenzym|mesh-list
20093323|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093324|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
20093325|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093326|NCT00002312|Zidovudine|zidovudine|mesh-list
20093327|NCT00002312|Delavirdine|delavirdine|mesh-list
20093328|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
20093329|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093330|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093331|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093332|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093333|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
20093334|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093335|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093336|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093337|NCT00002313|Didanosine|didanosine|mesh-list
20093338|NCT00002313|Nystatin|nystatin|mesh-list
20093339|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
20093340|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093341|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093342|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093343|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093344|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
20093345|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093346|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093347|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093348|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19500689|NCT03097211|Benserazide|benserazide|mesh-list
20093349|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
20093350|NCT00002313|Ionophores|ionophores|mesh-ancestor
19500690|NCT03097211|Resveratrol|resveratrol|mesh-list
19500691|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19500692|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19500693|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19500694|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
19500695|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500696|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500697|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500698|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
19500699|NCT03097211|Protective Agents|protective agents|mesh-ancestor
19500700|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500701|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19500702|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19500703|NCT03097198|Tropicamide|tropicamide|mesh-list
19500704|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19500705|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
19500706|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
19500707|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500708|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500709|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19500710|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19500711|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
19500712|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500713|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500714|NCT03097003|Apremilast|apremilast|mesh-list
20093351|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20093352|NCT00002315|Acyclovir|acyclovir|mesh-list
20093353|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
20093354|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
20093355|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093356|NCT00002316|Amphotericin B|amphotericin b|mesh-list
20093357|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20093358|NCT00002316|Amebicides|amebicides|mesh-ancestor
20093359|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093360|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093361|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093362|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093363|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
20093364|NCT00002317|Leucovorin|leucovorin|mesh-list
20093365|NCT00002317|Trimetrexate|trimetrexate|mesh-list
20093366|NCT00002317|Calcium|calcium|mesh-list
20093367|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
20093368|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19500715|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19500716|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500717|NCT03097003|Analgesics|analgesics|mesh-ancestor
19500718|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
19500719|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20093369|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093370|NCT00002317|Antidotes|antidotes|mesh-ancestor
20093371|NCT00002317|Protective Agents|protective agents|mesh-ancestor
20093372|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
20093373|NCT00002317|Vitamins|vitamins|mesh-ancestor
20093374|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
20093375|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
20093376|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500720|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500721|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500722|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500723|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20602923|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602924|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602925|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20602926|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
20602927|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602928|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20602929|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20602930|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20602931|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19500724|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19500725|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748888|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19500726|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500727|NCT03096990|Apremilast|apremilast|mesh-list
19500728|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19748889|NCT05366192|Ritonavir|ritonavir|mesh-list
20093377|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19500729|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500730|NCT03096990|Analgesics|analgesics|mesh-ancestor
19500731|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
19500732|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500733|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500734|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19500735|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500736|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19500737|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19500738|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500739|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500740|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
19500741|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
19500742|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500743|NCT03096756|Protective Agents|protective agents|mesh-ancestor
19500744|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570477|NCT02330926|Ibuprofen|ibuprofen|mesh-list
19570478|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19570479|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19570480|NCT02330926|Analgesics|analgesics|mesh-ancestor
19570481|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
19570482|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570483|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570484|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570485|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570486|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19570487|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570488|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570489|NCT02274285|Vaccines|vaccines|mesh-list
19570490|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
19570491|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570492|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19570493|NCT02120469|Everolimus|everolimus|mesh-list
19570494|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570495|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570496|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
19570497|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093378|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
20093379|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093380|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093381|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20093382|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093383|NCT00002318|Doxorubicin|doxorubicin|mesh-list
20093384|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20093385|NCT00002318|Bleomycin|bleomycin|mesh-list
20093386|NCT00002318|Vincristine|vincristine|mesh-list
20093387|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20093388|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093389|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20093390|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20093391|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093392|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602932|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
19500745|NCT03096704|Vitamin D|vitamin d|mesh-list
19500746|NCT03096704|Vitamins|vitamins|mesh-ancestor
19500747|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
19500748|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500749|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19500750|NCT03096470|Anesthetics|anesthetics|mesh-list
19500751|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500752|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500753|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
20093393|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20093394|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
19500754|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500755|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
19500756|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
20093395|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
20093396|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
20093397|NCT00002319|Doxorubicin|doxorubicin|mesh-list
20093398|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20093399|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20093400|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093401|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20093402|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20093403|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093404|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093405|NCT00002320|Lamivudine|lamivudine|mesh-list
20093406|NCT00002320|Zidovudine|zidovudine|mesh-list
20093407|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093408|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093409|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093410|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093411|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
20093412|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093413|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20602933|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20602934|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602935|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
20602936|NCT02218762|Hormones|hormones|mesh-ancestor
20602937|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602938|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
20602939|NCT02218775|Aticaprant|aticaprant|mesh-list
20602940|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20602941|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602942|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
20602943|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602944|NCT02218814|Bupivacaine|bupivacaine|mesh-list
20602945|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
20602946|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
20602947|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20602948|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602949|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
20602950|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602951|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20602952|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20602953|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20602954|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
20602955|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20602956|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
20602957|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602958|NCT02219100|Mifepristone|mifepristone|mesh-list
20602959|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20602960|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
20602961|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20602962|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602963|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20602964|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20093414|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093415|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
20093416|NCT00002321|Aldesleukin|aldesleukin|mesh-list
20093417|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093418|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093419|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093420|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
20602965|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19500757|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
19500758|NCT03096327|Montelukast|montelukast|mesh-list
19500759|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19500760|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
19500761|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19500762|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
19500763|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500764|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500765|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19500766|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19500767|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500768|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
19500769|NCT03096340|Irinotecan|irinotecan|mesh-list
19500770|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19500771|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500772|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19500773|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19500774|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093421|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093422|NCT00002322|Zidovudine|zidovudine|mesh-list
20093423|NCT00002322|Atevirdine|atevirdine|mesh-list
20093424|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
20093425|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093426|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20602966|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
20602967|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20602968|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20602969|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
20602970|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602971|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
20093427|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093428|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093429|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
20093430|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093431|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093432|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093433|NCT00002323|Zidovudine|zidovudine|mesh-list
20093434|NCT00002323|Nevirapine|nevirapine|mesh-list
20093435|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
20093436|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093437|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093438|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093439|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093440|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
20093441|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093442|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093443|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093444|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20093445|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20602972|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20602973|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20602974|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
20602975|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20602976|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20602977|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20602978|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
20093446|NCT00002324|Zidovudine|zidovudine|mesh-list
20093447|NCT00002324|Nevirapine|nevirapine|mesh-list
20093448|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
20093449|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093450|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093451|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093452|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093453|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
20093454|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093455|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093456|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093457|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20602979|NCT02219152|Coagulants|coagulants|mesh-ancestor
20093458|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19500775|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500776|NCT03096392|Insulin|insulin|mesh-list
19500777|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19500778|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
19500779|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20093459|NCT00002325|Fluconazole|fluconazole|mesh-list
20093460|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
20093461|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093462|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093463|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093464|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093465|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093466|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093467|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093468|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093469|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093470|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093471|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093472|NCT00002326|Zidovudine|zidovudine|mesh-list
20093473|NCT00002326|Adefovir|adefovir|mesh-list
20093474|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
20093475|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093476|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093477|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093478|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093479|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
20093480|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093481|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093482|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093483|NCT00002327|Cidofovir|cidofovir|mesh-list
20093484|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
20093485|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093486|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093487|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093488|NCT00002328|Azithromycin|azithromycin|mesh-list
20093489|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093490|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093491|NCT00002330|Ganciclovir|ganciclovir|mesh-list
20093492|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20093493|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
20093494|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093495|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093496|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093497|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093498|NCT00002331|Clarithromycin|clarithromycin|mesh-list
20093499|NCT00002331|Ethambutol|ethambutol|mesh-list
20093500|NCT00002331|Clofazimine|clofazimine|mesh-list
20093501|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093502|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093503|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20093504|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093505|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093506|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093507|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093508|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
20602980|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
20602981|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20602982|NCT02219165|Antibodies|antibodies|mesh-list
20602983|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
20602984|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602985|NCT02219178|Dexamethasone|dexamethasone|mesh-list
20602986|NCT02219178|Lenalidomide|lenalidomide|mesh-list
20602987|NCT02219178|Bortezomib|bortezomib|mesh-list
20602988|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602989|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
20602990|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
20602991|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20602992|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20602993|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20602994|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
20602995|NCT02219178|Hormones|hormones|mesh-ancestor
20093509|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20602996|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20602997|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20602998|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20602999|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
20603000|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20603001|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20603002|NCT02219178|Growth Substances|growth substances|mesh-ancestor
20603003|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
19500780|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093510|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
20093511|NCT00002332|Thymopentin|thymopentin|mesh-list
20093512|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093513|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
20093514|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093515|NCT00002333|Saquinavir|saquinavir|mesh-list
20093516|NCT00002333|Zalcitabine|zalcitabine|mesh-list
20093517|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093518|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093519|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093520|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093521|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093522|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093523|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093524|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
20093525|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500781|NCT03096522|Phenytoin|phenytoin|mesh-list
19500782|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
19500783|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19500784|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19500785|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19500786|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500787|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19500788|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19500789|NCT03096457|Paromomycin|paromomycin|mesh-list
19500790|NCT03096457|Pentamidine|pentamidine|mesh-list
19500791|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19500792|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093526|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093527|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093528|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
20093529|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093530|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093531|NCT00002334|Zidovudine|zidovudine|mesh-list
20093532|NCT00002334|Zalcitabine|zalcitabine|mesh-list
20093533|NCT00002334|Saquinavir|saquinavir|mesh-list
20093534|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
20093535|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093536|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093537|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093538|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093539|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
20093540|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093541|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093542|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093543|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093544|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20603004|NCT02219191|Puerarin|puerarin|mesh-list
20603005|NCT02219191|Atorvastatin|atorvastatin|mesh-list
20093545|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093546|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093547|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093548|NCT00002335|Emtricitabine|emtricitabine|mesh-list
20093549|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
20093550|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093551|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093552|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093553|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093554|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093555|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603006|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20093556|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093557|NCT00002336|Clarithromycin|clarithromycin|mesh-list
20093558|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093559|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603007|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20603008|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
19500793|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093560|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20093561|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093562|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093563|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093564|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093565|NCT00002337|Vesnarinone|vesnarinone|mesh-list
20093566|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20093567|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
20093568|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093569|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093570|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
20603009|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603010|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20603011|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20603012|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603013|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
20603014|NCT02219217|Dolutegravir|dolutegravir|mesh-list
20603015|NCT02219217|Cobicistat|cobicistat|mesh-list
20603016|NCT02219217|Elvitegravir|elvitegravir|mesh-list
20603017|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20603018|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20093571|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093572|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20093573|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20093574|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093575|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093576|NCT00002337|Protective Agents|protective agents|mesh-ancestor
20093577|NCT00002339|Fluconazole|fluconazole|mesh-list
20093578|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
20093579|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748890|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19748891|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19748892|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
19748893|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093580|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093581|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093582|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093583|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093584|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093585|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093586|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093587|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093588|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093589|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093590|NCT00002340|Atovaquone|atovaquone|mesh-list
20093591|NCT00002340|Pentamidine|pentamidine|mesh-list
20093592|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603019|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603020|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603021|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603022|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20603023|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
20603024|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603025|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20603026|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20603027|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
20603028|NCT02219373|Gabapentin|gabapentin|mesh-list
20603029|NCT02219373|Analgesics|analgesics|mesh-ancestor
20603030|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
20603031|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603032|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500794|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19500795|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
19500796|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19500797|NCT03096405|Methicillin|methicillin|mesh-list
19500798|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19500799|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500800|NCT03096249|Oxytocin|oxytocin|mesh-list
19500801|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
19500802|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19500803|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500804|NCT03096223|KHK4083|khk4083|mesh-list
19500805|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
19500806|NCT03095872|Petrolatum|petrolatum|mesh-list
19500807|NCT03095872|Emollients|emollients|mesh-ancestor
19500808|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
19500809|NCT03096184|Apatinib|apatinib|mesh-list
19500810|NCT03096184|Tegafur|tegafur|mesh-list
19500811|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500812|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19500813|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500814|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500815|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19500816|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
19500817|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
19500818|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
19500819|NCT03096028|Vitamins|vitamins|mesh-ancestor
19500820|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
19500821|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093593|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
20603033|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
20603034|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20603035|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20093594|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20093595|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20093596|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093597|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093598|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
20093599|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20093600|NCT00002341|Itraconazole|itraconazole|mesh-list
20093601|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
20093602|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093603|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093604|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093605|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093606|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093607|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093608|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093609|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093610|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093611|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093612|NCT00002343|Ethambutol|ethambutol|mesh-list
20093613|NCT00002343|Rifabutin|rifabutin|mesh-list
19500822|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
19500823|NCT03096028|Hematinics|hematinics|mesh-ancestor
19500824|NCT03095547|Cyclosporine|cyclosporine|mesh-list
19500825|NCT03095547|Posaconazole|posaconazole|mesh-list
19500826|NCT03095547|Olorofim|olorofim|mesh-list
19500827|NCT03095547|Pantoprazole|pantoprazole|mesh-list
19500828|NCT03095547|Tacrolimus|tacrolimus|mesh-list
19500829|NCT03095547|Cyclosporins|cyclosporins|mesh-list
20093614|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
20093615|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093616|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093617|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20093618|NCT00002344|Azithromycin|azithromycin|mesh-list
20093619|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093620|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093621|NCT00002345|Megestrol|megestrol|mesh-list
20093622|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
20093623|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20093624|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20093625|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20093626|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
20093627|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19500830|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20093628|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500831|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
19500832|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500833|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19500834|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500835|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500836|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
19500837|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500838|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
19500839|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19500840|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19500841|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19500842|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19500843|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19500844|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19500845|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19500846|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19500847|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19500848|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19500849|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
19500850|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19500851|NCT03095703|Sirolimus|sirolimus|mesh-list
19500852|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19500853|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500854|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19500855|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500856|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
19500857|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500858|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
19500859|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500860|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
19500861|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19500862|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500863|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500864|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19500865|NCT03095469|Analgesics|analgesics|mesh-ancestor
20093629|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20093630|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20093631|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20093632|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093633|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
20093634|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20093635|NCT00002346|Adefovir|adefovir|mesh-list
20093636|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20093637|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
20093638|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093639|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093640|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093641|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093642|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093643|NCT00002347|Zidovudine|zidovudine|mesh-list
20093644|NCT00002347|Nevirapine|nevirapine|mesh-list
20093645|NCT00002347|Zalcitabine|zalcitabine|mesh-list
20093646|NCT00002347|Saquinavir|saquinavir|mesh-list
20093647|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
20093648|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093649|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093650|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093651|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093652|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
20093653|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093654|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093655|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093656|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20603036|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603037|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20603038|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20603039|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20603040|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603041|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603042|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
20603043|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20603044|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20603045|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20603046|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20603047|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19500866|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
19500867|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500868|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19500869|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20093657|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20093658|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093659|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093660|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093661|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093662|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20603048|NCT02219412|Aspirin|aspirin|mesh-list
20603049|NCT02219412|Ticagrelor|ticagrelor|mesh-list
20603050|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20603051|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20603052|NCT02219412|Analgesics|analgesics|mesh-ancestor
20603053|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
20603054|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603055|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603056|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603057|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20603058|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20603059|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20603060|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603061|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20603062|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20603063|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603064|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
20603065|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20603066|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20603067|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20603068|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
20093663|NCT00002348|Mitoguazone|mitoguazone|mesh-list
20093664|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093665|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093666|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093667|NCT00002349|Stavudine|stavudine|mesh-list
20093668|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
20093669|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093670|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093671|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093672|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093673|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
20093674|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093675|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093676|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093677|NCT00002351|Indinavir|indinavir|mesh-list
20093678|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093679|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093680|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603069|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603070|NCT02219490|Ribavirin|ribavirin|mesh-list
20603071|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
20603072|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603073|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
20603074|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603075|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20603076|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
20603077|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20603078|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20603079|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603080|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603081|NCT02219646|Urological Agents|urological agents|mesh-ancestor
20603082|NCT02219659|Fentanyl|fentanyl|mesh-list
20603083|NCT02219659|Midazolam|midazolam|mesh-list
20603084|NCT02219659|Propofol|propofol|mesh-list
20603085|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20603086|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603087|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603088|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19500870|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19500871|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
19500872|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500873|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500874|NCT03095404|Lidocaine|lidocaine|mesh-list
19500875|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19500876|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
19500877|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
19500878|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500879|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500880|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
19500881|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500882|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19500883|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19500884|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19500885|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19500886|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500887|NCT03095274|Durvalumab|durvalumab|mesh-list
19500888|NCT03095274|Tremelimumab|tremelimumab|mesh-list
19500889|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19500890|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500891|NCT03095144|Anesthetics|anesthetics|mesh-list
19500892|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500893|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500894|NCT03095352|Carboplatin|carboplatin|mesh-list
19500895|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
19500896|NCT03095352|Trastuzumab|trastuzumab|mesh-list
19500897|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500898|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19500899|NCT03095209|Paclitaxel|paclitaxel|mesh-list
19500900|NCT03095209|Carboplatin|carboplatin|mesh-list
19500901|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19500902|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500903|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
19500904|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
19500905|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
19500906|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500907|NCT03095222|Ketamine|ketamine|mesh-list
19500908|NCT03095222|Analgesics|analgesics|mesh-ancestor
19500909|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
19500910|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500911|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500912|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19500913|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19500914|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
19500915|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
19500916|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19500917|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19500918|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19500919|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19500920|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500921|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
19500922|NCT03095378|Tetracycline|tetracycline|mesh-list
19500923|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19500924|NCT03095378|Citric Acid|citric acid|mesh-list
19500925|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
19500926|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19500927|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603089|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
20603090|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
20603091|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20603092|NCT02219659|Narcotics|narcotics|mesh-ancestor
20603093|NCT02219659|Analgesics|analgesics|mesh-ancestor
20603094|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
20093681|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093682|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093683|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093684|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093685|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
20093686|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093687|NCT00002352|Lobucavir|lobucavir|mesh-list
20093688|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603095|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500928|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500929|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
20603096|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19500930|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19500931|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
19500932|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
19500933|NCT03095326|Zinc|zinc|mesh-list
19500934|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
19500935|NCT03095326|Vaccines|vaccines|mesh-list
19500936|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
19500937|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500938|NCT03095326|Trace Elements|trace elements|mesh-ancestor
19500939|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
20093689|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093690|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093691|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093692|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
20093693|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093694|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093695|NCT00002354|Stavudine|stavudine|mesh-list
20093696|NCT00002354|Indinavir|indinavir|mesh-list
20093697|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
20093698|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093699|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093700|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093701|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093702|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
20093703|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093704|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093705|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093706|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093707|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093708|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093709|NCT00002355|Fomivirsen|fomivirsen|mesh-list
20093710|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
20093711|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093712|NCT00002356|Fomivirsen|fomivirsen|mesh-list
20093713|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
20093714|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093715|NCT00002357|Zidovudine|zidovudine|mesh-list
20093716|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
20093717|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093718|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093719|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093720|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093721|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
20093722|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093723|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093724|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093725|NCT00002358|Sorivudine|sorivudine|mesh-list
20093726|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
20093727|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093728|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093729|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093730|NCT00002360|Didanosine|didanosine|mesh-list
20093731|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
20093732|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093733|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093734|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093735|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093736|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
20093737|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093738|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093739|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093740|NCT00002361|Ritonavir|ritonavir|mesh-list
20093741|NCT00002361|Indinavir|indinavir|mesh-list
20093742|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093743|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093744|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093745|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093746|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093747|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093748|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093749|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
20093750|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093751|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19500940|NCT03095326|Astringents|astringents|mesh-ancestor
19500941|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
20093752|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093753|NCT00002362|Emtricitabine|emtricitabine|mesh-list
20093754|NCT00002362|Efavirenz|efavirenz|mesh-list
20093755|NCT00002362|Abacavir|abacavir|mesh-list
19500942|NCT03095235|Riboflavin|riboflavin|mesh-list
19500943|NCT03095235|Vitamins|vitamins|mesh-ancestor
19500944|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
19500945|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500946|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
19500947|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19500948|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
20093756|NCT00002362|Stavudine|stavudine|mesh-list
20093757|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
20093758|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093759|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093760|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093761|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093762|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093763|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093764|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093765|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20093766|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093767|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20093768|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20093769|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20093770|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20093771|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
20093772|NCT00002364|Abacavir|abacavir|mesh-list
20093773|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093774|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093775|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093776|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093777|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
20093778|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093779|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093780|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093781|NCT00002366|Ritonavir|ritonavir|mesh-list
20093782|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093783|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093784|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093785|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093786|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093787|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093788|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093789|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
20093790|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093791|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093792|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093793|NCT00002367|Lamivudine|lamivudine|mesh-list
20093794|NCT00002367|Zidovudine|zidovudine|mesh-list
20093795|NCT00002367|Saquinavir|saquinavir|mesh-list
20093796|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093797|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093798|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093799|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093800|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
20093801|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093802|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093803|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093804|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
20093805|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093806|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093807|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093808|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093809|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093810|NCT00002368|Lamivudine|lamivudine|mesh-list
20093811|NCT00002368|Nevirapine|nevirapine|mesh-list
20093812|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093813|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093814|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093815|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093816|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
19500949|NCT03095105|Resveratrol|resveratrol|mesh-list
19500950|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
19500951|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749468|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20093817|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19500952|NCT03095105|Protective Agents|protective agents|mesh-ancestor
20093818|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19500953|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500954|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500955|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19500956|NCT03095079|Endostatins|endostatins|mesh-list
19500957|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19500958|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19500959|NCT03095079|Growth Substances|growth substances|mesh-ancestor
19500960|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500961|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
19500962|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500963|NCT03095040|Everolimus|everolimus|mesh-list
19500964|NCT03095040|Vorolanib|vorolanib|mesh-list
19500965|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500966|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19500967|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
19500968|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500969|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20093819|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093820|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20093821|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20093822|NCT00002369|Lamivudine|lamivudine|mesh-list
20093823|NCT00002369|Zidovudine|zidovudine|mesh-list
20093824|NCT00002369|Stavudine|stavudine|mesh-list
20093825|NCT00002369|Indinavir|indinavir|mesh-list
20093826|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093827|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093828|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093829|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093830|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
20093831|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093832|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093833|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093834|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
20093835|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093836|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093837|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093838|NCT00002370|Itraconazole|itraconazole|mesh-list
20093839|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
20093840|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093841|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20093842|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093843|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093844|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093845|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20093846|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
20093847|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20093848|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20093849|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093850|NCT00002372|Nelfinavir|nelfinavir|mesh-list
20093851|NCT00002372|Indinavir|indinavir|mesh-list
20093852|NCT00002372|Saquinavir|saquinavir|mesh-list
20093853|NCT00002372|Amprenavir|amprenavir|mesh-list
20093854|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093855|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093856|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093857|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093858|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093859|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093860|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093861|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
20093862|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093863|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093864|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093865|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20093866|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
20093867|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20093868|NCT00002373|Maribavir|maribavir|mesh-list
20093869|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
20093870|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093871|NCT00002374|Ritonavir|ritonavir|mesh-list
20093872|NCT00002374|Nelfinavir|nelfinavir|mesh-list
20093873|NCT00002374|Saquinavir|saquinavir|mesh-list
20093874|NCT00002374|Stavudine|stavudine|mesh-list
20093875|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093876|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093877|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093878|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500970|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19500971|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093879|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093880|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093881|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093882|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
20093883|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093884|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093885|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20093886|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
20093887|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093888|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093889|NCT00002375|Nelfinavir|nelfinavir|mesh-list
20093890|NCT00002375|Indinavir|indinavir|mesh-list
20093891|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093892|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093893|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093894|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093895|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093896|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093897|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093898|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
20093899|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093900|NCT00002376|Lamivudine|lamivudine|mesh-list
20093901|NCT00002376|Zidovudine|zidovudine|mesh-list
20093902|NCT00002376|Stavudine|stavudine|mesh-list
20093903|NCT00002376|Didanosine|didanosine|mesh-list
20093904|NCT00002376|Indinavir|indinavir|mesh-list
20093905|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093906|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093907|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603097|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20093908|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093909|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
20093910|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093911|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093912|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093913|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
20093914|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093915|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093916|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603098|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20093917|NCT00002377|Valganciclovir|valganciclovir|mesh-list
20093918|NCT00002377|Ganciclovir|ganciclovir|mesh-list
20093919|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20093920|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
20093921|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093922|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093923|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093924|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093925|NCT00002378|Ritonavir|ritonavir|mesh-list
20093926|NCT00002378|Nelfinavir|nelfinavir|mesh-list
20093927|NCT00002378|Saquinavir|saquinavir|mesh-list
20093928|NCT00002378|Lamivudine|lamivudine|mesh-list
20093929|NCT00002378|Zidovudine|zidovudine|mesh-list
20093930|NCT00002378|Stavudine|stavudine|mesh-list
20093931|NCT00002378|Delavirdine|delavirdine|mesh-list
20093932|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093933|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093934|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093935|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093936|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093937|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093938|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093939|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
20093940|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093941|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093942|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19500972|NCT03095001|Paclitaxel|paclitaxel|mesh-list
20093943|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093944|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093945|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
20093946|NCT00002379|Lamivudine|lamivudine|mesh-list
20093947|NCT00002379|Zidovudine|zidovudine|mesh-list
20093948|NCT00002379|Stavudine|stavudine|mesh-list
20093949|NCT00002379|Adefovir|adefovir|mesh-list
20093950|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20093951|NCT00002379|Indinavir|indinavir|mesh-list
20093952|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093953|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093954|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093955|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093956|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
20093957|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093958|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093959|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093960|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
20093961|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093962|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093963|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093964|NCT00002380|Nelfinavir|nelfinavir|mesh-list
20093965|NCT00002380|Saquinavir|saquinavir|mesh-list
20093966|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093967|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093968|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093969|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093970|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093971|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093972|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093973|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
20093974|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093975|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20093976|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19500973|NCT03095001|Bevacizumab|bevacizumab|mesh-list
19500974|NCT03095001|Carboplatin|carboplatin|mesh-list
19500975|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19500976|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19500977|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
19500978|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
19500979|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
19500980|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500981|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20093977|NCT00002381|Nevirapine|nevirapine|mesh-list
20093978|NCT00002381|Stavudine|stavudine|mesh-list
20093979|NCT00002381|Nelfinavir|nelfinavir|mesh-list
20093980|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20093981|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20093982|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093983|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20093984|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
20093985|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20093986|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20093987|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20093988|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20093989|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20093990|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
20093991|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093992|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093993|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093994|NCT00002382|Saquinavir|saquinavir|mesh-list
20093995|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20093996|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20093997|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
20093998|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20093999|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094000|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094001|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094002|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
20094003|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094004|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19500982|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20094005|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094006|NCT00002383|Saquinavir|saquinavir|mesh-list
20603099|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20094007|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19500983|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19500984|NCT03095001|Growth Substances|growth substances|mesh-ancestor
19500985|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500986|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
19500987|NCT03094663|Cefazolin|cefazolin|mesh-list
19500988|NCT03094663|Dexamethasone|dexamethasone|mesh-list
19500989|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
19500990|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
19500991|NCT03094663|Epinephrine|epinephrine|mesh-list
19500992|NCT03094663|Bupivacaine|bupivacaine|mesh-list
19500993|NCT03094663|BB 1101|bb 1101|mesh-list
19500994|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20094008|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094009|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094010|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094011|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19500995|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
19500996|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
19500997|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19500998|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19500999|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501000|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
19501001|NCT03094663|Hormones|hormones|mesh-ancestor
19501002|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501003|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19501004|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501005|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
19501006|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501007|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501008|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
19501009|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
19501010|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501011|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
19501012|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19501013|NCT03094663|Protective Agents|protective agents|mesh-ancestor
19501014|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19501015|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19501016|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
19501017|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501018|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19501019|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19501020|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19501021|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
19501022|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
19501023|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
19501024|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19501025|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19501026|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501027|NCT03094481|Epinephrine|epinephrine|mesh-list
19501028|NCT03094481|Bupivacaine|bupivacaine|mesh-list
19501029|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
19501030|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
19501031|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501032|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501033|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
19501034|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501035|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19501036|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19501037|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
19501038|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501039|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501040|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19501041|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19501042|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
19501043|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19501044|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
19501045|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
19501046|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
19501047|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20094012|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094013|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094014|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
20309019|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19501048|NCT03094533|Propofol|propofol|mesh-list
19501049|NCT03094533|Sevoflurane|sevoflurane|mesh-list
19501050|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19501051|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20094015|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094016|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19501052|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094017|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094018|NCT00002384|Cidofovir|cidofovir|mesh-list
20094019|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
20094020|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094021|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094022|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094023|NCT00002386|Lamivudine|lamivudine|mesh-list
20094024|NCT00002386|Zidovudine|zidovudine|mesh-list
20094025|NCT00002386|Stavudine|stavudine|mesh-list
20094026|NCT00002386|Didanosine|didanosine|mesh-list
20094027|NCT00002386|Zalcitabine|zalcitabine|mesh-list
20094028|NCT00002386|Indinavir|indinavir|mesh-list
20094029|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094030|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094031|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094032|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094033|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
20094034|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501053|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19501054|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
19501055|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
19501056|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19501057|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19501058|NCT03094403|Azelaic acid|azelaic acid|mesh-list
19501059|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501060|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
19501061|NCT03094468|Terbinafine|terbinafine|mesh-list
19501062|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
19501063|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501064|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501065|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501066|NCT03094507|Darunavir|darunavir|mesh-list
20094035|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094036|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094037|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
20094038|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094039|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094040|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094041|NCT00002387|Efavirenz|efavirenz|mesh-list
20094042|NCT00002387|Indinavir|indinavir|mesh-list
20094043|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094044|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094045|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094046|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094047|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
20094048|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094049|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20094050|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094051|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20094052|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19501067|NCT03094507|Dolutegravir|dolutegravir|mesh-list
19501068|NCT03094507|Cobicistat|cobicistat|mesh-list
19501069|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19501070|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19501071|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
19501072|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501073|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501074|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19501075|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19501076|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
19501077|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501078|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19501079|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19501080|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19501081|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19501082|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19501083|NCT03094182|Hematinics|hematinics|mesh-ancestor
19501084|NCT03094442|Dexamethasone|dexamethasone|mesh-list
19501085|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501086|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
20094053|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19501087|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
19501088|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603100|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
20603101|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
20603102|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603103|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603104|NCT02219672|Ritonavir|ritonavir|mesh-list
19501089|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094054|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20094055|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19501090|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501091|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
19501092|NCT03094442|Hormones|hormones|mesh-ancestor
19501093|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501094|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19501095|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501096|NCT03094247|Amoxicillin|amoxicillin|mesh-list
19501097|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19501098|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501099|NCT03094156|Resveratrol|resveratrol|mesh-list
19501100|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19501101|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
19501102|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501103|NCT03094156|Protective Agents|protective agents|mesh-ancestor
19501104|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501105|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501106|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19501107|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
19501108|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501109|NCT03093805|Calcipotriene|calcipotriene|mesh-list
19501110|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
19501111|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19501112|NCT03093883|Hematinics|hematinics|mesh-ancestor
19501113|NCT03093909|Gemcitabine|gemcitabine|mesh-list
19501114|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19501115|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
19501116|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501117|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501118|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
19501119|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501120|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501121|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501122|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
19501123|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501124|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
19501125|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
19501126|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
19501127|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19501128|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19501129|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501130|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501131|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
19501132|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19501133|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
19501134|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501135|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
19501136|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19501137|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501138|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
19501139|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19501140|NCT03093545|Antibodies|antibodies|mesh-list
19501141|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
19501142|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501143|NCT03093597|Petrolatum|petrolatum|mesh-list
19501144|NCT03093597|Emollients|emollients|mesh-ancestor
19501145|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
19501146|NCT03093402|Lenabasum|lenabasum|mesh-list
19501147|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19501148|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19501149|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501150|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501151|NCT03093402|Hormones|hormones|mesh-ancestor
19501152|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501153|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603105|NCT02219672|Lopinavir|lopinavir|mesh-list
19501154|NCT03093129|Artesunate|artesunate|mesh-list
19501155|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
19501156|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19501157|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19501158|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501159|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501160|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
19501161|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
19501162|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19501163|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
19501164|NCT03093389|Resveratrol|resveratrol|mesh-list
19501165|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
19501166|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501167|NCT03093389|Protective Agents|protective agents|mesh-ancestor
19501168|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501169|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501170|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19501171|NCT03093090|Furosemide|furosemide|mesh-list
19501172|NCT03093090|Diuretics|diuretics|mesh-ancestor
19501173|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
19501174|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501175|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19501176|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19501177|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501178|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
19501179|NCT03093168|Fludarabine|fludarabine|mesh-list
19501180|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501181|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
19501182|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501183|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501184|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19501185|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
19501186|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501187|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501188|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19501189|NCT03093103|Empagliflozin|empagliflozin|mesh-list
19501190|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19501191|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501192|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19501193|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501194|NCT03092986|Paclitaxel|paclitaxel|mesh-list
19501195|NCT03092986|Vinblastine|vinblastine|mesh-list
19501196|NCT03092986|Carboplatin|carboplatin|mesh-list
19501197|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19501198|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501199|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
19501200|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
19501201|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
19501202|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501203|NCT03092908|Acetic Acid|acetic acid|mesh-list
19501204|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19501205|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501206|NCT03092817|Dexamethasone|dexamethasone|mesh-list
19501207|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501208|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
19501209|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
19501210|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501211|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501212|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501213|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
19501214|NCT03092817|Hormones|hormones|mesh-ancestor
19501215|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501216|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19501217|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603106|NCT02219672|Tenofovir|tenofovir|mesh-list
19501218|NCT03092856|Axitinib|axitinib|mesh-list
19501219|NCT03092856|Antibodies|antibodies|mesh-list
19501220|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
20603107|NCT02219672|Lamivudine|lamivudine|mesh-list
20603108|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
20603109|NCT02219672|Triptolide|triptolide|mesh-list
19501221|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501222|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501223|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19501224|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501225|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501226|NCT03092765|Quetmolimab|quetmolimab|mesh-list
19501227|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501228|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19501229|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
19501230|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501231|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
19501232|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501233|NCT03092310|Pancrelipase|pancrelipase|mesh-list
19501234|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501235|NCT03092193|Naproxen|naproxen|mesh-list
19501236|NCT03092193|Esomeprazole|esomeprazole|mesh-list
19501237|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19501238|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501239|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19501240|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501241|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501242|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19501243|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501244|NCT03092193|Analgesics|analgesics|mesh-ancestor
19501245|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
19501246|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501247|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501248|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501249|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501250|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
19501251|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19501252|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19501253|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19501254|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19501255|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19501256|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
19501257|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501258|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19501259|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19501260|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501261|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501262|NCT03092466|Ropivacaine|ropivacaine|mesh-list
19501263|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
19501264|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
19501265|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501266|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501267|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
19501268|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501269|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
19501270|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
19501271|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501272|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19501273|NCT03092076|Ticagrelor|ticagrelor|mesh-list
19501274|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19501275|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19501276|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19501277|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19501278|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
19501279|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501280|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501281|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501282|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
19501283|NCT03091894|Propofol|propofol|mesh-list
19501284|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19501285|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501286|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501287|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19501288|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
19501289|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
19501290|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501291|NCT03091894|Analgesics|analgesics|mesh-ancestor
19501292|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
19501293|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501294|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19501295|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20603110|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20603111|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20603112|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603113|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501296|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19501297|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
19501298|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501299|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501300|NCT03091881|Granisetron|granisetron|mesh-list
19501301|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
19501302|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
19501303|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094056|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094057|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094058|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094059|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19501304|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501305|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501306|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19501307|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
19501308|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501309|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501310|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19501311|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19501312|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
19501313|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501314|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20094060|NCT00002388|Abacavir|abacavir|mesh-list
20094061|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094062|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094063|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094064|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501315|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19501316|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
19501317|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
19501318|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501319|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501320|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19501321|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
19501322|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
19501323|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501324|NCT03091712|Insulin|insulin|mesh-list
19501325|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19501326|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501327|NCT03091699|Nicotine|nicotine|mesh-list
19501328|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19501329|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
19501330|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501331|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501332|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19501333|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19501334|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
19501335|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501336|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501337|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19501338|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501339|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501340|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
19501341|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20094065|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
20094066|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501342|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501343|NCT03091491|Nivolumab|nivolumab|mesh-list
19501344|NCT03091491|Ipilimumab|ipilimumab|mesh-list
19501345|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19501346|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501347|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20094067|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094068|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094069|NCT00002389|Lamivudine|lamivudine|mesh-list
19501348|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501349|NCT03091569|Vitamin K|vitamin k|mesh-list
19501350|NCT03091569|Vitamins|vitamins|mesh-ancestor
19501351|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
19501352|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501353|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19501354|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19501355|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501356|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
19501357|NCT03091569|Coagulants|coagulants|mesh-ancestor
19501358|NCT03091595|Drospirenone|drospirenone|mesh-list
19501359|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19501360|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19501361|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19501362|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19501363|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
19501364|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19501365|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501366|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19501367|NCT03091595|Estrogens|estrogens|mesh-ancestor
19501368|NCT03091595|Hormones|hormones|mesh-ancestor
19501369|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501370|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19501371|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
19501372|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19501373|NCT03091595|Diuretics|diuretics|mesh-ancestor
19501374|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
19501375|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
19501376|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570577|NCT02091960|Trastuzumab|trastuzumab|mesh-list
19570578|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570579|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570580|NCT02078427|BAX 855|bax 855|mesh-list
19570581|NCT02078427|Coagulants|coagulants|mesh-ancestor
19570582|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19570583|NCT02046434|Glycerol|glycerol|mesh-list
19570584|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19570585|NCT02046434|Protective Agents|protective agents|mesh-ancestor
19749469|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501377|NCT03091504|Albuterol|albuterol|mesh-list
19501378|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19501379|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
19501380|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501381|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501382|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19501383|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
19501384|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
19501385|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19501386|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19501387|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19501388|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19501389|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
19501390|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501391|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501392|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
19501393|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19501394|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501395|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501396|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501397|NCT03091166|Analgesics|analgesics|mesh-ancestor
19501398|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
19501399|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501400|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19501401|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19501402|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19501403|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19501404|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501405|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501406|NCT03091075|Oxandrolone|oxandrolone|mesh-list
19501407|NCT03091075|Androgens|androgens|mesh-ancestor
19501408|NCT03091075|Hormones|hormones|mesh-ancestor
19501409|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501410|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501411|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
19501412|NCT03091257|Trametinib|trametinib|mesh-list
19501413|NCT03091257|Dabrafenib|dabrafenib|mesh-list
19501414|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501415|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19501416|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501417|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501418|NCT03090971|Diclofenac|diclofenac|mesh-list
19501419|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19501420|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501421|NCT03090971|Analgesics|analgesics|mesh-ancestor
19501422|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
19501423|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501424|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501425|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501426|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501427|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19501428|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501429|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501430|NCT03090698|Triamcinolone|triamcinolone|mesh-list
19501431|NCT03090698|Hylan|hylan|mesh-list
19501432|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501433|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
19501434|NCT03090698|Hormones|hormones|mesh-ancestor
19501435|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501436|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501437|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
19501438|NCT03090698|Protective Agents|protective agents|mesh-ancestor
19501439|NCT03090776|Ketamine|ketamine|mesh-list
19501440|NCT03090776|Analgesics|analgesics|mesh-ancestor
19501441|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
19501442|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501443|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501444|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19501445|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19501446|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
19501447|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
19501448|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501449|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19501450|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19501451|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501452|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501453|NCT03090880|Tinzaparin|tinzaparin|mesh-list
19501454|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19501455|NCT03090880|Dalteparin|dalteparin|mesh-list
19501456|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
19501457|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19501458|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19501459|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501460|NCT03090503|Risperidone|risperidone|mesh-list
19501461|NCT03090503|Aripiprazole|aripiprazole|mesh-list
19501462|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19501463|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
19501464|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501465|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501466|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501467|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19501468|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19501469|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501470|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19501471|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19501472|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
19501473|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
19501474|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
19501475|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19501476|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19501477|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19501478|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19501479|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
19501480|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19501481|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501482|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501483|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19501484|NCT03090516|Donepezil|donepezil|mesh-list
19501485|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19501486|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501487|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501488|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
19501489|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501490|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094070|NCT00002389|Zidovudine|zidovudine|mesh-list
20094071|NCT00002389|Abacavir|abacavir|mesh-list
19501491|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
19501492|NCT03090269|Methylphenidate|methylphenidate|mesh-list
19501493|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19501494|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501495|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19501496|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19501497|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19501498|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501499|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
19501500|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501501|NCT03090087|Regadenoson|regadenoson|mesh-list
20094072|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094073|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094074|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094075|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094076|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
20094077|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501502|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19501503|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19501504|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
19501505|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
19501506|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501507|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501508|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501509|NCT03090152|Bupivacaine|bupivacaine|mesh-list
19501510|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
19501511|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
19501512|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501513|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501514|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
20094078|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19501515|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501516|NCT03089957|Urinastatin|urinastatin|mesh-list
19501517|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19501518|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19501519|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
19501520|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501521|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501522|NCT03090048|Vitamin A|vitamin a|mesh-list
19501523|NCT03090048|Azithromycin|azithromycin|mesh-list
19501524|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
19501525|NCT03090048|Vitamins|vitamins|mesh-ancestor
19501526|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
19501527|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501528|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19501529|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501530|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
19501531|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501532|NCT03090048|Protective Agents|protective agents|mesh-ancestor
19501533|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19501534|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501535|NCT03090035|Interferons|interferons|mesh-list
19501536|NCT03090035|Ribavirin|ribavirin|mesh-list
19501537|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501538|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
19501539|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501540|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
19501541|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501542|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
19501543|NCT03090009|Analgesics|analgesics|mesh-ancestor
19501544|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
19501545|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501546|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501547|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19501548|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501549|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501550|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501551|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19501552|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501553|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501554|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19501555|NCT03089671|Vitamins|vitamins|mesh-list
19501556|NCT03089671|Riboflavin|riboflavin|mesh-list
19501557|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
19501558|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
19501559|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501560|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19501561|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
19570586|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570587|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577853|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
19577854|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577855|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577856|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19577857|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19577858|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
19577859|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
19577860|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577861|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19577862|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19577863|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577864|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577865|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19577866|NCT03854500|Tenecteplase|tenecteplase|mesh-list
19577867|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19577868|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19577869|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577870|NCT03847649|Prednisone|prednisone|mesh-list
19577871|NCT03847649|Durvalumab|durvalumab|mesh-list
19577872|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577873|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
19577874|NCT03847649|Hormones|hormones|mesh-ancestor
19577875|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577876|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577877|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577878|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501562|NCT03089645|Docetaxel|docetaxel|mesh-list
19501563|NCT03089645|Durvalumab|durvalumab|mesh-list
19501564|NCT03089645|Tremelimumab|tremelimumab|mesh-list
19501565|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19501566|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501567|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
19501568|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
19501569|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
19501570|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501571|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19501572|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
19501573|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501574|NCT03089567|Listerine|listerine|mesh-list
19501575|NCT03089567|Fluorides|fluorides|mesh-list
19501576|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
19501577|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
19501578|NCT03089567|Protective Agents|protective agents|mesh-ancestor
19501579|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501580|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19501581|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501582|NCT03089658|Avelumab|avelumab|mesh-list
19501583|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19501584|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501585|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
19501586|NCT03089333|Glyburide|glyburide|mesh-list
19501587|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19501588|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501589|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19501590|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501591|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19501592|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
19501593|NCT03089073|Coagulants|coagulants|mesh-ancestor
19501594|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19501595|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
19501596|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501597|NCT03088891|Antioxidants|antioxidants|mesh-list
19501598|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501599|NCT03088891|Protective Agents|protective agents|mesh-ancestor
19501600|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501601|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
19501602|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19501603|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501604|NCT03088631|Metformin|metformin|mesh-list
19501605|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19501606|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501607|NCT03088670|Metformin|metformin|mesh-list
19501608|NCT03088670|Vildagliptin|vildagliptin|mesh-list
19501609|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19501610|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501611|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19501612|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
19501613|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501614|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501615|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
19501616|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
19501617|NCT03088709|Tacrolimus|tacrolimus|mesh-list
19501618|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501619|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
19501620|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501621|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501622|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19501623|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
19501624|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501625|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501626|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19501627|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19501628|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501629|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19501630|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19501631|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
19501632|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19501633|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501634|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
19501635|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19501636|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501637|NCT03088358|Enoxaparin|enoxaparin|mesh-list
20094079|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094080|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
20094081|NCT00002390|Abacavir|abacavir|mesh-list
20094082|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094083|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19501638|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
19501639|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19501640|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19501641|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501642|NCT03088254|Amlodipine|amlodipine|mesh-list
19501643|NCT03088254|Telmisartan|telmisartan|mesh-list
19501644|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19501645|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19501646|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19501647|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19501648|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501649|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19501650|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501651|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
19501652|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19501653|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19501654|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
19501655|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19501656|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19501657|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501658|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19501659|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19501660|NCT03088371|Lidocaine|lidocaine|mesh-list
19501661|NCT03088371|Bupivacaine|bupivacaine|mesh-list
20094084|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094085|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094086|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
20094087|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094088|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094089|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094090|NCT00002391|Lamivudine|lamivudine|mesh-list
20094091|NCT00002391|Zidovudine|zidovudine|mesh-list
20094092|NCT00002391|Abacavir|abacavir|mesh-list
20094093|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094094|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094095|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094096|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094097|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
20094098|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094099|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094100|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094101|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
20094102|NCT00002392|Thalidomide|thalidomide|mesh-list
20094103|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094104|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
20094105|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094106|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
20094107|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094108|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603114|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603115|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603116|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19501662|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
19501663|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
19501664|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501665|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501666|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
19501667|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501668|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19501669|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19501670|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19501671|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19501672|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501673|NCT03088410|Zidovudine|zidovudine|mesh-list
19501674|NCT03088410|Nevirapine|nevirapine|mesh-list
20094109|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20603117|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
20603118|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603119|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19501675|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
19501676|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501677|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19501678|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19501679|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603120|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20603121|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20603122|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20603123|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20094110|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20094111|NCT00002392|Growth Substances|growth substances|mesh-ancestor
20094112|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
20094113|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094114|NCT00002393|Efavirenz|efavirenz|mesh-list
20094115|NCT00002393|Indinavir|indinavir|mesh-list
20094116|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094117|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094118|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094119|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094120|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
20094121|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094122|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20094123|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094124|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20094125|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20094126|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20094127|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19501680|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
19501681|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501682|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19501683|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19501684|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19501685|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19501686|NCT03088540|Gemcitabine|gemcitabine|mesh-list
19501687|NCT03088540|Paclitaxel|paclitaxel|mesh-list
19501688|NCT03088540|Carboplatin|carboplatin|mesh-list
19501689|NCT03088540|Pemetrexed|pemetrexed|mesh-list
19501690|NCT03088540|Cemiplimab|cemiplimab|mesh-list
19501691|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19501692|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501693|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
19501694|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
19501695|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
19501696|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501697|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19501698|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
19501699|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
19501700|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501701|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501702|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501703|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
19501704|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501705|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19501706|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19501707|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19501708|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
19501709|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
19501710|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501711|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501712|NCT03088306|Acetaminophen|acetaminophen|mesh-list
19501713|NCT03088306|Fentanyl|fentanyl|mesh-list
19501714|NCT03088306|Ketamine|ketamine|mesh-list
19501715|NCT03088306|Gabapentin|gabapentin|mesh-list
19501716|NCT03088306|Hydromorphone|hydromorphone|mesh-list
19501717|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
19501718|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501719|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501720|NCT03088306|Analgesics|analgesics|mesh-ancestor
19501721|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
19501722|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603124|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19501723|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19501724|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19501725|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
19570588|NCT01743651|Baclofen|baclofen|mesh-list
19501726|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19501727|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19501728|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501729|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501730|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19501731|NCT03088306|Narcotics|narcotics|mesh-ancestor
19501732|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19501733|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501734|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
19501735|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
19501736|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19501737|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19501738|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19501739|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
19501740|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
19501741|NCT03088293|Infliximab|infliximab|mesh-list
19501742|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501743|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
19501744|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501745|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501746|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19501747|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
19501748|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501749|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501750|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19501751|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
19501752|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501753|NCT03087968|Prednisolone|prednisolone|mesh-list
19501754|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501755|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
19501756|NCT03087968|Hormones|hormones|mesh-ancestor
19501757|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501758|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501759|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19501760|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501761|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
19501762|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19501763|NCT03087942|Growth Substances|growth substances|mesh-ancestor
19501764|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501765|NCT03088046|Progesterone|progesterone|mesh-list
19501766|NCT03088046|Progestins|progestins|mesh-ancestor
19501767|NCT03088046|Hormones|hormones|mesh-ancestor
20094128|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094129|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19501768|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501769|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570589|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19570590|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570591|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19570592|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570593|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19570594|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
19570595|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
19570596|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570597|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570598|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19570599|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19570600|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19570601|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19570602|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19570603|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19570604|NCT00981656|Fluorouracil|fluorouracil|mesh-list
19570605|NCT00981656|Mitomycins|mitomycins|mesh-list
20603125|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20603126|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603127|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19570606|NCT00981656|Mitomycin|mitomycin|mesh-list
19570607|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570608|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
19570609|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570610|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094130|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603128|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
20094131|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19501770|NCT03088384|Ketamine|ketamine|mesh-list
19501771|NCT03088384|Analgesics|analgesics|mesh-ancestor
19501772|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
19501773|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501774|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501775|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19501776|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19501777|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
19501778|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
19501779|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19501780|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19501781|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19501782|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501783|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501784|NCT03088176|Trametinib|trametinib|mesh-list
19501785|NCT03088176|Dabrafenib|dabrafenib|mesh-list
19501786|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19501787|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501788|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19501789|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501790|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501791|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19501792|NCT03088072|Aspirin|aspirin|mesh-list
19501793|NCT03088072|Warfarin|warfarin|mesh-list
19501794|NCT03088072|Edoxaban|edoxaban|mesh-list
19501795|NCT03088072|Clopidogrel|clopidogrel|mesh-list
19501796|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19501797|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501798|NCT03088072|Analgesics|analgesics|mesh-ancestor
19501799|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
19501800|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501801|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501802|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501803|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19501804|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19501805|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19501806|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501807|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19501808|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19501809|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501810|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
19501811|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19501812|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19501813|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20094132|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094133|NCT00002394|Terbinafine|terbinafine|mesh-list
20094134|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
20094135|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501814|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
19501815|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501816|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
19501817|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19501818|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
19501819|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19501820|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
19501821|NCT03087890|Trimethoprim|trimethoprim|mesh-list
19501822|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19501823|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
19501824|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19501825|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501826|NCT03087890|Renal Agents|renal agents|mesh-ancestor
19501827|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
19501828|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19501829|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19501830|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19501831|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501832|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501833|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19501834|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19501835|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19501836|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19501837|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
20094136|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094137|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094138|NCT00002395|Topotecan|topotecan|mesh-list
19501838|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19501839|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501840|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
19501841|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501842|NCT03087903|Protective Agents|protective agents|mesh-ancestor
19501843|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501844|NCT03087877|Acetaminophen|acetaminophen|mesh-list
19501845|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19501846|NCT03087877|Analgesics|analgesics|mesh-ancestor
19501847|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
19501848|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501849|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501850|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
19501851|NCT03087864|Paclitaxel|paclitaxel|mesh-list
19501852|NCT03087864|Carboplatin|carboplatin|mesh-list
19501853|NCT03087864|Atezolizumab|atezolizumab|mesh-list
19501854|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19501855|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501856|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
19501857|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
19501858|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
20094139|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20094140|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20094141|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603129|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19501859|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501860|NCT03087669|Norepinephrine|norepinephrine|mesh-list
19501861|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19501862|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19501863|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
19501864|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19501865|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501866|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501867|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
19501868|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
19501869|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501870|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19501871|NCT03087539|Abciximab|abciximab|mesh-list
19501872|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
19501873|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19501874|NCT03087708|Naloxegol|naloxegol|mesh-list
19501875|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19501876|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501877|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
19501878|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501879|NCT03087201|Nabiximols|nabiximols|mesh-list
19501880|NCT03087201|Analgesics|analgesics|mesh-ancestor
19501881|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
19501882|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19501883|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501884|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
19501885|NCT03087032|Liraglutide|liraglutide|mesh-list
19501886|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19501887|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501888|NCT03087032|Incretins|incretins|mesh-ancestor
19501889|NCT03087032|Hormones|hormones|mesh-ancestor
19501890|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501891|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
19501892|NCT03087162|Lansoprazole|lansoprazole|mesh-list
19501893|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19501894|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19501895|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19501896|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501897|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501898|NCT03087149|Vitamin D|vitamin d|mesh-list
19501899|NCT03087149|Vitamins|vitamins|mesh-ancestor
19501900|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
19501901|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501902|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19501903|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
19501904|NCT03087136|Antibodies|antibodies|mesh-list
19501905|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
19501906|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501907|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19501908|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20603130|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501909|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094142|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094143|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094144|NCT00002396|Tenofovir|tenofovir|mesh-list
20603131|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
19501910|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
19501911|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501912|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
19501913|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19501914|NCT03087136|Protective Agents|protective agents|mesh-ancestor
19501915|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19501916|NCT03087071|Panitumumab|panitumumab|mesh-list
19501917|NCT03087071|Trametinib|trametinib|mesh-list
19501918|NCT03087071|Antibodies|antibodies|mesh-list
19501919|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
19501920|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19501921|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
19501922|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501923|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501924|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19501925|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501926|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501927|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19501928|NCT03086720|Eusol|eusol|mesh-list
19501929|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
19501930|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501931|NCT03086681|Cisplatin|cisplatin|mesh-list
19501932|NCT03086681|Endostar protein|endostar protein|mesh-list
19501933|NCT03086681|Endostatins|endostatins|mesh-list
19501934|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501935|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19501936|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19501937|NCT03086681|Growth Substances|growth substances|mesh-ancestor
19501938|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501939|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19501940|NCT03086759|Triamcinolone|triamcinolone|mesh-list
19501941|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19501942|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19501943|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19501944|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19501945|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
19501946|NCT03086759|Hormones|hormones|mesh-ancestor
19501947|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501948|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501949|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19501950|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
19501951|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094145|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
20094146|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094147|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094148|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094149|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094150|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094151|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094152|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094153|NCT00002397|Lamivudine|lamivudine|mesh-list
20094154|NCT00002397|Stavudine|stavudine|mesh-list
20094155|NCT00002397|Nelfinavir|nelfinavir|mesh-list
20094156|NCT00002397|Saquinavir|saquinavir|mesh-list
20094157|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094158|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094159|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094160|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094161|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
20094162|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094163|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094164|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094165|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
20094166|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094167|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094168|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094169|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20094170|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20603132|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20603133|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
19501952|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501953|NCT03086733|Metformin|metformin|mesh-list
20094171|NCT00002398|Adefovir|adefovir|mesh-list
19501954|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19501955|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19501956|NCT03086785|Apatinib|apatinib|mesh-list
19501957|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501958|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19501959|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501960|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501961|NCT03086382|Lacosamide|lacosamide|mesh-list
19501962|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
19501963|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19501964|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19501965|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19501966|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501967|NCT03086538|Pemetrexed|pemetrexed|mesh-list
19501968|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19501969|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19501970|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501971|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501972|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19501973|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19501974|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19501975|NCT03086226|Itraconazole|itraconazole|mesh-list
19501976|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
19501977|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19501978|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19501979|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19501980|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501981|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501982|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19501983|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
19501984|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19501985|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094172|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20094173|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
20094174|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094175|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19501986|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19501987|NCT03086291|Simvastatin|simvastatin|mesh-list
19501988|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19501989|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19501990|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
19501991|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19501992|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19501993|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20094176|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094177|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094178|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094179|NCT00002399|Fluconazole|fluconazole|mesh-list
20094180|NCT00002399|Posaconazole|posaconazole|mesh-list
20094181|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
20094182|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094183|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20094184|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094185|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094186|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094187|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20094188|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
19501994|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19501995|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
19501996|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19501997|NCT03086564|Estrogens|estrogens|mesh-ancestor
19501998|NCT03086564|Hormones|hormones|mesh-ancestor
19501999|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502000|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502001|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19502002|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502003|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
19502004|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502005|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094189|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502006|NCT03086473|Caffeine|caffeine|mesh-list
19502007|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
19502008|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502009|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19502010|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502011|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19502012|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502013|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19502014|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19502015|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
19502016|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502017|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19502018|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19502019|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502020|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502021|NCT03086174|Antibodies|antibodies|mesh-list
19502022|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19502023|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
19502024|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502025|NCT03085992|Bevacizumab|bevacizumab|mesh-list
19502026|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502027|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502028|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19502029|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19502030|NCT03085992|Growth Substances|growth substances|mesh-ancestor
19502031|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502032|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19502033|NCT03086005|Metformin|metformin|mesh-list
19502034|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19502035|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094190|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094191|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20094192|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20094193|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20094194|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20094195|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19502036|NCT03086070|Omeprazole|omeprazole|mesh-list
19502037|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19502038|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502039|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19502040|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502041|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502042|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
19502043|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
19502044|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19502045|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19502046|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502047|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502048|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502049|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19502050|NCT03086148|Ketamine|ketamine|mesh-list
19502051|NCT03086148|Analgesics|analgesics|mesh-ancestor
19502052|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
19502053|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502054|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502055|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19502056|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19502057|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
19502058|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
19502059|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502060|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20094196|NCT00002400|Lamivudine|lamivudine|mesh-list
19502061|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19502062|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502063|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502064|NCT03085654|Oxytocin|oxytocin|mesh-list
19502065|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
19502066|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19502067|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502068|NCT03085628|Oxytocin|oxytocin|mesh-list
19502069|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
19502070|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19502071|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748894|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748895|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748896|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19748897|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
19748898|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748899|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19502078|NCT03085784|Aflibercept|aflibercept|mesh-list
19502079|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19502080|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19502081|NCT03085784|Growth Substances|growth substances|mesh-ancestor
19502082|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094197|NCT00002400|Zidovudine|zidovudine|mesh-list
20094198|NCT00002400|Delavirdine|delavirdine|mesh-list
20094199|NCT00002400|Indinavir|indinavir|mesh-list
20094200|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094201|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094202|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502083|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
19502084|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502085|NCT03085849|Durvalumab|durvalumab|mesh-list
19502086|NCT03085849|Tremelimumab|tremelimumab|mesh-list
20094203|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094204|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
20094205|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094206|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094207|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094208|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
20094209|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094210|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094211|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094212|NCT00002401|Lamivudine|lamivudine|mesh-list
20094213|NCT00002401|Zidovudine|zidovudine|mesh-list
20094214|NCT00002401|Delavirdine|delavirdine|mesh-list
20094215|NCT00002401|Indinavir|indinavir|mesh-list
20094216|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094217|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094218|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094219|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094220|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
20094221|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094222|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094223|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094224|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
20094225|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19502087|NCT03085849|Guadecitabine|guadecitabine|mesh-list
19502088|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502089|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502090|NCT03085823|Sirolimus|sirolimus|mesh-list
19502091|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19502092|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502093|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19502094|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502095|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
19502096|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502097|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
19502098|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502099|NCT03085563|Midazolam|midazolam|mesh-list
19502100|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
19502101|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19502102|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19502103|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502104|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502105|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19502106|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20094226|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094227|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
19502107|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19502108|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19502109|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
19502110|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
20094228|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20094229|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20094230|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
20094231|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094232|NCT00002402|Antacids|antacids|mesh-ancestor
20094233|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094234|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20094235|NCT00002404|Valacyclovir|valacyclovir|mesh-list
20094236|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
19502111|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
19502112|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
19502113|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502114|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502115|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19502116|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19502117|NCT03085563|Analgesics|analgesics|mesh-ancestor
20603134|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603135|NCT02219698|Acetaminophen|acetaminophen|mesh-list
20603136|NCT02219698|Ibuprofen|ibuprofen|mesh-list
20603137|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20603138|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19502118|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
19502119|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502120|NCT03085225|Durvalumab|durvalumab|mesh-list
19502121|NCT03085225|Trabectedin|trabectedin|mesh-list
19502122|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502123|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502124|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19502125|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
19502126|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603139|NCT02219698|Analgesics|analgesics|mesh-ancestor
20603140|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
20603141|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603142|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603143|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603144|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20603145|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20603146|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502127|NCT03085368|Trastuzumab|trastuzumab|mesh-list
19502128|NCT03085368|Lapatinib|lapatinib|mesh-list
19502129|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502130|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502131|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19502132|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502133|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502134|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19502135|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19502136|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
19502137|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20094237|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094238|NCT00002405|Amprenavir|amprenavir|mesh-list
20094239|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20094240|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
20607888|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502138|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19502139|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502140|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
19502141|NCT03085394|Coagulants|coagulants|mesh-ancestor
19502142|NCT03085186|Crizotinib|crizotinib|mesh-list
19502143|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502144|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19502145|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502146|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502147|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19502148|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19502149|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19502150|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502151|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19502152|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20094241|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094242|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502153|NCT03084978|Anesthetics|anesthetics|mesh-list
19502154|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502155|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502156|NCT03085030|Antioxidants|antioxidants|mesh-list
19502157|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502158|NCT03085030|Protective Agents|protective agents|mesh-ancestor
19502159|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502160|NCT03084809|Leucovorin|leucovorin|mesh-list
19502161|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
19502162|NCT03084809|Fluorouracil|fluorouracil|mesh-list
19502163|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
19502164|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094243|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094244|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094245|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094246|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094247|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094248|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094249|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19502165|NCT03084809|Antidotes|antidotes|mesh-ancestor
19502166|NCT03084809|Protective Agents|protective agents|mesh-ancestor
19502167|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502168|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
19502169|NCT03084809|Vitamins|vitamins|mesh-ancestor
20094250|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
20094251|NCT00002406|Indinavir|indinavir|mesh-list
20094252|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094253|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094254|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094255|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094256|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094257|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094258|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19502170|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
19502171|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
19502172|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502173|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502174|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502175|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
19502176|NCT03084588|Methadone|methadone|mesh-list
19502177|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19502178|NCT03084588|Narcotics|narcotics|mesh-ancestor
19502179|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502180|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502181|NCT03084588|Analgesics|analgesics|mesh-ancestor
19502182|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
19502183|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502184|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
19502185|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
19502186|NCT03084575|Glycerol|glycerol|mesh-list
19502187|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19502188|NCT03084575|Protective Agents|protective agents|mesh-ancestor
19502189|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502190|NCT03084783|Dexamethasone|dexamethasone|mesh-list
19502191|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19502192|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
19502193|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
19502194|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502195|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502196|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502197|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
19502198|NCT03084783|Hormones|hormones|mesh-ancestor
19502199|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502200|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19502201|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502202|NCT03084250|Tenofovir|tenofovir|mesh-list
19502203|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19502204|NCT03084250|Entecavir|entecavir|mesh-list
19502205|NCT03084250|Adefovir|adefovir|mesh-list
19502206|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
19502207|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502208|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19502209|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19502210|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570611|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094259|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
20094260|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094261|NCT00002407|Lamivudine|lamivudine|mesh-list
19502211|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502212|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19502213|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19570612|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
19570613|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570614|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20094262|NCT00002407|Nevirapine|nevirapine|mesh-list
20094263|NCT00002407|Stavudine|stavudine|mesh-list
19570615|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
19570616|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19570617|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570618|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
19570619|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19570620|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
19570621|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570622|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570623|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19570624|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
19570625|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19570626|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
20094264|NCT00002407|Didanosine|didanosine|mesh-list
20094265|NCT00002407|Indinavir|indinavir|mesh-list
20094266|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094267|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094268|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570627|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570628|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570629|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19570630|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
19570631|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
19570632|NCT00848731|Protective Agents|protective agents|mesh-ancestor
19570633|NCT00838526|Rabeprazole|rabeprazole|mesh-list
19570634|NCT00838526|Ranitidine|ranitidine|mesh-list
19570635|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19570636|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19570637|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19570638|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19570639|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570640|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570641|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19570642|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
19570643|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
19570644|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570645|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570646|NCT00716066|Cytarabine|cytarabine|mesh-list
19570647|NCT00716066|Prednisone|prednisone|mesh-list
19570648|NCT00716066|Cortisone|cortisone|mesh-list
19570649|NCT00716066|Etoposide|etoposide|mesh-list
20094269|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094270|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
20094271|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094272|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094273|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094274|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19570650|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
19570651|NCT00716066|Melphalan|melphalan|mesh-list
19570652|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
19570653|NCT00716066|Carmustine|carmustine|mesh-list
19570654|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
19570655|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19570656|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
19570657|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19570658|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570659|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
19570660|NCT00716066|Hormones|hormones|mesh-ancestor
19570661|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20094275|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20094276|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
20094277|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094278|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19570662|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570663|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20094279|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094280|NCT00002409|Lamivudine|lamivudine|mesh-list
20094281|NCT00002409|Zidovudine|zidovudine|mesh-list
20094282|NCT00002409|Abacavir|abacavir|mesh-list
19570664|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094283|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19502214|NCT03084419|Abatacept|abatacept|mesh-list
19502215|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19502216|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502217|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502218|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502219|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
19502220|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502221|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19502222|NCT03084328|Vitamin D|vitamin d|mesh-list
19502223|NCT03084328|Vitamins|vitamins|mesh-ancestor
19502224|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
19502225|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502226|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19502227|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
19502228|NCT03084380|Fludarabine|fludarabine|mesh-list
19502229|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502230|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
19502231|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502232|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19502233|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19502234|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
19502235|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502236|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502237|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19502238|NCT03084237|Docetaxel|docetaxel|mesh-list
19502239|NCT03084237|Trastuzumab|trastuzumab|mesh-list
19502240|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502241|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
20094284|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094285|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094286|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094287|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094288|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
20094289|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094290|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603147|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502242|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
19502243|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
19502244|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502245|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502246|NCT03084601|Calcium|calcium|mesh-list
19502247|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19502248|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502249|NCT03084029|Oxytocin|oxytocin|mesh-list
19502250|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
19502251|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19502252|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502253|NCT03083821|Entecavir|entecavir|mesh-list
19502254|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
19502255|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502256|NCT03083782|Cyclosporine|cyclosporine|mesh-list
19502257|NCT03083782|Apixaban|apixaban|mesh-list
19502258|NCT03083782|Tacrolimus|tacrolimus|mesh-list
19502259|NCT03083782|Cyclosporins|cyclosporins|mesh-list
19502260|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502261|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
19502262|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502263|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19502264|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502265|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502266|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
19502267|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502268|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
19502269|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19502270|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19502271|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
19502272|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19502273|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
19502274|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
19502275|NCT03083834|Cosyntropin|cosyntropin|mesh-list
19502276|NCT03083834|Hormones|hormones|mesh-ancestor
19502277|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502278|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502279|NCT03083613|Paclitaxel|paclitaxel|mesh-list
19502280|NCT03083613|Raltitrexed|raltitrexed|mesh-list
19502281|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20094291|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094292|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
20094293|NCT00002410|Lamivudine|lamivudine|mesh-list
19502282|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502283|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
19502284|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
19502285|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
19502286|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502287|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502288|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
19502289|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19502290|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502291|NCT03083691|Nivolumab|nivolumab|mesh-list
19502292|NCT03083691|Ipilimumab|ipilimumab|mesh-list
19502293|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502294|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502295|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19502296|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502297|NCT03083704|Enoxaparin|enoxaparin|mesh-list
19502298|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
19502299|NCT03083704|Apixaban|apixaban|mesh-list
19502300|NCT03083704|Edoxaban|edoxaban|mesh-list
19502301|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
19502302|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20094294|NCT00002410|Zidovudine|zidovudine|mesh-list
20094295|NCT00002410|Indinavir|indinavir|mesh-list
20094296|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094297|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094298|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094299|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094300|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
20094301|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094302|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094303|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094304|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
20094305|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19502303|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
19502304|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19502305|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
19502306|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502307|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502308|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
19502309|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19502310|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19502311|NCT03083457|Anesthetics|anesthetics|mesh-list
19502312|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
19502313|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502314|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502315|NCT03083405|Opipramol|opipramol|mesh-list
19502316|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19502317|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
19502318|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19502319|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19502320|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19502321|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19502322|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502323|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
20094306|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094307|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094308|NCT00002412|Stavudine|stavudine|mesh-list
20094309|NCT00002412|Didanosine|didanosine|mesh-list
19502324|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502325|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502326|NCT03083431|Propranolol|propranolol|mesh-list
19502327|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19502328|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19502329|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
19502330|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502331|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502332|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094310|NCT00002412|Emivirine|emivirine|mesh-list
20094311|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
19502333|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19502334|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19502335|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
20094312|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094313|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
20094314|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094315|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094316|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094317|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
20094318|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094319|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
20094320|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094321|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19502344|NCT03083210|Lanreotide|lanreotide|mesh-list
19502345|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502346|NCT03083184|Ethanol|ethanol|mesh-list
19502347|NCT03083184|Enoxaparin|enoxaparin|mesh-list
19502348|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
19502349|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19502350|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19502351|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502352|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19502353|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502354|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502355|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502356|NCT03083041|Apatinib|apatinib|mesh-list
19502357|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502358|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19502359|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502360|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502361|NCT03083080|Epinephrine|epinephrine|mesh-list
19502362|NCT03083080|Ropivacaine|ropivacaine|mesh-list
19502363|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
19502364|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
19502365|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502366|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502367|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
19502368|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502369|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19502370|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19502371|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
19502372|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502373|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502374|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19502375|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19502376|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
19502377|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19502378|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
19502379|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
19502380|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
19502381|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19502382|NCT03082846|Temozolomide|temozolomide|mesh-list
19502383|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19502384|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
19502385|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502386|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502387|NCT03082885|Thymalfasin|thymalfasin|mesh-list
19502388|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19502389|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
19502390|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570665|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19570666|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19570667|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19570668|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570669|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570670|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094322|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094323|NCT00002413|Emivirine|emivirine|mesh-list
20094324|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094325|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094326|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094327|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094328|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
20094329|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094330|NCT00002415|Tenofovir|tenofovir|mesh-list
20094331|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
20094332|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570671|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
20094333|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094334|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094335|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094336|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094337|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094338|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094339|NCT00002416|Lamivudine|lamivudine|mesh-list
20094340|NCT00002416|Emtricitabine|emtricitabine|mesh-list
20094341|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094342|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094343|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094344|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094345|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
20094346|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094347|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094348|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094349|NCT00002417|Amprenavir|amprenavir|mesh-list
20094350|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20094351|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
20094352|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094353|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094354|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094355|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094356|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094357|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094358|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094359|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094360|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094361|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
20094362|NCT00002418|Nevirapine|nevirapine|mesh-list
19502391|NCT03082677|Ixazomib|ixazomib|mesh-list
19502392|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502393|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
19502394|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502395|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502396|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19502397|NCT03082742|Furosemide|furosemide|mesh-list
19502398|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19502399|NCT03082742|Diuretics|diuretics|mesh-ancestor
19502400|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
19502401|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502402|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19502403|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19502404|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502405|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19502406|NCT03082339|Cortisone|cortisone|mesh-list
19502407|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19502408|NCT03082300|Naquotinib|naquotinib|mesh-list
19502409|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502410|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19502411|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502412|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502413|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19502414|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502415|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19502416|NCT03082573|Hormones|hormones|mesh-ancestor
19502417|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502418|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502419|NCT03082352|Metoprolol|metoprolol|mesh-list
19502420|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19502421|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19502422|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
19502423|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
19502424|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502425|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502426|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19502427|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19502428|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19502429|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
19502430|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502431|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094363|NCT00002418|Stavudine|stavudine|mesh-list
20094364|NCT00002418|Didanosine|didanosine|mesh-list
20094365|NCT00002418|Emivirine|emivirine|mesh-list
20603148|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
20094366|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
19502432|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
19502433|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19502434|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19502435|NCT03082092|Prednisolone|prednisolone|mesh-list
19502436|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
19502437|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19502438|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
19502439|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19502440|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
19502441|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
19502442|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502443|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502444|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502445|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
19502446|NCT03082092|Hormones|hormones|mesh-ancestor
19502447|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502448|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19502449|NCT03082092|Protective Agents|protective agents|mesh-ancestor
19502450|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19502451|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603149|NCT02219737|Rituximab|rituximab|mesh-list
19502452|NCT03082183|Rifampin|rifampin|mesh-list
19502453|NCT03082183|BI 425809|bi 425809|mesh-list
19502454|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19502455|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
19502456|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20603150|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20603151|NCT02219737|Carboplatin|carboplatin|mesh-list
20603152|NCT02219737|Etoposide|etoposide|mesh-list
20603153|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
19502457|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502458|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
19502459|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19502460|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502461|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502462|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19502463|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19502464|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19502465|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19502466|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19502467|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19502468|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
19502469|NCT03082053|Capecitabine|capecitabine|mesh-list
19502470|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502471|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
19502472|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502473|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502474|NCT03081923|Durvalumab|durvalumab|mesh-list
19502475|NCT03081923|Tremelimumab|tremelimumab|mesh-list
19502476|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502477|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502478|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19502479|NCT03081949|Selenium|selenium|mesh-list
19502480|NCT03081949|Selenious Acid|selenious acid|mesh-list
19502481|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
19502482|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
19502483|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502484|NCT03081949|Protective Agents|protective agents|mesh-ancestor
19502485|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502486|NCT03081949|Trace Elements|trace elements|mesh-ancestor
19502487|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
19502488|NCT03081832|Oxytocin|oxytocin|mesh-list
19502489|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
19502490|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19502491|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502492|NCT03082482|Nicotine|nicotine|mesh-list
19502493|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19502494|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
19502495|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502496|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502497|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19502498|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20603154|NCT02219737|Ifosfamide|ifosfamide|mesh-list
19502499|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
19502500|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570672|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
20603155|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
19502501|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502502|NCT03081494|Spartalizumab|spartalizumab|mesh-list
19502503|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19502504|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502505|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502506|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
19502507|NCT03081702|Itraconazole|itraconazole|mesh-list
19502508|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
19502509|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19502510|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19502511|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502512|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502513|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502514|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19502515|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
20094367|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094368|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094369|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094370|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094371|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
20094372|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502516|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19502517|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19502518|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19502519|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
19502520|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502521|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502522|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19502523|NCT03081728|Acetaminophen|acetaminophen|mesh-list
19502524|NCT03081728|Diclofenac|diclofenac|mesh-list
19502525|NCT03081728|Ropivacaine|ropivacaine|mesh-list
19502526|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
20603156|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
20603157|NCT02219737|Antibodies|antibodies|mesh-list
20603158|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
20603159|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20603160|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
20603161|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603162|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603163|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20603164|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20603165|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20603166|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20603167|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603168|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603169|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19502527|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
19502528|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502529|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502530|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
19502531|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502532|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19502533|NCT03081728|Analgesics|analgesics|mesh-ancestor
19502534|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
20094373|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094374|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094375|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20094376|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20094377|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094378|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
20094379|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
20094380|NCT00002419|Efavirenz|efavirenz|mesh-list
20094381|NCT00002419|Abacavir|abacavir|mesh-list
20094382|NCT00002419|Adefovir|adefovir|mesh-list
20094383|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20094384|NCT00002419|Amprenavir|amprenavir|mesh-list
20094385|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094386|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19502535|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19502536|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19502537|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19502538|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19502539|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502540|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502541|NCT03081689|Paclitaxel|paclitaxel|mesh-list
19502542|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19502543|NCT03081689|Carboplatin|carboplatin|mesh-list
19502544|NCT03081689|Nivolumab|nivolumab|mesh-list
19502545|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19502546|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502547|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
19502548|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
19502549|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
19502550|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502551|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502552|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19502553|NCT03081676|Glimepiride|glimepiride|mesh-list
19502554|NCT03081676|Glucagon|glucagon|mesh-list
19502555|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
19502556|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19502557|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19502558|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19502559|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502560|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502561|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
19502562|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502563|NCT03081676|Hormones|hormones|mesh-ancestor
19502564|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502565|NCT03081676|Incretins|incretins|mesh-ancestor
19502566|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
19502567|NCT03081416|Dexamethasone|dexamethasone|mesh-list
19502568|NCT03081416|Ketorolac|ketorolac|mesh-list
19502569|NCT03081416|Ketamine|ketamine|mesh-list
19502570|NCT03081416|Metoclopramide|metoclopramide|mesh-list
19502571|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19502572|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
19502573|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
19502574|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094387|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094388|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094389|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
20094390|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094391|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19502575|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502576|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502577|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
20094392|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094393|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20094394|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20094395|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20094396|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20094397|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094398|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094399|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20094400|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
20094401|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094402|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094403|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19502578|NCT03081416|Hormones|hormones|mesh-ancestor
19502579|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502580|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19502581|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502582|NCT03081416|Analgesics|analgesics|mesh-ancestor
19502583|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
19502584|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19502585|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20603170|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
19502586|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
19502587|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
19502588|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502589|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19502590|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19502591|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20094404|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094405|NCT00002420|Stavudine|stavudine|mesh-list
20094406|NCT00002420|Didanosine|didanosine|mesh-list
20094407|NCT00002420|Delavirdine|delavirdine|mesh-list
20094408|NCT00002420|Emivirine|emivirine|mesh-list
20094409|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
19502592|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502593|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20094410|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094411|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
20094412|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094413|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094414|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094415|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
20094416|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094417|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
20094418|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094419|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094420|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094421|NCT00002423|Lamivudine|lamivudine|mesh-list
20094422|NCT00002423|Abacavir|abacavir|mesh-list
20094423|NCT00002423|Nelfinavir|nelfinavir|mesh-list
20094424|NCT00002423|Indinavir|indinavir|mesh-list
20094425|NCT00002423|Amprenavir|amprenavir|mesh-list
20094426|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094427|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094428|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094429|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094430|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
19502594|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19502595|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19502596|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19502597|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502598|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19502599|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19502600|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
19502601|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19502602|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19502603|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
19502604|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19502605|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
19502606|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
19502607|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19502608|NCT03081039|Gemcitabine|gemcitabine|mesh-list
19502609|NCT03081039|Carboplatin|carboplatin|mesh-list
19502610|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502611|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502612|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
19502613|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094431|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094432|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19502614|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
19502615|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502616|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502617|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502618|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
19502619|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502620|NCT03081169|Heparin|heparin|mesh-list
19502621|NCT03081169|Enoxaparin|enoxaparin|mesh-list
19502622|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
19502623|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
19502624|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19502625|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19502626|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570673|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570674|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570675|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
19570676|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19570677|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
19570678|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19570679|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
19570680|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
19570681|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
19570682|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
20094433|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19570683|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
20094434|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094435|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19502627|NCT03081442|Misoprostol|misoprostol|mesh-list
19502628|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
19502629|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19502630|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
19502631|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19502632|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502633|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19502634|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502635|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
19502636|NCT03080974|Nivolumab|nivolumab|mesh-list
19502637|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19502638|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502639|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19502640|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502641|NCT03080675|Vitamins|vitamins|mesh-list
19502642|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
19502643|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502644|NCT03080740|Metronidazole|metronidazole|mesh-list
19502645|NCT03080740|Clindamycin|clindamycin|mesh-list
19502646|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
19502647|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
19502648|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502649|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19502650|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19502651|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19502652|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19502653|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502654|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502655|NCT03080766|Decitabine|decitabine|mesh-list
19502656|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502657|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
19502658|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502659|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502660|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502661|NCT03080441|Midodrine|midodrine|mesh-list
19502662|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
19502663|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
19502664|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502665|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502666|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19502667|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19502668|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19502669|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19502670|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
19502671|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502672|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502673|NCT03080805|Capecitabine|capecitabine|mesh-list
19502674|NCT03080805|Lapatinib|lapatinib|mesh-list
19502675|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502676|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
20094436|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094437|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20094438|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
20094439|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094440|NCT00002424|Lamivudine|lamivudine|mesh-list
20094441|NCT00002424|Stavudine|stavudine|mesh-list
20603171|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
20603172|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
19502677|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502678|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502679|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19502680|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502681|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
19502682|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
19502683|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502684|NCT03080363|Lidocaine|lidocaine|mesh-list
19502685|NCT03080363|Bupivacaine|bupivacaine|mesh-list
19502686|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
19502687|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
20094442|NCT00002424|Indinavir|indinavir|mesh-list
20094443|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19502688|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502689|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502690|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
19502691|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502692|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20603173|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
19502693|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20306094|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306095|NCT00653874|Bilirubin|bilirubin|mesh-list
20306096|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
20306097|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094444|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094445|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094446|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094447|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
20094448|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094449|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094450|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094451|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
20094452|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094453|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19502694|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19502695|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19502696|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502697|NCT03080324|Fentanyl|fentanyl|mesh-list
19502698|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19502699|NCT03080324|Narcotics|narcotics|mesh-ancestor
19502700|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502701|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502702|NCT03080324|Analgesics|analgesics|mesh-ancestor
19502703|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
19502704|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502705|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19502706|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19502707|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
19502708|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
19502709|NCT03080545|Calcitriol|calcitriol|mesh-list
19502710|NCT03080545|Betamethasone|betamethasone|mesh-list
19502711|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19502712|NCT03080545|Calcipotriene|calcipotriene|mesh-list
19502713|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19502714|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
19502715|NCT03080545|Hormones|hormones|mesh-ancestor
19502716|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502717|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502718|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19502719|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
19502720|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19502721|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19502722|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19502723|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502724|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19502725|NCT03080545|Vitamins|vitamins|mesh-ancestor
19502726|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
19502727|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19502728|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
19502729|NCT03080480|Pioglitazone|pioglitazone|mesh-list
19502730|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19502731|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502732|NCT03080350|Fentanyl|fentanyl|mesh-list
19502733|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19502734|NCT03080350|Narcotics|narcotics|mesh-ancestor
20094454|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094455|NCT00002425|Saquinavir|saquinavir|mesh-list
20094456|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094457|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094458|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094459|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094460|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094461|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19502735|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502736|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502737|NCT03080350|Analgesics|analgesics|mesh-ancestor
19502738|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
19502739|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502740|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19502741|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19502742|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
20094462|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094463|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
20094464|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502743|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
19502744|NCT03080181|Pasireotide|pasireotide|mesh-list
19502745|NCT03080181|Hormones|hormones|mesh-ancestor
19502746|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502747|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502748|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19502749|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19502750|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19502751|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502752|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502753|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19502754|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19502755|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19502756|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
19502757|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502758|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502759|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19502760|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19502761|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
19502762|NCT03079973|Calcipotriene|calcipotriene|mesh-list
19502763|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
19502764|NCT03079830|Pirinitramide|pirinitramide|mesh-list
19502765|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19502766|NCT03079830|Narcotics|narcotics|mesh-ancestor
19502767|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502768|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502769|NCT03079830|Analgesics|analgesics|mesh-ancestor
19502770|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
19502771|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502772|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19502773|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502774|NCT03079895|Nicotine|nicotine|mesh-list
19502775|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19502776|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
19502777|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502778|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502779|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19502780|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19502781|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
19502782|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502783|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502784|NCT03079687|Olaparib|olaparib|mesh-list
19502785|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19502786|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502787|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502788|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502789|NCT03079440|Capecitabine|capecitabine|mesh-list
19502790|NCT03079440|Temozolomide|temozolomide|mesh-list
19502791|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502792|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
19502793|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502794|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502795|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19502796|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
19570684|NCT00627250|Amantadine|amantadine|mesh-list
19570685|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19570686|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19570687|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
19570688|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570689|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
19570690|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570691|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570692|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570693|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19570694|NCT00627250|Analgesics|analgesics|mesh-ancestor
19570695|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
19570696|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570697|NCT00454285|Amoxicillin|amoxicillin|mesh-list
19570698|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570699|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570700|NCT00452023|Interferons|interferons|mesh-list
19570701|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
19570702|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
19570703|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19570704|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570705|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
19502797|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
19502798|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19502799|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19502800|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19502801|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19502802|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502803|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
19502804|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502805|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502806|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19502807|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502808|NCT03079453|Dexamethasone|dexamethasone|mesh-list
19502809|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19502810|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
19502811|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
19502812|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502813|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502814|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502815|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
19502816|NCT03079453|Hormones|hormones|mesh-ancestor
19502817|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502818|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19502819|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502820|NCT03079388|Azithromycin|azithromycin|mesh-list
19502821|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
19502822|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
19502823|NCT03079388|Albendazole|albendazole|mesh-list
19502824|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19502825|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094465|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20094466|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094467|NCT00002426|Adefovir|adefovir|mesh-list
19502826|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502827|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
19502828|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19502829|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19502830|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19502831|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502832|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502833|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19502834|NCT03079388|Renal Agents|renal agents|mesh-ancestor
19502835|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
19502836|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
19502837|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19502838|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
19502839|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
19502840|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
19502841|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502842|NCT03079544|Asparaginase|asparaginase|mesh-list
19502843|NCT03079544|Pegaspargase|pegaspargase|mesh-list
19502844|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502845|NCT03079505|Dasatinib|dasatinib|mesh-list
19502846|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502847|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19502848|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502849|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502850|NCT03079427|Gemcitabine|gemcitabine|mesh-list
19502851|NCT03079427|Cisplatin|cisplatin|mesh-list
19502852|NCT03079427|Capecitabine|capecitabine|mesh-list
19502853|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502854|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19502855|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
19502856|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502857|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
19502858|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19502859|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502860|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19502861|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
19502862|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502863|NCT03079219|Dexamethasone|dexamethasone|mesh-list
19502864|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
19502865|NCT03079219|Ondansetron|ondansetron|mesh-list
19502866|NCT03079219|Olanzapine|olanzapine|mesh-list
19502867|NCT03079219|Aprepitant|aprepitant|mesh-list
19502868|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
19502869|NCT03079219|BB 1101|bb 1101|mesh-list
19502870|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20094468|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19502871|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
19502872|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
19502873|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094469|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
20094470|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094471|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094472|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094473|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094474|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094475|NCT00002427|Stavudine|stavudine|mesh-list
20094476|NCT00002427|Didanosine|didanosine|mesh-list
19502874|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502875|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502876|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
19502877|NCT03079219|Hormones|hormones|mesh-ancestor
19502878|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502879|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19502880|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502881|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
19502882|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502883|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502884|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
19502885|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
19502886|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19502887|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
19502888|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502889|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19502890|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19502891|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502892|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19502893|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19502894|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19502895|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19502896|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19502897|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19502898|NCT03079271|Benzocaine|benzocaine|mesh-list
19502899|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
19502900|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
19502901|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502902|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502903|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
19502904|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502905|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
19502906|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19502907|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
19502908|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502909|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502910|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19502911|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
19502912|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19502913|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
19502914|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502915|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502916|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19502917|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
19502918|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
19502919|NCT03078933|Protective Agents|protective agents|mesh-ancestor
19502920|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
19502921|NCT03079167|Hematinics|hematinics|mesh-ancestor
19502922|NCT03078829|Leuprolide|leuprolide|mesh-list
19502923|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19502924|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
19502925|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19502926|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502927|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19502928|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19502929|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
19502930|NCT03079050|Lansoprazole|lansoprazole|mesh-list
19502931|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19502932|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19502933|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19502934|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502935|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502936|NCT03079076|Bupivacaine|bupivacaine|mesh-list
20094477|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
20094478|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094479|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
20094480|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094481|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094482|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094483|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
20094484|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094485|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
20094486|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094487|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094488|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094489|NCT00002428|Vaccines|vaccines|mesh-list
20603174|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
20603175|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
20603176|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20603177|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603178|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603179|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
20603180|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19502937|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
19502938|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
19502939|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19502940|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502941|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
19502942|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19502943|NCT03079141|Eplerenone|eplerenone|mesh-list
19502944|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19502945|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
19502946|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502947|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502948|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19502949|NCT03079141|Diuretics|diuretics|mesh-ancestor
19502950|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
19502951|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19502952|NCT03079115|Atorvastatin|atorvastatin|mesh-list
19502953|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19502954|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19502955|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
19502956|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502957|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19502958|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19502959|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19502960|NCT03078842|Zinc|zinc|mesh-list
19502961|NCT03078842|Trace Elements|trace elements|mesh-ancestor
19502962|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
19502963|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502964|NCT03078725|Metformin|metformin|mesh-list
19502965|NCT03078725|Glyburide|glyburide|mesh-list
19502966|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19502967|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502968|NCT03078465|Clopidogrel|clopidogrel|mesh-list
19502969|NCT03078465|Ticagrelor|ticagrelor|mesh-list
19502970|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19502971|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19502972|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19502973|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19502974|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
19502975|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502976|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502977|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502978|NCT03078777|Fexofenadine|fexofenadine|mesh-list
19502979|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19502980|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19502981|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19502982|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
19502983|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
19502984|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19502985|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19502986|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502987|NCT03078374|Warfarin|warfarin|mesh-list
19502988|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
19502989|NCT03078309|Cannabidiol|cannabidiol|mesh-list
19502990|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
19502991|NCT03078569|Testosterone|testosterone|mesh-list
19502992|NCT03078569|Androgens|androgens|mesh-ancestor
19502993|NCT03078569|Hormones|hormones|mesh-ancestor
19502994|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19502995|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19502996|NCT03078257|Aspirin|aspirin|mesh-list
19502997|NCT03078257|Tirofiban|tirofiban|mesh-list
19502998|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
19502999|NCT03078257|Clopidogrel|clopidogrel|mesh-list
19503000|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503001|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503002|NCT03078257|Analgesics|analgesics|mesh-ancestor
19503003|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
19503004|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503005|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503006|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503007|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503008|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19503009|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19503010|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503011|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19503012|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19503013|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503014|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
19503015|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19503016|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19503017|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19503018|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
19503019|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503020|NCT03078231|Mydriatics|mydriatics|mesh-list
19503021|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
19503022|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503023|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503024|NCT03078062|Dexamethasone|dexamethasone|mesh-list
19503025|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503026|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
19503027|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
19503028|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503029|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503030|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19503031|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
19503032|NCT03078062|Hormones|hormones|mesh-ancestor
19503033|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503034|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19503035|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503036|NCT03078101|Empagliflozin|empagliflozin|mesh-list
19503037|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19503038|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503039|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19503040|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570706|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570707|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
19570708|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570709|NCT00405613|Aspirin|aspirin|mesh-list
19570710|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19570711|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19570712|NCT00405613|Analgesics|analgesics|mesh-ancestor
19570713|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
19570714|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570715|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570716|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570717|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570718|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19570719|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19570720|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570721|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19570722|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19570723|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570724|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
19570725|NCT00126672|Sirolimus|sirolimus|mesh-list
19570726|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570727|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570728|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19570729|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503041|NCT03077633|Progesterone|progesterone|mesh-list
19503042|NCT03077633|Progestins|progestins|mesh-ancestor
19503043|NCT03077633|Hormones|hormones|mesh-ancestor
19503044|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503045|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503046|NCT03077698|Megestrol|megestrol|mesh-list
19503047|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
19503048|NCT03077698|Progestins|progestins|mesh-list
19503049|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
19503050|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19503051|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19503052|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19503053|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
19503054|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19503055|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503056|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19503057|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19503058|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19503059|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503060|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
19503061|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19503062|NCT03077698|Hormones|hormones|mesh-ancestor
19503063|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503064|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
19503065|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
19503066|NCT03077581|Anesthetics|anesthetics|mesh-list
19503067|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503068|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503069|NCT03077828|Carboplatin|carboplatin|mesh-list
19503070|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
19503071|NCT03077828|Etoposide|etoposide|mesh-list
19503072|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
19503073|NCT03077828|Ifosfamide|ifosfamide|mesh-list
19503074|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
19503075|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
19503076|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503077|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19503078|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19503079|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19503080|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19503081|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503082|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503083|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19503084|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
19503085|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
19503086|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
19503087|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
19503088|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
19503089|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
19503090|NCT03077503|Fentanyl|fentanyl|mesh-list
19503091|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
19503092|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19503093|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503094|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503095|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503096|NCT03077503|Analgesics|analgesics|mesh-ancestor
19503097|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
19503098|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503099|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19503100|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19503101|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19503102|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19503103|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503104|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503105|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19503106|NCT03077503|Narcotics|narcotics|mesh-ancestor
19503107|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19503108|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19503109|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
19503110|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
19503111|NCT03077516|Meloxicam|meloxicam|mesh-list
19503112|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503113|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503114|NCT03077516|Analgesics|analgesics|mesh-ancestor
19503115|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
19570730|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
19503116|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503117|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503118|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503119|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503120|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20094490|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
20094491|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094492|NCT00002430|Lamivudine|lamivudine|mesh-list
20094493|NCT00002430|Stavudine|stavudine|mesh-list
20094494|NCT00002430|Nelfinavir|nelfinavir|mesh-list
20094495|NCT00002430|Indinavir|indinavir|mesh-list
20094496|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094497|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094498|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094499|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094500|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
20603181|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20603182|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20603183|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603184|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
20603185|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
20603186|NCT02219789|Fulvestrant|fulvestrant|mesh-list
20603187|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20603188|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603189|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20603190|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20603191|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
19503121|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19503122|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503123|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503124|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19503125|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19503126|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19503127|NCT03077555|Estradiol|estradiol|mesh-list
19503128|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19503129|NCT03077555|Estrogens|estrogens|mesh-ancestor
19503130|NCT03077555|Hormones|hormones|mesh-ancestor
19503131|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503132|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503133|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19503134|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
19503135|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19503136|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20094501|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094502|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094503|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094504|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
20094505|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094506|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094507|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094508|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
20094509|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20094510|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20094511|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094512|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
19503137|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19503138|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19503139|NCT03077451|Nelfinavir|nelfinavir|mesh-list
19503140|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19503141|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19503142|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
19503143|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503144|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503145|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19503146|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19503147|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
19503148|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503149|NCT03077217|Rifaximin|rifaximin|mesh-list
19503150|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19503151|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503152|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19503153|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
20094513|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
20094514|NCT00002432|Foscarnet|foscarnet|mesh-list
20094515|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20094516|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
20306098|NCT00653874|Protective Agents|protective agents|mesh-ancestor
19503154|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19503155|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
19503156|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503157|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
19503158|NCT03077009|Protective Agents|protective agents|mesh-ancestor
19503159|NCT03076905|Olorofim|olorofim|mesh-list
19503160|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
19503161|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503162|NCT03076710|Bupivacaine|bupivacaine|mesh-list
19503163|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503164|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
19503165|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503166|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503167|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
19503168|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503169|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19503170|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19503171|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19503172|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503173|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503174|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19503175|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19503176|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503177|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
19503178|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503179|NCT03076684|Allopurinol|allopurinol|mesh-list
19503180|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
19503181|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503182|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503183|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
19503184|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503185|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19503186|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
19503187|NCT03076684|Protective Agents|protective agents|mesh-ancestor
19503188|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503189|NCT03076151|Tacrolimus|tacrolimus|mesh-list
19503190|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19503191|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
19503192|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503193|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19503194|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503195|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503196|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19503197|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
19503198|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19503199|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503200|NCT03076112|Incretins|incretins|mesh-ancestor
19503201|NCT03076112|Hormones|hormones|mesh-ancestor
19503202|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503203|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19503204|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19503205|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503206|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503207|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19503208|NCT03076203|Niraparib|niraparib|mesh-list
19503209|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19503210|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19503211|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503212|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503213|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503214|NCT03076320|Adapalene|adapalene|mesh-list
19503215|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19503216|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
19503217|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503218|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503219|NCT03076320|Analgesics|analgesics|mesh-ancestor
19503220|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
19503221|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503222|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503223|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503224|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503225|NCT03076281|Metformin|metformin|mesh-list
19503226|NCT03076281|Doxycycline|doxycycline|mesh-list
19503227|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19503228|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503229|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19503230|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503231|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
19503232|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19503233|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19503234|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
19503235|NCT03076021|Isotretinoin|isotretinoin|mesh-list
19503236|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
19503237|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
19503238|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19503239|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19503240|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503241|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503242|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503243|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
19570731|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570732|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
19570733|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570734|NCT03172780|Diclofenac|diclofenac|mesh-list
19570735|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19570736|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19570737|NCT03172780|Analgesics|analgesics|mesh-ancestor
19570738|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
19570739|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570740|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570741|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570742|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570743|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19570744|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570745|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570746|NCT03169972|Factor VIII|factor viii|mesh-list
19570747|NCT03169972|BAX 855|bax 855|mesh-list
19570748|NCT03169972|Coagulants|coagulants|mesh-ancestor
19570749|NCT03151304|Azacitidine|azacitidine|mesh-list
19570750|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19570751|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
19570752|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570753|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570754|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570755|NCT03148418|Atezolizumab|atezolizumab|mesh-list
19570756|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570757|NCT03134196|Valacyclovir|valacyclovir|mesh-list
20094517|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094518|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094519|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094520|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094521|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094522|NCT00002433|Interferons|interferons|mesh-list
19570758|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
19570759|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570760|NCT03128034|Cyclosporine|cyclosporine|mesh-list
19570761|NCT03128034|Sirolimus|sirolimus|mesh-list
19570762|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
19570763|NCT03128034|Fludarabine|fludarabine|mesh-list
19570764|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
19570765|NCT03128034|Cyclosporins|cyclosporins|mesh-list
19570766|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570767|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19570768|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
19570769|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570770|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570771|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
19570772|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570773|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570774|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
19570775|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570776|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
19570777|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570778|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19570779|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19570780|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19570781|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
19570782|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094523|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
19570783|NCT03113409|Naltrexone|naltrexone|mesh-list
19570784|NCT03113409|Buprenorphine|buprenorphine|mesh-list
20094524|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503244|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
19503245|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19503246|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503247|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503248|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503249|NCT03076099|Analgesics|analgesics|mesh-ancestor
19503250|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
19503251|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503252|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19503253|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19503254|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19503255|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
19503256|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503257|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503258|NCT03075657|Haloperidol|haloperidol|mesh-list
19503259|NCT03075657|Risperidone|risperidone|mesh-list
19503260|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
19503261|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19503262|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
19503263|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503264|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503265|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503266|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19503267|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19503268|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503269|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20603192|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603193|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603194|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20603195|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20603196|NCT02219867|Ketamine|ketamine|mesh-list
20603197|NCT02219867|Analgesics|analgesics|mesh-ancestor
20603198|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
20603199|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503270|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19503271|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
19503272|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
19503273|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
19503274|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503275|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19503276|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19503277|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19503278|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19503279|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19503280|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19503281|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503282|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
19503283|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503284|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503285|NCT03075358|Lidocaine|lidocaine|mesh-list
19503286|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503287|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
19503288|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503289|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503290|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
20094525|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
20094526|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094527|NCT00002434|Leucovorin|leucovorin|mesh-list
20094528|NCT00002434|Trimetrexate|trimetrexate|mesh-list
20603200|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570785|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20094529|NCT00002434|Calcium|calcium|mesh-list
19503291|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503292|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19503293|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19503294|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19503295|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19503296|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503297|NCT03074942|Reslizumab|reslizumab|mesh-list
19503298|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19503299|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
19503300|NCT03074968|Benzydamine|benzydamine|mesh-list
19503301|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503302|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
19503303|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
19503304|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503305|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
19503306|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503307|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503308|NCT03074994|Anesthetics|anesthetics|mesh-list
19503309|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
19503310|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503311|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503312|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
19503313|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503314|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20094530|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
20094531|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20094532|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094533|NCT00002434|Antidotes|antidotes|mesh-ancestor
20094534|NCT00002434|Protective Agents|protective agents|mesh-ancestor
20094535|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
20094536|NCT00002434|Vitamins|vitamins|mesh-ancestor
20094537|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
20094538|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
20094539|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094540|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094541|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
20094542|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094543|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094544|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20094545|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094546|NCT00002435|Zidovudine|zidovudine|mesh-list
20094547|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
20094548|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094549|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094550|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19503315|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503316|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19503317|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503318|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094551|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094552|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
20094553|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094554|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19503319|NCT03075241|Zolpidem|zolpidem|mesh-list
19503320|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19503321|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19503322|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503323|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503324|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19503325|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
19503326|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
19503327|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503328|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503329|NCT03074825|Chiauranib|chiauranib|mesh-list
19503330|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503331|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19503332|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503333|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503334|NCT03074773|Dexamethasone|dexamethasone|mesh-list
19503335|NCT03074773|Bupivacaine|bupivacaine|mesh-list
20094555|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094556|NCT00002436|Lamivudine|lamivudine|mesh-list
20094557|NCT00002436|Zidovudine|zidovudine|mesh-list
20094558|NCT00002436|Zalcitabine|zalcitabine|mesh-list
19503336|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503337|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
20094559|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094560|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094561|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094562|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094563|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
20094564|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503338|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
19503339|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503340|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503341|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19503342|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
19503343|NCT03074773|Hormones|hormones|mesh-ancestor
20094565|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094566|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094567|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
19503344|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503345|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19503346|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503347|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503348|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
19503349|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503350|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
19503351|NCT03074786|Tenofovir|tenofovir|mesh-list
19503352|NCT03074786|Emtricitabine|emtricitabine|mesh-list
19503353|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19503354|NCT03074786|Dapivirine|dapivirine|mesh-list
19503355|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
19503356|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503357|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19503358|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19503359|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503360|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503361|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19503362|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19503363|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
19503364|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19503365|NCT03074591|Hematinics|hematinics|mesh-ancestor
19503366|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19503367|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19503368|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
20094568|NCT00002437|Cidofovir|cidofovir|mesh-list
20094569|NCT00002437|Probenecid|probenecid|mesh-list
20094570|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
20094571|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
20094572|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503369|NCT03074578|Hormones|hormones|mesh-ancestor
19503370|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503371|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503372|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503373|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503374|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
19503375|NCT03074448|Cathartics|cathartics|mesh-ancestor
19503376|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19503377|NCT03074435|Ivermectin|ivermectin|mesh-list
19503378|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19503379|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503380|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
19503381|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19503382|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
19503383|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503384|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
19503385|NCT03074344|Protective Agents|protective agents|mesh-ancestor
19570786|NCT03113409|Narcotics|narcotics|mesh-ancestor
19570787|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19570788|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094573|NCT00002437|Renal Agents|renal agents|mesh-ancestor
20094574|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
20094575|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094576|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094577|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094578|NCT00002438|Itraconazole|itraconazole|mesh-list
20094579|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
20094580|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607889|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20094581|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20094582|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094583|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094584|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094585|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20094586|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
20094587|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20094588|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094589|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20094590|NCT00002439|Alitretinoin|alitretinoin|mesh-list
20094591|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094592|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20094593|NCT00002440|Ritonavir|ritonavir|mesh-list
20094594|NCT00002440|Nelfinavir|nelfinavir|mesh-list
20094595|NCT00002440|Indinavir|indinavir|mesh-list
20094596|NCT00002440|Saquinavir|saquinavir|mesh-list
20094597|NCT00002440|Amprenavir|amprenavir|mesh-list
20094598|NCT00002440|Abacavir|abacavir|mesh-list
20094599|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094600|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19503386|NCT03074097|Bupivacaine|bupivacaine|mesh-list
19503387|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503388|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
19503389|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503390|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503391|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
19503392|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503393|NCT03074123|Cosyntropin|cosyntropin|mesh-list
19503394|NCT03074123|Hormones|hormones|mesh-ancestor
19503395|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503396|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503397|NCT03073928|Ropivacaine|ropivacaine|mesh-list
19503398|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503399|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
19503400|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503401|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503402|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
19503403|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748900|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19748901|NCT05366049|Acetaminophen|acetaminophen|mesh-list
19748902|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19748903|NCT05366049|Analgesics|analgesics|mesh-ancestor
19748904|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
19748905|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094601|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094602|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503404|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19503405|NCT03074136|Eusol|eusol|mesh-list
19503406|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
19503407|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503408|NCT03073850|Aspirin|aspirin|mesh-list
19503409|NCT03073850|Edoxaban|edoxaban|mesh-list
19503410|NCT03073850|Anticoagulants|anticoagulants|mesh-list
19503411|NCT03073850|Clopidogrel|clopidogrel|mesh-list
19503412|NCT03073850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503413|NCT03073850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503414|NCT03073850|Analgesics|analgesics|mesh-ancestor
19503415|NCT03073850|Sensory System Agents|sensory system agents|mesh-ancestor
19503416|NCT03073850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503417|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503418|NCT03073850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503419|NCT03073850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503420|NCT03073850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19503421|NCT03073850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19503422|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503423|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19503424|NCT03073850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19503425|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503426|NCT03073850|Antipyretics|antipyretics|mesh-ancestor
19503427|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19503428|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19503429|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20094603|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094604|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748906|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503430|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
19503431|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20094605|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094606|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
20094607|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094608|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20094609|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094610|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19503432|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19503433|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
19503434|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19503435|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
19503436|NCT03073863|Atorvastatin|atorvastatin|mesh-list
19503437|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19503438|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19503439|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
19503440|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094611|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094612|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20094613|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
20094614|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094615|NCT00002442|Lamivudine|lamivudine|mesh-list
20094616|NCT00002442|Stavudine|stavudine|mesh-list
20094617|NCT00002442|Nelfinavir|nelfinavir|mesh-list
20094618|NCT00002442|Indinavir|indinavir|mesh-list
20094619|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19503441|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19503442|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19503443|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503444|NCT03073889|Ropivacaine|ropivacaine|mesh-list
19503445|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503446|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
19503447|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503448|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503449|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
19503450|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503451|NCT03073694|Melphalan|melphalan|mesh-list
19503452|NCT03073694|Mitomycins|mitomycins|mesh-list
19503453|NCT03073694|Mitomycin|mitomycin|mesh-list
19503454|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19503455|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
19503456|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503457|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503458|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19503459|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19503460|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
19503461|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503462|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19503463|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19503464|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503465|NCT03073408|Propofol|propofol|mesh-list
19503466|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19503467|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503468|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503469|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19503470|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
19503471|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
19503472|NCT03073317|Mitogens|mitogens|mesh-list
20094620|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094621|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503473|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
20094622|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503474|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503475|NCT03073343|Betaine|betaine|mesh-list
19503476|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19503477|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
19503478|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19503479|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
19503480|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503481|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19503482|NCT03072992|Curcumin|curcumin|mesh-list
19503483|NCT03072992|Paclitaxel|paclitaxel|mesh-list
20094623|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
20094624|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094625|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094626|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094627|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
20094628|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094629|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094630|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094631|NCT00002443|Zidovudine|zidovudine|mesh-list
20094632|NCT00002443|Indinavir|indinavir|mesh-list
20094633|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
19503484|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19503485|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503486|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19503487|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19503488|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19503489|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503490|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503491|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503492|NCT03072992|Analgesics|analgesics|mesh-ancestor
19503493|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
19503494|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503495|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503496|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503497|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503498|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503499|NCT03073265|Apixaban|apixaban|mesh-list
19503500|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19503501|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
19503502|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19503503|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
19503504|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503505|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503506|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
19503507|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19503508|NCT03073057|Budesonide|budesonide|mesh-list
19503509|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
19503510|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19503511|NCT03073057|Charcoal|charcoal|mesh-list
19503512|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503513|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20094634|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094635|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094636|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19503514|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
19503515|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503516|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503517|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19503518|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
19503519|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
19503520|NCT03073057|Hormones|hormones|mesh-ancestor
19503521|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503522|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19503523|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19503524|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19503525|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
19503526|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503527|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503528|NCT03073057|Antidotes|antidotes|mesh-ancestor
19503529|NCT03073057|Protective Agents|protective agents|mesh-ancestor
19503530|NCT03073018|Fosinopril|fosinopril|mesh-list
19503531|NCT03073018|Pravastatin|pravastatin|mesh-list
20094637|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503532|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19503533|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20094638|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
19503534|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
19503535|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503536|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19503537|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19503538|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503539|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19503540|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
19503541|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19503542|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
19503543|NCT03073369|Vitamin D|vitamin d|mesh-list
19503544|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19503545|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503546|NCT03073369|Vitamins|vitamins|mesh-ancestor
19503547|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
19503548|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19503549|NCT03072849|Fluticasone|fluticasone|mesh-list
19503550|NCT03072849|Azithromycin|azithromycin|mesh-list
19503551|NCT03072849|Montelukast|montelukast|mesh-list
19503552|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503553|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19503554|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
19503555|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503556|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503557|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19503558|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
19503559|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
19503560|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19503561|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094639|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094640|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094641|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094642|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094643|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094644|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094645|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
20094646|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20094647|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094648|NCT00002446|Fluconazole|fluconazole|mesh-list
19503562|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503563|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19503564|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
19503565|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503566|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19503567|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19503568|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503569|NCT03072485|Metformin|metformin|mesh-list
19503570|NCT03072485|Sirolimus|sirolimus|mesh-list
19503571|NCT03072485|Diclofenac|diclofenac|mesh-list
19503572|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19503573|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503574|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19503575|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503576|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19503577|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503578|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
19503579|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19503580|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
19503581|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503582|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503583|NCT03072485|Analgesics|analgesics|mesh-ancestor
19503584|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
19503585|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503586|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503587|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20094649|NCT00002446|Posaconazole|posaconazole|mesh-list
20094650|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
20094651|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094652|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20094653|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094654|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094655|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094656|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19503588|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19503589|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094657|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
19503590|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503591|NCT03072589|Regadenoson|regadenoson|mesh-list
19503592|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19503593|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19503594|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
19503595|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
19503596|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503597|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503598|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570789|NCT03113409|Analgesics|analgesics|mesh-ancestor
19570790|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
19570791|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570792|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19570793|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19570794|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
19570795|NCT03096275|Hormones|hormones|mesh-ancestor
19570796|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570797|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570798|NCT03094052|Trastuzumab|trastuzumab|mesh-list
19570799|NCT03094052|Atropine|atropine|mesh-list
19570800|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
19570801|NCT03094052|Loperamide|loperamide|mesh-list
19570802|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
19570803|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
19570804|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570805|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570806|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19570807|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19570808|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19570809|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
19570810|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570811|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570812|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19570813|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
19570814|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
19570815|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
19570816|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19570817|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19570818|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
19570819|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570820|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570821|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19570822|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19570823|NCT03094052|Narcotics|narcotics|mesh-ancestor
19570824|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19570825|NCT03094052|Analgesics|analgesics|mesh-ancestor
19570826|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
19570827|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
19570828|NCT03089905|Remifentanil|remifentanil|mesh-list
19570829|NCT03089905|Sevoflurane|sevoflurane|mesh-list
19570830|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19570831|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19570832|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570833|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19570834|NCT03089905|Analgesics|analgesics|mesh-ancestor
19570835|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
19570836|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570837|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19570838|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19570839|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19570840|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
19570841|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19570842|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570843|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19570844|NCT03089905|Narcotics|narcotics|mesh-ancestor
19570845|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19570846|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19570847|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
19570848|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
19570849|NCT03074513|Bevacizumab|bevacizumab|mesh-list
19570850|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19570851|NCT03074513|Atezolizumab|atezolizumab|mesh-list
19570852|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
19570853|NCT03074513|Antibodies|antibodies|mesh-list
19570854|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
19503599|NCT03072511|Nicotine|nicotine|mesh-list
19503600|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19503601|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
19503602|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503603|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503604|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19503605|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19503606|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
19503607|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503608|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503609|NCT03072264|Fluoxetine|fluoxetine|mesh-list
19503610|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19503611|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19503612|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20094658|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20094659|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094660|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20094661|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20094662|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20094663|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19503613|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503614|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503615|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
19503616|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503617|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19503618|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
19503619|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19503620|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19503621|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19503622|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503623|NCT03072394|Lidocaine|lidocaine|mesh-list
19503624|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
19503625|NCT03072394|Anesthetics|anesthetics|mesh-list
19503626|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503627|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503628|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
19503629|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503630|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19503631|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19503632|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19503633|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19503634|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503635|NCT03072329|Bupivacaine|bupivacaine|mesh-list
19503636|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503637|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
19503638|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503639|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503640|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
19503641|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503642|NCT03072082|Aspirin|aspirin|mesh-list
19503643|NCT03072082|Metoprolol|metoprolol|mesh-list
19503644|NCT03072082|Isosorbide|isosorbide|mesh-list
19503645|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19503646|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19503647|NCT03072082|Trimetazidine|trimetazidine|mesh-list
19503648|NCT03072082|Clopidogrel|clopidogrel|mesh-list
19503649|NCT03072082|Atorvastatin|atorvastatin|mesh-list
19503650|NCT03072082|Calcium|calcium|mesh-list
19503651|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19503652|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503653|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503654|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503655|NCT03072082|Analgesics|analgesics|mesh-ancestor
19503656|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
19503657|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503658|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503659|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503660|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19503661|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19503662|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503663|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19503664|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20094664|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19503665|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503666|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
19503667|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19503668|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19503669|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
19503670|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19503671|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19503672|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19503673|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19503674|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19503675|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
19503676|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503677|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19503678|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19503679|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
19503680|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
19503681|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19503682|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19503683|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19503684|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
19503685|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19503686|NCT03072082|Diuretics|diuretics|mesh-ancestor
19503687|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
19503688|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
19503689|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19503690|NCT03072290|Triamcinolone|triamcinolone|mesh-list
19503691|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19503692|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19503693|NCT03072290|Lidocaine|lidocaine|mesh-list
19503694|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19503695|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19503696|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
19503697|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19503698|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503699|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
19503700|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503701|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19503702|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19503703|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19503704|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19503705|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503706|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503707|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
19503708|NCT03072290|Hormones|hormones|mesh-ancestor
19503709|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503710|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19503711|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
19503712|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503713|NCT03072121|Aspirin|aspirin|mesh-list
19503714|NCT03072121|Metoprolol|metoprolol|mesh-list
19503715|NCT03072121|Isosorbide|isosorbide|mesh-list
19503716|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19503717|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19503718|NCT03072121|Trimetazidine|trimetazidine|mesh-list
20094665|NCT00002447|Ritonavir|ritonavir|mesh-list
20094666|NCT00002447|Saquinavir|saquinavir|mesh-list
20094667|NCT00002447|Efavirenz|efavirenz|mesh-list
19503719|NCT03072121|Clopidogrel|clopidogrel|mesh-list
19503720|NCT03072121|Atorvastatin|atorvastatin|mesh-list
19503721|NCT03072121|Calcium|calcium|mesh-list
19503722|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20094668|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094669|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094670|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094671|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094672|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094673|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094674|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094675|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
19503723|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503724|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503725|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503726|NCT03072121|Analgesics|analgesics|mesh-ancestor
19503727|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
19503728|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094676|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094677|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19503729|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503730|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503731|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19503732|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19503733|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503734|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19503735|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19503736|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503737|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
19503738|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19503739|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19503740|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
19503741|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19503742|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19503743|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19503744|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20094678|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094679|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094680|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094681|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20603201|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19503745|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19503746|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
19503747|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503748|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19503749|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19503750|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
19503751|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
19503752|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19503753|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19503754|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19503755|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19503756|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19503757|NCT03072121|Diuretics|diuretics|mesh-ancestor
19503758|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
19503759|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
19503760|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19503761|NCT03072173|Xylometazoline|xylometazoline|mesh-list
19503762|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
19503763|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19503764|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
19503765|NCT03072199|Rituximab|rituximab|mesh-list
19503766|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19503767|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503768|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
19503769|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503770|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20094682|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20094683|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19503773|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
20603202|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19503774|NCT03071679|Imiquimod|imiquimod|mesh-list
19503775|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19503776|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
19503777|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503778|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503779|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
19503780|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503781|NCT03071822|Gemcitabine|gemcitabine|mesh-list
19503782|NCT03071822|Dexamethasone|dexamethasone|mesh-list
19503783|NCT03071822|Etoposide|etoposide|mesh-list
19503784|NCT03071822|Asparaginase|asparaginase|mesh-list
19503785|NCT03071822|Ifosfamide|ifosfamide|mesh-list
19503786|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094684|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20094685|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20094686|NCT00002448|Ritonavir|ritonavir|mesh-list
20094687|NCT00002448|Saquinavir|saquinavir|mesh-list
20094688|NCT00002448|Efavirenz|efavirenz|mesh-list
20094689|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094690|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094691|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094692|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603203|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
19503787|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503788|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
20094693|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094694|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094695|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094696|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
20094697|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094698|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19503789|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
19503790|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503791|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503792|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19503793|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
19503794|NCT03071822|Hormones|hormones|mesh-ancestor
19503795|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503796|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19503797|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19503798|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
19503799|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503800|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
19503801|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503802|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503803|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19503804|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
19503805|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19503806|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19503807|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19503808|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19503809|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
19503810|NCT03071731|Bromides|bromides|mesh-list
19503811|NCT03071731|Ipratropium|ipratropium|mesh-list
19503812|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
19503813|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
19503814|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
19503815|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503816|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503817|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19503818|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
19503819|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503820|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503821|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19503822|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
19503823|NCT03071536|Furosemide|furosemide|mesh-list
19503824|NCT03071536|Diuretics|diuretics|mesh-ancestor
19503825|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
19503826|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503827|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19503828|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19503829|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503830|NCT03071575|Vaccines|vaccines|mesh-list
19503831|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
19503832|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094699|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094700|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19503833|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
19503834|NCT03071549|Salicylates|salicylates|mesh-list
19503835|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503836|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
19503837|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
19503838|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
19503839|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503840|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503841|NCT03071549|Analgesics|analgesics|mesh-ancestor
19503842|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
19503843|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503844|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503845|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503846|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503847|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19503848|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503849|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094701|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094702|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20094703|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19503850|NCT03071770|Ivosidenib|ivosidenib|mesh-list
19503851|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503852|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503853|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503854|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
19503855|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
19503856|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19503857|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
19503858|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503859|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503860|NCT03071705|Metformin|metformin|mesh-list
19503861|NCT03071705|Gefitinib|gefitinib|mesh-list
19503862|NCT03071705|Afatinib|afatinib|mesh-list
19503863|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19503864|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503865|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503866|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19503867|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503868|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503869|NCT03071289|Cisplatin|cisplatin|mesh-list
19503870|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503871|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
19503872|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
19503873|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
19503874|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503875|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503876|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
19503877|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19503878|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
19503879|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19503880|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
19503881|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503882|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503883|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
19503884|NCT03071055|Ranibizumab|ranibizumab|mesh-list
19503885|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19503886|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19503887|NCT03071055|Growth Substances|growth substances|mesh-ancestor
19503888|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503889|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
19503890|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503891|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19503892|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19503893|NCT03071172|Progesterone|progesterone|mesh-list
19503894|NCT03071172|Hormones|hormones|mesh-ancestor
19503895|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503896|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503897|NCT03071172|Progestins|progestins|mesh-ancestor
19503898|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
19503899|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19503900|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
19503901|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19503902|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19503903|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19503904|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503905|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
19503906|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19503907|NCT03071042|Docetaxel|docetaxel|mesh-list
19503908|NCT03071042|Apatinib|apatinib|mesh-list
19503909|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503910|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
19503911|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
19503912|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
19503913|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503914|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19503915|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503916|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19503917|NCT03071068|Antibodies|antibodies|mesh-list
19503918|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
19503919|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20094704|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20603204|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
19503920|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
19503921|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503922|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503923|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
19503924|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19503925|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19503926|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19503927|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503928|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
19503929|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19503930|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19503931|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503932|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
19503933|NCT03070847|Coagulants|coagulants|mesh-ancestor
19570855|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19570856|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
19570857|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570858|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19570859|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19570860|NCT03074513|Growth Substances|growth substances|mesh-ancestor
19570861|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570862|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
19570863|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
19570864|NCT03039036|Misoprostol|misoprostol|mesh-list
19570865|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19570866|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
19570867|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19570868|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570869|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19570870|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19570871|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
19570872|NCT03026517|Phenformin|phenformin|mesh-list
19570873|NCT03026517|Trametinib|trametinib|mesh-list
19570874|NCT03026517|Dabrafenib|dabrafenib|mesh-list
19570875|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570876|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19570877|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570878|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570879|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570880|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570881|NCT03007979|Letrozole|letrozole|mesh-list
19570882|NCT03007979|Fulvestrant|fulvestrant|mesh-list
19570883|NCT03007979|Palbociclib|palbociclib|mesh-list
19570884|NCT03007979|Goserelin|goserelin|mesh-list
19570885|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570886|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19570887|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20603205|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603206|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20603207|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20603208|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607890|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570888|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570889|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570890|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19570891|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
19570892|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570893|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570894|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19570895|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19570896|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19570897|NCT02997605|Prednisone|prednisone|mesh-list
19570898|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
19570899|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
19570900|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570901|NCT02997605|Hormones|hormones|mesh-ancestor
19570902|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19570903|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570904|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20094705|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20094706|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20094707|NCT00002449|Aldesleukin|aldesleukin|mesh-list
20094708|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094709|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094710|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094711|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
20094712|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570905|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570906|NCT02988297|RNS60|rns60|mesh-list
20094713|NCT00002450|Tenofovir|tenofovir|mesh-list
20094714|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
20094715|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503934|NCT03070665|Norepinephrine|norepinephrine|mesh-list
19503935|NCT03070665|Ephedrine|ephedrine|mesh-list
19503936|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19503937|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19503938|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
19503939|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19503940|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503941|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503942|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
19503943|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
19503944|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503945|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19503946|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19503947|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19503948|NCT03070574|Mesalamine|mesalamine|mesh-list
19503949|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503950|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503951|NCT03070574|Analgesics|analgesics|mesh-ancestor
19503952|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
19503953|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503954|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503955|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503956|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503957|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
19503958|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19503959|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19503960|NCT03070704|Liraglutide|liraglutide|mesh-list
19503961|NCT03070704|Xultophy|xultophy|mesh-list
19503962|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19503963|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503964|NCT03070704|Incretins|incretins|mesh-ancestor
19503965|NCT03070704|Hormones|hormones|mesh-ancestor
19503966|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503967|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19503968|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
19503969|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19503970|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19503971|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19503972|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503973|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19503974|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19503975|NCT03070678|Analgesics|analgesics|mesh-ancestor
19503976|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
19503977|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19503978|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503979|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19503980|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19503981|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19503982|NCT03070522|Prednisone|prednisone|mesh-list
19503983|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19503984|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
19503985|NCT03070522|Hormones|hormones|mesh-ancestor
19503986|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19503987|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503988|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19503989|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19503990|NCT03070613|Lectins|lectins|mesh-list
19503991|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
19503992|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
20094716|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094717|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094718|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094719|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094720|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094721|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094722|NCT00002451|Ritonavir|ritonavir|mesh-list
20094723|NCT00002451|Indinavir|indinavir|mesh-list
20094724|NCT00002451|Lamivudine|lamivudine|mesh-list
20094725|NCT00002451|Stavudine|stavudine|mesh-list
20094726|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19748907|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
20094727|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19503993|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503994|NCT03070613|Coagulants|coagulants|mesh-ancestor
19503995|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19503996|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19503997|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19503998|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19503999|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19504000|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504001|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504002|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
19504003|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504004|NCT03070379|Lidocaine|lidocaine|mesh-list
19504005|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504006|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
19504007|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504008|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504009|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
19504010|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504011|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19504012|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19504013|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19504014|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504015|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504016|NCT03070405|Tenofovir|tenofovir|mesh-list
19504017|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19504018|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
19504019|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504020|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19504021|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19504022|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504023|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504024|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19504025|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19504026|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
19504027|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19504028|NCT03070353|Dextrans|dextrans|mesh-list
19504029|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
19504030|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
19504031|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
19504032|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19504033|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
19504034|NCT03070275|Coagulants|coagulants|mesh-ancestor
19504035|NCT03070223|Pitavastatin|pitavastatin|mesh-list
19504036|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19504037|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19504038|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19504039|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
19504040|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504041|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504042|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19504043|NCT03070028|Phenol|phenol|mesh-list
19504044|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19504045|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504046|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
19504047|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19504048|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19504049|NCT03070054|Epinephrine|epinephrine|mesh-list
19504050|NCT03070054|Bupivacaine|bupivacaine|mesh-list
19504051|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504052|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
19504053|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504054|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504055|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
19504056|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504057|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19504058|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19504059|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504060|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504061|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504062|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19504063|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19504064|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
19504065|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19504066|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
20603209|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603210|NCT02219893|Immunotoxins|immunotoxins|mesh-list
20603211|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
20603212|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603213|NCT02219906|Resveratrol|resveratrol|mesh-list
19504067|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
19504068|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
19504069|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19504070|NCT03069976|Metronidazole|metronidazole|mesh-list
19504071|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504072|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19504073|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19504074|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19504075|NCT03069950|Leucovorin|leucovorin|mesh-list
19504076|NCT03069950|Dexamethasone|dexamethasone|mesh-list
19504077|NCT03069950|Fluorouracil|fluorouracil|mesh-list
19504078|NCT03069950|Irinotecan|irinotecan|mesh-list
19504079|NCT03069950|Panitumumab|panitumumab|mesh-list
19504080|NCT03069950|Floxuridine|floxuridine|mesh-list
19504081|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504082|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
19504083|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
19504084|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504085|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504086|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504087|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
19504088|NCT03069950|Hormones|hormones|mesh-ancestor
19504089|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504090|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19504091|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504092|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
20094728|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094729|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094730|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094731|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094732|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094733|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
20094734|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504093|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504094|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094735|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20094736|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20094737|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094738|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094739|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
20094740|NCT00002452|Indinavir|indinavir|mesh-list
20094741|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20094742|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20094743|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
20094744|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094745|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094746|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20094747|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094748|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
20094749|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094750|NCT00002453|Tenofovir|tenofovir|mesh-list
20094751|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
20094752|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094753|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20094754|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19504095|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19504096|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
19504097|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19504098|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20094755|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094756|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504099|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504100|NCT03069950|Antidotes|antidotes|mesh-ancestor
19504101|NCT03069950|Protective Agents|protective agents|mesh-ancestor
19504102|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
19504103|NCT03069950|Vitamins|vitamins|mesh-ancestor
19504104|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
20094757|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603214|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
19504105|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504106|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19504107|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19504108|NCT03069781|Estradiol|estradiol|mesh-list
19504109|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19504110|NCT03069781|Estrogens|estrogens|mesh-ancestor
19504111|NCT03069781|Hormones|hormones|mesh-ancestor
19504112|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504113|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504114|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19504115|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
19504116|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504117|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19504118|NCT03069820|Docetaxel|docetaxel|mesh-list
19504119|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504120|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
19504121|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
19504122|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
19504123|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504124|NCT03069768|Varenicline|varenicline|mesh-list
19504125|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19504126|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19504127|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
19504128|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504129|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504130|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504131|NCT03069703|Rituximab|rituximab|mesh-list
19504132|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504133|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504134|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
19504135|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504136|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504137|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
20094758|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20094759|NCT00002456|Cyclosporine|cyclosporine|mesh-list
20094760|NCT00002456|Methotrexate|methotrexate|mesh-list
20094761|NCT00002456|Cyclosporins|cyclosporins|mesh-list
20094762|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20094763|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
20094764|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20094765|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094766|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094767|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
20094768|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094769|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094770|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
20094771|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094772|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20094773|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094774|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
20094775|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20094776|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094777|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
20094778|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094779|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20094780|NCT00002458|Antibodies|antibodies|mesh-list
19504138|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19504139|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19504140|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19504141|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504142|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504143|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
19504144|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504145|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504146|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19504147|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504148|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
19504149|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19504150|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504151|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504152|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504153|NCT03069638|Analgesics|analgesics|mesh-ancestor
19504154|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
19504155|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504156|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19504157|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20094781|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19504158|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19504159|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504160|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504161|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504162|NCT03069339|Carvedilol|carvedilol|mesh-list
19504163|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19504164|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19504165|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504166|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504167|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504168|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504169|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19504170|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
19504171|NCT03069339|Protective Agents|protective agents|mesh-ancestor
19504172|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19504173|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504174|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19504175|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
19504176|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19504177|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19504178|NCT03069001|Ribavirin|ribavirin|mesh-list
19504179|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
19504180|NCT03069001|Simeprevir|simeprevir|mesh-list
19504181|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
19504182|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504183|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
19504184|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094782|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
20094783|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094784|NCT00002460|Tamoxifen|tamoxifen|mesh-list
20094785|NCT00002460|Goserelin|goserelin|mesh-list
19504185|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
19504186|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504187|NCT03069131|Rifaximin|rifaximin|mesh-list
20094786|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20094787|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
20094788|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20094789|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094790|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20094791|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094792|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20094793|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20094794|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20094795|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
20094796|NCT00002461|Carmustine|carmustine|mesh-list
20094797|NCT00002461|Etoposide|etoposide|mesh-list
19504188|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19504189|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504190|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504191|NCT03069027|Lidocaine|lidocaine|mesh-list
19504192|NCT03069027|Epinephrine|epinephrine|mesh-list
20094798|NCT00002461|Sargramostim|sargramostim|mesh-list
20094799|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094800|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
20094801|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094802|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20094803|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20094804|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
20094805|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094806|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094807|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20094808|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20094809|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20094810|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20094811|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094812|NCT00002462|Cobalt|cobalt|mesh-list
20094813|NCT00002462|Prednisone|prednisone|mesh-list
20094814|NCT00002462|Doxorubicin|doxorubicin|mesh-list
20094815|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20094816|NCT00002462|Bleomycin|bleomycin|mesh-list
20094817|NCT00002462|Vincristine|vincristine|mesh-list
20094818|NCT00002462|Vinblastine|vinblastine|mesh-list
19504193|NCT03069027|Racepinephrine|racepinephrine|mesh-list
19504194|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
19504195|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504196|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
20094819|NCT00002462|Procarbazine|procarbazine|mesh-list
20094820|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
19504197|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504198|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504199|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
19504200|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504201|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19504202|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19504203|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19504204|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504205|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504206|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19504207|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19504208|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504209|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504210|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19504211|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19504212|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
19504213|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19504214|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
19504215|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
19504216|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
19504217|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19504218|NCT03069183|Ropivacaine|ropivacaine|mesh-list
19504219|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504220|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
19504221|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504222|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504223|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
19504224|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504225|NCT03069248|Interferons|interferons|mesh-list
19504226|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
19504227|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19504228|NCT03069248|Rituximab|rituximab|mesh-list
19504229|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504230|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504231|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
19504232|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504233|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504234|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
19504235|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504236|NCT03068975|Alvimopan|alvimopan|mesh-list
19504237|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19570907|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19570908|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19570909|NCT02988297|Analgesics|analgesics|mesh-ancestor
19570910|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
19570911|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19570912|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570913|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19570914|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570915|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19570916|NCT02967692|Trametinib|trametinib|mesh-list
19570917|NCT02967692|Dabrafenib|dabrafenib|mesh-list
19570918|NCT02967692|Spartalizumab|spartalizumab|mesh-list
19570919|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570920|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19570921|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570922|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570923|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19570924|NCT02955940|Capecitabine|capecitabine|mesh-list
19570925|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19570926|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
19570927|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570928|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570929|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
19570930|NCT02953340|Docetaxel|docetaxel|mesh-list
19570931|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570932|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
19570933|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570934|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19570935|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19570936|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
19570937|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570938|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570939|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19570940|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
20094821|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20094822|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094823|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20094824|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20094825|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094826|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094827|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20094828|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
20094829|NCT00002462|Hormones|hormones|mesh-ancestor
20094830|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20094831|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504238|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19504239|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504240|NCT03068936|Cisplatin|cisplatin|mesh-list
19504241|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504242|NCT03068832|Poly I-C|poly i-c|mesh-list
19504243|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19504244|NCT03068832|Poly ICLC|poly iclc|mesh-list
19504245|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
19504246|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
19504247|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504248|NCT03068832|Laxatives|laxatives|mesh-ancestor
19504249|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504250|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
19504251|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504252|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
19504253|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20094832|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20094833|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20094834|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
20094835|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
20094836|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
19504254|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504255|NCT03069144|Calcitriol|calcitriol|mesh-list
19504256|NCT03069144|Calcipotriene|calcipotriene|mesh-list
19504257|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
19504258|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20094837|NCT00002462|Trace Elements|trace elements|mesh-ancestor
20094838|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
20094839|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
20094840|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20094841|NCT00002463|Leucovorin|leucovorin|mesh-list
20094842|NCT00002463|Prednisone|prednisone|mesh-list
20094843|NCT00002463|Methotrexate|methotrexate|mesh-list
20094844|NCT00002463|Vincristine|vincristine|mesh-list
20094845|NCT00002463|Procarbazine|procarbazine|mesh-list
20094846|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
20094847|NCT00002463|Calcium|calcium|mesh-list
20094848|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
19504259|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504260|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19504261|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504262|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504263|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19504264|NCT03069144|Vitamins|vitamins|mesh-ancestor
19504265|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
19504266|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19504267|NCT03068650|Rindopepimut|rindopepimut|mesh-list
19504268|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504269|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504270|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
20094849|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20094850|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094851|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20094852|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
20094853|NCT00002463|Hormones|hormones|mesh-ancestor
20094854|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20094855|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20094856|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504271|NCT03068533|Calcium|calcium|mesh-list
20094857|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20094858|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
20094859|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504272|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19504273|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504274|NCT03068533|Antacids|antacids|mesh-ancestor
20094860|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094861|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
20094862|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094863|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
20094864|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094865|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20094866|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094867|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
20094868|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504275|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504276|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504277|NCT03068442|Flutemetamol|flutemetamol|mesh-list
19504278|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19504279|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094869|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094870|NCT00002463|Antidotes|antidotes|mesh-ancestor
20094871|NCT00002463|Protective Agents|protective agents|mesh-ancestor
20094872|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
20094873|NCT00002463|Vitamins|vitamins|mesh-ancestor
20094874|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
20094875|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20094876|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
20094877|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
20094878|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
19504280|NCT03068429|Sertraline|sertraline|mesh-list
19504281|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
19504282|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19504283|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19504284|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19504285|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20094879|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
20094880|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19504286|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504287|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504288|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
19504289|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504290|NCT03068351|Daratumumab|daratumumab|mesh-list
19504291|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094881|NCT00002465|Megestrol|megestrol|mesh-list
20094882|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
20094883|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20094884|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20094885|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19504292|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19504293|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19504294|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19504295|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504296|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504297|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504298|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504299|NCT03068247|Analgesics|analgesics|mesh-ancestor
19504300|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
19504301|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504302|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
19504303|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19504304|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
19504305|NCT03068065|Metformin|metformin|mesh-list
19504306|NCT03068065|Liraglutide|liraglutide|mesh-list
19504307|NCT03068065|Gliclazide|gliclazide|mesh-list
19504308|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19504309|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504310|NCT03068065|Incretins|incretins|mesh-ancestor
19504311|NCT03068065|Hormones|hormones|mesh-ancestor
19504312|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504313|NCT03068234|Pirfenidone|pirfenidone|mesh-list
19504314|NCT03068234|Analgesics|analgesics|mesh-ancestor
19504315|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
20094886|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
20094887|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20094888|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094889|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20094890|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20094891|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19504316|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094892|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504317|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504318|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19504319|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504320|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504321|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504322|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504323|NCT03068260|Acetaminophen|acetaminophen|mesh-list
19504324|NCT03068260|Ibuprofen|ibuprofen|mesh-list
19504325|NCT03068260|Morphine|morphine|mesh-list
19504326|NCT03068260|Ropivacaine|ropivacaine|mesh-list
19504327|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19504328|NCT03068260|Narcotics|narcotics|mesh-ancestor
19504329|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504330|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504331|NCT03068260|Analgesics|analgesics|mesh-ancestor
19504332|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
19504333|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504334|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504335|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
19504336|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504337|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
19504338|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19504339|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504340|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504341|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19504342|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504343|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504344|NCT03068208|Methylene Blue|methylene blue|mesh-list
19504345|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504346|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504347|NCT03067974|Ketamine|ketamine|mesh-list
19504348|NCT03067974|Analgesics|analgesics|mesh-ancestor
19504349|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
19504350|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504351|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504352|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19504353|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19504354|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
19504355|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
19504356|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504357|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19504358|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20094893|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
20094894|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20094895|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
19504359|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504360|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504361|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
20094896|NCT00002466|Ifosfamide|ifosfamide|mesh-list
20094897|NCT00002466|Doxorubicin|doxorubicin|mesh-list
20094898|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20094899|NCT00002466|Etoposide|etoposide|mesh-list
20094900|NCT00002466|Vincristine|vincristine|mesh-list
20094901|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094902|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
20094903|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094904|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20094905|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20094906|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
19504362|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504363|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504364|NCT03067883|Ritonavir|ritonavir|mesh-list
19504365|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19504366|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19504367|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
19504368|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094907|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094908|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094909|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20094910|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20094911|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20094912|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20094913|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094914|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19504369|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504370|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19504371|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19504372|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
19504373|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504374|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19504375|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19504376|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
19504377|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
19504378|NCT03067896|Bupivacaine|bupivacaine|mesh-list
19504379|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504380|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
19504381|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504382|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504383|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
19504384|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504385|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19504386|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504387|NCT03067896|Analgesics|analgesics|mesh-ancestor
19504388|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19504389|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19504390|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19504391|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504392|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504393|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504394|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19504395|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
19504396|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19504397|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504398|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19504399|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
19504400|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504401|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
19504402|NCT03067740|Bupivacaine|bupivacaine|mesh-list
19504403|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504404|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
19504405|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504406|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504407|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
19504408|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504409|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19504410|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504411|NCT03067740|Analgesics|analgesics|mesh-ancestor
19504412|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19504413|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19504414|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19504415|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504416|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504417|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504418|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
19504419|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
19504420|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504421|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
19504422|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504423|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504424|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
19504425|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19504426|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19504427|NCT03067753|Prednisolone|prednisolone|mesh-list
19504428|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
19504429|NCT03067753|Hormones|hormones|mesh-list
19504430|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19504431|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
19504432|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504433|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504434|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504435|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
19504436|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
19504437|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504438|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504439|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
19504440|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19504441|NCT03067753|Protective Agents|protective agents|mesh-ancestor
19504442|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19504443|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504444|NCT03067792|Leucovorin|leucovorin|mesh-list
19504445|NCT03067792|Docetaxel|docetaxel|mesh-list
19504446|NCT03067792|Fluorouracil|fluorouracil|mesh-list
19504447|NCT03067792|Irinotecan|irinotecan|mesh-list
19504448|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504449|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
19504450|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
19504451|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
19504452|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504453|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
19504454|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19504455|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19504456|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
19504457|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504458|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19504459|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19504460|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504461|NCT03067792|Antidotes|antidotes|mesh-ancestor
19504462|NCT03067792|Protective Agents|protective agents|mesh-ancestor
19504463|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
19504464|NCT03067792|Vitamins|vitamins|mesh-ancestor
19504465|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
19504466|NCT03067597|Dinoprostone|dinoprostone|mesh-list
19504467|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
19504468|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504469|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504470|NCT03067688|Amlodipine|amlodipine|mesh-list
19504471|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19504472|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19504473|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19504474|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19504475|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504476|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504477|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19504478|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504479|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
19504480|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19504481|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19504482|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
19504483|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19504484|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19504485|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504486|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19504487|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19504488|NCT03067727|Dinoprostone|dinoprostone|mesh-list
19504489|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
19504490|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504491|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504492|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
19504493|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504494|NCT03067103|Ketamine|ketamine|mesh-list
19504495|NCT03067103|Tramadol|tramadol|mesh-list
19504496|NCT03067103|Analgesics|analgesics|mesh-ancestor
19504497|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
19504498|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504499|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504500|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19504501|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19504502|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
19504503|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
19504504|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504505|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19504506|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19504507|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504508|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504509|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19504510|NCT03067103|Narcotics|narcotics|mesh-ancestor
19504511|NCT03067168|Bupivacaine|bupivacaine|mesh-list
19504512|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504513|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
19504514|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504515|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504516|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
19504517|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504518|NCT03067194|Celecoxib|celecoxib|mesh-list
19504519|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19504520|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504521|NCT03067194|Analgesics|analgesics|mesh-ancestor
19504522|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
19504523|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504524|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504525|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504526|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504527|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19504528|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19504529|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504530|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570941|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
19570942|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
19570943|NCT02891603|Sirolimus|sirolimus|mesh-list
19570944|NCT02891603|Tacrolimus|tacrolimus|mesh-list
19570945|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570946|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
19570947|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570948|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19570949|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570950|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570951|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570952|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570953|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19570954|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570955|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
19570956|NCT02874430|Metformin|metformin|mesh-list
19570957|NCT02874430|Doxycycline|doxycycline|mesh-list
19570958|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19570959|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570960|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19570961|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570962|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
19570963|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19570964|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19570965|NCT02870920|Durvalumab|durvalumab|mesh-list
20094915|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
20094916|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
20094917|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
20094918|NCT00002470|Interferons|interferons|mesh-list
20094919|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
20094920|NCT00002470|Fluorouracil|fluorouracil|mesh-list
20094921|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
19570966|NCT02870920|Tremelimumab|tremelimumab|mesh-list
19570967|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19570968|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570969|NCT02855944|Gemcitabine|gemcitabine|mesh-list
19570970|NCT02855944|Paclitaxel|paclitaxel|mesh-list
19570971|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19570972|NCT02855944|Cisplatin|cisplatin|mesh-list
19570973|NCT02855944|Carboplatin|carboplatin|mesh-list
19570974|NCT02855944|Rucaparib|rucaparib|mesh-list
19570975|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19570976|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19570977|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
19570978|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
19570979|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
19570980|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570981|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19570982|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
19570983|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
19570984|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19570985|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19570986|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19570987|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
19570988|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570989|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19570990|NCT02851407|Defibrotide|defibrotide|mesh-list
19570991|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19570992|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19570993|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19570994|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19570995|NCT02851290|Anesthetics|anesthetics|mesh-list
19570996|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19570997|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19570998|NCT02803203|Bevacizumab|bevacizumab|mesh-list
19570999|NCT02803203|Osimertinib|osimertinib|mesh-list
20094922|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504531|NCT03067051|Verteporfin|verteporfin|mesh-list
19504532|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19504533|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
19504534|NCT03067415|Latanoprost|latanoprost|mesh-list
19504535|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19504536|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19504537|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
19504538|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19504539|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19504540|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19504541|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504542|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504543|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
19504544|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504545|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504546|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19504547|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504548|NCT03066791|Curcumin|curcumin|mesh-list
19504549|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19504550|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504551|NCT03066791|Analgesics|analgesics|mesh-ancestor
19504552|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
19504553|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504554|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504555|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504556|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504557|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504558|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504559|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504560|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
19504561|NCT03066817|Vitamin D|vitamin d|mesh-list
19504562|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20094923|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094924|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094925|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094926|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
20094927|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504563|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504564|NCT03066817|Vitamins|vitamins|mesh-ancestor
19504565|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
19504566|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19504567|NCT03066661|Entrectinib|entrectinib|mesh-list
19504568|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20094928|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
20094929|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20094930|NCT00002471|Leucovorin|leucovorin|mesh-list
20094931|NCT00002471|Cytarabine|cytarabine|mesh-list
20094932|NCT00002471|Dexamethasone|dexamethasone|mesh-list
20094933|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
20094934|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
20094935|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20094936|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20094937|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20094938|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
20094939|NCT00002471|Thiotepa|thiotepa|mesh-list
20094940|NCT00002471|Methotrexate|methotrexate|mesh-list
20094941|NCT00002471|Etoposide|etoposide|mesh-list
20094942|NCT00002471|Vincristine|vincristine|mesh-list
20094943|NCT00002471|Daunorubicin|daunorubicin|mesh-list
20094944|NCT00002471|Asparaginase|asparaginase|mesh-list
20094945|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
20094946|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094947|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
20094948|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20094949|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20094950|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20094951|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
19504569|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504570|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504571|NCT03066700|Hemostatics|hemostatics|mesh-list
19504572|NCT03066700|Coagulants|coagulants|mesh-ancestor
20094952|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504573|NCT03066557|Apatinib|apatinib|mesh-list
19504574|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
20094953|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094954|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20094955|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20094956|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
20094957|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
20094958|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094959|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20094960|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
20094961|NCT00002471|Hormones|hormones|mesh-ancestor
20094962|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20094963|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20094964|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20094965|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
20094966|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20094967|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094968|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
20094969|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
20094970|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094971|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20094972|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20094973|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20094974|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20094975|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20094976|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
20094977|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504575|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504576|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19504577|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504578|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504579|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19504580|NCT03066557|Estrogens|estrogens|mesh-ancestor
19504581|NCT03066557|Hormones|hormones|mesh-ancestor
19504582|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504583|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504584|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19504585|NCT03066544|Dexamethasone|dexamethasone|mesh-list
19504586|NCT03066544|Ketorolac|ketorolac|mesh-list
19504587|NCT03066544|Naratriptan|naratriptan|mesh-list
19504588|NCT03066544|Bupivacaine|bupivacaine|mesh-list
19504589|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504590|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
19504591|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
19504592|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504593|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504594|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504595|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
19504596|NCT03066544|Hormones|hormones|mesh-ancestor
19504597|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504598|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19504599|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504600|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504601|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
19504602|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504603|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
19504604|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19504605|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504606|NCT03066544|Analgesics|analgesics|mesh-ancestor
19504607|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504608|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19504609|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504610|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504611|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19504612|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19504613|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19504614|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
19504615|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504616|NCT03066466|Methotrexate|methotrexate|mesh-list
19504617|NCT03066466|Atorvastatin|atorvastatin|mesh-list
19504618|NCT03066466|Tacrolimus|tacrolimus|mesh-list
19504619|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19504620|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
19504621|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504622|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504623|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20094978|NCT00002471|Antidotes|antidotes|mesh-ancestor
19504624|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
19504625|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504626|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504627|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
19504628|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504629|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19504630|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19504631|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
19504632|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504633|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19504634|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20094979|NCT00002471|Protective Agents|protective agents|mesh-ancestor
20094980|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
19504635|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19504636|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19504637|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19504638|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19504639|NCT03066518|Melatonin|melatonin|mesh-list
19504640|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
19504641|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504642|NCT03066518|Protective Agents|protective agents|mesh-ancestor
19504643|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504644|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504645|NCT03066427|Sunitinib|sunitinib|mesh-list
19504646|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504647|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19504648|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19504649|NCT03066427|Growth Substances|growth substances|mesh-ancestor
19504650|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504651|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
19504652|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19504653|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504654|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504655|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
19504656|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
19504657|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
19504658|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504659|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
19504660|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504661|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504662|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
19504663|NCT03066115|Ketorolac|ketorolac|mesh-list
19504664|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19504665|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504666|NCT03066115|Analgesics|analgesics|mesh-ancestor
19504667|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
19504668|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20094981|NCT00002471|Vitamins|vitamins|mesh-ancestor
20094982|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
20094983|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
20094984|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
20094985|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
20094986|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20094987|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20094988|NCT00002472|Etoposide|etoposide|mesh-list
20094989|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20094990|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20094991|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19504669|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504670|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504671|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504672|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19504673|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504674|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504675|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
20094992|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20094993|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20094994|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20094995|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
20094996|NCT00002474|Carboplatin|carboplatin|mesh-list
20094997|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
19504676|NCT03066115|Protective Agents|protective agents|mesh-ancestor
19504677|NCT03066115|Vitamins|vitamins|mesh-ancestor
19504678|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
19504679|NCT03066154|Ritonavir|ritonavir|mesh-list
19504680|NCT03066154|Docetaxel|docetaxel|mesh-list
19504681|NCT03066154|Androgens|androgens|mesh-list
20094998|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20094999|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
19504682|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504683|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
19504684|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
19504685|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
19504686|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504687|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19504688|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20095000|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095001|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095002|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095003|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
20095004|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095005|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504689|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
19504690|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504691|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19504692|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19504693|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
19504694|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504695|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19504696|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19504697|NCT03066154|Hormones|hormones|mesh-ancestor
19504698|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504699|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504700|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
19504701|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504702|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504703|NCT03065868|Clarithromycin|clarithromycin|mesh-list
19504704|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19504705|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504706|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19504707|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504708|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504709|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19504710|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19504711|NCT03066011|Voriconazole|voriconazole|mesh-list
19504712|NCT03066011|Posaconazole|posaconazole|mesh-list
19504713|NCT03066011|Isavuconazole|isavuconazole|mesh-list
19504714|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
19504715|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504716|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19504717|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19504718|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504719|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504720|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19504721|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
19504722|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504723|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504724|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19504725|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19504726|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19504727|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19504728|NCT03065998|Baclofen|baclofen|mesh-list
19504729|NCT03065998|Opipramol|opipramol|mesh-list
19504730|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19504731|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504732|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19504733|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504734|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19504735|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
19504736|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
19504737|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504738|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504739|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19504740|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
19504741|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19504742|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19504743|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19504744|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19504745|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
19571000|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504746|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
19504747|NCT03065816|Antacids|antacids|mesh-ancestor
19504748|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095006|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095007|NCT00002474|Analgesics|analgesics|mesh-ancestor
20095008|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
20095009|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095010|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095011|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095012|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504749|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504750|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
19504751|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504752|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571001|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571002|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19571003|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19571004|NCT02803203|Growth Substances|growth substances|mesh-ancestor
19571005|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571006|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
19571007|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571008|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571009|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571010|NCT02780024|Metformin|metformin|mesh-list
19571011|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19571012|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571013|NCT02737436|Oxytocin|oxytocin|mesh-list
19571014|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
19571015|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571016|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571017|NCT02727998|Midazolam|midazolam|mesh-list
19571018|NCT02727998|Ketamine|ketamine|mesh-list
19571019|NCT02727998|Analgesics|analgesics|mesh-ancestor
19571020|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
19571021|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571022|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571023|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19571024|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19571025|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
19571026|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
19571027|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571028|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19571029|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19571030|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571031|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571032|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19571033|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19571034|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19571035|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19571036|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19571037|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
19571038|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
19571039|NCT02715609|Copper|copper|mesh-list
19571040|NCT02715609|Temozolomide|temozolomide|mesh-list
19571041|NCT02715609|Disulfiram|disulfiram|mesh-list
20603215|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603216|NCT02219906|Protective Agents|protective agents|mesh-ancestor
19571042|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571043|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
19571044|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571045|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095013|NCT00002475|Interferons|interferons|mesh-list
20095014|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
20095015|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
19571046|NCT02715609|Trace Elements|trace elements|mesh-ancestor
19571047|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
19571048|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571049|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19571050|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19571051|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571052|NCT02713997|Etanercept|etanercept|mesh-list
19571053|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19571054|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
20095016|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
20095017|NCT00002475|Vaccines|vaccines|mesh-list
20095018|NCT00002475|Sargramostim|sargramostim|mesh-list
19504753|NCT03065504|Turmeric extract|turmeric extract|mesh-list
19504754|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
19504755|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504756|NCT03065504|Protective Agents|protective agents|mesh-ancestor
19504757|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504758|NCT03065387|Everolimus|everolimus|mesh-list
19504759|NCT03065387|Palbociclib|palbociclib|mesh-list
19504760|NCT03065387|Trametinib|trametinib|mesh-list
20095019|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
20095020|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095021|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095022|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095023|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095024|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
20095025|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095026|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095027|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095028|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
19504761|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504762|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19504763|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
19504764|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504765|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19504766|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504767|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504768|NCT03065569|Bupivacaine|bupivacaine|mesh-list
19504769|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504770|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
19504771|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504772|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504773|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
19504774|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504775|NCT03065660|Mifepristone|mifepristone|mesh-list
19504776|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19504777|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
19504778|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504779|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504780|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19504781|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19504782|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19504783|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
19504784|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19504785|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19504786|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
19504787|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504788|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
19504789|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19504790|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19504791|NCT03065621|Palbociclib|palbociclib|mesh-list
19504792|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504793|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19504794|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504795|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504796|NCT03065309|Remifentanil|remifentanil|mesh-list
19504797|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19504798|NCT03065309|Narcotics|narcotics|mesh-ancestor
19504799|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504800|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504801|NCT03065309|Analgesics|analgesics|mesh-ancestor
19504802|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
19504803|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504804|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19504805|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19504806|NCT03064906|Pancrelipase|pancrelipase|mesh-list
19504807|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504808|NCT03064633|Dexamethasone|dexamethasone|mesh-list
19504809|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
19504810|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
19504811|NCT03064633|Bupivacaine|bupivacaine|mesh-list
19504812|NCT03064633|BB 1101|bb 1101|mesh-list
19504813|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748908|NCT05364489|Bevacizumab|bevacizumab|mesh-list
19504814|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
19504815|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
19504816|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19748909|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
19504817|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504818|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504819|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
19504820|NCT03064633|Hormones|hormones|mesh-ancestor
19504821|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504822|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19504823|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504824|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
19504825|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504826|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504827|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504828|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
19504829|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504830|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
19504831|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19504832|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504833|NCT03064633|Analgesics|analgesics|mesh-ancestor
19504834|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19504835|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19504836|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19504837|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504838|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504839|NCT03064542|Carbimazole|carbimazole|mesh-list
19504840|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
19504841|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
19504842|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19504843|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504844|NCT03064568|Misoprostol|misoprostol|mesh-list
19504845|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19504846|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
19504847|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504848|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504849|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19504850|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19504851|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
19504852|NCT03064282|Papaverine|papaverine|mesh-list
19504853|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19504854|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504855|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504856|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
19504857|NCT03064282|Urological Agents|urological agents|mesh-ancestor
19504858|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
19504859|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
19504860|NCT03064191|Calcium|calcium|mesh-list
19504861|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19504862|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504863|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19504864|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19504865|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504866|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
19504867|NCT03064165|Epinephrine|epinephrine|mesh-list
19504868|NCT03064165|Bupivacaine|bupivacaine|mesh-list
19504869|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
19504870|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
19504871|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504872|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504873|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
19504874|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504875|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19504876|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19504877|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
19504878|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504879|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504880|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19504881|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19504882|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
19504883|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19504884|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
19504885|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
19504886|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
19504887|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19504888|NCT03064295|Adenosine|adenosine|mesh-list
19504889|NCT03064295|Regadenoson|regadenoson|mesh-list
19504890|NCT03064295|Analgesics|analgesics|mesh-ancestor
19504891|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
20095029|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095030|NCT00002476|Leucovorin|leucovorin|mesh-list
20095031|NCT00002476|Cobalt|cobalt|mesh-list
20095032|NCT00002476|Fluorouracil|fluorouracil|mesh-list
19504892|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504893|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504894|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19504895|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
19504896|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19504897|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
19504898|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
19504899|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19504900|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504901|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19504902|NCT03064243|Apatinib|apatinib|mesh-list
19504903|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504904|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19504905|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504906|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504907|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
19504908|NCT03063983|Methotrexate|methotrexate|mesh-list
19504909|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19504910|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
19504911|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504912|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504913|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19504914|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
19504915|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504916|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504917|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19504918|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19504919|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
19504920|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19504921|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19504922|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
19504923|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
19504924|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504925|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19504926|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19504927|NCT03064035|Thrombin|thrombin|mesh-list
19504928|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
19504929|NCT03064035|Coagulants|coagulants|mesh-ancestor
19571055|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19571056|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19571057|NCT02713997|Analgesics|analgesics|mesh-ancestor
19571058|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
19571059|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571060|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571061|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19571062|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571063|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19571064|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571065|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
19571066|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19571067|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19571068|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
19571069|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095033|NCT00002476|Methotrexate|methotrexate|mesh-list
20095034|NCT00002476|Vincristine|vincristine|mesh-list
19571070|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571071|NCT02684058|Carboplatin|carboplatin|mesh-list
19571072|NCT02684058|Vincristine|vincristine|mesh-list
19571073|NCT02684058|Trametinib|trametinib|mesh-list
19571074|NCT02684058|Dabrafenib|dabrafenib|mesh-list
19571075|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571076|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571077|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571078|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571079|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571080|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571081|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571082|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095035|NCT00002476|Bleomycin|bleomycin|mesh-list
20095036|NCT00002476|Calcium|calcium|mesh-list
19571083|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
20095037|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
20120377|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504930|NCT03063762|Bevacizumab|bevacizumab|mesh-list
19504931|NCT03063762|Atezolizumab|atezolizumab|mesh-list
19504932|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19504933|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504934|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19504935|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19504936|NCT03063762|Growth Substances|growth substances|mesh-ancestor
19504937|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504938|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
19504939|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
19504940|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19504941|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19504942|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504943|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
19504944|NCT03063892|Coagulants|coagulants|mesh-ancestor
19504945|NCT03063905|Buprenorphine|buprenorphine|mesh-list
19504946|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20095038|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20095039|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095040|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
20095041|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095042|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095043|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095044|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19504947|NCT03063905|Narcotics|narcotics|mesh-ancestor
19504948|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19504949|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504950|NCT03063905|Analgesics|analgesics|mesh-ancestor
19504951|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
19504952|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504953|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19504954|NCT03063710|Olaparib|olaparib|mesh-list
19504955|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19504956|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504957|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504958|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19504959|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
19504960|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
19504961|NCT03063775|Coagulants|coagulants|mesh-ancestor
19504962|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
19504963|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
19504964|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504965|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19504966|NCT03063580|Rifampin|rifampin|mesh-list
19504967|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19504968|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
19504969|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19504970|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19504971|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
19504972|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19504973|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504974|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504975|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19504976|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20095045|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
20095046|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19504977|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19504978|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19504979|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19504980|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19504981|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19504982|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19504983|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504984|NCT03063541|Aspirin|aspirin|mesh-list
19504985|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19504986|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19504987|NCT03063541|Analgesics|analgesics|mesh-ancestor
19504988|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
19504989|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19504990|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19504991|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19504992|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19504993|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19504994|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19504995|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19504996|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19504997|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19504998|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19504999|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
19505000|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
19505001|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19505002|NCT03063723|Ledipasvir|ledipasvir|mesh-list
19505003|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
20095047|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095048|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095049|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095050|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505004|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505005|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
19505006|NCT03063671|Ketamine|ketamine|mesh-list
19505007|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19505008|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505009|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505010|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505011|NCT03063671|Analgesics|analgesics|mesh-ancestor
19505012|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
19505013|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505014|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19505015|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19505016|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19505017|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505018|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505019|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505020|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19505021|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19505022|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
19505023|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
19505024|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19505025|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19505026|NCT03063632|Interferons|interferons|mesh-list
19505027|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
19505028|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
19505029|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19505030|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505031|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
19505032|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505033|NCT03063788|Copper|copper|mesh-list
19505034|NCT03063788|Trace Elements|trace elements|mesh-ancestor
19505035|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
19505036|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505037|NCT03063658|Acetaminophen|acetaminophen|mesh-list
19505038|NCT03063658|Ibuprofen|ibuprofen|mesh-list
19505039|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19505040|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505041|NCT03063658|Analgesics|analgesics|mesh-ancestor
19505042|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
19505043|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505044|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505045|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505046|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505047|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19505048|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505049|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505050|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
19505051|NCT03063619|Tamoxifen|tamoxifen|mesh-list
19505052|NCT03063619|Afimoxifene|afimoxifene|mesh-list
19505053|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19505054|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
19505055|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505056|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095051|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095052|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095053|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095054|NCT00002476|Antidotes|antidotes|mesh-ancestor
20095055|NCT00002476|Protective Agents|protective agents|mesh-ancestor
19505057|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095056|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
19505058|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505059|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19505060|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19505061|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19505062|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19505063|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19505064|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19505065|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505066|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505067|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19505068|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19505069|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505070|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505071|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20095057|NCT00002476|Vitamins|vitamins|mesh-ancestor
20095058|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
20095059|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095060|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095061|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095062|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095063|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095064|NCT00002476|Trace Elements|trace elements|mesh-ancestor
20095065|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
20095066|NCT00002477|Carboplatin|carboplatin|mesh-list
20095067|NCT00002477|Doxorubicin|doxorubicin|mesh-list
20095068|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095069|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505072|NCT03063866|Fentanyl|fentanyl|mesh-list
19505073|NCT03063866|Midazolam|midazolam|mesh-list
19505074|NCT03063866|Propofol|propofol|mesh-list
19505075|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19505076|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505077|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505078|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19505079|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
19505080|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
19505081|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19505082|NCT03063866|Narcotics|narcotics|mesh-ancestor
19505083|NCT03063866|Analgesics|analgesics|mesh-ancestor
19505084|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
19505085|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505086|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19505087|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19505088|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19505089|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19505090|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
19505091|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
19505092|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505093|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505094|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19505095|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19505096|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095070|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
20095071|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095072|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095073|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095074|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
20095075|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095076|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505097|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505098|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505099|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505100|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505101|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19505102|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19505103|NCT03063307|Fluorides|fluorides|mesh-list
19505104|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
19505105|NCT03063307|Protective Agents|protective agents|mesh-ancestor
19505106|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505107|NCT03063359|Fentanyl|fentanyl|mesh-list
19505108|NCT03063359|Morphine|morphine|mesh-list
19505109|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19505110|NCT03063359|Narcotics|narcotics|mesh-ancestor
19505111|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505112|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505113|NCT03063359|Analgesics|analgesics|mesh-ancestor
20095077|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095078|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095079|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095080|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095081|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095082|NCT00002478|Etoposide|etoposide|mesh-list
20095083|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095084|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095085|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095086|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095087|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095088|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095089|NCT00002481|Cytarabine|cytarabine|mesh-list
20095090|NCT00002481|Dexamethasone|dexamethasone|mesh-list
20095091|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
20095092|NCT00002481|Etoposide|etoposide|mesh-list
20095093|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095094|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
20095095|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095096|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505114|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
19505115|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505116|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19505117|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19505118|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
19505119|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
19505120|NCT03063190|Vitamin D|vitamin d|mesh-list
19505121|NCT03063190|Vitamins|vitamins|mesh-ancestor
19505122|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
19505123|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505124|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19505125|NCT03063242|Sargramostim|sargramostim|mesh-list
19505126|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
19505127|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505128|NCT03062943|Nintedanib|nintedanib|mesh-list
19505129|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505130|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19505131|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505132|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505133|NCT03062839|Melatonin|melatonin|mesh-list
19505134|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
19505135|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505136|NCT03062839|Protective Agents|protective agents|mesh-ancestor
19505137|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505138|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505139|NCT03062800|Thalidomide|thalidomide|mesh-list
19505140|NCT03062800|Carboplatin|carboplatin|mesh-list
19505141|NCT03062800|Pemetrexed|pemetrexed|mesh-list
19505142|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505143|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505144|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505145|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19505146|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505147|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505148|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
19505149|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505150|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
19505151|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19505152|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505153|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19505154|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19505155|NCT03062800|Growth Substances|growth substances|mesh-ancestor
19505156|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19505157|NCT03062813|Entecavir|entecavir|mesh-list
19505158|NCT03062813|Tacrolimus|tacrolimus|mesh-list
19505159|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505160|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
19505161|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505162|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19505163|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505164|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505165|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
20095097|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095098|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
19505166|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505167|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
19505168|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
19505169|NCT03062904|Miotics|miotics|mesh-ancestor
19505170|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
19505171|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505172|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505173|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19505174|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19505175|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
19505176|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19505177|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19505178|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505179|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505180|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505181|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19505182|NCT03062787|Triamcinolone|triamcinolone|mesh-list
19505183|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19505184|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19505185|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
19505186|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19505187|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505188|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
19505189|NCT03062787|Hormones|hormones|mesh-ancestor
19505190|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505191|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505192|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505193|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
19505194|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505195|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505196|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19505197|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
19505198|NCT03062787|Protective Agents|protective agents|mesh-ancestor
19505199|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
19505200|NCT03063073|Bupivacaine|bupivacaine|mesh-list
19505201|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
19505202|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
19505203|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505204|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505205|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
19505206|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505207|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19505208|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505209|NCT03063073|Analgesics|analgesics|mesh-ancestor
19505210|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19505211|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19505212|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19505213|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505214|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505215|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505216|NCT03063112|Ethanol|ethanol|mesh-list
19505217|NCT03063112|Lidocaine|lidocaine|mesh-list
19505218|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
19505219|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
19505220|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505221|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505222|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
19505223|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505224|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20095099|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095100|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095101|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095102|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095103|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
20095104|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
20095105|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095106|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095107|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
19505225|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19505226|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19505227|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19505228|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505229|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19505230|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505231|NCT03063060|Vitamin D|vitamin d|mesh-list
19505232|NCT03063060|Calcium|calcium|mesh-list
19505233|NCT03063060|Vitamins|vitamins|mesh-ancestor
19505234|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
19505235|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505236|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19505237|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19505238|NCT03062644|Celecoxib|celecoxib|mesh-list
19505239|NCT03062644|Tramadol|tramadol|mesh-list
19505240|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19505241|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505242|NCT03062644|Analgesics|analgesics|mesh-ancestor
19505243|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
19505244|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603217|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603218|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603219|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20603220|NCT02219984|Anticoagulants|anticoagulants|mesh-list
20607891|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607892|NCT02244073|Insulin|insulin|mesh-list
20607893|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20607894|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20607895|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607896|NCT02244086|Bupivacaine|bupivacaine|mesh-list
19505245|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505246|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095108|NCT00002481|Hormones|hormones|mesh-ancestor
20095109|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095110|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19505247|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505248|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19505249|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19505250|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505251|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505252|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19505253|NCT03062644|Narcotics|narcotics|mesh-ancestor
19505254|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505255|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
19505256|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
19505257|NCT03062436|Protective Agents|protective agents|mesh-ancestor
19505258|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505259|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
19505260|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
19505261|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505262|NCT03062631|Amifampridine|amifampridine|mesh-list
19505263|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19505264|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505265|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505266|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19505267|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19505268|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505269|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
19505270|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505271|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
19505272|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505273|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505274|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505275|NCT03062462|Clopidogrel|clopidogrel|mesh-list
19505276|NCT03062462|Ticagrelor|ticagrelor|mesh-list
19505277|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19505278|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19505279|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19505280|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19505281|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
19505282|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505283|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505284|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505285|NCT03062319|Anticoagulants|anticoagulants|mesh-list
19505286|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19571084|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19571085|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571086|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
19571087|NCT02643420|Docetaxel|docetaxel|mesh-list
19571088|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571089|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
19571090|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607897|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
20607898|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
20603221|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
19505287|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19505288|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505289|NCT03061955|Vaccines|vaccines|mesh-list
19505290|NCT03061955|Immunologic Factors|immunologic factors|mesh-ancestor
19505291|NCT03061955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505292|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
19505293|NCT03061838|Rituximab|rituximab|mesh-list
19505294|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19505295|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505296|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
19505297|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505298|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505299|NCT03061981|Metformin|metformin|mesh-list
19505300|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19505301|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505302|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19505303|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505304|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
19505305|NCT03062163|Resveratrol|resveratrol|mesh-list
19505306|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
19505307|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505308|NCT03062163|Protective Agents|protective agents|mesh-ancestor
19505309|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505310|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505311|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19505312|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
19505313|NCT03062163|Vitamins|vitamins|mesh-ancestor
19505314|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
19505315|NCT03061734|Acetaminophen|acetaminophen|mesh-list
19505316|NCT03061734|Naltrexone|naltrexone|mesh-list
19505317|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505318|NCT03061734|Analgesics|analgesics|mesh-ancestor
19505319|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
19505320|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505321|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505322|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
19505323|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19505324|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19505325|NCT03062150|Cycloserine|cycloserine|mesh-list
19505326|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
19505327|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19505328|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505329|NCT03062150|Renal Agents|renal agents|mesh-ancestor
19505330|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19505331|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
19505332|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19505333|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
19505334|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505335|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505336|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
19505337|NCT03061656|Melphalan|melphalan|mesh-list
19505338|NCT03061656|Thiotepa|thiotepa|mesh-list
19505339|NCT03061656|Carboplatin|carboplatin|mesh-list
19505340|NCT03061656|Etoposide|etoposide|mesh-list
19505341|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505342|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
19505343|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505344|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505345|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19505346|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
19505347|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505348|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505349|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19505350|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19505351|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19505352|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19505353|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505354|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
19505355|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19505356|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19505357|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505358|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
19505359|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
19505360|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19505361|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
19505362|NCT03061604|Octreotide|octreotide|mesh-list
19505363|NCT03061604|Hemostatics|hemostatics|mesh-list
19505364|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505365|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19505366|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19505367|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505368|NCT03061604|Coagulants|coagulants|mesh-ancestor
19505369|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
19505370|NCT03061565|Hematinics|hematinics|mesh-ancestor
19505371|NCT03061253|Nicotine|nicotine|mesh-list
19505372|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19505373|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
19505374|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505375|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505376|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19505377|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19505378|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505379|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505380|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505381|NCT03061058|Docetaxel|docetaxel|mesh-list
19505382|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
19505383|NCT03061058|Irinotecan|irinotecan|mesh-list
19505384|NCT03061058|Pemetrexed|pemetrexed|mesh-list
19505385|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505386|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
19505387|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
19505388|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
19505389|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505390|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19505391|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095111|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095112|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095113|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095114|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095115|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095116|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
20095117|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
20095118|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095119|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
20095120|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
20095121|NCT00002482|Antibodies|antibodies|mesh-list
20095122|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095123|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
20095124|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095125|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095126|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095127|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
20095128|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095129|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095130|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095131|NCT00002487|Methotrexate|methotrexate|mesh-list
19505392|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505393|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19505394|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505395|NCT03061006|Warfarin|warfarin|mesh-list
19505396|NCT03061006|Dabigatran|dabigatran|mesh-list
19505397|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
19505398|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
19505399|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19505400|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
19505401|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505402|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505403|NCT03061227|Glucagon|glucagon|mesh-list
19505404|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19505405|NCT03061227|Hormones|hormones|mesh-ancestor
20095132|NCT00002487|Dipyridamole|dipyridamole|mesh-list
20095133|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19505406|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571091|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505407|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505408|NCT03061136|Clonazepam|clonazepam|mesh-list
19505409|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
19505410|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
19505411|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
19505412|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505413|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505414|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505415|NCT03061032|Ribavirin|ribavirin|mesh-list
19505416|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
19505417|NCT03061032|Ledipasvir|ledipasvir|mesh-list
19505418|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
19505419|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505420|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
19505421|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505422|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
19505423|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19505424|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19505425|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505426|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
19505427|NCT03060889|Coagulants|coagulants|mesh-ancestor
19505428|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
19505429|NCT03060603|Hematinics|hematinics|mesh-ancestor
19505430|NCT03060707|Bromides|bromides|mesh-list
19505431|NCT03060707|Rocuronium|rocuronium|mesh-list
19505432|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
19505433|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19505434|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19505435|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19505436|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505437|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505438|NCT03060681|Bupivacaine|bupivacaine|mesh-list
19505439|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
19505440|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
19505441|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505442|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505443|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
19505444|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505445|NCT03060850|Abivertinib|abivertinib|mesh-list
19505446|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19505447|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505448|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505449|NCT03060798|Desflurane|desflurane|mesh-list
19505450|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19505451|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
19505452|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
19505453|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505454|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505455|NCT03060785|Tenofovir|tenofovir|mesh-list
19505456|NCT03060785|Emtricitabine|emtricitabine|mesh-list
19505457|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
19505458|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505459|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19505460|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505461|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505462|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505463|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19505464|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19571092|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571093|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
19571094|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571095|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095134|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095135|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095136|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095137|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571096|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571097|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571098|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571099|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571100|NCT02643303|Durvalumab|durvalumab|mesh-list
19571101|NCT02643303|Tremelimumab|tremelimumab|mesh-list
20095138|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
19571102|NCT02643303|Poly ICLC|poly iclc|mesh-list
19571103|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748910|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19505465|NCT03060278|Nicotine|nicotine|mesh-list
19505466|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19505467|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
19505468|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505469|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505470|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19505471|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19505472|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505473|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505474|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505475|NCT03060304|Tamoxifen|tamoxifen|mesh-list
19505476|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19505477|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19505478|NCT03060304|Estradiol|estradiol|mesh-list
19505479|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19505480|NCT03060304|Estrogens|estrogens|mesh-ancestor
19505481|NCT03060304|Hormones|hormones|mesh-ancestor
19505482|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505483|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505484|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19505485|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
19505486|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19505487|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19505488|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19505489|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
19505490|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19505491|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505492|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19505493|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19505494|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19505495|NCT03060265|Acetaminophen|acetaminophen|mesh-list
19505496|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505497|NCT03060265|Analgesics|analgesics|mesh-ancestor
19505498|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
19505499|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505500|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505501|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
19505502|NCT03060083|Nicotine|nicotine|mesh-list
19505503|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19505504|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
19505505|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505506|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505507|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19505508|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19505509|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505510|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505511|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505512|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
19505513|NCT03060070|Ketamine|ketamine|mesh-list
19505514|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19505515|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505516|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505517|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505518|NCT03060070|Analgesics|analgesics|mesh-ancestor
19505519|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
19505520|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505521|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19505522|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19505523|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19505524|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505525|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505526|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505527|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19505528|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19505529|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
19505530|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
19505531|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20095139|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095140|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095141|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095142|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095143|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095144|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095145|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
20095146|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095147|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505532|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19505533|NCT03059888|Abatacept|abatacept|mesh-list
19505534|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19505535|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505536|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095148|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20095149|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20095150|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
20095151|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
20095152|NCT00002488|Etoposide|etoposide|mesh-list
20095153|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095154|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
20095155|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095156|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095157|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095158|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
19505537|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505538|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
19505539|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505540|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505541|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
19505542|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
19505543|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505544|NCT03059849|Adalimumab|adalimumab|mesh-list
19505545|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505546|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505547|NCT03060018|Oxitropium|oxitropium|mesh-list
19505548|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
19505549|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
20095159|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095160|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095161|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095162|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095163|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095164|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095165|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095166|NCT00002489|Leucovorin|leucovorin|mesh-list
20095167|NCT00002489|Dactinomycin|dactinomycin|mesh-list
20095168|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
20095169|NCT00002489|Carboplatin|carboplatin|mesh-list
20095170|NCT00002489|Doxorubicin|doxorubicin|mesh-list
20095171|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095172|NCT00002489|Methotrexate|methotrexate|mesh-list
20095173|NCT00002489|Etoposide|etoposide|mesh-list
20095174|NCT00002489|Vincristine|vincristine|mesh-list
20095175|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
20095176|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095177|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
20095178|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095179|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095180|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095181|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
19505550|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505551|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505552|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
19505553|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19505554|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19505555|NCT03059979|Prednisolone|prednisolone|mesh-list
19505556|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
19505557|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19505558|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
19505559|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505560|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
19505561|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
19505562|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095182|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095183|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095184|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095185|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19505563|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505564|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19505565|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
19505566|NCT03059979|Hormones|hormones|mesh-ancestor
19571104|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095186|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095187|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095188|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095189|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20095190|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095191|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095192|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19505567|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505568|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19505569|NCT03059979|Protective Agents|protective agents|mesh-ancestor
19505570|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19505571|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505572|NCT03060044|Fluticasone|fluticasone|mesh-list
19505573|NCT03060044|Xhance|xhance|mesh-list
19505574|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19505575|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19505576|NCT03060044|Charcoal|charcoal|mesh-list
19505577|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505578|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19505579|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
19505580|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505581|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505582|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19505583|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
19505584|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
19505585|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19505586|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19505587|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19505588|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19505589|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505590|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505591|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505592|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
19505593|NCT03060044|Hormones|hormones|mesh-ancestor
19505594|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505595|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
19505596|NCT03060044|Antidotes|antidotes|mesh-ancestor
19505597|NCT03060044|Protective Agents|protective agents|mesh-ancestor
19505598|NCT03059719|Exenatide|exenatide|mesh-list
19505599|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19505600|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505601|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20095193|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
20095194|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095195|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095196|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095197|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095198|NCT00002489|Antidotes|antidotes|mesh-ancestor
19505602|NCT03059719|Incretins|incretins|mesh-ancestor
19505603|NCT03059719|Hormones|hormones|mesh-ancestor
19505604|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505605|NCT03059862|Tryptophan|tryptophan|mesh-list
19505606|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19505607|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
19505608|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19505609|NCT03060031|Oxytocin|oxytocin|mesh-list
19505610|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
19505611|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19505612|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505613|NCT03060005|Dextrans|dextrans|mesh-list
19505614|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
19505615|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
19505616|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
19505617|NCT03059940|Nicotine|nicotine|mesh-list
19505618|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
19505619|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19505620|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
19505621|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505622|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505623|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19505624|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19505625|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505626|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505627|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505628|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
19505629|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
19505630|NCT03059667|Carboplatin|carboplatin|mesh-list
19505631|NCT03059667|Etoposide|etoposide|mesh-list
19505632|NCT03059667|Atezolizumab|atezolizumab|mesh-list
19505633|NCT03059667|Topotecan|topotecan|mesh-list
19505634|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505635|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19505636|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19505637|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19505638|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505639|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505640|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19505641|NCT03059563|Varenicline|varenicline|mesh-list
19505642|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19505643|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19505644|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505645|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505646|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505647|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505648|NCT03059615|Doxorubicin|doxorubicin|mesh-list
19505649|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19505650|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505651|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19505652|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19505653|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505654|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505655|NCT03059277|Aflibercept|aflibercept|mesh-list
19505656|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19505657|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19505658|NCT03059277|Growth Substances|growth substances|mesh-ancestor
19505659|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505660|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
19505661|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505662|NCT03059316|Labetalol|labetalol|mesh-list
19505663|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
19505664|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
19505665|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19505666|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19505667|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505668|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505669|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505670|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505671|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19505672|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
19505673|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
19505674|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505675|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19505676|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20095199|NCT00002489|Protective Agents|protective agents|mesh-ancestor
19505677|NCT03059303|Simeprevir|simeprevir|mesh-list
19505678|NCT03059303|Odalasvir|odalasvir|mesh-list
19505679|NCT03059303|Omeprazole|omeprazole|mesh-list
19505680|NCT03059303|Lansoprazole|lansoprazole|mesh-list
19505681|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
19505682|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19505683|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19505684|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19505685|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505686|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505687|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
19505688|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505689|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
19505690|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19505691|NCT03059537|Cathartics|cathartics|mesh-ancestor
19505692|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19505693|NCT03059238|Celecoxib|celecoxib|mesh-list
19505694|NCT03059238|Parecoxib|parecoxib|mesh-list
19505695|NCT03059238|Oxycodone|oxycodone|mesh-list
19505696|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19505697|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505698|NCT03059238|Analgesics|analgesics|mesh-ancestor
19505699|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
19505700|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505701|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505702|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505703|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505704|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19505705|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19505706|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505707|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505708|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19505709|NCT03059238|Narcotics|narcotics|mesh-ancestor
19505710|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505711|NCT03059134|Mirabegron|mirabegron|mesh-list
19505712|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19505713|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19505714|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19505715|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505716|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505717|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505718|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505719|NCT03059134|Urological Agents|urological agents|mesh-ancestor
19505720|NCT03058939|Tamoxifen|tamoxifen|mesh-list
19505721|NCT03058939|Paclitaxel|paclitaxel|mesh-list
19505722|NCT03058939|Carboplatin|carboplatin|mesh-list
19505723|NCT03058939|Trastuzumab|trastuzumab|mesh-list
19505724|NCT03058939|Letrozole|letrozole|mesh-list
19505725|NCT03058939|Pertuzumab|pertuzumab|mesh-list
19505726|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19505727|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505728|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
19505729|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
19505730|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
19505731|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505732|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19505733|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19505734|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19505735|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505736|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19505737|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
19505738|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505739|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505740|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19505741|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19505742|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19505743|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19505744|NCT03058978|Etonogestrel|etonogestrel|mesh-list
19505745|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19505746|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
19505747|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19505748|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505749|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19505750|NCT03059004|TEMPO|tempo|mesh-list
19505751|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
19505752|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505753|NCT03059004|Protective Agents|protective agents|mesh-ancestor
19748911|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505754|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505755|NCT03058900|Methotrexate|methotrexate|mesh-list
19505756|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19505757|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
19505758|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19505759|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505760|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19505761|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
19505762|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505763|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505764|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
19505765|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505766|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19505767|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505768|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
19505769|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505770|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505771|NCT03058835|Tenofovir|tenofovir|mesh-list
19505772|NCT03058835|Emtricitabine|emtricitabine|mesh-list
19505773|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
19505774|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505775|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19505776|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505777|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505778|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505779|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19505780|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19505781|NCT03059017|Albuterol|albuterol|mesh-list
19505782|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19505783|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
19505784|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505785|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505786|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19505787|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
19505788|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
19505789|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19505790|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19505791|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19505792|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19505793|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505794|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505795|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571105|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
19571106|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
19571107|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571108|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
19571109|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19571110|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19571111|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571112|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
19571113|NCT02606045|Coagulants|coagulants|mesh-ancestor
19571114|NCT02601586|Oxycodone|oxycodone|mesh-list
19571115|NCT02601586|Levodopa|levodopa|mesh-list
19571116|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19571117|NCT02601586|Narcotics|narcotics|mesh-ancestor
19571118|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571119|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571120|NCT02601586|Analgesics|analgesics|mesh-ancestor
19571121|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
19571122|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571123|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19571124|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19571125|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
19571126|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571127|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571128|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
19571129|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
19571130|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571131|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571132|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571133|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571134|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571135|NCT02549209|Paclitaxel|paclitaxel|mesh-list
19571136|NCT02549209|Carboplatin|carboplatin|mesh-list
19571137|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
20095200|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
20095201|NCT00002489|Vitamins|vitamins|mesh-ancestor
19505796|NCT03058744|Clobetasol|clobetasol|mesh-list
19505797|NCT03058744|Halobetasol|halobetasol|mesh-list
19505798|NCT03058744|Tazarotene|tazarotene|mesh-list
19505799|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
19505800|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
19505801|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19505802|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505803|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
19505804|NCT03058744|Hormones|hormones|mesh-ancestor
19505805|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505806|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505807|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
20095202|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
20095203|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095204|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095205|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095206|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20095207|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095208|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20095209|NCT00002490|Mitomycins|mitomycins|mesh-list
20095210|NCT00002490|Mitomycin|mitomycin|mesh-list
20095211|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
20095212|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095213|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095214|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
20095215|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095216|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095217|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095218|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20095219|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
20095220|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095221|NCT00002492|Doxorubicin|doxorubicin|mesh-list
20095222|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095223|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095224|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095225|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095226|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095227|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095228|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095229|NCT00002493|Doxorubicin|doxorubicin|mesh-list
20095230|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095231|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095232|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095233|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095234|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095235|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095236|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095237|NCT00002494|Leucovorin|leucovorin|mesh-list
20095238|NCT00002494|Cobalt|cobalt|mesh-list
20095239|NCT00002494|Cytarabine|cytarabine|mesh-list
20095240|NCT00002494|Dexamethasone|dexamethasone|mesh-list
20095241|NCT00002494|Prednisone|prednisone|mesh-list
20095242|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
20095243|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20095244|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20095245|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20095246|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
20095247|NCT00002494|Ifosfamide|ifosfamide|mesh-list
20095248|NCT00002494|Doxorubicin|doxorubicin|mesh-list
20095249|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095250|NCT00002494|Methotrexate|methotrexate|mesh-list
20095251|NCT00002494|Etoposide|etoposide|mesh-list
20095252|NCT00002494|Vincristine|vincristine|mesh-list
20095253|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
20095254|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095255|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
20095256|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095257|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095258|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095259|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
20095260|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095261|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095262|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095263|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505808|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19505809|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505810|NCT03059056|Empagliflozin|empagliflozin|mesh-list
19505811|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19505812|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095264|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
20095265|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
20095266|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095267|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095268|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
20095269|NCT00002494|Hormones|hormones|mesh-ancestor
20095270|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095271|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095272|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19505813|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19505814|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505815|NCT03058666|Calfactant|calfactant|mesh-list
19505816|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19505817|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
19505818|NCT03058354|Propofol|propofol|mesh-list
19505819|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
19505820|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505821|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505822|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19505823|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19505824|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
19505825|NCT03058419|Midazolam|midazolam|mesh-list
19505826|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
19505827|NCT03058419|Caffeine|caffeine|mesh-list
19505828|NCT03058419|Bupropion|bupropion|mesh-list
19505829|NCT03058419|Omeprazole|omeprazole|mesh-list
19505830|NCT03058419|Warfarin|warfarin|mesh-list
19505831|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19505832|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19505833|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505834|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505835|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19505836|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19505837|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19505838|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19505839|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
19505840|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
19505841|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
19505842|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
19505843|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505844|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505845|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
19505846|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19505847|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19505848|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19505849|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505850|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19505851|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19505852|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19505853|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19505854|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
19505855|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19505856|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
19505857|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19505858|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20095273|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095274|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095275|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095276|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19505859|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19505860|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
19505861|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19505862|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19505863|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
19505864|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
19505865|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19505866|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19505867|NCT03058536|Progesterone|progesterone|mesh-list
19505868|NCT03058536|Progestins|progestins|mesh-ancestor
19505869|NCT03058536|Hormones|hormones|mesh-ancestor
19505870|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19505871|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505872|NCT03058341|Propofol|propofol|mesh-list
19505873|NCT03058341|Sevoflurane|sevoflurane|mesh-list
19505874|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19505875|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19505876|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505877|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19505878|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
19505879|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
20095277|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095278|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095279|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095280|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
19505880|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19505881|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19505882|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
19505883|NCT03058289|Ipilimumab|ipilimumab|mesh-list
19505884|NCT03058289|Antibodies|antibodies|mesh-list
19505885|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
19505886|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
19505887|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505888|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19505889|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505890|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19505891|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505892|NCT03058471|Methotrexate|methotrexate|mesh-list
19505893|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19505894|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
19505895|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19505896|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505897|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19505898|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
19505899|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505900|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505901|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
19505902|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505903|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19505904|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19505905|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
19505906|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505907|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505908|NCT03058263|Neostigmine|neostigmine|mesh-list
19505909|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19505910|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505911|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505912|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
19505913|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505914|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505915|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19505916|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
19505917|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505918|NCT03058224|Acetaminophen|acetaminophen|mesh-list
19505919|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505920|NCT03058224|Analgesics|analgesics|mesh-ancestor
20095281|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095282|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19505921|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
19505922|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505923|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505924|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
19505925|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
19505926|NCT03058237|Baclofen|baclofen|mesh-list
19505927|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19505928|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505929|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19505930|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505931|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19505932|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
19505933|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
20603222|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20603223|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
20603224|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603225|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603226|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20603227|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
19505934|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505935|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505936|NCT03058094|Pemetrexed|pemetrexed|mesh-list
19505937|NCT03058094|Abivertinib|abivertinib|mesh-list
20095283|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095284|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095285|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
20095286|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095287|NCT00002494|Antidotes|antidotes|mesh-ancestor
20095288|NCT00002494|Protective Agents|protective agents|mesh-ancestor
20095289|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
20095290|NCT00002494|Vitamins|vitamins|mesh-ancestor
20095291|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
20095292|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095293|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095294|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095295|NCT00002494|Trace Elements|trace elements|mesh-ancestor
20095296|NCT00002495|Doxorubicin|doxorubicin|mesh-list
20095297|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19505938|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505939|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505940|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505941|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19505942|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19505943|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19505944|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
19505945|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
19505946|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19505947|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19505948|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505949|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19505950|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505951|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095298|NCT00002495|Vinblastine|vinblastine|mesh-list
20095299|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19505952|NCT03057951|Empagliflozin|empagliflozin|mesh-list
19505953|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19505954|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505955|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19505956|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505957|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
19505958|NCT03057847|Velpatasvir|velpatasvir|mesh-list
19505959|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
19505960|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505961|NCT03057769|Indomethacin|indomethacin|mesh-list
19505962|NCT03057769|Epinephrine|epinephrine|mesh-list
19505963|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19505964|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19505965|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
19505966|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19505967|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19505968|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19505969|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19505970|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20095300|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095301|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095302|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095303|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095304|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095305|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095306|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
19505971|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
19505972|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19505973|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19505974|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
19505975|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
19505976|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
19505977|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19505978|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19505979|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19505980|NCT03057769|Analgesics|analgesics|mesh-ancestor
19505981|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
19505982|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19505983|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19505984|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
19505985|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
19505986|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19505987|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19505988|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19505989|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19505990|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19505991|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19505992|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
19505993|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19505994|NCT03057509|Octreotide|octreotide|mesh-list
19505995|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19505996|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095307|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095308|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095309|NCT00002496|Cobalt|cobalt|mesh-list
19505997|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19505998|NCT03057483|Vaccines|vaccines|mesh-list
19505999|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
19506000|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571138|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571139|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571140|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095310|NCT00002496|Fluorouracil|fluorouracil|mesh-list
20095311|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095312|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
20095313|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095314|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095315|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095316|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
20095317|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095318|NCT00002496|Trace Elements|trace elements|mesh-ancestor
20095319|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
20095320|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
20095321|NCT00002498|Fluorouracil|fluorouracil|mesh-list
20095322|NCT00002498|Methotrexate|methotrexate|mesh-list
20095323|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
20095324|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095325|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
20095326|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095327|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095328|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095329|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
20603228|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20603229|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
20603230|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571141|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571142|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571143|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571144|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571145|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
19571146|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19571147|NCT02549170|Antibodies|antibodies|mesh-list
19571148|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
19571149|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
19571150|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19748912|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19748913|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20095330|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506001|NCT03057470|Insulin|insulin|mesh-list
19506002|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19506003|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19506004|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506005|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
19506006|NCT03057314|Calcium|calcium|mesh-list
19506007|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19506008|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506009|NCT03057314|Antacids|antacids|mesh-ancestor
19506010|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506011|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506012|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19506013|NCT03057574|Hormones|hormones|mesh-ancestor
19506014|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506015|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506016|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19506017|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
19506018|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
19506019|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506020|NCT03057145|Olaparib|olaparib|mesh-list
19506021|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19506022|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506023|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506024|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506025|NCT03057041|Fentanyl|fentanyl|mesh-list
19506026|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19506027|NCT03057041|Narcotics|narcotics|mesh-ancestor
19506028|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506029|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506030|NCT03057041|Analgesics|analgesics|mesh-ancestor
19506031|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
19506032|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506033|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19506034|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506035|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
19506036|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
19506037|NCT03056846|Sulfalene|sulfalene|mesh-list
19506038|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506039|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19506040|NCT03056846|Renal Agents|renal agents|mesh-ancestor
19506041|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
19506042|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19506043|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19506044|NCT03057015|Dexamethasone|dexamethasone|mesh-list
19506045|NCT03057015|Clonidine|clonidine|mesh-list
19506046|NCT03057015|Epinephrine|epinephrine|mesh-list
19506047|NCT03057015|Ropivacaine|ropivacaine|mesh-list
19506048|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506049|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
19506050|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
19506051|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506052|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506053|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506054|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
19506055|NCT03057015|Hormones|hormones|mesh-ancestor
19506056|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506057|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19506058|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506059|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
19506060|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
19506061|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506062|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
19506063|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19506064|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19506065|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
19506066|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506067|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506068|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19506069|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19506070|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19506071|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
19506072|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
19506073|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
19506074|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19506075|NCT03057015|Analgesics|analgesics|mesh-ancestor
19506076|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19506077|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
19506078|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19506079|NCT03056924|Vaccines|vaccines|mesh-list
19506080|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
19506081|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506082|NCT03056833|Paclitaxel|paclitaxel|mesh-list
19506083|NCT03056833|Carboplatin|carboplatin|mesh-list
19506084|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19506085|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506086|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
19506087|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
19506088|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
19506089|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506090|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19506091|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19506092|NCT03056495|Vorinostat|vorinostat|mesh-list
19506093|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506094|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19506095|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506096|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506097|NCT03056625|Vitamin A|vitamin a|mesh-list
19506098|NCT03056625|Vitamins|vitamins|mesh-ancestor
19506099|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
19506100|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506101|NCT03056703|Aspirin|aspirin|mesh-list
20095331|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095332|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095333|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
20095334|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095335|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20095336|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095337|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095338|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095339|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095340|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095341|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095342|NCT00002498|Analgesics|analgesics|mesh-ancestor
20095343|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
20095344|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095345|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095346|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095347|NCT00002499|Cytarabine|cytarabine|mesh-list
20095348|NCT00002499|Dexamethasone|dexamethasone|mesh-list
20095349|NCT00002499|Prednisone|prednisone|mesh-list
20095350|NCT00002499|Methotrexate|methotrexate|mesh-list
19506102|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19506103|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19506104|NCT03056703|Analgesics|analgesics|mesh-ancestor
19506105|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
19506106|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506107|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506108|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506109|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19506110|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19506111|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19506112|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506113|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19506114|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19506115|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506116|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
19506117|NCT03056482|Haloperidol|haloperidol|mesh-list
19506118|NCT03056482|Ondansetron|ondansetron|mesh-list
19506119|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
19506120|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
19506121|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
19506122|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506123|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506124|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506125|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
20095351|NCT00002499|Vincristine|vincristine|mesh-list
19506126|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
19506127|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19506128|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
19506129|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571151|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
20095352|NCT00002499|Daunorubicin|daunorubicin|mesh-list
20095353|NCT00002499|Asparaginase|asparaginase|mesh-list
19506130|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506131|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19506132|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19506133|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506134|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506135|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19506136|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19506137|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
19506138|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19506139|NCT03056599|Gemcitabine|gemcitabine|mesh-list
19506140|NCT03056599|Interferons|interferons|mesh-list
19506141|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
19506142|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
19506143|NCT03056599|Aldesleukin|aldesleukin|mesh-list
19506144|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
19506145|NCT03056599|Docetaxel|docetaxel|mesh-list
19506146|NCT03056599|Doxorubicin|doxorubicin|mesh-list
19506147|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
19506148|NCT03056599|Nivolumab|nivolumab|mesh-list
19506149|NCT03056599|Bortezomib|bortezomib|mesh-list
19506150|NCT03056599|Ipilimumab|ipilimumab|mesh-list
19506151|NCT03056599|Atezolizumab|atezolizumab|mesh-list
19506152|NCT03056599|Durvalumab|durvalumab|mesh-list
19506153|NCT03056599|Avelumab|avelumab|mesh-list
19506154|NCT03056599|Trabectedin|trabectedin|mesh-list
19506155|NCT03056599|Olaratumab|olaratumab|mesh-list
19506156|NCT03056599|Entrectinib|entrectinib|mesh-list
19506157|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19506158|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
19506159|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506160|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506161|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
19506162|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506163|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506164|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19506165|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
19506166|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506167|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
19506168|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
19506169|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
19506170|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19506171|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19506172|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19506173|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19506174|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19506175|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19506176|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19506177|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19506178|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
19506179|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20095354|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095355|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
20095356|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
20095357|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095358|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095359|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095360|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
19506180|NCT03056391|Acetaminophen|acetaminophen|mesh-list
19506181|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19506182|NCT03056391|Analgesics|analgesics|mesh-ancestor
19506183|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
19506184|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506185|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506186|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
19506187|NCT03056274|Metformin|metformin|mesh-list
19506188|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19506189|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19506190|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506191|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19506192|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506193|NCT03056118|Aspirin|aspirin|mesh-list
19506194|NCT03056118|Clopidogrel|clopidogrel|mesh-list
19506195|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19506196|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19506197|NCT03056118|Analgesics|analgesics|mesh-ancestor
20095361|NCT00002499|Hormones|hormones|mesh-ancestor
19506198|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
19506199|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506200|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506201|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506202|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19506203|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19506204|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19506205|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506206|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19506207|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19506208|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506209|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
19506210|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19506211|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19506212|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19506213|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
19506214|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506215|NCT03056079|Aflibercept|aflibercept|mesh-list
19506216|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20095362|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095363|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095364|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095365|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20095366|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095367|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095368|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095369|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
20095370|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095371|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095372|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095373|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095374|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095375|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
20095376|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095377|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095378|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
20095379|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095380|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095381|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095382|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095383|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095384|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095385|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19506217|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19506218|NCT03056079|Growth Substances|growth substances|mesh-ancestor
19506219|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506220|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
19506221|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506222|NCT03056053|Zolpidem|zolpidem|mesh-list
19506223|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19506224|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19506225|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506226|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506227|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19506228|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
19506229|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
19506230|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506231|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506232|NCT03056261|Anesthetics|anesthetics|mesh-list
19506233|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506234|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506235|NCT03056092|Ranibizumab|ranibizumab|mesh-list
19506236|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19506237|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19506238|NCT03056092|Growth Substances|growth substances|mesh-ancestor
20095386|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19506239|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506240|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
19506241|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506242|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
19506243|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
19506244|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506245|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506246|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506247|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
19506248|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748914|NCT05364489|Growth Substances|growth substances|mesh-ancestor
19506249|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506250|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506251|NCT03055663|Midazolam|midazolam|mesh-list
19506252|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19506253|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20095387|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
20095388|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095389|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
20095390|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095391|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095392|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095393|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
20095394|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095395|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095396|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095397|NCT00002502|Cytarabine|cytarabine|mesh-list
20095398|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
20095399|NCT00002502|Busulfan|busulfan|mesh-list
20095400|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095401|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
20095402|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095403|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095404|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095405|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
20095406|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095407|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095408|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095409|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095410|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
20095411|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
20095412|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095413|NCT00002504|Interferons|interferons|mesh-list
20095414|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
20095415|NCT00002504|Aldesleukin|aldesleukin|mesh-list
20095416|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095417|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
19506254|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506255|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506256|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19506257|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19506258|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506259|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506260|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
19506261|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
20095418|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095419|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
19506262|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
19506263|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
19506264|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506265|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506266|NCT03055741|Donepezil|donepezil|mesh-list
19506267|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19506268|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506269|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506270|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
19506271|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506272|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506273|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
19506274|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19506275|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19506276|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19506277|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506278|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506279|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20095420|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095421|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20095422|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20095423|NCT00002505|Interferons|interferons|mesh-list
20095424|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
20095425|NCT00002505|Vaccines|vaccines|mesh-list
20095426|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095427|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
19506280|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19506281|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095428|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095429|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
19506282|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
19506283|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506284|NCT03055793|Budesonide|budesonide|mesh-list
19506285|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
19506286|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095430|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095431|NCT00002506|Interferons|interferons|mesh-list
20095432|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
20095433|NCT00002506|Isotretinoin|isotretinoin|mesh-list
20095434|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095435|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
20095436|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095437|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
20095438|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095439|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095440|NCT00002507|Mitomycins|mitomycins|mesh-list
19506287|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19506288|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
20306099|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306100|NCT00653926|Epinephrine|epinephrine|mesh-list
20306101|NCT00653926|Ropivacaine|ropivacaine|mesh-list
20306102|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
20306103|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
20306104|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306105|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306106|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
19506289|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506290|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506291|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19506292|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
20095441|NCT00002507|Mitomycin|mitomycin|mesh-list
20095442|NCT00002507|Porfiromycin|porfiromycin|mesh-list
20095443|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095444|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095445|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
20095446|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095447|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095448|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095449|NCT00002508|Carboplatin|carboplatin|mesh-list
19506293|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
19506294|NCT03055793|Hormones|hormones|mesh-ancestor
19506295|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506296|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19506297|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19506298|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19506299|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
19506300|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506301|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506302|NCT03055546|Oxytocin|oxytocin|mesh-list
19506303|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
19506304|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19506305|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571152|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571153|NCT02509546|Adenosine|adenosine|mesh-list
19571154|NCT02509546|Analgesics|analgesics|mesh-ancestor
19571155|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
19571156|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571157|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571158|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19571159|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
19571160|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19571161|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
19571162|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
19571163|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571164|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571165|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
19571166|NCT02496676|Analgesics|analgesics|mesh-ancestor
19571167|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
20095450|NCT00002508|Etoposide|etoposide|mesh-list
20095451|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603231|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571168|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571169|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095452|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095453|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095454|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19506306|NCT03055507|Acetaminophen|acetaminophen|mesh-list
19506307|NCT03055507|Ibuprofen|ibuprofen|mesh-list
19506308|NCT03055507|Oxycodone|oxycodone|mesh-list
19506309|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19506310|NCT03055507|Analgesics|analgesics|mesh-ancestor
20095455|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095456|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095457|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
20095458|NCT00002509|Carboplatin|carboplatin|mesh-list
20095459|NCT00002509|Etoposide|etoposide|mesh-list
20095460|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095461|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
20095462|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095463|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095464|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19506311|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
19506312|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506313|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506314|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
19506315|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20095465|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
20095466|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095467|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095468|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095469|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095470|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095471|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095472|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095473|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
20095474|NCT00002510|Etoposide|etoposide|mesh-list
20095475|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19506316|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506317|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19506318|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19506319|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506320|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506321|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19506322|NCT03055507|Narcotics|narcotics|mesh-ancestor
19506323|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506324|NCT03055234|Treprostinil|treprostinil|mesh-list
19506325|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20095476|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
20095477|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095478|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095479|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095480|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
20095481|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095482|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095483|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095484|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095485|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095486|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095487|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095488|NCT00002514|Leucovorin|leucovorin|mesh-list
20095489|NCT00002514|Cytarabine|cytarabine|mesh-list
20095490|NCT00002514|Dexamethasone|dexamethasone|mesh-list
20095491|NCT00002514|Prednisone|prednisone|mesh-list
20095492|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
19506326|NCT03055312|Bicalutamide|bicalutamide|mesh-list
19506327|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
19506328|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
19506329|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506330|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506331|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506332|NCT03055247|Ibuprofen|ibuprofen|mesh-list
19506333|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19506334|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20095493|NCT00002514|Methotrexate|methotrexate|mesh-list
19506335|NCT03055247|Analgesics|analgesics|mesh-ancestor
19506336|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
19506337|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506338|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506339|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506340|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19506341|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19506342|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506343|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506344|NCT03055442|Inositol|inositol|mesh-list
19506345|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
19506346|NCT03055442|Vitamins|vitamins|mesh-ancestor
19506347|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
19506348|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506349|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
19506350|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19506351|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
19506352|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506353|NCT03055377|Expectorants|expectorants|mesh-ancestor
19506354|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
19506355|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19506356|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
19506357|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506358|NCT03055377|Protective Agents|protective agents|mesh-ancestor
19506359|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506360|NCT03055377|Antidotes|antidotes|mesh-ancestor
20095494|NCT00002514|Etoposide|etoposide|mesh-list
20095495|NCT00002514|Vincristine|vincristine|mesh-list
20095496|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
20095497|NCT00002514|Daunorubicin|daunorubicin|mesh-list
20095498|NCT00002514|Asparaginase|asparaginase|mesh-list
20095499|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
20095500|NCT00002514|Thioguanine|thioguanine|mesh-list
20095501|NCT00002514|Sargramostim|sargramostim|mesh-list
20095502|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
20095503|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095504|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
20095505|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095506|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095507|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095508|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
20306107|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306108|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20306109|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19506361|NCT03055091|Sorbitol|sorbitol|mesh-list
19506362|NCT03055091|Cathartics|cathartics|mesh-ancestor
19506363|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506364|NCT03054896|Venetoclax|venetoclax|mesh-list
19506365|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506366|NCT03054948|SMOFlipid|smoflipid|mesh-list
19506367|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19506368|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19506369|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19506370|NCT03054831|Oxycodone|oxycodone|mesh-list
19506371|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19506372|NCT03054831|Narcotics|narcotics|mesh-ancestor
19506373|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506374|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506375|NCT03054831|Analgesics|analgesics|mesh-ancestor
20603232|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20603233|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
20603234|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
20603235|NCT02220023|Protective Agents|protective agents|mesh-ancestor
20603236|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
20603237|NCT02220036|Antacids|antacids|mesh-ancestor
19506376|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
19506377|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095509|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095510|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095511|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095512|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095513|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
20095514|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
20095515|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506378|NCT03054766|Ranibizumab|ranibizumab|mesh-list
19506379|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19506380|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20603238|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506381|NCT03054766|Growth Substances|growth substances|mesh-ancestor
19506382|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095516|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095517|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
20095518|NCT00002514|Hormones|hormones|mesh-ancestor
20095519|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095520|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095521|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20095522|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095523|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095524|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095525|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
20095526|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095527|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095528|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095529|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095530|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095531|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20306110|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
19506383|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
20306111|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306112|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306113|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20306114|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19506384|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506385|NCT03054662|Hemostatics|hemostatics|mesh-list
19506386|NCT03054662|Coagulants|coagulants|mesh-ancestor
19506387|NCT03054610|Betamethasone|betamethasone|mesh-list
19506388|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
19506389|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19506390|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
19506391|NCT03054610|Ropivacaine|ropivacaine|mesh-list
19506392|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
19506393|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19506394|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
19506395|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19506396|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19506397|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
19506398|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
19506399|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506400|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506401|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
19506402|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506403|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19506404|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19506405|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506406|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
19506407|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506408|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506409|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
19506410|NCT03054610|Hormones|hormones|mesh-ancestor
19506411|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506412|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19506413|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
19506414|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19506415|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19506416|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
19506417|NCT03054532|Durvalumab|durvalumab|mesh-list
19506418|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19506419|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506420|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
19506421|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19506422|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19506423|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19506424|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19506425|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506426|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
19506427|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506428|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506429|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19506430|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506431|NCT03054207|Clopidogrel|clopidogrel|mesh-list
19506432|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19506433|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19506434|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19506435|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19506436|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19506437|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
19506438|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506439|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506440|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506441|NCT03054285|Levetiracetam|levetiracetam|mesh-list
19506442|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
19506443|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
19506444|NCT03054467|Amlodipine|amlodipine|mesh-list
19506445|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19506446|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19506447|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20095532|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095533|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
20095534|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095535|NCT00002514|Antidotes|antidotes|mesh-ancestor
20095536|NCT00002514|Protective Agents|protective agents|mesh-ancestor
20095537|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
20095538|NCT00002514|Vitamins|vitamins|mesh-ancestor
20095539|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
20095540|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
19506448|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506449|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19506450|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506451|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
19506452|NCT03054168|Goserelin|goserelin|mesh-list
19506453|NCT03054168|Testosterone|testosterone|mesh-list
19506454|NCT03054168|Hormones|hormones|mesh-ancestor
19506455|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506456|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506457|NCT03054168|Androgens|androgens|mesh-ancestor
19506458|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19506459|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506460|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19506461|NCT03054220|Tramadol|tramadol|mesh-list
19506462|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
19506463|NCT03054220|Paroxetine|paroxetine|mesh-list
19506464|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19506465|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19506466|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19506467|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506468|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506469|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506470|NCT03054220|Analgesics|analgesics|mesh-ancestor
19506471|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
19506472|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506473|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
19506474|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506475|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
19506476|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19506477|NCT03054220|Narcotics|narcotics|mesh-ancestor
19506478|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506479|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19506480|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
19506481|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19506482|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19506483|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19506484|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506485|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
19506486|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
19506487|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19506488|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19506489|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
19506490|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20306115|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
20306116|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20306117|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
20306118|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
20306119|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
20306120|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19506491|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19506492|NCT03054259|Prednisolone|prednisolone|mesh-list
20306121|NCT00653952|Paclitaxel|paclitaxel|mesh-list
19506493|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
20095541|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095542|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
19506494|NCT03054259|Rituximab|rituximab|mesh-list
19506495|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19506496|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
19506497|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19506498|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506499|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
19506500|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506501|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19506502|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506503|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
19506504|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
19506505|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506506|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506507|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
19506508|NCT03054259|Hormones|hormones|mesh-ancestor
19506509|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506510|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19506511|NCT03054259|Protective Agents|protective agents|mesh-ancestor
19506512|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19506513|NCT03053739|Bosentan|bosentan|mesh-list
19506514|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
19506515|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
19506516|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19506517|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19506518|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506519|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506520|NCT03053739|Urological Agents|urological agents|mesh-ancestor
19506521|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19506522|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19506523|NCT03053856|Paclitaxel|paclitaxel|mesh-list
19506524|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
19506525|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19506526|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095543|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20095544|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095545|NCT00002515|Carboplatin|carboplatin|mesh-list
20095546|NCT00002515|Topotecan|topotecan|mesh-list
20095547|NCT00002515|Thiotepa|thiotepa|mesh-list
20095548|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095549|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
19506527|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
19506528|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
19506529|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
19506530|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506531|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19506532|NCT03053869|Diazepam|diazepam|mesh-list
20095550|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095551|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20095552|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19506533|NCT03053869|Lorazepam|lorazepam|mesh-list
19506534|NCT03053869|Alprazolam|alprazolam|mesh-list
19506535|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
19506536|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
19506537|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
19506538|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506539|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506540|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506541|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19506542|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506543|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19506544|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19506545|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506546|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
19506547|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
19506548|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506549|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506550|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19506551|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19506552|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19506553|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506554|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
19506555|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
19506556|NCT03053947|Ketamine|ketamine|mesh-list
19506557|NCT03053947|Analgesics|analgesics|mesh-ancestor
19506558|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
20095553|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506559|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506560|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506561|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19506562|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506563|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
19506564|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
19506565|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506566|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19506567|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19506568|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506569|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506570|NCT03053830|Ketamine|ketamine|mesh-list
19506571|NCT03053830|Analgesics|analgesics|mesh-ancestor
19506572|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
20095554|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095555|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095556|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
20095557|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095558|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095559|NCT00002516|Cobalt|cobalt|mesh-list
20095560|NCT00002516|Dactinomycin|dactinomycin|mesh-list
19506573|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506574|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506575|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19506576|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506577|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
19506578|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
19506579|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506580|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19506581|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19506582|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506583|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571170|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
19571171|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571172|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19571173|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
19571174|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19571175|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19571176|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571177|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19571178|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
19571179|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19577879|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577880|NCT03847506|Amlodipine|amlodipine|mesh-list
19577881|NCT03847506|Candesartan|candesartan|mesh-list
19577882|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
19577883|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19577884|NCT03847506|Ezetimibe|ezetimibe|mesh-list
19577885|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19577886|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19577887|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19577888|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577889|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19577890|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577891|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
19577892|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19577893|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19577894|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
19577895|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19577896|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19577897|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577898|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19577899|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19577900|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
19577901|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19577902|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
19577903|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
19577904|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577905|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095561|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
20095562|NCT00002516|Ifosfamide|ifosfamide|mesh-list
20095563|NCT00002516|Doxorubicin|doxorubicin|mesh-list
19577906|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20095564|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19506584|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
19506585|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19506586|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
19506587|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506588|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506589|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19506590|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
19506591|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19506592|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
19506593|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506594|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506595|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19506596|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
19506597|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
19506598|NCT03053388|Protective Agents|protective agents|mesh-ancestor
19506599|NCT03053544|Metformin|metformin|mesh-list
19506600|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19506601|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506602|NCT03053622|Mirikizumab|mirikizumab|mesh-list
19506603|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19506604|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19506605|NCT03053622|Analgesics|analgesics|mesh-ancestor
19506606|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
19506607|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506608|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506609|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506610|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19506611|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19506612|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506613|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
19506614|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
19506615|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
19506616|NCT03053414|Vitamin D|vitamin d|mesh-list
19506617|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
19506618|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
19506619|NCT03053414|Vitamins|vitamins|mesh-ancestor
19506620|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
19506621|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095565|NCT00002516|Etoposide|etoposide|mesh-list
20095566|NCT00002516|Vincristine|vincristine|mesh-list
20095567|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095568|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
20095569|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095570|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095571|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095572|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
20095573|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506622|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19506623|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19506624|NCT03053505|Vancomycin|vancomycin|mesh-list
19506625|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
19506626|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19506627|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506628|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19506629|NCT03053284|Pasireotide|pasireotide|mesh-list
19506630|NCT03053284|Hormones|hormones|mesh-ancestor
19506631|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506632|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506633|NCT03053219|Abivertinib|abivertinib|mesh-list
19506634|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19506635|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506636|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506637|NCT03052998|Ivermectin|ivermectin|mesh-list
19506638|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
19506639|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19506640|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506641|NCT03053167|Irinotecan|irinotecan|mesh-list
19506642|NCT03053167|Raltitrexed|raltitrexed|mesh-list
19506643|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19506644|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19506645|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506646|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506647|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506648|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19506649|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
19506650|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19506651|NCT03052933|Gemcitabine|gemcitabine|mesh-list
19506652|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19506653|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
19506654|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506655|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506656|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
19506657|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506658|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506659|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19506660|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
19506661|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506662|NCT03052673|Fentanyl|fentanyl|mesh-list
19506663|NCT03052673|Ketamine|ketamine|mesh-list
19506664|NCT03052673|Analgesics|analgesics|mesh-ancestor
19506665|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
19506666|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506667|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506668|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19506669|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506670|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
19506671|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
19506672|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506673|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19506674|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19506675|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506676|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506677|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20095574|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095575|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095576|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095577|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095578|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095579|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095580|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19506678|NCT03052673|Narcotics|narcotics|mesh-ancestor
19506679|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19506680|NCT03052569|Agerafenib|agerafenib|mesh-list
19506681|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19506682|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748915|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748916|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
19748917|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
19748918|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748919|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19748920|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19748921|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748922|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
19748923|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19748924|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748925|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095581|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
19506683|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506684|NCT03052660|Midazolam|midazolam|mesh-list
19506685|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19506686|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19506687|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506688|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095582|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095583|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095584|NCT00002516|Trace Elements|trace elements|mesh-ancestor
20095585|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
20095586|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19506689|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19506690|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19506691|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506692|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506693|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
19506694|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
19506695|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
19506696|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
20095587|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095588|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20095589|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19506697|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506698|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095590|NCT00002517|Cytarabine|cytarabine|mesh-list
20095591|NCT00002517|Dexamethasone|dexamethasone|mesh-list
19506699|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
19506700|NCT03052348|Betamethasone|betamethasone|mesh-list
19506701|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
19506702|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19506703|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
19506704|NCT03052348|Ether|ether|mesh-list
19506705|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19506706|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506707|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
19506708|NCT03052348|Hormones|hormones|mesh-ancestor
19506709|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506710|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506711|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19506712|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
19506713|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19506714|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
19506715|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
19506716|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506717|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19506718|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506719|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19506720|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506721|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506722|NCT03052400|Mifepristone|mifepristone|mesh-list
19506723|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19506724|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
19506725|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19506726|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506727|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19506728|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19506729|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19506730|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
19506731|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19506732|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19506733|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
19506734|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506735|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
19506736|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19506737|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19506738|NCT03052361|Ondansetron|ondansetron|mesh-list
19506739|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
20095592|NCT00002517|Etoposide|etoposide|mesh-list
20095593|NCT00002517|Daunorubicin|daunorubicin|mesh-list
20095594|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
20095595|NCT00002517|Idarubicin|idarubicin|mesh-list
19506740|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
19506741|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506742|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506743|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506744|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
19506745|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
19506746|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19506747|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
19506748|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506749|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506750|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19506751|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19506752|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506753|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506754|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19506755|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19506756|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19506757|NCT03051932|Acetaminophen|acetaminophen|mesh-list
19506758|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19506759|NCT03051932|Analgesics|analgesics|mesh-ancestor
19506760|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
19506761|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506762|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506763|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
19506764|NCT03051945|Ketamine|ketamine|mesh-list
19506765|NCT03051945|Analgesics|analgesics|mesh-ancestor
20095596|NCT00002517|Thioguanine|thioguanine|mesh-list
20095597|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095598|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
20095599|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
19506766|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
19506767|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095600|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095601|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095602|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095603|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
20095604|NCT00002517|Hormones|hormones|mesh-ancestor
20095605|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095606|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095607|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095608|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095609|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095610|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095611|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095612|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095613|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095614|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
20095615|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
20095616|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095617|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095618|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
20095619|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095620|NCT00002517|Analgesics|analgesics|mesh-ancestor
20095621|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
20120378|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20120379|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
20120380|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20120381|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506768|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506769|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19506770|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506771|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
19506772|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
19506773|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506774|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19506775|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19506776|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506777|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506778|NCT03051906|Cetuximab|cetuximab|mesh-list
20120382|NCT00006351|Gemcitabine|gemcitabine|mesh-list
20120383|NCT00006351|Lonafarnib|lonafarnib|mesh-list
20120384|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120385|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
20120386|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120387|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120388|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
20120389|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120390|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506779|NCT03051906|Durvalumab|durvalumab|mesh-list
19506780|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19506781|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506782|NCT03051841|Dexamethasone|dexamethasone|mesh-list
19506783|NCT03051841|Bortezomib|bortezomib|mesh-list
19506784|NCT03051841|CKD-581|ckd-581|mesh-list
19506785|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506786|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
19506787|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
19506788|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506789|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506790|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506791|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
19506792|NCT03051841|Hormones|hormones|mesh-ancestor
19506793|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506794|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19506795|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506796|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506797|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506798|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19571180|NCT02494141|Curcumin|curcumin|mesh-list
19571181|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19571182|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19571183|NCT02494141|Analgesics|analgesics|mesh-ancestor
19571184|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
20120391|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19506799|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19506800|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19506801|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506802|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19506803|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19506804|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506805|NCT03051711|Pyrazole|pyrazole|mesh-list
19506806|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506807|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506808|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19506809|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19506810|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506811|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19506812|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19506813|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506814|NCT03051529|Anesthetics|anesthetics|mesh-list
19506815|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506816|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506817|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19506818|NCT03051698|Metronidazole|metronidazole|mesh-list
19506819|NCT03051698|Vancomycin|vancomycin|mesh-list
19506820|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
19506821|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506822|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19506823|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19506824|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19506825|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19506826|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506827|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506828|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506829|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19506830|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19506831|NCT03051503|Fentanyl|fentanyl|mesh-list
19506832|NCT03051503|Morphine|morphine|mesh-list
19506833|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19506834|NCT03051503|Narcotics|narcotics|mesh-ancestor
19506835|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506836|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506837|NCT03051503|Analgesics|analgesics|mesh-ancestor
19506838|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
19506839|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506840|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19506841|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19506842|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
19506843|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
19506844|NCT03051451|Metformin|metformin|mesh-list
19506845|NCT03051451|Fluoxetine|fluoxetine|mesh-list
19506846|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19506847|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506848|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19506849|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19506850|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19506851|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506852|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506853|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
19506854|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19506855|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
19506856|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19506857|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19506858|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19506859|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506860|NCT03051373|Gemcitabine|gemcitabine|mesh-list
20095622|NCT00002519|Paclitaxel|paclitaxel|mesh-list
20095623|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095624|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095625|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095626|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095627|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095628|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095629|NCT00002520|Nicotine|nicotine|mesh-list
20095630|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19506861|NCT03051373|Paclitaxel|paclitaxel|mesh-list
19506862|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19506863|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095631|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
20095632|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095633|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095634|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20095635|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19506864|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506865|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
19506866|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
19506867|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
19506868|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506869|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19506870|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
19506871|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
19506872|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506873|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095636|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
20095637|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20095638|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095639|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
20095640|NCT00002521|Etoposide|etoposide|mesh-list
20095641|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095642|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
20095643|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095644|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095645|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095646|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
20095647|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095648|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095649|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095650|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095651|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095652|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095653|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095654|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
20095655|NCT00002522|Etoposide|etoposide|mesh-list
20095656|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095657|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
20095658|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095659|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095660|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095661|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
20095662|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095663|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095664|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19506874|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19506875|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
19506876|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506877|NCT03051087|Ganirelix|ganirelix|mesh-list
19506878|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
19506879|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506880|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506881|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
19506882|NCT03051269|Calcium|calcium|mesh-list
19506883|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19506884|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506885|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19506886|NCT03051243|Insulin|insulin|mesh-list
19506887|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19506888|NCT03051243|Linagliptin|linagliptin|mesh-list
19506889|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19506890|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506891|NCT03051243|Incretins|incretins|mesh-ancestor
19506892|NCT03051243|Hormones|hormones|mesh-ancestor
19506893|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506894|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19506895|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
19506896|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506897|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506898|NCT03050866|Antiemetics|antiemetics|mesh-list
19506899|NCT03050866|Histamine|histamine|mesh-list
19506900|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
20095665|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095666|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19506901|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19506902|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
19506903|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
19506904|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506905|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506906|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506907|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
19506908|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506909|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506910|NCT03050905|Ritonavir|ritonavir|mesh-list
19506911|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19506912|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19506913|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
19506914|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506915|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506916|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19506917|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19506918|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
19506919|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506920|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19506921|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19506922|NCT03050827|Oxybutynin|oxybutynin|mesh-list
19506923|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
19506924|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
19506925|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506926|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506927|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19506928|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19506929|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
19506930|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19506931|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506932|NCT03050827|Urological Agents|urological agents|mesh-ancestor
19506933|NCT03050957|Menthol|menthol|mesh-list
19506934|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
19506935|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
19506936|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19506937|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
19506938|NCT03051009|Coagulants|coagulants|mesh-ancestor
19506939|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19506940|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
19506941|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506942|NCT03051022|Dexamethasone|dexamethasone|mesh-list
19506943|NCT03051022|Morphine|morphine|mesh-list
19506944|NCT03051022|Bupivacaine|bupivacaine|mesh-list
20095667|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095668|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095669|NCT00002523|Leucovorin|leucovorin|mesh-list
19506945|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19506946|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
19506947|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
19506948|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506949|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506950|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19506951|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
19506952|NCT03051022|Hormones|hormones|mesh-ancestor
19506953|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19506954|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19506955|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506956|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
20603239|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20603240|NCT02220049|Bortezomib|bortezomib|mesh-list
19506957|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
20095670|NCT00002523|Fluorouracil|fluorouracil|mesh-list
20095671|NCT00002523|Calcium|calcium|mesh-list
20095672|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
20095673|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20095674|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506958|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506959|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
19506960|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19506961|NCT03051022|Narcotics|narcotics|mesh-ancestor
19506962|NCT03051022|Analgesics|analgesics|mesh-ancestor
20095675|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
19506963|NCT03050710|Lidocaine|lidocaine|mesh-list
19506964|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
20603241|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603242|NCT02220088|Leucovorin|leucovorin|mesh-list
20603243|NCT02220088|Fluorouracil|fluorouracil|mesh-list
19506965|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
19506966|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19506967|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19506968|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
19506969|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19506970|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19506971|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19506972|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19506973|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19506974|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506975|NCT03050437|Pemetrexed|pemetrexed|mesh-list
19506976|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506977|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506978|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506979|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19506980|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19506981|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19506982|NCT03050411|Apatinib|apatinib|mesh-list
19506983|NCT03050411|Gefitinib|gefitinib|mesh-list
19506984|NCT03050411|Osimertinib|osimertinib|mesh-list
19506985|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506986|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19506987|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19506988|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19506989|NCT03050554|Avelumab|avelumab|mesh-list
19506990|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19506991|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19506992|NCT03050086|Minocycline|minocycline|mesh-list
19506993|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19506994|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19506995|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
19506996|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19506997|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19506998|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20095676|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095677|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19506999|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
19507000|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507001|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507002|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571185|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571186|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571187|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19571188|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571189|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571190|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571191|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571192|NCT02478099|Atezolizumab|atezolizumab|mesh-list
19571193|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571194|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
20603244|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
20603245|NCT02220088|Sorafenib|sorafenib|mesh-list
20603246|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
20603247|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603248|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20603249|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095678|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095679|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095680|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
20095681|NCT00002523|Antidotes|antidotes|mesh-ancestor
20095682|NCT00002523|Protective Agents|protective agents|mesh-ancestor
20095683|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
20095684|NCT00002523|Vitamins|vitamins|mesh-ancestor
20095685|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
20095686|NCT00002524|Leucovorin|leucovorin|mesh-list
20095687|NCT00002524|Cytarabine|cytarabine|mesh-list
20095688|NCT00002524|Zidovudine|zidovudine|mesh-list
20095689|NCT00002524|Trimethoprim|trimethoprim|mesh-list
20095690|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
20095691|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20095692|NCT00002524|Pentamidine|pentamidine|mesh-list
19571195|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19571196|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095693|NCT00002524|Prednisone|prednisone|mesh-list
20095694|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
20603250|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507003|NCT03050177|Gefitinib|gefitinib|mesh-list
19507004|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095695|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20095696|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20095697|NCT00002524|Prednisolone|prednisolone|mesh-list
20095698|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
20095699|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
20095700|NCT00002524|Ifosfamide|ifosfamide|mesh-list
20095701|NCT00002524|Doxorubicin|doxorubicin|mesh-list
20095702|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095703|NCT00002524|Fluorouracil|fluorouracil|mesh-list
20095704|NCT00002524|Methotrexate|methotrexate|mesh-list
20095705|NCT00002524|Etoposide|etoposide|mesh-list
20095706|NCT00002524|Vincristine|vincristine|mesh-list
20095707|NCT00002524|Bleomycin|bleomycin|mesh-list
20095708|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20095709|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
20095710|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
20095711|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095712|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
20095713|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095714|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095715|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095716|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
20095717|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095718|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507005|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19507006|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507007|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507008|NCT03050229|Empagliflozin|empagliflozin|mesh-list
19507009|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19507010|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095719|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095720|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095721|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095722|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095723|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095724|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095725|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
20095726|NCT00002524|Hormones|hormones|mesh-ancestor
20095727|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095728|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095729|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
20095730|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095731|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20095732|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
19507011|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19507012|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507013|NCT03050164|Gefitinib|gefitinib|mesh-list
19507014|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507015|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19507016|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507017|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507018|NCT03049930|Ketamine|ketamine|mesh-list
19507019|NCT03049930|Analgesics|analgesics|mesh-ancestor
20095733|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095734|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095735|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095736|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095737|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095738|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
20095739|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095740|NCT00002524|Antidotes|antidotes|mesh-ancestor
20095741|NCT00002524|Protective Agents|protective agents|mesh-ancestor
20095742|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
20095743|NCT00002524|Vitamins|vitamins|mesh-ancestor
20095744|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
20095745|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095746|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095747|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095748|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
20095749|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
20095750|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095751|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095752|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20095753|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20095754|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20095755|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20095756|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20095757|NCT00002524|Renal Agents|renal agents|mesh-ancestor
19507020|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
19507021|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507022|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507023|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19507024|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19507025|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
19507026|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
19507027|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507028|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19507029|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19507030|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507031|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507032|NCT03049878|Acetaminophen|acetaminophen|mesh-list
19507033|NCT03049878|Codeine|codeine|mesh-list
19507034|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19507035|NCT03049878|Analgesics|analgesics|mesh-ancestor
19507036|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
19507037|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507038|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507039|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
19507040|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19507041|NCT03049878|Narcotics|narcotics|mesh-ancestor
19507042|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507043|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
19507044|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
19507045|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
19507046|NCT03049163|Propoxycaine|propoxycaine|mesh-list
19507047|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
19507048|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507049|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507050|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
19507051|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
19507052|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507053|NCT03049176|Tenofovir|tenofovir|mesh-list
19507054|NCT03049176|Emtricitabine|emtricitabine|mesh-list
19507055|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19507056|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19507057|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
19507058|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507059|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19507060|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19507061|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507062|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507063|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19507064|NCT03049059|Hydroquinone|hydroquinone|mesh-list
19507065|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
19507066|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507067|NCT03049059|Protective Agents|protective agents|mesh-ancestor
19507068|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507069|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19507070|NCT03049293|Midazolam|midazolam|mesh-list
19507071|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19507072|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19507073|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507074|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507075|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19507076|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19507077|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19507078|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19507079|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
19507080|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
19507081|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
19507082|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
19507083|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507084|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507085|NCT03049267|Apremilast|apremilast|mesh-list
19507086|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19507087|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20095758|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
20095759|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19507088|NCT03049267|Analgesics|analgesics|mesh-ancestor
20095760|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20095761|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20095762|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19507089|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
20603251|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
20603252|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507090|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507091|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603253|NCT02220088|Antidotes|antidotes|mesh-ancestor
20095763|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20095764|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20095765|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
20095766|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20095767|NCT00002526|Doxorubicin|doxorubicin|mesh-list
20095768|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095769|NCT00002526|Ifosfamide|ifosfamide|mesh-list
20095770|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19507092|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095771|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095772|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095773|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19507093|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19507094|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19507095|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19507096|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507097|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507098|NCT03049046|Caffeic acid|caffeic acid|mesh-list
19507099|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
19507100|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507101|NCT03049046|Protective Agents|protective agents|mesh-ancestor
19507102|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507103|NCT03049085|Aspirin|aspirin|mesh-list
19507104|NCT03049085|Ascorbic Acid|ascorbic acid|mesh-list
19507105|NCT03049085|Vitamins|vitamins|mesh-ancestor
19507106|NCT03049085|Micronutrients|micronutrients|mesh-ancestor
19507107|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507108|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19507109|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19507110|NCT03049085|Analgesics|analgesics|mesh-ancestor
19507111|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
19507112|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507113|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19507114|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19507115|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19507116|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19507117|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507118|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19507119|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19507120|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507121|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
19507122|NCT03049085|Antioxidants|antioxidants|mesh-ancestor
19507123|NCT03049085|Protective Agents|protective agents|mesh-ancestor
19507124|NCT03049345|Methylene Blue|methylene blue|mesh-list
19507125|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507126|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507127|NCT03048877|Apatinib|apatinib|mesh-list
19507128|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507129|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19507130|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507131|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507132|NCT03048825|Colchicine|colchicine|mesh-list
19507133|NCT03048825|Spironolactone|spironolactone|mesh-list
19507134|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
19507135|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19507136|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
19507137|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507138|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507139|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507140|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095774|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095775|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603254|NCT02220088|Protective Agents|protective agents|mesh-ancestor
19507141|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19507142|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
20603255|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
20603256|NCT02220088|Vitamins|vitamins|mesh-ancestor
19507143|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19507144|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507145|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19507146|NCT03048825|Diuretics|diuretics|mesh-ancestor
19507147|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
19507148|NCT03048942|Paclitaxel|paclitaxel|mesh-list
19507149|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19507150|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507151|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
19507152|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507153|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507154|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507155|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19507156|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095776|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095777|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
20095778|NCT00002527|Aspirin|aspirin|mesh-list
20095779|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20095780|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20095781|NCT00002527|Analgesics|analgesics|mesh-ancestor
20095782|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
20095783|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095784|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095785|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095786|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095787|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20095788|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20095789|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095790|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20095791|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20095792|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095793|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
20095794|NCT00002528|Tamoxifen|tamoxifen|mesh-list
20095795|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20095796|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
20095797|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095798|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095799|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095800|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095801|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20095802|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20095803|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20095804|NCT00002529|Tamoxifen|tamoxifen|mesh-list
19507157|NCT03048474|Nivolumab|nivolumab|mesh-list
19507158|NCT03048474|Ipilimumab|ipilimumab|mesh-list
19507159|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19507160|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507161|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19507162|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571197|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571198|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571199|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571200|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571201|NCT02453984|Atezolizumab|atezolizumab|mesh-list
19571202|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571203|NCT02412618|Misoprostol|misoprostol|mesh-list
19571204|NCT02412618|Mifepristone|mifepristone|mesh-list
19571205|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19571206|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
19571207|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095805|NCT00002529|Toremifene|toremifene|mesh-list
20095806|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
19571208|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571209|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19571210|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19571211|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
19571212|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19571213|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19571214|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19571215|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19571216|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
19571217|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19571218|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19507163|NCT03048214|Anesthetics|anesthetics|mesh-list
19507164|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507165|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507166|NCT03048110|Itraconazole|itraconazole|mesh-list
19507167|NCT03048110|Rifampin|rifampin|mesh-list
19507168|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
19507169|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507170|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19507171|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19507172|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306122|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20306123|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306124|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
20306125|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
20306126|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
20306127|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306128|NCT00653965|Atorvastatin|atorvastatin|mesh-list
19507173|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507174|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19507175|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
19507176|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19507177|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507178|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19507179|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19507180|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
19507181|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507182|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
19507183|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19507184|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20095807|NCT00002529|Doxorubicin|doxorubicin|mesh-list
20095808|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095809|NCT00002529|Epirubicin|epirubicin|mesh-list
20095810|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095811|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
20095812|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095813|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095814|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095815|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
20095816|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095817|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095818|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095819|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095820|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095821|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19507185|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19507186|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19507187|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19507188|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19507189|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19507190|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19507191|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19507192|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095822|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095823|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20095824|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
20095825|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095826|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095827|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20095828|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20095829|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20095830|NCT00002531|Leucovorin|leucovorin|mesh-list
20095831|NCT00002531|Cytarabine|cytarabine|mesh-list
20095832|NCT00002531|Dexamethasone|dexamethasone|mesh-list
20095833|NCT00002531|Prednisolone|prednisolone|mesh-list
20095834|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
20095835|NCT00002531|Ifosfamide|ifosfamide|mesh-list
20095836|NCT00002531|Doxorubicin|doxorubicin|mesh-list
20095837|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20095838|NCT00002531|Methotrexate|methotrexate|mesh-list
20095839|NCT00002531|Etoposide|etoposide|mesh-list
19507193|NCT03047837|Aspirin|aspirin|mesh-list
20095840|NCT00002531|Vincristine|vincristine|mesh-list
19507194|NCT03047837|Metformin|metformin|mesh-list
20095841|NCT00002531|Daunorubicin|daunorubicin|mesh-list
19507195|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19507196|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507197|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19507198|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19507199|NCT03047837|Analgesics|analgesics|mesh-ancestor
19507200|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
19507201|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507202|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19507203|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19507204|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19507205|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19507206|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507207|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19507208|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19507209|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507210|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
19507211|NCT03048084|Levetiracetam|levetiracetam|mesh-list
19507212|NCT03048084|Valproic Acid|valproic acid|mesh-list
19507213|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
19507214|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
19507215|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507216|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507217|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
19507218|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507219|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507220|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
19507221|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19507222|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507223|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19507224|NCT03048136|Nivolumab|nivolumab|mesh-list
19507225|NCT03048136|Ipilimumab|ipilimumab|mesh-list
19507226|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19507227|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507228|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19507229|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507230|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
19507231|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19507232|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
19507233|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507234|NCT03048019|Tirofiban|tirofiban|mesh-list
19507235|NCT03048019|Cangrelor|cangrelor|mesh-list
19507236|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19507237|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19507238|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507239|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19507240|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19507241|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19507242|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19507243|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
19507244|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507245|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507246|NCT03047772|Atorvastatin|atorvastatin|mesh-list
19507247|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19507248|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20603257|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
20603258|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20603259|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603260|NCT02220114|Vigabatrin|vigabatrin|mesh-list
19507249|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
20095842|NCT00002531|Asparaginase|asparaginase|mesh-list
20095843|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
20095844|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
20095845|NCT00002531|Thioguanine|thioguanine|mesh-list
20095846|NCT00002531|Vindesine|vindesine|mesh-list
20095847|NCT00002531|Teniposide|teniposide|mesh-list
20095848|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
20095849|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095850|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
20095851|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095852|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095853|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20603261|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
19507250|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507251|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19571219|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
20095854|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
20120392|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
20095855|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095856|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095857|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095858|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095859|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
20095860|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
19507252|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20095861|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095862|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095863|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
20095864|NCT00002531|Hormones|hormones|mesh-ancestor
20095865|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095866|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19507253|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507254|NCT03047538|Amlodipine|amlodipine|mesh-list
19507255|NCT03047538|Perindopril|perindopril|mesh-list
19507256|NCT03047538|Atorvastatin|atorvastatin|mesh-list
19507257|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19507258|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306129|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306130|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306131|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306132|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
20306133|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306134|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306135|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306136|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306137|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
20306138|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
20306139|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20306140|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20306141|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306142|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306143|NCT00654017|Urological Agents|urological agents|mesh-ancestor
20306144|NCT00654043|Torsemide|torsemide|mesh-list
20306145|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20603262|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507259|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
19507260|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507261|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19507262|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19507263|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507264|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19507265|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19507266|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507267|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19507268|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507269|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
19507270|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19507271|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
19507272|NCT03047473|Avelumab|avelumab|mesh-list
19507273|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19507274|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507275|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
19507276|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19507277|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19507278|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19507279|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507280|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507281|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
19507282|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507283|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507284|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19507285|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095867|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095868|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095869|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095870|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095871|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20095872|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095873|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20306146|NCT00654043|Diuretics|diuretics|mesh-ancestor
19507286|NCT03047733|Tacrolimus|tacrolimus|mesh-list
19507287|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507288|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
19507289|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507290|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19507291|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507292|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507293|NCT03047278|Cetirizine|cetirizine|mesh-list
19507294|NCT03047278|Gabapentin|gabapentin|mesh-list
19507295|NCT03047278|Analgesics|analgesics|mesh-ancestor
19507296|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
19507297|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507298|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507299|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
19507300|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19507301|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19507302|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507303|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19507304|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19507305|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19507306|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507307|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507308|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
19507309|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19507310|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19507311|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19507312|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
19507313|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
19507314|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
19507315|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19507316|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
20095874|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095875|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
20095876|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095877|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095878|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19507317|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507318|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
19507319|NCT03047096|Protective Agents|protective agents|mesh-ancestor
19507320|NCT03046953|Avelumab|avelumab|mesh-list
19507321|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19507322|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507323|NCT03046979|Apatinib|apatinib|mesh-list
19507324|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507325|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19507326|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095879|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095880|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
20095881|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095882|NCT00002531|Antidotes|antidotes|mesh-ancestor
20095883|NCT00002531|Protective Agents|protective agents|mesh-ancestor
20095884|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
20095885|NCT00002531|Vitamins|vitamins|mesh-ancestor
20095886|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
20095887|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095888|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095889|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095890|NCT00002531|Analgesics|analgesics|mesh-ancestor
20095891|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
20095892|NCT00002532|Leucovorin|leucovorin|mesh-list
20095893|NCT00002532|Cytarabine|cytarabine|mesh-list
20095894|NCT00002532|Dexamethasone|dexamethasone|mesh-list
20095895|NCT00002532|Prednisolone|prednisolone|mesh-list
20095896|NCT00002532|Methotrexate|methotrexate|mesh-list
20095897|NCT00002532|Etoposide|etoposide|mesh-list
19507327|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507328|NCT03047057|Lidocaine|lidocaine|mesh-list
19507329|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
19507330|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
19507331|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507332|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507333|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
19507334|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095898|NCT00002532|Daunorubicin|daunorubicin|mesh-list
20095899|NCT00002532|Asparaginase|asparaginase|mesh-list
20095900|NCT00002532|Ifosfamide|ifosfamide|mesh-list
20095901|NCT00002532|Idarubicin|idarubicin|mesh-list
20095902|NCT00002532|Vindesine|vindesine|mesh-list
20095903|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
20095904|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095905|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
20095906|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
20095907|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095908|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095909|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095910|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
20095911|NCT00002532|Hormones|hormones|mesh-ancestor
20095912|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095913|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20095914|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095915|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20095916|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
20095917|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20095918|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095919|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
20095920|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095921|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
20095922|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20095923|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20095924|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507335|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19507336|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19507337|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19507338|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507339|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507340|NCT03047109|Phenylephrine|phenylephrine|mesh-list
19507341|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
19507342|NCT03047109|Ephedrine|ephedrine|mesh-list
19507343|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19507344|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
19507345|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
19507346|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507347|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507348|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
19507349|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19507350|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
19507351|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
19507352|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19507353|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19507354|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19507355|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
19507356|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507357|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507358|NCT03047109|Protective Agents|protective agents|mesh-ancestor
19507359|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19507360|NCT03047265|Paclitaxel|paclitaxel|mesh-list
19507361|NCT03047265|Cisplatin|cisplatin|mesh-list
19507362|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095925|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
20095926|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095927|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20095928|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20095929|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20095930|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20095931|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
20095932|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095933|NCT00002532|Antidotes|antidotes|mesh-ancestor
20095934|NCT00002532|Protective Agents|protective agents|mesh-ancestor
20095935|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
20095936|NCT00002532|Vitamins|vitamins|mesh-ancestor
20095937|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
20095938|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20095939|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095940|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
20095941|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
20095942|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
20095943|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
20095944|NCT00002533|Fluconazole|fluconazole|mesh-list
20095945|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
20095946|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095947|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20095948|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20095949|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507363|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507364|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
19507365|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507366|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507367|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507368|NCT03046901|Vancomycin|vancomycin|mesh-list
19507369|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507370|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507371|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19507372|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
19507373|NCT03046758|Metronidazole|metronidazole|mesh-list
20095950|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095951|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19507374|NCT03046758|Fosfomycin|fosfomycin|mesh-list
19507375|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507376|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507377|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19507378|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19571220|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571221|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
20095952|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
20095953|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095954|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095955|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20095956|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20095957|NCT00002534|Cytarabine|cytarabine|mesh-list
19571222|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19571223|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19571224|NCT02402660|Vitamin A|vitamin a|mesh-list
19571225|NCT02402660|Retinol acetate|retinol acetate|mesh-list
19571226|NCT02402660|Vitamins|vitamins|mesh-ancestor
19571227|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
19571228|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571229|NCT02402660|Protective Agents|protective agents|mesh-ancestor
19571230|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19571231|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571232|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19571233|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
19571234|NCT02351180|Beclomethasone|beclomethasone|mesh-list
19571235|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095958|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
19571236|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
19571237|NCT02351180|Hormones|hormones|mesh-ancestor
19571238|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571239|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571240|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19571241|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
19571242|NCT02327403|Abatacept|abatacept|mesh-list
19571243|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19571244|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571245|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571246|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571247|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
19571248|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571249|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571250|NCT02313389|Rituximab|rituximab|mesh-list
19571251|NCT02313389|Methotrexate|methotrexate|mesh-list
19571252|NCT02313389|Temozolomide|temozolomide|mesh-list
19571253|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571254|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571255|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
19571256|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571257|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571258|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19571259|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
19571260|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571261|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571262|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
19571263|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571264|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
19571265|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571266|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19571267|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571268|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19571269|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19507379|NCT03046511|Cefazolin|cefazolin|mesh-list
19507380|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507381|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507382|NCT03046719|Bupivacaine|bupivacaine|mesh-list
19507383|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
19507384|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
19507385|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507386|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507387|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
19507388|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507389|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19507390|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507391|NCT03046173|Mitogens|mitogens|mesh-list
19507392|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507393|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507394|NCT03046017|Lidocaine|lidocaine|mesh-list
19507395|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
19507396|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
19507397|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507398|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507399|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
19507400|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507401|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19507402|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19507403|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19507404|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507405|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507406|NCT03046251|Natalizumab|natalizumab|mesh-list
19507407|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
19507408|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507409|NCT03046108|Triamcinolone|triamcinolone|mesh-list
19507410|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19507411|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19507412|NCT03046108|Mepivacaine|mepivacaine|mesh-list
19507413|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19507414|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19507415|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
19507416|NCT03046108|Hormones|hormones|mesh-ancestor
19507417|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19507418|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507419|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507420|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
19507421|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507422|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507423|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
19507424|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
19507425|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507426|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
19507427|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507428|NCT03046290|Lidocaine|lidocaine|mesh-list
19507429|NCT03046290|Ropivacaine|ropivacaine|mesh-list
19507430|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19507431|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
19507432|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507433|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507434|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
19507435|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507436|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19507437|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19507438|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19507439|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507440|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507441|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
19507442|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19507443|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507444|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507445|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19507446|NCT03046238|Analgesics|analgesics|mesh-ancestor
19507447|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
19507448|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507449|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19507450|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19507451|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19507452|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
19507453|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507454|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507455|NCT03045783|Cefotiam|cefotiam|mesh-list
19507456|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507457|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507458|NCT03045770|Leucovorin|leucovorin|mesh-list
19507459|NCT03045770|Paclitaxel|paclitaxel|mesh-list
19507460|NCT03045770|Fluorouracil|fluorouracil|mesh-list
19507461|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
19507462|NCT03045770|Irinotecan|irinotecan|mesh-list
19507463|NCT03045770|Calcium|calcium|mesh-list
19507464|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
19507465|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19507466|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507467|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
19507468|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507469|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507470|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507471|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19507472|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507473|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
19507474|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19507475|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507476|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
19507477|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19507478|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19507479|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507480|NCT03045770|Antidotes|antidotes|mesh-ancestor
19507481|NCT03045770|Protective Agents|protective agents|mesh-ancestor
19507482|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
19507483|NCT03045770|Vitamins|vitamins|mesh-ancestor
19507484|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
19507485|NCT03045627|Cytarabine|cytarabine|mesh-list
19507486|NCT03045627|Aclarubicin|aclarubicin|mesh-list
19507487|NCT03045627|Lenograstim|lenograstim|mesh-list
19507488|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19507489|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
19507490|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507491|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507492|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
19507493|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507494|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507495|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
19507496|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507497|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19507498|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19507499|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19507500|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19507501|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507502|NCT03045484|Oxycodone|oxycodone|mesh-list
19507503|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19507504|NCT03045484|Narcotics|narcotics|mesh-ancestor
19507505|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507506|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507507|NCT03045484|Analgesics|analgesics|mesh-ancestor
19507508|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
19507509|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507510|NCT03045471|Prednisolone|prednisolone|mesh-list
19507511|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19507512|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
19507513|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19507514|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
19507515|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
19507516|NCT03045471|Rituximab|rituximab|mesh-list
19507517|NCT03045471|Etoposide|etoposide|mesh-list
19507518|NCT03045471|Vincristine|vincristine|mesh-list
19507519|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19507520|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
19507521|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507522|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
19507523|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507524|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19507525|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19507526|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
19507527|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507528|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507529|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19507530|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20306147|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
20306148|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306149|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20306150|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306151|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306152|NCT00654056|Insulin|insulin|mesh-list
20306153|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20095959|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
20095960|NCT00002534|Thiotepa|thiotepa|mesh-list
20095961|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20306154|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20306155|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306156|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
20306157|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
20603263|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603264|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
20603265|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603266|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603267|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
20603268|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20603269|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
20603270|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603271|NCT02220218|Metformin|metformin|mesh-list
20603272|NCT02220218|Canagliflozin|canagliflozin|mesh-list
20603273|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19507531|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19507532|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19507533|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19507534|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507535|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095962|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20095963|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
19507536|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
20095964|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095965|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095966|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095967|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
20095968|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095969|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095970|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20095971|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095972|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
20095973|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
20095974|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20095975|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20095976|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
19507537|NCT03045471|Hormones|hormones|mesh-ancestor
19507538|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19507539|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19507540|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
19507541|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
19507542|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507543|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19507544|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19507545|NCT03045471|Protective Agents|protective agents|mesh-ancestor
19507546|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
19507547|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507548|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507549|NCT03045510|Decitabine|decitabine|mesh-list
20095977|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
20095978|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20095979|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20095980|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
20095981|NCT00002534|Hormones|hormones|mesh-ancestor
20095982|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20095983|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20095984|NCT00002534|Protective Agents|protective agents|mesh-ancestor
20095985|NCT00002535|Aldesleukin|aldesleukin|mesh-list
20095986|NCT00002535|Indomethacin|indomethacin|mesh-list
20095987|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
20095988|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20603274|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507550|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20095989|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
20095990|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20095991|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20095992|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20095993|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
20095994|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20095995|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20095996|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19507551|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
19507552|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507553|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507554|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507555|NCT03045406|Dalteparin|dalteparin|mesh-list
19507556|NCT03045406|Tinzaparin|tinzaparin|mesh-list
19507557|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19507558|NCT03045406|Apixaban|apixaban|mesh-list
19507559|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19507560|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
19507561|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19507562|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
19507563|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507564|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507565|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
19507566|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19507567|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19507568|NCT03045185|Metronidazole|metronidazole|mesh-list
19507569|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
19507570|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507571|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507572|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19507573|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19507574|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19507575|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19507576|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507577|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507578|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507579|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19507580|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19507581|NCT03045198|Azithromycin|azithromycin|mesh-list
19507582|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507583|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507584|NCT03045341|Naltrexone|naltrexone|mesh-list
19507585|NCT03045341|Bupropion|bupropion|mesh-list
19507586|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19507587|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19507588|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507589|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
19507590|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507591|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19507592|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
19507593|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19507594|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19507595|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19507596|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507597|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507598|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
19507599|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507600|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19507601|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19507602|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571270|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
19571271|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
20095997|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20095998|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20095999|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
20096000|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096001|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20096002|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20096003|NCT00002535|Analgesics|analgesics|mesh-ancestor
20096004|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
20096005|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096006|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096007|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
20096008|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
20096009|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19577907|NCT03826693|Analgesics|analgesics|mesh-ancestor
19507603|NCT03045393|Maytansine|maytansine|mesh-list
19507604|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19507605|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507606|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
19507607|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507608|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507609|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507610|NCT03045133|Morphine|morphine|mesh-list
19507611|NCT03045133|Methadone|methadone|mesh-list
19507612|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19507613|NCT03045133|Narcotics|narcotics|mesh-ancestor
19507614|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507615|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507616|NCT03045133|Analgesics|analgesics|mesh-ancestor
19507617|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
19507618|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507619|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
19507620|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
19507621|NCT03045016|Prazosin|prazosin|mesh-list
19507622|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20096010|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20096011|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096012|NCT00002536|Vincristine|vincristine|mesh-list
20096013|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096014|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096015|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096016|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507623|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19507624|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19507625|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19507626|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
19507627|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507628|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507629|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507630|NCT03045029|Treprostinil|treprostinil|mesh-list
19507631|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20096017|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507632|NCT03044912|Mirabegron|mirabegron|mesh-list
19507633|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19507634|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19507635|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19507636|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
19507637|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507638|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507639|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507640|NCT03044912|Urological Agents|urological agents|mesh-ancestor
19507641|NCT03044964|Ranolazine|ranolazine|mesh-list
19507642|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19507643|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507644|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507645|NCT03044873|BMS-986165|bms-986165|mesh-list
19507646|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19507647|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19507648|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19507649|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
19507650|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507651|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19507652|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19507653|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507654|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
19507655|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19507656|NCT03044626|Nivolumab|nivolumab|mesh-list
19507657|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19507658|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507659|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19507660|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507661|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
19507662|NCT03044743|Fludarabine|fludarabine|mesh-list
19507663|NCT03044743|Interleukin-2|interleukin-2|mesh-list
19507664|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507665|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
19507666|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507667|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096018|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096019|NCT00002537|Topotecan|topotecan|mesh-list
19507668|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19507669|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
19507670|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507671|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507672|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19507673|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19507674|NCT03044743|Analgesics|analgesics|mesh-ancestor
19507675|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
19507676|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507677|NCT03044795|Veliparib|veliparib|mesh-list
19507678|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19507679|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507680|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507681|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507682|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19507683|NCT03044665|Ezetimibe|ezetimibe|mesh-list
20096020|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20096021|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096022|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096023|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096024|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096025|NCT00002539|Doxorubicin|doxorubicin|mesh-list
19507684|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19507685|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19507686|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
19507687|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507688|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19507689|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19507690|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507691|NCT03044587|Leucovorin|leucovorin|mesh-list
19507692|NCT03044587|Gemcitabine|gemcitabine|mesh-list
19507693|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507694|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19507695|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
19507696|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507697|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
19507698|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507699|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507700|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507701|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
19507702|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507703|NCT03044587|Antidotes|antidotes|mesh-ancestor
19507704|NCT03044587|Protective Agents|protective agents|mesh-ancestor
19507705|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
19507706|NCT03044587|Vitamins|vitamins|mesh-ancestor
20306158|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20306159|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20306160|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306161|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306162|NCT00654082|Urological Agents|urological agents|mesh-ancestor
20306163|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
20306164|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
20306165|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20306166|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306167|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20306168|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20306169|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306170|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507707|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
19507708|NCT03044808|Lidocaine|lidocaine|mesh-list
19507709|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
19507710|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
19507711|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507712|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507713|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
19507714|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507715|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19507716|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19507717|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19507718|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507719|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096026|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19507720|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
20096027|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507721|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507722|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
19507723|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19507724|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19507725|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507726|NCT03044561|Urological Agents|urological agents|mesh-ancestor
19507727|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
19507728|NCT03044522|Narcotics|narcotics|mesh-ancestor
19507729|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507730|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507731|NCT03044522|Analgesics|analgesics|mesh-ancestor
19507732|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
19507733|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507734|NCT03044938|Albuterol|albuterol|mesh-list
19507735|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19507736|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
19507737|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507738|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507739|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19507740|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
19507741|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
19507742|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19507743|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19507744|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19507745|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19507746|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
19507747|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507748|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507749|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19507750|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19507751|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19507752|NCT03044366|Anesthetics|anesthetics|mesh-list
19507753|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507754|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507755|NCT03044379|Dapivirine|dapivirine|mesh-list
19507756|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19507757|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19507758|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
19507759|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507760|NCT03044171|Listerine|listerine|mesh-list
19507761|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19507762|NCT03044171|Fluorides|fluorides|mesh-list
19507763|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
19507764|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
19507765|NCT03044171|Protective Agents|protective agents|mesh-ancestor
19507766|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507767|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19507768|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507769|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
19507770|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
19507771|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19507772|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19507773|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507774|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
19507775|NCT03044184|Coagulants|coagulants|mesh-ancestor
19507776|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
19507777|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19507778|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19507779|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507780|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19507781|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19507782|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20096028|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096029|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096030|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096031|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507783|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507784|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
19507785|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19507786|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19507787|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096032|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507788|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
19507789|NCT03044041|Coagulants|coagulants|mesh-ancestor
19507790|NCT03044093|Misoprostol|misoprostol|mesh-list
19507791|NCT03044093|Mifepristone|mifepristone|mesh-list
20096033|NCT00002542|Tamoxifen|tamoxifen|mesh-list
20096034|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
20096035|NCT00002542|Doxorubicin|doxorubicin|mesh-list
20096036|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096037|NCT00002542|Fluorouracil|fluorouracil|mesh-list
19507792|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19507793|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
19507794|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19507795|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507796|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19507797|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19507798|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
19507799|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19507800|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19507801|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19507802|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19507803|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
19507804|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19507805|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20096038|NCT00002542|Methotrexate|methotrexate|mesh-list
20096039|NCT00002542|Epirubicin|epirubicin|mesh-list
20096040|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096041|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
20096042|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096043|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096044|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096045|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
20096046|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096047|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096048|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19507806|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19507807|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19507808|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
19507809|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19507810|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19507811|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19507812|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19507813|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19507814|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19507815|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507816|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507817|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19507818|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507819|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507820|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
19507821|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507822|NCT03043677|Adalimumab|adalimumab|mesh-list
19507823|NCT03043677|Golimumab|golimumab|mesh-list
19507824|NCT03043677|Infliximab|infliximab|mesh-list
19507825|NCT03043677|Ustekinumab|ustekinumab|mesh-list
19507826|NCT03043677|Vedolizumab|vedolizumab|mesh-list
19507827|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19507828|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096049|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096050|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096051|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096052|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096053|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
20096054|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096055|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096056|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096057|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096058|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096059|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096060|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096061|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20096062|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
20096063|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096064|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096065|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20096066|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20096067|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20096068|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
20096069|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20096070|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096071|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507829|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
19507830|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19507831|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19507832|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19507833|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
19507834|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507835|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19507836|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19507837|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
19507838|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19507839|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507840|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19507841|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19507842|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19507843|NCT03043989|Clarithromycin|clarithromycin|mesh-list
19507844|NCT03043989|Docetaxel|docetaxel|mesh-list
19507845|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507846|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
19507847|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
19507848|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
19507849|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507850|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19507851|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507852|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19507853|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507854|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19507855|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19507856|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
19507857|NCT03043664|Lanreotide|lanreotide|mesh-list
19507858|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19507859|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507860|NCT03043950|Panitumumab|panitumumab|mesh-list
19507861|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19507862|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507863|NCT03043612|Doxazosin|doxazosin|mesh-list
19507864|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19507865|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20096072|NCT00002544|Docetaxel|docetaxel|mesh-list
20096073|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
19507866|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19507867|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19507868|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
19507869|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507870|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507871|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507872|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
19507873|NCT03043521|Lansoprazole|lansoprazole|mesh-list
19507874|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19507875|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19507876|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19507877|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507878|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571272|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571273|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571274|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
19571275|NCT02306161|Ifosfamide|ifosfamide|mesh-list
20096074|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096075|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096076|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096077|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096078|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096079|NCT00002544|Analgesics|analgesics|mesh-ancestor
20096080|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
20096081|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096082|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096083|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096084|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096085|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096086|NCT00002545|Carmustine|carmustine|mesh-list
19571276|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
19571277|NCT02306161|Doxorubicin|doxorubicin|mesh-list
20096087|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096088|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
20096089|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096090|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096091|NCT00002546|Ifosfamide|ifosfamide|mesh-list
20096092|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096093|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096094|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
19507879|NCT03043430|Midazolam|midazolam|mesh-list
19507880|NCT03043430|Ketamine|ketamine|mesh-list
19507881|NCT03043430|Analgesics|analgesics|mesh-ancestor
19507882|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
19507883|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507884|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507885|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19507886|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19507887|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
19507888|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
19507889|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507890|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20096095|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096096|NCT00002547|Cytarabine|cytarabine|mesh-list
20096097|NCT00002547|Cyclosporine|cyclosporine|mesh-list
20096098|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
20096099|NCT00002547|Busulfan|busulfan|mesh-list
20096100|NCT00002547|Methotrexate|methotrexate|mesh-list
20096101|NCT00002547|Cyclosporins|cyclosporins|mesh-list
20096102|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096103|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
20096104|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507891|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19507892|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507893|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507894|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19507895|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19507896|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19507897|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19507898|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19507899|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
19507900|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
19507901|NCT03043248|Digoxin|digoxin|mesh-list
19507902|NCT03043248|Midazolam|midazolam|mesh-list
19507903|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19507904|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19507905|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507906|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507907|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19507908|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19507909|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19507910|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19507911|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
19507912|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
19507913|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
19507914|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
19507915|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507916|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507917|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19507918|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19507919|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507920|NCT03043248|Protective Agents|protective agents|mesh-ancestor
19507921|NCT03043326|Tenofovir|tenofovir|mesh-list
19507922|NCT03043326|Emtricitabine|emtricitabine|mesh-list
19507923|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
19507924|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19507925|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19507926|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096105|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096106|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096107|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
20096108|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096109|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096110|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096111|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19507927|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096112|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
19507928|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507929|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19507930|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19507931|NCT03043482|Calcitriol|calcitriol|mesh-list
20096113|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096114|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096115|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
20096116|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096117|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096118|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096119|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096120|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
20096121|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096122|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
20096123|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20096124|NCT00002548|Interferons|interferons|mesh-list
20096125|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
20096126|NCT00002548|Dexamethasone|dexamethasone|mesh-list
20096127|NCT00002548|Prednisone|prednisone|mesh-list
20096128|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
20096129|NCT00002548|Melphalan|melphalan|mesh-list
19507932|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19507933|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507934|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19507935|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19507936|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507937|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19507938|NCT03043482|Vitamins|vitamins|mesh-ancestor
19507939|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
19507940|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19507941|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
19507942|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19507943|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19507944|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19507945|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20096130|NCT00002548|Carmustine|carmustine|mesh-list
20096131|NCT00002548|Doxorubicin|doxorubicin|mesh-list
20096132|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096133|NCT00002548|Vincristine|vincristine|mesh-list
20096134|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096135|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
20096136|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507946|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507947|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
19507948|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19507949|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507950|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19507951|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507952|NCT03043443|Melatonin|melatonin|mesh-list
19507953|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
19507954|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507955|NCT03043443|Protective Agents|protective agents|mesh-ancestor
19507956|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507957|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19507958|NCT03043495|Dexamethasone|dexamethasone|mesh-list
19507959|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19507960|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
19507961|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
19507962|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507963|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507964|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19507965|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
19507966|NCT03043495|Hormones|hormones|mesh-ancestor
19507967|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19507968|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19507969|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19507970|NCT03043157|Rocuronium|rocuronium|mesh-list
19507971|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19507972|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19507973|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20096137|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096138|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096139|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
20096140|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096141|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096142|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096143|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096144|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
19507974|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19507975|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507976|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19507977|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19507978|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19507979|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
19507980|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19507981|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19507982|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19507983|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19507984|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
19507985|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19507986|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19507987|NCT03042936|Insulin|insulin|mesh-list
19507988|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19507989|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507990|NCT03042923|Mannitol|mannitol|mesh-list
19507991|NCT03042923|Lactulose|lactulose|mesh-list
19507992|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19507993|NCT03042923|Diuretics|diuretics|mesh-ancestor
19507994|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
19507995|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19507996|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19507997|NCT03043001|Memantine|memantine|mesh-list
19507998|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19507999|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19508000|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
19508001|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508002|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508003|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508004|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19508005|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19508006|NCT03043027|Bupivacaine|bupivacaine|mesh-list
19508007|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
20096145|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
20096146|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508008|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
19508009|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508010|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508011|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
19508012|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508013|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19508014|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19508015|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508016|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
19508017|NCT03043014|Misoprostol|misoprostol|mesh-list
19508018|NCT03043014|Mifepristone|mifepristone|mesh-list
19508019|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19508020|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
19508021|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19508022|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508023|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19508024|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19508025|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
19508026|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19508027|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19508028|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19508029|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19508030|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
19508031|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19508032|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19508033|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
19508034|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508035|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
19508036|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19508037|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19508038|NCT03042871|Ranibizumab|ranibizumab|mesh-list
19508039|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19508040|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19508041|NCT03042871|Growth Substances|growth substances|mesh-ancestor
19508042|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508043|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
19508044|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508045|NCT03042546|Calcium|calcium|mesh-list
19571278|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19508046|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508047|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508048|NCT03042637|Tacrolimus|tacrolimus|mesh-list
19508049|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508050|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
19508051|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508052|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20096147|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20096148|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
20096149|NCT00002548|Hormones|hormones|mesh-ancestor
20096150|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096151|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096152|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096153|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096154|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096155|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508053|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508054|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508055|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
19508056|NCT03042429|Ifosfamide|ifosfamide|mesh-list
19508057|NCT03042429|Cisplatin|cisplatin|mesh-list
20096156|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
20096157|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096158|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096159|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096160|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096161|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096162|NCT00002549|Cytarabine|cytarabine|mesh-list
20096163|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
19508058|NCT03042429|Doxorubicin|doxorubicin|mesh-list
19508059|NCT03042429|Etoposide|etoposide|mesh-list
19508060|NCT03042429|Topotecan|topotecan|mesh-list
19508061|NCT03042429|Vindesine|vindesine|mesh-list
20603275|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20603276|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603277|NCT02220296|Insulin|insulin|mesh-list
20603278|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20603279|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
20603280|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603281|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603282|NCT02220335|Digoxin|digoxin|mesh-list
20603283|NCT02220335|Diuretics|diuretics|mesh-list
20603284|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20603285|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20603286|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20603287|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19508062|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508063|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
19508064|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508065|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508066|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19508067|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
19508068|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508069|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508070|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19508071|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19508072|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19508073|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19508074|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508075|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19508076|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19508077|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
19508078|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
19508079|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
19508080|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
19508081|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19508082|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19508083|NCT03042377|Calcium|calcium|mesh-list
19508084|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508085|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508086|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19508087|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096164|NCT00002549|Busulfan|busulfan|mesh-list
19508088|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
20096165|NCT00002549|Etoposide|etoposide|mesh-list
20603288|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508089|NCT03042611|Apatinib|apatinib|mesh-list
19508090|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508091|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19508092|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508093|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508094|NCT03042325|Alogliptin|alogliptin|mesh-list
19508095|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19508096|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508097|NCT03042325|Incretins|incretins|mesh-ancestor
19508098|NCT03042325|Hormones|hormones|mesh-ancestor
19508099|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508100|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19508101|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603289|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508102|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508103|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508104|NCT03042260|Trimethoprim|trimethoprim|mesh-list
19508105|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19508106|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
19508107|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19508108|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508109|NCT03042260|Renal Agents|renal agents|mesh-ancestor
19508110|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
19508111|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19508112|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19508113|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19508114|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508115|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508116|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19508117|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19508118|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19508119|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19508120|NCT03042234|Insulin|insulin|mesh-list
19508121|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19508122|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19508123|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508124|NCT03041883|Riboflavin|riboflavin|mesh-list
19508125|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
19508126|NCT03041883|Vitamins|vitamins|mesh-ancestor
19508127|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
19508128|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508129|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19508130|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
19508131|NCT03041935|Acetaminophen|acetaminophen|mesh-list
19508132|NCT03041935|Dexamethasone|dexamethasone|mesh-list
19508133|NCT03041935|Ketorolac|ketorolac|mesh-list
19508134|NCT03041935|Morphine|morphine|mesh-list
19508135|NCT03041935|Remifentanil|remifentanil|mesh-list
19508136|NCT03041935|Ondansetron|ondansetron|mesh-list
19508137|NCT03041935|Propofol|propofol|mesh-list
19508138|NCT03041935|Ropivacaine|ropivacaine|mesh-list
19508139|NCT03041935|Sevoflurane|sevoflurane|mesh-list
19508140|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508141|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
19508142|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
19508143|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508144|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508145|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19508146|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
19508147|NCT03041935|Hormones|hormones|mesh-ancestor
19508148|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508149|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19508150|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508151|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19508152|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508153|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19508154|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
19508155|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
19508156|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19508157|NCT03041935|Narcotics|narcotics|mesh-ancestor
19508158|NCT03041935|Analgesics|analgesics|mesh-ancestor
19508159|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
19508160|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
19508161|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508162|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
19508163|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19508164|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19508165|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
19508166|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
19508167|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19508168|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
19508169|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508170|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508171|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19508172|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19508173|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508174|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19508175|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19508176|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508177|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19508178|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508179|NCT03042013|Naquotinib|naquotinib|mesh-list
19508180|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508181|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19508182|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508183|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508184|NCT03042000|Capecitabine|capecitabine|mesh-list
19508185|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
19508186|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19508187|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
19508188|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508189|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508190|NCT03041948|Acetaminophen|acetaminophen|mesh-list
19508191|NCT03041948|Dexamethasone|dexamethasone|mesh-list
19508192|NCT03041948|Ketorolac|ketorolac|mesh-list
19508193|NCT03041948|Morphine|morphine|mesh-list
19508194|NCT03041948|Remifentanil|remifentanil|mesh-list
19508195|NCT03041948|Ondansetron|ondansetron|mesh-list
19508196|NCT03041948|Propofol|propofol|mesh-list
19508197|NCT03041948|Sevoflurane|sevoflurane|mesh-list
19508198|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508199|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
19508200|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
19508201|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508202|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508203|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19508204|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
19508205|NCT03041948|Hormones|hormones|mesh-ancestor
19508206|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508207|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19508208|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508209|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19508210|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508211|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19508212|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
19508213|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
19508214|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19508215|NCT03041948|Narcotics|narcotics|mesh-ancestor
19508216|NCT03041948|Analgesics|analgesics|mesh-ancestor
19508217|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
19508218|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508219|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
19508220|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19508221|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19508222|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
19508223|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
19508224|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19508225|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
19508226|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508227|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508228|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19508229|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19508230|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508231|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19508232|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20603290|NCT02220335|Protective Agents|protective agents|mesh-ancestor
20603291|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603292|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
20603293|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603294|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
19508233|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508234|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19508235|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508236|NCT03042182|Vaccines|vaccines|mesh-list
19508237|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
19508238|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508239|NCT03042091|Metronidazole|metronidazole|mesh-list
19508240|NCT03042091|Ethanol|ethanol|mesh-list
19508241|NCT03042091|Neomycin|neomycin|mesh-list
19508242|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508243|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19508244|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19508245|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19508246|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20096166|NCT00002549|Daunorubicin|daunorubicin|mesh-list
20096167|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
19508247|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508248|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508249|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19508250|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508251|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508252|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
19508253|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19508254|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508255|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508256|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
19508257|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508258|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508259|NCT03041779|Acetaminophen|acetaminophen|mesh-list
19508260|NCT03041779|Diclofenac|diclofenac|mesh-list
19508261|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508262|NCT03041779|Analgesics|analgesics|mesh-ancestor
19508263|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
19508264|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508265|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508266|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
19508267|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19508268|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508269|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508270|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19508271|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508272|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571279|NCT02306161|Etoposide|etoposide|mesh-list
19571280|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
19571281|NCT02306161|Vincristine|vincristine|mesh-list
19571282|NCT02306161|Daunorubicin|daunorubicin|mesh-list
19571283|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
19571284|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19571285|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571286|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
19571287|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571288|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571289|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571290|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
19571291|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571292|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571293|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571294|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19571295|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19571296|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19571297|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571298|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571299|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571300|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571301|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571302|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
19571303|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
19571304|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
19571305|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19571306|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
19571307|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571308|NCT02273375|Durvalumab|durvalumab|mesh-list
19571309|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571310|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571311|NCT02255799|Donepezil|donepezil|mesh-list
19571312|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19571313|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571314|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571315|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
20096168|NCT00002549|Idarubicin|idarubicin|mesh-list
19508273|NCT03041506|Lidocaine|lidocaine|mesh-list
19508274|NCT03041506|Midazolam|midazolam|mesh-list
19508275|NCT03041506|Ketamine|ketamine|mesh-list
19508276|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
19508277|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
19508278|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508279|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508280|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
19508281|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508282|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19508283|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19508284|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19508285|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508286|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508287|NCT03041506|Analgesics|analgesics|mesh-ancestor
19508288|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19508289|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19508290|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
19508291|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19508292|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19508293|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508294|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19508295|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19508296|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19508297|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19508298|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508299|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
19508300|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
19508301|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19508302|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508303|NCT03040999|Cisplatin|cisplatin|mesh-list
19508304|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
19508305|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508306|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19508307|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19508308|NCT03041012|Romidepsin|romidepsin|mesh-list
19508309|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
19508310|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
19508311|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508312|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19508313|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508314|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
19508315|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508316|NCT03040934|Sirolimus|sirolimus|mesh-list
19508317|NCT03040934|Everolimus|everolimus|mesh-list
19508318|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508319|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508320|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
19508321|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508322|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19508323|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508324|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19508325|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
19508326|NCT03040791|Nivolumab|nivolumab|mesh-list
19508327|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19508328|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508329|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19508330|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508331|NCT03040830|Progesterone|progesterone|mesh-list
19508332|NCT03040830|Progestins|progestins|mesh-ancestor
19508333|NCT03040830|Hormones|hormones|mesh-ancestor
19508334|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508335|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508336|NCT03040752|Nifedipine|nifedipine|mesh-list
19508337|NCT03040752|Ritodrine|ritodrine|mesh-list
19508338|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19508339|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508340|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508341|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508342|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508343|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
19508344|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
19508345|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19508346|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
19508347|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
19508348|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508349|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19508350|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19508351|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19508352|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
19508353|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508354|NCT03040817|Esomeprazole|esomeprazole|mesh-list
19508355|NCT03040817|Mosapride|mosapride|mesh-list
19508356|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508357|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19508358|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19508359|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19508360|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508361|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19508362|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
19508363|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508364|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508365|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
19508366|NCT03040765|Denosumab|denosumab|mesh-list
19508367|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19508368|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508369|NCT03040635|Risdiplam|risdiplam|mesh-list
19508370|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19508371|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508372|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508373|NCT03040596|Fluticasone|fluticasone|mesh-list
19508374|NCT03040596|Xhance|xhance|mesh-list
19508375|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508376|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19508377|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
19508378|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508379|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508380|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19508381|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
19508382|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
19508383|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19508384|NCT03040531|Vitamin D|vitamin d|mesh-list
19508385|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
19508386|NCT03040531|Alendronate|alendronate|mesh-list
19508387|NCT03040531|Genistein|genistein|mesh-list
19508388|NCT03040531|Calcium|calcium|mesh-list
19508389|NCT03040531|Vitamins|vitamins|mesh-ancestor
19508390|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
19508391|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508392|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508393|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19508394|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19508395|NCT03040531|Protective Agents|protective agents|mesh-ancestor
19508396|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508397|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19508398|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508399|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508400|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
19508401|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19508402|NCT03040531|Estrogens|estrogens|mesh-ancestor
19508403|NCT03040531|Hormones|hormones|mesh-ancestor
19508404|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508405|NCT03040219|Folic Acid|folic acid|mesh-list
19508406|NCT03040219|Hematinics|hematinics|mesh-ancestor
19508407|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
19508408|NCT03040219|Vitamins|vitamins|mesh-ancestor
19508409|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
19508410|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508411|NCT03040141|Oseltamivir|oseltamivir|mesh-list
19508412|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
19508413|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508414|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508415|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508416|NCT03040401|Aldesleukin|aldesleukin|mesh-list
19508417|NCT03040401|Interleukin-2|interleukin-2|mesh-list
19508418|NCT03040401|Histamine|histamine|mesh-list
19508419|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
19508420|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508421|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19508422|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20096169|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508423|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
19508424|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096170|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
19508425|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508426|NCT03040401|Analgesics|analgesics|mesh-ancestor
19508427|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
19508428|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508429|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508430|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
19508431|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
19508432|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508433|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508434|NCT03040180|Bleomycin|bleomycin|mesh-list
19508435|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19508436|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508437|NCT03040167|Epinephrine|epinephrine|mesh-list
19508438|NCT03040167|Bupivacaine|bupivacaine|mesh-list
19508439|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
19508440|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
19508441|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508442|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508443|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
19508444|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508445|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19508446|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19508447|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
19508448|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508449|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508450|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19508451|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19508452|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
19508453|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19508454|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
19508455|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
19508456|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
19508457|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19508458|NCT03040193|Lidocaine|lidocaine|mesh-list
19508459|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
19508460|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
19508461|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508462|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508463|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
19508464|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508465|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19508466|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19508467|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19508468|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508469|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508470|NCT03040128|Minocycline|minocycline|mesh-list
19508471|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19508472|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508473|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
19508474|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
19508475|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508476|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508477|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508478|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
19508479|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19508480|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508481|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571316|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571317|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571318|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
19571319|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
19571320|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19571321|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571322|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
19571323|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19571324|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571325|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19571326|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571327|NCT02145143|Vemurafenib|vemurafenib|mesh-list
19571328|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571329|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571330|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571331|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607899|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571332|NCT02131493|Gemcitabine|gemcitabine|mesh-list
19508482|NCT03039842|Valproic Acid|valproic acid|mesh-list
19508483|NCT03039842|Memantine|memantine|mesh-list
19508484|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
19508485|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19508486|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19508487|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
19508488|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508489|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508490|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508491|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19508492|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20096171|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096172|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096173|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096174|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
20096175|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096176|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508493|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
19508494|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
19508495|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
19508496|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508497|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
19508498|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
19508499|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19508500|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508501|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508502|NCT03039608|Prednisone|prednisone|mesh-list
19508503|NCT03039608|Triamcinolone|triamcinolone|mesh-list
19508504|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508505|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
19508506|NCT03039608|Hormones|hormones|mesh-ancestor
19508507|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508508|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508509|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19508510|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508511|NCT03039413|Copper|copper|mesh-list
19508512|NCT03039413|Trace Elements|trace elements|mesh-ancestor
19508513|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
19508514|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508515|NCT03039491|Vaccines|vaccines|mesh-list
19508516|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19508517|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
19508518|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508519|NCT03039426|Diclofenac|diclofenac|mesh-list
19508520|NCT03039426|Bupivacaine|bupivacaine|mesh-list
19508521|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
19508522|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
19508523|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508524|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508525|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
19508526|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508527|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19508528|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508529|NCT03039426|Analgesics|analgesics|mesh-ancestor
19508530|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508531|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508532|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19508533|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508534|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508535|NCT03039478|Erythritol|erythritol|mesh-list
19508536|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
19508537|NCT03039205|Clopidogrel|clopidogrel|mesh-list
19508538|NCT03039205|Ticagrelor|ticagrelor|mesh-list
19508539|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19508540|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19508541|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19508542|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19508543|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
19508544|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508545|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508546|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508547|NCT03039257|Vitamin A|vitamin a|mesh-list
20096177|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19508548|NCT03039257|Vitamins|vitamins|mesh-ancestor
19508549|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
19508550|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508551|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
19508552|NCT03038919|Testosterone|testosterone|mesh-list
19508553|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
19508554|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
19508555|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19508556|NCT03038919|Androgens|androgens|mesh-ancestor
19508557|NCT03038919|Hormones|hormones|mesh-ancestor
19508558|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508559|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508560|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19508561|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508562|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
19508563|NCT03039101|Montelukast|montelukast|mesh-list
19508564|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19508565|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
19508566|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19508567|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
19508568|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508569|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508570|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19508571|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19508572|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508573|NCT03038958|Prilocaine|prilocaine|mesh-list
19508574|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
19508575|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
20096178|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096179|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096180|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096181|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096182|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096183|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
20096184|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
20096185|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508576|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
19508577|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508578|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508579|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
19508580|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508581|NCT03039075|Metformin|metformin|mesh-list
19508582|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19508583|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508584|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19508585|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
20096186|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096187|NCT00002549|Analgesics|analgesics|mesh-ancestor
20096188|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
20096189|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096190|NCT00002550|Etoposide|etoposide|mesh-list
20096191|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096192|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096193|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096194|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096195|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096196|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096197|NCT00002551|Leucovorin|leucovorin|mesh-list
20096198|NCT00002551|Levamisole|levamisole|mesh-list
20096199|NCT00002551|Fluorouracil|fluorouracil|mesh-list
20096200|NCT00002551|Calcium|calcium|mesh-list
20096201|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
20096202|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20096203|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096204|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
20096205|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096206|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19508586|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19508587|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
19508588|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19508589|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508590|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19508591|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19508592|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508593|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
19508594|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
19508595|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
20096207|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096208|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096209|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
20096210|NCT00002551|Antidotes|antidotes|mesh-ancestor
20096211|NCT00002551|Protective Agents|protective agents|mesh-ancestor
20096212|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096213|NCT00002551|Vitamins|vitamins|mesh-ancestor
20096214|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
20096215|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20096216|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
20096217|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
20096218|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20096219|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096220|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096221|NCT00002552|Leucovorin|leucovorin|mesh-list
20096222|NCT00002552|Cytarabine|cytarabine|mesh-list
20096223|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
20096224|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20096225|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19508596|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508597|NCT03038607|Aspirin|aspirin|mesh-list
20096226|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20096227|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
20096228|NCT00002552|Carmustine|carmustine|mesh-list
19508598|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19508599|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508600|NCT03038607|Analgesics|analgesics|mesh-ancestor
19508601|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
19508602|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508603|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508604|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508605|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508606|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19508607|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19508608|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508609|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19508610|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19508611|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508612|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
19508613|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
19508614|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508615|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508616|NCT03038516|Vitamins|vitamins|mesh-ancestor
19508617|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
20096229|NCT00002552|Methotrexate|methotrexate|mesh-list
20096230|NCT00002552|Etoposide|etoposide|mesh-list
20096231|NCT00002552|Sargramostim|sargramostim|mesh-list
19508618|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19508619|NCT03038477|Durvalumab|durvalumab|mesh-list
19508620|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19508621|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508622|NCT03038503|Terlipressin|terlipressin|mesh-list
19508623|NCT03038503|Methylene Blue|methylene blue|mesh-list
19508624|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508625|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508626|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19508627|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19508628|NCT03038451|Amlodipine|amlodipine|mesh-list
19508629|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19508630|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19508631|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508632|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508633|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508634|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508635|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
19508636|NCT03038243|Vaccines|vaccines|mesh-list
19508637|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
19508638|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508639|NCT03038295|Propranolol|propranolol|mesh-list
19508640|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19508641|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20096232|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
20096233|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096234|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
20096235|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096236|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096237|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096238|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
19508642|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
20096239|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096240|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508643|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508644|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508645|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508646|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19508647|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19508648|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
19508649|NCT03038321|Levofloxacin|levofloxacin|mesh-list
19508650|NCT03038321|Lornoxicam|lornoxicam|mesh-list
19508651|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19508652|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508653|NCT03038321|Renal Agents|renal agents|mesh-ancestor
19508654|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19508655|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19508656|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19508657|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508658|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508659|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508660|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19508661|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19508662|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19508663|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508664|NCT03038321|Analgesics|analgesics|mesh-ancestor
19508665|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
19508666|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508667|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508668|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508669|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508670|NCT03038282|Chromium|chromium|mesh-list
19508671|NCT03038282|Chromous chloride|chromous chloride|mesh-list
19508672|NCT03038282|Trace Elements|trace elements|mesh-ancestor
19508673|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
19508674|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096241|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096242|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096243|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096244|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096245|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096246|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
20096247|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096248|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096249|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096250|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096251|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096252|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096253|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096254|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
20096255|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508675|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
19508676|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508677|NCT03038282|Protective Agents|protective agents|mesh-ancestor
19508678|NCT03038217|Capecitabine|capecitabine|mesh-list
19508679|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
19508680|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19508681|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
19508682|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508683|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508684|NCT03038425|Ropivacaine|ropivacaine|mesh-list
19508685|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
19508686|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
20096256|NCT00002552|Antidotes|antidotes|mesh-ancestor
20096257|NCT00002552|Protective Agents|protective agents|mesh-ancestor
20096258|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096259|NCT00002552|Vitamins|vitamins|mesh-ancestor
20096260|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
20096261|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096262|NCT00002553|Cobalt|cobalt|mesh-list
20096263|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
20096264|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508687|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20096265|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
20096266|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508688|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508689|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
19508690|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508691|NCT03038256|Capecitabine|capecitabine|mesh-list
19508692|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19508693|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
19508694|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508695|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508696|NCT03038230|Antibodies|antibodies|mesh-list
19508697|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19508698|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
19508699|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508700|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
19508701|NCT03038334|Analgesics|analgesics|mesh-ancestor
19508702|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
19508703|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508704|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508705|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
19508706|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508707|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19508708|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
19508709|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19508710|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508711|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508712|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508713|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
19508714|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571333|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571334|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
19571335|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571336|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571337|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
19571338|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571339|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571340|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571341|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
19571342|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571343|NCT02115295|Cytarabine|cytarabine|mesh-list
19571344|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19571345|NCT02115295|Venetoclax|venetoclax|mesh-list
19571346|NCT02115295|Idarubicin|idarubicin|mesh-list
19571347|NCT02115295|Cladribine|cladribine|mesh-list
19571348|NCT02115295|Midostaurin|midostaurin|mesh-list
19571349|NCT02115295|Staurosporine|staurosporine|mesh-list
19571350|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571351|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
19571352|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571353|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571354|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
19571355|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571356|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571357|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
19571358|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571359|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19571360|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19571361|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19571362|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571363|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571364|NCT02108964|Nazartinib|nazartinib|mesh-list
19571365|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571366|NCT02096159|Trimethoprim|trimethoprim|mesh-list
19571367|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19571368|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
19571369|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19571370|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571371|NCT02096159|Renal Agents|renal agents|mesh-ancestor
19571372|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
19571373|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19571374|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19571375|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19571376|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571377|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571378|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19571379|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19571380|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19508715|NCT03037970|Becaplermin|becaplermin|mesh-list
19508716|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
19508717|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
19508718|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19508719|NCT03037970|Growth Substances|growth substances|mesh-ancestor
19508720|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508721|NCT03037944|Drospirenone|drospirenone|mesh-list
19508722|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
19508723|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19508724|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19508725|NCT03037944|Estradiol|estradiol|mesh-list
19508726|NCT03037944|Estrogens|estrogens|mesh-ancestor
19508727|NCT03037944|Hormones|hormones|mesh-ancestor
19508728|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508729|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508730|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19508731|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
19508732|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19508733|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19508734|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19508735|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19508736|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19508737|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19508738|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
19508739|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19508740|NCT03037944|Diuretics|diuretics|mesh-ancestor
19508741|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
19508742|NCT03038048|Ranibizumab|ranibizumab|mesh-list
19508743|NCT03038048|Aflibercept|aflibercept|mesh-list
19508744|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19508745|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19508746|NCT03038048|Growth Substances|growth substances|mesh-ancestor
19508747|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508748|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
19508749|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508750|NCT03037775|Nicotine|nicotine|mesh-list
19508751|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19508752|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
19508753|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508754|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508755|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19508756|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19508757|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
19508758|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508759|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508760|NCT03037736|Bevacizumab|bevacizumab|mesh-list
19508761|NCT03037736|Fluorouracil|fluorouracil|mesh-list
19508762|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20096267|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508763|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508764|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19508765|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19508766|NCT03037736|Growth Substances|growth substances|mesh-ancestor
19508767|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508768|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
19508769|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
19508770|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508771|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19508772|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508773|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
19508774|NCT03037892|Fentanyl|fentanyl|mesh-list
19508775|NCT03037892|Midazolam|midazolam|mesh-list
19508776|NCT03037892|Remifentanil|remifentanil|mesh-list
19508777|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19508778|NCT03037892|Narcotics|narcotics|mesh-ancestor
19508779|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508780|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508781|NCT03037892|Analgesics|analgesics|mesh-ancestor
20096268|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096269|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
20096270|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096271|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096272|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19508782|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
19508783|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508784|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19508785|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19508786|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
19508787|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
19508788|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19508789|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19508790|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19508791|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508792|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
19508793|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
19508794|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508795|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508796|NCT03038009|Pantoprazole|pantoprazole|mesh-list
19508797|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19508798|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19508799|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19508800|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508801|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508802|NCT03037606|Rabeprazole|rabeprazole|mesh-list
19508803|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19508804|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19508805|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19508806|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508807|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508808|NCT03037593|Vitamin D|vitamin d|mesh-list
19508809|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
19508810|NCT03037593|Vitamins|vitamins|mesh-ancestor
19508811|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
19508812|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508813|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19508814|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19508815|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
19508816|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20096273|NCT00002553|Trace Elements|trace elements|mesh-ancestor
20096274|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
20096275|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
20096276|NCT00002554|Busulfan|busulfan|mesh-list
20096277|NCT00002554|Methotrexate|methotrexate|mesh-list
20096278|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508817|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19508818|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096279|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
20096280|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096281|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096282|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096283|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
20096284|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508819|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
19508820|NCT03037515|Coagulants|coagulants|mesh-ancestor
19508821|NCT03037372|Atorvastatin|atorvastatin|mesh-list
19508822|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19508823|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19508824|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19508825|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19508826|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
19508827|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508828|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19508829|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508830|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
19508831|NCT03037437|Sorafenib|sorafenib|mesh-list
19508832|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508833|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19508834|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508835|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508836|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
19508837|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19508838|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19508839|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508840|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508841|NCT03036995|Apremilast|apremilast|mesh-list
19508842|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19508843|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19508844|NCT03036995|Analgesics|analgesics|mesh-ancestor
19508845|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
19508846|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096285|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096286|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096287|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096288|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096289|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19508847|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508848|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508849|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508850|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19508851|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19508852|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508853|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508854|NCT03036826|Meropenem|meropenem|mesh-list
19508855|NCT03036826|Tazobactam|tazobactam|mesh-list
19508856|NCT03036826|Piperacillin|piperacillin|mesh-list
19508857|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19508858|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19508859|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19508860|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19508861|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508862|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508863|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19508864|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19508865|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19508866|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508867|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508868|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19508869|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508870|NCT03037073|Analgesics|analgesics|mesh-ancestor
19508871|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
19508872|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508873|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
19508874|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508875|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
19508876|NCT03036891|Naloxegol|naloxegol|mesh-list
19508877|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19508878|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508879|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
19508880|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096290|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096291|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
20096292|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096293|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096294|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096295|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19508881|NCT03036800|Liraglutide|liraglutide|mesh-list
19508882|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19508883|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508884|NCT03036800|Incretins|incretins|mesh-ancestor
19508885|NCT03036800|Hormones|hormones|mesh-ancestor
19508886|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508887|NCT03036904|Prednisone|prednisone|mesh-list
19508888|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
20096296|NCT00002555|Cobalt|cobalt|mesh-list
20096297|NCT00002555|Trace Elements|trace elements|mesh-ancestor
20096298|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
20096299|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096300|NCT00002556|Interferons|interferons|mesh-list
20096301|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
19508889|NCT03036904|Rituximab|rituximab|mesh-list
19508890|NCT03036904|Doxorubicin|doxorubicin|mesh-list
19508891|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19508892|NCT03036904|Etoposide|etoposide|mesh-list
19508893|NCT03036904|Vincristine|vincristine|mesh-list
19508894|NCT03036904|Venetoclax|venetoclax|mesh-list
19508895|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508896|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
19508897|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508898|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508899|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19508900|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
19508901|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508902|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748926|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096302|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
20096303|NCT00002556|Prednisone|prednisone|mesh-list
20096304|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
19508903|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19508904|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19508905|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19508906|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19508907|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19508908|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508909|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508910|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
19508911|NCT03036904|Hormones|hormones|mesh-ancestor
19508912|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508913|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19508914|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19508915|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
19508916|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
19508917|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
19508918|NCT03036748|Amiloride|amiloride|mesh-list
19508919|NCT03036748|Diuretics|diuretics|mesh-ancestor
19508920|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
19508921|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508922|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19508923|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19508924|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19508925|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508926|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19508927|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19508928|NCT03036488|Paclitaxel|paclitaxel|mesh-list
19508929|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
19508930|NCT03036488|Carboplatin|carboplatin|mesh-list
19508931|NCT03036488|Doxorubicin|doxorubicin|mesh-list
19508932|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
19508933|NCT03036488|Epirubicin|epirubicin|mesh-list
19508934|NCT03036488|Lenograstim|lenograstim|mesh-list
19508935|NCT03036488|Sargramostim|sargramostim|mesh-list
19508936|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19508937|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508938|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
19508939|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
19508940|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
19508941|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508942|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19508943|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
19508944|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508945|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19508946|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19508947|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
19508948|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19508949|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19508950|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19508951|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19508952|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508953|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19508954|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19508955|NCT03036605|Dexamethasone|dexamethasone|mesh-list
19508956|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
19508957|NCT03036605|Bupivacaine|bupivacaine|mesh-list
19508958|NCT03036605|BB 1101|bb 1101|mesh-list
19508959|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19508960|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
19508961|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
19508962|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508963|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508964|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19508965|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
19508966|NCT03036605|Hormones|hormones|mesh-ancestor
19508967|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19508968|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19508969|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508970|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
19508971|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508972|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508973|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
19508974|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
19508975|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508976|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
19508977|NCT03036501|Risdiplam|risdiplam|mesh-list
19508978|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19508979|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508980|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508981|NCT03036514|Sufentanil|sufentanil|mesh-list
20096305|NCT00002556|Melphalan|melphalan|mesh-list
20096306|NCT00002556|Carmustine|carmustine|mesh-list
20096307|NCT00002556|Vincristine|vincristine|mesh-list
20096308|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096309|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
19508982|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19508983|NCT03036514|Narcotics|narcotics|mesh-ancestor
19508984|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19508985|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19508986|NCT03036514|Analgesics|analgesics|mesh-ancestor
20096310|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096311|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096312|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096313|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
20096314|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096315|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19508987|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
19508988|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19508989|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19508990|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20096316|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096317|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096318|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
20096319|NCT00002556|Hormones|hormones|mesh-ancestor
20096320|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096321|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096322|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
20096323|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096324|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19508991|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
19508992|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
19508993|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
19508994|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
19508995|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19508996|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19508997|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19508998|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
19508999|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19509000|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509001|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571381|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19571382|NCT02079740|Trametinib|trametinib|mesh-list
19571383|NCT02079740|Navitoclax|navitoclax|mesh-list
19571384|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096325|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096326|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096327|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571385|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571386|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571387|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571388|NCT01989598|Trametinib|trametinib|mesh-list
19571389|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571390|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571391|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571392|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571393|NCT01939275|Copper|copper|mesh-list
19571394|NCT01939275|Trastuzumab|trastuzumab|mesh-list
19571395|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20096328|NCT00002557|Leucovorin|leucovorin|mesh-list
20096329|NCT00002557|Doxorubicin|doxorubicin|mesh-list
20096330|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096331|NCT00002557|Etoposide|etoposide|mesh-list
20096332|NCT00002557|Methotrexate|methotrexate|mesh-list
20096333|NCT00002557|Calcium|calcium|mesh-list
20096334|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
20096335|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096336|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571396|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096337|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096338|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19571397|NCT01939275|Trace Elements|trace elements|mesh-ancestor
19571398|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
20096339|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509002|NCT03036644|Nicotine|nicotine|mesh-list
19509003|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19509004|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
19509005|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509006|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509007|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19509008|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19509009|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
19509010|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509011|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509012|NCT03036046|Fluconazole|fluconazole|mesh-list
19509013|NCT03036046|Posaconazole|posaconazole|mesh-list
19509014|NCT03036046|Olorofim|olorofim|mesh-list
19509015|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
19509016|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509017|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19509018|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19509019|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509020|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509021|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19509022|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
19509023|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509024|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603295|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603296|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20603297|NCT02220348|Linaclotide|linaclotide|mesh-list
20603298|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20603299|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
20607900|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509025|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19509026|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19509027|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19509028|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19509029|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19509030|NCT03036202|Epinephrine|epinephrine|mesh-list
19509031|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19509032|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19509033|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509034|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509035|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509036|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509037|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19509038|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19509039|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
19509040|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509041|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19509042|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
19509043|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
19509044|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
19509045|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19509046|NCT03036059|Ivermectin|ivermectin|mesh-list
19509047|NCT03036059|Albendazole|albendazole|mesh-list
19509048|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19509049|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509050|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
19509051|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
19509052|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19509053|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19509054|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
19509055|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
19509056|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
19509057|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509058|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509059|NCT03036111|Trimebutine|trimebutine|mesh-list
19509060|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509061|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
19509062|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
19509063|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509064|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509065|NCT03036085|Epinephrine|epinephrine|mesh-list
19509066|NCT03036085|Bupivacaine|bupivacaine|mesh-list
19509067|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509068|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
19509069|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19748927|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509070|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509071|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
19509072|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509073|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19509074|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19509075|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509076|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509077|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509078|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19509079|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19509080|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
19509081|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19509082|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
19509083|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
19509084|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
19509085|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19509086|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
19509087|NCT03035838|Aprepitant|aprepitant|mesh-list
19509088|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
19509089|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
19509090|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509091|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509092|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509093|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19509094|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509095|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509096|NCT03035656|Ropivacaine|ropivacaine|mesh-list
19509097|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509098|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
19509099|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509100|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509101|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
19509102|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509103|NCT03035695|Hemostatics|hemostatics|mesh-list
19509104|NCT03035695|Coagulants|coagulants|mesh-ancestor
19509105|NCT03035578|Morphine|morphine|mesh-list
19509106|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19509107|NCT03035578|Narcotics|narcotics|mesh-ancestor
19509108|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509109|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509110|NCT03035578|Analgesics|analgesics|mesh-ancestor
19509111|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
19509112|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509113|NCT03035617|Bupivacaine|bupivacaine|mesh-list
19509114|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509115|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
19509116|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509117|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509118|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
19509119|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509120|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19509121|NCT03035357|Daratumumab|daratumumab|mesh-list
19509122|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509123|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
19509124|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
19509125|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19509126|NCT03035305|Amodiaquine|amodiaquine|mesh-list
19509127|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
19509128|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19509129|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19509130|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509131|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19509132|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509133|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509134|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19509135|NCT03035305|Renal Agents|renal agents|mesh-ancestor
19509136|NCT03035214|Dexamethasone|dexamethasone|mesh-list
19509137|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
19509138|NCT03035214|BB 1101|bb 1101|mesh-list
19509139|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509140|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
19509141|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
19509142|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509143|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509144|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509145|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
19509146|NCT03035214|Hormones|hormones|mesh-ancestor
19509147|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509148|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19509149|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509150|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
19509151|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509152|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509153|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
19509154|NCT03035331|Vaccines|vaccines|mesh-list
19509155|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
20096340|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096341|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20096342|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096343|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096344|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096345|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096346|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096347|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
20096348|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
19509156|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509157|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19509158|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509159|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19509160|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
19509161|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509162|NCT03035084|Vitamin D|vitamin d|mesh-list
19509163|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
19509164|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
19509165|NCT03035084|Vitamins|vitamins|mesh-list
19509166|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
19509167|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509168|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19509169|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20096349|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096350|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096351|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
20096352|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19509170|NCT03034941|Metformin|metformin|mesh-list
19509171|NCT03034941|Liraglutide|liraglutide|mesh-list
19509172|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19509173|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509174|NCT03034941|Incretins|incretins|mesh-ancestor
19509175|NCT03034941|Hormones|hormones|mesh-ancestor
19509176|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509177|NCT03034850|Doxorubicin|doxorubicin|mesh-list
19509178|NCT03034850|Fluorouracil|fluorouracil|mesh-list
19509179|NCT03034850|Ifosfamide|ifosfamide|mesh-list
19509180|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19509181|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509182|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19509183|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19509184|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509185|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509186|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
19509187|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19509188|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19509189|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
19509190|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509191|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19509192|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
19509193|NCT03034759|Insulin|insulin|mesh-list
19509194|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19509195|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509196|NCT03035058|Vedolizumab|vedolizumab|mesh-list
19509197|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509198|NCT03035045|Acetaminophen|acetaminophen|mesh-list
19509199|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19509200|NCT03035045|Analgesics|analgesics|mesh-ancestor
19509201|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
19509202|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509203|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509204|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
19509205|NCT03034733|Dexamethasone|dexamethasone|mesh-list
19509206|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509207|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
19509208|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
19509209|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509210|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509211|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509212|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
19509213|NCT03034733|Hormones|hormones|mesh-ancestor
19509214|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509215|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19509216|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509217|NCT03034707|Biotin|biotin|mesh-list
19509218|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
19509219|NCT03034707|Vitamins|vitamins|mesh-ancestor
19509220|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
19509221|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571399|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571400|NCT01831076|Tamoxifen|tamoxifen|mesh-list
19571401|NCT01831076|Exemestane|exemestane|mesh-list
19571402|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19571403|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
19571404|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571405|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571406|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096353|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096354|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096355|NCT00002557|Antidotes|antidotes|mesh-ancestor
20096356|NCT00002557|Protective Agents|protective agents|mesh-ancestor
20096357|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096358|NCT00002557|Vitamins|vitamins|mesh-ancestor
20096359|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
20096360|NCT00002559|Paclitaxel|paclitaxel|mesh-list
20096361|NCT00002559|Ifosfamide|ifosfamide|mesh-list
20096362|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096363|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096364|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096365|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096366|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096367|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096368|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096369|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
20096370|NCT00002560|Antibodies|antibodies|mesh-list
20096371|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20096372|NCT00002560|Sargramostim|sargramostim|mesh-list
20096373|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
20096374|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096375|NCT00002561|Doxorubicin|doxorubicin|mesh-list
20096376|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096377|NCT00002561|Bleomycin|bleomycin|mesh-list
20096378|NCT00002561|Dacarbazine|dacarbazine|mesh-list
20096379|NCT00002561|Vinblastine|vinblastine|mesh-list
19571407|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571408|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19571409|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19571410|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19571411|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19571412|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19571413|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571414|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571415|NCT01625611|Naltrexone|naltrexone|mesh-list
19571416|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19571417|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19571418|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571419|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
19571420|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603300|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603301|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20096380|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096381|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603302|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
20603303|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19509222|NCT03034408|Mannitol|mannitol|mesh-list
19509223|NCT03034408|Baclofen|baclofen|mesh-list
19509224|NCT03034408|Nalmefene|nalmefene|mesh-list
19509225|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19509226|NCT03034408|Diuretics|diuretics|mesh-ancestor
19509227|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
19509228|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509229|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19509230|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19509231|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509232|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19509233|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
19509234|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
19509235|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509236|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509237|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19509238|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
19509239|NCT03034382|Lidocaine|lidocaine|mesh-list
19509240|NCT03034382|Epinephrine|epinephrine|mesh-list
19509241|NCT03034382|Morphine|morphine|mesh-list
19509242|NCT03034382|Nalbuphine|nalbuphine|mesh-list
19509243|NCT03034382|Bupivacaine|bupivacaine|mesh-list
19509244|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509245|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
19509246|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509247|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509248|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
19509249|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509250|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19509251|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19509252|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19509253|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509254|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509255|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19509256|NCT03034382|Narcotics|narcotics|mesh-ancestor
19509257|NCT03034382|Analgesics|analgesics|mesh-ancestor
19509258|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19509259|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19509260|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509261|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509262|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20096382|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096383|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096384|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509263|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19509264|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
19509265|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19509266|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
19509267|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
19509268|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
19509269|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19509270|NCT03034304|Ifosfamide|ifosfamide|mesh-list
19509271|NCT03034304|Antibodies|antibodies|mesh-list
19509272|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
19509273|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509274|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19509275|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
20096385|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096386|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096387|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
20096388|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096389|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
19509276|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509277|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509278|NCT03034005|Budesonide|budesonide|mesh-list
19509279|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509280|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19509281|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
19509282|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509283|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509284|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19509285|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
19509286|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
19509287|NCT03034005|Hormones|hormones|mesh-ancestor
19509288|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509289|NCT03033589|Bupivacaine|bupivacaine|mesh-list
20096390|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096391|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096392|NCT00002562|Paclitaxel|paclitaxel|mesh-list
19509290|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19509291|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509292|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
19509293|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509294|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509295|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
19509296|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509297|NCT03033537|Verapamil|verapamil|mesh-list
19509298|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
19509299|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19509300|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096393|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096394|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096395|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096396|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096397|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096398|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096399|NCT00002565|Cytarabine|cytarabine|mesh-list
20096400|NCT00002565|Prednisone|prednisone|mesh-list
20096401|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
20096402|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
20096403|NCT00002565|Ifosfamide|ifosfamide|mesh-list
20096404|NCT00002565|Doxorubicin|doxorubicin|mesh-list
20096405|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096406|NCT00002565|Etoposide|etoposide|mesh-list
19509301|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19509302|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509303|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509304|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
19509305|NCT03033758|Budesonide|budesonide|mesh-list
19509306|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
19509307|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509308|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19509309|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
19509310|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509311|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096407|NCT00002565|Vincristine|vincristine|mesh-list
20096408|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
20096409|NCT00002565|Idarubicin|idarubicin|mesh-list
20096410|NCT00002565|Bleomycin|bleomycin|mesh-list
20096411|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096412|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
20096413|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096414|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096415|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096416|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
20096417|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096418|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096419|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19509312|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19509313|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
19509314|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
19509315|NCT03033758|Hormones|hormones|mesh-ancestor
19509316|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509317|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19509318|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19509319|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19509320|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509321|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509322|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509323|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
19509324|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19509325|NCT03033654|Protective Agents|protective agents|mesh-ancestor
19509326|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509327|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
19509328|NCT03033732|Buprenorphine|buprenorphine|mesh-list
19509329|NCT03033732|Methadone|methadone|mesh-list
19509330|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20096420|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19509331|NCT03033732|Naloxone|naloxone|mesh-list
20096421|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096422|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096423|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096424|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096425|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
20096426|NCT00002565|Hormones|hormones|mesh-ancestor
20096427|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096428|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096429|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096430|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096431|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
20096432|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
20096433|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096434|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096435|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096436|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096437|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
20096438|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
20096439|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096440|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20096441|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20096442|NCT00002565|Protective Agents|protective agents|mesh-ancestor
20096443|NCT00002565|Analgesics|analgesics|mesh-ancestor
19509332|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19509333|NCT03033732|Narcotics|narcotics|mesh-ancestor
19509334|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20096444|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
20096445|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
20096446|NCT00002566|Ifosfamide|ifosfamide|mesh-list
20096447|NCT00002566|Carboplatin|carboplatin|mesh-list
20096448|NCT00002566|Etoposide|etoposide|mesh-list
20096449|NCT00002566|Vinblastine|vinblastine|mesh-list
19509335|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509336|NCT03033732|Analgesics|analgesics|mesh-ancestor
19509337|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
19509338|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509339|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19509340|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
19509341|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
19509342|NCT03033472|Clindamycin|clindamycin|mesh-list
19509343|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
19509344|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
19509345|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19509346|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509347|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19509348|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509349|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509350|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19509351|NCT03033836|Dolutegravir|dolutegravir|mesh-list
19509352|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19509353|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19509354|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509355|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509356|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
19509357|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509358|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19509359|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19509360|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19509361|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19509362|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
20096450|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096451|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
20096452|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096453|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096454|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096455|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
20096456|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096457|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096458|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096459|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096460|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096461|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096462|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096463|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096464|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
19509363|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19509364|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20096465|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
19509365|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19509366|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509367|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509368|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
19509369|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509370|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509371|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19509372|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509373|NCT03033121|Hormones|hormones|mesh-list
19509374|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509375|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509376|NCT03033264|Dinoprostone|dinoprostone|mesh-list
19509377|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
19509378|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19509379|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509380|NCT03033199|Dexamethasone|dexamethasone|mesh-list
19509381|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509382|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
19509383|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
19509384|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509385|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509386|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509387|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
19509388|NCT03033199|Hormones|hormones|mesh-ancestor
19509389|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509390|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19509391|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509392|NCT03033368|Rilpivirine|rilpivirine|mesh-list
19509393|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19509394|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19509395|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509396|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509397|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
19509398|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509399|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19509400|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19509401|NCT03033147|Amoxicillin|amoxicillin|mesh-list
19509402|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
19509403|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
19509404|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19509405|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19509406|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509407|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19509408|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509409|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509410|NCT03033342|Omeprazole|omeprazole|mesh-list
19509411|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19509412|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509413|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19509414|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509415|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509416|NCT03033095|Etanercept|etanercept|mesh-list
19509417|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19509418|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19509419|NCT03033095|Analgesics|analgesics|mesh-ancestor
19509420|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
19509421|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096466|NCT00002567|Etoposide|etoposide|mesh-list
20096467|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096468|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509422|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509423|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509424|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19509425|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509426|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096469|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096470|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096471|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509427|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
19509428|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
19509429|NCT03032978|Calcium|calcium|mesh-list
19509430|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19509431|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509432|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19509433|NCT03033160|Estradiol|estradiol|mesh-list
19509434|NCT03033160|Estrogens|estrogens|mesh-ancestor
19509435|NCT03033160|Hormones|hormones|mesh-ancestor
19509436|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509437|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509438|NCT03033316|Dexamethasone|dexamethasone|mesh-list
19509439|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509440|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
19509441|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
19509442|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509443|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509444|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509445|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
19509446|NCT03033316|Hormones|hormones|mesh-ancestor
20096472|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096473|NCT00002568|Paclitaxel|paclitaxel|mesh-list
20096474|NCT00002568|Cisplatin|cisplatin|mesh-list
20096475|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096476|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096477|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096478|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096479|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096480|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096481|NCT00002569|Vincristine|vincristine|mesh-list
20096482|NCT00002569|Lomustine|lomustine|mesh-list
20096483|NCT00002569|Procarbazine|procarbazine|mesh-list
20096484|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096485|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096486|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096487|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096488|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096489|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096490|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19509447|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509448|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19509449|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509450|NCT03032848|Estrogens|estrogens|mesh-list
19509451|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19509452|NCT03032848|Hormones|hormones|mesh-ancestor
19509453|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096491|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
19509454|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571421|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
19571422|NCT01595581|Testosterone|testosterone|mesh-list
19571423|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
19571424|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
19571425|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20096492|NCT00002570|Leucovorin|leucovorin|mesh-list
20096493|NCT00002570|Fluorouracil|fluorouracil|mesh-list
20096494|NCT00002570|Calcium|calcium|mesh-list
20096495|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
20096496|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20096497|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096498|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
20096499|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571426|NCT01595581|Androgens|androgens|mesh-ancestor
20096500|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096501|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571427|NCT01595581|Hormones|hormones|mesh-ancestor
19509455|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
19509456|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
19509457|NCT03032783|Tacrolimus|tacrolimus|mesh-list
19509458|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20603304|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509459|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
19509460|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509461|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19509462|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19509463|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
19509464|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509465|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509466|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19509467|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19509468|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509469|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19509470|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19509471|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
19509472|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19509473|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509474|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
19509475|NCT03032666|Velpatasvir|velpatasvir|mesh-list
19509476|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
19509477|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509478|NCT03032536|Tenofovir|tenofovir|mesh-list
19509479|NCT03032536|Entecavir|entecavir|mesh-list
19509480|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
19509481|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509482|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19509483|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19509484|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509485|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509486|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19509487|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19509488|NCT03032484|Bevacizumab|bevacizumab|mesh-list
19509489|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19509490|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509491|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19509492|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19509493|NCT03032484|Growth Substances|growth substances|mesh-ancestor
19509494|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509495|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
19509496|NCT03032614|Carboplatin|carboplatin|mesh-list
19509497|NCT03032614|Veliparib|veliparib|mesh-list
19509498|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509499|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19509500|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509501|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509502|NCT03032458|Ketorolac|ketorolac|mesh-list
19509503|NCT03032458|Lidocaine|lidocaine|mesh-list
19509504|NCT03032458|Meperidine|meperidine|mesh-list
19509505|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509506|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
19509507|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509508|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509509|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
19509510|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509511|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19509512|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19509513|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19509514|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509515|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509516|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19509517|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19509518|NCT03032458|Analgesics|analgesics|mesh-ancestor
19509519|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19509520|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19509521|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19509522|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509523|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19509524|NCT03032458|Narcotics|narcotics|mesh-ancestor
19509525|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19509526|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
20603305|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509527|NCT03032406|Everolimus|everolimus|mesh-list
19509528|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509529|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19509530|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
19509531|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509532|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
19509533|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20096502|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096503|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
20096504|NCT00002570|Antidotes|antidotes|mesh-ancestor
20096505|NCT00002570|Protective Agents|protective agents|mesh-ancestor
20096506|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096507|NCT00002570|Vitamins|vitamins|mesh-ancestor
20096508|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
20096509|NCT00002571|Leucovorin|leucovorin|mesh-list
20096510|NCT00002571|Cytarabine|cytarabine|mesh-list
20096511|NCT00002571|Trimethoprim|trimethoprim|mesh-list
20096512|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
20096513|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19509534|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19509535|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509536|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509537|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509538|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19509539|NCT03032367|Bedaquiline|bedaquiline|mesh-list
19509540|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
19509541|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19509542|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509543|NCT03032419|Vaccines|vaccines|mesh-list
19509544|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
19509545|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509546|NCT03032042|Azithromycin|azithromycin|mesh-list
19509547|NCT03032042|Albendazole|albendazole|mesh-list
19509548|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19509549|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509550|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
19509551|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19509552|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
19509553|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19509554|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19509555|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
19509556|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
19509557|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
19509558|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509559|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509560|NCT03032315|Amlodipine|amlodipine|mesh-list
19509561|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19509562|NCT03032315|Telmisartan|telmisartan|mesh-list
19509563|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19509564|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19509565|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20096514|NCT00002571|Prednisone|prednisone|mesh-list
20096515|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
20096516|NCT00002571|Doxorubicin|doxorubicin|mesh-list
20096517|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096518|NCT00002571|Methotrexate|methotrexate|mesh-list
20096519|NCT00002571|Etoposide|etoposide|mesh-list
20096520|NCT00002571|Vincristine|vincristine|mesh-list
20096521|NCT00002571|Bleomycin|bleomycin|mesh-list
19509566|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509567|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509568|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19509569|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509570|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
19509571|NCT03032315|Diuretics|diuretics|mesh-ancestor
19509572|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
20096522|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
20096523|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096524|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
20096525|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509573|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20096526|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096527|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096528|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
19509574|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19509575|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20096529|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096530|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096531|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096532|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19509576|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
19509577|NCT03032107|Trastuzumab|trastuzumab|mesh-list
19509578|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19509579|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19509580|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509581|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19509582|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19509583|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19509584|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509585|NCT03031834|Quinapril|quinapril|mesh-list
19509586|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19509587|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
19509588|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509589|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509590|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19509591|NCT03031691|Trifluridine|trifluridine|mesh-list
20096533|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096534|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096535|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096536|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096537|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
20096538|NCT00002571|Hormones|hormones|mesh-ancestor
19509592|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
19509593|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509594|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
19509595|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509596|NCT03031808|Lidocaine|lidocaine|mesh-list
19509597|NCT03031808|Rocuronium|rocuronium|mesh-list
19509598|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509599|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
19509600|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509601|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509602|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
19509603|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509604|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19509605|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19509606|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19509607|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509608|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509609|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19509610|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20096539|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096540|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096541|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096542|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096543|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096544|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096545|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
20096546|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096547|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096548|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096549|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096550|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
20096551|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096552|NCT00002571|Antidotes|antidotes|mesh-ancestor
20096553|NCT00002571|Protective Agents|protective agents|mesh-ancestor
20096554|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096555|NCT00002571|Vitamins|vitamins|mesh-ancestor
20096556|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
20096557|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096558|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096559|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096560|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20096561|NCT00002571|Renal Agents|renal agents|mesh-ancestor
20096562|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
20096563|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20096564|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19509611|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19509612|NCT03031756|Glycine|glycine|mesh-list
19509613|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
19509614|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509615|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509616|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509617|NCT03031535|Octreotide|octreotide|mesh-list
20603306|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19509618|NCT03031535|Hormones|hormones|mesh-list
19509619|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19509620|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509621|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509622|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509623|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19509624|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509625|NCT03031405|Oxytocin|oxytocin|mesh-list
19509626|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
19509627|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19509628|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096565|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20096566|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20096567|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20096568|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20096569|NCT00002572|Aldesleukin|aldesleukin|mesh-list
20096570|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
20096571|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509629|NCT03031444|Leucovorin|leucovorin|mesh-list
20096572|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20096573|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20096574|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
19509630|NCT03031444|Cetuximab|cetuximab|mesh-list
19509631|NCT03031444|Fluorouracil|fluorouracil|mesh-list
19509632|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
19509633|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19509634|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509635|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
19509636|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509637|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19509638|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19509639|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
19509640|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509641|NCT03031444|Antidotes|antidotes|mesh-ancestor
19509642|NCT03031444|Protective Agents|protective agents|mesh-ancestor
19509643|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
19509644|NCT03031444|Vitamins|vitamins|mesh-ancestor
19509645|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
19509646|NCT03031249|Cytarabine|cytarabine|mesh-list
19509647|NCT03031249|Tretinoin|tretinoin|mesh-list
19509648|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
19509649|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19509650|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
19509651|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509652|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509653|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
19509654|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509655|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19509656|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
19509657|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509658|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
19509659|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
19509660|NCT03031184|Mirtazapine|mirtazapine|mesh-list
19509661|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
19509662|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19509663|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20096575|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096576|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
20096577|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096578|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096579|NCT00002574|Interferons|interferons|mesh-list
20096580|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
20096581|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
20096582|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096583|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
20096584|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096585|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
20096586|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096587|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096588|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20096589|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509664|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
19509665|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
19509666|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20096590|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096591|NCT00002576|Prednisolone|prednisolone|mesh-list
20096592|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
19509667|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509668|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509669|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19509670|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19509671|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509672|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19509673|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19509674|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19509675|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509676|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19509677|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19509678|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
19509679|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19509680|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19509681|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
19509682|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19509683|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19509684|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
19509685|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509686|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
19509687|NCT03031327|Protective Agents|protective agents|mesh-ancestor
19509688|NCT03031353|Misoprostol|misoprostol|mesh-list
19509689|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19509690|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
19509691|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19509692|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509693|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19509694|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509695|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
19509696|NCT03031483|Clarithromycin|clarithromycin|mesh-list
19509697|NCT03031483|Lenalidomide|lenalidomide|mesh-list
19509698|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
19509699|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509700|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19509701|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19509702|NCT03031483|Growth Substances|growth substances|mesh-ancestor
19509703|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
19509704|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509705|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19509706|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509707|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19509708|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509709|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509710|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19509711|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19509712|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
19509713|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19509714|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
19509715|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509716|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
19509717|NCT03031054|Protective Agents|protective agents|mesh-ancestor
19571428|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571429|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571430|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19571431|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571432|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
19571433|NCT01542021|Androgens|androgens|mesh-list
19571434|NCT01542021|Hormones|hormones|mesh-ancestor
19571435|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571436|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571437|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19571438|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
19571439|NCT01455389|Promethazine|promethazine|mesh-list
19571440|NCT01455389|Dexamethasone|dexamethasone|mesh-list
19571441|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19571442|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19571443|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
19571444|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
19571445|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571446|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571447|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19571448|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
19571449|NCT01455389|Hormones|hormones|mesh-ancestor
19571450|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19509718|NCT03030911|Fentanyl|fentanyl|mesh-list
19509719|NCT03030911|Midazolam|midazolam|mesh-list
19509720|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
19509721|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19509722|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509723|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509724|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19509725|NCT03030911|Analgesics|analgesics|mesh-ancestor
19509726|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
19509727|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509728|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19509729|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19509730|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19509731|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509732|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509733|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509734|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19509735|NCT03030911|Narcotics|narcotics|mesh-ancestor
19509736|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19509737|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19509738|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
19509739|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
19509740|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19509741|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19509742|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19509743|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
20096593|NCT00002576|Doxorubicin|doxorubicin|mesh-list
20096594|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096595|NCT00002576|Vincristine|vincristine|mesh-list
20096596|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
19509744|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
19509745|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
19509746|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19509747|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509748|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509749|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19509750|NCT03030950|Analgesics|analgesics|mesh-ancestor
19509751|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
19509752|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509753|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19509754|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19509755|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19509756|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509757|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509758|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509759|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19509760|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19509761|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19509762|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509763|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509764|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
19509765|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509766|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19509767|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19509768|NCT03030937|Irinotecan|irinotecan|mesh-list
19509769|NCT03030937|Apatinib|apatinib|mesh-list
19509770|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19509771|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19509772|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509773|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509774|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509775|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19509776|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
19509777|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19509778|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
19509779|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509780|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19509781|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19509782|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
19509783|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509784|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509785|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19509786|NCT03030690|Methamphetamine|methamphetamine|mesh-list
20096597|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096598|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
20603307|NCT02220361|Analgesics|analgesics|mesh-ancestor
19509787|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19509788|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509789|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
19509790|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
19509791|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509792|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
19509793|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509794|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509795|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509796|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19509797|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19509798|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509799|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19509800|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
19509801|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
19509802|NCT03030716|Procyanidin|procyanidin|mesh-list
19509803|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19509804|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509805|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
19509806|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509807|NCT03030716|Protective Agents|protective agents|mesh-ancestor
19509808|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509809|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19509810|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19509811|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509812|NCT03031119|Atorvastatin|atorvastatin|mesh-list
19509813|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19509814|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19509815|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
19509816|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509817|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19509818|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19509819|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509820|NCT03030430|Bevacizumab|bevacizumab|mesh-list
19509821|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19509822|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509823|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19509824|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19509825|NCT03030430|Growth Substances|growth substances|mesh-ancestor
19509826|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509827|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
19509828|NCT03030703|Inositol|inositol|mesh-list
19509829|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
19509830|NCT03030703|Vitamins|vitamins|mesh-ancestor
19509831|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
19509832|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509833|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
19509834|NCT03030469|Analgesics|analgesics|mesh-list
19509835|NCT03030469|Narcotics|narcotics|mesh-ancestor
19509836|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509837|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509838|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
19509839|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509840|NCT03030560|Lidocaine|lidocaine|mesh-list
19509841|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509842|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
19509843|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509844|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509845|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
19509846|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509847|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19509848|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19509849|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19509850|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509851|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509852|NCT03030677|Lidocaine|lidocaine|mesh-list
19509853|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
19509854|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
19509855|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509856|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509857|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
19509858|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509859|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19509860|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19509861|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19509862|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509863|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509864|NCT03031262|Cytarabine|cytarabine|mesh-list
19509865|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19509866|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
19509867|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096599|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096600|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096601|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096602|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
20096603|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096604|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096605|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096606|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096607|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096608|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096609|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096610|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096611|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096612|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096613|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096614|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096615|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
20096616|NCT00002576|Hormones|hormones|mesh-ancestor
20096617|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096618|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19509868|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509869|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
19509870|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509871|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19509872|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
19509873|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509874|NCT03030131|Durvalumab|durvalumab|mesh-list
19509875|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19509876|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509877|NCT03030287|Paclitaxel|paclitaxel|mesh-list
19509878|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19509879|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19509880|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509881|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
19509882|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096619|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096620|NCT00002576|Analgesics|analgesics|mesh-ancestor
20096621|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
20096622|NCT00002578|Leucovorin|leucovorin|mesh-list
20096623|NCT00002578|Cytarabine|cytarabine|mesh-list
20096624|NCT00002578|Methotrexate|methotrexate|mesh-list
20096625|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
20096626|NCT00002578|Calcium|calcium|mesh-list
20096627|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
20096628|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20096629|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096630|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19509883|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
19509884|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509885|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
19509886|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509887|NCT03030300|Metformin|metformin|mesh-list
19509888|NCT03030300|Pioglitazone|pioglitazone|mesh-list
19509889|NCT03030300|Insulin|insulin|mesh-list
19509890|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19509891|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509892|NCT03030001|Antibodies|antibodies|mesh-list
19509893|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
19509894|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509895|NCT03030196|Denosumab|denosumab|mesh-list
19509896|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19509897|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509898|NCT03030105|Scopolamine|scopolamine|mesh-list
19509899|NCT03030105|Donepezil|donepezil|mesh-list
19509900|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19509901|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19509902|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509903|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509904|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
19509905|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509906|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509907|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
19509908|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19509909|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
19509910|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
19509911|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509912|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19509913|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
19509914|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19509915|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19509916|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
19509917|NCT03030248|Vancomycin|vancomycin|mesh-list
19509918|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19509919|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509920|NCT03030157|Pirarubicin|pirarubicin|mesh-list
19509921|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509922|NCT03029533|Leuprolide|leuprolide|mesh-list
19509923|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19509924|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
19509925|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19509926|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509927|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19509928|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19509929|NCT03029676|Fentanyl|fentanyl|mesh-list
19509930|NCT03029676|Midazolam|midazolam|mesh-list
19509931|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
20096631|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096632|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096633|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19509932|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19509933|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509934|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19509935|NCT03029676|Narcotics|narcotics|mesh-ancestor
19509936|NCT03029676|Analgesics|analgesics|mesh-ancestor
19509937|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
19509938|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509939|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19509940|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19509941|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
19509942|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19509943|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19509944|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19509945|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19509946|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
19509947|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
19509948|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509949|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509950|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
19509951|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19509952|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19509953|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
19509954|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19509955|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19509956|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19509957|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509958|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509959|NCT03029455|Ivacaftor|ivacaftor|mesh-list
19509960|NCT03029455|VX-659|vx-659|mesh-list
19509961|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19509962|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19509963|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096634|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
20096635|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096636|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096637|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
19509964|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
19509965|NCT03029494|Vitamins|vitamins|mesh-ancestor
19509966|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
19509967|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509968|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
19509969|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509970|NCT03029494|Protective Agents|protective agents|mesh-ancestor
19509971|NCT03029845|Propranolol|propranolol|mesh-list
19509972|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19509973|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19509974|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
19509975|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19509976|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509977|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509978|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19509979|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19509980|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
19509981|NCT03029442|Denosumab|denosumab|mesh-list
19509982|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19509983|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571451|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19571452|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571453|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571454|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571455|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571456|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19571457|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19571458|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571459|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
19571460|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
19571461|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
19571462|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19571463|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
19571464|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
19571465|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571466|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19571467|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
19571468|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
19571469|NCT01453140|Sirolimus|sirolimus|mesh-list
19571470|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
19571471|NCT01453140|Interleukin-2|interleukin-2|mesh-list
19571472|NCT01453140|Azacitidine|azacitidine|mesh-list
19571473|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571474|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
19571475|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571476|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571477|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571478|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
19571479|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571480|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571481|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571482|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19571483|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571484|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19571485|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
19571486|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19571487|NCT01453140|Analgesics|analgesics|mesh-ancestor
19571488|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
19571489|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571490|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571491|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
19571492|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571493|NCT01408641|Topiramate|topiramate|mesh-list
19571494|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
19571495|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19571496|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571497|NCT01246310|Inositol|inositol|mesh-list
19571498|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
19571499|NCT01246310|Vitamins|vitamins|mesh-ancestor
19571500|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
19571501|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571502|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
19571503|NCT01203722|Sirolimus|sirolimus|mesh-list
20096638|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096639|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096640|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096641|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
20096642|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096643|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096644|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
20096645|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096646|NCT00002578|Antidotes|antidotes|mesh-ancestor
20096647|NCT00002578|Protective Agents|protective agents|mesh-ancestor
19571504|NCT01203722|Fludarabine|fludarabine|mesh-list
19571505|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
20096648|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096649|NCT00002578|Vitamins|vitamins|mesh-ancestor
19509984|NCT03029390|Metformin|metformin|mesh-list
19509985|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19509986|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509987|NCT03029429|Theophylline|theophylline|mesh-list
19509988|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19509989|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
19509990|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19509991|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19509992|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19509993|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
19509994|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19509995|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19509996|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19509997|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
19509998|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19509999|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19510000|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
19510001|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510002|NCT03029351|Exenatide|exenatide|mesh-list
19510003|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19510004|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510005|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19510006|NCT03029351|Incretins|incretins|mesh-ancestor
19510007|NCT03029351|Hormones|hormones|mesh-ancestor
19510008|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510009|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
19510010|NCT03029273|Fludarabine|fludarabine|mesh-list
19510011|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510012|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
19510013|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510014|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510015|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19510016|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
19510017|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510018|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510019|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19510020|NCT03029013|Apatinib|apatinib|mesh-list
19510021|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510022|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19510023|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510024|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510025|NCT03028883|Buprenorphine|buprenorphine|mesh-list
19510026|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19510027|NCT03028883|Narcotics|narcotics|mesh-ancestor
19510028|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510029|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510030|NCT03028883|Analgesics|analgesics|mesh-ancestor
19510031|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
19510032|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510033|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19510034|NCT03029169|Amiodarone|amiodarone|mesh-list
19510035|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19510036|NCT03029169|Propafenone|propafenone|mesh-list
19510037|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
19510038|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19510039|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19510040|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510041|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19510042|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20096650|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
20096651|NCT00002579|Tamoxifen|tamoxifen|mesh-list
20096652|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
20096653|NCT00002579|Fluorouracil|fluorouracil|mesh-list
19510043|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19510044|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510045|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19510046|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19510047|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19510048|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19510049|NCT03028701|Budesonide|budesonide|mesh-list
19510050|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
19510051|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096654|NCT00002579|Methotrexate|methotrexate|mesh-list
20096655|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096656|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
19510052|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19510053|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
19510054|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510055|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510056|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19510057|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
19510058|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
19510059|NCT03028701|Hormones|hormones|mesh-ancestor
19510060|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510061|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19510062|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19510063|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19510064|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
19510065|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510066|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510067|NCT03028766|Adavosertib|adavosertib|mesh-list
19510068|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510069|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510070|NCT03028909|Oseltamivir|oseltamivir|mesh-list
19510071|NCT03028909|MEDI8852|medi8852|mesh-list
19510072|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
19510073|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510074|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510075|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510076|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
19510077|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19510078|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510079|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
19510080|NCT03028298|Citric Acid|citric acid|mesh-list
19510081|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
19510082|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
19510083|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19510084|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
19510085|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
19510086|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510087|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
19510088|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19510089|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19510090|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510091|NCT03028298|Urological Agents|urological agents|mesh-ancestor
19510092|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
19510093|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19510094|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
19510095|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510096|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
19510097|NCT03028428|Protective Agents|protective agents|mesh-ancestor
19510098|NCT03028571|Trimethaphan|trimethaphan|mesh-list
19510099|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
19510100|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19510101|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19510102|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19510103|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
19510104|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510105|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510106|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19510107|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19510108|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
19510109|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510110|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510111|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
19510112|NCT03028532|Clomiphene|clomiphene|mesh-list
19510113|NCT03028532|Enclomiphene|enclomiphene|mesh-list
19510114|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
19510115|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19510116|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
19510117|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510118|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510119|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19510120|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
19510121|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19510122|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19510123|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19510124|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
19510125|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510126|NCT03027960|Empagliflozin|empagliflozin|mesh-list
19510127|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19510128|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510129|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19510130|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510131|NCT03027934|Ticagrelor|ticagrelor|mesh-list
19510132|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19510133|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20096657|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096658|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096659|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096660|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
20096661|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096662|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096663|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096664|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
20096665|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096666|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19510134|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19510135|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19510136|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19510137|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
19510138|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510139|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510140|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510141|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
19510142|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
19510143|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19510144|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19510145|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510146|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
20096667|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096668|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096669|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096670|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096671|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096672|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096673|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20096674|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
20096675|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096676|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096677|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20096678|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20096679|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19510147|NCT03027973|Coagulants|coagulants|mesh-ancestor
19510148|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19510149|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
19510150|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19510151|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510152|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19510153|NCT03027908|Fluorides|fluorides|mesh-list
19510154|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
19510155|NCT03027908|Protective Agents|protective agents|mesh-ancestor
19510156|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510157|NCT03027843|Hormones|hormones|mesh-list
19510158|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510159|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510160|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
19510161|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19510162|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510163|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19510164|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19510165|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510166|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510167|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510168|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19510169|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19571506|NCT01203722|Tacrolimus|tacrolimus|mesh-list
19571507|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571508|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571509|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510170|NCT03027674|Nifedipine|nifedipine|mesh-list
19510171|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
19510172|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
19510173|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19510174|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19510175|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510176|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510177|NCT03027674|Urological Agents|urological agents|mesh-ancestor
19510178|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19510179|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19510180|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19510181|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510182|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
19510183|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19510184|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
19510185|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19510186|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
19510187|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19510188|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510189|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19510190|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19510191|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19510192|NCT03027284|Gemcitabine|gemcitabine|mesh-list
19510193|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510194|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510195|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
19510196|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096680|NCT00002580|Tamoxifen|tamoxifen|mesh-list
20096681|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
20096682|NCT00002580|Fluorouracil|fluorouracil|mesh-list
20096683|NCT00002580|Methotrexate|methotrexate|mesh-list
20096684|NCT00002580|Leuprolide|leuprolide|mesh-list
20096685|NCT00002580|Goserelin|goserelin|mesh-list
20096686|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096687|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
20096688|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096689|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096690|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096691|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
20096692|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096693|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096694|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096695|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
19510197|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
19510198|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510199|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510200|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510201|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
19510202|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510203|NCT03027167|Aspirin|aspirin|mesh-list
19510204|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19510205|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510206|NCT03027167|Analgesics|analgesics|mesh-ancestor
19510207|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
19510208|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510209|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510210|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510211|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510212|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19510213|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19510214|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510215|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19510216|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19510217|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510218|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
19510219|NCT03027219|Alprostadil|alprostadil|mesh-list
19510220|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19510221|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
19510222|NCT03027219|Urological Agents|urological agents|mesh-ancestor
19510223|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19510224|NCT03026933|Calcium|calcium|mesh-list
19510225|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19510226|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096696|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096697|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096698|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096699|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096700|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096701|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096702|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096703|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096704|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20096705|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
20096706|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096707|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096708|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20096709|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20096710|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20096711|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20096712|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
19510227|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19510228|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19510229|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
19510230|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510231|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19510232|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19510233|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510234|NCT03026842|Cytarabine|cytarabine|mesh-list
19510235|NCT03026842|Decitabine|decitabine|mesh-list
19510236|NCT03026842|Daunorubicin|daunorubicin|mesh-list
19510237|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
19510238|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
19510239|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510240|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
19510241|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510242|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510243|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
19510244|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510245|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510246|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
20096713|NCT00002581|Tamoxifen|tamoxifen|mesh-list
20096714|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
20096715|NCT00002581|Fluorouracil|fluorouracil|mesh-list
20096716|NCT00002581|Methotrexate|methotrexate|mesh-list
20096717|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096718|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
19510247|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510248|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510249|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19510250|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19510251|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19510252|NCT03026842|Analgesics|analgesics|mesh-ancestor
19510253|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
19510254|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510255|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19510256|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
19510257|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510258|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
19510259|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
19510260|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510261|NCT03027115|Tamsulosin|tamsulosin|mesh-list
19510262|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19510263|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19510264|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19510265|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
19510266|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510267|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510268|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510269|NCT03027115|Urological Agents|urological agents|mesh-ancestor
20096719|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096720|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096721|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096722|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
20096723|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096724|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510270|NCT03026881|Paclitaxel|paclitaxel|mesh-list
19510271|NCT03026881|Apatinib|apatinib|mesh-list
19510272|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19510273|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510274|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
19510275|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19510276|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
19510277|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510278|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19510279|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510280|NCT03026946|Cyclosporine|cyclosporine|mesh-list
19510281|NCT03026946|Alitretinoin|alitretinoin|mesh-list
19510282|NCT03026946|Cyclosporins|cyclosporins|mesh-list
19510283|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510284|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510285|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510286|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
19510287|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510288|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
19510289|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510290|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510291|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510292|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19510293|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510294|NCT03026907|Azathioprine|azathioprine|mesh-list
19510295|NCT03026907|Alitretinoin|alitretinoin|mesh-list
19510296|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510297|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510298|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
19510299|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510300|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510301|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510302|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
19510303|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510304|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510305|NCT03026725|Calcium|calcium|mesh-list
19510306|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19510307|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510308|NCT03026478|Betamethasone|betamethasone|mesh-list
19510309|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
19510310|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19510311|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
19510312|NCT03026478|Clobetasol|clobetasol|mesh-list
19510313|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19510314|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096725|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096726|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
20096727|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510315|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
19510316|NCT03026478|Hormones|hormones|mesh-ancestor
19510317|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510318|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510319|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19510320|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
19510321|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
19510322|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19510323|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510324|NCT03026244|Vitamin D|vitamin d|mesh-list
19510325|NCT03026244|Caseins|caseins|mesh-list
19510326|NCT03026244|Vitamins|vitamins|mesh-ancestor
19510327|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
19510328|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510329|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19510330|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
19510331|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
19510332|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510333|NCT03026140|Celecoxib|celecoxib|mesh-list
19510334|NCT03026140|Nivolumab|nivolumab|mesh-list
19510335|NCT03026140|Ipilimumab|ipilimumab|mesh-list
19510336|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510337|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510338|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19510339|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510340|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19510341|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510342|NCT03026140|Analgesics|analgesics|mesh-ancestor
19510343|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
19510344|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510345|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510346|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510347|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510348|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19510349|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19510350|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510351|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
19510352|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
19510353|NCT03026036|Raclopride|raclopride|mesh-list
19510354|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19510355|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19510356|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510357|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510358|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19510359|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19510360|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
19510361|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510362|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510363|NCT03026023|Ribavirin|ribavirin|mesh-list
19510364|NCT03026023|Grazoprevir|grazoprevir|mesh-list
19510365|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
19510366|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510367|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
19510368|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571510|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
19571511|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571512|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19571513|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571514|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571515|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571516|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
19571517|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571518|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19571519|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19571520|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
19571521|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19571522|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571523|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
19571524|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
19571525|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19571526|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571527|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19571528|NCT01029717|Minocycline|minocycline|mesh-list
19571529|NCT01029717|Rifampin|rifampin|mesh-list
19571530|NCT01029717|Heparin|heparin|mesh-list
19571531|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571532|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19571533|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
19571534|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
19571535|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19571536|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19571537|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571538|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
19571539|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19571540|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571541|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19571542|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19571543|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20096728|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096729|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096730|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571544|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19571545|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19571546|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19571547|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19571548|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
19571549|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571550|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
19571551|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571552|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571553|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571554|NCT00700076|Ketamine|ketamine|mesh-list
19571555|NCT00700076|Analgesics|analgesics|mesh-ancestor
19571556|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
19571557|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096731|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510369|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19510370|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19510371|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510372|NCT03025750|Vaccines|vaccines|mesh-list
19510373|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
19510374|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510375|NCT03025867|Niraparib|niraparib|mesh-list
19510376|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19510377|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510378|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510379|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510380|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19510381|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19510382|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510383|NCT03025880|Gemcitabine|gemcitabine|mesh-list
19510384|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
19510385|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510386|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
19510387|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096732|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096733|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096734|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096735|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20096736|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
20096737|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096738|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096739|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20096740|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20096741|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20096742|NCT00002582|Tamoxifen|tamoxifen|mesh-list
20096743|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
20096744|NCT00002582|Doxorubicin|doxorubicin|mesh-list
20096745|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096746|NCT00002582|Fluorouracil|fluorouracil|mesh-list
20096747|NCT00002582|Methotrexate|methotrexate|mesh-list
20096748|NCT00002582|Leuprolide|leuprolide|mesh-list
20096749|NCT00002582|Goserelin|goserelin|mesh-list
20096750|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096751|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
20096752|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096753|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096754|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096755|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
20096756|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096757|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096758|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096759|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096760|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096761|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096762|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096763|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
20096764|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510388|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510389|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
19510390|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510391|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510392|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510393|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
19510394|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510395|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510396|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19510397|NCT03025828|Hormones|hormones|mesh-ancestor
20096765|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096766|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096767|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571558|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096768|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510398|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510399|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510400|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
19510401|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510402|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510403|NCT03025893|Sunitinib|sunitinib|mesh-list
19510404|NCT03025893|Lomustine|lomustine|mesh-list
19510405|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510406|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19510407|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19510408|NCT03025893|Growth Substances|growth substances|mesh-ancestor
19510409|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510410|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
19510411|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19510412|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510413|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510414|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19510415|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
19510416|NCT03025906|Valproic Acid|valproic acid|mesh-list
19510417|NCT03025906|Phenobarbital|phenobarbital|mesh-list
19510418|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
19510419|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510420|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510421|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
19510422|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510423|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510424|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
19510425|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19510426|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510427|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19510428|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19510429|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19510430|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19510431|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
19510432|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19510433|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19510434|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19510435|NCT03025477|Paclitaxel|paclitaxel|mesh-list
19510436|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19510437|NCT03025477|Cisplatin|cisplatin|mesh-list
19510438|NCT03025477|Carboplatin|carboplatin|mesh-list
19510439|NCT03025477|Epirubicin|epirubicin|mesh-list
19510440|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19510441|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510442|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
19510443|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
19510444|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
19510445|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510446|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19510447|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19510448|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19510449|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510450|NCT03025594|Ketorolac|ketorolac|mesh-list
19510451|NCT03025594|Epinephrine|epinephrine|mesh-list
19510452|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
19510453|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19510454|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19510455|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
19510456|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510457|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510458|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510459|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19510460|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20096769|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096770|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096771|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20096772|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
20096773|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096774|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096775|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20096776|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19510461|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
19510462|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510463|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19510464|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
19510465|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
19510466|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
19510467|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19510468|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19510469|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510470|NCT03025594|Analgesics|analgesics|mesh-ancestor
19510471|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
19510472|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510473|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096777|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20096778|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20096779|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
20096780|NCT00002583|Vinorelbine|vinorelbine|mesh-list
19510474|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19510475|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510476|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
19510477|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
19510478|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510479|NCT03025282|Betamethasone|betamethasone|mesh-list
19510480|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
19510481|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19510482|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510483|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
19510484|NCT03025282|Hormones|hormones|mesh-ancestor
19510485|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510486|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510487|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19510488|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
19510489|NCT03025256|Nivolumab|nivolumab|mesh-list
19510490|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510491|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510492|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19510493|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510494|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
19510495|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19510496|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510497|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510498|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510499|NCT03025295|Analgesics|analgesics|mesh-ancestor
19510500|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
19510501|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510502|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19510503|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19510504|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19510505|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
19510506|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510507|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510508|NCT03025009|Insulin|insulin|mesh-list
19510509|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19510510|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
19510511|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19510512|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510513|NCT03024879|Erythromycin|erythromycin|mesh-list
19510514|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
19510515|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19510516|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
19510517|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19510518|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510519|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19510520|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19510521|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510522|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510523|NCT03024905|Misoprostol|misoprostol|mesh-list
19510524|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19510525|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
19510526|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19510527|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510528|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19510529|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19510530|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
19510531|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
19510532|NCT03024957|Morphine|morphine|mesh-list
19510533|NCT03024957|Bupivacaine|bupivacaine|mesh-list
20096781|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096782|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096783|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
19510534|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
19510535|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
19510536|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510537|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510538|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
19510539|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510540|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19510541|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510542|NCT03024957|Analgesics|analgesics|mesh-ancestor
19510543|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19510544|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19510545|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19510546|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
19510547|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510548|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510549|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19510550|NCT03024957|Narcotics|narcotics|mesh-ancestor
19510551|NCT03025113|Ketoprofen|ketoprofen|mesh-list
19510552|NCT03025113|Amitriptyline|amitriptyline|mesh-list
19510553|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
19510554|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19510555|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510556|NCT03025113|Analgesics|analgesics|mesh-ancestor
19510557|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
19510558|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510559|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510560|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510561|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510562|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19510563|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510564|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096784|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096785|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096786|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510565|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19510566|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
19510567|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19510568|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19510569|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19510570|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19510571|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510572|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19510573|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19510574|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19510575|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19510576|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20096787|NCT00002585|NSC 366140|nsc 366140|mesh-list
20096788|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096789|NCT00002586|Vitamin E|vitamin e|mesh-list
20096790|NCT00002586|Tocopherols|tocopherols|mesh-list
20096791|NCT00002586|Tocotrienols|tocotrienols|mesh-list
20096792|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
20096793|NCT00002586|Tretinoin|tretinoin|mesh-list
20096794|NCT00002586|Isotretinoin|isotretinoin|mesh-list
20096795|NCT00002586|Vitamins|vitamins|mesh-ancestor
20096796|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
20096797|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096798|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
20096799|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096800|NCT00002586|Protective Agents|protective agents|mesh-ancestor
20096801|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096802|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
20096803|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096804|NCT00002587|Paclitaxel|paclitaxel|mesh-list
20096805|NCT00002587|Topotecan|topotecan|mesh-list
20096806|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096807|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096808|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096809|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19510577|NCT03024840|Propofol|propofol|mesh-list
20603308|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
20096810|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096811|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510578|NCT03024840|Sevoflurane|sevoflurane|mesh-list
19510579|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19510580|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510581|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510582|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19510583|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
19510584|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
19510585|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19510586|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19510587|NCT03024814|Acetaminophen|acetaminophen|mesh-list
19510588|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510589|NCT03024814|Analgesics|analgesics|mesh-ancestor
19510590|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
19510591|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510592|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510593|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
19510594|NCT03024502|Clotrimazole|clotrimazole|mesh-list
19510595|NCT03024502|Miconazole|miconazole|mesh-list
19510596|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19510597|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510598|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
19510599|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19510600|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19510601|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510602|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510603|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19510604|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
19510605|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510606|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510607|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19510608|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19510609|NCT03024580|Tamoxifen|tamoxifen|mesh-list
19510610|NCT03024580|Letrozole|letrozole|mesh-list
19510611|NCT03024580|Fulvestrant|fulvestrant|mesh-list
19510612|NCT03024580|Anastrozole|anastrozole|mesh-list
19510613|NCT03024580|Exemestane|exemestane|mesh-list
19510614|NCT03024580|Megestrol|megestrol|mesh-list
19510615|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
19510616|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510617|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19510618|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19510619|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510620|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510621|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19510622|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
19510623|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510624|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510625|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19510626|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19510627|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19510628|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19510629|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19510630|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19510631|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19510632|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19510633|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
19510634|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19510635|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19510636|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19510637|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
19510638|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19510639|NCT03024489|Cetuximab|cetuximab|mesh-list
19510640|NCT03024489|Palbociclib|palbociclib|mesh-list
19510641|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510642|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510643|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19510644|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510645|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510646|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
19510647|NCT03024515|Narcotics|narcotics|mesh-ancestor
19510648|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510649|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510650|NCT03024515|Analgesics|analgesics|mesh-ancestor
20096812|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20096813|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096814|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510651|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
19510652|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510653|NCT03024450|Trastuzumab|trastuzumab|mesh-list
19510654|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510655|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510656|NCT03024697|Anesthetics|anesthetics|mesh-list
19510657|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
19510658|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20096815|NCT00002588|Etoposide|etoposide|mesh-list
20096816|NCT00002588|Topotecan|topotecan|mesh-list
20096817|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096818|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096819|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096820|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096821|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096822|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096823|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20096824|NCT00002589|Aldesleukin|aldesleukin|mesh-list
20096825|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
20096826|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096827|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20096828|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20096829|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
20096830|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096831|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
20096832|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096833|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096834|NCT00002590|Leucovorin|leucovorin|mesh-list
20096835|NCT00002590|Cytarabine|cytarabine|mesh-list
20096836|NCT00002590|Prednisone|prednisone|mesh-list
20096837|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
20096838|NCT00002590|Doxorubicin|doxorubicin|mesh-list
20096839|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20096840|NCT00002590|Methotrexate|methotrexate|mesh-list
20096841|NCT00002590|Etoposide|etoposide|mesh-list
20096842|NCT00002590|Vincristine|vincristine|mesh-list
20096843|NCT00002590|Daunorubicin|daunorubicin|mesh-list
20096844|NCT00002590|Asparaginase|asparaginase|mesh-list
20096845|NCT00002590|Pegaspargase|pegaspargase|mesh-list
20096846|NCT00002590|Thioguanine|thioguanine|mesh-list
20096847|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
20096848|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096849|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
20096850|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096851|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096852|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096853|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
19510659|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510660|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
19510661|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510662|NCT03024476|Olmesartan|olmesartan|mesh-list
19510663|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19510664|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19510665|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19510666|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571559|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19571560|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19571561|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
19571562|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
19571563|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571564|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19571565|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19571566|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571567|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571568|NCT00679783|Olaparib|olaparib|mesh-list
19571569|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19571570|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571571|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096854|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096855|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096856|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096857|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20096858|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19510667|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19510668|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19510669|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510670|NCT03024216|Atezolizumab|atezolizumab|mesh-list
19510671|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510672|NCT03023982|Morphine|morphine|mesh-list
19510673|NCT03023982|Bupivacaine|bupivacaine|mesh-list
19510674|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19510675|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
19510676|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510677|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510678|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
19510679|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510680|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19510681|NCT03023982|Narcotics|narcotics|mesh-ancestor
19510682|NCT03023982|Analgesics|analgesics|mesh-ancestor
19510683|NCT03023852|Oseltamivir|oseltamivir|mesh-list
19510684|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
19510685|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510686|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510687|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510688|NCT03023774|Sargramostim|sargramostim|mesh-list
19510689|NCT03023774|Lenograstim|lenograstim|mesh-list
19510690|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
19510691|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510692|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19510693|NCT03023904|Nivolumab|nivolumab|mesh-list
19510694|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510695|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510696|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19510697|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510698|NCT03023527|Dexamethasone|dexamethasone|mesh-list
19510699|NCT03023527|Nivolumab|nivolumab|mesh-list
20096859|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096860|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096861|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20096862|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
20096863|NCT00002590|Hormones|hormones|mesh-ancestor
20096864|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096865|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096866|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096867|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
20096868|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20096869|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510700|NCT03023527|Pomalidomide|pomalidomide|mesh-list
19510701|NCT03023527|Elotuzumab|elotuzumab|mesh-list
19510702|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510703|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
19510704|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
20096870|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
20096871|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
20096872|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20096873|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096874|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096875|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
20096876|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096877|NCT00002590|Antidotes|antidotes|mesh-ancestor
20096878|NCT00002590|Protective Agents|protective agents|mesh-ancestor
20096879|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096880|NCT00002590|Vitamins|vitamins|mesh-ancestor
19510705|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510706|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510707|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19510708|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
19510709|NCT03023527|Hormones|hormones|mesh-ancestor
19510710|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510711|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096881|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
20096882|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
20096883|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
20096884|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
20096885|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
19510712|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510713|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510714|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19510715|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096886|NCT00002592|Busulfan|busulfan|mesh-list
19510716|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
19510717|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19510718|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19510719|NCT03023527|Growth Substances|growth substances|mesh-ancestor
19510720|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
19510721|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
19510722|NCT03023514|Progesterone|progesterone|mesh-list
20096887|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096888|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
20096889|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510723|NCT03023514|Progestins|progestins|mesh-ancestor
19510724|NCT03023514|Hormones|hormones|mesh-ancestor
19510725|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510726|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510727|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
19510728|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510729|NCT03023514|Protective Agents|protective agents|mesh-ancestor
19510730|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
19510731|NCT03023514|Vitamins|vitamins|mesh-ancestor
19510732|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
19510733|NCT03023501|Gabapentin|gabapentin|mesh-list
19510734|NCT03023501|Analgesics|analgesics|mesh-ancestor
19510735|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
19510736|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510737|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510738|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
19510739|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19510740|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19510741|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510742|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19510743|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19510744|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19510745|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20096890|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096891|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096892|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
20096893|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096894|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096895|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096896|NCT00002593|Leucovorin|leucovorin|mesh-list
20096897|NCT00002593|Levamisole|levamisole|mesh-list
20096898|NCT00002593|Fluorouracil|fluorouracil|mesh-list
20096899|NCT00002593|Calcium|calcium|mesh-list
20096900|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
20096901|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19510746|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510747|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
19510748|NCT03023436|Fluorouracil|fluorouracil|mesh-list
19510749|NCT03023436|Capecitabine|capecitabine|mesh-list
19510750|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510751|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
19510752|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510753|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19510754|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510755|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
19510756|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510757|NCT03023046|Prednisone|prednisone|mesh-list
20096902|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096903|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
20096904|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096905|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096906|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096907|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096908|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
20096909|NCT00002593|Antidotes|antidotes|mesh-ancestor
20096910|NCT00002593|Protective Agents|protective agents|mesh-ancestor
20096911|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
20096912|NCT00002593|Vitamins|vitamins|mesh-ancestor
20096913|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
20096914|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20096915|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
20096916|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
19510758|NCT03023046|Cortisone|cortisone|mesh-list
19510759|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
20096917|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20096918|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096919|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510760|NCT03023046|Rituximab|rituximab|mesh-list
19510761|NCT03023046|Doxorubicin|doxorubicin|mesh-list
19510762|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19510763|NCT03023046|Etoposide|etoposide|mesh-list
19510764|NCT03023046|Vincristine|vincristine|mesh-list
19510765|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
19510766|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
19510767|NCT03023046|Daunorubicin|daunorubicin|mesh-list
19510768|NCT03023046|Dasatinib|dasatinib|mesh-list
19510769|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
19510770|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19510771|NCT03023046|Antibodies|antibodies|mesh-list
19510772|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
19510773|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19510774|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510775|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
19510776|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510777|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510778|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19510779|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
19510780|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510781|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510782|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19510783|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19510784|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096920|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
20096921|NCT00002594|Melphalan|melphalan|mesh-list
20096922|NCT00002594|Molgramostim|molgramostim|mesh-list
20096923|NCT00002594|Sargramostim|sargramostim|mesh-list
20096924|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096925|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
20096926|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096927|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096928|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096929|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
20096930|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096931|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096932|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096933|NCT00002595|Toremifene|toremifene|mesh-list
20096934|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20096935|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096936|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20096937|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20096938|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
19510785|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19510786|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510787|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510788|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
19510789|NCT03023046|Hormones|hormones|mesh-ancestor
19510790|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510791|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19510792|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19510793|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
19510794|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
19510795|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
19510796|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19510797|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
19510798|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510799|NCT03023306|Antiemetics|antiemetics|mesh-list
19510800|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
19510801|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510802|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510803|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19510804|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
19510805|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19510806|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19748928|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096939|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20096940|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096941|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20096942|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
20096943|NCT00002596|Carboplatin|carboplatin|mesh-list
20096944|NCT00002596|Etoposide|etoposide|mesh-list
20096945|NCT00002596|Bleomycin|bleomycin|mesh-list
20096946|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096947|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
20096948|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096949|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096950|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20096951|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
20096952|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20096953|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096954|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19510807|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510808|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
19510809|NCT03023189|Coagulants|coagulants|mesh-ancestor
19510810|NCT03023111|Miltefosine|miltefosine|mesh-list
19510811|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19510812|NCT03023111|Molgramostim|molgramostim|mesh-list
19510813|NCT03023111|Sargramostim|sargramostim|mesh-list
19510814|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
19510815|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510816|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510817|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
19510818|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19510819|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19510820|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19510821|NCT03023358|Prednisone|prednisone|mesh-list
19510822|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
19510823|NCT03023358|Doxorubicin|doxorubicin|mesh-list
19510824|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19510825|NCT03023358|Vincristine|vincristine|mesh-list
19510826|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19510827|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
19510828|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510829|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510830|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19510831|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
19510832|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510833|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510834|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19510835|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19510836|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19510837|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19510838|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510839|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510840|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
19510841|NCT03023358|Hormones|hormones|mesh-ancestor
19510842|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19510843|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19510844|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19510845|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19510846|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19510847|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19510848|NCT03023059|Levodopa|levodopa|mesh-list
19510849|NCT03023059|Carbidopa|carbidopa|mesh-list
19510850|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19510851|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19510852|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19510853|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
19510854|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510855|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510856|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510857|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19510858|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510859|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19510860|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
19510861|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
19510862|NCT03023319|Pemetrexed|pemetrexed|mesh-list
19510863|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510864|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510865|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510866|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19510867|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096955|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096956|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096957|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096958|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510868|NCT03023020|Aspirin|aspirin|mesh-list
19510869|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20096959|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19510870|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19510871|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510872|NCT03023020|Analgesics|analgesics|mesh-ancestor
19510873|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
19510874|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510875|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510876|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510877|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510878|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19510879|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19510880|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510881|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19510882|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510883|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
19510884|NCT03023007|Anesthetics|anesthetics|mesh-list
19510885|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510886|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510887|NCT03022838|Caffeine|caffeine|mesh-list
19510888|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19510889|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510890|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19510891|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510892|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510893|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19510894|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19510895|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
19510896|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510897|NCT03022877|Simendan|simendan|mesh-list
19510898|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19510899|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
19510900|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19510901|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20096960|NCT00002598|Interferons|interferons|mesh-list
20096961|NCT00002598|Cytarabine|cytarabine|mesh-list
20096962|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
20096963|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
20096964|NCT00002598|Methotrexate|methotrexate|mesh-list
20096965|NCT00002598|Etoposide|etoposide|mesh-list
20096966|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
19510902|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510903|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510904|NCT03022877|Protective Agents|protective agents|mesh-ancestor
19510905|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510906|NCT03022773|Carotenoids|carotenoids|mesh-list
19510907|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
19510908|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510909|NCT03022773|Protective Agents|protective agents|mesh-ancestor
19510910|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510911|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
19510912|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19571572|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571573|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
19571574|NCT00653068|Leucovorin|leucovorin|mesh-list
19571575|NCT00653068|Folic Acid|folic acid|mesh-list
19571576|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
20096967|NCT00002598|Sargramostim|sargramostim|mesh-list
20096968|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096969|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
20096970|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096971|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20096972|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571577|NCT00653068|Thiotepa|thiotepa|mesh-list
19571578|NCT00653068|Cisplatin|cisplatin|mesh-list
19571579|NCT00653068|Carboplatin|carboplatin|mesh-list
19571580|NCT00653068|Methotrexate|methotrexate|mesh-list
19571581|NCT00653068|Etoposide|etoposide|mesh-list
19571582|NCT00653068|Vincristine|vincristine|mesh-list
19571583|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
19571584|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
19571585|NCT00653068|Lenograstim|lenograstim|mesh-list
19571586|NCT00653068|Calcium|calcium|mesh-list
19571587|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
19571588|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20096973|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
19571589|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
19571590|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20096974|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571591|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510913|NCT03022747|Allopurinol|allopurinol|mesh-list
19510914|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
19510915|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510916|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510917|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
19510918|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510919|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19510920|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
19510921|NCT03022747|Protective Agents|protective agents|mesh-ancestor
19510922|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510923|NCT03022565|Vorinostat|vorinostat|mesh-list
19510924|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510925|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19510926|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510927|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510928|NCT03022318|Levodopa|levodopa|mesh-list
19510929|NCT03022318|Carbidopa|carbidopa|mesh-list
19510930|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19510931|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19510932|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19510933|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
20096975|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20096976|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20096977|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20096978|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
19510934|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510935|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510936|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510937|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19510938|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510939|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19510940|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
19510941|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
19510942|NCT03022409|Olaparib|olaparib|mesh-list
19510943|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19510944|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510945|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510946|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19510947|NCT03022240|Ondansetron|ondansetron|mesh-list
19510948|NCT03022240|Propofol|propofol|mesh-list
19510949|NCT03022240|Sevoflurane|sevoflurane|mesh-list
19510950|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19510951|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19510952|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510953|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19510954|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
19510955|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
19510956|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19510957|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19510958|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
19510959|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
19510960|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510961|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19510962|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
19510963|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
19510964|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19510965|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
19510966|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510967|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510968|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19510969|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19510970|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19510971|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19510972|NCT03022201|Domperidone|domperidone|mesh-list
19510973|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
19510974|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
19510975|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510976|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510977|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19510978|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19510979|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
19510980|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19510981|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510982|NCT03022253|Acetaminophen|acetaminophen|mesh-list
19510983|NCT03022253|Ibuprofen|ibuprofen|mesh-list
19510984|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20096979|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19510985|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19510986|NCT03022253|Analgesics|analgesics|mesh-ancestor
19510987|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
19510988|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19510989|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19510990|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19510991|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19510992|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19510993|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19510994|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19510995|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
19510996|NCT03022500|Durvalumab|durvalumab|mesh-list
19510997|NCT03022500|Tremelimumab|tremelimumab|mesh-list
19510998|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19510999|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511000|NCT03021772|Dexamethasone|dexamethasone|mesh-list
19511001|NCT03021772|Neostigmine|neostigmine|mesh-list
19511002|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511003|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
19511004|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
19511005|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511006|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511007|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511008|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
19511009|NCT03021772|Hormones|hormones|mesh-ancestor
19511010|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511011|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19511012|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511013|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19511014|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511015|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511016|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
19511017|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511018|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19511019|NCT03022123|Prednisone|prednisone|mesh-list
19511020|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
19511021|NCT03022123|Doxorubicin|doxorubicin|mesh-list
19511022|NCT03022123|Vincristine|vincristine|mesh-list
19511023|NCT03022123|Epirubicin|epirubicin|mesh-list
19511024|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511025|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
19511026|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511027|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511028|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19511029|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
19511030|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511031|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511032|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19511033|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19511034|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19511035|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19511036|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511037|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511038|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
19511039|NCT03022123|Hormones|hormones|mesh-ancestor
19511040|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511041|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19511042|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19511043|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
19511044|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
19511045|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
19511046|NCT03021785|Bevacizumab|bevacizumab|mesh-list
19511047|NCT03021785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19511048|NCT03021785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511049|NCT03021785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19511050|NCT03021785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19511051|NCT03021785|Growth Substances|growth substances|mesh-ancestor
19511052|NCT03021785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603309|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511053|NCT03021785|Growth Inhibitors|growth inhibitors|mesh-ancestor
19511054|NCT03022006|Grazoprevir|grazoprevir|mesh-list
19511055|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
19511056|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511057|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
19511058|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19511059|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511060|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19511061|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19511062|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511063|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511064|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511065|NCT03021486|Haloperidol|haloperidol|mesh-list
19511066|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
19511067|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
19511068|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
19511069|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
19511070|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511071|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511072|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511073|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19511074|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19511075|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511076|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19511077|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19511078|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
19511079|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511080|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511081|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19511082|NCT03021629|Vitamin D|vitamin d|mesh-list
19511083|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19511084|NCT03021629|Vitamins|vitamins|mesh-ancestor
19511085|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
19511086|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511087|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19511088|NCT03021590|Amoxicillin|amoxicillin|mesh-list
19511089|NCT03021590|Clarithromycin|clarithromycin|mesh-list
19511090|NCT03021590|Levofloxacin|levofloxacin|mesh-list
19511091|NCT03021590|Ofloxacin|ofloxacin|mesh-list
19511092|NCT03021590|Tinidazole|tinidazole|mesh-list
19511093|NCT03021590|Esomeprazole|esomeprazole|mesh-list
19511094|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19511095|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511096|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19511097|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511098|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19511099|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511100|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511101|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19511102|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19511103|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19511104|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19511105|NCT03021590|Renal Agents|renal agents|mesh-ancestor
19511106|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19511107|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19511108|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511109|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19511110|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
19511111|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19511112|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19511113|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19511114|NCT03021694|Caseins|caseins|mesh-list
19511115|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
19511116|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
19511117|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511118|NCT03021395|Decitabine|decitabine|mesh-list
19511119|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19511120|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
19511121|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511122|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511123|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511124|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19511125|NCT03021317|Hormones|hormones|mesh-ancestor
19511126|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511127|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511128|NCT03021330|Cytarabine|cytarabine|mesh-list
19511129|NCT03021330|Daunorubicin|daunorubicin|mesh-list
19511130|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19511131|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
19511132|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511133|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511134|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
19511135|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511136|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511137|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
19511138|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511139|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19511140|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19511141|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19511142|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511143|NCT03021421|Bupivacaine|bupivacaine|mesh-list
19511144|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
19511145|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
19511146|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511147|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511148|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
19511149|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511150|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
19511151|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19511152|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511153|NCT03020979|Apatinib|apatinib|mesh-list
19511154|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511155|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19511156|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511157|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511158|NCT03020953|Estrogens|estrogens|mesh-list
19511159|NCT03020953|Hormones|hormones|mesh-ancestor
19511160|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511161|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511162|NCT03020940|Cefuroxime|cefuroxime|mesh-list
19511163|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
19511164|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19511165|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511166|NCT03020901|Teicoplanin|teicoplanin|mesh-list
19511167|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19511168|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511169|NCT03020680|Ubiquinone|ubiquinone|mesh-list
19511170|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
19511171|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
19511172|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511173|NCT03020680|Vitamins|vitamins|mesh-ancestor
19511174|NCT03020563|Bupivacaine|bupivacaine|mesh-list
19511175|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
19511176|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
19511177|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511178|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511179|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
19511180|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511181|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
19511182|NCT03020706|Analgesics|analgesics|mesh-ancestor
19511183|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
19511184|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511185|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511186|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
19511187|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511188|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19511189|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
19511190|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19511191|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20096980|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20096981|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
20096982|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
19511192|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511193|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19511194|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
19511195|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571592|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571593|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
19571594|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571595|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571596|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571597|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19571598|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20096983|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20096984|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19511196|NCT03020602|Ubiquinone|ubiquinone|mesh-list
19511197|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
19511198|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
19511199|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511200|NCT03020602|Vitamins|vitamins|mesh-ancestor
19511201|NCT03020589|Tacrolimus|tacrolimus|mesh-list
19511202|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511203|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
19511204|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511205|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19511206|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511207|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511208|NCT03020368|Diclofenac|diclofenac|mesh-list
20096985|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20096986|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20096987|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20096988|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20096989|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
20096990|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20096991|NCT00002598|Analgesics|analgesics|mesh-ancestor
20096992|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
20096993|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20096994|NCT00002599|Cobalt|cobalt|mesh-list
20096995|NCT00002599|Interferons|interferons|mesh-list
20096996|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
20096997|NCT00002599|Prednisone|prednisone|mesh-list
20096998|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
20096999|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
20097000|NCT00002599|Melphalan|melphalan|mesh-list
20097001|NCT00002599|Carmustine|carmustine|mesh-list
20097002|NCT00002599|Doxorubicin|doxorubicin|mesh-list
20097003|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097004|NCT00002599|Vincristine|vincristine|mesh-list
19511209|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19511210|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19511211|NCT03020368|Analgesics|analgesics|mesh-ancestor
19511212|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
19511213|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511214|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511215|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511216|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511217|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19511218|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511219|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511220|NCT03020329|Paclitaxel|paclitaxel|mesh-list
19511221|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19511222|NCT03020329|Cisplatin|cisplatin|mesh-list
19511223|NCT03020329|Fluorouracil|fluorouracil|mesh-list
19511224|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19511225|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511226|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097005|NCT00002599|Sargramostim|sargramostim|mesh-list
20097006|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097007|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
20097008|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511227|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
19511228|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
19511229|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097009|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097010|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097011|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
20097012|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511230|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
19511231|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19511232|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511233|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
19511234|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511235|NCT03020303|Spironolactone|spironolactone|mesh-list
19511236|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19511237|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
19511238|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511239|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511240|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20097013|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097014|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19511241|NCT03020303|Diuretics|diuretics|mesh-ancestor
20097015|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19511242|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
19511243|NCT03020134|Ritonavir|ritonavir|mesh-list
19511244|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19511245|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19511246|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
19511247|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511248|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511249|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19511250|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19511251|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
19511252|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511253|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19511254|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19511255|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19511256|NCT03020056|Antioxidants|antioxidants|mesh-list
19511257|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19511258|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511259|NCT03020056|Protective Agents|protective agents|mesh-ancestor
19511260|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511261|NCT03019822|Amphetamine|amphetamine|mesh-list
19511262|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
19511263|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19511264|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19511265|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19511266|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511267|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
19511268|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
19511269|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511270|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
19511271|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511272|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511273|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
19511274|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19511275|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19511276|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19511277|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19511278|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
19511279|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20097016|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097017|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097018|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097019|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097020|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
19511280|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
19511281|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19511282|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19511283|NCT03019991|Ritonavir|ritonavir|mesh-list
19511284|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19511285|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19511286|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
19511287|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511288|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511289|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20097021|NCT00002599|Hormones|hormones|mesh-ancestor
20097022|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097023|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097024|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
19511290|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19511291|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
19511292|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511293|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19511294|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19511295|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
19511296|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
19511297|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19511298|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19511299|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511300|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511301|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511302|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511303|NCT03019835|Neostigmine|neostigmine|mesh-list
19511304|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20097025|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097026|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19511305|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511306|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511307|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
19511308|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511309|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511310|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19511311|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
19511312|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511313|NCT03019848|Curcumin|curcumin|mesh-list
19511314|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19511315|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19511316|NCT03019848|Analgesics|analgesics|mesh-ancestor
19511317|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
19511318|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511319|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511320|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511321|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511322|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511323|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511324|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511325|NCT03019809|Plerixafor|plerixafor|mesh-list
19511326|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19511327|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19511328|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
19511329|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511330|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
19511331|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511332|NCT03019666|Niacinamide|niacinamide|mesh-list
19511333|NCT03019666|Niacin|niacin|mesh-list
19511334|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
19511335|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
19511336|NCT03019666|Vitamins|vitamins|mesh-ancestor
19511337|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
19511338|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511339|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19511340|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
19511341|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511342|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19511343|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
19511344|NCT03019536|Flutemetamol|flutemetamol|mesh-list
19511345|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19511346|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511347|NCT03019523|Caffeine|caffeine|mesh-list
19511348|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19511349|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511350|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19511351|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511352|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511353|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19511354|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19511355|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
19511356|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20097027|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
19511357|NCT03019562|Fentanyl|fentanyl|mesh-list
19511358|NCT03019562|Oxycodone|oxycodone|mesh-list
19511359|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19511360|NCT03019562|Narcotics|narcotics|mesh-ancestor
19511361|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511362|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511363|NCT03019562|Analgesics|analgesics|mesh-ancestor
19511364|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
19511365|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511366|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19511367|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19511368|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
19511369|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
19511370|NCT03019237|Omalizumab|omalizumab|mesh-list
19511371|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19511372|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19511373|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
19511374|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19511375|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19511376|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511377|NCT03019081|Isoproterenol|isoproterenol|mesh-list
19511378|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19511379|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19511380|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
20097028|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097029|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
19511381|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511382|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511383|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511384|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19511385|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
19511386|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511387|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19511388|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
19511389|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19511390|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
19511391|NCT03019081|Protective Agents|protective agents|mesh-ancestor
19511392|NCT03019120|Vitamin D|vitamin d|mesh-list
19511393|NCT03019120|Vitamins|vitamins|mesh-ancestor
19511394|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
19511395|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511396|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19511397|NCT03018899|Anesthetics|anesthetics|mesh-list
19511398|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511399|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511400|NCT03018990|Ethanol|ethanol|mesh-list
19511401|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19511402|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511403|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511404|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511405|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19511406|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511407|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511408|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
19511409|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19511410|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19511411|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511412|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
19511413|NCT03019198|Coagulants|coagulants|mesh-ancestor
19571599|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19571600|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
19571601|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571602|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571603|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
19571604|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
19571605|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571606|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19571607|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19571608|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571609|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19571610|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19571611|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19571612|NCT00653068|Antidotes|antidotes|mesh-ancestor
19571613|NCT00653068|Protective Agents|protective agents|mesh-ancestor
19571614|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
19571615|NCT00653068|Vitamins|vitamins|mesh-ancestor
19571616|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
19571617|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571618|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571619|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571620|NCT00653068|Hematinics|hematinics|mesh-ancestor
19571621|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
19571622|NCT00482157|Vitamin D|vitamin d|mesh-list
19571623|NCT00482157|Calcitriol|calcitriol|mesh-list
19571624|NCT00482157|Vitamins|vitamins|mesh-ancestor
19571625|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
19571626|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571627|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19571628|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20097030|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
20097031|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
20097032|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097033|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097034|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20097035|NCT00002599|Protective Agents|protective agents|mesh-ancestor
20097036|NCT00002599|Trace Elements|trace elements|mesh-ancestor
20097037|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
20097038|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
19571629|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19571630|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20097039|NCT00002600|Carboplatin|carboplatin|mesh-list
19511414|NCT03018821|Tenofovir|tenofovir|mesh-list
19511415|NCT03018821|Entecavir|entecavir|mesh-list
19511416|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
19511417|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511418|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19511419|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19511420|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511421|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511422|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19511423|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19511424|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19511425|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511426|NCT03018665|Metformin|metformin|mesh-list
19511427|NCT03018665|Exenatide|exenatide|mesh-list
19511428|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19511429|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511430|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19511431|NCT03018665|Incretins|incretins|mesh-ancestor
19511432|NCT03018665|Hormones|hormones|mesh-ancestor
19511433|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511434|NCT03018626|Prednisone|prednisone|mesh-list
19511435|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
19511436|NCT03018626|Rituximab|rituximab|mesh-list
19511437|NCT03018626|Doxorubicin|doxorubicin|mesh-list
19511438|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19511439|NCT03018626|Etoposide|etoposide|mesh-list
19511440|NCT03018626|Vincristine|vincristine|mesh-list
19511441|NCT03018626|Bleomycin|bleomycin|mesh-list
19511442|NCT03018626|Vindesine|vindesine|mesh-list
19511443|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511444|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
19511445|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511446|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511447|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19511448|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
19511449|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511450|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511451|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19511452|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19511453|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19511454|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19511455|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19511456|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511457|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511458|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
19511459|NCT03018626|Hormones|hormones|mesh-ancestor
19511460|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511461|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19511462|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19511463|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
19511464|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
19511465|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
19511466|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
19511467|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19511468|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19511469|NCT03018535|Prednisolone|prednisolone|mesh-list
19511470|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
19511471|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
19511472|NCT03018535|Rituximab|rituximab|mesh-list
19511473|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19511474|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
19511475|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511476|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
19511477|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511478|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511479|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19511480|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
19511481|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511482|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511483|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19511484|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19511485|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511486|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
19511487|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
19511488|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511489|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097040|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097041|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
19511490|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
19511491|NCT03018535|Hormones|hormones|mesh-ancestor
19511492|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511493|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19511494|NCT03018535|Protective Agents|protective agents|mesh-ancestor
19511495|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19511496|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
19511497|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19511498|NCT03018652|Antibodies|antibodies|mesh-list
19511499|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
19511500|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19511501|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
19511502|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511503|NCT03018704|Topiramate|topiramate|mesh-list
19511504|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
19511505|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19511506|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511507|NCT03018756|Fentanyl|fentanyl|mesh-list
19511508|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19511509|NCT03018756|Narcotics|narcotics|mesh-ancestor
19511510|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511511|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511512|NCT03018756|Analgesics|analgesics|mesh-ancestor
19511513|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
19511514|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511515|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19511516|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19511517|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
19511518|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
19511519|NCT03018444|Atorvastatin|atorvastatin|mesh-list
19511520|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19511521|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20097042|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097043|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097044|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097045|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
20097046|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097047|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097048|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097049|NCT00002604|Carmustine|carmustine|mesh-list
20097050|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20097051|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097052|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
20097053|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097054|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511522|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
19511523|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511524|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19511525|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19511526|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511527|NCT03018418|Mitomycins|mitomycins|mesh-list
19511528|NCT03018418|Mitomycin|mitomycin|mesh-list
19511529|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19511530|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511531|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
19511532|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511533|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19511534|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511535|NCT03018171|Clonidine|clonidine|mesh-list
19511536|NCT03018171|Sufentanil|sufentanil|mesh-list
19511537|NCT03018171|Analgesics|analgesics|mesh-ancestor
19511538|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
19511539|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511540|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511541|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19511542|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
19511543|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
19511544|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19511545|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20097055|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097056|NCT00002608|Tamoxifen|tamoxifen|mesh-list
19511546|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19511547|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
19511548|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511549|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511550|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19511551|NCT03018171|Narcotics|narcotics|mesh-ancestor
19511552|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511553|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19511554|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19511555|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
19511556|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
19511557|NCT03018301|Ketamine|ketamine|mesh-list
19511558|NCT03018301|Analgesics|analgesics|mesh-ancestor
19511559|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
19511560|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511561|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511562|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19511563|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19511564|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
19511565|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
19511566|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511567|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19511568|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20097057|NCT00002608|Doxorubicin|doxorubicin|mesh-list
20097058|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097059|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097060|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097061|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097062|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097063|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097064|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097065|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20097066|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
20097067|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097068|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097069|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097070|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20097071|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20097072|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20097073|NCT00002609|Cytarabine|cytarabine|mesh-list
20097074|NCT00002609|Idarubicin|idarubicin|mesh-list
20097075|NCT00002609|Lintuzumab|lintuzumab|mesh-list
20097076|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097077|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
20097078|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097079|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511569|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511570|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511571|NCT03018236|Ethanol|ethanol|mesh-list
19511572|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
19511573|NCT03018236|Cocaine|cocaine|mesh-list
19511574|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19511575|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19511576|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511577|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511578|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511579|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
19511580|NCT03018236|Expectorants|expectorants|mesh-ancestor
19511581|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
19511582|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19511583|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
19511584|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511585|NCT03018236|Protective Agents|protective agents|mesh-ancestor
19511586|NCT03018236|Antidotes|antidotes|mesh-ancestor
19511587|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
19511588|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
19511589|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
19511590|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511591|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19511592|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19511593|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19511594|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19511595|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
19511596|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511597|NCT03018015|Ibuprofen|ibuprofen|mesh-list
19511598|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19511599|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19511600|NCT03018015|Analgesics|analgesics|mesh-ancestor
19511601|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
19511602|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511603|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511604|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511605|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511606|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19511607|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511608|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511609|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
19511610|NCT03017963|Antidotes|antidotes|mesh-ancestor
19511611|NCT03017963|Protective Agents|protective agents|mesh-ancestor
19511612|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511613|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
19511614|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511615|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
19511616|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19511617|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511618|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
19511619|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
19511620|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19511621|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
20097080|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
19511622|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511623|NCT03017872|Ritonavir|ritonavir|mesh-list
19511624|NCT03017872|Darunavir|darunavir|mesh-list
19511625|NCT03017872|Dolutegravir|dolutegravir|mesh-list
19511626|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19511627|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19511628|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
19511629|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511630|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511631|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19511632|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19511633|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
19511634|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511635|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19511636|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19511637|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19511638|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19511639|NCT03017703|Eplerenone|eplerenone|mesh-list
19511640|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19511641|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
19511642|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511643|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511644|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19511645|NCT03017703|Diuretics|diuretics|mesh-ancestor
19511646|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
19511647|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19511648|NCT03017768|Tryptophan|tryptophan|mesh-list
19511649|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19511650|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
19511651|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19511652|NCT03017807|Antibodies|antibodies|mesh-list
19511653|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
19511654|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511655|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
19511656|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19511657|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19511658|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19511659|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19511660|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511661|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
20097081|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511662|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511663|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511664|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19511665|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511666|NCT03017495|Midazolam|midazolam|mesh-list
19511667|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19511668|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19511669|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511670|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511671|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19511672|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19511673|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19511674|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19511675|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
19511676|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
19511677|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
19511678|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
19511679|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511680|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511681|NCT03017222|Ondansetron|ondansetron|mesh-list
19511682|NCT03017222|Ramosetron|ramosetron|mesh-list
19511683|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
20603310|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19511684|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
19511685|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511686|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511687|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511688|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
19511689|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
19511690|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19511691|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
19511692|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511693|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511694|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19511695|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19511696|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511697|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19511698|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19511699|NCT03017248|Ketamine|ketamine|mesh-list
19511700|NCT03017248|Morphine|morphine|mesh-list
19511701|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19511702|NCT03017248|Analgesics|analgesics|mesh-ancestor
19511703|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
19511704|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511705|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511706|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19511707|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19511708|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
19511709|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
19511710|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511711|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19511712|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19511713|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511714|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511715|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19511716|NCT03017248|Narcotics|narcotics|mesh-ancestor
19511717|NCT03017391|Dexamethasone|dexamethasone|mesh-list
19511718|NCT03017391|Metoclopramide|metoclopramide|mesh-list
19511719|NCT03017391|Granisetron|granisetron|mesh-list
19511720|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511721|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
19511722|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
19511723|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511724|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511725|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511726|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
19511727|NCT03017391|Hormones|hormones|mesh-ancestor
19511728|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511729|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19511730|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511731|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19511732|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19511733|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
19511734|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511735|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511736|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19511737|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
19511738|NCT03017430|Ketorolac|ketorolac|mesh-list
19511739|NCT03017430|Phenazepam|phenazepam|mesh-list
19511740|NCT03017430|Clonidine|clonidine|mesh-list
19511741|NCT03017430|Pregabalin|pregabalin|mesh-list
19511742|NCT03017430|Metoclopramide|metoclopramide|mesh-list
19511743|NCT03017430|Loperamide|loperamide|mesh-list
19511744|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
19511745|NCT03017430|Analgesics|analgesics|mesh-ancestor
19511746|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
19511747|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511748|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511749|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
19511750|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19511751|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19511752|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511753|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19511754|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19511755|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19511756|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511757|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19511758|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19511759|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19511760|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511761|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511762|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19511763|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511764|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19511765|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
19511766|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
19511767|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19511768|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19511769|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19511770|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19511771|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511772|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
19511773|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511774|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19511775|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19511776|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
19511777|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19511778|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
19511779|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19511780|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
19571631|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571632|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19571633|NCT00193479|Prednisone|prednisone|mesh-list
19571634|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
19571635|NCT00193479|Rituximab|rituximab|mesh-list
20097082|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097083|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
20097084|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097085|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097086|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097087|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097088|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097089|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20097090|NCT00002610|Dactinomycin|dactinomycin|mesh-list
20097091|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
20097092|NCT00002610|Carboplatin|carboplatin|mesh-list
20097093|NCT00002610|Doxorubicin|doxorubicin|mesh-list
20097094|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097095|NCT00002610|Etoposide|etoposide|mesh-list
20097096|NCT00002610|Vincristine|vincristine|mesh-list
20097097|NCT00002610|Lenograstim|lenograstim|mesh-list
20097098|NCT00002610|Sargramostim|sargramostim|mesh-list
20097099|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097100|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
20097101|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097102|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097103|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097104|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
20097105|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097106|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571636|NCT00193479|Vincristine|vincristine|mesh-list
20097107|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571637|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
19571638|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511781|NCT03017352|Exenatide|exenatide|mesh-list
19511782|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19511783|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511784|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19511785|NCT03017352|Incretins|incretins|mesh-ancestor
19511786|NCT03017352|Hormones|hormones|mesh-ancestor
19511787|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511788|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
19511789|NCT03017404|Docetaxel|docetaxel|mesh-list
19511790|NCT03017404|Doxorubicin|doxorubicin|mesh-list
19511791|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19511792|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511793|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
19511794|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511795|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511796|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19511797|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
19511798|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511799|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511800|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19511801|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
19511802|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
19511803|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
19511804|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19511805|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19511806|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19511807|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511808|NCT03016884|Vaccines|vaccines|mesh-list
19511809|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
19511810|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511811|NCT03016988|Cytarabine|cytarabine|mesh-list
19511812|NCT03016988|Fludarabine|fludarabine|mesh-list
19511813|NCT03016988|Bortezomib|bortezomib|mesh-list
19511814|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511815|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19511816|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
19511817|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511818|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511819|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
19511820|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511821|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
19511822|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511823|NCT03017066|Anesthetics|anesthetics|mesh-list
19511824|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511825|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511826|NCT03016832|Irbesartan|irbesartan|mesh-list
19511827|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19511828|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19511829|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19511830|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511831|NCT03016871|Carboplatin|carboplatin|mesh-list
19511832|NCT03016871|Nivolumab|nivolumab|mesh-list
19511833|NCT03016871|Etoposide|etoposide|mesh-list
19511834|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
19511835|NCT03016871|Ifosfamide|ifosfamide|mesh-list
19511836|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
19511837|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
19511838|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511839|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19511840|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19511841|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511842|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19511843|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19511844|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19511845|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511846|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19511847|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
19511848|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
19511849|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
19511850|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
19511851|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19511852|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19511853|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
19511854|NCT03016806|Melphalan|melphalan|mesh-list
19511855|NCT03016806|Busulfan|busulfan|mesh-list
19511856|NCT03016806|Fludarabine|fludarabine|mesh-list
19511857|NCT03016806|Mesna|mesna|mesh-list
19511858|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511859|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
19511860|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511861|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511862|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19511863|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
19511864|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511865|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511866|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19511867|NCT03016806|Protective Agents|protective agents|mesh-ancestor
19511868|NCT03016715|Sirolimus|sirolimus|mesh-list
19511869|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19511870|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511871|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19511872|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511873|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
20097108|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097109|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097110|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097111|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097112|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097113|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20097114|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19511874|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511875|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
19511876|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511877|NCT03016793|Puerarin|puerarin|mesh-list
19511878|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
19511879|NCT03016741|Prednisone|prednisone|mesh-list
19511880|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
19511881|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511882|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
19511883|NCT03016741|Hormones|hormones|mesh-ancestor
19511884|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19511885|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511886|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19511887|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511888|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19511889|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511890|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511891|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
19511892|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19511893|NCT03016650|Acetaminophen|acetaminophen|mesh-list
19511894|NCT03016650|Ibuprofen|ibuprofen|mesh-list
19511895|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19511896|NCT03016650|Analgesics|analgesics|mesh-ancestor
19511897|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
19511898|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511899|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511900|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
19511901|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19511902|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511903|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511904|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19511905|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511906|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511907|NCT03016611|Ticagrelor|ticagrelor|mesh-list
19511908|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19511909|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19511910|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19511911|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19511912|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19511913|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
19511914|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19511915|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511916|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511917|NCT03016442|Dinoprostone|dinoprostone|mesh-list
19511918|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
20097115|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097116|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097117|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20097118|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097119|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19511919|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19511920|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511921|NCT03016260|Adalimumab|adalimumab|mesh-list
19511922|NCT03016260|Etanercept|etanercept|mesh-list
19511923|NCT03016260|Golimumab|golimumab|mesh-list
19511924|NCT03016260|Infliximab|infliximab|mesh-list
19511925|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
19511926|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097120|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20097121|NCT00002611|Dactinomycin|dactinomycin|mesh-list
20097122|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
20097123|NCT00002611|Doxorubicin|doxorubicin|mesh-list
20097124|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097125|NCT00002611|Etoposide|etoposide|mesh-list
19511927|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511928|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
19511929|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511930|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19511931|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19511932|NCT03016260|Analgesics|analgesics|mesh-ancestor
19511933|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
19511934|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511935|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511936|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511937|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
19511938|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19511939|NCT03016234|Propofol|propofol|mesh-list
19511940|NCT03016234|Desflurane|desflurane|mesh-list
19511941|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19511942|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19511943|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511944|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19511945|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
19511946|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
19511947|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19511948|NCT03016468|Treprostinil|treprostinil|mesh-list
19511949|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19511950|NCT03016208|Misoprostol|misoprostol|mesh-list
19511951|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19511952|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
19511953|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19511954|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511955|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19511956|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19511957|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
19511958|NCT03016000|Thalidomide|thalidomide|mesh-list
19511959|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511960|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
19511961|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511962|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
19511963|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19511964|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19511965|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19511966|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19511967|NCT03016000|Growth Substances|growth substances|mesh-ancestor
19511968|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
19511969|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511970|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19511971|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511972|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511973|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511974|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19511975|NCT03016039|Curcumin|curcumin|mesh-list
19511976|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19511977|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19511978|NCT03016039|Analgesics|analgesics|mesh-ancestor
19511979|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
19511980|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19511981|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511982|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19511983|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19511984|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19511985|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19511986|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19511987|NCT03015818|Calcium|calcium|mesh-list
19511988|NCT03015818|Fluorides|fluorides|mesh-list
20097126|NCT00002611|Vincristine|vincristine|mesh-list
20097127|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19511989|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20097128|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
20097129|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097130|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097131|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097132|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
20097133|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097134|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097135|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097136|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097137|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097138|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097139|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097140|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097141|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097142|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097143|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
19511990|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19511991|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
19511992|NCT03015818|Protective Agents|protective agents|mesh-ancestor
19511993|NCT03015857|Phenylephrine|phenylephrine|mesh-list
19511994|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
19511995|NCT03015857|Norepinephrine|norepinephrine|mesh-list
19511996|NCT03015857|Fentanyl|fentanyl|mesh-list
19511997|NCT03015857|Bupivacaine|bupivacaine|mesh-list
19511998|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
19511999|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
19512000|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512001|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512002|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
19512003|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512004|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512005|NCT03015857|Narcotics|narcotics|mesh-ancestor
19512006|NCT03015857|Analgesics|analgesics|mesh-ancestor
19512007|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19512008|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19512009|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
19512010|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19512011|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
19512012|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
20097144|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20097145|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097146|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20097147|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20097148|NCT00002615|Fluorouracil|fluorouracil|mesh-list
20097149|NCT00002615|Epirubicin|epirubicin|mesh-list
20097150|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097151|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
20097152|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097153|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097154|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097155|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
20097156|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097157|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19512013|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
19512014|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19512015|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
19512016|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
19512017|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19512018|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19512019|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19512020|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
19512021|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512022|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512023|NCT03015857|Protective Agents|protective agents|mesh-ancestor
19512024|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
19512025|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512026|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512027|NCT03015922|Lenalidomide|lenalidomide|mesh-list
19512028|NCT03015922|Pomalidomide|pomalidomide|mesh-list
19512029|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
19512030|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097158|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19512031|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19512032|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19512033|NCT03015922|Growth Substances|growth substances|mesh-ancestor
19512034|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
19512035|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512036|NCT03015727|Docetaxel|docetaxel|mesh-list
19512037|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512038|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
19512039|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
19512040|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
19512041|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512042|NCT03015896|Nivolumab|nivolumab|mesh-list
19512043|NCT03015896|Lenalidomide|lenalidomide|mesh-list
19512044|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512045|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512046|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19512047|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512048|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
19512049|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512050|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19512051|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19512052|NCT03015896|Growth Substances|growth substances|mesh-ancestor
19512053|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
19512054|NCT03015831|Colchicine|colchicine|mesh-list
19512055|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
19512056|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512057|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
19512058|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
19512059|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
19512060|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512061|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512062|NCT03015701|Mifepristone|mifepristone|mesh-list
19512063|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19512064|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
19512065|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19512066|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512067|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19512068|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19512069|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19512070|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
19512071|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19512072|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19512073|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
19512074|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512075|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
19512076|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19512077|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19512078|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
19512079|NCT03015675|Vitamins|vitamins|mesh-ancestor
19512080|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
19512081|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512082|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
19512083|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512084|NCT03015675|Protective Agents|protective agents|mesh-ancestor
19512085|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
19512086|NCT03015519|Incretins|incretins|mesh-ancestor
19512087|NCT03015519|Hormones|hormones|mesh-ancestor
19512088|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512089|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571639|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
19571640|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097159|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097160|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097161|NCT00002616|Aldesleukin|aldesleukin|mesh-list
20097162|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
20097163|NCT00002616|Thiotepa|thiotepa|mesh-list
20097164|NCT00002616|Carboplatin|carboplatin|mesh-list
20097165|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097166|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
20097167|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097168|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097169|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097170|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
20097171|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603311|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20603312|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19571641|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097172|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603313|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
19512097|NCT03015350|Sevoflurane|sevoflurane|mesh-list
19512098|NCT03015350|Desflurane|desflurane|mesh-list
19512099|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19512100|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19512101|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
19512102|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
19512103|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512104|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512105|NCT03015246|Morphine|morphine|mesh-list
20097173|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097174|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20097175|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20603314|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603315|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603316|NCT02220400|Ketamine|ketamine|mesh-list
20603317|NCT02220400|Analgesics|analgesics|mesh-ancestor
20097176|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
20097177|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097178|NCT00002618|Leucovorin|leucovorin|mesh-list
20097179|NCT00002618|Cobalt|cobalt|mesh-list
20097180|NCT00002618|Cytarabine|cytarabine|mesh-list
20097181|NCT00002618|Prednisone|prednisone|mesh-list
19512106|NCT03015246|Buprenorphine|buprenorphine|mesh-list
19512107|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20097182|NCT00002618|Doxorubicin|doxorubicin|mesh-list
20097183|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097184|NCT00002618|Methotrexate|methotrexate|mesh-list
20097185|NCT00002618|Vincristine|vincristine|mesh-list
20097186|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
20097187|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
20097188|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097189|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097190|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097191|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097192|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097193|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097194|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097195|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097196|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
20097197|NCT00002618|Hormones|hormones|mesh-ancestor
20097198|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097199|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19512108|NCT03015246|Naloxone|naloxone|mesh-list
19512109|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20097200|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20097201|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
20097202|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20097203|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097204|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
20097205|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
20097206|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20097207|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097208|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
19512110|NCT03015246|Narcotics|narcotics|mesh-ancestor
19512111|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512112|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512113|NCT03015246|Analgesics|analgesics|mesh-ancestor
19512114|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
19512115|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512116|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19512117|NCT03014947|Adalimumab|adalimumab|mesh-list
19512118|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512119|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512120|NCT03015168|Capecitabine|capecitabine|mesh-list
19512121|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19512122|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
19512123|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097209|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097210|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19512124|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097211|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
20097212|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097213|NCT00002618|Antidotes|antidotes|mesh-ancestor
19512125|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
19512126|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
19512127|NCT03014843|Bromides|bromides|mesh-list
19512128|NCT03014843|Naloxone|naloxone|mesh-list
20097214|NCT00002618|Protective Agents|protective agents|mesh-ancestor
20097215|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
20097216|NCT00002618|Vitamins|vitamins|mesh-ancestor
20097217|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
20097218|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097219|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097220|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097221|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097222|NCT00002618|Trace Elements|trace elements|mesh-ancestor
20097223|NCT00002619|Carboplatin|carboplatin|mesh-list
20097224|NCT00002619|Thiotepa|thiotepa|mesh-list
20097225|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097226|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
20097227|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097228|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097229|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
20097230|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097231|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097232|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097233|NCT00002620|Cobalt|cobalt|mesh-list
19512129|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
19512130|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
19512131|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19512132|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512133|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
19512134|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512135|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
19512136|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19512137|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
19512138|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512139|NCT03014882|Expectorants|expectorants|mesh-ancestor
19512140|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
19512141|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19512142|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
19512143|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512144|NCT03014882|Protective Agents|protective agents|mesh-ancestor
19512145|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512146|NCT03014882|Antidotes|antidotes|mesh-ancestor
19512147|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
19512148|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
19512149|NCT03014713|Dezocine|dezocine|mesh-list
19512150|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19512151|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512152|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512153|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19512154|NCT03014713|Analgesics|analgesics|mesh-ancestor
20097234|NCT00002620|Carmustine|carmustine|mesh-list
20097235|NCT00002620|Mitolactol|mitolactol|mesh-list
20097236|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097237|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
20097238|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097239|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097240|NCT00002620|Trace Elements|trace elements|mesh-ancestor
20097241|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
19512155|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
19512156|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512157|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19512158|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20097242|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097243|NCT00002621|Interferons|interferons|mesh-list
20097244|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
20097245|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
20097246|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097247|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
20097248|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512159|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19512160|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
19512161|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512162|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097249|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
20097250|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097251|NCT00002623|Carboplatin|carboplatin|mesh-list
20097252|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512163|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512164|NCT03014713|Narcotics|narcotics|mesh-ancestor
19512165|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19512166|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512167|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512168|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19512169|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512170|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19512171|NCT03014687|Cefdinir|cefdinir|mesh-list
19512172|NCT03014687|Cephalosporins|cephalosporins|mesh-list
19512173|NCT03014687|Trimethoprim|trimethoprim|mesh-list
19512174|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
19512175|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512176|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19512177|NCT03014687|Renal Agents|renal agents|mesh-ancestor
19512178|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
19512179|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19512180|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19512181|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19512182|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512183|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512184|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19512185|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19512186|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19512187|NCT03014804|Nivolumab|nivolumab|mesh-list
19512188|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512189|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512190|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19512191|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512192|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
19512193|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19512194|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
19512195|NCT03014778|Povidone|povidone|mesh-list
19512196|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19512197|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512198|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
19512199|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512200|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
19512201|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
19512202|NCT03014440|Cannabidiol|cannabidiol|mesh-list
19512203|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
19512204|NCT03014323|Galantamine|galantamine|mesh-list
19512205|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19512206|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512207|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512208|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
19512209|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512210|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512211|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19512212|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
19512213|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512214|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
19512215|NCT03014297|Everolimus|everolimus|mesh-list
19512216|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
19512217|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512218|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19512219|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
19512220|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512221|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19512222|NCT03014167|Albendazole|albendazole|mesh-list
19512223|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
19512224|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19512225|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512226|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
19512227|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19512228|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19512229|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
19512230|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
19512231|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
19512232|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512233|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512234|NCT03014076|Trastuzumab|trastuzumab|mesh-list
19512235|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512236|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512237|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
19512238|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19512239|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20097253|NCT00002625|Topotecan|topotecan|mesh-list
20097254|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20097255|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097256|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097257|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512240|NCT03013959|Analgesics|analgesics|mesh-ancestor
19512241|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
19512242|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512243|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512244|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512245|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512246|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
19512247|NCT03013881|Trastuzumab|trastuzumab|mesh-list
19512248|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512249|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512250|NCT03013751|Udenafil|udenafil|mesh-list
19512251|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19512252|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19512253|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512254|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571642|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571643|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
19571644|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571645|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571646|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571647|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571648|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19571649|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
19571650|NCT00193479|Hormones|hormones|mesh-ancestor
19571651|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571652|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19571653|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571654|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571655|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571656|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571657|NCT00193479|Analgesics|analgesics|mesh-ancestor
19571658|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
19571659|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571660|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19571661|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19571662|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571663|NCT00193427|Gemcitabine|gemcitabine|mesh-list
19571664|NCT00193427|Carboplatin|carboplatin|mesh-list
19571665|NCT00193427|Docetaxel|docetaxel|mesh-list
19571666|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097258|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097259|NCT00002627|Paclitaxel|paclitaxel|mesh-list
20097260|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
20097261|NCT00002627|Carboplatin|carboplatin|mesh-list
19571667|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571668|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
19571669|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571670|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
19571671|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571672|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571673|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571674|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
19571675|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097262|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097263|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097264|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097265|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097266|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097267|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097268|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097269|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
20097270|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097271|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097272|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097273|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
19512255|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19512256|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19512257|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19512258|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512259|NCT03013790|Melatonin|melatonin|mesh-list
19512260|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
19512261|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512262|NCT03013790|Protective Agents|protective agents|mesh-ancestor
19512263|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512264|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20097274|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097275|NCT00002628|Paclitaxel|paclitaxel|mesh-list
20097276|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
20097277|NCT00002628|Carboplatin|carboplatin|mesh-list
20097278|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097279|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097280|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097281|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
19512265|NCT03013335|Nivolumab|nivolumab|mesh-list
19512266|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512267|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512268|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19512269|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512270|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19512271|NCT03013439|Hematinics|hematinics|mesh-ancestor
19512272|NCT03013218|Paclitaxel|paclitaxel|mesh-list
19512273|NCT03013218|Rituximab|rituximab|mesh-list
19512274|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
19512275|NCT03013218|Trastuzumab|trastuzumab|mesh-list
19512276|NCT03013218|Ramucirumab|ramucirumab|mesh-list
19512277|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19512278|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512279|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
19512280|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
19512281|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
19512282|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512283|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512284|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
19512285|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512286|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512287|NCT03013387|Octreotide|octreotide|mesh-list
19512288|NCT03013387|Edotreotide|edotreotide|mesh-list
19512289|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512290|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19512291|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512292|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19512293|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512294|NCT03013556|Tenofovir|tenofovir|mesh-list
19512295|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19512296|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
19512297|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
19512298|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512299|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19512300|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19512301|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512302|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512303|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19512304|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19512305|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
19512306|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512307|NCT03013205|Triamcinolone|triamcinolone|mesh-list
19512308|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19512309|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19512310|NCT03013205|Lidocaine|lidocaine|mesh-list
19512311|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20097282|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
19512312|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512313|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
19512314|NCT03013205|Hormones|hormones|mesh-ancestor
19512315|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512316|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512317|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19512318|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
19512319|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512320|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512321|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
19512322|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
19512323|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512324|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
19512325|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512326|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19512327|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19512328|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19512329|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19512330|NCT03013400|Ebselen|ebselen|mesh-list
19512331|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19512332|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19512333|NCT03013400|Analgesics|analgesics|mesh-ancestor
19512334|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
19512335|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512336|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512337|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512338|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512339|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19512340|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512341|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
19512342|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097283|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097284|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097285|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
20097286|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097287|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097288|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097289|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
20097290|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097291|NCT00002630|Cobalt|cobalt|mesh-list
20097292|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
19512343|NCT03013400|Protective Agents|protective agents|mesh-ancestor
19512344|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19512345|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512346|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19512347|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
19512348|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19512349|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512350|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512351|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19512352|NCT03013634|Analgesics|analgesics|mesh-ancestor
19512353|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
19512354|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512355|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19512356|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19512357|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19512358|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19512359|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512360|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512361|NCT03013322|Physostigmine|physostigmine|mesh-list
19512362|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19512363|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512364|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512365|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
19512366|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512367|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512368|NCT03013322|Miotics|miotics|mesh-ancestor
19512369|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
19512370|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512371|NCT03013361|Bupivacaine|bupivacaine|mesh-list
19512372|NCT03013361|Ropivacaine|ropivacaine|mesh-list
19512373|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
19512374|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
19571676|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
19512375|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512376|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512377|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
19512378|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512379|NCT03013036|Fentanyl|fentanyl|mesh-list
19512380|NCT03013036|Midazolam|midazolam|mesh-list
19512381|NCT03013036|Propofol|propofol|mesh-list
19512382|NCT03013036|Sevoflurane|sevoflurane|mesh-list
19512383|NCT03013036|Rocuronium|rocuronium|mesh-list
19512384|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19512385|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512386|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512387|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19512388|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
19512389|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
19512390|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512391|NCT03013036|Narcotics|narcotics|mesh-ancestor
19512392|NCT03013036|Analgesics|analgesics|mesh-ancestor
19512393|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
19512394|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512395|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19512396|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19512397|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19512398|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19512399|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
19512400|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
19512401|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512402|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512403|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19512404|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19512405|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19512406|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19512407|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19512408|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
19512409|NCT03013010|Tegafur|tegafur|mesh-list
19512410|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512411|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19512412|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
19512413|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512414|NCT03012945|Anesthetics|anesthetics|mesh-list
19512415|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512416|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512417|NCT03013140|Anesthetics|anesthetics|mesh-list
19512418|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20097293|NCT00002630|Melphalan|melphalan|mesh-list
20097294|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097295|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
20097296|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097297|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097298|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097299|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
19512419|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512420|NCT03013075|Morphine|morphine|mesh-list
19512421|NCT03013075|Bupivacaine|bupivacaine|mesh-list
20097300|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097301|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097302|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097303|NCT00002630|Trace Elements|trace elements|mesh-ancestor
20097304|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
20097305|NCT00002631|Fluorouracil|fluorouracil|mesh-list
20097306|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097307|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
20097308|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097309|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097310|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097311|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
20097312|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512422|NCT03013075|Anesthetics|anesthetics|mesh-list
20097313|NCT00002632|Paclitaxel|paclitaxel|mesh-list
19512423|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
19512424|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
20097314|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097315|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512425|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512426|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512427|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
19512428|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512429|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512430|NCT03013075|Narcotics|narcotics|mesh-ancestor
19512431|NCT03013075|Analgesics|analgesics|mesh-ancestor
19512432|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
19512433|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512434|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512435|NCT03013101|Antibodies|antibodies|mesh-list
19512436|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19512437|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
19512438|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512439|NCT03013114|Bortezomib|bortezomib|mesh-list
19512440|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512441|NCT03012880|Dexamethasone|dexamethasone|mesh-list
19512442|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
19512443|NCT03012880|Lenalidomide|lenalidomide|mesh-list
19512444|NCT03012880|Daratumumab|daratumumab|mesh-list
19512445|NCT03012880|Ixazomib|ixazomib|mesh-list
19512446|NCT03012880|Ichthammol|ichthammol|mesh-list
19512447|NCT03012880|BB 1101|bb 1101|mesh-list
19512448|NCT03012880|Glycine|glycine|mesh-list
19512449|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097316|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097317|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097318|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097319|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097320|NCT00002633|Leuprolide|leuprolide|mesh-list
20097321|NCT00002633|Goserelin|goserelin|mesh-list
20097322|NCT00002633|Flutamide|flutamide|mesh-list
20097323|NCT00002633|Bicalutamide|bicalutamide|mesh-list
19512450|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
19512451|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
19512452|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512453|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512454|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512455|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
19512456|NCT03012880|Hormones|hormones|mesh-ancestor
19512457|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512458|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19512459|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512460|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
19512461|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19512462|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19512463|NCT03012880|Growth Substances|growth substances|mesh-ancestor
19512464|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
19512465|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512466|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
19512467|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512468|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512469|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
19512470|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512471|NCT03012646|Treprostinil|treprostinil|mesh-list
19512472|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19512473|NCT03012763|Acetaminophen|acetaminophen|mesh-list
19512474|NCT03012763|Fexofenadine|fexofenadine|mesh-list
19512475|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
19512476|NCT03012763|Valsartan|valsartan|mesh-list
19512477|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19512478|NCT03012763|Analgesics|analgesics|mesh-ancestor
19512479|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
19512480|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512481|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097324|NCT00002633|Nilutamide|nilutamide|mesh-list
20097325|NCT00002633|Buserelin|buserelin|mesh-list
20097326|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20097327|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
20097328|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20097329|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097330|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097331|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097332|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
20097333|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
20097334|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512482|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
19512483|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20097335|NCT00002634|Cobalt|cobalt|mesh-list
20097336|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
19512484|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19512485|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20097337|NCT00002634|Doxorubicin|doxorubicin|mesh-list
19512486|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512487|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19512488|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19512489|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19512490|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
19512491|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
19512492|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512493|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512494|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19512495|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512496|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512497|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512498|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19512499|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19512500|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19512501|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512502|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512503|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
19512504|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512505|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19512506|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19512507|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
19512508|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19512509|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512510|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
19512511|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512512|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512513|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
19512514|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512515|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
19512516|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19512517|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19512518|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512519|NCT03012386|Urological Agents|urological agents|mesh-ancestor
19512520|NCT03012321|Prednisone|prednisone|mesh-list
19512521|NCT03012321|Olaparib|olaparib|mesh-list
19512522|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
19512523|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512524|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
19512525|NCT03012321|Hormones|hormones|mesh-ancestor
19512526|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512527|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512528|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19512529|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512530|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19512531|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512532|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512533|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19512534|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
19512535|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19571677|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097338|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097339|NCT00002634|Etoposide|etoposide|mesh-list
20097340|NCT00002634|Vincristine|vincristine|mesh-list
20097341|NCT00002634|Antibodies|antibodies|mesh-list
20097342|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20097343|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097344|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
20097345|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097346|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097347|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097348|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
20097349|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097350|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097351|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097352|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097353|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097354|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097355|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097356|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097357|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097358|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097359|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097360|NCT00002634|Trace Elements|trace elements|mesh-ancestor
20097361|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
20097362|NCT00002635|Lenograstim|lenograstim|mesh-list
20097363|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19512536|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
19512537|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19512538|NCT03012347|Protective Agents|protective agents|mesh-ancestor
19512539|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512540|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512541|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
19512542|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
19512543|NCT03012360|Linezolid|linezolid|mesh-list
19512544|NCT03012360|Imipenem|imipenem|mesh-list
19512545|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19512546|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512547|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19512548|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19512549|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512550|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512551|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512552|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19512553|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19512554|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19512555|NCT03011970|Oxytocin|oxytocin|mesh-list
19512556|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
19512557|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19512558|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512559|NCT03011905|Acetaminophen|acetaminophen|mesh-list
19512560|NCT03011905|Dexamethasone|dexamethasone|mesh-list
19512561|NCT03011905|Etoricoxib|etoricoxib|mesh-list
19512562|NCT03011905|Oxycodone|oxycodone|mesh-list
19512563|NCT03011905|Ropivacaine|ropivacaine|mesh-list
19512564|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512565|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
19512566|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
19512567|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512568|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512569|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512570|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
19512571|NCT03011905|Hormones|hormones|mesh-ancestor
19512572|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512573|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19512574|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512575|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
19512576|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
19512577|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512578|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
19512579|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19512580|NCT03011905|Analgesics|analgesics|mesh-ancestor
19512581|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
19512582|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512583|NCT03011905|Narcotics|narcotics|mesh-ancestor
19512584|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19512585|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512586|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19512587|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19512588|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097364|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
20097365|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097366|NCT00002637|Interferons|interferons|mesh-list
20097367|NCT00002637|Aldesleukin|aldesleukin|mesh-list
20097368|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
20097369|NCT00002637|Vaccines|vaccines|mesh-list
20097370|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512589|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512590|NCT03011918|Vitamin D|vitamin d|mesh-list
19512591|NCT03011918|Vitamins|vitamins|mesh-ancestor
19512592|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
19512593|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512594|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19512595|NCT03012009|Lidocaine|lidocaine|mesh-list
19512596|NCT03012009|Epinephrine|epinephrine|mesh-list
20097371|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
19512597|NCT03012009|Racepinephrine|racepinephrine|mesh-list
19512598|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
19512599|NCT03012009|Anesthetics|anesthetics|mesh-list
20097372|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097373|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20097374|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19512600|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19512601|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
19512602|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512603|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512604|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
19512605|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512606|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19512607|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19512608|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19512609|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19512610|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512611|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19512612|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19512613|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
19512614|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512615|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19512616|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19512617|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
19512618|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19512619|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
19512620|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
19512621|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
19512622|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19512623|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19512624|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512625|NCT03012113|Mirabegron|mirabegron|mesh-list
19512626|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19512627|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19512628|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19512629|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19512630|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512631|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512632|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512633|NCT03012113|Urological Agents|urological agents|mesh-ancestor
19512634|NCT03011931|Simvastatin|simvastatin|mesh-list
19512635|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19512636|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19512637|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
19512638|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512639|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19512640|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19512641|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512642|NCT03011996|Amoxicillin|amoxicillin|mesh-list
19512643|NCT03011996|Clarithromycin|clarithromycin|mesh-list
19512644|NCT03011996|Pantoprazole|pantoprazole|mesh-list
19512645|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19512646|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512647|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19512648|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512649|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512650|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19512651|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19512652|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19512653|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512654|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19512655|NCT03011476|Donepezil|donepezil|mesh-list
19512656|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19512657|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512658|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512659|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
19512660|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512661|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512662|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
19512663|NCT03011463|Clarithromycin|clarithromycin|mesh-list
19512664|NCT03011463|Ranitidine|ranitidine|mesh-list
19512665|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19512666|NCT03011463|Trospium chloride|trospium chloride|mesh-list
19512667|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19512668|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512669|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19512670|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571678|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097375|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
20097376|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512671|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512672|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19512673|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19512674|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19512675|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512676|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20097377|NCT00002638|Cytarabine|cytarabine|mesh-list
20097378|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
20097379|NCT00002638|Carmustine|carmustine|mesh-list
20097380|NCT00002638|Etoposide|etoposide|mesh-list
20097381|NCT00002638|Sargramostim|sargramostim|mesh-list
20097382|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19512677|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
19512678|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
19512679|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512680|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512681|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
19512682|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
19512683|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512684|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19512685|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19512686|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
19512687|NCT03011463|Urological Agents|urological agents|mesh-ancestor
19512688|NCT03011645|Ziprasidone|ziprasidone|mesh-list
19512689|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19512690|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
19512691|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512692|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512693|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512694|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19512695|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19512696|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512697|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19512698|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19512699|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
19512700|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
19512701|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512702|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512703|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19512704|NCT03011567|Acetaminophen|acetaminophen|mesh-list
19512705|NCT03011567|Ibuprofen|ibuprofen|mesh-list
20097383|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
20097384|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097385|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097386|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097387|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
19512706|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19512707|NCT03011567|Analgesics|analgesics|mesh-ancestor
19512708|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
19512709|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512710|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512711|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
19512712|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19512713|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512714|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512715|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19512716|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512717|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512718|NCT03011281|Tofacitinib|tofacitinib|mesh-list
19512719|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19512720|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512721|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512722|NCT03011177|Linagliptin|linagliptin|mesh-list
19512723|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19512724|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512725|NCT03011177|Incretins|incretins|mesh-ancestor
19512726|NCT03011177|Hormones|hormones|mesh-ancestor
19512727|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512728|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19512729|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
20097388|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512730|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512731|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097389|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097390|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19512732|NCT03011268|Adalimumab|adalimumab|mesh-list
19512733|NCT03011268|Golimumab|golimumab|mesh-list
19512734|NCT03011268|Infliximab|infliximab|mesh-list
19512735|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19512736|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512737|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512738|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512739|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512740|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19512741|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19512742|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
19512743|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512744|NCT03010917|Ethanol|ethanol|mesh-list
19512745|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19512746|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512747|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512748|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512749|NCT03010865|Butyric Acid|butyric acid|mesh-list
19512750|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
19512751|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
19512752|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512753|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512754|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512755|NCT03011008|Liraglutide|liraglutide|mesh-list
19512756|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19512757|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512758|NCT03011008|Incretins|incretins|mesh-ancestor
19512759|NCT03011008|Hormones|hormones|mesh-ancestor
19512760|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512761|NCT03010995|Prazosin|prazosin|mesh-list
19512762|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19512763|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19512764|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19512765|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19512766|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
19512767|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512768|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512769|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512770|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
19512771|NCT03011125|Lansoprazole|lansoprazole|mesh-list
19512772|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19512773|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512774|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19512775|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097391|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097392|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097393|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097394|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097395|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097396|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
20097397|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
20097398|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19512776|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512777|NCT03011060|Capecitabine|capecitabine|mesh-list
19512778|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19512779|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
19512780|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512781|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512782|NCT03010670|Oxytocin|oxytocin|mesh-list
19512783|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
19512784|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19512785|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512786|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
19512787|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
19512788|NCT03010579|Hematinics|hematinics|mesh-list
19512789|NCT03010761|Citalopram|citalopram|mesh-list
19512790|NCT03010761|Moclobemide|moclobemide|mesh-list
19512791|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19512792|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19512793|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19512794|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512795|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512796|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
19512797|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512798|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19512799|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
19512800|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19512801|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19512802|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571679|NCT00193414|Gemcitabine|gemcitabine|mesh-list
19571680|NCT00193414|Pemetrexed|pemetrexed|mesh-list
19571681|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571682|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
19571683|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571684|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571685|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
19571686|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571687|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571688|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571689|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
19571690|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571691|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19571692|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19571693|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
19571694|NCT00085735|Lomustine|lomustine|mesh-list
20097399|NCT00002639|Suramin|suramin|mesh-list
20097400|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
20097401|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
20097402|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20097403|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097404|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097405|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20097406|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20120393|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120394|NCT00006352|Antibodies|antibodies|mesh-list
20120395|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20120396|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
19571695|NCT00085735|Cisplatin|cisplatin|mesh-list
19571696|NCT00085735|Vincristine|vincristine|mesh-list
19571697|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120397|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
20120398|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120399|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20120400|NCT00006353|Temozolomide|temozolomide|mesh-list
20120401|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120402|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
20603318|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
19571698|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
19571699|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571700|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571701|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571702|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
19571703|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571704|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571705|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19571706|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571707|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571708|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571709|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571710|NCT00003042|Tamoxifen|tamoxifen|mesh-list
19571711|NCT00003042|Paclitaxel|paclitaxel|mesh-list
19571712|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
19571713|NCT00003042|Doxorubicin|doxorubicin|mesh-list
19571714|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19571715|NCT00003042|Melphalan|melphalan|mesh-list
19571716|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571717|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571718|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571719|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571720|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571721|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571722|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571723|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
19571724|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571725|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571726|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571727|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
19571728|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20120403|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571729|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20120404|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603319|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097407|NCT00002641|Doxorubicin|doxorubicin|mesh-list
20097408|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097409|NCT00002641|Ifosfamide|ifosfamide|mesh-list
20097410|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097411|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097412|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097413|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097414|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097415|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097416|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097417|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
20097418|NCT00002642|Cobalt|cobalt|mesh-list
20097419|NCT00002642|Etoposide|etoposide|mesh-list
20097420|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097421|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097422|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097423|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097424|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097425|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097426|NCT00002642|Trace Elements|trace elements|mesh-ancestor
20097427|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
20097428|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097429|NCT00002643|Cobalt|cobalt|mesh-list
20097430|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
20097431|NCT00002643|Ifosfamide|ifosfamide|mesh-list
20097432|NCT00002643|Doxorubicin|doxorubicin|mesh-list
20097433|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19512803|NCT03011021|Liraglutide|liraglutide|mesh-list
19512804|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19512805|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512806|NCT03011021|Incretins|incretins|mesh-ancestor
19512807|NCT03011021|Hormones|hormones|mesh-ancestor
19512808|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512809|NCT03010540|Fentanyl|fentanyl|mesh-list
19512810|NCT03010540|Morphine|morphine|mesh-list
19512811|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512812|NCT03010540|Narcotics|narcotics|mesh-ancestor
19512813|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512814|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512815|NCT03010540|Analgesics|analgesics|mesh-ancestor
19512816|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
19512817|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512818|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19512819|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19512820|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
19512821|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
19512822|NCT03010475|Furosemide|furosemide|mesh-list
20097434|NCT00002643|Etoposide|etoposide|mesh-list
20097435|NCT00002643|Vincristine|vincristine|mesh-list
20097436|NCT00002643|Topotecan|topotecan|mesh-list
20097437|NCT00002643|Amifostine|amifostine|mesh-list
20097438|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097439|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
20097440|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512823|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19512824|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19512825|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19512826|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
19512827|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512828|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19512829|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19512830|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512831|NCT03010475|Diuretics|diuretics|mesh-ancestor
20097441|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097442|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097443|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
20097444|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097445|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097446|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097447|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097448|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097449|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097450|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512832|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
19512833|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512834|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20097451|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19512835|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19512836|NCT03010436|Benralizumab|benralizumab|mesh-list
19512837|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19512838|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
19512839|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
19512840|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512841|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512842|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
19512843|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19512844|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
19512845|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512846|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19512847|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19512848|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
19512849|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512850|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512851|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19512852|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19512853|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19512854|NCT03010202|Dexamethasone|dexamethasone|mesh-list
19512855|NCT03010202|Rituximab|rituximab|mesh-list
19512856|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19512857|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512858|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
19512859|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512860|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19512861|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512862|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
19512863|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
19512864|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512865|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512866|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
19512867|NCT03010202|Hormones|hormones|mesh-ancestor
19512868|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512869|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19512870|NCT03010098|Remifentanil|remifentanil|mesh-list
19512871|NCT03010098|Propofol|propofol|mesh-list
19512872|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19512873|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512874|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512875|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19512876|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
19512877|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
19512878|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512879|NCT03010098|Narcotics|narcotics|mesh-ancestor
19512880|NCT03010098|Analgesics|analgesics|mesh-ancestor
19512881|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
19512882|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512883|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
19512884|NCT03010072|Hematinics|hematinics|mesh-ancestor
19512885|NCT03009877|Fentanyl|fentanyl|mesh-list
19512886|NCT03009877|Midazolam|midazolam|mesh-list
19512887|NCT03009877|Propofol|propofol|mesh-list
19512888|NCT03009877|Rocuronium|rocuronium|mesh-list
20097452|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097453|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097454|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097455|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20097456|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19512889|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19512890|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512891|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512892|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19512893|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
19512894|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
19512895|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19512896|NCT03009877|Narcotics|narcotics|mesh-ancestor
19512897|NCT03009877|Analgesics|analgesics|mesh-ancestor
19512898|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
19512899|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512900|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19512901|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20097457|NCT00002643|Protective Agents|protective agents|mesh-ancestor
20097458|NCT00002643|Trace Elements|trace elements|mesh-ancestor
19512902|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19512903|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19512904|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
19512905|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
19512906|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512907|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512908|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19512909|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19512910|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19512911|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19512912|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19512913|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19512914|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
19512915|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512916|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19512917|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
19512918|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19512919|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
19512920|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512921|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512922|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19512923|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
19512924|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19512925|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
19512926|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512927|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19512928|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19512929|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
20097459|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
20097460|NCT00002644|Tamoxifen|tamoxifen|mesh-list
20097461|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20097462|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
20097463|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512930|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
19512931|NCT03009643|Protective Agents|protective agents|mesh-ancestor
19512932|NCT03009604|Simethicone|simethicone|mesh-list
19512933|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
19512934|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512935|NCT03009604|Emollients|emollients|mesh-ancestor
19512936|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
19512937|NCT03009682|Olaparib|olaparib|mesh-list
19512938|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19512939|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512940|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512941|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512942|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19512943|NCT03009799|Laxatives|laxatives|mesh-ancestor
19512944|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19512945|NCT03009461|Sorafenib|sorafenib|mesh-list
19512946|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512947|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19512948|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512949|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512950|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
19512951|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19512952|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19512953|NCT03009500|Prednisolone|prednisolone|mesh-list
19512954|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
19512955|NCT03009500|Lidocaine|lidocaine|mesh-list
19512956|NCT03009500|Bupivacaine|bupivacaine|mesh-list
19512957|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19512958|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
19512959|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
19512960|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
19512961|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19512962|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512963|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
19512964|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19512965|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19512966|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19512967|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19512968|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19512969|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512970|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19512971|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
19512972|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
19512973|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20120405|NCT00006355|NSC 366140|nsc 366140|mesh-list
20097464|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097465|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097466|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097467|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20097468|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20097469|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20097470|NCT00002646|Tamoxifen|tamoxifen|mesh-list
20097471|NCT00002646|Fenretinide|fenretinide|mesh-list
20097472|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20097473|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
20097474|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097475|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097476|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097477|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097478|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20097479|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19512974|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
19512975|NCT03009500|Hormones|hormones|mesh-ancestor
19512976|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19512977|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19512978|NCT03009500|Protective Agents|protective agents|mesh-ancestor
19512979|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19512980|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19512981|NCT03009513|Glimepiride|glimepiride|mesh-list
19512982|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19512983|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19512984|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19512985|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19512986|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
19512987|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19512988|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19512989|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19512990|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19512991|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
19512992|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19512993|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19512994|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19512995|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19512996|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19512997|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
19512998|NCT03009526|Piperaquine|piperaquine|mesh-list
19512999|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
20097480|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20097481|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20097482|NCT00002646|Protective Agents|protective agents|mesh-ancestor
20097483|NCT00002647|Verteporfin|verteporfin|mesh-list
20097484|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20097485|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
19513000|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19513001|NCT03009526|Artenimol|artenimol|mesh-list
19513002|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
19513003|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19513004|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20097486|NCT00002649|Aldesleukin|aldesleukin|mesh-list
20097487|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
20097488|NCT00002649|Etoposide|etoposide|mesh-list
20097489|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
20097490|NCT00002649|Interleukin-2|interleukin-2|mesh-list
20097491|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097492|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
20097493|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097494|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097495|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097496|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
20097497|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097498|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097499|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097500|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097501|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097502|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097503|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513005|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513006|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20097504|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20603320|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603321|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20603322|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20603323|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
20603324|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
20603325|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603326|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20603327|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20603328|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603329|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603330|NCT02220426|Xenon|xenon|mesh-list
20603331|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20097505|NCT00002649|Analgesics|analgesics|mesh-ancestor
20097506|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
20097507|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097508|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20097509|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20097510|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
20097511|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097512|NCT00002650|Folic Acid|folic acid|mesh-list
20097513|NCT00002650|Hematinics|hematinics|mesh-ancestor
20097514|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
20097515|NCT00002650|Vitamins|vitamins|mesh-ancestor
20097516|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
20097517|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097518|NCT00002652|Suramin|suramin|mesh-list
20097519|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
20097520|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
20097521|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20097522|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097523|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097524|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20097525|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20097526|NCT00002653|Prednisone|prednisone|mesh-list
20097527|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
20097528|NCT00002653|Melphalan|melphalan|mesh-list
20097529|NCT00002653|Carmustine|carmustine|mesh-list
20097530|NCT00002653|Doxorubicin|doxorubicin|mesh-list
20097531|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097532|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097533|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
20097534|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097535|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097536|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097537|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
20097538|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097539|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097540|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097541|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097542|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097543|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097544|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513007|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513008|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513009|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19513010|NCT03009526|Renal Agents|renal agents|mesh-ancestor
19513011|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19513012|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19513013|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19513014|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513015|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
19513016|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19513017|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
19513018|NCT03009292|Lenvatinib|lenvatinib|mesh-list
20097545|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097546|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
20097547|NCT00002653|Hormones|hormones|mesh-ancestor
20097548|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097549|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097550|NCT00002654|Cobalt|cobalt|mesh-list
20097551|NCT00002654|Trace Elements|trace elements|mesh-ancestor
19513019|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097552|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
19513020|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20097553|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097554|NCT00002656|NSC 366140|nsc 366140|mesh-list
20097555|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097556|NCT00002657|Interferons|interferons|mesh-list
19513021|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513022|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513023|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19513024|NCT03009578|Hematinics|hematinics|mesh-ancestor
19513025|NCT03009097|Atorvastatin|atorvastatin|mesh-list
19513026|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19513027|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19513028|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
19513029|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513030|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19513031|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19513032|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513033|NCT03009045|Tedizolid|tedizolid|mesh-list
19513034|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
19513035|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
19513036|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19513037|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513038|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19513039|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097557|NCT00002657|Cytarabine|cytarabine|mesh-list
20097558|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
20097559|NCT00002657|Prednisone|prednisone|mesh-list
20097560|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
20097561|NCT00002657|Doxorubicin|doxorubicin|mesh-list
20097562|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097563|NCT00002657|Methotrexate|methotrexate|mesh-list
19513040|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513041|NCT03009058|Leucovorin|leucovorin|mesh-list
19513042|NCT03009058|Folic Acid|folic acid|mesh-list
19513043|NCT03009058|Gemcitabine|gemcitabine|mesh-list
19513044|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
19513045|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
19513046|NCT03009058|Fluorouracil|fluorouracil|mesh-list
19513047|NCT03009058|Capecitabine|capecitabine|mesh-list
19513048|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
19513049|NCT03009058|Nivolumab|nivolumab|mesh-list
19513050|NCT03009058|Irinotecan|irinotecan|mesh-list
19513051|NCT03009058|Cetuximab|cetuximab|mesh-list
19513052|NCT03009058|Ipilimumab|ipilimumab|mesh-list
19513053|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19513054|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
19513055|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513056|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
19513057|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513058|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19513059|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19513060|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
19513061|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513062|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513063|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19513064|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19513065|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
19513066|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
19513067|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513068|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513069|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19513070|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19513071|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19513072|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19513073|NCT03009058|Antidotes|antidotes|mesh-ancestor
19513074|NCT03009058|Protective Agents|protective agents|mesh-ancestor
19513075|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
19513076|NCT03009058|Vitamins|vitamins|mesh-ancestor
19513077|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
19513078|NCT03009058|Hematinics|hematinics|mesh-ancestor
19571730|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19571731|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19571732|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571733|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19571734|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
19571735|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571736|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19571737|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19571738|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19571739|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19571740|NCT00002874|Bicalutamide|bicalutamide|mesh-list
19571741|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
19571742|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
20097564|NCT00002657|Etoposide|etoposide|mesh-list
19513079|NCT03009409|Ketamine|ketamine|mesh-list
19513080|NCT03009409|Analgesics|analgesics|mesh-ancestor
19513081|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
19513082|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513083|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513084|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19513085|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19513086|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
19513087|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
19513088|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513089|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19513090|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19513091|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513092|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513093|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
19513094|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
19513095|NCT03009006|Calcium|calcium|mesh-list
19513096|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19513097|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513098|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19513099|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19513100|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513101|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
19513102|NCT03008876|Acetaminophen|acetaminophen|mesh-list
19513103|NCT03008876|Ibuprofen|ibuprofen|mesh-list
19513104|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19513105|NCT03008876|Analgesics|analgesics|mesh-ancestor
19513106|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
19513107|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513108|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513109|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
19513110|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19513111|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513112|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19513113|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19513114|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513115|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513116|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
19513117|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19513118|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19513119|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513120|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
19513121|NCT03008655|Coagulants|coagulants|mesh-ancestor
19513122|NCT03008512|Paclitaxel|paclitaxel|mesh-list
19513123|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19513124|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513125|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
19513126|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
19513127|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
19513128|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513129|NCT03008551|Metformin|metformin|mesh-list
19513130|NCT03008551|Empagliflozin|empagliflozin|mesh-list
19513131|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19513132|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513133|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19513134|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513135|NCT03008408|Everolimus|everolimus|mesh-list
19513136|NCT03008408|Letrozole|letrozole|mesh-list
19513137|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513138|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513139|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
19513140|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513141|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19513142|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19513143|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513144|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513145|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19513146|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
19513147|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513148|NCT03008317|Chromium|chromium|mesh-list
19513149|NCT03008317|Trace Elements|trace elements|mesh-ancestor
19513150|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
20097565|NCT00002657|Vincristine|vincristine|mesh-list
20097566|NCT00002657|Bleomycin|bleomycin|mesh-list
20097567|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513151|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513152|NCT03008252|Caseins|caseins|mesh-list
19513153|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
19513154|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
19513155|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513156|NCT03008148|Temozolomide|temozolomide|mesh-list
19513157|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19513158|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
19513159|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513160|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513161|NCT03007927|Dexamethasone|dexamethasone|mesh-list
19513162|NCT03007927|Bupivacaine|bupivacaine|mesh-list
19513163|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513164|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
19513165|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
19513166|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513167|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513168|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19513169|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
19513170|NCT03007927|Hormones|hormones|mesh-ancestor
19513171|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513172|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19513173|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513174|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
19513175|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
19513176|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513177|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
19513178|NCT03008005|Dronabinol|dronabinol|mesh-list
19513179|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
19513180|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513181|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19513182|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19513183|NCT03008005|Analgesics|analgesics|mesh-ancestor
19513184|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
19513185|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513186|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19513187|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19513188|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513189|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513190|NCT03008005|Hormones|hormones|mesh-ancestor
19513191|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513192|NCT03008109|Endostatins|endostatins|mesh-list
19513193|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513194|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19513195|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19513196|NCT03008109|Growth Substances|growth substances|mesh-ancestor
19513197|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513198|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
19513199|NCT03007992|Vinorelbine|vinorelbine|mesh-list
19513200|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19513201|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513202|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19513203|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19513204|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19513205|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513206|NCT03008057|Vitamin D|vitamin d|mesh-list
19513207|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
19513208|NCT03008057|Vitamins|vitamins|mesh-list
19513209|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
19513210|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513211|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19513212|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19513213|NCT03008083|Clopidogrel|clopidogrel|mesh-list
19513214|NCT03008083|Ticagrelor|ticagrelor|mesh-list
19513215|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19513216|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19513217|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19513218|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19513219|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
19513220|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513221|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513222|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097568|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
20097569|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097570|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097571|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097572|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
20097573|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603332|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
19513223|NCT03007810|Hemay005|hemay005|mesh-list
19513224|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
19513225|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19513226|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19513227|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513228|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513229|NCT03007797|Vaccines|vaccines|mesh-list
19513230|NCT03007797|Immunologic Factors|immunologic factors|mesh-ancestor
19513231|NCT03007797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513232|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
19513233|NCT03007446|Apatinib|apatinib|mesh-list
19513234|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513235|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19513236|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513237|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513238|NCT03007420|Lidocaine|lidocaine|mesh-list
19513239|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
19513240|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
19513241|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513242|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513243|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
19513244|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513245|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19513246|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19513247|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19513248|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19513249|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513250|NCT03007381|Ketorolac|ketorolac|mesh-list
19513251|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19513252|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19513253|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19513254|NCT03007381|Analgesics|analgesics|mesh-ancestor
19513255|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
19513256|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513257|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513258|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513259|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19513260|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19513261|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513262|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513263|NCT03007303|Olanzapine|olanzapine|mesh-list
19513264|NCT03007303|Risperidone|risperidone|mesh-list
19513265|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19513266|NCT03007303|Ziprasidone|ziprasidone|mesh-list
19513267|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
19513268|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19513269|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
19513270|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513271|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513272|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513273|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19513274|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513275|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19513276|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19513277|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
19513278|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
19513279|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
19513280|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513281|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19513282|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19513283|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19513284|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19513285|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
19513286|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
19513287|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19513288|NCT03007589|Protective Agents|protective agents|mesh-ancestor
19513289|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513290|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
20097574|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097575|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097576|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097577|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097578|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19513291|NCT03007342|Amoxicillin|amoxicillin|mesh-list
19513292|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
19513293|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
19513294|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19513295|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19513296|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513297|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19513298|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513299|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513300|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
19513301|NCT03007537|Hematinics|hematinics|mesh-ancestor
19513302|NCT03007563|Bilirubin|bilirubin|mesh-list
19513303|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
19513304|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513305|NCT03007563|Protective Agents|protective agents|mesh-ancestor
19513306|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513307|NCT03007407|Durvalumab|durvalumab|mesh-list
19513308|NCT03007407|Tremelimumab|tremelimumab|mesh-list
19513309|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19513310|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513311|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
19513312|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19513313|NCT03007524|Calcium|calcium|mesh-list
19513314|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19513315|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513316|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19513317|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19513318|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19513319|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
19513320|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513321|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19513322|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19513323|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513324|NCT03007654|Chitosan|chitosan|mesh-list
19513325|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19513326|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19513327|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
19513328|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513329|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19513330|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
19513331|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
19513332|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
19513333|NCT03007654|Coagulants|coagulants|mesh-ancestor
19571743|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571744|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571745|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571746|NCT02706158|Vitamin D|vitamin d|mesh-list
19571747|NCT02706158|Calcium|calcium|mesh-list
19571748|NCT02706158|Vitamins|vitamins|mesh-ancestor
19571749|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
19571750|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571751|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19571752|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19571753|NCT02706119|Insulin|insulin|mesh-list
19571754|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19571755|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
19571756|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19571757|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571758|NCT02705859|Trastuzumab|trastuzumab|mesh-list
20097579|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571759|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20097580|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603333|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
20603334|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603335|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603336|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
20603337|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20603338|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513334|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
19513335|NCT03007160|Diuretics|diuretics|mesh-ancestor
19513336|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
19513337|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513338|NCT03007160|Expectorants|expectorants|mesh-ancestor
19513339|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
19513340|NCT03006874|Esomeprazole|esomeprazole|mesh-list
19513341|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19513342|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19513343|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19513344|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097581|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
20097582|NCT00002657|Hormones|hormones|mesh-ancestor
20097583|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097584|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097585|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20097586|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
20097587|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20097588|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097589|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
20097590|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
20097591|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19513345|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513346|NCT03006965|Factor VIII|factor viii|mesh-list
19513347|NCT03006965|BAX 855|bax 855|mesh-list
19513348|NCT03006965|Coagulants|coagulants|mesh-ancestor
19513349|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19513350|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
19513351|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19513352|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19513353|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19513354|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19513355|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513356|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
19513357|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513358|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513359|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19513360|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513361|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19513362|NCT03007121|Sufentanil|sufentanil|mesh-list
19513363|NCT03007121|Morphine|morphine|mesh-list
19513364|NCT03007121|Dsuvia|dsuvia|mesh-list
19513365|NCT03007121|Bupivacaine|bupivacaine|mesh-list
19513366|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
20097592|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20097593|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19513367|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
19513368|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513369|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513370|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
19513371|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513372|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19513373|NCT03007121|Narcotics|narcotics|mesh-ancestor
19513374|NCT03007121|Analgesics|analgesics|mesh-ancestor
19513375|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19513376|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19513377|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
19513378|NCT03006835|Clopidogrel|clopidogrel|mesh-list
19513379|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19513380|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19513381|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19513382|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19513383|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
19513384|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513385|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513386|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513387|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19513388|NCT03006809|Metronidazole|metronidazole|mesh-list
19513389|NCT03006809|Vancomycin|vancomycin|mesh-list
20097594|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
20097595|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097596|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
19513390|NCT03006809|Neomycin|neomycin|mesh-list
19513391|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513392|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19513393|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19513394|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19513395|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513396|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513397|NCT03006952|Losartan|losartan|mesh-list
19513398|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
19513399|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19513400|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19513401|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19513402|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19513403|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513404|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19513405|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513406|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19513407|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19513408|NCT03006952|Protective Agents|protective agents|mesh-ancestor
19513409|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513410|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
19513411|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19513412|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
19513413|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
19513414|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
19513415|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19513416|NCT03006757|Protective Agents|protective agents|mesh-ancestor
19513417|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513418|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
19513419|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19513420|NCT03006679|Meropenem|meropenem|mesh-list
19513421|NCT03006679|Tazobactam|tazobactam|mesh-list
19513422|NCT03006679|Piperacillin|piperacillin|mesh-list
19513423|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19513424|NCT03006679|Vaborbactam|vaborbactam|mesh-list
19513425|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19513426|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513427|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19513428|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513429|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513430|NCT03006614|Gemcitabine|gemcitabine|mesh-list
19513431|NCT03006614|Cisplatin|cisplatin|mesh-list
19513432|NCT03006614|Docetaxel|docetaxel|mesh-list
19513433|NCT03006614|Capecitabine|capecitabine|mesh-list
19513434|NCT03006614|Trastuzumab|trastuzumab|mesh-list
19513435|NCT03006614|Vinorelbine|vinorelbine|mesh-list
19513436|NCT03006614|Epirubicin|epirubicin|mesh-list
19513437|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513438|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19513439|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
19513440|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513441|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
19513442|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513443|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513444|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513445|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
19513446|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513447|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
19513448|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
19513449|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
19513450|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19513451|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19513452|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19513453|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19513454|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19513455|NCT03006380|Oxytocin|oxytocin|mesh-list
19513456|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
19513457|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19513458|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513459|NCT03006445|Dotinurad|dotinurad|mesh-list
19513460|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
19513461|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
19513462|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19513463|NCT03006445|Renal Agents|renal agents|mesh-ancestor
19513464|NCT03006627|Morphine|morphine|mesh-list
19513465|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20097597|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
19513466|NCT03006627|Narcotics|narcotics|mesh-ancestor
19513467|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513468|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513469|NCT03006627|Analgesics|analgesics|mesh-ancestor
19513470|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
19513471|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513472|NCT03006250|Sevoflurane|sevoflurane|mesh-list
19513473|NCT03006250|Desflurane|desflurane|mesh-list
19513474|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19513475|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19513476|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
19513477|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
20097598|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097599|NCT00002658|Cytarabine|cytarabine|mesh-list
20097600|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
20097601|NCT00002658|Etoposide|etoposide|mesh-list
20097602|NCT00002658|Daunorubicin|daunorubicin|mesh-list
20097603|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
20097604|NCT00002658|Idarubicin|idarubicin|mesh-list
20097605|NCT00002658|Tretinoin|tretinoin|mesh-list
20097606|NCT00002658|Thioguanine|thioguanine|mesh-list
19513478|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513479|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513480|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
19513481|NCT03006419|Basiliximab|basiliximab|mesh-list
19513482|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
19513483|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513484|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513485|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
19513486|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
19513487|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19513488|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
19513489|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
20097607|NCT00002658|Amsacrine|amsacrine|mesh-list
20097608|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097609|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
20097610|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097611|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097612|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097613|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
20097614|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097615|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097616|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097617|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097618|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097619|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097620|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097621|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097622|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
20097623|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
19513490|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513491|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513492|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19513493|NCT03006211|Analgesics|analgesics|mesh-ancestor
19513494|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
19513495|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513496|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19513497|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
19513498|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19513499|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
19513500|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19513501|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
19513502|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513503|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513504|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19513505|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
19513506|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
19513507|NCT03006211|Protective Agents|protective agents|mesh-ancestor
19513508|NCT03006146|Molgramostim|molgramostim|mesh-list
19513509|NCT03006146|Sargramostim|sargramostim|mesh-list
19513510|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
19513511|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513512|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513513|NCT03006003|Alendronate|alendronate|mesh-list
19513514|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20097624|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306171|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513515|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19513516|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097625|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097626|NCT00002658|Analgesics|analgesics|mesh-ancestor
20097627|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
20097628|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097629|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
20097630|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
20097631|NCT00002659|Cisplatin|cisplatin|mesh-list
19513517|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19513518|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
19513519|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097632|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097633|NCT00002662|Paclitaxel|paclitaxel|mesh-list
20097634|NCT00002662|Docetaxel|docetaxel|mesh-list
20097635|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097636|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097637|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097638|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097639|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097640|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097641|NCT00002664|Sargramostim|sargramostim|mesh-list
20097642|NCT00002664|Edrecolomab|edrecolomab|mesh-list
20097643|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
20097644|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097645|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20097646|NCT00002665|Leucovorin|leucovorin|mesh-list
20097647|NCT00002665|Cytarabine|cytarabine|mesh-list
20097648|NCT00002665|Dexamethasone|dexamethasone|mesh-list
20097649|NCT00002665|Prednisone|prednisone|mesh-list
20097650|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
20097651|NCT00002665|Doxorubicin|doxorubicin|mesh-list
20097652|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097653|NCT00002665|Methotrexate|methotrexate|mesh-list
20097654|NCT00002665|Etoposide|etoposide|mesh-list
19513520|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19513521|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19513522|NCT03006107|Piroxicam|piroxicam|mesh-list
19513523|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19513524|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19513525|NCT03006107|Analgesics|analgesics|mesh-ancestor
19513526|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
19513527|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513528|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513529|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513530|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097655|NCT00002665|Vincristine|vincristine|mesh-list
20097656|NCT00002665|Daunorubicin|daunorubicin|mesh-list
20097657|NCT00002665|Asparaginase|asparaginase|mesh-list
20097658|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
20097659|NCT00002665|Thioguanine|thioguanine|mesh-list
20097660|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
20097661|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097662|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
20097663|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097664|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097665|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097666|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
20097667|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097668|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097669|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097670|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097671|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
20097672|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
20097673|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097674|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097675|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
20097676|NCT00002665|Hormones|hormones|mesh-ancestor
20097677|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097678|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097679|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097680|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097681|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097682|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097683|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20603339|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513531|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20097684|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
20097685|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20097686|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097687|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
20097688|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
19513532|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513533|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513534|NCT03006081|Aflibercept|aflibercept|mesh-list
19513535|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19513536|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19513537|NCT03006081|Growth Substances|growth substances|mesh-ancestor
19513538|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513539|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
19513540|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513541|NCT03005860|Fentanyl|fentanyl|mesh-list
19513542|NCT03005860|Propofol|propofol|mesh-list
19513543|NCT03005860|Sevoflurane|sevoflurane|mesh-list
19513544|NCT03005860|Atracurium|atracurium|mesh-list
19513545|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19513546|NCT03005860|Narcotics|narcotics|mesh-ancestor
19513547|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513548|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513549|NCT03005860|Analgesics|analgesics|mesh-ancestor
19513550|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
19513551|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513552|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19513553|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19513554|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
19513555|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
19513556|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513557|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19513558|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19513559|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19513560|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19513561|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19513562|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19513563|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19513564|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
19513565|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513566|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19513567|NCT03006042|Bupivacaine|bupivacaine|mesh-list
19513568|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
19513569|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
19513570|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513571|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513572|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
19513573|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513574|NCT03005639|Vemurafenib|vemurafenib|mesh-list
19513575|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513576|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20097689|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20097690|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20097691|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097692|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
20097693|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097694|NCT00002665|Antidotes|antidotes|mesh-ancestor
20097695|NCT00002665|Protective Agents|protective agents|mesh-ancestor
20097696|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
20097697|NCT00002665|Vitamins|vitamins|mesh-ancestor
20097698|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
19513577|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513578|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513579|NCT03005496|Vitamin D|vitamin d|mesh-list
19513580|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
19513581|NCT03005496|Beta Carotene|beta carotene|mesh-list
19513582|NCT03005496|Zinc|zinc|mesh-list
19513583|NCT03005496|Dexamethasone|dexamethasone|mesh-list
19513584|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
19513585|NCT03005496|Nifedipine|nifedipine|mesh-list
19513586|NCT03005496|BB 1101|bb 1101|mesh-list
19513587|NCT03005496|Carotenoids|carotenoids|mesh-list
19513588|NCT03005496|Picolinic acid|picolinic acid|mesh-list
19513589|NCT03005496|Vitamins|vitamins|mesh-ancestor
19513590|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
19513591|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097699|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097700|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097701|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
19513592|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513593|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
19513594|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
19513595|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513596|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097702|NCT00002669|Interferons|interferons|mesh-list
19513597|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
19513598|NCT03005496|Hormones|hormones|mesh-ancestor
19513599|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513600|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19513601|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513602|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
19513603|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513604|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513605|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20097703|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
20097704|NCT00002669|Aldesleukin|aldesleukin|mesh-list
20097705|NCT00002669|Dacarbazine|dacarbazine|mesh-list
20097706|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097707|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
20097708|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097709|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
20097710|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097711|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20097712|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20097713|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097714|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
20097715|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097716|NCT00002670|Cobalt|cobalt|mesh-list
20097717|NCT00002670|Trace Elements|trace elements|mesh-ancestor
20097718|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
20097719|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097720|NCT00002674|Cytarabine|cytarabine|mesh-list
19513606|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19513607|NCT03005496|Trace Elements|trace elements|mesh-ancestor
19513608|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19513609|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19513610|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
19513611|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
19513612|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19513613|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
19513614|NCT03005496|Protective Agents|protective agents|mesh-ancestor
19513615|NCT03005496|Provitamins|provitamins|mesh-ancestor
19513616|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19513617|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
19513618|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
19513619|NCT03005808|Ropivacaine|ropivacaine|mesh-list
19513620|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
19513621|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
19513622|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513623|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513624|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
19513625|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571760|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571761|NCT02705950|Baclofen|baclofen|mesh-list
19571762|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19571763|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571764|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20097721|NCT00002674|Etoposide|etoposide|mesh-list
20097722|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
20097723|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
20097724|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097725|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097726|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097727|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097728|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097729|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097730|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097731|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
19571765|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571766|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19571767|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
19571768|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
19571769|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571770|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577908|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
19577909|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577910|NCT03817853|Prednisone|prednisone|mesh-list
19577911|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
20097732|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
20097733|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097734|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513626|NCT03005665|Acetazolamide|acetazolamide|mesh-list
19513627|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
19513628|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19513629|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513630|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513631|NCT03005665|Diuretics|diuretics|mesh-ancestor
19513632|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
19513633|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513634|NCT03005405|Methamphetamine|methamphetamine|mesh-list
19513635|NCT03005405|Fluorides|fluorides|mesh-list
19513636|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
19513637|NCT03005405|Protective Agents|protective agents|mesh-ancestor
19513638|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513639|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19513640|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
19513641|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
19513642|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513643|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
19513644|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513645|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513646|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
20097735|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
20097736|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513647|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19513648|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19513649|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19513650|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19513651|NCT03005444|Enoxaparin|enoxaparin|mesh-list
19513652|NCT03005444|Nadroparin|nadroparin|mesh-list
19513653|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
19513654|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19513655|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
19513656|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19513657|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
19513658|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513659|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513660|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
19513661|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19513662|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19513663|NCT03005704|Aspirin|aspirin|mesh-list
19513664|NCT03005704|Ticagrelor|ticagrelor|mesh-list
19513665|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19513666|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19513667|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19513668|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19513669|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
19513670|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513671|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513672|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513673|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19513674|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19513675|NCT03005704|Analgesics|analgesics|mesh-ancestor
19513676|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
19513677|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097737|NCT00002674|Analgesics|analgesics|mesh-ancestor
20097738|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
20097739|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097740|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
20097741|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20097742|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
20097743|NCT00002675|Carboplatin|carboplatin|mesh-list
20097744|NCT00002675|Etoposide|etoposide|mesh-list
20097745|NCT00002675|Vincristine|vincristine|mesh-list
19513678|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513679|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19513680|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19513681|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19513682|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19513683|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513684|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
19513685|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19513686|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19513687|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
19513688|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513689|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097746|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097747|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
20097748|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097749|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097750|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097751|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
20097752|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097753|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097754|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097755|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097756|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097757|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097758|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097759|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097760|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097761|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097762|NCT00002676|Cobalt|cobalt|mesh-list
20097763|NCT00002676|Cytarabine|cytarabine|mesh-list
20097764|NCT00002676|Dexamethasone|dexamethasone|mesh-list
20097765|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
20097766|NCT00002676|Carmustine|carmustine|mesh-list
20097767|NCT00002676|Doxorubicin|doxorubicin|mesh-list
19513690|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19513691|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
19513692|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20097768|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097769|NCT00002676|Methotrexate|methotrexate|mesh-list
20097770|NCT00002676|Vincristine|vincristine|mesh-list
19513693|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19513694|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19513695|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
19513696|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513697|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513698|NCT03005678|Denosumab|denosumab|mesh-list
19513699|NCT03005678|Alendronate|alendronate|mesh-list
19513700|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19513701|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513702|NCT03005548|Morphine|morphine|mesh-list
19513703|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19513704|NCT03005548|Narcotics|narcotics|mesh-ancestor
20097771|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097772|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
20603340|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20603341|NCT02220530|Fentanyl|fentanyl|mesh-list
20603342|NCT02220530|Midazolam|midazolam|mesh-list
20603343|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19513705|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513706|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097773|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097774|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097775|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097776|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
20097777|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097778|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097779|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097780|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097781|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
20097782|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
19513707|NCT03005548|Analgesics|analgesics|mesh-ancestor
19513708|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
19513709|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513710|NCT03005483|Gabapentin|gabapentin|mesh-list
19513711|NCT03005483|Analgesics|analgesics|mesh-ancestor
19513712|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
19513713|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513714|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513715|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
19513716|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19513717|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19513718|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513719|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19513720|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19513721|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19513722|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19513723|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097783|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603344|NCT02220530|Narcotics|narcotics|mesh-ancestor
20603345|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513724|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
19513725|NCT03005522|Dexamethasone|dexamethasone|mesh-list
19513726|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513727|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
19513728|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
19513729|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513730|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513731|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19513732|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
19513733|NCT03005522|Hormones|hormones|mesh-ancestor
19513734|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513735|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19513736|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513737|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19513738|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
19513739|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513740|NCT03005353|Clotrimazole|clotrimazole|mesh-list
19513741|NCT03005353|Miconazole|miconazole|mesh-list
19513742|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19513743|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513744|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
19513745|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19513746|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19513747|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513748|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513749|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19513750|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
19513751|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513752|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513753|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19513754|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19513755|NCT03005015|Doxorubicin|doxorubicin|mesh-list
19513756|NCT03005015|Lenvatinib|lenvatinib|mesh-list
19513757|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19513758|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513759|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19513760|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19513761|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513762|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513763|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19513764|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
19513765|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
19513766|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19513767|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513768|NCT03005340|Vitamins|vitamins|mesh-ancestor
19513769|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
19513770|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19513771|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20097784|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097785|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
19513772|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19513773|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
19513774|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513775|NCT03005171|Lidocaine|lidocaine|mesh-list
19513776|NCT03005171|Bupivacaine|bupivacaine|mesh-list
19513777|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
19513778|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
19513779|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513780|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513781|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
19513782|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513783|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19513784|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19513785|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19513786|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19513787|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097786|NCT00002676|Hormones|hormones|mesh-ancestor
20097787|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097788|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097789|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097790|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097791|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19513788|NCT03005366|Flecainide|flecainide|mesh-list
19513789|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19513790|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19513791|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19513792|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19513793|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513794|NCT03005184|Icatibant|icatibant|mesh-list
19513795|NCT03005184|Valsartan|valsartan|mesh-list
19513796|NCT03005184|Enalapril|enalapril|mesh-list
19513797|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19513798|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19513799|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19513800|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20097792|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097793|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20097794|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
20097795|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20097796|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097797|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
20097798|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
20097799|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20097800|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20097801|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
20097802|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097803|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097804|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097805|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097806|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097807|NCT00002676|Trace Elements|trace elements|mesh-ancestor
20097808|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
20097809|NCT00002678|Dexamethasone|dexamethasone|mesh-list
20097810|NCT00002678|Prednisone|prednisone|mesh-list
20097811|NCT00002678|Melphalan|melphalan|mesh-list
20097812|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097813|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
20097814|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
20097815|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097816|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097817|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097818|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
20097819|NCT00002678|Hormones|hormones|mesh-ancestor
19513801|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513802|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19513803|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
19513804|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513805|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19513806|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19513807|NCT03005184|Analgesics|analgesics|mesh-ancestor
19513808|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
19513809|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513810|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513811|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513812|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19513813|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19571771|NCT02705872|Sufentanil|sufentanil|mesh-list
20097820|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097821|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097822|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097823|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097824|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
20097825|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097826|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097827|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097828|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
20097829|NCT00002679|Tamoxifen|tamoxifen|mesh-list
20097830|NCT00002679|Paclitaxel|paclitaxel|mesh-list
20097831|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
20097832|NCT00002679|Doxorubicin|doxorubicin|mesh-list
20097833|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20097834|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097835|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097836|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097837|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097838|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
19513814|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19513815|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20097839|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097840|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513816|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513817|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
19513818|NCT03005002|Durvalumab|durvalumab|mesh-list
19513819|NCT03005002|Ipilimumab|ipilimumab|mesh-list
19513820|NCT03005002|Tremelimumab|tremelimumab|mesh-list
19513821|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
19513822|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19513823|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
19513824|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19513825|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513826|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
19513827|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513828|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19513829|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513830|NCT03004833|Nivolumab|nivolumab|mesh-list
19513831|NCT03004833|Doxorubicin|doxorubicin|mesh-list
19513832|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19513833|NCT03004833|Dacarbazine|dacarbazine|mesh-list
19513834|NCT03004833|Vinblastine|vinblastine|mesh-list
19513835|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19513836|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513837|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19513838|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513839|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19513840|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19513841|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19513842|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513843|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19513844|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
19513845|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097841|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
20097842|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097843|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097844|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097845|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
20097846|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097847|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20097848|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20097849|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097850|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097851|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20097852|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
20097853|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097854|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097855|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20097856|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20097857|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20097858|NCT00002680|Tamoxifen|tamoxifen|mesh-list
20097859|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
20097860|NCT00002680|Melphalan|melphalan|mesh-list
20097861|NCT00002680|Thiotepa|thiotepa|mesh-list
20097862|NCT00002680|Megestrol|megestrol|mesh-list
20097863|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
20097864|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097865|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
20097866|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097867|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097868|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097869|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
20097870|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097871|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097872|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097873|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19513846|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
19513847|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
19513848|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
19513849|NCT03004768|BMS-986165|bms-986165|mesh-list
19513850|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
20097874|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
20603346|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571772|NCT02705872|Dsuvia|dsuvia|mesh-list
20097875|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097876|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19513851|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19513852|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513853|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513854|NCT03005236|Tacrolimus|tacrolimus|mesh-list
19513855|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513856|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
19513857|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513858|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19513859|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513860|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513861|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19513862|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19513863|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513864|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
19513865|NCT03004625|Ribavirin|ribavirin|mesh-list
19513866|NCT03004625|Asunaprevir|asunaprevir|mesh-list
19513867|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
19513868|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513869|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
19513870|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513871|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
19513872|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513873|NCT03004612|Metformin|metformin|mesh-list
19513874|NCT03004612|Linagliptin|linagliptin|mesh-list
19513875|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19513876|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513877|NCT03004612|Incretins|incretins|mesh-ancestor
19513878|NCT03004612|Hormones|hormones|mesh-ancestor
19513879|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513880|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19513881|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
19513882|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513883|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513884|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19513885|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
20097877|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20097878|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20097879|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20603347|NCT02220530|Analgesics|analgesics|mesh-ancestor
20603348|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
20603349|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603350|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20603351|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20603352|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
20603353|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
20603354|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20603355|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20603356|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20603357|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20603358|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
20603359|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
20603360|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603361|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097880|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20097881|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20097882|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20097883|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
20097884|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20097885|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20097886|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20097887|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
20097888|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20097889|NCT00002681|Aldesleukin|aldesleukin|mesh-list
20097890|NCT00002681|Daclizumab|daclizumab|mesh-list
20097891|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097892|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20097893|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20097894|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
20097895|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603362|NCT02220608|Bortezomib|bortezomib|mesh-list
20603363|NCT02220608|Lenograstim|lenograstim|mesh-list
20603364|NCT02220608|Sargramostim|sargramostim|mesh-list
20603365|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19513886|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19513887|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19513888|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19513889|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513890|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513891|NCT03004183|Valacyclovir|valacyclovir|mesh-list
19513892|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
19513893|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19513894|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513895|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
19513896|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513897|NCT03004287|Thalidomide|thalidomide|mesh-list
19513898|NCT03004287|Dexamethasone|dexamethasone|mesh-list
19513899|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
19513900|NCT03004287|Melphalan|melphalan|mesh-list
19513901|NCT03004287|Doxorubicin|doxorubicin|mesh-list
19513902|NCT03004287|Etoposide|etoposide|mesh-list
19513903|NCT03004287|Lenalidomide|lenalidomide|mesh-list
19513904|NCT03004287|Bortezomib|bortezomib|mesh-list
19513905|NCT03004287|Daratumumab|daratumumab|mesh-list
19513906|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19513907|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
19513908|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513909|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19513910|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19513911|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
19513912|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513913|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513914|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19513915|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513916|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
19513917|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
19513918|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513919|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19513920|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
19513921|NCT03004287|Hormones|hormones|mesh-ancestor
19513922|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513923|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19513924|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19513925|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19513926|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19513927|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513928|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19513929|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19513930|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19513931|NCT03004287|Growth Substances|growth substances|mesh-ancestor
19513932|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
19513933|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
19513934|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19513935|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513936|NCT03004105|Durvalumab|durvalumab|mesh-list
19513937|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19513938|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19513939|NCT03004339|Betamethasone|betamethasone|mesh-list
19513940|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
19513941|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19513942|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
19513943|NCT03004339|Calcipotriene|calcipotriene|mesh-list
19513944|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19513945|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19513946|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
19513947|NCT03004339|Hormones|hormones|mesh-ancestor
19513948|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19513949|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513950|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19513951|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
19513952|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
19513953|NCT03004066|Daptomycin|daptomycin|mesh-list
19513954|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19513955|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513956|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19513957|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19513958|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19513959|NCT03004222|Bupivacaine|bupivacaine|mesh-list
19513960|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
19513961|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
19513962|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513963|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513964|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
19513965|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19513966|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
19513967|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19513968|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513969|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
19513970|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
19513971|NCT03004209|Hematinics|hematinics|mesh-ancestor
19571773|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
19571774|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19571775|NCT02705872|Narcotics|narcotics|mesh-ancestor
19571776|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571777|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571778|NCT02705872|Analgesics|analgesics|mesh-ancestor
19571779|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
19571780|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571781|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19571782|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19571783|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
19571784|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
19571785|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
19571786|NCT02706054|Meloxicam|meloxicam|mesh-list
19571787|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19571788|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19571789|NCT02706054|Analgesics|analgesics|mesh-ancestor
19571790|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
20097896|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097897|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
19571791|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571792|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571793|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19571794|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571795|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19571796|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19571797|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571798|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571799|NCT02706015|Dipyrone|dipyrone|mesh-list
19571800|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
19571801|NCT02706015|Caffeine|caffeine|mesh-list
19571802|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19571803|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571804|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19571805|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571806|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571807|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19571808|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19571809|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
19571810|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571811|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19571812|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19571813|NCT02706015|Analgesics|analgesics|mesh-ancestor
19571814|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
19571815|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571816|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19571817|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571818|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
19571819|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19571820|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
19571821|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
19571822|NCT02705976|Warfarin|warfarin|mesh-list
19571823|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
19571824|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
19571825|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571826|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571827|NCT02705989|Branebrutinib|branebrutinib|mesh-list
20097898|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097899|NCT00002682|Amoxicillin|amoxicillin|mesh-list
20097900|NCT00002682|Metronidazole|metronidazole|mesh-list
20097901|NCT00002682|Clarithromycin|clarithromycin|mesh-list
20097902|NCT00002682|Tetracycline|tetracycline|mesh-list
20097903|NCT00002682|Omeprazole|omeprazole|mesh-list
19571828|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19571829|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571830|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097904|NCT00002682|Bismuth|bismuth|mesh-list
20097905|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19513972|NCT03004261|Ganciclovir|ganciclovir|mesh-list
19513973|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19513974|NCT03004261|Foscarnet|foscarnet|mesh-list
19513975|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
19513976|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19513977|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19513978|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513979|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513980|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19513981|NCT03004014|Propofol|propofol|mesh-list
19513982|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19513983|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19513984|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513985|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19513986|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
19513987|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
19513988|NCT03004001|Atorvastatin|atorvastatin|mesh-list
19513989|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19513990|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19513991|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19513992|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
19513993|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19513994|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19513995|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19513996|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19513997|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
19513998|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19513999|NCT03003884|Propofol|propofol|mesh-list
19514000|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19514001|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514002|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514003|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19514004|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
20097906|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20097907|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097908|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20097909|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20097910|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20097911|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097912|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20097913|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097914|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097915|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20097916|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20097917|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20097918|NCT00002682|Antacids|antacids|mesh-ancestor
20097919|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
20097920|NCT00002684|Paclitaxel|paclitaxel|mesh-list
20097921|NCT00002684|Ifosfamide|ifosfamide|mesh-list
20097922|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20097923|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097924|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
20097925|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
20097926|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
20097927|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097928|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097929|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
19514005|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
19514006|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
19514007|NCT03003832|Analgesics|analgesics|mesh-list
19514008|NCT03003832|Narcotics|narcotics|mesh-ancestor
19514009|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514010|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097930|NCT00002687|Aldesleukin|aldesleukin|mesh-list
20097931|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097932|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20097933|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20097934|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
20097935|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097936|NCT00002688|Cyclosporine|cyclosporine|mesh-list
20097937|NCT00002688|Etoposide|etoposide|mesh-list
19514011|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
19514012|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514013|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
20097938|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
20097939|NCT00002688|Cyclosporins|cyclosporins|mesh-list
20097940|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19514014|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19514015|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19514016|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514017|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
19514018|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
19514019|NCT03003728|Melphalan|melphalan|mesh-list
19514020|NCT03003728|Elotuzumab|elotuzumab|mesh-list
19514021|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19514022|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
19514023|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514024|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514025|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19514026|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514027|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
19514028|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514029|NCT03003637|Nivolumab|nivolumab|mesh-list
19514030|NCT03003637|Ipilimumab|ipilimumab|mesh-list
19514031|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514032|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514033|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19514034|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514035|NCT03003611|Anesthetics|anesthetics|mesh-list
19514036|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514037|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514038|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19514039|NCT03003273|Amoxicillin|amoxicillin|mesh-list
19514040|NCT03003273|Levofloxacin|levofloxacin|mesh-list
19514041|NCT03003273|Ofloxacin|ofloxacin|mesh-list
19514042|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
19514043|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
19514044|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514045|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19514046|NCT03003273|Renal Agents|renal agents|mesh-ancestor
19514047|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19514048|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19514049|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097941|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097942|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19514050|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514051|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514052|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19514053|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19514054|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19514055|NCT03003416|Dexamethasone|dexamethasone|mesh-list
19514056|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514057|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
19514058|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
19514059|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514060|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097943|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097944|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097945|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097946|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097947|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
20097948|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514061|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514062|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
19514063|NCT03003416|Hormones|hormones|mesh-ancestor
19514064|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514065|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514066|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514067|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
19514068|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514069|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514070|NCT03003143|Vigabatrin|vigabatrin|mesh-list
19514071|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
19514072|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20097949|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
20097950|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20097951|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
20097952|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097953|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19514073|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514074|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
20097954|NCT00002688|Analgesics|analgesics|mesh-ancestor
19514075|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514076|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097955|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
20097956|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097957|NCT00002689|Dexamethasone|dexamethasone|mesh-list
19514077|NCT03003039|Rituximab|rituximab|mesh-list
19514078|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514079|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514080|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
19514081|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514082|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514083|NCT03002844|Gemcitabine|gemcitabine|mesh-list
19514084|NCT03002844|Carboplatin|carboplatin|mesh-list
19514085|NCT03002844|Pemetrexed|pemetrexed|mesh-list
19514086|NCT03002844|Gefitinib|gefitinib|mesh-list
19514087|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514088|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514089|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
19514090|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514091|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
19514092|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514093|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514094|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514095|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
19514096|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514097|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19514098|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19514099|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19514100|NCT03002831|Tegafur|tegafur|mesh-list
19514101|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514102|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
19514103|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514104|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514105|NCT03002961|Buprenorphine|buprenorphine|mesh-list
20603366|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
20603367|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603368|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603369|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
20603370|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19514106|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19514107|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19514108|NCT03002961|Narcotics|narcotics|mesh-ancestor
19514109|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514110|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514111|NCT03002961|Analgesics|analgesics|mesh-ancestor
19514112|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
19514113|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514114|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19514115|NCT03002805|Doxorubicin|doxorubicin|mesh-list
20097958|NCT00002689|Fluorouracil|fluorouracil|mesh-list
20097959|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097960|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
20097961|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
20097962|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097963|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097964|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097965|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
20097966|NCT00002689|Hormones|hormones|mesh-ancestor
20097967|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20097968|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20097969|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097970|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
20097971|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097972|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20097973|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097974|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
20097975|NCT00002691|Leucovorin|leucovorin|mesh-list
20097976|NCT00002691|Cytarabine|cytarabine|mesh-list
20097977|NCT00002691|Dexamethasone|dexamethasone|mesh-list
20097978|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
20097979|NCT00002691|Methotrexate|methotrexate|mesh-list
19514116|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19514117|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097980|NCT00002691|Etoposide|etoposide|mesh-list
19514118|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19514119|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20097981|NCT00002691|Vincristine|vincristine|mesh-list
19514120|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514121|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514122|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
19514123|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
19514124|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514125|NCT03002935|Vitamins|vitamins|mesh-ancestor
19514126|NCT03002792|Anesthetics|anesthetics|mesh-list
19514127|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514128|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514129|NCT03002675|Exenatide|exenatide|mesh-list
19514130|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19514131|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514132|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19514133|NCT03002675|Incretins|incretins|mesh-ancestor
19514134|NCT03002675|Hormones|hormones|mesh-ancestor
19514135|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514136|NCT03002493|Rifampin|rifampin|mesh-list
19514137|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19514138|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
19514139|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19514140|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514141|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
19514142|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19514143|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514144|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514145|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19514146|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19514147|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19514148|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19514149|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19514150|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19514151|NCT03002428|Teriparatide|teriparatide|mesh-list
19514152|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19514153|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097982|NCT00002691|Daunorubicin|daunorubicin|mesh-list
20097983|NCT00002691|Asparaginase|asparaginase|mesh-list
20097984|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
20097985|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20097986|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
20097987|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20097988|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20097989|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20097990|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
20097991|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20097992|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20097993|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20097994|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20097995|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
20097996|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
20097997|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20097998|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20097999|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
20098000|NCT00002691|Hormones|hormones|mesh-ancestor
20098001|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098002|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098003|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098004|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098005|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098006|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098007|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
20098008|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098009|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098010|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098011|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098012|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098013|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098014|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098015|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
20098016|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098017|NCT00002691|Antidotes|antidotes|mesh-ancestor
20098018|NCT00002691|Protective Agents|protective agents|mesh-ancestor
19571831|NCT02706067|Orlistat|orlistat|mesh-list
20098019|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098020|NCT00002691|Vitamins|vitamins|mesh-ancestor
19514154|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19514155|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
19514156|NCT03002545|Cathartics|cathartics|mesh-ancestor
19514157|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514158|NCT03002649|Tofacitinib|tofacitinib|mesh-list
19514159|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514160|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19514161|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514162|NCT03002636|Anesthetics|anesthetics|mesh-list
19514163|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514164|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571832|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571833|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571834|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19571835|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19571836|NCT02705768|Carbamazepine|carbamazepine|mesh-list
19571837|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
20098021|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
20098022|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098023|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098024|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098025|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098026|NCT00002692|Leucovorin|leucovorin|mesh-list
20098027|NCT00002692|Fluorouracil|fluorouracil|mesh-list
20098028|NCT00002692|Calcium|calcium|mesh-list
20098029|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
19571838|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
19571839|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
19571840|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19571841|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571842|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571843|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19571844|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20098030|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20098031|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098032|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
20098033|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098034|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098035|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098036|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098037|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
20098038|NCT00002692|Antidotes|antidotes|mesh-ancestor
20098039|NCT00002692|Protective Agents|protective agents|mesh-ancestor
20098040|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098041|NCT00002692|Vitamins|vitamins|mesh-ancestor
20098042|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
20098043|NCT00002693|Carboplatin|carboplatin|mesh-list
20098044|NCT00002693|Topotecan|topotecan|mesh-list
20098045|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098046|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20098047|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098048|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098049|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098050|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
20098051|NCT00002696|Doxorubicin|doxorubicin|mesh-list
20098052|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098053|NCT00002696|Fluorouracil|fluorouracil|mesh-list
20098054|NCT00002696|Methotrexate|methotrexate|mesh-list
20098055|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098056|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
20098057|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098058|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098059|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098060|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
20098061|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098062|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098063|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098064|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098065|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098066|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098067|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098068|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
20098069|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098070|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098071|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098072|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19571845|NCT02705768|Analgesics|analgesics|mesh-ancestor
19514165|NCT03002259|Dexamethasone|dexamethasone|mesh-list
19514166|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514167|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
19514168|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
19514169|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514170|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514171|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514172|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
19514173|NCT03002259|Hormones|hormones|mesh-ancestor
19514174|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514175|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514176|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514177|NCT03002376|Cemiplimab|cemiplimab|mesh-list
19514178|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514179|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514180|NCT03002064|Docetaxel|docetaxel|mesh-list
19514181|NCT03002064|Fluorouracil|fluorouracil|mesh-list
19514182|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514183|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
19514184|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
19514185|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
19514186|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514187|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
19514188|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514189|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514190|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
19514191|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514192|NCT03002090|Iron|iron|mesh-list
19514193|NCT03002090|Trace Elements|trace elements|mesh-ancestor
19514194|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
19514195|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514196|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19514197|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19514198|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514199|NCT03001960|Clopidogrel|clopidogrel|mesh-list
19514200|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19514201|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19514202|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19514203|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19514204|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
19514205|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514206|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514207|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514208|NCT03001687|Vitamin D|vitamin d|mesh-list
19514209|NCT03001687|Vitamins|vitamins|mesh-ancestor
19514210|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
19514211|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514212|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19514213|NCT03001739|Urapidil|urapidil|mesh-list
19514214|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514215|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
19514216|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20098073|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098074|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098075|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098076|NCT00002697|Carboplatin|carboplatin|mesh-list
20098077|NCT00002697|Etoposide|etoposide|mesh-list
20098078|NCT00002697|Ifosfamide|ifosfamide|mesh-list
20098079|NCT00002697|Sargramostim|sargramostim|mesh-list
20098080|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098081|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098082|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098083|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098084|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098085|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098086|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
20098087|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098088|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098089|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
20098090|NCT00002700|Leucovorin|leucovorin|mesh-list
20098091|NCT00002700|Cytarabine|cytarabine|mesh-list
20098092|NCT00002700|Dexamethasone|dexamethasone|mesh-list
20098093|NCT00002700|Prednisone|prednisone|mesh-list
19514217|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
20098094|NCT00002700|Prednisolone|prednisolone|mesh-list
19514218|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20098095|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
20098096|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20098097|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20098098|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20098099|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
20098100|NCT00002700|Doxorubicin|doxorubicin|mesh-list
20098101|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098102|NCT00002700|Methotrexate|methotrexate|mesh-list
20098103|NCT00002700|Vincristine|vincristine|mesh-list
20098104|NCT00002700|Daunorubicin|daunorubicin|mesh-list
20098105|NCT00002700|Asparaginase|asparaginase|mesh-list
20098106|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
20098107|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
20098108|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
20098109|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514219|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514220|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514221|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19514222|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19514223|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19514224|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
19514225|NCT03001609|Abivertinib|abivertinib|mesh-list
19514226|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19514227|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514228|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514229|NCT03001661|Dinoprostone|dinoprostone|mesh-list
19514230|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
19514231|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19514232|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514233|NCT03001635|Oxytocin|oxytocin|mesh-list
19514234|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
19514235|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19514236|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514237|NCT03001570|Cetuximab|cetuximab|mesh-list
19514238|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514239|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514240|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19514241|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19514242|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19514243|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514244|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
19514245|NCT03001349|Octreotide|octreotide|mesh-list
19514246|NCT03001349|Edotreotide|edotreotide|mesh-list
19514247|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514248|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514249|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514250|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514251|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19514252|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
19514253|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514254|NCT03001193|Oxytocin|oxytocin|mesh-list
20098110|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
20098111|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098112|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098113|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098114|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
20098115|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098116|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098117|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098118|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098119|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
20098120|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
20098121|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098122|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098123|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
19514255|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
19514256|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19514257|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514258|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
19514259|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19514260|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
19514261|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19514262|NCT03001102|Povidone|povidone|mesh-list
19514263|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514264|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
19514265|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
19514266|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
19514267|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
20098124|NCT00002700|Hormones|hormones|mesh-ancestor
19514268|NCT03000946|Octreotide|octreotide|mesh-list
19514269|NCT03000946|Somatostatin|somatostatin|mesh-list
19514270|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514271|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514272|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514273|NCT03000946|Hormones|hormones|mesh-ancestor
19514274|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514275|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514276|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19514277|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
19514278|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514279|NCT03000660|Dexamethasone|dexamethasone|mesh-list
19514280|NCT03000660|Venetoclax|venetoclax|mesh-list
19514281|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514282|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
19514283|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
19514284|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514285|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514286|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514287|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
19514288|NCT03000660|Hormones|hormones|mesh-ancestor
19514289|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514290|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514291|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571846|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
19571847|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571848|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19571849|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19571850|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571851|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19571852|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19571853|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19571854|NCT02705729|Methamphetamine|methamphetamine|mesh-list
19571855|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19571856|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571857|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
20098125|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098126|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098127|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098128|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098129|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098130|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098131|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098132|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098133|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098134|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098135|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
20098136|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098137|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098138|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098139|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
20098140|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098141|NCT00002700|Antidotes|antidotes|mesh-ancestor
20098142|NCT00002700|Protective Agents|protective agents|mesh-ancestor
19571858|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
19571859|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571860|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
20098143|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098144|NCT00002700|Vitamins|vitamins|mesh-ancestor
20098145|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
20098146|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098147|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098148|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098149|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098150|NCT00002700|Analgesics|analgesics|mesh-ancestor
20098151|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
20098152|NCT00002701|Cytarabine|cytarabine|mesh-list
20098153|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
20098154|NCT00002701|Busulfan|busulfan|mesh-list
20098155|NCT00002701|Methotrexate|methotrexate|mesh-list
20098156|NCT00002701|Etoposide|etoposide|mesh-list
19571861|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571862|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098157|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
20098158|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
20098159|NCT00002701|Idarubicin|idarubicin|mesh-list
19514292|NCT03000413|Fentanyl|fentanyl|mesh-list
19514293|NCT03000413|Ketamine|ketamine|mesh-list
19514294|NCT03000413|Analgesics|analgesics|mesh-ancestor
19514295|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
19514296|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514297|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514298|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19514299|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19514300|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
19514301|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
19514302|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514303|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19514304|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19514305|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514306|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514307|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19514308|NCT03000413|Narcotics|narcotics|mesh-ancestor
19514309|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19514310|NCT03000777|Melatonin|melatonin|mesh-list
19514311|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
19514312|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098160|NCT00002701|Tretinoin|tretinoin|mesh-list
20098161|NCT00002701|Thioguanine|thioguanine|mesh-list
20098162|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098163|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
20098164|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098165|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098166|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098167|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
20098168|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098169|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098170|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098171|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098172|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098173|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098174|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098175|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
20098176|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098177|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098178|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098179|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098180|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098181|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098182|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098183|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
20098184|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098185|NCT00002701|Analgesics|analgesics|mesh-ancestor
20098186|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
20098187|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098188|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098189|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
20098190|NCT00002702|Aldesleukin|aldesleukin|mesh-list
20098191|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098192|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20098193|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20098194|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
20098195|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098196|NCT00002704|Leucovorin|leucovorin|mesh-list
20098197|NCT00002704|Cytarabine|cytarabine|mesh-list
20098198|NCT00002704|Dexamethasone|dexamethasone|mesh-list
20098199|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
20098200|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20098201|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20098202|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20098203|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
20098204|NCT00002704|Thiotepa|thiotepa|mesh-list
20098205|NCT00002704|Methotrexate|methotrexate|mesh-list
20098206|NCT00002704|Etoposide|etoposide|mesh-list
20098207|NCT00002704|Vincristine|vincristine|mesh-list
20098208|NCT00002704|Daunorubicin|daunorubicin|mesh-list
20098209|NCT00002704|Asparaginase|asparaginase|mesh-list
20098210|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
20098211|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
19514313|NCT03000777|Protective Agents|protective agents|mesh-ancestor
19514314|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098212|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098213|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
20098214|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514315|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514316|NCT03000634|Dexamethasone|dexamethasone|mesh-list
19514317|NCT03000634|Lenalidomide|lenalidomide|mesh-list
19514318|NCT03000634|Bortezomib|bortezomib|mesh-list
19514319|NCT03000634|Elotuzumab|elotuzumab|mesh-list
19514320|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514321|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
19514322|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
19514323|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514324|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514325|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514326|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
19514327|NCT03000634|Hormones|hormones|mesh-ancestor
19514328|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514329|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514330|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514331|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
19514332|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19514333|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19514334|NCT03000634|Growth Substances|growth substances|mesh-ancestor
19514335|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
19514336|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19514337|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
19514338|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19514339|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19514340|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
19514341|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514342|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
20098215|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098216|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098217|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
20098218|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098219|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098220|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098221|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098222|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
20098223|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
20098224|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098225|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098226|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
20098227|NCT00002704|Hormones|hormones|mesh-ancestor
20098228|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098229|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098230|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098231|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098232|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098233|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098234|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
20098235|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098236|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098237|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098238|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098239|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098240|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098241|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098242|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
20098243|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098244|NCT00002704|Antidotes|antidotes|mesh-ancestor
20098245|NCT00002704|Protective Agents|protective agents|mesh-ancestor
20306172|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20306173|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20306174|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
20098246|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098247|NCT00002704|Vitamins|vitamins|mesh-ancestor
20098248|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
20098249|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098250|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098251|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098252|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098253|NCT00002705|Topotecan|topotecan|mesh-list
20098254|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19514343|NCT03000556|Protective Agents|protective agents|mesh-ancestor
19514344|NCT03000387|Nicotine|nicotine|mesh-list
19514345|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20098255|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098256|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514346|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
19514347|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514348|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514349|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19514350|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19514351|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
19514352|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514353|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514354|NCT03000127|Testosterone|testosterone|mesh-list
19514355|NCT03000127|Androgens|androgens|mesh-ancestor
19514356|NCT03000127|Hormones|hormones|mesh-ancestor
19514357|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514358|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514359|NCT03000218|Metformin|metformin|mesh-list
20098257|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098258|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098259|NCT00002707|Tamoxifen|tamoxifen|mesh-list
20098260|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
20098261|NCT00002707|Docetaxel|docetaxel|mesh-list
20098262|NCT00002707|Doxorubicin|doxorubicin|mesh-list
20098263|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098264|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
20098265|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098266|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098267|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098268|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
20098269|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098270|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098271|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098272|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098273|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098274|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098275|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098276|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098277|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098278|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098279|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20098280|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
19514360|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19514361|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19514362|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514363|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19514364|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514365|NCT03000205|Lidocaine|lidocaine|mesh-list
19514366|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
19514367|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
19514368|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20098281|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098282|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098283|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20098284|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20098285|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20098286|NCT00002711|Paclitaxel|paclitaxel|mesh-list
20098287|NCT00002711|Cisplatin|cisplatin|mesh-list
20098288|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098289|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098290|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098291|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098292|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098293|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098294|NCT00002714|Prednisone|prednisone|mesh-list
20098295|NCT00002714|Doxorubicin|doxorubicin|mesh-list
20098296|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098297|NCT00002714|Bleomycin|bleomycin|mesh-list
20098298|NCT00002714|Etoposide|etoposide|mesh-list
20098299|NCT00002714|Vincristine|vincristine|mesh-list
20098300|NCT00002714|Vinblastine|vinblastine|mesh-list
20098301|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
20098302|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098303|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098304|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098305|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19514369|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514370|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
20098306|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120406|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514371|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514372|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19514373|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19514374|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19514375|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19514376|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514377|NCT03000036|Doxorubicin|doxorubicin|mesh-list
19514378|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19514379|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19514380|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514381|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19514382|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19514383|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514384|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514385|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
19514386|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
19514387|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
19514388|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
19514389|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
19514390|NCT02999958|Antioxidants|antioxidants|mesh-list
19514391|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19514392|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514393|NCT02999958|Protective Agents|protective agents|mesh-ancestor
19514394|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514395|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
19514396|NCT02999958|Vitamins|vitamins|mesh-ancestor
19514397|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
19514398|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
19514399|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
20603371|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
20603372|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603373|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
20603374|NCT02220621|Protective Agents|protective agents|mesh-ancestor
19514400|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514401|NCT02999958|Expectorants|expectorants|mesh-ancestor
19514402|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
19514403|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19514404|NCT02999958|Antidotes|antidotes|mesh-ancestor
19514405|NCT02999776|Etanercept|etanercept|mesh-list
19514406|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19514407|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19514408|NCT02999776|Analgesics|analgesics|mesh-ancestor
19514409|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
19514410|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514411|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514412|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514413|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514414|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514415|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514416|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
19514417|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
19514418|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19514419|NCT02999815|Antibodies|antibodies|mesh-list
19514420|NCT02999815|Antitoxins|antitoxins|mesh-list
19514421|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
19514422|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514423|NCT02999841|Vildagliptin|vildagliptin|mesh-list
19514424|NCT02999841|Acarbose|acarbose|mesh-list
19514425|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19514426|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514427|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19514428|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
19514429|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514430|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514431|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20603375|NCT02220634|Regadenoson|regadenoson|mesh-list
20603376|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20603377|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20603378|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
20603379|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
20603380|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603381|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603382|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514432|NCT02999906|Treprostinil|treprostinil|mesh-list
19514433|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514434|NCT02999724|Gabapentin|gabapentin|mesh-list
19514435|NCT02999724|Analgesics|analgesics|mesh-ancestor
19514436|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
19514437|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514438|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514439|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
19514440|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19514441|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19514442|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514443|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19514444|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19514445|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19514446|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514447|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514448|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
19514449|NCT02999919|Bupivacaine|bupivacaine|mesh-list
19514450|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
19514451|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
19514452|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514453|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514454|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
19514455|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514456|NCT02999594|Tramadol|tramadol|mesh-list
19514457|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19514458|NCT02999594|Narcotics|narcotics|mesh-ancestor
19514459|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514460|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514461|NCT02999594|Analgesics|analgesics|mesh-ancestor
19514462|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
19514463|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514464|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19514465|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19514466|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514467|NCT02999295|Nivolumab|nivolumab|mesh-list
19514468|NCT02999295|Ramucirumab|ramucirumab|mesh-list
19514469|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514470|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514471|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19514472|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514473|NCT02999230|Listerine|listerine|mesh-list
19514474|NCT02999230|Fluorides|fluorides|mesh-list
19514475|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
19514476|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
19514477|NCT02999230|Protective Agents|protective agents|mesh-ancestor
19514478|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514479|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19514480|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514481|NCT02999204|Vitamin D|vitamin d|mesh-list
19514482|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
20603383|NCT02220647|Metformin|metformin|mesh-list
20098307|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098308|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098309|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
20098310|NCT00002714|Hormones|hormones|mesh-ancestor
20098311|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098312|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098313|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098314|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098315|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098316|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098317|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098318|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
20098319|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098320|NCT00002715|Prednisone|prednisone|mesh-list
20098321|NCT00002715|Doxorubicin|doxorubicin|mesh-list
20098322|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098323|NCT00002715|Bleomycin|bleomycin|mesh-list
20098324|NCT00002715|Etoposide|etoposide|mesh-list
20098325|NCT00002715|Vincristine|vincristine|mesh-list
20098326|NCT00002715|Vinblastine|vinblastine|mesh-list
20098327|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
19514483|NCT02999204|Vitamins|vitamins|mesh-ancestor
19514484|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
19514485|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098328|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098329|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098330|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19514486|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19514487|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19514488|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19514489|NCT02999217|Hematinics|hematinics|mesh-ancestor
19514490|NCT02999126|Remifentanil|remifentanil|mesh-list
19514491|NCT02999126|Propofol|propofol|mesh-list
19514492|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19514493|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514494|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514495|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19514496|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
19514497|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
19514498|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19514499|NCT02999126|Narcotics|narcotics|mesh-ancestor
19514500|NCT02999126|Analgesics|analgesics|mesh-ancestor
19514501|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
19514502|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514503|NCT02998970|Empagliflozin|empagliflozin|mesh-list
19514504|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19514505|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514506|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19514507|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514508|NCT02998918|Curcumin|curcumin|mesh-list
19514509|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19514510|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19514511|NCT02998918|Analgesics|analgesics|mesh-ancestor
19514512|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
20098331|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098332|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098333|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098334|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098335|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
20098336|NCT00002715|Hormones|hormones|mesh-ancestor
20098337|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098338|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098339|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098340|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098341|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098342|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098343|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098344|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
20098345|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098346|NCT00002716|Leucovorin|leucovorin|mesh-list
20098347|NCT00002716|Dexamethasone|dexamethasone|mesh-list
20098348|NCT00002716|Fluorouracil|fluorouracil|mesh-list
20098349|NCT00002716|Floxuridine|floxuridine|mesh-list
20098350|NCT00002716|Calcium|calcium|mesh-list
20098351|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
20098352|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098353|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
20098354|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
20098355|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098356|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098357|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098358|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
20098359|NCT00002716|Hormones|hormones|mesh-ancestor
20098360|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098361|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098362|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098363|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20098364|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
20098365|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098366|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098367|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098368|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
20098369|NCT00002716|Antidotes|antidotes|mesh-ancestor
20098370|NCT00002716|Protective Agents|protective agents|mesh-ancestor
20098371|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098372|NCT00002716|Vitamins|vitamins|mesh-ancestor
20098373|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
20098374|NCT00002717|Paclitaxel|paclitaxel|mesh-list
19514513|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098375|NCT00002717|Cisplatin|cisplatin|mesh-list
20098376|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098377|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098378|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098379|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098380|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098381|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098382|NCT00002718|Cytarabine|cytarabine|mesh-list
20098383|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
20098384|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
20098385|NCT00002718|Thiotepa|thiotepa|mesh-list
20098386|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20098387|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098388|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
20098389|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098390|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098391|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098392|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
20098393|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098394|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098395|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098396|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098397|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
20098398|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
20098399|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098400|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098401|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
20098402|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
20098403|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098404|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098405|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
20098406|NCT00002718|Hormones|hormones|mesh-ancestor
20098407|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098408|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20098409|NCT00002718|Protective Agents|protective agents|mesh-ancestor
20098410|NCT00002719|Cytarabine|cytarabine|mesh-list
20098411|NCT00002719|Etoposide|etoposide|mesh-list
20098412|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
20098413|NCT00002719|Idarubicin|idarubicin|mesh-list
20098414|NCT00002719|Carmustine|carmustine|mesh-list
20098415|NCT00002719|Amsacrine|amsacrine|mesh-list
20098416|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098417|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098418|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098419|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098420|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098421|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098422|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098423|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
20098424|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
20098425|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098426|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098427|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
20098428|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098429|NCT00002719|Analgesics|analgesics|mesh-ancestor
20098430|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
20098431|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098432|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098433|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098434|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
20098435|NCT00002720|Tamoxifen|tamoxifen|mesh-list
20098436|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20098437|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
20098438|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098439|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098440|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098441|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098442|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20098443|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20098444|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20098445|NCT00002721|Doxorubicin|doxorubicin|mesh-list
20098446|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098447|NCT00002721|Estramustine|estramustine|mesh-list
20098448|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098449|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098450|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098451|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19514514|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514515|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514516|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514517|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514518|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514519|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514520|NCT02998827|Thalidomide|thalidomide|mesh-list
19514521|NCT02998827|Azathioprine|azathioprine|mesh-list
19514522|NCT02998827|Infliximab|infliximab|mesh-list
19514523|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19514524|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098452|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098453|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098454|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098455|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
20098456|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098457|NCT00002722|Leucovorin|leucovorin|mesh-list
20098458|NCT00002722|Fluorouracil|fluorouracil|mesh-list
20098459|NCT00002722|Calcium|calcium|mesh-list
20098460|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
20098461|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098462|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20098463|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098464|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
20098465|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098466|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098467|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098468|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
20098469|NCT00002722|Antidotes|antidotes|mesh-ancestor
20306175|NCT00654108|Protective Agents|protective agents|mesh-ancestor
20306176|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306177|NCT00654108|Vitamins|vitamins|mesh-ancestor
20306178|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
20306179|NCT00654121|Insulin|insulin|mesh-list
20306180|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20306181|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20306182|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306183|NCT00654160|Leucovorin|leucovorin|mesh-list
20306184|NCT00654160|Fluorouracil|fluorouracil|mesh-list
20306185|NCT00654160|Irinotecan|irinotecan|mesh-list
20306186|NCT00654160|Calcium|calcium|mesh-list
20098470|NCT00002722|Protective Agents|protective agents|mesh-ancestor
20098471|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098472|NCT00002722|Vitamins|vitamins|mesh-ancestor
20098473|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
20098474|NCT00002723|Suramin|suramin|mesh-list
20098475|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
20098476|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
20098477|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20098478|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098479|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098480|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20098481|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20098482|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
20098483|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20098484|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
20098485|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098486|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098487|NCT00002730|Melphalan|melphalan|mesh-list
20098488|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
20098489|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098490|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
20098491|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514525|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514526|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306187|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
19514527|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
19514528|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514529|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
19514530|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19514531|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098492|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098493|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098494|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098495|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
20098496|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098497|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
20098498|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098499|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098500|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20098501|NCT00002730|Protective Agents|protective agents|mesh-ancestor
20098502|NCT00002733|Interferons|interferons|mesh-list
20098503|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
20098504|NCT00002733|Aldesleukin|aldesleukin|mesh-list
20098505|NCT00002733|Cimetidine|cimetidine|mesh-list
20098506|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098507|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
20098508|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098509|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
20098510|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098511|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20098512|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20098513|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20098514|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098515|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20098516|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
20098517|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
20098518|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20098519|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098520|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20098521|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20098522|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098523|NCT00002734|Interferons|interferons|mesh-list
20098524|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
20098525|NCT00002734|Paclitaxel|paclitaxel|mesh-list
20098526|NCT00002734|Topotecan|topotecan|mesh-list
20098527|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20098528|NCT00002734|Antibodies|antibodies|mesh-list
20098529|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
20098530|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20098531|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098532|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098533|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098534|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098535|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098536|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098537|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
20098538|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098539|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
20098540|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098541|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19514532|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20098542|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098543|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098544|NCT00002735|Cobalt|cobalt|mesh-list
20098545|NCT00002735|Cisplatin|cisplatin|mesh-list
20098546|NCT00002735|Fluorouracil|fluorouracil|mesh-list
20098547|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098548|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
20098549|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098550|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098551|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098552|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
20098553|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098554|NCT00002735|Trace Elements|trace elements|mesh-ancestor
20603384|NCT02220647|Linagliptin|linagliptin|mesh-list
20603385|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603386|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603387|NCT02220647|Incretins|incretins|mesh-ancestor
20098555|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
20098556|NCT00002737|Interferons|interferons|mesh-list
20098557|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
20098558|NCT00002737|Isotretinoin|isotretinoin|mesh-list
20098559|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514533|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19514534|NCT02998827|Growth Substances|growth substances|mesh-ancestor
19514535|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
19514536|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514537|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
19514538|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514539|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571863|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
19571864|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19571865|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19571866|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19571867|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19571868|NCT02705534|Ribavirin|ribavirin|mesh-list
19571869|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
19571870|NCT02705534|Ledipasvir|ledipasvir|mesh-list
20603388|NCT02220647|Hormones|hormones|mesh-ancestor
20603389|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603390|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20603391|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603392|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603393|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603394|NCT02220660|Olodaterol|olodaterol|mesh-list
20603395|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20098560|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
20098561|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571871|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
19571872|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098562|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
20098563|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098564|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098565|NCT00002738|Leucovorin|leucovorin|mesh-list
20098566|NCT00002738|Trimetrexate|trimetrexate|mesh-list
20098567|NCT00002738|Calcium|calcium|mesh-list
20098568|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
20098569|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20098570|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098571|NCT00002738|Antidotes|antidotes|mesh-ancestor
20098572|NCT00002738|Protective Agents|protective agents|mesh-ancestor
20098573|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098574|NCT00002738|Vitamins|vitamins|mesh-ancestor
20098575|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
20098576|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
20098577|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098578|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098579|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
20098580|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098581|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098582|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098583|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098584|NCT00002740|Cobalt|cobalt|mesh-list
20098585|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
20098586|NCT00002740|Carboplatin|carboplatin|mesh-list
20098587|NCT00002740|Doxorubicin|doxorubicin|mesh-list
20098588|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098589|NCT00002740|Etoposide|etoposide|mesh-list
20098590|NCT00002740|Vincristine|vincristine|mesh-list
20098591|NCT00002740|Lenograstim|lenograstim|mesh-list
20098592|NCT00002740|Mesna|mesna|mesh-list
20098593|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098594|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
20098595|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098596|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098597|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19571873|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
19571874|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571875|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19571876|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19571877|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19571878|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
19571879|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571880|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20098598|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
19577912|NCT03817853|Prednisolone|prednisolone|mesh-list
20098599|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098600|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603396|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
20098601|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19514540|NCT02998905|Aspirin|aspirin|mesh-list
19514541|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19514542|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19514543|NCT02998905|Analgesics|analgesics|mesh-ancestor
19514544|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
19514545|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514546|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514547|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514548|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514549|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19514550|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19514551|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514552|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20098602|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098603|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098604|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098605|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098606|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098607|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20098608|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098609|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098610|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
19514553|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19514554|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514555|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
19514556|NCT02998736|Tadalafil|tadalafil|mesh-list
19514557|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
19514558|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19514559|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19514560|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514561|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514562|NCT02998736|Urological Agents|urological agents|mesh-ancestor
19514563|NCT02998606|Naloxegol|naloxegol|mesh-list
19514564|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20098611|NCT00002740|Protective Agents|protective agents|mesh-ancestor
20098612|NCT00002740|Trace Elements|trace elements|mesh-ancestor
20098613|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
20098614|NCT00002742|Amphotericin B|amphotericin b|mesh-list
20098615|NCT00002742|Nystatin|nystatin|mesh-list
20098616|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20098617|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20098618|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
20098619|NCT00002742|Amebicides|amebicides|mesh-ancestor
20098620|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20098621|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20098622|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098623|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20098624|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
20098625|NCT00002742|Ionophores|ionophores|mesh-ancestor
20098626|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20098627|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098628|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20098629|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098630|NCT00002744|Cobalt|cobalt|mesh-list
20098631|NCT00002744|Cytarabine|cytarabine|mesh-list
20098632|NCT00002744|Dexamethasone|dexamethasone|mesh-list
20098633|NCT00002744|Prednisone|prednisone|mesh-list
20098634|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
20098635|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20098636|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20098637|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20098638|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
20098639|NCT00002744|Doxorubicin|doxorubicin|mesh-list
20098640|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098641|NCT00002744|Methotrexate|methotrexate|mesh-list
20098642|NCT00002744|Vincristine|vincristine|mesh-list
20098643|NCT00002744|Daunorubicin|daunorubicin|mesh-list
20098644|NCT00002744|Asparaginase|asparaginase|mesh-list
20098645|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
20098646|NCT00002744|Pegaspargase|pegaspargase|mesh-list
20098647|NCT00002744|Thioguanine|thioguanine|mesh-list
19514565|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098648|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098649|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
20603397|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514566|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
20098650|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098651|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120407|NCT00006356|Carboplatin|carboplatin|mesh-list
19514567|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514568|NCT02998437|Amoxicillin|amoxicillin|mesh-list
19514569|NCT02998437|Clarithromycin|clarithromycin|mesh-list
19514570|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19514571|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514572|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20098652|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098653|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
20098654|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098655|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098656|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098657|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098658|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
20098659|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
20098660|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098661|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20098662|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
20098663|NCT00002744|Hormones|hormones|mesh-ancestor
20098664|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098665|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098666|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098667|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098668|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098669|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098670|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098671|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098672|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098673|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098674|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
20098675|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098676|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098677|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098678|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
20098679|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098680|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098681|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098682|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098683|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098684|NCT00002744|Trace Elements|trace elements|mesh-ancestor
20098685|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
20098686|NCT00002746|Aldesleukin|aldesleukin|mesh-list
20603398|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603399|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20098687|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098688|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20098689|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20098690|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
20098691|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603400|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
20603401|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
20603402|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
20603403|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603404|NCT02220673|Protective Agents|protective agents|mesh-ancestor
20603405|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603406|NCT02220751|Doxycycline|doxycycline|mesh-list
20603407|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20603408|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098692|NCT00002747|Cobalt|cobalt|mesh-list
20098693|NCT00002747|Fluorouracil|fluorouracil|mesh-list
20098694|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098695|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
20098696|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098697|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20603409|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
19514573|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603410|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19514574|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514575|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19514576|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19748929|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098698|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098699|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
20098700|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098701|NCT00002747|Trace Elements|trace elements|mesh-ancestor
20098702|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
20098703|NCT00002748|Interleukin-2|interleukin-2|mesh-list
20098704|NCT00002748|Vaccines|vaccines|mesh-list
20098705|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098706|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20098707|NCT00002748|Analgesics|analgesics|mesh-ancestor
20098708|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
20098709|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20098710|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098711|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
20098712|NCT00002749|Carboplatin|carboplatin|mesh-list
20098713|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098714|NCT00002750|Melphalan|melphalan|mesh-list
20098715|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098716|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
20098717|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098718|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098719|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098720|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098721|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
20098722|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098723|NCT00002751|Antibodies|antibodies|mesh-list
20098724|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20098725|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
20098726|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098727|NCT00002752|Antibodies|antibodies|mesh-list
20098728|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20098729|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
20098730|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098731|NCT00002753|Antibodies|antibodies|mesh-list
20098732|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20098733|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
20098734|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098735|NCT00002754|Antibodies|antibodies|mesh-list
20098736|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20098737|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
20098738|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098739|NCT00002755|Tamoxifen|tamoxifen|mesh-list
20098740|NCT00002755|Cobalt|cobalt|mesh-list
20098741|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
20098742|NCT00002755|Thiotepa|thiotepa|mesh-list
20098743|NCT00002755|Doxorubicin|doxorubicin|mesh-list
20098744|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098745|NCT00002755|Fluorouracil|fluorouracil|mesh-list
20098746|NCT00002755|Methotrexate|methotrexate|mesh-list
20098747|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098748|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
20098749|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098750|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098751|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098752|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
20098753|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098754|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098755|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098756|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098757|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098758|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098759|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098760|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
20098761|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098762|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098763|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098764|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098765|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098766|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098767|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19577913|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
20098768|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20098769|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
19748930|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
19748931|NCT05347485|Fludarabine|fludarabine|mesh-list
20098770|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098771|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098772|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20098773|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20098774|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20098775|NCT00002755|Trace Elements|trace elements|mesh-ancestor
20098776|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
20098777|NCT00002756|Leucovorin|leucovorin|mesh-list
20098778|NCT00002756|Cytarabine|cytarabine|mesh-list
20098779|NCT00002756|Prednisone|prednisone|mesh-list
20098780|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
20098781|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20098782|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20098783|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20098784|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
20098785|NCT00002756|Methotrexate|methotrexate|mesh-list
20098786|NCT00002756|Etoposide|etoposide|mesh-list
20098787|NCT00002756|Vincristine|vincristine|mesh-list
20098788|NCT00002756|Daunorubicin|daunorubicin|mesh-list
20098789|NCT00002756|Asparaginase|asparaginase|mesh-list
20098790|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
20098791|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
20098792|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098793|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
20098794|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098795|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098796|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098797|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
20098798|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098799|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098800|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098801|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098802|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
20098803|NCT00002756|Hormones|hormones|mesh-ancestor
20098804|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098805|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098806|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098807|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098808|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098809|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098810|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
20098811|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098812|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098813|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098814|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098815|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098816|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098817|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098818|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
20098819|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098820|NCT00002756|Antidotes|antidotes|mesh-ancestor
20098821|NCT00002756|Protective Agents|protective agents|mesh-ancestor
20098822|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
20098823|NCT00002756|Vitamins|vitamins|mesh-ancestor
20098824|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
20098825|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098826|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098827|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098828|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098829|NCT00002757|Cytarabine|cytarabine|mesh-list
20098830|NCT00002757|Prednisone|prednisone|mesh-list
20098831|NCT00002757|Prednisolone|prednisolone|mesh-list
20098832|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
20098833|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20098834|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20098835|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20098836|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
20098837|NCT00002757|Doxorubicin|doxorubicin|mesh-list
20098838|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19514581|NCT02998424|Propofol|propofol|mesh-list
20098839|NCT00002757|Methotrexate|methotrexate|mesh-list
20098840|NCT00002757|Etoposide|etoposide|mesh-list
20098841|NCT00002757|Vincristine|vincristine|mesh-list
20098842|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514582|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20098843|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
20098844|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514583|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514584|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514585|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19514586|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
19514587|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
19514588|NCT02998242|Apatinib|apatinib|mesh-list
19514589|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514590|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19514591|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098845|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098846|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098847|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
20098848|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514592|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514593|NCT02998398|Infliximab|infliximab|mesh-list
19514594|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
19514595|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514596|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098849|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098850|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098851|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098852|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098853|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098854|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098855|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098856|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
20098857|NCT00002757|Hormones|hormones|mesh-ancestor
20098858|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098859|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20098860|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098861|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098862|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098863|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098864|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
20098865|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098866|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20098867|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098868|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098869|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
20098870|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098871|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
20098872|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098873|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
20098874|NCT00002759|Cyclosporine|cyclosporine|mesh-list
20098875|NCT00002759|Irinotecan|irinotecan|mesh-list
20098876|NCT00002759|Phenobarbital|phenobarbital|mesh-list
20098877|NCT00002759|Cyclosporins|cyclosporins|mesh-list
20098878|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20098879|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20306188|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20306189|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306190|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
20306191|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306192|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20306193|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306194|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306195|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
20306196|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20306197|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20306198|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306199|NCT00654160|Antidotes|antidotes|mesh-ancestor
20306200|NCT00654160|Protective Agents|protective agents|mesh-ancestor
19514597|NCT02998268|Paclitaxel|paclitaxel|mesh-list
20098880|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098881|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098882|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098883|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098884|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
20098885|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098886|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
20098887|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098888|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098889|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098890|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19514598|NCT02998268|Carboplatin|carboplatin|mesh-list
19514599|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
19514600|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19514601|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514602|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
19514603|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
19514604|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
19514605|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514606|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514607|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19514608|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19514609|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19514610|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
19514611|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514612|NCT02997969|Vaccines|vaccines|mesh-list
19514613|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
19514614|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
19514615|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514616|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19514617|NCT02997995|Durvalumab|durvalumab|mesh-list
19514618|NCT02997995|Tremelimumab|tremelimumab|mesh-list
19514619|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514620|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514621|NCT02997800|Labetalol|labetalol|mesh-list
19514622|NCT02997800|Fentanyl|fentanyl|mesh-list
19514623|NCT02997800|Esmolol|esmolol|mesh-list
19514624|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19514625|NCT02997800|Narcotics|narcotics|mesh-ancestor
19514626|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514627|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514628|NCT02997800|Analgesics|analgesics|mesh-ancestor
19514629|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
19514630|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514631|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19514632|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19514633|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
19514634|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
19514635|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19514636|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19514637|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19514638|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
19514639|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514640|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514641|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514642|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
19514643|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
19514644|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19514645|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19514646|NCT02997982|Valacyclovir|valacyclovir|mesh-list
19514647|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
19514648|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514649|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19514650|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19514651|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514652|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
20098891|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
20098892|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20098893|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20098894|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20098895|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20098896|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20098897|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
20098898|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
20098899|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20098900|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19514653|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514654|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
19514655|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
19514656|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098901|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20603411|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19514657|NCT02997332|Docetaxel|docetaxel|mesh-list
19514658|NCT02997332|Fluorouracil|fluorouracil|mesh-list
19514659|NCT02997332|Durvalumab|durvalumab|mesh-list
19514660|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514661|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
19514662|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
20098902|NCT00002760|Ketoconazole|ketoconazole|mesh-list
20098903|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
20098904|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20098905|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20098906|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20098907|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
20098908|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20098909|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
20098910|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098911|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20098912|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20098913|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098914|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098915|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20098916|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
19514663|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
19514664|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514665|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
19514666|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514667|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514668|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
19514669|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514670|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514671|NCT02997215|Lidocaine|lidocaine|mesh-list
19514672|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
19514673|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
19514674|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514675|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098917|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20098918|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098919|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20098920|NCT00002761|Interferons|interferons|mesh-list
20098921|NCT00002761|Cytarabine|cytarabine|mesh-list
20098922|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
20098923|NCT00002761|Cyclosporine|cyclosporine|mesh-list
20098924|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
20098925|NCT00002761|Busulfan|busulfan|mesh-list
20098926|NCT00002761|Idarubicin|idarubicin|mesh-list
20098927|NCT00002761|Cyclosporins|cyclosporins|mesh-list
20098928|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20098929|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
20098930|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098931|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098932|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098933|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
19514676|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
19514677|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514678|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19514679|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19514680|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19514681|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19514682|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571881|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19571882|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571883|NCT02705573|Mannitol|mannitol|mesh-list
19571884|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19571885|NCT02705573|Diuretics|diuretics|mesh-ancestor
19571886|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
19571887|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571888|NCT02705508|Gemcitabine|gemcitabine|mesh-list
19571889|NCT02705508|Etoposide|etoposide|mesh-list
19571890|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
19571891|NCT02705508|Pegaspargase|pegaspargase|mesh-list
19571892|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571893|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
19571894|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098934|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098935|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098936|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20098937|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
20098938|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098939|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098940|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
20603412|NCT02220777|Omeprazole|omeprazole|mesh-list
20603413|NCT02220777|ASP8477|asp8477|mesh-list
20098941|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098942|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
20098943|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098944|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19514683|NCT02996916|Amlodipine|amlodipine|mesh-list
19514684|NCT02996916|Olmesartan|olmesartan|mesh-list
19514685|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514686|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19514687|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19514688|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514689|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19514690|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514691|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
19514692|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19514693|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19514694|NCT02996942|Factor VIII|factor viii|mesh-list
19514695|NCT02996942|Coagulants|coagulants|mesh-ancestor
19514696|NCT02997059|Fluconazole|fluconazole|mesh-list
19514697|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
19514698|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514699|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19514700|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19514701|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514702|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514703|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19514704|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
19514705|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514706|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514707|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19514708|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19514709|NCT02996734|Denosumab|denosumab|mesh-list
19514710|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19514711|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514712|NCT02996656|Cefazolin|cefazolin|mesh-list
19514713|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
19514714|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19514715|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514716|NCT02996721|Vitamin D|vitamin d|mesh-list
19514717|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
19514718|NCT02996721|Vitamins|vitamins|mesh-ancestor
19514719|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
19514720|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514721|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19514722|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19514723|NCT02996695|Artesunate|artesunate|mesh-list
19514724|NCT02996695|Chloroquine|chloroquine|mesh-list
19514725|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
20098945|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098946|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098947|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098948|NCT00002763|Interferons|interferons|mesh-list
20098949|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
20098950|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514726|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19514727|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19514728|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514729|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514730|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
19514731|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
19514732|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19514733|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
19514734|NCT02996695|Amebicides|amebicides|mesh-ancestor
19514735|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514736|NCT02996513|Vitamin A|vitamin a|mesh-list
19514737|NCT02996513|Vitamins|vitamins|mesh-ancestor
19514738|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
19514739|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514740|NCT02996487|Vancomycin|vancomycin|mesh-list
19514741|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19514742|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514743|NCT02996409|Lidocaine|lidocaine|mesh-list
19514744|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
20603414|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20603415|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514745|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
19514746|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514747|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514748|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
19514749|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514750|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19514751|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19514752|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19514753|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19514754|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514755|NCT02996318|Sirolimus|sirolimus|mesh-list
19514756|NCT02996318|Paclitaxel|paclitaxel|mesh-list
19514757|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19514758|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514759|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
19514760|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
19514761|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
19514762|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514763|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19514764|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514765|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19514766|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
19514767|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514768|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
20098951|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
19514769|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514770|NCT02996227|Bupivacaine|bupivacaine|mesh-list
19514771|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
19514772|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
19514773|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514774|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514775|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
19514776|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514777|NCT02996214|Gemcitabine|gemcitabine|mesh-list
19514778|NCT02996214|Paclitaxel|paclitaxel|mesh-list
19514779|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19514780|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514781|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
19514782|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
19514783|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
19514784|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514785|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514786|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
19514787|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
19514788|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514789|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514790|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514791|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
19514792|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514793|NCT02995954|Amlodipine|amlodipine|mesh-list
19514794|NCT02995954|Perindopril|perindopril|mesh-list
19514795|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514796|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19514797|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19514798|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514799|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19514800|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514801|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
19514802|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19514803|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
19514804|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514805|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
19514806|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19514807|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514808|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514809|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19514810|NCT02996058|Analgesics|analgesics|mesh-ancestor
19514811|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
19514812|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514813|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19514814|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19514815|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19514816|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
19514817|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20098952|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20098953|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
20306201|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
19514818|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514819|NCT02996019|Etrolizumab|etrolizumab|mesh-list
19514820|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514821|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
19514822|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514823|NCT02995772|Tamoxifen|tamoxifen|mesh-list
19514824|NCT02995772|Fluorouracil|fluorouracil|mesh-list
19514825|NCT02995772|Letrozole|letrozole|mesh-list
19514826|NCT02995772|Anastrozole|anastrozole|mesh-list
19514827|NCT02995772|Exemestane|exemestane|mesh-list
19514828|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19514829|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
19514830|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514831|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514832|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514833|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514834|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
19514835|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514836|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098954|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098955|NCT00002764|Doxorubicin|doxorubicin|mesh-list
20098956|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20098957|NCT00002764|Ifosfamide|ifosfamide|mesh-list
20098958|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20098959|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098960|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098961|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20098962|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098963|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098964|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20098965|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
20098966|NCT00002765|Immunotoxins|immunotoxins|mesh-list
20098967|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
20098968|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098969|NCT00002767|Interferons|interferons|mesh-list
19514837|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19514838|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19514839|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
19514840|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514841|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514842|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19514843|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19514844|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19514845|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
19514846|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19514847|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19514848|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
19514849|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514850|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19514851|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19514852|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514853|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098970|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
20098971|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
20098972|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098973|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
20098974|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514854|NCT02995720|Amlodipine|amlodipine|mesh-list
19514855|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19514856|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514857|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19514858|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19514859|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514860|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19514861|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514862|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
19514863|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19514864|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19514865|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
19514866|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19514867|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20098975|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
20098976|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20098977|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20098978|NCT00002768|Cytarabine|cytarabine|mesh-list
19514868|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514869|NCT02995707|Thalidomide|thalidomide|mesh-list
19514870|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514871|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
19514872|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514873|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
19514874|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19514875|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19514876|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19514877|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19514878|NCT02995707|Growth Substances|growth substances|mesh-ancestor
19514879|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
19514880|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098979|NCT00002768|Methotrexate|methotrexate|mesh-list
20098980|NCT00002768|Etoposide|etoposide|mesh-list
20098981|NCT00002768|Busulfan|busulfan|mesh-list
20098982|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20098983|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
20098984|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20098985|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514881|NCT02995746|Dexamethasone|dexamethasone|mesh-list
19514882|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514883|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
19514884|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
19514885|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514886|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514887|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19514888|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
19514889|NCT02995746|Hormones|hormones|mesh-ancestor
19514890|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514891|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514892|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514893|NCT02995512|Colchicine|colchicine|mesh-list
19514894|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
19514895|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514896|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
19514897|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
19514898|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
19514899|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514900|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514901|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
19514902|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514903|NCT02995655|Azacitidine|azacitidine|mesh-list
19514904|NCT02995655|Heparin|heparin|mesh-list
19514905|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514906|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
19514907|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514908|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514909|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514910|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
19514911|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19514912|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19571895|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571896|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
19571897|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571898|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571899|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571900|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
19571901|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571902|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571903|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19571904|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19571905|NCT02705482|Durvalumab|durvalumab|mesh-list
19571906|NCT02705482|Tremelimumab|tremelimumab|mesh-list
19571907|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571908|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571909|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
19571910|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571911|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571912|NCT02705664|Amorolfine|amorolfine|mesh-list
19571913|NCT02705664|Bifonazole|bifonazole|mesh-list
19571914|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
19571915|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571916|NCT02705378|Naloxegol|naloxegol|mesh-list
19571917|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19571918|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571919|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
19514913|NCT02995291|Phentolamine|phentolamine|mesh-list
19514914|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19514915|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19514916|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
19514917|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514918|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514919|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514920|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19514921|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
19514922|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
19514923|NCT02995330|Testosterone|testosterone|mesh-list
19514924|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
19514925|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
20603416|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20603417|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603418|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603419|NCT02220803|Acetazolamide|acetazolamide|mesh-list
20603420|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
20603421|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20603422|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603423|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603424|NCT02220803|Diuretics|diuretics|mesh-ancestor
20603425|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
19514926|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19514927|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514928|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
19514929|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514930|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514931|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19514932|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
19514933|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514934|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514935|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19514936|NCT02995330|Androgens|androgens|mesh-ancestor
19514937|NCT02995330|Hormones|hormones|mesh-ancestor
19514938|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514939|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514940|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
19514941|NCT02995187|Apatinib|apatinib|mesh-list
19514942|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514943|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19514944|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19514945|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514946|NCT02995057|Nickel|nickel|mesh-list
19514947|NCT02995057|Trace Elements|trace elements|mesh-ancestor
19514948|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
19514949|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514950|NCT02995304|Midazolam|midazolam|mesh-list
19514951|NCT02995304|Morphine|morphine|mesh-list
19514952|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19514953|NCT02995304|Narcotics|narcotics|mesh-ancestor
20098986|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20098987|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
20098988|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20098989|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20098990|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
20098991|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20098992|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19514954|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19514955|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514956|NCT02995304|Analgesics|analgesics|mesh-ancestor
19514957|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
19514958|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19514959|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19514960|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19514961|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19514962|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19514963|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19514964|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19514965|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
19514966|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
19514967|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
20603426|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514968|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
20098993|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20603427|NCT02220829|Silodosin|silodosin|mesh-list
19514969|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19514970|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514971|NCT02994927|Prednisone|prednisone|mesh-list
19514972|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
19514973|NCT02994927|Rituximab|rituximab|mesh-list
19514974|NCT02994927|Azathioprine|azathioprine|mesh-list
19514975|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19514976|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
19514977|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514978|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19514979|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19514980|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
19514981|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19514982|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514983|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19514984|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514985|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19514986|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
19514987|NCT02994927|Hormones|hormones|mesh-ancestor
19514988|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19514989|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19514990|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
19514991|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19514992|NCT02994953|Avelumab|avelumab|mesh-list
19514993|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19514994|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19514995|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19514996|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
19514997|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19514998|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
19514999|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19515000|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19515001|NCT02995083|Prednisolone|prednisolone|mesh-list
19515002|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
19515003|NCT02995083|Lidocaine|lidocaine|mesh-list
19515004|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19515005|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
19515006|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
19515007|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
20098994|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
20098995|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20098996|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20098997|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20098998|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20098999|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099000|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
20099001|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099002|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
20099003|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099004|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099005|NCT00002771|Interferons|interferons|mesh-list
20099006|NCT00002771|Cytarabine|cytarabine|mesh-list
19515008|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515009|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515010|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
19515011|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515012|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19515013|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19515014|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19515015|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515016|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515017|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19515018|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
19515019|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
19515020|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19515021|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
19515022|NCT02995083|Hormones|hormones|mesh-ancestor
19515023|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515024|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19515025|NCT02995083|Protective Agents|protective agents|mesh-ancestor
19515026|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515027|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515028|NCT02994745|Atorvastatin|atorvastatin|mesh-list
19515029|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19515030|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19515031|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
19515032|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515033|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19515034|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19515035|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515036|NCT02994888|Cetuximab|cetuximab|mesh-list
19515037|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19515038|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515039|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
19515040|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19515041|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
19515042|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515043|NCT02994875|Expectorants|expectorants|mesh-ancestor
19515044|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
19515045|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19515046|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
19515047|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515048|NCT02994875|Protective Agents|protective agents|mesh-ancestor
19515049|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515050|NCT02994875|Antidotes|antidotes|mesh-ancestor
19515051|NCT02994719|Amantadine|amantadine|mesh-list
19515052|NCT02994719|Levodopa|levodopa|mesh-list
19515053|NCT02994719|Carbidopa|carbidopa|mesh-list
19515054|NCT02994719|Pramipexole|pramipexole|mesh-list
19515055|NCT02994719|Ropinirole|ropinirole|mesh-list
19515056|NCT02994719|Entacapone|entacapone|mesh-list
19515057|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19515058|NCT02994719|Tolcapone|tolcapone|mesh-list
19515059|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19515060|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19515061|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
19515062|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515063|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515064|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515065|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19515066|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515067|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
19515068|NCT02994719|Protective Agents|protective agents|mesh-ancestor
19515069|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
19515070|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
19515071|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515072|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19515073|NCT02994719|Analgesics|analgesics|mesh-ancestor
19515074|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
19515075|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515076|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19515077|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19515078|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
19515079|NCT02995005|Tenofovir|tenofovir|mesh-list
19515080|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
19515081|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515082|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19515083|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19515084|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515085|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515086|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19515087|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19515088|NCT02994576|Atezolizumab|atezolizumab|mesh-list
19515089|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515090|NCT02994381|Ozanimod|ozanimod|mesh-list
19515091|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19515092|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515093|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19515094|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
19515095|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515096|NCT02994602|ST 1435|st 1435|mesh-list
19515097|NCT02994602|Testosterone|testosterone|mesh-list
19515098|NCT02994602|Androgens|androgens|mesh-ancestor
19515099|NCT02994602|Hormones|hormones|mesh-ancestor
19515100|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515101|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515102|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19515103|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
19515104|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19515105|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19515106|NCT02994290|Vaccines|vaccines|mesh-list
20099007|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
19515107|NCT02994290|Immunologic Factors|immunologic factors|mesh-ancestor
19515108|NCT02994290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515109|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
19515110|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19515111|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
19515112|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
19515113|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515114|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515115|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19515116|NCT02994433|Analgesics|analgesics|mesh-ancestor
19515117|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
19515118|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515119|NCT02994485|Simvastatin|simvastatin|mesh-list
19515120|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19515121|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19515122|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
19515123|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515124|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19515125|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19515126|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515127|NCT02994173|Ketamine|ketamine|mesh-list
19515128|NCT02994173|Oxycodone|oxycodone|mesh-list
19515129|NCT02994173|Esketamine|esketamine|mesh-list
19515130|NCT02994173|Analgesics|analgesics|mesh-ancestor
19515131|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
19515132|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515133|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515134|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19515135|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19515136|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
19515137|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
19515138|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515139|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19515140|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19515141|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515142|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515143|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19515144|NCT02994173|Narcotics|narcotics|mesh-ancestor
19515145|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
19515146|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19515147|NCT02994082|Bupropion|bupropion|mesh-list
19515148|NCT02994082|Nicotine|nicotine|mesh-list
19515149|NCT02994082|Varenicline|varenicline|mesh-list
19515150|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19515151|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
19515152|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515153|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515154|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19515155|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19515156|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
19515157|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515158|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515159|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19515160|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
19515161|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19515162|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19515163|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19515164|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515165|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
19515166|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19515167|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19515168|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515169|NCT02995096|Sirolimus|sirolimus|mesh-list
19515170|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19515171|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515172|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19515173|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515174|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
19515175|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19515176|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
19515177|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515178|NCT02993991|Durvalumab|durvalumab|mesh-list
19515179|NCT02993991|Mocetinostat|mocetinostat|mesh-list
19515180|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20099008|NCT00002771|Busulfan|busulfan|mesh-list
20099009|NCT00002771|Idarubicin|idarubicin|mesh-list
20099010|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
20099011|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099012|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
20099013|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099014|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099015|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
19515181|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515182|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19515183|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515184|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515185|NCT02993835|Iron|iron|mesh-list
19515186|NCT02993835|Trace Elements|trace elements|mesh-ancestor
19515187|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
19515188|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515189|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
19515190|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
19515191|NCT02993718|Propofol|propofol|mesh-list
19515192|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19515193|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515194|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515195|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19515196|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
19515197|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
19515198|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19515199|NCT02993718|Analgesics|analgesics|mesh-ancestor
19515200|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
19515201|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515202|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19515203|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19515204|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19515205|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
19515206|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515207|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571920|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571921|NCT02705638|Rituximab|rituximab|mesh-list
19571922|NCT02705638|Lenalidomide|lenalidomide|mesh-list
19571923|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571924|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571925|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
19571926|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571927|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19571928|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19571929|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19571930|NCT02705638|Growth Substances|growth substances|mesh-ancestor
19571931|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
19571932|NCT02705651|Somatostatin|somatostatin|mesh-list
19571933|NCT02705651|Hormones|hormones|mesh-ancestor
19571934|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571935|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571936|NCT02705287|Vitamin D|vitamin d|mesh-list
19571937|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
19571938|NCT02705287|Vitamins|vitamins|mesh-list
19571939|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
19571940|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571941|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19571942|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19571943|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19571944|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19571945|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571946|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19571947|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
19571948|NCT02705053|Insulin|insulin|mesh-list
19571949|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19571950|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571951|NCT02705274|Bevacizumab|bevacizumab|mesh-list
19571952|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19571953|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571954|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19571955|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19571956|NCT02705274|Growth Substances|growth substances|mesh-ancestor
19571957|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571958|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
20099016|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571959|NCT02705196|Gemcitabine|gemcitabine|mesh-list
19571960|NCT02705196|Paclitaxel|paclitaxel|mesh-list
20099017|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099018|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
20099019|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099020|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
20099021|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099022|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099023|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19515208|NCT02993575|Floxacillin|floxacillin|mesh-list
20099024|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099025|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099026|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099027|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
20099028|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099029|NCT00002772|Tamoxifen|tamoxifen|mesh-list
20099030|NCT00002772|Paclitaxel|paclitaxel|mesh-list
20099031|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
20099032|NCT00002772|Carboplatin|carboplatin|mesh-list
20099033|NCT00002772|Doxorubicin|doxorubicin|mesh-list
20099034|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099035|NCT00002772|Thiotepa|thiotepa|mesh-list
20099036|NCT00002772|Carmustine|carmustine|mesh-list
20099037|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099038|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515209|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19515210|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515211|NCT02993640|Vasopressins|vasopressins|mesh-list
19515212|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
19515213|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
19515214|NCT02993640|Coagulants|coagulants|mesh-ancestor
19515215|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19515216|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19515217|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
19515218|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515219|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19515220|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19515221|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
19515222|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515223|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19515224|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515225|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19515226|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515227|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19515228|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20099039|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099040|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099041|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099042|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099043|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099044|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
20099045|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099046|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099047|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099048|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
20099049|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19515229|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19515230|NCT02993367|Protective Agents|protective agents|mesh-ancestor
19515231|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515232|NCT02993523|Azacitidine|azacitidine|mesh-list
19515233|NCT02993523|Venetoclax|venetoclax|mesh-list
19515234|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19515235|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
19515236|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515237|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515238|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515239|NCT02993588|Melatonin|melatonin|mesh-list
19515240|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
19515241|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515242|NCT02993588|Protective Agents|protective agents|mesh-ancestor
19515243|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515244|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20099050|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19515245|NCT02993705|Trabectedin|trabectedin|mesh-list
19515246|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19515247|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
20099051|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099052|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19515248|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515249|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515250|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
19515251|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20099053|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099054|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20099055|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
19515252|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19515253|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515254|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
19515255|NCT02993341|Coagulants|coagulants|mesh-ancestor
19515256|NCT02993315|Vaccines|vaccines|mesh-list
19515257|NCT02993315|Immunologic Factors|immunologic factors|mesh-ancestor
19515258|NCT02993315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515259|NCT02993094|Carboplatin|carboplatin|mesh-list
19515260|NCT02993094|Ixazomib|ixazomib|mesh-list
19515261|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515262|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
19515263|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515264|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515265|NCT02993159|Tamoxifen|tamoxifen|mesh-list
19515266|NCT02993159|Afimoxifene|afimoxifene|mesh-list
19515267|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19515268|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
19515269|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515270|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515271|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515272|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515273|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19515274|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19515275|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19515276|NCT02993029|Celecoxib|celecoxib|mesh-list
19515277|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19515278|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19515279|NCT02993029|Analgesics|analgesics|mesh-ancestor
19515280|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
19515281|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515282|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515283|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19515284|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19515285|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19515286|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19515287|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515288|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515289|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
19515290|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19515291|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515292|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19515293|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
19515294|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19515295|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515296|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515297|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515298|NCT02992808|Menotropins|menotropins|mesh-list
19515299|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19515300|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
19515301|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19515302|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515303|NCT02992756|Mitogens|mitogens|mesh-list
19515304|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
19515305|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515306|NCT02992938|Acetazolamide|acetazolamide|mesh-list
19515307|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
19515308|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19515309|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515310|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515311|NCT02992938|Diuretics|diuretics|mesh-ancestor
19515312|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
19515313|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515314|NCT02992886|Raltitrexed|raltitrexed|mesh-list
19515315|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19515316|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
19515317|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306202|NCT00654160|Vitamins|vitamins|mesh-ancestor
20099056|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099057|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099058|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20099059|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20099060|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19515318|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515319|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19515320|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515321|NCT02992925|Vaccines|vaccines|mesh-list
19515322|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
19515323|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515324|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
19515325|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19515326|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515327|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515328|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19515329|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19515330|NCT02992678|Protective Agents|protective agents|mesh-ancestor
19515331|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515332|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
19515333|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19515334|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
19515335|NCT02992912|Atezolizumab|atezolizumab|mesh-list
19515336|NCT02992912|Antibodies|antibodies|mesh-list
19515337|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
19515338|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515339|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515340|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19515341|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
19515342|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515343|NCT02992496|Midazolam|midazolam|mesh-list
19515344|NCT02992496|Ketamine|ketamine|mesh-list
19515345|NCT02992496|Analgesics|analgesics|mesh-ancestor
19515346|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
19515347|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515348|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515349|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19515350|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19515351|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
19515352|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
19515353|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515354|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19515355|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19515356|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20099061|NCT00002773|Interferons|interferons|mesh-list
20099062|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
20099063|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
20099064|NCT00002773|Sargramostim|sargramostim|mesh-list
20099065|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099066|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
20099067|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099068|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099069|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099070|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
20099071|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515357|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515358|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19515359|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19515360|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19515361|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19515362|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19515363|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
20099072|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099073|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099074|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
20099075|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120408|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120409|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
20120410|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120411|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20120412|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120413|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515364|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
19515365|NCT02992665|Ionophores|ionophores|mesh-list
19515366|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20099076|NCT00002774|Cisplatin|cisplatin|mesh-list
20099077|NCT00002774|Fluorouracil|fluorouracil|mesh-list
20099078|NCT00002774|Tirapazamine|tirapazamine|mesh-list
20099079|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099080|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
20099081|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099082|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19515367|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515368|NCT02992548|Pravastatin|pravastatin|mesh-list
19515369|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19515370|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19515371|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
19515372|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515373|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19515374|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19515375|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515376|NCT02992652|Allopurinol|allopurinol|mesh-list
19515377|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
19515378|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515379|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515380|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
19515381|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099083|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099084|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
20099085|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099086|NCT00002775|Docetaxel|docetaxel|mesh-list
20099087|NCT00002775|Estramustine|estramustine|mesh-list
20099088|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603428|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19515382|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20099089|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099090|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099091|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099092|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099093|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19515383|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
19515384|NCT02992652|Protective Agents|protective agents|mesh-ancestor
19515385|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515386|NCT02992457|Interferons|interferons|mesh-list
19515387|NCT02992457|Ribavirin|ribavirin|mesh-list
20099094|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
19515388|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
19515389|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
19515390|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19515391|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
19515392|NCT02992457|Ledipasvir|ledipasvir|mesh-list
19515393|NCT02992457|Simeprevir|simeprevir|mesh-list
19515394|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19515395|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515396|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
19515397|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515398|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
19515399|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515400|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
19515401|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515402|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
19515403|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515404|NCT02992392|Dextrans|dextrans|mesh-list
19515405|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
19515406|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
19515407|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
19515408|NCT02992340|Gemcitabine|gemcitabine|mesh-list
19515409|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515410|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19515411|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
19515412|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515413|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
19515414|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515415|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515416|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19515417|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
19515418|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099095|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515419|NCT02992028|Vitamins|vitamins|mesh-list
19515420|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
19571961|NCT02705196|Atezolizumab|atezolizumab|mesh-list
19515421|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571962|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19571963|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19571964|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
19571965|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
19571966|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
19571967|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571968|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19571969|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
20099096|NCT00002777|Tamoxifen|tamoxifen|mesh-list
20099097|NCT00002777|Exemestane|exemestane|mesh-list
20099098|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099099|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20099100|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
20099101|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099102|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099103|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099104|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099105|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20099106|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20099107|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20099108|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20099109|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19571970|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
19571971|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19571972|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19571973|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19571974|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
19571975|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571976|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19571977|NCT02705014|Hormones|hormones|mesh-list
19571978|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19571979|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571980|NCT02704962|Olanzapine|olanzapine|mesh-list
19571981|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
19571982|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
19571983|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19571984|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571985|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19571986|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19571987|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19571988|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19571989|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19571990|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19571991|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19571992|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19571993|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571994|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19571995|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
20099110|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099111|NCT00002778|Sargramostim|sargramostim|mesh-list
20099112|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
20099113|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099114|NCT00002779|Fludarabine|fludarabine|mesh-list
20099115|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
20099116|NCT00002779|Octreotide|octreotide|mesh-list
20099117|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099118|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099119|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
20099120|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099121|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099122|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
20099123|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099124|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20099125|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099126|NCT00002780|Aldesleukin|aldesleukin|mesh-list
20099127|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
20099128|NCT00002780|Thiotepa|thiotepa|mesh-list
20099129|NCT00002780|Carboplatin|carboplatin|mesh-list
20099130|NCT00002780|Sargramostim|sargramostim|mesh-list
19571996|NCT02704715|Anesthetics|anesthetics|mesh-list
19571997|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20099131|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099132|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
19515422|NCT02991950|Parnaparin|parnaparin|mesh-list
19515423|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
19515424|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19515425|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19515426|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515427|NCT02991781|Varenicline|varenicline|mesh-list
19515428|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19515429|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19515430|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
19515431|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515432|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515433|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515434|NCT02991768|Budesonide|budesonide|mesh-list
19515435|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19515436|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19515437|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
19515438|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515439|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515440|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19515441|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
19515442|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
19515443|NCT02991768|Hormones|hormones|mesh-ancestor
19515444|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515445|NCT02991612|Rifaximin|rifaximin|mesh-list
19515446|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19515447|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515448|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19515449|NCT02991339|Dexamethasone|dexamethasone|mesh-list
19515450|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
19515451|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19515452|NCT02991339|BB 1101|bb 1101|mesh-list
19515453|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19515454|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
19515455|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
19515456|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515457|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515458|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19515459|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
19515460|NCT02991339|Hormones|hormones|mesh-ancestor
19515461|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515462|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515463|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515464|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
19515465|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515466|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515467|NCT02991209|Testosterone|testosterone|mesh-list
19515468|NCT02991209|Androgens|androgens|mesh-ancestor
19515469|NCT02991209|Hormones|hormones|mesh-ancestor
19515470|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515471|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515472|NCT02991196|Nivolumab|nivolumab|mesh-list
19515473|NCT02991196|DS-8273a|ds-8273a|mesh-list
19515474|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19515475|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515476|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19515477|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515478|NCT02991131|Linezolid|linezolid|mesh-list
19515479|NCT02991131|Tedizolid|tedizolid|mesh-list
19515480|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
19515481|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19515482|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515483|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19515484|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515485|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515486|NCT02991157|Nimodipine|nimodipine|mesh-list
19515487|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19515488|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19515489|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515490|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515491|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19515492|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515493|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
19515494|NCT02990975|Ketamine|ketamine|mesh-list
19515495|NCT02990975|Analgesics|analgesics|mesh-ancestor
19515496|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
19515497|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515498|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515499|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19515500|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19515501|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
19515502|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
19515503|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515504|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19515505|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19515506|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515507|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515508|NCT02991053|Ketamine|ketamine|mesh-list
19515509|NCT02991053|Analgesics|analgesics|mesh-ancestor
19515510|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
19515511|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515512|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515513|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19515514|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19515515|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
19515516|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
19515517|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515518|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19515519|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19515520|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515521|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515522|NCT02990728|Metformin|metformin|mesh-list
19515523|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19515524|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515525|NCT02990962|Triamcinolone|triamcinolone|mesh-list
19515526|NCT02990962|Lidocaine|lidocaine|mesh-list
19515527|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19515528|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
19515529|NCT02990962|Hormones|hormones|mesh-ancestor
19515530|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515531|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515532|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515533|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
19515534|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
19515535|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515536|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
19515537|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515538|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19515539|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19515540|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19515541|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515542|NCT02990702|Bupivacaine|bupivacaine|mesh-list
19515543|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
19515544|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
19515545|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515546|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515547|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
19515548|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515549|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
19515550|NCT02990845|Leuprolide|leuprolide|mesh-list
19515551|NCT02990845|Exemestane|exemestane|mesh-list
20099133|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099134|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099135|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099136|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
20099137|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099138|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099139|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099140|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19515552|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19515553|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515554|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19515555|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
19515556|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19515557|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515558|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515559|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19515560|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20099141|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20099142|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
20099143|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099144|NCT00002783|Leucovorin|leucovorin|mesh-list
20099145|NCT00002783|Fluorouracil|fluorouracil|mesh-list
20099146|NCT00002783|Floxuridine|floxuridine|mesh-list
20099147|NCT00002783|Calcium|calcium|mesh-list
20099148|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
20099149|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099150|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20099151|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099152|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
20099153|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099154|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099155|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099156|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
20099157|NCT00002783|Antidotes|antidotes|mesh-ancestor
20099158|NCT00002783|Protective Agents|protective agents|mesh-ancestor
20099159|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
20099160|NCT00002783|Vitamins|vitamins|mesh-ancestor
20099161|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
20099162|NCT00002784|Tamoxifen|tamoxifen|mesh-list
20099163|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
20099164|NCT00002784|Doxorubicin|doxorubicin|mesh-list
19515561|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515562|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515563|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20099165|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099166|NCT00002784|Fluorouracil|fluorouracil|mesh-list
20099167|NCT00002784|Methotrexate|methotrexate|mesh-list
20099168|NCT00002784|Epirubicin|epirubicin|mesh-list
20099169|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099170|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
20099171|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099172|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099173|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099174|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
20099175|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099176|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099177|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099178|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099179|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099180|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19515564|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
19515565|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515566|NCT02990884|Ketamine|ketamine|mesh-list
19515567|NCT02990884|Analgesics|analgesics|mesh-ancestor
19515568|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
19515569|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515570|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515571|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20099181|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099182|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
19515572|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19515573|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
19515574|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
19515575|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515576|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19515577|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19515578|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515579|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515580|NCT02990858|Leronlimab|leronlimab|mesh-list
19515581|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19515582|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19515583|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515584|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19515585|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19515586|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
20099183|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099184|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099185|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099186|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099187|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099188|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099189|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099190|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20099191|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
19515587|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515588|NCT02990403|Aspirin|aspirin|mesh-list
19515589|NCT02990403|Prednisone|prednisone|mesh-list
19515590|NCT02990403|Heparin|heparin|mesh-list
19515591|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
19515592|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
19515593|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19515594|NCT02990403|Antibodies|antibodies|mesh-list
19515595|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19515596|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
19515597|NCT02990403|Hormones|hormones|mesh-ancestor
19515598|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515599|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515600|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515601|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515602|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19515603|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19515604|NCT02990403|Analgesics|analgesics|mesh-ancestor
19515605|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
19515606|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515607|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19515608|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19515609|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19515610|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515611|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19515612|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19515613|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515614|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
19515615|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
19515616|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
19515617|NCT02990403|Progestins|progestins|mesh-ancestor
20099192|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099193|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515618|NCT02990455|Nicotine|nicotine|mesh-list
19515619|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19515620|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
19515621|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515622|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515623|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19515624|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19515625|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
19515626|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515627|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515628|NCT02990364|Lidocaine|lidocaine|mesh-list
19515629|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
19515630|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19515631|NCT02990364|Anesthetics|anesthetics|mesh-list
19515632|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515633|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515634|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
19515635|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515636|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19515637|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19515638|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19515639|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515640|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515641|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19515642|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
19515643|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19515644|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515645|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
19515646|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19515647|NCT02990507|Testosterone|testosterone|mesh-list
19515648|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
19515649|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
19515650|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515651|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515652|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
19515653|NCT02990507|Hormones|hormones|mesh-ancestor
19515654|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515655|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515656|NCT02990507|Androgens|androgens|mesh-ancestor
19515657|NCT02990468|Cisplatin|cisplatin|mesh-list
19515658|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515659|NCT02990546|Midodrine|midodrine|mesh-list
19515660|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
19515661|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
19515662|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515663|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515664|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19515665|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19515666|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19515667|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19515668|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
19515669|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515670|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515671|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
19515672|NCT02990286|Rituximab|rituximab|mesh-list
19515673|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19515674|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515675|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
19515676|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515677|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19515678|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19515679|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19515680|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
19515681|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19515682|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515683|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515684|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19571998|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19571999|NCT02704624|Vitamin D|vitamin d|mesh-list
19572000|NCT02704624|Vitamins|vitamins|mesh-ancestor
19572001|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
19572002|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572003|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19572004|NCT02704754|Suvorexant|suvorexant|mesh-list
19572005|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19572006|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20099194|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20099195|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20099196|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20099197|NCT00002785|Leucovorin|leucovorin|mesh-list
20099198|NCT00002785|Cobalt|cobalt|mesh-list
20099199|NCT00002785|Cytarabine|cytarabine|mesh-list
20099200|NCT00002785|Cyclosporine|cyclosporine|mesh-list
20099201|NCT00002785|Dexamethasone|dexamethasone|mesh-list
20099202|NCT00002785|Prednisone|prednisone|mesh-list
20099203|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
20099204|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
20099205|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20099206|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20099207|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20099208|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
20099209|NCT00002785|Methotrexate|methotrexate|mesh-list
20099210|NCT00002785|Etoposide|etoposide|mesh-list
20603429|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19572007|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572008|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572009|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19572010|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20099211|NCT00002785|Vincristine|vincristine|mesh-list
20099212|NCT00002785|Daunorubicin|daunorubicin|mesh-list
20603430|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20603431|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
20603432|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20099213|NCT00002785|Asparaginase|asparaginase|mesh-list
20099214|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
20099215|NCT00002785|Pegaspargase|pegaspargase|mesh-list
20099216|NCT00002785|Cyclosporins|cyclosporins|mesh-list
20603433|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603434|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515685|NCT02990312|Sirolimus|sirolimus|mesh-list
19515686|NCT02990312|Maraviroc|maraviroc|mesh-list
19515687|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19515688|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515689|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19515690|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515691|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
19515692|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19515693|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
19515694|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515695|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19515696|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19515697|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515698|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19515699|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19515700|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
19515701|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19515702|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
19515703|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515704|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
20099217|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
20099218|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099219|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
20099220|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099221|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099222|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099223|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
20099224|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099225|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099226|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099227|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20099228|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
20099229|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
20099230|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099231|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20099232|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
19515705|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19515706|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19515707|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515708|NCT02990078|Urological Agents|urological agents|mesh-ancestor
19515709|NCT02989870|Sorafenib|sorafenib|mesh-list
19515710|NCT02989870|Bavituximab|bavituximab|mesh-list
19515711|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515712|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19515713|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515714|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515715|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19515716|NCT02989662|Mifepristone|mifepristone|mesh-list
19515717|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19515718|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
19515719|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19515720|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099233|NCT00002785|Hormones|hormones|mesh-ancestor
20099234|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099235|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099236|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099237|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099238|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099239|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099240|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
20099241|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099242|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099243|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099244|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099245|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099246|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099247|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099248|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
20099249|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099250|NCT00002785|Antidotes|antidotes|mesh-ancestor
20603435|NCT02220829|Urological Agents|urological agents|mesh-ancestor
19515721|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19515722|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20603436|NCT02220842|Atezolizumab|atezolizumab|mesh-list
19515723|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19515724|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
19515725|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19515726|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19515727|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
19515728|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515729|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
19515730|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19515731|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19515732|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
19515733|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
19515734|NCT02990013|Povidone|povidone|mesh-list
19515735|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19515736|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515737|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
19515738|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
19515739|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
19515740|NCT02989701|Plerixafor|plerixafor|mesh-list
19515741|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19515742|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19515743|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
19515744|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515745|NCT02989584|Gemcitabine|gemcitabine|mesh-list
19515746|NCT02989584|Atezolizumab|atezolizumab|mesh-list
19515747|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515748|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19515749|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
19515750|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515751|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
19515752|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515753|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515754|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19515755|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
19515756|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515757|NCT02989519|Progesterone|progesterone|mesh-list
19515758|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
19515759|NCT02989519|Progestins|progestins|mesh-ancestor
19515760|NCT02989519|Hormones|hormones|mesh-ancestor
19515761|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515762|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515763|NCT02989623|Copper|copper|mesh-list
19515764|NCT02989623|Trace Elements|trace elements|mesh-ancestor
19515765|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
19515766|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515767|NCT02989558|Aspirin|aspirin|mesh-list
19515768|NCT02989558|Clopidogrel|clopidogrel|mesh-list
19515769|NCT02989558|Ticagrelor|ticagrelor|mesh-list
19515770|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19515771|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19515772|NCT02989558|Analgesics|analgesics|mesh-ancestor
19515773|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
19515774|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515775|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515776|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19515777|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19515778|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19515779|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19515780|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515781|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19515782|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19515783|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515784|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
19515785|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19515786|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19515787|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19515788|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
19515789|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515790|NCT02989467|Aprepitant|aprepitant|mesh-list
19515791|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
19515792|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
19515793|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515794|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515795|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19515796|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19515797|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515798|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099251|NCT00002785|Protective Agents|protective agents|mesh-ancestor
20099252|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
20099253|NCT00002785|Vitamins|vitamins|mesh-ancestor
20099254|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
20099255|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
19515799|NCT02989324|Misoprostol|misoprostol|mesh-list
19515800|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19515801|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
19515802|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19515803|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515804|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19515805|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19515806|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
19515807|NCT02989259|Apatinib|apatinib|mesh-list
19515808|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515809|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19515810|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515811|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515812|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
19515813|NCT02989272|Analgesics|analgesics|mesh-ancestor
19515814|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
19515815|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515816|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515817|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
19515818|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515819|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19515820|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
20099256|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099257|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099258|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
20099259|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20099260|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20099261|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099262|NCT00002785|Trace Elements|trace elements|mesh-ancestor
19515821|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19515822|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515823|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515824|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19515825|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
19515826|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19515827|NCT02989038|Nicotine|nicotine|mesh-list
19515828|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19515829|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
19515830|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515831|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515832|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19515833|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19515834|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
19515835|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515836|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099263|NCT00002786|Aldesleukin|aldesleukin|mesh-list
20099264|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099265|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20099266|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20099267|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
20099268|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099269|NCT00002787|Aldesleukin|aldesleukin|mesh-list
20099270|NCT00002787|Interleukin-2|interleukin-2|mesh-list
19515837|NCT02989207|Mitomycins|mitomycins|mesh-list
19515838|NCT02989207|Mitomycin|mitomycin|mesh-list
19515839|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19515840|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515841|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
19515842|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515843|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19515844|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515845|NCT02989311|Iron|iron|mesh-list
19515846|NCT02989311|Trace Elements|trace elements|mesh-ancestor
19515847|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
19515848|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515849|NCT02989129|Quercetin|quercetin|mesh-list
19515850|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
19577914|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20099271|NCT00002787|Vaccines|vaccines|mesh-list
20099272|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
20099273|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20099274|NCT00002787|Antibodies|antibodies|mesh-list
20099275|NCT00002787|Sargramostim|sargramostim|mesh-list
20603437|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
20603438|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603439|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20603440|NCT02220868|Ribavirin|ribavirin|mesh-list
20603441|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
20603442|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20603443|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
20603444|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603445|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
20603446|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603447|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603448|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20603449|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20603450|NCT02221063|Thiamine|thiamine|mesh-list
20603451|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
20603452|NCT02221063|Vitamins|vitamins|mesh-ancestor
20603453|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
20603454|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515851|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515852|NCT02989129|Protective Agents|protective agents|mesh-ancestor
19515853|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515854|NCT02988999|Erythritol|erythritol|mesh-list
19515855|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
19515856|NCT02989012|Oseltamivir|oseltamivir|mesh-list
20603455|NCT02221102|Aspirin|aspirin|mesh-list
19515857|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
19515858|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515859|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515860|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515861|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
19515862|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
19515863|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19515864|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
19515865|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515866|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515867|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19515868|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
19515869|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19515870|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19515871|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19515872|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
19515873|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515874|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515875|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
19515876|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19515877|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
19515878|NCT02988921|Paclitaxel|paclitaxel|mesh-list
19515879|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19515880|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515881|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
19515882|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
19515883|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
19515884|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515885|NCT02988908|Donepezil|donepezil|mesh-list
19515886|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19515887|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515888|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515889|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
19515890|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515891|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515892|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
19515893|NCT02988700|Bupivacaine|bupivacaine|mesh-list
19515894|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
19515895|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
19515896|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603456|NCT02221102|Edoxaban|edoxaban|mesh-list
19515897|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515898|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
19515899|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572011|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572012|NCT02704923|Atropine|atropine|mesh-list
19572013|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19572014|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19572015|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19572016|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19572017|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19572018|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
19572019|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572020|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572021|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19572022|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19572023|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
19572024|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
19572025|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19572026|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19572027|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
19572028|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572029|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572030|NCT02704598|Warfarin|warfarin|mesh-list
19572031|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
20099276|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20099277|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20099278|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
20099279|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603457|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19572032|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
19572033|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19572034|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
19572035|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19572036|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
19572037|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572038|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572039|NCT02704767|Apatinib|apatinib|mesh-list
19572040|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19572041|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572042|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19572043|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572044|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572045|NCT02704780|Misoprostol|misoprostol|mesh-list
19572046|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19572047|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
19572048|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19572049|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572050|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19572051|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572052|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
19572053|NCT02704546|Methylphenidate|methylphenidate|mesh-list
19572054|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19572055|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572056|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19572057|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19572058|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572059|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572060|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
19572061|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572062|NCT02704481|Misoprostol|misoprostol|mesh-list
19572063|NCT02704481|Mifepristone|mifepristone|mesh-list
19572064|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19572065|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
19572066|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19572067|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572068|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19572069|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572070|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
19572071|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20603458|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20603459|NCT02221102|Analgesics|analgesics|mesh-ancestor
19572072|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20099280|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603460|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
19515900|NCT02988362|Amlodipine|amlodipine|mesh-list
19515901|NCT02988362|Candesartan|candesartan|mesh-list
19515902|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19515903|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19515904|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515905|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515906|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19515907|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515908|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
19515909|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19515910|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19515911|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19515912|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19515913|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19515914|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515915|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515916|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19515917|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515918|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
19515919|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20099281|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20099282|NCT00002787|Analgesics|analgesics|mesh-ancestor
20099283|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
20099284|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099285|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20099286|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20099287|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
20603461|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603462|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603463|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603464|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20603465|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20603466|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20099288|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099289|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20099290|NCT00002788|Dexamethasone|dexamethasone|mesh-list
20099291|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
20099292|NCT00002788|Etoposide|etoposide|mesh-list
20099293|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099294|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
20099295|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099296|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099297|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099298|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
20099299|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099300|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099301|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099302|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20099303|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
20099304|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
20099305|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099306|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20099307|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
20099308|NCT00002788|Hormones|hormones|mesh-ancestor
20099309|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099310|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099311|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099312|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099313|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099314|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099315|NCT00002789|Cyclosporine|cyclosporine|mesh-list
20099316|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
20099317|NCT00002789|Busulfan|busulfan|mesh-list
20099318|NCT00002789|Methotrexate|methotrexate|mesh-list
20099319|NCT00002789|Cyclosporins|cyclosporins|mesh-list
20099320|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099321|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
20099322|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515920|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
19515921|NCT02987998|Etoposide|etoposide|mesh-list
19515922|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099323|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099324|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099325|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
19515923|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19515924|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19515925|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19515926|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19515927|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515928|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515929|NCT02988440|Sorafenib|sorafenib|mesh-list
19515930|NCT02988440|Spartalizumab|spartalizumab|mesh-list
19515931|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515932|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19515933|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515934|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515935|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19515936|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19515937|NCT02988089|Amoxicillin|amoxicillin|mesh-list
19515938|NCT02988089|Metronidazole|metronidazole|mesh-list
19515939|NCT02988089|Clarithromycin|clarithromycin|mesh-list
19515940|NCT02988089|Levofloxacin|levofloxacin|mesh-list
19515941|NCT02988089|Ofloxacin|ofloxacin|mesh-list
19515942|NCT02988089|Tetracycline|tetracycline|mesh-list
19515943|NCT02988089|Tinidazole|tinidazole|mesh-list
19515944|NCT02988089|Furazolidone|furazolidone|mesh-list
19515945|NCT02988089|Bismuth|bismuth|mesh-list
19515946|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19515947|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515948|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19515949|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19515950|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19515951|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19515952|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099326|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099327|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099328|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099329|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099330|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099331|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099332|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099333|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
20099334|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099335|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099336|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099337|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099338|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
20099339|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19515953|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19515954|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19515955|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19515956|NCT02988089|Renal Agents|renal agents|mesh-ancestor
19515957|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19515958|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19515959|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515960|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19515961|NCT02988089|Antacids|antacids|mesh-ancestor
19515962|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19515963|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
19515964|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19515965|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19515966|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19515967|NCT02988063|Polidocanol|polidocanol|mesh-list
19515968|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19515969|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19515970|NCT02987985|Acetaminophen|acetaminophen|mesh-list
19515971|NCT02987985|Dexamethasone|dexamethasone|mesh-list
19515972|NCT02987985|Lidocaine|lidocaine|mesh-list
19515973|NCT02987985|Fentanyl|fentanyl|mesh-list
19515974|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
19515975|NCT02987985|Ketamine|ketamine|mesh-list
19515976|NCT02987985|Gabapentin|gabapentin|mesh-list
19515977|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
19515978|NCT02987985|Ondansetron|ondansetron|mesh-list
19515979|NCT02987985|Sevoflurane|sevoflurane|mesh-list
20099340|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20099341|NCT00002790|Cyclosporine|cyclosporine|mesh-list
20099342|NCT00002790|Sirolimus|sirolimus|mesh-list
19515980|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20099343|NCT00002790|Methotrexate|methotrexate|mesh-list
19515981|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
19515982|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
19515983|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19515984|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19515985|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19515986|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
19515987|NCT02987985|Hormones|hormones|mesh-ancestor
19515988|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19515989|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19515990|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19515991|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
19515992|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
19515993|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19515994|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
19515995|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20099344|NCT00002790|Cyclosporins|cyclosporins|mesh-list
20099345|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099346|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
19515996|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20099347|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099348|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099349|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099350|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
20603467|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19515997|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19515998|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19515999|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516000|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19516001|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516002|NCT02987985|Analgesics|analgesics|mesh-ancestor
19516003|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19516004|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19516005|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19516006|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
19516007|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516008|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19516009|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19516010|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
19516011|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19516012|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19516013|NCT02987985|Narcotics|narcotics|mesh-ancestor
19516014|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19516015|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
19516016|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19516017|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19516018|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
19516019|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19516020|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19516021|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19516022|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
19516023|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
19516024|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516025|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19516026|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
19516027|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19516028|NCT02987920|Acetaminophen|acetaminophen|mesh-list
19516029|NCT02987920|Celecoxib|celecoxib|mesh-list
19516030|NCT02987920|Ketorolac|ketorolac|mesh-list
19516031|NCT02987920|Oxycodone|oxycodone|mesh-list
19516032|NCT02987920|Gabapentin|gabapentin|mesh-list
19516033|NCT02987920|Hydromorphone|hydromorphone|mesh-list
19516034|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
19516035|NCT02987920|Pantoprazole|pantoprazole|mesh-list
19516036|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516037|NCT02987920|Analgesics|analgesics|mesh-ancestor
19516038|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
19516039|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516040|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516041|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
19516042|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19516043|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516044|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516045|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19516046|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516047|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516048|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516049|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19516050|NCT02987920|Narcotics|narcotics|mesh-ancestor
19516051|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20099351|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099352|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099353|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099354|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099355|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099356|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099357|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
20099358|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099359|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19516052|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
20099360|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
20099361|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099362|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20099363|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20099364|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099365|NCT00002791|Doxorubicin|doxorubicin|mesh-list
20099366|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099367|NCT00002791|Ifosfamide|ifosfamide|mesh-list
20099368|NCT00002791|Dacarbazine|dacarbazine|mesh-list
19516053|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19516054|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19516055|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19516056|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19516057|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19516058|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516059|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
19516060|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19516061|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516062|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19516063|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
19516064|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
19516065|NCT02987907|Dexamethasone|dexamethasone|mesh-list
19516066|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516067|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
19516068|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
19516069|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516070|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516071|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516072|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
19516073|NCT02987907|Hormones|hormones|mesh-ancestor
19516074|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516075|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19516076|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516077|NCT02987751|Insulin|insulin|mesh-list
19516078|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
19516079|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516080|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516081|NCT02987699|Leucovorin|leucovorin|mesh-list
19516082|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
19516083|NCT02987699|Fluorouracil|fluorouracil|mesh-list
19516084|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
19516085|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516086|NCT02987699|Antidotes|antidotes|mesh-ancestor
19516087|NCT02987699|Protective Agents|protective agents|mesh-ancestor
19516088|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516089|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
19516090|NCT02987699|Vitamins|vitamins|mesh-ancestor
19516091|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
19516092|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
19516093|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516094|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19516095|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516096|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
19516097|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
19516098|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20099369|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099370|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099371|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099372|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099373|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099374|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099375|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20603468|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19516099|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516100|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516101|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516102|NCT02987556|Insulin|insulin|mesh-list
19516103|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516104|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516105|NCT02987465|Norepinephrine|norepinephrine|mesh-list
19516106|NCT02987465|Acetylcholine|acetylcholine|mesh-list
19516107|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
19516108|NCT02987465|Hematinics|hematinics|mesh-ancestor
19516109|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19516110|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19516111|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
19516112|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20099376|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
20099377|NCT00002792|Cyclosporine|cyclosporine|mesh-list
20099378|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
20099379|NCT00002792|Busulfan|busulfan|mesh-list
20099380|NCT00002792|Methotrexate|methotrexate|mesh-list
20099381|NCT00002792|Tacrolimus|tacrolimus|mesh-list
20099382|NCT00002792|Cyclosporins|cyclosporins|mesh-list
20099383|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099384|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
20099385|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099386|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099387|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099388|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
20099389|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099390|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099391|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19516113|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516114|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516115|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
19516116|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
19516117|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516118|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19516119|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
19516120|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19516121|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
19516122|NCT02987400|Venetoclax|venetoclax|mesh-list
19516123|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
19516124|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516125|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19516126|NCT02987218|Propofol|propofol|mesh-list
19516127|NCT02987218|Desflurane|desflurane|mesh-list
19516128|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19516129|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516130|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516131|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19516132|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
19516133|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
19516134|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19516135|NCT02987270|Piperaquine|piperaquine|mesh-list
19516136|NCT02987270|Artenimol|artenimol|mesh-list
19516137|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
19516138|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19516139|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19516140|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516141|NCT02987244|Prednisone|prednisone|mesh-list
19516142|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
19516143|NCT02987244|Etoposide|etoposide|mesh-list
20099392|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099393|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099394|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099395|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099396|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
20099397|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099398|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099399|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099400|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099401|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19516144|NCT02987244|Epirubicin|epirubicin|mesh-list
19516145|NCT02987244|Vindesine|vindesine|mesh-list
19516146|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516147|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
19516148|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516149|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516150|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19516151|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
19516152|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516153|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099402|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
19516154|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19516155|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516156|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
19516157|NCT02987244|Hormones|hormones|mesh-ancestor
19516158|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516159|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19516160|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19516161|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19516162|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19516163|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516164|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19516165|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
19516166|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
19516167|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
19516168|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
19516169|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19516170|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516171|NCT02987348|Insulin|insulin|mesh-list
19516172|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19516173|NCT02987348|Exenatide|exenatide|mesh-list
19516174|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
19516175|NCT02987348|Glucagon|glucagon|mesh-list
19516176|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19516177|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516178|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516179|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19516180|NCT02987348|Incretins|incretins|mesh-ancestor
19516181|NCT02987348|Hormones|hormones|mesh-ancestor
19516182|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516183|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516184|NCT02986685|Rabeprazole|rabeprazole|mesh-list
19516185|NCT02986685|Trimebutine|trimebutine|mesh-list
19516186|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516187|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516188|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19516189|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516190|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19516191|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
19516192|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
19516193|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516194|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516195|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19516196|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19516197|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
19516198|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19516199|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19516200|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19516201|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19516202|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516203|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
19516204|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516205|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516206|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19516207|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516208|NCT02986906|Triamcinolone|triamcinolone|mesh-list
19516209|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516210|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
19516211|NCT02986906|Hormones|hormones|mesh-ancestor
19516212|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516213|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572073|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19572074|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19572075|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
19572076|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19572077|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19572078|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
19572079|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572080|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
19572081|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19572082|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19577915|NCT03817853|Doxorubicin|doxorubicin|mesh-list
19577916|NCT03817853|Vincristine|vincristine|mesh-list
19577917|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
19577918|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577919|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
19516214|NCT02986347|Epinephrine|epinephrine|mesh-list
19516215|NCT02986347|Racepinephrine|racepinephrine|mesh-list
19516216|NCT02986347|Anesthetics|anesthetics|mesh-list
19516217|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
19516218|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516219|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516220|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19516221|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19516222|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
19516223|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516224|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516225|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19516226|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19516227|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
19516228|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516229|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19516230|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
19516231|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
19516232|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
19516233|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19516234|NCT02986503|Cisplatin|cisplatin|mesh-list
19516235|NCT02986503|Doxorubicin|doxorubicin|mesh-list
19516236|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19516237|NCT02986503|Methotrexate|methotrexate|mesh-list
19516238|NCT02986503|Ifosfamide|ifosfamide|mesh-list
19516239|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
19516240|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516241|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19516242|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19516243|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19516244|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516245|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516246|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19516247|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
19516248|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19516249|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516250|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19516251|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
20099403|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099404|NCT00002793|Leucovorin|leucovorin|mesh-list
20099405|NCT00002793|Fluorouracil|fluorouracil|mesh-list
20099406|NCT00002793|Calcium|calcium|mesh-list
20099407|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
20099408|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20099409|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099410|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
20099411|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516252|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516253|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19516254|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516255|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
19516256|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516257|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19516258|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19516259|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
19516260|NCT02986451|Clarithromycin|clarithromycin|mesh-list
19516261|NCT02986451|Dexamethasone|dexamethasone|mesh-list
19516262|NCT02986451|Lenalidomide|lenalidomide|mesh-list
19516263|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516264|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
19516265|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
19516266|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516267|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516268|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516269|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
19516270|NCT02986451|Hormones|hormones|mesh-ancestor
19516271|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516272|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19516273|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516274|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
20099412|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099413|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516275|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19516276|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19516277|NCT02986451|Growth Substances|growth substances|mesh-ancestor
19516278|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
19516279|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19516280|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516281|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19516282|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516283|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516284|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19516285|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19516286|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
19516287|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19516288|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516289|NCT02986334|Naproxen|naproxen|mesh-list
19516290|NCT02986334|Omeprazole|omeprazole|mesh-list
19516291|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19516292|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516293|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19516294|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516295|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516296|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19516297|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516298|NCT02986334|Analgesics|analgesics|mesh-ancestor
19516299|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
19516300|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516301|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516302|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516303|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516304|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
19516305|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516306|NCT02986321|Budesonide|budesonide|mesh-list
19516307|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516308|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20099414|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099415|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
20099416|NCT00002793|Antidotes|antidotes|mesh-ancestor
20099417|NCT00002793|Protective Agents|protective agents|mesh-ancestor
20099418|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
20099419|NCT00002793|Vitamins|vitamins|mesh-ancestor
19516309|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
19516310|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516311|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516312|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19516313|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
19516314|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
19516315|NCT02986321|Hormones|hormones|mesh-ancestor
19516316|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516317|NCT02986594|Aspirin|aspirin|mesh-list
19516318|NCT02986594|Heparin|heparin|mesh-list
19516319|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19516320|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516321|NCT02986594|Analgesics|analgesics|mesh-ancestor
19516322|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
19516323|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516324|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516325|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516326|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516327|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19516328|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19516329|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516330|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19516331|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516332|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516333|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
19516334|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
19516335|NCT02986100|Rucaparib|rucaparib|mesh-list
19516336|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19516337|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516338|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516339|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516340|NCT02985736|Desoximetasone|desoximetasone|mesh-list
19516341|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516342|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
19516343|NCT02985736|Hormones|hormones|mesh-ancestor
20099420|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
20099421|NCT00002794|Carboplatin|carboplatin|mesh-list
19572083|NCT02704494|Losartan|losartan|mesh-list
20099422|NCT00002794|Vincristine|vincristine|mesh-list
20099423|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516344|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516345|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516346|NCT02985697|Midazolam|midazolam|mesh-list
19516347|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
19516348|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
20099424|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099425|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099426|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099427|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
19516349|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19516350|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516351|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516352|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516353|NCT02985697|Analgesics|analgesics|mesh-ancestor
19516354|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
19516355|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516356|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19516357|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19516358|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19516359|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
19516360|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516361|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516362|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19516363|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19516364|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19516365|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19516366|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19516367|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
19516368|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
19516369|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
19516370|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
19516371|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19516372|NCT02985866|Pancrelipase|pancrelipase|mesh-list
19516373|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516374|NCT02985983|Brodalumab|brodalumab|mesh-list
19516375|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516376|NCT02985749|Oxytocin|oxytocin|mesh-list
19516377|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
19516378|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19516379|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516380|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
19516381|NCT02985905|Astringents|astringents|mesh-ancestor
19516382|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516383|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516384|NCT02985658|Cisplatin|cisplatin|mesh-list
19516385|NCT02985658|Vinorelbine|vinorelbine|mesh-list
19516386|NCT02985658|Veliparib|veliparib|mesh-list
19516387|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516388|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19516389|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
19516390|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
19516391|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
19516392|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516393|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19516394|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516395|NCT02985671|Acetaminophen|acetaminophen|mesh-list
19516396|NCT02985671|Diclofenac|diclofenac|mesh-list
19516397|NCT02985671|Orphenadrine|orphenadrine|mesh-list
19516398|NCT02985671|Caffeine|caffeine|mesh-list
19516399|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20099428|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099429|NCT00002796|Interferons|interferons|mesh-list
20099430|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
20099431|NCT00002796|Indomethacin|indomethacin|mesh-list
20099432|NCT00002796|Fluorouracil|fluorouracil|mesh-list
20099433|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19516400|NCT02985671|Analgesics|analgesics|mesh-ancestor
19516401|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
19516402|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516403|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516404|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
19516405|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19516406|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516407|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516408|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516409|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516410|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099434|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
19516411|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19516412|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20099435|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099436|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099437|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516413|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19516414|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19516415|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
19516416|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516417|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19516418|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19516419|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19516420|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19516421|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
19516422|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
19516423|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19516424|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19516425|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
19516426|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
19516427|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19516428|NCT02985593|KHK4083|khk4083|mesh-list
19516429|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516430|NCT02985606|Caffeine|caffeine|mesh-list
19516431|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19516432|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516433|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19516434|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516435|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516436|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19516437|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19516438|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
19516439|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516440|NCT02985229|Misoprostol|misoprostol|mesh-list
19516441|NCT02985229|Mifepristone|mifepristone|mesh-list
19516442|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19516443|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
19516444|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19516445|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516446|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19516447|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516448|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
19516449|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19516450|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19516451|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19516452|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19516453|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
19516454|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19516455|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19516456|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
19516457|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516458|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
19516459|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19516460|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19516461|NCT02985372|Cytarabine|cytarabine|mesh-list
19516462|NCT02985372|Decitabine|decitabine|mesh-list
19516463|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19516464|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
19516465|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516466|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516467|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
19516468|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516469|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516470|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
19516471|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516472|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516473|NCT02985216|Pregabalin|pregabalin|mesh-list
19516474|NCT02985216|Analgesics|analgesics|mesh-ancestor
19516475|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
19516476|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516477|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516478|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
19516479|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20099438|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099439|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
20099440|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516480|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19516481|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516482|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19516483|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19516484|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19516485|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516486|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19516487|NCT02985333|Dexamethasone|dexamethasone|mesh-list
19516488|NCT02985333|Paclitaxel|paclitaxel|mesh-list
19516489|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
19516490|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19516491|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516492|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
19516493|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
19516494|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
19516495|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516496|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516497|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
19516498|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516499|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516500|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19516501|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
19516502|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19516503|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516504|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
19516505|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
19516506|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516507|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516508|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
19516509|NCT02985333|Hormones|hormones|mesh-ancestor
20099441|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
20099442|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603469|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20603470|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603471|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
20603472|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19516510|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099443|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20099444|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20099445|NCT00002796|Analgesics|analgesics|mesh-ancestor
20099446|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
20099447|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099448|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20099449|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099450|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
20099451|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
19516511|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19516512|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19516513|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
19516514|NCT02985190|Azacitidine|azacitidine|mesh-list
19516515|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19516516|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
19516517|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516518|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516519|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516520|NCT02985177|Ibuprofen|ibuprofen|mesh-list
19516521|NCT02985177|Fentanyl|fentanyl|mesh-list
19516522|NCT02985177|Hydromorphone|hydromorphone|mesh-list
19516523|NCT02985177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19516524|NCT02985177|Narcotics|narcotics|mesh-ancestor
19516525|NCT02985177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516526|NCT02985177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516527|NCT02985177|Analgesics|analgesics|mesh-ancestor
19516528|NCT02985177|Sensory System Agents|sensory system agents|mesh-ancestor
19516529|NCT02985177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516530|NCT02985177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19516531|NCT02985177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19516532|NCT02985177|Anesthetics, General|anesthetics, general|mesh-ancestor
19516533|NCT02985177|Anesthetics|anesthetics|mesh-ancestor
20099452|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19516534|NCT02985177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20099453|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20603473|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
20099454|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099455|NCT00002798|Cytarabine|cytarabine|mesh-list
20099456|NCT00002798|Aldesleukin|aldesleukin|mesh-list
19516535|NCT02985177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516536|NCT02985177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516537|NCT02985177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516538|NCT02985177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516539|NCT02985177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516540|NCT02985177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516541|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19516542|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19516543|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516544|NCT02985255|Docetaxel|docetaxel|mesh-list
19516545|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516546|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
19516547|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
19516548|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
19516549|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516550|NCT02985203|Vinorelbine|vinorelbine|mesh-list
19516551|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19516552|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516553|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
19516554|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
19516555|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
19516556|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516557|NCT02985554|Nivolumab|nivolumab|mesh-list
19516558|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19516559|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516560|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19516561|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516562|NCT02985242|Empagliflozin|empagliflozin|mesh-list
19516563|NCT02985242|Glimepiride|glimepiride|mesh-list
19516564|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19516565|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516566|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516567|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516568|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19516569|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516570|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
19516571|NCT02985281|Ribavirin|ribavirin|mesh-list
19516572|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
19516573|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
19516574|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516575|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
19516576|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516577|NCT02985125|Everolimus|everolimus|mesh-list
19516578|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516579|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516580|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
19516581|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516582|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19516583|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19516584|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19516585|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
19516586|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516587|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19516588|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19516589|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516590|NCT02984930|Esomeprazole|esomeprazole|mesh-list
19516591|NCT02984930|Mosapride|mosapride|mesh-list
19516592|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19516593|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516594|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19516595|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516596|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516597|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19516598|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
19516599|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516600|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572084|NCT02704494|Resveratrol|resveratrol|mesh-list
19572085|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20099457|NCT00002798|Dexamethasone|dexamethasone|mesh-list
19572086|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20099458|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
20099459|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19516601|NCT02985086|Cefoxitin|cefoxitin|mesh-list
19516602|NCT02985086|Misoprostol|misoprostol|mesh-list
19516603|NCT02985086|Oxytocin|oxytocin|mesh-list
19516604|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
19516605|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19516606|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516607|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19516608|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
19516609|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19516610|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516611|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19516612|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516613|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
19516614|NCT02984865|Sufentanil|sufentanil|mesh-list
19516615|NCT02984865|Nalbuphine|nalbuphine|mesh-list
19516616|NCT02984865|Dsuvia|dsuvia|mesh-list
19516617|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19516618|NCT02984865|Narcotics|narcotics|mesh-ancestor
19516619|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516620|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516621|NCT02984865|Analgesics|analgesics|mesh-ancestor
19516622|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
19516623|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516624|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19516625|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19516626|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
19516627|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
19516628|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19516629|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516630|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516631|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099460|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20099461|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20099462|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
20099463|NCT00002798|Busulfan|busulfan|mesh-list
20099464|NCT00002798|Methotrexate|methotrexate|mesh-list
19516632|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516633|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516634|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516635|NCT02984852|Tenofovir|tenofovir|mesh-list
19516636|NCT02984852|Emtricitabine|emtricitabine|mesh-list
19516637|NCT02984852|Darunavir|darunavir|mesh-list
19516638|NCT02984852|Cobicistat|cobicistat|mesh-list
19516639|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
19516640|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516641|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19516642|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19516643|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516644|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516645|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19516646|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19516647|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19516648|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19516649|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
19516650|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19516651|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19516652|NCT02984722|Metformin|metformin|mesh-list
19516653|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516654|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516655|NCT02984696|Estradiol|estradiol|mesh-list
19516656|NCT02984696|Estrogens|estrogens|mesh-ancestor
19516657|NCT02984696|Hormones|hormones|mesh-ancestor
19516658|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516659|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516660|NCT02984657|Anesthetics|anesthetics|mesh-list
19516661|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516662|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516663|NCT02984345|Caseins|caseins|mesh-list
19516664|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
19516665|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
19516666|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516667|NCT02984475|Metformin|metformin|mesh-list
19516668|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516669|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516670|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
19516671|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
19577920|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099465|NCT00002798|Fludarabine|fludarabine|mesh-list
20099466|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
19516672|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516673|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
19516674|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516675|NCT02984397|Ketotifen|ketotifen|mesh-list
19516676|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
19516677|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516678|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19516679|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
19516680|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
19516681|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516682|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516683|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516684|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19516685|NCT02984293|Atorvastatin|atorvastatin|mesh-list
19516686|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19516687|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19516688|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
19516689|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516690|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19516691|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19516692|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516693|NCT02984176|Simethicone|simethicone|mesh-list
19516694|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
19516695|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516696|NCT02984176|Emollients|emollients|mesh-ancestor
19516697|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516698|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
19516699|NCT02984111|Hematinics|hematinics|mesh-ancestor
19516700|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
19516701|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19516702|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
19516703|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516704|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
19516705|NCT02984228|Protective Agents|protective agents|mesh-ancestor
19516706|NCT02984072|Menthol|menthol|mesh-list
19516707|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
19516708|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516709|NCT02983591|Misoprostol|misoprostol|mesh-list
19516710|NCT02983591|Oxytocin|oxytocin|mesh-list
19516711|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
19516712|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19516713|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516714|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19516715|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
19516716|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19516717|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516718|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19516719|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
19516720|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516721|NCT02983682|Lidocaine|lidocaine|mesh-list
19516722|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
19516723|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
19516724|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516725|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099467|NCT00002798|Etoposide|etoposide|mesh-list
20099468|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
20099469|NCT00002798|Daunorubicin|daunorubicin|mesh-list
20099470|NCT00002798|Interleukin-2|interleukin-2|mesh-list
20099471|NCT00002798|Asparaginase|asparaginase|mesh-list
20099472|NCT00002798|Idarubicin|idarubicin|mesh-list
20099473|NCT00002798|Thioguanine|thioguanine|mesh-list
20099474|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099475|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
20099476|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099477|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099478|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099479|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
20099480|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099481|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099482|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099483|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20099484|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
20099485|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
20099486|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516726|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
19516727|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099487|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20099488|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
19516728|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19516729|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19516730|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19516731|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19516732|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516733|NCT02983773|Dronabinol|dronabinol|mesh-list
19516734|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
19516735|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516736|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19516737|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516738|NCT02983773|Analgesics|analgesics|mesh-ancestor
19516739|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
19516740|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516741|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19516742|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19516743|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516744|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516745|NCT02983773|Hormones|hormones|mesh-ancestor
19516746|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516747|NCT02983734|Cycloserine|cycloserine|mesh-list
19516748|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19516749|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516750|NCT02983734|Renal Agents|renal agents|mesh-ancestor
19516751|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19516752|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
19516753|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19516754|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
19516755|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516756|NCT02983630|Penicillins|penicillins|mesh-list
19516757|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19516758|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516766|NCT02983214|Cilostazol|cilostazol|mesh-list
19516767|NCT02983214|Clopidogrel|clopidogrel|mesh-list
19516768|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19516769|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19516770|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19516771|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19516772|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
19516773|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516774|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516775|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516776|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19516777|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
19516778|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516779|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19516780|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
20099489|NCT00002798|Hormones|hormones|mesh-ancestor
20099490|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099491|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099492|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099493|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099494|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099495|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099496|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
20099497|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099498|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099499|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099500|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19516781|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19516782|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19516783|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
19516784|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19516785|NCT02983214|Protective Agents|protective agents|mesh-ancestor
19516786|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20099501|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19516787|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19516788|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516789|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
19516790|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19516791|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516792|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516793|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19572087|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19572088|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19572089|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572090|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
19572091|NCT02704494|Protective Agents|protective agents|mesh-ancestor
19572092|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572093|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572094|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19572095|NCT02704520|Leucovorin|leucovorin|mesh-list
20603474|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20603475|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603476|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
20603477|NCT02221154|Folic Acid|folic acid|mesh-list
20603478|NCT02221154|Hematinics|hematinics|mesh-ancestor
20603479|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
20603480|NCT02221154|Vitamins|vitamins|mesh-ancestor
20603481|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
20603482|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603483|NCT02221180|Metformin|metformin|mesh-list
20603484|NCT02221180|Canagliflozin|canagliflozin|mesh-list
20603485|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603486|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603487|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20603488|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603489|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
20603490|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603491|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603492|NCT02221375|Ciclesonide|ciclesonide|mesh-list
20603493|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
20603494|NCT02221375|Hormones|hormones|mesh-ancestor
19572096|NCT02704520|Folic Acid|folic acid|mesh-list
19572097|NCT02704520|Fluorouracil|fluorouracil|mesh-list
19572098|NCT02704520|Capecitabine|capecitabine|mesh-list
19572099|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
19572100|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
19572101|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572102|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
19572103|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572104|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19572105|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099502|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20603495|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572106|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572107|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
19572108|NCT02704520|Antidotes|antidotes|mesh-ancestor
19572109|NCT02704520|Protective Agents|protective agents|mesh-ancestor
19572110|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
19572111|NCT02704520|Vitamins|vitamins|mesh-ancestor
19572112|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
19572113|NCT02704520|Hematinics|hematinics|mesh-ancestor
19572114|NCT02704208|Nicotine|nicotine|mesh-list
19572115|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19572116|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
19572117|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572118|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572119|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19572120|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19572121|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
19572122|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572123|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572124|NCT02704507|Triamcinolone|triamcinolone|mesh-list
19572125|NCT02704507|Tretinoin|tretinoin|mesh-list
19572126|NCT02704507|Emollients|emollients|mesh-list
19572127|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572128|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
19572129|NCT02704507|Hormones|hormones|mesh-ancestor
20603496|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603497|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19572130|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572131|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120414|NCT00006358|Thalidomide|thalidomide|mesh-list
19516794|NCT02983344|Fentanyl|fentanyl|mesh-list
20099503|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099504|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
20099505|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099506|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099507|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20099508|NCT00002798|Analgesics|analgesics|mesh-ancestor
20099509|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
20099510|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20099511|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20099512|NCT00002800|Cytarabine|cytarabine|mesh-list
20099513|NCT00002800|Etoposide|etoposide|mesh-list
20099514|NCT00002800|Idarubicin|idarubicin|mesh-list
19516795|NCT02983344|Ropivacaine|ropivacaine|mesh-list
19516796|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
20099515|NCT00002800|Lintuzumab|lintuzumab|mesh-list
20099516|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099517|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099518|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099519|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099520|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099521|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099522|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099523|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
20099524|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
20099525|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099526|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099527|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
20099528|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099529|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099530|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20099531|NCT00002801|Leucovorin|leucovorin|mesh-list
20099532|NCT00002801|Tegafur|tegafur|mesh-list
19516797|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
19516798|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516799|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516800|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
19516801|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516802|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19516803|NCT02983344|Narcotics|narcotics|mesh-ancestor
19516804|NCT02983344|Analgesics|analgesics|mesh-ancestor
19516805|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19516806|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19516807|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
19516808|NCT02983084|Copper|copper|mesh-list
19516809|NCT02983084|Nickel|nickel|mesh-list
19516810|NCT02983084|Trace Elements|trace elements|mesh-ancestor
19516811|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
19516812|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516813|NCT02983422|Aminophylline|aminophylline|mesh-list
19516814|NCT02983422|Furosemide|furosemide|mesh-list
19516815|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19516816|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
19516817|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516818|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516819|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19516820|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
19516821|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19516822|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19516823|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516824|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516825|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19516826|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19516827|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
19516828|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516829|NCT02983422|Protective Agents|protective agents|mesh-ancestor
20099533|NCT00002801|Calcium|calcium|mesh-list
20099534|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
20099535|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20120415|NCT00006358|Temozolomide|temozolomide|mesh-list
19516830|NCT02983422|Diuretics|diuretics|mesh-ancestor
19516831|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
19516832|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19516833|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19516834|NCT02983097|Cytarabine|cytarabine|mesh-list
19516835|NCT02983097|Dexamethasone|dexamethasone|mesh-list
19516836|NCT02983097|Rituximab|rituximab|mesh-list
19516837|NCT02983097|Carboplatin|carboplatin|mesh-list
19516838|NCT02983097|Lenalidomide|lenalidomide|mesh-list
19516839|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516840|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19516841|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
19516842|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516843|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516844|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516845|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
20099536|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099537|NCT00002801|Antidotes|antidotes|mesh-ancestor
20099538|NCT00002801|Protective Agents|protective agents|mesh-ancestor
20099539|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
20099540|NCT00002801|Vitamins|vitamins|mesh-ancestor
20099541|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
20603498|NCT02221401|Metformin|metformin|mesh-list
20603499|NCT02221401|Linagliptin|linagliptin|mesh-list
19516846|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
19516847|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516848|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19516849|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
19516850|NCT02983097|Hormones|hormones|mesh-ancestor
19516851|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19516852|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19516853|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19516854|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
19516855|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516856|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
19516857|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516858|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19516859|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19516860|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19516861|NCT02983097|Growth Substances|growth substances|mesh-ancestor
19516862|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
19516863|NCT02983383|Anesthetics|anesthetics|mesh-list
19516864|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516865|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516866|NCT02982798|Metformin|metformin|mesh-list
19516867|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19516868|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516869|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516870|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19516871|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19516872|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
19516873|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516874|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19516875|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19516876|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516877|NCT02982889|Bupivacaine|bupivacaine|mesh-list
19516878|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
19516879|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19516880|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
19516881|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516882|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516883|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
19516884|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516885|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19516886|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
19516887|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
19516888|NCT02982889|Protective Agents|protective agents|mesh-ancestor
19516889|NCT02982694|Bevacizumab|bevacizumab|mesh-list
19516890|NCT02982694|Atezolizumab|atezolizumab|mesh-list
19516891|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19516892|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516893|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19516894|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20099542|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099543|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
20120416|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20603500|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516895|NCT02982694|Growth Substances|growth substances|mesh-ancestor
19516896|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516897|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
19516898|NCT02982850|Aspirin|aspirin|mesh-list
19516899|NCT02982850|Warfarin|warfarin|mesh-list
19516900|NCT02982850|Dabigatran|dabigatran|mesh-list
19516901|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19516902|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516903|NCT02982850|Analgesics|analgesics|mesh-ancestor
19516904|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
19516905|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516906|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516907|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516908|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516909|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19516910|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19516911|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516912|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19516913|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516914|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516915|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
19516916|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
19516917|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
19516918|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19516919|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
19516920|NCT02982551|Insulin|insulin|mesh-list
19516921|NCT02982551|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19516922|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19516923|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516924|NCT02982486|Nivolumab|nivolumab|mesh-list
19516925|NCT02982486|Ipilimumab|ipilimumab|mesh-list
19516926|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19516927|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516928|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19516929|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516930|NCT02982577|Pilocarpine|pilocarpine|mesh-list
20099544|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099545|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099546|NCT00002802|Cobalt|cobalt|mesh-list
20099547|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
20099548|NCT00002802|Melphalan|melphalan|mesh-list
20099549|NCT00002802|Ifosfamide|ifosfamide|mesh-list
20099550|NCT00002802|Dacarbazine|dacarbazine|mesh-list
20099551|NCT00002802|Carboplatin|carboplatin|mesh-list
20099552|NCT00002802|Doxorubicin|doxorubicin|mesh-list
20099553|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099554|NCT00002802|Etoposide|etoposide|mesh-list
20099555|NCT00002802|Vincristine|vincristine|mesh-list
20099556|NCT00002802|Vindesine|vindesine|mesh-list
20099557|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099558|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
19516931|NCT02982577|Miotics|miotics|mesh-ancestor
19516932|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
19516933|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516934|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516935|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19516936|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19516937|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
19516938|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516939|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516940|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
19516941|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19516942|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516943|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516944|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516945|NCT02982512|Analgesics|analgesics|mesh-ancestor
19516946|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
19516947|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516948|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19516949|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19516950|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19516951|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
19516952|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516953|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516954|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
20099559|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099560|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120417|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
19516955|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19516956|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19516957|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516958|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
19516959|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19516960|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516961|NCT02982161|Celecoxib|celecoxib|mesh-list
19516962|NCT02982161|Tramadol|tramadol|mesh-list
19516963|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19516964|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19516965|NCT02982161|Analgesics|analgesics|mesh-ancestor
19516966|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
19516967|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19516968|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516969|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19516970|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19516971|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19516972|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19516973|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516974|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516975|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19516976|NCT02982161|Narcotics|narcotics|mesh-ancestor
19516977|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516978|NCT02982395|Ethanol|ethanol|mesh-list
19516979|NCT02982395|Docetaxel|docetaxel|mesh-list
19516980|NCT02982395|Mitomycins|mitomycins|mesh-list
19516981|NCT02982395|Mitomycin|mitomycin|mesh-list
19516982|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19516983|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
19516984|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
19516985|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
19516986|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19516987|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19516988|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
19516989|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19516990|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516991|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19516992|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19516993|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19516994|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19516995|NCT02982005|Brodalumab|brodalumab|mesh-list
19516996|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
19516997|NCT02982148|Methylene Blue|methylene blue|mesh-list
19516998|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19516999|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099561|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099562|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
19517000|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19517001|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
19517002|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19517003|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517004|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19517005|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517006|NCT02981979|Prednisone|prednisone|mesh-list
19517007|NCT02981979|Leflunomide|leflunomide|mesh-list
19517008|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19517009|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
19517010|NCT02981979|Hormones|hormones|mesh-ancestor
19517011|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517012|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517013|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19517014|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517015|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517016|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517017|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517018|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
19517019|NCT02981836|Vaccines|vaccines|mesh-list
19517020|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
19517021|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517022|NCT02981784|Ponatinib|ponatinib|mesh-list
19517023|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517024|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19517025|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099563|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517026|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517027|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
19517028|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517029|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572132|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572133|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
19572134|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
19572135|NCT02703857|Cefoxitin|cefoxitin|mesh-list
19572136|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572137|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572138|NCT02704052|Enoxaparin|enoxaparin|mesh-list
19572139|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
19572140|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
19572141|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19572142|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19572143|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572144|NCT02703896|Esomeprazole|esomeprazole|mesh-list
19572145|NCT02703896|Omeprazole|omeprazole|mesh-list
19572146|NCT02703896|Pantoprazole|pantoprazole|mesh-list
19572147|NCT02703896|Lansoprazole|lansoprazole|mesh-list
19572148|NCT02703896|Famotidine|famotidine|mesh-list
19572149|NCT02703896|Ranitidine|ranitidine|mesh-list
19572150|NCT02703896|Cimetidine|cimetidine|mesh-list
19572151|NCT02703896|Nizatidine|nizatidine|mesh-list
19572152|NCT02703896|Lafutidine|lafutidine|mesh-list
19572153|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19572154|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572155|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19572156|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572157|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572158|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19572159|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
19572160|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
19572161|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572162|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572163|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19572164|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19572165|NCT02704013|Oxybutynin|oxybutynin|mesh-list
19572166|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
19572167|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
19572168|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572169|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572170|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19572171|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19572172|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
20099564|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099565|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099566|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099567|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099568|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099569|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099570|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099571|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099572|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
19572173|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572174|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572175|NCT02704013|Urological Agents|urological agents|mesh-ancestor
19572176|NCT02703961|Cisplatin|cisplatin|mesh-list
19572177|NCT02703961|Docetaxel|docetaxel|mesh-list
19572178|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572179|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
19572180|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
19572181|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
19572182|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572183|NCT02703649|Letrozole|letrozole|mesh-list
19572184|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572185|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19572186|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19572187|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572188|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099573|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099574|NCT00002802|Trace Elements|trace elements|mesh-ancestor
19572189|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19572190|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
19572191|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572192|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572193|NCT02703571|Trametinib|trametinib|mesh-list
19517030|NCT02981719|Gemcitabine|gemcitabine|mesh-list
19517031|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19517032|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
19517033|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517034|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517035|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
19517036|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517037|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099575|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
20099576|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
20099577|NCT00002803|Doxorubicin|doxorubicin|mesh-list
20099578|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099579|NCT00002803|Vincristine|vincristine|mesh-list
20099580|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517038|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517039|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
19517040|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517041|NCT02981615|Levofloxacin|levofloxacin|mesh-list
19517042|NCT02981615|Ofloxacin|ofloxacin|mesh-list
19517043|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19517044|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517045|NCT02981615|Renal Agents|renal agents|mesh-ancestor
19517046|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517047|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19517048|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19517049|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517050|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517051|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517052|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19517053|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19517054|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19517055|NCT02981446|Latanoprost|latanoprost|mesh-list
19517056|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19517057|NCT02981329|Metformin|metformin|mesh-list
19517058|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19517059|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517060|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
19517061|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19517062|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517063|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19517064|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
20099581|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
20099582|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099583|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099584|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099585|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
20099586|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099587|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099588|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099589|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099590|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099591|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099592|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099593|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099594|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099595|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099596|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517065|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517066|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517067|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517068|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517069|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
19517070|NCT02981212|Prednisolone|prednisolone|mesh-list
19517071|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19517072|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099597|NCT00002804|Cobalt|cobalt|mesh-list
20099598|NCT00002804|Doxorubicin|doxorubicin|mesh-list
20099599|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099600|NCT00002804|Vincristine|vincristine|mesh-list
20099601|NCT00002804|Ifosfamide|ifosfamide|mesh-list
20099602|NCT00002804|Lenograstim|lenograstim|mesh-list
20099603|NCT00002804|Sargramostim|sargramostim|mesh-list
19517073|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517074|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19517075|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
20099604|NCT00002804|Mesna|mesna|mesh-list
20099605|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19517076|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517077|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517078|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517079|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517080|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19517081|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
19517082|NCT02981212|Hormones|hormones|mesh-ancestor
19517083|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517084|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517085|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19517086|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
19517087|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
19517088|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517089|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517090|NCT02981264|Lidocaine|lidocaine|mesh-list
19517091|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
19517092|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
19517093|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517094|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517095|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
19517096|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517097|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19517098|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19517099|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19517100|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19517101|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099606|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099607|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099608|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099609|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099610|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099611|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20099612|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
20099613|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099614|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19517102|NCT02981459|Mirabegron|mirabegron|mesh-list
19517103|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19517104|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19517105|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19517106|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
19517107|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517108|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517109|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517110|NCT02981459|Urological Agents|urological agents|mesh-ancestor
19517111|NCT02981173|Psilocybin|psilocybin|mesh-list
19517112|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
19517113|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517114|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19517115|NCT02981121|Metformin|metformin|mesh-list
19517116|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19517117|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517118|NCT02981095|Bupivacaine|bupivacaine|mesh-list
19517119|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
19517120|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
19517121|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517122|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517123|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
19517124|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517125|NCT02980991|Pemetrexed|pemetrexed|mesh-list
19517126|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517127|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517128|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517129|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19517130|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19517131|NCT02981030|Misoprostol|misoprostol|mesh-list
19517132|NCT02981030|Mifepristone|mifepristone|mesh-list
19517133|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19517134|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
19517135|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19517136|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517137|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19517138|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517139|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
19517140|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19517141|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20099615|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099616|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099617|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099618|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099619|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
20099620|NCT00002804|Protective Agents|protective agents|mesh-ancestor
20099621|NCT00002804|Trace Elements|trace elements|mesh-ancestor
20099622|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
20099623|NCT00002805|Cobalt|cobalt|mesh-list
20099624|NCT00002805|Cytarabine|cytarabine|mesh-list
20099625|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
20099626|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19517142|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19517143|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19517144|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
19517145|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19517146|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19517147|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
19517148|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517149|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
19517150|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19517151|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19517152|NCT02980809|Apatinib|apatinib|mesh-list
19517153|NCT02980809|Topotecan|topotecan|mesh-list
19517154|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517155|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19517156|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517157|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099627|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20099628|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20099629|NCT00002805|Methotrexate|methotrexate|mesh-list
20099630|NCT00002805|Etoposide|etoposide|mesh-list
20099631|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
19517158|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19517159|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19517160|NCT02980926|Bupivacaine|bupivacaine|mesh-list
19517161|NCT02980926|Mepivacaine|mepivacaine|mesh-list
19517162|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
19517163|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
19517164|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517165|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517166|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
19517167|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517168|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19517169|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19517170|NCT02980835|Dexamethasone|dexamethasone|mesh-list
19517171|NCT02980835|Epinephrine|epinephrine|mesh-list
19517172|NCT02980835|Ropivacaine|ropivacaine|mesh-list
19517173|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19517174|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
19517175|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
19517176|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517177|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517178|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517179|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
19517180|NCT02980835|Hormones|hormones|mesh-ancestor
19517181|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517182|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19517183|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517184|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
19517185|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
19517186|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517187|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
19517188|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19517189|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19517190|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
19517191|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517192|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517193|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19517194|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19517195|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20099632|NCT00002805|Cladribine|cladribine|mesh-list
20099633|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099634|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
19517196|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
19517197|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
19517198|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
19517199|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19517200|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
19517201|NCT02980965|Docetaxel|docetaxel|mesh-list
19517202|NCT02980965|Fluorouracil|fluorouracil|mesh-list
19517203|NCT02980965|Letrozole|letrozole|mesh-list
19517204|NCT02980965|Epirubicin|epirubicin|mesh-list
19517205|NCT02980965|Leuprolide|leuprolide|mesh-list
19517206|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517207|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
19517208|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099635|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099636|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099637|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099638|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
20099639|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099640|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099641|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099642|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099643|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099644|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099645|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
20099646|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099647|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099648|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099649|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099650|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099651|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
20099652|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099653|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20099654|NCT00002805|Analgesics|analgesics|mesh-ancestor
20099655|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
20099656|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099657|NCT00002805|Trace Elements|trace elements|mesh-ancestor
20099658|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
20099659|NCT00002806|Vincristine|vincristine|mesh-list
20099660|NCT00002806|Lomustine|lomustine|mesh-list
20099661|NCT00002806|Procarbazine|procarbazine|mesh-list
20099662|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20603501|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603502|NCT02221401|Incretins|incretins|mesh-ancestor
20603503|NCT02221401|Hormones|hormones|mesh-ancestor
20603504|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517209|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19517210|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099663|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099664|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517211|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
19517212|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517213|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517214|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19517215|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517216|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
19517217|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517218|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
19517219|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19517220|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19517221|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19517222|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517223|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19517224|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
19517225|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517226|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19517227|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19517228|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19517229|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19517230|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
19517231|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19517232|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099665|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099666|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517233|NCT02980757|Gliclazide|gliclazide|mesh-list
20099667|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517234|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19517235|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517236|NCT02980653|Megestrol|megestrol|mesh-list
19517237|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
19517238|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19517239|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19517240|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19517241|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
19517242|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19517243|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517244|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19517245|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19517246|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19517247|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517248|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
19517249|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19517250|NCT02980562|Bisacodyl|bisacodyl|mesh-list
19517251|NCT02980562|Cathartics|cathartics|mesh-ancestor
19517252|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517253|NCT02980562|Laxatives|laxatives|mesh-ancestor
19517254|NCT02980497|Ethanol|ethanol|mesh-list
19517255|NCT02980497|Listerine|listerine|mesh-list
19517256|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19517257|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
19517258|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517259|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517260|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517261|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
19517262|NCT02980497|Protective Agents|protective agents|mesh-ancestor
19517263|NCT02980510|Leucovorin|leucovorin|mesh-list
19517264|NCT02980510|Folic Acid|folic acid|mesh-list
19517265|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
19517266|NCT02980510|Irinotecan|irinotecan|mesh-list
19517267|NCT02980510|Panitumumab|panitumumab|mesh-list
19517268|NCT02980510|Fluorouracil|fluorouracil|mesh-list
19517269|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
19517270|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517271|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19517272|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19517273|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099668|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099669|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
20099670|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
20099671|NCT00002809|Methotrexate|methotrexate|mesh-list
19517274|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517275|NCT02980510|Antidotes|antidotes|mesh-ancestor
19517276|NCT02980510|Protective Agents|protective agents|mesh-ancestor
19517277|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517278|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
19517279|NCT02980510|Vitamins|vitamins|mesh-ancestor
19517280|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
19517281|NCT02980510|Hematinics|hematinics|mesh-ancestor
19517282|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517283|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
19517284|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19517285|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517286|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
19517287|NCT02980458|Deferiprone|deferiprone|mesh-list
19517288|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19517289|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
19517290|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
19517291|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517292|NCT02980250|Domperidone|domperidone|mesh-list
19517293|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
19517294|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
19517295|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099672|NCT00002809|Tacrolimus|tacrolimus|mesh-list
20099673|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20099674|NCT00002809|Sargramostim|sargramostim|mesh-list
20099675|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
20099676|NCT00002809|Antibodies|antibodies|mesh-list
20099677|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
20099678|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20099679|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19517296|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517297|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517298|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19517299|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
19517300|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20099680|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099681|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
20099682|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099683|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099684|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099685|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
20099686|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099687|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099688|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099689|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099690|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099691|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19517301|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517302|NCT02980094|Vitamins|vitamins|mesh-list
19517303|NCT02980094|Vitamin E|vitamin e|mesh-list
19517304|NCT02980094|Tocopherols|tocopherols|mesh-list
19517305|NCT02980094|Tocotrienols|tocotrienols|mesh-list
19517306|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
19517307|NCT02980094|Selenium|selenium|mesh-list
19517308|NCT02980094|Antioxidants|antioxidants|mesh-list
19517309|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
19517310|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517311|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517312|NCT02980094|Protective Agents|protective agents|mesh-ancestor
19517313|NCT02980094|Trace Elements|trace elements|mesh-ancestor
19517314|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19517315|NCT02979886|Menotropins|menotropins|mesh-list
19517316|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
19517317|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19517318|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
19517319|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19517320|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517321|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19517322|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19517323|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517324|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19517325|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
19572194|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572195|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19572196|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572197|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572198|NCT02703740|Lidocaine|lidocaine|mesh-list
19572199|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
19572200|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
19572201|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
19572202|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572203|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572204|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
19572205|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572206|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19572207|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19572208|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19572209|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572210|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572211|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20099692|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099693|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
20099694|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
19572212|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
19572213|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
19572214|NCT02703740|Protective Agents|protective agents|mesh-ancestor
19572215|NCT02703363|Minocycline|minocycline|mesh-list
19572216|NCT02703363|Celecoxib|celecoxib|mesh-list
19572217|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19572218|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572219|NCT02703363|Analgesics|analgesics|mesh-ancestor
19572220|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
19572221|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572222|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572223|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572224|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572225|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19572226|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20099695|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572227|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099696|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20306203|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
19517326|NCT02980016|Isoniazid|isoniazid|mesh-list
19517327|NCT02980016|Rifapentine|rifapentine|mesh-list
19517328|NCT02980016|Rifampin|rifampin|mesh-list
19517329|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
19517330|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517331|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517332|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19517333|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19517334|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
19517335|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517336|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19517337|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19517338|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
19517339|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19517340|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517341|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19517342|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19517343|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19517344|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19517345|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19517346|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19517347|NCT02979665|Ranibizumab|ranibizumab|mesh-list
19517348|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19517349|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19517350|NCT02979665|Growth Substances|growth substances|mesh-ancestor
19517351|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517352|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
19517353|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517354|NCT02979704|Atorvastatin|atorvastatin|mesh-list
19517355|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19517356|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19517357|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19517358|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
19517359|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517360|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19517361|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19517362|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517363|NCT02979548|Ondansetron|ondansetron|mesh-list
19517364|NCT02979548|Aprepitant|aprepitant|mesh-list
19517365|NCT02979548|Metoclopramide|metoclopramide|mesh-list
19517366|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
19517367|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
19517368|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517369|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517370|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517371|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
19517372|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
19517373|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19517374|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
19517375|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517376|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517377|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19517378|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19517379|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517380|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19517381|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19517382|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19517383|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19517384|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19517385|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
19517386|NCT02979561|Warfarin|warfarin|mesh-list
19517387|NCT02979561|Dabigatran|dabigatran|mesh-list
19517388|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
19517389|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
20099697|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099698|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20099699|NCT00002810|Melphalan|melphalan|mesh-list
20099700|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
20099701|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099702|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19517390|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19517391|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
19517392|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517393|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517394|NCT02979405|Phenylephrine|phenylephrine|mesh-list
19517395|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
19517396|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19517397|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
19517398|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
19517399|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517400|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517401|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
19517402|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19517403|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
19517404|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
19517405|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19517406|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19517407|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19517408|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
19517409|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517410|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517411|NCT02979405|Protective Agents|protective agents|mesh-ancestor
19517412|NCT02979392|Paclitaxel|paclitaxel|mesh-list
19517413|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19517414|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517415|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517416|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
19517417|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517418|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517419|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
19517420|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
19517421|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
19517422|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517423|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
19517424|NCT02979223|Protective Agents|protective agents|mesh-ancestor
19517425|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517426|NCT02979223|Vitamins|vitamins|mesh-ancestor
19517427|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
19517428|NCT02979223|Cathartics|cathartics|mesh-ancestor
19517429|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517430|NCT02979093|Oxytocin|oxytocin|mesh-list
19517431|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
19517432|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19517433|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517434|NCT02978976|Betamethasone|betamethasone|mesh-list
19517435|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19517436|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
19517437|NCT02978976|Hormones|hormones|mesh-ancestor
19517438|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517439|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517440|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19517441|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
20099703|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
20099704|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099705|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517442|NCT02979132|Iron|iron|mesh-list
19517443|NCT02979132|Trace Elements|trace elements|mesh-ancestor
19517444|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
19517445|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517446|NCT02978482|Durvalumab|durvalumab|mesh-list
19517447|NCT02978482|Tremelimumab|tremelimumab|mesh-list
19517448|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19517449|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517450|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517451|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
19517452|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517453|NCT02978313|Cetuximab|cetuximab|mesh-list
19517454|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517455|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517456|NCT02978404|Nivolumab|nivolumab|mesh-list
19517457|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517458|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517459|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19517460|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517461|NCT02978495|Paclitaxel|paclitaxel|mesh-list
19517462|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
19517463|NCT02978495|Carboplatin|carboplatin|mesh-list
19517464|NCT02978495|Doxorubicin|doxorubicin|mesh-list
20603505|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19517465|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19517466|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517467|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517468|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
19517469|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517470|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517471|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517472|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
19517473|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517474|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099706|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099707|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099708|NCT00002812|Cytarabine|cytarabine|mesh-list
19517475|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19517476|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
19517477|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19517478|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19517479|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19517480|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19517481|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517482|NCT02978547|Metformin|metformin|mesh-list
19517483|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19517484|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517485|NCT02978222|Molgramostim|molgramostim|mesh-list
19517486|NCT02978222|Sargramostim|sargramostim|mesh-list
19517487|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
19517488|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517489|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517490|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19517491|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
19517492|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19517493|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19517494|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19517495|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517496|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517497|NCT02978443|Nivolumab|nivolumab|mesh-list
19517498|NCT02978443|Ipilimumab|ipilimumab|mesh-list
19517499|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517500|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517501|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19517502|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572228|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572229|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20099709|NCT00002812|Dexamethasone|dexamethasone|mesh-list
20099710|NCT00002812|Prednisone|prednisone|mesh-list
20099711|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
20099712|NCT00002812|Doxorubicin|doxorubicin|mesh-list
20099713|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099714|NCT00002812|Methotrexate|methotrexate|mesh-list
20099715|NCT00002812|Vincristine|vincristine|mesh-list
20099716|NCT00002812|Daunorubicin|daunorubicin|mesh-list
20099717|NCT00002812|Asparaginase|asparaginase|mesh-list
20099718|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
20099719|NCT00002812|Idarubicin|idarubicin|mesh-list
20099720|NCT00002812|Pegaspargase|pegaspargase|mesh-list
20099721|NCT00002812|Thioguanine|thioguanine|mesh-list
20099722|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572230|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572231|NCT02703376|Prednisone|prednisone|mesh-list
19572232|NCT02703376|Prednisolone|prednisolone|mesh-list
19572233|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572234|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
19572235|NCT02703376|Hormones|hormones|mesh-ancestor
19572236|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572237|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572238|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19572239|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572240|NCT02703610|Acetaminophen|acetaminophen|mesh-list
19572241|NCT02703610|Ibuprofen|ibuprofen|mesh-list
19572242|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19572243|NCT02703610|Oxycodone|oxycodone|mesh-list
19572244|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572245|NCT02703610|Analgesics|analgesics|mesh-ancestor
19572246|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
20099723|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
19572247|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572248|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099724|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099725|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099726|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099727|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
19517503|NCT02977897|Octreotide|octreotide|mesh-list
19517504|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517505|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19517506|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517507|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19517508|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19517509|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
19517510|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517511|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517512|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19517513|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19517514|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19517515|NCT02978040|Tirofiban|tirofiban|mesh-list
19517516|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19517517|NCT02978040|Cangrelor|cangrelor|mesh-list
20099728|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099729|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099730|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19517518|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19517519|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19517520|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19517521|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099731|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19517522|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19517523|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19517524|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19517525|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
19517526|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517527|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517528|NCT02977832|Alfuzosin|alfuzosin|mesh-list
19517529|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19517530|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19517531|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19517532|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
19517533|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517534|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517535|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517536|NCT02977832|Urological Agents|urological agents|mesh-ancestor
19517537|NCT02978066|Anesthetics|anesthetics|mesh-list
19517538|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517539|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517540|NCT02978001|Glycerol|glycerol|mesh-list
19517541|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19517542|NCT02978001|Protective Agents|protective agents|mesh-ancestor
19517543|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517544|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
19517545|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517546|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517547|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19517548|NCT02977637|Hematinics|hematinics|mesh-ancestor
19517549|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19517550|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19517551|NCT02977741|Olanzapine|olanzapine|mesh-list
19517552|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
19517553|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
19517554|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517555|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517556|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517557|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19517558|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19517559|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517560|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19517561|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19517562|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19517563|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19517564|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517565|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517566|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
19517567|NCT02977533|Acyclovir|acyclovir|mesh-list
19517568|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
19517569|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517570|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19517571|NCT02977611|Hematinics|hematinics|mesh-ancestor
19517587|NCT02977208|Gabapentin|gabapentin|mesh-list
19517588|NCT02977208|Analgesics|analgesics|mesh-ancestor
19517589|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
19517590|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517591|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517592|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
19517593|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19517594|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19517595|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517596|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19517597|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19517598|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19517599|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517600|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517601|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
19517602|NCT02977169|Cisplatin|cisplatin|mesh-list
19517603|NCT02977169|Carboplatin|carboplatin|mesh-list
19517604|NCT02977169|Pemetrexed|pemetrexed|mesh-list
20099732|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
20099733|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
20099734|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099735|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20099736|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
20099737|NCT00002812|Hormones|hormones|mesh-ancestor
20099738|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099739|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099740|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099741|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19517605|NCT02977169|Vinorelbine|vinorelbine|mesh-list
19517606|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517607|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517608|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517609|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19517610|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19517611|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19517612|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517613|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
19517614|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517615|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
19517616|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19517617|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
19517618|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517619|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19517620|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517621|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517622|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
19517623|NCT02977286|Naloxegol|naloxegol|mesh-list
19517624|NCT02977286|Bisacodyl|bisacodyl|mesh-list
19517625|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
19517626|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19517627|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19517628|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517629|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
19517630|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517631|NCT02977286|Cathartics|cathartics|mesh-ancestor
19517632|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517633|NCT02977286|Laxatives|laxatives|mesh-ancestor
19517634|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
19517635|NCT02977065|Atorvastatin|atorvastatin|mesh-list
19517636|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19517637|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19517638|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19517639|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
19517640|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517641|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19517642|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19517643|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517644|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19517645|NCT02977013|Dalteparin|dalteparin|mesh-list
19517646|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
19517647|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19517648|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19517649|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517650|NCT02977000|Propranolol|propranolol|mesh-list
19517651|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19517652|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19517653|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
19517654|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517655|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517656|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517657|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19517658|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19517659|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
19517660|NCT02976987|Cidofovir|cidofovir|mesh-list
19517661|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
20099742|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099743|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099744|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099745|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099746|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19517662|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517663|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517664|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517665|NCT02976805|Bisacodyl|bisacodyl|mesh-list
19517666|NCT02976805|Cathartics|cathartics|mesh-ancestor
19517667|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517668|NCT02976805|Laxatives|laxatives|mesh-ancestor
19517669|NCT02976909|Paclitaxel|paclitaxel|mesh-list
19517670|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19517671|NCT02976909|Cisplatin|cisplatin|mesh-list
19517672|NCT02976909|Fluorouracil|fluorouracil|mesh-list
19517673|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19517674|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517675|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517676|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
19517677|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517678|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517679|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
20099747|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099748|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
20603506|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
19517680|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19517681|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517682|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
19517683|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517684|NCT02976727|Vitamin D|vitamin d|mesh-list
19517685|NCT02976727|Lidocaine|lidocaine|mesh-list
19517686|NCT02976727|Prilocaine|prilocaine|mesh-list
19517687|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19517688|NCT02976727|Calcipotriene|calcipotriene|mesh-list
19517689|NCT02976727|Vitamins|vitamins|mesh-ancestor
19517690|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
19517691|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517692|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
19517693|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
19517694|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517695|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
19517696|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517697|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19517698|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19517699|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19517700|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19517701|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517702|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19517703|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
19517704|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19517705|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
19517706|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517707|NCT02976571|Bupivacaine|bupivacaine|mesh-list
19517708|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
19517709|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
19517710|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517711|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517712|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
19517713|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517714|NCT02976935|Xenon|xenon|mesh-list
19517715|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19517716|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
19517717|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
19517718|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517719|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517720|NCT02976623|Metronidazole|metronidazole|mesh-list
19517721|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099749|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099750|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099751|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099752|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
20099753|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517722|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517723|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19517724|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19517725|NCT02976896|Apatinib|apatinib|mesh-list
19517726|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517727|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19517728|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517729|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572249|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
19572250|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19572251|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572252|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572253|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19572254|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572255|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572256|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19572257|NCT02703610|Narcotics|narcotics|mesh-ancestor
19572258|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572259|NCT02703415|Tramadol|tramadol|mesh-list
19572260|NCT02703415|Bupivacaine|bupivacaine|mesh-list
19572261|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
19572262|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
19572263|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572264|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572265|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
19572266|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572267|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19572268|NCT02703415|Narcotics|narcotics|mesh-ancestor
19572269|NCT02703415|Analgesics|analgesics|mesh-ancestor
19572270|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
19572271|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572272|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572273|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
19572274|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19572275|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
19572276|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
20099754|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099755|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099756|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099757|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099758|NCT00002813|Vinorelbine|vinorelbine|mesh-list
19572277|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572278|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572279|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572280|NCT02703233|Analgesics|analgesics|mesh-ancestor
19572281|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
19572282|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572283|NCT02703272|Dexamethasone|dexamethasone|mesh-list
19572284|NCT02703272|Rituximab|rituximab|mesh-list
19572285|NCT02703272|Carboplatin|carboplatin|mesh-list
19572286|NCT02703272|Etoposide|etoposide|mesh-list
19572287|NCT02703272|Vincristine|vincristine|mesh-list
20099759|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572288|NCT02703272|Ifosfamide|ifosfamide|mesh-list
19572289|NCT02703272|Idarubicin|idarubicin|mesh-list
19572290|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19572291|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517730|NCT02976272|Bortezomib|bortezomib|mesh-list
19517731|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517732|NCT02976259|Dolutegravir|dolutegravir|mesh-list
19517733|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19517734|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19517735|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517736|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517737|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19517738|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19517739|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
19517740|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517741|NCT02976597|Morphine|morphine|mesh-list
19517742|NCT02976597|Bupivacaine|bupivacaine|mesh-list
19517743|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
19517744|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
19517745|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517746|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517747|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
19517748|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517749|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19517750|NCT02976597|Narcotics|narcotics|mesh-ancestor
19517751|NCT02976597|Analgesics|analgesics|mesh-ancestor
19517752|NCT02976194|Ranibizumab|ranibizumab|mesh-list
19517753|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19517754|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19517755|NCT02976194|Growth Substances|growth substances|mesh-ancestor
19517756|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517757|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
19517758|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517759|NCT02976467|Fulacimstat|fulacimstat|mesh-list
19517760|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517761|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517762|NCT02976441|Temozolomide|temozolomide|mesh-list
19517763|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19517764|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
19517765|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603507|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517766|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517767|NCT02976246|Vitamin K|vitamin k|mesh-list
19517768|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
19517769|NCT02976246|Vitamins|vitamins|mesh-ancestor
19517770|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
20607901|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
19517771|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517772|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19517773|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19517774|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517775|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
19517776|NCT02976246|Coagulants|coagulants|mesh-ancestor
19517777|NCT02976116|Gefitinib|gefitinib|mesh-list
19517778|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517779|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19517780|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517781|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517782|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
19517783|NCT02975921|Povidone|povidone|mesh-list
19517784|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
19517785|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
19517786|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19517787|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517788|NCT02975843|Beclomethasone|beclomethasone|mesh-list
19517789|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
19517790|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
19517791|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19517792|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
19517793|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517794|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517795|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19517796|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
19517797|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19517798|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19517799|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19517800|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
19517801|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517802|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517803|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19517804|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19517805|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19517806|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
19517807|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19517808|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
19517809|NCT02975843|Hormones|hormones|mesh-ancestor
20603508|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517810|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517811|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
19517812|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19517813|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517814|NCT02975999|Vasopressins|vasopressins|mesh-list
19517815|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
19517816|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
19517817|NCT02975999|Coagulants|coagulants|mesh-ancestor
19517818|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19517819|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19517820|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
19517821|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517822|NCT02976012|Aflibercept|aflibercept|mesh-list
19517823|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19517824|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19517825|NCT02976012|Growth Substances|growth substances|mesh-ancestor
19517826|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517827|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
19517828|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517829|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
19517830|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19517831|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
19517832|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19517833|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
19517834|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517835|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517836|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
19517837|NCT02975440|Rifampin|rifampin|mesh-list
19517838|NCT02975440|Midazolam|midazolam|mesh-list
19517839|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19517840|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19517841|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19517842|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517843|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19517844|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20099760|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099761|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517845|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19517846|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19517847|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
19517848|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
19517849|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
19517850|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
19517851|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517852|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517853|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19517854|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
19517855|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517856|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099762|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099763|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099764|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099765|NCT00002814|Paclitaxel|paclitaxel|mesh-list
20099766|NCT00002814|Topotecan|topotecan|mesh-list
20603509|NCT02221414|Metformin|metformin|mesh-list
19517857|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
19572292|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
20099767|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20603510|NCT02221414|Linagliptin|linagliptin|mesh-list
20603511|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603512|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603513|NCT02221414|Incretins|incretins|mesh-ancestor
20603514|NCT02221414|Hormones|hormones|mesh-ancestor
20603515|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517858|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19517859|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517860|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19517861|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20099768|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099769|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099770|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099771|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099772|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099773|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20099774|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099775|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099776|NCT00002816|Leucovorin|leucovorin|mesh-list
20099777|NCT00002816|Cobalt|cobalt|mesh-list
19517862|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19517863|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19517864|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19517865|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19517866|NCT02975583|Vorapaxar|vorapaxar|mesh-list
19517867|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19517868|NCT02975570|Levofloxacin|levofloxacin|mesh-list
19517869|NCT02975570|Ofloxacin|ofloxacin|mesh-list
19517870|NCT02975570|Linezolid|linezolid|mesh-list
19517871|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
19517872|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19517873|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517874|NCT02975570|Renal Agents|renal agents|mesh-ancestor
19517875|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517876|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19517877|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19517878|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517879|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517880|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517881|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20099778|NCT00002816|Cytarabine|cytarabine|mesh-list
20099779|NCT00002816|Dexamethasone|dexamethasone|mesh-list
20099780|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
20099781|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20099782|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19517882|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19517883|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19517884|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
19517885|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
20099783|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20099784|NCT00002816|Methotrexate|methotrexate|mesh-list
20099785|NCT00002816|Etoposide|etoposide|mesh-list
20099786|NCT00002816|Vincristine|vincristine|mesh-list
20099787|NCT00002816|Asparaginase|asparaginase|mesh-list
20099788|NCT00002816|Ifosfamide|ifosfamide|mesh-list
19517886|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
19517887|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20099789|NCT00002816|Idarubicin|idarubicin|mesh-list
20099790|NCT00002816|Pegaspargase|pegaspargase|mesh-list
20099791|NCT00002816|Thioguanine|thioguanine|mesh-list
20099792|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
20099793|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20099794|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
19517888|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
19517889|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19517890|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517891|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19517892|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
19517893|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19517894|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
19517895|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517896|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517897|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19517898|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
19517899|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
19517900|NCT02975258|Protective Agents|protective agents|mesh-ancestor
19517901|NCT02975258|Miotics|miotics|mesh-ancestor
19517902|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19517903|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19517904|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19517905|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20099795|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
20099796|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099797|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099798|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20099799|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
20099800|NCT00002816|Hormones|hormones|mesh-ancestor
20099801|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20099802|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20099803|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099804|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20099805|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
20099806|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20099807|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099808|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
20099809|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099810|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
20099811|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099812|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099813|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099814|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
20099815|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099816|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19517906|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
19517907|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19517908|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19517909|NCT02975076|Aspirin|aspirin|mesh-list
19517910|NCT02975076|Clopidogrel|clopidogrel|mesh-list
19517911|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19517912|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19517913|NCT02975076|Analgesics|analgesics|mesh-ancestor
19517914|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
19517915|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099817|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099818|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099819|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099820|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
20099821|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099822|NCT00002816|Antidotes|antidotes|mesh-ancestor
20099823|NCT00002816|Protective Agents|protective agents|mesh-ancestor
20099824|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
19517916|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517917|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19517918|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19517919|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19517920|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19517921|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517922|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19517923|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19517924|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517925|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
19517926|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19517927|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19517928|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19517929|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
19517930|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517931|NCT02975037|Itraconazole|itraconazole|mesh-list
19517932|NCT02975037|Erythromycin|erythromycin|mesh-list
19517933|NCT02975037|Erythromycin Estolate|erythromycin estolate|mesh-list
19517934|NCT02975037|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19517935|NCT02975037|Erythromycin stearate|erythromycin stearate|mesh-list
19517936|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
19517937|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
19517938|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20099825|NCT00002816|Vitamins|vitamins|mesh-ancestor
20099826|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
20099827|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099828|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099829|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099830|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19517939|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19517940|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517941|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517942|NCT02975037|Urological Agents|urological agents|mesh-ancestor
19517943|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
19517944|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099831|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
20099832|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099833|NCT00002816|Trace Elements|trace elements|mesh-ancestor
19517945|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19517946|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19517947|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19517948|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
20099834|NCT00002817|Sargramostim|sargramostim|mesh-list
20099835|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
20099836|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099837|NCT00002818|Cytarabine|cytarabine|mesh-list
20099838|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099839|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
20099840|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099841|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099842|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
19517949|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19517950|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517951|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19517952|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19517953|NCT02975037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19517954|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19517955|NCT02975219|Bevacizumab|bevacizumab|mesh-list
19517956|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19517957|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517958|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19517959|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19517960|NCT02975219|Growth Substances|growth substances|mesh-ancestor
19517961|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517962|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
19517963|NCT02975323|Carvedilol|carvedilol|mesh-list
19517964|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19517965|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19517966|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
19517967|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19517968|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517969|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517970|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19517971|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
19517972|NCT02975323|Protective Agents|protective agents|mesh-ancestor
20603516|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20603517|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603518|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603519|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603520|NCT02221453|Triamcinolone|triamcinolone|mesh-list
20603521|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20603522|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20099843|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099844|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099845|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
20099846|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099847|NCT00002819|Paclitaxel|paclitaxel|mesh-list
19517973|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19517974|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19517975|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19517976|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
19517977|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19517978|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19517979|NCT02975141|Gemcitabine|gemcitabine|mesh-list
19517980|NCT02975141|Paclitaxel|paclitaxel|mesh-list
19517981|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19517982|NCT02975141|Afatinib|afatinib|mesh-list
19517983|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19517984|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19517985|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
19517986|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
19517987|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
19517988|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19517989|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19517990|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
20099848|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
20099849|NCT00002819|Carboplatin|carboplatin|mesh-list
20099850|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
20099851|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099852|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099853|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099854|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
19517991|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
19517992|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19517993|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19517994|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19517995|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
19517996|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19517997|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19517998|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
19517999|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19518000|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
19518001|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518002|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
19518003|NCT02974985|Protective Agents|protective agents|mesh-ancestor
19572293|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572294|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572295|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572296|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
19572297|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
19572298|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572299|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572300|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
19572301|NCT02703272|Hormones|hormones|mesh-ancestor
19572302|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572303|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19572304|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19572305|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19572306|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19572307|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572308|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572309|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
19572310|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
19572311|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
19572312|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19572313|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
19572314|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19572315|NCT02703194|Prednisone|prednisone|mesh-list
19572316|NCT02703194|Prednisolone|prednisolone|mesh-list
19572317|NCT02703194|Leflunomide|leflunomide|mesh-list
19572318|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572319|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
19572320|NCT02703194|Hormones|hormones|mesh-ancestor
19572321|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572322|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572323|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19572324|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572325|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572326|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572327|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572328|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
19572329|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
20099855|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099856|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099857|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099858|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
19572330|NCT02702960|Prednisone|prednisone|mesh-list
19572331|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
19572332|NCT02702960|Fludarabine|fludarabine|mesh-list
19572333|NCT02702960|Tacrolimus|tacrolimus|mesh-list
19572334|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19572335|NCT02702960|Mesna|mesna|mesh-list
19572336|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572337|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
19572338|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572339|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572340|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19572341|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
19572342|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572343|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572344|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19572345|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603523|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19572346|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
19572347|NCT02702960|Hormones|hormones|mesh-ancestor
19572348|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572349|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19518004|NCT02974920|Aspirin|aspirin|mesh-list
19518005|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
19518006|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19518007|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518008|NCT02974920|Analgesics|analgesics|mesh-ancestor
19518009|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
19518010|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518011|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518012|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518013|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518014|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19518015|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19518016|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518017|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19518018|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19518019|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518020|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
19518021|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19518022|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
19518023|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19518024|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
19518025|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
19518026|NCT02974933|Pemetrexed|pemetrexed|mesh-list
19518027|NCT02974933|Apatinib|apatinib|mesh-list
19518028|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518029|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518030|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518031|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19518032|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19518033|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19518034|NCT02974712|Fentanyl|fentanyl|mesh-list
19518035|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19518036|NCT02974712|Narcotics|narcotics|mesh-ancestor
19518037|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518038|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518039|NCT02974712|Analgesics|analgesics|mesh-ancestor
19518040|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
19518041|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518042|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19518043|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19518044|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
19518045|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
19518046|NCT02974556|Capecitabine|capecitabine|mesh-list
19518047|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
19518048|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19518049|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
19518050|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518051|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518052|NCT02974660|Protamines|protamines|mesh-list
19518053|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
19518054|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518055|NCT02974660|Coagulants|coagulants|mesh-ancestor
20099859|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099860|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20099861|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19518056|NCT02974439|Amlodipine|amlodipine|mesh-list
19518057|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19518058|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19518059|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19518060|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518061|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19518062|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518063|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
19518064|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19518065|NCT02974387|Fluorometholone|fluorometholone|mesh-list
19518066|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19518067|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518068|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
19518069|NCT02974387|Hormones|hormones|mesh-ancestor
19518070|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518071|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518072|NCT02974504|Linagliptin|linagliptin|mesh-list
20099862|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
20099863|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099864|NCT00002819|Analgesics|analgesics|mesh-ancestor
19518073|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20099865|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
20099866|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20099867|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19518074|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518075|NCT02974504|Incretins|incretins|mesh-ancestor
19518076|NCT02974504|Hormones|hormones|mesh-ancestor
19518077|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518078|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19518079|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
19518080|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099868|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099869|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099870|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
20099871|NCT00002822|Ifosfamide|ifosfamide|mesh-list
20099872|NCT00002822|Carboplatin|carboplatin|mesh-list
20099873|NCT00002822|Doxorubicin|doxorubicin|mesh-list
20099874|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099875|NCT00002822|Etoposide|etoposide|mesh-list
20099876|NCT00002822|Vincristine|vincristine|mesh-list
20099877|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099878|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
19518081|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518082|NCT02974426|Cisplatin|cisplatin|mesh-list
19518083|NCT02974426|Carboplatin|carboplatin|mesh-list
19518084|NCT02974426|Pemetrexed|pemetrexed|mesh-list
19518085|NCT02974426|Vinorelbine|vinorelbine|mesh-list
19518086|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518087|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518088|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518089|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19518090|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19518091|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19518092|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
19518093|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
19518094|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
19518095|NCT02974244|Exenatide|exenatide|mesh-list
19518096|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19518097|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518098|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19518099|NCT02974244|Incretins|incretins|mesh-ancestor
19518100|NCT02974244|Hormones|hormones|mesh-ancestor
19518101|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518102|NCT02974361|Ibuprofen|ibuprofen|mesh-list
19518103|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19518104|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518105|NCT02974361|Analgesics|analgesics|mesh-ancestor
19518106|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
19518107|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518108|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518109|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518110|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518111|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19518112|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518113|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518114|NCT02974348|Acetaminophen|acetaminophen|mesh-list
19518115|NCT02974348|Amoxicillin|amoxicillin|mesh-list
19518116|NCT02974348|Artesunate|artesunate|mesh-list
19518117|NCT02974348|Lumefantrine|lumefantrine|mesh-list
19518118|NCT02974348|Piperaquine|piperaquine|mesh-list
19518119|NCT02974348|Artenimol|artenimol|mesh-list
19518120|NCT02974348|Mefloquine|mefloquine|mesh-list
19518121|NCT02974348|Quinine|quinine|mesh-list
19518122|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19518123|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518124|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518125|NCT02974348|Analgesics|analgesics|mesh-ancestor
19518126|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
19518127|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518128|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518129|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
19518130|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
19518131|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19518132|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19518133|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518134|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
19518135|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
19518136|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20099879|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099880|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518137|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
19518138|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19518139|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19518140|NCT02974166|Ibuprofen|ibuprofen|mesh-list
19518141|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19518142|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
19518143|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19518144|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518145|NCT02974166|Analgesics|analgesics|mesh-ancestor
19518146|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
19518147|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518148|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518149|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518150|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19518151|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518152|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518153|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19518154|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
19518155|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19518156|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19518157|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19518158|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19518159|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518160|NCT02974270|Leuprolide|leuprolide|mesh-list
19518161|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19518162|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
19518163|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19518164|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518165|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19518166|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518167|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19518168|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19518169|NCT02973958|Acetaminophen|acetaminophen|mesh-list
19518170|NCT02973958|Ibuprofen|ibuprofen|mesh-list
19518171|NCT02973958|Ketorolac|ketorolac|mesh-list
19518172|NCT02973958|Bupivacaine|bupivacaine|mesh-list
19518173|NCT02973958|Sevoflurane|sevoflurane|mesh-list
19518174|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
19518175|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
19518176|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518177|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518178|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
19518179|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518180|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518181|NCT02973958|Analgesics|analgesics|mesh-ancestor
19518182|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
19518183|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19518184|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518185|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518186|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19518187|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518188|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518189|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19518190|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19518191|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
19518192|NCT02973737|Capecitabine|capecitabine|mesh-list
19518193|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19518194|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
19518195|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518196|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518197|NCT02973763|Aflutinib|aflutinib|mesh-list
19518198|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19518199|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518200|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518201|NCT02973724|Remifentanil|remifentanil|mesh-list
19518202|NCT02973724|Propofol|propofol|mesh-list
19518203|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
19518204|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518205|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518206|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19518207|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19518208|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
19518209|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19518210|NCT02973724|Narcotics|narcotics|mesh-ancestor
19518211|NCT02973724|Analgesics|analgesics|mesh-ancestor
19518212|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
19518213|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518214|NCT02973776|Clobetasol|clobetasol|mesh-list
19518215|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19518216|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518217|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
19518218|NCT02973776|Hormones|hormones|mesh-ancestor
20099881|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20099882|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
20099883|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518219|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518220|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518221|NCT02973646|Tenofovir|tenofovir|mesh-list
19518222|NCT02973646|Entecavir|entecavir|mesh-list
19518223|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19518224|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
19518225|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518226|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19518227|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19518228|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518229|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518230|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19518231|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19518232|NCT02973659|Oxybutynin|oxybutynin|mesh-list
19518233|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
19518234|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
19518235|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518236|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099884|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099885|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19518237|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19518238|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19518239|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
19518240|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518241|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518242|NCT02973659|Urological Agents|urological agents|mesh-ancestor
19518243|NCT02973620|Simendan|simendan|mesh-list
19518244|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19518245|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
19518246|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19518247|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19518248|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518249|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518250|NCT02973620|Protective Agents|protective agents|mesh-ancestor
19518251|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518252|NCT02973451|Bupivacaine|bupivacaine|mesh-list
19518253|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
19518254|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
19518255|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518256|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518257|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
19518258|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518259|NCT02973464|Valganciclovir|valganciclovir|mesh-list
19518260|NCT02973464|Ganciclovir|ganciclovir|mesh-list
19518261|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19518262|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
19518263|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518264|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19518265|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518266|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518267|NCT02973295|Silymarin|silymarin|mesh-list
19518268|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
19518269|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518270|NCT02973295|Protective Agents|protective agents|mesh-ancestor
19518271|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518272|NCT02973581|Acetaminophen|acetaminophen|mesh-list
19518273|NCT02973581|Dipyrone|dipyrone|mesh-list
19518274|NCT02973581|Lidocaine|lidocaine|mesh-list
19518275|NCT02973581|Bupivacaine|bupivacaine|mesh-list
19518276|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
19518277|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
19518278|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
19518279|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518280|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518281|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
19518282|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518283|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19518284|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19518285|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19518286|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19518287|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518288|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518289|NCT02973581|Analgesics|analgesics|mesh-ancestor
20099886|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099887|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099888|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099889|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099890|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099891|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099892|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099893|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099894|NCT00002823|Etoposide|etoposide|mesh-list
20099895|NCT00002823|Vinorelbine|vinorelbine|mesh-list
20099896|NCT00002823|Vinblastine|vinblastine|mesh-list
20099897|NCT00002823|Vindesine|vindesine|mesh-list
20099898|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099899|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099900|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099901|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099902|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099903|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099904|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099905|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099906|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099907|NCT00002824|Ganciclovir|ganciclovir|mesh-list
20099908|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20099909|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
20099910|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099911|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20099912|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099913|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099914|NCT00002825|Docetaxel|docetaxel|mesh-list
20099915|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099916|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099917|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099918|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099919|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099920|NCT00002826|Paclitaxel|paclitaxel|mesh-list
19518290|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
19518291|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19518292|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518293|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518294|NCT02973113|Nivolumab|nivolumab|mesh-list
19518295|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19518296|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518297|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19518298|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518299|NCT02973204|Everolimus|everolimus|mesh-list
19518300|NCT02973204|Sorafenib|sorafenib|mesh-list
19518301|NCT02973204|Octreotide|octreotide|mesh-list
19518302|NCT02973204|Lanreotide|lanreotide|mesh-list
19518303|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518304|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518305|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
19518306|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518307|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19518308|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518309|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518310|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19518311|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19572350|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19572351|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572352|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19572353|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19572354|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
19572355|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572356|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572357|NCT02702960|Protective Agents|protective agents|mesh-ancestor
19572358|NCT02703051|Lenograstim|lenograstim|mesh-list
20099921|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099922|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518312|NCT02973035|Amlodipine|amlodipine|mesh-list
19518313|NCT02973035|Valsartan|valsartan|mesh-list
19518314|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19518315|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19518316|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19518317|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518318|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19518319|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518320|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
19518321|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19518322|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19518323|NCT02972918|Simendan|simendan|mesh-list
19518324|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19518325|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
19518326|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19518327|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19518328|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518329|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518330|NCT02972918|Protective Agents|protective agents|mesh-ancestor
19518331|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518332|NCT02972957|Azithromycin|azithromycin|mesh-list
19518333|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19518334|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518335|NCT02972983|Daptomycin|daptomycin|mesh-list
19518336|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19518337|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518338|NCT02972905|Nemiralisib|nemiralisib|mesh-list
19518339|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19518340|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518341|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518342|NCT02972866|Budesonide|budesonide|mesh-list
19518343|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518344|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19518345|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
19518346|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518347|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518348|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19518349|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
19518350|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
19518351|NCT02972866|Hormones|hormones|mesh-ancestor
19518352|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518353|NCT02972723|Metformin|metformin|mesh-list
19518354|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20099923|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099924|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099925|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099926|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099927|NCT00002827|Cobalt|cobalt|mesh-list
20099928|NCT00002827|Doxorubicin|doxorubicin|mesh-list
20099929|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20099930|NCT00002827|Bleomycin|bleomycin|mesh-list
20099931|NCT00002827|Etoposide|etoposide|mesh-list
20099932|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
20099933|NCT00002827|Vincristine|vincristine|mesh-list
20099934|NCT00002827|Razoxane|razoxane|mesh-list
20099935|NCT00002827|Lenograstim|lenograstim|mesh-list
20099936|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20099937|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099938|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20099939|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20099940|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20099941|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099942|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099943|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20099944|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
20099945|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099946|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
20099947|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
20099948|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
20099949|NCT00002827|Trace Elements|trace elements|mesh-ancestor
20099950|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
20099951|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19518355|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099952|NCT00002827|Protective Agents|protective agents|mesh-ancestor
20099953|NCT00002828|Fluorouracil|fluorouracil|mesh-list
20099954|NCT00002828|Raltitrexed|raltitrexed|mesh-list
19518356|NCT02972762|Propofol|propofol|mesh-list
19518357|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19518358|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518359|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518360|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19518361|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
19518362|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
19518363|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
19518364|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19518365|NCT02972463|Antibodies|antibodies|mesh-list
19518366|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
19518367|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099955|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
20099956|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099957|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20099958|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518368|NCT02972450|Vedolizumab|vedolizumab|mesh-list
19518369|NCT02972450|Vaccines|vaccines|mesh-list
19518370|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
19518371|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518372|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19518373|NCT02972476|Fluticasone|fluticasone|mesh-list
20099959|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099960|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
20099961|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518374|NCT02972476|Xhance|xhance|mesh-list
19518375|NCT02972476|Budesonide|budesonide|mesh-list
19518376|NCT02972476|Bromides|bromides|mesh-list
19518377|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
19518378|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19518379|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19518380|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518381|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19518382|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
19518383|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518384|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518385|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19518386|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
19518387|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
19518388|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19518389|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
19518390|NCT02972476|Hormones|hormones|mesh-ancestor
20099962|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20099963|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518391|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518392|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19518393|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19518394|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19518395|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
19518396|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518397|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518398|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
19518399|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
19518400|NCT02972320|Temozolomide|temozolomide|mesh-list
19518401|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19518402|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
19518403|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518404|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099964|NCT00002829|Interferons|interferons|mesh-list
20099965|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
20099966|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
20099967|NCT00002829|Etoposide|etoposide|mesh-list
20099968|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20099969|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
20099970|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099971|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518405|NCT02972333|Osimertinib|osimertinib|mesh-list
19518406|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518407|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19518408|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518409|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518410|NCT02972294|Iron|iron|mesh-list
19518411|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
19518412|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19518413|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
19518414|NCT02972294|Trace Elements|trace elements|mesh-ancestor
19518415|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
20306204|NCT00654173|Atorvastatin|atorvastatin|mesh-list
19518416|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20099972|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19518417|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19518418|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19518419|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518420|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
19518421|NCT02972294|Coagulants|coagulants|mesh-ancestor
19518422|NCT02972294|Hematinics|hematinics|mesh-ancestor
19518423|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19518424|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19518425|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
19518426|NCT02972346|Hormones|hormones|mesh-ancestor
19518427|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518428|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518429|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518430|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518431|NCT02972411|Acetazolamide|acetazolamide|mesh-list
19518432|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
19518433|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19518434|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518435|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518436|NCT02972411|Diuretics|diuretics|mesh-ancestor
19518437|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
19518438|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518439|NCT02972424|Teriparatide|teriparatide|mesh-list
19518440|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19518441|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518442|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19518443|NCT02972268|Tamsulosin|tamsulosin|mesh-list
19518444|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
19518445|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19518446|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19518447|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19518448|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
19518449|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518450|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518451|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518452|NCT02972268|Urological Agents|urological agents|mesh-ancestor
19518453|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19518454|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19518455|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
19518456|NCT02972216|Docetaxel|docetaxel|mesh-list
19518457|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518458|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
19518459|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
19518460|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
19518461|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518462|NCT02972255|Meropenem|meropenem|mesh-list
19518463|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19518464|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518465|NCT02971930|Factor VIII|factor viii|mesh-list
19518466|NCT02971930|Coagulants|coagulants|mesh-ancestor
19518467|NCT02971982|Dexamethasone|dexamethasone|mesh-list
19518468|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
19518469|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
19518470|NCT02971982|Rituximab|rituximab|mesh-list
19518471|NCT02971982|Bortezomib|bortezomib|mesh-list
19518472|NCT02971982|BB 1101|bb 1101|mesh-list
19518473|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518474|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
19518475|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518476|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518477|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19518478|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
19518479|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518480|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518481|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19518482|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19518483|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518484|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
19518485|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
19518486|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518487|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19518488|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
19518489|NCT02971982|Hormones|hormones|mesh-ancestor
19518490|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518491|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19518492|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
19518493|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518494|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
19518495|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19518496|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518497|NCT02972125|Lacosamide|lacosamide|mesh-list
19518498|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
19518499|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19518500|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19518501|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19518502|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518503|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
19518504|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19518505|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518506|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
19518507|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
19518508|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
19518509|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19518510|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
19518511|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518512|NCT02971878|Protective Agents|protective agents|mesh-ancestor
19518513|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518514|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
19518515|NCT02971878|Vitamins|vitamins|mesh-ancestor
19518516|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
19518517|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
19518518|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
19518519|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518520|NCT02971878|Expectorants|expectorants|mesh-ancestor
19518521|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
19518522|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19518523|NCT02971878|Antidotes|antidotes|mesh-ancestor
19518524|NCT02971644|Cobalt|cobalt|mesh-list
19518525|NCT02971644|Trace Elements|trace elements|mesh-ancestor
19518526|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
19518527|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518528|NCT02971475|Analgesics|analgesics|mesh-list
19518529|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
19518530|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518531|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518532|NCT02971696|Sorafenib|sorafenib|mesh-list
19518533|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518534|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19518535|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518536|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572359|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19572360|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
19572361|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572362|NCT02703090|Remifentanil|remifentanil|mesh-list
19572363|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19572364|NCT02703090|Narcotics|narcotics|mesh-ancestor
19572365|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572366|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572367|NCT02703090|Analgesics|analgesics|mesh-ancestor
19572368|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
19572369|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572370|NCT02702843|Xenon|xenon|mesh-list
19572371|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19572372|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
19572373|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
19572374|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572375|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572376|NCT02702817|Naproxen|naproxen|mesh-list
19572377|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19572378|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572379|NCT02702817|Analgesics|analgesics|mesh-ancestor
19572380|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
19572381|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572382|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572383|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603524|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572384|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572385|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
19572386|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20603525|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
19518537|NCT02971423|Imipenem|imipenem|mesh-list
19518538|NCT02971423|Sulbactam|sulbactam|mesh-list
19518539|NCT02971423|Cilastatin|cilastatin|mesh-list
19518540|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19518541|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518542|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
19518543|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518544|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518545|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19518546|NCT02971410|Simvastatin|simvastatin|mesh-list
19518547|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19518548|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19518549|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
19518550|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518551|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19518552|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19518553|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518554|NCT02971540|Dipyrone|dipyrone|mesh-list
19518555|NCT02971540|Tramadol|tramadol|mesh-list
19518556|NCT02971540|Bupivacaine|bupivacaine|mesh-list
19518557|NCT02971540|Ropivacaine|ropivacaine|mesh-list
19518558|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
19518559|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
20099973|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
20099974|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20099975|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20099976|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20099977|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20099978|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19518560|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518561|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518562|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
19518563|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518564|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19518565|NCT02971540|Narcotics|narcotics|mesh-ancestor
19518566|NCT02971540|Analgesics|analgesics|mesh-ancestor
19518567|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19518568|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518569|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518570|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518571|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
19518572|NCT02971397|Cytarabine|cytarabine|mesh-list
19518573|NCT02971397|Daunorubicin|daunorubicin|mesh-list
19518574|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19518575|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
19518576|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518577|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518578|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
19518579|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518580|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518581|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
19518582|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518583|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19518584|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19518585|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19518586|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518587|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
19518588|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19518589|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
19518590|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518591|NCT02971306|Expectorants|expectorants|mesh-ancestor
19518592|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
19518593|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19518594|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
19518595|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518596|NCT02971306|Protective Agents|protective agents|mesh-ancestor
19518597|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518598|NCT02971306|Antidotes|antidotes|mesh-ancestor
19518599|NCT02971254|Sevoflurane|sevoflurane|mesh-list
19518600|NCT02971254|Desflurane|desflurane|mesh-list
19518601|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20099979|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20306205|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19518602|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19518603|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
19518604|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
19518605|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518606|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518607|NCT02971345|Iodine|iodine|mesh-list
19518608|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
19518609|NCT02971345|Epirubicin|epirubicin|mesh-list
19518610|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
19518611|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19518612|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518613|NCT02971345|Trace Elements|trace elements|mesh-ancestor
19518614|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
19518615|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518616|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19518617|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518618|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19518619|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19518620|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518621|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518622|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
19518623|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19518624|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518625|NCT02971033|Ezetimibe|ezetimibe|mesh-list
19518626|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19518627|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19518628|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
19518629|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518630|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19518631|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
19518632|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19518633|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
19518634|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19518635|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
19518636|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518637|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518638|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
19518639|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
19518640|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
19518641|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19518642|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19518643|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518644|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518645|NCT02970916|Aflibercept|aflibercept|mesh-list
19518646|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19518647|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19518648|NCT02970916|Growth Substances|growth substances|mesh-ancestor
19518649|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518650|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
19518651|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518652|NCT02970630|Everolimus|everolimus|mesh-list
19518653|NCT02970630|Tacrolimus|tacrolimus|mesh-list
19518654|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518655|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
19518656|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518657|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19518658|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518659|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518660|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518661|NCT02970643|Olanzapine|olanzapine|mesh-list
19518662|NCT02970643|Palonosetron|palonosetron|mesh-list
19518663|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
19518664|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
19518665|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518666|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518667|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19518668|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20099980|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518669|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19518670|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20099981|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
20099982|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20099983|NCT00002831|Cyclosporine|cyclosporine|mesh-list
20099984|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
20099985|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20099986|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19518671|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19518672|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19518673|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19518674|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19518675|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518676|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518677|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
19518678|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19518679|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19518680|NCT02970539|Paclitaxel|paclitaxel|mesh-list
19518681|NCT02970539|Ramucirumab|ramucirumab|mesh-list
19518682|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19518683|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518684|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
19518685|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
19518686|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
19518687|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518688|NCT02970604|Aspirin|aspirin|mesh-list
19518689|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19518690|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19518691|NCT02970604|Analgesics|analgesics|mesh-ancestor
19518692|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
19518693|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518694|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518695|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19518696|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518697|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19518698|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19518699|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518700|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19518701|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19518702|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518703|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
19518704|NCT02970682|Tamoxifen|tamoxifen|mesh-list
19518705|NCT02970682|Fulvestrant|fulvestrant|mesh-list
19518706|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19518707|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19518708|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
19518709|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518710|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518711|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19518712|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518713|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19518714|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19518715|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19518716|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19518717|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19518718|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518719|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518720|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
19518721|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518722|NCT02970409|Heparin|heparin|mesh-list
19518723|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
19518724|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19518725|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19518726|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518727|NCT02970383|Narcotics|narcotics|mesh-list
19518728|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518729|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518730|NCT02970383|Analgesics|analgesics|mesh-ancestor
19518731|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
19518732|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518733|NCT02970175|Terlipressin|terlipressin|mesh-list
19518734|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19518735|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19518736|NCT02970097|Fentanyl|fentanyl|mesh-list
19518737|NCT02970097|Midazolam|midazolam|mesh-list
20099987|NCT00002831|Prednisolone|prednisolone|mesh-list
19518738|NCT02970097|Ropivacaine|ropivacaine|mesh-list
19518739|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19518740|NCT02970097|Narcotics|narcotics|mesh-ancestor
19518741|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518742|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518743|NCT02970097|Analgesics|analgesics|mesh-ancestor
19518744|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
19518745|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518746|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19518747|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19518748|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
19518749|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
19518750|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19518751|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19518752|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19518753|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19518754|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
19518755|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
19518756|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518757|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518758|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
19518759|NCT02970084|Vitamin K|vitamin k|mesh-list
19518760|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
19518761|NCT02970084|Vitamins|vitamins|mesh-ancestor
19518762|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
19518763|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518764|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19518765|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19518766|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518767|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
19518768|NCT02970084|Coagulants|coagulants|mesh-ancestor
20099988|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
20099989|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
20099990|NCT00002831|Busulfan|busulfan|mesh-list
20099991|NCT00002831|Methotrexate|methotrexate|mesh-list
20099992|NCT00002831|Decitabine|decitabine|mesh-list
20099993|NCT00002831|Tacrolimus|tacrolimus|mesh-list
20099994|NCT00002831|Cyclosporins|cyclosporins|mesh-list
20099995|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20099996|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
20099997|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518769|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
19518770|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518771|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
19518772|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518773|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518774|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19518775|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
19518776|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518777|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518778|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19518779|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
19518780|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
19518781|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19518782|NCT02969720|Protective Agents|protective agents|mesh-ancestor
19518783|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518784|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
19518785|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19518786|NCT02969746|Charcoal|charcoal|mesh-list
19518787|NCT02969746|Antidotes|antidotes|mesh-ancestor
19518788|NCT02969746|Protective Agents|protective agents|mesh-ancestor
19518789|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518790|NCT02969733|Lidocaine|lidocaine|mesh-list
19518791|NCT02969733|Ketamine|ketamine|mesh-list
19518792|NCT02969733|Analgesics|analgesics|mesh-ancestor
19518793|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
19518794|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518795|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518796|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19518797|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19518798|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
19518799|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
19518800|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19518801|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19518802|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19518803|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20099998|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
20099999|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100000|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518804|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518805|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
19518806|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19518807|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19518808|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19518809|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572387|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572388|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572389|NCT02702700|Verteporfin|verteporfin|mesh-list
19572390|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19572391|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
19572392|NCT02702674|Propranolol|propranolol|mesh-list
19572393|NCT02702674|Oxytocin|oxytocin|mesh-list
19572394|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
19572395|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19572396|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572397|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19572398|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19572399|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
19572400|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572401|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572402|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19572403|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19572404|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
19572405|NCT02702739|Ribavirin|ribavirin|mesh-list
19572406|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
19572407|NCT02702739|Simeprevir|simeprevir|mesh-list
19572408|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
19572409|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572410|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
19572411|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572412|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
19572413|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572414|NCT02702622|Provitamins|provitamins|mesh-list
19572415|NCT02702622|Beta Carotene|beta carotene|mesh-list
19572416|NCT02702622|Vitamins|vitamins|mesh-ancestor
19572417|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
19572418|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572419|NCT02702661|Anesthetics|anesthetics|mesh-list
19572420|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
19572421|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
19572422|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572423|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572424|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
19572425|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577921|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577922|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19577923|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
19577924|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577925|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577926|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19577927|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19577928|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19577929|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19577930|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577931|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577932|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
19577933|NCT03817853|Hormones|hormones|mesh-ancestor
19577934|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577935|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577936|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19577937|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577938|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100001|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100002|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
20100003|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100004|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100005|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100006|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20100007|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
19577939|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577940|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
20306206|NCT00654173|Simvastatin|simvastatin|mesh-list
19577941|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
19577942|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100008|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19518810|NCT02969798|Metformin|metformin|mesh-list
19518811|NCT02969798|Pioglitazone|pioglitazone|mesh-list
19518812|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
19518813|NCT02969798|Saxagliptin|saxagliptin|mesh-list
19518814|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20100009|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100010|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
20100011|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100012|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100013|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20100014|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20100015|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20100016|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
20100017|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100018|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20100019|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
20100020|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
20100021|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100022|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100023|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
20100024|NCT00002831|Hormones|hormones|mesh-ancestor
20100025|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100026|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20100027|NCT00002831|Protective Agents|protective agents|mesh-ancestor
20100028|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100029|NCT00002832|Cyclosporine|cyclosporine|mesh-list
20100030|NCT00002832|Decitabine|decitabine|mesh-list
19518815|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518816|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19518817|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518818|NCT02969798|Incretins|incretins|mesh-ancestor
19518819|NCT02969798|Hormones|hormones|mesh-ancestor
19518820|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518821|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19518822|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
19518823|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518824|NCT02969629|Apomorphine|apomorphine|mesh-list
19518825|NCT02969629|Emetics|emetics|mesh-ancestor
20100031|NCT00002832|Cyclosporins|cyclosporins|mesh-list
20100032|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
20100033|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100034|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100035|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518826|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518827|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
19518828|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518829|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19518830|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
19518831|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
19518832|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518833|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518834|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
19518835|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518836|NCT02969681|Vitamins|vitamins|mesh-ancestor
19518837|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
19518838|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
20100036|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100037|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
20100038|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100039|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100040|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100041|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20100042|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100043|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
20100044|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100045|NCT00002833|Cytarabine|cytarabine|mesh-list
20100046|NCT00002833|Cyclosporine|cyclosporine|mesh-list
20100047|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
20100048|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20100049|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19518839|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518840|NCT02969681|Protective Agents|protective agents|mesh-ancestor
19518841|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
20100050|NCT00002833|Prednisolone|prednisolone|mesh-list
20100051|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
19518842|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19518843|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518844|NCT02969447|Oxytocin|oxytocin|mesh-list
19518845|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
19518846|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19518847|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518848|NCT02969473|Cisplatin|cisplatin|mesh-list
19518849|NCT02969473|Docetaxel|docetaxel|mesh-list
19518850|NCT02969473|Fluorouracil|fluorouracil|mesh-list
19518851|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518852|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
19518853|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
19518854|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
19518855|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518856|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
19518857|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19518858|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518859|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
19518860|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518861|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19518862|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
19518863|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518864|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
19518865|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518866|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19518867|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19518868|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518869|NCT02969265|Amlodipine|amlodipine|mesh-list
19518870|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
19518871|NCT02969265|Candesartan|candesartan|mesh-list
19518872|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19518873|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19518874|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19518875|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518876|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19518877|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518878|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
19518879|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19518880|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19518881|NCT02969252|Rifamycins|rifamycins|mesh-list
19518882|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
19518883|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19518884|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518885|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518886|NCT02969239|Phenylephrine|phenylephrine|mesh-list
19518887|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
19518888|NCT02969239|Norepinephrine|norepinephrine|mesh-list
19518889|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19518890|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19518891|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
19518892|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
19518893|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518894|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518895|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
19518896|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
20100052|NCT00002833|Fludarabine|fludarabine|mesh-list
20100053|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
20100054|NCT00002833|Idarubicin|idarubicin|mesh-list
19518897|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
19518898|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19518899|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19518900|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19518901|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
19518902|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518903|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518904|NCT02969239|Protective Agents|protective agents|mesh-ancestor
19518905|NCT02968901|Tadalafil|tadalafil|mesh-list
19518906|NCT02968901|Macitentan|macitentan|mesh-list
19518907|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
19518908|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19518909|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19518910|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518911|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518912|NCT02968901|Urological Agents|urological agents|mesh-ancestor
19518913|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19572426|NCT02702778|Prednisone|prednisone|mesh-list
20100055|NCT00002833|Cladribine|cladribine|mesh-list
19518914|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20100056|NCT00002833|Cyclosporins|cyclosporins|mesh-list
20100057|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20100058|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
20100059|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100060|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19518915|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19518916|NCT02968927|Vitamin D|vitamin d|mesh-list
19518917|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
19518918|NCT02968927|Rifabutin|rifabutin|mesh-list
19518919|NCT02968927|Everolimus|everolimus|mesh-list
19518920|NCT02968927|Auranofin|auranofin|mesh-list
19518921|NCT02968927|Vitamins|vitamins|mesh-ancestor
19518922|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
19518923|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518924|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19518925|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518926|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19518927|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
19518928|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19518929|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19518930|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518931|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19518932|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
19518933|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518934|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19518935|NCT02968693|Vancomycin|vancomycin|mesh-list
19518936|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19518937|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19518938|NCT02968693|Calcium|calcium|mesh-list
19518939|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19518940|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518941|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518942|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
19518943|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19518944|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19518945|NCT02968693|Protective Agents|protective agents|mesh-ancestor
19518946|NCT02968719|Donepezil|donepezil|mesh-list
19518947|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19518948|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518949|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100061|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
20100062|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100063|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100064|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
20100065|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100066|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
20100067|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518950|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
19518951|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518952|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518953|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
19518954|NCT02968641|Ritonavir|ritonavir|mesh-list
19518955|NCT02968641|Lonafarnib|lonafarnib|mesh-list
19518956|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19518957|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19518958|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
19518959|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518960|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518961|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19518962|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20603526|NCT02221453|Hormones|hormones|mesh-ancestor
19518963|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
19518964|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19518965|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19518966|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19518967|NCT02968498|Methamphetamine|methamphetamine|mesh-list
19518968|NCT02968498|Lactulose|lactulose|mesh-list
19518969|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100068|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100069|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
20100070|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
20607902|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518970|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19518971|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100071|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19518972|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
19518973|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
19518974|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19518975|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
19518976|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19518977|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518978|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
19518979|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19518980|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19518981|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19518982|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19518983|NCT02968394|Omalizumab|omalizumab|mesh-list
19518984|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19518985|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19518986|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
19518987|NCT02968342|Progesterone|progesterone|mesh-list
19518988|NCT02968342|Progestins|progestins|mesh-ancestor
19518989|NCT02968342|Hormones|hormones|mesh-ancestor
19518990|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19518991|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19518992|NCT02968303|Vemurafenib|vemurafenib|mesh-list
19518993|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19518994|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19518995|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19518996|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19518997|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
19518998|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
19518999|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519000|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519001|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519002|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
19519003|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
19519004|NCT02968160|Telmisartan|telmisartan|mesh-list
19519005|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19519006|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19519007|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19519008|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
19519009|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519010|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19519011|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19519012|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519013|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19519014|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19519015|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19519016|NCT02968082|Scopolamine|scopolamine|mesh-list
19519017|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19519018|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19519019|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
19519020|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
19519021|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519022|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519023|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519024|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
19519025|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19519026|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
19519027|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519028|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519029|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19519030|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
19519031|NCT02967939|Tenofovir|tenofovir|mesh-list
19519032|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
19519033|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519034|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19519035|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19519036|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519037|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519038|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20100072|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20100073|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519039|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19519040|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
19519041|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19519042|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
19519043|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519044|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
20100074|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
20100075|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
20100076|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100077|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100078|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
20100079|NCT00002833|Hormones|hormones|mesh-ancestor
20100080|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100081|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20100082|NCT00002833|Protective Agents|protective agents|mesh-ancestor
20100083|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100084|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100085|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100086|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100087|NCT00002835|Leucovorin|leucovorin|mesh-list
20100088|NCT00002835|Interferons|interferons|mesh-list
19519045|NCT02967874|Protective Agents|protective agents|mesh-ancestor
19572427|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572428|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
19572429|NCT02702778|Hormones|hormones|mesh-ancestor
19572430|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572431|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572432|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19572433|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572434|NCT02702492|Niacin|niacin|mesh-list
19572435|NCT02702492|Nivolumab|nivolumab|mesh-list
19572436|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20100089|NCT00002835|Cytarabine|cytarabine|mesh-list
20100090|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
20100091|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
20100092|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20100093|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19572437|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572438|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19572439|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572440|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19572441|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
19572442|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19572443|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
19572444|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
19572445|NCT02702492|Vitamins|vitamins|mesh-ancestor
19572446|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
19572447|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572448|NCT02702206|Triamcinolone|triamcinolone|mesh-list
19572449|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
19572450|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572451|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
19572452|NCT02702206|Hormones|hormones|mesh-ancestor
19572453|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572454|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572455|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
19572456|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19572457|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
19572458|NCT02702206|Protective Agents|protective agents|mesh-ancestor
19572459|NCT02702323|Apatinib|apatinib|mesh-list
19572460|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572461|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19572462|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572463|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572464|NCT02702349|Penicillins|penicillins|mesh-list
19572465|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572466|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572467|NCT02702076|Apomorphine|apomorphine|mesh-list
19572468|NCT02702076|Emetics|emetics|mesh-ancestor
19572469|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572470|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
19572471|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572472|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572473|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
19572474|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
19572475|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572476|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572477|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
19572478|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20306207|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19572479|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20100094|NCT00002835|Prednisolone|prednisolone|mesh-list
20100095|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
19519046|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
19519047|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19519048|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519049|NCT02967757|Liraglutide|liraglutide|mesh-list
19519050|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519051|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519052|NCT02967757|Incretins|incretins|mesh-ancestor
19519053|NCT02967757|Hormones|hormones|mesh-ancestor
19519054|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519055|NCT02967887|Fluorouracil|fluorouracil|mesh-list
19519056|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519057|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
19519058|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519059|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19519060|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519061|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
19519062|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519063|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
19519064|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519065|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
19519066|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19519067|NCT02967302|Triamcinolone|triamcinolone|mesh-list
19519068|NCT02967302|Morphine|morphine|mesh-list
19519069|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19519070|NCT02967302|Narcotics|narcotics|mesh-ancestor
19519071|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519072|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519073|NCT02967302|Analgesics|analgesics|mesh-ancestor
19519074|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
19519075|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519076|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519077|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
19519078|NCT02967302|Hormones|hormones|mesh-ancestor
19519079|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519080|NCT02967653|Atorvastatin|atorvastatin|mesh-list
19519081|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19519082|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19519083|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
19519084|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519085|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19519086|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19519087|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519088|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
19519089|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19519090|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519091|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19519092|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19519093|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519094|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519095|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519096|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19519097|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19519098|NCT02967614|Timolol|timolol|mesh-list
19519099|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19519100|NCT02967614|Dorzolamide|dorzolamide|mesh-list
19519101|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19519102|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19519103|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519104|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519105|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519106|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519107|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19519108|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19519109|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19519110|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19519111|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19519112|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19519113|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519114|NCT02967289|Irinotecan|irinotecan|mesh-list
19519115|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19519116|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19519117|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603527|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519118|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519119|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519120|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
19519121|NCT02967380|Antidotes|antidotes|mesh-ancestor
19519122|NCT02967380|Protective Agents|protective agents|mesh-ancestor
19519123|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519124|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
20100096|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
20100097|NCT00002835|Melphalan|melphalan|mesh-list
20100098|NCT00002835|Ifosfamide|ifosfamide|mesh-list
20100099|NCT00002835|Carmustine|carmustine|mesh-list
20100100|NCT00002835|Cisplatin|cisplatin|mesh-list
20100101|NCT00002835|Methotrexate|methotrexate|mesh-list
19519125|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
19519126|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519127|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19519128|NCT02967276|Metformin|metformin|mesh-list
19519129|NCT02967276|Dexamethasone|dexamethasone|mesh-list
19519130|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519131|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
19519132|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
19519133|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519134|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519135|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519136|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
19519137|NCT02967276|Hormones|hormones|mesh-ancestor
19519138|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519139|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19519140|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519141|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519142|NCT02967432|Mupirocin|mupirocin|mesh-list
19519143|NCT02967432|Petrolatum|petrolatum|mesh-list
19519144|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19519145|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519146|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19519147|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519148|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519149|NCT02967432|Emollients|emollients|mesh-ancestor
19519150|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
19519151|NCT02967172|Epinephrine|epinephrine|mesh-list
19519152|NCT02967172|Morphine|morphine|mesh-list
19519153|NCT02967172|Ropivacaine|ropivacaine|mesh-list
19519154|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19519155|NCT02967172|Narcotics|narcotics|mesh-ancestor
19519156|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519157|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519158|NCT02967172|Analgesics|analgesics|mesh-ancestor
19519159|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
19519160|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519161|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
19519162|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
19519163|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19519164|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19519165|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519166|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519167|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519168|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19519169|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19519170|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
19519171|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19519172|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
19519173|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
19519174|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
19519175|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19519176|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
19519177|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519178|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519179|NCT02967211|Insulin|insulin|mesh-list
19519180|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19519181|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
19519182|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
19519183|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
19519184|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
20100102|NCT00002835|Etoposide|etoposide|mesh-list
20100103|NCT00002835|Vincristine|vincristine|mesh-list
19519185|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
19519186|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519187|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100104|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
20100105|NCT00002835|Idarubicin|idarubicin|mesh-list
20100106|NCT00002835|Bleomycin|bleomycin|mesh-list
19519188|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
19519189|NCT02966912|Antacids|antacids|mesh-ancestor
19519190|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519191|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519192|NCT02967029|Remifentanil|remifentanil|mesh-list
19519193|NCT02967029|Esmolol|esmolol|mesh-list
19519194|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19519195|NCT02967029|Narcotics|narcotics|mesh-ancestor
19519196|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519197|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519198|NCT02967029|Analgesics|analgesics|mesh-ancestor
19519199|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
19519200|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519201|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19519202|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19519203|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19519204|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519205|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519206|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519207|NCT02967094|Expectorants|expectorants|mesh-list
19519208|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
19519209|NCT02967224|Insulin|insulin|mesh-list
19519210|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19519211|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
19519212|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
19519213|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
19519214|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
19519215|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
19519216|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519217|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519218|NCT02966847|Anesthetics|anesthetics|mesh-list
19519219|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519220|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519221|NCT02966717|Rituximab|rituximab|mesh-list
19519222|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19519223|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519224|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
19519225|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519226|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19519227|NCT02966522|Thalidomide|thalidomide|mesh-list
19519228|NCT02966522|Dexamethasone|dexamethasone|mesh-list
19519229|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519230|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
19519231|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
19519232|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519233|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519234|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519235|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
19519236|NCT02966522|Hormones|hormones|mesh-ancestor
19519237|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519238|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19519239|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519240|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519241|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
19519242|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
19519243|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19519244|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519245|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19519246|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19519247|NCT02966522|Growth Substances|growth substances|mesh-ancestor
19519248|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
19519249|NCT02966587|Durvalumab|durvalumab|mesh-list
19519250|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
19519251|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19519252|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
19519253|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19519254|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519255|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
19519256|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519257|NCT02966457|Colistin|colistin|mesh-list
19519258|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19519259|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519260|NCT02966665|Vitamins|vitamins|mesh-list
19519261|NCT02966665|Vitamin E|vitamin e|mesh-list
19519262|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
19519263|NCT02966665|Fexofenadine|fexofenadine|mesh-list
19519264|NCT02966665|Valsartan|valsartan|mesh-list
19519265|NCT02966665|Nitroprusside|nitroprusside|mesh-list
19519266|NCT02966665|Phentolamine|phentolamine|mesh-list
20100107|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
19519267|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
19519268|NCT02966665|Norepinephrine|norepinephrine|mesh-list
19519269|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
19519270|NCT02966665|Giapreza|giapreza|mesh-list
19519271|NCT02966665|Acetylcholine|acetylcholine|mesh-list
19519272|NCT02966665|Ranitidine|ranitidine|mesh-list
19519273|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
19519274|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
19519275|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519276|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19519277|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19519278|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19519279|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519280|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
19519281|NCT02966665|Protective Agents|protective agents|mesh-ancestor
19519282|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19519283|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19519284|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519285|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519286|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
20100108|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20100109|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
20100110|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100111|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
20100112|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100113|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100114|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100115|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
20100116|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100117|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100118|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19519287|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
19519288|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519289|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19519290|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
19519291|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19519292|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19519293|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19519294|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
19519295|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
19519296|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19519297|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519298|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19519299|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
19519300|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19519301|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19519302|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
19519303|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519304|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19519305|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
19519306|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19519307|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19519308|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19519309|NCT02966743|Midazolam|midazolam|mesh-list
19519310|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
19519311|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19519312|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519313|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519314|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19519315|NCT02966743|Analgesics|analgesics|mesh-ancestor
19519316|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
19519317|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519318|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19519319|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19519320|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19519321|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519322|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519323|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519324|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20100119|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20100120|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
20100121|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19519325|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19519326|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19519327|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19519328|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19519329|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
19519330|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
19519331|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
19519332|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
19519333|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
19519334|NCT02966652|Testosterone|testosterone|mesh-list
19519335|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
19519336|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
19519337|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19519338|NCT02966652|Androgens|androgens|mesh-ancestor
19519339|NCT02966652|Hormones|hormones|mesh-ancestor
20100122|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100123|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
20100124|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100125|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100126|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20100127|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20100128|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100129|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19519340|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519341|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519342|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19519343|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519344|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
19519345|NCT02966288|Ibuprofen|ibuprofen|mesh-list
19519346|NCT02966288|Ketorolac|ketorolac|mesh-list
19519347|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19519348|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19519349|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19519350|NCT02966288|Analgesics|analgesics|mesh-ancestor
19519351|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
20100130|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100131|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
20100132|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100133|NCT00002835|Antidotes|antidotes|mesh-ancestor
19519352|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519353|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519354|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519355|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19519356|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19519357|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519358|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519359|NCT02966704|Caseins|caseins|mesh-list
19519360|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
19519361|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
19519362|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519363|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
19519364|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19519365|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19519366|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519367|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
19519368|NCT02966236|Coagulants|coagulants|mesh-ancestor
19519369|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
19519370|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519371|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
19519372|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519373|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19519374|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19519375|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
19519376|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519377|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519378|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19572480|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572481|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
20100134|NCT00002835|Protective Agents|protective agents|mesh-ancestor
20100135|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
20100136|NCT00002835|Vitamins|vitamins|mesh-ancestor
20100137|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
20100138|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100139|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100140|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100141|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20100142|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
20100143|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
20306208|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19519379|NCT02966067|Anesthetics|anesthetics|mesh-list
19519380|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19519381|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519382|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519383|NCT02966041|Ondansetron|ondansetron|mesh-list
19519384|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
20100144|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100145|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100146|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
20100147|NCT00002835|Hormones|hormones|mesh-ancestor
20100148|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100149|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19519385|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
19519386|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519387|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519388|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519389|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
19519390|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
19519391|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19519392|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
19519393|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519394|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519395|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19519396|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19519397|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519398|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19519399|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19519400|NCT02965911|Fenofibrate|fenofibrate|mesh-list
19519401|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19519402|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
19519403|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519404|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19519405|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
19519406|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
19519407|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
19519408|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519409|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519410|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
19519411|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100150|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100151|NCT00002835|Analgesics|analgesics|mesh-ancestor
20100152|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
20100153|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100154|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
19519412|NCT02966080|Heparin|heparin|mesh-list
19519413|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
19519414|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19519415|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19519416|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519417|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
19519418|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19519419|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19519420|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19519421|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19519422|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19519423|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519424|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
19519425|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519426|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519427|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19519428|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519429|NCT02965859|Adefovir|adefovir|mesh-list
19519430|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19519431|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
19519432|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100155|NCT00002836|Thiotepa|thiotepa|mesh-list
19519433|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19519434|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19519435|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519436|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519437|NCT02965404|Vaccines|vaccines|mesh-list
19519438|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
19519439|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519440|NCT02965677|Paclitaxel|paclitaxel|mesh-list
20100156|NCT00002836|Carmustine|carmustine|mesh-list
20100157|NCT00002836|Cisplatin|cisplatin|mesh-list
20100158|NCT00002836|Etoposide|etoposide|mesh-list
20100159|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100160|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
20100161|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100162|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100163|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19519441|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100164|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
20100165|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100166|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100167|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100168|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100169|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100170|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100171|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100172|NCT00002837|Paclitaxel|paclitaxel|mesh-list
20100173|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
20100174|NCT00002837|Doxorubicin|doxorubicin|mesh-list
20100175|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20100176|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100177|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100178|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100179|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100180|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100181|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519442|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519443|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
19519444|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
19519445|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
19519446|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519447|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
19519448|NCT02965443|Saxagliptin|saxagliptin|mesh-list
19519449|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19519450|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519451|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519452|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519453|NCT02965443|Incretins|incretins|mesh-ancestor
19519454|NCT02965443|Hormones|hormones|mesh-ancestor
19519455|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519456|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19519457|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
19519458|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519459|NCT02965768|Naltrexone|naltrexone|mesh-list
19519460|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20100182|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100183|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
20100184|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100185|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100186|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19519461|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19519462|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519463|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
19519464|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519465|NCT02965053|Sevelamer|sevelamer|mesh-list
19519466|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
19519467|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
19519468|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519469|NCT02965196|Dexamethasone|dexamethasone|mesh-list
20100187|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
20100188|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100189|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100190|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100191|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100192|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100193|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
20607903|NCT02244112|Midazolam|midazolam|mesh-list
19519470|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519471|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
19519472|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
19519473|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519474|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519475|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519476|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
20100194|NCT00002838|Fludarabine|fludarabine|mesh-list
20100195|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
19519477|NCT02965196|Hormones|hormones|mesh-ancestor
19519478|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519479|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19519480|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519481|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
19519482|NCT02965248|Leucovorin|leucovorin|mesh-list
19519483|NCT02965248|Capecitabine|capecitabine|mesh-list
19519484|NCT02965248|Raltitrexed|raltitrexed|mesh-list
19519485|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
19519486|NCT02965248|Calcium|calcium|mesh-list
19519487|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
19519488|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19519489|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519490|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19519491|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19519492|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
19519493|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519494|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519495|NCT02965248|Antidotes|antidotes|mesh-ancestor
19519496|NCT02965248|Protective Agents|protective agents|mesh-ancestor
19519497|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
19519498|NCT02965248|Vitamins|vitamins|mesh-ancestor
19519499|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
19519500|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19519501|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519502|NCT02965274|Fluoxetine|fluoxetine|mesh-list
19519503|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19519504|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19519505|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19519506|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519507|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519508|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
19519509|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519510|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19519511|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
19519512|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19519513|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19519514|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19519515|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519516|NCT02965261|Fluoxetine|fluoxetine|mesh-list
19519517|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19519518|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19519519|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19519520|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519521|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519522|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
19519523|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519524|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19519525|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
19519526|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19519527|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19519528|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19519529|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519530|NCT02965027|Prazosin|prazosin|mesh-list
19519531|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19519532|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19519533|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19519534|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19519535|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519536|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20100196|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100197|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
20100198|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100199|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100200|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100201|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
20100202|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519537|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519538|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519539|NCT02964715|Empagliflozin|empagliflozin|mesh-list
20100203|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100204|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19519540|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19519541|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519542|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519543|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519544|NCT02964949|Edoxaban|edoxaban|mesh-list
19519545|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19519546|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
19519547|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19519548|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
19519549|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519550|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519551|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
19519552|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
19519553|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19519554|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19519555|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19519556|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19519557|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519558|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
19519559|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519560|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519561|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19519562|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519563|NCT02964689|Pemetrexed|pemetrexed|mesh-list
19519564|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519565|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519566|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519567|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19519568|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19519569|NCT02964455|Docetaxel|docetaxel|mesh-list
19519570|NCT02964455|Nedaplatin|nedaplatin|mesh-list
19519571|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519572|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
19519573|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
19519574|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
19519575|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519576|NCT02964572|Empagliflozin|empagliflozin|mesh-list
19519577|NCT02964572|Glimepiride|glimepiride|mesh-list
19519578|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19519579|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519580|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519581|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519582|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19519583|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519584|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
19572482|NCT02702128|Coagulants|coagulants|mesh-ancestor
19572483|NCT02701933|Ketamine|ketamine|mesh-list
19572484|NCT02701933|Analgesics|analgesics|mesh-ancestor
19572485|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
19572486|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572487|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572488|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19572489|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19572490|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
19572491|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
19572492|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572493|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19572494|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19572495|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572496|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572497|NCT02701673|Pyridoxine|pyridoxine|mesh-list
19572498|NCT02701673|Gemcitabine|gemcitabine|mesh-list
19572499|NCT02701673|Azacitidine|azacitidine|mesh-list
19572500|NCT02701673|Melphalan|melphalan|mesh-list
19572501|NCT02701673|Busulfan|busulfan|mesh-list
19572502|NCT02701673|Belinostat|belinostat|mesh-list
19572503|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19572504|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
19572505|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748932|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100205|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100206|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
20100207|NCT00002839|Fluorouracil|fluorouracil|mesh-list
20100208|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100209|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
19519585|NCT02964195|Rifaximin|rifaximin|mesh-list
19519586|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19519587|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519588|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19519589|NCT02964104|Insulin|insulin|mesh-list
19519590|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19519591|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519592|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519593|NCT02964403|Indomethacin|indomethacin|mesh-list
19519594|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19519595|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19519596|NCT02964403|Analgesics|analgesics|mesh-ancestor
19519597|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
19519598|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519599|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519600|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519601|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100210|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100211|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100212|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100213|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
20100214|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100215|NCT00002840|Vincristine|vincristine|mesh-list
20100216|NCT00002840|Lomustine|lomustine|mesh-list
20100217|NCT00002840|Procarbazine|procarbazine|mesh-list
20100218|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100219|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100220|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100221|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100222|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100223|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100224|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100225|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
20100226|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
20100227|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519602|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
19519603|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
19519604|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19519605|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19519606|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519607|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519608|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
19519609|NCT02964091|Ledipasvir|ledipasvir|mesh-list
19519610|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
19519611|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519612|NCT02963779|Apremilast|apremilast|mesh-list
19519613|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19519614|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19519615|NCT02963779|Analgesics|analgesics|mesh-ancestor
19519616|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
19519617|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519618|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519619|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519620|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19519621|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19519622|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19519623|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519624|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519625|NCT02963896|Gentamicins|gentamicins|mesh-list
19519626|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19519627|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519628|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19519629|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519630|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519631|NCT02963402|Adalimumab|adalimumab|mesh-list
19519632|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519633|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100228|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
20100229|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100230|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100231|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19519634|NCT02963454|Simendan|simendan|mesh-list
19519635|NCT02963454|Dobutamine|dobutamine|mesh-list
20100232|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
19519636|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19519637|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
19519638|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19519639|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19519640|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519641|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519642|NCT02963454|Protective Agents|protective agents|mesh-ancestor
19519643|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519644|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
19519645|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
19519646|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519647|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19519648|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19519649|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19519650|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519651|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519652|NCT02963051|Copper|copper|mesh-list
19519653|NCT02963051|Disulfiram|disulfiram|mesh-list
19519654|NCT02963051|Trace Elements|trace elements|mesh-ancestor
19519655|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
19519656|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519657|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19519658|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19519659|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519660|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519661|NCT02963194|Oxytocin|oxytocin|mesh-list
19519662|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
19519663|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19519664|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519665|NCT02963129|Mupirocin|mupirocin|mesh-list
19519666|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19519667|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519668|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19519669|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519670|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519671|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
19519672|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19519673|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20100233|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519674|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
19519675|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519676|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19519677|NCT02963168|Docetaxel|docetaxel|mesh-list
19519678|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100234|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100235|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100236|NCT00002845|Aldesleukin|aldesleukin|mesh-list
20100237|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100238|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603528|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603529|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519679|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
19519680|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
19519681|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
19519682|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519683|NCT02963181|Melatonin|melatonin|mesh-list
19519684|NCT02963181|Yohimbine|yohimbine|mesh-list
19519685|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
19519686|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519687|NCT02963181|Protective Agents|protective agents|mesh-ancestor
19519688|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519689|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519690|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
19519691|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
19519692|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519693|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20603530|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
19519694|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19519695|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19519696|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519697|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519698|NCT02963181|Urological Agents|urological agents|mesh-ancestor
19519699|NCT02963337|Remifentanil|remifentanil|mesh-list
19519700|NCT02963337|Bupivacaine|bupivacaine|mesh-list
20603531|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519701|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
19519702|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
19748933|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
19519703|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519704|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100239|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20100240|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
20100241|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100242|NCT00002846|Aldesleukin|aldesleukin|mesh-list
20100243|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519705|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
19519706|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519707|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19519708|NCT02963337|Narcotics|narcotics|mesh-ancestor
19519709|NCT02963337|Analgesics|analgesics|mesh-ancestor
19519710|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
19519711|NCT02963090|Topotecan|topotecan|mesh-list
19519712|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19519713|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519714|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19519715|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19519716|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519717|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519718|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19519719|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19519720|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19519721|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
19519722|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519723|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19519724|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19519725|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519726|NCT02963103|Tacrolimus|tacrolimus|mesh-list
19519727|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519728|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
19519729|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100244|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20100245|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20100246|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
20100247|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100248|NCT00002847|Interferons|interferons|mesh-list
20100249|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
20100250|NCT00002847|Aldesleukin|aldesleukin|mesh-list
20100251|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519730|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19519731|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519732|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519733|NCT02962999|Ketamine|ketamine|mesh-list
19519734|NCT02962999|Analgesics|analgesics|mesh-ancestor
19519735|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
19519736|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519737|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519738|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19519739|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19519740|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
19519741|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
19519742|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519743|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19519744|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19519745|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20100252|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
19519746|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519747|NCT02962986|Phenylephrine|phenylephrine|mesh-list
19519748|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
19519749|NCT02962986|Norepinephrine|norepinephrine|mesh-list
19519750|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19519751|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
19519752|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
19519753|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519754|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519755|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
19519756|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19519757|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
19519758|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
19519759|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19519760|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19519761|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20100253|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519762|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
20100254|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
19519763|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519764|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519765|NCT02962986|Protective Agents|protective agents|mesh-ancestor
19519766|NCT02963324|Ivermectin|ivermectin|mesh-list
19519767|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19519768|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519769|NCT02962947|Propranolol|propranolol|mesh-list
19519770|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19519771|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19519772|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519773|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519774|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519775|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519776|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19519777|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19519778|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
19519779|NCT02962804|Nivolumab|nivolumab|mesh-list
19519780|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19519781|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519782|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19519783|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519784|NCT02962830|Sufentanil|sufentanil|mesh-list
19519785|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19519786|NCT02962830|Narcotics|narcotics|mesh-ancestor
19519787|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519788|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519789|NCT02962830|Analgesics|analgesics|mesh-ancestor
19519790|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
19519791|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519792|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19519793|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19519794|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
19519795|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
19519796|NCT02962921|Insulin|insulin|mesh-list
19519797|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19519798|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
19519799|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519800|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519801|NCT02962232|Paclitaxel|paclitaxel|mesh-list
19519802|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19519803|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519804|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
19519805|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
19519806|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
19519807|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519808|NCT02962388|Anagrelide|anagrelide|mesh-list
19519809|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19519810|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19519811|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519812|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19519813|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
19519814|NCT02962401|Idelalisib|idelalisib|mesh-list
19519815|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19519816|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519817|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519818|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519819|NCT02962258|Amlodipine|amlodipine|mesh-list
19519820|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19519821|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19519822|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19519823|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19519824|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519825|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19519826|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519827|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
19519828|NCT02962258|Diuretics|diuretics|mesh-ancestor
19519829|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
19519830|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19519831|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
19519832|NCT02962492|Exenatide|exenatide|mesh-list
19519833|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19519834|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519835|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19519836|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519837|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19519838|NCT02962492|Incretins|incretins|mesh-ancestor
19519839|NCT02962492|Hormones|hormones|mesh-ancestor
19519840|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572506|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603532|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603533|NCT02221479|Plerixafor|plerixafor|mesh-list
19572507|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
19572508|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572509|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572510|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572511|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
19572512|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572513|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19572514|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
19572515|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19572516|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
19572517|NCT02701673|Vitamins|vitamins|mesh-ancestor
19572518|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
19572519|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19572520|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19572521|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19572522|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100255|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572523|NCT02701595|Amoxicillin|amoxicillin|mesh-list
19572524|NCT02701595|Vancomycin|vancomycin|mesh-list
19572525|NCT02701595|Gentamicins|gentamicins|mesh-list
19572526|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
19572527|NCT02701595|Penicillins|penicillins|mesh-list
19572528|NCT02701595|Penicillin G|penicillin g|mesh-list
19572529|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19572530|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
19572531|NCT02701595|Netilmicin|netilmicin|mesh-list
19572532|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572533|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572534|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19572535|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572536|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572537|NCT02701608|Levofloxacin|levofloxacin|mesh-list
19572538|NCT02701608|Ofloxacin|ofloxacin|mesh-list
19572539|NCT02701608|Rifampin|rifampin|mesh-list
19572540|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
19572541|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19572542|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100256|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20100257|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20100258|NCT00002849|Interferons|interferons|mesh-list
20100259|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
19572543|NCT02701608|Renal Agents|renal agents|mesh-ancestor
19572544|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572545|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19572546|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19572547|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572548|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572549|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572550|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20100260|NCT00002849|Dexamethasone|dexamethasone|mesh-list
20100261|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572551|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19572552|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19572553|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
19572554|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
19572555|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19572556|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19572557|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20100262|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
20100263|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
20100264|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100265|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100266|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100267|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
20100268|NCT00002849|Hormones|hormones|mesh-ancestor
20100269|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603534|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19572558|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20100270|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100271|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100272|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
20100273|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100274|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
20100275|NCT00002852|Paclitaxel|paclitaxel|mesh-list
20100276|NCT00002852|Carboplatin|carboplatin|mesh-list
20100277|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100278|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100279|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100280|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100281|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100282|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100283|NCT00002854|Paclitaxel|paclitaxel|mesh-list
20100284|NCT00002854|Etoposide|etoposide|mesh-list
19519841|NCT02962518|Triamcinolone|triamcinolone|mesh-list
20100285|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
19519842|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519843|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
19519844|NCT02962518|Hormones|hormones|mesh-ancestor
19519845|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19519846|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519847|NCT02962336|Amlodipine|amlodipine|mesh-list
19519848|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19519849|NCT02962336|Olmesartan|olmesartan|mesh-list
19519850|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19519851|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19519852|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19519853|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19519854|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519855|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19519856|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519857|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
19519858|NCT02962336|Diuretics|diuretics|mesh-ancestor
19519859|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
19519860|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19519861|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19519862|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19519863|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19519864|NCT02962310|Calcium|calcium|mesh-list
19519865|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19519866|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519867|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19519868|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19519869|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
19519870|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519871|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19519872|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19519873|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519874|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19519875|NCT02962323|Calcium|calcium|mesh-list
19519876|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19519877|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519878|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19519879|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19519880|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
19519881|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519882|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20100286|NCT00002854|Carboplatin|carboplatin|mesh-list
20100287|NCT00002854|Ifosfamide|ifosfamide|mesh-list
20100288|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100289|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100290|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100291|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100292|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100293|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100294|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100295|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
20100296|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100297|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100298|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100299|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
20100300|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100301|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100302|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19519883|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19519884|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519885|NCT02962050|Capsaicin|capsaicin|mesh-list
19519886|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
19519887|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
19519888|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
19519889|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519890|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519891|NCT02962141|Paclitaxel|paclitaxel|mesh-list
19519892|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19519893|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519894|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
19519895|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
19519896|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
19519897|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519898|NCT02961855|Diclofenac|diclofenac|mesh-list
19519899|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19519900|NCT02961855|Lidocaine|lidocaine|mesh-list
19519901|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
19519902|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
19519903|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519904|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519905|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
19519906|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519907|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19519908|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19519909|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19519910|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19519911|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519912|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19519913|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19519914|NCT02961855|Analgesics|analgesics|mesh-ancestor
19519915|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19519916|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19519917|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519918|NCT02961998|Celecoxib|celecoxib|mesh-list
19519919|NCT02961998|Sorafenib|sorafenib|mesh-list
19519920|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19519921|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19519922|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519923|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519924|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19519925|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19519926|NCT02961998|Analgesics|analgesics|mesh-ancestor
19519927|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
20603535|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20603536|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
20603537|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603538|NCT02221492|Plerixafor|plerixafor|mesh-list
20603539|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20603540|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20603541|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
20603542|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603543|NCT02221531|Carbetocin|carbetocin|mesh-list
20603544|NCT02221531|Oxytocin|oxytocin|mesh-list
20603545|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
20603546|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20603547|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607904|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20607905|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20607906|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20607907|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607908|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20607909|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20607910|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20607911|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20607912|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
19519928|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519929|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519930|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19519931|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19519932|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19519933|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20607913|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
20607914|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
20607915|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
19519934|NCT02961829|Niacinamide|niacinamide|mesh-list
19519935|NCT02961829|Maraviroc|maraviroc|mesh-list
19519936|NCT02961829|Dolutegravir|dolutegravir|mesh-list
19519937|NCT02961829|Auranofin|auranofin|mesh-list
19519938|NCT02961829|Vaccines|vaccines|mesh-list
19519939|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19519940|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
19519941|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519942|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19519943|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19519944|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519945|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19519946|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19519947|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
19519948|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19519949|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19519950|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19519951|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19519952|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519953|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
19519954|NCT02961829|Vitamins|vitamins|mesh-ancestor
19519955|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
19519956|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19519957|NCT02961842|Ephedrine|ephedrine|mesh-list
19519958|NCT02961842|Fentanyl|fentanyl|mesh-list
19519959|NCT02961842|Bupivacaine|bupivacaine|mesh-list
20100303|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100304|NCT00002855|Ketoconazole|ketoconazole|mesh-list
20100305|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
20100306|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20603548|NCT02221570|Baclofen|baclofen|mesh-list
20603549|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20603550|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603551|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20603552|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603553|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19519960|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
19519961|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
19519962|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519963|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100307|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20100308|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20100309|NCT00002855|Doxorubicin|doxorubicin|mesh-list
20100310|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20100311|NCT00002855|Bicalutamide|bicalutamide|mesh-list
20100312|NCT00002855|Vinblastine|vinblastine|mesh-list
20100313|NCT00002855|Flutamide|flutamide|mesh-list
20603554|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
19519964|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
19519965|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519966|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19519967|NCT02961842|Narcotics|narcotics|mesh-ancestor
19519968|NCT02961842|Analgesics|analgesics|mesh-ancestor
19519969|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19519970|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19519971|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
19519972|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19519973|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
19519974|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
19519975|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19519976|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
19519977|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519978|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519979|NCT02962024|Morphine|morphine|mesh-list
19519980|NCT02962024|Bupivacaine|bupivacaine|mesh-list
19519981|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
19519982|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
19519983|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20100314|NCT00002855|Estramustine|estramustine|mesh-list
20603555|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
20603556|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19519984|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519985|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
19519986|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19519987|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19519988|NCT02962024|Narcotics|narcotics|mesh-ancestor
19519989|NCT02962024|Analgesics|analgesics|mesh-ancestor
20100315|NCT00002855|Nilutamide|nilutamide|mesh-list
20306209|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
20100316|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100317|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100318|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20603557|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603558|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
20603559|NCT02221583|Tacrolimus|tacrolimus|mesh-list
20603560|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19519990|NCT02962037|Melatonin|melatonin|mesh-list
20100319|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100320|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19519991|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
19519992|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19519993|NCT02962037|Protective Agents|protective agents|mesh-ancestor
19519994|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19519995|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19519996|NCT02961816|Pyridoxine|pyridoxine|mesh-list
19519997|NCT02961816|Gemcitabine|gemcitabine|mesh-list
19519998|NCT02961816|Dexamethasone|dexamethasone|mesh-list
19519999|NCT02961816|Rituximab|rituximab|mesh-list
19520000|NCT02961816|Melphalan|melphalan|mesh-list
19520001|NCT02961816|Busulfan|busulfan|mesh-list
19520002|NCT02961816|Panobinostat|panobinostat|mesh-list
19520003|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19520004|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520005|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
19520006|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520007|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520008|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520009|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
19520010|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
19520011|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520012|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520013|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
19520014|NCT02961816|Hormones|hormones|mesh-ancestor
19520015|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520016|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19520017|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19520018|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
19520019|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520020|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
19520021|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520022|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520023|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520024|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19520025|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
19520026|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19520027|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19520028|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
19520029|NCT02961816|Vitamins|vitamins|mesh-ancestor
19520030|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
19520031|NCT02961803|Biotin|biotin|mesh-list
19520032|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
19520033|NCT02961803|Vitamins|vitamins|mesh-ancestor
19520034|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
19520035|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520036|NCT02961660|Odalasvir|odalasvir|mesh-list
19520037|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
19520038|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520039|NCT02961608|Tacrolimus|tacrolimus|mesh-list
19520040|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520041|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
19520042|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520043|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19520044|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520045|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520046|NCT02961634|Ciclopirox|ciclopirox|mesh-list
20100321|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100322|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20100323|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
20100324|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603561|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
20603562|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603563|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19520047|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
19520048|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520049|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19520050|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520051|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520052|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520053|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19520054|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
19520055|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19520056|NCT02961166|Antibodies|antibodies|mesh-list
19520057|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
20100325|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20100326|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20100327|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20100328|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
20100329|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100330|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100331|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20100332|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
20100333|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100334|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100335|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100336|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
19520058|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520059|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
19520060|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
19520061|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520062|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
19520063|NCT02961361|Ropivacaine|ropivacaine|mesh-list
19520064|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19520065|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520066|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520067|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520068|NCT02961361|Analgesics|analgesics|mesh-ancestor
19520069|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
19520070|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520071|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19520072|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19520073|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19520074|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
19520075|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520076|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520077|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
19520078|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
19520079|NCT02961101|Decitabine|decitabine|mesh-list
19520080|NCT02961101|Antibodies|antibodies|mesh-list
19520081|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
19520082|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520083|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19520084|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
19520085|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520086|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520087|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520088|NCT02961075|Anesthetics|anesthetics|mesh-list
19520089|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520090|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520091|NCT02960828|Bevacizumab|bevacizumab|mesh-list
19520092|NCT02960828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19520093|NCT02960828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520094|NCT02960828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19520095|NCT02960828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19520096|NCT02960828|Growth Substances|growth substances|mesh-ancestor
19520097|NCT02960828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520098|NCT02960828|Growth Inhibitors|growth inhibitors|mesh-ancestor
19520099|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
19520100|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
19520101|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19520102|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
19520103|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19520104|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
19520105|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520106|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520107|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
19520108|NCT02960906|Nivolumab|nivolumab|mesh-list
19520109|NCT02960906|Ipilimumab|ipilimumab|mesh-list
19520110|NCT02960906|Sunitinib|sunitinib|mesh-list
19520111|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19520112|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603564|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603565|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603566|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20603567|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603568|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19520113|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19520114|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520115|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19520116|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19520117|NCT02960906|Growth Substances|growth substances|mesh-ancestor
19520118|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520119|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
19520120|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19520121|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572559|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19572560|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19572561|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19572562|NCT02701348|Letrozole|letrozole|mesh-list
19572563|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19572564|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572565|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19572566|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572567|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572568|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19572569|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
19572570|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572571|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572572|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
19572573|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19572574|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
19572575|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
19572576|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572577|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572578|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572579|NCT02701478|Analgesics|analgesics|mesh-ancestor
19572580|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
20603569|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
20603570|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572581|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572582|NCT02701517|Cyclosporine|cyclosporine|mesh-list
19572583|NCT02701517|Methotrexate|methotrexate|mesh-list
19572584|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
19572585|NCT02701517|Cyclosporins|cyclosporins|mesh-list
20603571|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603572|NCT02221596|Vitamin D|vitamin d|mesh-list
20603573|NCT02221596|Vitamins|vitamins|mesh-ancestor
20603574|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
19572586|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19572587|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
19572588|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19572589|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572590|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19572591|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
19572592|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572593|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572594|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
19572595|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572596|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19572597|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572598|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
19572599|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572600|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19572601|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
19572602|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572603|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19572604|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19572605|NCT02701309|Iron|iron|mesh-list
19572606|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
19572607|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
19572608|NCT02701309|Trace Elements|trace elements|mesh-ancestor
19572609|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
19572610|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572611|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20603575|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520122|NCT02960919|Amoxicillin|amoxicillin|mesh-list
19520123|NCT02960919|Gentamicins|gentamicins|mesh-list
19520124|NCT02960919|Penicillins|penicillins|mesh-list
19520125|NCT02960919|Ampicillin|ampicillin|mesh-list
19520126|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19520127|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520128|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19520129|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520130|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520131|NCT02960815|Imiquimod|imiquimod|mesh-list
19520132|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19520133|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
19520134|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520135|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520136|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
19520137|NCT02960503|Azithromycin|azithromycin|mesh-list
20603576|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20603577|NCT02221622|Pregnanolone|pregnanolone|mesh-list
20603578|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20603579|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
20603580|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603581|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603582|NCT02221635|Risperidone|risperidone|mesh-list
20603583|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20603584|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
20603585|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20607916|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20100337|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19520138|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19520139|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520140|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
19520141|NCT02960646|Melphalan|melphalan|mesh-list
19520142|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
19520143|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19520144|NCT02960646|Rituximab|rituximab|mesh-list
19520145|NCT02960646|Fludarabine|fludarabine|mesh-list
19520146|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
19520147|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19520148|NCT02960646|Tacrolimus|tacrolimus|mesh-list
19520149|NCT02960646|Antibodies|antibodies|mesh-list
19520150|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
19520151|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19520152|NCT02960646|Lenograstim|lenograstim|mesh-list
19520153|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520154|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
19520155|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520156|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520157|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19520158|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
19520159|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520160|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520161|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19520162|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19520163|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
19520164|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19520165|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19520166|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520167|NCT02960412|Furosemide|furosemide|mesh-list
19520168|NCT02960412|Diuretics|diuretics|mesh-ancestor
19520169|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
19520170|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520171|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19520172|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19520173|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520174|NCT02960711|Metformin|metformin|mesh-list
19520175|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19520176|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520177|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
19520178|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520179|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
20100338|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100339|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
19520180|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
19520181|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
19520182|NCT02960126|Aspirin|aspirin|mesh-list
19520183|NCT02960126|Clopidogrel|clopidogrel|mesh-list
19520184|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19520185|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520186|NCT02960126|Analgesics|analgesics|mesh-ancestor
19520187|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
19520188|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520189|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520190|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520191|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520192|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19520193|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19520194|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520195|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19520196|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19520197|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100340|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
20100341|NCT00002858|Doxorubicin|doxorubicin|mesh-list
20100342|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20100343|NCT00002858|Etoposide|etoposide|mesh-list
20100344|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100345|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
20100346|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100347|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100348|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100349|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
20100350|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100351|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100352|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100353|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100354|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100355|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100356|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100357|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100358|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
20100359|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100360|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100361|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100362|NCT00002864|Tamoxifen|tamoxifen|mesh-list
20100363|NCT00002864|Octreotide|octreotide|mesh-list
20100364|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20100365|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
20100366|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100367|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100368|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100369|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100370|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20100371|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20100372|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20100373|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100374|NCT00002865|Leucovorin|leucovorin|mesh-list
20100375|NCT00002865|Cobalt|cobalt|mesh-list
20100376|NCT00002865|Cytarabine|cytarabine|mesh-list
20100377|NCT00002865|Dexamethasone|dexamethasone|mesh-list
20100378|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
20100379|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20100380|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19520198|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
19520199|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19520200|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19520201|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19520202|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
19520203|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520204|NCT02960113|Scopolamine|scopolamine|mesh-list
19520205|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19520206|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19520207|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
19520208|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
19520209|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520210|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520211|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520212|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
19520213|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19520214|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
19520215|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520216|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100381|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20100382|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
19520217|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19520218|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
19520219|NCT02959957|Cefotaxime|cefotaxime|mesh-list
19520220|NCT02959957|Cefoxitin|cefoxitin|mesh-list
19520221|NCT02959957|Temocillin|temocillin|mesh-list
19520222|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19520223|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520224|NCT02960035|Etanercept|etanercept|mesh-list
19520225|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19520226|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520227|NCT02960035|Analgesics|analgesics|mesh-ancestor
19520228|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
19520229|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520230|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520231|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520232|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520233|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520234|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520235|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
19520236|NCT02959879|Folfirinox|folfirinox|mesh-list
19520237|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520238|NCT02959905|Vidarabine|vidarabine|mesh-list
19520239|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
19520240|NCT02959905|Fludarabine|fludarabine|mesh-list
19520241|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
19520242|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520243|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
19520244|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520245|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520246|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19520247|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
19520248|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520249|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520250|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19520251|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19520252|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
19520253|NCT02959905|Antiviral Agents|antiviral agents|mesh-ancestor
19520254|NCT02959905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520255|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
19520256|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
19520257|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520258|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
19520259|NCT02959762|Vitamins|vitamins|mesh-list
19520260|NCT02959762|Vitamin K|vitamin k|mesh-list
19520261|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
19520262|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
19520263|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
19520264|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520265|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19520266|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19520267|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520268|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
19520269|NCT02959762|Coagulants|coagulants|mesh-ancestor
19520270|NCT02959749|Bevacizumab|bevacizumab|mesh-list
19520271|NCT02959749|Docetaxel|docetaxel|mesh-list
19520272|NCT02959749|Osimertinib|osimertinib|mesh-list
19520273|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19520274|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520275|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19520276|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19520277|NCT02959749|Growth Substances|growth substances|mesh-ancestor
19520278|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520279|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
19520280|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
19520281|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
19520282|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
19520283|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520284|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19520285|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520286|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19520287|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
19520288|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520289|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
19520290|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520291|NCT02959697|Lidocaine|lidocaine|mesh-list
19520292|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
19520293|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
19520294|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520295|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520296|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
19520297|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520298|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19520299|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19520300|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19520301|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19520302|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520303|NCT02959554|Nivolumab|nivolumab|mesh-list
19520304|NCT02959554|Sunitinib|sunitinib|mesh-list
19520305|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19520306|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520307|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19520308|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520309|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19520310|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19520311|NCT02959554|Growth Substances|growth substances|mesh-ancestor
19520312|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520313|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
19520314|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19520315|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520316|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
19520317|NCT02959606|Clopidogrel|clopidogrel|mesh-list
19520318|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19520319|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19520320|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19520321|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19520322|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
19520323|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520324|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520325|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520326|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19520327|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19520328|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19520329|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
19520330|NCT02959541|Leucovorin|leucovorin|mesh-list
19520331|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
20100383|NCT00002865|Ifosfamide|ifosfamide|mesh-list
20100384|NCT00002865|Doxorubicin|doxorubicin|mesh-list
20100385|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20100386|NCT00002865|Methotrexate|methotrexate|mesh-list
20100387|NCT00002865|Etoposide|etoposide|mesh-list
19520332|NCT02959541|Antidotes|antidotes|mesh-ancestor
19520333|NCT02959541|Protective Agents|protective agents|mesh-ancestor
19520334|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520335|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
19520336|NCT02959541|Vitamins|vitamins|mesh-ancestor
19520337|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
19520338|NCT02959476|Ropivacaine|ropivacaine|mesh-list
19520339|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
19520340|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
19520341|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520342|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520343|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
19520344|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520345|NCT02959255|Esomeprazole|esomeprazole|mesh-list
19520346|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19520347|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520348|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19520349|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520350|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520351|NCT02959229|Lactoferrin|lactoferrin|mesh-list
19520352|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520353|NCT02959359|Ribavirin|ribavirin|mesh-list
19520354|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
19520355|NCT02959359|Ledipasvir|ledipasvir|mesh-list
19520356|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
19520357|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520358|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
19520359|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520360|NCT02959411|Tolvaptan|tolvaptan|mesh-list
19520361|NCT02959411|Diuretics|diuretics|mesh-list
20100388|NCT00002865|Vincristine|vincristine|mesh-list
19520362|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
19520363|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520364|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19572612|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100389|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
19520365|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520366|NCT02959125|Micronutrients|micronutrients|mesh-list
19520367|NCT02959125|Trace Elements|trace elements|mesh-list
19520368|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520369|NCT02959112|Indomethacin|indomethacin|mesh-list
19520370|NCT02959112|Epinephrine|epinephrine|mesh-list
19520371|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19520372|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19520373|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
19520374|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520375|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520376|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520377|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19520378|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19520379|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
19520380|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520381|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19520382|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
19520383|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
19520384|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
19520385|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19520386|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19520387|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520388|NCT02959112|Analgesics|analgesics|mesh-ancestor
19520389|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
19520390|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520391|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520392|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
19520393|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
19520394|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19520395|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19520396|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520397|NCT02959060|Rifampin|rifampin|mesh-list
19520398|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19520399|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
19520400|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19520401|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520402|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
19520403|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19520404|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520405|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520406|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19520407|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19520408|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19520409|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19520410|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19520411|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19520412|NCT02958917|Pirfenidone|pirfenidone|mesh-list
19520413|NCT02958917|Analgesics|analgesics|mesh-ancestor
19520414|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
19520415|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520416|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520417|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19520418|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520419|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520420|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520421|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520422|NCT02958852|Letrozole|letrozole|mesh-list
19520423|NCT02958852|Fulvestrant|fulvestrant|mesh-list
19520424|NCT02958852|Atorvastatin|atorvastatin|mesh-list
19520425|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19520426|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19520427|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
19520428|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520429|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19520430|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19520431|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520432|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520433|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19520434|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19520435|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19520436|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
19520437|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520438|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520439|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19520440|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19520441|NCT02958878|Tamsulosin|tamsulosin|mesh-list
19520442|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19520443|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19520444|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19520445|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
19520446|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520447|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520448|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520449|NCT02958878|Urological Agents|urological agents|mesh-ancestor
19520450|NCT02958800|Olanzapine|olanzapine|mesh-list
19520451|NCT02958800|Risperidone|risperidone|mesh-list
19520452|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19520453|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
19520454|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19520455|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
20100390|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100391|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
19520456|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520457|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520458|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520459|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19520460|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520461|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19520462|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19520463|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
19520464|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
19520465|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
19520466|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520467|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520468|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19520469|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19520470|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19520471|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
19520472|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
19520473|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19520474|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
19520475|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520476|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
19520477|NCT02958761|Protective Agents|protective agents|mesh-ancestor
19572613|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572614|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572615|NCT02701179|Lidocaine|lidocaine|mesh-list
19572616|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20100392|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100393|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100394|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100395|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
20100396|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100397|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100398|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100399|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20100400|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
20100401|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
20100402|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100403|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100404|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
19572617|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
19572618|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
19572619|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572620|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572621|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
19572622|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572623|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19572624|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19572625|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19572626|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572627|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100405|NCT00002865|Hormones|hormones|mesh-ancestor
20100406|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100407|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100408|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100409|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100410|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100411|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100412|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20100413|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
20100414|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20100415|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100416|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
20100417|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100418|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20100419|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19520478|NCT02958566|Acetaminophen|acetaminophen|mesh-list
19520479|NCT02958566|Ketorolac|ketorolac|mesh-list
19520480|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19520481|NCT02958566|Lidocaine|lidocaine|mesh-list
19520482|NCT02958566|Fentanyl|fentanyl|mesh-list
19520483|NCT02958566|Ketamine|ketamine|mesh-list
19520484|NCT02958566|Morphine|morphine|mesh-list
20100420|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100421|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
20100422|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100423|NCT00002865|Antidotes|antidotes|mesh-ancestor
20100424|NCT00002865|Protective Agents|protective agents|mesh-ancestor
20100425|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
20100426|NCT00002865|Vitamins|vitamins|mesh-ancestor
20100427|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
20100428|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100429|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100430|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100431|NCT00002865|Trace Elements|trace elements|mesh-ancestor
20100432|NCT00002866|Docetaxel|docetaxel|mesh-list
20100433|NCT00002866|Epirubicin|epirubicin|mesh-list
19520485|NCT02958566|Gabapentin|gabapentin|mesh-list
19520486|NCT02958566|Tramadol|tramadol|mesh-list
19520487|NCT02958566|Methadone|methadone|mesh-list
20100434|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100435|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100436|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
19520488|NCT02958566|Hydrocodone|hydrocodone|mesh-list
19520489|NCT02958566|Hydromorphone|hydromorphone|mesh-list
19520490|NCT02958566|Orphenadrine|orphenadrine|mesh-list
19520491|NCT02958566|Bupivacaine|bupivacaine|mesh-list
19520492|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
19520493|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
19520494|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520495|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520496|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
19520497|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520498|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19520499|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20100437|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100438|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100439|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100440|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100441|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100442|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100443|NCT00002868|Interferons|interferons|mesh-list
20100444|NCT00002868|Cytarabine|cytarabine|mesh-list
20100445|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
20100446|NCT00002868|Etoposide|etoposide|mesh-list
20603586|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520500|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19520501|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19520502|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520503|NCT02958566|Analgesics|analgesics|mesh-ancestor
19520504|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19520505|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19520506|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
19520507|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19520508|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19520509|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520510|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19520511|NCT02958566|Narcotics|narcotics|mesh-ancestor
19520512|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19520513|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520514|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
20100447|NCT00002868|Idarubicin|idarubicin|mesh-list
20100448|NCT00002868|Busulfan|busulfan|mesh-list
20100449|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
20100450|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100451|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100452|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100453|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100454|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100455|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100456|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
20100457|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520515|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
19520516|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19520517|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19520518|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19520519|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
19520520|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19520521|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520522|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520523|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19520524|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520525|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
19520526|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
19520527|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19520528|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19520529|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19520530|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19520531|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
19520532|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
19520533|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19520534|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19520535|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
19520536|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
19520537|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19520538|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
19520539|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19520540|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520541|NCT02958501|Vitamins|vitamins|mesh-ancestor
19520542|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
19520543|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19520544|NCT02958631|Losartan|losartan|mesh-list
19520545|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19520546|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19520547|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19520548|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19520549|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520550|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
19520551|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19520552|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
19520553|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520554|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520555|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520556|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19520557|NCT02958059|Cefoxitin|cefoxitin|mesh-list
19520558|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520559|NCT02958046|Domperidone|domperidone|mesh-list
19520560|NCT02958046|Lansoprazole|lansoprazole|mesh-list
19520561|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
19520562|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19520563|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520564|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19520565|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520566|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520567|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
19520568|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
19520569|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520570|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520571|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19520572|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
19520573|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520574|NCT02957994|Tenofovir|tenofovir|mesh-list
19520575|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
19520576|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520577|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19520578|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19520579|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572628|NCT02701127|Niacinamide|niacinamide|mesh-list
19572629|NCT02701127|Niacin|niacin|mesh-list
19520580|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520581|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19520582|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19520583|NCT02958111|Capecitabine|capecitabine|mesh-list
19520584|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19520585|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
19520586|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520587|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520588|NCT02958163|Doxorubicin|doxorubicin|mesh-list
19520589|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19520590|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520591|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19520592|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19520593|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520594|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520595|NCT02958215|Phenylephrine|phenylephrine|mesh-list
19520596|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
19520597|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19520598|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
19520599|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
19520600|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520601|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520602|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
19520603|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19520604|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
19520605|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
20100458|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100459|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
20100460|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100461|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
20100462|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100463|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
20100464|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19520606|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19520607|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19520608|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19520609|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
19520610|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520611|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520612|NCT02958215|Protective Agents|protective agents|mesh-ancestor
19520613|NCT02957903|Ropivacaine|ropivacaine|mesh-list
20100465|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100466|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100467|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
20100468|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20100469|NCT00002869|Interferons|interferons|mesh-list
20100470|NCT00002869|Cytarabine|cytarabine|mesh-list
20100471|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
20100472|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
20100473|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100474|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
20100475|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100476|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100477|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
20100478|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100479|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100480|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
20100481|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100482|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
19520614|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
19520615|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
19520616|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520617|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520618|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
19520619|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520620|NCT02957864|Tenofovir|tenofovir|mesh-list
19520621|NCT02957864|Abacavir|abacavir|mesh-list
19520622|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
19520623|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520624|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19520625|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19520626|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100483|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603587|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603588|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19520627|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520628|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19520629|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19520630|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
19520631|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520632|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
19520633|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520634|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520635|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19520636|NCT02957786|Varenicline|varenicline|mesh-list
19520637|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19520638|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19520639|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
19520640|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520641|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520642|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520643|NCT02957877|Heparin|heparin|mesh-list
19520644|NCT02957877|Calcium heparin|calcium heparin|mesh-list
19520645|NCT02957877|Nadroparin|nadroparin|mesh-list
19520646|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
19520647|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19520648|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19520649|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520650|NCT02957890|Vaccines|vaccines|mesh-list
19520651|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
20603589|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20603590|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603591|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20603592|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19520652|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520653|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
19520654|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19520655|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
19520656|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
19520657|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520658|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520659|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520660|NCT02957851|Analgesics|analgesics|mesh-ancestor
19520661|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
19520662|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520663|NCT02957643|Iron|iron|mesh-list
19520664|NCT02957643|Trace Elements|trace elements|mesh-ancestor
20603593|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
20603594|NCT02221752|Folic Acid|folic acid|mesh-list
20603595|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
19520665|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
19520666|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520667|NCT02957604|Evolocumab|evolocumab|mesh-list
19520668|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19520669|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19520670|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
19520671|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520672|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19520673|NCT02957435|Eplerenone|eplerenone|mesh-list
19520674|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19520675|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
19520676|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520677|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520678|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19520679|NCT02957435|Diuretics|diuretics|mesh-ancestor
19520680|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
19520681|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19520682|NCT02957448|Rifampin|rifampin|mesh-list
19520683|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19520684|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
19520685|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19520686|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748934|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748935|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520687|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
20603596|NCT02221752|Hematinics|hematinics|mesh-ancestor
19520688|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19520689|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520690|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520691|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19520692|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19520693|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19520694|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19520695|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19520696|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19520697|NCT02957656|Vaccines|vaccines|mesh-list
19520698|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
19520699|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520700|NCT02957630|Drospirenone|drospirenone|mesh-list
19520701|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
19520702|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19520703|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19520704|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
19520705|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19520706|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520707|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19520708|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19520709|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19520710|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19520711|NCT02957630|Estrogens|estrogens|mesh-ancestor
19520712|NCT02957630|Hormones|hormones|mesh-ancestor
19520713|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520714|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19520715|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
19520716|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19520717|NCT02957630|Diuretics|diuretics|mesh-ancestor
19520718|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
19520719|NCT02957474|Omeprazole|omeprazole|mesh-list
19520720|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19520721|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520722|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19520723|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520724|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520725|NCT02957266|Gemcitabine|gemcitabine|mesh-list
19520726|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520727|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19520728|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
19520729|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520730|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
19520731|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520732|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520733|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520734|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
19520735|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520736|NCT02957162|Atorvastatin|atorvastatin|mesh-list
19520737|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19520738|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19520739|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
19520740|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520741|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19520742|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19520743|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520744|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19520745|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520746|NCT02957097|Gabapentin|gabapentin|mesh-list
19520747|NCT02957097|Analgesics|analgesics|mesh-ancestor
19520748|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
19520749|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520750|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520751|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
19520752|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19520753|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19520754|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520755|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19520756|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19520757|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19520758|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520759|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520760|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
19572630|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
19572631|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
19572632|NCT02701127|Vitamins|vitamins|mesh-ancestor
19572633|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
19572634|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572635|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19572636|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
19572637|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572638|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19572639|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
19572640|NCT02701166|Bezafibrate|bezafibrate|mesh-list
19572641|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19572642|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
19572643|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572644|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19572645|NCT02700893|Atropine|atropine|mesh-list
19572646|NCT02700893|Sufentanil|sufentanil|mesh-list
19572647|NCT02700893|Propofol|propofol|mesh-list
19572648|NCT02700893|Atracurium|atracurium|mesh-list
19572649|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19572650|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572651|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572652|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19572653|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
19572654|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
19572655|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19572656|NCT02700893|Narcotics|narcotics|mesh-ancestor
19572657|NCT02700893|Analgesics|analgesics|mesh-ancestor
19572658|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
19572659|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603597|NCT02221752|Vitamins|vitamins|mesh-ancestor
20603598|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
20603599|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603600|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
20603601|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20603602|NCT02221765|Hormones|hormones|mesh-ancestor
20603603|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603604|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603605|NCT02221830|Oxytocin|oxytocin|mesh-list
20603606|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
20603607|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20603608|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603609|NCT02221960|Durvalumab|durvalumab|mesh-list
20603610|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20603611|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603612|NCT02221999|Paclitaxel|paclitaxel|mesh-list
20603613|NCT02221999|Letrozole|letrozole|mesh-list
19572660|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19572661|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19572662|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20603614|NCT02221999|Hormones|hormones|mesh-list
19520761|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
19520762|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520763|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
19520764|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19520765|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520766|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19520767|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520768|NCT02956655|Insulin|insulin|mesh-list
19520769|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19520770|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19520771|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520772|NCT02956538|Thalidomide|thalidomide|mesh-list
19520773|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520774|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
19520775|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520776|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
19520777|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19520778|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19520779|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19520780|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19520781|NCT02956538|Growth Substances|growth substances|mesh-ancestor
19520782|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
19520783|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520784|NCT02956785|Dinoprostone|dinoprostone|mesh-list
19520785|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
19520786|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19520787|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520788|NCT02957409|Valsartan|valsartan|mesh-list
19520789|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19520790|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19520791|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19520792|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520793|NCT02956590|Pitavastatin|pitavastatin|mesh-list
19520794|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19520795|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19520796|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19520797|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
19520798|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520799|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520800|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19520801|NCT02956447|Hormones|hormones|mesh-list
19520802|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520803|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520804|NCT02956252|Anesthetics|anesthetics|mesh-list
19520805|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520806|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520807|NCT02956408|Vitamin D|vitamin d|mesh-list
19520808|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
19520809|NCT02956408|Vitamins|vitamins|mesh-ancestor
19520810|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
19520811|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100484|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20100485|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
20100486|NCT00002870|Thiotepa|thiotepa|mesh-list
20100487|NCT00002870|Fluorouracil|fluorouracil|mesh-list
20100488|NCT00002870|Epirubicin|epirubicin|mesh-list
20100489|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100490|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
20100491|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100492|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100493|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100494|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
20100495|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100496|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100497|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100498|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
20100499|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100500|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100501|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100502|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19520812|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19520813|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19520814|NCT02956421|Vaccines|vaccines|mesh-list
19520815|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
19520816|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520817|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19520818|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19520819|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520820|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520821|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
19520822|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520823|NCT02955810|Dexamethasone|dexamethasone|mesh-list
19520824|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
19520825|NCT02955810|Bortezomib|bortezomib|mesh-list
20100503|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100504|NCT00002872|Doxycycline|doxycycline|mesh-list
20100505|NCT00002872|Bleomycin|bleomycin|mesh-list
20100506|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20100507|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100508|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
20100509|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20100510|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20100511|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100512|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100513|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
20100514|NCT00002875|Lomustine|lomustine|mesh-list
20100515|NCT00002875|Cisplatin|cisplatin|mesh-list
20100516|NCT00002875|Vincristine|vincristine|mesh-list
20100517|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100518|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
20100519|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100520|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520826|NCT02955810|Daratumumab|daratumumab|mesh-list
19520827|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520828|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
19520829|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520830|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520831|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19520832|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
19520833|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520834|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520835|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19520836|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520837|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
19520838|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
19520839|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520840|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520841|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
19520842|NCT02955810|Hormones|hormones|mesh-ancestor
19520843|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520844|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19520845|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19520846|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19520847|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
19520848|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19520849|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520850|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520851|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520852|NCT02955732|Analgesics|analgesics|mesh-ancestor
19520853|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
19520854|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520855|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19520856|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20100521|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100522|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
20100523|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100524|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100525|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20100526|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100527|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100528|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100529|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
19520857|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19520858|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
19520859|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20100530|NCT00002876|Etoposide|etoposide|mesh-list
20100531|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100532|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100533|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100534|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100535|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100536|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100537|NCT00002878|Dexamethasone|dexamethasone|mesh-list
20100538|NCT00002878|Doxorubicin|doxorubicin|mesh-list
20100539|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19520860|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520861|NCT02955719|Sertraline|sertraline|mesh-list
19520862|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19520863|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
19520864|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19520865|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19520866|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19520867|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19520868|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520869|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520870|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
19520871|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520872|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19520873|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19520874|NCT02955524|Lidocaine|lidocaine|mesh-list
19520875|NCT02955524|Tetracaine|tetracaine|mesh-list
19520876|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
19520877|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
19520878|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520879|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520880|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
19520881|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520882|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19520883|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19520884|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19520885|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19520886|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520887|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19520888|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
19520889|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520890|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
19520891|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520892|NCT02955602|Seladelpar|seladelpar|mesh-list
19520893|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19520894|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
19520895|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520896|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19520897|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
19520898|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
19520899|NCT02955706|Vitamins|vitamins|mesh-ancestor
19520900|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
20100540|NCT00002878|Vincristine|vincristine|mesh-list
19520901|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520902|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
19520903|NCT02955641|Dexamethasone|dexamethasone|mesh-list
19520904|NCT02955641|Nepafenac|nepafenac|mesh-list
19520905|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19520906|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520907|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
19520908|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
19520909|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100541|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20100542|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
20100543|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
20100544|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100545|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100546|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100547|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
20100548|NCT00002878|Hormones|hormones|mesh-ancestor
20100549|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100550|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100551|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100552|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19520910|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100553|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19520911|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19520912|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
19520913|NCT02955641|Hormones|hormones|mesh-ancestor
19520914|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520915|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19520916|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520917|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19520918|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19520919|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19520920|NCT02955641|Analgesics|analgesics|mesh-ancestor
19520921|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
19520922|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19520923|NCT02955927|Atropine|atropine|mesh-list
19520924|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19520925|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19520926|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19520927|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19520928|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19520929|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
19520930|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19520931|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520932|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19520933|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
19520934|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
19520935|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
19520936|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19520937|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19520938|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
19520939|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520940|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520941|NCT02955654|Aripiprazole|aripiprazole|mesh-list
19520942|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
19520943|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19520944|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19520945|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19520946|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19520947|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520948|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
19520949|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
19520950|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19520951|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520952|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19520953|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19520954|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
19520955|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19520956|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19520957|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19520958|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19572663|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
19572664|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19572665|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
19572666|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
19572667|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
19572668|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19572669|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19572670|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
19572671|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572672|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572673|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20100554|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100555|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100556|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603615|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20603616|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603617|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
20603618|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
20603619|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
20603620|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603621|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603622|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100557|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100558|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100559|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100560|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100561|NCT00002879|Cladribine|cladribine|mesh-list
20100562|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100563|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100564|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
20100565|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100566|NCT00002880|Etoposide|etoposide|mesh-list
20100567|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
20100568|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100569|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520959|NCT02955056|Teriparatide|teriparatide|mesh-list
19520960|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520961|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19520962|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19520963|NCT02954939|Prednisone|prednisone|mesh-list
19520964|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19520965|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
19520966|NCT02954939|Hormones|hormones|mesh-ancestor
19520967|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19520968|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520969|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19520970|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520971|NCT02955251|Nivolumab|nivolumab|mesh-list
20100570|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100571|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100572|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520972|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19520973|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19520974|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19520975|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520976|NCT02954913|Liver Extracts|liver extracts|mesh-list
19520977|NCT02954913|Hematinics|hematinics|mesh-ancestor
19520978|NCT02954692|Metformin|metformin|mesh-list
19520979|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
19520980|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19520981|NCT02954692|Meglitinide|meglitinide|mesh-list
19520982|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
19520983|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19520984|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520985|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19520986|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19520987|NCT02954822|Glimepiride|glimepiride|mesh-list
19520988|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19520989|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19520990|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520991|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19520992|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
19520993|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
19520994|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
19520995|NCT02954588|Vitamins|vitamins|mesh-ancestor
19520996|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
19520997|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19520998|NCT02954549|Vitamin D|vitamin d|mesh-list
19520999|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
19521000|NCT02954549|Vitamins|vitamins|mesh-ancestor
19521001|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
19521002|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521003|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19521004|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19521005|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
19521006|NCT02954536|Fluorouracil|fluorouracil|mesh-list
19521007|NCT02954536|Capecitabine|capecitabine|mesh-list
19521008|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
19521009|NCT02954536|Trastuzumab|trastuzumab|mesh-list
19521010|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521011|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521012|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
19521013|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521014|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19521015|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521016|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
19521017|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521018|NCT02954393|Amoxicillin|amoxicillin|mesh-list
19521019|NCT02954393|Metronidazole|metronidazole|mesh-list
19521020|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19521021|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521022|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19521023|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19521024|NCT02954276|Sumatriptan|sumatriptan|mesh-list
19521025|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19521026|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20100573|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100574|NCT00002881|Suramin|suramin|mesh-list
20100575|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
20100576|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19521027|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19521028|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
19521029|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521030|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521031|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521032|NCT02954484|Acetaminophen|acetaminophen|mesh-list
19521033|NCT02954484|Etoricoxib|etoricoxib|mesh-list
19521034|NCT02954484|Pregabalin|pregabalin|mesh-list
19521035|NCT02954484|Morphine|morphine|mesh-list
19521036|NCT02954484|Ropivacaine|ropivacaine|mesh-list
19521037|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19521038|NCT02954484|Narcotics|narcotics|mesh-ancestor
19521039|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521040|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521041|NCT02954484|Analgesics|analgesics|mesh-ancestor
19521042|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
19521043|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521044|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
19521045|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
19521046|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19521047|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
19521048|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
19521049|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19521050|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521051|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521052|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19521053|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19521054|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20100577|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20100578|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20100579|NCT00002881|Leuprolide|leuprolide|mesh-list
20100580|NCT00002881|Goserelin|goserelin|mesh-list
20100581|NCT00002881|Flutamide|flutamide|mesh-list
19521055|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19521056|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19521057|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521058|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521059|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19521060|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19521061|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521062|NCT02954068|Oxytocin|oxytocin|mesh-list
19521063|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
19521064|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19521065|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521066|NCT02954029|Hemostatics|hemostatics|mesh-list
19521067|NCT02954029|Coagulants|coagulants|mesh-ancestor
19521068|NCT02954055|Paclitaxel|paclitaxel|mesh-list
19521069|NCT02954055|Vinorelbine|vinorelbine|mesh-list
19521070|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19521071|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
19521072|NCT02954055|Capecitabine|capecitabine|mesh-list
19521073|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19521074|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521075|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
19521076|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
19521077|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
19521078|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521079|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521080|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
19521081|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521082|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521083|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19521084|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
19521085|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19521086|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19521087|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
20100582|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521088|NCT02953834|Insulin|insulin|mesh-list
20100583|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19521089|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19521090|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521091|NCT02953847|Rifampin|rifampin|mesh-list
19521092|NCT02953847|Isoniazid|isoniazid|mesh-list
19521093|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19521094|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
19521095|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19521096|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100584|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
20100585|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20100586|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100587|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100588|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100589|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
20100590|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
20100591|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521097|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
19521098|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19521099|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521100|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521101|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19521102|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19521103|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19521104|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19521105|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19521106|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19521107|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19521108|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19521109|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
19521110|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19521111|NCT02953743|Lenvatinib|lenvatinib|mesh-list
19521112|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521113|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19521114|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521115|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521116|NCT02953522|Folic Acid|folic acid|mesh-list
19521117|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
19521118|NCT02953522|Hematinics|hematinics|mesh-ancestor
19521119|NCT02953522|Vitamins|vitamins|mesh-ancestor
19521120|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
19521121|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521122|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
19521123|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
19521124|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572674|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19572675|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19572676|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19572677|NCT02700906|Lidocaine|lidocaine|mesh-list
19572678|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
19572679|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
19572680|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572681|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572682|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
19572683|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572684|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19572685|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19572686|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19572687|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572688|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572689|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
19572690|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19572691|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572692|NCT02700568|Axitinib|axitinib|mesh-list
19572693|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572694|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19572695|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577943|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100592|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
20100593|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
20100594|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20100595|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100596|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20100597|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20100598|NCT00002882|Interferons|interferons|mesh-list
20603623|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20100599|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
20100600|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
20100601|NCT00002882|Aldesleukin|aldesleukin|mesh-list
20100602|NCT00002882|Cisplatin|cisplatin|mesh-list
20100603|NCT00002882|Interleukin-2|interleukin-2|mesh-list
20100604|NCT00002882|Dacarbazine|dacarbazine|mesh-list
20100605|NCT00002882|Vinblastine|vinblastine|mesh-list
20100606|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100607|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
20100608|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100609|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
20100610|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521125|NCT02953457|Durvalumab|durvalumab|mesh-list
19521126|NCT02953457|Ipilimumab|ipilimumab|mesh-list
19521127|NCT02953457|Olaparib|olaparib|mesh-list
19521128|NCT02953457|Tremelimumab|tremelimumab|mesh-list
19521129|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19521130|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
19521131|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19521132|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
19521133|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521134|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521135|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
19521136|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521137|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521138|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521139|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19521140|NCT02953405|Clopidogrel|clopidogrel|mesh-list
19521141|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19521142|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19521143|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19521144|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19521145|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
19521146|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521147|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603624|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20603625|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100611|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20100612|NCT00002882|Analgesics|analgesics|mesh-ancestor
20100613|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
20100614|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100615|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20100616|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19521148|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521149|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
19521150|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521151|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
19521152|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19521153|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
19521154|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521155|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
19521156|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19521157|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
19521158|NCT02953275|Vedolizumab|vedolizumab|mesh-list
19521159|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19521160|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521161|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521162|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19521163|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19521164|NCT02953275|Protective Agents|protective agents|mesh-ancestor
19521165|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521166|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
19521167|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19521168|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
19521169|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521170|NCT02953210|Dexamethasone|dexamethasone|mesh-list
19521171|NCT02953210|Ketorolac|ketorolac|mesh-list
19521172|NCT02953210|Lidocaine|lidocaine|mesh-list
19521173|NCT02953210|Clonidine|clonidine|mesh-list
19521174|NCT02953210|Fentanyl|fentanyl|mesh-list
19521175|NCT02953210|Midazolam|midazolam|mesh-list
19521176|NCT02953210|Ketamine|ketamine|mesh-list
19521177|NCT02953210|Ondansetron|ondansetron|mesh-list
20100617|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19521178|NCT02953210|Bupivacaine|bupivacaine|mesh-list
19521179|NCT02953210|Propofol|propofol|mesh-list
19521180|NCT02953210|Isoflurane|isoflurane|mesh-list
19521181|NCT02953210|Ranitidine|ranitidine|mesh-list
19521182|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20100618|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
19521183|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19521184|NCT02953210|Rocuronium|rocuronium|mesh-list
19521185|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521186|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
19521187|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
19521188|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521189|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603626|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20603627|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
20603628|NCT02222142|Anesthetics|anesthetics|mesh-list
20603629|NCT02222142|Isoflurane|isoflurane|mesh-list
19521190|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521191|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
19521192|NCT02953210|Hormones|hormones|mesh-ancestor
19521193|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521194|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521195|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521196|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
19521197|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
19521198|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521199|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
19521200|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19521201|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19521202|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19521203|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20603630|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603631|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603632|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20603633|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
20603634|NCT02222168|BI 409306|bi 409306|mesh-list
20603635|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20603636|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521204|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521205|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19521206|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19521207|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
19521208|NCT02953210|Analgesics|analgesics|mesh-ancestor
19521209|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19521210|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19521211|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19521212|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521213|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19521214|NCT02953210|Narcotics|narcotics|mesh-ancestor
19521215|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19521216|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19521217|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19521218|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19521219|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
19521220|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
19521221|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
19521222|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
19521223|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19521224|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
19521225|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19521226|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19521227|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19521228|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521229|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19521230|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521231|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19521232|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19521233|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19521234|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19521235|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
19521236|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19521237|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19521238|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19521239|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
19521240|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19521241|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19521242|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20100619|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100620|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20603637|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603638|NCT02222220|Metoclopramide|metoclopramide|mesh-list
19521243|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
19521244|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
19521245|NCT02953106|Fluticasone|fluticasone|mesh-list
19521246|NCT02953106|Azelastine|azelastine|mesh-list
19521247|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521248|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19521249|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
19521250|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521251|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521252|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19521253|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
19521254|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
19521255|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19521256|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19521257|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521258|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521259|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19521260|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19521261|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
19521262|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
19521263|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521264|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
19521265|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521266|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521267|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
19521268|NCT02953041|Bromides|bromides|mesh-list
19521269|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
19521270|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19521271|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19521272|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20100621|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100622|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100623|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100624|NCT00002883|Fluorouracil|fluorouracil|mesh-list
20100625|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100626|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
20100627|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100628|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100629|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100630|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
20100631|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521273|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
19521274|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521275|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521276|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521277|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19521278|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19521279|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20100632|NCT00002884|Fluorouracil|fluorouracil|mesh-list
20100633|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100634|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
19521280|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100635|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100636|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19521281|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521282|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19521283|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521284|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100637|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100638|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
20100639|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100640|NCT00002887|Etoposide|etoposide|mesh-list
20100641|NCT00002887|Vinorelbine|vinorelbine|mesh-list
20100642|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
20100643|NCT00002887|Vinblastine|vinblastine|mesh-list
20100644|NCT00002887|Vindesine|vindesine|mesh-list
20100645|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100646|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100647|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19521285|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
19521286|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521287|NCT02953184|Vitamins|vitamins|mesh-list
19521288|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
19521289|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
19521290|NCT02953184|Docetaxel|docetaxel|mesh-list
19521291|NCT02953184|Doxorubicin|doxorubicin|mesh-list
20100648|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100649|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100650|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100651|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100652|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100653|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100654|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
20100655|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19521292|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19521293|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
19521294|NCT02953184|Razoxane|razoxane|mesh-list
19521295|NCT02953184|Pirarubicin|pirarubicin|mesh-list
19521296|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521297|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
19521298|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521299|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521300|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19521301|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
19521302|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521303|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521304|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19521305|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
19521306|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
19521307|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
19521308|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
19521309|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19521310|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19521311|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19521312|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521313|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19521314|NCT02953184|Protective Agents|protective agents|mesh-ancestor
19521315|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19521316|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19521317|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19521318|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19521319|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
19521320|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521321|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19521322|NCT02952963|Cathartics|cathartics|mesh-ancestor
19521323|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521324|NCT02952573|Dexamethasone|dexamethasone|mesh-list
19521325|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
19521326|NCT02952573|BB 1101|bb 1101|mesh-list
19521327|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521328|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
19521329|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
19521330|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521331|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521332|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521333|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
19521334|NCT02952573|Hormones|hormones|mesh-ancestor
19521335|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521336|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521337|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521338|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
19521339|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521340|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521341|NCT02952599|Edoxaban|edoxaban|mesh-list
19521342|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19521343|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
19521344|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19521345|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
19521346|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521347|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521348|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
19521349|NCT02952807|Misoprostol|misoprostol|mesh-list
19521350|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19521351|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
19521352|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19521353|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521354|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20100656|NCT00002888|Paclitaxel|paclitaxel|mesh-list
19521355|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521356|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
19521357|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
19521358|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20100657|NCT00002888|Fluorouracil|fluorouracil|mesh-list
19521359|NCT02952235|Protective Agents|protective agents|mesh-ancestor
19521360|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521361|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
19521362|NCT02952469|Edetic Acid|edetic acid|mesh-list
19521363|NCT02952469|Chelating Agents|chelating agents|mesh-ancestor
19521364|NCT02952469|Sequestering Agents|sequestering agents|mesh-ancestor
19521365|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521366|NCT02952469|Anticoagulants|anticoagulants|mesh-ancestor
19521367|NCT02952469|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19521368|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
20100658|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100659|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100660|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100661|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100662|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100663|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521369|NCT02952092|Hematinics|hematinics|mesh-ancestor
19521370|NCT02952157|Lidocaine|lidocaine|mesh-list
19521371|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
19521372|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
19521373|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521374|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521375|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
19521376|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521377|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19521378|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19521379|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19521380|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521381|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521382|NCT02951754|Methylphenidate|methylphenidate|mesh-list
19521383|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19521384|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521385|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19521386|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19521387|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521388|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521389|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
19521390|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521391|NCT02951728|Prednisone|prednisone|mesh-list
19521392|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
19521393|NCT02951728|Rituximab|rituximab|mesh-list
19521394|NCT02951728|Doxorubicin|doxorubicin|mesh-list
19521395|NCT02951728|Vincristine|vincristine|mesh-list
19521396|NCT02951728|Decitabine|decitabine|mesh-list
19521397|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521398|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
19521399|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521400|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521401|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19521402|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
19521403|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521404|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521405|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19521406|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521407|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19521408|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19521409|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19521410|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521411|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521412|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
19521413|NCT02951728|Hormones|hormones|mesh-ancestor
19521414|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521415|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521416|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19521417|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
19521418|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
19521419|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
19521420|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19521421|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
19521422|NCT02951975|Dexamethasone|dexamethasone|mesh-list
19521423|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521424|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
19521425|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
19521426|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521427|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521428|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521429|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
20100664|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
20100665|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100666|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521430|NCT02951975|Hormones|hormones|mesh-ancestor
19521431|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521432|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521433|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521434|NCT02951806|Fentanyl|fentanyl|mesh-list
19521435|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19521436|NCT02951806|Narcotics|narcotics|mesh-ancestor
19521437|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521438|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521439|NCT02951806|Analgesics|analgesics|mesh-ancestor
19521440|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
20603639|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
19521441|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521442|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19521443|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19521444|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
19521445|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
19521446|NCT02951962|Amlodipine|amlodipine|mesh-list
19521447|NCT02951962|Telmisartan|telmisartan|mesh-list
19521448|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19521449|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19521450|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19521451|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19521452|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521453|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521454|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19521455|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521456|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
19521457|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19521458|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19521459|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
19521460|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19521461|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19521462|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521463|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19521464|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19572696|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577944|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19577945|NCT03817853|Protective Agents|protective agents|mesh-ancestor
19577946|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577947|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
19577948|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577949|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577950|NCT03794349|Eflornithine|eflornithine|mesh-list
19577951|NCT03794349|Irinotecan|irinotecan|mesh-list
19577952|NCT03794349|Camptothecin|camptothecin|mesh-list
19577953|NCT03794349|Temozolomide|temozolomide|mesh-list
19577954|NCT03794349|Dinutuximab|dinutuximab|mesh-list
19577955|NCT03794349|Sargramostim|sargramostim|mesh-list
19577956|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19577957|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19577958|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577959|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577960|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577961|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19577962|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
20100667|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
20100668|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100669|NCT00002889|Leuprolide|leuprolide|mesh-list
20100670|NCT00002889|Goserelin|goserelin|mesh-list
19577963|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
19577964|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577965|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19577966|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19577967|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19577968|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19577969|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577970|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20100671|NCT00002889|Flutamide|flutamide|mesh-list
19521465|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
19521466|NCT02951897|Pemetrexed|pemetrexed|mesh-list
19521467|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521468|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521469|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521470|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19521471|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19521472|NCT02951637|Carboplatin|carboplatin|mesh-list
19521473|NCT02951637|Pemetrexed|pemetrexed|mesh-list
19521474|NCT02951637|Gefitinib|gefitinib|mesh-list
19521475|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521476|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521477|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521478|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19521479|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19521480|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19521481|NCT02951234|Aspirin|aspirin|mesh-list
19521482|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19521483|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
19521484|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19521485|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19521486|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19521487|NCT02951234|Analgesics|analgesics|mesh-ancestor
19521488|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
19521489|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100672|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20100673|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
20100674|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20100675|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100676|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100677|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100678|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
20100679|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
20100680|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100681|NCT00002890|Lintuzumab|lintuzumab|mesh-list
20100682|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20100683|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100684|NCT00002892|Interferons|interferons|mesh-list
20100685|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
19521490|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521491|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521492|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521493|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19521494|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19521495|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521496|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19521497|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19521498|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521499|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
19521500|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
19521501|NCT02951260|Metformin|metformin|mesh-list
19521502|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19521503|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521504|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
19521505|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19521506|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521507|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521508|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19521509|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19521510|NCT02951299|Protective Agents|protective agents|mesh-ancestor
19521511|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521512|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
19521513|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19521514|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
19521515|NCT02950948|Progesterone|progesterone|mesh-list
19521516|NCT02950948|Progestins|progestins|mesh-ancestor
19521517|NCT02950948|Hormones|hormones|mesh-ancestor
19521518|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521519|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521520|NCT02951039|Edoxaban|edoxaban|mesh-list
19521521|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19521522|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
19521523|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19521524|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
20100686|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521525|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521526|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521527|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
19521528|NCT02951117|Dexamethasone|dexamethasone|mesh-list
19521529|NCT02951117|Venetoclax|venetoclax|mesh-list
19521530|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521531|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
19521532|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
19521533|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521534|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521535|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20100687|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
20603640|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
19521536|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
20100688|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100689|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
20100690|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100691|NCT00002893|Leucovorin|leucovorin|mesh-list
20100692|NCT00002893|Fluorouracil|fluorouracil|mesh-list
19521537|NCT02951117|Hormones|hormones|mesh-ancestor
19521538|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521539|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521540|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521541|NCT02950935|Progesterone|progesterone|mesh-list
19521542|NCT02950935|Progestins|progestins|mesh-ancestor
19521543|NCT02950935|Hormones|hormones|mesh-ancestor
20100693|NCT00002893|Raltitrexed|raltitrexed|mesh-list
20100694|NCT00002893|Calcium|calcium|mesh-list
20100695|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
20100696|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20100697|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100698|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
20100699|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100700|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100701|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100702|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100703|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
20100704|NCT00002893|Antidotes|antidotes|mesh-ancestor
20100705|NCT00002893|Protective Agents|protective agents|mesh-ancestor
20100706|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
19521544|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521545|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521546|NCT02950870|Ritonavir|ritonavir|mesh-list
19521547|NCT02950870|Ribavirin|ribavirin|mesh-list
19521548|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19521549|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19521550|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
19521551|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521552|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521553|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19521554|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19521555|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
19521556|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521557|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19521558|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19521559|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
20603641|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603642|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603643|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521560|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
19521561|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
19521562|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20100707|NCT00002893|Vitamins|vitamins|mesh-ancestor
20603644|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19521563|NCT02950623|Protective Agents|protective agents|mesh-ancestor
19521564|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521565|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
19521566|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19521567|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
19521568|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
19521569|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19521570|NCT02950584|Protective Agents|protective agents|mesh-ancestor
19521571|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521572|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100708|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
20100709|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20100710|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521573|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19521574|NCT02950441|Niacinamide|niacinamide|mesh-list
19521575|NCT02950441|Niacin|niacin|mesh-list
19521576|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
19521577|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
19521578|NCT02950441|Vitamins|vitamins|mesh-ancestor
19521579|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
19521580|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521581|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19521582|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
19521583|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521584|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19521585|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
19521586|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
19521587|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19521588|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521589|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
19521590|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
19521591|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521592|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521593|NCT02950168|Edoxaban|edoxaban|mesh-list
19521594|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19521595|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
19521596|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19521597|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
19521598|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521599|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521600|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
19521601|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
20100711|NCT00002894|Paclitaxel|paclitaxel|mesh-list
20100712|NCT00002894|Carboplatin|carboplatin|mesh-list
20100713|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100714|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521602|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19521603|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19521604|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521605|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521606|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100715|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100716|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100717|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100718|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100719|NCT00002896|Leucovorin|leucovorin|mesh-list
19521607|NCT02950155|Rituximab|rituximab|mesh-list
19521608|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521609|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521610|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
19521611|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521612|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521613|NCT02950038|Nivolumab|nivolumab|mesh-list
19521614|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521615|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521616|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19521617|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521618|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
19521619|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19521620|NCT02950051|Rituximab|rituximab|mesh-list
19521621|NCT02950051|Fludarabine|fludarabine|mesh-list
19521622|NCT02950051|Venetoclax|venetoclax|mesh-list
19521623|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
19521624|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521625|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
19521626|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521627|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521628|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19521629|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
19521630|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521631|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521632|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19521633|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19572697|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19572698|NCT02700711|Methylphenidate|methylphenidate|mesh-list
20100720|NCT00002896|Cobalt|cobalt|mesh-list
19572699|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19572700|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100721|NCT00002896|Fluorouracil|fluorouracil|mesh-list
20100722|NCT00002896|Calcium|calcium|mesh-list
19521634|NCT02949752|Aripiprazole|aripiprazole|mesh-list
19521635|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
19521636|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19521637|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19521638|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19521639|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521640|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521641|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
20100723|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
20100724|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20100725|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100726|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
20100727|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100728|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100729|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521642|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
19521643|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521644|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521645|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19521646|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19521647|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
19521648|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19521649|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19521650|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19521651|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19521652|NCT02949895|Etoposide|etoposide|mesh-list
19521653|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521654|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19521655|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19521656|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19521657|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521658|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521659|NCT02949648|Nicotine|nicotine|mesh-list
19521660|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19521661|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
19521662|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521663|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521664|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19521665|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19521666|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
19521667|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521668|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521669|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
19521670|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19521671|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521672|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
19521673|NCT02949765|Iron|iron|mesh-list
19521674|NCT02949765|Trace Elements|trace elements|mesh-ancestor
19521675|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
20100730|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100731|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
20100732|NCT00002896|Antidotes|antidotes|mesh-ancestor
19521676|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521677|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
19521678|NCT02949843|Nivolumab|nivolumab|mesh-list
19521679|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521680|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521681|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19521682|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521683|NCT02949778|Ropivacaine|ropivacaine|mesh-list
19521684|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
19521685|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
19521686|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521687|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521688|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
19521689|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521690|NCT02949492|Interleukin-2|interleukin-2|mesh-list
19521691|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521692|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19521693|NCT02949492|Analgesics|analgesics|mesh-ancestor
19521694|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
19521695|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521696|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521697|NCT02949232|Prednisolone|prednisolone|mesh-list
19521698|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521699|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
19521700|NCT02949232|Hormones|hormones|mesh-ancestor
19521701|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521702|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100733|NCT00002896|Protective Agents|protective agents|mesh-ancestor
20603645|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19521703|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521704|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521705|NCT02949466|Triamcinolone|triamcinolone|mesh-list
19521706|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
19521707|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521708|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
19521709|NCT02949466|Hormones|hormones|mesh-ancestor
19521710|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521711|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521712|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
19521713|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19521714|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
19521715|NCT02949466|Protective Agents|protective agents|mesh-ancestor
19521716|NCT02949310|Nefopam|nefopam|mesh-list
19521717|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19521718|NCT02949310|Analgesics|analgesics|mesh-ancestor
19521719|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
20603646|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
20603647|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603648|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603649|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
20603650|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20603651|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521720|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521721|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521722|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
19521723|NCT02949349|Prednisolone|prednisolone|mesh-list
19521724|NCT02949349|Azathioprine|azathioprine|mesh-list
19521725|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19521726|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521727|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19521728|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
19521729|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19521730|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521731|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521732|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521733|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521734|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
19521735|NCT02949349|Hormones|hormones|mesh-ancestor
19521736|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521737|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521738|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521739|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
19521740|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19521741|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521742|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
20603652|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20603653|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20603654|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603655|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603656|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521743|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521744|NCT02949206|Thrombin|thrombin|mesh-list
19521745|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
19521746|NCT02949206|Coagulants|coagulants|mesh-ancestor
19521747|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
19521748|NCT02949258|Etoposide|etoposide|mesh-list
19521749|NCT02949258|Epirubicin|epirubicin|mesh-list
19521750|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521751|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19521752|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19521753|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19521754|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521755|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521756|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19521757|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19521758|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19521759|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748936|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19521760|NCT02949193|Incretins|incretins|mesh-ancestor
19521761|NCT02949193|Hormones|hormones|mesh-ancestor
19521762|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521763|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19521764|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
19521765|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603657|NCT02222350|Firuglipel|firuglipel|mesh-list
20603658|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603659|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603660|NCT02222376|Pirfenidone|pirfenidone|mesh-list
19521766|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521767|NCT02948985|Cetuximab|cetuximab|mesh-list
19521768|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521769|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521770|NCT02948998|Spironolactone|spironolactone|mesh-list
19521771|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19521772|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
19521773|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521774|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521775|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20603661|NCT02222376|Analgesics|analgesics|mesh-ancestor
20603662|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
20100734|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
20100735|NCT00002896|Vitamins|vitamins|mesh-ancestor
20100736|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
20100737|NCT00002896|Trace Elements|trace elements|mesh-ancestor
20100738|NCT00002897|Fluorouracil|fluorouracil|mesh-list
20100739|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603663|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603664|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603665|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20603666|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20603667|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521776|NCT02948998|Diuretics|diuretics|mesh-ancestor
20100740|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
20100741|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100742|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100743|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100744|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
20100745|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100746|NCT00002898|Dactinomycin|dactinomycin|mesh-list
20100747|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
20100748|NCT00002898|Ifosfamide|ifosfamide|mesh-list
20100749|NCT00002898|Carboplatin|carboplatin|mesh-list
20100750|NCT00002898|Etoposide|etoposide|mesh-list
20603668|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521777|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
19521778|NCT02948920|Ephedrine|ephedrine|mesh-list
19521779|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19521780|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521781|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
19521782|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
19521783|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521784|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19521785|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
19521786|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521787|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521788|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
19521789|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19521790|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521791|NCT02948543|Mitomycins|mitomycins|mesh-list
19521792|NCT02948543|Mitomycin|mitomycin|mesh-list
19521793|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19521794|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521795|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
19521796|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521797|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19521798|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521799|NCT02948348|Capecitabine|capecitabine|mesh-list
19521800|NCT02948348|Nivolumab|nivolumab|mesh-list
19521801|NCT02948348|Ipilimumab|ipilimumab|mesh-list
19521802|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100751|NCT00002898|Vincristine|vincristine|mesh-list
20100752|NCT00002898|Epirubicin|epirubicin|mesh-list
20100753|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100754|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
20603669|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521803|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
19521804|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521805|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521806|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521807|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19572701|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19572702|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19572703|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572704|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572705|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
19572706|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572707|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19572708|NCT02700711|Analgesics|analgesics|mesh-ancestor
19572709|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
19572710|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572711|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
19572712|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19572713|NCT02700685|Methylphenidate|methylphenidate|mesh-list
19572714|NCT02700685|Pycnogenols|pycnogenols|mesh-list
19572715|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19572716|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572717|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19572718|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19572719|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572720|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572721|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
19572722|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572723|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19572724|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
19572725|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
19572726|NCT02700685|Protective Agents|protective agents|mesh-ancestor
19572727|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19572728|NCT02700763|Dabrafenib|dabrafenib|mesh-list
19572729|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572730|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19572731|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572732|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572733|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
19572734|NCT02700347|Allopurinol|allopurinol|mesh-list
19572735|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
19572736|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572737|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572738|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
19572739|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572740|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19572741|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
19572742|NCT02700347|Protective Agents|protective agents|mesh-ancestor
19572743|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572744|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
19572745|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572746|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572747|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
19572748|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
19572749|NCT02700217|Remifentanil|remifentanil|mesh-list
19572750|NCT02700217|Heroin|heroin|mesh-list
19572751|NCT02700217|Bupivacaine|bupivacaine|mesh-list
19572752|NCT02700217|Propofol|propofol|mesh-list
19572753|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
19572754|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
19572755|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572756|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572757|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
19572758|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572759|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19572760|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19572761|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
19572762|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19572763|NCT02700217|Narcotics|narcotics|mesh-ancestor
19572764|NCT02700217|Analgesics|analgesics|mesh-ancestor
19572765|NCT02701205|Etanercept|etanercept|mesh-list
19572766|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19572767|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572768|NCT02701205|Analgesics|analgesics|mesh-ancestor
19572769|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
19572770|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521808|NCT02948283|Metformin|metformin|mesh-list
19521809|NCT02948283|Ritonavir|ritonavir|mesh-list
19521810|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19521811|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521812|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19521813|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19521814|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
19521815|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521816|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521817|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19521818|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19521819|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
19521820|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521821|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19521822|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19521823|NCT02947945|Reslizumab|reslizumab|mesh-list
19521824|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19521825|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
19521826|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
19521827|NCT02948101|Antibodies|antibodies|mesh-list
19521828|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19521829|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19521830|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
19521831|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521832|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521833|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19521834|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
19521835|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521836|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521837|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19521838|NCT02948075|Paclitaxel|paclitaxel|mesh-list
19521839|NCT02948075|Carboplatin|carboplatin|mesh-list
19521840|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19521841|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521842|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
19521843|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
19521844|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
19521845|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521846|NCT02947932|Indomethacin|indomethacin|mesh-list
19521847|NCT02947932|Resveratrol|resveratrol|mesh-list
19521848|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
19521849|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521850|NCT02947932|Protective Agents|protective agents|mesh-ancestor
19521851|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521852|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521853|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19521854|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19521855|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19521856|NCT02947932|Analgesics|analgesics|mesh-ancestor
19521857|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
20100755|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100756|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521858|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100757|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100758|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
19521859|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521860|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521861|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
19521862|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
19521863|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19521864|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19521865|NCT02947880|Bumetanide|bumetanide|mesh-list
19521866|NCT02947880|Diuretics|diuretics|mesh-ancestor
19521867|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
19521868|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521869|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19521870|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521871|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521872|NCT02947711|Diltiazem|diltiazem|mesh-list
19521873|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20100759|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100760|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100761|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19521874|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19521875|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521876|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521877|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19521878|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521879|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
19521880|NCT02947620|Metformin|metformin|mesh-list
19521881|NCT02947620|Atorvastatin|atorvastatin|mesh-list
19521882|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19521883|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521884|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19521885|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19521886|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
19521887|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521888|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20100762|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100763|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100764|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19521889|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19521890|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521891|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
19521892|NCT02947854|Poly ICLC|poly iclc|mesh-list
19521893|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19521894|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
19521895|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
19521896|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521897|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19521898|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
19521899|NCT02947763|Metronidazole|metronidazole|mesh-list
19521900|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
19521901|NCT02947763|Minocycline|minocycline|mesh-list
19521902|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521903|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19521904|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19521905|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19521906|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19521907|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19521908|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521909|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521910|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521911|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19521912|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19521913|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
19521914|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19521915|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19521916|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19521917|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19521918|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521919|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
19521920|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521921|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521922|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19521923|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521924|NCT02947737|Gentamicins|gentamicins|mesh-list
19521925|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19521926|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19521927|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19521928|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521929|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521930|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
19521931|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19521932|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19521933|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521934|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
19521935|NCT02947529|Coagulants|coagulants|mesh-ancestor
19521936|NCT02947672|Dexamethasone|dexamethasone|mesh-list
20100765|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100766|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100767|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100768|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100769|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100770|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20100771|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100772|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20603670|NCT02222428|Olodaterol|olodaterol|mesh-list
20100773|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120418|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120419|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521937|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19521938|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
19521939|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
19521940|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521941|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521942|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521943|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
19521944|NCT02947672|Hormones|hormones|mesh-ancestor
19521945|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19521946|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19521947|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521948|NCT02947178|Bupivacaine|bupivacaine|mesh-list
19521949|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
19521950|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
19521951|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521952|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521953|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
19521954|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521955|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
19521956|NCT02947438|Hematinics|hematinics|mesh-ancestor
19521957|NCT02947347|Rituximab|rituximab|mesh-list
19521958|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19521959|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521960|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
19521961|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521962|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19521963|NCT02947113|Etoposide|etoposide|mesh-list
19521964|NCT02947113|Pemetrexed|pemetrexed|mesh-list
19521965|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19521966|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19521967|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19521968|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19521969|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19521970|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521971|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19521972|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19521973|NCT02947334|Bococizumab|bococizumab|mesh-list
19521974|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19521975|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19521976|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
19521977|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521978|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19521979|NCT02947269|Prucalopride|prucalopride|mesh-list
19521980|NCT02947269|Laxatives|laxatives|mesh-ancestor
19521981|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19521982|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19521983|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19521984|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
19521985|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19521986|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19521987|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521988|NCT02947243|Morphine|morphine|mesh-list
19521989|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20120420|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120421|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
20120422|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120423|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
20120424|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20120425|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120426|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19521990|NCT02947243|Narcotics|narcotics|mesh-ancestor
19521991|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19521992|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19521993|NCT02947243|Analgesics|analgesics|mesh-ancestor
19521994|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
19521995|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19521996|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19521997|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
19521998|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19521999|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522000|NCT02947126|Antidotes|antidotes|mesh-ancestor
19522001|NCT02947126|Protective Agents|protective agents|mesh-ancestor
19522002|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522003|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
19522004|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
19522005|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19522006|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
19522007|NCT02946944|Apixaban|apixaban|mesh-list
19522008|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
19522009|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19522010|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19522011|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522012|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522013|NCT02946944|Urological Agents|urological agents|mesh-ancestor
19522014|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19522015|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
19522016|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19522017|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522018|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
19522019|NCT02946970|Quinine|quinine|mesh-list
19522020|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
19522021|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19522022|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19522023|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522024|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19522025|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522026|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19522027|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522028|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19522029|NCT02946970|Analgesics|analgesics|mesh-ancestor
19522030|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
19522031|NCT02947061|Docetaxel|docetaxel|mesh-list
19522032|NCT02947061|Capecitabine|capecitabine|mesh-list
19522033|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522034|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
19522035|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
19522036|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
19522037|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522038|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522039|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
19522040|NCT02946671|Nivolumab|nivolumab|mesh-list
19522041|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
19522042|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522043|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522044|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19522045|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522046|NCT02946684|Letrozole|letrozole|mesh-list
19522047|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19522048|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522049|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20100774|NCT00002901|Docetaxel|docetaxel|mesh-list
20100775|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100776|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100777|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100778|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100779|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100780|NCT00002902|Irinotecan|irinotecan|mesh-list
20100781|NCT00002902|Raltitrexed|raltitrexed|mesh-list
20100782|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20100783|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100784|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100785|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100786|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100787|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100788|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
20100789|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20100790|NCT00002903|Docetaxel|docetaxel|mesh-list
20100791|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100792|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100793|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100794|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100795|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522050|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522051|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522052|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19522053|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
20100796|NCT00002904|Trabectedin|trabectedin|mesh-list
19522054|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522055|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522056|NCT02946801|Listerine|listerine|mesh-list
19522057|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
19522058|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19522059|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522060|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
19522061|NCT02946801|Protective Agents|protective agents|mesh-ancestor
19522062|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522063|NCT02946359|Bevacizumab|bevacizumab|mesh-list
19522064|NCT02946359|Crizotinib|crizotinib|mesh-list
19522065|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522066|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522067|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19522068|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19522069|NCT02946359|Growth Substances|growth substances|mesh-ancestor
19522070|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522071|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
19522072|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19522073|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522074|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522075|NCT02946437|Midazolam|midazolam|mesh-list
19522076|NCT02946437|Propofol|propofol|mesh-list
19522077|NCT02946437|Sevoflurane|sevoflurane|mesh-list
19522078|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19522079|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522080|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522081|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19522082|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
19522083|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
19522084|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19522085|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20100797|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20100798|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
20100799|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100800|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100801|NCT00002905|Zidovudine|zidovudine|mesh-list
19522086|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19522087|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19522088|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
19522089|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
19522090|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522091|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522092|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19522093|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19522094|NCT02946814|Listerine|listerine|mesh-list
19522095|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
19522096|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19522097|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522098|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
19522099|NCT02946814|Protective Agents|protective agents|mesh-ancestor
19522100|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572771|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572772|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572773|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572774|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572775|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572776|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
19572777|NCT02700087|Famotidine|famotidine|mesh-list
19572778|NCT02700087|Ranitidine|ranitidine|mesh-list
19572779|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19572780|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19572781|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572782|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19572783|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
19572784|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
19572785|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572786|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572787|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572788|NCT02700048|Naloxone|naloxone|mesh-list
19572789|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19572790|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572791|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
19572792|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572793|NCT02699879|Pirfenidone|pirfenidone|mesh-list
19572794|NCT02699879|Analgesics|analgesics|mesh-ancestor
19522101|NCT02946632|Metformin|metformin|mesh-list
19522102|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19522103|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
19522104|NCT02946632|Glimepiride|glimepiride|mesh-list
19522105|NCT02946632|Saxagliptin|saxagliptin|mesh-list
19522106|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19522107|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522108|NCT02946632|Incretins|incretins|mesh-ancestor
19522109|NCT02946632|Hormones|hormones|mesh-ancestor
19522110|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522111|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19522112|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522113|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522114|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522115|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19522116|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19522117|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522118|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
19522122|NCT02946294|Epinephrine|epinephrine|mesh-list
19522123|NCT02946294|Racepinephrine|racepinephrine|mesh-list
19522124|NCT02946294|Bupivacaine|bupivacaine|mesh-list
19522125|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
19522126|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
19522127|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
19522128|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522129|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522130|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
19522131|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522132|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19522133|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19522134|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
19522135|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522136|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522137|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19522138|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19522139|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
19522140|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19522141|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
19522142|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
19522143|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
19522144|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19522145|NCT02946268|Ropivacaine|ropivacaine|mesh-list
19522146|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
19522147|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
19522148|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522149|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522150|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
19522151|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522152|NCT02946060|TEMPO|tempo|mesh-list
19522153|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
19522154|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522155|NCT02946060|Protective Agents|protective agents|mesh-ancestor
19522156|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522157|NCT02945982|Entecavir|entecavir|mesh-list
19522158|NCT02945982|Carvedilol|carvedilol|mesh-list
19522159|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
20100802|NCT00002905|Didanosine|didanosine|mesh-list
20100803|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
20100804|NCT00002905|Prednimustine|prednimustine|mesh-list
20100805|NCT00002905|Doxorubicin|doxorubicin|mesh-list
20100806|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20100807|NCT00002905|Etoposide|etoposide|mesh-list
20100808|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
19522160|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522161|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19522162|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19522163|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
19522164|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522165|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522166|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748937|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
19522167|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19522168|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
19749531|NCT04944134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100809|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522169|NCT02945982|Protective Agents|protective agents|mesh-ancestor
19522170|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19522171|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522172|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19522173|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
19522174|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19522175|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19522176|NCT02945956|Entecavir|entecavir|mesh-list
19522177|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
19522178|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522179|NCT02945696|Ropivacaine|ropivacaine|mesh-list
19522180|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
19522181|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
19522182|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522183|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522184|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
19522185|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522186|NCT02945839|Topiramate|topiramate|mesh-list
19522187|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
19522188|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19522189|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522190|NCT02945852|Apatinib|apatinib|mesh-list
19522191|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522192|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19522193|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522194|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522195|NCT02945644|Trazodone|trazodone|mesh-list
19522196|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19522197|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19522198|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20100810|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
20100811|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100812|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100813|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19522199|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522200|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19522201|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19522202|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19522203|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522204|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522205|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522206|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
19522207|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19522208|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
19522209|NCT02945527|Dexamethasone|dexamethasone|mesh-list
19522210|NCT02945527|Acetazolamide|acetazolamide|mesh-list
19522211|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19522212|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
19522213|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
19522214|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522215|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522216|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19522217|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
19522218|NCT02945527|Hormones|hormones|mesh-ancestor
19522219|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522220|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19522221|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522222|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
19522223|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19522224|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522225|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522226|NCT02945527|Diuretics|diuretics|mesh-ancestor
19522227|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
19522228|NCT02945293|Oxycodone|oxycodone|mesh-list
19522229|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19522230|NCT02945293|Narcotics|narcotics|mesh-ancestor
19522231|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522232|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522233|NCT02945293|Analgesics|analgesics|mesh-ancestor
19522234|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
19522235|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522236|NCT02945280|Apixaban|apixaban|mesh-list
19522237|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20100814|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
19522238|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
20100815|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100816|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100817|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19522239|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19522240|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522241|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522242|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522243|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
19522244|NCT02945267|Tegafur|tegafur|mesh-list
19522245|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
19522246|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522247|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
19522248|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522249|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522250|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522251|NCT02945241|Vancomycin|vancomycin|mesh-list
19522252|NCT02945241|Cystatins|cystatins|mesh-list
19522253|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19522254|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522255|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19522256|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522257|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522258|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522259|NCT02945163|Tenofovir|tenofovir|mesh-list
19522260|NCT02945163|Lamivudine|lamivudine|mesh-list
19522261|NCT02945163|Efavirenz|efavirenz|mesh-list
19522262|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
19522263|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522264|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19522265|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19522266|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522267|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522268|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19522269|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19522270|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19522271|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19522272|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19522273|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19522274|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19522275|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19522276|NCT02945215|Rituximab|rituximab|mesh-list
19522277|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522278|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522279|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
19522280|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100818|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100819|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100820|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100821|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100822|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19522281|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19522282|NCT02945072|Sevoflurane|sevoflurane|mesh-list
19522283|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19522284|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19522285|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
19522286|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
19522287|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522288|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522289|NCT02944942|Anesthetics|anesthetics|mesh-list
19522290|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522291|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522292|NCT02945020|Simeprevir|simeprevir|mesh-list
19522293|NCT02945020|Odalasvir|odalasvir|mesh-list
19522294|NCT02945020|Dabigatran|dabigatran|mesh-list
19522295|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
19522296|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19522297|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522298|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522299|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522300|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
19522301|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
19522302|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572795|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
19572796|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522303|NCT02944981|Gabapentin|gabapentin|mesh-list
19522304|NCT02944981|Analgesics|analgesics|mesh-ancestor
19522305|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
19522306|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522307|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522308|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
19522309|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19522310|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19522311|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522312|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19522313|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19522314|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19522315|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522316|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522317|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
19522318|NCT02945033|Aspirin|aspirin|mesh-list
19522319|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19522320|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19522321|NCT02945033|Analgesics|analgesics|mesh-ancestor
19522322|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
19522323|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522324|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522325|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19522326|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19522327|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19522328|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19522329|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522330|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19522331|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19522332|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522333|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
19522334|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
19522335|NCT02944825|Trimethoprim|trimethoprim|mesh-list
19522336|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
19522337|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19522338|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522339|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19522340|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19522341|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522342|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522343|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522344|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19522345|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19522346|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19522347|NCT02944825|Renal Agents|renal agents|mesh-ancestor
19522348|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
19522349|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19522350|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19522351|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19522352|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19522353|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19522354|NCT02944734|Amlodipine|amlodipine|mesh-list
19522355|NCT02944734|Candesartan|candesartan|mesh-list
19522356|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
19522357|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19522358|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19522359|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522360|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100823|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
20100824|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20100825|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20100826|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
20100827|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100828|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20100829|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19522361|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19522362|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522363|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
19522364|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19522365|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19522366|NCT02944227|Ranibizumab|ranibizumab|mesh-list
19522367|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19522368|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20100830|NCT00002905|Analgesics|analgesics|mesh-ancestor
19522369|NCT02944227|Growth Substances|growth substances|mesh-ancestor
19522370|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522371|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
19522372|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522373|NCT02944292|Propofol|propofol|mesh-list
19522374|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19522375|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20100831|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
20100832|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100833|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
20100834|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20100835|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
19522376|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522377|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19522378|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
19522379|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
19522380|NCT02944357|Gemcitabine|gemcitabine|mesh-list
19522381|NCT02944357|Cisplatin|cisplatin|mesh-list
19522382|NCT02944357|Vaccines|vaccines|mesh-list
19522383|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522384|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522385|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
19522386|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522387|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
19522388|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522389|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522390|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522391|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
19522392|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522393|NCT02944214|Febuxostat|febuxostat|mesh-list
19522394|NCT02944214|Benzbromarone|benzbromarone|mesh-list
19522395|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
19522396|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20100836|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100837|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100838|NCT00002908|Vincristine|vincristine|mesh-list
20100839|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
20100840|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19522397|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
19522398|NCT02944214|Renal Agents|renal agents|mesh-ancestor
19522399|NCT02944396|Paclitaxel|paclitaxel|mesh-list
19522400|NCT02944396|Carboplatin|carboplatin|mesh-list
19522401|NCT02944396|Nivolumab|nivolumab|mesh-list
19522402|NCT02944396|Pemetrexed|pemetrexed|mesh-list
19522403|NCT02944396|Veliparib|veliparib|mesh-list
19522404|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19522405|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522406|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
19522407|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
19522408|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
19522409|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522410|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522411|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19522412|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522413|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19522414|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19522415|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19522416|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
19522417|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19522418|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
19522419|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522420|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19522421|NCT02944526|Ropivacaine|ropivacaine|mesh-list
19522422|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
19522423|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
19522424|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522425|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522426|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
20100841|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522427|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522428|NCT02944500|Liraglutide|liraglutide|mesh-list
19522429|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19522430|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100842|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
19522431|NCT02944500|Incretins|incretins|mesh-ancestor
19522432|NCT02944500|Hormones|hormones|mesh-ancestor
19522433|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522434|NCT02944201|Carvedilol|carvedilol|mesh-list
19522435|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19522436|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19522437|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
19522438|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522439|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522440|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522441|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19522442|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
19522443|NCT02944201|Protective Agents|protective agents|mesh-ancestor
19522444|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19522445|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522446|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19522447|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
19522448|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19522449|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19522450|NCT02944123|Clopidogrel|clopidogrel|mesh-list
19522451|NCT02944123|Ticagrelor|ticagrelor|mesh-list
19522452|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19522453|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19522454|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19522455|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19522456|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19522457|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
19522458|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603671|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20603672|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
20603673|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603674|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603675|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20603676|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
19522459|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522460|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522461|NCT02944019|Edoxaban|edoxaban|mesh-list
20603677|NCT02222441|Pioglitazone|pioglitazone|mesh-list
20603678|NCT02222441|Palbociclib|palbociclib|mesh-list
20603679|NCT02222441|Modafinil|modafinil|mesh-list
20603680|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603681|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603682|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603683|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19522462|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19522463|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
19522464|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19522465|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522466|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522467|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522468|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
19522469|NCT02944175|Neostigmine|neostigmine|mesh-list
19522470|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19522471|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522472|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522473|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
19522474|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522475|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522476|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19522477|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
20603684|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603685|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603686|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20603687|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19522478|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522479|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
19522480|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19522481|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19522482|NCT02944045|Prednisolone|prednisolone|mesh-list
19522483|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
19522484|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19522485|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
19748938|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522486|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19522487|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
19522488|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
19522489|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522490|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100843|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100844|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
19522491|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19522492|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
19522493|NCT02944045|Hormones|hormones|mesh-ancestor
19522494|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522495|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19522496|NCT02944045|Protective Agents|protective agents|mesh-ancestor
19522497|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19522498|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100845|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100846|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20100847|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
20100848|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522499|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
19522500|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19522501|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19522502|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522503|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
19522504|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
19522505|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19522506|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19522507|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19522508|NCT02944110|Glucagon|glucagon|mesh-list
19522509|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19522510|NCT02944110|Hormones|hormones|mesh-ancestor
19522511|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522512|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522513|NCT02943798|Paclitaxel|paclitaxel|mesh-list
19522514|NCT02943798|Etoposide|etoposide|mesh-list
19522515|NCT02943798|Carboplatin|carboplatin|mesh-list
19522516|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19522517|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522518|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100849|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20100850|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100851|NCT00002911|Marimastat|marimastat|mesh-list
20100852|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100853|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100854|NCT00002912|Etoposide|etoposide|mesh-list
20100855|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
20100856|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100857|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100858|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100859|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100860|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100861|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100862|NCT00002912|Analgesics|analgesics|mesh-ancestor
20100863|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
20100864|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20100865|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100866|NCT00002913|Paclitaxel|paclitaxel|mesh-list
20100867|NCT00002913|Topotecan|topotecan|mesh-list
20100868|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100869|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100870|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100871|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100872|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100873|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100874|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20100875|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100876|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100877|NCT00002914|Piritrexim|piritrexim|mesh-list
20100878|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100879|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19522519|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100880|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120427|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19522520|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
19522521|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522522|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19522523|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19522524|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522525|NCT02943902|Vaccines|vaccines|mesh-list
19522526|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19522527|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
19522528|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522529|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
19522530|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19522531|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
19522532|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
19522533|NCT02943655|Progesterone|progesterone|mesh-list
19522534|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19522535|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522536|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19522537|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19522538|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19522539|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19522540|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19522541|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19522542|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19522543|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522544|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19522545|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19522546|NCT02943655|Analgesics|analgesics|mesh-ancestor
19522547|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
19522548|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522549|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19522550|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19522551|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19522552|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522553|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522554|NCT02943655|Progestins|progestins|mesh-ancestor
19522555|NCT02943655|Hormones|hormones|mesh-ancestor
19522556|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522557|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
19522558|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522559|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522560|NCT02943369|Ticagrelor|ticagrelor|mesh-list
19522561|NCT02943369|Cangrelor|cangrelor|mesh-list
19522562|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19522563|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19522564|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19522565|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19522566|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
19522567|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522568|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522569|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522570|NCT02943317|Avelumab|avelumab|mesh-list
19522571|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522572|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522573|NCT02943642|Vorinostat|vorinostat|mesh-list
19522574|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522575|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19522576|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522577|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522578|NCT02943356|Tadalafil|tadalafil|mesh-list
19522579|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
19522580|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19522581|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19522582|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522583|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522584|NCT02943356|Urological Agents|urological agents|mesh-ancestor
20100881|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100882|NCT00002915|Penclomedine|penclomedine|mesh-list
19522585|NCT02943252|Apatinib|apatinib|mesh-list
19522586|NCT02943252|Tegafur|tegafur|mesh-list
19522587|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522588|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19522589|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522590|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577971|NCT03781960|Nivolumab|nivolumab|mesh-list
19522591|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522592|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
19572797|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572798|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19572799|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572800|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572801|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572802|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572803|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
19572804|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
19572805|NCT02699827|Analgesics|analgesics|mesh-ancestor
19572806|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
19572807|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572808|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572809|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
19572810|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572811|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19572812|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
19572813|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19572814|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572815|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572816|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19572817|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
19572818|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19572819|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
19572820|NCT02699723|Itraconazole|itraconazole|mesh-list
19572821|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
19572822|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
19572823|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572824|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19572825|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19572826|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572827|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572828|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19572829|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
19572830|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572831|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572832|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19572833|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572834|NCT02699645|Amlodipine|amlodipine|mesh-list
19572835|NCT02699645|Telmisartan|telmisartan|mesh-list
19572836|NCT02699645|Indapamide|indapamide|mesh-list
19572837|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19572838|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19572839|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572840|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572841|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19572842|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572843|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
19572844|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19572845|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19572846|NCT02699645|Diuretics|diuretics|mesh-ancestor
19572847|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
19572848|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19572849|NCT02700022|Prednisone|prednisone|mesh-list
19572850|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
19572851|NCT02700022|Doxorubicin|doxorubicin|mesh-list
19572852|NCT02700022|Etoposide|etoposide|mesh-list
19572853|NCT02700022|Vincristine|vincristine|mesh-list
19572854|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572855|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
19572856|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572857|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572858|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19572859|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
19572860|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100883|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100884|NCT00002917|Paclitaxel|paclitaxel|mesh-list
20100885|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100886|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100887|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100888|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100889|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
19522593|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
19522594|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19522595|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522596|NCT02943135|Lidocaine|lidocaine|mesh-list
19522597|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
19522598|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
19522599|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522600|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522601|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
19522602|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522603|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19522604|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19522605|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19522606|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522607|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100890|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100891|NCT00002919|Doxorubicin|doxorubicin|mesh-list
20100892|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20100893|NCT00002919|Methotrexate|methotrexate|mesh-list
20100894|NCT00002919|Vinblastine|vinblastine|mesh-list
19522608|NCT02943057|Ganciclovir|ganciclovir|mesh-list
19522609|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19522610|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
19522611|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522612|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19522613|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522614|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100895|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100896|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100897|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100898|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100899|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100900|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100901|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19522615|NCT02942888|Niacinamide|niacinamide|mesh-list
19522616|NCT02942888|Niacin|niacin|mesh-list
19522617|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
19522618|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
19522619|NCT02942888|Vitamins|vitamins|mesh-ancestor
19522620|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
19522621|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522622|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19522623|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
19522624|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522625|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19522626|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
19522627|NCT02942810|Cefepime|cefepime|mesh-list
19522628|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19522629|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522630|NCT02942680|Aspirin|aspirin|mesh-list
19522631|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19522632|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19522633|NCT02942680|Analgesics|analgesics|mesh-ancestor
19522634|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
19522635|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522636|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522637|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19522638|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19522639|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19522640|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19522641|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522642|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19522643|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19522644|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522645|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
19522646|NCT02942693|Apatinib|apatinib|mesh-list
19522647|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522648|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19522649|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522650|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522651|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
19522652|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19522653|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522654|NCT02942732|Vitamins|vitamins|mesh-ancestor
19522655|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
19522656|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19522657|NCT02942758|Pioglitazone|pioglitazone|mesh-list
19522658|NCT02942758|Azacitidine|azacitidine|mesh-list
19522659|NCT02942758|Tretinoin|tretinoin|mesh-list
19522660|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522661|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
19522662|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522663|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522664|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522665|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19522666|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522667|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
19522668|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100902|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
20100903|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20100904|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522669|NCT02942563|Capecitabine|capecitabine|mesh-list
19522670|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
19522671|NCT02942563|Irinotecan|irinotecan|mesh-list
19522672|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522673|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
19522674|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522675|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522676|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19522677|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19522678|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522679|NCT02942420|Bucillamine|bucillamine|mesh-list
19522680|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19522681|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19522682|NCT02942420|Analgesics|analgesics|mesh-ancestor
19522683|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
19522684|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522685|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522686|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19522687|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19522688|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
19522689|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522690|NCT02942420|Protective Agents|protective agents|mesh-ancestor
19522691|NCT02942706|Cetuximab|cetuximab|mesh-list
19522692|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522693|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522694|NCT02942498|Vitamins|vitamins|mesh-list
19522695|NCT02942498|Ascorbic Acid|ascorbic acid|mesh-list
19522696|NCT02942498|Vitamin E|vitamin e|mesh-list
19522697|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
19522698|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522699|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
19522700|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522701|NCT02942498|Protective Agents|protective agents|mesh-ancestor
19522702|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
19522703|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
19522704|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19522705|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19522706|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522707|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522708|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522709|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19522710|NCT02942550|Bromides|bromides|mesh-list
19522711|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
19522712|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
19522713|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19522714|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100905|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100906|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
20100907|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
20100908|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20100909|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100910|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
20100911|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19522715|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
20100912|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19522716|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522717|NCT02942602|Atorvastatin|atorvastatin|mesh-list
19522718|NCT02942602|Ezetimibe|ezetimibe|mesh-list
19522719|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
19522720|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20100913|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100914|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100915|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100916|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100917|NCT00002920|Tamoxifen|tamoxifen|mesh-list
20100918|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20100919|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
20100920|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20100921|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
20100922|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20100923|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100924|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20100925|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100926|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20100927|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20100928|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20100929|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20100930|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20100931|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20100932|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
20100933|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19522721|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19522722|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
19522723|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522724|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19522725|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19522726|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522727|NCT02942329|Apatinib|apatinib|mesh-list
19522728|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522729|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19522730|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522731|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522732|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19522733|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19522734|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522735|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522736|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
19522737|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522738|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522739|NCT02942212|Nicotine|nicotine|mesh-list
19522740|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19522741|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
19522742|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522743|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522744|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19522745|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19522746|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
19522747|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522748|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522749|NCT02942043|Bevacizumab|bevacizumab|mesh-list
19522750|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522751|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522752|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19522753|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20100934|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20100935|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20100936|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20100937|NCT00002921|Suramin|suramin|mesh-list
20100938|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
20100939|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20100940|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20100941|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20100942|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20100943|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
20100944|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
20100945|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20100946|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100947|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100948|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20100949|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19522754|NCT02942043|Growth Substances|growth substances|mesh-ancestor
19522755|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100950|NCT00002922|Paclitaxel|paclitaxel|mesh-list
19522756|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
19522757|NCT02941913|Palonosetron|palonosetron|mesh-list
19522758|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
19522759|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
19522760|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522761|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522762|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19522763|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19522764|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19522765|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
19522766|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522767|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522768|NCT02941575|Methamphetamine|methamphetamine|mesh-list
19522769|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19522770|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522771|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
19522772|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
19522773|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522774|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
19522775|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522776|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522777|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
19522778|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19522779|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19522780|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522781|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19522782|NCT02941562|Leucovorin|leucovorin|mesh-list
19522783|NCT02941562|Fluorouracil|fluorouracil|mesh-list
19522784|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
19522785|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
19522786|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522787|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522788|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522789|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522790|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
19522791|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522792|NCT02941562|Antidotes|antidotes|mesh-ancestor
19522793|NCT02941562|Protective Agents|protective agents|mesh-ancestor
19522794|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
19522795|NCT02941562|Vitamins|vitamins|mesh-ancestor
19522796|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
19522797|NCT02941731|Oseltamivir|oseltamivir|mesh-list
19522798|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
20100951|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100952|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100953|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100954|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100955|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
20100956|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522799|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522800|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522801|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522802|NCT02941744|Nivolumab|nivolumab|mesh-list
19522803|NCT02941744|Ipilimumab|ipilimumab|mesh-list
19522804|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19522805|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522806|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19522807|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522808|NCT02941822|Ambroxol|ambroxol|mesh-list
19522809|NCT02941822|Expectorants|expectorants|mesh-ancestor
19522810|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
19522811|NCT02941445|Metformin|metformin|mesh-list
19522812|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19522813|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19522814|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522815|NCT02941445|Incretins|incretins|mesh-ancestor
19522816|NCT02941445|Hormones|hormones|mesh-ancestor
19522817|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522818|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20100957|NCT00002923|KRN 5500|krn 5500|mesh-list
20100958|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100959|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20100960|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522819|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522820|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120428|NCT00006358|Growth Substances|growth substances|mesh-ancestor
19522821|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522822|NCT02941510|Budesonide|budesonide|mesh-list
19522823|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19522824|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19522825|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
20100961|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100962|NCT00002925|Aldesleukin|aldesleukin|mesh-list
20100963|NCT00002925|Etoposide|etoposide|mesh-list
20100964|NCT00002925|Daunorubicin|daunorubicin|mesh-list
20100965|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100966|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100967|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19522826|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522827|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522828|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19522829|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
19522830|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
19522831|NCT02941510|Hormones|hormones|mesh-ancestor
19522832|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522833|NCT02941601|Gemcitabine|gemcitabine|mesh-list
19522834|NCT02941601|Carboplatin|carboplatin|mesh-list
19522835|NCT02941601|Necitumumab|necitumumab|mesh-list
19522836|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522837|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522838|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
19522839|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522840|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
19522841|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522842|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522843|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522844|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
19522845|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522846|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19572861|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572862|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19572863|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19572864|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19572865|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19572866|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572867|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572868|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
19572869|NCT02700022|Hormones|hormones|mesh-ancestor
19572870|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572871|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19572872|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19572873|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
19572874|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
19572875|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
19572876|NCT02699658|Levofloxacin|levofloxacin|mesh-list
19572877|NCT02699658|Ofloxacin|ofloxacin|mesh-list
19572878|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19572879|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572880|NCT02699658|Renal Agents|renal agents|mesh-ancestor
19572881|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19572882|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19572883|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19572884|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572885|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572886|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572887|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19572888|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19572889|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
19572890|NCT02699801|Propofol|propofol|mesh-list
19572891|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19572892|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572893|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572894|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19572895|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
19572896|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
19572897|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572898|NCT02699801|Analgesics|analgesics|mesh-ancestor
19572899|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
19572900|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572901|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19522847|NCT02941367|Metformin|metformin|mesh-list
20100968|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20100969|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100970|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100971|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19522848|NCT02941367|Lixisenatide|lixisenatide|mesh-list
19522849|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19522850|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522851|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19522852|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19522853|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522854|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522855|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
19522856|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522857|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522858|NCT02941315|Captopril|captopril|mesh-list
19522859|NCT02941315|Spironolactone|spironolactone|mesh-list
19522860|NCT02941315|Furosemide|furosemide|mesh-list
19522861|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19522862|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19522863|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
19522864|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522865|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522866|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19522867|NCT02941315|Diuretics|diuretics|mesh-ancestor
19522868|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
19522869|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19522870|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
19522871|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522872|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522873|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19522874|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
19522875|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522876|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19522877|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19522878|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19522879|NCT02941224|Sirolimus|sirolimus|mesh-list
19522880|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19522881|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522882|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19522883|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522884|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
19522885|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522886|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
19522887|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522888|NCT02941198|Copper|copper|mesh-list
19522889|NCT02941198|Trace Elements|trace elements|mesh-ancestor
19522890|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
19522891|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522892|NCT02940990|Gemcitabine|gemcitabine|mesh-list
19522893|NCT02940990|Paclitaxel|paclitaxel|mesh-list
19522894|NCT02940990|Etoposide|etoposide|mesh-list
19522895|NCT02940990|Vinorelbine|vinorelbine|mesh-list
19522896|NCT02940990|Docetaxel|docetaxel|mesh-list
19522897|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19522898|NCT02940990|Carboplatin|carboplatin|mesh-list
19522899|NCT02940990|Pemetrexed|pemetrexed|mesh-list
19522900|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19522901|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522902|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
19522903|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
19522904|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
19522905|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522906|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522907|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
19522908|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
19522909|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522910|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522911|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522912|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
19522913|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522914|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19522915|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19522916|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19522917|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19522918|NCT02940925|Cisplatin|cisplatin|mesh-list
19522919|NCT02940925|Fluorouracil|fluorouracil|mesh-list
19522920|NCT02940925|Capecitabine|capecitabine|mesh-list
19522921|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522922|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
19522923|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522924|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19522925|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19522926|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
19522927|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522928|NCT02941016|Evolocumab|evolocumab|mesh-list
19522929|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19522930|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20100972|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20100973|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20100974|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
20100975|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522931|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
19522932|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522933|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19522934|NCT02940912|Apomorphine|apomorphine|mesh-list
19522935|NCT02940912|Emetics|emetics|mesh-ancestor
19522936|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522937|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
19522938|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19522939|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19522940|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
19522941|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
19522942|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522943|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522944|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19522945|NCT02940821|Fluorides|fluorides|mesh-list
19522946|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
19522947|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
19522948|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
19522949|NCT02940821|Protective Agents|protective agents|mesh-ancestor
19522950|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522951|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19522952|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522953|NCT02940808|Caffeine|caffeine|mesh-list
19522954|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19522955|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522956|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19522957|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522958|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522959|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19522960|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19522961|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
19522962|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19522963|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
19522964|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
19522965|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19522966|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522967|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522968|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
19522969|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19522970|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19522971|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19522972|NCT02940756|Artesunate|artesunate|mesh-list
19522973|NCT02940756|Lumefantrine|lumefantrine|mesh-list
19522974|NCT02940756|Artemether|artemether|mesh-list
19522975|NCT02940756|Piperaquine|piperaquine|mesh-list
19522976|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19522977|NCT02940756|Amodiaquine|amodiaquine|mesh-list
19522978|NCT02940756|Artenimol|artenimol|mesh-list
19522979|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
19522980|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19522981|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19522982|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19522983|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19522984|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
19522985|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
19522986|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19522987|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
19522988|NCT02941068|Fluconazole|fluconazole|mesh-list
19522989|NCT02941068|Caspofungin|caspofungin|mesh-list
19522990|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
19522991|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100976|NCT00002926|Cytarabine|cytarabine|mesh-list
19522992|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19522993|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19522994|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19522995|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19522996|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19522997|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
19522998|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19522999|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523000|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19523001|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19523002|NCT02940301|Nivolumab|nivolumab|mesh-list
19523003|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19523004|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523005|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19523006|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523007|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19523008|NCT02940379|Metoprolol|metoprolol|mesh-list
19523009|NCT02940379|Midazolam|midazolam|mesh-list
19523010|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19523011|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19523012|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523013|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523014|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19523015|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19523016|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19523017|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19523018|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
19523019|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
19523020|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
19523021|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
19523022|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20100977|NCT00002926|Etoposide|etoposide|mesh-list
19523023|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523024|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19523025|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19523026|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
19523027|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
19523028|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523029|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19523030|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19523031|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19523032|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
19523033|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19523034|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19523035|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20100978|NCT00002926|Idarubicin|idarubicin|mesh-list
20100979|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100980|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100981|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20100982|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20603688|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20603689|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20603690|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20603691|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19523036|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20100983|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20100984|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20100985|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20100986|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
20100987|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
20100988|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20100989|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20100990|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
20100991|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20100992|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20100993|NCT00002928|Paclitaxel|paclitaxel|mesh-list
20100994|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20100995|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20100996|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
20100997|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
20100998|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
20603692|NCT02222480|Diuretics|diuretics|mesh-ancestor
19523037|NCT02940535|Menotropins|menotropins|mesh-list
19523038|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
19523039|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19523040|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
19523041|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19523042|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523043|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19523044|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19523045|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523046|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19523047|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
20100999|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101000|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20101001|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20101002|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101003|NCT00002932|Cisplatin|cisplatin|mesh-list
20101004|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101005|NCT00002933|Irinotecan|irinotecan|mesh-list
20101006|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20101007|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101008|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101009|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101010|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101011|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20101012|NCT00002935|Trioxsalen|trioxsalen|mesh-list
20101013|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101014|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
20101015|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20101016|NCT00002936|Etoposide|etoposide|mesh-list
20101017|NCT00002936|Altretamine|altretamine|mesh-list
20101018|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101019|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101020|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19523070|NCT02940561|Methotrexate|methotrexate|mesh-list
19523071|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19523072|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
19523073|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19523074|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523075|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19523076|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
19523077|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523078|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523079|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
19523080|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523081|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19523082|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523083|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
19523084|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523085|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19523086|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
19523087|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19523088|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19523089|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
19523090|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523091|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523092|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523093|NCT02940314|Urological Agents|urological agents|mesh-ancestor
19523094|NCT02940366|Atorvastatin|atorvastatin|mesh-list
19523095|NCT02940366|Pitavastatin|pitavastatin|mesh-list
19523096|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19523097|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19523098|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
19572902|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20101021|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101022|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101023|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101024|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101025|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
20101026|NCT00002937|Paclitaxel|paclitaxel|mesh-list
20101027|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101028|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101029|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
20603693|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
20101030|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101031|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101032|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101033|NCT00002939|Paclitaxel|paclitaxel|mesh-list
20101034|NCT00002939|Irinotecan|irinotecan|mesh-list
20101035|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101036|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523099|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523100|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19523101|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19523102|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523103|NCT02940405|Ketorolac|ketorolac|mesh-list
19523104|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19523105|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19523106|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19523107|NCT02940405|Analgesics|analgesics|mesh-ancestor
19523108|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
19523109|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523110|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523111|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523112|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523113|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19523114|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523115|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523116|NCT02940444|Heparin|heparin|mesh-list
19523117|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
19523118|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19523119|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19523120|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523121|NCT02940483|Azacitidine|azacitidine|mesh-list
19523122|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19523123|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
19523124|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523125|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523126|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523127|NCT02940262|Edetic Acid|edetic acid|mesh-list
19523128|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19523129|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
19523130|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
19523131|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523132|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
19523133|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19523134|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19523135|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19523136|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19523137|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523138|NCT02940184|Incretins|incretins|mesh-ancestor
19523139|NCT02940184|Hormones|hormones|mesh-ancestor
19523140|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523141|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19523142|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
19523143|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101037|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101038|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101039|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101040|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101041|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20101042|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101043|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101044|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
20101045|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523144|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523145|NCT02940002|Betamethasone|betamethasone|mesh-list
19523146|NCT02940002|Clobetasol|clobetasol|mesh-list
19523147|NCT02940002|Calcipotriene|calcipotriene|mesh-list
19523148|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523149|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
19523150|NCT02940002|Hormones|hormones|mesh-ancestor
19523151|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523152|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523153|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20101046|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
20101047|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101048|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572903|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19523154|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
19523155|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
19523156|NCT02939833|Ropivacaine|ropivacaine|mesh-list
19523157|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
19523158|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
19523159|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523160|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523161|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
19523162|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523163|NCT02939872|Aspirin|aspirin|mesh-list
19523164|NCT02939872|Clopidogrel|clopidogrel|mesh-list
19523165|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19523166|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19523167|NCT02939872|Analgesics|analgesics|mesh-ancestor
19523168|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
19523169|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523170|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523171|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523172|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523173|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19523174|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19523175|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523176|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19523177|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19523178|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523179|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
19523180|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19523181|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19523182|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19523183|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
19523184|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523185|NCT02939898|Letrozole|letrozole|mesh-list
19523186|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19523187|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523188|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19523189|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523190|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523191|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19523192|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
19523193|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523194|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572904|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
19572905|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572906|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572907|NCT02699710|Folic Acid|folic acid|mesh-list
19572908|NCT02699710|Methotrexate|methotrexate|mesh-list
19572909|NCT02699710|Rabeprazole|rabeprazole|mesh-list
19572910|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19572911|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
19572912|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19572913|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572914|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19572915|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
19572916|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572917|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19572918|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
19572919|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19572920|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19572921|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19572922|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
19572923|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572924|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19572925|NCT02699710|Hematinics|hematinics|mesh-ancestor
19572926|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
19572927|NCT02699710|Vitamins|vitamins|mesh-ancestor
19572928|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
20101049|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101050|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
20101051|NCT00002941|Carmustine|carmustine|mesh-list
20101052|NCT00002941|Etoposide|etoposide|mesh-list
20101053|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101054|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
19572929|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19572930|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20101055|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101056|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101057|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101058|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
20101059|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101060|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101061|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101062|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101063|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101064|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101065|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523195|NCT02939846|Trametinib|trametinib|mesh-list
19523196|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523197|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19523198|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523199|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523200|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
19523201|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
20101066|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
20101067|NCT00002943|Carboplatin|carboplatin|mesh-list
20101068|NCT00002943|Etoposide|etoposide|mesh-list
20101069|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101070|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
20101071|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101072|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101073|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101074|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
19523202|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19523203|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19523204|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523205|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523206|NCT02939495|Urological Agents|urological agents|mesh-ancestor
19523207|NCT02939482|Triamcinolone|triamcinolone|mesh-list
19523208|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19523209|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19523210|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19523211|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523212|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
19523213|NCT02939482|Hormones|hormones|mesh-ancestor
19523214|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523215|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523216|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523217|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
19523218|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523219|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523220|NCT02939430|Atropine|atropine|mesh-list
19523221|NCT02939430|Neostigmine|neostigmine|mesh-list
19523222|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19523223|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19523224|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19523225|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
19523226|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523227|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523228|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19523229|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
19523230|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
19523231|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
19523232|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19523233|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19523234|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
19523235|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523236|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523237|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19523238|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523239|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19523240|NCT02939365|Abatacept|abatacept|mesh-list
19523241|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19523242|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523243|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523244|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523245|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
19523246|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523247|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120429|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
19523248|NCT02939547|Betadex|betadex|mesh-list
19523249|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
19523250|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523251|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
19523252|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19523253|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523254|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
19523255|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523256|NCT02939417|Protective Agents|protective agents|mesh-ancestor
19523257|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523258|NCT02939274|Verteporfin|verteporfin|mesh-list
19523259|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19523260|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
19523261|NCT02939287|Olanzapine|olanzapine|mesh-list
19523262|NCT02939287|Aprepitant|aprepitant|mesh-list
19523263|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
19523264|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
19523265|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
19523266|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523267|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523268|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523269|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19523270|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19523271|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523272|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19523273|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19523274|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19523275|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19523276|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523277|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20101075|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101076|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101077|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101078|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101079|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101080|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101081|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101082|NCT00002944|Carboplatin|carboplatin|mesh-list
20101083|NCT00002944|Vincristine|vincristine|mesh-list
20101084|NCT00002944|Thioguanine|thioguanine|mesh-list
20101085|NCT00002944|Lomustine|lomustine|mesh-list
20101086|NCT00002944|Procarbazine|procarbazine|mesh-list
20101087|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101088|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101089|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101090|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
19523278|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
19523279|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19523280|NCT02939300|Nivolumab|nivolumab|mesh-list
19523281|NCT02939300|Ipilimumab|ipilimumab|mesh-list
19523282|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19523283|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523284|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19523285|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523286|NCT02939248|Morphine|morphine|mesh-list
19523287|NCT02939248|Naloxone|naloxone|mesh-list
19523288|NCT02939248|Ticagrelor|ticagrelor|mesh-list
19523289|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19523290|NCT02939248|Narcotics|narcotics|mesh-ancestor
19523291|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523292|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523293|NCT02939248|Analgesics|analgesics|mesh-ancestor
19523294|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
19523295|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523296|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19523297|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19523298|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19523299|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19523300|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
19523301|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523302|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523303|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19523304|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
19523305|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19523306|NCT02938988|Methylene Blue|methylene blue|mesh-list
20101091|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
19523307|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523308|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523309|NCT02939235|Morphine|morphine|mesh-list
19523310|NCT02939235|Metoclopramide|metoclopramide|mesh-list
19523311|NCT02939235|Ticagrelor|ticagrelor|mesh-list
19523312|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19523313|NCT02939235|Narcotics|narcotics|mesh-ancestor
19523314|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523315|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523316|NCT02939235|Analgesics|analgesics|mesh-ancestor
19523317|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
19523318|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523319|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19523320|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19523321|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19523322|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19523323|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
19523324|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523325|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523326|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
19523327|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
19523328|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523329|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19523330|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19523331|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
19523332|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
19523333|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19523334|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19523335|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523336|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
19523337|NCT02938962|Coagulants|coagulants|mesh-ancestor
19523338|NCT02938975|Permethrin|permethrin|mesh-list
19523339|NCT02938975|Insect Repellents|insect repellents|mesh-list
19523340|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523341|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523342|NCT02938975|Protective Agents|protective agents|mesh-ancestor
19523343|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523344|NCT02939209|Hydromorphone|hydromorphone|mesh-list
19523345|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19523346|NCT02939209|Narcotics|narcotics|mesh-ancestor
19523347|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523348|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523349|NCT02939209|Analgesics|analgesics|mesh-ancestor
19523350|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
19523351|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523352|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
19523353|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19523354|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523355|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
19523356|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
19523357|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
19523358|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523359|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523360|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19523361|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19523362|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523363|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
19523364|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19523365|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523366|NCT02938468|Dexamethasone|dexamethasone|mesh-list
19523367|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523368|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
19523369|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
19523370|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523371|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523372|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523373|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
19523374|NCT02938468|Hormones|hormones|mesh-ancestor
20101092|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101093|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101094|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
20101095|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19523375|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523376|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19523377|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101096|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
20101097|NCT00002945|Cytarabine|cytarabine|mesh-list
20101098|NCT00002945|Aldesleukin|aldesleukin|mesh-list
20101099|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
20101100|NCT00002945|Melphalan|melphalan|mesh-list
20101101|NCT00002945|Etoposide|etoposide|mesh-list
20101102|NCT00002945|Idarubicin|idarubicin|mesh-list
20101103|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101104|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
20101105|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101106|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101107|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101108|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
20101109|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101110|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101111|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101112|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101113|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101114|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101115|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101116|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101117|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
20101118|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
20101119|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523378|NCT02938507|Solabegron|solabegron|mesh-list
19523379|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19523380|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19523381|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19523382|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
19523383|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523384|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523385|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523386|NCT02938260|Metoprolol|metoprolol|mesh-list
19523387|NCT02938260|Diltiazem|diltiazem|mesh-list
19523388|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19523389|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19523390|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
19523391|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
19523392|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523393|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523394|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19523395|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19523396|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19523397|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
19523398|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523399|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523400|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19523401|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19523402|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19523403|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
19523404|NCT02938273|Cetuximab|cetuximab|mesh-list
19523405|NCT02938273|Avelumab|avelumab|mesh-list
19523406|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19523407|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523408|NCT02938286|Epinephrine|epinephrine|mesh-list
19523409|NCT02938286|Carticaine|carticaine|mesh-list
19523410|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19523411|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19523412|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
19523413|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523414|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523415|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523416|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19523417|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19523418|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
19523419|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523420|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19523421|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
19523422|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
19523423|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
19523424|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19523425|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
19523426|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
19749532|NCT04940338|Dexamethasone|dexamethasone|mesh-list
20101120|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20101121|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120430|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
19523427|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523428|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
19523429|NCT02938182|Clopidogrel|clopidogrel|mesh-list
19523430|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19523431|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19523432|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19523433|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19523434|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
19523435|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523436|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523437|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572931|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19572932|NCT02699437|Antibodies|antibodies|mesh-list
19572933|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
19572934|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
19572935|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572936|NCT02699281|Palmidrol|palmidrol|mesh-list
20603694|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572937|NCT02699281|Analgesics|analgesics|mesh-ancestor
19572938|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
20603695|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20603696|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20603697|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572939|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572940|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572941|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19572942|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19572943|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19572944|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19572945|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
19572946|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19572947|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19572948|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19572949|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572950|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572951|NCT02699281|Hormones|hormones|mesh-ancestor
19572952|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19572953|NCT02699385|Domperidone|domperidone|mesh-list
19572954|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
19572955|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
19572956|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19572957|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572958|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19572959|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19572960|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
19572961|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572962|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572963|NCT02699528|Methylphenidate|methylphenidate|mesh-list
19572964|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19572965|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572966|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19572967|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19572968|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572969|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572970|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
19572971|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572972|NCT02699008|Clopidogrel|clopidogrel|mesh-list
19572973|NCT02699008|Ticagrelor|ticagrelor|mesh-list
19572974|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19572975|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19572976|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19572977|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19572978|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
19572979|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572980|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572981|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577972|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577973|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577974|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20603698|NCT02222519|Bromides|bromides|mesh-list
20603699|NCT02222519|Rocuronium|rocuronium|mesh-list
19523438|NCT02937662|Cytarabine|cytarabine|mesh-list
19523439|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
19523440|NCT02937662|Idarubicin|idarubicin|mesh-list
19523441|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523442|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
19523443|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523444|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523445|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101122|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101123|NCT00002946|Penclomedine|penclomedine|mesh-list
20101124|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101125|NCT00002948|Topotecan|topotecan|mesh-list
20101126|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19523446|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
19523447|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523448|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523449|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19523450|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19523451|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
19523452|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
19523453|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523454|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19523455|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19523456|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19523457|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523458|NCT02937857|Antipyretics|antipyretics|mesh-list
19523459|NCT02937857|Expectorants|expectorants|mesh-list
19523460|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
19523461|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523462|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
19523463|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
19523464|NCT02937844|Fludarabine|fludarabine|mesh-list
19523465|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101127|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101128|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101129|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101130|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101131|NCT00002949|Paclitaxel|paclitaxel|mesh-list
20101132|NCT00002949|Vinorelbine|vinorelbine|mesh-list
20101133|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101134|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101135|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19523466|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
20101136|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101137|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101138|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101139|NCT00002950|Topotecan|topotecan|mesh-list
20101140|NCT00002950|Sargramostim|sargramostim|mesh-list
20101141|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20101142|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101143|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101144|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101145|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101146|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
20101147|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101148|NCT00002951|Fluorouracil|fluorouracil|mesh-list
20101149|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
20101150|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
20101151|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101152|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101153|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101154|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101155|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
20101156|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101157|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
20101158|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101159|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19523467|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523468|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523469|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19523470|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
19523471|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523472|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523473|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19523474|NCT02937896|Ketorolac|ketorolac|mesh-list
19523475|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19523476|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19523477|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19523478|NCT02937896|Analgesics|analgesics|mesh-ancestor
19523479|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
19523480|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523481|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523482|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523483|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523484|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19523485|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523486|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523487|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
19523488|NCT02937896|Coagulants|coagulants|mesh-ancestor
19523489|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19523490|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
19523491|NCT02937792|Bupivacaine|bupivacaine|mesh-list
19523492|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
19523493|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
19523494|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523495|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523496|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
19523497|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523498|NCT02937779|Tenofovir|tenofovir|mesh-list
19523499|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
19523500|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523501|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19523502|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19523503|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523504|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523505|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19523506|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19523507|NCT02937519|Cisplatin|cisplatin|mesh-list
19523508|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523509|NCT02937415|Antioxidants|antioxidants|mesh-list
19523510|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
19523511|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523512|NCT02937415|Protective Agents|protective agents|mesh-ancestor
19523513|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523514|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
19523515|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
19523516|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523517|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
19523518|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
19523519|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523520|NCT02937363|Protective Agents|protective agents|mesh-ancestor
19523521|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523522|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
19523523|NCT02937363|Vitamins|vitamins|mesh-ancestor
19523524|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
19523525|NCT02937285|Interferons|interferons|mesh-list
19523526|NCT02937285|Interferon-beta|interferon-beta|mesh-list
19523527|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
19523528|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
19523529|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523530|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
19523531|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523532|NCT02937285|Analgesics|analgesics|mesh-ancestor
19523533|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
19523534|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523535|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523536|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19523537|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19523538|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523539|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523540|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
19523541|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19523542|NCT02937272|Gemcitabine|gemcitabine|mesh-list
19523543|NCT02937272|Paclitaxel|paclitaxel|mesh-list
19523544|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19523545|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523546|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
19523547|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
19523548|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
19523549|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523550|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19523551|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
19523552|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
19523553|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523554|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523555|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523556|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
19523557|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523558|NCT02936934|Morphine|morphine|mesh-list
19523559|NCT02936934|Oxycodone|oxycodone|mesh-list
19523560|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19523561|NCT02936934|Narcotics|narcotics|mesh-ancestor
19523562|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523563|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523564|NCT02936934|Analgesics|analgesics|mesh-ancestor
19523565|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
19523566|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523567|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19523568|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19523569|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523570|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19523571|NCT02937012|Bezafibrate|bezafibrate|mesh-list
19523572|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19523573|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523574|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19523575|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
19523576|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523577|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19523578|NCT02936895|Vitamin D|vitamin d|mesh-list
19523579|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
19523580|NCT02936895|Vitamins|vitamins|mesh-ancestor
19523581|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
19523582|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523583|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19523584|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19523585|NCT02936830|Listerine|listerine|mesh-list
19523586|NCT02936830|Fluorides|fluorides|mesh-list
19523587|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
19523588|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
19523589|NCT02936830|Glycerol|glycerol|mesh-list
19523590|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
19523591|NCT02936830|Protective Agents|protective agents|mesh-ancestor
19523592|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523593|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19523594|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523595|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19523596|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
19523597|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19523598|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19523599|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101160|NCT00002952|Interleukin-12|interleukin-12|mesh-list
20101161|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20101162|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
20101163|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101164|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20101165|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20101166|NCT00002952|Growth Substances|growth substances|mesh-ancestor
20101167|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
20101168|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101169|NCT00002953|Paclitaxel|paclitaxel|mesh-list
20101170|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
20101171|NCT00002953|Epirubicin|epirubicin|mesh-list
20101172|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101173|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101174|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101175|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101176|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101177|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523600|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
19523601|NCT02936661|Coagulants|coagulants|mesh-ancestor
20101178|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523602|NCT02936622|Paclitaxel|paclitaxel|mesh-list
20101179|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
20101180|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101181|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101182|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101183|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
20101184|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101185|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101186|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101187|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101188|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101189|NCT00002955|Leucovorin|leucovorin|mesh-list
20101190|NCT00002955|Trimetrexate|trimetrexate|mesh-list
20101191|NCT00002955|Fluorouracil|fluorouracil|mesh-list
20101192|NCT00002955|Calcium|calcium|mesh-list
20101193|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
20101194|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20101195|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101196|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
20101197|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101198|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101199|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101200|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101201|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
20101202|NCT00002955|Antidotes|antidotes|mesh-ancestor
20101203|NCT00002955|Protective Agents|protective agents|mesh-ancestor
20101204|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
19523603|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19523604|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19523605|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523606|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
19523607|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
19523608|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
19523609|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523610|NCT02936492|Clobetasol|clobetasol|mesh-list
19523611|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523612|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
19523613|NCT02936492|Hormones|hormones|mesh-ancestor
19523614|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523615|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523616|NCT02936505|Cyclosporine|cyclosporine|mesh-list
19523617|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
20101205|NCT00002955|Vitamins|vitamins|mesh-ancestor
20101206|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
20101207|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
20101208|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101209|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20101210|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101211|NCT00002961|Cyclosporine|cyclosporine|mesh-list
20101212|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
20101213|NCT00002961|Busulfan|busulfan|mesh-list
20101214|NCT00002961|Methotrexate|methotrexate|mesh-list
20101215|NCT00002961|Etoposide|etoposide|mesh-list
20101216|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
20101217|NCT00002961|Cyclosporins|cyclosporins|mesh-list
20101218|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101219|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
20101220|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101221|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101222|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101223|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
20101224|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101225|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101226|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101227|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20101228|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
20101229|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20101230|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101231|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
20101232|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
20101233|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101234|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20101235|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101236|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19523618|NCT02936505|Tacrolimus|tacrolimus|mesh-list
19523619|NCT02936505|Cyclosporins|cyclosporins|mesh-list
20101237|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101238|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19523620|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
19523621|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19523622|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523623|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
19523624|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523625|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19523626|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523627|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523628|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
19523629|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523630|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
19523631|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523632|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19523633|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523634|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19523635|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
19523636|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19523637|NCT02936427|Dexamethasone|dexamethasone|mesh-list
19523638|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
19523639|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19523640|NCT02936427|BB 1101|bb 1101|mesh-list
19523641|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523642|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
19523643|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
19523644|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523645|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523646|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523647|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
19523648|NCT02936427|Hormones|hormones|mesh-ancestor
19523649|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523650|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101239|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
20101240|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101241|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20101242|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20101243|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20101244|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
20101245|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20101246|NCT00002964|Trioxsalen|trioxsalen|mesh-list
20101247|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101248|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
20101249|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20101250|NCT00002965|Interferons|interferons|mesh-list
19523651|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523652|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
19523653|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523654|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523655|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
20101251|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
20101252|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
20603700|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
20603701|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20603702|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20101253|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20101254|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101255|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
20101256|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101257|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
20101258|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101259|NCT00002967|Tamoxifen|tamoxifen|mesh-list
20101260|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
20101261|NCT00002967|Doxorubicin|doxorubicin|mesh-list
20101262|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101263|NCT00002967|Octreotide|octreotide|mesh-list
20101264|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101265|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
20101266|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101267|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101268|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101269|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
20101270|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101271|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101272|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101273|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101274|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20603703|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20101275|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19523656|NCT02936375|Azathioprine|azathioprine|mesh-list
19523657|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523658|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
19523659|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523660|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19523661|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19523662|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
19523663|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523664|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523665|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19523666|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
19523667|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19572982|NCT02699138|Trazodone|trazodone|mesh-list
19572983|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19572984|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19572985|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572986|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572987|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19572988|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19572989|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19572990|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19572991|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19572992|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19572993|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
19572994|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19572995|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
19572996|NCT02698982|Anesthetics|anesthetics|mesh-list
19572997|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19572998|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19572999|NCT02698969|Atropine|atropine|mesh-list
19573000|NCT02698969|Fentanyl|fentanyl|mesh-list
19573001|NCT02698969|Propofol|propofol|mesh-list
19573002|NCT02698969|Sevoflurane|sevoflurane|mesh-list
19573003|NCT02698969|Rocuronium|rocuronium|mesh-list
19573004|NCT02698969|Neostigmine|neostigmine|mesh-list
19573005|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19573006|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573007|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573008|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19573009|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
19573010|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
19573011|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19573012|NCT02698969|Narcotics|narcotics|mesh-ancestor
19573013|NCT02698969|Analgesics|analgesics|mesh-ancestor
19573014|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
19573015|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573016|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19573017|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19573018|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19573019|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19573020|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19573021|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19573022|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19573023|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19573024|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
19573025|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19573026|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
19573027|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
19573028|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
19573029|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19573030|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19573031|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
19573032|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573033|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573034|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19573035|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573036|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19573037|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
19573038|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19573039|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573040|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573041|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573042|NCT02698930|Analgesics|analgesics|mesh-ancestor
19573043|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
19573044|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523668|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
19523669|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19523670|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19523671|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
19523672|NCT02935933|Morphine|morphine|mesh-list
19523673|NCT02935933|Bupivacaine|bupivacaine|mesh-list
19523674|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
19523675|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
19523676|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523677|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523678|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
19523679|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523680|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19523681|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19523682|NCT02935933|Analgesics|analgesics|mesh-ancestor
19523683|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19523684|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19523685|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19523686|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
19523687|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523688|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523689|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19523690|NCT02935933|Narcotics|narcotics|mesh-ancestor
19523691|NCT02935725|Ketamine|ketamine|mesh-list
19523692|NCT02935725|Analgesics|analgesics|mesh-ancestor
19523693|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
19523694|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523695|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523696|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19523697|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19523698|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
19523699|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
19523700|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523701|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19523702|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19523703|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523704|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523705|NCT02935764|Leucovorin|leucovorin|mesh-list
19523706|NCT02935764|Fluorouracil|fluorouracil|mesh-list
19523707|NCT02935764|Irinotecan|irinotecan|mesh-list
19523708|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
20101276|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101277|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20101278|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
20101279|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101280|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101281|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20101282|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20101283|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20101284|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20101285|NCT00002968|Edrecolomab|edrecolomab|mesh-list
20101286|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20101287|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
20101288|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101289|NCT00002969|Paclitaxel|paclitaxel|mesh-list
20101290|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101291|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101292|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101293|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101294|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101295|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101296|NCT00002970|Cytarabine|cytarabine|mesh-list
20101297|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
20101298|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20101299|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20101300|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20101301|NCT00002970|Methotrexate|methotrexate|mesh-list
20101302|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20603704|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603705|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603706|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
20603707|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19523709|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749533|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
19523710|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19523711|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523712|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19523713|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
19523714|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523715|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19523716|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19523717|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523718|NCT02935764|Antidotes|antidotes|mesh-ancestor
19523719|NCT02935764|Protective Agents|protective agents|mesh-ancestor
19523720|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
19523721|NCT02935764|Vitamins|vitamins|mesh-ancestor
19523722|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
19523723|NCT02935751|Apixaban|apixaban|mesh-list
19523724|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19523725|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
19523726|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19523727|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
19523728|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523729|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523730|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
19523731|NCT02935998|Ziprasidone|ziprasidone|mesh-list
19523732|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19523733|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
19523734|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523735|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523736|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523737|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19523738|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19523739|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523740|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19523741|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19523742|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
19523743|NCT02935790|Nivolumab|nivolumab|mesh-list
19523744|NCT02935790|Ipilimumab|ipilimumab|mesh-list
20101303|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
20101304|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20101305|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101306|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101307|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
20101308|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101309|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101310|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
20101311|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101312|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20101313|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101314|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
20101315|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101316|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101317|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
20101318|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101319|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20101320|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20101321|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101322|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101323|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101324|NCT00002972|Paclitaxel|paclitaxel|mesh-list
20101325|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101326|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101327|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101328|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101329|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101330|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101331|NCT00002973|Melphalan|melphalan|mesh-list
20101332|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101333|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
20101334|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101335|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101336|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101337|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101338|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
19523745|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19523746|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523747|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19523748|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523749|NCT02935829|Locust bean gum|locust bean gum|mesh-list
19523750|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
19523751|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523752|NCT02935959|Midazolam|midazolam|mesh-list
19523753|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
19523754|NCT02935959|Ketamine|ketamine|mesh-list
19523755|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19523756|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523757|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523758|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19523759|NCT02935959|Analgesics|analgesics|mesh-ancestor
19523760|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
19523761|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523762|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19523763|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19523764|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19523765|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
19523766|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523767|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523768|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19523769|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19523770|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
19523771|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
19523772|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19523773|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19523774|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19523775|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19523776|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19523777|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19523778|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
19523779|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
20101339|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101340|NCT00002974|Carboplatin|carboplatin|mesh-list
20101341|NCT00002974|Etoposide|etoposide|mesh-list
20101342|NCT00002974|Ifosfamide|ifosfamide|mesh-list
20101343|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101344|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101345|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101346|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101347|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101348|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101349|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101350|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
20101351|NCT00002976|Estrogens|estrogens|mesh-list
20101352|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20101353|NCT00002976|Hormones|hormones|mesh-ancestor
20101354|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101355|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101356|NCT00002977|Melphalan|melphalan|mesh-list
20101357|NCT00002977|Thiotepa|thiotepa|mesh-list
20101358|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
20101359|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101360|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101361|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
20101362|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101363|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101364|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101365|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101366|NCT00002980|Decitabine|decitabine|mesh-list
20101367|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101368|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
20101369|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101370|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101371|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101372|NCT00002982|Cytarabine|cytarabine|mesh-list
20101373|NCT00002982|Carboplatin|carboplatin|mesh-list
20101374|NCT00002982|Etoposide|etoposide|mesh-list
20101375|NCT00002982|Melphalan|melphalan|mesh-list
20101376|NCT00002982|Ifosfamide|ifosfamide|mesh-list
20101377|NCT00002982|Carmustine|carmustine|mesh-list
20101378|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523780|NCT02935972|Lidocaine|lidocaine|mesh-list
19523781|NCT02935972|Diazepam|diazepam|mesh-list
19523782|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
20101379|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101380|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19523783|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
19523784|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523785|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523786|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
19523787|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523788|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19523789|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19523790|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19523791|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19523792|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523793|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19523794|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
19523795|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
19523796|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
19523797|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523798|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19523799|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19523800|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19523801|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19523802|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19523803|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19523804|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19523805|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
19523806|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
19523807|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
19523808|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523809|NCT02935855|Warfarin|warfarin|mesh-list
19523810|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
19523811|NCT02935855|Dabigatran|dabigatran|mesh-list
19523812|NCT02935855|Apixaban|apixaban|mesh-list
19523813|NCT02935855|Edoxaban|edoxaban|mesh-list
19523814|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
19523815|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19523816|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
19523817|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20101381|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101382|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101383|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101384|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101385|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
20101386|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
20101387|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101388|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101389|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
20101390|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101391|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101392|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
20101393|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101394|NCT00002984|Paclitaxel|paclitaxel|mesh-list
20101395|NCT00002984|Fluorouracil|fluorouracil|mesh-list
20101396|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101397|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101398|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101399|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101400|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101401|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101402|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
20101403|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101404|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101405|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
20101406|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101407|NCT00002985|Doxorubicin|doxorubicin|mesh-list
20101408|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101409|NCT00002985|Daunorubicin|daunorubicin|mesh-list
20101410|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101411|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101412|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101413|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101414|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101415|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101416|NCT00002986|Topotecan|topotecan|mesh-list
20101417|NCT00002986|Carmustine|carmustine|mesh-list
20101418|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20101419|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19523818|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
19523819|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749534|NCT04940338|Bromfenac|bromfenac|mesh-list
20101420|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101421|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101422|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101423|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101424|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
20101425|NCT00002987|Prednisolone|prednisolone|mesh-list
20101426|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
20101427|NCT00002987|Doxorubicin|doxorubicin|mesh-list
20101428|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101429|NCT00002987|Etoposide|etoposide|mesh-list
20101430|NCT00002987|Vincristine|vincristine|mesh-list
20101431|NCT00002987|Bleomycin|bleomycin|mesh-list
20101432|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101433|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
20101434|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101435|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101436|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101437|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
19523820|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523821|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
19523822|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19523823|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19523824|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523825|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
19523826|NCT02935985|Coagulants|coagulants|mesh-ancestor
19523827|NCT02935647|Propofol|propofol|mesh-list
19523828|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19523829|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19523830|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523831|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19523832|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
19523833|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
19523834|NCT02935582|Betamethasone|betamethasone|mesh-list
19523835|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
19523836|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19523837|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
19523838|NCT02935582|Calcipotriene|calcipotriene|mesh-list
19523839|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19523840|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523841|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
19523842|NCT02935582|Hormones|hormones|mesh-ancestor
19523843|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523844|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523845|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19523846|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
19523847|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
19523848|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19523849|NCT02935530|Tinzaparin|tinzaparin|mesh-list
19523850|NCT02935530|Dalteparin|dalteparin|mesh-list
19523851|NCT02935530|Argatroban|argatroban|mesh-list
19523852|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
19523853|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19523854|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19523855|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523856|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
19523857|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19523858|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
19523859|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523860|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19523861|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19523862|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
19523863|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19523864|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523865|NCT02935231|Nicotine|nicotine|mesh-list
19523866|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19523867|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
19523868|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523869|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523870|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19523871|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19523872|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
20120431|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
20603708|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523873|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523874|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523875|NCT02935374|Amoxicillin|amoxicillin|mesh-list
19523876|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
19523877|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
19523878|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19523879|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523880|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19523881|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523882|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523883|NCT02935361|Atezolizumab|atezolizumab|mesh-list
19523884|NCT02935361|Guadecitabine|guadecitabine|mesh-list
19523885|NCT02935361|Azacitidine|azacitidine|mesh-list
19523886|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19523887|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523888|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
19523889|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523890|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19523891|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
19523892|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523893|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523894|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
19523895|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19523896|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19523897|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523898|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
19523899|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
19523900|NCT02935335|Menotropins|menotropins|mesh-list
19523901|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19523902|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
19523903|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19523904|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523905|NCT02935075|Tenofovir|tenofovir|mesh-list
19523906|NCT02935075|Lamivudine|lamivudine|mesh-list
19523907|NCT02935075|Efavirenz|efavirenz|mesh-list
19523908|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
19523909|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523910|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19523911|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19523912|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523913|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523914|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19523915|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19523916|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19523917|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19523918|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19523919|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19523920|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19523921|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19523922|NCT02935101|Prednisolone|prednisolone|mesh-list
20101438|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101439|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101440|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20603709|NCT02222636|Fentanyl|fentanyl|mesh-list
19523923|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20101441|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20603710|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
20603711|NCT02222636|Anesthetics|anesthetics|mesh-list
20603712|NCT02222636|Sevoflurane|sevoflurane|mesh-list
20603713|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603714|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603715|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20603716|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20603717|NCT02222636|Analgesics|analgesics|mesh-ancestor
20603718|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
20603719|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603720|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20603721|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20603722|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19523924|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
19523925|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20101442|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101443|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101444|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101445|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20603723|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
20603724|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19523926|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
19749535|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20603725|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603726|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20603727|NCT02222636|Narcotics|narcotics|mesh-ancestor
19523927|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19523928|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
20101446|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101447|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101448|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101449|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20101450|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
20101451|NCT00002987|Hormones|hormones|mesh-ancestor
19523929|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523930|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
19523931|NCT02935101|Hormones|hormones|mesh-ancestor
19523932|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523933|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523934|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19523935|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19523936|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
19523937|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
19523938|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523939|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523940|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19523941|NCT02935101|Protective Agents|protective agents|mesh-ancestor
19523942|NCT02934945|Budesonide|budesonide|mesh-list
19523943|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
19523944|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19523945|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19523946|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
19523947|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523948|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523949|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19523950|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
19523951|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
19523952|NCT02934945|Hormones|hormones|mesh-ancestor
20101452|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101453|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101454|NCT00002988|Irinotecan|irinotecan|mesh-list
20101455|NCT00002988|Carmustine|carmustine|mesh-list
20101456|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20101457|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19523953|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19523954|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19523955|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19523956|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19523957|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
19523958|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20101458|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101459|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101460|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101461|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101462|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
20101463|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
20101464|NCT00002989|Melphalan|melphalan|mesh-list
20101465|NCT00002989|Busulfan|busulfan|mesh-list
20101466|NCT00002989|Idarubicin|idarubicin|mesh-list
20101467|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101468|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
20101469|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101470|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101471|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101472|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
20101473|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101474|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101475|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101476|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101477|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101478|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101479|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101480|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
20101481|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20101482|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
20101483|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603728|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19523959|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523960|NCT02934919|Nalmefene|nalmefene|mesh-list
19523961|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19523962|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523963|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
19523964|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19523965|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
19523966|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
19523967|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19523968|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19523969|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523970|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19523971|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
19523972|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19523973|NCT02934906|Antibodies|antibodies|mesh-list
19523974|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
19523975|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19523976|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
19523977|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19523978|NCT02935010|Amoxicillin|amoxicillin|mesh-list
19523979|NCT02935010|Metronidazole|metronidazole|mesh-list
19523980|NCT02935010|Clarithromycin|clarithromycin|mesh-list
19523981|NCT02935010|Levofloxacin|levofloxacin|mesh-list
19523982|NCT02935010|Ofloxacin|ofloxacin|mesh-list
19523983|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
19523984|NCT02935010|Esomeprazole|esomeprazole|mesh-list
19523985|NCT02935010|Bismuth|bismuth|mesh-list
19523986|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19523987|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19523988|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19523989|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19523990|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19523991|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19523992|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19523993|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19523994|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19523995|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19523996|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19523997|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19523998|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19523999|NCT02935010|Renal Agents|renal agents|mesh-ancestor
19524000|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19524001|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19524002|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524003|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19524004|NCT02935010|Antacids|antacids|mesh-ancestor
19524005|NCT02935010|Diuretics|diuretics|mesh-ancestor
19524006|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
19524007|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524008|NCT02935010|Expectorants|expectorants|mesh-ancestor
19524009|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
19524010|NCT02934763|Propranolol|propranolol|mesh-list
19524011|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19524012|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19524013|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
20101484|NCT00002993|Doxorubicin|doxorubicin|mesh-list
20101485|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101486|NCT00002993|Mitomycins|mitomycins|mesh-list
20101487|NCT00002993|Mitomycin|mitomycin|mesh-list
20101488|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101489|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101490|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101491|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101492|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101493|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101494|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
20101495|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101496|NCT00002994|Interleukin-2|interleukin-2|mesh-list
20101497|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101498|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20101499|NCT00002994|Analgesics|analgesics|mesh-ancestor
20101500|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
19524014|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524015|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524016|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524017|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20101501|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20101502|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524018|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19524019|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
19524020|NCT02934464|Leucovorin|leucovorin|mesh-list
19524021|NCT02934464|Paclitaxel|paclitaxel|mesh-list
19524022|NCT02934464|Ramucirumab|ramucirumab|mesh-list
19524023|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
19524024|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
19524025|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19524026|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524027|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
19524028|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
19524029|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
19524030|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524031|NCT02934464|Antidotes|antidotes|mesh-ancestor
20101503|NCT00002995|Dactinomycin|dactinomycin|mesh-list
20101504|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
20101505|NCT00002995|Vincristine|vincristine|mesh-list
20101506|NCT00002995|Sargramostim|sargramostim|mesh-list
20101507|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101508|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
20101509|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101510|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101511|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101512|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
20101513|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101514|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101515|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101516|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101517|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101518|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101519|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101520|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20101521|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101522|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19524032|NCT02934464|Protective Agents|protective agents|mesh-ancestor
19524033|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101523|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20101524|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101525|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101526|NCT00002996|Flecainide|flecainide|mesh-list
20101527|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20101528|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20101529|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20101530|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20101531|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101532|NCT00002998|Gemcitabine|gemcitabine|mesh-list
20101533|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101534|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101535|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
20101536|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101537|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
20101538|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101539|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101540|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101541|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
20101542|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524034|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
19524035|NCT02934464|Vitamins|vitamins|mesh-ancestor
19524036|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
19524037|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19524038|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19524039|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
19573045|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19573046|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19573047|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19573048|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
19573049|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573050|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573051|NCT02698995|Acetaminophen|acetaminophen|mesh-list
19573052|NCT02698995|Dexamethasone|dexamethasone|mesh-list
19573053|NCT02698995|Lidocaine|lidocaine|mesh-list
20101543|NCT00002999|Fluorouracil|fluorouracil|mesh-list
20101544|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101545|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
19573054|NCT02698995|Morphine|morphine|mesh-list
19573055|NCT02698995|Ropivacaine|ropivacaine|mesh-list
19524040|NCT02934321|Erythritol|erythritol|mesh-list
19524041|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
20101546|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101547|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101548|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101549|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
20101550|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524042|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19524043|NCT02934035|Citalopram|citalopram|mesh-list
19524044|NCT02934035|Fluoxetine|fluoxetine|mesh-list
19524045|NCT02934035|Paroxetine|paroxetine|mesh-list
19524046|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19524047|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
19524048|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19524049|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19524050|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524051|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524052|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524053|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
19524054|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524055|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19524056|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19524057|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524058|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19524059|NCT02934035|Analgesics|analgesics|mesh-ancestor
19524060|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
19524061|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
19524062|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19524063|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19524064|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524065|NCT02934152|Amoxicillin|amoxicillin|mesh-list
19524066|NCT02934152|Clarithromycin|clarithromycin|mesh-list
19524067|NCT02934152|Rabeprazole|rabeprazole|mesh-list
19524068|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524069|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524070|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19524071|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524072|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524073|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19524074|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19524075|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19524076|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524077|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20101551|NCT00003000|Fentanyl|fentanyl|mesh-list
20101552|NCT00003000|Morphine|morphine|mesh-list
20101553|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20101554|NCT00003000|Narcotics|narcotics|mesh-ancestor
20101555|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20101556|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101557|NCT00003000|Analgesics|analgesics|mesh-ancestor
20101558|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
20101559|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20101560|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20101561|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20101562|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
20101563|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
20101564|NCT00003001|Leucovorin|leucovorin|mesh-list
20101565|NCT00003001|Gemcitabine|gemcitabine|mesh-list
20101566|NCT00003001|Fluorouracil|fluorouracil|mesh-list
20101567|NCT00003001|Calcium|calcium|mesh-list
20101568|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
20101569|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101570|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
20101571|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101572|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101573|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
20101574|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101575|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101576|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101577|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
20101578|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101579|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20101580|NCT00003001|Antidotes|antidotes|mesh-ancestor
19524078|NCT02934295|Antibodies|antibodies|mesh-list
20101581|NCT00003001|Protective Agents|protective agents|mesh-ancestor
20101582|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
20101583|NCT00003001|Vitamins|vitamins|mesh-ancestor
19524079|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
19524080|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524081|NCT02934022|Maraviroc|maraviroc|mesh-list
19524082|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20603729|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20603730|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
20603731|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20603732|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20603733|NCT02222649|Vitamin D|vitamin d|mesh-list
20603734|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
20603735|NCT02222649|Vitamins|vitamins|mesh-ancestor
20603736|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
19524083|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19524084|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524085|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19524086|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19524087|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
19524088|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524089|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19524090|NCT02934204|Methotrexate|methotrexate|mesh-list
19524091|NCT02934204|Temozolomide|temozolomide|mesh-list
19524092|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19524093|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
19524094|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19524095|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524096|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101584|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
20101585|NCT00003002|Sargramostim|sargramostim|mesh-list
20101586|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
20101587|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101588|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
20101589|NCT00003003|Mitomycins|mitomycins|mesh-list
20101590|NCT00003003|Mitomycin|mitomycin|mesh-list
20101591|NCT00003003|Sargramostim|sargramostim|mesh-list
20101592|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
20101593|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101594|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101595|NCT00003003|Analgesics|analgesics|mesh-ancestor
20101596|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
20101597|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20101598|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101599|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101600|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101601|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524097|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
19524098|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524099|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524100|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524101|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524102|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19524103|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524104|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
19524105|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524106|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20603737|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603738|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20603739|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20101602|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101603|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
20101604|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101605|NCT00003004|Paclitaxel|paclitaxel|mesh-list
20101606|NCT00003004|Alvocidib|alvocidib|mesh-list
20101607|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101608|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101609|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101610|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101611|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101612|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101613|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
20101614|NCT00003004|Growth Substances|growth substances|mesh-ancestor
20101615|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101616|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20101617|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603740|NCT02222727|Donepezil|donepezil|mesh-list
20603741|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19524107|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19524108|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
19524109|NCT02934061|Tizanidine|tizanidine|mesh-list
19524110|NCT02934061|Analgesics|analgesics|mesh-ancestor
19524111|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
19524112|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524113|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524114|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
20101618|NCT00003005|Cordycepin|cordycepin|mesh-list
20101619|NCT00003005|Pentostatin|pentostatin|mesh-list
20101620|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101621|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20101622|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101623|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101624|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
20101625|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101626|NCT00003007|Interferons|interferons|mesh-list
20101627|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
20101628|NCT00003007|Dexamethasone|dexamethasone|mesh-list
20101629|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
20101630|NCT00003007|Melphalan|melphalan|mesh-list
20101631|NCT00003007|Sargramostim|sargramostim|mesh-list
20101632|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101633|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
20101634|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101635|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101636|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19524115|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19524116|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19524117|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
19524118|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
19524119|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19524120|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19524121|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19524122|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
19524123|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524124|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524125|NCT02934217|Cyclosporine|cyclosporine|mesh-list
19524126|NCT02934217|Cyclosporins|cyclosporins|mesh-list
19524127|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524128|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101637|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
20101638|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101639|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101640|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101641|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20101642|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
20101643|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
20101644|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20101645|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20101646|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
20101647|NCT00003007|Hormones|hormones|mesh-ancestor
20101648|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101649|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101650|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
20101651|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101652|NCT00003008|Ritonavir|ritonavir|mesh-list
20101653|NCT00003008|Nelfinavir|nelfinavir|mesh-list
20101654|NCT00003008|Indinavir|indinavir|mesh-list
20101655|NCT00003008|Saquinavir|saquinavir|mesh-list
20101656|NCT00003008|Paclitaxel|paclitaxel|mesh-list
20101657|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101658|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101659|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101660|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101661|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101662|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101663|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20101664|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20101665|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
20101666|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101667|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20101668|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20101669|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
20101670|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101671|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20101672|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19524129|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524130|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
19524131|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524132|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
19524133|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524134|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524135|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524136|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19524137|NCT02933905|Ranibizumab|ranibizumab|mesh-list
19524138|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19524139|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19524140|NCT02933905|Growth Substances|growth substances|mesh-ancestor
20101673|NCT00003009|Aldesleukin|aldesleukin|mesh-list
20101674|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101675|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20101676|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20101677|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
20101678|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101679|NCT00003010|Marimastat|marimastat|mesh-list
20101680|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101681|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101682|NCT00003011|Marimastat|marimastat|mesh-list
20101683|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101684|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101685|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
20101686|NCT00003012|Fluorouracil|fluorouracil|mesh-list
20101687|NCT00003012|Methotrexate|methotrexate|mesh-list
20101688|NCT00003012|Epirubicin|epirubicin|mesh-list
20101689|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101690|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
20101691|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101692|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101693|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101694|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
20101695|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101696|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101697|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101698|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
20101699|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101700|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20101701|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
20101702|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20101703|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
20101704|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101705|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20101706|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101707|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101708|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101709|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101710|NCT00003013|Tamoxifen|tamoxifen|mesh-list
20101711|NCT00003013|Paclitaxel|paclitaxel|mesh-list
20101712|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
20101713|NCT00003013|Doxorubicin|doxorubicin|mesh-list
20101714|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101715|NCT00003013|Fluorouracil|fluorouracil|mesh-list
20101716|NCT00003013|Methotrexate|methotrexate|mesh-list
20101717|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101718|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101719|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101720|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101721|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101722|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101723|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101724|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
20101725|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524141|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524142|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
19524143|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524144|NCT02933697|Apixaban|apixaban|mesh-list
19524145|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
19524146|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19524147|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
20101726|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101727|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19524148|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19524149|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
20101728|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
19524150|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524151|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524152|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
19524153|NCT02933814|Bupivacaine|bupivacaine|mesh-list
19524154|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
19524155|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
19524156|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524157|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524158|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
20101729|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101730|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101731|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101732|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101733|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101734|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
20101735|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101736|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20101737|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
20101738|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20101739|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524159|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524160|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
19524161|NCT02933775|Fludarabine|fludarabine|mesh-list
19524162|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524163|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
19524164|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524165|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524166|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19524167|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
19524168|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524169|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524170|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19524171|NCT02933788|Aspirin|aspirin|mesh-list
19524172|NCT02933788|Cilostazol|cilostazol|mesh-list
19524173|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19524174|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524175|NCT02933788|Analgesics|analgesics|mesh-ancestor
19524176|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
19524177|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524178|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524179|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524180|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101740|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20101741|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101742|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20101743|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
20101744|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101745|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101746|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20101747|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20101748|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20101749|NCT00003014|Carboplatin|carboplatin|mesh-list
20101750|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101751|NCT00003015|Carboplatin|carboplatin|mesh-list
20101752|NCT00003015|Vincristine|vincristine|mesh-list
20101753|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101754|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101755|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101756|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
20306210|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306211|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306212|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306213|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306214|NCT00654225|Atorvastatin|atorvastatin|mesh-list
20306215|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306216|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306217|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306218|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
20306219|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306220|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306221|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19524181|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19524182|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20306222|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306223|NCT00654277|Ondansetron|ondansetron|mesh-list
20306224|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
19524183|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524184|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19524185|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19524186|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524187|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
19524188|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19524189|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
19524190|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19524191|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
19524192|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
19524193|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20101757|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
20306225|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
20306226|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306227|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101758|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101759|NCT00003016|Tamoxifen|tamoxifen|mesh-list
20101760|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20101761|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
20101762|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101763|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101764|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101765|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101766|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20101767|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20101768|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20101769|NCT00003017|Interleukin-12|interleukin-12|mesh-list
20101770|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20306228|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20306229|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
20306230|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
20306231|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20306232|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
20306233|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306234|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306235|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20306236|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20306237|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306238|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20306239|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20306240|NCT00654290|Propranolol|propranolol|mesh-list
20306241|NCT00654290|Amiodarone|amiodarone|mesh-list
20306242|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20306243|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20306244|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
19524194|NCT02933788|Protective Agents|protective agents|mesh-ancestor
20101771|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
20101772|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101773|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20101774|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20101775|NCT00003017|Growth Substances|growth substances|mesh-ancestor
20101776|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
20101777|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101778|NCT00003018|Leucovorin|leucovorin|mesh-list
20101779|NCT00003018|Fluorouracil|fluorouracil|mesh-list
20101780|NCT00003018|Mitomycins|mitomycins|mesh-list
20101781|NCT00003018|Mitomycin|mitomycin|mesh-list
20101782|NCT00003018|Dipyridamole|dipyridamole|mesh-list
20101783|NCT00003018|Calcium|calcium|mesh-list
20101784|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
20101785|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20101786|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101787|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
20101788|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101789|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101790|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101791|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101792|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
20101793|NCT00003018|Antidotes|antidotes|mesh-ancestor
20101794|NCT00003018|Protective Agents|protective agents|mesh-ancestor
20101795|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
20101796|NCT00003018|Vitamins|vitamins|mesh-ancestor
20306245|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524195|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19524196|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19524197|NCT02933658|Amlodipine|amlodipine|mesh-list
19524198|NCT02933658|Telmisartan|telmisartan|mesh-list
19524199|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19524200|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19524201|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19524202|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524203|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524204|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524205|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524206|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
19524207|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20101797|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
20101798|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20306246|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306247|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306248|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20306249|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20306250|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
20306251|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20306252|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306253|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20306254|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20306255|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20306256|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306257|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20306258|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20306259|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20306260|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306261|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306262|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306263|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
20306264|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306265|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306266|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306267|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306268|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19524208|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20101799|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
20101800|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101801|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101802|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20101803|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20101804|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
20101805|NCT00003019|Methotrexate|methotrexate|mesh-list
20101806|NCT00003019|Vinblastine|vinblastine|mesh-list
20101807|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20101808|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
20101809|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20101810|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101811|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101812|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
20101813|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101814|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101815|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
20101816|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101817|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20101818|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101819|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
20101820|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101821|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20101822|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101823|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101824|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101825|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120432|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120433|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120434|NCT00006361|Semaxinib|semaxinib|mesh-list
20120435|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19524209|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
19524210|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19524211|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19524212|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524213|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19524214|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19524215|NCT02933593|Labetalol|labetalol|mesh-list
19524216|NCT02933593|Hydralazine|hydralazine|mesh-list
19524217|NCT02933593|Nifedipine|nifedipine|mesh-list
19524218|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19524219|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524220|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524221|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524222|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524223|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
19524224|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
19524225|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19524226|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19524227|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19524228|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19524229|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524230|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19524231|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
19524232|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
19524233|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524234|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19524235|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19524236|NCT02933853|Insulin|insulin|mesh-list
19524237|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20101826|NCT00003020|Immunotoxins|immunotoxins|mesh-list
20101827|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
20101828|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101829|NCT00003021|Bizelesin|bizelesin|mesh-list
20101830|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101831|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101832|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101833|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
20101834|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101835|NCT00003022|Antibodies|antibodies|mesh-list
20306269|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306270|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306271|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
20306272|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306273|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306274|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306275|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306276|NCT00654407|Atorvastatin|atorvastatin|mesh-list
20306277|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306278|NCT00654407|Simvastatin|simvastatin|mesh-list
20306279|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306280|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306281|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
20306282|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306283|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306284|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306285|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306286|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306287|NCT00654446|Simvastatin|simvastatin|mesh-list
20306288|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306289|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306290|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
20306291|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306292|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306293|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306294|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306295|NCT00654459|Policosanol|policosanol|mesh-list
20306296|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306297|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306298|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
20306299|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306300|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306301|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20308888|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603742|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524238|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
19524239|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
19524240|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19524241|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524242|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524243|NCT02933645|Insulin|insulin|mesh-list
19524244|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19524245|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524246|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524247|NCT02933684|Cycloserine|cycloserine|mesh-list
19524248|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19524249|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524250|NCT02933684|Renal Agents|renal agents|mesh-ancestor
19524251|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19524252|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
19524253|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524254|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
19524255|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524256|NCT02933333|Molgramostim|molgramostim|mesh-list
20101836|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20101837|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
19748939|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748940|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19748941|NCT05344495|Midazolam|midazolam|mesh-list
19748942|NCT05344495|Bupivacaine|bupivacaine|mesh-list
20101838|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101839|NCT00003023|Vaccines|vaccines|mesh-list
20101840|NCT00003023|Antibodies|antibodies|mesh-list
20101841|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19524257|NCT02933333|Lenograstim|lenograstim|mesh-list
19524258|NCT02933333|Sargramostim|sargramostim|mesh-list
19524259|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19524260|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
19524261|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524262|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524263|NCT02933437|Ajmaline|ajmaline|mesh-list
20101842|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
20101843|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
20101844|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101845|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20101846|NCT00003026|Bicalutamide|bicalutamide|mesh-list
20101847|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20101848|NCT00003026|Flutamide|flutamide|mesh-list
20101849|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
20101850|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
20101851|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101852|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101853|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101854|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
20101855|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20101856|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
20101857|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20101858|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20101859|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101860|NCT00003027|Interferons|interferons|mesh-list
20101861|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
20101862|NCT00003027|Aldesleukin|aldesleukin|mesh-list
20101863|NCT00003027|Dacarbazine|dacarbazine|mesh-list
20101864|NCT00003027|Vinblastine|vinblastine|mesh-list
20101865|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101866|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
20101867|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524264|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19524265|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19748943|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
20101868|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
20101869|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524266|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19524267|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524268|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524269|NCT02932930|Ropivacaine|ropivacaine|mesh-list
19524270|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
19524271|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
19524272|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524273|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524274|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
19524275|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20101870|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20101871|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20101872|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101873|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
20101874|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101875|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20101876|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101877|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101878|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101879|NCT00003029|Fluorouracil|fluorouracil|mesh-list
20101880|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101881|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
19524276|NCT02932826|Insulin|insulin|mesh-list
19524277|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524278|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524279|NCT02933099|Dexamethasone|dexamethasone|mesh-list
19524280|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
19524281|NCT02933099|Aprepitant|aprepitant|mesh-list
19524282|NCT02933099|Palonosetron|palonosetron|mesh-list
19524283|NCT02933099|BB 1101|bb 1101|mesh-list
19524284|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524285|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
19524286|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
19524287|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524288|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524289|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524290|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
19524291|NCT02933099|Hormones|hormones|mesh-ancestor
19524292|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524293|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101882|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101883|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101884|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101885|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
20101886|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101887|NCT00003031|Voriconazole|voriconazole|mesh-list
20101888|NCT00003031|Amphotericin B|amphotericin b|mesh-list
20101889|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20101890|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20101891|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
20101892|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
20101893|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101894|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20101895|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20101896|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101897|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101898|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20101899|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
20101900|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101901|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101902|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20101903|NCT00003031|Amebicides|amebicides|mesh-ancestor
20101904|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20101905|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20101906|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20101907|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20101908|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20101909|NCT00003032|Tamoxifen|tamoxifen|mesh-list
20101910|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
20101911|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
20101912|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101913|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
19524294|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524295|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
19524296|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524297|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524298|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19524299|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524300|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20101914|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101915|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20101916|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20101917|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
20101918|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101919|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101920|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20101921|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20101922|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
20101923|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101924|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101925|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20101926|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20101927|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20101928|NCT00003032|Analgesics|analgesics|mesh-ancestor
20101929|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
20101930|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20101931|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101932|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101933|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101934|NCT00003034|Doxorubicin|doxorubicin|mesh-list
20101935|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101936|NCT00003034|Ranpirnase|ranpirnase|mesh-list
20101937|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101938|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101939|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101940|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101941|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101942|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101943|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20101944|NCT00003035|Tamoxifen|tamoxifen|mesh-list
20101945|NCT00003035|Paclitaxel|paclitaxel|mesh-list
20101946|NCT00003035|Doxorubicin|doxorubicin|mesh-list
20101947|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101948|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20306302|NCT00654485|Atorvastatin|atorvastatin|mesh-list
20306303|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306304|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306305|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306306|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
20306307|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306308|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306309|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306310|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306311|NCT00654524|Vitamin D|vitamin d|mesh-list
20306312|NCT00654524|Goserelin|goserelin|mesh-list
20306313|NCT00654524|Hormones|hormones|mesh-list
20306314|NCT00654524|Vitamins|vitamins|mesh-ancestor
20306315|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
20306316|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306317|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20306318|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306319|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20306320|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306321|NCT00654537|Atorvastatin|atorvastatin|mesh-list
20101949|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101950|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101951|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101952|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101953|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101954|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101955|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101956|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101957|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101958|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20101959|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20101960|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
20101961|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20101962|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20101963|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20101964|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20101965|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20101966|NCT00003037|Gemcitabine|gemcitabine|mesh-list
20101967|NCT00003037|Docetaxel|docetaxel|mesh-list
20101968|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101969|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20101970|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
20101971|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101972|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
20101973|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101974|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101975|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20101976|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
20101977|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306322|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306323|NCT00654537|Simvastatin|simvastatin|mesh-list
20306324|NCT00654537|Pravastatin|pravastatin|mesh-list
20306325|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306326|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306327|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
20306328|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101978|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
20101979|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
20101980|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
20101981|NCT00003038|Suramin|suramin|mesh-list
20101982|NCT00003038|Doxorubicin|doxorubicin|mesh-list
20101983|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20101984|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20101985|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101986|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20101987|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20101988|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20101989|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20101990|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
20101991|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
20101992|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20101993|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20101994|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20101995|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20101996|NCT00003039|Alvocidib|alvocidib|mesh-list
20101997|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20101998|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
20101999|NCT00003039|Growth Substances|growth substances|mesh-ancestor
20102000|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102001|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20102002|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102003|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102004|NCT00003041|NSC 366140|nsc 366140|mesh-list
20102005|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102006|NCT00003044|Cisplatin|cisplatin|mesh-list
20306329|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306330|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306331|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306332|NCT00654576|Olanzapine|olanzapine|mesh-list
20306333|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
20306334|NCT00654576|Risperidone|risperidone|mesh-list
20306335|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20306336|NCT00654576|Clozapine|clozapine|mesh-list
20306337|NCT00654576|Sulpiride|sulpiride|mesh-list
20306338|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20306339|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
20306340|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306341|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306342|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306343|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20306344|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20306345|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306346|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20102007|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102008|NCT00003046|Interleukin-12|interleukin-12|mesh-list
20102009|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102010|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
20102011|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306347|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20306348|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
19524301|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19524302|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
19524303|NCT02932722|Anesthetics|anesthetics|mesh-list
19524304|NCT02932722|Propofol|propofol|mesh-list
20102012|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20102013|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20102014|NCT00003046|Growth Substances|growth substances|mesh-ancestor
20102015|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
20102016|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102017|NCT00003048|Amifostine|amifostine|mesh-list
20102018|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102019|NCT00003048|Protective Agents|protective agents|mesh-ancestor
20102020|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306349|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
20306350|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
20306351|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102021|NCT00003049|Leucovorin|leucovorin|mesh-list
20102022|NCT00003049|Fluorouracil|fluorouracil|mesh-list
20102023|NCT00003049|Calcium|calcium|mesh-list
20102024|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
20102025|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20102026|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102027|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
20102028|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102029|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102030|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102031|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102032|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
20102033|NCT00003049|Antidotes|antidotes|mesh-ancestor
20102034|NCT00003049|Protective Agents|protective agents|mesh-ancestor
20102035|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
20102036|NCT00003049|Vitamins|vitamins|mesh-ancestor
20603743|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603744|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
20102037|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
20102038|NCT00003050|Tamoxifen|tamoxifen|mesh-list
20102039|NCT00003050|Paclitaxel|paclitaxel|mesh-list
20102040|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
20102041|NCT00003050|Doxorubicin|doxorubicin|mesh-list
20102042|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20102043|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102044|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102045|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102046|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102047|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102048|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102049|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102050|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
20102051|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102052|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102053|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102054|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
20102055|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20306352|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20306353|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20306354|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20306355|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306356|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
20306357|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
20306358|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
20306359|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20306360|NCT00654589|Deferasirox|deferasirox|mesh-list
20306361|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20306362|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
20306363|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
20306364|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306365|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20306366|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20102056|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102057|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102058|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20306367|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20603745|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524305|NCT02932722|Sevoflurane|sevoflurane|mesh-list
19748944|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
20102059|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102060|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20306368|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
19524306|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524307|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524308|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19524309|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19524310|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
19524311|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19524312|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19524313|NCT02932761|Goserelin|goserelin|mesh-list
19524314|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20306369|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306370|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306371|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20306372|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102061|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
20102062|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20102063|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20102064|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20102065|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20102066|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20102067|NCT00003052|Doxorubicin|doxorubicin|mesh-list
20102068|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20102069|NCT00003052|Etoposide|etoposide|mesh-list
20102070|NCT00003052|Ifosfamide|ifosfamide|mesh-list
20102071|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102072|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102073|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102074|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102075|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102076|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102077|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102078|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102079|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
20603746|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603747|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
20603748|NCT02222740|Hydrocodone|hydrocodone|mesh-list
20603749|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20603750|NCT02222740|Narcotics|narcotics|mesh-ancestor
20603751|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603752|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603753|NCT02222740|Analgesics|analgesics|mesh-ancestor
20603754|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
20603755|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603756|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
20102080|NCT00003053|Etoposide|etoposide|mesh-list
20102081|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102082|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102083|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102084|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102085|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102086|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102087|NCT00003054|Paclitaxel|paclitaxel|mesh-list
20102088|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102089|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102090|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102091|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102092|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102093|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102094|NCT00003055|Irinotecan|irinotecan|mesh-list
20102095|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102096|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20102097|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102098|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102099|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102100|NCT00003056|Cyclosporine|cyclosporine|mesh-list
20102101|NCT00003056|Methotrexate|methotrexate|mesh-list
20102102|NCT00003056|Cyclosporins|cyclosporins|mesh-list
20102103|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20102104|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
20306373|NCT00654667|Resveratrol|resveratrol|mesh-list
20306374|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
20306375|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306376|NCT00654667|Protective Agents|protective agents|mesh-ancestor
20603757|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
20306377|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306378|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306379|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20306380|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20306381|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
20306382|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20306383|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20306384|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306385|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306386|NCT00654680|Urological Agents|urological agents|mesh-ancestor
20102105|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20102106|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102107|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102108|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
20102109|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102110|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102111|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
20102112|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102113|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20102114|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102115|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
20102116|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102117|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20102118|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
20102119|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102120|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20102121|NCT00003057|Octreotide|octreotide|mesh-list
20102122|NCT00003057|Loperamide|loperamide|mesh-list
20102123|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
20102124|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20102125|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20102126|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102127|NCT00003058|Troglitazone|troglitazone|mesh-list
20102128|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20102129|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102130|NCT00003060|Cyclosporine|cyclosporine|mesh-list
20102131|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
20102132|NCT00003060|Busulfan|busulfan|mesh-list
20102133|NCT00003060|Methotrexate|methotrexate|mesh-list
20102134|NCT00003060|Cyclosporins|cyclosporins|mesh-list
20102135|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102136|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
20102137|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102138|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102139|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102140|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
20102141|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102142|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102143|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102144|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20102145|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
20102146|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20306387|NCT00654758|Paclitaxel|paclitaxel|mesh-list
20306388|NCT00654758|Carboplatin|carboplatin|mesh-list
20306389|NCT00654758|Volociximab|volociximab|mesh-list
20306390|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20306391|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102147|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102148|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
20102149|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
20102150|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102151|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20102152|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20102153|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
20102154|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102155|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20102156|NCT00003061|Cytarabine|cytarabine|mesh-list
20102157|NCT00003061|Methotrexate|methotrexate|mesh-list
20102158|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20102159|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
20102160|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20102161|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102162|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102163|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
20102164|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524315|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573056|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573057|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
19573058|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
19573059|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573060|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573061|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573062|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
19573063|NCT02698995|Hormones|hormones|mesh-ancestor
19573064|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573065|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573066|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573067|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
19573068|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
19573069|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573070|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
19573071|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19573072|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19573073|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19573074|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573075|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573076|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19573077|NCT02698995|Narcotics|narcotics|mesh-ancestor
19573078|NCT02698995|Analgesics|analgesics|mesh-ancestor
19573079|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573080|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
19573081|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
19573082|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19573083|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
19573084|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573085|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
19573086|NCT02698813|Protective Agents|protective agents|mesh-ancestor
19573087|NCT02698553|Bupropion|bupropion|mesh-list
19573088|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19573089|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
19573090|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573091|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19573092|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20603758|NCT02222987|Clopidogrel|clopidogrel|mesh-list
20603759|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20603760|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19573093|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573094|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573095|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
19573096|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573097|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573098|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19573099|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19573100|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573101|NCT02698514|Sevoflurane|sevoflurane|mesh-list
19573102|NCT02698514|Desflurane|desflurane|mesh-list
19573103|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19573104|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19573105|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
19573106|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
19573107|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573108|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306392|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573109|NCT02698527|Lidocaine|lidocaine|mesh-list
19573110|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
19573111|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
19573112|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573113|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573114|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
19573115|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573116|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19573117|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19573118|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19573119|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573120|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573121|NCT02698748|Chloroquine|chloroquine|mesh-list
19573122|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19573123|NCT02698748|Amebicides|amebicides|mesh-ancestor
19524316|NCT02932774|Cetirizine|cetirizine|mesh-list
19524317|NCT02932774|Loratadine|loratadine|mesh-list
19524318|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19524319|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19524320|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19524321|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
19524322|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
19524323|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524324|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524325|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524326|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
19524327|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524328|NCT02932605|Cannabidiol|cannabidiol|mesh-list
19524329|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
19524330|NCT02932488|Sumatriptan|sumatriptan|mesh-list
19524331|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19524332|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20102165|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102166|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524333|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19524334|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
19524335|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524336|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524337|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524338|NCT02932397|Propofol|propofol|mesh-list
19524339|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19524340|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524341|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102167|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102168|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20102169|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524342|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19524343|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
19524344|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
19524345|NCT02932566|Pirfenidone|pirfenidone|mesh-list
19524346|NCT02932566|Analgesics|analgesics|mesh-ancestor
19524347|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
19524348|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524349|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524350|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19524351|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524352|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524353|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524354|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524355|NCT02932644|Vitamin D|vitamin d|mesh-list
19524356|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
19524357|NCT02932644|Vitamins|vitamins|mesh-list
19524358|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
19524359|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524360|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19524361|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524362|NCT02932436|Empagliflozin|empagliflozin|mesh-list
19524363|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19524364|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524365|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524366|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524367|NCT02932007|Chloroquine|chloroquine|mesh-list
19524368|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19524369|NCT02932007|Amebicides|amebicides|mesh-ancestor
19524370|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19524371|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19524372|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524373|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
19524374|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524375|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19524376|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524377|NCT02932007|Analgesics|analgesics|mesh-ancestor
19524378|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
19524379|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524380|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524381|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524382|NCT02932007|Filaricides|filaricides|mesh-ancestor
19524383|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
19524384|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
19524385|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19524386|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
19524387|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19524388|NCT02932020|Prednisolone|prednisolone|mesh-list
19524389|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
19524390|NCT02932020|Bupivacaine|bupivacaine|mesh-list
19524391|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19524392|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
19524393|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
19524394|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
19524395|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524396|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524397|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
19524398|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524399|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524400|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
19524401|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
19524402|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524403|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
19524404|NCT02932020|Hormones|hormones|mesh-ancestor
19524405|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524406|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19524407|NCT02932020|Protective Agents|protective agents|mesh-ancestor
19524408|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19524409|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524410|NCT02932137|Interleukin-2|interleukin-2|mesh-list
19524411|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524412|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524413|NCT02932137|Analgesics|analgesics|mesh-ancestor
19524414|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
19524415|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524416|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524417|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
19524418|NCT02932254|Analgesics|analgesics|mesh-ancestor
19524419|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
19524420|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524421|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524422|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
19524423|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524424|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19524425|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
19524426|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19524427|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524428|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524429|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524430|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
19524431|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19524432|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
19524433|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
19524434|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19524435|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524436|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524437|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
19524438|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19524439|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524440|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524441|NCT02931786|Ketamine|ketamine|mesh-list
19524442|NCT02931786|Propofol|propofol|mesh-list
19524443|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19524444|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524445|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524446|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19524447|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
19524448|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
19524449|NCT02931786|Analgesics|analgesics|mesh-ancestor
19524450|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
19524451|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524452|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19524453|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19524454|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19524455|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20102170|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
20102171|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102172|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20102173|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
19524456|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524457|NCT02931877|Propofol|propofol|mesh-list
20102174|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524458|NCT02931877|Sevoflurane|sevoflurane|mesh-list
19524459|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19524460|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524461|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524462|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19524463|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
19524464|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
19524465|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19524466|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19524467|NCT02931591|Metformin|metformin|mesh-list
19524468|NCT02931591|Hormones|hormones|mesh-list
19524469|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524470|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524471|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524472|NCT02931383|Liraglutide|liraglutide|mesh-list
19524473|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524474|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524475|NCT02931383|Incretins|incretins|mesh-ancestor
19524476|NCT02931383|Hormones|hormones|mesh-ancestor
19524477|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524478|NCT02931474|Tesamorelin|tesamorelin|mesh-list
19524479|NCT02931474|Growth Substances|growth substances|mesh-ancestor
19524480|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524481|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
19524482|NCT02931357|Lidocaine|lidocaine|mesh-list
19524483|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
19524484|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
19524485|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
19524486|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524487|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524488|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
19524489|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524490|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19524491|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19524492|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19524493|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524494|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524495|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19524496|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
19524497|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
19524498|NCT02931357|Protective Agents|protective agents|mesh-ancestor
19524499|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19524500|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524501|NCT02931526|Tigecycline|tigecycline|mesh-list
19524502|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524503|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102175|NCT00003062|Temozolomide|temozolomide|mesh-list
20102176|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19524504|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19524505|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524506|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524507|NCT02931123|Rifaximin|rifaximin|mesh-list
19524508|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524509|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524510|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524511|NCT02931136|Huperzine A|huperzine a|mesh-list
19524512|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19524513|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524514|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524515|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
19524516|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524517|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524518|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19524519|NCT02931136|Protective Agents|protective agents|mesh-ancestor
19524520|NCT02931188|Anacetrapib|anacetrapib|mesh-list
19524521|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19524522|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19524523|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
19524524|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524525|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20102177|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
20120436|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20306393|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
19524526|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19524527|NCT02931175|Hormones|hormones|mesh-ancestor
19524528|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524529|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102178|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102179|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102180|NCT00003063|Leucovorin|leucovorin|mesh-list
20102181|NCT00003063|Interferons|interferons|mesh-list
20102182|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
20102183|NCT00003063|Levamisole|levamisole|mesh-list
19573124|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19573125|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19573126|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573127|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
19573128|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573129|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19573130|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573131|NCT02698748|Analgesics|analgesics|mesh-ancestor
19573132|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
19573133|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573134|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573135|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573136|NCT02698748|Filaricides|filaricides|mesh-ancestor
19573137|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
19573138|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
19573139|NCT02698267|Itraconazole|itraconazole|mesh-list
19573140|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
19573141|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573142|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19573143|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19573144|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573145|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573146|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19573147|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
19573148|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573149|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573150|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19573151|NCT02698254|Bevacizumab|bevacizumab|mesh-list
19573152|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20102184|NCT00003063|Fluorouracil|fluorouracil|mesh-list
20306394|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
19573153|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
19573154|NCT02698254|Antibodies|antibodies|mesh-list
19573155|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
19573156|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19573157|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
19573158|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573159|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19573160|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19573161|NCT02698254|Growth Substances|growth substances|mesh-ancestor
19573162|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573163|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
19573164|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
19573165|NCT02698280|Bevacizumab|bevacizumab|mesh-list
19573166|NCT02698280|Nimustine|nimustine|mesh-list
19573167|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19573168|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573169|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19573170|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19573171|NCT02698280|Growth Substances|growth substances|mesh-ancestor
19573172|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573173|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
19573174|NCT02698124|Decitabine|decitabine|mesh-list
19573175|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19573176|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
19573177|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306395|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
20306396|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306397|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20306398|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20306399|NCT00654758|Growth Substances|growth substances|mesh-ancestor
19573178|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573179|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102185|NCT00003063|Calcium|calcium|mesh-list
20102186|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
20306400|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524530|NCT02931071|Plerixafor|plerixafor|mesh-list
19524531|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19524532|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19524533|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
19524534|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524535|NCT02930733|Bupivacaine|bupivacaine|mesh-list
19524536|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
20306401|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
20306402|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
20306403|NCT00654888|Mitomycins|mitomycins|mesh-list
20306404|NCT00654888|Mitomycin|mitomycin|mesh-list
20306405|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20306406|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524537|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
19524538|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524539|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524540|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
19524541|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524542|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
19524543|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
19524544|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19524545|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19524546|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524547|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524548|NCT02930811|Urological Agents|urological agents|mesh-ancestor
19524549|NCT02930954|Gemcitabine|gemcitabine|mesh-list
19524550|NCT02930954|Bevacizumab|bevacizumab|mesh-list
19524551|NCT02930954|Carboplatin|carboplatin|mesh-list
19524552|NCT02930954|Pemetrexed|pemetrexed|mesh-list
19524553|NCT02930954|Gefitinib|gefitinib|mesh-list
19524554|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19524555|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524556|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19524557|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19524558|NCT02930954|Growth Substances|growth substances|mesh-ancestor
19524559|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524560|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
19524561|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19524562|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
19524563|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524564|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
19524565|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524566|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524567|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524568|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
19524569|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19524570|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19524571|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19524572|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19524573|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20102187|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20102188|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102189|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
20102190|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102191|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102192|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102193|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102194|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
20102195|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
20102196|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102197|NCT00003063|Antidotes|antidotes|mesh-ancestor
20102198|NCT00003063|Protective Agents|protective agents|mesh-ancestor
20102199|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
20102200|NCT00003063|Vitamins|vitamins|mesh-ancestor
20102201|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
20102202|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102203|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
20102204|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
20102205|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20102206|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102207|NCT00003064|Paclitaxel|paclitaxel|mesh-list
20102208|NCT00003064|Etoposide|etoposide|mesh-list
20102209|NCT00003064|Carboplatin|carboplatin|mesh-list
20102210|NCT00003064|Topotecan|topotecan|mesh-list
20102211|NCT00003064|Thiotepa|thiotepa|mesh-list
20102212|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
20102213|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102214|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306407|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
20306408|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306409|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20102215|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102216|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102217|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
20306410|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306411|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19524574|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524575|NCT02930551|Lidocaine|lidocaine|mesh-list
19524576|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
19524577|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
19524578|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524579|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524580|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
19524581|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524582|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19524583|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19524584|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19524585|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524586|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524587|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
19524588|NCT02930707|Bupivacaine|bupivacaine|mesh-list
19524589|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
19524590|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
19524591|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524592|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524593|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
19524594|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524595|NCT02930707|Analgesics|analgesics|mesh-ancestor
20306412|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
20306413|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19524596|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19524597|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
19524598|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19524599|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524600|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524601|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524602|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
19524603|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19524604|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
19524605|NCT02930434|Vitamin D|vitamin d|mesh-list
19524606|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
19524607|NCT02930434|Vitamins|vitamins|mesh-ancestor
19524608|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
19524609|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524610|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19524611|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524612|NCT02930317|Factor VIII|factor viii|mesh-list
19524613|NCT02930317|Coagulants|coagulants|mesh-ancestor
19524614|NCT02930057|Betamethasone|betamethasone|mesh-list
19524615|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524616|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
19524617|NCT02930057|Hormones|hormones|mesh-ancestor
19524618|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524619|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524620|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19524621|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
19524622|NCT02930109|Cytarabine|cytarabine|mesh-list
19524623|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19524624|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
19524625|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524626|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524627|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
19524628|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524629|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102218|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102219|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102220|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102221|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102222|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
20102223|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102224|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20306414|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19524630|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
19524631|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524632|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
19524633|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19524634|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
19524635|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524636|NCT02930031|Expectorants|expectorants|mesh-ancestor
19524637|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
19524638|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19524639|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
19524640|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524641|NCT02930031|Protective Agents|protective agents|mesh-ancestor
19524642|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524643|NCT02930031|Antidotes|antidotes|mesh-ancestor
19524644|NCT02930265|Liraglutide|liraglutide|mesh-list
19524645|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524646|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524647|NCT02930265|Incretins|incretins|mesh-ancestor
19524648|NCT02930265|Hormones|hormones|mesh-ancestor
19524649|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524650|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19524651|NCT02929927|Eusol|eusol|mesh-list
19524652|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
19524653|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524654|NCT02929797|Gemcitabine|gemcitabine|mesh-list
19524655|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19524656|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
19524657|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524658|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524659|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
19524660|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524661|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524662|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524663|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
19524664|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524665|NCT02929901|Caffeine|caffeine|mesh-list
19524666|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19524667|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524668|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19524669|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524670|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524671|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19524672|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19524673|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
19524674|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524675|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
19524676|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19524677|NCT02929706|Azathioprine|azathioprine|mesh-list
19524678|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
19524679|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524680|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19524681|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524682|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524683|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
19524684|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524685|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524686|NCT02929693|Gefitinib|gefitinib|mesh-list
19524687|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524688|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19524689|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524690|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102225|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102226|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
20102227|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19524691|NCT02929719|Dapsone|dapsone|mesh-list
19524692|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524693|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
19524694|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19524695|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20102228|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102229|NCT00003065|Paclitaxel|paclitaxel|mesh-list
20102230|NCT00003065|Topotecan|topotecan|mesh-list
20102231|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102232|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102233|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
19524696|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19524697|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524698|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524699|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
19524700|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524701|NCT02929524|Ketamine|ketamine|mesh-list
19524702|NCT02929524|Analgesics|analgesics|mesh-ancestor
19524703|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
19524704|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524705|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524706|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19524707|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19524708|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
19524709|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
19524710|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524711|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19524712|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19524713|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524714|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524715|NCT02929888|Aspirin|aspirin|mesh-list
19524716|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19524717|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524718|NCT02929888|Analgesics|analgesics|mesh-ancestor
19524719|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
19524720|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524721|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524722|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524723|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524724|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19524725|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19524726|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524727|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19524728|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19524729|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524730|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
19524731|NCT02929563|Pantoprazole|pantoprazole|mesh-list
19524732|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19524733|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524734|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19524735|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524736|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573180|NCT02698306|Dexamethasone|dexamethasone|mesh-list
19573181|NCT02698306|Diclofenac|diclofenac|mesh-list
19573182|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573183|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
19573184|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
19573185|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573186|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573187|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573188|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
19573189|NCT02698306|Hormones|hormones|mesh-ancestor
19573190|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573191|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573192|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573193|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19573194|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573195|NCT02698306|Analgesics|analgesics|mesh-ancestor
19573196|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
19573197|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573198|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19573199|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573200|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573201|NCT02698098|Methadone|methadone|mesh-list
19573202|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19573203|NCT02698098|Narcotics|narcotics|mesh-ancestor
19573204|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573205|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573206|NCT02698098|Analgesics|analgesics|mesh-ancestor
19573207|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
19573208|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573209|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
19573210|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
19573211|NCT02698228|Morphine|morphine|mesh-list
20102234|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
19573212|NCT02698228|Bupivacaine|bupivacaine|mesh-list
19524737|NCT02929459|Vitamins|vitamins|mesh-list
19524738|NCT02929459|Riboflavin|riboflavin|mesh-list
19524739|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
19524740|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
19524741|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524742|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19524743|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524744|NCT02929576|Paclitaxel|paclitaxel|mesh-list
19524745|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19524746|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524747|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
19524748|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
19524749|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
19524750|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524751|NCT02929121|Doxycycline|doxycycline|mesh-list
19524752|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524753|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524754|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
19524755|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19524756|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19524757|NCT02929134|Doxycycline|doxycycline|mesh-list
19524758|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524759|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524760|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
19524761|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19524762|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19524763|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19524764|NCT02929147|Morphine|morphine|mesh-list
19524765|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19524766|NCT02929147|Narcotics|narcotics|mesh-ancestor
19524767|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524768|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524769|NCT02929147|Analgesics|analgesics|mesh-ancestor
19524770|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
19524771|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524772|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19524773|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524774|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524775|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524776|NCT02929212|Acetaminophen|acetaminophen|mesh-list
19524777|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524778|NCT02929212|Analgesics|analgesics|mesh-ancestor
19524779|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
19524780|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524781|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524782|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
19524783|NCT02929251|Adalimumab|adalimumab|mesh-list
19524784|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19524785|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19524786|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19524787|NCT02929394|Trabectedin|trabectedin|mesh-list
19524788|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19524789|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
19524790|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524791|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524792|NCT02929316|Vedolizumab|vedolizumab|mesh-list
19524793|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524794|NCT02929095|Midazolam|midazolam|mesh-list
19524795|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
19524796|NCT02929095|Remifentanil|remifentanil|mesh-list
19524797|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19524798|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524799|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524800|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19524801|NCT02929095|Analgesics|analgesics|mesh-ancestor
19524802|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
20102235|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
19524803|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524804|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19524805|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19524806|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19524807|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
19524808|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524809|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524810|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19524811|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19524812|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19524813|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19524814|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19524815|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
19524816|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
19524817|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
19524818|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
19524819|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19524820|NCT02929095|Narcotics|narcotics|mesh-ancestor
19524821|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19524822|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19524823|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524824|NCT02928965|Minocycline|minocycline|mesh-list
19524825|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524826|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524827|NCT02928692|Minocycline|minocycline|mesh-list
19524828|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19524829|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524830|NCT02928991|Vidarabine|vidarabine|mesh-list
19524831|NCT02928991|Fludarabine|fludarabine|mesh-list
19524832|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
19524833|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524834|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19524835|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
19524836|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524837|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19524838|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
19524839|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524840|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
19524841|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19524842|NCT02928679|Liraglutide|liraglutide|mesh-list
19524843|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524844|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524845|NCT02928679|Incretins|incretins|mesh-ancestor
19524846|NCT02928679|Hormones|hormones|mesh-ancestor
19524847|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524848|NCT02928510|Idelalisib|idelalisib|mesh-list
19524849|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524850|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524851|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524852|NCT02928419|Lenalidomide|lenalidomide|mesh-list
19524853|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
19524854|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524855|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19524856|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19524857|NCT02928419|Growth Substances|growth substances|mesh-ancestor
19524858|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
19524859|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524860|NCT02928614|Liraglutide|liraglutide|mesh-list
19524861|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19524862|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524863|NCT02928614|Incretins|incretins|mesh-ancestor
19524864|NCT02928614|Hormones|hormones|mesh-ancestor
19524865|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19524866|NCT02928601|Ondansetron|ondansetron|mesh-list
19524867|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
19524868|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
19524869|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524870|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524871|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524872|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
19524873|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524874|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20120437|NCT00006361|Growth Substances|growth substances|mesh-ancestor
19524875|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
19524876|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524877|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524878|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19524879|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19524880|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524881|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19524882|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19524883|NCT02928575|Temozolomide|temozolomide|mesh-list
19524884|NCT02928575|Sunitinib|sunitinib|mesh-list
19524885|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19524886|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
19524887|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524888|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524889|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19524890|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19524891|NCT02928575|Growth Substances|growth substances|mesh-ancestor
19524892|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524893|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
19524894|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19524895|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19524896|NCT02928328|Lidocaine|lidocaine|mesh-list
19524897|NCT02928328|Lorazepam|lorazepam|mesh-list
19524898|NCT02928328|Capsaicin|capsaicin|mesh-list
19524899|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
19524900|NCT02928328|Butyric Acid|butyric acid|mesh-list
19524901|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
20102236|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102237|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20102238|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20306415|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306416|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306417|NCT00654914|Urological Agents|urological agents|mesh-ancestor
20306418|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
20306419|NCT00655018|Tocopherols|tocopherols|mesh-list
19524902|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
19524903|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524904|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524905|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
19524906|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524907|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19524908|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19524909|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20603761|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19524910|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524911|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524912|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
19524913|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
19524914|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
19524915|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
19524916|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
19524917|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19524918|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19524919|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19524920|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19524921|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19524922|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
19524923|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
19524924|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524925|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
19524926|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
19524927|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
19524928|NCT02928315|Analgesics|analgesics|mesh-ancestor
20306420|NCT00655018|Vitamin E|vitamin e|mesh-list
20306421|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
20603762|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20603763|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
20603764|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603765|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524929|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
19524930|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524931|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524932|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
19524933|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524934|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19524935|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
19524936|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19524937|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524938|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524939|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524940|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
19524941|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20306422|NCT00655018|Vitamins|vitamins|mesh-ancestor
19524942|NCT02927951|Pregabalin|pregabalin|mesh-list
19524943|NCT02927951|Analgesics|analgesics|mesh-ancestor
19524944|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
19524945|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524946|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524947|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
19524948|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19524949|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524950|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524951|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19524952|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19524953|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19524954|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524955|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573213|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
19573214|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
19573215|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573216|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573217|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
19573218|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573219|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19573220|NCT02698228|Narcotics|narcotics|mesh-ancestor
19573221|NCT02698228|Analgesics|analgesics|mesh-ancestor
19573222|NCT02697955|Epinephrine|epinephrine|mesh-list
19573223|NCT02697955|Bupivacaine|bupivacaine|mesh-list
19573224|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
19573225|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
20603766|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102239|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102240|NCT00003066|Docetaxel|docetaxel|mesh-list
19573226|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573227|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573228|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
19573229|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573230|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19573231|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19573232|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
19573233|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573234|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573235|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19573236|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19573237|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
19573238|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19573239|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
19573240|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
19573241|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
19573242|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19573243|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19573244|NCT02697851|Cobicistat|cobicistat|mesh-list
19573245|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
19573246|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19573247|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19573248|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19573249|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19573250|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
19573251|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19573252|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573253|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20102241|NCT00003066|Estramustine|estramustine|mesh-list
20306423|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
20306424|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306425|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
20102242|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102243|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102244|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102245|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102246|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102247|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102248|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
20102249|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20102250|NCT00003067|Aldesleukin|aldesleukin|mesh-list
20102251|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306426|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573254|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19524956|NCT02927847|Nicotine|nicotine|mesh-list
19524957|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19524958|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
19524959|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524960|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524961|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19524962|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19524963|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
19524964|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524965|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524966|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
19524967|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19524968|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19524969|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19524970|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
19524971|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19524972|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524973|NCT02927587|Propofol|propofol|mesh-list
19524974|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19524975|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524976|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524977|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19524978|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
19524979|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
19524980|NCT02927392|Leuprolide|leuprolide|mesh-list
19524981|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19524982|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
19524983|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19524984|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524985|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19524986|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19524987|NCT02927405|Gabapentin|gabapentin|mesh-list
19524988|NCT02927405|Analgesics|analgesics|mesh-ancestor
19524989|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
19524990|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19524991|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19524992|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
19524993|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19524994|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19524995|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19524996|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19524997|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19524998|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19524999|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525000|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525001|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
19525002|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
19525003|NCT02927379|Ketamine|ketamine|mesh-list
19525004|NCT02927379|Bupivacaine|bupivacaine|mesh-list
19525005|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
19525006|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
19525007|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525008|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525009|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
19525010|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525011|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19525012|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525013|NCT02927379|Analgesics|analgesics|mesh-ancestor
19525014|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19525015|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19525016|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19525017|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525018|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525019|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525020|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19525021|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19525022|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
19525023|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19525024|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19525025|NCT02927496|Doxycycline|doxycycline|mesh-list
19525026|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19525027|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525028|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
19525029|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19525030|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19525031|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19525032|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525033|NCT02927353|Adalimumab|adalimumab|mesh-list
19525034|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525035|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525036|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19525037|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
19525038|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525039|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19525040|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19525041|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525042|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525043|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525044|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525045|NCT02927522|Donepezil|donepezil|mesh-list
19525046|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19525047|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525048|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525049|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
19525050|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525051|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525052|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
19525053|NCT02926976|Valproic Acid|valproic acid|mesh-list
19525054|NCT02926976|Risperidone|risperidone|mesh-list
19525055|NCT02926976|Aripiprazole|aripiprazole|mesh-list
19525056|NCT02926976|Clozapine|clozapine|mesh-list
19525057|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19525058|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
19525059|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525060|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525061|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525062|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19525063|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19525064|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525065|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19525066|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19525067|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
19525068|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
19525069|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
19525070|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19525071|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19525072|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19525073|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19525074|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
19525075|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525076|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
19525077|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
19525078|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
19525079|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
19525080|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19525081|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19525082|NCT02926885|Liver Extracts|liver extracts|mesh-list
19525083|NCT02926885|Hematinics|hematinics|mesh-ancestor
19525084|NCT02926859|Cannabidiol|cannabidiol|mesh-list
19525085|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
19525086|NCT02927015|Iproplatin|iproplatin|mesh-list
19525087|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525088|NCT02926846|Vancomycin|vancomycin|mesh-list
19525089|NCT02926846|Gentamicins|gentamicins|mesh-list
19525090|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19525091|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525092|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19525093|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525094|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525095|NCT02926690|OTS167|ots167|mesh-list
19525096|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19525097|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102252|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20102253|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20102254|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
19525098|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525099|NCT02926248|Colchicine|colchicine|mesh-list
19525100|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
19525101|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525102|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
20306427|NCT00655018|Protective Agents|protective agents|mesh-ancestor
19525103|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525104|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525105|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525106|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525107|NCT02926326|Azithromycin|azithromycin|mesh-list
19525108|NCT02926326|Acumapimod|acumapimod|mesh-list
19525109|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19525110|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525111|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19525112|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525113|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525114|NCT02926183|Gemcitabine|gemcitabine|mesh-list
19525115|NCT02926183|Paclitaxel|paclitaxel|mesh-list
19525116|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19525117|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525118|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102255|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306428|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
20306429|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20306430|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306431|NCT00655109|Fluticasone|fluticasone|mesh-list
19525119|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525120|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525121|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525122|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19525123|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
19525124|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
19525125|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525126|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525127|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525128|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
19525129|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525130|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
19525131|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19525132|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
19525133|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19525134|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
19525135|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525136|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525137|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
19573255|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19573256|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19573257|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19573258|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
19573259|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573260|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573261|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19573262|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19573263|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
19573264|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573265|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19573266|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19573267|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19573268|NCT02697851|Estrogens|estrogens|mesh-ancestor
19573269|NCT02697851|Hormones|hormones|mesh-ancestor
19573270|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573271|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19573272|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19573273|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19573274|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19573275|NCT02697877|Regadenoson|regadenoson|mesh-list
19573276|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19573277|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19573278|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
19573279|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
19573280|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573281|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573282|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573283|NCT02697929|Neostigmine|neostigmine|mesh-list
20102256|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
20102257|NCT00003068|Thiotepa|thiotepa|mesh-list
20102258|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
20102259|NCT00003068|Amifostine|amifostine|mesh-list
20102260|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102261|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
20102262|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525138|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
19525139|NCT02926053|Fludarabine|fludarabine|mesh-list
19525140|NCT02926053|Interleukin-2|interleukin-2|mesh-list
19525141|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525142|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
19525143|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525144|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525145|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19525146|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
19525147|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525148|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525149|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19525150|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525151|NCT02926053|Analgesics|analgesics|mesh-ancestor
19525152|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
19525153|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525154|NCT02925832|Bupivacaine|bupivacaine|mesh-list
19525155|NCT02925832|Ropivacaine|ropivacaine|mesh-list
19525156|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
19525157|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
19525158|NCT02925832|Anesthetics|anesthetics|mesh-list
19525159|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525160|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306432|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20102263|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102264|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19525161|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
19525162|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525163|NCT02925975|Carvedilol|carvedilol|mesh-list
19525164|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19525165|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19525166|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525167|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525168|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525169|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525170|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19525171|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
19525172|NCT02925975|Protective Agents|protective agents|mesh-ancestor
19525173|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19525174|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525175|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19525176|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
19525177|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19525178|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19525179|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19525180|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525181|NCT02925351|Clofarabine|clofarabine|mesh-list
19525182|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19525183|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
19525184|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525185|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525186|NCT02925299|Insulin|insulin|mesh-list
19525187|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19525188|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525189|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
19525190|NCT02925559|Gliclazide|gliclazide|mesh-list
19525191|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19525192|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525193|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19525194|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525195|NCT02925247|Anticoagulants|anticoagulants|mesh-list
19525196|NCT02925416|Oritavancin|oritavancin|mesh-list
19525197|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20102265|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
20102266|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102267|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102268|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102269|NCT00003068|Analgesics|analgesics|mesh-ancestor
20102270|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
20102271|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525198|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525199|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
19525200|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20306433|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
19525201|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525202|NCT02924922|Mannitol|mannitol|mesh-list
19525203|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19525204|NCT02924922|Diuretics|diuretics|mesh-ancestor
19525205|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
19525206|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525207|NCT02925026|Lactoferrin|lactoferrin|mesh-list
19525208|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525209|NCT02925130|Albuterol|albuterol|mesh-list
19525210|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19525211|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
19525212|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525213|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525214|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19525215|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
19525216|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
19525217|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19525218|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19525219|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19525220|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19525221|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525222|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525223|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525224|NCT02925000|Vinorelbine|vinorelbine|mesh-list
19525225|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19525226|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525227|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
19525228|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525229|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525230|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525231|NCT02924987|Aflibercept|aflibercept|mesh-list
19525232|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19525233|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19525234|NCT02924987|Growth Substances|growth substances|mesh-ancestor
19525235|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525236|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
19525237|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525238|NCT02924974|Lidocaine|lidocaine|mesh-list
19525239|NCT02924974|Morphine|morphine|mesh-list
19525240|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
19525241|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
19525242|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525243|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525244|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
19525245|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525246|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19525247|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19525248|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19525249|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525250|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525251|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19525252|NCT02924974|Narcotics|narcotics|mesh-ancestor
19525253|NCT02924974|Analgesics|analgesics|mesh-ancestor
19525254|NCT02924909|Paclitaxel|paclitaxel|mesh-list
19525255|NCT02924909|Carboplatin|carboplatin|mesh-list
19525256|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19525257|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525258|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19525259|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525260|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525261|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525262|NCT02924857|Paclitaxel|paclitaxel|mesh-list
19525263|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19525264|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525265|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19525266|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525267|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525268|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525269|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
19525270|NCT02924753|Fludarabine|fludarabine|mesh-list
19525271|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525272|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
19525273|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525274|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525275|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19525276|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
19525277|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525278|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525279|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19525280|NCT02924766|Prednisone|prednisone|mesh-list
19525281|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
19525282|NCT02924766|Niraparib|niraparib|mesh-list
19525283|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525284|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
19525285|NCT02924766|Hormones|hormones|mesh-ancestor
19525286|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525287|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525288|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19525289|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525290|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19525291|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525292|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525293|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
19525294|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19525295|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19525296|NCT02924675|Pregabalin|pregabalin|mesh-list
19525297|NCT02924675|Analgesics|analgesics|mesh-ancestor
19525298|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
19525299|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525300|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525301|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
19525302|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19525303|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525304|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525305|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19525306|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19525307|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19525308|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525309|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19525310|NCT02924532|Hormones|hormones|mesh-list
19525311|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
19525312|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525313|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525314|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19525315|NCT02924506|Meloxicam|meloxicam|mesh-list
19525316|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19525317|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525318|NCT02924506|Analgesics|analgesics|mesh-ancestor
19525319|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
19525320|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525321|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525322|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525323|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525324|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19525325|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19525326|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525327|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525328|NCT02924727|Valsartan|valsartan|mesh-list
19525329|NCT02924727|Ramipril|ramipril|mesh-list
19525330|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19525331|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19525332|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19525333|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19525334|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525335|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19525336|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
19525337|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525338|NCT02924311|Aflibercept|aflibercept|mesh-list
19525339|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19525340|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19525341|NCT02924311|Growth Substances|growth substances|mesh-ancestor
19525342|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525343|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
19525344|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525345|NCT02924285|Amiodarone|amiodarone|mesh-list
19525346|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19525347|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
19749536|NCT04940338|BB 1101|bb 1101|mesh-list
19525348|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19525349|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525350|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525351|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19525352|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19525353|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19525354|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525355|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19525356|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19525357|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19573284|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19573285|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573286|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573287|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
19573288|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573289|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573290|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19573291|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
19573292|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573293|NCT02697838|Paclitaxel|paclitaxel|mesh-list
19573294|NCT02697838|Apatinib|apatinib|mesh-list
19573295|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19573296|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573297|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
19573298|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
19573299|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
19573300|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573301|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19573302|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573303|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
19573304|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19573305|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19573306|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19573307|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573308|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573309|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
19573310|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573311|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573312|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19573313|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573314|NCT05324800|Turmeric extract|turmeric extract|mesh-list
19573315|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
19573316|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573317|NCT05324800|Protective Agents|protective agents|mesh-ancestor
19573318|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577975|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577976|NCT03768570|Durvalumab|durvalumab|mesh-list
19577977|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577978|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577979|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
19577980|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19577981|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577982|NCT03742505|Vitamins|vitamins|mesh-ancestor
19577983|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
19577984|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19577985|NCT03683251|Ranibizumab|ranibizumab|mesh-list
19577986|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19577987|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19577988|NCT03683251|Growth Substances|growth substances|mesh-ancestor
19577989|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577990|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
19577991|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577992|NCT03661320|Gemcitabine|gemcitabine|mesh-list
19577993|NCT03661320|Nivolumab|nivolumab|mesh-list
19577994|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577995|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577996|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
19577997|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577998|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
19577999|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578000|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578001|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525358|NCT02924454|Metoprolol|metoprolol|mesh-list
19525359|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19525360|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19525361|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19525362|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19525363|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19525364|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
19525365|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
19525366|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525367|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525368|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19525369|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19525370|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19525371|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525372|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525373|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525374|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19525375|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
19525376|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19525377|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525378|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19525379|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19525380|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525381|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525382|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525383|NCT02924246|Vaccines|vaccines|mesh-list
19525384|NCT02924246|Immunologic Factors|immunologic factors|mesh-ancestor
19525385|NCT02924246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525386|NCT02924233|Nivolumab|nivolumab|mesh-list
19525387|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19525388|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525389|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19525390|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525391|NCT02923986|Dasatinib|dasatinib|mesh-list
19525392|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525393|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19525394|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525395|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525396|NCT02923934|Nivolumab|nivolumab|mesh-list
19525397|NCT02923934|Ipilimumab|ipilimumab|mesh-list
19525398|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19525399|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525400|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19525401|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102272|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102273|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102274|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102275|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102276|NCT00003068|Protective Agents|protective agents|mesh-ancestor
20102277|NCT00003070|Enalapril|enalapril|mesh-list
20102278|NCT00003070|Enalaprilat|enalaprilat|mesh-list
19525402|NCT02924038|Poly ICLC|poly iclc|mesh-list
19525403|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
19525404|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
19525405|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525406|NCT02924090|Ketamine|ketamine|mesh-list
19525407|NCT02924090|Etomidate|etomidate|mesh-list
19525408|NCT02924090|Analgesics|analgesics|mesh-ancestor
19525409|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
19525410|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525411|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525412|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19525413|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19525414|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
19525415|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
19525416|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525417|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19525418|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19525419|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525420|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525421|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19525422|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20102279|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120438|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525423|NCT02923999|Antibodies|antibodies|mesh-list
19525424|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
19525425|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19525426|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
19525427|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102280|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102281|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19525428|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525429|NCT02923856|Clarithromycin|clarithromycin|mesh-list
19525430|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19525431|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102282|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20102283|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19525432|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19525433|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525434|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525435|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19525436|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19525437|NCT02923869|Bupivacaine|bupivacaine|mesh-list
19525438|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
19525439|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
19525440|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
19525441|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525442|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525443|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
19525444|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525445|NCT02923791|Lenograstim|lenograstim|mesh-list
19525446|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19525447|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
19525448|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525449|NCT02923687|Ketorolac|ketorolac|mesh-list
19525450|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19525451|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19525452|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525453|NCT02923687|Analgesics|analgesics|mesh-ancestor
19525454|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
19525455|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525456|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525457|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525458|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525459|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19525460|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525461|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525462|NCT02923557|Pirarubicin|pirarubicin|mesh-list
19525463|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525464|NCT02923583|Abatacept|abatacept|mesh-list
19525465|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19525466|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525467|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525468|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525469|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
19525470|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525471|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525472|NCT02923388|Vitamins|vitamins|mesh-list
19525473|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
19525474|NCT02923388|Pyridoxine|pyridoxine|mesh-list
19525475|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
19525476|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
19525477|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
19525478|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525479|NCT02923258|Docetaxel|docetaxel|mesh-list
19525480|NCT02923258|Cisplatin|cisplatin|mesh-list
19525481|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525482|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
19525483|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525484|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102284|NCT00003072|Paclitaxel|paclitaxel|mesh-list
20102285|NCT00003072|Carboplatin|carboplatin|mesh-list
20102286|NCT00003072|Amifostine|amifostine|mesh-list
20102287|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102288|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102289|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102290|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102291|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525485|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525486|NCT02923336|Propranolol|propranolol|mesh-list
19525487|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19525488|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19525489|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525490|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525491|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525492|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525493|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19525494|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19525495|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
19525496|NCT02923128|Sufentanil|sufentanil|mesh-list
19525497|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
19525498|NCT02923128|Dsuvia|dsuvia|mesh-list
19525499|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19525500|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525501|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525502|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525503|NCT02923128|Analgesics|analgesics|mesh-ancestor
19525504|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
19525505|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525506|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19525507|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19525508|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19525509|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525510|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525511|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525512|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19525513|NCT02923128|Narcotics|narcotics|mesh-ancestor
19525514|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19525515|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19525516|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
19525517|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
19525518|NCT02922894|Trazodone|trazodone|mesh-list
19525519|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19525520|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19525521|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525522|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525523|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19525524|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19525525|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19525526|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525527|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525528|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525529|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
19525530|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19525531|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
19525532|NCT02922933|Entinostat|entinostat|mesh-list
19525533|NCT02922933|Omeprazole|omeprazole|mesh-list
19525534|NCT02922933|Famotidine|famotidine|mesh-list
19525535|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19525536|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19525537|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19525538|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525539|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525540|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19525541|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
19525542|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
19525543|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525544|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525545|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525546|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19525547|NCT02922946|Entinostat|entinostat|mesh-list
19525548|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525549|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19525550|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525551|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525552|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
19525553|NCT02922803|Vitamin D|vitamin d|mesh-list
19525554|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
19525555|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
19525556|NCT02922803|Vitamins|vitamins|mesh-list
19525557|NCT02922803|Calcium|calcium|mesh-list
19525558|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
19525559|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525560|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19525561|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19525566|NCT02922686|Floxacillin|floxacillin|mesh-list
19525567|NCT02922686|Penicillin V|penicillin v|mesh-list
19525568|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19525569|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525570|NCT02922712|Nimesulide|nimesulide|mesh-list
19525571|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19525572|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525573|NCT02922712|Analgesics|analgesics|mesh-ancestor
19525574|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
19525575|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525576|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525577|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525578|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525579|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20102292|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102293|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102294|NCT00003072|Protective Agents|protective agents|mesh-ancestor
19525580|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525581|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525582|NCT02922699|Omeprazole|omeprazole|mesh-list
19525583|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19525584|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19525585|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19525586|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525587|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525588|NCT02922673|Aspirin|aspirin|mesh-list
19525589|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19525590|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525591|NCT02922673|Analgesics|analgesics|mesh-ancestor
19525592|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
20102295|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102296|NCT00003073|Cytarabine|cytarabine|mesh-list
20102297|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102298|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
20102299|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102300|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102301|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
20102302|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102303|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525593|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525594|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525595|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525596|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525597|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19525598|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19525599|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525600|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20102304|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
20603767|NCT02223026|Metformin|metformin|mesh-list
20603768|NCT02223026|Linagliptin|linagliptin|mesh-list
20603769|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20603770|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603771|NCT02223026|Incretins|incretins|mesh-ancestor
20603772|NCT02223026|Hormones|hormones|mesh-ancestor
20603773|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603774|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20603775|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
20603776|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102305|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102306|NCT00003075|Fenretinide|fenretinide|mesh-list
19525601|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19525602|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525603|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
19525604|NCT02922660|Remifentanil|remifentanil|mesh-list
19525605|NCT02922660|Anesthetics|anesthetics|mesh-list
19525606|NCT02922660|Propofol|propofol|mesh-list
19525607|NCT02922660|Desflurane|desflurane|mesh-list
19525608|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525609|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525610|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19525611|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20102307|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525612|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
19525613|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19525614|NCT02922660|Narcotics|narcotics|mesh-ancestor
19525615|NCT02922660|Analgesics|analgesics|mesh-ancestor
19525616|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
19525617|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525618|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19525619|NCT02922465|Clopidogrel|clopidogrel|mesh-list
19525620|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19525621|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19525622|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19525623|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19525624|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
19525625|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525626|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525627|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525628|NCT02922426|Olanzapine|olanzapine|mesh-list
19525629|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
19525630|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
19525631|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525632|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525633|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19525634|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19525635|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19525636|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525637|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19525638|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19525639|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19525640|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525641|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525642|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525643|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
19573319|NCT05324774|Aflibercept|aflibercept|mesh-list
19573320|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19573321|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19573322|NCT05324774|Growth Substances|growth substances|mesh-ancestor
19573323|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573324|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
19573325|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573326|NCT05324761|Pregabalin|pregabalin|mesh-list
19573327|NCT05324761|Gabapentin|gabapentin|mesh-list
19573328|NCT05324761|Analgesics|analgesics|mesh-ancestor
19573329|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
19573330|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573331|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573332|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
19573333|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19573334|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573335|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573336|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19573337|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19573338|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19573339|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573340|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573341|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19573342|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19573343|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573344|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
19573345|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
19573346|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19573347|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19573348|NCT05324748|Prednisolone|prednisolone|mesh-list
19573349|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
19573350|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19573351|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
19573352|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573353|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
19573354|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
19573355|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573356|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573357|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573358|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
19573359|NCT05324748|Hormones|hormones|mesh-ancestor
19573360|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525644|NCT02922491|Vitamin E|vitamin e|mesh-list
19525645|NCT02922491|Vitamins|vitamins|mesh-ancestor
20102308|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20102309|NCT00003075|Protective Agents|protective agents|mesh-ancestor
20102310|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102311|NCT00003076|Eflornithine|eflornithine|mesh-list
20102312|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102313|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19525646|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
20102314|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20102315|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19525647|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525648|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
19525649|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525650|NCT02922491|Protective Agents|protective agents|mesh-ancestor
19525651|NCT02922179|Insulin|insulin|mesh-list
19525652|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
19525653|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19525654|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525655|NCT02922283|Interleukin-2|interleukin-2|mesh-list
19525656|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525657|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525658|NCT02922283|Analgesics|analgesics|mesh-ancestor
19525659|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
19525660|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525661|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102316|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102317|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20102318|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102319|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102320|NCT00003078|Fluorouracil|fluorouracil|mesh-list
20102321|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525662|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
19525663|NCT02922075|Amoxicillin|amoxicillin|mesh-list
19525664|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
19525665|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19525666|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525667|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19525668|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
19525669|NCT02922166|SRX246|srx246|mesh-list
19525670|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19525671|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525672|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
19525673|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525674|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19525675|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19525676|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19525677|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
19525678|NCT02922348|Norgestimate|norgestimate|mesh-list
19525679|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
19525680|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
19525681|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19525682|NCT02922348|Hormones|hormones|mesh-list
19525683|NCT02922348|Estradiol|estradiol|mesh-list
19525684|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19525685|NCT02922348|Progestins|progestins|mesh-list
19525686|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525687|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525688|NCT02922348|Estrogens|estrogens|mesh-ancestor
19525689|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19525690|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19525691|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19525692|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19525693|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19525694|NCT02922387|Varenicline|varenicline|mesh-list
20102322|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
20102323|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102324|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102325|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102326|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
20102327|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525695|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19525696|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19525697|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
19525698|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525699|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102328|NCT00003079|Cytarabine|cytarabine|mesh-list
20102329|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
19525700|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525701|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
19525702|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
20102330|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102331|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
20102332|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102333|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102334|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
19525703|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
19525704|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19525705|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19525706|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525707|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19525708|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19525709|NCT02921984|Docetaxel|docetaxel|mesh-list
19525710|NCT02921984|Pemetrexed|pemetrexed|mesh-list
19525711|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525712|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102335|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102336|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102337|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
19525713|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525714|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525715|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525716|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525717|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19525718|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19525719|NCT02921906|Acetaminophen|acetaminophen|mesh-list
20603777|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525720|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525721|NCT02921906|Analgesics|analgesics|mesh-ancestor
19525722|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
19525723|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525724|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525725|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
19525726|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
19525727|NCT02921763|Progestins|progestins|mesh-ancestor
19525728|NCT02921763|Hormones|hormones|mesh-ancestor
19525729|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525730|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525731|NCT02921659|Niacinamide|niacinamide|mesh-list
19525732|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
19525733|NCT02921659|Vitamins|vitamins|mesh-ancestor
19525734|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
19525735|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525736|NCT02921919|Talazoparib|talazoparib|mesh-list
19525737|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19525738|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525739|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525740|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525741|NCT02921269|Bevacizumab|bevacizumab|mesh-list
19525742|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19525743|NCT02921269|Atezolizumab|atezolizumab|mesh-list
19525744|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
19525745|NCT02921269|Antibodies|antibodies|mesh-list
19525746|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
19525747|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19525748|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
19525749|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525750|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19525751|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19525752|NCT02921269|Growth Substances|growth substances|mesh-ancestor
19525753|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525754|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
19525755|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
19525756|NCT02921282|Dopamine|dopamine|mesh-list
19525757|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19525758|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
20102338|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525759|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
19525760|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525761|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525762|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
19578002|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
19525763|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525764|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525765|NCT02921282|Protective Agents|protective agents|mesh-ancestor
19525766|NCT02921360|Aspirin|aspirin|mesh-list
19525767|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19525768|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525769|NCT02921360|Analgesics|analgesics|mesh-ancestor
19525770|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
19525771|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525772|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102339|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102340|NCT00003080|Tamoxifen|tamoxifen|mesh-list
19525773|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525774|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525775|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19525776|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19525777|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525778|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19525779|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19525780|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525781|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
19525782|NCT02921204|Vitamin D|vitamin d|mesh-list
19525783|NCT02921204|Vitamins|vitamins|mesh-ancestor
19525784|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
19525785|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525786|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19525787|NCT02921191|Lenograstim|lenograstim|mesh-list
19525788|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19525789|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
19525790|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525791|NCT02921178|Omalizumab|omalizumab|mesh-list
19525792|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19525793|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19525794|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
19525795|NCT02921165|Aspirin|aspirin|mesh-list
19525796|NCT02921165|Analgesics|analgesics|mesh-list
19525797|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19525798|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19525799|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
19525800|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525801|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525802|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525803|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19525804|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19525805|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19525806|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525807|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19525808|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19525809|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525810|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
19525811|NCT02920931|Tenofovir|tenofovir|mesh-list
19525812|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
19525813|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525814|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19525815|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19525816|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525817|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525818|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19525819|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19525820|NCT02920827|Dapivirine|dapivirine|mesh-list
19525821|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19525822|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19525823|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
19525824|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525825|NCT02920801|Metformin|metformin|mesh-list
19525826|NCT02920801|Saxagliptin|saxagliptin|mesh-list
19525827|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19525828|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525829|NCT02920801|Incretins|incretins|mesh-ancestor
19525830|NCT02920801|Hormones|hormones|mesh-ancestor
19525831|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525832|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19525833|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
19525834|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525835|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102341|NCT00003080|Melphalan|melphalan|mesh-list
20102342|NCT00003080|Thiotepa|thiotepa|mesh-list
20102343|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
20102344|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102345|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102346|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
20102347|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102348|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102349|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102350|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
20102351|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525836|NCT02921022|Gemcitabine|gemcitabine|mesh-list
19525837|NCT02921022|Paclitaxel|paclitaxel|mesh-list
19525838|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19525839|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525840|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
19525841|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
19525842|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
19525843|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525844|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19525845|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
19525846|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
19525847|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525848|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525849|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525850|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
19525851|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525852|NCT02920905|Lidocaine|lidocaine|mesh-list
19525853|NCT02920905|Atracurium|atracurium|mesh-list
19525854|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
19525855|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
19525856|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525857|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525858|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
19525859|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525860|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19525861|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19525862|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19525863|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525864|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525865|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19525866|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20102352|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20102353|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
20102354|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20102355|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20102356|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20102357|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20102358|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20102359|NCT00003080|Analgesics|analgesics|mesh-ancestor
20102360|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
20102361|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102362|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102363|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102364|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102365|NCT00003081|Melphalan|melphalan|mesh-list
20102366|NCT00003081|Busulfan|busulfan|mesh-list
20102367|NCT00003081|Thiotepa|thiotepa|mesh-list
20102368|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
20102369|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102370|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102371|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
20102372|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102373|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102374|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102375|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525867|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19525868|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19525869|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19525870|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
19525871|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525872|NCT02920567|Octreotide|octreotide|mesh-list
19525873|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20102376|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20102377|NCT00003082|Antibodies|antibodies|mesh-list
19525874|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19525875|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525876|NCT02920515|Leuprolide|leuprolide|mesh-list
19525877|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19525878|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
19525879|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19525880|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525881|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19525882|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573361|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19573362|NCT05324748|Protective Agents|protective agents|mesh-ancestor
19573363|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573364|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573365|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
19573366|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19573367|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573368|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573369|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19573370|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19573371|NCT05324735|Protective Agents|protective agents|mesh-ancestor
19573372|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573373|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
19573374|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19573375|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
19573376|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
19573377|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19573378|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19573379|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19573380|NCT05324618|Tacrolimus|tacrolimus|mesh-list
19573381|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19573382|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
19573383|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573384|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19573385|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573386|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573387|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573388|NCT05324592|Aflibercept|aflibercept|mesh-list
19573389|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19573390|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19573391|NCT05324592|Growth Substances|growth substances|mesh-ancestor
19573392|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573393|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
19573394|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573395|NCT05324501|Lomustine|lomustine|mesh-list
19573396|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19573397|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
19573398|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573399|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573400|NCT05324462|Xultophy|xultophy|mesh-list
19573401|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19573402|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573403|NCT05324462|Incretins|incretins|mesh-ancestor
19573404|NCT05324462|Hormones|hormones|mesh-ancestor
19573405|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573406|NCT05324358|Ketorolac|ketorolac|mesh-list
19573407|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19573408|NCT05324358|Morphine|morphine|mesh-list
19573409|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19573410|NCT05324358|Narcotics|narcotics|mesh-ancestor
19573411|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573412|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573413|NCT05324358|Analgesics|analgesics|mesh-ancestor
19573414|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
19573415|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573416|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19573417|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573418|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573419|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573420|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19573421|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573422|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573423|NCT05324332|Edetic Acid|edetic acid|mesh-list
19573424|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19573425|NCT05324332|Anticoagulants|anticoagulants|mesh-ancestor
19573426|NCT05324332|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19525883|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19525884|NCT02920710|Hormones|hormones|mesh-ancestor
19525885|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525886|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525887|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
19525888|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19525889|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525890|NCT02920502|Vitamins|vitamins|mesh-ancestor
19525891|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
19525892|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19525893|NCT02920593|Vitamin D|vitamin d|mesh-list
19525894|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
19525895|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
19525896|NCT02920593|Vitamins|vitamins|mesh-list
19525897|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
19525898|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525899|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19525900|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19525901|NCT02920658|Betamethasone|betamethasone|mesh-list
19525902|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
19525903|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19525904|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
19525905|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19525906|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19525907|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
19525908|NCT02920658|Hormones|hormones|mesh-ancestor
19525909|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525910|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525911|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19525912|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
19525913|NCT02920359|Leuprolide|leuprolide|mesh-list
19525914|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19525915|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
19525916|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19525917|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525918|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19525919|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19525920|NCT02920489|Sufentanil|sufentanil|mesh-list
19525921|NCT02920489|Dsuvia|dsuvia|mesh-list
19525922|NCT02920489|Ropivacaine|ropivacaine|mesh-list
19525923|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
19525924|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
19525925|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525926|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525927|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
19525928|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525929|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19525930|NCT02920489|Narcotics|narcotics|mesh-ancestor
19525931|NCT02920489|Analgesics|analgesics|mesh-ancestor
19525932|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19525933|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19525934|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
19525935|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
19525936|NCT02920372|Hematinics|hematinics|mesh-ancestor
19525937|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19525938|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19525939|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525940|NCT02919917|Midodrine|midodrine|mesh-list
19525941|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
19525942|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
19525943|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19525944|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525945|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19525946|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19525947|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19525948|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19525949|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
19525950|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525951|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525952|NCT02920047|Amlodipine|amlodipine|mesh-list
19525953|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19525954|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19525955|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19525956|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525957|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19525958|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525959|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
19525960|NCT02920190|Liraglutide|liraglutide|mesh-list
19525961|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19525962|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525963|NCT02920190|Incretins|incretins|mesh-ancestor
19525964|NCT02920190|Hormones|hormones|mesh-ancestor
19525965|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19525966|NCT02920060|Levetiracetam|levetiracetam|mesh-list
19525967|NCT02920060|Valproic Acid|valproic acid|mesh-list
19525968|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
19525969|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
19525970|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525971|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525972|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
19525973|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19525974|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525975|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
19525976|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19525977|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19525978|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19525979|NCT02919878|Gemcitabine|gemcitabine|mesh-list
19525980|NCT02919878|Capecitabine|capecitabine|mesh-list
19525981|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19525982|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
19525983|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19525984|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102378|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
20102379|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20102380|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
20102381|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102382|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102383|NCT00003084|Ketoconazole|ketoconazole|mesh-list
20102384|NCT00003084|Paclitaxel|paclitaxel|mesh-list
20102385|NCT00003084|Etoposide|etoposide|mesh-list
20102386|NCT00003084|Vinblastine|vinblastine|mesh-list
20102387|NCT00003084|Doxorubicin|doxorubicin|mesh-list
20102388|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19525985|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
19525986|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525987|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19525988|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19525989|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
19525990|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19525991|NCT02919605|Pentamidine|pentamidine|mesh-list
19525992|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
19525993|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19525994|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19525995|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19525996|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19525997|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19525998|NCT02919787|Irinotecan|irinotecan|mesh-list
19525999|NCT02919787|Fluorouracil|fluorouracil|mesh-list
19526000|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
19526001|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19526002|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19526003|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526004|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526005|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526006|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
19526007|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19526008|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526009|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
20102389|NCT00003084|Estramustine|estramustine|mesh-list
19526010|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526011|NCT02919501|Vortioxetine|vortioxetine|mesh-list
20102390|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102391|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526012|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
19526013|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19526014|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19526015|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19526016|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526017|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526018|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19526019|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20102392|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102393|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102394|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102395|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102396|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102397|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19526020|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526021|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526022|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526023|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
19526024|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19526025|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19526026|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20102398|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102399|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102400|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
20102401|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102402|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20102403|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20102404|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20102405|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
20120439|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
20306434|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20306435|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20306436|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
19526027|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19526028|NCT02919579|Esketamine|esketamine|mesh-list
19526029|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
19526030|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19526031|NCT02919462|Cisplatin|cisplatin|mesh-list
19526032|NCT02919462|Pemetrexed|pemetrexed|mesh-list
19526033|NCT02919462|Vinorelbine|vinorelbine|mesh-list
19526034|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306437|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306438|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306439|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20306440|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
20306441|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
20306442|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20306443|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20306444|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20306445|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20306446|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20306447|NCT00655109|Analgesics|analgesics|mesh-ancestor
19526035|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526036|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526037|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19526038|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19526039|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19526040|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
19526041|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
19526042|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
19526043|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
19526044|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19526045|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19526046|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526047|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
19526048|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
19526049|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526050|NCT02919293|Vaccines|vaccines|mesh-list
19526051|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
20306448|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
20306449|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306450|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20306451|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20306452|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
20306453|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
20102406|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20102407|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102408|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20102409|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102410|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
20102411|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20102412|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
20102413|NCT00003086|Carboplatin|carboplatin|mesh-list
20102414|NCT00003086|Doxorubicin|doxorubicin|mesh-list
20102415|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19526052|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526053|NCT02919371|Bevacizumab|bevacizumab|mesh-list
19526054|NCT02919371|Sunitinib|sunitinib|mesh-list
19526055|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19526056|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102416|NCT00003086|Fluorouracil|fluorouracil|mesh-list
20102417|NCT00003086|Melphalan|melphalan|mesh-list
20102418|NCT00003086|Ifosfamide|ifosfamide|mesh-list
20102419|NCT00003086|Thiotepa|thiotepa|mesh-list
20102420|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
20102421|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102422|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102423|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102424|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
20306454|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306455|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306456|NCT00655122|Dalteparin|dalteparin|mesh-list
20306457|NCT00655122|Tinzaparin|tinzaparin|mesh-list
20306458|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20306459|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
20306460|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20306461|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20306462|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306463|NCT00655135|Vedolizumab|vedolizumab|mesh-list
20306464|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20306465|NCT00655148|Vaccines|vaccines|mesh-list
20306466|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
19526057|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19526058|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19526059|NCT02919371|Growth Substances|growth substances|mesh-ancestor
19526060|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526061|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
19526062|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19526063|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526064|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526065|NCT02919202|Listerine|listerine|mesh-list
19526066|NCT02919202|Fluorides|fluorides|mesh-list
19526067|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
19526068|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
19526069|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
19526070|NCT02919202|Protective Agents|protective agents|mesh-ancestor
20306467|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306468|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
20306469|NCT00655174|Sertraline|sertraline|mesh-list
20306470|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
20306471|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20306472|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20306473|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20306474|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306475|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306476|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306477|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
20306478|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526071|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526072|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19526073|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526074|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
19526075|NCT02919345|Glyburide|glyburide|mesh-list
19526076|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19526077|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526078|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19526079|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306479|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20306480|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19526080|NCT02919449|Atezolizumab|atezolizumab|mesh-list
19526081|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526082|NCT02919176|Pioglitazone|pioglitazone|mesh-list
19526083|NCT02919176|Mirabegron|mirabegron|mesh-list
19526084|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19526085|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526086|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19526087|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19526088|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19526089|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19526090|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526091|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526092|NCT02919176|Urological Agents|urological agents|mesh-ancestor
19526093|NCT02919072|Ropivacaine|ropivacaine|mesh-list
19526094|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
19526095|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
19526096|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
19526097|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526098|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526099|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
19526100|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526101|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
19526102|NCT02919059|Glimepiride|glimepiride|mesh-list
19526103|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19526104|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526105|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19526106|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526107|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19526108|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526109|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
20306481|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306482|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19573427|NCT05324332|Chelating Agents|chelating agents|mesh-ancestor
19573428|NCT05324332|Sequestering Agents|sequestering agents|mesh-ancestor
19573429|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573430|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19573431|NCT05323981|Pertuzumab|pertuzumab|mesh-list
19573432|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19573433|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573434|NCT05323955|Trastuzumab|trastuzumab|mesh-list
19573435|NCT05323955|Pertuzumab|pertuzumab|mesh-list
19573436|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19573437|NCT05323955|Maytansine|maytansine|mesh-list
19573438|NCT05323955|Tucatinib|tucatinib|mesh-list
19573439|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19573440|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573441|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19573442|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
19573443|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
19573444|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
19573445|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573446|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19573447|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573448|NCT05323812|Edaravone|edaravone|mesh-list
19573449|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19573450|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
19573451|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573452|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19573453|NCT05323812|Protective Agents|protective agents|mesh-ancestor
19573454|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573455|NCT05323786|Anesthetics|anesthetics|mesh-list
19573456|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20102425|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102426|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102427|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102428|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
20102429|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102430|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102431|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102432|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102433|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102434|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
20102435|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102436|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20102437|NCT00003086|Analgesics|analgesics|mesh-ancestor
19526110|NCT02918812|Diclofenac|diclofenac|mesh-list
19526111|NCT02918812|Lidocaine|lidocaine|mesh-list
19526112|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
19526113|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
19526114|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526115|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526116|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
19526117|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526118|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19526119|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19526120|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19526121|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526122|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526123|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19526124|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19526125|NCT02918812|Analgesics|analgesics|mesh-ancestor
19526126|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526127|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102438|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
20102439|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102440|NCT00003087|Paclitaxel|paclitaxel|mesh-list
20102441|NCT00003087|Cisplatin|cisplatin|mesh-list
19526128|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19526129|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526130|NCT02918864|Oxytocin|oxytocin|mesh-list
19526131|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
19526132|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19526133|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526134|NCT02918825|Olanzapine|olanzapine|mesh-list
19526135|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19526136|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
19526137|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
19526138|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526139|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526140|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526141|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19526142|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19526143|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526144|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19526145|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19526146|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19526147|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526148|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526149|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526150|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
19526151|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19526152|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19526153|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19526154|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19526155|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
19526156|NCT02918760|Gabapentin|gabapentin|mesh-list
19526157|NCT02918760|Analgesics|analgesics|mesh-ancestor
19526158|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
19526159|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526160|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526161|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
19526162|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19526163|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19526164|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526165|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19526166|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19526167|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19526168|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526169|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526170|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
19526171|NCT02918747|Gemcitabine|gemcitabine|mesh-list
19526172|NCT02918747|Dexamethasone|dexamethasone|mesh-list
19526173|NCT02918747|Prednisone|prednisone|mesh-list
19526174|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
19526175|NCT02918747|Doxorubicin|doxorubicin|mesh-list
19526176|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
19526177|NCT02918747|Vincristine|vincristine|mesh-list
19526178|NCT02918747|Pegaspargase|pegaspargase|mesh-list
19526179|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526180|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
19526181|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526182|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526183|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19526184|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
19526185|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526186|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526187|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19526188|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526189|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
19526190|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
19526191|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526192|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526193|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
19526194|NCT02918747|Hormones|hormones|mesh-ancestor
19526195|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526196|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526197|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19526198|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
19526199|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
19526200|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526201|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526202|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19526203|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19526204|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19526205|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19526206|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
19526207|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
19526208|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
19526209|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19526210|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
19526211|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526212|NCT02918591|Empagliflozin|empagliflozin|mesh-list
19526213|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19526214|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526215|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19526216|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526217|NCT02918409|Tobramycin|tobramycin|mesh-list
19526218|NCT02918409|Colistin|colistin|mesh-list
19526219|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19526220|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526221|NCT02918331|Dexamethasone|dexamethasone|mesh-list
19526222|NCT02918331|Lenalidomide|lenalidomide|mesh-list
19526223|NCT02918331|Daratumumab|daratumumab|mesh-list
19526224|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526225|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
19526226|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
19526227|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526228|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526229|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526230|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
19526231|NCT02918331|Hormones|hormones|mesh-ancestor
19526232|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526233|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526234|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526235|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
19526236|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19526237|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19526238|NCT02918331|Growth Substances|growth substances|mesh-ancestor
19526239|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
19526240|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
19526241|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
19526242|NCT02918045|Coagulants|coagulants|mesh-ancestor
19526243|NCT02918136|Cortisone|cortisone|mesh-list
19526244|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526245|NCT02918110|Misoprostol|misoprostol|mesh-list
19526246|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19526247|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
19526248|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19526249|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526250|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19526251|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526252|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
19526253|NCT02917889|Caffeine|caffeine|mesh-list
19526254|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19526255|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526256|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19526257|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526258|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526259|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19526260|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19526261|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
19526262|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526263|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
19526264|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19526265|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526266|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526267|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
19526268|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526269|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526270|NCT02917772|Nivolumab|nivolumab|mesh-list
19526271|NCT02917772|Ipilimumab|ipilimumab|mesh-list
19526272|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19526273|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526274|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19526275|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526276|NCT02917746|Imiquimod|imiquimod|mesh-list
19526277|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19526278|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
19526279|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526280|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526281|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
19526282|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19526283|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19526284|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526285|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
19526286|NCT02917512|Cyclosporine|cyclosporine|mesh-list
19526287|NCT02917512|Cyclosporins|cyclosporins|mesh-list
19526288|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526289|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526290|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526291|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
19526292|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526293|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
19526294|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526295|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
19526296|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526297|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19526298|NCT02917525|Vitamin K|vitamin k|mesh-list
19526299|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
19526300|NCT02917525|Vitamins|vitamins|mesh-ancestor
19526301|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
19526302|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526303|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19526304|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19526305|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526306|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
19526307|NCT02917525|Coagulants|coagulants|mesh-ancestor
19526308|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
19526309|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19526310|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526311|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19526312|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19526313|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526314|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526315|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573457|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573458|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
19573459|NCT05323721|Piperaquine|piperaquine|mesh-list
19573460|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
19573461|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19573462|NCT05323721|Amodiaquine|amodiaquine|mesh-list
19573463|NCT05323721|Artenimol|artenimol|mesh-list
19573464|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
19573465|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19573466|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19573467|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573468|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19573469|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573470|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573471|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19573472|NCT05323721|Renal Agents|renal agents|mesh-ancestor
19573473|NCT05323617|Cyclosporine|cyclosporine|mesh-list
19573474|NCT05323617|Cyclosporins|cyclosporins|mesh-list
19526316|NCT02917005|Palbociclib|palbociclib|mesh-list
19526317|NCT02917005|Exemestane|exemestane|mesh-list
19526318|NCT02917005|Goserelin|goserelin|mesh-list
19526319|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526320|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19526321|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526322|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526323|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19526324|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19526325|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19526326|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
19526327|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526328|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526329|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526330|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
19526331|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19526332|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526333|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526334|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19526335|NCT02917018|Analgesics|analgesics|mesh-ancestor
19526336|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
19526337|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526338|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19526339|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19526340|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19526341|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
19526342|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526343|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526344|NCT02917057|Exenatide|exenatide|mesh-list
19526345|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19526346|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526347|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19526348|NCT02917057|Incretins|incretins|mesh-ancestor
19526349|NCT02917057|Hormones|hormones|mesh-ancestor
19526350|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526351|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
19526352|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526353|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
19526354|NCT02916940|Hormones|hormones|mesh-ancestor
19526355|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526356|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526357|NCT02916654|Iron|iron|mesh-list
19526358|NCT02916654|Trace Elements|trace elements|mesh-ancestor
19526359|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
19526360|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526361|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19526362|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526363|NCT02916420|Dexamethasone|dexamethasone|mesh-list
19526364|NCT02916420|Pomalidomide|pomalidomide|mesh-list
19526365|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526366|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
19526367|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
19526368|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526369|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526370|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526371|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
19526372|NCT02916420|Hormones|hormones|mesh-ancestor
19526373|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526374|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526375|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526376|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
19526377|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19526378|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19526379|NCT02916420|Growth Substances|growth substances|mesh-ancestor
19526380|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
19526381|NCT02916511|Paclitaxel|paclitaxel|mesh-list
19526382|NCT02916511|Carboplatin|carboplatin|mesh-list
19526383|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19526384|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526385|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
19526386|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
19526387|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
19526388|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526389|NCT02916485|Sirolimus|sirolimus|mesh-list
19526390|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19526391|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526392|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19526393|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526394|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
19526395|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526396|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
19526397|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526398|NCT02916602|Losartan|losartan|mesh-list
19526399|NCT02916602|Amlodipine|amlodipine|mesh-list
19526400|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
19526401|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19526402|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19526403|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526404|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526405|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19526406|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526407|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
19526408|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19526409|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19526410|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19526411|NCT02916602|Diuretics|diuretics|mesh-ancestor
19526412|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
20306483|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20603778|NCT02223052|Azacitidine|azacitidine|mesh-list
20603779|NCT02223052|Cc-486|cc-486|mesh-list
20603780|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102442|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102443|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102444|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
19526413|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19526414|NCT02916381|Anesthetics|anesthetics|mesh-list
19526415|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526416|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526417|NCT02916251|Glucagon|glucagon|mesh-list
19526418|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19526419|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526420|NCT02916251|Hormones|hormones|mesh-ancestor
19526421|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526422|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526423|NCT02916251|Incretins|incretins|mesh-ancestor
19526424|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19526425|NCT02916173|Hormones|hormones|mesh-list
19526426|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526427|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526428|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19526429|NCT02916238|Fluoxetine|fluoxetine|mesh-list
19526430|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19526431|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19526432|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526433|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526434|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526435|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
19526436|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526437|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19526438|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
19526439|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19526440|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19526441|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19526442|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526443|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19526444|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526445|NCT02916160|Valsartan|valsartan|mesh-list
19526446|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19526447|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19526448|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19526449|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19526450|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102445|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102446|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102447|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102448|NCT00003088|Paclitaxel|paclitaxel|mesh-list
19526451|NCT02916121|Folic Acid|folic acid|mesh-list
19526452|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
19526453|NCT02916121|Vitamins|vitamins|mesh-ancestor
19526454|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
19526455|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526456|NCT02916121|Hematinics|hematinics|mesh-ancestor
19526457|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
19526458|NCT02916147|Propofol|propofol|mesh-list
19526459|NCT02916147|Sevoflurane|sevoflurane|mesh-list
19526460|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19526461|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526462|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526463|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19526464|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
19526465|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
19526466|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19526467|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19526468|NCT02915731|Vitamin A|vitamin a|mesh-list
19526469|NCT02915731|Vitamins|vitamins|mesh-ancestor
19526470|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
19526471|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526472|NCT02915666|Trametinib|trametinib|mesh-list
19526473|NCT02915666|Dabrafenib|dabrafenib|mesh-list
19526474|NCT02915666|Digoxin|digoxin|mesh-list
19526475|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526476|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19526477|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526478|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526479|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19526480|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19526481|NCT02915666|Protective Agents|protective agents|mesh-ancestor
19526482|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526483|NCT02915809|Vaccines|vaccines|mesh-list
19526484|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
19526485|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526486|NCT02915523|Avelumab|avelumab|mesh-list
19526487|NCT02915523|Entinostat|entinostat|mesh-list
19526488|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19526489|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526490|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20102449|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
19526491|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526492|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526493|NCT02915796|Lenograstim|lenograstim|mesh-list
19526494|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19526495|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
19526496|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526497|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
19526498|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
19526499|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573475|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19573476|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573477|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573478|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19573479|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
19573480|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573481|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
19573482|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573483|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
19573484|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573485|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19573486|NCT05323565|Dexamethasone|dexamethasone|mesh-list
19573487|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
19573488|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573489|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
19573490|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
19573491|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573492|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526500|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
19526501|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19526502|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526503|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
19526504|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19526505|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
19526506|NCT02915289|Povidone|povidone|mesh-list
19526507|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19526508|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526509|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
19526510|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
19526511|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
19526512|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
19526513|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
19526514|NCT02915224|Chlorambucil|chlorambucil|mesh-list
19526515|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19526516|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526517|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20603781|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
20603782|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603783|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603784|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20607917|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607918|NCT02244125|Dexamethasone|dexamethasone|mesh-list
20607919|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
20607920|NCT02244125|Pomalidomide|pomalidomide|mesh-list
20607921|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607922|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
20607923|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20607924|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20607925|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20607926|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
20607927|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607928|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607929|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20607930|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20607931|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
19526518|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
19526519|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526520|NCT02915354|Etanercept|etanercept|mesh-list
20102450|NCT00003088|Doxorubicin|doxorubicin|mesh-list
20102451|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20102452|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102453|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102454|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102455|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102456|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102457|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102458|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526521|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19526522|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19526523|NCT02915354|Analgesics|analgesics|mesh-ancestor
20102459|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
20306484|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20306485|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306486|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20306487|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
19526524|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
19526525|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526526|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306488|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20306489|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306490|NCT00655252|Everolimus|everolimus|mesh-list
20102460|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526527|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526528|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526529|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526530|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526531|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
19526532|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19526533|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526534|NCT02915172|Capecitabine|capecitabine|mesh-list
19526535|NCT02915172|Lenvatinib|lenvatinib|mesh-list
19526536|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20306491|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526537|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
19526538|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526539|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526540|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19526541|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526542|NCT02915055|Acetaminophen|acetaminophen|mesh-list
19526543|NCT02915055|Ibuprofen|ibuprofen|mesh-list
19526544|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19526545|NCT02915055|Oxycodone|oxycodone|mesh-list
19526546|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19526547|NCT02915055|Analgesics|analgesics|mesh-ancestor
19526548|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
19526549|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526550|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526551|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
19526552|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19526553|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526554|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526555|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19526556|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526557|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526558|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19526559|NCT02915055|Narcotics|narcotics|mesh-ancestor
19526560|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526561|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
19526562|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19526563|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526564|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526565|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20102461|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102462|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102463|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
19526566|NCT02915042|Analgesics|analgesics|mesh-ancestor
19526567|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
19526568|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526569|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19526570|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19526571|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19526572|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
19526573|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526574|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526575|NCT02914886|Insulin|insulin|mesh-list
19526576|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19526577|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19526578|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526579|NCT02914652|Albuterol|albuterol|mesh-list
19526580|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19526581|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
19526582|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526583|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526584|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19526585|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
19526586|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
19526587|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19526588|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19526589|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20102464|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102465|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19526590|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19526591|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
19526592|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526593|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526594|NCT02914678|Fentanyl|fentanyl|mesh-list
19526595|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19526596|NCT02914678|Narcotics|narcotics|mesh-ancestor
19526597|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526598|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526599|NCT02914678|Analgesics|analgesics|mesh-ancestor
19526600|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
19526601|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526602|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19526603|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19526604|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
19526605|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
19526606|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19526607|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20102466|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102467|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102468|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102469|NCT00003089|Paclitaxel|paclitaxel|mesh-list
20102470|NCT00003089|Carboplatin|carboplatin|mesh-list
20102471|NCT00003089|Amifostine|amifostine|mesh-list
20306492|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306493|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
19526608|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19526609|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19526610|NCT02914626|Ranibizumab|ranibizumab|mesh-list
19526611|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19526612|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19526613|NCT02914626|Growth Substances|growth substances|mesh-ancestor
19526614|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526615|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
19526616|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526617|NCT02914366|Ambroxol|ambroxol|mesh-list
19526618|NCT02914366|Expectorants|expectorants|mesh-ancestor
19526619|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
19526620|NCT02914158|Tamoxifen|tamoxifen|mesh-list
19526621|NCT02914158|Goserelin|goserelin|mesh-list
19526622|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19526623|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19526624|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
19526625|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526626|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526627|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526628|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526629|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19526630|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19526631|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19526632|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19526633|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526634|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526635|NCT02914015|Morphine|morphine|mesh-list
19526636|NCT02914015|Ropivacaine|ropivacaine|mesh-list
19526637|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
19526638|NCT02914015|Anesthetics|anesthetics|mesh-list
19526639|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19526640|NCT02914015|Narcotics|narcotics|mesh-ancestor
19526641|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526642|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526643|NCT02914015|Analgesics|analgesics|mesh-ancestor
19526644|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
19526645|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526646|NCT02914054|Dexamethasone|dexamethasone|mesh-list
19526647|NCT02914054|Prednisone|prednisone|mesh-list
19526648|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526649|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
19526650|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
19526651|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526652|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526653|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526654|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
19526655|NCT02914054|Hormones|hormones|mesh-ancestor
19526656|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526657|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526658|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526659|NCT02914145|Piperaquine|piperaquine|mesh-list
19526660|NCT02914145|Artenimol|artenimol|mesh-list
19526661|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
19526662|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19526663|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19526664|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526665|NCT02913885|Fluorides|fluorides|mesh-list
19526666|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
19526667|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
19526668|NCT02913885|Protective Agents|protective agents|mesh-ancestor
19526669|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526670|NCT02914028|Acetaminophen|acetaminophen|mesh-list
19526671|NCT02914028|Tramadol|tramadol|mesh-list
20102472|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102473|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526672|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19526673|NCT02914028|Analgesics|analgesics|mesh-ancestor
20603785|NCT02223299|Tryptophan|tryptophan|mesh-list
19526674|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
19526675|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526676|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526677|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
19526678|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19526679|NCT02914028|Narcotics|narcotics|mesh-ancestor
19526680|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526681|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
19526682|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
19526683|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526684|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526685|NCT02913768|Ondansetron|ondansetron|mesh-list
19526686|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
19526687|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
19526688|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526689|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526690|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526691|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
20306494|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306495|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20306496|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306497|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306498|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
20306499|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306500|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306501|NCT00655330|Valsartan|valsartan|mesh-list
20306502|NCT00655330|Probucol|probucol|mesh-list
20306503|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20102474|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102475|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102476|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102477|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102478|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19526692|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
19526693|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19526694|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
19526695|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526696|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526697|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19526698|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19526699|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526700|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19526701|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19526702|NCT02913417|Nivolumab|nivolumab|mesh-list
19526703|NCT02913417|Ipilimumab|ipilimumab|mesh-list
19526704|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19526705|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526706|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19526707|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526708|NCT02913573|Bupivacaine|bupivacaine|mesh-list
19526709|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
19526710|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
19526711|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526712|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102479|NCT00003089|Protective Agents|protective agents|mesh-ancestor
20306504|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20306505|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20306506|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306507|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20306508|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19526713|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
19526714|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573493|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573494|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
19573495|NCT05323565|Hormones|hormones|mesh-ancestor
19573496|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573497|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573498|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102480|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102481|NCT00003090|Aldesleukin|aldesleukin|mesh-list
20306509|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
19573499|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573500|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19526715|NCT02913430|Tamoxifen|tamoxifen|mesh-list
19526716|NCT02913430|Fulvestrant|fulvestrant|mesh-list
19526717|NCT02913430|Palbociclib|palbociclib|mesh-list
19526718|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19526719|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
19526720|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526721|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526722|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526723|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102482|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102483|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20102484|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20102485|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
20102486|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102487|NCT00003091|Interferons|interferons|mesh-list
20102488|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
20102489|NCT00003091|Aldesleukin|aldesleukin|mesh-list
19526724|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20102490|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102491|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
20102492|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102493|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
20102494|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102495|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20102496|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20102497|NCT00003092|Paclitaxel|paclitaxel|mesh-list
20102498|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102499|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102500|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102501|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102502|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102503|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102504|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
20102505|NCT00003093|Carboplatin|carboplatin|mesh-list
19526725|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19526726|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19526727|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19526728|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19526729|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526730|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526731|NCT02913469|Morphine|morphine|mesh-list
19526732|NCT02913469|Metoclopramide|metoclopramide|mesh-list
19526733|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19526734|NCT02913469|Narcotics|narcotics|mesh-ancestor
19526735|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20102506|NCT00003093|Doxorubicin|doxorubicin|mesh-list
20306510|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20306511|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
19526736|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526737|NCT02913469|Analgesics|analgesics|mesh-ancestor
19526738|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
19526739|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526740|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
19526741|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
19526742|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526743|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19526744|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19526745|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
19526746|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526747|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526748|NCT02913508|Vedolizumab|vedolizumab|mesh-list
19526749|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526750|NCT02913300|Lidocaine|lidocaine|mesh-list
19526751|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19526752|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
19526753|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
19526754|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526755|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526756|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
20102507|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19526757|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526758|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19526759|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19526760|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19526761|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526762|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526763|NCT02913690|Vitamin E|vitamin e|mesh-list
19526764|NCT02913690|Vitamins|vitamins|mesh-ancestor
19526765|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
19526766|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526767|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
19526768|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526769|NCT02913690|Protective Agents|protective agents|mesh-ancestor
19526770|NCT02913196|Prednisone|prednisone|mesh-list
19526771|NCT02913196|Docetaxel|docetaxel|mesh-list
19526772|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
19526773|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526774|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
19526775|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
19526776|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
19526777|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526778|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526779|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
19526780|NCT02913196|Hormones|hormones|mesh-ancestor
19526781|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526782|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526783|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526784|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19526785|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526786|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
19526787|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19526788|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
19526789|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
19526790|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19526791|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19526792|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526793|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526794|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526795|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526796|NCT02913118|Amoxicillin|amoxicillin|mesh-list
19526797|NCT02913118|Azithromycin|azithromycin|mesh-list
19526798|NCT02913118|Doxycycline|doxycycline|mesh-list
19526799|NCT02913118|Minocycline|minocycline|mesh-list
19526800|NCT02913118|Cephalosporins|cephalosporins|mesh-list
19526801|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
19526802|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19526803|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526804|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
19526805|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19526806|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19526807|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19526808|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526809|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526810|NCT02913066|Cisplatin|cisplatin|mesh-list
19526811|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526812|NCT02912793|Betadex|betadex|mesh-list
20306512|NCT00655330|Protective Agents|protective agents|mesh-ancestor
20306513|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306514|NCT00655408|Iron|iron|mesh-list
20306515|NCT00655408|Trace Elements|trace elements|mesh-ancestor
20306516|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
20306517|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306518|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
20306519|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
20306520|NCT00655421|Coagulants|coagulants|mesh-ancestor
20306521|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
20306522|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306523|NCT00655512|Clobetasol|clobetasol|mesh-list
20306524|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
19526813|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
19526814|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526815|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
20306525|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20306526|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
20306527|NCT00655512|Hormones|hormones|mesh-ancestor
19526816|NCT02912663|Verapamil|verapamil|mesh-list
19526817|NCT02912663|Analgesics|analgesics|mesh-ancestor
20308889|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526818|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
19526819|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526820|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526821|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
19526822|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526823|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19526824|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
19526825|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19526826|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526827|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526828|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20102508|NCT00003093|Etoposide|etoposide|mesh-list
20102509|NCT00003093|Molgramostim|molgramostim|mesh-list
20102510|NCT00003093|Lenograstim|lenograstim|mesh-list
20102511|NCT00003093|Sargramostim|sargramostim|mesh-list
20102512|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102513|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
20102514|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102515|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526829|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
19526830|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19526831|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
19526832|NCT02912637|Xenon|xenon|mesh-list
19526833|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19526834|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
19526835|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
19526836|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526837|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526838|NCT02912715|Paclitaxel|paclitaxel|mesh-list
19526839|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19526840|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526841|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
19526842|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
19526843|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
19526844|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526845|NCT02912910|Labetalol|labetalol|mesh-list
19526846|NCT02912910|Nifedipine|nifedipine|mesh-list
19526847|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19526848|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19526849|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526850|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19526851|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526852|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
19526853|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
19526854|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19526855|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19526856|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19526857|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
19526858|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19526859|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19526860|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
19526861|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
19526862|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526863|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19526864|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19526865|NCT02912702|Dexamethasone|dexamethasone|mesh-list
19526866|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
19526867|NCT02912702|Doxorubicin|doxorubicin|mesh-list
19526868|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19526869|NCT02912702|Etoposide|etoposide|mesh-list
19526870|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
19526871|NCT02912702|Pegaspargase|pegaspargase|mesh-list
19526872|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526873|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
20102516|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102517|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
20102518|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102519|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102520|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102521|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102522|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102523|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19526874|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
19526875|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102524|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308890|NCT00666107|Vaccines|vaccines|mesh-list
20102525|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20308891|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
19526876|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526877|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526878|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
19526879|NCT02912702|Hormones|hormones|mesh-ancestor
19526880|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526881|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526882|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526883|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19526884|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19526885|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19526886|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526887|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526888|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19526889|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19526890|NCT02912702|Protective Agents|protective agents|mesh-ancestor
19526891|NCT02912572|Avelumab|avelumab|mesh-list
19526892|NCT02912572|Axitinib|axitinib|mesh-list
19526893|NCT02912572|Talazoparib|talazoparib|mesh-list
19526894|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19526895|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526896|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19526897|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526898|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526899|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19526900|NCT02912676|Methotrexate|methotrexate|mesh-list
19526901|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
19526902|NCT02912676|Thioguanine|thioguanine|mesh-list
19526903|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19526904|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
19526905|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19526906|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526907|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19526908|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
19526909|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526910|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526911|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
19526912|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526913|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19526914|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19526915|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
19526916|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526917|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19526918|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
19526919|NCT02912494|Hematinics|hematinics|mesh-ancestor
19526920|NCT02912156|Voriconazole|voriconazole|mesh-list
19526921|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
19526922|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526923|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19526924|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19526925|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526926|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526927|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19526928|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
19526929|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526930|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526931|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19526932|NCT02912169|Anesthetics|anesthetics|mesh-list
19526933|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526934|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526935|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19526936|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526937|NCT02912182|Prednisolone|prednisolone|mesh-list
19526938|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19526939|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
19526940|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19526941|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
19526942|NCT02912182|Betamethasone|betamethasone|mesh-list
19526943|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19526944|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
19526945|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748945|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19526946|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
19526947|NCT02912182|Hormones|hormones|mesh-ancestor
19526948|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19526949|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526950|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19526951|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526952|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
19526953|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
19526954|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526955|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19526956|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19526957|NCT02912182|Protective Agents|protective agents|mesh-ancestor
19526958|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19526959|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
19526960|NCT02912247|Adalimumab|adalimumab|mesh-list
19526961|NCT02912247|Antibodies|antibodies|mesh-list
19526962|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19526963|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
19526964|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526965|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19526966|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19526967|NCT02912234|Clarithromycin|clarithromycin|mesh-list
19526968|NCT02912234|Apixaban|apixaban|mesh-list
19526969|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19526970|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526971|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19526972|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526973|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526974|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19526975|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19526976|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19526977|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
19526978|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19526979|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
19526980|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
19526981|NCT02912026|Olorofim|olorofim|mesh-list
19526982|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
19526983|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526984|NCT02911961|Acetaminophen|acetaminophen|mesh-list
19526985|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19526986|NCT02911961|Analgesics|analgesics|mesh-ancestor
19526987|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
19526988|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19526989|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19526990|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
19573501|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573502|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573503|NCT05323565|Analgesics|analgesics|mesh-ancestor
19573504|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
19573505|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20102526|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102527|NCT00003099|Tamoxifen|tamoxifen|mesh-list
20306528|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306529|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573506|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19573507|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19573508|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
19573509|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573510|NCT05323487|Bumetanide|bumetanide|mesh-list
19573511|NCT05323487|Diuretics|diuretics|mesh-ancestor
19573512|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
19573513|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573514|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19573515|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573516|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573517|NCT05323435|Vaccines|vaccines|mesh-list
19573518|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
19573519|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573520|NCT05323422|Ketamine|ketamine|mesh-list
19573521|NCT05323422|Analgesics|analgesics|mesh-ancestor
19573522|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
19573523|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573524|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573525|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20102528|NCT00003099|Fenretinide|fenretinide|mesh-list
20102529|NCT00003099|Retinamide|retinamide|mesh-list
19526991|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
19526992|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19526993|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19526994|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19526995|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19526996|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19526997|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19526998|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19526999|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
19527000|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19527001|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19527002|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527003|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
19527004|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
19527005|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
19527006|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19527007|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19527008|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527009|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
19527010|NCT02911831|Coagulants|coagulants|mesh-ancestor
19527011|NCT02911662|Cephalexin|cephalexin|mesh-list
19527012|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
20603786|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19527013|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19527014|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527015|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19527016|NCT02911662|Renal Agents|renal agents|mesh-ancestor
19527017|NCT02911701|Acetaminophen|acetaminophen|mesh-list
19527018|NCT02911701|Ibuprofen|ibuprofen|mesh-list
19527019|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19527020|NCT02911701|Analgesics|analgesics|mesh-ancestor
19527021|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
20603787|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
20603788|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19527022|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527023|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527024|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
19527025|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19527026|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527027|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527028|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19527029|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527030|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527031|NCT02911597|Naltrexone|naltrexone|mesh-list
19527032|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19527033|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19527034|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527035|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
19527036|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527037|NCT02911298|Metronidazole|metronidazole|mesh-list
19527038|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527039|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19527040|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19527041|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19527042|NCT02911350|Paclitaxel|paclitaxel|mesh-list
19527043|NCT02911350|Hormones|hormones|mesh-list
19527044|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19527045|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527046|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
19527047|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
19527048|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527049|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527050|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527051|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527052|NCT02911480|Oxytocin|oxytocin|mesh-list
19527053|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
19527054|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19527055|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306530|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20306531|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20306532|NCT00655512|Analgesics|analgesics|mesh-ancestor
19527056|NCT02911272|Oxytocin|oxytocin|mesh-list
19527057|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
19527058|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19527059|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527060|NCT02910778|Ticagrelor|ticagrelor|mesh-list
19527061|NCT02910778|Atorvastatin|atorvastatin|mesh-list
19527062|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19527063|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19527064|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
19527065|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306533|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
20306534|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306535|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306536|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
20306537|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306538|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
19527066|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19527067|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19527068|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527069|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19527070|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19527071|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19527072|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19527073|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
19527074|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527075|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527076|NCT02910882|Gemcitabine|gemcitabine|mesh-list
19527077|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19527078|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
19527079|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527080|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527081|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
19527082|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527083|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527084|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527085|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
19527086|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527087|NCT02910817|Metformin|metformin|mesh-list
19527088|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527089|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527090|NCT02910765|Methylene Blue|methylene blue|mesh-list
19527091|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527092|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527093|NCT02910518|Insulin|insulin|mesh-list
19527094|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19527095|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
19527096|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
19527097|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
19527098|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
19527099|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
19527100|NCT02910518|Heparin|heparin|mesh-list
19527101|NCT02910518|Calcium heparin|calcium heparin|mesh-list
19527102|NCT02910518|Glucagon|glucagon|mesh-list
19527103|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527104|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527105|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
19527106|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19527107|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19527108|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527109|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527110|NCT02910518|Hormones|hormones|mesh-ancestor
19527111|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527112|NCT02910414|Ethanol|ethanol|mesh-list
20306539|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20306540|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306541|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306542|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
20306543|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20306544|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
20306545|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20306546|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20306547|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306548|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306549|NCT00655590|Urological Agents|urological agents|mesh-ancestor
20306550|NCT00655603|Pancrelipase|pancrelipase|mesh-list
20306551|NCT00655603|Hormones|hormones|mesh-list
20306552|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306553|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306554|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527113|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20102530|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20102531|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
20102532|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20102533|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102534|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20306555|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20306556|NCT00655616|Montelukast|montelukast|mesh-list
20306557|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20306558|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
20306559|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102535|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102536|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20102537|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19527114|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102538|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20102539|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20102540|NCT00003099|Protective Agents|protective agents|mesh-ancestor
20102541|NCT00003101|Vincristine|vincristine|mesh-list
20102542|NCT00003101|Busulfan|busulfan|mesh-list
19527115|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527116|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527117|NCT02910596|Bethanechol|bethanechol|mesh-list
19527118|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19527119|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
19527120|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527121|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527122|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19527123|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19527124|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
19527125|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20102543|NCT00003101|Thiotepa|thiotepa|mesh-list
20102544|NCT00003101|Lomustine|lomustine|mesh-list
20102545|NCT00003101|Procarbazine|procarbazine|mesh-list
20102546|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
19527126|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527127|NCT02910570|Liraglutide|liraglutide|mesh-list
19527128|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527129|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527130|NCT02910570|Incretins|incretins|mesh-ancestor
19527131|NCT02910570|Hormones|hormones|mesh-ancestor
19527132|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527133|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
19527134|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
19527135|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527136|NCT02910531|Protective Agents|protective agents|mesh-ancestor
19527137|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527138|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
19527139|NCT02910531|Vitamins|vitamins|mesh-ancestor
19527140|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
19527141|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
19527142|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
19527143|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19527144|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19527145|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527146|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527147|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527148|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527149|NCT02910141|Insulin|insulin|mesh-list
19527150|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19527151|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527152|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102547|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102548|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102549|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102550|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102551|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102552|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102553|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527153|NCT02910115|Oxytocin|oxytocin|mesh-list
19527154|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
19527155|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19527156|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527157|NCT02910206|Sufentanil|sufentanil|mesh-list
19527158|NCT02910206|Propofol|propofol|mesh-list
19527159|NCT02910206|Etomidate|etomidate|mesh-list
19527160|NCT02910206|Cisatracurium|cisatracurium|mesh-list
20102554|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
20102555|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102556|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102557|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102558|NCT00003103|Docetaxel|docetaxel|mesh-list
20102559|NCT00003103|Oblimersen|oblimersen|mesh-list
19527161|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19527162|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527163|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527164|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19527165|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
19527166|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
19527167|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19527168|NCT02910206|Narcotics|narcotics|mesh-ancestor
19527169|NCT02910206|Analgesics|analgesics|mesh-ancestor
19527170|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
19527171|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527172|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19527173|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19527174|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19527175|NCT02909972|Cytarabine|cytarabine|mesh-list
19527176|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19527177|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
19527178|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527179|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527180|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
19527181|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527182|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527183|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
19527184|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573526|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19573527|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
20306560|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306561|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20306562|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
20306563|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20306564|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20306565|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20102560|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102561|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102562|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102563|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102564|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102565|NCT00003105|Gemcitabine|gemcitabine|mesh-list
20102566|NCT00003105|Paclitaxel|paclitaxel|mesh-list
19573528|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
19573529|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573530|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20102567|NCT00003105|Doxorubicin|doxorubicin|mesh-list
20102568|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20306566|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
20306567|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306568|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306569|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19573531|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19573532|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573533|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573534|NCT05323214|Fentanyl|fentanyl|mesh-list
19573535|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
19573536|NCT05323214|Analgesics|analgesics|mesh-list
20603789|NCT02223377|Morphine|morphine|mesh-list
19573537|NCT05323214|Bupivacaine|bupivacaine|mesh-list
20306570|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
19573538|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
20102569|NCT00003105|Ifosfamide|ifosfamide|mesh-list
20603790|NCT02223377|Hydromorphone|hydromorphone|mesh-list
20603791|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20603792|NCT02223377|Narcotics|narcotics|mesh-ancestor
20603793|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603794|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603795|NCT02223377|Analgesics|analgesics|mesh-ancestor
20603796|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
20603797|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603798|NCT02223416|Teriparatide|teriparatide|mesh-list
20603799|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20607932|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
19527185|NCT02910050|Letrozole|letrozole|mesh-list
19527186|NCT02910050|Anastrozole|anastrozole|mesh-list
19527187|NCT02910050|Exemestane|exemestane|mesh-list
19527188|NCT02910050|Bicalutamide|bicalutamide|mesh-list
19527189|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19527190|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527191|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19527192|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527193|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527194|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19527195|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
19527196|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527197|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527198|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527199|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
19527200|NCT02909933|Metformin|metformin|mesh-list
19527201|NCT02909933|Liraglutide|liraglutide|mesh-list
19527202|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527203|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527204|NCT02909933|Incretins|incretins|mesh-ancestor
19527205|NCT02909933|Hormones|hormones|mesh-ancestor
19527206|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527207|NCT02910245|Prednisone|prednisone|mesh-list
19527208|NCT02910245|Mesalamine|mesalamine|mesh-list
19527209|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
19527210|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527211|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
20306571|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306572|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20306573|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20306574|NCT00655655|Everolimus|everolimus|mesh-list
20306575|NCT00655655|Vatalanib|vatalanib|mesh-list
20306576|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102570|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102571|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102572|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102573|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102574|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102575|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102576|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102577|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
20102578|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
20102579|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102580|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102581|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102582|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
20102583|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102584|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102585|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102586|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19527212|NCT02910245|Hormones|hormones|mesh-ancestor
19527213|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527214|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527215|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527216|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527217|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
19527218|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527219|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19527220|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527221|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
19527222|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19527223|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527224|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19527225|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19527226|NCT02910245|Analgesics|analgesics|mesh-ancestor
19527227|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
19527228|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527229|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527230|NCT02909751|Tocotrienols|tocotrienols|mesh-list
19527231|NCT02909751|Vitamin E|vitamin e|mesh-list
19527232|NCT02909751|Tocopherols|tocopherols|mesh-list
19527233|NCT02909751|Docetaxel|docetaxel|mesh-list
19527234|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
19527235|NCT02909751|Trastuzumab|trastuzumab|mesh-list
19527236|NCT02909751|Epirubicin|epirubicin|mesh-list
19527237|NCT02909751|Pertuzumab|pertuzumab|mesh-list
19527238|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527239|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
19527240|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
19527241|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527242|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527243|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527244|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
19527245|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527246|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527247|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19527248|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
19527249|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19527250|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527251|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19527252|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19527253|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19527254|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527255|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
19527256|NCT02909751|Protective Agents|protective agents|mesh-ancestor
19527257|NCT02909751|Vitamins|vitamins|mesh-ancestor
19527258|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
19527259|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
19527260|NCT02909712|Piperaquine|piperaquine|mesh-list
19527261|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
19527262|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19527263|NCT02909712|Artenimol|artenimol|mesh-list
19527264|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
19527265|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19527266|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19527267|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527268|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19527269|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527270|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527271|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19527272|NCT02909712|Renal Agents|renal agents|mesh-ancestor
19527273|NCT02909465|Midazolam|midazolam|mesh-list
19527274|NCT02909465|Ketamine|ketamine|mesh-list
19527275|NCT02909465|Haloperidol|haloperidol|mesh-list
19527276|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
19527277|NCT02909465|Analgesics|analgesics|mesh-ancestor
19527278|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
19527279|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527280|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527281|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19527282|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19527283|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
20102587|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102588|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
20102589|NCT00003107|Interleukin-12|interleukin-12|mesh-list
20102590|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102591|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
19527284|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
20306577|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306578|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
19527285|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527286|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19527287|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19527288|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527289|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527290|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19527291|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19527292|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19527293|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19527294|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19527295|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
19527296|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
19527297|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
19527298|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
19748946|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748947|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
20102592|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102593|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20102594|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20102595|NCT00003107|Growth Substances|growth substances|mesh-ancestor
20102596|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
20102597|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102598|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
19527299|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527300|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19527301|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19527302|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
19527303|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19527304|NCT02909413|Sevoflurane|sevoflurane|mesh-list
19527305|NCT02909413|Desflurane|desflurane|mesh-list
19527306|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19527307|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19527308|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
19527309|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
19527310|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527311|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527312|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
19527313|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
19527314|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527315|NCT02909400|Protective Agents|protective agents|mesh-ancestor
19527316|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527317|NCT02909257|Bupivacaine|bupivacaine|mesh-list
19527318|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
19527319|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
19527320|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527321|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527322|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
19527323|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527324|NCT02909478|Dexamethasone|dexamethasone|mesh-list
19527325|NCT02909478|Aprepitant|aprepitant|mesh-list
19527326|NCT02909478|Tropisetron|tropisetron|mesh-list
19527327|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527328|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
19527329|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
19527330|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527331|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527332|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527333|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
19527334|NCT02909478|Hormones|hormones|mesh-ancestor
19527335|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527336|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527337|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527338|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19527339|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527340|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527341|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19527342|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19527343|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
19527344|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
19527345|NCT02909335|Prednisone|prednisone|mesh-list
19527346|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
19527347|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19527348|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19527349|NCT02909335|Prednisolone|prednisolone|mesh-list
19527350|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
19527351|NCT02909335|Everolimus|everolimus|mesh-list
19527352|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19527353|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
19527354|NCT02909335|Tacrolimus|tacrolimus|mesh-list
19527355|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527356|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
19527357|NCT02909335|Hormones|hormones|mesh-ancestor
19527358|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527359|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527360|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527361|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527362|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527363|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
19527364|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19527365|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527366|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527367|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19527368|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19527369|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
19527370|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19527371|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527372|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
19527373|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
19573539|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
19527374|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527375|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527376|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19527377|NCT02909335|Protective Agents|protective agents|mesh-ancestor
19527378|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
19527379|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527380|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527381|NCT02908945|Ketamine|ketamine|mesh-list
19527382|NCT02908945|Analgesics|analgesics|mesh-ancestor
19527383|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
19527384|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527385|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527386|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19527387|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19527388|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
19527389|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
19527390|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527391|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19527392|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19527393|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527394|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527395|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19527396|NCT05312762|Chitosan|chitosan|mesh-list
19527397|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19527398|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19527399|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
19527400|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527401|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19527402|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
19527403|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
19527404|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
19527405|NCT05312762|Coagulants|coagulants|mesh-ancestor
19527406|NCT05312762|Laxatives|laxatives|mesh-ancestor
19527407|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527408|NCT05312671|Cisplatin|cisplatin|mesh-list
19527409|NCT05312671|Carboplatin|carboplatin|mesh-list
19527410|NCT05312671|Etoposide|etoposide|mesh-list
19527411|NCT05312671|Atezolizumab|atezolizumab|mesh-list
19527412|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
19527413|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527414|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19527415|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19527416|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19527417|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527418|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527419|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
19527420|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
19527421|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
19527422|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
19527423|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527424|NCT05312645|Diclofenac|diclofenac|mesh-list
19527425|NCT05312645|Petrolatum|petrolatum|mesh-list
19527426|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19527427|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19527428|NCT05312645|Analgesics|analgesics|mesh-ancestor
19527429|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
19527430|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527431|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527432|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527433|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527434|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19527435|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527436|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527437|NCT05312645|Emollients|emollients|mesh-ancestor
19527438|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
19527439|NCT05312541|Bupivacaine|bupivacaine|mesh-list
19527440|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
19527441|NCT05312541|Anesthetics|anesthetics|mesh-list
19527442|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306579|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306580|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20306581|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306582|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603800|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102599|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102600|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102601|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
19527443|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527444|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
19527445|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527446|NCT05312398|Irinotecan|irinotecan|mesh-list
19527447|NCT05312398|Cetuximab|cetuximab|mesh-list
19527448|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19527449|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19527450|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527451|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527452|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527453|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527454|NCT05312372|Paclitaxel|paclitaxel|mesh-list
19527455|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19527456|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527457|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
19527458|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
19527459|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527460|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527461|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
19527462|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
19527463|NCT05312346|Hematinics|hematinics|mesh-ancestor
19527464|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
19527465|NCT05312346|Vitamins|vitamins|mesh-ancestor
19527466|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
19527467|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527468|NCT05312294|Vaccines|vaccines|mesh-list
19527469|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
19527470|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527471|NCT05312242|Folic Acid|folic acid|mesh-list
19527472|NCT05312242|Micronutrients|micronutrients|mesh-list
19527473|NCT05312242|Trace Elements|trace elements|mesh-list
19527474|NCT05312242|Hematinics|hematinics|mesh-ancestor
19527475|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
19527476|NCT05312242|Vitamins|vitamins|mesh-ancestor
19527477|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527478|NCT05312216|Durvalumab|durvalumab|mesh-list
19527479|NCT05312216|Lenvatinib|lenvatinib|mesh-list
19527480|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527481|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527482|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19527483|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527484|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527485|NCT05312190|Progesterone|progesterone|mesh-list
19527486|NCT05312190|Progestins|progestins|mesh-ancestor
19527487|NCT05312190|Hormones|hormones|mesh-ancestor
19527488|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527489|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527490|NCT05312112|Venetoclax|venetoclax|mesh-list
19527491|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527492|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
19527493|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19527494|NCT05312008|Oxytocin|oxytocin|mesh-list
19527495|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
20102602|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603801|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20603802|NCT02223533|Morphine|morphine|mesh-list
20603803|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20603804|NCT02223533|Narcotics|narcotics|mesh-ancestor
20603805|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603806|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603807|NCT02223533|Analgesics|analgesics|mesh-ancestor
20102603|NCT00003109|Irinotecan|irinotecan|mesh-list
19527496|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19527497|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573540|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573541|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102604|NCT00003109|Raltitrexed|raltitrexed|mesh-list
19527498|NCT05311852|Palmidrol|palmidrol|mesh-list
19527499|NCT05311852|Antioxidants|antioxidants|mesh-list
19527500|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527501|NCT05311852|Protective Agents|protective agents|mesh-ancestor
19527502|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527503|NCT05311852|Analgesics|analgesics|mesh-ancestor
19527504|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
19527505|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527506|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19527507|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19527508|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527509|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527510|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
19527511|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527512|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19527513|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19527514|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527515|NCT05311852|Hormones|hormones|mesh-ancestor
19527516|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527517|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19527518|NCT05311774|Tramadol|tramadol|mesh-list
19527519|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19527520|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19527521|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19527522|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527523|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527524|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527525|NCT05311774|Analgesics|analgesics|mesh-ancestor
19527526|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
19527527|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527528|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
19527529|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20102605|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20102606|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102607|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102608|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102609|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102610|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102611|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
20102612|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20603808|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
20603809|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527530|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
19527531|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19527532|NCT05311774|Narcotics|narcotics|mesh-ancestor
19527533|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527534|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
19527535|NCT05311722|Ketamine|ketamine|mesh-list
20603810|NCT02223598|Dexamethasone|dexamethasone|mesh-list
20603811|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603812|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
20102613|NCT00003110|Bleomycin|bleomycin|mesh-list
20102614|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102615|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102616|NCT00003111|Paclitaxel|paclitaxel|mesh-list
20102617|NCT00003111|Carboplatin|carboplatin|mesh-list
20102618|NCT00003111|Irinotecan|irinotecan|mesh-list
20102619|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102620|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102621|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
20603813|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
20603814|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603815|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603816|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20603817|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
20603818|NCT02223598|Hormones|hormones|mesh-ancestor
19527536|NCT05311722|Tramadol|tramadol|mesh-list
19527537|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19527538|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20102622|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102623|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527539|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527540|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20102624|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607933|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527541|NCT05311722|Analgesics|analgesics|mesh-ancestor
19527542|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
20306583|NCT00655681|Pamidronate|pamidronate|mesh-list
20306584|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19527543|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527544|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19527545|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19527546|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19527547|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
19527548|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527549|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527550|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19527551|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19527552|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
19527553|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
19527554|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19527555|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19527556|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19527557|NCT05311722|Narcotics|narcotics|mesh-ancestor
19527558|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
19527559|NCT05311540|Astringents|astringents|mesh-ancestor
19527560|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527561|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
19527562|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19527563|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19527564|NCT05311254|Fosfomycin|fosfomycin|mesh-list
19527565|NCT05311254|Calcium|calcium|mesh-list
19527566|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19527567|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527568|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19527569|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527570|NCT05311228|Azithromycin|azithromycin|mesh-list
19527571|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19527572|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527573|NCT05311189|Trastuzumab|trastuzumab|mesh-list
19527574|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527575|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527576|NCT05311085|Nicotine|nicotine|mesh-list
19527577|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19527578|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
19527579|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527580|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527581|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19527582|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19527583|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
19527584|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527585|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102625|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20102626|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102627|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102628|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
20102629|NCT00003113|Lomustine|lomustine|mesh-list
19527586|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
19527587|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19527588|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19527589|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527590|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
19527591|NCT05311033|Coagulants|coagulants|mesh-ancestor
19527592|NCT05310929|Labetalol|labetalol|mesh-list
19527593|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
19527594|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
19527595|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19527596|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19527597|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
19527598|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527599|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527600|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527601|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19527602|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
20102630|NCT00003113|Etoposide|etoposide|mesh-list
20102631|NCT00003113|Procarbazine|procarbazine|mesh-list
20102632|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102633|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
20102634|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102635|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102636|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19527603|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
19527604|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527605|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19527606|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19527607|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
19527608|NCT05310786|Narcotics|narcotics|mesh-ancestor
19527609|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527610|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527611|NCT05310786|Analgesics|analgesics|mesh-ancestor
19527612|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
19527613|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527614|NCT05310591|Nivolumab|nivolumab|mesh-list
19527615|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527616|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527617|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19527618|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527619|NCT05303727|Cyclosporine|cyclosporine|mesh-list
19527620|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
19527621|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
19527622|NCT05303727|Melphalan|melphalan|mesh-list
19527623|NCT05303727|Busulfan|busulfan|mesh-list
19527624|NCT05303727|Thiotepa|thiotepa|mesh-list
19527625|NCT05303727|Methotrexate|methotrexate|mesh-list
19527626|NCT05303727|Fludarabine|fludarabine|mesh-list
19527627|NCT05303727|Topotecan|topotecan|mesh-list
19527628|NCT05303727|Tacrolimus|tacrolimus|mesh-list
19527629|NCT05303727|Cyclosporins|cyclosporins|mesh-list
19527630|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19527631|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527632|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
19527633|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527634|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527635|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19527636|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
19527637|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527638|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527639|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19527640|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19527641|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
19527642|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19527643|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19527644|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
19527645|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
19527646|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527647|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19527648|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19527649|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19527650|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
19527651|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527652|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19527653|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19527654|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
19527655|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19527656|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19527657|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19527658|NCT05299008|Bethanechol|bethanechol|mesh-list
19527659|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20306585|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306586|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
20306587|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
20306588|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
20306589|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306590|NCT00655785|Gemcitabine|gemcitabine|mesh-list
19527660|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
19527661|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527662|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527663|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19527664|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19527665|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
19527666|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527667|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748948|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603819|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527668|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
19527669|NCT05296512|Lenvatinib|lenvatinib|mesh-list
19748949|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20306591|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20306592|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
20306593|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306594|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306595|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
19527670|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527671|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527672|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19527673|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527674|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527675|NCT05296278|Lenvatinib|lenvatinib|mesh-list
19527676|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527677|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19527678|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527679|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527680|NCT05296213|Calcium|calcium|mesh-list
19527681|NCT05296213|Fluorides|fluorides|mesh-list
19527682|NCT05296213|Caseins|caseins|mesh-list
19527683|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19527684|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527685|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
19527686|NCT05296213|Protective Agents|protective agents|mesh-ancestor
19527687|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
19527688|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
19527689|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527690|NCT05289193|Nivolumab|nivolumab|mesh-list
19527691|NCT05289193|Ipilimumab|ipilimumab|mesh-list
19527692|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19527693|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527694|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19527695|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573542|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
19573543|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573544|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19573545|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573546|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19573547|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19573548|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19573549|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
19573550|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573551|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573552|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19573553|NCT05323214|Narcotics|narcotics|mesh-ancestor
19573554|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19573555|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19573556|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
19573557|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
19573558|NCT05323201|Fludarabine|fludarabine|mesh-list
19573559|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19573560|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
19573561|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573562|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573563|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19573564|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
20102637|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
20102638|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102639|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102640|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102641|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102642|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102643|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102644|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102645|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
20102646|NCT00003114|Lomustine|lomustine|mesh-list
20102647|NCT00003114|Etoposide|etoposide|mesh-list
20102648|NCT00003114|Procarbazine|procarbazine|mesh-list
20102649|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102650|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
20102651|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102652|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102653|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102654|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
20102655|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527696|NCT05287568|Venetoclax|venetoclax|mesh-list
19527697|NCT05287568|Cc-486|cc-486|mesh-list
19527698|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527699|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19527700|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
19527701|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527702|NCT05277623|Mannitol|mannitol|mesh-list
20306596|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306597|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102656|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102657|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102658|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102659|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102660|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102661|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102662|NCT00003115|Hydromorphone|hydromorphone|mesh-list
20102663|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20102664|NCT00003115|Narcotics|narcotics|mesh-ancestor
19527703|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19527704|NCT05277623|Diuretics|diuretics|mesh-ancestor
19527705|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
19527706|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527707|NCT05276206|Anesthetics|anesthetics|mesh-list
19527708|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
19527709|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527710|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527711|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
19527712|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527713|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
19527714|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19527715|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527716|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527717|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527718|NCT05264870|Norepinephrine|norepinephrine|mesh-list
19527719|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19527720|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19527721|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
19527722|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527723|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527724|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527725|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
19527726|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
19527727|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527728|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19527729|NCT05262400|Letrozole|letrozole|mesh-list
19527730|NCT05262400|Fulvestrant|fulvestrant|mesh-list
19527731|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527732|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19527733|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19527734|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527735|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102665|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527736|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19527737|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
19527738|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527739|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527740|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527741|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19527742|NCT05260320|Anesthetics|anesthetics|mesh-list
19527743|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527744|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527745|NCT05259631|Propofol|propofol|mesh-list
20102666|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102667|NCT00003115|Analgesics|analgesics|mesh-ancestor
20102668|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
20102669|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102670|NCT00003116|Cyclosporine|cyclosporine|mesh-list
20102671|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
20102672|NCT00003116|Busulfan|busulfan|mesh-list
20306598|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306599|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
19527746|NCT05259631|Sevoflurane|sevoflurane|mesh-list
19527747|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19527748|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20102673|NCT00003116|Cyclosporins|cyclosporins|mesh-list
20306600|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527749|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527750|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19527751|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
19527752|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
19527753|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19527754|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19527755|NCT05247268|Letrozole|letrozole|mesh-list
19527756|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19527757|NCT05247268|Megestrol|megestrol|mesh-list
19527758|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
19527759|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
19527760|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527761|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19527762|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19527763|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527764|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527765|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19527766|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
19527767|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20102674|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102675|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
19527768|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527769|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19527770|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19527771|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19527772|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
19527773|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20102676|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102677|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102678|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102679|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
20102680|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102681|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102682|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102683|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102684|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
20102685|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102686|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
19527774|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19527775|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19527776|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19527777|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527778|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
19527779|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19527780|NCT05246293|Tofacitinib|tofacitinib|mesh-list
19527781|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19527782|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527783|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748950|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19748951|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19748952|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19748953|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19748954|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19748955|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
19748956|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
19748957|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
19748958|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19748959|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748960|NCT05341609|Ritonavir|ritonavir|mesh-list
19748961|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19748962|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20102687|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20102688|NCT00003117|Paclitaxel|paclitaxel|mesh-list
20102689|NCT00003117|Carboplatin|carboplatin|mesh-list
20102690|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748963|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
20102691|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527799|NCT05214976|Paclitaxel|paclitaxel|mesh-list
19527800|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19527801|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527802|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
19527803|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
19527804|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527805|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527806|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
19527807|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19527808|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527809|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527810|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527812|NCT05189717|Everolimus|everolimus|mesh-list
19527813|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527814|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527815|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
19527816|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527817|NCT05184842|Decitabine|decitabine|mesh-list
19527818|NCT05184842|Venetoclax|venetoclax|mesh-list
19527819|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20603820|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20603821|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603822|NCT02223611|Cisplatin|cisplatin|mesh-list
20603823|NCT02223611|Vinorelbine|vinorelbine|mesh-list
20603824|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527820|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
19527821|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527822|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527823|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527824|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19527825|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
19527826|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527827|NCT05174065|Apremilast|apremilast|mesh-list
19527828|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19527829|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19527830|NCT05174065|Analgesics|analgesics|mesh-ancestor
19527831|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
19527832|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527833|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527834|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527835|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19527836|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19527837|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19527838|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527839|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527840|NCT05171387|Androgens|androgens|mesh-list
19527841|NCT05171387|Hormones|hormones|mesh-ancestor
19527842|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527843|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527844|NCT05168813|Vaccines|vaccines|mesh-list
19527845|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
19527846|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527847|NCT05158998|Propofol|propofol|mesh-list
19527848|NCT05158998|Sevoflurane|sevoflurane|mesh-list
19527849|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19527850|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527851|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527852|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19527853|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
19527854|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
19527855|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19527856|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19527857|NCT05148195|Leucovorin|leucovorin|mesh-list
19527858|NCT05148195|Docetaxel|docetaxel|mesh-list
20102692|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102693|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102694|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102695|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102696|NCT00003118|Fluorouracil|fluorouracil|mesh-list
20102697|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102698|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
20102699|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102700|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20603825|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20603826|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
20603827|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
20603828|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527859|NCT05148195|Irinotecan|irinotecan|mesh-list
19527860|NCT05148195|Calcium|calcium|mesh-list
19527861|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
20603829|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102701|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19527862|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527863|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
19527864|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
19527865|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
19527866|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527867|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19527868|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527869|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19527870|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19527871|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527872|NCT05148195|Antidotes|antidotes|mesh-ancestor
19527873|NCT05148195|Protective Agents|protective agents|mesh-ancestor
19527874|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
19527875|NCT05148195|Vitamins|vitamins|mesh-ancestor
19527876|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
19527877|NCT05139420|Topiramate|topiramate|mesh-list
19527878|NCT05139420|Phentermine|phentermine|mesh-list
19527879|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
19527880|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527881|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527882|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19527883|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
19527884|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19527885|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
19527886|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
19527887|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527888|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
19527889|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527890|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573565|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573566|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573567|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19573568|NCT05323175|Ropivacaine|ropivacaine|mesh-list
19573569|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
19573570|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
19573571|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573572|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573573|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
20102702|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
20306601|NCT00655798|Antioxidants|antioxidants|mesh-list
19573574|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573575|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
19573576|NCT05322889|Telmisartan|telmisartan|mesh-list
19573577|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19573578|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19573579|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19573580|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578003|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578004|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578005|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578006|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
19578007|NCT03624036|Fludarabine|fludarabine|mesh-list
19578008|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578009|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
19578010|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578011|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578012|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578013|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
19578014|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578015|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578016|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19578017|NCT03606967|Gemcitabine|gemcitabine|mesh-list
19578018|NCT03606967|Poly I-C|poly i-c|mesh-list
19578019|NCT03606967|Paclitaxel|paclitaxel|mesh-list
19578020|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19578021|NCT03606967|Carboplatin|carboplatin|mesh-list
19578022|NCT03606967|Durvalumab|durvalumab|mesh-list
19578023|NCT03606967|Tremelimumab|tremelimumab|mesh-list
19578024|NCT03606967|Ipilimumab|ipilimumab|mesh-list
19578025|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19578026|NCT03606967|Vaccines|vaccines|mesh-list
19578027|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
19578028|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578029|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
19578030|NCT03606967|Poly ICLC|poly iclc|mesh-list
19578031|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
19578032|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527891|NCT05124067|Dexamethasone|dexamethasone|mesh-list
19527892|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
19527893|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
19527894|NCT05124067|Ondansetron|ondansetron|mesh-list
19527895|NCT05124067|BB 1101|bb 1101|mesh-list
19527896|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20102703|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102704|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
20102705|NCT00003119|Carboplatin|carboplatin|mesh-list
20102706|NCT00003119|Doxorubicin|doxorubicin|mesh-list
20102707|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19527897|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
19527898|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
19527899|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527900|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527901|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527902|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
19527903|NCT05124067|Hormones|hormones|mesh-ancestor
19527904|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527905|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527906|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527907|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
19527908|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527909|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527910|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19527911|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527912|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19527913|NCT05124067|Analgesics|analgesics|mesh-ancestor
20102708|NCT00003119|Etoposide|etoposide|mesh-list
20102709|NCT00003119|Sargramostim|sargramostim|mesh-list
20102710|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102711|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
20102712|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102713|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102714|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102715|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
20102716|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102717|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102718|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102719|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102720|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102721|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102722|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19527914|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
19527915|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19527916|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19527917|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19527918|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
19527919|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527920|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
19527921|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
19527922|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19527923|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
19527924|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19527925|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19527926|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19527927|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19527928|NCT05123040|Prednisone|prednisone|mesh-list
19527929|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
19527930|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527931|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
20102723|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102724|NCT00003120|Paclitaxel|paclitaxel|mesh-list
20102725|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102726|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102727|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102728|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102729|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102730|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102731|NCT00003123|Amifostine|amifostine|mesh-list
20102732|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102733|NCT00003123|Protective Agents|protective agents|mesh-ancestor
20102734|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527932|NCT05123040|Hormones|hormones|mesh-ancestor
20102735|NCT00003124|Leuprolide|leuprolide|mesh-list
19527933|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527934|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527935|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527936|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527937|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
19527938|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
19527939|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527940|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527941|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19527942|NCT05123040|Protective Agents|protective agents|mesh-ancestor
19527943|NCT05117736|Valsartan|valsartan|mesh-list
19527944|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19527945|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19527946|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19527947|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527948|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19527949|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19527950|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19527951|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527952|NCT05105061|Ketamine|ketamine|mesh-list
19527953|NCT05105061|Analgesics|analgesics|mesh-ancestor
19527954|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
19527955|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527956|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527957|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19527958|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19527959|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
19527960|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
19527961|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19527962|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19527963|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19527964|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527965|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527966|NCT05098470|Metformin|metformin|mesh-list
19527967|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
19527968|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19527969|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527970|NCT05095961|Prednisone|prednisone|mesh-list
19527971|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19527972|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
19527973|NCT05095961|Hormones|hormones|mesh-ancestor
19527974|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527975|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527976|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19527977|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19527978|NCT05056584|Glucagon|glucagon|mesh-list
19527979|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19527980|NCT05056584|Hormones|hormones|mesh-ancestor
19527981|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19527982|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527983|NCT05054881|Iodine|iodine|mesh-list
19527984|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19527985|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19527986|NCT05054881|Trace Elements|trace elements|mesh-ancestor
19527987|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
19527988|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527989|NCT05046535|Nicotine|nicotine|mesh-list
19527990|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20102736|NCT00003124|Flutamide|flutamide|mesh-list
19527991|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
19527992|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19527993|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19527994|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19527995|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19527996|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
19527997|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19527998|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19527999|NCT05011214|Ketamine|ketamine|mesh-list
19528000|NCT05011214|Sevoflurane|sevoflurane|mesh-list
19528001|NCT05011214|Esketamine|esketamine|mesh-list
19528002|NCT05011214|Analgesics|analgesics|mesh-ancestor
19528003|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
19528004|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528005|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528006|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19528007|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20603830|NCT02223819|Crizotinib|crizotinib|mesh-list
19528008|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
19528009|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
19528010|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528011|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19528012|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19528013|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528014|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528015|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19528016|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19528017|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
19528018|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19528019|NCT04980040|Alogliptin|alogliptin|mesh-list
19528020|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19528021|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528022|NCT04980040|Incretins|incretins|mesh-ancestor
19528023|NCT04980040|Hormones|hormones|mesh-ancestor
19528024|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528025|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19528026|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
19528027|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528028|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528029|NCT04965155|Dexamethasone|dexamethasone|mesh-list
19528030|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528031|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
19528032|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
19528033|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528034|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528035|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528036|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
19528037|NCT04965155|Hormones|hormones|mesh-ancestor
19528038|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528039|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19528040|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528041|NCT04951206|Clobetasol|clobetasol|mesh-list
19528042|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528043|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
19528044|NCT04951206|Hormones|hormones|mesh-ancestor
19528045|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528046|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528047|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19528048|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528049|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
19528050|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19528051|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102737|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20306602|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306603|NCT00655798|Protective Agents|protective agents|mesh-ancestor
20306604|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306605|NCT00655824|Ofatumumab|ofatumumab|mesh-list
20306606|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528052|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
20102738|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
20102739|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20102740|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102741|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20102742|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102743|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
20102744|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
19528053|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528054|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528055|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19528056|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
19528057|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528058|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528059|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19528060|NCT04932083|Fentanyl|fentanyl|mesh-list
19528061|NCT04932083|Midazolam|midazolam|mesh-list
19528062|NCT04932083|Nalbuphine|nalbuphine|mesh-list
19528063|NCT04932083|Bupivacaine|bupivacaine|mesh-list
19528064|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
19528065|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
20102745|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528066|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528067|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528068|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
19528069|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528070|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19528071|NCT04932083|Narcotics|narcotics|mesh-ancestor
20102746|NCT00003125|Aldesleukin|aldesleukin|mesh-list
20102747|NCT00003125|Vaccines|vaccines|mesh-list
20102748|NCT00003125|Sargramostim|sargramostim|mesh-list
20102749|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
20102750|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102751|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102752|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20102753|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20102754|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
20102755|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528072|NCT04932083|Analgesics|analgesics|mesh-ancestor
19528073|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19528074|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19528075|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
20102756|NCT00003126|Aldesleukin|aldesleukin|mesh-list
20102757|NCT00003126|Interleukin-2|interleukin-2|mesh-list
20102758|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102759|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20102760|NCT00003126|Analgesics|analgesics|mesh-ancestor
20102761|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
20102762|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102763|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102764|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20102765|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20102766|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
20102767|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102768|NCT00003127|Paclitaxel|paclitaxel|mesh-list
20102769|NCT00003127|Carboplatin|carboplatin|mesh-list
20102770|NCT00003127|Amifostine|amifostine|mesh-list
19528076|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19528077|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19528078|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19528079|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19528080|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
19528081|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
19528082|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528083|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528084|NCT04925960|Epalrestat|epalrestat|mesh-list
19528085|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528086|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528087|NCT04910425|Fluorides|fluorides|mesh-list
19528088|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
19528089|NCT04910425|Protective Agents|protective agents|mesh-ancestor
19528090|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573581|NCT05322720|Paclitaxel|paclitaxel|mesh-list
19573582|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19573583|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19573584|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573585|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
19573586|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
19573587|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
19573588|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573589|NCT05322681|Pregabalin|pregabalin|mesh-list
19573590|NCT05322681|Analgesics|analgesics|mesh-ancestor
19573591|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
19573592|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573593|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573594|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
19573595|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19573596|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573597|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573598|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19573599|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19573600|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19573601|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573602|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573603|NCT05322603|Diclofenac|diclofenac|mesh-list
19573604|NCT05322603|Morphine|morphine|mesh-list
19573605|NCT05322603|Analgesics|analgesics|mesh-list
19573606|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19573607|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20102771|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102772|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102773|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102774|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528091|NCT04907253|Quercetin|quercetin|mesh-list
19528092|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
19528093|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528094|NCT04907253|Protective Agents|protective agents|mesh-ancestor
19528095|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528096|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19528097|NCT04890873|Antacids|antacids|mesh-ancestor
19528098|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528099|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528100|NCT04885972|Triamcinolone|triamcinolone|mesh-list
19528101|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19528102|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19528103|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19528104|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528105|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
19528106|NCT04885972|Hormones|hormones|mesh-ancestor
19528107|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528108|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528109|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528110|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
19528111|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528112|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528113|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
19528114|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19528115|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19528116|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528117|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
19528118|NCT04863339|Coagulants|coagulants|mesh-ancestor
19528119|NCT04862780|Osimertinib|osimertinib|mesh-list
19528120|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528121|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19528122|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528123|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528124|NCT04862143|Fulvestrant|fulvestrant|mesh-list
19528125|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19528126|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528127|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19528128|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19528129|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
19528130|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528131|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528132|NCT04858490|Diazepam|diazepam|mesh-list
19528133|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19528134|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
20102775|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102776|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102777|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102778|NCT00003127|Protective Agents|protective agents|mesh-ancestor
20102779|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102780|NCT00003128|Paclitaxel|paclitaxel|mesh-list
20102781|NCT00003128|Ifosfamide|ifosfamide|mesh-list
20102782|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102783|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102784|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102785|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102786|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102787|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102788|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102789|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
20102790|NCT00003129|Valrubicin|valrubicin|mesh-list
20102791|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102792|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102793|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102794|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306607|NCT00655837|Gemcitabine|gemcitabine|mesh-list
19528135|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
19528136|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
19528137|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528138|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528139|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528140|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19528141|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528142|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19528143|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19528144|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19528145|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19528146|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19528147|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19528148|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
19528149|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
19528150|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
19528151|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
19528152|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528153|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528154|NCT04858425|Niclosamide|niclosamide|mesh-list
19528155|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
19528156|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19528157|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
19528158|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19528159|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528160|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
19528161|NCT04844957|Vitamin D|vitamin d|mesh-list
19528162|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
19528163|NCT04844957|Vitamins|vitamins|mesh-list
19528164|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
19528165|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528166|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19528167|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19528168|NCT04823845|Adapalene|adapalene|mesh-list
19528169|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19528170|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528171|NCT04823845|Analgesics|analgesics|mesh-ancestor
19528172|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
19528173|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528174|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528175|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528176|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528177|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
19528178|NCT04819399|Catumaxomab|catumaxomab|mesh-list
19528179|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528180|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
19528181|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19528182|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
19528183|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528184|NCT04790045|Venetoclax|venetoclax|mesh-list
20102795|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102796|NCT00003130|Paclitaxel|paclitaxel|mesh-list
20102797|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102798|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102799|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
20102800|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102801|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102802|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102803|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
19528185|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528186|NCT04772274|Ustekinumab|ustekinumab|mesh-list
19528187|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
19528188|NCT04759833|Prucalopride|prucalopride|mesh-list
19528189|NCT04759833|Laxatives|laxatives|mesh-ancestor
19528190|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528191|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19528192|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19528193|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
19528194|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528195|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528196|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528197|NCT04758975|Rituximab|rituximab|mesh-list
19748964|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306608|NCT00655837|Rituximab|rituximab|mesh-list
19528198|NCT04758975|Venetoclax|venetoclax|mesh-list
19528199|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528200|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528201|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
19528202|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528203|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528204|NCT04729595|Tempol|tempol|mesh-list
19528205|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
19528206|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528207|NCT04729595|Protective Agents|protective agents|mesh-ancestor
19528208|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528209|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19528210|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528211|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19528212|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19528220|NCT04685577|Nefopam|nefopam|mesh-list
19528221|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528222|NCT04685577|Analgesics|analgesics|mesh-ancestor
19528223|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
19528224|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528225|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528226|NCT04677972|Ebselen|ebselen|mesh-list
19528227|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20102804|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20102805|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102806|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
20102807|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102808|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102809|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
20102810|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102811|NCT00003133|Gemcitabine|gemcitabine|mesh-list
20102812|NCT00003133|Paclitaxel|paclitaxel|mesh-list
20102813|NCT00003133|Doxorubicin|doxorubicin|mesh-list
20102814|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20102815|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102816|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102817|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528228|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528229|NCT04677972|Analgesics|analgesics|mesh-ancestor
19528230|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
19528231|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528232|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528233|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528234|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528235|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19528236|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528237|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
19528238|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528239|NCT04677972|Protective Agents|protective agents|mesh-ancestor
19528240|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19528241|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528242|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19528243|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
19528244|NCT04669210|Tacrolimus|tacrolimus|mesh-list
19528245|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528246|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
19528247|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528248|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19748965|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748966|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19748967|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19748968|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
19748969|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19748970|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19748971|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19748972|NCT05329766|Leucovorin|leucovorin|mesh-list
19748973|NCT05329766|Fluorouracil|fluorouracil|mesh-list
20102818|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528249|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102819|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102820|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748974|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
19748975|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
19528250|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528251|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19528252|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528253|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19528254|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
19528255|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528256|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528257|NCT04660760|Trifluridine|trifluridine|mesh-list
19528258|NCT04660760|Paclitaxel|paclitaxel|mesh-list
19528259|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19528260|NCT04660760|Ramucirumab|ramucirumab|mesh-list
19528261|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19528262|NCT04660760|Antibodies|antibodies|mesh-list
19528263|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
20102821|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102822|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
20102823|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
20102824|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102825|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102826|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102827|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
20102828|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102829|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102830|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102831|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102832|NCT00003134|Irinotecan|irinotecan|mesh-list
20102833|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20102834|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19528264|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19528265|NCT04660760|Lexatumumab|lexatumumab|mesh-list
19528266|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19528267|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528268|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528269|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528270|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
19528271|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528272|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
19528273|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528274|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
19528275|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
19528276|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528277|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
19528278|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528279|NCT04656951|Daratumumab|daratumumab|mesh-list
19528280|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528281|NCT04640779|Salicylates|salicylates|mesh-list
19528282|NCT04640779|Choline|choline|mesh-list
19528283|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
19528284|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19528285|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
19528286|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528287|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528288|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19528289|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
19528290|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20306609|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
20306610|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20306611|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306612|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
20306613|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306614|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306615|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20306616|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
20306617|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306618|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
19528291|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528292|NCT04640779|Analgesics|analgesics|mesh-ancestor
19528293|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
19528294|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528295|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528296|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748976|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102835|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528297|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528298|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19528299|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528300|NCT04630964|Niacin|niacin|mesh-list
20603831|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603832|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20603833|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603834|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603835|NCT02223832|Ponesimod|ponesimod|mesh-list
20603836|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20603837|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306619|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306620|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306621|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306622|NCT00655915|Betamethasone|betamethasone|mesh-list
19528301|NCT04630964|Psilocybin|psilocybin|mesh-list
19528302|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19528303|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
19528304|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528305|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19528306|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
19528307|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
19528308|NCT04630964|Vitamins|vitamins|mesh-ancestor
19528309|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
19528310|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528311|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
19528312|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573608|NCT05322603|Narcotics|narcotics|mesh-ancestor
19573609|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573610|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573611|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
19573612|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573613|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19573614|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573615|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573616|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19573617|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573618|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573619|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
19573620|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19573621|NCT05322564|Narcotics|narcotics|mesh-ancestor
19573622|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20102836|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306623|NCT00655915|Lidocaine|lidocaine|mesh-list
20306624|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
20603838|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20603839|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
20603840|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573623|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573624|NCT05322564|Analgesics|analgesics|mesh-ancestor
19573625|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
19573626|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102837|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102838|NCT00003135|Doxorubicin|doxorubicin|mesh-list
20102839|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20102840|NCT00003135|Fluorouracil|fluorouracil|mesh-list
20102841|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20102842|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102843|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102844|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102845|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102846|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102847|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
20102848|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20306625|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
19528313|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
19528314|NCT04613596|Adagrasib|adagrasib|mesh-list
19528315|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528316|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528317|NCT04609020|Lidocaine|lidocaine|mesh-list
19528318|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
19528319|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
19528320|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528321|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528322|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
19528323|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528324|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19528325|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19528326|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19528327|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19528328|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528329|NCT04607252|Metformin|metformin|mesh-list
19528330|NCT04607252|Megestrol|megestrol|mesh-list
19528331|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
19528332|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19528333|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528334|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19528335|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19528336|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19528337|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
19528338|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19528339|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19528340|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19528341|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19528342|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528343|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
19528344|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19528345|NCT04573556|Lemborexant|lemborexant|mesh-list
19528346|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19528347|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528348|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102849|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102850|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
20102851|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102852|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
20102853|NCT00003136|Carboplatin|carboplatin|mesh-list
20102854|NCT00003136|Amifostine|amifostine|mesh-list
20102855|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102856|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
20102857|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102858|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102859|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102860|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
20102861|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102862|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102863|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102864|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102865|NCT00003136|Protective Agents|protective agents|mesh-ancestor
20120440|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120441|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20120442|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120443|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120444|NCT00006362|Bortezomib|bortezomib|mesh-list
20120445|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120446|NCT00006363|Cytarabine|cytarabine|mesh-list
20120447|NCT00006363|Aldesleukin|aldesleukin|mesh-list
20120448|NCT00006363|Etoposide|etoposide|mesh-list
20120449|NCT00006363|Daunorubicin|daunorubicin|mesh-list
20120450|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
20120451|NCT00006363|Busulfan|busulfan|mesh-list
20120452|NCT00006363|Interleukin-2|interleukin-2|mesh-list
20120453|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120454|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120455|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120456|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120457|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528349|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20120458|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120459|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19528350|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19528351|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528352|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528353|NCT04567160|Propofol|propofol|mesh-list
19528354|NCT04567160|Sevoflurane|sevoflurane|mesh-list
19528355|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19528356|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528357|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528358|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19528359|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
19528360|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
19528361|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19528362|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19528363|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19528364|NCT04566250|Analgesics|analgesics|mesh-ancestor
19528365|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
19528366|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528367|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528368|NCT04556084|Blinatumomab|blinatumomab|mesh-list
19528369|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528370|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
19528371|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528372|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
19528373|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528374|NCT04545866|Budesonide|budesonide|mesh-list
19528375|NCT04545866|Poractant alfa|poractant alfa|mesh-list
19528376|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19528377|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528378|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19528379|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
19528380|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528381|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528382|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19528383|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
19528384|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
19528385|NCT04545866|Hormones|hormones|mesh-ancestor
19528386|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528387|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
19528388|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528389|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
19528390|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528391|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
19528392|NCT04541355|Cisplatin|cisplatin|mesh-list
19528393|NCT04541355|Antidotes|antidotes|mesh-list
19528394|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528395|NCT04541355|Protective Agents|protective agents|mesh-ancestor
19528396|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528397|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
19528398|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528399|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
19528400|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528401|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528402|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
19528403|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
19528404|NCT04531059|Metronidazole|metronidazole|mesh-list
19528405|NCT04531059|Minocycline|minocycline|mesh-list
19528406|NCT04531059|Tetracycline|tetracycline|mesh-list
19528407|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
19528408|NCT04531059|Esomeprazole|esomeprazole|mesh-list
19528409|NCT04531059|Bismuth|bismuth|mesh-list
19528410|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528411|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528412|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528413|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19528414|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19528415|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20102866|NCT00003137|Irinotecan|irinotecan|mesh-list
20102867|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20102868|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102869|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102870|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603841|NCT02223884|Carboplatin|carboplatin|mesh-list
19528416|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528417|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19528418|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528419|NCT04531059|Antacids|antacids|mesh-ancestor
20102871|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528420|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19528421|NCT04531059|Diuretics|diuretics|mesh-ancestor
19528422|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
19528423|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102872|NCT00003139|Pilocarpine|pilocarpine|mesh-list
20102873|NCT00003139|Miotics|miotics|mesh-ancestor
20102874|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
20102875|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102876|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102877|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20102878|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20102879|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
20102880|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20102881|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102882|NCT00003140|Letrozole|letrozole|mesh-list
20102883|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102884|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20102885|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20102886|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102887|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102888|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20306626|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306627|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306628|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
19528424|NCT04531059|Expectorants|expectorants|mesh-ancestor
19528425|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
20306629|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20102889|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
19528426|NCT04515576|Dulaglutide|dulaglutide|mesh-list
19528427|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19528428|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528429|NCT04460560|Terlipressin|terlipressin|mesh-list
19528430|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19528431|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19528432|NCT04414475|Dexamethasone|dexamethasone|mesh-list
19528433|NCT04414475|Bortezomib|bortezomib|mesh-list
19528434|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528435|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
19528436|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
19528437|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528438|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528439|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528440|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
19528441|NCT04414475|Hormones|hormones|mesh-ancestor
19528442|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528443|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20102890|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20102891|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102892|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
20102893|NCT00003141|Thiotepa|thiotepa|mesh-list
20102894|NCT00003141|Cisplatin|cisplatin|mesh-list
19528444|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528445|NCT04401995|Nivolumab|nivolumab|mesh-list
19528446|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528447|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528448|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19528449|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528450|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
19528451|NCT04390698|Anesthetics|anesthetics|mesh-list
19528452|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528453|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528454|NCT04390698|Narcotics|narcotics|mesh-ancestor
19528455|NCT04390698|Analgesics|analgesics|mesh-ancestor
19528456|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
19528457|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528458|NCT04366713|Capecitabine|capecitabine|mesh-list
19528459|NCT04366713|Loperamide|loperamide|mesh-list
19528460|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
19528461|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19528462|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
19528463|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102895|NCT00003141|Carboplatin|carboplatin|mesh-list
20102896|NCT00003141|Etoposide|etoposide|mesh-list
20102897|NCT00003141|Vincristine|vincristine|mesh-list
19528464|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528465|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20102898|NCT00003141|Lenograstim|lenograstim|mesh-list
19528466|NCT04356326|Aspirin|aspirin|mesh-list
19528467|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19528468|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528469|NCT04356326|Analgesics|analgesics|mesh-ancestor
19528470|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
19528471|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528472|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528473|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528474|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528475|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19528476|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19528477|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528478|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19528479|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19528480|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528481|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
19528482|NCT04322123|Azithromycin|azithromycin|mesh-list
19528483|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
19528484|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528485|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528486|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
19528487|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19528488|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19528489|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528490|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102899|NCT00003141|Sargramostim|sargramostim|mesh-list
20102900|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102901|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
20102902|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102903|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102904|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102905|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
20102906|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102907|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102908|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102909|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20102910|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20102911|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20102912|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102913|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102914|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528491|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528492|NCT04299880|Leucovorin|leucovorin|mesh-list
19528493|NCT04299880|Gemcitabine|gemcitabine|mesh-list
19528494|NCT04299880|Paclitaxel|paclitaxel|mesh-list
19528495|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19528496|NCT04299880|Bevacizumab|bevacizumab|mesh-list
19528497|NCT04299880|Fluorouracil|fluorouracil|mesh-list
20102915|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
20102916|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
20102917|NCT00003143|Amifostine|amifostine|mesh-list
19528498|NCT04299880|Nivolumab|nivolumab|mesh-list
19528499|NCT04299880|Irinotecan|irinotecan|mesh-list
19528500|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19528501|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528502|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528503|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528504|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
19528505|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528506|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528507|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19528508|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20102918|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102919|NCT00003143|Protective Agents|protective agents|mesh-ancestor
20102920|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528509|NCT04299880|Growth Substances|growth substances|mesh-ancestor
19528510|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528511|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
19528512|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19528513|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
19528514|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
19528515|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603842|NCT02223884|Docetaxel|docetaxel|mesh-list
19528516|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528517|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102921|NCT00003144|Gemcitabine|gemcitabine|mesh-list
20102922|NCT00003144|Amifostine|amifostine|mesh-list
19528518|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
19528519|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19528520|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19528521|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19528522|NCT04299880|Antidotes|antidotes|mesh-ancestor
19528523|NCT04299880|Protective Agents|protective agents|mesh-ancestor
19528524|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
19528525|NCT04299880|Vitamins|vitamins|mesh-ancestor
19528526|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
19528527|NCT04273139|Venetoclax|venetoclax|mesh-list
19528528|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528529|NCT04268706|Fludarabine|fludarabine|mesh-list
19528530|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19528531|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528532|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528533|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19528534|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
19528535|NCT04265053|Ketorolac|ketorolac|mesh-list
19528536|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19528537|NCT04265053|Estradiol|estradiol|mesh-list
20102923|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102924|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102925|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
20102926|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102927|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
20102928|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102929|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102930|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102931|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
20102932|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102933|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20102934|NCT00003144|Protective Agents|protective agents|mesh-ancestor
20102935|NCT00003145|Cyclosporine|cyclosporine|mesh-list
20102936|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
20306630|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20306631|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20306632|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20306633|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306634|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306635|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528538|NCT04265053|Testosterone|testosterone|mesh-list
19528539|NCT04265053|Ganirelix|ganirelix|mesh-list
19528540|NCT04265053|Estrogens|estrogens|mesh-ancestor
19528541|NCT04265053|Hormones|hormones|mesh-ancestor
19528542|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528543|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528544|NCT04265053|Androgens|androgens|mesh-ancestor
19528545|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19528546|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528547|NCT04265053|Analgesics|analgesics|mesh-ancestor
19528548|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
19528549|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528550|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528551|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528552|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19528553|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528554|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528555|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
19573627|NCT05322538|Vitamin D|vitamin d|mesh-list
19573628|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
20603843|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603844|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
20603845|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
20603846|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
20603847|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603848|NCT02223949|Alprostadil|alprostadil|mesh-list
20603849|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20603850|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
20603851|NCT02223949|Urological Agents|urological agents|mesh-ancestor
19573629|NCT05322538|Vitamins|vitamins|mesh-list
20306636|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
19573630|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19573631|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
19573632|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102937|NCT00003145|Fludarabine|fludarabine|mesh-list
20102938|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
20102939|NCT00003145|Cyclosporins|cyclosporins|mesh-list
19528556|NCT04259138|Vedolizumab|vedolizumab|mesh-list
19528557|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528558|NCT04256707|Docetaxel|docetaxel|mesh-list
19528559|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
19528560|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528561|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528562|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528563|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
19528564|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528565|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528566|NCT04244630|Antioxidants|antioxidants|mesh-list
19528567|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528568|NCT04244630|Protective Agents|protective agents|mesh-ancestor
19528569|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528570|NCT04243616|Paclitaxel|paclitaxel|mesh-list
19528571|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
19528572|NCT04243616|Carboplatin|carboplatin|mesh-list
19528573|NCT04243616|Doxorubicin|doxorubicin|mesh-list
19528574|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19528575|NCT04243616|Cemiplimab|cemiplimab|mesh-list
19528576|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19528577|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528578|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528579|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528580|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19528581|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528582|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528583|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
19528584|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528585|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528586|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19528587|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
19528588|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19528589|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19528590|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19528591|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19528592|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528593|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528594|NCT04239053|Bupivacaine|bupivacaine|mesh-list
19528595|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
19528596|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
19528597|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528598|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528599|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
19528600|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306637|NCT00655915|Hormones|hormones|mesh-ancestor
20306638|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528601|NCT04237623|Sargramostim|sargramostim|mesh-list
19528602|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
19528603|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528604|NCT04235036|Rituximab|rituximab|mesh-list
19528605|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528606|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528607|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
19528608|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528609|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306639|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20306640|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
20102940|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102941|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102942|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
20102943|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102944|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102945|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
20102946|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102947|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102948|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
20102949|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102950|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
20102951|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102952|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19528610|NCT04226950|Interferons|interferons|mesh-list
19528611|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
19528612|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
19528613|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20102953|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19528614|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528615|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
19528616|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528617|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
20102954|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20306641|NCT00655967|Acamprosate|acamprosate|mesh-list
19528618|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528619|NCT04172532|Peposertib|peposertib|mesh-list
19528620|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19528621|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528622|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528623|NCT04167670|Amoxicillin|amoxicillin|mesh-list
19528624|NCT04167670|Clarithromycin|clarithromycin|mesh-list
19528625|NCT04167670|Lansoprazole|lansoprazole|mesh-list
19528626|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
19528627|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528628|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528629|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19528630|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528631|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528632|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19528633|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19528634|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19528635|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19528636|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20306642|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20306643|NCT00656006|Ribavirin|ribavirin|mesh-list
19528637|NCT04148495|Acetaminophen|acetaminophen|mesh-list
19528638|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528639|NCT04148495|Analgesics|analgesics|mesh-ancestor
19528640|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
19528641|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528642|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528643|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
19528644|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
19528645|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19528646|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
19528647|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528648|NCT04119284|Protective Agents|protective agents|mesh-ancestor
19528649|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528650|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
19528651|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528652|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528653|NCT04105270|Carboplatin|carboplatin|mesh-list
20306644|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
20306645|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528654|NCT04105270|Pemetrexed|pemetrexed|mesh-list
19528655|NCT04105270|Durvalumab|durvalumab|mesh-list
19528656|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528657|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528658|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528659|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19528660|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19528661|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528662|NCT04105114|Buspirone|buspirone|mesh-list
19528663|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19528664|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19528665|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528666|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528667|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19528668|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19528669|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
19528670|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528671|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528672|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
19528673|NCT04087096|Denosumab|denosumab|mesh-list
19528674|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19528675|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528676|NCT04072835|Etripamil|etripamil|mesh-list
19528677|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19528678|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19528679|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102955|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
20102956|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20102957|NCT00003146|Melphalan|melphalan|mesh-list
20102958|NCT00003146|Busulfan|busulfan|mesh-list
19528680|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19528681|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528682|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
20306646|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
20306647|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102959|NCT00003146|Thiotepa|thiotepa|mesh-list
20102960|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102961|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
20102962|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20102963|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102964|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20102965|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102966|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
20102967|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102968|NCT00003148|Aldesleukin|aldesleukin|mesh-list
20102969|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102970|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20102971|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20102972|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
20102973|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20102974|NCT00003149|Interleukin-12|interleukin-12|mesh-list
20102975|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20102976|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
20102977|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528683|NCT04019379|Calcium|calcium|mesh-list
19528684|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19528685|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528686|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19528687|NCT04000009|Pimavanserin|pimavanserin|mesh-list
19528688|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19528689|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19528690|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19528691|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19528692|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528693|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528694|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19528695|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19528696|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19528697|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
19528698|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528699|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528700|NCT03989362|Ipilimumab|ipilimumab|mesh-list
19528701|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528702|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528703|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19528704|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528705|NCT03984565|Cannabidiol|cannabidiol|mesh-list
19528706|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
19528707|NCT03974139|Metformin|metformin|mesh-list
19528708|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19528709|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528710|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19528711|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528712|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528713|NCT03936998|Vancomycin|vancomycin|mesh-list
19528714|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528715|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528716|NCT03910998|Rocuronium|rocuronium|mesh-list
19528717|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19528718|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19528719|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19528720|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528721|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528722|NCT03888079|Anesthetics|anesthetics|mesh-list
19528723|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
19528724|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
19528725|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528726|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528727|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
19528728|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528729|NCT03883893|Acetaminophen|acetaminophen|mesh-list
19748977|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20102978|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20120460|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
20306648|NCT00656032|Cinacalcet|cinacalcet|mesh-list
19528730|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528731|NCT03883893|Analgesics|analgesics|mesh-ancestor
19528732|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
19528733|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528734|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528735|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
19528736|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19528737|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
19528738|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528739|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
19528740|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528741|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
19528742|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19528743|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19528744|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573633|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19573634|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20102979|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20102980|NCT00003149|Growth Substances|growth substances|mesh-ancestor
20102981|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
20102982|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573635|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19573636|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19573637|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19573638|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573639|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573640|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573641|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19573642|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19573643|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
19573644|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573645|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573646|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19573647|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19573648|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
19573649|NCT05321394|Ritonavir|ritonavir|mesh-list
19573650|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19573651|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19573652|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
19573653|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573654|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573655|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19573656|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19573657|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
19573658|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573659|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19573660|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19573661|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
19573662|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19573663|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19573664|NCT05317624|Prednisolone|prednisolone|mesh-list
19573665|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
19573666|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19573667|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
19573668|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573669|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
19573670|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
19573671|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573672|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573673|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573674|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
19573675|NCT05317624|Hormones|hormones|mesh-ancestor
19573676|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573677|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19573678|NCT05317624|Protective Agents|protective agents|mesh-ancestor
19573679|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573680|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573681|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
19573682|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19573683|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19573684|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748978|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573685|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
19573686|NCT05309525|Coagulants|coagulants|mesh-ancestor
19528745|NCT03782740|Melatonin|melatonin|mesh-list
19528746|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
19528747|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528748|NCT03782740|Protective Agents|protective agents|mesh-ancestor
19528749|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528750|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19528751|NCT03778424|Rufinamide|rufinamide|mesh-list
19528752|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
19528753|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19528754|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19528755|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19528756|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528757|NCT03777904|Iron|iron|mesh-list
19528758|NCT03777904|Trace Elements|trace elements|mesh-ancestor
19528759|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
19528760|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528761|NCT03766581|Aspirin|aspirin|mesh-list
19528762|NCT03766581|Clopidogrel|clopidogrel|mesh-list
19528763|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19528764|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19528765|NCT03766581|Analgesics|analgesics|mesh-ancestor
19528766|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
19528767|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528768|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528769|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528770|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528771|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19528772|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19528773|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528774|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19528775|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19528776|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528777|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
19528778|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19528779|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19528780|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19528781|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
19528782|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19528783|NCT03732820|Olaparib|olaparib|mesh-list
19528784|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
19528785|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19528786|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528787|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528788|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528789|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19528790|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
19528791|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528792|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528793|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19528794|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19528795|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748979|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528796|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20102983|NCT00003150|Prednisone|prednisone|mesh-list
20102984|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
19528797|NCT03719092|Vitamins|vitamins|mesh-list
19528798|NCT03719092|Vitamin A|vitamin a|mesh-list
20102985|NCT00003150|Rituximab|rituximab|mesh-list
20102986|NCT00003150|Doxorubicin|doxorubicin|mesh-list
19528799|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
19528800|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
19528801|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528802|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
19528803|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528804|NCT03719092|Protective Agents|protective agents|mesh-ancestor
20102987|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20102988|NCT00003150|Vincristine|vincristine|mesh-list
20102989|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20102990|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
20306649|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19528805|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19528806|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528807|NCT03694262|Bevacizumab|bevacizumab|mesh-list
19528808|NCT03694262|Atezolizumab|atezolizumab|mesh-list
19528809|NCT03694262|Rucaparib|rucaparib|mesh-list
20306650|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306651|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19528810|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528811|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528812|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19528813|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19528814|NCT03694262|Growth Substances|growth substances|mesh-ancestor
19528815|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528816|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
19528817|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19528818|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528819|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528820|NCT03686150|Vitamin D|vitamin d|mesh-list
19528821|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
19528822|NCT03686150|Vitamins|vitamins|mesh-ancestor
19528823|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
19528824|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528825|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20306652|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
20102991|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20102992|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20102993|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20102994|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
20102995|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528826|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19528827|NCT03685253|Niacinamide|niacinamide|mesh-list
19528828|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
19528829|NCT03685253|Vitamins|vitamins|mesh-ancestor
19528830|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
19528831|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528832|NCT03674112|Trastuzumab|trastuzumab|mesh-list
19528833|NCT03674112|Pertuzumab|pertuzumab|mesh-list
19528834|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528835|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528836|NCT03669367|Abatacept|abatacept|mesh-list
19528837|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19528838|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528839|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528840|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528841|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
19528842|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528843|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528844|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
19528845|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528846|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528847|NCT03641560|Androgens|androgens|mesh-list
19528848|NCT03641560|Hormones|hormones|mesh-ancestor
19528849|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19528850|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528851|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
19528852|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748980|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
20102996|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528853|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528854|NCT03618641|Nivolumab|nivolumab|mesh-list
20102997|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19528855|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528856|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528857|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19528858|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528859|NCT03617445|Vancomycin|vancomycin|mesh-list
19528860|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528861|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528862|NCT03392246|Osimertinib|osimertinib|mesh-list
19528863|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528864|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19528865|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20102998|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20102999|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103000|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103001|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103002|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103003|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19528866|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528867|NCT03384914|Vaccines|vaccines|mesh-list
19528868|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
19528869|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528870|NCT03218826|Docetaxel|docetaxel|mesh-list
19528871|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528872|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528873|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528874|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
19528875|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528876|NCT03165721|Guadecitabine|guadecitabine|mesh-list
19528877|NCT03165721|Azacitidine|azacitidine|mesh-list
19528878|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528879|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19528880|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
19528881|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528882|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528883|NCT03138733|Daptomycin|daptomycin|mesh-list
19528884|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
19528885|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19528886|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19528887|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19528888|NCT03130959|Nivolumab|nivolumab|mesh-list
19528889|NCT03130959|Ipilimumab|ipilimumab|mesh-list
19528890|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528891|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528892|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19528893|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528894|NCT02955797|Vaccines|vaccines|mesh-list
19528895|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
19528896|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528897|NCT02884908|Pregabalin|pregabalin|mesh-list
19528898|NCT02884908|Analgesics|analgesics|mesh-ancestor
19528899|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
19528900|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19528901|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528902|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
19528903|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19528904|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19528905|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528906|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19528907|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19528908|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19528909|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20103004|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
20103005|NCT00003150|Hormones|hormones|mesh-ancestor
20103006|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103007|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103008|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103009|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528910|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19528911|NCT02867813|Evolocumab|evolocumab|mesh-list
19528912|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20103010|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
19528913|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19528914|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
19528915|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528916|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19528917|NCT02859415|Plicamycin|plicamycin|mesh-list
19528918|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19528919|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528920|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19528921|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528922|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19528923|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528924|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528925|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19528926|NCT02859064|Lanreotide|lanreotide|mesh-list
19528927|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528928|NCT02842866|Vaccines|vaccines|mesh-list
19528929|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
19528930|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528931|NCT02842853|Vaccines|vaccines|mesh-list
19528932|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
19528933|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528934|NCT02834559|Fluorouracil|fluorouracil|mesh-list
19528935|NCT02834559|Heparin|heparin|mesh-list
19528936|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19528937|NCT02834559|Tinzaparin|tinzaparin|mesh-list
19528938|NCT02834559|Dalteparin|dalteparin|mesh-list
19528939|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
19528940|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528941|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103011|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103012|NCT00003151|Amoxicillin|amoxicillin|mesh-list
20103013|NCT00003151|Metronidazole|metronidazole|mesh-list
20103014|NCT00003151|Clarithromycin|clarithromycin|mesh-list
20103015|NCT00003151|Tetracycline|tetracycline|mesh-list
20103016|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20103017|NCT00003151|Omeprazole|omeprazole|mesh-list
20103018|NCT00003151|Bismuth|bismuth|mesh-list
20103019|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20103020|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103021|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20103022|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20103023|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20103024|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20103025|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20103026|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103027|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103028|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20103029|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20103030|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20306653|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306654|NCT00656110|Ethanol|ethanol|mesh-list
20306655|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
20306656|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20103031|NCT00003151|Antacids|antacids|mesh-ancestor
20103032|NCT00003152|Interferons|interferons|mesh-list
20103033|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
20103034|NCT00003152|Prednisone|prednisone|mesh-list
20103035|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
20103036|NCT00003152|Vincristine|vincristine|mesh-list
20103037|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528942|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528943|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528944|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
19528945|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528946|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
19528947|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19528948|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19528949|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
19528950|NCT02828592|Fludarabine|fludarabine|mesh-list
19528951|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
19528952|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103038|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
20103039|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103040|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528953|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
19528954|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528955|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528956|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19528957|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
19528958|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528959|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528960|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19528961|NCT02817451|Vaccines|vaccines|mesh-list
19528962|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
19528963|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528964|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
19528965|NCT02771197|Fludarabine|fludarabine|mesh-list
19528966|NCT02771197|Melphalan|melphalan|mesh-list
19528967|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19528968|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528969|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528970|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528971|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
19528972|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528973|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19528974|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
19528975|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19528976|NCT02752906|Vaccines|vaccines|mesh-list
20103041|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103042|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
20103043|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103044|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103045|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103046|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20103047|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
20103048|NCT00003152|Hormones|hormones|mesh-ancestor
20103049|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103050|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103051|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
20103052|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103053|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103054|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
19528977|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
19528978|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528979|NCT02716012|Sorafenib|sorafenib|mesh-list
19528980|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528981|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20103055|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103056|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103057|NCT00003156|Topotecan|topotecan|mesh-list
20103058|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20103059|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103060|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103061|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103062|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103063|NCT00003157|Gemcitabine|gemcitabine|mesh-list
20103064|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103065|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103066|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
20120461|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
19528982|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19528983|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528984|NCT02627092|Copper|copper|mesh-list
19528985|NCT02627092|Trace Elements|trace elements|mesh-ancestor
19528986|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
19528987|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528988|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
19528989|NCT02581007|Melphalan|melphalan|mesh-list
19528990|NCT02581007|Fludarabine|fludarabine|mesh-list
19528991|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19528992|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
19528993|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19528994|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19528995|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19528996|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
19528997|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19528998|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19528999|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19529000|NCT02540330|Fulvestrant|fulvestrant|mesh-list
19529001|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529002|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529003|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19529004|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19529005|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
19529006|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529007|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103067|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603852|NCT02224014|Brotizolam|brotizolam|mesh-list
19529008|NCT02483260|Ribavirin|ribavirin|mesh-list
19529009|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
19529010|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529011|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
19529012|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529013|NCT02483247|Paclitaxel|paclitaxel|mesh-list
19529014|NCT02483247|Doxorubicin|doxorubicin|mesh-list
19529015|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
19529016|NCT02483247|Capecitabine|capecitabine|mesh-list
19529017|NCT02483247|Nivolumab|nivolumab|mesh-list
19529018|NCT02483247|Sunitinib|sunitinib|mesh-list
19529019|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19529020|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529021|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529022|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
19529023|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529024|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529025|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19529026|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19529027|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19529028|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529029|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19529030|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19529031|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
19529032|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19529033|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19529034|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19529035|NCT02483247|Growth Substances|growth substances|mesh-ancestor
19529036|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529037|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
19529038|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19529039|NCT02474368|Cisplatin|cisplatin|mesh-list
19529040|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529041|NCT02469519|Dexamethasone|dexamethasone|mesh-list
19529042|NCT02469519|Betamethasone|betamethasone|mesh-list
19529043|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529044|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
19529045|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
19529046|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529047|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529048|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529049|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
19529050|NCT02469519|Hormones|hormones|mesh-ancestor
19529051|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529052|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529053|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529054|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19529055|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
19529056|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
19529057|NCT02467361|Nivolumab|nivolumab|mesh-list
19529058|NCT02467361|Ipilimumab|ipilimumab|mesh-list
19529059|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19529060|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529061|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19573687|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20103068|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
20103069|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103070|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103071|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103072|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
20103073|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103074|NCT00003158|Paclitaxel|paclitaxel|mesh-list
20103075|NCT00003158|Etoposide|etoposide|mesh-list
20103076|NCT00003158|Carboplatin|carboplatin|mesh-list
20103077|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103078|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103079|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529062|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573688|NCT05308446|Nivolumab|nivolumab|mesh-list
19573689|NCT05308446|Cetuximab|cetuximab|mesh-list
19573690|NCT05308446|Antibodies|antibodies|mesh-list
19573691|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
19573692|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19573693|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
19573694|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573695|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573696|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19573697|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573698|NCT05304585|Dactinomycin|dactinomycin|mesh-list
19573699|NCT05304585|Cactinomycin|cactinomycin|mesh-list
19573700|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
19573701|NCT05304585|Vincristine|vincristine|mesh-list
19573702|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19573703|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
19573704|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573705|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573706|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19573707|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
19573708|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573709|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573710|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19573711|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19573712|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
19573713|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
19573714|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
19573715|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19573716|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573717|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19573718|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19573719|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573720|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19573721|NCT05300594|Vitamins|vitamins|mesh-list
19573722|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
19573723|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573724|NCT05300451|Daratumumab|daratumumab|mesh-list
19573725|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573730|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19573731|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
19573732|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573733|NCT05297851|Riboflavin|riboflavin|mesh-list
19573734|NCT05297851|Niacinamide|niacinamide|mesh-list
19573735|NCT05297851|Niacin|niacin|mesh-list
19573736|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
19573737|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
19573738|NCT05297851|Vitamins|vitamins|mesh-ancestor
19573739|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
19573740|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573741|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19573742|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
19573743|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20306657|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20306658|NCT00656110|Prednisolone|prednisolone|mesh-list
20306659|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
20306660|NCT00656110|Lidocaine|lidocaine|mesh-list
20306661|NCT00656110|Bupivacaine|bupivacaine|mesh-list
20306662|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19573744|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
19573745|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573746|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19573747|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
19573748|NCT05295394|Lamivudine|lamivudine|mesh-list
19573749|NCT05295394|Dolutegravir|dolutegravir|mesh-list
19573750|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19573751|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19573752|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573753|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603853|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19573754|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
19573755|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573756|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20306663|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
19529063|NCT02388906|Nivolumab|nivolumab|mesh-list
19529064|NCT02388906|Ipilimumab|ipilimumab|mesh-list
19529065|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19529066|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529067|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19529068|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529069|NCT02352753|Denosumab|denosumab|mesh-list
19529070|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19529071|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529072|NCT02352558|Dexamethasone|dexamethasone|mesh-list
19529073|NCT02352558|Bortezomib|bortezomib|mesh-list
19529074|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
19529075|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529076|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
19529077|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
19529078|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529079|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529080|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529081|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
19529082|NCT02352558|Hormones|hormones|mesh-ancestor
19529083|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529084|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529085|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529086|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19529087|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529088|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529089|NCT02343042|Clarithromycin|clarithromycin|mesh-list
19529090|NCT02343042|Dexamethasone|dexamethasone|mesh-list
19529091|NCT02343042|Lenalidomide|lenalidomide|mesh-list
19529092|NCT02343042|Bortezomib|bortezomib|mesh-list
19529093|NCT02343042|Daratumumab|daratumumab|mesh-list
19529094|NCT02343042|Pomalidomide|pomalidomide|mesh-list
19529095|NCT02343042|Ixazomib|ixazomib|mesh-list
19529096|NCT02343042|Elotuzumab|elotuzumab|mesh-list
19529097|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529098|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
19529099|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
19529100|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529101|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529102|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529103|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
19529104|NCT02343042|Hormones|hormones|mesh-ancestor
19529105|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529106|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529107|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529108|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
19529109|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19529110|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19529111|NCT02343042|Growth Substances|growth substances|mesh-ancestor
19529112|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
19529113|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19529114|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529115|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19529116|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529117|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529118|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19529119|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19529120|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19529121|NCT02324283|Propofol|propofol|mesh-list
19529122|NCT02324283|Desflurane|desflurane|mesh-list
19529123|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19529124|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529125|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306664|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
20306665|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
20306666|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306667|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306668|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
20306669|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306670|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20306671|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19529126|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19529127|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
19529128|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
19529129|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19529130|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19529131|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19529132|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529133|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19529134|NCT02304302|Memantine|memantine|mesh-list
19529135|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19529136|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19529137|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
20306672|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20306673|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19529138|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20103080|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
19529139|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529140|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529141|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19529142|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19529143|NCT02269670|Tamoxifen|tamoxifen|mesh-list
19529144|NCT02269670|Everolimus|everolimus|mesh-list
19529145|NCT02269670|Letrozole|letrozole|mesh-list
19529146|NCT02269670|Fulvestrant|fulvestrant|mesh-list
19529147|NCT02269670|Anastrozole|anastrozole|mesh-list
19529148|NCT02269670|Megestrol|megestrol|mesh-list
19529149|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
19529150|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529151|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529152|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529153|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
19529154|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529155|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19529156|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19529157|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529158|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19529159|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
19529160|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529161|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529162|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19529163|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19529164|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19529165|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19529166|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19529167|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19529168|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19529169|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
19529170|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529171|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19529172|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19529173|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
19529174|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19529175|NCT02240407|Acetaminophen|acetaminophen|mesh-list
19529176|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
19529177|NCT02240407|Promethazine|promethazine|mesh-list
19529178|NCT02240407|Sirolimus|sirolimus|mesh-list
19529179|NCT02240407|Rituximab|rituximab|mesh-list
19529180|NCT02240407|Lidocaine|lidocaine|mesh-list
19529181|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19529182|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529183|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
19529184|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529185|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529186|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
19529187|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
19529188|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529189|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
19529190|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529191|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19529192|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19529193|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19529194|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19529195|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529196|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19529197|NCT02240407|Analgesics|analgesics|mesh-ancestor
19529198|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
19529199|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20103081|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529200|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529201|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19529202|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
19529203|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529204|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19529205|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19529206|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
19529207|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
19529208|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529209|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19529210|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
19529211|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
19529212|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529213|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19529214|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
19529215|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
19529216|NCT02231723|Leucovorin|leucovorin|mesh-list
19529217|NCT02231723|Gemcitabine|gemcitabine|mesh-list
19529218|NCT02231723|Paclitaxel|paclitaxel|mesh-list
19529219|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19529220|NCT02231723|Fluorouracil|fluorouracil|mesh-list
19529221|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
19529222|NCT02231723|Irinotecan|irinotecan|mesh-list
19529223|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19748981|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529224|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529225|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529226|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
19529227|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529228|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529229|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19529230|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
19529231|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
19529232|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529233|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529234|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529235|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
19529236|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529237|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19529238|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19529239|NCT02231723|Antidotes|antidotes|mesh-ancestor
19529240|NCT02231723|Protective Agents|protective agents|mesh-ancestor
19529241|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
19529242|NCT02231723|Vitamins|vitamins|mesh-ancestor
19529243|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
19529244|NCT02086175|Rituximab|rituximab|mesh-list
19529245|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19529246|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529247|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
19529248|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529249|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529250|NCT02072148|Cisplatin|cisplatin|mesh-list
19529251|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529252|NCT02051218|Denosumab|denosumab|mesh-list
19529253|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19529254|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529255|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19529256|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19529257|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529258|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
19529259|NCT01860976|Abatacept|abatacept|mesh-list
19529260|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19529261|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529262|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529263|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529264|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
19529265|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529266|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529267|NCT01761266|Sorafenib|sorafenib|mesh-list
19529268|NCT01761266|Lenvatinib|lenvatinib|mesh-list
19529269|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529270|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19529271|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529272|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529273|NCT01550289|Vaccines|vaccines|mesh-list
19748982|NCT05329766|Antidotes|antidotes|mesh-ancestor
19529274|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
19529275|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529276|NCT01325441|Paclitaxel|paclitaxel|mesh-list
20103082|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103083|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19529277|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19529278|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529279|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529280|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19529281|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529282|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529283|NCT01101438|Metformin|metformin|mesh-list
19529284|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19529285|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529286|NCT01081951|Paclitaxel|paclitaxel|mesh-list
19529287|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19529288|NCT01081951|Carboplatin|carboplatin|mesh-list
19529289|NCT01081951|Olaparib|olaparib|mesh-list
19529290|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19529291|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529292|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529293|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
19529294|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529295|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529296|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19529297|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529298|NCT01074190|Fentanyl|fentanyl|mesh-list
19529299|NCT01074190|Bupivacaine|bupivacaine|mesh-list
19529300|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
19529301|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
19529302|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529303|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529304|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
19529305|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529306|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19529307|NCT01074190|Narcotics|narcotics|mesh-ancestor
19529308|NCT01074190|Analgesics|analgesics|mesh-ancestor
19529309|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19529310|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19529311|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
19529312|NCT00875524|Vaccines|vaccines|mesh-list
19529313|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
20103084|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103085|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103086|NCT00003159|Gemcitabine|gemcitabine|mesh-list
20103087|NCT00003159|Paclitaxel|paclitaxel|mesh-list
19529314|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529315|NCT00842530|Vaccines|vaccines|mesh-list
19529316|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
19529317|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529318|NCT00788151|Vaccines|vaccines|mesh-list
19529319|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19529320|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
19529321|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529322|NCT00781612|Paclitaxel|paclitaxel|mesh-list
20103088|NCT00003159|Vinorelbine|vinorelbine|mesh-list
20103089|NCT00003159|Vinblastine|vinblastine|mesh-list
20103090|NCT00003159|Docetaxel|docetaxel|mesh-list
20103091|NCT00003159|Carboplatin|carboplatin|mesh-list
20103092|NCT00003159|Ifosfamide|ifosfamide|mesh-list
20103093|NCT00003159|Mitomycins|mitomycins|mesh-list
20103094|NCT00003159|Mitomycin|mitomycin|mesh-list
20103095|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103096|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529323|NCT00781612|Maytansine|maytansine|mesh-list
20103097|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529324|NCT00781612|Docetaxel|docetaxel|mesh-list
19529325|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20103098|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103099|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529326|NCT00781612|Trastuzumab|trastuzumab|mesh-list
19529327|NCT00781612|Atezolizumab|atezolizumab|mesh-list
19529328|NCT00781612|Pertuzumab|pertuzumab|mesh-list
19529329|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19529330|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529331|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529332|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
19529333|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529334|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529335|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19529336|NCT00539591|Interferons|interferons|mesh-list
19529337|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
19529338|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
19529339|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19529340|NCT00539591|Temozolomide|temozolomide|mesh-list
19529341|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529342|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
20103100|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103101|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103102|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
19529343|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529344|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19529345|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
19529346|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529347|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
19529348|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529349|NCT02909088|Ecopipam|ecopipam|mesh-list
19529350|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19529351|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19529352|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529353|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529354|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19529355|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19529356|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
19529357|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529358|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529359|NCT02909049|Midazolam|midazolam|mesh-list
19529360|NCT02909049|Ketamine|ketamine|mesh-list
19529361|NCT02909049|Mepivacaine|mepivacaine|mesh-list
19529362|NCT02909049|Analgesics|analgesics|mesh-ancestor
19529363|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
19529364|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529365|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529366|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19529367|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19529368|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
19529369|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
19529370|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529371|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19529372|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19529373|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529374|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529375|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19529376|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19529377|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19529378|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19529379|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19529380|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
19529381|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
19529382|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
19529383|NCT02908581|Folic Acid|folic acid|mesh-list
20103103|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
20103104|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103105|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103106|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103107|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
19529384|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
19529385|NCT02908581|Hematinics|hematinics|mesh-ancestor
19529386|NCT02908581|Vitamins|vitamins|mesh-ancestor
19529387|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
19529388|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529389|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
19529390|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19529391|NCT02908711|Ropivacaine|ropivacaine|mesh-list
19529392|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
19529393|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
19529394|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529395|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529396|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
19529397|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529398|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19529399|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19529400|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
19529401|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529402|NCT02908698|Prednisone|prednisone|mesh-list
19529403|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529404|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
19529405|NCT02908698|Hormones|hormones|mesh-ancestor
19529406|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529407|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529408|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529409|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529410|NCT02908438|Hormones|hormones|mesh-list
19529411|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529412|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529413|NCT02908412|Bupivacaine|bupivacaine|mesh-list
19529414|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
19529415|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
19529416|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529417|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529418|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
19529419|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573757|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19573758|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19573759|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19573760|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
19573761|NCT05273632|Oxytocin|oxytocin|mesh-list
19573762|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
19573763|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19573764|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573765|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20103108|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306674|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306675|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20306676|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
20306677|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
19573766|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19573767|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573768|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
19573769|NCT05273632|Coagulants|coagulants|mesh-ancestor
19573770|NCT05257629|Nicotine|nicotine|mesh-list
19573771|NCT05257629|Varenicline|varenicline|mesh-list
19573772|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19573773|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
19573774|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573775|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573776|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19573777|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19573778|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
19573779|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573780|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573781|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
19573782|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19573783|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573784|NCT05228041|Benralizumab|benralizumab|mesh-list
19573785|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19573786|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
19573787|NCT05210062|Succinylcholine|succinylcholine|mesh-list
19573788|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19573789|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19573790|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19573791|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20103109|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103110|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
20103111|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103112|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20103113|NCT00003160|Paclitaxel|paclitaxel|mesh-list
20103114|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103115|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306678|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573792|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103116|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103117|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
20306679|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
20306680|NCT00656110|Hormones|hormones|mesh-ancestor
20306681|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529420|NCT02908191|Tenofovir|tenofovir|mesh-list
19529421|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19529422|NCT02908191|Entecavir|entecavir|mesh-list
19529423|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
19529424|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529425|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19529426|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19529427|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529428|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529429|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19529430|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19529431|NCT02908295|Misoprostol|misoprostol|mesh-list
19529432|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19529433|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
19529434|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529435|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529436|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19529437|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529438|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
19529439|NCT02908165|Sorafenib|sorafenib|mesh-list
19529440|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
19529441|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529442|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19529443|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529444|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529445|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19529446|NCT02908165|Estrogens|estrogens|mesh-ancestor
19529447|NCT02908165|Hormones|hormones|mesh-ancestor
19529448|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529449|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529450|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529451|NCT02908282|Povidone|povidone|mesh-list
19529452|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
19529453|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
19529454|NCT02908152|Curcumin|curcumin|mesh-list
19529455|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19529456|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19529457|NCT02908152|Analgesics|analgesics|mesh-ancestor
19529458|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
19529459|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529460|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529461|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529462|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529463|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529464|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529465|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529466|NCT02908126|Oxytocin|oxytocin|mesh-list
19529467|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
19529468|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529469|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529470|NCT02907957|Anesthetics|anesthetics|mesh-list
19529471|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529472|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529473|NCT02908035|Sirolimus|sirolimus|mesh-list
19529474|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19529475|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529476|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19529477|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529478|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
19529479|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529480|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
19529481|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529482|NCT02907749|Carvedilol|carvedilol|mesh-list
19529483|NCT02907749|Spironolactone|spironolactone|mesh-list
19529484|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19529485|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
19529486|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529487|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103118|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
20603854|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529488|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19529489|NCT02907749|Diuretics|diuretics|mesh-ancestor
19529490|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
19529491|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19529492|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19529493|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
19529494|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529495|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529496|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19529497|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
19529498|NCT02907749|Protective Agents|protective agents|mesh-ancestor
19529499|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19529500|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19529501|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19529502|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
19529503|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19529504|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19529505|NCT02907593|Budesonide|budesonide|mesh-list
19529506|NCT02907593|Calfactant|calfactant|mesh-list
19529507|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529508|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19529509|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
19529510|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529511|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529512|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19529513|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
19529514|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
19529515|NCT02907593|Hormones|hormones|mesh-ancestor
19529516|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529517|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19529518|NCT02907710|Endostar protein|endostar protein|mesh-list
19529519|NCT02907710|Endostatins|endostatins|mesh-list
19529520|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19529521|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19529522|NCT02907710|Growth Substances|growth substances|mesh-ancestor
19529523|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529524|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
19529525|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529526|NCT02907554|Cyclosporine|cyclosporine|mesh-list
19529527|NCT02907554|Cyclosporins|cyclosporins|mesh-list
19529528|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529529|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529530|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529531|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
19529532|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529533|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
19529534|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529535|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
19529536|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529537|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19529538|NCT02907632|Metoclopramide|metoclopramide|mesh-list
19529539|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
19529540|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
19529541|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529542|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529543|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529544|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19529545|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19529546|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
19529547|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529548|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529549|NCT02907437|Minocycline|minocycline|mesh-list
19529550|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19529551|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529552|NCT02907307|Clotrimazole|clotrimazole|mesh-list
19529553|NCT02907307|Miconazole|miconazole|mesh-list
19529554|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19529555|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529556|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
19529557|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19529558|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19529559|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103119|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103120|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
20103121|NCT00003163|Melphalan|melphalan|mesh-list
20103122|NCT00003163|Sargramostim|sargramostim|mesh-list
20306682|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20306683|NCT00656110|Protective Agents|protective agents|mesh-ancestor
20306684|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20306685|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306686|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20306687|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306688|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
20306689|NCT00656123|Molgramostim|molgramostim|mesh-list
20103123|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103124|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
20103125|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103126|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103127|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103128|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
20603855|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529560|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529561|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19529562|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
19529563|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529564|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529565|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19529566|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19529567|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19529568|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19529569|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
19529570|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529571|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529572|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529573|NCT02906722|Colistin|colistin|mesh-list
19529574|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19529575|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529576|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
19529577|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19529578|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603856|NCT02224040|Azithromycin|azithromycin|mesh-list
20603857|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
20603858|NCT02224040|Cefixime|cefixime|mesh-list
20603859|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20603860|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20603861|NCT02224066|Aspirin|aspirin|mesh-list
20603862|NCT02224066|Clopidogrel|clopidogrel|mesh-list
20603863|NCT02224066|Ticagrelor|ticagrelor|mesh-list
20603864|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20603865|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19529579|NCT02906995|Nicotine|nicotine|mesh-list
19529580|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19529581|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
19529582|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529583|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529584|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19529585|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19529586|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
19529587|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529588|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529589|NCT02906800|Digoxin|digoxin|mesh-list
19529590|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19529591|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19529592|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529593|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603866|NCT02224066|Analgesics|analgesics|mesh-ancestor
20603867|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
20603868|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529594|NCT02906800|Protective Agents|protective agents|mesh-ancestor
19529595|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19748983|NCT05329766|Protective Agents|protective agents|mesh-ancestor
19748984|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
19748985|NCT05329766|Vitamins|vitamins|mesh-ancestor
20103129|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103130|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103131|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20306690|NCT00656123|Sargramostim|sargramostim|mesh-list
19748986|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
20603869|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603870|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19748987|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
19748988|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748989|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529596|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19529597|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
19529598|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
19529599|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
19748990|NCT05322577|Nivolumab|nivolumab|mesh-list
19748991|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
19748992|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19748993|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19748994|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19748995|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19748996|NCT05312151|Psilocybin|psilocybin|mesh-list
19748997|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
19748998|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103132|NCT00003165|Doxorubicin|doxorubicin|mesh-list
19529600|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
19529601|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19529602|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529603|NCT02906150|Cisplatin|cisplatin|mesh-list
19529604|NCT02906150|Carboplatin|carboplatin|mesh-list
19529605|NCT02906150|Pemetrexed|pemetrexed|mesh-list
19529606|NCT02906150|Thymalfasin|thymalfasin|mesh-list
20103133|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103134|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103135|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19529607|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103136|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103137|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529608|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103138|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306691|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
20306692|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306693|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306694|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306695|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20306696|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
20306697|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529609|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529610|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19529611|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19529612|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19529613|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
19529614|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529615|NCT02906059|Irinotecan|irinotecan|mesh-list
19529616|NCT02906059|Adavosertib|adavosertib|mesh-list
19529617|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19529618|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19529619|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529620|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529621|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529622|NCT02906176|Voriconazole|voriconazole|mesh-list
19529623|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
19529624|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529625|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19529626|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19529627|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529628|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529629|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19529630|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
19529631|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529632|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529633|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19529634|NCT02905994|Cytarabine|cytarabine|mesh-list
19529635|NCT02905994|Idarubicin|idarubicin|mesh-list
19529636|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19529637|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
19529638|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529639|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529640|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
19529641|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573793|NCT05205447|Itraconazole|itraconazole|mesh-list
19748999|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19529642|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529643|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
19529644|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529645|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19529646|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19529647|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19529648|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529649|NCT02905890|Norethindrone|norethindrone|mesh-list
19529650|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
19529651|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
19529652|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19529653|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19529654|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19529655|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
19529656|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529657|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529658|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19529659|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19529660|NCT02906163|Gefitinib|gefitinib|mesh-list
19529661|NCT02906163|Afatinib|afatinib|mesh-list
19529662|NCT02906163|Thymalfasin|thymalfasin|mesh-list
19529663|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529664|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19529665|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529666|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529667|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19529668|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
19529669|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529670|NCT02905864|Liraglutide|liraglutide|mesh-list
19529671|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19529672|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529673|NCT02905864|Incretins|incretins|mesh-ancestor
19529674|NCT02905864|Hormones|hormones|mesh-ancestor
19529675|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529676|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
20306698|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306699|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20306700|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20306701|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
20306702|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20306703|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20103139|NCT00003166|Vincristine|vincristine|mesh-list
20103140|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
20103141|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103142|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103143|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103144|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103145|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103146|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103147|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19529677|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
19529678|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
19529679|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529680|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529681|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
19529682|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529683|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19529684|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
19529685|NCT02905682|Coagulants|coagulants|mesh-ancestor
19529686|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19529687|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
19529688|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529689|NCT02905708|Charcoal|charcoal|mesh-list
19529690|NCT02905708|Antidotes|antidotes|mesh-ancestor
19529691|NCT02905708|Protective Agents|protective agents|mesh-ancestor
19529692|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529693|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
19529694|NCT02905591|Paclitaxel|paclitaxel|mesh-list
19529695|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19529696|NCT02905591|Carboplatin|carboplatin|mesh-list
19529697|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19529698|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529699|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749000|NCT05310110|Lidocaine|lidocaine|mesh-list
19749001|NCT05310110|Propofol|propofol|mesh-list
19529700|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
19749002|NCT05310110|Cisatracurium|cisatracurium|mesh-list
19529701|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529702|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529703|NCT02905591|Vitamins|vitamins|mesh-ancestor
19529704|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
19529705|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529706|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
19529707|NCT02905591|Protective Agents|protective agents|mesh-ancestor
19529708|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19529709|NCT02905539|Hematinics|hematinics|mesh-ancestor
19529710|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
19529711|NCT02905578|Gemcitabine|gemcitabine|mesh-list
19529712|NCT02905578|Paclitaxel|paclitaxel|mesh-list
19529713|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19529714|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529715|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
19529716|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
19529717|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
19529718|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529719|NCT02905578|Vitamins|vitamins|mesh-ancestor
19529720|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
19529721|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529722|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19529723|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
19529724|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
19529725|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529726|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529727|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529728|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
19529729|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
19529730|NCT02905578|Protective Agents|protective agents|mesh-ancestor
19529731|NCT02905734|Nicotine|nicotine|mesh-list
19529732|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19529733|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
19529734|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529735|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529736|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19529737|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19529738|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
19529739|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529740|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529741|NCT02905760|Furosemide|furosemide|mesh-list
19529742|NCT02905760|Diuretics|diuretics|mesh-list
19529743|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
19529744|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529745|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19529746|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19529747|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529748|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
19529749|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529750|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529751|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
19529752|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20103148|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
20103149|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103150|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
19529753|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529754|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
19529755|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529756|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529757|NCT02905305|Dexamethasone|dexamethasone|mesh-list
19529758|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529759|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
19529760|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
19529761|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529762|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529763|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529764|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
19529765|NCT02905305|Hormones|hormones|mesh-ancestor
19529766|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529767|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529768|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529769|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
19529770|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19529771|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19529772|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
20103151|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19529773|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529774|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529775|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529776|NCT02905058|Ketoprofen|ketoprofen|mesh-list
19529777|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19529778|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19529779|NCT02905058|Analgesics|analgesics|mesh-ancestor
19529780|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
19529781|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529782|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529783|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529784|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529785|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19529786|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529787|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529788|NCT02905045|Ketoprofen|ketoprofen|mesh-list
19529789|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19529790|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19529791|NCT02905045|Analgesics|analgesics|mesh-ancestor
20103152|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
20103153|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103154|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103155|NCT00003172|Interferons|interferons|mesh-list
20103156|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
20306704|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306705|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529792|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
19529793|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529794|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529795|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529796|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529797|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19529798|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529799|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529800|NCT02904772|Cyclosporine|cyclosporine|mesh-list
19529801|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
19529802|NCT02904772|Prednisolone|prednisolone|mesh-list
19529803|NCT02904772|Cyclosporins|cyclosporins|mesh-list
19529804|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529805|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529806|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529807|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
19529808|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529809|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
19529810|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529811|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
19529812|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529813|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19529814|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19529815|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529816|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19529817|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
19529818|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19529819|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529820|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
19529821|NCT02904772|Hormones|hormones|mesh-ancestor
19529822|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529823|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573794|NCT05205447|Carbamazepine|carbamazepine|mesh-list
20306706|NCT00656188|Urological Agents|urological agents|mesh-ancestor
20306707|NCT00656214|Lycopene|lycopene|mesh-list
19573795|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
19573796|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573797|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20103157|NCT00003172|Docetaxel|docetaxel|mesh-list
20103158|NCT00003172|Doxorubicin|doxorubicin|mesh-list
20103159|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20103160|NCT00003172|Fluorouracil|fluorouracil|mesh-list
20103161|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
20103162|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103163|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103164|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103165|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103166|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306708|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529824|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19529825|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
19529826|NCT02904759|Coagulants|coagulants|mesh-ancestor
19529827|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19529828|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
19529829|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529830|NCT02904564|Fluorouracil|fluorouracil|mesh-list
19529831|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
19529832|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529833|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19529834|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529835|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529836|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
19529837|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529838|NCT02904538|Dexamethasone|dexamethasone|mesh-list
19529839|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529840|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
19529841|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
19529842|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529843|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529844|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19529845|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
19529846|NCT02904538|Hormones|hormones|mesh-ancestor
19529847|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19529848|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19529849|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529850|NCT02904499|Dabigatran|dabigatran|mesh-list
20306709|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
20306710|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306711|NCT00656214|Protective Agents|protective agents|mesh-ancestor
20306712|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306713|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20306714|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19529851|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
19529852|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19529853|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
19529854|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529855|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529856|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
19529857|NCT02904369|Tenofovir|tenofovir|mesh-list
19529858|NCT02904369|Emtricitabine|emtricitabine|mesh-list
19529859|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
19529860|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529861|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19529862|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19529863|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529864|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529865|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19529866|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19529867|NCT02904291|Amlodipine|amlodipine|mesh-list
19529868|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19529869|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19529870|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19529871|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529872|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19529873|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529874|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
19529875|NCT02904304|Ibuprofen|ibuprofen|mesh-list
19529876|NCT02904304|Phenylephrine|phenylephrine|mesh-list
19529877|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
19529878|NCT02904304|Desloratadine|desloratadine|mesh-list
19529879|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19529880|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19529881|NCT02904304|Analgesics|analgesics|mesh-ancestor
19529882|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
19529883|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529884|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529885|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19529886|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529887|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19529888|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529889|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529890|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19529891|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
19529892|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
19529893|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
19529894|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19529895|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
19529896|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19529897|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19529898|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19529899|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20306715|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306716|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20306717|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20306718|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
20306719|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20306720|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306721|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20103167|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103168|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103169|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103170|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103171|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
20103172|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103173|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103174|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
20103175|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103176|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
20103177|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103178|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
20103179|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20103180|NCT00003173|Thiotepa|thiotepa|mesh-list
20103181|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
20103182|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103183|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103184|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
20103185|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103186|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103187|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103188|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103189|NCT00003174|Cladribine|cladribine|mesh-list
20103190|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
20103191|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103192|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103193|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
20103194|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103195|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20306722|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
19529900|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
19529901|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19529902|NCT02904304|Protective Agents|protective agents|mesh-ancestor
19529903|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19529904|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
19529905|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19529906|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19529907|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
19529908|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
19529909|NCT02904031|Leucovorin|leucovorin|mesh-list
19529910|NCT02904031|Fluorouracil|fluorouracil|mesh-list
19529911|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
19529912|NCT02904031|Panitumumab|panitumumab|mesh-list
19529913|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
19529914|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
19529915|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529916|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19529917|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529918|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529919|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
19529920|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529921|NCT02904031|Antidotes|antidotes|mesh-ancestor
19529922|NCT02904031|Protective Agents|protective agents|mesh-ancestor
19529923|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
19529924|NCT02904031|Vitamins|vitamins|mesh-ancestor
19529925|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
19529926|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749003|NCT05310110|Atracurium|atracurium|mesh-list
19529927|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
19529928|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19749004|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
20103196|NCT00003175|Fluorouracil|fluorouracil|mesh-list
20103197|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
19529929|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
19529930|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529931|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529932|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19529933|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19529934|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19529935|NCT02904109|Mannitol|mannitol|mesh-list
19529936|NCT02904109|Triflusal|triflusal|mesh-list
19529937|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20103198|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103199|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103200|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103201|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103202|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
20103203|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529938|NCT02904109|Diuretics|diuretics|mesh-ancestor
19529939|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
19529940|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529941|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19529942|NCT02903901|Melatonin|melatonin|mesh-list
19529943|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
19529944|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529945|NCT02903901|Protective Agents|protective agents|mesh-ancestor
19529946|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529947|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529948|NCT02903498|Tegafur|tegafur|mesh-list
19529949|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19529950|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
19529951|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529952|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529953|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
19529954|NCT02903524|Doxorubicin|doxorubicin|mesh-list
19529955|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19529956|NCT02903524|Pirarubicin|pirarubicin|mesh-list
19529957|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19529958|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
19529959|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529960|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19529961|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19529962|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
19529963|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19529964|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529965|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19529966|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19529967|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19529968|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19529969|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529970|NCT02903485|Anesthetics|anesthetics|mesh-list
19529971|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529972|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529973|NCT02903719|Ropivacaine|ropivacaine|mesh-list
19529974|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
19529975|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
19529976|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19529977|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529978|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
19529979|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19529980|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
19529981|NCT02903537|Interferons|interferons|mesh-list
19529982|NCT02903537|Interferon-beta|interferon-beta|mesh-list
19529983|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19529984|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
19529985|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19529986|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
19529987|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19529988|NCT02903537|Vitamins|vitamins|mesh-ancestor
19529989|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
19529990|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19529991|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19529992|NCT02903251|Oxytocin|oxytocin|mesh-list
19529993|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
19529994|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19529995|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573798|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19573799|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19529996|NCT02903004|Gemcitabine|gemcitabine|mesh-list
19529997|NCT02903004|Paclitaxel|paclitaxel|mesh-list
19529998|NCT02903004|Carboplatin|carboplatin|mesh-list
19529999|NCT02903004|Doxorubicin|doxorubicin|mesh-list
19530000|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19530001|NCT02903004|Topotecan|topotecan|mesh-list
19530002|NCT02903004|Trabectedin|trabectedin|mesh-list
19530003|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19530004|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530005|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19530006|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19530007|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19530008|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530009|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530010|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
19530011|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
19530012|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530013|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530014|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530015|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
19530016|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530017|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19530018|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19530019|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19530020|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19530021|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19530022|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
19530023|NCT02902861|Methotrexate|methotrexate|mesh-list
19530024|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19530025|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
19530026|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19530027|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530028|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530029|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
19530030|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530031|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530032|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
19530033|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530034|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19530035|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530036|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
19530037|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530038|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19530039|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
19530040|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19530041|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19530042|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530043|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
19530044|NCT02903017|Coagulants|coagulants|mesh-ancestor
19530045|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19530046|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530047|NCT02903069|Temozolomide|temozolomide|mesh-list
19530048|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19530049|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
19530050|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530051|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530052|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19530053|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530054|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
19530055|NCT02902744|Hormones|hormones|mesh-ancestor
19530056|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530057|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530058|NCT02902666|Acetaminophen|acetaminophen|mesh-list
19530059|NCT02902666|Codeine|codeine|mesh-list
19530060|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530061|NCT02902666|Analgesics|analgesics|mesh-ancestor
19530062|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
19530063|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530064|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530065|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
19530066|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19530067|NCT02902666|Narcotics|narcotics|mesh-ancestor
19530068|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20103204|NCT00003176|Temozolomide|temozolomide|mesh-list
19530069|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
19530070|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
19530071|NCT02902653|Misoprostol|misoprostol|mesh-list
19530072|NCT02902653|Dinoprostone|dinoprostone|mesh-list
19530073|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19530074|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
19530075|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19530076|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530077|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19530078|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19530079|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
19530080|NCT02902640|Trimethoprim|trimethoprim|mesh-list
19530081|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
19530082|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
19530083|NCT02902640|Guaifenesin|guaifenesin|mesh-list
19530084|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19530085|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19530086|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530087|NCT02902640|Renal Agents|renal agents|mesh-ancestor
19530088|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
19530089|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19530090|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19530091|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19530092|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530093|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530094|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19530095|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19530096|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19530097|NCT02902640|Expectorants|expectorants|mesh-ancestor
19530098|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
19530099|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19530100|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19530101|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
19530102|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530103|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530104|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
19530105|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19530106|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
19530107|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
19530108|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530109|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
19530110|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19530111|NCT02902354|Nifedipine|nifedipine|mesh-list
19530112|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19530113|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19530114|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530115|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19530116|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530117|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
19530118|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
19530119|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19530120|NCT02902315|Vitamins|vitamins|mesh-list
19530121|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
19530122|NCT02902315|Tocopherols|tocopherols|mesh-list
19530123|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
19530124|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
19530125|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530126|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
19530127|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530128|NCT02902315|Protective Agents|protective agents|mesh-ancestor
19530129|NCT02902302|Ibuprofen|ibuprofen|mesh-list
19530130|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19530131|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530132|NCT02902302|Analgesics|analgesics|mesh-ancestor
19530133|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
19530134|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530135|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530136|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530137|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530138|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19530139|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530140|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530141|NCT02902523|Tenofovir|tenofovir|mesh-list
19530142|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
19530143|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530144|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19530145|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19530146|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530147|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530148|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19530149|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19530150|NCT02902432|Endostar protein|endostar protein|mesh-list
19530151|NCT02902432|Endostatins|endostatins|mesh-list
19530152|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19530153|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20103205|NCT00003176|Carmustine|carmustine|mesh-list
20103206|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103207|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
20103208|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103209|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103210|NCT00003178|Idarubicin|idarubicin|mesh-list
20103211|NCT00003178|Cladribine|cladribine|mesh-list
20103212|NCT00003178|Lenograstim|lenograstim|mesh-list
20103213|NCT00003178|Sargramostim|sargramostim|mesh-list
19530154|NCT02902432|Growth Substances|growth substances|mesh-ancestor
19530155|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530156|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
19530157|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530158|NCT02902484|Nintedanib|nintedanib|mesh-list
19530159|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530160|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19530161|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530162|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530163|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
19530164|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19530165|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530166|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530167|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530168|NCT02902380|Analgesics|analgesics|mesh-ancestor
19530169|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
19530170|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530171|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19530172|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19530173|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19530174|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
19530175|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530176|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530177|NCT02902289|Ibuprofen|ibuprofen|mesh-list
19530178|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20103214|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20103215|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
20103216|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103217|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103218|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103219|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103220|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103221|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603871|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20603872|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20603873|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20603874|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603875|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20103222|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103223|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306723|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20306724|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306725|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306726|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306727|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
20306728|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
20306729|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20306730|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20306731|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306732|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20306733|NCT00656331|Amlodipine|amlodipine|mesh-list
20306734|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19530179|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530180|NCT02902289|Analgesics|analgesics|mesh-ancestor
19530181|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
20103224|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19530182|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530183|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530184|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603876|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20603877|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603878|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
20603879|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20603880|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19530185|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530186|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19530187|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530188|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530189|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
19530190|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19530191|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530192|NCT02902133|Acetazolamide|acetazolamide|mesh-list
19530193|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
19530194|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19530195|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530196|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530197|NCT02902133|Diuretics|diuretics|mesh-ancestor
19530198|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
19530199|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530200|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19530201|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19530202|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530203|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530204|NCT02901977|Ramipril|ramipril|mesh-list
19530205|NCT02901977|Doxazosin|doxazosin|mesh-list
20103225|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
20103226|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20103227|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20103228|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20103229|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
20103230|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20103231|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530206|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20103232|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20103233|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20103234|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19530207|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
19530208|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530209|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530210|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19530211|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19530212|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19530213|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19530214|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
20603881|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20603882|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
20603883|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603884|NCT02224105|Prednisolone|prednisolone|mesh-list
20603885|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20603886|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
20603887|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20603888|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
20603889|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20603890|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
20603891|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603892|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
19530215|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530216|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530217|NCT02902198|Quinine|quinine|mesh-list
19530218|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
19530219|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19530220|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20603893|NCT02224105|Hormones|hormones|mesh-ancestor
20603894|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603895|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530221|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530222|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19530223|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530224|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19749005|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
19530225|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530226|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530227|NCT02902198|Analgesics|analgesics|mesh-ancestor
19530228|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
19530229|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19530230|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
19530231|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19530232|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19530233|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19530234|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530235|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530236|NCT02901561|Misoprostol|misoprostol|mesh-list
19530237|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19530238|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
19530239|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19530240|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530241|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19530242|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19530243|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
19573800|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573801|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19573802|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
19573803|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573804|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573805|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19573806|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
19573807|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
19573808|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19573809|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573810|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573811|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573812|NCT05205447|Analgesics|analgesics|mesh-ancestor
19573813|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
19573814|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573815|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19573816|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19573817|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19573818|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19573819|NCT05196932|Antibodies|antibodies|mesh-list
19573820|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
19573821|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103235|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103236|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573822|NCT05182658|Empagliflozin|empagliflozin|mesh-list
19573823|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19573824|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573825|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19573826|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573827|NCT05180474|Antibodies|antibodies|mesh-list
19573828|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19573829|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
19573830|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578033|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578034|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578035|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578036|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578037|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578038|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578039|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578040|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
19578041|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
19578042|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578043|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578044|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578045|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578046|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578047|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
19578048|NCT03606967|Laxatives|laxatives|mesh-ancestor
19578049|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19578050|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19578051|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20103237|NCT00003181|Aldesleukin|aldesleukin|mesh-list
20103238|NCT00003181|Vinblastine|vinblastine|mesh-list
20103239|NCT00003181|Sargramostim|sargramostim|mesh-list
19530244|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
19530245|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
19530246|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103240|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
20103241|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103242|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103243|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20103244|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19530247|NCT02901366|Dotinurad|dotinurad|mesh-list
19530248|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
19530249|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
19530250|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530251|NCT02901366|Renal Agents|renal agents|mesh-ancestor
19530252|NCT02901379|Atorvastatin|atorvastatin|mesh-list
19530253|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19530254|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19530255|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
19530256|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530257|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19530258|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19530259|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530260|NCT02901353|Sirolimus|sirolimus|mesh-list
19530261|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530262|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530263|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19530264|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530265|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
19530266|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530267|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
19530268|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530269|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20306735|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20306736|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306737|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530270|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
19530271|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530272|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
19530273|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530274|NCT02901288|Levofloxacin|levofloxacin|mesh-list
19530275|NCT02901288|Ofloxacin|ofloxacin|mesh-list
19530276|NCT02901288|Rifampin|rifampin|mesh-list
19530277|NCT02901288|Isoniazid|isoniazid|mesh-list
20306738|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20306739|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306740|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
20306741|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19530278|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
19530279|NCT02901288|Ethambutol|ethambutol|mesh-list
19530280|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19530281|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530282|NCT02901288|Renal Agents|renal agents|mesh-ancestor
20306742|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
20306743|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306744|NCT00656422|Insulin|insulin|mesh-list
20306745|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20306746|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
20306747|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20306748|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306749|NCT00656435|Bevacizumab|bevacizumab|mesh-list
20306750|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20306751|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306752|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20306753|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20306754|NCT00656435|Growth Substances|growth substances|mesh-ancestor
20306755|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306756|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
20308892|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308893|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
20308894|NCT00666159|Tacrolimus|tacrolimus|mesh-list
20308895|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530283|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530284|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103245|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
20103246|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103247|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20308896|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
19530285|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103248|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103249|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103250|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
20306757|NCT00656526|Lidocaine|lidocaine|mesh-list
20306758|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
20306759|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
20306760|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306761|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306762|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
20306763|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306764|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20306765|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20306766|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20306767|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306768|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306769|NCT00656552|Citalopram|citalopram|mesh-list
20306770|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20306771|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20306772|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306773|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306774|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530286|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103251|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103252|NCT00003182|Gemcitabine|gemcitabine|mesh-list
20103253|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530287|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530288|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530289|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19530290|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19530291|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19530292|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
19530293|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
19530294|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19530295|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19530296|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19530297|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19530298|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19530299|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19530300|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19530301|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19530302|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19530303|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
19530304|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19530305|NCT02901184|Spironolactone|spironolactone|mesh-list
19530306|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19530307|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
19530308|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530309|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530310|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19530311|NCT02901184|Diuretics|diuretics|mesh-ancestor
19530312|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
19530313|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
19530314|NCT02901145|Nivolumab|nivolumab|mesh-list
19530315|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530316|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
19530317|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530318|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530319|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19530320|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
19530321|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530322|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530323|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19530324|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19530325|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19530326|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
19530327|NCT02901301|Capecitabine|capecitabine|mesh-list
19530328|NCT02901301|Trastuzumab|trastuzumab|mesh-list
19530329|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530330|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20103254|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103255|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
19530331|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530332|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
19530333|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530334|NCT02901236|Bevacizumab|bevacizumab|mesh-list
19530335|NCT02901236|Mitomycins|mitomycins|mesh-list
20103256|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103257|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
20103258|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103259|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103260|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530336|NCT02901236|Mitomycin|mitomycin|mesh-list
19530337|NCT02901236|Antimetabolites|antimetabolites|mesh-list
19530338|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19530339|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530340|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19530341|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19530342|NCT02901236|Growth Substances|growth substances|mesh-ancestor
19530343|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530344|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
19530345|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19530346|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
19530347|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530348|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19530349|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530350|NCT02900976|Rituximab|rituximab|mesh-list
19530351|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19530352|NCT02900976|Antibodies|antibodies|mesh-list
19530353|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
19530354|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19530355|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
19530356|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530357|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530358|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530359|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19530360|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19530361|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530362|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
19530363|NCT02900729|Losartan|losartan|mesh-list
19530364|NCT02900729|Amlodipine|amlodipine|mesh-list
19530365|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19530366|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19530367|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19530368|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19530369|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530370|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19530371|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530372|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
19530373|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19530374|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19530375|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19530376|NCT02900729|Diuretics|diuretics|mesh-ancestor
19530377|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
19530378|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19530379|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
19530380|NCT02900560|Azacitidine|azacitidine|mesh-list
19530381|NCT02900560|Cc-486|cc-486|mesh-list
19530382|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19530383|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530384|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530385|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
19530386|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530387|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530388|NCT02900742|Gemcitabine|gemcitabine|mesh-list
19530389|NCT02900742|Docetaxel|docetaxel|mesh-list
19530390|NCT02900742|Pemetrexed|pemetrexed|mesh-list
20103261|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
20103262|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103263|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
20103264|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103265|NCT00003183|Analgesics|analgesics|mesh-ancestor
20103266|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
20103267|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20103268|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103269|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19530391|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103270|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103271|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530392|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
19530393|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530394|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530395|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
19530396|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530397|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530398|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530399|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
19530400|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530401|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
19530402|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
19530403|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
19530404|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19530405|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19530406|NCT02900209|Vaccines|vaccines|mesh-list
19530407|NCT02900209|Immunologic Factors|immunologic factors|mesh-ancestor
19530408|NCT02900209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530409|NCT02900352|Zonisamide|zonisamide|mesh-list
19530410|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
19530411|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19530412|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19530413|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530414|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19530415|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530416|NCT02900469|Denosumab|denosumab|mesh-list
19530417|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19530418|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530435|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19530436|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19530437|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530438|NCT02900417|Incretins|incretins|mesh-ancestor
19530439|NCT02900417|Hormones|hormones|mesh-ancestor
19530440|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530441|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19530442|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
19530443|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530444|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530445|NCT02900157|Durvalumab|durvalumab|mesh-list
20103272|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103273|NCT00003184|Vaccines|vaccines|mesh-list
20103274|NCT00003184|Sargramostim|sargramostim|mesh-list
20103275|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
20103276|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
20103277|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103278|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20103279|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
20103280|NCT00003185|Sargramostim|sargramostim|mesh-list
20103281|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103282|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
20103283|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103284|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103285|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103286|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
20103287|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103288|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530446|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20103289|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103290|NCT00003187|Cytarabine|cytarabine|mesh-list
20103291|NCT00003187|Cyclosporine|cyclosporine|mesh-list
20103292|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
20103293|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
20103294|NCT00003187|Methotrexate|methotrexate|mesh-list
20103295|NCT00003187|Cyclosporins|cyclosporins|mesh-list
19530447|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530448|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
19530449|NCT02900430|Clotrimazole|clotrimazole|mesh-list
19530450|NCT02900430|Miconazole|miconazole|mesh-list
19530451|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530452|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19530453|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19530454|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19530455|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530456|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530457|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19530458|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
19530459|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530460|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530461|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19530462|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19530463|NCT02900105|Letrozole|letrozole|mesh-list
19530464|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530465|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19530466|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19530467|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530468|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530469|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19530470|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
19530471|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530472|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573831|NCT05151744|Ranibizumab|ranibizumab|mesh-list
19573832|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19573833|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19573834|NCT05151744|Growth Substances|growth substances|mesh-ancestor
19573835|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573836|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
19573837|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573838|NCT05151731|Ranibizumab|ranibizumab|mesh-list
19573839|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19573840|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19573841|NCT05151731|Growth Substances|growth substances|mesh-ancestor
19573842|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573843|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
19573844|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573845|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19573846|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19573847|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103296|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103297|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
20103298|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103299|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103300|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103301|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
20103302|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103303|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103304|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103305|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20103306|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
19573848|NCT05115513|Dronabinol|dronabinol|mesh-list
19573849|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
19573850|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103307|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20103308|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103309|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
19530473|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19530474|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
19530475|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530476|NCT02899611|Valproic Acid|valproic acid|mesh-list
19530477|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
20306775|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
20306776|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306777|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20306778|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
20306779|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20306780|NCT00656591|Methotrexate|methotrexate|mesh-list
20306781|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19530478|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530479|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530480|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
19530481|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530482|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530483|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
19530484|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19530485|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530486|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19530487|NCT02899507|Amoxicillin|amoxicillin|mesh-list
19530488|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19530489|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
19530490|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
19530491|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530492|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530493|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19530494|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530495|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530496|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19530497|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19530498|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530499|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
19530500|NCT02899364|Antidotes|antidotes|mesh-ancestor
19530501|NCT02899364|Protective Agents|protective agents|mesh-ancestor
19530502|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530503|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
19530504|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530505|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
19530506|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530507|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530508|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
19530509|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
19530510|NCT02899286|BCT-100|bct-100|mesh-list
19530511|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530512|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
19530513|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19530514|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
19530515|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
19530516|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530517|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530518|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530519|NCT02899182|Analgesics|analgesics|mesh-ancestor
19530520|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
19530521|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530522|NCT02899169|Tretinoin|tretinoin|mesh-list
19530523|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
19530524|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
19530525|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530526|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
19530527|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
19530528|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
19530529|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530530|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530531|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19530532|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19530533|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530534|NCT02899000|Doxycycline|doxycycline|mesh-list
19530535|NCT02899000|Adapalene|adapalene|mesh-list
19530536|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19530537|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530538|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306782|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
19530539|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
19530540|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19530541|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19530542|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
19530543|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19530544|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530545|NCT02899000|Analgesics|analgesics|mesh-ancestor
19530546|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
19530547|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530548|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530549|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530550|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530551|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19530552|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530553|NCT02899026|Prednisone|prednisone|mesh-list
19530554|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19530555|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530556|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
19530557|NCT02899026|Hormones|hormones|mesh-ancestor
19530558|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530559|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530560|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19530561|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530562|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
19530563|NCT02898961|Gentamicins|gentamicins|mesh-list
19530564|NCT02898961|Amikacin|amikacin|mesh-list
19530565|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530566|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530567|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19530568|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530569|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530570|NCT02898792|Remifentanil|remifentanil|mesh-list
19530571|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19530572|NCT02898792|Narcotics|narcotics|mesh-ancestor
19530573|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530574|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530575|NCT02898792|Analgesics|analgesics|mesh-ancestor
19530576|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
19530577|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530578|NCT02898779|Primaquine|primaquine|mesh-list
19530579|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
19530580|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19530581|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19530582|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530583|NCT02898571|Ascorbic Acid|ascorbic acid|mesh-list
19530584|NCT02898571|Vitamins|vitamins|mesh-ancestor
20306783|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20306784|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306785|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530585|NCT02898571|Micronutrients|micronutrients|mesh-ancestor
19530586|NCT02898571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530587|NCT02898571|Antioxidants|antioxidants|mesh-ancestor
19530588|NCT02898571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530589|NCT02898571|Protective Agents|protective agents|mesh-ancestor
19530590|NCT02898376|Tocopherols|tocopherols|mesh-list
19530591|NCT02898376|Vitamin E|vitamin e|mesh-list
19530592|NCT02898376|Tocotrienols|tocotrienols|mesh-list
19530593|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
19530594|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
19530595|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19530596|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530597|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530598|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19530599|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19530600|NCT02898376|Protective Agents|protective agents|mesh-ancestor
19530601|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530602|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
19530603|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19530604|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
19530605|NCT02898376|Vitamins|vitamins|mesh-ancestor
19530606|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
20306786|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
20306787|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306788|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530607|NCT02898610|Colchicine|colchicine|mesh-list
19530608|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
19530609|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530610|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19530611|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
19530612|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
19530613|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530614|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573851|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573852|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19573853|NCT05115513|Analgesics|analgesics|mesh-ancestor
19573854|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
19573855|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573856|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19573857|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19573858|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573859|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573860|NCT05115513|Hormones|hormones|mesh-ancestor
19573861|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573862|NCT05113940|Midazolam|midazolam|mesh-list
19573863|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19573864|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19573865|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306789|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
20306790|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306791|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20603896|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20603897|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573866|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573867|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20306792|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306793|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
20103310|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
20103311|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103312|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20103313|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20103314|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
20103315|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103316|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
20103317|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20103318|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20103319|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
20103320|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
19573868|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19573869|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573870|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19573871|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
19573872|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
19573873|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
19573874|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
19573875|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573876|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573877|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19573878|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
19573879|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573880|NCT05063656|Gabapentin|gabapentin|mesh-list
19573881|NCT05063656|Analgesics|analgesics|mesh-ancestor
19573882|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
19573883|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573884|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573885|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
19573886|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19573887|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19573888|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573889|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19573890|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19573891|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19573892|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573893|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573894|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
19573895|NCT05059860|Insulin|insulin|mesh-list
19573896|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19573897|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573898|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19573899|NCT05055128|Lansoprazole|lansoprazole|mesh-list
19573900|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
19573901|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20103321|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20103322|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20103323|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
19530615|NCT02897934|Bupivacaine|bupivacaine|mesh-list
19530616|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
19530617|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
19530618|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530619|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530620|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
19530621|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530622|NCT02897986|Vinorelbine|vinorelbine|mesh-list
19530623|NCT02897986|Propranolol|propranolol|mesh-list
20103324|NCT00003187|Hormones|hormones|mesh-ancestor
20103325|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103326|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20103327|NCT00003187|Protective Agents|protective agents|mesh-ancestor
20103328|NCT00003190|Cytarabine|cytarabine|mesh-list
20103329|NCT00003190|Etoposide|etoposide|mesh-list
20103330|NCT00003190|Daunorubicin|daunorubicin|mesh-list
19530624|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19530625|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530626|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103331|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
19530627|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
19530628|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
19530629|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530630|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19530631|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19530632|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
19530633|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530634|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530635|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19530636|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19530637|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
19530638|NCT02898012|Bevacizumab|bevacizumab|mesh-list
19530639|NCT02898012|Temozolomide|temozolomide|mesh-list
19530640|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19530641|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530642|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19530643|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19530644|NCT02898012|Growth Substances|growth substances|mesh-ancestor
19530645|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530646|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
19530647|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19530648|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
19530649|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530650|NCT02897869|Amikacin|amikacin|mesh-list
19530651|NCT02897869|Murepavadin|murepavadin|mesh-list
19530652|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530653|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530654|NCT02897856|Midazolam|midazolam|mesh-list
19530655|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19530656|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19530657|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530658|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530659|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19530660|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19530661|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19530662|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19530663|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
19530664|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
19530665|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
19530666|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
19530667|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530668|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530669|NCT02897830|Dexamethasone|dexamethasone|mesh-list
19530670|NCT02897830|Lenalidomide|lenalidomide|mesh-list
19530671|NCT02897830|Ixazomib|ixazomib|mesh-list
19530672|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530673|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
19530674|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
19530675|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530676|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530677|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19530678|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
19530679|NCT02897830|Hormones|hormones|mesh-ancestor
19530680|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530681|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103332|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103333|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103334|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19530682|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530683|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
19530684|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19530685|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19530686|NCT02897830|Growth Substances|growth substances|mesh-ancestor
19530687|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
19530688|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
19530689|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530690|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530691|NCT02897765|Nivolumab|nivolumab|mesh-list
19530692|NCT02897765|Poly ICLC|poly iclc|mesh-list
19530693|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
19530694|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530695|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19530696|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530697|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19530698|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530699|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
19530700|NCT02897557|Pancrelipase|pancrelipase|mesh-list
19530701|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19530702|NCT02897596|Grazoprevir|grazoprevir|mesh-list
19530703|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
19530704|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530705|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
19530706|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19530707|NCT02897206|Imipenem|imipenem|mesh-list
19530708|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
19530709|NCT02897206|Cilastatin|cilastatin|mesh-list
19530710|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530711|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530712|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
19530713|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530714|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103335|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103336|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103337|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103338|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103339|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
20103340|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
20103341|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103342|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103343|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
20103344|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103345|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19530715|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
19530716|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
19530717|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530718|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
19530719|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530720|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530721|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
19530722|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19530723|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530724|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19530725|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530726|NCT02897063|Midodrine|midodrine|mesh-list
19530727|NCT02897063|Droxidopa|droxidopa|mesh-list
19530728|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
19530729|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
19530730|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530731|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530732|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19530733|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19530734|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19530735|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19530736|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
19530737|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530738|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530739|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20103346|NCT00003191|Fenretinide|fenretinide|mesh-list
20103347|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103348|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20103349|NCT00003191|Protective Agents|protective agents|mesh-ancestor
19530740|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19530741|NCT02897076|Betamethasone|betamethasone|mesh-list
19530742|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
19530743|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19530744|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
19530745|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19530746|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530747|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
19530748|NCT02897076|Hormones|hormones|mesh-ancestor
19530749|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530750|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530751|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19530752|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
19530753|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
19530754|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530755|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19530756|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530757|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530758|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
19530759|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530760|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19530761|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530762|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530763|NCT02896803|Fluorouracil|fluorouracil|mesh-list
19530764|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
19530765|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
19530766|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530767|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530768|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530769|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530770|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
19530771|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530772|NCT02897037|Heparin|heparin|mesh-list
19530773|NCT02897037|Bivalirudin|bivalirudin|mesh-list
19530774|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
19530775|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19530776|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19530777|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530778|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
19530779|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19530780|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
19530781|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530782|NCT02897011|Methotrexate|methotrexate|mesh-list
19530783|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19530784|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
19530785|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19530786|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530787|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530788|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
19530789|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530790|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530791|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
19530792|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530793|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19530794|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530795|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
19530796|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530797|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19573902|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573903|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19573904|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573905|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573906|NCT05048498|Azacitidine|azacitidine|mesh-list
20103350|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103351|NCT00003193|Paclitaxel|paclitaxel|mesh-list
20103352|NCT00003193|Amifostine|amifostine|mesh-list
20103353|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103354|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103355|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103356|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103357|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103358|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103359|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20103360|NCT00003193|Protective Agents|protective agents|mesh-ancestor
19530798|NCT02896621|Amlodipine|amlodipine|mesh-list
19530799|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
19530800|NCT02896621|Amiloride|amiloride|mesh-list
19530801|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19530802|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19530803|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19530804|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530805|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19530806|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530807|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
20103361|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103362|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
20103363|NCT00003194|Thiotepa|thiotepa|mesh-list
20103364|NCT00003194|Carboplatin|carboplatin|mesh-list
20103365|NCT00003194|Etoposide|etoposide|mesh-list
19530808|NCT02896621|Diuretics|diuretics|mesh-ancestor
19530809|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
19530810|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19530811|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19530812|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19530813|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19530814|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19530815|NCT02896582|Cytarabine|cytarabine|mesh-list
19530816|NCT02896582|Dexamethasone|dexamethasone|mesh-list
19530817|NCT02896582|Etoposide|etoposide|mesh-list
19530818|NCT02896582|Melphalan|melphalan|mesh-list
19530819|NCT02896582|Cisplatin|cisplatin|mesh-list
19530820|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
19530821|NCT02896582|Carmustine|carmustine|mesh-list
19530822|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530823|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
19530824|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
19530825|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530826|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103366|NCT00003194|Topotecan|topotecan|mesh-list
20103367|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103368|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
20103369|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103370|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306794|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530827|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19530828|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
19530829|NCT02896582|Hormones|hormones|mesh-ancestor
19530830|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530831|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19530832|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530833|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19530834|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19530835|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19530836|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530837|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530838|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19530839|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
19530840|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
19530841|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530842|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530843|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
19530844|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19530845|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
19530846|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19530847|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19530848|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
19530849|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19530850|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530851|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530852|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530853|NCT02896413|Analgesics|analgesics|mesh-ancestor
19530854|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
19530855|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530856|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19530857|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19530858|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19530859|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
19530860|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20103371|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103372|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
19530861|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530862|NCT02896270|Valproic Acid|valproic acid|mesh-list
19530863|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
19530864|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530865|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530866|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
19530867|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530868|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530869|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
19530870|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19530871|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530872|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19530873|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
19530874|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19530875|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19530876|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19530877|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
19749006|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19749007|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749008|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
19530878|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19530879|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530880|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530881|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530882|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
19530883|NCT02896101|Tacrolimus|tacrolimus|mesh-list
19530884|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19530885|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530886|NCT02896101|Analgesics|analgesics|mesh-ancestor
19530887|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
19530888|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530889|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530890|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530891|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530892|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
19530893|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19530894|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
19530895|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19530896|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530897|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530898|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19530899|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
19530900|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530901|NCT02896023|Menotropins|menotropins|mesh-list
19530902|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19530903|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
19530904|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19530905|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530906|NCT02895659|Norepinephrine|norepinephrine|mesh-list
19530907|NCT02895659|Epinephrine|epinephrine|mesh-list
19530908|NCT02895659|Racepinephrine|racepinephrine|mesh-list
19530909|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
19530910|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19530911|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19530912|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
19530913|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19530914|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530915|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530916|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
19530917|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
19530918|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530919|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19530920|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19530921|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19530922|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19530923|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
19530924|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
19530925|NCT02895529|Itraconazole|itraconazole|mesh-list
19530926|NCT02895529|Caspofungin|caspofungin|mesh-list
19530927|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
19530928|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530929|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19530930|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20306795|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19530931|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530932|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530933|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19530934|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
19530935|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530936|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530937|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19530938|NCT02895672|Exenatide|exenatide|mesh-list
19530939|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19530940|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530941|NCT02895672|Incretins|incretins|mesh-ancestor
19530942|NCT02895672|Hormones|hormones|mesh-ancestor
19530943|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19530944|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19530945|NCT02895750|Metformin|metformin|mesh-list
19530946|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19530947|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530948|NCT02895191|Urinastatin|urinastatin|mesh-list
19530949|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
19530950|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19530951|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
19530952|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530953|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530954|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
19530955|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19530956|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19530957|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530958|NCT02895061|Vitamins|vitamins|mesh-ancestor
19530959|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
19530960|NCT02895113|Aspirin|aspirin|mesh-list
19530961|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19530962|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19530963|NCT02895113|Analgesics|analgesics|mesh-ancestor
19530964|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
19530965|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530966|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530967|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19530968|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19530969|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19530970|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19530971|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19530972|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19530973|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19530974|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530975|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
19530976|NCT02895321|Listerine|listerine|mesh-list
19530977|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
19530978|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
19530979|NCT02895321|Protective Agents|protective agents|mesh-ancestor
19530980|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530981|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19530982|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19530983|NCT02894983|Calpastatin|calpastatin|mesh-list
19530984|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19530985|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
19530986|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19530987|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573907|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19573908|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
19573909|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573910|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573911|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573912|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19573913|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19573914|NCT05036226|Metformin|metformin|mesh-list
19573915|NCT05036226|Sirolimus|sirolimus|mesh-list
19573916|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
19573917|NCT05036226|Nelfinavir|nelfinavir|mesh-list
19573918|NCT05036226|Dasatinib|dasatinib|mesh-list
19573919|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19573920|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573921|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19573922|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306796|NCT00656643|Sirolimus|sirolimus|mesh-list
19573923|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19573924|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603898|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
20306797|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20306798|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306799|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103373|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103374|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103375|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103376|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103377|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103378|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103379|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103380|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20103381|NCT00003195|Interferons|interferons|mesh-list
20103382|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
20103383|NCT00003195|Busulfan|busulfan|mesh-list
20103384|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103385|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
20103386|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103387|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
20103388|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530988|NCT02895022|Lidocaine|lidocaine|mesh-list
19530989|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
19530990|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
19530991|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19530992|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19530993|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
19530994|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19530995|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19530996|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19530997|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19530998|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19530999|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531000|NCT02894957|Varenicline|varenicline|mesh-list
19531001|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19531002|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19531003|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
19531004|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531005|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531006|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531007|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
19531008|NCT02895074|Tropicamide|tropicamide|mesh-list
19531009|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
19531010|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
19531011|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531012|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531013|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19531014|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19531015|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
19531016|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531017|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531018|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
19531019|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
19531020|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531021|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
19531022|NCT02894892|Esomeprazole|esomeprazole|mesh-list
19531023|NCT02894892|Bismuth|bismuth|mesh-list
19531024|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19531025|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531026|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19531027|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531028|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531029|NCT02894892|Antacids|antacids|mesh-ancestor
19531030|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
19531031|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
19531032|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531033|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19531034|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
19531035|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531036|NCT02894593|Ethanol|ethanol|mesh-list
19531037|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
19531038|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19531039|NCT02894593|Listerine|listerine|mesh-list
19531040|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
19531041|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20103389|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
19531042|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573925|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
19531043|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531044|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531045|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
19531046|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
19531047|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
19531048|NCT02894593|Protective Agents|protective agents|mesh-ancestor
19531049|NCT02894554|Lamivudine|lamivudine|mesh-list
19531050|NCT02894554|Telbivudine|telbivudine|mesh-list
19531051|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19531052|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19531053|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531054|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531055|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
19531056|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531057|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19531058|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20103390|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103391|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19531059|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
19531060|NCT02894606|Basiliximab|basiliximab|mesh-list
19531061|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
19531062|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531063|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19531064|NCT02894684|Aztreonam|aztreonam|mesh-list
19531065|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19531066|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531067|NCT02894710|Lidocaine|lidocaine|mesh-list
19531068|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
19531069|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
19531070|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531071|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531072|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
19531073|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531074|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19531075|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19531076|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19531077|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19531078|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531079|NCT02894645|Cytarabine|cytarabine|mesh-list
19531080|NCT02894645|Dexamethasone|dexamethasone|mesh-list
19531081|NCT02894645|Prednisolone|prednisolone|mesh-list
19531082|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
20103392|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103393|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103394|NCT00003196|Cyclosporine|cyclosporine|mesh-list
20103395|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
20103396|NCT00003196|Cyclosporins|cyclosporins|mesh-list
20103397|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103398|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531083|NCT02894645|Doxorubicin|doxorubicin|mesh-list
19531084|NCT02894645|Methotrexate|methotrexate|mesh-list
19531085|NCT02894645|Fludarabine|fludarabine|mesh-list
19531086|NCT02894645|Vincristine|vincristine|mesh-list
19531087|NCT02894645|Daunorubicin|daunorubicin|mesh-list
19531088|NCT02894645|Asparaginase|asparaginase|mesh-list
19531089|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
19531090|NCT02894645|Thioguanine|thioguanine|mesh-list
19531091|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19531092|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
19531093|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531094|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531095|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19531096|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
19531097|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531098|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531099|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19531100|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531101|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
19531102|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
19531103|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531104|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531105|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
19531106|NCT02894645|Hormones|hormones|mesh-ancestor
20603899|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
19531107|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531108|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19531109|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20603900|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603901|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20603902|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20603903|NCT02224105|Protective Agents|protective agents|mesh-ancestor
20603904|NCT02224131|Aspirin|aspirin|mesh-list
20603905|NCT02224131|Clopidogrel|clopidogrel|mesh-list
20603906|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20603907|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19531110|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19531111|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19531112|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531113|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19531114|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
19531115|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19531116|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19531117|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
19531118|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
19531119|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19531120|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19531121|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
19531122|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531123|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19531124|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531125|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
19531126|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531127|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19531128|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19531129|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19531130|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531131|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
19531132|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19531133|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
19531134|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19531135|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
19531136|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531137|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531138|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
19531139|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19531140|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
19531141|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19531142|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19531143|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19531144|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
19531145|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19531146|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531147|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19531148|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19531149|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19531150|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19531151|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531152|NCT02893995|Treprostinil|treprostinil|mesh-list
19531153|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19531154|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19531155|NCT02894268|Doxycycline|doxycycline|mesh-list
19531156|NCT02894268|Furazolidone|furazolidone|mesh-list
19531157|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19531158|NCT02894268|Esomeprazole|esomeprazole|mesh-list
19531159|NCT02894268|Bismuth|bismuth|mesh-list
19531160|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531161|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19531162|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531163|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19531164|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531165|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531166|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
19531167|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19531168|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19531169|NCT02894268|Antacids|antacids|mesh-ancestor
19531170|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19531171|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19531172|NCT02894268|Renal Agents|renal agents|mesh-ancestor
19531173|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19531174|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19531175|NCT02893618|Diazoxide|diazoxide|mesh-list
19531176|NCT02893618|Choline|choline|mesh-list
20603908|NCT02224131|Analgesics|analgesics|mesh-ancestor
19531177|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
19531178|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19531179|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
19531180|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531181|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20103399|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103400|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
20103401|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103402|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
20103403|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103404|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
20103405|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103406|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19531182|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19531183|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
19531184|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19531185|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
19531186|NCT02893722|Oxytocin|oxytocin|mesh-list
19531187|NCT02893722|Atosiban|atosiban|mesh-list
19531188|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
19531189|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19531190|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531191|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
19531192|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531193|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
19531194|NCT02893709|Omeprazole|omeprazole|mesh-list
19531195|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19531196|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531197|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19531198|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531199|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573926|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19573927|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
19573928|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
19573929|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19573930|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19573931|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573932|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573933|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19573934|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19573935|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19573936|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19573937|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
19573938|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19573939|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20103407|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20306800|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306801|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
20306802|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306803|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
20306804|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306805|NCT00656695|Cyclosporine|cyclosporine|mesh-list
20306806|NCT00656695|Cyclosporins|cyclosporins|mesh-list
20306807|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
20306808|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306809|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
20306810|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306811|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306812|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306813|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
20306814|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306815|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306816|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20306817|NCT00656747|Amoxicillin|amoxicillin|mesh-list
20306818|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
19573940|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
19573941|NCT05035862|Interferons|interferons|mesh-list
19573942|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
19573943|NCT05035862|Prednisone|prednisone|mesh-list
19573944|NCT05035862|Albuterol|albuterol|mesh-list
19573945|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573946|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
19573947|NCT05035862|Hormones|hormones|mesh-ancestor
19573948|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103408|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306819|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
20306820|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
19531200|NCT02893826|Nimodipine|nimodipine|mesh-list
19531201|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19531202|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19531203|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19531204|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531205|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19531206|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531207|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
19531208|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19531209|NCT02893332|Gefitinib|gefitinib|mesh-list
19531210|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531211|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19531212|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531213|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531214|NCT02893280|Aspirin|aspirin|mesh-list
20103409|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20103410|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
20103411|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20103412|NCT00003198|Topotecan|topotecan|mesh-list
20103413|NCT00003198|Ifosfamide|ifosfamide|mesh-list
20103414|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20103415|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103416|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103417|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103418|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103419|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103420|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
20103421|NCT00003200|Docetaxel|docetaxel|mesh-list
20103422|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103423|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103424|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
19531215|NCT02893280|Enoxaparin|enoxaparin|mesh-list
19531216|NCT02893280|Streptokinase|streptokinase|mesh-list
19531217|NCT02893280|Clopidogrel|clopidogrel|mesh-list
19531218|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19531219|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20103425|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103426|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103427|NCT00003202|Gemcitabine|gemcitabine|mesh-list
20103428|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103429|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19531220|NCT02893280|Analgesics|analgesics|mesh-ancestor
19531221|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
19531222|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531223|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531224|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531225|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531226|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19531227|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19531228|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531229|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19531230|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19531231|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531232|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
19531233|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19531234|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19531235|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19531236|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
19531237|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531238|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
19531239|NCT02893553|Midodrine|midodrine|mesh-list
19531240|NCT02893553|Bromides|bromides|mesh-list
19531241|NCT02893553|Mirabegron|mirabegron|mesh-list
19531242|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19531243|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
19531244|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19531245|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19531246|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19531247|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
19531248|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531249|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103430|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
20103431|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531250|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531251|NCT02893553|Urological Agents|urological agents|mesh-ancestor
19531252|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
19531253|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
19531254|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531255|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19531256|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19531257|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19531258|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19531259|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531260|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
19531261|NCT02893540|Capecitabine|capecitabine|mesh-list
19531262|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19531263|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
19531264|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531265|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531266|NCT02893371|Lamotrigine|lamotrigine|mesh-list
19531267|NCT02893371|Carbamazepine|carbamazepine|mesh-list
19531268|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
19531269|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19531270|NCT02893371|Valproic Acid|valproic acid|mesh-list
19531271|NCT02893371|Haloperidol|haloperidol|mesh-list
20103432|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
20103433|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531272|NCT02893371|Olanzapine|olanzapine|mesh-list
19531273|NCT02893371|Risperidone|risperidone|mesh-list
19531274|NCT02893371|Aripiprazole|aripiprazole|mesh-list
19531275|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19531276|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19531277|NCT02893371|Ziprasidone|ziprasidone|mesh-list
19531278|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19531279|NCT02893371|Clozapine|clozapine|mesh-list
19531280|NCT02893371|Asenapine|asenapine|mesh-list
19531281|NCT02893371|Perphenazine|perphenazine|mesh-list
19531282|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
19531283|NCT02893371|Mirtazapine|mirtazapine|mesh-list
19531284|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
19531285|NCT02893371|Doxepin|doxepin|mesh-list
19531286|NCT02893371|Citalopram|citalopram|mesh-list
19531287|NCT02893371|Bupropion|bupropion|mesh-list
19531288|NCT02893371|Sertraline|sertraline|mesh-list
19531289|NCT02893371|Fluoxetine|fluoxetine|mesh-list
19531290|NCT02893371|Paroxetine|paroxetine|mesh-list
19531291|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19531292|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19531293|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19531294|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19531295|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
19531296|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531297|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531298|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531299|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19531300|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19531301|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531302|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19531303|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19531304|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
19531305|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19531306|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19531307|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19531308|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19531309|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
19531310|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19531311|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
19531312|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531313|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
19531314|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531315|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19531316|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19531317|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19531318|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531319|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
19531320|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19531321|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19531322|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19531323|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19531324|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19531325|NCT02893371|Analgesics|analgesics|mesh-ancestor
19531326|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
20103434|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531327|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
19531328|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
19531329|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19531330|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19531331|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19531332|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
19531333|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19531334|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
19531335|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
19531336|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19531337|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19531338|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19531339|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19531340|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
19531341|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19531342|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19531343|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19531344|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19531345|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
19531346|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19531347|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19531348|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19531349|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19531350|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19531351|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20603909|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
20603910|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531352|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19531353|NCT02893293|Hematinics|hematinics|mesh-ancestor
19531354|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19531355|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19531356|NCT02893423|Ropivacaine|ropivacaine|mesh-list
19531357|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
19531358|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
19531359|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531360|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531361|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
19531362|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531363|NCT02893176|Macitentan|macitentan|mesh-list
19531364|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19531365|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19531366|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531367|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19531368|NCT02893384|Anesthetics|anesthetics|mesh-list
19531369|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
19531370|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531371|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531372|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
19531373|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531374|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
19531375|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
19531376|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
20103435|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103436|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
20103437|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103438|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
20103439|NCT00003203|Cisplatin|cisplatin|mesh-list
20103440|NCT00003203|Carboplatin|carboplatin|mesh-list
20103441|NCT00003203|Vincristine|vincristine|mesh-list
20103442|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103443|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
20103444|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531377|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531378|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531379|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
19531380|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531381|NCT02893488|Lamivudine|lamivudine|mesh-list
19531382|NCT02893488|Dolutegravir|dolutegravir|mesh-list
19531383|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19531384|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19531385|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103445|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103446|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103447|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
19531386|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531387|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
19531388|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531389|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19531390|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19531391|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19531392|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19531393|NCT02893254|Adalimumab|adalimumab|mesh-list
19531394|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531395|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531396|NCT02893111|Bortezomib|bortezomib|mesh-list
19531397|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531398|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19531399|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19531400|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
19531401|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531402|NCT02892916|Ketamine|ketamine|mesh-list
19531403|NCT02892916|Analgesics|analgesics|mesh-ancestor
19531404|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
19531405|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531406|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531407|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19531408|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19531409|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
19531410|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
19531411|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531412|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19531413|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19531414|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531415|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531416|NCT02892942|Cetrorelix|cetrorelix|mesh-list
19531417|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19531418|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
19531419|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19531420|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531421|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
19531422|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531423|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19531424|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
19531425|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531426|NCT02892591|Oxycodone|oxycodone|mesh-list
19531427|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19531428|NCT02892591|Narcotics|narcotics|mesh-ancestor
19531429|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531430|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531431|NCT02892591|Analgesics|analgesics|mesh-ancestor
19531432|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
19531433|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531434|NCT02892357|Omeprazole|omeprazole|mesh-list
19531435|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19531436|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531437|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19531438|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531439|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531440|NCT02892318|Atezolizumab|atezolizumab|mesh-list
19531441|NCT02892318|Guadecitabine|guadecitabine|mesh-list
19531442|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531443|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
19531444|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19531445|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573949|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573950|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573951|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573952|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
19573953|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19573954|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19573955|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
19573956|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573957|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19573958|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
19573959|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
19573960|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19573961|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19573962|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19573963|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19531446|NCT02891967|Z 350|z 350|mesh-list
19531447|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19531448|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19531449|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531450|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531451|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
19531452|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531453|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531454|NCT02891980|Vaccines|vaccines|mesh-list
19531455|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
20103448|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103449|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103450|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103451|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103452|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103453|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103454|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103455|NCT00003204|Prednisone|prednisone|mesh-list
20103456|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
20103457|NCT00003204|Rituximab|rituximab|mesh-list
20103458|NCT00003204|Fludarabine|fludarabine|mesh-list
19531456|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531457|NCT02891785|Antipain|antipain|mesh-list
19531458|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
19531459|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531460|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531461|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19531462|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19531463|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531464|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
19531465|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531466|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19531467|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531468|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531469|NCT02891161|Durvalumab|durvalumab|mesh-list
19531470|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19531471|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531472|NCT02891278|Cytarabine|cytarabine|mesh-list
19531473|NCT02891278|Sertraline|sertraline|mesh-list
19531474|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19531475|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
19531476|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531477|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531478|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
19531479|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531480|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19531481|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
19531482|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531483|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
19531484|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19531485|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19531486|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19531487|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19531488|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531489|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
19531490|NCT02891018|Paclitaxel|paclitaxel|mesh-list
19531491|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19531492|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103459|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
20603911|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603912|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603913|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20603914|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19531493|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531494|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531495|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19531496|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531497|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531498|NCT02891083|Paclitaxel|paclitaxel|mesh-list
19531499|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19531500|NCT02891083|Cisplatin|cisplatin|mesh-list
20603915|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20603916|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603917|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20103460|NCT00003204|Vincristine|vincristine|mesh-list
19531501|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19531502|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531503|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531504|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19531505|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531506|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531507|NCT02891005|Paclitaxel|paclitaxel|mesh-list
19531508|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19531509|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531510|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531511|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
19531512|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531513|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531514|NCT02890875|Ethanol|ethanol|mesh-list
19531515|NCT02890875|Heparin|heparin|mesh-list
19531516|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
19531517|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19531518|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19531519|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531520|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19531521|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531522|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531523|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531524|NCT02890719|Ribavirin|ribavirin|mesh-list
19531525|NCT02890719|Grazoprevir|grazoprevir|mesh-list
19531526|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
19531527|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531528|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
19531529|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531530|NCT02890745|Empagliflozin|empagliflozin|mesh-list
19531531|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19531532|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531533|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19531534|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531535|NCT02890771|Turmeric extract|turmeric extract|mesh-list
19531536|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
19531537|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531538|NCT02890771|Protective Agents|protective agents|mesh-ancestor
19531539|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531540|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
19531541|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19531542|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531543|NCT02890823|Vitamins|vitamins|mesh-ancestor
19531544|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
19531545|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19531546|NCT02890602|Prednisolone|prednisolone|mesh-list
19531547|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
19531548|NCT02890602|Vincristine|vincristine|mesh-list
19531549|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
19531550|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19531551|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
19531552|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531553|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531554|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19531555|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
19531556|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531557|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531558|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19531559|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19531560|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531561|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
19531562|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531563|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531564|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
19531565|NCT02890602|Hormones|hormones|mesh-ancestor
19531566|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531567|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19531568|NCT02890602|Hematinics|hematinics|mesh-ancestor
19531569|NCT02890784|Dasatinib|dasatinib|mesh-list
19531570|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531571|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19531572|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531573|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531574|NCT02890589|Chromium|chromium|mesh-list
19531575|NCT02890589|Everolimus|everolimus|mesh-list
19531576|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531577|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19531578|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
20603918|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20603919|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603920|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
20603921|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20603922|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20603923|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20603924|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
20603925|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603926|NCT02224170|Dexamethasone|dexamethasone|mesh-list
20603927|NCT02224170|Lidocaine|lidocaine|mesh-list
20603928|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20603929|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
20306821|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20306822|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20306823|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20306824|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306825|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20306826|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20306827|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306828|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306829|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306830|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20306831|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
20306832|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20306833|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306834|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19531579|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531580|NCT02890589|Trace Elements|trace elements|mesh-ancestor
19531581|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
19531582|NCT02890173|Eplerenone|eplerenone|mesh-list
19531583|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19531584|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
19531585|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531586|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531587|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19531588|NCT02890173|Diuretics|diuretics|mesh-ancestor
19531589|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
19531590|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19531591|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
19531592|NCT02890238|Citric Acid|citric acid|mesh-list
19531593|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
19531594|NCT02890238|Clomiphene|clomiphene|mesh-list
19531595|NCT02890238|Enclomiphene|enclomiphene|mesh-list
19531596|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
19531597|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
19531598|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19531599|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
19531600|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
19531601|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531602|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
19531603|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19531604|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19531605|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531606|NCT02890238|Urological Agents|urological agents|mesh-ancestor
19531607|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19531608|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
19531609|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531610|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531611|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20306835|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20306836|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20306837|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20306838|NCT00656773|Sufentanil|sufentanil|mesh-list
19531612|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
19531613|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19531614|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19531615|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19531616|NCT02890511|Paclitaxel|paclitaxel|mesh-list
19531617|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19531618|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603930|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
19531619|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531620|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
20306839|NCT00656773|Morphine|morphine|mesh-list
20306840|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20103461|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103462|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
20103463|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103464|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103465|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103466|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
20103467|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103468|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103469|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103470|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20103471|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20306841|NCT00656773|Narcotics|narcotics|mesh-ancestor
20306842|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603931|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531621|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531622|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573964|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
19573965|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19573966|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573967|NCT05004116|Irinotecan|irinotecan|mesh-list
19573968|NCT05004116|Temozolomide|temozolomide|mesh-list
19573969|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19573970|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19573971|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19573972|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19573973|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573974|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19573975|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
19573976|NCT05000658|Dexamethasone|dexamethasone|mesh-list
19573977|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19573978|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19573979|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
19573980|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
19573981|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573982|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573983|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19573984|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
19573985|NCT05000658|Hormones|hormones|mesh-ancestor
19573986|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19573987|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19573988|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19573989|NCT04969510|Pramoxine|pramoxine|mesh-list
19573990|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
19573991|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
19573992|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19573993|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573994|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
19573995|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19573996|NCT04965272|Cariprazine|cariprazine|mesh-list
20103472|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
20603932|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19573997|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19573998|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19573999|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574000|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574001|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574002|NCT04961593|Caspofungin|caspofungin|mesh-list
19574003|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
19574004|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574005|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574006|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574007|NCT04961580|Ceftazidime|ceftazidime|mesh-list
19574008|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19574009|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574010|NCT04958772|Lenograstim|lenograstim|mesh-list
19574011|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19574012|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
19574013|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574014|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
19574015|NCT04954989|Hematinics|hematinics|mesh-ancestor
19574016|NCT04937738|Leucovorin|leucovorin|mesh-list
20306843|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531623|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
19531624|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19531625|NCT02890277|Chitosan|chitosan|mesh-list
19531626|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20103473|NCT00003204|Hormones|hormones|mesh-ancestor
20103474|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103475|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103476|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103477|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
20103478|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103479|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531627|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19531628|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
19531629|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531630|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19531631|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
19531632|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
19531633|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
20103480|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103481|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103482|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
19531634|NCT02890277|Coagulants|coagulants|mesh-ancestor
19531635|NCT02890186|Remifentanil|remifentanil|mesh-list
19531636|NCT02890186|Propofol|propofol|mesh-list
19531637|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19531638|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531639|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531640|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19531641|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
19531642|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
19531643|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19531644|NCT02890186|Narcotics|narcotics|mesh-ancestor
19531645|NCT02890186|Analgesics|analgesics|mesh-ancestor
19531646|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
19531647|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531648|NCT02890199|Lidocaine|lidocaine|mesh-list
19531649|NCT02890199|Bupivacaine|bupivacaine|mesh-list
19531650|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
19531651|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
19531652|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531653|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531654|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
19531655|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531656|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19531657|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19531658|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19531659|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19531660|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531661|NCT02890082|Tamoxifen|tamoxifen|mesh-list
19531662|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19531663|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
19531664|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531665|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531666|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19531667|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531668|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19531669|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19531670|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19531671|NCT02890368|Interferons|interferons|mesh-list
19531672|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19531673|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19531674|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
19531675|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531676|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
19531677|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531678|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19531679|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
19531680|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531681|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531682|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
20103483|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20103484|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
20103485|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103486|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574017|NCT04937738|Docetaxel|docetaxel|mesh-list
19531683|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19531684|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531685|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
19531686|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19531687|NCT02889692|Gefitinib|gefitinib|mesh-list
19531688|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531689|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19531690|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531691|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531692|NCT02889822|Alprostadil|alprostadil|mesh-list
19531693|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19531694|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
19531695|NCT02889822|Urological Agents|urological agents|mesh-ancestor
19531696|NCT02889653|Anticoagulants|anticoagulants|mesh-list
19531697|NCT02889523|Prednisolone|prednisolone|mesh-list
20103487|NCT00003206|Paclitaxel|paclitaxel|mesh-list
20103488|NCT00003206|Carboplatin|carboplatin|mesh-list
20103489|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19531698|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
19531699|NCT02889523|Rituximab|rituximab|mesh-list
19531700|NCT02889523|Doxorubicin|doxorubicin|mesh-list
19531701|NCT02889523|Vincristine|vincristine|mesh-list
19531702|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19531703|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
19531704|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531705|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531706|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19531707|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
19531708|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531709|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531710|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19531711|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19531712|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19531713|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19531714|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19531715|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531716|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19531717|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531718|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
19531719|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531720|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531721|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
19531722|NCT02889523|Hormones|hormones|mesh-ancestor
19531723|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531724|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19531725|NCT02889549|Clopidogrel|clopidogrel|mesh-list
19531726|NCT02889549|Ticagrelor|ticagrelor|mesh-list
19531727|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19531728|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19531729|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19531730|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19531731|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
19531732|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531733|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531734|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531735|NCT02889432|Melatonin|melatonin|mesh-list
19531736|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
19531737|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531738|NCT02889432|Protective Agents|protective agents|mesh-ancestor
19531739|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531740|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531741|NCT02889497|Vaccines|vaccines|mesh-list
19531742|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
19531743|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531744|NCT02889367|Odalasvir|odalasvir|mesh-list
19531745|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
19531746|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531747|NCT02889081|Vitamin D|vitamin d|mesh-list
19531748|NCT02889081|Vitamins|vitamins|mesh-ancestor
19531749|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
19531750|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531751|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19531752|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
19531753|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531754|NCT02888990|Dasatinib|dasatinib|mesh-list
20103490|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103491|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19531755|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531756|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19531757|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531758|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531759|NCT02888899|Loperamide|loperamide|mesh-list
19531760|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
20103492|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103493|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103494|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103495|NCT00003207|Doxorubicin|doxorubicin|mesh-list
20103496|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20306844|NCT00656773|Analgesics|analgesics|mesh-ancestor
20306845|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
20306846|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306847|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20306848|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20306849|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
20306850|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
20306851|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
20306852|NCT00656786|Vitamin K|vitamin k|mesh-list
20306853|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20306854|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20306855|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306856|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
19531761|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
19531762|NCT02888899|Psyllium|psyllium|mesh-list
20103497|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103498|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103499|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103500|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19531763|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531764|NCT02888899|Cathartics|cathartics|mesh-ancestor
19531765|NCT02889003|Pioglitazone|pioglitazone|mesh-list
19531766|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19531767|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574018|NCT04937738|Fluorouracil|fluorouracil|mesh-list
19574019|NCT04937738|Capecitabine|capecitabine|mesh-list
19574020|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
19574021|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574022|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574023|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574024|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574025|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574026|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
19574027|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19574028|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574029|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
19574030|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103501|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103502|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103503|NCT00003209|Fluorouracil|fluorouracil|mesh-list
20103504|NCT00003209|Methotrexate|methotrexate|mesh-list
20103505|NCT00003209|Ifosfamide|ifosfamide|mesh-list
20103506|NCT00003209|Mitomycins|mitomycins|mesh-list
20103507|NCT00003209|Mitomycin|mitomycin|mesh-list
20103508|NCT00003209|Bleomycin|bleomycin|mesh-list
20103509|NCT00003209|Vinblastine|vinblastine|mesh-list
20103510|NCT00003209|Vindesine|vindesine|mesh-list
20103511|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103512|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
20103513|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103514|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103515|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103516|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
20103517|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103518|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19574031|NCT04937738|Antidotes|antidotes|mesh-ancestor
19574032|NCT04937738|Protective Agents|protective agents|mesh-ancestor
19574033|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
19574034|NCT04937738|Vitamins|vitamins|mesh-ancestor
20103519|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
19574035|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
19578052|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103520|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20103521|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578053|NCT03577704|Gemcitabine|gemcitabine|mesh-list
19578054|NCT03577704|Paclitaxel|paclitaxel|mesh-list
20306857|NCT00656786|Coagulants|coagulants|mesh-ancestor
20306858|NCT00656786|Vitamins|vitamins|mesh-ancestor
20306859|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
19531768|NCT02888704|Remestemcel-l|remestemcel-l|mesh-list
19531769|NCT02888704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531770|NCT02888704|Antiviral Agents|antiviral agents|mesh-ancestor
19531771|NCT02888704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531772|NCT02888730|Tobramycin|tobramycin|mesh-list
19531773|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19531774|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531775|NCT02888652|Clopidogrel|clopidogrel|mesh-list
19531776|NCT02888652|Ticagrelor|ticagrelor|mesh-list
19531777|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19531778|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19531779|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19531780|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19531781|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
19531782|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531783|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531784|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531785|NCT02888574|Oxytocin|oxytocin|mesh-list
19531786|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
19531787|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19531788|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531789|NCT02888301|Clofarabine|clofarabine|mesh-list
19531790|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19531791|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
19531792|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531793|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531794|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
20103522|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103523|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19531795|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19531796|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19531797|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19531798|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19531799|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531800|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
20103524|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103525|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20103526|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103527|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
20103528|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103529|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103530|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103531|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103532|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103533|NCT00003210|Interleukin-12|interleukin-12|mesh-list
20103534|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20103535|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
20103536|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103537|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20103538|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20103539|NCT00003210|Growth Substances|growth substances|mesh-ancestor
20103540|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
20103541|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531801|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531802|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531803|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19531804|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531805|NCT02888327|Oseltamivir|oseltamivir|mesh-list
19531806|NCT02888327|Digoxin|digoxin|mesh-list
19531807|NCT02888327|Midazolam|midazolam|mesh-list
19531808|NCT02888327|Pitavastatin|pitavastatin|mesh-list
19531809|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19531810|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19531811|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531812|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531813|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19531814|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19531815|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19531816|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19531817|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
19531818|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
19531819|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
19531820|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
19531821|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531822|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531823|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19531824|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19531825|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531826|NCT02888327|Protective Agents|protective agents|mesh-ancestor
19531827|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
19531828|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531829|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19531830|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19531831|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19531832|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
19531833|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19531834|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
19531835|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19531836|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531837|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531838|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19531839|NCT02888275|Analgesics|analgesics|mesh-ancestor
19531840|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
19531841|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531842|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19531843|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19531844|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19531845|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
19531846|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531847|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103542|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
20103543|NCT00003211|Vincristine|vincristine|mesh-list
20103544|NCT00003211|Amifostine|amifostine|mesh-list
20306860|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306861|NCT00656812|Rituximab|rituximab|mesh-list
19531848|NCT02888561|Dobutamine|dobutamine|mesh-list
19531849|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19531850|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
19531851|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
19531852|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531853|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531854|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19531855|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19531856|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19531857|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
19531858|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531859|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603933|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20603934|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
20603935|NCT02224170|Hormones|hormones|mesh-ancestor
20603936|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20603937|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20603938|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603939|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
20603940|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
20603941|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531860|NCT02888561|Protective Agents|protective agents|mesh-ancestor
19531861|NCT02888444|Varenicline|varenicline|mesh-list
19531862|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19531863|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19531864|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
19531865|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306862|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20306863|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306864|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
20306865|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306866|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531866|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531867|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531868|NCT02888054|Allopurinol|allopurinol|mesh-list
19531869|NCT02888054|Lesinurad|lesinurad|mesh-list
19531870|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
19531871|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531872|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531873|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
19531874|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531875|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19531876|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
20306867|NCT00656864|Pioglitazone|pioglitazone|mesh-list
20603942|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
19531877|NCT02888054|Protective Agents|protective agents|mesh-ancestor
19531878|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531879|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
19531880|NCT02888054|Renal Agents|renal agents|mesh-ancestor
19531881|NCT02888392|Psyllium|psyllium|mesh-list
19531882|NCT02888392|Cathartics|cathartics|mesh-ancestor
19531883|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531884|NCT02888223|Factor VIII|factor viii|mesh-list
19531885|NCT02888223|Coagulants|coagulants|mesh-ancestor
19531886|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
19531887|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20103545|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103546|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
20103547|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306868|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20306869|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306870|NCT00656929|Vitamin D|vitamin d|mesh-list
20306871|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
20306872|NCT00656929|Vitamins|vitamins|mesh-ancestor
20306873|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
20306874|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306875|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20306876|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20306877|NCT00657007|Belimumab|belimumab|mesh-list
20306878|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20306879|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
20306880|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306881|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20306882|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
20603943|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20603944|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19531888|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19531889|NCT02887976|Prednisolone|prednisolone|mesh-list
19531890|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
19531891|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
19531892|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19531893|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
19531894|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19531895|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
19531896|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
19531897|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531898|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531899|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531900|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
19531901|NCT02887976|Hormones|hormones|mesh-ancestor
19531902|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19531903|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19531904|NCT02887976|Protective Agents|protective agents|mesh-ancestor
19531905|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19531906|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531907|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19531908|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531909|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531910|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
19531911|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19531912|NCT02888041|Dinoprostone|dinoprostone|mesh-list
19531913|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
19531914|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19531915|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531916|NCT02887807|Cyclosporine|cyclosporine|mesh-list
19531917|NCT02887807|Cyclosporins|cyclosporins|mesh-list
19531918|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531919|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531920|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103548|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103549|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103550|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
20103551|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306883|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19531921|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
19531922|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531923|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
19531924|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19531925|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
19531926|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19531927|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19531928|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
19531929|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19531930|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531931|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19531932|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531933|NCT02887573|Mosapride|mosapride|mesh-list
19531934|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531935|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19531936|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19531937|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
19531938|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531939|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531940|NCT02887534|Tizanidine|tizanidine|mesh-list
19531941|NCT02887534|Analgesics|analgesics|mesh-ancestor
19531942|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
19531943|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306884|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20103552|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103553|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103554|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103555|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103556|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103557|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
19531944|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531945|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
19531946|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19531947|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19531948|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
19531949|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
19531950|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19531951|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19531952|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19531953|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
19531954|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531955|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531956|NCT02887443|Midazolam|midazolam|mesh-list
19531957|NCT02887443|Idebenone|idebenone|mesh-list
19531958|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19531959|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19531960|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531961|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531962|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19531963|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19531964|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19531965|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19531966|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
19531967|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
19531968|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
19531969|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
19531970|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19531971|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531972|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
19531973|NCT02887443|Protective Agents|protective agents|mesh-ancestor
19531974|NCT02887365|Tegafur|tegafur|mesh-list
19531975|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19531976|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
19531977|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19531978|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19531979|NCT02887625|Insulin|insulin|mesh-list
19531980|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
19531981|NCT02887625|Pioglitazone|pioglitazone|mesh-list
19531982|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
19531983|NCT02887625|Exenatide|exenatide|mesh-list
19531984|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19531985|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531986|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19531987|NCT02887625|Incretins|incretins|mesh-ancestor
19531988|NCT02887625|Hormones|hormones|mesh-ancestor
19531989|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103558|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20103559|NCT00003211|Protective Agents|protective agents|mesh-ancestor
20103560|NCT00003212|Doxorubicin|doxorubicin|mesh-list
20103561|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20103562|NCT00003212|Ifosfamide|ifosfamide|mesh-list
20103563|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103564|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103565|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103566|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103567|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19531990|NCT02887222|Bupivacaine|bupivacaine|mesh-list
19531991|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
19531992|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
19531993|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19531994|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19531995|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
19531996|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19531997|NCT02887313|Leucovorin|leucovorin|mesh-list
19531998|NCT02887313|Fluorouracil|fluorouracil|mesh-list
19531999|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
19532000|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
19532001|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532002|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532003|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532004|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532005|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
19532006|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532007|NCT02887313|Antidotes|antidotes|mesh-ancestor
19532008|NCT02887313|Protective Agents|protective agents|mesh-ancestor
19532009|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
19532010|NCT02887313|Vitamins|vitamins|mesh-ancestor
19532011|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
19532012|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
19532013|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19532014|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19532015|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19532016|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532017|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532018|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
19532019|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532020|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532021|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19532022|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574036|NCT04924621|Midazolam|midazolam|mesh-list
19574037|NCT04924621|Sufentanil|sufentanil|mesh-list
19574038|NCT04924621|Propofol|propofol|mesh-list
19574039|NCT04924621|Tetracaine|tetracaine|mesh-list
20103568|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103569|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103570|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
20103571|NCT00003213|Dexamethasone|dexamethasone|mesh-list
20103572|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
20103573|NCT00003213|Metoclopramide|metoclopramide|mesh-list
20103574|NCT00003213|Granisetron|granisetron|mesh-list
20103575|NCT00003213|BB 1101|bb 1101|mesh-list
20103576|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20103577|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
20306885|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306886|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306887|NCT00657033|Urological Agents|urological agents|mesh-ancestor
20306888|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
20103578|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
20103579|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20103580|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103581|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20103582|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
20103583|NCT00003213|Hormones|hormones|mesh-ancestor
20103584|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103585|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103586|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103587|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
20103588|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574040|NCT04924621|Rocuronium|rocuronium|mesh-list
19574041|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20103589|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306889|NCT00657059|Prednisone|prednisone|mesh-list
20103590|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20103591|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19532023|NCT02886897|Antibodies|antibodies|mesh-list
19532024|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
19532025|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532026|NCT02886962|Vitamin K|vitamin k|mesh-list
20103592|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
20103593|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20103594|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20603945|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20603946|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532027|NCT02886962|Vitamins|vitamins|mesh-ancestor
19532028|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
19532029|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532030|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19532031|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19532032|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532033|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
19532034|NCT02886962|Coagulants|coagulants|mesh-ancestor
20603947|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603948|NCT02224391|Nicotine|nicotine|mesh-list
20603949|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20603950|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
20603951|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603952|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20603953|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20603954|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20603955|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
20603956|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603957|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20603958|NCT02224443|Fentanyl|fentanyl|mesh-list
20603959|NCT02224443|Midazolam|midazolam|mesh-list
20603960|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
20603961|NCT02224443|Remifentanil|remifentanil|mesh-list
19532035|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
19532036|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532037|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532038|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
19532039|NCT02886429|Bupivacaine|bupivacaine|mesh-list
19532040|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
19532041|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
19532042|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532043|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532044|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
19532045|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532046|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19532047|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532048|NCT02886429|Analgesics|analgesics|mesh-ancestor
19532049|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19532050|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19532051|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19532052|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
19532053|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532054|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532055|NCT02886377|Antibodies|antibodies|mesh-list
19532056|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
19532057|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532058|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
19532059|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19532060|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
19532061|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
19532062|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532063|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532064|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532065|NCT02886351|Analgesics|analgesics|mesh-ancestor
19532066|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
19532067|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532068|NCT02886195|Pemetrexed|pemetrexed|mesh-list
19532069|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19532070|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532071|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532072|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532073|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19532074|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19532075|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20103595|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
20603962|NCT02224443|Propofol|propofol|mesh-list
19532076|NCT02886299|Simvastatin|simvastatin|mesh-list
19532077|NCT02886299|Fenofibrate|fenofibrate|mesh-list
19532078|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19532079|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19532080|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
19532081|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532082|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19532083|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19532084|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532085|NCT02886065|Lenalidomide|lenalidomide|mesh-list
19532086|NCT02886065|Poly ICLC|poly iclc|mesh-list
19532087|NCT02886065|Citarinostat|citarinostat|mesh-list
19532088|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
19532089|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532090|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19532091|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19532092|NCT02886065|Growth Substances|growth substances|mesh-ancestor
19532093|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
19532094|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532095|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
19532096|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19532097|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532098|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532099|NCT02885974|Gemcitabine|gemcitabine|mesh-list
19532100|NCT02885974|Celecoxib|celecoxib|mesh-list
19532101|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532102|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532103|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
19532104|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103596|NCT00003214|Paclitaxel|paclitaxel|mesh-list
20103597|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
20103598|NCT00003214|Carboplatin|carboplatin|mesh-list
20103599|NCT00003214|Doxorubicin|doxorubicin|mesh-list
20103600|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20306890|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
20306891|NCT00657059|Irbesartan|irbesartan|mesh-list
20306892|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20306893|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
20306894|NCT00657059|Hormones|hormones|mesh-ancestor
20306895|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306896|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306897|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20306898|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306899|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20306900|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20306901|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
19532105|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
19532106|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532107|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532108|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532109|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
19532110|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532111|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19532112|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532113|NCT02885974|Analgesics|analgesics|mesh-ancestor
19532114|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
19532115|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532116|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532117|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306902|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20306903|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306904|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306905|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306906|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
20306907|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
20306908|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306909|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19532118|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20103601|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19532119|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19532120|NCT02885961|Dabigatran|dabigatran|mesh-list
19532121|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
20103602|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103603|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103604|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
20306910|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19532122|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19532123|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
19532124|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532125|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532126|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
19532127|NCT02885727|Durvalumab|durvalumab|mesh-list
19532128|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532129|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532130|NCT02885909|Insulin|insulin|mesh-list
19532131|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19532132|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532133|NCT02885740|Adenosine|adenosine|mesh-list
19532134|NCT02885740|Analgesics|analgesics|mesh-ancestor
19532135|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
19532136|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532137|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532138|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19532139|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
19532140|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19532141|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
19532142|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
19532143|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532144|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532145|NCT02885948|Naloxone|naloxone|mesh-list
19532146|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19532147|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532148|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
19532149|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532150|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19532151|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532152|NCT02885441|Ketorolac|ketorolac|mesh-list
19532153|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19532154|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532155|NCT02885441|Analgesics|analgesics|mesh-ancestor
19532156|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
19532157|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532158|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532159|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532160|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532161|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19532162|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532163|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532164|NCT02885688|Insulin|insulin|mesh-list
19532165|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19532166|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532167|NCT02885597|Methotrexate|methotrexate|mesh-list
19532168|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19532169|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
19532170|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532171|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532172|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532173|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
19532174|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532175|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532176|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532177|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532178|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19532179|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532180|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
19532181|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532182|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19532183|NCT02885558|Efonidipine|efonidipine|mesh-list
19532184|NCT02885558|Nifedipine|nifedipine|mesh-list
19532185|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19532186|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532187|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532188|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19532189|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532190|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
19532191|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
19532192|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532193|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19532194|NCT02885558|Diuretics|diuretics|mesh-ancestor
19532195|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
20103605|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103606|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306911|NCT00657059|Protective Agents|protective agents|mesh-ancestor
19532196|NCT02885545|Anticoagulants|anticoagulants|mesh-list
19532197|NCT02885454|Simeprevir|simeprevir|mesh-list
19532198|NCT02885454|Odalasvir|odalasvir|mesh-list
19532199|NCT02885454|Drospirenone|drospirenone|mesh-list
19532200|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19532201|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19532202|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19532203|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19532204|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19532205|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
19532206|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532207|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532208|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19532209|NCT02885454|Estrogens|estrogens|mesh-ancestor
19532210|NCT02885454|Hormones|hormones|mesh-ancestor
19532211|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532212|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19532213|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
19532214|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19532215|NCT02885454|Diuretics|diuretics|mesh-ancestor
19532216|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
19532217|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
19532218|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532219|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
19532220|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532221|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532222|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19532223|NCT02885168|Phenylephrine|phenylephrine|mesh-list
19532224|NCT02885168|Protein C|protein c|mesh-list
19532225|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
19532226|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19532227|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
19532228|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
19532229|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532230|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532231|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
19532232|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19532233|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
19532234|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
19532235|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19532236|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19532237|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19532238|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
19532239|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532240|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532241|NCT02885168|Protective Agents|protective agents|mesh-ancestor
19532242|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
19532243|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19532244|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19532245|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532246|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
19532247|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19532248|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19532249|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532250|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
19532251|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
19532252|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532253|NCT02885311|Naltrexone|naltrexone|mesh-list
19532254|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19532255|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19532256|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532257|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
19532258|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532259|NCT02884986|Etoricoxib|etoricoxib|mesh-list
19532260|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19532261|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532262|NCT02884986|Analgesics|analgesics|mesh-ancestor
19532263|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
19532264|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532265|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532266|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532267|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532268|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19532269|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19532270|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532271|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532272|NCT02884921|Acetaminophen|acetaminophen|mesh-list
19532273|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532274|NCT02884921|Analgesics|analgesics|mesh-ancestor
19532275|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
19532276|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532277|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532278|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
19532279|NCT02884596|Serotonin|serotonin|mesh-list
19532280|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19532281|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19532282|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
19532283|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532284|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532285|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532286|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19532287|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532288|NCT02884817|Listerine|listerine|mesh-list
19532289|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19532290|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532291|NCT02884713|Doxycycline|doxycycline|mesh-list
19532292|NCT02884713|Levofloxacin|levofloxacin|mesh-list
19532293|NCT02884713|Ofloxacin|ofloxacin|mesh-list
19532294|NCT02884713|Esomeprazole|esomeprazole|mesh-list
20306912|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20306913|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20306914|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20306915|NCT00657137|Capecitabine|capecitabine|mesh-list
20306916|NCT00657137|Lapatinib|lapatinib|mesh-list
20306917|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20306918|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
20306919|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306920|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306921|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20306922|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306923|NCT00657163|Fluoxetine|fluoxetine|mesh-list
20306924|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20306925|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20306926|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20306927|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532295|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19532296|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19532297|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19532298|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532299|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532300|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19532301|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532302|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
19532303|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20306928|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20306929|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
20306930|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306931|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19532304|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19532305|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20103607|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103608|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
20103609|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103610|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103611|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103612|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
20103613|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103614|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103615|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103616|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103617|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103618|NCT00003215|Leucovorin|leucovorin|mesh-list
20103619|NCT00003215|Cytarabine|cytarabine|mesh-list
19532306|NCT02884713|Renal Agents|renal agents|mesh-ancestor
19532307|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103620|NCT00003215|Prednisone|prednisone|mesh-list
20103621|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
20103622|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
20103623|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20103624|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19532308|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19532309|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532310|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19532311|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19532312|NCT02884388|Anesthetics|anesthetics|mesh-list
19532313|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532314|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532315|NCT02884440|Ropivacaine|ropivacaine|mesh-list
19532316|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
19532317|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532318|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532319|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
19532320|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
20103625|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20103626|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
20103627|NCT00003215|Melphalan|melphalan|mesh-list
20103628|NCT00003215|Doxorubicin|doxorubicin|mesh-list
20306932|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
20306933|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19532321|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532322|NCT02884635|Methotrexate|methotrexate|mesh-list
19532323|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19532324|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
19532325|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532326|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532327|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532328|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
19532329|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532330|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532331|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532332|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532333|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19532334|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532335|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
19532336|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532337|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19574042|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574043|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574044|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19574045|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
19574046|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
19574047|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19574048|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19574049|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574050|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574051|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
19574052|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
19574053|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574054|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574055|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19574056|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19574057|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19574058|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574059|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19574060|NCT04924621|Narcotics|narcotics|mesh-ancestor
20603963|NCT02224443|Etomidate|etomidate|mesh-list
19574061|NCT04924621|Analgesics|analgesics|mesh-ancestor
19574062|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
19574063|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
19574064|NCT04909073|Afatinib|afatinib|mesh-list
19574065|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574066|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19574067|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574068|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574069|NCT04903197|Lenalidomide|lenalidomide|mesh-list
19574070|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
19574071|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574072|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20103629|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20103630|NCT00003215|Methotrexate|methotrexate|mesh-list
20103631|NCT00003215|Etoposide|etoposide|mesh-list
20103632|NCT00003215|Vincristine|vincristine|mesh-list
20103633|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
20103634|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
19532338|NCT02884479|Docetaxel|docetaxel|mesh-list
19532339|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532340|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
19532341|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
19532342|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
19532343|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532344|NCT02884310|Remifentanil|remifentanil|mesh-list
19532345|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19532346|NCT02884310|Narcotics|narcotics|mesh-ancestor
19532347|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532348|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532349|NCT02884310|Analgesics|analgesics|mesh-ancestor
19532350|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
19532351|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532352|NCT02884219|Ibuprofen|ibuprofen|mesh-list
19532353|NCT02884219|Indomethacin|indomethacin|mesh-list
19532354|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
19532355|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19532356|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532357|NCT02884219|Analgesics|analgesics|mesh-ancestor
19532358|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
19532359|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532360|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532361|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532362|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532363|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532364|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532365|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
19532366|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
19532367|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532368|NCT02884050|Topiramate|topiramate|mesh-list
19532369|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
19532370|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19532371|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532372|NCT02884115|Penicillins|penicillins|mesh-list
19532373|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19532374|NCT02884115|Penicillin G|penicillin g|mesh-list
19532375|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
19532376|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19532377|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532378|NCT02884128|Leucovorin|leucovorin|mesh-list
19532379|NCT02884128|Fluorouracil|fluorouracil|mesh-list
19532380|NCT02884128|Irinotecan|irinotecan|mesh-list
19532381|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
19532382|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532383|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532384|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532385|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532386|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
19532387|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532388|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19532389|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19532390|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532391|NCT02884128|Antidotes|antidotes|mesh-ancestor
19532392|NCT02884128|Protective Agents|protective agents|mesh-ancestor
19532393|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
19532394|NCT02884128|Vitamins|vitamins|mesh-ancestor
19532395|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
19532396|NCT02884037|Rifaximin|rifaximin|mesh-list
19532397|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19532398|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532399|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574073|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19574074|NCT04903197|Growth Substances|growth substances|mesh-ancestor
19574075|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
19574076|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574077|NCT04899232|Antithrombins|antithrombins|mesh-list
19574078|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
19574079|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19574080|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
19574081|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574082|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574083|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
19574084|NCT04897919|Lumefantrine|lumefantrine|mesh-list
19574085|NCT04897919|Artemether|artemether|mesh-list
19574086|NCT04897919|Piperaquine|piperaquine|mesh-list
19574087|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19532400|NCT02884180|Dexamethasone|dexamethasone|mesh-list
19532401|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532402|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
19532403|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
19532404|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532405|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532406|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19532407|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
19532408|NCT02884180|Hormones|hormones|mesh-ancestor
19532409|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532410|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19532411|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532412|NCT02883647|Tenofovir|tenofovir|mesh-list
19532413|NCT02883647|Entecavir|entecavir|mesh-list
19532414|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
19532415|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532416|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19532417|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19532418|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532419|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532420|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19532421|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19532422|NCT02883595|Thymalfasin|thymalfasin|mesh-list
19532423|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19532424|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
19532425|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532426|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
19532427|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532428|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532429|NCT02883569|Ibuprofen|ibuprofen|mesh-list
19532430|NCT02883569|Aceclofenac|aceclofenac|mesh-list
19532431|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19532432|NCT02883569|Tramadol|tramadol|mesh-list
19532433|NCT02883569|Codeine|codeine|mesh-list
19532434|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19532435|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532436|NCT02883569|Analgesics|analgesics|mesh-ancestor
19532437|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
19532438|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532439|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532440|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532441|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20306934|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20306935|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20306936|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306937|NCT00657202|Ranibizumab|ranibizumab|mesh-list
20306938|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20306939|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20306940|NCT00657202|Growth Substances|growth substances|mesh-ancestor
20306941|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306942|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
19532442|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19532443|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532444|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532445|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19532446|NCT02883569|Narcotics|narcotics|mesh-ancestor
19532447|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532448|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
19532449|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
19532450|NCT02883478|Riboflavin|riboflavin|mesh-list
19532451|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
19532452|NCT02883478|Vitamins|vitamins|mesh-ancestor
19532453|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
19532454|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532455|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19532456|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532457|NCT02883179|Lidocaine|lidocaine|mesh-list
19532458|NCT02883179|Prilocaine|prilocaine|mesh-list
19532459|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19532460|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
20603964|NCT02224443|Sevoflurane|sevoflurane|mesh-list
20603965|NCT02224443|Atracurium|atracurium|mesh-list
20603966|NCT02224443|Cisatracurium|cisatracurium|mesh-list
19532461|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
19532462|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603967|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19574088|NCT04897919|Artenimol|artenimol|mesh-list
19532463|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532464|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
19532465|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532466|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19532467|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19532468|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19532469|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532470|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532471|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19532472|NCT02883192|Ondansetron|ondansetron|mesh-list
19532473|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
19532474|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
19532475|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532476|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532477|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19532478|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
19532479|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532480|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19532481|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
19532482|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532483|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532484|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19532485|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19532486|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532487|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19532488|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19532489|NCT02883439|Fluticasone|fluticasone|mesh-list
19532490|NCT02883439|Xhance|xhance|mesh-list
19532491|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532492|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19532493|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
19532494|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532495|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532496|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19532497|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
19532498|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532499|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19532500|NCT02883426|Vaccines|vaccines|mesh-list
19532501|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
19532502|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532503|NCT02883114|Itraconazole|itraconazole|mesh-list
19532504|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
19532505|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532506|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19532507|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19532508|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532509|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532510|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19532511|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
19532512|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532513|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532514|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19532515|NCT02883023|Bleomycin|bleomycin|mesh-list
19532516|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19532517|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532518|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19532519|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19532520|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19532521|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532522|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532523|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19532524|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532525|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532526|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
19532527|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532528|NCT02882828|Tacrolimus|tacrolimus|mesh-list
19532529|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532530|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
19532531|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532532|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19532533|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532534|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532535|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19532536|NCT02882984|Gefitinib|gefitinib|mesh-list
19532537|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532538|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19532539|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532540|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532541|NCT02882789|Delpazolid|delpazolid|mesh-list
19532542|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
19532543|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19532544|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532545|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19532546|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532547|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532548|NCT02882737|Glucagon|glucagon|mesh-list
19532549|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19532550|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19532551|NCT02882737|Hormones|hormones|mesh-ancestor
19532552|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532553|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532554|NCT02882737|Incretins|incretins|mesh-ancestor
19532555|NCT02882555|Capsaicin|capsaicin|mesh-list
19532556|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
19532557|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532558|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
19532559|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532560|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532561|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19532562|NCT02882308|Durvalumab|durvalumab|mesh-list
19532563|NCT02882308|Olaparib|olaparib|mesh-list
19532564|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532565|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532566|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19532567|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532568|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574089|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
19574090|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19574091|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19574092|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574093|NCT04872790|Prednisone|prednisone|mesh-list
19574094|NCT04872790|Cortisone|cortisone|mesh-list
19574095|NCT04872790|Rituximab|rituximab|mesh-list
19574096|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19574097|NCT04872790|Methotrexate|methotrexate|mesh-list
19574098|NCT04872790|Dasatinib|dasatinib|mesh-list
19574099|NCT04872790|Venetoclax|venetoclax|mesh-list
19574100|NCT04872790|Antibodies|antibodies|mesh-list
19574101|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
19574102|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19574103|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
19574104|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574105|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603968|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20603969|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574106|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574107|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574108|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
19574109|NCT04872790|Hormones|hormones|mesh-ancestor
19574110|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574111|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574112|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19574113|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
19574114|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19574115|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19574116|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
19574117|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574118|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
19574119|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574120|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19574121|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20603970|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20103635|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103636|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
20103637|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574122|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19574123|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19574124|NCT04865042|Gabapentin|gabapentin|mesh-list
19574125|NCT04865042|Analgesics|analgesics|mesh-ancestor
19532569|NCT02882581|Metformin|metformin|mesh-list
19532570|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19532571|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532572|NCT02882347|Somatostatin|somatostatin|mesh-list
19532573|NCT02882347|Hormones|hormones|mesh-ancestor
19532574|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532575|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532576|NCT02882477|Metformin|metformin|mesh-list
19532577|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19532578|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
19532579|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19532580|NCT02882477|Deferiprone|deferiprone|mesh-list
19532581|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19532582|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532583|NCT02882477|Incretins|incretins|mesh-ancestor
19532584|NCT02882477|Hormones|hormones|mesh-ancestor
19532585|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532586|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19532587|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
19532588|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532589|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532590|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
19532591|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532592|NCT02882477|Expectorants|expectorants|mesh-ancestor
19532593|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
19532594|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19532595|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
19532596|NCT02882477|Protective Agents|protective agents|mesh-ancestor
19532597|NCT02882477|Antidotes|antidotes|mesh-ancestor
19532598|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19532599|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
19532600|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
19532601|NCT02882425|Selexipag|selexipag|mesh-list
19532602|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19532603|NCT02882451|Ascorbic Acid|ascorbic acid|mesh-list
19532604|NCT02882451|Pinaverium|pinaverium|mesh-list
19532605|NCT02882451|Bromides|bromides|mesh-list
19532606|NCT02882451|Vitamins|vitamins|mesh-ancestor
19532607|NCT02882451|Micronutrients|micronutrients|mesh-ancestor
19532608|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532609|NCT02882451|Antioxidants|antioxidants|mesh-ancestor
19532610|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532611|NCT02882451|Protective Agents|protective agents|mesh-ancestor
19532612|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
19532613|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19532614|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532615|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19532616|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
19532617|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
19532618|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532619|NCT02882269|Capecitabine|capecitabine|mesh-list
19532620|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532621|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
19532622|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532623|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532624|NCT02882594|Anesthetics|anesthetics|mesh-list
19532625|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532626|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532627|NCT02882100|Vaccines|vaccines|mesh-list
19532628|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
19532629|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532630|NCT02882113|Tacrolimus|tacrolimus|mesh-list
19532631|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532632|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
19532633|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532634|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19532635|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532636|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532637|NCT02882217|Histamine|histamine|mesh-list
19532638|NCT02882217|Glutarimide|glutarimide|mesh-list
19532639|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
19532640|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
19532641|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532642|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532643|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532644|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19532645|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532646|NCT02881866|Furosemide|furosemide|mesh-list
19532647|NCT02881866|Diuretics|diuretics|mesh-ancestor
19532648|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
19532649|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532650|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19532651|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532652|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532653|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
19532654|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19532655|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
19532656|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19532657|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
19532658|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532659|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532660|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19532661|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19532662|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19532663|NCT02882126|Treprostinil|treprostinil|mesh-list
19532664|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19532665|NCT02882230|Dolutegravir|dolutegravir|mesh-list
19532666|NCT02882230|Rilpivirine|rilpivirine|mesh-list
19532667|NCT02882230|Elvitegravir|elvitegravir|mesh-list
19532668|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19532669|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19532670|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532671|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532672|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19532673|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19532674|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
19532675|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532676|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19532677|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19532678|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
19532679|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
19532680|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532681|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19532682|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532683|NCT02881762|Maraviroc|maraviroc|mesh-list
19532684|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19532685|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19532686|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532687|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19532688|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19532689|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
19532690|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19532691|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19532692|NCT02882087|Methotrexate|methotrexate|mesh-list
19532693|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19532694|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
19532695|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532696|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532697|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532698|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
19532699|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532700|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532701|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532702|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532703|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19532704|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532705|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
19532706|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532707|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19532708|NCT02881346|Betamethasone|betamethasone|mesh-list
19532709|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
19532710|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19532711|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
19532712|NCT02881346|Calcipotriene|calcipotriene|mesh-list
19532713|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19532714|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532715|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
19532716|NCT02881346|Hormones|hormones|mesh-ancestor
19532717|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532718|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532719|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19532720|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
19532721|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
19532722|NCT02881528|Metformin|metformin|mesh-list
19532723|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19532724|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532725|NCT02881619|Etodolac|etodolac|mesh-list
20103638|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103639|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103640|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
20103641|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103642|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103643|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103644|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103645|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103646|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103647|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103648|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20103649|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
20103650|NCT00003215|Hormones|hormones|mesh-ancestor
20103651|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103652|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103653|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20103654|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
20103655|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20103656|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20306943|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20603971|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
20603972|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
20603973|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20603974|NCT02224443|Analgesics|analgesics|mesh-ancestor
20603975|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
20603976|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20603977|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20603978|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20103657|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
20103658|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
20103659|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20103660|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20103661|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103662|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
20103663|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103664|NCT00003215|Antidotes|antidotes|mesh-ancestor
20103665|NCT00003215|Protective Agents|protective agents|mesh-ancestor
19532726|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19532727|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532728|NCT02881619|Analgesics|analgesics|mesh-ancestor
19532729|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
19532730|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532731|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532732|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19532733|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532734|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19532735|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19532736|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532737|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532738|NCT02880995|Amisulpride|amisulpride|mesh-list
19532739|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19532740|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19532741|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532742|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532743|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19532744|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19532745|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
19532746|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532747|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532748|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19532749|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
19532750|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19532751|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532752|NCT02881177|Oxytocin|oxytocin|mesh-list
19532753|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
19532754|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532755|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532756|NCT02881125|Paclitaxel|paclitaxel|mesh-list
19532757|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19532758|NCT02881125|Nortriptyline|nortriptyline|mesh-list
19532759|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103666|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
20103667|NCT00003215|Vitamins|vitamins|mesh-ancestor
20306944|NCT00657228|Heparin|heparin|mesh-list
20306945|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
20103668|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
20306946|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19532760|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532761|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19532762|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
19532763|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19532764|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532765|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19532766|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
19532767|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19532768|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19532769|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19532770|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532771|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
19532772|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532773|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532774|NCT02880787|Rocuronium|rocuronium|mesh-list
19532775|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19532776|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19532777|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19532778|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532779|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574126|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
19574127|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574128|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574129|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
19574130|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19574131|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574132|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574133|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574134|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19574135|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19574136|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574137|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574138|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
19574139|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20306947|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20306948|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306949|NCT00657254|Sorafenib|sorafenib|mesh-list
19574140|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
19574141|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19574142|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19574143|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19574144|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19574145|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574146|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
19574147|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574148|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574149|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19574150|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574151|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
19574152|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
19574153|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574154|NCT04853251|Ranibizumab|ranibizumab|mesh-list
20306950|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306951|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20306952|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20306953|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306954|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
20306955|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20306956|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
20306957|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
20306958|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20306959|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20306960|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306961|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
20306962|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20306963|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20306964|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306965|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
19574155|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19574156|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19574157|NCT04853251|Growth Substances|growth substances|mesh-ancestor
19749009|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532780|NCT02880800|Morphine|morphine|mesh-list
19532781|NCT02880800|Hydromorphone|hydromorphone|mesh-list
19532782|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19532783|NCT02880800|Narcotics|narcotics|mesh-ancestor
19532784|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532785|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532786|NCT02880800|Analgesics|analgesics|mesh-ancestor
19532787|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
19532788|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532789|NCT02880462|Sulforaphane|sulforaphane|mesh-list
19532790|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19532791|NCT02880462|Protective Agents|protective agents|mesh-ancestor
19532792|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532793|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532794|NCT02880410|Temozolomide|temozolomide|mesh-list
19532795|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19532796|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
19532797|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532798|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532799|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
19532800|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532801|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532802|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
19532803|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532804|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532805|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19532806|NCT02880280|Menotropins|menotropins|mesh-list
19532807|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19532808|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532809|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19532810|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
19532811|NCT02879955|Acarbose|acarbose|mesh-list
19532812|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19532813|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532814|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532815|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19532816|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532817|NCT02880033|Deferiprone|deferiprone|mesh-list
19532818|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19532819|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
19532820|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
19532821|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532822|NCT02879981|Trimethoprim|trimethoprim|mesh-list
19532823|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
19532824|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
19532825|NCT02879981|Guaifenesin|guaifenesin|mesh-list
19532826|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19532827|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19532828|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20306966|NCT00657384|Coagulants|coagulants|mesh-ancestor
20306967|NCT00657397|Methadone|methadone|mesh-list
20306968|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20306969|NCT00657397|Narcotics|narcotics|mesh-ancestor
20306970|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20306971|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306972|NCT00657397|Analgesics|analgesics|mesh-ancestor
20306973|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
20103669|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103670|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103671|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103672|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
20103673|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
20103674|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20103675|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20103676|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20103677|NCT00003215|Analgesics|analgesics|mesh-ancestor
19532829|NCT02879981|Renal Agents|renal agents|mesh-ancestor
20103678|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
20103679|NCT00003216|Gemcitabine|gemcitabine|mesh-list
20103680|NCT00003216|Fluorouracil|fluorouracil|mesh-list
20103681|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103682|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
20103683|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306974|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532830|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
20103684|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306975|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
19532831|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19532832|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19532833|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19532834|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532835|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532836|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19532837|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19532838|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19532839|NCT02879981|Expectorants|expectorants|mesh-ancestor
19532840|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
19532841|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19532842|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19532843|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
19532844|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532845|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532846|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
19532847|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19532848|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
19532849|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
19532850|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532851|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
19532852|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19532853|NCT02880007|Cisplatin|cisplatin|mesh-list
19532854|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532855|NCT02880085|Lidocaine|lidocaine|mesh-list
19532856|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
19532857|NCT02880085|Anesthetics|anesthetics|mesh-list
19532858|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532859|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532860|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
19532861|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532862|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19532863|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19532864|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19532865|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19532866|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532867|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
19532868|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
19532869|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
19532870|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532871|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532872|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
19532873|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532874|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
19532875|NCT02879669|Carboplatin|carboplatin|mesh-list
19532876|NCT02879669|Pemetrexed|pemetrexed|mesh-list
19532877|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532878|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
19532879|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532880|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532881|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19532882|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
19532883|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532884|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532885|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19532886|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532887|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19532888|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19532889|NCT02879435|Bupivacaine|bupivacaine|mesh-list
19532890|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
19532891|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
19532892|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532893|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532894|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
19532895|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532896|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
19532897|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532898|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532899|NCT02879513|Paclitaxel|paclitaxel|mesh-list
19532900|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
19532901|NCT02879513|Epirubicin|epirubicin|mesh-list
19532902|NCT02879513|Fluorouracil|fluorouracil|mesh-list
19532903|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19532904|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532905|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
19532906|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
19532907|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
19532908|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532909|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19532910|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
19532911|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532912|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19532913|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19532914|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
19532915|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19532916|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19532917|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19532918|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19532919|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532920|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
19532921|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532922|NCT02879643|Vincristine|vincristine|mesh-list
19532923|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19532924|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532925|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
19532926|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
19532927|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
19532928|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532929|NCT02879721|Candesartan|candesartan|mesh-list
20103685|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
20103686|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103687|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103688|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103689|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
20103690|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103691|NCT00003217|Cytarabine|cytarabine|mesh-list
20103692|NCT00003217|Dexamethasone|dexamethasone|mesh-list
20103693|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
20103694|NCT00003217|Doxorubicin|doxorubicin|mesh-list
20103695|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20103696|NCT00003217|Methotrexate|methotrexate|mesh-list
20103697|NCT00003217|Vincristine|vincristine|mesh-list
20103698|NCT00003217|Lenograstim|lenograstim|mesh-list
20103699|NCT00003217|Sargramostim|sargramostim|mesh-list
20103700|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103701|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
20103702|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103703|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103704|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103705|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
20103706|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103707|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103708|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103709|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20103710|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
20103711|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
20103712|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20103713|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20103714|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
20103715|NCT00003217|Hormones|hormones|mesh-ancestor
20103716|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19532930|NCT02879721|Enalapril|enalapril|mesh-list
19532931|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19532932|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19532933|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19532934|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532935|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19532936|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
19532937|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532938|NCT02879292|Anesthetics|anesthetics|mesh-list
19532939|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20103717|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103718|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103719|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103720|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103721|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103722|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20103723|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
20603979|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20103724|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20103725|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103726|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
20103727|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
20103728|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20103729|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20103730|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
20103731|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103732|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20103733|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103734|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103735|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20306976|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
20306977|NCT00657410|Dexamethasone|dexamethasone|mesh-list
20306978|NCT00657410|Prednisone|prednisone|mesh-list
20306979|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20306980|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
20306981|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
19532940|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532941|NCT02879227|Cisplatin|cisplatin|mesh-list
19532942|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
19532943|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306982|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306983|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306984|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20306985|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
20306986|NCT00657410|Hormones|hormones|mesh-ancestor
20306987|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20306988|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20306989|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306990|NCT00657423|Cisplatin|cisplatin|mesh-list
20306991|NCT00657423|Docetaxel|docetaxel|mesh-list
19532944|NCT02879110|Sulforaphane|sulforaphane|mesh-list
19532945|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19532946|NCT02879110|Protective Agents|protective agents|mesh-ancestor
19532947|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532948|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532949|NCT02879097|Paclitaxel|paclitaxel|mesh-list
19532950|NCT02879097|Carboplatin|carboplatin|mesh-list
19532951|NCT02879097|Bevacizumab|bevacizumab|mesh-list
19532952|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19532953|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532954|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
19532955|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
19532956|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
19532957|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532958|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19532959|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19532960|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19532961|NCT02879097|Growth Substances|growth substances|mesh-ancestor
19532962|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532963|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
19532964|NCT02879006|Omalizumab|omalizumab|mesh-list
19532965|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19532966|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19532967|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
19532968|NCT02878837|Midazolam|midazolam|mesh-list
19532969|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
19532970|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19532971|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19532972|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19532973|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19532974|NCT02878837|Analgesics|analgesics|mesh-ancestor
19532975|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
19532976|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19532977|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19532978|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19532979|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19532980|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
19532981|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19532982|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20306992|NCT00657423|Endostar protein|endostar protein|mesh-list
20306993|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20306994|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
19532983|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19532984|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20306995|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
20306996|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
19532985|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19532986|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19532987|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19532988|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
19532989|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
19532990|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
19532991|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
19574158|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574159|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
19574160|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574161|NCT04821310|Pantoprazole|pantoprazole|mesh-list
19574162|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19574163|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574164|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19574165|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574166|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574167|NCT04808531|Oxycodone|oxycodone|mesh-list
19574168|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19574169|NCT04808531|Narcotics|narcotics|mesh-ancestor
19574170|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574171|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574172|NCT04808531|Analgesics|analgesics|mesh-ancestor
19574173|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
19574174|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20306997|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103736|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103737|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
20103738|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103739|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103740|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103741|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
20103742|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20103743|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
19574175|NCT04804644|Memantine|memantine|mesh-list
19574176|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19574177|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19574178|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
20103744|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103745|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103746|NCT00003223|Fenretinide|fenretinide|mesh-list
20103747|NCT00003223|Retinamide|retinamide|mesh-list
19574179|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574180|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574181|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574182|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19574183|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19574184|NCT04803084|TEMPO|tempo|mesh-list
19574185|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
19574186|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574187|NCT04803084|Protective Agents|protective agents|mesh-ancestor
19574188|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574189|NCT04801849|Vitamin E|vitamin e|mesh-list
19574190|NCT04801849|Tocopherols|tocopherols|mesh-list
19574191|NCT04801849|Tocotrienols|tocotrienols|mesh-list
19574192|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
19574193|NCT04801849|Vitamins|vitamins|mesh-ancestor
19574194|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
19574195|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574196|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
19574197|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574198|NCT04801849|Protective Agents|protective agents|mesh-ancestor
19574199|NCT04770623|Docetaxel|docetaxel|mesh-list
19574200|NCT04770623|Irinotecan|irinotecan|mesh-list
19574201|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574202|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574203|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574204|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574205|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574206|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19574207|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19574208|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574209|NCT04769414|Gemcitabine|gemcitabine|mesh-list
19574210|NCT04769414|Fluorouracil|fluorouracil|mesh-list
19574211|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19574212|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
19574213|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574214|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532992|NCT02878785|Decitabine|decitabine|mesh-list
19532993|NCT02878785|Talazoparib|talazoparib|mesh-list
19532994|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19532995|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
19532996|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19532997|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19532998|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19532999|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19533000|NCT02878863|Peoniflorin|peoniflorin|mesh-list
19533001|NCT02878863|Silymarin|silymarin|mesh-list
19533002|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
19533003|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533004|NCT02878863|Protective Agents|protective agents|mesh-ancestor
19533005|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533006|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19533007|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533008|NCT02878863|Analgesics|analgesics|mesh-ancestor
19533009|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
19533010|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533011|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533012|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533013|NCT02878772|Aspirin|aspirin|mesh-list
19533014|NCT02878772|Vinpocetine|vinpocetine|mesh-list
19533015|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19533016|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533017|NCT02878772|Analgesics|analgesics|mesh-ancestor
19533018|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
19533019|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533020|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533021|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533022|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533023|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19533024|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19533025|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533026|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19533027|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19533028|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533029|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
19533030|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19533031|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
19533032|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19533033|NCT02878772|Protective Agents|protective agents|mesh-ancestor
19533034|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
19533035|NCT02878564|Praziquantel|praziquantel|mesh-list
19533036|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
19533037|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19533038|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533039|NCT02878512|Anesthetics|anesthetics|mesh-list
19533040|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533041|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533042|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
19533043|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19533044|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533045|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533046|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533047|NCT02878707|Analgesics|analgesics|mesh-ancestor
19533048|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
19533049|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533050|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19533051|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19533052|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19533053|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
19533054|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533055|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533056|NCT02878681|Ranibizumab|ranibizumab|mesh-list
19533057|NCT02878681|Aflibercept|aflibercept|mesh-list
19533058|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19533059|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19533060|NCT02878681|Growth Substances|growth substances|mesh-ancestor
19533061|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533062|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19533063|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533064|NCT02878421|Nicotine|nicotine|mesh-list
19533065|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19533066|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
19533067|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533068|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533069|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19533070|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19533071|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
19533072|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533073|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533074|NCT02878538|Deferiprone|deferiprone|mesh-list
19533075|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19533076|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
19533077|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
19533078|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533079|NCT02878200|Piperaquine|piperaquine|mesh-list
19533080|NCT02878200|Artenimol|artenimol|mesh-list
19533081|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
19533082|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19533083|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19533084|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533085|NCT02878291|Vaccines|vaccines|mesh-list
19533086|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
19533087|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533088|NCT02878083|Adalimumab|adalimumab|mesh-list
19533089|NCT02878083|Vedolizumab|vedolizumab|mesh-list
19533090|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533091|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533092|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533093|NCT02878265|Vitamins|vitamins|mesh-list
19533094|NCT02878265|Vitamin A|vitamin a|mesh-list
19533095|NCT02878265|Zinc|zinc|mesh-list
19533096|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
19533097|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
19533098|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533099|NCT02878265|Trace Elements|trace elements|mesh-ancestor
19533100|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
19533101|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533102|NCT02878265|Protective Agents|protective agents|mesh-ancestor
19533103|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19533104|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533105|NCT02878161|Prednisone|prednisone|mesh-list
19533106|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
19533107|NCT02878161|Adalimumab|adalimumab|mesh-list
19533108|NCT02878161|Etanercept|etanercept|mesh-list
19533109|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19533110|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19533111|NCT02878161|Methotrexate|methotrexate|mesh-list
19533112|NCT02878161|Infliximab|infliximab|mesh-list
19533113|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
19533114|NCT02878161|Leflunomide|leflunomide|mesh-list
19533115|NCT02878161|Hormones|hormones|mesh-ancestor
19533116|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533117|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533118|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533119|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533120|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19533121|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
19533122|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19533123|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19533124|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
19533125|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533126|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
19533127|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533128|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19533129|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533130|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
19533131|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533132|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19533133|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
19533134|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
19533135|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533136|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533137|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19533138|NCT02878161|Protective Agents|protective agents|mesh-ancestor
19533139|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533140|NCT02878161|Analgesics|analgesics|mesh-ancestor
19533141|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
19533142|NCT02878018|Hormones|hormones|mesh-list
19533143|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
19533144|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19574215|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
19533145|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19533146|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533147|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533148|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533149|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533150|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
19533151|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
19533152|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533153|NCT02878031|Amoxicillin|amoxicillin|mesh-list
19533154|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19749010|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19749011|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19533155|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533156|NCT02878122|Carboplatin|carboplatin|mesh-list
19533157|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533158|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19533159|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19533160|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19533161|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
19533162|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533163|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533164|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533165|NCT02877901|Urological Agents|urological agents|mesh-ancestor
19533166|NCT02877888|Fluorides|fluorides|mesh-list
19533167|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
19533168|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
19533169|NCT02877888|Protective Agents|protective agents|mesh-ancestor
19533170|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533171|NCT02877615|S44819|s44819|mesh-list
19533172|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
19533173|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
19533174|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
19533175|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533176|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533177|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533178|NCT02877771|Insulin|insulin|mesh-list
19533179|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19533180|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533181|NCT02877537|Albuterol|albuterol|mesh-list
19533182|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19533183|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
19533184|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533185|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533186|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19533187|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
19533188|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
19533189|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19533190|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19533191|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19533192|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19533193|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
19533194|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533195|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533196|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
19533197|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19533198|NCT02877511|Protective Agents|protective agents|mesh-ancestor
19533199|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533200|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
19533201|NCT02877641|Vitamin D|vitamin d|mesh-list
19533202|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
19533203|NCT02877641|Vitamins|vitamins|mesh-list
19533204|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
19533205|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533206|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19533207|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19574216|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574217|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574218|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574219|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
19574220|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574221|NCT04766008|Metformin|metformin|mesh-list
19574222|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19574223|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574224|NCT04760132|Vaccines|vaccines|mesh-list
19574225|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
19533208|NCT02877238|Sevoflurane|sevoflurane|mesh-list
19533209|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
19533210|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533211|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533212|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19533213|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19533214|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
19533215|NCT02877173|Alprostadil|alprostadil|mesh-list
19533216|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19533217|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
19533218|NCT02877173|Urological Agents|urological agents|mesh-ancestor
19533219|NCT02877277|Ascorbic Acid|ascorbic acid|mesh-list
19533220|NCT02877277|Vitamins|vitamins|mesh-ancestor
19533221|NCT02877277|Micronutrients|micronutrients|mesh-ancestor
19533222|NCT02877277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533223|NCT02877277|Antioxidants|antioxidants|mesh-ancestor
19533224|NCT02877277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533225|NCT02877277|Protective Agents|protective agents|mesh-ancestor
19533226|NCT02877303|Cytarabine|cytarabine|mesh-list
19533227|NCT02877303|Dexamethasone|dexamethasone|mesh-list
19533228|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
19533229|NCT02877303|Prednisone|prednisone|mesh-list
19533230|NCT02877303|Cortisone|cortisone|mesh-list
19533231|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
19533232|NCT02877303|Rituximab|rituximab|mesh-list
19533233|NCT02877303|Doxorubicin|doxorubicin|mesh-list
19533234|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19533235|NCT02877303|Methotrexate|methotrexate|mesh-list
19533236|NCT02877303|Vincristine|vincristine|mesh-list
19533237|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
19533238|NCT02877303|Ofatumumab|ofatumumab|mesh-list
19533239|NCT02877303|Blinatumomab|blinatumomab|mesh-list
19533240|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20103748|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103749|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20103750|NCT00003223|Protective Agents|protective agents|mesh-ancestor
19533241|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19533242|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
19533243|NCT02877303|Antibodies|antibodies|mesh-list
19533244|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
19533245|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19533246|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19533247|NCT02877303|BB 1101|bb 1101|mesh-list
19533248|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533249|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
19533250|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533251|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533252|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19533253|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
19533254|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533255|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103751|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20306998|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20306999|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20307000|NCT00657423|Growth Substances|growth substances|mesh-ancestor
20307001|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307002|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
20307003|NCT00657449|Valdecoxib|valdecoxib|mesh-list
20307004|NCT00657449|Rofecoxib|rofecoxib|mesh-list
19533256|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19533257|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20103752|NCT00003225|Irinotecan|irinotecan|mesh-list
20103753|NCT00003225|Amifostine|amifostine|mesh-list
19533258|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
19533259|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
19533260|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533261|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533262|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
19533263|NCT02877303|Hormones|hormones|mesh-ancestor
19533264|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533265|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533266|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
19533267|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533268|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19533269|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103754|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20103755|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307005|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20307006|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19533270|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19533271|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19533272|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
19533273|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19533274|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19533275|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
19533276|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
19533277|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19533278|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19533279|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
19533280|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533281|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19533282|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
19533283|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
19533284|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533285|NCT02876991|Listerine|listerine|mesh-list
19533286|NCT02876991|Fluorides|fluorides|mesh-list
19533287|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
19533288|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
19533289|NCT02876991|Protective Agents|protective agents|mesh-ancestor
19533290|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533291|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19533292|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533293|NCT02876770|Melatonin|melatonin|mesh-list
20103756|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103757|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103758|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103759|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20103760|NCT00003225|Protective Agents|protective agents|mesh-ancestor
20103761|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103762|NCT00003229|Aldesleukin|aldesleukin|mesh-list
20103763|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103764|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20103765|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20103766|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
20103767|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103768|NCT00003230|Paclitaxel|paclitaxel|mesh-list
19533294|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
19533295|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533296|NCT02876770|Protective Agents|protective agents|mesh-ancestor
19533297|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533298|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533299|NCT02876822|Vitamin D|vitamin d|mesh-list
19533300|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
19533301|NCT02876822|Vitamins|vitamins|mesh-ancestor
19533302|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
19533303|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103769|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103770|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103771|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103772|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103773|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103774|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103775|NCT00003231|Docetaxel|docetaxel|mesh-list
20103776|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533304|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19533305|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19533306|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
19533307|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19533308|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
19533309|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19533310|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
19533311|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533312|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533313|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
19533314|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
19533315|NCT02876978|Fludarabine|fludarabine|mesh-list
19533316|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533317|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
19533318|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533319|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533320|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19533321|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
19533322|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533323|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103777|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
19533324|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19533325|NCT02876679|Cyclosporine|cyclosporine|mesh-list
19533326|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
19533327|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
19533328|NCT02876679|Cyclosporins|cyclosporins|mesh-list
19533329|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19533330|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533331|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
19533332|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533333|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533334|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19533335|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
19533336|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533337|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533338|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19533339|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533340|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
19533341|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533342|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
19533343|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19533344|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19533345|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19533346|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
19533347|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19533348|NCT02876796|Firsocostat|firsocostat|mesh-list
19533349|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533350|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533351|NCT02876549|Chloroquine|chloroquine|mesh-list
19533352|NCT02876549|Primaquine|primaquine|mesh-list
19533353|NCT02876549|Amebicides|amebicides|mesh-ancestor
19533354|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19533355|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19533356|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533357|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
19533358|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533359|NCT02876432|Diclofenac|diclofenac|mesh-list
19533360|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19533361|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533362|NCT02876432|Analgesics|analgesics|mesh-ancestor
19533363|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
19533364|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533365|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533366|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533367|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533368|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19533369|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533370|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533371|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
19533372|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19533373|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
19533374|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533375|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
19533376|NCT02876276|Protective Agents|protective agents|mesh-ancestor
19533377|NCT02876354|Vitamin K|vitamin k|mesh-list
19533378|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
20103778|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103779|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103780|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103781|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
20103782|NCT00003232|Prednisone|prednisone|mesh-list
20103783|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
20103784|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20103785|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
20103786|NCT00003232|Hormones|hormones|mesh-ancestor
20103787|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103788|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307007|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307008|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307009|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20103789|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20103790|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533379|NCT02876354|Vitamins|vitamins|mesh-ancestor
19533380|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
19533381|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533382|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19533383|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20103791|NCT00003232|Analgesics|analgesics|mesh-ancestor
20103792|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
19533384|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533385|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
19533386|NCT02876354|Coagulants|coagulants|mesh-ancestor
19533387|NCT02876224|Bevacizumab|bevacizumab|mesh-list
19533388|NCT02876224|Atezolizumab|atezolizumab|mesh-list
19533389|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19533390|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533391|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19533392|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19533393|NCT02876224|Growth Substances|growth substances|mesh-ancestor
19533394|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533395|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
19533396|NCT02876250|Cyclosporine|cyclosporine|mesh-list
19533397|NCT02876250|Cyclosporins|cyclosporins|mesh-list
19533398|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533399|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533400|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533401|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
19533402|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533403|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
19533404|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533405|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19533406|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533407|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19533408|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19533409|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19533410|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20103793|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20103794|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20103795|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103796|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103797|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103798|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20103799|NCT00003234|Vinorelbine|vinorelbine|mesh-list
20103800|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103801|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103802|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103803|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103804|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103805|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103806|NCT00003235|Paclitaxel|paclitaxel|mesh-list
20103807|NCT00003235|Carboplatin|carboplatin|mesh-list
20103808|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103809|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103810|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103811|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103812|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533411|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19533412|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
19533413|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533414|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19533415|NCT02876484|Cathartics|cathartics|mesh-ancestor
19533416|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533417|NCT02876211|Vitamin D|vitamin d|mesh-list
19533418|NCT02876211|Vitamins|vitamins|mesh-ancestor
19533419|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
19533420|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533421|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19533422|NCT02876094|Celecoxib|celecoxib|mesh-list
19533423|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19533424|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533425|NCT02876094|Analgesics|analgesics|mesh-ancestor
20103813|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103814|NCT00003236|ISIS 5132|isis 5132|mesh-list
20103815|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103816|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533426|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
19533427|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533428|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533429|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533430|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533431|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19533432|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19533433|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533434|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533435|NCT02876081|Afatinib|afatinib|mesh-list
19533436|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533437|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19533438|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533439|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533440|NCT02876146|Albendazole|albendazole|mesh-list
19533441|NCT02876146|Benzimidazole|benzimidazole|mesh-list
19533442|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
19533443|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19533444|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533445|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
19533446|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19533447|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19533448|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
19533449|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
19533450|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533451|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533452|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533453|NCT02875756|Ivermectin|ivermectin|mesh-list
19533454|NCT02875756|Selamectin|selamectin|mesh-list
19533455|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19533456|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533457|NCT02875743|Posaconazole|posaconazole|mesh-list
19533458|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
19533459|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533460|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19533461|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19533462|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19533463|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19533464|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19533465|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533466|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533467|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19533468|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
19533469|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533470|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533471|NCT02875821|Metformin|metformin|mesh-list
19533472|NCT02875821|Pioglitazone|pioglitazone|mesh-list
19533473|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
19533474|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19533475|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533476|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19533477|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533478|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19533479|NCT02875886|Amiloride|amiloride|mesh-list
19533480|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19533481|NCT02875886|Diuretics|diuretics|mesh-ancestor
19533482|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
19533483|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533484|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19533485|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19533486|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533487|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19533488|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19533489|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19533490|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19574226|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574227|NCT04752566|Eculizumab|eculizumab|mesh-list
19574228|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19574229|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574230|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
19574231|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574232|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
19574233|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574234|NCT04743505|Osimertinib|osimertinib|mesh-list
19574235|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574236|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19574237|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103817|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103818|NCT00003237|Paclitaxel|paclitaxel|mesh-list
19574238|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574239|NCT04741139|Acetaminophen|acetaminophen|mesh-list
19533491|NCT02875873|Methamphetamine|methamphetamine|mesh-list
19533492|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
19533493|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19533494|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533495|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
19533496|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
19533497|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533498|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
19533499|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533500|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533501|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
19533502|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19533503|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19533504|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19533505|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20103819|NCT00003237|Cisplatin|cisplatin|mesh-list
20103820|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103821|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103822|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103823|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103824|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103825|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103826|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
20103827|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103828|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103829|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103830|NCT00003239|Interferons|interferons|mesh-list
20103831|NCT00003239|Cytarabine|cytarabine|mesh-list
20103832|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
20103833|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
20103834|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
20103835|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307010|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20307011|NCT00657449|Analgesics|analgesics|mesh-ancestor
20307012|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
19533506|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19533507|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19533508|NCT02875457|Cisplatin|cisplatin|mesh-list
19533509|NCT02875457|Etoposide|etoposide|mesh-list
19533510|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
19533511|NCT02875457|Apatinib|apatinib|mesh-list
19533512|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533513|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19533514|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19533515|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19533516|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533517|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533518|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19533519|NCT02875587|Cabergoline|cabergoline|mesh-list
19533520|NCT02875587|Calcium|calcium|mesh-list
19533521|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19533522|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533523|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19533524|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19533525|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
19533526|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
19533527|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533528|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533529|NCT02876107|Paclitaxel|paclitaxel|mesh-list
19533530|NCT02876107|Carboplatin|carboplatin|mesh-list
19533531|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19533532|NCT02876107|Panitumumab|panitumumab|mesh-list
19533533|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19533534|NCT02876107|Antibodies|antibodies|mesh-list
19533535|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
19533536|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19533537|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19533538|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533539|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19533540|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19533541|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533542|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533543|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
19533544|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103836|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
20307013|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533545|NCT02875717|Aspirin|aspirin|mesh-list
19533546|NCT02875717|Heparin|heparin|mesh-list
19533547|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19533548|NCT02875717|Tinzaparin|tinzaparin|mesh-list
19533549|NCT02875717|Dalteparin|dalteparin|mesh-list
19533550|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
19533551|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19533552|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19533553|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533554|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19533555|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533556|NCT02875717|Analgesics|analgesics|mesh-ancestor
19533557|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
19533558|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533559|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533560|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533561|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533562|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19533563|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19533564|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533565|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
19533566|NCT02875262|Deferoxamine|deferoxamine|mesh-list
19533567|NCT02875262|Siderophores|siderophores|mesh-ancestor
19533568|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19533569|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
19533570|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
19533571|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533572|NCT02875093|Cytarabine|cytarabine|mesh-list
19533573|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19533574|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
19533575|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533576|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533577|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
19533578|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307014|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307015|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307016|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307017|NCT00657475|Heparin|heparin|mesh-list
20307018|NCT00657475|Calcium heparin|calcium heparin|mesh-list
20307019|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
20307020|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20307021|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20307022|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307023|NCT00657488|Thalidomide|thalidomide|mesh-list
20307024|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307025|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
19533579|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533580|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
19533581|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533582|NCT02875288|Bupivacaine|bupivacaine|mesh-list
19533583|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
19533584|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
19533585|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533586|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533587|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
19533588|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533589|NCT02875015|Lidocaine|lidocaine|mesh-list
19533590|NCT02875015|Bupivacaine|bupivacaine|mesh-list
19533591|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
19533592|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
19533593|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533594|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533595|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
19533596|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533597|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19533598|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19533599|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19533600|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19533601|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533602|NCT02875002|Belinostat|belinostat|mesh-list
19533603|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307026|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533604|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19533605|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307027|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
20307028|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19533606|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533607|NCT02874989|Dasatinib|dasatinib|mesh-list
19533608|NCT02874989|Quercetin|quercetin|mesh-list
19533609|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307029|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307030|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20307031|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20307032|NCT00657488|Growth Substances|growth substances|mesh-ancestor
20307033|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
20307034|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307035|NCT00657514|Ranolazine|ranolazine|mesh-list
20307036|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20307037|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20103837|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103838|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103839|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
20103840|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103841|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103842|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
20103843|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103844|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103845|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20103846|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103847|NCT00003240|Vinorelbine|vinorelbine|mesh-list
20103848|NCT00003240|Ifosfamide|ifosfamide|mesh-list
20103849|NCT00003240|Mitomycins|mitomycins|mesh-list
20103850|NCT00003240|Mitomycin|mitomycin|mesh-list
20103851|NCT00003240|Vinblastine|vinblastine|mesh-list
20103852|NCT00003240|Vindesine|vindesine|mesh-list
19533610|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19533611|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533612|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533613|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
19533614|NCT02874989|Protective Agents|protective agents|mesh-ancestor
19533615|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533616|NCT02874963|Ethanol|ethanol|mesh-list
19533617|NCT02874963|Listerine|listerine|mesh-list
19533618|NCT02874963|Eucalyptol|eucalyptol|mesh-list
19533619|NCT02874963|Salicylates|salicylates|mesh-list
19533620|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
19533621|NCT02874963|Menthol|menthol|mesh-list
19533622|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19533623|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533624|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533625|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103853|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103854|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103855|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103856|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
20307038|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307039|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19533626|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
19533627|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
19533628|NCT02874963|Protective Agents|protective agents|mesh-ancestor
19533629|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19533630|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533631|NCT02874963|Analgesics|analgesics|mesh-ancestor
19533632|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
19533633|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533634|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533635|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533636|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19533637|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533638|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533639|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
19533640|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
19533641|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
19533642|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
19533643|NCT02874768|Propofol|propofol|mesh-list
19533644|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19533645|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533646|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307040|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20307041|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19533647|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19533648|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
20103857|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533649|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
19533650|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533651|NCT02874768|Analgesics|analgesics|mesh-ancestor
19533652|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
19533653|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533654|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19533655|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19533656|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19533657|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
19533658|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20103858|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103859|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103860|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
20103861|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103862|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20103863|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533659|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533660|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20307042|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
20307043|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307044|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20307045|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19533661|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
19533662|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533663|NCT02874690|Methylphenidate|methylphenidate|mesh-list
19533664|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19533665|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533666|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19533667|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19533668|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19533669|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533670|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
19533671|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533672|NCT02874807|Empagliflozin|empagliflozin|mesh-list
19533673|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19533674|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533675|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19533676|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533677|NCT02874820|Idazoxan|idazoxan|mesh-list
19533678|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19533679|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19533680|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19533681|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
19533682|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533683|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533684|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533685|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
19533686|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19533687|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533688|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533689|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19533690|NCT02874378|Analgesics|analgesics|mesh-ancestor
19533691|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
19533692|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533693|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19533694|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20307046|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307047|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20307048|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20307049|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307050|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
20307051|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20307052|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20307053|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307054|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307055|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307056|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307057|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307058|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103864|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
19533695|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19533696|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
19533697|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533698|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533699|NCT02874326|Octreotide|octreotide|mesh-list
19533700|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533701|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533702|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533703|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
19533704|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
19533705|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19533706|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19533707|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533708|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533709|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533710|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574240|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
19574241|NCT04741139|Promethazine|promethazine|mesh-list
19574242|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19574243|NCT04741139|Analgesics|analgesics|mesh-ancestor
19574244|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
19574245|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574246|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574247|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
19574248|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19574249|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20307059|NCT00657644|Urological Agents|urological agents|mesh-ancestor
20603980|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
20103865|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103866|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
20103867|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574250|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20103868|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103869|NCT00003242|Paclitaxel|paclitaxel|mesh-list
19574251|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
19574252|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
19574253|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
19574254|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
19574255|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574256|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19574257|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
19574258|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
19574259|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574260|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574261|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19574262|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
19574263|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
19574264|NCT04734197|Cyclosporine|cyclosporine|mesh-list
19574265|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
19574266|NCT04734197|Betamethasone|betamethasone|mesh-list
19574267|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
19574268|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19574269|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
19574270|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19574271|NCT04734197|Lifitegrast|lifitegrast|mesh-list
19574272|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19574273|NCT04734197|Cyclosporins|cyclosporins|mesh-list
19574274|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19574275|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574276|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574277|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574278|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
19574279|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574280|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
19574281|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574282|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
19574283|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574284|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19574285|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574286|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
19574287|NCT04734197|Hormones|hormones|mesh-ancestor
20103870|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
20103871|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103872|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103873|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103874|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103875|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533711|NCT02874248|Drospirenone|drospirenone|mesh-list
19533712|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19533713|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
19533714|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533715|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533716|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19533717|NCT02874248|Diuretics|diuretics|mesh-ancestor
19533718|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
19533719|NCT02873598|Gemcitabine|gemcitabine|mesh-list
19533720|NCT02873598|Paclitaxel|paclitaxel|mesh-list
19533721|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19533722|NCT02873598|Folfirinox|folfirinox|mesh-list
19533723|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19533724|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533725|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
19533726|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
19533727|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533728|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533729|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19533730|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
19533731|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
19533732|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533733|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533734|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533735|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
19533736|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533737|NCT02873650|Dabrafenib|dabrafenib|mesh-list
19533738|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533739|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19533740|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533741|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533742|NCT02873806|Tobramycin|tobramycin|mesh-list
19533743|NCT02873806|Dexamethasone|dexamethasone|mesh-list
19533744|NCT02873806|Travoprost|travoprost|mesh-list
19533745|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533746|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
19533747|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
19533748|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533749|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533750|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533751|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
19533752|NCT02873806|Hormones|hormones|mesh-ancestor
19533753|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533754|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533755|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533756|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19533757|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19533758|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533759|NCT02873559|Testosterone|testosterone|mesh-list
19533760|NCT02873559|Androgens|androgens|mesh-ancestor
19533761|NCT02873559|Hormones|hormones|mesh-ancestor
19533762|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533763|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533764|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19533765|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533766|NCT02873871|Hemostatics|hemostatics|mesh-list
19533767|NCT02873871|Coagulants|coagulants|mesh-ancestor
19533768|NCT02873273|Dexamethasone|dexamethasone|mesh-list
19533769|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533770|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
19533771|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
19533772|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533773|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533774|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533775|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
19533776|NCT02873273|Hormones|hormones|mesh-ancestor
19533777|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533778|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533779|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533780|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
19533781|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533782|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
19533783|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19533784|NCT02873364|Vitamin D|vitamin d|mesh-list
19533785|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
19533786|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
19533787|NCT02873364|Vitamins|vitamins|mesh-list
19533788|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
19533789|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533790|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19533791|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19533792|NCT02873351|Levodopa|levodopa|mesh-list
19533793|NCT02873351|Carbidopa|carbidopa|mesh-list
19533794|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19533795|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19533796|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19533797|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
19533798|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533799|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533800|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533801|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19533802|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533803|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19533804|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
19533805|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
19533806|NCT02873091|Sufentanil|sufentanil|mesh-list
19533807|NCT02873091|Ropivacaine|ropivacaine|mesh-list
19533808|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
19533809|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
19533810|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533811|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533812|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
19533813|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533814|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19533815|NCT02873091|Narcotics|narcotics|mesh-ancestor
19533816|NCT02873091|Analgesics|analgesics|mesh-ancestor
19533817|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19533818|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19533819|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
19533820|NCT02873065|Amoxicillin|amoxicillin|mesh-list
19533821|NCT02873065|Clarithromycin|clarithromycin|mesh-list
20307060|NCT00657748|Triacetin|triacetin|mesh-list
20307061|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
20307062|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
19533822|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
19533823|NCT02873065|Bismuth|bismuth|mesh-list
19533824|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533825|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19533826|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533827|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19533828|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533829|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19533830|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19533831|NCT02873065|Antacids|antacids|mesh-ancestor
19533832|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533833|NCT02873065|Diuretics|diuretics|mesh-ancestor
19533834|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
19533835|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533836|NCT02873065|Expectorants|expectorants|mesh-ancestor
20307063|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307064|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307065|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307066|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
20307067|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20307068|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20307069|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307070|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
19533837|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
19533838|NCT02872818|Metformin|metformin|mesh-list
20307071|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533839|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19533840|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19533841|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19533842|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
19533843|NCT02872818|Estradiol|estradiol|mesh-list
19533844|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19533845|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20103876|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103877|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20103878|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
20103879|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103880|NCT00003243|Aldesleukin|aldesleukin|mesh-list
20103881|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
20103882|NCT00003243|Doxorubicin|doxorubicin|mesh-list
20103883|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20103884|NCT00003243|Etoposide|etoposide|mesh-list
20307072|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
20307073|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20307074|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20307075|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307076|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20307077|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20307078|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
20307079|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533846|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533847|NCT02872818|Estrogens|estrogens|mesh-ancestor
19533848|NCT02872818|Hormones|hormones|mesh-ancestor
19533849|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533850|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19533851|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
19533852|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19533853|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19533854|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19533855|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19533856|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19533857|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19533858|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533859|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533860|NCT02873026|Triamcinolone|triamcinolone|mesh-list
19533861|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19533862|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19533863|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19533864|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533865|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
19533866|NCT02873026|Hormones|hormones|mesh-ancestor
19533867|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533868|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533869|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533870|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
19533871|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533872|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533873|NCT02872584|Prednisone|prednisone|mesh-list
19533874|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533875|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
19533876|NCT02872584|Hormones|hormones|mesh-ancestor
19533877|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533878|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533879|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533880|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533881|NCT02872597|Dexamethasone|dexamethasone|mesh-list
19533882|NCT02872597|Prednisone|prednisone|mesh-list
19533883|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
19533884|NCT02872597|Prednisolone|prednisolone|mesh-list
19533885|NCT02872597|Albuterol|albuterol|mesh-list
19533886|NCT02872597|Ipratropium|ipratropium|mesh-list
19533887|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533888|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
19533889|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
19533890|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307080|NCT00657774|Prednisone|prednisone|mesh-list
20307081|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307082|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
20307083|NCT00657774|Hormones|hormones|mesh-ancestor
20307084|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307085|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103885|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103886|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
19533891|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533892|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533893|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
19533894|NCT02872597|Hormones|hormones|mesh-ancestor
19533895|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533896|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533897|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103887|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103888|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103889|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20103890|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
19533898|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533899|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19533900|NCT02872597|Protective Agents|protective agents|mesh-ancestor
19533901|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19533902|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19533903|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
19533904|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
19533905|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19533906|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19533907|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19533908|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19533909|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
19533910|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533911|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19533912|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
20103891|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103892|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307086|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20307087|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533913|NCT02872649|Warfarin|warfarin|mesh-list
19533914|NCT02872649|Dabigatran|dabigatran|mesh-list
19533915|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
19533916|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
19533917|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
19533918|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19533919|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
19533920|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533921|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533922|NCT02872389|Sevoflurane|sevoflurane|mesh-list
20103893|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20103894|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20103895|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19533923|NCT02872389|Desflurane|desflurane|mesh-list
19533924|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19533925|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19533926|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
19533927|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
19533928|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533929|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307088|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307089|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307090|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307091|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307092|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307093|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307094|NCT00657839|Urological Agents|urological agents|mesh-ancestor
20307095|NCT00657852|Pamidronate|pamidronate|mesh-list
20603981|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20603982|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307096|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20103896|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20603983|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19533930|NCT02872272|Amikacin|amikacin|mesh-list
19533931|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19533932|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574288|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574289|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19574290|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
19574291|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19574292|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574293|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19574294|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
19574295|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19574296|NCT04733144|Dexamethasone|dexamethasone|mesh-list
19574297|NCT04733144|Prednisolone|prednisolone|mesh-list
20603984|NCT02224443|Narcotics|narcotics|mesh-ancestor
20603985|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20603986|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19574298|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574299|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
19574300|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
19574301|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574302|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103897|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574303|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533933|NCT02872428|Valproic Acid|valproic acid|mesh-list
20103898|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103899|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20103900|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20103901|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
20103902|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19533934|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
19533935|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533936|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533937|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
19533938|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19533939|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533940|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
19533941|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19533942|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19533943|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19533944|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
19533945|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19533946|NCT02871869|Buformin|buformin|mesh-list
19533947|NCT02871869|Prednisone|prednisone|mesh-list
19533948|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
19533949|NCT02871869|Rituximab|rituximab|mesh-list
19533950|NCT02871869|Epirubicin|epirubicin|mesh-list
19533951|NCT02871869|Vindesine|vindesine|mesh-list
19533952|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533953|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
19533954|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533955|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19533956|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19533957|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
19533958|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19533959|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533960|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19533961|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19533962|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19533963|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
19533964|NCT02871869|Hormones|hormones|mesh-ancestor
19533965|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19533966|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19533967|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19533968|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19533969|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19533970|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533971|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19533972|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
19533973|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
19533974|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
19533975|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19533976|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
19533977|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
19533978|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19533979|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
19533980|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19533981|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19533982|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19533983|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
19533984|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
19533985|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20103903|NCT00003245|Irinotecan|irinotecan|mesh-list
20103904|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20103905|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20103906|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19533986|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
19533987|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20103907|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103908|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103909|NCT00003248|Rituximab|rituximab|mesh-list
20103910|NCT00003248|Fludarabine|fludarabine|mesh-list
20103911|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
20103912|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20103913|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533988|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103914|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
19533989|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19533990|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19533991|NCT02871791|Everolimus|everolimus|mesh-list
19533992|NCT02871791|Palbociclib|palbociclib|mesh-list
19533993|NCT02871791|Exemestane|exemestane|mesh-list
19533994|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19533995|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19533996|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
19533997|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103915|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103916|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20103917|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103918|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
20103919|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103920|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103921|NCT00003249|Ketoconazole|ketoconazole|mesh-list
20103922|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
20103923|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
20103924|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20103925|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20103926|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20103927|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103928|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103929|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20103930|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
20103931|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20103932|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103933|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20103934|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103935|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20103936|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20103937|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20103938|NCT00003250|Fenretinide|fenretinide|mesh-list
20103939|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103940|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20103941|NCT00003250|Protective Agents|protective agents|mesh-ancestor
20103942|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103943|NCT00003251|Paclitaxel|paclitaxel|mesh-list
20103944|NCT00003251|Amifostine|amifostine|mesh-list
20103945|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19533998|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19533999|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534000|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534001|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19534002|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19534003|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19534004|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
19534005|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534006|NCT02872064|Verteporfin|verteporfin|mesh-list
19534007|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19534008|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
19534009|NCT02871661|Amitriptyline|amitriptyline|mesh-list
19534010|NCT02871661|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19534011|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19534012|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
19534013|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534014|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534015|NCT02871661|Analgesics|analgesics|mesh-ancestor
19534016|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
19534017|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534018|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534019|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19534020|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19534021|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19534022|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534023|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
19534024|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534025|NCT02871661|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19534026|NCT02871661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19534027|NCT02871661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20103946|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103947|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103948|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103949|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103950|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103951|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20307097|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307098|NCT00657865|Ramipril|ramipril|mesh-list
20307099|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19534028|NCT02871986|Estrogens|estrogens|mesh-list
19534029|NCT02871986|Hormones|hormones|mesh-ancestor
19534030|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534031|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534032|NCT02871713|Morphine|morphine|mesh-list
19534033|NCT02871713|Ropivacaine|ropivacaine|mesh-list
19534034|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19534035|NCT02871713|Narcotics|narcotics|mesh-ancestor
19534036|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534037|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534038|NCT02871713|Analgesics|analgesics|mesh-ancestor
19534039|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
19534040|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534041|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
19534042|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
19534043|NCT02871765|Warfarin|warfarin|mesh-list
19534044|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
19534045|NCT02871687|Simvastatin|simvastatin|mesh-list
19534046|NCT02871687|Pravastatin|pravastatin|mesh-list
19534047|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19534048|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19534049|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
19534050|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534051|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19534052|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19534053|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534054|NCT02872038|Cefazolin|cefazolin|mesh-list
19534055|NCT02872038|Ceftazidime|ceftazidime|mesh-list
19534056|NCT02872038|Cefepime|cefepime|mesh-list
19534057|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19534058|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534059|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
19534060|NCT02871648|Eplerenone|eplerenone|mesh-list
19534061|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19534062|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
19534063|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534064|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534065|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19534066|NCT02871648|Diuretics|diuretics|mesh-ancestor
19534067|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
19534068|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19534069|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534070|NCT02871323|Durvalumab|durvalumab|mesh-list
19534071|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
19534072|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19534073|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
19534074|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19534075|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534076|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
19534077|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534078|NCT02871518|Cisplatin|cisplatin|mesh-list
19534079|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534080|NCT02871505|Penicillins|penicillins|mesh-list
19534081|NCT02871505|Penicillin G|penicillin g|mesh-list
19534082|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19534083|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
19534084|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19534085|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534086|NCT02871349|Propranolol|propranolol|mesh-list
19534087|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19534088|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19534089|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
19534090|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534091|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534092|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534093|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20307100|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
19534094|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19534095|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
19534096|NCT02871193|Dexamethasone|dexamethasone|mesh-list
19534097|NCT02871193|Ropivacaine|ropivacaine|mesh-list
19534098|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534099|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
19534100|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
19534101|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534102|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534103|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19534104|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
19534105|NCT02871193|Hormones|hormones|mesh-ancestor
19534106|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534107|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19534108|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534109|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
19534110|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
19534111|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534112|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
19534113|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
19534114|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534115|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
19534116|NCT02870907|Thiotepa|thiotepa|mesh-list
19534117|NCT02870907|Carboplatin|carboplatin|mesh-list
19534118|NCT02870907|Etoposide|etoposide|mesh-list
19534119|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
19534120|NCT02870907|Vincristine|vincristine|mesh-list
19534121|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534122|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
19534123|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534124|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534125|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19534126|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
19534127|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534128|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534129|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19534130|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19534131|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19534132|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534133|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534134|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
19534135|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
19534136|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
19534137|NCT02870634|Copper|copper|mesh-list
19534138|NCT02870634|Trace Elements|trace elements|mesh-ancestor
19534139|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
19534140|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534141|NCT02870478|Atropine|atropine|mesh-list
19534142|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19534143|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19534144|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19534145|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19534146|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19534147|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
19534148|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534149|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534150|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19534151|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
19534152|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
19534153|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
19534154|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19534155|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19534156|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
19534157|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534158|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534159|NCT02870673|Triamcinolone|triamcinolone|mesh-list
19534160|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19534161|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19534162|NCT02870673|Lidocaine|lidocaine|mesh-list
19534163|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19534164|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534165|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
20307101|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307102|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307103|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20307104|NCT00657878|Gemcitabine|gemcitabine|mesh-list
20603987|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20603988|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534166|NCT02870673|Hormones|hormones|mesh-ancestor
20603989|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
19534167|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534168|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307105|NCT00657878|Paclitaxel|paclitaxel|mesh-list
20307106|NCT00657878|Carboplatin|carboplatin|mesh-list
20307107|NCT00657878|Doxorubicin|doxorubicin|mesh-list
20307108|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20307109|NCT00657878|Topotecan|topotecan|mesh-list
20103952|NCT00003251|Protective Agents|protective agents|mesh-ancestor
20103953|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103954|NCT00003252|Amifostine|amifostine|mesh-list
20103955|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20103956|NCT00003252|Protective Agents|protective agents|mesh-ancestor
20103957|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103958|NCT00003253|Paclitaxel|paclitaxel|mesh-list
20103959|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
20103960|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103961|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
19534169|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534170|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
19534171|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534172|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534173|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
19534174|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
19534175|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534176|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
19534177|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534178|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19534179|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19534180|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19534181|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19534182|NCT02870361|Insulin|insulin|mesh-list
19534183|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19534184|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534185|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19534186|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19534187|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19534188|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534189|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534190|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
19534191|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534192|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19534193|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19574304|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
19574305|NCT04733144|Hormones|hormones|mesh-ancestor
19574306|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574307|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574308|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103962|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103963|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103964|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103965|NCT00003254|Fluorouracil|fluorouracil|mesh-list
20103966|NCT00003254|Eniluracil|eniluracil|mesh-list
20103967|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
20103968|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103969|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20103970|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103971|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20103972|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
20103973|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103974|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103975|NCT00003255|Carboplatin|carboplatin|mesh-list
20103976|NCT00003255|Topotecan|topotecan|mesh-list
20103977|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103978|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20103979|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20603990|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
19574309|NCT04724720|Famotidine|famotidine|mesh-list
19574310|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19574311|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574312|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19574313|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
19574314|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
19574315|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574316|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103980|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603991|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20307110|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19534194|NCT02870231|Liraglutide|liraglutide|mesh-list
19534195|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19534196|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534197|NCT02870231|Incretins|incretins|mesh-ancestor
19534198|NCT02870231|Hormones|hormones|mesh-ancestor
19534199|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534200|NCT02869984|Ramosetron|ramosetron|mesh-list
19534201|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
19534202|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
19534203|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534204|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534205|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19534206|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19534207|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
19534208|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534209|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534210|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
19534211|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534212|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
19534213|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
19534214|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
19534215|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534216|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534217|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
19534218|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534219|NCT02870036|Leucovorin|leucovorin|mesh-list
19534220|NCT02870036|Thalidomide|thalidomide|mesh-list
19534221|NCT02870036|Fluorouracil|fluorouracil|mesh-list
19534222|NCT02870036|Calcium|calcium|mesh-list
20103981|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103982|NCT00003256|Alvocidib|alvocidib|mesh-list
20103983|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103984|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
20103985|NCT00003256|Growth Substances|growth substances|mesh-ancestor
20103986|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20103987|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20103988|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20103989|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103990|NCT00003259|Vinorelbine|vinorelbine|mesh-list
20103991|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20103992|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20103993|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
20103994|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
20103995|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
20103996|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20103997|NCT00003260|Leucovorin|leucovorin|mesh-list
20103998|NCT00003260|Fluorouracil|fluorouracil|mesh-list
20103999|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
20104000|NCT00003260|Irinotecan|irinotecan|mesh-list
20104001|NCT00003260|Calcium|calcium|mesh-list
20104002|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
20104003|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20104004|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104005|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
20104006|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104007|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19534223|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
19534224|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19534225|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534226|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
19534227|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534228|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19534229|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534230|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534231|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
19534232|NCT02870036|Antidotes|antidotes|mesh-ancestor
19534233|NCT02870036|Protective Agents|protective agents|mesh-ancestor
19534234|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
20104008|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104009|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104010|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
20307111|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534235|NCT02870036|Vitamins|vitamins|mesh-ancestor
19534236|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
19534237|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
20104011|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19534238|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19534239|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534240|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19534241|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19534242|NCT02870036|Growth Substances|growth substances|mesh-ancestor
19534243|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
19534244|NCT02869815|Methylene Blue|methylene blue|mesh-list
19534245|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20603992|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20603993|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20603994|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20603995|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20603996|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20603997|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20603998|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
20603999|NCT02224456|Tenofovir|tenofovir|mesh-list
20604000|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
20604001|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604002|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20604003|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20604004|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604005|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604006|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20604007|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20604008|NCT02224534|Clopidogrel|clopidogrel|mesh-list
20604009|NCT02224534|Ticagrelor|ticagrelor|mesh-list
20604010|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20604011|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19534246|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534247|NCT02869763|Ethanol|ethanol|mesh-list
19534248|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19534249|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534250|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534251|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534252|NCT02869672|Vaccines|vaccines|mesh-list
19534253|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
19534254|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534255|NCT02869347|Complement C1s|complement c1s|mesh-list
19534256|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19534257|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19534258|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
19534259|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534260|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19534261|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534262|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
19534263|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19534264|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534265|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
19534266|NCT02869204|Ascorbic Acid|ascorbic acid|mesh-list
19534267|NCT02869204|Vitamins|vitamins|mesh-ancestor
19534268|NCT02869204|Micronutrients|micronutrients|mesh-ancestor
19534269|NCT02869204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534270|NCT02869204|Antioxidants|antioxidants|mesh-ancestor
19534271|NCT02869204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534272|NCT02869204|Protective Agents|protective agents|mesh-ancestor
19534273|NCT02869321|Fentanyl|fentanyl|mesh-list
19534274|NCT02869321|Morphine|morphine|mesh-list
19534275|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19534276|NCT02869321|Narcotics|narcotics|mesh-ancestor
19534277|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534278|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534279|NCT02869321|Analgesics|analgesics|mesh-ancestor
19534280|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
19534281|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534282|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19534283|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19534284|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
19534285|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
19534286|NCT02869165|Estrogens|estrogens|mesh-list
19534287|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19534288|NCT02869165|Hormones|hormones|mesh-ancestor
20307112|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
20307113|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
20307114|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
20307115|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534289|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307116|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307117|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
19534290|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534291|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19534292|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19534293|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534294|NCT02869100|Listerine|listerine|mesh-list
19534295|NCT02869100|Fluorides|fluorides|mesh-list
19534296|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
19534297|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
19534298|NCT02869100|Protective Agents|protective agents|mesh-ancestor
19534299|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534300|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19534301|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534302|NCT02868944|Sufentanil|sufentanil|mesh-list
19534303|NCT02868944|Morphine|morphine|mesh-list
20307118|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
20307119|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307120|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307121|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104012|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104013|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104014|NCT00003260|Antidotes|antidotes|mesh-ancestor
20104015|NCT00003260|Protective Agents|protective agents|mesh-ancestor
20104016|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
20104017|NCT00003260|Vitamins|vitamins|mesh-ancestor
20104018|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
20104019|NCT00003261|Zidovudine|zidovudine|mesh-list
20104020|NCT00003261|Methotrexate|methotrexate|mesh-list
20104021|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20104022|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
20104023|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20104024|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104025|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104026|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
20104027|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104028|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104029|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
20104030|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104031|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20104032|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104033|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
20104034|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104035|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20104036|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20104037|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
20104038|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104039|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20104040|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20104041|NCT00003262|Prednisone|prednisone|mesh-list
20104042|NCT00003262|Doxorubicin|doxorubicin|mesh-list
20104043|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104044|NCT00003262|Epirubicin|epirubicin|mesh-list
20104045|NCT00003262|Bleomycin|bleomycin|mesh-list
20104046|NCT00003262|Etoposide|etoposide|mesh-list
20104047|NCT00003262|Vincristine|vincristine|mesh-list
20104048|NCT00003262|Vinblastine|vinblastine|mesh-list
20307122|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
19534304|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
19534305|NCT02868944|Anesthetics|anesthetics|mesh-list
19534306|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
19534307|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19534308|NCT02868944|Narcotics|narcotics|mesh-ancestor
19534309|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534310|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534311|NCT02868944|Analgesics|analgesics|mesh-ancestor
19534312|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
19534313|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534314|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19534315|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19534316|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
19534317|NCT02868931|Insulin|insulin|mesh-list
19534318|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19534319|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534320|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
20104049|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
20104050|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104051|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104052|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104053|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534321|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19534322|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
19534323|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534324|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
19534325|NCT02868749|Protective Agents|protective agents|mesh-ancestor
19574317|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574318|NCT04695340|Psyllium|psyllium|mesh-list
19574319|NCT04695340|Cathartics|cathartics|mesh-ancestor
19574320|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574321|NCT04682405|Melphalan|melphalan|mesh-list
19574322|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19574323|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
19574324|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574325|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574326|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19574327|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574328|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
19574329|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578055|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19578056|NCT03577704|Cisplatin|cisplatin|mesh-list
19578057|NCT03577704|Carboplatin|carboplatin|mesh-list
19578058|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
19578059|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20104054|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104055|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104056|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20104057|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
20104058|NCT00003262|Hormones|hormones|mesh-ancestor
20104059|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578060|NCT03577704|Antibodies|antibodies|mesh-list
19578061|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
19578062|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578063|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578064|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578065|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578066|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578067|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578068|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578069|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
19578070|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578071|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578072|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
19578073|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
19578074|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578075|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578076|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578077|NCT03557931|Olanzapine|olanzapine|mesh-list
19578078|NCT03557931|Risperidone|risperidone|mesh-list
19578079|NCT03557931|Aripiprazole|aripiprazole|mesh-list
19578080|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19578081|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19578082|NCT03557931|Ziprasidone|ziprasidone|mesh-list
19578083|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19578084|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
19578085|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19578086|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
19578087|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19578088|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578089|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578090|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19578091|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19578092|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19578093|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19578094|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19578095|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
19578096|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
19578097|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
19578098|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578099|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19578100|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19578101|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19578102|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19578103|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
19578104|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
19749012|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19578105|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19534326|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19534327|NCT02869035|Citalopram|citalopram|mesh-list
19534328|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19534329|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19534330|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19534331|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534332|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534333|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
19534334|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534335|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19534336|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
20104060|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104061|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20104062|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19534337|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534338|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534339|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19534340|NCT02869035|Analgesics|analgesics|mesh-ancestor
19534341|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
19534342|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
19534343|NCT02868996|Kallikreins|kallikreins|mesh-list
19534344|NCT02868996|Coagulants|coagulants|mesh-ancestor
19534345|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19534346|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
19534347|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19534348|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534349|NCT02868814|Pregabalin|pregabalin|mesh-list
19534350|NCT02868814|Analgesics|analgesics|mesh-ancestor
19534351|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
19534352|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534353|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534354|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
19534355|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19534356|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19534357|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534358|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19534359|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19534360|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19534361|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534362|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534363|NCT02868801|Pregabalin|pregabalin|mesh-list
19534364|NCT02868801|Analgesics|analgesics|mesh-ancestor
19534365|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
19534366|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534367|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534368|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
19534369|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19534370|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20604012|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20604013|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20604014|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
20604015|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604016|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604017|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604018|NCT02224768|Ipilimumab|ipilimumab|mesh-list
19534371|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104063|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104064|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104065|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
19534372|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19534373|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19534374|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19534375|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534376|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534377|NCT02868580|Lamivudine|lamivudine|mesh-list
19534378|NCT02868580|Abacavir|abacavir|mesh-list
19534379|NCT02868580|Dolutegravir|dolutegravir|mesh-list
19534380|NCT02868580|Triumeq|triumeq|mesh-list
19534381|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19534382|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19534383|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534384|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534385|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
19534386|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534387|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19534388|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19534389|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19534390|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19534391|NCT02868827|Vitamin D|vitamin d|mesh-list
19534392|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
19534393|NCT02868827|Vitamins|vitamins|mesh-ancestor
19534394|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
19534395|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534396|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19534397|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19534398|NCT02868606|Insulin|insulin|mesh-list
19534399|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19534400|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19534401|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534402|NCT02868385|Praziquantel|praziquantel|mesh-list
19534403|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
19534404|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19534405|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534406|NCT02868632|Durvalumab|durvalumab|mesh-list
19534407|NCT02868632|Tremelimumab|tremelimumab|mesh-list
19534408|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19534409|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534410|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
19534411|NCT02868372|Povidone|povidone|mesh-list
19534412|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
20604019|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604020|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604021|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20604022|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604023|NCT02224937|Melatonin|melatonin|mesh-list
20604024|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
20604025|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604026|NCT02224937|Protective Agents|protective agents|mesh-ancestor
20604027|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604028|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534413|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
19534414|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20104066|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
20604029|NCT02224950|Emollients|emollients|mesh-list
19534415|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534416|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
19534417|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19534418|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
19534419|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534420|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
19534421|NCT02868437|Protective Agents|protective agents|mesh-ancestor
19534422|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
19534423|NCT02868151|Vitamins|vitamins|mesh-ancestor
19534424|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
19534425|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534426|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
19534427|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534428|NCT02868151|Protective Agents|protective agents|mesh-ancestor
19534429|NCT02868073|Vaccines|vaccines|mesh-list
19534430|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
19534431|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534432|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19534433|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534434|NCT02867956|Etoposide|etoposide|mesh-list
19534435|NCT02867956|Apatinib|apatinib|mesh-list
19534436|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19534437|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534438|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19534439|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534440|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534441|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534442|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19534443|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
19534444|NCT02867930|Ketamine|ketamine|mesh-list
20604030|NCT02224950|Chitosan|chitosan|mesh-list
19534445|NCT02867930|Propofol|propofol|mesh-list
19534446|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19534447|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534448|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534449|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19534450|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
19534451|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
19534452|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534453|NCT02867930|Analgesics|analgesics|mesh-ancestor
19534454|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
19534455|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534456|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19534457|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19534458|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19534459|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
19534460|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534461|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104067|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120462|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120463|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120464|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
20120465|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120466|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
20120467|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120468|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20120469|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20120470|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20120471|NCT00006363|Analgesics|analgesics|mesh-ancestor
19534462|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19534463|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19534464|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19534465|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
19534466|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19534467|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19534468|NCT02867904|Prednisolone|prednisolone|mesh-list
19534469|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
19534470|NCT02867904|Bupivacaine|bupivacaine|mesh-list
19534471|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19534472|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
19534473|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534474|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
19534475|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
19534476|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534477|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534478|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19534479|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
19534480|NCT02867904|Hormones|hormones|mesh-ancestor
19534481|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534482|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19534483|NCT02867904|Protective Agents|protective agents|mesh-ancestor
19534484|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19534485|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534486|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
19534487|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
19534488|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534489|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
19534490|NCT02867878|Adenosine|adenosine|mesh-list
19534491|NCT02867878|Analgesics|analgesics|mesh-ancestor
19534492|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
19534493|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534494|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534495|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20120472|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
20120473|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120474|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120475|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120476|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
20120477|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120478|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307123|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307124|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20307125|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19534496|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
19534497|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19534498|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
20307126|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534499|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
19534500|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120479|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19534501|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534502|NCT02867865|Gemcitabine|gemcitabine|mesh-list
19534503|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534504|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19534505|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
19534506|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534507|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
19534508|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534509|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534510|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534511|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
19534512|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534513|NCT02867917|Psyllium|psyllium|mesh-list
19534514|NCT02867917|Cathartics|cathartics|mesh-ancestor
19534515|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19534516|NCT02867566|Rituximab|rituximab|mesh-list
19534517|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19534518|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534519|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
19534520|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534521|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534522|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
19534523|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534524|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19534525|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534526|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534527|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
19534528|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534529|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534530|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19534531|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19534532|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19534533|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
19534534|NCT02867553|Rituximab|rituximab|mesh-list
19534535|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19534536|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534537|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
19534538|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534539|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534540|NCT02867800|Acetaminophen|acetaminophen|mesh-list
19534541|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
19534542|NCT02867800|Promethazine|promethazine|mesh-list
19534543|NCT02867800|Cyclosporine|cyclosporine|mesh-list
19534544|NCT02867800|Sirolimus|sirolimus|mesh-list
19534545|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
19534546|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
19534547|NCT02867800|Methotrexate|methotrexate|mesh-list
19534548|NCT02867800|Fludarabine|fludarabine|mesh-list
19534549|NCT02867800|Melphalan|melphalan|mesh-list
19534550|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
19534551|NCT02867800|Thiotepa|thiotepa|mesh-list
19534552|NCT02867800|Abatacept|abatacept|mesh-list
19534553|NCT02867800|Meperidine|meperidine|mesh-list
20307127|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20307128|NCT00657891|Omalizumab|omalizumab|mesh-list
20307129|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20307130|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19534554|NCT02867800|Tacrolimus|tacrolimus|mesh-list
19534555|NCT02867800|Cyclosporins|cyclosporins|mesh-list
19534556|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
19534557|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20307131|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
20104068|NCT00003263|Interferons|interferons|mesh-list
20104069|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
19534558|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
19534559|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19534560|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534561|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19534562|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
19534563|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534564|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534565|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
19534566|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534567|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19534568|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307132|NCT00657904|Bicalutamide|bicalutamide|mesh-list
19534569|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
19534570|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534571|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19534572|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19534573|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
19534574|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534575|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534576|NCT02867800|Analgesics|analgesics|mesh-ancestor
19534577|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
19534578|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534579|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
19534580|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19534581|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19534582|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
19534583|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19534584|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534585|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
19534586|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
19534587|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19534588|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
19534589|NCT02867800|Hormones|hormones|mesh-ancestor
19534590|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534591|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19534592|NCT02867800|Protective Agents|protective agents|mesh-ancestor
19534593|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19534594|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
19534595|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19534596|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19534597|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19534598|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19534599|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19534600|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534601|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
19534602|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
19534603|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19534604|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
19534605|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
19534606|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20104070|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104071|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
20104072|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534607|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19534608|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
19534609|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19534610|NCT02867800|Narcotics|narcotics|mesh-ancestor
19534611|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19534612|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
19534613|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534614|NCT02867176|Ketorolac|ketorolac|mesh-list
19534615|NCT02867176|Gabapentin|gabapentin|mesh-list
19534616|NCT02867176|Analgesics|analgesics|mesh-ancestor
19534617|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
19534618|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534619|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534620|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
19534621|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19534622|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19534623|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534624|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534625|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19534626|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19534627|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534628|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534629|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
19534630|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19534631|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534632|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534633|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534634|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19534635|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534636|NCT02867293|Anesthetics|anesthetics|mesh-list
19534637|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534638|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574330|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20104073|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
19574331|NCT04668144|Cangrelor|cangrelor|mesh-list
19574332|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20104074|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534639|NCT02867306|Methotrexate|methotrexate|mesh-list
19534640|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19534641|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
19534642|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19534643|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534644|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19534645|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
19534646|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534647|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534648|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
19534649|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534650|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19534651|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534652|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
19534653|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534654|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19534655|NCT02867267|Thymalfasin|thymalfasin|mesh-list
19534656|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19534657|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
19534658|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534659|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
19534660|NCT02867397|Epirubicin|epirubicin|mesh-list
19534661|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534662|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19534663|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19534664|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534665|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534666|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534667|NCT02867280|Sorafenib|sorafenib|mesh-list
19534668|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534669|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19534670|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534671|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534672|NCT02867124|Naltrexone|naltrexone|mesh-list
19534673|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19534674|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19534675|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534676|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
19534677|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534678|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
19534679|NCT02867332|Interleukin-2|interleukin-2|mesh-list
19534680|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534681|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
20104075|NCT00003264|Gemcitabine|gemcitabine|mesh-list
19534682|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534683|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534684|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19534685|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
19534686|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534687|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534688|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19534689|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534690|NCT02867332|Analgesics|analgesics|mesh-ancestor
19534691|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
19534692|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534693|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
19534694|NCT02867345|Interleukin-2|interleukin-2|mesh-list
19534695|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534696|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
19534697|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534698|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534699|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19534700|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
19534701|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534702|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534703|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19534704|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534705|NCT02867345|Analgesics|analgesics|mesh-ancestor
19534706|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
19534707|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534708|NCT02866903|Bevacizumab|bevacizumab|mesh-list
19534709|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
19534710|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19534711|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534712|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19534713|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19534714|NCT02866903|Growth Substances|growth substances|mesh-ancestor
19534715|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534716|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
19534717|NCT02867046|Dexamethasone|dexamethasone|mesh-list
19534718|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534719|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
19534720|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
19534721|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534722|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534723|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19534724|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
19534725|NCT02867046|Hormones|hormones|mesh-ancestor
19534726|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534727|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19534728|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534729|NCT02867020|Prednisone|prednisone|mesh-list
19534730|NCT02867020|Goserelin|goserelin|mesh-list
19534731|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534732|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
19534733|NCT02867020|Hormones|hormones|mesh-ancestor
19534734|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534735|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534736|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19534737|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534738|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
19534739|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534740|NCT02866955|Tamoxifen|tamoxifen|mesh-list
19534741|NCT02866955|Estramustine|estramustine|mesh-list
19534742|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19534743|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
19534744|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534745|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534746|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19534747|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534748|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19534749|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19534750|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19534751|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19534752|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
19534753|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534754|NCT02866786|Metformin|metformin|mesh-list
19534755|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
19534756|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19534757|NCT02866786|Estradiol|estradiol|mesh-list
19534758|NCT02866786|Cyproterone|cyproterone|mesh-list
19534759|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19534760|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534761|NCT02866786|Estrogens|estrogens|mesh-ancestor
19534762|NCT02866786|Hormones|hormones|mesh-ancestor
19534763|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534764|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19534765|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
19534766|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19534767|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19534768|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19534769|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19534770|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
19534771|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
19534772|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534773|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19534774|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
19534775|NCT02866409|Bupivacaine|bupivacaine|mesh-list
19534776|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
19534777|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
19534778|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534779|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534780|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
19534781|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534782|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19534783|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534784|NCT02866409|Analgesics|analgesics|mesh-ancestor
19534785|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19534786|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19534787|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19534788|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
19534789|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534790|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534791|NCT02866214|Febuxostat|febuxostat|mesh-list
19534792|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
19534793|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534794|NCT02866448|Aspirin|aspirin|mesh-list
19534795|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19534796|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534797|NCT02866448|Analgesics|analgesics|mesh-ancestor
19534798|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
19534799|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534800|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534801|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534802|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534803|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19534804|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19534805|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534806|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19534807|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19534808|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534809|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
19534810|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
19534811|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534812|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
19534813|NCT02866435|Protective Agents|protective agents|mesh-ancestor
19534814|NCT02866370|Paclitaxel|paclitaxel|mesh-list
19534815|NCT02866370|Carboplatin|carboplatin|mesh-list
19534816|NCT02866370|Doxorubicin|doxorubicin|mesh-list
19534817|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104076|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534818|NCT02866370|Topotecan|topotecan|mesh-list
19534819|NCT02866370|Nintedanib|nintedanib|mesh-list
19534820|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19534821|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534822|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
19534823|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
19534824|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
19534825|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534826|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19534827|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19534828|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534829|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534830|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19534831|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19534832|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19534833|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19534834|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
19534835|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534836|NCT02866396|Pregabalin|pregabalin|mesh-list
19534837|NCT02866396|Analgesics|analgesics|mesh-ancestor
19534838|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
19534839|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534840|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534841|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
19534842|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19534843|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19534844|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534845|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19534846|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19534847|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19534848|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534849|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534850|NCT02866136|Carboplatin|carboplatin|mesh-list
19534851|NCT02866136|Etoposide|etoposide|mesh-list
19534852|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
19534853|NCT02866136|Melphalan|melphalan|mesh-list
19534854|NCT02866136|Vincristine|vincristine|mesh-list
19534855|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534856|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19534857|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19534858|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534859|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104077|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307133|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
19574333|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19534860|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534861|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19534862|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
19534863|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19534864|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534865|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
19534866|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534867|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
19534868|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
19534869|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
19534870|NCT02865824|Aspirin|aspirin|mesh-list
19534871|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19534872|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19534873|NCT02865824|Analgesics|analgesics|mesh-ancestor
19534874|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
19534875|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534876|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534877|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19534878|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19534879|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19534880|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19534881|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604031|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20604032|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20604033|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
20604034|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604035|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20604036|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
20604037|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
20604038|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
20604039|NCT02224950|Coagulants|coagulants|mesh-ancestor
20604040|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
19534882|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19534883|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19534884|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534885|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
19534886|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
19534887|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19534888|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534889|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19534890|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19534891|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19534892|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19534893|NCT02866032|Ciclopirox|ciclopirox|mesh-list
19534894|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
19534895|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534896|NCT02866006|Topotecan|topotecan|mesh-list
19534897|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19534898|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19534899|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534900|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534901|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534902|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
19534903|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19534904|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574334|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19574335|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19574336|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
19574337|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574338|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574339|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574340|NCT04666129|Prednisone|prednisone|mesh-list
19574341|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
19574342|NCT04666129|Docetaxel|docetaxel|mesh-list
19574343|NCT04666129|Relugolix|relugolix|mesh-list
19574344|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574345|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574346|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574347|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574348|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574349|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574350|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
19574351|NCT04666129|Hormones|hormones|mesh-ancestor
20104078|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
20604041|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
20604042|NCT02225054|Ropivacaine|ropivacaine|mesh-list
19534905|NCT02866071|Ketamine|ketamine|mesh-list
19534906|NCT02866071|Analgesics|analgesics|mesh-ancestor
19534907|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
19534908|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19534909|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534910|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19534911|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19534912|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
19534913|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
19534914|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19534915|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19534916|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19534917|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534918|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534919|NCT02865733|Treprostinil|treprostinil|mesh-list
19534920|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19534921|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
19534922|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19534923|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
19534924|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534925|NCT02865629|Expectorants|expectorants|mesh-ancestor
19534926|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
19534927|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19534928|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
19534929|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534930|NCT02865629|Protective Agents|protective agents|mesh-ancestor
19534931|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534932|NCT02865629|Antidotes|antidotes|mesh-ancestor
19534933|NCT02865681|Letrozole|letrozole|mesh-list
19534934|NCT02865681|Clomiphene|clomiphene|mesh-list
19534935|NCT02865681|Enclomiphene|enclomiphene|mesh-list
19534936|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
19534937|NCT02865681|Menotropins|menotropins|mesh-list
20104079|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104080|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
20104081|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104082|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534938|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534939|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19534940|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19534941|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19534942|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534943|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19534944|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
19534945|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19534946|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534947|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19534948|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
19534949|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19534950|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19534951|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19534952|NCT02865642|Citalopram|citalopram|mesh-list
19534953|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19534954|NCT02865642|Serotonin|serotonin|mesh-list
19534955|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19534956|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19534957|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534958|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19534959|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
19534960|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534961|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19534962|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
19534963|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19534964|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19534965|NCT02865668|Metformin|metformin|mesh-list
19534966|NCT02865668|Canagliflozin|canagliflozin|mesh-list
19534967|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19534968|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534969|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19534970|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534971|NCT02865564|Gentamicins|gentamicins|mesh-list
19534972|NCT02865564|Ampicillin|ampicillin|mesh-list
19534973|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20104083|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534974|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534975|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19534976|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534977|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534978|NCT02865616|Vancomycin|vancomycin|mesh-list
19534979|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19534980|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534981|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
19534982|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
19534983|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534984|NCT02865460|Vitamins|vitamins|mesh-ancestor
19534985|NCT02865369|Asunaprevir|asunaprevir|mesh-list
19534986|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
19534987|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534988|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534989|NCT02865356|Cyclosporine|cyclosporine|mesh-list
19534990|NCT02865356|Cyclosporins|cyclosporins|mesh-list
19534991|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19534992|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19534993|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19534994|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
19534995|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19534996|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
19534997|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19534998|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
19534999|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535000|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20104084|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
20104085|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104086|NCT00003266|Methylphenidate|methylphenidate|mesh-list
20104087|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20104088|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104089|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20104090|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20104091|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20104092|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104093|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
20104094|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20104095|NCT00003268|Cytarabine|cytarabine|mesh-list
20104096|NCT00003268|Idarubicin|idarubicin|mesh-list
20104097|NCT00003268|Amifostine|amifostine|mesh-list
20104098|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104099|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
20104100|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104101|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104102|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
20104103|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104104|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535001|NCT02865304|Endostar protein|endostar protein|mesh-list
19535002|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19535003|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19535004|NCT02865304|Growth Substances|growth substances|mesh-ancestor
19535005|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535006|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
19535007|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535008|NCT02865174|Heparin|heparin|mesh-list
19535009|NCT02865174|Enoxaparin|enoxaparin|mesh-list
20104105|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
20104106|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535010|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19535011|NCT02865174|Tinzaparin|tinzaparin|mesh-list
19535012|NCT02865174|Dalteparin|dalteparin|mesh-list
19535013|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
19535014|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
19535015|NCT02865174|Thrombin|thrombin|mesh-list
19535016|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
19535017|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19535018|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19535019|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535020|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19535021|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
19535022|NCT02865174|Coagulants|coagulants|mesh-ancestor
20104107|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104108|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104109|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19535023|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
19535024|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20104110|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104111|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20104112|NCT00003268|Protective Agents|protective agents|mesh-ancestor
20104113|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
19535025|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19535026|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535027|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19535028|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19535029|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535030|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535031|NCT02865005|Dapsone|dapsone|mesh-list
19535032|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535033|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
19535034|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19535035|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19535036|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19535037|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535038|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535039|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
19535040|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19535041|NCT02864927|Vaccines|vaccines|mesh-list
19535042|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
19535043|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535044|NCT02864849|Capecitabine|capecitabine|mesh-list
19535045|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
19535046|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535047|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
19535048|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535049|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535050|NCT02865018|Cetirizine|cetirizine|mesh-list
19535051|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19535052|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19535053|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19535054|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
19535055|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
19535056|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535057|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535058|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535059|NCT02864758|Vitamin K|vitamin k|mesh-list
19535060|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
19535061|NCT02864758|Dabigatran|dabigatran|mesh-list
19535062|NCT02864758|Vitamins|vitamins|mesh-ancestor
19535063|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
19535064|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535065|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19535066|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
19535067|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19535068|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
19535069|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535070|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535071|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
19535072|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19535073|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19535074|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
19535075|NCT02864758|Coagulants|coagulants|mesh-ancestor
19535076|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
19535077|NCT02864784|Calcium|calcium|mesh-list
19535078|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19535079|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535080|NCT02864784|Antacids|antacids|mesh-ancestor
20104114|NCT00003269|Etoposide|etoposide|mesh-list
20104115|NCT00003269|Sargramostim|sargramostim|mesh-list
20104116|NCT00003269|Amifostine|amifostine|mesh-list
20104117|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104118|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
19535081|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535082|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535083|NCT02864602|Dexamethasone|dexamethasone|mesh-list
19535084|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
20104119|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604043|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20604044|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604045|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535085|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19535086|NCT02864602|BB 1101|bb 1101|mesh-list
19535087|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20604046|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20104120|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535088|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
19535089|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
19535090|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535091|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535092|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535093|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
19535094|NCT02864602|Hormones|hormones|mesh-ancestor
19535095|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535096|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19535097|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604047|NCT02225054|Analgesics|analgesics|mesh-ancestor
20604048|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
20604049|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604050|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20104121|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104122|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
20604051|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20604052|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20604053|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
20104123|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104124|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104125|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104126|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104127|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104128|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104129|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104130|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20104131|NCT00003269|Protective Agents|protective agents|mesh-ancestor
20104132|NCT00003273|Leucovorin|leucovorin|mesh-list
20604054|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604055|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604056|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
20604057|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
20604058|NCT02225067|Calcium|calcium|mesh-list
20604059|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20604060|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604061|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
20604062|NCT02225093|Caffeine|caffeine|mesh-list
20604063|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20604064|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604065|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20604066|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604067|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604068|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20604069|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19535098|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
19535099|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535100|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535101|NCT02864472|Ranibizumab|ranibizumab|mesh-list
19535102|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19535103|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19535104|NCT02864472|Growth Substances|growth substances|mesh-ancestor
19535105|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535106|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
19535107|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104133|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
20104134|NCT00003273|Temozolomide|temozolomide|mesh-list
19535108|NCT02864550|Doxycycline|doxycycline|mesh-list
19535109|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19535110|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535111|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
19535112|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19535113|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19535114|NCT02864264|Interferons|interferons|mesh-list
19535115|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
19535116|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535117|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
19535118|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535119|NCT02864199|Ribavirin|ribavirin|mesh-list
19535120|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19535121|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
19535122|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535123|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
20307134|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
20308897|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535124|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574352|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574353|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574354|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574355|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
19574356|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
19574357|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574358|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574359|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19574360|NCT04666129|Protective Agents|protective agents|mesh-ancestor
19574361|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
19574362|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
19574363|NCT04662515|Warfarin|warfarin|mesh-list
19574364|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
19574365|NCT04662515|Dabigatran|dabigatran|mesh-list
19574366|NCT04662515|Apixaban|apixaban|mesh-list
19574367|NCT04662515|Edoxaban|edoxaban|mesh-list
19574368|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
19574369|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19574370|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
19574371|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19574372|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
19574373|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574374|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574375|NCT04660097|Etoposide|etoposide|mesh-list
19574376|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
19574377|NCT04660097|Durvalumab|durvalumab|mesh-list
19574378|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19574379|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19574380|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574381|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19574382|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19574383|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574384|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574385|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574386|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
19574387|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574388|NCT04658849|Pioglitazone|pioglitazone|mesh-list
19574389|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19574390|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574391|NCT04656301|Psilocybin|psilocybin|mesh-list
19574392|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
19574393|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574394|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574395|NCT04648540|Acetaminophen|acetaminophen|mesh-list
19574396|NCT04648540|Celecoxib|celecoxib|mesh-list
19574397|NCT04648540|Ketorolac|ketorolac|mesh-list
19574398|NCT04648540|Lidocaine|lidocaine|mesh-list
19574399|NCT04648540|Pregabalin|pregabalin|mesh-list
19574400|NCT04648540|Fentanyl|fentanyl|mesh-list
19574401|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
19574402|NCT04648540|Morphine|morphine|mesh-list
19574403|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
19574404|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
19574405|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574406|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574407|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
19574408|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574409|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19574410|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19574411|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19574412|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19574413|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574414|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19574415|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19574416|NCT04648540|Analgesics|analgesics|mesh-ancestor
19574417|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19574418|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19574419|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19574420|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
19574421|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574422|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19574423|NCT04648540|Narcotics|narcotics|mesh-ancestor
19574424|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19574425|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19574426|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
19574427|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
19574428|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
19535125|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
19535126|NCT02863861|Ketamine|ketamine|mesh-list
19535127|NCT02863861|Propofol|propofol|mesh-list
19535128|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19535129|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535130|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535131|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19535132|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
20307135|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307136|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535133|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
19535134|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19535135|NCT02863861|Analgesics|analgesics|mesh-ancestor
19535136|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
19535137|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535138|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19535139|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19535140|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19535141|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535142|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604070|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
20604071|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535143|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535144|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19535145|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19535146|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19535147|NCT02864147|Imiquimod|imiquimod|mesh-list
19535148|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19535149|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
19535150|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535151|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535152|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
19535153|NCT02864095|Epinephrine|epinephrine|mesh-list
19535154|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
19535155|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19535156|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19535157|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535158|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535159|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535160|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535161|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19535162|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19535163|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
19535164|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535165|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19535166|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
19535167|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
19535168|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
19535169|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19535170|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19535171|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19535172|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
19535173|NCT02864095|Coagulants|coagulants|mesh-ancestor
19535174|NCT02863835|Albuterol|albuterol|mesh-list
19535175|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19535176|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
19535177|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535178|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535179|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19535180|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
19535181|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
19535182|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19535183|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20307137|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307138|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
20307139|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307140|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307141|NCT00657943|Insulin|insulin|mesh-list
20307142|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20307143|NCT00657943|Metformin|metformin|mesh-list
20307144|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
20604072|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
19535184|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19535185|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20307145|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
20308898|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20308899|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104135|NCT00003273|Thiotepa|thiotepa|mesh-list
20104136|NCT00003273|Carboplatin|carboplatin|mesh-list
19535186|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535187|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535188|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535189|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
19535190|NCT02863913|Interleukin-2|interleukin-2|mesh-list
19535191|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535192|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
19535193|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535194|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535195|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19535196|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
19535197|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535198|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535199|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19535200|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19535201|NCT02863913|Analgesics|analgesics|mesh-ancestor
19535202|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
19535203|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535204|NCT02863614|Ibuprofen|ibuprofen|mesh-list
19535205|NCT02863614|Lorazepam|lorazepam|mesh-list
19535206|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19535207|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19535208|NCT02863614|Analgesics|analgesics|mesh-ancestor
19535209|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
20104137|NCT00003273|Methotrexate|methotrexate|mesh-list
20104138|NCT00003273|Etoposide|etoposide|mesh-list
20104139|NCT00003273|Vincristine|vincristine|mesh-list
20104140|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
20104141|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104142|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
20104143|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535210|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535211|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535212|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535213|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535214|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19535215|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535216|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535217|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
19535218|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
19535219|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
19535220|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535221|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19535222|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535223|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19535224|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19535225|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19535226|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
19535227|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
19535228|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535229|NCT02863809|Riboflavin|riboflavin|mesh-list
19535230|NCT02863809|Dextrans|dextrans|mesh-list
19535231|NCT02863809|Vitamins|vitamins|mesh-ancestor
19535232|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
19535233|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535234|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
19535235|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19535236|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
19535237|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
19535238|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
19535239|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
19535240|NCT02863367|Gemcitabine|gemcitabine|mesh-list
19535241|NCT02863367|Apatinib|apatinib|mesh-list
19535242|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535243|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
19535244|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535245|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535246|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
20104144|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535247|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535248|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104145|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19535249|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535250|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
20104146|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
20120480|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535251|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535252|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19535253|NCT02863679|Tetracaine|tetracaine|mesh-list
19535254|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535255|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
19535256|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535257|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535258|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
19535259|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535260|NCT02863705|Timolol|timolol|mesh-list
19535261|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19535262|NCT02863705|Bimatoprost|bimatoprost|mesh-list
19535263|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19535264|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19535265|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19535266|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19535267|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535268|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535269|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535270|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535271|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19535272|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19535273|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19535274|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19535275|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19535276|NCT02863471|Gemcitabine|gemcitabine|mesh-list
19535277|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535278|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
19535279|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535280|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535281|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
19535282|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535283|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535284|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535285|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
19535286|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535287|NCT02863276|Insulin|insulin|mesh-list
19535288|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19535289|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19535290|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535291|NCT02863055|Nintedanib|nintedanib|mesh-list
19535292|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535293|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19535294|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535295|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535296|NCT02862977|Ketoprofen|ketoprofen|mesh-list
19535297|NCT02862977|Amitriptyline|amitriptyline|mesh-list
19535298|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
19535299|NCT02862977|Caffeine|caffeine|mesh-list
19535300|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19535301|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535302|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19535303|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535304|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535305|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19535306|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19535307|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
19535308|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535309|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19535310|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19535311|NCT02862977|Analgesics|analgesics|mesh-ancestor
19535312|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
19535313|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535314|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535315|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535316|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19535317|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19535318|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
19535319|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19535320|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19535321|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19535322|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19535323|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535324|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20307146|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20307147|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
20307148|NCT00657943|Protamines|protamines|mesh-list
20604073|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
20604074|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20604075|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20607934|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20607935|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
20607936|NCT02244125|Hormones|hormones|mesh-ancestor
20607937|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535325|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20307149|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307150|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535326|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19535327|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535328|NCT02863120|Bupivacaine|bupivacaine|mesh-list
19535329|NCT02863120|Ropivacaine|ropivacaine|mesh-list
19535330|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535331|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
19535332|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535333|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535334|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
20307151|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
20307152|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307153|NCT00657943|Coagulants|coagulants|mesh-ancestor
20307154|NCT00657982|Everolimus|everolimus|mesh-list
19535335|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535336|NCT02863185|Atorvastatin|atorvastatin|mesh-list
19535337|NCT02863185|Pitavastatin|pitavastatin|mesh-list
19535338|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19535339|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19535340|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
19535341|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535342|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19535343|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19535344|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535345|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19535346|NCT02862665|Hematinics|hematinics|mesh-ancestor
19535347|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19535348|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19535349|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
20307155|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307156|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307157|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
20307158|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307159|NCT00657995|Pancrelipase|pancrelipase|mesh-list
20307160|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535350|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19535351|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
19535352|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19535353|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535354|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19535355|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19535356|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535357|NCT02862873|Ondansetron|ondansetron|mesh-list
19535358|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535359|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535360|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
19535361|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
19535362|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535363|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535364|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
19535365|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
19535366|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19535367|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
19535368|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535369|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535370|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19535371|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19535372|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19535373|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19535374|NCT02862691|Acetaminophen|acetaminophen|mesh-list
20307161|NCT00658099|Insulin|insulin|mesh-list
19574429|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20307162|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19535375|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19535376|NCT02862691|Oxycodone|oxycodone|mesh-list
19535377|NCT02862691|Analgesics|analgesics|mesh-list
19535378|NCT02862691|Bupivacaine|bupivacaine|mesh-list
19535379|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
19535380|NCT02862691|Anesthetics|anesthetics|mesh-list
19535381|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535382|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535383|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
19535384|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535385|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19535386|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
19535387|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19535388|NCT02862691|Narcotics|narcotics|mesh-ancestor
19535389|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19535390|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535391|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535392|NCT02862769|Lidocaine|lidocaine|mesh-list
19535393|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535394|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
20307163|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
20104147|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104148|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104149|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104150|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20104151|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
20104152|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20104153|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104154|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
20104155|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
20104156|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104157|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20104158|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19535395|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535396|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535397|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
19535398|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535399|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19535400|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19535401|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19535402|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19535403|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535404|NCT02862483|Tadalafil|tadalafil|mesh-list
19535405|NCT02862483|Tamsulosin|tamsulosin|mesh-list
19535406|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
19535407|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19535408|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19535409|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535410|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535411|NCT02862483|Urological Agents|urological agents|mesh-ancestor
19535412|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20104159|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104160|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104161|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104162|NCT00003273|Antidotes|antidotes|mesh-ancestor
19535413|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19535414|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19535415|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535416|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535417|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535418|NCT02862509|Budesonide|budesonide|mesh-list
19535419|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535420|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19535421|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
19535422|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535423|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535424|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19535425|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
19535426|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
19535427|NCT02862509|Hormones|hormones|mesh-ancestor
20104163|NCT00003273|Protective Agents|protective agents|mesh-ancestor
20104164|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
20104165|NCT00003273|Vitamins|vitamins|mesh-ancestor
20104166|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
20104167|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
19535428|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535429|NCT02862145|Dexamethasone|dexamethasone|mesh-list
19535430|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535431|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
19535432|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
19535433|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535434|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535435|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535436|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
19535437|NCT02862145|Hormones|hormones|mesh-ancestor
19535438|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535439|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19535440|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574430|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19574431|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19574432|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574433|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574434|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19574435|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574436|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574437|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19574438|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19574439|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574440|NCT04592913|Durvalumab|durvalumab|mesh-list
19574441|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574442|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574443|NCT04588259|Insulin|insulin|mesh-list
19574444|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19574445|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
19574446|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
19574447|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19574448|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19574449|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574450|NCT04556617|Prednisone|prednisone|mesh-list
19574451|NCT04556617|Olaparib|olaparib|mesh-list
19574452|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
19574453|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574454|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
19574455|NCT04556617|Hormones|hormones|mesh-ancestor
19574456|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574457|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574458|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574459|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574460|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19574461|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574462|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574463|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19574464|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
19574465|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20604076|NCT02225210|Fentanyl|fentanyl|mesh-list
20604077|NCT02225210|Midazolam|midazolam|mesh-list
19574466|NCT04555798|Meropenem|meropenem|mesh-list
19574467|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19574468|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574469|NCT04521647|Nicotine|nicotine|mesh-list
19574470|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19574471|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
19574472|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104168|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104169|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104170|NCT00003274|Sargramostim|sargramostim|mesh-list
20307164|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
20307165|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
20307166|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
20307167|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307168|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307169|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20604078|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
20104171|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
20104172|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
20104173|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104174|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20104175|NCT00003276|Irinotecan|irinotecan|mesh-list
20104176|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104177|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104178|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307170|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
19535441|NCT02862327|Dexamethasone|dexamethasone|mesh-list
19535442|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
19535443|NCT02862327|Ropivacaine|ropivacaine|mesh-list
19535444|NCT02862327|BB 1101|bb 1101|mesh-list
19535445|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535446|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
19535447|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
19535448|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535449|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535450|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535451|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
19535452|NCT02862327|Hormones|hormones|mesh-ancestor
19535453|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535454|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19535455|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535456|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
19535457|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535458|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535459|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535460|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
19535461|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535462|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
19535463|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
19535464|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
19535465|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307171|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307172|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307173|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535466|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535467|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535468|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
19535469|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19535470|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535471|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535472|NCT02861950|Bupivacaine|bupivacaine|mesh-list
19535473|NCT02861950|Ropivacaine|ropivacaine|mesh-list
20307174|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307175|NCT00658177|Urological Agents|urological agents|mesh-ancestor
20307176|NCT00658255|Budesonide|budesonide|mesh-list
20307177|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
20307178|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307179|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19535474|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535475|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
19535476|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535477|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535478|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
19535479|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535480|NCT02862015|Gemcitabine|gemcitabine|mesh-list
19535481|NCT02862015|Folfirinox|folfirinox|mesh-list
19535482|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535483|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
19535484|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535485|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535486|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
19535487|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535488|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307180|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
20307181|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307182|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535489|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535490|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
19535491|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535492|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
19535493|NCT02861976|Narcotics|narcotics|mesh-ancestor
19535494|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535495|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535496|NCT02861976|Analgesics|analgesics|mesh-ancestor
19535497|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
19535498|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535499|NCT02861859|Olanzapine|olanzapine|mesh-list
20307183|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19535500|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
19535501|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
19535502|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535503|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535504|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535505|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19535506|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19535507|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535508|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19535509|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19535510|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19535511|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19535512|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535513|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535514|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
19535515|NCT02861482|Oxytocin|oxytocin|mesh-list
19535516|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
19535517|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
19535518|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20307184|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
20307185|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
20307186|NCT00658255|Hormones|hormones|mesh-ancestor
20307187|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307188|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20307189|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20307190|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19535519|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535520|NCT02861716|Fentanyl|fentanyl|mesh-list
19535521|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
19535522|NCT02861716|Bupivacaine|bupivacaine|mesh-list
19535523|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535524|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
19535525|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535526|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535527|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
19535528|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535529|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20307191|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
20307192|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307193|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307194|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
20307195|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20307196|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308900|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308901|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308902|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308903|NCT00666159|Analgesics|analgesics|mesh-ancestor
20308904|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
20308905|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308906|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308907|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308908|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308909|NCT00666185|Fluconazole|fluconazole|mesh-list
20308910|NCT00666185|Micafungin|micafungin|mesh-list
20308911|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
20308912|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308913|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20308914|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20308915|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308916|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308917|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20104179|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104180|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104181|NCT00003278|Dexamethasone|dexamethasone|mesh-list
20104182|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308918|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
20308919|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308920|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308921|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19535530|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19535531|NCT02861716|Analgesics|analgesics|mesh-ancestor
20104183|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
20104184|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
20104185|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535532|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19535533|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19535534|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19535535|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535536|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535537|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535538|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19535539|NCT02861716|Narcotics|narcotics|mesh-ancestor
19535540|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19535541|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19535542|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
19535543|NCT02861690|Paclitaxel|paclitaxel|mesh-list
19535544|NCT02861690|Nedaplatin|nedaplatin|mesh-list
19535545|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19535546|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535547|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
19535548|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19535549|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
19535550|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535551|NCT02861261|Promethazine|promethazine|mesh-list
19535552|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
19535553|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
19535554|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
19535555|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19535556|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
20104186|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104187|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20104188|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
20104189|NCT00003278|Hormones|hormones|mesh-ancestor
20104190|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20104191|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20104192|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104193|NCT00003279|Antibodies|antibodies|mesh-list
20104194|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20104195|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
20104196|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
20104197|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307197|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20307198|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20307199|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19535557|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
19535558|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535559|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535560|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535561|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19535562|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19535563|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20307200|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
20307201|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535564|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535565|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535566|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
19535567|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
19535568|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535569|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
19535570|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
19535571|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535572|NCT02861222|Doxorubicin|doxorubicin|mesh-list
19535573|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19535574|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535575|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19535576|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19535577|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535578|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535579|NCT02861378|Phentolamine|phentolamine|mesh-list
19535580|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19535581|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19535582|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535583|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535584|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535585|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535586|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19535587|NCT02861105|Enoxaparin|enoxaparin|mesh-list
19535588|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19535589|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
20104198|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19535590|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19535591|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19535592|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535593|NCT02860936|Lenvatinib|lenvatinib|mesh-list
19535594|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535595|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19535596|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535597|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535598|NCT02860949|Ketorolac|ketorolac|mesh-list
19535599|NCT02860949|Epinephrine|epinephrine|mesh-list
19535600|NCT02860949|Morphine|morphine|mesh-list
19535601|NCT02860949|Bupivacaine|bupivacaine|mesh-list
19535602|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535603|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
19535604|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535605|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535606|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
19535607|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535608|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19535609|NCT02860949|Narcotics|narcotics|mesh-ancestor
19535610|NCT02860949|Analgesics|analgesics|mesh-ancestor
19535611|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19535612|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19535613|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535614|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535615|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535616|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19535617|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19535618|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
19535619|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19535620|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
19535621|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
19535622|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
19535623|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19535624|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19535625|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19535626|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535627|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535628|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19535629|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535630|NCT02860923|Exenatide|exenatide|mesh-list
19535631|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19535632|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535633|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19535634|NCT02860923|Incretins|incretins|mesh-ancestor
19535635|NCT02860923|Hormones|hormones|mesh-ancestor
19535636|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535637|NCT02861040|Vincristine|vincristine|mesh-list
19535638|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19535639|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535640|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
19535641|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
19535642|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
19535643|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535644|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
19535645|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
19535646|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
19535647|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19535648|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19535649|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535650|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535651|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535652|NCT02860858|Aflibercept|aflibercept|mesh-list
19535653|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19535654|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19535655|NCT02860858|Growth Substances|growth substances|mesh-ancestor
19535656|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535657|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
19535658|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535659|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19535660|NCT02860897|Estrogens|estrogens|mesh-ancestor
19535661|NCT02860897|Hormones|hormones|mesh-ancestor
19535662|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535663|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307202|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19535664|NCT02860819|Gemcitabine|gemcitabine|mesh-list
19535665|NCT02860819|Carboplatin|carboplatin|mesh-list
20307203|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20307204|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307205|NCT00658580|Etoposide|etoposide|mesh-list
20307206|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
20307207|NCT00658580|Epirubicin|epirubicin|mesh-list
20307208|NCT00658580|Ifosfamide|ifosfamide|mesh-list
20307209|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104199|NCT00003280|Rituximab|rituximab|mesh-list
20104200|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20104201|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104202|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
20104203|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535666|NCT02860819|Veliparib|veliparib|mesh-list
19535667|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535668|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535669|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
19535670|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535671|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
19535672|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535673|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535674|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535675|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
19535676|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535677|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19574473|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574474|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19574475|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19574476|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
19574477|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574478|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574479|NCT04513717|Leuprolide|leuprolide|mesh-list
19574480|NCT04513717|Goserelin|goserelin|mesh-list
19574481|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19574482|NCT04513717|Flutamide|flutamide|mesh-list
19574483|NCT04513717|Bicalutamide|bicalutamide|mesh-list
19574484|NCT04513717|Tryptophan|tryptophan|mesh-list
19574485|NCT04513717|Buserelin|buserelin|mesh-list
19574486|NCT04513717|Hormones|hormones|mesh-list
19574487|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574488|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574489|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19574490|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
19574491|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19574492|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574493|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574494|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
19574495|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
19574496|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
19574497|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19574498|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
19574499|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19574500|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19574501|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
19574502|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574503|NCT04493619|Carboplatin|carboplatin|mesh-list
19574504|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574505|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19574506|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19574507|NCT04464265|Propofol|propofol|mesh-list
19574508|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19574509|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574510|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574511|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19574512|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
19574513|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
19574514|NCT04430894|Dexamethasone|dexamethasone|mesh-list
19574515|NCT04430894|Lenalidomide|lenalidomide|mesh-list
20604079|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19574516|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574517|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
19574518|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
19574519|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307210|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19574520|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104204|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104205|NCT00003281|Paclitaxel|paclitaxel|mesh-list
20104206|NCT00003281|Topotecan|topotecan|mesh-list
20104207|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104208|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104209|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104210|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104211|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104212|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104213|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104214|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307211|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19535678|NCT02860663|Vitamin D|vitamin d|mesh-list
19535679|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
19535680|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
19535681|NCT02860663|Vitamins|vitamins|mesh-list
19535682|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
19535683|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535684|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19535685|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19535686|NCT02860624|Esomeprazole|esomeprazole|mesh-list
19535687|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20307212|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307213|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307214|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307215|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20307216|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19535688|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535689|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19535690|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535691|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535692|NCT02860494|Everolimus|everolimus|mesh-list
19535693|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535694|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535695|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
19535696|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535697|NCT02860234|Capecitabine|capecitabine|mesh-list
19535698|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
19535699|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535700|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
19535701|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535702|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535703|NCT02860299|Heparin|heparin|mesh-list
19535704|NCT02860299|Calcium heparin|calcium heparin|mesh-list
19535705|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
19535706|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535707|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19535708|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19535709|NCT02860117|Ketamine|ketamine|mesh-list
19535710|NCT02860117|Analgesics|analgesics|mesh-ancestor
19535711|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
19535712|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535713|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535714|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19535715|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19535716|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
19535717|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
19535718|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535719|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19535720|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19535721|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535722|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535723|NCT02860221|Epinephrine|epinephrine|mesh-list
19535724|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
19535725|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19535726|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19535727|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
19535728|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535729|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535730|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535731|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20307217|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
20307218|NCT00658593|Gemcitabine|gemcitabine|mesh-list
19535732|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19535733|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
19535734|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535735|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19535736|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
19535737|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
19535738|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
19535739|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19535740|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19535741|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19535742|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
19535743|NCT02860221|Coagulants|coagulants|mesh-ancestor
19535744|NCT02859792|Riluzole|riluzole|mesh-list
19535745|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
19535746|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19535747|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19535748|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307219|NCT00658593|Capecitabine|capecitabine|mesh-list
20307220|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307221|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
20307222|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307223|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307224|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
20307225|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104215|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104216|NCT00003283|Prednisone|prednisone|mesh-list
20104217|NCT00003283|Octreotide|octreotide|mesh-list
20104218|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20104219|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
20104220|NCT00003283|Hormones|hormones|mesh-ancestor
20104221|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604080|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19535749|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535750|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535751|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19535752|NCT02859792|Protective Agents|protective agents|mesh-ancestor
19535753|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
19535754|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19535755|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
19535756|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535757|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19535758|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20104222|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104223|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20104224|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104225|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20104226|NCT00003284|Paclitaxel|paclitaxel|mesh-list
20104227|NCT00003284|Etoposide|etoposide|mesh-list
20104228|NCT00003284|Carboplatin|carboplatin|mesh-list
20307226|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604081|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535759|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19535760|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
19535761|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535762|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19535763|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19535764|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604082|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20604083|NCT02225210|Analgesics|analgesics|mesh-ancestor
20604084|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
20604085|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604086|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20604087|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19535765|NCT02859402|Fludarabine|fludarabine|mesh-list
19535766|NCT02859402|Busulfan|busulfan|mesh-list
19535767|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535768|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535769|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535770|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
19535771|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535772|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
19535773|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19535774|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19535775|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
20104229|NCT00003284|Ifosfamide|ifosfamide|mesh-list
20104230|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20307227|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535776|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19535777|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19535778|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19535779|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535780|NCT02859571|Oxytocin|oxytocin|mesh-list
20104231|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104232|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104233|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104234|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104235|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307228|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
19535781|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
19535782|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20307229|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307230|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20307231|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
20307232|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307233|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20307234|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20307235|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20307236|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307237|NCT00658840|Capecitabine|capecitabine|mesh-list
20307238|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535783|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535784|NCT02859285|Estradiol|estradiol|mesh-list
19535785|NCT02859285|Estrogens|estrogens|mesh-ancestor
19535786|NCT02859285|Hormones|hormones|mesh-ancestor
19535787|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535788|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535789|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19535790|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19535791|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19535792|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19535793|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
19535794|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535795|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19535796|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19535797|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535798|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19535799|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19535800|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19535801|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19535802|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19535803|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535804|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535805|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535806|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
19535807|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574521|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574522|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
19574523|NCT04430894|Hormones|hormones|mesh-ancestor
19574524|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574525|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574526|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574527|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
19574528|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19574529|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19574530|NCT04430894|Growth Substances|growth substances|mesh-ancestor
19574531|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
19574532|NCT04409834|Heparin|heparin|mesh-list
19574533|NCT04409834|Calcium heparin|calcium heparin|mesh-list
19574534|NCT04409834|Enoxaparin|enoxaparin|mesh-list
19574535|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
19574536|NCT04409834|Clopidogrel|clopidogrel|mesh-list
19574537|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19574538|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19574539|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19574540|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19574541|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
19574542|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307239|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
20307240|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307241|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535808|NCT02859259|Fostemsavir|fostemsavir|mesh-list
19535809|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19535810|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19535811|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
19535812|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535813|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19535814|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19535815|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535816|NCT02859077|Gemcitabine|gemcitabine|mesh-list
19535817|NCT02859077|Carboplatin|carboplatin|mesh-list
19535818|NCT02859077|Pemetrexed|pemetrexed|mesh-list
19535819|NCT02859077|Gefitinib|gefitinib|mesh-list
19535820|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535821|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535822|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
19535823|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535824|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
19535825|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535826|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535827|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535828|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
19535829|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604088|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20604089|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
20604090|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604091|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604092|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20604093|NCT02225210|Narcotics|narcotics|mesh-ancestor
20604094|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20604095|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19535830|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19535831|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19535832|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19535833|NCT02858843|Ivacaftor|ivacaftor|mesh-list
19535834|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19535835|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19535836|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535837|NCT02858817|Atovaquone|atovaquone|mesh-list
19535838|NCT02858817|Proguanil|proguanil|mesh-list
19535839|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19535840|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535841|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
19535842|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19535843|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19535844|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535845|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535846|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
19535847|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
19535848|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535849|NCT02858856|Mitogens|mitogens|mesh-ancestor
19535850|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
19535851|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535852|NCT02858622|Fentanyl|fentanyl|mesh-list
20307242|NCT00658892|Antibodies|antibodies|mesh-list
20307243|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
20307244|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307245|NCT00658918|Ciclesonide|ciclesonide|mesh-list
20307246|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
20307247|NCT00658918|Hormones|hormones|mesh-ancestor
20307248|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604096|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
20604097|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
20104236|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104237|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104238|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535853|NCT02858622|Meperidine|meperidine|mesh-list
19535854|NCT02858622|Bupivacaine|bupivacaine|mesh-list
19535855|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
19535856|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
19535857|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20104239|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104240|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
20104241|NCT00003287|Leucovorin|leucovorin|mesh-list
20104242|NCT00003287|Fluorouracil|fluorouracil|mesh-list
20104243|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
20104244|NCT00003287|Calcium|calcium|mesh-list
20104245|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
20104246|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19535858|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535859|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
19535860|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535861|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19535862|NCT02858622|Narcotics|narcotics|mesh-ancestor
19535863|NCT02858622|Analgesics|analgesics|mesh-ancestor
19535864|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19535865|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19535866|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
19535867|NCT02858804|Cytarabine|cytarabine|mesh-list
19535868|NCT02858804|Thalidomide|thalidomide|mesh-list
19535869|NCT02858804|Dexamethasone|dexamethasone|mesh-list
19535870|NCT02858804|Prednisone|prednisone|mesh-list
19535871|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
19535872|NCT02858804|Rituximab|rituximab|mesh-list
19535873|NCT02858804|Doxorubicin|doxorubicin|mesh-list
19535874|NCT02858804|Etoposide|etoposide|mesh-list
19535875|NCT02858804|Vincristine|vincristine|mesh-list
19535876|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535877|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
19535878|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535879|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535880|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19535881|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
19535882|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535883|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535884|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19535885|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19535886|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535887|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
19535888|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
19535889|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535890|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19535891|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
19535892|NCT02858804|Hormones|hormones|mesh-ancestor
19535893|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535894|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19535895|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19535896|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19535897|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19535898|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535899|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19535900|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19535901|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
19535902|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
19535903|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535904|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
19535905|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
19535906|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
19535907|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
19535908|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19535909|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19535910|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19535911|NCT02858804|Growth Substances|growth substances|mesh-ancestor
19535912|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
19535913|NCT02858505|Iron|iron|mesh-list
19535914|NCT02858505|Trace Elements|trace elements|mesh-ancestor
19535915|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
20104247|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104248|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
20104249|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535916|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535917|NCT02858258|Rituximab|rituximab|mesh-list
19535918|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20104250|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104251|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104252|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104253|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
20104254|NCT00003287|Antidotes|antidotes|mesh-ancestor
20307249|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535919|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535920|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
19535921|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535922|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19535923|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
20104255|NCT00003287|Protective Agents|protective agents|mesh-ancestor
19535924|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19535925|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19535926|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19535927|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19535928|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535929|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
19535930|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19535931|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535932|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19535933|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19535934|NCT02858297|Triamcinolone|triamcinolone|mesh-list
19535935|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20307250|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20307251|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20307252|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20307253|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20307254|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20307255|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535936|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19535937|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19535938|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19535939|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
19535940|NCT02858297|Hormones|hormones|mesh-ancestor
19535941|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535942|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535943|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19535944|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
19535945|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535946|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535947|NCT02858193|Carbocysteine|carbocysteine|mesh-list
19535948|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19535949|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535950|NCT02858193|Expectorants|expectorants|mesh-ancestor
19535951|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19535952|NCT02858024|Dapivirine|dapivirine|mesh-list
19535953|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19535954|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19535955|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
19535956|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535957|NCT02858206|Paclitaxel|paclitaxel|mesh-list
20307256|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307257|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535958|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
19535959|NCT02858206|Nedaplatin|nedaplatin|mesh-list
19535960|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19535961|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535962|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19535963|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
19535964|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
19535965|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535966|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19535967|NCT02857959|Penicillins|penicillins|mesh-list
19535968|NCT02857959|Penicillin G|penicillin g|mesh-list
19535969|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19535970|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
19535971|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19535972|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19535973|NCT02857946|Linagliptin|linagliptin|mesh-list
19535974|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19535975|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535976|NCT02857946|Incretins|incretins|mesh-ancestor
19535977|NCT02857946|Hormones|hormones|mesh-ancestor
19535978|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19535979|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19535980|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
19535981|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535982|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535983|NCT02857712|Axitinib|axitinib|mesh-list
19535984|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535985|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19535986|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19535987|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19535988|NCT02857920|Bevacizumab|bevacizumab|mesh-list
19535989|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20307258|NCT00658931|Analgesics|analgesics|mesh-ancestor
19535990|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19535991|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19535992|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19535993|NCT02857920|Growth Substances|growth substances|mesh-ancestor
19535994|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535995|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
19535996|NCT02857829|Caffeine|caffeine|mesh-list
19535997|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20307259|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
20307260|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307261|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
20307262|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307263|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
19535998|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19535999|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19536000|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536001|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536002|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19536003|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19536004|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
19536005|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536006|NCT02857842|Prednisolone|prednisolone|mesh-list
19536007|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536008|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
19536009|NCT02857842|Hormones|hormones|mesh-ancestor
19536010|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536011|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536012|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19536013|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536014|NCT02857777|Esketamine|esketamine|mesh-list
19536015|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
19536016|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536017|NCT02857686|Anesthetics|anesthetics|mesh-list
19536018|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536019|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536020|NCT02857582|Metronidazole|metronidazole|mesh-list
19536021|NCT02857582|Vancomycin|vancomycin|mesh-list
19536022|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536023|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19536024|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19536025|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19536026|NCT02857569|Nivolumab|nivolumab|mesh-list
19536027|NCT02857569|Ipilimumab|ipilimumab|mesh-list
19536028|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536029|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536030|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19536031|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307264|NCT00658957|Gentamicins|gentamicins|mesh-list
20307265|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20307266|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307267|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20307268|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307269|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307270|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
20307271|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307272|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307273|NCT00659022|Bevacizumab|bevacizumab|mesh-list
19536032|NCT02857491|Ranibizumab|ranibizumab|mesh-list
20104256|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
20104257|NCT00003287|Vitamins|vitamins|mesh-ancestor
20104258|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
20104259|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
20104260|NCT00003288|Tirapazamine|tirapazamine|mesh-list
19536033|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19536034|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20104261|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104262|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
20104263|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104264|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104265|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104266|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
20104267|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104268|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104269|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104270|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20307274|NCT00659022|Capecitabine|capecitabine|mesh-list
20307275|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
20307276|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20307277|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307278|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20307279|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19536035|NCT02857491|Growth Substances|growth substances|mesh-ancestor
19536036|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536037|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
19536038|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574543|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574544|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574545|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
20307280|NCT00659022|Growth Substances|growth substances|mesh-ancestor
20307281|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307282|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
20307283|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307284|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
20307285|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307286|NCT00659048|Ciclesonide|ciclesonide|mesh-list
19574546|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19574547|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19574548|NCT04399356|Niclosamide|niclosamide|mesh-list
19574549|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
20307287|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
20307288|NCT00659048|Hormones|hormones|mesh-ancestor
20307289|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307290|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307291|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20307292|NCT00659074|Ondansetron|ondansetron|mesh-list
20307293|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
20307294|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
20307295|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307296|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307297|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20104271|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574550|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19574551|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
19574552|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19574553|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574554|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
19574555|NCT04397003|Durvalumab|durvalumab|mesh-list
19574556|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574557|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574558|NCT04391049|Paclitaxel|paclitaxel|mesh-list
20104272|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20104273|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104274|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104275|NCT00003290|Hormones|hormones|mesh-list
19574559|NCT04391049|Carboplatin|carboplatin|mesh-list
19574560|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19574561|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19574562|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574563|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574564|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574565|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574566|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574567|NCT04382885|Cariprazine|cariprazine|mesh-list
20104276|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20104277|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104278|NCT00003292|Ifosfamide|ifosfamide|mesh-list
20104279|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19574568|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19574569|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574570|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574571|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574572|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574573|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19574574|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574575|NCT04360681|Lofexidine|lofexidine|mesh-list
19574576|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19574577|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19574578|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104280|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
19574579|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
19536039|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19536040|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19536041|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
19536042|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536043|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
19536044|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536045|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536046|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19536047|NCT02857309|Diuretics|diuretics|mesh-ancestor
19536048|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
19536049|NCT02857309|Hormones|hormones|mesh-ancestor
19536050|NCT02857465|Dexamethasone|dexamethasone|mesh-list
19536051|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
19536052|NCT02857465|Sufentanil|sufentanil|mesh-list
19536053|NCT02857465|Dsuvia|dsuvia|mesh-list
19536054|NCT02857465|Ropivacaine|ropivacaine|mesh-list
19536055|NCT02857465|BB 1101|bb 1101|mesh-list
19536056|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536057|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
19536058|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
19536059|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536060|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536061|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19536062|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
19536063|NCT02857465|Hormones|hormones|mesh-ancestor
19536064|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536065|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19536066|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536067|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
19536068|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536069|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536070|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
19536071|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
19536072|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536073|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
19536074|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19536075|NCT02857465|Narcotics|narcotics|mesh-ancestor
19536076|NCT02857465|Analgesics|analgesics|mesh-ancestor
19536077|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19536078|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19536079|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
19536080|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19536081|NCT02857218|Hematinics|hematinics|mesh-ancestor
19536082|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19536083|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19536084|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19536085|NCT02857244|Modafinil|modafinil|mesh-list
19536086|NCT02857244|Donepezil|donepezil|mesh-list
19536087|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19536088|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19536089|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19536090|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536091|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536092|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536093|NCT02857244|Analgesics|analgesics|mesh-ancestor
19536094|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
19536095|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536096|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
20104281|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307298|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
19536097|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536098|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
20104282|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104283|NCT00003293|Procarbazine|procarbazine|mesh-list
20104284|NCT00003293|Leflunomide|leflunomide|mesh-list
20104285|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104286|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104287|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104288|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
20104289|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104290|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104291|NCT00003294|Paclitaxel|paclitaxel|mesh-list
20104292|NCT00003294|Carboplatin|carboplatin|mesh-list
20104293|NCT00003294|Amifostine|amifostine|mesh-list
20104294|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19536099|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19536100|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536101|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
19536102|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
19536103|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19536104|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19536105|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19536106|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19536107|NCT02857361|Ketamine|ketamine|mesh-list
19536108|NCT02857361|Analgesics|analgesics|mesh-ancestor
19536109|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
19536110|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536111|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536112|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19536113|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19536114|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
19536115|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
19536116|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536117|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19536118|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19536119|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536120|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536121|NCT02857270|Gemcitabine|gemcitabine|mesh-list
19536122|NCT02857270|Paclitaxel|paclitaxel|mesh-list
19536123|NCT02857270|Cetuximab|cetuximab|mesh-list
19536124|NCT02857270|Midazolam|midazolam|mesh-list
19536125|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19536126|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536127|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
19536128|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
20307299|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
20307300|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20307301|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
20307302|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307303|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104295|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104296|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104297|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104298|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104299|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104300|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104301|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19536129|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
19536130|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536131|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19536132|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
19536133|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
19536134|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536135|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536136|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19536137|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
19536138|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536139|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20104302|NCT00003294|Protective Agents|protective agents|mesh-ancestor
20104303|NCT00003296|Doxorubicin|doxorubicin|mesh-list
20104304|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104305|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19536140|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19536141|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536142|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19536143|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19536144|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536145|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19536146|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
19536147|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
19536148|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
19536149|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
19536150|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536151|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536152|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19536153|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19536154|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20604098|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19536155|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19536156|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20104306|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104307|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104308|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104309|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536157|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
19536158|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536159|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536160|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536161|NCT02856854|Cocaine|cocaine|mesh-list
19536162|NCT02856854|Oxazepam|oxazepam|mesh-list
19536163|NCT02856854|Metyrapone|metyrapone|mesh-list
19536164|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
19536165|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
19536166|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536167|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536168|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
19536169|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536170|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19536171|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19536172|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19536173|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19536174|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536175|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
19536176|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536177|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
19536178|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536179|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19536180|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19536181|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19536182|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536183|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
19536184|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
19536185|NCT02857062|Emollients|emollients|mesh-list
19536186|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
19536187|NCT02856893|Gefitinib|gefitinib|mesh-list
19536188|NCT02856893|Osimertinib|osimertinib|mesh-list
19536189|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536190|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536191|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536192|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536193|NCT02857166|Antibodies|antibodies|mesh-list
19536194|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19536195|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
19536196|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536197|NCT02856932|Methamphetamine|methamphetamine|mesh-list
19536198|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19536199|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536200|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
19536201|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
19536202|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536203|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
20104310|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104311|NCT00003297|Topotecan|topotecan|mesh-list
20104312|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
20104313|NCT00003297|Thiotepa|thiotepa|mesh-list
20104314|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104315|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104316|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104317|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104318|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104319|NCT00003297|Analgesics|analgesics|mesh-ancestor
20104320|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
20104321|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104322|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104323|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104324|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104325|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
20104326|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104327|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104328|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
20104329|NCT00003299|Paclitaxel|paclitaxel|mesh-list
20104330|NCT00003299|Etoposide|etoposide|mesh-list
20104331|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104332|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104333|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
20307304|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20307305|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20307306|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20307307|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307308|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20307309|NCT00659100|Gabapentin|gabapentin|mesh-list
20307310|NCT00659100|Analgesics|analgesics|mesh-ancestor
20307311|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
20307312|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536204|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536205|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536206|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
19536207|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19536208|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19536209|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19536210|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19536211|NCT02856867|Leucovorin|leucovorin|mesh-list
19536212|NCT02856867|Fluorouracil|fluorouracil|mesh-list
19536213|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
19536214|NCT02856867|Nintedanib|nintedanib|mesh-list
19536215|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
19536216|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536217|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19536218|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536219|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19536220|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
19536221|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536222|NCT02856867|Antidotes|antidotes|mesh-ancestor
19536223|NCT02856867|Protective Agents|protective agents|mesh-ancestor
19536224|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
19536225|NCT02856867|Vitamins|vitamins|mesh-ancestor
19536226|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
19536227|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536228|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536229|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
19536230|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536231|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
19536232|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
19536233|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19536234|NCT02857153|Urapidil|urapidil|mesh-list
19536235|NCT02857153|Phenylephrine|phenylephrine|mesh-list
19536236|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
19536237|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19536238|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
19536239|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
19536240|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536241|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536242|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
19536243|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19536244|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
19536245|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
19536246|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19536247|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19536248|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19536249|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
19536250|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536251|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536252|NCT02857153|Protective Agents|protective agents|mesh-ancestor
19536253|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19536254|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
19536255|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19536256|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
19536257|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19536258|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19536259|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19536260|NCT02856789|Hemostatics|hemostatics|mesh-list
19536261|NCT02856789|Coagulants|coagulants|mesh-ancestor
19536262|NCT02856724|Dinoprostone|dinoprostone|mesh-list
20104334|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104335|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104336|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104337|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20307313|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307314|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
19536263|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
20104338|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307315|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19536264|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19536265|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536266|NCT02856776|Vitamin D|vitamin d|mesh-list
19536267|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
19536268|NCT02856776|Vitamins|vitamins|mesh-ancestor
19536269|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
19536270|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536271|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19536272|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19536273|NCT02856750|Gabapentin|gabapentin|mesh-list
19536274|NCT02856750|Analgesics|analgesics|mesh-ancestor
19536275|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
19536276|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536277|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536278|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
19536279|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19536280|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19536281|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536282|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536283|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19536284|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19536285|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536286|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536287|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
19536288|NCT02856581|Varenicline|varenicline|mesh-list
19536289|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19536290|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19536291|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19536292|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536293|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536294|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536295|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
19536296|NCT02856685|Analgesics|analgesics|mesh-ancestor
20307316|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20307317|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20307318|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307319|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20307320|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20104339|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104340|NCT00003301|Irinotecan|irinotecan|mesh-list
20104341|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104342|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104343|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104344|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104345|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104346|NCT00003304|Temozolomide|temozolomide|mesh-list
20104347|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104348|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
20104349|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307321|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307322|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307323|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
19536297|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
19536298|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536299|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536300|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536301|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19536302|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19536303|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536304|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536305|NCT02856568|Gemcitabine|gemcitabine|mesh-list
19536306|NCT02856568|Cisplatin|cisplatin|mesh-list
19536307|NCT02856568|Ricolinostat|ricolinostat|mesh-list
19536308|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536309|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19536310|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
19536311|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536312|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
19536313|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536314|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307324|NCT00659113|Tegafur|tegafur|mesh-list
20307325|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307326|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20604099|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19536315|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19536316|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
19536317|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536318|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19536319|NCT02856451|Nivolumab|nivolumab|mesh-list
19536320|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536321|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536322|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19536323|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536324|NCT02856295|Enoxaparin|enoxaparin|mesh-list
19536325|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
19536326|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19536327|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19536328|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536329|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
19536330|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536331|NCT02856503|Vitamin D|vitamin d|mesh-list
19536332|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
19536333|NCT02856503|Vitamins|vitamins|mesh-ancestor
19536334|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
19536335|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536336|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19536337|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20307327|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
20307328|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307329|NCT00659178|Doxorubicin|doxorubicin|mesh-list
19536338|NCT02856178|Caspofungin|caspofungin|mesh-list
19536339|NCT02856178|Olorofim|olorofim|mesh-list
19536340|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
19536341|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536342|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536343|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536344|NCT02856542|Betamethasone|betamethasone|mesh-list
19536345|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
19536346|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19536347|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
19536348|NCT02856542|Calcipotriene|calcipotriene|mesh-list
19536349|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20307330|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20307331|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20307332|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307333|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19536350|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536351|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
19536352|NCT02856542|Hormones|hormones|mesh-ancestor
19536353|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536354|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536355|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19536356|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
19536357|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
19536358|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
19536359|NCT02856425|Nintedanib|nintedanib|mesh-list
19536360|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536361|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536362|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536363|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536364|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536365|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19536366|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536367|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19536368|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
19536369|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20307334|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307335|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307336|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307337|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
20307338|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
20307339|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20307340|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307341|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307342|NCT00659321|Nicotine|nicotine|mesh-list
20307343|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19536370|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
20307344|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
19536371|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19536372|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536373|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19536374|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19536375|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536376|NCT02856230|Paclitaxel|paclitaxel|mesh-list
20307345|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104350|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104351|NCT00003305|Leucovorin|leucovorin|mesh-list
19536377|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19536378|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536379|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
19536380|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
19536381|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
19536382|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536383|NCT02856126|Sorafenib|sorafenib|mesh-list
19536384|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536385|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536386|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536387|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536388|NCT02856087|Remifentanil|remifentanil|mesh-list
19536389|NCT02856087|Naloxone|naloxone|mesh-list
19536390|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19536391|NCT02856087|Narcotics|narcotics|mesh-ancestor
19536392|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536393|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536394|NCT02856087|Analgesics|analgesics|mesh-ancestor
19536395|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
19536396|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536397|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19574580|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574581|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19574582|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19574583|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19574584|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
19574585|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574586|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574587|NCT04355832|Glucagon|glucagon|mesh-list
19574588|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19574589|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19574590|NCT04355832|Hormones|hormones|mesh-ancestor
19574591|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574592|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574593|NCT04355832|Incretins|incretins|mesh-ancestor
19578106|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20104352|NCT00003305|Calcium|calcium|mesh-list
20104353|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
19578107|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19578108|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19578109|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19578110|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19578111|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19578112|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
19578113|NCT03547271|Vaccines|vaccines|mesh-list
19578114|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19578115|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
19578116|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578117|NCT03539822|Durvalumab|durvalumab|mesh-list
19578118|NCT03539822|Tremelimumab|tremelimumab|mesh-list
19578119|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19578120|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578121|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578122|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578123|NCT03533582|Gemcitabine|gemcitabine|mesh-list
19578124|NCT03533582|Cisplatin|cisplatin|mesh-list
19578125|NCT03533582|Carboplatin|carboplatin|mesh-list
19578126|NCT03533582|Doxorubicin|doxorubicin|mesh-list
19578127|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19578128|NCT03533582|Fluorouracil|fluorouracil|mesh-list
19578129|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
19578130|NCT03533582|Irinotecan|irinotecan|mesh-list
19578131|NCT03533582|Etoposide|etoposide|mesh-list
19578132|NCT03533582|Vincristine|vincristine|mesh-list
20307346|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578133|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
19578134|NCT03533582|Sorafenib|sorafenib|mesh-list
20104354|NCT00003305|Aminopterin|aminopterin|mesh-list
19536398|NCT02855632|Hormones|hormones|mesh-list
19536399|NCT02855632|Progesterone|progesterone|mesh-list
19536400|NCT02855632|Sargramostim|sargramostim|mesh-list
19536401|NCT02855632|Lenograstim|lenograstim|mesh-list
19536402|NCT02855632|Estrogens|estrogens|mesh-list
19536403|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536404|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536405|NCT02855632|Progestins|progestins|mesh-ancestor
19536406|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
19536407|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19536408|NCT02855684|Insulin|insulin|mesh-list
19536409|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19536410|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
19536411|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19536412|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536413|NCT02855866|Acetaminophen|acetaminophen|mesh-list
19536414|NCT02855866|Dexamethasone|dexamethasone|mesh-list
20104355|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20104356|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104357|NCT00003305|Antidotes|antidotes|mesh-ancestor
20104358|NCT00003305|Protective Agents|protective agents|mesh-ancestor
20104359|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
20104360|NCT00003305|Vitamins|vitamins|mesh-ancestor
20104361|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
20104362|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19536415|NCT02855866|Cortisone|cortisone|mesh-list
19536416|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
19536417|NCT02855866|BB 1101|bb 1101|mesh-list
19536418|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536419|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
19536420|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
19536421|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536422|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536423|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19536424|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
19536425|NCT02855866|Hormones|hormones|mesh-ancestor
19536426|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536427|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19536428|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536429|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19536430|NCT02855866|Analgesics|analgesics|mesh-ancestor
19536431|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
19536432|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
19536433|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
19536434|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536435|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536436|NCT02855788|Leucovorin|leucovorin|mesh-list
19536437|NCT02855788|Paclitaxel|paclitaxel|mesh-list
19536438|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
19536439|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19536440|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536441|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
19536442|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
19536443|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
19536444|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536445|NCT02855788|Antidotes|antidotes|mesh-ancestor
19536446|NCT02855788|Protective Agents|protective agents|mesh-ancestor
19536447|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536448|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
19536449|NCT02855788|Vitamins|vitamins|mesh-ancestor
19536450|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
19536451|NCT02855502|Prednisolone|prednisolone|mesh-list
19536452|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536453|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
19536454|NCT02855502|Hormones|hormones|mesh-ancestor
20104363|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104364|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104365|NCT00003307|Amifostine|amifostine|mesh-list
20104366|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20104367|NCT00003307|Protective Agents|protective agents|mesh-ancestor
20104368|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104369|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
20104370|NCT00003309|Etoposide|etoposide|mesh-list
19536455|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536456|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536457|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19536458|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536459|NCT02855515|Anesthetics|anesthetics|mesh-list
20104371|NCT00003309|Vincristine|vincristine|mesh-list
20104372|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19536460|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536461|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536462|NCT02855346|Dapivirine|dapivirine|mesh-list
20104373|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
20104374|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104375|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19536463|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
19536464|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19536465|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
20104376|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20307347|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20307348|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20307349|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
19536466|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19536467|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536468|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19536469|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19536470|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19536471|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19536472|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19536473|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
19536474|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536475|NCT02855307|Insulin|insulin|mesh-list
19536476|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19536477|NCT02855307|Hormones|hormones|mesh-list
19536478|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536479|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536480|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536481|NCT02855294|Drospirenone|drospirenone|mesh-list
19536482|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19536483|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
19536484|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536485|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536486|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19536487|NCT02855294|Diuretics|diuretics|mesh-ancestor
19536488|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
19536489|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
19536490|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536491|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536492|NCT02855138|Isotretinoin|isotretinoin|mesh-list
19536493|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
19536494|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
19536495|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19536496|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
19536497|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536498|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
19536499|NCT02855073|Protective Agents|protective agents|mesh-ancestor
19536500|NCT02854995|Triamcinolone|triamcinolone|mesh-list
19536501|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536502|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
19536503|NCT02854995|Hormones|hormones|mesh-ancestor
19536504|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536505|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536506|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
19536507|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19536508|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536509|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536510|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19536511|NCT02854904|Analgesics|analgesics|mesh-ancestor
19536512|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
19536513|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536514|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19536515|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19536516|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19536517|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19536518|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536519|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536520|NCT02854670|Capsaicin|capsaicin|mesh-list
20104377|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
20104378|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536521|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
20307350|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307351|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536522|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19536523|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
19536524|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536525|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536526|NCT02854761|Vitamin D|vitamin d|mesh-list
19536527|NCT02854761|Vitamins|vitamins|mesh-ancestor
20604100|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604101|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
20604102|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
20604103|NCT02225275|Lenalidomide|lenalidomide|mesh-list
20604104|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
20604105|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
20604106|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604107|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20604108|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20604109|NCT02225275|Growth Substances|growth substances|mesh-ancestor
20604110|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
20604111|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604112|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536528|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
19536529|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536530|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19536531|NCT02854748|Empagliflozin|empagliflozin|mesh-list
19536532|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19536533|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536534|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536535|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536536|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20307352|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
20604113|NCT02225418|Ropivacaine|ropivacaine|mesh-list
20604114|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
20604115|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
20604116|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604117|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604118|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
20604119|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604120|NCT02225470|Vinorelbine|vinorelbine|mesh-list
20604121|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604122|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604123|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604124|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20604125|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604126|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604127|NCT02225548|Tadalafil|tadalafil|mesh-list
20604128|NCT02225548|Selegiline|selegiline|mesh-list
20307353|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20307354|NCT00659386|Antibodies|antibodies|mesh-list
20307355|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
20604129|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
20604130|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20604131|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20104379|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307356|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20307357|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
20307358|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307359|NCT00659399|PENTA|penta|mesh-list
20307360|NCT00659399|Fondaparinux|fondaparinux|mesh-list
20307361|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20307362|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
20307363|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20307364|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
20307365|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307366|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307367|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
20307368|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20307369|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20307370|NCT00659412|Methotrexate|methotrexate|mesh-list
20307371|NCT00659412|Alefacept|alefacept|mesh-list
20307372|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20307373|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
20307374|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20307375|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604132|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604133|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604134|NCT02225548|Urological Agents|urological agents|mesh-ancestor
20307376|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104380|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104381|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104382|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20307377|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
20307378|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307379|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307380|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
20307381|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307382|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19536537|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19536538|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19536539|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536540|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
19536541|NCT02854722|Vitamin D|vitamin d|mesh-list
19536542|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
19536543|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
19536544|NCT02854722|Vitamins|vitamins|mesh-list
19536545|NCT02854722|Calcium|calcium|mesh-list
19536546|NCT02854722|Deferasirox|deferasirox|mesh-list
19536547|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
19536548|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536549|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19536550|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19536551|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19536552|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
19536553|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
19536554|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536555|NCT02854787|Phenylephrine|phenylephrine|mesh-list
19536556|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
19536557|NCT02854787|Norepinephrine|norepinephrine|mesh-list
19536558|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19536559|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
19536560|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
19536561|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536562|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536563|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
19536564|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19536565|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
19536566|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
19536567|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19536568|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19536569|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19536570|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
19536571|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536572|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536573|NCT02854787|Protective Agents|protective agents|mesh-ancestor
19536574|NCT02854241|Liver Extracts|liver extracts|mesh-list
19536575|NCT02854241|Hematinics|hematinics|mesh-ancestor
20307383|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307384|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
20307385|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307386|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20307387|NCT00659451|Losartan|losartan|mesh-list
19574594|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
19574595|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19574596|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19574597|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574598|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
19574599|NCT04349982|Coagulants|coagulants|mesh-ancestor
19574600|NCT04340947|Nicotine|nicotine|mesh-list
19574601|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19574602|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
20104383|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104384|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104385|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104386|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104387|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104388|NCT00003311|Cytarabine|cytarabine|mesh-list
20104389|NCT00003311|Dexamethasone|dexamethasone|mesh-list
20104390|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
19574603|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574604|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104391|NCT00003311|Doxorubicin|doxorubicin|mesh-list
20104392|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104393|NCT00003311|Methotrexate|methotrexate|mesh-list
19574605|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19574606|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19574607|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
19536576|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
19536577|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19536578|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536579|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
20104394|NCT00003311|Vincristine|vincristine|mesh-list
20104395|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104396|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
20104397|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104398|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104399|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104400|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
20104401|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104402|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307388|NCT00659451|Amlodipine|amlodipine|mesh-list
20307389|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20307390|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20307391|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20307392|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307393|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20307394|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307395|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
19536580|NCT02853864|Propofol|propofol|mesh-list
19536581|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19536582|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536583|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536584|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19536585|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
19536586|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
19536587|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19536588|NCT02853864|Analgesics|analgesics|mesh-ancestor
19536589|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
19536590|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536591|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19536592|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19536593|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19536594|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
19536595|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536596|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536597|NCT02854072|Gemcitabine|gemcitabine|mesh-list
19536598|NCT02854072|Capecitabine|capecitabine|mesh-list
19536599|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19536600|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
19536601|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536602|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536603|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
19536604|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536605|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536606|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19536607|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
19536608|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536609|NCT02853799|Insulin|insulin|mesh-list
19536610|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307396|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19536611|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536612|NCT02853630|Metformin|metformin|mesh-list
19536613|NCT02853630|Vildagliptin|vildagliptin|mesh-list
19536614|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536615|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536616|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19536617|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
20307397|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20307398|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20307399|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
20307400|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307401|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307402|NCT00659503|Ciclesonide|ciclesonide|mesh-list
20307403|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
20307404|NCT00659503|Hormones|hormones|mesh-ancestor
19536618|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536619|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536620|NCT02853539|Denosumab|denosumab|mesh-list
20104403|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19536621|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19536622|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536623|NCT02853526|Propranolol|propranolol|mesh-list
19536624|NCT02853526|Warfarin|warfarin|mesh-list
19536625|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
19536626|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19536627|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19536628|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19536629|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536630|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536631|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536632|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19536633|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19536634|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
19536635|NCT02853552|Misoprostol|misoprostol|mesh-list
19536636|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19536637|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
19536638|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19536639|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536640|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20307405|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307406|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536641|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19536642|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
19536643|NCT02853253|SMOFlipid|smoflipid|mesh-list
19536644|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19536645|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19536646|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19536647|NCT02853370|Rituximab|rituximab|mesh-list
19536648|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19536649|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536650|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536651|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
19536652|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536653|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19536654|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19536655|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
20307407|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19536656|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536657|NCT02853578|Budesonide|budesonide|mesh-list
19536658|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536659|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19536660|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
19536661|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104404|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20104405|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
20307408|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20307409|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20307410|NCT00659568|Metformin|metformin|mesh-list
19536662|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307411|NCT00659568|Sirolimus|sirolimus|mesh-list
20307412|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307413|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307414|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19536663|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19536664|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
19536665|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
19536666|NCT02853578|Hormones|hormones|mesh-ancestor
19536667|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536668|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
19536669|NCT02853136|BI 409306|bi 409306|mesh-list
19536670|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19536671|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19536672|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536673|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536674|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536675|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19536676|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19536677|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19536678|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536679|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536680|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
19536681|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19536682|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
19536683|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20104406|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
19536684|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19536685|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536686|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19536687|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19536688|NCT02853071|Estramustine|estramustine|mesh-list
19536689|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19536690|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
19536691|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536692|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536693|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19536694|NCT02852837|Daratumumab|daratumumab|mesh-list
19536695|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536696|NCT02852798|Docetaxel|docetaxel|mesh-list
19536697|NCT02852798|Apatinib|apatinib|mesh-list
19536698|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536699|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
19536700|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
19536701|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
19536702|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536703|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536704|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536705|NCT02852681|Drospirenone|drospirenone|mesh-list
19536706|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19536707|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
19536708|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536709|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536710|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19536711|NCT02852681|Diuretics|diuretics|mesh-ancestor
19536712|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
19536713|NCT02852694|Adalimumab|adalimumab|mesh-list
19536714|NCT02852694|Methotrexate|methotrexate|mesh-list
19536715|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
19536716|NCT02852694|Azathioprine|azathioprine|mesh-list
19536717|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19536718|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
19536719|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19536720|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536721|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19536722|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
19536723|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536724|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536725|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
20104407|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104408|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19536726|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536727|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19536728|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19536729|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
19536730|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19536731|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19536732|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536733|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
19536734|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536735|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536736|NCT02852720|Anesthetics|anesthetics|mesh-list
19536737|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
19536738|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536739|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536740|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
19536741|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
19536742|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307415|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307416|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19574608|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574609|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574610|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
19574611|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
19574612|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20104409|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
20104410|NCT00003311|Hormones|hormones|mesh-ancestor
20104411|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20104412|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20104413|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20307417|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536743|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
19536744|NCT02852564|Diuretics|diuretics|mesh-ancestor
19536745|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
19536746|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536747|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536748|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307418|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
20307419|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307420|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
19536749|NCT02852577|Clonazepam|clonazepam|mesh-list
19536750|NCT02852577|Paroxetine|paroxetine|mesh-list
19536751|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19536752|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19536753|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19536754|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536755|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536756|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
19536757|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536758|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19536759|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
19536760|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536761|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19536762|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19536763|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536764|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
19536765|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
19536766|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
19536767|NCT02852486|Pioglitazone|pioglitazone|mesh-list
19536768|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
19536769|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536770|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536771|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536772|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536773|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536774|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536775|NCT02852083|Pioglitazone|pioglitazone|mesh-list
19536776|NCT02852083|Clarithromycin|clarithromycin|mesh-list
19536777|NCT02852083|Nivolumab|nivolumab|mesh-list
19536778|NCT02852083|Treosulfan|treosulfan|mesh-list
20307421|NCT00659594|Ciclesonide|ciclesonide|mesh-list
20307422|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
20307423|NCT00659594|Hormones|hormones|mesh-ancestor
20307424|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307425|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307426|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20307427|NCT00659659|Benralizumab|benralizumab|mesh-list
20307428|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20307429|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
20307430|NCT00659685|Ondansetron|ondansetron|mesh-list
19536779|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536780|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536781|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19536782|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536783|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536784|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536785|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19536786|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536787|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19536788|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536789|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19536790|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19536791|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104414|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104415|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19536792|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
20104416|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104417|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20104418|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
20104419|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20104420|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104421|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
20104422|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
20104423|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20307431|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
20307432|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
19536793|NCT02852239|Dabrafenib|dabrafenib|mesh-list
19536794|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536795|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536796|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536797|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536798|NCT02852122|Choline|choline|mesh-list
19536799|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
19536800|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19536801|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
19536802|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536803|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19536804|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19536805|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
19536806|NCT02852382|Morphine|morphine|mesh-list
19536807|NCT02852382|Bupivacaine|bupivacaine|mesh-list
19536808|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
19536809|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
19536810|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536811|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536812|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
20307433|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307434|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307435|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20307436|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
20307437|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
20307438|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20307439|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
20307440|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307441|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307442|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20307443|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20307444|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20307445|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307446|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20307447|NCT00659698|Pancrelipase|pancrelipase|mesh-list
20307448|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20307449|NCT00659750|Ciclesonide|ciclesonide|mesh-list
20604135|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
20604136|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604137|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20604138|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20604139|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20604140|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20604141|NCT02225548|Protective Agents|protective agents|mesh-ancestor
20604142|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536813|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536814|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19536815|NCT02852382|Narcotics|narcotics|mesh-ancestor
19536816|NCT02852382|Analgesics|analgesics|mesh-ancestor
19536817|NCT02851888|Ropivacaine|ropivacaine|mesh-list
19536818|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
19536819|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536820|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536821|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
19536822|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
19536823|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536824|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
19536825|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
19536826|NCT02851914|Serotonin|serotonin|mesh-list
19536827|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19536828|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19536829|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19536830|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
19536831|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536832|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536833|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536834|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19536835|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19536836|NCT02851745|Linagliptin|linagliptin|mesh-list
19536837|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536838|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536839|NCT02851745|Incretins|incretins|mesh-ancestor
20604143|NCT02225652|Paclitaxel|paclitaxel|mesh-list
19536840|NCT02851745|Hormones|hormones|mesh-ancestor
19574613|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20307450|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
20307451|NCT00659750|Hormones|hormones|mesh-ancestor
19536841|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19536842|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19536843|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
19536844|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536845|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536846|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
19536847|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19536848|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
19536849|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536850|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536851|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19536852|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
19536853|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19536854|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
20604144|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
20604145|NCT02225652|Fluorouracil|fluorouracil|mesh-list
20604146|NCT02225652|Epirubicin|epirubicin|mesh-list
20604147|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604148|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604149|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
19536855|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536856|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19536857|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19536858|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
19536859|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
19536860|NCT02851472|Protective Agents|protective agents|mesh-ancestor
20604150|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
20604151|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604152|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604153|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604154|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
20604155|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604156|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307452|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307453|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307454|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20307455|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20307456|NCT00659776|Hematinics|hematinics|mesh-ancestor
20307457|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19536861|NCT02851459|Vaccines|vaccines|mesh-list
19536862|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
19536863|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536864|NCT02851433|Anesthetics|anesthetics|mesh-list
19536865|NCT02851433|Propofol|propofol|mesh-list
19536866|NCT02851433|Sevoflurane|sevoflurane|mesh-list
19536867|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536868|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536869|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19536870|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19536871|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
20307458|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20307459|NCT00659841|Ciclesonide|ciclesonide|mesh-list
20307460|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
20307461|NCT00659841|Hormones|hormones|mesh-ancestor
20307462|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307463|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307464|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20104424|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20104425|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
20104426|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104427|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104428|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104429|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104430|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104431|NCT00003313|Paclitaxel|paclitaxel|mesh-list
20104432|NCT00003313|Carboplatin|carboplatin|mesh-list
20104433|NCT00003313|Amifostine|amifostine|mesh-list
20104434|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104435|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104436|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104437|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104438|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104439|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604157|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104440|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104441|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20104442|NCT00003313|Protective Agents|protective agents|mesh-ancestor
19536872|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19536873|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19536874|NCT02851095|Metformin|metformin|mesh-list
19536875|NCT02851095|Canagliflozin|canagliflozin|mesh-list
19536876|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536877|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536878|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19536879|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536880|NCT02851394|Tramadol|tramadol|mesh-list
19536881|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
19536882|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19536883|NCT02851394|Narcotics|narcotics|mesh-ancestor
19536884|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536885|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536886|NCT02851394|Analgesics|analgesics|mesh-ancestor
19536887|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
19536888|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536889|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
19536890|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
19536891|NCT02851303|Morphine|morphine|mesh-list
19536892|NCT02851303|Methadone|methadone|mesh-list
19536893|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19536894|NCT02851303|Narcotics|narcotics|mesh-ancestor
19536895|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536896|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536897|NCT02851303|Analgesics|analgesics|mesh-ancestor
19536898|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
19536899|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536900|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
19536901|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
20104443|NCT00003315|Amphotericin B|amphotericin b|mesh-list
20104444|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19574614|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574615|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574616|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574617|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574618|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
19574619|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574620|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574621|NCT04315350|Prednisolone|prednisolone|mesh-list
19574622|NCT04315350|Curcumin|curcumin|mesh-list
19574623|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574624|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
19574625|NCT04315350|Hormones|hormones|mesh-ancestor
19574626|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574627|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574628|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574629|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574630|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574631|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19574632|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19574633|NCT04315350|Analgesics|analgesics|mesh-ancestor
19574634|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
19574635|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574636|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574637|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574638|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
19574639|NCT04314219|Methotrexate|methotrexate|mesh-list
20307465|NCT00659919|Trazodone|trazodone|mesh-list
20307466|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20307467|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20307468|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20307469|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307470|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307471|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20307472|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20307473|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19574640|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574641|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
19574642|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574643|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104445|NCT00003315|Sargramostim|sargramostim|mesh-list
19536902|NCT02851212|Metformin|metformin|mesh-list
19536903|NCT02851212|Canagliflozin|canagliflozin|mesh-list
19536904|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19536905|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536906|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19536907|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536908|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
19536909|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536910|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536911|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
19536912|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
19536913|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19536914|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19536915|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536916|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536917|NCT02850718|Urological Agents|urological agents|mesh-ancestor
19536918|NCT02850744|Temozolomide|temozolomide|mesh-list
20307474|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307475|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307476|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
20307477|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20307478|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
20307479|NCT00659958|Zonisamide|zonisamide|mesh-list
20307480|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
19536919|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19536920|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
19536921|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536922|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536923|NCT02850887|Anesthetics|anesthetics|mesh-list
19536924|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536925|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536926|NCT02850913|Doxycycline|doxycycline|mesh-list
19536927|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19536928|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536929|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
19536930|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19536931|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19536932|NCT02850848|Entecavir|entecavir|mesh-list
19536933|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
19536934|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19536935|NCT05383131|Pirfenidone|pirfenidone|mesh-list
19536936|NCT05383131|Nintedanib|nintedanib|mesh-list
19536937|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536938|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19536939|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536940|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536941|NCT05383131|Analgesics|analgesics|mesh-ancestor
19536942|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
19536943|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536944|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536945|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19536946|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19536947|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536948|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19536949|NCT05383001|Durvalumab|durvalumab|mesh-list
19536950|NCT05383001|Tremelimumab|tremelimumab|mesh-list
19536951|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536952|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536953|NCT05382923|Melatonin|melatonin|mesh-list
19536954|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
19536955|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536956|NCT05382923|Protective Agents|protective agents|mesh-ancestor
19536957|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536958|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536959|NCT05382871|Vaccines|vaccines|mesh-list
19536960|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
19536961|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536962|NCT05382741|Durvalumab|durvalumab|mesh-list
19536963|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19536964|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536965|NCT05382728|Osimertinib|osimertinib|mesh-list
19536966|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19536967|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20307481|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20307482|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19536968|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536969|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536970|NCT05382715|Ozanimod|ozanimod|mesh-list
19536971|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19536972|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536973|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19536974|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
19536975|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536976|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
19536977|NCT05382650|Antibodies|antibodies|mesh-list
19536978|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
19536979|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19536980|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19536981|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
19536982|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536983|NCT05382624|Anesthetics|anesthetics|mesh-list
19536984|NCT05382624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19536985|NCT05382624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536986|NCT05382546|Ketorolac|ketorolac|mesh-list
19536987|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19536988|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19536989|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19536990|NCT05382546|Analgesics|analgesics|mesh-ancestor
19536991|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
19536992|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19536993|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19536994|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19536995|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307483|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307484|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20307485|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307486|NCT00659997|Albendazole|albendazole|mesh-list
20307487|NCT00659997|Levamisole|levamisole|mesh-list
20307488|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
20307489|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20307490|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307491|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
20307492|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20307493|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20307494|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
20307495|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
20307496|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
20307497|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307498|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307499|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20307500|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
20307501|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307502|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
20307503|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19536996|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19536997|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19536998|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19536999|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
19537000|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537001|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537002|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19537003|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19537004|NCT05382481|Dalteparin|dalteparin|mesh-list
20307504|NCT00660036|Etoposide|etoposide|mesh-list
20307505|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
20307506|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
20307507|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20307508|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307509|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20307510|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307511|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307512|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307513|NCT00660036|Analgesics|analgesics|mesh-ancestor
20307514|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
20307515|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307516|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307517|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537005|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
19537006|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20307518|NCT00660062|Dexetimide|dexetimide|mesh-list
20307519|NCT00660062|Citalopram|citalopram|mesh-list
20307520|NCT00660062|Nortriptyline|nortriptyline|mesh-list
20307521|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20307522|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20307523|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20307524|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307525|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307526|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
20307527|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307528|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20307529|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
20307530|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19537007|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19537008|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537009|NCT05382442|Leucovorin|leucovorin|mesh-list
19537010|NCT05382442|Bevacizumab|bevacizumab|mesh-list
19537011|NCT05382442|Fluorouracil|fluorouracil|mesh-list
19537012|NCT05382442|Capecitabine|capecitabine|mesh-list
19537013|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
19537014|NCT05382442|Irinotecan|irinotecan|mesh-list
19537015|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537016|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537017|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19537018|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19537019|NCT05382442|Growth Substances|growth substances|mesh-ancestor
19537020|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537021|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
19537022|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
20307531|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20307532|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20307533|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
20307534|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
20307535|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307536|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20307537|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20307538|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
20307539|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20307540|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20307541|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
20307542|NCT00660140|Gemcitabine|gemcitabine|mesh-list
20307543|NCT00660140|Carboplatin|carboplatin|mesh-list
20307544|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307545|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20604158|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
20604159|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19537023|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537024|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537025|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537026|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
19537027|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19537028|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19537029|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537030|NCT05382442|Antidotes|antidotes|mesh-ancestor
19537031|NCT05382442|Protective Agents|protective agents|mesh-ancestor
19537032|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
19537033|NCT05382442|Vitamins|vitamins|mesh-ancestor
19537034|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
19537035|NCT05382390|Cytarabine|cytarabine|mesh-list
19537036|NCT05382390|Decitabine|decitabine|mesh-list
20104446|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
20104447|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104448|NCT00003315|Amebicides|amebicides|mesh-ancestor
20104449|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20104450|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20604160|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
20604161|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20604162|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20604163|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104451|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104452|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20104453|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
20104454|NCT00003316|Gemcitabine|gemcitabine|mesh-list
20307546|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
19537037|NCT05382390|Aclarubicin|aclarubicin|mesh-list
19537038|NCT05382390|Lenograstim|lenograstim|mesh-list
20104455|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20308922|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20604164|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307547|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104456|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
20104457|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104458|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104459|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
20104460|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104461|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104462|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104463|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
20104464|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104465|NCT00003317|Paclitaxel|paclitaxel|mesh-list
19537039|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537040|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
19537041|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537042|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537043|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
19537044|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537045|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537046|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
19537047|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537048|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19537049|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537050|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19537051|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19537052|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19537053|NCT05382364|Tucatinib|tucatinib|mesh-list
19537054|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537055|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19537056|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537057|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537058|NCT05382351|Tenofovir|tenofovir|mesh-list
19537059|NCT05382351|Entecavir|entecavir|mesh-list
19537060|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
19537061|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537062|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19537063|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19537064|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537065|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537066|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19537067|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19537068|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
19537069|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
19537070|NCT05382338|Lomustine|lomustine|mesh-list
19537071|NCT05382338|Vincristine|vincristine|mesh-list
19537072|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537073|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
19537074|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307548|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
20307549|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307550|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307551|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307552|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
19537075|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537076|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19537077|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
19537078|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537079|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537080|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19537081|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19537082|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
19537083|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
19537084|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
19537085|NCT05382338|Protective Agents|protective agents|mesh-ancestor
19537086|NCT05382338|Antidotes|antidotes|mesh-ancestor
20104466|NCT00003317|Carboplatin|carboplatin|mesh-list
20104467|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104468|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104469|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104470|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104471|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104472|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307553|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307554|NCT00660231|Gemcitabine|gemcitabine|mesh-list
20104473|NCT00003322|Paclitaxel|paclitaxel|mesh-list
19537087|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
19537088|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
19537089|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19537090|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537091|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
20604165|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604166|NCT02225756|Cyclosporine|cyclosporine|mesh-list
20604167|NCT02225756|Cyclosporins|cyclosporins|mesh-list
20604168|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604169|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604170|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604171|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
20604172|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604173|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
19537092|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
19537093|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
19537094|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537095|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537096|NCT05382312|Bedaquiline|bedaquiline|mesh-list
19537097|NCT05382312|GSK656|gsk656|mesh-list
19537098|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
19537099|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19537100|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537101|NCT05382299|Gemcitabine|gemcitabine|mesh-list
19537102|NCT05382299|Paclitaxel|paclitaxel|mesh-list
19537103|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19537104|NCT05382299|Carboplatin|carboplatin|mesh-list
20307555|NCT00660231|Bexarotene|bexarotene|mesh-list
20104474|NCT00003322|Cisplatin|cisplatin|mesh-list
20104475|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19537105|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19537106|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537107|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
19537108|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
19537109|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
19537110|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537111|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537112|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
19537113|NCT05382299|Antiviral Agents|antiviral agents|mesh-ancestor
19537114|NCT05382299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537115|NCT05382299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537116|NCT05382299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537117|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
19537118|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537119|NCT05382286|Gemcitabine|gemcitabine|mesh-list
19537120|NCT05382286|Paclitaxel|paclitaxel|mesh-list
19537121|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19537122|NCT05382286|Carboplatin|carboplatin|mesh-list
19537123|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
19537124|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19537125|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537126|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
19537127|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
19537128|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
19537129|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537130|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537131|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
19537132|NCT05382286|Antiviral Agents|antiviral agents|mesh-ancestor
19537133|NCT05382286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537134|NCT05382286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537135|NCT05382286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537136|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
20104476|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104477|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104478|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104479|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104480|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104481|NCT00003323|Flutamide|flutamide|mesh-list
20104482|NCT00003323|Finasteride|finasteride|mesh-list
20104483|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20104484|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19537137|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104485|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604174|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537138|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574644|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20307556|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537139|NCT05382208|Doxycycline|doxycycline|mesh-list
19537140|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19537141|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537142|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
19537143|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19537144|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19537145|NCT05382182|Androgens|androgens|mesh-list
19537146|NCT05382182|Hormones|hormones|mesh-ancestor
19537147|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537148|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104486|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104487|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
20104488|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20104489|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104490|NCT00003323|Urological Agents|urological agents|mesh-ancestor
19537149|NCT05382143|Atosiban|atosiban|mesh-list
19537150|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
19537151|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537152|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104491|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
20104492|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19537153|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
19537154|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20104493|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104494|NCT00003326|Paclitaxel|paclitaxel|mesh-list
20104495|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19537158|NCT05382091|Naltrexone|naltrexone|mesh-list
19537159|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19537160|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19537161|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537162|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
19537163|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537164|NCT05381974|Psilocybin|psilocybin|mesh-list
19537165|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
19537166|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537167|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19537168|NCT05381948|Aflibercept|aflibercept|mesh-list
19537169|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19537170|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19537171|NCT05381948|Growth Substances|growth substances|mesh-ancestor
19537172|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537173|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
19537174|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537175|NCT05381909|Paclitaxel|paclitaxel|mesh-list
19537176|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19537177|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537178|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19537179|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
19537180|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
19537181|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537182|NCT05381753|Sunitinib|sunitinib|mesh-list
19537183|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
19537184|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537185|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19537186|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19537187|NCT05381753|Growth Substances|growth substances|mesh-ancestor
19537188|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537189|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
19537190|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19537191|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537192|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537193|NCT05381623|Hemostatics|hemostatics|mesh-list
19537194|NCT05381623|Coagulants|coagulants|mesh-ancestor
19537195|NCT05381597|Fluorouracil|fluorouracil|mesh-list
19537196|NCT05381597|Calcipotriene|calcipotriene|mesh-list
19537197|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
19537198|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104496|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104497|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104498|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104499|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
19537199|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537200|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537201|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537202|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
19537203|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537204|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537205|NCT05381558|Triamcinolone|triamcinolone|mesh-list
19537206|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537207|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
19537208|NCT05381558|Hormones|hormones|mesh-ancestor
19537209|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537210|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537211|NCT05381428|Indomethacin|indomethacin|mesh-list
19537212|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19537213|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19537214|NCT05381428|Analgesics|analgesics|mesh-ancestor
19537215|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
19537216|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537217|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537218|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537219|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537220|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
19537221|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
19537222|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19537223|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19537224|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537225|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537226|NCT05381389|Bupivacaine|bupivacaine|mesh-list
19537227|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
19537228|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
19537229|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537230|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104500|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104501|NCT00003327|Paclitaxel|paclitaxel|mesh-list
20104502|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104503|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537231|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
19537232|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537233|NCT05381363|Interferons|interferons|mesh-list
19537234|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537235|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
19537236|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537237|NCT05381350|Vaccines|vaccines|mesh-list
19537238|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
19537239|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537240|NCT05381207|Fluticasone|fluticasone|mesh-list
19537241|NCT05381207|Xhance|xhance|mesh-list
19537242|NCT05381207|Montelukast|montelukast|mesh-list
19537243|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537244|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19537245|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
19537246|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537247|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537248|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19537249|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
19537250|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537251|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19537252|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19537253|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
19537254|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537255|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19537256|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19537257|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537258|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
19537259|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
19537260|NCT05381168|Calcium|calcium|mesh-list
19537261|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19537262|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537263|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19537264|NCT05381168|Antacids|antacids|mesh-ancestor
19537265|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537266|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537267|NCT05381038|Paclitaxel|paclitaxel|mesh-list
19537268|NCT05381038|Docetaxel|docetaxel|mesh-list
19537269|NCT05381038|Irinotecan|irinotecan|mesh-list
19537270|NCT05381038|Azacitidine|azacitidine|mesh-list
19537271|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19537272|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537273|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
19537274|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
19537275|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
19537276|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104504|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104505|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104506|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
20307557|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
20307558|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307559|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307560|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
20307561|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307562|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307563|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307564|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
20307565|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307566|NCT00660244|Anastrozole|anastrozole|mesh-list
19537277|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19537278|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19537279|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537280|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537281|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
19537282|NCT05380986|Apatinib|apatinib|mesh-list
19537283|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537284|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19537285|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537286|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537287|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
19537288|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19537289|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19537290|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537291|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
19537292|NCT05380960|Coagulants|coagulants|mesh-ancestor
19537293|NCT05380947|Rabeprazole|rabeprazole|mesh-list
19537294|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19537295|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537296|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19537297|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537298|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537299|NCT05380934|Methotrexate|methotrexate|mesh-list
19537300|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19537301|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
20104507|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104508|NCT00003328|Porfiromycin|porfiromycin|mesh-list
20104509|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104510|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104511|NCT00003330|Interleukin-12|interleukin-12|mesh-list
19537302|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19537303|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537304|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307567|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20307568|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307569|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20307570|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20307571|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307572|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307573|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20307574|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
20307575|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307576|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307577|NCT00660257|Vaccines|vaccines|mesh-list
19537305|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
19537306|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537307|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537308|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537309|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537310|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19537311|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537312|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
19537313|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537314|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19537315|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19574645|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
20307578|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
20307579|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537316|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537317|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574646|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307580|NCT00660270|Gemcitabine|gemcitabine|mesh-list
20307581|NCT00660270|Interferons|interferons|mesh-list
20307582|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
20307583|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20307584|NCT00660270|Fluorouracil|fluorouracil|mesh-list
20307585|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307586|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307587|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
20307588|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307589|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
20307590|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307591|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307592|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307593|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
20307594|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307595|NCT00660283|Temozolomide|temozolomide|mesh-list
19574647|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574648|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19574649|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19574650|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
19574651|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19574652|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19574653|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
19574654|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
19574655|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574656|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20307596|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20307597|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
20307598|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104512|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20104513|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
20104514|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104515|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20104516|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20104517|NCT00003330|Growth Substances|growth substances|mesh-ancestor
20104518|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
20104519|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104520|NCT00003331|Leucovorin|leucovorin|mesh-list
20104521|NCT00003331|Fluorouracil|fluorouracil|mesh-list
20104522|NCT00003331|Topotecan|topotecan|mesh-list
20104523|NCT00003331|Calcium|calcium|mesh-list
20104524|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
20104525|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20104526|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104527|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
20104528|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104529|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104530|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574657|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19574658|NCT04309552|Alovudine|alovudine|mesh-list
19574659|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
20104531|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104532|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
20104533|NCT00003331|Antidotes|antidotes|mesh-ancestor
20307599|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307600|NCT00660335|Secretin|secretin|mesh-list
19574660|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574661|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
19574662|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19574663|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19574664|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307601|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20307602|NCT00660335|Hormones|hormones|mesh-ancestor
20307603|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307604|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307605|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
20307606|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
19574665|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
19574666|NCT04304625|Coagulants|coagulants|mesh-ancestor
19574667|NCT04298541|Edotreotide|edotreotide|mesh-list
20104534|NCT00003331|Protective Agents|protective agents|mesh-ancestor
20104535|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
20104536|NCT00003331|Vitamins|vitamins|mesh-ancestor
20307607|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
20307608|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20307609|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537318|NCT05380778|Anesthetics|anesthetics|mesh-list
19537319|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537320|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537321|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
19537322|NCT05380713|Durvalumab|durvalumab|mesh-list
19537323|NCT05380713|Tremelimumab|tremelimumab|mesh-list
19537324|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537325|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
19537326|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537327|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537328|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19537329|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
19537330|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537331|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537332|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20307610|NCT00660426|Gemcitabine|gemcitabine|mesh-list
20307611|NCT00660426|Capecitabine|capecitabine|mesh-list
20307612|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
20307613|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307614|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
20307615|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307616|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307617|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
20307618|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307619|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104537|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
20104538|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104539|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104540|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104541|NCT00003332|Gemcitabine|gemcitabine|mesh-list
20104542|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104543|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104544|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
19537333|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537334|NCT05380635|Hypericin|hypericin|mesh-list
19537335|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
19537336|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19537337|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537338|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
19537339|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537340|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104545|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104546|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
20104547|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104548|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104549|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537341|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537342|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537343|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
19537344|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537345|NCT05380479|Megestrol|megestrol|mesh-list
19537346|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
19537347|NCT05380479|Mirtazapine|mirtazapine|mesh-list
19537348|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
19537349|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19537350|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19537351|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
19537352|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
19537353|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19537354|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537355|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537356|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19537357|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19537358|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537359|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19537360|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19537361|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19537362|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
19537363|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20104550|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
20104551|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307620|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537364|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19537365|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
19537366|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19537367|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19537368|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19537369|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20104552|NCT00003334|Paclitaxel|paclitaxel|mesh-list
20104553|NCT00003334|Doxorubicin|doxorubicin|mesh-list
20104554|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104555|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104556|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537370|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
19537371|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19537372|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19537373|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19537374|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19537375|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537376|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
19537377|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19537378|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19537379|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
19537380|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537381|NCT05380388|Vaccines|vaccines|mesh-list
19537382|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
19537383|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537384|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19537385|NCT05380245|Clarithromycin|clarithromycin|mesh-list
19537386|NCT05380245|Voriconazole|voriconazole|mesh-list
19537387|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19537388|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537389|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19537390|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537391|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537392|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19537393|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19537394|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
19537395|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19537396|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19537397|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
19537398|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537399|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104557|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104558|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104559|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104560|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104561|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104562|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104563|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104564|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104565|NCT00003335|Cyclosporine|cyclosporine|mesh-list
20104566|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
20104567|NCT00003335|Melphalan|melphalan|mesh-list
19537409|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
19537410|NCT05379972|Olaparib|olaparib|mesh-list
19537411|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537412|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537413|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19537414|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537415|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104568|NCT00003335|Busulfan|busulfan|mesh-list
20104569|NCT00003335|Cyclosporins|cyclosporins|mesh-list
20104570|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20104571|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104572|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104573|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104574|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
20307621|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
20307622|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308923|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
20308924|NCT00666302|Tacrolimus|tacrolimus|mesh-list
20308925|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308926|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
20308927|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604175|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537416|NCT05379959|Methamphetamine|methamphetamine|mesh-list
19537417|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19537418|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537419|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
19537420|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
19537421|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537422|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
19537423|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19537424|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537425|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
19537426|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19537427|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19537428|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19537429|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19537430|NCT05379686|Glucagon|glucagon|mesh-list
19537431|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537432|NCT05379686|Hormones|hormones|mesh-ancestor
19537433|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537434|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537435|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
19537436|NCT05379647|Rituximab|rituximab|mesh-list
19537437|NCT05379647|Fludarabine|fludarabine|mesh-list
19537438|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537439|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
19537440|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537441|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537442|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19537443|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
19537444|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537445|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537446|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19537447|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537448|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
19537449|NCT05379634|Hormones|hormones|mesh-ancestor
19537450|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537451|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537452|NCT05379595|Leucovorin|leucovorin|mesh-list
19537453|NCT05379595|Fluorouracil|fluorouracil|mesh-list
19537454|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
19537455|NCT05379595|Irinotecan|irinotecan|mesh-list
19537456|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19537457|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
19537458|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537459|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537460|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537461|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537462|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
19537463|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537464|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19537465|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19537466|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537467|NCT05379595|Antidotes|antidotes|mesh-ancestor
19537468|NCT05379595|Protective Agents|protective agents|mesh-ancestor
19537469|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
19537470|NCT05379595|Vitamins|vitamins|mesh-ancestor
19537471|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
19537472|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537473|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
19537474|NCT05379569|Fludarabine|fludarabine|mesh-list
19537475|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537476|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
19537477|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537478|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537479|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19537480|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
20307623|NCT00660582|Leucovorin|leucovorin|mesh-list
20307624|NCT00660582|Folic Acid|folic acid|mesh-list
20307625|NCT00660582|Fluorouracil|fluorouracil|mesh-list
20307626|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
20307627|NCT00660582|Cetuximab|cetuximab|mesh-list
20307628|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
20307629|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
19537481|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537482|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307630|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307631|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537483|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19537484|NCT05379530|Anesthetics|anesthetics|mesh-list
19537485|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537486|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537487|NCT05379491|Linaclotide|linaclotide|mesh-list
19537488|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19537489|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
19537490|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537491|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537492|NCT05379478|Antibodies|antibodies|mesh-list
19537493|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
19537494|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537495|NCT05379322|Adalimumab|adalimumab|mesh-list
19537496|NCT05379322|Etanercept|etanercept|mesh-list
19537497|NCT05379322|Golimumab|golimumab|mesh-list
19537498|NCT05379322|Upadacitinib|upadacitinib|mesh-list
19537499|NCT05379322|Tofacitinib|tofacitinib|mesh-list
19537500|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19537501|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537502|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537503|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19537504|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19537505|NCT05379322|Analgesics|analgesics|mesh-ancestor
19537506|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
19537507|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537508|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537509|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537510|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537511|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
19537512|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19537513|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537514|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537515|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19537516|NCT05379283|Lidocaine|lidocaine|mesh-list
19537517|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
19537518|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
19537519|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537520|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537521|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
19537522|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537523|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20307632|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307633|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307634|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
19537524|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19537525|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19537526|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19537527|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574668|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19574669|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574670|NCT04294654|Vortioxetine|vortioxetine|mesh-list
19574671|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
19574672|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574673|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19574674|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574675|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574676|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574677|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19574678|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19574679|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19574680|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574681|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574682|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
19574683|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19574684|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19574685|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19574686|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19574687|NCT04288206|Cefazolin|cefazolin|mesh-list
19574688|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19574689|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574690|NCT04278625|Acetaminophen|acetaminophen|mesh-list
19574691|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20307635|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537528|NCT05379257|Furosemide|furosemide|mesh-list
19537529|NCT05379257|Diuretics|diuretics|mesh-ancestor
19537530|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
19537531|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537532|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19537533|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19537534|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537535|NCT05379166|Azacitidine|azacitidine|mesh-list
19537536|NCT05379166|Venetoclax|venetoclax|mesh-list
19537537|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537538|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
19537539|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537540|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537541|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537542|NCT05379049|Adalimumab|adalimumab|mesh-list
19537543|NCT05379049|Etanercept|etanercept|mesh-list
19537544|NCT05379049|Infliximab|infliximab|mesh-list
19537545|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537546|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537547|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537548|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537549|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19537550|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19537551|NCT05379049|Analgesics|analgesics|mesh-ancestor
19537552|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
19537553|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537554|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537555|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537556|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
19537557|NCT05378971|Pomalidomide|pomalidomide|mesh-list
19537558|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
19537559|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537560|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19537561|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19537562|NCT05378971|Growth Substances|growth substances|mesh-ancestor
19537563|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
19537564|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537565|NCT05378932|Melatonin|melatonin|mesh-list
19537566|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
20307636|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20307637|NCT00660582|Antidotes|antidotes|mesh-ancestor
20307638|NCT00660582|Protective Agents|protective agents|mesh-ancestor
20307639|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
20307640|NCT00660582|Vitamins|vitamins|mesh-ancestor
20307641|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
20307642|NCT00660582|Hematinics|hematinics|mesh-ancestor
20307643|NCT00660621|Bevacizumab|bevacizumab|mesh-list
20307644|NCT00660621|Temozolomide|temozolomide|mesh-list
19537567|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537568|NCT05378932|Protective Agents|protective agents|mesh-ancestor
19537569|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537570|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537571|NCT05378919|Folic Acid|folic acid|mesh-list
19537572|NCT05378919|Leucovorin|leucovorin|mesh-list
20307645|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20307646|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307647|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19537573|NCT05378919|Fluorouracil|fluorouracil|mesh-list
19537574|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
19537575|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
20307648|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20307649|NCT00660621|Growth Substances|growth substances|mesh-ancestor
20307650|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307651|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
20307652|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19537576|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
19537577|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537578|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537579|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537580|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537581|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
19537582|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537583|NCT05378919|Hematinics|hematinics|mesh-ancestor
19537584|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
19537585|NCT05378919|Vitamins|vitamins|mesh-ancestor
19537586|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
19537587|NCT05378919|Antidotes|antidotes|mesh-ancestor
20307653|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
19537588|NCT05378919|Protective Agents|protective agents|mesh-ancestor
19537589|NCT05378906|Darunavir|darunavir|mesh-list
19537590|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19537591|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19537592|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
19537593|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537594|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537595|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19537596|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19537597|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
19537598|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537599|NCT05378867|Bevacizumab|bevacizumab|mesh-list
19537600|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537601|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537602|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19537603|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19537604|NCT05378867|Growth Substances|growth substances|mesh-ancestor
19537605|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537606|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
19537607|NCT05378763|Docetaxel|docetaxel|mesh-list
19537608|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537609|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
19537610|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
20307654|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307655|NCT00660647|Adalimumab|adalimumab|mesh-list
20307656|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307657|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307658|NCT00660725|Gemcitabine|gemcitabine|mesh-list
20307659|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
20307660|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537611|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104575|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104576|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
20104577|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104578|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
20104579|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104580|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20104581|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20104582|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
20104583|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
20104584|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104585|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20104586|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
20104587|NCT00003335|Hormones|hormones|mesh-ancestor
19537612|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537613|NCT05378737|Exatecan|exatecan|mesh-list
19537614|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19537615|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19537616|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104588|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20104589|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20104590|NCT00003335|Protective Agents|protective agents|mesh-ancestor
20104591|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104592|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104593|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
20104594|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104595|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
20104596|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
19537617|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537618|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537619|NCT05378711|Fluoxetine|fluoxetine|mesh-list
19537620|NCT05378711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19537621|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19537622|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19537623|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537624|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19537625|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
19537626|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537627|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19537628|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
19537629|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19537630|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20104597|NCT00003336|Melphalan|melphalan|mesh-list
20104598|NCT00003336|Busulfan|busulfan|mesh-list
20307661|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
19537631|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19537632|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537633|NCT05378646|Interferons|interferons|mesh-list
19537634|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
19537635|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537636|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
19537637|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537638|NCT05378555|Ketamine|ketamine|mesh-list
19537639|NCT05378555|Analgesics|analgesics|mesh-ancestor
19537640|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
19537641|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537642|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537643|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19537644|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19537645|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
19537646|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
19537647|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537648|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19537649|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19537650|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20104599|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20104600|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104601|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
20104602|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104603|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537651|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537652|NCT05378503|Topiramate|topiramate|mesh-list
19537653|NCT05378503|Phentermine|phentermine|mesh-list
19537654|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
19537655|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19537656|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537657|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19537658|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
19537659|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19537660|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
19537661|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
19537662|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537663|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19537664|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19537665|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537666|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
19537667|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537668|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537669|NCT05378269|Tamoxifen|tamoxifen|mesh-list
19537670|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19537671|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
19537672|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537673|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104604|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104605|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
20104606|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604176|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537674|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19537675|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537676|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19537677|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19537678|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19537679|NCT05378191|Vaccines|vaccines|mesh-list
19537680|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
19537681|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537682|NCT05378113|Lidocaine|lidocaine|mesh-list
19537683|NCT05378113|Ondansetron|ondansetron|mesh-list
19537684|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
19537685|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
19537686|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537687|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537688|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
19537689|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537690|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19537691|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19537692|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19537693|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19537694|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537695|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
19537696|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
19537697|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537698|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
19537699|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537700|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19537701|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
19537702|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19537703|NCT05378113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20104607|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104608|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104609|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20104610|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
20104611|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
20307662|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537704|NCT05378113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19537705|NCT05378113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19537706|NCT05378113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19537707|NCT05377788|Lazertinib|lazertinib|mesh-list
19537708|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19537709|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537710|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537711|NCT05372380|Atorvastatin|atorvastatin|mesh-list
19537712|NCT05372380|Ezetimibe|ezetimibe|mesh-list
19537713|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19537714|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19537715|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
19537716|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537717|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19537718|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19537719|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574692|NCT04278625|Analgesics|analgesics|mesh-ancestor
19574693|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
19574694|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574695|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574696|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
19574697|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
19574698|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19574699|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
19574700|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19574701|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
19574702|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574703|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574704|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
19574705|NCT04210310|Oxytocin|oxytocin|mesh-list
19574706|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
19574707|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20307663|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307664|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
19574708|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574709|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
19574710|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574711|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574712|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19574713|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574714|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574715|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574716|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574717|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19574718|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19574719|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19574720|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574721|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
19574722|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19574723|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
19574724|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19574725|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19574726|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19574727|NCT04147013|Celecoxib|celecoxib|mesh-list
19574728|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19574729|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19574730|NCT04147013|Analgesics|analgesics|mesh-ancestor
19574731|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
19574732|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104612|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307665|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537720|NCT05370911|Psilocybin|psilocybin|mesh-list
19537721|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
19537722|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537723|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19537724|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
19537725|NCT05370898|Antacids|antacids|mesh-ancestor
19537726|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537727|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537728|NCT05366764|Albuterol|albuterol|mesh-list
19537729|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19537730|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
19537731|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537732|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537733|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19537734|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
19537735|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
19537736|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20307666|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307667|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307668|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
20307669|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307670|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20307671|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20307672|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20307673|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20307674|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307675|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307676|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537737|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19537738|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19537739|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19537740|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
19537741|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19537742|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537743|NCT05358704|Leucovorin|leucovorin|mesh-list
19537744|NCT05358704|Fluorouracil|fluorouracil|mesh-list
19537745|NCT05358704|Capecitabine|capecitabine|mesh-list
19537746|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
19537747|NCT05358704|Irinotecan|irinotecan|mesh-list
19537748|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
19537749|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537750|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19537751|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537752|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537753|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
19537754|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537755|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19537756|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19537757|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537758|NCT05358704|Antidotes|antidotes|mesh-ancestor
19537759|NCT05358704|Protective Agents|protective agents|mesh-ancestor
19537760|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
19537761|NCT05358704|Vitamins|vitamins|mesh-ancestor
19537762|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
19537763|NCT05358691|Durvalumab|durvalumab|mesh-list
19537764|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537765|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537766|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
19537767|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537768|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537769|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19537770|NCT05354453|Protective Agents|protective agents|mesh-ancestor
19537771|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537772|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537773|NCT05345717|Abatacept|abatacept|mesh-list
19537774|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19537775|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19537776|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537777|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537778|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537779|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
19537780|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537781|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537782|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
19537783|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537784|NCT05341115|Leuprolide|leuprolide|mesh-list
19537785|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19537786|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
19537787|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19537788|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307677|NCT00660751|Analgesics|analgesics|mesh-ancestor
20307678|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
20104613|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20104614|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
20104615|NCT00003336|Hormones|hormones|mesh-ancestor
20104616|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20104617|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20104618|NCT00003336|Protective Agents|protective agents|mesh-ancestor
20104619|NCT00003337|Epratuzumab|epratuzumab|mesh-list
20104620|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20104621|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104622|NCT00003338|Epratuzumab|epratuzumab|mesh-list
20104623|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20104624|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104625|NCT00003339|Interleukin-12|interleukin-12|mesh-list
20104626|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
20104627|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19537789|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19537790|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537791|NCT05336968|Triamcinolone|triamcinolone|mesh-list
19537792|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19537793|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19537794|NCT05336968|Ketorolac|ketorolac|mesh-list
19537795|NCT05336968|Ropivacaine|ropivacaine|mesh-list
19537796|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19537797|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
19537798|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
19537799|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537800|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537801|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
19537802|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537803|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537804|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
19537805|NCT05336968|Hormones|hormones|mesh-ancestor
19537806|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537807|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537808|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
19537809|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537810|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537811|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19537812|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19537813|NCT05336968|Analgesics|analgesics|mesh-ancestor
19537814|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537815|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19537816|NCT05335993|Niraparib|niraparib|mesh-list
19537817|NCT05335993|Oregovomab|oregovomab|mesh-list
19537818|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19537819|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537820|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537821|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537822|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537823|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19537824|NCT05332444|Amoxicillin|amoxicillin|mesh-list
19537825|NCT05332444|Metronidazole|metronidazole|mesh-list
19537826|NCT05332444|Clarithromycin|clarithromycin|mesh-list
19537827|NCT05332444|Levofloxacin|levofloxacin|mesh-list
19537828|NCT05332444|Tetracycline|tetracycline|mesh-list
19537829|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19537830|NCT05332444|Rabeprazole|rabeprazole|mesh-list
19537831|NCT05332444|Bismuth|bismuth|mesh-list
19537832|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19537833|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537834|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
19537835|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19537836|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19537837|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19537838|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537839|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104628|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
19537840|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19537841|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19537842|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19537843|NCT05332444|Renal Agents|renal agents|mesh-ancestor
19537844|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19537845|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19537846|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537847|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19537848|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19537849|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19537850|NCT05332444|Antacids|antacids|mesh-ancestor
19537851|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
19537852|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537853|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537854|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
19537855|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537856|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
19537857|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
19537858|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
20104629|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104630|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20104631|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20104632|NCT00003339|Growth Substances|growth substances|mesh-ancestor
20104633|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
19537873|NCT05312892|Amlodipine|amlodipine|mesh-list
19537874|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
19537875|NCT05312892|Moxonidine|moxonidine|mesh-list
19537876|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19537877|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19537878|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537879|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19537880|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537881|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
19574733|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574734|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574735|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574736|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19574737|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19574738|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104634|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104635|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
20104636|NCT00003340|Topotecan|topotecan|mesh-list
19574739|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574740|NCT04134260|Hormones|hormones|mesh-list
19574741|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574742|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574743|NCT04126070|Docetaxel|docetaxel|mesh-list
19574744|NCT04126070|Nivolumab|nivolumab|mesh-list
19574745|NCT04126070|Leuprolide|leuprolide|mesh-list
19574746|NCT04126070|Goserelin|goserelin|mesh-list
19574747|NCT04126070|Androgens|androgens|mesh-list
19574748|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574749|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574750|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574751|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574752|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104637|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104638|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
19574753|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574754|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19574755|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19574756|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
20104639|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537882|NCT05303909|Gentamicins|gentamicins|mesh-list
19537883|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19537884|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19537885|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19537886|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537887|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537888|NCT05301322|Vaccines|vaccines|mesh-list
19537889|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
19537890|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537891|NCT05298085|Oxytocin|oxytocin|mesh-list
19537892|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
19537893|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19537894|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537895|NCT05293964|Palbociclib|palbociclib|mesh-list
19537896|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104640|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104641|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104642|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
20104643|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307679|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537897|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19537898|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537899|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537903|NCT05292339|Triamcinolone|triamcinolone|mesh-list
19537904|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19537905|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19537906|NCT05292339|Ketorolac|ketorolac|mesh-list
19537907|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19537908|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19537909|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19537910|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
19537911|NCT05292339|Hormones|hormones|mesh-ancestor
19537912|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537913|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537914|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19537915|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
19537916|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537917|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537918|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19537919|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19537920|NCT05292339|Analgesics|analgesics|mesh-ancestor
19537921|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
19537922|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537923|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537924|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19537925|NCT05291598|Ketorolac|ketorolac|mesh-list
19537926|NCT05291598|Meloxicam|meloxicam|mesh-list
19537927|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19537928|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19537929|NCT05291598|Analgesics|analgesics|mesh-ancestor
19537930|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
19537931|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19537932|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537933|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307680|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
20307681|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20307682|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
20307683|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20307684|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19537934|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19537935|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20104644|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104645|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104646|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104647|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104648|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104649|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
20104650|NCT00003341|Hematinics|hematinics|mesh-ancestor
20104651|NCT00003342|Gemcitabine|gemcitabine|mesh-list
20104652|NCT00003342|Paclitaxel|paclitaxel|mesh-list
20104653|NCT00003342|Carboplatin|carboplatin|mesh-list
20104654|NCT00003342|Doxorubicin|doxorubicin|mesh-list
20307685|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19537936|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537937|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537938|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19537939|NCT05289804|Lidocaine|lidocaine|mesh-list
19537940|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
19537941|NCT05289804|Prilocaine|prilocaine|mesh-list
19537942|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19537943|NCT05289804|Anesthetics|anesthetics|mesh-list
19537944|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19537945|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537946|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
19537947|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307686|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
20307687|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307688|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19537948|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19537949|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19537950|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19537951|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19537952|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537953|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19537954|NCT05285904|Ofatumumab|ofatumumab|mesh-list
19537955|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537956|NCT05283837|Pertuzumab|pertuzumab|mesh-list
19537957|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19537958|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19537959|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
19537960|NCT05279456|Paraproteins|paraproteins|mesh-list
19537961|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
20307689|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20307690|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307691|NCT00660803|Fulvestrant|fulvestrant|mesh-list
19537962|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537963|NCT05277922|Nitroprusside|nitroprusside|mesh-list
19537964|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19537965|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
19537966|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19537967|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537968|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
19537969|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19537970|NCT05272787|Protective Agents|protective agents|mesh-ancestor
19537971|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537972|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
19537973|NCT05269706|Cannabidiol|cannabidiol|mesh-list
19537974|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
19537975|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19537976|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
19537977|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19537978|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537979|NCT05266404|Incretins|incretins|mesh-ancestor
19537980|NCT05266404|Hormones|hormones|mesh-ancestor
19537981|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537982|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19537983|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
20307692|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20307693|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307694|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20307695|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20307696|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
20104655|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104656|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104657|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104658|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104659|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104660|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104661|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104662|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104663|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
20104664|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
20104665|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104666|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307697|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19537984|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578135|NCT03533582|Daunorubicin|daunorubicin|mesh-list
20104667|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104668|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
19537985|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537986|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19537987|NCT05265806|Oxytocin|oxytocin|mesh-list
19537988|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
19537989|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19537990|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19537991|NCT05263908|Ritonavir|ritonavir|mesh-list
19537992|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19537993|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19537994|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
19537995|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19537996|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19537997|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19537998|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19537999|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
19538000|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538001|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19538002|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19538003|NCT05261594|Caffeine|caffeine|mesh-list
19538004|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19538005|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538006|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19538007|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538008|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538009|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19538010|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19538011|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
19538012|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538013|NCT05256225|Paclitaxel|paclitaxel|mesh-list
20104669|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104670|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104671|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104672|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104673|NCT00003343|Prednisone|prednisone|mesh-list
19538014|NCT05256225|Carboplatin|carboplatin|mesh-list
19538015|NCT05256225|Trastuzumab|trastuzumab|mesh-list
19538016|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19538017|NCT05256225|Pertuzumab|pertuzumab|mesh-list
19538018|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19538019|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538020|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
19538021|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
19538022|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
19538023|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538024|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538025|NCT05253417|Cannabidiol|cannabidiol|mesh-list
19538026|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
19538027|NCT05242484|Golimumab|golimumab|mesh-list
19538028|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19538029|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19538030|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19538031|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
19538032|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574757|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19574758|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574759|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19574760|NCT04126070|Hormones|hormones|mesh-ancestor
19574761|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574762|NCT04108156|Ranibizumab|ranibizumab|mesh-list
19574763|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19574764|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19574765|NCT04108156|Growth Substances|growth substances|mesh-ancestor
19574766|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574767|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
19574768|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574769|NCT04064697|Valganciclovir|valganciclovir|mesh-list
19574770|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
19574771|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574772|NCT04062669|Vaccines|vaccines|mesh-list
19574773|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
19574774|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104674|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
19574775|NCT04052620|Diclofenac|diclofenac|mesh-list
19538033|NCT05233709|Fesoterodine|fesoterodine|mesh-list
19538034|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19538035|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19538036|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
19538037|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538038|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538039|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538040|NCT05233709|Urological Agents|urological agents|mesh-ancestor
19538041|NCT05220020|Lenvatinib|lenvatinib|mesh-list
19538042|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538043|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538044|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538045|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538046|NCT05215951|Osimertinib|osimertinib|mesh-list
19538047|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538048|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538049|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538050|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104675|NCT00003343|Prinomastat|prinomastat|mesh-list
20104676|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20104677|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
20104678|NCT00003343|Hormones|hormones|mesh-ancestor
20104679|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20104680|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104681|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20104682|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104683|NCT00003343|Analgesics|analgesics|mesh-ancestor
20104684|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
20104685|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538051|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
19538052|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538053|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538054|NCT05215431|Antioxidants|antioxidants|mesh-list
19538055|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538056|NCT05215431|Protective Agents|protective agents|mesh-ancestor
19538057|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538058|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19538059|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19538060|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
19538061|NCT05199038|Octreotide|octreotide|mesh-list
19538062|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538063|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19538064|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538065|NCT05198934|Trifluridine|trifluridine|mesh-list
19538066|NCT05198934|Panitumumab|panitumumab|mesh-list
19538067|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538068|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538069|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
19538070|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538071|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
19538072|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538073|NCT05198804|Niraparib|niraparib|mesh-list
19538074|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19538075|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538076|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538077|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538078|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
19538079|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538080|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538081|NCT05191862|Cilostazol|cilostazol|mesh-list
19538082|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19538083|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
19538084|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538085|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538086|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19538087|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
19538088|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19538089|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19538090|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538091|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19538092|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
20104686|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104687|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19538093|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19538094|NCT05191862|Protective Agents|protective agents|mesh-ancestor
19538095|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19538096|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19538097|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538098|NCT05190432|Taxifolin|taxifolin|mesh-list
19538099|NCT05190432|Ergothioneine|ergothioneine|mesh-list
19538100|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
19538101|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538102|NCT05190432|Protective Agents|protective agents|mesh-ancestor
19538103|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538104|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19538105|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538106|NCT05190432|Analgesics|analgesics|mesh-ancestor
19538107|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
19538108|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538109|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20104688|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104689|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104690|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
20104691|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
20104692|NCT00003344|Irinotecan|irinotecan|mesh-list
20104693|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104694|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104695|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307698|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538110|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538111|NCT05187429|Nivolumab|nivolumab|mesh-list
19538112|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538113|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538114|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19538115|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538116|NCT05182840|Empagliflozin|empagliflozin|mesh-list
19538117|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19538118|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538119|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19538120|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538121|NCT05180968|Dronabinol|dronabinol|mesh-list
19538122|NCT05180968|Nabilone|nabilone|mesh-list
19538123|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
19538124|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
19538125|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538126|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538127|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538128|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19538129|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19538130|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19538131|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538132|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
19538133|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538134|NCT05180968|Analgesics|analgesics|mesh-ancestor
19538135|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
19538136|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19538137|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19538138|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538139|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538140|NCT05180968|Hormones|hormones|mesh-ancestor
19538141|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538142|NCT05179733|Rituximab|rituximab|mesh-list
19538143|NCT05179733|Lenalidomide|lenalidomide|mesh-list
19538144|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
19538145|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538146|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538147|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
19538148|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538149|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538150|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19538151|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19538152|NCT05179733|Growth Substances|growth substances|mesh-ancestor
19538153|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
19538154|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538155|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538156|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307699|NCT00660842|Paclitaxel|paclitaxel|mesh-list
20104696|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104697|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104698|NCT00003345|Irinotecan|irinotecan|mesh-list
20104699|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104700|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104701|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104702|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104703|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104704|NCT00003346|Acetaminophen|acetaminophen|mesh-list
20104705|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
20104706|NCT00003346|Carmustine|carmustine|mesh-list
20104707|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19538157|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19538158|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19538159|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538160|NCT05176158|Analgesics|analgesics|mesh-ancestor
19538161|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
19538162|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538163|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538164|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19538165|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538166|NCT05170009|Oseltamivir|oseltamivir|mesh-list
19538167|NCT05170009|Baloxavir|baloxavir|mesh-list
19538168|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
19538169|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538170|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538171|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538172|NCT05169437|Niraparib|niraparib|mesh-list
19538173|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19538174|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538175|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538176|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538177|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19538178|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19538179|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538180|NCT05169060|Analgesics|analgesics|mesh-ancestor
20104708|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20104709|NCT00003346|Analgesics|analgesics|mesh-ancestor
19538181|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
19538182|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538183|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538184|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19538185|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538186|NCT05165771|Tofacitinib|tofacitinib|mesh-list
19538187|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538188|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538189|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538190|NCT05158374|Aspirin|aspirin|mesh-list
19538191|NCT05158374|Metformin|metformin|mesh-list
19538192|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19538193|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538194|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19538195|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538196|NCT05158374|Analgesics|analgesics|mesh-ancestor
19538197|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
19538198|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538199|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19538200|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538201|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19538202|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19538203|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538204|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20104710|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
20104711|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20104712|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538205|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19538206|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538207|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
19574776|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19574777|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19574778|NCT04052620|Analgesics|analgesics|mesh-ancestor
19574779|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
19574780|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574781|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538208|NCT05156606|Testosterone|testosterone|mesh-list
19538209|NCT05156606|Androgens|androgens|mesh-ancestor
19538210|NCT05156606|Hormones|hormones|mesh-ancestor
19538211|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538212|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538213|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
19538214|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538215|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538216|NCT05153174|Sulforaphane|sulforaphane|mesh-list
19538217|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19538218|NCT05153174|Protective Agents|protective agents|mesh-ancestor
19538219|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538220|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538221|NCT05151328|Plecanatide|plecanatide|mesh-list
19538222|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19538223|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
19538224|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538225|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538226|NCT05150938|Vitamin K|vitamin k|mesh-list
19538227|NCT05150938|Heparin|heparin|mesh-list
19538228|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19538229|NCT05150938|Tinzaparin|tinzaparin|mesh-list
19538230|NCT05150938|Dalteparin|dalteparin|mesh-list
19538231|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
19538232|NCT05150938|Vitamins|vitamins|mesh-ancestor
19538233|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
19538234|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538235|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
19538236|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19538237|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19538238|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538239|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19538240|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
19538241|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19538242|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
19538243|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538244|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19538245|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
19538246|NCT05150938|Coagulants|coagulants|mesh-ancestor
19538247|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19538248|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19538249|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538250|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
19538251|NCT05147272|Gemcitabine|gemcitabine|mesh-list
19538252|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19538253|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
19538254|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538255|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538256|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
19538257|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538258|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538259|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19538260|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
19538261|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538262|NCT05146154|Imipenem|imipenem|mesh-list
19538263|NCT05146154|Relebactam|relebactam|mesh-list
19538264|NCT05146154|Cilastatin|cilastatin|mesh-list
19538265|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19538266|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538267|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
19538268|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538269|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538270|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19538271|NCT05144945|Vaccines|vaccines|mesh-list
19538272|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
19538273|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538274|NCT05132920|Dexamethasone|dexamethasone|mesh-list
19538275|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19538276|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
19538277|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
19538278|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538279|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538280|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538281|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
19538282|NCT05132920|Hormones|hormones|mesh-ancestor
19538283|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538284|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19538285|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538286|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
19538287|NCT05122481|Vitamins|vitamins|mesh-ancestor
19538288|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
19538289|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538290|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
19538291|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538292|NCT05122481|Protective Agents|protective agents|mesh-ancestor
19538293|NCT05121909|Listerine|listerine|mesh-list
19538294|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19538295|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
19538296|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
19538297|NCT05121909|Protective Agents|protective agents|mesh-ancestor
19538298|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538299|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538300|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
19538301|NCT05115136|Promethazine|promethazine|mesh-list
19538302|NCT05115136|Doxepin|doxepin|mesh-list
19538303|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19538304|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19538305|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19538306|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538307|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
19538308|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
19538309|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
19538310|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538311|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
19538312|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
19538313|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538314|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19538315|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
19538316|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
19538317|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538318|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538319|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19538320|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
19538321|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
19538322|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19538323|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
19538324|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538325|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19538326|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
19538327|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19538328|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538329|NCT05113251|Paclitaxel|paclitaxel|mesh-list
19538330|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
19538331|NCT05113251|Doxorubicin|doxorubicin|mesh-list
19538332|NCT05113251|Trastuzumab|trastuzumab|mesh-list
19538333|NCT05113251|Pertuzumab|pertuzumab|mesh-list
19538334|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19538335|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538336|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19538337|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19538338|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19538339|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538340|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19538341|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
19538342|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538343|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538344|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19538345|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
19538346|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19538347|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19538348|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19538349|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19538350|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538351|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538352|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
19538353|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19538354|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
19538355|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19538356|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
19538357|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538358|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538359|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
19538360|NCT05107219|Linaclotide|linaclotide|mesh-list
19538361|NCT05107219|Plecanatide|plecanatide|mesh-list
19538362|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19538363|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
19538364|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538365|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538366|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
19538367|NCT05101629|Lenvatinib|lenvatinib|mesh-list
19538368|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538369|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538370|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538371|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538372|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538373|NCT05094336|Docetaxel|docetaxel|mesh-list
19538374|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538375|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
19538376|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
19538377|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
19538378|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538379|NCT05092958|Avelumab|avelumab|mesh-list
19538380|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19538381|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538382|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538383|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
19538384|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538385|NCT05091567|Carboplatin|carboplatin|mesh-list
19538386|NCT05091567|Etoposide|etoposide|mesh-list
19538387|NCT05091567|Atezolizumab|atezolizumab|mesh-list
19538388|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538389|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19538390|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19538391|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19538392|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538393|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538394|NCT05090085|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19538395|NCT05090085|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19538396|NCT05090085|Protective Agents|protective agents|mesh-ancestor
19538397|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538398|NCT05090085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19538399|NCT05090085|Antioxidants|antioxidants|mesh-ancestor
19538400|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538401|NCT05088876|Acetaminophen|acetaminophen|mesh-list
19538402|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538403|NCT05088876|Analgesics|analgesics|mesh-ancestor
19538404|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
19538405|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538406|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538407|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
19538408|NCT05084508|Vaccines|vaccines|mesh-list
19538409|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19538410|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
19538411|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538412|NCT05083052|Propolis|propolis|mesh-list
19538413|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574782|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574783|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574784|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19574785|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574786|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574787|NCT04048278|Lidocaine|lidocaine|mesh-list
19574788|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
19574789|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
19574790|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574791|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574792|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
19574793|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574794|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19574795|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19574796|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19574797|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19574798|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574799|NCT04037254|Niraparib|niraparib|mesh-list
19574800|NCT04037254|Hormones|hormones|mesh-list
19574801|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19574802|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19538414|NCT05073315|Adalimumab|adalimumab|mesh-list
19538415|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19538416|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538417|NCT05065736|Clofarabine|clofarabine|mesh-list
19538418|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19538419|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
19538420|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538421|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538422|NCT05064878|Fenfluramine|fenfluramine|mesh-list
19538423|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19538424|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19538425|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19538426|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538427|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538428|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
19538429|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538430|NCT05063552|Bevacizumab|bevacizumab|mesh-list
19538431|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19538432|NCT05063552|Cetuximab|cetuximab|mesh-list
19538433|NCT05063552|Cisplatin|cisplatin|mesh-list
19538434|NCT05063552|Carboplatin|carboplatin|mesh-list
19538435|NCT05063552|Docetaxel|docetaxel|mesh-list
19538436|NCT05063552|Atezolizumab|atezolizumab|mesh-list
19538437|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
19538438|NCT05063552|Antibodies|antibodies|mesh-list
19538439|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
19538440|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19538441|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
19538442|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538443|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19538444|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19538445|NCT05063552|Growth Substances|growth substances|mesh-ancestor
19538446|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538447|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
19538448|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
19538449|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
19538450|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
19538451|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
19538452|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538453|NCT05059223|Reboxetine|reboxetine|mesh-list
19538454|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
19538455|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538456|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19538457|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19538458|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19538459|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538460|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
19538461|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538462|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538463|NCT05056727|Valsartan|valsartan|mesh-list
19538464|NCT05056727|Lisinopril|lisinopril|mesh-list
20104713|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
20104714|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
20104715|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104716|NCT00003346|Expectorants|expectorants|mesh-ancestor
20104717|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
20104718|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20104719|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
20104720|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307700|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20307701|NCT00660842|Carboplatin|carboplatin|mesh-list
20307702|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20307703|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307704|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
20307705|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
20307706|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
20307707|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307708|NCT00660855|Parecoxib|parecoxib|mesh-list
20307709|NCT00660855|Valdecoxib|valdecoxib|mesh-list
20307710|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20307711|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20307712|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538465|NCT05056727|Irbesartan|irbesartan|mesh-list
19538466|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20104721|NCT00003346|Protective Agents|protective agents|mesh-ancestor
20104722|NCT00003346|Antidotes|antidotes|mesh-ancestor
19538467|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19538468|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19538469|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538470|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19538471|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
19538472|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538473|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19538474|NCT05056727|Protective Agents|protective agents|mesh-ancestor
19538475|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538476|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
19538477|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538478|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538479|NCT05052541|Dronabinol|dronabinol|mesh-list
19538480|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
20307713|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307714|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20307715|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20307716|NCT00660855|Analgesics|analgesics|mesh-ancestor
20307717|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
20307718|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307719|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307720|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307721|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307722|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
20307723|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307724|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538481|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538482|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538483|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538484|NCT05052541|Analgesics|analgesics|mesh-ancestor
19538485|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
19538486|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538487|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19538488|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19538489|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538490|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538491|NCT05052541|Hormones|hormones|mesh-ancestor
19538492|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538493|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
19538494|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19538495|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
19538496|NCT05049863|Irinotecan|irinotecan|mesh-list
19538497|NCT05049863|Allopurinol|allopurinol|mesh-list
19538498|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19538499|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19538500|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538501|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538502|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538503|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19538504|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19538505|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
19538506|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19538507|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538508|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
19538509|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
19538510|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104723|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104724|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
20104725|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104726|NCT00003348|Carmustine|carmustine|mesh-list
20104727|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20104728|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104729|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
20104730|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104731|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104732|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104733|NCT00003350|Paclitaxel|paclitaxel|mesh-list
20104734|NCT00003350|Doxorubicin|doxorubicin|mesh-list
20104735|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104736|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104737|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104738|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104739|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
19538511|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19538512|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
19538513|NCT05049863|Protective Agents|protective agents|mesh-ancestor
19538514|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538515|NCT05036278|Factor VIII|factor viii|mesh-list
19538516|NCT05036278|Coagulants|coagulants|mesh-ancestor
19538517|NCT05026567|Midazolam|midazolam|mesh-list
19538518|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20104740|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104741|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104742|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20604177|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19538519|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19538520|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19538521|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538522|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19538523|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19538524|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538525|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19538526|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
19538527|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
19538528|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
19538529|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
19538530|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538531|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538532|NCT05026203|Midazolam|midazolam|mesh-list
19538533|NCT05026203|Ketamine|ketamine|mesh-list
19538534|NCT05026203|Analgesics|analgesics|mesh-ancestor
19538535|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
19538536|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538537|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538538|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19538539|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19538540|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
19538541|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
19538542|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19538543|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19538544|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19538545|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538546|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538547|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19538548|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19538549|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19538550|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19538551|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538552|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
19538553|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
19538554|NCT05023967|Metformin|metformin|mesh-list
19538555|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19538556|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538557|NCT05020665|Cytarabine|cytarabine|mesh-list
19538558|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19538559|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
19538560|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538561|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538562|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
19538563|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538564|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19538565|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
19538566|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538567|NCT05019534|Cetuximab|cetuximab|mesh-list
19538568|NCT05019534|Vemurafenib|vemurafenib|mesh-list
19538569|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538570|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538571|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538572|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538573|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538574|NCT05014438|Branebrutinib|branebrutinib|mesh-list
19538575|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538576|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604178|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20604179|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19538577|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538578|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
19538579|NCT05013463|Indapamide|indapamide|mesh-list
19538580|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
19538581|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19538582|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19538583|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538584|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538585|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538586|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538587|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19538588|NCT05013463|Diuretics|diuretics|mesh-ancestor
19538589|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
19538590|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538591|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19538592|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19538593|NCT05011123|Vaccines|vaccines|mesh-list
19538594|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
19538595|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538596|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
19538597|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538598|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538599|NCT05001152|Ozanimod|ozanimod|mesh-list
19538600|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19538601|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538602|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19538603|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
19538604|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538605|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
19538606|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19538607|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
19538608|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538609|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538610|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19538611|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
19538612|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19538613|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
19538614|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538615|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538616|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19538617|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
19538618|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
19538619|NCT04996667|Protective Agents|protective agents|mesh-ancestor
19538620|NCT04992156|Palbociclib|palbociclib|mesh-list
19538621|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538622|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538623|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538624|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538625|NCT04991480|Niraparib|niraparib|mesh-list
19538626|NCT04991480|Talazoparib|talazoparib|mesh-list
19538627|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19538628|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538629|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538630|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574803|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574804|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574805|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19574806|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574807|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574808|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574809|NCT04009681|Antibodies|antibodies|mesh-list
19574810|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
19574811|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578136|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
19578137|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578138|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578139|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
19578140|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578141|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
19578142|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578143|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578144|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578145|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
19578146|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578147|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20307725|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538631|NCT04982614|Vaccines|vaccines|mesh-list
19538632|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
19538633|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538634|NCT04979780|Heparin|heparin|mesh-list
19538635|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19538636|NCT04979780|Tinzaparin|tinzaparin|mesh-list
19538637|NCT04979780|Dalteparin|dalteparin|mesh-list
19538638|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
19538639|NCT04979780|Anticoagulants|anticoagulants|mesh-list
19538640|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19538641|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19538642|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538643|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19538644|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
19538645|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19538646|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
19538647|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538648|NCT04975997|Dexamethasone|dexamethasone|mesh-list
19538649|NCT04975997|Bortezomib|bortezomib|mesh-list
19538650|NCT04975997|Daratumumab|daratumumab|mesh-list
19538651|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19538652|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
19538653|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
19538654|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538655|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104743|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104744|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104745|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104746|NCT00003351|Irinotecan|irinotecan|mesh-list
20104747|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104748|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104749|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104750|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104751|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104752|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
19538656|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538657|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
19538658|NCT04975997|Hormones|hormones|mesh-ancestor
19538659|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538660|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19538661|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538662|NCT04975152|Cemiplimab|cemiplimab|mesh-list
19538663|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538664|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538665|NCT04974385|Bupivacaine|bupivacaine|mesh-list
19538666|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
19538667|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
19538668|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19538669|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538670|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
19538671|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538672|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
19538673|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19538674|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19538675|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19538676|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19538677|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19538678|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538679|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
19538680|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538681|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538682|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19538683|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538684|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
19538685|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19538686|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
19538687|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538688|NCT04964843|Expectorants|expectorants|mesh-ancestor
19538689|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
19538690|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19538691|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
19538692|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538693|NCT04964843|Protective Agents|protective agents|mesh-ancestor
19538694|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538695|NCT04964843|Antidotes|antidotes|mesh-ancestor
19538696|NCT04956705|Vitamin D|vitamin d|mesh-list
19538697|NCT04956705|Calcium|calcium|mesh-list
19538698|NCT04956705|Vitamins|vitamins|mesh-ancestor
19538699|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
19538700|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538701|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19538702|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19538703|NCT04953962|Nivolumab|nivolumab|mesh-list
19538704|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538705|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538706|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19538707|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538708|NCT04951323|Vaccines|vaccines|mesh-list
19538709|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
19538710|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538711|NCT04950764|Seladelpar|seladelpar|mesh-list
19538712|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19538713|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
19538714|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538715|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19538716|NCT04945720|Durvalumab|durvalumab|mesh-list
19538717|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19538718|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538719|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538720|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
19538721|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538722|NCT04942210|Vaccines|vaccines|mesh-list
19538723|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
19538724|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538725|NCT04939935|Metformin|metformin|mesh-list
19538726|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19538727|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538728|NCT04937881|Tenofovir|tenofovir|mesh-list
19538729|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
19538730|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538731|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19538732|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19538733|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538734|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538735|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19538736|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19538737|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19538738|NCT04937062|Glycerol|glycerol|mesh-list
19538739|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19538740|NCT04937062|Protective Agents|protective agents|mesh-ancestor
20104753|NCT00003352|Docetaxel|docetaxel|mesh-list
20104754|NCT00003352|Doxorubicin|doxorubicin|mesh-list
20104755|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104756|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104757|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
19538741|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538742|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538743|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19538744|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19538745|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19538746|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538747|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
19538748|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538749|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538750|NCT04932980|Aflibercept|aflibercept|mesh-list
19538751|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19538752|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19538753|NCT04932980|Growth Substances|growth substances|mesh-ancestor
19538754|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538755|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
19538756|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538757|NCT04931342|Maytansine|maytansine|mesh-list
19538758|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19538759|NCT04931342|Bevacizumab|bevacizumab|mesh-list
19538760|NCT04931342|Trastuzumab|trastuzumab|mesh-list
19538761|NCT04931342|Atezolizumab|atezolizumab|mesh-list
20104758|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104759|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104760|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104761|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
20104762|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104763|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538762|NCT04931342|Letrozole|letrozole|mesh-list
19538763|NCT04931342|Olaparib|olaparib|mesh-list
20104764|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104765|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104766|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104767|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104768|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104769|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19538764|NCT04931342|Palbociclib|palbociclib|mesh-list
19538765|NCT04931342|Hormones|hormones|mesh-list
19538766|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19538767|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19538768|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538769|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
19538770|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
19538771|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
19538772|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538773|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538774|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19538775|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19538776|NCT04931342|Growth Substances|growth substances|mesh-ancestor
19538777|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538778|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
19538779|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538780|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19538781|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19538782|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538783|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19538784|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
19538785|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19538786|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538787|NCT04929041|Paclitaxel|paclitaxel|mesh-list
19538788|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19538789|NCT04929041|Carboplatin|carboplatin|mesh-list
19538790|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
19538791|NCT04929041|Nivolumab|nivolumab|mesh-list
19538792|NCT04929041|Pemetrexed|pemetrexed|mesh-list
19538793|NCT04929041|Ipilimumab|ipilimumab|mesh-list
19538794|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19538795|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538796|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
19538797|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
19538798|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
19538799|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538800|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538801|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19538802|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538803|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19538804|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19538805|NCT04925375|Abatacept|abatacept|mesh-list
19538806|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19538807|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538808|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538809|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19538810|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
19538811|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538812|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19538813|NCT04925284|Nivolumab|nivolumab|mesh-list
19538814|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538815|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538816|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19538817|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538818|NCT04924322|Enoxaparin|enoxaparin|mesh-list
19538819|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
19538820|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19538821|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19538822|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538823|NCT04923542|Hormones|hormones|mesh-list
19538824|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538825|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538826|NCT04920682|Iodine|iodine|mesh-list
19538827|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20104770|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307726|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20307727|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20307728|NCT00660868|Protective Agents|protective agents|mesh-ancestor
19538828|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538829|NCT04920682|Trace Elements|trace elements|mesh-ancestor
19538830|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
19538831|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538832|NCT04907721|Glucagon|glucagon|mesh-list
19538833|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19538834|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538835|NCT04907721|Hormones|hormones|mesh-ancestor
19538836|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538837|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538838|NCT04907721|Incretins|incretins|mesh-ancestor
19538839|NCT04907019|Rifampin|rifampin|mesh-list
19538840|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19538841|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
20307729|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307730|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307731|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20307732|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
20307733|NCT00660894|Leucovorin|leucovorin|mesh-list
20307734|NCT00660894|Tegafur|tegafur|mesh-list
20307735|NCT00660894|Calcium|calcium|mesh-list
20307736|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
20604180|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20604181|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538842|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20307737|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19538843|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538844|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
19538845|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19538846|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538847|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538848|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19538849|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19538850|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19538851|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19538852|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20307738|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307739|NCT00660894|Antidotes|antidotes|mesh-ancestor
20307740|NCT00660894|Protective Agents|protective agents|mesh-ancestor
20307741|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
20307742|NCT00660894|Vitamins|vitamins|mesh-ancestor
20307743|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
20307744|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307745|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
20307746|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307747|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307748|NCT00660920|Ponatinib|ponatinib|mesh-list
20307749|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307750|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19538853|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19538854|NCT04904549|Vaccines|vaccines|mesh-list
19538855|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
19538856|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538857|NCT04903509|Acetaminophen|acetaminophen|mesh-list
19538858|NCT04903509|Liraglutide|liraglutide|mesh-list
19538859|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20307751|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307752|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307753|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20307754|NCT00660933|Hematinics|hematinics|mesh-ancestor
19538860|NCT04903509|Analgesics|analgesics|mesh-ancestor
20307755|NCT00660972|Tenofovir|tenofovir|mesh-list
20307756|NCT00660972|Emtricitabine|emtricitabine|mesh-list
20104771|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104772|NCT00003353|Melphalan|melphalan|mesh-list
20104773|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
20104774|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104775|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104776|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
20104777|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104778|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104779|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20104780|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104781|NCT00003356|Aldesleukin|aldesleukin|mesh-list
20307757|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
20308928|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19538861|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
19538862|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538863|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538864|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
19538865|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19538866|NCT04903509|Incretins|incretins|mesh-ancestor
19538867|NCT04903509|Hormones|hormones|mesh-ancestor
19538868|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538869|NCT04895709|Nivolumab|nivolumab|mesh-list
19538870|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19538871|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538872|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19538873|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104782|NCT00003356|Rituximab|rituximab|mesh-list
20104783|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20104784|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104785|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
20104786|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104787|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104788|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20104789|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20104790|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
20104791|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104792|NCT00003358|Gemcitabine|gemcitabine|mesh-list
20104793|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104794|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104795|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
20104796|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104797|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
20104798|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104799|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104800|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19538893|NCT04887857|Azacitidine|azacitidine|mesh-list
19538894|NCT04887857|Venetoclax|venetoclax|mesh-list
19538895|NCT04887857|Cc-486|cc-486|mesh-list
19538896|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19538897|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
19538898|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538899|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538900|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538901|NCT04883255|Dronabinol|dronabinol|mesh-list
19538902|NCT04883255|Cannabidiol|cannabidiol|mesh-list
19538903|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
19538904|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
19538905|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538906|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538907|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19538908|NCT04883255|Analgesics|analgesics|mesh-ancestor
19538909|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
19538910|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538911|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19538912|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19538913|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538914|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538915|NCT04883255|Hormones|hormones|mesh-ancestor
19538916|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538917|NCT04882085|Ceftazidime|ceftazidime|mesh-list
19538918|NCT04882085|Avibactam|avibactam|mesh-list
19538919|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19538920|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19538921|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538922|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19538923|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538924|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574812|NCT03969420|Cytarabine|cytarabine|mesh-list
19574813|NCT03969420|Alvocidib|alvocidib|mesh-list
19574814|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19574815|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
19574816|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574817|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574818|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
19574819|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574820|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574821|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
19574822|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538925|NCT04879134|Apomorphine|apomorphine|mesh-list
19538926|NCT04879134|Emetics|emetics|mesh-ancestor
19538927|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538928|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
19538929|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538930|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19538931|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
19538932|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
19538933|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538934|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538935|NCT04876248|Lenalidomide|lenalidomide|mesh-list
19538936|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
19538937|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538938|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19538939|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19538940|NCT04876248|Growth Substances|growth substances|mesh-ancestor
19538941|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
19538942|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538943|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19538944|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
19538945|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538946|NCT04873557|Copper|copper|mesh-list
19538947|NCT04873557|Trace Elements|trace elements|mesh-ancestor
19538948|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
19538949|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538950|NCT04859660|Tamsulosin|tamsulosin|mesh-list
19538951|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19538952|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19538953|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19538954|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
19538955|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538956|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538957|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538958|NCT04859660|Urological Agents|urological agents|mesh-ancestor
19538959|NCT04851613|Fulvestrant|fulvestrant|mesh-list
19538960|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19538961|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19538962|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19538963|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19538964|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
19538965|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19538966|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538967|NCT04847440|Tenofovir|tenofovir|mesh-list
19538968|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
19538969|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19538970|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19538971|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19538972|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19538973|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19538974|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19538975|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19538976|NCT04846881|BI 425809|bi 425809|mesh-list
19538977|NCT04846881|Nootropic Agents|nootropic agents|mesh-ancestor
19538978|NCT04846868|BI 425809|bi 425809|mesh-list
19538979|NCT04846868|Nootropic Agents|nootropic agents|mesh-ancestor
19538980|NCT04846829|Citalopram|citalopram|mesh-list
19538981|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19538982|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19538983|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19538984|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104801|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
20104802|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104803|NCT00003360|Antibodies|antibodies|mesh-list
20104804|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20104805|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
20104806|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104807|NCT00003361|Decitabine|decitabine|mesh-list
20104808|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104809|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
20604182|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
19538985|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19538986|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
19538987|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574823|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
20104810|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104811|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104812|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104813|NCT00003362|Sargramostim|sargramostim|mesh-list
20104814|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
20104815|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
20104816|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104817|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20104818|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
20104819|NCT00003364|Doxorubicin|doxorubicin|mesh-list
20104820|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104821|NCT00003364|Etoposide|etoposide|mesh-list
20104822|NCT00003364|Vincristine|vincristine|mesh-list
20104823|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104824|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
20104825|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307758|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20307759|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
20307760|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307761|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20307762|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20307763|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307764|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307765|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20307766|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19538988|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19538989|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
19538990|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19538991|NCT04844216|Lidocaine|lidocaine|mesh-list
19538992|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
19538993|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
19538994|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
19538995|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19538996|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19538997|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
19538998|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19538999|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19539000|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19539001|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19539002|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19539003|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539004|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19539005|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
19539006|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
19539007|NCT04844216|Protective Agents|protective agents|mesh-ancestor
19539008|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
19539009|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539010|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
19539011|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
19539012|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539013|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
19539014|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19539015|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539016|NCT04831047|Phenylephrine|phenylephrine|mesh-list
19539017|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
19539018|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19539019|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19539020|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19539021|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19539022|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
19539023|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19539024|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539025|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539026|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
19539027|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
19539028|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539029|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
20104826|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104827|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104828|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
20104829|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539030|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20104830|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104831|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19539031|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
19539032|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19539033|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
19539034|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19539035|NCT04831047|Protective Agents|protective agents|mesh-ancestor
19539036|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
19539037|NCT04827992|Narcotics|narcotics|mesh-ancestor
19539038|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539039|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539040|NCT04827992|Analgesics|analgesics|mesh-ancestor
19539041|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
19539042|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539043|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
19539044|NCT04825496|Fludarabine|fludarabine|mesh-list
19539045|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539046|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
19539047|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539048|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19539049|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19539050|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
19539051|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539052|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539053|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19539054|NCT04825223|Vaccines|vaccines|mesh-list
19539055|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
19539056|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539060|NCT04821622|Talazoparib|talazoparib|mesh-list
19539061|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19539062|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539063|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539064|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539065|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
19539066|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
19539067|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539068|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574824|NCT03969420|Growth Substances|growth substances|mesh-ancestor
19574825|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19574826|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574827|NCT03954041|Glyburide|glyburide|mesh-list
19574828|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19574829|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574830|NCT03950037|Albendazole|albendazole|mesh-list
19574831|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
19574832|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19574833|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574834|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
19574835|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19574836|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19574837|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574838|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574839|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574840|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574841|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574842|NCT03944772|Carboplatin|carboplatin|mesh-list
19574843|NCT03944772|Etoposide|etoposide|mesh-list
19574844|NCT03944772|Pemetrexed|pemetrexed|mesh-list
19574845|NCT03944772|Durvalumab|durvalumab|mesh-list
19574846|NCT03944772|Gefitinib|gefitinib|mesh-list
19574847|NCT03944772|Osimertinib|osimertinib|mesh-list
19574848|NCT03944772|Necitumumab|necitumumab|mesh-list
19574849|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574850|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19574851|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19574852|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104832|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104833|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104834|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104835|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104836|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104837|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604183|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20104838|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574853|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574854|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104839|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104840|NCT00003365|Curcumin|curcumin|mesh-list
20104841|NCT00003365|Sulindac|sulindac|mesh-list
20104842|NCT00003365|Quercetin|quercetin|mesh-list
20104843|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20104844|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20104845|NCT00003365|Analgesics|analgesics|mesh-ancestor
20104846|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
20104847|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539069|NCT04811014|Buprenorphine|buprenorphine|mesh-list
19539070|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19539071|NCT04811014|Naloxone|naloxone|mesh-list
19539072|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19539073|NCT04811014|Narcotics|narcotics|mesh-ancestor
19539074|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539075|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539076|NCT04811014|Analgesics|analgesics|mesh-ancestor
19539077|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
19539078|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539079|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19539080|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
19539081|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19539082|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
19539083|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539084|NCT04803877|Nivolumab|nivolumab|mesh-list
19539085|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539086|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539087|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19539088|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539089|NCT04801368|Anesthetics|anesthetics|mesh-list
19539090|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
20104848|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104849|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539091|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539092|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539093|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
19539094|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539095|NCT04798638|Osimertinib|osimertinib|mesh-list
19539096|NCT04798638|Complement Factor H|complement factor h|mesh-list
19539097|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539098|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539099|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539100|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539101|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19539102|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539103|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
19539104|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539105|NCT04797780|Azacitidine|azacitidine|mesh-list
19539106|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19539107|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
19539108|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539109|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539110|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539111|NCT04796220|Gemcitabine|gemcitabine|mesh-list
19539112|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19539113|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
19539114|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539115|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539116|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
19539117|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539118|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539119|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539120|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
19539121|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539122|NCT04792502|Lenalidomide|lenalidomide|mesh-list
19539123|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
19539124|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539125|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539126|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539127|NCT04792502|Growth Substances|growth substances|mesh-ancestor
20104850|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104851|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104852|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539128|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
20104853|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539129|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539130|NCT04790370|Heparin|heparin|mesh-list
19539131|NCT04790370|Calcium heparin|calcium heparin|mesh-list
19539132|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
19539133|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19539134|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19539135|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539136|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
19539137|NCT04782037|Calcium|calcium|mesh-list
19539138|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19539139|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539140|NCT04781192|Durvalumab|durvalumab|mesh-list
19539141|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539142|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539143|NCT04781088|Paclitaxel|paclitaxel|mesh-list
19539144|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
19539145|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19539146|NCT04781088|Lenvatinib|lenvatinib|mesh-list
19539147|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19539148|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539149|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539150|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539151|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539152|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539153|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539154|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539155|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539156|NCT04777994|Mitogens|mitogens|mesh-list
19539157|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
19539158|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539159|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539160|NCT04777994|Growth Substances|growth substances|mesh-ancestor
19539161|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539162|NCT04776993|Methimazole|methimazole|mesh-list
19539163|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
19539164|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
19539165|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539166|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539167|NCT04772001|Carboplatin|carboplatin|mesh-list
19539168|NCT04772001|Cisplatin|cisplatin|mesh-list
19539169|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539170|NCT04770896|Sorafenib|sorafenib|mesh-list
19539171|NCT04770896|Atezolizumab|atezolizumab|mesh-list
19539172|NCT04770896|Lenvatinib|lenvatinib|mesh-list
19539173|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539174|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539175|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539176|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539177|NCT04768504|Tofacitinib|tofacitinib|mesh-list
19539178|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539179|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539180|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539181|NCT04767698|Belimumab|belimumab|mesh-list
19539182|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
19539183|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539184|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
19539185|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539186|NCT04765202|Carisoprodol|carisoprodol|mesh-list
19539187|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19539188|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539189|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19539190|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539191|NCT04762082|Tadalafil|tadalafil|mesh-list
20104854|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
20104855|NCT00003365|Protective Agents|protective agents|mesh-ancestor
20104856|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20104857|NCT00003367|Vitamin E|vitamin e|mesh-list
20104858|NCT00003367|Vitamins|vitamins|mesh-ancestor
20104859|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
20104860|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104861|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
20104862|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104863|NCT00003367|Protective Agents|protective agents|mesh-ancestor
20104864|NCT00003368|Irinotecan|irinotecan|mesh-list
19539192|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
19539193|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20104865|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104866|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104867|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307767|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20307768|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20307769|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307770|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307771|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307772|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19539194|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19539195|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539196|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539197|NCT04762082|Urological Agents|urological agents|mesh-ancestor
19539198|NCT04761822|Vaccines|vaccines|mesh-list
19539199|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
19539200|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539201|NCT04757636|Aflibercept|aflibercept|mesh-list
19539202|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539203|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539204|NCT04757636|Growth Substances|growth substances|mesh-ancestor
19539205|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539206|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
19539207|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539208|NCT04757610|Ranibizumab|ranibizumab|mesh-list
19539209|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539210|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539211|NCT04757610|Growth Substances|growth substances|mesh-ancestor
19539212|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539213|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
19539214|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539215|NCT04755218|Misoprostol|misoprostol|mesh-list
19539216|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19539217|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
19539218|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19539219|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539220|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19539221|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19539222|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
19539223|NCT04751370|Nivolumab|nivolumab|mesh-list
19539224|NCT04751370|Ipilimumab|ipilimumab|mesh-list
19539225|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539226|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539227|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19539228|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539229|NCT04748991|Amiodarone|amiodarone|mesh-list
19539230|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19539231|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
19539232|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20307773|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307774|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307775|NCT00660998|Urological Agents|urological agents|mesh-ancestor
19539233|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19539234|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539235|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19539236|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19539237|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19539238|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539239|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19539240|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19539241|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19539242|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19539243|NCT04747912|Dexamethasone|dexamethasone|mesh-list
19539244|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
19539245|NCT04747912|Methotrexate|methotrexate|mesh-list
19539246|NCT04747912|Vincristine|vincristine|mesh-list
19539247|NCT04747912|Dasatinib|dasatinib|mesh-list
19539248|NCT04747912|Ponatinib|ponatinib|mesh-list
19539249|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19539250|NCT04747912|BB 1101|bb 1101|mesh-list
19539251|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539252|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
19539253|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
19539254|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539255|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539256|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20104868|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539257|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
19539258|NCT04747912|Hormones|hormones|mesh-ancestor
19539259|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539260|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539261|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539262|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
19539263|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539264|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539265|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19539266|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
19539267|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19539268|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19539269|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
19539270|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19539271|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19539272|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539273|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
19539274|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19539275|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19539276|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19539277|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539278|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539279|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539280|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539281|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539282|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19539283|NCT04746547|Dolutegravir|dolutegravir|mesh-list
19539284|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19539285|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19539286|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539287|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539288|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19539289|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19539290|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
19539291|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539292|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
19539293|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19539294|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539295|NCT04742634|Decitabine|decitabine|mesh-list
19539296|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19539297|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
19539298|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539299|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539300|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539301|NCT04740905|Aflibercept|aflibercept|mesh-list
19539302|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539303|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539304|NCT04740905|Growth Substances|growth substances|mesh-ancestor
20307776|NCT00661063|Clonidine|clonidine|mesh-list
20604184|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
20604185|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604186|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
20604187|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604188|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307777|NCT00661063|Ketamine|ketamine|mesh-list
20604189|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20307778|NCT00661063|Analgesics|analgesics|mesh-ancestor
19539305|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104869|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104870|NCT00003369|Tirapazamine|tirapazamine|mesh-list
20104871|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104872|NCT00003370|Irofulven|irofulven|mesh-list
20104873|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104874|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
20104875|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104876|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104877|NCT00003372|Topotecan|topotecan|mesh-list
20104878|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104879|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104880|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104881|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104882|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104883|NCT00003375|Vincristine|vincristine|mesh-list
20307779|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
20604190|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
20307780|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307781|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307782|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19539306|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
19539307|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574855|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19574856|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19574857|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574858|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19574859|NCT03936309|Lidocaine|lidocaine|mesh-list
19574860|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
19574861|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
19574862|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574863|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574864|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
19574865|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574866|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19574867|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19574868|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19574869|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19574870|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574871|NCT03933449|Paclitaxel|paclitaxel|mesh-list
19574872|NCT03933449|Docetaxel|docetaxel|mesh-list
19574873|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
19574874|NCT03933449|Irinotecan|irinotecan|mesh-list
19574875|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19574876|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574877|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574878|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574879|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574880|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574881|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574882|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19574883|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19574884|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574885|NCT03921242|Metformin|metformin|mesh-list
19574886|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19574887|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19574888|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19574889|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574890|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574891|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
19574892|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574893|NCT03915496|Abrocitinib|abrocitinib|mesh-list
19574894|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19574895|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574896|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574897|NCT03890666|Albuterol|albuterol|mesh-list
19574898|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19574899|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
19574900|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574901|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307783|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20307784|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
20307785|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
20307786|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20307787|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20307788|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20307789|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307790|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307791|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20307792|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
19574902|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19574903|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
19574904|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
19574905|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19574906|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19574907|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19574908|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19574909|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
19574910|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19574911|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104884|NCT00003375|Lomustine|lomustine|mesh-list
20104885|NCT00003375|Procarbazine|procarbazine|mesh-list
20104886|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104887|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104888|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539313|NCT04738695|Antibodies|antibodies|mesh-list
19539314|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
19539315|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539316|NCT04733742|Tenecteplase|tenecteplase|mesh-list
19539317|NCT04733742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19539318|NCT04733742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19539319|NCT04733742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539320|NCT04730349|Nivolumab|nivolumab|mesh-list
20104889|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104890|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104891|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104892|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20604191|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604192|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604193|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20604194|NCT02225834|Atorvastatin|atorvastatin|mesh-list
20604195|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20604196|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20604197|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
19539321|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539322|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539323|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19539324|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539325|NCT04725656|Nicotine|nicotine|mesh-list
19539326|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19539327|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
19539328|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539329|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539330|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19539331|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19539332|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
19539333|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19539334|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539339|NCT04713969|Pantoprazole|pantoprazole|mesh-list
19539340|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20604198|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604199|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19539341|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19539342|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19539343|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539344|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539345|NCT04706130|Artesunate|artesunate|mesh-list
19539346|NCT04706130|Primaquine|primaquine|mesh-list
19539347|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
19539348|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19539349|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19539350|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539351|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539352|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
20104893|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
20104894|NCT00003376|Paclitaxel|paclitaxel|mesh-list
20104895|NCT00003376|Vinblastine|vinblastine|mesh-list
20104896|NCT00003376|Carboplatin|carboplatin|mesh-list
20104897|NCT00003376|Doxorubicin|doxorubicin|mesh-list
20104898|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104899|NCT00003376|Methotrexate|methotrexate|mesh-list
20104900|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104901|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307793|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
20307794|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20307795|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19539353|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
19539354|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19539355|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
20307796|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19539356|NCT04704154|Nivolumab|nivolumab|mesh-list
20104902|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
20307797|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
19539357|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539358|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539359|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19539360|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539361|NCT04702893|Nintedanib|nintedanib|mesh-list
19539362|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539363|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539364|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539365|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539366|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19539367|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19539368|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539369|NCT04691804|Prednisone|prednisone|mesh-list
19539370|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
19539371|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539372|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
19539373|NCT04691804|Hormones|hormones|mesh-ancestor
19539374|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539375|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539376|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539377|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539378|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19539379|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539380|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539381|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
19539382|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19539387|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
19539388|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
19539389|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
19539390|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539391|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
19539392|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539393|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539394|NCT04677504|Gemcitabine|gemcitabine|mesh-list
19539395|NCT04677504|Bevacizumab|bevacizumab|mesh-list
19539396|NCT04677504|Atezolizumab|atezolizumab|mesh-list
19539397|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539398|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539399|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539400|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539401|NCT04677504|Growth Substances|growth substances|mesh-ancestor
19539402|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539403|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
19539404|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19539405|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
19539406|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539407|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
19539408|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539409|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539410|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539411|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
19539412|NCT04669782|Teriparatide|teriparatide|mesh-list
19539413|NCT04669782|Vitamin K|vitamin k|mesh-list
19539414|NCT04669782|Vitamins|vitamins|mesh-ancestor
19539415|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
19539416|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539417|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19539418|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19539419|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539420|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
19539421|NCT04669782|Coagulants|coagulants|mesh-ancestor
19539422|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19539423|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19539424|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19539425|NCT04669041|Ezetimibe|ezetimibe|mesh-list
19539426|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19539427|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19539428|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
19539429|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307798|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20307799|NCT00661076|Adefovir|adefovir|mesh-list
19539430|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19539431|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19539432|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539433|NCT04666948|Vancomycin|vancomycin|mesh-list
19539434|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19539435|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539436|NCT04666649|Venetoclax|venetoclax|mesh-list
19539437|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539438|NCT04665843|Atezolizumab|atezolizumab|mesh-list
19539439|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539440|NCT04665739|Everolimus|everolimus|mesh-list
19539441|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19539442|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539443|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539444|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
19539445|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539446|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539447|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19539448|NCT04662944|Ranibizumab|ranibizumab|mesh-list
19539449|NCT04662944|Aflibercept|aflibercept|mesh-list
19539450|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539451|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539452|NCT04662944|Growth Substances|growth substances|mesh-ancestor
19539453|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539454|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
19539455|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539456|NCT04650282|Lidocaine|lidocaine|mesh-list
19539457|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
19539458|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
19539459|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539460|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539461|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
19539462|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539463|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19539464|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19539465|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19539466|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19539467|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539468|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
19539469|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539470|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
19539471|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539472|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104903|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539473|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20104904|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104905|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539474|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
19539475|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539476|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539477|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19539478|NCT04646187|Adalimumab|adalimumab|mesh-list
19539479|NCT04646187|Infliximab|infliximab|mesh-list
19539480|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539481|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19539482|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
19539483|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19539484|NCT04643093|Ezetimibe|ezetimibe|mesh-list
19539485|NCT04643093|Pitavastatin|pitavastatin|mesh-list
19539486|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19539487|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19539488|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
19539489|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539490|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19539491|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19539492|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104906|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104907|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104908|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104909|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104910|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20104911|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
20104912|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19539493|NCT04642807|Calpastatin|calpastatin|mesh-list
19539494|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19539495|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
19539496|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539497|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307800|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20307801|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
20307802|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307803|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20307804|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20604200|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20604201|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604202|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
20604203|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
20604204|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604205|NCT02225886|Protective Agents|protective agents|mesh-ancestor
19539498|NCT04641871|Irinotecan|irinotecan|mesh-list
20307805|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308929|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539499|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19539500|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19539501|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539502|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539503|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574912|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19574913|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574914|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
19574915|NCT03844061|Rituximab|rituximab|mesh-list
19574916|NCT03844061|Belimumab|belimumab|mesh-list
19574917|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574918|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574919|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
19574920|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574921|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574922|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19574923|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19574924|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
19574925|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19574926|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19574927|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574928|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574929|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574930|NCT03838263|Cisplatin|cisplatin|mesh-list
19574931|NCT03838263|Nivolumab|nivolumab|mesh-list
19574932|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574933|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19574934|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19574935|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574936|NCT03801876|Paclitaxel|paclitaxel|mesh-list
19574937|NCT03801876|Docetaxel|docetaxel|mesh-list
19574938|NCT03801876|Carboplatin|carboplatin|mesh-list
19574939|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19574940|NCT03801876|Fluorouracil|fluorouracil|mesh-list
19574941|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19574942|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574943|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
19574944|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
19574945|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
19574946|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574947|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
19574948|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19574949|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19574950|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
19574951|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574952|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
19574953|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19574954|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574955|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19574956|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574957|NCT03771651|Aspirin|aspirin|mesh-list
19574958|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19574959|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20604206|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604207|NCT02225886|Vitamins|vitamins|mesh-ancestor
19539504|NCT04636255|Calcium|calcium|mesh-list
19539505|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19539506|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539507|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
19539508|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19539509|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539510|NCT04636086|Vitamins|vitamins|mesh-ancestor
19539511|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
19539512|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19539513|NCT04635839|Heparin|heparin|mesh-list
19539514|NCT04635839|Calcium heparin|calcium heparin|mesh-list
19539515|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
19539516|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19539517|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19539518|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539519|NCT04628988|Prednisone|prednisone|mesh-list
19539520|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
19539521|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539522|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
19539523|NCT04628988|Hormones|hormones|mesh-ancestor
19539524|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539525|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539526|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539527|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539528|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307806|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307807|NCT00661102|Capecitabine|capecitabine|mesh-list
20307808|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307809|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
20307810|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307811|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539529|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104913|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104914|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104915|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
20104916|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
20104917|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20104918|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104919|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
20104920|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104921|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20104922|NCT00003378|Gemcitabine|gemcitabine|mesh-list
20104923|NCT00003378|Paclitaxel|paclitaxel|mesh-list
20104924|NCT00003378|Carboplatin|carboplatin|mesh-list
20104925|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104926|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104927|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104928|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104929|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539530|NCT04628026|Venetoclax|venetoclax|mesh-list
19539531|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539532|NCT04619316|Trametinib|trametinib|mesh-list
19539533|NCT04619316|Dabrafenib|dabrafenib|mesh-list
19539534|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539535|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539536|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539537|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539538|NCT04619095|Psyllium|psyllium|mesh-list
19539539|NCT04619095|Cathartics|cathartics|mesh-ancestor
19539540|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19539541|NCT04616547|Edetic Acid|edetic acid|mesh-list
19539542|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
19539543|NCT04616547|Antidotes|antidotes|mesh-ancestor
19539544|NCT04616547|Protective Agents|protective agents|mesh-ancestor
19539545|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539546|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
19539547|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
19539548|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539549|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19539550|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
19539551|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19539552|NCT04616534|Gemcitabine|gemcitabine|mesh-list
19539553|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19539554|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
20104930|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574960|NCT03771651|Analgesics|analgesics|mesh-ancestor
20604208|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
20604209|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20604210|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20604211|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604212|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604213|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
20604214|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604215|NCT02226068|Cyclosporine|cyclosporine|mesh-list
20604216|NCT02226068|Cyclosporins|cyclosporins|mesh-list
20604217|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604218|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539555|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539556|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539557|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
19539558|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539559|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539560|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539561|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
19539562|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539563|NCT04613518|BMS-986165|bms-986165|mesh-list
19539564|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
19539565|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539566|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539567|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539568|NCT04612920|Acetaminophen|acetaminophen|mesh-list
19539569|NCT04612920|Ibuprofen|ibuprofen|mesh-list
19539570|NCT04612920|Oxycodone|oxycodone|mesh-list
19539571|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19539572|NCT04612920|Analgesics|analgesics|mesh-ancestor
19539573|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
19539574|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539575|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539576|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
19539577|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19539578|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539579|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19539580|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19539581|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539582|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539583|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19539584|NCT04612920|Narcotics|narcotics|mesh-ancestor
19539585|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539586|NCT04612751|Carboplatin|carboplatin|mesh-list
19539587|NCT04612751|Durvalumab|durvalumab|mesh-list
19539588|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539589|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539590|NCT04610658|Nivolumab|nivolumab|mesh-list
19539591|NCT04610658|Ipilimumab|ipilimumab|mesh-list
19539592|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539593|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539594|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19539595|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539596|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19539597|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19539598|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
19539599|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19539600|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539601|NCT04597099|Flutamide|flutamide|mesh-list
19539602|NCT04597099|Estradiol|estradiol|mesh-list
19539603|NCT04597099|Progesterone|progesterone|mesh-list
19539604|NCT04597099|Estrogens|estrogens|mesh-ancestor
19539605|NCT04597099|Hormones|hormones|mesh-ancestor
19539606|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539607|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539608|NCT04597099|Progestins|progestins|mesh-ancestor
19539609|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
19539610|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
19539611|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539612|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539613|NCT04590963|Cetuximab|cetuximab|mesh-list
19539614|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539615|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604219|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539616|NCT04582266|Remdesivir|remdesivir|mesh-list
19539617|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
19539618|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539619|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
19539620|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539621|NCT04580121|Acetaminophen|acetaminophen|mesh-list
19539622|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
19539623|NCT04580121|Promethazine|promethazine|mesh-list
19539624|NCT04580121|Dexamethasone|dexamethasone|mesh-list
19539625|NCT04580121|Dasatinib|dasatinib|mesh-list
19539626|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539627|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
19539628|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
19539629|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539630|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539631|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19539632|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
19539633|NCT04580121|Hormones|hormones|mesh-ancestor
19539634|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539635|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539636|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539637|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19539638|NCT04580121|Analgesics|analgesics|mesh-ancestor
19539639|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
19539640|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
19539641|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539642|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539643|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539644|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19539645|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19539646|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539647|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
19539648|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
19539649|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19539650|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
19539651|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
19539652|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19539653|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19539654|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
19539655|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
19539656|NCT04577716|Listerine|listerine|mesh-list
19539657|NCT04577716|Fluorides|fluorides|mesh-list
19539658|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
19539659|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
19539660|NCT04577716|Protective Agents|protective agents|mesh-ancestor
19539661|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539662|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19539663|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539664|NCT04576455|Fulvestrant|fulvestrant|mesh-list
19539665|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19539666|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539667|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539668|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19539669|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19539670|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
19539671|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539672|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539673|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19539674|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539675|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539676|NCT04576156|Imetelstat|imetelstat|mesh-list
19539677|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
19539678|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539679|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539680|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539681|NCT04576104|Metformin|metformin|mesh-list
19539682|NCT04576104|Megestrol|megestrol|mesh-list
19539683|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
19539684|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19539685|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539686|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19539687|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19539688|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19539689|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
19539690|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19539691|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19539692|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19539693|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539694|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539695|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
19539696|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19539697|NCT04575844|Liraglutide|liraglutide|mesh-list
19539698|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19539699|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539700|NCT04575844|Incretins|incretins|mesh-ancestor
19539701|NCT04575844|Hormones|hormones|mesh-ancestor
19539702|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539703|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
19539704|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19539705|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539706|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19539707|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539708|NCT04564547|Islatravir|islatravir|mesh-list
19539709|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
19539710|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539711|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539712|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539713|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20104931|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104932|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
20104933|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
20104934|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20104935|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539714|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19539715|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19539716|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
19539717|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
19539718|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539719|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
19539720|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19539721|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574961|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
19574962|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19574963|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574964|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19574965|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20104936|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104937|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
20104938|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574966|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19574967|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19574968|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574969|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19574970|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19574971|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574972|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
19574973|NCT03747042|Letrozole|letrozole|mesh-list
19574974|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19574975|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19574976|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19574977|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19574978|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19574979|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19574980|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
19574981|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19574982|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574983|NCT03739203|Cariprazine|cariprazine|mesh-list
19574984|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19574985|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574986|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574987|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574988|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574989|NCT03738215|Cariprazine|cariprazine|mesh-list
19574990|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19574991|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19574992|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19574993|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19574994|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19574995|NCT03735901|Levodopa|levodopa|mesh-list
19574996|NCT03735901|Carbidopa|carbidopa|mesh-list
20104939|NCT00003379|Paclitaxel|paclitaxel|mesh-list
20104940|NCT00003379|Cisplatin|cisplatin|mesh-list
19539722|NCT04547439|Melatonin|melatonin|mesh-list
19539723|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
19539724|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539725|NCT04547439|Protective Agents|protective agents|mesh-ancestor
19539726|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539727|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539728|NCT04546009|Letrozole|letrozole|mesh-list
19539729|NCT04546009|Palbociclib|palbociclib|mesh-list
19539730|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539731|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19539732|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19539733|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539734|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539735|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19539736|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
19539737|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539738|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539739|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539740|NCT04543942|Ethanol|ethanol|mesh-list
19539741|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19539742|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539743|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539744|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539745|NCT04540705|Nivolumab|nivolumab|mesh-list
20104941|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104942|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104943|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104944|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
20104945|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
20104946|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104947|NCT00003380|Doxorubicin|doxorubicin|mesh-list
20104948|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19539746|NCT04540705|Axitinib|axitinib|mesh-list
19539747|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539748|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539749|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19539750|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539751|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539752|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539753|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
19539754|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19539755|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
19539756|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539757|NCT04525547|Nintedanib|nintedanib|mesh-list
19539758|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539759|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539760|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539761|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539762|NCT04524689|Carboplatin|carboplatin|mesh-list
19539763|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
19539764|NCT04524689|Pemetrexed|pemetrexed|mesh-list
19539765|NCT04524689|Maytansine|maytansine|mesh-list
19539766|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104949|NCT00003380|Etoposide|etoposide|mesh-list
20307812|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307813|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
19539767|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539768|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539769|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539770|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19539771|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19539772|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19539773|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539774|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539775|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539776|NCT04522544|Durvalumab|durvalumab|mesh-list
19539777|NCT04522544|Tremelimumab|tremelimumab|mesh-list
19539778|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539779|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539780|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19539781|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
19539782|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20104950|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20307814|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19539783|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19539784|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19539785|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539786|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539787|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19539788|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539789|NCT04520451|Prednisone|prednisone|mesh-list
19539790|NCT04520451|Prednisolone|prednisolone|mesh-list
19539791|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
19539792|NCT04520451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539793|NCT04520451|Hormones|hormones|mesh-ancestor
19539794|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19539795|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539796|NCT04520451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19539797|NCT04520451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539798|NCT04515394|Cetuximab|cetuximab|mesh-list
19539799|NCT04515394|Tepotinib|tepotinib|mesh-list
19539800|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539801|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539802|NCT04515134|Ubiquinone|ubiquinone|mesh-list
19539803|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
19539804|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
19539805|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539806|NCT04515134|Vitamins|vitamins|mesh-ancestor
19539807|NCT04510844|Evolocumab|evolocumab|mesh-list
19539808|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19539809|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19539810|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
19539811|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539812|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19539813|NCT04509674|Empagliflozin|empagliflozin|mesh-list
19539814|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19539815|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539816|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19539817|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539818|NCT04496063|Ustekinumab|ustekinumab|mesh-list
19539819|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
19539820|NCT04486352|Bevacizumab|bevacizumab|mesh-list
19539821|NCT04486352|Trastuzumab|trastuzumab|mesh-list
19539822|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19539823|NCT04486352|Atezolizumab|atezolizumab|mesh-list
19539824|NCT04486352|Talazoparib|talazoparib|mesh-list
19539825|NCT04486352|Maytansine|maytansine|mesh-list
19539826|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19539827|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539828|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539829|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539830|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539831|NCT04486352|Growth Substances|growth substances|mesh-ancestor
19539832|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539833|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
19539834|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
19539835|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19539836|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539837|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539838|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19539839|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539840|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539841|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539842|NCT04483960|Nafamostat|nafamostat|mesh-list
19539843|NCT04483960|Enoxaparin|enoxaparin|mesh-list
19539844|NCT04483960|Dalteparin|dalteparin|mesh-list
19539845|NCT04483960|Tinzaparin|tinzaparin|mesh-list
19539846|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19539847|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
19539848|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19539849|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19539850|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539851|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19539852|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19539853|NCT04483960|Analgesics|analgesics|mesh-ancestor
19539854|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
19539855|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539856|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539857|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19539858|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19539859|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
19539860|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539861|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19539862|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19539863|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19539864|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539865|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
19539866|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19539867|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19539868|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539869|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539870|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
19539871|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539872|NCT04480554|Naltrexone|naltrexone|mesh-list
19539873|NCT04480554|Buprenorphine|buprenorphine|mesh-list
19539874|NCT04480554|Methadone|methadone|mesh-list
19539875|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19539876|NCT04480554|Naloxone|naloxone|mesh-list
19539877|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20307815|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307816|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539878|NCT04480554|Narcotics|narcotics|mesh-ancestor
19539879|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539880|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539881|NCT04480554|Analgesics|analgesics|mesh-ancestor
19539882|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
19539883|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19539884|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19539885|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19539886|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
19539887|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
19539888|NCT04476550|Lenograstim|lenograstim|mesh-list
19539889|NCT04476550|Sargramostim|sargramostim|mesh-list
19539890|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19539891|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
19539892|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539895|NCT04471428|Docetaxel|docetaxel|mesh-list
19539896|NCT04471428|Atezolizumab|atezolizumab|mesh-list
19539897|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539898|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539899|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539900|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539901|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539902|NCT04461639|Factor VIII|factor viii|mesh-list
19539903|NCT04461639|Coagulants|coagulants|mesh-ancestor
19539904|NCT04458909|Gemcitabine|gemcitabine|mesh-list
19539905|NCT04458909|Cisplatin|cisplatin|mesh-list
19539906|NCT04458909|Carboplatin|carboplatin|mesh-list
19539907|NCT04458909|Nivolumab|nivolumab|mesh-list
19539908|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539909|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19539910|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
19539911|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539912|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
19539913|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539914|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539915|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19539916|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
19539917|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539918|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539919|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19539920|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
19539921|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19539922|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19539923|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539924|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539925|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19539926|NCT04449536|Mesna|mesna|mesh-list
19539927|NCT04449536|Protective Agents|protective agents|mesh-ancestor
19539928|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539929|NCT04447911|Empagliflozin|empagliflozin|mesh-list
19539930|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19539931|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539932|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19574997|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20604220|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
19539933|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539934|NCT04435015|Camostat|camostat|mesh-list
19539935|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
19539936|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539937|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539938|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19539939|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20307817|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307818|NCT00661115|Urological Agents|urological agents|mesh-ancestor
20307819|NCT00661154|Bevacizumab|bevacizumab|mesh-list
20307820|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539940|NCT04427072|Docetaxel|docetaxel|mesh-list
19539941|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539942|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539943|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539944|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539945|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539946|NCT04423718|Aflibercept|aflibercept|mesh-list
19539947|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19539948|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19539949|NCT04423718|Growth Substances|growth substances|mesh-ancestor
19539950|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539951|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
19539952|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539953|NCT04421560|Rituximab|rituximab|mesh-list
20307821|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307822|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20307823|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20307824|NCT00661154|Growth Substances|growth substances|mesh-ancestor
20307825|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307826|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
20307827|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20307828|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307829|NCT00661180|Sorafenib|sorafenib|mesh-list
20307830|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307831|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539954|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
19539955|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19539956|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539957|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
19539958|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539959|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19574998|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19574999|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
19575000|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575001|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575002|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575003|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19575004|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575005|NCT03725007|Upadacitinib|upadacitinib|mesh-list
19575006|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19575007|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575008|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575009|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575010|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575011|NCT03703856|Memantine|memantine|mesh-list
19575012|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20307832|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307833|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307834|NCT00661206|Clopidogrel|clopidogrel|mesh-list
20307835|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20307836|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20307837|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20307838|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19575013|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19575014|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
19575015|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575016|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575017|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575018|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20307839|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
20307840|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307841|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539960|NCT04417621|Trametinib|trametinib|mesh-list
19539961|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539962|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539963|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539964|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539965|NCT04414228|Anesthetics|anesthetics|mesh-list
19539966|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19539967|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539968|NCT04413201|Osimertinib|osimertinib|mesh-list
19539969|NCT04413201|Afatinib|afatinib|mesh-list
19539970|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539971|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19539972|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19539973|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539974|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19539975|NCT04409873|Listerine|listerine|mesh-list
19539976|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
19539977|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
20307842|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307843|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307844|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307845|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307846|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19539978|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19539979|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539980|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
19539981|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
19539982|NCT04407754|Inositol|inositol|mesh-list
19539983|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
19539984|NCT04407754|Vitamins|vitamins|mesh-ancestor
19539985|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
19539986|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19539987|NCT04404140|Docetaxel|docetaxel|mesh-list
19539988|NCT04404140|Atezolizumab|atezolizumab|mesh-list
19539989|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19539990|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19539991|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19539992|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19539993|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19539994|NCT04404049|UB-421|ub-421|mesh-list
19539995|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19539996|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
19539997|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19539998|NCT04400539|Nivolumab|nivolumab|mesh-list
19539999|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540000|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540001|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540002|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540003|NCT04395248|Anesthetics|anesthetics|mesh-list
19540004|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540005|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540006|NCT04387617|Cannabidiol|cannabidiol|mesh-list
19540007|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
19540008|NCT04384562|Methylphenidate|methylphenidate|mesh-list
19540009|NCT04384562|Reboxetine|reboxetine|mesh-list
19540010|NCT04384562|Nicotine|nicotine|mesh-list
19540011|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19540012|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
19540013|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540014|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540015|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19540016|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19540017|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
20104951|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104952|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104953|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20104954|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104955|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104956|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104957|NCT00003382|Gemcitabine|gemcitabine|mesh-list
20104958|NCT00003382|Topotecan|topotecan|mesh-list
20104959|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20104960|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
20104961|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104962|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104963|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
20104964|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540018|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540019|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540020|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19540021|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19540022|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19540023|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19540024|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
19540025|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
19540026|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19540027|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20104965|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104966|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104967|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
20104968|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104969|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20104970|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19540028|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
19540029|NCT04374630|Paclitaxel|paclitaxel|mesh-list
19540030|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540031|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540032|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540033|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540034|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540035|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540036|NCT04344717|Apixaban|apixaban|mesh-list
19540037|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19540038|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
19540039|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19540040|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
19540041|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540042|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540043|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
19540044|NCT04338269|Atezolizumab|atezolizumab|mesh-list
19540045|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540046|NCT04338165|Evolocumab|evolocumab|mesh-list
19540047|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19540048|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19540049|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
20104971|NCT00003385|Paclitaxel|paclitaxel|mesh-list
19540050|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540051|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19540052|NCT04334759|Cisplatin|cisplatin|mesh-list
19540053|NCT04334759|Carboplatin|carboplatin|mesh-list
19540054|NCT04334759|Pemetrexed|pemetrexed|mesh-list
19540055|NCT04334759|Durvalumab|durvalumab|mesh-list
19540056|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540057|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540058|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540059|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19540060|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19540061|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540062|NCT04329949|Paclitaxel|paclitaxel|mesh-list
19540063|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540064|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540065|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540066|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540067|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540068|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540069|NCT04329442|Tenofovir|tenofovir|mesh-list
19540070|NCT04329442|Emtricitabine|emtricitabine|mesh-list
19540071|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
19540072|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540073|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19540074|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19540075|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540076|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540077|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19540078|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19540079|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19540080|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19540081|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19540082|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19540083|NCT04321330|Atezolizumab|atezolizumab|mesh-list
20104972|NCT00003385|Carboplatin|carboplatin|mesh-list
20307847|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540084|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540085|NCT04317105|Nivolumab|nivolumab|mesh-list
19540086|NCT04317105|Ipilimumab|ipilimumab|mesh-list
19540087|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540088|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540089|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540090|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540091|NCT04310930|Azithromycin|azithromycin|mesh-list
19540092|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
20104973|NCT00003385|Doxorubicin|doxorubicin|mesh-list
20104974|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20104975|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540093|NCT04310930|Clarithromycin|clarithromycin|mesh-list
19540094|NCT04310930|Doxycycline|doxycycline|mesh-list
19540095|NCT04310930|Linezolid|linezolid|mesh-list
19540096|NCT04310930|Imipenem|imipenem|mesh-list
19540097|NCT04310930|Amikacin|amikacin|mesh-list
20104976|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104977|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
20104978|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
20307848|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307849|NCT00661219|Urological Agents|urological agents|mesh-ancestor
20307850|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307851|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307852|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307853|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307854|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307855|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307856|NCT00661297|Urological Agents|urological agents|mesh-ancestor
20307857|NCT00661336|Melphalan|melphalan|mesh-list
20307858|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
19540098|NCT04310930|Ethambutol|ethambutol|mesh-list
19540099|NCT04310930|Rifabutin|rifabutin|mesh-list
19540100|NCT04310930|Tigecycline|tigecycline|mesh-list
19540101|NCT04310930|Bedaquiline|bedaquiline|mesh-list
19540102|NCT04310930|Clofazimine|clofazimine|mesh-list
19540103|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19540104|NCT04310930|Cefoxitin|cefoxitin|mesh-list
19540105|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19540106|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540107|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19540108|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19540109|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540110|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540111|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540112|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19540113|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20307859|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20307860|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
20307861|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307862|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307863|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20307864|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307865|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
20307866|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307867|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
20307868|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20307869|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307870|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20307871|NCT00661336|Protective Agents|protective agents|mesh-ancestor
20307872|NCT00661349|Ritonavir|ritonavir|mesh-list
20307873|NCT00661349|Lopinavir|lopinavir|mesh-list
20307874|NCT00661349|Nevirapine|nevirapine|mesh-list
20307875|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20307876|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20307877|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
20307878|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307879|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307880|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20307881|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20307882|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
19540114|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19540115|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
19540116|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19540117|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20104979|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
20307883|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307884|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19540118|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
19540119|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19540120|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19540121|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
19540122|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19540123|NCT04310930|Renal Agents|renal agents|mesh-ancestor
19540124|NCT04308863|Chitosan|chitosan|mesh-list
20307885|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20307886|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20307887|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20307888|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20307889|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20307890|NCT00661375|Sorafenib|sorafenib|mesh-list
20307891|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307892|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20307893|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307894|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307895|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
20604221|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104980|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104981|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20104982|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20104983|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20604222|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
20604223|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604224|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
20604225|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604226|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20604227|NCT02226276|Copper|copper|mesh-list
20604228|NCT02226276|Trastuzumab|trastuzumab|mesh-list
20604229|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20604230|NCT02226276|Maytansine|maytansine|mesh-list
20604231|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20604232|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
19540125|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540126|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19540127|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19540128|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
19540129|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19540130|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
19540131|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
19540132|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
19540133|NCT04308863|Coagulants|coagulants|mesh-ancestor
19540134|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
19540135|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19540136|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
19540137|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540138|NCT04300920|Expectorants|expectorants|mesh-ancestor
19540139|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
19540140|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19540141|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
19540142|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540143|NCT04300920|Protective Agents|protective agents|mesh-ancestor
19540144|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540145|NCT04300920|Antidotes|antidotes|mesh-ancestor
19540146|NCT04285580|Bimatoprost|bimatoprost|mesh-list
19540147|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19540148|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
19540149|NCT04284787|Azacitidine|azacitidine|mesh-list
19540150|NCT04284787|Venetoclax|venetoclax|mesh-list
19540151|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540152|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104984|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104985|NCT00003386|Paclitaxel|paclitaxel|mesh-list
20104986|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
20104987|NCT00003386|Carboplatin|carboplatin|mesh-list
20104988|NCT00003386|Vaccines|vaccines|mesh-list
20104989|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
20104990|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
20104991|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20104992|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20104993|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20104994|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540153|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540154|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
20104995|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540155|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540156|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104996|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
20307896|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
20307897|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307898|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307899|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307900|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307901|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307902|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307903|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307904|NCT00661596|Urological Agents|urological agents|mesh-ancestor
20307905|NCT00661635|Valdecoxib|valdecoxib|mesh-list
20307906|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20307907|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20307908|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307909|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307910|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20307911|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20307912|NCT00661635|Analgesics|analgesics|mesh-ancestor
20307913|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
20307914|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307915|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307916|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307917|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307918|NCT00661648|Pancrelipase|pancrelipase|mesh-list
20307919|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20307920|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20307921|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
20307922|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20307923|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20307924|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20104997|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20104998|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20104999|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105000|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105001|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
20105002|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105003|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20105004|NCT00003387|Paclitaxel|paclitaxel|mesh-list
20105005|NCT00003387|Carboplatin|carboplatin|mesh-list
20105006|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105007|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105008|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105009|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105010|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105011|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105012|NCT00003388|Cytarabine|cytarabine|mesh-list
20105013|NCT00003388|Prednisone|prednisone|mesh-list
20105014|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
20105015|NCT00003388|Doxorubicin|doxorubicin|mesh-list
20105016|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20105017|NCT00003388|Methotrexate|methotrexate|mesh-list
19575019|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19575020|NCT03699995|Lidocaine|lidocaine|mesh-list
19575021|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
19575022|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
19575023|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575024|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575025|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
19575026|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575027|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19575028|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19575029|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19575030|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19575031|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575032|NCT03689946|Listerine|listerine|mesh-list
19575033|NCT03689946|Evolocumab|evolocumab|mesh-list
19575034|NCT03689946|Fluorides|fluorides|mesh-list
19575035|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
19575036|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
20105018|NCT00003388|Vincristine|vincristine|mesh-list
20105019|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105020|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
19575037|NCT03689946|Protective Agents|protective agents|mesh-ancestor
19540157|NCT04280692|Lumefantrine|lumefantrine|mesh-list
19540158|NCT04280692|Artemether|artemether|mesh-list
19540159|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
19540160|NCT04280692|Piperaquine|piperaquine|mesh-list
19540161|NCT04280692|Primaquine|primaquine|mesh-list
19540162|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
19540163|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19540164|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19540165|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
19540166|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19540167|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19540168|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540169|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19540170|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540171|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540172|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19540173|NCT04280692|Renal Agents|renal agents|mesh-ancestor
19540174|NCT04279847|INCB057643|incb057643|mesh-list
19540175|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540176|NCT04276298|Metronidazole|metronidazole|mesh-list
19540177|NCT04276298|Lidocaine|lidocaine|mesh-list
19540178|NCT04276298|Diltiazem|diltiazem|mesh-list
19540179|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
19540180|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
19540181|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540182|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540183|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
19540184|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540185|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19540186|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19540187|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19540188|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19540189|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540190|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540191|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19540192|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19540193|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19540194|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19540195|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19540196|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19540197|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
19540198|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
19540199|NCT04273880|Methylphenidate|methylphenidate|mesh-list
19540200|NCT04273880|Vitamins|vitamins|mesh-ancestor
19540201|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
19540202|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540203|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19540204|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19540205|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19540206|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19540207|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540208|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
19540209|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540210|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
19540211|NCT04273880|Protective Agents|protective agents|mesh-ancestor
20105021|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105022|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105023|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105024|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
20105025|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105026|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105027|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105028|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105029|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105030|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19540212|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
19540213|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540214|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540215|NCT04266301|Azacitidine|azacitidine|mesh-list
19540216|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540217|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
19540218|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540219|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540220|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540221|NCT04260464|PF-06700841|pf-06700841|mesh-list
19540222|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19540223|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540224|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540225|NCT04260412|Psyllium|psyllium|mesh-list
19540226|NCT04260412|Cathartics|cathartics|mesh-ancestor
19540227|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19540228|NCT04257448|Gemcitabine|gemcitabine|mesh-list
19540229|NCT04257448|Paclitaxel|paclitaxel|mesh-list
19540230|NCT04257448|Lenalidomide|lenalidomide|mesh-list
19540231|NCT04257448|Azacitidine|azacitidine|mesh-list
19540232|NCT04257448|Durvalumab|durvalumab|mesh-list
19540233|NCT04257448|Romidepsin|romidepsin|mesh-list
19540234|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540235|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540236|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540237|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540238|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540239|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540240|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540241|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
19540242|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
19540243|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540244|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540245|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540246|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
19540247|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540248|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19540249|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19540250|NCT04257448|Growth Substances|growth substances|mesh-ancestor
19540251|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
19540252|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540253|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19540254|NCT04247867|Psyllium|psyllium|mesh-list
19540255|NCT04247867|Cathartics|cathartics|mesh-ancestor
19540256|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19540257|NCT04238390|Meropenem|meropenem|mesh-list
19540258|NCT04238390|Tazobactam|tazobactam|mesh-list
19540259|NCT04238390|Ceftolozane|ceftolozane|mesh-list
19540260|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19540261|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19540262|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540263|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19540264|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540265|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540266|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19540267|NCT04238390|Renal Agents|renal agents|mesh-ancestor
19540268|NCT04236830|Fluorides|fluorides|mesh-list
19540269|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
19540270|NCT04236830|Protective Agents|protective agents|mesh-ancestor
19540271|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540272|NCT04232969|Exenatide|exenatide|mesh-list
19540273|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19540274|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540275|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19540276|NCT04232969|Incretins|incretins|mesh-ancestor
19540277|NCT04232969|Hormones|hormones|mesh-ancestor
19540278|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19540279|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
19540280|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19540281|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
19540282|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540283|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
19540284|NCT04219722|Protective Agents|protective agents|mesh-ancestor
19540285|NCT04216797|Diazepam|diazepam|mesh-list
19540286|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19540287|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
19540288|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
19540289|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
19540290|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540291|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540292|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19540293|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19540294|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540295|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19540296|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19540297|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19540298|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19540299|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19540300|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19540301|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
19540302|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
19540303|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
19540304|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
20307925|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307926|NCT00661700|Urological Agents|urological agents|mesh-ancestor
20307927|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20307928|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20307929|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
19540305|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540306|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105031|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105032|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105033|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
20105034|NCT00003388|Hormones|hormones|mesh-ancestor
20105035|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105036|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105037|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20105038|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
20105039|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20105040|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105041|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
20105042|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105043|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20105044|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20105045|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
20105046|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105047|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105048|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105049|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105050|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105051|NCT00003390|Irofulven|irofulven|mesh-list
20105052|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105053|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
19540330|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
19540331|NCT04210505|Povidone|povidone|mesh-list
19540332|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
20307930|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307931|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307932|NCT00661765|Varenicline|varenicline|mesh-list
20105054|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105055|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105056|NCT00003391|Antibodies|antibodies|mesh-list
20105057|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20105058|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
20105059|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120481|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120482|NCT00006366|Fluorouracil|fluorouracil|mesh-list
20120483|NCT00006366|Irinotecan|irinotecan|mesh-list
20120484|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
20120485|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120486|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120487|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120488|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120489|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
20120490|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120491|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20120492|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120493|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120494|NCT00006367|Cytarabine|cytarabine|mesh-list
20120495|NCT00006367|Busulfan|busulfan|mesh-list
20120496|NCT00006367|Idarubicin|idarubicin|mesh-list
19540333|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
19540334|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20120497|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120498|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
19540335|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540336|NCT04210037|Paclitaxel|paclitaxel|mesh-list
19540337|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540338|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540339|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540340|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540341|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540342|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540343|NCT04205812|Paclitaxel|paclitaxel|mesh-list
19540344|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19540345|NCT04205812|Carboplatin|carboplatin|mesh-list
19540346|NCT04205812|Pemetrexed|pemetrexed|mesh-list
19540347|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540348|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540349|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540350|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540351|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540352|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540353|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540354|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19540355|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19540356|NCT04205552|Nivolumab|nivolumab|mesh-list
19540357|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19540358|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540359|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540360|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540361|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540362|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
19540363|NCT04166877|Analgesics|analgesics|mesh-ancestor
19540364|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
19540365|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540366|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540367|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
19540368|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540369|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19540370|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
19540371|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19540372|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19540373|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540374|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19540375|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
19540376|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19540377|NCT04166409|Carboplatin|carboplatin|mesh-list
19540378|NCT04166409|Vincristine|vincristine|mesh-list
19540379|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540380|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540381|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540382|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540383|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540384|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540385|NCT04166292|Lidocaine|lidocaine|mesh-list
19540386|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
19540387|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
19540388|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540389|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540390|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
19540391|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540392|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19540393|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19540394|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19540395|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19540396|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105060|NCT00003392|Paclitaxel|paclitaxel|mesh-list
20105061|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
20105062|NCT00003392|Carboplatin|carboplatin|mesh-list
20105063|NCT00003392|Melphalan|melphalan|mesh-list
20105064|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20307933|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19540397|NCT04158141|Cisplatin|cisplatin|mesh-list
19540398|NCT04158141|Carboplatin|carboplatin|mesh-list
19540399|NCT04158141|Pemetrexed|pemetrexed|mesh-list
19540400|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540401|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540402|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540403|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19540404|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19540405|NCT04156087|Gemcitabine|gemcitabine|mesh-list
20105065|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307934|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20307935|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
19540406|NCT04156087|Durvalumab|durvalumab|mesh-list
19540407|NCT04156087|Tremelimumab|tremelimumab|mesh-list
19540408|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540409|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
19540410|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540411|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540412|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
20307936|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20307937|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307938|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307939|NCT00661856|Genistein|genistein|mesh-list
20307940|NCT00661856|Daidzein|daidzein|mesh-list
19540413|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540414|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540415|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540416|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
19540417|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540418|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540419|NCT04156074|Vitamin D|vitamin d|mesh-list
19540420|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
19540421|NCT04156074|Vitamins|vitamins|mesh-list
19540422|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
19540423|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540424|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19540425|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19575038|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575039|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19575040|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575041|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19575042|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19575043|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
19575044|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575045|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19575046|NCT03664180|Heparin|heparin|mesh-list
19575047|NCT03664180|Calcium heparin|calcium heparin|mesh-list
19575048|NCT03664180|Enoxaparin|enoxaparin|mesh-list
19575049|NCT03664180|Hirudins|hirudins|mesh-list
19575050|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
19575051|NCT03664180|Bivalirudin|bivalirudin|mesh-list
19575052|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
19575053|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19575054|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19575055|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575056|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
19575057|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19575058|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
19575059|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575060|NCT03612713|Oxycodone|oxycodone|mesh-list
19575061|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19575062|NCT03612713|Narcotics|narcotics|mesh-ancestor
19575063|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575064|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575065|NCT03612713|Analgesics|analgesics|mesh-ancestor
19575066|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
19575067|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575068|NCT03601923|Niraparib|niraparib|mesh-list
19575069|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19575070|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575071|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575072|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575073|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
19575074|NCT03600909|Busulfan|busulfan|mesh-list
19575075|NCT03600909|Fludarabine|fludarabine|mesh-list
19575076|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19575077|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
19575078|NCT03600909|Sargramostim|sargramostim|mesh-list
19575079|NCT03600909|Lenograstim|lenograstim|mesh-list
19575080|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575081|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
19575082|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307941|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20307942|NCT00661856|Protective Agents|protective agents|mesh-ancestor
19575083|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575084|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575085|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
19575086|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575087|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540426|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19540427|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540428|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19540429|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540430|NCT04145115|Nivolumab|nivolumab|mesh-list
19540431|NCT04145115|Ipilimumab|ipilimumab|mesh-list
19540432|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540433|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540434|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540435|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540436|NCT04132791|Aspirin|aspirin|mesh-list
19540437|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19540438|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19540439|NCT04132791|Analgesics|analgesics|mesh-ancestor
19540440|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
19540441|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540442|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307943|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307944|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20307945|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20307946|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540443|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19540444|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540445|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19540446|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19540447|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307947|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307948|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
20307949|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20307950|NCT00661856|Estrogens|estrogens|mesh-ancestor
20307951|NCT00661856|Hormones|hormones|mesh-ancestor
20105066|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105067|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105068|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540448|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19540449|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19540450|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540451|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
19540452|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19540453|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19540454|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540455|NCT04122170|Aspirin|aspirin|mesh-list
19540456|NCT04122170|Ticagrelor|ticagrelor|mesh-list
19540457|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19540458|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19540459|NCT04122170|Analgesics|analgesics|mesh-ancestor
19540460|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
19540461|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540462|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540463|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19540464|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540465|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19540466|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19540467|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540468|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19540469|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19540470|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540471|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
19540472|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19540473|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19540474|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19540475|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
19540476|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540477|NCT04117763|Empagliflozin|empagliflozin|mesh-list
19540478|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19540479|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540480|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20105069|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105070|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105071|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
20105072|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307952|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307953|NCT00661973|Budesonide|budesonide|mesh-list
19540481|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540482|NCT04117451|Propolis|propolis|mesh-list
19540483|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540484|NCT04109924|Trifluridine|trifluridine|mesh-list
19540485|NCT04109924|Bevacizumab|bevacizumab|mesh-list
19540486|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19540487|NCT04109924|Irinotecan|irinotecan|mesh-list
19540488|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
19540489|NCT04109924|Antibodies|antibodies|mesh-list
19540490|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
19540491|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19540492|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540493|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19540494|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19540495|NCT04109924|Growth Substances|growth substances|mesh-ancestor
19540496|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540497|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
19540498|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
19540499|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19540500|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19540501|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540502|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540503|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
19540504|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
19540505|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540506|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540507|NCT04096391|Analgesics|analgesics|mesh-list
19540508|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
19540509|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540510|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540511|NCT04094558|Lactulose|lactulose|mesh-list
19540512|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19540513|NCT04093362|Gemcitabine|gemcitabine|mesh-list
19540514|NCT04093362|Futibatinib|futibatinib|mesh-list
19540515|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540516|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540517|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
19540518|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540519|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
19540520|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540521|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540522|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540523|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
19540524|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540525|NCT04093024|Nintedanib|nintedanib|mesh-list
19540526|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540527|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19540528|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540529|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105073|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20307954|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20307955|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19540530|NCT04091386|Factor VIII|factor viii|mesh-list
19540531|NCT04091386|Coagulants|coagulants|mesh-ancestor
19540541|NCT04084106|Amoxicillin|amoxicillin|mesh-list
19540542|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
19540543|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
19540544|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19540545|NCT04084106|Penicillin V|penicillin v|mesh-list
19540546|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19540547|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540548|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540549|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540550|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19540551|NCT04083157|Imiquimod|imiquimod|mesh-list
19540552|NCT04083157|Vaccines|vaccines|mesh-list
19540553|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
19540554|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540555|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20307956|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
20307957|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20307958|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540556|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540557|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
19540558|NCT04074330|Rituximab|rituximab|mesh-list
19540559|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540560|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540561|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
19540562|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540563|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540564|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
19540565|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540566|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540567|NCT04072952|Palbociclib|palbociclib|mesh-list
19540568|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540569|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19540570|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540571|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540572|NCT04072341|Propolis|propolis|mesh-list
19540573|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540574|NCT04071821|Cetirizine|cetirizine|mesh-list
19540575|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19540576|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19540577|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19540578|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
20307959|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19540579|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
19540580|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540581|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540582|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540583|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19540584|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
19540585|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19540586|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
19540587|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19540588|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540589|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19540590|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19540591|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540592|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19540593|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
19540594|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540595|NCT04060394|Prednisone|prednisone|mesh-list
19540596|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19540597|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
19540598|NCT04060394|Hormones|hormones|mesh-ancestor
19540599|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19540600|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540601|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19540602|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540603|NCT04047836|Nicotine|nicotine|mesh-list
19540604|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19540605|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
19540606|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540607|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540608|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19540609|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19540610|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
19540611|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540612|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540613|NCT04047641|Cytarabine|cytarabine|mesh-list
19540614|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19540615|NCT04047641|Idarubicin|idarubicin|mesh-list
19540616|NCT04047641|Cladribine|cladribine|mesh-list
19540617|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540618|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
19540619|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540620|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540621|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
19540622|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540623|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540624|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
20307960|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
19540625|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540626|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19540627|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19540628|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19540629|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540630|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
19540631|NCT04046094|Vitamins|vitamins|mesh-ancestor
19540632|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
19540633|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540634|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
19540635|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540636|NCT04046094|Protective Agents|protective agents|mesh-ancestor
19540637|NCT04042753|Nivolumab|nivolumab|mesh-list
19540638|NCT04042753|Ipilimumab|ipilimumab|mesh-list
19540639|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540640|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540641|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540642|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540643|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19540644|NCT04034927|Olaparib|olaparib|mesh-list
19540645|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19540646|NCT04034927|Tremelimumab|tremelimumab|mesh-list
19540647|NCT04034927|Ipilimumab|ipilimumab|mesh-list
19540648|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540649|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540650|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540651|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540652|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540653|NCT04027348|Dexamethasone|dexamethasone|mesh-list
19540654|NCT04027348|Octreotide|octreotide|mesh-list
19540655|NCT04027348|Metoclopramide|metoclopramide|mesh-list
19540656|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19540657|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
19540658|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
19540659|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540660|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540661|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19540662|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
19540663|NCT04027348|Hormones|hormones|mesh-ancestor
19540664|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19540665|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19540666|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540667|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19540668|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19540669|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
19540670|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540671|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575088|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19575089|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19575090|NCT03563560|Cytarabine|cytarabine|mesh-list
19575091|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
19575092|NCT03563560|Alvocidib|alvocidib|mesh-list
19575093|NCT03563560|Daunorubicin|daunorubicin|mesh-list
19575094|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19575095|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
19575096|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575097|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575098|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
19575099|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575100|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575101|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
19575102|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575103|NCT03563560|Analgesics|analgesics|mesh-ancestor
19575104|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
19575105|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575106|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19575107|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19575108|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575109|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
19575110|NCT03563560|Growth Substances|growth substances|mesh-ancestor
19575111|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575112|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19575113|NCT03551691|Omeprazole|omeprazole|mesh-list
19575114|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19575115|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19575116|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19540672|NCT03998176|Tenofovir|tenofovir|mesh-list
19540673|NCT03998176|Emtricitabine|emtricitabine|mesh-list
19540674|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19540675|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
19540676|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540677|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19540678|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19540679|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540680|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540681|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19540682|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19540683|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
19540684|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19540685|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540686|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540687|NCT03994627|Olaratumab|olaratumab|mesh-list
19540688|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540689|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
19540690|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
19540691|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19540692|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
19540693|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540694|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307961|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
20307962|NCT00661973|Hormones|hormones|mesh-ancestor
20307963|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20307964|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
20307965|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20307966|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307967|NCT00662220|Ribavirin|ribavirin|mesh-list
20307968|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20307969|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
19540695|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540696|NCT03978611|Ipilimumab|ipilimumab|mesh-list
19540697|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540698|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540699|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540700|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540701|NCT03956680|Nivolumab|nivolumab|mesh-list
19540702|NCT03956680|Ipilimumab|ipilimumab|mesh-list
19540703|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540704|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540705|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19540706|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540707|NCT03954366|Rucaparib|rucaparib|mesh-list
19540708|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19540709|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
19540710|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
19540711|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19540712|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19540713|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
20307970|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
20307971|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307972|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
20307973|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20307974|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
20307975|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307976|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
20307977|NCT00662233|Ifosfamide|ifosfamide|mesh-list
20307978|NCT00662233|Doxorubicin|doxorubicin|mesh-list
20307979|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20307980|NCT00662233|Etoposide|etoposide|mesh-list
20307981|NCT00662233|Vincristine|vincristine|mesh-list
20307982|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540714|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540715|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19540716|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19540717|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540718|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19540719|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540720|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19575117|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307983|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
20307984|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20307985|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540721|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20307986|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20307987|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
20307988|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20307989|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105074|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105075|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
20105076|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105077|NCT00003394|Paclitaxel|paclitaxel|mesh-list
20105078|NCT00003394|Carboplatin|carboplatin|mesh-list
20105079|NCT00003394|Leuprolide|leuprolide|mesh-list
20105080|NCT00003394|Goserelin|goserelin|mesh-list
20105081|NCT00003394|Estramustine|estramustine|mesh-list
20105082|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105083|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105084|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540722|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540723|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19540724|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540725|NCT03947827|Minocycline|minocycline|mesh-list
19540726|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19540727|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540728|NCT03943667|Gemcitabine|gemcitabine|mesh-list
19540729|NCT03943667|Paclitaxel|paclitaxel|mesh-list
19540730|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540731|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540732|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540733|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540734|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540735|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540736|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540737|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
19540738|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
19540739|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540740|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540741|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540742|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
19540743|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540744|NCT03939767|Aflibercept|aflibercept|mesh-list
19540745|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19540746|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19540747|NCT03939767|Growth Substances|growth substances|mesh-ancestor
19540748|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540749|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
19540750|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540751|NCT03937986|Cocaine|cocaine|mesh-list
19540752|NCT03937986|Suvorexant|suvorexant|mesh-list
19540753|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
19540754|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
19540755|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540756|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540757|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
19540758|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540759|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19540760|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19540761|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19540762|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19540763|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540764|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
19540765|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540766|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19540767|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19540768|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19540769|NCT03933202|Cladribine|cladribine|mesh-list
19540770|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540771|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540772|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
19540773|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540774|NCT03923725|Artesunate|artesunate|mesh-list
19540775|NCT03923725|Lumefantrine|lumefantrine|mesh-list
19540776|NCT03923725|Artemether|artemether|mesh-list
19540777|NCT03923725|Piperaquine|piperaquine|mesh-list
19540778|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20105085|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540779|NCT03923725|Amodiaquine|amodiaquine|mesh-list
19540780|NCT03923725|Mefloquine|mefloquine|mesh-list
20105086|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105087|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105088|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20105089|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
19540781|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
19540782|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19540783|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19540784|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540785|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540786|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
19540787|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
19540788|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19540789|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
19540790|NCT03922048|Bupivacaine|bupivacaine|mesh-list
19540791|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
19540792|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
19540793|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540794|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540795|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
19540796|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540797|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
19540798|NCT03919526|Fludarabine|fludarabine|mesh-list
19540799|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19540800|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
19540801|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540802|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540803|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19540804|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
19540805|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540806|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540807|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19540808|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
19540809|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19540810|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
19540811|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19540812|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
19540813|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105090|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20105091|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105092|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105093|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105094|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
20105095|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
20105096|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540822|NCT03865290|Ondansetron|ondansetron|mesh-list
19540823|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
19540824|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
19540825|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540826|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540827|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19540828|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
19540829|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
19540830|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19540831|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
19540832|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540833|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540834|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19540835|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19540836|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540837|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19540838|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19540839|NCT03859973|BI 425809|bi 425809|mesh-list
19540840|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
19540841|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
19540842|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19540843|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540844|NCT03844815|Decitabine|decitabine|mesh-list
19540845|NCT03844815|Venetoclax|venetoclax|mesh-list
19540846|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540847|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
19540848|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540849|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540850|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575118|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575119|NCT03548805|Mitomycins|mitomycins|mesh-list
19575120|NCT03548805|Mitomycin|mitomycin|mesh-list
19575121|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19540851|NCT03839914|Vancomycin|vancomycin|mesh-list
19540852|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19540853|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19540854|NCT03836040|Erenumab|erenumab|mesh-list
20105097|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
20105098|NCT00003396|Melphalan|melphalan|mesh-list
20105099|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20105100|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20307990|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20307991|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19540855|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19540856|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19540857|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540858|NCT03836040|Analgesics|analgesics|mesh-ancestor
19540859|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
19540860|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540861|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540862|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
19540863|NCT03832972|Estrogens|estrogens|mesh-list
19540864|NCT03832972|Hormones|hormones|mesh-ancestor
19540865|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19540866|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540867|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
19540868|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19540869|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19540870|NCT03820726|Nintedanib|nintedanib|mesh-list
19540871|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540872|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19540873|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540874|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540875|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
19540876|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
19540877|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540878|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
19540879|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19540880|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540881|NCT03798691|Vaccines|vaccines|mesh-list
19540882|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
19540883|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540884|NCT03786783|Vitamin A|vitamin a|mesh-list
19540885|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
19540886|NCT03786783|Melphalan|melphalan|mesh-list
19540887|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
19540888|NCT03786783|Thiotepa|thiotepa|mesh-list
19540889|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19540890|NCT03786783|Cisplatin|cisplatin|mesh-list
19540891|NCT03786783|Carboplatin|carboplatin|mesh-list
19540892|NCT03786783|Doxorubicin|doxorubicin|mesh-list
19540893|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19540894|NCT03786783|Etoposide|etoposide|mesh-list
19540895|NCT03786783|Vincristine|vincristine|mesh-list
19540896|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
19540897|NCT03786783|Topotecan|topotecan|mesh-list
19540898|NCT03786783|Daunorubicin|daunorubicin|mesh-list
19540899|NCT03786783|Tretinoin|tretinoin|mesh-list
19540900|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
19540901|NCT03786783|Dinutuximab|dinutuximab|mesh-list
20307992|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20307993|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20307994|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20307995|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20307996|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
20307997|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540902|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
19540903|NCT03786783|Razoxane|razoxane|mesh-list
19540904|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
19540905|NCT03786783|Isotretinoin|isotretinoin|mesh-list
19540906|NCT03786783|Sargramostim|sargramostim|mesh-list
19540907|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105101|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
20105102|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105103|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105104|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105105|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
20105106|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105107|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105108|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105109|NCT00003397|Gemcitabine|gemcitabine|mesh-list
20105110|NCT00003397|Dexamethasone|dexamethasone|mesh-list
19540908|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
19540909|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540910|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540911|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19540912|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
19540913|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540914|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540915|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19540916|NCT03786783|Vitamins|vitamins|mesh-ancestor
19540917|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
19540918|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19540919|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19540920|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19540921|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540922|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19540923|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
19540924|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
19540925|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
19540926|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19540927|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
19540928|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
19540929|NCT03786783|Protective Agents|protective agents|mesh-ancestor
19540930|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19540931|NCT03785405|Valsartan|valsartan|mesh-list
19540932|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19540933|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19540934|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19540935|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540936|NCT03775525|Capecitabine|capecitabine|mesh-list
19540937|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540938|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
19540939|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540940|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540941|NCT03770338|Teriparatide|teriparatide|mesh-list
19540942|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19540943|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540944|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19540945|NCT03767933|Acetaminophen|acetaminophen|mesh-list
19540946|NCT03767933|Ibuprofen|ibuprofen|mesh-list
19540947|NCT03767933|Hydromorphone|hydromorphone|mesh-list
19540948|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19540949|NCT03767933|Analgesics|analgesics|mesh-ancestor
19540950|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
19540951|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19540952|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540953|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
19540954|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19540955|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19540956|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19540957|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19540958|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540959|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540960|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20307998|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
20307999|NCT00662272|Vaccines|vaccines|mesh-list
20308000|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
20308001|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308002|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
20308003|NCT00662337|Promethazine|promethazine|mesh-list
20308004|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20308005|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20308006|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540961|NCT03767933|Narcotics|narcotics|mesh-ancestor
19540962|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19540963|NCT03767244|Androgens|androgens|mesh-list
19540964|NCT03767244|Hormones|hormones|mesh-ancestor
19540965|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19540966|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540967|NCT03755791|Sorafenib|sorafenib|mesh-list
19540968|NCT03755791|Atezolizumab|atezolizumab|mesh-list
19540969|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540970|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19540971|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19540972|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540973|NCT03749902|Misoprostol|misoprostol|mesh-list
19540974|NCT03749902|Oxytocin|oxytocin|mesh-list
19540975|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
19540976|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19540977|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540978|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19540979|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
19540980|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19540981|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19540982|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19540983|NCT03741517|Edotreotide|edotreotide|mesh-list
19540984|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19540985|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540986|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
19540987|NCT03739853|Adalimumab|adalimumab|mesh-list
19540988|NCT03739853|Methotrexate|methotrexate|mesh-list
19540989|NCT03739853|Leflunomide|leflunomide|mesh-list
19540990|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19540991|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
19540992|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19540993|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19540994|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19540995|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
19540996|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19540997|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19540998|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
19540999|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541000|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19541001|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541002|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
19541003|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541004|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19541005|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541006|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19541007|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19541008|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19541009|NCT03739853|Analgesics|analgesics|mesh-ancestor
19541010|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
20604233|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604234|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604235|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541011|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541012|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541013|NCT03735121|Atezolizumab|atezolizumab|mesh-list
19541014|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541015|NCT03734770|Progesterone|progesterone|mesh-list
19541016|NCT03734770|Progestins|progestins|mesh-ancestor
19541017|NCT03734770|Hormones|hormones|mesh-ancestor
19541018|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541019|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541020|NCT03730194|Melatonin|melatonin|mesh-list
19541021|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
19541022|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541023|NCT03730194|Protective Agents|protective agents|mesh-ancestor
19541024|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541025|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541026|NCT03718130|Vaccines|vaccines|mesh-list
19541027|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
20105111|NCT00003397|Paclitaxel|paclitaxel|mesh-list
20105112|NCT00003397|Etoposide|etoposide|mesh-list
20105113|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
20105114|NCT00003397|Rituximab|rituximab|mesh-list
19541028|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541029|NCT03714308|Aflibercept|aflibercept|mesh-list
19541030|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19541031|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19541032|NCT03714308|Growth Substances|growth substances|mesh-ancestor
19541033|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541034|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
19541035|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541036|NCT03672500|Epinephrine|epinephrine|mesh-list
19541037|NCT03672500|Bupivacaine|bupivacaine|mesh-list
19541038|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
19541039|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
19541040|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19749013|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20105115|NCT00003397|Melphalan|melphalan|mesh-list
19541041|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541042|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
19541043|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541044|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19541045|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19541046|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
19541047|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541048|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541049|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19541050|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19541051|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
19541052|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19541053|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
19541054|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
19541055|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
19541056|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19541057|NCT03667820|Osimertinib|osimertinib|mesh-list
19541058|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541059|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19541060|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541061|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541062|NCT03667651|Decanoic acid|decanoic acid|mesh-list
19541063|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
19541064|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19541065|NCT03656536|Gemcitabine|gemcitabine|mesh-list
19541066|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541067|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541068|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
20308007|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308008|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
20308009|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
20308010|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
20308011|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308012|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
19541069|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541070|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
19541071|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19541072|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541073|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541074|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
19541075|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541076|NCT03654989|Treprostinil|treprostinil|mesh-list
19541077|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19541078|NCT03649061|Etanercept|etanercept|mesh-list
19541079|NCT03649061|Leflunomide|leflunomide|mesh-list
19541080|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19541081|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19541082|NCT03649061|Analgesics|analgesics|mesh-ancestor
19541083|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
19541084|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541085|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541086|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541087|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541088|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541089|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541090|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
19541091|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541092|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541093|NCT03646058|Buprenorphine|buprenorphine|mesh-list
19541094|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19541095|NCT03646058|Narcotics|narcotics|mesh-ancestor
19541096|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541097|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541098|NCT03646058|Analgesics|analgesics|mesh-ancestor
19541099|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
19541100|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541101|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19541102|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
19541103|NCT03644485|Tacrolimus|tacrolimus|mesh-list
19541104|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541105|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
20308013|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
20308014|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541106|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541107|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19541108|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541109|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541110|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19541111|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541112|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19541113|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
19541114|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19541115|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575122|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575123|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
19575124|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575125|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19575126|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575127|NCT03535116|Ketorolac|ketorolac|mesh-list
19575128|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19575129|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19575130|NCT03535116|Analgesics|analgesics|mesh-ancestor
20105116|NCT00003397|Carmustine|carmustine|mesh-list
20105117|NCT00003397|Sargramostim|sargramostim|mesh-list
20105118|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105119|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105120|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105121|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105122|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105123|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105124|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105125|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
20105126|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105127|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575131|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
19575132|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575133|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575134|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575135|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575136|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19575137|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575138|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575139|NCT03471143|Betadex|betadex|mesh-list
19575140|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
19575141|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578148|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578149|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578150|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19578151|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578152|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578153|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578154|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578155|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578156|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
19578157|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578158|NCT03485677|Eliglustat|eliglustat|mesh-list
19578159|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578160|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578161|NCT03480776|Aspirin|aspirin|mesh-list
19578162|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19578163|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19578164|NCT03480776|Analgesics|analgesics|mesh-ancestor
19578165|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
19578166|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578167|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578168|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578169|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578170|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19578171|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19578172|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578173|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19578174|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19578175|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578176|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
19578177|NCT03410615|Durvalumab|durvalumab|mesh-list
19578178|NCT03410615|Tremelimumab|tremelimumab|mesh-list
19578179|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105128|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19541116|NCT03606694|Metformin|metformin|mesh-list
19541117|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19541118|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541119|NCT03600701|Atezolizumab|atezolizumab|mesh-list
19541120|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19541121|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541122|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
19541123|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541124|NCT03597776|Lidocaine|lidocaine|mesh-list
19541125|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
19541126|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
19541127|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541128|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541129|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
19541130|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541131|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19541132|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19541133|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19541134|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19541135|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541136|NCT03581292|Temozolomide|temozolomide|mesh-list
19541137|NCT03581292|Veliparib|veliparib|mesh-list
19541138|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19541139|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
19541140|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541141|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541142|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19541143|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541144|NCT03560882|Atorvastatin|atorvastatin|mesh-list
19541145|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19541146|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19541147|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
19541148|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541149|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19541150|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19541151|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541152|NCT03559647|Atezolizumab|atezolizumab|mesh-list
19541153|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541154|NCT03556202|Mirikizumab|mirikizumab|mesh-list
19541155|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19541156|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19541157|NCT03556202|Analgesics|analgesics|mesh-ancestor
19541158|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
19541159|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541160|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541161|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541162|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541163|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19541164|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541165|NCT03553563|Esomeprazole|esomeprazole|mesh-list
19541166|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19541167|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541168|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19541169|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308015|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20308016|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
19541170|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541171|NCT03553004|Niraparib|niraparib|mesh-list
19541172|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19541173|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541174|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541175|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541176|NCT03542266|Azacitidine|azacitidine|mesh-list
19541177|NCT03542266|Cc-486|cc-486|mesh-list
19541178|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541179|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
19541180|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541181|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541182|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541183|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
19541184|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19541185|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541186|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20308017|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
19541187|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541188|NCT03534284|Trazodone|trazodone|mesh-list
19541189|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19541190|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19541191|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541192|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541193|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19541194|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20308018|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308019|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308020|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20308021|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
19541195|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19541196|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19541197|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541198|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541199|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
19541200|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19541201|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
19541202|NCT03531073|Methotrexate|methotrexate|mesh-list
19541203|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19541204|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
20308022|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
19541205|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19541206|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541207|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541208|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
19541209|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541210|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541211|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
19541212|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541213|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19541214|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541215|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
19541216|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105129|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
20105130|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105131|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20105132|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105133|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
20105134|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
19541217|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19541218|NCT03530683|Dexamethasone|dexamethasone|mesh-list
19541219|NCT03530683|Azacitidine|azacitidine|mesh-list
19541220|NCT03530683|Venetoclax|venetoclax|mesh-list
19541221|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541222|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
19541223|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
19541224|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541225|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541226|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541227|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
19541228|NCT03530683|Hormones|hormones|mesh-ancestor
19541229|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541230|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19541231|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541232|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541233|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
19541234|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541235|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541236|NCT03528694|Durvalumab|durvalumab|mesh-list
19541237|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
19541238|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541239|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541240|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19541241|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
19541242|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541243|NCT03525795|Ipilimumab|ipilimumab|mesh-list
19541244|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
19541245|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20105135|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541246|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105136|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105137|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
20105138|NCT00003397|Hormones|hormones|mesh-ancestor
20105139|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105140|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105141|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105142|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
20105143|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
20105144|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308023|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20308024|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
20308025|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20308026|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20105145|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105146|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19541247|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541248|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541249|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541250|NCT03523975|Rituximab|rituximab|mesh-list
19541251|NCT03523975|Lenalidomide|lenalidomide|mesh-list
19541252|NCT03523975|Venetoclax|venetoclax|mesh-list
19541253|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541254|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541255|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
19541256|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541257|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541258|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19541259|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19541260|NCT03523975|Growth Substances|growth substances|mesh-ancestor
19541261|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19541262|NCT03523000|Fentanyl|fentanyl|mesh-list
19541263|NCT03523000|Bupivacaine|bupivacaine|mesh-list
19541264|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
19541265|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
19541266|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541267|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541268|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
19541269|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541270|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19541271|NCT03523000|Narcotics|narcotics|mesh-ancestor
19541272|NCT03523000|Analgesics|analgesics|mesh-ancestor
19541273|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19541274|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19541275|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
19541276|NCT03522831|Albuterol|albuterol|mesh-list
19541277|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19541278|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
19541279|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541280|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541281|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19541282|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
19541283|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
19541284|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19541285|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20105147|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105148|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
20308027|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308028|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308029|NCT00662441|Urological Agents|urological agents|mesh-ancestor
20308030|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19541286|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19541287|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19541288|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
19541289|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541290|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541291|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
19541292|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19541293|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
19541294|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19541295|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
19541296|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541297|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308031|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20308032|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
20105149|NCT00003398|Thiotepa|thiotepa|mesh-list
19541298|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
19541299|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
19541300|NCT03516812|Olaparib|olaparib|mesh-list
19541301|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19541302|NCT03516812|Testosterone|testosterone|mesh-list
19541303|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
19541304|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
19541305|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19541306|NCT03516812|Androgens|androgens|mesh-ancestor
19541307|NCT03516812|Hormones|hormones|mesh-ancestor
19541308|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541309|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541310|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19541311|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541312|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
19541313|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308033|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20308034|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20308035|NCT00662454|Estradiol|estradiol|mesh-list
20308036|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20308037|NCT00662454|Estrogens|estrogens|mesh-ancestor
20308038|NCT00662454|Hormones|hormones|mesh-ancestor
20308039|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308040|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308041|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20308042|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
20308043|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19541314|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541315|NCT03511196|Prednisone|prednisone|mesh-list
19541316|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
19541317|NCT03511196|Androgens|androgens|mesh-list
19541318|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541319|NCT03511196|Hormones|hormones|mesh-ancestor
19541320|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541321|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541322|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19541323|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541324|NCT03504501|Lamotrigine|lamotrigine|mesh-list
19541325|NCT03504501|Lovastatin|lovastatin|mesh-list
19541326|NCT03504501|L 647318|l 647318|mesh-list
19541327|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
19541328|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
19541329|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20308044|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20308045|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20308046|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20308047|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20308048|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20308049|NCT00662467|Aspirin|aspirin|mesh-list
20308050|NCT00662467|Warfarin|warfarin|mesh-list
20308051|NCT00662467|Clopidogrel|clopidogrel|mesh-list
20308052|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308053|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308054|NCT00662467|Analgesics|analgesics|mesh-ancestor
20308055|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
20308056|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308057|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541330|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19541331|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541332|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19541333|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541334|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19541335|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19541336|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541337|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19541338|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19541339|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19541340|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19541341|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
19541342|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19541343|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19541344|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541345|NCT03504397|Leucovorin|leucovorin|mesh-list
19541346|NCT03504397|Folic Acid|folic acid|mesh-list
19541347|NCT03504397|Fluorouracil|fluorouracil|mesh-list
19541348|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
19541349|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
19541350|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
19541351|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541352|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541353|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541354|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541355|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
19541356|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541357|NCT03504397|Antidotes|antidotes|mesh-ancestor
19541358|NCT03504397|Protective Agents|protective agents|mesh-ancestor
19541359|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
19541360|NCT03504397|Vitamins|vitamins|mesh-ancestor
19541361|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
19541362|NCT03504397|Hematinics|hematinics|mesh-ancestor
19541363|NCT03494322|Cetuximab|cetuximab|mesh-list
19541364|NCT03494322|Avelumab|avelumab|mesh-list
19541365|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541366|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541367|NCT03493685|Irbesartan|irbesartan|mesh-list
19541368|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19541369|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19541370|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19541371|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541372|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
19541373|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541374|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541375|NCT03485274|Vortioxetine|vortioxetine|mesh-list
19541376|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
19541377|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19541378|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19541379|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19541380|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541381|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541382|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19541383|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19541384|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19541385|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541386|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541387|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
19541388|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19541389|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19541390|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19541391|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19541392|NCT03477396|Estrogens|estrogens|mesh-list
19541393|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19541394|NCT03477396|Hormones|hormones|mesh-ancestor
19541395|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541396|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541397|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19541398|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541399|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541400|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19541401|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
19541402|NCT03468985|Nivolumab|nivolumab|mesh-list
19541403|NCT03468985|Ipilimumab|ipilimumab|mesh-list
19541404|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541405|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541406|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541407|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541408|NCT03464461|Ketorolac|ketorolac|mesh-list
19541409|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19541410|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19541411|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19541412|NCT03464461|Analgesics|analgesics|mesh-ancestor
19541413|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
20308058|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308059|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308060|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20308061|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20308062|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308063|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19541414|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541415|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541416|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541417|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541418|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19541419|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541420|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541421|NCT03464045|Empagliflozin|empagliflozin|mesh-list
19541422|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19541423|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19541424|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541425|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19541426|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541427|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
19541428|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541429|NCT03463577|Vaccines|vaccines|mesh-list
19541430|NCT03463577|Immunologic Factors|immunologic factors|mesh-ancestor
19541431|NCT03463577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541432|NCT03454529|Simvastatin|simvastatin|mesh-list
19541433|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19541434|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19541435|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
19541436|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541437|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19541438|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19541439|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541440|NCT03448159|Fluoxetine|fluoxetine|mesh-list
19541441|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19541442|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19541443|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19541444|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541445|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541446|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
19541447|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541448|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19541449|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
19541450|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19541451|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19541452|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19541453|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541454|NCT03439891|Nivolumab|nivolumab|mesh-list
19541455|NCT03439891|Sorafenib|sorafenib|mesh-list
19541456|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541457|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541458|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541459|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541460|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19541461|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308064|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308065|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308066|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
20308067|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19541462|NCT03439865|Ivacaftor|ivacaftor|mesh-list
19541463|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19541464|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19541465|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541466|NCT03429543|Empagliflozin|empagliflozin|mesh-list
19541467|NCT03429543|Linagliptin|linagliptin|mesh-list
19541468|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19541469|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541470|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19541471|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541472|NCT03429543|Incretins|incretins|mesh-ancestor
19541473|NCT03429543|Hormones|hormones|mesh-ancestor
19541474|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541475|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19541476|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
19541477|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541478|NCT03416244|Nivolumab|nivolumab|mesh-list
19541479|NCT03416244|Ipilimumab|ipilimumab|mesh-list
19541480|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541481|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541482|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20308068|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19541483|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541484|NCT03409848|Nivolumab|nivolumab|mesh-list
20604236|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20604237|NCT02226276|Trace Elements|trace elements|mesh-ancestor
20604238|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
20604239|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604240|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604241|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
19541485|NCT03409848|Ipilimumab|ipilimumab|mesh-list
19541486|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541487|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541488|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541489|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541490|NCT03401047|Estradiol|estradiol|mesh-list
19541491|NCT03401047|Estrogens|estrogens|mesh-ancestor
19541492|NCT03401047|Hormones|hormones|mesh-ancestor
19541493|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541494|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541495|NCT03400332|Nivolumab|nivolumab|mesh-list
19541496|NCT03400332|Ipilimumab|ipilimumab|mesh-list
19541497|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541498|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541499|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541500|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541501|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
19541502|NCT03399773|Thiotepa|thiotepa|mesh-list
19541503|NCT03399773|Fludarabine|fludarabine|mesh-list
19541504|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541505|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
19541506|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541507|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541508|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19541509|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
19541510|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541511|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541512|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19575142|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
19575143|NCT03434366|Ketamine|ketamine|mesh-list
19575144|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20308069|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20308070|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
20308071|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308072|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
20308930|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308931|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308932|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308933|NCT00666302|Analgesics|analgesics|mesh-ancestor
20308934|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
20308935|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308936|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308937|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308938|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105150|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19575145|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575146|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575147|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19575148|NCT03434366|Analgesics|analgesics|mesh-ancestor
19575149|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
19575150|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575151|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20105151|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105152|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
20105153|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105154|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105155|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20604242|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
19575152|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19575153|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19575154|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
19575155|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575156|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575157|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20105156|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
20604243|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
19541513|NCT03396926|Bevacizumab|bevacizumab|mesh-list
19541514|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20308073|NCT00662519|Sargramostim|sargramostim|mesh-list
20308074|NCT00662519|Lenograstim|lenograstim|mesh-list
20308075|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
20308076|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308077|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20308078|NCT00662571|Acamprosate|acamprosate|mesh-list
20308079|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20308080|NCT00662610|Naproxen|naproxen|mesh-list
20308081|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
19541515|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
19541516|NCT03396926|Capecitabine|capecitabine|mesh-list
19541517|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
19541518|NCT03396926|Antibodies|antibodies|mesh-list
19541519|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
19541520|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19541521|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
19541522|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541523|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19541524|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19541525|NCT03396926|Growth Substances|growth substances|mesh-ancestor
19541526|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541527|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
19541528|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
19541529|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541530|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
19541531|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541532|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19541533|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19541534|NCT03396276|Narcotics|narcotics|mesh-ancestor
19541535|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541536|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541537|NCT03396276|Analgesics|analgesics|mesh-ancestor
19541538|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
19541539|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541540|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19541541|NCT03395197|Talazoparib|talazoparib|mesh-list
19541542|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19541543|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541544|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541545|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541546|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19541547|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
19541548|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541549|NCT03379428|Trastuzumab|trastuzumab|mesh-list
19541550|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541551|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541552|NCT03377361|Nivolumab|nivolumab|mesh-list
19541553|NCT03377361|Ipilimumab|ipilimumab|mesh-list
19541554|NCT03377361|Trametinib|trametinib|mesh-list
19541555|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541556|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541557|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541558|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541559|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19541560|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541561|NCT03375307|Olaparib|olaparib|mesh-list
19541562|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19541563|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541564|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541565|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541566|NCT03373760|Durvalumab|durvalumab|mesh-list
19541567|NCT03373760|Ipilimumab|ipilimumab|mesh-list
19541568|NCT03373760|Tremelimumab|tremelimumab|mesh-list
19541569|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
19541570|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19541571|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
19541572|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541573|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541574|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
19541575|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308082|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308083|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308084|NCT00662610|Analgesics|analgesics|mesh-ancestor
20308085|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
19541576|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541577|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541578|NCT03367572|Dexamethasone|dexamethasone|mesh-list
19541579|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
19541580|NCT03367572|Olanzapine|olanzapine|mesh-list
19541581|NCT03367572|Palonosetron|palonosetron|mesh-list
19541582|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
19541583|NCT03367572|Ichthammol|ichthammol|mesh-list
19541584|NCT03367572|BB 1101|bb 1101|mesh-list
19541585|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541586|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
19541587|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
19541588|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541589|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541590|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541591|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
19541592|NCT03367572|Hormones|hormones|mesh-ancestor
19541593|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308086|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308087|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308088|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308089|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308090|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
20308091|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308092|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308093|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308094|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20308095|NCT00662636|Dasatinib|dasatinib|mesh-list
20308096|NCT00662636|Lapatinib|lapatinib|mesh-list
20308097|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308098|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20308099|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308100|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308101|NCT00662714|Insulin|insulin|mesh-list
20308102|NCT00662714|Repaglinide|repaglinide|mesh-list
20308103|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20308104|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
20308105|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20308106|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308107|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
20105157|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105158|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105159|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105160|NCT00003399|Dexamethasone|dexamethasone|mesh-list
20105161|NCT00003399|Paclitaxel|paclitaxel|mesh-list
20105162|NCT00003399|Etoposide|etoposide|mesh-list
20105163|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
19541594|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105164|NCT00003399|Melphalan|melphalan|mesh-list
20308108|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20308109|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
20308110|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308111|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308112|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20308113|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
20308114|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20308115|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20308116|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20308117|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
20308118|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308119|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105165|NCT00003399|Carmustine|carmustine|mesh-list
19541595|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541596|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19541597|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19541598|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541599|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19541600|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19541601|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19541602|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19541603|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105166|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105167|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105168|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105169|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105170|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
19541604|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541605|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
19541606|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
19541607|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541608|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19541609|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19541610|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19541611|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19541612|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
19541613|NCT03366103|Navitoclax|navitoclax|mesh-list
19541614|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541615|NCT03354039|Tamoxifen|tamoxifen|mesh-list
19541616|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20105171|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105172|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105173|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
20105174|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105175|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105176|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105177|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
20105178|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105179|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105180|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
20105181|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
20105182|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105183|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105184|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
20105185|NCT00003399|Hormones|hormones|mesh-ancestor
20105186|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541617|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
19541618|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541619|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541620|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19541621|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541622|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19541623|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19541624|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19541625|NCT03345810|Gemcitabine|gemcitabine|mesh-list
19541626|NCT03345810|Paclitaxel|paclitaxel|mesh-list
19541627|NCT03345810|Vinorelbine|vinorelbine|mesh-list
19541628|NCT03345810|Carboplatin|carboplatin|mesh-list
19541629|NCT03345810|Durvalumab|durvalumab|mesh-list
19541630|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19541631|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541632|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
19541633|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
19541634|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
19541635|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541636|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541637|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
19541638|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
19541639|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19541640|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541641|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541642|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
19541643|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541644|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541645|NCT03338790|Prednisone|prednisone|mesh-list
19541646|NCT03338790|Docetaxel|docetaxel|mesh-list
19541647|NCT03338790|Nivolumab|nivolumab|mesh-list
19541648|NCT03338790|Rucaparib|rucaparib|mesh-list
19541649|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541650|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
19541651|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
19541652|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
19541653|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105187|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105188|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105189|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105190|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105191|NCT00003400|Melphalan|melphalan|mesh-list
20105192|NCT00003400|Vinorelbine|vinorelbine|mesh-list
20105193|NCT00003400|Carmustine|carmustine|mesh-list
20105194|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541654|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541655|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
19541656|NCT03338790|Hormones|hormones|mesh-ancestor
19541657|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541658|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541659|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19541660|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541661|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541662|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19541663|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541664|NCT03326310|Azacitidine|azacitidine|mesh-list
19541665|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541666|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
19541667|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541668|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541669|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541670|NCT03314363|Trace Elements|trace elements|mesh-list
19541671|NCT03314363|Micronutrients|micronutrients|mesh-list
19541672|NCT03314363|Citric Acid|citric acid|mesh-list
19541673|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
19541674|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541675|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
19541676|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19541677|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
19541678|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
19541679|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541680|NCT03302728|Lenalidomide|lenalidomide|mesh-list
19541681|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19541682|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
19541683|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541684|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19541685|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19541686|NCT03302728|Growth Substances|growth substances|mesh-ancestor
19541687|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
19541688|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541689|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541690|NCT03299660|Fluorouracil|fluorouracil|mesh-list
19541691|NCT03299660|Capecitabine|capecitabine|mesh-list
19541692|NCT03299660|Avelumab|avelumab|mesh-list
19541693|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
19541694|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541695|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541696|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541697|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541698|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
19541699|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541700|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541701|NCT03290794|Aflibercept|aflibercept|mesh-list
19541702|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19541703|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19541704|NCT03290794|Growth Substances|growth substances|mesh-ancestor
19541705|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541706|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
19541707|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541708|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19541709|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
19541710|NCT03255174|Coagulants|coagulants|mesh-ancestor
19541711|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
19541712|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541713|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541714|NCT03248167|Cannabidiol|cannabidiol|mesh-list
19541715|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
19541716|NCT03246828|Gliclazide|gliclazide|mesh-list
19541717|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19541718|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541719|NCT03245840|Budesonide|budesonide|mesh-list
19541720|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541721|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19541722|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
19541723|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541724|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541725|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19541726|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
19541727|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
19541728|NCT03245840|Hormones|hormones|mesh-ancestor
19541729|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541730|NCT03230604|Z 350|z 350|mesh-list
19541731|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20105195|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
19541732|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19541733|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541734|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541735|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
19541736|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541737|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541738|NCT03221036|Vedolizumab|vedolizumab|mesh-list
19541739|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541780|NCT03217747|Avelumab|avelumab|mesh-list
19541781|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19541782|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
19541783|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541784|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541785|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
19541786|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541787|NCT03217669|Sirolimus|sirolimus|mesh-list
19541788|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19541789|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19541790|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19541791|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541792|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
19541793|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541794|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
19541795|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541796|NCT03212274|Olaparib|olaparib|mesh-list
19541797|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19541798|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541799|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541800|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541801|NCT03207958|Belimumab|belimumab|mesh-list
19541802|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541803|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
19541804|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541805|NCT03203525|Leucovorin|leucovorin|mesh-list
19541806|NCT03203525|Sirolimus|sirolimus|mesh-list
19541807|NCT03203525|Bevacizumab|bevacizumab|mesh-list
19541808|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19541809|NCT03203525|Doxorubicin|doxorubicin|mesh-list
19541810|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19541811|NCT03203525|Fluorouracil|fluorouracil|mesh-list
19541812|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
19541813|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
19541814|NCT03203525|Antibodies|antibodies|mesh-list
19541815|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
19541816|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19541817|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
19541818|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541819|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19541820|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19541821|NCT03203525|Growth Substances|growth substances|mesh-ancestor
19541822|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541823|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
19541824|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
19541825|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19541826|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19541827|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19541828|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541829|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541830|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
19541831|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541832|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541833|NCT03203525|Antidotes|antidotes|mesh-ancestor
19541834|NCT03203525|Protective Agents|protective agents|mesh-ancestor
19541835|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
19541836|NCT03203525|Vitamins|vitamins|mesh-ancestor
20105196|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105197|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105198|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
20105199|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308120|NCT00662805|Fluticasone|fluticasone|mesh-list
19541837|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
19541838|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19541839|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19541840|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
19541841|NCT03202628|Dexamethasone|dexamethasone|mesh-list
19541842|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
19541843|NCT03202628|Pomalidomide|pomalidomide|mesh-list
19541844|NCT03202628|Ixazomib|ixazomib|mesh-list
19541845|NCT03202628|Ichthammol|ichthammol|mesh-list
19541846|NCT03202628|BB 1101|bb 1101|mesh-list
19541847|NCT03202628|Glycine|glycine|mesh-list
19541848|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541849|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
19541850|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
19541851|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541852|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541853|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541854|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
19541855|NCT03202628|Hormones|hormones|mesh-ancestor
19541856|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541857|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19541858|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541859|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541860|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
19541861|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541862|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
19541863|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19541864|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19541865|NCT03202628|Growth Substances|growth substances|mesh-ancestor
19541866|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
19541867|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
19541868|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
19541869|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541870|NCT03198741|Aspirin|aspirin|mesh-list
19541871|NCT03198741|Clopidogrel|clopidogrel|mesh-list
19541872|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19541873|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19541874|NCT03198741|Analgesics|analgesics|mesh-ancestor
19541875|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
20105200|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105201|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105202|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105203|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105204|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105205|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
19541876|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541877|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541878|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541879|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541880|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19541881|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19541882|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541883|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19541884|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19541885|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541886|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
19541887|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19541888|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19541889|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19541890|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
19541891|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541892|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19541893|NCT03168555|Cathartics|cathartics|mesh-ancestor
19541894|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541895|NCT03153527|Prednisone|prednisone|mesh-list
19541896|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541897|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
19541898|NCT03153527|Hormones|hormones|mesh-ancestor
19541899|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541900|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541901|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19541902|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541903|NCT03141203|Romidepsin|romidepsin|mesh-list
19541904|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19541905|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541906|NCT03136146|Dexamethasone|dexamethasone|mesh-list
19541907|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
19541908|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
19541909|NCT03136146|Rituximab|rituximab|mesh-list
19541910|NCT03136146|Etoposide|etoposide|mesh-list
19541911|NCT03136146|Vincristine|vincristine|mesh-list
19541912|NCT03136146|Bortezomib|bortezomib|mesh-list
19541913|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
19541914|NCT03136146|Clofarabine|clofarabine|mesh-list
19541915|NCT03136146|Ofatumumab|ofatumumab|mesh-list
19541916|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
19541917|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20308121|NCT00662805|Xhance|xhance|mesh-list
20308122|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20308123|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308124|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20308125|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
20105206|NCT00003401|Gemcitabine|gemcitabine|mesh-list
20105207|NCT00003401|Dexamethasone|dexamethasone|mesh-list
20105208|NCT00003401|Paclitaxel|paclitaxel|mesh-list
20105209|NCT00003401|Etoposide|etoposide|mesh-list
20105210|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
20105211|NCT00003401|Melphalan|melphalan|mesh-list
20105212|NCT00003401|Carmustine|carmustine|mesh-list
20105213|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105214|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105215|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105216|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105217|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
19541918|NCT03136146|Antibodies|antibodies|mesh-list
19541919|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
19541920|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19541921|NCT03136146|Lenograstim|lenograstim|mesh-list
19541922|NCT03136146|BB 1101|bb 1101|mesh-list
19541923|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19541924|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
19541925|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541926|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541927|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19541928|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
19541929|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541930|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105218|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308126|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541931|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19541932|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19541933|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
19541934|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
20105219|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105220|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
20105221|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105222|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105223|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105224|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
20105225|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20308127|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541935|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541936|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19541937|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
20308128|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20308129|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
20308130|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308131|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20308132|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20308133|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20308134|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20308135|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
20308136|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308137|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308138|NCT00662844|Vitamin D|vitamin d|mesh-list
20308139|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
20308140|NCT00662844|Vitamins|vitamins|mesh-ancestor
20308141|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
20105226|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105227|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
20105228|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
20105229|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105230|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105231|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
20105232|NCT00003401|Hormones|hormones|mesh-ancestor
20105233|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105234|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105235|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105236|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
20105237|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
19541938|NCT03136146|Hormones|hormones|mesh-ancestor
19541939|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541940|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105238|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105239|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105240|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105241|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19541941|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
19541942|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19541943|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19541944|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19541945|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19541946|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19541947|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
19541948|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105242|NCT00003402|Dexamethasone|dexamethasone|mesh-list
20105243|NCT00003402|Paclitaxel|paclitaxel|mesh-list
20105244|NCT00003402|Etoposide|etoposide|mesh-list
20105245|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
20105246|NCT00003402|Melphalan|melphalan|mesh-list
20105247|NCT00003402|Carmustine|carmustine|mesh-list
20105248|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105249|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105250|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105251|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105252|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105253|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105254|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105255|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
20105256|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105257|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19541949|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
19541950|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19541951|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
19541952|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
20105258|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105259|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
20105260|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105261|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105262|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
19541953|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
19541954|NCT03099499|TIC10 compound|tic10 compound|mesh-list
19541955|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541956|NCT03087773|Empagliflozin|empagliflozin|mesh-list
19541957|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19541958|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541959|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20105263|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
20105264|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105265|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105266|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
20105267|NCT00003402|Hormones|hormones|mesh-ancestor
20105268|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105269|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105270|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105271|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19541960|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575158|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19575159|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
19575160|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
19575161|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19575162|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19575163|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19575164|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19575165|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575166|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
19575167|NCT03405792|Temozolomide|temozolomide|mesh-list
19575168|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575169|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575170|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575171|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
19575172|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575183|NCT03244059|Belimumab|belimumab|mesh-list
19575184|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575185|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
19575186|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575187|NCT03207867|Spartalizumab|spartalizumab|mesh-list
19575188|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19575189|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575190|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575191|NCT03170960|Atezolizumab|atezolizumab|mesh-list
19575192|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575193|NCT03131219|Ravulizumab|ravulizumab|mesh-list
19575194|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19575195|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105272|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105273|NCT00003405|Interferons|interferons|mesh-list
20105274|NCT00003405|Cytarabine|cytarabine|mesh-list
20105275|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
20105276|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
20105277|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
19575196|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
19575197|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575198|NCT03075527|Durvalumab|durvalumab|mesh-list
19575199|NCT03075527|Tremelimumab|tremelimumab|mesh-list
19575200|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20105278|NCT00003405|Idoxuridine|idoxuridine|mesh-list
20105279|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
20105280|NCT00003405|Idarubicin|idarubicin|mesh-list
20105281|NCT00003405|Isotretinoin|isotretinoin|mesh-list
20308142|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105282|NCT00003405|Amifostine|amifostine|mesh-list
19541961|NCT03082755|Gabapentin|gabapentin|mesh-list
19541962|NCT03082755|Analgesics|analgesics|mesh-ancestor
19541963|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
19541964|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19541965|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541966|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
19541967|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19541968|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19541969|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19541970|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19541971|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19541972|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19541973|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19541974|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541975|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
19541976|NCT03068910|Spironolactone|spironolactone|mesh-list
19541977|NCT03068910|Progesterone|progesterone|mesh-list
19541978|NCT03068910|Progestins|progestins|mesh-ancestor
19541979|NCT03068910|Hormones|hormones|mesh-ancestor
19541980|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19541981|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19541982|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19541983|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
19541984|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19541985|NCT03068910|Diuretics|diuretics|mesh-ancestor
19541986|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
19541987|NCT03059147|Nivolumab|nivolumab|mesh-list
19541988|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541989|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541990|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541991|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541992|NCT03055013|Nivolumab|nivolumab|mesh-list
19541993|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19541994|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19541995|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19541996|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19541997|NCT03043729|Leucovorin|leucovorin|mesh-list
19541998|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
19541999|NCT03043729|Aflibercept|aflibercept|mesh-list
19542000|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542001|NCT03043729|Antidotes|antidotes|mesh-ancestor
19542002|NCT03043729|Protective Agents|protective agents|mesh-ancestor
19542003|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542004|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
19542005|NCT03043729|Vitamins|vitamins|mesh-ancestor
20105283|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105284|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
19542006|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
19542007|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19542008|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20105285|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105286|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105287|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
20105288|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105289|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105290|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
20105291|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105292|NCT00003405|Analgesics|analgesics|mesh-ancestor
20105293|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
19542009|NCT03043729|Growth Substances|growth substances|mesh-ancestor
19542010|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
19542011|NCT03043547|Leucovorin|leucovorin|mesh-list
20105294|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105295|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105296|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105297|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105298|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19542012|NCT03043547|Antidotes|antidotes|mesh-ancestor
19542013|NCT03043547|Protective Agents|protective agents|mesh-ancestor
19542014|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105299|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308143|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20308144|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20308145|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
20308146|NCT00662883|Ketamine|ketamine|mesh-list
20308147|NCT00662883|Analgesics|analgesics|mesh-ancestor
20308148|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
20308149|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604244|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
19542015|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
19542016|NCT03043547|Vitamins|vitamins|mesh-ancestor
20308150|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308151|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20308152|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20308153|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
20308154|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
20308155|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542017|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
19542018|NCT03017326|Gemcitabine|gemcitabine|mesh-list
19542019|NCT03017326|Carboplatin|carboplatin|mesh-list
19542020|NCT03017326|Doxorubicin|doxorubicin|mesh-list
19542021|NCT03017326|Fluorouracil|fluorouracil|mesh-list
19542022|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
19542023|NCT03017326|Irinotecan|irinotecan|mesh-list
19542024|NCT03017326|Etoposide|etoposide|mesh-list
19542025|NCT03017326|Vincristine|vincristine|mesh-list
19542026|NCT03017326|Sorafenib|sorafenib|mesh-list
19542027|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542028|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19542029|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
19542030|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542031|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
19542032|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542033|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542034|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542035|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
19542036|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542037|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19542038|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19542039|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19542040|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19542041|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542042|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542043|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542044|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20308156|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20308157|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20308158|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308159|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308160|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308161|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308162|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19542045|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20105300|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20105301|NCT00003405|Protective Agents|protective agents|mesh-ancestor
20105302|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20105303|NCT00003406|Carboplatin|carboplatin|mesh-list
20105304|NCT00003406|Docetaxel|docetaxel|mesh-list
19542059|NCT02992964|Nivolumab|nivolumab|mesh-list
20105305|NCT00003406|Ifosfamide|ifosfamide|mesh-list
20105306|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105307|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105308|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542060|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542061|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308163|NCT00662896|Ibuprofen|ibuprofen|mesh-list
19542062|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19542063|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542064|NCT02981472|Vitamin K|vitamin k|mesh-list
19542065|NCT02981472|Heparin|heparin|mesh-list
19542066|NCT02981472|Enoxaparin|enoxaparin|mesh-list
19542067|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19542068|NCT02981472|Tinzaparin|tinzaparin|mesh-list
19542069|NCT02981472|Dalteparin|dalteparin|mesh-list
19542070|NCT02981472|Warfarin|warfarin|mesh-list
19542071|NCT02981472|Apixaban|apixaban|mesh-list
19542072|NCT02981472|Vitamins|vitamins|mesh-ancestor
19542073|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
19542074|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542075|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
19542076|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19542077|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19542078|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542079|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19542080|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
19542081|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19542082|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
19542083|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542084|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19542085|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
19542086|NCT02981472|Coagulants|coagulants|mesh-ancestor
19542087|NCT02962063|Paclitaxel|paclitaxel|mesh-list
19542088|NCT02962063|Carboplatin|carboplatin|mesh-list
19542089|NCT02962063|Durvalumab|durvalumab|mesh-list
19542090|NCT02962063|Tremelimumab|tremelimumab|mesh-list
19542091|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542092|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542093|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542094|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542095|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542096|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542097|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542098|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19542099|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542100|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542101|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542102|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542103|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
19542104|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542105|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542106|NCT02941783|Factor VIII|factor viii|mesh-list
19542107|NCT02941783|Coagulants|coagulants|mesh-ancestor
19542108|NCT02936102|Spartalizumab|spartalizumab|mesh-list
19542109|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19542110|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542111|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542112|NCT02918955|Cisplatin|cisplatin|mesh-list
19542113|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542114|NCT02911792|Metformin|metformin|mesh-list
19542115|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
19542116|NCT02911792|Glipizide|glipizide|mesh-list
19542117|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19542118|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542119|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19542120|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542121|NCT02890212|Selenium|selenium|mesh-list
19542122|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
19542123|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542124|NCT02890212|Protective Agents|protective agents|mesh-ancestor
19542125|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542126|NCT02890212|Trace Elements|trace elements|mesh-ancestor
19542127|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
19542128|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19542129|NCT02879695|Nivolumab|nivolumab|mesh-list
19542130|NCT02879695|Ipilimumab|ipilimumab|mesh-list
19542131|NCT02879695|Blinatumomab|blinatumomab|mesh-list
19542132|NCT02879695|Antibodies|antibodies|mesh-list
19542133|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
19542134|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19542135|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
19542136|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19542137|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
19542138|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542139|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542140|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19542141|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542142|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542143|NCT02873962|Bevacizumab|bevacizumab|mesh-list
19542144|NCT02873962|Nivolumab|nivolumab|mesh-list
19542145|NCT02873962|Rucaparib|rucaparib|mesh-list
19542146|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542147|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542148|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19542149|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19542150|NCT02873962|Growth Substances|growth substances|mesh-ancestor
19542151|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542152|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
19542153|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19542154|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542155|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19542156|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542157|NCT02869789|Nivolumab|nivolumab|mesh-list
19542158|NCT02869789|Ipilimumab|ipilimumab|mesh-list
19542159|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542160|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542161|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19542162|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542163|NCT02862275|Atezolizumab|atezolizumab|mesh-list
19542164|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19542165|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542166|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
19542167|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542168|NCT02856698|Midazolam|midazolam|mesh-list
19542169|NCT02856698|Morphine|morphine|mesh-list
19542170|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19542171|NCT02856698|Narcotics|narcotics|mesh-ancestor
19542172|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542173|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542174|NCT02856698|Analgesics|analgesics|mesh-ancestor
19542175|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
19542176|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542177|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19542178|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19542179|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19542180|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19542181|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19542182|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19542183|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
19542184|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
19542185|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
19542186|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
19542187|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542188|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542189|NCT02823028|Nicotine|nicotine|mesh-list
19542190|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19542191|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
19542192|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542193|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542194|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19542195|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19542196|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
19542197|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542198|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542199|NCT02821923|Erythritol|erythritol|mesh-list
19542200|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
19542201|NCT02794402|Exenatide|exenatide|mesh-list
19542202|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19542203|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542204|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19542205|NCT02794402|Incretins|incretins|mesh-ancestor
19542206|NCT02794402|Hormones|hormones|mesh-ancestor
20105309|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105310|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105311|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105312|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
19542207|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542208|NCT02789657|Paclitaxel|paclitaxel|mesh-list
20105313|NCT00003407|Cytarabine|cytarabine|mesh-list
19542209|NCT02789657|Carboplatin|carboplatin|mesh-list
19542210|NCT02789657|Trastuzumab|trastuzumab|mesh-list
19542211|NCT02789657|Pertuzumab|pertuzumab|mesh-list
20105314|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
19542212|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542213|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542214|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542215|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542216|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542217|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542218|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20105315|NCT00003407|Amifostine|amifostine|mesh-list
20105316|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105317|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
20105318|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105319|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105320|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
19542219|NCT02783092|Cannabidiol|cannabidiol|mesh-list
19542220|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
19542221|NCT02776917|Paclitaxel|paclitaxel|mesh-list
19542222|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542223|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542224|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542225|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542226|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542227|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542228|NCT02775812|Cisplatin|cisplatin|mesh-list
19542229|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
19542230|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542231|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542232|NCT02768948|Losartan|losartan|mesh-list
19542233|NCT02768948|Telmisartan|telmisartan|mesh-list
19542234|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19542235|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19542236|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19542237|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19542238|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105321|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105322|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105323|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
20105324|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105325|NCT00003407|Analgesics|analgesics|mesh-ancestor
20105326|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
20105327|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105328|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105329|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105330|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105331|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20105332|NCT00003407|Protective Agents|protective agents|mesh-ancestor
20105333|NCT00003408|Interferons|interferons|mesh-list
19542239|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
19542240|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19542241|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19542242|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542243|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542244|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19542245|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
19542246|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
19542247|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542248|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542249|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19542250|NCT02685605|Temozolomide|temozolomide|mesh-list
19542251|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19542252|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
19542253|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542254|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542255|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
19542256|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19542257|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19542258|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19542259|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19542260|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542261|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
20105334|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
20105335|NCT00003408|Aldesleukin|aldesleukin|mesh-list
20308164|NCT00662896|Naproxen|naproxen|mesh-list
20308165|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
19542262|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542263|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542264|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19542265|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575201|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575202|NCT03070886|Docetaxel|docetaxel|mesh-list
19575203|NCT03070886|Leuprolide|leuprolide|mesh-list
19575204|NCT03070886|Goserelin|goserelin|mesh-list
19575205|NCT03070886|Bicalutamide|bicalutamide|mesh-list
19575206|NCT03070886|Flutamide|flutamide|mesh-list
19575207|NCT03070886|Nilutamide|nilutamide|mesh-list
19575208|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575209|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575210|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
19575211|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575212|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575213|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19575214|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
19575215|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19575216|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575217|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19575218|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
19575219|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
19575220|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575221|NCT03064867|Rituximab|rituximab|mesh-list
19575222|NCT03064867|Carboplatin|carboplatin|mesh-list
19575223|NCT03064867|Etoposide|etoposide|mesh-list
19575224|NCT03064867|Ifosfamide|ifosfamide|mesh-list
19575225|NCT03064867|Venetoclax|venetoclax|mesh-list
19575226|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575227|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575228|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
19575229|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575230|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575231|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575232|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19575233|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19575234|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575235|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575236|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575237|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
19575238|NCT03049189|Everolimus|everolimus|mesh-list
19575239|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19575240|NCT03049189|Edotreotide|edotreotide|mesh-list
19575241|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575242|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575243|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
19575244|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575245|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19575246|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575247|NCT03014648|Atezolizumab|atezolizumab|mesh-list
19575248|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575249|NCT02756611|Venetoclax|venetoclax|mesh-list
19575250|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575251|NCT02740335|Protein C|protein c|mesh-list
19575252|NCT02740335|Protein S|protein s|mesh-list
19575253|NCT02740335|Thrombin|thrombin|mesh-list
19575254|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
19575255|NCT02740335|Coagulants|coagulants|mesh-ancestor
19575256|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
19575257|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19575258|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19575259|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575260|NCT02724878|Bevacizumab|bevacizumab|mesh-list
19575261|NCT02724878|Atezolizumab|atezolizumab|mesh-list
19749014|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308166|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308167|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308168|NCT00662896|Analgesics|analgesics|mesh-ancestor
19749015|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19749016|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19575262|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575263|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575264|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19575265|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19575266|NCT02724878|Growth Substances|growth substances|mesh-ancestor
19749017|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
19542266|NCT02672917|Folfirinox|folfirinox|mesh-list
19542267|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542268|NCT02640222|Vitamin K|vitamin k|mesh-list
19542269|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
19542270|NCT02640222|Apixaban|apixaban|mesh-list
19542271|NCT02640222|Dabigatran|dabigatran|mesh-list
19542272|NCT02640222|Vitamins|vitamins|mesh-ancestor
19542273|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
19542274|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542275|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19542276|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
19542277|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19542278|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
19542279|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542280|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542281|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
19542282|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19542283|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19542284|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
19542285|NCT02640222|Coagulants|coagulants|mesh-ancestor
19542286|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
19542287|NCT02630628|Tacrolimus|tacrolimus|mesh-list
19542288|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542289|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
19542290|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542291|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19542292|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542293|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542294|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19542295|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542296|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19542297|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
19542298|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19542299|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542300|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
19542301|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19542302|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542303|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19542304|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542305|NCT02603848|Ibuprofen|ibuprofen|mesh-list
19542306|NCT02603848|Morphine|morphine|mesh-list
19542307|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19542308|NCT02603848|Narcotics|narcotics|mesh-ancestor
19542309|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542310|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542311|NCT02603848|Analgesics|analgesics|mesh-ancestor
19542312|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
19542313|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542314|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19542315|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19542316|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19542317|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542318|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19542319|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542320|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542321|NCT02600117|Tenofovir|tenofovir|mesh-list
19542322|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
19542323|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542324|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19542325|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19542326|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542327|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542328|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19542329|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19542330|NCT02586038|Thalidomide|thalidomide|mesh-list
19542331|NCT02586038|Dexamethasone|dexamethasone|mesh-list
20308169|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
20308170|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308171|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308172|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19542332|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
19542333|NCT02586038|Ixazomib|ixazomib|mesh-list
19542334|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542335|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
19542336|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542337|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542338|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20308173|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308174|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20308175|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308176|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308177|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
20308178|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20105336|NCT00003408|Sargramostim|sargramostim|mesh-list
20105337|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105338|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
20105339|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105340|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
20105341|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105342|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20105343|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20105344|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
20105345|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105346|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20105347|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105348|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
20105349|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542339|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
19542340|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542341|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542342|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19542343|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19542344|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
19542345|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
19542346|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542347|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19542348|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
19542349|NCT02586038|Hormones|hormones|mesh-ancestor
19542350|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542351|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542352|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
19542353|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19542354|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542355|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19542356|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19542357|NCT02586038|Growth Substances|growth substances|mesh-ancestor
19542358|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
19542359|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
20105350|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20105351|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105352|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
20105353|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105354|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19542360|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542361|NCT02555839|Thalidomide|thalidomide|mesh-list
19542362|NCT02555839|Dexamethasone|dexamethasone|mesh-list
19542363|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
19542364|NCT02555839|Bortezomib|bortezomib|mesh-list
19542365|NCT02555839|Pomalidomide|pomalidomide|mesh-list
19542366|NCT02555839|BB 1101|bb 1101|mesh-list
20105355|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105356|NCT00003412|Interleukin-12|interleukin-12|mesh-list
20105357|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20105358|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
20105359|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105360|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20105361|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20105362|NCT00003412|Growth Substances|growth substances|mesh-ancestor
20105363|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
20105364|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105365|NCT00003413|Paclitaxel|paclitaxel|mesh-list
20105366|NCT00003413|Melphalan|melphalan|mesh-list
20105367|NCT00003413|Carmustine|carmustine|mesh-list
20308179|NCT00662948|Rituximab|rituximab|mesh-list
20308180|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20308181|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308182|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
19542367|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19542368|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
20308183|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308184|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542369|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
19542370|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105368|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20308185|NCT00662987|Amoxicillin|amoxicillin|mesh-list
19542371|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542372|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19542373|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
19542374|NCT02555839|Hormones|hormones|mesh-ancestor
19542375|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542376|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542377|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542378|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
19542379|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542380|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542381|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
19542382|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19542383|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19542384|NCT02555839|Growth Substances|growth substances|mesh-ancestor
19542385|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
19542386|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542387|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
19542388|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19542389|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542390|NCT02555787|Tacrolimus|tacrolimus|mesh-list
19542391|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542392|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
19542393|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542394|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19542395|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542396|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542397|NCT02535936|Anesthetics|anesthetics|mesh-list
19542398|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542399|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542400|NCT02527434|Durvalumab|durvalumab|mesh-list
19542401|NCT02527434|Tremelimumab|tremelimumab|mesh-list
19542402|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19542403|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542404|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542405|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
19542406|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542407|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
19542408|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19542409|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542410|NCT02513667|Ceritinib|ceritinib|mesh-list
19542411|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542412|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542413|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542414|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542415|NCT02498613|Misonidazole|misonidazole|mesh-list
19542416|NCT02498613|Olaparib|olaparib|mesh-list
19542417|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19542418|NCT02498613|Cediranib|cediranib|mesh-list
19542419|NCT02498613|Maleic acid|maleic acid|mesh-list
19542420|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542421|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542422|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542423|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542424|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19542425|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19542426|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542427|NCT02486718|Gemcitabine|gemcitabine|mesh-list
19542428|NCT02486718|Docetaxel|docetaxel|mesh-list
19542429|NCT02486718|Pemetrexed|pemetrexed|mesh-list
19542430|NCT02486718|Atezolizumab|atezolizumab|mesh-list
19542431|NCT02486718|Vinorelbine|vinorelbine|mesh-list
19542432|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542433|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19542434|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
19542435|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749018|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19749019|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19749020|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19749021|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19749022|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19749023|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
19749024|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542436|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
19749025|NCT05306340|Dexamethasone|dexamethasone|mesh-list
19542437|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542438|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308186|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308187|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308188|NCT00663052|Etanercept|etanercept|mesh-list
20308189|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308190|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19542439|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542440|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
19542441|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542442|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542443|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542444|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542445|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19542446|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19542447|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20308191|NCT00663052|Analgesics|analgesics|mesh-ancestor
20308192|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
20308193|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308194|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308195|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308196|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308197|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20308198|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308199|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
20308200|NCT00663130|Tadalafil|tadalafil|mesh-list
20308201|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19542448|NCT02446600|Gemcitabine|gemcitabine|mesh-list
19542449|NCT02446600|Paclitaxel|paclitaxel|mesh-list
19542450|NCT02446600|Carboplatin|carboplatin|mesh-list
19542451|NCT02446600|Doxorubicin|doxorubicin|mesh-list
19542452|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19542453|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19542454|NCT02446600|Olaparib|olaparib|mesh-list
19542455|NCT02446600|Cediranib|cediranib|mesh-list
19542456|NCT02446600|Maleic acid|maleic acid|mesh-list
19542457|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542458|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542459|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542460|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542461|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542462|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542463|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19542464|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
19542465|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
19542466|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542467|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542468|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542469|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
19542470|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542471|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19542472|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19542473|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19542474|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19542475|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542476|NCT02422615|Fulvestrant|fulvestrant|mesh-list
19542477|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542478|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542479|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19542480|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19542481|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
19542482|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542483|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542484|NCT02415556|Insulin|insulin|mesh-list
19542485|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19542486|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19542487|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542488|NCT02398773|Estradiol|estradiol|mesh-list
19542489|NCT02398773|Estrogens|estrogens|mesh-ancestor
20105369|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105370|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105371|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105372|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105373|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308202|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
20105374|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
20105375|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308203|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19542490|NCT02398773|Hormones|hormones|mesh-ancestor
19542491|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542492|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542493|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
19542494|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542495|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542496|NCT02392429|Cytarabine|cytarabine|mesh-list
19542497|NCT02392429|Alovudine|alovudine|mesh-list
19542498|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19542499|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
19542500|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542501|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542502|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
19542503|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542504|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542505|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
19542506|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542507|NCT02389374|Chloroquine|chloroquine|mesh-list
20105376|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20308204|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20308205|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308206|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308207|NCT00663130|Urological Agents|urological agents|mesh-ancestor
20308208|NCT00663182|Entecavir|entecavir|mesh-list
20308209|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
20308210|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542508|NCT02389374|Lumefantrine|lumefantrine|mesh-list
19542509|NCT02389374|Artemether|artemether|mesh-list
19542510|NCT02389374|Primaquine|primaquine|mesh-list
19542511|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19542512|NCT02389374|Amebicides|amebicides|mesh-ancestor
19542513|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19542514|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19542515|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542516|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
19542517|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542518|NCT02386839|Mecasermin|mecasermin|mesh-list
19542519|NCT02386839|Growth Substances|growth substances|mesh-ancestor
19542520|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542521|NCT02376699|Gemcitabine|gemcitabine|mesh-list
19542522|NCT02376699|Paclitaxel|paclitaxel|mesh-list
19542523|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
19542524|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542525|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542526|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542527|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542528|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542529|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542530|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19542531|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
19542532|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
19542533|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542534|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542535|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542536|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
19542537|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542538|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542539|NCT02362503|Fostemsavir|fostemsavir|mesh-list
19542540|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19542541|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19542542|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
19542543|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542544|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19542545|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19542546|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542547|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
19542548|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19542549|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
19542550|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19542551|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542552|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19542553|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19542554|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20308211|NCT00663195|Furosemide|furosemide|mesh-list
19542555|NCT02347111|Sotalol|sotalol|mesh-list
19542556|NCT02347111|Flecainide|flecainide|mesh-list
19542557|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19542558|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19542559|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
19542560|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542561|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542562|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542563|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19542564|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
19542565|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
19542566|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542567|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19542568|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19542569|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19542570|NCT02339532|Carboplatin|carboplatin|mesh-list
19542571|NCT02339532|Docetaxel|docetaxel|mesh-list
19542572|NCT02339532|Trastuzumab|trastuzumab|mesh-list
19542573|NCT02339532|Pertuzumab|pertuzumab|mesh-list
19542574|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542575|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542576|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542577|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542578|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542579|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542580|NCT02312258|Ixazomib|ixazomib|mesh-list
19542581|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542582|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
19542583|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542584|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542585|NCT02304809|Vemurafenib|vemurafenib|mesh-list
19542586|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542587|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542588|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542589|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542590|NCT02231775|Trametinib|trametinib|mesh-list
19542591|NCT02231775|Dabrafenib|dabrafenib|mesh-list
19542592|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542593|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542594|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542595|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542596|NCT02219581|Dexamethasone|dexamethasone|mesh-list
19542597|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
19542598|NCT02219581|BB 1101|bb 1101|mesh-list
19542599|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19542600|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
19542601|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
19542602|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542603|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542604|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20308212|NCT00663195|Spironolactone|spironolactone|mesh-list
20308213|NCT00663195|Diuretics|diuretics|mesh-ancestor
20308214|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
19542605|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
19542606|NCT02219581|Hormones|hormones|mesh-ancestor
19542607|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542608|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542609|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542610|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
19542611|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542612|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542613|NCT02218164|Interferons|interferons|mesh-list
19542614|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
19542615|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
19542616|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19542617|NCT02218164|Fluorouracil|fluorouracil|mesh-list
19542618|NCT02218164|Capecitabine|capecitabine|mesh-list
19542619|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
19542620|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542621|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20308215|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308216|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19542622|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542623|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542624|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
19542625|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542626|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
19542627|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542628|NCT02213380|Anesthetics|anesthetics|mesh-list
19542629|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542630|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542631|NCT02187991|Paclitaxel|paclitaxel|mesh-list
19542632|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542633|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542634|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542635|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542636|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542637|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542638|NCT02185560|Sorafenib|sorafenib|mesh-list
19542639|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542640|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542641|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542642|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542643|NCT02184195|Olaparib|olaparib|mesh-list
19542644|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19542645|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542646|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542647|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542648|NCT02179086|Temozolomide|temozolomide|mesh-list
19542649|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19542650|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
19542651|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542652|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542653|NCT02142803|Bevacizumab|bevacizumab|mesh-list
19542654|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19542655|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
19542656|NCT02142803|Antibodies|antibodies|mesh-list
19542657|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
19542658|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19542659|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
19542660|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542661|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19542662|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19542663|NCT02142803|Growth Substances|growth substances|mesh-ancestor
19542664|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542665|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
19542666|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
19542667|NCT02131753|Cladribine|cladribine|mesh-list
19542668|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542669|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542670|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
19542671|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542672|NCT02122185|Metformin|metformin|mesh-list
19542673|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19542674|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542675|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
19542676|NCT02089685|Ipilimumab|ipilimumab|mesh-list
19542677|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542678|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542679|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19542680|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542681|NCT02087865|Donepezil|donepezil|mesh-list
19542682|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19542683|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542684|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542685|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
19542686|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542687|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542688|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
19575267|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575268|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
19575269|NCT02723955|Gemcitabine|gemcitabine|mesh-list
19575270|NCT02723955|Paclitaxel|paclitaxel|mesh-list
19575271|NCT02723955|Docetaxel|docetaxel|mesh-list
19575272|NCT02723955|Carboplatin|carboplatin|mesh-list
19575273|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
19575274|NCT02723955|Fluorouracil|fluorouracil|mesh-list
19575275|NCT02723955|Pemetrexed|pemetrexed|mesh-list
19575276|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575277|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575278|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575279|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542689|NCT02034981|Crizotinib|crizotinib|mesh-list
19542690|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542691|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542692|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542693|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542694|NCT02007512|Exemestane|exemestane|mesh-list
19542695|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542696|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19542697|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19542698|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542699|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542700|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19542701|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
19542702|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542703|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542704|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
19542705|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
19542706|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
19542707|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542708|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542709|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
19542710|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542711|NCT02000089|Secretin|secretin|mesh-list
19542712|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19542713|NCT02000089|Hormones|hormones|mesh-ancestor
19542714|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542715|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542716|NCT01999179|Heparin|heparin|mesh-list
19542717|NCT01999179|Enoxaparin|enoxaparin|mesh-list
20308217|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20308218|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308219|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20308220|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
20308221|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308222|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20308223|NCT00663221|Vitamin D|vitamin d|mesh-list
19542718|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19542719|NCT01999179|Tinzaparin|tinzaparin|mesh-list
19542720|NCT01999179|Dalteparin|dalteparin|mesh-list
20308224|NCT00663221|Calcium|calcium|mesh-list
20308225|NCT00663221|Vitamins|vitamins|mesh-ancestor
20308226|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
20308227|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308228|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20308229|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20308230|NCT00663247|Mesalamine|mesalamine|mesh-list
20308231|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20308232|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20308233|NCT00663247|Analgesics|analgesics|mesh-ancestor
20308234|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
20308235|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308939|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
19542721|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
19542722|NCT01999179|Dabigatran|dabigatran|mesh-list
19542723|NCT01999179|Apixaban|apixaban|mesh-list
19542724|NCT01999179|Edoxaban|edoxaban|mesh-list
19542725|NCT01999179|Anticoagulants|anticoagulants|mesh-list
19542726|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19542727|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19542728|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542729|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19542730|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
19542731|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19542732|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
19542733|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542734|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
19542735|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19542736|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
19542737|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19542738|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542739|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19542740|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19542741|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19542742|NCT01889199|Flutamide|flutamide|mesh-list
19542743|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
19542744|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
19542745|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542746|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542747|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542748|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542749|NCT01868269|Dexamethasone|dexamethasone|mesh-list
19542750|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
19542751|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
19542752|NCT01868269|Rituximab|rituximab|mesh-list
19542753|NCT01868269|BB 1101|bb 1101|mesh-list
19542754|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542755|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
19542756|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542757|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542758|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19542759|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
19542760|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542761|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542762|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19542763|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542764|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19542765|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
19542766|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
19542767|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542768|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19542769|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
19542770|NCT01868269|Hormones|hormones|mesh-ancestor
19542771|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542772|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542773|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
19542774|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542775|NCT01810913|Cisplatin|cisplatin|mesh-list
19542776|NCT01810913|Docetaxel|docetaxel|mesh-list
19542777|NCT01810913|Cetuximab|cetuximab|mesh-list
19542778|NCT01810913|Atezolizumab|atezolizumab|mesh-list
19542779|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19542780|NCT01810913|Antibodies|antibodies|mesh-list
19542781|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
19542782|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19542783|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
19542784|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542785|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542786|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542787|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542788|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542789|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542790|NCT01796197|Paclitaxel|paclitaxel|mesh-list
19542791|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
19542792|NCT01796197|Doxorubicin|doxorubicin|mesh-list
19542793|NCT01796197|Trastuzumab|trastuzumab|mesh-list
19542794|NCT01796197|Pertuzumab|pertuzumab|mesh-list
19542795|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542796|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542797|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542798|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542799|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542800|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542801|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542802|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
19542803|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542804|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542805|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19542806|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
19542807|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19542808|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19542809|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19542810|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19542811|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542812|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542813|NCT01748448|Vitamin D|vitamin d|mesh-list
19542814|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
19542815|NCT01748448|Vitamins|vitamins|mesh-ancestor
19542816|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
19542817|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542818|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19542819|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19542820|NCT01730313|Pyridoxine|pyridoxine|mesh-list
19542821|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
19542822|NCT01730313|Phenytoin|phenytoin|mesh-list
19542823|NCT01730313|Valproic Acid|valproic acid|mesh-list
19542824|NCT01730313|Vitamins|vitamins|mesh-ancestor
19542825|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
19542826|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308236|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308237|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20308238|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20308239|NCT00663286|Clindamycin|clindamycin|mesh-list
20308240|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
19542827|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
19542828|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
19542829|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542830|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542831|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
19542832|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542833|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
19542834|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19542835|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19542836|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19542837|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19542838|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19542839|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19542840|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19542841|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19542842|NCT01679119|Gemcitabine|gemcitabine|mesh-list
19542843|NCT01679119|Prednisolone|prednisolone|mesh-list
19542844|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
19542845|NCT01679119|Rituximab|rituximab|mesh-list
19542846|NCT01679119|Vincristine|vincristine|mesh-list
19542847|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19542848|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542849|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
19542850|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542851|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542852|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19542853|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
19542854|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542855|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542856|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19542857|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542858|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19542859|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
19542860|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
19542861|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542862|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542863|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542864|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
19542865|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
19542866|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
19542867|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19542868|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
19542869|NCT01679119|Hormones|hormones|mesh-ancestor
19542870|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542871|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542872|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19542873|NCT01665144|Siponimod|siponimod|mesh-list
19542874|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19542875|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542876|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19542877|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
19542878|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542879|NCT01617096|Dapivirine|dapivirine|mesh-list
19542880|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19542881|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19542882|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
20308241|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
20308242|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20308243|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20308244|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308245|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19542883|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19542884|NCT01478698|Plasminogen|plasminogen|mesh-list
19542885|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20308246|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308247|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542886|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19542887|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19542888|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542889|NCT01473628|Rituximab|rituximab|mesh-list
19542890|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19542891|NCT01473628|Antibodies|antibodies|mesh-list
19542892|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
19542893|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19542894|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
19542895|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542896|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542897|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542898|NCT01428089|Progesterone|progesterone|mesh-list
19542899|NCT01428089|Progestins|progestins|mesh-ancestor
19542900|NCT01428089|Hormones|hormones|mesh-ancestor
19542901|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542902|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542903|NCT01372254|Nicotine|nicotine|mesh-list
19542904|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19542905|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
19542906|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542907|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542908|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19542909|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19542910|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
19542911|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542912|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542913|NCT01351766|Nicotine|nicotine|mesh-list
19542914|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19542915|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
19542916|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19542917|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542918|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19542919|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19542920|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
19542921|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542922|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542923|NCT01340430|Trastuzumab|trastuzumab|mesh-list
19542924|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542925|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542926|NCT01303341|Sorafenib|sorafenib|mesh-list
19542927|NCT01303341|Riluzole|riluzole|mesh-list
19542928|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542929|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19542930|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542931|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542932|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
20308248|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308249|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20105377|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
20105378|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105379|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105380|NCT00003414|Interferons|interferons|mesh-list
20105381|NCT00003414|Aldesleukin|aldesleukin|mesh-list
20308250|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20308251|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308252|NCT00663338|Rotigotine|rotigotine|mesh-list
20308253|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
20308254|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
20308255|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308256|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308257|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308258|NCT00663377|Losartan|losartan|mesh-list
19542933|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19542934|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19542935|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542936|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542937|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19542938|NCT01303341|Protective Agents|protective agents|mesh-ancestor
19542939|NCT01199380|Nicotine|nicotine|mesh-list
19749026|NCT05306340|Everolimus|everolimus|mesh-list
19542940|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19542941|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
19749027|NCT05306340|Exemestane|exemestane|mesh-list
20105382|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
20105383|NCT00003414|Cyclosporine|cyclosporine|mesh-list
20105384|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
19542942|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20308259|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19542943|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542944|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19542945|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19542946|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
19542947|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19542948|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542949|NCT01064635|Letrozole|letrozole|mesh-list
19542950|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542951|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19542952|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19542953|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542954|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542955|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19542956|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
19542957|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542958|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542959|NCT00930228|Flutamide|flutamide|mesh-list
19542960|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
19542961|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
19542962|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542963|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542964|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19542965|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542966|NCT00929006|Progesterone|progesterone|mesh-list
19542967|NCT00929006|Progestins|progestins|mesh-ancestor
19542968|NCT00929006|Hormones|hormones|mesh-ancestor
19542969|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19542970|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542971|NCT00903110|Mecasermin|mecasermin|mesh-list
19542972|NCT00903110|Growth Substances|growth substances|mesh-ancestor
19542973|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542974|NCT00877214|Rituximab|rituximab|mesh-list
19542975|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542976|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542977|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
19542978|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542979|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19542980|NCT00810017|Trastuzumab|trastuzumab|mesh-list
19542981|NCT00810017|Etoposide|etoposide|mesh-list
19542982|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19542983|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19542984|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19542985|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19542986|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19542987|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19542988|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19542989|NCT00669669|Plerixafor|plerixafor|mesh-list
19542990|NCT00669669|Temozolomide|temozolomide|mesh-list
19542991|NCT00669669|Carmustine|carmustine|mesh-list
19542992|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19542993|NCT00669669|Lenograstim|lenograstim|mesh-list
19542994|NCT00669669|Sargramostim|sargramostim|mesh-list
19542995|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19542996|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
19542997|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19542998|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19542999|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
19543000|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543001|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543002|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19543003|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19543004|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
19543005|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543006|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543007|NCT00601900|Tamoxifen|tamoxifen|mesh-list
19543008|NCT00601900|Bevacizumab|bevacizumab|mesh-list
19543009|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19543010|NCT00601900|Letrozole|letrozole|mesh-list
20105385|NCT00003414|Busulfan|busulfan|mesh-list
20105386|NCT00003414|Cyclosporins|cyclosporins|mesh-list
20105387|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105388|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
20308260|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20604245|NCT02226289|Bevacizumab|bevacizumab|mesh-list
19543011|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
19543012|NCT00601900|Antibodies|antibodies|mesh-list
19543013|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
19543014|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19543015|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
19543016|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543017|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19543018|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19543019|NCT00601900|Growth Substances|growth substances|mesh-ancestor
19543020|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543021|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
19543022|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
19543023|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308261|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20308262|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20308263|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308264|NCT00663442|Methylphenidate|methylphenidate|mesh-list
20308265|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20308266|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308267|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20308268|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20308269|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20308270|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308271|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
19543024|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19543025|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20308272|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20308273|NCT00663455|Cyclosporine|cyclosporine|mesh-list
20308274|NCT00663455|Cyclosporins|cyclosporins|mesh-list
20308275|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308276|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20308277|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308278|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
20308279|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308280|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
19543026|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543027|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19543028|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
19543029|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543030|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19543031|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19543032|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19543033|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19543034|NCT00549848|Cytarabine|cytarabine|mesh-list
19543035|NCT00549848|Dexamethasone|dexamethasone|mesh-list
19543036|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
19543037|NCT00549848|Prednisone|prednisone|mesh-list
19543038|NCT00549848|Prednisolone|prednisolone|mesh-list
19543039|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
19543040|NCT00549848|Doxorubicin|doxorubicin|mesh-list
19543041|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19543042|NCT00549848|Methotrexate|methotrexate|mesh-list
19543043|NCT00549848|Etoposide|etoposide|mesh-list
19543044|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
19543045|NCT00549848|Vincristine|vincristine|mesh-list
19543046|NCT00549848|Daunorubicin|daunorubicin|mesh-list
19543047|NCT00549848|Asparaginase|asparaginase|mesh-list
19543048|NCT00549848|Dasatinib|dasatinib|mesh-list
19543049|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
19543050|NCT00549848|Clofarabine|clofarabine|mesh-list
19543051|NCT00549848|Pegaspargase|pegaspargase|mesh-list
19543052|NCT00549848|Thioguanine|thioguanine|mesh-list
19543053|NCT00549848|BB 1101|bb 1101|mesh-list
19543054|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543055|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
19543056|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543057|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543058|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19543059|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
19543060|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543061|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543062|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19749028|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543063|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543064|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
19543065|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
19749029|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
19543066|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543067|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543068|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
19543069|NCT00549848|Hormones|hormones|mesh-ancestor
19543070|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543071|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19543072|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
19543073|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543074|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19543075|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19543076|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19543077|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19543078|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
19543079|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19543080|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19543081|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
19543082|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
19543083|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19543084|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19543085|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19543086|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
19543087|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543088|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
19543089|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
19543090|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
19543091|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19543092|NCT00504712|Testosterone|testosterone|mesh-list
19543093|NCT00504712|Androgens|androgens|mesh-ancestor
19543094|NCT00504712|Hormones|hormones|mesh-ancestor
19543095|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543096|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543097|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
19543098|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19543099|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19543100|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543101|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
19543102|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543103|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543104|NCT00433511|Paclitaxel|paclitaxel|mesh-list
19543105|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
19543106|NCT00433511|Bevacizumab|bevacizumab|mesh-list
19543107|NCT00433511|Doxorubicin|doxorubicin|mesh-list
19543108|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19543109|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19543110|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19543111|NCT00433511|Antibodies|antibodies|mesh-list
19543112|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
19543113|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19543114|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
19543115|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
19543116|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19543117|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543118|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
19543119|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
19543120|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
19543121|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543122|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543123|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
19543124|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543125|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543126|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19543127|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
19543128|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19543129|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19543130|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19543131|NCT00433511|Growth Substances|growth substances|mesh-ancestor
19543132|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
19543133|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19543134|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19543135|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19543136|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543137|NCT00433420|Paclitaxel|paclitaxel|mesh-list
19543138|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
19543139|NCT00433420|Fluorouracil|fluorouracil|mesh-list
19543140|NCT00433420|Epirubicin|epirubicin|mesh-list
19543141|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20308281|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20308282|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
20308283|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543142|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543143|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19543144|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19543145|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19543146|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543147|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543148|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
19543149|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543150|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543151|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19543152|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
19543153|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19543154|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
19543155|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19543156|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19543157|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19543158|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19543159|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543160|NCT00390325|Sorafenib|sorafenib|mesh-list
19543161|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543162|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19543163|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543164|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575280|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575281|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575282|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19575283|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
20308284|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20308285|NCT00663481|Leucovorin|leucovorin|mesh-list
20308286|NCT00663481|Antidotes|antidotes|mesh-ancestor
20308287|NCT00663481|Protective Agents|protective agents|mesh-ancestor
20308288|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575284|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
19575285|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575286|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575287|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20308289|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
19575288|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
19575289|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575290|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575291|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19575292|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19575293|NCT02720068|Leucovorin|leucovorin|mesh-list
19575294|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
19575295|NCT02720068|Fluorouracil|fluorouracil|mesh-list
19575296|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
19575297|NCT02720068|Irinotecan|irinotecan|mesh-list
19575298|NCT02720068|Lenvatinib|lenvatinib|mesh-list
19575299|NCT02720068|Calcium|calcium|mesh-list
19575300|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
19575301|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19575302|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575303|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575304|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575305|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
19575306|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575307|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19575308|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575309|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
19575310|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19575311|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19575312|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575313|NCT02720068|Antidotes|antidotes|mesh-ancestor
19575314|NCT02720068|Protective Agents|protective agents|mesh-ancestor
19575315|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
19575316|NCT02720068|Vitamins|vitamins|mesh-ancestor
19575317|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
19575318|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575319|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
19575320|NCT02693535|Nivolumab|nivolumab|mesh-list
19575321|NCT02693535|Trastuzumab|trastuzumab|mesh-list
19575322|NCT02693535|Ipilimumab|ipilimumab|mesh-list
19575323|NCT02693535|Pertuzumab|pertuzumab|mesh-list
20308290|NCT00663481|Vitamins|vitamins|mesh-ancestor
19543165|NCT00221988|Levetiracetam|levetiracetam|mesh-list
19543166|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
19543167|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
19543168|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19543169|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19543170|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19543171|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19543172|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543173|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543174|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543175|NCT00071708|Analgesics|analgesics|mesh-ancestor
19543176|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
19543177|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543178|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
19543179|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19543180|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
20308291|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
20308292|NCT00663559|Sunitinib|sunitinib|mesh-list
20308293|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20308294|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20308295|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20308296|NCT00663559|Growth Substances|growth substances|mesh-ancestor
20308297|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308298|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
20308299|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20308300|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20308301|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105389|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105390|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105391|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105392|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
20105393|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105394|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105395|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105396|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
20105397|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105398|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105399|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
20105400|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105401|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20105402|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20105403|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20105404|NCT00003415|Topotecan|topotecan|mesh-list
20105405|NCT00003415|Amifostine|amifostine|mesh-list
20105406|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20105407|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105408|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543181|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19543182|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19543183|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543184|NCT02850250|Cefuroxime|cefuroxime|mesh-list
19543185|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
19543186|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19543187|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543188|NCT02850445|Olanzapine|olanzapine|mesh-list
19543189|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
19543190|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
19543191|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543192|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543193|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543194|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19543195|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19543196|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543197|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19543198|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19543199|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19543200|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19543201|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543202|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543203|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
19543204|NCT02850211|Ibuprofen|ibuprofen|mesh-list
19543205|NCT02850211|Celecoxib|celecoxib|mesh-list
19543206|NCT02850211|Tramadol|tramadol|mesh-list
20105409|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543207|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19543208|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543209|NCT02850211|Analgesics|analgesics|mesh-ancestor
19543210|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
19543211|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543212|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543213|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543214|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543215|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19543216|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543217|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543218|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19543219|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19543220|NCT02850211|Narcotics|narcotics|mesh-ancestor
19543221|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543222|NCT02850289|Interferons|interferons|mesh-list
19543223|NCT02850289|Ribavirin|ribavirin|mesh-list
19543224|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543225|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
19543226|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543227|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
19543228|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543229|NCT02850484|Budesonide|budesonide|mesh-list
19543230|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
19543231|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543232|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19543233|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
19543234|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543235|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543236|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19543237|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
19543238|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
19543239|NCT02850484|Hormones|hormones|mesh-ancestor
19543240|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543241|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19543242|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20105410|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543243|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19543244|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
19543245|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543246|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543247|NCT02850081|Atorvastatin|atorvastatin|mesh-list
19543248|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19543249|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19543250|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19543251|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
19543252|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543253|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19543254|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543255|NCT02849873|Tazarotene|tazarotene|mesh-list
19543256|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
19543257|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
19543258|NCT02850016|Romidepsin|romidepsin|mesh-list
19543259|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19543260|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19543261|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543262|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543263|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543264|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
19543265|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19543266|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19543267|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543268|NCT02849899|Vildagliptin|vildagliptin|mesh-list
19543269|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543270|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543271|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19543272|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
19543273|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543274|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105411|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20105412|NCT00003415|Protective Agents|protective agents|mesh-ancestor
20105413|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105414|NCT00003416|Interferons|interferons|mesh-list
19543275|NCT02849743|Oxytocin|oxytocin|mesh-list
19543276|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
19543277|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19543278|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543279|NCT02849483|Ramosetron|ramosetron|mesh-list
19543280|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
19543281|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
19543282|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543283|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543284|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543285|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19543286|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
19543287|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543288|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543289|NCT02849730|Fentanyl|fentanyl|mesh-list
20105415|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
20105416|NCT00003416|Dexamethasone|dexamethasone|mesh-list
20105417|NCT00003416|Melphalan|melphalan|mesh-list
20105418|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105419|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
20105420|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
20105421|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105422|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105423|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105424|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
20105425|NCT00003416|Hormones|hormones|mesh-ancestor
20105426|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105427|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105428|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105429|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
20105430|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105431|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
20105432|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105433|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
20105434|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105435|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105436|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105437|NCT00003417|Carmustine|carmustine|mesh-list
20105438|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105439|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
19543290|NCT02849730|Analgesics|analgesics|mesh-list
19543291|NCT02849730|Ropivacaine|ropivacaine|mesh-list
19543292|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
19543293|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
19543294|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543295|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543296|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
19543297|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543298|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19543299|NCT02849730|Narcotics|narcotics|mesh-ancestor
19543300|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19543301|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19543302|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
19543303|NCT02849470|Complement Factor H|complement factor h|mesh-list
19543304|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19543305|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543306|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
19543307|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543308|NCT02849548|Suvorexant|suvorexant|mesh-list
19543309|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19543310|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19543311|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543312|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543313|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19543314|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543315|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543316|NCT02849236|Ropivacaine|ropivacaine|mesh-list
19543317|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
19543318|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
19543319|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575324|NCT02693535|Atezolizumab|atezolizumab|mesh-list
19749030|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
20105440|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105441|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105442|NCT00003418|Tamoxifen|tamoxifen|mesh-list
20105443|NCT00003418|Exemestane|exemestane|mesh-list
20105444|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105445|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19543320|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543321|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
19543322|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575325|NCT02693535|Sunitinib|sunitinib|mesh-list
19575326|NCT02693535|Olaparib|olaparib|mesh-list
19575327|NCT02693535|Palbociclib|palbociclib|mesh-list
19575328|NCT02693535|Afatinib|afatinib|mesh-list
19575329|NCT02693535|Vemurafenib|vemurafenib|mesh-list
19575330|NCT02693535|Crizotinib|crizotinib|mesh-list
19575331|NCT02693535|Talazoparib|talazoparib|mesh-list
19575332|NCT02693535|Tucatinib|tucatinib|mesh-list
19575333|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19575334|NCT02693535|Entrectinib|entrectinib|mesh-list
19575335|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575336|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575337|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19575338|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575339|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
19575340|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575341|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19575342|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19575343|NCT02693535|Growth Substances|growth substances|mesh-ancestor
19575344|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
19575345|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575346|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575347|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19575348|NCT02692313|Epinephrine|epinephrine|mesh-list
19575349|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19575350|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19575351|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
19575352|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575353|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575354|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575355|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19575356|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19575357|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
19575358|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575359|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19575360|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
19575361|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
19575362|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
19575363|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19575364|NCT02666105|Exemestane|exemestane|mesh-list
19575365|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575366|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19575367|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19575368|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575369|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575370|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19575371|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
19575372|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575373|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575374|NCT02641873|Leucovorin|leucovorin|mesh-list
19575375|NCT02641873|Bevacizumab|bevacizumab|mesh-list
19575376|NCT02641873|Irinotecan|irinotecan|mesh-list
19575377|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
19575378|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575379|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575380|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19575381|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19575382|NCT02641873|Growth Substances|growth substances|mesh-ancestor
19575383|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575384|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
19575385|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20604246|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604247|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604248|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20604249|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20604250|NCT02226289|Growth Substances|growth substances|mesh-ancestor
19575386|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19575387|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575388|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749031|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575389|NCT02641873|Antidotes|antidotes|mesh-ancestor
19575390|NCT02641873|Protective Agents|protective agents|mesh-ancestor
19575391|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
19749032|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749033|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19749034|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
19749035|NCT05306340|Hormones|hormones|mesh-ancestor
20105446|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
20105447|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105448|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105449|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105450|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543323|NCT02848963|Ketamine|ketamine|mesh-list
19543324|NCT02848963|Propofol|propofol|mesh-list
19543325|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19543326|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543327|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543328|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19543329|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
19543330|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
19543331|NCT02848963|Analgesics|analgesics|mesh-ancestor
19543332|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
20105451|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20105452|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20105453|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20105454|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20105455|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20105456|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105457|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
19543333|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543334|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19543335|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19543336|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19543337|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543338|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543339|NCT02848937|Citric Acid|citric acid|mesh-list
19543340|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
19543341|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
19543342|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19543343|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
19543344|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
19543345|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543346|NCT02848950|Metformin|metformin|mesh-list
19543347|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543348|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105458|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105459|NCT00003421|Prednisolone|prednisolone|mesh-list
20105460|NCT00003421|Doxorubicin|doxorubicin|mesh-list
19543349|NCT02849132|Entecavir|entecavir|mesh-list
19543350|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
19543351|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543352|NCT02849171|Choline|choline|mesh-list
19543353|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
19543354|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19543355|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
19543356|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543357|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543358|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19543359|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
19543360|NCT02848612|Heparin|heparin|mesh-list
19543361|NCT02848612|Calcium heparin|calcium heparin|mesh-list
19543362|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
19543363|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19543364|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19543365|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543366|NCT02848794|Irinotecan|irinotecan|mesh-list
19543367|NCT02848794|Apatinib|apatinib|mesh-list
19543368|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19543369|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19543370|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543371|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543372|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543373|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19543374|NCT02848820|Amoxicillin|amoxicillin|mesh-list
19543375|NCT02848820|Gentamicins|gentamicins|mesh-list
19543376|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20105461|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19543377|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
19543378|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
19575392|NCT02641873|Vitamins|vitamins|mesh-ancestor
19543379|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19543380|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543381|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19543382|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543383|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543384|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19543385|NCT02848560|Xenon|xenon|mesh-list
19543386|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19543387|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
19543388|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
19543389|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543390|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543391|NCT02848768|Sunitinib|sunitinib|mesh-list
19543392|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543393|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19543394|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20105462|NCT00003421|Bleomycin|bleomycin|mesh-list
20105463|NCT00003421|Etoposide|etoposide|mesh-list
20105464|NCT00003421|Vincristine|vincristine|mesh-list
20105465|NCT00003421|Dacarbazine|dacarbazine|mesh-list
20105466|NCT00003421|Vinblastine|vinblastine|mesh-list
20105467|NCT00003421|Procarbazine|procarbazine|mesh-list
20105468|NCT00003421|Chlorambucil|chlorambucil|mesh-list
20105469|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105470|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105471|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105472|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105473|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105474|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105475|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105476|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
19543395|NCT02848768|Growth Substances|growth substances|mesh-ancestor
19543396|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543397|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
19543398|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19543399|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543400|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543401|NCT02848508|Metformin|metformin|mesh-list
19543402|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543403|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543404|NCT02848443|Trifluridine|trifluridine|mesh-list
19543405|NCT02848443|Bevacizumab|bevacizumab|mesh-list
19543406|NCT02848443|Nivolumab|nivolumab|mesh-list
19543407|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
19543408|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19543409|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543410|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19543411|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19543412|NCT02848443|Growth Substances|growth substances|mesh-ancestor
19543413|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543414|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
19543415|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19543416|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543417|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
19543418|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
19543419|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543420|NCT02848183|Cytarabine|cytarabine|mesh-list
19543421|NCT02848183|Etoposide|etoposide|mesh-list
19543422|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
19543423|NCT02848183|Idarubicin|idarubicin|mesh-list
19543424|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19543425|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543426|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19543427|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19543428|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543429|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543430|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19543431|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
19543432|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
19543433|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105477|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105478|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604251|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543434|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543435|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
19543436|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105479|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543437|NCT02848183|Analgesics|analgesics|mesh-ancestor
19543438|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
19543439|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543440|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105480|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
20105481|NCT00003421|Hormones|hormones|mesh-ancestor
20105482|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105483|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105484|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105485|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105486|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
20105487|NCT00003422|Leucovorin|leucovorin|mesh-list
20105488|NCT00003422|Fluorouracil|fluorouracil|mesh-list
20105489|NCT00003422|Calcium|calcium|mesh-list
19543441|NCT02848417|Curcumin|curcumin|mesh-list
19543442|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19543443|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543444|NCT02848417|Analgesics|analgesics|mesh-ancestor
19543445|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
19543446|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543447|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543448|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543449|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543450|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543451|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543452|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543453|NCT02848209|Phenol|phenol|mesh-list
19543454|NCT02848209|Croton Oil|croton oil|mesh-list
19543455|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19543456|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543457|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
19543458|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19543459|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19543460|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
19543461|NCT02848300|Bimatoprost|bimatoprost|mesh-list
19543462|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19543463|NCT02848170|Olmesartan|olmesartan|mesh-list
19543464|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19543465|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19543466|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19543467|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19543468|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543469|NCT02848339|Aspirin|aspirin|mesh-list
20105490|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
20105491|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20105492|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105493|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
20105494|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105495|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105496|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604252|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
19543470|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19543471|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543472|NCT02848339|Analgesics|analgesics|mesh-ancestor
19543473|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
19543474|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543475|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543476|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543477|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543478|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19543479|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19543480|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543481|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19543482|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19543483|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543484|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
19543485|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
19543486|NCT02848157|Ropivacaine|ropivacaine|mesh-list
20105497|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105498|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
19543487|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19543488|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543489|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543490|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20604253|NCT02226328|Fentanyl|fentanyl|mesh-list
19543491|NCT02848157|Analgesics|analgesics|mesh-ancestor
19543492|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
19543493|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543494|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19543495|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20105499|NCT00003422|Antidotes|antidotes|mesh-ancestor
20105500|NCT00003422|Protective Agents|protective agents|mesh-ancestor
20105501|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
20105502|NCT00003422|Vitamins|vitamins|mesh-ancestor
20105503|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
20105504|NCT00003423|Cytarabine|cytarabine|mesh-list
20105505|NCT00003423|Dexamethasone|dexamethasone|mesh-list
20105506|NCT00003423|Prednisolone|prednisolone|mesh-list
20105507|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
20105508|NCT00003423|Methotrexate|methotrexate|mesh-list
20105509|NCT00003423|Etoposide|etoposide|mesh-list
20105510|NCT00003423|Vincristine|vincristine|mesh-list
20105511|NCT00003423|Daunorubicin|daunorubicin|mesh-list
20105512|NCT00003423|Asparaginase|asparaginase|mesh-list
20105513|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
20105514|NCT00003423|Thioguanine|thioguanine|mesh-list
20105515|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105516|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
20105517|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105518|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105519|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105520|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
19543496|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19543497|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
19543498|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543499|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543500|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
19543501|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
19543502|NCT02848287|Ropivacaine|ropivacaine|mesh-list
19543503|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
19543504|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
19543505|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543506|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543507|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
19543508|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543509|NCT02847884|Infliximab|infliximab|mesh-list
19543510|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
19543511|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543512|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543513|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
19543514|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543515|NCT02847806|Insulin|insulin|mesh-list
19543516|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19543517|NCT02847806|Estradiol|estradiol|mesh-list
19543518|NCT02847806|Testosterone|testosterone|mesh-list
19543519|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543520|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543521|NCT02847806|Estrogens|estrogens|mesh-ancestor
19543522|NCT02847806|Hormones|hormones|mesh-ancestor
19543523|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543524|NCT02847806|Androgens|androgens|mesh-ancestor
19543525|NCT02847702|Naproxen|naproxen|mesh-list
19543526|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19543527|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543528|NCT02847702|Analgesics|analgesics|mesh-ancestor
19543529|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
19543530|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543531|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543532|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543533|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543534|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
19543535|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20105521|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105522|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105523|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20308302|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19543536|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543537|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543538|NCT02847442|Levodopa|levodopa|mesh-list
19543539|NCT02847442|Opicapone|opicapone|mesh-list
19543540|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
19575393|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
20105524|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105525|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
20105526|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
20105527|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105528|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105529|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
20105530|NCT00003423|Hormones|hormones|mesh-ancestor
20105531|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105532|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105533|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20105534|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
20105535|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19543541|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
19543542|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19543543|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19543544|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
19543545|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543546|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543547|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543548|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19543549|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575394|NCT02629120|Sirolimus|sirolimus|mesh-list
19575395|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
19575396|NCT02629120|Busulfan|busulfan|mesh-list
19575397|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
19575398|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575399|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
19575400|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575401|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575402|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575403|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
19575404|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575405|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575406|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19575407|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19575408|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575409|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19575410|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
19575411|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575412|NCT02605993|Ravulizumab|ravulizumab|mesh-list
19575413|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19575414|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105536|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105537|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
20105538|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105539|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575415|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
19575416|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575417|NCT02598726|Curcumin|curcumin|mesh-list
19575418|NCT02598726|Piperine|piperine|mesh-list
19575419|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19575420|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19575421|NCT02598726|Analgesics|analgesics|mesh-ancestor
19575422|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
19575423|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575424|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575425|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105540|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20105541|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20105542|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105543|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105544|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105545|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
20105546|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105547|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105548|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105549|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105550|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105551|NCT00003424|Tamoxifen|tamoxifen|mesh-list
20105552|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20105553|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
20105554|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575426|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105555|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105556|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105557|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543550|NCT02847455|Rabeprazole|rabeprazole|mesh-list
19543551|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19543552|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543553|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19543554|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543555|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543556|NCT02847429|Crenolanib|crenolanib|mesh-list
19543557|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543558|NCT02847403|Exenatide|exenatide|mesh-list
19543559|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543560|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543561|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19543562|NCT02847403|Incretins|incretins|mesh-ancestor
19543563|NCT02847403|Hormones|hormones|mesh-ancestor
19543564|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543565|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19543566|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19543567|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543568|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
19543569|NCT02847338|Amlodipine|amlodipine|mesh-list
19543570|NCT02847338|Lisinopril|lisinopril|mesh-list
19543571|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
19543572|NCT02847338|Amiloride|amiloride|mesh-list
19543573|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19543574|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19543575|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20105558|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20105559|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20105560|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20105561|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
20105562|NCT00003425|Melphalan|melphalan|mesh-list
19543576|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543577|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19543578|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543579|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
19543580|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19543581|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
19543582|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543583|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19543584|NCT02847338|Protective Agents|protective agents|mesh-ancestor
19543585|NCT02847338|Diuretics|diuretics|mesh-ancestor
19543586|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
19543587|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19543588|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19543589|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19543590|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19543591|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19543592|NCT02847104|Insulin|insulin|mesh-list
19543593|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19543594|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543595|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543596|NCT02847013|Bupivacaine|bupivacaine|mesh-list
19543597|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
19543598|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
19543599|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543600|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543601|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
19543602|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543603|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
19543604|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543605|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543606|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20105563|NCT00003425|Amifostine|amifostine|mesh-list
20105564|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105565|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
20105566|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105567|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105568|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105569|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
20105570|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543607|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543608|NCT02846909|Progesterone|progesterone|mesh-list
19543609|NCT02846909|Progestins|progestins|mesh-ancestor
19543610|NCT02846909|Hormones|hormones|mesh-ancestor
20105571|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543611|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543612|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105572|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19543613|NCT02846935|Decitabine|decitabine|mesh-list
19543614|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
19543615|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19543616|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
19543617|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543618|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543619|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543620|NCT02847286|Dapivirine|dapivirine|mesh-list
19543621|NCT02847286|Clotrimazole|clotrimazole|mesh-list
19543622|NCT02847286|Miconazole|miconazole|mesh-list
19543623|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19543624|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19543625|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
19543626|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543627|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19543628|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
19543629|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19543630|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19543631|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543632|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543633|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19543634|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
19543635|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543636|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543637|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19543638|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19543639|NCT02847000|Decitabine|decitabine|mesh-list
19543640|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
19543641|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19543642|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
19543643|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543644|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543645|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543646|NCT02847143|Oxytocin|oxytocin|mesh-list
19543647|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
19543648|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19543649|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543650|NCT02846857|Insulin|insulin|mesh-list
19543651|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19543652|NCT02846857|Glucagon|glucagon|mesh-list
19543653|NCT02846857|Hormones|hormones|mesh-list
19543654|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543655|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543656|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543657|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19543658|NCT02846623|Atezolizumab|atezolizumab|mesh-list
19543659|NCT02846623|Venetoclax|venetoclax|mesh-list
19543660|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
19543661|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19543662|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543663|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
19543664|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543665|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19543666|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19543667|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19543668|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19543669|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19543670|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543671|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543672|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543673|NCT02846701|Analgesics|analgesics|mesh-ancestor
19543674|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
19543675|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543676|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
19543677|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19543678|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
19543679|NCT02846831|Insulin|insulin|mesh-list
19543680|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19543681|NCT02846831|Hormones|hormones|mesh-list
19543682|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543683|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543684|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543685|NCT02846766|Lenvatinib|lenvatinib|mesh-list
19543686|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543687|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19543688|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543689|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543690|NCT02846493|Dexamethasone|dexamethasone|mesh-list
19543691|NCT02846493|Bromocriptine|bromocriptine|mesh-list
19543692|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19543693|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
19543694|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
19543695|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543696|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543697|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105573|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20105574|NCT00003425|Protective Agents|protective agents|mesh-ancestor
19543698|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
19543699|NCT02846493|Hormones|hormones|mesh-ancestor
19543700|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543701|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19543702|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543703|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19543704|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19543705|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
19543706|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
19543707|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
19543708|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543709|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543710|NCT02846519|Rifampin|rifampin|mesh-list
19543711|NCT02846519|Esketamine|esketamine|mesh-list
19543712|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19543713|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
19543714|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19543715|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543716|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
19543717|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19543718|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543719|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543720|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19543721|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19543722|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19543723|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19543724|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19543725|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19543726|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
19543727|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19543728|NCT02846506|Metformin|metformin|mesh-list
19543729|NCT02846506|Canagliflozin|canagliflozin|mesh-list
19543730|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19543731|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543732|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19543733|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543734|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
19543735|NCT02846428|Docetaxel|docetaxel|mesh-list
19543736|NCT02846428|Fluorouracil|fluorouracil|mesh-list
19543737|NCT02846428|Capecitabine|capecitabine|mesh-list
19543738|NCT02846428|Epirubicin|epirubicin|mesh-list
19543739|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543740|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
19543741|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543742|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543743|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19543744|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
20105575|NCT00003426|Gemcitabine|gemcitabine|mesh-list
20105576|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105577|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
20105578|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105579|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105580|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
20105581|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105582|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543745|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543746|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105583|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543747|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19543748|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19543749|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19543750|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19543751|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
19543752|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19543753|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19543754|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19543755|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19543756|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543757|NCT02846376|Nivolumab|nivolumab|mesh-list
19543758|NCT02846376|Ipilimumab|ipilimumab|mesh-list
19543759|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19543760|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543761|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19543762|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543763|NCT02846155|Simethicone|simethicone|mesh-list
19543764|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
19543765|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543766|NCT02846155|Emollients|emollients|mesh-ancestor
19543767|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
19543768|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
19543769|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19543770|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543771|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543772|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543773|NCT02846090|Analgesics|analgesics|mesh-ancestor
19543774|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
19543775|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543776|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19543777|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19543778|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19543779|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
19543780|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543781|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543782|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
19543783|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19543784|NCT02846142|Estradiol|estradiol|mesh-list
19543785|NCT02846142|Estrogens|estrogens|mesh-ancestor
19543786|NCT02846142|Hormones|hormones|mesh-ancestor
19543787|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543788|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543789|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19543790|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
19543791|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19543792|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19543793|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19543794|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19543795|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19543796|NCT02846025|Folic Acid|folic acid|mesh-list
19543797|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
19543798|NCT02846025|Antioxidants|antioxidants|mesh-list
19543799|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543800|NCT02846025|Protective Agents|protective agents|mesh-ancestor
19543801|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543802|NCT02846025|Hematinics|hematinics|mesh-ancestor
19543803|NCT02846025|Vitamins|vitamins|mesh-ancestor
19543804|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
19543805|NCT02845804|Everolimus|everolimus|mesh-list
19543806|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543807|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543808|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
19543809|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575427|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604254|NCT02226328|Midazolam|midazolam|mesh-list
20604255|NCT02226328|Propofol|propofol|mesh-list
20604256|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20604257|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604258|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575428|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575429|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575430|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19575431|NCT02562235|Riociguat|riociguat|mesh-list
19575432|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
20105584|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
20604259|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19543810|NCT02845856|Cetuximab|cetuximab|mesh-list
19543811|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19543812|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543813|NCT02845843|Interferons|interferons|mesh-list
19543814|NCT02845843|Ritonavir|ritonavir|mesh-list
19543815|NCT02845843|Lopinavir|lopinavir|mesh-list
19543816|NCT02845843|Interferon-beta|interferon-beta|mesh-list
19543817|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
19543818|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543819|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
19543820|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543821|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19543822|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20105585|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105586|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
20105587|NCT00003427|Irinotecan|irinotecan|mesh-list
20105588|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105589|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20105590|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105591|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105592|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105593|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19543823|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
19543824|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543825|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543826|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19543827|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19543828|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19543829|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19543830|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
19543831|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543832|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19543833|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
19543834|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19543835|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543836|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543837|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543838|NCT02845661|Analgesics|analgesics|mesh-ancestor
19543839|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
19543840|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543841|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19543842|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19543843|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19543844|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
19543845|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543846|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543847|NCT02845908|Leucovorin|leucovorin|mesh-list
19543848|NCT02845908|Fluorouracil|fluorouracil|mesh-list
19543849|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
20105594|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20105595|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105596|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
20105597|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20105598|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
20105599|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105600|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20105601|NCT00003431|Protective Agents|protective agents|mesh-ancestor
20105602|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
20105603|NCT00003435|Melphalan|melphalan|mesh-list
19543850|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
19543851|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543852|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19543853|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543854|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543855|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
19543856|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543857|NCT02845908|Antidotes|antidotes|mesh-ancestor
19543858|NCT02845908|Protective Agents|protective agents|mesh-ancestor
19543859|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
19543860|NCT02845908|Vitamins|vitamins|mesh-ancestor
19543861|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
19543862|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
19543863|NCT02845999|Fludarabine|fludarabine|mesh-list
19543864|NCT02845999|Cetuximab|cetuximab|mesh-list
19543865|NCT02845999|Interleukin-2|interleukin-2|mesh-list
19543866|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105604|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19543867|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
19543868|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543869|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19543870|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19543871|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
19543872|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543873|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543874|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19543875|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19543876|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543877|NCT02845999|Analgesics|analgesics|mesh-ancestor
19543878|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
19543879|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543880|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19543881|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
19543882|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543883|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543884|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543885|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
19543886|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19543887|NCT02845778|Melatonin|melatonin|mesh-list
19543888|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
19543889|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543890|NCT02845778|Protective Agents|protective agents|mesh-ancestor
19543891|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543892|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20105605|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105606|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
20105607|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105608|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105609|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105610|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105611|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
20105612|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105613|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105614|NCT00003436|Cytarabine|cytarabine|mesh-list
20105615|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
20105616|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20105617|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20105618|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20105619|NCT00003436|Methotrexate|methotrexate|mesh-list
20105620|NCT00003436|Etoposide|etoposide|mesh-list
20105621|NCT00003436|Daunorubicin|daunorubicin|mesh-list
20105622|NCT00003436|Asparaginase|asparaginase|mesh-list
20105623|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
20105624|NCT00003436|Amsacrine|amsacrine|mesh-list
20105625|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20105626|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
20105627|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20105628|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105629|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105630|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
20105631|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105632|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105633|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105634|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105635|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20105636|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19543893|NCT02845713|Ivermectin|ivermectin|mesh-list
19543894|NCT02845713|Albendazole|albendazole|mesh-list
19543895|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
19543896|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19543897|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543898|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
19543899|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
19543900|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19543901|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19543902|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
19543903|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
19543904|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
19543905|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105637|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
19543906|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105638|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105639|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19543907|NCT02845713|Filaricides|filaricides|mesh-ancestor
19543908|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
19543909|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19543910|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543911|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19543912|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19543913|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543914|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543915|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19543916|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20105640|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105641|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105642|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105643|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
20105644|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105645|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105646|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105647|NCT00003436|Analgesics|analgesics|mesh-ancestor
20105648|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
20105649|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105650|NCT00003437|Cytarabine|cytarabine|mesh-list
20105651|NCT00003437|Dexamethasone|dexamethasone|mesh-list
20105652|NCT00003437|Prednisolone|prednisolone|mesh-list
20105653|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
20105654|NCT00003437|Doxorubicin|doxorubicin|mesh-list
20105655|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19543917|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543918|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
19543919|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19543920|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19543921|NCT02845388|Estradiol|estradiol|mesh-list
19543922|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19543923|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543924|NCT02845388|Estrogens|estrogens|mesh-ancestor
19543925|NCT02845388|Hormones|hormones|mesh-ancestor
19543926|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19543927|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543928|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19543929|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
19543930|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19543931|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19543932|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
19543933|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19543934|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19543935|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19543936|NCT02845388|Urological Agents|urological agents|mesh-ancestor
19543937|NCT02845466|Becaplermin|becaplermin|mesh-list
20105656|NCT00003437|Methotrexate|methotrexate|mesh-list
19543938|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
19543939|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
19543940|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19543941|NCT02845466|Growth Substances|growth substances|mesh-ancestor
19543942|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543943|NCT02845349|Vortioxetine|vortioxetine|mesh-list
19543944|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
19543945|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19543946|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19543947|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19543948|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543949|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543950|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19543951|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19543952|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19543953|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543954|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543955|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
19543956|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19543957|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19543958|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19543959|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20105657|NCT00003437|Vincristine|vincristine|mesh-list
19543960|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20105658|NCT00003437|Daunorubicin|daunorubicin|mesh-list
20105659|NCT00003437|Asparaginase|asparaginase|mesh-list
20105660|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
19543961|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19543962|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19543963|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
19543964|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19543965|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543966|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19543967|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19543968|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19543969|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19543970|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19543971|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19543972|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19543973|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20604260|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
20604261|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
20604262|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20604263|NCT02226328|Narcotics|narcotics|mesh-ancestor
20604264|NCT02226328|Analgesics|analgesics|mesh-ancestor
19543974|NCT02845024|Doxycycline|doxycycline|mesh-list
19543975|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19543976|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19543977|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
19543978|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19543979|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19543980|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
19543981|NCT02844894|Esmolol|esmolol|mesh-list
19543982|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19543983|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19543984|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19543985|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19543986|NCT02844894|Analgesics|analgesics|mesh-ancestor
19543987|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
19543988|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19543989|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19543990|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19543991|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19543992|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
19543993|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19543994|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19543995|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19543996|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19543997|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19543998|NCT02844790|Insulin|insulin|mesh-list
19543999|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
19544000|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544001|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544002|NCT02844933|Cannabidiol|cannabidiol|mesh-list
19544003|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
19544004|NCT02844881|Apatinib|apatinib|mesh-list
19544005|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544006|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19544007|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544008|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544009|NCT02844712|beta-Lactams|beta-lactams|mesh-list
19544010|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19544011|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544012|NCT02845050|Cisplatin|cisplatin|mesh-list
19544013|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544014|NCT02844621|Omeprazole|omeprazole|mesh-list
19544015|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19544016|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544017|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19544018|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544019|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544020|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
19544021|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544022|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
19544023|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544024|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544025|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19544026|NCT02844803|Metformin|metformin|mesh-list
19544027|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544028|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544029|NCT02844530|Epratuzumab|epratuzumab|mesh-list
20604265|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
19544030|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19544031|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544032|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544033|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
19544034|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
19544035|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544036|NCT02844517|Pancrelipase|pancrelipase|mesh-list
19544037|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544038|NCT02844634|Tenofovir|tenofovir|mesh-list
19544039|NCT02844634|Emtricitabine|emtricitabine|mesh-list
19544040|NCT02844634|Doxycycline|doxycycline|mesh-list
19544041|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
19544042|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544043|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19544044|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19544045|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544046|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544047|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19544048|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20105661|NCT00003437|Pegaspargase|pegaspargase|mesh-list
20105662|NCT00003437|Thioguanine|thioguanine|mesh-list
20105663|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105664|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
20105665|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544049|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19544050|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
19544051|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19544052|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19544053|NCT02844153|Metformin|metformin|mesh-list
19544054|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544055|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544056|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19544057|NCT02844322|Rituximab|rituximab|mesh-list
19544058|NCT02844322|Bortezomib|bortezomib|mesh-list
19544059|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544060|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544061|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
19544062|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544063|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575433|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575434|NCT02553460|Leucovorin|leucovorin|mesh-list
19575435|NCT02553460|Cytarabine|cytarabine|mesh-list
19575436|NCT02553460|Dexamethasone|dexamethasone|mesh-list
19575437|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
19575438|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
19575439|NCT02553460|Methotrexate|methotrexate|mesh-list
19575440|NCT02553460|Etoposide|etoposide|mesh-list
19575441|NCT02553460|Vincristine|vincristine|mesh-list
19575442|NCT02553460|Bortezomib|bortezomib|mesh-list
19575443|NCT02553460|Asparaginase|asparaginase|mesh-list
19575444|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
19575445|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
19575446|NCT02553460|Vorinostat|vorinostat|mesh-list
19575447|NCT02553460|Pegaspargase|pegaspargase|mesh-list
19575448|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
19575449|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575450|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
19575451|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575452|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575453|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575454|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
19575455|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575456|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575457|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19575458|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575459|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
19575460|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
19575461|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575462|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19575463|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
19575464|NCT02553460|Hormones|hormones|mesh-ancestor
19575465|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575466|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19575467|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19575468|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
19575469|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19575470|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105666|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544064|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
19544065|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544066|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544067|NCT02844309|Thalidomide|thalidomide|mesh-list
19544068|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105667|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105668|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
20105669|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105670|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105671|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105672|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544069|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
19544070|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544071|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
19544072|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19544073|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544074|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19544075|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19544076|NCT02844309|Growth Substances|growth substances|mesh-ancestor
19544077|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
19544078|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544079|NCT05242926|Docetaxel|docetaxel|mesh-list
19544080|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544081|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
19544082|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
19544083|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
19544084|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544085|NCT05242783|Terlipressin|terlipressin|mesh-list
19544086|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19544087|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19544088|NCT05242718|Palmidrol|palmidrol|mesh-list
19544089|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
19544090|NCT05242718|Curcumin|curcumin|mesh-list
19544091|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19544092|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19544093|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19544094|NCT05242718|Analgesics|analgesics|mesh-ancestor
19544095|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
19544096|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544097|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544098|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544099|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544100|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544101|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544102|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544103|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
19544104|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544105|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19544106|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19544107|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544108|NCT05242718|Hormones|hormones|mesh-ancestor
19544109|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544110|NCT05242718|Expectorants|expectorants|mesh-ancestor
19544111|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
19544112|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19544113|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
19544114|NCT05242718|Protective Agents|protective agents|mesh-ancestor
19544115|NCT05242718|Antidotes|antidotes|mesh-ancestor
19544116|NCT05242419|Huperzine A|huperzine a|mesh-list
19544117|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19544118|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544119|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544120|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
19544121|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20105673|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
20105674|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
20105675|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105676|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105677|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
20105678|NCT00003437|Hormones|hormones|mesh-ancestor
20105679|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105680|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20308303|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19544122|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544123|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19544124|NCT05242419|Protective Agents|protective agents|mesh-ancestor
19544125|NCT05242133|Interferons|interferons|mesh-list
19544126|NCT05242133|Interferon-beta|interferon-beta|mesh-list
19544127|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
19544128|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544129|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
19544130|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544131|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
19544132|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544133|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19544134|NCT05242120|Anesthetics|anesthetics|mesh-list
19544135|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544136|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544137|NCT05242081|Fentanyl|fentanyl|mesh-list
19544138|NCT05242081|Ketamine|ketamine|mesh-list
19544139|NCT05242081|Esketamine|esketamine|mesh-list
19544140|NCT05242081|Analgesics|analgesics|mesh-ancestor
19544141|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
19544142|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544143|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544144|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19544145|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19544146|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
19544147|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
19544148|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544149|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19544150|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19544151|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544152|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544153|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19544154|NCT05242081|Narcotics|narcotics|mesh-ancestor
19544155|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19544156|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
19544157|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19544158|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19544159|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19544160|NCT05241912|Dobutamine|dobutamine|mesh-list
19544161|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19544162|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
19544163|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
19544164|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544165|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544166|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19544167|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19544168|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19544169|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
19544170|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544171|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544172|NCT05241912|Protective Agents|protective agents|mesh-ancestor
19544173|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19544174|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19544175|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544176|NCT05239182|Gemcitabine|gemcitabine|mesh-list
19544177|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19544178|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19544179|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
20105681|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105682|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105683|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105684|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105685|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20105686|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
19544180|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544181|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544182|NCT05239182|Antiviral Agents|antiviral agents|mesh-ancestor
19544183|NCT05239182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544184|NCT05239182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544185|NCT05239182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19544186|NCT05239182|Immunologic Factors|immunologic factors|mesh-ancestor
19544187|NCT05239182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544188|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
20105687|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19544189|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19544190|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544191|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544192|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544193|NCT05201547|Paclitaxel|paclitaxel|mesh-list
19544194|NCT05201547|Carboplatin|carboplatin|mesh-list
19544195|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19544196|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544197|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
19544198|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
19544199|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
19544200|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575471|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
19575472|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19575473|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575474|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19575475|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19575476|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575477|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19575478|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105688|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105689|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
20105690|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105691|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20105692|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20105693|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
20105694|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105695|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105696|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105697|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105698|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105699|NCT00003439|Interleukin-12|interleukin-12|mesh-list
20105700|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19575479|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
19575480|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575481|NCT02553460|Antidotes|antidotes|mesh-ancestor
19575482|NCT02553460|Protective Agents|protective agents|mesh-ancestor
19575483|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
19575484|NCT02553460|Vitamins|vitamins|mesh-ancestor
19575485|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
19575486|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575487|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
19575488|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575489|NCT02553460|Analgesics|analgesics|mesh-ancestor
19575490|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
19575491|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19575492|NCT02522715|Prednisone|prednisone|mesh-list
19575493|NCT02522715|Cortisone|cortisone|mesh-list
19575494|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575495|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
19575496|NCT02522715|Hormones|hormones|mesh-ancestor
19575497|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575498|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575499|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19575500|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575501|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
19575502|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575503|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575504|NCT02487095|Topotecan|topotecan|mesh-list
19575505|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19575506|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19575507|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575508|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575509|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575510|NCT02471911|Dexamethasone|dexamethasone|mesh-list
19575511|NCT02471911|Rituximab|rituximab|mesh-list
19575512|NCT02471911|Carboplatin|carboplatin|mesh-list
19575513|NCT02471911|Etoposide|etoposide|mesh-list
19575514|NCT02471911|Ifosfamide|ifosfamide|mesh-list
19575515|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575516|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575517|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
19575518|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575519|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105701|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
19575520|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575521|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
19575522|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
19575523|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105702|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544201|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
19544202|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544203|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544204|NCT05168462|Norepinephrine|norepinephrine|mesh-list
19544205|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20105703|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20105704|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20105705|NCT00003439|Growth Substances|growth substances|mesh-ancestor
20105706|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
20105707|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105708|NCT00003440|Paclitaxel|paclitaxel|mesh-list
20105709|NCT00003440|Trastuzumab|trastuzumab|mesh-list
20105710|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105711|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105712|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
19544206|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19544207|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
19544208|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544209|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544210|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544211|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
19544212|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
19544213|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544214|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19544215|NCT05150236|Nivolumab|nivolumab|mesh-list
19544216|NCT05150236|Ipilimumab|ipilimumab|mesh-list
19544217|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
19544218|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544219|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544220|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19544221|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544222|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19544223|NCT05135104|Palbociclib|palbociclib|mesh-list
19544224|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544225|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19544226|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544227|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544228|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
19544229|NCT05114421|Lenvatinib|lenvatinib|mesh-list
19544230|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544231|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544232|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19544233|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544234|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544235|NCT05109052|Bevacizumab|bevacizumab|mesh-list
19544236|NCT05109052|Atezolizumab|atezolizumab|mesh-list
19544237|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544238|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544239|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19544240|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19544241|NCT05109052|Growth Substances|growth substances|mesh-ancestor
19544242|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544243|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
19544244|NCT05104047|Lobeline|lobeline|mesh-list
19544245|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19544246|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
19544247|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544248|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544249|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19544250|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19544251|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
19544252|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544253|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544254|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
19544255|NCT05078502|Vitamin D|vitamin d|mesh-list
19544256|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
19544257|NCT05078502|Vitamins|vitamins|mesh-ancestor
19544258|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
19544259|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544260|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19544261|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20105713|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
19544262|NCT05040880|Telmisartan|telmisartan|mesh-list
19544263|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19544264|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19544265|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19544266|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544267|NCT05007509|Vaccines|vaccines|mesh-list
19544268|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
19544269|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544270|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19544271|NCT04985760|Vaccines|vaccines|mesh-list
19544272|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
19544273|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
19544274|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544275|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19544276|NCT04985760|Antacids|antacids|mesh-ancestor
19544277|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544278|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544279|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
19544280|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544281|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544282|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
19544283|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19544284|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
19544285|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20105714|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105715|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105716|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544286|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
19544287|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544288|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544289|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
19544290|NCT04954365|Amisulpride|amisulpride|mesh-list
19544291|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19544292|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19544293|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544294|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544295|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19544296|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19544297|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
19544298|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544299|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544300|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19544301|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
19544302|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
19544303|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20105717|NCT00003441|Irofulven|irofulven|mesh-list
20105718|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105719|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
19544304|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544305|NCT04918810|Docetaxel|docetaxel|mesh-list
19544306|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544307|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
19544308|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
19544309|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
19544310|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544311|NCT04905446|Niacinamide|niacinamide|mesh-list
19544312|NCT04905446|Niacin|niacin|mesh-list
19544313|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
19544314|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
19544315|NCT04905446|Vitamins|vitamins|mesh-ancestor
19544316|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
19544317|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544318|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20105720|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105721|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105722|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
20105723|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20105724|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
20105725|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105726|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105727|NCT00003444|Interferons|interferons|mesh-list
20105728|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
19544319|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
19544320|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544321|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19544322|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
19544323|NCT04887402|Clomiphene|clomiphene|mesh-list
19544324|NCT04887402|Enclomiphene|enclomiphene|mesh-list
19544325|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
19544326|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19544327|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
19544328|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544329|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544330|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19544331|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
19544332|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19544333|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19544334|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19544335|NCT04793568|Interferons|interferons|mesh-list
19544336|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
19544337|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544338|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
19544339|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544340|NCT04793490|Acetaminophen|acetaminophen|mesh-list
19544341|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19544342|NCT04793490|Analgesics|analgesics|mesh-ancestor
19544343|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
19544344|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544345|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544346|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
19544347|NCT04782700|Prednisone|prednisone|mesh-list
19544348|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544349|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
19544350|NCT04782700|Hormones|hormones|mesh-ancestor
19544351|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544352|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544353|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19544354|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544355|NCT04760782|Abaloparatide|abaloparatide|mesh-list
19544356|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19544357|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544358|NCT04750005|Listerine|listerine|mesh-list
19544359|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19544360|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544361|NCT04748783|Listerine|listerine|mesh-list
19544362|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
19544363|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19544364|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19544365|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
19544366|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
19544367|NCT04748783|Protective Agents|protective agents|mesh-ancestor
19544368|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544369|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19544370|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544371|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
19544372|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
19544373|NCT04739384|Ticagrelor|ticagrelor|mesh-list
19544374|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19544375|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19544376|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19544377|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19544378|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
19544379|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544380|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544381|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575524|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19575525|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
19575526|NCT02471911|Hormones|hormones|mesh-ancestor
19575527|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575528|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19575529|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575530|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19575531|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19575532|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575533|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575534|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575535|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
19575536|NCT02432417|Chloroquine|chloroquine|mesh-list
19575537|NCT02432417|Amebicides|amebicides|mesh-ancestor
19575538|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19575539|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19575540|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575541|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
20105729|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544382|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19544383|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
19544384|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544385|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19544386|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
19544387|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544388|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19544389|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544390|NCT04646967|Acetaminophen|acetaminophen|mesh-list
19544391|NCT04646967|Ibuprofen|ibuprofen|mesh-list
19544392|NCT04646967|Ketorolac|ketorolac|mesh-list
19544393|NCT04646967|Bupivacaine|bupivacaine|mesh-list
19544394|NCT04646967|Sevoflurane|sevoflurane|mesh-list
19544395|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
19544396|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
19544397|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544398|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544399|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
19544400|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544401|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19544402|NCT04646967|Analgesics|analgesics|mesh-ancestor
19544403|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
19544404|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19544405|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544406|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544407|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19544408|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544409|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544410|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19544411|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19544412|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
19544413|NCT04646655|Enoxaparin|enoxaparin|mesh-list
19544414|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
19544415|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19544416|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19544417|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544418|NCT04646356|Tacrolimus|tacrolimus|mesh-list
19544419|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19544420|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
19544421|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544422|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19544423|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544424|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544425|NCT04635241|Heparin|heparin|mesh-list
19544426|NCT04635241|Calcium heparin|calcium heparin|mesh-list
19544427|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
19544428|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19544429|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19544430|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544431|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
19544432|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19544433|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544434|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544435|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19544436|NCT04628663|Analgesics|analgesics|mesh-ancestor
19544437|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
19544438|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544439|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19544440|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19544441|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19544442|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
19544443|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544444|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544445|NCT04616560|Trastuzumab|trastuzumab|mesh-list
19544446|NCT04616560|Camptothecin|camptothecin|mesh-list
19544447|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
19544448|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544449|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544450|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19544451|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19544452|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19544453|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544454|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544455|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
19544456|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544457|NCT04590404|Nicotine|nicotine|mesh-list
20105730|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
20105731|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105732|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
20105733|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105734|NCT00003445|Docetaxel|docetaxel|mesh-list
20105735|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105736|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105737|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105738|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105739|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105740|NCT00003446|Leucovorin|leucovorin|mesh-list
20105741|NCT00003446|Trimetrexate|trimetrexate|mesh-list
20105742|NCT00003446|Fluorouracil|fluorouracil|mesh-list
20105743|NCT00003446|Calcium|calcium|mesh-list
20105744|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
20105745|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20105746|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105747|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
20105748|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105749|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105750|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105751|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105752|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
20105753|NCT00003446|Antidotes|antidotes|mesh-ancestor
20105754|NCT00003446|Protective Agents|protective agents|mesh-ancestor
20105755|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
20105756|NCT00003446|Vitamins|vitamins|mesh-ancestor
20105757|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
20105758|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
20105759|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105760|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20105761|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105762|NCT00003447|Gemcitabine|gemcitabine|mesh-list
20105763|NCT00003447|Vinorelbine|vinorelbine|mesh-list
20105764|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105765|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
19544458|NCT04590404|Varenicline|varenicline|mesh-list
19544459|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19544460|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
19544461|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544462|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544463|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19544464|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19544465|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
20105766|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105767|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105768|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
19544466|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544467|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544468|NCT04570176|Epinephrine|epinephrine|mesh-list
19544469|NCT04570176|Racepinephrine|racepinephrine|mesh-list
19544470|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
19544471|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19544472|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19544473|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19544474|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544475|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544476|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544477|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19544478|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19544479|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
19544480|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544481|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19544482|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19544483|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
19544484|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
19544485|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19544486|NCT04561362|Nivolumab|nivolumab|mesh-list
19544487|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544488|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544489|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19544490|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105769|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544491|NCT04545541|Heparin|heparin|mesh-list
19544492|NCT04545541|Calcium heparin|calcium heparin|mesh-list
19544493|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
19544494|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19544495|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19544496|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544497|NCT04522167|Aflibercept|aflibercept|mesh-list
19544498|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19544499|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19544500|NCT04522167|Growth Substances|growth substances|mesh-ancestor
19544501|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544502|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
19544503|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544504|NCT04481308|Fentanyl|fentanyl|mesh-list
20105770|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105771|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105772|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
20105773|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105774|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105775|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105776|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105777|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105778|NCT00003449|Gemcitabine|gemcitabine|mesh-list
20105779|NCT00003449|Dexamethasone|dexamethasone|mesh-list
20105780|NCT00003449|Paclitaxel|paclitaxel|mesh-list
19544505|NCT04481308|Propofol|propofol|mesh-list
19544506|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19544507|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544508|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544509|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19544510|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
19544511|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
19544512|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19544513|NCT04481308|Narcotics|narcotics|mesh-ancestor
19544514|NCT04481308|Analgesics|analgesics|mesh-ancestor
19544515|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
19544516|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544517|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19544518|NCT04475848|Midazolam|midazolam|mesh-list
19544519|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19544520|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19544521|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544522|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544523|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19544524|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19544525|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19544526|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19544527|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
19544528|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
19544529|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
19544530|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
19544531|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544532|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544533|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19544534|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19544535|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
19544536|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19544537|NCT04452565|Dexamethasone|dexamethasone|mesh-list
19544538|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
19544539|NCT04452565|BB 1101|bb 1101|mesh-list
19544540|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544541|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
19544542|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
19544543|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544544|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544545|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544546|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
19544547|NCT04452565|Hormones|hormones|mesh-ancestor
19544548|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544549|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19544550|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544551|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
19544552|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544553|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544554|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19544555|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19544556|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19544557|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20105781|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19544558|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
19544559|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544560|NCT04425018|Paclitaxel|paclitaxel|mesh-list
19544561|NCT04425018|Trastuzumab|trastuzumab|mesh-list
19544562|NCT04425018|Pertuzumab|pertuzumab|mesh-list
19544563|NCT04425018|Margetuximab|margetuximab|mesh-list
19544564|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19544565|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544566|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19544567|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105782|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105783|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105784|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105785|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105786|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105787|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105788|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
20105789|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
20105790|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105791|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105792|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105793|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
20105794|NCT00003449|Hormones|hormones|mesh-ancestor
19544568|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19544569|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544570|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544571|NCT04410328|Aspirin|aspirin|mesh-list
19544572|NCT04410328|Dipyridamole|dipyridamole|mesh-list
19544573|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19544574|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19544575|NCT04410328|Analgesics|analgesics|mesh-ancestor
19544576|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
19544577|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544578|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544579|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544580|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544581|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19544582|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19544583|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544584|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19544585|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19544586|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544587|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
19544588|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19544589|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
19544590|NCT04400474|Atezolizumab|atezolizumab|mesh-list
19544591|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544592|NCT04393285|Letrozole|letrozole|mesh-list
19544593|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544594|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19544595|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19544596|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544597|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544598|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19544599|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
19544600|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544601|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544602|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
20604266|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604267|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20604268|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20604269|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20604270|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604271|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
20604272|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
20604273|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604274|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604275|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
20604276|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20604277|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20604278|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604279|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20604280|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
19575542|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604281|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20604282|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604283|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604284|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604285|NCT02226341|Hormones|hormones|mesh-ancestor
20604286|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604287|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604288|NCT02226367|Prazosin|prazosin|mesh-list
20604289|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19544603|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19544604|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544605|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544606|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544607|NCT04375787|Atorvastatin|atorvastatin|mesh-list
19544608|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19544609|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19544610|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
20105795|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105796|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105797|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105798|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
20105799|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
20105800|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105801|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105802|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105803|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
20105804|NCT00003451|Interferons|interferons|mesh-list
19544611|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544612|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19544613|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19544614|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105805|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
20105806|NCT00003451|Interleukin-12|interleukin-12|mesh-list
20105807|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105808|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
20105809|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105810|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
20105811|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105812|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20105813|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20105814|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20105815|NCT00003451|Growth Substances|growth substances|mesh-ancestor
20105816|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
20105817|NCT00003461|Antibodies|antibodies|mesh-list
20105818|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20105819|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
20105820|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105821|NCT00003462|Busulfan|busulfan|mesh-list
20105822|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
20105823|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105824|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105825|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
20105826|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105827|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105828|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544615|NCT04355143|Colchicine|colchicine|mesh-list
19544616|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
19544617|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544618|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
19544619|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
19544620|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
19544621|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544622|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544623|NCT04345796|Empagliflozin|empagliflozin|mesh-list
19544624|NCT04345796|Carvedilol|carvedilol|mesh-list
19544625|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19544626|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544627|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544628|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544629|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19544630|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19544631|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
19544632|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20105829|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105830|NCT00003463|Irinotecan|irinotecan|mesh-list
20105831|NCT00003463|Carmustine|carmustine|mesh-list
19544633|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19544634|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
19544635|NCT04345796|Protective Agents|protective agents|mesh-ancestor
19544636|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19544637|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19544638|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19544639|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
19544640|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19544641|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19544642|NCT04327063|Ropivacaine|ropivacaine|mesh-list
19544643|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
19544644|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
19544645|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544646|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544647|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
19544648|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105832|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20105833|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105834|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105835|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105836|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105837|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105838|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
20105839|NCT00003464|Temozolomide|temozolomide|mesh-list
20105840|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105841|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
20105842|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105843|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105844|NCT00003465|Temozolomide|temozolomide|mesh-list
20105845|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105846|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
20105847|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105848|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105849|NCT00003466|Temozolomide|temozolomide|mesh-list
20105850|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105851|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
20105852|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105853|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105854|NCT00003467|Carmustine|carmustine|mesh-list
20105855|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105856|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
20105857|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105858|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105859|NCT00003478|Antibodies|antibodies|mesh-list
20105860|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20105861|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
20105862|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105863|NCT00003484|Irinotecan|irinotecan|mesh-list
20105864|NCT00003484|Carmustine|carmustine|mesh-list
20105865|NCT00003484|Antibodies|antibodies|mesh-list
20105866|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20105867|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
20105868|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544680|NCT04280601|Vitamin D|vitamin d|mesh-list
19544681|NCT04280601|Vitamins|vitamins|mesh-ancestor
19544682|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
19544683|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544684|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19544685|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
19544686|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
19544687|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19544688|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
19544689|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544690|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544691|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19544692|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
19544693|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544694|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544695|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19544696|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544697|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
19544698|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19544699|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544700|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544701|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544702|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19544703|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19544704|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19544705|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19544706|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544707|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544708|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544709|NCT04224584|Analgesics|analgesics|mesh-ancestor
19544710|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
19544711|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544712|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
19544713|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19544714|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
19544715|NCT04191421|Spartalizumab|spartalizumab|mesh-list
19544716|NCT04191421|Siltuximab|siltuximab|mesh-list
19544717|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19544718|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105869|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20105870|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105871|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105872|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105873|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105874|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105875|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
20105876|NCT00003490|Prednisone|prednisone|mesh-list
20105877|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
20105878|NCT00003490|Vincristine|vincristine|mesh-list
20105879|NCT00003490|Sargramostim|sargramostim|mesh-list
20105880|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19544719|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575543|NCT02407119|Amoxicillin|amoxicillin|mesh-list
19575544|NCT02407119|Clarithromycin|clarithromycin|mesh-list
19575545|NCT02407119|Omeprazole|omeprazole|mesh-list
19575546|NCT02407119|Rabeprazole|rabeprazole|mesh-list
19575547|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19575548|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19575549|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575550|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19575551|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19575552|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105881|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
20105882|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105883|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544720|NCT04139434|Azacitidine|azacitidine|mesh-list
19544721|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19544722|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
19544723|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544724|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544725|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544726|NCT04135937|Bupropion|bupropion|mesh-list
19544727|NCT04135937|Nicotine|nicotine|mesh-list
19544728|NCT04135937|Varenicline|varenicline|mesh-list
19544729|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19544730|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
19544731|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544732|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544733|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19544734|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19544735|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
19544736|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544737|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544738|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19544739|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
19544740|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19544741|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19544742|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19544743|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19544744|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
19544745|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19544746|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19544747|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544748|NCT04135495|Ivacaftor|ivacaftor|mesh-list
19544749|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19544750|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19544751|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544752|NCT04129437|Ibuprofen|ibuprofen|mesh-list
19544753|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19544754|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19544755|NCT04129437|Analgesics|analgesics|mesh-ancestor
19544756|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
20105884|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105885|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
20105886|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105887|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105888|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105889|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105890|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
20105891|NCT00003490|Hormones|hormones|mesh-ancestor
19544757|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544758|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544759|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544760|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544761|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19544762|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544763|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544764|NCT04073290|Rifaximin|rifaximin|mesh-list
19544765|NCT04073290|Lactulose|lactulose|mesh-list
19544766|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19544767|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544768|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544769|NCT04066348|Etanercept|etanercept|mesh-list
19544770|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19544771|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19544772|NCT04066348|Analgesics|analgesics|mesh-ancestor
19544773|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
19544774|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544775|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544776|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19544777|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544778|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544779|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19544780|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
19544781|NCT03998488|Psyllium|psyllium|mesh-list
19544782|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
19544783|NCT03998488|Cathartics|cathartics|mesh-ancestor
19544784|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544785|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
19544786|NCT03987685|Topotecan|topotecan|mesh-list
19544787|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19544788|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19544789|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544790|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544791|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544792|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
19544793|NCT03967223|Fludarabine|fludarabine|mesh-list
19544794|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19544795|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
19544796|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544797|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19544798|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19544799|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
19544800|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544801|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544802|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19544803|NCT03936790|Fentanyl|fentanyl|mesh-list
19544804|NCT03936790|Ropivacaine|ropivacaine|mesh-list
19544805|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
19544806|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
19544807|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544808|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544809|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
19544810|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544811|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19544812|NCT03936790|Narcotics|narcotics|mesh-ancestor
19544813|NCT03936790|Analgesics|analgesics|mesh-ancestor
19544814|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19544815|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19544816|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
19544817|NCT03931057|Midazolam|midazolam|mesh-list
19544818|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19544819|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19544820|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544821|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544822|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19544823|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19544824|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19544825|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19544826|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
19544827|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
19544828|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
19544829|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
19544830|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544831|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105892|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105893|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105894|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105895|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105896|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105897|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105898|NCT00003493|Dexamethasone|dexamethasone|mesh-list
20105899|NCT00003493|Doxorubicin|doxorubicin|mesh-list
20105900|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20105901|NCT00003493|Vincristine|vincristine|mesh-list
20105902|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20105903|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
20105904|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
20105905|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20105906|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105907|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20105908|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
20105909|NCT00003493|Hormones|hormones|mesh-ancestor
20105910|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105911|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19544832|NCT03904498|Tolcapone|tolcapone|mesh-list
19544833|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19544834|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19544835|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19544836|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544837|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544838|NCT03904329|Anticoagulants|anticoagulants|mesh-list
19544839|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19544840|NCT03896880|Clotrimazole|clotrimazole|mesh-list
20105912|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544841|NCT03896880|Miconazole|miconazole|mesh-list
19544842|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
19544843|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544844|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19544845|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20105913|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105914|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105915|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105916|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544846|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19544847|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544848|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544849|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19544850|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
19544851|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544852|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544853|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19544854|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19544855|NCT03866668|Esomeprazole|esomeprazole|mesh-list
19544856|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19544857|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19544858|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19544859|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544860|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544861|NCT03845894|Bupivacaine|bupivacaine|mesh-list
19544862|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
19544863|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
19544864|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544865|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544866|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
19544867|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544868|NCT03845582|Vitamin A|vitamin a|mesh-list
19544869|NCT03845582|Retinol acetate|retinol acetate|mesh-list
19544870|NCT03845582|Vitamins|vitamins|mesh-ancestor
19544871|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
19544872|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544873|NCT03845582|Protective Agents|protective agents|mesh-ancestor
19544874|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19544875|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544876|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19544877|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
19544878|NCT03809481|Danaparoid|danaparoid|mesh-list
19544879|NCT03809481|Argatroban|argatroban|mesh-list
19544880|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
19544881|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19544882|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
19544883|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544884|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544885|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
19544886|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19544887|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19544888|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19544889|NCT03789110|Nivolumab|nivolumab|mesh-list
19544890|NCT03789110|Ipilimumab|ipilimumab|mesh-list
19544891|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544892|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544893|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19544894|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544895|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19544896|NCT03773237|SMOFlipid|smoflipid|mesh-list
19544897|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19544898|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19544899|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19544900|NCT03721406|Ropivacaine|ropivacaine|mesh-list
19544901|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
19544902|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
19544903|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19544904|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544905|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
19544906|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544907|NCT03708549|Metformin|metformin|mesh-list
19544908|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19544909|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544910|NCT03673124|Letrozole|letrozole|mesh-list
19544911|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544912|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19544913|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19544914|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544915|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544916|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19544917|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
19544918|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544919|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544920|NCT03635489|Paclitaxel|paclitaxel|mesh-list
19544921|NCT03635489|Bevacizumab|bevacizumab|mesh-list
19544922|NCT03635489|Carboplatin|carboplatin|mesh-list
19544923|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19544924|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544925|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19544926|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19544927|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19544928|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544929|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544930|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19544931|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19544932|NCT03635489|Growth Substances|growth substances|mesh-ancestor
19544933|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544934|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
19544935|NCT03610061|Durvalumab|durvalumab|mesh-list
19544936|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544937|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544938|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
19544939|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20105917|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105918|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105919|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105920|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105921|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105922|NCT00003517|Leuprolide|leuprolide|mesh-list
20105923|NCT00003517|Flutamide|flutamide|mesh-list
20105924|NCT00003517|Bicalutamide|bicalutamide|mesh-list
20105925|NCT00003517|Hormones|hormones|mesh-list
20105926|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
20105927|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20105928|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105929|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20105930|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
20105931|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20105932|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20105933|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105934|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
20105935|NCT00003518|Gemcitabine|gemcitabine|mesh-list
20105936|NCT00003518|Paclitaxel|paclitaxel|mesh-list
20105937|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105938|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105939|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105940|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105941|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105942|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105943|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105944|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
20105945|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
19544940|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20105946|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20105947|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105948|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19544941|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544942|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
19544943|NCT03582293|Coagulants|coagulants|mesh-ancestor
19544944|NCT03574337|Neostigmine|neostigmine|mesh-list
19544945|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19544946|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544947|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544948|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
19544949|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19544950|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544951|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20105949|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
20105950|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544952|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
19544953|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19544954|NCT03567876|Venetoclax|venetoclax|mesh-list
19544955|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544956|NCT03530696|Palbociclib|palbociclib|mesh-list
19544957|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544958|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19544959|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544960|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544961|NCT03213457|Norethindrone|norethindrone|mesh-list
19544962|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
19544963|NCT03213457|Estradiol|estradiol|mesh-list
19544964|NCT03213457|Estrogens|estrogens|mesh-ancestor
19544965|NCT03213457|Hormones|hormones|mesh-ancestor
19544966|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19544967|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19544968|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19544969|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
19544970|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19544971|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19544972|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19544973|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19544974|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19544975|NCT03126110|Nivolumab|nivolumab|mesh-list
19544976|NCT03126110|Ipilimumab|ipilimumab|mesh-list
19544977|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544978|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544979|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19544980|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544981|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19544982|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
19544983|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19544984|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19544985|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
19544986|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19544987|NCT02721342|Ramipril|ramipril|mesh-list
19544988|NCT02721342|Irbesartan|irbesartan|mesh-list
19544989|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19544990|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
19544991|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19544992|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19544993|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19544994|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19544995|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19575553|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575554|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19575555|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19575556|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19575557|NCT02377271|Bosentan|bosentan|mesh-list
19575558|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19575559|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19575560|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575561|NCT02364713|Gemcitabine|gemcitabine|mesh-list
19575562|NCT02364713|Paclitaxel|paclitaxel|mesh-list
19575563|NCT02364713|Bevacizumab|bevacizumab|mesh-list
19575564|NCT02364713|Doxorubicin|doxorubicin|mesh-list
19575565|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19575566|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19575567|NCT02364713|Topotecan|topotecan|mesh-list
19575568|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19575569|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
19575570|NCT02364713|Antibodies|antibodies|mesh-list
19575571|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
19575572|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19575573|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
19575574|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575575|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575576|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575577|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
19575578|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575579|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575580|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19575581|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20105951|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
20105952|NCT00003519|Docetaxel|docetaxel|mesh-list
19544996|NCT02594371|Paclitaxel|paclitaxel|mesh-list
20105953|NCT00003519|Doxorubicin|doxorubicin|mesh-list
20105954|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19544997|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19544998|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19544999|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545000|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
19545001|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
19545002|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
19545003|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545004|NCT02390869|Rituximab|rituximab|mesh-list
19545005|NCT02390869|Lenalidomide|lenalidomide|mesh-list
19545006|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19545007|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545008|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
19545009|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545010|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545011|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19545012|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19545013|NCT02390869|Growth Substances|growth substances|mesh-ancestor
19545014|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
19545015|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
19545016|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19545017|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545018|NCT02223208|Prednisone|prednisone|mesh-list
19545019|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
19545020|NCT02223208|Doxorubicin|doxorubicin|mesh-list
19545021|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19545022|NCT02223208|Etoposide|etoposide|mesh-list
19545023|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
19545024|NCT02223208|Romidepsin|romidepsin|mesh-list
19545025|NCT02223208|Vincristine|vincristine|mesh-list
19545026|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19545027|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
19545028|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545029|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545030|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19545031|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
19545032|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545033|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545034|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19545035|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19545036|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19545037|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19545038|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545039|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545040|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
19545041|NCT02223208|Hormones|hormones|mesh-ancestor
19545042|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545043|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19545044|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19545045|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
19545046|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
19545047|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
19545048|NCT02153645|Amantadine|amantadine|mesh-list
19545049|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19545050|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19545051|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
19545052|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19545053|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
19545054|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545055|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545056|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545057|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545058|NCT02153645|Analgesics|analgesics|mesh-ancestor
19545059|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
19545060|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545061|NCT02153632|Amantadine|amantadine|mesh-list
19545062|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19545063|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20105955|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105956|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
19545064|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
20105957|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545065|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19545066|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
19545067|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545068|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545069|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545070|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545071|NCT02153632|Analgesics|analgesics|mesh-ancestor
19545072|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
19545073|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545074|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
19545075|NCT02065362|Fludarabine|fludarabine|mesh-list
19545076|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19545077|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
19545078|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545079|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545080|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19545081|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
19545082|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545083|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545084|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105958|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105959|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20105960|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
20105961|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105962|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105963|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20105964|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
20105965|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
20105966|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
20105967|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20105968|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20105969|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20105970|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105971|NCT00003528|Raltitrexed|raltitrexed|mesh-list
20105972|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105973|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
20105974|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105975|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545085|NCT02013141|Telavancin|telavancin|mesh-list
19545086|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19545087|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19545088|NCT01942135|Fulvestrant|fulvestrant|mesh-list
19545089|NCT01942135|Palbociclib|palbociclib|mesh-list
19545090|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19545091|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545092|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19545093|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19545094|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
19545095|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545096|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545097|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19545098|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545099|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545100|NCT01934452|Sunitinib|sunitinib|mesh-list
19545101|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545102|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19545103|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19545104|NCT01934452|Growth Substances|growth substances|mesh-ancestor
19545105|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545106|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
19545107|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19545108|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545109|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545110|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19545111|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545112|NCT01773083|Heparin|heparin|mesh-list
19545113|NCT01773083|Calcium heparin|calcium heparin|mesh-list
19545114|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
19545115|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19545116|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19545117|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545118|NCT01723579|Estradiol|estradiol|mesh-list
19545119|NCT01723579|Estrogens|estrogens|mesh-ancestor
19545120|NCT01723579|Hormones|hormones|mesh-ancestor
19545121|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545122|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545123|NCT01689909|Zolpidem|zolpidem|mesh-list
19545124|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19545125|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19545126|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19545127|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545128|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19545129|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
19545130|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
19545131|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545132|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545133|NCT01615874|Prednisone|prednisone|mesh-list
19545134|NCT01615874|Prednisolone|prednisolone|mesh-list
19545135|NCT01615874|Montelukast|montelukast|mesh-list
19545136|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
19545137|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545138|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
19545139|NCT01615874|Hormones|hormones|mesh-ancestor
19545140|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545141|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545142|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19545143|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545144|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
19545145|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545146|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545147|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545148|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19545149|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
19545150|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19545151|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19545152|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545153|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19545154|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
19545155|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
19545156|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
19545157|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20105976|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20105977|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120499|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545158|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
19545159|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545160|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545161|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545162|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545163|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19545164|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19545165|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19545166|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
19545167|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545168|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545169|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545170|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545171|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545172|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
19545173|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545174|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545175|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545176|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
19545177|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545178|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19545179|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545180|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545181|NCT01236430|Atorvastatin|atorvastatin|mesh-list
19545182|NCT01236430|Ezetimibe|ezetimibe|mesh-list
19545183|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545184|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20120500|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120501|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
20120502|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120503|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120504|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
20120505|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120506|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
19545185|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
20105978|NCT00003536|Methotrexate|methotrexate|mesh-list
20105979|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20105980|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
20604290|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20604291|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20604292|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20604293|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
20604294|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604295|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545186|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545187|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545188|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545189|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545190|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
19545191|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545192|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545193|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545194|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
19545195|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545196|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545197|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545198|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
19545199|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545200|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545201|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545202|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
19545203|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545204|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545205|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545206|NCT00867165|Ezetimibe|ezetimibe|mesh-list
19545207|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545208|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545209|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
19545210|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545211|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545212|NCT00817076|Desloratadine|desloratadine|mesh-list
19545213|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545214|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545215|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545216|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545217|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545218|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545219|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545220|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545221|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
19545222|NCT00817050|Fluticasone|fluticasone|mesh-list
19545223|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
19545224|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545225|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19545226|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
19545227|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545228|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545229|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545230|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545231|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545232|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545233|NCT00816972|Loratadine|loratadine|mesh-list
19545234|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
19545235|NCT00816972|Oxybutynin|oxybutynin|mesh-list
19545236|NCT00816972|Desloratadine|desloratadine|mesh-list
19545237|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
19545238|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
19545239|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545240|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545241|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19545242|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545243|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545244|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545245|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545246|NCT00816972|Urological Agents|urological agents|mesh-ancestor
20105981|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20105982|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545247|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19545248|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19545249|NCT00816972|Renal Agents|renal agents|mesh-ancestor
19545250|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545251|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545252|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545253|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
19545254|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
19545255|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545256|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545257|NCT00805324|Desloratadine|desloratadine|mesh-list
19545258|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545259|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
20105983|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20105984|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
20105985|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20105986|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105987|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
20105988|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20105989|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20105990|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20105991|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
20105992|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20105993|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20105994|NCT00003539|Paclitaxel|paclitaxel|mesh-list
20105995|NCT00003539|Trastuzumab|trastuzumab|mesh-list
20105996|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20105997|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20105998|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604296|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20105999|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106000|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106001|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106002|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20106003|NCT00003540|Gemcitabine|gemcitabine|mesh-list
20106004|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106005|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
20106006|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106007|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106008|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
20106009|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604297|NCT02226484|Quercetin|quercetin|mesh-list
19545260|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20106010|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106011|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106012|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
20106013|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106014|NCT00003541|Prednisone|prednisone|mesh-list
20106015|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
20106016|NCT00003541|Ifosfamide|ifosfamide|mesh-list
20106017|NCT00003541|Carboplatin|carboplatin|mesh-list
20106018|NCT00003541|Doxorubicin|doxorubicin|mesh-list
20106019|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20106020|NCT00003541|Etoposide|etoposide|mesh-list
20106021|NCT00003541|Vincristine|vincristine|mesh-list
20106022|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106023|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
20106024|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106025|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106026|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106027|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
20106028|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106029|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106030|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106031|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106032|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106033|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106034|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106035|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106036|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
19545261|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545262|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545263|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545264|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20106037|NCT00003541|Hormones|hormones|mesh-ancestor
20106038|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20308304|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20604298|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
19545265|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545266|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
19545267|NCT00794794|Cetirizine|cetirizine|mesh-list
19545268|NCT00794794|Desloratadine|desloratadine|mesh-list
19545269|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20604299|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604300|NCT02226484|Protective Agents|protective agents|mesh-ancestor
19545270|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545271|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545272|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545273|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
19545274|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545275|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545276|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545277|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545278|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545279|NCT00794378|Cetirizine|cetirizine|mesh-list
19545280|NCT00794378|Desloratadine|desloratadine|mesh-list
19545281|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545282|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545283|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545284|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545285|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
19545286|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545287|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545288|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545289|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545290|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545291|NCT00789152|Levocetirizine|levocetirizine|mesh-list
19545292|NCT00789152|Desloratadine|desloratadine|mesh-list
19545293|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545294|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545295|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
20106039|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20106040|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106041|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
19545296|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
19545297|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545298|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545299|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545300|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545301|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545302|NCT00783458|Fluticasone|fluticasone|mesh-list
19545303|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
19545304|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545305|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19545306|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
19545307|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545308|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545309|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545310|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545311|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545312|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545313|NCT00783211|Fexofenadine|fexofenadine|mesh-list
19545314|NCT00783211|Desloratadine|desloratadine|mesh-list
19545315|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545316|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545317|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545318|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545319|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545320|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545321|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545322|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545323|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
19545324|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545325|NCT00783146|Fexofenadine|fexofenadine|mesh-list
19545326|NCT00783146|Desloratadine|desloratadine|mesh-list
19545327|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545328|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545329|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545330|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545331|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575582|NCT02364713|Growth Substances|growth substances|mesh-ancestor
19545332|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545333|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545334|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545335|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
19545336|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545337|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
19545338|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545339|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545340|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545341|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
19545342|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545343|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545344|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545345|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
19545346|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19545347|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19545348|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19545349|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19545350|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19545351|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545352|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545353|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545354|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19545355|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
19545356|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19545357|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545358|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19545359|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19545360|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19545361|NCT00751218|Cetirizine|cetirizine|mesh-list
19545362|NCT00751218|Desloratadine|desloratadine|mesh-list
19545363|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545364|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545365|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545366|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545367|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
19545368|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545369|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545370|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545371|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545372|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545373|NCT00751166|Cetirizine|cetirizine|mesh-list
19545374|NCT00751166|Desloratadine|desloratadine|mesh-list
20604301|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604302|NCT02226510|Metformin|metformin|mesh-list
20604303|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20604304|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545375|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545376|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545377|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545378|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545379|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
19545380|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545381|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545382|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545383|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545384|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545385|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
19545386|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545387|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545388|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545389|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
19545390|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545391|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545392|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20106042|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106043|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106044|NCT00003542|Interferons|interferons|mesh-list
20106045|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
20604305|NCT02226588|Misoprostol|misoprostol|mesh-list
20604306|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20604307|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
20106046|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106047|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
20106048|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106049|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
20106050|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106051|NCT00003543|Fluorouracil|fluorouracil|mesh-list
20106052|NCT00003543|Vincristine|vincristine|mesh-list
20106053|NCT00003543|Carmustine|carmustine|mesh-list
20106054|NCT00003543|Streptozocin|streptozocin|mesh-list
20106055|NCT00003543|Antibodies|antibodies|mesh-list
20106056|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20106057|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
20106058|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106059|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
20106060|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106061|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106062|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106063|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106064|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106065|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106066|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106067|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106068|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106069|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
20106070|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106071|NCT00003544|Irinotecan|irinotecan|mesh-list
20106072|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20106073|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106074|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106075|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106076|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106077|NCT00003546|Gemcitabine|gemcitabine|mesh-list
20106078|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20604308|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20604309|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604310|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20106079|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
20106080|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106081|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106082|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
20106083|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106084|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106085|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106086|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
20106087|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106088|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
20106089|NCT00003549|Fluorouracil|fluorouracil|mesh-list
20106090|NCT00003549|Methotrexate|methotrexate|mesh-list
20106091|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106092|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
19545393|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
19545394|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545395|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545396|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545397|NCT00726856|Ezetimibe|ezetimibe|mesh-list
19545398|NCT00726856|Fenofibrate|fenofibrate|mesh-list
19545399|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545400|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545401|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
19545402|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545403|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545404|NCT00705211|Ezetimibe|ezetimibe|mesh-list
19545405|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545406|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545407|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
19545408|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545409|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545410|NCT00704444|Ezetimibe|ezetimibe|mesh-list
19545411|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545412|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545413|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
19545414|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545415|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545416|NCT00654095|Atorvastatin|atorvastatin|mesh-list
19545417|NCT00654095|Ezetimibe|ezetimibe|mesh-list
19545418|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545419|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545420|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
19749470|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545421|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545422|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545423|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545424|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545425|NCT00653913|Ezetimibe|ezetimibe|mesh-list
19545426|NCT00653913|Pitavastatin|pitavastatin|mesh-list
19545427|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545428|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545429|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
19545430|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545431|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545432|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545433|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106093|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106094|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106095|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106096|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
20106097|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545434|NCT00653523|Simvastatin|simvastatin|mesh-list
19545435|NCT00653523|Ezetimibe|ezetimibe|mesh-list
19545436|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545437|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545438|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
19545439|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545440|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545441|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545442|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545443|NCT00652431|Niacin|niacin|mesh-list
19545444|NCT00652431|Niacinamide|niacinamide|mesh-list
19545445|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
19545446|NCT00652431|Simvastatin|simvastatin|mesh-list
19545447|NCT00652431|Ezetimibe|ezetimibe|mesh-list
19545448|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19545449|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545450|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545451|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
19545452|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545453|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545454|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545455|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545456|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
19545457|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
19545458|NCT00652431|Vitamins|vitamins|mesh-ancestor
19545459|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
19545460|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545461|NCT00651378|Atorvastatin|atorvastatin|mesh-list
19545462|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19545463|NCT00651378|Ezetimibe|ezetimibe|mesh-list
19545464|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545465|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545466|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
19545467|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545468|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545469|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545470|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545471|NCT00651274|Ezetimibe|ezetimibe|mesh-list
19545472|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545473|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545474|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
19545475|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545476|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545477|NCT00650819|Simvastatin|simvastatin|mesh-list
19545478|NCT00650819|Ezetimibe|ezetimibe|mesh-list
19545479|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545480|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545481|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
19545482|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545483|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545484|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545485|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545486|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
19545487|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545488|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545489|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545490|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
19545491|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545492|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545493|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545494|NCT00546052|Losartan|losartan|mesh-list
19545495|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19545496|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19545497|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19545498|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19545499|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19545500|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545501|NCT00546052|Diuretics|diuretics|mesh-ancestor
19545502|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
19545503|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545504|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19545505|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545506|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
19545507|NCT00442117|Budesonide|budesonide|mesh-list
19545508|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545509|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19545510|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
19545511|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545512|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545513|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545514|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545515|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
19545516|NCT00442117|Hormones|hormones|mesh-ancestor
19545517|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545518|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545519|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20106098|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106099|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106100|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
20106101|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19545520|NCT00424008|Fluticasone|fluticasone|mesh-list
19545521|NCT00424008|Xhance|xhance|mesh-list
19545522|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
19545523|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
19545524|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19545525|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19545526|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545527|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19545528|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
20106102|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20106103|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
20106104|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20106105|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106106|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106107|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19545529|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545530|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545531|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545532|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545533|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545534|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545535|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19545536|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19545537|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19545538|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
19545539|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545540|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545541|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
19545542|NCT00424008|Hormones|hormones|mesh-ancestor
19545543|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545544|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
19545545|NCT00423995|Loratadine|loratadine|mesh-list
19545546|NCT00423995|Montelukast|montelukast|mesh-list
19545547|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545548|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545549|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19545550|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
19545551|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545552|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545553|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19545554|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20106108|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19545555|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545556|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
19545557|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545558|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545559|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545560|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545561|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545562|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
19545563|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545564|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19545565|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19545566|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19545567|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
19545568|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
19545569|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
19545570|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19545571|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
19545572|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545573|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545574|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545575|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545576|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19545577|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19545578|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19545579|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19545580|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545581|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545582|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545583|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545584|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545585|NCT00380627|Etoricoxib|etoricoxib|mesh-list
19545586|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545587|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545588|NCT00380627|Analgesics|analgesics|mesh-ancestor
19545589|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
20106109|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
20106110|NCT00003552|Fludarabine|fludarabine|mesh-list
20106111|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20106112|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106113|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
20106114|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106115|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106116|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106117|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
20106118|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545590|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545591|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545592|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545593|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545594|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545595|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545596|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545597|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545598|NCT00380523|Etoricoxib|etoricoxib|mesh-list
19545599|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545600|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545601|NCT00380523|Analgesics|analgesics|mesh-ancestor
19545602|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
19545603|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545604|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545605|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545606|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545607|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545608|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545609|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545610|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545611|NCT00319995|Loratadine|loratadine|mesh-list
19545612|NCT00319995|Montelukast|montelukast|mesh-list
19545613|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19545614|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
19545615|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20106119|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19545616|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
19545617|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545618|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545619|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19545620|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19545621|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545622|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
19545623|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
19545624|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19545625|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545626|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545627|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545628|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
19545629|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545630|NCT00311844|Desloratadine|desloratadine|mesh-list
19545631|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19545632|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
19545633|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545634|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545635|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545636|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19545637|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19545638|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
19545639|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
19545640|NCT00212836|Olanzapine|olanzapine|mesh-list
19545641|NCT00212836|Asenapine|asenapine|mesh-list
19545642|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
19545643|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
19545644|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545645|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545646|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20106120|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106121|NCT00003554|Prednisone|prednisone|mesh-list
20106122|NCT00003554|Rituximab|rituximab|mesh-list
20106123|NCT00003554|Melphalan|melphalan|mesh-list
20106124|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20106125|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106126|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
20106127|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106128|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106129|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106130|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
20106131|NCT00003554|Hormones|hormones|mesh-ancestor
19545647|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19545648|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19545649|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19545650|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20106132|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20106133|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19545651|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19545652|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19545653|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545654|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545655|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545656|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
19545657|NCT00212784|Olanzapine|olanzapine|mesh-list
19545658|NCT00212784|Asenapine|asenapine|mesh-list
19545659|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
19545660|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
19545661|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545662|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545663|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19545664|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19545665|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19545666|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19545667|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19545668|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19545669|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19545670|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545671|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545672|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545673|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
19545674|NCT00212771|Olanzapine|olanzapine|mesh-list
19545675|NCT00212771|Asenapine|asenapine|mesh-list
19545676|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
19545677|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
19545678|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545679|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545680|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19545681|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19545682|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19545683|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19545684|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19545685|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19545686|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19545687|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545688|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545689|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545690|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
19545691|NCT00202904|Ezetimibe|ezetimibe|mesh-list
19545692|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545693|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545694|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
19545695|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545696|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545697|NCT00157924|Atorvastatin|atorvastatin|mesh-list
19545698|NCT00157924|Simvastatin|simvastatin|mesh-list
19545699|NCT00157924|Ezetimibe|ezetimibe|mesh-list
19545700|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545701|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545702|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
19545703|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545704|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545705|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545706|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545707|NCT00157911|Simvastatin|simvastatin|mesh-list
19545708|NCT00157911|Ezetimibe|ezetimibe|mesh-list
19545709|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545710|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545711|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
19545712|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545713|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545714|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545715|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545716|NCT00156117|Olanzapine|olanzapine|mesh-list
19545717|NCT00156117|Asenapine|asenapine|mesh-list
19545718|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
19545719|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
19545720|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545721|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545722|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19545723|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19545724|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19545725|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19545726|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19545727|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19545728|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19545729|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545730|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545731|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545732|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
19575583|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575584|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
19575585|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
19575586|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19575587|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
19575588|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
19575589|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575590|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575591|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575592|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19575593|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19575594|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19575595|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19575596|NCT02358395|Sorafenib|sorafenib|mesh-list
19575597|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575598|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575599|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575600|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545733|NCT00156104|Haloperidol|haloperidol|mesh-list
19545734|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
19545735|NCT00156104|Asenapine|asenapine|mesh-list
19545736|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
19545737|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
19545738|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545739|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545740|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19545741|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19545742|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19545743|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19545744|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19545745|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19545746|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
19545747|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545748|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545749|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19545750|NCT00156091|Olanzapine|olanzapine|mesh-list
19545751|NCT00156091|Asenapine|asenapine|mesh-list
19545752|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
19545753|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
19545754|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545755|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545756|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19545757|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19545758|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19545759|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19545760|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19545761|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19545762|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19545763|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545764|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545765|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545766|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
19545767|NCT00142558|Indomethacin|indomethacin|mesh-list
19545768|NCT00142558|Etoricoxib|etoricoxib|mesh-list
19545769|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545770|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545771|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545772|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545773|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545774|NCT00142558|Analgesics|analgesics|mesh-ancestor
19545775|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
19545776|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545777|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545778|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
19545779|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
19545780|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19545781|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20106134|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106135|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
20106136|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106137|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106138|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106139|NCT00003555|Paclitaxel|paclitaxel|mesh-list
20106140|NCT00003555|Amifostine|amifostine|mesh-list
20106141|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106142|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106143|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106144|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106145|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
19545782|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545783|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545784|NCT00140985|Losartan|losartan|mesh-list
19545785|NCT00140985|Amlodipine|amlodipine|mesh-list
19545786|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19545787|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19545788|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545789|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545790|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19545791|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545792|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
19545793|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19545794|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19575601|NCT02354898|Sorafenib|sorafenib|mesh-list
19545795|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19545796|NCT00140972|Diclofenac|diclofenac|mesh-list
19545797|NCT00140972|Etoricoxib|etoricoxib|mesh-list
19545798|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545799|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545800|NCT00140972|Analgesics|analgesics|mesh-ancestor
19545801|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
19545802|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545803|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545804|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545805|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545806|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545807|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545808|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545809|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545810|NCT00140959|Losartan|losartan|mesh-list
19545811|NCT00140959|Atenolol|atenolol|mesh-list
19545812|NCT00140959|Amlodipine|amlodipine|mesh-list
19545813|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19545814|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19545815|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19545816|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545817|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19545818|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545819|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
19545820|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19545821|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19545822|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19545823|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
19545824|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19545825|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
19545826|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545827|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
19545828|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19545829|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19545830|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19545831|NCT00140907|Losartan|losartan|mesh-list
19545832|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19545833|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19545834|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19545835|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19545836|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545837|NCT00132717|Atorvastatin|atorvastatin|mesh-list
19545838|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19545839|NCT00132717|Simvastatin|simvastatin|mesh-list
19545840|NCT00132717|Ezetimibe|ezetimibe|mesh-list
19545841|NCT00132717|Pravastatin|pravastatin|mesh-list
19545842|NCT00132717|Lovastatin|lovastatin|mesh-list
19545843|NCT00132717|L 647318|l 647318|mesh-list
19545844|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
19545845|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545846|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545847|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
19545848|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545849|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545850|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20106146|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106147|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20106148|NCT00003555|Protective Agents|protective agents|mesh-ancestor
20106149|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106150|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
20106151|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106152|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106153|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106154|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106155|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106156|NCT00003558|Leucovorin|leucovorin|mesh-list
20106157|NCT00003558|Paclitaxel|paclitaxel|mesh-list
20106158|NCT00003558|Etoposide|etoposide|mesh-list
20106159|NCT00003558|Carboplatin|carboplatin|mesh-list
20106160|NCT00003558|Fluorouracil|fluorouracil|mesh-list
20106161|NCT00003558|Calcium|calcium|mesh-list
19545851|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106162|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
19545852|NCT00127179|Finasteride|finasteride|mesh-list
20106163|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19545853|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545854|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545855|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19545856|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19545857|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545858|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
19545859|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19545860|NCT00127179|Urological Agents|urological agents|mesh-ancestor
19545861|NCT00110435|Atorvastatin|atorvastatin|mesh-list
19545862|NCT00110435|Simvastatin|simvastatin|mesh-list
19545863|NCT00110435|Ezetimibe|ezetimibe|mesh-list
19545864|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545865|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545866|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
19545867|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545868|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545869|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545870|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545871|NCT00095017|Etoricoxib|etoricoxib|mesh-list
19545872|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545873|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545874|NCT00095017|Analgesics|analgesics|mesh-ancestor
19545875|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
19545876|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545877|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545878|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545879|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545880|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545881|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545882|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545883|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545884|NCT00093899|Simvastatin|simvastatin|mesh-list
19545885|NCT00093899|Ezetimibe|ezetimibe|mesh-list
19545886|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545887|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545888|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
19545889|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545890|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545891|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19545892|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545893|NCT00092898|Ezetimibe|ezetimibe|mesh-list
19545894|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545895|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545896|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
19545897|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545898|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545899|NCT00092820|Ezetimibe|ezetimibe|mesh-list
19545900|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545901|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545902|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
19545903|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545904|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545905|NCT00092807|Ezetimibe|ezetimibe|mesh-list
19545906|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19545907|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19545908|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
19545909|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545910|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19545911|NCT00092781|Celecoxib|celecoxib|mesh-list
19545912|NCT00092781|Etoricoxib|etoricoxib|mesh-list
19545913|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545914|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545915|NCT00092781|Analgesics|analgesics|mesh-ancestor
19545916|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
19545917|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545918|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545919|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545920|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545921|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545922|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545923|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545924|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545925|NCT00092768|Celecoxib|celecoxib|mesh-list
19545926|NCT00092768|Etoricoxib|etoricoxib|mesh-list
19545927|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545928|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545929|NCT00092768|Analgesics|analgesics|mesh-ancestor
19545930|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
19545931|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545932|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545933|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545934|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545935|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545936|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545937|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545938|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545939|NCT00092755|Ibuprofen|ibuprofen|mesh-list
20106164|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106165|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106166|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106167|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106168|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106169|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20106170|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545940|NCT00092755|Etoricoxib|etoricoxib|mesh-list
19545941|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545942|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545943|NCT00092755|Analgesics|analgesics|mesh-ancestor
19545944|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
19545945|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545946|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545947|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545948|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545949|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545950|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545951|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545952|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545953|NCT00092742|Diclofenac|diclofenac|mesh-list
19545954|NCT00092742|Etoricoxib|etoricoxib|mesh-list
19545955|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545956|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545957|NCT00092742|Analgesics|analgesics|mesh-ancestor
19545958|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
19545959|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545960|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545961|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545962|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545963|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545964|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545965|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545966|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545967|NCT00092729|Naproxen|naproxen|mesh-list
19545968|NCT00092729|Etoricoxib|etoricoxib|mesh-list
19545969|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545970|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545971|NCT00092729|Analgesics|analgesics|mesh-ancestor
19545972|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
19545973|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545974|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545975|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545976|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545977|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
19545978|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545979|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545980|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545981|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545982|NCT00092703|Diclofenac|diclofenac|mesh-list
19545983|NCT00092703|Etoricoxib|etoricoxib|mesh-list
19545984|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19545985|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19545986|NCT00092703|Analgesics|analgesics|mesh-ancestor
19545987|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
19545988|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19545989|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19545990|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19545991|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19545992|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19545993|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19545994|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19545995|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19545996|NCT02844270|Sirolimus|sirolimus|mesh-list
19545997|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19545998|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19545999|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19546000|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546001|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
19546002|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546003|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
19546004|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546005|NCT02843984|Lactoferrin|lactoferrin|mesh-list
19546006|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546007|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
19546008|NCT02844062|Fludarabine|fludarabine|mesh-list
19546009|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546010|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
19546011|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546012|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546013|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19546014|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
19546015|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546016|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546017|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19546018|NCT02844114|Gemcitabine|gemcitabine|mesh-list
19546019|NCT02844114|Cisplatin|cisplatin|mesh-list
19546020|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546021|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546022|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
19546023|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604311|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604312|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
20604313|NCT02226601|Aprepitant|aprepitant|mesh-list
20604314|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
19546024|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
19546025|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106171|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
20106172|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106173|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106174|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
19546026|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546027|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546028|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
19546029|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546030|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
19546031|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19546032|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546033|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546034|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546035|NCT02843698|Analgesics|analgesics|mesh-ancestor
19546036|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
19546037|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546038|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19546039|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19546040|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19546041|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
19546042|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546043|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546044|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19546045|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546046|NCT02843321|Vaccines|vaccines|mesh-list
19546047|NCT02843321|Immunologic Factors|immunologic factors|mesh-ancestor
19546048|NCT02843321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546049|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19546050|NCT02843490|Ranibizumab|ranibizumab|mesh-list
19546051|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19546052|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19546053|NCT02843490|Growth Substances|growth substances|mesh-ancestor
19546054|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546055|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
19546056|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546057|NCT02842983|Esmolol|esmolol|mesh-list
20106175|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20604315|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
20604316|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546058|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19546059|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19546060|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
19546061|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20106176|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106177|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106178|NCT00003558|Antidotes|antidotes|mesh-ancestor
20106179|NCT00003558|Protective Agents|protective agents|mesh-ancestor
20106180|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
20106181|NCT00003558|Vitamins|vitamins|mesh-ancestor
19546062|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546063|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546064|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19546065|NCT02843126|Trastuzumab|trastuzumab|mesh-list
19546066|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546067|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546068|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
19546069|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546070|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546071|NCT02843061|Rituximab|rituximab|mesh-list
19546072|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546073|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546074|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
19546075|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546076|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546077|NCT02842931|Prednisone|prednisone|mesh-list
19546078|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
19546079|NCT02842931|Doxorubicin|doxorubicin|mesh-list
19546080|NCT02842931|Etoposide|etoposide|mesh-list
19546081|NCT02842931|Vincristine|vincristine|mesh-list
19546082|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546083|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
19546084|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546085|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546086|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19546087|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
19546088|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546089|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546090|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19546091|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19546092|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19546093|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19546094|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106182|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
20106183|NCT00003560|Carboplatin|carboplatin|mesh-list
20106184|NCT00003560|Docetaxel|docetaxel|mesh-list
20106185|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546095|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19546096|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546097|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
19546098|NCT02842931|Hormones|hormones|mesh-ancestor
19546099|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546100|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19546101|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
19546102|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
19546103|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575602|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575603|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575604|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575605|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575606|NCT02347917|Pemetrexed|pemetrexed|mesh-list
19575607|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575608|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575609|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575610|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19575611|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19575612|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
19575613|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575614|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575615|NCT02303795|Warfarin|warfarin|mesh-list
19575616|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
19575617|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
19575618|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19575619|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
20106186|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106187|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
19546104|NCT02842749|Everolimus|everolimus|mesh-list
20106188|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106189|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106190|NCT00003561|Interferons|interferons|mesh-list
20106191|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
20106192|NCT00003561|Sargramostim|sargramostim|mesh-list
20106193|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106194|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
20106195|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106196|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
20106197|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106198|NCT00003562|Carboplatin|carboplatin|mesh-list
20106199|NCT00003562|Docetaxel|docetaxel|mesh-list
20106200|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106201|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106202|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106203|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106204|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106205|NCT00003564|Procarbazine|procarbazine|mesh-list
19546105|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546106|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546107|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
19546108|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546109|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
19546110|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
19546111|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
19546112|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19546113|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19546114|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546115|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546116|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546117|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546118|NCT02842814|Hormones|hormones|mesh-ancestor
19546119|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546120|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546121|NCT02842567|Vitamin E|vitamin e|mesh-list
19546122|NCT02842567|Tocopherols|tocopherols|mesh-list
19546123|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
19546124|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
19546125|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
19546126|NCT02842567|Vitamins|vitamins|mesh-ancestor
19546127|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
19546128|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546129|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
19546130|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546131|NCT02842567|Protective Agents|protective agents|mesh-ancestor
19546132|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546133|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19546134|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19546135|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
19546136|NCT02842580|Leucovorin|leucovorin|mesh-list
19546137|NCT02842580|Bevacizumab|bevacizumab|mesh-list
19546138|NCT02842580|Capecitabine|capecitabine|mesh-list
19546139|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
19546140|NCT02842580|Irinotecan|irinotecan|mesh-list
19546141|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
19546142|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546143|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546144|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19546145|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19546146|NCT02842580|Growth Substances|growth substances|mesh-ancestor
19546147|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546148|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
20106206|NCT00003564|Isotretinoin|isotretinoin|mesh-list
20106207|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106208|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106209|NCT00003565|Docetaxel|docetaxel|mesh-list
20106210|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106211|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106212|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106213|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604317|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106214|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546149|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546150|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
19546151|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106215|NCT00003567|Temozolomide|temozolomide|mesh-list
20106216|NCT00003567|Carmustine|carmustine|mesh-list
19546152|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19546153|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20604318|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604319|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20604320|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604321|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607938|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20607939|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20607940|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19546154|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106217|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19546155|NCT02842580|Antidotes|antidotes|mesh-ancestor
19546156|NCT02842580|Protective Agents|protective agents|mesh-ancestor
19546157|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
19546158|NCT02842580|Vitamins|vitamins|mesh-ancestor
19546159|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
19546160|NCT02842281|Levan|levan|mesh-list
19546161|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546162|NCT02842294|Bevacizumab|bevacizumab|mesh-list
19546163|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546164|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546165|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19546166|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19546167|NCT02842294|Growth Substances|growth substances|mesh-ancestor
19546168|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546169|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
19546170|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
19546171|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19546172|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546173|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546174|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546175|NCT02842437|Analgesics|analgesics|mesh-ancestor
19546176|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
19546177|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546178|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19546179|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19546180|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19546181|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
19546182|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546183|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546184|NCT02842424|Ramipril|ramipril|mesh-list
19546185|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19546186|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
19546187|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546188|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546189|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19546190|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
19546191|NCT02842125|Nivolumab|nivolumab|mesh-list
19546192|NCT02842125|Capecitabine|capecitabine|mesh-list
20106218|NCT00003567|Sargramostim|sargramostim|mesh-list
20106219|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
20106220|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106221|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106222|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
19546193|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546194|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546195|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546196|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
19546197|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546198|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19546199|NCT02841982|Morphine|morphine|mesh-list
19546200|NCT02841982|Ropivacaine|ropivacaine|mesh-list
19546201|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19546202|NCT02841982|Narcotics|narcotics|mesh-ancestor
19546203|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546204|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546205|NCT02841982|Analgesics|analgesics|mesh-ancestor
19546206|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
19546207|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546208|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546209|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
19546210|NCT02841839|Fluorides|fluorides|mesh-list
20106223|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546211|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
19546212|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
19546213|NCT02841839|Protective Agents|protective agents|mesh-ancestor
19546214|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546215|NCT02841488|Fentanyl|fentanyl|mesh-list
19546216|NCT02841488|Ropivacaine|ropivacaine|mesh-list
19546217|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546218|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
19546219|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546220|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546221|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
19546222|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546223|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19546224|NCT02841488|Narcotics|narcotics|mesh-ancestor
19546225|NCT02841488|Analgesics|analgesics|mesh-ancestor
19546226|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19546227|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19546228|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
19546229|NCT02841722|Sargramostim|sargramostim|mesh-list
19546230|NCT02841722|Lenograstim|lenograstim|mesh-list
19546231|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
19546232|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546233|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19546234|NCT02841579|Osimertinib|osimertinib|mesh-list
19546235|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546236|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19546237|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546238|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546239|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19546240|NCT02841774|Pravastatin|pravastatin|mesh-list
19546241|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19546242|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19546243|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
19546244|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546245|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19546246|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19546247|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546248|NCT02841800|Phenobarbital|phenobarbital|mesh-list
19546249|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
19546250|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20106224|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106225|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106226|NCT00003568|Aldesleukin|aldesleukin|mesh-list
20106227|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
20106228|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106229|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20106230|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20106231|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
20106232|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106233|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20106234|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
20106235|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546251|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546252|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546253|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19546254|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19546255|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546256|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546257|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
19546258|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
19546259|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19546260|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19546261|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19546262|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19546263|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20106236|NCT00003569|Paclitaxel|paclitaxel|mesh-list
20106237|NCT00003569|Cisplatin|cisplatin|mesh-list
20106238|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106239|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106240|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106241|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106242|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106243|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106244|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
20106245|NCT00003572|Tacrolimus|tacrolimus|mesh-list
20106246|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546264|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20106247|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
20106248|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106249|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20106250|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106251|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106252|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106253|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106254|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20106255|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
20106256|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20106257|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106258|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
20106259|NCT00003573|Cisplatin|cisplatin|mesh-list
20106260|NCT00003573|Etoposide|etoposide|mesh-list
20106261|NCT00003573|Vincristine|vincristine|mesh-list
19546265|NCT02841332|Misonidazole|misonidazole|mesh-list
19546266|NCT02841332|Bevacizumab|bevacizumab|mesh-list
19546267|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546268|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546269|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19546270|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19546271|NCT02841332|Growth Substances|growth substances|mesh-ancestor
19546272|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546273|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
19546274|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19546275|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19546276|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546277|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
19546278|NCT02840994|Nivolumab|nivolumab|mesh-list
19546279|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546280|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546281|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19546282|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575620|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19575621|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
19575622|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575623|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575624|NCT02178566|Treprostinil|treprostinil|mesh-list
19575625|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19578180|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578181|NCT03385655|Carboplatin|carboplatin|mesh-list
19578182|NCT03385655|Durvalumab|durvalumab|mesh-list
19578183|NCT03385655|Tremelimumab|tremelimumab|mesh-list
19578184|NCT03385655|Adavosertib|adavosertib|mesh-list
19578185|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578186|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578187|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578188|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578354|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19578355|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
19578356|NCT02724579|Lomustine|lomustine|mesh-list
19578357|NCT02724579|Cisplatin|cisplatin|mesh-list
19578358|NCT02724579|Vincristine|vincristine|mesh-list
19578359|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578360|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
19578361|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578362|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578363|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578364|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
19578365|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578366|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578367|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19578368|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578369|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578370|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578371|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106262|NCT00003573|Lenograstim|lenograstim|mesh-list
20106263|NCT00003573|Sargramostim|sargramostim|mesh-list
20106264|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106265|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
20106266|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106267|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106268|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106269|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
19578372|NCT02596035|Nivolumab|nivolumab|mesh-list
20106270|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106271|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546283|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
19546284|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
19546285|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19546286|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19546287|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546288|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19546289|NCT02841137|Progesterone|progesterone|mesh-list
19546290|NCT02841137|Progestins|progestins|mesh-ancestor
19546291|NCT02841137|Hormones|hormones|mesh-ancestor
19546292|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546293|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546294|NCT02841176|Golimumab|golimumab|mesh-list
19546295|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19546296|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546297|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546298|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
19546299|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546300|NCT02840929|Esomeprazole|esomeprazole|mesh-list
19546301|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19546302|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546303|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19546304|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546305|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546306|NCT02840708|Sargramostim|sargramostim|mesh-list
19546307|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
19546308|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546309|NCT02840539|Cytarabine|cytarabine|mesh-list
19546310|NCT02840539|Dexamethasone|dexamethasone|mesh-list
19546311|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
19546312|NCT02840539|Bortezomib|bortezomib|mesh-list
19546313|NCT02840539|BB 1101|bb 1101|mesh-list
19546314|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546315|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
19546316|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
19546317|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546318|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546319|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546320|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
19546321|NCT02840539|Hormones|hormones|mesh-ancestor
19546322|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546323|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19546324|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546325|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
19546326|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546327|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546328|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546329|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
19546330|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
19546331|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546332|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546333|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
19546334|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19546335|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
20106272|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106273|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106274|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106275|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106276|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106277|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20106278|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106279|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
19546336|NCT02840240|Gabapentin|gabapentin|mesh-list
19546337|NCT02840240|Analgesics|analgesics|mesh-ancestor
19546338|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
19546339|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546340|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546341|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
19546342|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19546343|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19546344|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546345|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19546346|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20106280|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106281|NCT00003575|Etoposide|etoposide|mesh-list
19546347|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20106282|NCT00003575|Ifosfamide|ifosfamide|mesh-list
20106283|NCT00003575|Interleukin-12|interleukin-12|mesh-list
20106284|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106285|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106286|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106287|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106288|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106289|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546348|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546349|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546350|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
19546351|NCT02840526|Acetaminophen|acetaminophen|mesh-list
19546352|NCT02840526|Fentanyl|fentanyl|mesh-list
19546353|NCT02840526|Bupivacaine|bupivacaine|mesh-list
19546354|NCT02840526|Propofol|propofol|mesh-list
19546355|NCT02840526|Sevoflurane|sevoflurane|mesh-list
19546356|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546357|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
19546358|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546359|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546360|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
19546361|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106290|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20106291|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
20106292|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106293|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106294|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
19546362|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19546363|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19546364|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
19546365|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19546366|NCT02840526|Narcotics|narcotics|mesh-ancestor
19546367|NCT02840526|Analgesics|analgesics|mesh-ancestor
19546368|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19546369|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546370|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
19546371|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19546372|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19546373|NCT02840409|Bevacizumab|bevacizumab|mesh-list
19546374|NCT02840409|Vinblastine|vinblastine|mesh-list
19546375|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546376|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546377|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19546378|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19546379|NCT02840409|Growth Substances|growth substances|mesh-ancestor
19546380|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546381|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
19546382|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19546383|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
19546384|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
19546385|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
19546386|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546387|NCT02840175|Adalimumab|adalimumab|mesh-list
19546388|NCT02840175|Etanercept|etanercept|mesh-list
19546389|NCT02840175|Abatacept|abatacept|mesh-list
20106295|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20106296|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20106297|NCT00003575|Growth Substances|growth substances|mesh-ancestor
20106298|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
20106299|NCT00003576|Fluorouracil|fluorouracil|mesh-list
20106300|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106301|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
20106302|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106303|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546390|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546391|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546392|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19546393|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546394|NCT02840175|Analgesics|analgesics|mesh-ancestor
19546395|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
19546396|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546397|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106304|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106305|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
20106306|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106307|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
19546398|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546399|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546400|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
19546401|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19546402|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546403|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106308|NCT00003577|Fluorouracil|fluorouracil|mesh-list
20106309|NCT00003577|Methotrexate|methotrexate|mesh-list
20106310|NCT00003577|Epirubicin|epirubicin|mesh-list
20106311|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106312|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
20106313|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106314|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106315|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106316|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
20106317|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106318|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106319|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106320|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
20106321|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106322|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20106323|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
20106324|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19546404|NCT02840162|Celecoxib|celecoxib|mesh-list
19546405|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
19546406|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19546407|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546408|NCT02840162|Analgesics|analgesics|mesh-ancestor
19546409|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
19546410|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546411|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546412|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546413|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546414|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19546415|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19546416|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546417|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546418|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19546419|NCT02840006|Anesthetics|anesthetics|mesh-list
19546420|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546421|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546422|NCT02839928|Ketamine|ketamine|mesh-list
19546423|NCT02839928|Analgesics|analgesics|mesh-list
19546424|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19546425|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
19546426|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546427|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546428|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19546429|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19546430|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
19546431|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
19546432|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546433|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19546434|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19546435|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546436|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546437|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546438|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19546439|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
19546440|NCT02839941|Tacrolimus|tacrolimus|mesh-list
19546441|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
19546442|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546443|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
19546444|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546445|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19546446|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546447|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546448|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19546449|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546450|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19546451|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
19546452|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19546453|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546454|NCT02839941|Hormones|hormones|mesh-ancestor
19575626|NCT02167763|Copper|copper|mesh-list
20106325|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
19546455|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546456|NCT02839694|Celecoxib|celecoxib|mesh-list
19546457|NCT02839694|Decitabine|decitabine|mesh-list
19546458|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
19546459|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19546460|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20106326|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106327|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20106328|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20106329|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106330|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106331|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106332|NCT00003578|Cytarabine|cytarabine|mesh-list
20106333|NCT00003578|Prednisone|prednisone|mesh-list
20106334|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
20106335|NCT00003578|Melphalan|melphalan|mesh-list
20106336|NCT00003578|Carmustine|carmustine|mesh-list
20106337|NCT00003578|Doxorubicin|doxorubicin|mesh-list
20106338|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20106339|NCT00003578|Etoposide|etoposide|mesh-list
20106340|NCT00003578|Vincristine|vincristine|mesh-list
20106341|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106342|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
20106343|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106344|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546461|NCT02839694|Analgesics|analgesics|mesh-ancestor
20106345|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106346|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
20106347|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106348|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106349|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106350|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106351|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106352|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19546462|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
19546463|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546464|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546465|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546466|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546467|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19546468|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19546469|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546470|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546471|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546472|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
19546473|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546474|NCT02839785|Ibuprofen|ibuprofen|mesh-list
19546475|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19546476|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546477|NCT02839785|Analgesics|analgesics|mesh-ancestor
19546478|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
19546479|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546480|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546481|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546482|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546483|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19546484|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546485|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546486|NCT02839668|Acetaminophen|acetaminophen|mesh-list
19546487|NCT02839668|Lidocaine|lidocaine|mesh-list
19546488|NCT02839668|Atropine|atropine|mesh-list
19546489|NCT02839668|Tramadol|tramadol|mesh-list
19546490|NCT02839668|Sevoflurane|sevoflurane|mesh-list
19546491|NCT02839668|Neostigmine|neostigmine|mesh-list
19546492|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546493|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
19546494|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546495|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546496|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
19546497|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546498|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19546499|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19546500|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19546501|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20106353|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106354|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546502|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546503|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546504|NCT02839668|Analgesics|analgesics|mesh-ancestor
19546505|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
19546506|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19546507|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19546508|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
19546509|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19546510|NCT02839668|Narcotics|narcotics|mesh-ancestor
19546511|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19546512|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19546513|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
19546514|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19546515|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
19546516|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
19546517|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
19546518|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19546519|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19546520|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
19546521|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546522|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19546523|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546524|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19546525|NCT02839642|Rivastigmine|rivastigmine|mesh-list
19546526|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19546527|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546528|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546529|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
19546530|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546531|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546532|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19546533|NCT02839642|Protective Agents|protective agents|mesh-ancestor
19546534|NCT02839538|Anesthetics|anesthetics|mesh-list
19546535|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546536|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546537|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
19546538|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19546539|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546540|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19546541|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19546542|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546543|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546544|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546545|NCT02839356|Epinephrine|epinephrine|mesh-list
19546546|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19546547|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19546548|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
19546549|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546550|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546551|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546552|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19546553|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19546554|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
19546555|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546556|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19546557|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
19546558|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
19546559|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
19546560|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19546561|NCT02839408|Azithromycin|azithromycin|mesh-list
19546562|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19546563|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546564|NCT02839239|Vitamin D|vitamin d|mesh-list
19546565|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
19546566|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
20106355|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
19546567|NCT02839239|Vitamins|vitamins|mesh-list
19546568|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
19546569|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546570|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19546571|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19546572|NCT02839213|Scopolamine|scopolamine|mesh-list
19546573|NCT02839213|Bromides|bromides|mesh-list
20106356|NCT00003578|Hormones|hormones|mesh-ancestor
19546574|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20106357|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546575|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
19546576|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19546577|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
19546578|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
19546579|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546580|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546581|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546582|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
19546583|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19546584|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
19546585|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546586|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546587|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19546588|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
19575627|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
19575628|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19575629|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575630|NCT02167763|Trace Elements|trace elements|mesh-ancestor
19575631|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
19575632|NCT02043678|Prednisone|prednisone|mesh-list
19575633|NCT02043678|Prednisolone|prednisolone|mesh-list
19575634|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19575635|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575636|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
19575637|NCT02043678|Hormones|hormones|mesh-ancestor
19575638|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575639|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575640|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19575641|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575642|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19575643|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19575644|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20106358|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20106359|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106360|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106361|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
20106362|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
20106363|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106364|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106365|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106366|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106367|NCT00003580|Amifostine|amifostine|mesh-list
20106368|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20106369|NCT00003580|Protective Agents|protective agents|mesh-ancestor
19575645|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575646|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575647|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19575648|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19575649|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19575650|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20106370|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106371|NCT00003582|Paclitaxel|paclitaxel|mesh-list
20106372|NCT00003582|Fluorouracil|fluorouracil|mesh-list
20106373|NCT00003582|Amifostine|amifostine|mesh-list
20106374|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106375|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106376|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106377|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106378|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106379|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106380|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
20106381|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106382|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106383|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
20106384|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106385|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20106386|NCT00003582|Protective Agents|protective agents|mesh-ancestor
20106387|NCT00003583|Etoposide|etoposide|mesh-list
20106388|NCT00003583|Amifostine|amifostine|mesh-list
20604322|NCT02226757|Paclitaxel|paclitaxel|mesh-list
20604323|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604324|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575651|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
19575652|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604325|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106389|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604326|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106390|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106391|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106392|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106393|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106394|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106395|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20106396|NCT00003583|Protective Agents|protective agents|mesh-ancestor
20106397|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106398|NCT00003584|Prednisone|prednisone|mesh-list
20106399|NCT00003584|Estramustine|estramustine|mesh-list
20106400|NCT00003584|Vinorelbine|vinorelbine|mesh-list
20106401|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106402|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
20106403|NCT00003584|Hormones|hormones|mesh-ancestor
20106404|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20106405|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106406|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19546589|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19546590|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19546591|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
19546592|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546593|NCT02839161|Antacids|antacids|mesh-ancestor
19546594|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546595|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546596|NCT02839486|Vancomycin|vancomycin|mesh-list
19546597|NCT02839486|Cefoxitin|cefoxitin|mesh-list
19546598|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19546599|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546600|NCT02839122|Tadalafil|tadalafil|mesh-list
19546601|NCT02839122|Dutasteride|dutasteride|mesh-list
19546602|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
19546603|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19546604|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19546605|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546606|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546607|NCT02839122|Urological Agents|urological agents|mesh-ancestor
19546608|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19546609|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19546610|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
19546611|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546612|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546613|NCT02839135|Scopolamine|scopolamine|mesh-list
19546614|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19546615|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19546616|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
19546617|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
19546618|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546619|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546620|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546621|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
20106407|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106408|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106409|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106410|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106411|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106412|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106413|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106414|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
20106415|NCT00003585|Interferons|interferons|mesh-list
20106416|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
20106417|NCT00003585|Aldesleukin|aldesleukin|mesh-list
20106418|NCT00003585|Fluorouracil|fluorouracil|mesh-list
20106419|NCT00003585|Isotretinoin|isotretinoin|mesh-list
19546622|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19546623|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
19546624|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546625|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546626|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19546627|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
19546628|NCT02838823|Antibodies|antibodies|mesh-list
19546629|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19546630|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
20106420|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
20604327|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
19546631|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546632|NCT02838992|Cyclosporine|cyclosporine|mesh-list
19546633|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
19546634|NCT02838992|Cyclosporins|cyclosporins|mesh-list
19546635|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
19546636|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546637|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
19546638|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546639|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546640|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19546641|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
19546642|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546643|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546644|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19546645|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546646|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
19546647|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546648|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
19546649|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19546650|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
19546651|NCT02839044|Vitamin K|vitamin k|mesh-list
19546652|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
19546653|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19546654|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19546655|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546656|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
19546657|NCT02839044|Coagulants|coagulants|mesh-ancestor
19546658|NCT02839044|Vitamins|vitamins|mesh-ancestor
19546659|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
19546660|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546661|NCT02838940|Cefazolin|cefazolin|mesh-list
19546662|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19546663|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546664|NCT02838758|Lidocaine|lidocaine|mesh-list
19546665|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546666|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
19546667|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546668|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546669|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
19546670|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546671|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19546672|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19546673|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19546674|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19546675|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546676|NCT02838719|Dexamethasone|dexamethasone|mesh-list
19546677|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
19546678|NCT02838719|BB 1101|bb 1101|mesh-list
19546679|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546680|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
19546681|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
19546682|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106421|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106422|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106423|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106424|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106425|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
20106426|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106427|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
20106428|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106429|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20106430|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20106431|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106432|NCT00003587|Gemcitabine|gemcitabine|mesh-list
20106433|NCT00003587|Paclitaxel|paclitaxel|mesh-list
20106434|NCT00003587|Vinorelbine|vinorelbine|mesh-list
20106435|NCT00003587|Docetaxel|docetaxel|mesh-list
20106436|NCT00003587|Carboplatin|carboplatin|mesh-list
20106437|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106438|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106439|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
19546683|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546684|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546685|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
19546686|NCT02838719|Hormones|hormones|mesh-ancestor
19546687|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20106440|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19546688|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19546689|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106441|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106442|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106443|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106444|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
20106445|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
20106446|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546690|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
19546691|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546692|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546693|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
19546694|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19546695|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
19546696|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546697|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546698|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546699|NCT02838589|Exenatide|exenatide|mesh-list
19546700|NCT02838589|Glucagon|glucagon|mesh-list
19546701|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19546702|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19546703|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546704|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19546705|NCT02838589|Incretins|incretins|mesh-ancestor
19546706|NCT02838589|Hormones|hormones|mesh-ancestor
19546707|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546708|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546709|NCT02838576|Estrogens|estrogens|mesh-list
19546710|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19546711|NCT02838576|Hormones|hormones|mesh-ancestor
19546712|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546713|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546714|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
19546715|NCT02838472|Vitamins|vitamins|mesh-ancestor
19546716|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
19546717|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546718|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
19546719|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546720|NCT02838472|Protective Agents|protective agents|mesh-ancestor
19546721|NCT02838238|Capecitabine|capecitabine|mesh-list
19546722|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546723|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
19546724|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546725|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546726|NCT02838329|Ropivacaine|ropivacaine|mesh-list
19546727|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546728|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
19546729|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19546730|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546731|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
19546732|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546733|NCT02838342|Interferons|interferons|mesh-list
19546734|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
19546735|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
19546736|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546737|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
19546738|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546739|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546740|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19546741|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
19546742|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546743|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546744|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19546745|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
19546746|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546747|NCT02838615|Dexamethasone|dexamethasone|mesh-list
19546748|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546749|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
19546750|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
19546751|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546752|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546753|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546754|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
19546755|NCT02838615|Hormones|hormones|mesh-ancestor
19578189|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19546756|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546757|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19546758|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546759|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
19546760|NCT02838225|Docetaxel|docetaxel|mesh-list
19546761|NCT02838225|Doxorubicin|doxorubicin|mesh-list
19546762|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19546763|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546764|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
19546765|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546766|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546767|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19546768|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
19546769|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546770|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546771|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19546772|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
19546773|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
19546774|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106447|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106448|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106449|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
20106450|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106451|NCT00003589|Gemcitabine|gemcitabine|mesh-list
20604328|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604329|NCT02226783|Omeprazole|omeprazole|mesh-list
20604330|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20106452|NCT00003589|Paclitaxel|paclitaxel|mesh-list
20106453|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19546775|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19546776|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19546777|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19546778|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546779|NCT02838264|Itraconazole|itraconazole|mesh-list
19546780|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
19546781|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546782|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19546783|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19546784|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546785|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546786|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19546787|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
19546788|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546789|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546790|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19546791|NCT02837978|Methotrexate|methotrexate|mesh-list
19546792|NCT02837978|Tacrolimus|tacrolimus|mesh-list
19546793|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19546794|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
19546795|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19546796|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546797|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546798|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
19546799|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546800|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546801|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
19546802|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546803|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19546804|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546805|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
19546806|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546807|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19546808|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19546809|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
19546810|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19546811|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546812|NCT02837965|Doxycycline|doxycycline|mesh-list
19546813|NCT02837965|Prednisone|prednisone|mesh-list
19546814|NCT02837965|Methotrexate|methotrexate|mesh-list
20604331|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604332|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20106454|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106455|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106456|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
20604333|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546815|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546816|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
19546817|NCT02837965|Hormones|hormones|mesh-ancestor
19546818|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546819|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546820|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19546821|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546822|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19546823|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
19546824|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19546825|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546826|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
19546827|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546828|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
19546829|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546830|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19546831|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546832|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
19546833|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546834|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19546835|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20604334|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604335|NCT02226913|Lidocaine|lidocaine|mesh-list
20604336|NCT02226913|Epinephrine|epinephrine|mesh-list
20604337|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
20604338|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
20106457|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106458|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106459|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106460|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
20106461|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
19546836|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546837|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
19546838|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19546839|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19546840|NCT02838173|Ropivacaine|ropivacaine|mesh-list
19546841|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
19546842|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
19546843|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20106462|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106463|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106464|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106465|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
20106466|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106467|NCT00003591|Paclitaxel|paclitaxel|mesh-list
20106468|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106469|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546844|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546845|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
19546846|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546847|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
19546848|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546849|NCT02838030|Aspirin|aspirin|mesh-list
19546850|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19546851|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546852|NCT02838030|Analgesics|analgesics|mesh-ancestor
19546853|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
20106470|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106471|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106472|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106473|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106474|NCT00003592|Paclitaxel|paclitaxel|mesh-list
20106475|NCT00003592|Methotrexate|methotrexate|mesh-list
20106476|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106477|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106478|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106479|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106480|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106481|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604339|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604340|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604341|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
20604342|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106482|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20106483|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
20106484|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20106485|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106486|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106487|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
20106488|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106489|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106490|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19546854|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546855|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546856|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546857|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546858|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19546859|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19546860|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546861|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19546862|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19546863|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106491|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106492|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
20106493|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106494|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20106495|NCT00003593|Cytarabine|cytarabine|mesh-list
20106496|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
20106497|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20106498|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20106499|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20106500|NCT00003593|Methotrexate|methotrexate|mesh-list
20106501|NCT00003593|Thioguanine|thioguanine|mesh-list
20106502|NCT00003593|Daunorubicin|daunorubicin|mesh-list
19546864|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
19575653|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575654|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19575655|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19575656|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
19575657|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19575658|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19575659|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
19575660|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19575661|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19575662|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19575663|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575664|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575665|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19575666|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19575667|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19575668|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19575669|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
19575670|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575671|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575672|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19575673|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20106503|NCT00003593|Asparaginase|asparaginase|mesh-list
20106504|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20106505|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
20106506|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20106507|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106508|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106509|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
20106510|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106511|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106512|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106513|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106514|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20604343|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20604344|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19575674|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
19575675|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19575676|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20106515|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106516|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
20106517|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546865|NCT02837835|Ceftazidime|ceftazidime|mesh-list
19546866|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19546867|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546868|NCT02837614|Acetaminophen|acetaminophen|mesh-list
19546869|NCT02837614|Amoxicillin|amoxicillin|mesh-list
20106518|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20106519|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
20106520|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106521|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106522|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106523|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20604345|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20604346|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20604347|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604348|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20106524|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106525|NCT00003594|Leucovorin|leucovorin|mesh-list
20106526|NCT00003594|Fluorouracil|fluorouracil|mesh-list
20106527|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
20106528|NCT00003594|Irinotecan|irinotecan|mesh-list
20106529|NCT00003594|Calcium|calcium|mesh-list
20106530|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
20106531|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20106532|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106533|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
20106534|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546870|NCT02837614|Dexamethasone|dexamethasone|mesh-list
19546871|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
19546872|NCT02837614|BB 1101|bb 1101|mesh-list
19546873|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546874|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
19546875|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
19546876|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546877|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546878|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19546879|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
20106535|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106536|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106537|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106538|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
19546880|NCT02837614|Hormones|hormones|mesh-ancestor
20106539|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20106540|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106541|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546881|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19546882|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19546883|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546884|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
19546885|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546886|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546887|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19546888|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19546889|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546890|NCT02837614|Analgesics|analgesics|mesh-ancestor
19546891|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
19546892|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
19546893|NCT02837640|Levodopa|levodopa|mesh-list
20106542|NCT00003594|Antidotes|antidotes|mesh-ancestor
20106543|NCT00003594|Protective Agents|protective agents|mesh-ancestor
20106544|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
20106545|NCT00003594|Vitamins|vitamins|mesh-ancestor
20106546|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
20106547|NCT00003595|Prednisone|prednisone|mesh-list
20106548|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
20106549|NCT00003595|Rituximab|rituximab|mesh-list
20106550|NCT00003595|Doxorubicin|doxorubicin|mesh-list
20106551|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20106552|NCT00003595|Vincristine|vincristine|mesh-list
20106553|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106554|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
20106555|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546894|NCT02837640|Carbidopa|carbidopa|mesh-list
19546895|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19546896|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20106556|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106557|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106558|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
20120507|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19546897|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19546898|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
19546899|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546900|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546901|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546902|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19546903|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546904|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20604349|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20604350|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
20604351|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604352|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20604353|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20604354|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
19546905|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
19546906|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
19546907|NCT02837770|Diclofenac|diclofenac|mesh-list
19546908|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19546909|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
19546910|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19546911|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19546912|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546913|NCT02837770|Analgesics|analgesics|mesh-ancestor
19546914|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
19546915|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546916|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546917|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546918|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546919|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19546920|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546921|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546922|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
19546923|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546924|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546925|NCT02837146|Methotrexate|methotrexate|mesh-list
19546926|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19546927|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
19546928|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19546929|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546930|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546931|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
19546932|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546933|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546934|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
19546935|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546936|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19546937|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546938|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
19546939|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546940|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19546941|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
19546942|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19546943|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
19546944|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19546945|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546946|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
19546947|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19546948|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19546949|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546950|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
19546951|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19546952|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546953|NCT02837198|Dotinurad|dotinurad|mesh-list
19546954|NCT02837198|FYX-051|fyx-051|mesh-list
19546955|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
19546956|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
19546957|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546958|NCT02837198|Renal Agents|renal agents|mesh-ancestor
19546959|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106559|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106560|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604355|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20607941|NCT02244125|Growth Substances|growth substances|mesh-ancestor
19546960|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546961|NCT02837094|Insulin|insulin|mesh-list
19546962|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19546963|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546964|NCT02837003|Aspirin|aspirin|mesh-list
19546965|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19546966|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19546967|NCT02837003|Analgesics|analgesics|mesh-ancestor
19546968|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
19546969|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19546970|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546971|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19546972|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19546973|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19546974|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19546975|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546976|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19546977|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19546978|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546979|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
19546980|NCT02836977|Tegafur|tegafur|mesh-list
19546981|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19546982|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
19546983|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546984|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546985|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
19546986|NCT02836639|Etoposide|etoposide|mesh-list
19546987|NCT02836639|Busulfan|busulfan|mesh-list
19546988|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19546989|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19546990|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19546991|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19546992|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19546993|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19546994|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19546995|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
19546996|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19546997|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
19546998|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19546999|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19547000|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19547001|NCT02836847|Trastuzumab|trastuzumab|mesh-list
19547002|NCT02836847|Cetuximab|cetuximab|mesh-list
19547003|NCT02836847|Everolimus|everolimus|mesh-list
19547004|NCT02836847|Sorafenib|sorafenib|mesh-list
19547005|NCT02836847|Lapatinib|lapatinib|mesh-list
19547006|NCT02836847|Gefitinib|gefitinib|mesh-list
19547007|NCT02836847|Crizotinib|crizotinib|mesh-list
19547008|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547009|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547010|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19547011|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
19547012|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547013|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19547014|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547015|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547016|NCT02836821|Rifampin|rifampin|mesh-list
19547017|NCT02836821|Apatinib|apatinib|mesh-list
19547018|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547019|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19547020|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547021|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547022|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19547023|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
19547024|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547025|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547026|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
19547027|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19547028|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19547029|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19547030|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19547031|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19547032|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20106561|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19547033|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19547034|NCT02836548|Vorinostat|vorinostat|mesh-list
19547035|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19547036|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547037|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106562|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20106563|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106564|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19547038|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547039|NCT02836743|Melatonin|melatonin|mesh-list
19547040|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
19547041|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547042|NCT02836743|Protective Agents|protective agents|mesh-ancestor
19547043|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547044|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547045|NCT02836704|Metformin|metformin|mesh-list
19547046|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
19547047|NCT02836704|Acarbose|acarbose|mesh-list
19547048|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19547049|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547050|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19547051|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547052|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547053|NCT02836795|Antibodies|antibodies|mesh-list
19547054|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19547055|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
19547056|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547057|NCT02836509|Acetaminophen|acetaminophen|mesh-list
19547058|NCT02836509|Ibuprofen|ibuprofen|mesh-list
19547059|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19547060|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19547061|NCT02836509|Analgesics|analgesics|mesh-ancestor
19547062|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
19547063|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547064|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547065|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547066|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19547067|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19547068|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547069|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547070|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
19547071|NCT02836483|Linezolid|linezolid|mesh-list
19547072|NCT02836483|Delpazolid|delpazolid|mesh-list
19547073|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
19547074|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547075|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547076|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19547077|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547078|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547079|NCT02836171|Itraconazole|itraconazole|mesh-list
19547080|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20106565|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106566|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106567|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106568|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
20106569|NCT00003595|Hormones|hormones|mesh-ancestor
20106570|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20106571|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20106572|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106573|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106574|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106575|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106576|NCT00003596|Fluorouracil|fluorouracil|mesh-list
19547081|NCT02836171|Apatinib|apatinib|mesh-list
19547082|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547083|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19547084|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547085|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106577|NCT00003596|Mitomycins|mitomycins|mesh-list
20106578|NCT00003596|Mitomycin|mitomycin|mesh-list
20106579|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106580|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
20106581|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106582|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19547086|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
19547087|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575677|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
20106583|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106584|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
20106585|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106586|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106587|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
20106588|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20106589|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106590|NCT00003597|Carboplatin|carboplatin|mesh-list
20106591|NCT00003597|Etoposide|etoposide|mesh-list
20106592|NCT00003597|Ifosfamide|ifosfamide|mesh-list
20106593|NCT00003597|Sargramostim|sargramostim|mesh-list
20106594|NCT00003597|Lenograstim|lenograstim|mesh-list
19547088|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19547089|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19547090|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19547091|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
19547092|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547093|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547094|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19547095|NCT02836288|Ketamine|ketamine|mesh-list
19547096|NCT02836288|Analgesics|analgesics|mesh-ancestor
19547097|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
19547098|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547099|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547100|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19547101|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19547102|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
19547103|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
19547104|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547105|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19547106|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19547107|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547108|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547109|NCT02836184|Niacin|niacin|mesh-list
19547110|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
19547111|NCT02836184|Niacinamide|niacinamide|mesh-list
19547112|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
19547113|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547114|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19547115|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
19547116|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547117|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19547118|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
19547119|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
19547120|NCT02836184|Vitamins|vitamins|mesh-ancestor
19547121|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
19547122|NCT02836184|Antacids|antacids|mesh-ancestor
19547123|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547124|NCT02836353|Rifaximin|rifaximin|mesh-list
19547125|NCT02836353|Somatostatin|somatostatin|mesh-list
19547126|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547127|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547128|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547129|NCT02836353|Hormones|hormones|mesh-ancestor
19547130|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547131|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575678|NCT01972035|Valacyclovir|valacyclovir|mesh-list
19575679|NCT01972035|Valganciclovir|valganciclovir|mesh-list
19575680|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
19575681|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575682|NCT01955980|Budesonide|budesonide|mesh-list
19575683|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575684|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19575685|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
19575686|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575687|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575688|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19575689|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
19575690|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
19575691|NCT01955980|Hormones|hormones|mesh-ancestor
19575692|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575693|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
20106595|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106596|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575694|NCT01953900|Fludarabine|fludarabine|mesh-list
19575695|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607942|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
19547132|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
19547133|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19547134|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547135|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547136|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19547137|NCT02836431|Analgesics|analgesics|mesh-ancestor
20106597|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106598|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106599|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106600|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106601|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106602|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
20106603|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
20106604|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106605|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20106606|NCT00003598|Tretinoin|tretinoin|mesh-list
20106607|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106608|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
20106609|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106610|NCT00003599|Vitamin E|vitamin e|mesh-list
20106611|NCT00003599|Tocopherols|tocopherols|mesh-list
20106612|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
20106613|NCT00003599|Isotretinoin|isotretinoin|mesh-list
20106614|NCT00003599|Vitamins|vitamins|mesh-ancestor
19547138|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
19547139|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547140|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19547141|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19547142|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19547143|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
19547144|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547145|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547146|NCT02835794|Azacitidine|azacitidine|mesh-list
19547147|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
19547148|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19547149|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
19547150|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547151|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547152|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547153|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19547154|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19547155|NCT02836028|Temozolomide|temozolomide|mesh-list
19547156|NCT02836028|Talazoparib|talazoparib|mesh-list
19547157|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19547158|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
19547159|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547160|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547161|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19547162|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547163|NCT02835833|Bevacizumab|bevacizumab|mesh-list
19547164|NCT02835833|Nintedanib|nintedanib|mesh-list
19547165|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547166|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547167|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19547168|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19547169|NCT02835833|Growth Substances|growth substances|mesh-ancestor
19547170|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547171|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
19547172|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19547173|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547174|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547175|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
19547176|NCT02836002|Piperaquine|piperaquine|mesh-list
19547177|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
19547178|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20106615|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
20106616|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106617|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
20106618|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106619|NCT00003599|Protective Agents|protective agents|mesh-ancestor
20106620|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106621|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
20106622|NCT00003600|Hematinics|hematinics|mesh-ancestor
20106623|NCT00003601|Tretinoin|tretinoin|mesh-list
20106624|NCT00003601|Fenretinide|fenretinide|mesh-list
20607943|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20106625|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106626|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
20106627|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106628|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20106629|NCT00003601|Protective Agents|protective agents|mesh-ancestor
20106630|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106631|NCT00003602|Cytarabine|cytarabine|mesh-list
20106632|NCT00003602|Etoposide|etoposide|mesh-list
20106633|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
20106634|NCT00003602|Idarubicin|idarubicin|mesh-list
20106635|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106636|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106637|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106638|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106639|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106640|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106641|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19547179|NCT02836002|Atovaquone|atovaquone|mesh-list
19547180|NCT02836002|Proguanil|proguanil|mesh-list
19547181|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19547182|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
19547183|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19547184|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19547185|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547186|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19547187|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547188|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547189|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19547190|NCT02836002|Renal Agents|renal agents|mesh-ancestor
19547191|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
19547192|NCT02835742|Sargramostim|sargramostim|mesh-list
19547193|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
19547194|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547195|NCT02835729|Cytarabine|cytarabine|mesh-list
19547196|NCT02835729|Idarubicin|idarubicin|mesh-list
19547197|NCT02835729|Tryptophan|tryptophan|mesh-list
19547198|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19547199|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
19547200|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547201|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547202|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
19547203|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547204|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106642|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
20106643|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
20106644|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106645|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106646|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
20106647|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106648|NCT00003602|Analgesics|analgesics|mesh-ancestor
20106649|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
20106650|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106651|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106652|NCT00003603|Dexamethasone|dexamethasone|mesh-list
20106653|NCT00003603|Prednisolone|prednisolone|mesh-list
20106654|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
20106655|NCT00003603|Melphalan|melphalan|mesh-list
20106656|NCT00003603|Lomustine|lomustine|mesh-list
20106657|NCT00003603|Idarubicin|idarubicin|mesh-list
20106658|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106659|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
20106660|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106661|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106662|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19547205|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
19547206|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106663|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
20106664|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106665|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106666|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106667|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106668|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
20106669|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
20106670|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106671|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20106672|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
19547207|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19547208|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106673|NCT00003603|Hormones|hormones|mesh-ancestor
19547209|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19547210|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547211|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19547212|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
19547213|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19547214|NCT02835716|Ustekinumab|ustekinumab|mesh-list
19547215|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106674|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20106675|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20106676|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106677|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106678|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106679|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106680|NCT00003604|Aldesleukin|aldesleukin|mesh-list
20106681|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106682|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20106683|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20106684|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
20106685|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106686|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
20106687|NCT00003605|Rituximab|rituximab|mesh-list
20106688|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106689|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
19547216|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
19547217|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547218|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547219|NCT02835469|Menotropins|menotropins|mesh-list
19547220|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19547221|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
20106690|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106691|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106692|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106693|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
20106694|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547222|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19547223|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547224|NCT02835664|Niacinamide|niacinamide|mesh-list
19547225|NCT02835664|Niacin|niacin|mesh-list
19547226|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
19547227|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
19547228|NCT02835664|Vitamins|vitamins|mesh-ancestor
19547229|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
19547230|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547231|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19547232|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
19547233|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547234|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19547235|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
19547236|NCT02835586|Paclitaxel|paclitaxel|mesh-list
19547237|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19547238|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547239|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
19547240|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
19547241|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
19547242|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547243|NCT02835521|Triamcinolone|triamcinolone|mesh-list
19547244|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19547245|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19547246|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19547247|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547248|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
19547249|NCT02835521|Hormones|hormones|mesh-ancestor
19547250|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547251|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547252|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19547253|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
19547254|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547255|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547256|NCT02835404|Nedaplatin|nedaplatin|mesh-list
19547257|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547258|NCT02835391|Surgiflo|surgiflo|mesh-list
20106695|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106696|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19547259|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
19547260|NCT02835391|Coagulants|coagulants|mesh-ancestor
19547261|NCT02835079|Tamoxifen|tamoxifen|mesh-list
19547262|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19547263|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
19547264|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547265|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547266|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19547267|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547268|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19547269|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19547270|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19547271|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
19547272|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19547273|NCT02835170|Antibodies|antibodies|mesh-list
19547274|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
19547275|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547276|NCT02835183|Insulin|insulin|mesh-list
19547277|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19547278|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547279|NCT02835131|Pasireotide|pasireotide|mesh-list
19547280|NCT02835131|Hormones|hormones|mesh-ancestor
19547281|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547282|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106697|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20106698|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
20106699|NCT00003606|Etoposide|etoposide|mesh-list
20106700|NCT00003606|Epirubicin|epirubicin|mesh-list
20106701|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106702|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
20106703|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547283|NCT02834676|Ethanol|ethanol|mesh-list
19547284|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19547285|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547286|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547287|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547288|NCT02834637|Vaccines|vaccines|mesh-list
19547289|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
19547290|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547291|NCT02834754|Vedolizumab|vedolizumab|mesh-list
19547292|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547293|NCT02834845|Sevoflurane|sevoflurane|mesh-list
19547294|NCT02834845|Desflurane|desflurane|mesh-list
19547295|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19547296|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19547297|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
19547298|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
19547299|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547300|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547301|NCT02834507|Levodopa|levodopa|mesh-list
19547302|NCT02834507|Carbidopa|carbidopa|mesh-list
19547303|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19547304|NCT02834507|Entacapone|entacapone|mesh-list
19547305|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19547306|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19547307|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
19547308|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547309|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547310|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547311|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19547312|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547313|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19547314|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
19547315|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
19547316|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19575696|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
19575697|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575698|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19575699|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575700|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
19575701|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575702|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575703|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19575704|NCT01946711|Budesonide|budesonide|mesh-list
20604356|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
20106704|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604357|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
20604358|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
19547317|NCT02834546|Sorafenib|sorafenib|mesh-list
19547318|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547319|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19547320|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547321|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547322|NCT02834260|Dexamethasone|dexamethasone|mesh-list
19547323|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547324|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
19547325|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
19547326|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547327|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547328|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547329|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
19547330|NCT02834260|Hormones|hormones|mesh-ancestor
19547331|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547332|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20604359|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20604360|NCT02226926|Aspirin|aspirin|mesh-list
20604361|NCT02226926|Dipyridamole|dipyridamole|mesh-list
20604362|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20604363|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20604364|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20604365|NCT02226926|Analgesics|analgesics|mesh-ancestor
20106705|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106706|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
20106707|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106708|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604366|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
20604367|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547333|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547334|NCT02834286|Dexamethasone|dexamethasone|mesh-list
19547335|NCT02834286|Rituximab|rituximab|mesh-list
19547336|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547337|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547338|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
19547339|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547340|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19547341|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547342|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
19547343|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
19547344|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547345|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547346|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
19547347|NCT02834286|Hormones|hormones|mesh-ancestor
19547348|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547349|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19547350|NCT02834052|Poly I-C|poly i-c|mesh-list
19547351|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
19547352|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19547353|NCT02834052|Poly ICLC|poly iclc|mesh-list
19547354|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547355|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547356|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
20604368|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604369|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20604370|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604371|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20604372|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20604373|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604374|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19547357|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
19547358|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547359|NCT02834052|Laxatives|laxatives|mesh-ancestor
19547360|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547361|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
19547362|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547363|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
19547364|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547365|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547366|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19547367|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19547368|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547369|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547370|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547371|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
19547372|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
19547373|NCT02833805|Fludarabine|fludarabine|mesh-list
20604375|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20604376|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604377|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
19547374|NCT02833805|Tacrolimus|tacrolimus|mesh-list
19547375|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
19547376|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20604378|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20604379|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
19547377|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106709|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106710|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106711|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106712|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106713|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106714|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106715|NCT00003610|Capsaicin|capsaicin|mesh-list
20106716|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
20106717|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106718|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
20106719|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106720|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106721|NCT00003611|Acitretin|acitretin|mesh-list
20106722|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
20106723|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106724|NCT00003612|Paclitaxel|paclitaxel|mesh-list
19547378|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
19547379|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547380|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19547381|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19547382|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
19547383|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106725|NCT00003612|Carboplatin|carboplatin|mesh-list
20106726|NCT00003612|Trastuzumab|trastuzumab|mesh-list
20106727|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106728|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547384|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547385|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19547386|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19547387|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547388|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19547389|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19547390|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
19547391|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547392|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547393|NCT02833987|Warfarin|warfarin|mesh-list
19547394|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
19547395|NCT02833987|Dabigatran|dabigatran|mesh-list
20106729|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106730|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106731|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106732|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106733|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20106734|NCT00003613|Carmustine|carmustine|mesh-list
19547396|NCT02833987|Apixaban|apixaban|mesh-list
19547397|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
19547398|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19547399|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
19547400|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19547401|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
19547402|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547403|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547404|NCT02833766|Doxorubicin|doxorubicin|mesh-list
19547405|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106735|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20106736|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106737|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
20106738|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106739|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106740|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106741|NCT00003614|Paclitaxel|paclitaxel|mesh-list
20106742|NCT00003614|Estramustine|estramustine|mesh-list
20106743|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106744|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547406|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547407|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20604380|NCT02226978|Ritonavir|ritonavir|mesh-list
20106745|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106746|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106747|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
19547408|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19547409|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547410|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106748|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106749|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106750|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
20106751|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19547413|NCT02833610|Denosumab|denosumab|mesh-list
19547414|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20106752|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
20106753|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106754|NCT00003616|Irinotecan|irinotecan|mesh-list
20106755|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20106756|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106757|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106758|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106759|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106760|NCT00003617|Clarithromycin|clarithromycin|mesh-list
20106761|NCT00003617|Tinidazole|tinidazole|mesh-list
20106762|NCT00003617|Chlorambucil|chlorambucil|mesh-list
20106763|NCT00003617|Omeprazole|omeprazole|mesh-list
20106764|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20106765|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20106766|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20106767|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106768|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106769|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20106770|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106771|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20106772|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20106773|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20106774|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106775|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
20106776|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106777|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20106778|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20106779|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20106780|NCT00003619|Vitamin E|vitamin e|mesh-list
20106781|NCT00003619|Cytarabine|cytarabine|mesh-list
20106782|NCT00003619|Fludarabine|fludarabine|mesh-list
20106783|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
20106784|NCT00003619|Etoposide|etoposide|mesh-list
20106785|NCT00003619|Busulfan|busulfan|mesh-list
20106786|NCT00003619|Topotecan|topotecan|mesh-list
19547415|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547416|NCT02833480|Fluticasone|fluticasone|mesh-list
19547417|NCT02833480|Budesonide|budesonide|mesh-list
19547418|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
19547419|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547420|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19547421|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
19547422|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547423|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547424|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19547425|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
19547426|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
19547427|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19547428|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
19547429|NCT02833480|Hormones|hormones|mesh-ancestor
20106787|NCT00003619|Isotretinoin|isotretinoin|mesh-list
20106788|NCT00003619|Vitamins|vitamins|mesh-ancestor
20106789|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
20106790|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547430|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547431|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20604381|NCT02226978|Tipranavir|tipranavir|mesh-list
19547432|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19547433|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19547434|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
20106791|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106792|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106793|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
20604382|NCT02226978|Valacyclovir|valacyclovir|mesh-list
20106794|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106795|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19547435|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547436|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547437|NCT02833506|Sirolimus|sirolimus|mesh-list
19547438|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547439|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547440|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19547441|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547442|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
19547443|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19547444|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
19547445|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547446|NCT02833701|Vitamins|vitamins|mesh-list
19547447|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
19547448|NCT02833701|Bevacizumab|bevacizumab|mesh-list
19547449|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19547450|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
19547451|NCT02833701|Antibodies|antibodies|mesh-list
19547452|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
19547453|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19547454|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
19547455|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547456|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19547457|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19547458|NCT02833701|Growth Substances|growth substances|mesh-ancestor
19547459|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547460|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
19547461|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
19547462|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
19547463|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547464|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
19547465|NCT02833701|Protective Agents|protective agents|mesh-ancestor
19547466|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
19547467|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19547468|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547469|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547470|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19547471|NCT02833688|Analgesics|analgesics|mesh-ancestor
19547472|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
19547473|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547474|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19547475|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19547476|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19547477|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19547478|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547479|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547480|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
19547481|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19547482|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547483|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
19547484|NCT02833233|Nivolumab|nivolumab|mesh-list
19547485|NCT02833233|Ipilimumab|ipilimumab|mesh-list
19547486|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547487|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547488|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19547489|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547490|NCT02833584|Acetaminophen|acetaminophen|mesh-list
19547491|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19547492|NCT02833584|Analgesics|analgesics|mesh-ancestor
19547493|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
20106796|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
20106797|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106798|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106799|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106800|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106801|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
20106802|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106803|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
20106804|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106805|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106806|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20106807|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
19547494|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547495|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106808|NCT00003619|Protective Agents|protective agents|mesh-ancestor
20106809|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106810|NCT00003620|Alvocidib|alvocidib|mesh-list
20106811|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106812|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
20106813|NCT00003620|Growth Substances|growth substances|mesh-ancestor
20106814|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106815|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20106816|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106817|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106818|NCT00003621|Etoposide|etoposide|mesh-list
20106819|NCT00003621|Carmustine|carmustine|mesh-list
20106820|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547496|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
19547497|NCT02833025|Thrombin|thrombin|mesh-list
19547498|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
19547499|NCT02833025|Coagulants|coagulants|mesh-ancestor
19547500|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
19547501|NCT02833038|Analgesics|analgesics|mesh-ancestor
19547502|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
19547503|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547504|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547505|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
20106821|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106822|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106823|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106824|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106825|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106826|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106827|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
19547506|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547507|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19547508|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
19547509|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19547510|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19547511|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547512|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20106828|NCT00003622|Paclitaxel|paclitaxel|mesh-list
20106829|NCT00003622|Vinorelbine|vinorelbine|mesh-list
20106830|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106831|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106832|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106833|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106834|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106835|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106836|NCT00003624|Paclitaxel|paclitaxel|mesh-list
20106837|NCT00003624|Amifostine|amifostine|mesh-list
19547513|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
19547514|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19547515|NCT02833103|Pinaverium|pinaverium|mesh-list
19547516|NCT02833103|Bromides|bromides|mesh-list
19547517|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
19547518|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19547519|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19547520|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547521|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19547522|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547523|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
19547524|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
19547525|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106838|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106839|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106840|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106841|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106842|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106843|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106844|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20106845|NCT00003624|Protective Agents|protective agents|mesh-ancestor
20106846|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106847|NCT00003625|Cyclosporine|cyclosporine|mesh-list
20106848|NCT00003625|Etoposide|etoposide|mesh-list
20106849|NCT00003625|Vincristine|vincristine|mesh-list
20106850|NCT00003625|Cyclosporins|cyclosporins|mesh-list
20106851|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20106852|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547526|NCT02833155|Exemestane|exemestane|mesh-list
19547527|NCT02833155|Entinostat|entinostat|mesh-list
20106853|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106854|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106855|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106856|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106857|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106858|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
19547528|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547529|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20106859|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106860|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106861|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
20106862|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106863|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
20106864|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106865|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106866|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106867|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20106868|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
19547530|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19547531|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547532|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547533|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19547534|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
19547535|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547536|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547537|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19547538|NCT02833116|Dexamethasone|dexamethasone|mesh-list
19547539|NCT02833116|Betamethasone|betamethasone|mesh-list
20106869|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106870|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106871|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106872|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106873|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106874|NCT00003627|Fluorouracil|fluorouracil|mesh-list
20106875|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106876|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
20106877|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106878|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106879|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106880|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
20106881|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106882|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
20106883|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106884|NCT00003632|Cytarabine|cytarabine|mesh-list
19547540|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547541|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
19547542|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
19547543|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106885|NCT00003632|Methotrexate|methotrexate|mesh-list
20106886|NCT00003632|Etoposide|etoposide|mesh-list
20106887|NCT00003632|Melphalan|melphalan|mesh-list
20106888|NCT00003632|Carmustine|carmustine|mesh-list
19547544|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547545|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547546|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
19547547|NCT02833116|Hormones|hormones|mesh-ancestor
19547548|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547549|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19547550|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547551|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19547552|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
19547553|NCT02832973|Ramipril|ramipril|mesh-list
19547554|NCT02832973|Bisoprolol|bisoprolol|mesh-list
19547555|NCT02832973|Amiloride|amiloride|mesh-list
19547556|NCT02832973|Furosemide|furosemide|mesh-list
19547557|NCT02832973|Spironolactone|spironolactone|mesh-list
19547558|NCT02832973|Diuretics|diuretics|mesh-list
19547559|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19547560|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
19547561|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106889|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20106890|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
20604383|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19575705|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106891|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20604384|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19547562|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19547563|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19547564|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547565|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19547566|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
19547567|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547568|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19547569|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
19547570|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547571|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19547572|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
19547573|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
19547574|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547575|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19547576|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19547577|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19547578|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
19547579|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20106892|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106893|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20106894|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
20106895|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106896|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106897|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
19547580|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19547581|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19547582|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19575706|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19575707|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
19575708|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575709|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575710|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20106898|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106899|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20106900|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106901|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
20106902|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106903|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20106904|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575711|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
19575712|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
19575713|NCT01946711|Hormones|hormones|mesh-ancestor
19575714|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575715|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19575716|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19575717|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575718|NCT01864746|Palbociclib|palbociclib|mesh-list
19575719|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575720|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575721|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575722|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575723|NCT01858896|Glucagon|glucagon|mesh-list
19575724|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19575725|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19575726|NCT01858896|Hormones|hormones|mesh-ancestor
19575727|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575728|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575729|NCT01858896|Incretins|incretins|mesh-ancestor
19575730|NCT01740427|Letrozole|letrozole|mesh-list
19575731|NCT01740427|Palbociclib|palbociclib|mesh-list
19575732|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575733|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19575734|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19575735|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575736|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575737|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20106905|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106906|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106907|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
20106908|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106909|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106910|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
20106911|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106912|NCT00003633|Prednisone|prednisone|mesh-list
20106913|NCT00003633|Docetaxel|docetaxel|mesh-list
20106914|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
19547583|NCT02832778|Tenofovir|tenofovir|mesh-list
19547584|NCT02832778|Lamivudine|lamivudine|mesh-list
19547585|NCT02832778|Zidovudine|zidovudine|mesh-list
19547586|NCT02832778|Emtricitabine|emtricitabine|mesh-list
19547587|NCT02832778|Efavirenz|efavirenz|mesh-list
19547588|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19547589|NCT02832778|Isoniazid|isoniazid|mesh-list
19547590|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
19547591|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547592|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19547593|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19547594|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547595|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547596|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19547597|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19547598|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
19547599|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19547600|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19547601|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19547602|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19547603|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19547604|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19547605|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
19547606|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547607|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19547608|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19547609|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19547610|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
19547611|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19547612|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
19547613|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19547614|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
19547615|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547616|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547617|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
19547618|NCT02832999|Liraglutide|liraglutide|mesh-list
19547619|NCT02832999|Vildagliptin|vildagliptin|mesh-list
19547620|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19547621|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547622|NCT02832999|Incretins|incretins|mesh-ancestor
19547623|NCT02832999|Hormones|hormones|mesh-ancestor
19547624|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547625|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20106915|NCT00003633|Estramustine|estramustine|mesh-list
20106916|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106917|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
20106918|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
20106919|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
20106920|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106921|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106922|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
20106923|NCT00003633|Hormones|hormones|mesh-ancestor
20106924|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20106925|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106926|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20106927|NCT00003633|Analgesics|analgesics|mesh-ancestor
20106928|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
20106929|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106930|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106931|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106932|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547626|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
19547627|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106933|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106934|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
20106935|NCT00003634|Oregovomab|oregovomab|mesh-list
20106936|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20106937|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547628|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547629|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
20106938|NCT00003636|Carboplatin|carboplatin|mesh-list
20106939|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547630|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19547631|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19547632|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
19547633|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19547634|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19547635|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547636|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
20106940|NCT00003637|Fluorouracil|fluorouracil|mesh-list
20106941|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106942|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
20106943|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547637|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547638|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547639|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19547640|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
19547641|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
19547642|NCT02832713|Protective Agents|protective agents|mesh-ancestor
19547643|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19547644|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547645|NCT02832700|Caseins|caseins|mesh-list
19547646|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
19547647|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
19547648|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547649|NCT02832531|Aspirin|aspirin|mesh-list
19547650|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
19547651|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19547652|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19547653|NCT02832531|Analgesics|analgesics|mesh-ancestor
19547654|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
19547655|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547656|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547657|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547658|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19547659|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19547660|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19547661|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547662|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19547663|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19547664|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547665|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
19547666|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19547667|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
19547668|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19547669|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
19547670|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
19547671|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
19547672|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
19547673|NCT02832726|Vitamins|vitamins|mesh-ancestor
19547674|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
19547675|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547676|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
19547677|NCT02832726|Hematinics|hematinics|mesh-ancestor
19547678|NCT02832544|Vitamin K|vitamin k|mesh-list
19547679|NCT02832544|Warfarin|warfarin|mesh-list
19547680|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
19547681|NCT02832544|Vitamins|vitamins|mesh-ancestor
19547682|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
19547683|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547684|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
19547685|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19547686|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
20106944|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19547687|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19547688|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
19547689|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547690|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547691|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19547692|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19547693|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
19547694|NCT02832544|Coagulants|coagulants|mesh-ancestor
19547695|NCT02832635|Temozolomide|temozolomide|mesh-list
19547696|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19547697|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
19547698|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547699|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547700|NCT02832336|Caffeine|caffeine|mesh-list
19547701|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
19547702|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547703|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19547704|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547705|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19547706|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547707|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19547708|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19547709|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
20106945|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106946|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
20106947|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106948|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
20106949|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20106950|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
20106951|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20106952|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
20106953|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106954|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20106955|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106956|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
20106957|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106958|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106959|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20106960|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20106961|NCT00003639|Interferons|interferons|mesh-list
20106962|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
20106963|NCT00003639|Dexamethasone|dexamethasone|mesh-list
20106964|NCT00003639|Idarubicin|idarubicin|mesh-list
19547710|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547711|NCT02832596|Norepinephrine|norepinephrine|mesh-list
19547712|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19547713|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19547714|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
19547715|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547716|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547717|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547718|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
19547719|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
19547720|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547721|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19547722|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
19547723|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
19547724|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19547725|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19547726|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547727|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547728|NCT02832570|Urological Agents|urological agents|mesh-ancestor
19547729|NCT02832401|Caffeine|caffeine|mesh-list
19547730|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19547731|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547732|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19547733|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547734|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547735|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19547736|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19547737|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
19547738|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547739|NCT02832089|Carvedilol|carvedilol|mesh-list
19547740|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19547741|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19547742|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
19547743|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547744|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547745|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547746|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19547747|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
20106965|NCT00003639|Chlorambucil|chlorambucil|mesh-list
20106966|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20106967|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
20106968|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
20106969|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20106970|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20106971|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547748|NCT02832089|Protective Agents|protective agents|mesh-ancestor
19547749|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19547750|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19547751|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19547752|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
19547753|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19547754|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19547755|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19547756|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547757|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547758|NCT02831972|Itraconazole|itraconazole|mesh-list
19547759|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
19547760|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547761|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19547762|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19547763|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547764|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547765|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19547766|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
19547767|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547768|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547769|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19547770|NCT02831933|Valacyclovir|valacyclovir|mesh-list
19547771|NCT02831933|Nivolumab|nivolumab|mesh-list
19547772|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547773|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547774|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19547775|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547776|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
19547777|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547778|NCT02831842|Bevacizumab|bevacizumab|mesh-list
19547779|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547780|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547781|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19547782|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19547783|NCT02831842|Growth Substances|growth substances|mesh-ancestor
19547784|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547785|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
19547786|NCT02831751|Vaccines|vaccines|mesh-list
19547787|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
19547788|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547789|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
19547790|NCT02831712|Trace Elements|trace elements|mesh-ancestor
19547791|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
19547792|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547793|NCT02831686|Dexamethasone|dexamethasone|mesh-list
19547794|NCT02831686|Ixazomib|ixazomib|mesh-list
19547795|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547796|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
19547797|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
19547798|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547799|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547800|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20106972|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
20106973|NCT00003639|Hormones|hormones|mesh-ancestor
20106974|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20106975|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20106976|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106977|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
20106978|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20106979|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
20106980|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106981|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106982|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106983|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106984|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547801|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
19547802|NCT02831686|Hormones|hormones|mesh-ancestor
19547803|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19547804|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19547805|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547806|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
20604385|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
19547807|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547808|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547809|NCT02831543|Mosapride|mosapride|mesh-list
19547810|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547811|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547812|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19547813|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
19547814|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547815|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547816|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
19547817|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19547818|NCT02831478|Protective Agents|protective agents|mesh-ancestor
19547819|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547820|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
20106985|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20106986|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
20106987|NCT00003640|Doxorubicin|doxorubicin|mesh-list
19547821|NCT02831361|Metformin|metformin|mesh-list
19547822|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19547823|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547824|NCT02831374|Anesthetics|anesthetics|mesh-list
19547825|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547826|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547827|NCT02831205|Cobalt|cobalt|mesh-list
19547828|NCT02831205|Chromium|chromium|mesh-list
19547829|NCT02831205|Everolimus|everolimus|mesh-list
20106988|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20106989|NCT00003640|Methotrexate|methotrexate|mesh-list
20106990|NCT00003640|Vinblastine|vinblastine|mesh-list
20106991|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20106992|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20106993|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20106994|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20106995|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20106996|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20106997|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20106998|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
20106999|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107000|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547830|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547831|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107001|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107002|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
20107003|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107004|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107005|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107006|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
20107007|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107008|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19547832|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
19547833|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547834|NCT02831205|Trace Elements|trace elements|mesh-ancestor
19547835|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
19547836|NCT02831218|Aspirin|aspirin|mesh-list
19547837|NCT02831218|Clopidogrel|clopidogrel|mesh-list
19547838|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19547839|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19547840|NCT02831218|Analgesics|analgesics|mesh-ancestor
19547841|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
19547842|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547843|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547844|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547845|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19547846|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19547847|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19547848|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547849|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19547850|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19547851|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547852|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
19547853|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19547854|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19547855|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19547856|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
19547857|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547858|NCT02831491|Docetaxel|docetaxel|mesh-list
19547859|NCT02831491|Ramucirumab|ramucirumab|mesh-list
19547860|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547861|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
19547862|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
19547863|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
19547864|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575738|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
19575739|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575740|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575741|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575742|NCT01723202|Trametinib|trametinib|mesh-list
19575743|NCT01723202|Dabrafenib|dabrafenib|mesh-list
19575744|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575745|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575746|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575747|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575748|NCT01680965|Ofatumumab|ofatumumab|mesh-list
19575749|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575750|NCT01678027|Clarithromycin|clarithromycin|mesh-list
19575751|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19575752|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575753|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19575754|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575755|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575756|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19575757|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19575758|NCT01672255|Fluoxetine|fluoxetine|mesh-list
19575759|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19575760|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19575761|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19575762|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575763|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575764|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
19575765|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575766|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19575767|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
19575768|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19575769|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19575770|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19575771|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575772|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19575773|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19575774|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19575775|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575776|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575777|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19575778|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19575779|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19575780|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19575781|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
19575782|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575783|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575784|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19575785|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19575786|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
19575787|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19575788|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19575789|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
19575790|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19575791|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19575792|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19575793|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575794|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575795|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19575796|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19575797|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19575798|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19575799|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
19575800|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575801|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547865|NCT02831101|Sufentanil|sufentanil|mesh-list
19547866|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19547867|NCT02831101|Narcotics|narcotics|mesh-ancestor
19547868|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19547869|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547870|NCT02831101|Analgesics|analgesics|mesh-ancestor
19547871|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
19547872|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547873|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19547874|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19547875|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
19547876|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
19547877|NCT02831088|Salicylates|salicylates|mesh-list
19547878|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19547879|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19547880|NCT02831088|Analgesics|analgesics|mesh-ancestor
19547881|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
19547882|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547883|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547884|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19547885|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19547886|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19547887|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547888|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547889|NCT02831179|Capecitabine|capecitabine|mesh-list
19547890|NCT02831179|Temozolomide|temozolomide|mesh-list
19547891|NCT02831179|Veliparib|veliparib|mesh-list
19547892|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19547893|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
19547894|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547895|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547896|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19547897|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
19547898|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19547899|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547900|NCT02831231|Xanomeline|xanomeline|mesh-list
19547901|NCT02831231|Trospium chloride|trospium chloride|mesh-list
19547902|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
19547903|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
19547904|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547905|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547906|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19547907|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20107009|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107010|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107011|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107012|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107013|NCT00003642|Fluorouracil|fluorouracil|mesh-list
20107014|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107015|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
19547908|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
19547909|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547910|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547911|NCT02831231|Urological Agents|urological agents|mesh-ancestor
19547912|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19547913|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19547914|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19547915|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19547916|NCT02830906|Ondansetron|ondansetron|mesh-list
19547917|NCT02830906|Ramosetron|ramosetron|mesh-list
19547918|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
19547919|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
19547920|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547921|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547922|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547923|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
19547924|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19547925|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19547926|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
19547927|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547928|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547929|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19547930|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19547931|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20107016|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107017|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19547932|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19547933|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19547934|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
19547935|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
19547936|NCT02830789|Calcium|calcium|mesh-list
19547937|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19547938|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547939|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19547940|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547941|NCT02830789|Antacids|antacids|mesh-ancestor
19547942|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19547943|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
19547944|NCT02831023|Piperaquine|piperaquine|mesh-list
19547945|NCT02831023|Primaquine|primaquine|mesh-list
19547946|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
19547947|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19547948|NCT02831023|Amodiaquine|amodiaquine|mesh-list
19547949|NCT02831023|Artenimol|artenimol|mesh-list
19547950|NCT02831023|Methylene Blue|methylene blue|mesh-list
19547951|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
19547952|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19547953|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19547954|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547955|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19547956|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547957|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547958|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19547959|NCT02831023|Renal Agents|renal agents|mesh-ancestor
19547960|NCT02830932|Vaccines|vaccines|mesh-list
19547961|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
20107018|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107019|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
20107020|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107021|NCT00003643|Paclitaxel|paclitaxel|mesh-list
20107022|NCT00003643|Etoposide|etoposide|mesh-list
19547962|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547963|NCT02830360|Amiodarone|amiodarone|mesh-list
19547964|NCT02830360|Sotalol|sotalol|mesh-list
19547965|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19547966|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
19547967|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19547968|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19547969|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19547970|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19547971|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19547972|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19547973|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19547974|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19547975|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19547976|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19547977|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19547978|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19547979|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
19547980|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19547981|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19547982|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
19547983|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
19547984|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19547985|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
19547986|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19547987|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19547988|NCT02830347|Amoxicillin|amoxicillin|mesh-list
19547989|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547990|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547991|NCT02830230|Azithromycin|azithromycin|mesh-list
19547992|NCT02830230|Cefixime|cefixime|mesh-list
19547993|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19547994|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19547995|NCT02830243|Sevoflurane|sevoflurane|mesh-list
19547996|NCT02830243|Desflurane|desflurane|mesh-list
19547997|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19547998|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19547999|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
19548000|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
19548001|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548002|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548003|NCT02830048|Glyburide|glyburide|mesh-list
20107023|NCT00003643|Bleomycin|bleomycin|mesh-list
19548004|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19548005|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548006|NCT02830126|Anesthetics|anesthetics|mesh-list
19548007|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548008|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548009|NCT02829879|Listerine|listerine|mesh-list
19548010|NCT02829879|Fluorides|fluorides|mesh-list
19548011|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
19548012|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
19548013|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
19548014|NCT02829879|Protective Agents|protective agents|mesh-ancestor
19548015|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548016|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19548017|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548018|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
19548019|NCT02829957|Apixaban|apixaban|mesh-list
19548020|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19548021|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
19548022|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19548023|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
19548024|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548025|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548026|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
19548027|NCT02830139|Capecitabine|capecitabine|mesh-list
19548028|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
19548029|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548030|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19548031|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
19548032|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548033|NCT02829840|Azacitidine|azacitidine|mesh-list
19548034|NCT02829840|Ponatinib|ponatinib|mesh-list
19548035|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19548036|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
19548037|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548038|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548039|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548040|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19575802|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19575803|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19575804|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
19575805|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19575806|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19575807|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
19575808|NCT01592370|Dexamethasone|dexamethasone|mesh-list
19575809|NCT01592370|Nivolumab|nivolumab|mesh-list
19575810|NCT01592370|Ipilimumab|ipilimumab|mesh-list
19575811|NCT01592370|Daratumumab|daratumumab|mesh-list
19575812|NCT01592370|Pomalidomide|pomalidomide|mesh-list
19575813|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575814|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
19575815|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
19575816|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575817|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575818|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19575819|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
19575820|NCT01592370|Hormones|hormones|mesh-ancestor
19575821|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575822|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19575823|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575824|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575825|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19575826|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575827|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
19575828|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19575829|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19575830|NCT01592370|Growth Substances|growth substances|mesh-ancestor
19575831|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
19575832|NCT01526603|Carboplatin|carboplatin|mesh-list
19575833|NCT01526603|Etoposide|etoposide|mesh-list
19575834|NCT01526603|Melphalan|melphalan|mesh-list
19575835|NCT01526603|Tretinoin|tretinoin|mesh-list
19575836|NCT01526603|Isotretinoin|isotretinoin|mesh-list
19575837|NCT01526603|Sargramostim|sargramostim|mesh-list
19575838|NCT01526603|Lenograstim|lenograstim|mesh-list
19575839|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575840|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575841|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19575842|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19548041|NCT02829385|Apatinib|apatinib|mesh-list
19548042|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548043|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19548044|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548045|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548046|NCT02829424|Methotrexate|methotrexate|mesh-list
19548047|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19548048|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
19548049|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19548050|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548051|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19548052|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
19548053|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548054|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548055|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
19548056|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548057|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19548058|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19548059|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
19548060|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548061|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19548062|NCT02829359|Entecavir|entecavir|mesh-list
19548063|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
19548064|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548065|NCT02829372|Antibodies|antibodies|mesh-list
19548066|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19548067|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19548068|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
19548069|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548070|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
19548071|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19548072|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19548073|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548074|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
19548075|NCT02829346|Coagulants|coagulants|mesh-ancestor
19548076|NCT02829333|Anesthetics|anesthetics|mesh-list
19548077|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548078|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548079|NCT02829697|Ropivacaine|ropivacaine|mesh-list
19548080|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
19548081|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
19548082|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548083|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548084|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
19548085|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548086|NCT02829151|Aspirin|aspirin|mesh-list
19548087|NCT02829151|Cilostazol|cilostazol|mesh-list
19548088|NCT02829151|Clopidogrel|clopidogrel|mesh-list
19548089|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19548090|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19548091|NCT02829151|Analgesics|analgesics|mesh-ancestor
19548092|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
19548093|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548094|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548095|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548096|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548097|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19548098|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19548099|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548100|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19548101|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19548102|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548103|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
19548104|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19548105|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19548106|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19548107|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
19548108|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548109|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19548110|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
19548111|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19548112|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
19548113|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
19548114|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19548115|NCT02829151|Protective Agents|protective agents|mesh-ancestor
19548116|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19548117|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19548118|NCT02829177|Allopurinol|allopurinol|mesh-list
19548119|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
19548120|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548121|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548122|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
19548123|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548124|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19548125|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
19548126|NCT02829177|Protective Agents|protective agents|mesh-ancestor
19548127|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548128|NCT02829281|Triamcinolone|triamcinolone|mesh-list
19548129|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19548130|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20107024|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107025|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107026|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
19548131|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
19548132|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19548133|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19548134|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19548135|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19548136|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19548137|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107027|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
19548138|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
19548139|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548140|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548141|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548142|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
19548143|NCT02829281|Hormones|hormones|mesh-ancestor
19548144|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548145|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19548146|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
19548147|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548148|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19548149|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548150|NCT02829060|Gentamicins|gentamicins|mesh-list
19548151|NCT02829060|Ampicillin|ampicillin|mesh-list
19548152|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
19548153|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19548154|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548155|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19548156|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107028|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107029|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107030|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107031|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20604386|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548157|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107032|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107033|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107034|NCT00003647|Dacarbazine|dacarbazine|mesh-list
20107035|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107036|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
20107037|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107038|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107039|NCT00003650|Cytarabine|cytarabine|mesh-list
20107040|NCT00003650|Dexamethasone|dexamethasone|mesh-list
20107041|NCT00003650|Prednisone|prednisone|mesh-list
20107042|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
20107043|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
20107044|NCT00003650|Methotrexate|methotrexate|mesh-list
20107045|NCT00003650|Etoposide|etoposide|mesh-list
20107046|NCT00003650|Vincristine|vincristine|mesh-list
20107047|NCT00003650|Daunorubicin|daunorubicin|mesh-list
20107048|NCT00003650|Asparaginase|asparaginase|mesh-list
20107049|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
20107050|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
19548158|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19548159|NCT02829060|Renal Agents|renal agents|mesh-ancestor
19548160|NCT02829008|Bevacizumab|bevacizumab|mesh-list
19548161|NCT02829008|Pemetrexed|pemetrexed|mesh-list
19548162|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20107051|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107052|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
19548163|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548164|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19548165|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19548166|NCT02829008|Growth Substances|growth substances|mesh-ancestor
19548167|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548168|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
19548169|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548170|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548171|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19548172|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19548173|NCT02828384|Psyllium|psyllium|mesh-list
19548174|NCT02828384|Cathartics|cathartics|mesh-ancestor
19548175|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19548176|NCT02828566|Ketamine|ketamine|mesh-list
19548177|NCT02828566|Analgesics|analgesics|mesh-ancestor
19548178|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
19548179|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548180|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548181|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19548182|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19548183|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
19548184|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
19548185|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548186|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19548187|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19548188|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548189|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107053|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107054|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107055|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107056|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
20107057|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107058|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107059|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107060|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548190|NCT02828163|Triamcinolone|triamcinolone|mesh-list
19548191|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19548192|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19548193|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19548194|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548195|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
19548196|NCT02828163|Hormones|hormones|mesh-ancestor
19548197|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548198|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548199|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19548200|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
19548201|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548202|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548203|NCT02828176|Anesthetics|anesthetics|mesh-list
19548204|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548205|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548206|NCT02828059|Ropivacaine|ropivacaine|mesh-list
19548207|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
19548208|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
19548209|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548210|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548211|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
19548212|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548213|NCT02828228|Vitamin D|vitamin d|mesh-list
19548214|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
19548215|NCT02828228|Vitamins|vitamins|mesh-ancestor
19548216|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
19548217|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548218|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19548219|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19575843|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575844|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575845|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19575846|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
19575847|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19575848|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575849|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
20107061|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
19548220|NCT02827903|Metformin|metformin|mesh-list
19548221|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19548222|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19548223|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548224|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19548225|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19548226|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
19548227|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548228|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19548229|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19548230|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548231|NCT02828033|Rilonacept|rilonacept|mesh-list
19548232|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548233|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19548234|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19548235|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548236|NCT02827890|Incretins|incretins|mesh-ancestor
19548237|NCT02827890|Hormones|hormones|mesh-ancestor
19548238|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548239|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19548240|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
19548241|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548242|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548243|NCT02827877|Copper|copper|mesh-list
19548244|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19548245|NCT02827877|Trastuzumab|trastuzumab|mesh-list
19548246|NCT02827877|Pertuzumab|pertuzumab|mesh-list
19548247|NCT02827877|Antibodies|antibodies|mesh-list
19548248|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
19548249|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19548250|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
19548251|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548252|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107062|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
20107063|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107064|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107065|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
20107066|NCT00003650|Hormones|hormones|mesh-ancestor
20107067|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107068|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107069|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20107070|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
20107071|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107072|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107073|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
19548253|NCT02827877|Trace Elements|trace elements|mesh-ancestor
19548254|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
19548255|NCT02827643|Vitamin D|vitamin d|mesh-list
19548256|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
19548257|NCT02827643|Lamivudine|lamivudine|mesh-list
19548258|NCT02827643|Calcium|calcium|mesh-list
19548259|NCT02827643|Vitamins|vitamins|mesh-ancestor
19548260|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
19548261|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548262|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19548263|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19548264|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19548265|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19548266|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548267|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548268|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
19548269|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548270|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19548271|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19548272|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19548273|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
19548274|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19548275|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
19548276|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19548277|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548278|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20107074|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
19548279|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19548280|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548281|NCT02827747|Vitamin A|vitamin a|mesh-list
19548282|NCT02827747|Antioxidants|antioxidants|mesh-list
19548283|NCT02827747|Vitamins|vitamins|mesh-ancestor
19548284|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
19548285|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548286|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548287|NCT02827747|Protective Agents|protective agents|mesh-ancestor
19548288|NCT02827578|Tamsulosin|tamsulosin|mesh-list
19548289|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
19548290|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19548291|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19548292|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19548293|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
19548294|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548295|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548296|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548297|NCT02827578|Urological Agents|urological agents|mesh-ancestor
19548298|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19548299|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19548300|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
19548301|NCT02827682|Anesthetics|anesthetics|mesh-list
19548302|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548303|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548304|NCT02827435|Bromides|bromides|mesh-list
19548305|NCT02827435|Rocuronium|rocuronium|mesh-list
19548306|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
19548307|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19548308|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19548309|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19548310|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548311|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548312|NCT02827487|Celecoxib|celecoxib|mesh-list
19548313|NCT02827487|Tramadol|tramadol|mesh-list
19548314|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19548315|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19548316|NCT02827487|Analgesics|analgesics|mesh-ancestor
19548317|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
19548318|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548319|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548320|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548321|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548322|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19548323|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19548324|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548325|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548326|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20107075|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107076|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107077|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107078|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107079|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19548327|NCT02827487|Narcotics|narcotics|mesh-ancestor
19548328|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548329|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
19548330|NCT02827266|Hematinics|hematinics|mesh-ancestor
19548331|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19548332|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
19548333|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
19548334|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19548335|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548336|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548337|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19548338|NCT02827942|Amoxicillin|amoxicillin|mesh-list
19548339|NCT02827942|Metronidazole|metronidazole|mesh-list
19548340|NCT02827942|Clarithromycin|clarithromycin|mesh-list
19548341|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20107080|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107081|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
20107082|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107083|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107084|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107085|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107086|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20107087|NCT00003650|Protective Agents|protective agents|mesh-ancestor
20107088|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107089|NCT00003650|Analgesics|analgesics|mesh-ancestor
19548342|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548343|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19548344|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19548345|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19548346|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548347|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548348|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19548349|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19548350|NCT02827136|Lidocaine|lidocaine|mesh-list
19548351|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
19548352|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
19548353|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548354|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548355|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
19548356|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107090|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
20107091|NCT00003652|Fluorouracil|fluorouracil|mesh-list
20107092|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107093|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
20107094|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107095|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107096|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107097|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
20107098|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107099|NCT00003653|Leuprolide|leuprolide|mesh-list
20107100|NCT00003653|Goserelin|goserelin|mesh-list
20107101|NCT00003653|Flutamide|flutamide|mesh-list
20107102|NCT00003653|Bicalutamide|bicalutamide|mesh-list
20107103|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
20107104|NCT00003653|Nilutamide|nilutamide|mesh-list
20107105|NCT00003653|Buserelin|buserelin|mesh-list
20107106|NCT00003653|Cyproterone|cyproterone|mesh-list
20107107|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20107108|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
20107109|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107110|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548357|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19548358|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19548359|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19548360|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19548361|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548362|NCT02826902|Remifentanil|remifentanil|mesh-list
19548363|NCT02826902|Propofol|propofol|mesh-list
19548364|NCT02826902|Desflurane|desflurane|mesh-list
20107111|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107112|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107113|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
20107114|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
20107115|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107116|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20107117|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
19548365|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19548366|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548367|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548368|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19548369|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
19548370|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
19548371|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19548372|NCT02826902|Narcotics|narcotics|mesh-ancestor
19548373|NCT02826902|Analgesics|analgesics|mesh-ancestor
19548374|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
19548375|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548376|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19548377|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
19548378|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19548379|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548380|NCT02826616|Trimetazidine|trimetazidine|mesh-list
19548381|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
19548382|NCT02826772|Androgens|androgens|mesh-list
19548383|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
19548384|NCT02826772|Hormones|hormones|mesh-ancestor
19548385|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548386|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107118|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19548387|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
20107119|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20120508|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19548388|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
19548389|NCT02826876|Ropivacaine|ropivacaine|mesh-list
19548390|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
19548391|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
19548392|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548393|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548394|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
19548395|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548396|NCT02826759|Insulin|insulin|mesh-list
19548397|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20107120|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120509|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20120510|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120511|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120512|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120513|NCT00006368|Edotreotide|edotreotide|mesh-list
20120514|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19548398|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548399|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
19548400|NCT02826746|Analgesics|analgesics|mesh-ancestor
19548401|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
19548402|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548403|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548404|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
20120515|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120516|NCT00006370|Edotreotide|edotreotide|mesh-list
20120517|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20120518|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120519|NCT00006371|Ketoconazole|ketoconazole|mesh-list
20120520|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
19548405|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20120521|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20120522|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20120523|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20604387|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604388|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19548406|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19548407|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
19548408|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19548409|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19548410|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548411|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19548412|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
19548413|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19548414|NCT02826837|Bevacizumab|bevacizumab|mesh-list
19548415|NCT02826837|Cetuximab|cetuximab|mesh-list
19548416|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19548417|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548418|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19548419|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19548420|NCT02826837|Growth Substances|growth substances|mesh-ancestor
19548421|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548422|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
19548423|NCT02826408|Rabeprazole|rabeprazole|mesh-list
19548424|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19548425|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19548426|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19548427|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548428|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575850|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575851|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19575852|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
19575853|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
19575854|NCT01475123|Nicorandil|nicorandil|mesh-list
19575855|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19575856|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19575857|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
19575858|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
19575859|NCT01475123|Vitamins|vitamins|mesh-ancestor
19575860|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
19575861|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575862|NCT01207011|Docetaxel|docetaxel|mesh-list
19575863|NCT01207011|Amrubicin|amrubicin|mesh-list
19575864|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120524|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
19548429|NCT02826434|Durvalumab|durvalumab|mesh-list
19548430|NCT02826434|Poly ICLC|poly iclc|mesh-list
19548431|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19548432|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548433|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
19548434|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
19548435|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548436|NCT02826343|Xenon|xenon|mesh-list
19548437|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19548438|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19548439|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
19548440|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
19548441|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548442|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548443|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19548444|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
19548445|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548446|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19548447|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
19548448|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
20107121|NCT00003657|Carboplatin|carboplatin|mesh-list
20107122|NCT00003657|Etoposide|etoposide|mesh-list
20107123|NCT00003657|Ifosfamide|ifosfamide|mesh-list
20107124|NCT00003657|Amifostine|amifostine|mesh-list
20107125|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107126|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107127|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107128|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107129|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107130|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107131|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107132|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107133|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
20107134|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20107135|NCT00003657|Protective Agents|protective agents|mesh-ancestor
20107136|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
20107137|NCT00003658|Rituximab|rituximab|mesh-list
20107138|NCT00003658|Pentostatin|pentostatin|mesh-list
20107139|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107140|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
19548449|NCT02826343|Hormones|hormones|mesh-ancestor
19548450|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548451|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
19548452|NCT02826252|Iloprost|iloprost|mesh-list
19548453|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19548454|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
19548455|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
19548456|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
19548457|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19548458|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
19548459|NCT02826070|Adefovir|adefovir|mesh-list
19548460|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19548461|NCT02826070|Telbivudine|telbivudine|mesh-list
19548462|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
19548463|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548464|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19548465|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19548466|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548467|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548468|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
19548469|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
19548470|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107141|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107142|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107143|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107144|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
20107145|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107146|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107147|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107148|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20107149|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19548471|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548472|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19548473|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
19548474|NCT02825979|Sotalol|sotalol|mesh-list
19548475|NCT02825979|Flecainide|flecainide|mesh-list
20107150|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107151|NCT00003661|Cyclosporine|cyclosporine|mesh-list
20107152|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
20107153|NCT00003661|Melphalan|melphalan|mesh-list
20107154|NCT00003661|Busulfan|busulfan|mesh-list
20107155|NCT00003661|Cyclosporins|cyclosporins|mesh-list
20107156|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20107157|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107158|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548476|NCT02825979|Dronedarone|dronedarone|mesh-list
19548477|NCT02825979|Propafenone|propafenone|mesh-list
19548478|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19548479|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19548480|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19548481|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
19548482|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548483|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548484|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548485|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
19548486|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
19548487|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548488|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19548489|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19548490|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19548491|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19548492|NCT02826174|Anesthetics|anesthetics|mesh-list
19548493|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548494|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548495|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
19548496|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19548497|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
19548498|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548499|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
19548500|NCT02826031|Protective Agents|protective agents|mesh-ancestor
19548501|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
19548502|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
19548503|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19548504|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19548505|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548506|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
19548507|NCT02825719|Coagulants|coagulants|mesh-ancestor
19548508|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19548509|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
19548510|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19548511|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548512|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19548513|NCT02825914|Caseins|caseins|mesh-list
19548514|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
19548515|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
19548516|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548517|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
19548518|NCT02825576|Neostigmine|neostigmine|mesh-list
20107159|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107160|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
20107161|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107162|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
20107163|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107164|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107165|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107166|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20107167|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20107168|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
19548519|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19548520|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548521|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548522|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
19548523|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548524|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548525|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19548526|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
19548527|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548528|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19548529|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19548530|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20107169|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
20107170|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548531|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19548532|NCT02825797|Antibodies|antibodies|mesh-list
19548533|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
19548534|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19548535|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
19548536|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548537|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548538|NCT02825394|Ecarin|ecarin|mesh-list
19548539|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19548540|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19548541|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548542|NCT02825147|Dexamethasone|dexamethasone|mesh-list
19548543|NCT02825147|Methotrexate|methotrexate|mesh-list
19548544|NCT02825147|Etoposide|etoposide|mesh-list
19548545|NCT02825147|Pegaspargase|pegaspargase|mesh-list
19548546|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548547|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
19548548|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
19548549|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548550|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548551|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19548552|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
19548553|NCT02825147|Hormones|hormones|mesh-ancestor
19548554|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548555|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19548556|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548557|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19548558|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
19548559|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19548560|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19548561|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
19548562|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548563|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
19548564|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107171|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107172|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
20107173|NCT00003661|Hormones|hormones|mesh-ancestor
20107174|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107175|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20107176|NCT00003661|Protective Agents|protective agents|mesh-ancestor
20107177|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107178|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19548565|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19548566|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19548567|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
19548568|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548569|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19548570|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19548571|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19548572|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19548573|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19548574|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19548575|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
19548576|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19548577|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
19548578|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19548579|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548580|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19548581|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19548582|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548583|NCT02825342|Citalopram|citalopram|mesh-list
19548584|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19548585|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20107179|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
20107180|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107181|NCT00003662|Cyclosporine|cyclosporine|mesh-list
20107182|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
20107183|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
20107184|NCT00003662|Melphalan|melphalan|mesh-list
20107185|NCT00003662|Busulfan|busulfan|mesh-list
20107186|NCT00003662|Cyclosporins|cyclosporins|mesh-list
20107187|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19548586|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19548587|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20107188|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107189|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
19548588|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548589|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548590|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
19548591|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548592|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19548593|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
19548594|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19548595|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548596|NCT02825225|Anesthetics|anesthetics|mesh-list
19548597|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548598|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548599|NCT02825186|Dexamethasone|dexamethasone|mesh-list
19548600|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548601|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
19548602|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
19548603|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548604|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548605|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19548606|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
19548607|NCT02825186|Hormones|hormones|mesh-ancestor
19548608|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548609|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19548610|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548611|NCT02825095|Lidocaine|lidocaine|mesh-list
19548612|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
19548613|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
19548614|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548615|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548616|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
19548617|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548618|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19548619|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19548620|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19548621|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19548622|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548623|NCT02825121|Iodine|iodine|mesh-list
19548624|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19548625|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107190|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548626|NCT02825121|Trace Elements|trace elements|mesh-ancestor
19548627|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
19548628|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548629|NCT02825199|Caffeine|caffeine|mesh-list
19548630|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19548631|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548632|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19548633|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548634|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548635|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19548636|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19548637|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
19548638|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548639|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
19548640|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19548641|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548642|NCT02825056|Morphine|morphine|mesh-list
19548643|NCT02825056|Bupivacaine|bupivacaine|mesh-list
19548644|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
19548645|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
19548646|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548647|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548648|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
19548649|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548650|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19548651|NCT02825056|Narcotics|narcotics|mesh-ancestor
19548652|NCT02825056|Analgesics|analgesics|mesh-ancestor
19548653|NCT02824926|Ketoconazole|ketoconazole|mesh-list
19548654|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
19548655|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548656|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19548657|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19548658|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548659|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107191|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548660|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19548661|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
19548662|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548663|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548664|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19575865|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575866|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
19575867|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575868|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575869|NCT01176461|Nivolumab|nivolumab|mesh-list
19575870|NCT01176461|Vaccines|vaccines|mesh-list
19575871|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
19575872|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575873|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575874|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575875|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19575876|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575877|NCT01165632|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19575878|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575879|NCT01165632|Dopamine Agents|dopamine agents|mesh-ancestor
19575880|NCT01165632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575881|NCT01165632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575882|NCT01003964|Gemcitabine|gemcitabine|mesh-list
19575883|NCT01003964|Cisplatin|cisplatin|mesh-list
19575884|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575885|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19575886|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
19575887|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575888|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
19575889|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575890|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575891|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19575892|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
19575893|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575894|NCT00980954|Paclitaxel|paclitaxel|mesh-list
19575895|NCT00980954|Carboplatin|carboplatin|mesh-list
19575896|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575897|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575898|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575899|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
19575900|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107192|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107193|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
20107194|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107195|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107196|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107197|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107198|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
20107199|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107200|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107201|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19575901|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575902|NCT00890266|Riboflavin|riboflavin|mesh-list
19575903|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
19575904|NCT00890266|Vitamins|vitamins|mesh-ancestor
19575905|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
19575906|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575907|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19575908|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
19575909|NCT00711269|Risperidone|risperidone|mesh-list
19575910|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19575911|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19575912|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
19575913|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575914|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575915|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575916|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19575917|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19575918|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575919|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19575920|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19575921|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
20107202|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19575922|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20107203|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
20107204|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
20107205|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107206|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107207|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
20107208|NCT00003662|Hormones|hormones|mesh-ancestor
20107209|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107210|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20107211|NCT00003662|Protective Agents|protective agents|mesh-ancestor
20107212|NCT00003663|Dexamethasone|dexamethasone|mesh-list
20107213|NCT00003663|Rituximab|rituximab|mesh-list
19548665|NCT02824601|Calcium|calcium|mesh-list
19548666|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19548667|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548668|NCT02824770|Tramadol|tramadol|mesh-list
19548669|NCT02824770|Bupivacaine|bupivacaine|mesh-list
19548670|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
19548671|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
19548672|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548673|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548674|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
19548675|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548676|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19548677|NCT02824770|Narcotics|narcotics|mesh-ancestor
19548678|NCT02824770|Analgesics|analgesics|mesh-ancestor
19548679|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19548680|NCT02824536|Antibodies|antibodies|mesh-list
19548681|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
19548682|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19548683|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
19548684|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548685|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548686|NCT02824666|Fallypride|fallypride|mesh-list
19548687|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19548688|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19548689|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
19548690|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20107214|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20107215|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107216|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
20107217|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107218|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548691|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548692|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548693|NCT02824718|Teriparatide|teriparatide|mesh-list
19548694|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
19548695|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19548696|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
19548697|NCT02824718|Diuretics|diuretics|mesh-list
19548698|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
19548699|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19548700|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548701|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19548702|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
19548703|NCT02824718|Vitamins|vitamins|mesh-ancestor
19548704|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
19548705|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19548706|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548707|NCT02824627|Oxytocin|oxytocin|mesh-list
19548708|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
19548709|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107219|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20107220|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
20107221|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
20107222|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107223|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107224|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
20107225|NCT00003663|Hormones|hormones|mesh-ancestor
20107226|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107227|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107228|NCT00003664|Gemcitabine|gemcitabine|mesh-list
20107229|NCT00003664|Interferons|interferons|mesh-list
20107230|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
19548710|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548711|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20107231|NCT00003664|Aldesleukin|aldesleukin|mesh-list
20107232|NCT00003664|Fluorouracil|fluorouracil|mesh-list
19548712|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19548713|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548714|NCT02824874|Incretins|incretins|mesh-ancestor
19548715|NCT02824874|Hormones|hormones|mesh-ancestor
19548716|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548717|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19548718|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
19548719|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548720|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548721|NCT02824614|Erythritol|erythritol|mesh-list
19548722|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
19548723|NCT02824510|Insulin|insulin|mesh-list
19548724|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19548725|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
19548726|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19548727|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548728|NCT02824523|Aspirin|aspirin|mesh-list
19548729|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19548730|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19548731|NCT02824523|Analgesics|analgesics|mesh-ancestor
19548732|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
19548733|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107233|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107234|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
20107235|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107236|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107237|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
20107238|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107239|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548734|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548735|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548736|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548737|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20107240|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107241|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
20107242|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107243|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19548738|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19548739|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548740|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19548741|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19548742|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548743|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
19548744|NCT02824458|Apatinib|apatinib|mesh-list
19548745|NCT02824458|Gefitinib|gefitinib|mesh-list
19548746|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548747|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19548748|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548749|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548750|NCT02824094|Crizotinib|crizotinib|mesh-list
20107244|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20107245|NCT00003666|Irofulven|irofulven|mesh-list
20107246|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107247|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
20107248|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107249|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107250|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
20107251|NCT00003667|Doxorubicin|doxorubicin|mesh-list
20107252|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20107253|NCT00003667|Vincristine|vincristine|mesh-list
20107254|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
20107255|NCT00003667|Razoxane|razoxane|mesh-list
20107256|NCT00003667|Glycerol|glycerol|mesh-list
20107257|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107258|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
20107259|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107260|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107261|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107262|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
20107263|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107264|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107265|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107266|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107267|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107268|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19548751|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107269|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107270|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107271|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107272|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107273|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
19548752|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19548753|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548754|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548755|NCT02824315|Simeprevir|simeprevir|mesh-list
19548756|NCT02824315|Odalasvir|odalasvir|mesh-list
19548757|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
19548758|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548759|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
19548760|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548761|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548762|NCT02824406|Acetazolamide|acetazolamide|mesh-list
19548763|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
19548764|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19548765|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548766|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548767|NCT02824406|Diuretics|diuretics|mesh-ancestor
20107274|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20107275|NCT00003667|Protective Agents|protective agents|mesh-ancestor
20107276|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20107277|NCT00003671|Leucovorin|leucovorin|mesh-list
20107278|NCT00003671|Cytarabine|cytarabine|mesh-list
19548768|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
19548769|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548770|NCT02824354|Nalmefene|nalmefene|mesh-list
19548771|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19548772|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548773|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
19548774|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548775|NCT02824276|Morphine|morphine|mesh-list
19548776|NCT02824276|Oxycodone|oxycodone|mesh-list
19548777|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19548778|NCT02824276|Narcotics|narcotics|mesh-ancestor
19548779|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548780|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548781|NCT02824276|Analgesics|analgesics|mesh-ancestor
19548782|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
19548783|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548784|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
19548785|NCT02823977|Ketamine|ketamine|mesh-list
19548786|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19548787|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548788|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548789|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19548790|NCT02823977|Analgesics|analgesics|mesh-ancestor
19548791|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
19548792|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548793|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19548794|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19548795|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19548796|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
19548797|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548798|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548799|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19548800|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19548801|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
19548802|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
19548803|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19548804|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19548805|NCT02823808|Glimepiride|glimepiride|mesh-list
19548806|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19548807|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19548808|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548809|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19548810|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
19548811|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19548812|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
19548813|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19548814|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
19548815|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20308305|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19548816|NCT02823912|Capsaicin|capsaicin|mesh-list
20107279|NCT00003671|Dexamethasone|dexamethasone|mesh-list
19548817|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
19548818|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
19548819|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19548820|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
19548821|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548822|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548823|NCT02823912|Antacids|antacids|mesh-ancestor
19548824|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548825|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19548826|NCT02823743|Aspirin|aspirin|mesh-list
19548827|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19548828|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19548829|NCT02823743|Analgesics|analgesics|mesh-ancestor
19548830|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
19548831|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548832|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107280|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
20107281|NCT00003671|Methotrexate|methotrexate|mesh-list
20107282|NCT00003671|Vincristine|vincristine|mesh-list
20107283|NCT00003671|Daunorubicin|daunorubicin|mesh-list
20107284|NCT00003671|Asparaginase|asparaginase|mesh-list
20107285|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
20107286|NCT00003671|Thioguanine|thioguanine|mesh-list
20107287|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
19548833|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548834|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548835|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19548836|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19548837|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548838|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19548839|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19548840|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548841|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
19548842|NCT02823665|Atropine|atropine|mesh-list
19548843|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19548844|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19548845|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19548846|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
19548847|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548848|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548849|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19548850|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
19548851|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
19548852|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
19548853|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19548854|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19548855|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
19548856|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548857|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548858|NCT02823626|Spironolactone|spironolactone|mesh-list
19548859|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19548860|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
19548861|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548862|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548863|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19548864|NCT02823626|Diuretics|diuretics|mesh-ancestor
19548865|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
19548866|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
19548867|NCT02823925|Pamidronate|pamidronate|mesh-list
19548868|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19548869|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548870|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
19548871|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19548872|NCT02823496|Protective Agents|protective agents|mesh-ancestor
19548873|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548874|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
19548875|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
20107288|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107289|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
20107290|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107291|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107292|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107293|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
20107294|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548876|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20107295|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107296|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107297|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20107298|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
20107299|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
20107300|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107301|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107302|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
20107303|NCT00003671|Hormones|hormones|mesh-ancestor
19548877|NCT02823483|Protective Agents|protective agents|mesh-ancestor
20107304|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107305|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107306|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20107307|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
20107308|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107309|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19548878|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548879|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
19548880|NCT02823691|Metformin|metformin|mesh-list
19548881|NCT02823691|Lanreotide|lanreotide|mesh-list
19548882|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19548883|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548884|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548885|NCT02824042|Itraconazole|itraconazole|mesh-list
19548886|NCT02824042|Maytansine|maytansine|mesh-list
19548887|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
19548888|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19548889|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19548890|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19548891|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548892|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548893|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19548894|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
19548895|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548896|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548897|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19548898|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19548899|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548900|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
19548901|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
19548902|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
19548903|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
19548904|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19548905|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548906|NCT02823236|Triamcinolone|triamcinolone|mesh-list
19548907|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19548908|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19548909|NCT02823236|Pirfenidone|pirfenidone|mesh-list
19548910|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19548911|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19548912|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
19548913|NCT02823236|Hormones|hormones|mesh-ancestor
19548914|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19548915|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548916|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107310|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
19548917|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
19548918|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548919|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548920|NCT02823236|Analgesics|analgesics|mesh-ancestor
19548921|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
19548922|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19548923|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19548924|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19548925|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19548926|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19548927|NCT02823249|Erythritol|erythritol|mesh-list
19548928|NCT02823249|Tryptophan|tryptophan|mesh-list
19548929|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19548930|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
19548931|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19548932|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
19575923|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20308306|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19548933|NCT02823353|Fenofibrate|fenofibrate|mesh-list
19548934|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19548935|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
19548936|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548937|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19548938|NCT02823106|Verapamil|verapamil|mesh-list
19548939|NCT02823106|Choline|choline|mesh-list
19548940|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19548941|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
19548942|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19548943|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
19548944|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548945|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19548946|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19548947|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
19548948|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19548949|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19548950|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19548951|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19548952|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548953|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
19548954|NCT02823366|Fenofibrate|fenofibrate|mesh-list
19548955|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19548956|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
19548957|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548958|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20107311|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107312|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107313|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107314|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107315|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
20107316|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107317|NCT00003671|Antidotes|antidotes|mesh-ancestor
20107318|NCT00003671|Protective Agents|protective agents|mesh-ancestor
20107319|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
20107320|NCT00003671|Vitamins|vitamins|mesh-ancestor
19548967|NCT02822729|Timolol|timolol|mesh-list
19548968|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19548969|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19548970|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19548971|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19548972|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
19548973|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548974|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548975|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548976|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19548977|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19548978|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19548979|NCT02822742|Latanoprost|latanoprost|mesh-list
20107321|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
20107322|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107323|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107324|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107325|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107326|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107327|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107328|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107329|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
20107330|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20107331|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107332|NCT00003674|Dalteparin|dalteparin|mesh-list
20107333|NCT00003674|Tinzaparin|tinzaparin|mesh-list
20107334|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19548980|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19548981|NCT02822937|Triazolam|triazolam|mesh-list
19548982|NCT02822937|Methylphenidate|methylphenidate|mesh-list
19548983|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19548984|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19548985|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19548986|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19548987|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20107335|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
20107336|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20107337|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20107338|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107339|NCT00003675|Topotecan|topotecan|mesh-list
19548988|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19548989|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
19548990|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19548991|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19548992|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19548993|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19548994|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19548995|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19548996|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
19548997|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
19548998|NCT02822482|Cetuximab|cetuximab|mesh-list
19548999|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19549000|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549001|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20107340|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107341|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107342|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107343|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107344|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107345|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
20107346|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107347|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107348|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
19549002|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
19549003|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549004|NCT02822573|Donepezil|donepezil|mesh-list
19549005|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19549006|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549007|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549008|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
19549009|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549010|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549011|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
19549012|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19549013|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19549014|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549015|NCT02822131|Sevelamer|sevelamer|mesh-list
19549016|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
19549017|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
19549018|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549019|NCT02821897|Anesthetics|anesthetics|mesh-list
19549020|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549021|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549022|NCT02821858|Odalasvir|odalasvir|mesh-list
19549023|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
19549024|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549025|NCT02822144|Lidocaine|lidocaine|mesh-list
19549026|NCT02822144|Remifentanil|remifentanil|mesh-list
19549027|NCT02822144|Propofol|propofol|mesh-list
19549028|NCT02822144|Etomidate|etomidate|mesh-list
19549029|NCT02822144|Succinylcholine|succinylcholine|mesh-list
19549030|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549031|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
19549032|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549033|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549034|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
19549035|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549036|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19549037|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19549038|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19549039|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549040|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549041|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549042|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19549043|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
19549044|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20107349|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107350|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107351|NCT00003678|Tamoxifen|tamoxifen|mesh-list
20107352|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20107353|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
19549045|NCT02822144|Narcotics|narcotics|mesh-ancestor
20107354|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107355|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549046|NCT02822144|Analgesics|analgesics|mesh-ancestor
20607944|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
19549047|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19549048|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19549049|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19549050|NCT02822196|Lidocaine|lidocaine|mesh-list
19549051|NCT02822196|Bupivacaine|bupivacaine|mesh-list
19549052|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549053|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
19549054|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549055|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549056|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
19549057|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549058|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19549059|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19549060|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19549061|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549062|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549063|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
20107356|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107357|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107358|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20107359|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20107360|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20107361|NCT00003679|Tamoxifen|tamoxifen|mesh-list
20107362|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
20107363|NCT00003679|Docetaxel|docetaxel|mesh-list
20107364|NCT00003679|Doxorubicin|doxorubicin|mesh-list
20107365|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20107366|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107367|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
20107368|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107369|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107370|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107371|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
20107372|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107373|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107374|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107375|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107376|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107377|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107378|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107379|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107380|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107381|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107382|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20107383|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
20107384|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107385|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107386|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20107387|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20107388|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20107389|NCT00003680|Tamoxifen|tamoxifen|mesh-list
20107390|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
20107391|NCT00003680|Thiotepa|thiotepa|mesh-list
20107392|NCT00003680|Fluorouracil|fluorouracil|mesh-list
19549064|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19549065|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19549066|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
19549067|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549068|NCT02822157|Gemcitabine|gemcitabine|mesh-list
19549069|NCT02822157|Paclitaxel|paclitaxel|mesh-list
19549070|NCT02822157|Carboplatin|carboplatin|mesh-list
19549071|NCT02822157|Doxorubicin|doxorubicin|mesh-list
19549072|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19549073|NCT02822157|Topotecan|topotecan|mesh-list
19549074|NCT02822157|Olaparib|olaparib|mesh-list
19549075|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19549076|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549077|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
19549078|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
19549079|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19549080|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549081|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107393|NCT00003680|Methotrexate|methotrexate|mesh-list
19549082|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
19549083|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
19549084|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549085|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549086|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19549087|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
19549088|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549089|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19549090|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19549091|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19549092|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19549093|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19549094|NCT02821689|Pirfenidone|pirfenidone|mesh-list
19549095|NCT02821689|Analgesics|analgesics|mesh-ancestor
19549096|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
19549097|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549098|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549099|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19549100|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549101|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549102|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19549103|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549104|NCT02821520|Verteporfin|verteporfin|mesh-list
19549105|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19549106|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
19549107|NCT02821533|Cisplatin|cisplatin|mesh-list
19549108|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
19549109|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19575924|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19575925|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
19575926|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19575927|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19575928|NCT00411138|Paclitaxel|paclitaxel|mesh-list
19575929|NCT00411138|Carboplatin|carboplatin|mesh-list
19575930|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575931|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575932|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575933|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107394|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107395|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
19575934|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575935|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575936|NCT00291525|Warfarin|warfarin|mesh-list
19575937|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
19575938|NCT00286169|Amrubicin|amrubicin|mesh-list
19575939|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575940|NCT00188539|Anesthetics|anesthetics|mesh-list
19575941|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575942|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575943|NCT00152477|Paclitaxel|paclitaxel|mesh-list
19575944|NCT00152477|Carboplatin|carboplatin|mesh-list
19575945|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19575946|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575947|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
19575948|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
19575949|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
19575950|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575951|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19575952|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19575953|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575954|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
19575955|NCT02697630|Entinostat|entinostat|mesh-list
19575956|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19575957|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19575958|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19575959|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549110|NCT02821468|Acetaminophen|acetaminophen|mesh-list
19549111|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19549112|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549113|NCT02821468|Analgesics|analgesics|mesh-ancestor
19549114|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
19549115|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549116|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549117|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
19549118|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19549119|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549120|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549121|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19549122|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549123|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19549124|NCT02821676|Anesthetics|anesthetics|mesh-list
19549125|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549126|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549127|NCT02821559|Bevacizumab|bevacizumab|mesh-list
19549128|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
19549129|NCT02821559|Raltitrexed|raltitrexed|mesh-list
19549130|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19549131|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549132|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19549133|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19549134|NCT02821559|Growth Substances|growth substances|mesh-ancestor
20107396|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107397|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107398|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107399|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
20107400|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107401|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107402|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107403|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
20107404|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107405|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20107406|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
19549135|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549136|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
19549137|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19549138|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
19549139|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549140|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19549141|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549142|NCT02821390|Nepafenac|nepafenac|mesh-list
19549143|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19549144|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
19549145|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19549146|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20107407|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107408|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107409|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107410|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107411|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107412|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20107413|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
20107414|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549147|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549148|NCT02821390|Analgesics|analgesics|mesh-ancestor
19549149|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
19549150|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549151|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549152|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549153|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19549154|NCT02821312|DA-8010|da-8010|mesh-list
19549155|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19549156|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20107415|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19549157|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19549158|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549159|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549160|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549161|NCT02821377|Furosemide|furosemide|mesh-list
19549162|NCT02821377|Diuretics|diuretics|mesh-ancestor
19549163|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
19549164|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549165|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19549166|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549167|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549168|NCT02820987|Meropenem|meropenem|mesh-list
19549169|NCT02820987|Tazobactam|tazobactam|mesh-list
19549170|NCT02820987|Piperacillin|piperacillin|mesh-list
19549171|NCT02820987|Cefepime|cefepime|mesh-list
19549172|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19549173|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19549174|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549175|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19549176|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549177|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549178|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
19549179|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19549180|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
19549181|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549182|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549183|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19549184|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
19549185|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19549186|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
19549187|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549188|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549189|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19549190|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
19549191|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
19549192|NCT02821156|Protective Agents|protective agents|mesh-ancestor
19549193|NCT02821169|Ropivacaine|ropivacaine|mesh-list
19549194|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549195|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
19549196|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549197|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549198|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
19549199|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549200|NCT02820935|Itraconazole|itraconazole|mesh-list
19549201|NCT02820935|Rifampin|rifampin|mesh-list
19549202|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
19549203|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549204|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19549205|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19549206|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549207|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549208|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19549209|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
19549210|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549211|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549212|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19549213|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19549214|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
19549215|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19549216|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
19549217|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19549218|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19549219|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19549220|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19549221|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19549222|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19549223|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19549224|NCT02821052|Insulin|insulin|mesh-list
19549225|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
19549226|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19549227|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107416|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20107417|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20107418|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20107419|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
20107420|NCT00003681|Amifostine|amifostine|mesh-list
19549228|NCT02820948|Vitamins|vitamins|mesh-list
19549229|NCT02820948|Vitamin E|vitamin e|mesh-list
19549230|NCT02820948|Tocopherols|tocopherols|mesh-list
19549231|NCT02820948|Tocotrienols|tocotrienols|mesh-list
19549232|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
19549233|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
19549234|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549235|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
19549236|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549237|NCT02820948|Protective Agents|protective agents|mesh-ancestor
19549238|NCT02820922|Anesthetics|anesthetics|mesh-list
19549239|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549240|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549241|NCT02821247|Aflibercept|aflibercept|mesh-list
19549242|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19549243|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19549244|NCT02821247|Growth Substances|growth substances|mesh-ancestor
19549245|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549246|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
19549247|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549248|NCT02820883|Vaccines|vaccines|mesh-list
19549249|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
19549250|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549251|NCT02820519|Loxapine|loxapine|mesh-list
20107421|NCT00003681|Hematinics|hematinics|mesh-ancestor
20107422|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19549252|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20107423|NCT00003681|Protective Agents|protective agents|mesh-ancestor
20107424|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107425|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
20107426|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19549253|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19549254|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549255|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549256|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19549257|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19549258|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
19549259|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549260|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549261|NCT02820688|Bupivacaine|bupivacaine|mesh-list
19549262|NCT02820688|Prilocaine|prilocaine|mesh-list
19549263|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549264|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
19549265|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549266|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549267|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
19549268|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549269|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
19549270|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
19549271|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549272|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549273|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549274|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549275|NCT02820610|Analgesics|analgesics|mesh-ancestor
19549276|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
19549277|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549278|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19549279|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19549280|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549281|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549282|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549283|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549284|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
19549285|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20107427|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19549286|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
19549287|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19549288|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549289|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19549290|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
19549291|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19549292|NCT02820493|Vedolizumab|vedolizumab|mesh-list
19549293|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549294|NCT02820441|Zopiclone|zopiclone|mesh-list
19549295|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549296|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549297|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549298|NCT02820558|Substance P|substance p|mesh-list
19549299|NCT02820558|Neurokinin A|neurokinin a|mesh-list
19549300|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549301|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549302|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549303|NCT02820259|Tacrolimus|tacrolimus|mesh-list
19549304|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19549305|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
19549306|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549307|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19549308|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549309|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549310|NCT02820077|Hemostatics|hemostatics|mesh-list
19549311|NCT02820077|Coagulants|coagulants|mesh-ancestor
19549312|NCT02819999|Etoposide|etoposide|mesh-list
19549313|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549314|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19549315|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19549316|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19549317|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549318|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549319|NCT02820025|Doxapram|doxapram|mesh-list
19549320|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19549321|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549322|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
19549323|NCT02820051|Lidocaine|lidocaine|mesh-list
19549324|NCT02820051|Midazolam|midazolam|mesh-list
19549325|NCT02820051|Nalbuphine|nalbuphine|mesh-list
19549326|NCT02820051|Propofol|propofol|mesh-list
19549327|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549328|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
19549329|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549330|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549331|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
19549332|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549333|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19549334|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19549335|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19549336|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549337|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549338|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549339|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19549340|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
20107428|NCT00003682|Prednisolone|prednisolone|mesh-list
20107429|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
20107430|NCT00003682|Doxorubicin|doxorubicin|mesh-list
20107431|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19549341|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19549342|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19549343|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19549344|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19549345|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
19549346|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
19549347|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549348|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19549349|NCT02820051|Narcotics|narcotics|mesh-ancestor
19549350|NCT02820051|Analgesics|analgesics|mesh-ancestor
19575960|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575961|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20107432|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20107433|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
19575962|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20107434|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19575963|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604389|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20604390|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
20604391|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604392|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20604393|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19549351|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19549352|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19549353|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19549354|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549355|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549356|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549357|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549358|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
19549359|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19549360|NCT02819856|Ebselen|ebselen|mesh-list
19549361|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19549362|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549363|NCT02819856|Analgesics|analgesics|mesh-ancestor
19549364|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
19549365|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549366|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549367|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549368|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19549369|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19549370|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549371|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
20107435|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107436|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107437|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107438|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107439|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107440|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20107441|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
19549372|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549373|NCT02819856|Protective Agents|protective agents|mesh-ancestor
19549374|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19549375|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549376|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19549377|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19549378|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19549379|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549380|NCT02819661|Morphine|morphine|mesh-list
19549381|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549382|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549383|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19549384|NCT02819661|Narcotics|narcotics|mesh-ancestor
19549385|NCT02819661|Analgesics|analgesics|mesh-ancestor
19549386|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
20107442|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
20107443|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107444|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107445|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107446|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
20107447|NCT00003682|Hormones|hormones|mesh-ancestor
19549387|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549388|NCT02819869|Metformin|metformin|mesh-list
19549389|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19549390|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549391|NCT02819648|Prednisolone|prednisolone|mesh-list
19549392|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
19549393|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549394|NCT02819648|Hormones|hormones|mesh-ancestor
19549395|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549396|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549397|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19549398|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549399|NCT02819414|Acetaminophen|acetaminophen|mesh-list
19549400|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549401|NCT02819414|Analgesics|analgesics|mesh-ancestor
19549402|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
19549403|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549404|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107448|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549405|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
19549406|NCT02819544|Ropivacaine|ropivacaine|mesh-list
19549407|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549408|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
19549409|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549410|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549411|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
19549412|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549413|NCT02819570|Ampicillin|ampicillin|mesh-list
19549414|NCT02819570|Cefuroxime|cefuroxime|mesh-list
19549415|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
19549416|NCT02819570|Roxithromycin|roxithromycin|mesh-list
19549417|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19549418|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549419|NCT02819375|Ketamine|ketamine|mesh-list
19549420|NCT02819375|Remifentanil|remifentanil|mesh-list
19549421|NCT02819375|Propofol|propofol|mesh-list
19549422|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549423|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549424|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549425|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19549426|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
19549427|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
20107449|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20107450|NCT00003682|Protective Agents|protective agents|mesh-ancestor
20107451|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107452|NCT00003683|Doxorubicin|doxorubicin|mesh-list
20107453|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20107454|NCT00003683|Ifosfamide|ifosfamide|mesh-list
20107455|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107456|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107457|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107458|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107459|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107460|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549428|NCT02819375|Analgesics|analgesics|mesh-ancestor
19549429|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
19549430|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549431|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19549432|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19549433|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20107461|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107462|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
20107463|NCT00003684|Theophylline|theophylline|mesh-list
20107464|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20107465|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
20107466|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107467|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107468|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20107469|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
20107470|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19549434|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549435|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549436|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19549437|NCT02819375|Narcotics|narcotics|mesh-ancestor
19549438|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
19549439|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19549440|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549441|NCT02819115|Vaccines|vaccines|mesh-list
19549442|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
19549443|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549444|NCT02819102|Berotralstat|berotralstat|mesh-list
19549445|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549446|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549447|NCT02818985|Dexamethasone|dexamethasone|mesh-list
19549448|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
19549449|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549450|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
19549451|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
19549452|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549453|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549454|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549455|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
19549456|NCT02818985|Hormones|hormones|mesh-ancestor
19549457|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549458|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19549459|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549460|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549461|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549462|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549463|NCT02818985|Analgesics|analgesics|mesh-ancestor
19549464|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
19549465|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19549466|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19549467|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549468|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549469|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549470|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549471|NCT02819180|Vaccines|vaccines|mesh-list
19549472|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
19549473|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549474|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
19549475|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549476|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549477|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549478|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549479|NCT02819089|Analgesics|analgesics|mesh-ancestor
19549480|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
20107471|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107472|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107473|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
20107474|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20107475|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20107476|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
20107477|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20107478|NCT00003686|Pilocarpine|pilocarpine|mesh-list
20107479|NCT00003686|Miotics|miotics|mesh-ancestor
20107480|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
20107481|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107482|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107483|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20107484|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20107485|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
20107486|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549481|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549482|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19549483|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19549484|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549485|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549486|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549487|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549488|NCT02818881|Methamphetamine|methamphetamine|mesh-list
19549489|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19549490|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549491|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
19549492|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
19549493|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549494|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
19549495|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549496|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549497|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549498|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19549499|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19549500|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549501|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19549502|NCT02818725|Cisplatin|cisplatin|mesh-list
19549503|NCT02818725|Doxorubicin|doxorubicin|mesh-list
19549504|NCT02818725|Methotrexate|methotrexate|mesh-list
19549505|NCT02818725|Panitumumab|panitumumab|mesh-list
19549506|NCT02818725|Vinblastine|vinblastine|mesh-list
19549507|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549508|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19549509|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19549510|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19549511|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549512|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549513|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20107487|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549514|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
20107488|NCT00003687|Morphine|morphine|mesh-list
20107489|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
20107490|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20107491|NCT00003687|Narcotics|narcotics|mesh-ancestor
20107492|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20107493|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107494|NCT00003687|Analgesics|analgesics|mesh-ancestor
20107495|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
20107496|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107497|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
20107498|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
20107499|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20107500|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19549515|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19549516|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549517|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19549518|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
19549519|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
19549520|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19549521|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19549522|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
19549523|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19549524|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19549525|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20107501|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20107502|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107503|NCT00003688|Dactinomycin|dactinomycin|mesh-list
20107504|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20107505|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107506|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107507|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107508|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20107509|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107510|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107511|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107512|NCT00003690|Carboplatin|carboplatin|mesh-list
19549526|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19549527|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
19549528|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
19549529|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
19549530|NCT02818803|Propolis|propolis|mesh-list
19549531|NCT02818803|Miconazole|miconazole|mesh-list
19549532|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549533|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
19549534|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19549535|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19549536|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549537|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549538|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19549539|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
19549540|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549541|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549542|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19549543|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19549544|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19549545|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19549546|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19549547|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19549548|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20107513|NCT00003690|Alvocidib|alvocidib|mesh-list
20107514|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107515|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
20107516|NCT00003690|Growth Substances|growth substances|mesh-ancestor
20107517|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107518|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19549549|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19549550|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19549551|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549552|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549553|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20107519|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107520|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549554|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549555|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549556|NCT02818816|Laxatives|laxatives|mesh-ancestor
19549557|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107521|NCT00003691|Paclitaxel|paclitaxel|mesh-list
20107522|NCT00003691|Doxorubicin|doxorubicin|mesh-list
20107523|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20107524|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107525|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107526|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107527|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107528|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107529|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107530|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107531|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107532|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19549558|NCT02818660|Cosyntropin|cosyntropin|mesh-list
19549559|NCT02818660|Hormones|hormones|mesh-ancestor
19549560|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549561|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549562|NCT02818751|Citalopram|citalopram|mesh-list
19549563|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19549564|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19549565|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549566|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549567|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549568|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
19549569|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549570|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19549571|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
20604394|NCT02226991|Ritonavir|ritonavir|mesh-list
20107533|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107534|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
20107535|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107536|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107537|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107538|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
19549572|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19549573|NCT02818738|Levamisole|levamisole|mesh-list
19549574|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19549575|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
19549576|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549577|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
19549578|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
19549579|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19549580|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549581|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19549582|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
19549583|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549584|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549585|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549586|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19549587|NCT02818621|Analgesics|analgesics|mesh-ancestor
19549588|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
19549589|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549590|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19549591|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19549592|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549593|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549594|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549595|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549596|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
20107539|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107540|NCT00003694|Cytarabine|cytarabine|mesh-list
20107541|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
20107542|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107543|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
20107544|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107545|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107546|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
20107547|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107548|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107549|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
20107550|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549597|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19549598|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
19549599|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549600|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
19549601|NCT02818556|Protective Agents|protective agents|mesh-ancestor
19549602|NCT02818491|Dexamethasone|dexamethasone|mesh-list
19549603|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
20107551|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107552|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20107553|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107554|NCT00003696|Paclitaxel|paclitaxel|mesh-list
20107555|NCT00003696|Etoposide|etoposide|mesh-list
20107556|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
19549604|NCT02818491|Ropivacaine|ropivacaine|mesh-list
19549605|NCT02818491|BB 1101|bb 1101|mesh-list
19549606|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549607|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
19549608|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
19549609|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549610|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549611|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549612|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
19549613|NCT02818491|Hormones|hormones|mesh-ancestor
19549614|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549615|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19549616|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549617|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
19549618|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549619|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549620|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549621|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
19549622|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549623|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
19549624|NCT02818309|Lesogaberan|lesogaberan|mesh-list
19549625|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549626|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19549627|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
19549628|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
19549629|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549630|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549631|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549632|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
19549633|NCT02818270|Albuterol|albuterol|mesh-list
19549634|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19549635|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
19549636|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549637|NCT02818270|Expectorants|expectorants|mesh-ancestor
19549638|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
19549639|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19549640|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
19549641|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549642|NCT02818270|Protective Agents|protective agents|mesh-ancestor
19549643|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549644|NCT02818270|Antidotes|antidotes|mesh-ancestor
19549645|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19549646|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
19549647|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549648|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19549649|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
19549650|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107557|NCT00003696|Carboplatin|carboplatin|mesh-list
20107558|NCT00003696|Doxorubicin|doxorubicin|mesh-list
20107559|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20107560|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107561|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107562|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107563|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107564|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
19549651|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19549652|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19549653|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549654|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549655|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549656|NCT02818387|Midazolam|midazolam|mesh-list
19549657|NCT02818387|Remifentanil|remifentanil|mesh-list
19549658|NCT02818387|Propofol|propofol|mesh-list
19549659|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549660|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20107565|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549661|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549662|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19549663|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
19549664|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
19549665|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19549666|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19549667|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19549668|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19549669|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
19549670|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
19549671|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549672|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549673|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19549674|NCT02818387|Narcotics|narcotics|mesh-ancestor
19549675|NCT02818387|Analgesics|analgesics|mesh-ancestor
19549676|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
19549677|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549678|NCT02818348|Darunavir|darunavir|mesh-list
19549679|NCT02818348|Cobicistat|cobicistat|mesh-list
19549680|NCT02818348|Etravirine|etravirine|mesh-list
19549681|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19549682|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19549683|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
19549684|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549685|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604395|NCT02226991|Tipranavir|tipranavir|mesh-list
20604396|NCT02226991|Efavirenz|efavirenz|mesh-list
20604397|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20604398|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19549686|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19549687|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19549688|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
19549689|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549690|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19549691|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19549692|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19549693|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19549694|NCT02818140|Ropivacaine|ropivacaine|mesh-list
19549695|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549696|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
19549697|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549698|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549699|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
19549700|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19575964|NCT02697253|Incretins|incretins|mesh-ancestor
20107566|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107567|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
20107568|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107569|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107570|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107571|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
20107572|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107573|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107574|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107575|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107576|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107577|NCT00003697|Vadimezan|vadimezan|mesh-list
20107578|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107579|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
20107580|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107581|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107582|NCT00003700|Leucovorin|leucovorin|mesh-list
20107583|NCT00003700|Cytarabine|cytarabine|mesh-list
20107584|NCT00003700|Prednisone|prednisone|mesh-list
20107585|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
20604399|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
20107586|NCT00003700|Methotrexate|methotrexate|mesh-list
20107587|NCT00003700|Vincristine|vincristine|mesh-list
20107588|NCT00003700|Daunorubicin|daunorubicin|mesh-list
20107589|NCT00003700|Asparaginase|asparaginase|mesh-list
20107590|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
19575965|NCT02697253|Hormones|hormones|mesh-ancestor
19575966|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575967|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20107591|NCT00003700|Allopurinol|allopurinol|mesh-list
20107592|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
20107593|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107594|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
20604400|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107595|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107596|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107597|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107598|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
20107599|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107600|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107601|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107602|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20107603|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
20107604|NCT00003700|Hormones|hormones|mesh-ancestor
20107605|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549701|NCT02817932|Ranolazine|ranolazine|mesh-list
19549702|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19549703|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549704|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549705|NCT02817750|Zolpidem|zolpidem|mesh-list
19549706|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19549707|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19549708|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549709|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549710|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19549711|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
19549712|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
19549713|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549714|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549715|NCT02817477|Ketamine|ketamine|mesh-list
19549716|NCT02817477|Morphine|morphine|mesh-list
19549717|NCT02817477|Analgesics|analgesics|mesh-ancestor
19549718|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
19549719|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549720|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549721|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19549722|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19549723|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
19549724|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
19549725|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549726|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19549727|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19549728|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549729|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549730|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19549731|NCT02817477|Narcotics|narcotics|mesh-ancestor
19549732|NCT02817503|Folic Acid|folic acid|mesh-list
19549733|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
19549734|NCT02817503|Amlodipine|amlodipine|mesh-list
19549735|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19549736|NCT02817503|Enalapril|enalapril|mesh-list
19549737|NCT02817503|Enalaprilat|enalaprilat|mesh-list
20107606|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107607|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20107608|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
19549738|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20107609|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107610|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107611|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
20107612|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
19549739|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19549740|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549741|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549742|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19549743|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549744|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
19549745|NCT02817503|Diuretics|diuretics|mesh-ancestor
19549746|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
19549747|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19549748|NCT02817503|Hematinics|hematinics|mesh-ancestor
19549749|NCT02817503|Vitamins|vitamins|mesh-ancestor
19549750|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
19549751|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19549752|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
20107613|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107614|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19549753|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549754|NCT02817321|Morphine|morphine|mesh-list
19549755|NCT02817321|Ropivacaine|ropivacaine|mesh-list
19549756|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19549757|NCT02817321|Narcotics|narcotics|mesh-ancestor
19549758|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549759|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549760|NCT02817321|Analgesics|analgesics|mesh-ancestor
19549761|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
19549762|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549763|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
19549764|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
19549765|NCT02817360|Losartan|losartan|mesh-list
19549766|NCT02817360|Valsartan|valsartan|mesh-list
19549767|NCT02817360|Carvedilol|carvedilol|mesh-list
19549768|NCT02817360|Candesartan|candesartan|mesh-list
19549769|NCT02817360|Ramipril|ramipril|mesh-list
19549770|NCT02817360|Enalapril|enalapril|mesh-list
19549771|NCT02817360|Lisinopril|lisinopril|mesh-list
19549772|NCT02817360|Irbesartan|irbesartan|mesh-list
19549773|NCT02817360|Nebivolol|nebivolol|mesh-list
19549774|NCT02817360|Bisoprolol|bisoprolol|mesh-list
19549775|NCT02817360|Perindopril|perindopril|mesh-list
19549776|NCT02817360|Captopril|captopril|mesh-list
19549777|NCT02817360|Quinapril|quinapril|mesh-list
19549778|NCT02817360|Trandolapril|trandolapril|mesh-list
19549779|NCT02817360|Fosinopril|fosinopril|mesh-list
19549780|NCT02817360|Eprosartan|eprosartan|mesh-list
19549781|NCT02817360|Zofenopril|zofenopril|mesh-list
19549782|NCT02817360|Spirapril|spirapril|mesh-list
19549783|NCT02817360|Cilazapril|cilazapril|mesh-list
19549784|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19549785|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19549786|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19549787|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19549788|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549789|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19549790|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19549791|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549792|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549793|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549794|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
19549795|NCT02817360|Protective Agents|protective agents|mesh-ancestor
19549796|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19549797|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549798|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19549799|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
19549800|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19549801|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19549802|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19549803|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
19549804|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549805|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19549806|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19549807|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19549808|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549809|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
19549810|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
19549811|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107615|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107616|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
20107617|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107618|NCT00003700|Antidotes|antidotes|mesh-ancestor
20107619|NCT00003700|Protective Agents|protective agents|mesh-ancestor
20107620|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
20107621|NCT00003700|Vitamins|vitamins|mesh-ancestor
20107622|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
19549812|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19549813|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
19549814|NCT02816970|Vildagliptin|vildagliptin|mesh-list
19549815|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19549816|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549817|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19549818|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
19549819|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549820|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549821|NCT02817191|Tobramycin|tobramycin|mesh-list
19549822|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19549823|NCT02817191|Dexamethasone|dexamethasone|mesh-list
19549824|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
19549825|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19549826|NCT02817191|BB 1101|bb 1101|mesh-list
19549827|NCT02817191|Dipivefrin|dipivefrin|mesh-list
20107623|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107624|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107625|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107626|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107627|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107628|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107629|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107630|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
20107631|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20107632|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
20107633|NCT00003701|Paclitaxel|paclitaxel|mesh-list
20107634|NCT00003701|Vinblastine|vinblastine|mesh-list
19549828|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549829|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
19549830|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
19549831|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549832|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549833|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549834|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
19549835|NCT02817191|Hormones|hormones|mesh-ancestor
19549836|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549837|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19549838|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549839|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
19549840|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549841|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549842|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19549843|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19549844|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549845|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19549846|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19549847|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549848|NCT02817217|Valsartan|valsartan|mesh-list
19549849|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19549850|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19549851|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19549852|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549853|NCT02817256|Vitamins|vitamins|mesh-list
19549854|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
19549855|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549856|NCT02817243|Simvastatin|simvastatin|mesh-list
19549857|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19549858|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19549859|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
19549860|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549861|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19549862|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19549863|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549864|NCT02817100|Itraconazole|itraconazole|mesh-list
19549865|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
19549866|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107635|NCT00003701|Carboplatin|carboplatin|mesh-list
20107636|NCT00003701|Doxorubicin|doxorubicin|mesh-list
20107637|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20107638|NCT00003701|Methotrexate|methotrexate|mesh-list
20107639|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107640|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107641|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
19549867|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19549868|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19549869|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549870|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549871|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19549872|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
19549873|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549874|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549875|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19549876|NCT02817113|Fluorouracil|fluorouracil|mesh-list
19549877|NCT02817113|Cetuximab|cetuximab|mesh-list
19549878|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
19549879|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107642|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107643|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107644|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549880|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19549881|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549882|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19549883|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
19549884|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549885|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19549886|NCT02816905|Fluorometholone|fluorometholone|mesh-list
19549887|NCT02816905|Dexamethasone|dexamethasone|mesh-list
19549888|NCT02816905|Rimexolone|rimexolone|mesh-list
19549889|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19549890|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
19549891|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
19549892|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549893|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549894|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549895|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
19549896|NCT02816905|Hormones|hormones|mesh-ancestor
19549897|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19549898|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19549899|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107645|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107646|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107647|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107648|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107649|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20107650|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
20107651|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19549900|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19549901|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19549902|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
19549903|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549904|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
19549905|NCT02816853|Domperidone|domperidone|mesh-list
19549906|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19549907|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107652|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107653|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107654|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
20107655|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107656|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107657|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107658|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
19549908|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107659|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107660|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107661|NCT00003704|Capecitabine|capecitabine|mesh-list
20107662|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107663|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
20107664|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107665|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549909|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19549910|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549911|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549912|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549913|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549914|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
19549915|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
19549916|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549917|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19549918|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19549919|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
19549920|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549921|NCT02816476|Daratumumab|daratumumab|mesh-list
19549922|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549923|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19549924|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
19549925|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19549926|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549927|NCT02816567|Sufentanil|sufentanil|mesh-list
19549928|NCT02816567|Propofol|propofol|mesh-list
19549929|NCT02816567|Cisatracurium|cisatracurium|mesh-list
19549930|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20107666|NCT00003706|Pemetrexed|pemetrexed|mesh-list
19549931|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19549932|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549933|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19549934|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
19549935|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
19549936|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19549937|NCT02816567|Narcotics|narcotics|mesh-ancestor
19549938|NCT02816567|Analgesics|analgesics|mesh-ancestor
20107667|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107668|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107669|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549939|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
19549940|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549941|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19549942|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19549943|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19575968|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
19575969|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19575970|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575971|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19575972|NCT02697162|Octenidine|octenidine|mesh-list
19575973|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19575974|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19575975|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19575976|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19575977|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19575978|NCT02697331|Progesterone|progesterone|mesh-list
19575979|NCT02697331|Progestins|progestins|mesh-ancestor
20107670|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107671|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107672|NCT00003707|Gemcitabine|gemcitabine|mesh-list
20107673|NCT00003707|Tipifarnib|tipifarnib|mesh-list
20107674|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107675|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
19575980|NCT02697331|Hormones|hormones|mesh-ancestor
19575981|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19575982|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575983|NCT02697370|Factor VIII|factor viii|mesh-list
19575984|NCT02697370|Coagulants|coagulants|mesh-ancestor
19575985|NCT02697045|Aripiprazole|aripiprazole|mesh-list
19575986|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
19575987|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19575988|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20107676|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107677|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107678|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
19575989|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19575990|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19575991|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19575992|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
19575993|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
19575994|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19575995|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19575996|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19575997|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19575998|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
19575999|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19576000|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19576001|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19576002|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19576003|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
19576004|NCT02697058|Leucovorin|leucovorin|mesh-list
19576005|NCT02697058|Fluorouracil|fluorouracil|mesh-list
19576006|NCT02697058|Calcium|calcium|mesh-list
19576007|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
19576008|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19576009|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576010|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19576011|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
19576012|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576013|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19576014|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576015|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19576016|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
20107679|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576017|NCT02697058|Antidotes|antidotes|mesh-ancestor
19576018|NCT02697058|Protective Agents|protective agents|mesh-ancestor
19576019|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
19576020|NCT02697058|Vitamins|vitamins|mesh-ancestor
19549944|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
19549945|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19549946|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549947|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19549948|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19549949|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549950|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549951|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19549952|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19549953|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19549954|NCT02816411|Caseins|caseins|mesh-list
20107680|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107681|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107682|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
20107683|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107684|NCT00003708|Temozolomide|temozolomide|mesh-list
20107685|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107686|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
20107687|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107688|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107689|NCT00003709|Carbendazim|carbendazim|mesh-list
20107690|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
20107691|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
20107692|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20107693|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107694|NCT00003710|Irinotecan|irinotecan|mesh-list
20107695|NCT00003710|Mitomycins|mitomycins|mesh-list
20107696|NCT00003710|Mitomycin|mitomycin|mesh-list
20107697|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107698|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107699|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549955|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
19549956|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
19549957|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549958|NCT02815865|Oxytocin|oxytocin|mesh-list
19549959|NCT02815865|Dinoprostone|dinoprostone|mesh-list
20107700|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107701|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107702|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19549960|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
20107703|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
20107704|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107705|NCT00003711|Irinotecan|irinotecan|mesh-list
20107706|NCT00003711|Pemetrexed|pemetrexed|mesh-list
20107707|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107708|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107709|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107710|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549961|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107711|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107712|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107713|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107714|NCT00003712|Sirolimus|sirolimus|mesh-list
19549962|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549963|NCT02815657|Valsartan|valsartan|mesh-list
19549964|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19549965|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19549966|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19549967|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549968|NCT02815787|Glyburide|glyburide|mesh-list
19549969|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19549970|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19549971|NCT02815722|Simvastatin|simvastatin|mesh-list
19549972|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19549973|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20107715|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20107716|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549974|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
19549975|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549976|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19549977|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19549978|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549979|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19549980|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20107717|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19549981|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19549982|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19549983|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107718|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107719|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
20107720|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604401|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549984|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19549985|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19549986|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549987|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
19549988|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19549989|NCT02816203|Hemostatics|hemostatics|mesh-list
19549990|NCT02816203|Coagulants|coagulants|mesh-ancestor
19549991|NCT02815566|Tenofovir|tenofovir|mesh-list
19549992|NCT02815566|Emtricitabine|emtricitabine|mesh-list
19549993|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
19549994|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19549995|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20107721|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
20107722|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107723|NCT00003714|NSC 366140|nsc 366140|mesh-list
20107724|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107725|NCT00003715|Interferons|interferons|mesh-list
20107726|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
20107727|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
19549996|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19549997|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19549998|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19549999|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19550000|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19550001|NCT02815319|Dexamethasone|dexamethasone|mesh-list
19550002|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550003|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
19550004|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
19550005|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550006|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550007|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550008|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
19550009|NCT02815319|Hormones|hormones|mesh-ancestor
19550010|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550011|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19550012|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550013|NCT02815410|Levetiracetam|levetiracetam|mesh-list
19550014|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
19550015|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
19550016|NCT02815475|Curcumin|curcumin|mesh-list
19550017|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19550018|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550019|NCT02815475|Analgesics|analgesics|mesh-ancestor
19550020|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
19550021|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550022|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550023|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550024|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550025|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550026|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550027|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550028|NCT02815449|Iron|iron|mesh-list
19550029|NCT02815449|Trace Elements|trace elements|mesh-ancestor
19550030|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
19550031|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550032|NCT02815332|Minocycline|minocycline|mesh-list
19550033|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19550034|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550035|NCT02815189|Acetaminophen|acetaminophen|mesh-list
19550036|NCT02815189|Ibuprofen|ibuprofen|mesh-list
19550037|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550038|NCT02815189|Analgesics|analgesics|mesh-ancestor
19550039|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
19550040|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550041|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550042|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
20604402|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19550043|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19550044|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550045|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550046|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19550047|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550048|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550049|NCT02815111|Acetaminophen|acetaminophen|mesh-list
19550050|NCT02815111|Lidocaine|lidocaine|mesh-list
19550051|NCT02815111|Ketamine|ketamine|mesh-list
19550052|NCT02815111|Gabapentin|gabapentin|mesh-list
19550053|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
19550054|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
19550055|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550056|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550057|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
19550058|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550059|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19550060|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19550061|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19550062|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550063|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550064|NCT02815111|Analgesics|analgesics|mesh-ancestor
19550065|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19550066|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19550067|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
19550068|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19550069|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19550070|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550071|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550072|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
20107728|NCT00003715|Vaccines|vaccines|mesh-list
20107729|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
20107730|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
20107731|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107732|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107733|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107734|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107735|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
20107736|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550073|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
19550074|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20604403|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19550075|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19550076|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19550077|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
20604404|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
20604405|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604406|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20604407|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20604408|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20604409|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20604410|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20604411|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20604412|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20604413|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20604414|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19550078|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
19550079|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
19550080|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19550081|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19550082|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19550083|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20107737|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107738|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19550084|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107739|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
19550085|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
19550086|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550087|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550088|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19550089|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550090|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19550091|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550092|NCT02815059|Prednisone|prednisone|mesh-list
19550093|NCT02815059|Dasatinib|dasatinib|mesh-list
19550094|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550095|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
19550096|NCT02815059|Hormones|hormones|mesh-ancestor
19550097|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550098|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550099|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19550100|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550101|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19550102|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550103|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576021|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
19576022|NCT02697318|Timolol|timolol|mesh-list
19576023|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19576024|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19576025|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19576026|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19576027|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576028|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576029|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576030|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576031|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19576032|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19576033|NCT02697344|Acetic Acid|acetic acid|mesh-list
20107740|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107741|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20107748|NCT00003717|Paclitaxel|paclitaxel|mesh-list
19576034|NCT02697344|Dexamethasone|dexamethasone|mesh-list
19576035|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
19576036|NCT02697344|Lenalidomide|lenalidomide|mesh-list
19576037|NCT02697344|Retinol acetate|retinol acetate|mesh-list
19576038|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
19576039|NCT02697344|Gossypol|gossypol|mesh-list
19576040|NCT02697344|BB 1101|bb 1101|mesh-list
19576041|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576042|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
19576043|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
19576044|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576045|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576046|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576047|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
19576048|NCT02697344|Hormones|hormones|mesh-ancestor
19576049|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576050|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576051|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576052|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
19576053|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19576054|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19576055|NCT02697344|Growth Substances|growth substances|mesh-ancestor
19576056|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
19576057|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
20107749|NCT00003717|Estramustine|estramustine|mesh-list
20107750|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107751|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107752|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
19576058|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107753|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107754|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107755|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107756|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107757|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
20107758|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107759|NCT00003718|Temozolomide|temozolomide|mesh-list
20107760|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107761|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
20107762|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107763|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107764|NCT00003719|Irinotecan|irinotecan|mesh-list
20107765|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107766|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107767|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107768|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107769|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107770|NCT00003720|Semaxinib|semaxinib|mesh-list
20107771|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20107772|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20107773|NCT00003720|Growth Substances|growth substances|mesh-ancestor
20107774|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107775|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
20107776|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107777|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20107778|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107779|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107780|NCT00003723|Gemcitabine|gemcitabine|mesh-list
20107781|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107782|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
20107783|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107784|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107785|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
20107786|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107787|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107788|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107789|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
20107790|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550104|NCT02814500|Amlodipine|amlodipine|mesh-list
19550105|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19550106|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550107|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19550108|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550109|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550110|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19550111|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550112|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
19550113|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20604415|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20604416|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20604417|NCT02227056|Methylphenidate|methylphenidate|mesh-list
20604418|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19550114|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19550115|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
19550116|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19550117|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19550118|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107791|NCT00003725|Valrubicin|valrubicin|mesh-list
20107792|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107793|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107794|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107795|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107796|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107797|NCT00003727|Gemcitabine|gemcitabine|mesh-list
20107798|NCT00003727|Interferons|interferons|mesh-list
20107799|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
20107800|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
20107801|NCT00003727|Melphalan|melphalan|mesh-list
20107802|NCT00003727|Carmustine|carmustine|mesh-list
20107803|NCT00003727|Etoposide|etoposide|mesh-list
20107804|NCT00003727|Sargramostim|sargramostim|mesh-list
20107805|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107806|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
20107807|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550119|NCT02814669|Atezolizumab|atezolizumab|mesh-list
20107808|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550120|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19550121|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550122|NCT02814461|Axitinib|axitinib|mesh-list
19550123|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550124|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19550125|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550126|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550127|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19550128|NCT02814409|Plasminogen|plasminogen|mesh-list
19550129|NCT02814409|Tenecteplase|tenecteplase|mesh-list
20107809|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107810|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
20107811|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107812|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107813|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19550130|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19550131|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19550132|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550133|NCT02814630|Omalizumab|omalizumab|mesh-list
19550134|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19550135|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19550136|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
19550137|NCT02814058|Zolpidem|zolpidem|mesh-list
19550138|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19550139|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19550140|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550141|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550142|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19550143|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
19550144|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
19550145|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550146|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550147|NCT02814110|Lenograstim|lenograstim|mesh-list
19550148|NCT02814110|Sargramostim|sargramostim|mesh-list
19550149|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19550150|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
19550151|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107814|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107815|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
20107816|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
19550152|NCT02813863|Metformin|metformin|mesh-list
19550153|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19550154|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550155|NCT02813824|Aspirin|aspirin|mesh-list
19550156|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
19550157|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19550158|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550159|NCT02813824|Analgesics|analgesics|mesh-ancestor
19550160|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
19550161|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550162|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550163|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550164|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550165|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19550166|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19550167|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550168|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19550169|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19550170|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550171|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
19550172|NCT02813356|Naloxegol|naloxegol|mesh-list
19550173|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19550174|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550175|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
19550176|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550177|NCT02813369|Naloxegol|naloxegol|mesh-list
19550178|NCT02813369|Laxatives|laxatives|mesh-list
19550179|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19550180|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550181|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
19550182|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550183|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550184|NCT02813382|Bupivacaine|bupivacaine|mesh-list
19550185|NCT02813382|Prilocaine|prilocaine|mesh-list
19550186|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
19550187|NCT02813382|Procaine|procaine|mesh-list
19550188|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
19550189|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
19550190|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550191|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550192|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
19550193|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550194|NCT02813135|Carboplatin|carboplatin|mesh-list
19550195|NCT02813135|Nivolumab|nivolumab|mesh-list
19550196|NCT02813135|Irinotecan|irinotecan|mesh-list
19550197|NCT02813135|Temozolomide|temozolomide|mesh-list
19550198|NCT02813135|Topotecan|topotecan|mesh-list
19550199|NCT02813135|Olaparib|olaparib|mesh-list
19550200|NCT02813135|Adavosertib|adavosertib|mesh-list
19550201|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550202|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19550203|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19550204|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550205|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19550206|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19550207|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550208|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19550209|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
19550210|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19550211|NCT02813486|Vaccines|vaccines|mesh-list
19550212|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
19550213|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550214|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19550215|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19550216|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
19550217|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19550218|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
19550219|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19550220|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550221|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19550222|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19550223|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550224|NCT02813018|Ropivacaine|ropivacaine|mesh-list
19550225|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
19550226|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
19550227|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550228|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550229|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
19550230|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550231|NCT02813148|Naloxegol|naloxegol|mesh-list
19550232|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19550233|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550234|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
19550235|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550236|NCT02813044|Anesthetics|anesthetics|mesh-list
19550237|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550238|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550239|NCT02812888|Propranolol|propranolol|mesh-list
19550240|NCT02812888|Methimazole|methimazole|mesh-list
19550241|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
19550242|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19550243|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19550244|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550245|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550246|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550247|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550248|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19550249|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550250|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
19550251|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
19550252|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
19550253|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550254|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
19576059|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576060|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19576061|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576062|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19576063|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19576064|NCT02697344|Protective Agents|protective agents|mesh-ancestor
19576065|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19550255|NCT02812979|Albuterol|albuterol|mesh-list
19550256|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19550257|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
19550258|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550259|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550260|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19550261|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
19550262|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
19550263|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19550264|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19550265|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19550266|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19550267|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550268|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550269|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107817|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107818|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107819|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107820|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107821|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107822|NCT00003728|Leucovorin|leucovorin|mesh-list
20107823|NCT00003728|Cytarabine|cytarabine|mesh-list
20107824|NCT00003728|Dexamethasone|dexamethasone|mesh-list
20107825|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
20107826|NCT00003728|Prednisolone|prednisolone|mesh-list
20107827|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
20107828|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20107829|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20107830|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20107831|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
20107832|NCT00003728|Doxorubicin|doxorubicin|mesh-list
20107833|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20107834|NCT00003728|Methotrexate|methotrexate|mesh-list
20107835|NCT00003728|Etoposide|etoposide|mesh-list
20107836|NCT00003728|Vincristine|vincristine|mesh-list
20107837|NCT00003728|Daunorubicin|daunorubicin|mesh-list
20107838|NCT00003728|Asparaginase|asparaginase|mesh-list
20107839|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
20107840|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
20107841|NCT00003728|Thioguanine|thioguanine|mesh-list
20107842|NCT00003728|Vindesine|vindesine|mesh-list
20107843|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
20107844|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107845|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
19550270|NCT02812940|Everolimus|everolimus|mesh-list
19550271|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550272|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550273|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
19550274|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107846|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107847|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20107848|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107849|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
20107850|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107851|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107852|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20107853|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20107854|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
20107855|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
20107856|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20107857|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20107858|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
20107859|NCT00003728|Hormones|hormones|mesh-ancestor
20107860|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107861|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107862|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107863|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107864|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107865|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107866|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20107867|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
20107868|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19550275|NCT02812654|Doxorubicin|doxorubicin|mesh-list
20107869|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107870|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
20107871|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107872|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20107873|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20107874|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107875|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
20107876|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107877|NCT00003728|Antidotes|antidotes|mesh-ancestor
20107878|NCT00003728|Protective Agents|protective agents|mesh-ancestor
20107879|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
20107880|NCT00003728|Vitamins|vitamins|mesh-ancestor
20107881|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
19550276|NCT02812654|Ifosfamide|ifosfamide|mesh-list
19550277|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107882|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107883|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
19550278|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550279|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19550280|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19550281|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550282|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550283|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19550284|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
19550285|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
19550286|NCT02812719|Salicylates|salicylates|mesh-list
19550287|NCT02812719|Glycolic acid|glycolic acid|mesh-list
19550288|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550289|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
19550290|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
19550291|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19550292|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19550293|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550294|NCT02812719|Analgesics|analgesics|mesh-ancestor
19550295|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
19550296|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550297|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550298|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550299|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550300|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19550301|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550302|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550303|NCT02812992|Gemcitabine|gemcitabine|mesh-list
19550304|NCT02812992|Paclitaxel|paclitaxel|mesh-list
19550305|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19550306|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550307|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19550308|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19550309|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19550310|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550311|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19550312|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
19550313|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
19550314|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550315|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550316|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550317|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
19550318|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550319|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
19550320|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
19550321|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19550322|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550323|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19550324|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550325|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550326|NCT02812641|Bevacizumab|bevacizumab|mesh-list
19550327|NCT02812641|Cisplatin|cisplatin|mesh-list
19550328|NCT02812641|Fluorouracil|fluorouracil|mesh-list
19550329|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19550330|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550331|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19550332|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19550333|NCT02812641|Growth Substances|growth substances|mesh-ancestor
19550334|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550335|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
19550336|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
19550337|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107884|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107885|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20107886|NCT00003728|Analgesics|analgesics|mesh-ancestor
20604419|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550338|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19550339|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550340|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
19550341|NCT02812602|Lidocaine|lidocaine|mesh-list
19550342|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
20107887|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
20107888|NCT00003729|Cytarabine|cytarabine|mesh-list
20107889|NCT00003729|Fludarabine|fludarabine|mesh-list
20107890|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
20107891|NCT00003729|Idarubicin|idarubicin|mesh-list
20107892|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107893|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107894|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
20107895|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107896|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107897|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
20107898|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550343|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
19550344|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550345|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550346|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
19550347|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550348|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19550349|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19550350|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19550351|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550352|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550353|NCT02812368|Clonidine|clonidine|mesh-list
19550354|NCT02812368|Analgesics|analgesics|mesh-ancestor
19550355|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
19550356|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550357|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550358|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550359|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
19550360|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
19550361|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19550362|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19550363|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19550364|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550365|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20107899|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
20107900|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20107901|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20107902|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20107903|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107904|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107905|NCT00003730|Fluorouracil|fluorouracil|mesh-list
20107906|NCT00003730|Vinorelbine|vinorelbine|mesh-list
20107907|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
20107908|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107909|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20107910|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107911|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20107912|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
20107913|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107914|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107915|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107916|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107917|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107918|NCT00003731|Temozolomide|temozolomide|mesh-list
20107919|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20107920|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
20107921|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107922|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107923|NCT00003732|Paclitaxel|paclitaxel|mesh-list
20107924|NCT00003732|Carboplatin|carboplatin|mesh-list
20107925|NCT00003732|Topotecan|topotecan|mesh-list
19550366|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107926|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107927|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107928|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
19550367|NCT02812394|Levodopa|levodopa|mesh-list
20107929|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107930|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107931|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107932|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107933|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19550368|NCT02812394|Carbidopa|carbidopa|mesh-list
19550369|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19550370|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20107934|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107935|NCT00003733|Paclitaxel|paclitaxel|mesh-list
20107936|NCT00003733|Carboplatin|carboplatin|mesh-list
20107937|NCT00003733|Topotecan|topotecan|mesh-list
20107938|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107939|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107940|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107941|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107942|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107943|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107944|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107945|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107946|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550371|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19550372|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
19550373|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550374|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550375|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550376|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19550377|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550378|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19550379|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
19550380|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
19550381|NCT02812199|Lidocaine|lidocaine|mesh-list
19550382|NCT02812199|Epinephrine|epinephrine|mesh-list
19550383|NCT02812199|Racepinephrine|racepinephrine|mesh-list
19550384|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
19550385|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
19550386|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
19550387|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550388|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550389|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
19550390|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550391|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19550392|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20107947|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20107948|NCT00003734|Flutamide|flutamide|mesh-list
20107949|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
20107950|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20107951|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
20107952|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20107953|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107954|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20107955|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20107956|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107957|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
20107958|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
20107959|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20107960|NCT00003735|Topotecan|topotecan|mesh-list
20107961|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
20107962|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107963|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107964|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107965|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107966|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107967|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107968|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
20107969|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107970|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20107971|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
20107972|NCT00003739|Lenograstim|lenograstim|mesh-list
20107973|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20107974|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
20107975|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107976|NCT00003740|Trastuzumab|trastuzumab|mesh-list
20107977|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20107978|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107979|NCT00003741|Antibodies|antibodies|mesh-list
20604420|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20604421|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20604422|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20604423|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107980|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20107981|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
20107982|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20107983|NCT00003742|Paclitaxel|paclitaxel|mesh-list
20107984|NCT00003742|Irinotecan|irinotecan|mesh-list
20107985|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20107986|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107987|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
20107988|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
20107989|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
20107990|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20107991|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20107992|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20107993|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20107994|NCT00003743|Aldesleukin|aldesleukin|mesh-list
20107995|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20107996|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20107997|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20107998|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
20107999|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108000|NCT00003744|Gemcitabine|gemcitabine|mesh-list
20108001|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108002|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
20108003|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108004|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108005|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
20108006|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108007|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108008|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108009|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
20108010|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550393|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19550394|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550395|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550396|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19550397|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19550398|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550399|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550400|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19550401|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19550402|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
19550403|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19550404|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
19550405|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
19550406|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
20108011|NCT00003745|Topotecan|topotecan|mesh-list
20108012|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20108013|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108014|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108015|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108016|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108017|NCT00003746|Cladribine|cladribine|mesh-list
20108018|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108019|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108020|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
20108021|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108022|NCT00003747|Carboplatin|carboplatin|mesh-list
20108023|NCT00003747|Temozolomide|temozolomide|mesh-list
20108024|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108025|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108026|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
20108027|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550407|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19550408|NCT02812212|Diuretics|diuretics|mesh-list
19550409|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
19550410|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550411|NCT02812147|Droxidopa|droxidopa|mesh-list
20108028|NCT00003748|Irinotecan|irinotecan|mesh-list
20108029|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20108030|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20604424|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
19550412|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19550413|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19550414|NCT02812043|Amorolfine|amorolfine|mesh-list
19550415|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
19550416|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550417|NCT02811978|Dexamethasone|dexamethasone|mesh-list
19550418|NCT02811978|Bortezomib|bortezomib|mesh-list
19550419|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550420|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
19550421|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
19550422|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550423|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550424|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550425|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
19550426|NCT02811978|Hormones|hormones|mesh-ancestor
19550427|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550428|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19550429|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550430|NCT02812355|Heparin|heparin|mesh-list
19550431|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
19550432|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19550433|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19550434|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550435|NCT02811731|Amlodipine|amlodipine|mesh-list
19550436|NCT02811731|Candesartan|candesartan|mesh-list
19550437|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550438|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19550439|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550440|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550441|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19550442|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550443|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
19550444|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19550445|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19550446|NCT02811809|Leuprolide|leuprolide|mesh-list
19550447|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19550448|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
19550449|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19550450|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550451|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20108031|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108032|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108033|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108034|NCT00003751|Penicillamine|penicillamine|mesh-list
20108035|NCT00003751|Antidotes|antidotes|mesh-ancestor
20108036|NCT00003751|Protective Agents|protective agents|mesh-ancestor
20108037|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108038|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
19550452|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550453|NCT02811991|Acetaminophen|acetaminophen|mesh-list
19550454|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550455|NCT02811991|Analgesics|analgesics|mesh-ancestor
19550456|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
19550457|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550458|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550459|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
19550460|NCT02811692|Aflibercept|aflibercept|mesh-list
19550461|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19550462|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19550463|NCT02811692|Growth Substances|growth substances|mesh-ancestor
19550464|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550465|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
19550466|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550467|NCT02811627|Memantine|memantine|mesh-list
19550468|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19550469|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19550470|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
19550471|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550472|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550473|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550474|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19550475|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19550476|NCT02811497|Azacitidine|azacitidine|mesh-list
20108039|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
20108040|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550477|NCT02811497|Durvalumab|durvalumab|mesh-list
19550478|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19550479|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
19550480|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550481|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550482|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550483|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19550484|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
19550485|NCT02811484|Exenatide|exenatide|mesh-list
19550486|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19550487|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550488|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19550489|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550490|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19550491|NCT02811484|Incretins|incretins|mesh-ancestor
19550492|NCT02811484|Hormones|hormones|mesh-ancestor
19550493|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576066|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
19576067|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19576068|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19576069|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19576070|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19576071|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19576072|NCT02697032|Bicalutamide|bicalutamide|mesh-list
19576073|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
19576074|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
20108041|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108042|NCT00003752|Bexarotene|bexarotene|mesh-list
20108043|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108044|NCT00003753|Dexamethasone|dexamethasone|mesh-list
20108045|NCT00003753|Irinotecan|irinotecan|mesh-list
20108046|NCT00003753|Floxuridine|floxuridine|mesh-list
20108047|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20108048|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
20108049|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
20108050|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20108051|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108052|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20108053|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
20108054|NCT00003753|Hormones|hormones|mesh-ancestor
20108055|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108056|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576075|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576076|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576077|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576078|NCT02696837|Rocuronium|rocuronium|mesh-list
19576079|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19576080|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19576081|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20108057|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108058|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19576082|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576083|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576084|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
19576085|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576086|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
19576087|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576088|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576089|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19576090|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19576091|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
19576092|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19576093|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576094|NCT05368857|Afamelanotide|afamelanotide|mesh-list
20108059|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108060|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108061|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108062|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108063|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
20108064|NCT00003754|Thalidomide|thalidomide|mesh-list
20108065|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
20108066|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108067|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
20108068|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108069|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108070|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108071|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
20108072|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108073|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108074|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108075|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
19550494|NCT02811289|Mirabegron|mirabegron|mesh-list
19550495|NCT02811289|Glycerol|glycerol|mesh-list
19550496|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19550497|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19550498|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19550499|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550500|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550501|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550502|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550503|NCT02811289|Urological Agents|urological agents|mesh-ancestor
19550504|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19550505|NCT02811289|Protective Agents|protective agents|mesh-ancestor
19550506|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19550507|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19550508|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550509|NCT02811341|Scopolamine|scopolamine|mesh-list
19550510|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19550511|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19550512|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
20108076|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20108077|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108078|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20108079|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20108080|NCT00003754|Growth Substances|growth substances|mesh-ancestor
20108081|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
20108082|NCT00003757|Rituximab|rituximab|mesh-list
20108083|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20108084|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108085|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
20108086|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108087|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108088|NCT00003758|Cytarabine|cytarabine|mesh-list
20108089|NCT00003758|Idarubicin|idarubicin|mesh-list
20108090|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108091|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
20604425|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604426|NCT02227082|Olaparib|olaparib|mesh-list
20604427|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20604428|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604429|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604430|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604431|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
20604432|NCT02227173|Digoxin|digoxin|mesh-list
20604433|NCT02227173|Montelukast|montelukast|mesh-list
20604434|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20604435|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
20604436|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20604437|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
19550513|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
19550514|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550515|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550516|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550517|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
19550518|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19550519|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
19550520|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550521|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550522|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19550523|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
19550524|NCT02811354|Osimertinib|osimertinib|mesh-list
20108092|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108093|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108094|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
20108095|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108096|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604438|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604439|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108097|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
19550525|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550526|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19550527|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550528|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550529|NCT02811055|Aprepitant|aprepitant|mesh-list
19550530|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
19550531|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
19550532|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550533|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550534|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550535|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19550536|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550537|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108098|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108099|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108100|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108101|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108102|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550538|NCT02811016|Budesonide|budesonide|mesh-list
20108103|NCT00003759|Valrubicin|valrubicin|mesh-list
20108104|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
20108105|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20108106|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
20108107|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108108|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108109|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108110|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108111|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108112|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108113|NCT00003760|Irofulven|irofulven|mesh-list
20108114|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108115|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
20108116|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108117|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108118|NCT00003762|Gemcitabine|gemcitabine|mesh-list
20108119|NCT00003762|Docetaxel|docetaxel|mesh-list
20108120|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108121|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
20108122|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108123|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550539|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550540|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19550541|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
19550542|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550543|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550544|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20604440|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19550545|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
19550546|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
19550547|NCT02811016|Hormones|hormones|mesh-ancestor
19550548|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604441|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20604442|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604443|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20604444|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19550549|NCT02810808|Ranibizumab|ranibizumab|mesh-list
19550550|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19550551|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20108124|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
20108125|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108126|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108127|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604445|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604446|NCT02227173|Protective Agents|protective agents|mesh-ancestor
20604447|NCT02227173|Analgesics|analgesics|mesh-ancestor
20604448|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
20604449|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604450|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20604451|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20604452|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550552|NCT02810808|Growth Substances|growth substances|mesh-ancestor
19550553|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604453|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604454|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20604455|NCT02227186|Vaccines|vaccines|mesh-list
19550554|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
19550555|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550556|NCT02810886|Edetic Acid|edetic acid|mesh-list
19550557|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20108128|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
20108129|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108130|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108131|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108132|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108133|NCT00003763|Folic Acid|folic acid|mesh-list
20108134|NCT00003763|Hematinics|hematinics|mesh-ancestor
20108135|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
20108136|NCT00003763|Vitamins|vitamins|mesh-ancestor
19550558|NCT02810886|Anticoagulants|anticoagulants|mesh-ancestor
19550559|NCT02810886|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19550560|NCT02810886|Chelating Agents|chelating agents|mesh-ancestor
19550561|NCT02810886|Sequestering Agents|sequestering agents|mesh-ancestor
19550562|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550563|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19550564|NCT02810782|Morphine|morphine|mesh-list
19550565|NCT02810782|Phenobarbital|phenobarbital|mesh-list
19550566|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
19550567|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19550568|NCT02810782|Narcotics|narcotics|mesh-ancestor
20108137|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
20108138|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108139|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
20108140|NCT00003764|Fludarabine|fludarabine|mesh-list
20108141|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
20108142|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550569|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550570|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550571|NCT02810782|Analgesics|analgesics|mesh-ancestor
19550572|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
19550573|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550574|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
19550575|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19550576|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19550577|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19550578|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550579|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108143|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
20108144|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108145|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108146|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108147|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
20108148|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108149|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108150|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19550580|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
20108151|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108152|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
20108153|NCT00003765|Carmustine|carmustine|mesh-list
20108154|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20108155|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19550581|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
19550582|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19550583|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19550584|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19550585|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
19550586|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
19550587|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550588|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19550589|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20108156|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
20108157|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108158|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108159|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604456|NCT02227186|Immunologic Factors|immunologic factors|mesh-ancestor
19550590|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604457|NCT02227186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550591|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19550592|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
20108160|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20108161|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108162|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108163|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108164|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
20108165|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108166|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108167|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
20108168|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108169|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108170|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120525|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20120526|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
19550593|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
19550594|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19550595|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550596|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550597|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550598|NCT02810899|Analgesics|analgesics|mesh-ancestor
19550599|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
19550600|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550601|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19550602|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19550603|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19550604|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550605|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550606|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550607|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19550608|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550609|NCT02810704|Aspirin|aspirin|mesh-list
19550610|NCT02810704|Warfarin|warfarin|mesh-list
19550611|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
19550612|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19550613|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550614|NCT02810704|Analgesics|analgesics|mesh-ancestor
19550615|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
19550616|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120527|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120528|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20120529|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20120530|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120531|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120532|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20120533|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
20120534|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120535|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120536|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20120537|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20120538|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120539|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19550617|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550618|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550619|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550620|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19550621|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19550622|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550623|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19550624|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19550625|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550626|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
19550627|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
19550628|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19550629|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
19550630|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19550631|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
19550632|NCT02810548|Mitogens|mitogens|mesh-list
19550633|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
19550634|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550635|NCT02810275|Leucovorin|leucovorin|mesh-list
19550636|NCT02810275|Folic Acid|folic acid|mesh-list
19550637|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
19550638|NCT02810275|Antidotes|antidotes|mesh-ancestor
19550639|NCT02810275|Protective Agents|protective agents|mesh-ancestor
19550640|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550641|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
19550642|NCT02810275|Vitamins|vitamins|mesh-ancestor
19550643|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
19550644|NCT02810275|Hematinics|hematinics|mesh-ancestor
19550645|NCT02810483|Topiramate|topiramate|mesh-list
19550646|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
20108171|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20108172|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20108173|NCT00003771|Norethindrone|norethindrone|mesh-list
20108174|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
20108175|NCT00003771|Estradiol|estradiol|mesh-list
19550647|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19550648|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550649|NCT02810132|Metformin|metformin|mesh-list
19550650|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19550651|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550652|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
19550653|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19550654|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19550655|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19550656|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550657|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550658|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
19550659|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550660|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550661|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19550662|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550663|NCT02809781|Etanercept|etanercept|mesh-list
19550664|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19550665|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550666|NCT02809781|Analgesics|analgesics|mesh-ancestor
19550667|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
19550668|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550669|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550670|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20108176|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20108177|NCT00003771|Estrogens|estrogens|mesh-ancestor
20108178|NCT00003771|Hormones|hormones|mesh-ancestor
20108179|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108180|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108181|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20108182|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
20108183|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20108184|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20108185|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20108186|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20108187|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20108188|NCT00003775|Leflunomide|leflunomide|mesh-list
20108189|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108190|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108191|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108192|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
20108193|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550671|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550672|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550673|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550674|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
19550675|NCT02809768|Itraconazole|itraconazole|mesh-list
19550676|NCT02809768|Fluconazole|fluconazole|mesh-list
19550677|NCT02809768|Rifampin|rifampin|mesh-list
19550678|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
20108194|NCT00003776|Leucovorin|leucovorin|mesh-list
20108195|NCT00003776|Trimetrexate|trimetrexate|mesh-list
20108196|NCT00003776|Doxorubicin|doxorubicin|mesh-list
20108197|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20108198|NCT00003776|Methotrexate|methotrexate|mesh-list
20108199|NCT00003776|Ifosfamide|ifosfamide|mesh-list
20108200|NCT00003776|Calcium|calcium|mesh-list
20108201|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
20108202|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108203|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108204|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108205|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108206|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108207|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108208|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20108209|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108210|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19550679|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108211|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
20108212|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20108213|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108214|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
20108215|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108216|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20108217|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108218|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
20108219|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108220|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20108221|NCT00003776|Antidotes|antidotes|mesh-ancestor
20108222|NCT00003776|Protective Agents|protective agents|mesh-ancestor
20108223|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
20108224|NCT00003776|Vitamins|vitamins|mesh-ancestor
20108225|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
20108226|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19550680|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19550681|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19550682|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550683|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550684|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19550685|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
19550686|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550687|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550688|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19550689|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19550690|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
19550691|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20108227|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
20108228|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
20108229|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550692|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
19550693|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19550694|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19550695|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19550696|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19550697|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19550698|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19550699|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19550700|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19550701|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19550702|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
19550703|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19550704|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20108230|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
20108231|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108232|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108233|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108234|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604458|NCT02227212|Insulin|insulin|mesh-list
20604459|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
20604460|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20604461|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604462|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
19550705|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550706|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550707|NCT02809937|Analgesics|analgesics|mesh-ancestor
19550708|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
19550709|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550710|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19550711|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19550712|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19550713|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550714|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604463|NCT02227264|Cinacalcet|cinacalcet|mesh-list
20604464|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20108235|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108236|NCT00003780|Gemcitabine|gemcitabine|mesh-list
20108237|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108238|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
20108239|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108240|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550715|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550716|NCT02809963|Eplerenone|eplerenone|mesh-list
19550717|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19550718|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
19550719|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550720|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108241|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
20108242|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108243|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108244|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108245|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
20108246|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108247|NCT00003781|Docetaxel|docetaxel|mesh-list
20108248|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108249|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108250|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108251|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108252|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108253|NCT00003783|Leucovorin|leucovorin|mesh-list
20108254|NCT00003783|Cytarabine|cytarabine|mesh-list
20108255|NCT00003783|Dexamethasone|dexamethasone|mesh-list
20108256|NCT00003783|Prednisone|prednisone|mesh-list
19550721|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19550722|NCT02809963|Diuretics|diuretics|mesh-ancestor
19550723|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
19550724|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550725|NCT02809742|Ropivacaine|ropivacaine|mesh-list
19550726|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
19550727|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
19550728|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550729|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550730|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
19550731|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550732|NCT02809755|Lidocaine|lidocaine|mesh-list
19550733|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
19550734|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
19550735|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550736|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550737|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
19550738|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550739|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19550740|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19550741|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19550742|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20108257|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
20108258|NCT00003783|Methotrexate|methotrexate|mesh-list
19550743|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550744|NCT02809690|Clevudine|clevudine|mesh-list
19550745|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
19576095|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108259|NCT00003783|Etoposide|etoposide|mesh-list
20108260|NCT00003783|Vincristine|vincristine|mesh-list
20108261|NCT00003783|Daunorubicin|daunorubicin|mesh-list
20108262|NCT00003783|Asparaginase|asparaginase|mesh-list
20108263|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
20108264|NCT00003783|Idarubicin|idarubicin|mesh-list
20108265|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
20108266|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108267|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
20108268|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108269|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108270|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108271|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
20108272|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108273|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108274|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108275|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20108276|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
20108277|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
20108278|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20108279|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20108280|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
20108281|NCT00003783|Hormones|hormones|mesh-ancestor
20108282|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108283|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20108284|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19550746|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550747|NCT02809729|Cefazolin|cefazolin|mesh-list
19550748|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19550749|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576096|NCT05368805|Dabigatran|dabigatran|mesh-list
19576097|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19576098|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19576099|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19576100|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
19576101|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576102|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19576103|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19576104|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576105|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
19576106|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19576107|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
19576108|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
19578190|NCT03365882|Trastuzumab|trastuzumab|mesh-list
19578191|NCT03365882|Cetuximab|cetuximab|mesh-list
19578192|NCT03365882|Pertuzumab|pertuzumab|mesh-list
19578193|NCT03365882|Irinotecan|irinotecan|mesh-list
19578194|NCT03365882|Camptothecin|camptothecin|mesh-list
19578195|NCT03365882|Antibodies|antibodies|mesh-list
19578196|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
19578197|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578198|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
19578199|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578200|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578201|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19578202|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578203|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578204|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578205|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578206|NCT03297606|Nivolumab|nivolumab|mesh-list
19578207|NCT03297606|Trastuzumab|trastuzumab|mesh-list
19578208|NCT03297606|Ipilimumab|ipilimumab|mesh-list
19578209|NCT03297606|Pertuzumab|pertuzumab|mesh-list
19578210|NCT03297606|Sunitinib|sunitinib|mesh-list
19578211|NCT03297606|Dasatinib|dasatinib|mesh-list
19578212|NCT03297606|Olaparib|olaparib|mesh-list
19578213|NCT03297606|Palbociclib|palbociclib|mesh-list
19578214|NCT03297606|Axitinib|axitinib|mesh-list
19578215|NCT03297606|Vemurafenib|vemurafenib|mesh-list
19578216|NCT03297606|Crizotinib|crizotinib|mesh-list
19578217|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578218|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578219|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578220|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578221|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578222|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578223|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19578224|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19578225|NCT03297606|Growth Substances|growth substances|mesh-ancestor
19578226|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578227|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
19578228|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19578229|NCT03245151|Everolimus|everolimus|mesh-list
19578230|NCT03245151|Lenvatinib|lenvatinib|mesh-list
19578231|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578232|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578233|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
19578234|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578235|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578236|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578237|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578238|NCT03186638|Ibuprofen|ibuprofen|mesh-list
19578239|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19578240|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19578241|NCT03186638|Analgesics|analgesics|mesh-ancestor
19578242|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
19578243|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578244|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578245|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578246|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578247|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19578248|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578249|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578250|NCT03138889|Paclitaxel|paclitaxel|mesh-list
19550750|NCT02809573|Prednisone|prednisone|mesh-list
19550751|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
19550752|NCT02809573|Vincristine|vincristine|mesh-list
19550753|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550754|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
19550755|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550756|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550757|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19550758|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
19550759|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550760|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550761|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19550762|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550763|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
19550764|NCT02809573|Hormones|hormones|mesh-ancestor
19550765|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550766|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19550767|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19550768|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
19550769|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
19550770|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
19550771|NCT02809378|Remifentanil|remifentanil|mesh-list
19550772|NCT02809378|Thiopental|thiopental|mesh-list
19550773|NCT02809378|Palonosetron|palonosetron|mesh-list
19550774|NCT02809378|Propofol|propofol|mesh-list
19550775|NCT02809378|Sevoflurane|sevoflurane|mesh-list
19550776|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19550777|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550778|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550779|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19550780|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
19550781|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
19550782|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19550783|NCT02809378|Narcotics|narcotics|mesh-ancestor
19550784|NCT02809378|Analgesics|analgesics|mesh-ancestor
19550785|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
19550786|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550787|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19550788|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19550789|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
19550790|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
19550791|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550792|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19550793|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19550794|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
19550795|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550796|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550797|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
19550798|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
20108285|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
20108286|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20108287|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108288|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
20108289|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108290|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108291|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20108292|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20108293|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108294|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108295|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108296|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
20108297|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108298|NCT00003783|Antidotes|antidotes|mesh-ancestor
20108299|NCT00003783|Protective Agents|protective agents|mesh-ancestor
19550799|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
19550800|NCT02809404|Everolimus|everolimus|mesh-list
19550801|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550802|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550803|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
19550804|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550805|NCT02809456|Nicorandil|nicorandil|mesh-list
19550806|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19550807|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550808|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
19550809|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
20604465|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550810|NCT02809456|Vitamins|vitamins|mesh-ancestor
19550811|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
20108300|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
20108301|NCT00003783|Vitamins|vitamins|mesh-ancestor
20108302|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
19550812|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550813|NCT02809469|Apixaban|apixaban|mesh-list
19550814|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19550815|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
19550816|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19550817|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
19550818|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550819|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550820|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
19550821|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
19550822|NCT02809079|Prednisone|prednisone|mesh-list
19550823|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550824|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
19550825|NCT02809079|Hormones|hormones|mesh-ancestor
19550826|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550827|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550828|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19550829|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550830|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19550831|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19550832|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
19550833|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19550834|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108303|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108304|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108305|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108306|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108307|NCT00003784|Prednisone|prednisone|mesh-list
20108308|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
20108309|NCT00003784|Doxorubicin|doxorubicin|mesh-list
20108310|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20108311|NCT00003784|Vincristine|vincristine|mesh-list
20108312|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
20108313|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108314|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
20108315|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108316|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108317|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108318|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
20108319|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108320|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108321|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108322|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108323|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108324|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108325|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108326|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20108327|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
20108328|NCT00003784|Hormones|hormones|mesh-ancestor
20108329|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108330|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20108331|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108332|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108333|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108334|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108335|NCT00003786|Irofulven|irofulven|mesh-list
20108336|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108337|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
20108338|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108339|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108340|NCT00003788|Carmustine|carmustine|mesh-list
20108341|NCT00003788|Lomustine|lomustine|mesh-list
20108342|NCT00003788|Procarbazine|procarbazine|mesh-list
20108343|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20108344|NCT00003788|Trioxsalen|trioxsalen|mesh-list
20108345|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108346|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
20308307|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550835|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576109|NCT05368766|Diuretics|diuretics|mesh-list
20108347|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108348|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108349|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108350|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20108351|NCT00003789|Melphalan|melphalan|mesh-list
20108352|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108353|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
20108354|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108355|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108356|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108357|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108358|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
20108359|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108360|NCT00003792|Lenograstim|lenograstim|mesh-list
20108361|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20108362|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
20108363|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108364|NCT00003796|Irofulven|irofulven|mesh-list
20108365|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108366|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
20108367|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108368|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108369|NCT00003797|Gemcitabine|gemcitabine|mesh-list
20108370|NCT00003797|Trastuzumab|trastuzumab|mesh-list
19550836|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550837|NCT02809105|Linaclotide|linaclotide|mesh-list
19550838|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19550839|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
19550840|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550841|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19550842|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
19550843|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20108371|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20604466|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20604467|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
20604468|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108372|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
20108373|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108374|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550844|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550845|NCT02808949|Dapivirine|dapivirine|mesh-list
19550846|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19550847|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19550848|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
19550849|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550850|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
19550851|NCT02809066|Calcium|calcium|mesh-list
19550852|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19550853|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550854|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20604469|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20604470|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
20604471|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
20604472|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604473|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604474|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20604475|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604476|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20604477|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604478|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604479|NCT02227550|Vitamin K|vitamin k|mesh-list
20604480|NCT02227550|Warfarin|warfarin|mesh-list
20604481|NCT02227550|Apixaban|apixaban|mesh-list
20604482|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
20604483|NCT02227550|Fluindione|fluindione|mesh-list
19550855|NCT02808871|Pirfenidone|pirfenidone|mesh-list
19550856|NCT02808871|Analgesics|analgesics|mesh-ancestor
19550857|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
19550858|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550859|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550860|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19550861|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19550862|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19550863|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19550864|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604484|NCT02227550|Vitamins|vitamins|mesh-ancestor
20604485|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
19550865|NCT02808767|Ticagrelor|ticagrelor|mesh-list
19550866|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19550867|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19550868|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20108375|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
20108376|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108377|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108378|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550869|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19550870|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19550871|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
19550872|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550873|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108379|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
20108380|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108381|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20108382|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
19550874|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550875|NCT02808741|Olorofim|olorofim|mesh-list
19550876|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
19550877|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550878|NCT02808728|Bupivacaine|bupivacaine|mesh-list
19550879|NCT02808728|Ropivacaine|ropivacaine|mesh-list
19550880|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
19550881|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
19550882|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550883|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550884|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
19550885|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19550886|NCT02808676|Vitamin D|vitamin d|mesh-list
19550887|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
19550888|NCT02808676|Vitamins|vitamins|mesh-ancestor
19550889|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
19550890|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108383|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108384|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20108385|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108386|NCT00003799|Leucovorin|leucovorin|mesh-list
20108387|NCT00003799|Fluorouracil|fluorouracil|mesh-list
20108388|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
20108389|NCT00003799|Calcium|calcium|mesh-list
20108390|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
20108391|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20108392|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108393|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
20108394|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108395|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108396|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108397|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108398|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
20108399|NCT00003799|Antidotes|antidotes|mesh-ancestor
20108400|NCT00003799|Protective Agents|protective agents|mesh-ancestor
20108401|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
20108402|NCT00003799|Vitamins|vitamins|mesh-ancestor
20108403|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
20108404|NCT00003802|NSC 366140|nsc 366140|mesh-list
20108405|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108406|NCT00003803|Gemcitabine|gemcitabine|mesh-list
20108407|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108408|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108409|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
20108410|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108411|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
20108412|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108413|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108414|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108415|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
20108416|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108417|NCT00003804|Dactinomycin|dactinomycin|mesh-list
20108418|NCT00003804|Vincristine|vincristine|mesh-list
20108419|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108420|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108421|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108422|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108423|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108424|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550891|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20108425|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20108426|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108427|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108428|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20108429|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108430|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20108431|NCT00003805|Vancomycin|vancomycin|mesh-list
20108432|NCT00003805|Tazobactam|tazobactam|mesh-list
20108433|NCT00003805|Piperacillin|piperacillin|mesh-list
20108434|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20108435|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20108436|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550892|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19550893|NCT02808611|Propranolol|propranolol|mesh-list
19550894|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19550895|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19550896|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550897|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550898|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550899|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550900|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19550901|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550902|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
19550903|NCT02808533|Topiramate|topiramate|mesh-list
19550904|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
19550905|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19550906|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108437|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20108438|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108439|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108440|NCT00003808|Theophylline|theophylline|mesh-list
20108441|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20108442|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
20108443|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20108444|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108445|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20108446|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
20108447|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20108448|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550910|NCT02808325|Polygeline|polygeline|mesh-list
19550911|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
19550912|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
19550913|NCT02808247|Ifosfamide|ifosfamide|mesh-list
19550914|NCT02808247|Nintedanib|nintedanib|mesh-list
19550915|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19550916|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
19550917|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108449|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108450|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
20108451|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20108452|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20108453|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
19550918|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550919|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19550920|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550921|NCT02808091|Bortezomib|bortezomib|mesh-list
19550922|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550923|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
19550924|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19550925|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
19550926|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19550927|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550928|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19550929|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
19550930|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550931|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
19550932|NCT02808065|Tacrolimus|tacrolimus|mesh-list
19550933|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19550934|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
19550935|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550936|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19550937|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550938|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550939|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108454|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550940|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19550941|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19550942|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
19550943|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19550944|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550945|NCT02808117|Micronutrients|micronutrients|mesh-list
19550946|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550947|NCT02807909|Itraconazole|itraconazole|mesh-list
19550948|NCT02807909|Diltiazem|diltiazem|mesh-list
19550949|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
19550950|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19550951|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19550952|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19550953|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19550954|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550955|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19550956|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
19550957|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19550958|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550959|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19550960|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19550961|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19550962|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550963|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19550964|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
19550965|NCT02807922|Zopiclone|zopiclone|mesh-list
19550966|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19550967|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550968|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576110|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
19576111|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576112|NCT05368753|Lidocaine|lidocaine|mesh-list
19576113|NCT05368753|Ropivacaine|ropivacaine|mesh-list
19576114|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
19576115|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
19576116|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576117|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576118|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
19576119|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576120|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19576121|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19576122|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20108455|NCT00003809|Cetuximab|cetuximab|mesh-list
20108456|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108457|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20108458|NCT00003810|Gemcitabine|gemcitabine|mesh-list
20108459|NCT00003810|Docetaxel|docetaxel|mesh-list
20108460|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19576123|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19576124|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576125|NCT05368675|Buprenorphine|buprenorphine|mesh-list
19576126|NCT05368675|Methadone|methadone|mesh-list
19576127|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19576128|NCT05368675|Naloxone|naloxone|mesh-list
19576129|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19576130|NCT05368675|Narcotics|narcotics|mesh-ancestor
19576131|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576132|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576133|NCT05368675|Analgesics|analgesics|mesh-ancestor
19576134|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
20108461|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
20108462|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108463|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108464|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
20108465|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108466|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108467|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108468|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
20108469|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576135|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20108470|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108471|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108472|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108473|NCT00003811|Etoposide|etoposide|mesh-list
20108474|NCT00003811|Bleomycin|bleomycin|mesh-list
20108475|NCT00003811|Amifostine|amifostine|mesh-list
20108476|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108477|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108478|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108479|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108480|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108481|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108482|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108483|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20108484|NCT00003811|Protective Agents|protective agents|mesh-ancestor
20604486|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550969|NCT02808104|Mazindol|mazindol|mesh-list
19550970|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19550971|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550972|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19550973|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19550974|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550975|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550976|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
19550977|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550978|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19550979|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
19550980|NCT02807870|Methylphenidate|methylphenidate|mesh-list
19550981|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19550982|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550983|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19550984|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19550985|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19550986|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19550987|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
19550988|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19550989|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19550990|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19550991|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19550992|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19550993|NCT02807610|Propofol|propofol|mesh-list
19550994|NCT02807610|Etomidate|etomidate|mesh-list
19550995|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19550996|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19550997|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19550998|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19550999|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
19551000|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
19551001|NCT02807571|Anesthetics|anesthetics|mesh-list
19551002|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551003|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551004|NCT02807441|Aspirin|aspirin|mesh-list
19551005|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19551006|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551007|NCT02807441|Analgesics|analgesics|mesh-ancestor
19551008|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
20604487|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
20604488|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20604489|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
20604490|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20604491|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
20604492|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551009|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551010|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551011|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551012|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551013|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19551014|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20108485|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108486|NCT00003812|Paclitaxel|paclitaxel|mesh-list
20108487|NCT00003812|Etoposide|etoposide|mesh-list
20108488|NCT00003812|Carboplatin|carboplatin|mesh-list
20108489|NCT00003812|Topotecan|topotecan|mesh-list
20108490|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108491|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108492|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108493|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108494|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108495|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108496|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108497|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108498|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108499|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20108500|NCT00003814|Eflornithine|eflornithine|mesh-list
20108501|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108502|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20108503|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20108504|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20604493|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551015|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551016|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19551017|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19551018|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551019|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
19551020|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
19551021|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
19551022|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551023|NCT02807415|Ivacaftor|ivacaftor|mesh-list
19551024|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19551025|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19551026|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551027|NCT02807272|Tipifarnib|tipifarnib|mesh-list
19551028|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551029|NCT02807298|Lidocaine|lidocaine|mesh-list
19551030|NCT02807298|Epinephrine|epinephrine|mesh-list
19551031|NCT02807298|Carticaine|carticaine|mesh-list
19551032|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19551033|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19551034|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
19551035|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551036|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551037|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551038|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19551039|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19551040|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
19551041|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551042|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19551043|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
19551044|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
19551045|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
19551046|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19551047|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
19551048|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
19551049|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551050|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
19551051|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19551052|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19551053|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19551054|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19551055|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
19551056|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551057|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551058|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19551059|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19551060|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551061|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551062|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551063|NCT02806999|Insulin|insulin|mesh-list
19551064|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19551065|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19551066|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551067|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
19551068|NCT02807103|Rituximab|rituximab|mesh-list
19551069|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551070|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
19551071|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551072|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551073|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19551074|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
19551075|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551076|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551077|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19551078|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19551079|NCT02807194|Anesthetics|anesthetics|mesh-list
19551080|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551081|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551082|NCT02807116|Rifampin|rifampin|mesh-list
19551083|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19551084|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
19551085|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551086|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551087|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
19551088|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19551089|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551090|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551091|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19551092|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19551093|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19551094|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19551095|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19551096|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20108505|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108506|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19551097|NCT02807051|Clarithromycin|clarithromycin|mesh-list
19551098|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551099|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551100|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19551101|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551102|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551103|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19551104|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19551105|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19551106|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551107|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551108|NCT02806791|Lenograstim|lenograstim|mesh-list
19551109|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19551110|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
19551111|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551112|NCT02806817|Bevacizumab|bevacizumab|mesh-list
19551113|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19551114|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551115|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19551116|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19551117|NCT02806817|Growth Substances|growth substances|mesh-ancestor
19551118|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551119|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
19551120|NCT02806804|Vaccines|vaccines|mesh-list
19551121|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
19551122|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551123|NCT02806648|Palbociclib|palbociclib|mesh-list
19551124|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551125|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19551126|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551127|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551128|NCT02806752|Triamcinolone|triamcinolone|mesh-list
19551129|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19551130|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19551131|NCT02806752|Ranibizumab|ranibizumab|mesh-list
19551132|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19551133|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19551134|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19551135|NCT02806752|Growth Substances|growth substances|mesh-ancestor
19551136|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551137|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
19551138|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551139|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551140|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
19551141|NCT02806752|Hormones|hormones|mesh-ancestor
19551142|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108507|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108508|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108509|NCT00003815|Cytarabine|cytarabine|mesh-list
20108510|NCT00003815|Prednisolone|prednisolone|mesh-list
20108511|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
20108512|NCT00003815|Melphalan|melphalan|mesh-list
20108513|NCT00003815|Carmustine|carmustine|mesh-list
20108514|NCT00003815|Doxorubicin|doxorubicin|mesh-list
20108515|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20108516|NCT00003815|Etoposide|etoposide|mesh-list
20108517|NCT00003815|Vincristine|vincristine|mesh-list
20108518|NCT00003815|Bleomycin|bleomycin|mesh-list
20108519|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108520|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
20108521|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108522|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108523|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19551143|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551144|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
19551145|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551146|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551147|NCT02806596|Sevoflurane|sevoflurane|mesh-list
19551148|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19551149|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19551150|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
19551151|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
19551152|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551153|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108524|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
20108525|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108526|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108527|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108528|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108529|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108530|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108531|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108532|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108533|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108534|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
20108535|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
20108536|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108537|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108538|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108539|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108540|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20108541|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
20108542|NCT00003815|Hormones|hormones|mesh-ancestor
20108543|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108544|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20108545|NCT00003817|Ondansetron|ondansetron|mesh-list
20108546|NCT00003817|Granisetron|granisetron|mesh-list
20108547|NCT00003817|Tropisetron|tropisetron|mesh-list
20108548|NCT00003817|Dolasetron|dolasetron|mesh-list
20108549|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
20108550|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
20108551|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20108552|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108553|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20108554|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
20108555|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108556|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20108557|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
20108558|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604494|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19551154|NCT02806492|Phenylephrine|phenylephrine|mesh-list
19551155|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
19551156|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19551157|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
20108559|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551158|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
19551159|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551160|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551161|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
19551162|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19551163|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
19551164|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
19551165|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19551166|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19551167|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19551168|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
20108560|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19551169|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551170|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108561|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20108562|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551171|NCT02806492|Protective Agents|protective agents|mesh-ancestor
19551172|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19551173|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
19551174|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551175|NCT02806440|Naltrexone|naltrexone|mesh-list
20108563|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20108564|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20108565|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20108566|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20108567|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20108568|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
19551176|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19551177|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19551178|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551179|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
19551180|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551181|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
19551182|NCT02806375|Busulfan|busulfan|mesh-list
19551183|NCT02806375|Fludarabine|fludarabine|mesh-list
20108569|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108570|NCT00003821|Aminopterin|aminopterin|mesh-list
20108571|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20108572|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551184|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
19551185|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551186|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
19551187|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551188|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551189|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19551190|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
19551191|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551192|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551193|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19551194|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19551195|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
19551196|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
19551197|NCT02806349|Cathartics|cathartics|mesh-ancestor
19551198|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551199|NCT02806362|Ritonavir|ritonavir|mesh-list
19551200|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19551201|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19551202|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
19551203|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551204|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551205|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19551206|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19551207|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
19551208|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551209|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19551210|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19551211|NCT02806206|Prucalopride|prucalopride|mesh-list
19551212|NCT02806206|Laxatives|laxatives|mesh-ancestor
19551213|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551214|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19551215|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19551216|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
19551217|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551218|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551219|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576136|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20108573|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108574|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20108575|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
20108576|NCT00003824|Cephalexin|cephalexin|mesh-list
20108577|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108578|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108579|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108580|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108581|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108582|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576137|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
19576138|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
19576139|NCT05368623|Mydriatics|mydriatics|mesh-list
19551220|NCT02806141|Colistin|colistin|mesh-list
19551221|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551222|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551223|NCT02806128|Kallikreins|kallikreins|mesh-list
19551224|NCT02806128|Coagulants|coagulants|mesh-ancestor
19551225|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19551226|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
19551227|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19551228|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551229|NCT02806115|Acetic Acid|acetic acid|mesh-list
19551230|NCT02806115|Retinol acetate|retinol acetate|mesh-list
19551231|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551232|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551233|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19551234|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
19551235|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551236|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19551237|NCT02806115|Protective Agents|protective agents|mesh-ancestor
19551238|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551239|NCT02806050|Letrozole|letrozole|mesh-list
20108583|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20108584|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20108585|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
20108586|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
20604495|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20604496|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
19551240|NCT02806050|Palbociclib|palbociclib|mesh-list
19551241|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108587|NCT00003827|Cytarabine|cytarabine|mesh-list
20604497|NCT02227550|Coagulants|coagulants|mesh-ancestor
20604498|NCT02227745|Dorzolamide|dorzolamide|mesh-list
20604499|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
19551242|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19551243|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19551244|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551245|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551246|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19551247|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
19551248|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551249|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551250|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19551251|NCT02805946|Posaconazole|posaconazole|mesh-list
19551252|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
19551253|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551254|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19551255|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19551256|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19551257|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19551258|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19551259|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551260|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551261|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19551262|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
19551263|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551264|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551265|NCT02805738|Tenofovir|tenofovir|mesh-list
19551266|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
19551267|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551268|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19551269|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19551270|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551271|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551272|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19551273|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19551274|NCT02805920|Bupivacaine|bupivacaine|mesh-list
19551275|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
20108588|NCT00003827|Topotecan|topotecan|mesh-list
20108589|NCT00003827|Amifostine|amifostine|mesh-list
20108590|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108591|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
20108592|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551276|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
19551277|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20108593|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604500|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20604501|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
19551278|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551279|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
19551280|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551281|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19551282|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19551283|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551284|NCT02805842|Tacrolimus|tacrolimus|mesh-list
19551285|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551286|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
19551287|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108594|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
19551288|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19551289|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551290|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551291|NCT02805829|Trastuzumab|trastuzumab|mesh-list
20108595|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108596|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604502|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604503|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
20604504|NCT02227745|Protective Agents|protective agents|mesh-ancestor
20604505|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19551292|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19551293|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551294|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
19551295|NCT02805725|Trabectedin|trabectedin|mesh-list
19551296|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551297|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
20108597|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
20108598|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551298|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551299|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551300|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19551301|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
19551302|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551303|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551304|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19551305|NCT02805868|Siltuximab|siltuximab|mesh-list
19551306|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19551307|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551308|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
19551309|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551310|NCT02805556|Fostemsavir|fostemsavir|mesh-list
19551311|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20108599|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20108600|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108601|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108602|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20108603|NCT00003827|Protective Agents|protective agents|mesh-ancestor
20108604|NCT00003828|Vinorelbine|vinorelbine|mesh-list
20108605|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108606|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108607|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108608|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108609|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108610|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108611|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
20108612|NCT00003829|Fludarabine|fludarabine|mesh-list
20604506|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20604507|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551312|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19551313|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
19551314|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108613|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
20108614|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551315|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19551316|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19551317|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551318|NCT02805426|Misoprostol|misoprostol|mesh-list
19551319|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
19551320|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19551321|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19551322|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551323|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
19551324|NCT02805426|Coagulants|coagulants|mesh-ancestor
19551325|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19551326|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
20108615|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
20108616|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108617|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108618|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108619|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
20108620|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108621|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108622|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19551327|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19551328|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551329|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19551330|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551331|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
19551332|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
19551333|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19551334|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19551335|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
19551336|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551337|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551338|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551339|NCT02805452|Urological Agents|urological agents|mesh-ancestor
19551340|NCT02805049|Caspofungin|caspofungin|mesh-list
19551341|NCT02805049|Micafungin|micafungin|mesh-list
19551342|NCT02805049|Echinocandins|echinocandins|mesh-list
19551343|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
19551344|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551345|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551346|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551347|NCT02805231|Vitamin D|vitamin d|mesh-list
19551348|NCT02805231|Vitamins|vitamins|mesh-ancestor
19551349|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
19551350|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551351|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19551352|NCT02805010|Abatacept|abatacept|mesh-list
19551353|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20108623|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108624|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
20108625|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
20108626|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
20108627|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
20108628|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108629|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120540|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19551354|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108630|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108631|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
20108632|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108633|NCT00003834|Leucovorin|leucovorin|mesh-list
20108634|NCT00003834|Fluorouracil|fluorouracil|mesh-list
20108635|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
20108636|NCT00003834|Calcium|calcium|mesh-list
20108637|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
20108638|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20108639|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108640|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
20108641|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108642|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108643|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108644|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108645|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
20604508|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604509|NCT02227797|Voriconazole|voriconazole|mesh-list
20604510|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
20604511|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551355|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604512|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20604513|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20604514|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108646|NCT00003834|Antidotes|antidotes|mesh-ancestor
20108647|NCT00003834|Protective Agents|protective agents|mesh-ancestor
20108648|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
20108649|NCT00003834|Vitamins|vitamins|mesh-ancestor
20108650|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
20108651|NCT00003835|Leucovorin|leucovorin|mesh-list
20108652|NCT00003835|Fluorouracil|fluorouracil|mesh-list
19551356|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551357|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
19551358|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551359|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551360|NCT02804815|Aspirin|aspirin|mesh-list
19551361|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19551362|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551363|NCT02804815|Analgesics|analgesics|mesh-ancestor
19551364|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
19551365|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551366|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551367|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551368|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551369|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19551370|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19551371|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551372|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19551373|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19551374|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551375|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
19551376|NCT02804841|Vitamin D|vitamin d|mesh-list
19551377|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
20108653|NCT00003835|Irinotecan|irinotecan|mesh-list
20108654|NCT00003835|Calcium|calcium|mesh-list
20108655|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
20108656|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20108657|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108658|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
20108659|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108660|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108661|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108662|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108663|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
20108664|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20108665|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108666|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108667|NCT00003835|Antidotes|antidotes|mesh-ancestor
20108668|NCT00003835|Protective Agents|protective agents|mesh-ancestor
20604515|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551378|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
19551379|NCT02804841|Vitamins|vitamins|mesh-list
19551380|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
19551381|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108669|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
20108670|NCT00003835|Vitamins|vitamins|mesh-ancestor
20108671|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
20108672|NCT00003842|Interleukin-4|interleukin-4|mesh-list
20108673|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20108674|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
20108675|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108676|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108677|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108678|NCT00003843|Irinotecan|irinotecan|mesh-list
20108679|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20108680|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108681|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551382|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19551383|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19551384|NCT02804711|Vaccines|vaccines|mesh-list
19551385|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
19551386|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551387|NCT02804776|Gefitinib|gefitinib|mesh-list
19551388|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551389|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19551390|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551391|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551392|NCT02804633|Acetaminophen|acetaminophen|mesh-list
19551393|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551394|NCT02804633|Analgesics|analgesics|mesh-ancestor
19551395|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
19551396|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551397|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551398|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
20108682|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108683|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108684|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
20108685|NCT00003846|Thiotepa|thiotepa|mesh-list
20108686|NCT00003846|Carboplatin|carboplatin|mesh-list
20108687|NCT00003846|Vincristine|vincristine|mesh-list
20108688|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108689|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
20108690|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551399|NCT02804646|Carboplatin|carboplatin|mesh-list
19551400|NCT02804646|Pemetrexed|pemetrexed|mesh-list
19551401|NCT02804646|Endostatins|endostatins|mesh-list
19551402|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551403|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551404|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551405|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19551406|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19551407|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19551408|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19551409|NCT02804646|Growth Substances|growth substances|mesh-ancestor
19551410|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551411|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
20108691|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108692|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108693|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
20108694|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576140|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
19576141|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576142|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576143|NCT05368558|Cariprazine|cariprazine|mesh-list
19576144|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19576145|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19576146|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576147|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576148|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19576149|NCT05368545|Atorvastatin|atorvastatin|mesh-list
19576150|NCT05368545|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19576151|NCT05368545|Ezetimibe|ezetimibe|mesh-list
20108695|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576152|NCT05368545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19576153|NCT05368545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19576154|NCT05368545|Antimetabolites|antimetabolites|mesh-ancestor
19576155|NCT05368545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576156|NCT05368545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19576157|NCT05368545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19576158|NCT05368545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576159|NCT05368441|Midazolam|midazolam|mesh-list
20108696|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108697|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108698|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108699|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108700|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19551412|NCT02804490|Vitamin A|vitamin a|mesh-list
19551413|NCT02804490|Beta Carotene|beta carotene|mesh-list
19551414|NCT02804490|Provitamins|provitamins|mesh-list
19551415|NCT02804490|Carotenoids|carotenoids|mesh-list
19551416|NCT02804490|Vitamins|vitamins|mesh-ancestor
19551417|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
19551418|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551419|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
19551420|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551421|NCT02804490|Protective Agents|protective agents|mesh-ancestor
19551422|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
19551423|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
19551424|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551425|NCT02804360|Dexamethasone|dexamethasone|mesh-list
19551426|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
19551427|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551428|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
19551429|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
19551430|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551431|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551432|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551433|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
19551434|NCT02804360|Hormones|hormones|mesh-ancestor
19551435|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551436|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19551437|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551438|NCT02804373|Oxytocin|oxytocin|mesh-list
19551439|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
19551440|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19551441|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551442|NCT02804165|Vaccines|vaccines|mesh-list
19551443|NCT02804165|Immunologic Factors|immunologic factors|mesh-ancestor
19551444|NCT02804165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551445|NCT02804126|Acetaminophen|acetaminophen|mesh-list
19551446|NCT02804126|Dipyrone|dipyrone|mesh-list
19551447|NCT02804126|Ketoprofen|ketoprofen|mesh-list
19551448|NCT02804126|Morphine|morphine|mesh-list
19551449|NCT02804126|Bupivacaine|bupivacaine|mesh-list
19551450|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
19551451|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
19551452|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551453|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551454|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
19551455|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551456|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19551457|NCT02804126|Narcotics|narcotics|mesh-ancestor
19551458|NCT02804126|Analgesics|analgesics|mesh-ancestor
19551459|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551460|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
19551461|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19551462|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551463|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551464|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19551465|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551466|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551467|NCT02803918|Metformin|metformin|mesh-list
19551468|NCT02803918|Lixisenatide|lixisenatide|mesh-list
19551469|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19551470|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551471|NCT02803944|Azithromycin|azithromycin|mesh-list
19551472|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551473|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551474|NCT02803892|Vildagliptin|vildagliptin|mesh-list
19551475|NCT02803892|Sirolimus|sirolimus|mesh-list
19551476|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551477|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551478|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19551479|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551480|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
19551481|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19551482|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
19551483|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551484|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20108701|NCT00003847|Doxorubicin|doxorubicin|mesh-list
19551485|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19551486|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
19551487|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551488|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551489|NCT02803788|Dexamethasone|dexamethasone|mesh-list
19551490|NCT02803788|Ondansetron|ondansetron|mesh-list
19551491|NCT02803788|Ramosetron|ramosetron|mesh-list
19551492|NCT02803788|Antiemetics|antiemetics|mesh-list
19551493|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551494|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
19551495|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551496|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551497|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551498|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
19551499|NCT02803788|Hormones|hormones|mesh-ancestor
19551500|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551501|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19551502|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551503|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
19551504|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
19551505|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19551506|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
20108702|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20108703|NCT00003847|Vincristine|vincristine|mesh-list
20108704|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108705|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108706|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108707|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108708|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108709|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108710|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108711|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108712|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108713|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108714|NCT00003849|Rituximab|rituximab|mesh-list
20108715|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20108716|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108717|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
20108718|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108719|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108720|NCT00003850|Thalidomide|thalidomide|mesh-list
20108721|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108722|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
20108723|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108724|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
20108725|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20108726|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108727|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20108728|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20108729|NCT00003850|Growth Substances|growth substances|mesh-ancestor
20108730|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
19551507|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20108731|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108732|NCT00003851|Gemcitabine|gemcitabine|mesh-list
20108733|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108734|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
20108735|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108736|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108737|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
19551508|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551509|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19551510|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19551511|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551512|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19551513|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19551514|NCT02803502|Thrombin|thrombin|mesh-list
19551515|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
19551516|NCT02803502|Coagulants|coagulants|mesh-ancestor
19551517|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
19551518|NCT02803385|Anesthetics|anesthetics|mesh-list
19551519|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
19551520|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551521|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108738|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604516|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20604517|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
19551522|NCT02803385|Narcotics|narcotics|mesh-ancestor
20108739|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120541|NCT00006372|Gemcitabine|gemcitabine|mesh-list
19551523|NCT02803385|Analgesics|analgesics|mesh-ancestor
20108740|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108741|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
20108742|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108743|NCT00003852|Paclitaxel|paclitaxel|mesh-list
19551524|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
19551525|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551526|NCT02803216|Amoxicillin|amoxicillin|mesh-list
19551527|NCT02803216|Clarithromycin|clarithromycin|mesh-list
19551528|NCT02803216|Omeprazole|omeprazole|mesh-list
19551529|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551530|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551531|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19551532|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551533|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19551534|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551535|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551536|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19551537|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19551538|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19551539|NCT02802995|Thrombin|thrombin|mesh-list
19551540|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
19551541|NCT02802995|Coagulants|coagulants|mesh-ancestor
19551542|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
19551543|NCT02803073|Testosterone|testosterone|mesh-list
19551544|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
19551545|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
19551546|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19551547|NCT02803073|Androgens|androgens|mesh-ancestor
20108744|NCT00003852|Etoposide|etoposide|mesh-list
20108745|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
20108746|NCT00003852|Carboplatin|carboplatin|mesh-list
20108747|NCT00003852|Epirubicin|epirubicin|mesh-list
20108748|NCT00003852|Ifosfamide|ifosfamide|mesh-list
20108749|NCT00003852|Thiotepa|thiotepa|mesh-list
20108750|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108751|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108752|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
19551548|NCT02803073|Hormones|hormones|mesh-ancestor
19551549|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551550|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551551|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19551552|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551553|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
19551554|NCT02802943|Imiquimod|imiquimod|mesh-list
19551555|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19551556|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
19551557|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551558|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551559|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
19576160|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19576161|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576162|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576163|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108753|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108754|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108755|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108756|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108757|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
20108758|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108759|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108760|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108761|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
20108762|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19576164|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19576165|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19576166|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19576167|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576168|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
19576169|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
19576170|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
19576171|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
19576172|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20108763|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19576173|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576174|NCT05368415|Norepinephrine|norepinephrine|mesh-list
20108764|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108765|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551560|NCT02802748|Letrozole|letrozole|mesh-list
19551561|NCT02802748|Vinorelbine|vinorelbine|mesh-list
19551562|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551563|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19551564|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19551565|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551566|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551567|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19551568|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
19551569|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108766|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108767|NCT00003853|Esorubicin|esorubicin|mesh-list
20108768|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20108769|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108770|NCT00003856|Temoporfin|temoporfin|mesh-list
20108771|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108772|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20108773|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108774|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
20108775|NCT00003858|Analgesics|analgesics|mesh-ancestor
20108776|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
19551570|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551571|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19551572|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
19551573|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
19551574|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
19551575|NCT02802631|Minocycline|minocycline|mesh-list
19551576|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551577|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551578|NCT02802722|Vitamin D|vitamin d|mesh-list
19551579|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
19551580|NCT02802722|Vitamins|vitamins|mesh-ancestor
19551581|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
19551582|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551583|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19551584|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19551585|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19551586|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19551587|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551588|NCT02802644|Incretins|incretins|mesh-ancestor
19551589|NCT02802644|Hormones|hormones|mesh-ancestor
19551590|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551591|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19551592|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
19551593|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551594|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551595|NCT02802683|Phenylephrine|phenylephrine|mesh-list
19551596|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
19551597|NCT02802683|Bupivacaine|bupivacaine|mesh-list
19551598|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
19551599|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
19551600|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
19551601|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551602|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551603|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
19551604|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551605|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19551606|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
20108777|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20108778|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108779|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551607|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
19551608|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
19551609|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19551610|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
19551611|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
19551612|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19551613|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20108780|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108781|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108782|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108783|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551614|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19551615|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
19551616|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20108784|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
19551617|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551618|NCT02802683|Protective Agents|protective agents|mesh-ancestor
19551619|NCT02802696|Furosemide|furosemide|mesh-list
20108785|NCT00003859|Carboplatin|carboplatin|mesh-list
20108786|NCT00003859|Etoposide|etoposide|mesh-list
20108787|NCT00003859|Vincristine|vincristine|mesh-list
20108788|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108789|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
20108790|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108791|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551620|NCT02802696|Diuretics|diuretics|mesh-ancestor
19551621|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
19551622|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551623|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19551624|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19551625|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551626|NCT02802605|Bemiparin|bemiparin|mesh-list
19551627|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
19551628|NCT02802540|Nabilone|nabilone|mesh-list
19551629|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
19551630|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
19551631|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551632|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551633|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551634|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19551635|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19551636|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551637|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19551638|NCT02802215|Folic Acid|folic acid|mesh-list
19551639|NCT02802215|Metformin|metformin|mesh-list
19551640|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19551641|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551642|NCT02802215|Hematinics|hematinics|mesh-ancestor
19551643|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
19551644|NCT02802215|Vitamins|vitamins|mesh-ancestor
19551645|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
19551646|NCT02802163|Dexamethasone|dexamethasone|mesh-list
19551647|NCT02802163|Lenalidomide|lenalidomide|mesh-list
19551648|NCT02802163|Panobinostat|panobinostat|mesh-list
19551649|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551650|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
19551651|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
19551652|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551653|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551654|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551655|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
19551656|NCT02802163|Hormones|hormones|mesh-ancestor
19551657|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551658|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19551659|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551660|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
19551661|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19551662|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19551663|NCT02802163|Growth Substances|growth substances|mesh-ancestor
19551664|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
19551665|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19551666|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551667|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551668|NCT02802072|Aspirin|aspirin|mesh-list
19551669|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19551670|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551671|NCT02802072|Analgesics|analgesics|mesh-ancestor
19551672|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
19551673|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551674|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551675|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551676|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551677|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19551678|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19551679|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108792|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108793|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
20108794|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108795|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551680|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19551681|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20108796|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108797|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108798|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108799|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108800|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108801|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108802|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108803|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
19551682|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551683|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
19551684|NCT02802137|Timolol|timolol|mesh-list
19551685|NCT02802137|Dorzolamide|dorzolamide|mesh-list
19551686|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19551687|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19551688|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
19551689|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551690|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551691|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551692|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19551693|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19551694|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19551695|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551696|NCT02801799|Ropivacaine|ropivacaine|mesh-list
19551697|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
19551698|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
19551699|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551700|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108804|NCT00003860|Carboplatin|carboplatin|mesh-list
20108805|NCT00003860|Etoposide|etoposide|mesh-list
20108806|NCT00003860|Ifosfamide|ifosfamide|mesh-list
20108807|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108808|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108809|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20108810|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20108811|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108812|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108813|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108814|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
20108815|NCT00003862|Leucovorin|leucovorin|mesh-list
20108816|NCT00003862|Paclitaxel|paclitaxel|mesh-list
20108817|NCT00003862|Fluorouracil|fluorouracil|mesh-list
19551701|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
19551702|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551703|NCT02801786|Tamoxifen|tamoxifen|mesh-list
19551704|NCT02801786|Lidocaine|lidocaine|mesh-list
19551705|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
19551706|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
19551707|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551708|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551709|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
19551710|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551711|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19551712|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19551713|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19551714|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19551715|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551716|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19551717|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
19551718|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19551719|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19551720|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551721|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19551722|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19551723|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19551724|NCT02801838|Morphine|morphine|mesh-list
19551725|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19551726|NCT02801838|Narcotics|narcotics|mesh-ancestor
19551727|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551728|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551729|NCT02801838|Analgesics|analgesics|mesh-ancestor
19551730|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
20108818|NCT00003862|Calcium|calcium|mesh-list
20108819|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
20108820|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108821|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551731|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551732|NCT02802098|Bevacizumab|bevacizumab|mesh-list
19551733|NCT02802098|Durvalumab|durvalumab|mesh-list
19551734|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19551735|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108822|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108823|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108824|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108825|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108826|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20108827|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108828|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
20108829|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108830|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108831|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
20108832|NCT00003862|Antidotes|antidotes|mesh-ancestor
20108833|NCT00003862|Protective Agents|protective agents|mesh-ancestor
20108834|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
20108835|NCT00003862|Vitamins|vitamins|mesh-ancestor
20108836|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
20108837|NCT00003864|Carboplatin|carboplatin|mesh-list
20108838|NCT00003864|Docetaxel|docetaxel|mesh-list
20108839|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108840|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108841|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108842|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108843|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108844|NCT00003865|Toremifene|toremifene|mesh-list
20108845|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20108846|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108847|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20108848|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20108849|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
20108850|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108851|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108852|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20108853|NCT00003867|Capecitabine|capecitabine|mesh-list
20108854|NCT00003867|Irinotecan|irinotecan|mesh-list
20108855|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108856|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
20108857|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108858|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108859|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20108860|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19551736|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19551737|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19551738|NCT02802098|Growth Substances|growth substances|mesh-ancestor
19551739|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551740|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
19551741|NCT02801487|Cisplatin|cisplatin|mesh-list
19551742|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551743|NCT02801526|Amlodipine|amlodipine|mesh-list
19551744|NCT02801526|Candesartan|candesartan|mesh-list
19551745|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20108861|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108862|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
19551746|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19551747|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19551748|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551749|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19551750|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551751|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
19551752|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19551753|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19551754|NCT02801357|Lofexidine|lofexidine|mesh-list
19551755|NCT02801357|Buprenorphine|buprenorphine|mesh-list
19551756|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19551757|NCT02801357|Narcotics|narcotics|mesh-ancestor
19551758|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551759|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551760|NCT02801357|Analgesics|analgesics|mesh-ancestor
19551761|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
19551762|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20108863|NCT00003868|Methotrexate|methotrexate|mesh-list
20108864|NCT00003868|Antibodies|antibodies|mesh-list
19551763|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19551764|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19551765|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19551766|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19551767|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19551768|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
19551769|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551770|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551771|NCT02801383|Interferons|interferons|mesh-list
20108865|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20108866|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108867|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
20108868|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108869|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108870|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108871|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
20108872|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108873|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108874|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108875|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20108876|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
20108877|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19551772|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551773|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
19551774|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551775|NCT02801409|Anesthetics|anesthetics|mesh-list
19551776|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551777|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551778|NCT02801292|Ketamine|ketamine|mesh-list
19551779|NCT02801292|Analgesics|analgesics|mesh-ancestor
19551780|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
19551781|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551782|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551783|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19551784|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19551785|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
19551786|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
19551787|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551788|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19551789|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19551790|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551791|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551792|NCT02801305|Diltiazem|diltiazem|mesh-list
19551793|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
19551794|NCT02801305|Petrolatum|petrolatum|mesh-list
19551795|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
19551796|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19551797|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19551798|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19551799|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551800|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19551801|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551802|NCT02801305|Emollients|emollients|mesh-ancestor
19551803|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
19576175|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19576176|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576177|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576178|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576179|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576180|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108878|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108879|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
20108880|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108881|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108882|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20108883|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20108884|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
20108885|NCT00003870|Methotrexate|methotrexate|mesh-list
20108886|NCT00003870|Antibodies|antibodies|mesh-list
20108887|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20108888|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607945|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19576181|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
19576182|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
20108889|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
20108890|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108891|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108892|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108893|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
20108894|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108895|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108896|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108897|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20108898|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
20108899|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20108900|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108901|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
20108902|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
20108903|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108904|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20108905|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20108906|NCT00003871|Vaccines|vaccines|mesh-list
20108907|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
19551804|NCT02801227|Oxytocin|oxytocin|mesh-list
19551805|NCT02801227|Dinoprostone|dinoprostone|mesh-list
19551806|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
19551807|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19551808|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551809|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
19551810|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19551811|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551812|NCT02801201|Midazolam|midazolam|mesh-list
19551813|NCT02801201|Bupivacaine|bupivacaine|mesh-list
19551814|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
19551815|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
19551816|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551817|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551818|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
19551819|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551820|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19551821|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20108908|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108909|NCT00003873|Fluorouracil|fluorouracil|mesh-list
20108910|NCT00003873|Eniluracil|eniluracil|mesh-list
20108911|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
20108912|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108913|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20108914|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108915|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108916|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
20108917|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108918|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20108919|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20108920|NCT00003874|Antibodies|antibodies|mesh-list
20108921|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
19551822|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19551823|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19551824|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19551825|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19551826|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
19551827|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
19551828|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
19551829|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551830|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551831|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
20108922|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20108923|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
20108924|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108925|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551832|NCT02801188|Bupivacaine|bupivacaine|mesh-list
19551833|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
19551834|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
19551835|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551836|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551837|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
20108926|NCT00003876|Carmustine|carmustine|mesh-list
20108927|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108928|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
19551838|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551839|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19551840|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551841|NCT02801188|Analgesics|analgesics|mesh-ancestor
19551842|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19551843|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19551844|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19551845|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
19551846|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551847|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551848|NCT02800902|Atorvastatin|atorvastatin|mesh-list
19551849|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19551850|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19551851|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19551852|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
19551853|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551854|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20108929|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108930|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108931|NCT00003877|Paclitaxel|paclitaxel|mesh-list
20108932|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
20108933|NCT00003877|Carboplatin|carboplatin|mesh-list
20108934|NCT00003877|Thiotepa|thiotepa|mesh-list
20108935|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108936|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108937|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108938|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
19551855|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19551856|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551857|NCT02801032|Tadalafil|tadalafil|mesh-list
19551858|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
19551859|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19551860|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19551861|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551862|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551863|NCT02801032|Urological Agents|urological agents|mesh-ancestor
19551864|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
19551865|NCT02800785|Metronidazole|metronidazole|mesh-list
19551866|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
19551867|NCT02800785|Levofloxacin|levofloxacin|mesh-list
19551868|NCT02800785|Cefazolin|cefazolin|mesh-list
19551869|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
19551870|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
19551871|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
19551872|NCT02800785|Ertapenem|ertapenem|mesh-list
19551873|NCT02800785|Cefuroxime|cefuroxime|mesh-list
19551874|NCT02800785|Tigecycline|tigecycline|mesh-list
19551875|NCT02800785|Cefotaxime|cefotaxime|mesh-list
19551876|NCT02800785|Cefoxitin|cefoxitin|mesh-list
19551877|NCT02800785|Ticarcillin|ticarcillin|mesh-list
19551878|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
19551879|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551880|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551881|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19551882|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19551883|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551884|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551885|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108939|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108940|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108941|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20108942|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
20108943|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108944|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20108945|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108946|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
20108947|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20108948|NCT00003878|Carmustine|carmustine|mesh-list
20108949|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20108950|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
20108951|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108952|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108953|NCT00003880|Paclitaxel|paclitaxel|mesh-list
20108954|NCT00003880|Carboplatin|carboplatin|mesh-list
19551886|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19551887|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19551888|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20108955|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120542|NCT00006372|Doxorubicin|doxorubicin|mesh-list
19551889|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19551890|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19551891|NCT02800785|Renal Agents|renal agents|mesh-ancestor
19551892|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19551893|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19551894|NCT02800889|Pixantrone|pixantrone|mesh-list
19551895|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19551896|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19551897|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551898|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551899|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551900|NCT02800447|Procarbazine|procarbazine|mesh-list
19551901|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551902|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
19551903|NCT02800408|Provitamins|provitamins|mesh-ancestor
19551904|NCT02800408|Vitamins|vitamins|mesh-ancestor
19551905|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
19551906|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551907|NCT02800772|Acetic Acid|acetic acid|mesh-list
19551908|NCT02800772|Retinol acetate|retinol acetate|mesh-list
19551909|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19551910|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19551911|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19551912|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
19551913|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551914|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19551915|NCT02800772|Protective Agents|protective agents|mesh-ancestor
19551916|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551917|NCT02800590|Abp-700|abp-700|mesh-list
19551918|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19551919|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
19551920|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
19551921|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551922|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108956|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108957|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108958|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
20108959|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108960|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108961|NCT00003881|Paclitaxel|paclitaxel|mesh-list
20108962|NCT00003881|Carboplatin|carboplatin|mesh-list
20108963|NCT00003881|Trastuzumab|trastuzumab|mesh-list
20108964|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20108965|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108966|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108967|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19551923|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551924|NCT02800694|Fentanyl|fentanyl|mesh-list
19551925|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19551926|NCT02800694|Narcotics|narcotics|mesh-ancestor
20108968|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108969|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108970|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19551927|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19551928|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551929|NCT02800694|Analgesics|analgesics|mesh-ancestor
19551930|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
19551931|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551932|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19551933|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19551934|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
19551935|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
19551936|NCT02800486|Cetuximab|cetuximab|mesh-list
19551937|NCT02800486|Mannitol|mannitol|mesh-list
19551938|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19551939|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551940|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19551941|NCT02800486|Diuretics|diuretics|mesh-ancestor
19551942|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
20108971|NCT00003883|Itraconazole|itraconazole|mesh-list
20108972|NCT00003883|Fluconazole|fluconazole|mesh-list
20108973|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
20108974|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20108975|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19551943|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551944|NCT02800252|Aspirin|aspirin|mesh-list
20120543|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19551945|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19551946|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551947|NCT02800252|Analgesics|analgesics|mesh-ancestor
19551948|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
19551949|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551950|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551951|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551952|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551953|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19551954|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19551955|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551956|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19551957|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19551958|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551959|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
19551960|NCT02800174|Aspirin|aspirin|mesh-list
20108976|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20108977|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551961|NCT02800174|Clopidogrel|clopidogrel|mesh-list
19551962|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19551963|NCT02800174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19551964|NCT02800174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19551965|NCT02800174|Analgesics|analgesics|mesh-ancestor
19551966|NCT02800174|Sensory System Agents|sensory system agents|mesh-ancestor
19551967|NCT02800174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19551968|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551969|NCT02800174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19551970|NCT02800174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19551971|NCT02800174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20108978|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108979|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20108980|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
20108981|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20108982|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108983|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20108984|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20108985|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20108986|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
20108987|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20108988|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20108989|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
20108990|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108991|NCT00003888|Docetaxel|docetaxel|mesh-list
20108992|NCT00003888|Fluorouracil|fluorouracil|mesh-list
20108993|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20108994|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
20108995|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
19551972|NCT02800174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19551973|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108996|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
20108997|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20108998|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
20108999|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109000|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109001|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
20109002|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109003|NCT00003891|Lurtotecan|lurtotecan|mesh-list
20109004|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109005|NCT00003892|ISIS 5132|isis 5132|mesh-list
20109006|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109007|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109008|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109009|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
20109010|NCT00003893|Doxorubicin|doxorubicin|mesh-list
20109011|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109012|NCT00003893|Fluorouracil|fluorouracil|mesh-list
20109013|NCT00003893|Methotrexate|methotrexate|mesh-list
20109014|NCT00003893|Epirubicin|epirubicin|mesh-list
20109015|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
20109016|NCT00003893|Mitomycins|mitomycins|mesh-list
20109017|NCT00003893|Mitomycin|mitomycin|mesh-list
20109018|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109019|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
20109020|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551974|NCT02800174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19551975|NCT02800174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551976|NCT02800174|Antipyretics|antipyretics|mesh-ancestor
19551977|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19551978|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19551979|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19551980|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
19551981|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19551982|NCT02800330|Esomeprazole|esomeprazole|mesh-list
19551983|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19551984|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19551985|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19551986|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19551987|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551988|NCT02799862|Paclitaxel|paclitaxel|mesh-list
19551989|NCT02799862|Carboplatin|carboplatin|mesh-list
19551990|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19551991|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19551992|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
19551993|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
19551994|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
19551995|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19551996|NCT02799927|Calcium|calcium|mesh-list
19551997|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19551998|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19551999|NCT02799888|Cyclosporine|cyclosporine|mesh-list
19552000|NCT02799888|Maraviroc|maraviroc|mesh-list
19552001|NCT02799888|Methotrexate|methotrexate|mesh-list
19552002|NCT02799888|Tacrolimus|tacrolimus|mesh-list
19552003|NCT02799888|Cyclosporins|cyclosporins|mesh-list
19552004|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19552005|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
19552006|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19552007|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552008|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109021|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109022|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109023|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
20109024|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109025|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552009|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
19552010|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552011|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552012|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552013|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552014|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20109026|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109027|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19552015|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552016|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
19552017|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552018|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19552019|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19552020|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
19552021|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552022|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19552023|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19552024|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19552025|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19552026|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
19552027|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19552028|NCT02800135|Furosemide|furosemide|mesh-list
19552029|NCT02800135|Diuretics|diuretics|mesh-ancestor
20109028|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109029|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109030|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109031|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
20109032|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109033|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20109034|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
20109035|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20109036|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109037|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19552030|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
19552031|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109038|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20109039|NCT00003893|Analgesics|analgesics|mesh-ancestor
20109040|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
20109041|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109042|NCT00003894|Thalidomide|thalidomide|mesh-list
20109043|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109044|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
20109045|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109046|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
20109047|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20109048|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109049|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20109050|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20604518|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604519|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604520|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20604521|NCT02227823|Bromides|bromides|mesh-list
20604522|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20604523|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
20604524|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20604525|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604526|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604527|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
20604528|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604529|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604530|NCT02227901|Temozolomide|temozolomide|mesh-list
20604531|NCT02227901|Tipifarnib|tipifarnib|mesh-list
20604532|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20604533|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
20604534|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604535|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604536|NCT02227914|Sorafenib|sorafenib|mesh-list
20604537|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604538|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20109051|NCT00003894|Growth Substances|growth substances|mesh-ancestor
20109052|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
20109053|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552032|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19552033|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19552034|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552035|NCT02799901|Nivolumab|nivolumab|mesh-list
19552036|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19552037|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552038|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19552039|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552040|NCT02800265|Sulforaphane|sulforaphane|mesh-list
19552041|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20109054|NCT00003897|Sargramostim|sargramostim|mesh-list
20109055|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
20109056|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109057|NCT00003899|Paclitaxel|paclitaxel|mesh-list
20109058|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
20109059|NCT00003899|Melphalan|melphalan|mesh-list
19552042|NCT02800265|Protective Agents|protective agents|mesh-ancestor
19552043|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552044|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552045|NCT02799797|Sufentanil|sufentanil|mesh-list
19552046|NCT02799797|Dsuvia|dsuvia|mesh-list
19552047|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19552048|NCT02799797|Narcotics|narcotics|mesh-ancestor
19552049|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552050|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552051|NCT02799797|Analgesics|analgesics|mesh-ancestor
19552052|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
19552053|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552054|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19552055|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19552056|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
19552057|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
19552058|NCT02799615|Infliximab|infliximab|mesh-list
19552059|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109060|NCT00003899|Thiotepa|thiotepa|mesh-list
20109061|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109062|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109063|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552060|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19552061|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576183|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576184|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19576185|NCT05368376|Metoprolol|metoprolol|mesh-list
19576186|NCT05368376|Labetalol|labetalol|mesh-list
19576187|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19576188|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19576189|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
19576190|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
19576191|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576192|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576193|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19576194|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19576195|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19576196|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576197|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576198|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576199|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
19576200|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19576201|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20109064|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109065|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109066|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109067|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109068|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
20109069|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109070|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576202|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
19576203|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576204|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576205|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
19576206|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19576207|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19576208|NCT05368181|Prednisolone|prednisolone|mesh-list
19576209|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
19576210|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19576211|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
19576212|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576213|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
19576214|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
19576215|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576216|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576217|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576218|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
19576219|NCT05368181|Hormones|hormones|mesh-ancestor
19576220|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576221|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19576222|NCT05368181|Protective Agents|protective agents|mesh-ancestor
19576223|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576224|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576225|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
19576226|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19576227|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
19576228|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576229|NCT05368090|Epinephrine|epinephrine|mesh-list
19576230|NCT05368090|Racepinephrine|racepinephrine|mesh-list
19576231|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
19576232|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19576233|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576234|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576235|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576236|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576237|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576238|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19576239|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19576240|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
19576241|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576242|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19576243|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
19576244|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
19576245|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
19576246|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19576247|NCT05368051|Capecitabine|capecitabine|mesh-list
19576248|NCT05368051|Antibodies|antibodies|mesh-list
19576249|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19552062|NCT02799758|Pitavastatin|pitavastatin|mesh-list
19552063|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19552064|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19552065|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19552066|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
19552067|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552068|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552069|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20109071|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109072|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
19552070|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
19552071|NCT02799589|Remifentanil|remifentanil|mesh-list
19552072|NCT02799589|Ropivacaine|ropivacaine|mesh-list
19552073|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19552074|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552075|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552076|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19552077|NCT02799589|Analgesics|analgesics|mesh-ancestor
19552078|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
19552079|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552080|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19552081|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19552082|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19552083|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
19552084|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552085|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552086|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
19552087|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
19552088|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19552089|NCT02799589|Narcotics|narcotics|mesh-ancestor
19552090|NCT02799459|Anesthetics|anesthetics|mesh-list
19552091|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552092|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552093|NCT02799446|Reslizumab|reslizumab|mesh-list
19552094|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19552095|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
19552096|NCT02799355|Interferons|interferons|mesh-list
19552097|NCT02799355|Ribavirin|ribavirin|mesh-list
19552098|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
19552099|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552100|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
19552101|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109073|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109074|NCT00003900|Docetaxel|docetaxel|mesh-list
20109075|NCT00003900|Irinotecan|irinotecan|mesh-list
20109076|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109077|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109078|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109079|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109080|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109081|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109082|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109083|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109084|NCT00003902|Capecitabine|capecitabine|mesh-list
19552102|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
19552103|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552104|NCT02799498|Etanercept|etanercept|mesh-list
19552105|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19552106|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19552107|NCT02799498|Analgesics|analgesics|mesh-ancestor
19552108|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
19552109|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552110|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552111|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552112|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552113|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19552114|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552115|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
20109085|NCT00003902|Vinorelbine|vinorelbine|mesh-list
20109086|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109087|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
20109088|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109089|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109090|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19552116|NCT02799316|Antibodies|antibodies|mesh-list
19552117|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
20109091|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109092|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552118|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552119|NCT02799238|Temozolomide|temozolomide|mesh-list
19552120|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552121|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
19552122|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552123|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552124|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19552125|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19552126|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552127|NCT02799277|Testosterone|testosterone|mesh-list
19552128|NCT02799277|Androgens|androgens|mesh-ancestor
19552129|NCT02799277|Hormones|hormones|mesh-ancestor
19552130|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552131|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552132|NCT02799147|Fludarabine|fludarabine|mesh-list
19552133|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
19552134|NCT02799147|Busulfan|busulfan|mesh-list
19552135|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19552136|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552137|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552138|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
19552139|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552140|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552141|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
19552142|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552143|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
19552144|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552145|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19552146|NCT02798913|Clopidogrel|clopidogrel|mesh-list
19552147|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19552148|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19552149|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19552150|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19552151|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
19552152|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552153|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552154|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552155|NCT02798874|Clopidogrel|clopidogrel|mesh-list
19552156|NCT02798874|Ticagrelor|ticagrelor|mesh-list
19552157|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19552158|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19552159|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19552160|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19552161|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
19552162|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552163|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552164|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552165|NCT02799264|Cabotegravir|cabotegravir|mesh-list
19552166|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19552167|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19552168|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552169|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552170|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19552171|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20109093|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120544|NCT00006372|Vinorelbine|vinorelbine|mesh-list
20120545|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552172|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
19552173|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552174|NCT02798653|Progesterone|progesterone|mesh-list
19552175|NCT02798653|Progestins|progestins|mesh-ancestor
19552176|NCT02798653|Hormones|hormones|mesh-ancestor
19552177|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120546|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
20120547|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120548|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120549|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
20120550|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120551|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120552|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120553|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
20120554|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109094|NCT00003906|Tamoxifen|tamoxifen|mesh-list
20109095|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20109096|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20109097|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
20109098|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109099|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109100|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20109101|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109102|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20109103|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20109104|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20109105|NCT00003908|Carboplatin|carboplatin|mesh-list
20109106|NCT00003908|Docetaxel|docetaxel|mesh-list
20109107|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109108|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109109|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109110|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109111|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109112|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
20109113|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109114|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20109115|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109116|NCT00003912|Carboplatin|carboplatin|mesh-list
20109117|NCT00003912|Doxorubicin|doxorubicin|mesh-list
20109118|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109119|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109120|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109121|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109122|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109123|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109124|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109125|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
20109126|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
20109127|NCT00003913|Busulfan|busulfan|mesh-list
20109128|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20109129|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109130|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
20109131|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109132|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109133|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109134|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
19552178|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552179|NCT02798744|Empagliflozin|empagliflozin|mesh-list
19552180|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19552181|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552182|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20109135|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552183|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552184|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
19552185|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19552186|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552187|NCT02798510|Gemcitabine|gemcitabine|mesh-list
19552188|NCT02798510|Capecitabine|capecitabine|mesh-list
19552189|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552190|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
19552191|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109136|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109137|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109138|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552192|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552193|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
19552194|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552195|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552196|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109139|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
20109140|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
19552197|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
19552198|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552199|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
19552200|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19576250|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
20109141|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109142|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20109143|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
20109144|NCT00003913|Hormones|hormones|mesh-ancestor
19552201|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552202|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552203|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552204|NCT02798367|Melatonin|melatonin|mesh-list
19552205|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
20109145|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109146|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20109147|NCT00003913|Protective Agents|protective agents|mesh-ancestor
20109148|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
20109149|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109150|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109151|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552206|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552207|NCT02798367|Protective Agents|protective agents|mesh-ancestor
19552208|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552209|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552210|NCT02798250|Insulin|insulin|mesh-list
19552211|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19552212|NCT02798250|Glucagon|glucagon|mesh-list
19552213|NCT02798250|Hormones|hormones|mesh-list
19552214|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552215|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552216|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552217|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19552218|NCT02798055|Bosentan|bosentan|mesh-list
19552219|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19552220|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19552221|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109152|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109153|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109154|NCT00003917|Topotecan|topotecan|mesh-list
20109155|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19552222|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
19552223|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552224|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
19552225|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19552226|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19552227|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552228|NCT02798159|Urological Agents|urological agents|mesh-ancestor
20109156|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109157|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109158|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552229|NCT02798172|Metformin|metformin|mesh-list
19552230|NCT02798172|Alogliptin|alogliptin|mesh-list
19552231|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552232|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552233|NCT02798172|Incretins|incretins|mesh-ancestor
19552234|NCT02798172|Hormones|hormones|mesh-ancestor
19552235|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552236|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19552237|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
19552238|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552239|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552240|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
19552241|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19552242|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19552243|NCT02798068|Prednisolone|prednisolone|mesh-list
19552244|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
19552245|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19552246|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
19552247|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552248|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
19552249|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
19552250|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552251|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552252|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19552253|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
19552254|NCT02798068|Hormones|hormones|mesh-ancestor
19552255|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552256|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19552257|NCT02798068|Protective Agents|protective agents|mesh-ancestor
19552258|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20109159|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109160|NCT00003920|Cyclosporine|cyclosporine|mesh-list
19552259|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576251|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576252|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19576253|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
19576254|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576255|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576256|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
19576257|NCT05367765|HH-GV-678|hh-gv-678|mesh-list
19576258|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576259|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19576260|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576261|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576262|NCT05367687|Apatinib|apatinib|mesh-list
19576263|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576264|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19576265|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576266|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576267|NCT05367492|Varenicline|varenicline|mesh-list
19576268|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19576269|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19576270|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
19576271|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576272|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576273|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576274|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19576275|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576276|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
19576277|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576278|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19576279|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109161|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20109162|NCT00003920|Antibodies|antibodies|mesh-list
20109163|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
20109164|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20109165|NCT00003920|Cyclosporins|cyclosporins|mesh-list
20109166|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
20109167|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109168|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109169|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109170|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109171|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109172|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
20109173|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109174|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109175|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109176|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20109177|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20109178|NCT00003923|Trioxsalen|trioxsalen|mesh-list
20109179|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109180|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109181|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20109182|NCT00003924|Interferons|interferons|mesh-list
20109183|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
20109184|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109185|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
20109186|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109187|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
20109188|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604539|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604540|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604541|NCT02227940|Gemcitabine|gemcitabine|mesh-list
20604542|NCT02227940|Paclitaxel|paclitaxel|mesh-list
20604543|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20604544|NCT02227940|Cisplatin|cisplatin|mesh-list
20604545|NCT02227940|Ceritinib|ceritinib|mesh-list
20604546|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604547|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604548|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604549|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
19576280|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576281|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
20109189|NCT00003925|Leucovorin|leucovorin|mesh-list
20109190|NCT00003925|Gemcitabine|gemcitabine|mesh-list
20109191|NCT00003925|Tegafur|tegafur|mesh-list
20109192|NCT00003925|Calcium|calcium|mesh-list
20604550|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
20607946|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
19552260|NCT02797704|Aflibercept|aflibercept|mesh-list
19552261|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19552262|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19552263|NCT02797704|Growth Substances|growth substances|mesh-ancestor
19552264|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552265|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
19552266|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552267|NCT02797717|Prednisone|prednisone|mesh-list
19552268|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
19552269|NCT02797717|Dacarbazine|dacarbazine|mesh-list
19552270|NCT02797717|Doxorubicin|doxorubicin|mesh-list
19552271|NCT02797717|Etoposide|etoposide|mesh-list
19552272|NCT02797717|Vincristine|vincristine|mesh-list
19552273|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552274|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
20109193|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
19552275|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109194|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109195|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
20109196|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109197|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109198|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
20109199|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109200|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109201|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109202|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
20109203|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109204|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20109205|NCT00003925|Antidotes|antidotes|mesh-ancestor
20109206|NCT00003925|Protective Agents|protective agents|mesh-ancestor
19552276|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552277|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552278|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
19552279|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552280|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552281|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19552282|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109207|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
20109208|NCT00003925|Vitamins|vitamins|mesh-ancestor
20109209|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
20109210|NCT00003926|Melphalan|melphalan|mesh-list
20109211|NCT00003926|Busulfan|busulfan|mesh-list
20109212|NCT00003926|Thiotepa|thiotepa|mesh-list
20109213|NCT00003926|Lenograstim|lenograstim|mesh-list
20109214|NCT00003926|Sargramostim|sargramostim|mesh-list
19552283|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19552284|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19552285|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552286|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552287|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
19552288|NCT02797717|Hormones|hormones|mesh-ancestor
19552289|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552290|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19552291|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19552292|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552293|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552294|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552295|NCT02797860|Rocuronium|rocuronium|mesh-list
19552296|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20109215|NCT00003926|Amifostine|amifostine|mesh-list
20109216|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20109217|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
20109218|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109219|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109220|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
20109221|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109222|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109223|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109224|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109225|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20109226|NCT00003926|Protective Agents|protective agents|mesh-ancestor
20109227|NCT00003928|Gemcitabine|gemcitabine|mesh-list
20109228|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109229|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552297|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19552298|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20109230|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
19552299|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552300|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552301|NCT02797782|Antibodies|antibodies|mesh-list
19552302|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
19552303|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552304|NCT02797977|Gemcitabine|gemcitabine|mesh-list
19552305|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552306|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552307|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
19552308|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552309|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
19552310|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552311|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552312|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552313|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
19552314|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552315|NCT02797587|Nicotine|nicotine|mesh-list
19552316|NCT02797587|Varenicline|varenicline|mesh-list
19552317|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19552318|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
19552319|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552320|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552321|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19552322|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19552323|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
19552324|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552325|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109231|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109232|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
20109233|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109234|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109235|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109236|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
20109237|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109238|NCT00003929|Lomustine|lomustine|mesh-list
20109239|NCT00003929|Procarbazine|procarbazine|mesh-list
20109240|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109241|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
20109242|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109243|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109244|NCT00003930|Gemcitabine|gemcitabine|mesh-list
20109245|NCT00003930|Paclitaxel|paclitaxel|mesh-list
20109246|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109247|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109248|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109249|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109250|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
20607947|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19552326|NCT02797548|Aspirin|aspirin|mesh-list
19552327|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19552328|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19552329|NCT02797548|Analgesics|analgesics|mesh-ancestor
19552330|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
19552331|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552332|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109251|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109252|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109253|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
19552333|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552334|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552335|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19552336|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19552337|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552338|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20109254|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
20109255|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109256|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109257|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109258|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
20109259|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109260|NCT00003934|Cytarabine|cytarabine|mesh-list
19552339|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19552340|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109261|NCT00003934|Methotrexate|methotrexate|mesh-list
20109262|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
19552341|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
19552342|NCT02797470|Cytarabine|cytarabine|mesh-list
19552343|NCT02797470|Etoposide|etoposide|mesh-list
19552344|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
19552345|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
19552346|NCT02797470|Melphalan|melphalan|mesh-list
19552347|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
19552348|NCT02797470|Carmustine|carmustine|mesh-list
20109263|NCT00003934|Daunorubicin|daunorubicin|mesh-list
20109264|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
20109265|NCT00003934|Tretinoin|tretinoin|mesh-list
20109266|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20109267|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
20109268|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20109269|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109270|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109271|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
20109272|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109273|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109274|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109275|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109276|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20109277|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109278|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
20109279|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109280|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20109281|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
20109282|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109283|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109284|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109285|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109286|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
20109287|NCT00003935|Etoposide|etoposide|mesh-list
20109288|NCT00003935|Vincristine|vincristine|mesh-list
20109289|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109290|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552349|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19552350|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19552351|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552352|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19552353|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19552354|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552355|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552356|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552357|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
19552358|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
19552359|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552360|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552361|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
19552362|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552363|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552364|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
19552365|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19552366|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
19552367|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552368|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552369|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552370|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552371|NCT02797236|Vaccines|vaccines|mesh-list
19552372|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
19552373|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552374|NCT02797249|Aspirin|aspirin|mesh-list
19552375|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
19552376|NCT02797249|Salicylates|salicylates|mesh-list
19552377|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19552378|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19552379|NCT02797249|Analgesics|analgesics|mesh-ancestor
19552380|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
19552381|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552382|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552383|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552384|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552385|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19552386|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19552387|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109291|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19552388|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19552389|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19552390|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552391|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
19552392|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552393|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
19552394|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
19552395|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552396|NCT02797340|Metformin|metformin|mesh-list
19552397|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552398|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552399|NCT02797145|Digoxin|digoxin|mesh-list
19552400|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19552401|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19552402|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552403|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552404|NCT02797145|Protective Agents|protective agents|mesh-ancestor
19552405|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109292|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109293|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109294|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604551|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604552|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552406|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
20109295|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109296|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109297|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109298|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
20109299|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20109300|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
20109301|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109302|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109303|NCT00003937|Cisplatin|cisplatin|mesh-list
20109304|NCT00003937|Doxorubicin|doxorubicin|mesh-list
20109305|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109306|NCT00003937|Methotrexate|methotrexate|mesh-list
20109307|NCT00003937|Etoposide|etoposide|mesh-list
20109308|NCT00003937|Ifosfamide|ifosfamide|mesh-list
20109309|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
20109310|NCT00003937|Razoxane|razoxane|mesh-list
20109311|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109312|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109313|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109314|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109315|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109316|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109317|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20109318|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
20109319|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19552407|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19552408|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20109320|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109321|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552409|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552410|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
19552411|NCT02797119|Coagulants|coagulants|mesh-ancestor
19552412|NCT02797067|Indomethacin|indomethacin|mesh-list
19552413|NCT02797067|Glycerol|glycerol|mesh-list
19552414|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19552415|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19552416|NCT02797067|Analgesics|analgesics|mesh-ancestor
19552417|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
20109322|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
20109323|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109324|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20109325|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109326|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
20109327|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109328|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20109329|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109330|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109331|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
19552418|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552419|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109332|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20109333|NCT00003937|Protective Agents|protective agents|mesh-ancestor
20604553|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
19552420|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552421|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552422|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
19552423|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
19552424|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19552425|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19552426|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552427|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552428|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20109334|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109335|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109336|NCT00003938|Amphotericin B|amphotericin b|mesh-list
20109337|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20109338|NCT00003938|Amebicides|amebicides|mesh-ancestor
20109339|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20109340|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20109341|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552429|NCT02797067|Protective Agents|protective agents|mesh-ancestor
19552430|NCT02797028|Allopurinol|allopurinol|mesh-list
19552431|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
19552432|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552433|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109342|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20109343|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
20109344|NCT00003939|Trabectedin|trabectedin|mesh-list
20109345|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109346|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
20109347|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109348|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109349|NCT00003941|Etoposide|etoposide|mesh-list
20109350|NCT00003941|Ifosfamide|ifosfamide|mesh-list
20109351|NCT00003941|Bleomycin|bleomycin|mesh-list
20109352|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109353|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109354|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109355|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19552434|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
19552435|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552436|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19552437|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
19552438|NCT02797028|Protective Agents|protective agents|mesh-ancestor
19552439|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552440|NCT02797015|Ozanimod|ozanimod|mesh-list
19552441|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19552442|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552443|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552444|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
19552445|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552446|NCT02797041|Bortezomib|bortezomib|mesh-list
20109356|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109357|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109358|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109359|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
20109360|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109361|NCT00003943|Paclitaxel|paclitaxel|mesh-list
20109362|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
20109363|NCT00003943|Carboplatin|carboplatin|mesh-list
20109364|NCT00003943|Topotecan|topotecan|mesh-list
20109365|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109366|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109367|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109368|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109369|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552447|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552448|NCT02796794|Genistein|genistein|mesh-list
19552449|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19552450|NCT02796794|Protective Agents|protective agents|mesh-ancestor
19552451|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552452|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552453|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19552454|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552455|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552456|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
19552457|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20109370|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109371|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552458|NCT02796794|Estrogens|estrogens|mesh-ancestor
19552459|NCT02796794|Hormones|hormones|mesh-ancestor
19552460|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552461|NCT02796833|SMOFlipid|smoflipid|mesh-list
19552462|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19552463|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19552464|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19552465|NCT02796950|Acipimox|acipimox|mesh-list
19552466|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20109372|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
20109373|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109374|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109375|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109376|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
19552467|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
20109377|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109378|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109379|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109380|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109381|NCT00003944|Paclitaxel|paclitaxel|mesh-list
20109382|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
20109383|NCT00003944|Carboplatin|carboplatin|mesh-list
20109384|NCT00003944|Topotecan|topotecan|mesh-list
20109385|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109386|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109387|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109388|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109389|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109390|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109391|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109392|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
20109393|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109394|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109395|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109396|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
20109397|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109398|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109399|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109400|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109401|NCT00003945|Topotecan|topotecan|mesh-list
20109402|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109403|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109404|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109405|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109406|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109407|NCT00003946|Danazol|danazol|mesh-list
19552468|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552469|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19552470|NCT02796859|Siltuximab|siltuximab|mesh-list
19552471|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552472|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
19552473|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
20109408|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20109409|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
20109410|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552474|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
19552475|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552476|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552477|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
19552478|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552479|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
19552480|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19552481|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552482|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552483|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19552484|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19552485|NCT02796469|Protective Agents|protective agents|mesh-ancestor
19552486|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552487|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
19552488|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19552489|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
20109411|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552490|NCT02796378|Ubiquinone|ubiquinone|mesh-list
19552491|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
19552492|NCT02796378|Simvastatin|simvastatin|mesh-list
20109412|NCT00003950|Cyclosporine|cyclosporine|mesh-list
20109413|NCT00003950|Irinotecan|irinotecan|mesh-list
19552493|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19552494|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19552495|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
19552496|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552497|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19552498|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19552499|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552500|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
19552501|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552502|NCT02796378|Vitamins|vitamins|mesh-ancestor
19552503|NCT02796157|Everolimus|everolimus|mesh-list
19552504|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552505|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552506|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
19552507|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552508|NCT02796196|Coal Tar|coal tar|mesh-list
19552509|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
19552510|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552511|NCT02796183|Bevacizumab|bevacizumab|mesh-list
19552512|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19552513|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552514|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19552515|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19552516|NCT02796183|Growth Substances|growth substances|mesh-ancestor
19552517|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552518|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
19576282|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576283|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576284|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19576285|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
19576286|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19576287|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576288|NCT05367362|Minocycline|minocycline|mesh-list
19576289|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19576290|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576291|NCT05367336|Fentanyl|fentanyl|mesh-list
19576292|NCT05367336|Morphine|morphine|mesh-list
19576293|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20109414|NCT00003950|Cyclosporins|cyclosporins|mesh-list
20109415|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109416|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109417|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109418|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109419|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109420|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109421|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
20109422|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109423|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
20109424|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576294|NCT05367336|Narcotics|narcotics|mesh-ancestor
19576295|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576296|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576297|NCT05367336|Analgesics|analgesics|mesh-ancestor
19576298|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
19576299|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576300|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19576301|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576302|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
19576303|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
19576304|NCT05367284|Testosterone|testosterone|mesh-list
20109425|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109426|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576305|NCT05367284|Androgens|androgens|mesh-ancestor
19576306|NCT05367284|Hormones|hormones|mesh-ancestor
19576307|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576308|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576309|NCT05367271|Dexamethasone|dexamethasone|mesh-list
19576310|NCT05367271|Cortisone|cortisone|mesh-list
19576311|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19576312|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
19576313|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20109427|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20109428|NCT00003951|Exatecan|exatecan|mesh-list
20109429|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19576314|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576315|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
19552519|NCT02796105|Ganirelix|ganirelix|mesh-list
19552520|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
19552521|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552522|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552523|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19552524|NCT02795949|Amoxicillin|amoxicillin|mesh-list
19552525|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
19552526|NCT02795949|Meropenem|meropenem|mesh-list
19552527|NCT02795949|Tazobactam|tazobactam|mesh-list
19552528|NCT02795949|Piperacillin|piperacillin|mesh-list
19552529|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
19552530|NCT02795949|Imipenem|imipenem|mesh-list
19552531|NCT02795949|Ceftazidime|ceftazidime|mesh-list
19552532|NCT02795949|Ampicillin|ampicillin|mesh-list
19552533|NCT02795949|Ertapenem|ertapenem|mesh-list
19552534|NCT02795949|Cefuroxime|cefuroxime|mesh-list
19552535|NCT02795949|Cefepime|cefepime|mesh-list
19552536|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19552537|NCT02795949|Lactams|lactams|mesh-list
19552538|NCT02795949|Aztreonam|aztreonam|mesh-list
19552539|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19552540|NCT02795949|beta-Lactams|beta-lactams|mesh-list
19552541|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19552542|NCT02795949|Trimethoprim|trimethoprim|mesh-list
19552543|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
19552544|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552545|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
19552546|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19552547|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19552548|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552549|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552550|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552551|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19552552|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19552553|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19552554|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19552555|NCT02795949|Renal Agents|renal agents|mesh-ancestor
19552556|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
19552557|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19552558|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19552559|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19552560|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19552561|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19552562|NCT02795884|Cisplatin|cisplatin|mesh-list
19552563|NCT02795884|Pemetrexed|pemetrexed|mesh-list
19552564|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19552565|NCT02795884|Vinorelbine|vinorelbine|mesh-list
19552566|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552567|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552568|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552569|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19552570|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19552571|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19552572|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19552573|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552574|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552575|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552576|NCT02795572|Vitamin D|vitamin d|mesh-list
19552577|NCT02795572|Vitamins|vitamins|mesh-list
19552578|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
19552579|NCT02795572|Hydroxocobalamin|hydroxocobalamin|mesh-list
19552580|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
19552581|NCT02795572|Pyridoxal|pyridoxal|mesh-list
19552582|NCT02795572|Pyridoxine|pyridoxine|mesh-list
19552583|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
20604554|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
20604555|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604556|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552584|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
19552585|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552586|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19552587|NCT02795572|Hematinics|hematinics|mesh-ancestor
20604557|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552588|NCT02795754|Ritonavir|ritonavir|mesh-list
19552589|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
19552590|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19552591|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19552592|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
19552593|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576316|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
20604558|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
19552594|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552595|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19552596|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19552597|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
19552598|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552599|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19552600|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19552601|NCT02795546|Alendronate|alendronate|mesh-list
19552602|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19552603|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552604|NCT02795299|Folic Acid|folic acid|mesh-list
19552605|NCT02795299|Methotrexate|methotrexate|mesh-list
19552606|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19552607|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
19552608|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19552609|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552610|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552611|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
19552612|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552613|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552614|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552615|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552616|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19552617|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552618|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
19552619|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552620|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19552621|NCT02795299|Hematinics|hematinics|mesh-ancestor
19552622|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
19552623|NCT02795299|Vitamins|vitamins|mesh-ancestor
19552624|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
19552625|NCT02795143|Isotretinoin|isotretinoin|mesh-list
19552626|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552627|NCT02795429|Spartalizumab|spartalizumab|mesh-list
19552628|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20109430|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109431|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109432|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109433|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109434|NCT00003953|Tamoxifen|tamoxifen|mesh-list
20109435|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
20109436|NCT00003953|Docetaxel|docetaxel|mesh-list
20109437|NCT00003953|Doxorubicin|doxorubicin|mesh-list
20109438|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109439|NCT00003953|Fluorouracil|fluorouracil|mesh-list
20109440|NCT00003953|Methotrexate|methotrexate|mesh-list
20109441|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109442|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
20109443|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109444|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109445|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552629|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552630|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552631|NCT02795039|Fulvestrant|fulvestrant|mesh-list
19552632|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19552633|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552634|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19552635|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19552636|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
19552637|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552638|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552639|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
19552640|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552641|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19552642|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109446|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
20109447|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109448|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109449|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109450|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109451|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109452|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552643|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109453|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19552644|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
19552645|NCT02794922|Vitamins|vitamins|mesh-ancestor
19552646|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
19552647|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109454|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109455|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109456|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109457|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
20109458|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552648|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19552649|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19552650|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
19552651|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552652|NCT02795065|Enoxaparin|enoxaparin|mesh-list
19552653|NCT02795065|Bemiparin|bemiparin|mesh-list
19552654|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
19552655|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19552656|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19552657|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552658|NCT02794792|Metformin|metformin|mesh-list
19552659|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
19552660|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552661|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552662|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19552663|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552664|NCT02794779|Oxytocin|oxytocin|mesh-list
19552665|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
20109459|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20109460|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
20109461|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20109462|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109463|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20109464|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20109465|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20109466|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
20109467|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552666|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19552667|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109468|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20109469|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20109470|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20109471|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20109472|NCT00003954|Cyclosporine|cyclosporine|mesh-list
19552668|NCT02794714|Rocuronium|rocuronium|mesh-list
19552669|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19552670|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19552671|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19552672|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552673|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552674|NCT02794610|Tacrolimus|tacrolimus|mesh-list
19552675|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552676|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
19552677|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552678|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19552679|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552680|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552681|NCT02794428|Eflornithine|eflornithine|mesh-list
19552682|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552683|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19552684|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19552685|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19552686|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552687|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19552688|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552689|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109473|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
20109474|NCT00003954|Melphalan|melphalan|mesh-list
20109475|NCT00003954|Cyclosporins|cyclosporins|mesh-list
20109476|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109477|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109478|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552690|NCT02794506|Propolis|propolis|mesh-list
19552691|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576317|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552692|NCT02794584|Sufentanil|sufentanil|mesh-list
19552693|NCT02794584|Dsuvia|dsuvia|mesh-list
19552694|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
19552695|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552696|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552697|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19552698|NCT02794584|Narcotics|narcotics|mesh-ancestor
19552699|NCT02794584|Analgesics|analgesics|mesh-ancestor
19552700|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
19552701|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552702|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19552703|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19552704|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
19552705|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
19552706|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19552707|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
19552708|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552709|NCT02794389|Expectorants|expectorants|mesh-ancestor
20109479|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
20109480|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109481|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
20109482|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109483|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
20109484|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109485|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20109486|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109487|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109488|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20109489|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
20109490|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20109491|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109492|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
19552710|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
19552711|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19552712|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
19552713|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552714|NCT02794389|Protective Agents|protective agents|mesh-ancestor
19552715|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552716|NCT02794389|Antidotes|antidotes|mesh-ancestor
19552717|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
19552718|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552719|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
19552720|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552721|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552722|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552723|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
19552724|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552725|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552726|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19552727|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
19552728|NCT02793986|Propofol|propofol|mesh-list
20109493|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109494|NCT00003955|Dactinomycin|dactinomycin|mesh-list
20109495|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
20109496|NCT00003955|Irinotecan|irinotecan|mesh-list
20109497|NCT00003955|Vincristine|vincristine|mesh-list
19552729|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19552730|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552731|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552732|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19552733|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
19552734|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
19552735|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19552736|NCT02793986|Analgesics|analgesics|mesh-ancestor
20109498|NCT00003955|Sargramostim|sargramostim|mesh-list
20109499|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109500|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
20109501|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109502|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109503|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109504|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
20109505|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552737|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
20109506|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552738|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109507|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19552739|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19552740|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19552741|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19552742|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
19552743|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552744|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552745|NCT02794025|Esmolol|esmolol|mesh-list
19552746|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19552747|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19552748|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19552749|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
19552750|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552751|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552752|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552753|NCT02794220|Nicotine|nicotine|mesh-list
19552754|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19552755|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
20109508|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109509|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109510|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109511|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109512|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109513|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109514|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109515|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20109516|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109517|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109518|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20109519|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20109520|NCT00003956|Leucovorin|leucovorin|mesh-list
20109521|NCT00003956|Fluorouracil|fluorouracil|mesh-list
20109522|NCT00003956|Calcium|calcium|mesh-list
20109523|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
20109524|NCT00003956|Lonafarnib|lonafarnib|mesh-list
20109525|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20109526|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109527|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
20109528|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109529|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109530|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109531|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109532|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
20109533|NCT00003956|Antidotes|antidotes|mesh-ancestor
20109534|NCT00003956|Protective Agents|protective agents|mesh-ancestor
20109535|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
20109536|NCT00003956|Vitamins|vitamins|mesh-ancestor
20109537|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
20109538|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109539|NCT00003957|Cytarabine|cytarabine|mesh-list
20109540|NCT00003957|Paclitaxel|paclitaxel|mesh-list
20109541|NCT00003957|Etoposide|etoposide|mesh-list
20109542|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
20109543|NCT00003957|Melphalan|melphalan|mesh-list
20109544|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
20109545|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109546|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109547|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109548|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109549|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109550|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109551|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109552|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
20109553|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109554|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109555|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109556|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
20109557|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109558|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109559|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109560|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109561|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109562|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
20109563|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
19552756|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109564|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109565|NCT00003957|Analgesics|analgesics|mesh-ancestor
20109566|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
20308308|NCT00663598|Urological Agents|urological agents|mesh-ancestor
20109567|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109568|NCT00003958|Dactinomycin|dactinomycin|mesh-list
20109569|NCT00003958|Cactinomycin|cactinomycin|mesh-list
20109570|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
20109571|NCT00003958|Vincristine|vincristine|mesh-list
20109572|NCT00003958|Topotecan|topotecan|mesh-list
20109573|NCT00003958|Sargramostim|sargramostim|mesh-list
20109574|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109575|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
20109576|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109577|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109578|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109579|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
20109580|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109581|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109582|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109583|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109584|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109585|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109586|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109587|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109588|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109589|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109590|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20109591|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109592|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109593|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20109594|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20109595|NCT00003959|Sargramostim|sargramostim|mesh-list
20109596|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
20109597|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109598|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
20109599|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20109600|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20109601|NCT00003960|Prednisolone|prednisolone|mesh-list
20109602|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
20109603|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
20109604|NCT00003960|Busulfan|busulfan|mesh-list
20109605|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20109606|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
20109607|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109608|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
20109609|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109610|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109611|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109612|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
20109613|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109614|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109615|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109616|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552757|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109617|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
20109618|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
20109619|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109620|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20109621|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
20109622|NCT00003960|Hormones|hormones|mesh-ancestor
20109623|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109624|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20109625|NCT00003960|Protective Agents|protective agents|mesh-ancestor
20109626|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19552758|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19552759|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19552760|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
19552761|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552762|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552763|NCT02794155|Insulin|insulin|mesh-list
19552764|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19552765|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
19552766|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552767|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552768|NCT02793843|Dexamethasone|dexamethasone|mesh-list
19552769|NCT02793843|Ondansetron|ondansetron|mesh-list
20109627|NCT00003961|Sargramostim|sargramostim|mesh-list
20109628|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
20109629|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552770|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552771|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
19552772|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
19552773|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552774|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552775|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19552776|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
19552777|NCT02793843|Hormones|hormones|mesh-ancestor
20109630|NCT00003962|Aldesleukin|aldesleukin|mesh-list
20109631|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109632|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20109633|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20109634|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
20109635|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109636|NCT00003963|Rituximab|rituximab|mesh-list
20109637|NCT00003963|Vinorelbine|vinorelbine|mesh-list
20109638|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20109639|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109640|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
20109641|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109642|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109643|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109644|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109645|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109646|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109647|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109648|NCT00003966|Defibrotide|defibrotide|mesh-list
20109649|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20109650|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20109651|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109652|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20109653|NCT00003967|Etoposide|etoposide|mesh-list
20109654|NCT00003967|Topotecan|topotecan|mesh-list
20109655|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109656|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109657|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109658|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109659|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109660|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109661|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109662|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
20109663|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20109664|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
20109665|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109666|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109667|NCT00003970|Irinotecan|irinotecan|mesh-list
20109668|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109669|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109670|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109671|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109672|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109673|NCT00003972|Tamoxifen|tamoxifen|mesh-list
20109674|NCT00003972|Paclitaxel|paclitaxel|mesh-list
20109675|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
20109676|NCT00003972|Carboplatin|carboplatin|mesh-list
20109677|NCT00003972|Melphalan|melphalan|mesh-list
20109678|NCT00003972|Busulfan|busulfan|mesh-list
20109679|NCT00003972|Thiotepa|thiotepa|mesh-list
20109680|NCT00003972|Sargramostim|sargramostim|mesh-list
20109681|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109682|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109683|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109684|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109685|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109686|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109687|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109688|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
20109689|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109690|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109691|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109692|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
20109693|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109694|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20109695|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
20109696|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576318|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109697|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20109698|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20109699|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20109700|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20109701|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
20109702|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109703|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
20109704|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109705|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109706|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109707|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
19552778|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552779|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19552780|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552781|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552782|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552783|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
19552784|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
19552785|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19552786|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
20109708|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109709|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109710|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109711|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20109712|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109713|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20109714|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552787|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552788|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19552789|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20109715|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109716|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20109717|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109718|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20109719|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109720|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109721|NCT00003984|Lintuzumab|lintuzumab|mesh-list
20109722|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20109723|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109724|NCT00003985|KRN 7000|krn 7000|mesh-list
20109725|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19552790|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19552791|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19552792|NCT02793908|Progesterone|progesterone|mesh-list
19552793|NCT02793908|Progestins|progestins|mesh-ancestor
19552794|NCT02793908|Hormones|hormones|mesh-ancestor
19552795|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109726|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
20109727|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109728|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109729|NCT00003991|Aldesleukin|aldesleukin|mesh-list
19552796|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552797|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
19552798|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
20109730|NCT00003991|Histamine|histamine|mesh-list
20109731|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
20109732|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109733|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20109734|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20109735|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
20109736|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109737|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
20109738|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
20109739|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552799|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552800|NCT02793687|Protective Agents|protective agents|mesh-ancestor
19552801|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552802|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19552803|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19552804|NCT02793765|Docetaxel|docetaxel|mesh-list
20109740|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109741|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552805|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552806|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552807|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552808|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552809|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552810|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
19552811|NCT02793544|Sirolimus|sirolimus|mesh-list
19552812|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
19552813|NCT02793544|Busulfan|busulfan|mesh-list
19552814|NCT02793544|Fludarabine|fludarabine|mesh-list
19552815|NCT02793544|Mesna|mesna|mesh-list
20109742|NCT00003992|Tamoxifen|tamoxifen|mesh-list
20109743|NCT00003992|Paclitaxel|paclitaxel|mesh-list
20109744|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
20109745|NCT00003992|Doxorubicin|doxorubicin|mesh-list
20109746|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109747|NCT00003992|Trastuzumab|trastuzumab|mesh-list
20109748|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109749|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109750|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552816|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552817|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
19552818|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552819|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552820|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552821|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
19552822|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552823|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552824|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19552825|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19552826|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19552827|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
19552828|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19552829|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552830|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552831|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
19552832|NCT02793544|Protective Agents|protective agents|mesh-ancestor
19552833|NCT02793388|Primaquine|primaquine|mesh-list
19552834|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
20109751|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109752|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109753|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109754|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109755|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
19552835|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19552836|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19552837|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552838|NCT02793648|Vitamins|vitamins|mesh-list
19552839|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
20109756|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109757|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109758|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109759|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
20109760|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109761|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109762|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109763|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109764|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109765|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20109766|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20109767|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
20109768|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109769|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20109770|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20109771|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20109772|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20109773|NCT00003993|Aldesleukin|aldesleukin|mesh-list
20109774|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
20109775|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109776|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20109777|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20109778|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
20109779|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552840|NCT02793648|Vitamin E|vitamin e|mesh-list
19552841|NCT02793648|Tocopherols|tocopherols|mesh-list
19552842|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
19552843|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
19552844|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109780|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20109781|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
20109782|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109783|NCT00003994|Carboplatin|carboplatin|mesh-list
20109784|NCT00003994|Fluorouracil|fluorouracil|mesh-list
20109785|NCT00003994|Vincristine|vincristine|mesh-list
20109786|NCT00003994|Amifostine|amifostine|mesh-list
20109787|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109788|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
20109789|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109790|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19552845|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
19552846|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552847|NCT02793648|Protective Agents|protective agents|mesh-ancestor
19552848|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
19552849|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19552850|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
20109791|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109792|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
20109793|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109794|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109795|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109796|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552851|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552852|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
19552853|NCT02793739|Protective Agents|protective agents|mesh-ancestor
19552854|NCT02793323|Anesthetics|anesthetics|mesh-list
19552855|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19552856|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552857|NCT02793375|Montelukast|montelukast|mesh-list
19552858|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19552859|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
19552860|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19552861|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
19552862|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552863|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552864|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19552865|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19552866|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552867|NCT02793440|Cortivazol|cortivazol|mesh-list
19552868|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552869|NCT02793505|Metformin|metformin|mesh-list
19552870|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552871|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552872|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19552873|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19552874|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552875|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
19552876|NCT02793466|Durvalumab|durvalumab|mesh-list
19552877|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19552878|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19552879|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552880|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
19552881|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552882|NCT02793219|Docetaxel|docetaxel|mesh-list
19552883|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552884|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552885|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109797|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109798|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20109799|NCT00003994|Protective Agents|protective agents|mesh-ancestor
20109800|NCT00003995|Trastuzumab|trastuzumab|mesh-list
20109801|NCT00003995|Irinotecan|irinotecan|mesh-list
20109802|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20109803|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109804|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109805|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109806|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109807|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109808|NCT00003996|Etoposide|etoposide|mesh-list
20109809|NCT00003996|Carmustine|carmustine|mesh-list
20109810|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109811|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19552886|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109812|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109813|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109814|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109815|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109816|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109817|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
20109818|NCT00003997|Irofulven|irofulven|mesh-list
20109819|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109820|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
20109821|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109822|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109823|NCT00003998|Paclitaxel|paclitaxel|mesh-list
20109824|NCT00003998|Docetaxel|docetaxel|mesh-list
20109825|NCT00003998|Carboplatin|carboplatin|mesh-list
20109826|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109827|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109828|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552887|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552888|NCT02793050|Trabectedin|trabectedin|mesh-list
19552889|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552890|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
19552891|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552892|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552893|NCT02793011|Dexamethasone|dexamethasone|mesh-list
19552894|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19552895|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
19552896|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
19552897|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19552898|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552899|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19552900|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
19552901|NCT02793011|Hormones|hormones|mesh-ancestor
19552902|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552903|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19552904|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552905|NCT02792816|Artesunate|artesunate|mesh-list
19552906|NCT02792816|Artemether|artemether|mesh-list
19552907|NCT02792816|Piperaquine|piperaquine|mesh-list
19552908|NCT02792816|Artenimol|artenimol|mesh-list
19552909|NCT02792816|Mefloquine|mefloquine|mesh-list
20109829|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109830|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109831|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109832|NCT00004001|Prednisone|prednisone|mesh-list
20109833|NCT00004001|Docetaxel|docetaxel|mesh-list
20109834|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
20109835|NCT00004001|Estramustine|estramustine|mesh-list
20109836|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109837|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552910|NCT02792816|Antimalarials|antimalarials|mesh-list
19552911|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19552912|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19552913|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19552914|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552915|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
19552916|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
19552917|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19552918|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
19552919|NCT02792712|Clopidogrel|clopidogrel|mesh-list
19552920|NCT02792712|Ticagrelor|ticagrelor|mesh-list
19552921|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19552922|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19552923|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19552924|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19552925|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
20109838|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109839|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109840|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109841|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20109842|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
20109843|NCT00004001|Hormones|hormones|mesh-ancestor
20109844|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109845|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552926|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552927|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109846|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20109847|NCT00004001|Analgesics|analgesics|mesh-ancestor
20109848|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
20109849|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109850|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109851|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109852|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109853|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109854|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
20109855|NCT00004002|Bortezomib|bortezomib|mesh-list
20109856|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109857|NCT00004003|Gemcitabine|gemcitabine|mesh-list
20109858|NCT00004003|Fluorouracil|fluorouracil|mesh-list
20109859|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109860|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109861|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
20109862|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109863|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
20109864|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109865|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552928|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109866|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109867|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
20109868|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109869|NCT00004004|Procarbazine|procarbazine|mesh-list
20109870|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576319|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20109871|NCT00004005|Leucovorin|leucovorin|mesh-list
19576320|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
19576321|NCT05367271|Hormones|hormones|mesh-ancestor
19576322|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576323|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576324|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576325|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19576326|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19576327|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576328|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
19576329|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576330|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19576331|NCT05367245|Butyric Acid|butyric acid|mesh-list
19576332|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576333|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
19576334|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
19576335|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576336|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576337|NCT05367206|Paclitaxel|paclitaxel|mesh-list
19576338|NCT05367206|Carboplatin|carboplatin|mesh-list
19576339|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19576340|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19576341|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576342|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19576343|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
19576344|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
19576345|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578251|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19578252|NCT03138889|Carboplatin|carboplatin|mesh-list
19578253|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
19578254|NCT03138889|Pemetrexed|pemetrexed|mesh-list
19578255|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578256|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578257|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578258|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578259|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578260|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578261|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578262|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578263|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19578264|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19578265|NCT03087448|Trametinib|trametinib|mesh-list
19578266|NCT03087448|Ceritinib|ceritinib|mesh-list
19578267|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578268|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578269|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109872|NCT00004005|Fluorouracil|fluorouracil|mesh-list
20109873|NCT00004005|Irinotecan|irinotecan|mesh-list
20109874|NCT00004005|Calcium|calcium|mesh-list
20109875|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
20109876|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20604559|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604560|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20604561|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20604562|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
20604563|NCT02227992|Coagulants|coagulants|mesh-ancestor
20604564|NCT02228005|Sertraline|sertraline|mesh-list
20604565|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
20604566|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604567|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19552929|NCT02792491|Prednisone|prednisone|mesh-list
19552930|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
19552931|NCT02792491|Rituximab|rituximab|mesh-list
19552932|NCT02792491|Doxorubicin|doxorubicin|mesh-list
19552933|NCT02792491|Vincristine|vincristine|mesh-list
19552934|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19552935|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
19552936|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552937|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19552938|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19552939|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
20109877|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109878|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
20109879|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109880|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109881|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109882|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109883|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
20109884|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109885|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109886|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109887|NCT00004005|Antidotes|antidotes|mesh-ancestor
20109888|NCT00004005|Protective Agents|protective agents|mesh-ancestor
20109889|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
20109890|NCT00004005|Vitamins|vitamins|mesh-ancestor
20109891|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
20109892|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
20109893|NCT00004006|Carboplatin|carboplatin|mesh-list
20109894|NCT00004006|Doxorubicin|doxorubicin|mesh-list
20109895|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109896|NCT00004006|Etoposide|etoposide|mesh-list
20109897|NCT00004006|Topotecan|topotecan|mesh-list
20109898|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109899|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
20109900|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109901|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109902|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109903|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
20109904|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109905|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109906|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109907|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109908|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109909|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109910|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109911|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109912|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20109913|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
20109914|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20109915|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
20109916|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109917|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109918|NCT00004009|Tipifarnib|tipifarnib|mesh-list
20604568|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20109919|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552940|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552941|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552942|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19552943|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19552944|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19552945|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19552946|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19552947|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604569|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19552948|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20109920|NCT00004010|Prednisone|prednisone|mesh-list
20109921|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
20109922|NCT00004010|Dacarbazine|dacarbazine|mesh-list
19552949|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
19552950|NCT02792491|Hormones|hormones|mesh-ancestor
19552951|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552952|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19552953|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19552954|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
19552955|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
19552956|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552957|NCT02792803|Latanoprost|latanoprost|mesh-list
19552958|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19552959|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19552960|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
19552961|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19552962|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
19552963|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552964|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
19552965|NCT02792673|Protective Agents|protective agents|mesh-ancestor
19552966|NCT02792621|Acipimox|acipimox|mesh-list
19552967|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19552968|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
19552969|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552970|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19552971|NCT02792426|Nicotine|nicotine|mesh-list
19552972|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19552973|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
19552974|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20109923|NCT00004010|Doxorubicin|doxorubicin|mesh-list
20109924|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109925|NCT00004010|Etoposide|etoposide|mesh-list
20109926|NCT00004010|Vincristine|vincristine|mesh-list
20109927|NCT00004010|Bleomycin|bleomycin|mesh-list
20109928|NCT00004010|Vinblastine|vinblastine|mesh-list
20109929|NCT00004010|Procarbazine|procarbazine|mesh-list
20109930|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20109931|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
20109932|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109933|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20109934|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20109935|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
20109936|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109937|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552975|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552976|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19552977|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20109938|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20109939|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109940|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109941|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109942|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109943|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20109944|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
20109945|NCT00004010|Hormones|hormones|mesh-ancestor
20109946|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109947|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19552978|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
19552979|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19552980|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109948|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109949|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109950|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109951|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109952|NCT00004011|Paclitaxel|paclitaxel|mesh-list
19552981|NCT02792400|Empagliflozin|empagliflozin|mesh-list
19552982|NCT02792400|Linagliptin|linagliptin|mesh-list
19552983|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19552984|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19552985|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19552986|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19552987|NCT02792400|Incretins|incretins|mesh-ancestor
19552988|NCT02792400|Hormones|hormones|mesh-ancestor
19552989|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19552990|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20109953|NCT00004011|Carboplatin|carboplatin|mesh-list
19552991|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
20109954|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109955|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19552992|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19552993|NCT02792335|Warfarin|warfarin|mesh-list
19552994|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
19552995|NCT02792335|Dabigatran|dabigatran|mesh-list
19552996|NCT02792335|Apixaban|apixaban|mesh-list
20109956|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109957|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109958|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
20109959|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109960|NCT00004012|Capecitabine|capecitabine|mesh-list
20109961|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20109962|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
20109963|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109964|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109965|NCT00004013|Paclitaxel|paclitaxel|mesh-list
20109966|NCT00004013|Trastuzumab|trastuzumab|mesh-list
20109967|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20109968|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109969|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
20109970|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
20109971|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
19552997|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
19552998|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19552999|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
19553000|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19553001|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
19553002|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553003|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553004|NCT02792088|Tenofovir|tenofovir|mesh-list
19553005|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
19553006|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553007|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19553008|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19553009|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553010|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553011|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19553012|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19553013|NCT02792036|Carboplatin|carboplatin|mesh-list
19553014|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553015|NCT02792153|Estradiol|estradiol|mesh-list
19553016|NCT02792153|Estrogens|estrogens|mesh-ancestor
19553017|NCT02792153|Hormones|hormones|mesh-ancestor
19553018|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19553019|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553020|NCT02792257|Dronabinol|dronabinol|mesh-list
19553021|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
19553022|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553023|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19553024|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553025|NCT02792257|Analgesics|analgesics|mesh-ancestor
19553026|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
19553027|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553028|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19553029|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19553030|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553031|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553032|NCT02792257|Hormones|hormones|mesh-ancestor
19553033|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20109972|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109973|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20109974|NCT00004014|Doxorubicin|doxorubicin|mesh-list
20109975|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20109976|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20109977|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109978|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20109979|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20109980|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20109981|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20109982|NCT00004016|Interferons|interferons|mesh-list
20109983|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
19553034|NCT02791958|Ramipril|ramipril|mesh-list
19553035|NCT02791958|Atorvastatin|atorvastatin|mesh-list
19553036|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19553037|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19553038|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
19553039|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553040|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19553041|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19553042|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553043|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19553044|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
19553045|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553046|NCT02792140|Naltrexone|naltrexone|mesh-list
19553047|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19553048|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19553049|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553050|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
19553051|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553052|NCT02791919|Cytarabine|cytarabine|mesh-list
19553053|NCT02791919|Fludarabine|fludarabine|mesh-list
19553054|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
19553055|NCT02791919|Lenograstim|lenograstim|mesh-list
19553056|NCT02791919|Sargramostim|sargramostim|mesh-list
19553057|NCT02791919|Adavosertib|adavosertib|mesh-list
19553058|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553059|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19553060|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
19553061|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553062|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553063|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
19553064|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109984|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109985|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
20109986|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109987|NCT00004017|Antibodies|antibodies|mesh-list
20109988|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20109989|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
20109990|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20109991|NCT00004022|Aldesleukin|aldesleukin|mesh-list
20109992|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
20109993|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20109994|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20109995|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20109996|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
20109997|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20109998|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
20109999|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110000|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110001|NCT00004024|Aldesleukin|aldesleukin|mesh-list
20110002|NCT00004024|Sargramostim|sargramostim|mesh-list
20110003|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
20110004|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
19553065|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
19553066|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553067|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19553068|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553069|NCT02791737|Coal Tar|coal tar|mesh-list
19553070|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
19553071|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
19553072|NCT02791815|Selexipag|selexipag|mesh-list
20110005|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110006|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110007|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20110008|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20110009|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
20110010|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110011|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110012|NCT00004025|Aldesleukin|aldesleukin|mesh-list
20110013|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110014|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20110015|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20110016|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
20110017|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110018|NCT00004028|Carmustine|carmustine|mesh-list
20110019|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110020|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
19553073|NCT02791815|Midazolam|midazolam|mesh-list
19553074|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20110021|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110022|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553075|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576346|NCT05367089|Fluconazole|fluconazole|mesh-list
20110023|NCT00004029|Sargramostim|sargramostim|mesh-list
20110024|NCT00004029|Vaccines|vaccines|mesh-list
20110025|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
20110026|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553076|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553077|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553078|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19553079|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19553080|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19553081|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19553082|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
19553083|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
19553084|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
19553085|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
19553086|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553087|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553088|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553089|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
19553090|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19553091|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553092|NCT02791243|Finasteride|finasteride|mesh-list
19553093|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19553094|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19553095|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553096|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110027|NCT00004030|Doxorubicin|doxorubicin|mesh-list
19553097|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
19553098|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19553099|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553100|NCT02791243|Urological Agents|urological agents|mesh-ancestor
19553101|NCT02791334|Ramucirumab|ramucirumab|mesh-list
19553102|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553103|NCT02791373|Gemcitabine|gemcitabine|mesh-list
19553104|NCT02791373|Vinorelbine|vinorelbine|mesh-list
19553105|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19553106|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
19553107|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553108|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553109|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
19553110|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553111|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553112|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553113|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
19553114|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553115|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19553116|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
19553117|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
19553118|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
19553119|NCT02791256|Ribavirin|ribavirin|mesh-list
19553120|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19553121|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
19553122|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553123|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
19553124|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576347|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
19576348|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576349|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19576350|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19576351|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576352|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576353|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19576354|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
20110028|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20110029|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110030|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110031|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110032|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110033|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110034|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110035|NCT00004032|Interferons|interferons|mesh-list
20110036|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
20110037|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110038|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
20110039|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110040|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
20110041|NCT00004036|Carboplatin|carboplatin|mesh-list
19578373|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110042|NCT00004036|Sargramostim|sargramostim|mesh-list
20110043|NCT00004036|Amifostine|amifostine|mesh-list
20110044|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110045|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
20110046|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110047|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110048|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110049|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
20110050|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553125|NCT02790853|Proflavine|proflavine|mesh-list
19553126|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19553127|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553128|NCT02790957|Plerixafor|plerixafor|mesh-list
19553129|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19553130|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19553131|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
20110051|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110052|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110053|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20110054|NCT00004036|Protective Agents|protective agents|mesh-ancestor
20110055|NCT00004037|Docetaxel|docetaxel|mesh-list
20110056|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110057|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110058|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
19553132|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553133|NCT02790996|Vancomycin|vancomycin|mesh-list
19553134|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19553135|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110059|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110060|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110061|NCT00004039|Interferons|interferons|mesh-list
19553136|NCT02790775|Bevacizumab|bevacizumab|mesh-list
19553137|NCT02790775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19553138|NCT02790775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553139|NCT02790775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20110062|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
20110063|NCT00004039|Prednisone|prednisone|mesh-list
19553140|NCT02790775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19553141|NCT02790775|Growth Substances|growth substances|mesh-ancestor
19553142|NCT02790775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553143|NCT02790775|Growth Inhibitors|growth inhibitors|mesh-ancestor
19553144|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
19553145|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19553146|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553147|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19553148|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553149|NCT02790840|Omeprazole|omeprazole|mesh-list
20110064|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
20110065|NCT00004039|Rituximab|rituximab|mesh-list
20110066|NCT00004039|Doxorubicin|doxorubicin|mesh-list
20110067|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20110068|NCT00004039|Vincristine|vincristine|mesh-list
20110069|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110070|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
20110071|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110072|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553150|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19553151|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19553152|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19553153|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553154|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553155|NCT02790710|Propranolol|propranolol|mesh-list
19553156|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19553157|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19553158|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553159|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553160|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553161|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553162|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19553163|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553164|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
19553165|NCT02790684|Firuglipel|firuglipel|mesh-list
20110073|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110074|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
19553166|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20110075|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110076|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553167|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553168|NCT02790671|Firuglipel|firuglipel|mesh-list
19553169|NCT02790671|Itraconazole|itraconazole|mesh-list
19553170|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
19553171|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553172|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19553173|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19553174|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553175|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110077|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110078|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110079|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110080|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110081|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110082|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110083|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20110084|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
20110085|NCT00004039|Hormones|hormones|mesh-ancestor
20110086|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20110087|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20110088|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
20110089|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110090|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110091|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110092|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
19553176|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19553177|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
19553178|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19553179|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553180|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19553181|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19553182|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
19553183|NCT02790580|Doxorubicin|doxorubicin|mesh-list
19553184|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19553185|NCT02790580|Sunitinib|sunitinib|mesh-list
19553186|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553187|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
19553188|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553189|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110093|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110094|NCT00004040|Interferons|interferons|mesh-list
20110095|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
20110096|NCT00004040|Rituximab|rituximab|mesh-list
20110097|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110098|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110099|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
20110100|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110101|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110102|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
20110103|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120555|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20120556|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120557|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120558|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120559|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
19553190|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19553191|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
19553192|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553193|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553194|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19553195|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20120560|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
20120561|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604570|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553196|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19553197|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19553198|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553199|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19553200|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19553201|NCT02790580|Growth Substances|growth substances|mesh-ancestor
20120562|NCT00006373|Etoposide|etoposide|mesh-list
19553202|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
20120563|NCT00006373|Topotecan|topotecan|mesh-list
20120564|NCT00006373|Ifosfamide|ifosfamide|mesh-list
19553203|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19553204|NCT02790450|Benzbromarone|benzbromarone|mesh-list
19553205|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
19553206|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
19553207|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553208|NCT02790450|Renal Agents|renal agents|mesh-ancestor
19553209|NCT02790632|Nimodipine|nimodipine|mesh-list
19553210|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553211|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19553212|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553213|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553214|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19553215|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553216|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
19553217|NCT02790528|Atorvastatin|atorvastatin|mesh-list
19553218|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19553219|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19553220|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
19553221|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553222|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19553223|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19553224|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553225|NCT02790099|Morphine|morphine|mesh-list
19553226|NCT02790099|Bupivacaine|bupivacaine|mesh-list
19553227|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553228|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
19553229|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553230|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553231|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
19553232|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553233|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19553234|NCT02790099|Narcotics|narcotics|mesh-ancestor
19553235|NCT02790099|Analgesics|analgesics|mesh-ancestor
19553236|NCT02790203|Celecoxib|celecoxib|mesh-list
19553237|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19553238|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553239|NCT02790203|Analgesics|analgesics|mesh-ancestor
19553240|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
19553241|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553242|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553243|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19553244|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553245|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19553246|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19553247|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553248|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553249|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
19553250|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19553251|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
19553252|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553253|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
19553254|NCT02790177|Protective Agents|protective agents|mesh-ancestor
19553255|NCT02790164|Rocuronium|rocuronium|mesh-list
19553256|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19553257|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19553258|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19553259|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553260|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553261|NCT02789969|Fentanyl|fentanyl|mesh-list
19553262|NCT02789969|Hydromorphone|hydromorphone|mesh-list
19553263|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19553264|NCT02789969|Narcotics|narcotics|mesh-ancestor
19553265|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553266|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553267|NCT02789969|Analgesics|analgesics|mesh-ancestor
19553268|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
19553269|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553270|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19553271|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19553272|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
19553273|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
19553274|NCT02789982|Propranolol|propranolol|mesh-list
19553275|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
19553276|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
19553277|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19553278|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553279|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553280|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553281|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19553282|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553283|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
19553284|NCT02789878|Prednisone|prednisone|mesh-list
19553285|NCT02789878|Goserelin|goserelin|mesh-list
19553286|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19553287|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
19553288|NCT02789878|Hormones|hormones|mesh-ancestor
19553289|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19553290|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553291|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19553292|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553293|NCT02789865|Metronidazole|metronidazole|mesh-list
19553294|NCT02789865|Levofloxacin|levofloxacin|mesh-list
19553295|NCT02789865|Ofloxacin|ofloxacin|mesh-list
19553296|NCT02789865|Ertapenem|ertapenem|mesh-list
19553297|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553298|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19553299|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19553300|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19553301|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19553302|NCT02789865|Renal Agents|renal agents|mesh-ancestor
19553303|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19553304|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19553305|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553306|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553307|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553308|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19553309|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19553310|NCT02789930|Anesthetics|anesthetics|mesh-list
19553311|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553312|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553313|NCT02789813|Valproic Acid|valproic acid|mesh-list
19553314|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
19553315|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553316|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553317|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
20110104|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20110105|NCT00004042|Antibodies|antibodies|mesh-list
20110106|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
19553318|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553319|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553320|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
19553321|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19553322|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553323|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19553324|NCT02789592|Clonazepam|clonazepam|mesh-list
19553325|NCT02789592|Melatonin|melatonin|mesh-list
19553326|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
19553327|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553328|NCT02789592|Protective Agents|protective agents|mesh-ancestor
19553329|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553330|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553331|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
20110107|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20110108|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
20110109|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110110|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110111|NCT00004043|Calcitriol|calcitriol|mesh-list
20110112|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20110113|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110114|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20110115|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20110116|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110117|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19553332|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
19553333|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
19553334|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576355|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576356|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576357|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20110118|NCT00004043|Vitamins|vitamins|mesh-ancestor
20110119|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
19553335|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19553336|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19553337|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19553338|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19553339|NCT02789579|Levofloxacin|levofloxacin|mesh-list
19553340|NCT02789579|Ofloxacin|ofloxacin|mesh-list
19553341|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
19553342|NCT02789579|Cefuroxime|cefuroxime|mesh-list
19553343|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
19553344|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19553345|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553346|NCT02789579|Renal Agents|renal agents|mesh-ancestor
19553347|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19553348|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19553349|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19553350|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553351|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553352|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553353|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19553354|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19553355|NCT02789150|Norepinephrine|norepinephrine|mesh-list
19553356|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19553357|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19553358|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553359|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553360|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553361|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553362|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
19553363|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
19553364|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553365|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19553366|NCT02789358|Adenosine|adenosine|mesh-list
19553367|NCT02789358|Analgesics|analgesics|mesh-ancestor
19553368|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
19553369|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553370|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553371|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19553372|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
20110120|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20110121|NCT00004045|Exatecan|exatecan|mesh-list
20110122|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110123|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110124|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553373|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19553374|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
19553375|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
19553376|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553377|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110125|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110126|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110127|NCT00004046|Exatecan|exatecan|mesh-list
20110128|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19553378|NCT02789475|Amlodipine|amlodipine|mesh-list
19553379|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19553380|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553381|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19553382|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553383|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553384|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19553385|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553386|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
19553387|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19553388|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19553389|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
19553390|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19553391|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19553392|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553393|NCT02789332|Paclitaxel|paclitaxel|mesh-list
19553394|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19553395|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
19553396|NCT02789332|Carboplatin|carboplatin|mesh-list
19553397|NCT02789332|Epirubicin|epirubicin|mesh-list
19553398|NCT02789332|Olaparib|olaparib|mesh-list
19553399|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110129|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19553400|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553401|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
19553402|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
19553403|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
19553404|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553405|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553406|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
19553407|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553408|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553409|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19553410|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
19553411|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19553412|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19553413|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19553414|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19553415|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553416|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19553417|NCT02789397|Rituximab|rituximab|mesh-list
19553418|NCT02789397|Azathioprine|azathioprine|mesh-list
19553419|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19553420|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553421|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
19553422|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553423|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553424|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
19553425|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553426|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19553427|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553428|NCT02789566|Primaquine|primaquine|mesh-list
19553429|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
19553430|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19553431|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19553432|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553433|NCT02789202|Fluorides|fluorides|mesh-list
19553434|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
19553435|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
19553436|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
19553437|NCT02789202|Protective Agents|protective agents|mesh-ancestor
19553438|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553439|NCT02789189|Gemcitabine|gemcitabine|mesh-list
19553440|NCT02789189|Nedaplatin|nedaplatin|mesh-list
19553441|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19553442|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
19553443|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553444|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553445|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
19553446|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553447|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553448|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553449|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
19553450|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553451|NCT02788864|Piperaquine|piperaquine|mesh-list
19553452|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
20110130|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110131|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110132|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110133|NCT00004047|Exatecan|exatecan|mesh-list
20110134|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110135|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110136|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110137|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110138|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110139|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19553453|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19553454|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19553455|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553456|NCT02788851|Guanfacine|guanfacine|mesh-list
19553457|NCT02788851|Methylphenidate|methylphenidate|mesh-list
19553458|NCT02788851|Amphetamine|amphetamine|mesh-list
19553459|NCT02788851|Adderall|adderall|mesh-list
19553460|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
19553461|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19553462|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20110140|NCT00004048|Doxorubicin|doxorubicin|mesh-list
19553463|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553464|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19553465|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19553466|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553467|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553468|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
19553469|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553470|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
19553471|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
19553472|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553473|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553474|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19553475|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553476|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19553477|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19553478|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19553479|NCT02788877|Aflibercept|aflibercept|mesh-list
19553480|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19553481|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19553482|NCT02788877|Growth Substances|growth substances|mesh-ancestor
19553483|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553484|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
19553485|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553486|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
19553487|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19553488|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
19553489|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19553490|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553491|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
19553492|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
19553493|NCT02788552|Vitamins|vitamins|mesh-list
19553494|NCT02788552|Thiamine|thiamine|mesh-list
19553495|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
19553496|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553497|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
19553498|NCT02788305|Misoprostol|misoprostol|mesh-list
19553499|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19553500|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
19553501|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19553502|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553503|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19553504|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19553505|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
19553506|NCT02788240|Meropenem|meropenem|mesh-list
19553507|NCT02788240|Terlipressin|terlipressin|mesh-list
19553508|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19553509|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553510|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553511|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19553512|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
19553513|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19553514|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
19553515|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553516|NCT02788292|Expectorants|expectorants|mesh-ancestor
19553517|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
19553518|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19553519|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
19553520|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553521|NCT02788292|Protective Agents|protective agents|mesh-ancestor
19553522|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110141|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20110142|NCT00004048|Antibodies|antibodies|mesh-list
20110143|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
20110144|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20110145|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
20110146|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110147|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110148|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110149|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110150|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110151|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553523|NCT02788292|Antidotes|antidotes|mesh-ancestor
19553524|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19553525|NCT02787824|Hematinics|hematinics|mesh-ancestor
19553526|NCT02787967|Beclomethasone|beclomethasone|mesh-list
19553527|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
19553528|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19553529|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
20110152|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110153|NCT00004050|Interleukin-2|interleukin-2|mesh-list
19553530|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553531|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110154|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110155|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20110156|NCT00004050|Analgesics|analgesics|mesh-ancestor
20110157|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
20110158|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20110159|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110160|NCT00004051|Irinotecan|irinotecan|mesh-list
20110161|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110162|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110163|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110164|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110165|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110166|NCT00004055|Paclitaxel|paclitaxel|mesh-list
20110167|NCT00004055|Topotecan|topotecan|mesh-list
20110168|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110169|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110170|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110171|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110172|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110173|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110174|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110175|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110176|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110177|NCT00004056|Cytarabine|cytarabine|mesh-list
20110178|NCT00004056|Thioguanine|thioguanine|mesh-list
20110179|NCT00004056|Melphalan|melphalan|mesh-list
20110180|NCT00004056|Daunorubicin|daunorubicin|mesh-list
20110181|NCT00004056|Asparaginase|asparaginase|mesh-list
20110182|NCT00004056|Lenograstim|lenograstim|mesh-list
20110183|NCT00004056|Sargramostim|sargramostim|mesh-list
20110184|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19553532|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19553533|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
19553534|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19553535|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19553536|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19553537|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553538|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553539|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553540|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19553541|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
19553542|NCT02787967|Hormones|hormones|mesh-ancestor
19553543|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19553544|NCT02787928|Hydromorphone|hydromorphone|mesh-list
19553545|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19553546|NCT02787928|Narcotics|narcotics|mesh-ancestor
19553547|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553548|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553549|NCT02787928|Analgesics|analgesics|mesh-ancestor
19553550|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
19553551|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553552|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19553553|NCT02788123|Pantoprazole|pantoprazole|mesh-list
19553554|NCT02788123|Bismuth|bismuth|mesh-list
19553555|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19553556|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19553557|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19553558|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553559|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553560|NCT02788123|Antacids|antacids|mesh-ancestor
19553561|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576358|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19576359|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19576360|NCT05367063|Canagliflozin|canagliflozin|mesh-list
19576361|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19576362|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576363|NCT05367063|Incretins|incretins|mesh-ancestor
19576364|NCT05367063|Hormones|hormones|mesh-ancestor
19576365|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576366|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19576367|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
19576368|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110185|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
20110186|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110187|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110188|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
20110189|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110190|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110191|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
19553562|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19553563|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19553564|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553565|NCT02788058|Gefitinib|gefitinib|mesh-list
20110192|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110193|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19553566|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553567|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19553568|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553569|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553570|NCT02787642|Olaparib|olaparib|mesh-list
19553571|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19553572|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553573|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110194|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110195|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
20110196|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110197|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110198|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110199|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110200|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110201|NCT00004057|Paclitaxel|paclitaxel|mesh-list
20110202|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110203|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110204|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110205|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110206|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110207|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553574|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553575|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19553576|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553577|NCT02787746|Donepezil|donepezil|mesh-list
19553578|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19553579|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553580|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553581|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
19553582|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553583|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553584|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
19553585|NCT02787798|Valsartan|valsartan|mesh-list
19553586|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19553587|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553588|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19553589|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19553590|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553591|NCT02787473|Docetaxel|docetaxel|mesh-list
19553592|NCT02787473|Pemetrexed|pemetrexed|mesh-list
19553593|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553594|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
19553595|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
19553596|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
19553597|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553598|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553599|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19553600|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19553601|NCT02787447|Gefitinib|gefitinib|mesh-list
19553602|NCT02787447|Thymalfasin|thymalfasin|mesh-list
19553603|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553604|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20110208|NCT00004059|Fluorouracil|fluorouracil|mesh-list
20110209|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
19553605|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553606|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553607|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19553608|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
19553609|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110210|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
20110211|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553610|NCT02787369|Idelalisib|idelalisib|mesh-list
19553611|NCT02787369|Ricolinostat|ricolinostat|mesh-list
19553612|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553613|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553614|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553615|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20110212|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110213|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110214|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553616|NCT02787317|Heparin|heparin|mesh-list
19553617|NCT02787317|Bivalirudin|bivalirudin|mesh-list
19553618|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
19553619|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19553620|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19553621|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553622|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
19553623|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19553624|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
19553625|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553626|NCT02787356|Lidocaine|lidocaine|mesh-list
19553627|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553628|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
19553629|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553630|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553631|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
19553632|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553633|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19553634|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19553635|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19553636|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553637|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553638|NCT02787278|Otaplimastat|otaplimastat|mesh-list
19553639|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19553640|NCT02787278|Protective Agents|protective agents|mesh-ancestor
19553641|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553642|NCT02786979|Aspirin|aspirin|mesh-list
19553643|NCT02786979|Beraprost|beraprost|mesh-list
19553644|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19553645|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553646|NCT02786979|Analgesics|analgesics|mesh-ancestor
19553647|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
19553648|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553649|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553650|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19553651|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553652|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19553653|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19553654|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553655|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19553656|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19553657|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553658|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
19553659|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
19553660|NCT02787226|Bupivacaine|bupivacaine|mesh-list
19553661|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553662|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
19553663|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553664|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553665|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
19553666|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553667|NCT02787018|Dexamethasone|dexamethasone|mesh-list
19553668|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
19553669|NCT02787018|Ropivacaine|ropivacaine|mesh-list
19553670|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19553671|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
19553672|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
19553673|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553674|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110215|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
19553675|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19553676|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
19553677|NCT02787018|Hormones|hormones|mesh-ancestor
19553678|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19553679|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20110216|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553680|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553681|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19553682|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553683|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553684|NCT02787018|Analgesics|analgesics|mesh-ancestor
19553685|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
19553686|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19553687|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19553688|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19553689|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553690|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553691|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553692|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553693|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
19553694|NCT02787031|Anesthetics|anesthetics|mesh-list
19553695|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553696|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553697|NCT02786992|Misoprostol|misoprostol|mesh-list
19553698|NCT02786992|Oxytocin|oxytocin|mesh-list
19553699|NCT02786992|Carbetocin|carbetocin|mesh-list
19553700|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
20110217|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20110218|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110219|NCT00004060|Exatecan|exatecan|mesh-list
20110220|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110221|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110222|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110223|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110224|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110225|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
20110226|NCT00004061|Ifosfamide|ifosfamide|mesh-list
19553701|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19553702|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553703|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19553704|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
19553705|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19553706|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19553707|NCT02786823|Folic Acid|folic acid|mesh-list
19553708|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
19553709|NCT02786823|Hydroxocobalamin|hydroxocobalamin|mesh-list
19553710|NCT02786823|Metformin|metformin|mesh-list
19553711|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19553712|NCT02786823|Vitamins|vitamins|mesh-ancestor
19553713|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
19553714|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553715|NCT02786823|Hematinics|hematinics|mesh-ancestor
19553716|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
19553717|NCT02786732|Ustekinumab|ustekinumab|mesh-list
19553718|NCT02786732|Brodalumab|brodalumab|mesh-list
19553719|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19553720|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
19553721|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
19553722|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553723|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
19553724|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19553725|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19553726|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19553727|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553728|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553729|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
19553730|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553731|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553732|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19553733|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553734|NCT02786667|Rotigotine|rotigotine|mesh-list
19553735|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
19553736|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
19553737|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553738|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553739|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553740|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
19553741|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19553742|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19553743|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19553744|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20110227|NCT00004061|Etoposide|etoposide|mesh-list
20110228|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110229|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
19553745|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553746|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
19553747|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553748|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553749|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19553750|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553751|NCT02786641|Cisplatin|cisplatin|mesh-list
19553752|NCT02786641|Docetaxel|docetaxel|mesh-list
19553753|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553754|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
19553755|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
19553756|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
19553757|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553758|NCT02786446|Naproxen|naproxen|mesh-list
19553759|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19553760|NCT02786446|Lidocaine|lidocaine|mesh-list
19553761|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553762|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
19553763|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553764|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553765|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
20110230|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110231|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110232|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110233|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
20110234|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110235|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110236|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110237|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110238|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110239|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19553766|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553767|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19553768|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19553769|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19553770|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553771|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553772|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553773|NCT02786446|Analgesics|analgesics|mesh-ancestor
19553774|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20110240|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110241|NCT00004062|Azacitidine|azacitidine|mesh-list
20110242|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110243|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
20110244|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110245|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110246|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110247|NCT00004063|Gemcitabine|gemcitabine|mesh-list
20110248|NCT00004063|Interferons|interferons|mesh-list
20110249|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
19553775|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553776|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
19553777|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19553778|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553779|NCT02786264|Fentanyl|fentanyl|mesh-list
19553780|NCT02786264|Midazolam|midazolam|mesh-list
19553781|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
19553782|NCT02786264|Propofol|propofol|mesh-list
19553783|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19553784|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553785|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553786|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19553787|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
19553788|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
19553789|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553790|NCT02786264|Analgesics|analgesics|mesh-ancestor
19553791|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
19553792|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553793|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20110250|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110251|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110252|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
19553794|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20308309|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
19553795|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20110253|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110254|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
20110255|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110256|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110257|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110258|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
19553796|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553797|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553798|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110259|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110260|NCT00004064|Oregovomab|oregovomab|mesh-list
20110261|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110262|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110263|NCT00004066|Gemcitabine|gemcitabine|mesh-list
20110264|NCT00004066|Docetaxel|docetaxel|mesh-list
20110265|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110266|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
20110267|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110268|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110269|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
19553799|NCT02786264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19553800|NCT02786264|Narcotics|narcotics|mesh-ancestor
19553801|NCT02786264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19553802|NCT02786264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19553803|NCT02786264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19553804|NCT02786264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19553805|NCT02786264|GABA Modulators|gaba modulators|mesh-ancestor
19553806|NCT02786264|GABA Agents|gaba agents|mesh-ancestor
19576369|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576370|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19576371|NCT05363319|Cemiplimab|cemiplimab|mesh-list
19576372|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110270|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110271|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110272|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19576373|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576374|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
19576375|NCT05358938|Ipilimumab|ipilimumab|mesh-list
19576376|NCT05358938|Avelumab|avelumab|mesh-list
19576377|NCT05358938|Cemiplimab|cemiplimab|mesh-list
19576378|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19576379|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576380|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576381|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576382|NCT05353933|Pantoprazole|pantoprazole|mesh-list
19576383|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19576384|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576385|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19576386|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576387|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576388|NCT05352685|Propofol|propofol|mesh-list
19576389|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576390|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576391|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576392|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576393|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
19576394|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
19576395|NCT05347069|Aspirin|aspirin|mesh-list
19576396|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19576397|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19576398|NCT05347069|Analgesics|analgesics|mesh-ancestor
19576399|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
19576400|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576401|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110273|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
20110274|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110275|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110276|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110277|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110278|NCT00004067|Paclitaxel|paclitaxel|mesh-list
20110279|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
20110280|NCT00004067|Doxorubicin|doxorubicin|mesh-list
19576402|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576403|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576404|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20110281|NCT00004067|Trastuzumab|trastuzumab|mesh-list
20110282|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20110283|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110284|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110285|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110286|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110287|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110288|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110289|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110290|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
20110291|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110292|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110293|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110294|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
20110295|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110296|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19553807|NCT02785978|Levodopa|levodopa|mesh-list
19553808|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19553809|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19553810|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
20110297|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110298|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110299|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110300|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110301|NCT00004068|Irinotecan|irinotecan|mesh-list
19553811|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553812|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553813|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553814|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
19553815|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19553816|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553817|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553818|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553819|NCT02786212|Analgesics|analgesics|mesh-ancestor
19553820|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
19553821|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553822|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19553823|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19553824|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19553825|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553826|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20110302|NCT00004068|Temozolomide|temozolomide|mesh-list
20110303|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110304|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110305|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110306|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110307|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110308|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110309|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
19553827|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553828|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19553829|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19553830|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19553831|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553832|NCT02785757|Thrombin|thrombin|mesh-list
19553833|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
19553834|NCT02785757|Coagulants|coagulants|mesh-ancestor
19553835|NCT02785601|Trazodone|trazodone|mesh-list
19553836|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19553837|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19553838|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553839|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553840|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604571|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604572|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
20604573|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604574|NCT02228031|Oxytocin|oxytocin|mesh-list
20604575|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
20604576|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20604577|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604578|NCT02228083|Lidocaine|lidocaine|mesh-list
20110310|NCT00004070|Interleukin-12|interleukin-12|mesh-list
20110311|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20110312|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
20604579|NCT02228083|Epinephrine|epinephrine|mesh-list
20604580|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553841|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19553842|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19553843|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553844|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553845|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553846|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
19553847|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19553848|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
19553849|NCT02785705|Vaccines|vaccines|mesh-list
19553850|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
19553851|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553852|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
19553853|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
19553854|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19553855|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553856|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19553857|NCT02785666|Ribavirin|ribavirin|mesh-list
19553858|NCT02785666|Grazoprevir|grazoprevir|mesh-list
19553859|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
19553860|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553861|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
20110313|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110314|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20110315|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20110316|NCT00004070|Growth Substances|growth substances|mesh-ancestor
20110317|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
20110318|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110319|NCT00004071|Prednisone|prednisone|mesh-list
20110320|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
20110321|NCT00004071|Leflunomide|leflunomide|mesh-list
20110322|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20110323|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
20110324|NCT00004071|Hormones|hormones|mesh-ancestor
20110325|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20110326|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553862|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553863|NCT02785614|Trazodone|trazodone|mesh-list
19553864|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19553865|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19553866|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553867|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553868|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19553869|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19553870|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19553871|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553872|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553873|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553874|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
19553875|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19553876|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
19553877|NCT02785653|Sevoflurane|sevoflurane|mesh-list
19553878|NCT02785653|Rocuronium|rocuronium|mesh-list
19553879|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19553880|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19553881|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
19553882|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
19553883|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553884|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553885|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19553886|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19553887|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19553888|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553889|NCT02785718|Hemostatics|hemostatics|mesh-list
19553890|NCT02785718|Coagulants|coagulants|mesh-ancestor
19553891|NCT02785549|Acetaminophen|acetaminophen|mesh-list
19553892|NCT02785549|Amoxicillin|amoxicillin|mesh-list
19553893|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
19553894|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
19553895|NCT02785549|Ibuprofen|ibuprofen|mesh-list
19553896|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19553897|NCT02785549|Analgesics|analgesics|mesh-ancestor
19553898|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
19553899|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20110327|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19553900|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553901|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
19553902|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19553903|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19553904|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553905|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19553906|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19553907|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553908|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19553909|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19553910|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19553911|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
19553912|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553913|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
19553914|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553915|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19553916|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19553917|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
20110328|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110329|NCT00004071|Analgesics|analgesics|mesh-ancestor
20110330|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
20110331|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20110332|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110333|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110334|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110335|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110336|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110337|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
20110338|NCT00004072|Carmustine|carmustine|mesh-list
20110339|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20110340|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110341|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
20120565|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19553918|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553919|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553920|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19553921|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
19553922|NCT02785146|Leucovorin|leucovorin|mesh-list
19553923|NCT02785146|Fluorouracil|fluorouracil|mesh-list
19553924|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
19553925|NCT02785146|Calcium|calcium|mesh-list
19553926|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
19553927|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19553928|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553929|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19553930|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
19553931|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553932|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19553933|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19553934|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19553935|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
19553936|NCT02785146|Antidotes|antidotes|mesh-ancestor
19553937|NCT02785146|Protective Agents|protective agents|mesh-ancestor
19553938|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
19553939|NCT02785146|Vitamins|vitamins|mesh-ancestor
19553940|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
19553941|NCT02785393|Doxazosin|doxazosin|mesh-list
19553942|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19553943|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19553944|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19553945|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19553946|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
19553947|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19553948|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553949|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553950|NCT02785276|Ropivacaine|ropivacaine|mesh-list
19553951|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553952|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
19553953|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553954|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553955|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
19553956|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553957|NCT02784899|Iloprost|iloprost|mesh-list
19553958|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19553959|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
19553960|NCT02784860|Lidocaine|lidocaine|mesh-list
19553961|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553962|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
19553963|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553964|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553965|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
19553966|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553967|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19553968|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19553969|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19553970|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19553971|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19553972|NCT02785055|Hydromorphone|hydromorphone|mesh-list
19553973|NCT02785055|Bupivacaine|bupivacaine|mesh-list
19553974|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
19553975|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
19553976|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553977|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553978|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
19553979|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553980|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19553981|NCT02785055|Narcotics|narcotics|mesh-ancestor
19553982|NCT02785055|Analgesics|analgesics|mesh-ancestor
19553983|NCT02785003|Acetaminophen|acetaminophen|mesh-list
19553984|NCT02785003|Ketamine|ketamine|mesh-list
19553985|NCT02785003|Morphine|morphine|mesh-list
19553986|NCT02785003|Narcotics|narcotics|mesh-list
20110342|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110343|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110344|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110345|NCT00004073|Suramin|suramin|mesh-list
20110346|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
20110347|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
20110348|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19553987|NCT02785003|Alvimopan|alvimopan|mesh-list
19553988|NCT02785003|Analgesics|analgesics|mesh-ancestor
19553989|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
19553990|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19553991|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19553992|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19553993|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19553994|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
19553995|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
19553996|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19553997|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19553998|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19553999|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554000|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554001|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19554002|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554003|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
19554004|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554005|NCT02785068|Leucovorin|leucovorin|mesh-list
19554006|NCT02785068|Fluorouracil|fluorouracil|mesh-list
19554007|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
19554008|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554009|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19554010|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554011|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554012|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
19554013|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554014|NCT02785068|Antidotes|antidotes|mesh-ancestor
19554015|NCT02785068|Protective Agents|protective agents|mesh-ancestor
19554016|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
19554017|NCT02785068|Vitamins|vitamins|mesh-ancestor
19554018|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
19554019|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19554020|NCT02784821|Gentamicins|gentamicins|mesh-list
19554021|NCT02784821|Ampicillin|ampicillin|mesh-list
19554022|NCT02784821|Cefotaxime|cefotaxime|mesh-list
19554023|NCT02784821|Cefoxitin|cefoxitin|mesh-list
19554024|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19554025|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554026|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
19554027|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19554028|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554029|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554030|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
19554031|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19554032|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
19554033|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19554034|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
19554035|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110349|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110350|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110351|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20110352|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20110353|NCT00004074|Carboplatin|carboplatin|mesh-list
20110354|NCT00004074|Trastuzumab|trastuzumab|mesh-list
20110355|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20110356|NCT00004074|Interleukin-12|interleukin-12|mesh-list
20110357|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110358|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110359|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20110360|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
20110361|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110362|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20110363|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20110364|NCT00004074|Growth Substances|growth substances|mesh-ancestor
20110365|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
20110366|NCT00004077|Paclitaxel|paclitaxel|mesh-list
20110367|NCT00004077|Ifosfamide|ifosfamide|mesh-list
20110368|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554036|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554037|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
19554038|NCT02784795|Gemcitabine|gemcitabine|mesh-list
19554039|NCT02784795|Carboplatin|carboplatin|mesh-list
19554040|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554041|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19554042|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
19554043|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554044|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
19554045|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554046|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554047|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554048|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
19554049|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554050|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
20110369|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110370|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110371|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110372|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110373|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554051|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
19554052|NCT02784626|Propofol|propofol|mesh-list
19554053|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19554054|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554055|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554056|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19554057|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
19554058|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
19554059|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554060|NCT02784626|Analgesics|analgesics|mesh-ancestor
19554061|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
19554062|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554063|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19554064|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19554065|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20110374|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110375|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
20110376|NCT00004078|Irinotecan|irinotecan|mesh-list
20110377|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20604581|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
20110378|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110379|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110380|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110381|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604582|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554066|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
19554067|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20110382|NCT00004081|Docetaxel|docetaxel|mesh-list
19554068|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554069|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
20110383|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604583|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604584|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
20604585|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554070|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19554071|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554072|NCT02784457|Cetrorelix|cetrorelix|mesh-list
19554073|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19554074|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
19554075|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20110384|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110385|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110386|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110387|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110388|NCT00004082|Gemcitabine|gemcitabine|mesh-list
20110389|NCT00004082|Carboplatin|carboplatin|mesh-list
20110390|NCT00004082|Docetaxel|docetaxel|mesh-list
20110391|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110392|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110393|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
20110394|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110395|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
20110396|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110397|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110398|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110399|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
20110400|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110401|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110402|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110403|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110404|NCT00004083|Cisplatin|cisplatin|mesh-list
20110405|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110406|NCT00004084|Epratuzumab|epratuzumab|mesh-list
20110407|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110408|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110409|NCT00004085|Antibodies|antibodies|mesh-list
20110410|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20110411|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
20110412|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110413|NCT00004086|Cytarabine|cytarabine|mesh-list
20110414|NCT00004086|Etoposide|etoposide|mesh-list
20110415|NCT00004086|Ifosfamide|ifosfamide|mesh-list
20110416|NCT00004086|Epratuzumab|epratuzumab|mesh-list
20110417|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110418|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110419|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110420|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110421|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110422|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110423|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110424|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
20110425|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
20110426|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110427|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110428|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
20110429|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110430|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20604586|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19554076|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110431|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
20110432|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110433|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20110434|NCT00004087|Antibodies|antibodies|mesh-list
20110435|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
20110436|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20110437|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
20110438|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110439|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110440|NCT00004089|Paclitaxel|paclitaxel|mesh-list
20110441|NCT00004089|Fluorouracil|fluorouracil|mesh-list
20110442|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
20110443|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110444|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110445|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110446|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110447|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110448|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110449|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
19554077|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
19554078|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554079|NCT02784743|Ivermectin|ivermectin|mesh-list
19554080|NCT02784743|Albendazole|albendazole|mesh-list
19554081|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19554082|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110450|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110451|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110452|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
20110453|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110454|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
20110455|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110456|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20110457|NCT00004090|Gemcitabine|gemcitabine|mesh-list
20110458|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554083|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
19554084|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
19554085|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19554086|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19554087|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
19554088|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
19554089|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
19554090|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554091|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554092|NCT02784483|Atezolizumab|atezolizumab|mesh-list
19554093|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554094|NCT02784561|Vidarabine|vidarabine|mesh-list
19554095|NCT02784561|Cytarabine|cytarabine|mesh-list
19554096|NCT02784561|Fludarabine|fludarabine|mesh-list
19554097|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
19554098|NCT02784561|Busulfan|busulfan|mesh-list
19554099|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
19554100|NCT02784561|Sargramostim|sargramostim|mesh-list
19554101|NCT02784561|Lenograstim|lenograstim|mesh-list
19554102|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554103|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19554104|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
19554105|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554106|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554107|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
19554108|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554109|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
19554110|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554111|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
19554112|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19554113|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110459|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110460|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
20110461|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110462|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
20110463|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110464|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110465|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110466|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
20110467|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110468|NCT00004091|Antibodies|antibodies|mesh-list
20110469|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
20110470|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110471|NCT00004094|Paclitaxel|paclitaxel|mesh-list
20110472|NCT00004094|Carboplatin|carboplatin|mesh-list
20110473|NCT00004094|Fluorouracil|fluorouracil|mesh-list
20110474|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
19554114|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19576405|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19576406|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576407|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19576408|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19576409|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576410|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
19576411|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19576412|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576413|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19576414|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576415|NCT05331027|Sevoflurane|sevoflurane|mesh-list
20110475|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110476|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110477|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110478|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110479|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110480|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110481|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
20110482|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110483|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554115|NCT02784340|Dexamethasone|dexamethasone|mesh-list
19554116|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
19554117|NCT02784340|Bupivacaine|bupivacaine|mesh-list
19554118|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19554119|NCT02784340|BB 1101|bb 1101|mesh-list
19554120|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554121|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
19554122|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
19554123|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554124|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554125|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554126|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
19554127|NCT02784340|Hormones|hormones|mesh-ancestor
19554128|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554129|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19554130|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554131|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
19554132|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554133|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554134|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
19554135|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
19554136|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554137|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
19554138|NCT02784327|Ropivacaine|ropivacaine|mesh-list
19554139|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
19554140|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
19554141|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554142|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554143|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
19554144|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554145|NCT02784223|Choline|choline|mesh-list
19554146|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
19554147|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19554148|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
19554149|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554150|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554151|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19554152|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
19554153|NCT02784392|Metoclopramide|metoclopramide|mesh-list
19554154|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
19554155|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
19554156|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554157|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554158|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554159|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19554160|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19554161|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
19554162|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554163|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554164|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
19554165|NCT02784054|Melphalan|melphalan|mesh-list
19554166|NCT02784054|Thiotepa|thiotepa|mesh-list
19554167|NCT02784054|Carboplatin|carboplatin|mesh-list
19554168|NCT02784054|Etoposide|etoposide|mesh-list
19554169|NCT02784054|Bleomycin|bleomycin|mesh-list
19554170|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554171|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
19554172|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554173|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554174|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19554175|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
19554176|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554177|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554178|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19554179|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554180|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19554181|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19554182|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110484|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
19554183|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19554184|NCT02784080|Isoantibodies|isoantibodies|mesh-list
19554185|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
19554186|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554187|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
19554188|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19554189|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110485|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110486|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
20110487|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110488|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20110489|NCT00004095|Gemcitabine|gemcitabine|mesh-list
20110490|NCT00004095|Irinotecan|irinotecan|mesh-list
20110491|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19554190|NCT02783924|Vitamins|vitamins|mesh-ancestor
19554191|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
19554192|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19554193|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
19554194|NCT02784015|Melphalan|melphalan|mesh-list
19554195|NCT02784015|Ifosfamide|ifosfamide|mesh-list
19554196|NCT02784015|Thiotepa|thiotepa|mesh-list
19554197|NCT02784015|Carboplatin|carboplatin|mesh-list
19554198|NCT02784015|Doxorubicin|doxorubicin|mesh-list
19554199|NCT02784015|Etoposide|etoposide|mesh-list
19554200|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554201|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
19554202|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554203|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554204|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19554205|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
19554206|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554207|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554208|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19554209|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19554210|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110492|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
20110493|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110494|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110495|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
20110496|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110497|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110498|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554211|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19554212|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554213|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554214|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
19554215|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19554216|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
19554217|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554218|NCT02783989|Protective Agents|protective agents|mesh-ancestor
19554219|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554220|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
19554221|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
19554222|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554223|NCT02783937|Lenograstim|lenograstim|mesh-list
19554224|NCT02783937|Sargramostim|sargramostim|mesh-list
19554225|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19554226|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
19554227|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554228|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
19554229|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19554230|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554231|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554232|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554233|NCT02783846|Analgesics|analgesics|mesh-ancestor
19554234|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
19554235|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554236|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19554237|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19554238|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19554239|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
19554240|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554241|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554242|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
19554243|NCT02783378|Antacids|antacids|mesh-ancestor
19554244|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554245|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554246|NCT02783508|Meperidine|meperidine|mesh-list
20110499|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
20110500|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110501|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19554247|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
20110502|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110503|NCT00004097|Gemcitabine|gemcitabine|mesh-list
20110504|NCT00004097|Paclitaxel|paclitaxel|mesh-list
20110505|NCT00004097|Fluorouracil|fluorouracil|mesh-list
20110506|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110507|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110508|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110509|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
19554248|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19554249|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
19554250|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
19554251|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554252|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554253|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554254|NCT02783508|Analgesics|analgesics|mesh-ancestor
19554255|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
19554256|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554257|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19554258|NCT02783508|Narcotics|narcotics|mesh-ancestor
19554259|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19554260|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
19554261|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
19554262|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19554263|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19554264|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
19554265|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554266|NCT02783586|Bupivacaine|bupivacaine|mesh-list
19554267|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
19554268|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
19554269|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554270|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554271|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
19554272|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554273|NCT02783547|Azacitidine|azacitidine|mesh-list
19554274|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19554275|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
19554276|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554277|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554278|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554279|NCT02783430|Ketamine|ketamine|mesh-list
19554280|NCT02783430|Milnacipran|milnacipran|mesh-list
19554281|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
19554282|NCT02783430|Analgesics|analgesics|mesh-ancestor
19554283|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
19554284|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554285|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554286|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19554287|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19554288|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
19554289|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
19554290|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554291|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19554292|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19554293|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554294|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110510|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110511|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110512|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110513|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
20110514|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
20110515|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110516|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110517|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554295|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19554296|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20110518|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
20110519|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554297|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19554298|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554299|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
19554300|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19554301|NCT02783638|Pregabalin|pregabalin|mesh-list
19554302|NCT02783638|Analgesics|analgesics|mesh-ancestor
19554303|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
19554304|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554305|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554306|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
19554307|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19554308|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19554309|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554310|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19554311|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19554312|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19554313|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554314|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19554315|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
19554316|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
19554317|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19554318|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110520|NCT00004099|Leucovorin|leucovorin|mesh-list
19554319|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554320|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554321|NCT02783053|Metformin|metformin|mesh-list
19554322|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19554323|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554324|NCT02783144|Dexamethasone|dexamethasone|mesh-list
19554325|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
19554326|NCT02783144|BB 1101|bb 1101|mesh-list
19554327|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554328|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
19554329|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
19554330|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554331|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554332|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554333|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
19554334|NCT02783144|Hormones|hormones|mesh-ancestor
19554335|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554336|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19554337|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554338|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
19554339|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554340|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554341|NCT02783040|Digoxin|digoxin|mesh-list
19554342|NCT02783040|Midazolam|midazolam|mesh-list
19554343|NCT02783040|BI 425809|bi 425809|mesh-list
19554344|NCT02783040|Omeprazole|omeprazole|mesh-list
19554345|NCT02783040|Warfarin|warfarin|mesh-list
19554346|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19554347|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19554348|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554349|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554350|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19554351|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19554352|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19554353|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19554354|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
19554355|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
19554356|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
19554357|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
19554358|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554359|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554360|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
19554361|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19554362|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554363|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19554364|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554365|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19554366|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19554367|NCT02783040|Protective Agents|protective agents|mesh-ancestor
19554368|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
19554369|NCT02783183|Pregabalin|pregabalin|mesh-list
19554370|NCT02783183|Analgesics|analgesics|mesh-ancestor
19554371|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
19554372|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20110521|NCT00004099|Fluorouracil|fluorouracil|mesh-list
19554373|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554374|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
19554375|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19554376|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19554377|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554378|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19554379|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19554380|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19554381|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554382|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19554383|NCT02783196|Liraglutide|liraglutide|mesh-list
19554384|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19554385|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554386|NCT02783196|Incretins|incretins|mesh-ancestor
19554387|NCT02783196|Hormones|hormones|mesh-ancestor
19554388|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554389|NCT02783222|Paclitaxel|paclitaxel|mesh-list
19554390|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554391|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554392|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
19554393|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
19554394|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
19554395|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554396|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19554397|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
19554398|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19554399|NCT02782897|Antibodies|antibodies|mesh-list
19554400|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
19554401|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554402|NCT02782624|Empagliflozin|empagliflozin|mesh-list
19554403|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19554404|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554405|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19554406|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554407|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
19554408|NCT02782754|Carboplatin|carboplatin|mesh-list
19554409|NCT02782754|Etoposide|etoposide|mesh-list
19554410|NCT02782754|Bleomycin|bleomycin|mesh-list
19554411|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554412|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
19554413|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554414|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554415|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19554416|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
19554417|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554418|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554419|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19554420|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554421|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19554422|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19554423|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554424|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19554425|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
19554426|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
19554427|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19554428|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19554429|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554430|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554431|NCT02782559|Urological Agents|urological agents|mesh-ancestor
19576416|NCT05331027|Desflurane|desflurane|mesh-list
20110522|NCT00004099|Calcium|calcium|mesh-list
20110523|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
19576417|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19576418|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19576419|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
19576420|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
19576421|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576422|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576423|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
19576424|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576425|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576426|NCT05321576|Narcotics|narcotics|mesh-ancestor
19576427|NCT05321576|Analgesics|analgesics|mesh-ancestor
19576428|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
19554432|NCT02782338|Diclofenac|diclofenac|mesh-list
19554433|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19554434|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554435|NCT02782338|Analgesics|analgesics|mesh-ancestor
19554436|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
19554437|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554438|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554439|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554440|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554441|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19554442|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554443|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554444|NCT02782260|Dipyridamole|dipyridamole|mesh-list
19554445|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19554446|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554447|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554448|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19554449|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
19554450|NCT02782273|Ketorolac|ketorolac|mesh-list
19554451|NCT02782273|Morphine|morphine|mesh-list
19554452|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19554453|NCT02782273|Narcotics|narcotics|mesh-ancestor
19554454|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554455|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554456|NCT02782273|Analgesics|analgesics|mesh-ancestor
19554457|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
20110524|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110525|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20110526|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110527|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
20110528|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110529|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110530|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110531|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
20110532|NCT00004099|Antidotes|antidotes|mesh-ancestor
20110533|NCT00004099|Protective Agents|protective agents|mesh-ancestor
20110534|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
20110535|NCT00004099|Vitamins|vitamins|mesh-ancestor
19554458|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554459|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19554460|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554461|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554462|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554463|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19554464|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554465|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554466|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19554467|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19554468|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
19554469|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554470|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554471|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19554472|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
19554473|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
19554474|NCT02782312|Hormones|hormones|mesh-ancestor
19554475|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554476|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
19554477|NCT02782403|Axitinib|axitinib|mesh-list
19554478|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554479|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19554480|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554481|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554482|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
19554483|NCT02782546|Tacrolimus|tacrolimus|mesh-list
19554484|NCT02782546|Sargramostim|sargramostim|mesh-list
19554485|NCT02782546|Lenograstim|lenograstim|mesh-list
19554486|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110536|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
20110537|NCT00004100|Gemcitabine|gemcitabine|mesh-list
20110538|NCT00004100|Vinorelbine|vinorelbine|mesh-list
20110539|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110540|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110541|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
19554487|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
19554488|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110542|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110543|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
20110544|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110545|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110546|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110547|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
20110548|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110549|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110550|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110551|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110552|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110553|NCT00004102|Leucovorin|leucovorin|mesh-list
19554489|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19554490|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554491|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110554|NCT00004102|Fluorouracil|fluorouracil|mesh-list
20110555|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
19554492|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19554493|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554494|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20110556|NCT00004102|Calcium|calcium|mesh-list
20110557|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
20110558|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20110559|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110560|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
20110561|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110562|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110563|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110564|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110565|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
20110566|NCT00004102|Antidotes|antidotes|mesh-ancestor
20110567|NCT00004102|Protective Agents|protective agents|mesh-ancestor
20110568|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
20110569|NCT00004102|Vitamins|vitamins|mesh-ancestor
20110570|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
20110571|NCT00004103|Irinotecan|irinotecan|mesh-list
20110572|NCT00004103|Floxuridine|floxuridine|mesh-list
20110573|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110574|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110575|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110576|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110577|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110578|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110579|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
20110580|NCT00004104|Interferons|interferons|mesh-list
19554495|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
19554496|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19554497|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554498|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19554499|NCT02782481|Levodopa|levodopa|mesh-list
19554500|NCT02782481|Carbidopa|carbidopa|mesh-list
19554501|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19554502|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19554503|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19554504|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
19554505|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20110581|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
20110582|NCT00004104|Interleukin-2|interleukin-2|mesh-list
20110583|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110584|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
20110585|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110586|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
20110587|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110588|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20110589|NCT00004104|Analgesics|analgesics|mesh-ancestor
20110590|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
20110591|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20110592|NCT00004105|Paclitaxel|paclitaxel|mesh-list
19554506|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554507|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554508|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19554509|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554510|NCT02782286|Ketorolac|ketorolac|mesh-list
19554511|NCT02782286|Morphine|morphine|mesh-list
20110593|NCT00004105|Vinorelbine|vinorelbine|mesh-list
20110594|NCT00004105|Estramustine|estramustine|mesh-list
20110595|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554512|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19554513|NCT02782286|Narcotics|narcotics|mesh-ancestor
19554514|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20110596|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110597|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110598|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110599|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110600|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554515|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554516|NCT02782286|Analgesics|analgesics|mesh-ancestor
19554517|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
19554518|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554519|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19554520|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554521|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554522|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554523|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19554524|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554525|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554526|NCT02782429|Ketamine|ketamine|mesh-list
19554527|NCT02782429|Analgesics|analgesics|mesh-ancestor
19554528|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
19554529|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554530|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554531|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19554532|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19554533|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
19554534|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
19554535|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554536|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19554537|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19554538|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554539|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554540|NCT02782221|Hormones|hormones|mesh-list
20110601|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110602|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
20110603|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20110604|NCT00004107|Epratuzumab|epratuzumab|mesh-list
20110605|NCT00004107|Antibodies|antibodies|mesh-list
20110606|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20110607|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
20110608|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110609|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110610|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110611|NCT00004108|Exatecan|exatecan|mesh-list
19554541|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554542|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554543|NCT02782208|Acipimox|acipimox|mesh-list
19554544|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19554545|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
19554546|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554547|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19554548|NCT02782182|Leucovorin|leucovorin|mesh-list
19554549|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
19554550|NCT02782182|Irinotecan|irinotecan|mesh-list
19554551|NCT02782182|Folfirinox|folfirinox|mesh-list
19554552|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554553|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19554554|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19554555|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554556|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554557|NCT02782182|Antidotes|antidotes|mesh-ancestor
19554558|NCT02782182|Protective Agents|protective agents|mesh-ancestor
19554559|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554560|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
19554561|NCT02782182|Vitamins|vitamins|mesh-ancestor
19554562|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
19554563|NCT02782078|Clindamycin|clindamycin|mesh-list
19554564|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
19554565|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
19554566|NCT02782078|Rifampin|rifampin|mesh-list
19554567|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19554568|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554569|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20110612|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19554570|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554571|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554572|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19554573|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
19554574|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
19554575|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19554576|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19554577|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19554578|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19554579|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19554580|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19554581|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20110613|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110614|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110615|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110616|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110617|NCT00004109|Doxorubicin|doxorubicin|mesh-list
20110618|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20110619|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110620|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110621|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110622|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110623|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110624|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110625|NCT00004110|Etoposide|etoposide|mesh-list
20110626|NCT00004110|Isotretinoin|isotretinoin|mesh-list
20110627|NCT00004110|Antibodies|antibodies|mesh-list
20110628|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20110629|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
20110630|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110631|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110632|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110633|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110634|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110635|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110636|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554582|NCT02782052|Bromides|bromides|mesh-list
19554583|NCT02782052|Albuterol|albuterol|mesh-list
19554584|NCT02782052|Ipratropium|ipratropium|mesh-list
19554585|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
19554586|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19554587|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
19554588|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554589|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554590|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19554591|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
19554592|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
19554593|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19554594|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19554595|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19554596|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19554597|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
19554598|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554599|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554600|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19554601|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
19554602|NCT02781909|Ibuprofen|ibuprofen|mesh-list
19554603|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19554604|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554605|NCT02781909|Analgesics|analgesics|mesh-ancestor
19554606|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
19554607|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554608|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554609|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554610|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554611|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19554612|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554613|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554614|NCT02781766|Thrombin|thrombin|mesh-list
19554615|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
19554616|NCT02781766|Coagulants|coagulants|mesh-ancestor
19554617|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
19554618|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20110637|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
19554619|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19554620|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554621|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
19554622|NCT02781597|Coagulants|coagulants|mesh-ancestor
19554623|NCT02781805|Alendronate|alendronate|mesh-list
19554624|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19554625|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554626|NCT02781493|Prucalopride|prucalopride|mesh-list
19554627|NCT02781493|Laxatives|laxatives|mesh-ancestor
19554628|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554629|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19554630|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19554631|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
19554632|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554633|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554634|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554635|NCT02781753|Interferons|interferons|mesh-list
19554636|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
19554637|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
19554638|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554639|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
19554640|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554641|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
19554642|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554643|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19554644|NCT02781779|Laxatives|laxatives|mesh-ancestor
19554645|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554646|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
19554647|NCT02781467|Fludarabine|fludarabine|mesh-list
19554648|NCT02781467|Interleukin-2|interleukin-2|mesh-list
19554649|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554650|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
19554651|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554652|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554653|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19554654|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
19554655|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554656|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554657|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19554658|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554659|NCT02781467|Analgesics|analgesics|mesh-ancestor
19554660|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
19554661|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554662|NCT02781506|Nivolumab|nivolumab|mesh-list
19554663|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110638|NCT00004112|Prednisone|prednisone|mesh-list
20110639|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
20110640|NCT00004112|Rituximab|rituximab|mesh-list
20110641|NCT00004112|Doxorubicin|doxorubicin|mesh-list
20110642|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20110643|NCT00004112|Vincristine|vincristine|mesh-list
20110644|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110645|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
20110646|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110647|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110648|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110649|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
20110650|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110651|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110652|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110653|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20110654|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110655|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110656|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110657|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110658|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20110659|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
20110660|NCT00004112|Hormones|hormones|mesh-ancestor
20110661|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20110662|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20110663|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554664|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554665|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19554666|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607948|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554667|NCT02781415|Morphine|morphine|mesh-list
19554668|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19554669|NCT02781415|Narcotics|narcotics|mesh-ancestor
19554670|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554671|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554672|NCT02781415|Analgesics|analgesics|mesh-ancestor
19554673|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
19554674|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554675|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
19554676|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19554677|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554678|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554679|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554680|NCT02781246|Analgesics|analgesics|mesh-ancestor
19554681|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
19554682|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554683|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19554684|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19554685|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19554686|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
19554687|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554688|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554689|NCT02781064|Atorvastatin|atorvastatin|mesh-list
19554690|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19554691|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19554692|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
19554693|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554694|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19554695|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19554696|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554697|NCT02780804|Entinostat|entinostat|mesh-list
19554698|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19554699|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554700|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554701|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554702|NCT02780882|Pasireotide|pasireotide|mesh-list
19554703|NCT02780882|Hormones|hormones|mesh-ancestor
19554704|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554705|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554706|NCT02780778|Docetaxel|docetaxel|mesh-list
19554707|NCT02780778|Apatinib|apatinib|mesh-list
19554708|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554709|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
19554710|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
19554711|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
19554712|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554713|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19554714|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576429|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576430|NCT05321251|Insulin|insulin|mesh-list
19576431|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19576432|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576433|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
19576434|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576435|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576436|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576437|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19576438|NCT05320705|Analgesics|analgesics|mesh-ancestor
19576439|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
19576440|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576441|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19576442|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19576443|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576444|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576445|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576446|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576447|NCT05297682|Propofol|propofol|mesh-list
19576448|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
19576449|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576450|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576451|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576452|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576453|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
19576454|NCT05296629|Doxycycline|doxycycline|mesh-list
20110664|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110665|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110666|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110667|NCT00004113|Temozolomide|temozolomide|mesh-list
20110668|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110669|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
20110670|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110671|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110672|NCT00004114|Cytarabine|cytarabine|mesh-list
20110673|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
20110674|NCT00004114|Fludarabine|fludarabine|mesh-list
20110675|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
20110676|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110677|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
20110678|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110679|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110680|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110681|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
20110682|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110683|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110684|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110685|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110686|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
19554715|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
19554716|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19554717|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554718|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554719|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554720|NCT02780427|Analgesics|analgesics|mesh-ancestor
19554721|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
19554722|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554723|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19554724|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19554725|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19554726|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
19554727|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554728|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554729|NCT02780479|Dexamethasone|dexamethasone|mesh-list
19554730|NCT02780479|Prednisone|prednisone|mesh-list
19554731|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554732|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
19554733|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
19554734|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20110687|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
20110688|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110689|NCT00004115|Antibodies|antibodies|mesh-list
20110690|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20110691|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
20110692|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110693|NCT00004122|Interferons|interferons|mesh-list
20110694|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
20110695|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
20110696|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110697|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
20110698|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110699|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
20110700|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110701|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20110702|NCT00004123|Doxorubicin|doxorubicin|mesh-list
20110703|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19554735|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554736|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554737|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
19554738|NCT02780479|Hormones|hormones|mesh-ancestor
19576455|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20110704|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110705|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110706|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110707|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110708|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110709|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110710|NCT00004125|Tamoxifen|tamoxifen|mesh-list
20110711|NCT00004125|Paclitaxel|paclitaxel|mesh-list
20110712|NCT00004125|Docetaxel|docetaxel|mesh-list
20110713|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
20110714|NCT00004125|Doxorubicin|doxorubicin|mesh-list
20110715|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20308310|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19554739|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554740|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19554741|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554742|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
19554743|NCT02780505|Vitamins|vitamins|mesh-ancestor
19554744|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
19554745|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554746|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
19554747|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554748|NCT02780505|Protective Agents|protective agents|mesh-ancestor
19554749|NCT02780102|Methylphenidate|methylphenidate|mesh-list
19554750|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19554751|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554752|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19554753|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19554754|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19554755|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554756|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
20110716|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110717|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110718|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110719|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110720|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110721|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110722|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110723|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
20110724|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110725|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110726|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110727|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
20110728|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19554757|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554758|NCT02780128|Ceritinib|ceritinib|mesh-list
19554759|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554760|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19554761|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554762|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554763|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
19554764|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19554765|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19554766|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554767|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
19554768|NCT02780245|Coagulants|coagulants|mesh-ancestor
19554769|NCT02780323|Celecoxib|celecoxib|mesh-list
19554770|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19554771|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554772|NCT02780323|Analgesics|analgesics|mesh-ancestor
19554773|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
19554774|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554775|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554776|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554777|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554778|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19554779|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19554780|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554781|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554782|NCT02780310|Lenvatinib|lenvatinib|mesh-list
19554783|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554784|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19554785|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554786|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554787|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
19554788|NCT02779751|Anastrozole|anastrozole|mesh-list
19554789|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19554790|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554791|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19554792|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19554793|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19554794|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576456|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110729|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110730|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19554795|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554796|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19554797|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
19554798|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554799|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554800|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19554801|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19554802|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554803|NCT02779881|Caseins|caseins|mesh-list
19554804|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
19554805|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
19554806|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554807|NCT02779777|Tipifarnib|tipifarnib|mesh-list
20110731|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110732|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110733|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20110734|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
20110735|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554808|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554809|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
19554810|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
19554811|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
19554812|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554813|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554814|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554815|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19554816|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19554817|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19554818|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19554819|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19554820|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
19554821|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19554822|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554823|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
19554824|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
19554825|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554826|NCT02779634|Vitamins|vitamins|mesh-ancestor
19554827|NCT02779348|Warfarin|warfarin|mesh-list
20110736|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20110737|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20110738|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20110739|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20110740|NCT00004126|Paclitaxel|paclitaxel|mesh-list
19554828|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
19554829|NCT02779608|Docetaxel|docetaxel|mesh-list
19554830|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554831|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
19554832|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
19554833|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
19554834|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554835|NCT02779582|Progesterone|progesterone|mesh-list
19554836|NCT02779582|Progestins|progestins|mesh-ancestor
20110741|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
20110742|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554837|NCT02779582|Hormones|hormones|mesh-ancestor
20110743|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110744|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
19554838|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554839|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554840|NCT02779387|Goserelin|goserelin|mesh-list
19554841|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19554842|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554843|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
19554844|NCT02779283|Leucovorin|leucovorin|mesh-list
19554845|NCT02779283|Folic Acid|folic acid|mesh-list
19554846|NCT02779283|Cytarabine|cytarabine|mesh-list
19554847|NCT02779283|Dexamethasone|dexamethasone|mesh-list
19554848|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
19554849|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19554850|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19554851|NCT02779283|Prednisolone|prednisolone|mesh-list
19554852|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
19554853|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
19554854|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
19554855|NCT02779283|Rituximab|rituximab|mesh-list
19554856|NCT02779283|Doxorubicin|doxorubicin|mesh-list
19554857|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19554858|NCT02779283|Methotrexate|methotrexate|mesh-list
19554859|NCT02779283|Vincristine|vincristine|mesh-list
19554860|NCT02779283|Sorafenib|sorafenib|mesh-list
19554861|NCT02779283|Sunitinib|sunitinib|mesh-list
19554862|NCT02779283|Dasatinib|dasatinib|mesh-list
19554863|NCT02779283|Idarubicin|idarubicin|mesh-list
19554864|NCT02779283|Ponatinib|ponatinib|mesh-list
19554865|NCT02779283|Idelalisib|idelalisib|mesh-list
19554866|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19554867|NCT02779283|Antibodies|antibodies|mesh-list
19554868|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
19554869|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19554870|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19554871|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
20110745|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110746|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110747|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110748|NCT00004127|Leucovorin|leucovorin|mesh-list
20110749|NCT00004127|Fluorouracil|fluorouracil|mesh-list
20110750|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
20110751|NCT00004127|Calcium|calcium|mesh-list
20110752|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
20110753|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20110754|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110755|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
20110756|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110757|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110758|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110759|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110760|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
19554872|NCT02779283|BB 1101|bb 1101|mesh-list
19554873|NCT02779283|Calcium|calcium|mesh-list
19554874|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
19554875|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554876|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
19554877|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554878|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554879|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19554880|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
19554881|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554882|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554883|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19554884|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554885|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
19554886|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
19554887|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554888|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554889|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
19554890|NCT02779283|Hormones|hormones|mesh-ancestor
19554891|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19554892|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19554893|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19554894|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19554895|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19554896|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554897|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19554898|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19554899|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19554900|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
19554901|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19554902|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19554903|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
19554904|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
19554905|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19554906|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19554907|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
19554908|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554909|NCT02779283|Antidotes|antidotes|mesh-ancestor
19554910|NCT02779283|Protective Agents|protective agents|mesh-ancestor
19554911|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
19554912|NCT02779283|Vitamins|vitamins|mesh-ancestor
19554913|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
20110761|NCT00004127|Antidotes|antidotes|mesh-ancestor
20110762|NCT00004127|Protective Agents|protective agents|mesh-ancestor
19554914|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19554915|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
19554916|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110763|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
20110764|NCT00004127|Vitamins|vitamins|mesh-ancestor
20110765|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
20110766|NCT00004128|Cytarabine|cytarabine|mesh-list
20110767|NCT00004128|Aldesleukin|aldesleukin|mesh-list
20110768|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
20110769|NCT00004128|Busulfan|busulfan|mesh-list
20110770|NCT00004128|Etoposide|etoposide|mesh-list
20110771|NCT00004128|Daunorubicin|daunorubicin|mesh-list
20110772|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110773|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
20110774|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110775|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110776|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110777|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
19554917|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
19554918|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19554919|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19554920|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19554921|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19554922|NCT02779283|Growth Substances|growth substances|mesh-ancestor
19554923|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19554924|NCT02779283|Hematinics|hematinics|mesh-ancestor
19554925|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
19554926|NCT02779413|Insulin|insulin|mesh-list
19554927|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19554928|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554929|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
19554930|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20110778|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110779|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110780|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110781|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110782|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110783|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110784|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110785|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110786|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
20110787|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
20110788|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554931|NCT02779270|Protective Agents|protective agents|mesh-ancestor
19554932|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110789|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110790|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20110791|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20110792|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
20110793|NCT00004132|Ifosfamide|ifosfamide|mesh-list
20110794|NCT00004132|Etoposide|etoposide|mesh-list
20110795|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110796|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
20110797|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110798|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110799|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110800|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
20110801|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110802|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110803|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110804|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110805|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110806|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110807|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554933|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
20110808|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
20110809|NCT00004135|Fludarabine|fludarabine|mesh-list
20110810|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
20110811|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110812|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
20110813|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110814|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110815|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110816|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
20110817|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110818|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110819|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110820|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110821|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
19554934|NCT02779465|Vitamin D|vitamin d|mesh-list
20110822|NCT00004137|Paclitaxel|paclitaxel|mesh-list
20110823|NCT00004137|Carboplatin|carboplatin|mesh-list
20110824|NCT00004137|Topotecan|topotecan|mesh-list
20110825|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110826|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110827|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110828|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110829|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110830|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110831|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110832|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110833|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110834|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20110835|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19554935|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
19554936|NCT02779465|Vitamins|vitamins|mesh-ancestor
19554937|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
19554938|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554939|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20110836|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110837|NCT00004139|Gemcitabine|gemcitabine|mesh-list
20110838|NCT00004139|Docetaxel|docetaxel|mesh-list
19554940|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19554941|NCT02779530|Diclofenac|diclofenac|mesh-list
19554942|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19554943|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554944|NCT02779530|Analgesics|analgesics|mesh-ancestor
19554945|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
19554946|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554947|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554948|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554949|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554950|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19554951|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554952|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554953|NCT02779192|Ebselen|ebselen|mesh-list
19554954|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19554955|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19554956|NCT02779192|Analgesics|analgesics|mesh-ancestor
19554957|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
19554958|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19554959|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554960|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554961|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554962|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19554963|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554964|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
19554965|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554966|NCT02779192|Protective Agents|protective agents|mesh-ancestor
19554967|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19554968|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554969|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19576457|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
20110839|NCT00004139|Irinotecan|irinotecan|mesh-list
20110840|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19576458|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19576459|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19576460|NCT05294146|Clofazimine|clofazimine|mesh-list
19576461|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576462|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
19576463|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19576464|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576465|NCT05279092|Dexamethasone|dexamethasone|mesh-list
19576466|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
19576467|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19576468|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19576469|NCT05279092|Prednisolone|prednisolone|mesh-list
19576470|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
20110841|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
20110842|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110843|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110844|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
20110845|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110846|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576471|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
19576472|NCT05279092|Bupivacaine|bupivacaine|mesh-list
20110847|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20607949|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19554970|NCT02778906|Abatacept|abatacept|mesh-list
19554971|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19554972|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554973|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554974|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19554975|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
19554976|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19554977|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554978|NCT02779569|Decitabine|decitabine|mesh-list
19554979|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19554980|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
19554981|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554982|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19554983|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554984|NCT02778828|Linezolid|linezolid|mesh-list
19554985|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19554986|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19554987|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19554988|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19554989|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19554990|NCT02778789|Adalimumab|adalimumab|mesh-list
19554991|NCT02778789|Etanercept|etanercept|mesh-list
19554992|NCT02778789|Golimumab|golimumab|mesh-list
19554993|NCT02778789|Infliximab|infliximab|mesh-list
19554994|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
19554995|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19554996|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19554997|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
19554998|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19554999|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19555000|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555001|NCT02778789|Analgesics|analgesics|mesh-ancestor
19555002|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
19555003|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555004|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555005|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555006|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
19555007|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19555008|NCT02778958|Acetaminophen|acetaminophen|mesh-list
19555009|NCT02778958|Ibuprofen|ibuprofen|mesh-list
19555010|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20110848|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
20110849|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110850|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110851|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
19555011|NCT02778958|Analgesics|analgesics|mesh-ancestor
19555012|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
19555013|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555014|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555015|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
19555016|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19555017|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555018|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555019|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19555020|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555021|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555022|NCT02778971|Flutemetamol|flutemetamol|mesh-list
19555023|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19555024|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555025|NCT02778945|Rocuronium|rocuronium|mesh-list
19555026|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19555027|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19555028|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19555029|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555030|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555031|NCT02778776|Metformin|metformin|mesh-list
19555032|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19555033|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555034|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
20110852|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110853|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20110854|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110855|NCT00004141|Dacarbazine|dacarbazine|mesh-list
19555035|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19555036|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555037|NCT02778919|Leuprolide|leuprolide|mesh-list
19555038|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19555039|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
19555040|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19555041|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555042|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19555043|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555044|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19555045|NCT02779153|Hormones|hormones|mesh-ancestor
19555046|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555047|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555048|NCT02778893|Thalidomide|thalidomide|mesh-list
19555049|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555050|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
19555051|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555052|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
19555053|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19555054|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555055|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19555056|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19555057|NCT02778893|Growth Substances|growth substances|mesh-ancestor
19555058|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
19555059|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555060|NCT02778659|Zolpidem|zolpidem|mesh-list
19555061|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19555062|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19555063|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555064|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555065|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19555066|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
19555067|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
19555068|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555069|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555070|NCT02778594|Levodopa|levodopa|mesh-list
19555071|NCT02778594|Benserazide|benserazide|mesh-list
19555072|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19555073|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19555074|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
19555075|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555076|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555077|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110856|NCT00004141|Molgramostim|molgramostim|mesh-list
20110857|NCT00004141|Sargramostim|sargramostim|mesh-list
20110858|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110859|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
20110860|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110861|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110862|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
20110863|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110864|NCT00004142|Fluorouracil|fluorouracil|mesh-list
20110865|NCT00004142|Floxuridine|floxuridine|mesh-list
20110866|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
20110867|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110868|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110869|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110870|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110871|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
20110872|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110873|NCT00004144|Gemcitabine|gemcitabine|mesh-list
20110874|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
20110875|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110876|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
20110877|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110878|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110879|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
20110880|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110881|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110882|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110883|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
20110884|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110885|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20110886|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
20110887|NCT00004145|Fludarabine|fludarabine|mesh-list
20110888|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
19555078|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110889|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20110890|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110891|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
20110892|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110893|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110894|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110895|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
20110896|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110897|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555079|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19555080|NCT02778425|Somatostatin|somatostatin|mesh-list
19555081|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19555082|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555083|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555084|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555085|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555086|NCT02778425|Hormones|hormones|mesh-ancestor
20110898|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110899|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110900|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
20110901|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
20110902|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110903|NCT00004150|Leucovorin|leucovorin|mesh-list
20110904|NCT00004150|Fluorouracil|fluorouracil|mesh-list
20110905|NCT00004150|Calcium|calcium|mesh-list
20110906|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
20110907|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20110908|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110909|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
20110910|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110911|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110912|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110913|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110914|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
20110915|NCT00004150|Antidotes|antidotes|mesh-ancestor
20110916|NCT00004150|Protective Agents|protective agents|mesh-ancestor
20110917|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
20110918|NCT00004150|Vitamins|vitamins|mesh-ancestor
20110919|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
20110920|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20110921|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20110922|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110923|NCT00004154|Fenretinide|fenretinide|mesh-list
20110924|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110925|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20110926|NCT00004154|Protective Agents|protective agents|mesh-ancestor
20110927|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110928|NCT00004157|Oprelvekin|oprelvekin|mesh-list
20110929|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110930|NCT00004158|Melphalan|melphalan|mesh-list
20110931|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20110932|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
20110933|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110934|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110935|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20110936|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110937|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
20110938|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110939|NCT00004159|Gemcitabine|gemcitabine|mesh-list
20110940|NCT00004159|Paclitaxel|paclitaxel|mesh-list
20110941|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19555087|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555088|NCT02778360|Methylphenidate|methylphenidate|mesh-list
19555089|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19555090|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555091|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19555092|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19555093|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19555094|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555095|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
19555096|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20110942|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110943|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
20110944|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
19555097|NCT02778308|Gemcitabine|gemcitabine|mesh-list
19555098|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555099|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555100|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
19555101|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555102|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
19555103|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555104|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555105|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555106|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
19555107|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555108|NCT02778178|Clonidine|clonidine|mesh-list
19555109|NCT02778178|Ropivacaine|ropivacaine|mesh-list
19555110|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
19555111|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
19555112|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20110945|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110946|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110947|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110948|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
20110949|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
20110950|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20110951|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110952|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555113|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555114|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
19555115|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555116|NCT02778178|Analgesics|analgesics|mesh-ancestor
19555117|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19555118|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
19555119|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
19555120|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19555121|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19555122|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19555123|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
20110953|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
20110954|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110955|NCT00004160|Gemcitabine|gemcitabine|mesh-list
20110956|NCT00004160|Paclitaxel|paclitaxel|mesh-list
20110957|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110958|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110959|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
19555124|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555125|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555126|NCT02778191|Carboplatin|carboplatin|mesh-list
19555127|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555128|NCT02777814|Entecavir|entecavir|mesh-list
19555129|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
19555130|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555131|NCT02777866|Bupivacaine|bupivacaine|mesh-list
19555132|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
19555133|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
19555134|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555135|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555136|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
19555137|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555138|NCT02777801|Entecavir|entecavir|mesh-list
19555139|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
19555140|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555141|NCT02777788|Gemcitabine|gemcitabine|mesh-list
19555142|NCT02777788|Paclitaxel|paclitaxel|mesh-list
19555143|NCT02777788|Vinorelbine|vinorelbine|mesh-list
19555144|NCT02777788|Docetaxel|docetaxel|mesh-list
19555145|NCT02777788|Carboplatin|carboplatin|mesh-list
19555146|NCT02777788|Pemetrexed|pemetrexed|mesh-list
19555147|NCT02777788|Cisplatin|cisplatin|mesh-list
19555148|NCT02777788|Nedaplatin|nedaplatin|mesh-list
19555149|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20110960|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
20110961|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110962|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110963|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110964|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
20110965|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
20110966|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555150|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555151|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
19555152|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
19555153|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
20110967|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110968|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110969|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
20110970|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110971|NCT00004161|Fenretinide|fenretinide|mesh-list
20110972|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110973|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20110974|NCT00004161|Protective Agents|protective agents|mesh-ancestor
20110975|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110976|NCT00004162|Doxorubicin|doxorubicin|mesh-list
20110977|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20110978|NCT00004162|Methotrexate|methotrexate|mesh-list
20110979|NCT00004162|Vincristine|vincristine|mesh-list
19555154|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555155|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555156|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
19555157|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
19555158|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555159|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555160|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555161|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
19555162|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555163|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19555164|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19555165|NCT02777736|Methotrexate|methotrexate|mesh-list
19555166|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19555167|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
19555168|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19555169|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555170|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555171|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
19555172|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555173|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555174|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
19555175|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555176|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19555177|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555178|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
19555179|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555180|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19555181|NCT02777710|Durvalumab|durvalumab|mesh-list
20110980|NCT00004162|Sargramostim|sargramostim|mesh-list
20110981|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20110982|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20110983|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20110984|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20110985|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20110986|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20110987|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20110988|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
20110989|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20110990|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20110991|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20110992|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
20110993|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
20110994|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20110995|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20110996|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
20110997|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20110998|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20110999|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111000|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111001|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111002|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111003|NCT00004163|Trastuzumab|trastuzumab|mesh-list
20111004|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20111005|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111006|NCT00004164|Leucovorin|leucovorin|mesh-list
19555182|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19555183|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555184|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
19555185|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111007|NCT00004164|Docetaxel|docetaxel|mesh-list
20111008|NCT00004164|Fluorouracil|fluorouracil|mesh-list
20111009|NCT00004164|Calcium|calcium|mesh-list
20111010|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
19555186|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
19555187|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555188|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
19555189|NCT02777723|Protective Agents|protective agents|mesh-ancestor
19555190|NCT02777411|Vaccines|vaccines|mesh-list
19555191|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
19555192|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555193|NCT02777489|Perindopril|perindopril|mesh-list
19555194|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19555195|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
19555196|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555197|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555198|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19555199|NCT02777580|Tenecteplase|tenecteplase|mesh-list
19555200|NCT02777580|Clopidogrel|clopidogrel|mesh-list
19555201|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20111011|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111012|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111013|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111014|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111015|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111016|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20111017|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111018|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
20111019|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111020|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555202|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19555203|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19555204|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19555205|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
19555206|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20111021|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
20111022|NCT00004164|Antidotes|antidotes|mesh-ancestor
20111023|NCT00004164|Protective Agents|protective agents|mesh-ancestor
20111024|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
20111025|NCT00004164|Vitamins|vitamins|mesh-ancestor
20111026|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
20111027|NCT00004173|Paclitaxel|paclitaxel|mesh-list
20111028|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
20111029|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111030|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111031|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111032|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111033|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111034|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111035|NCT00004174|Paclitaxel|paclitaxel|mesh-list
20111036|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
20111037|NCT00004174|Thiotepa|thiotepa|mesh-list
20111038|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19555207|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555208|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555209|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19555210|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19576473|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19576474|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
19576475|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19576476|NCT05279092|BB 1101|bb 1101|mesh-list
19576477|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576478|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
20111039|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111040|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
19576479|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
19576480|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576481|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576482|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576483|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
19576484|NCT05279092|Hormones|hormones|mesh-ancestor
19576485|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576486|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576487|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576488|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
20111041|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111042|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
19576489|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
19576490|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555211|NCT02777671|Gliclazide|gliclazide|mesh-list
19555212|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19555213|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
19555214|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19555215|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19555216|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19555217|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555218|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19555219|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555220|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
20111043|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111044|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111045|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
20111046|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111047|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111048|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111049|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
20111050|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111051|NCT00004176|Etoposide|etoposide|mesh-list
20111052|NCT00004176|Amifostine|amifostine|mesh-list
20111053|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111054|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111055|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111056|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111057|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111058|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555221|NCT02777619|Propofol|propofol|mesh-list
19555222|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19555223|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555224|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555225|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19555226|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
19555227|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
19555228|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555229|NCT02777619|Analgesics|analgesics|mesh-ancestor
19555230|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
19555231|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555232|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19555233|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19555234|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19555235|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555236|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555237|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555238|NCT02777320|Acetaminophen|acetaminophen|mesh-list
19555239|NCT02777320|Ibuprofen|ibuprofen|mesh-list
19555240|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19555241|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555242|NCT02777320|Analgesics|analgesics|mesh-ancestor
19555243|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
19555244|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555245|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555246|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555247|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555248|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19555249|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555250|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555251|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
20111059|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20111060|NCT00004176|Protective Agents|protective agents|mesh-ancestor
20111061|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120566|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120567|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120568|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120569|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120570|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120571|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20120572|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120573|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
20120574|NCT00006374|Paclitaxel|paclitaxel|mesh-list
20120575|NCT00006374|Etoposide|etoposide|mesh-list
20120576|NCT00006374|Topotecan|topotecan|mesh-list
20120577|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19555252|NCT02777229|Tenofovir|tenofovir|mesh-list
19555253|NCT02777229|Lamivudine|lamivudine|mesh-list
20111062|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20111063|NCT00004177|Antibodies|antibodies|mesh-list
20111064|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
20111065|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20111066|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
20111067|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111068|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111069|NCT00004179|Prednisone|prednisone|mesh-list
20111070|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
20111071|NCT00004179|Rituximab|rituximab|mesh-list
20111072|NCT00004179|Doxorubicin|doxorubicin|mesh-list
20111073|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19555254|NCT02777229|Efavirenz|efavirenz|mesh-list
19555255|NCT02777229|Dolutegravir|dolutegravir|mesh-list
19555256|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
19555257|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555258|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19555259|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19555260|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555261|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555262|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19555263|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19555264|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19555265|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19555266|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20111074|NCT00004179|Vincristine|vincristine|mesh-list
20111075|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111076|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
20111077|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111078|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555267|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19555268|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19555269|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19555270|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19555271|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19555272|NCT02777190|Misoprostol|misoprostol|mesh-list
19555273|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19555274|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
20111079|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111080|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
20111081|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111082|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111083|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111084|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19555275|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19555276|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555277|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19555278|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111085|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111086|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111087|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111088|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111089|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20111090|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
20111091|NCT00004179|Hormones|hormones|mesh-ancestor
20111092|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111093|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111094|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111095|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111096|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111097|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111098|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
20111099|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20111100|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111101|NCT00004183|Capecitabine|capecitabine|mesh-list
20111102|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111103|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
20111104|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111105|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111106|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20111107|NCT00004184|Antibodies|antibodies|mesh-list
20111108|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20111109|NCT00004184|Sargramostim|sargramostim|mesh-list
19555279|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
20111110|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
20111111|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
20111112|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111113|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111114|NCT00004184|Antacids|antacids|mesh-ancestor
20111115|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111116|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111117|NCT00004186|Carboplatin|carboplatin|mesh-list
20111118|NCT00004186|Etoposide|etoposide|mesh-list
20111119|NCT00004186|Topotecan|topotecan|mesh-list
20111120|NCT00004186|Ifosfamide|ifosfamide|mesh-list
19555280|NCT02777073|Liraglutide|liraglutide|mesh-list
19555281|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
19555282|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19555283|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555284|NCT02777073|Incretins|incretins|mesh-ancestor
19555285|NCT02777073|Hormones|hormones|mesh-ancestor
19555286|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555287|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19555288|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555289|NCT02776956|Atorvastatin|atorvastatin|mesh-list
19555290|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19555291|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19555292|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
19555293|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555294|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19555295|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19555296|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555297|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
19555298|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19555299|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
19555300|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555301|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
19555302|NCT02776943|Protective Agents|protective agents|mesh-ancestor
19555303|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19555304|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19555305|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19555306|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111121|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111122|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111123|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111124|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111125|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111126|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111127|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20111128|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111129|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
20111130|NCT00004187|Capecitabine|capecitabine|mesh-list
20111131|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
20111132|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111133|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
20111134|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111135|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111136|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
20111137|NCT00004188|Melphalan|melphalan|mesh-list
20111138|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
20111139|NCT00004188|Cisplatin|cisplatin|mesh-list
20111140|NCT00004188|Carboplatin|carboplatin|mesh-list
20111141|NCT00004188|Doxorubicin|doxorubicin|mesh-list
20111142|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20111143|NCT00004188|Etoposide|etoposide|mesh-list
20111144|NCT00004188|Vincristine|vincristine|mesh-list
20111145|NCT00004188|Topotecan|topotecan|mesh-list
20111146|NCT00004188|Isotretinoin|isotretinoin|mesh-list
19555307|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555308|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
19555309|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555310|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19555311|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19555312|NCT02776891|Citric Acid|citric acid|mesh-list
19555313|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
19555314|NCT02776891|Gallium citrate|gallium citrate|mesh-list
20111147|NCT00004188|Lenograstim|lenograstim|mesh-list
20111148|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555315|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
19555316|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20111149|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
20111150|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555317|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
19555318|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
19555319|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555320|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19555321|NCT02776722|Tagatose|tagatose|mesh-list
19555322|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19555323|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
19555324|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
19555325|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555326|NCT02776813|Rituximab|rituximab|mesh-list
19555327|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19555328|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555329|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
19555330|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555331|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555332|NCT02776761|Vaccines|vaccines|mesh-list
19555333|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
19555334|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555335|NCT02776878|Dasatinib|dasatinib|mesh-list
19555336|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111151|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111152|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111153|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
20111154|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111155|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111156|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111157|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111158|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111159|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111160|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111161|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111162|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111163|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111164|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111165|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111166|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20111167|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
20111168|NCT00004189|Cisplatin|cisplatin|mesh-list
20111169|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111170|NCT00004190|Gemcitabine|gemcitabine|mesh-list
20111171|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
20111172|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111173|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
20111174|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111175|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111176|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
20111177|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111178|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111179|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111180|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
20111181|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111182|NCT00004192|Cytarabine|cytarabine|mesh-list
20111183|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
19555337|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19555338|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555339|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111184|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20111185|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20111186|NCT00004192|Prednisolone|prednisolone|mesh-list
20111187|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
20111188|NCT00004192|Etoposide|etoposide|mesh-list
20111189|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20111190|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
20111191|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111192|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111193|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111194|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111195|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111196|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111197|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555340|NCT02776865|Lidocaine|lidocaine|mesh-list
19555341|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
19555342|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
20111198|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
20111199|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
20111200|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111201|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555343|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555344|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555345|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
19555346|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555347|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19555348|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19555349|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19555350|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19555351|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555352|NCT02776540|Aspirin|aspirin|mesh-list
19555353|NCT02776540|Clopidogrel|clopidogrel|mesh-list
20604587|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20604588|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20604589|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19555354|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20111202|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
20111203|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111204|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20111205|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
20111206|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
20111207|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111208|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111209|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
20111210|NCT00004192|Hormones|hormones|mesh-ancestor
20111211|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111212|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20111213|NCT00004192|Protective Agents|protective agents|mesh-ancestor
20111214|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111215|NCT00004194|Fludarabine|fludarabine|mesh-list
20111216|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
20111217|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111218|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111219|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
20111220|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111221|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111222|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
20111223|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111224|NCT00004195|Eniluracil|eniluracil|mesh-list
20111225|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111226|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111227|NCT00004196|Interferons|interferons|mesh-list
20111228|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
20111229|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111230|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
20111231|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111232|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
20111233|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111234|NCT00004197|Prednisone|prednisone|mesh-list
19555355|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555356|NCT02776540|Analgesics|analgesics|mesh-ancestor
19555357|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
19555358|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555359|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555360|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555361|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555362|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20111235|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
20111236|NCT00004197|Doxorubicin|doxorubicin|mesh-list
19555363|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19555364|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555365|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19555366|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19555367|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555368|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
19555369|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19555370|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19555371|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19555372|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
19555373|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555374|NCT02776527|Apatinib|apatinib|mesh-list
20111237|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20111238|NCT00004197|Vincristine|vincristine|mesh-list
20111239|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
20111240|NCT00004197|Sargramostim|sargramostim|mesh-list
20111241|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20111242|NCT00004197|Vaccines|vaccines|mesh-list
20111243|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111244|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
20111245|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111246|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111247|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111248|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
20111249|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111250|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111251|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111252|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111253|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111254|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111255|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111256|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20111257|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
20111258|NCT00004197|Hormones|hormones|mesh-ancestor
20111259|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111260|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111261|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19555375|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555376|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19555377|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555378|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555379|NCT02776163|Docetaxel|docetaxel|mesh-list
19555380|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555381|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19555382|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19555383|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19555384|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555385|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
19555386|NCT02776202|Sirolimus|sirolimus|mesh-list
20111262|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111263|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111264|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111265|NCT00004197|Analgesics|analgesics|mesh-ancestor
20111266|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
20111267|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111268|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111269|NCT00004198|Sargramostim|sargramostim|mesh-list
20111270|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20111271|NCT00004198|Vaccines|vaccines|mesh-list
20111272|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
20111273|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111274|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111275|NCT00004199|Gemcitabine|gemcitabine|mesh-list
20111276|NCT00004199|Prinomastat|prinomastat|mesh-list
19555387|NCT02776202|Fludarabine|fludarabine|mesh-list
19555388|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
19555389|NCT02776202|Melphalan|melphalan|mesh-list
19555390|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555391|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111277|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111278|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111279|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
20111280|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111281|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
20111282|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111283|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111284|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111285|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
20111286|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111287|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
20111288|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
19555392|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
19555393|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555394|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111289|NCT00004200|Temozolomide|temozolomide|mesh-list
20111290|NCT00004200|Prinomastat|prinomastat|mesh-list
20111291|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111292|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
20111293|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555395|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
20111294|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111295|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
20111296|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
20111297|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111298|NCT00004201|Gemcitabine|gemcitabine|mesh-list
20111299|NCT00004201|Carboplatin|carboplatin|mesh-list
20111300|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111301|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111302|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
20111303|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555396|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555397|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19555398|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19555399|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
19555400|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19555401|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555402|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555403|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
19555404|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19555405|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
19555406|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19555407|NCT02776189|Midazolam|midazolam|mesh-list
19555408|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
19555409|NCT02776189|Propofol|propofol|mesh-list
19555410|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19555411|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555412|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555413|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19555414|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
19555415|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
19555416|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555417|NCT02776189|Analgesics|analgesics|mesh-ancestor
19555418|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
19555419|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555420|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19555421|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19555422|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19555423|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555424|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555425|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555426|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19555427|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19555428|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19555429|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19555430|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
19555431|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
19555432|NCT02776137|Docetaxel|docetaxel|mesh-list
19555433|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111304|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
20111305|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111306|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111307|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111308|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
20111309|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111310|NCT00004202|Paclitaxel|paclitaxel|mesh-list
20111311|NCT00004202|Carboplatin|carboplatin|mesh-list
20111312|NCT00004202|Efaproxiral|efaproxiral|mesh-list
20111313|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111314|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111315|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111316|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111317|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111318|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111319|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
20111320|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
20111321|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111322|NCT00004204|Temozolomide|temozolomide|mesh-list
20111323|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111324|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
20111325|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111326|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111327|NCT00004205|Tamoxifen|tamoxifen|mesh-list
19555434|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111328|NCT00004205|Letrozole|letrozole|mesh-list
20111329|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555435|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19555436|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19555437|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555438|NCT02776228|Brotizolam|brotizolam|mesh-list
19555439|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19555440|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555441|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555442|NCT02776436|Dexamethasone|dexamethasone|mesh-list
19555443|NCT02776436|Prednisone|prednisone|mesh-list
19555444|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555445|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
19555446|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
19555447|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555448|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555449|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19555450|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
19555451|NCT02776436|Hormones|hormones|mesh-ancestor
19555452|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555453|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19555454|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555455|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
19555456|NCT02775773|Oxytocin|oxytocin|mesh-list
19555457|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
19555458|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19555459|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555460|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19555461|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19555462|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555463|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
19555464|NCT02775773|Coagulants|coagulants|mesh-ancestor
19555465|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19555466|NCT02775968|Azithromycin|azithromycin|mesh-list
19555467|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
19555468|NCT02775968|Erythromycin|erythromycin|mesh-list
19555469|NCT02775968|Cephalosporins|cephalosporins|mesh-list
19555470|NCT02775968|Cefamandole|cefamandole|mesh-list
19555471|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555472|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19555473|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19555474|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555475|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555476|NCT02776059|Prednisolone|prednisolone|mesh-list
19555477|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555478|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
19555479|NCT02776059|Hormones|hormones|mesh-ancestor
19555480|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555481|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555482|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19555483|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555484|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
19555485|NCT02775734|Clomiphene|clomiphene|mesh-list
20111330|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111331|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20111332|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20111333|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111334|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20111335|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
20111336|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111337|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111338|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111339|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20111340|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20111341|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20111342|NCT00004206|Leucovorin|leucovorin|mesh-list
20111343|NCT00004206|Fluorouracil|fluorouracil|mesh-list
20111344|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
20111345|NCT00004206|Calcium|calcium|mesh-list
20111346|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
20111347|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20111348|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111349|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
20111350|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111351|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555486|NCT02775734|Enclomiphene|enclomiphene|mesh-list
19555487|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
19555488|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19555489|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555490|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19555491|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
19555492|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555493|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555494|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19555495|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
19555496|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19555497|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19555498|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19555499|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
19555500|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555501|NCT02775734|Expectorants|expectorants|mesh-ancestor
19555502|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
19555503|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19555504|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
19555505|NCT02775734|Protective Agents|protective agents|mesh-ancestor
19555506|NCT02775734|Antidotes|antidotes|mesh-ancestor
19555507|NCT02776397|Vitamin E|vitamin e|mesh-list
19555508|NCT02776397|Tocopherols|tocopherols|mesh-list
19555509|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
19555510|NCT02776397|Vitamins|vitamins|mesh-ancestor
19555511|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
19555512|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555513|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
19555514|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555515|NCT02776397|Protective Agents|protective agents|mesh-ancestor
20604590|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604591|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20604592|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20604593|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
20604594|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20111352|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111353|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111354|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
19576491|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
19576492|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19576493|NCT05279092|Protective Agents|protective agents|mesh-ancestor
19576494|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
19576495|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576496|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576497|NCT05271721|Dexamethasone|dexamethasone|mesh-list
19576498|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
19576499|NCT05271721|BB 1101|bb 1101|mesh-list
19576500|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576501|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
19576502|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
19576503|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576504|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576505|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576506|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
19576507|NCT05271721|Hormones|hormones|mesh-ancestor
19576508|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576509|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576510|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576511|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
19576512|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576513|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111355|NCT00004206|Antidotes|antidotes|mesh-ancestor
19576514|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19576515|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
19576516|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576517|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576518|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19576519|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576520|NCT05267743|Lansoprazole|lansoprazole|mesh-list
19576521|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
19576522|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19576523|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576524|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19576525|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576526|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576527|NCT05267613|Esomeprazole|esomeprazole|mesh-list
19576528|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20111356|NCT00004206|Protective Agents|protective agents|mesh-ancestor
19555516|NCT02775695|Doxycycline|doxycycline|mesh-list
19555517|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19555518|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555519|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
19555520|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19555521|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19555522|NCT02775877|Letrozole|letrozole|mesh-list
19555523|NCT02775877|Clomiphene|clomiphene|mesh-list
19555524|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555525|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19555526|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19555527|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111357|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
20111358|NCT00004206|Vitamins|vitamins|mesh-ancestor
20111359|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
20111360|NCT00004207|Daunorubicin|daunorubicin|mesh-list
20111361|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111362|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111363|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111364|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111365|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111366|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111367|NCT00004209|Mitomycins|mitomycins|mesh-list
20111368|NCT00004209|Mitomycin|mitomycin|mesh-list
20111369|NCT00004209|Vinblastine|vinblastine|mesh-list
20111370|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111371|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111372|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
20111373|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111374|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20111375|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111376|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111377|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111378|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111379|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
19555528|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555529|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19555530|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
20111380|NCT00004212|Exatecan|exatecan|mesh-list
20111381|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20111382|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19555531|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555532|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555533|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19555534|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
19555535|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19555536|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19555537|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19555538|NCT02775474|Fentanyl|fentanyl|mesh-list
19555539|NCT02775474|Methadone|methadone|mesh-list
19555540|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19555541|NCT02775474|Narcotics|narcotics|mesh-ancestor
19555542|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555543|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555544|NCT02775474|Analgesics|analgesics|mesh-ancestor
19555545|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
19555546|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555547|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19555548|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19555549|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
19555550|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
19555551|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
19555552|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
19555553|NCT02775539|Mirabegron|mirabegron|mesh-list
19555554|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19555555|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19555556|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19555557|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555558|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555559|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555560|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111383|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111384|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555561|NCT02775539|Urological Agents|urological agents|mesh-ancestor
20111385|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111386|NCT00004215|Cytarabine|cytarabine|mesh-list
20111387|NCT00004215|Daunorubicin|daunorubicin|mesh-list
20111388|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111389|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
20111390|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111391|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111392|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
20111393|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111394|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111395|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
20111396|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111397|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111398|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111399|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111400|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111401|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
20111402|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
20111403|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20111404|NCT00004216|Cefixime|cefixime|mesh-list
20111405|NCT00004216|Trimethoprim|trimethoprim|mesh-list
20111406|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
20111407|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20111408|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111409|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111410|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111411|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111412|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111413|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111414|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20111415|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20111416|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20111417|NCT00004216|Renal Agents|renal agents|mesh-ancestor
20111418|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
20111419|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20111420|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19555562|NCT02775500|Apremilast|apremilast|mesh-list
19555563|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19555564|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555565|NCT02775500|Analgesics|analgesics|mesh-ancestor
19555566|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
19555567|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111421|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20111422|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20111423|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20111424|NCT00004217|Cytarabine|cytarabine|mesh-list
20111425|NCT00004217|Daunorubicin|daunorubicin|mesh-list
20111426|NCT00004217|Sargramostim|sargramostim|mesh-list
20111427|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111428|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
20111429|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111430|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111431|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
20111432|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555568|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555569|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555570|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555571|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19555572|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19555573|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555574|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555575|NCT02775318|Bupivacaine|bupivacaine|mesh-list
19555576|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
19555577|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
19555578|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555579|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555580|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
19555581|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555582|NCT02775292|Aldesleukin|aldesleukin|mesh-list
19555583|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
19555584|NCT02775292|Nivolumab|nivolumab|mesh-list
19555585|NCT02775292|Fludarabine|fludarabine|mesh-list
19555586|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
19555587|NCT02775292|Interleukin-2|interleukin-2|mesh-list
19555588|NCT02775292|Vaccines|vaccines|mesh-list
19555589|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
20111433|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111434|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
19555590|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555591|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555592|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555593|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19555594|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
19555595|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555596|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555597|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19555598|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19555599|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19555600|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555601|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
19555602|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555603|NCT02775292|Analgesics|analgesics|mesh-ancestor
19555604|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
19555605|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555606|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19555607|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19555608|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
20111435|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111436|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111437|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111438|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111439|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111440|NCT00004218|Prednisolone|prednisolone|mesh-list
20111441|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
19555609|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555610|NCT02775370|Apatinib|apatinib|mesh-list
19555611|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111442|NCT00004218|Chlorambucil|chlorambucil|mesh-list
20111443|NCT00004218|Doxorubicin|doxorubicin|mesh-list
20111444|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20111445|NCT00004218|Fludarabine|fludarabine|mesh-list
20111446|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
20111447|NCT00004218|Vincristine|vincristine|mesh-list
20111448|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111449|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
20111450|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111451|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111452|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111453|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
20111454|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111455|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555612|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19555613|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555614|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555615|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
19555616|NCT02775227|Pasireotide|pasireotide|mesh-list
19555617|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555618|NCT02775227|Hormones|hormones|mesh-ancestor
19555619|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111456|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111457|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111458|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111459|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111460|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111461|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555620|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555621|NCT02775110|Natalizumab|natalizumab|mesh-list
19555622|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
19555623|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555624|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
19555625|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
19555626|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555627|NCT02775266|Protective Agents|protective agents|mesh-ancestor
19555628|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555629|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
19555630|NCT02775266|Vitamins|vitamins|mesh-ancestor
19555631|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
19555632|NCT02774993|Doxycycline|doxycycline|mesh-list
19555633|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19555634|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555635|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
19555636|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20111462|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
20111463|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19555637|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19555638|NCT02775006|Docetaxel|docetaxel|mesh-list
19555639|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19555640|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555641|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
19555642|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
19555643|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
19555644|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555645|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19555646|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555647|NCT02774902|Clarithromycin|clarithromycin|mesh-list
19555648|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19555649|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555650|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19555651|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555652|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555653|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19555654|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19555655|NCT02774837|Tenofovir|tenofovir|mesh-list
19555656|NCT02774837|Telbivudine|telbivudine|mesh-list
19555657|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
19555658|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555659|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19555660|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19555661|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555662|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555663|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19555664|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19555665|NCT02774876|Insulin|insulin|mesh-list
19555666|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19555667|NCT02774876|Hormones|hormones|mesh-list
20111464|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111465|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111466|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111467|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555668|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19555669|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555670|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555671|NCT02774811|Bimatoprost|bimatoprost|mesh-list
19555672|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20111468|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
20111469|NCT00004218|Hormones|hormones|mesh-ancestor
20111470|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111471|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111472|NCT00004219|Granisetron|granisetron|mesh-list
20111473|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
20111474|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
20111475|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111476|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111477|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111478|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19555673|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19555674|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19555675|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
19555676|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555677|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19555678|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19555679|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
19555680|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
19555681|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555682|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555683|NCT02774382|Vancomycin|vancomycin|mesh-list
19555684|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19555685|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555686|NCT02774460|Amlodipine|amlodipine|mesh-list
19555687|NCT02774460|Candesartan|candesartan|mesh-list
19555688|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
19555689|NCT02774460|Lisinopril|lisinopril|mesh-list
19555690|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19555691|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19555692|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19555693|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111479|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
20111480|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20111481|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555694|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19555695|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555696|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
19555697|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19555698|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19555699|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19555700|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
19555701|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111482|NCT00004220|Gemcitabine|gemcitabine|mesh-list
20111483|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
20111484|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19749036|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749037|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111485|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
20111486|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111487|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111488|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
20111489|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111490|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555702|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19555703|NCT02774460|Protective Agents|protective agents|mesh-ancestor
19555704|NCT02774499|Methadone|methadone|mesh-list
19555705|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19555706|NCT02774499|Narcotics|narcotics|mesh-ancestor
19555707|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555708|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555709|NCT02774499|Analgesics|analgesics|mesh-ancestor
19555710|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
19555711|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555712|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
19555713|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
19555714|NCT02774525|Ethanol|ethanol|mesh-list
19555715|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19555716|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555717|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555718|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555719|NCT02774200|Apatinib|apatinib|mesh-list
19555720|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555721|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19555722|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555723|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555730|NCT02774044|Beractant|beractant|mesh-list
19555731|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
19555732|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19555733|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
19555734|NCT02774187|Leucovorin|leucovorin|mesh-list
19555735|NCT02774187|Fluorouracil|fluorouracil|mesh-list
19555736|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
19555737|NCT02774187|Sorafenib|sorafenib|mesh-list
19555738|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
19555739|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555740|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555741|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555742|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555743|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
19555744|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555745|NCT02774187|Antidotes|antidotes|mesh-ancestor
19555746|NCT02774187|Protective Agents|protective agents|mesh-ancestor
19555747|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
19555748|NCT02774187|Vitamins|vitamins|mesh-ancestor
19555749|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
19555750|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20111491|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111492|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
20111493|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111494|NCT00004221|Paclitaxel|paclitaxel|mesh-list
19555751|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576529|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576530|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20111495|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
19555752|NCT02774291|Aldesleukin|aldesleukin|mesh-list
19555753|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
19555754|NCT02774291|Fludarabine|fludarabine|mesh-list
19555755|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
19555756|NCT02774291|Interleukin-2|interleukin-2|mesh-list
19555757|NCT02774291|Lenograstim|lenograstim|mesh-list
19555758|NCT02774291|Sargramostim|sargramostim|mesh-list
19555759|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555760|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
19555761|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555762|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555763|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19555764|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
19555765|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555766|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555767|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19555768|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555769|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
19555770|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19555771|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555772|NCT02774291|Analgesics|analgesics|mesh-ancestor
19555773|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
19555774|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555775|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19555776|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19555777|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
19555778|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555779|NCT02774096|Xenon|xenon|mesh-list
20604595|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20604596|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19555780|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19555781|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
19555782|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
19555783|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20111496|NCT00004221|Carboplatin|carboplatin|mesh-list
20111497|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20111498|NCT00004221|Topotecan|topotecan|mesh-list
20111499|NCT00004221|Lenograstim|lenograstim|mesh-list
20111500|NCT00004221|Sargramostim|sargramostim|mesh-list
20111501|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111502|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111503|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111504|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111505|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111506|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111507|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111508|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
20111509|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111510|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111511|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111512|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
20111513|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111514|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111515|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20111516|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111517|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111518|NCT00004223|Gemcitabine|gemcitabine|mesh-list
20111519|NCT00004223|Docetaxel|docetaxel|mesh-list
20111520|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111521|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
20111522|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111523|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111524|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
20111525|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111526|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111527|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111528|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
20111529|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111530|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111531|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111532|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
19555784|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111533|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
20111534|NCT00004224|Etoposide|etoposide|mesh-list
19555785|NCT02773979|Chloroquine|chloroquine|mesh-list
19555786|NCT02773979|Amebicides|amebicides|mesh-ancestor
20111535|NCT00004224|Vincristine|vincristine|mesh-list
20111536|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111537|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
20111538|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111539|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111540|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19555787|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19555788|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19555789|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555790|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
19555791|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555792|NCT02774005|Idebenone|idebenone|mesh-list
19555793|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
19555794|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555795|NCT02774005|Protective Agents|protective agents|mesh-ancestor
19555796|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555797|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
19555798|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19555799|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555800|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555801|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555802|NCT02773797|Analgesics|analgesics|mesh-ancestor
19555803|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
19555804|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555805|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19555806|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19555807|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19555808|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555809|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555810|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555811|NCT02773875|Pancrelipase|pancrelipase|mesh-list
19555812|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19555813|NCT02773927|Metformin|metformin|mesh-list
19555814|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19555815|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555816|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
19555817|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19555818|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19555819|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19555820|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19555821|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555822|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
19555823|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555824|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555825|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19555826|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555827|NCT02773602|Dexamethasone|dexamethasone|mesh-list
19555828|NCT02773602|Clonidine|clonidine|mesh-list
19555829|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555830|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
19555831|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
19555832|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555833|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555834|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19555835|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
20111541|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
20111542|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111543|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111544|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111545|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111546|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111547|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111548|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111549|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111550|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111551|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111552|NCT00004227|Cetuximab|cetuximab|mesh-list
20111553|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20111554|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111555|NCT00004229|Endostatins|endostatins|mesh-list
20111556|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555836|NCT02773602|Hormones|hormones|mesh-ancestor
19555837|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111557|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20111558|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20111559|NCT00004229|Growth Substances|growth substances|mesh-ancestor
19555838|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19555839|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555840|NCT02773602|Analgesics|analgesics|mesh-ancestor
19555841|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
19555842|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19555843|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
19555844|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19555845|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19555846|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19555847|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555848|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555849|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555850|NCT02773459|Capecitabine|capecitabine|mesh-list
19555851|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19555852|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
19555853|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555854|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555855|NCT02773316|Morphine|morphine|mesh-list
19555856|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19555857|NCT02773316|Narcotics|narcotics|mesh-ancestor
19555858|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555859|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555860|NCT02773316|Analgesics|analgesics|mesh-ancestor
19555861|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
19555862|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555863|NCT02773199|Bupivacaine|bupivacaine|mesh-list
19555864|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
19555865|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
19555866|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555867|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555868|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
19555869|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555870|NCT02773550|Prednisone|prednisone|mesh-list
19555871|NCT02773550|Bortezomib|bortezomib|mesh-list
19555872|NCT02773550|Melphalan|melphalan|mesh-list
19555873|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19555874|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
19555875|NCT02773550|Hormones|hormones|mesh-ancestor
19555876|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555877|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555878|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19555879|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555880|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19555881|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
19555882|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555883|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19555884|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19555885|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
19555886|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19555887|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
19555888|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19555889|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
19555890|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555891|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
19555892|NCT02773251|Protective Agents|protective agents|mesh-ancestor
19555893|NCT02773251|Laxatives|laxatives|mesh-ancestor
19555894|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19555895|NCT02773407|Azithromycin|azithromycin|mesh-list
19555896|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19555897|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19555898|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555899|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19555900|NCT02773407|Renal Agents|renal agents|mesh-ancestor
19555901|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
19555902|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19555903|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19555904|NCT02773472|Morphine|morphine|mesh-list
19555905|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19555906|NCT02773472|Narcotics|narcotics|mesh-ancestor
20111560|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111561|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
20111562|NCT00004232|Cyclosporine|cyclosporine|mesh-list
20111563|NCT00004232|Prednisone|prednisone|mesh-list
19555907|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555908|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111564|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
20111565|NCT00004232|Cyclosporins|cyclosporins|mesh-list
20111566|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20111567|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
20111568|NCT00004232|Hormones|hormones|mesh-ancestor
20111569|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111570|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111571|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111572|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111573|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
20111574|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111575|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111576|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111577|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
20111578|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111579|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
20111580|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111581|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20111582|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
20111583|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
19555909|NCT02773472|Analgesics|analgesics|mesh-ancestor
19555910|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
19555911|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555912|NCT02773355|Liraglutide|liraglutide|mesh-list
19555913|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19555914|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555915|NCT02773355|Incretins|incretins|mesh-ancestor
19555916|NCT02773355|Hormones|hormones|mesh-ancestor
19555917|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19555918|NCT02773095|Lactitol|lactitol|mesh-list
19555919|NCT02773095|Cathartics|cathartics|mesh-ancestor
19555920|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19555921|NCT02772926|Benphothiamine|benphothiamine|mesh-list
19555922|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19555923|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
19555924|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555925|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
19555926|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
19555927|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555928|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
19555929|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19555930|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19555931|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555932|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19555933|NCT02773017|Analgesics|analgesics|mesh-ancestor
19555934|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
19555935|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555936|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19555937|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20111584|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111585|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111586|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20111587|NCT00004232|Protective Agents|protective agents|mesh-ancestor
20111588|NCT00004233|Leucovorin|leucovorin|mesh-list
20111589|NCT00004233|Fluorouracil|fluorouracil|mesh-list
20111590|NCT00004233|Calcium|calcium|mesh-list
20111591|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
20111592|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20111593|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111594|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
20111595|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111596|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111597|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111598|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111599|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
20111600|NCT00004233|Antidotes|antidotes|mesh-ancestor
20111601|NCT00004233|Protective Agents|protective agents|mesh-ancestor
20111602|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
20111603|NCT00004233|Vitamins|vitamins|mesh-ancestor
20111604|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
20111605|NCT00004235|Docetaxel|docetaxel|mesh-list
20111606|NCT00004235|Irinotecan|irinotecan|mesh-list
20111607|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111608|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111609|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
19555938|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20111610|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111611|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111612|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20111613|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111614|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111615|NCT00004236|Doxorubicin|doxorubicin|mesh-list
20111616|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20111617|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111618|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111619|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111620|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111621|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111622|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111623|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
20111624|NCT00004237|Doxorubicin|doxorubicin|mesh-list
20111625|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20111626|NCT00004237|Vinorelbine|vinorelbine|mesh-list
20111627|NCT00004237|Epirubicin|epirubicin|mesh-list
20111628|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
20111629|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604597|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
19555939|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555940|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555941|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555942|NCT02773147|Pyridoxine|pyridoxine|mesh-list
19555943|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
19555944|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
19555945|NCT02773147|Hematinics|hematinics|mesh-ancestor
19555946|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
19555947|NCT02773147|Vitamins|vitamins|mesh-ancestor
19555948|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
19555949|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555950|NCT02772822|Rituximab|rituximab|mesh-list
19555951|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19555952|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19555953|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
19555954|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555955|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19555956|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19555957|NCT02772640|Ezetimibe|ezetimibe|mesh-list
19555958|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19555959|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19555960|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
20111630|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
20111631|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111632|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111633|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111634|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
20111635|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555961|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555962|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19555963|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19555964|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19555965|NCT02772744|Ribavirin|ribavirin|mesh-list
19555966|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
19555967|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
19555968|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555969|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
19555970|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19555971|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19555972|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
19555973|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576531|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576532|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576533|NCT05260593|Vitamins|vitamins|mesh-list
19576534|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
19576535|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
19576536|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
19576537|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
19576538|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576539|NCT05260593|Hematinics|hematinics|mesh-ancestor
19578270|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578271|NCT03067181|Cisplatin|cisplatin|mesh-list
19578272|NCT03067181|Carboplatin|carboplatin|mesh-list
19578273|NCT03067181|Etoposide|etoposide|mesh-list
20111636|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111637|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19578274|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
19578275|NCT03067181|Bleomycin|bleomycin|mesh-list
19578276|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
19555974|NCT02772354|Metoprolol|metoprolol|mesh-list
19555975|NCT02772354|Verapamil|verapamil|mesh-list
19555976|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19555977|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20111638|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111639|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111640|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111641|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111642|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19555978|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
19555979|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
19555980|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19555981|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19555982|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19555983|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19555984|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19555985|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
19555986|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19555987|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19555988|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19555989|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19555990|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19555991|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
19555992|NCT02772419|Benralizumab|benralizumab|mesh-list
19555993|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19555994|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
19555995|NCT02772497|Aflibercept|aflibercept|mesh-list
19555996|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19555997|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19555998|NCT02772497|Growth Substances|growth substances|mesh-ancestor
19555999|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556000|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
19556001|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556002|NCT02772601|Metoprolol|metoprolol|mesh-list
19556003|NCT02772601|Midazolam|midazolam|mesh-list
19556004|NCT02772601|Caffeine|caffeine|mesh-list
19556005|NCT02772601|Omeprazole|omeprazole|mesh-list
19556006|NCT02772601|Warfarin|warfarin|mesh-list
19556007|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19556008|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19556009|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556010|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556011|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19556012|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19556013|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20111643|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111644|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111645|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111646|NCT00004237|Analgesics|analgesics|mesh-ancestor
20111647|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
20111648|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111649|NCT00004242|Gemcitabine|gemcitabine|mesh-list
20111650|NCT00004242|Fluorouracil|fluorouracil|mesh-list
20111651|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
20111652|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111653|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
20111654|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111655|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111656|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
20111657|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111658|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111659|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111660|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
20111661|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111662|NCT00004243|Docetaxel|docetaxel|mesh-list
20111663|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
20111664|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111665|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111666|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111667|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111668|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111669|NCT00004244|Interferons|interferons|mesh-list
20111670|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
19556014|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19556015|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
19556016|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
20111671|NCT00004244|Interleukin-12|interleukin-12|mesh-list
19556017|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
19556018|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
19556019|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556020|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556021|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
19556022|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19556023|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556024|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19556025|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556026|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19556027|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19556028|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19556029|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19556030|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
20111672|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111673|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
19556031|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19556032|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19556033|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
19556034|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
19556035|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556036|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19556037|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19556038|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19556039|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
19556040|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19556041|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
19556042|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556043|NCT02772107|Temozolomide|temozolomide|mesh-list
19556044|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19556045|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
19556046|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556047|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556048|NCT02772237|Riboflavin|riboflavin|mesh-list
19556049|NCT02772237|Vitamins|vitamins|mesh-ancestor
19556050|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
19556051|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556052|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
19556053|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19556054|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
19556055|NCT02772211|Cycloserine|cycloserine|mesh-list
19556056|NCT02772211|Ketamine|ketamine|mesh-list
19556057|NCT02772211|Analgesics|analgesics|mesh-ancestor
19556058|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
19556059|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556060|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556061|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19556062|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19556063|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
19556064|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
19556065|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556066|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19556067|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19556068|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556069|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556070|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19556071|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556072|NCT02772211|Renal Agents|renal agents|mesh-ancestor
19556073|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19556074|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
19556075|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19556076|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
19556077|NCT02772120|Progesterone|progesterone|mesh-list
19556078|NCT02772120|Progestins|progestins|mesh-ancestor
19556079|NCT02772120|Hormones|hormones|mesh-ancestor
19556080|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556081|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556082|NCT02772029|Apatinib|apatinib|mesh-list
19556083|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111674|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111675|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
20111676|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556084|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20111677|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19556085|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556086|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556087|NCT02771925|Gabapentin|gabapentin|mesh-list
19556088|NCT02771925|Analgesics|analgesics|mesh-ancestor
19556089|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
19556090|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556091|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556092|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
19556093|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19556094|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19556095|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556096|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19556097|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19556098|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19556099|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556100|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556101|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
19556102|NCT02771860|Denosumab|denosumab|mesh-list
19556103|NCT02771860|Calcium|calcium|mesh-list
19556104|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19556105|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556106|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19556107|NCT02771782|Vaccines|vaccines|mesh-list
19556108|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
19556109|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
19556110|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556111|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19556112|NCT02771795|Trastuzumab|trastuzumab|mesh-list
19556113|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19556114|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556115|NCT02771834|Vitamin D|vitamin d|mesh-list
19556116|NCT02771834|Vitamins|vitamins|mesh-ancestor
19556117|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
19556118|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556119|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19556120|NCT02771717|Budesonide|budesonide|mesh-list
19556121|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556122|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19556123|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
19556124|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556125|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556126|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19556127|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
19556128|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
19556129|NCT02771717|Hormones|hormones|mesh-ancestor
19556130|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556131|NCT02771912|Propofol|propofol|mesh-list
19556132|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19556133|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19556134|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556135|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556136|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19556137|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
19556138|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
19556139|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19556140|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19556141|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19556142|NCT02771457|Infliximab|infliximab|mesh-list
19556143|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
19556144|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556145|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556146|NCT02771392|Tetracaine|tetracaine|mesh-list
19556147|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19556148|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19749038|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111678|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20111679|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20111680|NCT00004244|Growth Substances|growth substances|mesh-ancestor
20111681|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
20111682|NCT00004245|Salicylates|salicylates|mesh-list
20111683|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
20111684|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20111685|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20111686|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20111687|NCT00004245|Analgesics|analgesics|mesh-ancestor
19556149|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
19556150|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604598|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19556151|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556152|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
19556153|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556154|NCT02771509|Mitogens|mitogens|mesh-list
19556155|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
19556156|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556157|NCT02771379|Idebenone|idebenone|mesh-list
19556158|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
19556159|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556160|NCT02771379|Protective Agents|protective agents|mesh-ancestor
19556161|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556162|NCT02771587|Ethanol|ethanol|mesh-list
19556163|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19556164|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556165|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556166|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556167|NCT02771704|Iodine|iodine|mesh-list
19556168|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
19556169|NCT02771704|Fluorides|fluorides|mesh-list
19556170|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
19556171|NCT02771704|Protective Agents|protective agents|mesh-ancestor
19556172|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556173|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19556174|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556175|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
19556176|NCT02771704|Trace Elements|trace elements|mesh-ancestor
19556177|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
19556178|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
19556179|NCT02771743|Ifosfamide|ifosfamide|mesh-list
19556180|NCT02771743|Carboplatin|carboplatin|mesh-list
19556181|NCT02771743|Doxorubicin|doxorubicin|mesh-list
19556182|NCT02771743|Etoposide|etoposide|mesh-list
19556183|NCT02771743|Interleukin-2|interleukin-2|mesh-list
19556184|NCT02771743|Isotretinoin|isotretinoin|mesh-list
19556185|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556186|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
19556187|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556188|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556189|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19556190|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
19556191|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556192|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556193|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19556194|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19556195|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19556196|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19556197|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556198|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19556199|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556200|NCT02771743|Analgesics|analgesics|mesh-ancestor
19556201|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
19556202|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556203|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
19556204|NCT02771418|Anesthetics|anesthetics|mesh-list
19556205|NCT02771418|Propofol|propofol|mesh-list
19556206|NCT02771418|Sevoflurane|sevoflurane|mesh-list
19556207|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556208|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556209|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19556210|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19556211|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
19556212|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19556213|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19556214|NCT02771600|Anesthetics|anesthetics|mesh-list
19556215|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
19556216|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556217|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556218|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
19556219|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556220|NCT02771405|Ribavirin|ribavirin|mesh-list
19556221|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
19556222|NCT02771405|Simeprevir|simeprevir|mesh-list
19556223|NCT02771405|Ledipasvir|ledipasvir|mesh-list
19556224|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
19556225|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556226|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
19556227|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556228|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
19556229|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556230|NCT02771314|Osimertinib|osimertinib|mesh-list
19556231|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556232|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19556233|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556234|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556235|NCT02770950|Indomethacin|indomethacin|mesh-list
19556236|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19556237|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556238|NCT02770950|Analgesics|analgesics|mesh-ancestor
19556239|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
19556240|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556241|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556242|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556243|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556244|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
19556245|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
19556246|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19556247|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19556248|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556249|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556250|NCT02771158|Midodrine|midodrine|mesh-list
19556251|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
19556252|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
19556253|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556254|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556255|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19556256|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19556257|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19556258|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19556259|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
19556260|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556261|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556262|NCT02770885|Dulaglutide|dulaglutide|mesh-list
19556263|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19556264|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576540|NCT05240391|Midodrine|midodrine|mesh-list
19576541|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
19576542|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
19576543|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576544|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576545|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19576546|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19576547|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19576548|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576549|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576550|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576551|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576552|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19576553|NCT05239468|Bezafibrate|bezafibrate|mesh-list
19576554|NCT05239468|Cathartics|cathartics|mesh-ancestor
19576555|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576556|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19576557|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
19576558|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576559|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19576560|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19576561|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19576562|NCT05212311|Chitosan|chitosan|mesh-list
19576563|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19576564|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19576565|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
19576566|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576567|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19576568|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
19576569|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
19576570|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
19576571|NCT05212311|Coagulants|coagulants|mesh-ancestor
19576572|NCT05209425|Vitamin D|vitamin d|mesh-list
19576573|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
19576574|NCT05209425|Vitamins|vitamins|mesh-ancestor
19576575|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
19576576|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576577|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20111688|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
19556265|NCT02770651|Everolimus|everolimus|mesh-list
19556266|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556267|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556268|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
19556269|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556270|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
19556271|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19556272|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19556273|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556274|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19556275|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19556276|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556277|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556278|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556279|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19556280|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
19556281|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19556282|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556283|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19556284|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19556285|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19556286|NCT02770794|Infliximab|infliximab|mesh-list
19556287|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
19556288|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111689|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111690|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111691|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20111692|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111693|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20111694|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111695|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111696|NCT00004246|Vidarabine|vidarabine|mesh-list
20111697|NCT00004246|Fludarabine|fludarabine|mesh-list
20111698|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
20111699|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111700|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111701|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
20111702|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111703|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556289|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556290|NCT02770690|Lidocaine|lidocaine|mesh-list
19556291|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
19556292|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
20111704|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
20111705|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111706|NCT00004246|Antiviral Agents|antiviral agents|mesh-ancestor
20111707|NCT00004246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111708|NCT00004248|Aldesleukin|aldesleukin|mesh-list
19556293|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
19556294|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556295|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111709|NCT00004248|Doxorubicin|doxorubicin|mesh-list
20111710|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20111711|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20111712|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111713|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20111714|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20111715|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111716|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111717|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20111718|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20111719|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
20111720|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111721|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20111722|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111723|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
19556296|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
20111724|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111725|NCT00004250|Dactinomycin|dactinomycin|mesh-list
20111726|NCT00004250|Melphalan|melphalan|mesh-list
20111727|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111728|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
20604599|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
20604600|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
19556297|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556298|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19556299|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19556300|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19556301|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19556302|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556303|NCT02770404|Nafithromycin|nafithromycin|mesh-list
19556304|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19556305|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556306|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19556307|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556308|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556309|NCT02770508|Ritonavir|ritonavir|mesh-list
19556310|NCT02770508|Darunavir|darunavir|mesh-list
19556311|NCT02770508|Tenofovir|tenofovir|mesh-list
19556312|NCT02770508|Lamivudine|lamivudine|mesh-list
20111729|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111730|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111731|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111732|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556313|NCT02770508|Emtricitabine|emtricitabine|mesh-list
19556314|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19556315|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20111733|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
20111734|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111735|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20111736|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111737|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19556316|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
19556317|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556318|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556319|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19556320|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19556321|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
19556322|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556323|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19556324|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19556325|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19556326|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19556327|NCT02770378|Ritonavir|ritonavir|mesh-list
19556328|NCT02770378|Itraconazole|itraconazole|mesh-list
19556329|NCT02770378|Minocycline|minocycline|mesh-list
19556330|NCT02770378|Celecoxib|celecoxib|mesh-list
19556331|NCT02770378|Temozolomide|temozolomide|mesh-list
19556332|NCT02770378|Auranofin|auranofin|mesh-list
19556333|NCT02770378|Captopril|captopril|mesh-list
19556334|NCT02770378|Disulfiram|disulfiram|mesh-list
19556335|NCT02770378|Aprepitant|aprepitant|mesh-list
19556336|NCT02770378|Sertraline|sertraline|mesh-list
19556337|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19556338|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19556339|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
19556340|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556341|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556342|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19556343|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19556344|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
19556345|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556346|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19556347|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19556348|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19556349|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
19556350|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556351|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19556352|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556353|NCT02770378|Analgesics|analgesics|mesh-ancestor
19556354|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
19556355|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556356|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556357|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556358|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556359|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19556360|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20604601|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
19556361|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
19556362|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19556363|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19556364|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19556365|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19556366|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556367|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
19556368|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
19556369|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19556370|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19556371|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
19556372|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556373|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19556374|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
20111738|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20111739|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111740|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19556375|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
19556376|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556377|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19556378|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19556379|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19556380|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19556381|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19556382|NCT02770261|Candesartan|candesartan|mesh-list
19556383|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
19556384|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19556385|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19556386|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19556387|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
19556388|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556389|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19556390|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19556391|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556392|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19556393|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19556394|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19556395|NCT02770430|Infliximab|infliximab|mesh-list
19556396|NCT02770430|Basiliximab|basiliximab|mesh-list
19556397|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
19556398|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556399|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556400|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556401|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
19556402|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556403|NCT02770274|Aspirin|aspirin|mesh-list
19556404|NCT02770274|Cilostazol|cilostazol|mesh-list
19556405|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19556406|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556407|NCT02770274|Analgesics|analgesics|mesh-ancestor
19556408|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
19556409|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556410|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556411|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556412|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556413|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19556414|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19556415|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556416|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19556417|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19556418|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556419|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
19556420|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19556421|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
20111741|NCT00004251|Letrozole|letrozole|mesh-list
20111742|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111743|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20111744|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20111745|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111746|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111747|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20111748|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
20111749|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111750|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111751|NCT00004252|Leucovorin|leucovorin|mesh-list
20111752|NCT00004252|Fluorouracil|fluorouracil|mesh-list
19556422|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19556423|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
19556424|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
19556425|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19556426|NCT02770274|Protective Agents|protective agents|mesh-ancestor
19556427|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19556428|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19556429|NCT02770222|Rifampin|rifampin|mesh-list
19556430|NCT02770222|Selexipag|selexipag|mesh-list
19556431|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
19556432|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19556433|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
19556434|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19556435|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556436|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
19556437|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19556438|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556439|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556440|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19556441|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19556442|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19556443|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19556444|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19556445|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19556446|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19556447|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
19556448|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19556449|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19556450|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19556451|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19556452|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19556453|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19556454|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
20111753|NCT00004252|Calcium|calcium|mesh-list
20111754|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
20111755|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20111756|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111757|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
20111758|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111759|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111760|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111761|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111762|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
20111763|NCT00004252|Antidotes|antidotes|mesh-ancestor
20111764|NCT00004252|Protective Agents|protective agents|mesh-ancestor
20111765|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
20111766|NCT00004252|Vitamins|vitamins|mesh-ancestor
20111767|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
20111768|NCT00004253|Paclitaxel|paclitaxel|mesh-list
20111769|NCT00004253|Carboplatin|carboplatin|mesh-list
20111770|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111771|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111772|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111773|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111774|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111775|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111776|NCT00004254|Raltitrexed|raltitrexed|mesh-list
20111777|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111778|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
20111779|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111780|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111781|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20111782|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111783|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
20111784|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
20111785|NCT00004255|Fludarabine|fludarabine|mesh-list
20111786|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
20111787|NCT00004255|Tacrolimus|tacrolimus|mesh-list
20111788|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20111789|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111790|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
20111791|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111792|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111793|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20111794|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
20111795|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111796|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111797|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20111798|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111799|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
20111800|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20111801|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111802|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20111803|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
20111804|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
20111805|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111806|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111807|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
20111808|NCT00004255|Hormones|hormones|mesh-ancestor
20111809|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111810|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20111811|NCT00004255|Protective Agents|protective agents|mesh-ancestor
20111812|NCT00004256|Sargramostim|sargramostim|mesh-list
20111813|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
20111814|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111815|NCT00004257|Fluorouracil|fluorouracil|mesh-list
20111816|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
20111817|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
20111818|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111819|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111820|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111821|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111822|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
20111823|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111824|NCT00004260|Rituximab|rituximab|mesh-list
20111825|NCT00004260|Interleukin-12|interleukin-12|mesh-list
20111826|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20111827|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111828|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
20111829|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111830|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111831|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20111832|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20111833|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20111834|NCT00004260|Growth Substances|growth substances|mesh-ancestor
20111835|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
20111836|NCT00004261|Antibodies|antibodies|mesh-list
20111837|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
20111838|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111839|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
20111840|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111841|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20111842|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
20111843|NCT00004263|Cytarabine|cytarabine|mesh-list
20111844|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20111845|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20111846|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
20111847|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556455|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556456|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556457|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556458|NCT02770105|Caffeine|caffeine|mesh-list
19556459|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20111848|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111849|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
20111850|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111851|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111852|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
20111853|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111854|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19556460|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556461|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19556462|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556463|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556464|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19556465|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19749039|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111855|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111856|NCT00004264|Docetaxel|docetaxel|mesh-list
20111857|NCT00004264|Amifostine|amifostine|mesh-list
19556466|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
19556467|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20111858|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111859|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111860|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111861|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111862|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111863|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20111864|NCT00004264|Protective Agents|protective agents|mesh-ancestor
19556468|NCT02769832|Gemcitabine|gemcitabine|mesh-list
19556469|NCT02769832|Paclitaxel|paclitaxel|mesh-list
19556470|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19556471|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19556472|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556473|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
19556474|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
19556475|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
19556476|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556477|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19556478|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
19556479|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
19556480|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556481|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556482|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556483|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
19556484|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556485|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
19556486|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556487|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
19556488|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556489|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556490|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19556491|NCT02769936|Cycloserine|cycloserine|mesh-list
19556492|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19556493|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556494|NCT02769936|Renal Agents|renal agents|mesh-ancestor
19556495|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19556496|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
19556497|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19556498|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
20111865|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111866|NCT00004265|Paclitaxel|paclitaxel|mesh-list
20111867|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20111868|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111869|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
20111870|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111871|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
20111872|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111873|NCT00004266|Lisinopril|lisinopril|mesh-list
20111874|NCT00004266|Nifedipine|nifedipine|mesh-list
20111875|NCT00004266|Simvastatin|simvastatin|mesh-list
20111876|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20111877|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20111878|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
20111879|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111880|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20111881|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20111882|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111883|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20111884|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20111885|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20111886|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111887|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
20111888|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
20111889|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20111890|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20111891|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
20111892|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20111893|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20111894|NCT00004266|Protective Agents|protective agents|mesh-ancestor
20111895|NCT00004268|Midodrine|midodrine|mesh-list
20111896|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
19556499|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556500|NCT02769910|Capsaicin|capsaicin|mesh-list
19556501|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
20111897|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
20111898|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111899|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111900|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20111901|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20111902|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19556502|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19556503|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
19556504|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556505|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556506|NCT02769884|Pancrelipase|pancrelipase|mesh-list
19556507|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556508|NCT02769793|Levodopa|levodopa|mesh-list
19556509|NCT02769793|Benserazide|benserazide|mesh-list
19556510|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19556511|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19556512|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19556513|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
19556514|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556515|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556516|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556517|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556518|NCT02769494|Riboflavin|riboflavin|mesh-list
19556519|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
19556520|NCT02769494|Mesalamine|mesalamine|mesh-list
19556521|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
20111903|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20111904|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
20111905|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20111906|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111907|NCT00004274|Estrogens|estrogens|mesh-list
20111908|NCT00004274|Hormones|hormones|mesh-ancestor
20111909|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111910|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111911|NCT00004275|Hormones|hormones|mesh-list
20111912|NCT00004275|Oxandrolone|oxandrolone|mesh-list
20111913|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20111914|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111915|NCT00004275|Androgens|androgens|mesh-ancestor
20111916|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
20111917|NCT00004276|Thalidomide|thalidomide|mesh-list
20111918|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20111919|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
20111920|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111921|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
20111922|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20111923|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604602|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20604603|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19556522|NCT02769494|Vitamins|vitamins|mesh-ancestor
19556523|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
19556524|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556525|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19556526|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
19556527|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19556528|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556529|NCT02769494|Analgesics|analgesics|mesh-ancestor
19556530|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
19556531|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556532|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556533|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556534|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
19556535|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19556536|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19556537|NCT02769689|Prednisolone|prednisolone|mesh-list
19556538|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
19556539|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19556540|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
19556541|NCT02769689|Natalizumab|natalizumab|mesh-list
19556542|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556543|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
20604604|NCT02228122|Laxatives|laxatives|mesh-ancestor
19556544|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
19556545|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556546|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111924|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19556547|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556548|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
19556549|NCT02769689|Hormones|hormones|mesh-ancestor
19556550|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556551|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19556552|NCT02769689|Protective Agents|protective agents|mesh-ancestor
19556553|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19556554|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556555|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
19556556|NCT02769572|Diclofenac|diclofenac|mesh-list
19556557|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19556558|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556559|NCT02769572|Analgesics|analgesics|mesh-ancestor
19556560|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
19556561|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556562|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556563|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556564|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556565|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19556566|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556567|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556568|NCT02769325|Ketorolac|ketorolac|mesh-list
19556569|NCT02769325|Atropine|atropine|mesh-list
19556570|NCT02769325|Morphine|morphine|mesh-list
19556571|NCT02769325|Propofol|propofol|mesh-list
19556572|NCT02769325|Sevoflurane|sevoflurane|mesh-list
19556573|NCT02769325|Rocuronium|rocuronium|mesh-list
19556574|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19556575|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556576|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556577|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19556578|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
19556579|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
19556580|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19556581|NCT02769325|Narcotics|narcotics|mesh-ancestor
19556582|NCT02769325|Analgesics|analgesics|mesh-ancestor
19556583|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
19556584|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556585|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19556586|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19556587|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19556588|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556589|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556590|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556591|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20111925|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20111926|NCT00004276|Growth Substances|growth substances|mesh-ancestor
20111927|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
20111928|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20111929|NCT00004278|Ganciclovir|ganciclovir|mesh-list
20111930|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20111931|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
20111932|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20111933|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19556592|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556593|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556594|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19556595|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19556596|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19556597|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19556598|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19556599|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19556600|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
19556601|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19749040|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
20111934|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20111935|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111936|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
20111937|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
20111938|NCT00004284|Diuretics|diuretics|mesh-ancestor
20111939|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
20111940|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111941|NCT00004284|Expectorants|expectorants|mesh-ancestor
19749041|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19556602|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
19556603|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
20111942|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
20111943|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
20111944|NCT00004284|Protective Agents|protective agents|mesh-ancestor
19556604|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
19556605|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19556606|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19556607|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
19556608|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556609|NCT02769390|Clonidine|clonidine|mesh-list
19556610|NCT02769390|Diazepam|diazepam|mesh-list
19556611|NCT02769390|Analgesics|analgesics|mesh-ancestor
19556612|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
19556613|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556614|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556615|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19556616|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
19556617|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
20111945|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
20111946|NCT00004286|Antibodies|antibodies|mesh-list
20111947|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
20111948|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20111949|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20111950|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
19556618|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19556619|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19556620|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19556621|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
19556622|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556623|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556624|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19556625|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
19556626|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
19556627|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556628|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19556629|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556630|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19556631|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19556632|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19556633|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19556634|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19556635|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19556636|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
19556637|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
19556638|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
19556639|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
19556640|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
19556641|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556642|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556643|NCT02769286|Osimertinib|osimertinib|mesh-list
19556644|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556645|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19556646|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556647|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556648|NCT02769130|Losartan|losartan|mesh-list
20111951|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111952|NCT00004288|Olsalazine|olsalazine|mesh-list
20111953|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20111954|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20111955|NCT00004288|Analgesics|analgesics|mesh-ancestor
20111956|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
20111957|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111958|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111959|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20111960|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20111961|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556649|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19556650|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19556651|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19556652|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19556653|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556654|NCT02769104|Docetaxel|docetaxel|mesh-list
19556655|NCT02769104|Letrozole|letrozole|mesh-list
19556656|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19556657|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556658|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
19556659|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
20111962|NCT00004297|Diazepam|diazepam|mesh-list
20111963|NCT00004297|Lorazepam|lorazepam|mesh-list
19556660|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
19556661|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556662|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19556663|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556664|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19556665|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
19556666|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556667|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576578|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19576579|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
19576580|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576581|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576582|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111964|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
20111965|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
20111966|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
20111967|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20111968|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111969|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20111970|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20111971|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20111972|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20111973|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20111974|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20111975|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
20111976|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
20111977|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576583|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19576584|NCT05208892|Analgesics|analgesics|mesh-ancestor
19576585|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
19576586|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576587|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19576588|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19576589|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576590|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576591|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576592|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576593|NCT05197192|Venetoclax|venetoclax|mesh-list
19576594|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
19576595|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
19576596|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576597|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576598|NCT05194111|Valsartan|valsartan|mesh-list
19576599|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19576600|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19576601|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20111978|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111979|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20111980|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20111981|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20111982|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20111983|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
19576602|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19576603|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576604|NCT05180097|Gemcitabine|gemcitabine|mesh-list
19576605|NCT05180097|Dexamethasone|dexamethasone|mesh-list
20111984|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
20111985|NCT00004300|Bromocriptine|bromocriptine|mesh-list
19576606|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
19576607|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19576608|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576609|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576610|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
19576611|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
19576612|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576613|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576614|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576615|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
19576616|NCT05180097|Hormones|hormones|mesh-ancestor
19576617|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576618|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20111986|NCT00004300|Sertraline|sertraline|mesh-list
20111987|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
20111988|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19556668|NCT02769169|Ranibizumab|ranibizumab|mesh-list
19556669|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19556670|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19556671|NCT02769169|Growth Substances|growth substances|mesh-ancestor
19556672|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556673|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
20111989|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20111990|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20111991|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20111992|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20111993|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20111994|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
20111995|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20111996|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20111997|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20111998|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
20111999|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112000|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
20112001|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
20112002|NCT00004310|Clomipramine|clomipramine|mesh-list
20112003|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20112004|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
20604605|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604606|NCT02228135|Dexamethasone|dexamethasone|mesh-list
19556674|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556675|NCT02768727|Xenon|xenon|mesh-list
19556676|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19556677|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
19556678|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
19556679|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556680|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556681|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
19556682|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19556683|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19556684|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19556685|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556686|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
19556687|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19556688|NCT02768961|Ledipasvir|ledipasvir|mesh-list
19556689|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
19556690|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556691|NCT02769013|Praziquantel|praziquantel|mesh-list
19556692|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
19556693|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19556694|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556695|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
19556696|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19556697|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556698|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556699|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556700|NCT02768688|Analgesics|analgesics|mesh-ancestor
19556701|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
19556702|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556703|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19556704|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19556705|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19556706|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19556707|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556708|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556709|NCT02768805|Vaccines|vaccines|mesh-list
19556710|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
19556711|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556712|NCT02768649|Risperidone|risperidone|mesh-list
19556713|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19556714|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
19556715|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556716|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556717|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556718|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19556719|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19556720|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556721|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19556722|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19556723|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
19556724|NCT02768545|Ezetimibe|ezetimibe|mesh-list
19556725|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19556726|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19556727|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
19556728|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556729|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19556730|NCT02768532|Vedolizumab|vedolizumab|mesh-list
19556731|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556732|NCT02768519|OTS167|ots167|mesh-list
19556733|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19556734|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112005|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112006|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20112007|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20112008|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112009|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556735|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556736|NCT02769078|Warfarin|warfarin|mesh-list
19556737|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
19556738|NCT02769078|Dabigatran|dabigatran|mesh-list
19556739|NCT02769078|Apixaban|apixaban|mesh-list
19556740|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
19556741|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19556742|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
19556743|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19556744|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
19556745|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556746|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556747|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
19556748|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19556749|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556750|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19556751|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19556752|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19556753|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556754|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
19556755|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556756|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
19556757|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19556758|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556759|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556760|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19556761|NCT02768610|Analgesics|analgesics|mesh-ancestor
19556762|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
19556763|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556764|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19556765|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19556766|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19556767|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
19556768|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556769|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556770|NCT02768493|Ropivacaine|ropivacaine|mesh-list
19556771|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
19556772|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
19556773|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556774|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556775|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
19556776|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556777|NCT02768415|Apatinib|apatinib|mesh-list
19556778|NCT02768415|Vinorelbine|vinorelbine|mesh-list
19556779|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556780|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19556781|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556782|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556783|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19556784|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
19556785|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
19556786|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
19556787|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19556788|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556789|NCT02768337|Afatinib|afatinib|mesh-list
19556790|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556791|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19556792|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576619|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19556793|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556794|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
19556795|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19556796|NCT02768571|Protective Agents|protective agents|mesh-ancestor
19556797|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556798|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
19556799|NCT02768376|Fentanyl|fentanyl|mesh-list
19556800|NCT02768376|Bupivacaine|bupivacaine|mesh-list
19556801|NCT02768376|Anesthetics|anesthetics|mesh-list
19556802|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
19556803|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556804|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556805|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
19556806|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556807|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19556808|NCT02768376|Narcotics|narcotics|mesh-ancestor
19556809|NCT02768376|Analgesics|analgesics|mesh-ancestor
19556810|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19556811|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19556812|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
19556813|NCT02768363|Valacyclovir|valacyclovir|mesh-list
19556814|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
19556815|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556816|NCT02768077|Melatonin|melatonin|mesh-list
19556817|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
19556818|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556819|NCT02768077|Protective Agents|protective agents|mesh-ancestor
20112010|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112011|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
20112012|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556820|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556821|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556822|NCT02768389|Bevacizumab|bevacizumab|mesh-list
19556823|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19556824|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556825|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19556826|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19556827|NCT02768389|Growth Substances|growth substances|mesh-ancestor
19556828|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556829|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
19556830|NCT02768220|Empagliflozin|empagliflozin|mesh-list
19556831|NCT02768220|Linagliptin|linagliptin|mesh-list
19556832|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19556833|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556834|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19556835|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556836|NCT02768220|Incretins|incretins|mesh-ancestor
19556837|NCT02768220|Hormones|hormones|mesh-ancestor
19556838|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556839|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19556840|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
19556841|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556842|NCT02768168|Dezocine|dezocine|mesh-list
19556843|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19556844|NCT02768168|Narcotics|narcotics|mesh-ancestor
19556845|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19556846|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556847|NCT02768168|Analgesics|analgesics|mesh-ancestor
19556848|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
19556849|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556850|NCT02768207|Vemurafenib|vemurafenib|mesh-list
19556851|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556852|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19556853|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556854|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556855|NCT02768116|Sirolimus|sirolimus|mesh-list
19556856|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19556857|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556858|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19556859|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556860|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
19556861|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556862|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
20112013|NCT00004311|Leuprolide|leuprolide|mesh-list
19556863|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556864|NCT02767999|Fluoxetine|fluoxetine|mesh-list
19556865|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19556866|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19556867|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19556868|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556869|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556870|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
19556871|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556872|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19556873|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
19556874|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19556875|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19556876|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19556877|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556878|NCT02767661|Capecitabine|capecitabine|mesh-list
19556879|NCT02767661|Letrozole|letrozole|mesh-list
19556880|NCT02767661|Anastrozole|anastrozole|mesh-list
19556881|NCT02767661|Exemestane|exemestane|mesh-list
19556882|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19556883|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19556884|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
19556885|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556886|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556887|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19556888|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556889|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19556890|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
19556891|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556892|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556893|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19556894|NCT02767635|Triamcinolone|triamcinolone|mesh-list
19556895|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19556896|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19556897|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19556898|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19556899|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19556900|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19556901|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556902|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556903|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19556904|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19556905|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556906|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
19556907|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19556908|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556909|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
19556910|NCT02767635|Hormones|hormones|mesh-ancestor
19556911|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556912|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556913|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
19556914|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556915|NCT02767596|Lixisenatide|lixisenatide|mesh-list
20112014|NCT00004311|Spironolactone|spironolactone|mesh-list
20112015|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20112016|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
20112017|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112018|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112019|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112020|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112021|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20112022|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
20112023|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112024|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20112025|NCT00004311|Diuretics|diuretics|mesh-ancestor
20112026|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
19556916|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19556917|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556918|NCT02767752|Gemcitabine|gemcitabine|mesh-list
19556919|NCT02767752|Capecitabine|capecitabine|mesh-list
19556920|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19556921|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
19556922|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556923|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556924|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
19556925|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556926|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556927|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556928|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
20112027|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20112028|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20112029|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
19556929|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556930|NCT02767713|Dexamethasone|dexamethasone|mesh-list
19556931|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556932|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
19556933|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
19556934|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19556935|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556936|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19556937|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
19556938|NCT02767713|Hormones|hormones|mesh-ancestor
19556939|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556940|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19556941|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556942|NCT02767674|Gemcitabine|gemcitabine|mesh-list
19556943|NCT02767674|Prednisone|prednisone|mesh-list
19556944|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
19556945|NCT02767674|Rituximab|rituximab|mesh-list
19556946|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
19556947|NCT02767674|Epirubicin|epirubicin|mesh-list
19556948|NCT02767674|Vindesine|vindesine|mesh-list
19556949|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556950|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
19556951|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556952|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19556953|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19556954|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
19556955|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556956|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556957|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19556958|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19556959|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19556960|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
19556961|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
19556962|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556963|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19556964|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19556965|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
19556966|NCT02767674|Hormones|hormones|mesh-ancestor
19556967|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19556968|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19556969|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19556970|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19556971|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19556972|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19556973|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
19556974|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19556975|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19556976|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
19556977|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19556978|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19556979|NCT02767245|Thiamine|thiamine|mesh-list
19556980|NCT02767245|Vitamins|vitamins|mesh-ancestor
19556981|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
19556982|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19556983|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
19556984|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19556985|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19556986|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19556987|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
19556988|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556989|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19556990|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19556991|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576620|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
19576621|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112030|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576622|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
19576623|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19556992|NCT02767375|Fluorouracil|fluorouracil|mesh-list
19556993|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
19556994|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
19556995|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19556996|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19556997|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19556998|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19556999|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
19557000|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557001|NCT02767362|Atorvastatin|atorvastatin|mesh-list
19557002|NCT02767362|Ezetimibe|ezetimibe|mesh-list
19557003|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19557004|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19557005|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
19557006|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557007|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19557008|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20112031|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20112032|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20112033|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557009|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557010|NCT02767401|Aspirin|aspirin|mesh-list
19557011|NCT02767401|Metoprolol|metoprolol|mesh-list
19557012|NCT02767401|Clopidogrel|clopidogrel|mesh-list
19557013|NCT02767401|Ticagrelor|ticagrelor|mesh-list
19557014|NCT02767401|Atorvastatin|atorvastatin|mesh-list
19557015|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19557016|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19557017|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557018|NCT02767401|Analgesics|analgesics|mesh-ancestor
19557019|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
19557020|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557021|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557022|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557023|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557024|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19557025|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19557026|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557027|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19557028|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19557029|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557030|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
19557031|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19557032|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19557033|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
19557034|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19557035|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19557036|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19557037|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19557038|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19557039|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
19557040|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557041|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19557042|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19557043|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
19557044|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
19557045|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19557046|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19557047|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19557048|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
19557049|NCT02767154|Mannitol|mannitol|mesh-list
19557050|NCT02767154|Dextrans|dextrans|mesh-list
19557051|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19557052|NCT02767154|Diuretics|diuretics|mesh-ancestor
19557053|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
19557054|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557055|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
19557056|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
19557057|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
19557058|NCT02767102|Melatonin|melatonin|mesh-list
19557059|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
19557060|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112034|NCT00004316|Capsaicin|capsaicin|mesh-list
20112035|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
19557061|NCT02767102|Protective Agents|protective agents|mesh-ancestor
19557062|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112036|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557063|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557064|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19557065|NCT02767232|Plasminogen|plasminogen|mesh-list
19557066|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19557067|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19557068|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557069|NCT02767479|Esomeprazole|esomeprazole|mesh-list
19557070|NCT02767479|Rabeprazole|rabeprazole|mesh-list
19557071|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19557072|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557073|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19557074|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557075|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557076|NCT02767089|Prednisone|prednisone|mesh-list
19557077|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557078|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
19557079|NCT02767089|Hormones|hormones|mesh-ancestor
19557080|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557081|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557082|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19557083|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557084|NCT02767219|Dexamethasone|dexamethasone|mesh-list
19557085|NCT02767219|Bevacizumab|bevacizumab|mesh-list
20112037|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
20112038|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112039|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112040|NCT00004317|Leucovorin|leucovorin|mesh-list
20112041|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
20112042|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
20112043|NCT00004317|Spiramycin|spiramycin|mesh-list
20112044|NCT00004317|Calcium|calcium|mesh-list
20112045|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
20112046|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112047|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112048|NCT00004317|Antidotes|antidotes|mesh-ancestor
20112049|NCT00004317|Protective Agents|protective agents|mesh-ancestor
20112050|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
20112051|NCT00004317|Vitamins|vitamins|mesh-ancestor
20112052|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
20112053|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
20112054|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20112055|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20112056|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557086|NCT02767219|Fluorouracil|fluorouracil|mesh-list
19557087|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19557088|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557089|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19557090|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19557091|NCT02767219|Growth Substances|growth substances|mesh-ancestor
19557092|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557093|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
19557094|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557095|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
19557096|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
19557097|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557098|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557099|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
19557100|NCT02767219|Hormones|hormones|mesh-ancestor
19557101|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557102|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19557103|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
19557104|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557105|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19557106|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19557107|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
19557108|NCT02767076|Anesthetics|anesthetics|mesh-list
19557109|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557110|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557111|NCT02767063|Pioglitazone|pioglitazone|mesh-list
19557112|NCT02767063|Avelumab|avelumab|mesh-list
19557113|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20112057|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20112058|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112059|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557114|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112060|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19557115|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19557116|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557117|NCT02766764|Hormones|hormones|mesh-list
19557118|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557119|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557120|NCT02766855|Cysteamine|cysteamine|mesh-list
19557121|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19557122|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557123|NCT02767024|Nitroprusside|nitroprusside|mesh-list
19557124|NCT02767024|Dobutamine|dobutamine|mesh-list
19557125|NCT02767024|Furosemide|furosemide|mesh-list
19557126|NCT02767024|Diuretics|diuretics|mesh-ancestor
19557127|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
19557128|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557129|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19557130|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19557131|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557132|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19557133|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
19557134|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
19557135|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112061|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
20112062|NCT00004323|Cyclosporine|cyclosporine|mesh-list
20112063|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
20112064|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
20112065|NCT00004323|Methotrexate|methotrexate|mesh-list
20112066|NCT00004323|Cyclosporins|cyclosporins|mesh-list
19557136|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19557137|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19557138|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19557139|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
19557140|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557141|NCT02767024|Protective Agents|protective agents|mesh-ancestor
19557142|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19557143|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
19557144|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19557145|NCT02766803|Resveratrol|resveratrol|mesh-list
19557146|NCT02766803|Simvastatin|simvastatin|mesh-list
19557147|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19557148|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19557149|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
20112067|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19557150|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557151|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19557152|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19557153|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557154|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
19557155|NCT02766803|Protective Agents|protective agents|mesh-ancestor
19557156|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557157|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19557158|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
19557159|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
19557160|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19557161|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19557162|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112068|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20112069|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
20112070|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112071|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557163|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557164|NCT02766725|Urological Agents|urological agents|mesh-ancestor
19557165|NCT02766647|Lenograstim|lenograstim|mesh-list
19557166|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19557167|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
19557168|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557169|NCT02766634|Lenograstim|lenograstim|mesh-list
19557170|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19557171|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
19557172|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557173|NCT02766439|Etanercept|etanercept|mesh-list
19557174|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20112072|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20112073|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
19557175|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557176|NCT02766439|Analgesics|analgesics|mesh-ancestor
19557177|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
19557178|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557179|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557180|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557181|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557182|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557183|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19557184|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
19557185|NCT02766192|Ketamine|ketamine|mesh-list
20112074|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112075|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112076|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20112077|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20112078|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
20112079|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112080|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20112081|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
20112082|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
20112083|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557186|NCT02766192|Analgesics|analgesics|mesh-ancestor
19557187|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
19557188|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557189|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112084|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20112085|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19557190|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19557191|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19557192|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
19557193|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
19557194|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557195|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19557196|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19557197|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112086|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
20112087|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112088|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20112089|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112090|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
20112091|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
20112092|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112093|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112094|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
20112095|NCT00004323|Hormones|hormones|mesh-ancestor
20112096|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112097|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20112098|NCT00004323|Protective Agents|protective agents|mesh-ancestor
20112099|NCT00004327|Octreotide|octreotide|mesh-list
20112100|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112101|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112102|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112103|NCT00004328|Enalapril|enalapril|mesh-list
20112104|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
20112105|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20112106|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
20112107|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112108|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112109|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20112110|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
20112111|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
20112112|NCT00004330|Hormones|hormones|mesh-list
20112113|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112114|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112115|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20112116|NCT00004339|Trientine|trientine|mesh-list
19557198|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557199|NCT02766270|Temozolomide|temozolomide|mesh-list
19557200|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19557201|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
19557202|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557203|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557204|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
19557205|NCT02766556|Ropivacaine|ropivacaine|mesh-list
19557206|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576624|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557207|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557208|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557209|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557210|NCT02766556|Analgesics|analgesics|mesh-ancestor
19557211|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
19557212|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557213|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19557214|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19557215|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19557216|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
19557217|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557218|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557219|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
19557220|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
19557221|NCT02766348|Gemcitabine|gemcitabine|mesh-list
19557222|NCT02766348|Cisplatin|cisplatin|mesh-list
19557223|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19557224|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
19557225|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557226|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557227|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
19557228|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557229|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557230|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19557231|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
19557232|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557233|NCT02766322|Ethanol|ethanol|mesh-list
19557234|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19557235|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557236|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557237|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557238|NCT02766257|Anesthetics|anesthetics|mesh-list
19557239|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557240|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557241|NCT02766140|Docetaxel|docetaxel|mesh-list
19557242|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557243|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19557244|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19557245|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19557246|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557247|NCT02766036|Propolis|propolis|mesh-list
19557248|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557249|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
19557250|NCT02765971|Cathartics|cathartics|mesh-ancestor
19557251|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557252|NCT02765815|Ketorolac|ketorolac|mesh-list
19557253|NCT02765815|Epinephrine|epinephrine|mesh-list
19557254|NCT02765815|Racepinephrine|racepinephrine|mesh-list
19557255|NCT02765815|Morphine|morphine|mesh-list
19557256|NCT02765815|Bupivacaine|bupivacaine|mesh-list
19557257|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
19557258|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
19557259|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
19557260|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557261|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557262|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
19557263|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557264|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19557265|NCT02765815|Narcotics|narcotics|mesh-ancestor
19557266|NCT02765815|Analgesics|analgesics|mesh-ancestor
19557267|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19557268|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19557269|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
20112117|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
20112118|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
20112119|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112120|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112121|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20112122|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20112123|NCT00004339|Growth Substances|growth substances|mesh-ancestor
19557270|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557271|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557272|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19557273|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19557274|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
19557275|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20112124|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112125|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
20112126|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112127|NCT00004340|Calcitriol|calcitriol|mesh-list
20112128|NCT00004340|Hormones|hormones|mesh-list
20112129|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112130|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112131|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112132|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19557276|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
19557277|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
19557278|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
19557279|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19557280|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19557281|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557282|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557283|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557284|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19557285|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576625|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19576626|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
20112133|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112134|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112135|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20112136|NCT00004340|Vitamins|vitamins|mesh-ancestor
20112137|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
20112138|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20112139|NCT00004344|Leuprolide|leuprolide|mesh-list
20112140|NCT00004344|Testosterone|testosterone|mesh-list
20112141|NCT00004344|Androgens|androgens|mesh-ancestor
20112142|NCT00004344|Hormones|hormones|mesh-ancestor
20112143|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604607|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20604608|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
19576627|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576628|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
19576629|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576630|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576631|NCT05170672|Abatacept|abatacept|mesh-list
19576632|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19576633|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576634|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576635|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19576636|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
19576637|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576638|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576639|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
19576640|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576641|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576642|NCT05162742|Colchicine|colchicine|mesh-list
19576643|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
19576644|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576645|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
19576646|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
19576647|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
19576648|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576649|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576650|NCT05160493|Pregabalin|pregabalin|mesh-list
19576651|NCT05160493|Ketamine|ketamine|mesh-list
19576652|NCT05160493|Esketamine|esketamine|mesh-list
19576653|NCT05160493|Analgesics|analgesics|mesh-ancestor
19576654|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
19576655|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576656|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576657|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19576658|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576659|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
19576660|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
19576661|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576662|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19576663|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19576664|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576665|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576666|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
20604609|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
19557286|NCT02765633|Cangrelor|cangrelor|mesh-list
19557287|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19557288|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19557289|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19557290|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19557291|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
19557292|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557293|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557294|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557295|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
19557296|NCT02765594|Valsartan|valsartan|mesh-list
19557297|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19557298|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19557299|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19557300|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557301|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
19557302|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19557303|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19557304|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557305|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557306|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557307|NCT02765347|Metformin|metformin|mesh-list
19557308|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19557309|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557310|NCT02765399|Liraglutide|liraglutide|mesh-list
19557311|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19557312|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557313|NCT02765399|Incretins|incretins|mesh-ancestor
19557314|NCT02765399|Hormones|hormones|mesh-ancestor
19557315|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557316|NCT02765373|Letrozole|letrozole|mesh-list
19557317|NCT02765373|Anastrozole|anastrozole|mesh-list
19557318|NCT02765373|Exemestane|exemestane|mesh-list
19557319|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557320|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19557321|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19557322|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557323|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557324|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19557325|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
19557326|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557327|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557328|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19557329|NCT02765217|Amoxicillin|amoxicillin|mesh-list
19557330|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
19557331|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
19557332|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19557333|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19557334|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557335|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557336|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557337|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19557338|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
19557339|NCT02765204|Saxagliptin|saxagliptin|mesh-list
19557340|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19557341|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557342|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19557343|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557344|NCT02765204|Incretins|incretins|mesh-ancestor
19557345|NCT02765204|Hormones|hormones|mesh-ancestor
19557346|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557347|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20604610|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604611|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604612|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604613|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
20604614|NCT02228135|Hormones|hormones|mesh-ancestor
20604615|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604616|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20604617|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604618|NCT02228239|Mirtazapine|mirtazapine|mesh-list
19557348|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
19557349|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557350|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19557351|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19557352|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
19557353|NCT02765022|Hormones|hormones|mesh-ancestor
19557354|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557355|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557356|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557357|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557358|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19557359|NCT02765009|Furosemide|furosemide|mesh-list
19557360|NCT02765009|Bumetanide|bumetanide|mesh-list
19557361|NCT02765009|Diuretics|diuretics|mesh-list
19557362|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19557363|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
19557364|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557365|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19557366|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19557367|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557368|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19557369|NCT02765126|Vaccines|vaccines|mesh-list
19557370|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
19557371|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557372|NCT02764619|Spironolactone|spironolactone|mesh-list
19557373|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19557374|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
19557375|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557376|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557377|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19557378|NCT02764619|Diuretics|diuretics|mesh-ancestor
19557379|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
19557380|NCT02764515|Methotrexate|methotrexate|mesh-list
20112144|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112145|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112146|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112147|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20112148|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
20112149|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112150|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20112151|NCT00004346|Lovastatin|lovastatin|mesh-list
20112152|NCT00004346|L 647318|l 647318|mesh-list
20112153|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
20112154|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20112155|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20112156|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
20112157|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112158|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20112159|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20604619|NCT02228239|Esketamine|esketamine|mesh-list
20604620|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
20604621|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20604622|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20604623|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
20604624|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
20604625|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604626|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604627|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604628|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20604629|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20604630|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20112160|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112161|NCT00004346|Cathartics|cathartics|mesh-ancestor
20112162|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112163|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
20112164|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20112165|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20112166|NCT00004357|Prednisolone|prednisolone|mesh-list
20112167|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
19557381|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19557382|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
20112168|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20112169|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
19557383|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112170|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112171|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
20112172|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
20112173|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112174|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112175|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112176|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
20112177|NCT00004357|Hormones|hormones|mesh-ancestor
20112178|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112179|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20112180|NCT00004357|Protective Agents|protective agents|mesh-ancestor
20112181|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20604631|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19557384|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557385|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19557386|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
19557387|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557388|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557389|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557390|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557391|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19557392|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19557393|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
19557394|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557395|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19557396|NCT02764736|Atorvastatin|atorvastatin|mesh-list
19557397|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19557398|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19557399|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
19557400|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557401|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19557402|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19557403|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557404|NCT02764723|Bupivacaine|bupivacaine|mesh-list
19557405|NCT02764723|Ropivacaine|ropivacaine|mesh-list
19557406|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
19557407|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
19557408|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557409|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557410|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
19557411|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557412|NCT02764710|Amoxicillin|amoxicillin|mesh-list
19557413|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
19557414|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
19557415|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19557416|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19557417|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557418|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19557419|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557420|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557421|NCT02764749|Phenol|phenol|mesh-list
19557422|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19557423|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557424|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
19557425|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19557426|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19557427|NCT02764593|Nivolumab|nivolumab|mesh-list
19557428|NCT02764593|Cetuximab|cetuximab|mesh-list
19557429|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557430|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19557431|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19557432|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557433|NCT02764359|Vancomycin|vancomycin|mesh-list
19557434|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19557435|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557436|NCT02764125|Levodopa|levodopa|mesh-list
19557437|NCT02764125|Carbidopa|carbidopa|mesh-list
19557438|NCT02764125|Entacapone|entacapone|mesh-list
19557439|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19557440|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19557441|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
19557442|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557443|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604632|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19557444|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557445|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19557446|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557447|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19557448|NCT02764281|Dexamethasone|dexamethasone|mesh-list
19557449|NCT02764281|Methotrexate|methotrexate|mesh-list
19557450|NCT02764281|Etoposide|etoposide|mesh-list
19557451|NCT02764281|Pegaspargase|pegaspargase|mesh-list
19557452|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557453|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
19557454|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
19557455|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557456|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557457|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557458|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
19557459|NCT02764281|Hormones|hormones|mesh-ancestor
19557460|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557461|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19557462|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557463|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557464|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557465|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19557466|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
19557467|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19557468|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19557469|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
19557470|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557471|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19557472|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20112182|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112183|NCT00004358|Calcitonin|calcitonin|mesh-list
20112184|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
20112185|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20112186|NCT00004358|Katacalcin|katacalcin|mesh-list
20112187|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19557473|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
19557474|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557475|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19557476|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19557477|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19557478|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19557479|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19557480|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19557481|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19557482|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19557483|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19557484|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
19557485|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557486|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557487|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576667|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19576668|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19576669|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19576670|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19576671|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19576672|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112188|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112189|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20112190|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
20112191|NCT00004359|Methoxsalen|methoxsalen|mesh-list
20112192|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20112193|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
20112194|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
20112195|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20112196|NCT00004360|Diuretics|diuretics|mesh-ancestor
20112197|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
20112198|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112199|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20112200|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112201|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112202|NCT00004361|Citric Acid|citric acid|mesh-list
20112203|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
20112204|NCT00004361|Calcium|calcium|mesh-list
20112205|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112206|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557488|NCT02763969|Interferons|interferons|mesh-list
19557489|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
19557490|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
19557491|NCT02763969|Ustekinumab|ustekinumab|mesh-list
19557492|NCT02763969|Famotidine|famotidine|mesh-list
19557493|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557494|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
19557495|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557496|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
20112207|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
20112208|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20112209|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
20604633|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20604634|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
20604635|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20604636|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20112210|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
20112211|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112212|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
20112213|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20112214|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
19557497|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557498|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557499|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20112215|NCT00004363|Coagulants|coagulants|mesh-ancestor
20112216|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20112217|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
20112218|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112219|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20112220|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20112221|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
20112222|NCT00004364|Coagulants|coagulants|mesh-ancestor
20112223|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20112224|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
20112225|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112226|NCT00004368|Colchicine|colchicine|mesh-list
20112227|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
20112228|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112229|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20112230|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
19557500|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557501|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19557502|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
19557503|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
19557504|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557505|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557506|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19557507|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557508|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557509|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
19557510|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557511|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557512|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19557513|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557514|NCT02763722|Emollients|emollients|mesh-list
19557515|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557516|NCT02763592|Lidocaine|lidocaine|mesh-list
19557517|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
19557518|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
19557519|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604637|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
19557520|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557521|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
19557522|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112231|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604638|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20604639|NCT02228252|Caseins|caseins|mesh-list
20604640|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
20604641|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
20607950|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19557523|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19557524|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19557525|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19557526|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19557527|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557528|NCT02763761|Prednisone|prednisone|mesh-list
19557529|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
19557530|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19557531|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19557532|NCT02763761|Prednisolone|prednisolone|mesh-list
19557533|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
19557534|NCT02763761|Infliximab|infliximab|mesh-list
19557535|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19557536|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
19557537|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557538|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
19557539|NCT02763761|Hormones|hormones|mesh-ancestor
19557540|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557541|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557542|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19557543|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112232|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112233|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112234|NCT00004373|Alprazolam|alprazolam|mesh-list
20112235|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20112236|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20112237|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112238|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20112239|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20112240|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112241|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
19557544|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
19557545|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
19557546|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557547|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557548|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19557549|NCT02763761|Protective Agents|protective agents|mesh-ancestor
19557550|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557551|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557552|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19557553|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19557554|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
19557555|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557556|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19557557|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19557558|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
19557559|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
19557560|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557561|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557562|NCT02764008|Bupivacaine|bupivacaine|mesh-list
19557563|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
19557564|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
19557565|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557566|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112242|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
20112243|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112244|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557567|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
19557568|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557569|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
19557570|NCT02763475|Fludarabine|fludarabine|mesh-list
19557571|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19557572|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
19557573|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557574|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557575|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19557576|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
19557577|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557578|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557579|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19557580|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19557581|NCT02763137|Carbidopa|carbidopa|mesh-list
20112245|NCT00004376|Guanfacine|guanfacine|mesh-list
20112246|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19557582|NCT02763137|Levodopa|levodopa|mesh-list
19557583|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19557584|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
19557585|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557586|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19557587|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19557588|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
19557589|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
19557590|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557591|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557592|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19557593|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557594|NCT02762955|Adalimumab|adalimumab|mesh-list
19557595|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557596|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557597|NCT02763098|Remifentanil|remifentanil|mesh-list
19557598|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19557599|NCT02763098|Narcotics|narcotics|mesh-ancestor
19557600|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557601|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557602|NCT02763098|Analgesics|analgesics|mesh-ancestor
19557603|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
19557604|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557605|NCT02763059|Acetaminophen|acetaminophen|mesh-list
19557606|NCT02763059|Dexamethasone|dexamethasone|mesh-list
19557607|NCT02763059|Ibuprofen|ibuprofen|mesh-list
19557608|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557609|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
19557610|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
19557611|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557612|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557613|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557614|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
19557615|NCT02763059|Hormones|hormones|mesh-ancestor
19557616|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557617|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19557618|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557619|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557620|NCT02763059|Analgesics|analgesics|mesh-ancestor
19557621|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
19557622|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
19557623|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19557624|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557625|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20112247|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20112248|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20112249|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20112250|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
20112251|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112252|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112253|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557626|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557627|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557628|NCT02763007|Pioglitazone|pioglitazone|mesh-list
19557629|NCT02763007|Alogliptin|alogliptin|mesh-list
19557630|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19557631|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557632|NCT02763007|Incretins|incretins|mesh-ancestor
19557633|NCT02763007|Hormones|hormones|mesh-ancestor
19557634|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557635|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19557636|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
19557637|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557638|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557639|NCT02762838|Folic Acid|folic acid|mesh-list
19557640|NCT02762838|Methotrexate|methotrexate|mesh-list
19557641|NCT02762838|Infliximab|infliximab|mesh-list
19557642|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19557643|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
19557644|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19557645|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557646|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19557647|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
19557648|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557649|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557650|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557651|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557652|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19557653|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19557654|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
19557655|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557656|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19557657|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557658|NCT02762838|Hematinics|hematinics|mesh-ancestor
20112254|NCT00004380|Methocarbamol|methocarbamol|mesh-list
20112255|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19557659|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
19557660|NCT02762838|Vitamins|vitamins|mesh-ancestor
19557661|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
19557662|NCT02762851|Vaccines|vaccines|mesh-list
19557663|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
19557664|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557665|NCT02762981|Paclitaxel|paclitaxel|mesh-list
19557666|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19557667|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19557668|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557669|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
19557670|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
19557671|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
19557672|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557673|NCT02762812|Infliximab|infliximab|mesh-list
19557674|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557675|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557676|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557677|NCT02762864|Aspirin|aspirin|mesh-list
19557678|NCT02762864|Clopidogrel|clopidogrel|mesh-list
19557679|NCT02762864|Ticagrelor|ticagrelor|mesh-list
19557680|NCT02762864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19557681|NCT02762864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557682|NCT02762864|Analgesics|analgesics|mesh-ancestor
19557683|NCT02762864|Sensory System Agents|sensory system agents|mesh-ancestor
19557684|NCT02762864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557685|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557686|NCT02762864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557687|NCT02762864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557688|NCT02762864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19557689|NCT02762864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19557690|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557691|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19557692|NCT02762864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19557693|NCT02762864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557694|NCT02762864|Antipyretics|antipyretics|mesh-ancestor
19557695|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19557696|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19557697|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19557698|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
19557699|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557700|NCT02762890|Iodine|iodine|mesh-list
19557701|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19557702|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557703|NCT02762890|Trace Elements|trace elements|mesh-ancestor
19557704|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
19557705|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557706|NCT02762942|Misoprostol|misoprostol|mesh-list
19557707|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19557708|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
19557709|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19557710|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557711|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19557712|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557713|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
19557714|NCT02762656|Lidocaine|lidocaine|mesh-list
19557715|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
19557716|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
19557717|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557718|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112256|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112257|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19557719|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
19557720|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557721|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20112258|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557722|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19557723|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19557724|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112259|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20112260|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112261|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112262|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20112263|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112264|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112265|NCT00004390|Morphine|morphine|mesh-list
20112266|NCT00004390|Methadone|methadone|mesh-list
20112267|NCT00004390|Nortriptyline|nortriptyline|mesh-list
20112268|NCT00004390|Desipramine|desipramine|mesh-list
19557725|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557726|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19557727|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19557728|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
19557729|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557730|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557731|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19557732|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19557733|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19557734|NCT02762617|Tenofovir|tenofovir|mesh-list
19557735|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
19557736|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557737|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19557738|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19557739|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557740|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557741|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19557742|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19557743|NCT02762591|Pimavanserin|pimavanserin|mesh-list
20112269|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20112270|NCT00004390|Narcotics|narcotics|mesh-ancestor
20112271|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557744|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19557745|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19557746|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19557747|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19557748|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557749|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557750|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19557751|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19557752|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19557753|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
19557754|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557755|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557756|NCT02762344|Heparin|heparin|mesh-list
19557757|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
19557758|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19557759|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19557760|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576673|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
19576674|NCT05154734|Belimumab|belimumab|mesh-list
19576675|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19576676|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
19576677|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576678|NCT05143164|Gentamicins|gentamicins|mesh-list
19576679|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19576680|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576681|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19576682|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576683|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576684|NCT05142189|Docetaxel|docetaxel|mesh-list
19576685|NCT05142189|Cemiplimab|cemiplimab|mesh-list
19576686|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576687|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
19576688|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
19576689|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
19576690|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112272|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112273|NCT00004390|Analgesics|analgesics|mesh-ancestor
20112274|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
19557761|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
19557762|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557763|NCT02762474|Paclitaxel|paclitaxel|mesh-list
20112275|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112276|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
20112277|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
20112278|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20112279|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
20112280|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112281|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20112282|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20112283|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112284|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112285|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
19557764|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19557765|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557766|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
19557767|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
19557768|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
19557769|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557770|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19557771|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
19557772|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557773|NCT02762448|Asunaprevir|asunaprevir|mesh-list
19557774|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
19557775|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557776|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557777|NCT02762253|Riboflavin|riboflavin|mesh-list
19557778|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
19557779|NCT02762253|Vitamins|vitamins|mesh-ancestor
19557780|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
19557781|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557782|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19557783|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
19557784|NCT02762006|Durvalumab|durvalumab|mesh-list
19557785|NCT02762006|Tremelimumab|tremelimumab|mesh-list
19557786|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19557787|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112286|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112287|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112288|NCT00004393|Risperidone|risperidone|mesh-list
20112289|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20112290|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
20112291|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112292|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557788|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
19557789|NCT02762123|Digoxin|digoxin|mesh-list
19557790|NCT02762123|Midazolam|midazolam|mesh-list
19557791|NCT02762123|Omeprazole|omeprazole|mesh-list
19557792|NCT02762123|Montelukast|montelukast|mesh-list
19557793|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19557794|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19557795|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557796|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557797|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19557798|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19557799|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19557800|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19557801|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
19557802|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
19557803|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
19557804|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
19557805|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557806|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557807|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19557808|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557809|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19557810|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557811|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19557812|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
19557813|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19557814|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
19557815|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19557816|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19557817|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19557818|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19557819|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19557820|NCT02762123|Protective Agents|protective agents|mesh-ancestor
19557821|NCT02762123|Analgesics|analgesics|mesh-ancestor
19557822|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
19557823|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557824|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19557825|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557826|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557827|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557828|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19557829|NCT02761512|Lansoprazole|lansoprazole|mesh-list
19557830|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
19557831|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19557832|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557833|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19557834|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557835|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557836|NCT02761486|Aspirin|aspirin|mesh-list
19557837|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19557838|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557839|NCT02761486|Analgesics|analgesics|mesh-ancestor
19557840|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
19557841|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557842|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557843|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557844|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557845|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19557846|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19557847|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557848|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19557849|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19557850|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557851|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
20112293|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112294|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20112295|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19557852|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
19557853|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19557854|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
19557855|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557856|NCT02761577|Expectorants|expectorants|mesh-ancestor
19557857|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
19557858|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19557859|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
19557860|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557861|NCT02761577|Protective Agents|protective agents|mesh-ancestor
19557862|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557863|NCT02761577|Antidotes|antidotes|mesh-ancestor
19557864|NCT02761161|Mianserin|mianserin|mesh-list
19557865|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19557866|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19557867|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
19557868|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557869|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557870|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557871|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19557872|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
19557873|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
19557874|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19557875|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
19557876|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20112296|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557877|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
19557878|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19557879|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19557880|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19557881|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19557882|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19557883|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19557884|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
19557885|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557886|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557887|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557888|NCT02761395|Deferasirox|deferasirox|mesh-list
19557889|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19557890|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
19557891|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
19557892|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557893|NCT02761317|Bisacodyl|bisacodyl|mesh-list
20112297|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112298|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20112299|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
19557894|NCT02761317|Cathartics|cathartics|mesh-ancestor
19557895|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19557896|NCT02761317|Laxatives|laxatives|mesh-ancestor
19557897|NCT02761070|Bevacizumab|bevacizumab|mesh-list
20112300|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20112301|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112302|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112303|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20112304|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112305|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112306|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20112307|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112308|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112309|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
20112310|NCT00004399|Nimodipine|nimodipine|mesh-list
20112311|NCT00004399|Analgesics|analgesics|mesh-ancestor
20112312|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
20112313|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112314|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112315|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
20112316|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557898|NCT02761070|Temozolomide|temozolomide|mesh-list
19557899|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19557900|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557901|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19557902|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19557903|NCT02761070|Growth Substances|growth substances|mesh-ancestor
19557904|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557905|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
19557906|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19557907|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
19557908|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557909|NCT02760888|Diclofenac|diclofenac|mesh-list
19557910|NCT02760888|Tramadol|tramadol|mesh-list
19557911|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19557912|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19557913|NCT02760888|Analgesics|analgesics|mesh-ancestor
20112317|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20112318|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
20112319|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20112320|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112321|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112322|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112323|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
20112324|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112325|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20112326|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
20112327|NCT00004400|Testosterone|testosterone|mesh-list
20112328|NCT00004400|Androgens|androgens|mesh-ancestor
20112329|NCT00004400|Hormones|hormones|mesh-ancestor
20112330|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112331|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112332|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
20112333|NCT00004401|Antibodies|antibodies|mesh-list
20112334|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
20112335|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20112336|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20112337|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
20112338|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112339|NCT00004402|Calcitriol|calcitriol|mesh-list
19557914|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
20112340|NCT00004402|Interferons|interferons|mesh-list
20112341|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
20112342|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604642|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557915|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557916|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557917|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19557918|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19557919|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19557920|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557921|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557922|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19557923|NCT02760888|Narcotics|narcotics|mesh-ancestor
19557924|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557925|NCT02761291|Gemcitabine|gemcitabine|mesh-list
19557926|NCT02761291|Valganciclovir|valganciclovir|mesh-list
19557927|NCT02761291|Valproic Acid|valproic acid|mesh-list
19557928|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19557929|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
19557930|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557931|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557932|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
19557933|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557934|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557935|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19557936|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
19557937|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557938|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
19557939|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
19557940|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557941|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
19557942|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19557943|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19557944|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19557945|NCT02760992|Baclofen|baclofen|mesh-list
19557946|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19557947|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557948|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19557949|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19557950|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19557951|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
19557952|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
19557953|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19557954|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557955|NCT02760979|Denosumab|denosumab|mesh-list
19557956|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19557957|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557958|NCT02760953|Epirubicin|epirubicin|mesh-list
19557959|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19557960|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557961|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20112343|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
20112344|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112345|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112346|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112347|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19557962|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19557963|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557964|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576691|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576692|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
20112348|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112349|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112350|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20112351|NCT00004402|Vitamins|vitamins|mesh-ancestor
20112352|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
20112353|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20112354|NCT00004403|Albendazole|albendazole|mesh-list
20112355|NCT00004403|Dexamethasone|dexamethasone|mesh-list
20112356|NCT00004403|Phenytoin|phenytoin|mesh-list
20112357|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112358|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
20112359|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
20112360|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112361|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604643|NCT02228369|Osimertinib|osimertinib|mesh-list
20112362|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112363|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
20112364|NCT00004403|Hormones|hormones|mesh-ancestor
19557965|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
19557966|NCT02760901|Mannitol|mannitol|mesh-list
19557967|NCT02760901|Acetazolamide|acetazolamide|mesh-list
19557968|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19557969|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
19557970|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19557971|NCT02760901|Expectorants|expectorants|mesh-ancestor
19557972|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
19557973|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19557974|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
19557975|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557976|NCT02760901|Protective Agents|protective agents|mesh-ancestor
19557977|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557978|NCT02760901|Antidotes|antidotes|mesh-ancestor
19557979|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19557980|NCT02760901|Diuretics|diuretics|mesh-ancestor
19557981|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
19557982|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
19557983|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19557984|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19557985|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
19557986|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
19557987|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19557988|NCT02760823|Protective Agents|protective agents|mesh-ancestor
19557989|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19557990|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
19557991|NCT02760823|Vitamins|vitamins|mesh-ancestor
19557992|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
19557993|NCT02760667|Cisplatin|cisplatin|mesh-list
19557994|NCT02760667|Carboplatin|carboplatin|mesh-list
19557995|NCT02760667|Docetaxel|docetaxel|mesh-list
19557996|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19557997|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
19557998|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
19557999|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
19558000|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558001|NCT02760420|Amoxicillin|amoxicillin|mesh-list
19558002|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19558003|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558004|NCT02760342|Metformin|metformin|mesh-list
19558005|NCT02760342|Peficitinib|peficitinib|mesh-list
19558006|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19558007|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558008|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558009|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558010|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558011|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
19558012|NCT02760615|Losartan|losartan|mesh-list
19558013|NCT02760615|Midazolam|midazolam|mesh-list
19558014|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
19558015|NCT02760615|Caffeine|caffeine|mesh-list
19558016|NCT02760615|Omeprazole|omeprazole|mesh-list
19558017|NCT02760615|Vedolizumab|vedolizumab|mesh-list
19558018|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19558019|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19558020|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558021|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558022|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19558023|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19558024|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19558025|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19558026|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
19558027|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
19558028|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
19558029|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
19558030|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558031|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558032|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19558033|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19558034|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19558035|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19558036|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19558037|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558038|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19558039|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558040|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19558041|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19558042|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19558043|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19558044|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
19558045|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
19558046|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
19558047|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19558048|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19558049|NCT02760355|Ribavirin|ribavirin|mesh-list
19558050|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
19558051|NCT02760355|Ledipasvir|ledipasvir|mesh-list
19558052|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
19558053|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558054|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
19558055|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558056|NCT02760459|Dexamethasone|dexamethasone|mesh-list
19558057|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558058|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
19558059|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
19558060|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112365|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112366|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112367|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112368|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
20112369|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19558061|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558062|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558063|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
19558064|NCT02760459|Hormones|hormones|mesh-ancestor
19558065|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558066|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19558067|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558068|NCT02760316|Prednisolone|prednisolone|mesh-list
19558069|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19558070|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
19558071|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19558072|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
19558073|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19558074|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
19558075|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558076|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
19558077|NCT02760316|Hormones|hormones|mesh-ancestor
19558078|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558079|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558080|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19558081|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558082|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
19558083|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
19558084|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558085|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558086|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19558087|NCT02760316|Protective Agents|protective agents|mesh-ancestor
19558088|NCT02760472|SMOFlipid|smoflipid|mesh-list
19558089|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19558090|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19558091|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19558092|NCT02760381|Acetic Acid|acetic acid|mesh-list
19558093|NCT02760381|Retinol acetate|retinol acetate|mesh-list
19558094|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19558095|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558096|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20112370|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558097|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
19558098|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558099|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19558100|NCT02760381|Protective Agents|protective agents|mesh-ancestor
19558101|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558102|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
19558103|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558104|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558105|NCT02760043|Dexamethasone|dexamethasone|mesh-list
19558106|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558107|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
19558108|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
19558109|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558110|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558111|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558112|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
19558113|NCT02760043|Hormones|hormones|mesh-ancestor
19558114|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558115|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19558116|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558117|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
19558118|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19558119|NCT02759861|Ledipasvir|ledipasvir|mesh-list
19558120|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
19558121|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558122|NCT02760121|Acetazolamide|acetazolamide|mesh-list
19558123|NCT02760121|Methazolamide|methazolamide|mesh-list
19558124|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
19558125|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19558126|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558127|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112371|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
20112372|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20112373|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20112374|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
20112375|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
20112376|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
20112377|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112378|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
20112379|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20112380|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20112381|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112382|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20112383|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20112384|NCT00004404|Clotrimazole|clotrimazole|mesh-list
20112385|NCT00004404|Miconazole|miconazole|mesh-list
20112386|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
20112387|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112388|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
20112389|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112390|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112391|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19558128|NCT02760121|Diuretics|diuretics|mesh-ancestor
19558129|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
19558130|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558131|NCT02759991|Vaccines|vaccines|mesh-list
19558132|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
19558133|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112392|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20112393|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558134|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19558135|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19558136|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558137|NCT02760030|Fulvestrant|fulvestrant|mesh-list
19558138|NCT02760030|Palbociclib|palbociclib|mesh-list
19558139|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19558140|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19558141|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558142|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19558143|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19558144|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
19558145|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558146|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558147|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19558148|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558149|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112394|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
20112395|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20112396|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20112397|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20112398|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
20112399|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112400|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112401|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20112402|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20112403|NCT00004406|Hormones|hormones|mesh-list
20112404|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
20112405|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112406|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112407|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112408|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
20112409|NCT00004407|Antibodies|antibodies|mesh-list
20112410|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
20112411|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20112412|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20112413|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
20112414|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558150|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19558151|NCT02760095|Vitamin A|vitamin a|mesh-list
19558152|NCT02760095|Acetic Acid|acetic acid|mesh-list
19558153|NCT02760095|Retinol acetate|retinol acetate|mesh-list
19558154|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
19558155|NCT02760095|Vitamins|vitamins|mesh-ancestor
19558156|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
19558157|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558158|NCT02760095|Protective Agents|protective agents|mesh-ancestor
19558159|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19558160|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558161|NCT02760095|Astringents|astringents|mesh-ancestor
19558162|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
19558163|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19558164|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
19558165|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19558166|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558167|NCT02759926|Quinine|quinine|mesh-list
19558168|NCT02759926|Denatonium|denatonium|mesh-list
19558169|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
19558170|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19558171|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19558172|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558173|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19558174|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558175|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19558176|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558177|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558178|NCT02759926|Analgesics|analgesics|mesh-ancestor
19558179|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
19558180|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
19558181|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558182|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
19558183|NCT02759614|Bevacizumab|bevacizumab|mesh-list
19558184|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19558185|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558186|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558187|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19558188|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19558189|NCT02759614|Growth Substances|growth substances|mesh-ancestor
19558190|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558191|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
19558192|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19558193|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558194|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558195|NCT02759510|Phenylephrine|phenylephrine|mesh-list
19558196|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
19558197|NCT02759510|Norepinephrine|norepinephrine|mesh-list
19558198|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19558199|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
19558200|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
19558201|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558202|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558203|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
19558204|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19558205|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
19558206|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
19558207|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19558208|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19558209|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19558210|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
19558211|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558212|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558213|NCT02759510|Protective Agents|protective agents|mesh-ancestor
19558214|NCT02759224|Irsogladine|irsogladine|mesh-list
19558215|NCT02759224|Lafutidine|lafutidine|mesh-list
19558216|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558217|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19558218|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558219|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19558220|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
19558221|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
19558222|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558223|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558224|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558225|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19558226|NCT02759224|Protective Agents|protective agents|mesh-ancestor
19558227|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19558228|NCT02759393|Lansoprazole|lansoprazole|mesh-list
19558229|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
19558230|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19558231|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558232|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19558233|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558234|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558235|NCT02759042|Leronlimab|leronlimab|mesh-list
19558236|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19558237|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19558238|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558239|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19558240|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19558241|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
19558242|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558243|NCT02759107|Dulaglutide|dulaglutide|mesh-list
19558244|NCT02759107|Tirzepatide|tirzepatide|mesh-list
19558245|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19558246|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558247|NCT02759107|Incretins|incretins|mesh-ancestor
19558248|NCT02759107|Hormones|hormones|mesh-ancestor
19558249|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558250|NCT02758951|Bevacizumab|bevacizumab|mesh-list
19558251|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558252|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558253|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19558254|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19558255|NCT02758951|Growth Substances|growth substances|mesh-ancestor
19558256|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558257|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
19576693|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20112415|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
20112416|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
19576694|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576695|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19576696|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576697|NCT05139316|Prednisolone|prednisolone|mesh-list
19576698|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576699|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
19576700|NCT05139316|Hormones|hormones|mesh-ancestor
19576701|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576702|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576703|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576704|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576705|NCT05136157|Insulin|insulin|mesh-list
19576706|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19576707|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
19576708|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20604644|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576709|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604645|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19576710|NCT05131646|Axitinib|axitinib|mesh-list
19558258|NCT02758925|Cytarabine|cytarabine|mesh-list
19558259|NCT02758925|Rituximab|rituximab|mesh-list
19558260|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19558261|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558262|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558263|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
19558264|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558265|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558266|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19558267|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
19558268|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558269|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
19558270|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558271|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558272|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19558273|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
19558274|NCT02758990|Vitamin D|vitamin d|mesh-list
19558275|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
19558276|NCT02758990|Vitamins|vitamins|mesh-list
19558277|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
19558278|NCT02758990|Vitamin E|vitamin e|mesh-list
19558279|NCT02758990|Tocopherols|tocopherols|mesh-list
19558280|NCT02758990|Vitamin A|vitamin a|mesh-list
19558281|NCT02758990|Niacinamide|niacinamide|mesh-list
19558282|NCT02758990|Niacin|niacin|mesh-list
19558283|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
19558284|NCT02758990|Pyridoxine|pyridoxine|mesh-list
19558285|NCT02758990|Pyridoxal|pyridoxal|mesh-list
19558286|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
19558287|NCT02758990|Caffeine|caffeine|mesh-list
19558288|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
19558289|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558290|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19558291|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19558292|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
19558293|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558294|NCT02758990|Protective Agents|protective agents|mesh-ancestor
19558295|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19558296|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19558297|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558298|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19558299|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19558300|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
19558301|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558302|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
19558303|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19558304|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
19558305|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19558306|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
19558307|NCT02759198|Celecoxib|celecoxib|mesh-list
19558308|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19558309|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558310|NCT02759198|Analgesics|analgesics|mesh-ancestor
19558311|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
19558312|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558313|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558314|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558315|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558316|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19558317|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19558318|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558319|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558320|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19558321|NCT02758873|Montelukast|montelukast|mesh-list
19558322|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19558323|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
19558324|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558325|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558326|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19558327|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
19558328|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19558329|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20112417|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112418|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19558330|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19558331|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
19558332|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112419|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558333|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558334|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19558335|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
19558336|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558337|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19558338|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19558339|NCT02758769|Abatacept|abatacept|mesh-list
19558340|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19558341|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558342|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558343|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558344|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
19558345|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558346|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558347|NCT02758782|Celecoxib|celecoxib|mesh-list
19558348|NCT02758782|Golimumab|golimumab|mesh-list
19558349|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19558350|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558351|NCT02758782|Analgesics|analgesics|mesh-ancestor
19558352|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
19558353|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558354|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558355|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558356|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558357|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19558358|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19558359|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558360|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558361|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19558362|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558363|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
19558364|NCT02758665|Venetoclax|venetoclax|mesh-list
19558365|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
19558366|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558367|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558368|NCT02758522|Insulin|insulin|mesh-list
19558369|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19558370|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19558371|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558372|NCT02758691|Insulin|insulin|mesh-list
19558373|NCT02758691|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19558374|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19558375|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558376|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
19558377|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558378|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558379|NCT02758509|Interferons|interferons|mesh-list
19558380|NCT02758509|Ritonavir|ritonavir|mesh-list
19558381|NCT02758509|Ribavirin|ribavirin|mesh-list
20112420|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
20112421|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20112422|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20112423|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20112424|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112425|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112426|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
20112427|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112428|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112429|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20112430|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604646|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558382|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
19558383|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
19558384|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
19558385|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19558386|NCT02758509|Ledipasvir|ledipasvir|mesh-list
19558387|NCT02758509|Simeprevir|simeprevir|mesh-list
19558388|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20604647|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604648|NCT02228473|Atropine|atropine|mesh-list
19558389|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604649|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
19558390|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
19558391|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558392|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20112431|NCT00004419|Mitogens|mitogens|mesh-list
20112432|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
19558393|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19558394|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
19558395|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558396|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558397|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19558398|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19558399|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19558400|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19558401|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
19558402|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
19558403|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558404|NCT02758444|Micronutrients|micronutrients|mesh-list
19558405|NCT02758444|Trace Elements|trace elements|mesh-list
19558406|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558407|NCT02758340|Misoprostol|misoprostol|mesh-list
19558408|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19558409|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
19558410|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19558411|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558412|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19558413|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558414|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
19558415|NCT02758249|Propofol|propofol|mesh-list
19558416|NCT02758249|Sevoflurane|sevoflurane|mesh-list
19558417|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19558418|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558419|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558420|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19558421|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
19558422|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
19558423|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19558424|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19558425|NCT02758366|Doxorubicin|doxorubicin|mesh-list
19558426|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19558427|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558428|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19558429|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19558430|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558431|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558432|NCT02758405|Fentanyl|fentanyl|mesh-list
19558433|NCT02758405|Bupivacaine|bupivacaine|mesh-list
19558434|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
19558435|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
19558436|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558437|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558438|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
19558439|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558440|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19558441|NCT02758405|Narcotics|narcotics|mesh-ancestor
20112433|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112434|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
20112435|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20112436|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20112437|NCT00004420|Analgesics|analgesics|mesh-ancestor
20112438|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
20112439|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112440|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112441|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112442|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112443|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20112444|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
20112445|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112446|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19558442|NCT02758405|Analgesics|analgesics|mesh-ancestor
19558443|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20112447|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
20112448|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
19558444|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19558445|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
19558446|NCT02758470|Acetazolamide|acetazolamide|mesh-list
19558447|NCT02758470|Methazolamide|methazolamide|mesh-list
19558448|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
19558449|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19558450|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558451|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558452|NCT02758470|Diuretics|diuretics|mesh-ancestor
19558453|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
19558454|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558455|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19558456|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19558457|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
19558458|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19558459|NCT02758327|Laxatives|laxatives|mesh-ancestor
19558460|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558461|NCT02758145|Vaccines|vaccines|mesh-list
19558462|NCT02758145|Immunologic Factors|immunologic factors|mesh-ancestor
19558463|NCT02758145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558464|NCT02758015|Betaine|betaine|mesh-list
19558465|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558466|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
19558467|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19558468|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
19558469|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558470|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19558471|NCT02758067|Risperidone|risperidone|mesh-list
19558472|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
19558473|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19558474|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
19558475|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558476|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558477|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558478|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19558479|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19558480|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558481|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19558482|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19558483|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
19558484|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
19558485|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19558486|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19558487|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558488|NCT02757703|Terlipressin|terlipressin|mesh-list
19558489|NCT02757703|Pantoprazole|pantoprazole|mesh-list
19558490|NCT02757703|Somatostatin|somatostatin|mesh-list
19558491|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19558492|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558493|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19558494|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558495|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558496|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19558497|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19558498|NCT02757703|Hormones|hormones|mesh-ancestor
19558499|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112449|NCT00004422|Antibodies|antibodies|mesh-list
20112450|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
20112451|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20112452|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20112453|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
20112454|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112455|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20112456|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
20112457|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20112458|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112459|NCT00004424|Fentanyl|fentanyl|mesh-list
20112460|NCT00004424|Midazolam|midazolam|mesh-list
19558500|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558501|NCT02757534|Domperidone|domperidone|mesh-list
20112461|NCT00004424|Propofol|propofol|mesh-list
19558502|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
19558503|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
20112462|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20112463|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20112464|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112465|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20112466|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
20112467|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
19558504|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558505|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558506|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558507|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19558508|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
19558509|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558510|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112468|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20112469|NCT00004424|Narcotics|narcotics|mesh-ancestor
20112470|NCT00004424|Analgesics|analgesics|mesh-ancestor
19558511|NCT02757508|Vitamins|vitamins|mesh-list
19558512|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
19558513|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558514|NCT02757313|Dronabinol|dronabinol|mesh-list
19558515|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
19558516|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558517|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112471|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
20112472|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112473|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20112474|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20112475|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20112476|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112477|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
20112478|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
20112479|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112480|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112481|NCT00004426|Leuprolide|leuprolide|mesh-list
20112482|NCT00004426|Hormones|hormones|mesh-list
20112483|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112484|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112485|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20112486|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
19558518|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558519|NCT02757313|Analgesics|analgesics|mesh-ancestor
19558520|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
19558521|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558522|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19558523|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19558524|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558525|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558526|NCT02757313|Hormones|hormones|mesh-ancestor
19558527|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558528|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
19558529|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19558530|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558531|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558532|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558533|NCT02757495|Analgesics|analgesics|mesh-ancestor
19558534|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
19558535|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558536|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19558537|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19558538|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20112487|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112488|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112489|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112490|NCT00004429|Hormones|hormones|mesh-list
20112491|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112492|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112493|NCT00004430|Prednisolone|prednisolone|mesh-list
20112494|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558539|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
19558540|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558541|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558542|NCT02757209|Fluticasone|fluticasone|mesh-list
20112495|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
20112496|NCT00004430|Hormones|hormones|mesh-ancestor
19558543|NCT02757209|Xhance|xhance|mesh-list
19558544|NCT02757209|Budesonide|budesonide|mesh-list
19558545|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
19558546|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19558547|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19558548|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558549|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19558550|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
19558551|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558552|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558553|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19558554|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
19558555|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
19558556|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19558557|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
19558558|NCT02757209|Hormones|hormones|mesh-ancestor
20112497|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112498|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112499|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112500|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112501|NCT00004431|Baclofen|baclofen|mesh-list
20112502|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20112503|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112504|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20112505|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112506|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20112507|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
20112508|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
20112509|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112510|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112511|NCT00004433|Pergolide|pergolide|mesh-list
19558559|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558560|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19558561|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19558562|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19558563|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
19558564|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558565|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558566|NCT02757287|Desogestrel|desogestrel|mesh-list
19558567|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19558568|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19558569|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19558570|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
20112512|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
20112513|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
20112514|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112515|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112516|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112517|NCT00004436|Prednisone|prednisone|mesh-list
20112518|NCT00004436|Leuprolide|leuprolide|mesh-list
20112519|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112520|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
20112521|NCT00004436|Hormones|hormones|mesh-ancestor
20112522|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112523|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112524|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112525|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112526|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20112527|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
20112528|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112529|NCT00004438|Leuprolide|leuprolide|mesh-list
20112530|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20112531|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
20112532|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20112533|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112534|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112535|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112536|NCT00004440|Ibuprofen|ibuprofen|mesh-list
20112537|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20112538|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20112539|NCT00004440|Analgesics|analgesics|mesh-ancestor
20112540|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
19558571|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19558572|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112541|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112542|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112543|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112544|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558573|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19558574|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19558575|NCT02757287|Progestins|progestins|mesh-ancestor
19558576|NCT02757287|Hormones|hormones|mesh-ancestor
19558577|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576711|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576712|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19576713|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576714|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576715|NCT05096468|Pregabalin|pregabalin|mesh-list
19576716|NCT05096468|Ketamine|ketamine|mesh-list
19576717|NCT05096468|Esketamine|esketamine|mesh-list
19576718|NCT05096468|Analgesics|analgesics|mesh-ancestor
19576719|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
19576720|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576721|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576722|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19576723|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576724|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
19576725|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
19576726|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576727|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19576728|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19576729|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576730|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576731|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
19576732|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19576733|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19576734|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19576735|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19576736|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19576737|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19576738|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
19576739|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19576740|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19576741|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19576742|NCT05086874|Protective Agents|protective agents|mesh-ancestor
19576743|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576744|NCT05085002|Letrozole|letrozole|mesh-list
19576745|NCT05085002|Fulvestrant|fulvestrant|mesh-list
19576746|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576747|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19576748|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19576749|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576750|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576751|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19576752|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
19576753|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576754|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576755|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19576756|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19576757|NCT05073679|Naltrexone|naltrexone|mesh-list
19576758|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19576759|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19576760|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576761|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
19576762|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576763|NCT05067933|Vaccines|vaccines|mesh-list
19576764|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
19576765|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576766|NCT05062356|Ketorolac|ketorolac|mesh-list
19576767|NCT05062356|Epinephrine|epinephrine|mesh-list
19576768|NCT05062356|Bupivacaine|bupivacaine|mesh-list
19576769|NCT05062356|Prilocaine|prilocaine|mesh-list
19576770|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19576771|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
20112545|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20112546|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120578|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604650|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19576772|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
19558578|NCT02757365|Aspirin|aspirin|mesh-list
19558579|NCT02757365|Levofloxacin|levofloxacin|mesh-list
19558580|NCT02757365|Ofloxacin|ofloxacin|mesh-list
20112547|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112548|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19558581|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19558582|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558583|NCT02757365|Analgesics|analgesics|mesh-ancestor
19558584|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
19558585|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558586|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558587|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558588|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558589|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19558590|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19558591|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558592|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19558593|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19558594|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558595|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
19558596|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19558597|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558598|NCT02757365|Renal Agents|renal agents|mesh-ancestor
19558599|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19558600|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19558601|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19558602|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112549|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20112550|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20112551|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112552|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
19558603|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19558604|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19558605|NCT02757469|Drospirenone|drospirenone|mesh-list
19558606|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19558607|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19558608|NCT02757469|Estradiol|estradiol|mesh-list
19558609|NCT02757469|Estrogens|estrogens|mesh-ancestor
19558610|NCT02757469|Hormones|hormones|mesh-ancestor
19558611|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558612|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558613|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19558614|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
19558615|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19558616|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19558617|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19558618|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19558619|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19558620|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
19558621|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19558622|NCT02757469|Diuretics|diuretics|mesh-ancestor
19558623|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
19558624|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19558625|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19558626|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558627|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558628|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19558629|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19558630|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558631|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
19558632|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558633|NCT02757391|Aldesleukin|aldesleukin|mesh-list
19558634|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
19558635|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
19558636|NCT02757391|Interleukin-2|interleukin-2|mesh-list
19558637|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
19558638|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558639|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558640|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112553|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112554|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20112555|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20112556|NCT00004442|Cholic Acids|cholic acids|mesh-list
20120579|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749042|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20112557|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20112558|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112559|NCT00004442|Cathartics|cathartics|mesh-ancestor
19558641|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19558642|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
19558643|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558644|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558645|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19558646|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558647|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558648|NCT02757391|Analgesics|analgesics|mesh-ancestor
19558649|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
19558650|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558651|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19558652|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19558653|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
19558654|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558655|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
19558656|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19558657|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19558658|NCT02757196|Prednisolone|prednisolone|mesh-list
19558659|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
19558660|NCT02757196|Rituximab|rituximab|mesh-list
19558661|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19558662|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
19558663|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558664|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558665|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
19558666|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558667|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558668|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558669|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
19558670|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
19558671|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558672|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558673|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
19558674|NCT02757196|Hormones|hormones|mesh-ancestor
19558675|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558676|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19558677|NCT02757196|Protective Agents|protective agents|mesh-ancestor
19558678|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19558679|NCT02757144|Esomeprazole|esomeprazole|mesh-list
19558680|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19558681|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558682|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19558683|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558684|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558685|NCT02757248|Romidepsin|romidepsin|mesh-list
19558686|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20112560|NCT00004444|Paromomycin|paromomycin|mesh-list
20112561|NCT00004444|Streptomycin|streptomycin|mesh-list
20112562|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20112563|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112564|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20112565|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20112566|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20112567|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112568|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112569|NCT00004446|Fluoxetine|fluoxetine|mesh-list
20112570|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20112571|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20112572|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112573|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112574|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112575|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
20112576|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112577|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20112578|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
20112579|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112580|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20120580|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
19558687|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558688|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
19558689|NCT02757443|Anesthetics|anesthetics|mesh-list
19749043|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112581|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19558690|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558691|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558692|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19558693|NCT02757443|Protective Agents|protective agents|mesh-ancestor
19558694|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
19558695|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558696|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
19558697|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
20112582|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112583|NCT00004448|Prednisone|prednisone|mesh-list
20112584|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112585|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
20112586|NCT00004448|Hormones|hormones|mesh-ancestor
20112587|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112588|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558698|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
19558699|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
19558700|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558701|NCT02757066|Melatonin|melatonin|mesh-list
19558702|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
19558703|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558704|NCT02757066|Protective Agents|protective agents|mesh-ancestor
20112589|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112590|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112591|NCT00004450|Interferons|interferons|mesh-list
20112592|NCT00004450|Interferon-beta|interferon-beta|mesh-list
20112593|NCT00004450|Thalidomide|thalidomide|mesh-list
20112594|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112595|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
20112596|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112597|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20112598|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
20112599|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112600|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
20112601|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20112602|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20112603|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19558705|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558706|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558707|NCT02757079|Melatonin|melatonin|mesh-list
19558708|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
19558709|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558710|NCT02757079|Protective Agents|protective agents|mesh-ancestor
20112604|NCT00004450|Growth Substances|growth substances|mesh-ancestor
20112605|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20120581|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120582|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120583|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120584|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120585|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558711|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558712|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558713|NCT02756598|Sufentanil|sufentanil|mesh-list
19558714|NCT02756598|Dsuvia|dsuvia|mesh-list
19558715|NCT02756598|Propofol|propofol|mesh-list
19558716|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19558717|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558718|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558719|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20120586|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20604651|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19558720|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
19558721|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
19558722|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19558723|NCT02756598|Narcotics|narcotics|mesh-ancestor
19558724|NCT02756598|Analgesics|analgesics|mesh-ancestor
19558725|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
19558726|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558727|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20120587|NCT00006376|Tipifarnib|tipifarnib|mesh-list
20120588|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120589|NCT00006377|Paclitaxel|paclitaxel|mesh-list
19558728|NCT02756728|Melphalan|melphalan|mesh-list
19558729|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19558730|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
20120590|NCT00006377|Carboplatin|carboplatin|mesh-list
19558731|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558732|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558733|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19558734|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558735|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
19558736|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558737|NCT02756663|Dexamethasone|dexamethasone|mesh-list
19558738|NCT02756663|Panobinostat|panobinostat|mesh-list
19558739|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558740|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
19558741|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
19558742|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558743|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558744|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558745|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
19558746|NCT02756663|Hormones|hormones|mesh-ancestor
19558747|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558748|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19558749|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112606|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
20112607|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20112608|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
19558750|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19558751|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558752|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558753|NCT02756715|Propofol|propofol|mesh-list
19558754|NCT02756715|Desflurane|desflurane|mesh-list
19558755|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19558756|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558757|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558758|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19558759|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
19558760|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
19558761|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19558762|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
19558763|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
19558764|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
19558765|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558766|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
19558767|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558768|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558769|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19558770|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
19558771|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558772|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558773|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19558774|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558775|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
19558776|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19558777|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19558778|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558779|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558780|NCT02756312|Anesthetics|anesthetics|mesh-list
19558781|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558782|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558783|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
19558784|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19558785|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
19558786|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19558787|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558788|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
19558789|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
19558790|NCT02756104|Vitamin D|vitamin d|mesh-list
19558791|NCT02756104|Vitamins|vitamins|mesh-ancestor
19558792|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
19558793|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558794|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19558795|NCT02756130|Carboplatin|carboplatin|mesh-list
19558796|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112609|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112610|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112611|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19558797|NCT02756026|Micronutrients|micronutrients|mesh-list
19558798|NCT02756026|Trace Elements|trace elements|mesh-list
19558799|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112612|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
19558800|NCT02755753|Lansoprazole|lansoprazole|mesh-list
19558801|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
19558802|NCT02755753|Rebamipide|rebamipide|mesh-list
19558803|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19558804|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558805|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19558806|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558807|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558808|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
19558809|NCT02755753|Protective Agents|protective agents|mesh-ancestor
19558810|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558811|NCT02755714|Bromides|bromides|mesh-list
19558812|NCT02755714|Ipratropium|ipratropium|mesh-list
19558813|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
19558814|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19558815|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
19558816|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558817|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558818|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19558819|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
19558820|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19558821|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
19558822|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558823|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558824|NCT02755909|Anesthetics|anesthetics|mesh-list
19558825|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558826|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558827|NCT02756000|Dobutamine|dobutamine|mesh-list
19558828|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19558829|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
19558830|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
19558831|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558832|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558833|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19558834|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19558835|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19558836|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
19558837|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19558838|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558839|NCT02756000|Protective Agents|protective agents|mesh-ancestor
19558840|NCT02755857|Itraconazole|itraconazole|mesh-list
19558841|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
19558842|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558843|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19558844|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19558845|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558846|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558847|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19558848|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19558849|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558850|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558851|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19558852|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
19558853|NCT02755545|Adapalene|adapalene|mesh-list
19558854|NCT02755545|Salicylates|salicylates|mesh-list
19558855|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19558856|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19558857|NCT02755545|Analgesics|analgesics|mesh-ancestor
19558858|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
19558859|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558860|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558861|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558862|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19558863|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
19558864|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558865|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
19558866|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
19558867|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19558868|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558869|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112613|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112614|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112615|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20112616|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
20112617|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20112618|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112619|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112620|NCT00004466|Atorvastatin|atorvastatin|mesh-list
20112621|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20112622|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20112623|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
20112624|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112625|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20112626|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20112627|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112628|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
20112629|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20112630|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
20112631|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112632|NCT00004467|Expectorants|expectorants|mesh-ancestor
20112633|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
20112634|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20112635|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
20112636|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112637|NCT00004467|Protective Agents|protective agents|mesh-ancestor
20112638|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112639|NCT00004467|Antidotes|antidotes|mesh-ancestor
20112640|NCT00004468|Calcitriol|calcitriol|mesh-list
20112641|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112642|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112643|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20112644|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20604652|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19558870|NCT02755532|Bupivacaine|bupivacaine|mesh-list
19558871|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
19558872|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
19558873|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19558874|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558875|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
19558876|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19558877|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
19558878|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19558879|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
19558880|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558881|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
19558882|NCT02755376|Protective Agents|protective agents|mesh-ancestor
19558883|NCT02755298|Acetazolamide|acetazolamide|mesh-list
19558884|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
19558885|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19558886|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558887|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558888|NCT02755298|Diuretics|diuretics|mesh-ancestor
19558889|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
19558890|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558891|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19558892|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19558893|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19558894|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558895|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558896|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
19558897|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558898|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19558899|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19558900|NCT02755311|Cisplatin|cisplatin|mesh-list
19558901|NCT02755311|Carboplatin|carboplatin|mesh-list
19558902|NCT02755311|Fluorouracil|fluorouracil|mesh-list
19558903|NCT02755311|Epirubicin|epirubicin|mesh-list
19558904|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
19558905|NCT02755311|Pirarubicin|pirarubicin|mesh-list
19558906|NCT02755311|Doxorubicin|doxorubicin|mesh-list
19558907|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19558908|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558909|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
19558910|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558911|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19558912|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558913|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
19558914|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749471|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19558915|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19558916|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19558917|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19558918|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558919|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
19558920|NCT02755311|Coagulants|coagulants|mesh-ancestor
19558921|NCT02755259|Acetazolamide|acetazolamide|mesh-list
19558922|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
19558923|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19558924|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558925|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558926|NCT02755259|Diuretics|diuretics|mesh-ancestor
19558927|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
19558928|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558929|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19558930|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19558931|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
19558932|NCT02754882|Paclitaxel|paclitaxel|mesh-list
19558933|NCT02754882|Bevacizumab|bevacizumab|mesh-list
19558934|NCT02754882|Carboplatin|carboplatin|mesh-list
19558935|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19558936|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558937|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
19558938|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
19558939|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
19558940|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558941|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19558942|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19558943|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19558944|NCT02754882|Growth Substances|growth substances|mesh-ancestor
19558945|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558946|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
19558947|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
19558948|NCT02754765|Levofloxacin|levofloxacin|mesh-list
19558949|NCT02754765|Ofloxacin|ofloxacin|mesh-list
19558950|NCT02754765|Linezolid|linezolid|mesh-list
19558951|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
19558952|NCT02754765|Bedaquiline|bedaquiline|mesh-list
19558953|NCT02754765|Clofazimine|clofazimine|mesh-list
19558954|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19558955|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558956|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19558957|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19558958|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19558959|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558960|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558961|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19558962|NCT02754765|Renal Agents|renal agents|mesh-ancestor
20112645|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112646|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20112647|NCT00004468|Vitamins|vitamins|mesh-ancestor
20112648|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
20112649|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20112650|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
20112651|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20112652|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558963|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19558964|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19558965|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19558966|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
19558967|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19558968|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
19558969|NCT02754817|Liraglutide|liraglutide|mesh-list
19558970|NCT02754817|Xultophy|xultophy|mesh-list
19558971|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19558972|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558973|NCT02754817|Incretins|incretins|mesh-ancestor
19558974|NCT02754817|Hormones|hormones|mesh-ancestor
19558975|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19558976|NCT02754960|Thalidomide|thalidomide|mesh-list
19558977|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19558978|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
19558979|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558980|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
19558981|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20112653|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
19558982|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558983|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19558984|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19558985|NCT02754960|Growth Substances|growth substances|mesh-ancestor
19558986|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
19558987|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19558988|NCT02755064|Erythromycin|erythromycin|mesh-list
19558989|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
19558990|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19558991|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
19558992|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
19558993|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19558994|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19558995|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19558996|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19558997|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112654|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19558998|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19558999|NCT02754726|Gemcitabine|gemcitabine|mesh-list
19559000|NCT02754726|Paclitaxel|paclitaxel|mesh-list
19559001|NCT02754726|Nivolumab|nivolumab|mesh-list
19559002|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19559003|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19559004|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559005|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
19559006|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
19559007|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
19559008|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559009|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19559010|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
19559011|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
19559012|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559013|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559014|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559015|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
19559016|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559017|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559018|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19559019|NCT02754739|Pravastatin|pravastatin|mesh-list
19559020|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19559021|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19559022|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
19559023|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559024|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19559025|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19559026|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559027|NCT02754583|Azithromycin|azithromycin|mesh-list
19559028|NCT02754583|Tetracycline|tetracycline|mesh-list
19559029|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19559030|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559031|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19559032|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559033|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559034|NCT02754596|Timolol|timolol|mesh-list
19559035|NCT02754596|Travoprost|travoprost|mesh-list
19559036|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19559037|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19559038|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19559039|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19559040|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
19559041|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559042|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559043|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559044|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20112655|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112656|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20112657|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
20112658|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112659|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112660|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20112661|NCT00004478|Droxidopa|droxidopa|mesh-list
20112662|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20112663|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20112664|NCT00004479|Midodrine|midodrine|mesh-list
20112665|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
20604653|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
19559045|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19559046|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
19559047|NCT02754687|Nandrolone|nandrolone|mesh-list
19559048|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
19559049|NCT02754687|Androgens|androgens|mesh-ancestor
19559050|NCT02754687|Hormones|hormones|mesh-ancestor
19559051|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559052|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559053|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
19559054|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19559055|NCT02754362|Bevacizumab|bevacizumab|mesh-list
19559056|NCT02754362|Poly ICLC|poly iclc|mesh-list
19559057|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19559058|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
19559059|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559060|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559061|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19559062|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19559063|NCT02754362|Growth Substances|growth substances|mesh-ancestor
19559064|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559065|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
19559066|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
20112666|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
20112667|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112668|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112669|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20112670|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19559067|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
19559068|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19559069|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19559070|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559071|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
19559072|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19559073|NCT02754102|Protective Agents|protective agents|mesh-ancestor
19559074|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559075|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
19559076|NCT02754258|Methylphenidate|methylphenidate|mesh-list
19559077|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19559078|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559079|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19559080|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19559081|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559082|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559083|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
19559084|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559085|NCT02753803|Pioglitazone|pioglitazone|mesh-list
19559086|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19559087|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559088|NCT02753855|Telavancin|telavancin|mesh-list
19559089|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19559090|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576773|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576774|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576775|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
19576776|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576777|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19576778|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576779|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576780|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576781|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576782|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19576783|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19576784|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
19576785|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19576786|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
19576787|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
19576788|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
19576789|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19576790|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19576791|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19576792|NCT05062356|Analgesics|analgesics|mesh-ancestor
19576793|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576794|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576795|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19559091|NCT02754180|Gemcitabine|gemcitabine|mesh-list
19559092|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19559093|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
19559094|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559095|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559096|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
19559097|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559098|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559099|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559100|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
19559101|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559102|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19559103|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19559104|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559105|NCT02753725|Fentanyl|fentanyl|mesh-list
19559106|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19559107|NCT02753725|Narcotics|narcotics|mesh-ancestor
19559108|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559109|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559110|NCT02753725|Analgesics|analgesics|mesh-ancestor
19559111|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
19559112|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559113|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19559114|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19559115|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
19559116|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
19559117|NCT02753764|Prednisone|prednisone|mesh-list
19559118|NCT02753764|AZD7624|azd7624|mesh-list
19559119|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559120|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
19559121|NCT02753764|Hormones|hormones|mesh-ancestor
19559122|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559123|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559124|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559125|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559126|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19559127|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559128|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559129|NCT02753738|Citalopram|citalopram|mesh-list
19559130|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19559131|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19559132|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559133|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559134|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559135|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
19559136|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559137|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19559138|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
19559139|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19559140|NCT02753712|Fluticasone|fluticasone|mesh-list
19559141|NCT02753712|Xhance|xhance|mesh-list
19559142|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
19559143|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559144|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19559145|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
19559146|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559147|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559148|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19559149|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
19559150|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
19559151|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19559152|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19559153|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19559154|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19559155|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
19559156|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559157|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559158|NCT02753647|Prednisone|prednisone|mesh-list
20112671|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20112672|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20112673|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
19559159|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
19559160|NCT02753647|Rituximab|rituximab|mesh-list
19559161|NCT02753647|Doxorubicin|doxorubicin|mesh-list
19559162|NCT02753647|Vincristine|vincristine|mesh-list
20120591|NCT00006377|Doxorubicin|doxorubicin|mesh-list
20112674|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112675|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112676|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
20112677|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20112678|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19559163|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559164|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
19559165|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559166|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559167|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19559168|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
19559169|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559170|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559171|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20112679|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20112680|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112681|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112682|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
19559172|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20112683|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112684|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112685|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20112686|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112687|NCT00004482|Cyclosporine|cyclosporine|mesh-list
20112688|NCT00004482|Prednisone|prednisone|mesh-list
20112689|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
20112690|NCT00004482|Cyclosporins|cyclosporins|mesh-list
19559173|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19559174|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20112691|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
20112692|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20112693|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
20112694|NCT00004482|Hormones|hormones|mesh-ancestor
20112695|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112696|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112697|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20112698|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112699|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559175|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19559176|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112700|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112701|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20112702|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
20112703|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
20112704|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112705|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
20112706|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112707|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20112708|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
19559177|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559178|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
19559179|NCT02753647|Hormones|hormones|mesh-ancestor
19559180|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559181|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559182|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19559183|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
19559184|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
19559185|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
19559186|NCT02753426|Doxycycline|doxycycline|mesh-list
19559187|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19559188|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559189|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
19559190|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19559191|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19559192|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
19559193|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19559194|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559195|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
19559196|NCT02753309|Sirolimus|sirolimus|mesh-list
20112709|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
19559197|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19559198|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112710|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559199|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19559200|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559201|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
20112711|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112712|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19559202|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559203|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
19559204|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559205|NCT02753140|Docetaxel|docetaxel|mesh-list
19559206|NCT02753140|Cetuximab|cetuximab|mesh-list
19559207|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559208|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19559209|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19559210|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19559211|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559212|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559213|NCT02753114|Ketamine|ketamine|mesh-list
19559214|NCT02753114|Analgesics|analgesics|mesh-ancestor
19559215|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
19559216|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559217|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559218|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19559219|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19559220|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
19559221|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
19559222|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559223|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19559224|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19559225|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559226|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559227|NCT02753218|Midazolam|midazolam|mesh-list
19559228|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19559229|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19559230|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559231|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559232|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19559233|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19559234|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19559235|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19559236|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
19559237|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
19559238|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
19559239|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
19559240|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559241|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559242|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
19559243|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19559244|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559245|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559246|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559247|NCT02753205|Analgesics|analgesics|mesh-ancestor
19559248|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
19559249|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559250|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19559251|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19559252|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19559253|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19559254|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559255|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559256|NCT02752971|Diclofenac|diclofenac|mesh-list
19559257|NCT02752971|Bupivacaine|bupivacaine|mesh-list
19559258|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559259|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
19559260|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559261|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559262|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
19559263|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559264|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19559265|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559266|NCT02752971|Analgesics|analgesics|mesh-ancestor
19559267|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559268|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559269|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19559270|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559271|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559272|NCT02753166|Dexamethasone|dexamethasone|mesh-list
19559273|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559274|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
19559275|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
19559276|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559277|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559278|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19559279|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
19559280|NCT02753166|Hormones|hormones|mesh-ancestor
19559281|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559282|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559283|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559284|NCT02752828|Insulin|insulin|mesh-list
19559285|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19559286|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
19559287|NCT02752828|Lixisenatide|lixisenatide|mesh-list
19559288|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19559289|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559290|NCT02752815|Prednisone|prednisone|mesh-list
19559291|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
19559292|NCT02752815|Rituximab|rituximab|mesh-list
19559293|NCT02752815|Vincristine|vincristine|mesh-list
19559294|NCT02752815|Epirubicin|epirubicin|mesh-list
19559295|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559296|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
19559297|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559298|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559299|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19559300|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
19559301|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559302|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559303|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19559304|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559305|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559306|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
19559307|NCT02752815|Hormones|hormones|mesh-ancestor
19559308|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559309|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559310|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19559311|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
19559312|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
19559313|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
19559314|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19559315|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19559316|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19559317|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559318|NCT02752685|Paclitaxel|paclitaxel|mesh-list
19559319|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
19559320|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19559321|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559322|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
19559323|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
19559324|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
19559325|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559326|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559327|NCT02752763|Dextrans|dextrans|mesh-list
19559328|NCT02752763|Povidone|povidone|mesh-list
20112713|NCT00004482|Protective Agents|protective agents|mesh-ancestor
20112714|NCT00004485|Cyclosporine|cyclosporine|mesh-list
20112715|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
20112716|NCT00004485|Fludarabine|fludarabine|mesh-list
20112717|NCT00004485|Cyclosporins|cyclosporins|mesh-list
20112718|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112719|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112720|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559329|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19559330|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
19559331|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19559332|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
19559333|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
19559334|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
19559335|NCT02753062|Rituximab|rituximab|mesh-list
19559336|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19559337|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559338|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112721|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
19559339|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
20112722|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559340|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112723|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112724|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
20112725|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112726|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
20112727|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112728|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20112729|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20112730|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20112731|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
20112732|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20112733|NCT00004486|Fluoxetine|fluoxetine|mesh-list
20112734|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20112735|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20112736|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20112737|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112738|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112739|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
20112740|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112741|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20112742|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
20112743|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20112744|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19559341|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559342|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19559343|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
19559344|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559345|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
19559346|NCT02753088|Mannitol|mannitol|mesh-list
19559347|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
19559348|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19559349|NCT02753088|Diuretics|diuretics|mesh-ancestor
19559350|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
19559351|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559352|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19559353|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
19559354|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559355|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559356|NCT02752646|Ketorolac|ketorolac|mesh-list
19559357|NCT02752646|Nepafenac|nepafenac|mesh-list
19559358|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19559359|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559360|NCT02752646|Analgesics|analgesics|mesh-ancestor
19559361|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
19559362|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559363|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559364|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559365|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559366|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19559367|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559368|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559369|NCT02752841|Vitamin D|vitamin d|mesh-list
19559370|NCT02752841|Vitamins|vitamins|mesh-ancestor
19559371|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
19559372|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559373|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19559374|NCT02752503|Nalmefene|nalmefene|mesh-list
19559375|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19559376|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559377|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
19559378|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559379|NCT02752555|Antioxidants|antioxidants|mesh-list
19559380|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559381|NCT02752555|Protective Agents|protective agents|mesh-ancestor
19559382|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559383|NCT02752724|Ketamine|ketamine|mesh-list
19559384|NCT02752724|Methohexital|methohexital|mesh-list
19559385|NCT02752724|Analgesics|analgesics|mesh-ancestor
19559386|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
20112745|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19559387|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559388|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559389|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19559390|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19559391|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
20112746|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112747|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
20112748|NCT00004488|Alendronate|alendronate|mesh-list
20112749|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
20112750|NCT00004488|Calcium|calcium|mesh-list
20112751|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112752|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112753|NCT00004488|Vitamins|vitamins|mesh-ancestor
20112754|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
20112755|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20112756|NCT00004488|Antacids|antacids|mesh-ancestor
20112757|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112758|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20112759|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
20112760|NCT00004489|Alendronate|alendronate|mesh-list
20112761|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
19559392|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
19559393|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559394|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19559395|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19559396|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559397|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559398|NCT02752529|Tacrolimus|tacrolimus|mesh-list
19559399|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559400|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
19559401|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559402|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19559403|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559404|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559405|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19559406|NCT02752191|Hematinics|hematinics|mesh-ancestor
19559407|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19559408|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19559409|NCT02752113|Metformin|metformin|mesh-list
19559410|NCT02752113|Empagliflozin|empagliflozin|mesh-list
19559411|NCT02752113|Linagliptin|linagliptin|mesh-list
19559412|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19559413|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559414|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19559415|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559416|NCT02752113|Incretins|incretins|mesh-ancestor
20112762|NCT00004489|Calcium|calcium|mesh-list
20112763|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20112764|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112765|NCT00004489|Vitamins|vitamins|mesh-ancestor
19559417|NCT02752113|Hormones|hormones|mesh-ancestor
19559418|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559419|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19559420|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
19559421|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559422|NCT02752204|Rituximab|rituximab|mesh-list
19559423|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559424|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559425|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
19559426|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559427|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559428|NCT02752308|Atropine|atropine|mesh-list
19559429|NCT02752308|Epinephrine|epinephrine|mesh-list
19559430|NCT02752308|Fentanyl|fentanyl|mesh-list
19559431|NCT02752308|Bupivacaine|bupivacaine|mesh-list
19559432|NCT02752308|Neostigmine|neostigmine|mesh-list
19559433|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559434|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
19559435|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559436|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559437|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
19559438|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559439|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20112766|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
20112767|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20112768|NCT00004489|Antacids|antacids|mesh-ancestor
20112769|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112770|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19559440|NCT02752308|Narcotics|narcotics|mesh-ancestor
19559441|NCT02752308|Analgesics|analgesics|mesh-ancestor
19559442|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20112771|NCT00004492|Clotrimazole|clotrimazole|mesh-list
19559443|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19559444|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
19559445|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19559446|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19559447|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
19559448|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559449|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559450|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19559451|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19559452|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
19559453|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19559454|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
19559455|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
19559456|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
19559457|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19559458|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19559459|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
19559460|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19559461|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19559462|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
19559463|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19559464|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559465|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19576796|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578277|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578278|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578279|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578280|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578281|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578282|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578283|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19578284|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
19578285|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578286|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578287|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578288|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578289|NCT03032172|Risdiplam|risdiplam|mesh-list
19578290|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19578291|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578292|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578293|NCT03006172|Metformin|metformin|mesh-list
19578294|NCT03006172|Trastuzumab|trastuzumab|mesh-list
19578295|NCT03006172|Pertuzumab|pertuzumab|mesh-list
19578296|NCT03006172|Letrozole|letrozole|mesh-list
19578297|NCT03006172|Fulvestrant|fulvestrant|mesh-list
19578298|NCT03006172|Palbociclib|palbociclib|mesh-list
19578299|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19578300|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578301|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578302|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578303|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19578304|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19578305|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578306|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578307|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19578308|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
19578309|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578310|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578311|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19578312|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578313|NCT02928406|Atezolizumab|atezolizumab|mesh-list
19578314|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578315|NCT02839707|Bevacizumab|bevacizumab|mesh-list
20112772|NCT00004492|Miconazole|miconazole|mesh-list
20112773|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
20112774|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112775|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
20112776|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112777|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112778|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20112779|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20112780|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112781|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
20112782|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19578316|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19578317|NCT02839707|Doxorubicin|doxorubicin|mesh-list
20112783|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20112784|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20112785|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
20112786|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112787|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112788|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20112789|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20112790|NCT00004495|Folic Acid|folic acid|mesh-list
20112791|NCT00004495|Pyridoxine|pyridoxine|mesh-list
20112792|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
20112793|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
20112794|NCT00004495|Hematinics|hematinics|mesh-ancestor
20112795|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
20112796|NCT00004495|Vitamins|vitamins|mesh-ancestor
20112797|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
20112798|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112799|NCT00004496|Hormones|hormones|mesh-list
20112800|NCT00004496|alpha-MSH|alpha-msh|mesh-list
20112801|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20112802|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19559466|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
19559467|NCT02752334|Bupivacaine|bupivacaine|mesh-list
19559468|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559469|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
19559470|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559471|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112803|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
20112804|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112805|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112806|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112807|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112808|NCT00004551|Nicotine|nicotine|mesh-list
20112809|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20112810|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
20112811|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112812|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112813|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20112814|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20112815|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
20112816|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112817|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112818|NCT00004552|Acamprosate|acamprosate|mesh-list
20112819|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20112820|NCT00004554|Naltrexone|naltrexone|mesh-list
20112821|NCT00004554|Sertraline|sertraline|mesh-list
20112822|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20112823|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20112824|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112825|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
20112826|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112827|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
20112828|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19559472|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
19559473|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559474|NCT02752334|Analgesics|analgesics|mesh-ancestor
19559475|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19559476|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
19559477|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19559478|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559479|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559480|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19559481|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
19559482|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19559483|NCT02751996|Tenofovir|tenofovir|mesh-list
19559484|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
19559485|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559486|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19559487|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19559488|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559489|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559490|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20112829|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20112830|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20112831|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20120592|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19559491|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19559492|NCT02751918|Doxorubicin|doxorubicin|mesh-list
19559493|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19559494|NCT02751918|Maytansine|maytansine|mesh-list
19559495|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19559496|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559497|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19559498|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19559499|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559500|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559501|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19559502|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
19559503|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
19559504|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
19559505|NCT02751840|Caffeine|caffeine|mesh-list
19559506|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19559507|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559508|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19559509|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559510|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559511|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19559512|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19559513|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
19559514|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559515|NCT02752477|Anesthetics|anesthetics|mesh-list
19559516|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
19559517|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559518|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559519|NCT02752412|Insulin|insulin|mesh-list
19559520|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19559521|NCT02752412|Metformin|metformin|mesh-list
19559522|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
19559523|NCT02752412|Lixisenatide|lixisenatide|mesh-list
19559524|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19559525|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559526|NCT02751593|Dexamethasone|dexamethasone|mesh-list
19559527|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559528|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
19559529|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
19559530|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559531|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559532|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19559533|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
19559534|NCT02751593|Hormones|hormones|mesh-ancestor
19559535|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559536|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559537|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559538|NCT02751632|Fluoxetine|fluoxetine|mesh-list
19559539|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19559540|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19559541|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559542|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559543|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559544|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
19559545|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559546|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19559547|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-ancestor
19559548|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19559549|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19559550|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19559551|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559552|NCT02751619|Lidocaine|lidocaine|mesh-list
19559553|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559554|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
19559555|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559556|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559557|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
19749044|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749045|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19749046|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
19749047|NCT05297032|Quercetin|quercetin|mesh-list
19749048|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
19749049|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749050|NCT05297032|Protective Agents|protective agents|mesh-ancestor
19559558|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559559|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19559560|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19559561|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19559562|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559563|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559564|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
19559565|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19559566|NCT02751541|Protective Agents|protective agents|mesh-ancestor
19559567|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559568|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
19559569|NCT02751476|Disinfectants|disinfectants|mesh-list
19559570|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559571|NCT02751528|Vaccines|vaccines|mesh-list
19559572|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
19559573|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559574|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
19559575|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19559576|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559577|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19559578|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559579|NCT02751294|Tafenoquine|tafenoquine|mesh-list
19559580|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
19559581|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19559582|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19559583|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559584|NCT02751307|Metformin|metformin|mesh-list
19559585|NCT02751307|Clozapine|clozapine|mesh-list
19559586|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19559587|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559588|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19559589|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
19559590|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559591|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559592|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19559593|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19559594|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559595|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19559596|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
19559597|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
19559598|NCT02751268|Ropivacaine|ropivacaine|mesh-list
19559599|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559600|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
19559601|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559602|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559603|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
19559604|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559605|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19559606|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19559607|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19559608|NCT02750904|Nicotine|nicotine|mesh-list
19559609|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19559610|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
19559611|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559612|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559613|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19559614|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19559615|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
19559616|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559617|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559618|NCT02750969|Lidocaine|lidocaine|mesh-list
19559619|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559620|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
19559621|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19749051|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749052|NCT05295927|Prednisone|prednisone|mesh-list
19749053|NCT05295927|Prednisolone|prednisolone|mesh-list
19749054|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
19749055|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749056|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
19749057|NCT05295927|Hormones|hormones|mesh-ancestor
19749058|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749059|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749060|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749061|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559622|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559623|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
19559624|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559625|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19559626|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19559627|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19559628|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559629|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559630|NCT02750917|Etoricoxib|etoricoxib|mesh-list
19559631|NCT02750917|Lornoxicam|lornoxicam|mesh-list
19559632|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19559633|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559634|NCT02750917|Analgesics|analgesics|mesh-ancestor
19559635|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
19559636|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559637|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559638|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559639|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559640|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19559641|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19559642|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559643|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559644|NCT02751034|Lidocaine|lidocaine|mesh-list
19559645|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559646|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
19559647|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559648|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559649|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
19559650|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559651|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19559652|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19559653|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19559654|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559655|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559656|NCT02750995|Azacitidine|azacitidine|mesh-list
19559657|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19559658|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
19559659|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559660|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559661|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559662|NCT02750748|Naltrexone|naltrexone|mesh-list
19559663|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19559664|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19559665|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559666|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
19559667|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559668|NCT02750696|Acetaminophen|acetaminophen|mesh-list
19559669|NCT02750696|Tramadol|tramadol|mesh-list
19559670|NCT02750696|Codeine|codeine|mesh-list
19559671|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559672|NCT02750696|Analgesics|analgesics|mesh-ancestor
19559673|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
19559674|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559675|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559676|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
19559677|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19559678|NCT02750696|Narcotics|narcotics|mesh-ancestor
19559679|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559680|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
19559681|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
19559682|NCT02750670|Gemcitabine|gemcitabine|mesh-list
19559683|NCT02750670|Dexamethasone|dexamethasone|mesh-list
19559684|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
19559685|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559686|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559687|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
19559688|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
19559689|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559690|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559691|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19559692|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
19559693|NCT02750670|Hormones|hormones|mesh-ancestor
19559694|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559695|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559696|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19559697|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
19559698|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559699|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
19559700|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559701|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559702|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559703|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
19559704|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559705|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
20112832|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112833|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559706|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19559707|NCT02750475|Protective Agents|protective agents|mesh-ancestor
19559708|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559709|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19576797|NCT05028725|Lugol's solution|lugol's solution|mesh-list
19576798|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
19576799|NCT05028725|Coagulants|coagulants|mesh-ancestor
19576800|NCT05025397|Propofol|propofol|mesh-list
19576801|NCT05025397|Sevoflurane|sevoflurane|mesh-list
19576802|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576803|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576804|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576805|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576806|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
19576807|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
19576808|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19576809|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19576810|NCT05011617|Anesthetics|anesthetics|mesh-list
19576811|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576812|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576813|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19576814|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19576815|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576816|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576817|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19576818|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19576819|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576820|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
19576821|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576822|NCT05003102|Fentanyl|fentanyl|mesh-list
19576823|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
19576824|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576825|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576826|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576827|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19576828|NCT05003102|Analgesics|analgesics|mesh-ancestor
19576829|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
19576830|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576831|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19576832|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19576833|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576834|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576835|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576836|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576837|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19576838|NCT05003102|Narcotics|narcotics|mesh-ancestor
19576839|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19576840|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576841|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
19576842|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
19576843|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19576844|NCT05001750|Doxycycline|doxycycline|mesh-list
19749062|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20112834|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
20112835|NCT00004564|Clopidogrel|clopidogrel|mesh-list
20112836|NCT00004564|Atorvastatin|atorvastatin|mesh-list
20112837|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20112838|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20112839|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
20112840|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112841|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20112842|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19576845|NCT05001750|Nafcillin|nafcillin|mesh-list
19559710|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
19559711|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19559712|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559713|NCT02750293|Vitamins|vitamins|mesh-ancestor
19559714|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
19559715|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19559716|NCT02750254|Plerixafor|plerixafor|mesh-list
19559717|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
19559718|NCT02750254|Melphalan|melphalan|mesh-list
19559719|NCT02750254|Busulfan|busulfan|mesh-list
19559720|NCT02750254|Fludarabine|fludarabine|mesh-list
19559721|NCT02750254|Azacitidine|azacitidine|mesh-list
19559722|NCT02750254|Sargramostim|sargramostim|mesh-list
19559723|NCT02750254|Lenograstim|lenograstim|mesh-list
19559724|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559725|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
19559726|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559727|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112843|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112844|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20112845|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19559728|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19559729|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
19559730|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559731|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559732|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19559733|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19559734|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
19559735|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559736|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19559737|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19559738|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19559739|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
19559740|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559741|NCT02750202|Vaccines|vaccines|mesh-list
19559742|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
19559743|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559744|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19559745|NCT02749994|Ezetimibe|ezetimibe|mesh-list
19559746|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19559747|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19559748|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
19559749|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559750|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19559751|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19559752|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559753|NCT02750137|Tetracaine|tetracaine|mesh-list
19559754|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559755|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
19559756|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559757|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559758|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
19559759|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559760|NCT02750059|Tenofovir|tenofovir|mesh-list
19559761|NCT02750059|Lamivudine|lamivudine|mesh-list
19559762|NCT02750059|Efavirenz|efavirenz|mesh-list
19559763|NCT02750059|Telmisartan|telmisartan|mesh-list
19559764|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
19559765|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112846|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20112847|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20112848|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
20112849|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20112850|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112851|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
20112852|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20112853|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20112854|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20112855|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
20112856|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20112857|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112858|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559766|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19559767|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19559768|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559769|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559770|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19559771|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19559772|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19559773|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19559774|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19559775|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19559776|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19559777|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19559778|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19559779|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19559780|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19559781|NCT02749825|Goserelin|goserelin|mesh-list
19559782|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19559783|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559784|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559785|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19559786|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559787|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
19559788|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19559789|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
19559790|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19559791|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
19559792|NCT02749890|Lixisenatide|lixisenatide|mesh-list
19559793|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19559794|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559795|NCT02750163|Acetaminophen|acetaminophen|mesh-list
19559796|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559797|NCT02750163|Analgesics|analgesics|mesh-ancestor
19559798|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
19559799|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559800|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559801|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
19559802|NCT02749747|Sulpiride|sulpiride|mesh-list
19559803|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19559804|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19559805|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559806|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559807|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19559808|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19559809|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
19559810|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559811|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559812|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19559813|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
19559814|NCT02749526|Tegafur|tegafur|mesh-list
19559815|NCT02749526|Endostar protein|endostar protein|mesh-list
19559816|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559817|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19559818|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
19559819|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559820|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19559821|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19559822|NCT02749526|Growth Substances|growth substances|mesh-ancestor
19559823|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559824|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
19559825|NCT02749578|Atorvastatin|atorvastatin|mesh-list
19559826|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19559827|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19559828|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
19559829|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559830|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19559831|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19559832|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559833|NCT02749656|Desoximetasone|desoximetasone|mesh-list
19559834|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559835|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
19559836|NCT02749656|Hormones|hormones|mesh-ancestor
19559837|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559838|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559839|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
19559840|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19559841|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19559842|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20112859|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112860|NCT00004573|Ganciclovir|ganciclovir|mesh-list
20112861|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20112862|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
20112863|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112864|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20112865|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112866|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112867|NCT00004575|Miconazole|miconazole|mesh-list
20112868|NCT00004575|Bradykinin|bradykinin|mesh-list
19559843|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559844|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112869|NCT00004575|Kininogens|kininogens|mesh-list
20112870|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112871|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112872|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
20112873|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112874|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20112875|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20112876|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19559845|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
19559846|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19559847|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112877|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
20112878|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20112879|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112880|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20112881|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20112882|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
20112883|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19559848|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19559849|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559850|NCT02749292|Rituximab|rituximab|mesh-list
19559851|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559852|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559853|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
19559854|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559855|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19559856|NCT02749409|Parecoxib|parecoxib|mesh-list
19559857|NCT02749409|Morphine|morphine|mesh-list
19559858|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19559859|NCT02749409|Narcotics|narcotics|mesh-ancestor
19559860|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559861|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559862|NCT02749409|Analgesics|analgesics|mesh-ancestor
20112884|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
20112885|NCT00004578|Ritonavir|ritonavir|mesh-list
20112886|NCT00004578|Lopinavir|lopinavir|mesh-list
19559863|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
19559864|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559865|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19559866|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19559867|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559868|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559869|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19559870|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559871|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559872|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20112887|NCT00004578|Lamivudine|lamivudine|mesh-list
20112888|NCT00004578|Stavudine|stavudine|mesh-list
20112889|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20112890|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20112891|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
20112892|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112893|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112894|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20112895|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20112896|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
20112897|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112898|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20112899|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20112900|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20112901|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19559873|NCT02749396|Interferons|interferons|mesh-list
19559874|NCT02749396|Interferon-beta|interferon-beta|mesh-list
19559875|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
19559876|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
19559877|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559878|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
19559879|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559880|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
19559881|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559882|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19559883|NCT02749123|Lidocaine|lidocaine|mesh-list
19559884|NCT02749123|Menthol|menthol|mesh-list
19559885|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559886|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
19559887|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559888|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559889|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
19559890|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559891|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19559892|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19559893|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19559894|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559895|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559896|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
19559897|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
19559898|NCT02749032|Metformin|metformin|mesh-list
19559899|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19559900|NCT02749032|Vildagliptin|vildagliptin|mesh-list
19559901|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19559902|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559903|NCT02749032|Incretins|incretins|mesh-ancestor
19559904|NCT02749032|Hormones|hormones|mesh-ancestor
19559905|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559906|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19559907|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
19559908|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559909|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559910|NCT02749162|Acetaminophen|acetaminophen|mesh-list
19559911|NCT02749162|Dexamethasone|dexamethasone|mesh-list
19559912|NCT02749162|Lidocaine|lidocaine|mesh-list
19559913|NCT02749162|Morphine|morphine|mesh-list
19559914|NCT02749162|Ropivacaine|ropivacaine|mesh-list
19559915|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19559916|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19559917|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
19559918|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
19559919|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559920|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559921|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19559922|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
19559923|NCT02749162|Hormones|hormones|mesh-ancestor
19559924|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19559925|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19559926|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559927|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
19559928|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
19559929|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19559930|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
19559931|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19559932|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19559933|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19559934|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19559935|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559936|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20112902|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
20112903|NCT00004580|Ritonavir|ritonavir|mesh-list
20112904|NCT00004580|Lopinavir|lopinavir|mesh-list
20112905|NCT00004580|Nevirapine|nevirapine|mesh-list
20112906|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20112907|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20112908|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
20112909|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559937|NCT02749162|Narcotics|narcotics|mesh-ancestor
19559938|NCT02749162|Analgesics|analgesics|mesh-ancestor
19559939|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559940|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
20112910|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559941|NCT02749136|Gemcitabine|gemcitabine|mesh-list
19559942|NCT02749136|Folfirinox|folfirinox|mesh-list
19559943|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19559944|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
19559945|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19559946|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559947|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
19559948|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559949|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19559950|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559951|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
19559952|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576846|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19576847|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576848|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
19576849|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
19576850|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19576851|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19576852|NCT04994132|Dactinomycin|dactinomycin|mesh-list
19576853|NCT04994132|Cactinomycin|cactinomycin|mesh-list
19576854|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
19576855|NCT04994132|Vincristine|vincristine|mesh-list
19576856|NCT04994132|Vinorelbine|vinorelbine|mesh-list
19576857|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19576858|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
19576859|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576860|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576861|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19576862|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
19576863|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576864|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576865|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19576866|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19576867|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
19576868|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
19576869|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
19576870|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19576871|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576872|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19576873|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19576874|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576875|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19576876|NCT04992572|Lidocaine|lidocaine|mesh-list
19576877|NCT04992572|Propofol|propofol|mesh-list
19576878|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
19576879|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
20112911|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20112912|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20112913|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
20112914|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112915|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20112916|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19576880|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19576881|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576882|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
19576883|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576884|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19576885|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19576886|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19576887|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19576888|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576889|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19576890|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19576891|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
19576892|NCT04988256|Cyclosporine|cyclosporine|mesh-list
19576893|NCT04988256|Prednisone|prednisone|mesh-list
19576894|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
19576895|NCT04988256|Cyclosporins|cyclosporins|mesh-list
19576896|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19576897|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
19576898|NCT04988256|Hormones|hormones|mesh-ancestor
19576899|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576900|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576901|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578318|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19559953|NCT02748772|Thalidomide|thalidomide|mesh-list
19559954|NCT02748772|Endostar protein|endostar protein|mesh-list
19559955|NCT02748772|Endostatins|endostatins|mesh-list
19559956|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19559957|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
19559958|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559959|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
19559960|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19559961|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559962|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20112917|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20112918|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19559963|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19559964|NCT02748772|Growth Substances|growth substances|mesh-ancestor
19559965|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
19559966|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559967|NCT02748564|Aldesleukin|aldesleukin|mesh-list
19559968|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
19559969|NCT02748564|Interleukin-2|interleukin-2|mesh-list
19559970|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19559971|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19559972|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19559973|NCT02748564|Analgesics|analgesics|mesh-ancestor
19559974|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
19559975|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559976|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559977|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19559978|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19559979|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
19559980|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19559981|NCT02748265|Epoprostenol|epoprostenol|mesh-list
19559982|NCT02748265|Phenylephrine|phenylephrine|mesh-list
19559983|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
19559984|NCT02748265|Tezosentan|tezosentan|mesh-list
19559985|NCT02748265|Propofol|propofol|mesh-list
19559986|NCT02748265|Sevoflurane|sevoflurane|mesh-list
19559987|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19559988|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20112919|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20112920|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20112921|NCT00004581|Ritonavir|ritonavir|mesh-list
19559989|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19559990|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19559991|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
19559992|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
19559993|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19559994|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19559995|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19559996|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
19559997|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
19559998|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19559999|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
19560000|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19560001|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
19560002|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
19560003|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19560004|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19560005|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19560006|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
19560007|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560008|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560009|NCT02748265|Protective Agents|protective agents|mesh-ancestor
19560010|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19560011|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
19560012|NCT02748304|Aspirin|aspirin|mesh-list
19560013|NCT02748304|Sorafenib|sorafenib|mesh-list
19560014|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19560015|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19560016|NCT02748304|Analgesics|analgesics|mesh-ancestor
19560017|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
19560018|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20112922|NCT00004581|Lopinavir|lopinavir|mesh-list
19560019|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560020|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560021|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560022|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19560023|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19578319|NCT02839707|Atezolizumab|atezolizumab|mesh-list
19560024|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560025|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19560026|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19560027|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560028|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
20112923|NCT00004581|Nevirapine|nevirapine|mesh-list
20112924|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20112925|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20112926|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
20112927|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112928|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112929|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20112930|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20112931|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
20112932|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112933|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20112934|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20112935|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20112936|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20112937|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20112938|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19560029|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560030|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19560031|NCT02748395|Triamcinolone|triamcinolone|mesh-list
19560032|NCT02748395|Lidocaine|lidocaine|mesh-list
19560033|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
19560034|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
19560035|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560036|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560037|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
19560038|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560039|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19560040|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19560041|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19560042|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560043|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560044|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560045|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
19560046|NCT02748395|Hormones|hormones|mesh-ancestor
19560047|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560048|NCT02748330|Aspirin|aspirin|mesh-list
19560049|NCT02748330|Clopidogrel|clopidogrel|mesh-list
19560050|NCT02748330|Ticagrelor|ticagrelor|mesh-list
19560051|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19560052|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19560053|NCT02748330|Analgesics|analgesics|mesh-ancestor
19560054|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
19560055|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560056|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560057|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560058|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560059|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19560060|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20112939|NCT00004582|Ritonavir|ritonavir|mesh-list
20112940|NCT00004582|Lopinavir|lopinavir|mesh-list
20112941|NCT00004582|Efavirenz|efavirenz|mesh-list
20112942|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20112943|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20112944|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
20112945|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560061|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560062|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19749063|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112946|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112947|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20112948|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20112949|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
20112950|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112951|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20112952|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20112953|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20112954|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20112955|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20112956|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20112957|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19560063|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19560064|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560065|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
19560066|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19560067|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20112958|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20112959|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20112960|NCT00004583|Ritonavir|ritonavir|mesh-list
20112961|NCT00004583|Lopinavir|lopinavir|mesh-list
20112962|NCT00004583|Nelfinavir|nelfinavir|mesh-list
20112963|NCT00004583|Lamivudine|lamivudine|mesh-list
20112964|NCT00004583|Stavudine|stavudine|mesh-list
20112965|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20112966|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19560068|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19560069|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
19560070|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560071|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19560072|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
19560073|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560074|NCT02747953|Afatinib|afatinib|mesh-list
19560075|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560076|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19560077|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560078|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560079|NCT02747940|Pregabalin|pregabalin|mesh-list
19560080|NCT02747940|Flunarizine|flunarizine|mesh-list
19560081|NCT02747940|Analgesics|analgesics|mesh-ancestor
19560082|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
19560083|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560084|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560085|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
19560086|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19560087|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560088|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560089|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19560090|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19560091|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19560092|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560093|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19560094|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19560095|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
19560096|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
19560097|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560098|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
19560099|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19560100|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560101|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19560102|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
19560103|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560104|NCT02747823|Bevacizumab|bevacizumab|mesh-list
19560105|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19560106|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560107|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19560108|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19560109|NCT02747823|Growth Substances|growth substances|mesh-ancestor
19560110|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560111|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
19560112|NCT02747511|Haloperidol|haloperidol|mesh-list
19560113|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
19560114|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
19560115|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
19560116|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560117|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112967|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
20112968|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112969|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112970|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20112971|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20112972|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
20112973|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112974|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19560118|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19560119|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19560120|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19560121|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560122|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19560123|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19560124|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
19560125|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560126|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560127|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19560128|NCT02747537|Irinotecan|irinotecan|mesh-list
19560129|NCT02747537|Sorafenib|sorafenib|mesh-list
19560130|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19560131|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19560132|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560133|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560134|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560135|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19560136|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
19560137|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19560138|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19560139|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560140|NCT02747381|Vitamins|vitamins|mesh-ancestor
19560141|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
19560142|NCT02747316|Iron|iron|mesh-list
19560143|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19560144|NCT02747316|Trace Elements|trace elements|mesh-ancestor
19560145|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
19560146|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576902|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576903|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576904|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576905|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19576906|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
19576907|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
19576908|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576909|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
19576910|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19576911|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19576912|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
19576913|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
19576914|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576915|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19576916|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19576917|NCT04988256|Protective Agents|protective agents|mesh-ancestor
19576918|NCT04979806|Meropenem|meropenem|mesh-list
19576919|NCT04979806|Cefepime|cefepime|mesh-list
19576920|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19576921|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576922|NCT04962841|Metformin|metformin|mesh-list
19576923|NCT04962841|Amlodipine|amlodipine|mesh-list
19576924|NCT04962841|Ramipril|ramipril|mesh-list
20112975|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20112976|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20112977|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20112978|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
20112979|NCT00004585|Lamivudine|lamivudine|mesh-list
20112980|NCT00004585|Zidovudine|zidovudine|mesh-list
20112981|NCT00004585|Efavirenz|efavirenz|mesh-list
20112982|NCT00004585|Abacavir|abacavir|mesh-list
20112983|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
20112984|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19576925|NCT04962841|Nebivolol|nebivolol|mesh-list
19576926|NCT04962841|Rivastigmine|rivastigmine|mesh-list
19576927|NCT04962841|Sertraline|sertraline|mesh-list
19576928|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19576929|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20112985|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20112986|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19560147|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19560148|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19560149|NCT02746744|Rituximab|rituximab|mesh-list
19560150|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19560151|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19560152|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560153|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
19560154|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560155|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560156|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
19560157|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19560158|NCT02746783|Vaccines|vaccines|mesh-list
19560159|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
19560160|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560161|NCT02746250|Amitriptyline|amitriptyline|mesh-list
19560162|NCT02746250|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19560163|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
19560164|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
19560165|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19560166|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19560167|NCT02746250|Analgesics|analgesics|mesh-ancestor
19560168|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
19560169|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560170|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560171|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19560172|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19560173|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560174|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560175|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
19560176|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560177|NCT02746250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19560178|NCT02746250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19560179|NCT02746250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560180|NCT02746185|Heparin|heparin|mesh-list
19560181|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19560182|NCT02746185|Tinzaparin|tinzaparin|mesh-list
20112987|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20112988|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20112989|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
20112990|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20112991|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20112992|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20112993|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
20112994|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20112995|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19560183|NCT02746185|Dalteparin|dalteparin|mesh-list
19560184|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
19560185|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
19560186|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19560187|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19560188|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560189|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19560190|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
20112996|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20112997|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19560191|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19560192|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
19560193|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560194|NCT02746276|Metronidazole|metronidazole|mesh-list
19560195|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
19560196|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560197|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19560198|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20112998|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20112999|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20113000|NCT00004637|Vitamin E|vitamin e|mesh-list
20113001|NCT00004637|Vitamins|vitamins|mesh-ancestor
20113002|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
20113003|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113004|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
20113005|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113006|NCT00004637|Protective Agents|protective agents|mesh-ancestor
20113007|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
20113008|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19560199|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20113009|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113010|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
20113011|NCT00004643|Cytarabine|cytarabine|mesh-list
20113012|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113013|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
20113014|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113015|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560200|NCT02746380|Adalimumab|adalimumab|mesh-list
19560201|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560202|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560203|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
19560204|NCT02745990|Hematinics|hematinics|mesh-ancestor
19560205|NCT02745925|Ibuprofen|ibuprofen|mesh-list
19560206|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19560207|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19560208|NCT02745925|Analgesics|analgesics|mesh-ancestor
19560209|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
19560210|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560211|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560212|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560213|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560214|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19560215|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560216|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560217|NCT02745912|Metformin|metformin|mesh-list
19560218|NCT02745912|Naltrexone|naltrexone|mesh-list
19560219|NCT02745912|Bupropion|bupropion|mesh-list
20113016|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
20113017|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113018|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113019|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
20113020|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113021|NCT00004644|Acyclovir|acyclovir|mesh-list
19560220|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560221|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560222|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19560223|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19560224|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
19560225|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560226|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19560227|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
19560228|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19560229|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19560230|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19560231|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560232|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560233|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
19560234|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560235|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19560236|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19560237|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560238|NCT02745886|Metformin|metformin|mesh-list
19560239|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560240|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560241|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
19560242|NCT02745873|Vitamins|vitamins|mesh-ancestor
19560243|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
19560244|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560245|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
19560246|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560247|NCT02745873|Protective Agents|protective agents|mesh-ancestor
19560248|NCT02745860|Selexipag|selexipag|mesh-list
19560249|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19560250|NCT02745639|Capecitabine|capecitabine|mesh-list
19560251|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
19560252|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19560253|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
19560254|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560255|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560256|NCT02745756|Vaccines|vaccines|mesh-list
19560257|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
19560258|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560259|NCT02745717|Cyclosporine|cyclosporine|mesh-list
19560260|NCT02745717|Cyclosporins|cyclosporins|mesh-list
19560261|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
20113022|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
19560262|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19560263|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560264|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560265|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19560266|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
19560267|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560268|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
19560269|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113023|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113024|NCT00004646|Prednisone|prednisone|mesh-list
20113025|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113026|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
20113027|NCT00004646|Hormones|hormones|mesh-ancestor
20113028|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113029|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113030|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113031|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113032|NCT00004647|Mexiletine|mexiletine|mesh-list
19560270|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
19560271|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560272|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19560273|NCT02745691|Gefitinib|gefitinib|mesh-list
19560274|NCT02745691|Crizotinib|crizotinib|mesh-list
19560275|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560276|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19560277|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113033|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20113034|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20113035|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19560278|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560279|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
19560280|NCT02745561|Endostatins|endostatins|mesh-list
19560281|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560282|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19560283|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19560284|NCT02745561|Growth Substances|growth substances|mesh-ancestor
19560285|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560286|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
19560287|NCT02745522|Oxytocin|oxytocin|mesh-list
19560288|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
19560289|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560290|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560291|NCT02745769|Ramucirumab|ramucirumab|mesh-list
20113036|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20113037|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113038|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20113039|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
20113040|NCT00004650|Estrogens|estrogens|mesh-list
20113041|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20113042|NCT00004650|Hormones|hormones|mesh-ancestor
20113043|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113044|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113045|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20113046|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20113047|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20113048|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
20113049|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113050|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20113051|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20113052|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20113053|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19560292|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113054|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113055|NCT00004652|Pimozide|pimozide|mesh-list
20113056|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20113057|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20113058|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113059|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113060|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19576930|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19576931|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19576932|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19578320|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
19560293|NCT02745470|Lixisenatide|lixisenatide|mesh-list
19560294|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560295|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560296|NCT02745431|Oxytocin|oxytocin|mesh-list
19560297|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
19560298|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560299|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560300|NCT02745054|Anticoagulants|anticoagulants|mesh-list
19560301|NCT02745093|Misoprostol|misoprostol|mesh-list
19560302|NCT02745093|Mifepristone|mifepristone|mesh-list
19560303|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19560304|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
19560305|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560306|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560307|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19560308|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19560309|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
19560310|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19560311|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19560312|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19560313|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19560314|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
20113061|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20113062|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
20113063|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113064|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113065|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20113066|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20113067|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20113068|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
20113069|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113070|NCT00004664|Megestrol|megestrol|mesh-list
20113071|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19560315|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19560316|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19560317|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19560318|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560319|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
19560320|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19560321|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19560322|NCT02744690|Mitomycins|mitomycins|mesh-list
19560323|NCT02744690|Mitomycin|mitomycin|mesh-list
19560324|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19560325|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560326|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
19560327|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560328|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19560329|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560330|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
19560331|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19560332|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113072|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20113073|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20113074|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
20113075|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113076|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113077|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20113078|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20113079|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113080|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113081|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20113082|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20113083|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
20113084|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113085|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
20113086|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113087|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
20113088|NCT00004682|Antibodies|antibodies|mesh-list
20113089|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
20113090|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19560333|NCT02744716|Aspirin|aspirin|mesh-list
19560334|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19560335|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20113091|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19560336|NCT02744716|Analgesics|analgesics|mesh-ancestor
19560337|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
19560338|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560339|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113092|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
20113093|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113094|NCT00004685|Albuterol|albuterol|mesh-list
19560340|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560341|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560342|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19560343|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19560344|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560345|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19560346|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19560347|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560348|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
19560349|NCT02744768|Dasatinib|dasatinib|mesh-list
19560350|NCT02744768|Blinatumomab|blinatumomab|mesh-list
19560351|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560352|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19560353|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560354|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560355|NCT02744872|Felodipine|felodipine|mesh-list
19560356|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19560357|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19560358|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19560359|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560360|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560361|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19560362|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560363|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
19560364|NCT02744703|Capecitabine|capecitabine|mesh-list
19560365|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19560366|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19560367|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
19560368|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560369|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560370|NCT02744638|Metronidazole|metronidazole|mesh-list
19560371|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560372|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19560373|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19560374|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19560375|NCT02744937|Aspirin|aspirin|mesh-list
19560376|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19560377|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19560378|NCT02744937|Analgesics|analgesics|mesh-ancestor
19560379|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
19560380|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560381|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560382|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560383|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113095|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20113096|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
20113097|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113098|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113099|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20113100|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
20113101|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
20113102|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560384|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19560385|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19560386|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560387|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19560388|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19560389|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560390|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
19560391|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19560392|NCT02744625|Propofol|propofol|mesh-list
19560393|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19560394|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113103|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19560395|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560396|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19560397|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
19560398|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
19560399|NCT02744417|Bupropion|bupropion|mesh-list
20113104|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20113105|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20113106|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
20113107|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113108|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113109|NCT00004686|Prednisone|prednisone|mesh-list
20113110|NCT00004686|Methotrexate|methotrexate|mesh-list
20113111|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560400|NCT02744417|Nicotine|nicotine|mesh-list
19560401|NCT02744417|Varenicline|varenicline|mesh-list
19560402|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19560403|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
19560404|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560405|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560406|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19560407|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19560408|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
19560409|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560410|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560411|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19560412|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
19560413|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20113112|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
20113113|NCT00004686|Hormones|hormones|mesh-ancestor
20113114|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113115|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113116|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113117|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113118|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20113119|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
20113120|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113121|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113122|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
20113123|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113124|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
20113125|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113126|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20113127|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113128|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
20113129|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113130|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113131|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
19560414|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19560415|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19560416|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560417|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
19560418|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19560419|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19560420|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560421|NCT02744339|Riociguat|riociguat|mesh-list
19560422|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
19560423|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560424|NCT02744508|Dexamethasone|dexamethasone|mesh-list
19560425|NCT02744508|Palonosetron|palonosetron|mesh-list
19560426|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560427|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
19560428|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
19560429|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560430|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560431|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19560432|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
19560433|NCT02744508|Hormones|hormones|mesh-ancestor
19560434|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560435|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19560436|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560437|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19560438|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19560439|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
19560440|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560441|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560442|NCT02744378|Clobetasol|clobetasol|mesh-list
19560443|NCT02744378|Tacrolimus|tacrolimus|mesh-list
20113132|NCT00004688|Carmustine|carmustine|mesh-list
19560444|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19560445|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
19560446|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560447|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19560448|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560449|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560450|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560451|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
19560452|NCT02744378|Hormones|hormones|mesh-ancestor
19560453|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560454|NCT02744456|Losartan|losartan|mesh-list
19560455|NCT02744456|Amlodipine|amlodipine|mesh-list
19560456|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19560457|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19560458|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19560459|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560460|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560461|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19560462|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113133|NCT00004688|Streptozocin|streptozocin|mesh-list
20113134|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
20113135|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113136|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113137|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113138|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113139|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
20113140|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113141|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113142|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113143|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20113144|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
20113145|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20113146|NCT00004689|Clarithromycin|clarithromycin|mesh-list
20113147|NCT00004689|Rifampin|rifampin|mesh-list
20113148|NCT00004689|Ethambutol|ethambutol|mesh-list
20113149|NCT00004689|Streptomycin|streptomycin|mesh-list
20113150|NCT00004689|Thioacetazone|thioacetazone|mesh-list
20113151|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20113152|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113153|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20113154|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113155|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113156|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20113157|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20113158|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20113159|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
20113160|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
20113161|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113162|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20113163|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20113164|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20113165|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20113166|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19560463|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
19560464|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19560465|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19560466|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19560467|NCT02744456|Diuretics|diuretics|mesh-ancestor
19560468|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
19560469|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19560470|NCT02744222|Interferons|interferons|mesh-list
19560471|NCT02744222|Interferon-beta|interferon-beta|mesh-list
19560472|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
19560473|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560474|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
19560475|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560476|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
19560477|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560478|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19560479|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
20113167|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20113168|NCT00004690|Monolaurin|monolaurin|mesh-list
19560480|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20113169|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
20113170|NCT00004690|Protective Agents|protective agents|mesh-ancestor
20113171|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113172|NCT00004694|Heparin|heparin|mesh-list
20113173|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
20113174|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20113175|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20113176|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113177|NCT00004695|Interleukin-2|interleukin-2|mesh-list
19560481|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560482|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560483|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19560484|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560485|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19560486|NCT02744495|Betamethasone|betamethasone|mesh-list
19560487|NCT02744495|Droperidol|droperidol|mesh-list
19560488|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560489|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
19560490|NCT02744495|Hormones|hormones|mesh-ancestor
19560491|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113178|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113179|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20113180|NCT00004695|Analgesics|analgesics|mesh-ancestor
20113181|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
20113182|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113183|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113184|NCT00004696|Morphine|morphine|mesh-list
20113185|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20113186|NCT00004696|Narcotics|narcotics|mesh-ancestor
20113187|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113188|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113189|NCT00004696|Analgesics|analgesics|mesh-ancestor
20113190|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
20113191|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113192|NCT00004697|Choline|choline|mesh-list
20113193|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
20113194|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20113195|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
20113196|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113197|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20113198|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20113199|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
20113200|NCT00004699|Mitogens|mitogens|mesh-list
20113201|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
20113202|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113203|NCT00004700|Mitogens|mitogens|mesh-list
20113204|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
20113205|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120593|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120594|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120595|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
20120596|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
20120597|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120598|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120599|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20120600|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20120601|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120602|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120603|NCT00006378|Paclitaxel|paclitaxel|mesh-list
20120604|NCT00006378|Carboplatin|carboplatin|mesh-list
20120605|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19560492|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560493|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19560494|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
19560495|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19560496|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
19560497|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
19560498|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560499|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20120606|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120607|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20120608|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20120609|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120610|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120611|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
20113206|NCT00004705|Amiloride|amiloride|mesh-list
20113207|NCT00004705|Diuretics|diuretics|mesh-ancestor
20113208|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
20113209|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113210|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20113211|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20113212|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20113213|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113214|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20113215|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20113216|NCT00004727|Aspirin|aspirin|mesh-list
20113217|NCT00004727|Ticlopidine|ticlopidine|mesh-list
20113218|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20113219|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20113220|NCT00004727|Analgesics|analgesics|mesh-ancestor
20113221|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
20113222|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113223|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113224|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113225|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113226|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20113227|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20113228|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113229|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20113230|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20113231|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113232|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
20113233|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20113234|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20113235|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20113236|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
20113237|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113238|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20113239|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20113240|NCT00004728|Aspirin|aspirin|mesh-list
20113241|NCT00004728|Warfarin|warfarin|mesh-list
19560500|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19560501|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19560502|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560503|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20113242|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20113243|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20113244|NCT00004728|Analgesics|analgesics|mesh-ancestor
20113245|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
20113246|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113247|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113248|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113249|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113250|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20113251|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20113252|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113253|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20113254|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20113255|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113256|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
20113257|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
20113258|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
20113259|NCT00004730|Analgesics|analgesics|mesh-ancestor
20113260|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
20113261|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113262|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113263|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
20113264|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113265|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20113266|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
20113267|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20113268|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20113269|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113270|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20113271|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
20113272|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113273|NCT00004731|Ubiquinone|ubiquinone|mesh-list
20113274|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
20113275|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
20113276|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113277|NCT00004731|Vitamins|vitamins|mesh-ancestor
20113278|NCT00004733|Levodopa|levodopa|mesh-list
20113279|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20113280|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20113281|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
20113282|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113283|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113284|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113285|NCT00004734|Folic Acid|folic acid|mesh-list
20113286|NCT00004734|Pyridoxine|pyridoxine|mesh-list
20113287|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
20113288|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
20113289|NCT00004734|Hematinics|hematinics|mesh-ancestor
20113290|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
20113291|NCT00004734|Vitamins|vitamins|mesh-ancestor
20113292|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
20113293|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113294|NCT00004736|Lamivudine|lamivudine|mesh-list
20113295|NCT00004736|Zidovudine|zidovudine|mesh-list
20113296|NCT00004736|Stavudine|stavudine|mesh-list
20113297|NCT00004736|Nelfinavir|nelfinavir|mesh-list
20113298|NCT00004736|Isoniazid|isoniazid|mesh-list
20113299|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
20113300|NCT00004736|Ethambutol|ethambutol|mesh-list
20113301|NCT00004736|Rifabutin|rifabutin|mesh-list
20113302|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20113303|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113304|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560504|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19560505|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19560506|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
19560507|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560508|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560509|NCT02744196|Methotrexate|methotrexate|mesh-list
19560510|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560511|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
19560512|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560513|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560514|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19560515|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
19560516|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560517|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19560518|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
19560519|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560520|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
19560521|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560522|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19560523|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19560524|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19560525|NCT02744183|Benzocaine|benzocaine|mesh-list
19560526|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
19560527|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
19560528|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113305|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113306|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
20113307|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560529|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560530|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
19560531|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560532|NCT02744131|Metformin|metformin|mesh-list
19560533|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
19560534|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
19560535|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
19560536|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19560537|NCT02744131|Estradiol|estradiol|mesh-list
19560538|NCT02744131|Cyproterone|cyproterone|mesh-list
19560539|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560540|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560541|NCT02744131|Estrogens|estrogens|mesh-ancestor
19560542|NCT02744131|Hormones|hormones|mesh-ancestor
20113308|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20113309|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19560543|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113310|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
19560544|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113311|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
20113312|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20120612|NCT00006379|Fludarabine|fludarabine|mesh-list
19560545|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19560546|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
19560547|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
19560548|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560549|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19560550|NCT02743975|Bevacizumab|bevacizumab|mesh-list
19560551|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19560552|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560553|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19560554|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19560555|NCT02743975|Growth Substances|growth substances|mesh-ancestor
19560556|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560557|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19560558|NCT02743663|Albuterol|albuterol|mesh-list
19560559|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
19560560|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
19560561|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113313|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20113314|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20113315|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20113316|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20113317|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20113318|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
20113319|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20113320|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20113321|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
20113322|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113323|NCT00004740|Isoniazid|isoniazid|mesh-list
20113324|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
20113325|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20113326|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113327|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20113328|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20113329|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
20113330|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113331|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20113332|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
20113333|NCT00004744|Antibodies|antibodies|mesh-list
20113334|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
20113335|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20113336|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20113337|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
20113338|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113339|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
20113340|NCT00004747|Antibodies|antibodies|mesh-list
20113341|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
20113342|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20113343|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20113344|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
20113345|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113346|NCT00004748|Methotrexate|methotrexate|mesh-list
20113347|NCT00004748|Colchicine|colchicine|mesh-list
20113348|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20113349|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20113350|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
20113351|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113352|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113353|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113354|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
20113355|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113356|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113357|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
20113358|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113359|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20113360|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113361|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
20113362|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113363|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113364|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
20113365|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
20113366|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
19560562|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560563|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20113367|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
20113368|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20120613|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
20113369|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20113370|NCT00004754|Epoprostenol|epoprostenol|mesh-list
20113371|NCT00004754|Tezosentan|tezosentan|mesh-list
20113372|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20113373|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20113374|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
20113375|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20113376|NCT00004755|Allopurinol|allopurinol|mesh-list
20113377|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
20113378|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113379|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113380|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
20113381|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113382|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20113383|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
20113384|NCT00004755|Protective Agents|protective agents|mesh-ancestor
20113385|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113386|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20113387|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20113388|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113389|NCT00004757|Acyclovir|acyclovir|mesh-list
20113390|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
20113391|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113392|NCT00004758|Pyridoxine|pyridoxine|mesh-list
20113393|NCT00004758|Carbamazepine|carbamazepine|mesh-list
20113394|NCT00004758|Valproic Acid|valproic acid|mesh-list
20113395|NCT00004758|Nitrazepam|nitrazepam|mesh-list
20113396|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20113397|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
20113398|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113399|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113400|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
20113401|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560564|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
19560565|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
19560566|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560567|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19560568|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19560569|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19560570|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
19560571|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560572|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560573|NCT02743572|Iron|iron|mesh-list
19560574|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19560575|NCT02743572|Trace Elements|trace elements|mesh-ancestor
19560576|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
19560577|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560578|NCT02743572|Hematinics|hematinics|mesh-ancestor
19576933|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576934|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19576935|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
19576936|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
20113402|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113403|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
20113404|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20113405|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113406|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20113407|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20113408|NCT00004758|Analgesics|analgesics|mesh-ancestor
20113409|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
20113410|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113411|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20113412|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20113413|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20113414|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20113415|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
20113416|NCT00004758|Vitamins|vitamins|mesh-ancestor
20113417|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
20113418|NCT00004758|Hormones|hormones|mesh-ancestor
20113419|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113420|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20113421|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20113422|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
20113423|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
20113424|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20113425|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20113426|NCT00004759|Prednisolone|prednisolone|mesh-list
20113427|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
20113428|NCT00004759|Tirilazad|tirilazad|mesh-list
19560579|NCT02743598|Liraglutide|liraglutide|mesh-list
19560580|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560581|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560582|NCT02743598|Incretins|incretins|mesh-ancestor
19560583|NCT02743598|Hormones|hormones|mesh-ancestor
19560584|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560585|NCT02743260|Metformin|metformin|mesh-list
19560586|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19560587|NCT02743260|Adefovir|adefovir|mesh-list
19560588|NCT02743260|Digoxin|digoxin|mesh-list
19560589|NCT02743260|Pitavastatin|pitavastatin|mesh-list
19560590|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560591|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560592|NCT02743260|Incretins|incretins|mesh-ancestor
19560593|NCT02743260|Hormones|hormones|mesh-ancestor
19560594|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560595|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19560596|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
19560597|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560598|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560599|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20604654|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604655|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604656|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20604657|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
20604658|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
20604659|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
20604660|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20604661|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20604662|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
20604663|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604664|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20607951|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20607952|NCT02244164|Liraglutide|liraglutide|mesh-list
20607953|NCT02244164|Exenatide|exenatide|mesh-list
20607954|NCT02244164|Lixisenatide|lixisenatide|mesh-list
20607955|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19560600|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19560601|NCT02743260|Protective Agents|protective agents|mesh-ancestor
19560602|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
19560603|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560604|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19560605|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19560606|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19560607|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19560608|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19560609|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
19560610|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19560611|NCT02743455|Vaccines|vaccines|mesh-list
19560612|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
19560613|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560614|NCT02743182|Interferons|interferons|mesh-list
19560615|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
19560616|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
19560617|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19560618|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560619|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
19560620|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560621|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
19560622|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560623|NCT02743429|Dinutuximab|dinutuximab|mesh-list
19560624|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560625|NCT02743234|Vancomycin|vancomycin|mesh-list
19560626|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
19560627|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19560628|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20607956|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560629|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
20113429|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19560630|NCT02743247|Tacrolimus|tacrolimus|mesh-list
19560631|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19560632|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
19560633|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560634|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19560635|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560636|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560637|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19560638|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560639|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19560640|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
19560641|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19560642|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560643|NCT02743390|Infliximab|infliximab|mesh-list
19560644|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
19560645|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19560646|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560647|NCT02743104|Lidocaine|lidocaine|mesh-list
19560648|NCT02743104|Atropine|atropine|mesh-list
19560649|NCT02743104|Midazolam|midazolam|mesh-list
19560650|NCT02743104|Ketamine|ketamine|mesh-list
19560651|NCT02743104|Propofol|propofol|mesh-list
19560652|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
19560653|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
19560654|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560655|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560656|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
19560657|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560658|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19560659|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19560660|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19560661|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560662|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560663|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19560664|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19560665|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
19560666|NCT02743104|Analgesics|analgesics|mesh-ancestor
19560667|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19560668|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19560669|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19560670|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560671|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20113430|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
20113431|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113432|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
20113433|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
20113434|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113435|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113436|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20113437|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
20113438|NCT00004759|Hormones|hormones|mesh-ancestor
20113439|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560672|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19560673|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19560674|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19560675|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
19560676|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
19560677|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19560678|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
19560679|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19560680|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
19560681|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
19560682|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
19560683|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19560684|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19560685|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
19560686|NCT02743065|Doxorubicin|doxorubicin|mesh-list
19560687|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19560688|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560689|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19560690|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20113440|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19560691|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560692|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560693|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19560694|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
19560695|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560696|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
19560697|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19560698|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560699|NCT02742675|Leuprolide|leuprolide|mesh-list
19560700|NCT02742675|Goserelin|goserelin|mesh-list
19560701|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19560702|NCT02742675|Flutamide|flutamide|mesh-list
19560703|NCT02742675|Bicalutamide|bicalutamide|mesh-list
19560704|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19560705|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
19560706|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560707|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560708|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19560709|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560710|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
19560711|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
19560712|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560713|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
19560714|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19560715|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
19560716|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19560717|NCT02742805|Vitamin D|vitamin d|mesh-list
19560718|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
19560719|NCT02742805|Vitamins|vitamins|mesh-list
19560720|NCT02742805|Omalizumab|omalizumab|mesh-list
19560721|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
19560722|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560723|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19560724|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19560725|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19560726|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19560727|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
19560728|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
19560729|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19560730|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
19560731|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19560732|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
19560733|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560734|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560735|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
19560736|NCT02742285|Lumefantrine|lumefantrine|mesh-list
19560737|NCT02742285|Artemether|artemether|mesh-list
19560738|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19560739|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
19560740|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19560741|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19560742|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560743|NCT02742480|Dabigatran|dabigatran|mesh-list
19560744|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
19560745|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
19560746|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19560747|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
19560748|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560749|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560750|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
19560751|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
19560752|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
19560753|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19560754|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
19560755|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560756|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
19560757|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560758|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560759|NCT02742233|Saxagliptin|saxagliptin|mesh-list
19560760|NCT02742233|Incretins|incretins|mesh-ancestor
19560761|NCT02742233|Hormones|hormones|mesh-ancestor
19560762|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560763|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113441|NCT00004759|Protective Agents|protective agents|mesh-ancestor
20113442|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19560764|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19560765|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
19560766|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113443|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560767|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560768|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20113444|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
20113445|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560769|NCT02742467|Amlodipine|amlodipine|mesh-list
19560770|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19560771|NCT02742467|Perindopril|perindopril|mesh-list
19560772|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19560773|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19560774|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560775|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560776|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19560777|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560778|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
19560779|NCT02742467|Diuretics|diuretics|mesh-ancestor
19560780|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
19560781|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19560782|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19560783|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
19560784|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560785|NCT02742181|Alvimopan|alvimopan|mesh-list
19560786|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19560787|NCT02742142|Fluorides|fluorides|mesh-list
19560788|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
19560789|NCT02742142|Protective Agents|protective agents|mesh-ancestor
19560790|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560791|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
19560792|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19560793|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560794|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
19560795|NCT02742051|Fluorouracil|fluorouracil|mesh-list
19560796|NCT02742051|Everolimus|everolimus|mesh-list
19560797|NCT02742051|Letrozole|letrozole|mesh-list
19560798|NCT02742051|Epirubicin|epirubicin|mesh-list
19560799|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19560800|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
19560801|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560802|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560803|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19560804|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
19560805|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113446|NCT00004762|Cladribine|cladribine|mesh-list
20113447|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113448|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113449|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
19560806|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560807|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19560808|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
19560809|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19560810|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19560811|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19560812|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560813|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19560814|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
19560815|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560816|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19560817|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19560818|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19560819|NCT02742038|Fluorides|fluorides|mesh-list
19560820|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
19560821|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
19560822|NCT02742038|Protective Agents|protective agents|mesh-ancestor
19749064|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749065|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
19560823|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560824|NCT02741947|Levodopa|levodopa|mesh-list
19560825|NCT02741947|Benserazide|benserazide|mesh-list
19560826|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
20113450|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113451|NCT00004763|Leuprolide|leuprolide|mesh-list
19560827|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19560828|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19560829|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
19560830|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560831|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560832|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560833|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560834|NCT02741960|Metformin|metformin|mesh-list
19560835|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19560836|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576937|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19576938|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19576939|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19576940|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19576941|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
19576942|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19576943|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
19576944|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576945|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19576946|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19576947|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19576948|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
19576949|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19576950|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
19576951|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19576952|NCT04962841|Protective Agents|protective agents|mesh-ancestor
19576953|NCT04958785|Paclitaxel|paclitaxel|mesh-list
19576954|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19576955|NCT04958785|Magrolimab|magrolimab|mesh-list
19576956|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19576957|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576958|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
19576959|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
19576960|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
19576961|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576962|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19576963|NCT04931017|Metformin|metformin|mesh-list
19576964|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19576965|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576966|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
19576967|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19576968|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
19576969|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19576970|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
19576971|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19576972|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
19576973|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576974|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576975|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
19576976|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
19576977|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19576978|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19576979|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576980|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19576981|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576982|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19576983|NCT04908800|Itraconazole|itraconazole|mesh-list
19576984|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
19576985|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19576986|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19576987|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19576988|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19576989|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19576990|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19576991|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
19576992|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19576993|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19576994|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19560837|NCT02741817|Aspirin|aspirin|mesh-list
19560838|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19560839|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19560840|NCT02741817|Analgesics|analgesics|mesh-ancestor
19560841|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
19560842|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560843|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560844|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19560845|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19560846|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19560847|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19560848|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560849|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19560850|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19560851|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560852|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
19560853|NCT02741856|Paclitaxel|paclitaxel|mesh-list
19560854|NCT02741856|Carboplatin|carboplatin|mesh-list
19560855|NCT02741856|Capecitabine|capecitabine|mesh-list
19560856|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19560857|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560858|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
19560859|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
19560860|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
19560861|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560862|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19560863|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
19560864|NCT02741232|Lidocaine|lidocaine|mesh-list
19560865|NCT02741232|Epinephrine|epinephrine|mesh-list
19560866|NCT02741232|Racepinephrine|racepinephrine|mesh-list
19560867|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
19560868|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
19560869|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
19560870|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560871|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560872|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
19560873|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560874|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19560875|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19560876|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19560877|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19560878|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560879|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19560880|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19560881|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
19560882|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560883|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19560884|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19560885|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
19560886|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19560887|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
19560888|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
19560889|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
19560890|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19560891|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
19560892|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19560893|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560894|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19560895|NCT02741414|Amoxicillin|amoxicillin|mesh-list
19560896|NCT02741414|Metronidazole|metronidazole|mesh-list
19560897|NCT02741414|Clarithromycin|clarithromycin|mesh-list
19560898|NCT02741414|Levofloxacin|levofloxacin|mesh-list
19560899|NCT02741414|Ofloxacin|ofloxacin|mesh-list
19560900|NCT02741414|Tetracycline|tetracycline|mesh-list
19560901|NCT02741414|Furazolidone|furazolidone|mesh-list
19560902|NCT02741414|Esomeprazole|esomeprazole|mesh-list
19560903|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560904|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19560905|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19560906|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19560907|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19560908|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19560909|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560910|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560911|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19560912|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19560913|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19560914|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19560915|NCT02741414|Renal Agents|renal agents|mesh-ancestor
19560916|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19560917|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19560918|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560919|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19560920|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19560921|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19560922|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19560923|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19560924|NCT02741219|Sufentanil|sufentanil|mesh-list
19560925|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
19560926|NCT02741219|Dsuvia|dsuvia|mesh-list
19560927|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19560928|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113452|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19560929|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560930|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19560931|NCT02741219|Analgesics|analgesics|mesh-ancestor
19560932|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
19560933|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19560934|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19560935|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19560936|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19560937|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
19560938|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19560939|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560940|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19560941|NCT02741219|Narcotics|narcotics|mesh-ancestor
19560942|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19560943|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19560944|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
19560945|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
19560946|NCT02740933|Demeclocycline|demeclocycline|mesh-list
19560947|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19560948|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19560949|NCT02740894|Gefitinib|gefitinib|mesh-list
19560950|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560951|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19560952|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560953|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560954|NCT02740829|Glucagon|glucagon|mesh-list
20113453|NCT00004763|Norethindrone|norethindrone|mesh-list
20113454|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
20113455|NCT00004763|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20113456|NCT00004763|Norinyl|norinyl|mesh-list
20113457|NCT00004763|Estradiol|estradiol|mesh-list
19560955|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19560956|NCT02740829|Hormones|hormones|mesh-ancestor
19560957|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560958|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560959|NCT02741063|Oxytocin|oxytocin|mesh-list
19560960|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
19560961|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560962|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560963|NCT02741115|Udenafil|udenafil|mesh-list
19560964|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20113458|NCT00004763|Estrogens|estrogens|mesh-ancestor
20113459|NCT00004763|Hormones|hormones|mesh-ancestor
20113460|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113461|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113462|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20113463|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
20113464|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560965|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19560966|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560967|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560968|NCT02740868|Xenon|xenon|mesh-list
19560969|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19560970|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
19560971|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
19560972|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19560973|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560974|NCT02741154|Letrozole|letrozole|mesh-list
19560975|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19560976|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19560977|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19560978|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19560979|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19560980|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19560981|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19560982|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
19560983|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19560984|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560985|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
19560986|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19560987|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
19560988|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19560989|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19560990|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19560991|NCT02740803|Listerine|listerine|mesh-list
19560992|NCT02740803|Fluorides|fluorides|mesh-list
19560993|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
19560994|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
19560995|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
19560996|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
19560997|NCT02740803|Protective Agents|protective agents|mesh-ancestor
19560998|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19560999|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19561000|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561001|NCT02741024|Artesunate|artesunate|mesh-list
19561002|NCT02741024|Lumefantrine|lumefantrine|mesh-list
19561003|NCT02741024|Artemether|artemether|mesh-list
19561004|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19561005|NCT02741024|Amodiaquine|amodiaquine|mesh-list
19561006|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
19561007|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19561008|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19561009|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561010|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561011|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
19561012|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
19561013|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19561014|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
19561015|NCT02740595|Nicotine|nicotine|mesh-list
19561016|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19561017|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
19561018|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561019|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561020|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19561021|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19561022|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
19561023|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561024|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561025|NCT02740647|Amoxicillin|amoxicillin|mesh-list
19561026|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
19561027|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
19561028|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19561029|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561030|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561031|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19561032|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561033|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561034|NCT02740712|Vitamin K|vitamin k|mesh-list
19561035|NCT02740712|Rucaparib|rucaparib|mesh-list
19561036|NCT02740712|Digoxin|digoxin|mesh-list
19561037|NCT02740712|Midazolam|midazolam|mesh-list
19561038|NCT02740712|Caffeine|caffeine|mesh-list
19561039|NCT02740712|Omeprazole|omeprazole|mesh-list
19561040|NCT02740712|Warfarin|warfarin|mesh-list
19561041|NCT02740712|Vitamins|vitamins|mesh-ancestor
19561042|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
19561043|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561044|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20113465|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20113466|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19561045|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19561046|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561047|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19561048|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19561049|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19561050|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19561051|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
19561052|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
19561053|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
19561054|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
19561055|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561056|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561057|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
19561058|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19561059|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561060|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19561061|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561062|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19561063|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19561064|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19561065|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19561066|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
19561067|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19561068|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19561069|NCT02740712|Protective Agents|protective agents|mesh-ancestor
19561070|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19561071|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19561072|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
19561073|NCT02740712|Coagulants|coagulants|mesh-ancestor
19561074|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19561075|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561076|NCT02740426|Pirarubicin|pirarubicin|mesh-list
19561077|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561078|NCT02740270|Spartalizumab|spartalizumab|mesh-list
19561079|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19561080|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561081|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561082|NCT02740101|Oxytocin|oxytocin|mesh-list
19561083|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
19561084|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19561085|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561086|NCT02740192|Bupivacaine|bupivacaine|mesh-list
19561087|NCT02740192|Ropivacaine|ropivacaine|mesh-list
19561088|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
19561089|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
19561090|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561091|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561092|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
19561093|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19576995|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19576996|NCT04902131|Menotropins|menotropins|mesh-list
19576997|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19576998|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
19576999|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19577000|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577001|NCT04873362|Trastuzumab|trastuzumab|mesh-list
19577002|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19577003|NCT04873362|Atezolizumab|atezolizumab|mesh-list
19577004|NCT04873362|Maytansine|maytansine|mesh-list
19577005|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577006|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577007|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19577008|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577009|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577010|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577011|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577012|NCT04840862|Rifabutin|rifabutin|mesh-list
19577013|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19577014|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577015|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20113467|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
20113468|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113469|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113470|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19561094|NCT02740166|Propranolol|propranolol|mesh-list
20113471|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20113472|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20113473|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20113474|NCT00004763|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20113475|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
20113476|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20113477|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
20113478|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561095|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19561096|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19561097|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19561098|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561099|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113479|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113480|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
20113481|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113482|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
20113483|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113484|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
20113485|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
20113486|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113487|NCT00004770|Protective Agents|protective agents|mesh-ancestor
20113488|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113489|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
20113490|NCT00004770|Vitamins|vitamins|mesh-ancestor
20113491|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
20113492|NCT00004771|Leuprolide|leuprolide|mesh-list
20113493|NCT00004771|Testosterone|testosterone|mesh-list
20113494|NCT00004771|Androgens|androgens|mesh-ancestor
20113495|NCT00004771|Hormones|hormones|mesh-ancestor
20113496|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113497|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561100|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561101|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19561102|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19561103|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
19561104|NCT02739958|Propofol|propofol|mesh-list
19561105|NCT02739958|Isoflurane|isoflurane|mesh-list
19561106|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19561107|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561108|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561109|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19561110|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
19561111|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
19561112|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19561113|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
19561114|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20113498|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113499|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113500|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20113501|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
20113502|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113503|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
20113504|NCT00004772|Antibodies|antibodies|mesh-list
20113505|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
20113506|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20113507|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20113508|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
20113509|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113510|NCT00004776|Topiramate|topiramate|mesh-list
20113511|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
20113512|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20113513|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113514|NCT00004778|Dexamethasone|dexamethasone|mesh-list
20113515|NCT00004778|Betamethasone|betamethasone|mesh-list
20113516|NCT00004778|Hormones|hormones|mesh-list
20113517|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
20113518|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113519|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
20113520|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
19561115|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
19578321|NCT02839707|Antibodies|antibodies|mesh-list
20113521|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113522|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113523|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20113524|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
20113525|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113526|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113527|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113528|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20113529|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
20113530|NCT00004784|Methotrexate|methotrexate|mesh-list
20113531|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20113532|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20113533|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
20113534|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20113535|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113536|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113537|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
20113538|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113539|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113540|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
20113541|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113542|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20113543|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113544|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
20113545|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113546|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113547|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20113548|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20113549|NCT00004785|Dexamethasone|dexamethasone|mesh-list
20113550|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
20113551|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20113552|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19561116|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561117|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
19561118|NCT02739880|Protective Agents|protective agents|mesh-ancestor
19561119|NCT02739906|Insulin|insulin|mesh-list
19561120|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19561121|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
19561122|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19561123|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561124|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19561125|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
19561126|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561127|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19561128|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19561129|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561130|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
19561131|NCT02739815|Coagulants|coagulants|mesh-ancestor
19561132|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
19561133|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19561134|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
19561135|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561136|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19561137|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561138|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
19561139|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561140|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
19561141|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19561142|NCT02739711|Protective Agents|protective agents|mesh-ancestor
19561143|NCT02739672|Amlodipine|amlodipine|mesh-list
20113553|NCT00004785|Prednisolone|prednisolone|mesh-list
20113554|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
20113555|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20113556|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
20113557|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113558|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
20113559|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
20113560|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113561|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113562|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20113563|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
20113564|NCT00004785|Hormones|hormones|mesh-ancestor
19561144|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19561145|NCT02739672|Telmisartan|telmisartan|mesh-list
19561146|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20113565|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113566|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113567|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561147|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19561148|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20113568|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20113569|NCT00004785|Protective Agents|protective agents|mesh-ancestor
20113570|NCT00004786|Iloprost|iloprost|mesh-list
20113571|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20113572|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
20113573|NCT00004787|Lenograstim|lenograstim|mesh-list
20113574|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20113575|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
20113576|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113577|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20113578|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113579|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113580|NCT00004794|Cidofovir|cidofovir|mesh-list
19561149|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19561150|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561151|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19561152|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561153|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
19561154|NCT02739672|Diuretics|diuretics|mesh-ancestor
19561155|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
19561156|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19561157|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19561158|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19561159|NCT02739685|Everolimus|everolimus|mesh-list
19561160|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561161|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561162|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
19561163|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561164|NCT02739633|Gemcitabine|gemcitabine|mesh-list
19561165|NCT02739633|Paclitaxel|paclitaxel|mesh-list
19561166|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19561167|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561168|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
19561169|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
19561170|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
19561171|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561172|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19561173|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
19561174|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
19561175|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561176|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561177|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561178|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
19561179|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561180|NCT02739477|Favipiravir|favipiravir|mesh-list
19561181|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
19561182|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561183|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20113581|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
20113582|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113583|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561184|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19561185|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19561186|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561187|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561188|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561189|NCT02739516|Letrozole|letrozole|mesh-list
19561190|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19561191|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561192|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19561193|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20113584|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113585|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20113586|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20113587|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
20113588|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113589|NCT00004796|Lactulose|lactulose|mesh-list
20113590|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561194|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561195|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561196|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20113591|NCT00004799|Vaccines|vaccines|mesh-list
20113592|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
20113593|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113594|NCT00004800|Vaccines|vaccines|mesh-list
20113595|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
19561197|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
19561198|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561199|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561200|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19561201|NCT02739399|Phenylephrine|phenylephrine|mesh-list
19561202|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
19561203|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19561204|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
19561205|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
19561206|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561207|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561208|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
19561209|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19561210|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
19561211|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
19561212|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19561213|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19561214|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19561215|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
19561216|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561217|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561218|NCT02739399|Protective Agents|protective agents|mesh-ancestor
19561219|NCT02739295|Sargramostim|sargramostim|mesh-list
19561220|NCT02739295|Immunologic Factors|immunologic factors|mesh-ancestor
19561221|NCT02739295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561222|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19561223|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561224|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19561225|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561226|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561227|NCT02739412|Aldesleukin|aldesleukin|mesh-list
19561228|NCT02739412|Interleukin-2|interleukin-2|mesh-list
19561229|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561230|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19561231|NCT02739412|Analgesics|analgesics|mesh-ancestor
19561232|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
19561233|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561234|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561235|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19561236|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19561237|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
20113596|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113597|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
20113598|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20113599|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561238|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561239|NCT02739204|Celecoxib|celecoxib|mesh-list
19561240|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19561241|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19561242|NCT02739204|Analgesics|analgesics|mesh-ancestor
19561243|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
19561244|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561245|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561246|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19561247|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19561248|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19561249|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19561250|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561251|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561252|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
19561253|NCT02739061|Sertraline|sertraline|mesh-list
19561254|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
19561255|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20113600|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561256|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19561257|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19561258|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19561259|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561260|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561261|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
19561262|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561263|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19561264|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19561265|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113601|NCT00004804|Interferons|interferons|mesh-list
20113602|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
20113603|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113604|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
20113605|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113606|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
19561266|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19561267|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19561268|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19561269|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561270|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19561271|NCT02738970|Trastuzumab|trastuzumab|mesh-list
19561272|NCT02738970|Pertuzumab|pertuzumab|mesh-list
19561273|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561274|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561275|NCT02738918|Abatacept|abatacept|mesh-list
19561276|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19561277|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113607|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113608|NCT00004807|Topiramate|topiramate|mesh-list
20113609|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
19561278|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561279|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561280|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
19561281|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561282|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19561283|NCT02738931|Lamivudine|lamivudine|mesh-list
19561284|NCT02738931|Dolutegravir|dolutegravir|mesh-list
19561285|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19561286|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19561287|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561288|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561289|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
19561290|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561291|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19561292|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19561293|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19561294|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19561295|NCT02738905|Rifaximin|rifaximin|mesh-list
19561296|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561297|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561298|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561299|NCT02738814|Propofol|propofol|mesh-list
19561300|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19561301|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561302|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113610|NCT00004807|Donepezil|donepezil|mesh-list
20113611|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20113612|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113613|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113614|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
20113615|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113616|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113617|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
20113618|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
20113619|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20113620|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
20113621|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
20113622|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20113623|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20113624|NCT00004808|Fluconazole|fluconazole|mesh-list
20113625|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
20113626|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113627|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20113628|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20113629|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113630|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113631|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20113632|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
20113633|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113634|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113635|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20113636|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20113637|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20113638|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
20113639|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20113640|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113641|NCT00004811|Itraconazole|itraconazole|mesh-list
20113642|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
20113643|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113644|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20113645|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20113646|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113647|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113648|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20113649|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
20113650|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113651|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113652|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20113653|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
20113654|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
19561303|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19561304|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
19561305|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
19561306|NCT02739386|Ipilimumab|ipilimumab|mesh-list
19561307|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561308|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561309|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19561310|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561311|NCT02738619|Vitamin D|vitamin d|mesh-list
19561312|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
19561313|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
19561314|NCT02738619|Vitamins|vitamins|mesh-list
19561315|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
19561316|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561317|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19561318|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19561319|NCT02738658|Everolimus|everolimus|mesh-list
19561320|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561321|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561322|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
19561323|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561324|NCT02738502|Ritonavir|ritonavir|mesh-list
19561325|NCT02738502|Darunavir|darunavir|mesh-list
19561326|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20113655|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20113656|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
20113657|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113658|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113659|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113660|NCT00004815|Hormones|hormones|mesh-list
19561327|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20113661|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113662|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113663|NCT00004816|Antibodies|antibodies|mesh-list
20113664|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20113665|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
20113666|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113667|NCT00004817|Phenytoin|phenytoin|mesh-list
20113668|NCT00004817|Valproic Acid|valproic acid|mesh-list
20113669|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
20113670|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113671|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113672|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
20113673|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113674|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113675|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
20113676|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20113677|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113678|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19561328|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
19561329|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113679|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20113680|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20113681|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19561330|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561331|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19561332|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19561333|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
19561334|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561335|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19561336|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19561337|NCT02738346|Carboplatin|carboplatin|mesh-list
19561338|NCT02738346|Etoposide|etoposide|mesh-list
19561339|NCT02738346|Topotecan|topotecan|mesh-list
19561340|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561341|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19561342|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19561343|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19561344|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561345|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561346|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19561347|NCT02738632|Amlodipine|amlodipine|mesh-list
19561348|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19561349|NCT02738632|Telmisartan|telmisartan|mesh-list
19561350|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19561351|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19561352|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19561353|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19561354|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561355|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19561356|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561357|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
19561358|NCT02738632|Diuretics|diuretics|mesh-ancestor
19561359|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
19561360|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19561361|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19561362|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19577016|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
19577017|NCT04834206|Docetaxel|docetaxel|mesh-list
19577018|NCT04834206|Fluorouracil|fluorouracil|mesh-list
19577019|NCT04834206|Nedaplatin|nedaplatin|mesh-list
19577020|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577021|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577022|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577023|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577024|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577025|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
19577026|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577027|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577028|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
19577029|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577030|NCT04829344|Carticaine|carticaine|mesh-list
19577031|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
20113682|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20113683|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19561363|NCT02738177|Isosorbide|isosorbide|mesh-list
19561364|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19561365|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19561366|NCT02738177|Misoprostol|misoprostol|mesh-list
19561367|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19561368|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
19561369|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19561370|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561371|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19561372|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561373|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
19561374|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20113684|NCT00004825|Insulin|insulin|mesh-list
20113685|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20113686|NCT00004825|Mitogens|mitogens|mesh-list
20113687|NCT00004825|Mecasermin|mecasermin|mesh-list
20113688|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20113689|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113690|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20113691|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561375|NCT02738177|Diuretics|diuretics|mesh-ancestor
19561376|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
19561377|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
19561378|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20113692|NCT00004825|Growth Substances|growth substances|mesh-ancestor
20113693|NCT00004826|Clozapine|clozapine|mesh-list
20113694|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20113695|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
20113696|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113697|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113698|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113699|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20113700|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19561379|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561380|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
19561381|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19561382|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19561383|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561384|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
19561385|NCT02738073|Coagulants|coagulants|mesh-ancestor
19561386|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19561387|NCT02737943|Analgesics|analgesics|mesh-list
19561388|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561389|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
19561390|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113701|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113702|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20113703|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
20113704|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
20113705|NCT00004829|Tobramycin|tobramycin|mesh-list
19561391|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561392|NCT02737709|Paclitaxel|paclitaxel|mesh-list
19561393|NCT02737709|Carboplatin|carboplatin|mesh-list
19561394|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19561395|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113706|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20113707|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113708|NCT00004832|Amifampridine|amifampridine|mesh-list
20113709|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20113710|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113711|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113712|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20113713|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19561396|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
19561397|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
19561398|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
19561399|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561400|NCT02737813|Bupivacaine|bupivacaine|mesh-list
19561401|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
19561402|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
19561403|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20113714|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561404|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561405|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
19561406|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561407|NCT02737787|Nivolumab|nivolumab|mesh-list
19561408|NCT02737787|Vaccines|vaccines|mesh-list
19561409|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
19561410|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113715|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
20113716|NCT00004833|Antibodies|antibodies|mesh-list
20113717|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
20113718|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20113719|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20113720|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
20113721|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113722|NCT00004834|Imipramine|imipramine|mesh-list
20113723|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20113724|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
20113725|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20113726|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19561411|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561412|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561413|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19561414|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561415|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19561416|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
19561417|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19561418|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
19561419|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561420|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19561421|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19561422|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19561423|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19561424|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561425|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19561426|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
19561427|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19561428|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
19561429|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19561430|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561431|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19561432|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19561433|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561434|NCT02737774|Carboplatin|carboplatin|mesh-list
19561435|NCT02737774|Pemetrexed|pemetrexed|mesh-list
19561436|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561437|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561438|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561439|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19561440|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19561441|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
19561442|NCT02737696|Narcotics|narcotics|mesh-ancestor
19561443|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561444|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561445|NCT02737696|Analgesics|analgesics|mesh-ancestor
19561446|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
19561447|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561448|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
19561449|NCT02737605|Esketamine|esketamine|mesh-list
19561450|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561451|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561452|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19561453|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19561454|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561455|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561456|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561457|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
19561458|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19561459|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
19561460|NCT02737371|Clotrimazole|clotrimazole|mesh-list
19561461|NCT02737371|Miconazole|miconazole|mesh-list
19561462|NCT02737371|Olorofim|olorofim|mesh-list
20113727|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20113728|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19561463|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561464|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19561465|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19561466|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19561467|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561468|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561469|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19561470|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
19561471|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561472|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561473|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19561474|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19561475|NCT02737423|Vitamin D|vitamin d|mesh-list
19561476|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
19561477|NCT02737423|Vitamins|vitamins|mesh-ancestor
19561478|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
19561479|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561480|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19561481|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19561482|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
19561483|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
19561484|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
19561485|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561486|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561487|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
19561488|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561489|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19561490|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19561491|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19561492|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
19561493|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561494|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19561495|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19561496|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561497|NCT02737254|Oxytocin|oxytocin|mesh-list
19561498|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
19561499|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19561500|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561501|NCT02737202|Saracatinib|saracatinib|mesh-list
19561502|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561503|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561504|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561505|NCT02737228|Gemcitabine|gemcitabine|mesh-list
19561506|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19561507|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19561508|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
19561509|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561510|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561511|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
19561512|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561513|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561514|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561515|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
19561516|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561517|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19561518|NCT02737124|Acetaminophen|acetaminophen|mesh-list
19561519|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19561520|NCT02737124|Analgesics|analgesics|mesh-ancestor
19561521|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
20113729|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113730|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
20113731|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113732|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113733|NCT00004838|Succimer|succimer|mesh-list
20113734|NCT00004838|Antidotes|antidotes|mesh-ancestor
19561522|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561523|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561524|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
19561525|NCT02737150|Anesthetics|anesthetics|mesh-list
19561526|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561527|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561528|NCT02737059|Codeine|codeine|mesh-list
19561529|NCT02737059|Naloxegol|naloxegol|mesh-list
19561530|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19561531|NCT02737059|Narcotics|narcotics|mesh-ancestor
19561532|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561533|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561534|NCT02737059|Analgesics|analgesics|mesh-ancestor
19561535|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
19561536|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561537|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
19561538|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
19561539|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19561540|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19561541|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19561542|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
19561543|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
19561544|NCT02736604|Anesthetics|anesthetics|mesh-list
19561545|NCT02736604|Sevoflurane|sevoflurane|mesh-list
19561546|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561547|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561548|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19561549|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19561550|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
19561551|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19561552|NCT02736604|Analgesics|analgesics|mesh-ancestor
19561553|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
19561554|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561555|NCT02736448|Capecitabine|capecitabine|mesh-list
19561556|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19561557|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
19561558|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561559|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561560|NCT02736591|Hormones|hormones|mesh-list
19561561|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19561562|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561563|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561564|NCT02736513|Osimertinib|osimertinib|mesh-list
19561565|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561566|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19561567|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561568|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561569|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19561570|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19561571|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561572|NCT02736435|Leuprolide|leuprolide|mesh-list
19561573|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19561574|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
19561575|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19561576|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561577|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19561578|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561579|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19561580|NCT02736682|Metronidazole|metronidazole|mesh-list
19561581|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19561582|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561583|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
19561584|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19561585|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19577032|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
19577033|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577034|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577035|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
19577036|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577037|NCT04816214|Carboplatin|carboplatin|mesh-list
19577038|NCT04816214|Pemetrexed|pemetrexed|mesh-list
19577039|NCT04816214|Osimertinib|osimertinib|mesh-list
19577040|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577041|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577042|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577043|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19577044|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19577045|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578322|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
19578323|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578324|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
19578325|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578326|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20113735|NCT00004838|Protective Agents|protective agents|mesh-ancestor
19561586|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19561587|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
19561588|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561589|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
19561590|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561591|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
19561592|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561593|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561594|NCT02736240|Vaccines|vaccines|mesh-list
19561595|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19561596|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
19561597|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561598|NCT02736227|Everolimus|everolimus|mesh-list
19561599|NCT02736227|Tacrolimus|tacrolimus|mesh-list
19561600|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561601|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
19561602|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561603|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19561604|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561605|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561606|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561607|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19561608|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19561609|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19561610|NCT02736032|Estradiol|estradiol|mesh-list
19561611|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19561612|NCT02736032|Progesterone|progesterone|mesh-list
19561613|NCT02736032|Estrogens|estrogens|mesh-ancestor
19561614|NCT02736032|Hormones|hormones|mesh-ancestor
19561615|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561616|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561617|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19561618|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
19561619|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19561620|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19561621|NCT02736032|Progestins|progestins|mesh-ancestor
19561622|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
19561623|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113736|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113737|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
20113738|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
20113739|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113740|NCT00004840|Hormones|hormones|mesh-list
20113741|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
20113742|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113743|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113744|NCT00004842|Budesonide|budesonide|mesh-list
19561624|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561625|NCT02736071|Celecoxib|celecoxib|mesh-list
19561626|NCT02736071|Tramadol|tramadol|mesh-list
19561627|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19561628|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19561629|NCT02736071|Analgesics|analgesics|mesh-ancestor
19561630|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
19561631|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561632|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561633|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19561634|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19561635|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19561636|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19561637|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561638|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561639|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19561640|NCT02736071|Narcotics|narcotics|mesh-ancestor
19561641|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561642|NCT02736123|Nivolumab|nivolumab|mesh-list
19561643|NCT02736123|Ipilimumab|ipilimumab|mesh-list
19561644|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561645|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561646|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19561647|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561648|NCT02736019|Celecoxib|celecoxib|mesh-list
19561649|NCT02736019|Tramadol|tramadol|mesh-list
20113745|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20120614|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19577046|NCT04788641|Cyclosporine|cyclosporine|mesh-list
19561650|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20113746|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20113747|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
20113748|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113749|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113750|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20113751|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
19561651|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19561652|NCT02736019|Analgesics|analgesics|mesh-ancestor
19561653|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
19561654|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561655|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561656|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19561657|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19561658|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19561659|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19561660|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561661|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561662|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19561663|NCT02736019|Narcotics|narcotics|mesh-ancestor
19561664|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561665|NCT02735837|Doxycycline|doxycycline|mesh-list
19561666|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561667|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561668|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
20113752|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
20113753|NCT00004842|Hormones|hormones|mesh-ancestor
20113754|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113755|NCT00004845|Naproxen|naproxen|mesh-list
20113756|NCT00004845|Rofecoxib|rofecoxib|mesh-list
20113757|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20113758|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20113759|NCT00004845|Analgesics|analgesics|mesh-ancestor
20113760|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
20113761|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20113762|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113763|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113764|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20113765|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
20113766|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20113767|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113768|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113769|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19561669|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19561670|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19561671|NCT02735928|Doxorubicin|doxorubicin|mesh-list
19561672|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561673|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19561674|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19561675|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19561676|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561677|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561678|NCT02735876|Rituximab|rituximab|mesh-list
19561679|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
19561680|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561681|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561682|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
19561683|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561684|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19561685|NCT02735902|Aspirin|aspirin|mesh-list
19561686|NCT02735902|Vitamin K|vitamin k|mesh-list
19561687|NCT02735902|Anticoagulants|anticoagulants|mesh-list
19561688|NCT02735902|Vitamins|vitamins|mesh-ancestor
19561689|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
19561690|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561691|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19561692|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19561693|NCT02735902|Analgesics|analgesics|mesh-ancestor
19561694|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
19561695|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561696|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19561697|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19561698|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19561699|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19561700|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561701|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19561702|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19561703|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561704|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
19561705|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19561706|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
19561707|NCT02735902|Coagulants|coagulants|mesh-ancestor
19561708|NCT02735798|Trastuzumab|trastuzumab|mesh-list
19561709|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561710|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561711|NCT02735590|Isoniazid|isoniazid|mesh-list
19561712|NCT02735590|Rifapentine|rifapentine|mesh-list
19561713|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
19561714|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561715|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561716|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19561717|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19561718|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
19561719|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561720|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19561721|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19561722|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
19561723|NCT02735694|Cycloserine|cycloserine|mesh-list
19561724|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19561725|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561726|NCT02735694|Renal Agents|renal agents|mesh-ancestor
19561727|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19561728|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
19561729|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561730|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
19561731|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561732|NCT02735395|Amoxicillin|amoxicillin|mesh-list
19561733|NCT02735395|Metronidazole|metronidazole|mesh-list
19561734|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561735|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561736|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19561737|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19561738|NCT02735473|Choline|choline|mesh-list
19561739|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
19561740|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19561741|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
19561742|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561743|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561744|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19561745|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
19561746|NCT02735343|Ketamine|ketamine|mesh-list
19561747|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
19561748|NCT02735343|Analgesics|analgesics|mesh-ancestor
19561749|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
19561750|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561751|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561752|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19561753|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20113770|NCT00004852|Lamivudine|lamivudine|mesh-list
20113771|NCT00004852|Zidovudine|zidovudine|mesh-list
20113772|NCT00004852|Efavirenz|efavirenz|mesh-list
20113773|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19561754|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
19561755|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
19561756|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561757|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19561758|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19561759|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561760|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561761|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
19561762|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
19561763|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561764|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20113774|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113775|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113776|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113777|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
20113778|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561765|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19561766|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19561767|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19561768|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
19561769|NCT02735356|Itraconazole|itraconazole|mesh-list
19561770|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
19561771|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561772|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19561773|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19561774|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561775|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561776|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19561777|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
19561778|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561779|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113779|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20113780|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20113781|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
20113782|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20113783|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20113784|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20113785|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20113786|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20113787|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20113788|NCT00004853|Lenograstim|lenograstim|mesh-list
19561780|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19561781|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
19561782|NCT02735603|Naltrexone|naltrexone|mesh-list
19561783|NCT02735603|Bupropion|bupropion|mesh-list
19561784|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561785|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561786|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19561787|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19561788|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561789|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561790|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561791|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561792|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19561793|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19561794|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
19561795|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561796|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19561797|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
19561798|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19561799|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19561800|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19561801|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19561802|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
19561803|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561804|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19561805|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19561806|NCT02735330|Ethanol|ethanol|mesh-list
19561807|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19561808|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561809|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561810|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561811|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
19561812|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
19561813|NCT02735317|Gentamicins|gentamicins|mesh-list
19561814|NCT02735317|Dexamethasone|dexamethasone|mesh-list
19561815|NCT02735317|Procaine|procaine|mesh-list
19561816|NCT02735317|Vitamins|vitamins|mesh-ancestor
19561817|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
19561818|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561819|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19561820|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
19561821|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
19561822|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561823|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561824|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
19561825|NCT02735317|Hormones|hormones|mesh-ancestor
19561826|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561827|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19561828|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561829|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
19561830|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19577047|NCT04788641|Tacrolimus|tacrolimus|mesh-list
20113789|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19561831|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561832|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19561833|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561834|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561835|NCT02735317|Hematinics|hematinics|mesh-ancestor
19561836|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
20113790|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
20113791|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113792|NCT00004854|Carvedilol|carvedilol|mesh-list
20113793|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20113794|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20113795|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
20113796|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20113797|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561837|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
19561838|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561839|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
19561840|NCT02735031|Exenatide|exenatide|mesh-list
19561841|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19561842|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561843|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19561844|NCT02735031|Incretins|incretins|mesh-ancestor
19561845|NCT02735031|Hormones|hormones|mesh-ancestor
19561846|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561847|NCT02735057|Paclitaxel|paclitaxel|mesh-list
19561848|NCT02735057|Carboplatin|carboplatin|mesh-list
19561849|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19561850|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561851|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
19561852|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
19561853|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
19561854|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561855|NCT02734875|Anticoagulants|anticoagulants|mesh-list
19561856|NCT02735018|Epinephrine|epinephrine|mesh-list
19561857|NCT02735018|Racepinephrine|racepinephrine|mesh-list
19561858|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
19561859|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19561860|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19561861|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
19561862|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561863|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561864|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561865|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19561866|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19561867|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
19561868|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561869|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19561870|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
19561871|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
19561872|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
19561873|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19561874|NCT02734771|Prednisone|prednisone|mesh-list
19561875|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
19561876|NCT02734771|Rituximab|rituximab|mesh-list
19561877|NCT02734771|Doxorubicin|doxorubicin|mesh-list
19561878|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19561879|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19561880|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
19561881|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561882|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19561883|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19561884|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
19561885|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561886|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561887|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19561888|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561889|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19561890|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19561891|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19561892|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561893|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19561894|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
20113798|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561895|NCT02734771|Hormones|hormones|mesh-ancestor
19561896|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19561897|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19561898|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
19561899|NCT02734732|Trimethoprim|trimethoprim|mesh-list
19561900|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
19561901|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19561902|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561903|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19561904|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19561905|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561906|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561907|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561908|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19561909|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19561910|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19561911|NCT02734732|Renal Agents|renal agents|mesh-ancestor
19561912|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
19561913|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19561914|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19561915|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19561916|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19561917|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20113799|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20113800|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
20113801|NCT00004854|Protective Agents|protective agents|mesh-ancestor
20113802|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20113803|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20113804|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20113805|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
20113806|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20113807|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20113808|NCT00004855|Ritonavir|ritonavir|mesh-list
20113809|NCT00004855|Lopinavir|lopinavir|mesh-list
20113810|NCT00004855|Lamivudine|lamivudine|mesh-list
20113811|NCT00004855|Nevirapine|nevirapine|mesh-list
20113812|NCT00004855|Abacavir|abacavir|mesh-list
19577048|NCT04788641|Cyclosporins|cyclosporins|mesh-list
19577049|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577050|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
19577051|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577052|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19577053|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577054|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577055|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
19577056|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577057|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577058|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577059|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19577060|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19577061|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
19577062|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577063|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577064|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577065|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
19577066|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19577067|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
19577068|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577069|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
19577070|NCT04756063|Vitamins|vitamins|mesh-ancestor
19577071|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
19577072|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577073|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
19577074|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577075|NCT04756063|Protective Agents|protective agents|mesh-ancestor
19577076|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20113813|NCT00004855|Stavudine|stavudine|mesh-list
20113814|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20113815|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20113816|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
20113817|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113818|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113819|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20113820|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19577077|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20113821|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
20113822|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577078|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
20113823|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20113824|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20113825|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20113826|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20113827|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20113828|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19561918|NCT02734524|Carboplatin|carboplatin|mesh-list
19561919|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561920|NCT02734511|Propofol|propofol|mesh-list
19561921|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19561922|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561923|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561924|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19561925|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
19561926|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
19561927|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
19561928|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
19561929|NCT02734420|Coagulants|coagulants|mesh-ancestor
19561930|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
19561931|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561932|NCT02734407|Aflibercept|aflibercept|mesh-list
19561933|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19561934|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19561935|NCT02734407|Growth Substances|growth substances|mesh-ancestor
19561936|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561937|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
19561938|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561939|NCT02734173|Ritonavir|ritonavir|mesh-list
20113829|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
20113830|NCT00004856|Trastuzumab|trastuzumab|mesh-list
20113831|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561940|NCT02734173|Ribavirin|ribavirin|mesh-list
19561941|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19561942|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19561943|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
19561944|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561945|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561946|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19561947|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19561948|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
19561949|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19561950|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19561951|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19561952|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
19561953|NCT02734069|Carboplatin|carboplatin|mesh-list
19561954|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561955|NCT02734186|Praziquantel|praziquantel|mesh-list
20113832|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561956|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
19561957|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19561958|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113833|NCT00004857|Fludarabine|fludarabine|mesh-list
20113834|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
20113835|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
20113836|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561959|NCT02734160|Durvalumab|durvalumab|mesh-list
19561960|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19561961|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561962|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
19561963|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19561964|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19561965|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561966|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
20113837|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113838|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
20113839|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113840|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113841|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
20113842|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113843|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20113844|NCT00004858|Genistein|genistein|mesh-list
20113845|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
20113846|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20113847|NCT00004858|Protective Agents|protective agents|mesh-ancestor
20604665|NCT02228512|Prednisone|prednisone|mesh-list
19561967|NCT02733952|Coagulants|coagulants|mesh-ancestor
19561968|NCT02733809|Sorafenib|sorafenib|mesh-list
20113848|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113849|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113850|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20113851|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113852|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113853|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
20113854|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20113855|NCT00004858|Estrogens|estrogens|mesh-ancestor
20113856|NCT00004858|Hormones|hormones|mesh-ancestor
20113857|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20113858|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
20113859|NCT00004860|Leucovorin|leucovorin|mesh-list
20113860|NCT00004860|Tegafur|tegafur|mesh-list
20113861|NCT00004860|Calcium|calcium|mesh-list
20113862|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
20113863|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20113864|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113865|NCT00004860|Antidotes|antidotes|mesh-ancestor
20113866|NCT00004860|Protective Agents|protective agents|mesh-ancestor
20113867|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
20113868|NCT00004860|Vitamins|vitamins|mesh-ancestor
19561969|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19561970|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19561971|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561972|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561973|NCT02733640|Pantoprazole|pantoprazole|mesh-list
19561974|NCT02733640|Ranitidine|ranitidine|mesh-list
19561975|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19561976|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19561977|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19561978|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19561979|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19561980|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561981|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19561982|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
19561983|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
19561984|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19561985|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561986|NCT02733835|Remifentanil|remifentanil|mesh-list
19561987|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19561988|NCT02733835|Narcotics|narcotics|mesh-ancestor
19561989|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19561990|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19561991|NCT02733835|Analgesics|analgesics|mesh-ancestor
19561992|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
19561993|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19561994|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19561995|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19561996|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19561997|NCT02733822|Naloxone|naloxone|mesh-list
20113869|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
20113870|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113871|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
20113872|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113873|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113874|NCT00004861|Gemcitabine|gemcitabine|mesh-list
19561998|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19561999|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562000|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
19562001|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562002|NCT02733679|Metformin|metformin|mesh-list
19562003|NCT02733679|Pioglitazone|pioglitazone|mesh-list
19562004|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19562005|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562006|NCT02733874|Betamethasone|betamethasone|mesh-list
19562007|NCT02733874|Clobetasol|clobetasol|mesh-list
19562008|NCT02733874|Calcipotriene|calcipotriene|mesh-list
19562009|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562010|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
19562011|NCT02733874|Hormones|hormones|mesh-ancestor
20113875|NCT00004861|Tacedinaline|tacedinaline|mesh-list
19562012|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562013|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113876|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19562014|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20113877|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
20120615|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562015|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
19562016|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
19562017|NCT02733705|Fentanyl|fentanyl|mesh-list
19562018|NCT02733705|Propofol|propofol|mesh-list
19562019|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19562020|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562021|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562022|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19562023|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
19562024|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
19562025|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19562026|NCT02733705|Narcotics|narcotics|mesh-ancestor
19562027|NCT02733705|Analgesics|analgesics|mesh-ancestor
19562028|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
19562029|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562030|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19562031|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
19562032|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19562033|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19562034|NCT02733510|Prednisolone|prednisolone|mesh-list
19562035|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
19562036|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19562037|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
19562038|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562039|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
19562040|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
19562041|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562042|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562043|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562044|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
19562045|NCT02733510|Hormones|hormones|mesh-ancestor
19562046|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562047|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19562048|NCT02733510|Protective Agents|protective agents|mesh-ancestor
19562049|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562050|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562051|NCT02733471|Lidocaine|lidocaine|mesh-list
19562052|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
19562053|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
19562054|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562055|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562056|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
19562057|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562058|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562059|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19562060|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19562061|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20113878|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113879|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562062|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562063|NCT02733458|Gemcitabine|gemcitabine|mesh-list
19562064|NCT02733458|Dexamethasone|dexamethasone|mesh-list
19562065|NCT02733458|Etoposide|etoposide|mesh-list
19562066|NCT02733458|Pegaspargase|pegaspargase|mesh-list
19562067|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562068|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
19562069|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
19562070|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562071|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562072|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562073|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
19562074|NCT02733458|Hormones|hormones|mesh-ancestor
19562075|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562076|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562077|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562078|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562079|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562080|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19562081|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
19562082|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
20113880|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
19562083|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562084|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562085|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
19562086|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562087|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19562088|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19562089|NCT02733445|Dasatinib|dasatinib|mesh-list
19562090|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562091|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19562092|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562093|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562094|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
19562095|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19562096|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562097|NCT02733107|Etoposide|etoposide|mesh-list
19562098|NCT02733107|Apatinib|apatinib|mesh-list
19562099|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562100|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562101|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19562102|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19562103|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562104|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562105|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19562106|NCT02733237|Oxytocin|oxytocin|mesh-list
19562107|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
19562108|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562109|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562110|NCT02733250|Paclitaxel|paclitaxel|mesh-list
19562111|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
19562112|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562113|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562114|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
19562115|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
19562116|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
19562117|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562118|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19562119|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19562120|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
19562121|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
19562122|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562123|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19562124|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19562125|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562126|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19562127|NCT02733393|Lidocaine|lidocaine|mesh-list
19562128|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
19562129|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
19562130|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562131|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562132|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
19562133|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562134|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562135|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19562136|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19562137|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19562138|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562139|NCT02733380|Thalidomide|thalidomide|mesh-list
19562140|NCT02733380|Dexamethasone|dexamethasone|mesh-list
19562141|NCT02733380|Doxorubicin|doxorubicin|mesh-list
20113881|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113882|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113883|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113884|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
20113885|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113886|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20113887|NCT00004862|Cytarabine|cytarabine|mesh-list
20113888|NCT00004862|Fludarabine|fludarabine|mesh-list
20113889|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
20113890|NCT00004862|Oblimersen|oblimersen|mesh-list
20113891|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113892|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113893|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
20113894|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113895|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113896|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
20113897|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562142|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19562143|NCT02733380|Vinorelbine|vinorelbine|mesh-list
20113898|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
19562144|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
19562145|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562146|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
19562147|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
19562148|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562149|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562150|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562151|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
19562152|NCT02733380|Hormones|hormones|mesh-ancestor
19562153|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562154|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562155|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562156|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19562157|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19562158|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19562159|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562160|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113899|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113900|NCT00004863|Paclitaxel|paclitaxel|mesh-list
20113901|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20113902|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113903|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
20113904|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
20113905|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
19562161|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562162|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
19562163|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
19562164|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
19562165|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562166|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
19562167|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
19562168|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562169|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562170|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19562171|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19562172|NCT02733380|Growth Substances|growth substances|mesh-ancestor
19562173|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
19562174|NCT02733380|Analgesics|analgesics|mesh-ancestor
19562175|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
19562176|NCT02733341|Ticagrelor|ticagrelor|mesh-list
19562177|NCT02733341|Cangrelor|cangrelor|mesh-list
19562178|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19562179|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19562180|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19562181|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19562182|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
19562183|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562184|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562185|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113906|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113907|NCT00004864|Docetaxel|docetaxel|mesh-list
20113908|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113909|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
20113910|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
20113911|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
20113912|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113913|NCT00004865|Paclitaxel|paclitaxel|mesh-list
20113914|NCT00004865|Fluorouracil|fluorouracil|mesh-list
20113915|NCT00004865|Cetuximab|cetuximab|mesh-list
19577079|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19577080|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
19577081|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577082|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19577083|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
19577084|NCT04740645|Coagulants|coagulants|mesh-ancestor
19577085|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19577086|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
19577087|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577088|NCT04729608|Paclitaxel|paclitaxel|mesh-list
19577089|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19577090|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577091|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
20113916|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120616|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
19577092|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
20113917|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113918|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
20113919|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
19562186|NCT02732795|Morphine|morphine|mesh-list
19562187|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19562188|NCT02732795|Narcotics|narcotics|mesh-ancestor
19562189|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562190|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562191|NCT02732795|Analgesics|analgesics|mesh-ancestor
19562192|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
19562193|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562194|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19562195|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19562196|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19562197|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562198|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562199|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
19562200|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562201|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19562202|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19562203|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
19562204|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19562205|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19562206|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
19562207|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562208|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562209|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562210|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
19562211|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
20113920|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
20113921|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113922|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
20113923|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19562212|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562213|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
19562214|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19562215|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
19562216|NCT02732522|Misoprostol|misoprostol|mesh-list
19562217|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19562218|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
19562219|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562220|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562221|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19562222|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562223|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
19562224|NCT02732678|Propranolol|propranolol|mesh-list
19562225|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19562226|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19562227|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
19562228|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562229|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562230|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562231|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562232|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19562233|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
19562234|NCT02732405|Grazoprevir|grazoprevir|mesh-list
19562235|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
19562236|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562237|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19562238|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
19562239|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
20113924|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113925|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
20113926|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113927|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20113928|NCT00004866|Exatecan|exatecan|mesh-list
20113929|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20113930|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20113931|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113932|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604666|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
20604667|NCT02228512|Rituximab|rituximab|mesh-list
19577093|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604668|NCT02228512|Doxorubicin|doxorubicin|mesh-list
19562240|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562241|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562242|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19562243|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19562244|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19562245|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562246|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562247|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19562248|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19562249|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19562250|NCT02732197|Thiopental|thiopental|mesh-list
19562251|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
19562252|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19562253|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562254|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113933|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113934|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20113935|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20113936|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113937|NCT00004868|Semaxinib|semaxinib|mesh-list
20113938|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20113939|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20113940|NCT00004868|Growth Substances|growth substances|mesh-ancestor
20113941|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113942|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
20113943|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113944|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20113945|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562255|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19562256|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
19562257|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
19562258|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
19562259|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
19562260|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562261|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562262|NCT02732067|Anesthetics|anesthetics|mesh-list
19562263|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562264|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562265|NCT02732262|Oxycodone|oxycodone|mesh-list
19562266|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19562267|NCT02732262|Narcotics|narcotics|mesh-ancestor
19562268|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562269|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562270|NCT02732262|Analgesics|analgesics|mesh-ancestor
19562271|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
19562272|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562273|NCT02732132|Fentanyl|fentanyl|mesh-list
19562274|NCT02732132|Midazolam|midazolam|mesh-list
19562275|NCT02732132|Ketamine|ketamine|mesh-list
19562276|NCT02732132|Propofol|propofol|mesh-list
19562277|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19562278|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562279|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562280|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19562281|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
19562282|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
19562283|NCT02732132|Analgesics|analgesics|mesh-ancestor
19562284|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
19562285|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562286|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19562287|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19562288|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19562289|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562290|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562291|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19562292|NCT02732132|Narcotics|narcotics|mesh-ancestor
19562293|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19562294|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19562295|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19562296|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19562297|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
19562298|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
19562299|NCT02732249|Metronidazole|metronidazole|mesh-list
19562300|NCT02732249|Clarithromycin|clarithromycin|mesh-list
20604669|NCT02228512|Etoposide|etoposide|mesh-list
19562301|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
19562302|NCT02732249|Esomeprazole|esomeprazole|mesh-list
19562303|NCT02732249|Bismuth|bismuth|mesh-list
19562304|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562305|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562306|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562307|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19562308|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19562309|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19562310|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562311|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19562312|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562313|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19562314|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19562315|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19562316|NCT02732249|Antacids|antacids|mesh-ancestor
19562317|NCT02732249|Diuretics|diuretics|mesh-ancestor
19562318|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
19562319|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562320|NCT02732249|Expectorants|expectorants|mesh-ancestor
19562321|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
19562322|NCT02732314|Desonide|desonide|mesh-list
19562323|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562324|NCT02732093|Lidocaine|lidocaine|mesh-list
19562325|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
19562326|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
19562327|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562328|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562329|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
19562330|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562331|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562332|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19562333|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19562334|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19562335|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562336|NCT02732236|Rituximab|rituximab|mesh-list
19562337|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19562338|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562339|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
19562340|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562341|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19562342|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
19562343|NCT02731950|Bupivacaine|bupivacaine|mesh-list
19562344|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
19562345|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
19562346|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562347|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562348|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
19562349|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562350|NCT02731950|Analgesics|analgesics|mesh-ancestor
19562351|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562352|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
19562353|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19562354|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19562355|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562356|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19562357|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
19562358|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562359|NCT02731911|Dexamethasone|dexamethasone|mesh-list
19562360|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562361|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
19562362|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
19562363|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562364|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562365|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562366|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
19562367|NCT02731911|Hormones|hormones|mesh-ancestor
19562368|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562369|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20113946|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120617|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120618|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20120619|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120620|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
20120621|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562370|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562371|NCT02731664|Glucagon|glucagon|mesh-list
19562372|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19562373|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562374|NCT02731664|Hormones|hormones|mesh-ancestor
19562375|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562376|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562377|NCT02731664|Incretins|incretins|mesh-ancestor
19562378|NCT02731846|Fluticasone|fluticasone|mesh-list
19562379|NCT02731846|Xhance|xhance|mesh-list
19562380|NCT02731846|Albuterol|albuterol|mesh-list
19562381|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562382|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19562383|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
19562384|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562385|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562386|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19562387|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
19562388|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
19562389|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19562390|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
19562391|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562392|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19562393|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19562394|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19562395|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
19562396|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562397|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562398|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19562399|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19562400|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19562401|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562402|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562403|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19562404|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19562405|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19562406|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19562407|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
19562408|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562409|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562410|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19562411|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19562412|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
19562413|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19562414|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19562415|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
19562416|NCT02731560|Rituximab|rituximab|mesh-list
19562417|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19562418|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562419|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
19562420|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562421|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19562422|NCT02731378|Iron|iron|mesh-list
19562423|NCT02731378|Dextrans|dextrans|mesh-list
19562424|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
19562425|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
19562426|NCT02731378|Trace Elements|trace elements|mesh-ancestor
19562427|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
19562428|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562429|NCT02731378|Hematinics|hematinics|mesh-ancestor
19562430|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
19562431|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
19562432|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
19562433|NCT02731430|Morphine|morphine|mesh-list
19562434|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19562435|NCT02731430|Narcotics|narcotics|mesh-ancestor
19562436|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562437|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562438|NCT02731430|Analgesics|analgesics|mesh-ancestor
19562439|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
19562440|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562441|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19562442|NCT02731534|Hematinics|hematinics|mesh-ancestor
19562443|NCT02731287|Timolol|timolol|mesh-list
19562444|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19562445|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19562446|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
19562447|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562448|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562449|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562450|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562451|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19562452|NCT02731092|Lactoferrin|lactoferrin|mesh-list
19562453|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562454|NCT02731105|Clindamycin|clindamycin|mesh-list
19562455|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
20113947|NCT00004870|Irinotecan|irinotecan|mesh-list
20113948|NCT00004870|Oblimersen|oblimersen|mesh-list
20113949|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20113950|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20113951|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113952|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113953|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562456|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
19562457|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20113954|NCT00004871|Azacitidine|azacitidine|mesh-list
20113955|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20113956|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113957|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
20113958|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113959|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113960|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113961|NCT00004872|Endostatins|endostatins|mesh-list
20113962|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113963|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20113964|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19562458|NCT02731105|Tretinoin|tretinoin|mesh-list
19562459|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562460|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562461|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19562462|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562463|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113965|NCT00004872|Growth Substances|growth substances|mesh-ancestor
20113966|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113967|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
20113968|NCT00004873|Docetaxel|docetaxel|mesh-list
20113969|NCT00004873|Fluorouracil|fluorouracil|mesh-list
20113970|NCT00004873|Epirubicin|epirubicin|mesh-list
20113971|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20113972|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
20113973|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
20113974|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
20113975|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113976|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
20113977|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20113978|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20113979|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
20113980|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20113981|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20113982|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20113983|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19562464|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562465|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
19562466|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
19562467|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19562468|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19562469|NCT02731105|Analgesics|analgesics|mesh-ancestor
19562470|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
19562471|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562472|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562473|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20113984|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20113985|NCT00004874|Iodine|iodine|mesh-list
20113986|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
20113987|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20113988|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20113989|NCT00004874|Trace Elements|trace elements|mesh-ancestor
20113990|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
20113991|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562474|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577094|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113992|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562475|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
19562476|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19562477|NCT02730949|Folic Acid|folic acid|mesh-list
19562478|NCT02730949|Inositol|inositol|mesh-list
19562479|NCT02730949|Hematinics|hematinics|mesh-ancestor
19562480|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
19562481|NCT02730949|Vitamins|vitamins|mesh-ancestor
19562482|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
19562483|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562484|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
20113993|NCT00004875|Heparin|heparin|mesh-list
20113994|NCT00004875|Enoxaparin|enoxaparin|mesh-list
20113995|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
20113996|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20113997|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20113998|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20113999|NCT00004876|Thalidomide|thalidomide|mesh-list
20114000|NCT00004876|Carboplatin|carboplatin|mesh-list
19562485|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
19562486|NCT02731040|Diphosphonates|diphosphonates|mesh-list
19562487|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19562488|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562489|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
19562490|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562491|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19562492|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562493|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562494|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562495|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562496|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562497|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19562498|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
19562499|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19562500|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562501|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562502|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19562503|NCT02730845|Analgesics|analgesics|mesh-ancestor
19562504|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
19562505|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562506|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19562507|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19562508|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19562509|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
20114001|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114002|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114003|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
20114004|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114005|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
20114006|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20114007|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114008|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20114009|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20114010|NCT00004876|Growth Substances|growth substances|mesh-ancestor
20114011|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
20114012|NCT00004878|Cytarabine|cytarabine|mesh-list
20114013|NCT00004878|Methotrexate|methotrexate|mesh-list
20114014|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
20114015|NCT00004878|Fludarabine|fludarabine|mesh-list
20114016|NCT00004878|Idarubicin|idarubicin|mesh-list
20114017|NCT00004878|Tacrolimus|tacrolimus|mesh-list
20114018|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19562510|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562511|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562512|NCT02730923|Anastrozole|anastrozole|mesh-list
19562513|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562514|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562515|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19562516|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19562517|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562518|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114019|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
20114020|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562519|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20114021|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114022|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114023|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
19562520|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562521|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562522|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562523|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
19562524|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19562525|NCT02730715|Basiliximab|basiliximab|mesh-list
19562526|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
19562527|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562528|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562529|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19562530|NCT02730689|Ezetimibe|ezetimibe|mesh-list
19562531|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19562532|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19562533|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
19562534|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562535|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19562536|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19562537|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562538|NCT02730533|Esomeprazole|esomeprazole|mesh-list
19562539|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19562540|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562541|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19562542|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562543|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562544|NCT02730676|Menthol|menthol|mesh-list
19562545|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
19562546|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
20114024|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562547|NCT02730624|Tazobactam|tazobactam|mesh-list
19562548|NCT02730624|Piperacillin|piperacillin|mesh-list
19562549|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19562550|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562551|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562552|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19562553|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562554|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562555|NCT02730481|Paclitaxel|paclitaxel|mesh-list
19562556|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562557|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562558|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
19562559|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
19562560|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
19562561|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562562|NCT02730572|Methylphenidate|methylphenidate|mesh-list
19562563|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19562564|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562565|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19562566|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19562567|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19562568|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562569|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
20114025|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114026|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
20114027|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114028|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20114029|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114030|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
19562570|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562571|NCT02730442|Fluconazole|fluconazole|mesh-list
19562572|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
19562573|NCT02730442|Clotrimazole|clotrimazole|mesh-list
19562574|NCT02730442|Miconazole|miconazole|mesh-list
19562575|NCT02730442|Olorofim|olorofim|mesh-list
19562576|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562577|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19562578|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19562579|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562580|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562581|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20114031|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114032|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114033|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
20114034|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562582|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562583|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562584|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562585|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19562586|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19562587|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19562588|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19562589|NCT02730364|Acetaminophen|acetaminophen|mesh-list
19562590|NCT02730364|Ascorbic Acid|ascorbic acid|mesh-list
19562591|NCT02730364|Pheniramine|pheniramine|mesh-list
19562592|NCT02730364|Phenylephrine|phenylephrine|mesh-list
19562593|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
19562594|NCT02730364|Vitamins|vitamins|mesh-ancestor
19562595|NCT02730364|Micronutrients|micronutrients|mesh-ancestor
19562596|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562597|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19562598|NCT02730364|Analgesics|analgesics|mesh-ancestor
19562599|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
19562600|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562601|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
19562602|NCT02730364|Antioxidants|antioxidants|mesh-ancestor
19562603|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562604|NCT02730364|Protective Agents|protective agents|mesh-ancestor
19562605|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19562606|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
19562607|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
19562608|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
19562609|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19562610|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
19562611|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
19562612|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19562613|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19562614|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19562615|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
19562616|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562617|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
19562618|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
19562619|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19562620|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
19562621|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
19562622|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19562623|NCT02730117|Cephalosporins|cephalosporins|mesh-list
19562624|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19562625|NCT02730117|Dobutamine|dobutamine|mesh-list
19562626|NCT02730117|Dopamine|dopamine|mesh-list
19562627|NCT02730117|Milrinone|milrinone|mesh-list
19562628|NCT02730117|Norepinephrine|norepinephrine|mesh-list
19562629|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19562630|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19562631|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19562632|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
19562633|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562634|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562635|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562636|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
19562637|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
19562638|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562639|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20114035|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20114036|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20114037|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19562640|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19562641|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19562642|NCT02730117|Protective Agents|protective agents|mesh-ancestor
19562643|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
19562644|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19562645|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
19562646|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19562647|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19562648|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562649|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114038|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19562650|NCT02730091|Letrozole|letrozole|mesh-list
19562651|NCT02730091|Vinorelbine|vinorelbine|mesh-list
19562652|NCT02730091|Anastrozole|anastrozole|mesh-list
19562653|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562654|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19562655|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19562656|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562657|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562658|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19562659|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562660|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562661|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562662|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562663|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
19562664|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
19562665|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
19562666|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562667|NCT02730026|Ketoprofen|ketoprofen|mesh-list
19562668|NCT02730026|Omeprazole|omeprazole|mesh-list
19562669|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19562670|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562671|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19562672|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562673|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562674|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19562675|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19562676|NCT02730026|Analgesics|analgesics|mesh-ancestor
19562677|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
20114039|NCT00004879|Panitumumab|panitumumab|mesh-list
20114040|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20114041|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114042|NCT00004880|Vaccines|vaccines|mesh-list
19562678|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562679|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562680|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562681|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19562682|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19562683|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19562684|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19562685|NCT02729961|Ceritinib|ceritinib|mesh-list
19562686|NCT02729961|Antibodies|antibodies|mesh-list
19562687|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
19562688|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19562689|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
19562690|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
19562691|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562692|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562693|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19562694|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562695|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562696|NCT02729662|Tolvaptan|tolvaptan|mesh-list
19562697|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19562698|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562699|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
19562700|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562701|NCT02729766|Empagliflozin|empagliflozin|mesh-list
19562702|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19562703|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562704|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19562705|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114043|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
20114044|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114045|NCT00004883|Trastuzumab|trastuzumab|mesh-list
20114046|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20114047|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114048|NCT00004884|Gemcitabine|gemcitabine|mesh-list
20114049|NCT00004884|Docetaxel|docetaxel|mesh-list
20114050|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114051|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114052|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
20114053|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114054|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
20114055|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114056|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562706|NCT02729714|Suvorexant|suvorexant|mesh-list
19562707|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20114057|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562708|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19562709|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562710|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562711|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19562712|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562713|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562714|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19562715|NCT02729870|Laxatives|laxatives|mesh-ancestor
19562716|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562717|NCT02729805|Ketamine|ketamine|mesh-list
19562718|NCT02729805|Analgesics|analgesics|mesh-ancestor
19562719|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
19562720|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562721|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562722|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19562723|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19562724|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
19562725|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
19562726|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562727|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19562728|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19562729|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562730|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562731|NCT02729935|Parecoxib|parecoxib|mesh-list
19562732|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19562733|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19562734|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562735|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562736|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19562737|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19562738|NCT02729935|Analgesics|analgesics|mesh-ancestor
19562739|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
19562740|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562741|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562742|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562743|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19562744|NCT02729285|Ketorolac|ketorolac|mesh-list
19562745|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19562746|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19562747|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19562748|NCT02729285|Analgesics|analgesics|mesh-ancestor
19562749|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
19562750|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562751|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562752|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562753|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19562754|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19562755|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577095|NCT04726592|Ketoprofen|ketoprofen|mesh-list
20114058|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
20114059|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114060|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114061|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114062|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114063|NCT00004885|Leucovorin|leucovorin|mesh-list
20114064|NCT00004885|Fluorouracil|fluorouracil|mesh-list
20114065|NCT00004885|Irinotecan|irinotecan|mesh-list
20114066|NCT00004885|Calcium|calcium|mesh-list
20114067|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
20114068|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114069|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114070|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
20114071|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114072|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114073|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114074|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114075|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
20114076|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114077|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114078|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114079|NCT00004885|Antidotes|antidotes|mesh-ancestor
20114080|NCT00004885|Protective Agents|protective agents|mesh-ancestor
20114081|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
20114082|NCT00004885|Vitamins|vitamins|mesh-ancestor
20114083|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
20114084|NCT00004886|Docetaxel|docetaxel|mesh-list
19562756|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562757|NCT02729441|Ramipril|ramipril|mesh-list
19562758|NCT02729441|Perindopril|perindopril|mesh-list
19562759|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19562760|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
19562761|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562762|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562763|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19562764|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
19562765|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562766|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562767|NCT02729467|Itraconazole|itraconazole|mesh-list
19562768|NCT02729467|Rifampin|rifampin|mesh-list
19562769|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
19562770|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562771|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19562772|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19562773|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562774|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562775|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19562776|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562777|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562778|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562779|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19562780|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19562781|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
19562782|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562783|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
19562784|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19562785|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19562786|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19562787|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19562788|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19562789|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19562790|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19562791|NCT02729324|Protective Agents|protective agents|mesh-list
19562792|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
19562793|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577096|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
20114085|NCT00004886|Dofequidar|dofequidar|mesh-list
20114086|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114087|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114088|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114089|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577097|NCT04726592|Metoclopramide|metoclopramide|mesh-list
19577098|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
19577099|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
19577100|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577101|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577102|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19577103|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19577104|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19577105|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
19577106|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577107|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577108|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19577109|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19577110|NCT04726592|Analgesics|analgesics|mesh-ancestor
19577111|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
19577112|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577113|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577114|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19577115|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577116|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
19577117|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19577118|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19577119|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577120|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19577121|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
19577122|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
19577123|NCT04711824|Gemcitabine|gemcitabine|mesh-list
20604670|NCT02228512|Vincristine|vincristine|mesh-list
19562794|NCT02729064|Insulin|insulin|mesh-list
19562795|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19562796|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19562797|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562798|NCT02728869|Vaccines|vaccines|mesh-list
19562799|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
19562800|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562801|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19562802|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
19562803|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19562804|NCT02728856|Protective Agents|protective agents|mesh-ancestor
19562805|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562806|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
19562807|NCT02728947|Rotigotine|rotigotine|mesh-list
19562808|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
19562809|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
19562810|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19562811|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562812|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562813|NCT02728934|Golimumab|golimumab|mesh-list
19562814|NCT02728934|Infliximab|infliximab|mesh-list
19562815|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
19562816|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19562817|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19562818|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19562819|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19562820|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562821|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
19562822|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562823|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19562824|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562825|NCT02728843|Deferiprone|deferiprone|mesh-list
19562826|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19562827|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
19562828|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
19562829|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562830|NCT02728518|Amikacin|amikacin|mesh-list
19562831|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562832|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562833|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
19562834|NCT02728700|Sirolimus|sirolimus|mesh-list
20114090|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562835|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19562836|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562837|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19562838|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
19562839|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562840|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562841|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562842|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562843|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
19562844|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562845|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
19562846|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562847|NCT02728453|Empagliflozin|empagliflozin|mesh-list
19562848|NCT02728453|Glimepiride|glimepiride|mesh-list
19562849|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19562850|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562851|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19562852|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562853|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562854|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19562855|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
19562856|NCT02728622|Tamoxifen|tamoxifen|mesh-list
19562857|NCT02728622|Paclitaxel|paclitaxel|mesh-list
19562858|NCT02728622|Doxorubicin|doxorubicin|mesh-list
19562859|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19562860|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562861|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562862|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
19562863|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
19562864|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
19562865|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562866|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19562867|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19562868|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19562869|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562870|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19562871|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562872|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562873|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562874|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562875|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19562876|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19562877|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19562878|NCT02728687|Mannitol|mannitol|mesh-list
19562879|NCT02728687|Menthol|menthol|mesh-list
19562880|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19562881|NCT02728687|Diuretics|diuretics|mesh-ancestor
19562882|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
19562883|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562884|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
19562885|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
19562886|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
19562887|NCT02728466|Procyanidin|procyanidin|mesh-list
19562888|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
19562889|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562890|NCT02728466|Protective Agents|protective agents|mesh-ancestor
19562891|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562892|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19562893|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19562894|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562895|NCT02728492|Gemcitabine|gemcitabine|mesh-list
19562896|NCT02728492|Paclitaxel|paclitaxel|mesh-list
19562897|NCT02728492|Carboplatin|carboplatin|mesh-list
19562898|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19562899|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562900|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
19562901|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
19562902|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
19562903|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562904|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19562905|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
19562906|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
19562907|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562908|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19562909|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114091|NCT00004887|Paclitaxel|paclitaxel|mesh-list
20114092|NCT00004887|Vinblastine|vinblastine|mesh-list
20114093|NCT00004887|Carboplatin|carboplatin|mesh-list
20114094|NCT00004887|Ifosfamide|ifosfamide|mesh-list
20114095|NCT00004887|Mitomycins|mitomycins|mesh-list
19562910|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
19562911|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562912|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19562913|NCT02728440|Menotropins|menotropins|mesh-list
19562914|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562915|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562916|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19562917|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
19562918|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
19562919|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
20114096|NCT00004887|Mitomycin|mitomycin|mesh-list
19562920|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
19562921|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562922|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562923|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
19562924|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562925|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
19562926|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
19562927|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
19562928|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562929|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562930|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
19562931|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562932|NCT02728037|Lidocaine|lidocaine|mesh-list
19562933|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
19562934|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
19562935|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
19562936|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562937|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562938|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
20114097|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604671|NCT02228512|Pomalidomide|pomalidomide|mesh-list
19562939|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19562940|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19562941|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19562942|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19562943|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19562944|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562945|NCT02728037|Analgesics|analgesics|mesh-ancestor
19562946|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
19562947|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19562948|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19562949|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
19562950|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562951|NCT02728245|Dienogest|dienogest|mesh-list
19562952|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19562953|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
19562954|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19562955|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562956|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19562957|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19562958|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19562959|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19562960|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562961|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562962|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19562963|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562964|NCT02727712|Anesthetics|anesthetics|mesh-list
19562965|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19562966|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562967|NCT02727647|Factor VIII|factor viii|mesh-list
19562968|NCT02727647|Coagulants|coagulants|mesh-ancestor
19562969|NCT02727881|Squalamine|squalamine|mesh-list
19562970|NCT02727881|Ranibizumab|ranibizumab|mesh-list
19562971|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19562972|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19562973|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19562974|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19562975|NCT02727881|Growth Substances|growth substances|mesh-ancestor
19562976|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562977|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
19562978|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562979|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19562980|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19562981|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19562982|NCT02727881|Protective Agents|protective agents|mesh-ancestor
19562983|NCT02727738|Selenium|selenium|mesh-list
19562984|NCT02727738|Methimazole|methimazole|mesh-list
19562985|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
19562986|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19562987|NCT02727738|Protective Agents|protective agents|mesh-ancestor
19562988|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19562989|NCT02727738|Trace Elements|trace elements|mesh-ancestor
19562990|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
19562991|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
19562992|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
19562993|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19562994|NCT02727907|Interferons|interferons|mesh-list
19562995|NCT02727907|Interferon-beta|interferon-beta|mesh-list
19562996|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
19562997|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19562998|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
19562999|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563000|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
19563001|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563002|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19563003|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
19563004|NCT02727621|Propofol|propofol|mesh-list
19563005|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19563006|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563007|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563008|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19563009|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
19563010|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
19563011|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563012|NCT02727621|Analgesics|analgesics|mesh-ancestor
19563013|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
19563014|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563015|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19563016|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19563017|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19563018|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
19563019|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563020|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563021|NCT02727608|Eculizumab|eculizumab|mesh-list
19563022|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19563023|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563024|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
19563025|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563026|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
19563027|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
19563028|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
19563029|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19563030|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19563031|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563032|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563033|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577124|NCT04711824|Paclitaxel|paclitaxel|mesh-list
19577125|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19577126|NCT04711824|Cisplatin|cisplatin|mesh-list
19577127|NCT04711824|Carboplatin|carboplatin|mesh-list
19577128|NCT04711824|Capecitabine|capecitabine|mesh-list
19577129|NCT04711824|Durvalumab|durvalumab|mesh-list
19577130|NCT04711824|Olaparib|olaparib|mesh-list
19577131|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19577132|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114098|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114099|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577133|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577134|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577135|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577136|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577137|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577138|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
19577139|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
19577140|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577141|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577142|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577143|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
19577144|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577145|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577146|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19577147|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
19577148|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577149|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577150|NCT04697485|Eplerenone|eplerenone|mesh-list
20114100|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577151|NCT04697485|Bumetanide|bumetanide|mesh-list
19577152|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19577153|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
19577154|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577155|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577156|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19577157|NCT04697485|Diuretics|diuretics|mesh-ancestor
19577158|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
19577159|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19577160|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19577161|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19577162|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577163|NCT04686305|Carboplatin|carboplatin|mesh-list
19577164|NCT04686305|Trastuzumab|trastuzumab|mesh-list
19577165|NCT04686305|Pemetrexed|pemetrexed|mesh-list
19577166|NCT04686305|Durvalumab|durvalumab|mesh-list
19577167|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114101|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114102|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577168|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577169|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577170|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577171|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19563034|NCT02727504|Dobutamine|dobutamine|mesh-list
19563035|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19563036|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
19563037|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
19563038|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563039|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563040|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19563041|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19563042|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19563043|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
19563044|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563045|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563046|NCT02727504|Protective Agents|protective agents|mesh-ancestor
19563047|NCT02727309|Apatinib|apatinib|mesh-list
19563048|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563049|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19563050|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563051|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563052|NCT02727296|Propofol|propofol|mesh-list
19563053|NCT02727296|Sevoflurane|sevoflurane|mesh-list
19563054|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19563055|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563056|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563057|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19563058|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
19563059|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
19563060|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19563061|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19563062|NCT02727348|Anesthetics|anesthetics|mesh-list
19563063|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563064|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563065|NCT02726919|Clobazam|clobazam|mesh-list
19563066|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
19563067|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20114103|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114104|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
20114105|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20114106|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114107|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563068|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19563069|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563070|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563071|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19563072|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19563073|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
19563074|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
20114108|NCT00004889|Rituximab|rituximab|mesh-list
20114109|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20114110|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114111|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
20114112|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114113|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114114|NCT00004890|Aldesleukin|aldesleukin|mesh-list
20114115|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114116|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114117|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114118|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
20114119|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114120|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20114121|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20114122|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114123|NCT00004892|Carmustine|carmustine|mesh-list
20114124|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20114125|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114126|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
20114127|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114128|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114129|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114130|NCT00004893|Interleukin-12|interleukin-12|mesh-list
20114131|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20114132|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
19563075|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20114133|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563076|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563077|NCT02727205|Rotigotine|rotigotine|mesh-list
19563078|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
19563079|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
19563080|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563081|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563082|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563083|NCT02726867|Lacosamide|lacosamide|mesh-list
19563084|NCT02726867|Ketamine|ketamine|mesh-list
19563085|NCT02726867|Levetiracetam|levetiracetam|mesh-list
19563086|NCT02726867|Phenobarbital|phenobarbital|mesh-list
19563087|NCT02726867|Analgesics|analgesics|mesh-ancestor
19563088|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
19563089|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563090|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563091|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19563092|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19563093|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
19563094|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
19563095|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563096|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19563097|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19563098|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563099|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563100|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
19563101|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
19563102|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19563103|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19563104|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563105|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19563106|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
19563107|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
19563108|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19563109|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19563110|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19563111|NCT02726984|Listerine|listerine|mesh-list
19563112|NCT02726984|Fluorides|fluorides|mesh-list
20114134|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20114135|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20114136|NCT00004893|Growth Substances|growth substances|mesh-ancestor
20114137|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
20114138|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114139|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
20114140|NCT00004900|Thiotepa|thiotepa|mesh-list
20114141|NCT00004900|Carboplatin|carboplatin|mesh-list
19563113|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
19563114|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
19563115|NCT02726984|Protective Agents|protective agents|mesh-ancestor
19563116|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563117|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19563118|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563119|NCT02726854|Apatinib|apatinib|mesh-list
19563120|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563121|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19563122|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563123|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563124|NCT02726828|Ketamine|ketamine|mesh-list
19563125|NCT02726828|Morphine|morphine|mesh-list
19563126|NCT02726828|Analgesics|analgesics|mesh-ancestor
19563127|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
19563128|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563129|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563130|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19563131|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19563132|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
19563133|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
19563134|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563135|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19563136|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19563137|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20114142|NCT00004900|Etoposide|etoposide|mesh-list
20114143|NCT00004900|Anastrozole|anastrozole|mesh-list
19563138|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114144|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563139|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19563140|NCT02726828|Narcotics|narcotics|mesh-ancestor
19563141|NCT02726503|Lenvatinib|lenvatinib|mesh-list
20114145|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
20114146|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114147|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114148|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19563142|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563143|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19563144|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563145|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563146|NCT02726555|Atorvastatin|atorvastatin|mesh-list
19563147|NCT02726555|Red yeast rice|red yeast rice|mesh-list
19563148|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19563149|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19563150|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
19563151|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563152|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19563153|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19563154|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563155|NCT02726490|Metformin|metformin|mesh-list
19563156|NCT02726490|Glyburide|glyburide|mesh-list
19563157|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19563158|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563159|NCT02726737|Lidocaine|lidocaine|mesh-list
19563160|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
19563161|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
19563162|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563163|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563164|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
19563165|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563166|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19563167|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19563168|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19563169|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563170|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563171|NCT02726711|Trimethaphan|trimethaphan|mesh-list
19563172|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
19563173|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19563174|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19563175|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19563176|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
19563177|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563178|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563179|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19563180|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19563181|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
19563182|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563183|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563184|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
19563185|NCT02726646|Doxycycline|doxycycline|mesh-list
19563186|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19563187|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563188|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
19563189|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19563190|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19563191|NCT02726308|Dexamethasone|dexamethasone|mesh-list
19563192|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19563193|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
19563194|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
19563195|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563196|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563197|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19563198|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
19563199|NCT02726308|Hormones|hormones|mesh-ancestor
19563200|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19563201|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19563202|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563203|NCT02726269|Ofloxacin|ofloxacin|mesh-list
19563204|NCT02726269|Levofloxacin|levofloxacin|mesh-list
19563205|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19563206|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563207|NCT02726269|Renal Agents|renal agents|mesh-ancestor
19563208|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19563209|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19563210|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563211|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114149|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
19577172|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19563212|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563213|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563214|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19563215|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19563216|NCT02726126|Fentanyl|fentanyl|mesh-list
19563217|NCT02726126|Melatonin|melatonin|mesh-list
19563218|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19563219|NCT02726126|Narcotics|narcotics|mesh-ancestor
19563220|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563221|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563222|NCT02726126|Analgesics|analgesics|mesh-ancestor
19563223|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
19563224|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563225|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19563226|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19563227|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
19563228|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
19563229|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
19563230|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563231|NCT02726126|Protective Agents|protective agents|mesh-ancestor
19563232|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19563233|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
19563234|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563235|NCT02726035|Naltrexone|naltrexone|mesh-list
19563236|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19563237|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19563238|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563239|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
19563240|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563241|NCT02725736|Nifedipine|nifedipine|mesh-list
19563242|NCT02725736|Atosiban|atosiban|mesh-list
19563243|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19563244|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563245|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563246|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19563247|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563248|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
19563249|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
19563250|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19563251|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
19563252|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19563253|NCT02725918|Pemetrexed|pemetrexed|mesh-list
19563254|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563255|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563256|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563257|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19563258|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19577173|NCT04672525|Rifampin|rifampin|mesh-list
19577174|NCT04672525|Rifabutin|rifabutin|mesh-list
19577175|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19577176|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
19577177|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19577178|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577179|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
19577180|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19577181|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577182|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577183|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19577184|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19577185|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19577186|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19577187|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19577188|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19577189|NCT04650581|Fulvestrant|fulvestrant|mesh-list
19577190|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577191|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577192|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19577193|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19577194|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
19577195|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577196|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577197|NCT04650269|Emtricitabine|emtricitabine|mesh-list
19563259|NCT02725541|Trastuzumab|trastuzumab|mesh-list
19563260|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19563261|NCT02725541|Maytansine|maytansine|mesh-list
19563262|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19563263|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563264|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19563265|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
19563266|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
19563267|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
19563268|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563269|NCT02725502|Linagliptin|linagliptin|mesh-list
19563270|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19563271|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563272|NCT02725502|Incretins|incretins|mesh-ancestor
19563273|NCT02725502|Hormones|hormones|mesh-ancestor
19563274|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19563275|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19563276|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
20604672|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604673|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
20604674|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604675|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20604676|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20604677|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
20114150|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114151|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563277|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563278|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563279|NCT02725398|Scopolamine|scopolamine|mesh-list
19563280|NCT02725398|Bromides|bromides|mesh-list
19563281|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19563282|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
19563283|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19563284|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
19563285|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
19563286|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563287|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563288|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19563289|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
20114152|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20114153|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114154|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114155|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114156|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114157|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20114158|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20114159|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20114160|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20114161|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
20114162|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20114163|NCT00004901|Fluorouracil|fluorouracil|mesh-list
20114164|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
20114165|NCT00004901|Eniluracil|eniluracil|mesh-list
20114166|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
20114167|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114168|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114169|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114170|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114171|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
20114172|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114173|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
20114174|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114175|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19563290|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20604678|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604679|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604680|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20604681|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604682|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20604683|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20604684|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563291|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
19563292|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563293|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563294|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19563295|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
19563296|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
19563297|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19563298|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
19563299|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563300|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563301|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20114176|NCT00004903|Interferons|interferons|mesh-list
20114177|NCT00004903|Cytarabine|cytarabine|mesh-list
20114178|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
20114179|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
20114180|NCT00004903|Melphalan|melphalan|mesh-list
19563302|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
19563303|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19563304|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
19563305|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563306|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563307|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19563308|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
19563309|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
19563310|NCT02725372|Protective Agents|protective agents|mesh-ancestor
19563311|NCT02725255|Albendazole|albendazole|mesh-list
19563312|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
19563313|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19563314|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563315|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
19563316|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19563317|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19563318|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
19563319|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
19563320|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
19563321|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563322|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563323|NCT02725424|Docetaxel|docetaxel|mesh-list
19563324|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
19563325|NCT02725424|Trastuzumab|trastuzumab|mesh-list
19563326|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563327|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
19563328|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
19563329|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
19563330|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563331|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19563332|NCT02725359|Tizanidine|tizanidine|mesh-list
19563333|NCT02725359|Bupivacaine|bupivacaine|mesh-list
19563334|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
19563335|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
19563336|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563337|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563338|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
19563339|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563340|NCT02725359|Analgesics|analgesics|mesh-ancestor
19563341|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
19563342|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19563343|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19563344|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
19563345|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
19563346|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19563347|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19563348|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19563349|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
20114181|NCT00004903|Etoposide|etoposide|mesh-list
20114182|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114183|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
20114184|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114185|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114186|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114187|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
20114188|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563350|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563351|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563352|NCT02725489|Durvalumab|durvalumab|mesh-list
20114189|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114190|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19563353|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19563354|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563355|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
19563356|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
19563357|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
19563358|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563359|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563360|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
19563361|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563362|NCT02725242|Budesonide|budesonide|mesh-list
19563363|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
19563364|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19563365|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19563366|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
19563367|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563368|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563369|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20114191|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114192|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114193|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114194|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114195|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
20114196|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114197|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114198|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
20114199|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
20114200|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
20114201|NCT00004904|Etoposide|etoposide|mesh-list
20114202|NCT00004904|Cladribine|cladribine|mesh-list
20114203|NCT00004904|Tacrolimus|tacrolimus|mesh-list
20114204|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20114205|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114206|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
19563370|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
19563371|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
19563372|NCT02725242|Hormones|hormones|mesh-ancestor
19563373|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19563374|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19563375|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19563376|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19563377|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
19563378|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563379|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563380|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
19563381|NCT02725164|Sevoflurane|sevoflurane|mesh-list
19563382|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19563383|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20114207|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114208|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114209|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114210|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
20114211|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114212|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114213|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20114214|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604685|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604686|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20604687|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
20604688|NCT02228512|Hormones|hormones|mesh-ancestor
20604689|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604690|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20604691|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604692|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604693|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
20604694|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604695|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20604696|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19563384|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
19563385|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
19563386|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563387|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114215|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114216|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19577198|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
20604697|NCT02228512|Growth Substances|growth substances|mesh-ancestor
19563388|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563389|NCT02725164|Analgesics|analgesics|mesh-ancestor
19563390|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
19563391|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563392|NCT02725099|Ticagrelor|ticagrelor|mesh-list
19563393|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19563394|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19563395|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19563396|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19563397|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
19563398|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563399|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563400|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563401|NCT02724904|Methotrexate|methotrexate|mesh-list
19563402|NCT02724904|Fludarabine|fludarabine|mesh-list
19563403|NCT02724904|Thiotepa|thiotepa|mesh-list
19563404|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19563405|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
19563406|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19563407|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563408|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563409|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
19563410|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563411|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563412|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
19563413|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563414|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19563415|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563416|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
20114217|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114218|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20114219|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20114220|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
20114221|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
20114222|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20114223|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20114224|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
20114225|NCT00004904|Hormones|hormones|mesh-ancestor
19563417|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563418|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19563419|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19563420|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
19563421|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19563422|NCT02725112|Pregabalin|pregabalin|mesh-list
19563423|NCT02725112|Analgesics|analgesics|mesh-ancestor
19563424|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
19563425|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563426|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563427|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
19563428|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19563429|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563430|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563431|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19563432|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19563433|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19563434|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563435|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19563436|NCT02725060|Phenylephrine|phenylephrine|mesh-list
19563437|NCT02725060|Isoproterenol|isoproterenol|mesh-list
19563438|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
19563439|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19563440|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
19563441|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
19563442|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563443|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563444|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
19563445|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19563446|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
19563447|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
19563448|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19563449|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19563450|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19563451|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
19563452|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563453|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563454|NCT02725060|Protective Agents|protective agents|mesh-ancestor
19563455|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19563456|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19563457|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19563458|NCT02724761|Epinephrine|epinephrine|mesh-list
19563459|NCT02724761|Racepinephrine|racepinephrine|mesh-list
19563460|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
19563461|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19563462|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19563463|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
19563464|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563465|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563466|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563467|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19563468|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19563469|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
19563470|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563471|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19563472|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
19563473|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
19563474|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
19563475|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19563476|NCT02724618|Curcumin|curcumin|mesh-list
19563477|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19563478|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563479|NCT02724618|Analgesics|analgesics|mesh-ancestor
19563480|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
19563481|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563482|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563483|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19563484|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563485|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563486|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563487|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563488|NCT02724332|Sirolimus|sirolimus|mesh-list
19563489|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19563490|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563491|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19563492|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563493|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
19563494|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563495|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
19563496|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563497|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
19563498|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19563499|NCT02724358|Estrogens|estrogens|mesh-ancestor
19563500|NCT02724358|Hormones|hormones|mesh-ancestor
19563501|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19563502|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563503|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19563504|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563505|NCT02724202|Curcumin|curcumin|mesh-list
19563506|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20114226|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20114227|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20114228|NCT00004904|Protective Agents|protective agents|mesh-ancestor
20114229|NCT00004905|Interferons|interferons|mesh-list
20114230|NCT00004905|Cytarabine|cytarabine|mesh-list
20114231|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
20114232|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
20114233|NCT00004905|Etoposide|etoposide|mesh-list
20114234|NCT00004905|Idarubicin|idarubicin|mesh-list
20114235|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114236|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
20114237|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114238|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114239|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114240|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
20114241|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114242|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114243|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20114244|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114245|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19563507|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563508|NCT02724202|Analgesics|analgesics|mesh-ancestor
20114246|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114247|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114248|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
20114249|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114250|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114251|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
20114252|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20114253|NCT00004906|Pamidronate|pamidronate|mesh-list
20114254|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
20114255|NCT00004906|Thiotepa|thiotepa|mesh-list
20114256|NCT00004906|Carboplatin|carboplatin|mesh-list
20114257|NCT00004906|Docetaxel|docetaxel|mesh-list
20114258|NCT00004906|Doxorubicin|doxorubicin|mesh-list
20114259|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20114260|NCT00004906|Etoposide|etoposide|mesh-list
20114261|NCT00004906|Anastrozole|anastrozole|mesh-list
20114262|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114263|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
20114264|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114265|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114266|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19563509|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
19563510|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563511|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563512|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19563513|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563514|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563515|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563516|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604698|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
20604699|NCT02228616|Lactulose|lactulose|mesh-list
19563517|NCT02724150|Omeprazole|omeprazole|mesh-list
20114267|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
20114268|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114269|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114270|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20114271|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
19563518|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19563519|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19563520|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19563521|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563522|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563523|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
19563524|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19563525|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563526|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563527|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563528|NCT02724098|Analgesics|analgesics|mesh-ancestor
19563529|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
19563530|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563531|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19563532|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19563533|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20114272|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114273|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114274|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20604700|NCT02228616|Prucalopride|prucalopride|mesh-list
19563534|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
19563535|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563536|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563537|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
19563538|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19563539|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563540|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19563541|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563542|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563543|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563544|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563545|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19563546|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19563547|NCT02724293|Pregabalin|pregabalin|mesh-list
19563548|NCT02724293|Analgesics|analgesics|mesh-ancestor
20114275|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114276|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20604701|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20604702|NCT02228616|Laxatives|laxatives|mesh-ancestor
19563549|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
19563550|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563551|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563552|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
19563553|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19563554|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563555|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563556|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19563557|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19563558|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19563559|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563560|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19563561|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19577199|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577200|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114277|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114278|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114279|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20114280|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20114281|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20114282|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20114283|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
20114284|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20114285|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20114286|NCT00004913|Leucovorin|leucovorin|mesh-list
20114287|NCT00004913|Docetaxel|docetaxel|mesh-list
20114288|NCT00004913|Fluorouracil|fluorouracil|mesh-list
20114289|NCT00004913|Calcium|calcium|mesh-list
20114290|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
20114291|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577201|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19577202|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577203|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577204|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19577205|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19577206|NCT04646005|Cemiplimab|cemiplimab|mesh-list
19577207|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577208|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577209|NCT04644289|Durvalumab|durvalumab|mesh-list
19577210|NCT04644289|Olaparib|olaparib|mesh-list
19577211|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577212|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577213|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19577214|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577215|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577216|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
19577217|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20114292|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114293|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114294|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114295|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114296|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114297|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114298|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
20114299|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114300|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114301|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
20114302|NCT00004913|Antidotes|antidotes|mesh-ancestor
20114303|NCT00004913|Protective Agents|protective agents|mesh-ancestor
20114304|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
20114305|NCT00004913|Vitamins|vitamins|mesh-ancestor
20114306|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
20114307|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
19563562|NCT02724163|Cytarabine|cytarabine|mesh-list
19563563|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
19563564|NCT02724163|Busulfan|busulfan|mesh-list
19563565|NCT02724163|Fludarabine|fludarabine|mesh-list
19563566|NCT02724163|Daunorubicin|daunorubicin|mesh-list
19563567|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
19563568|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
19563569|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563570|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
19563571|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563572|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563573|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19563574|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
19563575|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563576|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563577|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19563578|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563579|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
19563580|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
19563581|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563582|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19563583|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19563584|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563585|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563586|NCT02724163|Analgesics|analgesics|mesh-ancestor
19563587|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
19563588|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563589|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19563590|NCT02723981|Vitamins|vitamins|mesh-list
19563591|NCT02723981|Vitamin K|vitamin k|mesh-list
19563592|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
19563593|NCT02723981|Dabigatran|dabigatran|mesh-list
19563594|NCT02723981|Anticoagulants|anticoagulants|mesh-list
19563595|NCT02723981|Clopidogrel|clopidogrel|mesh-list
19563596|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
19563597|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563598|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19563599|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19563600|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20114308|NCT00004917|Hematinics|hematinics|mesh-ancestor
20114309|NCT00004918|Sargramostim|sargramostim|mesh-list
20114310|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
20114311|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114312|NCT00004919|Irinotecan|irinotecan|mesh-list
20114313|NCT00004919|Amifostine|amifostine|mesh-list
20114314|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114315|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114316|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114317|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114318|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114319|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20114320|NCT00004919|Protective Agents|protective agents|mesh-ancestor
20114321|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114322|NCT00004920|Raltitrexed|raltitrexed|mesh-list
20114323|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114324|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114325|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
19563601|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19563602|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
19563603|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563604|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563605|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19563606|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
19563607|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19563608|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
19563609|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563610|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19563611|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19563612|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
19563613|NCT02723981|Coagulants|coagulants|mesh-ancestor
19563614|NCT02723903|Fluoxetine|fluoxetine|mesh-list
19563615|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19563616|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19563617|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563618|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563619|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563620|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
19563621|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563622|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19563623|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
19563624|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19563625|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19563626|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19563627|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563628|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
19563629|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19563630|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563631|NCT02723578|Pemetrexed|pemetrexed|mesh-list
19563632|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19563633|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563634|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563635|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563636|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19563637|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19563638|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19563639|NCT02723838|Gemcitabine|gemcitabine|mesh-list
19563640|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563641|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563642|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
19563643|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563644|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
19563645|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563646|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114326|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114327|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20114328|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114329|NCT00004921|Paclitaxel|paclitaxel|mesh-list
20114330|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
20114331|NCT00004921|Carboplatin|carboplatin|mesh-list
20114332|NCT00004921|Melphalan|melphalan|mesh-list
20114333|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114334|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114335|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114336|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114337|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114338|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114339|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114340|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
19563647|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563648|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
19563649|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563650|NCT02723500|Xenon|xenon|mesh-list
19563651|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19563652|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
19563653|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
19563654|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563655|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563656|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
19563657|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19563658|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
19563659|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563660|NCT02723669|Expectorants|expectorants|mesh-ancestor
19563661|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
19563662|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19563663|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
19563664|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563665|NCT02723669|Protective Agents|protective agents|mesh-ancestor
19563666|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563667|NCT02723669|Antidotes|antidotes|mesh-ancestor
19563668|NCT02723513|Xenon|xenon|mesh-list
19563669|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19563670|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
19563671|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
19563672|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563673|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563674|NCT02723461|Oxytocin|oxytocin|mesh-list
19563675|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
19563676|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19563677|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114341|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563678|NCT02723487|Bupivacaine|bupivacaine|mesh-list
19563679|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
19563680|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
19563681|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563682|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563683|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
19563684|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563685|NCT02723448|Aclarubicin|aclarubicin|mesh-list
19563686|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
19563687|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19563688|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563689|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19563690|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563691|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563692|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563693|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19563694|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
19563695|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563696|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19563697|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19563698|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19563699|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
19563700|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563701|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563702|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563703|NCT02723279|Urological Agents|urological agents|mesh-ancestor
19563704|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
19563705|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
19563706|NCT02723266|Protective Agents|protective agents|mesh-ancestor
19563707|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563708|NCT02723253|Raltitrexed|raltitrexed|mesh-list
19563709|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563710|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563711|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
19563712|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563713|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19563714|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563715|NCT02723383|Baclofen|baclofen|mesh-list
19563716|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19563717|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563718|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19563719|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563720|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19563721|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
19563722|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
19563723|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563724|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114342|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114343|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114344|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
20114345|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20114346|NCT00004922|Irinotecan|irinotecan|mesh-list
20114347|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114348|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114349|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114350|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114351|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114352|NCT00004923|Docetaxel|docetaxel|mesh-list
20114353|NCT00004923|Irinotecan|irinotecan|mesh-list
19563725|NCT02723435|Midostaurin|midostaurin|mesh-list
19563726|NCT02723435|Staurosporine|staurosporine|mesh-list
19563727|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563728|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19563729|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563730|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563731|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
19563732|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19563733|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563734|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
19563735|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
19563736|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563737|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19563738|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19563739|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19563740|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19563741|NCT02722811|Etanercept|etanercept|mesh-list
20114354|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114355|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114356|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114357|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114358|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114359|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114360|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114361|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114362|NCT00004924|Paclitaxel|paclitaxel|mesh-list
20114363|NCT00004924|Irinotecan|irinotecan|mesh-list
20114364|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114365|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563742|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19563743|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563744|NCT02722811|Analgesics|analgesics|mesh-ancestor
19563745|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
19563746|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563747|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563748|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19563749|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563750|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19563751|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563752|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
19563753|NCT02722538|Gemcitabine|gemcitabine|mesh-list
19563754|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563755|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
19563756|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563757|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563758|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
19563759|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563760|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563761|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563762|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
19563763|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563764|NCT02722746|Epinephrine|epinephrine|mesh-list
20114366|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114367|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114368|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114369|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563765|NCT02722746|Ropivacaine|ropivacaine|mesh-list
19563766|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
19563767|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
19563768|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563769|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563770|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
19563771|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563772|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19563773|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19563774|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
19563775|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563776|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563777|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19563778|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19563779|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
19563780|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19563781|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
19563782|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
19563783|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
19563784|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20114370|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114371|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563787|NCT02722772|Etanercept|etanercept|mesh-list
19563788|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19563789|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563790|NCT02722772|Analgesics|analgesics|mesh-ancestor
19563791|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
19563792|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20114372|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114373|NCT00004925|Doxorubicin|doxorubicin|mesh-list
20114374|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20114375|NCT00004925|Trastuzumab|trastuzumab|mesh-list
20114376|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20114377|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563793|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749066|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19563794|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19563795|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563796|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19563797|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563798|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
19563799|NCT02722733|Cytarabine|cytarabine|mesh-list
19563800|NCT02722733|Lenograstim|lenograstim|mesh-list
19563801|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19563802|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
19563803|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563804|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563805|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
19563806|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563807|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563808|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
19563809|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563810|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563811|NCT02722694|Methotrexate|methotrexate|mesh-list
19563812|NCT02722694|Abatacept|abatacept|mesh-list
19563813|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19563814|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
19563815|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19563816|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563817|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563818|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
19563819|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563820|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563821|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
19563822|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563823|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19563824|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563825|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
19563826|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563827|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19563828|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19563829|NCT02722603|Gabapentin|gabapentin|mesh-list
19563830|NCT02722603|Tramadol|tramadol|mesh-list
19563831|NCT02722603|Analgesics|analgesics|mesh-ancestor
19563832|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
19563833|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563834|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563835|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
19563836|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19563837|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19563838|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563839|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19563840|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19563841|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19563842|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20114378|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114379|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563843|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563844|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
19563845|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19563846|NCT02722603|Narcotics|narcotics|mesh-ancestor
19563847|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
19563848|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19563849|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
19563850|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19563851|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
19563852|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563853|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563854|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
20114380|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114381|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114382|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20114383|NCT00004926|Vitamin D|vitamin d|mesh-list
20114384|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
20114385|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
20114386|NCT00004926|Vitamins|vitamins|mesh-ancestor
20114387|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
20114388|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114389|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19563855|NCT02722421|Efavirenz|efavirenz|mesh-list
20114390|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19563856|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
19563857|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19563858|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19563859|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114391|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114392|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
20114393|NCT00004928|Calcitriol|calcitriol|mesh-list
20114394|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20114395|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114396|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114397|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20114398|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20114399|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114400|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20114401|NCT00004928|Vitamins|vitamins|mesh-ancestor
20114402|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
20114403|NCT00004930|Doxorubicin|doxorubicin|mesh-list
20604703|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20604704|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20604705|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
20604706|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604707|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604708|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604709|NCT02228772|Cytarabine|cytarabine|mesh-list
20604710|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
20604711|NCT02228772|Doxorubicin|doxorubicin|mesh-list
20604712|NCT02228772|Methotrexate|methotrexate|mesh-list
19563860|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114404|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20114405|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20114406|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114407|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114408|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114409|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114410|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114411|NCT00004931|Leucovorin|leucovorin|mesh-list
20114412|NCT00004931|Fluorouracil|fluorouracil|mesh-list
20114413|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
19563861|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
20114414|NCT00004931|Calcium|calcium|mesh-list
20114415|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
20114416|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114417|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114418|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
20114419|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114420|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114421|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114422|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114423|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
19563862|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563863|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19563864|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19563865|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19563866|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19563867|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19563868|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19563869|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19563870|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
19563871|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19563872|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563873|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19563874|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19563875|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19563876|NCT02722369|Gemcitabine|gemcitabine|mesh-list
19563877|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
19563878|NCT02722369|Carboplatin|carboplatin|mesh-list
19563879|NCT02722369|Etoposide|etoposide|mesh-list
19563880|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563881|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19563882|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
19563883|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114424|NCT00004931|Antidotes|antidotes|mesh-ancestor
20114425|NCT00004931|Protective Agents|protective agents|mesh-ancestor
20114426|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
20114427|NCT00004931|Vitamins|vitamins|mesh-ancestor
19563884|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
19563885|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563886|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563887|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19563888|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
19563889|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563890|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114428|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
20114429|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
20114430|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604713|NCT02228772|Vincristine|vincristine|mesh-list
19563891|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19563892|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19563893|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
19563894|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19563895|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19563896|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563897|NCT02722356|Oxytocin|oxytocin|mesh-list
19563898|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
19563899|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19563900|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563901|NCT02722343|Tenofovir|tenofovir|mesh-list
19563902|NCT02722343|Emtricitabine|emtricitabine|mesh-list
19563903|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19563904|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
19563905|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563906|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19563907|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19563908|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563909|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563910|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19563911|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19577218|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19577219|NCT04629248|Acetaminophen|acetaminophen|mesh-list
19577220|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
19577221|NCT04629248|Promethazine|promethazine|mesh-list
20114431|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20114432|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114433|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114434|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
20114435|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
20114436|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114437|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
20114438|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114439|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577222|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
19577223|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
19577224|NCT04629248|Tacrolimus|tacrolimus|mesh-list
19577225|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577226|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
19577227|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577228|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19577229|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577230|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577231|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19577232|NCT04629248|Analgesics|analgesics|mesh-ancestor
19577233|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
19577234|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577235|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
19577236|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20604714|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
20604715|NCT02228772|Ixazomib|ixazomib|mesh-list
20604716|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604717|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
19577237|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
19577238|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
19577239|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19577240|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
19577241|NCT04629248|Hormones|hormones|mesh-ancestor
19577242|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577243|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19577244|NCT04629248|Protective Agents|protective agents|mesh-ancestor
19577245|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604718|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577246|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577247|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20604719|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19563912|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
19563913|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563914|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
19563915|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
19563916|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19563917|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
19563918|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
19563919|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19563920|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563921|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19563922|NCT02722096|Lidocaine|lidocaine|mesh-list
19563923|NCT02722096|Ropivacaine|ropivacaine|mesh-list
19563924|NCT02722096|Anesthetics|anesthetics|mesh-list
19563925|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
19563926|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563927|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563928|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
19563929|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563930|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19563931|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19563932|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19563933|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563934|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114440|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114441|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114442|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20114443|NCT00004934|Paclitaxel|paclitaxel|mesh-list
20114444|NCT00004934|Carboplatin|carboplatin|mesh-list
20114445|NCT00004934|Epirubicin|epirubicin|mesh-list
20114446|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114447|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114448|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
19563935|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
19563936|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19563937|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563938|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19563939|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19563940|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19563941|NCT02721888|Liraglutide|liraglutide|mesh-list
19563942|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19563943|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563944|NCT02721888|Incretins|incretins|mesh-ancestor
19563945|NCT02721888|Hormones|hormones|mesh-ancestor
19563946|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19563947|NCT02721511|Furosemide|furosemide|mesh-list
19563948|NCT02721511|Diuretics|diuretics|mesh-ancestor
19563949|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
19563950|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563951|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19563952|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563953|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563954|NCT02721420|Piperaquine|piperaquine|mesh-list
19563955|NCT02721420|Artenimol|artenimol|mesh-list
19563956|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
19563957|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19563958|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19563959|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19563960|NCT02721368|Lidocaine|lidocaine|mesh-list
19563961|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
19563962|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
19563963|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19563964|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563965|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
20114449|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114450|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114451|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114452|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20114453|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114454|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114455|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19563966|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20114456|NCT00004938|Fluconazole|fluconazole|mesh-list
20114457|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
20114458|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114459|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19563967|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19563968|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19563969|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19563970|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19563971|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19563972|NCT02721329|Acetaminophen|acetaminophen|mesh-list
20114460|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20114461|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114462|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604720|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20604721|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
19563973|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19563974|NCT02721329|Analgesics|analgesics|mesh-ancestor
19563975|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
19563976|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19563977|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563978|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
19563979|NCT02721433|Denosumab|denosumab|mesh-list
19563980|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
19563981|NCT02721433|Pamidronate|pamidronate|mesh-list
19563982|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19563983|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563984|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
19563985|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19563986|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19563987|NCT02721043|Lenalidomide|lenalidomide|mesh-list
19563988|NCT02721043|Vaccines|vaccines|mesh-list
19563989|NCT02721043|Poly ICLC|poly iclc|mesh-list
19563990|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
19563991|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19563992|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19563993|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19563994|NCT02721043|Growth Substances|growth substances|mesh-ancestor
19563995|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
19563996|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19563997|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
19563998|NCT02721290|Ropivacaine|ropivacaine|mesh-list
19563999|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19564000|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
19564001|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564002|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564003|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
19564004|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564005|NCT02721082|Nicotine|nicotine|mesh-list
19564006|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19564007|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
19564008|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564009|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114463|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20114464|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
20114465|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20114466|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564010|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19564011|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19564012|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
19564013|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564014|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564015|NCT02721173|Clindamycin|clindamycin|mesh-list
19564016|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
19564017|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
19564018|NCT02721173|Adapalene|adapalene|mesh-list
19564019|NCT02721173|Tazarotene|tazarotene|mesh-list
19564020|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19564021|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564022|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19564023|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564024|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564025|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19564026|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564027|NCT02721173|Analgesics|analgesics|mesh-ancestor
19564028|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
19564029|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564030|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749067|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
19564031|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564032|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564033|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564034|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
19564035|NCT02721186|Piperaquine|piperaquine|mesh-list
19564036|NCT02721186|Primaquine|primaquine|mesh-list
19564037|NCT02721186|Artenimol|artenimol|mesh-list
19564038|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
19564039|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19564040|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19564041|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564042|NCT02720978|Oxytocin|oxytocin|mesh-list
19564043|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
19564044|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564045|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564046|NCT02720991|Misoprostol|misoprostol|mesh-list
19564047|NCT02720991|Mifepristone|mifepristone|mesh-list
19564048|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19564049|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
19564050|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564051|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564052|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19564053|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19564054|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
19564055|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19564056|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19564057|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19564058|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19564059|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
20114467|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20114468|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20114469|NCT00004941|Infliximab|infliximab|mesh-list
20114470|NCT00004941|Antibodies|antibodies|mesh-list
20114471|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20114472|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
20114473|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114474|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
20114475|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20114476|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114477|NCT00004979|Paclitaxel|paclitaxel|mesh-list
20114478|NCT00004979|Topotecan|topotecan|mesh-list
20114479|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114480|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114481|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114482|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114483|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114484|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114485|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114486|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114487|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114488|NCT00004981|Lamivudine|lamivudine|mesh-list
20114489|NCT00004981|Zidovudine|zidovudine|mesh-list
20114490|NCT00004981|Abacavir|abacavir|mesh-list
20114491|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
20114492|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19564060|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19564061|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19564062|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
19564063|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564064|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
19564065|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19564066|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19564067|NCT02720822|Morphine|morphine|mesh-list
19564068|NCT02720822|Laxatives|laxatives|mesh-list
20114493|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114494|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114495|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114496|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114497|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
20114498|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564069|NCT02720822|Cathartics|cathartics|mesh-list
20114499|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114500|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19564070|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19564071|NCT02720822|Narcotics|narcotics|mesh-ancestor
19749068|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
20114501|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
20114502|NCT00004984|Insulin|insulin|mesh-list
19564072|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564073|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564074|NCT02720822|Analgesics|analgesics|mesh-ancestor
19564075|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
19564076|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564077|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19564078|NCT02720770|Hormones|hormones|mesh-list
19564079|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564080|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564081|NCT02720926|Capecitabine|capecitabine|mesh-list
19564082|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
19564083|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564084|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
19564085|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564086|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564087|NCT02720965|Anesthetics|anesthetics|mesh-list
19564088|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
19564089|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564090|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564091|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
19564092|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564093|NCT02720783|Econazole|econazole|mesh-list
19564094|NCT02720783|Benzydamine|benzydamine|mesh-list
19564095|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564096|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
19564097|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564098|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19564099|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19564100|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564101|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114503|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19564102|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19564103|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
19564104|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564105|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564106|NCT02720692|Meloxicam|meloxicam|mesh-list
19564107|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19564108|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564109|NCT02720692|Analgesics|analgesics|mesh-ancestor
19564110|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
19564111|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564112|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749069|NCT05294588|Cefixime|cefixime|mesh-list
20114504|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20114505|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114506|NCT00004985|Nelfinavir|nelfinavir|mesh-list
20114507|NCT00004985|Capravirine|capravirine|mesh-list
20114508|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20114509|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20114510|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
20114511|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114512|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114513|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114514|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114515|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
20114516|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114517|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114518|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114519|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
20114520|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20114521|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114522|NCT00004990|Dexamethasone|dexamethasone|mesh-list
20114523|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20114524|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
20114525|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
20114526|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20114527|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114528|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20114529|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
20114530|NCT00004990|Hormones|hormones|mesh-ancestor
20114531|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20114532|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20114533|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114534|NCT00004992|Metformin|metformin|mesh-list
19564113|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564114|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564115|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19564116|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19564117|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564118|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564119|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
19564120|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19564121|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20114535|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20114536|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114537|NCT00004993|Hormones|hormones|mesh-list
19564122|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564123|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564124|NCT02720705|Analgesics|analgesics|mesh-ancestor
19564125|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
19564126|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564127|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19564128|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19564129|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19564130|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
19564131|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564132|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564133|NCT02720471|Anesthetics|anesthetics|mesh-list
19564134|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
19564135|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564136|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564137|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
19564138|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564139|NCT02720601|Capecitabine|capecitabine|mesh-list
19564140|NCT02720601|Irinotecan|irinotecan|mesh-list
19564141|NCT02720601|Camptothecin|camptothecin|mesh-list
19564142|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564143|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
19564144|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564145|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564146|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19564147|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19564148|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564149|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19564150|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19564151|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564152|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564153|NCT02720575|Vitamin D|vitamin d|mesh-list
19564154|NCT02720575|Vitamins|vitamins|mesh-ancestor
19564155|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
19564156|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564157|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20114538|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
20114539|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20114540|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114541|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114542|NCT00004997|Leucovorin|leucovorin|mesh-list
19577248|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19577249|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577250|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
19577251|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
19577252|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19577253|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
19577254|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
19577255|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577256|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19577257|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
19577258|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577259|NCT04626128|Aflibercept|aflibercept|mesh-list
19577260|NCT04626128|Axitinib|axitinib|mesh-list
20114543|NCT00004997|Antidotes|antidotes|mesh-ancestor
20114544|NCT00004997|Protective Agents|protective agents|mesh-ancestor
20114545|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114546|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
20114547|NCT00004997|Vitamins|vitamins|mesh-ancestor
20114548|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
20114549|NCT00004998|Lamivudine|lamivudine|mesh-list
20114550|NCT00004998|Zidovudine|zidovudine|mesh-list
20114551|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20114552|NCT00004998|Capravirine|capravirine|mesh-list
19564158|NCT02720406|Ketamine|ketamine|mesh-list
19564159|NCT02720406|Analgesics|analgesics|mesh-ancestor
19564160|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
19564161|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564162|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564163|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19564164|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20114553|NCT00004998|Nelfinavir|nelfinavir|mesh-list
20114554|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114555|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114556|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114557|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114558|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
20114559|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114560|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114561|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114562|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
20114563|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20114564|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20114565|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
20114566|NCT00004999|Lamivudine|lamivudine|mesh-list
20114567|NCT00004999|Zidovudine|zidovudine|mesh-list
20114568|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20114569|NCT00004999|Capravirine|capravirine|mesh-list
20114570|NCT00004999|Nelfinavir|nelfinavir|mesh-list
20114571|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114572|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114573|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114574|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114575|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
19564165|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
19564166|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
19564167|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564168|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19564169|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19564170|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564171|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564172|NCT02720367|Gemcitabine|gemcitabine|mesh-list
19564173|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564174|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
19564175|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564176|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564177|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
19564178|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564179|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564180|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564181|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
19564182|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564183|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
19564184|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
19564185|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564186|NCT02720094|Cabotegravir|cabotegravir|mesh-list
19564187|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19564188|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19564189|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564190|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564191|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19564192|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19564193|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
19564194|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564195|NCT02720341|Armin|armin|mesh-list
19564196|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19564197|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564198|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564199|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
19564200|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20114576|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114577|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114578|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114579|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
20114580|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20114581|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20114582|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
19564201|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114583|NCT00005000|Lamivudine|lamivudine|mesh-list
20114584|NCT00005000|Zidovudine|zidovudine|mesh-list
20114585|NCT00005000|Efavirenz|efavirenz|mesh-list
20114586|NCT00005000|Stavudine|stavudine|mesh-list
20114587|NCT00005000|Didanosine|didanosine|mesh-list
19564202|NCT02719756|Metformin|metformin|mesh-list
19564203|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
19564204|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19564205|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564206|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19564207|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564208|NCT02719795|Ropivacaine|ropivacaine|mesh-list
19564209|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
19564210|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
19564211|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564212|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564213|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
19564214|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564215|NCT02719834|Acetaminophen|acetaminophen|mesh-list
19564216|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564217|NCT02719834|Analgesics|analgesics|mesh-ancestor
19564218|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
19564219|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564220|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564221|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
19564222|NCT02719808|Tenofovir|tenofovir|mesh-list
19564223|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
19564224|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114588|NCT00005000|Nelfinavir|nelfinavir|mesh-list
20114589|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20114590|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19564225|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19564226|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19564227|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564228|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564229|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19564230|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19564231|NCT02719574|Cytarabine|cytarabine|mesh-list
19564232|NCT02719574|Azacitidine|azacitidine|mesh-list
19564233|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564234|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
19564235|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564236|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564237|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
19564238|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564239|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564240|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
19564241|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564242|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564243|NCT02719405|Caseins|caseins|mesh-list
19564244|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
20114591|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114592|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114593|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114594|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
20114595|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114596|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114597|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114598|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
20114599|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20114600|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20114601|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20114602|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20114603|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20114604|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20114605|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20114606|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20114607|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
20114608|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20114609|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
20114610|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114611|NCT00005002|Lamivudine|lamivudine|mesh-list
20114612|NCT00005002|Zidovudine|zidovudine|mesh-list
19564245|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
19564246|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564247|NCT02719418|Tinzaparin|tinzaparin|mesh-list
20114613|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20114614|NCT00005002|Nelfinavir|nelfinavir|mesh-list
20114615|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114616|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114617|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114618|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114619|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
20114620|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114621|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114622|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114623|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
20114624|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20114625|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19564248|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19564249|NCT02719418|Dalteparin|dalteparin|mesh-list
19564250|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
19564251|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19564252|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19564253|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564254|NCT02719431|Warfarin|warfarin|mesh-list
19564255|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
19564256|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19564257|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
19564258|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564259|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19564260|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19564261|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19564262|NCT02719210|Mannitol|mannitol|mesh-list
19564263|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19564264|NCT02719210|Diuretics|diuretics|mesh-ancestor
19564265|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
19564266|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564267|NCT02719132|Metformin|metformin|mesh-list
19564268|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
19564269|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19564270|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564271|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19564272|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564273|NCT02718820|Docetaxel|docetaxel|mesh-list
19564274|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
19564275|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114626|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
20114627|NCT00005005|Alendronate|alendronate|mesh-list
20114628|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20114629|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114630|NCT00005006|Alendronate|alendronate|mesh-list
20114631|NCT00005006|Teriparatide|teriparatide|mesh-list
20114632|NCT00005006|Hormones|hormones|mesh-list
20114633|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
20114634|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20114635|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114636|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20114637|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114638|NCT00005007|Etanercept|etanercept|mesh-list
20604722|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564276|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
19564277|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564278|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564279|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564280|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19564281|NCT02718950|Liraglutide|liraglutide|mesh-list
19564282|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19564283|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564284|NCT02718950|Incretins|incretins|mesh-ancestor
19564285|NCT02718950|Hormones|hormones|mesh-ancestor
19564286|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564287|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
19564288|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19564289|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564290|NCT02718911|Durvalumab|durvalumab|mesh-list
19564291|NCT02718911|Tremelimumab|tremelimumab|mesh-list
19564292|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604723|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564293|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564294|NCT02718755|Vidarabine|vidarabine|mesh-list
19564295|NCT02718755|Cytarabine|cytarabine|mesh-list
19564296|NCT02718755|Fludarabine|fludarabine|mesh-list
19564297|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
19564298|NCT02718755|Asparaginase|asparaginase|mesh-list
19564299|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564300|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564301|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
19564302|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564303|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564304|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
19564305|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564306|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
20114639|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20114640|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20114641|NCT00005007|Analgesics|analgesics|mesh-ancestor
20114642|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
20114643|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564307|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564308|NCT02718976|Lidocaine|lidocaine|mesh-list
19564309|NCT02718976|Epinephrine|epinephrine|mesh-list
19564310|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19564311|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
19564312|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
19564313|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564314|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564315|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
19564316|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564317|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19564318|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19564319|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19564320|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19564321|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564322|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19564323|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19564324|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
19564325|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564326|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19564327|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19564328|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
19564329|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19564330|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
19564331|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
19564332|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
20114644|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114645|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20114646|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114647|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20114648|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114649|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
20604724|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20604725|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20604726|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20604727|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19564333|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19564334|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
19564335|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
19564336|NCT02718677|Factor VIII|factor viii|mesh-list
20114650|NCT00005009|Vaccines|vaccines|mesh-list
20114651|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
20114652|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114653|NCT00005010|Irbesartan|irbesartan|mesh-list
20114654|NCT00005010|Pravastatin|pravastatin|mesh-list
20114655|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20114656|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20114657|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
20114658|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114659|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20114660|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20114661|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114662|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20114663|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20114664|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20114665|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20604728|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114666|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
20114667|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114668|NCT00005013|Sertraline|sertraline|mesh-list
20114669|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
20114670|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20114671|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20114672|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20114673|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20114674|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114675|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564337|NCT02718677|Coagulants|coagulants|mesh-ancestor
19577261|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577262|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19577263|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19577264|NCT04626128|Growth Substances|growth substances|mesh-ancestor
20114676|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
20114677|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114678|NCT00005014|Risperidone|risperidone|mesh-list
20114679|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19577265|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577266|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
19577267|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19577268|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577269|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577270|NCT04608448|Sirolimus|sirolimus|mesh-list
19577271|NCT04608448|Petrolatum|petrolatum|mesh-list
19577272|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19577273|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577274|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19577275|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577276|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
19577277|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577278|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
19577279|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577280|NCT04608448|Emollients|emollients|mesh-ancestor
19577281|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577282|NCT04599075|Insulin|insulin|mesh-list
19577283|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19577284|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19577285|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577286|NCT04598477|Prednisone|prednisone|mesh-list
19577287|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577288|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
19577289|NCT04598477|Hormones|hormones|mesh-ancestor
19577290|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577291|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577292|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577293|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577294|NCT04598451|Prednisone|prednisone|mesh-list
19577295|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577296|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
19577297|NCT04598451|Hormones|hormones|mesh-ancestor
19577298|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577299|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577300|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577301|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577302|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19577303|NCT04579367|Ezetimibe|ezetimibe|mesh-list
19577304|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19577305|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19577306|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
19577307|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577308|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19577309|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577310|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19577311|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577312|NCT04572763|Venetoclax|venetoclax|mesh-list
19577313|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577314|NCT04551495|Letrozole|letrozole|mesh-list
19577315|NCT04551495|Goserelin|goserelin|mesh-list
19577316|NCT04551495|Entrectinib|entrectinib|mesh-list
19577317|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114680|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
19577318|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19577319|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19577320|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564338|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
19564339|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564340|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
19564341|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564342|NCT02718547|Timolol|timolol|mesh-list
19564343|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19564344|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19564345|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
20114681|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20114682|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114683|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114684|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20114685|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20114686|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20114687|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20114688|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20114689|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
19564346|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19564347|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19564348|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19564349|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
19564350|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564351|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564352|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564353|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19564354|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19564355|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19564356|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19564357|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19564358|NCT02718742|Paclitaxel|paclitaxel|mesh-list
19564359|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19564360|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19564361|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564362|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
19564363|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564364|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564365|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564366|NCT02718404|Analgesics|analgesics|mesh-list
19564367|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
19564368|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564369|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564370|NCT02718469|Vaccines|vaccines|mesh-list
19564371|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
19564372|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564373|NCT02718521|Isosorbide|isosorbide|mesh-list
19564374|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19564375|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19564376|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19564377|NCT02718521|Diuretics|diuretics|mesh-ancestor
19564378|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
19564379|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114690|NCT00005015|Fluoxetine|fluoxetine|mesh-list
20114691|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20114692|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20114693|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20114694|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114695|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20114696|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
20114697|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114698|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20114699|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
20114700|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20114701|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20114702|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20114703|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564380|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
19564381|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19564382|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114704|NCT00005017|Ritonavir|ritonavir|mesh-list
20604729|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19564383|NCT02718482|Gemcitabine|gemcitabine|mesh-list
19564384|NCT02718482|Docetaxel|docetaxel|mesh-list
19564385|NCT02718482|Ifosfamide|ifosfamide|mesh-list
19564386|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
19564387|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564388|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
19564389|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564390|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564391|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
19564392|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564393|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564394|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564395|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
19564396|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564397|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
19564398|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564399|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564400|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19564401|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
19564402|NCT02718599|Terlipressin|terlipressin|mesh-list
19564403|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19564404|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19564405|NCT02718261|Pantoprazole|pantoprazole|mesh-list
19564406|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19564407|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19564408|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19564409|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564410|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564411|NCT02717884|Cytarabine|cytarabine|mesh-list
19564412|NCT02717884|Tretinoin|tretinoin|mesh-list
19564413|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
19564414|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564415|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
19564416|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564417|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564418|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
19564419|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564420|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564421|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
19564422|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564423|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
19564424|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564425|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
19564426|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19564427|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19564428|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564429|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19564430|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19564431|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564432|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19564433|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
19564434|NCT02718079|Mannitol|mannitol|mesh-list
19564435|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19564436|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564437|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19564438|NCT02718079|Diuretics|diuretics|mesh-ancestor
19564439|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
19564440|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564441|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
19564442|NCT02718079|Expectorants|expectorants|mesh-ancestor
19564443|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
19564444|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19564445|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
19564446|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564447|NCT02718079|Protective Agents|protective agents|mesh-ancestor
19564448|NCT02718079|Antidotes|antidotes|mesh-ancestor
19564449|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20114705|NCT00005017|Amprenavir|amprenavir|mesh-list
20114706|NCT00005017|Lamivudine|lamivudine|mesh-list
20114707|NCT00005017|Abacavir|abacavir|mesh-list
20114708|NCT00005017|Stavudine|stavudine|mesh-list
20114709|NCT00005017|Efavirenz|efavirenz|mesh-list
20114710|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20114711|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19564450|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
19564451|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19564452|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564453|NCT02717923|Capecitabine|capecitabine|mesh-list
19564454|NCT02717923|Cetuximab|cetuximab|mesh-list
19564455|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564456|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
20114712|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
20114713|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564457|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564458|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564459|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19564460|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
19564461|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
19564462|NCT02717871|Levofloxacin|levofloxacin|mesh-list
19564463|NCT02717871|Ofloxacin|ofloxacin|mesh-list
19564464|NCT02717871|Gentamicins|gentamicins|mesh-list
19564465|NCT02717871|Cefazolin|cefazolin|mesh-list
19564466|NCT02717871|Tobramycin|tobramycin|mesh-list
19564467|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
19564468|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
19564469|NCT02717871|Besifloxacin|besifloxacin|mesh-list
19564470|NCT02717871|Prednisolone|prednisolone|mesh-list
19564471|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19564472|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
19564473|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19564474|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
19564475|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19564476|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19564477|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
19564478|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
19564479|NCT02717871|Mydriatics|mydriatics|mesh-list
19564480|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564481|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
19564482|NCT02717871|Hormones|hormones|mesh-ancestor
20114714|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114715|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114716|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114717|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
20114718|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114719|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20114720|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19564483|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564484|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564485|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19564486|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114721|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114722|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114723|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20114724|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20114725|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20114726|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19564487|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
19564488|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
19564489|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564490|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19564491|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19564492|NCT02717871|Protective Agents|protective agents|mesh-ancestor
19564493|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19564494|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564495|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19564496|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19564497|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564498|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564499|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19564500|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19564501|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19564502|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19564503|NCT02717871|Renal Agents|renal agents|mesh-ancestor
19564504|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19564505|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19564506|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
19564507|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19564508|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19564509|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
19564510|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564511|NCT02717858|Liraglutide|liraglutide|mesh-list
19564512|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19564513|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564514|NCT02717858|Incretins|incretins|mesh-ancestor
19564515|NCT02717858|Hormones|hormones|mesh-ancestor
19564516|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564517|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19564518|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19564519|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564520|NCT02717819|Vitamin D|vitamin d|mesh-list
19564521|NCT02717819|Vitamins|vitamins|mesh-ancestor
19564522|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
19564523|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114727|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20114728|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
19564524|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19564525|NCT02717780|Fentanyl|fentanyl|mesh-list
19564526|NCT02717780|Remifentanil|remifentanil|mesh-list
20114729|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20114730|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
20114731|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20114732|NCT00005018|Efavirenz|efavirenz|mesh-list
20114733|NCT00005018|Abacavir|abacavir|mesh-list
20114734|NCT00005018|Didanosine|didanosine|mesh-list
19564527|NCT02717780|Sevoflurane|sevoflurane|mesh-list
19564528|NCT02717780|Desflurane|desflurane|mesh-list
19564529|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19564530|NCT02717780|Narcotics|narcotics|mesh-ancestor
19564531|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564532|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564533|NCT02717780|Analgesics|analgesics|mesh-ancestor
19564534|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
19564535|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564536|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19564537|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19564538|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
19564539|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
19564540|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19564541|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19564542|NCT02717052|Ketamine|ketamine|mesh-list
19564543|NCT02717052|Esketamine|esketamine|mesh-list
19564544|NCT02717052|Analgesics|analgesics|mesh-ancestor
19564545|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
19564546|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564547|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564548|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19564549|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19564550|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
19564551|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
19564552|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564553|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19564554|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19564555|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564556|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564557|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
19564558|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19564559|NCT02717091|Gemcitabine|gemcitabine|mesh-list
19564560|NCT02717091|Paclitaxel|paclitaxel|mesh-list
19564561|NCT02717091|Folfirinox|folfirinox|mesh-list
19564562|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19564563|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564564|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
19564565|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564566|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564567|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564568|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564569|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
19564570|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
19564571|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564572|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564573|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564574|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
19564575|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577321|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114735|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
20114736|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20114737|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114738|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114739|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114740|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
19577322|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19577323|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
20114741|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578327|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20604730|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
19564576|NCT02716974|Docetaxel|docetaxel|mesh-list
19564577|NCT02716974|Leuprolide|leuprolide|mesh-list
19564578|NCT02716974|Bicalutamide|bicalutamide|mesh-list
19564579|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564580|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
19564581|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564582|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564583|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564584|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19564585|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
19564586|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564587|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564588|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19564589|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
19564590|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
19564591|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564592|NCT02716961|Gemcitabine|gemcitabine|mesh-list
19564593|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564594|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564595|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
19564596|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564597|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
19564598|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564599|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564600|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564601|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
19564602|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564603|NCT02716857|Oxycodone|oxycodone|mesh-list
19564604|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19564605|NCT02716857|Narcotics|narcotics|mesh-ancestor
19564606|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564607|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114742|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20114743|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20114744|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20114745|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19564608|NCT02716857|Analgesics|analgesics|mesh-ancestor
19564609|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
19564610|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564611|NCT02716766|Capecitabine|capecitabine|mesh-list
19564612|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
19564613|NCT02716766|Sorafenib|sorafenib|mesh-list
19564614|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564615|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
19564616|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564617|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564618|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19564619|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564620|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
19564621|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19564622|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564623|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
19564624|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19564625|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564626|NCT02716415|Menthol|menthol|mesh-list
19564627|NCT02716415|Petrolatum|petrolatum|mesh-list
19564628|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
19564629|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
19564630|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564631|NCT02716415|Emollients|emollients|mesh-ancestor
19564632|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
19564633|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19564634|NCT02716415|Protective Agents|protective agents|mesh-ancestor
19564635|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564636|NCT02716428|Ribavirin|ribavirin|mesh-list
19564637|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
19564638|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564639|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
19564640|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564641|NCT02716311|Cetuximab|cetuximab|mesh-list
19564642|NCT02716311|Afatinib|afatinib|mesh-list
19564643|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19564644|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564645|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19564646|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564647|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564648|NCT02716285|Peppermint oil|peppermint oil|mesh-list
19564649|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
19564650|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
19564651|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564652|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564653|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19564654|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
19564655|NCT02716129|Morphine|morphine|mesh-list
19564656|NCT02716129|Nalbuphine|nalbuphine|mesh-list
19564657|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19564658|NCT02716129|Narcotics|narcotics|mesh-ancestor
19564659|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564660|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564661|NCT02716129|Analgesics|analgesics|mesh-ancestor
19564662|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
19564663|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564664|NCT02716259|Fluorides|fluorides|mesh-list
19564665|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
19564666|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
19564667|NCT02716259|Protective Agents|protective agents|mesh-ancestor
19564668|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564669|NCT02716233|Pegaspargase|pegaspargase|mesh-list
19564670|NCT02716233|Asparaginase|asparaginase|mesh-list
19564671|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564672|NCT02716272|Nivolumab|nivolumab|mesh-list
19564673|NCT02716272|Ipilimumab|ipilimumab|mesh-list
19564674|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19564675|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564676|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19564677|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564678|NCT02716142|Misoprostol|misoprostol|mesh-list
19564679|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19564680|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
19564681|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564682|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564683|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19564684|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19564685|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
19564686|NCT02716038|Paclitaxel|paclitaxel|mesh-list
19564687|NCT02716038|Carboplatin|carboplatin|mesh-list
19564688|NCT02716038|Atezolizumab|atezolizumab|mesh-list
19564689|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19564690|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564691|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
19564692|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564693|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564694|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564695|NCT02716090|Adapalene|adapalene|mesh-list
19564696|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19564697|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564698|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19564699|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564700|NCT02716090|Analgesics|analgesics|mesh-ancestor
19564701|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
19564702|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564703|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564704|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564705|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564706|NCT02715869|Sevoflurane|sevoflurane|mesh-list
19564707|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19564708|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19564709|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
19564710|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
19564711|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564712|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564713|NCT02715687|Amiodarone|amiodarone|mesh-list
19564714|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19564715|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
19564716|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19564717|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19564718|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564719|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19564720|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19564721|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19564722|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564723|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19578328|NCT02839707|Growth Substances|growth substances|mesh-ancestor
19564724|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19564725|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19564726|NCT02715947|Methotrexate|methotrexate|mesh-list
19564727|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19564728|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
19564729|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564730|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564731|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564732|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
19564733|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564734|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564735|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564736|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564737|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19564738|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564739|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
19564740|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564741|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19564742|NCT02715960|Vitamin A|vitamin a|mesh-list
19564743|NCT02715960|Tretinoin|tretinoin|mesh-list
19564744|NCT02715960|Acitretin|acitretin|mesh-list
19564745|NCT02715960|Vitamins|vitamins|mesh-ancestor
19564746|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
19564747|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114746|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20114747|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19564748|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564749|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
19564750|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564751|NCT02715492|Enoxaparin|enoxaparin|mesh-list
19564752|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
19564753|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19564754|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19564755|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564756|NCT02715531|Leucovorin|leucovorin|mesh-list
19564757|NCT02715531|Gemcitabine|gemcitabine|mesh-list
19564758|NCT02715531|Paclitaxel|paclitaxel|mesh-list
19564759|NCT02715531|Bevacizumab|bevacizumab|mesh-list
19564760|NCT02715531|Capecitabine|capecitabine|mesh-list
19564761|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
19564762|NCT02715531|Atezolizumab|atezolizumab|mesh-list
19564763|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19564764|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564765|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
19564766|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564767|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564768|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564769|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19564770|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19564771|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19564772|NCT02715531|Growth Substances|growth substances|mesh-ancestor
19564773|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564774|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
19564775|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564776|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
19564777|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
19564778|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564779|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564780|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564781|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
19564782|NCT02715531|Antidotes|antidotes|mesh-ancestor
19564783|NCT02715531|Protective Agents|protective agents|mesh-ancestor
19564784|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
19564785|NCT02715531|Vitamins|vitamins|mesh-ancestor
19564786|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
19564787|NCT02715479|Dolutegravir|dolutegravir|mesh-list
19564788|NCT02715479|BMS-955176|bms-955176|mesh-list
19564789|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19564790|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19564791|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564792|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564793|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19564794|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19564795|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
19564796|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564797|NCT02715336|Leuprolide|leuprolide|mesh-list
19564798|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19564799|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
19564800|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564801|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564802|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19564803|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577324|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577325|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577326|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577327|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19577328|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
19577329|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577330|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114748|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114749|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20114750|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114751|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
20114752|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
20114753|NCT00005021|Paclitaxel|paclitaxel|mesh-list
20114754|NCT00005021|Carboplatin|carboplatin|mesh-list
20114755|NCT00005021|Topotecan|topotecan|mesh-list
19577331|NCT04513652|Carticaine|carticaine|mesh-list
19577332|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
19577333|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
19577334|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577335|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114756|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114757|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114758|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114759|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114760|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114761|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114762|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114763|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114764|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114765|NCT00005022|Etoposide|etoposide|mesh-list
20114766|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114767|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114768|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114769|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114770|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114771|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114772|NCT00005023|Sargramostim|sargramostim|mesh-list
20114773|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
20114774|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577336|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
19577337|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577338|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
19577339|NCT04505878|Vitamins|vitamins|mesh-ancestor
19577340|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
19577341|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577342|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
19577343|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577344|NCT04505878|Protective Agents|protective agents|mesh-ancestor
19578329|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578330|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
19578331|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
19578332|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19578333|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578334|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578335|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578336|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578337|NCT02744092|Enoxaparin|enoxaparin|mesh-list
19578338|NCT02744092|Dalteparin|dalteparin|mesh-list
19578339|NCT02744092|PENTA|penta|mesh-list
20114775|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
20114776|NCT00005024|Carboplatin|carboplatin|mesh-list
20114777|NCT00005024|Doxorubicin|doxorubicin|mesh-list
20114778|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20114779|NCT00005024|Granisetron|granisetron|mesh-list
20114780|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114781|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
20114782|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114783|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114784|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578340|NCT02744092|Warfarin|warfarin|mesh-list
19578341|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
20114785|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
20114786|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114787|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114788|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20114789|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20114790|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20114791|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19564804|NCT02714998|Methotrexate|methotrexate|mesh-list
19564805|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19564806|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
19564807|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564808|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564809|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564810|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
19564811|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564812|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564813|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564814|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564815|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19564816|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564817|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
19564818|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564819|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19564820|NCT02715024|Tamsulosin|tamsulosin|mesh-list
19564821|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
19564822|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19564823|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19564824|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19564825|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
19564826|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564827|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564828|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564829|NCT02715024|Urological Agents|urological agents|mesh-ancestor
19564830|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19564831|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19564832|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
19564833|NCT02715193|Volagidemab|volagidemab|mesh-list
19564834|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20114792|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114793|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
20114794|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
20114795|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20114796|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20114797|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20114798|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
20114799|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20114800|NCT00005025|Ganciclovir|ganciclovir|mesh-list
20114801|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20114802|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
20114803|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564835|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564836|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
19564837|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19564838|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564839|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564840|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564841|NCT02715154|Analgesics|analgesics|mesh-ancestor
19564842|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
19564843|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564844|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19564845|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19564846|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19564847|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
19564848|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564849|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564850|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19564851|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
19564852|NCT02715232|Lynestrenol|lynestrenol|mesh-list
19564853|NCT02715232|Estradiol|estradiol|mesh-list
19564854|NCT02715232|Testosterone|testosterone|mesh-list
19564855|NCT02715232|Cyproterone|cyproterone|mesh-list
19564856|NCT02715232|Estrogens|estrogens|mesh-ancestor
19564857|NCT02715232|Hormones|hormones|mesh-ancestor
19564858|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564859|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564860|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19564861|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
19564862|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564863|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19564864|NCT02715232|Androgens|androgens|mesh-ancestor
19564865|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19564866|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564867|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
19564868|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
19564869|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
19564870|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19564871|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19564872|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19564873|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19564874|NCT02715167|Budesonide|budesonide|mesh-list
20114804|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114805|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114806|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114807|NCT00005026|Paclitaxel|paclitaxel|mesh-list
20114808|NCT00005026|Carboplatin|carboplatin|mesh-list
20114809|NCT00005026|Topotecan|topotecan|mesh-list
20114810|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114811|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564875|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564876|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19564877|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
19564878|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564879|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564880|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20114812|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114813|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
19564881|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
19564882|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
19564883|NCT02715167|Hormones|hormones|mesh-ancestor
19564884|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19564885|NCT02714959|Aldesleukin|aldesleukin|mesh-list
19564886|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564887|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19564888|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19564889|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
19564890|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564891|NCT02714894|Clozapine|clozapine|mesh-list
19564892|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19564893|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
19564894|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564895|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564896|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564897|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19564898|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19564899|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564900|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19564901|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
19564902|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
19564903|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
20114814|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
19564904|NCT02714634|Methotrexate|methotrexate|mesh-list
20114815|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114816|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114817|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114818|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114819|NCT00005028|Paclitaxel|paclitaxel|mesh-list
20114820|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
20114821|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114822|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114823|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114824|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114825|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114826|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114827|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20114828|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
20114829|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114830|NCT00005029|Topotecan|topotecan|mesh-list
19564905|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19564906|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
19564907|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19564908|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564909|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19564910|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
19564911|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564912|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19564913|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
19564914|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564915|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19564916|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564917|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
19564918|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564919|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19564920|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
19564921|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19564922|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19564923|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564924|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
19564925|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19564926|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
19564927|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564928|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564929|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
19564930|NCT02714725|Propofol|propofol|mesh-list
19564931|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19564932|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19564933|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564934|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19564935|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
19564936|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
19564937|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564938|NCT02714725|Analgesics|analgesics|mesh-ancestor
19564939|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
19564940|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564941|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19564942|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19564943|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20114831|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114832|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114833|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114834|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114835|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120622|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120623|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20120624|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120625|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
20120626|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20120627|NCT00006380|Antibodies|antibodies|mesh-list
20120628|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
19564944|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
19564945|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564946|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564947|NCT02714842|Diclofenac|diclofenac|mesh-list
19564948|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19564949|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564950|NCT02714842|Analgesics|analgesics|mesh-ancestor
19564951|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
19564952|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564953|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564954|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564955|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564956|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19564957|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564958|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120629|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20120630|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
20120631|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120632|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120633|NCT00006381|Celecoxib|celecoxib|mesh-list
20120634|NCT00006381|Trastuzumab|trastuzumab|mesh-list
20120635|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20120636|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120637|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19564959|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19564960|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
19564961|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19564962|NCT02714699|Diclofenac|diclofenac|mesh-list
19564963|NCT02714699|Scopolamine|scopolamine|mesh-list
19564964|NCT02714699|Bromides|bromides|mesh-list
19564965|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19564966|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19564967|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19564968|NCT02714699|Analgesics|analgesics|mesh-ancestor
19564969|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
19564970|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19564971|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19564972|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19564973|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19564974|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19564975|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19564976|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564977|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
19564978|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19564979|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
19564980|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
19564981|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19564982|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
19564983|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19564984|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
19564985|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19564986|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19564987|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
19564988|NCT02714855|Apixaban|apixaban|mesh-list
19564989|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19564990|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
19564991|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19564992|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
19564993|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114836|NCT00005030|Lonafarnib|lonafarnib|mesh-list
19564994|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19564995|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
19564996|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
19564997|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
19564998|NCT02714543|Antioxidants|antioxidants|mesh-list
19564999|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565000|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19565001|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
19565002|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565003|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
19565004|NCT02714543|Protective Agents|protective agents|mesh-ancestor
19565005|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565006|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19565007|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565008|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19565009|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565010|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565011|NCT02714439|Proflavine|proflavine|mesh-list
19565012|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19565013|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565014|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
19565015|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19565016|NCT02714166|Protective Agents|protective agents|mesh-ancestor
19565017|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565018|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565019|NCT02714231|Diclofenac|diclofenac|mesh-list
19565020|NCT02714231|Scopolamine|scopolamine|mesh-list
19565021|NCT02714231|Bromides|bromides|mesh-list
19565022|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19565023|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19565024|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565025|NCT02714231|Analgesics|analgesics|mesh-ancestor
19565026|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
19565027|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565028|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565029|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565030|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20114837|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565031|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19565032|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565033|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565034|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
19565035|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19565036|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
19565037|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
19565038|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565039|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
19565040|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19565041|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
19565042|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565043|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19565044|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
19565045|NCT02714179|Acetaminophen|acetaminophen|mesh-list
19565046|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565047|NCT02714179|Analgesics|analgesics|mesh-ancestor
19565048|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
19565049|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565050|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565051|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
19565052|NCT02714361|Vitamin D|vitamin d|mesh-list
19565053|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
19565054|NCT02714361|Vitamins|vitamins|mesh-ancestor
19565055|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
19565056|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565057|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19565058|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19565059|NCT02714036|Ibudilast|ibudilast|mesh-list
19565060|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19565061|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
19565062|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565063|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565064|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19565065|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
19565066|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19565067|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565068|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565069|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19565070|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
19565071|NCT02713945|Simvastatin|simvastatin|mesh-list
19565072|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19565073|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19565074|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
19565075|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565076|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20114838|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114839|NCT00005031|Irofulven|irofulven|mesh-list
20114840|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114841|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
20114842|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114843|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114844|NCT00005032|Paclitaxel|paclitaxel|mesh-list
20114845|NCT00005032|Oblimersen|oblimersen|mesh-list
20114846|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114847|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114848|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114849|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114850|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114851|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114852|NCT00005033|Trastuzumab|trastuzumab|mesh-list
20114853|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20114854|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114855|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
20114856|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114857|NCT00005036|Leucovorin|leucovorin|mesh-list
20114858|NCT00005036|Fluorouracil|fluorouracil|mesh-list
20114859|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
20114860|NCT00005036|Irinotecan|irinotecan|mesh-list
20114861|NCT00005036|Calcium|calcium|mesh-list
20114862|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
20114863|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114864|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114865|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
20114866|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114867|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19565077|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20604731|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19565078|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114868|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114869|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19565079|NCT02713841|Insulin|insulin|mesh-list
20114870|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
20114871|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114872|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114873|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114874|NCT00005036|Antidotes|antidotes|mesh-ancestor
20114875|NCT00005036|Protective Agents|protective agents|mesh-ancestor
20114876|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
20114877|NCT00005036|Vitamins|vitamins|mesh-ancestor
20114878|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
20114879|NCT00005037|Temozolomide|temozolomide|mesh-list
20114880|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114881|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
19565080|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19565081|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
19565082|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19565083|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565084|NCT02713893|Econazole|econazole|mesh-list
19565085|NCT02713893|Benzydamine|benzydamine|mesh-list
19565086|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565087|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
19565088|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565089|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19565090|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19565091|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565092|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565093|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19565094|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
19565095|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19565096|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565097|NCT02714010|Gefitinib|gefitinib|mesh-list
19565098|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565099|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19565100|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565101|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565102|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
19565103|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19565104|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565105|NCT02714075|Zinc|zinc|mesh-list
19565106|NCT02714075|Iron|iron|mesh-list
20114882|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114883|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114884|NCT00005038|Aldesleukin|aldesleukin|mesh-list
19565107|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
19565108|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
19565109|NCT02714075|Citric Acid|citric acid|mesh-list
19565110|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
19565111|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
19565112|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19565113|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
19565114|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
19565115|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565116|NCT02714075|Trace Elements|trace elements|mesh-ancestor
19565117|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
19565118|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565119|NCT02714075|Astringents|astringents|mesh-ancestor
19565120|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565121|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
19565122|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19565123|NCT02714075|Protective Agents|protective agents|mesh-ancestor
19565124|NCT02713802|Propofol|propofol|mesh-list
19565125|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19565126|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565127|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565128|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565129|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
19565130|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
19577345|NCT04494880|Bupivacaine|bupivacaine|mesh-list
19577346|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
20114885|NCT00005038|Histamine|histamine|mesh-list
19577347|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
19577348|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19577349|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114886|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
19577350|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
20114887|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565131|NCT02713763|Sunitinib|sunitinib|mesh-list
19565132|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565133|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19565134|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19565135|NCT02713763|Growth Substances|growth substances|mesh-ancestor
19565136|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565137|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
19565138|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19565139|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565140|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565141|NCT02713607|Doxycycline|doxycycline|mesh-list
19565142|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565143|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565144|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
19565145|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19565146|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19565147|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19565148|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19565149|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19565150|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565151|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565152|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19565153|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19565154|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19565155|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
19565156|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565157|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565158|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19565159|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19565160|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
19565161|NCT02713477|Insulin|insulin|mesh-list
19565162|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19565163|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
19565164|NCT02713477|Lixisenatide|lixisenatide|mesh-list
19565165|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19565166|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565167|NCT02713139|Metronidazole|metronidazole|mesh-list
19565168|NCT02713139|Clotrimazole|clotrimazole|mesh-list
19565169|NCT02713139|Miconazole|miconazole|mesh-list
19565170|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565171|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565172|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19565173|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19565174|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19565175|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
19565176|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19565177|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19565178|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565179|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565180|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19565181|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
19565182|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19565183|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565184|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19565185|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19565186|NCT02713191|Fentanyl|fentanyl|mesh-list
20114888|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20114889|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19565187|NCT02713191|Midazolam|midazolam|mesh-list
19565188|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
19565189|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19565190|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565191|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565192|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565193|NCT02713191|Analgesics|analgesics|mesh-ancestor
19565194|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
19565195|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565196|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19565197|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19565198|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19565199|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19565200|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565201|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114890|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
19565202|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19565203|NCT02713191|Narcotics|narcotics|mesh-ancestor
19565204|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19565205|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565206|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
19565207|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
19565208|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19565209|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19565210|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19565211|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
19565212|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
19565213|NCT02713009|Vitamin D|vitamin d|mesh-list
19565214|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
19565215|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
19565216|NCT02713009|Vitamins|vitamins|mesh-list
19565217|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
19565218|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565219|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19565220|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19565221|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
19565222|NCT02713074|Povidone|povidone|mesh-list
19565223|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
19565224|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
19565225|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19565226|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565227|NCT02713087|Phenylephrine|phenylephrine|mesh-list
19565228|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
19565229|NCT02713087|Ephedrine|ephedrine|mesh-list
19565230|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19565231|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
19565232|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
19565233|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565234|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565235|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
19565236|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19565237|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
19565238|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
19565239|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19565240|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19565241|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19565242|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
19565243|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565244|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565245|NCT02713087|Protective Agents|protective agents|mesh-ancestor
19565246|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19565247|NCT02712957|Naproxen|naproxen|mesh-list
19565248|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19565249|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565250|NCT02712957|Analgesics|analgesics|mesh-ancestor
19565251|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
19565252|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565253|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565254|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565255|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19565256|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
19565257|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20114891|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114892|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
20114893|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
19565258|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565259|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565260|NCT02712944|Testosterone|testosterone|mesh-list
19565261|NCT02712944|Androgens|androgens|mesh-ancestor
19565262|NCT02712944|Hormones|hormones|mesh-ancestor
19565263|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19565264|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565265|NCT02712866|Vedolizumab|vedolizumab|mesh-list
19565266|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565267|NCT02712619|Metformin|metformin|mesh-list
19565268|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19565269|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565270|NCT02712671|Interferons|interferons|mesh-list
19565271|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
19565272|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565273|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
19565274|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565275|NCT02712697|Prednisone|prednisone|mesh-list
19565276|NCT02712697|Hormones|hormones|mesh-list
20114894|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565277|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20114895|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114896|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114897|NCT00005039|Vaccines|vaccines|mesh-list
20114898|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
20114899|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604732|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20604733|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
19565278|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
20114900|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
20114901|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114902|NCT00005041|Tipifarnib|tipifarnib|mesh-list
20114903|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114904|NCT00005042|Semaxinib|semaxinib|mesh-list
20114905|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20114906|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20114907|NCT00005042|Growth Substances|growth substances|mesh-ancestor
20114908|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114909|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
20114910|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114911|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20114912|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114913|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114914|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
20114915|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565279|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19565280|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565281|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19565282|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565283|NCT02712775|Minocycline|minocycline|mesh-list
19565284|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565285|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565286|NCT02712658|Terbutaline|terbutaline|mesh-list
19565287|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19565288|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
19565289|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565290|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565291|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19565292|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
19565293|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
19565294|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
19565295|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19565296|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19565297|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19565298|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19565299|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
19565300|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565301|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565302|NCT02712723|Letrozole|letrozole|mesh-list
19565303|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565304|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19565305|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19565306|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565307|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565308|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19565309|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
19565310|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19565311|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565312|NCT02712801|Ritonavir|ritonavir|mesh-list
19565313|NCT02712801|Lopinavir|lopinavir|mesh-list
19565314|NCT02712801|Lamivudine|lamivudine|mesh-list
19565315|NCT02712801|Zidovudine|zidovudine|mesh-list
19565316|NCT02712801|Nevirapine|nevirapine|mesh-list
19565317|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19565318|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19565319|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
19565320|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565321|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565322|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19565323|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19565324|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
20114916|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19565325|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114917|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20604734|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565326|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19565327|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20114918|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114919|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20114920|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565328|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19565329|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19565330|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
19565331|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19565332|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19565333|NCT02712528|Sufentanil|sufentanil|mesh-list
19565334|NCT02712528|Remifentanil|remifentanil|mesh-list
19565335|NCT02712528|Sevoflurane|sevoflurane|mesh-list
19565336|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19565337|NCT02712528|Narcotics|narcotics|mesh-ancestor
19565338|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565339|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565340|NCT02712528|Analgesics|analgesics|mesh-ancestor
19565341|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
19565342|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565343|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19565344|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19565345|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
19565346|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
19565347|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19565348|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565349|NCT02712502|Amoxicillin|amoxicillin|mesh-list
19565350|NCT02712502|Levofloxacin|levofloxacin|mesh-list
19565351|NCT02712502|Ofloxacin|ofloxacin|mesh-list
19565352|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
19565353|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
19565354|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19565355|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565356|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565357|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19565358|NCT02712502|Renal Agents|renal agents|mesh-ancestor
19565359|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19565360|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19565361|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565362|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565363|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565364|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19565365|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19565366|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19565367|NCT02712346|Ambrisentan|ambrisentan|mesh-list
19565368|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19565369|NCT02712476|Furosemide|furosemide|mesh-list
19565370|NCT02712476|Mannitol|mannitol|mesh-list
19565371|NCT02712476|Diuretics|diuretics|mesh-ancestor
19565372|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
19565373|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565374|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19565375|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19565376|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565377|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19565378|NCT02712125|Isosorbide|isosorbide|mesh-list
19565379|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19565380|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19565381|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19565382|NCT02712125|Diuretics|diuretics|mesh-ancestor
19565383|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
19565384|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565385|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
19565386|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20114921|NCT00005046|Paclitaxel|paclitaxel|mesh-list
20114922|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114923|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114924|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114925|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114926|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114927|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114928|NCT00005048|Paclitaxel|paclitaxel|mesh-list
20604735|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19565387|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565388|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19565389|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
19565390|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565391|NCT02712203|Vaccines|vaccines|mesh-list
19565392|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
19565393|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565394|NCT02712307|Penicillins|penicillins|mesh-list
19565395|NCT02712307|Penicillin V|penicillin v|mesh-list
19565396|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565397|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565398|NCT02712151|Ropivacaine|ropivacaine|mesh-list
19565399|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
19565400|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
19565401|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565402|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565403|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
19565404|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565405|NCT02711865|Antibodies|antibodies|mesh-list
19565406|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
19565407|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565408|NCT02711904|Remifentanil|remifentanil|mesh-list
19565409|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19565410|NCT02711904|Narcotics|narcotics|mesh-ancestor
19565411|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565412|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565413|NCT02711904|Analgesics|analgesics|mesh-ancestor
19565414|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
19565415|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565416|NCT02711969|Apatinib|apatinib|mesh-list
19565417|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565418|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19565419|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565420|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565421|NCT02711943|Levofloxacin|levofloxacin|mesh-list
19565422|NCT02711943|Ofloxacin|ofloxacin|mesh-list
19565423|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19565424|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565425|NCT02711943|Renal Agents|renal agents|mesh-ancestor
19565426|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565427|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19565428|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19565429|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565430|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565431|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565432|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19565433|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19565434|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
19565435|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19565436|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19565437|NCT02711982|Prednisolone|prednisolone|mesh-list
19565438|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
19565439|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19565440|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
19565441|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565442|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
19565443|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
19565444|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565445|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565446|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565447|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
19565448|NCT02711982|Hormones|hormones|mesh-ancestor
19565449|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19565450|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19565451|NCT02711982|Protective Agents|protective agents|mesh-ancestor
19565452|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19565453|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577351|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577352|NCT04489888|Paclitaxel|paclitaxel|mesh-list
20114929|NCT00005048|Estramustine|estramustine|mesh-list
20114930|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114931|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114932|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114933|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577353|NCT04489888|Carboplatin|carboplatin|mesh-list
19577354|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
19577355|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114934|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114935|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114936|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114937|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
20114938|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20114939|NCT00005049|Carboplatin|carboplatin|mesh-list
20114940|NCT00005049|Floxuridine|floxuridine|mesh-list
20114941|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114942|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114943|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
20114944|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114945|NCT00005050|Fluorouracil|fluorouracil|mesh-list
20114946|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
20114947|NCT00005050|Eniluracil|eniluracil|mesh-list
20114948|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
20114949|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565454|NCT02711891|Loperamide|loperamide|mesh-list
19565455|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
19565456|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565457|NCT02711917|Propofol|propofol|mesh-list
19565458|NCT02711917|Etomidate|etomidate|mesh-list
19565459|NCT02711917|Rocuronium|rocuronium|mesh-list
19565460|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19565461|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565462|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565463|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565464|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
19565465|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
19565466|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19565467|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19565468|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19565469|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565470|NCT02711735|Vaccines|vaccines|mesh-list
19565471|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
19565472|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565473|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
19565474|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19565475|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19565476|NCT02711449|Prednisolone|prednisolone|mesh-list
19565477|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
19565478|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19565479|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
19565480|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565481|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
19565482|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
19565483|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20114950|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20114951|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114952|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114953|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
20114954|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114955|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565484|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565485|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565486|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
19565487|NCT02711449|Hormones|hormones|mesh-ancestor
19565488|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19565489|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19565490|NCT02711449|Protective Agents|protective agents|mesh-ancestor
19565491|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19565492|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565493|NCT02711592|Analgesics|analgesics|mesh-list
19565494|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
19565495|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565496|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565497|NCT02711410|Clopidogrel|clopidogrel|mesh-list
19565498|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19565499|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19565500|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20114956|NCT00005051|Paclitaxel|paclitaxel|mesh-list
20114957|NCT00005051|Carboplatin|carboplatin|mesh-list
19565501|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19565502|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
20114958|NCT00005051|Topotecan|topotecan|mesh-list
19565503|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19577356|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565504|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565505|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565506|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19565507|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
19565508|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19565509|NCT02711670|Diuretics|diuretics|mesh-ancestor
19565510|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
19565511|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565512|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19565513|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19565514|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565515|NCT02711579|Celecoxib|celecoxib|mesh-list
19565516|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19565517|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565518|NCT02711579|Analgesics|analgesics|mesh-ancestor
19565519|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
19565520|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565521|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565522|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565523|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19565524|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19565525|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19565526|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565527|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565528|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19565529|NCT02711683|Donepezil|donepezil|mesh-list
19565530|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19565531|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565532|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114959|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19565533|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
19565534|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565535|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565536|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
19565537|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20114960|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114961|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114962|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114963|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114964|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114965|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20114966|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20114967|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114968|NCT00005054|Temozolomide|temozolomide|mesh-list
20114969|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20114970|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
19565538|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19565539|NCT02711683|Protective Agents|protective agents|mesh-ancestor
19565540|NCT02711176|Amoxicillin|amoxicillin|mesh-list
19565541|NCT02711176|Clarithromycin|clarithromycin|mesh-list
19565542|NCT02711176|Tinidazole|tinidazole|mesh-list
19565543|NCT02711176|Esomeprazole|esomeprazole|mesh-list
19565544|NCT02711176|Lansoprazole|lansoprazole|mesh-list
19565545|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565546|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565547|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19565548|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565549|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19565550|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565551|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114971|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114972|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114973|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
20114974|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20114975|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
19565552|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19565553|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19565554|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19565555|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
19565556|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19565557|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19565558|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20604736|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19565559|NCT02711189|Oxytocin|oxytocin|mesh-list
19565560|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
19565561|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19565562|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565563|NCT02711202|Sirolimus|sirolimus|mesh-list
19565564|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
19565565|NCT02711202|Infliximab|infliximab|mesh-list
19565566|NCT02711202|Tacrolimus|tacrolimus|mesh-list
19565567|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20114976|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20114977|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114978|NCT00005057|Ganciclovir|ganciclovir|mesh-list
20114979|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20114980|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
20114981|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20114982|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20114983|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20114984|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114985|NCT00005059|Paclitaxel|paclitaxel|mesh-list
19565568|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
19565569|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565570|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19565571|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565572|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565573|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565574|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565575|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19565576|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565577|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
19565578|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565579|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565580|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19565581|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19565582|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
19565583|NCT02711228|Antibodies|antibodies|mesh-list
19565584|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
19565585|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20114986|NCT00005059|Carboplatin|carboplatin|mesh-list
20114987|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20114988|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114989|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114990|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114991|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114992|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114993|NCT00005060|Docetaxel|docetaxel|mesh-list
20114994|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20114995|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
20114996|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
20114997|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
20114998|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20114999|NCT00005061|Bevacizumab|bevacizumab|mesh-list
19565586|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19565587|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
19565588|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565589|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19565590|NCT02711215|Mirtazapine|mirtazapine|mesh-list
19565591|NCT02711215|Citalopram|citalopram|mesh-list
19565592|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19565593|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19565594|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19565595|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19565596|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565597|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565598|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
19565599|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565600|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19565601|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
19565602|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19565603|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565604|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19565605|NCT02711215|Analgesics|analgesics|mesh-ancestor
19565606|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
19565607|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
19565608|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20115000|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19565609|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
19565610|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
19565611|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19565612|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19565613|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565614|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19565615|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19565616|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19565617|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
20115001|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115002|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19565618|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19565619|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19565620|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19565621|NCT02711358|Indomethacin|indomethacin|mesh-list
19565622|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19565623|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565624|NCT02711358|Analgesics|analgesics|mesh-ancestor
19565625|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
19565626|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565627|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565628|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565629|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19565630|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
19565631|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
19565632|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19565633|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19565634|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565635|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565636|NCT02711267|Acyclovir|acyclovir|mesh-list
19565637|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
19565638|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565639|NCT02711280|Propofol|propofol|mesh-list
19565640|NCT02711280|Sevoflurane|sevoflurane|mesh-list
19565641|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19565642|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565643|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565644|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565645|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
19565646|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
19565647|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19565648|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19565649|NCT02711241|Dipyrone|dipyrone|mesh-list
19565650|NCT02711241|Papaverine|papaverine|mesh-list
19565651|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19565652|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565653|NCT02711241|Analgesics|analgesics|mesh-ancestor
19565654|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
19565655|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565656|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565657|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565658|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19565659|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
19565660|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19565661|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565662|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565663|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
19565664|NCT02711241|Urological Agents|urological agents|mesh-ancestor
19565665|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
19565666|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19565667|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565668|NCT02711007|Apatinib|apatinib|mesh-list
19565669|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565670|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19565671|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565672|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565673|NCT02710877|Sufentanil|sufentanil|mesh-list
19565674|NCT02710877|Dsuvia|dsuvia|mesh-list
19565675|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
19565676|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
19565677|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
19565678|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565679|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565680|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
20115003|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19565681|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565682|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19565683|NCT02710877|Narcotics|narcotics|mesh-ancestor
19565684|NCT02710877|Analgesics|analgesics|mesh-ancestor
19565685|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19565686|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565687|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
19565688|NCT02710656|Paclitaxel|paclitaxel|mesh-list
19565689|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19565690|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565691|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
19565692|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
19565693|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
19565694|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565695|NCT02710539|Amlodipine|amlodipine|mesh-list
19565696|NCT02710539|Perindopril|perindopril|mesh-list
19565697|NCT02710539|Indapamide|indapamide|mesh-list
19565698|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19565699|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19565700|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19565701|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565702|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19565703|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565704|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
19565705|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19565706|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
19565707|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565708|NCT02710539|Diuretics|diuretics|mesh-ancestor
19565709|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
19565710|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19565711|NCT02710604|Tenofovir|tenofovir|mesh-list
19565712|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
19565713|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
19565714|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565715|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19565716|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19565717|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565718|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565719|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19565720|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19565721|NCT02710552|Amlodipine|amlodipine|mesh-list
19565722|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
19565723|NCT02710552|Perindopril|perindopril|mesh-list
19565724|NCT02710552|Indapamide|indapamide|mesh-list
19565725|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19565726|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115004|NCT00005061|Growth Substances|growth substances|mesh-ancestor
20115005|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115006|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
20115007|NCT00005064|Bortezomib|bortezomib|mesh-list
20115008|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115009|NCT00005065|Paclitaxel|paclitaxel|mesh-list
19565727|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565728|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19565729|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565730|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
19565731|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19565732|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
19565733|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565734|NCT02710552|Diuretics|diuretics|mesh-ancestor
19565735|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
19565736|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19565737|NCT02710448|Metformin|metformin|mesh-list
19565738|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19565739|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565740|NCT02710409|Vaccines|vaccines|mesh-list
19565741|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
19565742|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565743|NCT02710396|Paclitaxel|paclitaxel|mesh-list
19565744|NCT02710396|Carboplatin|carboplatin|mesh-list
19565745|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
19565746|NCT02710396|Pemetrexed|pemetrexed|mesh-list
20115010|NCT00005065|Carboplatin|carboplatin|mesh-list
19565747|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19565748|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115011|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
19565749|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
19565750|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
19565751|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
19565752|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565753|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115012|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115013|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115014|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115015|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115016|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115017|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115018|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20115019|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115020|NCT00005066|Carmustine|carmustine|mesh-list
20115021|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20115022|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115023|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
20115024|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115025|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115026|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115027|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
20115028|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20115029|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115030|NCT00005068|Leucovorin|leucovorin|mesh-list
20115031|NCT00005068|Fluorouracil|fluorouracil|mesh-list
20115032|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
20115033|NCT00005068|Irinotecan|irinotecan|mesh-list
20115034|NCT00005068|Calcium|calcium|mesh-list
20115035|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
20115036|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20115037|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115038|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
20115039|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115040|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115041|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115042|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115043|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
20115044|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20115045|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115046|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115047|NCT00005068|Antidotes|antidotes|mesh-ancestor
20115048|NCT00005068|Protective Agents|protective agents|mesh-ancestor
20115049|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
20115050|NCT00005068|Vitamins|vitamins|mesh-ancestor
20115051|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
20115052|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
20115053|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115054|NCT00005070|Irofulven|irofulven|mesh-list
20115055|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115056|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
19565754|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565755|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19565756|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19565757|NCT02710266|Gabexate|gabexate|mesh-list
19565758|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
20115057|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565759|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19565760|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
19565761|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115058|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565762|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577357|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577358|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577359|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577360|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577361|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577362|NCT04485559|Everolimus|everolimus|mesh-list
19577363|NCT04485559|Trametinib|trametinib|mesh-list
19577364|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577365|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577366|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
20115059|NCT00005072|Interleukin-2|interleukin-2|mesh-list
20115060|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115061|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19577367|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115062|NCT00005072|Analgesics|analgesics|mesh-ancestor
19565763|NCT02710305|Lidocaine|lidocaine|mesh-list
19565764|NCT02710305|Scopolamine|scopolamine|mesh-list
19565765|NCT02710305|Bromides|bromides|mesh-list
19565766|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19565767|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
19565768|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
19565769|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565770|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565771|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
19565772|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565773|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19565774|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19565775|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19565776|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19565777|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565778|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
19565779|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19565780|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
19565781|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
19565782|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565783|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
19565784|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19565785|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
19565786|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565787|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19565788|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
19565789|NCT02710318|Vaccines|vaccines|mesh-list
19565790|NCT02710318|Immunologic Factors|immunologic factors|mesh-ancestor
19565791|NCT02710318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565792|NCT02710110|Capsaicin|capsaicin|mesh-list
19565793|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
19565794|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565795|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
19565796|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565797|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565798|NCT02710162|Capsaicin|capsaicin|mesh-list
19565799|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
19565800|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565801|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
19565802|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115063|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
20115064|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115065|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115066|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
20115067|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20115068|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115069|NCT00005074|Alvocidib|alvocidib|mesh-list
19565803|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565804|NCT02709863|Propofol|propofol|mesh-list
19565805|NCT02709863|Sevoflurane|sevoflurane|mesh-list
19565806|NCT02709863|Desflurane|desflurane|mesh-list
19565807|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19565808|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565809|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565810|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565811|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
19565812|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
19565813|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19565814|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19565815|NCT02709902|Adapalene|adapalene|mesh-list
19565816|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19565817|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19565818|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115070|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115071|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
20115072|NCT00005074|Growth Substances|growth substances|mesh-ancestor
20115073|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115074|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20115075|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115076|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565819|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19565820|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20115077|NCT00005076|Irinotecan|irinotecan|mesh-list
19565821|NCT02709902|Analgesics|analgesics|mesh-ancestor
19565822|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
19565823|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578342|NCT02744092|Dabigatran|dabigatran|mesh-list
19565824|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565825|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565826|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19565827|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
19565828|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19565829|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19565830|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565831|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
19565832|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565833|NCT02709720|Cisplatin|cisplatin|mesh-list
19565834|NCT02709720|Vinorelbine|vinorelbine|mesh-list
19565835|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19565836|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19565837|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
19565838|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
19565839|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
19565840|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565841|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
19565842|NCT02709668|Vitamins|vitamins|mesh-ancestor
19565843|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
19565844|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115078|NCT00005076|Cetuximab|cetuximab|mesh-list
20115079|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20115080|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19565848|NCT02709590|Diclofenac|diclofenac|mesh-list
19565849|NCT02709590|Lidocaine|lidocaine|mesh-list
19565850|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
19565851|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
19565852|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565853|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565854|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
19565855|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565856|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19565857|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19565858|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19565859|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19565860|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565861|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19565862|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565863|NCT02709590|Analgesics|analgesics|mesh-ancestor
19565864|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19565865|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19565866|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19565867|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565868|NCT02709603|Scopolamine|scopolamine|mesh-list
19565869|NCT02709603|Bromides|bromides|mesh-list
19565870|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19565871|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
19565872|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19565873|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
19565874|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
19565875|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565876|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565877|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565878|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
19565879|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20115081|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115082|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115083|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115084|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19565880|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
19565881|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565882|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565883|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19565884|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
19565885|NCT02709564|Misoprostol|misoprostol|mesh-list
19565886|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19565887|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
19565888|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19565889|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115085|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
20115086|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115087|NCT00005078|Paclitaxel|paclitaxel|mesh-list
19565890|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19565891|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19565892|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
19565893|NCT02709265|Amikacin|amikacin|mesh-list
19565894|NCT02709265|Fosfomycin|fosfomycin|mesh-list
19565895|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565896|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565897|NCT02709304|Lidocaine|lidocaine|mesh-list
19565898|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
19565899|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
19565900|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565901|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565902|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
19565903|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565904|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19565905|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19565906|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19565907|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19565908|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565909|NCT02709473|Remifentanil|remifentanil|mesh-list
19565910|NCT02709473|Propofol|propofol|mesh-list
19565911|NCT02709473|Rocuronium|rocuronium|mesh-list
19565912|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19565913|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565914|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565915|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19565916|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
19565917|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
19565918|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19565919|NCT02709473|Narcotics|narcotics|mesh-ancestor
19565920|NCT02709473|Analgesics|analgesics|mesh-ancestor
19565921|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
19565922|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565923|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19565924|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19565925|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19565926|NCT02709187|Candesartan|candesartan|mesh-list
19565927|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
19565928|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19565929|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19565930|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19565931|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
19565932|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565933|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19565934|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19565935|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565936|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19565937|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19565938|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19565939|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
19565940|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19565941|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565942|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565943|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19565944|NCT02709200|Analgesics|analgesics|mesh-ancestor
19565945|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
19565946|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565947|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19565948|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19565949|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19565950|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
19565951|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19565952|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565953|NCT02709382|Tazobactam|tazobactam|mesh-list
19565954|NCT02709382|Cefepime|cefepime|mesh-list
19565955|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565956|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565957|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19565958|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19565959|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565960|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
19565961|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19565962|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
19565963|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565964|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
19565965|NCT02709525|Protective Agents|protective agents|mesh-ancestor
19565966|NCT02708992|Azithromycin|azithromycin|mesh-list
20604737|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
19565967|NCT02708992|Cefixime|cefixime|mesh-list
19565968|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19565969|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19565970|NCT02709031|Cicletanine|cicletanine|mesh-list
19565971|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19565972|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19565973|NCT02709031|Diuretics|diuretics|mesh-ancestor
19565974|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
19565975|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565976|NCT02708836|Anesthetics|anesthetics|mesh-list
19565977|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565978|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565979|NCT02708628|Heparin|heparin|mesh-list
19565980|NCT02708628|Allantoin|allantoin|mesh-list
19565981|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
19565982|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19565983|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19565984|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19565985|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
19565986|NCT02708693|Triamcinolone|triamcinolone|mesh-list
19565987|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19565988|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19565989|NCT02708693|Lidocaine|lidocaine|mesh-list
19565990|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19565991|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
19565992|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
19565993|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19565994|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19565995|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
19565996|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19565997|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19565998|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19565999|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20115088|NCT00005078|Carboplatin|carboplatin|mesh-list
20115089|NCT00005078|Tirapazamine|tirapazamine|mesh-list
20115090|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115091|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115092|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
19566000|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115093|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115094|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115095|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115096|NCT00005081|Carmustine|carmustine|mesh-list
20115097|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20115098|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115099|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
20115100|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115101|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115102|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115103|NCT00005086|Gemcitabine|gemcitabine|mesh-list
20115104|NCT00005086|Docetaxel|docetaxel|mesh-list
19566001|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566002|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19566003|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
19566004|NCT02708693|Hormones|hormones|mesh-ancestor
19566005|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566006|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566007|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
19566008|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566009|NCT02708511|Copper|copper|mesh-list
19566010|NCT02708511|Trace Elements|trace elements|mesh-ancestor
19566011|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
19566012|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566013|NCT02708394|Olanzapine|olanzapine|mesh-list
19566014|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
19566015|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
19566016|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566017|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566018|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566019|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19566020|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19566021|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566022|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19566023|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19566024|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19566025|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20115105|NCT00005086|Methotrexate|methotrexate|mesh-list
19566026|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566027|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566028|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
19577368|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19577369|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577370|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577371|NCT04478266|Letrozole|letrozole|mesh-list
19577372|NCT04478266|Palbociclib|palbociclib|mesh-list
19577373|NCT04478266|Goserelin|goserelin|mesh-list
19577374|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577375|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19577376|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19577377|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577378|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577379|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19577380|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
19577381|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577382|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577383|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19577384|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577385|NCT04474938|Dexamethasone|dexamethasone|mesh-list
19577386|NCT04474938|Bortezomib|bortezomib|mesh-list
19577387|NCT04474938|Daratumumab|daratumumab|mesh-list
19577388|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19577389|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
19577390|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
19577391|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19577392|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577393|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19577394|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
19577395|NCT04474938|Hormones|hormones|mesh-ancestor
19577396|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19577397|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19577398|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577399|NCT04470973|Amikacin|amikacin|mesh-list
19577400|NCT04470973|Cefuroxime|cefuroxime|mesh-list
19577401|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
19577402|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19577403|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577404|NCT04468815|Esomeprazole|esomeprazole|mesh-list
19577405|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19577406|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19577407|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19577408|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577409|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577410|NCT04460885|Insulin|insulin|mesh-list
19577411|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19577412|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
19577413|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19577414|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577415|NCT04451330|Doxycycline|doxycycline|mesh-list
19577416|NCT04451330|Trifarotene|trifarotene|mesh-list
19577417|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19577418|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577419|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
19577420|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19577421|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19577422|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
19577423|NCT04437329|Cisplatin|cisplatin|mesh-list
19577424|NCT04437329|Docetaxel|docetaxel|mesh-list
19577425|NCT04437329|Fluorouracil|fluorouracil|mesh-list
19577426|NCT04437329|Nedaplatin|nedaplatin|mesh-list
19577427|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577428|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
19577429|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
19577430|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
19577431|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577432|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
20115106|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115107|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115108|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
20115109|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115110|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
20115111|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19577433|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19577434|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19577435|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
19566029|NCT02708160|Fluorides|fluorides|mesh-list
19566030|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
19566031|NCT02708160|Protective Agents|protective agents|mesh-ancestor
19566032|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566033|NCT02708446|Misoprostol|misoprostol|mesh-list
19566034|NCT02708446|Mifepristone|mifepristone|mesh-list
19566035|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19566036|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
19566037|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19566038|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566039|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19566040|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566041|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
19566042|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19566043|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19566044|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19566045|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19566046|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
19566047|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19566048|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19566049|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
19566050|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566051|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
19566052|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19566053|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19566054|NCT02708251|Lidocaine|lidocaine|mesh-list
19566055|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
19566056|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566057|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
19566058|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566059|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566060|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
19566061|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566062|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19566063|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19566064|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19566065|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566066|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566067|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
19566068|NCT02708459|Morphine|morphine|mesh-list
19566069|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19566070|NCT02708459|Narcotics|narcotics|mesh-ancestor
19566071|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566072|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566073|NCT02708459|Analgesics|analgesics|mesh-ancestor
20115112|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115113|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115114|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
20115115|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115116|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115117|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115118|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115119|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20115120|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
20115121|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20115122|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115123|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19566074|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
19566075|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566076|NCT02708173|Vaccines|vaccines|mesh-list
19566077|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
19566078|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566079|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
19566080|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19566081|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566082|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566083|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19566084|NCT02707809|Analgesics|analgesics|mesh-ancestor
19566085|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
19566086|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566087|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19566088|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19566089|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20115124|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566090|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
19566091|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566092|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566093|NCT02707900|Vorinostat|vorinostat|mesh-list
19566094|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566095|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19566096|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566097|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566098|NCT02707874|Ropivacaine|ropivacaine|mesh-list
19566099|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566100|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
20115125|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20115126|NCT00005087|Paclitaxel|paclitaxel|mesh-list
20115127|NCT00005087|Cisplatin|cisplatin|mesh-list
20115128|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115129|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115130|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115131|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115132|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115133|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115134|NCT00005088|Cisplatin|cisplatin|mesh-list
20115135|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115136|NCT00005089|Prednisone|prednisone|mesh-list
20115137|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
19566101|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566102|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566103|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
19566104|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566105|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
19566106|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19566107|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
19566108|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566109|NCT02707913|Amlodipine|amlodipine|mesh-list
19566110|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19566111|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19566112|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566113|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566114|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19566115|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566116|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
19566117|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
19566118|NCT02707666|Pemetrexed|pemetrexed|mesh-list
19566119|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566120|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566121|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566122|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566123|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19566124|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19566125|NCT02707653|Misoprostol|misoprostol|mesh-list
19566126|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19566127|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
19566128|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19566129|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566130|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19566131|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566132|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
19566133|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19566134|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
19566135|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566136|NCT02707458|Probucol|probucol|mesh-list
19566137|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19566138|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19566139|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
19566140|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566141|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19566142|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
19566143|NCT02707458|Protective Agents|protective agents|mesh-ancestor
19566144|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566145|NCT02707484|Thalidomide|thalidomide|mesh-list
19566146|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566147|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
19566148|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566149|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
20115138|NCT00005089|Rituximab|rituximab|mesh-list
20115139|NCT00005089|Doxorubicin|doxorubicin|mesh-list
19566150|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19566151|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566152|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19566153|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19566154|NCT02707484|Growth Substances|growth substances|mesh-ancestor
19566155|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
19566156|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566157|NCT02707445|Clopidogrel|clopidogrel|mesh-list
19566158|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19566159|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19566160|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19566161|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19566162|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
19566163|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566164|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566165|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566166|NCT02707393|Cyclosporine|cyclosporine|mesh-list
19566167|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
19566168|NCT02707393|Fludarabine|fludarabine|mesh-list
19566169|NCT02707393|Melphalan|melphalan|mesh-list
19566170|NCT02707393|Thiotepa|thiotepa|mesh-list
19566171|NCT02707393|Cyclosporins|cyclosporins|mesh-list
19566172|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
19566173|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566174|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566175|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566176|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
19566177|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566178|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566179|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
19566180|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566181|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
19566182|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566183|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19566184|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19566185|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19566186|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
19566187|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19566188|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19566189|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
19566190|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19566191|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
19566192|NCT02707588|Cetuximab|cetuximab|mesh-list
19566193|NCT02707588|Antibodies|antibodies|mesh-list
19566194|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
19566195|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
19566196|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566197|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566198|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566199|NCT02707575|Ranibizumab|ranibizumab|mesh-list
19566200|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19566201|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19566202|NCT02707575|Growth Substances|growth substances|mesh-ancestor
19566203|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566204|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
19566205|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566206|NCT02707328|Gemcitabine|gemcitabine|mesh-list
19566207|NCT02707328|Paclitaxel|paclitaxel|mesh-list
19566208|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19566209|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566210|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
19566211|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
19566212|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
19566213|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566214|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566215|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
19566216|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
19566217|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566218|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566219|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566220|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
19566221|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566222|NCT02707315|Gemcitabine|gemcitabine|mesh-list
19566223|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566224|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
19566225|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566226|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566227|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
19566228|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566229|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566230|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566231|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
19566232|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566233|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19566234|NCT02706977|Carbidopa|carbidopa|mesh-list
19566235|NCT02706977|Levodopa|levodopa|mesh-list
19566236|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19566237|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
19566238|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566239|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19566240|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19566241|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
19566242|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
19566243|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566244|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566245|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19566246|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566247|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19566248|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
19566249|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19566250|NCT02707081|Lidocaine|lidocaine|mesh-list
20115140|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20115141|NCT00005089|Vincristine|vincristine|mesh-list
20604738|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20604739|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19566251|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566252|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
19566253|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566254|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566255|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
19566256|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566257|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19566258|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19566259|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19566260|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566261|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566262|NCT02707263|Heparin|heparin|mesh-list
19566263|NCT02707263|Calcium heparin|calcium heparin|mesh-list
19566264|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
19566265|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19566266|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19566267|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566268|NCT02707224|Candesartan|candesartan|mesh-list
19566269|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
19566270|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19566271|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19566272|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19566273|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
19566274|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566275|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19566276|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19566277|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566278|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19566279|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19566280|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19566281|NCT02707159|Gemcitabine|gemcitabine|mesh-list
19566282|NCT02707159|Paclitaxel|paclitaxel|mesh-list
19566283|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19566284|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19566285|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566286|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
19566287|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
19566288|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
19566289|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566290|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566291|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
19566292|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
19566293|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566294|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115142|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20604740|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604741|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
20604742|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604743|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
20604744|NCT02228850|Alprostadil|alprostadil|mesh-list
20604745|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20604746|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
20604747|NCT02228850|Urological Agents|urological agents|mesh-ancestor
20604748|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20604749|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20604750|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20604751|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604752|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604753|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19566295|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566296|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
19566297|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566298|NCT02707211|Antibodies|antibodies|mesh-list
19566299|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
19566300|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
19566301|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566302|NCT02707250|Meperidine|meperidine|mesh-list
19566303|NCT02707250|Bupivacaine|bupivacaine|mesh-list
19566304|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566305|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
19566306|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566307|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566308|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
19566309|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566310|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19566311|NCT02707250|Narcotics|narcotics|mesh-ancestor
19566312|NCT02707250|Analgesics|analgesics|mesh-ancestor
19566313|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19566314|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
19566315|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566316|NCT02707016|Sevoflurane|sevoflurane|mesh-list
19566317|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19566318|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19566319|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
19566320|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
19566321|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566322|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566323|NCT02706704|Adalimumab|adalimumab|mesh-list
19566324|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19566325|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566326|NCT02706769|Acetaminophen|acetaminophen|mesh-list
19566327|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19566328|NCT02706769|Analgesics|analgesics|mesh-ancestor
19566329|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
19566330|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566331|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566332|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
19566333|NCT02706678|Tacrolimus|tacrolimus|mesh-list
19566334|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566335|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
19566336|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566337|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19566338|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566339|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566340|NCT02706860|Atorvastatin|atorvastatin|mesh-list
19566341|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19566342|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19566343|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
19566344|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566345|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19566346|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19566347|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577436|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577437|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
19577438|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19577439|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577440|NCT04400994|Rituximab|rituximab|mesh-list
19577441|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19577442|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577443|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
20604754|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566348|NCT02706470|Cyclosporine|cyclosporine|mesh-list
19566349|NCT02706470|Cyclosporins|cyclosporins|mesh-list
19566350|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
19566351|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566352|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604755|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604756|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
20604757|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20604758|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
20604759|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
20604760|NCT02228902|Trace Elements|trace elements|mesh-ancestor
20604761|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
20604762|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604763|NCT02228902|Hematinics|hematinics|mesh-ancestor
20604764|NCT02228928|Capsaicin|capsaicin|mesh-list
20604765|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
20604766|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
20604767|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
20604768|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20604769|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604770|NCT02229045|Paclitaxel|paclitaxel|mesh-list
20604771|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20604772|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604773|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604774|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604775|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
19566353|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19566354|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
19566355|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566356|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
20115143|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
20115144|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115145|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566357|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566358|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
19566359|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566360|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19566361|NCT02706470|Progestins|progestins|mesh-ancestor
19566362|NCT02706470|Hormones|hormones|mesh-ancestor
19566363|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566364|NCT02706535|Itraconazole|itraconazole|mesh-list
19566365|NCT02706535|Rifampin|rifampin|mesh-list
19566366|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
19566367|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566368|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19566369|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19566370|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20604776|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604777|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604778|NCT02229058|Paclitaxel|paclitaxel|mesh-list
20604779|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20604780|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20604781|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604782|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
20604783|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
20604784|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
20604785|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20604786|NCT02229123|Levetiracetam|levetiracetam|mesh-list
20604787|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
20604788|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
20604789|NCT02229175|Bevacizumab|bevacizumab|mesh-list
20604790|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20604791|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20604792|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20604793|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20604794|NCT02229175|Growth Substances|growth substances|mesh-ancestor
20604795|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566371|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566372|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19566373|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
20115146|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115147|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
19566374|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604796|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
20604797|NCT02229201|Propofol|propofol|mesh-list
20604798|NCT02229201|Sevoflurane|sevoflurane|mesh-list
19566375|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566376|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19566377|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19566378|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
19566379|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19566380|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
19566381|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19566382|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19566383|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19566384|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19566385|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19566386|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19566387|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19566388|NCT02706509|Tramadol|tramadol|mesh-list
19566389|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566390|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566391|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19566392|NCT02706509|Narcotics|narcotics|mesh-ancestor
19566393|NCT02706509|Analgesics|analgesics|mesh-ancestor
19566394|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
19566395|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566396|NCT02706236|Pancrelipase|pancrelipase|mesh-list
19566397|NCT02706236|Pancreatin|pancreatin|mesh-list
19566398|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566399|NCT05265676|Enoxaparin|enoxaparin|mesh-list
19566400|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
19566401|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
19566402|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19566403|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19566404|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115148|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115149|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115150|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115151|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115152|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115153|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115154|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115155|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115156|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115157|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
20115158|NCT00005089|Hormones|hormones|mesh-ancestor
20115159|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115160|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20115161|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115162|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
19566405|NCT05265546|Psilocybin|psilocybin|mesh-list
19566406|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
19566407|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566408|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19566409|NCT05265442|Methadone|methadone|mesh-list
20115163|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115164|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115165|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
20115166|NCT00005090|Dacarbazine|dacarbazine|mesh-list
20115167|NCT00005090|Carmustine|carmustine|mesh-list
20115168|NCT00005090|Doxorubicin|doxorubicin|mesh-list
19566410|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19566411|NCT05265442|Narcotics|narcotics|mesh-ancestor
19566412|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566413|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566414|NCT05265442|Analgesics|analgesics|mesh-ancestor
19566415|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
19566416|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566417|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
19566418|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
19566419|NCT05265299|Aspirin|aspirin|mesh-list
19566420|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19566421|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19566422|NCT05265299|Analgesics|analgesics|mesh-ancestor
19566423|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
19566424|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566425|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566426|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19566427|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19566428|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19566429|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19566430|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566431|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19566432|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19566433|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566434|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
19566435|NCT05265286|Factor VIII|factor viii|mesh-list
19566436|NCT05265286|Coagulants|coagulants|mesh-ancestor
19566437|NCT05265065|Vaccines|vaccines|mesh-list
19566438|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
19566439|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566440|NCT05264974|Vaccines|vaccines|mesh-list
19566441|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
19566442|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566443|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19566444|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
19566445|NCT05264922|Coagulants|coagulants|mesh-ancestor
19566446|NCT05264883|Azacitidine|azacitidine|mesh-list
19566447|NCT05264883|Decitabine|decitabine|mesh-list
19566448|NCT05264883|Venetoclax|venetoclax|mesh-list
19566449|NCT05264883|Aclarubicin|aclarubicin|mesh-list
19566450|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566451|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
19566452|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566453|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566454|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566455|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19566456|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19566457|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19566458|NCT05264805|Bupivacaine|bupivacaine|mesh-list
19566459|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
19566460|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
19566461|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566462|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566463|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
19566464|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566465|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19566466|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
19566467|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566468|NCT05264506|Estradiol|estradiol|mesh-list
19566469|NCT05264506|Estrogens|estrogens|mesh-ancestor
19566470|NCT05264506|Hormones|hormones|mesh-ancestor
19566471|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566472|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566473|NCT05264493|Naloxone|naloxone|mesh-list
20115169|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20115170|NCT00005090|Etoposide|etoposide|mesh-list
20115171|NCT00005090|Bleomycin|bleomycin|mesh-list
20115172|NCT00005090|Vinblastine|vinblastine|mesh-list
20115173|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115174|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
20115175|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115176|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115177|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115178|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
20115179|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115180|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115181|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115182|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20115183|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20115184|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115185|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566474|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19566475|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566476|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
19566477|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566478|NCT05264142|Voriconazole|voriconazole|mesh-list
19566479|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
19566480|NCT05264142|Omeprazole|omeprazole|mesh-list
19566481|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19566482|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566483|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19566484|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566485|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566486|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
19566487|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115186|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19566488|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19566489|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19566490|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19566491|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
19566492|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566493|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566494|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19566495|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19566496|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19566497|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566498|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20115187|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115188|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115189|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115190|NCT00005091|Exatecan|exatecan|mesh-list
20115191|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20115192|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20115193|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115194|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115195|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115196|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
20115197|NCT00005092|Thiotepa|thiotepa|mesh-list
20115198|NCT00005092|Methoxsalen|methoxsalen|mesh-list
20115199|NCT00005092|Furocoumarins|furocoumarins|mesh-list
20115200|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115201|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
20115202|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115203|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115204|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20115205|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
19566499|NCT05264142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19566500|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19566501|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19566502|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566503|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
20115206|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115207|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566504|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19566505|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
19566506|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19566507|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19566508|NCT05264077|Midazolam|midazolam|mesh-list
19566509|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
19566510|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19566511|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566512|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566513|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19566514|NCT05264077|Analgesics|analgesics|mesh-ancestor
19566515|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
19566516|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566517|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19566518|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19566519|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19566520|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
19566521|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566522|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566523|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19566524|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19566525|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19566526|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19566527|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19566528|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
19566529|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
19566530|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
19566531|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
19577444|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577445|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19577446|NCT04400929|Molgramostim|molgramostim|mesh-list
19577447|NCT04400929|Sargramostim|sargramostim|mesh-list
19577448|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
19577449|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19577450|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115208|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20115209|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19566532|NCT05264025|Fexofenadine|fexofenadine|mesh-list
19566533|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19566534|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19566535|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19566536|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
19566537|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
19566538|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566539|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566540|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566541|NCT05263986|Adagrasib|adagrasib|mesh-list
19566542|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566543|NCT05263947|Bevacizumab|bevacizumab|mesh-list
19566544|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566545|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566546|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19566547|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19566548|NCT05263947|Growth Substances|growth substances|mesh-ancestor
19566549|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566550|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
19566551|NCT05263921|Ritonavir|ritonavir|mesh-list
19566552|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19566553|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19566554|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
19566555|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566556|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115210|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
20115211|NCT00005093|Gemcitabine|gemcitabine|mesh-list
20115212|NCT00005093|Tacedinaline|tacedinaline|mesh-list
20115213|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20115214|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
20115215|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115216|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115217|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
20115218|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115219|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115220|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115221|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
19566557|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19566558|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19566559|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
19566560|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566561|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20115222|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115223|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20115224|NCT00005094|Celecoxib|celecoxib|mesh-list
20115225|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19566562|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20115226|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19566563|NCT05263882|Gemcitabine|gemcitabine|mesh-list
19566564|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566565|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
20115227|NCT00005094|Analgesics|analgesics|mesh-ancestor
20115228|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
20115229|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115230|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115231|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20115232|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20115233|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20115234|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20115235|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115236|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115237|NCT00005096|Docetaxel|docetaxel|mesh-list
20115238|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20115239|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
20115240|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
20115241|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
20115242|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115243|NCT00005104|Metformin|metformin|mesh-list
20115244|NCT00005104|Clomiphene|clomiphene|mesh-list
20115245|NCT00005104|Enclomiphene|enclomiphene|mesh-list
20115246|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
20115247|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20115248|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115249|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20115250|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
20115251|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115252|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20115253|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
19566566|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566567|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566568|NCT05263882|Antiviral Agents|antiviral agents|mesh-ancestor
19566569|NCT05263882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566570|NCT05263882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566571|NCT05263882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115254|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20115255|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20115256|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20115257|NCT00005106|Lamivudine|lamivudine|mesh-list
20115258|NCT00005106|Zidovudine|zidovudine|mesh-list
20115259|NCT00005106|Abacavir|abacavir|mesh-list
20115260|NCT00005106|Stavudine|stavudine|mesh-list
20115261|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20115262|NCT00005106|Nelfinavir|nelfinavir|mesh-list
20115263|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19566572|NCT05263882|Immunologic Factors|immunologic factors|mesh-ancestor
19566573|NCT05263882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566574|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19566575|NCT05263778|Ezetimibe|ezetimibe|mesh-list
19566576|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19566577|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19566578|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
19566579|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566580|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19566581|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566582|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19566583|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566584|NCT05263700|FAPI-46|fapi-46|mesh-list
19566585|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19566586|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566587|NCT05260684|Trametinib|trametinib|mesh-list
19566588|NCT05260684|Vemurafenib|vemurafenib|mesh-list
19566589|NCT05260684|Dabrafenib|dabrafenib|mesh-list
19566590|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566591|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19566592|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566593|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566594|NCT05260619|Lenalidomide|lenalidomide|mesh-list
19566595|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
19566596|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566597|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19566598|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19566599|NCT05260619|Growth Substances|growth substances|mesh-ancestor
19566600|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
19566601|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566602|NCT05260554|Fosfomycin|fosfomycin|mesh-list
19566603|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19566604|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19566605|NCT05260255|Vitamin D|vitamin d|mesh-list
19566606|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
19566607|NCT05260255|Vitamins|vitamins|mesh-ancestor
19566608|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
19566609|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566610|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19566611|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19566612|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
19566613|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19566614|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19566615|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
19566616|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19566617|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566618|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566619|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
19566620|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
19566621|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566622|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
19566623|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19566624|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
20115264|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20115265|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115266|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566625|NCT05259839|Dexamethasone|dexamethasone|mesh-list
19566626|NCT05259839|Lenalidomide|lenalidomide|mesh-list
19566627|NCT05259839|Daratumumab|daratumumab|mesh-list
19566628|NCT05259839|Pomalidomide|pomalidomide|mesh-list
19566629|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19566630|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
19566631|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
19566632|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566633|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566634|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566635|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
19566636|NCT05259839|Hormones|hormones|mesh-ancestor
19566637|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566638|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19566639|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566640|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
19566641|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19566642|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19566643|NCT05259839|Growth Substances|growth substances|mesh-ancestor
19566644|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
19566645|NCT05259787|Propofol|propofol|mesh-list
19566646|NCT05259787|Etomidate|etomidate|mesh-list
19566647|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19566648|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566649|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566650|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19566651|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
20115267|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
20115268|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20115269|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20115270|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20115271|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
20115272|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20115273|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19566652|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
19566653|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
19566654|NCT05244031|Narcotics|narcotics|mesh-ancestor
19566655|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566656|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566657|NCT05244031|Analgesics|analgesics|mesh-ancestor
19566658|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
19566659|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19566660|NCT05243550|Mitomycins|mitomycins|mesh-list
19566661|NCT05243550|Mitomycin|mitomycin|mesh-list
19566662|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19566663|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566664|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
20604799|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20604800|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20604801|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604802|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20115274|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
20115275|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20115276|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115277|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115278|NCT00005108|Estradiol|estradiol|mesh-list
20115279|NCT00005108|Progesterone|progesterone|mesh-list
20115280|NCT00005108|Estrogens|estrogens|mesh-ancestor
20115281|NCT00005108|Hormones|hormones|mesh-ancestor
20604803|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
20604804|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
20604805|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19566665|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566666|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19566667|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566668|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19566669|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566670|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19577451|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20604806|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20604807|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
19577452|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19577453|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19577454|NCT04385277|Vitamin A|vitamin a|mesh-list
20604808|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19577455|NCT04385277|Irinotecan|irinotecan|mesh-list
20115282|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19566671|NCT05237947|Vaccines|vaccines|mesh-list
19566672|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
19566673|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566674|NCT05236647|Morphine|morphine|mesh-list
19566675|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19566676|NCT05236647|Narcotics|narcotics|mesh-ancestor
19566677|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19566678|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566679|NCT05236647|Analgesics|analgesics|mesh-ancestor
19566680|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
19566681|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115283|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115284|NCT00005108|Progestins|progestins|mesh-ancestor
20115285|NCT00005110|Albuterol|albuterol|mesh-list
19566685|NCT05233696|Paclitaxel|paclitaxel|mesh-list
19566686|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19566687|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
19566688|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20115286|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20115287|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20115288|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
20115289|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20115290|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566689|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566690|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
19566691|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
19566692|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
19566693|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566694|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19566695|NCT05227833|Pantoprazole|pantoprazole|mesh-list
19566696|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19566697|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19566698|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19566699|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19566700|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19566701|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19566702|NCT05225545|Iron|iron|mesh-list
20604809|NCT02229240|Incretins|incretins|mesh-ancestor
20604810|NCT02229240|Hormones|hormones|mesh-ancestor
20604811|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20604812|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20604813|NCT02229266|Cytarabine|cytarabine|mesh-list
20604814|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19566703|NCT05225545|Trace Elements|trace elements|mesh-ancestor
19566704|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
19566705|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19566706|NCT05222971|Durvalumab|durvalumab|mesh-list
19566707|NCT05222971|Olaparib|olaparib|mesh-list
19566708|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20115291|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20115292|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
20115293|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20115294|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20115295|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20115296|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
20115297|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20115298|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20115299|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
20115300|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20115301|NCT00005112|Hormones|hormones|mesh-list
20115302|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20115303|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115304|NCT00005113|Cyclosporine|cyclosporine|mesh-list
20115305|NCT00005113|Sirolimus|sirolimus|mesh-list
20115306|NCT00005113|Tacrolimus|tacrolimus|mesh-list
20115307|NCT00005113|Cyclosporins|cyclosporins|mesh-list
20115308|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20115309|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
19566709|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19566710|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20115310|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20115311|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20604815|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
19566711|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20115312|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19577456|NCT04385277|Temozolomide|temozolomide|mesh-list
19578374|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578375|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578376|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578377|NCT02580994|Carboplatin|carboplatin|mesh-list
19578378|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
19578379|NCT02580994|Etoposide|etoposide|mesh-list
19578380|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578381|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578382|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120785|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20120786|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120787|NCT00006427|Amitriptyline|amitriptyline|mesh-list
19578383|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578384|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578385|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578386|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578387|NCT02576509|Nivolumab|nivolumab|mesh-list
19578388|NCT02576509|Sorafenib|sorafenib|mesh-list
19578389|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578390|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578391|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578392|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578393|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578394|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578395|NCT02502266|Paclitaxel|paclitaxel|mesh-list
19578396|NCT02502266|Doxorubicin|doxorubicin|mesh-list
19578397|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19578398|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19578399|NCT02502266|Topotecan|topotecan|mesh-list
19578400|NCT02502266|Olaparib|olaparib|mesh-list
19578401|NCT02502266|Cediranib|cediranib|mesh-list
19578402|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19578403|NCT02502266|Maleic acid|maleic acid|mesh-list
19578404|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578405|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578406|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578407|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578408|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578409|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578410|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19578411|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578412|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578413|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578414|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19578415|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578416|NCT02498600|Nivolumab|nivolumab|mesh-list
19578417|NCT02498600|Ipilimumab|ipilimumab|mesh-list
19578418|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578419|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578420|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578421|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578422|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
19578423|NCT02448225|Fluorides|fluorides|mesh-list
19578424|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19578425|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
19578426|NCT02448225|Protective Agents|protective agents|mesh-ancestor
19578427|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578428|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19578429|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578430|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
19578431|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
19578432|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578433|NCT02436707|Gemcitabine|gemcitabine|mesh-list
19578434|NCT02436707|Dexamethasone|dexamethasone|mesh-list
19578435|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
19578436|NCT02436707|Rituximab|rituximab|mesh-list
19578437|NCT02436707|Etoposide|etoposide|mesh-list
19578438|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578439|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
19578440|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120788|NCT00006427|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20173308|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
19578441|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578442|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578443|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
19578444|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578445|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578446|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19578447|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578448|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578449|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
19578450|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
19578451|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578452|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19578453|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
19578454|NCT02436707|Hormones|hormones|mesh-ancestor
19578455|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578456|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578457|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578458|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
19578459|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
19578460|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578461|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578462|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578463|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578464|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578465|NCT02352948|Gemcitabine|gemcitabine|mesh-list
19578466|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19578467|NCT02352948|Durvalumab|durvalumab|mesh-list
19578468|NCT02352948|Vinorelbine|vinorelbine|mesh-list
19578469|NCT02352948|Tremelimumab|tremelimumab|mesh-list
19578470|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578471|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578472|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
19578473|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578474|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578475|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
19578476|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578477|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578478|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578479|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
19578480|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578481|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578482|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578483|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578484|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578485|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578486|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578487|NCT02339571|Nivolumab|nivolumab|mesh-list
19578488|NCT02339571|Ipilimumab|ipilimumab|mesh-list
19578489|NCT02339571|Sargramostim|sargramostim|mesh-list
19578490|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578491|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578492|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578493|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578494|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
19578495|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578496|NCT02320435|Trastuzumab|trastuzumab|mesh-list
19578497|NCT02320435|Pertuzumab|pertuzumab|mesh-list
19578498|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578499|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578500|NCT02318095|Gemcitabine|gemcitabine|mesh-list
19578501|NCT02318095|Paclitaxel|paclitaxel|mesh-list
19578502|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578503|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578504|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578505|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578506|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578507|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578508|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578509|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
19578510|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
19578511|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578512|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578513|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578514|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
19578515|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578516|NCT02257528|Nivolumab|nivolumab|mesh-list
19578517|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578518|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578519|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19666218|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19578520|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578521|NCT02200978|Cytarabine|cytarabine|mesh-list
19578522|NCT02200978|Methotrexate|methotrexate|mesh-list
19578523|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
19578524|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
19578525|NCT02200978|Tretinoin|tretinoin|mesh-list
19578526|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
19578527|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19578528|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
19578529|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19578530|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578531|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578532|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
19578533|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578534|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578535|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578536|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578537|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19578538|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578539|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
19578540|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578541|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19578542|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
19578543|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578544|NCT02200978|Analgesics|analgesics|mesh-ancestor
20120789|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20120790|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
20120791|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20120792|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20120793|NCT00006427|Analgesics|analgesics|mesh-ancestor
20120794|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
20120795|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120796|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120797|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20120798|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20120799|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20120800|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120801|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
20120802|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120803|NCT00006427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20120804|NCT00006427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20120805|NCT00006427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20120806|NCT00006428|Amitriptyline|amitriptyline|mesh-list
20120807|NCT00006428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20120808|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20120809|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
20120810|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20120811|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20120812|NCT00006428|Analgesics|analgesics|mesh-ancestor
20120813|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
20120814|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120815|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120816|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20120817|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20120818|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20120819|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120820|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
20120821|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20120822|NCT00006428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20120823|NCT00006428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20120824|NCT00006428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20120825|NCT00006441|Lamivudine|lamivudine|mesh-list
20120826|NCT00006441|Zidovudine|zidovudine|mesh-list
20120827|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20120828|NCT00006441|Aldesleukin|aldesleukin|mesh-list
20309020|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578545|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
19835421|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120829|NCT00006441|Nelfinavir|nelfinavir|mesh-list
20120830|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20120831|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120832|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120833|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120834|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
20120835|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578546|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578547|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578548|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20608165|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
20608166|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578549|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
19578550|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
19578551|NCT02176967|Carboplatin|carboplatin|mesh-list
19578552|NCT02176967|Doxorubicin|doxorubicin|mesh-list
19578553|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19578554|NCT02176967|Etoposide|etoposide|mesh-list
19578555|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
19578556|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
19578557|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578558|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
19578559|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578560|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578561|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578562|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
19578563|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578564|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578565|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19578566|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19578567|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578568|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578569|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578570|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578571|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
19578572|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578573|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578574|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578575|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578576|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19578577|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19578578|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19578579|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578580|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578581|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19578582|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19578583|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578584|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
19578585|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19578586|NCT02155647|Avelumab|avelumab|mesh-list
19578587|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578588|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578589|NCT02143414|Prednisone|prednisone|mesh-list
19578590|NCT02143414|Cortisone|cortisone|mesh-list
19578591|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19578592|NCT02143414|Methotrexate|methotrexate|mesh-list
19578593|NCT02143414|Vincristine|vincristine|mesh-list
19578594|NCT02143414|Dasatinib|dasatinib|mesh-list
19578595|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
19578596|NCT02143414|Blinatumomab|blinatumomab|mesh-list
19578597|NCT02143414|Antibodies|antibodies|mesh-list
20120836|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120837|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120838|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
20120839|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120840|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20120841|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20120842|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
20120843|NCT00006443|Lamivudine|lamivudine|mesh-list
20120844|NCT00006443|Stavudine|stavudine|mesh-list
20120845|NCT00006443|Nelfinavir|nelfinavir|mesh-list
20120846|NCT00006443|Indinavir|indinavir|mesh-list
20120847|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19578598|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
19578599|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578600|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
19578601|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20173309|NCT00161239|Hormones|hormones|mesh-ancestor
19578602|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
20120848|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120849|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578603|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578604|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578605|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578606|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
19578607|NCT02143414|Hormones|hormones|mesh-ancestor
19578608|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578609|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578610|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19578611|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
19578612|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19578613|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578614|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
19578615|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578616|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578617|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578618|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19578619|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578620|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578621|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19578622|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578623|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578624|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578625|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578626|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578627|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
19578628|NCT02059265|Dasatinib|dasatinib|mesh-list
19578629|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578630|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578631|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578632|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578633|NCT02032810|Ipilimumab|ipilimumab|mesh-list
19578634|NCT02032810|Panobinostat|panobinostat|mesh-list
19578635|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578636|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578637|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578638|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578639|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19578640|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578641|NCT02012114|Cysteamine|cysteamine|mesh-list
19578642|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19578643|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578644|NCT01979211|Cetuximab|cetuximab|mesh-list
19578645|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578646|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578647|NCT01965704|Ondansetron|ondansetron|mesh-list
19578648|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
19578649|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
19578650|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578651|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578652|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19578653|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
19578654|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578655|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19578656|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
19578657|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19578658|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578659|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19578660|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19578661|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19578662|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19578663|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19578664|NCT01962415|Fludarabine|fludarabine|mesh-list
19578665|NCT01962415|Melphalan|melphalan|mesh-list
19578666|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
19578667|NCT01962415|Thiotepa|thiotepa|mesh-list
19578668|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
19578669|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578670|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578671|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578672|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
19578673|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347179|NCT00858273|Protective Agents|protective agents|mesh-ancestor
19578674|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578675|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
19578676|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19578677|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578678|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
19578679|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578680|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19578681|NCT01904903|Trastuzumab|trastuzumab|mesh-list
19578682|NCT01904903|Pertuzumab|pertuzumab|mesh-list
19578683|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19578684|NCT01904903|Maytansine|maytansine|mesh-list
19578685|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578686|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578687|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578688|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578689|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578690|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578691|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578692|NCT01880359|Nimorazole|nimorazole|mesh-list
19578693|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19578694|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19578695|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19578696|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578697|NCT01827384|Carboplatin|carboplatin|mesh-list
19578698|NCT01827384|Everolimus|everolimus|mesh-list
19578699|NCT01827384|Temozolomide|temozolomide|mesh-list
19578700|NCT01827384|Trametinib|trametinib|mesh-list
19578701|NCT01827384|Veliparib|veliparib|mesh-list
19578702|NCT01827384|Adavosertib|adavosertib|mesh-list
19578703|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578704|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578705|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
19578706|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578707|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578708|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
20120850|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120851|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
19578709|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578710|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578711|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578712|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19578713|NCT01778946|Nicotine|nicotine|mesh-list
19578714|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19578715|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
19578716|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578717|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578718|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19578719|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19578720|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
19578721|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19578722|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578723|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19578724|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19578725|NCT01771107|Doxorubicin|doxorubicin|mesh-list
19578726|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19578727|NCT01771107|Dacarbazine|dacarbazine|mesh-list
19578728|NCT01771107|Vinblastine|vinblastine|mesh-list
19578729|NCT01771107|Antibodies|antibodies|mesh-list
19578730|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
19578731|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578732|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
19578733|NCT01771107|Imidazole|imidazole|mesh-list
19578734|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
19578735|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578736|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578737|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19578738|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578739|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578740|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578741|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578742|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578743|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
19578744|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578745|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578746|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578747|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578748|NCT01706692|Cyclosporine|cyclosporine|mesh-list
19578749|NCT01706692|Adalimumab|adalimumab|mesh-list
19578750|NCT01706692|Etanercept|etanercept|mesh-list
19578751|NCT01706692|Methotrexate|methotrexate|mesh-list
19578752|NCT01706692|Infliximab|infliximab|mesh-list
19578753|NCT01706692|Ustekinumab|ustekinumab|mesh-list
19578754|NCT01706692|Cyclosporins|cyclosporins|mesh-list
19578755|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19578756|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
19578757|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19578758|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578759|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19578760|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
19578761|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578762|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578763|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578764|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120852|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120853|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20120854|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20120855|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
20120856|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20120857|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20120858|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
20120859|NCT00006448|Methadone|methadone|mesh-list
20120860|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19578765|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19578766|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578767|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
19578768|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578769|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19578770|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
19578771|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578772|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19578773|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578774|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19578775|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19578776|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19578777|NCT01706692|Analgesics|analgesics|mesh-ancestor
19578778|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
19578779|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578780|NCT01597388|Fulvestrant|fulvestrant|mesh-list
19578781|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578782|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578783|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19578784|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19578785|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
19578786|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578787|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578788|NCT01524926|Crizotinib|crizotinib|mesh-list
19578789|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578790|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19578791|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578792|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578793|NCT01517802|Prednisone|prednisone|mesh-list
19578794|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
19578795|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578796|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
19578797|NCT01517802|Hormones|hormones|mesh-ancestor
19578798|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578799|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578800|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578801|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578802|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19578803|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578804|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578805|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
19578806|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19578807|NCT01409161|Vitamins|vitamins|mesh-list
19578808|NCT01409161|Vitamin A|vitamin a|mesh-list
19578809|NCT01409161|Tretinoin|tretinoin|mesh-list
19578810|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
19578811|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
19578812|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
19578813|NCT01409161|Calicheamicins|calicheamicins|mesh-list
19578814|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
19578815|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578816|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578817|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
19578818|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
20120861|NCT00006448|Narcotics|narcotics|mesh-ancestor
19578819|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
19578820|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578821|NCT01409161|Protective Agents|protective agents|mesh-ancestor
19578822|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19578823|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578824|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19578825|NCT01269424|Temozolomide|temozolomide|mesh-list
19578826|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19578827|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578828|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
19578829|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578830|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578831|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578832|NCT01134614|Ipilimumab|ipilimumab|mesh-list
19578833|NCT01134614|Sargramostim|sargramostim|mesh-list
19578834|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19578835|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578836|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19578837|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578838|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
19578839|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578840|NCT01081262|Paclitaxel|paclitaxel|mesh-list
19578841|NCT01081262|Bevacizumab|bevacizumab|mesh-list
19578842|NCT01081262|Carboplatin|carboplatin|mesh-list
19578843|NCT01081262|Capecitabine|capecitabine|mesh-list
19578844|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
19578845|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19578846|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19578847|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
19578848|NCT01081262|Antibodies|antibodies|mesh-list
19578849|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
19578850|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578851|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
19578852|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578853|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578854|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578855|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578856|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578857|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578858|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19578859|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19578860|NCT01081262|Growth Substances|growth substances|mesh-ancestor
19578861|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578862|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
19578863|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
19578864|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120862|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20120863|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120864|NCT00006448|Analgesics|analgesics|mesh-ancestor
20120865|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
20120866|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120867|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
20120868|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
20120869|NCT00006449|Naltrexone|naltrexone|mesh-list
20120870|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20120871|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20120872|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120873|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
20120874|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120875|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20120876|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120877|NCT00006451|Cyclosporine|cyclosporine|mesh-list
20120878|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
20120879|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
19578865|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
19578866|NCT01038778|Aldesleukin|aldesleukin|mesh-list
20120880|NCT00006451|Methotrexate|methotrexate|mesh-list
20120881|NCT00006451|Cyclosporins|cyclosporins|mesh-list
19578867|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
19578868|NCT01038778|Interleukin-2|interleukin-2|mesh-list
19578869|NCT01038778|Entinostat|entinostat|mesh-list
19578870|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19578871|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19578872|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578873|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19578874|NCT01038778|Analgesics|analgesics|mesh-ancestor
19578875|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
19578876|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578877|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578878|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19578879|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19578880|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
19578881|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578882|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19578883|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578884|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578885|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
19578886|NCT00972478|Prednisone|prednisone|mesh-list
19578887|NCT00972478|Cortisone|cortisone|mesh-list
19578888|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
19578889|NCT00972478|Rituximab|rituximab|mesh-list
19578890|NCT00972478|Doxorubicin|doxorubicin|mesh-list
19578891|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19578892|NCT00972478|Vincristine|vincristine|mesh-list
19578893|NCT00972478|Vorinostat|vorinostat|mesh-list
19578894|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19578895|NCT00972478|Antibodies|antibodies|mesh-list
19578896|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
19578897|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19578898|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19578899|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
20120882|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20120883|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120884|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
20120885|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120886|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578900|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578901|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19578902|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19578903|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
19578904|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578905|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578906|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19578907|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19578908|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19578909|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19578910|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578911|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578912|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
19578913|NCT00972478|Hormones|hormones|mesh-ancestor
19578914|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578915|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578916|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19578917|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
19578918|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
19578919|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
19578920|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19578921|NCT00715611|Carboplatin|carboplatin|mesh-list
19578922|NCT00715611|Pemetrexed|pemetrexed|mesh-list
19578923|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578924|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578925|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578926|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19578927|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19578928|NCT00455325|Chloroquine|chloroquine|mesh-list
19578929|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19578930|NCT00455325|Amebicides|amebicides|mesh-ancestor
19578931|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19578932|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20120887|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20120888|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
19578933|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578934|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
19578935|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20347180|NCT00858299|Valsartan|valsartan|mesh-list
19578936|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19578937|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19578938|NCT00455325|Analgesics|analgesics|mesh-ancestor
19578939|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
19578940|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578941|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578942|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20120889|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120890|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120891|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20120892|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20120893|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
20120894|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20120895|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120896|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
20120897|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578943|NCT00455325|Filaricides|filaricides|mesh-ancestor
19578944|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
19578945|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
19578946|NCT00382200|Decitabine|decitabine|mesh-list
19578947|NCT00382200|Tretinoin|tretinoin|mesh-list
19578948|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120898|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120899|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20120900|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20120901|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
20120902|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120903|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20120904|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20120905|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
20120906|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
20120907|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20120908|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20120909|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
20120910|NCT00006451|Hormones|hormones|mesh-ancestor
20120911|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20120912|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20120913|NCT00006451|Protective Agents|protective agents|mesh-ancestor
19578949|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
19578950|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578951|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578952|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578953|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
19578954|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578955|NCT00321555|Immunotoxins|immunotoxins|mesh-list
19578956|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
19578957|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578958|NCT00098475|Thalidomide|thalidomide|mesh-list
19578959|NCT00098475|Dexamethasone|dexamethasone|mesh-list
19578960|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
19578961|NCT00098475|Lenalidomide|lenalidomide|mesh-list
20120914|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
20120915|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578962|NCT00098475|Ichthammol|ichthammol|mesh-list
19578963|NCT00098475|BB 1101|bb 1101|mesh-list
19578964|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19578965|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
19578966|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
19578967|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19578968|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578969|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19578970|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
19578971|NCT00098475|Hormones|hormones|mesh-ancestor
19578972|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19578973|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19578974|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19578975|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
19578976|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19578977|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19578978|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
19578979|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19578980|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19578981|NCT00098475|Growth Substances|growth substances|mesh-ancestor
19578982|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
19578983|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20120916|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19578984|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
19578985|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19578986|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578987|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19578988|NCT02696928|Lumefantrine|lumefantrine|mesh-list
19578989|NCT02696928|Primaquine|primaquine|mesh-list
19578990|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
19578991|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19578992|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19578993|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19578994|NCT02696720|Lidocaine|lidocaine|mesh-list
19578995|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
19578996|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
19578997|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19578998|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19578999|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
20120917|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
20120918|NCT00006453|Gemcitabine|gemcitabine|mesh-list
20120919|NCT00006453|Carboplatin|carboplatin|mesh-list
20120920|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120921|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20120922|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
20120923|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120924|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
20120925|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20120926|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20120927|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579000|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579001|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579002|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19579003|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19579004|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579005|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579006|NCT02696694|Progesterone|progesterone|mesh-list
19579007|NCT02696694|Progestins|progestins|mesh-ancestor
19579008|NCT02696694|Hormones|hormones|mesh-ancestor
19579009|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579010|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120928|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
20120929|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20120930|NCT00006454|Paclitaxel|paclitaxel|mesh-list
20120931|NCT00006454|Carboplatin|carboplatin|mesh-list
20120932|NCT00006454|Topotecan|topotecan|mesh-list
20120933|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20120934|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20120935|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
20120936|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
20120937|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
20120938|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20120939|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20120940|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20120941|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656166|NCT04780464|Prednisone|prednisone|mesh-list
19656167|NCT04780464|Prednisolone|prednisolone|mesh-list
19656168|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
19656169|NCT04780464|Doxorubicin|doxorubicin|mesh-list
19656170|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19656171|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19656172|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
19656173|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579011|NCT02696993|Nivolumab|nivolumab|mesh-list
19579012|NCT02696993|Ipilimumab|ipilimumab|mesh-list
19579013|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19579014|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579015|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19579016|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579017|NCT02696941|Metformin|metformin|mesh-list
19579018|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19579019|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579020|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579021|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579022|NCT02696954|Lumefantrine|lumefantrine|mesh-list
19579023|NCT02696954|Artemether|artemether|mesh-list
19579024|NCT02696954|Primaquine|primaquine|mesh-list
19579025|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19579026|NCT02696954|Amodiaquine|amodiaquine|mesh-list
19579027|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
19579028|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19579029|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19579030|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579031|NCT02696733|Cephalosporins|cephalosporins|mesh-list
19579032|NCT02696733|Lidocaine|lidocaine|mesh-list
19579033|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579034|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
19579035|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579036|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579037|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
19579038|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579039|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579040|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19579041|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19579042|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579043|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579044|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19579045|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579046|NCT02696915|Fentanyl|fentanyl|mesh-list
19579047|NCT02696915|Bupivacaine|bupivacaine|mesh-list
19579048|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579049|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
19579050|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579051|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579052|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
19579053|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579054|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19579055|NCT02696915|Narcotics|narcotics|mesh-ancestor
19579056|NCT02696915|Analgesics|analgesics|mesh-ancestor
19579057|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19579058|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19579059|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
19579060|NCT02696564|Losartan|losartan|mesh-list
19579061|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579062|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19579063|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19579064|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19579065|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579066|NCT02696590|Vitamin D|vitamin d|mesh-list
19579067|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
19579068|NCT02696590|Vitamins|vitamins|mesh-ancestor
19579069|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
19579070|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579071|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19579072|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19579073|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
19579074|NCT02696512|Minocycline|minocycline|mesh-list
19579075|NCT02696512|Lamotrigine|lamotrigine|mesh-list
19579076|NCT02696512|Flumazenil|flumazenil|mesh-list
19579077|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19579078|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579079|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
19579080|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19579081|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579082|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579083|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19579084|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579085|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19579086|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19579087|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579088|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19579089|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19579090|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
19579091|NCT02696512|Protective Agents|protective agents|mesh-ancestor
19579092|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
19579093|NCT02696512|Vitamins|vitamins|mesh-ancestor
19579094|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
19579095|NCT02696512|Antidotes|antidotes|mesh-ancestor
19579096|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
19579097|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
19579098|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579099|NCT02696577|Aspirin|aspirin|mesh-list
19579100|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19579101|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579102|NCT02696577|Analgesics|analgesics|mesh-ancestor
19579103|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
19579104|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579105|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579106|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579107|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579108|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19579109|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19579110|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579111|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19579112|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19579113|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579114|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
19579115|NCT02696642|Maytansine|maytansine|mesh-list
19579116|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19579117|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579118|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
19579119|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
19579120|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
19579121|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579122|NCT02696460|Lidocaine|lidocaine|mesh-list
19579123|NCT02696460|Prilocaine|prilocaine|mesh-list
19579124|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19579125|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579126|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
19579127|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579128|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579129|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
19579130|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579131|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579132|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19579133|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19579134|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579135|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579136|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19579137|NCT02696330|Enoxaparin|enoxaparin|mesh-list
19579138|NCT02696330|Clopidogrel|clopidogrel|mesh-list
19579139|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19579140|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19579141|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19579142|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19579143|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
19579144|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579145|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579146|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579147|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
19579148|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19579149|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19579150|NCT02696369|Lidocaine|lidocaine|mesh-list
19579151|NCT02696369|Epinephrine|epinephrine|mesh-list
19579152|NCT02696369|Racepinephrine|racepinephrine|mesh-list
19579153|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
19579154|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579155|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
19579156|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579157|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579158|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
19579159|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579160|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579161|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19579162|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19579163|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579164|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579165|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19579166|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19579167|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
19579168|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579169|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19579170|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19579171|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
19579172|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19579173|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
19579174|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
19579175|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
19579176|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19579177|NCT02696096|Buprenorphine|buprenorphine|mesh-list
19579178|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19579179|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19579180|NCT02696096|Narcotics|narcotics|mesh-ancestor
19579181|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579182|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579183|NCT02696096|Analgesics|analgesics|mesh-ancestor
19579184|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
19579185|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579186|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19579187|NCT02696122|Anesthetics|anesthetics|mesh-list
19579188|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579189|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579190|NCT02696148|Liraglutide|liraglutide|mesh-list
19579191|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579192|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579193|NCT02696148|Incretins|incretins|mesh-ancestor
19579194|NCT02696148|Hormones|hormones|mesh-ancestor
19579195|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579196|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
19579197|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19579198|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19579199|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579200|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
19579201|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579202|NCT02695810|Metformin|metformin|mesh-list
19579203|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
19579204|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579205|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579206|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19579207|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579208|NCT02695797|Prednisolone|prednisolone|mesh-list
19579209|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579210|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
19579211|NCT02695797|Hormones|hormones|mesh-ancestor
19579212|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579213|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579214|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20120998|NCT00006457|Oltipraz|oltipraz|mesh-list
20120999|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
20121000|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121001|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
20121002|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20121003|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
20121004|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20121005|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20121006|NCT00006457|Protective Agents|protective agents|mesh-ancestor
20121007|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579215|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579216|NCT02695654|Clonidine|clonidine|mesh-list
19579217|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
19579218|NCT02695654|Analgesics|analgesics|mesh-ancestor
19579219|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
19579220|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579221|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579222|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19579223|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
19579224|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
19579225|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19579226|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19579227|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19579228|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
19579229|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579230|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579231|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579232|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
19579233|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579234|NCT02695771|Gemcitabine|gemcitabine|mesh-list
19579235|NCT02695771|Mitomycins|mitomycins|mesh-list
19579236|NCT02695771|Mitomycin|mitomycin|mesh-list
19579237|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19579238|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
19579239|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579240|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579241|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
19579242|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579243|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579244|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579245|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
19579246|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579247|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19579248|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
20121008|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579249|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19579250|NCT02695862|Terlipressin|terlipressin|mesh-list
20121009|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20121010|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19579251|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19579252|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19579253|NCT02695758|Bupivacaine|bupivacaine|mesh-list
19579254|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
20121011|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121012|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121013|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20121014|NCT00006458|Antibodies|antibodies|mesh-list
20121015|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
20121016|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20121017|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
20121018|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121019|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121020|NCT00006459|Gemcitabine|gemcitabine|mesh-list
20121021|NCT00006459|Paclitaxel|paclitaxel|mesh-list
20121022|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121023|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121024|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
20121025|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
20121026|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121027|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121028|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19579255|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
19579256|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579257|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579258|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
20121029|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
20121030|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
20121031|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121032|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121033|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121034|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
19579259|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579260|NCT02695563|Lactoferrin|lactoferrin|mesh-list
20121035|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579261|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579262|NCT02695459|Everolimus|everolimus|mesh-list
19579263|NCT02695459|Cisplatin|cisplatin|mesh-list
19579264|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579265|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579266|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
19579267|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579268|NCT02695641|Bevacizumab|bevacizumab|mesh-list
19579269|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19579270|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579271|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19579272|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19579273|NCT02695641|Growth Substances|growth substances|mesh-ancestor
19579274|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579275|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
19579276|NCT02695745|Celecoxib|celecoxib|mesh-list
19579277|NCT02695745|Capsaicin|capsaicin|mesh-list
19579278|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19579279|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579280|NCT02695745|Analgesics|analgesics|mesh-ancestor
19579281|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
19579282|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579283|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579284|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579285|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579286|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19579287|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19579288|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579289|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579290|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
19579291|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579292|NCT02695732|Carvedilol|carvedilol|mesh-list
19579293|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19579294|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19579295|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
19579296|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20121036|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
20121037|NCT00006461|Etoposide|etoposide|mesh-list
20121038|NCT00006461|Vincristine|vincristine|mesh-list
19579297|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656174|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579298|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579299|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20121039|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
20121040|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121041|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
20121042|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121043|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121044|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121045|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
20121046|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121047|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121048|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20121049|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121050|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121051|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121052|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121053|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
19579300|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
19579301|NCT02695732|Protective Agents|protective agents|mesh-ancestor
19579302|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19579303|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579304|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19579305|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
19579306|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19579307|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19579308|NCT02695381|Etodolac|etodolac|mesh-list
19579309|NCT02695381|Lidocaine|lidocaine|mesh-list
19579310|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579311|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
19579312|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579313|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579314|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
19579315|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579316|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579317|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19579318|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19579319|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579320|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579321|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19579322|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579323|NCT02695381|Analgesics|analgesics|mesh-ancestor
19579324|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579325|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579326|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19579327|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19579328|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579329|NCT02695355|Methylphenidate|methylphenidate|mesh-list
19579330|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19579331|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579332|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19579333|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19579334|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579335|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579336|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
19579337|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579338|NCT02695212|Apremilast|apremilast|mesh-list
19579339|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19579340|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579341|NCT02695212|Analgesics|analgesics|mesh-ancestor
19579342|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
19579343|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579344|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579345|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579346|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579347|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19579348|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19579349|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579350|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656175|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19656176|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
20121054|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
19579351|NCT02695004|Donepezil|donepezil|mesh-list
19579352|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19579353|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579354|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579355|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
19579356|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579357|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579358|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
19579359|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
19579360|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579361|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579362|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
19579363|NCT02694809|Estrogens|estrogens|mesh-list
19579364|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19579365|NCT02694809|Hormones|hormones|mesh-ancestor
19579366|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579367|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579368|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19579369|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19579370|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
19579371|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19579372|NCT02694692|Vaccines|vaccines|mesh-list
19579373|NCT02694692|Immunologic Factors|immunologic factors|mesh-ancestor
19579374|NCT02694692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579375|NCT02694848|Aspirin|aspirin|mesh-list
19579376|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19579377|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579378|NCT02694848|Analgesics|analgesics|mesh-ancestor
19579379|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
19579380|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579381|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579382|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579383|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121055|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121056|NCT00006462|Gemcitabine|gemcitabine|mesh-list
20121057|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121058|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
19579384|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19579385|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19579386|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121059|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121060|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121061|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
20121062|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121063|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121064|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121065|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
20121066|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121067|NCT00006463|Trabectedin|trabectedin|mesh-list
20121068|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121069|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
20121070|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579387|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19579388|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19579389|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579390|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
19579391|NCT02694588|Infliximab|infliximab|mesh-list
19579392|NCT02694588|Vedolizumab|vedolizumab|mesh-list
19579393|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579394|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20121071|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173310|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579395|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579396|NCT02694653|Acetaminophen|acetaminophen|mesh-list
19579397|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579398|NCT02694653|Analgesics|analgesics|mesh-ancestor
19579399|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
19579400|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579401|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579402|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
19579403|NCT02694458|Vancomycin|vancomycin|mesh-list
19579404|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20173311|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579405|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579406|NCT02694289|Metformin|metformin|mesh-list
19579407|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579408|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579409|NCT02694263|Pioglitazone|pioglitazone|mesh-list
19579410|NCT02694263|Glimepiride|glimepiride|mesh-list
19579411|NCT02694263|Canagliflozin|canagliflozin|mesh-list
19579412|NCT02694263|Repaglinide|repaglinide|mesh-list
19579413|NCT02694263|Gliclazide|gliclazide|mesh-list
19579414|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579415|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579416|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579417|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579418|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
19579419|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19579420|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579421|NCT02694146|Hylan|hylan|mesh-list
19579422|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
19579423|NCT02694146|Protective Agents|protective agents|mesh-ancestor
19579424|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579425|NCT02693769|Fluticasone|fluticasone|mesh-list
19579426|NCT02693769|Xhance|xhance|mesh-list
19579427|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
19579428|NCT02693769|Bromides|bromides|mesh-list
19579429|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
19579430|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579431|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19579432|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
19579433|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579434|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121072|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20121073|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579435|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19579436|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
19579437|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579438|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19579439|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19579440|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19579441|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19579442|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
19579443|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579444|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579445|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
19579446|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19579447|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19579448|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19579449|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
19579450|NCT02694224|Paclitaxel|paclitaxel|mesh-list
19579451|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
19579452|NCT02694224|Epirubicin|epirubicin|mesh-list
19579453|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19579454|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579455|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
19579456|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
19579457|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
19579458|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579459|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579460|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
19579461|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579462|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579463|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19579464|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
19579465|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19579466|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19579467|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19579468|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19579469|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579470|NCT02693951|Cefotiam|cefotiam|mesh-list
19579471|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19579472|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579473|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19579474|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
19579475|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579476|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
19579477|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20121074|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19579478|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
19579479|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579480|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
19579481|NCT02693808|Protective Agents|protective agents|mesh-ancestor
20121075|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121076|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121077|NCT00006465|Capecitabine|capecitabine|mesh-list
20121078|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
20121079|NCT00006465|Irinotecan|irinotecan|mesh-list
19579482|NCT02693574|Amoxicillin|amoxicillin|mesh-list
19579483|NCT02693574|Clarithromycin|clarithromycin|mesh-list
19579484|NCT02693574|Levofloxacin|levofloxacin|mesh-list
19579485|NCT02693574|Ofloxacin|ofloxacin|mesh-list
19579486|NCT02693574|Esomeprazole|esomeprazole|mesh-list
19579487|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19579488|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579489|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19579490|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579491|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19579492|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579493|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579494|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19579495|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20121080|NCT00006465|Camptothecin|camptothecin|mesh-list
20121081|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121082|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
20121083|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121084|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121085|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20121086|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121087|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121088|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121089|NCT00006467|Gemcitabine|gemcitabine|mesh-list
19579496|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19579497|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19579498|NCT02693574|Renal Agents|renal agents|mesh-ancestor
19579499|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19579500|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121090|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121091|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
20121092|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121093|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121094|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
20121095|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121096|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121097|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121098|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
20121099|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579501|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579502|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19579503|NCT02693470|Ustekinumab|ustekinumab|mesh-list
19579504|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579505|NCT02693444|Lidocaine|lidocaine|mesh-list
19579506|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579507|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
19579508|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579509|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579510|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
19579511|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579512|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19579513|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19579514|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19579515|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579516|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656177|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656178|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656179|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19656180|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19656181|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19656182|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19656183|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656184|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19656185|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
19656186|NCT04780464|Hormones|hormones|mesh-ancestor
19656187|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20121100|NCT00006468|Leucovorin|leucovorin|mesh-list
20121101|NCT00006468|Fluorouracil|fluorouracil|mesh-list
20121102|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
19579517|NCT02693288|Anesthetics|anesthetics|mesh-list
19579518|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579519|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579520|NCT02693392|Metformin|metformin|mesh-list
19579521|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19579522|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579523|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
19579524|NCT02693483|Povidone|povidone|mesh-list
19579525|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
19579526|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
19579527|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19579528|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579529|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19579530|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
19579531|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579532|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
19579533|NCT02693210|Rituximab|rituximab|mesh-list
19579534|NCT02693210|Methotrexate|methotrexate|mesh-list
19579535|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579536|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
19579537|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579538|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579539|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19579540|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
19579541|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579542|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579543|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19579544|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19579545|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19579546|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
19579547|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19579548|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19579549|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
19579550|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579551|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579552|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19579553|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19579554|NCT02692989|Anesthetics|anesthetics|mesh-list
19579555|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579556|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579557|NCT02692963|Vaccines|vaccines|mesh-list
19579558|NCT02692963|Immunologic Factors|immunologic factors|mesh-ancestor
20121103|NCT00006468|Calcium|calcium|mesh-list
20121104|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
20121105|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20121106|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121107|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
20121108|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121109|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121110|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579559|NCT02692963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579560|NCT02692976|Vaccines|vaccines|mesh-list
19579561|NCT02692976|Immunologic Factors|immunologic factors|mesh-ancestor
19579562|NCT02692976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579563|NCT02692599|Vaccines|vaccines|mesh-list
19579564|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
19579565|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579566|NCT02692534|Cocaine|cocaine|mesh-list
19579567|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579568|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
19579569|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579570|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579571|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
19579572|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579573|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19579574|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19579575|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19579576|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579577|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579578|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
19579579|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579580|NCT02692339|Dexamethasone|dexamethasone|mesh-list
19579581|NCT02692339|Lenalidomide|lenalidomide|mesh-list
19579582|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579583|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
19579584|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
19579585|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579586|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579587|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579588|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
19579589|NCT02692339|Hormones|hormones|mesh-ancestor
19579590|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579591|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579592|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579593|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
19579594|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19579595|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19579596|NCT02692339|Growth Substances|growth substances|mesh-ancestor
19579597|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
19579598|NCT02692248|Gemcitabine|gemcitabine|mesh-list
20121111|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121112|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
20121113|NCT00006468|Antidotes|antidotes|mesh-ancestor
20121114|NCT00006468|Protective Agents|protective agents|mesh-ancestor
20121115|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
19579599|NCT02692248|Dexamethasone|dexamethasone|mesh-list
19579600|NCT02692248|Rituximab|rituximab|mesh-list
19579601|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
19579602|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19579603|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579604|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
19579605|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579606|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579607|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579608|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
19579609|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
19579610|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579611|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579612|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
19579613|NCT02692248|Hormones|hormones|mesh-ancestor
19579614|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20121116|NCT00006468|Vitamins|vitamins|mesh-ancestor
20121117|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
20121118|NCT00006469|Paclitaxel|paclitaxel|mesh-list
20121119|NCT00006469|Carboplatin|carboplatin|mesh-list
20121120|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121121|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121122|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
20121123|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
19579615|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579616|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19579617|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
19579618|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579619|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
19579620|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579621|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579622|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579623|NCT02692365|Manganese|manganese|mesh-list
19579624|NCT02692365|Trace Elements|trace elements|mesh-ancestor
19579625|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
19579626|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579627|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
19579628|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19579629|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579630|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20121124|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173312|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579631|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
19579632|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19579633|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579634|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579635|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579636|NCT02691910|Chloroquine|chloroquine|mesh-list
19579637|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19579638|NCT02691910|Primaquine|primaquine|mesh-list
19579639|NCT02691910|Amebicides|amebicides|mesh-ancestor
19579640|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19579641|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19579642|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579643|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
19579644|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579645|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19579646|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579647|NCT02691910|Analgesics|analgesics|mesh-ancestor
19579648|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
19579649|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579650|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579651|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579652|NCT02691910|Filaricides|filaricides|mesh-ancestor
19579653|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
19579654|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
20121125|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121126|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20121127|NCT00006470|Vaccines|vaccines|mesh-list
20121128|NCT00006470|Antibodies|antibodies|mesh-list
20121129|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
20121130|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20121131|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20121132|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
19579655|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
19579656|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19579657|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579658|NCT02691871|Docetaxel|docetaxel|mesh-list
19579659|NCT02691871|Apatinib|apatinib|mesh-list
19579660|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579661|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
19579662|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19579663|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19579664|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579665|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19579666|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579667|NCT02691754|Acetaminophen|acetaminophen|mesh-list
19579668|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19579669|NCT02691754|Analgesics|analgesics|mesh-ancestor
19579670|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
19579671|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579672|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579673|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
19579674|NCT02691897|Melatonin|melatonin|mesh-list
19579675|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
19579676|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579677|NCT02691897|Protective Agents|protective agents|mesh-ancestor
19579678|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579679|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579680|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
19579681|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19579682|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19579683|NCT02691780|Sorafenib|sorafenib|mesh-list
19579684|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579685|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19579686|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579687|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579688|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19579689|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19579690|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579691|NCT02691793|Sunitinib|sunitinib|mesh-list
19579692|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579693|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19579694|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19579695|NCT02691793|Growth Substances|growth substances|mesh-ancestor
19749540|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579696|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579697|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
19579698|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19579699|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579700|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656188|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19656189|NCT04762316|Pyridoxal|pyridoxal|mesh-list
19656190|NCT04762316|Pyridoxine|pyridoxine|mesh-list
19656191|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
19656192|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
19656193|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
19656194|NCT04762316|Vitamins|vitamins|mesh-ancestor
19656195|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
19656196|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656197|NCT04759586|Prednisone|prednisone|mesh-list
19656198|NCT04759586|Prednisolone|prednisolone|mesh-list
19656199|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19656200|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
19656201|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19656202|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
19656203|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
19656204|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19656205|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19656206|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19656207|NCT04759586|Cortisone|cortisone|mesh-list
19656208|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
19656209|NCT04759586|Rituximab|rituximab|mesh-list
19656210|NCT04759586|Doxorubicin|doxorubicin|mesh-list
19656211|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19656212|NCT04759586|Nivolumab|nivolumab|mesh-list
19656213|NCT04759586|Etoposide|etoposide|mesh-list
19656214|NCT04759586|Vincristine|vincristine|mesh-list
19656215|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
19656216|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19656217|NCT04759586|Antibodies|antibodies|mesh-list
19656218|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
19656219|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19656220|NCT04759586|Lenograstim|lenograstim|mesh-list
19656221|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19656222|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
19656223|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19656224|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
19656225|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656226|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656227|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19656228|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
19656229|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656230|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656231|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19656232|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19656233|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19656234|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19656235|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656236|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19656237|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
19656238|NCT04759586|Hormones|hormones|mesh-ancestor
19656239|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19656240|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19656241|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19656242|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19656243|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19656244|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
19656245|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
19656246|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
19656247|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
19656248|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
19656249|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656250|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19656251|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19656252|NCT04759586|Protective Agents|protective agents|mesh-ancestor
19656253|NCT04753957|Progesterone|progesterone|mesh-list
19656254|NCT04753957|Progestins|progestins|mesh-ancestor
19656255|NCT04753957|Hormones|hormones|mesh-ancestor
20121133|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121134|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656256|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19656257|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656258|NCT04751994|Sorbitol|sorbitol|mesh-list
19656259|NCT04751994|Cathartics|cathartics|mesh-ancestor
19656260|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579701|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19579702|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19579703|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19579704|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19579705|NCT02691325|Charcoal|charcoal|mesh-list
19579706|NCT02691325|Nemiralisib|nemiralisib|mesh-list
19579707|NCT02691325|Antidotes|antidotes|mesh-ancestor
19579708|NCT02691325|Protective Agents|protective agents|mesh-ancestor
19579709|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579710|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19579711|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579712|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579713|NCT02691403|Bupivacaine|bupivacaine|mesh-list
19579714|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
19579715|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
20121135|NCT00006471|Fenretinide|fenretinide|mesh-list
20121136|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121137|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19579716|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
19579717|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579718|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579719|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
19579720|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579721|NCT02691442|Epinephrine|epinephrine|mesh-list
19579722|NCT02691442|Ropivacaine|ropivacaine|mesh-list
19579723|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
19579724|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
19579725|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
19579726|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579727|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579728|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
19579729|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579730|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19579731|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19579732|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
19579733|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579734|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579735|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19579736|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19579737|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
19579738|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19579739|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
19579740|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
19579741|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
19579742|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19579743|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
19579744|NCT02691156|Bilirubin|bilirubin|mesh-list
19579745|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
19579746|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579747|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
19579748|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579749|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579750|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
19579751|NCT02691156|Protective Agents|protective agents|mesh-ancestor
19579752|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
19579753|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20121138|NCT00006471|Protective Agents|protective agents|mesh-ancestor
20121139|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121140|NCT00006472|Paclitaxel|paclitaxel|mesh-list
20121141|NCT00006472|Carboplatin|carboplatin|mesh-list
20121142|NCT00006472|Fluorouracil|fluorouracil|mesh-list
20121143|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121144|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121145|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19579754|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579755|NCT02691195|Ropivacaine|ropivacaine|mesh-list
19579756|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
19579757|NCT02691195|Anesthetics|anesthetics|mesh-list
19579758|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579759|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579760|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
19579761|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579762|NCT02691078|Octreotide|octreotide|mesh-list
19579763|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579764|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20121146|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
20121147|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
19579765|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579766|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
19579767|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
19579768|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579769|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579770|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19579771|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121148|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121149|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
20121150|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19579772|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
19579773|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579774|NCT02690987|Exenatide|exenatide|mesh-list
19579775|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579776|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579777|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19579778|NCT02690987|Incretins|incretins|mesh-ancestor
19579779|NCT02690987|Hormones|hormones|mesh-ancestor
19579780|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579781|NCT02690922|Dexamethasone|dexamethasone|mesh-list
19579782|NCT02690922|Prednisone|prednisone|mesh-list
19579783|NCT02690922|Methotrexate|methotrexate|mesh-list
20121151|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121152|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
20121153|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121154|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
20121155|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121156|NCT00006474|Temozolomide|temozolomide|mesh-list
20121157|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19579784|NCT02690922|Dasatinib|dasatinib|mesh-list
19579785|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19579786|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
19579787|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
19579788|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579789|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579790|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579791|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
19579792|NCT02690922|Hormones|hormones|mesh-ancestor
19579793|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579794|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579795|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579796|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19579797|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
19579798|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19579799|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19579800|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
19579801|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579802|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
19579803|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579804|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19579805|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579806|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
19579807|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579808|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19579809|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19579810|NCT02690883|Exenatide|exenatide|mesh-list
19579811|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19579812|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579813|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19579814|NCT02690883|Incretins|incretins|mesh-ancestor
19579815|NCT02690883|Hormones|hormones|mesh-ancestor
19579816|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579817|NCT02690844|Clonazepam|clonazepam|mesh-list
19579818|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
19579819|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
19579820|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
19579821|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579822|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579823|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579824|NCT02690870|Tamoxifen|tamoxifen|mesh-list
19579825|NCT02690870|Clomiphene|clomiphene|mesh-list
20121158|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121159|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
20121160|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121161|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121162|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121163|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
20121164|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121165|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20121166|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121167|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121168|NCT00006476|Suramin|suramin|mesh-list
20121169|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
20121170|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
20121171|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20121172|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121173|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121174|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20121175|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20121176|NCT00006479|Leucovorin|leucovorin|mesh-list
19579826|NCT02690870|Enclomiphene|enclomiphene|mesh-list
19579827|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
19579828|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19579829|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
19579830|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579831|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579832|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579833|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579834|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19579835|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19579836|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19579837|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19579838|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
19579839|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19579840|NCT02690792|Vitamin E|vitamin e|mesh-list
19579841|NCT02690792|Vitamins|vitamins|mesh-ancestor
19579842|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
19579843|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579844|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
19579845|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579846|NCT02690792|Protective Agents|protective agents|mesh-ancestor
20121177|NCT00006479|Fluorouracil|fluorouracil|mesh-list
20121178|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
20121179|NCT00006479|Calcium|calcium|mesh-list
19579847|NCT02690506|Pregabalin|pregabalin|mesh-list
19579848|NCT02690506|Analgesics|analgesics|mesh-ancestor
19579849|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
19579850|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19579851|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579852|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
19579853|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19579854|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19579855|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579856|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19579857|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19579858|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19579859|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19579860|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19579861|NCT02690389|Flumazenil|flumazenil|mesh-list
19579862|NCT02690389|Antidotes|antidotes|mesh-ancestor
19579863|NCT02690389|Protective Agents|protective agents|mesh-ancestor
19579864|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579865|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
19579866|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
19579867|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19579868|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121180|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
20121181|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20121182|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121183|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
20121184|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121185|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121186|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121187|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19579869|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20121188|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
19579870|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19579871|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579872|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
19579873|NCT02690480|Fulvestrant|fulvestrant|mesh-list
19579874|NCT02690480|Palbociclib|palbociclib|mesh-list
19579875|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579876|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579877|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19579878|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19579879|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
19579880|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579881|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579882|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19579883|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579884|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579885|NCT02689999|Rabeprazole|rabeprazole|mesh-list
19579886|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19579887|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579888|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19579889|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579890|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579891|NCT02690064|Vitamins|vitamins|mesh-list
19579892|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
19579893|NCT02690064|Vitamin E|vitamin e|mesh-list
19579894|NCT02690064|Tocopherols|tocopherols|mesh-list
19579895|NCT02690064|Tocotrienols|tocotrienols|mesh-list
19579896|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
19579897|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
19579898|NCT02690064|Ubiquinone|ubiquinone|mesh-list
19579899|NCT02690064|Resveratrol|resveratrol|mesh-list
19579900|NCT02690064|Antioxidants|antioxidants|mesh-list
19579901|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
19579902|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579903|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579904|NCT02690064|Protective Agents|protective agents|mesh-ancestor
19579905|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579906|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19579907|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
19579908|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
19579909|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19579910|NCT02690038|Antibodies|antibodies|mesh-list
20121189|NCT00006479|Antidotes|antidotes|mesh-ancestor
20121190|NCT00006479|Protective Agents|protective agents|mesh-ancestor
20121191|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
20121192|NCT00006479|Vitamins|vitamins|mesh-ancestor
20121193|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
20121194|NCT00006480|Aldesleukin|aldesleukin|mesh-list
20121195|NCT00006480|Ganciclovir|ganciclovir|mesh-list
20121196|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20121197|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121198|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121199|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121200|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
20121201|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121202|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20121203|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579911|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
19579912|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19579913|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
19579914|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579915|NCT02690103|Ribavirin|ribavirin|mesh-list
19579916|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
19579917|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579918|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
19579919|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19579920|NCT02690155|Vitamin K|vitamin k|mesh-list
19579921|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
19579922|NCT02690155|Vitamins|vitamins|mesh-ancestor
19579923|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
19579924|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579925|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19579926|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
19579927|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19579928|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
19579929|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579930|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579931|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
20121204|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121205|NCT00006482|Gemcitabine|gemcitabine|mesh-list
19579932|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19579933|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19579934|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
19579935|NCT02690155|Coagulants|coagulants|mesh-ancestor
19579936|NCT02690129|Progesterone|progesterone|mesh-list
19579937|NCT02690129|Progestins|progestins|mesh-ancestor
19579938|NCT02690129|Hormones|hormones|mesh-ancestor
19579939|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579940|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579941|NCT02689960|Prednisone|prednisone|mesh-list
19579942|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20121206|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121207|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121208|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
19579943|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
19579944|NCT02689960|Hormones|hormones|mesh-ancestor
19579945|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579946|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579947|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579948|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579949|NCT02689882|Niacinamide|niacinamide|mesh-list
19579950|NCT02689882|Niacin|niacin|mesh-list
19579951|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
19579952|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
19579953|NCT02689882|Vitamins|vitamins|mesh-ancestor
19579954|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
19579955|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579956|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19579957|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
19579958|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579959|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19579960|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
20121209|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121210|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
20121211|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121212|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121213|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121214|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
20121215|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121216|NCT00006483|Sargramostim|sargramostim|mesh-list
20121217|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
20121218|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121219|NCT00006484|Paclitaxel|paclitaxel|mesh-list
20121220|NCT00006484|Carboplatin|carboplatin|mesh-list
20121221|NCT00006484|Tirapazamine|tirapazamine|mesh-list
20121222|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121223|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121224|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
19656278|NCT04739800|Paclitaxel|paclitaxel|mesh-list
19656279|NCT04739800|Doxorubicin|doxorubicin|mesh-list
19656280|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19656281|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19656282|NCT04739800|Durvalumab|durvalumab|mesh-list
19656283|NCT04739800|Topotecan|topotecan|mesh-list
19656284|NCT04739800|Olaparib|olaparib|mesh-list
19656285|NCT04739800|Cediranib|cediranib|mesh-list
20121225|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
20121226|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121227|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656286|NCT04739800|Maleic acid|maleic acid|mesh-list
19656287|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
19656288|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19656289|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
19656290|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19656291|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656292|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
19656293|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
20121228|NCT00006485|Irinotecan|irinotecan|mesh-list
20121229|NCT00006485|Alvocidib|alvocidib|mesh-list
20121230|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20121231|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121232|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656294|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
19656295|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656296|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19656297|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19656298|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19656299|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121233|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121234|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121235|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
20121236|NCT00006485|Growth Substances|growth substances|mesh-ancestor
19579961|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
19579962|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
19579963|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579964|NCT02690012|Cathartics|cathartics|mesh-ancestor
19579965|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19579966|NCT02690012|Antacids|antacids|mesh-ancestor
19579967|NCT02689986|Rituximab|rituximab|mesh-list
19579968|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19579969|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19579970|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579971|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
19579972|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579973|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19579974|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19579975|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
19579976|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579977|NCT02689921|Trastuzumab|trastuzumab|mesh-list
19579978|NCT02689921|Pertuzumab|pertuzumab|mesh-list
19579979|NCT02689921|Letrozole|letrozole|mesh-list
19579980|NCT02689921|Anastrozole|anastrozole|mesh-list
19579981|NCT02689921|Leuprolide|leuprolide|mesh-list
19579982|NCT02689921|Exemestane|exemestane|mesh-list
19579983|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19579984|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19579985|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19579986|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19579987|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19579988|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19579989|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19579990|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
19579991|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19579992|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19579993|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19579994|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19579995|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
19579996|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19579997|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19579998|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
19579999|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580000|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
19580001|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19580002|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19580003|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19580004|NCT02689856|Lidocaine|lidocaine|mesh-list
19580005|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
19580006|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
19580007|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580008|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580009|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
19580010|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580011|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19580012|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19580013|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19580014|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19580015|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580016|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580017|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
19580018|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19580019|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580020|NCT02689843|Metformin|metformin|mesh-list
19580021|NCT02689843|Pioglitazone|pioglitazone|mesh-list
19580022|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
19580023|NCT02689843|Spironolactone|spironolactone|mesh-list
19580024|NCT02689843|Cyproterone|cyproterone|mesh-list
19580025|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580026|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121237|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121238|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20121239|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
20121240|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580027|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19580028|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
19580029|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580030|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19580031|NCT02689843|Diuretics|diuretics|mesh-ancestor
19580032|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
19580033|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
19580034|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580035|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19580036|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
19580037|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19580038|NCT02689726|Imiquimod|imiquimod|mesh-list
19580039|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19580040|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
19580041|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580042|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580043|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
19580044|NCT02689388|Anesthetics|anesthetics|mesh-list
19580045|NCT02689388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580046|NCT02689388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580047|NCT02689713|Voriconazole|voriconazole|mesh-list
19580048|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
19580049|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580050|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19580051|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19580052|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580053|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580054|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19580055|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
19580056|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580057|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580058|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19580059|NCT02689778|Pirfenidone|pirfenidone|mesh-list
19580060|NCT02689778|Analgesics|analgesics|mesh-ancestor
19580061|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
19580062|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580063|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580064|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19580065|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19580066|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580067|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580068|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580069|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19580070|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580071|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580072|NCT02689362|Incretins|incretins|mesh-ancestor
19580073|NCT02689362|Hormones|hormones|mesh-ancestor
19580074|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580075|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19580076|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
19580077|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580078|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580079|NCT02689596|Oxytocin|oxytocin|mesh-list
19580080|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
19580081|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19580082|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580083|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19580084|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19580085|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580086|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
19580087|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19580088|NCT02689401|Hematinics|hematinics|mesh-ancestor
19580089|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19580090|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19580091|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19580092|NCT02689141|Ofatumumab|ofatumumab|mesh-list
19580093|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580094|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
19580095|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580096|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580097|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
19580098|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
19580099|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
19580100|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580101|NCT02689180|Furosemide|furosemide|mesh-list
19580102|NCT02689180|Diuretics|diuretics|mesh-ancestor
19580103|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
19580104|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580105|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19580106|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19580107|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580108|NCT02689245|Tenofovir|tenofovir|mesh-list
19580109|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
19580110|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580111|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19580112|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19580113|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580114|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580115|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19580116|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19580117|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19580118|NCT02689336|Temozolomide|temozolomide|mesh-list
19580119|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580120|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19580121|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580122|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580123|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580124|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
19580125|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
19580126|NCT02689284|Margetuximab|margetuximab|mesh-list
19580127|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19580128|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580129|NCT02689089|Rifapentine|rifapentine|mesh-list
19580130|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19580131|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
19580132|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580133|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580134|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
19580135|NCT02689024|Acetaminophen|acetaminophen|mesh-list
19580136|NCT02689024|Dipyrone|dipyrone|mesh-list
19580137|NCT02689024|Ibuprofen|ibuprofen|mesh-list
19580138|NCT02689024|Diclofenac|diclofenac|mesh-list
19580139|NCT02689024|Naproxen|naproxen|mesh-list
19580140|NCT02689024|Fentanyl|fentanyl|mesh-list
19580141|NCT02689024|Morphine|morphine|mesh-list
19580142|NCT02689024|Bupivacaine|bupivacaine|mesh-list
19580143|NCT02689024|Ropivacaine|ropivacaine|mesh-list
19580144|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
19580145|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
19580146|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
19580147|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580148|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580149|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
19580150|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580151|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19580152|NCT02689024|Narcotics|narcotics|mesh-ancestor
19580153|NCT02689024|Analgesics|analgesics|mesh-ancestor
19580154|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19580155|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19580156|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
19580157|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19580158|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
19580159|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19580160|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580161|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580162|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19580163|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580164|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580165|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
19580166|NCT02689037|Aspirin|aspirin|mesh-list
19580167|NCT02689037|Clopidogrel|clopidogrel|mesh-list
19580168|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19580169|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19580170|NCT02689037|Analgesics|analgesics|mesh-ancestor
19580171|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
19580172|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580173|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580174|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580175|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580176|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19580177|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580178|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580179|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19580180|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19580181|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580182|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
19580183|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19580184|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19580185|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19580186|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
19580187|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580188|NCT02688803|Paclitaxel|paclitaxel|mesh-list
19580189|NCT02688803|Docetaxel|docetaxel|mesh-list
19580190|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19580191|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
19580192|NCT02688803|Doxorubicin|doxorubicin|mesh-list
19580193|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19580194|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19580195|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580196|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
19580197|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
19580198|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
19580199|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580200|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580201|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
19580202|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580203|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580204|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580205|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
19580206|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19580207|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19580208|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19580209|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19580210|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580211|NCT02688738|Doxycycline|doxycycline|mesh-list
19580212|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580213|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580214|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
19580215|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19580216|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19580217|NCT02688881|Sirolimus|sirolimus|mesh-list
19580218|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580219|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580220|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19580221|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580222|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
19580223|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580224|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
19580225|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580226|NCT02688465|Apomorphine|apomorphine|mesh-list
19580227|NCT02688465|Emetics|emetics|mesh-ancestor
19580228|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580229|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
19256551|NCT04484675|Protective Agents|protective agents|mesh-ancestor
19580230|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580231|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580232|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
19580233|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
19580234|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580235|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580236|NCT02688907|Adavosertib|adavosertib|mesh-list
19580237|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580238|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580239|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19580240|NCT02688634|Amoxicillin|amoxicillin|mesh-list
19580241|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580242|NCT02688491|Sunitinib|sunitinib|mesh-list
19580243|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580244|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19580245|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19580246|NCT02688491|Growth Substances|growth substances|mesh-ancestor
19580247|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580248|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
19580249|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19580250|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580251|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580252|NCT02688595|Anesthetics|anesthetics|mesh-list
19580253|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580254|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580255|NCT02688400|Celecoxib|celecoxib|mesh-list
19580256|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
19580257|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19580258|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19580259|NCT02688400|Analgesics|analgesics|mesh-ancestor
19580260|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
19580261|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580262|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121241|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20121242|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20121243|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121244|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19580263|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580264|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580265|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19580266|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19580267|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580268|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580269|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
19580270|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19580271|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19580272|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
19580273|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580274|NCT02688361|Expectorants|expectorants|mesh-ancestor
19580275|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
19580276|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19580277|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
19580278|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580279|NCT02688361|Protective Agents|protective agents|mesh-ancestor
19580280|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580281|NCT02688361|Antidotes|antidotes|mesh-ancestor
19580282|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
19580283|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19580284|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580285|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580286|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
19580287|NCT02688127|Coagulants|coagulants|mesh-ancestor
19580288|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
19580289|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
19656300|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656301|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
19656302|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656303|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19656304|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20121245|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121246|NCT00006487|Etoposide|etoposide|mesh-list
20121247|NCT00006487|Tirapazamine|tirapazamine|mesh-list
20121248|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121249|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121250|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19656305|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19656306|NCT04738422|Glycine|glycine|mesh-list
19580290|NCT02688374|Nicotine|nicotine|mesh-list
19580291|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19580292|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
19580293|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580294|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580295|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19580296|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19580297|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
19580298|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580299|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580300|NCT02688088|Midazolam|midazolam|mesh-list
19580301|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
19580302|NCT02688088|Caffeine|caffeine|mesh-list
19580303|NCT02688088|Warfarin|warfarin|mesh-list
19580304|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19580305|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19580306|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580307|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580308|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19580309|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19580310|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19580311|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19580312|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
19580313|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
19580314|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
19580315|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
19580316|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580317|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580318|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
20121251|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121252|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121253|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580319|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19580320|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19580321|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580322|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19580323|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20121254|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
20121255|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20121256|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121257|NCT00006508|Insulin|insulin|mesh-list
20121258|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20121259|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580324|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
19580325|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
19580326|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
19580327|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19580328|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19580329|NCT02688322|Sulbactam|sulbactam|mesh-list
19580330|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580331|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580332|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20121260|NCT00006519|Capravirine|capravirine|mesh-list
20121261|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20121262|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20121263|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121264|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121265|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
20121266|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121267|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121268|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121269|NCT00006578|Ritonavir|ritonavir|mesh-list
20121270|NCT00006578|Amprenavir|amprenavir|mesh-list
20121271|NCT00006578|Lamivudine|lamivudine|mesh-list
20121272|NCT00006578|Abacavir|abacavir|mesh-list
20121273|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20121274|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19580333|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580334|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580335|NCT02687984|Risperidone|risperidone|mesh-list
19580336|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19580337|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
19580338|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580339|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656307|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
20121275|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
20121276|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580340|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121277|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121278|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121279|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121280|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
19580341|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19580342|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19580343|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580344|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19580345|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19580346|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
19580347|NCT02687971|Miltefosine|miltefosine|mesh-list
19580348|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
19580349|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580350|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580351|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19580352|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19580353|NCT02688023|Leucovorin|leucovorin|mesh-list
19580354|NCT02688023|Fluorouracil|fluorouracil|mesh-list
19580355|NCT02688023|Capecitabine|capecitabine|mesh-list
19580356|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
19580357|NCT02688023|Irinotecan|irinotecan|mesh-list
19580358|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
19580359|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580360|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19580361|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580362|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580363|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
19580364|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580365|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19580366|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19580367|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580368|NCT02688023|Antidotes|antidotes|mesh-ancestor
19580369|NCT02688023|Protective Agents|protective agents|mesh-ancestor
19580370|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
19580371|NCT02688023|Vitamins|vitamins|mesh-ancestor
19580372|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
19580373|NCT02687724|Golimumab|golimumab|mesh-list
19580374|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19580375|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580376|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580377|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
19580378|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580379|NCT02687958|Everolimus|everolimus|mesh-list
19580380|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121281|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121282|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20121283|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20121284|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20121285|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20121286|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20121287|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
20121288|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20121289|NCT00006591|Ritonavir|ritonavir|mesh-list
20121290|NCT00006591|Amprenavir|amprenavir|mesh-list
20121291|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19580381|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580382|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
19580383|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580384|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
19580385|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19580386|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580387|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580388|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19580389|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19580390|NCT02687841|Protective Agents|protective agents|mesh-ancestor
19580391|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580392|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
20608167|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
20608168|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
20608169|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
19580393|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19580394|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
19580395|NCT02687906|Meropenem|meropenem|mesh-list
19580396|NCT02687906|Vaborbactam|vaborbactam|mesh-list
19580397|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
19580398|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580399|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580400|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580401|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580402|NCT02687932|Valsartan|valsartan|mesh-list
19580403|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19580404|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19580405|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19580406|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19580407|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580408|NCT02687867|Vitamin K|vitamin k|mesh-list
19580409|NCT02687867|Dabigatran|dabigatran|mesh-list
19580410|NCT02687867|Vitamins|vitamins|mesh-ancestor
19580411|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
19580412|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580413|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
19580414|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19580415|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
19580416|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580417|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580418|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
19580419|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19580420|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580421|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
19580422|NCT02687867|Coagulants|coagulants|mesh-ancestor
19580423|NCT02687854|Vitamin K|vitamin k|mesh-list
19580424|NCT02687854|Apixaban|apixaban|mesh-list
19580425|NCT02687854|Vitamins|vitamins|mesh-ancestor
19580426|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
19580427|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580428|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19580429|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
19580430|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19580431|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
19580432|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580433|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580434|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
19580435|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19580436|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580437|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
19580438|NCT02687854|Coagulants|coagulants|mesh-ancestor
19580439|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19580440|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580441|NCT02687347|Morphine|morphine|mesh-list
19580442|NCT02687347|Methadone|methadone|mesh-list
19580443|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19580444|NCT02687347|Narcotics|narcotics|mesh-ancestor
19580445|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580446|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580447|NCT02687347|Analgesics|analgesics|mesh-ancestor
19580448|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
19580449|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580450|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
19580451|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
20121292|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20121293|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
20121294|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121295|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121296|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121297|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121298|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
20121299|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121300|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20121301|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20121302|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20121303|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
19580452|NCT02687425|Pioglitazone|pioglitazone|mesh-list
19580453|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
19580454|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20121304|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580455|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580456|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121305|NCT00006617|Lamivudine|lamivudine|mesh-list
20121306|NCT00006617|Zidovudine|zidovudine|mesh-list
20121307|NCT00006617|Abacavir|abacavir|mesh-list
20121308|NCT00006617|Amprenavir|amprenavir|mesh-list
20121309|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20121310|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20121311|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121312|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121313|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
20121314|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121315|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121316|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121317|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
20309021|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20309022|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20309023|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309024|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20309025|NCT00666653|Pramipexole|pramipexole|mesh-list
20309026|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
19580457|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19580458|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580459|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580460|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
19580461|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580462|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
19580463|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19580464|NCT02687256|Heparin|heparin|mesh-list
19580465|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
19580466|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19580467|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580468|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580469|NCT02687269|Ranolazine|ranolazine|mesh-list
19580470|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20309027|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309028|NCT00666653|Protective Agents|protective agents|mesh-ancestor
20309029|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309030|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20309031|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20309032|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
20309033|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
20309034|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309035|NCT00666692|Paclitaxel|paclitaxel|mesh-list
19580471|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19580472|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580473|NCT02687204|Enoxaparin|enoxaparin|mesh-list
19580474|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
19580475|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
19580476|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19580477|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580478|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580479|NCT02686983|Betamethasone|betamethasone|mesh-list
19580480|NCT02686983|Anesthetics|anesthetics|mesh-list
19580481|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
20121318|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20121319|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
20121320|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20121321|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20121322|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20121323|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
20121324|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
20121325|NCT00006630|Antibodies|antibodies|mesh-list
20121326|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
20121327|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20121328|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20121329|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
20121330|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121331|NCT00006656|Ethanol|ethanol|mesh-list
20121332|NCT00006656|Carmustine|carmustine|mesh-list
20121333|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20121334|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121335|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580482|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309036|NCT00666692|Bevacizumab|bevacizumab|mesh-list
20121336|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580483|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121337|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121338|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
20121339|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121340|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121341|NCT00006669|Prednisone|prednisone|mesh-list
20121342|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
20121343|NCT00006669|Rituximab|rituximab|mesh-list
19580484|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
19580485|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580486|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580487|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
19580488|NCT02686983|Hormones|hormones|mesh-ancestor
19580489|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580490|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19580491|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
19580492|NCT02687178|Canrenone|canrenone|mesh-list
19580493|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19580494|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
19580495|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580496|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580497|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19580498|NCT02687178|Diuretics|diuretics|mesh-ancestor
19580499|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
19580500|NCT02687009|Niclosamide|niclosamide|mesh-list
19580501|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
19580502|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19580503|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
19580504|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19580505|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580506|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
19580507|NCT02687100|Beclomethasone|beclomethasone|mesh-list
19580508|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580509|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
19580510|NCT02687100|Hormones|hormones|mesh-ancestor
19580511|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580512|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580513|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19580514|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
19580515|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
19580516|NCT02686905|Vitamin D|vitamin d|mesh-list
19580517|NCT02686905|Vitamins|vitamins|mesh-list
19580518|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
19580519|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
19580520|NCT02686905|Calcium|calcium|mesh-list
19580521|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
19580522|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580523|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19580524|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19580525|NCT02686905|Hematinics|hematinics|mesh-ancestor
19580526|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
19580527|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
19580528|NCT02686593|Clofarabine|clofarabine|mesh-list
19580529|NCT02686593|Analgesics|analgesics|mesh-ancestor
19580530|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
19580531|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580532|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580533|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580534|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19580535|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19580536|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580537|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580538|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19580539|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
19580540|NCT02686619|Cyclosporine|cyclosporine|mesh-list
19580541|NCT02686619|Sirolimus|sirolimus|mesh-list
19580542|NCT02686619|Prednisolone|prednisolone|mesh-list
19580543|NCT02686619|Cyclosporins|cyclosporins|mesh-list
19580544|NCT02686619|Daclizumab|daclizumab|mesh-list
19580545|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121344|NCT00006669|Doxorubicin|doxorubicin|mesh-list
19580546|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580547|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580548|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
20121345|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19580549|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580550|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
19580551|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580552|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
20121346|NCT00006669|Etoposide|etoposide|mesh-list
20121347|NCT00006669|Vincristine|vincristine|mesh-list
20121348|NCT00006669|Sargramostim|sargramostim|mesh-list
19580553|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580554|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19580555|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580556|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19580557|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580558|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580559|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
19580560|NCT02686619|Hormones|hormones|mesh-ancestor
19580561|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580562|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20121349|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121350|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
20121351|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121352|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121353|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121354|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
20121355|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121356|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121357|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20121358|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20121359|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20121360|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121361|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121362|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121363|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20121364|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
19580563|NCT02686710|Propofol|propofol|mesh-list
19580564|NCT02686710|Sevoflurane|sevoflurane|mesh-list
19580565|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19580566|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580567|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121365|NCT00006669|Hormones|hormones|mesh-ancestor
20121366|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20121367|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20121368|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121369|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
20121370|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
20121371|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121372|NCT00006682|Docetaxel|docetaxel|mesh-list
20121373|NCT00006682|Vinorelbine|vinorelbine|mesh-list
20121374|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121375|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
20121376|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
19580568|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19580569|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
19580570|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
19580571|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19580572|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19580573|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19580574|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
19580575|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580576|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
19580577|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580578|NCT02686645|Metronidazole|metronidazole|mesh-list
19580579|NCT02686645|Vancomycin|vancomycin|mesh-list
19580580|NCT02686645|Loperamide|loperamide|mesh-list
19580581|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
19580582|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580583|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580584|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19580585|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19580586|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580587|NCT02686853|Amphotericin B|amphotericin b|mesh-list
19580588|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19580589|NCT02686853|Amebicides|amebicides|mesh-ancestor
19580590|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19580591|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19580592|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580593|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19580594|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
19580595|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19580596|NCT02686840|Misoprostol|misoprostol|mesh-list
19580597|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19580598|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
20121377|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
19580599|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19580600|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580601|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19580602|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580603|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
19656308|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656309|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656310|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656311|NCT04727242|Gemcitabine|gemcitabine|mesh-list
19656312|NCT04727242|Dacarbazine|dacarbazine|mesh-list
19656313|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19656314|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
19656315|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656316|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656317|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
19656318|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19656319|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656320|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19656321|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
19656322|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656323|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19656324|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
19656325|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
19656326|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19656327|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19656328|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656329|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
19656330|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656331|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656332|NCT04718181|Omeprazole|omeprazole|mesh-list
19656333|NCT04718181|Risdiplam|risdiplam|mesh-list
19656334|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19656335|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19656336|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19656337|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656338|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121378|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656339|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19656340|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656341|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656342|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19656343|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19656344|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121379|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121380|NCT00006695|Iodine|iodine|mesh-list
20121381|NCT00006695|Cytarabine|cytarabine|mesh-list
20121382|NCT00006695|Etoposide|etoposide|mesh-list
20121383|NCT00006695|Melphalan|melphalan|mesh-list
19656350|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19656351|NCT04673357|Ustekinumab|ustekinumab|mesh-list
19656352|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
19656353|NCT04665531|Ropivacaine|ropivacaine|mesh-list
19656354|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
19656355|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
19656356|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19656357|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656358|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
19656359|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656360|NCT04655586|Heparin|heparin|mesh-list
19656361|NCT04655586|Protein C|protein c|mesh-list
19656362|NCT04655586|Anticoagulants|anticoagulants|mesh-list
19656363|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19656364|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20121384|NCT00006695|Carmustine|carmustine|mesh-list
20121385|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
20121386|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121387|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121388|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121389|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19656365|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656366|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
19656367|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20121390|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121391|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121392|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19580604|NCT02686827|Vitamin D|vitamin d|mesh-list
19580605|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
19580606|NCT02686827|Vitamins|vitamins|mesh-ancestor
19580607|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
19580608|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580609|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19580610|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19580611|NCT02686476|Empagliflozin|empagliflozin|mesh-list
19580612|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19580613|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580614|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580615|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580616|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
19580617|NCT02686385|Prednisolone|prednisolone|mesh-list
19580618|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19580619|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580620|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
19580621|NCT02686385|Hormones|hormones|mesh-ancestor
19580622|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580623|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580624|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19580625|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580626|NCT02686385|Protective Agents|protective agents|mesh-ancestor
19580627|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
19580628|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580629|NCT02686385|Expectorants|expectorants|mesh-ancestor
19580630|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
19580631|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19580632|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
19580633|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580634|NCT02686385|Antidotes|antidotes|mesh-ancestor
19580635|NCT02686151|Dexamethasone|dexamethasone|mesh-list
19580636|NCT02686151|Letrozole|letrozole|mesh-list
19580637|NCT02686151|Polygeline|polygeline|mesh-list
19580638|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580639|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
19580640|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
19580641|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580642|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580643|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580644|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
19580645|NCT02686151|Hormones|hormones|mesh-ancestor
19580646|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580647|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19580648|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580649|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19580650|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19580651|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580652|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580653|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19580654|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
19580655|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
19580656|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
19580657|NCT02686242|Anesthetics|anesthetics|mesh-list
19580658|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580659|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580660|NCT02686086|Albuterol|albuterol|mesh-list
19580661|NCT02686086|Ipratropium|ipratropium|mesh-list
19580662|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19580663|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
19580664|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580665|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580666|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19580667|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
19580668|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
19580669|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19580670|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19580671|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19580672|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19580673|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
19580674|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580675|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580676|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19580677|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
19580678|NCT02686177|Metformin|metformin|mesh-list
19580679|NCT02686177|Liraglutide|liraglutide|mesh-list
19580680|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580681|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580682|NCT02686177|Incretins|incretins|mesh-ancestor
19580683|NCT02686177|Hormones|hormones|mesh-ancestor
19580684|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580685|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
19580686|NCT02686047|Hylan|hylan|mesh-list
19580687|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19580688|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
19580689|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580690|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
19580691|NCT02686047|Protective Agents|protective agents|mesh-ancestor
19580692|NCT02685852|Exenatide|exenatide|mesh-list
19580693|NCT02685852|Acarbose|acarbose|mesh-list
19580694|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580695|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580696|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19580697|NCT02685852|Incretins|incretins|mesh-ancestor
19580698|NCT02685852|Hormones|hormones|mesh-ancestor
19580699|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580700|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19580701|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580702|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580703|NCT02686021|Dipyrone|dipyrone|mesh-list
19580704|NCT02686021|Ibuprofen|ibuprofen|mesh-list
19580705|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19580706|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19580707|NCT02686021|Analgesics|analgesics|mesh-ancestor
19580708|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
19580709|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580710|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580711|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580712|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580713|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19580714|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580715|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580716|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
19580717|NCT02685748|Aspirin|aspirin|mesh-list
19580718|NCT02685748|Pantoprazole|pantoprazole|mesh-list
19580719|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19580720|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19580721|NCT02685748|Analgesics|analgesics|mesh-ancestor
19580722|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
19580723|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580724|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580725|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580726|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580727|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19580728|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580729|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580730|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19580731|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19580732|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580733|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
19580734|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19580735|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580736|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19580737|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19580738|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19580739|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580740|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
19580741|NCT02685969|Flutemetamol|flutemetamol|mesh-list
19580742|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19580743|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580744|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
19580745|NCT02685657|Docetaxel|docetaxel|mesh-list
19580746|NCT02685657|Doxorubicin|doxorubicin|mesh-list
19580747|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580748|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
19580749|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580750|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580751|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580752|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
19580753|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580754|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580755|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20121393|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
20121394|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
19580756|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
19580757|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
19580758|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
19580759|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20121395|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121396|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121397|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
20121398|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121399|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121400|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
20121401|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20121402|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20121403|NCT00006695|Trace Elements|trace elements|mesh-ancestor
20121404|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
20121405|NCT00006708|Rituximab|rituximab|mesh-list
20121406|NCT00006708|Carboplatin|carboplatin|mesh-list
20121407|NCT00006708|Etoposide|etoposide|mesh-list
20121408|NCT00006708|Ifosfamide|ifosfamide|mesh-list
20121409|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20121410|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580760|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19580761|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121411|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
20121412|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121413|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121414|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121415|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121416|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121417|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121418|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121419|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121420|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
20121421|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
20121422|NCT00006734|Ifosfamide|ifosfamide|mesh-list
20121423|NCT00006734|Doxorubicin|doxorubicin|mesh-list
20121424|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20121425|NCT00006734|Etoposide|etoposide|mesh-list
20121426|NCT00006734|Vincristine|vincristine|mesh-list
20121427|NCT00006734|Lenograstim|lenograstim|mesh-list
20121428|NCT00006734|Sargramostim|sargramostim|mesh-list
20121429|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121430|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
20121431|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121432|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121433|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580762|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580763|NCT02685774|Metformin|metformin|mesh-list
19580764|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580765|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580766|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
19580767|NCT02685670|Fludarabine|fludarabine|mesh-list
19580768|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121434|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
20121435|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121436|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121437|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20121438|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20121439|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121440|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121441|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121442|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121443|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20121444|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
20121445|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
20121446|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121447|NCT00006747|Cytarabine|cytarabine|mesh-list
20121448|NCT00006747|Methotrexate|methotrexate|mesh-list
20121449|NCT00006747|Etoposide|etoposide|mesh-list
20121450|NCT00006747|Melphalan|melphalan|mesh-list
20121451|NCT00006747|Carmustine|carmustine|mesh-list
19580769|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
19580770|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121452|NCT00006747|Tacrolimus|tacrolimus|mesh-list
20121453|NCT00006747|Sargramostim|sargramostim|mesh-list
20121454|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20121455|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
20121456|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20121457|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121458|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121459|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
20121460|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121461|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580771|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580772|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580773|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
19580774|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580775|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580776|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19580777|NCT02686008|Olaparib|olaparib|mesh-list
19580778|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19580779|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580780|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580781|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580782|NCT02685618|Iloprost|iloprost|mesh-list
19580783|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19580784|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
19580785|NCT02685397|Leuprolide|leuprolide|mesh-list
19580786|NCT02685397|Goserelin|goserelin|mesh-list
19580787|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19580788|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19580789|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
19580790|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19580791|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580792|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19580793|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580794|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
19580795|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19580796|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
19580797|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19580798|NCT02685345|Firuglipel|firuglipel|mesh-list
19580799|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580800|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580801|NCT02685462|Digoxin|digoxin|mesh-list
19580802|NCT02685462|Caffeine|caffeine|mesh-list
19580803|NCT02685462|Atorvastatin|atorvastatin|mesh-list
19580804|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19580805|NCT02685462|Simvastatin|simvastatin|mesh-list
19580806|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19580807|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19580808|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
19580809|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580810|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19580811|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19580812|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580813|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19580814|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580815|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19580816|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19580817|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19580818|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
19580819|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580820|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19580821|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19580822|NCT02685462|Protective Agents|protective agents|mesh-ancestor
19580823|NCT02685306|Paclitaxel|paclitaxel|mesh-list
19580824|NCT02685306|Taxane|taxane|mesh-list
19580825|NCT02685306|Bavituximab|bavituximab|mesh-list
19580826|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19580827|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580828|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
19580829|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
19580830|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
19580831|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580832|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19580833|NCT02685449|Insulin|insulin|mesh-list
19580834|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19580835|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
19580836|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
19580837|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
20121462|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
20121463|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580838|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19580839|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580840|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19580841|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19580842|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
19580843|NCT02685228|Gemcitabine|gemcitabine|mesh-list
19580844|NCT02685228|Decitabine|decitabine|mesh-list
19580845|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19580846|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
19580847|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580848|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580849|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
19580850|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580851|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580852|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580853|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
19580854|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580855|NCT02685163|Antioxidants|antioxidants|mesh-list
19580856|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580857|NCT02685163|Protective Agents|protective agents|mesh-ancestor
20121464|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20121465|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121466|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
20121467|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121468|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20121469|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121470|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121471|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121472|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
20121473|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121474|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20121475|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580858|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580859|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
19580860|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580861|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580862|NCT02685111|Lenograstim|lenograstim|mesh-list
19580863|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19580864|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
19580865|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580866|NCT02685150|Omeprazole|omeprazole|mesh-list
19580867|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19580868|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19580869|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580870|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580871|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580872|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
19580873|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19580874|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19580875|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580876|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
19580877|NCT02684812|Coagulants|coagulants|mesh-ancestor
19580878|NCT02684786|Lidocaine|lidocaine|mesh-list
19580879|NCT02684786|Reserpine|reserpine|mesh-list
19580880|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
19580881|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
19580882|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19580883|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580884|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
19580885|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19580886|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19580887|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19580888|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19580889|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19580890|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580891|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19580892|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20121476|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
20121477|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19580893|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20121478|NCT00006760|Vinorelbine|vinorelbine|mesh-list
20121479|NCT00006760|Ifosfamide|ifosfamide|mesh-list
20121480|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121481|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121482|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
19580894|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20121483|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
19580895|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19580896|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19580897|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
19580898|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580899|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
20121484|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121485|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121486|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121487|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
20121488|NCT00006773|Bortezomib|bortezomib|mesh-list
20121489|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121490|NCT00006786|Leucovorin|leucovorin|mesh-list
20121491|NCT00006786|Bevacizumab|bevacizumab|mesh-list
20121492|NCT00006786|Fluorouracil|fluorouracil|mesh-list
19580900|NCT02684799|Omeprazole|omeprazole|mesh-list
19580901|NCT02684799|Famotidine|famotidine|mesh-list
19580902|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19580903|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580904|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19580905|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580906|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580907|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19580908|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
19580909|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
19580910|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580911|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580912|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20121493|NCT00006786|Irinotecan|irinotecan|mesh-list
20121494|NCT00006786|Calcium|calcium|mesh-list
20121495|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
20121496|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20121497|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121498|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20121499|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20121500|NCT00006786|Growth Substances|growth substances|mesh-ancestor
20121501|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121502|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
20121503|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19580913|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19580914|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19580915|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
19580916|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580917|NCT02685176|Charcoal|charcoal|mesh-list
19580918|NCT02685176|Antidotes|antidotes|mesh-ancestor
19580919|NCT02685176|Protective Agents|protective agents|mesh-ancestor
19580920|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580921|NCT02685085|Misoprostol|misoprostol|mesh-list
19580922|NCT02685085|Dinoprostone|dinoprostone|mesh-list
19580923|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19580924|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
19580925|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19580926|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580927|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19580928|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19580929|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
19656368|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19656369|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656370|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
19656371|NCT04651166|Coagulants|coagulants|mesh-ancestor
20121504|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
20121505|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121506|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121507|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121508|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
20121509|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20121510|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121511|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121512|NCT00006786|Antidotes|antidotes|mesh-ancestor
20121513|NCT00006786|Protective Agents|protective agents|mesh-ancestor
20121514|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
20121515|NCT00006786|Vitamins|vitamins|mesh-ancestor
20121516|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
20121517|NCT00006799|Megestrol|megestrol|mesh-list
20121518|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
20121519|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20121520|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20121521|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20121522|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
19580930|NCT02685059|Paclitaxel|paclitaxel|mesh-list
19580931|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
19580932|NCT02685059|Durvalumab|durvalumab|mesh-list
19580933|NCT02685059|Epirubicin|epirubicin|mesh-list
19580934|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19580935|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580936|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
19580937|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
19580938|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
19580939|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580940|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580941|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
19580942|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580943|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580944|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580945|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
19580946|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19580947|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19580948|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19580949|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19580950|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19580951|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580952|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
19580953|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121523|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20121524|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121525|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20121526|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20121527|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20121528|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121529|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
20121530|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20121531|NCT00006812|Capecitabine|capecitabine|mesh-list
20121532|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19580954|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580955|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
20121533|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
20121534|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121535|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121536|NCT00006825|Doxorubicin|doxorubicin|mesh-list
20121537|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20121538|NCT00006825|Trastuzumab|trastuzumab|mesh-list
20121539|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20121540|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121541|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121542|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19580956|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580957|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19580958|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580959|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580960|NCT02684708|Prednisone|prednisone|mesh-list
19580961|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
19580962|NCT02684708|Dacarbazine|dacarbazine|mesh-list
19580963|NCT02684708|Vincristine|vincristine|mesh-list
19580964|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19580965|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
19580966|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580967|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19580968|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19580969|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
19580970|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19580971|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19580972|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19580973|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19580974|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
19580975|NCT02684708|Hormones|hormones|mesh-ancestor
19580976|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19580977|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19580978|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19580979|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19580980|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19580981|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121543|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19580982|NCT02684487|Vitamin D|vitamin d|mesh-list
19580983|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
19580984|NCT02684487|Vitamins|vitamins|mesh-ancestor
19580985|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
19580986|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580987|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19580988|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20121544|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121545|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20121546|NCT00006864|Aldesleukin|aldesleukin|mesh-list
20121547|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121548|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121549|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121550|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
20121551|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19580989|NCT02684409|Sumatriptan|sumatriptan|mesh-list
19580990|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19580991|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19580992|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19580993|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
19580994|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19580995|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121552|NCT00006877|Temozolomide|temozolomide|mesh-list
19580996|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19580997|NCT02684474|HBOC 201|hboc 201|mesh-list
19580998|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
19580999|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
19581000|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19581001|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19581002|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581003|NCT02684669|Naloxone|naloxone|mesh-list
19581004|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19581005|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581006|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
19581007|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581008|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
19581009|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
19581010|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19581011|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581012|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581013|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581014|NCT02684019|Analgesics|analgesics|mesh-ancestor
19581015|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
19581016|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581017|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19581018|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19581019|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19581020|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19581021|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581022|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581023|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
19581024|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19581025|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
19581026|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19581027|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581028|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19581029|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
19581030|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19581031|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
19581032|NCT02684071|Methotrexate|methotrexate|mesh-list
19581033|NCT02684071|Topotecan|topotecan|mesh-list
19581034|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19581035|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
19581036|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581037|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581038|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19581039|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
19581040|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581041|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581042|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19581043|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19581044|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
19581045|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20121553|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121554|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
19581046|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19581047|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
19581048|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
19581049|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581050|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19581051|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19581052|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19581053|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19581054|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
19581055|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19581056|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581057|NCT02684084|Dexamethasone|dexamethasone|mesh-list
19581058|NCT02684084|Ranibizumab|ranibizumab|mesh-list
19581059|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581060|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
19581061|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
19581062|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581063|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581064|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581065|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
19581066|NCT02684084|Hormones|hormones|mesh-ancestor
19581067|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19581068|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19581069|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581070|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19581071|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19581072|NCT02684084|Growth Substances|growth substances|mesh-ancestor
19581073|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
19581074|NCT02684305|Oxytocin|oxytocin|mesh-list
19581075|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
19581076|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19581077|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581078|NCT02684318|Olaparib|olaparib|mesh-list
19581079|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19581080|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581081|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581082|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581083|NCT02684123|Apremilast|apremilast|mesh-list
19581084|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19581085|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581086|NCT02684123|Analgesics|analgesics|mesh-ancestor
19581087|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
19581088|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581089|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581090|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581091|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581092|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19581093|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19581094|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581095|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121555|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121556|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121557|NCT00006890|Thalidomide|thalidomide|mesh-list
20121558|NCT00006890|Prednisone|prednisone|mesh-list
20121559|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20121560|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
20121561|NCT00006890|Hormones|hormones|mesh-ancestor
20121562|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20121563|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121564|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20121565|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121566|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19581096|NCT02683837|Remifentanil|remifentanil|mesh-list
19581097|NCT02683837|Sevoflurane|sevoflurane|mesh-list
19581098|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19581099|NCT02683837|Narcotics|narcotics|mesh-ancestor
19581100|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581101|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581102|NCT02683837|Analgesics|analgesics|mesh-ancestor
20121567|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
19581103|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
19581104|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581105|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19581106|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20121568|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
19581107|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
19581108|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
19581109|NCT02683759|Curcumin|curcumin|mesh-list
19581110|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19581111|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581112|NCT02683759|Analgesics|analgesics|mesh-ancestor
19581113|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
19581114|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581115|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581116|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581117|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581118|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581119|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581120|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581121|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19581122|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
19581123|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19581124|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
19581125|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581126|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19581127|NCT02683733|Curcumin|curcumin|mesh-list
19581128|NCT02683733|Mesalamine|mesalamine|mesh-list
19581129|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19581130|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581131|NCT02683733|Analgesics|analgesics|mesh-ancestor
19581132|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
19581133|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581134|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581135|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581136|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581137|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581138|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581139|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581140|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
19581141|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581142|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581143|NCT02683655|Apatinib|apatinib|mesh-list
19581144|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581145|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19581146|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581147|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581148|NCT02683564|Infliximab|infliximab|mesh-list
19581149|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
19581150|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581151|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581152|NCT02683603|Imipenem|imipenem|mesh-list
19581153|NCT02683603|Colistin|colistin|mesh-list
19581154|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581155|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581156|NCT02683369|Iron|iron|mesh-list
19581157|NCT02683369|Trace Elements|trace elements|mesh-ancestor
19581158|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
19581159|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121569|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20121570|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121571|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20121572|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20121573|NCT00006890|Growth Substances|growth substances|mesh-ancestor
20121574|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
20121575|NCT00006929|Suramin|suramin|mesh-list
20121576|NCT00006929|Paclitaxel|paclitaxel|mesh-list
19581160|NCT02682953|Plerixafor|plerixafor|mesh-list
19581161|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19581162|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19581163|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
19581164|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581165|NCT02683031|Ionophores|ionophores|mesh-list
19581166|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581167|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581168|NCT02683213|Fluoxetine|fluoxetine|mesh-list
19581169|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19581170|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19581171|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581172|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581173|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581174|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
20121577|NCT00006929|Carboplatin|carboplatin|mesh-list
19581175|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581176|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19581177|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
19581178|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19581179|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19581180|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19581181|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581182|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
19581183|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19581184|NCT02683005|Ledipasvir|ledipasvir|mesh-list
19581185|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
19581186|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581187|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19581188|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19581189|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
19581190|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581191|NCT02683070|Tramadol|tramadol|mesh-list
19581192|NCT02683070|Ropivacaine|ropivacaine|mesh-list
19581193|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581194|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
20121578|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121579|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121580|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
20121581|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
20121582|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121583|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121584|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
20121585|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
20121586|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20121587|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121588|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20121589|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20121590|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
20121591|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121592|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19581195|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581196|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581197|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
19581198|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581199|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19581200|NCT02683070|Narcotics|narcotics|mesh-ancestor
19581201|NCT02683070|Analgesics|analgesics|mesh-ancestor
19581202|NCT02682927|Fenfluramine|fenfluramine|mesh-list
19581203|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19581204|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19581205|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581206|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581207|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581208|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
19581209|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581210|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
19581211|NCT02683291|Sirolimus|sirolimus|mesh-list
19581212|NCT02683291|Prednisone|prednisone|mesh-list
19581213|NCT02683291|Tacrolimus|tacrolimus|mesh-list
19581214|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
20121593|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
20121594|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121595|NCT00006968|Cyclosporine|cyclosporine|mesh-list
20121596|NCT00006968|Pentostatin|pentostatin|mesh-list
20121597|NCT00006968|Cyclosporins|cyclosporins|mesh-list
20121598|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
20121599|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121600|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121601|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121602|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121603|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
20121604|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121605|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
20121606|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121607|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20121608|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581215|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19581216|NCT02683291|Basiliximab|basiliximab|mesh-list
19581217|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20121609|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20121610|NCT00006981|Immunotoxins|immunotoxins|mesh-list
20121611|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
20121612|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581218|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
19581219|NCT02683291|Hormones|hormones|mesh-ancestor
19581220|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19581221|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581222|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19581223|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581224|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19581225|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
19581226|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19581227|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581228|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581229|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19581230|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19581231|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
19581232|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581233|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581234|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
19581235|NCT02682862|Bromides|bromides|mesh-list
19581236|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
19581237|NCT02682862|Olodaterol|olodaterol|mesh-list
19581238|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19581239|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
19581240|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581241|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581242|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19581243|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
19581244|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
19581245|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19581246|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
19581247|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581248|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581249|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
20121613|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
20121614|NCT00007033|Analgesics|analgesics|mesh-ancestor
20121615|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
20121616|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20121617|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121618|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
20121619|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20121620|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19656397|NCT04630028|Ustekinumab|ustekinumab|mesh-list
19656398|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
19656399|NCT04624230|Tofacitinib|tofacitinib|mesh-list
19656400|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19656401|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656402|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656403|NCT04605081|Naltrexone|naltrexone|mesh-list
19656404|NCT04605081|Bupropion|bupropion|mesh-list
19656405|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19656406|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19656407|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656408|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
19656409|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656410|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19656411|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656412|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19656413|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19656414|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19656415|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20121621|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
20121622|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20121623|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20121624|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121625|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20121626|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
20121627|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20121628|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
20121629|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20121630|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121631|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20121632|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
20121633|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309037|NCT00666692|Carboplatin|carboplatin|mesh-list
20121634|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581250|NCT02682693|Denosumab|denosumab|mesh-list
19581251|NCT02682693|Paclitaxel|paclitaxel|mesh-list
19581252|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
19581253|NCT02682693|Carboplatin|carboplatin|mesh-list
19581254|NCT02682693|Trastuzumab|trastuzumab|mesh-list
19581255|NCT02682693|Epirubicin|epirubicin|mesh-list
19581256|NCT02682693|Pertuzumab|pertuzumab|mesh-list
19581257|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19581258|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581259|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
19581260|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
19581261|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
19581262|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581263|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121635|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581264|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
19581265|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121636|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121637|NCT00007189|Celecoxib|celecoxib|mesh-list
20121638|NCT00007189|Naproxen|naproxen|mesh-list
20121639|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20121640|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20121641|NCT00007189|Analgesics|analgesics|mesh-ancestor
20121642|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
20121643|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581266|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581267|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19581268|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
19581269|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19581270|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19581271|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19581272|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19581273|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19581274|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581275|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19581276|NCT02682680|Ezetimibe|ezetimibe|mesh-list
19581277|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19581278|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19581279|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19581280|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
19581281|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581282|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19581283|NCT02682758|Xenon|xenon|mesh-list
19581284|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
19581285|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581286|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581287|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20121644|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121645|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20121646|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121647|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20121648|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20121649|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581288|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
20121650|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121651|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
20121652|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19581289|NCT02682524|Aceclofenac|aceclofenac|mesh-list
19581290|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19581291|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581292|NCT02682524|Analgesics|analgesics|mesh-ancestor
19581293|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
19581294|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581295|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581296|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581297|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581298|NCT02682511|Ifetroban|ifetroban|mesh-list
19581299|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19581300|NCT02682485|Metronidazole|metronidazole|mesh-list
19581301|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
19581302|NCT02682485|Neomycin|neomycin|mesh-list
19581303|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121653|NCT00007202|Stavudine|stavudine|mesh-list
20121654|NCT00007202|Didanosine|didanosine|mesh-list
19581304|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581305|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19581306|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19581307|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19581308|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19581309|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581310|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581311|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581312|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19581313|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19581314|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19581315|NCT02682186|Ropivacaine|ropivacaine|mesh-list
19581316|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581317|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
19581318|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581319|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581320|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
19581321|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581322|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
19581323|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
19581324|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19581325|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19581326|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581327|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581328|NCT02682147|Urological Agents|urological agents|mesh-ancestor
19581329|NCT02682134|Dexamethasone|dexamethasone|mesh-list
19581330|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
19581331|NCT02682134|Lidocaine|lidocaine|mesh-list
20121655|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20121656|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20121657|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
20121658|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121659|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121660|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121661|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121662|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
20121663|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121664|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
20121665|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20121666|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20173313|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173314|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20173315|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
20173316|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20173317|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20173318|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
20173319|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173320|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
20173321|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173322|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20173323|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173324|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
20173325|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173326|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20173327|NCT00161278|Paclitaxel|paclitaxel|mesh-list
20173328|NCT00161278|Carboplatin|carboplatin|mesh-list
20173329|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20173330|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173331|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
20173332|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
20173333|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173334|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173335|NCT00161291|Bevacizumab|bevacizumab|mesh-list
20173336|NCT00161291|Letrozole|letrozole|mesh-list
19581332|NCT02682134|BB 1101|bb 1101|mesh-list
19581333|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581334|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
19581335|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
19581336|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581337|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581338|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581339|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
20309038|NCT00666692|Volociximab|volociximab|mesh-list
19581340|NCT02682134|Hormones|hormones|mesh-ancestor
19656416|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581341|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19581342|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19581343|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581344|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
19581345|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581346|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581347|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581348|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
19581349|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581350|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
19581351|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19581352|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19581353|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19581354|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581355|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19581356|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
19581357|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19581358|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581359|NCT02682459|Lisinopril|lisinopril|mesh-list
19581360|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19581361|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
19581362|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581363|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581364|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19581365|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19581366|NCT02682459|Protective Agents|protective agents|mesh-ancestor
19581367|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581368|NCT02682225|Ketamine|ketamine|mesh-list
19581369|NCT02682225|Esketamine|esketamine|mesh-list
19581370|NCT02682225|Analgesics|analgesics|mesh-ancestor
19581371|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
19581372|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581373|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581374|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19581375|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19581376|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
19581377|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
19581378|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581379|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19581380|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19581381|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581382|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581383|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
19581384|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19581385|NCT02682121|Metformin|metformin|mesh-list
19581386|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19581387|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581388|NCT02682017|Fucoidan|fucoidan|mesh-list
19581389|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19581390|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581391|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
20121667|NCT00007306|Hormones|hormones|mesh-list
20121668|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
20121669|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20121670|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121671|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20121672|NCT00007358|Dexamethasone|dexamethasone|mesh-list
20121673|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581392|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581393|NCT02682082|Bupivacaine|bupivacaine|mesh-list
19581394|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581395|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
19581396|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581397|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581398|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
19581399|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581400|NCT02681848|Nicotine|nicotine|mesh-list
20121674|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
20121675|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
20121676|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20121677|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121678|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20121679|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
20121680|NCT00007358|Hormones|hormones|mesh-ancestor
19581401|NCT02681848|Varenicline|varenicline|mesh-list
19581402|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19581403|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
19581404|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581405|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581406|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19581407|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19581408|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
19581409|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581410|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581411|NCT02681887|Melatonin|melatonin|mesh-list
19581412|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
19581413|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581414|NCT02681887|Protective Agents|protective agents|mesh-ancestor
19581415|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581416|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581417|NCT02681913|Adenosine|adenosine|mesh-list
19581418|NCT02681913|Analgesics|analgesics|mesh-ancestor
19581419|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
19581420|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581421|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581422|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19581423|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
19581424|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19581425|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
19581426|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
19581427|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581428|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581429|NCT02681783|Aflibercept|aflibercept|mesh-list
19581430|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19581431|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19581432|NCT02681783|Growth Substances|growth substances|mesh-ancestor
19581433|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581434|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
19581435|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581436|NCT02681679|Bromfenac|bromfenac|mesh-list
19581437|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19581438|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19581439|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19581440|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581441|NCT02681679|Analgesics|analgesics|mesh-ancestor
19581442|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
19581443|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581444|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581445|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581446|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581447|NCT02681562|Olaparib|olaparib|mesh-list
19581448|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19581449|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581450|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581451|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581452|NCT02681705|Temozolomide|temozolomide|mesh-list
19581453|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19581454|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
19581455|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581456|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581457|NCT02681653|Atorvastatin|atorvastatin|mesh-list
19581458|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19581459|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19581460|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
19581461|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581462|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19581463|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19581464|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581465|NCT02681471|Mannitol|mannitol|mesh-list
19581466|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19581467|NCT02681471|Diuretics|diuretics|mesh-ancestor
19581468|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
20309039|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19581469|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581470|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19581471|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
19581472|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
19581473|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19581474|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19581475|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581476|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
19581477|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19581478|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19581479|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19581480|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581481|NCT02681796|Bupivacaine|bupivacaine|mesh-list
19581482|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581483|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
19581484|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581485|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581486|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
19581487|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581488|NCT02681198|Lofexidine|lofexidine|mesh-list
19581489|NCT02681198|Paroxetine|paroxetine|mesh-list
19581490|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19581491|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19581492|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581493|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121681|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20121682|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20121683|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121684|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
19581494|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581495|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
19581496|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581497|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19581498|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
19581499|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19581500|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19581501|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19581502|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581503|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19581504|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19581505|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
19581506|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581507|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19581508|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19581509|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19581510|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
19581511|NCT02681263|Temocillin|temocillin|mesh-list
19581512|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581513|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19656417|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
19656418|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656419|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19656420|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19656421|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656422|NCT04599855|Esketamine|esketamine|mesh-list
19656423|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656424|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20121685|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20121686|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
20121687|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121688|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20121689|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656430|NCT04573478|Atrasentan|atrasentan|mesh-list
19656431|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656432|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19656433|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19656434|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581514|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
19581515|NCT02681211|Promethazine|promethazine|mesh-list
19581516|NCT02681211|Ketorolac|ketorolac|mesh-list
19581517|NCT02681211|Metoclopramide|metoclopramide|mesh-list
19581518|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19581519|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581520|NCT02681211|Analgesics|analgesics|mesh-ancestor
19581521|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
19581522|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581523|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581524|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581525|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581526|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19581527|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581528|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581529|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19581530|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19581531|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581532|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581533|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
19581534|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
19581535|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
19581536|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20121690|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
20121691|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121692|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
19581537|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19581538|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
19581539|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
20121693|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20121694|NCT00007423|Protective Agents|protective agents|mesh-ancestor
20121695|NCT00007436|Tenofovir|tenofovir|mesh-list
20121696|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
20121697|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121698|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20121699|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20121700|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121701|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581540|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581541|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19581542|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
19581543|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
19581544|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19581545|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19581546|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
19581547|NCT02680977|Levodopa|levodopa|mesh-list
19581548|NCT02680977|Benserazide|benserazide|mesh-list
19581549|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19581550|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19581551|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
19581552|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581553|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581554|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581555|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581556|NCT02680938|Oxytocin|oxytocin|mesh-list
19581557|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
19581558|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19581559|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581560|NCT02680951|Cytarabine|cytarabine|mesh-list
19581561|NCT02680951|Fludarabine|fludarabine|mesh-list
19581562|NCT02680951|Dasatinib|dasatinib|mesh-list
19581563|NCT02680951|Idarubicin|idarubicin|mesh-list
19581564|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581565|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19581566|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
19581567|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581568|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19581569|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
19581570|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581571|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
19581572|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121702|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20121703|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121704|NCT00007527|Buprenorphine|buprenorphine|mesh-list
19581573|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19581574|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581575|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19581576|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19581577|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19581578|NCT02680717|Clobetasol|clobetasol|mesh-list
19581579|NCT02680717|Calcipotriene|calcipotriene|mesh-list
19581580|NCT02680717|Tacrolimus|tacrolimus|mesh-list
19581581|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19581582|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
19581583|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581584|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19581585|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581586|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581587|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581588|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
19581589|NCT02680717|Hormones|hormones|mesh-ancestor
19581590|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19581591|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
19581592|NCT02680795|Belinostat|belinostat|mesh-list
19581593|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581594|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19581595|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581596|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581597|NCT02680600|Cefepime|cefepime|mesh-list
19581598|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581599|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581600|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19581601|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
19581602|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19581603|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19581604|NCT02680548|Prednisolone|prednisolone|mesh-list
19581605|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
19581606|NCT02680548|Bupivacaine|bupivacaine|mesh-list
19581607|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19581608|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
19581609|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581610|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
19581611|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581612|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581613|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
19581614|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581615|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581616|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
19581617|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
19581618|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581619|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
19581620|NCT02680548|Hormones|hormones|mesh-ancestor
20121705|NCT00007527|Naloxone|naloxone|mesh-list
20121706|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20121707|NCT00007527|Narcotics|narcotics|mesh-ancestor
19581621|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19581622|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19581623|NCT02680548|Protective Agents|protective agents|mesh-ancestor
19581624|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19581625|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581626|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
19581627|NCT02680626|Ropivacaine|ropivacaine|mesh-list
19581628|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581629|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
19581630|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581631|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581632|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
19581633|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581634|NCT02680626|Analgesics|analgesics|mesh-ancestor
19581635|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19581636|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
19581637|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19581638|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581639|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581640|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19581641|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
19581642|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19581643|NCT02680808|Olorofim|olorofim|mesh-list
20121708|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20121709|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121710|NCT00007527|Analgesics|analgesics|mesh-ancestor
19581644|NCT02680808|Midazolam|midazolam|mesh-list
19581645|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19581646|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20121711|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
19581647|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581648|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581649|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19581650|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19581651|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19581652|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19581653|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
19581654|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
19581655|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
19581656|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
19581657|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581658|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581659|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
19581660|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581661|NCT02680379|Minocycline|minocycline|mesh-list
19581662|NCT02680379|Lovastatin|lovastatin|mesh-list
19581663|NCT02680379|L 647318|l 647318|mesh-list
19581664|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
19581665|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581666|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581667|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19581668|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19581669|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
19581670|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581671|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19581672|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19581673|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581674|NCT02680119|Esomeprazole|esomeprazole|mesh-list
19581675|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19581676|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581677|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19581678|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581679|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581680|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
19581681|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581682|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581683|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19581684|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19581685|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581686|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581687|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581688|NCT02680132|Esomeprazole|esomeprazole|mesh-list
19581689|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19581690|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581691|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19581692|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581693|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581694|NCT02679963|Olaparib|olaparib|mesh-list
20121712|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20121713|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20121714|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
20121715|NCT00007592|Furosemide|furosemide|mesh-list
20121716|NCT00007592|Diuretics|diuretics|mesh-ancestor
20121717|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
20121718|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121719|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20121720|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20121721|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121722|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20121723|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20121724|NCT00007605|Amiodarone|amiodarone|mesh-list
20121725|NCT00007605|Sotalol|sotalol|mesh-list
20121726|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20121727|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
20121728|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20121729|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20121730|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656435|NCT04572217|Topiramate|topiramate|mesh-list
20121731|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20121732|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20121733|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20121734|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121735|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20121736|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20121737|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20121738|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20121739|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20121740|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
20121741|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20121742|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121743|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
19581695|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19581696|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581697|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581698|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581699|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
19581700|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19581701|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
19581702|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581703|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
19581704|NCT02679924|Protective Agents|protective agents|mesh-ancestor
19581705|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19581706|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20121744|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
20121745|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20121746|NCT00007631|Tretinoin|tretinoin|mesh-list
20121747|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121748|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
20121749|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
20121750|NCT00007670|Lamotrigine|lamotrigine|mesh-list
19581707|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19581708|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
19581709|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581710|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19581711|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19581712|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581713|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
19581714|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
19581715|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
19581716|NCT02679833|Vitamins|vitamins|mesh-ancestor
19581717|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
19581718|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581719|NCT02679833|Hematinics|hematinics|mesh-ancestor
19581720|NCT02679820|Copper|copper|mesh-list
19581721|NCT02679820|Trace Elements|trace elements|mesh-ancestor
19581722|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
19581723|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581724|NCT02679339|Lidocaine|lidocaine|mesh-list
19581725|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581726|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
19581727|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581728|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581729|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
19581730|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581731|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19581732|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19581733|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19581734|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581735|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656436|NCT04572217|Phentermine|phentermine|mesh-list
19656437|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
19656438|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19656439|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656440|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19656441|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
19656442|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19656443|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
19656444|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
19656445|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656446|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
20121751|NCT00007670|Carbamazepine|carbamazepine|mesh-list
19656447|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656448|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121752|NCT00007670|Gabapentin|gabapentin|mesh-list
20121753|NCT00007670|Analgesics|analgesics|mesh-ancestor
19581736|NCT02679456|Fluconazole|fluconazole|mesh-list
19581737|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
19581738|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
19581739|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581740|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19581741|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19581742|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581743|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581744|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19581745|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
19581746|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19581747|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581748|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19581749|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19581750|NCT02679261|Atorvastatin|atorvastatin|mesh-list
19581751|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19581752|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19581753|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
19581754|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581755|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19581756|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19581757|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581758|NCT02678975|Copper|copper|mesh-list
19581759|NCT02678975|Temozolomide|temozolomide|mesh-list
20121754|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
20121755|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20121756|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121757|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
20121758|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20121759|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20121760|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20121761|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20121762|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20121763|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20121764|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20121765|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581760|NCT02678975|Lomustine|lomustine|mesh-list
19581761|NCT02678975|Disulfiram|disulfiram|mesh-list
19581762|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
19581763|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19581764|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581765|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581766|NCT02678975|Trace Elements|trace elements|mesh-ancestor
19581767|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
19581768|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121766|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
20121767|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20121768|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20121769|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20121770|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20121771|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20121772|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20121773|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20121774|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20121775|NCT00007683|Aspirin|aspirin|mesh-list
20121776|NCT00007683|Warfarin|warfarin|mesh-list
20121777|NCT00007683|Clopidogrel|clopidogrel|mesh-list
20121778|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20121779|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20121780|NCT00007683|Analgesics|analgesics|mesh-ancestor
20121781|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
20121782|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581769|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19581770|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19581771|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581772|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19581773|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581774|NCT02679131|Belinostat|belinostat|mesh-list
19581775|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581776|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19581777|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121783|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121784|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581778|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581779|NCT02679092|Misoprostol|misoprostol|mesh-list
19581780|NCT02679092|Mifepristone|mifepristone|mesh-list
19581781|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19581782|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
19581783|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19581784|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581785|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19581786|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19581787|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
19581788|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19581789|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19581790|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19581791|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19581792|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
19581793|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19581794|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19581795|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
19581796|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19581797|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
19581798|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19581799|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19581800|NCT02679040|Trastuzumab|trastuzumab|mesh-list
19581801|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19581802|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581803|NCT02678949|Fluticasone|fluticasone|mesh-list
19581804|NCT02678949|Xhance|xhance|mesh-list
19581805|NCT02678949|Albuterol|albuterol|mesh-list
19581806|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581807|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19581808|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
19581809|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581810|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581811|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19581812|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
19581813|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
19581814|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19581815|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
19581816|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19581817|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19581818|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19581819|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19581820|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
19581821|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581822|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581823|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19581824|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19581825|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581826|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
19581827|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19581828|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581829|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581830|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581831|NCT02678728|Analgesics|analgesics|mesh-ancestor
20121785|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121786|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20121787|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20121788|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121789|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20121790|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20121791|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121792|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
20121793|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20121794|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20121795|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20121796|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
20121797|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20121798|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
19581832|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
19581833|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581834|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20121799|NCT00007735|Doxycycline|doxycycline|mesh-list
19581835|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20121800|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20121801|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121802|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
20121803|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20121804|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20121805|NCT00007774|Haloperidol|haloperidol|mesh-list
20121806|NCT00007774|Olanzapine|olanzapine|mesh-list
20121807|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
20121808|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
20121809|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
20121810|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20121811|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121812|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20121813|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20121814|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20121815|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20121816|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20121817|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20121818|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20121819|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20121820|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121821|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20121822|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
20121823|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20121824|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
20121825|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20121826|NCT00007787|Cyclosporine|cyclosporine|mesh-list
20121827|NCT00007787|Tacrolimus|tacrolimus|mesh-list
19581836|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19581837|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
19581838|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581839|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581840|NCT02678780|Lenvatinib|lenvatinib|mesh-list
19581841|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581842|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19581843|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581844|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581845|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19581846|NCT02678767|Hematinics|hematinics|mesh-ancestor
19581847|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19581848|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19581849|NCT02678520|Goserelin|goserelin|mesh-list
19581850|NCT02678520|Bicalutamide|bicalutamide|mesh-list
20121828|NCT00007787|Cyclosporins|cyclosporins|mesh-list
20121829|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
20121830|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121831|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
20121832|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121833|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20121834|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121835|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121836|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
20121837|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121838|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
20121839|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121840|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
20121841|NCT00007813|Carboplatin|carboplatin|mesh-list
20121842|NCT00007813|Etoposide|etoposide|mesh-list
20121843|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121844|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
20121845|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121846|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121847|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121848|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
20121849|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121850|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121851|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19581851|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20121852|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19581852|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121853|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121854|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121855|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581853|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19581854|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581855|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
19581856|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
19581857|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19581858|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19581859|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19581860|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581861|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581862|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19581863|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581864|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581865|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
19581866|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581867|NCT02678650|Anesthetics|anesthetics|mesh-list
20121856|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20121857|NCT00007826|Vaccines|vaccines|mesh-list
20121858|NCT00007826|Antibodies|antibodies|mesh-list
20121859|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20121860|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
19581868|NCT02678650|Propofol|propofol|mesh-list
19581869|NCT02678650|Isoflurane|isoflurane|mesh-list
19581870|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581871|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581872|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19581873|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19581874|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
19581875|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19581876|NCT02678338|Magrolimab|magrolimab|mesh-list
19581877|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19581878|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581879|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
19581880|NCT02678507|Narcotics|narcotics|mesh-ancestor
19581881|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581882|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581883|NCT02678507|Analgesics|analgesics|mesh-ancestor
19581884|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
19581885|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581886|NCT02678598|Micafungin|micafungin|mesh-list
19581887|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
19581888|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581889|NCT02678364|Vitamin D|vitamin d|mesh-list
19581890|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
19581891|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19581892|NCT02678364|Calcifediol|calcifediol|mesh-list
19581893|NCT02678364|Vitamins|vitamins|mesh-ancestor
19581894|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
19581895|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581896|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19581897|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19581898|NCT02678585|Lidocaine|lidocaine|mesh-list
19581899|NCT02678585|Nalbuphine|nalbuphine|mesh-list
19581900|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
19581901|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
19581902|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581903|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581904|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
19581905|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581906|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19581907|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19581908|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19581909|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581910|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581911|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19581912|NCT02678585|Narcotics|narcotics|mesh-ancestor
19581913|NCT02678585|Analgesics|analgesics|mesh-ancestor
19581914|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
19581915|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19581916|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19581917|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581918|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
19581919|NCT02678208|Coagulants|coagulants|mesh-ancestor
19581920|NCT02678260|Spartalizumab|spartalizumab|mesh-list
19581921|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19581922|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121861|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
20121862|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
19581923|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19581924|NCT02678195|Amoxicillin|amoxicillin|mesh-list
19581925|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19581926|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581927|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
19581928|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19581929|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19581930|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19581931|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
19581932|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
19581933|NCT02678221|Aspirin|aspirin|mesh-list
19581934|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
19581935|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20121863|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121864|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20121865|NCT00007826|Antacids|antacids|mesh-ancestor
19581936|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581937|NCT02678221|Analgesics|analgesics|mesh-ancestor
19581938|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
19581939|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581940|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581941|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19581942|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19581943|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19581944|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19581945|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581946|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19581947|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19581948|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19581949|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
19581950|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
19581951|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19581952|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19581953|NCT02678221|Urological Agents|urological agents|mesh-ancestor
19581954|NCT02678234|Acetaminophen|acetaminophen|mesh-list
19581955|NCT02678234|Ascorbic Acid|ascorbic acid|mesh-list
19581956|NCT02678234|Phenylephrine|phenylephrine|mesh-list
19581957|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
19581958|NCT02678234|Vitamins|vitamins|mesh-ancestor
19581959|NCT02678234|Micronutrients|micronutrients|mesh-ancestor
19581960|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581961|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19581962|NCT02678234|Analgesics|analgesics|mesh-ancestor
19581963|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
19581964|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581965|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
19581966|NCT02678234|Antioxidants|antioxidants|mesh-ancestor
19581967|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581968|NCT02678234|Protective Agents|protective agents|mesh-ancestor
19581969|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19581970|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
19581971|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
19581972|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
19581973|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19581974|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
19581975|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
19581976|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19581977|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19581978|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19581979|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
19581980|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19581981|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
19581982|NCT02678117|Pregabalin|pregabalin|mesh-list
19581983|NCT02678117|Analgesics|analgesics|mesh-ancestor
19581984|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
19581985|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19581986|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19581987|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
19581988|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19581989|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19581990|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19581991|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19581992|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19581993|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19581994|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19581995|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19581996|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
19581997|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19581998|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
19581999|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19582000|NCT02678182|Capecitabine|capecitabine|mesh-list
19582001|NCT02678182|Trastuzumab|trastuzumab|mesh-list
19582002|NCT02678182|Durvalumab|durvalumab|mesh-list
19582003|NCT02678182|Ramucirumab|ramucirumab|mesh-list
19582004|NCT02678182|Rucaparib|rucaparib|mesh-list
19582005|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19582006|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
19582007|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582008|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582009|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582010|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19582011|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582012|NCT02678052|Vedolizumab|vedolizumab|mesh-list
19582013|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19582014|NCT02677597|Paclitaxel|paclitaxel|mesh-list
19582015|NCT02677597|Cisplatin|cisplatin|mesh-list
19582016|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19582017|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582018|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
19582019|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
19582020|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
19582021|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582022|NCT02677584|Caffeine|caffeine|mesh-list
19582023|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
19582024|NCT02677584|Citric Acid|citric acid|mesh-list
19582025|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
19582026|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
19582027|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19582028|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
19582029|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
19582030|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582031|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19582032|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582033|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19582034|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582035|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19582036|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19582037|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
19582038|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582039|NCT02677571|Morphine|morphine|mesh-list
20121866|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121867|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20121868|NCT00007852|Cytarabine|cytarabine|mesh-list
20121869|NCT00007852|Rituximab|rituximab|mesh-list
20121870|NCT00007852|Etoposide|etoposide|mesh-list
19582040|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
19582041|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19582042|NCT02677571|Narcotics|narcotics|mesh-ancestor
19582043|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582044|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582045|NCT02677571|Analgesics|analgesics|mesh-ancestor
19582046|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
19582047|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582048|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582049|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
19582050|NCT02677532|Acetaminophen|acetaminophen|mesh-list
19582051|NCT02677532|Sufentanil|sufentanil|mesh-list
19582052|NCT02677532|Morphine|morphine|mesh-list
19582053|NCT02677532|Dsuvia|dsuvia|mesh-list
19582054|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
19582055|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19582056|NCT02677532|Narcotics|narcotics|mesh-ancestor
19749541|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749542|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19749543|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
19749544|NCT04940338|Hormones|hormones|mesh-ancestor
19582057|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582058|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582059|NCT02677532|Analgesics|analgesics|mesh-ancestor
19582060|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
19582061|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20121871|NCT00007852|Melphalan|melphalan|mesh-list
20121872|NCT00007852|Carmustine|carmustine|mesh-list
20121873|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20121874|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121875|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
20121876|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121877|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121878|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121879|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121880|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121881|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582062|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19582063|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
19582064|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582065|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
19582066|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19582067|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19582068|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
19582069|NCT02677519|Methylphenidate|methylphenidate|mesh-list
19582070|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19582071|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582072|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19582073|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19582074|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582075|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582076|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
19582077|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582078|NCT02677415|Anesthetics|anesthetics|mesh-list
19582079|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19582080|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582081|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582082|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
19582083|NCT02677376|Listerine|listerine|mesh-list
19582084|NCT02677376|Fluorides|fluorides|mesh-list
19582085|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
19582086|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
20121882|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121883|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121884|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
20121885|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
20121886|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121887|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582087|NCT02677376|Protective Agents|protective agents|mesh-ancestor
20121888|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121889|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
20121890|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20121891|NCT00007865|Rituximab|rituximab|mesh-list
19582088|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582089|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19582090|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20121892|NCT00007865|Carboplatin|carboplatin|mesh-list
20121893|NCT00007865|Etoposide|etoposide|mesh-list
20121894|NCT00007865|Ifosfamide|ifosfamide|mesh-list
20121895|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20121896|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121897|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
20121898|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121899|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121900|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20121901|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19582091|NCT02677155|Rituximab|rituximab|mesh-list
19582092|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
19582093|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582094|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582095|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
19582096|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582097|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582098|NCT02677051|Sulforaphane|sulforaphane|mesh-list
19582099|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19582100|NCT02677051|Protective Agents|protective agents|mesh-ancestor
19582101|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582102|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582103|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19582104|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19582105|NCT02677259|Estradiol|estradiol|mesh-list
19582106|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19582107|NCT02677259|Progesterone|progesterone|mesh-list
19582108|NCT02677259|Estrogens|estrogens|mesh-ancestor
19582109|NCT02677259|Hormones|hormones|mesh-ancestor
19582110|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582111|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582112|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19582113|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
19582114|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19582115|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19582116|NCT02677259|Progestins|progestins|mesh-ancestor
19582117|NCT02677246|Denosumab|denosumab|mesh-list
19582118|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19582119|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582120|NCT02677077|Natalizumab|natalizumab|mesh-list
19582121|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
19582122|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582123|NCT02676986|Exemestane|exemestane|mesh-list
19582124|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582125|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19582126|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20121902|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121903|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121904|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121905|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121906|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
20121907|NCT00007878|Leucovorin|leucovorin|mesh-list
20121908|NCT00007878|Fluorouracil|fluorouracil|mesh-list
19582127|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121909|NCT00007878|Bortezomib|bortezomib|mesh-list
20121910|NCT00007878|Calcium|calcium|mesh-list
20121911|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
19582128|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582129|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19582130|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
19582131|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582132|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582133|NCT02676934|Anesthetics|anesthetics|mesh-list
19582134|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582135|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582136|NCT02676622|Aldesleukin|aldesleukin|mesh-list
19582137|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
19582138|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
19582139|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582140|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
19582141|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582142|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582143|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19582144|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
19582145|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582146|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582147|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19582148|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19582149|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19582150|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
19582151|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582152|NCT02676674|Vitamin D|vitamin d|mesh-list
19582153|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
19582154|NCT02676674|Vitamins|vitamins|mesh-ancestor
19582155|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
19582156|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582157|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19582158|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19582159|NCT02676609|Insulin|insulin|mesh-list
19582160|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19582161|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582162|NCT02676739|Adderall|adderall|mesh-list
19582163|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19582164|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582165|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
19582166|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582167|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582168|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
19582169|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19582170|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
19582171|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582172|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582173|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19582174|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
19582175|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
19582176|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19582177|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
19582178|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582179|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582180|NCT02676154|Fesoterodine|fesoterodine|mesh-list
19582181|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19582182|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19582183|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
19582184|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582185|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582186|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582187|NCT02676154|Urological Agents|urological agents|mesh-ancestor
19582188|NCT02676310|Bimatoprost|bimatoprost|mesh-list
19582189|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19582190|NCT02676323|Leucovorin|leucovorin|mesh-list
19582191|NCT02676323|Cytarabine|cytarabine|mesh-list
19582192|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
20121912|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20121913|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121914|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
20121915|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121916|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121917|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121918|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121919|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
20121920|NCT00007878|Antidotes|antidotes|mesh-ancestor
20121921|NCT00007878|Protective Agents|protective agents|mesh-ancestor
20121922|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
19582193|NCT02676323|Methotrexate|methotrexate|mesh-list
19582194|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
19582195|NCT02676323|Fludarabine|fludarabine|mesh-list
19582196|NCT02676323|Panobinostat|panobinostat|mesh-list
19582197|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
19582198|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582199|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19582200|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
19582201|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19582202|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19582203|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
19582204|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582205|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582206|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
19582207|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582208|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19582209|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582210|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
19582211|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582212|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19582213|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
20121923|NCT00007878|Vitamins|vitamins|mesh-ancestor
19582214|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582215|NCT02676323|Antidotes|antidotes|mesh-ancestor
19582216|NCT02676323|Protective Agents|protective agents|mesh-ancestor
19582217|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
19582218|NCT02676323|Vitamins|vitamins|mesh-ancestor
19582219|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
19582220|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582221|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19582222|NCT02676336|Iodine|iodine|mesh-list
19582223|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
19582224|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19582225|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582226|NCT02676336|Trace Elements|trace elements|mesh-ancestor
19582227|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
19582228|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582229|NCT02675868|Phenylephrine|phenylephrine|mesh-list
19582230|NCT02675868|Vasopressins|vasopressins|mesh-list
20121924|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
20121925|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20121926|NCT00007891|Antibodies|antibodies|mesh-list
20121927|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
20121928|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20121929|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
20121930|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121931|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121932|NCT00007904|Tamoxifen|tamoxifen|mesh-list
20121933|NCT00007904|Paclitaxel|paclitaxel|mesh-list
19582231|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
19582232|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
19582233|NCT02675868|Norepinephrine|norepinephrine|mesh-list
19582234|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19582235|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
19582236|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
19582237|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582238|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582239|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
19582240|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19582241|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
19582242|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
19582243|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19582244|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19582245|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19582246|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
19582247|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582248|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582249|NCT02675868|Protective Agents|protective agents|mesh-ancestor
19582250|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
19582251|NCT02675868|Coagulants|coagulants|mesh-ancestor
19582252|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19582253|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
19582254|NCT02676011|Atropine|atropine|mesh-list
19582255|NCT02676011|Succinylcholine|succinylcholine|mesh-list
20121934|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
20121935|NCT00007904|Doxorubicin|doxorubicin|mesh-list
20121936|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20121937|NCT00007904|Lenograstim|lenograstim|mesh-list
20121938|NCT00007904|Sargramostim|sargramostim|mesh-list
20121939|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19582256|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19582257|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19582258|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19582259|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
19582260|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582261|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582262|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19582263|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
19582264|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
19582265|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
19582266|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19582267|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19582268|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
19582269|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582270|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582271|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19582272|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20121940|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582273|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19582274|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
19582275|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19582276|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
20121941|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
20121942|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
19582277|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582278|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582279|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19582280|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
19582281|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
19582282|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19582283|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
19582284|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582285|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582286|NCT02675647|Heparin|heparin|mesh-list
19582287|NCT02675647|Protamines|protamines|mesh-list
19582288|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
19582289|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19582290|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19582291|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582292|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
19582293|NCT02675647|Coagulants|coagulants|mesh-ancestor
20121943|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
20121944|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121945|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121946|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
19656460|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
19656461|NCT04561557|Fludarabine|fludarabine|mesh-list
19656462|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19656463|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
19656464|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656465|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656466|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19656467|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
19656468|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656469|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656470|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19656471|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19656472|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19656473|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19656474|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19656475|NCT04551261|Ritonavir|ritonavir|mesh-list
19656476|NCT04551261|Tenofovir|tenofovir|mesh-list
19656477|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19656478|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19656479|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
19656480|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656481|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656482|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19656483|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19656484|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
19656485|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19656486|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19656487|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19656488|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19656489|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20121947|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121948|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20121949|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20121950|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
20121951|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20121952|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20121953|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20121954|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20121955|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121956|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19656500|NCT04534257|Sirolimus|sirolimus|mesh-list
19656501|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19656502|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19656503|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19656504|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656505|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
19656506|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121957|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20121958|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
20121959|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19656507|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
19656508|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656509|NCT04530565|Cytarabine|cytarabine|mesh-list
19582294|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19582295|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
20121960|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20121961|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20121962|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20121963|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19582296|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582297|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
19582298|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582299|NCT02675530|Ketamine|ketamine|mesh-list
19582300|NCT02675530|Analgesics|analgesics|mesh-ancestor
19582301|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
19582302|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582303|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582304|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19582305|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19582306|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
19582307|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
19582308|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582309|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19582310|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19582311|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582312|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582313|NCT02675400|Methylphenidate|methylphenidate|mesh-list
19582314|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19582315|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19582316|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582317|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19582318|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19582319|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582320|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582321|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
19582322|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582323|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19582324|NCT02675309|Simvastatin|simvastatin|mesh-list
19582325|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19582326|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19582327|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
19582328|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582329|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19582330|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19582331|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582332|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
19582333|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19582334|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
19582335|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
19582336|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582337|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582338|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582339|NCT02675387|Lidocaine|lidocaine|mesh-list
19582340|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582341|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
19582342|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582343|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582344|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
19582345|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582346|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19582347|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19656510|NCT04530565|Dexamethasone|dexamethasone|mesh-list
20121964|NCT00007917|Gemcitabine|gemcitabine|mesh-list
20121965|NCT00007917|Alvocidib|alvocidib|mesh-list
20121966|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121967|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
20121968|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121969|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121970|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
19582348|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19582349|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582350|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582351|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19582352|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19582353|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121971|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582354|NCT02675335|Incretins|incretins|mesh-ancestor
19582355|NCT02675335|Hormones|hormones|mesh-ancestor
19582356|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582357|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19582358|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
19582359|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582360|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121972|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20121973|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582361|NCT02675205|Aspirin|aspirin|mesh-list
19582362|NCT02675205|Clopidogrel|clopidogrel|mesh-list
19582363|NCT02675205|Ticagrelor|ticagrelor|mesh-list
19582364|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19582365|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19582366|NCT02675205|Analgesics|analgesics|mesh-ancestor
19582367|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
19582368|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582369|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582370|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582371|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582372|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19582373|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19582374|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582375|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19582376|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19582377|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582378|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
19582379|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19582380|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19582381|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19582382|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
19582383|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582384|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
19582385|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19582386|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19582387|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
19582388|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582389|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19582390|NCT02675153|Sirolimus|sirolimus|mesh-list
19582391|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19582392|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582393|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19582394|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582395|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
19582396|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582397|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
19582398|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582399|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
19582400|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19582401|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582402|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582403|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19582404|NCT02675049|Analgesics|analgesics|mesh-ancestor
19582405|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
19582406|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582407|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19582408|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20121974|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
20121975|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121976|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
20121977|NCT00007917|Growth Substances|growth substances|mesh-ancestor
20121978|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20121979|NCT00007943|Gemcitabine|gemcitabine|mesh-list
20121980|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20121981|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
20121982|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20121983|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20121984|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
20121985|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582409|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19582410|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
19582411|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582412|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582413|NCT02675140|Vitamins|vitamins|mesh-list
19582414|NCT02675140|Vitamin A|vitamin a|mesh-list
19582415|NCT02675140|Albendazole|albendazole|mesh-list
19582416|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
19582417|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
19582418|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582419|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
19582420|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582421|NCT02675140|Protective Agents|protective agents|mesh-ancestor
19582422|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19582423|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582424|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
19582425|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19582426|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582427|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
19582428|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19582429|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19582430|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19582431|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19582432|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19582433|NCT02675023|Adalimumab|adalimumab|mesh-list
19582434|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582435|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582436|NCT02674906|Heparin|heparin|mesh-list
19582437|NCT02674906|Calcium heparin|calcium heparin|mesh-list
19582438|NCT02674906|Anticoagulants|anticoagulants|mesh-list
19582439|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582440|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19582441|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19582442|NCT02674997|Factor VIII|factor viii|mesh-list
19582443|NCT02674997|Coagulants|coagulants|mesh-ancestor
19582444|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
19582445|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
19582446|NCT02674737|Tramadol|tramadol|mesh-list
19582447|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19582448|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582449|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582450|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19582451|NCT02674737|Analgesics|analgesics|mesh-ancestor
19582452|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
19582453|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582454|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19582455|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19582456|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19582457|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
19582458|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582459|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582460|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19582461|NCT02674737|Narcotics|narcotics|mesh-ancestor
19582462|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19582463|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582464|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582465|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19582466|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582467|NCT02674893|Liraglutide|liraglutide|mesh-list
19582468|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19582469|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582470|NCT02674893|Incretins|incretins|mesh-ancestor
19582471|NCT02674893|Hormones|hormones|mesh-ancestor
19582472|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582473|NCT02674581|Fostemsavir|fostemsavir|mesh-list
19582474|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19582475|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20121986|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582476|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
19582477|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582478|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19582479|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19582480|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582481|NCT02674295|Esketamine|esketamine|mesh-list
20121987|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20121988|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
20121989|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121990|NCT00007956|Antibodies|antibodies|mesh-list
20121991|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20121992|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
20121993|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20121994|NCT00007969|Verteporfin|verteporfin|mesh-list
20121995|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
20121996|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20121997|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
20121998|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20121999|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
20122000|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122001|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
20122002|NCT00007982|Thiotepa|thiotepa|mesh-list
20122003|NCT00007982|Carmustine|carmustine|mesh-list
20122004|NCT00007982|Etoposide|etoposide|mesh-list
20122005|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122006|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
20122007|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122008|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122009|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122010|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
20122011|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122012|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122013|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122014|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122015|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20122016|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122017|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582482|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
19582483|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19582484|NCT02674308|Vedolizumab|vedolizumab|mesh-list
19582485|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19582486|NCT02674555|Naquotinib|naquotinib|mesh-list
19582487|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582488|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19582489|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582490|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582491|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
19582492|NCT02674243|Povidone|povidone|mesh-list
19582493|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19582494|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
19582495|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
19582496|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19582497|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582498|NCT02674139|Copper|copper|mesh-list
19582499|NCT02674139|Trace Elements|trace elements|mesh-ancestor
19582500|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
19582501|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582502|NCT02673931|Exenatide|exenatide|mesh-list
19582503|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19582504|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582505|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19582506|NCT02673931|Incretins|incretins|mesh-ancestor
19582507|NCT02673931|Hormones|hormones|mesh-ancestor
19582508|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582509|NCT02674113|Bupivacaine|bupivacaine|mesh-list
19582510|NCT02674113|Anesthetics|anesthetics|mesh-list
19582511|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582512|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582513|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582514|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
19582515|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582516|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19582517|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19582518|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
19582519|NCT02674191|Clindamycin|clindamycin|mesh-list
19582520|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
19582521|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
20122018|NCT00007995|Interferons|interferons|mesh-list
20122019|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
19582522|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
19582523|NCT02674191|Mepivacaine|mepivacaine|mesh-list
19582524|NCT02674191|Benzocaine|benzocaine|mesh-list
19582525|NCT02674191|Povidone|povidone|mesh-list
19582526|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19582527|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122020|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
20122021|NCT00007995|Melphalan|melphalan|mesh-list
19582528|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19582529|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582530|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582531|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
19582532|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
19582533|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19582534|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582535|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
19582536|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582537|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582538|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
19582539|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582540|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19582541|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19582542|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19582543|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582544|NCT02673866|Pregabalin|pregabalin|mesh-list
19582545|NCT02673866|Analgesics|analgesics|mesh-ancestor
19582546|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
19582547|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582548|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582549|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
19582550|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19582551|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582552|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582553|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19582554|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19582555|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19582556|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582557|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19656511|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
19656512|NCT04530565|Prednisone|prednisone|mesh-list
19656513|NCT04530565|Cortisone|cortisone|mesh-list
19656514|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
19656515|NCT04530565|Doxorubicin|doxorubicin|mesh-list
19656516|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19656517|NCT04530565|Methotrexate|methotrexate|mesh-list
19656518|NCT04530565|Vincristine|vincristine|mesh-list
19656519|NCT04530565|Dasatinib|dasatinib|mesh-list
19656520|NCT04530565|Blinatumomab|blinatumomab|mesh-list
19656521|NCT04530565|Ponatinib|ponatinib|mesh-list
19656522|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19656523|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
19656524|NCT04530565|Antibodies|antibodies|mesh-list
19656525|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
19656526|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19656527|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19656528|NCT04530565|BB 1101|bb 1101|mesh-list
19656529|NCT04530565|Mesna|mesna|mesh-list
19656530|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19656531|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
19656532|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656533|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656534|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19656535|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
19656536|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656537|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656538|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19656539|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19656540|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
19656541|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
19656542|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656543|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19656544|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
19656545|NCT04530565|Hormones|hormones|mesh-ancestor
19656546|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19656547|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19656548|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
19656549|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656550|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19656551|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19656552|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19656553|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19656554|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
19656555|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19656556|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19582558|NCT02673840|Ketotifen|ketotifen|mesh-list
19582559|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
19582560|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
19582561|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19582562|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
19582563|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
19582564|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582565|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582566|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582567|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19582568|NCT02673814|Durvalumab|durvalumab|mesh-list
19582569|NCT02673814|Bavituximab|bavituximab|mesh-list
19582570|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582571|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582572|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19582573|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19582574|NCT02673606|Estradiol|estradiol|mesh-list
19582575|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19582576|NCT02673606|Estrogens|estrogens|mesh-ancestor
19582577|NCT02673606|Hormones|hormones|mesh-ancestor
19582578|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582579|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582580|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19582581|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
19582582|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19582583|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19582584|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20122022|NCT00007995|Busulfan|busulfan|mesh-list
20122023|NCT00007995|Sargramostim|sargramostim|mesh-list
20122024|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122025|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
20122026|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122027|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122028|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122029|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
20122030|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122031|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122032|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19582585|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
19582586|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19582587|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
19582588|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19582589|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582590|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19582591|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19582592|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582593|NCT02673463|Spironolactone|spironolactone|mesh-list
19582594|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19582595|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
19582596|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582597|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582598|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19582599|NCT02673463|Diuretics|diuretics|mesh-ancestor
20122033|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
20122034|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582600|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
19582601|NCT02673359|Progesterone|progesterone|mesh-list
19582602|NCT02673359|Progestins|progestins|mesh-ancestor
19582603|NCT02673359|Hormones|hormones|mesh-ancestor
19582604|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582605|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582606|NCT02673229|Bacitracin|bacitracin|mesh-list
19582607|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19582608|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582609|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19582610|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
19582611|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19582612|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20122035|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
20122036|NCT00008008|Thiotepa|thiotepa|mesh-list
20122037|NCT00008008|Sargramostim|sargramostim|mesh-list
20122038|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122039|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
20122040|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122041|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122042|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122043|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
20122044|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122045|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122046|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122047|NCT00008021|Cyclosporine|cyclosporine|mesh-list
20122048|NCT00008021|Paclitaxel|paclitaxel|mesh-list
20122049|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20122050|NCT00008021|Antibodies|antibodies|mesh-list
20122051|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
20122052|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19582613|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19582614|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582615|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582616|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
19582617|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582618|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582619|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19582620|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582621|NCT02672839|Betadex|betadex|mesh-list
19582622|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
19582623|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582624|NCT02672995|Bevacizumab|bevacizumab|mesh-list
19582625|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582626|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582627|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19582628|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19582629|NCT02672995|Growth Substances|growth substances|mesh-ancestor
19582630|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582631|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
19582632|NCT02672709|Apixaban|apixaban|mesh-list
19582633|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19582634|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
19582635|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19582636|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
19582637|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582638|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582639|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
20122053|NCT00008021|Cyclosporins|cyclosporins|mesh-list
20122054|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122055|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582640|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19582641|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582642|NCT02672527|Dexamethasone|dexamethasone|mesh-list
19582643|NCT02672527|Trabectedin|trabectedin|mesh-list
19582644|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582645|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
19582646|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
19582647|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122056|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122057|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122058|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122059|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122060|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
20122061|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122062|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122063|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122064|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
20122065|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122066|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
20122067|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122068|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122069|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
20122070|NCT00008034|Capecitabine|capecitabine|mesh-list
20122071|NCT00008034|Epirubicin|epirubicin|mesh-list
20122072|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582648|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122073|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
19582649|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20122074|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582650|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
19582651|NCT02672527|Hormones|hormones|mesh-ancestor
19582652|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582653|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19582654|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582655|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19582656|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
19582657|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582658|NCT02672566|Enoxaparin|enoxaparin|mesh-list
19582659|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
19582660|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19582661|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19582662|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582663|NCT02672488|Metformin|metformin|mesh-list
19582664|NCT02672488|Sorafenib|sorafenib|mesh-list
19582665|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19582666|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582667|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582668|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19582669|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582670|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582671|NCT02672345|Sevoflurane|sevoflurane|mesh-list
19582672|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19582673|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19582674|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
20122075|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122076|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122077|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
19582675|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
19582676|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582677|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582678|NCT02672358|Trametinib|trametinib|mesh-list
19582679|NCT02672358|Dabrafenib|dabrafenib|mesh-list
19582680|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582681|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19582682|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582683|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582684|NCT02672202|Pregabalin|pregabalin|mesh-list
19582685|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19582686|NCT02672202|Analgesics|analgesics|mesh-ancestor
19582687|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
19582688|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582689|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582690|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
19582691|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19582692|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582693|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582694|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19582695|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19582696|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19582697|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582698|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19582699|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19582700|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19582701|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582702|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
19582703|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
19582704|NCT02672241|Temozolomide|temozolomide|mesh-list
19582705|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
19582706|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19582707|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
19582708|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582709|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582710|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656557|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
19656558|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
19656559|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19656560|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19656561|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
19656562|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19656563|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19656564|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
20173337|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582711|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19582712|NCT02671864|Incretins|incretins|mesh-list
19582713|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582714|NCT02671864|Hormones|hormones|mesh-ancestor
19582715|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582716|NCT02671851|Acetaminophen|acetaminophen|mesh-list
19582717|NCT02671851|Dipyrone|dipyrone|mesh-list
20122078|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122079|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122080|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122081|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122082|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
20122083|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20122084|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20122085|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122086|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122087|NCT00008047|Paclitaxel|paclitaxel|mesh-list
20122088|NCT00008047|Fluorouracil|fluorouracil|mesh-list
20122089|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
20122090|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122091|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122092|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122093|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122094|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
19582718|NCT02671851|Fentanyl|fentanyl|mesh-list
19582719|NCT02671851|Tramadol|tramadol|mesh-list
19582720|NCT02671851|Bupivacaine|bupivacaine|mesh-list
19582721|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582722|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
19582723|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582724|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582725|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
19582726|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582727|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19582728|NCT02671851|Narcotics|narcotics|mesh-ancestor
20122095|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122096|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
20122097|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122098|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122099|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
20122100|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122101|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
20122102|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122103|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20122104|NCT00008060|Leucovorin|leucovorin|mesh-list
20122105|NCT00008060|Fluorouracil|fluorouracil|mesh-list
20122106|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
20122107|NCT00008060|Irinotecan|irinotecan|mesh-list
20122108|NCT00008060|Calcium|calcium|mesh-list
20122109|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
20122110|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122111|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122112|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
20122113|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122114|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122115|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122116|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122117|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
20122118|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20122119|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122120|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122121|NCT00008060|Antidotes|antidotes|mesh-ancestor
20122122|NCT00008060|Protective Agents|protective agents|mesh-ancestor
20122123|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
20122124|NCT00008060|Vitamins|vitamins|mesh-ancestor
20122125|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
20122126|NCT00008073|Doxorubicin|doxorubicin|mesh-list
20122127|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20122128|NCT00008073|Octreotide|octreotide|mesh-list
20122129|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19582729|NCT02671851|Analgesics|analgesics|mesh-ancestor
19582730|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19582731|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20122130|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122131|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20122132|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122133|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122134|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122135|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20122136|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20122137|NCT00008086|Calcitriol|calcitriol|mesh-list
20122138|NCT00008086|Carboplatin|carboplatin|mesh-list
20122139|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122140|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122141|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582732|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
19582733|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19582734|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
19582735|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19582736|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582737|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582738|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
19582739|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19582740|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
19582741|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
19582742|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582743|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582744|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19582745|NCT02671578|Analgesics|analgesics|mesh-ancestor
19582746|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
19582747|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582748|NCT02671695|Amlodipine|amlodipine|mesh-list
19582749|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19582750|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19582751|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582752|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582753|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19582754|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582755|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
19582756|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
19582757|NCT02671708|Busulfan|busulfan|mesh-list
19582758|NCT02671708|Idarubicin|idarubicin|mesh-list
19582759|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582760|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
19582761|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582762|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582763|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19582764|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
19582765|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582766|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582767|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19582768|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19582769|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19582770|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19582771|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582772|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
19582773|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19582774|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
19582775|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582776|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
19582777|NCT02671565|Protective Agents|protective agents|mesh-ancestor
19582778|NCT02671383|Lopinavir|lopinavir|mesh-list
19582779|NCT02671383|Darunavir|darunavir|mesh-list
19582780|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20122142|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20122143|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20122144|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122145|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20122146|NCT00008086|Vitamins|vitamins|mesh-ancestor
20122147|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
20122148|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20122149|NCT00008112|Cisplatin|cisplatin|mesh-list
20122150|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122151|NCT00008125|Gemcitabine|gemcitabine|mesh-list
20122152|NCT00008125|Carboplatin|carboplatin|mesh-list
20122153|NCT00008125|Docetaxel|docetaxel|mesh-list
20122154|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582781|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19582782|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
19582783|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582784|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122155|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19582785|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19582786|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19582787|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
19582788|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582789|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19582790|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19582791|NCT02671318|Sirolimus|sirolimus|mesh-list
19582792|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19582793|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582794|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19582795|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582796|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
19582797|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582798|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
19582799|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582800|NCT02671227|Bupivacaine|bupivacaine|mesh-list
19582801|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582802|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
19582803|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582804|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582805|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
20122156|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
20122157|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122158|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
20122159|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122160|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122161|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122162|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
20122163|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122164|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122165|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122166|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122167|NCT00008151|Cyclosporine|cyclosporine|mesh-list
19582806|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582807|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
19582808|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19582809|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19582810|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19582811|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582812|NCT02671084|Sevoflurane|sevoflurane|mesh-list
19582813|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19582814|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19582815|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
19582816|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
19582817|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582818|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582819|NCT02671175|Piperaquine|piperaquine|mesh-list
19582820|NCT02671175|Artenimol|artenimol|mesh-list
19582821|NCT02671175|Artemisinins|artemisinins|mesh-list
19582822|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
19582823|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19582824|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19582825|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582826|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19582827|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19582828|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19582829|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
20122168|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
20122169|NCT00008151|Methotrexate|methotrexate|mesh-list
20122170|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
20122171|NCT00008151|Fludarabine|fludarabine|mesh-list
20122172|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
20122173|NCT00008151|Cyclosporins|cyclosporins|mesh-list
20122174|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20122175|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
20122176|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20122177|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122178|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122179|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
20122180|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582830|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582831|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19582832|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20122181|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122182|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19582833|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582834|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
19582835|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
19582836|NCT02670954|Tramadol|tramadol|mesh-list
19582837|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19582838|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582839|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582840|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19582841|NCT02670954|Analgesics|analgesics|mesh-ancestor
19582842|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
19582843|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582844|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19582845|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19582846|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19582847|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
19582848|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19582849|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582850|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19582851|NCT02670954|Narcotics|narcotics|mesh-ancestor
19582852|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19582853|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582854|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582855|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19582856|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582857|NCT02670707|Cytarabine|cytarabine|mesh-list
19582858|NCT02670707|Prednisone|prednisone|mesh-list
19582859|NCT02670707|Vinblastine|vinblastine|mesh-list
19582860|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582861|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
19582862|NCT02670707|Hormones|hormones|mesh-ancestor
19582863|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582864|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582865|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19582866|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582867|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19582868|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
19582869|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582870|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
19582871|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582872|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582873|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
19582874|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19582875|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
19582876|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
19582877|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
19582878|NCT02670564|Busulfan|busulfan|mesh-list
19582879|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
19582880|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582881|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582882|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
19582883|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582884|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19582885|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582886|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19582887|NCT02670655|Lidocaine|lidocaine|mesh-list
19582888|NCT02670655|Prilocaine|prilocaine|mesh-list
19582889|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19582890|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582891|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
19582892|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582893|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582894|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
19582895|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582896|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19582897|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19582898|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19582899|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19582900|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582901|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19582902|NCT02670759|Bupivacaine|bupivacaine|mesh-list
19582903|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
19582904|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
19582905|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19582906|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582907|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
19582908|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19582909|NCT02670785|Estradiol|estradiol|mesh-list
19582910|NCT02670785|Estrogens|estrogens|mesh-ancestor
19582911|NCT02670785|Hormones|hormones|mesh-ancestor
19582912|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582913|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582914|NCT02670616|Prednisolone|prednisolone|mesh-list
19582915|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
19582916|NCT02670616|Rituximab|rituximab|mesh-list
19582917|NCT02670616|Doxorubicin|doxorubicin|mesh-list
19582918|NCT02670616|Vincristine|vincristine|mesh-list
19582919|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582920|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
19582921|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582922|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582923|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19582924|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
19582925|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582926|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582927|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19582928|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582929|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19582930|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19582931|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19582932|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582933|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19582934|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19582935|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19582936|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19582937|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582938|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
20122183|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122184|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20122185|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122186|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
20122187|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122188|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20122189|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
20122190|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582939|NCT02670616|Hormones|hormones|mesh-ancestor
19582940|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582941|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19582942|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19656565|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
19656566|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
19656567|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19656568|NCT04530565|Protective Agents|protective agents|mesh-ancestor
19656569|NCT04518228|Ritonavir|ritonavir|mesh-list
19656570|NCT04518228|Lopinavir|lopinavir|mesh-list
19656571|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19656572|NCT04518228|Darunavir|darunavir|mesh-list
19656573|NCT04518228|Tenofovir|tenofovir|mesh-list
19656574|NCT04518228|Dolutegravir|dolutegravir|mesh-list
19656575|NCT04518228|Cobicistat|cobicistat|mesh-list
19656576|NCT04518228|Cabotegravir|cabotegravir|mesh-list
19656577|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19656578|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19656579|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
19656580|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122191|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122192|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20122193|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20122194|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
20122195|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122196|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20122197|NCT00008177|Iodine|iodine|mesh-list
20122198|NCT00008177|Cyclosporine|cyclosporine|mesh-list
20122199|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
20122200|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20122201|NCT00008177|Fludarabine|fludarabine|mesh-list
20122202|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
19656581|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656582|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19656583|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122203|NCT00008177|Antibodies|antibodies|mesh-list
19656584|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
19656585|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122204|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
20122205|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20122206|NCT00008177|Cyclosporins|cyclosporins|mesh-list
20122207|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
19582943|NCT02670772|Tenofovir|tenofovir|mesh-list
19582944|NCT02670772|Stavudine|stavudine|mesh-list
19582945|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
19582946|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19582947|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19582948|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19582949|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582950|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582951|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19582952|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19582953|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
20122208|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122209|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122210|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122211|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
20122212|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122213|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122214|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582954|NCT02670642|Esomeprazole|esomeprazole|mesh-list
19582955|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19582956|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19582957|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19582958|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582959|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582960|NCT02670317|Prednisone|prednisone|mesh-list
19582961|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
19582962|NCT02670317|Doxorubicin|doxorubicin|mesh-list
19582963|NCT02670317|Vincristine|vincristine|mesh-list
19582964|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
19582965|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19582966|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
19582967|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19582968|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19582969|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19582970|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
19582971|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582972|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19582973|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19582974|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19582975|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19582976|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19582977|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582978|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19582979|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
19582980|NCT02670317|Hormones|hormones|mesh-ancestor
20122215|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
20122216|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122217|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
20122218|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122219|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122220|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20122221|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20122222|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
20122223|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122224|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20122225|NCT00008177|Trace Elements|trace elements|mesh-ancestor
19582981|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19582982|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19582983|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19582984|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
19582985|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
19582986|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
19582987|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19582988|NCT02670434|Pitavastatin|pitavastatin|mesh-list
19582989|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19582990|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19582991|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19582992|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
20122226|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
20122227|NCT00008190|Aldesleukin|aldesleukin|mesh-list
20122228|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
20122229|NCT00008190|Melphalan|melphalan|mesh-list
20122230|NCT00008190|Busulfan|busulfan|mesh-list
20122231|NCT00008190|Etoposide|etoposide|mesh-list
19582993|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19582994|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19582995|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19582996|NCT02670304|Aspirin|aspirin|mesh-list
19582997|NCT02670304|Letrozole|letrozole|mesh-list
19582998|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19582999|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19583000|NCT02670304|Analgesics|analgesics|mesh-ancestor
19583001|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
19583002|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583003|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583004|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583005|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583006|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19583007|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19583008|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583009|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19583010|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19583011|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583012|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
19583013|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583014|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20122232|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122233|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
20122234|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122235|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122236|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122237|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
20122238|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122239|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122240|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122241|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122242|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20122243|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122244|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122245|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20122246|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122247|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
20122248|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122249|NCT00008203|Interferons|interferons|mesh-list
20122250|NCT00008203|Aldesleukin|aldesleukin|mesh-list
20122251|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
20122252|NCT00008203|Cyclosporine|cyclosporine|mesh-list
20122253|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
20122254|NCT00008203|Thiotepa|thiotepa|mesh-list
20122255|NCT00008203|Carboplatin|carboplatin|mesh-list
20122256|NCT00008203|Cyclosporins|cyclosporins|mesh-list
20122257|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122258|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
20122259|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122260|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122261|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122262|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
20122263|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122264|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122265|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122266|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
19583015|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19583016|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19583017|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
19583018|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583019|NCT02670018|Metformin|metformin|mesh-list
19583020|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19583021|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583022|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19583023|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19583024|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19583025|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
19583026|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122267|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122268|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122269|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
20122270|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
20122271|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122272|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20608170|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20608171|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583027|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19583028|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19583029|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583030|NCT02670096|Acetazolamide|acetazolamide|mesh-list
19583031|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
19583032|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19583033|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583034|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583035|NCT02670096|Diuretics|diuretics|mesh-ancestor
19583036|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
19583037|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583038|NCT02670135|Triclosan|triclosan|mesh-list
19583039|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19583040|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583041|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19583042|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19583043|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
19583044|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583045|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19583046|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
19583047|NCT02670109|Busulfan|busulfan|mesh-list
19583048|NCT02670109|Carmustine|carmustine|mesh-list
19583049|NCT02670109|Carboplatin|carboplatin|mesh-list
19583050|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19583051|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
19583052|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583053|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583054|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19583055|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
19583056|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583057|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583058|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19583059|NCT02669901|Naloxone|naloxone|mesh-list
19583060|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19583061|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583062|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
19583063|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583064|NCT02669719|Carboplatin|carboplatin|mesh-list
19583065|NCT02669719|Pemetrexed|pemetrexed|mesh-list
19583066|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583067|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583068|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583069|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19583070|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19583071|NCT02669732|Firuglipel|firuglipel|mesh-list
19583072|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19583073|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583074|NCT02669706|Pentamidine|pentamidine|mesh-list
19583075|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
19583076|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583077|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19583078|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19583079|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19583080|NCT02669641|Choline|choline|mesh-list
19583081|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
19583082|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19583083|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
19583084|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583085|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583086|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19583087|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
19583088|NCT02669589|Heparin|heparin|mesh-list
19583089|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
19583090|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583091|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19583092|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19583093|NCT02669459|Imiquimod|imiquimod|mesh-list
19583094|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20608172|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20608173|NCT02244866|Hormones|hormones|mesh-ancestor
19583095|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
20612134|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19583096|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583097|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583098|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
19583099|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
19583100|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19583101|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19583102|NCT02669303|Prednisolone|prednisolone|mesh-list
19583103|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
19583104|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19583105|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
19583106|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583107|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
19583108|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
19583109|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583110|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583111|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583112|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
19583113|NCT02669303|Hormones|hormones|mesh-ancestor
19583114|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583115|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19583116|NCT02669303|Protective Agents|protective agents|mesh-ancestor
19583117|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583118|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583119|NCT02669238|Etonogestrel|etonogestrel|mesh-list
19583120|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19583121|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
19583122|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19583123|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583124|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19583125|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19583126|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
19583127|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19583128|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
20608174|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608175|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608176|NCT02244879|Resveratrol|resveratrol|mesh-list
20608177|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
20608178|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608179|NCT02244879|Protective Agents|protective agents|mesh-ancestor
20608180|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608181|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608182|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20608183|NCT02245022|Tenofovir|tenofovir|mesh-list
20608184|NCT02245022|Lamivudine|lamivudine|mesh-list
20122273|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122274|NCT00008229|Melphalan|melphalan|mesh-list
20122275|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
19583129|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583130|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
19583131|NCT02669368|Rocuronium|rocuronium|mesh-list
19583132|NCT02669368|Analgesics|analgesics|mesh-ancestor
19583133|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
19583134|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583135|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583136|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
19583137|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583138|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19583139|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
19583140|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19583141|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583142|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583143|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19583144|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
20122276|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122277|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122278|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
19583145|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19583146|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19583147|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19583148|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20122279|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583149|NCT02669030|Suvorexant|suvorexant|mesh-list
19583150|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19583151|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19583152|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583153|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583154|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19583155|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583156|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583157|NCT02669004|Morphine|morphine|mesh-list
19583158|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19583159|NCT02669004|Narcotics|narcotics|mesh-ancestor
19583160|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583161|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583162|NCT02669004|Analgesics|analgesics|mesh-ancestor
19583163|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
19583164|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583165|NCT02668666|Tamoxifen|tamoxifen|mesh-list
19583166|NCT02668666|Palbociclib|palbociclib|mesh-list
19583167|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19583168|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
19583169|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583170|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583171|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583172|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583173|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19583174|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19583175|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19583176|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19583177|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583178|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583179|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19583180|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19583181|NCT02668796|Estradiol|estradiol|mesh-list
19583182|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19583183|NCT02668796|Estrogens|estrogens|mesh-ancestor
19583184|NCT02668796|Hormones|hormones|mesh-ancestor
19583185|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583186|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583187|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19583188|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
19583189|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19583190|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19583191|NCT02668861|Vitamin D|vitamin d|mesh-list
19583192|NCT02668861|Budesonide|budesonide|mesh-list
19583193|NCT02668861|Vitamins|vitamins|mesh-ancestor
19583194|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
20122280|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122281|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122282|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122283|NCT00008242|Thalidomide|thalidomide|mesh-list
20122284|NCT00008242|Dexamethasone|dexamethasone|mesh-list
20122285|NCT00008242|Doxorubicin|doxorubicin|mesh-list
20122286|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20122287|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20122288|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
20122289|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
20122290|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122291|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122292|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583195|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583196|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19583197|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583198|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19583199|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
19583200|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583201|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19583202|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
19583203|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
19583204|NCT02668861|Hormones|hormones|mesh-ancestor
19583205|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583206|NCT02668926|Amphetamine|amphetamine|mesh-list
19583207|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19583208|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
19583209|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19583210|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583211|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
20122293|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
20122294|NCT00008242|Hormones|hormones|mesh-ancestor
19583212|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
19583213|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583214|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
19583215|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583216|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583217|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
19583218|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19583219|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19583220|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583221|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19583222|NCT02668679|Hormones|hormones|mesh-list
19583223|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583224|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583225|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19583226|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19583227|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656586|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19656587|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19656588|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19656589|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19656590|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19656591|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19656592|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19656593|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656594|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19656595|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19656596|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19656597|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19656598|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656599|NCT04508634|Metformin|metformin|mesh-list
19656600|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19656601|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656602|NCT04501614|Ponatinib|ponatinib|mesh-list
19656603|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656604|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19656605|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656606|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656607|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19656608|NCT04499495|Mesalamine|mesalamine|mesh-list
19656609|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19656610|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19656611|NCT04499495|Analgesics|analgesics|mesh-ancestor
19656612|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
19656613|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656614|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656615|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19656616|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656617|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
19656618|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19656619|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122295|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20122296|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20122297|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122298|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19656624|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19656625|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
19656626|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656627|NCT04476446|Esketamine|esketamine|mesh-list
19656628|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656629|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20122299|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20122300|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122301|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122302|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309040|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19656635|NCT04470128|Fentanyl|fentanyl|mesh-list
19656636|NCT04470128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19656637|NCT04470128|Narcotics|narcotics|mesh-ancestor
19656638|NCT04470128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19656639|NCT04470128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656640|NCT04470128|Analgesics|analgesics|mesh-ancestor
19656641|NCT04470128|Sensory System Agents|sensory system agents|mesh-ancestor
19583228|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
19583229|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19583230|NCT02668536|Protective Agents|protective agents|mesh-ancestor
19583231|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583232|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
19583233|NCT02668289|Anesthetics|anesthetics|mesh-list
19583234|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583235|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583236|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
19583237|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19583238|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19583239|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19583240|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19583241|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583242|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583243|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
19583244|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583245|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583246|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19583247|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583248|NCT02668588|Octreotide|octreotide|mesh-list
19583249|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583250|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20122303|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122304|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
20122305|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
20122306|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122307|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122308|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20122309|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20122310|NCT00008242|Growth Substances|growth substances|mesh-ancestor
20122311|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
20122312|NCT00008268|Melphalan|melphalan|mesh-list
19583251|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583252|NCT02667886|Axitinib|axitinib|mesh-list
19583253|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583254|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19583255|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583256|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583257|NCT02668016|Atorvastatin|atorvastatin|mesh-list
19583258|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19583259|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19583260|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19583261|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
19583262|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583263|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19583264|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583265|NCT02668159|Vitamin D|vitamin d|mesh-list
19583266|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
19583267|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
19583268|NCT02668159|Vitamins|vitamins|mesh-list
20122313|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
20122314|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122315|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19583269|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
19583270|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583271|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19583272|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19583273|NCT02668172|Pasireotide|pasireotide|mesh-list
19583274|NCT02668172|Hormones|hormones|mesh-ancestor
19583275|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583276|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583277|NCT02667925|Cisplatin|cisplatin|mesh-list
19583278|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583279|NCT02668094|Lidocaine|lidocaine|mesh-list
19583280|NCT02668094|Pregabalin|pregabalin|mesh-list
19583281|NCT02668094|Propofol|propofol|mesh-list
19583282|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
19583283|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
19583284|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583285|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583286|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
19583287|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583288|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19583289|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19583290|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19583291|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583292|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583293|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19583294|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19583295|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
19583296|NCT02668094|Analgesics|analgesics|mesh-ancestor
19583297|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
19583298|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19583299|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19583300|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19583301|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19583302|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19583303|NCT02667730|Acetaminophen|acetaminophen|mesh-list
19583304|NCT02667730|Celecoxib|celecoxib|mesh-list
19583305|NCT02667730|Naproxen|naproxen|mesh-list
19583306|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19583307|NCT02667730|Analgesics|analgesics|mesh-ancestor
19583308|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
19583309|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583310|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583311|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
19583312|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19583313|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583314|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583315|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19583316|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19583317|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583318|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583319|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
19583320|NCT02667743|Paclitaxel|paclitaxel|mesh-list
19583321|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19583322|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19583323|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583324|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
19583325|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
19583326|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
19583327|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583328|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
19583329|NCT02667561|Testosterone|testosterone|mesh-list
19583330|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
19583331|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
19583332|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19583333|NCT02667561|Androgens|androgens|mesh-ancestor
19583334|NCT02667561|Hormones|hormones|mesh-ancestor
19583335|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583336|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583337|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583338|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583339|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
19583340|NCT02667535|Isosorbide|isosorbide|mesh-list
19583341|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19583342|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19583343|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19583344|NCT02667535|Diuretics|diuretics|mesh-ancestor
20122316|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
20122317|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122318|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122319|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122320|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122321|NCT00008281|Leucovorin|leucovorin|mesh-list
20122322|NCT00008281|Fluorouracil|fluorouracil|mesh-list
20309041|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583345|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
19583346|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309042|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122323|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
20122324|NCT00008281|Calcium|calcium|mesh-list
20122325|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
19583347|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
19583348|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19583349|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583350|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
19583351|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19583352|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19583353|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
19583354|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583355|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122326|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122327|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583356|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583357|NCT02667470|Urological Agents|urological agents|mesh-ancestor
19583358|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
19583359|NCT02667197|Narcotics|narcotics|mesh-ancestor
19583360|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583361|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583362|NCT02667197|Analgesics|analgesics|mesh-ancestor
19583363|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
19583364|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583365|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
19583366|NCT02667262|Narcotics|narcotics|mesh-ancestor
19583367|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583368|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583369|NCT02667262|Analgesics|analgesics|mesh-ancestor
19583370|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
19583371|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583372|NCT02667223|Bococizumab|bococizumab|mesh-list
19583373|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19583374|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19583375|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
19583376|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583377|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19583378|NCT02667353|Anesthetics|anesthetics|mesh-list
19583379|NCT02667353|Etomidate|etomidate|mesh-list
19583380|NCT02667353|Succinylcholine|succinylcholine|mesh-list
19583381|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583382|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583383|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19583384|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19583385|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
19583386|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19583387|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19583388|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19583389|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583390|NCT02667496|Sargramostim|sargramostim|mesh-list
19583391|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
19583392|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583393|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
19583394|NCT02666898|Fludarabine|fludarabine|mesh-list
19583395|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
19583396|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19583397|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
19583398|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583399|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583400|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19583401|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
19583402|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583403|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583404|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19583405|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656642|NCT04470128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656643|NCT04470128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20122328|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
20122329|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122330|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122331|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122332|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19656644|NCT04470128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19656645|NCT04470128|Anesthetics, General|anesthetics, general|mesh-ancestor
19656646|NCT04470128|Anesthetics|anesthetics|mesh-ancestor
19583406|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
19583407|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19583408|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19583409|NCT02666703|Prednisolone|prednisolone|mesh-list
19583410|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
19583411|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19583412|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
19583413|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583414|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
19583415|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
19583416|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583417|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583418|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583419|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
19583420|NCT02666703|Hormones|hormones|mesh-ancestor
19583421|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583422|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19583423|NCT02666703|Protective Agents|protective agents|mesh-ancestor
19583424|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583425|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583426|NCT02667054|Anesthetics|anesthetics|mesh-list
19583427|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
19583428|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583429|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583430|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
19583431|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583432|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19583433|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19583434|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583435|NCT02666716|Fluconazole|fluconazole|mesh-list
19583436|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
19583437|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583438|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19583439|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19583440|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583441|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583442|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19583443|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
19583444|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583445|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583446|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19583447|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19583448|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19583449|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20122333|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
20122334|NCT00008281|Antidotes|antidotes|mesh-ancestor
19583450|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583451|NCT02666768|Interferons|interferons|mesh-list
19583452|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
19583453|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583454|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
19583455|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583456|NCT02666651|Tolvaptan|tolvaptan|mesh-list
19583457|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19583458|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583459|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
19583460|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583461|NCT02666534|Lidocaine|lidocaine|mesh-list
19583462|NCT02666534|Prilocaine|prilocaine|mesh-list
20122335|NCT00008281|Protective Agents|protective agents|mesh-ancestor
20122336|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
20122337|NCT00008281|Vitamins|vitamins|mesh-ancestor
20122338|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
20122339|NCT00008294|Leucovorin|leucovorin|mesh-list
20122340|NCT00008294|Dexamethasone|dexamethasone|mesh-list
20122341|NCT00008294|Fluorouracil|fluorouracil|mesh-list
20122342|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
20122343|NCT00008294|Floxuridine|floxuridine|mesh-list
20122344|NCT00008294|Calcium|calcium|mesh-list
20122345|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
19583463|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20122346|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20122347|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
20122348|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
20122349|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122350|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583464|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19583465|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19583466|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
19583467|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
19583468|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583469|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583470|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
19583471|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583472|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19583473|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19583474|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19583475|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583476|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583477|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19583478|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
19583479|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19583480|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
19583481|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
19583482|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583483|NCT02666170|Protective Agents|protective agents|mesh-ancestor
19583484|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583485|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
19583486|NCT02666170|Vitamins|vitamins|mesh-ancestor
19583487|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
19583488|NCT02666209|Dexamethasone|dexamethasone|mesh-list
19583489|NCT02666209|Lenalidomide|lenalidomide|mesh-list
19583490|NCT02666209|Bortezomib|bortezomib|mesh-list
19583491|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583492|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
19583493|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
19583494|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583495|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583496|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583497|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
19583498|NCT02666209|Hormones|hormones|mesh-ancestor
19583499|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583500|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583501|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583502|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
19583503|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19583504|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19583505|NCT02666209|Growth Substances|growth substances|mesh-ancestor
19583506|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
19583507|NCT02666365|Cefazolin|cefazolin|mesh-list
19583508|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19583509|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583510|NCT02666443|Dexamethasone|dexamethasone|mesh-list
19583511|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
19583512|NCT02666443|BB 1101|bb 1101|mesh-list
19583513|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583514|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
19583515|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
19583516|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583517|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583518|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583519|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
19583520|NCT02666443|Hormones|hormones|mesh-ancestor
19583521|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583522|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583523|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583524|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
19583525|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583526|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583527|NCT02666417|Iron|iron|mesh-list
19583528|NCT02666417|Trace Elements|trace elements|mesh-ancestor
19583529|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
19583530|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583531|NCT02666092|Antibodies|antibodies|mesh-list
19583532|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
19583533|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583534|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
19583535|NCT02666157|Apixaban|apixaban|mesh-list
19583536|NCT02666157|Dabigatran|dabigatran|mesh-list
19583537|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19583538|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
19583539|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19583540|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
19583541|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583542|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583543|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
19583544|NCT02666053|Fostemsavir|fostemsavir|mesh-list
19583545|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19583546|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19583547|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
19583548|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583549|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19583550|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19583551|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583552|NCT02666040|Anesthetics|anesthetics|mesh-list
19583553|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583554|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583555|NCT02665806|Fluticasone|fluticasone|mesh-list
19583556|NCT02665806|Ciclesonide|ciclesonide|mesh-list
19583557|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583558|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19583559|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
20122351|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20122352|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
20122353|NCT00008294|Hormones|hormones|mesh-ancestor
20122354|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20122355|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20122356|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122357|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122358|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
20122359|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122360|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122361|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122362|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
20122363|NCT00008294|Antidotes|antidotes|mesh-ancestor
20122364|NCT00008294|Protective Agents|protective agents|mesh-ancestor
20122365|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
20122366|NCT00008294|Vitamins|vitamins|mesh-ancestor
19583560|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583561|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583562|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19583563|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
19583564|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
19583565|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19583566|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
19583567|NCT02665806|Hormones|hormones|mesh-ancestor
19583568|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583569|NCT02666001|Fostemsavir|fostemsavir|mesh-list
19583570|NCT02666001|Buprenorphine|buprenorphine|mesh-list
19583571|NCT02666001|Methadone|methadone|mesh-list
19583572|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19583573|NCT02666001|Narcotics|narcotics|mesh-ancestor
19583574|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583575|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583576|NCT02666001|Analgesics|analgesics|mesh-ancestor
19583577|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
19583578|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583579|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19583580|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
19583581|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
19583582|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19583583|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19583584|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
19583585|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583586|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19583587|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19583588|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583589|NCT02665936|Dexamethasone|dexamethasone|mesh-list
19583590|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
20122367|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
20122368|NCT00008307|Cyclosporine|cyclosporine|mesh-list
20122369|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
20122370|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
20122371|NCT00008307|Fludarabine|fludarabine|mesh-list
20122372|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
20122373|NCT00008307|Melphalan|melphalan|mesh-list
20122374|NCT00008307|Cyclosporins|cyclosporins|mesh-list
19583591|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
19583592|NCT02665936|BB 1101|bb 1101|mesh-list
20122375|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19583593|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583594|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
19583595|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
19583596|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583597|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583598|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583599|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
19583600|NCT02665936|Hormones|hormones|mesh-ancestor
19583601|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583602|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583603|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583604|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
19583605|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583606|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583607|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
19583608|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
19583609|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583610|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
19583611|NCT02665871|Vaccines|vaccines|mesh-list
19583612|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
19583613|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583614|NCT02665845|Mesalamine|mesalamine|mesh-list
20122376|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122377|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122378|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
20122379|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122380|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122381|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
20122382|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122383|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122384|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
20122385|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122386|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
20122387|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122388|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122389|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19583615|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19583616|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19583617|NCT02665845|Analgesics|analgesics|mesh-ancestor
19583618|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
19583619|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583620|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583621|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583622|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583623|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
19583624|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19583625|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583626|NCT02665832|Amlodipine|amlodipine|mesh-list
19583627|NCT02665832|Olmesartan|olmesartan|mesh-list
19583628|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19583629|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19583630|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19583631|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583632|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583633|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19583634|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583635|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
19583636|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19583637|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19583638|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
19583639|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19583640|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19583641|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583642|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19583643|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19583644|NCT02666014|Neostigmine|neostigmine|mesh-list
19583645|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19583646|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583647|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583648|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
19583649|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583650|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122390|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19583651|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19583652|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
19583653|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583654|NCT02665702|Cisplatin|cisplatin|mesh-list
19583655|NCT02665702|Vinorelbine|vinorelbine|mesh-list
19583656|NCT02665702|Endostar protein|endostar protein|mesh-list
19583657|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583658|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19583659|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
19583660|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
19583661|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
19583662|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583663|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19583664|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19583665|NCT02665702|Growth Substances|growth substances|mesh-ancestor
19583666|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583667|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
19583668|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
19583669|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19583670|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583671|NCT02665637|Trastuzumab|trastuzumab|mesh-list
19583672|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19583673|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583674|NCT02665533|Dexamethasone|dexamethasone|mesh-list
19583675|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
19583676|NCT02665533|Diclofenac|diclofenac|mesh-list
19583677|NCT02665533|Codeine|codeine|mesh-list
19583678|NCT02665533|BB 1101|bb 1101|mesh-list
19583679|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583680|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
19583681|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
19583682|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583683|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583684|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583685|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
19583686|NCT02665533|Hormones|hormones|mesh-ancestor
19583687|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583688|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583689|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583690|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
19583691|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583692|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583693|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19583694|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19583695|NCT02665533|Analgesics|analgesics|mesh-ancestor
19583696|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
20122391|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
20122392|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122393|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20122394|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
20122395|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
20122396|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122397|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583697|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583698|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19583699|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19583700|NCT02665533|Narcotics|narcotics|mesh-ancestor
19583701|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583702|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
19583703|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
19583704|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
19583705|NCT02665624|Sennosides|sennosides|mesh-list
19583706|NCT02665624|Senna Extract|senna extract|mesh-list
19583707|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19583708|NCT02665624|Calcium|calcium|mesh-list
19583709|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19583710|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583711|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19583712|NCT02665624|Laxatives|laxatives|mesh-ancestor
19583713|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583714|NCT02665624|Cathartics|cathartics|mesh-ancestor
19583715|NCT02665351|Peramivir|peramivir|mesh-list
20309043|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
19583716|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
19583717|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583718|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122398|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
20122399|NCT00008307|Hormones|hormones|mesh-ancestor
19583719|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583720|NCT02665416|Bevacizumab|bevacizumab|mesh-list
19583721|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19583722|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583723|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19583724|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19583725|NCT02665416|Growth Substances|growth substances|mesh-ancestor
19583726|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583727|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
19583728|NCT02665208|Nicotine|nicotine|mesh-list
19583729|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19583730|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
19583731|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583732|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583733|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19583734|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19583735|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
19583736|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583737|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122400|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20122401|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20122402|NCT00008307|Protective Agents|protective agents|mesh-ancestor
20122403|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122404|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
20122405|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122406|NCT00008333|Vinorelbine|vinorelbine|mesh-list
20122407|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122408|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122409|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122410|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122411|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122412|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122413|NCT00008359|Amphotericin B|amphotericin b|mesh-list
20122414|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20122415|NCT00008359|Caspofungin|caspofungin|mesh-list
20122416|NCT00008359|Amebicides|amebicides|mesh-ancestor
20122417|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20122418|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20122419|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122420|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122421|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
20122422|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122423|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122424|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
20122425|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122426|NCT00008398|Sargramostim|sargramostim|mesh-list
20122427|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
20122428|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122429|NCT00008411|Docetaxel|docetaxel|mesh-list
20122430|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122431|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122432|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122433|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122434|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656680|NCT04444921|Paclitaxel|paclitaxel|mesh-list
19656681|NCT04444921|Carboplatin|carboplatin|mesh-list
19656682|NCT04444921|Nivolumab|nivolumab|mesh-list
19656683|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20122435|NCT00008424|Irinotecan|irinotecan|mesh-list
20122436|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20122437|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122438|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122439|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122440|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122441|NCT00008450|Cyclosporine|cyclosporine|mesh-list
19656684|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19656685|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656686|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
19656687|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
19656688|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
19656689|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656690|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656691|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19656692|NCT04429516|Morphine|morphine|mesh-list
19656693|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19583738|NCT02665039|Gemcitabine|gemcitabine|mesh-list
19583739|NCT02665039|Carboplatin|carboplatin|mesh-list
19583740|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583741|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19583742|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
19583743|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583744|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
19583745|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583746|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583747|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122442|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
20122443|NCT00008450|Cyclosporins|cyclosporins|mesh-list
20122444|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583748|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
19583749|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583750|NCT02664857|Vitamin D|vitamin d|mesh-list
19583751|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
19583752|NCT02664857|Vitamins|vitamins|mesh-list
19583753|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
19583754|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583755|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19583756|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19583757|NCT02664649|Apixaban|apixaban|mesh-list
19583758|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
19583759|NCT02664649|Anticoagulants|anticoagulants|mesh-list
19583760|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
19583761|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19583762|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
19583763|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583764|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583765|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
19583766|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19583767|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19583768|NCT02664493|Prednisolone|prednisolone|mesh-list
19583769|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
19583770|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19583771|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
19583772|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583773|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
19583774|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
19583775|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583776|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583777|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583778|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
19583779|NCT02664493|Hormones|hormones|mesh-ancestor
19583780|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583781|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19583782|NCT02664493|Protective Agents|protective agents|mesh-ancestor
19583783|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583784|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583785|NCT02664116|Diclofenac|diclofenac|mesh-list
19583786|NCT02664116|Ketorolac|ketorolac|mesh-list
19583787|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19583788|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19583789|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19583790|NCT02664116|Analgesics|analgesics|mesh-ancestor
19583791|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
19583792|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583793|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583794|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583795|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583796|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20122445|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122446|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122447|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
20122448|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122449|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
20122450|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122451|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
20122452|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583797|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583798|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583799|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
19749545|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749546|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19583800|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19583801|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
19583802|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583803|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583804|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19583805|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
19583806|NCT02664142|Anesthetics|anesthetics|mesh-list
19583807|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583808|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583809|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19583810|NCT02664168|Laxatives|laxatives|mesh-ancestor
19583811|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583812|NCT02663960|Citric Acid|citric acid|mesh-list
19583813|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
19583814|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
19583815|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19583816|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
19583817|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
20122453|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122454|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20122455|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583818|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583819|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
19583820|NCT02664103|Capecitabine|capecitabine|mesh-list
19583821|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19583822|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
19583823|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583824|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583825|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19583826|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
19583827|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583828|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583829|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19583830|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19583831|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
19583832|NCT02663999|Diazepam|diazepam|mesh-list
19583833|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19583834|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
19583835|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
19583836|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
19583837|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583838|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583839|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19583840|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19583841|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583842|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19583843|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19583844|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19583845|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19583846|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19583847|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19583848|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
19583849|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
19583850|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
19583851|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
19583852|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583853|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583854|NCT02664012|Menthol|menthol|mesh-list
19583855|NCT02664012|Nicotine|nicotine|mesh-list
19583856|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19583857|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
19583858|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583859|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583860|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19583861|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19583862|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
19583863|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583864|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583865|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
19583866|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
19583867|NCT02663713|Clopidogrel|clopidogrel|mesh-list
19583868|NCT02663713|Ticagrelor|ticagrelor|mesh-list
19656694|NCT04429516|Narcotics|narcotics|mesh-ancestor
20122456|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19583869|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19583870|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20122457|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
20122458|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122459|NCT00008463|Interferons|interferons|mesh-list
20122460|NCT00008463|Ribavirin|ribavirin|mesh-list
20122461|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
20122462|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
19583871|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19583872|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19583873|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
19583874|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583875|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583876|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583877|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
19583878|NCT02663830|Clomiphene|clomiphene|mesh-list
19583879|NCT02663830|Enclomiphene|enclomiphene|mesh-list
19583880|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
19583881|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583882|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
19583883|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19583884|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19583885|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583886|NCT02663830|Urological Agents|urological agents|mesh-ancestor
19583887|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20122463|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20122464|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122465|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
20122466|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122467|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
20122468|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122469|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
20122470|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583888|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
19583889|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19583890|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583891|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19583892|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
19583893|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19583894|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19583895|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19583896|NCT02663700|Artesunate|artesunate|mesh-list
19583897|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
19583898|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19583899|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19583900|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583901|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583902|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
19583903|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
19583904|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19583905|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
19583906|NCT02663596|Vancomycin|vancomycin|mesh-list
19583907|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19583908|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583909|NCT02663570|Melatonin|melatonin|mesh-list
19583910|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
19583911|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583912|NCT02663570|Protective Agents|protective agents|mesh-ancestor
19583913|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583914|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583915|NCT02663440|Temozolomide|temozolomide|mesh-list
19583916|NCT02663440|Molgramostim|molgramostim|mesh-list
19583917|NCT02663440|Sargramostim|sargramostim|mesh-list
19583918|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19583919|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
19583920|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583921|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583922|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
19583923|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583924|NCT02663323|Sirolimus|sirolimus|mesh-list
20122471|NCT00008476|Capsaicin|capsaicin|mesh-list
20122472|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
19749547|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608185|NCT02245022|Efavirenz|efavirenz|mesh-list
19583925|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122473|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
20608186|NCT02245022|Dolutegravir|dolutegravir|mesh-list
19583926|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19583927|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19583928|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583929|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
19583930|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19583931|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
19583932|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583933|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
19583934|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19583935|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583936|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583937|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
19583938|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583939|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656695|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19656696|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656697|NCT04429516|Analgesics|analgesics|mesh-ancestor
19656698|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
19656699|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656700|NCT04410341|Vildagliptin|vildagliptin|mesh-list
19656701|NCT04410341|Citalopram|citalopram|mesh-list
19656702|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19656703|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19656704|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19656705|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656706|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656707|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
19656708|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656709|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20122474|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
20122475|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122476|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122477|NCT00008489|Didanosine|didanosine|mesh-list
20122478|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
20122479|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122480|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20122481|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20122482|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122483|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
20122484|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122485|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20122486|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19656710|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656711|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19656712|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19656713|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19656714|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
19656715|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122487|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20122488|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20122489|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
20122490|NCT00008515|Hormones|hormones|mesh-ancestor
20122491|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19656721|NCT04401748|Azacitidine|azacitidine|mesh-list
19656722|NCT04401748|Venetoclax|venetoclax|mesh-list
19656723|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19656724|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
19656725|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656726|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656727|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122492|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122493|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
20122494|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20122495|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20122496|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122497|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20122498|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122499|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
20122500|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122501|NCT00008554|Lamivudine|lamivudine|mesh-list
20122502|NCT00008554|Abacavir|abacavir|mesh-list
20122503|NCT00008554|Nelfinavir|nelfinavir|mesh-list
20122504|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
20122505|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19583940|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
19583941|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19583942|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583943|NCT02663284|Ropivacaine|ropivacaine|mesh-list
19583944|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
19583945|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
19583946|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19583947|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583948|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
19583949|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583950|NCT02663141|Bevacizumab|bevacizumab|mesh-list
19583951|NCT02663141|Losartan|losartan|mesh-list
19583952|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19583953|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583954|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19583955|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19583956|NCT02663141|Growth Substances|growth substances|mesh-ancestor
19583957|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583958|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
20122506|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19583959|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19583960|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19583961|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19583962|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19583963|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583964|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19583965|NCT02663050|Diclofenac|diclofenac|mesh-list
19583966|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19583967|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19583968|NCT02663050|Analgesics|analgesics|mesh-ancestor
19583969|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
19583970|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583971|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583972|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19583973|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19583974|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19583975|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583976|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583977|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
19583978|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19583979|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19583980|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19583981|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19583982|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583983|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
19583984|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19583985|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19583986|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19583987|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19583988|NCT02662959|Irinotecan|irinotecan|mesh-list
19583989|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19583990|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19583991|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19583992|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19583993|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19583994|NCT02662894|Valsartan|valsartan|mesh-list
19583995|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19583996|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19583997|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19583998|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
19583999|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584000|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19584001|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19584002|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584003|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20122507|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122508|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122509|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
20122510|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584004|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19584005|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19584006|NCT02662855|Favipiravir|favipiravir|mesh-list
19584007|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
19584008|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584009|NCT02662647|Cytarabine|cytarabine|mesh-list
19584010|NCT02662647|Decitabine|decitabine|mesh-list
19584011|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
19584012|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19584013|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
19584014|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584015|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584016|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
19584017|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584018|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584019|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
19584020|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584021|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584022|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19584023|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19584024|NCT02662660|Acetaminophen|acetaminophen|mesh-list
19584025|NCT02662660|Dipyrone|dipyrone|mesh-list
19584026|NCT02662660|Bupivacaine|bupivacaine|mesh-list
19584027|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
19584028|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
19584029|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
19584030|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584031|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584032|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
19584033|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584034|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584035|NCT02662660|Analgesics|analgesics|mesh-ancestor
20122511|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20122512|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122513|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19584036|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
19584037|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19584038|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584039|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584040|NCT02662725|Ipilimumab|ipilimumab|mesh-list
19584041|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584042|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584043|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19584044|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584045|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
19584046|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19584047|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19584048|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19584049|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19584050|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584051|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
19584052|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584053|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584054|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20122514|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20122515|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
20122516|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
20122517|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122518|NCT00008736|Metoclopramide|metoclopramide|mesh-list
20122519|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
20122520|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
20122521|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122522|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122523|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19584055|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584056|NCT02662504|Cisplatin|cisplatin|mesh-list
20122524|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20122525|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20122526|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
20122527|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122528|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173338|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173339|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20173340|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19584057|NCT02662504|Pemetrexed|pemetrexed|mesh-list
19584058|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20608187|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
19584059|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584060|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584061|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584062|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19584063|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19584064|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
19584065|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19584066|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
19584067|NCT02662491|Vitamin D|vitamin d|mesh-list
19584068|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
19584069|NCT02662491|Vitamins|vitamins|mesh-list
19584070|NCT02662491|Calcium|calcium|mesh-list
19584071|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
20122529|NCT00008866|Didanosine|didanosine|mesh-list
20122530|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
20122531|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122532|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
20122533|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122534|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122535|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20122536|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
20122537|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20122538|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
19584072|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584073|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19584074|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20122539|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122540|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20122541|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122542|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20122543|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
20122544|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
20122545|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122546|NCT00009048|Levodopa|levodopa|mesh-list
20122547|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20122548|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20122549|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
20122550|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122551|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122552|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122553|NCT00009061|Ritonavir|ritonavir|mesh-list
20122554|NCT00009061|Nelfinavir|nelfinavir|mesh-list
20122555|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
20122556|NCT00009061|Lamivudine|lamivudine|mesh-list
20122557|NCT00009061|Abacavir|abacavir|mesh-list
20122558|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20122559|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20122560|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
20122561|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122562|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122563|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20122564|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122565|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
20122566|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122567|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19584075|NCT02662426|Oseltamivir|oseltamivir|mesh-list
19584076|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
19584077|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584078|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584079|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584080|NCT02662348|Aldesleukin|aldesleukin|mesh-list
19584081|NCT02662348|Interleukin-2|interleukin-2|mesh-list
19584082|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584083|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584084|NCT02662348|Analgesics|analgesics|mesh-ancestor
19584085|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
19584086|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584087|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584088|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19584089|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19584090|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
19584091|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584092|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19584093|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584094|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584095|NCT02662283|Acteoside|acteoside|mesh-list
19584096|NCT02662283|Prednisolone|prednisolone|mesh-list
20122568|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20122569|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19584097|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584098|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
19584099|NCT02662283|Hormones|hormones|mesh-ancestor
19584100|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584101|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584102|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19584103|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584104|NCT02662283|Protective Agents|protective agents|mesh-ancestor
19584105|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584106|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19584107|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
19584108|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584109|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
19584110|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
19584111|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584112|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
19584113|NCT02662296|Idelalisib|idelalisib|mesh-list
19584114|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584115|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584116|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584117|NCT02662309|Atezolizumab|atezolizumab|mesh-list
19584118|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584119|NCT02662374|Nystatin|nystatin|mesh-list
19584120|NCT02662374|Calcium|calcium|mesh-list
19584121|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19584122|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584123|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584124|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584125|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
19584126|NCT02662374|Ionophores|ionophores|mesh-ancestor
19584127|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19584128|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584129|NCT02661932|Letrozole|letrozole|mesh-list
19584130|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584131|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19584132|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19584133|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584134|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584135|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19584136|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
19584137|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584138|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584139|NCT02661893|Rifampin|rifampin|mesh-list
19584140|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19584141|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
19584142|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584143|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584144|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
19584145|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19584146|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584147|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584148|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19584149|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19584150|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19584151|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19584152|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19584153|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19584154|NCT02661711|Aflibercept|aflibercept|mesh-list
19584155|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19584156|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19584157|NCT02661711|Growth Substances|growth substances|mesh-ancestor
19584158|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584159|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
19584160|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584161|NCT02661789|Goserelin|goserelin|mesh-list
20122570|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20122571|NCT00009178|Fluoxetine|fluoxetine|mesh-list
20122572|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20122573|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20122574|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19584162|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20122575|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584163|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122576|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122577|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
20122578|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122579|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20122580|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656745|NCT04369950|Lidocaine|lidocaine|mesh-list
19656746|NCT04369950|Epinephrine|epinephrine|mesh-list
19656747|NCT04369950|Morphine|morphine|mesh-list
19656748|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
19656749|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
19656750|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
19656751|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19656752|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656753|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
19656754|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656755|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19656756|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19656757|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19656758|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19656759|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656760|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19656761|NCT04369950|Narcotics|narcotics|mesh-ancestor
19656762|NCT04369950|Analgesics|analgesics|mesh-ancestor
19656763|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19656764|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19656765|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19656766|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656767|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19656768|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19656769|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
19656770|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19656771|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
19656772|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
19656773|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
19656774|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19656775|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19656776|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
19656777|NCT04351230|Trastuzumab|trastuzumab|mesh-list
19656778|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19656779|NCT04351230|Maytansine|maytansine|mesh-list
19656780|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
19656781|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656782|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656783|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19656784|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
19656785|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
19656786|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
19656787|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656788|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
19656789|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122581|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20122582|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20122583|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20122584|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122585|NCT00009191|Sertraline|sertraline|mesh-list
20122586|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
20122587|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20122588|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20122589|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20122590|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20122591|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122592|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122593|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
20122594|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122595|NCT00009204|Perphenazine|perphenazine|mesh-list
20122596|NCT00009204|Citalopram|citalopram|mesh-list
20122597|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20122598|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20122599|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20122600|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122601|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122602|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
20122603|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173341|NCT00161291|Growth Substances|growth substances|mesh-ancestor
20122604|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20122605|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
20122606|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20122607|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20122608|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20122609|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20122610|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19584164|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
19584165|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
19584166|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584167|NCT02661373|Cobicistat|cobicistat|mesh-list
19584168|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19584169|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19584170|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
19584171|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584172|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19584173|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19584174|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584175|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584176|NCT02661503|Dexamethasone|dexamethasone|mesh-list
19584177|NCT02661503|Prednisone|prednisone|mesh-list
19584178|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
19584179|NCT02661503|Dacarbazine|dacarbazine|mesh-list
19584180|NCT02661503|Doxorubicin|doxorubicin|mesh-list
19584181|NCT02661503|Etoposide|etoposide|mesh-list
19584182|NCT02661503|Vincristine|vincristine|mesh-list
19584183|NCT02661503|Bleomycin|bleomycin|mesh-list
19584184|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19584185|NCT02661503|Procarbazine|procarbazine|mesh-list
19584186|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584187|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
19584188|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584189|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584190|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19584191|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
19584192|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584193|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584194|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19584195|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584196|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
19584197|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
19584198|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584199|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19584200|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
19584201|NCT02661503|Hormones|hormones|mesh-ancestor
19584202|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584203|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19584204|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19584205|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19584206|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19584207|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584208|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19584209|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
19584210|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
19584211|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
19584212|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584213|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
19584214|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584215|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584216|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19584217|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19584218|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584219|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584220|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584221|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19584222|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19584223|NCT02661347|Risperidone|risperidone|mesh-list
19584224|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20122611|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
20122612|NCT00009217|Haloperidol|haloperidol|mesh-list
20122613|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
20122614|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
19584225|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
19584226|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584227|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122615|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
20122616|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122617|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584228|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584229|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19584230|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19584231|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584232|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19584233|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19584234|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
19584235|NCT02661477|Interferons|interferons|mesh-list
19584236|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
19584237|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
19584238|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584239|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
19584240|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584241|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
19584242|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584243|NCT02661152|Nimorazole|nimorazole|mesh-list
19584244|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19584245|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19584246|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19584247|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584248|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
19584249|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19584250|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584251|NCT02661191|Vitamins|vitamins|mesh-ancestor
19584252|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
19584253|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19584254|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
19584255|NCT02661100|Poly ICLC|poly iclc|mesh-list
19584256|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584257|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584258|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
19584259|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
19584260|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584261|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
19584262|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
19584263|NCT02661035|Fludarabine|fludarabine|mesh-list
19584264|NCT02661035|Allopurinol|allopurinol|mesh-list
19584265|NCT02661035|Tacrolimus|tacrolimus|mesh-list
19584266|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19584267|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584268|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
19584269|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584270|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584271|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19584272|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
19584273|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584274|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584275|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19584276|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
19584277|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19584278|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584279|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20122618|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20122619|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20122620|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20122621|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20122622|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20122623|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20122624|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
20122625|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122626|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122627|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20122628|NCT00009230|Celecoxib|celecoxib|mesh-list
20122629|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20122630|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20122631|NCT00009230|Analgesics|analgesics|mesh-ancestor
20122632|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
19584280|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19584281|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
19584282|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584283|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584284|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
20122633|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122634|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584285|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19584286|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
19584287|NCT02661035|Protective Agents|protective agents|mesh-ancestor
19584288|NCT02660840|Flupenthixol|flupenthixol|mesh-list
19584289|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
19584290|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19584291|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19584292|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584293|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584294|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19584295|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19584296|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
19584297|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584298|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584299|NCT02660905|Tenofovir|tenofovir|mesh-list
19584300|NCT02660905|Emtricitabine|emtricitabine|mesh-list
19584301|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
19584302|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19584303|NCT02660905|Rilpivirine|rilpivirine|mesh-list
19584304|NCT02660905|Ledipasvir|ledipasvir|mesh-list
19584305|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
19584306|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584307|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19584308|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20122635|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20122636|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122637|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20122638|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20122639|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122640|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122641|NCT00009555|Testosterone|testosterone|mesh-list
20122642|NCT00009555|Androgens|androgens|mesh-ancestor
20122643|NCT00009555|Hormones|hormones|mesh-ancestor
20122644|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20122645|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122646|NCT00009581|Acetylcholine|acetylcholine|mesh-list
20122647|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
20122648|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20122649|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
20122650|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584309|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584310|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584311|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19584312|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19584313|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
19584314|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19584315|NCT02660736|Incretins|incretins|mesh-ancestor
19584316|NCT02660736|Hormones|hormones|mesh-ancestor
19584317|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584318|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584319|NCT02660866|Vorapaxar|vorapaxar|mesh-list
19584320|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19584321|NCT02660762|Cytarabine|cytarabine|mesh-list
19584322|NCT02660762|Dexamethasone|dexamethasone|mesh-list
19584323|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
19584324|NCT02660762|Prednisone|prednisone|mesh-list
19584325|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
19584326|NCT02660762|Methotrexate|methotrexate|mesh-list
19584327|NCT02660762|Etoposide|etoposide|mesh-list
19584328|NCT02660762|Vincristine|vincristine|mesh-list
19584329|NCT02660762|Daunorubicin|daunorubicin|mesh-list
19584330|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
19584331|NCT02660762|Pegaspargase|pegaspargase|mesh-list
19584332|NCT02660762|Thioguanine|thioguanine|mesh-list
20122651|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584333|NCT02660762|BB 1101|bb 1101|mesh-list
19584334|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584335|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
19584336|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584337|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584338|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19584339|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
19584340|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584341|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122652|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122653|NCT00009620|Phenobarbital|phenobarbital|mesh-list
20122654|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
20122655|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20122656|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20122657|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122658|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20122659|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20122660|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122661|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584342|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19584343|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584344|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
19584345|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
19584346|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584347|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19584348|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
19584349|NCT02660762|Hormones|hormones|mesh-ancestor
19584350|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584351|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19584352|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
19584353|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584354|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19584355|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
19584356|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19584357|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19584358|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
19584359|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
19584360|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19584361|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19584362|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19584363|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19584364|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19584365|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
19584366|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584367|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
19584368|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
19584369|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
19584370|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19584371|NCT02660684|Cyclosporine|cyclosporine|mesh-list
19584372|NCT02660684|Methotrexate|methotrexate|mesh-list
19584373|NCT02660684|Tacrolimus|tacrolimus|mesh-list
19584374|NCT02660684|Cyclosporins|cyclosporins|mesh-list
19584375|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19584376|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
20122662|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
20122663|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
20122664|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20122665|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20122666|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20122667|NCT00009646|Indomethacin|indomethacin|mesh-list
20122668|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20122669|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20122670|NCT00009646|Analgesics|analgesics|mesh-ancestor
20122671|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
20122672|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122673|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122674|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20122675|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122676|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
20122677|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
20122678|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20122679|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20122680|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122681|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122682|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
19584377|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19584378|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584379|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122683|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19584380|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
19584381|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584382|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584383|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
19584384|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584385|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19584386|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584387|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
19584388|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584389|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19584390|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19584391|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
19584392|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584393|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
19584394|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19584395|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584396|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584397|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584398|NCT02660658|Analgesics|analgesics|mesh-ancestor
19584399|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
19584400|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584401|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19584402|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19584403|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19584404|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
19584405|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584406|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584407|NCT02660502|Insulin|insulin|mesh-list
19584408|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19584409|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
19584410|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19584411|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584412|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
19584413|NCT02660606|Narcotics|narcotics|mesh-ancestor
19584414|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584415|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584416|NCT02660606|Analgesics|analgesics|mesh-ancestor
19584417|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
19584418|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584419|NCT02660346|Vancomycin|vancomycin|mesh-list
20122684|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
20122685|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20122686|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584420|NCT02660346|Daptomycin|daptomycin|mesh-list
19584421|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19584422|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584423|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584424|NCT02660255|Cannabidiol|cannabidiol|mesh-list
19584425|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
19584426|NCT02660177|Dipyrone|dipyrone|mesh-list
19584427|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19584428|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584429|NCT02660177|Analgesics|analgesics|mesh-ancestor
19584430|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
19584431|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584432|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584433|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584434|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584435|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
19584436|NCT02660008|Glucagon|glucagon|mesh-list
19584437|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19584438|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19584439|NCT02660008|Hormones|hormones|mesh-ancestor
19584440|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584441|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122687|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20122688|NCT00009672|Morphine|morphine|mesh-list
20122689|NCT00009672|Nortriptyline|nortriptyline|mesh-list
20122690|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20122691|NCT00009672|Narcotics|narcotics|mesh-ancestor
20122692|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20122693|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122694|NCT00009672|Analgesics|analgesics|mesh-ancestor
19584442|NCT02660008|Incretins|incretins|mesh-ancestor
19584443|NCT02660060|Pramipexole|pramipexole|mesh-list
19584444|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
20122695|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
19584445|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584446|NCT02660060|Protective Agents|protective agents|mesh-ancestor
19584447|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584448|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19584449|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19584450|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
19584451|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
19584452|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584453|NCT02660047|Liraglutide|liraglutide|mesh-list
19584454|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19584455|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584456|NCT02660047|Incretins|incretins|mesh-ancestor
19584457|NCT02660047|Hormones|hormones|mesh-ancestor
19584458|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584459|NCT02659683|Esomeprazole|esomeprazole|mesh-list
19584460|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19584461|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19584462|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19584463|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584464|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584465|NCT02659761|Lamivudine|lamivudine|mesh-list
19584466|NCT02659761|Abacavir|abacavir|mesh-list
19584467|NCT02659761|Dolutegravir|dolutegravir|mesh-list
19584468|NCT02659761|Triumeq|triumeq|mesh-list
19584469|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19584470|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19584471|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584472|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584473|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
19584474|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584475|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19584476|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19584477|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19584478|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19584479|NCT02659917|Methamphetamine|methamphetamine|mesh-list
19584480|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19584481|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584482|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
19584483|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
19584484|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584485|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
19584486|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584487|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584488|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
19584489|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19584490|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19584491|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19584492|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19584493|NCT02659657|Interleukin-2|interleukin-2|mesh-list
19584494|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584495|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584496|NCT02659657|Analgesics|analgesics|mesh-ancestor
19584497|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
19584498|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584499|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584500|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19584501|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
19584502|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122696|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122697|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20122698|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
20122699|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19656818|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19656819|NCT04338321|Esketamine|esketamine|mesh-list
19656820|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656821|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19656822|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19656823|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19656824|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19656825|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656826|NCT04330248|Carbamazepine|carbamazepine|mesh-list
19656827|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
19656828|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
19656829|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19656830|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584503|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19584504|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19584505|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584506|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19584507|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19584508|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19584509|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584510|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
20122700|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20122701|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20122702|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20122703|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122704|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
20122705|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20122706|NCT00009698|Aldesleukin|aldesleukin|mesh-list
20122707|NCT00009698|Interleukin-2|interleukin-2|mesh-list
20122708|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122709|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20122710|NCT00009698|Analgesics|analgesics|mesh-ancestor
19584511|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584512|NCT02659384|Aspirin|aspirin|mesh-list
19584513|NCT02659384|Bevacizumab|bevacizumab|mesh-list
19584514|NCT02659384|Atezolizumab|atezolizumab|mesh-list
19584515|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584516|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584517|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19584518|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19584519|NCT02659384|Growth Substances|growth substances|mesh-ancestor
19584520|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584521|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
19584522|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19584523|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584524|NCT02659384|Analgesics|analgesics|mesh-ancestor
19584525|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
19584526|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584527|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584528|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584529|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19584530|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19584531|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584532|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19584533|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19584534|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584535|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
19584536|NCT02659306|Metformin|metformin|mesh-list
19584537|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19584538|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584539|NCT02659254|Sirolimus|sirolimus|mesh-list
19584540|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584541|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584542|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19584543|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584544|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
19584545|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584546|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
19584547|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584548|NCT02659228|Anesthetics|anesthetics|mesh-list
19584549|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19584550|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584551|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584552|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
19584553|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19584554|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19584555|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584556|NCT02659293|Dexamethasone|dexamethasone|mesh-list
19584557|NCT02659293|Lenalidomide|lenalidomide|mesh-list
19584558|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584559|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
19584560|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
19584561|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584562|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584563|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20122711|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
19259131|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
19584564|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
19584565|NCT02659293|Hormones|hormones|mesh-ancestor
19584566|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584567|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19584568|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584569|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
19584570|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19584571|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19584572|NCT02659293|Growth Substances|growth substances|mesh-ancestor
19584573|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
19584574|NCT02659085|Ketamine|ketamine|mesh-list
19584575|NCT02659085|Analgesics|analgesics|mesh-ancestor
19584576|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
19584577|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584578|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584579|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19584580|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19584581|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
19584582|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
19584583|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584584|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20122712|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20122713|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122714|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20122715|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20122716|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
20122717|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584585|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19584586|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584587|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584588|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
19584589|NCT02659033|Cephalosporins|cephalosporins|mesh-list
19584590|NCT02659033|Cefotaxime|cefotaxime|mesh-list
20122718|NCT00009750|Cyclosporine|cyclosporine|mesh-list
20122719|NCT00009750|Paclitaxel|paclitaxel|mesh-list
20122720|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20122721|NCT00009750|Antibodies|antibodies|mesh-list
20122722|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
20122723|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20122724|NCT00009750|Cyclosporins|cyclosporins|mesh-list
20122725|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122726|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122727|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122728|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122729|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122730|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122731|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
20122732|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122733|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122734|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122735|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
20122736|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122737|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20122738|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122739|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122740|NCT00009763|Cyclosporine|cyclosporine|mesh-list
20122741|NCT00009763|Paclitaxel|paclitaxel|mesh-list
20122742|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20122743|NCT00009763|Antibodies|antibodies|mesh-list
20122744|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
20122745|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20122746|NCT00009763|Cyclosporins|cyclosporins|mesh-list
20122747|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122748|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122749|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122750|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122751|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122752|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122753|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
20122754|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122755|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122756|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584591|NCT02659033|Cefoxitin|cefoxitin|mesh-list
20122757|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
20122758|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122759|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
20122760|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122761|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122762|NCT00009776|Cyclosporine|cyclosporine|mesh-list
20122763|NCT00009776|Paclitaxel|paclitaxel|mesh-list
20122764|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20122765|NCT00009776|Antibodies|antibodies|mesh-list
20122766|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
20122767|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20122768|NCT00009776|Cyclosporins|cyclosporins|mesh-list
20122769|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122770|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122771|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122772|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122773|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122774|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122775|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
20122776|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122777|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122778|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122779|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
20122780|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256552|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256553|NCT04483115|Tadalafil|tadalafil|mesh-list
19256554|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
19256555|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19256556|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19584592|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584593|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584594|NCT02658864|Lafutidine|lafutidine|mesh-list
19584595|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19584596|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19584597|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19584598|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
19584599|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
19584600|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584601|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584602|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584603|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
19584604|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19584605|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584606|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584607|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19584608|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19584609|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584610|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584611|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584612|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19584613|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
19584614|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19584615|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584616|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19584617|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19584618|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19584619|NCT02658838|Heparin|heparin|mesh-list
19584620|NCT02658838|Calcium heparin|calcium heparin|mesh-list
19584621|NCT02658838|Enoxaparin|enoxaparin|mesh-list
19584622|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19584623|NCT02658838|Tinzaparin|tinzaparin|mesh-list
19584624|NCT02658838|Dalteparin|dalteparin|mesh-list
19584625|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
19584626|NCT02658838|Ticagrelor|ticagrelor|mesh-list
19584627|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19584628|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
19584629|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19584630|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19584631|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584632|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20122781|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
19584633|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19584634|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19256557|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584635|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
19584636|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584637|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584638|NCT02658799|Diclofenac|diclofenac|mesh-list
19584639|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19584640|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584641|NCT02658799|Analgesics|analgesics|mesh-ancestor
19584642|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
19584643|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584644|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584645|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584646|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584647|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19584648|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584649|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584650|NCT02658773|Lidocaine|lidocaine|mesh-list
19584651|NCT02658773|Prilocaine|prilocaine|mesh-list
19584652|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19584653|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
19584654|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
19584655|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584656|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584657|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
19584658|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584659|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19584660|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19584661|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19584662|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19584663|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584664|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19584665|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
19584666|NCT02658760|Bupivacaine|bupivacaine|mesh-list
19584667|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
20122782|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20122783|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20122784|NCT00009802|Calcitriol|calcitriol|mesh-list
20122785|NCT00009802|Paclitaxel|paclitaxel|mesh-list
20122786|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122787|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122788|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122789|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122790|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122791|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122792|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122793|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122794|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20122795|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20122796|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20122797|NCT00009802|Vitamins|vitamins|mesh-ancestor
20122798|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
20122799|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20122800|NCT00009815|Leucovorin|leucovorin|mesh-list
20122801|NCT00009815|Etoposide|etoposide|mesh-list
20122802|NCT00009815|Tegafur|tegafur|mesh-list
20122803|NCT00009815|Calcium|calcium|mesh-list
20122804|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
20122805|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122806|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122807|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122808|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122809|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20122810|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122811|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309044|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
19584668|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
19584669|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584670|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584671|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
19584672|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584673|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19584674|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584675|NCT02658760|Analgesics|analgesics|mesh-ancestor
19584676|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19584677|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19584678|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19584679|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
19584680|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584681|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584682|NCT02658721|Diclofenac|diclofenac|mesh-list
19584683|NCT02658721|Lidocaine|lidocaine|mesh-list
19584684|NCT02658721|Atropine|atropine|mesh-list
19584685|NCT02658721|Ephedrine|ephedrine|mesh-list
19584686|NCT02658721|Fentanyl|fentanyl|mesh-list
19584687|NCT02658721|Midazolam|midazolam|mesh-list
19584688|NCT02658721|Tramadol|tramadol|mesh-list
19584689|NCT02658721|Ondansetron|ondansetron|mesh-list
19584690|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
19584691|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
19584692|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20122812|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122813|NCT00009815|Antidotes|antidotes|mesh-ancestor
20122814|NCT00009815|Protective Agents|protective agents|mesh-ancestor
20122815|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
20122816|NCT00009815|Vitamins|vitamins|mesh-ancestor
20122817|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
20122818|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122819|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
19584693|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584694|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
19584695|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584696|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19584697|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19584698|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19749548|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
20122820|NCT00009828|Leucovorin|leucovorin|mesh-list
20122821|NCT00009828|Paclitaxel|paclitaxel|mesh-list
20122822|NCT00009828|Tegafur|tegafur|mesh-list
20122823|NCT00009828|Calcium|calcium|mesh-list
20122824|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
20122825|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122826|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122827|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122828|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122829|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122830|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122831|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122832|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122833|NCT00009828|Antidotes|antidotes|mesh-ancestor
20122834|NCT00009828|Protective Agents|protective agents|mesh-ancestor
20122835|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
20122836|NCT00009828|Vitamins|vitamins|mesh-ancestor
20122837|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
20122838|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122839|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
20122840|NCT00009841|Mitogens|mitogens|mesh-list
20122841|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122842|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122843|NCT00009854|Ethanol|ethanol|mesh-list
20122844|NCT00009854|Carmustine|carmustine|mesh-list
20122845|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20122846|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122847|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20122848|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122849|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122850|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
20122851|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584699|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20122852|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122853|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
20122854|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122855|NCT00009880|Paclitaxel|paclitaxel|mesh-list
20122856|NCT00009880|Fluorouracil|fluorouracil|mesh-list
20122857|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122858|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122859|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122860|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122861|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122862|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122863|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
20122864|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122865|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122866|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
20122867|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122868|NCT00009893|Leucovorin|leucovorin|mesh-list
20122869|NCT00009893|Gemcitabine|gemcitabine|mesh-list
20122870|NCT00009893|Fluorouracil|fluorouracil|mesh-list
20122871|NCT00009893|Calcium|calcium|mesh-list
20122872|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
20122873|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122874|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
20122875|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584700|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584701|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19584702|NCT02658721|Narcotics|narcotics|mesh-ancestor
19584703|NCT02658721|Analgesics|analgesics|mesh-ancestor
19584704|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19584705|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20122876|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584706|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
19584707|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19584708|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19584709|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20122877|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
20122878|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122879|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122880|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122881|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
20122882|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122883|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20122884|NCT00009893|Antidotes|antidotes|mesh-ancestor
19584710|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19584711|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
19584712|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
19584713|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584714|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
19584715|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
20122885|NCT00009893|Protective Agents|protective agents|mesh-ancestor
20122886|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
20122887|NCT00009893|Vitamins|vitamins|mesh-ancestor
20122888|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
20122889|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
20122890|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584716|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19584717|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
19584718|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19584719|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19584720|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
19584721|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19584722|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19584723|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19584724|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19584725|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584726|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19584727|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584728|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19584729|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19584730|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
19584731|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
19584732|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
19584733|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19584734|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19584735|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
19584736|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19584737|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
19584738|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19584739|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
19584740|NCT02658422|Montelukast|montelukast|mesh-list
20122891|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20122892|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584741|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19584742|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
19584743|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19584744|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
19584745|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584746|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584747|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19584748|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19584749|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584750|NCT02658526|Anesthetics|anesthetics|mesh-list
19584751|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584752|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584753|NCT02658435|Tafenoquine|tafenoquine|mesh-list
19584754|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
19584755|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19584756|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19584757|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584758|NCT02658409|Vaccines|vaccines|mesh-list
19584759|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
19584760|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584761|NCT02658188|Gabapentin|gabapentin|mesh-list
19584762|NCT02658188|Analgesics|analgesics|mesh-ancestor
19584763|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
19584764|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584765|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584766|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
19584767|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19584768|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19584769|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584770|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19584771|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19584772|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19584773|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19584774|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584775|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
19584776|NCT02658396|Bortezomib|bortezomib|mesh-list
19584777|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584778|NCT02658214|Leucovorin|leucovorin|mesh-list
19584779|NCT02658214|Folic Acid|folic acid|mesh-list
19584780|NCT02658214|Gemcitabine|gemcitabine|mesh-list
19584781|NCT02658214|Paclitaxel|paclitaxel|mesh-list
19584782|NCT02658214|Etoposide|etoposide|mesh-list
19584783|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19584784|NCT02658214|Carboplatin|carboplatin|mesh-list
19584785|NCT02658214|Fluorouracil|fluorouracil|mesh-list
19584786|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
19584787|NCT02658214|Durvalumab|durvalumab|mesh-list
19584788|NCT02658214|Tremelimumab|tremelimumab|mesh-list
19584789|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
19584790|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19584791|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584792|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
19584793|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
19584794|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
19584795|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584796|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19584797|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
19584798|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
19584799|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584800|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584801|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584802|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
19584803|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584804|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19584805|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19584806|NCT02658214|Antidotes|antidotes|mesh-ancestor
19584807|NCT02658214|Protective Agents|protective agents|mesh-ancestor
19584808|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
19584809|NCT02658214|Vitamins|vitamins|mesh-ancestor
19584810|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
19584811|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584812|NCT02658214|Hematinics|hematinics|mesh-ancestor
19584813|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19584814|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19584815|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
19584816|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584817|NCT02658253|Antacids|antacids|mesh-ancestor
19584818|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584819|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20122893|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122894|NCT00009919|Semaxinib|semaxinib|mesh-list
20122895|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20122896|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20122897|NCT00009919|Growth Substances|growth substances|mesh-ancestor
20122898|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122899|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
20122900|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122901|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20122902|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122903|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122904|NCT00009932|Paclitaxel|paclitaxel|mesh-list
20122905|NCT00009932|Fenretinide|fenretinide|mesh-list
19584820|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
19584821|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584822|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584823|NCT02658292|Naftifine|naftifine|mesh-list
19584824|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
19584825|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19656831|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656832|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19656833|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19656834|NCT04330248|Analgesics|analgesics|mesh-ancestor
19656835|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
19656836|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656837|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19656838|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19656839|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656840|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19656841|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19656842|NCT04312659|Infliximab|infliximab|mesh-list
19656843|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
19656844|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19656845|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656846|NCT04310020|Atezolizumab|atezolizumab|mesh-list
19656847|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19656848|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656849|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
19656850|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122906|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122907|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122908|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122909|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122910|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122911|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122912|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20122913|NCT00009932|Protective Agents|protective agents|mesh-ancestor
20122914|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122915|NCT00009958|Metronidazole|metronidazole|mesh-list
20122916|NCT00009958|Vaccines|vaccines|mesh-list
20122917|NCT00009958|Sargramostim|sargramostim|mesh-list
20122918|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
19656864|NCT04278092|Paclitaxel|paclitaxel|mesh-list
19656865|NCT04278092|Cetuximab|cetuximab|mesh-list
19656866|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19656867|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656868|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
19656869|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19656870|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19656871|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656872|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656873|NCT04269902|Venetoclax|venetoclax|mesh-list
19656874|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
19656875|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656876|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20122919|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122920|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122921|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122922|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20122923|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20122924|NCT00009971|Fenretinide|fenretinide|mesh-list
20122925|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749549|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122926|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20122927|NCT00009971|Protective Agents|protective agents|mesh-ancestor
20122928|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122929|NCT00009984|Thalidomide|thalidomide|mesh-list
20122930|NCT00009984|Fludarabine|fludarabine|mesh-list
19584826|NCT02657603|Lidocaine|lidocaine|mesh-list
19584827|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
19584828|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
19584829|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584830|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122931|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
20122932|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122933|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122934|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
20122935|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122936|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122937|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
20122938|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122939|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
20122940|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20122941|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20122942|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20122943|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20122944|NCT00009984|Growth Substances|growth substances|mesh-ancestor
20122945|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
20122946|NCT00009997|Tamoxifen|tamoxifen|mesh-list
20122947|NCT00009997|Paclitaxel|paclitaxel|mesh-list
20122948|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
20122949|NCT00009997|Doxorubicin|doxorubicin|mesh-list
20122950|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20122951|NCT00009997|Trastuzumab|trastuzumab|mesh-list
20122952|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20122953|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122954|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
20122955|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
20122956|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
20122957|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122958|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20122959|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
20122960|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122961|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19584831|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
19584832|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584833|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19584834|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19584835|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19584836|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19584837|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584838|NCT02657616|Vitamin K|vitamin k|mesh-list
19584839|NCT02657616|Anticoagulants|anticoagulants|mesh-list
19584840|NCT02657616|Vitamins|vitamins|mesh-ancestor
19584841|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
20122962|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20122963|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
20122964|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20122965|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20122966|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20122967|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122968|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122969|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20122970|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20122971|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
20122972|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20122973|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20122974|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20122975|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20122976|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20122977|NCT00010010|Exemestane|exemestane|mesh-list
20122978|NCT00010010|Goserelin|goserelin|mesh-list
20122979|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122980|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19584842|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584843|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20122981|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19584844|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20122982|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20122983|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122984|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20122985|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
20122986|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20122987|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20122988|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20122989|NCT00010023|Capecitabine|capecitabine|mesh-list
20122990|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122991|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20122992|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
20122993|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20122994|NCT00010036|Carboplatin|carboplatin|mesh-list
20122995|NCT00010036|Irinotecan|irinotecan|mesh-list
20122996|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20122997|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20122998|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20122999|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123000|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123001|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
20123002|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123003|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20123004|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123005|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123006|NCT00010062|Fluorouracil|fluorouracil|mesh-list
20123007|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
20123008|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123009|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19584845|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584846|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
19584847|NCT02657616|Coagulants|coagulants|mesh-ancestor
19584848|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
19584849|NCT02657694|Ledipasvir|ledipasvir|mesh-list
19584850|NCT02657694|Velpatasvir|velpatasvir|mesh-list
19584851|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
19584852|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584853|NCT02657460|Cisplatin|cisplatin|mesh-list
19584854|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584855|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19584856|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
19584857|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
19584858|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584859|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
19584860|NCT02657512|Charcoal|charcoal|mesh-list
19584861|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19584862|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
20123010|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123011|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123012|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
20123013|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123014|NCT00010075|Leucovorin|leucovorin|mesh-list
20123015|NCT00010075|Fluorouracil|fluorouracil|mesh-list
20123016|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
20123017|NCT00010075|Calcium|calcium|mesh-list
20123018|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
20123019|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20123020|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123021|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
20123022|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123023|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123024|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123025|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19584863|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19584864|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
19584865|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584866|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584867|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
19584868|NCT02657512|Antidotes|antidotes|mesh-ancestor
19584869|NCT02657512|Protective Agents|protective agents|mesh-ancestor
19584870|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584871|NCT02657486|Infigratinib|infigratinib|mesh-list
20123026|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
20123027|NCT00010075|Antidotes|antidotes|mesh-ancestor
19584872|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584873|NCT02657343|Trastuzumab|trastuzumab|mesh-list
19584874|NCT02657343|Fulvestrant|fulvestrant|mesh-list
19584875|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584876|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584877|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19584878|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19584879|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19584880|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
19584881|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584882|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584883|NCT02657291|Ropivacaine|ropivacaine|mesh-list
19584884|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
19584885|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
19584886|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584887|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584888|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
19584889|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584890|NCT02657473|Tobramycin|tobramycin|mesh-list
19584891|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19584892|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584893|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584894|NCT02657187|Rocuronium|rocuronium|mesh-list
19584895|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19584896|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19584897|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19584898|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584899|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584900|NCT02657213|Insulin|insulin|mesh-list
19584901|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19584902|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19584903|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584904|NCT02657161|Vaccines|vaccines|mesh-list
20123028|NCT00010075|Protective Agents|protective agents|mesh-ancestor
20123029|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
20123030|NCT00010075|Vitamins|vitamins|mesh-ancestor
20123031|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
20123032|NCT00010075|Analgesics|analgesics|mesh-ancestor
20123033|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
20123034|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19584905|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
19584906|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584907|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
19584908|NCT02657148|Etonogestrel|etonogestrel|mesh-list
19584909|NCT02657148|Desogestrel|desogestrel|mesh-list
19584910|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19584911|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584912|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19584913|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19584914|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19584915|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19584916|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19584917|NCT02657148|Progestins|progestins|mesh-ancestor
19584918|NCT02657148|Hormones|hormones|mesh-ancestor
19584919|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584920|NCT02657096|Hybenx|hybenx|mesh-list
19584921|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
19584922|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
19584923|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584924|NCT02656901|Anesthetics|anesthetics|mesh-list
19584925|NCT02656901|Sevoflurane|sevoflurane|mesh-list
19584926|NCT02656901|Desflurane|desflurane|mesh-list
19584927|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584928|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584929|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20123035|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20123036|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20123037|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123038|NCT00010088|Leucovorin|leucovorin|mesh-list
20123039|NCT00010088|Gemcitabine|gemcitabine|mesh-list
20123040|NCT00010088|Fluorouracil|fluorouracil|mesh-list
20123041|NCT00010088|Calcium|calcium|mesh-list
20123042|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
19584930|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19584931|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
19584932|NCT02656979|Latanoprost|latanoprost|mesh-list
19584933|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19584934|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20123043|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123044|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
20309045|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309046|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20309047|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19584935|NCT02656810|Teriparatide|teriparatide|mesh-list
19584936|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19584937|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584938|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19584939|NCT02656771|Metronidazole|metronidazole|mesh-list
19584940|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584941|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19584942|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19584943|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19584944|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19584945|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584946|NCT02656511|Tenofovir|tenofovir|mesh-list
19584947|NCT02656511|Emtricitabine|emtricitabine|mesh-list
19584948|NCT02656511|Dolutegravir|dolutegravir|mesh-list
19584949|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
19584950|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584951|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19584952|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19584953|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584954|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584955|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19584956|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19584957|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19584958|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19584959|NCT02656589|Capecitabine|capecitabine|mesh-list
19584960|NCT02656589|Trastuzumab|trastuzumab|mesh-list
19584961|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19584962|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
19584963|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584964|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584965|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19584966|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
19584967|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
19584968|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19584969|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19584970|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584971|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
19584972|NCT02656472|Coagulants|coagulants|mesh-ancestor
19584973|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
19584974|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19584975|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19584976|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123045|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123046|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123047|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
20123048|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123049|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19584977|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19584978|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
19584979|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19584980|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584981|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19584982|NCT02656251|Ethanol|ethanol|mesh-list
19584983|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
19584984|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19584985|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19584986|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19584987|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19584988|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584989|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
19584990|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
19584991|NCT02656121|Vitamin D|vitamin d|mesh-list
19584992|NCT02656121|Clomiphene|clomiphene|mesh-list
19584993|NCT02656121|Vitamins|vitamins|mesh-ancestor
19584994|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
20123050|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123051|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
20123052|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123053|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20123054|NCT00010088|Antidotes|antidotes|mesh-ancestor
19584995|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19584996|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19584997|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19584998|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
19584999|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585000|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19585001|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
19585002|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19585003|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19585004|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19585005|NCT02656342|Cycloserine|cycloserine|mesh-list
19585006|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19585007|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585008|NCT02656342|Renal Agents|renal agents|mesh-ancestor
19585009|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19585010|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
19585011|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19585012|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
19585013|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585014|NCT02656095|Heparin|heparin|mesh-list
19585015|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
19585016|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19585017|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19585018|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123055|NCT00010088|Protective Agents|protective agents|mesh-ancestor
20123056|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
20123057|NCT00010088|Vitamins|vitamins|mesh-ancestor
20123058|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
20123059|NCT00010140|Tamoxifen|tamoxifen|mesh-list
20123060|NCT00010140|Docetaxel|docetaxel|mesh-list
20123061|NCT00010140|Epirubicin|epirubicin|mesh-list
20123062|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123063|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
20123064|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
20123065|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123066|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123067|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20123068|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20123069|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20123070|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123071|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20123072|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
20123073|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123074|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123075|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123076|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19656901|NCT04262479|Vitamin D|vitamin d|mesh-list
19656902|NCT04262479|Vitamins|vitamins|mesh-ancestor
20123077|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20123078|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20123079|NCT00010153|Fulvestrant|fulvestrant|mesh-list
20123080|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123081|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656903|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
19656904|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656905|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19656906|NCT04262024|Cabergoline|cabergoline|mesh-list
19656907|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19656908|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19656909|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
19656910|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
19656911|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656912|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656913|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123082|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20123083|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20123084|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
20123085|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123086|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123087|NCT00010166|Gemcitabine|gemcitabine|mesh-list
20123088|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123089|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
19656914|NCT04236414|Olaparib|olaparib|mesh-list
19585019|NCT02656082|Etanercept|etanercept|mesh-list
19585020|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19585021|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19585022|NCT02656082|Analgesics|analgesics|mesh-ancestor
19585023|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
19585024|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585025|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585026|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585027|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585028|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19585029|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585030|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
19585031|NCT02656017|Metformin|metformin|mesh-list
19585032|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19585033|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585034|NCT02655692|Ketamine|ketamine|mesh-list
19585035|NCT02655692|Analgesics|analgesics|mesh-ancestor
19585036|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
19585037|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585038|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585039|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19585040|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585041|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
19585042|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
19585043|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585044|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19585045|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19585046|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585047|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585048|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19585049|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19585050|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585051|NCT02655757|Incretins|incretins|mesh-ancestor
19585052|NCT02655757|Hormones|hormones|mesh-ancestor
19585053|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585054|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19585055|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
19585056|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585057|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585058|NCT02655770|Liraglutide|liraglutide|mesh-list
19585059|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19585060|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585061|NCT02655770|Incretins|incretins|mesh-ancestor
19585062|NCT02655770|Hormones|hormones|mesh-ancestor
19585063|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585064|NCT02655874|Vaccines|vaccines|mesh-list
19585065|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
19585066|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585067|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
19585068|NCT02655913|Vitamins|vitamins|mesh-ancestor
19585069|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
19585070|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585071|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
19585072|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585073|NCT02655913|Protective Agents|protective agents|mesh-ancestor
19585074|NCT02655822|Atezolizumab|atezolizumab|mesh-list
19585075|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585076|NCT02655965|Clonidine|clonidine|mesh-list
19585077|NCT02655965|Ropivacaine|ropivacaine|mesh-list
19585078|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
19585079|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
19585080|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585081|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585082|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
19585083|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585084|NCT02655965|Analgesics|analgesics|mesh-ancestor
19585085|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19585086|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
19585087|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
19585088|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19585089|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19585090|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19585091|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
19585092|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585093|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585094|NCT02655705|Cyclosporine|cyclosporine|mesh-list
19585095|NCT02655705|Methotrexate|methotrexate|mesh-list
19585096|NCT02655705|Cyclosporins|cyclosporins|mesh-list
19585097|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19585098|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
19585099|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19585100|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585101|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19585102|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
19585103|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585104|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585105|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
19585106|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585107|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19585108|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585109|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
19585110|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585111|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19585112|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
19585113|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585114|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19585115|NCT02655614|Midazolam|midazolam|mesh-list
19585116|NCT02655614|Caffeine|caffeine|mesh-list
19585117|NCT02655614|Rabeprazole|rabeprazole|mesh-list
19585118|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19585119|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19585120|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585121|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585122|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19585123|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19585124|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19585125|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585126|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
19585127|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
19585128|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
19585129|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
19585130|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585131|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585132|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19585133|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19585134|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585135|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19585136|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19585137|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
19585138|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19585139|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19585140|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19585141|NCT02655601|Manganese|manganese|mesh-list
19585142|NCT02655601|Temozolomide|temozolomide|mesh-list
19585143|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19585144|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
19585145|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585146|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585147|NCT02655601|Trace Elements|trace elements|mesh-ancestor
19585148|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
19585149|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585150|NCT02655562|Montelukast|montelukast|mesh-list
19585151|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19585152|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
19585153|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19585154|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
19585155|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585156|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585157|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19585158|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19585159|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585160|NCT02655536|Bevacizumab|bevacizumab|mesh-list
19585161|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19585162|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19585163|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173342|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585164|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19585165|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19585166|NCT02655536|Growth Substances|growth substances|mesh-ancestor
19585167|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585168|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
19585169|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19585170|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585171|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585172|NCT02655380|Ketamine|ketamine|mesh-list
19585173|NCT02655380|Remifentanil|remifentanil|mesh-list
19585174|NCT02655380|Analgesics|analgesics|mesh-ancestor
19585175|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
19585176|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585177|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585178|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19585179|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585180|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
19585181|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
19585182|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123090|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123091|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123092|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
20123093|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123094|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123095|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123096|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
20123097|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123098|NCT00010179|Lurtotecan|lurtotecan|mesh-list
20123099|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123100|NCT00010192|Aldesleukin|aldesleukin|mesh-list
20123101|NCT00010192|Rituximab|rituximab|mesh-list
20123102|NCT00010192|Interleukin-2|interleukin-2|mesh-list
20123103|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20123104|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585183|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19585184|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19585185|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585186|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585187|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19585188|NCT02655380|Narcotics|narcotics|mesh-ancestor
19585189|NCT02655458|Lenalidomide|lenalidomide|mesh-list
19585190|NCT02655458|Elotuzumab|elotuzumab|mesh-list
19585191|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
19585192|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123105|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
20123106|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123107|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123108|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20123109|NCT00010192|Analgesics|analgesics|mesh-ancestor
20123110|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
20123111|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123112|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123113|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123114|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
20123115|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123116|NCT00010231|Calcitriol|calcitriol|mesh-list
20123117|NCT00010231|Dexamethasone|dexamethasone|mesh-list
20123118|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123119|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
20123120|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
20123121|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123122|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585193|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19585194|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19585195|NCT02655458|Growth Substances|growth substances|mesh-ancestor
19585196|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
19585197|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585198|NCT02655471|Zidovudine|zidovudine|mesh-list
19585199|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
20123123|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20123124|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
19585200|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
19585201|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585202|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20123125|NCT00010231|Hormones|hormones|mesh-ancestor
20123126|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123127|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123128|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123129|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20123130|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19585203|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19585204|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585205|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
19585206|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585207|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19585208|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19585209|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19585210|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19585211|NCT02655315|Deferiprone|deferiprone|mesh-list
19585212|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19585213|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
20123131|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20123132|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123133|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20123134|NCT00010231|Vitamins|vitamins|mesh-ancestor
20123135|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
20123136|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20123137|NCT00010270|Immunotoxins|immunotoxins|mesh-list
20123138|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
20123139|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123140|NCT00010283|Beclomethasone|beclomethasone|mesh-list
20123141|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123142|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
20123143|NCT00010283|Hormones|hormones|mesh-ancestor
20123144|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123145|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123146|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20123147|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
19585214|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
19585215|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585216|NCT02655276|Glycine|glycine|mesh-list
19585217|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
19585218|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585219|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585220|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585221|NCT02655198|Fenfluramine|fenfluramine|mesh-list
19585222|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19585223|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19585224|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19585225|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585226|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585227|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
19585228|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585229|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19585230|NCT02655146|Progesterone|progesterone|mesh-list
19585231|NCT02655146|Estradiol|estradiol|mesh-list
19585232|NCT02655146|Progestins|progestins|mesh-ancestor
19585233|NCT02655146|Hormones|hormones|mesh-ancestor
20123148|NCT00010322|Toremifene|toremifene|mesh-list
20123149|NCT00010322|Atamestane|atamestane|mesh-list
20123150|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123151|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123152|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20123153|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19585234|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585235|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123154|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
20123155|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123156|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123157|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19585236|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
19585237|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19585238|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
19585239|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19585240|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19585241|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19585242|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585243|NCT02655146|Estrogens|estrogens|mesh-ancestor
19585244|NCT02654847|Norepinephrine|norepinephrine|mesh-list
19585245|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19585246|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19585247|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
19585248|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585249|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585250|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585251|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
19585252|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
19585253|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585254|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19585255|NCT02655029|Amlodipine|amlodipine|mesh-list
19585256|NCT02655029|Perindopril|perindopril|mesh-list
19585257|NCT02655029|Indapamide|indapamide|mesh-list
19585258|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19585259|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20123158|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123159|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123160|NCT00010361|Cyclosporine|cyclosporine|mesh-list
20123161|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
20123162|NCT00010361|Fludarabine|fludarabine|mesh-list
20123163|NCT00010361|Cyclosporins|cyclosporins|mesh-list
20123164|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123165|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123166|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585260|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19585261|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585262|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19585263|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585264|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
19585265|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19585266|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
19585267|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585268|NCT02655029|Diuretics|diuretics|mesh-ancestor
19585269|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
19585270|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19585271|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
19585272|NCT02654834|Anesthetics|anesthetics|mesh-list
19585273|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585274|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585275|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19585276|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
19585277|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19585278|NCT02654834|Analgesics|analgesics|mesh-ancestor
19585279|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
20123167|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
20123168|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123169|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123170|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
20123171|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123172|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
20123173|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123174|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20123175|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20123176|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20123177|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
20123178|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19585280|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585281|NCT02654743|Sulforaphane|sulforaphane|mesh-list
19585282|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19585283|NCT02654743|Protective Agents|protective agents|mesh-ancestor
19585284|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585285|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585286|NCT02654561|Heparin|heparin|mesh-list
19585287|NCT02654561|Calcium heparin|calcium heparin|mesh-list
19585288|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
19585289|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19585290|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20123179|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
19585291|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585292|NCT02654665|Liraglutide|liraglutide|mesh-list
19585293|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19585294|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585295|NCT02654665|Incretins|incretins|mesh-ancestor
19585296|NCT02654665|Hormones|hormones|mesh-ancestor
19585297|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585298|NCT02654730|Piperaquine|piperaquine|mesh-list
19585299|NCT02654730|Primaquine|primaquine|mesh-list
19585300|NCT02654730|Artenimol|artenimol|mesh-list
19585301|NCT02654730|Artemisinins|artemisinins|mesh-list
19585302|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
19585303|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19585304|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19585305|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585306|NCT02654678|Enalapril|enalapril|mesh-list
19585307|NCT02654678|Enalaprilat|enalaprilat|mesh-list
19585308|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19585309|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
19585310|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585311|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585312|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19585313|NCT02654704|Vaccines|vaccines|mesh-list
19585314|NCT02654704|Immunologic Factors|immunologic factors|mesh-ancestor
19585315|NCT02654704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656915|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19656916|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656917|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656918|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123180|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123181|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
20123182|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123183|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123184|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123185|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
20123186|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123187|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123188|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20123189|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
20123190|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123191|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
20123192|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123193|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123194|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123195|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
20123196|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123197|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123198|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20123199|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
20123200|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123201|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
20123202|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123203|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123204|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123205|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
20123206|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123207|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123208|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20123209|NCT00010426|Cysteamine|cysteamine|mesh-list
20123210|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
20123211|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123212|NCT00010452|Picibanil|picibanil|mesh-list
20123213|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656949|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
19656950|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656951|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656952|NCT04211259|Loratadine|loratadine|mesh-list
19656953|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
19656954|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
19656955|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19259132|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19656956|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19656957|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19656958|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
19656959|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
19585316|NCT02654587|Docetaxel|docetaxel|mesh-list
19585317|NCT02654587|Pemetrexed|pemetrexed|mesh-list
19585318|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585319|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
19585320|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19585321|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
19585322|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585323|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585324|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19585325|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19585326|NCT02654405|Butyric Acid|butyric acid|mesh-list
19585327|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
19585328|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
19585329|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585330|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585331|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585332|NCT02654379|Rituximab|rituximab|mesh-list
19585333|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19585334|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585335|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
19585336|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585337|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585338|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
19585339|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19585340|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19585341|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585342|NCT02654093|Vitamins|vitamins|mesh-ancestor
19585343|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
19585344|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19585345|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19585346|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19585347|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585348|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19585349|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19585350|NCT02654106|Temozolomide|temozolomide|mesh-list
19585351|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19585352|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
19585353|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585354|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585355|NCT02654119|Paclitaxel|paclitaxel|mesh-list
19585356|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
19585357|NCT02654119|Trastuzumab|trastuzumab|mesh-list
19585358|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19585359|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19585360|NCT02654119|Antibodies|antibodies|mesh-list
19585361|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
19585362|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19585363|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19585364|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585365|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
19585366|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
19585367|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
19585368|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585369|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585370|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
19585371|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585372|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123214|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
19585373|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19585374|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
19585375|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19585376|NCT02654171|Ziresovir|ziresovir|mesh-list
19585377|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
19585378|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585379|NCT02654288|Gemcitabine|gemcitabine|mesh-list
19585380|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19585381|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
19585382|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585383|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585384|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
19585385|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585386|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585387|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585388|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
19585389|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585390|NCT02654041|Methimazole|methimazole|mesh-list
19585391|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
19585392|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
19585393|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585394|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585395|NCT02653898|Artesunate|artesunate|mesh-list
19585396|NCT02653898|Piperaquine|piperaquine|mesh-list
19585397|NCT02653898|Primaquine|primaquine|mesh-list
19585398|NCT02653898|Artenimol|artenimol|mesh-list
19585399|NCT02653898|Mefloquine|mefloquine|mesh-list
19585400|NCT02653898|Permethrin|permethrin|mesh-list
19585401|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
19585402|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19585403|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19585404|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123215|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20123216|NCT00010686|Estrogens|estrogens|mesh-ancestor
20123217|NCT00010686|Hormones|hormones|mesh-ancestor
20123218|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123219|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123220|NCT00010699|Vitamin E|vitamin e|mesh-list
19585405|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585406|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
19585407|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
19585408|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19585409|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
19585410|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585411|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585412|NCT02653833|Tadalafil|tadalafil|mesh-list
19585413|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
19585414|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19585415|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19585416|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585417|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585418|NCT02653833|Urological Agents|urological agents|mesh-ancestor
19585419|NCT02653703|Ethanol|ethanol|mesh-list
19585420|NCT02653703|Menthol|menthol|mesh-list
19585421|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19585422|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585423|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123221|NCT00010699|Vitamins|vitamins|mesh-ancestor
20123222|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
20123223|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123224|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
20123225|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123226|NCT00010699|Protective Agents|protective agents|mesh-ancestor
20123227|NCT00010725|Vitamins|vitamins|mesh-list
20123228|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
20123229|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123230|NCT00010842|Vitamin E|vitamin e|mesh-list
20123231|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
20123232|NCT00010842|Selenium|selenium|mesh-list
20123233|NCT00010842|Vitamins|vitamins|mesh-ancestor
20123234|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
20123235|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123236|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
19585424|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123237|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585425|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
20123238|NCT00010842|Protective Agents|protective agents|mesh-ancestor
20123239|NCT00010842|Trace Elements|trace elements|mesh-ancestor
20123240|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
20123241|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20123242|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123243|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585426|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
19585427|NCT02653742|Ketorolac|ketorolac|mesh-list
19585428|NCT02653742|Fentanyl|fentanyl|mesh-list
19585429|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19585430|NCT02653742|Narcotics|narcotics|mesh-ancestor
19585431|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585432|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585433|NCT02653742|Analgesics|analgesics|mesh-ancestor
19585434|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
19585435|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585436|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19585437|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585438|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
19585439|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
19585440|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19585441|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19585442|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585443|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585444|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19585445|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585446|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585447|NCT02653963|Triamcinolone|triamcinolone|mesh-list
20123244|NCT00010881|Antioxidants|antioxidants|mesh-list
20123245|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123246|NCT00010881|Protective Agents|protective agents|mesh-ancestor
20123247|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173343|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
19585448|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585449|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
19585450|NCT02653963|Hormones|hormones|mesh-ancestor
19585451|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585452|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585453|NCT02653651|Lidocaine|lidocaine|mesh-list
19585454|NCT02653651|Ketamine|ketamine|mesh-list
19585455|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
19585456|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
19585457|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585458|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585459|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
19585460|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585461|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19585462|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19585463|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20173344|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20173345|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20173346|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173347|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173348|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20173349|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
20173350|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173351|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
20173352|NCT00161304|Testosterone|testosterone|mesh-list
20173353|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
20173354|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
20173355|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20173356|NCT00161304|Androgens|androgens|mesh-ancestor
20173357|NCT00161304|Hormones|hormones|mesh-ancestor
19585464|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19585465|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585466|NCT02653651|Analgesics|analgesics|mesh-ancestor
19585467|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19585468|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585469|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
19585470|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19585471|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19585472|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173358|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173359|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585473|NCT02653638|Indomethacin|indomethacin|mesh-list
19656960|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585474|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19585475|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19585476|NCT02653638|Analgesics|analgesics|mesh-ancestor
19585477|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
19585478|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585479|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585480|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585481|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585482|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
19585483|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
19585484|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19585485|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19585486|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585487|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585488|NCT02653235|Vaccines|vaccines|mesh-list
19585489|NCT02653235|Immunologic Factors|immunologic factors|mesh-ancestor
19585490|NCT02653235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585491|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
19585492|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19585493|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19585494|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585495|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
19585496|NCT02653261|Coagulants|coagulants|mesh-ancestor
19585497|NCT02653196|Cyclosporine|cyclosporine|mesh-list
19585498|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
19585499|NCT02653196|Fludarabine|fludarabine|mesh-list
19585500|NCT02653196|Etoposide|etoposide|mesh-list
19585501|NCT02653196|Melphalan|melphalan|mesh-list
19585502|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
19585503|NCT02653196|Thiotepa|thiotepa|mesh-list
19585504|NCT02653196|Tacrolimus|tacrolimus|mesh-list
19585505|NCT02653196|Cyclosporins|cyclosporins|mesh-list
19585506|NCT02653196|Mitogens|mitogens|mesh-list
19585507|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585508|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585509|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585510|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
19585511|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585512|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19585513|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19585514|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19585515|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585516|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19585517|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
19585518|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585519|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
19585520|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585521|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19585522|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19585523|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
19585524|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19585525|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19585526|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
19585527|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19585528|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
19585529|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19585530|NCT02653209|Pioglitazone|pioglitazone|mesh-list
19585531|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19585532|NCT02653209|Canagliflozin|canagliflozin|mesh-list
19585533|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19585534|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585535|NCT02653209|Incretins|incretins|mesh-ancestor
19585536|NCT02653209|Hormones|hormones|mesh-ancestor
19585537|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585538|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19585539|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
19585540|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585541|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123248|NCT00011076|Pirfenidone|pirfenidone|mesh-list
19585542|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19585543|NCT02653339|Loratadine|loratadine|mesh-list
19585544|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
19585545|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
19585546|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20123249|NCT00011076|Analgesics|analgesics|mesh-ancestor
20123250|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
20123251|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123252|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123253|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20123254|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20123255|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123256|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123257|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123258|NCT00011089|Tenofovir|tenofovir|mesh-list
20123259|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
20123260|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123261|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20123262|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20123263|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123264|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123265|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123266|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123267|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20123268|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
20123269|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585547|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19585548|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19585549|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
19585550|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
19585551|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585552|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585553|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585554|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19585555|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19585556|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19585557|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585558|NCT02653131|Incretins|incretins|mesh-ancestor
19585559|NCT02653131|Hormones|hormones|mesh-ancestor
19585560|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585561|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
19585562|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585563|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585564|NCT02653027|Ivacaftor|ivacaftor|mesh-list
19585565|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19585566|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19585567|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585568|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19585569|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
19585570|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
19585571|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585572|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585573|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19585574|NCT02653014|Diuretics|diuretics|mesh-ancestor
19585575|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
19585576|NCT02653014|Hormones|hormones|mesh-ancestor
19585577|NCT02652793|Lamivudine|lamivudine|mesh-list
19585578|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19585579|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19585580|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19585581|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585582|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585583|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
19585584|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123270|NCT00011297|Gabapentin|gabapentin|mesh-list
19585585|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19585586|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123271|NCT00011297|Lorazepam|lorazepam|mesh-list
20123272|NCT00011297|Analgesics|analgesics|mesh-ancestor
19585587|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19585588|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19585589|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
19585590|NCT02652884|Betamethasone|betamethasone|mesh-list
19585591|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
19585592|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585593|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
19585594|NCT02652884|Hormones|hormones|mesh-ancestor
19585595|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585596|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585597|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19585598|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
19585599|NCT02652871|Cytarabine|cytarabine|mesh-list
19585600|NCT02652871|Idarubicin|idarubicin|mesh-list
19585601|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19585602|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
19585603|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585604|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585605|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
19585606|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585607|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585608|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
19585609|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585610|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19585611|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19585612|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19585613|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585614|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19585615|NCT02652650|Norethindrone|norethindrone|mesh-list
19585616|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
19585617|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19585618|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19585619|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19585620|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
19585621|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19585622|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585623|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19585624|NCT02652650|Estrogens|estrogens|mesh-ancestor
19585625|NCT02652650|Hormones|hormones|mesh-ancestor
19585626|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585627|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19585628|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
19585629|NCT02652806|Hematinics|hematinics|mesh-ancestor
19585630|NCT02652585|Naltrexone|naltrexone|mesh-list
19585631|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19585632|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19585633|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585634|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
19585635|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585636|NCT02652637|Metronidazole|metronidazole|mesh-list
19585637|NCT02652637|Neomycin|neomycin|mesh-list
19585638|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585639|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19585640|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19585641|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19585642|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19585643|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585644|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585645|NCT02652728|Enalapril|enalapril|mesh-list
20123273|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
20123274|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123275|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123276|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
19585646|NCT02652728|Enalaprilat|enalaprilat|mesh-list
19585647|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20123277|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19585648|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
20123278|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19585649|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585650|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585651|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19585652|NCT02652598|Tolcapone|tolcapone|mesh-list
19585653|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19585654|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19585655|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19585656|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585657|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585658|NCT02652741|Enalapril|enalapril|mesh-list
19585659|NCT02652741|Enalaprilat|enalaprilat|mesh-list
19585660|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19585661|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
19585662|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585663|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585664|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19656961|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656962|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123279|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123280|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20123281|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20123282|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20123283|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656968|NCT04209114|Nivolumab|nivolumab|mesh-list
19656969|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656970|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656971|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19656972|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123284|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123285|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
20123286|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
20123287|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
20123288|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20123289|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20123290|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
20123291|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
19656981|NCT04187053|Methylene Blue|methylene blue|mesh-list
19656982|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656983|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656984|NCT04182334|TEMPO|tempo|mesh-list
19656985|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
19656986|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123292|NCT00011362|Dexamethasone|dexamethasone|mesh-list
20123293|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
20123294|NCT00011362|BB 1101|bb 1101|mesh-list
20123295|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123296|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
20123297|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
20123298|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123299|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123300|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20123301|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
20123302|NCT00011362|Hormones|hormones|mesh-ancestor
19656987|NCT04182334|Protective Agents|protective agents|mesh-ancestor
19656988|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656989|NCT04167111|Vitamin D|vitamin d|mesh-list
19656990|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
19656991|NCT04167111|Vitamins|vitamins|mesh-ancestor
19656992|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
19656993|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656994|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19656995|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20123303|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123304|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123305|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123306|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
20123307|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173360|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19585665|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
19585666|NCT02652507|Ketamine|ketamine|mesh-list
19585667|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19585668|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585669|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585670|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19585671|NCT02652507|Analgesics|analgesics|mesh-ancestor
20123308|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123309|NCT00011375|Rolipram|rolipram|mesh-list
20123310|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
20123311|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20123312|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19585672|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
19585673|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585674|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19585675|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19585676|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19585677|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
19585678|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585679|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585680|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19585681|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585682|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
19585683|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
19585684|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19585685|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19585686|NCT02652273|Abatacept|abatacept|mesh-list
19585687|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19585688|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585689|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585690|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585691|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
19585692|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585693|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585694|NCT02652312|Diclofenac|diclofenac|mesh-list
19585695|NCT02652312|Fentanyl|fentanyl|mesh-list
19585696|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
19585697|NCT02652312|Ondansetron|ondansetron|mesh-list
19585698|NCT02652312|Propofol|propofol|mesh-list
19585699|NCT02652312|Desflurane|desflurane|mesh-list
19585700|NCT02652312|Atracurium|atracurium|mesh-list
19585701|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19585702|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585703|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585704|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585705|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
19585706|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
19585707|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19585708|NCT02652312|Analgesics|analgesics|mesh-ancestor
19585709|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
19585710|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585711|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19585712|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19585713|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19585714|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
19585715|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585716|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585717|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19585718|NCT02652312|Narcotics|narcotics|mesh-ancestor
19585719|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19585720|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
19585721|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
19585722|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19585723|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
19585724|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
19585725|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19585726|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
19585727|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19585728|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19585729|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19585730|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19585731|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19585732|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585733|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585734|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19585735|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585736|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19585737|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19585738|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19585739|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19585740|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19585741|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19585742|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19585743|NCT02652325|Iodine|iodine|mesh-list
19585744|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
19585745|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
19585746|NCT02652325|Povidone|povidone|mesh-list
19585747|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19585748|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585749|NCT02652325|Trace Elements|trace elements|mesh-ancestor
19585750|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
19585751|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585752|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
19585753|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
19585754|NCT02652234|Endostar protein|endostar protein|mesh-list
19585755|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19585756|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19585757|NCT02652234|Growth Substances|growth substances|mesh-ancestor
19585758|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585759|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
19585760|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585761|NCT02652065|Acetylcholine|acetylcholine|mesh-list
19585762|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
19585763|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19585764|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
19585765|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585766|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585767|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585768|NCT02652091|Interferons|interferons|mesh-list
19585769|NCT02652091|Interferon-beta|interferon-beta|mesh-list
19585770|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
19585771|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585772|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
19585773|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585774|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
19585775|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585776|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19585777|NCT02651870|Amlodipine|amlodipine|mesh-list
19585778|NCT02651870|Candesartan|candesartan|mesh-list
19585779|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19585780|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19585781|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19585782|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585783|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19585784|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585785|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
19585786|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19585787|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19585788|NCT02651792|Meperidine|meperidine|mesh-list
19585789|NCT02651792|Ketamine|ketamine|mesh-list
19585790|NCT02651792|Propofol|propofol|mesh-list
19585791|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19585792|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585793|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585794|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585795|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
19585796|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
19585797|NCT02651792|Analgesics|analgesics|mesh-ancestor
20123313|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20123314|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123315|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123316|NCT00011479|Abacavir|abacavir|mesh-list
20123317|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20123318|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20123319|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123320|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123321|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
20123322|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123323|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123324|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123325|NCT00011635|Silymarin|silymarin|mesh-list
19585798|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
19585799|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585800|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19585801|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19585802|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19585803|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585804|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585805|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19585806|NCT02651792|Narcotics|narcotics|mesh-ancestor
19585807|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19585808|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
19585809|NCT02651753|Atorvastatin|atorvastatin|mesh-list
19585810|NCT02651753|Fenofibrate|fenofibrate|mesh-list
19585811|NCT02651753|Calcium|calcium|mesh-list
19585812|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19585813|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585814|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19585815|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19585816|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19585817|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
19585818|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585819|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19585820|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19585821|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585822|NCT02651610|Paclitaxel|paclitaxel|mesh-list
19585823|NCT02651610|Docetaxel|docetaxel|mesh-list
19585824|NCT02651610|Taxane|taxane|mesh-list
19585825|NCT02651610|Bavituximab|bavituximab|mesh-list
19585826|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19585827|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585828|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19585829|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
19585830|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
19585831|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585832|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19585833|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
20123326|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
20123327|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123328|NCT00011635|Protective Agents|protective agents|mesh-ancestor
20123329|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123330|NCT00011765|Fluoxetine|fluoxetine|mesh-list
20123331|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20123332|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20123333|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20123334|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123335|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20123336|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
20123337|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123338|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20123339|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
20123340|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20123341|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20123342|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20123343|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123344|NCT00011778|Bortezomib|bortezomib|mesh-list
20123345|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585834|NCT02651623|Sertraline|sertraline|mesh-list
19585835|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19585836|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123346|NCT00011804|Topiramate|topiramate|mesh-list
20123347|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
20123348|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20123349|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123350|NCT00011895|Lamivudine|lamivudine|mesh-list
20123351|NCT00011895|Zidovudine|zidovudine|mesh-list
20123352|NCT00011895|Efavirenz|efavirenz|mesh-list
19585837|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19585838|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19585839|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585840|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585841|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585842|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585843|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
19585844|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19585845|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19585846|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19585847|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19585848|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585849|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
19585850|NCT02651727|Gemcitabine|gemcitabine|mesh-list
19585851|NCT02651727|Paclitaxel|paclitaxel|mesh-list
19585852|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19585853|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19585854|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585855|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
19585856|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
19585857|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
19585858|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585859|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19585860|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
19585861|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
19585862|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585863|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585864|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585865|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
19585866|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585867|NCT02651519|Ropivacaine|ropivacaine|mesh-list
19585868|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
19585869|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
19585870|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585871|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585872|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
19585873|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585874|NCT02651662|Cemiplimab|cemiplimab|mesh-list
19585875|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19585876|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585877|NCT02651636|Folic Acid|folic acid|mesh-list
19585878|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
19585879|NCT02651636|Inositol|inositol|mesh-list
19585880|NCT02651636|Hematinics|hematinics|mesh-ancestor
19585881|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
19585882|NCT02651636|Vitamins|vitamins|mesh-ancestor
19585883|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
19585884|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585885|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
19585886|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585887|NCT02651636|Protective Agents|protective agents|mesh-ancestor
19585888|NCT02651441|Gemcitabine|gemcitabine|mesh-list
19585889|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585890|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19585891|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
19585892|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585893|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
19585894|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585895|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585896|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19585897|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
19585898|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585899|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
19585900|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20123353|NCT00011895|Abacavir|abacavir|mesh-list
20123354|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20123355|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19585901|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19585902|NCT02651350|Prednisolone|prednisolone|mesh-list
19585903|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
19585904|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19585905|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
19585906|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585907|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
19585908|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
19585909|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585910|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585911|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19585912|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
19585913|NCT02651350|Hormones|hormones|mesh-ancestor
19585914|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19585915|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19585916|NCT02651350|Protective Agents|protective agents|mesh-ancestor
19585917|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19585918|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585919|NCT02651324|Ketamine|ketamine|mesh-list
19585920|NCT02651324|Analgesics|analgesics|mesh-ancestor
19585921|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
19585922|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585923|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585924|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19585925|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585926|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
19585927|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
19585928|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585929|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19585930|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19585931|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19585932|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585933|NCT02651311|Ibuprofen|ibuprofen|mesh-list
19585934|NCT02651311|Fentanyl|fentanyl|mesh-list
19585935|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19585936|NCT02651311|Narcotics|narcotics|mesh-ancestor
19585937|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585938|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585939|NCT02651311|Analgesics|analgesics|mesh-ancestor
19585940|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
19585941|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585942|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19585943|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19585944|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
19585945|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
19585946|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19585947|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19585948|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19585949|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19585950|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19585951|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585952|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585953|NCT02651168|Aflibercept|aflibercept|mesh-list
19585954|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19585955|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19585956|NCT02651168|Growth Substances|growth substances|mesh-ancestor
19585957|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585958|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
19585959|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123356|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123357|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123358|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
20123359|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123360|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123361|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123362|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
20123363|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19585960|NCT02651207|Lidocaine|lidocaine|mesh-list
19585961|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
19585962|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
19585963|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
19585964|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
19585965|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19585966|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585967|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
19585968|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19585969|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19585970|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19585971|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19585972|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19585973|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585974|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19585975|NCT02651038|Micafungin|micafungin|mesh-list
19585976|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
19585977|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19585978|NCT02650752|Capecitabine|capecitabine|mesh-list
19585979|NCT02650752|Lapatinib|lapatinib|mesh-list
19585980|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19585981|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
19585982|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585983|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19585984|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19585985|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19585986|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
20123364|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20123365|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20123366|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19585987|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19585988|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19585989|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19585990|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
19585991|NCT02650791|Coagulants|coagulants|mesh-ancestor
19585992|NCT02650713|Atezolizumab|atezolizumab|mesh-list
19585993|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123367|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20123368|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20123369|NCT00011908|Epratuzumab|epratuzumab|mesh-list
20123370|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20123371|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123372|NCT00011921|Paclitaxel|paclitaxel|mesh-list
19657008|NCT04150029|Azacitidine|azacitidine|mesh-list
19657009|NCT04150029|Venetoclax|venetoclax|mesh-list
19657010|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19657011|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
19657012|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657013|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657014|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123373|NCT00011921|Etoposide|etoposide|mesh-list
20123374|NCT00011921|Carboplatin|carboplatin|mesh-list
20123375|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
20123376|NCT00011921|Epirubicin|epirubicin|mesh-list
20123377|NCT00011921|Ifosfamide|ifosfamide|mesh-list
20123378|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20123379|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123380|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
20123381|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
20123382|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123383|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123384|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20123385|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19749550|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123386|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123387|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20123388|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123389|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
20123390|NCT00011934|Interferons|interferons|mesh-list
20123391|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
20123392|NCT00011934|Sargramostim|sargramostim|mesh-list
20123393|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123394|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
20123395|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123396|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
19749551|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20123397|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19585994|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
19585995|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19585996|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19585997|NCT02650609|Prednisolone|prednisolone|mesh-list
19585998|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
19585999|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19586000|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
19586001|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586002|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
19586003|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
19586004|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586005|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586006|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586007|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
19586008|NCT02650609|Hormones|hormones|mesh-ancestor
20123398|NCT00011960|Paclitaxel|paclitaxel|mesh-list
20123399|NCT00011960|Cisplatin|cisplatin|mesh-list
20123400|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19586009|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586010|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19586011|NCT02650609|Protective Agents|protective agents|mesh-ancestor
19586012|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586013|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586014|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
19586015|NCT02650635|Lenograstim|lenograstim|mesh-list
19586016|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19586017|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
19586018|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586019|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586020|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19586021|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
19586022|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586023|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586024|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19586025|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19586026|NCT02650596|Liraglutide|liraglutide|mesh-list
19586027|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586028|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586029|NCT02650596|Incretins|incretins|mesh-ancestor
19586030|NCT02650596|Hormones|hormones|mesh-ancestor
19586031|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586032|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19586033|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586034|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19586035|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586036|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586037|NCT02650427|Incretins|incretins|mesh-ancestor
19586038|NCT02650427|Hormones|hormones|mesh-ancestor
19586039|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586040|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19586041|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
19586042|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586043|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586044|NCT02650479|Exenatide|exenatide|mesh-list
19586045|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
19586046|NCT02650479|Palonosetron|palonosetron|mesh-list
19586047|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19586048|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586049|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19586050|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19586051|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123401|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123402|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
20123403|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
20123404|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123405|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586052|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586053|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586054|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586055|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586056|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19586057|NCT02650479|Incretins|incretins|mesh-ancestor
19586058|NCT02650479|Hormones|hormones|mesh-ancestor
20123406|NCT00011973|Fenretinide|fenretinide|mesh-list
19749552|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20612135|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19586059|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586060|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
19586061|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
19586062|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586063|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586064|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19586065|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19586066|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
19586067|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586068|NCT02650544|Mirtazapine|mirtazapine|mesh-list
19586069|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
19586070|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19586071|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19586072|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
19586073|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
19586074|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586075|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586076|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586077|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19586078|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19586079|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586080|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19586081|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19586082|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19586083|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
19586084|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19586085|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19586086|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
19586087|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19586088|NCT02650245|Lactulose|lactulose|mesh-list
19586089|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586090|NCT02650206|Liraglutide|liraglutide|mesh-list
19586091|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586092|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586093|NCT02650206|Incretins|incretins|mesh-ancestor
19586094|NCT02650206|Hormones|hormones|mesh-ancestor
19586095|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586096|NCT02650102|Olanzapine|olanzapine|mesh-list
19586097|NCT02650102|Risperidone|risperidone|mesh-list
19586098|NCT02650102|Aripiprazole|aripiprazole|mesh-list
19586099|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19586100|NCT02650102|Ziprasidone|ziprasidone|mesh-list
19586101|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19586102|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
19586103|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586104|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586105|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586106|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19586107|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19586108|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586109|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19586110|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19586111|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
19586112|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
19586113|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
19586114|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123407|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123408|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20123409|NCT00011973|Protective Agents|protective agents|mesh-ancestor
20123410|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123411|NCT00011999|Paclitaxel|paclitaxel|mesh-list
20123412|NCT00011999|Cisplatin|cisplatin|mesh-list
20123413|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20123414|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123415|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
20123416|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
20123417|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123418|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123419|NCT00012025|Fulvestrant|fulvestrant|mesh-list
20123420|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123421|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123422|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20123423|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20123424|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
20123425|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123426|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123427|NCT00012038|Irofulven|irofulven|mesh-list
20123428|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123429|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
20123430|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123431|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123432|NCT00012051|Cytarabine|cytarabine|mesh-list
20123433|NCT00012051|Dexamethasone|dexamethasone|mesh-list
20123434|NCT00012051|Rituximab|rituximab|mesh-list
20123435|NCT00012051|Methotrexate|methotrexate|mesh-list
20123436|NCT00012051|Etoposide|etoposide|mesh-list
20123437|NCT00012051|Melphalan|melphalan|mesh-list
20123438|NCT00012051|Ifosfamide|ifosfamide|mesh-list
20123439|NCT00012051|Carmustine|carmustine|mesh-list
20123440|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123441|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20123442|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
20123443|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123444|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123445|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123446|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
20123447|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
20123448|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123449|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586115|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586116|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19586117|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19586118|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19586119|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
19586120|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
19586121|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19586122|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19586123|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19586124|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19586125|NCT02649920|Dinoprostone|dinoprostone|mesh-list
20123450|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
20123451|NCT00012051|Hormones|hormones|mesh-ancestor
20123452|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123453|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123454|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20123455|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
20123456|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20123457|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123458|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
20123459|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123460|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
20123461|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123462|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20123463|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123464|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20123465|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20123466|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19586126|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
19586127|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19586128|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586129|NCT02649998|Furosemide|furosemide|mesh-list
19586130|NCT02649998|Isosorbide|isosorbide|mesh-list
19586131|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19586132|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19586133|NCT02649998|Diuretics|diuretics|mesh-ancestor
19586134|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
19586135|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586136|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19586137|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19586138|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586139|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19586140|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
19586141|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19586142|NCT02649751|Roscovitine|roscovitine|mesh-list
19586143|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586144|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
19586145|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586146|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19586147|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586148|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586149|NCT02649686|Trastuzumab|trastuzumab|mesh-list
19586150|NCT02649686|Durvalumab|durvalumab|mesh-list
19586151|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19586152|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586153|NCT02649829|Vaccines|vaccines|mesh-list
19586154|NCT02649829|Immunologic Factors|immunologic factors|mesh-ancestor
19586155|NCT02649829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586156|NCT02649673|Topotecan|topotecan|mesh-list
19586157|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19586158|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19586159|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586160|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586161|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586162|NCT02649582|Temozolomide|temozolomide|mesh-list
19586163|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19586164|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
19586165|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586166|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309048|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20309049|NCT00666692|Growth Substances|growth substances|mesh-ancestor
20309050|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309051|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
20309052|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
20309053|NCT00666770|Gabapentin|gabapentin|mesh-list
20309054|NCT00666770|Analgesics|analgesics|mesh-ancestor
20309055|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
20309056|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586167|NCT02649530|LGK974|lgk974|mesh-list
19586168|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586169|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586170|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19586171|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19586172|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
19586173|NCT02649504|Dexamethasone|dexamethasone|mesh-list
19586174|NCT02649504|Rituximab|rituximab|mesh-list
19586175|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19586176|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586177|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
19586178|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586179|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586180|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586181|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
19586182|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
19586183|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586184|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586185|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
19586186|NCT02649504|Hormones|hormones|mesh-ancestor
19586187|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586188|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586189|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19586190|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19586191|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
19586192|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19586193|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586194|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586195|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586196|NCT02649478|Fluticasone|fluticasone|mesh-list
19586197|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19586198|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19586199|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586200|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19586201|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
19586202|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123467|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20123468|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
20123469|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123470|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123471|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
20123472|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20123473|NCT00012090|Goserelin|goserelin|mesh-list
20123474|NCT00012090|Bicalutamide|bicalutamide|mesh-list
20309057|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123475|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586203|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586204|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19586205|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
19586206|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19586207|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20123476|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123477|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
20123478|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
19586208|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19586209|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19586210|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19586211|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
19586212|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586213|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586214|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
19586215|NCT02649478|Hormones|hormones|mesh-ancestor
19586216|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586217|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
19586218|NCT02649465|Glimepiride|glimepiride|mesh-list
19586219|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
19586220|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19586221|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586222|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586223|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19586224|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
19586225|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19586226|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586227|NCT02649179|Ropivacaine|ropivacaine|mesh-list
19586228|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
19586229|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
19586230|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586231|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586232|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
19586233|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586234|NCT02649335|Propranolol|propranolol|mesh-list
19586235|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19586236|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19586237|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
19586238|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586239|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586240|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586241|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19586242|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19586243|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
19586244|NCT02649413|Prednisone|prednisone|mesh-list
19586245|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586246|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
19586247|NCT02649413|Hormones|hormones|mesh-ancestor
19586248|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586249|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586250|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586251|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586252|NCT02649140|Acetic Acid|acetic acid|mesh-list
19586253|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19586254|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586255|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
19586256|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19586257|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123479|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123480|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123481|NCT00012116|Temozolomide|temozolomide|mesh-list
20123482|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123483|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
20123484|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123485|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123486|NCT00012129|Annamycin|annamycin|mesh-list
20123487|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20123488|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123489|NCT00012142|Sirolimus|sirolimus|mesh-list
20123490|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20123491|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586258|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586259|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19586260|NCT02648958|Analgesics|analgesics|mesh-ancestor
19586261|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
19586262|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586263|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20123492|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20123493|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123494|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
20123495|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123496|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
19586264|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19586265|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19586266|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
19586267|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586268|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586269|NCT02648854|Metformin|metformin|mesh-list
19586270|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586271|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586272|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
19586273|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19586274|NCT02649075|Antibodies|antibodies|mesh-list
19586275|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
19586276|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123497|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123498|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20123499|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20123500|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123501|NCT00012181|Alvocidib|alvocidib|mesh-list
20123502|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123503|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
20123504|NCT00012181|Growth Substances|growth substances|mesh-ancestor
19657037|NCT04133311|Latanoprost|latanoprost|mesh-list
19657038|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19657039|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19657040|NCT04128956|Aspirin|aspirin|mesh-list
19657041|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19657042|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19657043|NCT04128956|Analgesics|analgesics|mesh-ancestor
19657044|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
19657045|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657046|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657047|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19657048|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657049|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19657050|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19657051|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657052|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19657053|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19657054|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657055|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
20309058|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
20309059|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20309060|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20309061|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309062|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309063|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20309064|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20309065|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309066|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309067|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
20309068|NCT00666783|Palonosetron|palonosetron|mesh-list
20309069|NCT00666783|Granisetron|granisetron|mesh-list
20309070|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
20309071|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
20309072|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657056|NCT04126031|Ceftazidime|ceftazidime|mesh-list
20123505|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123506|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20123507|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123508|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309073|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657057|NCT04126031|Avibactam|avibactam|mesh-list
20612136|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
19586277|NCT02648906|Choline|choline|mesh-list
19586278|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
19586279|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19586280|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
19586281|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586282|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586283|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19586284|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
19586285|NCT02649101|Thalidomide|thalidomide|mesh-list
19586286|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19586287|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
19586288|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586289|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
19586290|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19586291|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586292|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19586293|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19586294|NCT02649101|Growth Substances|growth substances|mesh-ancestor
19586295|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
19586296|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586297|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19586298|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586299|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586300|NCT02648425|Leucovorin|leucovorin|mesh-list
19586301|NCT02648425|Cisplatin|cisplatin|mesh-list
19586302|NCT02648425|Fluorouracil|fluorouracil|mesh-list
19586303|NCT02648425|Capecitabine|capecitabine|mesh-list
19586304|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586305|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
19586306|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586307|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19586308|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19586309|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
19586310|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586311|NCT02648425|Antidotes|antidotes|mesh-ancestor
19586312|NCT02648425|Protective Agents|protective agents|mesh-ancestor
19586313|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
19586314|NCT02648425|Vitamins|vitamins|mesh-ancestor
19586315|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
19586316|NCT02648711|Leucovorin|leucovorin|mesh-list
19586317|NCT02648711|Bevacizumab|bevacizumab|mesh-list
19586318|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
19586319|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20123509|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20123510|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123511|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20123512|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123513|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123514|NCT00012207|Aldesleukin|aldesleukin|mesh-list
20123515|NCT00012207|Prednisone|prednisone|mesh-list
20123516|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
20123517|NCT00012207|Vincristine|vincristine|mesh-list
20123518|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123519|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
20123520|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586320|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586321|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19586322|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19586323|NCT02648711|Growth Substances|growth substances|mesh-ancestor
19586324|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586325|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
19586326|NCT02648711|Antidotes|antidotes|mesh-ancestor
19586327|NCT02648711|Protective Agents|protective agents|mesh-ancestor
19586328|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
19586329|NCT02648711|Vitamins|vitamins|mesh-ancestor
19586330|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
19586331|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
19586332|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
19586333|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19586334|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19586335|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586336|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586337|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123521|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586338|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123522|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19586339|NCT02648503|Atropine|atropine|mesh-list
19586340|NCT02648503|Rocuronium|rocuronium|mesh-list
19586341|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19586342|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19586343|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19586344|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
19586345|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586346|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586347|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19586348|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
19586349|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
19586350|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
20123523|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
20123524|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123525|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123526|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20123527|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586351|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19586352|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19586353|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
19586354|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586355|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586356|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19586357|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19586358|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19586359|NCT02648490|Acetaminophen|acetaminophen|mesh-list
19586360|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
19586361|NCT02648490|Promethazine|promethazine|mesh-list
19586362|NCT02648490|Dexamethasone|dexamethasone|mesh-list
19586363|NCT02648490|Cetuximab|cetuximab|mesh-list
19586364|NCT02648490|Ondansetron|ondansetron|mesh-list
20123528|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
20123529|NCT00012207|Hormones|hormones|mesh-ancestor
20123530|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123531|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123532|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19586365|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586366|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
19586367|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
19586368|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586369|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586370|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586371|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
19586372|NCT02648490|Hormones|hormones|mesh-ancestor
19586373|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586374|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586375|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586376|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19586377|NCT02648490|Analgesics|analgesics|mesh-ancestor
19586378|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
19586379|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
19586380|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
19586381|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
19586382|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19586383|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
19586384|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586385|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586386|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19586387|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19586388|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586389|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19586390|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19586391|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19586392|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19586393|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
19586394|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
19586395|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19586396|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
19586397|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
19586398|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19586399|NCT02648490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19586400|NCT02648633|Nivolumab|nivolumab|mesh-list
19586401|NCT02648633|Valproic Acid|valproic acid|mesh-list
19586402|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20123533|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
19586403|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586404|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19586405|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586406|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
19586407|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586408|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
19586409|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586410|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586411|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
19586412|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19586413|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586414|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19586415|NCT02648659|Amoxicillin|amoxicillin|mesh-list
19586416|NCT02648659|Metronidazole|metronidazole|mesh-list
19586417|NCT02648659|Clarithromycin|clarithromycin|mesh-list
19586418|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19586419|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586420|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19586421|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19586422|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19586423|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586424|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586425|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19586426|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19586427|NCT02648412|Ketamine|ketamine|mesh-list
19586428|NCT02648412|Analgesics|analgesics|mesh-ancestor
19586429|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
19586430|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586431|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586432|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19586433|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19586434|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
19586435|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
19586436|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586437|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19586438|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19586439|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309074|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20309075|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19586440|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586441|NCT02648048|Pirfenidone|pirfenidone|mesh-list
19586442|NCT02648048|Analgesics|analgesics|mesh-ancestor
19586443|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
19586444|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586445|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586446|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19586447|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19586448|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586449|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586450|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586451|NCT02647892|Lidocaine|lidocaine|mesh-list
19586452|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
19586453|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
19586454|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586455|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586456|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
19586457|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586458|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19586459|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19586460|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19586461|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19586462|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586463|NCT02647827|Metformin|metformin|mesh-list
19586464|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586465|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586466|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19586467|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19586468|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586469|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586470|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586471|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
20309076|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20309077|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
20309078|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347181|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19586472|NCT02647671|Calcium|calcium|mesh-list
19586473|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19586474|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123534|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
20123535|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123536|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123537|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123538|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
19586475|NCT02647671|Antacids|antacids|mesh-ancestor
19586476|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586477|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586478|NCT02647567|Caffeine|caffeine|mesh-list
19586479|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19586480|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586481|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19586482|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586483|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586484|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19586485|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19586486|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
19586487|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586488|NCT02647385|Lidocaine|lidocaine|mesh-list
19586489|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
19586490|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
19586491|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586492|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586493|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
19586494|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586495|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19586496|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19586497|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19586498|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19586499|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586500|NCT02647515|Ranibizumab|ranibizumab|mesh-list
19586501|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19586502|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19586503|NCT02647515|Growth Substances|growth substances|mesh-ancestor
19586504|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586505|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
19586506|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586507|NCT02647424|Letrozole|letrozole|mesh-list
19586508|NCT02647424|Clomiphene|clomiphene|mesh-list
19586509|NCT02647424|Enclomiphene|enclomiphene|mesh-list
19586510|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
19586511|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586512|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19586513|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19586514|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586515|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586516|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19586517|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
19586518|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586519|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586520|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19586521|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
19586522|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19586523|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19586524|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19586525|NCT02647632|Ribavirin|ribavirin|mesh-list
19586526|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
19586527|NCT02647632|Grazoprevir|grazoprevir|mesh-list
19586528|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
19586529|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586530|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
19586531|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586532|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19586533|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19586534|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
20123539|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123540|NCT00012220|Gemcitabine|gemcitabine|mesh-list
20123541|NCT00012220|Docetaxel|docetaxel|mesh-list
20123542|NCT00012220|Irinotecan|irinotecan|mesh-list
20123543|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586535|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123544|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19586536|NCT02647489|Antacids|antacids|mesh-ancestor
19586537|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586538|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586539|NCT02647554|Urinastatin|urinastatin|mesh-list
19586540|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
19586541|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19586542|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
19586543|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586544|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586545|NCT02647190|Asparaginase|asparaginase|mesh-list
19586546|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586547|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
19586548|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19586549|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19586550|NCT02647255|Prednisolone|prednisolone|mesh-list
19586551|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
19586552|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19586553|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
19586554|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586555|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
19586556|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
19586557|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586558|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586559|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586560|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
19586561|NCT02647255|Hormones|hormones|mesh-ancestor
19586562|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586563|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19586564|NCT02647255|Protective Agents|protective agents|mesh-ancestor
19586565|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586566|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586567|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
19586568|NCT02647268|Oxytocin|oxytocin|mesh-list
19586569|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
19586570|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19586571|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586572|NCT02647268|Analgesics|analgesics|mesh-ancestor
19586573|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
19586574|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586575|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
19586576|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586577|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19586578|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
19586579|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19586580|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19586581|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586582|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19586583|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
19657058|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19657059|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19657060|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657061|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20123545|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
19657062|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657063|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657064|NCT04117087|Nivolumab|nivolumab|mesh-list
20123546|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123547|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
20123548|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657065|NCT04117087|Ipilimumab|ipilimumab|mesh-list
19657066|NCT04117087|Poly ICLC|poly iclc|mesh-list
19657067|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657068|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657069|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657070|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657071|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
20123549|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123550|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123551|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
20123552|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123553|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
20123554|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
20123555|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
19657072|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
19657073|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123556|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20123557|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19586584|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19586585|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19586586|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19586587|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19586588|NCT02647047|Acetaminophen|acetaminophen|mesh-list
19586589|NCT02647047|Ketorolac|ketorolac|mesh-list
19586590|NCT02647047|Sufentanil|sufentanil|mesh-list
19586591|NCT02647047|Ropivacaine|ropivacaine|mesh-list
19586592|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
19586593|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
19586594|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586595|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586596|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
19586597|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586598|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19586599|NCT02647047|Analgesics|analgesics|mesh-ancestor
19586600|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
19586601|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19586602|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586603|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586604|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19586605|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586606|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586607|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19586608|NCT02647047|Narcotics|narcotics|mesh-ancestor
19586609|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19586610|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19586611|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
19586612|NCT02646800|Micafungin|micafungin|mesh-list
19586613|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
19586614|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586615|NCT02646774|Micafungin|micafungin|mesh-list
19586616|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
19586617|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586618|NCT02647086|Metoprolol|metoprolol|mesh-list
19586619|NCT02647086|Midazolam|midazolam|mesh-list
19586620|NCT02647086|Caffeine|caffeine|mesh-list
20309079|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309080|NCT00666796|Ethanol|ethanol|mesh-list
20309081|NCT00666796|Gabapentin|gabapentin|mesh-list
20309082|NCT00666796|Analgesics|analgesics|mesh-ancestor
20123558|NCT00012246|Sargramostim|sargramostim|mesh-list
20123559|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
20123560|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
20123561|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123562|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20123563|NCT00012259|Troxacitabine|troxacitabine|mesh-list
19586621|NCT02647086|Omeprazole|omeprazole|mesh-list
19586622|NCT02647086|Warfarin|warfarin|mesh-list
19586623|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19586624|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19586625|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586626|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586627|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19586628|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19586629|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19586630|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20123564|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123565|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123566|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123567|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
20123568|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123569|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
20123570|NCT00012311|Ifosfamide|ifosfamide|mesh-list
20123571|NCT00012311|Thiotepa|thiotepa|mesh-list
20123572|NCT00012311|Carboplatin|carboplatin|mesh-list
20123573|NCT00012311|Docetaxel|docetaxel|mesh-list
20123574|NCT00012311|Doxorubicin|doxorubicin|mesh-list
20123575|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20123576|NCT00012311|Fluorouracil|fluorouracil|mesh-list
20123577|NCT00012311|Methotrexate|methotrexate|mesh-list
19586631|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
19586632|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
19586633|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
19586634|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
20123578|NCT00012311|Etoposide|etoposide|mesh-list
20123579|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123580|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
20123581|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309083|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
19586635|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586636|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586637|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
19586638|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19586639|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586640|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19586641|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586642|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19586643|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19586644|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19586645|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19586646|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
19586647|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19586648|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19586649|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
19586650|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
19586651|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586652|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19586653|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19586654|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19586655|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
19586656|NCT02646904|Beclomethasone|beclomethasone|mesh-list
19586657|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586658|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
19586659|NCT02646904|Hormones|hormones|mesh-ancestor
19586660|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586661|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586662|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19586663|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
19586664|NCT02646709|Ketamine|ketamine|mesh-list
19586665|NCT02646709|Rocuronium|rocuronium|mesh-list
19586666|NCT02646709|Analgesics|analgesics|mesh-ancestor
19586667|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
19586668|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586669|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586670|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19586671|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19586672|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
19586673|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
19586674|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586675|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19586676|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19586677|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586678|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586679|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19586680|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19586681|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19586682|NCT02646735|Fulvestrant|fulvestrant|mesh-list
19586683|NCT02646735|Exemestane|exemestane|mesh-list
20123582|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123583|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123584|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
20123585|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123586|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123587|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20123588|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
19586684|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586685|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586686|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19586687|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19586688|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
19586689|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586690|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586691|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19586692|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19586693|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586694|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586695|NCT02646683|Vedolizumab|vedolizumab|mesh-list
19586696|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586697|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19586698|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19749553|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20123589|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
19586699|NCT02646397|Fosinopril|fosinopril|mesh-list
19586700|NCT02646397|Benidipine|benidipine|mesh-list
19586701|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19586702|NCT02646397|Diuretics|diuretics|mesh-ancestor
19586703|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
19586704|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586705|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19586706|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19586707|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586708|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19586709|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
19586710|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586711|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19586712|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19586713|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
19586714|NCT02646592|Alfentanil|alfentanil|mesh-list
19586715|NCT02646592|Propofol|propofol|mesh-list
19586716|NCT02646592|Sevoflurane|sevoflurane|mesh-list
19586717|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19586718|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586719|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586720|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19586721|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
19586722|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
19586723|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19586724|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19586725|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19586726|NCT02646592|Narcotics|narcotics|mesh-ancestor
19586727|NCT02646592|Analgesics|analgesics|mesh-ancestor
19586728|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
19586729|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586730|NCT02646670|Ranibizumab|ranibizumab|mesh-list
19586731|NCT02646670|Aflibercept|aflibercept|mesh-list
19586732|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19586733|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19586734|NCT02646670|Growth Substances|growth substances|mesh-ancestor
19586735|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586736|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
19586737|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586738|NCT02646657|Vedolizumab|vedolizumab|mesh-list
19586739|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586740|NCT02646540|Metolazone|metolazone|mesh-list
19586741|NCT02646540|Furosemide|furosemide|mesh-list
19586742|NCT02646540|Tolvaptan|tolvaptan|mesh-list
19586743|NCT02646540|Diuretics|diuretics|mesh-list
19586744|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
19586745|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586746|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19586747|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19586748|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586749|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19586750|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19586751|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19586752|NCT02646111|Ribavirin|ribavirin|mesh-list
19586753|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
19586754|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586755|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
19586756|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586757|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
19586758|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20123590|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123591|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20123592|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20123593|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20123594|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123595|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
20123596|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123597|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20123598|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
20123599|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20123600|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
19586759|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586760|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
19586761|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19586762|NCT02646137|Estrogens|estrogens|mesh-ancestor
20123601|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20123602|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20123603|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20123604|NCT00012324|Doxorubicin|doxorubicin|mesh-list
20123605|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20123606|NCT00012324|Nolatrexed|nolatrexed|mesh-list
20123607|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20123608|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123609|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20123610|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20123611|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123612|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123613|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123614|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
20123615|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20123616|NCT00012337|Gefitinib|gefitinib|mesh-list
20123617|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586763|NCT02646137|Hormones|hormones|mesh-ancestor
19586764|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586765|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123618|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20123619|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123620|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123621|NCT00012350|Tipifarnib|tipifarnib|mesh-list
20123622|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586766|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586767|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586768|NCT02646319|Sirolimus|sirolimus|mesh-list
19586769|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19586770|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586771|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19586772|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123623|NCT00012363|Gemcitabine|gemcitabine|mesh-list
20123624|NCT00012363|Irinotecan|irinotecan|mesh-list
20123625|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123626|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
20123627|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123628|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586773|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
19586774|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19586775|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
19586776|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586777|NCT02646267|Warfarin|warfarin|mesh-list
19586778|NCT02646267|Dabigatran|dabigatran|mesh-list
19586779|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
19586780|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
19586781|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19586782|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
19586783|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586784|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586785|NCT02646189|Interferons|interferons|mesh-list
19586786|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
19586787|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
19586788|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19586789|NCT02646189|REP 2139|rep 2139|mesh-list
19586790|NCT02646189|Thymalfasin|thymalfasin|mesh-list
19586791|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586792|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
19586793|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586794|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
19586795|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586796|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19586797|NCT02646072|Ketorolac|ketorolac|mesh-list
19586798|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19586799|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20123629|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
20123630|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123631|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123632|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123633|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
20309084|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309085|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586800|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19586801|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19586802|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19586803|NCT02646072|Analgesics|analgesics|mesh-ancestor
19586804|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
20123634|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123635|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20123636|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20123637|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
20123638|NCT00012376|Sargramostim|sargramostim|mesh-list
20123639|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
19586805|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586806|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586807|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586808|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586809|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19586810|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586811|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586812|NCT02645747|Aflibercept|aflibercept|mesh-list
19586813|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19586814|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19586815|NCT02645747|Growth Substances|growth substances|mesh-ancestor
19586816|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586817|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
19586818|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586819|NCT02645864|Irinotecan|irinotecan|mesh-list
19586820|NCT02645864|Apatinib|apatinib|mesh-list
19586821|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19586822|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19586823|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586824|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586825|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586826|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19586827|NCT02645994|Anesthetics|anesthetics|mesh-list
19586828|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586829|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586830|NCT02645734|Bevacizumab|bevacizumab|mesh-list
19586831|NCT02645734|Aflibercept|aflibercept|mesh-list
19586832|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19586833|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586834|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19586835|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19586836|NCT02645734|Growth Substances|growth substances|mesh-ancestor
19586837|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586838|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19586839|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
19586840|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19586841|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19586842|NCT02645565|Prednisolone|prednisolone|mesh-list
19586843|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
19586844|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
19586845|NCT02645565|Azathioprine|azathioprine|mesh-list
19586846|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19586847|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
19586848|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19586849|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
19586850|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586851|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586852|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19586853|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
19586854|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586855|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586856|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19586857|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586858|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
19586859|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
19586860|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586861|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586862|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
19586863|NCT02645565|Hormones|hormones|mesh-ancestor
19586864|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586865|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19586866|NCT02645565|Protective Agents|protective agents|mesh-ancestor
19586867|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19586868|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
19586869|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19586870|NCT02645903|Morphine|morphine|mesh-list
19586871|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586872|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123640|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586873|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19586874|NCT02645903|Narcotics|narcotics|mesh-ancestor
19586875|NCT02645903|Analgesics|analgesics|mesh-ancestor
19586876|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
19586877|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586878|NCT02645981|Sorafenib|sorafenib|mesh-list
19586879|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586880|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19586881|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586882|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586883|NCT02646020|Loratadine|loratadine|mesh-list
19586884|NCT02646020|Aprepitant|aprepitant|mesh-list
19586885|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
19586886|NCT02646020|Desloratadine|desloratadine|mesh-list
19586887|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
19586888|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
19586889|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586890|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586891|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19586892|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19586893|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586894|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586895|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19586896|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
19586897|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19586898|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19586899|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
19586900|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
19586901|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
19586902|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
19586903|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20123641|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123642|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20123643|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
20123644|NCT00012389|Irinotecan|irinotecan|mesh-list
20123645|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123646|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20123647|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20123648|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123649|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173361|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173362|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
20173363|NCT00161330|Amoxicillin|amoxicillin|mesh-list
20173364|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
20173365|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
20173366|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
20173367|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19657090|NCT04101357|Carboplatin|carboplatin|mesh-list
19657091|NCT04101357|Etoposide|etoposide|mesh-list
19657092|NCT04101357|Atezolizumab|atezolizumab|mesh-list
19657093|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657094|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19657095|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19657096|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19657097|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657098|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657099|NCT04098666|Metformin|metformin|mesh-list
19657100|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19657101|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657102|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
19657103|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657104|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657105|NCT04092283|Paclitaxel|paclitaxel|mesh-list
19657106|NCT04092283|Etoposide|etoposide|mesh-list
20309086|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
19586904|NCT02645656|Curcumin|curcumin|mesh-list
19586905|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19586906|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19586907|NCT02645656|Analgesics|analgesics|mesh-ancestor
19586908|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
19586909|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586910|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586911|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586912|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586913|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19586914|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586915|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586916|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
19586917|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19586918|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19586919|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586920|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
19586921|NCT02645552|Coagulants|coagulants|mesh-ancestor
19586922|NCT02645370|Topiramate|topiramate|mesh-list
19586923|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
19586924|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19586925|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586926|NCT02645461|Palmidrol|palmidrol|mesh-list
19586927|NCT02645461|Riluzole|riluzole|mesh-list
19586928|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
19586929|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19586930|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19586931|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586932|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586933|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586934|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19586935|NCT02645461|Protective Agents|protective agents|mesh-ancestor
19586936|NCT02645461|Analgesics|analgesics|mesh-ancestor
19586937|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
19586938|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586939|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19586940|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19586941|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19586942|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19586943|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
19586944|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586945|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19586946|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19586947|NCT02645461|Hormones|hormones|mesh-ancestor
19586948|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19586949|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19586950|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19586951|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19586952|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
19586953|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586954|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19586955|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19586956|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19586957|NCT02645240|Heparin|heparin|mesh-list
19586958|NCT02645240|Calcium heparin|calcium heparin|mesh-list
19586959|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19586960|NCT02645240|Tinzaparin|tinzaparin|mesh-list
19586961|NCT02645240|Dalteparin|dalteparin|mesh-list
19586962|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
19586963|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19586964|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19586965|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586966|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19586967|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586968|NCT02645266|Aflibercept|aflibercept|mesh-list
19586969|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19586970|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19586971|NCT02645266|Growth Substances|growth substances|mesh-ancestor
19586972|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586973|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
20123650|NCT00012467|Interferons|interferons|mesh-list
20123651|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
20123652|NCT00012467|Itraconazole|itraconazole|mesh-list
20123653|NCT00012467|Fluconazole|fluconazole|mesh-list
19586974|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123654|NCT00012467|Amphotericin B|amphotericin b|mesh-list
20123655|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20123656|NCT00012467|Flucytosine|flucytosine|mesh-list
20123657|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309087|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20309088|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20309089|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309090|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309091|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20309092|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20309093|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309094|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309095|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
20309096|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20309097|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309098|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20309099|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309100|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20309101|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309102|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309103|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309104|NCT00666809|Urological Agents|urological agents|mesh-ancestor
20123658|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
19586975|NCT02645279|Midazolam|midazolam|mesh-list
20123659|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123660|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
20123661|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20123662|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20123663|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123664|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123665|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20123666|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
20123667|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123668|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123669|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20123670|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20309105|NCT00666887|Minocycline|minocycline|mesh-list
20309106|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309107|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19586976|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19586977|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19586978|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19586979|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586980|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19586981|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19586982|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19586983|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19586984|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
19586985|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
19586986|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
19586987|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
19586988|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19586989|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19586990|NCT02645058|Analgesics|analgesics|mesh-list
19586991|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586992|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
19586993|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19586994|NCT02645032|Vaccines|vaccines|mesh-list
19586995|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
19586996|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19586997|NCT02644967|Pembrolizumab|pembrolizumab|mesh-list
19586998|NCT02644967|Ipilimumab|ipilimumab|mesh-list
20309108|NCT00666939|Gabapentin|gabapentin|mesh-list
20309109|NCT00666939|Analgesics|analgesics|mesh-ancestor
20309110|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
20309111|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309112|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309113|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
19586999|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19587000|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587001|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19587002|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587003|NCT02644980|Anesthetics|anesthetics|mesh-list
19587004|NCT02644980|Propofol|propofol|mesh-list
19587005|NCT02644980|Etomidate|etomidate|mesh-list
19587006|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587007|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587008|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19587009|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19587010|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
19587011|NCT02644954|Metformin|metformin|mesh-list
19587012|NCT02644954|Calcipotriene|calcipotriene|mesh-list
20123671|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20123672|NCT00012467|Amebicides|amebicides|mesh-ancestor
19587013|NCT02644954|Coal Tar|coal tar|mesh-list
19587014|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587015|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587016|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587017|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
19587018|NCT02644785|Protamines|protamines|mesh-list
19587019|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
19587020|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587021|NCT02644785|Coagulants|coagulants|mesh-ancestor
19587022|NCT02644694|Dexamethasone|dexamethasone|mesh-list
19587023|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19587024|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19587025|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587026|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
19587027|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
19587028|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587029|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587030|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19587031|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
19587032|NCT02644694|Hormones|hormones|mesh-ancestor
19587033|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587034|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19587035|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587036|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19587037|NCT02644707|Selenium|selenium|mesh-list
19587038|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
19587039|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123673|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20123674|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20123675|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20123676|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
20123677|NCT00012506|Etanercept|etanercept|mesh-list
20123678|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20123679|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20123680|NCT00012506|Analgesics|analgesics|mesh-ancestor
20123681|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
20123682|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123683|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123684|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123685|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123686|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20123687|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19587040|NCT02644707|Protective Agents|protective agents|mesh-ancestor
19587041|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587042|NCT02644707|Trace Elements|trace elements|mesh-ancestor
19587043|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
19587044|NCT02644720|Dexamethasone|dexamethasone|mesh-list
19587045|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587046|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
19587047|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
19587048|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587049|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587050|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19587051|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
19587052|NCT02644720|Hormones|hormones|mesh-ancestor
19587053|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587054|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19587055|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587056|NCT02644863|Paclitaxel|paclitaxel|mesh-list
19587057|NCT02644863|Cisplatin|cisplatin|mesh-list
19587058|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19587059|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587060|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749554|NCT04940338|Analgesics|analgesics|mesh-ancestor
19587061|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587062|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123688|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
20123689|NCT00012519|Ritonavir|ritonavir|mesh-list
20123690|NCT00012519|Indinavir|indinavir|mesh-list
19587063|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587064|NCT02644629|Ketamine|ketamine|mesh-list
20309114|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20309115|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19587065|NCT02644629|Analgesics|analgesics|mesh-ancestor
19587066|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
19587067|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587068|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587069|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19587070|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19587071|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
19587072|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
19587073|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587074|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19587075|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19587076|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587077|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587078|NCT02644915|Edaravone|edaravone|mesh-list
19587079|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19587080|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
19587081|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587082|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19587083|NCT02644915|Protective Agents|protective agents|mesh-ancestor
19587084|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587085|NCT02644811|Anesthetics|anesthetics|mesh-list
19587086|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587087|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587088|NCT02644616|Torsemide|torsemide|mesh-list
19587089|NCT02644616|Tolvaptan|tolvaptan|mesh-list
19587090|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19587091|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587092|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
19587093|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587094|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19587095|NCT02644616|Diuretics|diuretics|mesh-ancestor
19587096|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19587097|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587098|NCT02644499|Folic Acid|folic acid|mesh-list
19587099|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
19587100|NCT02644499|Prednisolone|prednisolone|mesh-list
19587101|NCT02644499|Methotrexate|methotrexate|mesh-list
19587102|NCT02644499|Leflunomide|leflunomide|mesh-list
19587103|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
19587104|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19587105|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
19587106|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587107|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587108|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19587109|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
19587110|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587111|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587112|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587113|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587114|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19587115|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19587116|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
19587117|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587118|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19587119|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587120|NCT02644499|Hormones|hormones|mesh-ancestor
19587121|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587122|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19587123|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
19587124|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19587125|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19587126|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587127|NCT02644499|Hematinics|hematinics|mesh-ancestor
19587128|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
19587129|NCT02644499|Vitamins|vitamins|mesh-ancestor
19587130|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
19587131|NCT02644590|Melatonin|melatonin|mesh-list
19587132|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
19587133|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587134|NCT02644590|Protective Agents|protective agents|mesh-ancestor
19587135|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587136|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587137|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19587138|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
19587139|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587140|NCT02644551|Ciclopirox|ciclopirox|mesh-list
19587141|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
19587142|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587143|NCT02644395|Amlodipine|amlodipine|mesh-list
19587144|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
19587145|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19587146|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19587147|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587148|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587149|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19587150|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587151|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
20123691|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20123692|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20123693|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
20123694|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123695|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123696|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123697|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19587152|NCT02644395|Diuretics|diuretics|mesh-ancestor
19587153|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
19587154|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19587155|NCT02644304|Cabergoline|cabergoline|mesh-list
19587156|NCT02644304|Clomiphene|clomiphene|mesh-list
19587157|NCT02644304|Enclomiphene|enclomiphene|mesh-list
19587158|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
19587159|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587160|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19587161|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
19587162|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587163|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587164|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19587165|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
19587166|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587167|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19587168|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19587169|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19587170|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19587171|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
19587172|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
19587173|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587174|NCT02644408|Megestrol|megestrol|mesh-list
19587175|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19587176|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19587177|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19587178|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
19587179|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587180|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587181|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19587182|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19587183|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19587184|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587185|NCT02644486|Irbesartan|irbesartan|mesh-list
19587186|NCT02644486|Sevelamer|sevelamer|mesh-list
19587187|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19587188|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19587189|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19587190|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587191|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
19587192|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
19587193|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
20123698|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
20123699|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123700|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20123701|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20123702|NCT00012558|Inositol|inositol|mesh-list
20123703|NCT00012558|Lamotrigine|lamotrigine|mesh-list
20123704|NCT00012558|Valproic Acid|valproic acid|mesh-list
20123705|NCT00012558|Risperidone|risperidone|mesh-list
20123706|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
19587194|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19587195|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19587196|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587197|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
19587198|NCT02644473|Coagulants|coagulants|mesh-ancestor
19587199|NCT02644577|Metformin|metformin|mesh-list
19587200|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587201|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587202|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19587203|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587204|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19587205|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
19587206|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587207|NCT02644421|Lidocaine|lidocaine|mesh-list
19587208|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
19587209|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
19587210|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587211|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587212|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
19587213|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587214|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19587215|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19587216|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19587217|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587218|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587219|NCT02644252|Tocotrienols|tocotrienols|mesh-list
19587220|NCT02644252|Vitamin E|vitamin e|mesh-list
19587221|NCT02644252|Tocopherols|tocopherols|mesh-list
19587222|NCT02644252|Carboplatin|carboplatin|mesh-list
19587223|NCT02644252|Vinorelbine|vinorelbine|mesh-list
19587224|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587225|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309116|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309117|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309118|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20309119|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20309120|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309121|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309122|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
20309123|NCT00666991|Paclitaxel|paclitaxel|mesh-list
20309124|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309125|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309126|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309127|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309128|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19587226|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
19587227|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587228|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
19587229|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587230|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
19587231|NCT02644252|Protective Agents|protective agents|mesh-ancestor
19587232|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587233|NCT02644252|Vitamins|vitamins|mesh-ancestor
19587234|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
19587235|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
19587236|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
19587237|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587238|NCT02644226|Sevoflurane|sevoflurane|mesh-list
19587239|NCT02644226|Desflurane|desflurane|mesh-list
19587240|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19587241|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19587242|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
19587243|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
19587244|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587245|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587246|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19587247|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19587248|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587249|NCT02644044|Methotrexate|methotrexate|mesh-list
19587250|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19587251|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
19587252|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587253|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587254|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19587255|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
20123707|NCT00012558|Bupropion|bupropion|mesh-list
20123708|NCT00012558|Paroxetine|paroxetine|mesh-list
20123709|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20123710|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
20123711|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587256|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587257|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587258|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587259|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587260|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19587261|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19587262|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
19587263|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587264|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19587265|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
19587266|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19587267|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
19587268|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587269|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19587270|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587271|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587272|NCT02644291|Mebendazole|mebendazole|mesh-list
19587273|NCT02644291|Piperazine|piperazine|mesh-list
19587274|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
19587275|NCT02644291|DMP 777|dmp 777|mesh-list
19587276|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
19587277|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
19587278|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19587279|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587280|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
19587281|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587282|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
19587283|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587284|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587285|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657107|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
19657108|NCT04092283|Cisplatin|cisplatin|mesh-list
19657109|NCT04092283|Carboplatin|carboplatin|mesh-list
19657110|NCT04092283|Pemetrexed|pemetrexed|mesh-list
19657111|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19657112|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
19657113|NCT04092283|Durvalumab|durvalumab|mesh-list
19657114|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
19657115|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19657116|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
19657117|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19657118|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657119|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
19657120|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
19657121|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
19657122|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657123|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19657124|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19657125|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657126|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19657127|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19657128|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20309129|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309130|NCT00667043|Fentanyl|fentanyl|mesh-list
20309131|NCT00667043|Midazolam|midazolam|mesh-list
20309132|NCT00667043|Remifentanil|remifentanil|mesh-list
20123712|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123713|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123714|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20123715|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20123716|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123717|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20123718|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20123719|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
20123720|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20123721|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
20309133|NCT00667043|Propofol|propofol|mesh-list
19657129|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
19657130|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657131|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
19657132|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
20309134|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19587286|NCT02644057|Dobutamine|dobutamine|mesh-list
19587287|NCT02644057|Milrinone|milrinone|mesh-list
19587288|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19587289|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
19587290|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
19587291|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587292|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587293|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19587294|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19587295|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19587296|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
19587297|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309135|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309136|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309137|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19587298|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587299|NCT02644057|Protective Agents|protective agents|mesh-ancestor
20123722|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20123723|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20123724|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20123725|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20123726|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20123727|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123728|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
20123729|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19587300|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19587301|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
19587302|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19587303|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19587304|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587305|NCT02643914|Nicotine|nicotine|mesh-list
19587306|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19587307|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
19587308|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587309|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587310|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19587311|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19587312|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
19587313|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587314|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587315|NCT02643563|Epinephrine|epinephrine|mesh-list
19587316|NCT02643563|Bupivacaine|bupivacaine|mesh-list
19587317|NCT02643563|Ropivacaine|ropivacaine|mesh-list
19587318|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
19587319|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
19587320|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587321|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587322|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
19587323|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587324|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19587325|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19587326|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
19587327|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587328|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587329|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19587330|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19587331|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
19587332|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19587333|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
19587334|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
19587335|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
19587336|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19587337|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19587338|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19587339|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19587340|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
19587341|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587342|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19587343|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19587344|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587345|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
19587346|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20123730|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
20309138|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
19587347|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587348|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
19587349|NCT02643823|Methotrexate|methotrexate|mesh-list
20608188|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608189|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19587350|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
19587351|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19587352|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
19587353|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587354|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587355|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19587356|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
19587357|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587358|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587359|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587360|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587361|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19587362|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19587363|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
19587364|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19587365|NCT02643719|Topiramate|topiramate|mesh-list
19587366|NCT02643719|Naproxen|naproxen|mesh-list
19587367|NCT02643719|Sumatriptan|sumatriptan|mesh-list
19587368|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19587369|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587370|NCT02643719|Analgesics|analgesics|mesh-ancestor
19587371|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
19587372|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587373|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587374|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587375|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587376|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
19587377|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19587378|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587379|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587380|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
19587381|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587382|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19587383|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19587384|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19587385|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
19587386|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587387|NCT02643732|Methylphenidate|methylphenidate|mesh-list
19587388|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19587389|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587390|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19587391|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19587392|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587393|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587394|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
19587395|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587396|NCT02643550|Cetuximab|cetuximab|mesh-list
19587397|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19587398|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587399|NCT02643602|Theophylline|theophylline|mesh-list
19587400|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19587401|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
20123731|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20123732|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20123733|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20123734|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
20123735|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
19587402|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587403|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749555|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
20123736|NCT00012558|Vitamins|vitamins|mesh-ancestor
20123737|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
20123738|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20123739|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20123740|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
20123741|NCT00012584|Methylphenidate|methylphenidate|mesh-list
20123742|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20123743|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123744|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19587404|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19587405|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
19587406|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19587407|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587408|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587409|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
19587410|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19587411|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19587412|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
19587413|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587414|NCT02643433|Vaccines|vaccines|mesh-list
19587415|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
19587416|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587417|NCT02643407|Docetaxel|docetaxel|mesh-list
19587418|NCT02643407|Nedaplatin|nedaplatin|mesh-list
19587419|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587420|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
19587421|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587422|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
19587423|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587424|NCT02643329|Gliclazide|gliclazide|mesh-list
19587425|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587426|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587427|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
19587428|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19587429|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587430|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587431|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587432|NCT02643017|Analgesics|analgesics|mesh-ancestor
19587433|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
19587434|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587435|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19587436|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19587437|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19587438|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
19587439|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587440|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587441|NCT02643173|Anesthetics|anesthetics|mesh-list
19587442|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19587443|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587444|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587445|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
19587446|NCT02643147|Furosemide|furosemide|mesh-list
19587447|NCT02643147|Diuretics|diuretics|mesh-list
19587448|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19587449|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
19587450|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587451|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587452|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587453|NCT02643186|Misoprostol|misoprostol|mesh-list
19587454|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19587455|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
19587456|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587457|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587458|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19587459|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19587460|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
19587461|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
20123745|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20123746|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20123747|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123748|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
20123749|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20123750|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20123751|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20123752|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123753|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20123754|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19587462|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19587463|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
19587464|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20123755|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
20123756|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20123757|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
19587465|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
19587466|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587467|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587468|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
19587469|NCT02642900|Nystatin|nystatin|mesh-list
19587470|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19587471|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587472|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
19587473|NCT02642900|Ionophores|ionophores|mesh-ancestor
19587474|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587475|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587476|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
19587477|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
19587478|NCT02642861|Calcium|calcium|mesh-list
19587479|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19587480|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587481|NCT02642861|Antacids|antacids|mesh-ancestor
19587482|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587483|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19587484|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19587485|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
19587486|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19587487|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19587488|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19587489|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587490|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19587491|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587492|NCT02642913|Sorafenib|sorafenib|mesh-list
19587493|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587494|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19587495|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587496|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587497|NCT02642874|Methocarbamol|methocarbamol|mesh-list
19587498|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
19587499|NCT02642874|Calcium|calcium|mesh-list
19587500|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19587501|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587502|NCT02642874|Antacids|antacids|mesh-ancestor
19587503|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587504|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19587505|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19587506|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19587507|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587508|NCT02642939|Mifepristone|mifepristone|mesh-list
19587509|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19587510|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
19587511|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587512|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587513|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19587514|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19587515|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19587516|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
19587517|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19587518|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19587519|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
19587520|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587521|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
19587522|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19587523|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19587524|NCT02642718|Ketorolac|ketorolac|mesh-list
19587525|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19587526|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19587527|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587528|NCT02642718|Analgesics|analgesics|mesh-ancestor
19587529|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
19587530|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587531|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587532|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587533|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587534|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19587535|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587536|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587537|NCT02642523|Insulin|insulin|mesh-list
19587538|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19587539|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19587540|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587541|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587542|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
19587543|NCT02642497|Ketamine|ketamine|mesh-list
19587544|NCT02642497|Analgesics|analgesics|mesh-ancestor
19587545|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
19587546|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587547|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587548|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19587549|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19587550|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
19587551|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
19587552|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587553|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19587554|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19587555|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587556|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587557|NCT02642484|Gabapentin|gabapentin|mesh-list
19587558|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
19587559|NCT02642484|Calcium|calcium|mesh-list
19587560|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19587561|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587562|NCT02642484|Analgesics|analgesics|mesh-ancestor
19587563|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
19587564|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587565|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
19587566|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19587567|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19587568|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587569|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19587570|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19587571|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19587572|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587573|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587574|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
19587575|NCT02642484|Antacids|antacids|mesh-ancestor
19587576|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19587577|NCT02642419|Aspirin|aspirin|mesh-list
19587578|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
19587579|NCT02642419|Clopidogrel|clopidogrel|mesh-list
19587580|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19587581|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19587582|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19587583|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587584|NCT02642419|Analgesics|analgesics|mesh-ancestor
19587585|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
19587586|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587587|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587588|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587589|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587590|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19587591|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19587592|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587593|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19587594|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587595|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
19587596|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19587597|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19587598|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19587599|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
19587600|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587601|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19587602|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
19587603|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19587604|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
19587605|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
19587606|NCT02642380|Dexamethasone|dexamethasone|mesh-list
19587607|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
19587608|NCT02642380|BB 1101|bb 1101|mesh-list
19587609|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587610|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
19587611|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
19587612|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587613|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587614|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19587615|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
19587616|NCT02642380|Hormones|hormones|mesh-ancestor
19587617|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587618|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19587619|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587620|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
19587621|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587622|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587623|NCT02642601|Indomethacin|indomethacin|mesh-list
19587624|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19587625|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587626|NCT02642601|Analgesics|analgesics|mesh-ancestor
19587627|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
20309139|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
20309140|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20309141|NCT00667043|Narcotics|narcotics|mesh-ancestor
20123758|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20123759|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20123760|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123761|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20123762|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
20123763|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20309142|NCT00667043|Analgesics|analgesics|mesh-ancestor
19587628|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123764|NCT00012688|Doxycycline|doxycycline|mesh-list
20123765|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20123766|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123767|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
20123768|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
20123769|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20123770|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
20123771|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20123772|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20123773|NCT00012857|Acetaminophen|acetaminophen|mesh-list
20123774|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20123775|NCT00012857|Analgesics|analgesics|mesh-ancestor
20123776|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
20123777|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123778|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123779|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
20123780|NCT00012909|Hormones|hormones|mesh-list
20123781|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123782|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123783|NCT00013520|Lamivudine|lamivudine|mesh-list
20123784|NCT00013520|Zidovudine|zidovudine|mesh-list
19587629|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587630|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587631|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587632|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
19587633|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
19587634|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587635|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19587636|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587637|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587638|NCT02642367|Rocuronium|rocuronium|mesh-list
19587639|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19587640|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19587641|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19587642|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587643|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587644|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
19587645|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
19587646|NCT02642146|Calcium|calcium|mesh-list
19587647|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
19587648|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19587649|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123785|NCT00013520|Efavirenz|efavirenz|mesh-list
20123786|NCT00013520|Nevirapine|nevirapine|mesh-list
20123787|NCT00013520|Abacavir|abacavir|mesh-list
20123788|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
20123789|NCT00013520|Stavudine|stavudine|mesh-list
19587650|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20123790|NCT00013520|Didanosine|didanosine|mesh-list
20123791|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20123792|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20309143|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
19587651|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587652|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587653|NCT02642250|Metronidazole|metronidazole|mesh-list
19587654|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587655|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19587656|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19587657|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19587658|NCT02642263|Carbetocin|carbetocin|mesh-list
19587659|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
19587660|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587661|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123793|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20123794|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20123795|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123796|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657138|NCT04072445|Trifluridine|trifluridine|mesh-list
19657139|NCT04072445|Irinotecan|irinotecan|mesh-list
19657140|NCT04072445|Camptothecin|camptothecin|mesh-list
19657141|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19657142|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19657143|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657144|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657145|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657146|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19657147|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
19657148|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
20123797|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
20309144|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657149|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657150|NCT04065113|Ethanol|ethanol|mesh-list
19657151|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19657152|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657153|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19657154|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309145|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20309146|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20123798|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123799|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123800|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123801|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
20123802|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20123803|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20123804|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19657158|NCT04052776|Levodopa|levodopa|mesh-list
19657159|NCT04052776|Carbidopa|carbidopa|mesh-list
19657160|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19657161|NCT04052776|Buspirone|buspirone|mesh-list
19657162|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19657163|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19657164|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
19657165|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19657166|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657167|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309147|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20309148|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309149|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
20309150|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
20309151|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20123805|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20123806|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20123807|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20123808|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20123809|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20123810|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
20123811|NCT00013585|Selegiline|selegiline|mesh-list
20123812|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
20123813|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20123814|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20123815|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20123816|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20309152|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309153|NCT00667056|Tacrolimus|tacrolimus|mesh-list
20309154|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657168|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20309155|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
20309156|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309157|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20309158|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309159|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309160|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20309161|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
20309162|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20309163|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
20309164|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309165|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309166|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20309167|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20309168|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309169|NCT00667082|Vorinostat|vorinostat|mesh-list
20309170|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20309171|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
20309172|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123817|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309173|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309174|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309175|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
20309176|NCT00667108|Gabapentin|gabapentin|mesh-list
20309177|NCT00667108|Analgesics|analgesics|mesh-ancestor
20309178|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
19587662|NCT02641990|Exenatide|exenatide|mesh-list
19587663|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587664|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123818|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123819|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20123820|NCT00013585|Protective Agents|protective agents|mesh-ancestor
20123821|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123822|NCT00013598|Pioglitazone|pioglitazone|mesh-list
20123823|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20123824|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587665|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19587666|NCT02641990|Incretins|incretins|mesh-ancestor
19587667|NCT02641990|Hormones|hormones|mesh-ancestor
19587668|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587669|NCT02642003|Sargramostim|sargramostim|mesh-list
19587670|NCT02642003|Lenograstim|lenograstim|mesh-list
19587671|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
19587672|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587673|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19587674|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
19587675|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19587676|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587677|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587678|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587679|NCT02641938|Analgesics|analgesics|mesh-ancestor
19587680|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
19587681|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587682|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19587683|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19587684|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19587685|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
19587686|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587687|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587688|NCT02641847|Gemcitabine|gemcitabine|mesh-list
19587689|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
19587690|NCT02641847|Docetaxel|docetaxel|mesh-list
19587691|NCT02641847|Doxorubicin|doxorubicin|mesh-list
19587692|NCT02641847|Epirubicin|epirubicin|mesh-list
19587693|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19587694|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
19587695|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123825|NCT00013624|Levodopa|levodopa|mesh-list
20123826|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20123827|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20123828|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
20123829|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20123830|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587696|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587697|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19587698|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
19587699|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587700|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587701|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19587702|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19587703|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
19587704|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
19587705|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587706|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587707|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
19587708|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587709|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
19587710|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19587711|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19587712|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19587713|NCT02641899|Acetaminophen|acetaminophen|mesh-list
19587714|NCT02641899|Exenatide|exenatide|mesh-list
19587715|NCT02641899|Digoxin|digoxin|mesh-list
19587716|NCT02641899|Lisinopril|lisinopril|mesh-list
19587717|NCT02641899|Warfarin|warfarin|mesh-list
20123831|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123832|NCT00013663|Aldesleukin|aldesleukin|mesh-list
20123833|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123834|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123835|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123836|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
20123837|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123838|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
20123839|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
20123840|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20123841|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
19587718|NCT02641899|Atorvastatin|atorvastatin|mesh-list
19587719|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19587720|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19587721|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
19587722|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587723|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19587724|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19587725|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309179|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309180|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309181|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
20309182|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20309183|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20309184|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309185|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309186|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20309187|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20309188|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309189|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309190|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
20309191|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20309192|NCT00667147|Paclitaxel|paclitaxel|mesh-list
19587726|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587727|NCT02641899|Analgesics|analgesics|mesh-ancestor
19587728|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
19587729|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587730|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587731|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
19587732|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
19587733|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20123842|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20123843|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20123844|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587734|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20123845|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20123846|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123847|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123848|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20123849|NCT00013689|Renal Agents|renal agents|mesh-ancestor
20123850|NCT00013702|Adefovir|adefovir|mesh-list
20123851|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
20123852|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587735|NCT02641899|Protective Agents|protective agents|mesh-ancestor
20123853|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19587736|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20123854|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20123855|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123856|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587737|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
19587738|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19587739|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587740|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19587741|NCT02641899|Incretins|incretins|mesh-ancestor
19587742|NCT02641899|Hormones|hormones|mesh-ancestor
19587743|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587744|NCT02641821|Nifedipine|nifedipine|mesh-list
19587745|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19587746|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587747|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587748|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19587749|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587750|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
19587751|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
19587752|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587753|NCT02641782|Aldesleukin|aldesleukin|mesh-list
19587754|NCT02641782|Interleukin-2|interleukin-2|mesh-list
19587755|NCT02641782|Tretinoin|tretinoin|mesh-list
19587756|NCT02641782|Dinutuximab|dinutuximab|mesh-list
19587757|NCT02641782|Isotretinoin|isotretinoin|mesh-list
19587758|NCT02641782|Antibodies|antibodies|mesh-list
19587759|NCT02641782|Sargramostim|sargramostim|mesh-list
19587760|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
19587761|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587762|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587763|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587764|NCT02641782|Analgesics|analgesics|mesh-ancestor
19587765|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
19587766|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587767|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
19587768|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587769|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19587770|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19587771|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
19587772|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587773|NCT02641652|Sertraline|sertraline|mesh-list
19587774|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
19587775|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19587776|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19587777|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19587778|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587779|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587780|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587781|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
19587782|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587783|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
19587784|NCT02641639|Combretastatin|combretastatin|mesh-list
19587785|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19587786|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587787|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
19587788|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587789|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
19587790|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587791|NCT02641457|Ranibizumab|ranibizumab|mesh-list
19587792|NCT02641457|Aflibercept|aflibercept|mesh-list
19587793|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19587794|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19587795|NCT02641457|Growth Substances|growth substances|mesh-ancestor
19587796|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587797|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
19587798|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587799|NCT02641210|Albendazole|albendazole|mesh-list
19587800|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
19587801|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19587802|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587803|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
20173368|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173369|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173370|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309193|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587804|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19587805|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19587806|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
19587807|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587808|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
19587809|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587810|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587811|NCT02641431|Ajmaline|ajmaline|mesh-list
19587812|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19587813|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19587814|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19587815|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587816|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587817|NCT02641301|Morphine|morphine|mesh-list
19587818|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19587819|NCT02641301|Narcotics|narcotics|mesh-ancestor
19587820|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587821|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309194|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309195|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309196|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309197|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
20309198|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309199|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
20309200|NCT00667160|Tacrolimus|tacrolimus|mesh-list
20309201|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309202|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
20309203|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587822|NCT02641301|Analgesics|analgesics|mesh-ancestor
19587823|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
19587824|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587825|NCT02641314|Celecoxib|celecoxib|mesh-list
19587826|NCT02641314|Propranolol|propranolol|mesh-list
19587827|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587828|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587829|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587830|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19587831|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587832|NCT02641314|Analgesics|analgesics|mesh-ancestor
19587833|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
19587834|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587835|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587836|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19587837|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19587838|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587839|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19587840|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19587841|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
19587842|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309204|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20309205|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309206|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309207|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20309208|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20123857|NCT00013871|Vaccines|vaccines|mesh-list
20123858|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20123859|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
20123860|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123861|NCT00013962|Vitamin D|vitamin d|mesh-list
20123862|NCT00013962|Vitamins|vitamins|mesh-ancestor
20309209|NCT00667160|Analgesics|analgesics|mesh-ancestor
20309210|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
20309211|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309212|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309213|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20309214|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587843|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19587844|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19587845|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
19587846|NCT02641288|Ropivacaine|ropivacaine|mesh-list
19587847|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
20123863|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
20123864|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123865|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20123866|NCT00014001|Olanzapine|olanzapine|mesh-list
20309215|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20123867|NCT00014001|Risperidone|risperidone|mesh-list
20123868|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19587848|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
19587849|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587850|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587851|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
19587852|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587853|NCT02641340|Fentanyl|fentanyl|mesh-list
19587854|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19587855|NCT02641340|Narcotics|narcotics|mesh-ancestor
20309216|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309217|NCT00667264|Ropivacaine|ropivacaine|mesh-list
20309218|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
19587856|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19587857|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587858|NCT02641340|Analgesics|analgesics|mesh-ancestor
19587859|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
19587860|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587861|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19587862|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19587863|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
19587864|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
19587865|NCT02641132|Mitomycins|mitomycins|mesh-list
19587866|NCT02641132|Mitomycin|mitomycin|mesh-list
19587867|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19587868|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587869|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
19587870|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587871|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19587872|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587873|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
19587874|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587875|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19587876|NCT02640989|Vaccines|vaccines|mesh-list
19587877|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
19587878|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587879|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19587880|NCT02640976|Cetrorelix|cetrorelix|mesh-list
19587881|NCT02640976|Menotropins|menotropins|mesh-list
19587882|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19587883|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587884|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19587885|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
19587886|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
19587887|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19587888|NCT02640846|Simendan|simendan|mesh-list
19587889|NCT02640846|Milrinone|milrinone|mesh-list
19587890|NCT02640846|Norepinephrine|norepinephrine|mesh-list
19587891|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19587892|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19587893|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
19587894|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587895|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587896|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587897|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
19587898|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
19587899|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587900|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19587901|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19587902|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
19587903|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19587904|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19587905|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587906|NCT02640846|Protective Agents|protective agents|mesh-ancestor
19587907|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19587908|NCT02640898|Docetaxel|docetaxel|mesh-list
19587909|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587910|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
19587911|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
19587912|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
20309219|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
19587913|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587914|NCT02641054|Levodopa|levodopa|mesh-list
19587915|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19587916|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19587917|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
19587918|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587919|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587920|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587921|NCT02640833|Venetoclax|venetoclax|mesh-list
19587922|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587923|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19587924|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
19587925|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587926|NCT02640794|Aspirin|aspirin|mesh-list
19587927|NCT02640794|Clopidogrel|clopidogrel|mesh-list
19587928|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19587929|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19587930|NCT02640794|Analgesics|analgesics|mesh-ancestor
19587931|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
19587932|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19587933|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587934|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19587935|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19587936|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19587937|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19587938|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587939|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19587940|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19587941|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587942|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
19587943|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20309220|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309221|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309222|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
20309223|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309224|NCT00667303|Antibodies|antibodies|mesh-list
20309225|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
20309226|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309227|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20309228|NCT00667407|Albuterol|albuterol|mesh-list
20309229|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19587944|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20123869|NCT00014001|Ziprasidone|ziprasidone|mesh-list
20123870|NCT00014001|Clozapine|clozapine|mesh-list
20123871|NCT00014001|Perphenazine|perphenazine|mesh-list
20123872|NCT00014001|Fluphenazine|fluphenazine|mesh-list
20123873|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
20123874|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
20123875|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20123876|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
20123877|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20123878|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123879|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123880|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20123881|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20123882|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20123883|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20123884|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19587945|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19587946|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
19587947|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19587948|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
19587949|NCT02640417|Vitamins|vitamins|mesh-ancestor
19587950|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
19587951|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587952|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
19587953|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19587954|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19587955|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587956|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
19587957|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
19587958|NCT02640495|Artesunate|artesunate|mesh-list
19587959|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
20309230|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
19587960|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19587961|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20123885|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
20123886|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
20123887|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
20123888|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123889|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20123890|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20123891|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20123892|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19587962|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19587963|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587964|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
19587965|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
19587966|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19587967|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
19587968|NCT02640508|Lenvatinib|lenvatinib|mesh-list
19587969|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587970|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19587971|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587972|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587973|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
19587974|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309231|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309232|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309233|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20309234|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
20309235|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
20309236|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309237|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20309238|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20309239|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20309240|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
20309241|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309242|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309243|NCT00667433|Tenofovir|tenofovir|mesh-list
20309244|NCT00667433|Emtricitabine|emtricitabine|mesh-list
20309245|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
20309246|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20309247|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
20309248|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309249|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20309250|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20309251|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309252|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309253|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20309254|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20309255|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19587975|NCT02640534|Metformin|metformin|mesh-list
19587976|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19587977|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657169|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657170|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19657171|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19657172|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19657173|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19657174|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19657175|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
19657176|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19657177|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
19657178|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
19657179|NCT04035187|Itraconazole|itraconazole|mesh-list
19657180|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19657181|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19657182|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
19657183|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657184|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19657185|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19657186|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657187|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123893|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
20123894|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
20309256|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20309257|NCT00667472|Ranibizumab|ranibizumab|mesh-list
20309258|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20309259|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19657188|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19657189|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
20123895|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
19587978|NCT02640365|Leucovorin|leucovorin|mesh-list
19587979|NCT02640365|Bevacizumab|bevacizumab|mesh-list
19587980|NCT02640365|Irinotecan|irinotecan|mesh-list
19587981|NCT02640365|Camptothecin|camptothecin|mesh-list
19587982|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19587983|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19587984|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19587985|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19587986|NCT02640365|Growth Substances|growth substances|mesh-ancestor
19587987|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19587988|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
19587989|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19587990|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19587991|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19587992|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19587993|NCT02640365|Antidotes|antidotes|mesh-ancestor
19587994|NCT02640365|Protective Agents|protective agents|mesh-ancestor
19587995|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
19587996|NCT02640365|Vitamins|vitamins|mesh-ancestor
19587997|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
19587998|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19587999|NCT02640313|Choline|choline|mesh-list
19588000|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
19588001|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19588002|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
19588003|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588004|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588005|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19588006|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
19588007|NCT02640300|Clozapine|clozapine|mesh-list
19588008|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19588009|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
19588010|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588011|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588012|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588013|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19588014|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588015|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588016|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588017|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
19588018|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
19588019|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
19588020|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19588021|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
19588022|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588023|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
19588024|NCT02640144|Protective Agents|protective agents|mesh-ancestor
19588025|NCT02640118|Lixisenatide|lixisenatide|mesh-list
19588026|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19588027|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588028|NCT02639858|Docetaxel|docetaxel|mesh-list
19588029|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588030|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
19588031|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
19588032|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
19588033|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123896|NCT00014014|Lamivudine|lamivudine|mesh-list
20123897|NCT00014014|Zidovudine|zidovudine|mesh-list
20123898|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20123899|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20123900|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20123901|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123902|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123903|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
20123904|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123905|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123906|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123907|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
20123908|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
20123909|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20123910|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
20309260|NCT00667472|Growth Substances|growth substances|mesh-ancestor
19588034|NCT02639767|Pemetrexed|pemetrexed|mesh-list
19588035|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588036|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123911|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588037|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588038|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19588039|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19588040|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
19588041|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19588042|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19588043|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588044|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
19588045|NCT02639819|Coagulants|coagulants|mesh-ancestor
19588046|NCT02639806|Lidocaine|lidocaine|mesh-list
19588047|NCT02639806|Sevoflurane|sevoflurane|mesh-list
19588048|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
19588049|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
19588050|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588051|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588052|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
19588053|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588054|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19588055|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19588056|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19588057|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588058|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588059|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19588060|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19588061|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
19588062|NCT02639741|Vitamins|vitamins|mesh-list
19588063|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
19588064|NCT02639741|Melatonin|melatonin|mesh-list
19588065|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
19588066|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588067|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
19588068|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588069|NCT02639741|Protective Agents|protective agents|mesh-ancestor
19588070|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588071|NCT02639650|Dactinomycin|dactinomycin|mesh-list
19588072|NCT02639650|Paclitaxel|paclitaxel|mesh-list
19588073|NCT02639650|Etoposide|etoposide|mesh-list
19588074|NCT02639650|Vincristine|vincristine|mesh-list
19588075|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
19588076|NCT02639650|Carboplatin|carboplatin|mesh-list
19588077|NCT02639650|Methotrexate|methotrexate|mesh-list
19588078|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19588079|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588080|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
19588081|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
19588082|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
19588083|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588084|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19588085|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
19588086|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588087|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588088|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19588089|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
19588090|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19588091|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19588092|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
20309261|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588093|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588094|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19588095|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
19588096|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
19588097|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588098|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19588099|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19588100|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19588101|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19588102|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588103|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588104|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19588105|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19588106|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
19588107|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19588108|NCT02639533|Pregabalin|pregabalin|mesh-list
19588109|NCT02639533|Analgesics|analgesics|mesh-ancestor
20309262|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
19588110|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
19588111|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588112|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588113|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
19588114|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19588115|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588116|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588117|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19588118|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19588119|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588120|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588121|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588122|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
19588123|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19588124|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19588125|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588126|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
19588127|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
19588128|NCT02639598|Topiramate|topiramate|mesh-list
19588129|NCT02639598|Flunarizine|flunarizine|mesh-list
19588130|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
19588131|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19588132|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123912|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123913|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20123914|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
20123915|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20123916|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
20123917|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123918|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20123919|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20123920|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
20123921|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
20123922|NCT00014040|Protective Agents|protective agents|mesh-ancestor
20123923|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
20123924|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
20123925|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20123926|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
20123927|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309263|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309264|NCT00667485|Sirolimus|sirolimus|mesh-list
20309265|NCT00667485|Bevacizumab|bevacizumab|mesh-list
20309266|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20309267|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309268|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19588133|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19588134|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588135|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588136|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19588137|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19588138|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
19588139|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
19588140|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588141|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19588142|NCT02639520|Fosfomycin|fosfomycin|mesh-list
19588143|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588144|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588145|NCT02639143|Clopidogrel|clopidogrel|mesh-list
20309269|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20309270|NCT00667485|Growth Substances|growth substances|mesh-ancestor
20309271|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309272|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
20309273|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309274|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309275|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20309276|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
20309277|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309278|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
20309279|NCT00667498|Metformin|metformin|mesh-list
20309280|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20309281|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309282|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20309283|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309284|NCT00667641|Paclitaxel|paclitaxel|mesh-list
20309285|NCT00667641|Bortezomib|bortezomib|mesh-list
19588146|NCT02639143|Ticagrelor|ticagrelor|mesh-list
19749556|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20123928|NCT00014092|Interferons|interferons|mesh-list
20309286|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309287|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309288|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309289|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309290|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
20309291|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588147|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19588148|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19588149|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19588150|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19588151|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
19588152|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588153|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588154|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588155|NCT02639065|Durvalumab|durvalumab|mesh-list
19588156|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19588157|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588158|NCT02639234|Nivolumab|nivolumab|mesh-list
19588159|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19588160|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588161|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19588162|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588163|NCT02639039|Cortisone|cortisone|mesh-list
19588164|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19588165|NCT02639091|Pemetrexed|pemetrexed|mesh-list
19588166|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588167|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588168|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588169|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19588170|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19588171|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19588172|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19588173|NCT02638922|Trisequens|trisequens|mesh-list
19588174|NCT02638922|Norethindrone|norethindrone|mesh-list
19588175|NCT02638922|Estradiol|estradiol|mesh-list
19588176|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19588177|NCT02638922|Estrogens|estrogens|mesh-ancestor
19588178|NCT02638922|Hormones|hormones|mesh-ancestor
19588179|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19588180|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588181|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19588182|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
19588183|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588184|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19588185|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19588186|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19588187|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19588188|NCT02638909|Ceritinib|ceritinib|mesh-list
19588189|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123929|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
20123930|NCT00014092|Aldesleukin|aldesleukin|mesh-list
20123931|NCT00014092|Temozolomide|temozolomide|mesh-list
20123932|NCT00014092|Sargramostim|sargramostim|mesh-list
20123933|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123934|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
20123935|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123936|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123937|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
20123938|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123939|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
20123940|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123941|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20123942|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20123943|NCT00014105|Carboplatin|carboplatin|mesh-list
20123944|NCT00014105|Temozolomide|temozolomide|mesh-list
20123945|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123946|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20123947|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
20123948|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123949|NCT00014118|Paclitaxel|paclitaxel|mesh-list
20123950|NCT00014118|Carboplatin|carboplatin|mesh-list
20123951|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309292|NCT00667758|Cetrorelix|cetrorelix|mesh-list
20123952|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309293|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20309294|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
20309295|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309296|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309297|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
20309298|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19588190|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19588191|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588192|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588193|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
19588194|NCT02638896|Celecoxib|celecoxib|mesh-list
19588195|NCT02638896|Etanercept|etanercept|mesh-list
19588196|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19588197|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19588198|NCT02638896|Analgesics|analgesics|mesh-ancestor
19588199|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
19588200|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588201|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588202|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19588203|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588204|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19588205|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19588206|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588207|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588208|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588209|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19588210|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
19588211|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588212|NCT02638870|Amitriptyline|amitriptyline|mesh-list
19588213|NCT02638870|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19588214|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19588215|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
19588216|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588217|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19588218|NCT02638870|Analgesics|analgesics|mesh-ancestor
19588219|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
19588220|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588221|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588222|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19588223|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19588224|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588225|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588226|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
19588227|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588228|NCT02638870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19588229|NCT02638870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588230|NCT02638870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588231|NCT02638857|Epirubicin|epirubicin|mesh-list
19588232|NCT02638857|Mitomycins|mitomycins|mesh-list
19588233|NCT02638857|Mitomycin|mitomycin|mesh-list
19588234|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
19588235|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19588236|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588237|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19588238|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19588239|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588240|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588241|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
19588242|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19588243|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
19588244|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19588245|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588246|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588247|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19588248|NCT02638545|Analgesics|analgesics|mesh-ancestor
19588249|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
19588250|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588251|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19588252|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19588253|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19588254|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
19588255|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588256|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588257|NCT02638831|Ketorolac|ketorolac|mesh-list
19588258|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19588259|NCT02638831|Ketoprofen|ketoprofen|mesh-list
19588260|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19588261|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19588262|NCT02638831|Analgesics|analgesics|mesh-ancestor
19588263|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
19588264|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588265|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123953|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
20123954|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
20123955|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19588266|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123956|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123957|NCT00014144|Gefitinib|gefitinib|mesh-list
20123958|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123959|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20123960|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123961|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123962|NCT00014170|Gefitinib|gefitinib|mesh-list
19588267|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588268|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19588269|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588270|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588271|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
19588272|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
19588273|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588274|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19588275|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657190|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19657191|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657192|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20123963|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123964|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20123965|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123966|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123967|NCT00014183|Gefitinib|gefitinib|mesh-list
20123968|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123969|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20123970|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123971|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123972|NCT00014196|Docetaxel|docetaxel|mesh-list
20123973|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123974|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
20123975|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
19657206|NCT04026256|Denosumab|denosumab|mesh-list
19657207|NCT04026256|Teriparatide|teriparatide|mesh-list
19657208|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19657209|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657210|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20123976|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
20123977|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657213|NCT04017013|Lidocaine|lidocaine|mesh-list
19657214|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
19657215|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
19657216|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19657217|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657218|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
19657219|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657220|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19657221|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19657222|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19657223|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19657224|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657225|NCT04003610|Gemcitabine|gemcitabine|mesh-list
19657226|NCT04003610|Carboplatin|carboplatin|mesh-list
19657227|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
19657228|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657229|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19657230|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
19657231|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123978|NCT00014209|Gemcitabine|gemcitabine|mesh-list
20123979|NCT00014209|Dexamethasone|dexamethasone|mesh-list
19588276|NCT02638519|Xenon|xenon|mesh-list
19588277|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19588278|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
19588279|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
19588280|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588281|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588282|NCT02638506|Fentanyl|fentanyl|mesh-list
19588283|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19588284|NCT02638506|Narcotics|narcotics|mesh-ancestor
19588285|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588286|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588287|NCT02638506|Analgesics|analgesics|mesh-ancestor
19588288|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
19588289|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588290|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19588291|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588292|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
19588293|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
19588294|NCT02638389|Sirolimus|sirolimus|mesh-list
19588295|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588296|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588297|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19588298|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588299|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
19588300|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19588301|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
19588302|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588303|NCT02638428|Cytarabine|cytarabine|mesh-list
19588304|NCT02638428|Carboplatin|carboplatin|mesh-list
19588305|NCT02638428|Trastuzumab|trastuzumab|mesh-list
19588306|NCT02638428|Fludarabine|fludarabine|mesh-list
19588307|NCT02638428|Etoposide|etoposide|mesh-list
19588308|NCT02638428|Everolimus|everolimus|mesh-list
19588309|NCT02638428|Sorafenib|sorafenib|mesh-list
19588310|NCT02638428|Ifosfamide|ifosfamide|mesh-list
19588311|NCT02638428|Dasatinib|dasatinib|mesh-list
19588312|NCT02638428|Axitinib|axitinib|mesh-list
19588313|NCT02638428|Vemurafenib|vemurafenib|mesh-list
19588314|NCT02638428|Crizotinib|crizotinib|mesh-list
19588315|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588316|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19588317|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19588318|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
19588319|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588320|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19588321|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
19588322|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588323|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19588324|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19588325|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19588326|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588327|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
19588328|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588329|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19588330|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19588331|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
19588332|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
19588333|NCT02638233|Ledipasvir|ledipasvir|mesh-list
19588334|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
19588335|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588336|NCT02638376|Riboflavin|riboflavin|mesh-list
19588337|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19588338|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19588339|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
19588340|NCT02638376|Vitamins|vitamins|mesh-ancestor
19588341|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
19588342|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588343|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19588344|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
19588345|NCT02638584|Rabeprazole|rabeprazole|mesh-list
19588346|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19588347|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588348|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19588349|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588350|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588351|NCT02638415|Carvedilol|carvedilol|mesh-list
19588352|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19588353|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19588354|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
19588355|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588356|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588357|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588358|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19588359|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
19588360|NCT02638415|Protective Agents|protective agents|mesh-ancestor
19588361|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19588362|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588363|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19588364|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
19588365|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19588366|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19588367|NCT02638285|Clomiphene|clomiphene|mesh-list
19588368|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19588369|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
19588370|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19588371|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588372|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19588373|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
19588374|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588375|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19588376|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19588377|NCT02638064|Surgiflo|surgiflo|mesh-list
19588378|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
19588379|NCT02638064|Coagulants|coagulants|mesh-ancestor
19588380|NCT02638142|Furosemide|furosemide|mesh-list
19588381|NCT02638142|Diuretics|diuretics|mesh-ancestor
19588382|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
19588383|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588384|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19588385|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588386|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588387|NCT02638116|Omeprazole|omeprazole|mesh-list
19588388|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19588389|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588390|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20123980|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123981|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20123982|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
19588391|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588392|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588393|NCT02637973|Empagliflozin|empagliflozin|mesh-list
19588394|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19588395|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588396|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19588397|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588398|NCT02637830|Fluorides|fluorides|mesh-list
19588399|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
19588400|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
19588401|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
19588402|NCT02637830|Protective Agents|protective agents|mesh-ancestor
19588403|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588404|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
19588405|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19588406|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588407|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
19588408|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
19588409|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588410|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588411|NCT02637726|Remifentanil|remifentanil|mesh-list
19588412|NCT02637726|Propofol|propofol|mesh-list
19588413|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19588414|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588415|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588416|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588417|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
19588418|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
19588419|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19588420|NCT02637726|Narcotics|narcotics|mesh-ancestor
19588421|NCT02637726|Analgesics|analgesics|mesh-ancestor
19588422|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
19588423|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588424|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
19588425|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19588426|NCT02637700|Antibodies|antibodies|mesh-list
20123983|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
19588427|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
19588428|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19588429|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
19588430|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588431|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19588432|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
19588433|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588434|NCT02637466|Vortioxetine|vortioxetine|mesh-list
19588435|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
19588436|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588437|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19588438|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588439|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588440|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588441|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19588442|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19588443|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588444|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588445|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588446|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
19588447|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19588448|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19588449|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19588450|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19588451|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
19588452|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19588453|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
19588454|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588455|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
19588456|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588457|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19588458|NCT02637284|BPC 157|bpc 157|mesh-list
19588459|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19588460|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588461|NCT02637375|Paclitaxel|paclitaxel|mesh-list
19588462|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
19588463|NCT02637375|Doxorubicin|doxorubicin|mesh-list
19588464|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19588465|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20123984|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20123985|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20123986|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20123987|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
20123988|NCT00014209|Hormones|hormones|mesh-ancestor
20123989|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20123990|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20123991|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20123992|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
20123993|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20123994|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
20123995|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20123996|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20123997|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20123998|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
20123999|NCT00014235|Cyclosporine|cyclosporine|mesh-list
19588466|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
19588467|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
19588468|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
19588469|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588470|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19588471|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
19588472|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588473|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588474|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19588475|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
19588476|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19588477|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19588478|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19588479|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19588480|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588481|NCT02637167|Rifaximin|rifaximin|mesh-list
19588482|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588483|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588484|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588485|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
19588486|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19588487|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588488|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588489|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19588490|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19588491|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309299|NCT00667771|Naltrexone|naltrexone|mesh-list
20309300|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20309301|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20309302|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309303|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
20309304|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309305|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20309306|NCT00667797|Albuterol|albuterol|mesh-list
20309307|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20309308|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
19588492|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588493|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588494|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588495|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19588496|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19588497|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588498|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588499|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19588500|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
19588501|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588502|NCT02637128|Artesunate|artesunate|mesh-list
19588503|NCT02637128|Lumefantrine|lumefantrine|mesh-list
19588504|NCT02637128|Artemether|artemether|mesh-list
19588505|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19588506|NCT02637128|Amodiaquine|amodiaquine|mesh-list
19588507|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
19588508|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19588509|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19588510|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588511|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588512|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
19588513|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
19588514|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19588515|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
19588516|NCT02636816|Carbetocin|carbetocin|mesh-list
19588517|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
19588518|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588519|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588520|NCT02636803|Albendazole|albendazole|mesh-list
19588521|NCT02636803|Oxfendazole|oxfendazole|mesh-list
19588522|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
19588523|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19588524|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588525|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
19588526|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19588527|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19588528|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
19588529|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
19588530|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124000|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
20124001|NCT00014235|Fludarabine|fludarabine|mesh-list
20124002|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
20124003|NCT00014235|Cyclosporins|cyclosporins|mesh-list
20124004|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124005|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124006|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
20124007|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124008|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124009|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
20124010|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124011|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124012|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
20124013|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588531|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588532|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588533|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
19588534|NCT02636829|Calcium|calcium|mesh-list
19657232|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
20124014|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124015|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588535|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19588536|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657233|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657234|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657235|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657236|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
19657237|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657238|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20124016|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20124017|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20124018|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20124019|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
20124020|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20124021|NCT00014248|Adenosine|adenosine|mesh-list
20124022|NCT00014248|Analgesics|analgesics|mesh-ancestor
20124023|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
20124024|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124025|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124026|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20124027|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
20124028|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20124029|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
20124030|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
20124031|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124032|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124033|NCT00014261|Interferons|interferons|mesh-list
20124034|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
20124035|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
20124036|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20124037|NCT00014261|Temozolomide|temozolomide|mesh-list
20124038|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124039|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
20124040|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124041|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124042|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
20124043|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124044|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
20124045|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124046|NCT00014274|Gemcitabine|gemcitabine|mesh-list
20124047|NCT00014274|Carboplatin|carboplatin|mesh-list
20124048|NCT00014274|Methotrexate|methotrexate|mesh-list
20124049|NCT00014274|Vinblastine|vinblastine|mesh-list
20124050|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124051|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124052|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
20309309|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309310|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309311|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20309312|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
19657269|NCT03981744|Ustekinumab|ustekinumab|mesh-list
19657270|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124053|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124054|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
20124055|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124056|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124057|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124058|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
20124059|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124060|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20124061|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
20124062|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20124063|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124064|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20124065|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124066|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20124067|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124068|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124069|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124070|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124071|NCT00014287|Gemcitabine|gemcitabine|mesh-list
20124072|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124073|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
20124074|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124075|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588537|NCT02636842|Aripiprazole|aripiprazole|mesh-list
19588538|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
19588539|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
19588540|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588541|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19588542|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588543|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588544|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588545|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
19588546|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
19588547|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588548|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588549|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19588550|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19588551|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
19588552|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19588553|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19588554|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19588555|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19588556|NCT02636426|Sorafenib|sorafenib|mesh-list
19588557|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588558|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19588559|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588560|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588561|NCT02636491|Insulin|insulin|mesh-list
19588562|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19588563|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19588564|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588565|NCT02636231|Endostatins|endostatins|mesh-list
19588566|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19588567|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19588568|NCT02636231|Growth Substances|growth substances|mesh-ancestor
19588569|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588570|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
19588571|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588572|NCT02636218|Ketamine|ketamine|mesh-list
19588573|NCT02636218|Analgesics|analgesics|mesh-ancestor
19588574|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
19588575|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588576|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588577|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19588578|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588579|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
19588580|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
19588581|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588582|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19588583|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19588584|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588585|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588586|NCT02636348|Vitamin D|vitamin d|mesh-list
19588587|NCT02636348|Calcium|calcium|mesh-list
19588588|NCT02636348|Vitamins|vitamins|mesh-ancestor
19588589|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
19588590|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588591|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19588592|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20124076|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
20124077|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124078|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124079|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124080|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
19588599|NCT02636101|Betamethasone|betamethasone|mesh-list
19588600|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
19588601|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19588602|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
19588603|NCT02636101|Calcipotriene|calcipotriene|mesh-list
19588604|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19588605|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19588606|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
20124081|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588607|NCT02636101|Hormones|hormones|mesh-ancestor
19588608|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19588609|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588610|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19588611|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
19588612|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
19588613|NCT02636088|Cetuximab|cetuximab|mesh-list
19588614|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19588615|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588616|NCT02635841|Deferiprone|deferiprone|mesh-list
19588617|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19588618|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
19588619|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
19588620|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588621|NCT02635802|Lidocaine|lidocaine|mesh-list
19588622|NCT02635802|Midazolam|midazolam|mesh-list
19588623|NCT02635802|Remifentanil|remifentanil|mesh-list
19588624|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
19588625|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
19588626|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588627|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588628|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
19588629|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588630|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19588631|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19588632|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19588633|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588634|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588635|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19588636|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19588637|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19588638|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20124082|NCT00014313|Etoposide|etoposide|mesh-list
20124083|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124084|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124085|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124086|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19588639|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588640|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588641|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
19588642|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
19588643|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
19588644|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588645|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19588646|NCT02635802|Narcotics|narcotics|mesh-ancestor
19588647|NCT02635802|Analgesics|analgesics|mesh-ancestor
19588648|NCT02635971|Gemcitabine|gemcitabine|mesh-list
19588649|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
19588650|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19588651|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
19588652|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588653|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588654|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
19588655|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588656|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588657|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19588658|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
19588659|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588660|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19588661|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19588662|NCT02635607|Ganirelix|ganirelix|mesh-list
19588663|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
19588664|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19588665|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
19588666|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588667|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124087|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124088|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124089|NCT00014339|Prednisone|prednisone|mesh-list
19588668|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19588669|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19588670|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588671|NCT02635607|Hormones|hormones|mesh-ancestor
20309313|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
19588672|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124090|NCT00014339|Melphalan|melphalan|mesh-list
19588673|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
19588674|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
19588675|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19588676|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588677|NCT02635750|Donepezil|donepezil|mesh-list
19588678|NCT02635750|BI 409306|bi 409306|mesh-list
19588679|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19588680|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588681|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588682|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
19588683|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588684|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588685|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
19588686|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19588687|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
19588688|NCT02635867|Calcium|calcium|mesh-list
19588689|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19588690|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588691|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19588692|NCT02635893|Cycloserine|cycloserine|mesh-list
19588693|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19588694|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588695|NCT02635893|Renal Agents|renal agents|mesh-ancestor
19588696|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19588697|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
19588698|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588699|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
19588700|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124091|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20124092|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
20124093|NCT00014339|Hormones|hormones|mesh-ancestor
20124094|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124095|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124096|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20124097|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124098|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124099|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
20124100|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124101|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20124102|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124103|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
19588701|NCT02635555|Phenylephrine|phenylephrine|mesh-list
19588702|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
19588703|NCT02635555|Ephedrine|ephedrine|mesh-list
19588704|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19588705|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
19588706|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
19588707|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588708|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588709|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
19588710|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19588711|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
19588712|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
19588713|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19588714|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19588715|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19588716|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
19588717|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588718|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588719|NCT02635555|Protective Agents|protective agents|mesh-ancestor
20124104|NCT00014352|Ketoconazole|ketoconazole|mesh-list
20124105|NCT00014352|Docetaxel|docetaxel|mesh-list
20124106|NCT00014352|Doxorubicin|doxorubicin|mesh-list
20124107|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20124108|NCT00014352|Estramustine|estramustine|mesh-list
20124109|NCT00014352|Warfarin|warfarin|mesh-list
20124110|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124111|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
19588720|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19588721|NCT02635243|Glucagon|glucagon|mesh-list
20124112|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
19588722|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588723|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588724|NCT02635243|Hormones|hormones|mesh-ancestor
20124113|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124114|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588725|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19588726|NCT02635334|Montelukast|montelukast|mesh-list
19588727|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19588728|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
19588729|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19588730|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
19588731|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19588732|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588733|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19588734|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19588735|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588736|NCT02635230|Aspirin|aspirin|mesh-list
20124115|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20124116|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124117|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124118|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124119|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
20124120|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
20124121|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124122|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20124123|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20124124|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20124125|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
20124126|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124127|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124128|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20124129|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124130|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
20309314|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309315|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19588737|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19588738|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19588739|NCT02635230|Analgesics|analgesics|mesh-ancestor
19588740|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
19588741|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588742|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588743|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19588744|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588745|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19588746|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19588747|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588748|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19588749|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19588750|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588751|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
19588752|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
19588753|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588754|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19588755|NCT02635282|Fentanyl|fentanyl|mesh-list
19588756|NCT02635282|Midazolam|midazolam|mesh-list
19588757|NCT02635282|Ketamine|ketamine|mesh-list
19588758|NCT02635282|Analgesics|analgesics|mesh-ancestor
19588759|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
19588760|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588761|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588762|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19588763|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588764|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
19588765|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
19588766|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588767|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19588768|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19588769|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588770|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588771|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19588772|NCT02635282|Narcotics|narcotics|mesh-ancestor
19588773|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19588774|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19588775|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19588776|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588777|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588778|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
19588779|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
19588780|NCT02635074|Cytarabine|cytarabine|mesh-list
19588781|NCT02635074|Idarubicin|idarubicin|mesh-list
19588782|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19588783|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
19588784|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588785|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588786|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
19588787|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588788|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19588789|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
19588790|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588791|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19588792|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19588793|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19588794|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588795|NCT02635191|Amoxicillin|amoxicillin|mesh-list
19588796|NCT02635191|Metronidazole|metronidazole|mesh-list
19588797|NCT02635191|Clarithromycin|clarithromycin|mesh-list
19588798|NCT02635191|Esomeprazole|esomeprazole|mesh-list
19588799|NCT02635191|Omeprazole|omeprazole|mesh-list
19588800|NCT02635191|Rabeprazole|rabeprazole|mesh-list
19588801|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588802|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588803|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19588804|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19588805|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19588806|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588807|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19588808|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588809|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588810|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19588811|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19588812|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20124131|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20124132|NCT00014391|Ribavirin|ribavirin|mesh-list
20124133|NCT00014391|Palivizumab|palivizumab|mesh-list
20124134|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
20124135|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124136|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
20124137|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124138|NCT00014404|Celecoxib|celecoxib|mesh-list
20124139|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20124140|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20124141|NCT00014404|Analgesics|analgesics|mesh-ancestor
20124142|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
20124143|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124144|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124145|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20124146|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124147|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20124148|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20124149|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124150|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124151|NCT00014430|Trastuzumab|trastuzumab|mesh-list
20124152|NCT00014430|Vinorelbine|vinorelbine|mesh-list
20124153|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20124154|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124155|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124156|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124157|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124158|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124159|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124160|NCT00014443|Thalidomide|thalidomide|mesh-list
20124161|NCT00014443|Topotecan|topotecan|mesh-list
20124162|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20124163|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124164|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124165|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124166|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124167|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124168|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
20124169|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124170|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
20124171|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20124172|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124173|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20124174|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20124175|NCT00014443|Growth Substances|growth substances|mesh-ancestor
20124176|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124177|NCT00014456|Gemcitabine|gemcitabine|mesh-list
20124178|NCT00014456|Docetaxel|docetaxel|mesh-list
20124179|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124180|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
19588813|NCT02635061|Nivolumab|nivolumab|mesh-list
19588814|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19588815|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588816|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19588817|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588818|NCT02634970|Ranibizumab|ranibizumab|mesh-list
20124181|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124182|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124183|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
20124184|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124185|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124186|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309316|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19588819|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19588820|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19588821|NCT02634970|Growth Substances|growth substances|mesh-ancestor
19588822|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588823|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
19588824|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588825|NCT02634723|Factor VIII|factor viii|mesh-list
19588826|NCT02634723|Coagulants|coagulants|mesh-ancestor
19588827|NCT02634541|Adalimumab|adalimumab|mesh-list
19588828|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19588829|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588830|NCT02634489|Tamsulosin|tamsulosin|mesh-list
19588831|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
19588832|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19588833|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19588834|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19588835|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
19588836|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588837|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588838|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588839|NCT02634489|Urological Agents|urological agents|mesh-ancestor
19588840|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19588841|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19588842|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
20309317|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20309318|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
20309319|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588843|NCT02634476|Ethanol|ethanol|mesh-list
19588844|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19588845|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588846|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588847|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588848|NCT02634528|Insulin|insulin|mesh-list
19588849|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19588850|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
19588851|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
19588852|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
19588853|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19588854|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588855|NCT02634463|Olanzapine|olanzapine|mesh-list
19588856|NCT02634463|Risperidone|risperidone|mesh-list
19588857|NCT02634463|Aripiprazole|aripiprazole|mesh-list
19588858|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19588859|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19588860|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
19588861|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588862|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588863|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588864|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19588865|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588866|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588867|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588868|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20124187|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
19588869|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
20309320|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309321|NCT00667901|Riluzole|riluzole|mesh-list
20309322|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
19588870|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
19588871|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
19588872|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588873|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19588874|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19588875|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124188|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124189|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124190|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
19588876|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19588877|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
19588878|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
19588879|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19588880|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19588881|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19588882|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19588883|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
20309323|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20309324|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20309325|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309326|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309327|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588884|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19588885|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
19588886|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588887|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588888|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19588889|NCT02634294|Interferons|interferons|mesh-list
19588890|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
19588891|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
19588892|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19588893|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19588894|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
19588895|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588896|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
19588897|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588898|NCT02634515|Insulin|insulin|mesh-list
19588899|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19588900|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19588901|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588902|NCT02634281|Varenicline|varenicline|mesh-list
19588903|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19588904|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19588905|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
19588906|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588907|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588908|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588909|NCT02634255|Fentanyl|fentanyl|mesh-list
19588910|NCT02634255|Propofol|propofol|mesh-list
19588911|NCT02634255|Rocuronium|rocuronium|mesh-list
19588912|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19588913|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588914|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588915|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588916|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
19588917|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
19588918|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19588919|NCT02634255|Narcotics|narcotics|mesh-ancestor
19588920|NCT02634255|Analgesics|analgesics|mesh-ancestor
19588921|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
19588922|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588923|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19588924|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19588925|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20124191|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124192|NCT00014469|Methotrexate|methotrexate|mesh-list
20124193|NCT00014469|Melphalan|melphalan|mesh-list
20124194|NCT00014469|Busulfan|busulfan|mesh-list
20124195|NCT00014469|Tacrolimus|tacrolimus|mesh-list
20124196|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20124197|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
20124198|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588926|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19588927|NCT02634034|Pitavastatin|pitavastatin|mesh-list
19588928|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19588929|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19588930|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19588931|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
19588932|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588933|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588934|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19588935|NCT02634203|Riociguat|riociguat|mesh-list
19588936|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
19588937|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588938|NCT02634021|Midazolam|midazolam|mesh-list
19588939|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
19588940|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19588941|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19588942|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588943|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19588944|NCT02634021|Analgesics|analgesics|mesh-ancestor
19588945|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
19588946|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588947|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19588948|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19588949|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19588950|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
19588951|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19588952|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588953|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19588954|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19588955|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19588956|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19588957|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19588958|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
19588959|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
19588960|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
19588961|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
19588962|NCT02633969|Indomethacin|indomethacin|mesh-list
19588963|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19588964|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19588965|NCT02633969|Analgesics|analgesics|mesh-ancestor
19588966|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
19588967|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19588968|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19588969|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19588970|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19588971|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
19588972|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
19588973|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19588974|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19588975|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588976|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588977|NCT02634008|Ritonavir|ritonavir|mesh-list
19588978|NCT02634008|Ribavirin|ribavirin|mesh-list
19588979|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19588980|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19588981|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
19588982|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19588983|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19588984|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19588985|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19588986|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
19588987|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588988|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19588989|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19588990|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
19588991|NCT02633930|Amoxicillin|amoxicillin|mesh-list
19588992|NCT02633930|Clarithromycin|clarithromycin|mesh-list
20124199|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124200|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124201|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
20124202|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124203|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124204|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124205|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124206|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20309328|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19588993|NCT02633930|Lansoprazole|lansoprazole|mesh-list
19588994|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
19588995|NCT02633930|Bismuth|bismuth|mesh-list
19588996|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19588997|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19588998|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19588999|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589000|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589001|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19589002|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19589003|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19589004|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589005|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19589006|NCT02633930|Antacids|antacids|mesh-ancestor
19589007|NCT02633995|Anesthetics|anesthetics|mesh-list
19589008|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589009|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589010|NCT02633878|Progesterone|progesterone|mesh-list
19589011|NCT02633878|Progestins|progestins|mesh-ancestor
19589012|NCT02633878|Hormones|hormones|mesh-ancestor
19589013|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589014|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589015|NCT02633696|Silybin|silybin|mesh-list
19589016|NCT02633696|Silymarin|silymarin|mesh-list
19589017|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
20309329|NCT00667901|Protective Agents|protective agents|mesh-ancestor
20309330|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
20309331|NCT00667927|Busulfan|busulfan|mesh-list
20309332|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309333|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
20309334|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309335|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20309336|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20309337|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
20309338|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309339|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309340|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19589018|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589019|NCT02633696|Protective Agents|protective agents|mesh-ancestor
19589020|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589021|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589022|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589023|NCT02633683|Gabapentin|gabapentin|mesh-list
19589024|NCT02633683|Analgesics|analgesics|mesh-ancestor
19589025|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
19589026|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589027|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589028|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
19589029|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19589030|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19589031|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589032|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19589033|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19589034|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19589035|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589036|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589037|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
19589038|NCT02633813|Naftifine|naftifine|mesh-list
19589039|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
19589040|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589041|NCT02633852|Aflibercept|aflibercept|mesh-list
19589042|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19589043|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19589044|NCT02633852|Growth Substances|growth substances|mesh-ancestor
20124207|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124208|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
20124209|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124210|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20124211|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20124212|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124213|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
19589045|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309341|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19589046|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124214|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20124215|NCT00014508|Cyclosporine|cyclosporine|mesh-list
20124216|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
20124217|NCT00014508|Melphalan|melphalan|mesh-list
20124218|NCT00014508|Fludarabine|fludarabine|mesh-list
20309342|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309343|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20309344|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309345|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309346|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309347|NCT00667966|Urological Agents|urological agents|mesh-ancestor
20124219|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
20124220|NCT00014508|Cyclosporins|cyclosporins|mesh-list
20124221|NCT00014508|Sargramostim|sargramostim|mesh-list
20124222|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124223|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
20124224|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124225|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124226|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124227|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
20124228|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124229|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124230|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20124231|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124232|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
20124233|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124234|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
20124235|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124236|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124237|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20124238|NCT00014534|Gemcitabine|gemcitabine|mesh-list
20124239|NCT00014534|Doxorubicin|doxorubicin|mesh-list
20124240|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20124241|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124242|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124243|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
20124244|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124245|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
20124246|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124247|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124248|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124249|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
20124250|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124251|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20124252|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124253|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124254|NCT00014547|BBR 3464|bbr 3464|mesh-list
20124255|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124256|NCT00014573|Aldesleukin|aldesleukin|mesh-list
20124257|NCT00014573|Paclitaxel|paclitaxel|mesh-list
20124258|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
19589047|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589048|NCT02633774|Propafenone|propafenone|mesh-list
19589049|NCT02633774|Apixaban|apixaban|mesh-list
19589050|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19589051|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
19589052|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20124259|NCT00014573|Carmustine|carmustine|mesh-list
20124260|NCT00014573|Sargramostim|sargramostim|mesh-list
20124261|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124262|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589053|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
19589054|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589055|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589056|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
19589057|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19589058|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19589059|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19589060|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19589061|NCT02633709|Itraconazole|itraconazole|mesh-list
19589062|NCT02633709|Risdiplam|risdiplam|mesh-list
20124263|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589063|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
19589064|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124264|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124265|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124266|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589065|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19589066|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19589067|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589068|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589069|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19589070|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
19589071|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589072|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589073|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19589074|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19589075|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589076|NCT02633657|Gabapentin|gabapentin|mesh-list
19589077|NCT02633657|Analgesics|analgesics|mesh-ancestor
19589078|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
19589079|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589080|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589081|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
19589082|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19589083|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19589084|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589085|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19589086|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19589087|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19589088|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589089|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589090|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
20309348|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20309349|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309350|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20309351|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19589091|NCT02633761|Misoprostol|misoprostol|mesh-list
19589092|NCT02633761|Mifepristone|mifepristone|mesh-list
19589093|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19589094|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
19589095|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19589096|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124267|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124268|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
20124269|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124270|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124271|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19589097|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19589098|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589099|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
19589100|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19589101|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19589102|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19589103|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19589104|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
19589105|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19589106|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19589107|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
19589108|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124272|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
20124273|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20124274|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20309352|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309353|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309354|NCT00667979|Urological Agents|urological agents|mesh-ancestor
20309355|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20309356|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
20124275|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20124276|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
20124277|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124278|NCT00014586|Goserelin|goserelin|mesh-list
20124279|NCT00014586|Bicalutamide|bicalutamide|mesh-list
20124280|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20124281|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124282|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
20124283|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
20124284|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309357|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20309358|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309359|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309360|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589109|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
19589110|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19589111|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19589112|NCT02633839|Carbidopa|carbidopa|mesh-list
19589113|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19589114|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19589115|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
19589116|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589117|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589118|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589119|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19589120|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589121|NCT02633579|Erythromycin|erythromycin|mesh-list
19589122|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
19589123|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19589124|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
19589125|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
19589126|NCT02633579|Atropine|atropine|mesh-list
19589127|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19589128|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19589129|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19589130|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
19589131|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589132|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589133|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19589134|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
19589135|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
19589136|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
19589137|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19589138|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19589139|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
19589140|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589141|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589142|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19589143|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589144|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589145|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19589146|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589147|NCT02633618|Neurotropin|neurotropin|mesh-list
19589148|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19589149|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
19589150|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589151|NCT02633618|Analgesics|analgesics|mesh-ancestor
19589152|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
19589153|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589154|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
19589155|NCT02633384|Sorbitol|sorbitol|mesh-list
19589156|NCT02633384|SMOFlipid|smoflipid|mesh-list
19589157|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20309361|NCT00668005|Urological Agents|urological agents|mesh-ancestor
20309362|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20309363|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309364|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19589158|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19589159|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19589160|NCT02633384|Cathartics|cathartics|mesh-ancestor
19589161|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589162|NCT02633462|Inositol|inositol|mesh-list
19589163|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
19589164|NCT02633462|Vitamins|vitamins|mesh-ancestor
19589165|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
20124285|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124286|NCT00014599|Paclitaxel|paclitaxel|mesh-list
20124287|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124288|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124289|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124290|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124291|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124292|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589166|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589167|NCT02633202|Cisplatin|cisplatin|mesh-list
19589168|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589169|NCT02633176|Docetaxel|docetaxel|mesh-list
19589170|NCT02633176|Capecitabine|capecitabine|mesh-list
19589171|NCT02633176|Cetuximab|cetuximab|mesh-list
19589172|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589173|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589174|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589175|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589176|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589177|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19589178|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
19589179|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19589180|NCT02633189|Bevacizumab|bevacizumab|mesh-list
19589181|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19589182|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19589183|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589184|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19589185|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19589186|NCT02633189|Growth Substances|growth substances|mesh-ancestor
20124293|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20124294|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124295|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20124296|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124297|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124298|NCT00014638|Letrozole|letrozole|mesh-list
20124299|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124300|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19589187|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589188|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19589189|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19589190|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589191|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589192|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
19589193|NCT02632916|Denosumab|denosumab|mesh-list
19589194|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19589195|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589196|NCT02633514|Etoposide|etoposide|mesh-list
19589197|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589198|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589199|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19589200|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589201|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589202|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124301|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20124302|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124303|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124304|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20124305|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
20173371|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19589203|NCT02633007|Levodopa|levodopa|mesh-list
19589204|NCT02633007|Carbidopa|carbidopa|mesh-list
19589205|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19589206|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19589207|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
19589208|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589209|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589210|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589211|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19589212|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589213|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
19589214|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19589215|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589216|NCT02632877|Pirfenidone|pirfenidone|mesh-list
19589217|NCT02632877|Ketanserin|ketanserin|mesh-list
19589218|NCT02632877|Analgesics|analgesics|mesh-ancestor
19589219|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
19589220|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589221|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589222|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19589223|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19589224|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19589225|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19589226|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589227|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19589228|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19589229|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19589230|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
19589231|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589232|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589233|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19589234|NCT02632760|Hematinics|hematinics|mesh-ancestor
19589235|NCT02632565|Lidocaine|lidocaine|mesh-list
19589236|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
19589237|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
19589238|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589239|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124306|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124307|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124308|NCT00014651|Vapreotide|vapreotide|mesh-list
20124309|NCT00014651|Analgesics|analgesics|mesh-ancestor
20124310|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
19589240|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
19589241|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589242|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19589243|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19589244|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19589245|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19589246|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589247|NCT02632578|Vaccines|vaccines|mesh-list
19589248|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
19589249|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589250|NCT02632474|Tenofovir|tenofovir|mesh-list
19589251|NCT02632474|Lamivudine|lamivudine|mesh-list
19589252|NCT02632474|Efavirenz|efavirenz|mesh-list
19589253|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
19589254|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589255|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19589256|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19589257|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589258|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589259|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19589260|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19589261|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19589262|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19589263|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19589264|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19589265|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19589266|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19589267|NCT02632331|Gabapentin|gabapentin|mesh-list
19589268|NCT02632331|Analgesics|analgesics|mesh-ancestor
19589269|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
19589270|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589271|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589272|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
19589273|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20124311|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124312|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124313|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124314|NCT00014677|Interleukin-4|interleukin-4|mesh-list
20124315|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20124316|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
19589274|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19589275|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589276|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19589277|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19589278|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19589279|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124317|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589280|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589281|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
19589282|NCT02632019|Gemcitabine|gemcitabine|mesh-list
19589283|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19589284|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
19589285|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589286|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589287|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
19589288|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589289|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589290|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19589291|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
19589292|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589293|NCT02632279|Tryptophan|tryptophan|mesh-list
19589294|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19589295|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
19589296|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19589297|NCT02632305|Gemcitabine|gemcitabine|mesh-list
19589298|NCT02632305|Paclitaxel|paclitaxel|mesh-list
19589299|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589300|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589301|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589302|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589303|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589304|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589305|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19589306|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
19589307|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
19589308|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589309|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589310|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19589311|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
19589312|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589313|NCT02632032|Insulin|insulin|mesh-list
19589314|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19589315|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19589316|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589317|NCT02631993|Furocoumarins|furocoumarins|mesh-list
19589318|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
19589319|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19589320|NCT02632136|Bupivacaine|bupivacaine|mesh-list
19589321|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
19589322|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
19589323|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589324|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589325|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
19589326|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589327|NCT02632071|Paclitaxel|paclitaxel|mesh-list
19589328|NCT02632071|Ricolinostat|ricolinostat|mesh-list
19589329|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589330|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589331|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589332|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589333|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589334|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589335|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19589336|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589337|NCT02631928|Insulin|insulin|mesh-list
19589338|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19589339|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
19589340|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19589341|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589342|NCT02631694|Propranolol|propranolol|mesh-list
19589343|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19589344|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19589345|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
19589346|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589347|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589348|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589349|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19589350|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19589351|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
19589352|NCT02631616|Somatostatin|somatostatin|mesh-list
19589353|NCT02631616|Hormones|hormones|mesh-ancestor
19589354|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124318|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124319|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124320|NCT00014690|Topotecan|topotecan|mesh-list
20124321|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20124322|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589355|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589356|NCT02631668|Ascorbic Acid|ascorbic acid|mesh-list
19589357|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
19589358|NCT02631668|Vitamins|vitamins|mesh-ancestor
19589359|NCT02631668|Micronutrients|micronutrients|mesh-ancestor
19589360|NCT02631668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589361|NCT02631668|Antioxidants|antioxidants|mesh-ancestor
19589362|NCT02631668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589363|NCT02631668|Protective Agents|protective agents|mesh-ancestor
19589364|NCT02631668|Hematinics|hematinics|mesh-ancestor
19589365|NCT02631603|Prednisolone|prednisolone|mesh-list
19589366|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19589367|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
19589368|NCT02631603|Hormones|hormones|mesh-ancestor
19589369|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589370|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589371|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19589372|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589373|NCT02631499|Epirubicin|epirubicin|mesh-list
19589374|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
19589375|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19589376|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589377|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19589378|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589379|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589380|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589381|NCT02631473|Ritonavir|ritonavir|mesh-list
19589382|NCT02631473|Lopinavir|lopinavir|mesh-list
19589383|NCT02631473|Efavirenz|efavirenz|mesh-list
19589384|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19589385|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19589386|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
19589387|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589388|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589389|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19589390|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19589391|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
19589392|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589393|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19589394|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19589395|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19589396|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19589397|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19589398|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19589399|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19589400|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19589401|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20124323|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124324|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124325|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124326|NCT00014729|Isotretinoin|isotretinoin|mesh-list
20124327|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124328|NCT00014755|Prednisone|prednisone|mesh-list
20124329|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
20124330|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20124331|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124332|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
20124333|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124334|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124335|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124336|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
20124337|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124338|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124339|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20124340|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20124341|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
20124342|NCT00014755|Hormones|hormones|mesh-ancestor
20124343|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124344|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20124345|NCT00014937|Ritonavir|ritonavir|mesh-list
19589402|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
19589403|NCT02631252|Etoposide|etoposide|mesh-list
19589404|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
19589405|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589406|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589407|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19589408|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589409|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589410|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589411|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
19589412|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19589413|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19589414|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589415|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19589416|NCT02631252|Analgesics|analgesics|mesh-ancestor
19589417|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
19589418|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589419|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589420|NCT02631460|Carboplatin|carboplatin|mesh-list
19589421|NCT02631460|Pemetrexed|pemetrexed|mesh-list
19589422|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589423|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589424|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589425|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19589426|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19589427|NCT02631408|Vancomycin|vancomycin|mesh-list
19589428|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19589429|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589430|NCT02631239|Dexamethasone|dexamethasone|mesh-list
19589431|NCT02631239|Methotrexate|methotrexate|mesh-list
19589432|NCT02631239|Etoposide|etoposide|mesh-list
19589433|NCT02631239|Pegaspargase|pegaspargase|mesh-list
19589434|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19589435|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
19589436|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
19589437|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589438|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589439|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589440|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
19589441|NCT02631239|Hormones|hormones|mesh-ancestor
19589442|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589443|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19589444|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589445|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19589446|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
19589447|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19589448|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19589449|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
19589450|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589451|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
19589452|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589453|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19589454|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19589455|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
19589456|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19589457|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19589458|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589459|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19589460|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589461|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
19589462|NCT02631135|Remifentanil|remifentanil|mesh-list
19589463|NCT02631135|Propofol|propofol|mesh-list
19589464|NCT02631135|Rocuronium|rocuronium|mesh-list
19589465|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19589466|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589467|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589468|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19589469|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
19589470|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
19589471|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19589472|NCT02631135|Analgesics|analgesics|mesh-ancestor
20124346|NCT00014937|Lopinavir|lopinavir|mesh-list
19589473|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
19589474|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589475|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20124347|NCT00014937|Lamivudine|lamivudine|mesh-list
20124348|NCT00014937|Zidovudine|zidovudine|mesh-list
19589476|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19589477|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19589478|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
19589479|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124349|NCT00014937|Stavudine|stavudine|mesh-list
20124350|NCT00014937|Didanosine|didanosine|mesh-list
20124351|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20124352|NCT00014937|Efavirenz|efavirenz|mesh-list
20124353|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20124354|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20124355|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
20124356|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124357|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124358|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20124359|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19589480|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589481|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19589482|NCT02631135|Narcotics|narcotics|mesh-ancestor
19589483|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19589484|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19589485|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19589486|NCT02631031|Valsartan|valsartan|mesh-list
19589487|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19589488|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19589489|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19589490|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589491|NCT02630862|Aspirin|aspirin|mesh-list
19589492|NCT02630862|Dipyridamole|dipyridamole|mesh-list
19589493|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19589494|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19589495|NCT02630862|Analgesics|analgesics|mesh-ancestor
19589496|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
19589497|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589498|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589499|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19589500|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19589501|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19589502|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19589503|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589504|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19589505|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19589506|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589507|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
19589508|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19589509|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
19589510|NCT02631174|Antithrombins|antithrombins|mesh-list
19589511|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
19589512|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19589513|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
20309365|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309366|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309367|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309368|NCT00668018|Urological Agents|urological agents|mesh-ancestor
20309369|NCT00668031|Aprotinin|aprotinin|mesh-list
20309370|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
20309371|NCT00668031|Coagulants|coagulants|mesh-ancestor
20309372|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20309373|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20309374|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
20309375|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309376|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309377|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
20309378|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309379|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309380|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20309381|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20309382|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309383|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309384|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309385|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20309386|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20124360|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
20124361|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124362|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19589514|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589515|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589516|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
19589517|NCT02630888|Memantine|memantine|mesh-list
19589518|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19589519|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19589520|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
19589521|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589522|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589523|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589524|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19589525|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20309387|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20309388|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309389|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20309390|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309391|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309392|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309393|NCT00668057|Urological Agents|urological agents|mesh-ancestor
20309394|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20309395|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309396|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20309397|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309398|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309399|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309400|NCT00668096|Urological Agents|urological agents|mesh-ancestor
20309401|NCT00668109|Tadalafil|tadalafil|mesh-list
20309402|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19589526|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
19589527|NCT02631109|Doxorubicin|doxorubicin|mesh-list
19589528|NCT02631109|Etoposide|etoposide|mesh-list
19589529|NCT02631109|Pegaspargase|pegaspargase|mesh-list
19589530|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20309403|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309404|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20309405|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309406|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309407|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309408|NCT00668109|Urological Agents|urological agents|mesh-ancestor
20309409|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
20309410|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309411|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309412|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20309413|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20309414|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309415|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309416|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309417|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20309418|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19589531|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589532|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19589533|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589534|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589535|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589536|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589537|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19589538|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
19589539|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
19589540|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589541|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589542|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589543|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
19589544|NCT02631109|Hormones|hormones|mesh-ancestor
19589545|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589546|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19589547|NCT02631109|Protective Agents|protective agents|mesh-ancestor
19589548|NCT02630823|Paclitaxel|paclitaxel|mesh-list
19589549|NCT02630823|Carboplatin|carboplatin|mesh-list
19589550|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
20309419|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20309420|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309421|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19589551|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589552|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589553|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589554|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589555|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589556|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589557|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19589558|NCT02630511|Mannitol|mannitol|mesh-list
19589559|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
19589560|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19589561|NCT02630511|Diuretics|diuretics|mesh-ancestor
19589562|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
19589563|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589564|NCT02630511|Miotics|miotics|mesh-ancestor
19589565|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
19589566|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589567|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19589568|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19589569|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
19589570|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19589571|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19589572|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
19589573|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309422|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20309423|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309424|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309425|NCT00668135|Urological Agents|urological agents|mesh-ancestor
20347182|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19589574|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589575|NCT02630485|Inositol|inositol|mesh-list
20124363|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20124364|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20124365|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20124366|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
20124367|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20124368|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20124369|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20124370|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20124371|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20124372|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
19589576|NCT02630485|Letrozole|letrozole|mesh-list
19589577|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589578|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19589579|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19589580|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589581|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589582|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19589583|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
19589584|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589585|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589586|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
19589587|NCT02630485|Vitamins|vitamins|mesh-ancestor
19589588|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
19589589|NCT02630420|Cetuximab|cetuximab|mesh-list
19589590|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19589591|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589592|NCT02630394|Azithromycin|azithromycin|mesh-list
19589593|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19589594|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124373|NCT00014989|Analgesics|analgesics|mesh-ancestor
20124374|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
20124375|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124376|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589595|NCT02630069|Choline|choline|mesh-list
19589596|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19589597|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
19589598|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20124377|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
20124378|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124379|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19589599|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
19589600|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589601|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589602|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19589603|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
19589604|NCT02630303|Coal Tar|coal tar|mesh-list
19589605|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
19589606|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
19589607|NCT02630264|Paclitaxel|paclitaxel|mesh-list
19589608|NCT02630264|Endostatins|endostatins|mesh-list
19589609|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589610|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589611|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589612|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589613|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589614|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589615|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19589616|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19589617|NCT02630264|Growth Substances|growth substances|mesh-ancestor
19589618|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589619|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
19589620|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
19589621|NCT02630290|Ropivacaine|ropivacaine|mesh-list
19589622|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19589623|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589624|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589625|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19589626|NCT02630290|Analgesics|analgesics|mesh-ancestor
19589627|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
19589628|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589629|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19589630|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19589631|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19589632|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
19589633|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589634|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589635|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19589636|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
19589637|NCT02630160|Epinephrine|epinephrine|mesh-list
19589638|NCT02630160|Bupivacaine|bupivacaine|mesh-list
19589639|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
19589640|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
19589641|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589642|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589643|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
19589644|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589645|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19589646|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19589647|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
19589648|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589649|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589650|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19589651|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19589652|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
19589653|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19589654|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
19589655|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
20124380|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
20124381|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20124382|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124383|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124384|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20124385|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
20124386|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20124387|NCT00015028|Buprenorphine|buprenorphine|mesh-list
20124388|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20124389|NCT00015028|Naloxone|naloxone|mesh-list
20124390|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20124391|NCT00015028|Narcotics|narcotics|mesh-ancestor
20124392|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124393|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124394|NCT00015028|Analgesics|analgesics|mesh-ancestor
20124395|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
20124396|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589656|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
19589657|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20124397|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19589658|NCT02630277|Aflibercept|aflibercept|mesh-list
19589659|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19589660|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19589661|NCT02630277|Growth Substances|growth substances|mesh-ancestor
19589662|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589663|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
19589664|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589665|NCT02630199|Paclitaxel|paclitaxel|mesh-list
19589666|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589667|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589668|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589669|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589670|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589671|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589672|NCT02630108|Epirubicin|epirubicin|mesh-list
19589673|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
19589674|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19589675|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589676|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19589677|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589678|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589679|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589680|NCT02630121|Phenylephrine|phenylephrine|mesh-list
19589681|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
19589682|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19589683|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20309426|NCT00668239|Triamcinolone|triamcinolone|mesh-list
20309427|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309428|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
20309429|NCT00668239|Hormones|hormones|mesh-ancestor
19589684|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19589685|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589686|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589687|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589688|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
19589689|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
19589690|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589691|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
19589692|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19589693|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
19589694|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19589695|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
19589696|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19589697|NCT02630121|Protective Agents|protective agents|mesh-ancestor
19589698|NCT02630095|Nadroparin|nadroparin|mesh-list
19589699|NCT02630095|Warfarin|warfarin|mesh-list
19589700|NCT02630095|Calcium|calcium|mesh-list
19589701|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19589702|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589703|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
19589704|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19589705|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19589706|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589707|NCT02630004|Melatonin|melatonin|mesh-list
19589708|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
19589709|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589710|NCT02630004|Protective Agents|protective agents|mesh-ancestor
19589711|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589712|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589713|NCT02629848|Paclitaxel|paclitaxel|mesh-list
19589714|NCT02629848|Carboplatin|carboplatin|mesh-list
19589715|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
19589716|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589717|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589718|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589719|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589720|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589721|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589722|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19589723|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589724|NCT02629835|Dexamethasone|dexamethasone|mesh-list
19589725|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
19589726|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19589727|NCT02629835|BB 1101|bb 1101|mesh-list
19589728|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19589729|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
20309430|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589730|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
19589731|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589732|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589733|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589734|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
19589735|NCT02629835|Hormones|hormones|mesh-ancestor
19589736|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589737|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19589738|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589739|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
19589740|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589741|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589742|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19589743|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589744|NCT02629744|Etrolizumab|etrolizumab|mesh-list
19589745|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589746|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
19589747|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589748|NCT02629718|Paclitaxel|paclitaxel|mesh-list
19589749|NCT02629718|Carboplatin|carboplatin|mesh-list
19589750|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309431|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309432|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
20309433|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19589751|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589752|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589753|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589754|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589755|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124398|NCT00015041|Buprenorphine|buprenorphine|mesh-list
20124399|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20124400|NCT00015041|Narcotics|narcotics|mesh-ancestor
20124401|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124402|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124403|NCT00015041|Analgesics|analgesics|mesh-ancestor
20124404|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
20124405|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124406|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20124407|NCT00015054|Methylphenidate|methylphenidate|mesh-list
20124408|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20124409|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124410|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20124411|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124412|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124413|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124414|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
20124415|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124416|NCT00015067|Methylphenidate|methylphenidate|mesh-list
20124417|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20124418|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124419|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20124420|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124421|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124422|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124423|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
20124424|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124425|NCT00015080|Naltrexone|naltrexone|mesh-list
20309434|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309435|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657344|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
19657345|NCT03935893|Fludarabine|fludarabine|mesh-list
19657346|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657347|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
19657348|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657349|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657350|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19657351|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
19657352|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657353|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657354|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20309436|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20309437|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19657355|NCT03927690|Ranibizumab|ranibizumab|mesh-list
19657356|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20309438|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309439|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309440|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309441|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20309442|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
20309443|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309444|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309445|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20309446|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20309447|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20309448|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
20309449|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
20309450|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
20309451|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20309452|NCT00668330|Calcium|calcium|mesh-list
20309453|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19589756|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
19589757|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19589758|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
20124426|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20124427|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20124428|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124429|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
20124430|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124431|NCT00015106|Lamotrigine|lamotrigine|mesh-list
20124432|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
20124433|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19589759|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589760|NCT02629536|Expectorants|expectorants|mesh-ancestor
19589761|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
19589762|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19589763|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
19589764|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589765|NCT02629536|Protective Agents|protective agents|mesh-ancestor
19589766|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589767|NCT02629536|Antidotes|antidotes|mesh-ancestor
19589768|NCT02629523|Afatinib|afatinib|mesh-list
19589769|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589770|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19589771|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589772|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589773|NCT02629627|Metformin|metformin|mesh-list
19589774|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19589775|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589776|NCT02629575|Sirolimus|sirolimus|mesh-list
19589777|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19589778|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589779|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19589780|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589781|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
19589782|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19589783|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
19589784|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589785|NCT02629224|Gabapentin|gabapentin|mesh-list
19589786|NCT02629224|Analgesics|analgesics|mesh-ancestor
19589787|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
19589788|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589789|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589790|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
19589791|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19589792|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19589793|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589794|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19589795|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19589796|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19589797|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589798|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589799|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
19589800|NCT02629315|Formaldehyde|formaldehyde|mesh-list
19589801|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
20124434|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19589802|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589803|NCT02629042|Prednisolone|prednisolone|mesh-list
19589804|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589805|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309454|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589806|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
19589807|NCT02629042|Hormones|hormones|mesh-ancestor
19589808|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589809|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19589810|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589811|NCT02629146|Fentanyl|fentanyl|mesh-list
19589812|NCT02629146|Midazolam|midazolam|mesh-list
19589813|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19589814|NCT02629146|Narcotics|narcotics|mesh-ancestor
19589815|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589816|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589817|NCT02629146|Analgesics|analgesics|mesh-ancestor
19589818|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
19589819|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589820|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19589821|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19589822|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
19589823|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
19589824|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19589825|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19589826|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19589827|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19589828|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
19589829|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
19589830|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589831|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589832|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
19589833|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19589834|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
19589835|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589836|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
19589837|NCT02629380|Protective Agents|protective agents|mesh-ancestor
19589838|NCT02628704|Dexamethasone|dexamethasone|mesh-list
19589839|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19589840|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
19589841|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
19589842|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589843|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589844|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19589845|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
19589846|NCT02628704|Hormones|hormones|mesh-ancestor
19589847|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19589848|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19589849|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589850|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
19589851|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589852|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
19589853|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19589854|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19589855|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589856|NCT02628847|Urological Agents|urological agents|mesh-ancestor
19589857|NCT02628951|Paclitaxel|paclitaxel|mesh-list
19589858|NCT02628951|Ramucirumab|ramucirumab|mesh-list
19589859|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589860|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589861|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
19589862|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
19589863|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589864|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124435|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124436|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19589865|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19589866|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
19589867|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589868|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
19589869|NCT02628860|Hematinics|hematinics|mesh-ancestor
19589870|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19589871|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
19589872|NCT02628665|Trioxsalen|trioxsalen|mesh-list
19589873|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
19589874|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589875|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
19589876|NCT02628613|Paclitaxel|paclitaxel|mesh-list
19589877|NCT02628613|Vinorelbine|vinorelbine|mesh-list
19589878|NCT02628613|Epirubicin|epirubicin|mesh-list
19589879|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589880|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589881|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309455|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20309456|NCT00668330|Vitamins|vitamins|mesh-ancestor
20309457|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
20309458|NCT00668343|Simvastatin|simvastatin|mesh-list
20309459|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20309460|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20309461|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
20309462|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309463|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20309464|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20309465|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309466|NCT00668356|Didanosine|didanosine|mesh-list
20309467|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
20309468|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309469|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19589882|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309470|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20309471|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309472|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
19589883|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
19589884|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589885|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19589886|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19589887|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19589888|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589889|NCT02628587|Clopidogrel|clopidogrel|mesh-list
19589890|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19589891|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19589892|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19589893|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19589894|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
19589895|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589896|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309473|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309474|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20309475|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20309476|NCT00668499|Pemetrexed|pemetrexed|mesh-list
20309477|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309478|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309479|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309480|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20309481|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20309482|NCT00668538|Miconazole|miconazole|mesh-list
20309483|NCT00668538|Clotrimazole|clotrimazole|mesh-list
20309484|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
20309485|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309486|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20309487|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20309488|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309489|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309490|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20309491|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
20309492|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309493|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309494|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20309495|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20124437|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124438|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20124439|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20124440|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124441|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20124442|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20124443|NCT00015132|Sertraline|sertraline|mesh-list
20309496|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19589897|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589898|NCT02628574|Gemcitabine|gemcitabine|mesh-list
19589899|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
19589900|NCT02628574|Nivolumab|nivolumab|mesh-list
19589901|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19589902|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
19589903|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589904|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19589905|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
20124444|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
20124445|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20124446|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19589906|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19589907|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589908|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19589909|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
19589910|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589911|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19589912|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19589913|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
20309497|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20309498|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20309499|NCT00668603|Estradiol|estradiol|mesh-list
20309500|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20309501|NCT00668603|Estrogens|estrogens|mesh-ancestor
20309502|NCT00668603|Hormones|hormones|mesh-ancestor
20309503|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309504|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309505|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19589914|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19589915|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19589916|NCT02628392|Firuglipel|firuglipel|mesh-list
19589917|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19589918|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309506|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
20309507|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309508|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20309509|NCT00668616|Paclitaxel|paclitaxel|mesh-list
20309510|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20309511|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
20309512|NCT00668616|Epirubicin|epirubicin|mesh-list
20309513|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589919|NCT02628392|Incretins|incretins|mesh-ancestor
19589920|NCT02628392|Hormones|hormones|mesh-ancestor
19589921|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124447|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124448|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124449|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124450|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124451|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
20124452|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124453|NCT00015171|Buprenorphine|buprenorphine|mesh-list
20124454|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20124455|NCT00015171|Naloxone|naloxone|mesh-list
20124456|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20124457|NCT00015171|Narcotics|narcotics|mesh-ancestor
20124458|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124459|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589922|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20124460|NCT00015171|Analgesics|analgesics|mesh-ancestor
20124461|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
20124462|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124463|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20124464|NCT00015210|Nefazodone|nefazodone|mesh-list
20124465|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20124466|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124467|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19589923|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
19589924|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19589925|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589926|NCT02628522|Lidocaine|lidocaine|mesh-list
19589927|NCT02628522|Epinephrine|epinephrine|mesh-list
19589928|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
19589929|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
19589930|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589931|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589932|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
19589933|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589934|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19589935|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19589936|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19589937|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19589938|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589939|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19589940|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19589941|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
19589942|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589943|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19589944|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19589945|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
19589946|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19589947|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
19589948|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
19589949|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
19589950|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20124468|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124469|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124470|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124471|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20124472|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
20124473|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19589951|NCT02628197|Vitamin D|vitamin d|mesh-list
19589952|NCT02628197|Calcium|calcium|mesh-list
19589953|NCT02628197|Vitamins|vitamins|mesh-ancestor
19589954|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
19589955|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589956|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19589957|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19589958|NCT02628002|Regadenoson|regadenoson|mesh-list
19589959|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19589960|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19589961|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
19589962|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
19589963|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589964|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589965|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589966|NCT02627846|Lidocaine|lidocaine|mesh-list
19589967|NCT02627846|Epinephrine|epinephrine|mesh-list
19589968|NCT02627846|Racepinephrine|racepinephrine|mesh-list
19589969|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19589970|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
19589971|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
19589972|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
19589973|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
19589974|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19589975|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19589976|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
19589977|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19589978|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19589979|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19589980|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19589981|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19589982|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589983|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19589984|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19589985|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
19589986|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19589987|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20309514|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309515|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309516|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309517|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
20309518|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19589988|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19589989|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
19589990|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19589991|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
19589992|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
19589993|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
19589994|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19589995|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19657357|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19657358|NCT03927690|Growth Substances|growth substances|mesh-ancestor
19657359|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657360|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
19657361|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657362|NCT03920293|Ravulizumab|ravulizumab|mesh-list
19657363|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19657364|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657365|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
19657366|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124474|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20124475|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20124476|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
20124477|NCT00015223|Methylphenidate|methylphenidate|mesh-list
20124478|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20124479|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124480|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20124481|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124482|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124483|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124484|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
20124485|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124486|NCT00015236|Amantadine|amantadine|mesh-list
20124487|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20124488|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20309519|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309520|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
20309521|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309522|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20309523|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20309524|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
20309525|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20309526|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20124489|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
20124490|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124491|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
20124492|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124493|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124494|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124495|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20124496|NCT00015236|Analgesics|analgesics|mesh-ancestor
20124497|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
20124498|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124499|NCT00015249|Amantadine|amantadine|mesh-list
20124500|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20124501|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20124502|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
20124503|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124504|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
20124505|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309527|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20309528|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124506|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124507|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124508|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20309529|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309530|NCT00668642|Dutasteride|dutasteride|mesh-list
20309531|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19589996|NCT02628132|Paclitaxel|paclitaxel|mesh-list
19589997|NCT02628132|Durvalumab|durvalumab|mesh-list
19589998|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19589999|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590000|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
19590001|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
19590002|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
19590003|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590004|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590005|NCT02628080|Atovaquone|atovaquone|mesh-list
19590006|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590007|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
19590008|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19590009|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19590010|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590011|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590012|NCT02627989|Diflucortolone|diflucortolone|mesh-list
19590013|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
19590014|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19590015|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
19590016|NCT02627989|Hormones|hormones|mesh-ancestor
19590017|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590018|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590019|NCT02627950|Metoclopramide|metoclopramide|mesh-list
19590020|NCT02627950|Ticagrelor|ticagrelor|mesh-list
19590021|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19590022|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19590023|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19590024|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19590025|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
19590026|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590027|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590028|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590029|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
19590030|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
19590031|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590032|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590033|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19590034|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19590035|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
19590036|NCT02627807|Gemcitabine|gemcitabine|mesh-list
19590037|NCT02627807|Cisplatin|cisplatin|mesh-list
19590038|NCT02627807|Docetaxel|docetaxel|mesh-list
19590039|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590040|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19590041|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
19590042|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590043|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
19590044|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590045|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590046|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19590047|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
19590048|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590049|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
19590050|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
19590051|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
19590052|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
19590053|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19590054|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
19590055|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590056|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590057|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19590058|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
19590059|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
19590060|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19590061|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
19590062|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590063|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590064|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
19590065|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
19590066|NCT02627573|Busulfan|busulfan|mesh-list
19590067|NCT02627573|Fludarabine|fludarabine|mesh-list
19590068|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
19590069|NCT02627573|Tacrolimus|tacrolimus|mesh-list
19590070|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
19590071|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608190|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20608191|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590072|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
19590073|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590074|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590075|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19590076|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
19590077|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590078|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590079|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20309532|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20309533|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309534|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309535|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
20309536|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309537|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309538|NCT00668655|Metronidazole|metronidazole|mesh-list
20309539|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309540|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19590080|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19590081|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
19590082|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19590083|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590084|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19590085|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19590086|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
19590087|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19590088|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124509|NCT00015249|Analgesics|analgesics|mesh-ancestor
20124510|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
20124511|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590089|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
19590090|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19590091|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19590092|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590093|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
19590094|NCT02627560|Coagulants|coagulants|mesh-ancestor
19590095|NCT02627521|Ticagrelor|ticagrelor|mesh-list
19590096|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19590097|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19590098|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19590099|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19590100|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
19590101|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590102|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590103|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590104|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
19590105|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19590106|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19590107|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
19590108|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19590109|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19590110|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590111|NCT02627469|Listerine|listerine|mesh-list
19590112|NCT02627469|Fluorides|fluorides|mesh-list
19590113|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
19590114|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
19590115|NCT02627469|Protective Agents|protective agents|mesh-ancestor
19590116|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590117|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19590118|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590119|NCT02627417|Dapsone|dapsone|mesh-list
19590120|NCT02627417|Prednisone|prednisone|mesh-list
20124512|NCT00015275|Cocaine|cocaine|mesh-list
20124513|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
20124514|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
20124515|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124516|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124517|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
20124518|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590121|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20124519|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19590122|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
20309541|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20309542|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20309543|NCT00668759|Amiodarone|amiodarone|mesh-list
20309544|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19590123|NCT02627417|Hormones|hormones|mesh-ancestor
19590124|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590125|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590126|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19590127|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590128|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590129|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
19590130|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19590131|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19590132|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19590133|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590134|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590135|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
19590136|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19590137|NCT02627430|Talazoparib|talazoparib|mesh-list
19590138|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19590139|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590140|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590141|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590142|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
19590143|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19590144|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
19590145|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19590146|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
19590147|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590148|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590149|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
19590150|NCT02627222|Vitamin A|vitamin a|mesh-list
19590151|NCT02627222|Provitamins|provitamins|mesh-list
19590152|NCT02627222|Vitamins|vitamins|mesh-ancestor
19590153|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
19590154|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590155|NCT02627027|Metformin|metformin|mesh-list
19590156|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590157|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590158|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
19590159|NCT02627248|Docetaxel|docetaxel|mesh-list
19590160|NCT02627248|Epirubicin|epirubicin|mesh-list
19590161|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19590162|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
19590163|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590164|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590165|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19590166|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
19590167|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590168|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590169|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19590170|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19590171|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19590172|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19590173|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19590174|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19590175|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19590176|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590177|NCT02626936|Insulin|insulin|mesh-list
19590178|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19590179|NCT02626936|Glucagon|glucagon|mesh-list
19590180|NCT02626936|Hormones|hormones|mesh-list
19590181|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590182|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590183|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590184|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590185|NCT02626754|Sunitinib|sunitinib|mesh-list
19590186|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590187|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19590188|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19590189|NCT02626754|Growth Substances|growth substances|mesh-ancestor
19590190|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590191|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
20309545|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
19590192|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19590193|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590194|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590195|NCT02626845|Rituximab|rituximab|mesh-list
19590196|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590197|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590198|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
19590199|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590200|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590201|NCT02626364|Crenolanib|crenolanib|mesh-list
19590202|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590203|NCT02626559|Bupivacaine|bupivacaine|mesh-list
19590204|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
19590205|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
19590206|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590207|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590208|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
19590209|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590210|NCT02626247|Vitamin A|vitamin a|mesh-list
19590211|NCT02626247|Vitamins|vitamins|mesh-ancestor
19590212|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
19590213|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124520|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20124521|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124522|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124523|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124524|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
20124525|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124526|NCT00015288|Buprenorphine|buprenorphine|mesh-list
20124527|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20124528|NCT00015288|Naloxone|naloxone|mesh-list
20124529|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20124530|NCT00015288|Narcotics|narcotics|mesh-ancestor
20124531|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124532|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124533|NCT00015288|Analgesics|analgesics|mesh-ancestor
20124534|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
20124535|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124536|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20124537|NCT00015301|Methylphenidate|methylphenidate|mesh-list
20124538|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20124539|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124540|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20124541|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20124542|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124543|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124544|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
19657409|NCT03909074|Vaccines|vaccines|mesh-list
19657410|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
19657411|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657412|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
19657413|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19657414|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
19657415|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657416|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
19657417|NCT03906877|Protective Agents|protective agents|mesh-ancestor
20124545|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124546|NCT00015340|Buprenorphine|buprenorphine|mesh-list
20124547|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20124548|NCT00015340|Naloxone|naloxone|mesh-list
20124549|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19657418|NCT03904108|Ramucirumab|ramucirumab|mesh-list
19657419|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657420|NCT03899961|Oxytocin|oxytocin|mesh-list
19657421|NCT03899961|Carbetocin|carbetocin|mesh-list
19657422|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
19657423|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19657424|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657425|NCT03880539|Vancomycin|vancomycin|mesh-list
20124550|NCT00015340|Narcotics|narcotics|mesh-ancestor
19657426|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19657427|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657428|NCT03869892|Trifluridine|trifluridine|mesh-list
19657429|NCT03869892|Bevacizumab|bevacizumab|mesh-list
19657430|NCT03869892|Capecitabine|capecitabine|mesh-list
19657431|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657432|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657433|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749557|NCT04923893|Dexamethasone|dexamethasone|mesh-list
20309546|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20309547|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19590214|NCT02626169|Clopidogrel|clopidogrel|mesh-list
19590215|NCT02626169|Ticagrelor|ticagrelor|mesh-list
19590216|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19590217|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19590218|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19590219|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19590220|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
19590221|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590222|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590223|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590224|NCT02626208|ST 1435|st 1435|mesh-list
19590225|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
19590226|NCT02626208|Estradiol|estradiol|mesh-list
19590227|NCT02626208|Estrogens|estrogens|mesh-ancestor
19590228|NCT02626208|Hormones|hormones|mesh-ancestor
19590229|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590230|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590231|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19590232|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19590233|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19590234|NCT02626234|Digoxin|digoxin|mesh-list
19590235|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19590236|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19590237|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19590238|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
19590239|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590240|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19590241|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19590242|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590243|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19590244|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19590245|NCT02626234|Protective Agents|protective agents|mesh-ancestor
19590246|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590247|NCT02626481|Dexamethasone|dexamethasone|mesh-list
19590248|NCT02626481|Daratumumab|daratumumab|mesh-list
19590249|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19590250|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
19590251|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
19590252|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590253|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590254|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590255|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
19590256|NCT02626481|Hormones|hormones|mesh-ancestor
19590257|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590258|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19590259|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590260|NCT02626065|Nivolumab|nivolumab|mesh-list
19590261|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590262|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309548|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309549|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20309550|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20309551|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20309552|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309553|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20309554|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20309555|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20309556|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20309557|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20309558|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20309559|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309560|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309561|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309562|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19590263|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19590264|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590265|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
19590266|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749558|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
19590267|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590268|NCT02626104|Lactoferrin|lactoferrin|mesh-list
19590269|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590270|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
19590271|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19590272|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19590273|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590274|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
19590275|NCT02625948|Coagulants|coagulants|mesh-ancestor
19590276|NCT02625753|Acetaminophen|acetaminophen|mesh-list
19590277|NCT02625753|Codeine|codeine|mesh-list
19590278|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19590279|NCT02625753|Analgesics|analgesics|mesh-ancestor
19590280|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
19590281|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590282|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590283|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
19590284|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19590285|NCT02625753|Narcotics|narcotics|mesh-ancestor
19590286|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590287|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
19590288|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
19590289|NCT02625779|Valproic Acid|valproic acid|mesh-list
19590290|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
19590291|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309563|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20309564|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
19590292|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590293|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
19590294|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590295|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590296|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
19590297|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19590298|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590299|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19590300|NCT02625805|Methylphenidate|methylphenidate|mesh-list
19590301|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19590302|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590303|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19590304|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19590305|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19590306|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590307|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
19590308|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590309|NCT02625740|Paclitaxel|paclitaxel|mesh-list
19590310|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19590311|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590312|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
19590313|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
19590314|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
19590315|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590316|NCT02625519|Hormones|hormones|mesh-list
19590317|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19590318|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590319|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590320|NCT02625636|Glucagon|glucagon|mesh-list
19590321|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19590322|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590323|NCT02625636|Hormones|hormones|mesh-ancestor
19590324|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590325|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590326|NCT02625636|Incretins|incretins|mesh-ancestor
19590327|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
20124551|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124552|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124553|NCT00015340|Analgesics|analgesics|mesh-ancestor
20124554|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
20124555|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124556|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20124557|NCT00015548|Olanzapine|olanzapine|mesh-list
20124558|NCT00015548|Risperidone|risperidone|mesh-list
20124559|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20124560|NCT00015548|Citalopram|citalopram|mesh-list
20124561|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20124562|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
20309565|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590328|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19590329|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
19590330|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309566|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309567|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20309568|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20309569|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
20309570|NCT00668850|Insulin|insulin|mesh-list
19590331|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
19590332|NCT02625727|Protective Agents|protective agents|mesh-ancestor
19590333|NCT02625506|Tramadol|tramadol|mesh-list
19590334|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
19590335|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19590336|NCT02625506|Narcotics|narcotics|mesh-ancestor
19590337|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590338|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590339|NCT02625506|Analgesics|analgesics|mesh-ancestor
19590340|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
19590341|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590342|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
19590343|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
19590344|NCT02625558|Riociguat|riociguat|mesh-list
19590345|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
19590346|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590347|NCT02625415|Vitamins|vitamins|mesh-list
19590348|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
19590349|NCT02625415|Pyridoxal|pyridoxal|mesh-list
19590350|NCT02625415|Pyridoxine|pyridoxine|mesh-list
19590351|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
19590352|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
19590353|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590354|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
19590355|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590356|NCT02625454|Acetaminophen|acetaminophen|mesh-list
19590357|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19590358|NCT02625454|Analgesics|analgesics|mesh-ancestor
19590359|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
19590360|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590361|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590362|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
20309571|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20124563|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124564|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590363|NCT02625103|Clozapine|clozapine|mesh-list
19590364|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19590365|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
19590366|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124565|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124566|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20124567|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20124568|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20124569|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20124570|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20124571|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
19590367|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590368|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590369|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19590370|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19590371|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590372|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19590373|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
19590374|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
19590375|NCT02625376|Resveratrol|resveratrol|mesh-list
19590376|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
19590377|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590378|NCT02625376|Protective Agents|protective agents|mesh-ancestor
20124572|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
20124573|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
20124574|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124575|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20309572|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20124576|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20124577|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20309573|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590379|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590380|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309574|NCT00668941|Vitamin D|vitamin d|mesh-list
19590381|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20124578|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124579|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
20309575|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
20309576|NCT00668941|Alendronate|alendronate|mesh-list
20309577|NCT00668941|Teriparatide|teriparatide|mesh-list
20309578|NCT00668941|Calcium|calcium|mesh-list
20309579|NCT00668941|Vitamins|vitamins|mesh-ancestor
20309580|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
20309581|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309582|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20309583|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19590382|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19590383|NCT02625168|Afatinib|afatinib|mesh-list
19590384|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590385|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19590386|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590387|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590388|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
19590389|NCT02625337|Trametinib|trametinib|mesh-list
19590390|NCT02625337|Dabrafenib|dabrafenib|mesh-list
19590391|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590392|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590393|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19590394|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590395|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590396|NCT02624999|Cisplatin|cisplatin|mesh-list
19590397|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590398|NCT02624856|Dexamethasone|dexamethasone|mesh-list
19590399|NCT02624856|Bupivacaine|bupivacaine|mesh-list
19590400|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19590401|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
19590402|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
19590403|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590404|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590405|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590406|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
20124580|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20173372|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19590407|NCT02624856|Hormones|hormones|mesh-ancestor
19590408|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590409|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19590410|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590411|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
19590412|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
19590413|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590414|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
20173373|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
20173374|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173375|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20173376|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20173377|NCT00161421|Leuprolide|leuprolide|mesh-list
20173378|NCT00161421|Testosterone|testosterone|mesh-list
19590415|NCT02624973|Tamoxifen|tamoxifen|mesh-list
19590416|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
19590417|NCT02624973|Docetaxel|docetaxel|mesh-list
19590418|NCT02624973|Trastuzumab|trastuzumab|mesh-list
19590419|NCT02624973|Letrozole|letrozole|mesh-list
19590420|NCT02624973|Epirubicin|epirubicin|mesh-list
19590421|NCT02624973|Olaparib|olaparib|mesh-list
19590422|NCT02624973|Palbociclib|palbociclib|mesh-list
19590423|NCT02624973|Pertuzumab|pertuzumab|mesh-list
19590424|NCT02624973|Goserelin|goserelin|mesh-list
19590425|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19590426|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
20173379|NCT00161421|Dutasteride|dutasteride|mesh-list
20173380|NCT00161421|Androgens|androgens|mesh-ancestor
20173381|NCT00161421|Hormones|hormones|mesh-ancestor
20173382|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173383|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173384|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20173385|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590427|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173386|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20173387|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
19590428|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590429|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19590430|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
20173388|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309584|NCT00668967|Verapamil|verapamil|mesh-list
20309585|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20309586|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20309587|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19590431|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590432|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590433|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19590434|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
19590435|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
19590436|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
19590437|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590438|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19590439|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19590440|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590441|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19590442|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
19590443|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590444|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19590445|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19590446|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19590447|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19590448|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19590449|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19590450|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19590451|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19590452|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19590453|NCT02624817|Glyburide|glyburide|mesh-list
19590454|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590455|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590456|NCT02624908|Canagliflozin|canagliflozin|mesh-list
19590457|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19590458|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590459|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590460|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590461|NCT02624726|Leucovorin|leucovorin|mesh-list
19590462|NCT02624726|Fluorouracil|fluorouracil|mesh-list
19590463|NCT02624726|Irinotecan|irinotecan|mesh-list
19590464|NCT02624726|Aflibercept|aflibercept|mesh-list
19590465|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
19590466|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
19590467|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590468|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19590469|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590470|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19590471|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
19590472|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590473|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19590474|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19590475|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590476|NCT02624726|Antidotes|antidotes|mesh-ancestor
19590477|NCT02624726|Protective Agents|protective agents|mesh-ancestor
19590478|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
20124581|NCT00015626|Metformin|metformin|mesh-list
20124582|NCT00015626|Pioglitazone|pioglitazone|mesh-list
20124583|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
20124584|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20124585|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124586|NCT00015652|Ribavirin|ribavirin|mesh-list
20124587|NCT00015652|Aldesleukin|aldesleukin|mesh-list
20124588|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20124589|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
20124590|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124591|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
20124592|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124593|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124594|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20124595|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20124596|NCT00015665|Voriconazole|voriconazole|mesh-list
20124597|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
20124598|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124599|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20124600|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20124601|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124602|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124603|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19590479|NCT02624726|Vitamins|vitamins|mesh-ancestor
19590480|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
19590481|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19590482|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19590483|NCT02624726|Growth Substances|growth substances|mesh-ancestor
19590484|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
19590485|NCT02624830|Glyburide|glyburide|mesh-list
19590486|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590487|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590488|NCT02624661|Glycerol|glycerol|mesh-list
19590489|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19590490|NCT02624661|Protective Agents|protective agents|mesh-ancestor
19590491|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590492|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
19590493|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19590494|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19590495|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590496|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
19590497|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
19590498|NCT02624505|Albuterol|albuterol|mesh-list
19590499|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19590500|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
20124604|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
20124605|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124606|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124607|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20124608|NCT00015691|Metformin|metformin|mesh-list
20124609|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
20124610|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20124611|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124612|NCT00015704|Aldesleukin|aldesleukin|mesh-list
20124613|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124614|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20124615|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20124616|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
20124617|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124618|NCT00015769|Levetiracetam|levetiracetam|mesh-list
20124619|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
20124620|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
20124621|NCT00015808|Idebenone|idebenone|mesh-list
20124622|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
20124623|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124624|NCT00015808|Protective Agents|protective agents|mesh-ancestor
20124625|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124626|NCT00015821|Thalidomide|thalidomide|mesh-list
20124627|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124628|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
19590501|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590502|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590503|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19590504|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
19590505|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
19590506|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19590507|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19590508|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19590509|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19590510|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
19590511|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590512|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590513|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
19590514|NCT02624479|Antidotes|antidotes|mesh-ancestor
19590515|NCT02624479|Protective Agents|protective agents|mesh-ancestor
19590516|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590517|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
19590518|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590519|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
19590520|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19590521|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590522|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
19590523|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
19657434|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19657435|NCT03869892|Growth Substances|growth substances|mesh-ancestor
20124629|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657436|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657437|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
19657438|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19657439|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
19590524|NCT02624544|Desonide|desonide|mesh-list
19590525|NCT02624544|Esomeprazole|esomeprazole|mesh-list
19590526|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19590527|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590528|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19590529|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590530|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590531|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19590532|NCT02624570|Midostaurin|midostaurin|mesh-list
19590533|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590534|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19590535|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590536|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590537|NCT02624453|Fluconazole|fluconazole|mesh-list
19590538|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19590539|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
19590540|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590541|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19590542|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19590543|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590544|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590545|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19590546|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
19590547|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590548|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590549|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19590550|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19590551|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
19590552|NCT02624388|Genistein|genistein|mesh-list
19590553|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19590554|NCT02624388|Protective Agents|protective agents|mesh-ancestor
19590555|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590556|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590557|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19590558|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590559|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590560|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
19590561|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19590562|NCT02624388|Estrogens|estrogens|mesh-ancestor
19590563|NCT02624388|Hormones|hormones|mesh-ancestor
19590564|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590565|NCT02624531|Cisplatin|cisplatin|mesh-list
19590566|NCT02624531|Taxane|taxane|mesh-list
19590567|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590568|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
19590569|NCT02624401|Ketamine|ketamine|mesh-list
19590570|NCT02624401|Propofol|propofol|mesh-list
19590571|NCT02624401|Sevoflurane|sevoflurane|mesh-list
19590572|NCT02624401|Esketamine|esketamine|mesh-list
19590573|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19590574|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590575|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590576|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19590577|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
19590578|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
19590579|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19590580|NCT02624401|Analgesics|analgesics|mesh-ancestor
19590581|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
20124630|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
20124631|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20124632|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124633|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20124634|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19590582|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590583|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19590584|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19590585|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19590586|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
19590587|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590588|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124635|NCT00015821|Growth Substances|growth substances|mesh-ancestor
20124636|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124637|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124638|NCT00015834|Cytarabine|cytarabine|mesh-list
19590589|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20309588|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309589|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19590590|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19590591|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19590592|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19590593|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19590594|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
20309590|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309591|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309592|NCT00669149|Aspirin|aspirin|mesh-list
20309593|NCT00669149|Heparin|heparin|mesh-list
20309594|NCT00669149|Enoxaparin|enoxaparin|mesh-list
20309595|NCT00669149|Bivalirudin|bivalirudin|mesh-list
20309596|NCT00669149|Clopidogrel|clopidogrel|mesh-list
20309597|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20309598|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20309599|NCT00669149|Analgesics|analgesics|mesh-ancestor
19590595|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19590596|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
19590597|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19590598|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124639|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
20124640|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124641|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
20124642|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124643|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124644|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
20124645|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124646|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124647|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
20124648|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124649|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20124650|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124651|NCT00015860|Prednisone|prednisone|mesh-list
20124652|NCT00015860|Vincristine|vincristine|mesh-list
20124653|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
20124654|NCT00015860|Daunorubicin|daunorubicin|mesh-list
20124655|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19590599|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
20124656|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
20124657|NCT00015860|Hormones|hormones|mesh-ancestor
20124658|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124659|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124660|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20124661|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124662|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124663|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124664|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124665|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124666|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124667|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20124668|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590600|NCT02624310|Droxidopa|droxidopa|mesh-list
19590601|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19590602|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19590603|NCT02624440|Clarithromycin|clarithromycin|mesh-list
19590604|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19590605|NCT02624440|Trimethoprim|trimethoprim|mesh-list
19590606|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
19590607|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19590608|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590609|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19590610|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590611|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590612|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19590613|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19590614|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19590615|NCT02624440|Renal Agents|renal agents|mesh-ancestor
19590616|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
19590617|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19590618|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19590619|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20124669|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19749559|NCT04923893|Fludarabine|fludarabine|mesh-list
20309600|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
19590620|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19590621|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19590622|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
19590623|NCT02624063|Simeprevir|simeprevir|mesh-list
19590624|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
19590625|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590626|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
19590627|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590628|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590629|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
19590630|NCT02624141|Hematinics|hematinics|mesh-ancestor
19590631|NCT02623881|Progesterone|progesterone|mesh-list
19590632|NCT02623881|Progestins|progestins|mesh-ancestor
19590633|NCT02623881|Hormones|hormones|mesh-ancestor
19590634|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590635|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309601|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309602|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309603|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19590636|NCT02624089|Ropivacaine|ropivacaine|mesh-list
19590637|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
19590638|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
19590639|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590640|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590641|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
19590642|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590643|NCT02623816|Omeprazole|omeprazole|mesh-list
19590644|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19590645|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590646|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19590647|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590648|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590649|NCT02623920|Rituximab|rituximab|mesh-list
19590650|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19590651|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19590652|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590653|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590654|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
19590655|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590656|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590657|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19590658|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
19590659|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590660|NCT02623751|Exemestane|exemestane|mesh-list
19590661|NCT02623751|Entinostat|entinostat|mesh-list
19590662|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590663|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19590664|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19590665|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590666|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590667|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19590668|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
19590669|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590670|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590671|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19590672|NCT02623621|Bevacizumab|bevacizumab|mesh-list
19590673|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590674|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124670|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124671|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124672|NCT00015873|Cytarabine|cytarabine|mesh-list
20124673|NCT00015873|Prednisolone|prednisolone|mesh-list
20124674|NCT00015873|Methotrexate|methotrexate|mesh-list
20124675|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
20124676|NCT00015873|Vincristine|vincristine|mesh-list
20124677|NCT00015873|Asparaginase|asparaginase|mesh-list
20124678|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20124679|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
20124680|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20124681|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124682|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124683|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
20309604|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590675|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19590676|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19590677|NCT02623621|Growth Substances|growth substances|mesh-ancestor
19590678|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590679|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
19590680|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19590681|NCT02623738|Latanoprost|latanoprost|mesh-list
19590682|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19590683|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
19590684|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19590685|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
19590686|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590687|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124684|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124685|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124686|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124687|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124688|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20124689|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19590688|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19590689|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
20309605|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20309606|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20309607|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590690|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590691|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590692|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19590693|NCT02623673|Dexamethasone|dexamethasone|mesh-list
19590694|NCT02623673|Bevacizumab|bevacizumab|mesh-list
19590695|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590696|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590697|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19590698|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19590699|NCT02623673|Growth Substances|growth substances|mesh-ancestor
19590700|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590701|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19590702|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309608|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20309609|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20309610|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309611|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
20309612|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20124690|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
20124691|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124692|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20124693|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
20124694|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124695|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124696|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309613|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20309614|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20309615|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
20309616|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309617|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
20309618|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
20309619|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19590703|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
19590704|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
19590705|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590706|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590707|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
19590708|NCT02623673|Hormones|hormones|mesh-ancestor
19590709|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590710|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19590711|NCT02623569|Atenolol|atenolol|mesh-list
19590712|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19590713|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20124697|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124698|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124699|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20124700|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
20124701|NCT00015873|Hormones|hormones|mesh-ancestor
20124702|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124703|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20124704|NCT00015886|Docetaxel|docetaxel|mesh-list
19590714|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
19590715|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
19590716|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590717|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590718|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19590719|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19590720|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19590721|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
19590722|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590723|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590724|NCT02623595|Molgramostim|molgramostim|mesh-list
19590725|NCT02623595|Sargramostim|sargramostim|mesh-list
19590726|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
19590727|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590728|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590729|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
19590730|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590731|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590732|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
19590733|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590734|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590735|NCT02623504|Carbamazepine|carbamazepine|mesh-list
19590736|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
19590737|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
19590738|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19590739|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590740|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590741|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19590742|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19590743|NCT02623504|Analgesics|analgesics|mesh-ancestor
19590744|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
19590745|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590746|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20124705|NCT00015886|Fluorouracil|fluorouracil|mesh-list
20124706|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124707|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124708|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124709|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124710|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124711|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
20124712|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124713|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124714|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
20124715|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124716|NCT00015899|Lonafarnib|lonafarnib|mesh-list
20124717|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309620|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
19590747|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19590748|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590749|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19590750|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19590751|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
19590752|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20309621|NCT00669344|Rivastigmine|rivastigmine|mesh-list
19590753|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590754|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
19590755|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19590756|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
19590757|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173389|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20309622|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19256558|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590758|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590759|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19590760|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
19590761|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590762|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124718|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124719|NCT00015912|Interferons|interferons|mesh-list
20124720|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
20124721|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
20124722|NCT00015912|Thalidomide|thalidomide|mesh-list
20124723|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124724|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
19590763|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19590764|NCT02623205|Citalopram|citalopram|mesh-list
19590765|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19590766|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19590767|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19590768|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590769|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590770|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
19590771|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590772|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19590773|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
19590774|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19590775|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
19590776|NCT02623062|Antacids|antacids|mesh-ancestor
19590777|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590778|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590779|NCT02623127|Sunitinib|sunitinib|mesh-list
19590780|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590781|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19590782|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19590783|NCT02623127|Growth Substances|growth substances|mesh-ancestor
19590784|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590785|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
19590786|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19590787|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590788|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590789|NCT02623036|Enalapril|enalapril|mesh-list
19590790|NCT02623036|Lisinopril|lisinopril|mesh-list
19590791|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19590792|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
19590793|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590794|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590795|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19590796|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19590797|NCT02623036|Protective Agents|protective agents|mesh-ancestor
19590798|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590799|NCT02623049|Anticoagulants|anticoagulants|mesh-list
19590800|NCT02623231|Citalopram|citalopram|mesh-list
19590801|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19590802|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19590803|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19590804|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590805|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590806|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
19590807|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590808|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19590809|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
19590810|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19590811|NCT02623153|Docetaxel|docetaxel|mesh-list
19590812|NCT02623153|Capecitabine|capecitabine|mesh-list
19590813|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
19590814|NCT02623153|Tegafur|tegafur|mesh-list
19590815|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590816|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
19590817|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124725|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124726|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
19590818|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
19590819|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590820|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19590821|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
19590822|NCT02623114|Methylphenidate|methylphenidate|mesh-list
19590823|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19590824|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19590825|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590826|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19590827|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19590828|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19590829|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590830|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
19590831|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590832|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19590833|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
19590834|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
19590835|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19590836|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19590837|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
19590838|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590839|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590840|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590841|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19590842|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19590843|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19657440|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657441|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
19657442|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657443|NCT03867799|Nivolumab|nivolumab|mesh-list
19657444|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657445|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657446|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657447|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657448|NCT03866239|Atezolizumab|atezolizumab|mesh-list
19657449|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
19657450|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657451|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20124727|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124728|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124729|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
20124730|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20124731|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20124732|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20124733|NCT00015912|Growth Substances|growth substances|mesh-ancestor
20124734|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124735|NCT00015925|Entinostat|entinostat|mesh-list
20124736|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124737|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20124738|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124739|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124740|NCT00015938|Docetaxel|docetaxel|mesh-list
20124741|NCT00015938|Vinorelbine|vinorelbine|mesh-list
20124742|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124743|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124744|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124745|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124746|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124747|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124748|NCT00015951|Cytarabine|cytarabine|mesh-list
20124749|NCT00015951|Bevacizumab|bevacizumab|mesh-list
20124750|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
20124751|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20124752|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124753|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20124754|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19657481|NCT03853187|Durvalumab|durvalumab|mesh-list
19657482|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19657483|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657484|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657485|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
19657486|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590844|NCT02622906|Pasireotide|pasireotide|mesh-list
19590845|NCT02622906|Hormones|hormones|mesh-ancestor
19590846|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590847|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590848|NCT02622854|Insulin|insulin|mesh-list
19590849|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19590850|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590851|NCT02622503|Rituximab|rituximab|mesh-list
19590852|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19590853|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590854|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
19590855|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590856|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590857|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19590858|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19590859|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
19590860|NCT02622555|Mirabegron|mirabegron|mesh-list
19590861|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19590862|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19590863|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19590864|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
19590865|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590866|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590867|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590868|NCT02622555|Urological Agents|urological agents|mesh-ancestor
20124755|NCT00015951|Growth Substances|growth substances|mesh-ancestor
19590869|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
19590870|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
19590871|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590872|NCT02622672|Vitamins|vitamins|mesh-ancestor
19590873|NCT02622802|Acetaminophen|acetaminophen|mesh-list
19590874|NCT02622802|Azithromycin|azithromycin|mesh-list
19590875|NCT02622802|Erythromycin|erythromycin|mesh-list
19590876|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
19590877|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19590878|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
19590879|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19590880|NCT02622802|Analgesics|analgesics|mesh-ancestor
19590881|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
19590882|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590883|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590884|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
19590885|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19590886|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590887|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590888|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19590889|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590890|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590891|NCT02622477|Pirfenidone|pirfenidone|mesh-list
19590892|NCT02622477|Analgesics|analgesics|mesh-ancestor
19590893|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
19590894|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590895|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590896|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19590897|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19590898|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19590899|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19590900|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590901|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19590902|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19590903|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19590904|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
19590905|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19590906|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590907|NCT02622334|Latanoprost|latanoprost|mesh-list
19590908|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19590909|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19590910|NCT02622386|Riboflavin|riboflavin|mesh-list
19590911|NCT02622386|Vitamins|vitamins|mesh-ancestor
19590912|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
19590913|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590914|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
19590915|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20124756|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590916|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
19590917|NCT02622126|Atropine|atropine|mesh-list
19590918|NCT02622126|Ephedrine|ephedrine|mesh-list
19590919|NCT02622126|Morphine|morphine|mesh-list
19590920|NCT02622126|Bupivacaine|bupivacaine|mesh-list
19590921|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
19590922|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
19590923|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590924|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590925|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
19590926|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590927|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19590928|NCT02622126|Narcotics|narcotics|mesh-ancestor
19590929|NCT02622126|Analgesics|analgesics|mesh-ancestor
19590930|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19590931|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19590932|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19590933|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
19590934|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19590935|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
20309623|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309624|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309625|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
20309626|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309627|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309628|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20309629|NCT00669344|Protective Agents|protective agents|mesh-ancestor
20124757|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124758|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124759|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
20124760|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124761|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
20124762|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124763|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124764|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
19590936|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
19590937|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
19590938|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19590939|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19590940|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
19590941|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590942|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590943|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20124765|NCT00015951|Analgesics|analgesics|mesh-ancestor
20309630|NCT00669370|Docetaxel|docetaxel|mesh-list
20309631|NCT00669370|Capecitabine|capecitabine|mesh-list
20309632|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309633|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309634|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
19590944|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
19590945|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19590946|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
20309635|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
20309636|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309637|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20309638|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
20309639|NCT00669435|Losartan|losartan|mesh-list
20309640|NCT00669435|Amlodipine|amlodipine|mesh-list
20309641|NCT00669435|Simvastatin|simvastatin|mesh-list
20309642|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20309643|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20309644|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20309645|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309646|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20309647|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309648|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309649|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20309650|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20309651|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
20309652|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20309653|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20309654|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309655|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19590947|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
19590948|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
19590949|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20124766|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
19590950|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
19590951|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590952|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590953|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19590954|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
19590955|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
19590956|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19590957|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
19590958|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19590959|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124767|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124768|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124769|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124770|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124771|NCT00015964|Gefitinib|gefitinib|mesh-list
20124772|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124773|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20124774|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124775|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124776|NCT00015977|Interleukin-12|interleukin-12|mesh-list
19590960|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19590961|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19590962|NCT02622022|Morphine|morphine|mesh-list
19590963|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19590964|NCT02622022|Narcotics|narcotics|mesh-ancestor
19590965|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19590966|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590967|NCT02622022|Analgesics|analgesics|mesh-ancestor
19590968|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
19590969|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19590970|NCT02621957|Pravastatin|pravastatin|mesh-list
19590971|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19590972|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19590973|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
19590974|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590975|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19590976|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19590977|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590978|NCT02621970|Cisplatin|cisplatin|mesh-list
19590979|NCT02621970|Docetaxel|docetaxel|mesh-list
19590980|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19590981|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
19590982|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
19590983|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
19590984|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590985|NCT02621905|Itraconazole|itraconazole|mesh-list
19590986|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19590987|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
19590988|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19590989|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20309656|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19590990|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19590991|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19590992|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19590993|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19590994|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
19590995|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19590996|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19590997|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19590998|NCT02621827|Calcifediol|calcifediol|mesh-list
19590999|NCT02621827|Vitamins|vitamins|mesh-ancestor
19591000|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
19591001|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591002|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19591003|NCT02621554|Resveratrol|resveratrol|mesh-list
19591004|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
19591005|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591006|NCT02621554|Protective Agents|protective agents|mesh-ancestor
19591007|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591008|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124777|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20124778|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
20124779|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124780|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19591009|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20124781|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20124782|NCT00015977|Growth Substances|growth substances|mesh-ancestor
20124783|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124784|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124785|NCT00015990|Thalidomide|thalidomide|mesh-list
20124786|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124787|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
20124788|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124789|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
20124790|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20124791|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124792|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20309657|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19591010|NCT02621515|Nivolumab|nivolumab|mesh-list
19591011|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19591012|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591013|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19591014|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591015|NCT02621385|Midazolam|midazolam|mesh-list
19591016|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19591017|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19591018|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591019|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591020|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19591021|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19591022|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19591023|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19591024|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
19591025|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
19591026|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
19591027|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
19591028|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591029|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591030|NCT02621489|Metformin|metformin|mesh-list
19591031|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
19591032|NCT02621489|Exenatide|exenatide|mesh-list
19591033|NCT02621489|Biguanides|biguanides|mesh-list
19591034|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19591035|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591036|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19591037|NCT02621489|Incretins|incretins|mesh-ancestor
19591038|NCT02621489|Hormones|hormones|mesh-ancestor
19591039|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20124793|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20124794|NCT00015990|Growth Substances|growth substances|mesh-ancestor
20124795|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
19657490|NCT03811015|Cisplatin|cisplatin|mesh-list
19657491|NCT03811015|Nivolumab|nivolumab|mesh-list
19657492|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657493|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657494|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657495|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309658|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20309659|NCT00669487|Lamivudine|lamivudine|mesh-list
20309660|NCT00669487|Stavudine|stavudine|mesh-list
20309661|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20309662|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20309663|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309664|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309665|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
20124796|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124797|NCT00016016|Cytarabine|cytarabine|mesh-list
20124798|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
20124799|NCT00016016|Alvocidib|alvocidib|mesh-list
20124800|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124801|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
20124802|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124803|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124804|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
20124805|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124806|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124807|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
20309666|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124808|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124809|NCT00016016|Analgesics|analgesics|mesh-ancestor
20124810|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
19591040|NCT02621359|Doxycycline|doxycycline|mesh-list
19591041|NCT02621359|Levofloxacin|levofloxacin|mesh-list
19591042|NCT02621359|Ofloxacin|ofloxacin|mesh-list
19591043|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
19591044|NCT02621359|Omeprazole|omeprazole|mesh-list
19591045|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19591046|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591047|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19591048|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591049|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591050|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591051|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591052|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
19591053|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19591054|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19591055|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19591056|NCT02621359|Renal Agents|renal agents|mesh-ancestor
19591057|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19591058|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19591059|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591060|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20124811|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20124812|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124813|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124814|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124815|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124816|NCT00016016|Growth Substances|growth substances|mesh-ancestor
20124817|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20124818|NCT00016042|Interferons|interferons|mesh-list
20124819|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
20124820|NCT00016042|Fluorouracil|fluorouracil|mesh-list
20124821|NCT00016042|Sargramostim|sargramostim|mesh-list
20124822|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
19591061|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19591062|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19591063|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19591064|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19591065|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591066|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591067|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
19591068|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591069|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19591070|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19591071|NCT02621320|Vitamin D|vitamin d|mesh-list
19591072|NCT02621320|Vitamins|vitamins|mesh-ancestor
19591073|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
19591074|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591075|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19591076|NCT02621255|Bupivacaine|bupivacaine|mesh-list
19591077|NCT02621255|Anesthetics|anesthetics|mesh-list
19591078|NCT02621255|Sevoflurane|sevoflurane|mesh-list
19591079|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591080|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591081|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591082|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
19591083|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591084|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19591085|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19591086|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
19591087|NCT02621112|Imiquimod|imiquimod|mesh-list
19591088|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19591089|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
19591090|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591091|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591092|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
19591093|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
19591094|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591095|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
19591096|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19591097|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19591098|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591099|NCT02620995|Urological Agents|urological agents|mesh-ancestor
19591100|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
20309667|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19591101|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20124823|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591102|NCT02620800|Leucovorin|leucovorin|mesh-list
19591103|NCT02620800|Paclitaxel|paclitaxel|mesh-list
19591104|NCT02620800|Bevacizumab|bevacizumab|mesh-list
19591105|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
19591106|NCT02620800|Calcium|calcium|mesh-list
19591107|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
19591108|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19591109|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591110|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
19591111|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
19591112|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
19591113|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591114|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19591115|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19591116|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19591117|NCT02620800|Growth Substances|growth substances|mesh-ancestor
20309668|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20309669|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
20309670|NCT00669565|Bavituximab|bavituximab|mesh-list
20309671|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20309672|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591118|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591119|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19591120|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19591121|NCT02620800|Antidotes|antidotes|mesh-ancestor
19591122|NCT02620800|Protective Agents|protective agents|mesh-ancestor
19591123|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
19591124|NCT02620800|Vitamins|vitamins|mesh-ancestor
19591125|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
19591126|NCT02620813|Tretinoin|tretinoin|mesh-list
19591127|NCT02620813|Isotretinoin|isotretinoin|mesh-list
19591128|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
19591129|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591130|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
19591131|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
19591132|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19591133|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19591134|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591135|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
19591136|NCT02620748|Coagulants|coagulants|mesh-ancestor
19591137|NCT02620839|Cisplatin|cisplatin|mesh-list
19591138|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591139|NCT02620761|Fenoldopam|fenoldopam|mesh-list
19591140|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19591141|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
19591142|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
19591143|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
19591144|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591145|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591146|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591147|NCT02620605|Cabergoline|cabergoline|mesh-list
19591148|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19591149|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19591150|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
19591151|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
19591152|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591153|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591154|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591155|NCT02620618|Infliximab|infliximab|mesh-list
19591156|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
19591157|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591158|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19591159|NCT02620566|Bupivacaine|bupivacaine|mesh-list
19591160|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591161|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
19591162|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591163|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591164|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
19591165|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591166|NCT02620501|Lidocaine|lidocaine|mesh-list
19591167|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591168|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
20309673|NCT00669591|Bavituximab|bavituximab|mesh-list
19591169|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591170|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591171|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
19591172|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591173|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19591174|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19591175|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19591176|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591177|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591178|NCT02620631|Morphine|morphine|mesh-list
19591179|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591180|NCT02620631|Narcotics|narcotics|mesh-ancestor
19591181|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591182|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591183|NCT02620631|Analgesics|analgesics|mesh-ancestor
20124824|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124825|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124826|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124827|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
20124828|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591184|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
19591185|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591186|NCT02620423|Leucovorin|leucovorin|mesh-list
19591187|NCT02620423|Gemcitabine|gemcitabine|mesh-list
19591188|NCT02620423|Fluorouracil|fluorouracil|mesh-list
19591189|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
19591190|NCT02620423|Irinotecan|irinotecan|mesh-list
19591191|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19591192|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
19591193|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591194|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591195|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
19591196|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591197|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591198|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19591199|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
19591200|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591201|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19591202|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19591203|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19591204|NCT02620423|Antidotes|antidotes|mesh-ancestor
19591205|NCT02620423|Protective Agents|protective agents|mesh-ancestor
19591206|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
19591207|NCT02620423|Vitamins|vitamins|mesh-ancestor
19591208|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
19591209|NCT02620150|Citalopram|citalopram|mesh-list
19591210|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19591211|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19591212|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591213|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591214|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591215|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
19591216|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591217|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19591218|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
19591219|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19591220|NCT02620163|Amlodipine|amlodipine|mesh-list
19591221|NCT02620163|Telmisartan|telmisartan|mesh-list
19591222|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
19591223|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19591224|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19591225|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19591226|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591227|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591228|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19591229|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124829|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
20124830|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124831|NCT00016055|Temozolomide|temozolomide|mesh-list
20124832|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124833|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
20124834|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124835|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124836|NCT00016068|Valganciclovir|valganciclovir|mesh-list
20124837|NCT00016068|Ganciclovir|ganciclovir|mesh-list
20124838|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20124839|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
19591230|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
20124840|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591231|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19591232|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19591233|NCT02620163|Diuretics|diuretics|mesh-ancestor
19591234|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
19591235|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19591236|NCT02620189|Adalimumab|adalimumab|mesh-list
19591237|NCT02620189|Etanercept|etanercept|mesh-list
19591238|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
19591239|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19591240|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19591241|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19591242|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19591243|NCT02620189|Analgesics|analgesics|mesh-ancestor
19591244|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
19591245|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591246|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591247|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591248|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19591249|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
19591250|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19591251|NCT02620124|Hormones|hormones|mesh-list
19591252|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591253|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591254|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
19591255|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19591256|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
19591257|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19591258|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19591259|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19591260|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591261|NCT02620215|Dinoprostone|dinoprostone|mesh-list
19591262|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
19591263|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19591264|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591265|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
19591266|NCT02620345|Progestins|progestins|mesh-ancestor
19591267|NCT02620345|Hormones|hormones|mesh-ancestor
19591268|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591269|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591270|NCT02620293|Emollients|emollients|mesh-list
19591271|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
19591272|NCT02619981|Lidocaine|lidocaine|mesh-list
19591273|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591274|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
19591275|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591276|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591277|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
19591278|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591279|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19591280|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19591281|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20309674|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19591282|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591283|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591284|NCT02620280|Paclitaxel|paclitaxel|mesh-list
19591285|NCT02620280|Carboplatin|carboplatin|mesh-list
19591286|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19591287|NCT02620280|Atezolizumab|atezolizumab|mesh-list
19591288|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19591289|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591290|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
19591291|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
19591292|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
19591293|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591294|NCT02619929|Vinorelbine|vinorelbine|mesh-list
19591295|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19591296|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591297|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
19591298|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
19591299|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
19591300|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591301|NCT02619994|Levofloxacin|levofloxacin|mesh-list
20309675|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591302|NCT02619994|Ofloxacin|ofloxacin|mesh-list
19591303|NCT02619994|Linezolid|linezolid|mesh-list
19591304|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
19591305|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19591306|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591307|NCT02619994|Renal Agents|renal agents|mesh-ancestor
19591308|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591309|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19591310|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19591311|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591312|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591313|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591314|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19591315|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19591316|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19591317|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
19591318|NCT02620072|Insulin|insulin|mesh-list
19591319|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19591320|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591321|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
19591322|NCT02620007|Rifaximin|rifaximin|mesh-list
19591323|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591324|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591325|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19591326|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19591327|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591328|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591329|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591330|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19591331|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19591332|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591333|NCT02619773|Mupirocin|mupirocin|mesh-list
19591334|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591335|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124841|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20124842|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124843|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124844|NCT00016081|Ribavirin|ribavirin|mesh-list
20124845|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
20124846|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124847|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
20124848|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591336|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19591337|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591338|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591339|NCT02619786|Colistin|colistin|mesh-list
19591340|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591341|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591342|NCT02619669|Letrozole|letrozole|mesh-list
19591343|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591344|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19591345|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19591346|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591347|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591348|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19591349|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
19591350|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591351|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591352|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
19591353|NCT02619513|Ropivacaine|ropivacaine|mesh-list
19591354|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19591355|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591356|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591357|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19591358|NCT02619513|Analgesics|analgesics|mesh-ancestor
19591359|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
19591360|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591361|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19591362|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19591363|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19591364|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
19591365|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591366|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124849|NCT00016094|Bevacizumab|bevacizumab|mesh-list
20124850|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19591367|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591368|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
19591369|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
19591370|NCT02619747|Antacids|antacids|mesh-ancestor
19591371|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591372|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20124851|NCT00016094|Antibodies|antibodies|mesh-list
20124852|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
20124853|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20124854|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124855|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20124856|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20124857|NCT00016094|Growth Substances|growth substances|mesh-ancestor
20124858|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124859|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124860|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
20124861|NCT00016107|Bevacizumab|bevacizumab|mesh-list
20124862|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20124863|NCT00016107|Docetaxel|docetaxel|mesh-list
20124864|NCT00016107|Estramustine|estramustine|mesh-list
19657523|NCT03793179|Carboplatin|carboplatin|mesh-list
19657524|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
19657525|NCT03793179|Pemetrexed|pemetrexed|mesh-list
19657526|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657527|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657528|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657529|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657530|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19657531|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19657532|NCT03793166|Nivolumab|nivolumab|mesh-list
19657533|NCT03793166|Ipilimumab|ipilimumab|mesh-list
19657534|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657535|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657536|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657537|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124865|NCT00016107|Antibodies|antibodies|mesh-list
20124866|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
20124867|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20124868|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124869|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20124870|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20124871|NCT00016107|Growth Substances|growth substances|mesh-ancestor
20124872|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124873|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124874|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
20124875|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124876|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309676|NCT00669643|Rifampin|rifampin|mesh-list
20309677|NCT00669643|Dapsone|dapsone|mesh-list
20309678|NCT00669643|Clofazimine|clofazimine|mesh-list
20309679|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20309680|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
20309681|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309682|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309683|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
20309684|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20309685|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309686|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309687|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20309688|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20309689|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20309690|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20124877|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124878|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124879|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124880|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
20124881|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20124882|NCT00016133|Leucovorin|leucovorin|mesh-list
20124883|NCT00016133|Fluorouracil|fluorouracil|mesh-list
20124884|NCT00016133|Vaccines|vaccines|mesh-list
19657558|NCT03782818|Olaparib|olaparib|mesh-list
19657559|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20124885|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
20124886|NCT00016133|Calcium|calcium|mesh-list
19591373|NCT02619448|Paclitaxel|paclitaxel|mesh-list
20124887|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
20124888|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
20124889|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124890|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20124891|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
20124892|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124893|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124894|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124895|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124896|NCT00016133|Antidotes|antidotes|mesh-ancestor
20124897|NCT00016133|Protective Agents|protective agents|mesh-ancestor
20124898|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
20124899|NCT00016133|Vitamins|vitamins|mesh-ancestor
20124900|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
20124901|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20124902|NCT00016159|Idarubicin|idarubicin|mesh-list
20124903|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
20124904|NCT00016159|Tretinoin|tretinoin|mesh-list
20124905|NCT00016159|Lintuzumab|lintuzumab|mesh-list
19591374|NCT02619448|Carboplatin|carboplatin|mesh-list
19591375|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19591376|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591377|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
19591378|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
19591379|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
19591380|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591381|NCT02619578|Remifentanil|remifentanil|mesh-list
20124906|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20309691|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20309692|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20309693|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
19591382|NCT02619578|Propofol|propofol|mesh-list
19591383|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
19591384|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19591385|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591386|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591387|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19591388|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
19591389|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
19591390|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591391|NCT02619578|Narcotics|narcotics|mesh-ancestor
19591392|NCT02619578|Analgesics|analgesics|mesh-ancestor
19591393|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
19591394|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591395|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19591396|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19591397|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19591398|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19591399|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19591400|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
19591401|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591402|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591403|NCT02619526|Carvedilol|carvedilol|mesh-list
19591404|NCT02619526|Nebivolol|nebivolol|mesh-list
19591405|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19591406|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19591407|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19591408|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591409|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591410|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591411|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19591412|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
19591413|NCT02619526|Protective Agents|protective agents|mesh-ancestor
19591414|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19591415|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591416|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19591417|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
19591418|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19591419|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19591420|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19591421|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19591422|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19591423|NCT02619201|Ondansetron|ondansetron|mesh-list
19591424|NCT02619201|Metoclopramide|metoclopramide|mesh-list
20124907|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591425|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
19591426|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
19591427|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591428|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591429|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591430|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
19591431|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
19591432|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19591433|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
19591434|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591435|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591436|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19591437|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19591438|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591439|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20124908|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124909|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124910|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124911|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124912|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
20124913|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20124914|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20124915|NCT00016172|Doxorubicin|doxorubicin|mesh-list
20124916|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19591440|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19591441|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19591442|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19591443|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
19591444|NCT02619162|Letrozole|letrozole|mesh-list
19591445|NCT02619162|Nintedanib|nintedanib|mesh-list
20124917|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20124918|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124919|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124920|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124921|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309694|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20309695|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19591446|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591447|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19591448|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19591449|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591450|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591451|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19591452|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
19591453|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591454|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591455|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19591456|NCT02619266|Megestrol|megestrol|mesh-list
19591457|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
19591458|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19591459|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19591460|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19591461|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
19591462|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19591463|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591464|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19591465|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19591466|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19591467|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591468|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
19591469|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19591470|NCT02619149|Tazobactam|tazobactam|mesh-list
19591471|NCT02619149|Piperacillin|piperacillin|mesh-list
19591472|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20309696|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20309697|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309698|NCT00669656|Vitamin D|vitamin d|mesh-list
20309699|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
20309700|NCT00669656|Vitamins|vitamins|mesh-list
20309701|NCT00669656|Vitamin E|vitamin e|mesh-list
20309702|NCT00669656|Tocopherols|tocopherols|mesh-list
20309703|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
19591473|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20124922|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309704|NCT00669656|Selenium|selenium|mesh-list
20309705|NCT00669656|Lycopene|lycopene|mesh-list
19591474|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591475|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20309706|NCT00669656|Daidzein|daidzein|mesh-list
20309707|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
19591476|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591477|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591478|NCT02619019|Dexamethasone|dexamethasone|mesh-list
19591479|NCT02619019|Meperidine|meperidine|mesh-list
19591480|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19591481|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
19591482|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
19591483|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591484|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591485|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591486|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
19591487|NCT02619019|Hormones|hormones|mesh-ancestor
19591488|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591489|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19591490|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591491|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591492|NCT02619019|Narcotics|narcotics|mesh-ancestor
19591493|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591494|NCT02619019|Analgesics|analgesics|mesh-ancestor
19591495|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
19591496|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19591497|NCT02619032|Fentanyl|fentanyl|mesh-list
19591498|NCT02619032|Remifentanil|remifentanil|mesh-list
19591499|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591500|NCT02619032|Narcotics|narcotics|mesh-ancestor
19591501|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591502|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591503|NCT02619032|Analgesics|analgesics|mesh-ancestor
19591504|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
19591505|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591506|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19591507|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19591508|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
19591509|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
19591510|NCT02618876|Nalbuphine|nalbuphine|mesh-list
19591511|NCT02618876|Bupivacaine|bupivacaine|mesh-list
19591512|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591513|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
19591514|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591515|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591516|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
19591517|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591518|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591519|NCT02618876|Narcotics|narcotics|mesh-ancestor
19591520|NCT02618876|Analgesics|analgesics|mesh-ancestor
19591521|NCT02618824|Tryptophan|tryptophan|mesh-list
19591522|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19591523|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
19591524|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19591525|NCT02618668|Ketamine|ketamine|mesh-list
19591526|NCT02618668|Propofol|propofol|mesh-list
19591527|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19591528|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591529|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591530|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19591531|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
19591532|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
19591533|NCT02618668|Analgesics|analgesics|mesh-ancestor
19591534|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
19591535|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591536|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19591537|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20309708|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591538|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19591539|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591540|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591541|NCT02618577|Edoxaban|edoxaban|mesh-list
20124923|NCT00016185|Docetaxel|docetaxel|mesh-list
20124924|NCT00016185|Alvocidib|alvocidib|mesh-list
20124925|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124926|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
20124927|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124928|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124929|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124930|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
20309709|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20309710|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20309711|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
20309712|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309713|NCT00669656|Protective Agents|protective agents|mesh-ancestor
20309714|NCT00669656|Trace Elements|trace elements|mesh-ancestor
20309715|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309716|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20309717|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20309718|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309719|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
20309720|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20309721|NCT00669656|Estrogens|estrogens|mesh-ancestor
20309722|NCT00669656|Hormones|hormones|mesh-ancestor
20309723|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309724|NCT00669695|Atorvastatin|atorvastatin|mesh-list
19591542|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19591543|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
19591544|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19591545|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
19591546|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591547|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591548|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
19591549|NCT02618395|Hydrocodone|hydrocodone|mesh-list
19591550|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591551|NCT02618395|Narcotics|narcotics|mesh-ancestor
19591552|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591553|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591554|NCT02618395|Analgesics|analgesics|mesh-ancestor
19591555|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
19591556|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591557|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
19591558|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
19591559|NCT02618564|Sennosides|sennosides|mesh-list
19591560|NCT02618564|Laxatives|laxatives|mesh-ancestor
19591561|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591562|NCT02618720|Ornidazole|ornidazole|mesh-list
19591563|NCT02618720|Amebicides|amebicides|mesh-ancestor
19591564|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19591565|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19591566|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591567|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19591568|NCT02618603|Triamcinolone|triamcinolone|mesh-list
19591569|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19591570|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19591571|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
19591572|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19591573|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19591574|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19591575|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19591576|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20124931|NCT00016185|Growth Substances|growth substances|mesh-ancestor
20124932|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124933|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20124934|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124935|NCT00016198|Leucovorin|leucovorin|mesh-list
20124936|NCT00016198|Fluorouracil|fluorouracil|mesh-list
20124937|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
20124938|NCT00016198|Calcium|calcium|mesh-list
20124939|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
20124940|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20124941|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591577|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591578|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
19591579|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20124942|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
20309725|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19591580|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309726|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20309727|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
20309728|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309729|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20309730|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20309731|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309732|NCT00669721|Heparin|heparin|mesh-list
20309733|NCT00669721|Calcium heparin|calcium heparin|mesh-list
20309734|NCT00669721|Nadroparin|nadroparin|mesh-list
20309735|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
20309736|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20309737|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20309738|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309739|NCT00669747|Carboplatin|carboplatin|mesh-list
19591581|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19591582|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
19591583|NCT02618603|Hormones|hormones|mesh-ancestor
19591584|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591585|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19591586|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
19591587|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591588|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19591589|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591590|NCT02618356|Raltitrexed|raltitrexed|mesh-list
19591591|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19591592|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
19591593|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591594|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591595|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19591596|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591597|NCT02618499|Oxytocin|oxytocin|mesh-list
19591598|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
19591599|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19591600|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591601|NCT02618317|Minocycline|minocycline|mesh-list
19591602|NCT02618317|Heparin|heparin|mesh-list
19591603|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
19591604|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591605|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19591606|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19591607|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591608|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591609|NCT02618096|Oxytocin|oxytocin|mesh-list
19591610|NCT02618096|Dinoprostone|dinoprostone|mesh-list
19591611|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
19591612|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20124943|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124944|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20124945|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124946|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124947|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
20124948|NCT00016198|Antidotes|antidotes|mesh-ancestor
20124949|NCT00016198|Protective Agents|protective agents|mesh-ancestor
20124950|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
20124951|NCT00016198|Vitamins|vitamins|mesh-ancestor
20124952|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
20124953|NCT00016224|Thalidomide|thalidomide|mesh-list
20124954|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124955|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
20124956|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124957|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
20124958|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20124959|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20124960|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20124961|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20124962|NCT00016224|Growth Substances|growth substances|mesh-ancestor
20124963|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
20124964|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124965|NCT00016263|Dacarbazine|dacarbazine|mesh-list
20309740|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591613|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124966|NCT00016263|Oblimersen|oblimersen|mesh-list
20124967|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124968|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
19591614|NCT02618733|Clopidogrel|clopidogrel|mesh-list
19591615|NCT02618733|Ticagrelor|ticagrelor|mesh-list
19591616|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19591617|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19591618|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19591619|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19591620|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
20124969|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124970|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124971|NCT00016276|Tamoxifen|tamoxifen|mesh-list
20124972|NCT00016276|Paclitaxel|paclitaxel|mesh-list
20124973|NCT00016276|Razoxane|razoxane|mesh-list
20124974|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
20124975|NCT00016276|Doxorubicin|doxorubicin|mesh-list
20124976|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20124977|NCT00016276|Trastuzumab|trastuzumab|mesh-list
20124978|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
20124979|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20124980|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20124981|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
19591621|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591622|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591623|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124982|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
20124983|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
20124984|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20124985|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20124986|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
20124987|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20124988|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20124989|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20124990|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
20124991|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20124992|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20124993|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20124994|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20124995|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20124996|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20124997|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20124998|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
20124999|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125000|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125001|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19657560|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657561|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657562|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657563|NCT03782376|Ustekinumab|ustekinumab|mesh-list
19657564|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
20309741|NCT00669773|Docetaxel|docetaxel|mesh-list
19657585|NCT03772028|Cisplatin|cisplatin|mesh-list
19657586|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125002|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20309742|NCT00669773|Doxorubicin|doxorubicin|mesh-list
19657587|NCT03767348|Nivolumab|nivolumab|mesh-list
20309743|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19591624|NCT02618057|Levofloxacin|levofloxacin|mesh-list
19591625|NCT02618057|Ofloxacin|ofloxacin|mesh-list
19591626|NCT02618057|Prednisolone|prednisolone|mesh-list
19591627|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19591628|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
19591629|NCT02618057|Hormones|hormones|mesh-ancestor
19591630|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591631|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591632|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19591633|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591634|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19591635|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591636|NCT02618057|Renal Agents|renal agents|mesh-ancestor
19591637|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591638|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19591639|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19591640|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309744|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309745|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309746|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309747|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
19591641|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591642|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19591643|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19591644|NCT02617862|Anesthetics|anesthetics|mesh-list
19591645|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591646|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256559|NCT04483115|Urological Agents|urological agents|mesh-ancestor
19591647|NCT02617849|Paclitaxel|paclitaxel|mesh-list
20309748|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309749|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20309750|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20309751|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20309752|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309753|NCT00669786|Menotropins|menotropins|mesh-list
20309754|NCT00669786|Hormones|hormones|mesh-list
20309755|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20309756|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309757|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591648|NCT02617849|Carboplatin|carboplatin|mesh-list
19591649|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
19591650|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19591651|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591652|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
19591653|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
19591654|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
19591655|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591656|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19591657|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
19591658|NCT02617680|Desflurane|desflurane|mesh-list
19591659|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19591660|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
19591661|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591662|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591663|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19591664|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
19591665|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20125003|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20125004|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20125005|NCT00016276|Protective Agents|protective agents|mesh-ancestor
20125006|NCT00016289|Interleukin-12|interleukin-12|mesh-list
20125007|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20125008|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
20125009|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125010|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20125011|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19591666|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
19657588|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20125012|NCT00016289|Growth Substances|growth substances|mesh-ancestor
19591667|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591668|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591669|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19591670|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
19591671|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
19591672|NCT02617680|Protective Agents|protective agents|mesh-ancestor
19591673|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19591674|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
19591675|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
19591676|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591677|NCT02617810|Midazolam|midazolam|mesh-list
19591678|NCT02617810|Warfarin|warfarin|mesh-list
19591679|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19591680|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19591681|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591682|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591683|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19591684|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19591685|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19591686|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19591687|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
19591688|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
19591689|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
19591690|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
19591691|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591692|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591693|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
19591694|NCT02617771|Vitamin D|vitamin d|mesh-list
19591695|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
19591696|NCT02617771|Vitamins|vitamins|mesh-ancestor
19591697|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
19591698|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591699|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19591700|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19591701|NCT02617459|Betaxolol|betaxolol|mesh-list
19591702|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19591703|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19591704|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19591705|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
19591706|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
19591707|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591708|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591709|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19591710|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19591711|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19591712|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
19591713|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591714|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591715|NCT02617758|Fentanyl|fentanyl|mesh-list
19591716|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591717|NCT02617758|Narcotics|narcotics|mesh-ancestor
19591718|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591719|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591720|NCT02617758|Analgesics|analgesics|mesh-ancestor
19591721|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
19591722|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591723|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19591724|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19591725|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
19591726|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
19591727|NCT02617654|Liraglutide|liraglutide|mesh-list
19591728|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19591729|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125013|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
20125014|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125015|NCT00016302|Leucovorin|leucovorin|mesh-list
20125016|NCT00016302|Cytarabine|cytarabine|mesh-list
20125017|NCT00016302|Dexamethasone|dexamethasone|mesh-list
20125018|NCT00016302|Prednisone|prednisone|mesh-list
20125019|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
20125020|NCT00016302|Doxorubicin|doxorubicin|mesh-list
20125021|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20125022|NCT00016302|Methotrexate|methotrexate|mesh-list
20309758|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19591730|NCT02617654|Incretins|incretins|mesh-ancestor
20125023|NCT00016302|Vincristine|vincristine|mesh-list
20309759|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
20125024|NCT00016302|Daunorubicin|daunorubicin|mesh-list
20125025|NCT00016302|Asparaginase|asparaginase|mesh-list
20125026|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
20125027|NCT00016302|Pegaspargase|pegaspargase|mesh-list
20125028|NCT00016302|Thioguanine|thioguanine|mesh-list
19591731|NCT02617654|Hormones|hormones|mesh-ancestor
19591732|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591733|NCT02617485|Prednisone|prednisone|mesh-list
19591734|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
19591735|NCT02617485|Rituximab|rituximab|mesh-list
19591736|NCT02617485|Doxorubicin|doxorubicin|mesh-list
19591737|NCT02617485|Vincristine|vincristine|mesh-list
19591738|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19591739|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
19591740|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591741|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19591742|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19591743|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
19591744|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591745|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591746|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19591747|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19591748|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19591749|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125029|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
20125030|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125031|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
20125032|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125033|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125034|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125035|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
20125036|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125037|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125038|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125039|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125040|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
20125041|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
20125042|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591750|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19591751|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591752|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125043|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20125044|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
20125045|NCT00016302|Hormones|hormones|mesh-ancestor
20125046|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125047|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125048|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20125049|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125050|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125051|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125052|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20125053|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
20125054|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20125055|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125056|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
20125057|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
20125058|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20125059|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125060|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
19591753|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
19591754|NCT02617485|Hormones|hormones|mesh-ancestor
19591755|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591756|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19591757|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19591758|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
19591759|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
19591760|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
19591761|NCT02617121|Gabapentin|gabapentin|mesh-list
19591762|NCT02617121|Ramosetron|ramosetron|mesh-list
19591763|NCT02617121|Analgesics|analgesics|mesh-ancestor
19591764|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
19591765|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591766|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591767|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
19591768|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20125061|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125062|NCT00016302|Antidotes|antidotes|mesh-ancestor
19591769|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19591770|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591771|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19591772|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19591773|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19591774|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591775|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591776|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
19591777|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
19591778|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
19591779|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591780|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19591781|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
19591782|NCT02617199|Fentanyl|fentanyl|mesh-list
19591783|NCT02617199|Analgesics|analgesics|mesh-list
19591784|NCT02617199|Ropivacaine|ropivacaine|mesh-list
19591785|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
19591786|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591787|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591788|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591789|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
19591790|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591791|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19591792|NCT02617199|Narcotics|narcotics|mesh-ancestor
19591793|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19591794|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19591795|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
19591796|NCT02617290|Clopidogrel|clopidogrel|mesh-list
19591797|NCT02617290|Ticagrelor|ticagrelor|mesh-list
19591798|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19591799|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19591800|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19591801|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19591802|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
19591803|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591804|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591805|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591806|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
19591807|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19591808|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591809|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591810|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
19591811|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591812|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591813|NCT02617017|Buspirone|buspirone|mesh-list
19591814|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19591815|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19591816|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591817|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591818|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19591819|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19591820|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
19591821|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591822|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591823|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
19591824|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591825|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591826|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19591827|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19591828|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591829|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591830|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591831|NCT02616770|Perflubron|perflubron|mesh-list
19591832|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19591833|NCT02616692|Sorafenib|sorafenib|mesh-list
19591834|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591835|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19591836|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591837|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591838|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
19591839|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19591840|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591841|NCT02616822|Resveratrol|resveratrol|mesh-list
19591842|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
19591843|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591844|NCT02616822|Protective Agents|protective agents|mesh-ancestor
19591845|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591846|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591847|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19591848|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
19591849|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19591850|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19591851|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591852|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
19591853|NCT02616731|Coagulants|coagulants|mesh-ancestor
19591854|NCT02616874|Romidepsin|romidepsin|mesh-list
19591855|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19591856|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591857|NCT02616861|Praliciguat|praliciguat|mesh-list
19591858|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19591859|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
19591860|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591861|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591862|NCT02616848|Everolimus|everolimus|mesh-list
19591863|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591864|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19591865|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
19591866|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591867|NCT02616640|Dexamethasone|dexamethasone|mesh-list
19591868|NCT02616640|Durvalumab|durvalumab|mesh-list
19591869|NCT02616640|Pomalidomide|pomalidomide|mesh-list
19591870|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19591871|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
19591872|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
19591873|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591874|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591875|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19591876|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
19591877|NCT02616640|Hormones|hormones|mesh-ancestor
19591878|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591879|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19591880|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19591881|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19591882|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
19591883|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19591884|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19591885|NCT02616640|Growth Substances|growth substances|mesh-ancestor
19591886|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
19591887|NCT02616354|Imipenem|imipenem|mesh-list
19591888|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19591889|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591890|NCT02616367|Bupivacaine|bupivacaine|mesh-list
19591891|NCT02616367|Ropivacaine|ropivacaine|mesh-list
19591892|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591893|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
19591894|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591895|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591896|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
20125063|NCT00016302|Protective Agents|protective agents|mesh-ancestor
20125064|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
20309760|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309761|NCT00669812|Cytarabine|cytarabine|mesh-list
20309762|NCT00669812|Prednisolone|prednisolone|mesh-list
20309763|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
19591897|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125065|NCT00016302|Vitamins|vitamins|mesh-ancestor
20125066|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
20125067|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125068|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125069|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125070|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125071|NCT00016315|Gemcitabine|gemcitabine|mesh-list
20125072|NCT00016315|Paclitaxel|paclitaxel|mesh-list
20125073|NCT00016315|Carboplatin|carboplatin|mesh-list
20125074|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125075|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125076|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
19657589|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125077|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125078|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
20309764|NCT00669812|Melphalan|melphalan|mesh-list
20309765|NCT00669812|Ifosfamide|ifosfamide|mesh-list
20309766|NCT00669812|Carmustine|carmustine|mesh-list
20309767|NCT00669812|Doxorubicin|doxorubicin|mesh-list
20309768|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20309769|NCT00669812|Methotrexate|methotrexate|mesh-list
20309770|NCT00669812|Etoposide|etoposide|mesh-list
19591898|NCT02616289|Emollients|emollients|mesh-list
19591899|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
19591900|NCT02616497|Aspirin|aspirin|mesh-list
19591901|NCT02616497|Triflusal|triflusal|mesh-list
19591902|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19591903|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19591904|NCT02616497|Analgesics|analgesics|mesh-ancestor
19591905|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
19591906|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591907|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591908|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19591909|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19591910|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19591911|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19591912|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591913|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19591914|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19591915|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591916|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
19591917|NCT02616419|Lidocaine|lidocaine|mesh-list
19591918|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
19591919|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
19591920|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309771|NCT00669812|Vincristine|vincristine|mesh-list
20309772|NCT00669812|Epirubicin|epirubicin|mesh-list
20309773|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309774|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
20309775|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309776|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20309777|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20309778|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
20309779|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309780|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309781|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19591921|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591922|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
19591923|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591924|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19591925|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19591926|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19591927|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591928|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591929|NCT02616315|Naltrexone|naltrexone|mesh-list
19591930|NCT02616315|Bupropion|bupropion|mesh-list
19591931|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19591932|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19591933|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591934|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
19591935|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591936|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19591937|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
19591938|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19591939|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19591940|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19591941|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19591942|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591943|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
19591944|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591945|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19591946|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19591947|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591948|NCT02616003|Liraglutide|liraglutide|mesh-list
19591949|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19591950|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591951|NCT02616003|Incretins|incretins|mesh-ancestor
19591952|NCT02616003|Hormones|hormones|mesh-ancestor
19591953|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19591954|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
20309782|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20309783|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19591955|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
19591956|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19591957|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19591958|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591959|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591960|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591961|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19591962|NCT02615977|Ethanol|ethanol|mesh-list
19591963|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19591964|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19591965|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19591966|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591967|NCT02616068|Loxoprofen|loxoprofen|mesh-list
19591968|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19591969|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19591970|NCT02616068|Analgesics|analgesics|mesh-ancestor
19591971|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
19591972|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19591973|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591974|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19591975|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19591976|NCT02615873|Levodopa|levodopa|mesh-list
19591977|NCT02615873|Carbidopa|carbidopa|mesh-list
19591978|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19591979|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19591980|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19591981|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
19591982|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591983|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591984|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591985|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19591986|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19591987|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19591988|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
19591989|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
19591990|NCT02615847|Memantine|memantine|mesh-list
19591991|NCT02615847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19591992|NCT02615847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19591993|NCT02615847|Dopamine Agents|dopamine agents|mesh-ancestor
19591994|NCT02615847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19591995|NCT02615847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19591996|NCT02615847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19591997|NCT02615847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19591998|NCT02615847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19591999|NCT02615912|Castor Oil|castor oil|mesh-list
19592000|NCT02615912|Cathartics|cathartics|mesh-ancestor
19592001|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592002|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19592003|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
19592004|NCT02615639|Entecavir|entecavir|mesh-list
19592005|NCT02615639|Telbivudine|telbivudine|mesh-list
19592006|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
19592007|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19592008|NCT02615639|Vaccines|vaccines|mesh-list
19592009|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
19592010|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592011|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
19592012|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592013|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19592014|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592015|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592016|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592017|NCT02615730|Paclitaxel|paclitaxel|mesh-list
19592018|NCT02615730|GSK2636771|gsk2636771|mesh-list
19592019|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19592020|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592021|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
19592022|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
19592023|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
19592024|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592025|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19592026|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592027|NCT02615782|Tadalafil|tadalafil|mesh-list
19592028|NCT02615782|Tamsulosin|tamsulosin|mesh-list
19592029|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
19592030|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19592031|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19592032|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592033|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592034|NCT02615782|Urological Agents|urological agents|mesh-ancestor
19592035|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19592036|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19592037|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19592038|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
19592039|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592040|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592041|NCT02615496|Aflibercept|aflibercept|mesh-list
19592042|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19592043|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19592044|NCT02615496|Growth Substances|growth substances|mesh-ancestor
19592045|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592046|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
19592047|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592048|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
19592049|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
19592050|NCT02615561|Vitamins|vitamins|mesh-ancestor
19592051|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
19592052|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592053|NCT02615691|Factor VIII|factor viii|mesh-list
19592054|NCT02615691|BAX 855|bax 855|mesh-list
19592055|NCT02615691|Coagulants|coagulants|mesh-ancestor
19592056|NCT02615574|Interferons|interferons|mesh-list
19592057|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19592058|NCT02615574|Celecoxib|celecoxib|mesh-list
19592059|NCT02615574|Vaccines|vaccines|mesh-list
19592060|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
19592061|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592062|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592063|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
19592064|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592065|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592066|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592067|NCT02615574|Analgesics|analgesics|mesh-ancestor
19592068|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
19592069|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592070|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592071|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592072|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19592073|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592074|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592075|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592076|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
19592077|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19592078|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19592079|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592080|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
19592081|NCT02615366|Coagulants|coagulants|mesh-ancestor
19592082|NCT02615223|Bicalutamide|bicalutamide|mesh-list
19592083|NCT02615223|Hormones|hormones|mesh-list
19592084|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19592085|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592086|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592087|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
19592088|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
19592089|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592090|NCT02615288|Vitamin D|vitamin d|mesh-list
19592091|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
19592092|NCT02615288|Vitamins|vitamins|mesh-ancestor
19592093|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
19592094|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592095|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19592096|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19592097|NCT02615041|Meropenem|meropenem|mesh-list
19592098|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19592099|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592100|NCT02615340|Melatonin|melatonin|mesh-list
19592101|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
19592102|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592103|NCT02615340|Protective Agents|protective agents|mesh-ancestor
19592104|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592105|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592106|NCT02615301|Vitamin D|vitamin d|mesh-list
19592107|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
19592108|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
20309784|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20309785|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309786|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20309787|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
20309788|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309789|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19592109|NCT02615301|Vitamins|vitamins|mesh-list
19592110|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
19592111|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592112|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19592113|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19592114|NCT02615080|Pemirolast|pemirolast|mesh-list
19592115|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
19592116|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
19592117|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592118|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592119|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592120|NCT02615106|Endostar protein|endostar protein|mesh-list
19592121|NCT02615106|Endostatins|endostatins|mesh-list
19592122|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19592123|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19592124|NCT02615106|Growth Substances|growth substances|mesh-ancestor
19592125|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592126|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
19592127|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592128|NCT02615262|Dexamethasone|dexamethasone|mesh-list
19592129|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592130|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
19592131|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
19592132|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592133|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592134|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592135|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
19592136|NCT02615262|Hormones|hormones|mesh-ancestor
19592137|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592138|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19592139|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592140|NCT02614937|Squalamine|squalamine|mesh-list
19592141|NCT02614937|Ranibizumab|ranibizumab|mesh-list
19592142|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19592143|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19592144|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19592145|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19592146|NCT02614937|Growth Substances|growth substances|mesh-ancestor
19592147|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592148|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
19592149|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592150|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19592151|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592152|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19592153|NCT02614937|Protective Agents|protective agents|mesh-ancestor
19592154|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19592155|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19592156|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19592157|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
19592158|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592159|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592160|NCT02614612|Prednisone|prednisone|mesh-list
19592161|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
19592162|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19592163|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20125079|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125080|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125081|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
20125082|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
20125083|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125084|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125085|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125086|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
20125087|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125088|NCT00016328|Sirolimus|sirolimus|mesh-list
20125089|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20125090|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125091|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19592164|NCT02614612|Prednisolone|prednisolone|mesh-list
19592165|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
19592166|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19592167|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
19592168|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592169|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
19592170|NCT02614612|Hormones|hormones|mesh-ancestor
19592171|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592172|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592173|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19592174|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592175|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
19592176|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
19592177|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592178|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592179|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19592180|NCT02614612|Protective Agents|protective agents|mesh-ancestor
19592181|NCT02614833|Paclitaxel|paclitaxel|mesh-list
19592182|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19592183|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592184|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
19592185|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
19592186|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
19592187|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657590|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657591|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125092|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125093|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
20125094|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125095|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
20125096|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125097|NCT00016341|Tamoxifen|tamoxifen|mesh-list
20125098|NCT00016341|Paclitaxel|paclitaxel|mesh-list
20125099|NCT00016341|Doxorubicin|doxorubicin|mesh-list
20125100|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20125101|NCT00016341|Megestrol|megestrol|mesh-list
20125102|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
20125103|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125104|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125105|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125106|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125107|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
19657608|NCT03743662|Bevacizumab|bevacizumab|mesh-list
19657609|NCT03743662|Nivolumab|nivolumab|mesh-list
19657610|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657611|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657612|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19657613|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19657614|NCT03743662|Growth Substances|growth substances|mesh-ancestor
19657615|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657616|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
19657617|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20125108|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125109|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20125110|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125111|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125112|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125113|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125114|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20125115|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
20125116|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125117|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125118|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20125119|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20309790|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
20309791|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
20309792|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20309793|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20309794|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309795|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
20309796|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309797|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309798|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
19666219|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125120|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20125121|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20125122|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20125123|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20125124|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
20125125|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20125126|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20125127|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20125128|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
20125129|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20125130|NCT00016367|Gemcitabine|gemcitabine|mesh-list
20125131|NCT00016367|Cisplatin|cisplatin|mesh-list
20125132|NCT00016367|Trastuzumab|trastuzumab|mesh-list
19592188|NCT02614482|Fesoterodine|fesoterodine|mesh-list
19592189|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19592190|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19592191|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
19592192|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592193|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592194|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592195|NCT02614482|Urological Agents|urological agents|mesh-ancestor
19592196|NCT02614456|Interferons|interferons|mesh-list
19592197|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
19592198|NCT02614456|Nivolumab|nivolumab|mesh-list
19592199|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19592200|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592201|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19592202|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592203|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
19592204|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592205|NCT02614352|Candesartan|candesartan|mesh-list
19592206|NCT02614352|Atorvastatin|atorvastatin|mesh-list
19592207|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19592208|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19592209|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
19592210|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592211|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19592212|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19592213|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592214|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19592215|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19592216|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19592217|NCT02614339|Metformin|metformin|mesh-list
19592218|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19592219|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592220|NCT02614534|Mitomycins|mitomycins|mesh-list
19592221|NCT02614534|Mitomycin|mitomycin|mesh-list
19592222|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19592223|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592224|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
19592225|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592226|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19592227|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592228|NCT02614404|Piperaquine|piperaquine|mesh-list
19592229|NCT02614404|Artenimol|artenimol|mesh-list
20125133|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125134|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125135|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
20125136|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125137|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
20125138|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125139|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592230|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
19592231|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592232|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19592233|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592234|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592235|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
19592236|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19592237|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19592238|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592239|NCT02614118|Acetaminophen|acetaminophen|mesh-list
19592240|NCT02614118|Ketorolac|ketorolac|mesh-list
19592241|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19592242|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592243|NCT02614118|Analgesics|analgesics|mesh-ancestor
19592244|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
19592245|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592246|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592247|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
19592248|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592249|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592250|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592251|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592252|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592253|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592254|NCT02614248|Protective Agents|protective agents|mesh-list
19592255|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592256|NCT02614508|Ofatumumab|ofatumumab|mesh-list
19592257|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19592258|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592259|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
19592260|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592261|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
19592262|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19592263|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19592264|NCT02613715|Ethanol|ethanol|mesh-list
19592265|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19592266|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592267|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592268|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592269|NCT02613585|Permethrin|permethrin|mesh-list
19592270|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592271|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592272|NCT02613676|Bilirubin|bilirubin|mesh-list
19592273|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
19592274|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592275|NCT02613676|Protective Agents|protective agents|mesh-ancestor
19592276|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592277|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
19592278|NCT02613494|Scopolamine|scopolamine|mesh-list
19592279|NCT02613494|Bromides|bromides|mesh-list
19592280|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19592281|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
20309799|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20309800|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592282|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19592283|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19592284|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19592285|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
19592286|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592287|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592288|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592289|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
19592290|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
19592291|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592292|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592293|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
19592294|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
19592295|NCT02613455|Triamcinolone|triamcinolone|mesh-list
19592296|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19592297|NCT02613455|Lidocaine|lidocaine|mesh-list
19592298|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
19592299|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
19592300|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592301|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309801|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
20309802|NCT00669812|Hormones|hormones|mesh-ancestor
20309803|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309804|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20309805|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
20309806|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
20309807|NCT00669890|Busulfan|busulfan|mesh-list
20309808|NCT00669890|Methotrexate|methotrexate|mesh-list
20309809|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
19592302|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
19592303|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309810|NCT00669890|Tacrolimus|tacrolimus|mesh-list
20309811|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
20309812|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19592304|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19592305|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19592306|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19592307|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19592308|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592309|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592310|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
19592311|NCT02613455|Hormones|hormones|mesh-ancestor
19592312|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592313|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19592314|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
19592315|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19592316|NCT02613247|Hylan|hylan|mesh-list
19592317|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
19592318|NCT02613247|Protective Agents|protective agents|mesh-ancestor
19592319|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592320|NCT02613130|Fluorides|fluorides|mesh-list
19592321|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
19592322|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
19592323|NCT02613130|Protective Agents|protective agents|mesh-ancestor
19592324|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592325|NCT02613091|Clemastine|clemastine|mesh-list
19592326|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
19592327|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
19592328|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19592329|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
19592330|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
19592331|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592332|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592333|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592334|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20125140|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125141|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
20125142|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592335|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19592336|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
19592337|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19592338|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19592339|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19592340|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592341|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592342|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
19592343|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19592344|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592345|NCT02613052|Propofol|propofol|mesh-list
19592346|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19592347|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592348|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592349|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19592350|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
19592351|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
19592352|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
19592353|NCT02613013|Pilocarpine|pilocarpine|mesh-list
20125143|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20125144|NCT00016380|Dexamethasone|dexamethasone|mesh-list
20125145|NCT00016380|Ondansetron|ondansetron|mesh-list
20125146|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125147|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
20125148|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
20125149|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125150|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125151|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20125152|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
20125153|NCT00016380|Hormones|hormones|mesh-ancestor
20125154|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125155|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125156|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125157|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
20125158|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
20125159|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20125160|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
20125161|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20125162|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125163|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20125164|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19592354|NCT02613013|Miotics|miotics|mesh-ancestor
19592355|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
19592356|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592357|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592358|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19592359|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19592360|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
19592361|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592362|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592363|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
19592364|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
19592365|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592366|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
19592367|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
19592368|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
19592369|NCT02613039|Estrogens|estrogens|mesh-list
20125165|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20125166|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19592370|NCT02613039|Progestins|progestins|mesh-list
19592371|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19592372|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592373|NCT02613039|Hormones|hormones|mesh-ancestor
19592374|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592375|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19592376|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
19592377|NCT02613026|Docetaxel|docetaxel|mesh-list
19592378|NCT02613026|Pirarubicin|pirarubicin|mesh-list
19592379|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19592380|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
19592381|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592382|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592383|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19592384|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
19592385|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592386|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592387|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19592388|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
19592389|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
19592390|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
19592391|NCT02612896|Praziquantel|praziquantel|mesh-list
19592392|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
19592393|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19592394|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657618|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657619|NCT03737981|Venetoclax|venetoclax|mesh-list
19657620|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
19657621|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657622|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20125167|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20125168|NCT00016406|Paclitaxel|paclitaxel|mesh-list
20125169|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
20125170|NCT00016406|Doxorubicin|doxorubicin|mesh-list
20125171|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125172|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125173|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125174|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
19657631|NCT03729349|Golimumab|golimumab|mesh-list
19657632|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19657633|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19657634|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657635|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
19657636|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657637|NCT03718767|Nivolumab|nivolumab|mesh-list
19657638|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657639|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657640|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657641|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125175|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125176|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125177|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657645|NCT03712345|Vilobelimab|vilobelimab|mesh-list
19657646|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19657647|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657648|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
19657649|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125178|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
19592395|NCT02612792|Atorvastatin|atorvastatin|mesh-list
19592396|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19592397|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19592398|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
19592399|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592400|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19592401|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19592402|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592403|NCT02612545|Piperaquine|piperaquine|mesh-list
19592404|NCT02612545|Artenimol|artenimol|mesh-list
19592405|NCT02612545|Mefloquine|mefloquine|mesh-list
19592406|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
19592407|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19592408|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19592409|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592410|NCT02612480|Aspirin|aspirin|mesh-list
19592411|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
19592412|NCT02612480|Clopidogrel|clopidogrel|mesh-list
19592413|NCT02612480|Ticagrelor|ticagrelor|mesh-list
19592414|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592415|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592416|NCT02612480|Analgesics|analgesics|mesh-ancestor
19592417|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
19592418|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592419|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592420|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592421|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592422|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19592423|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20125179|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125180|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125181|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125182|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
20125183|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19592424|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592425|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19592426|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592427|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592428|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
19592429|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19592430|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19592431|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19592432|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
19592433|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592434|NCT02612701|Nicotine|nicotine|mesh-list
19592435|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19592436|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
19592437|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592438|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592439|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19592440|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19592441|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
19592442|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592443|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592444|NCT02612649|Ramosetron|ramosetron|mesh-list
19592445|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
19592446|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
19592447|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592448|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125184|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20125185|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125186|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19592449|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592450|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19592451|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
19592452|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592453|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592454|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19592455|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19592456|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19592457|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
19749560|NCT04923893|Lenalidomide|lenalidomide|mesh-list
20125187|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125188|NCT00016419|Cyclosporine|cyclosporine|mesh-list
19592458|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749561|NCT04923893|Bortezomib|bortezomib|mesh-list
19592459|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19592460|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20125189|NCT00016419|Cyclosporins|cyclosporins|mesh-list
20125190|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20125191|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125192|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125193|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125194|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
20125195|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125196|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
20125197|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592461|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592462|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
19592463|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19592464|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592465|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592466|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592467|NCT02612363|Analgesics|analgesics|mesh-ancestor
19592468|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
19592469|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592470|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19592471|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19592472|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19592473|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
19592474|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592475|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592476|NCT02612272|Ketorolac|ketorolac|mesh-list
19592477|NCT02612272|Betamethasone|betamethasone|mesh-list
19592478|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592479|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592480|NCT02612272|Analgesics|analgesics|mesh-ancestor
19592481|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
19592482|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592483|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592484|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592485|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592486|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592487|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592488|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592489|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
19592490|NCT02612272|Hormones|hormones|mesh-ancestor
19592491|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592492|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19592493|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
19592494|NCT02612298|Metoprolol|metoprolol|mesh-list
19592495|NCT02612298|Arotinolol|arotinolol|mesh-list
20125198|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
20125199|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125200|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20309813|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
20309814|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309815|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20309816|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20309817|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
20309818|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309819|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309820|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20309821|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20309822|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
20309823|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20309824|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19592496|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20125201|NCT00016432|Exemestane|exemestane|mesh-list
20125202|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125203|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20125204|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20125205|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125206|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592497|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20125207|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19592498|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
19592499|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
19592500|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592501|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592502|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19592503|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19592504|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19592505|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
19592506|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592507|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592508|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19592509|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
19592510|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19592511|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592512|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592513|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592514|NCT02612181|Analgesics|analgesics|mesh-ancestor
19592515|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
19592516|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592517|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19592518|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19592519|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19592520|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
19592521|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592522|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592523|NCT02612259|Tryptophan|tryptophan|mesh-list
19592524|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19592525|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
19592526|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19592527|NCT02612233|Pregabalin|pregabalin|mesh-list
19592528|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19592529|NCT02612233|Analgesics|analgesics|mesh-ancestor
19592530|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
19592531|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592532|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592533|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
19592534|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19592535|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19592536|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592537|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19592538|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19592539|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19592540|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592541|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19592542|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19592543|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19592544|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592545|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
19592546|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
19592547|NCT02612207|Bilirubin|bilirubin|mesh-list
19592548|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
19592549|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592550|NCT02612207|Protective Agents|protective agents|mesh-ancestor
19592551|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592552|NCT02612116|Ticagrelor|ticagrelor|mesh-list
19592553|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19592554|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19592555|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19592556|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19592557|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
19592558|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592559|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592560|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592561|NCT02611973|Aspirin|aspirin|mesh-list
19592562|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
19592563|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592564|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592565|NCT02611973|Analgesics|analgesics|mesh-ancestor
19592566|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
19592567|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592568|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592569|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592570|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592571|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19592572|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20125208|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
20125209|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125210|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125211|NCT00016445|Hormones|hormones|mesh-list
20125212|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125213|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125214|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
20125215|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20125216|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125217|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
20125218|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125219|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125220|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125221|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
19592573|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592574|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19592575|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592576|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592577|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
19592578|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309825|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
20309826|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
20309827|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309828|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20309829|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20309830|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19592579|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
19592580|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19592581|NCT02612220|Hemostatics|hemostatics|mesh-list
19592582|NCT02612220|Coagulants|coagulants|mesh-ancestor
19592583|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19592584|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
19592585|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19592586|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592587|NCT02611921|Ketamine|ketamine|mesh-list
19592588|NCT02611921|Analgesics|analgesics|mesh-ancestor
19592589|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
19592590|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592591|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592592|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19592593|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19592594|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
19592595|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
19592596|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592597|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19592598|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19592599|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592600|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592601|NCT02611700|Paclitaxel|paclitaxel|mesh-list
19592602|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20608192|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608193|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20608194|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20608195|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20608196|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20608197|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20608198|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20608199|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19592603|NCT02611700|Cisplatin|cisplatin|mesh-list
19592604|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
19592605|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309831|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19592606|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125222|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125223|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125224|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125225|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
20125226|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19592607|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
19592608|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
19592609|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
19592610|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592611|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19592612|NCT02611596|Ranolazine|ranolazine|mesh-list
19592613|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19592614|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19592615|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592616|NCT02611635|Warfarin|warfarin|mesh-list
19592617|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
19592618|NCT02611635|Dabigatran|dabigatran|mesh-list
19592619|NCT02611635|Apixaban|apixaban|mesh-list
19592620|NCT02611635|Edoxaban|edoxaban|mesh-list
19592621|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
19592622|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19592623|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
19592624|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19592625|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
19592626|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592627|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592628|NCT02611804|Diclofenac|diclofenac|mesh-list
19592629|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592630|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592631|NCT02611804|Analgesics|analgesics|mesh-ancestor
19592632|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
19592633|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592634|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592635|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592636|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592637|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592638|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592639|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592640|NCT02611492|Cytarabine|cytarabine|mesh-list
19592641|NCT02611492|Dexamethasone|dexamethasone|mesh-list
19592642|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19592643|NCT02611492|Methotrexate|methotrexate|mesh-list
19592644|NCT02611492|Vincristine|vincristine|mesh-list
19592645|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
19592646|NCT02611492|Sargramostim|sargramostim|mesh-list
19592647|NCT02611492|Lenograstim|lenograstim|mesh-list
19592648|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592649|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
19592650|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
19592651|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592652|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592653|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592654|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
19592655|NCT02611492|Hormones|hormones|mesh-ancestor
19592656|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592657|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19592658|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592659|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19592660|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
19592661|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19592662|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19592663|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
19592664|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592665|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
19592666|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592667|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19592668|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19592669|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
19592670|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592671|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19592672|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19592673|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
19592674|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
19592675|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
19592676|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19592677|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
19592678|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592679|NCT02611518|Metformin|metformin|mesh-list
19592680|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19592681|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19592682|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592683|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19592684|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19592685|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
19592686|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592687|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19592688|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19592689|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592690|NCT02611505|Esketamine|esketamine|mesh-list
19592691|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
19592692|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19592693|NCT02611336|Tadalafil|tadalafil|mesh-list
19592694|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
20125227|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
20125228|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125229|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125230|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20125231|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
20125232|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20125233|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
20125234|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125235|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20125236|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20125237|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
20125238|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
20125239|NCT00016523|Protective Agents|protective agents|mesh-ancestor
20125240|NCT00016549|Bevacizumab|bevacizumab|mesh-list
20125241|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20125242|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592695|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19592696|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19592697|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592698|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592699|NCT02611336|Urological Agents|urological agents|mesh-ancestor
19592700|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19592701|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592702|NCT02611258|Tadalafil|tadalafil|mesh-list
19592703|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
19592704|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19592705|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19592706|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592707|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592708|NCT02611258|Urological Agents|urological agents|mesh-ancestor
19592709|NCT02611466|Naproxen|naproxen|mesh-list
19592710|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592711|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592712|NCT02611466|Analgesics|analgesics|mesh-ancestor
19592713|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
19592714|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592715|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592716|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592717|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592718|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
19592719|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592720|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592721|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592722|NCT02610920|Iron|iron|mesh-list
19592723|NCT02610920|Trace Elements|trace elements|mesh-ancestor
19592724|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
19592725|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657650|NCT03684811|Gemcitabine|gemcitabine|mesh-list
19657651|NCT03684811|Nivolumab|nivolumab|mesh-list
19657652|NCT03684811|Azacitidine|azacitidine|mesh-list
19657653|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657654|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19657655|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
19657656|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657657|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
19657658|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19657659|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657660|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657661|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
19657662|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657663|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20125243|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20125244|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20608200|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20608201|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20608202|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20608203|NCT02245087|Atorvastatin|atorvastatin|mesh-list
19592726|NCT02610933|Vitamin K|vitamin k|mesh-list
19592727|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
19592728|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
19592729|NCT02610933|Vitamins|vitamins|mesh-ancestor
19592730|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
19592731|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592732|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19592733|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
19592734|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19592735|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
19592736|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592737|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592738|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
19592739|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19592740|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19592741|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
19592742|NCT02610933|Coagulants|coagulants|mesh-ancestor
19592743|NCT02610881|Iron|iron|mesh-list
19592744|NCT02610881|Trace Elements|trace elements|mesh-list
19592745|NCT02610881|Folic Acid|folic acid|mesh-list
19592746|NCT02610881|Micronutrients|micronutrients|mesh-list
19592747|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592748|NCT02610881|Hematinics|hematinics|mesh-ancestor
19592749|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
19592750|NCT02610881|Vitamins|vitamins|mesh-ancestor
19592751|NCT02610712|Ketamine|ketamine|mesh-list
19592752|NCT02610712|Analgesics|analgesics|mesh-ancestor
19592753|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
19592754|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592755|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592756|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19592757|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19592758|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
19592759|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
19592760|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592761|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19592762|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19592763|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592764|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592765|NCT02610829|Vitamin E|vitamin e|mesh-list
19592766|NCT02610829|Tocopherols|tocopherols|mesh-list
19592767|NCT02610829|Tocotrienols|tocotrienols|mesh-list
19592768|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
19592769|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
19592770|NCT02610829|Vitamins|vitamins|mesh-ancestor
19592771|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
19592772|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592773|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
19592774|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592775|NCT02610829|Protective Agents|protective agents|mesh-ancestor
19592776|NCT02610686|Chloroquine|chloroquine|mesh-list
19592777|NCT02610686|Amebicides|amebicides|mesh-ancestor
19592778|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19592779|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19256560|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
19592780|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592781|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
19592782|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592783|NCT02610647|Anesthetics|anesthetics|mesh-list
19592784|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592785|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608204|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20608205|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20608206|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
20608207|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608208|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20608209|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20608210|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608211|NCT02245126|Lidocaine|lidocaine|mesh-list
20608212|NCT02245126|Bupivacaine|bupivacaine|mesh-list
20608213|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
20608214|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
20608215|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592786|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19592787|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592788|NCT02610556|Cisplatin|cisplatin|mesh-list
19592789|NCT02610556|Docetaxel|docetaxel|mesh-list
19592790|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592791|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19592792|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19592793|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19592794|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592795|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
19592796|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20309832|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20309833|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
19592797|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
19592798|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592799|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
19592800|NCT02610504|Protective Agents|protective agents|mesh-ancestor
19592801|NCT02610348|Vaccines|vaccines|mesh-list
19592802|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20125245|NCT00016549|Growth Substances|growth substances|mesh-ancestor
20125246|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125247|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
20125248|NCT00016588|Tenofovir|tenofovir|mesh-list
20125249|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
20125250|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592803|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
19592804|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592805|NCT02610153|Vitamin K|vitamin k|mesh-list
19592806|NCT02610153|Vitamins|vitamins|mesh-ancestor
19592807|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
19592808|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592809|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19592810|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19592811|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592812|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
19592813|NCT02610153|Coagulants|coagulants|mesh-ancestor
19592814|NCT02610010|Cisplatin|cisplatin|mesh-list
19592815|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592816|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
19592817|NCT02610088|Gliclazide|gliclazide|mesh-list
19592818|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19592819|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592820|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19592821|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592822|NCT02610127|Factor VIII|factor viii|mesh-list
19592823|NCT02610127|Coagulants|coagulants|mesh-ancestor
19592824|NCT02610075|Adavosertib|adavosertib|mesh-list
19592825|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592826|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592827|NCT02609932|Interferons|interferons|mesh-list
19592828|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
19592829|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592830|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
19592831|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592832|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
19592833|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
19592834|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19592835|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19592836|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
20125251|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20125252|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125253|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125254|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125255|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20125256|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19256561|NCT04475939|Niraparib|niraparib|mesh-list
19592837|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592838|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592839|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592840|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592841|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20125257|NCT00016601|Ritonavir|ritonavir|mesh-list
19592842|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592843|NCT02609997|Dexamethasone|dexamethasone|mesh-list
19592844|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
19592845|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592846|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
19592847|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
19592848|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592849|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309834|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309835|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309836|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20309837|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
20309838|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309839|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309840|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20309841|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20309842|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309843|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309844|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309845|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20309846|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20347183|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20608216|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125258|NCT00016601|Nelfinavir|nelfinavir|mesh-list
20125259|NCT00016601|Indinavir|indinavir|mesh-list
20125260|NCT00016601|Nevirapine|nevirapine|mesh-list
20125261|NCT00016601|Efavirenz|efavirenz|mesh-list
20125262|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19592850|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592851|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
19592852|NCT02609997|Hormones|hormones|mesh-ancestor
19592853|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19592854|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19592855|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592856|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
19592857|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
19592858|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592859|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
19592860|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19592861|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
19592862|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
19592863|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592864|NCT02609802|Sevoflurane|sevoflurane|mesh-list
19592865|NCT02609802|Desflurane|desflurane|mesh-list
19592866|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19592867|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19592868|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
19592869|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
19592870|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592871|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592872|NCT02609646|Vancomycin|vancomycin|mesh-list
19592873|NCT02609646|Meropenem|meropenem|mesh-list
19592874|NCT02609646|Tazobactam|tazobactam|mesh-list
19592875|NCT02609646|Linezolid|linezolid|mesh-list
19592876|NCT02609646|Piperacillin|piperacillin|mesh-list
19592877|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19592878|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19592879|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592880|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19592881|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592882|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592883|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19592884|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
19592885|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592886|NCT02609490|Olmesartan|olmesartan|mesh-list
19592887|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20125263|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
20125264|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20125265|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20125266|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
20125267|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125268|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592888|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20125269|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20125270|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19592889|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19592890|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19592891|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19592892|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592893|NCT02609711|Candesartan|candesartan|mesh-list
19592894|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
19592895|NCT02609711|Atorvastatin|atorvastatin|mesh-list
19592896|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19592897|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19592898|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
19592899|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592900|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19592901|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19592902|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592903|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19592904|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19592905|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19592906|NCT02609698|Aspirin|aspirin|mesh-list
19592907|NCT02609698|Clopidogrel|clopidogrel|mesh-list
19592908|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592909|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592910|NCT02609698|Analgesics|analgesics|mesh-ancestor
19592911|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
19592912|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592913|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592914|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592915|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592916|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19592917|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19592918|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592919|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19592920|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592921|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592922|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
19592923|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19592924|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19592925|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19592926|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
19592927|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592928|NCT02609477|Phentermine|phentermine|mesh-list
19592929|NCT02609477|Istradefylline|istradefylline|mesh-list
19592930|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19592931|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592932|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
19592933|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19592934|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
19592935|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
19592936|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592937|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
19592938|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592939|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592940|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
19592941|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19592942|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19592943|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
19592944|NCT02609386|Zinc|zinc|mesh-list
19592945|NCT02609386|Indomethacin|indomethacin|mesh-list
19592946|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
19592947|NCT02609386|Omeprazole|omeprazole|mesh-list
19592948|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19592949|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19592950|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
19592951|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592952|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19592953|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19592954|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
19592955|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592956|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592957|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19592958|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
20125271|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
20125272|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19592959|NCT02609386|Trace Elements|trace elements|mesh-ancestor
20125273|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19592960|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19592961|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19592962|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19592963|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19592964|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19592965|NCT02609386|Analgesics|analgesics|mesh-ancestor
19592966|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
19592967|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592968|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19592969|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
19592970|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
19592971|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19592972|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19592973|NCT02609230|TIC10 compound|tic10 compound|mesh-list
19592974|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19592975|NCT02609087|Propofol|propofol|mesh-list
19592976|NCT02609087|Sevoflurane|sevoflurane|mesh-list
19592977|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19592978|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19592979|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592980|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19592981|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
19592982|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
19592983|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19592984|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20125274|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20125275|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20125276|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125277|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20309847|NCT00670124|Menthol|menthol|mesh-list
20309848|NCT00670124|Antipruritics|antipruritics|mesh-ancestor
20309849|NCT00670124|Dermatologic Agents|dermatologic agents|mesh-ancestor
19657664|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657665|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
19657666|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657667|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125278|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20125279|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20125280|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20309850|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
20309851|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309852|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
20309853|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309854|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309855|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125281|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20125282|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20125283|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20125284|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20125285|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
20125286|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20125287|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125288|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20125289|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20125290|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20125291|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125292|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125293|NCT00016666|Propranolol|propranolol|mesh-list
20125294|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20309856|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20309857|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309858|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309859|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125295|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20125296|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
20125297|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20125298|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125299|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125300|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20125301|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20125302|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
20309860|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19592985|NCT02608944|Adenosine|adenosine|mesh-list
20309861|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20309862|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
20309863|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309864|NCT00670293|Raclopride|raclopride|mesh-list
20309865|NCT00670293|Methylphenidate|methylphenidate|mesh-list
19592986|NCT02608944|Regadenoson|regadenoson|mesh-list
19592987|NCT02608944|Analgesics|analgesics|mesh-ancestor
19592988|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
19592989|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19592990|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19592991|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19592992|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
19592993|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19592994|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
19592995|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
19592996|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19592997|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19592998|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19592999|NCT02609152|Esmolol|esmolol|mesh-list
19593000|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19593001|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19593002|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19593003|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
19593004|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593005|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593006|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593007|NCT02608918|BMS-955176|bms-955176|mesh-list
19593008|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19593009|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20309866|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20309867|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309868|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20309869|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20309870|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20309871|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309872|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
20309873|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309874|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20309875|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20309876|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309877|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20309878|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20309879|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20309880|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20309881|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
19593010|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
19593011|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593012|NCT02609061|Alendronate|alendronate|mesh-list
19593013|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19593014|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593015|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19593016|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
19593017|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125303|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20125304|NCT00016744|Genistein|genistein|mesh-list
20125305|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125306|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20125307|NCT00016744|Protective Agents|protective agents|mesh-ancestor
20125308|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125309|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20125310|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125311|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125312|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
20125313|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20125314|NCT00016744|Estrogens|estrogens|mesh-ancestor
20125315|NCT00016744|Hormones|hormones|mesh-ancestor
20125316|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125317|NCT00016835|Metronidazole|metronidazole|mesh-list
20125318|NCT00016835|Doxycycline|doxycycline|mesh-list
20125319|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125320|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20125321|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19593018|NCT02609334|Pemirolast|pemirolast|mesh-list
19593019|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
20125322|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20125323|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
20125324|NCT00016861|Irinotecan|irinotecan|mesh-list
20125325|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20125326|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125327|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125328|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125329|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125330|NCT00016874|Paclitaxel|paclitaxel|mesh-list
20125331|NCT00016874|Cisplatin|cisplatin|mesh-list
20125332|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125333|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125334|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125335|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125336|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125337|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125338|NCT00016887|Interferons|interferons|mesh-list
20125339|NCT00016887|Cytarabine|cytarabine|mesh-list
20125340|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
20125341|NCT00016887|Dexamethasone|dexamethasone|mesh-list
20125342|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
20125343|NCT00016887|Melphalan|melphalan|mesh-list
19593020|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
19593021|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593022|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593023|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593024|NCT02608931|Dronabinol|dronabinol|mesh-list
19593025|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
19593026|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593027|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19593028|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593029|NCT02608931|Analgesics|analgesics|mesh-ancestor
19593030|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
19593031|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593032|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19593033|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19593034|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593035|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593036|NCT02608931|Hormones|hormones|mesh-ancestor
19593037|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593038|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19593039|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19593040|NCT02608710|Verinurad|verinurad|mesh-list
19593041|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
19593042|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593043|NCT02608736|Valproic Acid|valproic acid|mesh-list
19593044|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
19593045|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593046|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593047|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
19593048|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593049|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593050|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
19593051|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19593052|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593053|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19593054|NCT02608788|Ketorolac|ketorolac|mesh-list
19593055|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593056|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593057|NCT02608788|Analgesics|analgesics|mesh-ancestor
19593058|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
19593059|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593060|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309882|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20309883|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309884|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20309885|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20309886|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20309887|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
20309888|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20125344|NCT00016887|Carmustine|carmustine|mesh-list
20125345|NCT00016887|Etoposide|etoposide|mesh-list
19593061|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125346|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125347|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
20125348|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593062|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593063|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19593064|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593065|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593066|NCT02608619|Choline|choline|mesh-list
19593067|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
19593068|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19593069|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
20125349|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125350|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125351|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
20125352|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125353|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593070|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593071|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19593072|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19593073|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
19593074|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
19593075|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19593076|NCT02608658|Antibodies|antibodies|mesh-list
19593077|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
19593078|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593079|NCT02608606|Tacrolimus|tacrolimus|mesh-list
19593080|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593081|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
19593082|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593083|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19593084|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593085|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593086|NCT02608437|Ipilimumab|ipilimumab|mesh-list
19593087|NCT02608437|Guadecitabine|guadecitabine|mesh-list
19593088|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19593089|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593090|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19593091|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593092|NCT02608242|Amlodipine|amlodipine|mesh-list
19593093|NCT02608242|Telmisartan|telmisartan|mesh-list
19593094|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19593095|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19593096|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19593097|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19593098|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19593099|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593100|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19593101|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593102|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
19593103|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19593104|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19593105|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
19593106|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19593107|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19593108|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593109|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19593110|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19593111|NCT02608320|Fentanyl|fentanyl|mesh-list
19593112|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19593113|NCT02608320|Narcotics|narcotics|mesh-ancestor
19593114|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593115|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593116|NCT02608320|Analgesics|analgesics|mesh-ancestor
19593117|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
19593118|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593119|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20125354|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125355|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125356|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
20125357|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
20125358|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125359|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20125360|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
20125361|NCT00016887|Hormones|hormones|mesh-ancestor
20125362|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593120|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20125363|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125364|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125365|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125366|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125367|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125368|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
20125369|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125370|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125371|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
20125372|NCT00016900|Paclitaxel|paclitaxel|mesh-list
20125373|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125374|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125375|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125376|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125377|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125378|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125379|NCT00016926|Capecitabine|capecitabine|mesh-list
19593121|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
19593122|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
19593123|NCT02608216|Paclitaxel|paclitaxel|mesh-list
19593124|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19593125|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593126|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125380|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125381|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
20125382|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125383|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125384|NCT00016939|Alvocidib|alvocidib|mesh-list
20125385|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125386|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
20125387|NCT00016939|Growth Substances|growth substances|mesh-ancestor
20125388|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125389|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20125390|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125391|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125392|NCT00016952|Leucovorin|leucovorin|mesh-list
20125393|NCT00016952|Fluorouracil|fluorouracil|mesh-list
19593127|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
19593128|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
19593129|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593130|NCT02608164|Vitamin D|vitamin d|mesh-list
19593131|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
19593132|NCT02608164|Vitamins|vitamins|mesh-ancestor
19593133|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
19593134|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593135|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19593136|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19593137|NCT02608112|Methotrexate|methotrexate|mesh-list
19593138|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19593139|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
19593140|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19593141|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593142|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19593143|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
19593144|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593145|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593146|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
19593147|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593148|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19593149|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593150|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
19593151|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593152|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19593153|NCT02607904|Cannabidiol|cannabidiol|mesh-list
19593154|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
19593155|NCT02607943|Insulin|insulin|mesh-list
19593156|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19593157|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
19593158|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19593159|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125394|NCT00016952|Irinotecan|irinotecan|mesh-list
20125395|NCT00016952|Calcium|calcium|mesh-list
20125396|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
19593160|NCT02607891|Cannabidiol|cannabidiol|mesh-list
19593161|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
19593162|NCT02607982|Paclitaxel|paclitaxel|mesh-list
19593163|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
19593164|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19593165|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593166|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19593167|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
19593168|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
19593169|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593170|NCT02608034|Itraconazole|itraconazole|mesh-list
19593171|NCT02608034|Rifampin|rifampin|mesh-list
19593172|NCT02608034|Vemurafenib|vemurafenib|mesh-list
19593173|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
19593174|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593175|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19593176|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19593177|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593178|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593179|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19593180|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
19593181|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593182|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593183|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19593184|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19593185|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
19593186|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19593187|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
19593188|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19593189|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19593190|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19593191|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19593192|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19593193|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19593194|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19593195|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593196|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19593197|NCT02608073|Capecitabine|capecitabine|mesh-list
19593198|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593199|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19593200|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
19593201|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593202|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
19593203|NCT02608060|Hematinics|hematinics|mesh-ancestor
19593204|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
19593205|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19593206|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593207|NCT02607657|Eplerenone|eplerenone|mesh-list
19593208|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19593209|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
19593210|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593211|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593212|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19593213|NCT02607657|Diuretics|diuretics|mesh-ancestor
19593214|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
19593215|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19593216|NCT02607748|Listerine|listerine|mesh-list
19593217|NCT02607748|Fluorides|fluorides|mesh-list
19593218|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
19593219|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
19593220|NCT02607748|Protective Agents|protective agents|mesh-ancestor
19593221|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593222|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19593223|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593224|NCT02607696|Zolpidem|zolpidem|mesh-list
19593225|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19593226|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19593227|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593228|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593229|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19593230|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
19593231|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
19593232|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593233|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593234|NCT02607774|Midazolam|midazolam|mesh-list
19593235|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19593236|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19593237|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593238|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593239|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19593240|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19593241|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19593242|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19593243|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
19593244|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
19593245|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
19593246|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
19593247|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593248|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593249|NCT02607579|Ropivacaine|ropivacaine|mesh-list
19593250|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
19593251|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
19593252|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593253|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593254|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
19593255|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593256|NCT02607540|Cisplatin|cisplatin|mesh-list
19593257|NCT02607540|Fluorouracil|fluorouracil|mesh-list
19593258|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593259|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
19593260|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593261|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20309889|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20309890|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593262|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593263|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
19593264|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593265|NCT02607410|Insulin|insulin|mesh-list
19593266|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19593267|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19593268|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
19593269|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
19593270|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
19593271|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
19593272|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19593273|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19593274|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593275|NCT02607410|Incretins|incretins|mesh-ancestor
19593276|NCT02607410|Hormones|hormones|mesh-ancestor
19593277|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593278|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
19593279|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593280|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125397|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20125398|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657695|NCT03606499|Ustekinumab|ustekinumab|mesh-list
19657696|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
19657697|NCT03604991|Paclitaxel|paclitaxel|mesh-list
19657698|NCT03604991|Carboplatin|carboplatin|mesh-list
19657699|NCT03604991|Nivolumab|nivolumab|mesh-list
19657700|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19657701|NCT03604991|Ipilimumab|ipilimumab|mesh-list
19657702|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19657703|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657704|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19657705|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19657706|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19657707|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657708|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657709|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20125399|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
20125400|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125401|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125402|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125403|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309891|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
20125404|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
19593281|NCT02607436|Aspirin|aspirin|mesh-list
19593282|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
19593283|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593284|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593285|NCT02607436|Analgesics|analgesics|mesh-ancestor
19593286|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
19593287|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593288|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593289|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593290|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593291|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19593292|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19593293|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593294|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19593295|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19593296|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593297|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
19593298|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19593299|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
19593300|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593301|NCT02607592|Pemetrexed|pemetrexed|mesh-list
19593302|NCT02607592|Nedaplatin|nedaplatin|mesh-list
19593303|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593304|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593305|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593306|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19593307|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19593308|NCT02607488|Lidocaine|lidocaine|mesh-list
19593309|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
19593310|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
19593311|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593312|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593313|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
19593314|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593315|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19593316|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19593317|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19593318|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19593319|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593320|NCT02607423|Gemcitabine|gemcitabine|mesh-list
19593321|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
19593322|NCT02607423|Cisplatin|cisplatin|mesh-list
19593323|NCT02607423|Docetaxel|docetaxel|mesh-list
19593324|NCT02607423|Pemetrexed|pemetrexed|mesh-list
19593325|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19593326|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593327|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19593328|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
19593329|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593330|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
19593331|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593332|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593333|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593334|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
19593335|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593336|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
19593337|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
19593338|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
19593339|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19593340|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19593341|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19593342|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19593343|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19593344|NCT02607293|Hormones|hormones|mesh-ancestor
19593345|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593346|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593347|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
19593348|NCT02607371|Apixaban|apixaban|mesh-list
19593349|NCT02607371|Edoxaban|edoxaban|mesh-list
19593350|NCT02607371|Dabigatran|dabigatran|mesh-list
19593351|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19593352|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
19593353|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19593354|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
19593355|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593356|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593357|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
19593358|NCT02607332|Paclitaxel|paclitaxel|mesh-list
19593359|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19593360|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593361|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
19593362|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
19593363|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
19593364|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593365|NCT02607072|Aspirin|aspirin|mesh-list
19593366|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593367|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593368|NCT02607072|Analgesics|analgesics|mesh-ancestor
19593369|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
19593370|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593371|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593372|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593373|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593374|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19593375|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19593376|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593377|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20125405|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20125406|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125407|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125408|NCT00016952|Antidotes|antidotes|mesh-ancestor
20125409|NCT00016952|Protective Agents|protective agents|mesh-ancestor
20125410|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
20125411|NCT00016952|Vitamins|vitamins|mesh-ancestor
20125412|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
20125413|NCT00016978|Leucovorin|leucovorin|mesh-list
20125414|NCT00016978|Fluorouracil|fluorouracil|mesh-list
20125415|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
19593378|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19593379|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593380|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
19593381|NCT02607202|Gemcitabine|gemcitabine|mesh-list
19593382|NCT02607202|Paclitaxel|paclitaxel|mesh-list
19593383|NCT02607202|Carboplatin|carboplatin|mesh-list
19593384|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19593385|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593386|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19593387|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19593388|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19593389|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593390|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19593391|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
19593392|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
19593393|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593394|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593395|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593396|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
19593397|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593398|NCT02607111|Dalteparin|dalteparin|mesh-list
19593399|NCT02607111|Tinzaparin|tinzaparin|mesh-list
19593400|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19593401|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
19593402|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19593403|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19593404|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593405|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
19593406|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19593407|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593408|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593409|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593410|NCT02607163|Analgesics|analgesics|mesh-ancestor
19593411|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
19593412|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125416|NCT00016978|Calcium|calcium|mesh-list
20125417|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
19593413|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19593414|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19593415|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19593416|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
19593417|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593418|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593419|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
19593420|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
19593421|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593422|NCT02606773|Protective Agents|protective agents|mesh-ancestor
19593423|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593424|NCT02606773|Vitamins|vitamins|mesh-ancestor
19593425|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
20309892|NCT00670345|Coagulants|coagulants|mesh-ancestor
20309893|NCT00670410|Fludarabine|fludarabine|mesh-list
20309894|NCT00670410|Busulfan|busulfan|mesh-list
20125418|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20125419|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125420|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
20125421|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125422|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125423|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309895|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
20309896|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309897|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309898|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309899|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
20309900|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309901|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
20309902|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20309903|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20309904|NCT00670423|Sirolimus|sirolimus|mesh-list
20309905|NCT00670423|Bortezomib|bortezomib|mesh-list
20309906|NCT00670423|Tacrolimus|tacrolimus|mesh-list
20309907|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20309908|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
20309909|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309910|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20125424|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125425|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
20125426|NCT00016978|Antidotes|antidotes|mesh-ancestor
20125427|NCT00016978|Protective Agents|protective agents|mesh-ancestor
20125428|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
20125429|NCT00016978|Vitamins|vitamins|mesh-ancestor
20125430|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
20125431|NCT00016991|Gefitinib|gefitinib|mesh-list
20125432|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125433|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20125434|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309911|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309912|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309913|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309914|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20309915|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20309916|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19593426|NCT02606864|Nifurtimox|nifurtimox|mesh-list
19593427|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19593428|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19593429|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19593430|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593431|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
19593432|NCT02606994|Lidocaine|lidocaine|mesh-list
19593433|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
19593434|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
19593435|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593436|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593437|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
19593438|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593439|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19593440|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19593441|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19593442|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20125435|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125436|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
20309917|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
20309918|NCT00670436|Paclitaxel|paclitaxel|mesh-list
19593443|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593444|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19593445|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19593446|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
19593447|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
19593448|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19593449|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19593450|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
19593451|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
19593452|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593453|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19593454|NCT02606981|Vitamins|vitamins|mesh-list
19593455|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
19593456|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
19593457|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593458|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
19593459|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593460|NCT02606981|Protective Agents|protective agents|mesh-ancestor
19593461|NCT02606617|Mosapride|mosapride|mesh-list
19593462|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19593463|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19593464|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
19593465|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593466|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593467|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593468|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
19593469|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19593470|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593471|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
19593472|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
19593473|NCT02606409|Propofol|propofol|mesh-list
19593474|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19593475|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593476|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593477|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19593478|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
19593479|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
19593480|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593481|NCT02606409|Analgesics|analgesics|mesh-ancestor
19593482|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
19593483|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593484|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19593485|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19593486|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19593487|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
19593488|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593489|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593490|NCT02606448|Bupivacaine|bupivacaine|mesh-list
19593491|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
19593492|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
19593493|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593494|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309919|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20309920|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20309921|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309922|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
20309923|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
20309924|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
19593495|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
19593496|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593497|NCT02606552|Aspirin|aspirin|mesh-list
19593498|NCT02606552|Clopidogrel|clopidogrel|mesh-list
19593499|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593500|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593501|NCT02606552|Analgesics|analgesics|mesh-ancestor
19593502|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
19593503|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593504|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593505|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593506|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20309925|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309926|NCT00670475|Piroxicam|piroxicam|mesh-list
20309927|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593507|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19593508|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19593509|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593510|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19593511|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19593512|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593513|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
19593514|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19593515|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20125437|NCT00017004|Hematinics|hematinics|mesh-ancestor
20125438|NCT00017017|Paclitaxel|paclitaxel|mesh-list
20125439|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19593516|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19593517|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
19593518|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593519|NCT02606539|Leucovorin|leucovorin|mesh-list
19593520|NCT02606539|Folic Acid|folic acid|mesh-list
19593521|NCT02606539|Methotrexate|methotrexate|mesh-list
19593522|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
19593523|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19593524|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
19593525|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20125440|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125441|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593526|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125442|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125443|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125444|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125445|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125446|NCT00017030|Trabectedin|trabectedin|mesh-list
20125447|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125448|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
20125449|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125450|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125451|NCT00017069|Dexamethasone|dexamethasone|mesh-list
20125452|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
19593527|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19593528|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
19593529|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593530|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593531|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
19593532|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593533|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19593534|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593535|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
19593536|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593537|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19593538|NCT02606539|Antidotes|antidotes|mesh-ancestor
19593539|NCT02606539|Protective Agents|protective agents|mesh-ancestor
19593540|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
19593541|NCT02606539|Vitamins|vitamins|mesh-ancestor
19593542|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
19593543|NCT02606539|Hematinics|hematinics|mesh-ancestor
19593544|NCT02606383|Ketoconazole|ketoconazole|mesh-list
19593545|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
19593546|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593547|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19593548|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19593549|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593550|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593551|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19593552|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
19593553|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593554|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593555|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19593556|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
19593557|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19593558|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593559|NCT02606266|Valganciclovir|valganciclovir|mesh-list
19593560|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
19593561|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593562|NCT02606084|Esketamine|esketamine|mesh-list
20125453|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125454|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
19593563|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
19593564|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20125455|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
19593565|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
19593566|NCT02605915|Carboplatin|carboplatin|mesh-list
19593567|NCT02605915|Docetaxel|docetaxel|mesh-list
19593568|NCT02605915|Doxorubicin|doxorubicin|mesh-list
19593569|NCT02605915|Trastuzumab|trastuzumab|mesh-list
19593570|NCT02605915|Atezolizumab|atezolizumab|mesh-list
19593571|NCT02605915|Pertuzumab|pertuzumab|mesh-list
20309928|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20309929|NCT00670475|Analgesics|analgesics|mesh-ancestor
20309930|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
20309931|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309932|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309933|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20309934|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593572|NCT02605915|Maytansine|maytansine|mesh-list
19593573|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19593574|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593575|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
19593576|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593577|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593578|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19593579|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
19593580|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593581|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593582|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19593583|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125456|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125457|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125458|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20125459|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
20125460|NCT00017069|Hormones|hormones|mesh-ancestor
19593584|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
19593585|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
19593586|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19593587|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19593588|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19593589|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593590|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19593591|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19593592|NCT02606032|Metronidazole|metronidazole|mesh-list
19593593|NCT02606032|Doxycycline|doxycycline|mesh-list
19593594|NCT02606032|Terbinafine|terbinafine|mesh-list
19593595|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593596|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19593597|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19593598|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19593599|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
19593600|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
19593601|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593602|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593603|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
19593604|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
20125461|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125462|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125463|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173390|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20173391|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309935|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20309936|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309937|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309938|NCT00670501|Vitamin D|vitamin d|mesh-list
20309939|NCT00670501|Teriparatide|teriparatide|mesh-list
20309940|NCT00670501|Calcium|calcium|mesh-list
19593605|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593606|NCT02605746|Ceritinib|ceritinib|mesh-list
19593607|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593608|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19593609|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593610|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593611|NCT02605772|Metformin|metformin|mesh-list
19593612|NCT02605772|Saxagliptin|saxagliptin|mesh-list
20173392|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309941|NCT00670501|Vitamins|vitamins|mesh-ancestor
19593613|NCT02605772|Acarbose|acarbose|mesh-list
20309942|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
19593614|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19593615|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593616|NCT02605772|Incretins|incretins|mesh-ancestor
19593617|NCT02605772|Hormones|hormones|mesh-ancestor
19593618|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593619|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19593620|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
19593621|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593622|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593623|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19593624|NCT02605811|Temozolomide|temozolomide|mesh-list
19593625|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19593626|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
19593627|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593628|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593629|NCT02605460|Plerixafor|plerixafor|mesh-list
19593630|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
19593631|NCT02605460|Busulfan|busulfan|mesh-list
20125464|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
20125465|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125466|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
20125467|NCT00017095|Docetaxel|docetaxel|mesh-list
20125468|NCT00017095|Fluorouracil|fluorouracil|mesh-list
20125469|NCT00017095|Epirubicin|epirubicin|mesh-list
20125470|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125471|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
20125472|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125473|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593632|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593633|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
19593634|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593635|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593636|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125474|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125475|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
20125476|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125477|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309943|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309944|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20309945|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20309946|NCT00670553|Panobinostat|panobinostat|mesh-list
20309947|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309948|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20309949|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309950|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309951|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20309952|NCT00670566|Irbesartan|irbesartan|mesh-list
20309953|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20309954|NCT00670566|Diuretics|diuretics|mesh-ancestor
20309955|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
20309956|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309957|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20309958|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20309959|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593637|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
19593638|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593639|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593640|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19593641|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19593642|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19593643|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
19593644|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125478|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125479|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125480|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125481|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
19657724|NCT03598257|Olaparib|olaparib|mesh-list
19657725|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19657726|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20309960|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20309961|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20309962|NCT00670618|Fluorides|fluorides|mesh-list
20309963|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
19657727|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657728|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657729|NCT03596645|Golimumab|golimumab|mesh-list
20125482|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
19593645|NCT02605720|Piperaquine|piperaquine|mesh-list
19593646|NCT02605720|Artenimol|artenimol|mesh-list
19593647|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
19593648|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19593649|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19593650|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593651|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
19593652|NCT02605421|Melphalan|melphalan|mesh-list
19593653|NCT02605421|Thiotepa|thiotepa|mesh-list
19593654|NCT02605421|Carboplatin|carboplatin|mesh-list
19593655|NCT02605421|Etoposide|etoposide|mesh-list
19593656|NCT02605421|Sargramostim|sargramostim|mesh-list
19593657|NCT02605421|Lenograstim|lenograstim|mesh-list
19593658|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593659|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
19593660|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593661|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593662|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19593663|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
19593664|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593665|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593666|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19593667|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19593668|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19593669|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19593670|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593671|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19593672|NCT02605694|Prednisone|prednisone|mesh-list
19593673|NCT02605694|Rituximab|rituximab|mesh-list
19593674|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19593675|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593676|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
19593677|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593678|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593679|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593680|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
19593681|NCT02605694|Hormones|hormones|mesh-ancestor
19593682|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593683|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19593684|NCT02605434|Levodopa|levodopa|mesh-list
19593685|NCT02605434|Carbidopa|carbidopa|mesh-list
19593686|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19593687|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19593688|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19593689|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
19593690|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593691|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593692|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593693|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19593694|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593695|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19593696|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
19593697|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
19593698|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
19593699|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19593700|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19593701|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593702|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
19593703|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
19593704|NCT02605356|Dexamethasone|dexamethasone|mesh-list
19593705|NCT02605356|Bortezomib|bortezomib|mesh-list
19593706|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19593707|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593708|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
19593709|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
19593710|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593711|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593712|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19593713|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
19593714|NCT02605356|Hormones|hormones|mesh-ancestor
19593715|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593716|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19593717|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593718|NCT02605213|Vancomycin|vancomycin|mesh-list
19593719|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19593720|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593721|NCT02605226|Bicalutamide|bicalutamide|mesh-list
19593722|NCT02605226|Hormones|hormones|mesh-list
19593723|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20309964|NCT00670618|Protective Agents|protective agents|mesh-ancestor
20309965|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309966|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20309967|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
20309968|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593724|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593725|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593726|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
19593727|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
19593728|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593729|NCT02604992|Dronabinol|dronabinol|mesh-list
19593730|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
19593731|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593732|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19593733|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593734|NCT02604992|Analgesics|analgesics|mesh-ancestor
19593735|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
19593736|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593737|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19593738|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19593739|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593740|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593741|NCT02604992|Hormones|hormones|mesh-ancestor
19593742|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593743|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19593744|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
19593745|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593746|NCT02604966|Artesunate|artesunate|mesh-list
19593747|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
19593748|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19593749|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19593750|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593751|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593752|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
19593753|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
19593754|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19593755|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
19593756|NCT02605265|Capecitabine|capecitabine|mesh-list
19593757|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
19593758|NCT02605265|Irinotecan|irinotecan|mesh-list
19593759|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19593760|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
19593761|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593762|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593763|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19593764|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125483|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125484|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19593765|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593766|NCT02604914|Levodopa|levodopa|mesh-list
19593767|NCT02604914|Carbidopa|carbidopa|mesh-list
19593768|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19593769|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19593770|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19593771|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
19593772|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593773|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593774|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125485|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125486|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125487|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125488|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
20125489|NCT00017108|Chlorambucil|chlorambucil|mesh-list
20125490|NCT00017108|Fludarabine|fludarabine|mesh-list
20309969|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19749562|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125491|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
19657730|NCT03596645|Infliximab|infliximab|mesh-list
20125492|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125493|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
20125494|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125495|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125496|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125497|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
20125498|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125499|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593775|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19593776|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593777|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19593778|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
19593779|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
19593780|NCT02604849|Gentamicins|gentamicins|mesh-list
19593781|NCT02604849|Neomycin|neomycin|mesh-list
19593782|NCT02604849|Streptomycin|streptomycin|mesh-list
19593783|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19593784|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593785|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19593786|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593787|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593788|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
19593789|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19593790|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593791|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593792|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593793|NCT02604940|Analgesics|analgesics|mesh-ancestor
19593794|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
19593795|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593796|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19593797|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19593798|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19593799|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
19593800|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593801|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593802|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19593803|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593804|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
19593805|NCT02604719|Ethamsylate|ethamsylate|mesh-list
19593806|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19593807|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19593808|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593809|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
19593810|NCT02604719|Coagulants|coagulants|mesh-ancestor
19593811|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
19593812|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19593813|NCT02604797|Sufentanil|sufentanil|mesh-list
19593814|NCT02604797|Dsuvia|dsuvia|mesh-list
19593815|NCT02604797|Nalbuphine|nalbuphine|mesh-list
19593816|NCT02604797|Ramosetron|ramosetron|mesh-list
19593817|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19593818|NCT02604797|Narcotics|narcotics|mesh-ancestor
19593819|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593820|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593821|NCT02604797|Analgesics|analgesics|mesh-ancestor
19593822|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
19593823|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593824|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19593825|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19593826|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
19593827|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
19593828|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593829|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593830|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593831|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593832|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19593833|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593834|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593835|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
19593836|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
19593837|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20309970|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19593838|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19593839|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
19593840|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593841|NCT02604784|Cisplatin|cisplatin|mesh-list
19593842|NCT02604784|Doxorubicin|doxorubicin|mesh-list
19593843|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19593844|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
19593845|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593846|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19593847|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19593848|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19593849|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593850|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593851|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19593852|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
19593853|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593854|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
19593855|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19593856|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593857|NCT02604615|Capecitabine|capecitabine|mesh-list
19593858|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
19593859|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19593860|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
19593861|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593862|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19593863|NCT02604576|Bromopride|bromopride|mesh-list
19593864|NCT02604576|Metoclopramide|metoclopramide|mesh-list
19593865|NCT02604576|Simethicone|simethicone|mesh-list
19593866|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
19593867|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593868|NCT02604576|Emollients|emollients|mesh-ancestor
19593869|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
20125500|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125501|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125502|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
20125503|NCT00017121|Sargramostim|sargramostim|mesh-list
20125504|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
20125505|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125506|NCT00017134|Fenretinide|fenretinide|mesh-list
20125507|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125508|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20125509|NCT00017134|Protective Agents|protective agents|mesh-ancestor
20125510|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125511|NCT00017147|Carmustine|carmustine|mesh-list
19593870|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
19593871|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
19593872|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593873|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593874|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19593875|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19593876|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
19593877|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593878|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19593879|NCT02604537|Ketorolac|ketorolac|mesh-list
19593880|NCT02604537|Betamethasone|betamethasone|mesh-list
19593881|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593882|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593883|NCT02604537|Analgesics|analgesics|mesh-ancestor
19593884|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
19593885|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593886|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593887|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593888|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593889|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19593890|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593891|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593892|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
19593893|NCT02604537|Hormones|hormones|mesh-ancestor
19593894|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19593895|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19593896|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
19593897|NCT02604420|Eculizumab|eculizumab|mesh-list
19593898|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19593899|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19593900|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
19593901|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593902|NCT02604459|Fentanyl|fentanyl|mesh-list
20125512|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20125513|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19593903|NCT02604459|Anesthetics|anesthetics|mesh-list
19593904|NCT02604459|Propofol|propofol|mesh-list
19593905|NCT02604459|Sevoflurane|sevoflurane|mesh-list
19593906|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593907|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593908|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19593909|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19593910|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
19593911|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19593912|NCT02604459|Narcotics|narcotics|mesh-ancestor
19593913|NCT02604459|Analgesics|analgesics|mesh-ancestor
19593914|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
19593915|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19593916|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19593917|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19593918|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20125514|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
19593919|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
19593920|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19593921|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
19593922|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
19593923|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593924|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593925|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19593926|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19593927|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19593928|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593929|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
19593930|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19593931|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19593932|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593933|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
19593934|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19593935|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593936|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
19593937|NCT02604134|Fluorides|fluorides|mesh-list
19593938|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
19593939|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
19593940|NCT02604134|Protective Agents|protective agents|mesh-ancestor
19593941|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593942|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19593943|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593944|NCT02604095|Melatonin|melatonin|mesh-list
19593945|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
19593946|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593947|NCT02604095|Protective Agents|protective agents|mesh-ancestor
19593948|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593949|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19593950|NCT02604004|Lamivudine|lamivudine|mesh-list
19593951|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19593952|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19593953|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593954|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593955|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
19593956|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19593957|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19593958|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19593959|NCT02603965|Copper|copper|mesh-list
19593960|NCT02603965|Trace Elements|trace elements|mesh-ancestor
19593961|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
19593962|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593963|NCT02603757|Vitamin D|vitamin d|mesh-list
19593964|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
19593965|NCT02603757|Vitamins|vitamins|mesh-ancestor
19593966|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
19593967|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593968|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19593969|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19593970|NCT02603822|Indomethacin|indomethacin|mesh-list
19593971|NCT02603822|Mannitol|mannitol|mesh-list
19593972|NCT02603822|Lactulose|lactulose|mesh-list
19593973|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19593974|NCT02603822|Diuretics|diuretics|mesh-ancestor
19593975|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
19593976|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593977|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19593978|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19593979|NCT02603822|Analgesics|analgesics|mesh-ancestor
19593980|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
20125515|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125516|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125517|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125518|NCT00017160|Doxorubicin|doxorubicin|mesh-list
20125519|NCT00017160|Ifosfamide|ifosfamide|mesh-list
20125520|NCT00017160|Sargramostim|sargramostim|mesh-list
20125521|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
20125522|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20608217|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
20608218|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608219|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20608220|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19593981|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125523|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125524|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125525|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125526|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125527|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125528|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125529|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19593982|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19593983|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19593984|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
19593985|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
19593986|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19593987|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19593988|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19593989|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593990|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19657731|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
19657732|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19657733|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657734|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19657735|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19657736|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657737|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
19657738|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657739|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
19657740|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
19657741|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657742|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
19657743|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19657744|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19657745|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657746|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
19657747|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
19657748|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125530|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
20125531|NCT00017173|Cisplatin|cisplatin|mesh-list
20125532|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125533|NCT00017186|Gemcitabine|gemcitabine|mesh-list
20125534|NCT00017186|Epirubicin|epirubicin|mesh-list
20125535|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125536|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
20125537|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125538|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657758|NCT03525379|Resveratrol|resveratrol|mesh-list
20125539|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
20125540|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125541|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125542|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125543|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
20125544|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125545|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20125546|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125547|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125548|NCT00017199|Bortezomib|bortezomib|mesh-list
20125549|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125550|NCT00017212|Exatecan|exatecan|mesh-list
20125551|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20125552|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125553|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125554|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125555|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20309971|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
20309972|NCT00670670|Caseins|caseins|mesh-list
20309973|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19593991|NCT02603861|Modafinil|modafinil|mesh-list
19593992|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19593993|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19593994|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19593995|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19593996|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19593997|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19593998|NCT02603783|Capsaicin|capsaicin|mesh-list
19593999|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
19594000|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
19594001|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
19594002|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594003|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594004|NCT02603770|Lovastatin|lovastatin|mesh-list
19594005|NCT02603770|L 647318|l 647318|mesh-list
19594006|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
19594007|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19594008|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19594009|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
19594010|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594011|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19594012|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19594013|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594014|NCT02603991|Levetiracetam|levetiracetam|mesh-list
19594015|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
19594016|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
19594017|NCT02603705|Oxycodone|oxycodone|mesh-list
19594018|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19594019|NCT02603705|Narcotics|narcotics|mesh-ancestor
19594020|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594021|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594022|NCT02603705|Analgesics|analgesics|mesh-ancestor
19594023|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
19594024|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594025|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
19594026|NCT02603406|Hematinics|hematinics|mesh-ancestor
19594027|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
19594028|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19594029|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594030|NCT02603575|Caspofungin|caspofungin|mesh-list
19594031|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
19594032|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
19594033|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
19594034|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594035|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
19594036|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
19594037|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594038|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594039|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19594040|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
19594041|NCT02603575|Hormones|hormones|mesh-ancestor
19594042|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594043|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19594044|NCT02603575|Protective Agents|protective agents|mesh-ancestor
19594045|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
19594046|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594047|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594048|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594049|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594050|NCT02603445|Idelalisib|idelalisib|mesh-list
19594051|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594052|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594053|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594054|NCT02603679|Tamoxifen|tamoxifen|mesh-list
19594055|NCT02603679|Paclitaxel|paclitaxel|mesh-list
19594056|NCT02603679|Letrozole|letrozole|mesh-list
19594057|NCT02603679|Palbociclib|palbociclib|mesh-list
20309974|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
19594058|NCT02603679|Anastrozole|anastrozole|mesh-list
19594059|NCT02603679|Exemestane|exemestane|mesh-list
19594060|NCT02603679|Goserelin|goserelin|mesh-list
19594061|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19594062|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19594063|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594064|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
19594065|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
19594066|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594067|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594068|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20309975|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20309976|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20309977|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309978|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
20309979|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
20309980|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
20309981|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20309982|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594069|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594070|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19594071|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
19594072|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594073|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594074|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19594075|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19594076|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19594077|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594078|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19594079|NCT02603497|Peficitinib|peficitinib|mesh-list
19594080|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594081|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594082|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594083|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
19594084|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594085|NCT02603315|Mitogens|mitogens|mesh-list
19594086|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
19594087|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594088|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594089|NCT02603315|Growth Substances|growth substances|mesh-ancestor
19594090|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594091|NCT02603068|Treprostinil|treprostinil|mesh-list
19594092|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19594093|NCT02603159|Capecitabine|capecitabine|mesh-list
19594094|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19594095|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
19594096|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594097|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594098|NCT02603003|Pemetrexed|pemetrexed|mesh-list
19594099|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594100|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594101|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594102|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19594103|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19594104|NCT02603081|Ebselen|ebselen|mesh-list
19594105|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594106|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20309983|NCT00670696|Tetracaine|tetracaine|mesh-list
20309984|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
20309985|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
20309986|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20309987|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20309988|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
20309989|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20309990|NCT00670722|Insulin|insulin|mesh-list
20309991|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20309992|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
20309993|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
20309994|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20309995|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
20309996|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
20309997|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20309998|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20309999|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310000|NCT00670761|Misoprostol|misoprostol|mesh-list
20310001|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20310002|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
20310003|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20310004|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310005|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20310006|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20310007|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
20310008|NCT00670787|Losartan|losartan|mesh-list
20310009|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20310010|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20310011|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20310012|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20310013|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20310014|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310015|NCT00670787|Diuretics|diuretics|mesh-ancestor
20310016|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
20310017|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310018|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20310019|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20310020|NCT00670813|Modafinil|modafinil|mesh-list
20310021|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20310022|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310023|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20125556|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
20125557|NCT00017225|Melphalan|melphalan|mesh-list
20125558|NCT00017225|Ifosfamide|ifosfamide|mesh-list
20125559|NCT00017225|Dacarbazine|dacarbazine|mesh-list
20125560|NCT00017225|Carboplatin|carboplatin|mesh-list
20125561|NCT00017225|Doxorubicin|doxorubicin|mesh-list
20125562|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20125563|NCT00017225|Etoposide|etoposide|mesh-list
20125564|NCT00017225|Vincristine|vincristine|mesh-list
20125565|NCT00017225|Tretinoin|tretinoin|mesh-list
20125566|NCT00017225|Vindesine|vindesine|mesh-list
20125567|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125568|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
20125569|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125570|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125571|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19594107|NCT02603081|Analgesics|analgesics|mesh-ancestor
19594108|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
19594109|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594110|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594111|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594112|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310024|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20310025|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20310026|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310027|NCT00670878|Gemcitabine|gemcitabine|mesh-list
20310028|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20310029|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
19594113|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19594114|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19594115|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
20310030|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310031|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310032|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
20310033|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608221|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20608222|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20608223|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608224|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19594116|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594117|NCT02603081|Protective Agents|protective agents|mesh-ancestor
19594118|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594119|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594120|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19594121|NCT02603276|Red yeast rice|red yeast rice|mesh-list
19594122|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20125572|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
20125573|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125574|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594123|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19594124|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19594125|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
19594126|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594127|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594128|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19594129|NCT02602938|Aspirin|aspirin|mesh-list
19594130|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594131|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594132|NCT02602938|Analgesics|analgesics|mesh-ancestor
19594133|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
19594134|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125575|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125576|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20125577|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125578|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125579|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125580|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125581|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125582|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125583|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594135|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594136|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594137|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594138|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19594139|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19594140|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594141|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19594142|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594143|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594144|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
19594145|NCT02603198|Epinephrine|epinephrine|mesh-list
19594146|NCT02603198|Nordefrin|nordefrin|mesh-list
19594147|NCT02603198|Anesthetics|anesthetics|mesh-list
19594148|NCT02603198|Mepivacaine|mepivacaine|mesh-list
19594149|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594150|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594151|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19594152|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19594153|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
19594154|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594155|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594156|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19594157|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19594158|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
19594159|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594160|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19594161|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
19594162|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
19594163|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
19594164|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19594165|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
19594166|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
19594167|NCT02603055|Vaccines|vaccines|mesh-list
19594168|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
19594169|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594170|NCT02602860|Levetiracetam|levetiracetam|mesh-list
19594171|NCT02602860|Brivaracetam|brivaracetam|mesh-list
19594172|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
19594173|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
19594174|NCT02602743|Ketamine|ketamine|mesh-list
19594175|NCT02602743|Remifentanil|remifentanil|mesh-list
19594176|NCT02602743|Propofol|propofol|mesh-list
19594177|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19594178|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594179|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594180|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19594181|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
19594182|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
19594183|NCT02602743|Analgesics|analgesics|mesh-ancestor
20125584|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
20125585|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
19594184|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
19594185|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594186|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19594187|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19594188|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19594189|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594190|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594191|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19594192|NCT02602743|Narcotics|narcotics|mesh-ancestor
19594193|NCT02602652|Vaccines|vaccines|mesh-list
19594194|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
19594195|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594196|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
19594197|NCT02602704|Calcium|calcium|mesh-list
19594198|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19594199|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594200|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19594201|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19594202|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
19594203|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594204|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594205|NCT02602600|Liraglutide|liraglutide|mesh-list
19594206|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19594207|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594208|NCT02602600|Incretins|incretins|mesh-ancestor
19594209|NCT02602600|Hormones|hormones|mesh-ancestor
19594210|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594211|NCT02602444|Ticagrelor|ticagrelor|mesh-list
19594212|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19594213|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19594214|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19594215|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19594216|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
19594217|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594218|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594219|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594220|NCT02602509|Rifampin|rifampin|mesh-list
19594221|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
19594222|NCT02602509|Celecoxib|celecoxib|mesh-list
19594223|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20125586|NCT00017238|KRN 5500|krn 5500|mesh-list
20125587|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125588|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20125589|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125590|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125591|NCT00017251|Carboplatin|carboplatin|mesh-list
20125592|NCT00017251|Etoposide|etoposide|mesh-list
20125593|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
20125594|NCT00017251|Oblimersen|oblimersen|mesh-list
20125595|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125596|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125597|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125598|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125599|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125600|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594224|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594225|NCT02602509|Analgesics|analgesics|mesh-ancestor
19594226|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
19594227|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594228|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594229|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594230|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594231|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19594232|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594233|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594234|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594235|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19594236|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
19594237|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594238|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594239|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
19594240|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125601|NCT00017264|Atrasentan|atrasentan|mesh-list
20125602|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125603|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20125604|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20125605|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125606|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
20608225|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594241|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19594242|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19594243|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19594244|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19594245|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20608226|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608227|NCT02245191|Phenylephrine|phenylephrine|mesh-list
19594246|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19594247|NCT02602470|Metronidazole|metronidazole|mesh-list
19594248|NCT02602470|Azelaic acid|azelaic acid|mesh-list
19594249|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19594250|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594251|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594252|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19594253|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19594254|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19594255|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19594256|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20608228|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
20608229|NCT02245191|Ephedrine|ephedrine|mesh-list
20310034|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310035|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20310036|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
20310037|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310038|NCT00671008|Insulin|insulin|mesh-list
20310039|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20310040|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
19594257|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19594258|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
19594259|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594260|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594261|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594262|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594263|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
19594264|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
19594265|NCT02602483|Ibuprofen|ibuprofen|mesh-list
20310041|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
20310042|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
20310043|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20310044|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310045|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310046|NCT00671112|Everolimus|everolimus|mesh-list
20310047|NCT00671112|Bortezomib|bortezomib|mesh-list
20310048|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594266|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594267|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594268|NCT02602483|Analgesics|analgesics|mesh-ancestor
19594269|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
19594270|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594271|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594272|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594273|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594274|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594275|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594276|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594277|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
19594278|NCT02602483|Protective Agents|protective agents|mesh-ancestor
19594279|NCT02602483|Vitamins|vitamins|mesh-ancestor
19594280|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
19594281|NCT02602197|Acetaminophen|acetaminophen|mesh-list
19594282|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19594283|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594284|NCT02602197|Analgesics|analgesics|mesh-ancestor
19594285|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
19594286|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594287|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594288|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
19594289|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594290|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594291|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310049|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20310050|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
19594292|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
19594293|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19594294|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594295|NCT02602002|Remifentanil|remifentanil|mesh-list
19594296|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19594297|NCT02602002|Narcotics|narcotics|mesh-ancestor
19594298|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594299|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310051|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310052|NCT00671138|Vaccines|vaccines|mesh-list
20310053|NCT00671138|Immunologic Factors|immunologic factors|mesh-ancestor
20310054|NCT00671138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310055|NCT00671151|Theophylline|theophylline|mesh-list
19594300|NCT02602002|Analgesics|analgesics|mesh-ancestor
19594301|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
19594302|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594303|NCT02602301|Oxytocin|oxytocin|mesh-list
19594304|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
19594305|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19594306|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594307|NCT02601989|Tadalafil|tadalafil|mesh-list
19594308|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
19594309|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19594310|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19594311|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594312|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594313|NCT02601989|Urological Agents|urological agents|mesh-ancestor
19594314|NCT02602028|Colchicine|colchicine|mesh-list
19594315|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
19594316|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594317|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
19594318|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
19594319|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594320|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594321|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594322|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
19594323|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
19594324|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19594325|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594326|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594327|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
19594328|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19594329|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594330|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594331|NCT02601911|Acetaminophen|acetaminophen|mesh-list
19594332|NCT02601911|Ketorolac|ketorolac|mesh-list
19594333|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19594334|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594335|NCT02601911|Analgesics|analgesics|mesh-ancestor
19594336|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
19594337|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594338|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594339|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
19594340|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594341|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594342|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594343|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594344|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594345|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594346|NCT02601963|Minocycline|minocycline|mesh-list
19594347|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594348|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594349|NCT02601924|Anesthetics|anesthetics|mesh-list
19594350|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
19594351|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594352|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594353|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
19594354|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594355|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
19594356|NCT02601898|Progesterone|progesterone|mesh-list
19594357|NCT02601898|Progestins|progestins|mesh-ancestor
19594358|NCT02601898|Hormones|hormones|mesh-ancestor
19594359|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594360|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594361|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
19594362|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594363|NCT02601898|Protective Agents|protective agents|mesh-ancestor
19594364|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
20310056|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19594365|NCT02601898|Vitamins|vitamins|mesh-ancestor
19594366|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
19594367|NCT02601677|Fluoxetine|fluoxetine|mesh-list
19594368|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19594369|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19594370|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19594371|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594372|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594373|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
19594374|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594375|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19594376|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
19594377|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19594378|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19594379|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19594380|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594381|NCT02601703|Tacrolimus|tacrolimus|mesh-list
19594382|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594383|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
19594384|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594385|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19594386|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594387|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594388|NCT02601651|Lidocaine|lidocaine|mesh-list
19594389|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
19594390|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
19594391|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594392|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594393|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
19594394|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594395|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19594396|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19594397|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19594398|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19594399|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594400|NCT02601508|Rocuronium|rocuronium|mesh-list
19594401|NCT02601508|Atracurium|atracurium|mesh-list
19594402|NCT02601508|Cisatracurium|cisatracurium|mesh-list
19594403|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20125607|NCT00017277|Hematinics|hematinics|mesh-ancestor
19594404|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19594405|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19594406|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594407|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594408|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19594409|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19594410|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19594411|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594412|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594413|NCT02601365|Molgramostim|molgramostim|mesh-list
19594414|NCT02601365|Sargramostim|sargramostim|mesh-list
19594415|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
19594416|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594417|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594418|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
19594419|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19594420|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19594421|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19594422|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19256562|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256563|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256564|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19256565|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256566|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256567|NCT04452383|Ketamine|ketamine|mesh-list
19256568|NCT04452383|Propofol|propofol|mesh-list
19256569|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20125608|NCT00017290|Prednisone|prednisone|mesh-list
19594423|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594424|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
19594425|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594426|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594427|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19594428|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594429|NCT02601157|Aspirin|aspirin|mesh-list
19594430|NCT02601157|Sirolimus|sirolimus|mesh-list
19594431|NCT02601157|Clopidogrel|clopidogrel|mesh-list
19594432|NCT02601157|Ticagrelor|ticagrelor|mesh-list
19594433|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19594434|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594435|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594436|NCT02601157|Analgesics|analgesics|mesh-ancestor
19594437|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
19594438|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594439|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594440|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594441|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594442|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19594443|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19594444|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594445|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19594446|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594447|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594448|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
19594449|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19594450|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19594451|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19594452|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
19594453|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594454|NCT02601157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594455|NCT02601157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594456|NCT02601157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19594457|NCT02601157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125609|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
20125610|NCT00017290|Vincristine|vincristine|mesh-list
20125611|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
20125612|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20125613|NCT00017290|Antibodies|antibodies|mesh-list
20125614|NCT00017290|Sargramostim|sargramostim|mesh-list
20125615|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20125616|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20125617|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125618|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
20125619|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125620|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125621|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125622|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
20125623|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125624|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125625|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125626|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125627|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
20125628|NCT00017290|Hormones|hormones|mesh-ancestor
20125629|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125630|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125631|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125632|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
20310057|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
20310058|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310059|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594458|NCT02601157|Antifungal Agents|antifungal agents|mesh-ancestor
19594459|NCT02601157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594460|NCT02601157|Immunologic Factors|immunologic factors|mesh-ancestor
19594461|NCT02601040|Vaccines|vaccines|mesh-list
19594462|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
19594463|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594464|NCT02601235|Pyrilamine|pyrilamine|mesh-list
19594465|NCT02601235|Phenylephrine|phenylephrine|mesh-list
20125633|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
20310060|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19594466|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
20310061|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
19594467|NCT02601235|Naphazoline|naphazoline|mesh-list
20125634|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594468|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594469|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19594470|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19594471|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
19594472|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594473|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594474|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
19594475|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
19594476|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594477|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
19594478|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19594479|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
19594480|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19594481|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
19594482|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19594483|NCT02601235|Protective Agents|protective agents|mesh-ancestor
19594484|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19594485|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19594486|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594487|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19594488|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
19594489|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
19594490|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19594491|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
19594492|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19594493|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
19594494|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19594495|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594496|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19594497|NCT02600988|Vitamin D|vitamin d|mesh-list
19594498|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
19594499|NCT02600988|Vitamins|vitamins|mesh-list
19594500|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
19594501|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594502|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594503|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19594504|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19594505|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594506|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594507|NCT02600806|Azithromycin|azithromycin|mesh-list
19594508|NCT02600806|Levofloxacin|levofloxacin|mesh-list
19594509|NCT02600806|Ofloxacin|ofloxacin|mesh-list
19594510|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594511|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594512|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19594513|NCT02600806|Renal Agents|renal agents|mesh-ancestor
19594514|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19594515|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19594516|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594517|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594518|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594519|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19594520|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19594521|NCT02600780|Allopurinol|allopurinol|mesh-list
19594522|NCT02600780|Febuxostat|febuxostat|mesh-list
19594523|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
19594524|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594525|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594526|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
19594527|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594528|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19594529|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
19594530|NCT02600780|Protective Agents|protective agents|mesh-ancestor
19594531|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594532|NCT02600741|Droperidol|droperidol|mesh-list
19594533|NCT02600741|Haloperidol|haloperidol|mesh-list
20125635|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20125636|NCT00017303|Paclitaxel|paclitaxel|mesh-list
20125637|NCT00017303|Carboplatin|carboplatin|mesh-list
20125638|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125639|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125640|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125641|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125642|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173393|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
19594534|NCT02600741|Pimozide|pimozide|mesh-list
19594535|NCT02600741|Olanzapine|olanzapine|mesh-list
19594536|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
19594537|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
19594538|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
19594539|NCT02600741|Risperidone|risperidone|mesh-list
19594540|NCT02600741|Aripiprazole|aripiprazole|mesh-list
19594541|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19594542|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19594543|NCT02600741|Ziprasidone|ziprasidone|mesh-list
19594544|NCT02600741|Clozapine|clozapine|mesh-list
19594545|NCT02600741|Asenapine|asenapine|mesh-list
19594546|NCT02600741|Loxapine|loxapine|mesh-list
19594547|NCT02600741|Iloperidone|iloperidone|mesh-list
19594548|NCT02600741|Perphenazine|perphenazine|mesh-list
19594549|NCT02600741|Fluphenazine|fluphenazine|mesh-list
19594550|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
19594551|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
19594552|NCT02600741|Thioridazine|thioridazine|mesh-list
19594553|NCT02600741|Thiothixene|thiothixene|mesh-list
19594554|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19594555|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
19594556|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594557|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594558|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594559|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19594560|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19594561|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594562|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19594563|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19594564|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
19594565|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
19594566|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
19594567|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594568|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19594569|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19594570|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19594571|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19594572|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
19594573|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
19594574|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19594575|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20125643|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125644|NCT00017316|Thalidomide|thalidomide|mesh-list
20125645|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125646|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
20125647|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125648|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
20125649|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20125650|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125651|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20125652|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20125653|NCT00017316|Growth Substances|growth substances|mesh-ancestor
19594576|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19594577|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19594578|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19594579|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
20125654|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
20125655|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125656|NCT00017329|Bortezomib|bortezomib|mesh-list
20125657|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125658|NCT00017342|Cytarabine|cytarabine|mesh-list
20125659|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
20125660|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125661|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
20125662|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125663|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125664|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
20125665|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749563|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
19749564|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749565|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749566|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19749567|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
19749568|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749569|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125666|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125667|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
20125668|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125669|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20125670|NCT00017355|Lenograstim|lenograstim|mesh-list
20125671|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20125672|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
20125673|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125674|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
19594580|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
19594581|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19594582|NCT02600650|Testosterone|testosterone|mesh-list
19594583|NCT02600650|Androgens|androgens|mesh-ancestor
19594584|NCT02600650|Hormones|hormones|mesh-ancestor
19594585|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594586|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594587|NCT02600585|Vaccines|vaccines|mesh-list
19594588|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
19594589|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594590|NCT02600455|Abatacept|abatacept|mesh-list
19594591|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19594592|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594593|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594594|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594595|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
19594596|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594597|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657759|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
19657760|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657761|NCT03525379|Protective Agents|protective agents|mesh-ancestor
19657762|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657763|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657764|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19657765|NCT03524092|Mirikizumab|mirikizumab|mesh-list
19657766|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19657767|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19657768|NCT03524092|Analgesics|analgesics|mesh-ancestor
19657769|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
19657770|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657771|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657772|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19657773|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657774|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19657775|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20125675|NCT00017368|Melphalan|melphalan|mesh-list
20125676|NCT00017368|Ifosfamide|ifosfamide|mesh-list
20125677|NCT00017368|Thiotepa|thiotepa|mesh-list
20125678|NCT00017368|Carboplatin|carboplatin|mesh-list
19749570|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19749571|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749572|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
20125679|NCT00017368|Doxorubicin|doxorubicin|mesh-list
20125680|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20125681|NCT00017368|Etoposide|etoposide|mesh-list
20125682|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
19749573|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
20125683|NCT00017368|Vincristine|vincristine|mesh-list
20125684|NCT00017368|Isotretinoin|isotretinoin|mesh-list
20125685|NCT00017368|Sargramostim|sargramostim|mesh-list
19594598|NCT02600468|Abatacept|abatacept|mesh-list
19594599|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19594600|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594601|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594602|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594603|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
19594604|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594605|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594606|NCT02600273|Nicotine|nicotine|mesh-list
19594607|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19594608|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
20310062|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20310063|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310064|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310065|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
20310066|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20310067|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20310068|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
20310069|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310070|NCT00671203|Erythromycin|erythromycin|mesh-list
20310071|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
20310072|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19594609|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594610|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594611|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19594612|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19594613|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
20310073|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
20310074|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310075|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310076|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20310077|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20310078|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310079|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310080|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
20310081|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20310082|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20310083|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310084|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
20310085|NCT00671281|Coagulants|coagulants|mesh-ancestor
20310086|NCT00671320|Diclofenac|diclofenac|mesh-list
20310087|NCT00671320|Valdecoxib|valdecoxib|mesh-list
20310088|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20310089|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20310090|NCT00671320|Analgesics|analgesics|mesh-ancestor
20310091|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
20310092|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310093|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310094|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20310095|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310096|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20310097|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310098|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310099|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20310100|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
20310101|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310102|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310103|NCT00671372|Bevacizumab|bevacizumab|mesh-list
20310104|NCT00671372|Cetuximab|cetuximab|mesh-list
20310105|NCT00671372|Irinotecan|irinotecan|mesh-list
19594614|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594615|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594616|NCT02600247|Acetaminophen|acetaminophen|mesh-list
19594617|NCT02600247|Celecoxib|celecoxib|mesh-list
19594618|NCT02600247|Pregabalin|pregabalin|mesh-list
19594619|NCT02600247|Oxycodone|oxycodone|mesh-list
19594620|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19594621|NCT02600247|Tramadol|tramadol|mesh-list
19594622|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20310106|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20310107|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310108|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19594623|NCT02600247|Analgesics|analgesics|mesh-ancestor
20310109|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20310110|NCT00671372|Growth Substances|growth substances|mesh-ancestor
19594624|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
19594625|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594626|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594627|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
19594628|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
19594629|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19594630|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19594631|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594632|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19594633|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19594634|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19594635|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594636|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19594637|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594638|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594639|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594640|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19594641|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594642|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594643|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19594644|NCT02600247|Narcotics|narcotics|mesh-ancestor
19594645|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19594646|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19594647|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594648|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
19594649|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
19594650|NCT02600260|Enoxaparin|enoxaparin|mesh-list
19594651|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
19594652|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
19594653|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19594654|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19594655|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594656|NCT02599701|Gabapentin|gabapentin|mesh-list
19594657|NCT02599701|Analgesics|analgesics|mesh-ancestor
19594658|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
19594659|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594660|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594661|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
19594662|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19594663|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19594664|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594665|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19594666|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19594667|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19594668|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594669|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594670|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
19594671|NCT02599675|Vitamin D|vitamin d|mesh-list
19594672|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
19594673|NCT02599675|Vitamins|vitamins|mesh-ancestor
19594674|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
19594675|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594676|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594677|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19594678|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
19594679|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19594680|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594681|NCT02599857|Bisoprolol|bisoprolol|mesh-list
19594682|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19594683|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
19594684|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
19594685|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594686|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594687|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19594688|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19594689|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20125686|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125687|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
20125688|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594690|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
19594691|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594692|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594693|NCT02599792|Ivacaftor|ivacaftor|mesh-list
19594694|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19594695|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19594696|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594697|NCT02599532|Apixaban|apixaban|mesh-list
19594698|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19594699|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
19594700|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19594701|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
19594702|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594703|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594704|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
19594705|NCT02599571|Nicotine|nicotine|mesh-list
19594706|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19594707|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
19594708|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594709|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594710|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19594711|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19594712|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
19594713|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594714|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594715|NCT02599623|Anesthetics|anesthetics|mesh-list
19594716|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594717|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594718|NCT02599493|Rifampin|rifampin|mesh-list
19594719|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19594720|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
20310111|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310112|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310113|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20310114|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19594721|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594722|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594723|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
19594724|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19594725|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594726|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594727|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19594728|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19594729|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19594730|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19594731|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19594732|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19594733|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19594734|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19594735|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19594736|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
19594737|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594738|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594739|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594740|NCT02599311|Urological Agents|urological agents|mesh-ancestor
19594741|NCT02599480|Mirabegron|mirabegron|mesh-list
19594742|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19594743|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19594744|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19594745|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
19594746|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594747|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594748|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594749|NCT02599480|Urological Agents|urological agents|mesh-ancestor
19594750|NCT02599337|Sorafenib|sorafenib|mesh-list
19594751|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594752|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19594753|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594754|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594755|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
19594756|NCT02599168|Propofol|propofol|mesh-list
19594757|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19594758|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594759|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125689|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125690|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125691|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
20125692|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125693|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594760|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19594761|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
19594762|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
19594763|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594764|NCT02599168|Analgesics|analgesics|mesh-ancestor
19594765|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
19594766|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594767|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19594768|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19594769|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19594770|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
19594771|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19594772|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594773|NCT02599077|Dienogest|dienogest|mesh-list
19594774|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
19594775|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19594776|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
19594777|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19594778|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594779|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19594780|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19594781|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19594782|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19594783|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19594784|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
19594785|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594786|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19594787|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594788|NCT02598830|Vitamin D|vitamin d|mesh-list
19594789|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
19594790|NCT02598830|Vitamins|vitamins|mesh-ancestor
19594791|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
19594792|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310115|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310116|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310117|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
20310118|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20310119|NCT00671424|Furosemide|furosemide|mesh-list
20310120|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20310121|NCT00671424|Diuretics|diuretics|mesh-ancestor
20310122|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
19594793|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594794|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19594795|NCT02599090|Temozolomide|temozolomide|mesh-list
19594796|NCT02599090|Sorafenib|sorafenib|mesh-list
19594797|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19594798|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
19594799|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594800|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594801|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19594802|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594803|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
19594804|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19594805|NCT02598778|Listerine|listerine|mesh-list
19594806|NCT02598778|Fluorides|fluorides|mesh-list
19594807|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
19594808|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
20125694|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125695|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20125696|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20125697|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20125698|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310123|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310124|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20310125|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19594809|NCT02598778|Protective Agents|protective agents|mesh-ancestor
19594810|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594811|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19594812|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594813|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
19594814|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
19594815|NCT02598856|Naloxone|naloxone|mesh-list
19594816|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19594817|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594818|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
20125699|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125700|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125701|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125702|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125703|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19594819|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594820|NCT02598869|Triamcinolone|triamcinolone|mesh-list
19594821|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19594822|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19594823|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19594824|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594825|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
19594826|NCT02598869|Hormones|hormones|mesh-ancestor
20310126|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310127|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20310128|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20310129|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310130|NCT00671476|Doxorubicin|doxorubicin|mesh-list
20310131|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20310132|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20310133|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310134|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20310135|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310136|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310137|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310138|NCT00671541|Gentamicins|gentamicins|mesh-list
20310139|NCT00671541|Bacitracin|bacitracin|mesh-list
20310140|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310141|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310142|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20310143|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310144|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310145|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20310146|NCT00671593|Phenol|phenol|mesh-list
19594827|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594828|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594829|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594830|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
19594831|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594832|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125704|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
20125705|NCT00017381|Rituximab|rituximab|mesh-list
20125706|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20125707|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125708|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
20125709|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125710|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310147|NCT00671593|Glycerol|glycerol|mesh-list
20310148|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20310149|NCT00671593|Protective Agents|protective agents|mesh-ancestor
20310150|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310151|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20310152|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310153|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
20125711|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125712|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
20125713|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125714|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125715|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125716|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20125717|NCT00017394|Bevacizumab|bevacizumab|mesh-list
20125718|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20125719|NCT00017394|Vinorelbine|vinorelbine|mesh-list
20125720|NCT00017394|Antibodies|antibodies|mesh-list
20125721|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
20125722|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20125723|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594833|NCT02598596|Azathioprine|azathioprine|mesh-list
19594834|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
19594835|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594836|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19594837|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594838|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594839|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
19594840|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594841|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594842|NCT02598791|Glucagon|glucagon|mesh-list
19594843|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19594844|NCT02598791|Incretins|incretins|mesh-ancestor
19594845|NCT02598791|Hormones|hormones|mesh-ancestor
19594846|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19594847|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594848|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19594849|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
19594850|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19594851|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125724|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20125725|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20125726|NCT00017394|Growth Substances|growth substances|mesh-ancestor
20310154|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19594852|NCT02598635|Vitamins|vitamins|mesh-ancestor
19594853|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
19594854|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594855|NCT02598687|Paclitaxel|paclitaxel|mesh-list
19594856|NCT02598687|Carboplatin|carboplatin|mesh-list
19594857|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19594858|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594859|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
19594860|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
19594861|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594862|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594863|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
19594864|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594865|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594866|NCT02598466|Abatacept|abatacept|mesh-list
19594867|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19594868|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594869|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594870|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594871|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
19594872|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594873|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594874|NCT02598427|Trastuzumab|trastuzumab|mesh-list
19594875|NCT02598427|Pertuzumab|pertuzumab|mesh-list
19594876|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19594877|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594878|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
19594879|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
19594880|NCT02598414|Protective Agents|protective agents|mesh-ancestor
19594881|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594882|NCT02598440|Alendronate|alendronate|mesh-list
19594883|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
19594884|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19594885|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125727|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125728|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
20125729|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
20125730|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20125731|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125732|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125733|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125734|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125735|NCT00017407|Paclitaxel|paclitaxel|mesh-list
20125736|NCT00017407|Carboplatin|carboplatin|mesh-list
20125737|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19594886|NCT02598310|Paclitaxel|paclitaxel|mesh-list
19594887|NCT02598310|Trastuzumab|trastuzumab|mesh-list
20125738|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594888|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19594889|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594890|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
19594891|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
19594892|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594893|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594894|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19594895|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
19594896|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19594897|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594898|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19594899|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19594900|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594901|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594902|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594903|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19594904|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19594905|NCT02598102|Diclofenac|diclofenac|mesh-list
19594906|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19594907|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19594908|NCT02598102|Analgesics|analgesics|mesh-ancestor
19594909|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
19594910|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594911|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594912|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19594913|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594914|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19594915|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594916|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594917|NCT02597998|BI 409306|bi 409306|mesh-list
19594918|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19594919|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594920|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594921|NCT02598063|Lamivudine|lamivudine|mesh-list
19594922|NCT02598063|Adefovir|adefovir|mesh-list
19594923|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19594924|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19594925|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19594926|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19594927|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594928|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594929|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
19594930|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594931|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19594932|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19594933|NCT02598011|Flucytosine|flucytosine|mesh-list
19594934|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
19594935|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594936|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
19594937|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594938|NCT02597868|Capecitabine|capecitabine|mesh-list
19594939|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19594940|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
19594941|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594942|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594943|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
19594944|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19594945|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
20310155|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20310156|NCT00671632|Triazolam|triazolam|mesh-list
20310157|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20310158|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20310159|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20125739|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125740|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125741|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125742|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125743|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
20125744|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125745|NCT00017459|Vinorelbine|vinorelbine|mesh-list
20125746|NCT00017459|Tirapazamine|tirapazamine|mesh-list
20310160|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20125747|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173394|NCT00161434|Valacyclovir|valacyclovir|mesh-list
20125748|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19594946|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594947|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19594948|NCT02597699|Lidocaine|lidocaine|mesh-list
19594949|NCT02597699|Sufentanil|sufentanil|mesh-list
20125749|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
20125750|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
20125751|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125752|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125753|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20125754|NCT00017472|Antibodies|antibodies|mesh-list
20125755|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
20125756|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20125757|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
20125758|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125759|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310161|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594950|NCT02597699|Remifentanil|remifentanil|mesh-list
19594951|NCT02597699|Dsuvia|dsuvia|mesh-list
19594952|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
19594953|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
19594954|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19594955|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310162|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310163|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
20310164|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
20310165|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310166|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310167|NCT00671645|Bevacizumab|bevacizumab|mesh-list
20310168|NCT00671645|Capecitabine|capecitabine|mesh-list
19594956|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
19594957|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594958|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19594959|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19594960|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19594961|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19594962|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594963|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19594964|NCT02597699|Narcotics|narcotics|mesh-ancestor
19594965|NCT02597699|Analgesics|analgesics|mesh-ancestor
19594966|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19594967|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19594968|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
19594969|NCT02597556|Albendazole|albendazole|mesh-list
19594970|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
19594971|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19594972|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19594973|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
19594974|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19594975|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19594976|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19594977|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19594978|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19594979|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594980|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594981|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
19594982|NCT02597387|Analgesics|analgesics|mesh-ancestor
19594983|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
19594984|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19594985|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594986|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19594987|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19594988|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19594989|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19594990|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594991|NCT02597400|Metformin|metformin|mesh-list
19594992|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19594993|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19594994|NCT02597361|Irbesartan|irbesartan|mesh-list
19594995|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19594996|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19594997|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20125760|NCT00017498|Gemcitabine|gemcitabine|mesh-list
19594998|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19594999|NCT02597283|Sirolimus|sirolimus|mesh-list
20310169|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595000|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19595001|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595002|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19595003|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595004|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
19595005|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19595006|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
19595007|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595008|NCT02597231|Melatonin|melatonin|mesh-list
19595009|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
19595010|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595011|NCT02597231|Protective Agents|protective agents|mesh-ancestor
19595012|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595013|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595014|NCT02597309|Canagliflozin|canagliflozin|mesh-list
19595015|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19595016|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595017|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19595018|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595019|NCT02597114|Insulin|insulin|mesh-list
19595020|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19595021|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19595022|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595023|NCT02597257|Lidocaine|lidocaine|mesh-list
19595024|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
19595025|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
19595026|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595027|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125761|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20125762|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
20125763|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125764|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125765|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
20125766|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125767|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125768|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125769|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
20125770|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125771|NCT00017511|Cevimeline|cevimeline|mesh-list
20125772|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20310170|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310171|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19595028|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
19595029|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595030|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19595031|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19595032|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19595033|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595034|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595035|NCT02597140|Lidocaine|lidocaine|mesh-list
19595036|NCT02597140|Propofol|propofol|mesh-list
19595037|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
19595038|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
20310172|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20310173|NCT00671645|Growth Substances|growth substances|mesh-ancestor
20310174|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310175|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310176|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20310177|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
19595039|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595040|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595041|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
19595042|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595043|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19595044|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19595045|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19595046|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595047|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125773|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
20125774|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125775|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595048|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19595049|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19595050|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
19595051|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
19595052|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19595053|NCT02597166|Ledipasvir|ledipasvir|mesh-list
19595054|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
19595055|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595056|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
19595057|NCT02597153|Analgesics|analgesics|mesh-ancestor
19595058|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
19595059|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595060|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595061|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595062|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19595063|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19595064|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595065|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595066|NCT02596984|Caspofungin|caspofungin|mesh-list
19595067|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
19595068|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595069|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595070|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595071|NCT02597322|Axitinib|axitinib|mesh-list
19595072|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595073|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19595074|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595075|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595076|NCT02597036|Paclitaxel|paclitaxel|mesh-list
19595077|NCT02597036|Ramucirumab|ramucirumab|mesh-list
19595078|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19595079|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595080|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
19595081|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
19595082|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
19595083|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657789|NCT03519906|Metoprolol|metoprolol|mesh-list
19657790|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19657791|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19657792|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
19657793|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
19657794|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310178|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310179|NCT00671697|Decitabine|decitabine|mesh-list
20310180|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
20310181|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20310182|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
20348573|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
19657795|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657796|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19657797|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19657798|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19657799|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
19657800|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19657801|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657802|NCT03519893|Losartan|losartan|mesh-list
19657803|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19657804|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19657805|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19657806|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19657807|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125776|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20125777|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20125778|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
20125779|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20125780|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125781|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20125782|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
20125783|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125784|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125785|NCT00017576|Calcitriol|calcitriol|mesh-list
20125786|NCT00017576|Carboplatin|carboplatin|mesh-list
20125787|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125788|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19595084|NCT02596880|Ribavirin|ribavirin|mesh-list
19595085|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
19595086|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
19595087|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595088|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
19595089|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595090|NCT02596828|Sirolimus|sirolimus|mesh-list
19595091|NCT02596828|Irinotecan|irinotecan|mesh-list
19595092|NCT02596828|Temozolomide|temozolomide|mesh-list
19595093|NCT02596828|Dasatinib|dasatinib|mesh-list
19595094|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19595095|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19595096|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595097|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595098|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595099|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19595100|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
19595101|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310183|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310184|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310185|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310186|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20310187|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20310188|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
20310189|NCT00671801|Irinotecan|irinotecan|mesh-list
19595102|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595103|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19595104|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
19595105|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19595106|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
19595107|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595108|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19595109|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
19595110|NCT02596776|Propranolol|propranolol|mesh-list
19595111|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19595112|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19595113|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
19595114|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595115|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595116|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595117|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19595118|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19595119|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
19595120|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595121|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19595122|NCT02596776|Protective Agents|protective agents|mesh-ancestor
19595123|NCT02596763|Baclofen|baclofen|mesh-list
19595124|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19595125|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595126|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19595127|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595128|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19595129|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
19595130|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
19595131|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595132|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595133|NCT02596685|Nicotine|nicotine|mesh-list
19595134|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19595135|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
20125789|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125790|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20125791|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20125792|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125793|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20125794|NCT00017576|Vitamins|vitamins|mesh-ancestor
20125795|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
20125796|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20125797|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
20125798|NCT00017589|Oblimersen|oblimersen|mesh-list
19595136|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595137|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173395|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
19595138|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19595139|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19595140|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
19595141|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595142|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595143|NCT02596555|Dabigatran|dabigatran|mesh-list
19595144|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
19595145|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19595146|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
19595147|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595148|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595149|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
19595150|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
19595151|NCT02596373|Analgesics|analgesics|mesh-ancestor
19595152|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
19595153|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595154|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595155|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595156|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19595157|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19595158|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595159|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595160|NCT02596282|Anesthetics|anesthetics|mesh-list
19595161|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595162|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595163|NCT02596334|Lamivudine|lamivudine|mesh-list
19595164|NCT02596334|Abacavir|abacavir|mesh-list
19595165|NCT02596334|Dolutegravir|dolutegravir|mesh-list
19595166|NCT02596334|Triumeq|triumeq|mesh-list
19595167|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19595168|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19595169|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595170|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595171|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
19595172|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595173|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19595174|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19595175|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19595176|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19595177|NCT02596100|Betrixaban|betrixaban|mesh-list
19595178|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19595179|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
19595180|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19595181|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
19595182|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595183|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595184|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
19595185|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19595186|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
19595187|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595188|NCT02596243|Vaccines|vaccines|mesh-list
19595189|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
19595190|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595191|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19595192|NCT02596269|Nefopam|nefopam|mesh-list
19595193|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19595194|NCT02596269|Analgesics|analgesics|mesh-ancestor
19595195|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
19595196|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595197|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595198|NCT02596256|Docetaxel|docetaxel|mesh-list
19595199|NCT02596256|Apatinib|apatinib|mesh-list
19595200|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595201|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19595202|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19595203|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19595204|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595205|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19595206|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595207|NCT02595801|Anesthetics|anesthetics|mesh-list
19595208|NCT02595801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595209|NCT02595801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595210|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
19595211|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19595212|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595213|NCT02595918|Nivolumab|nivolumab|mesh-list
19595214|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595215|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595216|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19595217|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595218|NCT02595840|Pemetrexed|pemetrexed|mesh-list
19595219|NCT02595840|Afatinib|afatinib|mesh-list
19595220|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595221|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595222|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595223|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19595224|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19595225|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19595226|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
19595227|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19595228|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
19595229|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595230|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
19595231|NCT02595606|Protective Agents|protective agents|mesh-ancestor
19595232|NCT02595554|Paclitaxel|paclitaxel|mesh-list
19595233|NCT02595554|Cisplatin|cisplatin|mesh-list
19595234|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19595235|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595236|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
19595237|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
19595238|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
19595239|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595240|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
19595241|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
19595242|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19595243|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19595244|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595245|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595246|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595247|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595248|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
19595249|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19595250|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595251|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19595252|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19595253|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595254|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595255|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595256|NCT02595463|Lidocaine|lidocaine|mesh-list
19595257|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
19595258|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
19595259|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595260|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595261|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
19595262|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595263|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19595264|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19595265|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19595266|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595267|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595268|NCT02595476|Remifentanil|remifentanil|mesh-list
20125799|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20125800|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125801|NCT00017602|Dexamethasone|dexamethasone|mesh-list
20125802|NCT00017602|Oblimersen|oblimersen|mesh-list
19595269|NCT02595476|Propofol|propofol|mesh-list
19595270|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19595271|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20125803|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19595272|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595273|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19595274|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
19595275|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
19595276|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19595277|NCT02595476|Narcotics|narcotics|mesh-ancestor
19595278|NCT02595476|Analgesics|analgesics|mesh-ancestor
19595279|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
19595280|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595281|NCT02595541|Milrinone|milrinone|mesh-list
19595282|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
19595283|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
19595284|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19595285|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19595286|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595287|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595288|NCT02595541|Urological Agents|urological agents|mesh-ancestor
19595289|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19595290|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19595291|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19595292|NCT02595541|Protective Agents|protective agents|mesh-ancestor
20125804|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
20125805|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
20125806|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125807|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125808|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19595293|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595294|NCT02595489|Vitamin D|vitamin d|mesh-list
20125809|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
20125810|NCT00017602|Hormones|hormones|mesh-ancestor
20125811|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125812|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125813|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125814|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
20125815|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20125816|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20125817|NCT00017628|Prednisolone|prednisolone|mesh-list
20125818|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
20125819|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
20125820|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19595295|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
19595296|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
19595297|NCT02595489|Vitamins|vitamins|mesh-list
19595298|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
19595299|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595300|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19595301|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19595302|NCT02595268|Pitavastatin|pitavastatin|mesh-list
19595303|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19595304|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19595305|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19595306|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
19595307|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595308|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595309|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19595310|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19595311|NCT02595190|Gabapentin|gabapentin|mesh-list
19595312|NCT02595190|Tramadol|tramadol|mesh-list
19595313|NCT02595190|Analgesics|analgesics|mesh-ancestor
19595314|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
20310190|NCT00671801|Lenalidomide|lenalidomide|mesh-list
20310191|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20348574|NCT00864773|Growth Substances|growth substances|mesh-ancestor
19595315|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595316|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595317|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
20125821|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
20125822|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125823|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
20125824|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595318|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19595319|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20125825|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595320|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595321|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19595322|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19595323|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19595324|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595325|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595326|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
19595327|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19595328|NCT02595190|Narcotics|narcotics|mesh-ancestor
19595329|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
19595330|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19595331|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595332|NCT02595242|Prednisone|prednisone|mesh-list
19595333|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
19595334|NCT02595242|Vincristine|vincristine|mesh-list
19595335|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125826|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19595336|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
19595337|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595338|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595339|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19595340|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
19595341|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595342|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595343|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19595344|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19595345|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
19595346|NCT02595242|Hormones|hormones|mesh-ancestor
19595347|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595348|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19595349|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19595350|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
19595351|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
19595352|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125827|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
20125828|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125829|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657825|NCT03505320|Leucovorin|leucovorin|mesh-list
19657826|NCT03505320|Folic Acid|folic acid|mesh-list
19657827|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
19657828|NCT03505320|Nivolumab|nivolumab|mesh-list
19657829|NCT03505320|Fluorouracil|fluorouracil|mesh-list
19657830|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
19657831|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
19657832|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657833|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657834|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
19657835|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657836|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19657837|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657838|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
19657839|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657840|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657841|NCT03505320|Antidotes|antidotes|mesh-ancestor
19657842|NCT03505320|Protective Agents|protective agents|mesh-ancestor
19657843|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
19657844|NCT03505320|Vitamins|vitamins|mesh-ancestor
19657845|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
19657846|NCT03505320|Hematinics|hematinics|mesh-ancestor
19657847|NCT03498716|Paclitaxel|paclitaxel|mesh-list
19657848|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
19657849|NCT03498716|Doxorubicin|doxorubicin|mesh-list
19657850|NCT03498716|Atezolizumab|atezolizumab|mesh-list
19657851|NCT03498716|Epirubicin|epirubicin|mesh-list
19657852|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19657853|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657854|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
19657855|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
19657856|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
19657857|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657858|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657859|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
19657860|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657861|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657862|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19657863|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
19595353|NCT02595034|Clindamycin|clindamycin|mesh-list
19595354|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
19595355|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
19595356|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19595357|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19595358|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595359|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19595360|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595361|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595362|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
19595363|NCT02594579|Vitamin D|vitamin d|mesh-list
19595364|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
19595365|NCT02594579|Vitamins|vitamins|mesh-ancestor
19595366|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
19595367|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595368|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19595369|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19595370|NCT02594761|Trastuzumab|trastuzumab|mesh-list
19595371|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595372|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595373|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19595374|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19595375|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19595376|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
19595377|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595378|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19595379|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19595380|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595381|NCT02594735|Abatacept|abatacept|mesh-list
19595382|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19595383|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595384|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595385|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19595386|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
19595387|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595388|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595389|NCT02594358|Caffeine|caffeine|mesh-list
19595390|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19595391|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595392|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19595393|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595394|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595395|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19595396|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19595397|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
19595398|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595399|NCT02594423|Bevacizumab|bevacizumab|mesh-list
19595400|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595401|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595402|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19595403|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19595404|NCT02594423|Growth Substances|growth substances|mesh-ancestor
19595405|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595406|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
19595407|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19595408|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
19595409|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595410|NCT02594410|Lercanidipine|lercanidipine|mesh-list
19595411|NCT02594410|Clopidogrel|clopidogrel|mesh-list
19595412|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19595413|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19595414|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19595415|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19595416|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
19595417|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595418|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595419|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595420|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19595421|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19595422|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595423|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19595424|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
19595425|NCT02594462|Etonogestrel|etonogestrel|mesh-list
19595426|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20125830|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125831|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125832|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
20125833|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
19595427|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595428|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19595429|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19595430|NCT02594241|Prednisolone|prednisolone|mesh-list
19595431|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20310192|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310193|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310194|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310195|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310196|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
20310197|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310198|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20310199|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19595432|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
19595433|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19595434|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
19595435|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19595436|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
19595437|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19595438|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
19595439|NCT02594241|Hormones|hormones|mesh-ancestor
19595440|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595441|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595442|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19595443|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595444|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
19595445|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
19595446|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595447|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19595448|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19595449|NCT02594241|Protective Agents|protective agents|mesh-ancestor
19595450|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19595451|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19595452|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595453|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
19595454|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19595455|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595456|NCT02593942|Remifentanil|remifentanil|mesh-list
19595457|NCT02593942|Propofol|propofol|mesh-list
19595458|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19595459|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20125834|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125835|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20125836|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
19595460|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595461|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19595462|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
19595463|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
19595464|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19595465|NCT02593942|Narcotics|narcotics|mesh-ancestor
20125837|NCT00017628|Hormones|hormones|mesh-ancestor
20125838|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20125839|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20125840|NCT00017628|Protective Agents|protective agents|mesh-ancestor
20125841|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20125842|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
20125843|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20310200|NCT00671801|Growth Substances|growth substances|mesh-ancestor
19595466|NCT02593942|Analgesics|analgesics|mesh-ancestor
20125844|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125845|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
19595467|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
19595468|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595469|NCT02594072|Goserelin|goserelin|mesh-list
19595470|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19595471|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595472|NCT02593968|Interferons|interferons|mesh-list
19595473|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595474|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
19595475|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595476|NCT02593747|Loratadine|loratadine|mesh-list
19595477|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
19595478|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
19595479|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19595480|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19595481|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19595482|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
19595483|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
19595484|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595485|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595486|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595487|NCT02593734|Olanzapine|olanzapine|mesh-list
19595488|NCT02593734|Risperidone|risperidone|mesh-list
19595489|NCT02593734|Fluoxetine|fluoxetine|mesh-list
19595490|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19595491|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
19595492|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595493|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595494|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595495|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19595496|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19595497|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595498|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19595499|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19595500|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
20125846|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125847|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125848|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125849|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
20125850|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125851|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125852|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125853|NCT00017654|Cyclosporine|cyclosporine|mesh-list
20125854|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
20125855|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
20125856|NCT00017654|Cyclosporins|cyclosporins|mesh-list
20125857|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20125858|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125859|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
20125860|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125861|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595501|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
19595502|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
19595503|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595504|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19595505|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19595506|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19595507|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595508|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19595509|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
19595510|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19595511|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19595512|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595513|NCT02593708|Paclitaxel|paclitaxel|mesh-list
19595514|NCT02593708|Trastuzumab|trastuzumab|mesh-list
20125862|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19595515|NCT02593708|Pertuzumab|pertuzumab|mesh-list
19595516|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19595517|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595518|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19595519|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19595520|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19595521|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595522|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595523|NCT02593695|Fluoxetine|fluoxetine|mesh-list
19595524|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19595525|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19595526|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595527|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595528|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595529|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
19595530|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595531|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19595532|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
19595533|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19595534|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19595535|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19595536|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595537|NCT02593721|Ibuprofen|ibuprofen|mesh-list
19595538|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19595539|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19595540|NCT02593721|Analgesics|analgesics|mesh-ancestor
19595541|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
19595542|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595543|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595544|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19595545|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595546|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19595547|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595548|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595549|NCT02593526|Bumetanide|bumetanide|mesh-list
19595550|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
19595551|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19595552|NCT02593526|Diuretics|diuretics|mesh-ancestor
19595553|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
19595554|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595555|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19595556|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595557|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595558|NCT02593643|Midazolam|midazolam|mesh-list
19595559|NCT02593643|Ketamine|ketamine|mesh-list
19595560|NCT02593643|Analgesics|analgesics|mesh-ancestor
19595561|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
19595562|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595563|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595564|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19595565|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19595566|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
19595567|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
19595568|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595569|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19595570|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19595571|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595572|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595573|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19595574|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19595575|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19595576|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19595577|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19595578|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
19595579|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
19595580|NCT02593669|Dexamethasone|dexamethasone|mesh-list
19595581|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19595582|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
19595583|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
19595584|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595585|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595586|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19595587|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
19595588|NCT02593669|Hormones|hormones|mesh-ancestor
19595589|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595590|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19595591|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595592|NCT02593500|Budesonide|budesonide|mesh-list
19595593|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125863|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
20125864|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125865|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595594|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19595595|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
19595596|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595597|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595598|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19595599|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
19595600|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
19595601|NCT02593500|Hormones|hormones|mesh-ancestor
19595602|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595603|NCT02593383|Clindamycin|clindamycin|mesh-list
19595604|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
19595605|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
19595606|NCT02593383|Adapalene|adapalene|mesh-list
19595607|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19595608|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595609|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19595610|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595611|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595612|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19595613|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19595614|NCT02593383|Analgesics|analgesics|mesh-ancestor
19595615|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
19595616|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595617|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595618|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125866|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125867|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125868|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
20125869|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310201|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
19595619|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595620|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
19595621|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19595622|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19595623|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19595624|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595625|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310202|NCT00671814|Linezolid|linezolid|mesh-list
20310203|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310204|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310205|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20310206|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310207|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347184|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595626|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
19595627|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595628|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19595629|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19595630|NCT02593474|Naltrexone|naltrexone|mesh-list
19595631|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19595632|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20347185|NCT00858325|Daptomycin|daptomycin|mesh-list
20347186|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347187|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347188|NCT00858338|Floxuridine|floxuridine|mesh-list
20347189|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19595633|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595634|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
20125870|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
20125871|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20125872|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20125873|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
20125874|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
20125875|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125876|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20125877|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
20125878|NCT00017654|Hormones|hormones|mesh-ancestor
20125879|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595635|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595636|NCT02593448|Anesthetics|anesthetics|mesh-list
19595637|NCT02593448|Propofol|propofol|mesh-list
19595638|NCT02593448|Sevoflurane|sevoflurane|mesh-list
19595639|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595640|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595641|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19595642|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19595643|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
19595644|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20125880|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20125881|NCT00017654|Protective Agents|protective agents|mesh-ancestor
20125882|NCT00017680|Melphalan|melphalan|mesh-list
19595645|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19657864|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19657865|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19657866|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19657867|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19657868|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125883|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20125884|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
20125885|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125886|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125887|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20125888|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20125889|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
20125890|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125891|NCT00017693|Interleukin-4|interleukin-4|mesh-list
20125892|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20125893|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
20125894|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125895|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125896|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20125897|NCT00017719|Lamivudine|lamivudine|mesh-list
20125898|NCT00017719|Zidovudine|zidovudine|mesh-list
20125899|NCT00017719|Nevirapine|nevirapine|mesh-list
20125900|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20125901|NCT00017719|Nelfinavir|nelfinavir|mesh-list
20125902|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19657889|NCT03476811|Analgesics|analgesics|mesh-list
19657890|NCT03476811|Bupivacaine|bupivacaine|mesh-list
19657891|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
19657892|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
19657893|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19657894|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657895|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
19657896|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657897|NCT03464942|Atezolizumab|atezolizumab|mesh-list
19657898|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20125903|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125904|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125905|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125906|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
20125907|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125908|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20125909|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20125910|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
20125911|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20125912|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20125913|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19657910|NCT03447379|Aspirin|aspirin|mesh-list
19657911|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19657912|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19657913|NCT03447379|Analgesics|analgesics|mesh-ancestor
19657914|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
19657915|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657916|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657917|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19657918|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657919|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20125914|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20125915|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
20125916|NCT00017758|Efavirenz|efavirenz|mesh-list
19657920|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19657921|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657922|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19595646|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19595647|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19595648|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19595649|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
19595650|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595651|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19595652|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19595653|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595654|NCT02593370|Lidocaine|lidocaine|mesh-list
19595655|NCT02593370|Epinephrine|epinephrine|mesh-list
19595656|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19595657|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
19595658|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
19595659|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595660|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595661|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
19595662|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595663|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19595664|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19595665|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19595666|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595667|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595668|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19595669|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19595670|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
19595671|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595672|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19595673|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19595674|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
19595675|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20125917|NCT00017758|Nelfinavir|nelfinavir|mesh-list
20125918|NCT00017758|Atorvastatin|atorvastatin|mesh-list
20125919|NCT00017758|Simvastatin|simvastatin|mesh-list
20125920|NCT00017758|Pravastatin|pravastatin|mesh-list
20125921|NCT00017758|Calcium|calcium|mesh-list
20125922|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20125923|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20125924|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20125925|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20125926|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
20125927|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595676|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
19595677|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
20125928|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20125929|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20125930|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125931|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20125932|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125933|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
20125934|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125935|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20125936|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20125937|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20125938|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20125939|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20125940|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20125941|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20125942|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20125943|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
20125944|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19595678|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
19595679|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19595680|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
19595681|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
19595682|NCT02593019|Adavosertib|adavosertib|mesh-list
19595683|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595684|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595685|NCT02593162|Ribavirin|ribavirin|mesh-list
19595686|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
19595687|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595688|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
19595689|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595690|NCT02592980|Warfarin|warfarin|mesh-list
19595691|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
19595692|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19595693|NCT02593201|Cefazolin|cefazolin|mesh-list
19595694|NCT02593201|Ceftazidime|ceftazidime|mesh-list
19595695|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19595696|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595697|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
19595698|NCT02592941|Deflazacort|deflazacort|mesh-list
19595699|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19595700|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19595701|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
19595702|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595703|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
19595704|NCT02593227|Vaccines|vaccines|mesh-list
19595705|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
19595706|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595707|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19595708|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19595709|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19595710|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
20310208|NCT00672022|Miglustat|miglustat|mesh-list
20310209|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595711|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595712|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595713|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19595714|NCT02593110|Telmisartan|telmisartan|mesh-list
19595715|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19595716|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19595717|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19595718|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595719|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
19595720|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19595721|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595722|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595723|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19595724|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19595725|NCT02592863|Protective Agents|protective agents|mesh-ancestor
19595726|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595727|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
19595728|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19595729|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
19595730|NCT02592772|Menthol|menthol|mesh-list
19595731|NCT02592772|Nicotine|nicotine|mesh-list
19595732|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19595733|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
19595734|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595735|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595736|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19595737|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19595738|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
19595739|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310210|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310211|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19595740|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595741|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
19595742|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
19595743|NCT02592915|Clonidine|clonidine|mesh-list
19595744|NCT02592915|Anesthetics|anesthetics|mesh-list
19595745|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595746|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595747|NCT02592915|Analgesics|analgesics|mesh-ancestor
19595748|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
20125945|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20125946|NCT00017784|Valganciclovir|valganciclovir|mesh-list
20125947|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
20125948|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125949|NCT00017862|Reslizumab|reslizumab|mesh-list
20125950|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20125951|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
20125952|NCT00017940|Mitogens|mitogens|mesh-list
20125953|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
20125954|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125955|NCT00017992|Ritonavir|ritonavir|mesh-list
20125956|NCT00017992|Lopinavir|lopinavir|mesh-list
20125957|NCT00017992|Emtricitabine|emtricitabine|mesh-list
20125958|NCT00017992|Stavudine|stavudine|mesh-list
20125959|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19595749|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595750|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19595751|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
19595752|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
19595753|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19595754|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19595755|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19595756|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
19595757|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595758|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595759|NCT02592720|Tenecteplase|tenecteplase|mesh-list
19595760|NCT02592720|Tirofiban|tirofiban|mesh-list
19595761|NCT02592720|Bivalirudin|bivalirudin|mesh-list
20125960|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20125961|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
20125962|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125963|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125964|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20125965|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20125966|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
20125967|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20125968|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20125969|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20125970|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20125971|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125972|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
20125973|NCT00018018|Zidovudine|zidovudine|mesh-list
20125974|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
20125975|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125976|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20125977|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125978|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125979|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
20310212|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20310213|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
20310214|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595762|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
19595763|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19595764|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
19595765|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595766|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595767|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
19595768|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19595769|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19595770|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19595771|NCT02592746|Capecitabine|capecitabine|mesh-list
19595772|NCT02592746|Palbociclib|palbociclib|mesh-list
19595773|NCT02592746|Leuprolide|leuprolide|mesh-list
19595774|NCT02592746|Exemestane|exemestane|mesh-list
19595775|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19595776|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
19595777|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595778|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595779|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19595780|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595781|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19595782|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
19595783|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19595784|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595785|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19595786|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19595787|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19595788|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19595789|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
19595790|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595791|NCT02592694|Tenecteplase|tenecteplase|mesh-list
19595792|NCT02592694|Tirofiban|tirofiban|mesh-list
19595793|NCT02592694|Bivalirudin|bivalirudin|mesh-list
19595794|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
20310215|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20310216|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310217|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595795|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20125980|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595796|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
20310218|NCT00672113|Nifedipine|nifedipine|mesh-list
20310219|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20310220|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20310221|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310222|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20310223|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310224|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
20310225|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
19595797|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595798|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595799|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
19595800|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19595801|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19595802|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19595803|NCT02592226|Anesthetics|anesthetics|mesh-list
20310226|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20310227|NCT00672165|Antibodies|antibodies|mesh-list
20310228|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20310229|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
20310230|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310231|NCT00672282|Bicalutamide|bicalutamide|mesh-list
20310232|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
20310233|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
19595804|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595805|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595806|NCT02592395|Folfirinox|folfirinox|mesh-list
19595807|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595808|NCT02592278|Listerine|listerine|mesh-list
20125981|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20125982|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20310234|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310235|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310236|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310237|NCT00672295|Paclitaxel|paclitaxel|mesh-list
20310238|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20310239|NCT00672295|Carboplatin|carboplatin|mesh-list
20310240|NCT00672295|Dasatinib|dasatinib|mesh-list
20310241|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20310242|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310243|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
20310244|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
20310245|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
20310246|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310247|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20310248|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20125983|NCT00018083|Efavirenz|efavirenz|mesh-list
20125984|NCT00018083|Isoniazid|isoniazid|mesh-list
20125985|NCT00018083|Rifabutin|rifabutin|mesh-list
20125986|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20125987|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20125988|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310249|NCT00672347|Clonidine|clonidine|mesh-list
20310250|NCT00672347|Morphine|morphine|mesh-list
19595809|NCT02592278|Fluorides|fluorides|mesh-list
19595810|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
19595811|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
19595812|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
19595813|NCT02592278|Protective Agents|protective agents|mesh-ancestor
19595814|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595815|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19595816|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595817|NCT02592083|Tamoxifen|tamoxifen|mesh-list
19595818|NCT02592083|Goserelin|goserelin|mesh-list
19595819|NCT02592083|Palbociclib|palbociclib|mesh-list
19595820|NCT02592083|Exemestane|exemestane|mesh-list
19595821|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19595822|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19595823|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
19595824|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595825|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595826|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19595827|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595828|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19595829|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20125989|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20125990|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
20125991|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595830|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19595831|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19595832|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595833|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310251|NCT00672347|Bupivacaine|bupivacaine|mesh-list
20310252|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
20310253|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
20310254|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310255|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310256|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
20310257|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310258|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20310259|NCT00672347|Narcotics|narcotics|mesh-ancestor
20310260|NCT00672347|Analgesics|analgesics|mesh-ancestor
20310261|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20310262|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
20310263|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
20310264|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20310265|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20310266|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20310267|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
20310268|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310269|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310270|NCT00672360|Folic Acid|folic acid|mesh-list
20310271|NCT00672360|Hematinics|hematinics|mesh-ancestor
20310272|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
20310273|NCT00672360|Vitamins|vitamins|mesh-ancestor
20310274|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
20310275|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310276|NCT00672399|Exenatide|exenatide|mesh-list
20310277|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
19595834|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19595835|NCT02592122|Bromides|bromides|mesh-list
19595836|NCT02592122|Albuterol|albuterol|mesh-list
19595837|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
19595838|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19595839|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
19595840|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595841|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595842|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19595843|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
19595844|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
19595845|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19595846|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19595847|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19595848|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19595849|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
19595850|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595851|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595852|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
19595853|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19595854|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19595855|NCT02591953|Prednisolone|prednisolone|mesh-list
19595856|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
19595857|NCT02591953|Lidocaine|lidocaine|mesh-list
19595858|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19595859|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
19595860|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
19595861|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
19595862|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595863|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595864|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
19595865|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595866|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19595867|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19595868|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19595869|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595870|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595871|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19595872|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
19595873|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
19595874|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19595875|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
20310278|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310279|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310280|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19595876|NCT02591953|Hormones|hormones|mesh-ancestor
19595877|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595878|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19595879|NCT02591953|Protective Agents|protective agents|mesh-ancestor
19595880|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19595881|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595882|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
19595883|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
19595884|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
19595885|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20310281|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310282|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310283|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310284|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595886|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595887|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
19595888|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19595889|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19595890|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19595891|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595892|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595893|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595894|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19595895|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
19595896|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
19595897|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595898|NCT02591914|Bevacizumab|bevacizumab|mesh-list
19595899|NCT02591914|Ranibizumab|ranibizumab|mesh-list
19595900|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595901|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595902|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19595903|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19595904|NCT02591914|Growth Substances|growth substances|mesh-ancestor
19595905|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595906|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
19595907|NCT02591927|Insulin|insulin|mesh-list
19595908|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19595909|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595910|NCT02591615|Paclitaxel|paclitaxel|mesh-list
19595911|NCT02591615|Carboplatin|carboplatin|mesh-list
19595912|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
19595913|NCT02591615|Pemetrexed|pemetrexed|mesh-list
19595914|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19595915|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595916|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
19595917|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19595918|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
19595919|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595920|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595921|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595922|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19595923|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19657923|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19657924|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19657925|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
20125992|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20125993|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20125994|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19749574|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20125995|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20125996|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20125997|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20125998|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
20125999|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20126000|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20126001|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20126002|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
20126003|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20126004|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20126005|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20126006|NCT00018135|Calcium|calcium|mesh-list
20126007|NCT00018135|Sevelamer|sevelamer|mesh-list
20126008|NCT00018135|Calcium acetate|calcium acetate|mesh-list
20126009|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19595924|NCT02591888|Bupivacaine|bupivacaine|mesh-list
19595925|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
19595926|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
19595927|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19595928|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595929|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
19595930|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595931|NCT02591771|Epinephrine|epinephrine|mesh-list
19595932|NCT02591771|Racepinephrine|racepinephrine|mesh-list
19595933|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
20310285|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310286|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310287|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20310288|NCT00672399|Incretins|incretins|mesh-ancestor
19595934|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20310289|NCT00672399|Hormones|hormones|mesh-ancestor
20310290|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310291|NCT00672464|Metformin|metformin|mesh-list
20310292|NCT00672464|Olanzapine|olanzapine|mesh-list
20310293|NCT00672464|Simvastatin|simvastatin|mesh-list
20310294|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310295|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310296|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20310297|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20310298|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
19595935|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19595936|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
19595937|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19595938|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595939|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595940|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19595941|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19595942|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
19595943|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595944|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19595945|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
19595946|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
19595947|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
19595948|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19595949|NCT02591836|Atorvastatin|atorvastatin|mesh-list
19595950|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19595951|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19595952|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
19595953|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595954|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19595955|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19595956|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19595957|NCT02591849|Glucagon|glucagon|mesh-list
19595958|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19595959|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19595960|NCT02591849|Hormones|hormones|mesh-ancestor
19595961|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19595962|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595963|NCT02591849|Incretins|incretins|mesh-ancestor
19595964|NCT02591667|Bevacizumab|bevacizumab|mesh-list
19595965|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19595966|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19595967|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19595968|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20126010|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126011|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
20126012|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
20126013|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126014|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126015|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
20126016|NCT00018135|Antacids|antacids|mesh-ancestor
20126017|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126018|NCT00018148|Nortriptyline|nortriptyline|mesh-list
20126019|NCT00018148|Nicotine|nicotine|mesh-list
20310299|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310300|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19595969|NCT02591667|Growth Substances|growth substances|mesh-ancestor
19595970|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595971|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
19595972|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
19595973|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19595974|NCT02591628|Diuretics|diuretics|mesh-ancestor
19595975|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
19595976|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595977|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19595978|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19595979|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19595980|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19595981|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
19595982|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595983|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
19595984|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
19595985|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
19595986|NCT02591251|Povidone|povidone|mesh-list
19595987|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19595988|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
19595989|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
19595990|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19595991|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19595992|NCT02590900|Acetaminophen|acetaminophen|mesh-list
19595993|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19595994|NCT02590900|Analgesics|analgesics|mesh-ancestor
19595995|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
19595996|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19595997|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19595998|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
19595999|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19596000|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
19596001|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
19596002|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19596003|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
20126020|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20126021|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
19596004|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19596005|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19596006|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
19596007|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596008|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596009|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19596010|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19596011|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19596012|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596013|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596014|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596015|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596016|NCT02590874|Analgesics|analgesics|mesh-ancestor
19596017|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
19596018|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596019|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
19596020|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19596021|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
19596022|NCT02591017|Ketamine|ketamine|mesh-list
19596023|NCT02591017|Morphine|morphine|mesh-list
19596024|NCT02591017|Chitosan|chitosan|mesh-list
19596025|NCT02591017|Analgesics|analgesics|mesh-ancestor
19596026|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
19596027|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596028|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126022|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126023|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126024|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20126025|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20126026|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
20310301|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19596029|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19596030|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19596031|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
19596032|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
19596033|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596034|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19596035|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19596036|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126027|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310302|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310303|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
20310304|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
19596037|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596038|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19596039|NCT02591017|Narcotics|narcotics|mesh-ancestor
19596040|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19596041|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19596042|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
20126028|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596043|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19596044|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
19596045|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
19596046|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
19596047|NCT02591017|Coagulants|coagulants|mesh-ancestor
19596048|NCT02591095|Navitoclax|navitoclax|mesh-list
19596049|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596050|NCT02591004|Nifedipine|nifedipine|mesh-list
19596051|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19596052|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596053|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596054|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19596055|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596056|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
19596057|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
19596058|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19596059|NCT02590653|Atorvastatin|atorvastatin|mesh-list
19596060|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19596061|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19596062|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
19596063|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596064|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19596065|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19596066|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596067|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
19596068|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126029|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20126030|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
19596069|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
19596070|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19596071|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19596072|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596073|NCT02590536|Urological Agents|urological agents|mesh-ancestor
19596074|NCT02590705|Lidocaine|lidocaine|mesh-list
19596075|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
19596076|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
19596077|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596078|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596079|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
19596080|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596081|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19596082|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19596083|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19596084|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596085|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596086|NCT02590601|Bromocriptine|bromocriptine|mesh-list
19596087|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19596088|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19596089|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
19596090|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596091|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596092|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
19596093|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
19596094|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596095|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596096|NCT02590627|Lumefantrine|lumefantrine|mesh-list
19596097|NCT02590627|Artemether|artemether|mesh-list
19596098|NCT02590627|Piperaquine|piperaquine|mesh-list
20126031|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126032|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20126033|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126034|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126035|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
20126036|NCT00018161|Mecamylamine|mecamylamine|mesh-list
19596099|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19596100|NCT02590627|Artenimol|artenimol|mesh-list
19596101|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
19596102|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19596103|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19596104|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596105|NCT02590614|Vitamin D|vitamin d|mesh-list
19596106|NCT02590614|Vitamins|vitamins|mesh-ancestor
19596107|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
19596108|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596109|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19596110|NCT02590510|Methotrexate|methotrexate|mesh-list
19596111|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19596112|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
19596113|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19596114|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596115|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19596116|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
19596117|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596118|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126037|NCT00018161|Nicotine|nicotine|mesh-list
20126038|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20126039|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
19596119|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
19596120|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596121|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20126040|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126041|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126042|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20126043|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20126044|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
20126045|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126046|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126047|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20126048|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20126049|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19596122|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596123|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
19596124|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19596125|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19596126|NCT02590263|Temozolomide|temozolomide|mesh-list
19596127|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19596128|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
19596129|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596130|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596131|NCT02590224|Glycine|glycine|mesh-list
19596132|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
19596133|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596134|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596135|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596136|NCT02590133|Fluorouracil|fluorouracil|mesh-list
19596137|NCT02590133|Endostar protein|endostar protein|mesh-list
19596138|NCT02590133|Endostatins|endostatins|mesh-list
19596139|NCT02590133|Nedaplatin|nedaplatin|mesh-list
19596140|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
19596141|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596142|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19596143|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596144|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749575|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19749576|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
19749577|NCT04923893|Hormones|hormones|mesh-ancestor
19749578|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749579|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749580|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749581|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749582|NCT04923893|Growth Substances|growth substances|mesh-ancestor
19749583|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749584|NCT04918069|Capsaicin|capsaicin|mesh-list
19749585|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
19749586|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
19749587|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
20126050|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20347190|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
19596145|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
20126051|NCT00018174|Fluoxetine|fluoxetine|mesh-list
19596146|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596147|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19596148|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19596149|NCT02590133|Growth Substances|growth substances|mesh-ancestor
19596150|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
19596151|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
19596152|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19596153|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19596154|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19596155|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596156|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596157|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
19596158|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596159|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596160|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19596161|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126052|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20126053|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19657936|NCT03424122|Rituximab|rituximab|mesh-list
19657937|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19657938|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657939|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657940|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
19657941|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657942|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19657943|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19657944|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
19657945|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657946|NCT03418922|Nivolumab|nivolumab|mesh-list
19657947|NCT03418922|Lenvatinib|lenvatinib|mesh-list
19657948|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657949|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19657950|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19657951|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19657952|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19657953|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126054|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126055|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126056|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126057|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
20126058|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126059|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20126060|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126061|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126062|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20126063|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126064|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126065|NCT00018187|Mecamylamine|mecamylamine|mesh-list
20126066|NCT00018187|Bupropion|bupropion|mesh-list
20126067|NCT00018187|Nicotine|nicotine|mesh-list
20126068|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20126069|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
20126070|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657972|NCT03410654|Tacrolimus|tacrolimus|mesh-list
19657973|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19657974|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
19657975|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657976|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19657977|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749588|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749589|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749590|NCT04908202|BMS-986165|bms-986165|mesh-list
19749591|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19749592|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19596162|NCT02590055|Gemcitabine|gemcitabine|mesh-list
19596163|NCT02590055|Docetaxel|docetaxel|mesh-list
19596164|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19596165|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
19596166|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596167|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596168|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
19596169|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596170|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596171|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596172|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
19596173|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596174|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
19596175|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
19596176|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
19596177|NCT02590016|Insulin|insulin|mesh-list
19596178|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
19596179|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596180|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596181|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
19596182|NCT02589782|Linezolid|linezolid|mesh-list
19596183|NCT02589782|Bedaquiline|bedaquiline|mesh-list
19596184|NCT02589782|Clofazimine|clofazimine|mesh-list
19596185|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19596186|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126071|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126072|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20126073|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20126074|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
20126075|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126076|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126077|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19596187|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19596188|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19596189|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596190|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596191|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596192|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19596193|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
19596194|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596195|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
19596196|NCT02589717|Atezolizumab|atezolizumab|mesh-list
19596197|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596198|NCT02589457|Tenofovir|tenofovir|mesh-list
19596199|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
19596200|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596201|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19596202|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19596203|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596204|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596205|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19596206|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19596207|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
19596208|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19596209|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596210|NCT02589444|Vitamin D|vitamin d|mesh-list
19596211|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
19596212|NCT02589444|Vitamins|vitamins|mesh-ancestor
19596213|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
19596214|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596215|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19596216|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19596217|NCT02589678|Vaccines|vaccines|mesh-list
19596218|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
20126078|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126079|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126080|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20126081|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126082|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126083|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
20310305|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596219|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596220|NCT02589652|Interferons|interferons|mesh-list
19596221|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
20126084|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19596222|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
19596223|NCT02589652|Entecavir|entecavir|mesh-list
19596224|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20126085|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126086|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126087|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20126088|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19596225|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596226|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
19596227|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310306|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20310307|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19596228|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
19596229|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596230|NCT02589340|Buspirone|buspirone|mesh-list
19596231|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19596232|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19596233|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596234|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596235|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19596236|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19596237|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
19596238|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596239|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596240|NCT02589288|Ropivacaine|ropivacaine|mesh-list
19596241|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
19596242|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
19596243|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596244|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596245|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
19596246|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596247|NCT02589041|Ropivacaine|ropivacaine|mesh-list
19596248|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
19596249|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
19596250|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596251|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596252|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
19596253|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596254|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19596255|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
19596256|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596257|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19596258|NCT02589158|Darunavir|darunavir|mesh-list
19596259|NCT02589158|Cobicistat|cobicistat|mesh-list
19596260|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19596261|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19596262|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
20310308|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20310309|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596263|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596264|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596265|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19596266|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19596267|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
19596268|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596269|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19596270|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19596271|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
19596272|NCT02588755|Tegafur|tegafur|mesh-list
19596273|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19596274|NCT02588755|Estrogens|estrogens|mesh-ancestor
19596275|NCT02588755|Hormones|hormones|mesh-ancestor
19596276|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596277|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596278|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596279|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596280|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19596281|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
20126089|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20126090|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20126091|NCT00018200|Benztropine|benztropine|mesh-list
20126092|NCT00018200|Fluoxetine|fluoxetine|mesh-list
20126093|NCT00018200|Desipramine|desipramine|mesh-list
20126094|NCT00018200|Clomipramine|clomipramine|mesh-list
20310310|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19596282|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596283|NCT02588781|Pemetrexed|pemetrexed|mesh-list
20310311|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19596284|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596285|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310312|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20310313|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20310314|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310315|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
20310316|NCT00672568|Capsaicin|capsaicin|mesh-list
20310317|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
20310318|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
20310319|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
20310320|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310321|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596286|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596287|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19596288|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19596289|NCT02588937|Entecavir|entecavir|mesh-list
19596290|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
19596291|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596292|NCT02588534|Etanercept|etanercept|mesh-list
19596293|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19596294|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19596295|NCT02588534|Analgesics|analgesics|mesh-ancestor
19596296|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
19596297|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596298|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596299|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596300|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20126095|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20126096|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126097|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126098|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126099|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126100|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
20126101|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126102|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20126103|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126104|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126105|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20126106|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126107|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126108|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20126109|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20126110|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
20126111|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20126112|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20126113|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
20126114|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
20126115|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126116|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20126117|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19596301|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19596302|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596303|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
20310322|NCT00672659|Dexetimide|dexetimide|mesh-list
20310323|NCT00672659|Pipamperone|pipamperone|mesh-list
20310324|NCT00672659|Citalopram|citalopram|mesh-list
20310325|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20310326|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20310327|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20310328|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310329|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310330|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
20310331|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310332|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20310333|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
20310334|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310335|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20310336|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20310337|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
19596304|NCT02588547|Granisetron|granisetron|mesh-list
20310338|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
19596305|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
19596306|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
19596307|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596308|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596309|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19596310|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19596311|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
19596312|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596313|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126118|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
20126119|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20126120|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
20126121|NCT00018213|Naltrexone|naltrexone|mesh-list
20126122|NCT00018213|Nicotine|nicotine|mesh-list
20126123|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20126124|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
20126125|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126126|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126127|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20126128|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20126129|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
20126130|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126131|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126132|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20126133|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20126134|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
20126135|NCT00018278|Donepezil|donepezil|mesh-list
20126136|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20126137|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126138|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126139|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
20126140|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126141|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126142|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
19596314|NCT02588443|Gemcitabine|gemcitabine|mesh-list
19596315|NCT02588443|Paclitaxel|paclitaxel|mesh-list
19596316|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19596317|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596318|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
19596319|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
19596320|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
19596321|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596322|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19596323|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
19596324|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
19596325|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596326|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596327|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20310339|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310340|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19596328|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
19596329|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596330|NCT02588742|Melatonin|melatonin|mesh-list
19596331|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
19596332|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596333|NCT02588742|Protective Agents|protective agents|mesh-ancestor
19596334|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596335|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596336|NCT02588716|Terlipressin|terlipressin|mesh-list
19596337|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19596338|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19596339|NCT02588417|Dexamethasone|dexamethasone|mesh-list
19596340|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
19596341|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596342|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
19596343|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
19596344|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596345|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596346|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126143|NCT00018291|Gabapentin|gabapentin|mesh-list
20126144|NCT00018291|Risperidone|risperidone|mesh-list
20126145|NCT00018291|Analgesics|analgesics|mesh-ancestor
20126146|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
20126147|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310341|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19596347|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
20126148|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596348|NCT02588417|Hormones|hormones|mesh-ancestor
20126149|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
20126150|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20126151|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20126152|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596349|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596350|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596351|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596352|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
19596353|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
19596354|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596355|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
19596356|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19596357|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596358|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596359|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
19596360|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19596361|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
19596362|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19596363|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596364|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19657978|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126153|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126154|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20126155|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20126156|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126157|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126158|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
20126159|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20126160|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
20126161|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19657988|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
19657989|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19657990|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126162|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20126163|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
20126164|NCT00018343|Estrogens|estrogens|mesh-list
19657994|NCT03367533|Ketamine|ketamine|mesh-list
19657995|NCT03367533|Analgesics|analgesics|mesh-ancestor
19657996|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
19657997|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19657998|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19657999|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19658000|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19658001|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
19658002|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
19658003|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19658004|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19658005|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19658006|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19658007|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126165|NCT00018343|Hormones|hormones|mesh-ancestor
20126166|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126167|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126168|NCT00018356|Testosterone|testosterone|mesh-list
20126169|NCT00018356|Androgens|androgens|mesh-ancestor
20126170|NCT00018356|Hormones|hormones|mesh-ancestor
20126171|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126172|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126173|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
20126174|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20126175|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126176|NCT00018447|Fluorides|fluorides|mesh-list
20126177|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
20126178|NCT00018447|Protective Agents|protective agents|mesh-ancestor
20126179|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126180|NCT00018460|Vitamins|vitamins|mesh-list
20126181|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
20126182|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
20126183|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173396|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173397|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20173398|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
20173399|NCT00161447|Testosterone|testosterone|mesh-list
20173400|NCT00161447|Acyline|acyline|mesh-list
19749593|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173401|NCT00161447|Androgens|androgens|mesh-ancestor
20310342|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
19596365|NCT02588287|Tenofovir|tenofovir|mesh-list
19596366|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
19596367|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596368|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20126184|NCT00018551|Folic Acid|folic acid|mesh-list
20126185|NCT00018551|Hematinics|hematinics|mesh-ancestor
20126186|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
20126187|NCT00018551|Vitamins|vitamins|mesh-ancestor
20126188|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
20126189|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126190|NCT00018603|Guanfacine|guanfacine|mesh-list
20126191|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20126192|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20126193|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20126194|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20126195|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
20126196|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126197|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126198|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126199|NCT00018642|Haloperidol|haloperidol|mesh-list
20126200|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20126201|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
20126202|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126203|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126204|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20126205|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20126206|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596369|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19596370|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596371|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596372|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19596373|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19596374|NCT02588235|Atorvastatin|atorvastatin|mesh-list
19596375|NCT02588235|Ezetimibe|ezetimibe|mesh-list
19596376|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19596377|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19596378|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
19596379|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596380|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19596381|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19596382|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596383|NCT02588196|Dexamethasone|dexamethasone|mesh-list
19596384|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
19596385|NCT02588196|BB 1101|bb 1101|mesh-list
19596386|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596387|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
19596388|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
19596389|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596390|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596391|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19596392|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
19596393|NCT02588196|Hormones|hormones|mesh-ancestor
19596394|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596395|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596396|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596397|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
19596398|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596399|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596400|NCT02588131|Durvalumab|durvalumab|mesh-list
19596401|NCT02588131|Tremelimumab|tremelimumab|mesh-list
19596402|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19596403|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596404|NCT02588118|Propofol|propofol|mesh-list
19596405|NCT02588118|Cisatracurium|cisatracurium|mesh-list
20126207|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126208|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
20126209|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
20126210|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310343|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19596406|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19596407|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596408|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596409|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20126211|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126212|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19596410|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
19596411|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
19596412|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19596413|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19596414|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596415|NCT02588027|Ibuprofen|ibuprofen|mesh-list
19596416|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19596417|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19596418|NCT02588027|Analgesics|analgesics|mesh-ancestor
19596419|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
20310344|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20310345|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20310346|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310347|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
19596420|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596421|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596422|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596423|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19596424|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19596425|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596426|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596427|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
19596428|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19596429|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19596430|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596431|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
19596432|NCT02587845|Coagulants|coagulants|mesh-ancestor
19596433|NCT02587871|Cytarabine|cytarabine|mesh-list
19596434|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19596435|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
19596436|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596437|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596438|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
19596439|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596440|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596441|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
19596442|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596443|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
19596444|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19596445|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596446|NCT02587533|Dopamine|dopamine|mesh-list
19596447|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19596448|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
19596449|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
19596450|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596451|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596452|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
19596453|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596454|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596455|NCT02587533|Protective Agents|protective agents|mesh-ancestor
20126213|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
20126214|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126215|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126216|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20126217|NCT00018668|Olanzapine|olanzapine|mesh-list
20126218|NCT00018668|Risperidone|risperidone|mesh-list
20126219|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20126220|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20126221|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
20126222|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126223|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126224|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126225|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19596456|NCT02587312|Nicotine|nicotine|mesh-list
19596457|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19596458|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
19596459|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596460|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596461|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19596462|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19596463|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19596464|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596465|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596466|NCT02587416|Atorvastatin|atorvastatin|mesh-list
19596467|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20126226|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20126227|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20126228|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126229|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20126230|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
20126231|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
20126232|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
20126233|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126234|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126235|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20126236|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126237|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126238|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126239|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20126240|NCT00018694|Cathartics|cathartics|mesh-ancestor
20126241|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126242|NCT00018733|Paroxetine|paroxetine|mesh-list
20126243|NCT00018733|Desipramine|desipramine|mesh-list
20126244|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20126245|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126246|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596468|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19596469|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
19596470|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596471|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19596472|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19596473|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596474|NCT02587390|Simvastatin|simvastatin|mesh-list
19596475|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19596476|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19596477|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
19596478|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596479|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19596480|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19596481|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596482|NCT02587325|Sirolimus|sirolimus|mesh-list
19596483|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19596484|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596485|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19596486|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596487|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
19596488|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596489|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
19596490|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596491|NCT02587273|Fentanyl|fentanyl|mesh-list
19596492|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19596493|NCT02587273|Narcotics|narcotics|mesh-ancestor
19596494|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596495|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596496|NCT02587273|Analgesics|analgesics|mesh-ancestor
19596497|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
19596498|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596499|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19596500|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19596501|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
19596502|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
19596503|NCT02587260|Clopidogrel|clopidogrel|mesh-list
19596504|NCT02587260|Ticagrelor|ticagrelor|mesh-list
19596505|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19596506|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19596507|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20126247|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596508|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19596509|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20126248|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596510|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
19596511|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126249|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
20126250|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126251|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20126252|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126253|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126254|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19596512|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596513|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596514|NCT02587247|Antibodies|antibodies|mesh-list
19596515|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
19596516|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596517|NCT02587741|Metformin|metformin|mesh-list
19596518|NCT02587741|Acarbose|acarbose|mesh-list
19596519|NCT02587741|Gliclazide|gliclazide|mesh-list
19596520|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19596521|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596522|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596523|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19596524|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596525|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596526|NCT02587052|Tacrolimus|tacrolimus|mesh-list
19596527|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596528|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
19596529|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596530|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19596531|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596532|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596533|NCT02587130|Ketamine|ketamine|mesh-list
19596534|NCT02587130|Analgesics|analgesics|mesh-ancestor
19596535|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
19596536|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596537|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596538|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19596539|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19596540|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
19596541|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
19596542|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596543|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19596544|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19596545|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596546|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596547|NCT02587195|Teriflunomide|teriflunomide|mesh-list
19596548|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20126255|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126256|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126257|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20126258|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20126259|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
20126260|NCT00018759|Paroxetine|paroxetine|mesh-list
20126261|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19596549|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19596550|NCT02587195|Analgesics|analgesics|mesh-ancestor
19596551|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
19596552|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596553|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596554|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596555|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19596556|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596557|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
19596558|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
19596559|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19596560|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
19596561|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19596562|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596563|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19596564|NCT02587169|Doxorubicin|doxorubicin|mesh-list
19596565|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19596566|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20310348|NCT00672763|Vitamin D|vitamin d|mesh-list
19596567|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596568|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19596569|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19596570|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596571|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596572|NCT02586987|Durvalumab|durvalumab|mesh-list
19596573|NCT02586987|Tremelimumab|tremelimumab|mesh-list
19596574|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19596575|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596576|NCT02586961|Betamethasone|betamethasone|mesh-list
19596577|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
19596578|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19596579|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
19596580|NCT02586961|Epinephrine|epinephrine|mesh-list
19596581|NCT02586961|Racepinephrine|racepinephrine|mesh-list
19596582|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19596583|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
19596584|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596585|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
19596586|NCT02586961|Hormones|hormones|mesh-ancestor
19596587|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596588|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596589|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19596590|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
19596591|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19596592|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19596593|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
19596594|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596595|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596596|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19596597|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19596598|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
19596599|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596600|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
19596601|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
20310349|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
20310350|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
20310351|NCT00672763|Vitamins|vitamins|mesh-list
20310352|NCT00672763|Calcium|calcium|mesh-list
19596602|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19596603|NCT02586753|Paclitaxel|paclitaxel|mesh-list
19596604|NCT02586753|Cisplatin|cisplatin|mesh-list
19596605|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19596606|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596607|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
19596608|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
19596609|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
19596610|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596611|NCT02586649|Bromides|bromides|mesh-list
20126262|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126263|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596612|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
19596613|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19596614|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19596615|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
19596616|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126264|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126265|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126266|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
20126267|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126268|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20126269|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126270|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126271|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19596617|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596618|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19596619|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
19596620|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
20126272|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126273|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126274|NCT00018824|Naltrexone|naltrexone|mesh-list
20126275|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20126276|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20310353|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
20310354|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596621|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
19596622|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608230|NCT02245191|Metaraminol|metaraminol|mesh-list
19596623|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596624|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
20126277|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126278|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
20126279|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126280|NCT00018850|Haloperidol|haloperidol|mesh-list
20126281|NCT00018850|Ondansetron|ondansetron|mesh-list
20126282|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
20126283|NCT00018850|Nicotine|nicotine|mesh-list
20126284|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19658020|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19658021|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19658022|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310355|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20310356|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20310357|NCT00672776|Paroxetine|paroxetine|mesh-list
20310358|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20310359|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20310360|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20310361|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658023|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
19658024|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19658025|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19658026|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658027|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19658028|NCT03355534|Analgesics|analgesics|mesh-ancestor
19658029|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
19658030|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658031|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19658032|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19658033|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19658034|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
19658035|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19658036|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658037|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19658038|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126285|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
20126286|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126287|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126288|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20126289|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20126290|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
20126291|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126292|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126293|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
20126294|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126295|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
20126296|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
20126297|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20126298|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
20126299|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20126300|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20126301|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20126302|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126303|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19658058|NCT03285763|Atezolizumab|atezolizumab|mesh-list
19658059|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126304|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20126305|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
20126306|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20126307|NCT00018863|Methylphenidate|methylphenidate|mesh-list
20310362|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310363|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
20310364|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310365|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20310366|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
20310367|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310368|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20310369|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126308|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19666220|NCT05103098|Misoprostol|misoprostol|mesh-list
20126309|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126310|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19596625|NCT02586636|Metformin|metformin|mesh-list
19596626|NCT02586636|Omeprazole|omeprazole|mesh-list
19596627|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596628|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596629|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19596630|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19596631|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19596632|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596633|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596634|NCT02586311|Amlodipine|amlodipine|mesh-list
19596635|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19596636|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19596637|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596638|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596639|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19596640|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596641|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
19596642|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
20310370|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310371|NCT00672867|Adefovir|adefovir|mesh-list
20310372|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20310373|NCT00672867|Clevudine|clevudine|mesh-list
20310374|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
19596643|NCT02586402|Hematinics|hematinics|mesh-ancestor
19596644|NCT02586259|Budesonide|budesonide|mesh-list
19596645|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596646|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19596647|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
19596648|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596649|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596650|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19596651|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
19596652|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
19596653|NCT02586259|Hormones|hormones|mesh-ancestor
19596654|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596655|NCT02586441|Bromides|bromides|mesh-list
19596656|NCT02586441|Propofol|propofol|mesh-list
19596657|NCT02586441|Rocuronium|rocuronium|mesh-list
19596658|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19596659|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596660|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596661|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19596662|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
19596663|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
19596664|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
19596665|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19596666|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19596667|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19596668|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596669|NCT02586454|Morphine|morphine|mesh-list
19596670|NCT02586454|Ropivacaine|ropivacaine|mesh-list
19596671|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19596672|NCT02586454|Narcotics|narcotics|mesh-ancestor
19596673|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596674|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596675|NCT02586454|Analgesics|analgesics|mesh-ancestor
19596676|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
19596677|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596678|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
19596679|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
19596680|NCT02586363|Entecavir|entecavir|mesh-list
19596681|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
19596682|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596683|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
19596684|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596685|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
19596686|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596687|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19596688|NCT02586194|Peficitinib|peficitinib|mesh-list
19596689|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596690|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596691|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596692|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
19596693|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596694|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
19596695|NCT02586181|Vitamin D|vitamin d|mesh-list
20310375|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310376|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19596696|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
19596697|NCT02586181|Vitamins|vitamins|mesh-list
19596698|NCT02586181|Folic Acid|folic acid|mesh-list
19596699|NCT02586181|Calcium|calcium|mesh-list
19596700|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
19596701|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596702|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19596703|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19596704|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
19596705|NCT02586181|Hematinics|hematinics|mesh-ancestor
19596706|NCT02586129|Metformin|metformin|mesh-list
19596707|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19596708|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596709|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596710|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19596711|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19596712|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
19596713|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596714|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20126311|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126312|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126313|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126314|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
20126315|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126316|NCT00018902|Fluoxetine|fluoxetine|mesh-list
20126317|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20126318|NCT00018902|Citalopram|citalopram|mesh-list
20126319|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20126320|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20126321|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126322|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126323|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126324|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
19596715|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19596716|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596717|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
19596718|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
19596719|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19596720|NCT02586051|Antibodies|antibodies|mesh-list
19596721|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
19596722|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19596723|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
19596724|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596725|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19596726|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596727|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
19596728|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19596729|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19596730|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19596731|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596732|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596733|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
19596734|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596735|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596736|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19596737|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596738|NCT02585973|Cisplatin|cisplatin|mesh-list
19596739|NCT02585973|Adavosertib|adavosertib|mesh-list
20310377|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20310378|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310379|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310380|NCT00672919|Pioglitazone|pioglitazone|mesh-list
20310381|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310382|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310383|NCT00672971|Permethrin|permethrin|mesh-list
20310384|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310385|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596740|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596741|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173402|NCT00161447|Hormones|hormones|mesh-ancestor
20310386|NCT00673088|Ropinirole|ropinirole|mesh-list
19666221|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19596742|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596743|NCT02585947|Tenofovir|tenofovir|mesh-list
19596744|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
19596745|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596746|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19596747|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19596748|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596749|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596750|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19596751|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19596752|NCT02585882|Fluorides|fluorides|mesh-list
19596753|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
20126325|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126326|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20126327|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126328|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20126329|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20126330|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126331|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126332|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19596754|NCT02585882|Protective Agents|protective agents|mesh-ancestor
19596755|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596756|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19596757|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19596758|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
19596759|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596760|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596761|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
19596762|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19596763|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596764|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596765|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596766|NCT02585791|Glycerol|glycerol|mesh-list
19596767|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19596768|NCT02585791|Protective Agents|protective agents|mesh-ancestor
19596769|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596770|NCT02585765|Pioglitazone|pioglitazone|mesh-list
19596771|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596772|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596773|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
19596774|NCT02586610|Capecitabine|capecitabine|mesh-list
19596775|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19596776|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596777|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19596778|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
19596779|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596780|NCT02585531|Dexamethasone|dexamethasone|mesh-list
19596781|NCT02585531|Epinephrine|epinephrine|mesh-list
20126333|NCT00018941|Aldesleukin|aldesleukin|mesh-list
19596782|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596783|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
19596784|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
19596785|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596786|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596787|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19596788|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
19596789|NCT02585531|Hormones|hormones|mesh-ancestor
19596790|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596791|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596792|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596793|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19596794|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19596795|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
19596796|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596797|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596798|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19596799|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19596800|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19596801|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
19596802|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
19596803|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
19596804|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19596805|NCT02585570|Phenylephrine|phenylephrine|mesh-list
19596806|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
19596807|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19596808|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
19596809|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
19596810|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596811|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596812|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
19596813|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19596814|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
19596815|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
19596816|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19596817|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19596818|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19596819|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
19596820|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596821|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596822|NCT02585570|Protective Agents|protective agents|mesh-ancestor
19596823|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
19596824|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
19596825|NCT02585479|Pirarubicin|pirarubicin|mesh-list
19596826|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19596827|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126334|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126335|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126336|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126337|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
20126338|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126339|NCT00018954|Cytarabine|cytarabine|mesh-list
20126340|NCT00018954|Prednisone|prednisone|mesh-list
20126341|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
20126342|NCT00018954|Ifosfamide|ifosfamide|mesh-list
20126343|NCT00018954|Doxorubicin|doxorubicin|mesh-list
20310387|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19596828|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
19596829|NCT02585479|Coagulants|coagulants|mesh-ancestor
19596830|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
19596831|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
19596832|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596833|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19596834|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19596835|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19596836|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19596837|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596838|NCT02585258|Prednisolone|prednisolone|mesh-list
19596839|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596840|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
19596841|NCT02585258|Hormones|hormones|mesh-ancestor
19596842|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596843|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596844|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596845|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596846|NCT02585401|Aflibercept|aflibercept|mesh-list
19596847|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19596848|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20126344|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20126345|NCT00018954|Methotrexate|methotrexate|mesh-list
19596849|NCT02585401|Growth Substances|growth substances|mesh-ancestor
19596850|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596851|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
19596852|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596853|NCT02585388|Letrozole|letrozole|mesh-list
19596854|NCT02585388|Vinorelbine|vinorelbine|mesh-list
19596855|NCT02585388|Anastrozole|anastrozole|mesh-list
19596856|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596857|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19596858|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19596859|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596860|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596861|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19596862|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
19596863|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596864|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596865|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19596866|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
19596867|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
19596868|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
19596869|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596870|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19596871|NCT02585141|Clindamycin|clindamycin|mesh-list
19596872|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
19596873|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
19596874|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596875|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19596876|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596877|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596878|NCT02585011|Epinephrine|epinephrine|mesh-list
19596879|NCT02585011|Ropivacaine|ropivacaine|mesh-list
19596880|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
19596881|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
19596882|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596883|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596884|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
19596885|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596886|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19596887|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19596888|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
19596889|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596890|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596891|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19596892|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19596893|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
19596894|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19596895|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
20126346|NCT00018954|Etoposide|etoposide|mesh-list
20126347|NCT00018954|Vincristine|vincristine|mesh-list
19596896|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
19596897|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
19596898|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19596899|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
19596900|NCT02584881|Narcotics|narcotics|mesh-ancestor
19596901|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596902|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596903|NCT02584881|Analgesics|analgesics|mesh-ancestor
19596904|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
19596905|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126348|NCT00018954|Daunorubicin|daunorubicin|mesh-list
20126349|NCT00018954|Asparaginase|asparaginase|mesh-list
20126350|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
20126351|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126352|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
20126353|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126354|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20126355|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20126356|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
20126357|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126358|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126359|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20126360|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19596906|NCT02584816|Vaccines|vaccines|mesh-list
19596907|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
19596908|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596909|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
19596910|NCT02584751|Omeprazole|omeprazole|mesh-list
19596911|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19596912|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19596913|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19596914|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19596915|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596916|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19596917|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
19596918|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596919|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596920|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19596921|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
19596922|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19596923|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
20310388|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20310389|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
20310390|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
20310391|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310392|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310393|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126361|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20126362|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20126363|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126364|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20126365|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
20310394|NCT00673205|Bicalutamide|bicalutamide|mesh-list
20310395|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
20310396|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
20310397|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310398|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310399|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310400|NCT00673218|Omalizumab|omalizumab|mesh-list
20310401|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20310402|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20310403|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
20310404|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
20310405|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20310406|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20310407|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20310408|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
19596924|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596925|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19596926|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
19596927|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
19596928|NCT02584751|Protective Agents|protective agents|mesh-ancestor
19596929|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
19596930|NCT02584738|Prednisolone|prednisolone|mesh-list
19596931|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
19596932|NCT02584738|Bromides|bromides|mesh-list
19596933|NCT02584738|Albuterol|albuterol|mesh-list
20126366|NCT00018954|Hormones|hormones|mesh-ancestor
20126367|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126368|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20126369|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20126370|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
20126371|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20126372|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126373|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
20126374|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
20126375|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19596934|NCT02584738|Ipratropium|ipratropium|mesh-list
20310409|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20310410|NCT00673296|Bevacizumab|bevacizumab|mesh-list
19596935|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19596936|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
19596937|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
19596938|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19596939|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596940|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19596941|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
19596942|NCT02584738|Hormones|hormones|mesh-ancestor
19596943|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596944|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19596945|NCT02584738|Protective Agents|protective agents|mesh-ancestor
19596946|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596947|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596948|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
19596949|NCT02584738|Analgesics|analgesics|mesh-ancestor
19596950|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
19596951|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
19596952|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19596953|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19596954|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19596955|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19596956|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19596957|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19596958|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
19596959|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19596960|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19596961|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19596962|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
19596963|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19596964|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19596965|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19596966|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
19596967|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19596968|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19596969|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
19596970|NCT02584647|Sirolimus|sirolimus|mesh-list
19596971|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19596972|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19596973|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19596974|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310411|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20310412|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596975|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
19596976|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19596977|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
19596978|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596979|NCT02584582|Liraglutide|liraglutide|mesh-list
19596980|NCT02584582|Exenatide|exenatide|mesh-list
20126376|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19596981|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19596982|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596983|NCT02584582|Incretins|incretins|mesh-ancestor
19596984|NCT02584582|Hormones|hormones|mesh-ancestor
19596985|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596986|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19596987|NCT02584543|Vaccines|vaccines|mesh-list
19596988|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
19596989|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19596990|NCT02584465|Tamoxifen|tamoxifen|mesh-list
19596991|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19596992|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
19596993|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19596994|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126377|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20126378|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
20126379|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126380|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
20126381|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126382|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
20126383|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
20126384|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126385|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
20126386|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126387|NCT00019019|Paclitaxel|paclitaxel|mesh-list
20126388|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
19596995|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19596996|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19596997|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19596998|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19596999|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19597000|NCT02584400|Imidazole|imidazole|mesh-list
19597001|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597002|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310413|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20310414|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19597003|NCT02584335|Lidocaine|lidocaine|mesh-list
19597004|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19597005|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
19597006|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
19597007|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597008|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597009|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
19597010|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597011|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19597012|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19597013|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19597014|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597015|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597016|NCT02584075|Metformin|metformin|mesh-list
19597017|NCT02584075|Exenatide|exenatide|mesh-list
19597018|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20126389|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20126390|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126391|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
20126392|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126393|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
20126394|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126395|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20126396|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126397|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20310415|NCT00673296|Growth Substances|growth substances|mesh-ancestor
20310416|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310417|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310418|NCT00673335|Letrozole|letrozole|mesh-list
20310419|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310420|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20310421|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20310422|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310423|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310424|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20310425|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
20310426|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310427|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126398|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126399|NCT00019032|Antibodies|antibodies|mesh-list
20126400|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20126401|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
20126402|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126403|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
20126404|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
20126405|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126406|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
19597019|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597020|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19597021|NCT02584075|Incretins|incretins|mesh-ancestor
19597022|NCT02584075|Hormones|hormones|mesh-ancestor
19597023|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597024|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19597025|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
19597026|NCT02584231|Coagulants|coagulants|mesh-ancestor
19597027|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19597028|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
19597029|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126407|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126408|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310428|NCT00673426|Enoxaparin|enoxaparin|mesh-list
19597030|NCT02584036|Vaccines|vaccines|mesh-list
19597031|NCT02584036|Immunologic Factors|immunologic factors|mesh-ancestor
19597032|NCT02584036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597033|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19597034|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
19597035|NCT02584153|Coagulants|coagulants|mesh-ancestor
19597036|NCT02584010|Silicon|silicon|mesh-list
19597037|NCT02584010|Trace Elements|trace elements|mesh-ancestor
19597038|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
19597039|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597040|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19597041|NCT02583958|Laxatives|laxatives|mesh-ancestor
19597042|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597043|NCT02583854|Hemostatics|hemostatics|mesh-list
19597044|NCT02583854|Coagulants|coagulants|mesh-ancestor
19597045|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
19597046|NCT02583828|Letrozole|letrozole|mesh-list
19597047|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597048|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
19597049|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597050|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19597051|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19597052|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
19597053|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597054|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597055|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19597056|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19597057|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19597058|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597059|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19597060|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
19597061|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597062|NCT02583893|Cytarabine|cytarabine|mesh-list
19597063|NCT02583893|Sirolimus|sirolimus|mesh-list
19597064|NCT02583893|Etoposide|etoposide|mesh-list
19597065|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
19597066|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
19597067|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20126409|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20126410|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20126411|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19597068|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597069|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19597070|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19597071|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597072|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597073|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597074|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
19597075|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
19597076|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597077|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597078|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
19597079|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597080|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19597081|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19597082|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
19597083|NCT02583893|Analgesics|analgesics|mesh-ancestor
19597084|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
19597085|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597086|NCT02583698|Carvedilol|carvedilol|mesh-list
19597087|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19597088|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19597089|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
19597090|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597091|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126412|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20126413|NCT00019058|Protective Agents|protective agents|mesh-ancestor
20126414|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126415|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
20126416|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20126417|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
20126418|NCT00019071|Cladribine|cladribine|mesh-list
20126419|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126420|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126421|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
20126422|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126423|NCT00019084|Aldesleukin|aldesleukin|mesh-list
20126424|NCT00019084|Vaccines|vaccines|mesh-list
19597092|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597093|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19597094|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
19597095|NCT02583698|Protective Agents|protective agents|mesh-ancestor
20310429|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
20310430|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20310431|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20310432|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310433|NCT00673504|Gemcitabine|gemcitabine|mesh-list
20310434|NCT00673504|Sunitinib|sunitinib|mesh-list
20310435|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597096|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19597097|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597098|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19597099|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
19597100|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19597101|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19597102|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
19597103|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19597104|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
19597105|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597106|NCT02583672|Expectorants|expectorants|mesh-ancestor
19597107|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
19597108|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19597109|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
19597110|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597111|NCT02583672|Protective Agents|protective agents|mesh-ancestor
19597112|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597113|NCT02583672|Antidotes|antidotes|mesh-ancestor
19597114|NCT02583594|Loratadine|loratadine|mesh-list
20126425|NCT00019084|Sargramostim|sargramostim|mesh-list
20126426|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
19597115|NCT02583594|Acyclovir|acyclovir|mesh-list
19597116|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
19597117|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
19597118|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
19597119|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19597120|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
19597121|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
19597122|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597123|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597124|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597125|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
19597126|NCT02583594|Hormones|hormones|mesh-ancestor
19597127|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597128|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19597129|NCT02583594|Protective Agents|protective agents|mesh-ancestor
19597130|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597131|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19597132|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
19597133|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597134|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
19597135|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
19597136|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19597137|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19597138|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19597139|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
19597140|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
19597141|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597142|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126427|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126428|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126429|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126430|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126431|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
20126432|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126433|NCT00019097|Melphalan|melphalan|mesh-list
20126434|NCT00019097|Sargramostim|sargramostim|mesh-list
20126435|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20126436|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19597143|NCT02583633|Nifedipine|nifedipine|mesh-list
19597144|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
19597145|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19597146|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19666222|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
20126437|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
20310436|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
19597147|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597148|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19597149|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597150|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
19597151|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
19597152|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19597153|NCT02583568|Bevacizumab|bevacizumab|mesh-list
19597154|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19597155|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597156|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19597157|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19597158|NCT02583568|Growth Substances|growth substances|mesh-ancestor
19597159|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310437|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310438|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310439|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
19597160|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
19597161|NCT02583451|Lemborexant|lemborexant|mesh-list
19597162|NCT02583451|Zopiclone|zopiclone|mesh-list
19597163|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19597164|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597165|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597166|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19597167|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19597168|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597169|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597170|NCT02583464|Tenofovir|tenofovir|mesh-list
19597171|NCT02583464|Emtricitabine|emtricitabine|mesh-list
19597172|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
19597173|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597174|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19597175|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19597176|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597177|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597178|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19597179|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19597180|NCT02583438|Saxagliptin|saxagliptin|mesh-list
19597181|NCT02583438|Incretins|incretins|mesh-ancestor
19597182|NCT02583438|Hormones|hormones|mesh-ancestor
19597183|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597184|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597185|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19597186|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
19597187|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597188|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597189|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19597190|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19597191|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
19597192|NCT02583685|Ribavirin|ribavirin|mesh-list
19597193|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19597194|NCT02583685|Simeprevir|simeprevir|mesh-list
19597195|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
19597196|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597197|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
19597198|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597199|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
19597200|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597201|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
19597202|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597203|NCT02583516|Vemurafenib|vemurafenib|mesh-list
19597204|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597205|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19597206|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597207|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597208|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19597209|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19597210|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126438|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126439|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126440|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20126441|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126442|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
20126443|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597211|NCT02582996|Acetaminophen|acetaminophen|mesh-list
19597212|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
19597213|NCT02582996|Metoclopramide|metoclopramide|mesh-list
19597214|NCT02582996|Caffeine|caffeine|mesh-list
19597215|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19597216|NCT02582996|Analgesics|analgesics|mesh-ancestor
19597217|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
19597218|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597219|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597220|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
19597221|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19597222|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19597223|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597224|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597225|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19597226|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19597227|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
19597228|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597229|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
19597230|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
19597231|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597232|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19597233|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19597234|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
19597235|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19597236|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
19597237|NCT02583217|Ketamine|ketamine|mesh-list
19597238|NCT02583217|Remifentanil|remifentanil|mesh-list
19597239|NCT02583217|Propofol|propofol|mesh-list
19597240|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19597241|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597242|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597243|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19597244|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
19597245|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
19597246|NCT02583217|Analgesics|analgesics|mesh-ancestor
19597247|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
19597248|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597249|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19597250|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19597251|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19597252|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597253|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597254|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19597255|NCT02583217|Narcotics|narcotics|mesh-ancestor
19597256|NCT02583243|Buprenorphine|buprenorphine|mesh-list
19597257|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19597258|NCT02583243|Narcotics|narcotics|mesh-ancestor
19597259|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20126444|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126445|NCT00019123|Thalidomide|thalidomide|mesh-list
20126446|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126447|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
20126448|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126449|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
19597260|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597261|NCT02583243|Analgesics|analgesics|mesh-ancestor
19597262|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
19597263|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597264|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19597265|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
19597266|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19597267|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
19597268|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19597269|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
19597270|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597271|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597272|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
19597273|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19597274|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19597275|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597276|NCT02583282|Doxycycline|doxycycline|mesh-list
19597277|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19597278|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597279|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
19597280|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19597281|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19597282|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
19597283|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19597284|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19597285|NCT02583022|Analgesics|analgesics|mesh-ancestor
19597286|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
19597287|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597288|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597289|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19597290|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19597291|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
19597292|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597293|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
19597294|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19597295|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597296|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597297|NCT02582892|Vitamin D|vitamin d|mesh-list
19597298|NCT02582892|Vitamins|vitamins|mesh-ancestor
19597299|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
19597300|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597301|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19597302|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
19597303|NCT02582736|Haloperidol|haloperidol|mesh-list
19597304|NCT02582736|Pimozide|pimozide|mesh-list
19597305|NCT02582736|Olanzapine|olanzapine|mesh-list
19597306|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
19597307|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
19597308|NCT02582736|Risperidone|risperidone|mesh-list
19597309|NCT02582736|Aripiprazole|aripiprazole|mesh-list
19597310|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19597311|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19597312|NCT02582736|Ziprasidone|ziprasidone|mesh-list
19597313|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
20126450|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20126451|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597314|NCT02582736|Clozapine|clozapine|mesh-list
19597315|NCT02582736|Loxapine|loxapine|mesh-list
19597316|NCT02582736|Perphenazine|perphenazine|mesh-list
19597317|NCT02582736|Fluphenazine|fluphenazine|mesh-list
19597318|NCT02582736|Thioridazine|thioridazine|mesh-list
19597319|NCT02582736|Flupenthixol|flupenthixol|mesh-list
19597320|NCT02582736|Clopenthixol|clopenthixol|mesh-list
19597321|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
19597322|NCT02582736|Fluspirilene|fluspirilene|mesh-list
19597323|NCT02582736|Thiothixene|thiothixene|mesh-list
19597324|NCT02582736|Mesoridazine|mesoridazine|mesh-list
19597325|NCT02582736|Chlormezanone|chlormezanone|mesh-list
19597326|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
19597327|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19597328|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
19597329|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597330|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597331|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597332|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19597333|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597334|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19597335|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19597336|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
20126452|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20126453|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20126454|NCT00019123|Growth Substances|growth substances|mesh-ancestor
19597337|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
19597338|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
19597339|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597340|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597341|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19597342|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19597343|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597344|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
19597345|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
19597346|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19597347|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19597348|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19597349|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19597350|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19597351|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
19597352|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
19597353|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19597354|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
19597355|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19597356|NCT02582736|Analgesics|analgesics|mesh-ancestor
19597357|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
19597358|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19597359|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19597360|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19597361|NCT02582359|Cytarabine|cytarabine|mesh-list
19597362|NCT02582359|Daunorubicin|daunorubicin|mesh-list
19597363|NCT02582359|Ixazomib|ixazomib|mesh-list
19597364|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597365|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
19597366|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597367|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597368|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
19597369|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597370|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597371|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
19597372|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597373|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19597374|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19597375|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19597376|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597377|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
19597378|NCT02582372|Fentanyl|fentanyl|mesh-list
19597379|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
20126455|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
20126456|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126457|NCT00019136|Aldesleukin|aldesleukin|mesh-list
19597380|NCT02582372|Bupivacaine|bupivacaine|mesh-list
19597381|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
19597382|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
19597383|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597384|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597385|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
19597386|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597387|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19597388|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19597389|NCT02582372|Analgesics|analgesics|mesh-ancestor
20126458|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126459|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126460|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126461|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
20126462|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608231|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20608232|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
20608233|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
20608234|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608235|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608236|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
20608237|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19597390|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19597391|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20126463|NCT00019175|Aldesleukin|aldesleukin|mesh-list
19597392|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19597393|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
19597394|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597395|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597396|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19597397|NCT02582372|Narcotics|narcotics|mesh-ancestor
19597398|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19597399|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19597400|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
19597401|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
19597402|NCT02582437|Narcotics|narcotics|mesh-ancestor
19597403|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597404|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597405|NCT02582437|Analgesics|analgesics|mesh-ancestor
19597406|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
19597407|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597408|NCT02582307|Acetaminophen|acetaminophen|mesh-list
19597409|NCT02582307|Scopolamine|scopolamine|mesh-list
19597410|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19597411|NCT02582307|Analgesics|analgesics|mesh-list
19597412|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19597413|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
19597414|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597415|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597416|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
19597417|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19597418|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
19597419|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
19597420|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597421|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
19597422|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19597423|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
19597424|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597425|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597426|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19597427|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
19597428|NCT02582476|Bumetanide|bumetanide|mesh-list
19597429|NCT02582476|Diuretics|diuretics|mesh-ancestor
19597430|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
19597431|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597432|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19597433|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597434|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597435|NCT02582190|Colchicine|colchicine|mesh-list
19597436|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
19597437|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19597438|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
19597439|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
19597440|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
19597441|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597442|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597443|NCT02582177|Ketoconazole|ketoconazole|mesh-list
19597444|NCT02582177|Clotrimazole|clotrimazole|mesh-list
19597445|NCT02582177|Miconazole|miconazole|mesh-list
19597446|NCT02582177|Dexamethasone|dexamethasone|mesh-list
19597447|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
19597448|NCT02582177|Betamethasone|betamethasone|mesh-list
19597449|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
19597450|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19597451|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
19597452|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19597453|NCT02582177|BB 1101|bb 1101|mesh-list
19597454|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19597455|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
19597456|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
19597457|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597458|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597459|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597460|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
19597461|NCT02582177|Hormones|hormones|mesh-ancestor
19597462|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597463|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19597464|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597465|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
19597466|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597467|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597468|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19597469|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
19597470|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
19597471|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597472|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19597473|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19597474|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19597475|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
19597476|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19597477|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19597478|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19597479|NCT02582203|Vancomycin|vancomycin|mesh-list
19597480|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19597481|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19597482|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597483|NCT02582047|Vaccines|vaccines|mesh-list
19597484|NCT02582047|Immunologic Factors|immunologic factors|mesh-ancestor
19597485|NCT02582047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597486|NCT02582099|Gentamicins|gentamicins|mesh-list
19597487|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19597488|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597489|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19597490|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597491|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597492|NCT02582008|Bupropion|bupropion|mesh-list
19597493|NCT02582008|Nicotine|nicotine|mesh-list
19597494|NCT02582008|Varenicline|varenicline|mesh-list
19597495|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19597496|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
19597497|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597498|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597499|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19597500|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19597501|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
19597502|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597503|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597504|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19597505|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
19597506|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19597507|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19597508|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19597509|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597510|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
19597511|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19597512|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19597513|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597514|NCT02581969|Factor VIII|factor viii|mesh-list
19597515|NCT02581969|Coagulants|coagulants|mesh-ancestor
19597516|NCT02581982|Paclitaxel|paclitaxel|mesh-list
19597517|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
19597518|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19597519|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19597520|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597521|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19597522|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
19597523|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
19597524|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597525|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19597526|NCT02581943|Paclitaxel|paclitaxel|mesh-list
19597527|NCT02581943|Carboplatin|carboplatin|mesh-list
19597528|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
19597529|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19597530|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19597531|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597532|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
19597533|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
19597534|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
19597535|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597536|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19597537|NCT02581826|Silodosin|silodosin|mesh-list
19597538|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19597539|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19597540|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19597541|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
19597542|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608238|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
19597543|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597544|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597545|NCT02581826|Urological Agents|urological agents|mesh-ancestor
19597546|NCT02581761|Misoprostol|misoprostol|mesh-list
19597547|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19597548|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
19597549|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19597550|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597551|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19597552|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597553|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
19597554|NCT02581696|Irsogladine|irsogladine|mesh-list
19597555|NCT02581696|Lafutidine|lafutidine|mesh-list
19597556|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597557|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19597558|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597559|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19597560|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
19597561|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
19597562|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597563|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597564|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597565|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19597566|NCT02581696|Protective Agents|protective agents|mesh-ancestor
19597567|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19597568|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
19597569|NCT02581683|Ropivacaine|ropivacaine|mesh-list
19597570|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
19597571|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
19597572|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597573|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597574|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
19597575|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597576|NCT02581683|Analgesics|analgesics|mesh-ancestor
19597577|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19597578|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
19597579|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19597580|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597581|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597582|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19597583|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
19597584|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19597585|NCT02581748|Trastuzumab|trastuzumab|mesh-list
19597586|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19597587|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597588|NCT02581553|Allopurinol|allopurinol|mesh-list
19597589|NCT02581553|Lesinurad|lesinurad|mesh-list
19597590|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
19597591|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597592|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597593|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
19597594|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19597595|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19597596|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
19597597|NCT02581553|Protective Agents|protective agents|mesh-ancestor
19597598|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597599|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
19597600|NCT02581553|Renal Agents|renal agents|mesh-ancestor
19597601|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
19597602|NCT02581566|Bupivacaine|bupivacaine|mesh-list
19597603|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
19597604|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
20310440|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310441|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597605|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597606|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597607|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
19597608|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597609|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20310442|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20310443|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
20310444|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310445|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20310446|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19597610|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19597611|NCT02581566|Analgesics|analgesics|mesh-ancestor
20310447|NCT00673504|Growth Substances|growth substances|mesh-ancestor
19597612|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19597613|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19597614|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19597615|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
19597616|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310448|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310449|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20310450|NCT00673556|Alefacept|alefacept|mesh-list
20310451|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
20310452|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
20310453|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310454|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20310455|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310456|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20310457|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310458|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310459|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20310460|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20310461|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19597617|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597618|NCT02581527|Rifampin|rifampin|mesh-list
19597619|NCT02581527|Isoniazid|isoniazid|mesh-list
19597620|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
19597621|NCT02581527|Ethambutol|ethambutol|mesh-list
19597622|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19597623|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
19597624|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19597625|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597626|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
19597627|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20310462|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
20310463|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310464|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20310465|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20310466|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310467|NCT00673608|Deferasirox|deferasirox|mesh-list
20310468|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20310469|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
19597628|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597629|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597630|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19597631|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19597632|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19597633|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19597634|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19597635|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19597636|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19597637|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19597638|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
19597639|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19597640|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
19597641|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19597642|NCT02581371|Protective Agents|protective agents|mesh-ancestor
19597643|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597644|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
19597645|NCT02581501|Gemcitabine|gemcitabine|mesh-list
19597646|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19597647|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597648|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
19597649|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597650|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597651|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
19597652|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597653|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597654|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597655|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
19597656|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597657|NCT02581462|Trastuzumab|trastuzumab|mesh-list
19597658|NCT02581462|Pertuzumab|pertuzumab|mesh-list
19597659|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19597660|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597661|NCT02581631|Nivolumab|nivolumab|mesh-list
19597662|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19597663|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19597664|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597665|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19597666|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126464|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126465|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126466|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126467|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
20126468|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126469|NCT00019188|Interleukin-12|interleukin-12|mesh-list
20126470|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126471|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
20126472|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126473|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20126474|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20126475|NCT00019188|Growth Substances|growth substances|mesh-ancestor
20126476|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
20126477|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126478|NCT00019214|Aldesleukin|aldesleukin|mesh-list
20126479|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126480|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126481|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126482|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
20126483|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126484|NCT00019227|Calcium|calcium|mesh-list
20126485|NCT00019227|Daclizumab|daclizumab|mesh-list
20126486|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
20310470|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
20310471|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310472|NCT00673621|Albuterol|albuterol|mesh-list
20310473|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
20310474|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310475|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20310476|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
20310477|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310478|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20310479|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
20310480|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
20310481|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20310482|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20310483|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20310484|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20126487|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20126488|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126489|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19658082|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19658083|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19658084|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
20126490|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
20126491|NCT00019227|Antidotes|antidotes|mesh-ancestor
20126492|NCT00019227|Protective Agents|protective agents|mesh-ancestor
20126493|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
20126494|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
20126495|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126496|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20126497|NCT00019240|Cidofovir|cidofovir|mesh-list
20126498|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
20126499|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126500|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749594|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126501|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126502|NCT00019318|Romidepsin|romidepsin|mesh-list
19597667|NCT02581423|Capecitabine|capecitabine|mesh-list
19597668|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597669|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
19597670|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597671|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597672|NCT02581124|Lapatinib|lapatinib|mesh-list
19597673|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597674|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19597675|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597676|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597677|NCT02581176|Apixaban|apixaban|mesh-list
19597678|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19597679|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
19597680|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19597681|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
19597682|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597683|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597684|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
19597685|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19597686|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19597687|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20310485|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
20310486|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310487|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310488|NCT00673621|Miotics|miotics|mesh-ancestor
20310489|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20310490|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20310491|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20310492|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20126503|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20126504|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126505|NCT00019331|Aldesleukin|aldesleukin|mesh-list
20126506|NCT00019331|Sargramostim|sargramostim|mesh-list
20126507|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
20126508|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126509|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126510|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126511|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126512|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
20126513|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126514|NCT00019344|Alvocidib|alvocidib|mesh-list
20126515|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126516|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
20126517|NCT00019344|Growth Substances|growth substances|mesh-ancestor
20126518|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126519|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20126520|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126521|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126522|NCT00019357|Aldesleukin|aldesleukin|mesh-list
20310493|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
20310494|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20310495|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20310496|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310497|NCT00673829|Interleukin-2|interleukin-2|mesh-list
20310498|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310499|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19597688|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597689|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597690|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19597691|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597692|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597693|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
19597694|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597695|NCT02580968|Flunarizine|flunarizine|mesh-list
19597696|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
19597697|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19597698|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19597699|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597700|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20126523|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597701|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597702|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19597703|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
20126524|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19597704|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
19597705|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597706|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
19597707|NCT02581046|Dexamethasone|dexamethasone|mesh-list
19597708|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19597709|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
19597710|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
19597711|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597712|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597713|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19597714|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
19597715|NCT02581046|Hormones|hormones|mesh-ancestor
19597716|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597717|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19597718|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597719|NCT02580773|Tinzaparin|tinzaparin|mesh-list
19597720|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
19597721|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19597722|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19597723|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597724|NCT02580604|Calcium|calcium|mesh-list
19597725|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19597726|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597727|NCT02580734|Melatonin|melatonin|mesh-list
19597728|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
19597729|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597730|NCT02580734|Protective Agents|protective agents|mesh-ancestor
19597731|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597732|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597733|NCT02580344|Ibuprofen|ibuprofen|mesh-list
19597734|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19597735|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19597736|NCT02580344|Analgesics|analgesics|mesh-ancestor
19597737|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
19597738|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597739|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597740|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19597741|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19597742|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19597743|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597744|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597745|NCT02580448|Seviteronel|seviteronel|mesh-list
19597746|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597747|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19597748|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597749|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597750|NCT02580331|Metformin|metformin|mesh-list
19597751|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19597752|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597753|NCT02580474|Asunaprevir|asunaprevir|mesh-list
19597754|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
19597755|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597756|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597757|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
19597758|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19597759|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
19597760|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597761|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
19597762|NCT02580695|Protective Agents|protective agents|mesh-ancestor
19597763|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
19597764|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19597765|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19597766|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597767|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
19597768|NCT02580227|Coagulants|coagulants|mesh-ancestor
19597769|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
19597770|NCT02580006|Hematinics|hematinics|mesh-ancestor
19597771|NCT02580149|Clopidogrel|clopidogrel|mesh-list
19597772|NCT02580149|Ticagrelor|ticagrelor|mesh-list
19597773|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19597774|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19597775|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19597776|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20608239|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
19597777|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
19597778|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597779|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597780|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597781|NCT02579642|Ketamine|ketamine|mesh-list
19597782|NCT02579642|Analgesics|analgesics|mesh-ancestor
19597783|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
19597784|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597785|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597786|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19597787|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19597788|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
19597789|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
19597790|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597791|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19597792|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19597793|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597794|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597795|NCT02579902|Vitamin D|vitamin d|mesh-list
19597796|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
19597797|NCT02579902|Vitamins|vitamins|mesh-ancestor
19597798|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
19597799|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597800|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19597801|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19597802|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19597803|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
19597804|NCT02579590|Desogestrel|desogestrel|mesh-list
19597805|NCT02579590|Etonogestrel|etonogestrel|mesh-list
19597806|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19597807|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19597808|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19597809|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
19597810|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19597811|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597812|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19597813|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19597814|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19597815|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19597816|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597817|NCT02579590|Progestins|progestins|mesh-ancestor
19597818|NCT02579590|Hormones|hormones|mesh-ancestor
19597819|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597820|NCT02579564|Gemcitabine|gemcitabine|mesh-list
19597821|NCT02579564|Paclitaxel|paclitaxel|mesh-list
19597822|NCT02579564|Vinorelbine|vinorelbine|mesh-list
19597823|NCT02579564|Pemetrexed|pemetrexed|mesh-list
19597824|NCT02579564|Endostar protein|endostar protein|mesh-list
19597825|NCT02579564|Endostatins|endostatins|mesh-list
19597826|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19597827|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597828|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
19597829|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
19597830|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
19597831|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597832|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597833|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
19597834|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
19597835|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597836|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597837|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597838|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
19597839|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597840|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19597841|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19597842|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19597843|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19597844|NCT02579564|Growth Substances|growth substances|mesh-ancestor
19597845|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
19597846|NCT02579707|Ivosidenib|ivosidenib|mesh-list
19597847|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126525|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126526|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
20310500|NCT00673829|Analgesics|analgesics|mesh-ancestor
20310501|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
20126527|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597848|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597849|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597850|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19597851|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
19597852|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597853|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
19597854|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597855|NCT02579733|Azathioprine|azathioprine|mesh-list
19597856|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
19597857|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597858|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597859|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597860|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597861|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
19597862|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310502|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310503|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310504|NCT00674011|Bevacizumab|bevacizumab|mesh-list
20310505|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20310506|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310507|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19597863|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20126528|NCT00019383|Aldesleukin|aldesleukin|mesh-list
20126529|NCT00019383|Sargramostim|sargramostim|mesh-list
20126530|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
20126531|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
20126532|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126533|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126534|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126535|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126536|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
20126537|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126538|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126539|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
20126540|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126541|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
20126542|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126543|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20126544|NCT00019396|Protective Agents|protective agents|mesh-ancestor
20126545|NCT00019409|Cytarabine|cytarabine|mesh-list
19658117|NCT03218488|Ustekinumab|ustekinumab|mesh-list
19658118|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
20126546|NCT00019409|Prednisone|prednisone|mesh-list
20126547|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
20126548|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20126549|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20126550|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20126551|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
20126552|NCT00019409|Methotrexate|methotrexate|mesh-list
19658126|NCT03196427|Vedolizumab|vedolizumab|mesh-list
19658127|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19658128|NCT03193853|Paclitaxel|paclitaxel|mesh-list
19658129|NCT03193853|Serabelisib|serabelisib|mesh-list
19658130|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19658131|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658132|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
19658133|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
19658134|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
19658135|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658136|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126553|NCT00019409|Vincristine|vincristine|mesh-list
20126554|NCT00019409|Daunorubicin|daunorubicin|mesh-list
20126555|NCT00019409|Asparaginase|asparaginase|mesh-list
20126556|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
20126557|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126558|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
20126559|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126560|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310508|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20126561|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20310509|NCT00674011|Growth Substances|growth substances|mesh-ancestor
20126562|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
20126563|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126564|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597864|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19597865|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19597866|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19597867|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
19597868|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597869|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597870|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19597871|NCT02579473|Rotigotine|rotigotine|mesh-list
19597872|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
19597873|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
19597874|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597875|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597876|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597877|NCT02579434|Midazolam|midazolam|mesh-list
19597878|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19597879|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19597880|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597881|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597882|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19597883|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19597884|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19597885|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19597886|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
19597887|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
19597888|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
19597889|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
19597890|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597891|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597892|NCT02579356|Telmisartan|telmisartan|mesh-list
19597893|NCT02579356|Atorvastatin|atorvastatin|mesh-list
19597894|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19597895|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19597896|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
19597897|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597898|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19597899|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19597900|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597901|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19597902|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19597903|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19597904|NCT02579187|Anesthetics|anesthetics|mesh-list
19597905|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597906|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597907|NCT02579161|Metronidazole|metronidazole|mesh-list
19597908|NCT02579161|Clindamycin|clindamycin|mesh-list
19597909|NCT02579161|Clindamycin palmitate|clindamycin palmitate|mesh-list
19597910|NCT02579161|Clindamycin phosphate|clindamycin phosphate|mesh-list
19597911|NCT02579161|Sulbactam|sulbactam|mesh-list
19597912|NCT02579161|Cephalosporins|cephalosporins|mesh-list
20310510|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310511|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310512|NCT00674050|Fluticasone|fluticasone|mesh-list
20310513|NCT00674050|Albuterol|albuterol|mesh-list
20310514|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310515|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20310516|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20310517|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
20310518|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310519|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20310520|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
20310521|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
20310522|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20310523|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
20310524|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20310525|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20310526|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20310527|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20310528|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
20310529|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310530|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597913|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
20310531|NCT00674063|Alefacept|alefacept|mesh-list
20310532|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
20310533|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
19597914|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597915|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19597916|NCT02579161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20126565|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20126566|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19597917|NCT02579161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19597918|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19597919|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597920|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597921|NCT02579161|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19597922|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19597923|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19597924|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19597925|NCT02579044|Everolimus|everolimus|mesh-list
19597926|NCT02579044|Lonafarnib|lonafarnib|mesh-list
19597927|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597928|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597929|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
19597930|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597931|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597932|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597933|NCT02578953|Dutasteride|dutasteride|mesh-list
19597934|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19597935|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19597936|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597937|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597938|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
19597939|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19597940|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597941|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19597942|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19597943|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
19597944|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597945|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19597946|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19597947|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
19597948|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
19597949|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19597950|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597951|NCT02578823|Antipyretics|antipyretics|mesh-list
19597952|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597953|NCT02578719|Bupivacaine|bupivacaine|mesh-list
19597954|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
19597955|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
19597956|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19597957|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597958|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
19597959|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19597960|NCT02578641|Gemcitabine|gemcitabine|mesh-list
19597961|NCT02578641|Carboplatin|carboplatin|mesh-list
19597962|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19597963|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19597964|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
19597965|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597966|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
19597967|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597968|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597969|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19597970|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
19597971|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597972|NCT02578602|Edetic Acid|edetic acid|mesh-list
19597973|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
19597974|NCT02578602|Antidotes|antidotes|mesh-ancestor
19597975|NCT02578602|Protective Agents|protective agents|mesh-ancestor
19597976|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19597977|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
19597978|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
19597979|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597980|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19597981|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
19597982|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20126567|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
20126568|NCT00019409|Hormones|hormones|mesh-ancestor
20126569|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126570|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19597983|NCT02578550|Tenofovir|tenofovir|mesh-list
19597984|NCT02578550|Emtricitabine|emtricitabine|mesh-list
19597985|NCT02578550|Darunavir|darunavir|mesh-list
19597986|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19597987|NCT02578550|Cobicistat|cobicistat|mesh-list
19597988|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19597989|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
19597990|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19597991|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19597992|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19597993|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19597994|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19597995|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19597996|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19597997|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19597998|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19597999|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598000|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20126571|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20126572|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
20126573|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20126574|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126575|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
20126576|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
20126577|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126578|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20126579|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20126580|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
20126581|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126582|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20126583|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
20126584|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126585|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
20126586|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20126587|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20126588|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19598001|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19598002|NCT02578251|Acetaminophen|acetaminophen|mesh-list
19598003|NCT02578251|Meperidine|meperidine|mesh-list
19598004|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19598005|NCT02578251|Analgesics|analgesics|mesh-ancestor
19598006|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
19598007|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598008|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598009|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
19598010|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598011|NCT02578251|Narcotics|narcotics|mesh-ancestor
19598012|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598013|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19598014|NCT02578277|BMS-955176|bms-955176|mesh-list
19598015|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19598016|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19598017|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
19598018|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598019|NCT02578537|Clopidogrel|clopidogrel|mesh-list
19598020|NCT02578537|Ticagrelor|ticagrelor|mesh-list
19598021|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19598022|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19598023|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19598024|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19598025|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
19598026|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598027|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598028|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598029|NCT02578472|Zolpidem|zolpidem|mesh-list
19598030|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19598031|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19598032|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598033|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598034|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19598035|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
20126589|NCT00019422|Carboplatin|carboplatin|mesh-list
20310534|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598036|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
19598037|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598038|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598039|NCT02578511|Ixazomib|ixazomib|mesh-list
19598040|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598041|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598042|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598043|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598044|NCT02578043|Clindamycin|clindamycin|mesh-list
19598045|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
19598046|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
19598047|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19598048|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19598049|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598050|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19598051|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598052|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598053|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
19598054|NCT02578108|Lidocaine|lidocaine|mesh-list
19598055|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
19598056|NCT02578108|Anesthetics|anesthetics|mesh-list
19598057|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598058|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598059|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
19598060|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598061|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19598062|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19598063|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19598064|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19598065|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598066|NCT02577965|Everolimus|everolimus|mesh-list
19598067|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598068|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598069|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
19598070|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598071|NCT02578121|Dexamethasone|dexamethasone|mesh-list
19598072|NCT02578121|Pomalidomide|pomalidomide|mesh-list
19598073|NCT02578121|Ixazomib|ixazomib|mesh-list
19598074|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598075|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
19598076|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
19598077|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598078|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598079|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19598080|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
19598081|NCT02578121|Hormones|hormones|mesh-ancestor
19598082|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598083|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19598084|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598085|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
19598086|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19598087|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19598088|NCT02578121|Growth Substances|growth substances|mesh-ancestor
19598089|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
19598090|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598091|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598092|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598093|NCT02577848|Liraglutide|liraglutide|mesh-list
19598094|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19598095|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598096|NCT02577848|Incretins|incretins|mesh-ancestor
19598097|NCT02577848|Hormones|hormones|mesh-ancestor
19598098|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598099|NCT02577809|Indomethacin|indomethacin|mesh-list
19598100|NCT02577809|Fentanyl|fentanyl|mesh-list
20126590|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126591|NCT00019435|Immunotoxins|immunotoxins|mesh-list
20126592|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
20126593|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126594|NCT00019448|Interleukin-2|interleukin-2|mesh-list
20126595|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598101|NCT02577809|Morphine|morphine|mesh-list
20126596|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20126597|NCT00019448|Analgesics|analgesics|mesh-ancestor
20126598|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
19598102|NCT02577809|Bupivacaine|bupivacaine|mesh-list
19598103|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
19598104|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
19598105|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598106|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598107|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
19598108|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598109|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598110|NCT02577809|Narcotics|narcotics|mesh-ancestor
19598111|NCT02577809|Analgesics|analgesics|mesh-ancestor
19598112|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19598113|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19598114|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
19598115|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19598116|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20126599|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126600|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126601|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
20126602|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126603|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20126604|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20126605|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126606|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20126607|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126608|NCT00019474|Interferons|interferons|mesh-list
20126609|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
20126610|NCT00019474|Fluorouracil|fluorouracil|mesh-list
19598117|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598118|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19598119|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
19598120|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
19598121|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19598122|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19598123|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598124|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598125|NCT02577783|Dexamethasone|dexamethasone|mesh-list
19598126|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
19598127|NCT02577783|Doxorubicin|doxorubicin|mesh-list
19598128|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19598129|NCT02577783|BB 1101|bb 1101|mesh-list
19598130|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598131|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
19598132|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
19598133|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598134|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598135|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19598136|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
19598137|NCT02577783|Hormones|hormones|mesh-ancestor
19598138|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598139|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19598140|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598141|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598142|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598143|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598144|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19598145|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19598146|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20126611|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
20126612|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
20126613|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126614|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20310535|NCT00674089|Vitamin A|vitamin a|mesh-list
19598147|NCT02577575|Oxytocin|oxytocin|mesh-list
19598148|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
19598149|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19598150|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598151|NCT02577614|Coagulants|coagulants|mesh-list
19598152|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
19598153|NCT02577458|Everolimus|everolimus|mesh-list
19598154|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598155|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598156|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
19598157|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598158|NCT02577341|Docetaxel|docetaxel|mesh-list
19598159|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
19598160|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598161|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
19598162|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
19598163|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
19598164|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598165|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19598166|NCT02577497|Fluticasone|fluticasone|mesh-list
19598167|NCT02577497|Beclomethasone|beclomethasone|mesh-list
19598168|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598169|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19598170|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
19598171|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598172|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598173|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19598174|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
19598175|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
19598176|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19598177|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
19598178|NCT02577497|Hormones|hormones|mesh-ancestor
19598179|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598180|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19598181|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
19598182|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598183|NCT02577393|Protective Agents|protective agents|mesh-ancestor
19598184|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598185|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19598186|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19598187|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598188|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19598189|NCT02577770|Caffeine|caffeine|mesh-list
19598190|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19598191|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598192|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19598193|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598194|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598195|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19598196|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19598197|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
19598198|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598199|NCT02577432|Fentanyl|fentanyl|mesh-list
19598200|NCT02577432|Bupivacaine|bupivacaine|mesh-list
19598201|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
19598202|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
19598203|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598204|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598205|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
19598206|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598207|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598208|NCT02577432|Narcotics|narcotics|mesh-ancestor
19598209|NCT02577432|Analgesics|analgesics|mesh-ancestor
19598210|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19598211|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19598212|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
19598213|NCT02577250|Ketamine|ketamine|mesh-list
19598214|NCT02577250|Analgesics|analgesics|mesh-ancestor
19598215|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
19598216|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126615|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126616|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126617|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
20126618|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126619|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
20126620|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598217|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598218|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19598219|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19598220|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
19598221|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
19598222|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598223|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19598224|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19598225|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598226|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598227|NCT02577120|Decanoic acid|decanoic acid|mesh-list
19598228|NCT02577120|Petrolatum|petrolatum|mesh-list
19598229|NCT02577120|Emollients|emollients|mesh-ancestor
19598230|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
20310536|NCT00674089|Vitamins|vitamins|mesh-ancestor
20310537|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
20126621|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
20126622|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126623|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20126624|NCT00019487|Aldesleukin|aldesleukin|mesh-list
20126625|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
20126626|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126627|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126628|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126629|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
20126630|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598231|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
19598232|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598233|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
19598234|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19598235|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19598236|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19598237|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19598238|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598239|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598240|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598241|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598242|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19598243|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598244|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19598245|NCT02576964|Capecitabine|capecitabine|mesh-list
19598246|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19598247|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
19598248|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598249|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598250|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
19598251|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598252|NCT02576782|Dexamethasone|dexamethasone|mesh-list
19598253|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
19598254|NCT02576782|Bupivacaine|bupivacaine|mesh-list
19598255|NCT02576782|BB 1101|bb 1101|mesh-list
19598256|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598257|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
19598258|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
19598259|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598260|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598261|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19598262|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
19598263|NCT02576782|Hormones|hormones|mesh-ancestor
19598264|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598265|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19598266|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598267|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598268|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598269|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598270|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
20126631|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19598271|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
19598272|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20126632|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
20126633|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310538|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310539|NCT00674102|Vadimezan|vadimezan|mesh-list
19598273|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
19598274|NCT02577094|Fludarabine|fludarabine|mesh-list
19598275|NCT02577094|Busulfan|busulfan|mesh-list
19598276|NCT02577094|Epratuzumab|epratuzumab|mesh-list
19598277|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
19598278|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598279|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598280|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598281|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
19598282|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598283|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
19598284|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19598285|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19598286|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19598287|NCT02577068|Propacetamol|propacetamol|mesh-list
19598288|NCT02577068|Nefopam|nefopam|mesh-list
19598289|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19598290|NCT02577068|Analgesics|analgesics|mesh-ancestor
19598291|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
19598292|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598293|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598294|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19598295|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598296|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19598297|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
19598298|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19598299|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598300|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19598301|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598302|NCT02576912|Dronabinol|dronabinol|mesh-list
19598303|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
19598304|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598305|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19598306|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19598307|NCT02576912|Analgesics|analgesics|mesh-ancestor
19598308|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
19598309|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598310|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19598311|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19598312|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598313|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598314|NCT02576912|Hormones|hormones|mesh-ancestor
19598315|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598316|NCT02576808|Loratadine|loratadine|mesh-list
19598317|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
19598318|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
19598319|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19598320|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19598321|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19598322|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
19598323|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
19598324|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598325|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598326|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598327|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
19598328|NCT02576626|Albuterol|albuterol|mesh-list
19598329|NCT02576626|Ipratropium|ipratropium|mesh-list
19598330|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19598331|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
19598332|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598333|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598334|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19598335|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
19598336|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
19598337|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19598338|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19598339|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19598340|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19598341|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
19598342|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598343|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598344|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19598345|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19598346|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19598347|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598348|NCT02576665|Flucytosine|flucytosine|mesh-list
19598349|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
19598350|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598351|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
19598352|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598353|NCT02576600|Remifentanil|remifentanil|mesh-list
19598354|NCT02576600|Propofol|propofol|mesh-list
19598355|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19598356|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598357|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598358|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19598359|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
19598360|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
19598361|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598362|NCT02576600|Narcotics|narcotics|mesh-ancestor
19598363|NCT02576600|Analgesics|analgesics|mesh-ancestor
19598364|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
19598365|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598366|NCT02576457|BMS-936559|bms-936559|mesh-list
19598367|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19598368|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598369|NCT02576444|Olaparib|olaparib|mesh-list
19598370|NCT02576444|Adavosertib|adavosertib|mesh-list
19598371|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19598372|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598373|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598374|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598375|NCT02576353|Fentanyl|fentanyl|mesh-list
19598376|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598377|NCT02576353|Narcotics|narcotics|mesh-ancestor
19598378|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598379|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598380|NCT02576353|Analgesics|analgesics|mesh-ancestor
19598381|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
19598382|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598383|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19598384|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19598385|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
19598386|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
19598387|NCT02576340|Octylonium|octylonium|mesh-list
19598388|NCT02576340|Bromides|bromides|mesh-list
19598389|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
19598390|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19598391|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19598392|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598393|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19598394|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598395|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126634|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20126635|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20126636|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
20126637|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126638|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126639|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20126640|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20126641|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20126642|NCT00019513|Leucovorin|leucovorin|mesh-list
20126643|NCT00019513|Gemcitabine|gemcitabine|mesh-list
20126644|NCT00019513|Fluorouracil|fluorouracil|mesh-list
20126645|NCT00019513|Calcium|calcium|mesh-list
20126646|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
20126647|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126648|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
20126649|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126650|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126651|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
20126652|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126653|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126654|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126655|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
20126656|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598396|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
19598397|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
20126657|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20310540|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598398|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598399|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19598400|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20310541|NCT00674141|Dexamethasone|dexamethasone|mesh-list
20310542|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20310543|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
20310544|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
20310545|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310546|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310547|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20310548|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
19598401|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598402|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598403|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
19598404|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19598405|NCT02576314|Ledipasvir|ledipasvir|mesh-list
19598406|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
19598407|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598408|NCT02576301|Cytarabine|cytarabine|mesh-list
19598409|NCT02576301|Combretastatin|combretastatin|mesh-list
19598410|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19598411|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
19598412|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598413|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598414|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
19598415|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310549|NCT00674141|Hormones|hormones|mesh-ancestor
19598416|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598417|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
19598418|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598419|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19598420|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
19598421|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
19598422|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
19598423|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19598424|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19598425|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598426|NCT02576288|Incretins|incretins|mesh-ancestor
19598427|NCT02576288|Hormones|hormones|mesh-ancestor
19598428|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126658|NCT00019513|Antidotes|antidotes|mesh-ancestor
20126659|NCT00019513|Protective Agents|protective agents|mesh-ancestor
20126660|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
20126661|NCT00019513|Vitamins|vitamins|mesh-ancestor
20126662|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
20126663|NCT00019539|Thalidomide|thalidomide|mesh-list
20126664|NCT00019539|Bevacizumab|bevacizumab|mesh-list
20126665|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20126666|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126667|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19598429|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19598430|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598431|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598432|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598433|NCT02576275|Rituximab|rituximab|mesh-list
19598434|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19598435|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20126668|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20126669|NCT00019539|Growth Substances|growth substances|mesh-ancestor
20126670|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126671|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
20126672|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126673|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
20126674|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
20126675|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20126676|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126677|NCT00019552|Irofulven|irofulven|mesh-list
20126678|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20126679|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
20126680|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126681|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310550|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126682|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19598436|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126683|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20126684|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598437|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
19598438|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598439|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19598440|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19598441|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
19598442|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598443|NCT02576223|Ropivacaine|ropivacaine|mesh-list
19598444|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
19598445|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
19598446|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598447|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598448|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
19598449|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598450|NCT02576366|Rifampin|rifampin|mesh-list
19598451|NCT02576366|Voriconazole|voriconazole|mesh-list
19598452|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19598453|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
19598454|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19598455|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598456|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
19598457|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19598458|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598459|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598460|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19598461|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19598462|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19598463|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19598464|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19598465|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19598466|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
19598467|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19598468|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19598469|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19598470|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
19598471|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598472|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598473|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19598474|NCT02576327|Dexamethasone|dexamethasone|mesh-list
19598475|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
19598476|NCT02576327|Aprepitant|aprepitant|mesh-list
19598477|NCT02576327|Tropisetron|tropisetron|mesh-list
19598478|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19598479|NCT02576327|BB 1101|bb 1101|mesh-list
19598480|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598481|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
19598482|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
19598483|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598484|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598485|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19598486|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
19598487|NCT02576327|Hormones|hormones|mesh-ancestor
19598488|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598489|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19598490|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598491|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598492|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598493|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598494|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19598495|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598496|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19598497|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19598498|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
19598499|NCT02576015|Lidocaine|lidocaine|mesh-list
19598500|NCT02576015|Ropivacaine|ropivacaine|mesh-list
19598501|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
19598502|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
19598503|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598504|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598505|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
19598506|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598507|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19598508|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19598509|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19598510|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19598511|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598512|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
19598513|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598514|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19598515|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598516|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598517|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
19598518|NCT02576119|BMS-955176|bms-955176|mesh-list
19598519|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19598520|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598521|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19598522|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19598523|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598524|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598525|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598526|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19598527|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126685|NCT00019591|Aldesleukin|aldesleukin|mesh-list
20310551|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20126686|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126687|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126688|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126689|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
20126690|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126691|NCT00019630|Doxorubicin|doxorubicin|mesh-list
20126692|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20126693|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20126694|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126695|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20126696|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20126697|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126698|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126699|NCT00019669|Aldesleukin|aldesleukin|mesh-list
20126700|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126701|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126702|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126703|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
20126704|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126705|NCT00019695|Alendronate|alendronate|mesh-list
20126706|NCT00019695|Ketoconazole|ketoconazole|mesh-list
20126707|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
20126708|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126709|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20126710|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20126711|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126712|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126713|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20126714|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
19598528|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
19598529|NCT02575924|Imidacloprid|imidacloprid|mesh-list
19598530|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598531|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598532|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598533|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598534|NCT02575859|Cisplatin|cisplatin|mesh-list
19598535|NCT02575859|Mitomycins|mitomycins|mesh-list
19598536|NCT02575859|Mitomycin|mitomycin|mesh-list
19598537|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126715|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126716|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126717|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20126718|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20126719|NCT00019721|Aldesleukin|aldesleukin|mesh-list
20126720|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
20126721|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126722|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126723|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126724|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
19598538|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19598539|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
20126725|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126726|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126727|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
20126728|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126729|NCT00019734|Aldesleukin|aldesleukin|mesh-list
20126730|NCT00019734|Vaccines|vaccines|mesh-list
20126731|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
20126732|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126733|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126734|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126735|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126736|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
20126737|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126738|NCT00019760|Leucovorin|leucovorin|mesh-list
20126739|NCT00019760|Melphalan|melphalan|mesh-list
20126740|NCT00019760|Floxuridine|floxuridine|mesh-list
20126741|NCT00019760|Calcium|calcium|mesh-list
20126742|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
20126743|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20126744|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126745|NCT00019760|Antidotes|antidotes|mesh-ancestor
20126746|NCT00019760|Protective Agents|protective agents|mesh-ancestor
20126747|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
20126748|NCT00019760|Vitamins|vitamins|mesh-ancestor
20126749|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
20126750|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20126751|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
20310552|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310553|NCT00674167|Docetaxel|docetaxel|mesh-list
20310554|NCT00674167|Capecitabine|capecitabine|mesh-list
20310555|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310556|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
20310557|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
20310558|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
20310559|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310560|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20310561|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
20310562|NCT00674232|Misoprostol|misoprostol|mesh-list
20310563|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20310564|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
20310565|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20310566|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310567|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19598540|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598541|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19598542|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598543|NCT02575885|Nicotine|nicotine|mesh-list
19598544|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19598545|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
19598546|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598547|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598548|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19598549|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19598550|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598551|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126752|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126753|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126754|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20126755|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126756|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
19598552|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598553|NCT02575768|Adenosine|adenosine|mesh-list
19598554|NCT02575768|Analgesics|analgesics|mesh-ancestor
19598555|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
19598556|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598557|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598558|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19598559|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
19598560|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19598561|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
19598562|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
19598563|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310568|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19749595|NCT04858334|Olaparib|olaparib|mesh-list
20126757|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126758|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
20126759|NCT00019773|Capecitabine|capecitabine|mesh-list
20126760|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
20126761|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126762|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
20126763|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126764|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126765|NCT00019786|Melphalan|melphalan|mesh-list
20126766|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20126767|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
20126768|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126769|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126770|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20126771|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126772|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
20126773|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310569|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
20310570|NCT00674245|Pantoprazole|pantoprazole|mesh-list
20310571|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20310572|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20126774|NCT00019812|Paclitaxel|paclitaxel|mesh-list
20126775|NCT00019812|Trastuzumab|trastuzumab|mesh-list
20126776|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20126777|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126778|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20126779|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126780|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20126781|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126782|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20126783|NCT00019825|Decitabine|decitabine|mesh-list
20126784|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126785|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
20310573|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20310574|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310575|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310576|NCT00674310|Ropinirole|ropinirole|mesh-list
20310577|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20310578|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20310579|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
20310580|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
20310581|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310582|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598564|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126786|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126787|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126788|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126789|NCT00019838|Fludarabine|fludarabine|mesh-list
20126790|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
20126791|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20126792|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126793|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126794|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
20126795|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126796|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19658163|NCT03185819|Midazolam|midazolam|mesh-list
19658164|NCT03185819|Esketamine|esketamine|mesh-list
19658165|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19658166|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19658167|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19658168|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658169|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19658170|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19658171|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19658172|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19658173|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
19658174|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
19658175|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
19658176|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
19658177|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19658178|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658179|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
20126797|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
20126798|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126799|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20126800|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658183|NCT03179995|Octreotide|octreotide|mesh-list
20310583|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598565|NCT02575755|Azithromycin|azithromycin|mesh-list
19598566|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
19598567|NCT02575755|Piperaquine|piperaquine|mesh-list
19598568|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
19598569|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19598570|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19598571|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598572|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
19598573|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19598574|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19598575|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19598576|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598577|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598578|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19598579|NCT02575755|Renal Agents|renal agents|mesh-ancestor
19598580|NCT02575729|Betamethasone|betamethasone|mesh-list
19598581|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
19598582|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598583|NCT02575729|Hormones|hormones|mesh-ancestor
19598584|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598585|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598586|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19598587|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
19598588|NCT02575677|Oxycodone|oxycodone|mesh-list
19598589|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598590|NCT02575677|Narcotics|narcotics|mesh-ancestor
20310584|NCT00674414|Trastuzumab|trastuzumab|mesh-list
20310585|NCT00674414|Everolimus|everolimus|mesh-list
19598591|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598592|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598593|NCT02575677|Analgesics|analgesics|mesh-ancestor
19598594|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
19598595|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598596|NCT02575443|Rocuronium|rocuronium|mesh-list
19598597|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19598598|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19598599|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19598600|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598601|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598602|NCT02575534|Procainamide|procainamide|mesh-list
19598603|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20310586|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20310587|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310588|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598604|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19598605|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19598606|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19598607|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598608|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
19598609|NCT02575521|Propofol|propofol|mesh-list
19598610|NCT02575521|Sevoflurane|sevoflurane|mesh-list
19598611|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19598612|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598613|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598614|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19598615|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
19598616|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
19598617|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19598618|NCT02575521|Analgesics|analgesics|mesh-ancestor
19598619|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
19598620|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310589|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
20310590|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310591|NCT00674557|Exemestane|exemestane|mesh-list
19598621|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19598622|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19598623|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19598624|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
19598625|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598626|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598627|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19598628|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19598629|NCT02575638|Camptothecin|camptothecin|mesh-list
20310592|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19598630|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19598631|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598632|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19598633|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19598634|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598635|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598636|NCT02575547|Docetaxel|docetaxel|mesh-list
19598637|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598638|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
19598639|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
19598640|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
19598641|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598642|NCT02575664|Buprenorphine|buprenorphine|mesh-list
19598643|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598644|NCT02575664|Narcotics|narcotics|mesh-ancestor
19598645|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598646|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598647|NCT02575664|Analgesics|analgesics|mesh-ancestor
19598648|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
19598649|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598650|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19598651|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19598652|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19598653|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598654|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
19598655|NCT02575508|Fluorouracil|fluorouracil|mesh-list
20608240|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19598656|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
19598657|NCT02575508|Irinotecan|irinotecan|mesh-list
19598658|NCT02575508|Camptothecin|camptothecin|mesh-list
19598659|NCT02575508|Infigratinib|infigratinib|mesh-list
20126801|NCT00019864|Leucovorin|leucovorin|mesh-list
20608241|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19598660|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
19598661|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598662|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19598663|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598664|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598665|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
19598666|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598667|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19598668|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19598669|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598670|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19598671|NCT02575248|Dienogest|dienogest|mesh-list
19598672|NCT02575248|Clomiphene|clomiphene|mesh-list
19598673|NCT02575248|Enclomiphene|enclomiphene|mesh-list
19598674|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
19598675|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20608242|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20608243|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608244|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608245|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608246|NCT02245191|Protective Agents|protective agents|mesh-ancestor
20608247|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20608248|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
19598676|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
20126802|NCT00019864|Doxorubicin|doxorubicin|mesh-list
20126803|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19598677|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598678|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598679|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20126804|NCT00019864|Methotrexate|methotrexate|mesh-list
20126805|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
20126806|NCT00019864|Razoxane|razoxane|mesh-list
20126807|NCT00019864|Calcium|calcium|mesh-list
20126808|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
20126809|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126810|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20126811|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20126812|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20126813|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126814|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126815|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19598680|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
19598681|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20126816|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598682|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19598683|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19598684|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19598685|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
19598686|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19598687|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20126817|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20126818|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
20126819|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20126820|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126821|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
20126822|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
19598688|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19598689|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19598690|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19598691|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598692|NCT02575183|Varenicline|varenicline|mesh-list
19598693|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19598694|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19598695|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598696|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598697|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598698|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598699|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19598700|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
19598701|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19598702|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598703|NCT02575222|Nivolumab|nivolumab|mesh-list
19598704|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19598705|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598706|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19598707|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598708|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19598709|NCT02574962|Hormones|hormones|mesh-ancestor
19598710|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598711|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598712|NCT02575092|Folic Acid|folic acid|mesh-list
19598713|NCT02575092|Enalapril|enalapril|mesh-list
19598714|NCT02575092|Enalaprilat|enalaprilat|mesh-list
19598715|NCT02575092|Maleic acid|maleic acid|mesh-list
19598716|NCT02575092|Hematinics|hematinics|mesh-ancestor
20126823|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20126824|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126825|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
20126826|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20126827|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20126828|NCT00019864|Antidotes|antidotes|mesh-ancestor
20126829|NCT00019864|Protective Agents|protective agents|mesh-ancestor
20126830|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
20126831|NCT00019864|Vitamins|vitamins|mesh-ancestor
20126832|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
20126833|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20126834|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126835|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
19598717|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
19598718|NCT02575092|Vitamins|vitamins|mesh-ancestor
19598719|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
19598720|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598721|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598722|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598723|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19598724|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
19598725|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19598726|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
19598727|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19598728|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19598729|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19598730|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598731|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
19598732|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19598733|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598734|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
19598735|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126836|NCT00019890|Sargramostim|sargramostim|mesh-list
20126837|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
19598736|NCT02574975|Budesonide|budesonide|mesh-list
19598737|NCT02574975|Adenosine|adenosine|mesh-list
19598738|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
19598739|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
19598740|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598741|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19598742|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
19598743|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598744|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598745|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19598746|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
19598747|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
19598748|NCT02574975|Hormones|hormones|mesh-ancestor
19598749|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598750|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19598751|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19598752|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19598753|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
19598754|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598755|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598756|NCT02574975|Analgesics|analgesics|mesh-ancestor
19598757|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
19598758|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20126838|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126839|NCT00019916|Aldesleukin|aldesleukin|mesh-list
20126840|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126841|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126842|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126843|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
20126844|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126845|NCT00019968|Melphalan|melphalan|mesh-list
20126846|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20126847|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
20126848|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126849|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126850|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20126851|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126852|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
20126853|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126854|NCT00019994|Aldesleukin|aldesleukin|mesh-list
20126855|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
20126856|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126857|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126858|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126859|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
20126860|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126861|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20126862|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
20126863|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126864|NCT00020007|Paclitaxel|paclitaxel|mesh-list
20126865|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19598759|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
19598760|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19598761|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
19598762|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
19598763|NCT02574975|Miotics|miotics|mesh-ancestor
19598764|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19598765|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19598766|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20126866|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126867|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
20126868|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126869|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
20126870|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126871|NCT00020046|Thalidomide|thalidomide|mesh-list
20126872|NCT00020046|Docetaxel|docetaxel|mesh-list
20126873|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126874|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
20126875|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126876|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
20126877|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126878|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598767|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19598768|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598769|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
19598770|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20126879|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
20126880|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598771|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19598772|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598773|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598774|NCT02574741|Aripiprazole|aripiprazole|mesh-list
20126881|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
20126882|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20126883|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126884|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20126885|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20126886|NCT00020046|Growth Substances|growth substances|mesh-ancestor
20126887|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
20126888|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
20126889|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126890|NCT00020124|Doxorubicin|doxorubicin|mesh-list
20126891|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20126892|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19598775|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
19598776|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19598777|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20126893|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126894|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20126895|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20126896|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126897|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126898|NCT00020150|Temozolomide|temozolomide|mesh-list
20126899|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20126900|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20126901|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
20126902|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126903|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126904|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126905|NCT00020176|Cyclosporine|cyclosporine|mesh-list
20126906|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
20126907|NCT00020176|Fludarabine|fludarabine|mesh-list
20126908|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
20126909|NCT00020176|Cyclosporins|cyclosporins|mesh-list
20126910|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126911|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
20126912|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126913|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20126914|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20126915|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
20126916|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126917|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126918|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20126919|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126920|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
20126921|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126922|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
20126923|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126924|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
20126925|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20126926|NCT00020189|Aspirin|aspirin|mesh-list
20126927|NCT00020189|Alvocidib|alvocidib|mesh-list
20126928|NCT00020189|Clopidogrel|clopidogrel|mesh-list
20126929|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20126930|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20126931|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20126932|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20126933|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
20126934|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20126935|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126936|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126937|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20126938|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20126939|NCT00020189|Analgesics|analgesics|mesh-ancestor
20126940|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
20126941|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126942|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20126943|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20126944|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20126945|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20126946|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20126947|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126948|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
20126949|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126950|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
20126951|NCT00020189|Growth Substances|growth substances|mesh-ancestor
20126952|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20126953|NCT00020202|Romidepsin|romidepsin|mesh-list
20126954|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20126955|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126956|NCT00020254|Aldesleukin|aldesleukin|mesh-list
20126957|NCT00020254|Nilutamide|nilutamide|mesh-list
20126958|NCT00020254|Vaccines|vaccines|mesh-list
20126959|NCT00020254|Sargramostim|sargramostim|mesh-list
20126960|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
20126961|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126962|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126963|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20126964|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20126965|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
20126966|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126967|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
20126968|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
20126969|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20126970|NCT00020267|Interleukin-2|interleukin-2|mesh-list
20126971|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126972|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19598778|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19598779|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598780|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598781|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
19598782|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
19598783|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598784|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598785|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19598786|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19598787|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
19598788|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19598789|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19598790|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19598791|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19598792|NCT02574663|Leucovorin|leucovorin|mesh-list
19598793|NCT02574663|Folic Acid|folic acid|mesh-list
19598794|NCT02574663|Gemcitabine|gemcitabine|mesh-list
19598795|NCT02574663|Paclitaxel|paclitaxel|mesh-list
20126973|NCT00020267|Analgesics|analgesics|mesh-ancestor
20126974|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
20126975|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20126976|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173403|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173404|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173405|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20173406|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173407|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20173408|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20173409|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20173410|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
20173411|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20173412|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20173413|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20173414|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20173415|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
20173416|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
20173417|NCT00161486|Testosterone|testosterone|mesh-list
20173418|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
20173419|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
20173420|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20173421|NCT00161486|Acyline|acyline|mesh-list
20173422|NCT00161486|Androgens|androgens|mesh-ancestor
20173423|NCT00161486|Hormones|hormones|mesh-ancestor
20173424|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173425|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173426|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19598796|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20173427|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173428|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
20126977|NCT00020332|Docetaxel|docetaxel|mesh-list
20126978|NCT00020332|Alvocidib|alvocidib|mesh-list
20126979|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20126980|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
20126981|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
20126982|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
20126983|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126984|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
20126985|NCT00020332|Growth Substances|growth substances|mesh-ancestor
20126986|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20126987|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20126988|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126989|NCT00020345|Gemcitabine|gemcitabine|mesh-list
20126990|NCT00020345|Fluorouracil|fluorouracil|mesh-list
20126991|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20126992|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
20126993|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20126994|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598797|NCT02574663|Bevacizumab|bevacizumab|mesh-list
19598798|NCT02574663|Fluorouracil|fluorouracil|mesh-list
20126995|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
20126996|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20126997|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20126998|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20126999|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
20127000|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127001|NCT00020358|Aldesleukin|aldesleukin|mesh-list
20127002|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
20127003|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127004|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127005|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127006|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
20127007|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127008|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20127009|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
20127010|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127011|NCT00020371|Lenograstim|lenograstim|mesh-list
20127012|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20127013|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
20127014|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127015|NCT00020397|Aldesleukin|aldesleukin|mesh-list
20127016|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127017|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127018|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127019|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
20127020|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127021|NCT00020410|Antibodies|antibodies|mesh-list
20127022|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20127023|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
20127024|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127025|NCT00020449|Paclitaxel|paclitaxel|mesh-list
20127026|NCT00020449|Doxorubicin|doxorubicin|mesh-list
20127027|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20127028|NCT00020449|Interleukin-12|interleukin-12|mesh-list
20127029|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127030|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127031|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127032|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127033|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127034|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127035|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127036|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127037|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127038|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127039|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20127040|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
20310593|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310594|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19598799|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
19598800|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
19598801|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19598802|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598803|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
19598804|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
20310595|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19598805|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127041|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127042|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19598806|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598807|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19598808|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19598809|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19598810|NCT02574663|Growth Substances|growth substances|mesh-ancestor
19598811|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598812|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
19598813|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19598814|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
19598815|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
19598816|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608249|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20608250|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608251|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608252|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20608253|NCT02245256|Analgesics|analgesics|mesh-ancestor
20608254|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
20608255|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310596|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310597|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127043|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20127044|NCT00020449|Growth Substances|growth substances|mesh-ancestor
20127045|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
20127046|NCT00020462|Aldesleukin|aldesleukin|mesh-list
20127047|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127048|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127049|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127050|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
20127051|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598817|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598818|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598819|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
19598820|NCT02574663|Antidotes|antidotes|mesh-ancestor
19598821|NCT02574663|Protective Agents|protective agents|mesh-ancestor
19598822|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127052|NCT00020475|Interleukin-2|interleukin-2|mesh-list
20127053|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127054|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20127055|NCT00020475|Analgesics|analgesics|mesh-ancestor
20127056|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
20127057|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127058|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127059|NCT00020488|Leucovorin|leucovorin|mesh-list
20127060|NCT00020488|Fluorouracil|fluorouracil|mesh-list
20127061|NCT00020488|Irinotecan|irinotecan|mesh-list
20127062|NCT00020488|Calcium|calcium|mesh-list
20127063|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
19598823|NCT02574663|Vitamins|vitamins|mesh-ancestor
19598824|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
19598825|NCT02574663|Hematinics|hematinics|mesh-ancestor
19598826|NCT02574468|Dexamethasone|dexamethasone|mesh-list
19598827|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
19598828|NCT02574468|BB 1101|bb 1101|mesh-list
19598829|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19598830|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
19598831|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
19598832|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598833|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598834|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19598835|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
19598836|NCT02574468|Hormones|hormones|mesh-ancestor
19598837|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19598838|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127064|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19598839|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598840|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
20127065|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127066|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
20127067|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598841|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598842|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598843|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
19598844|NCT02574611|Neostigmine|neostigmine|mesh-list
19598845|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19598846|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598847|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598848|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
19598849|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598850|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598851|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19598852|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
19598853|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598854|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19598855|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19598856|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19598857|NCT02574754|Warfarin|warfarin|mesh-list
19598858|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
19598859|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
19598860|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19598861|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
19598862|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19598863|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598864|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19598865|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19598866|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19598867|NCT02574403|Eculizumab|eculizumab|mesh-list
19598868|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19598869|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19598870|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
19598871|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598872|NCT02574377|Vaccines|vaccines|mesh-list
19598873|NCT02574377|Immunologic Factors|immunologic factors|mesh-ancestor
20127068|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127069|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127070|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127071|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
20127072|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20127073|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127074|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127075|NCT00020488|Antidotes|antidotes|mesh-ancestor
20127076|NCT00020488|Protective Agents|protective agents|mesh-ancestor
20127077|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127078|NCT00020488|Vitamins|vitamins|mesh-ancestor
20127079|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
20127080|NCT00020501|Leucovorin|leucovorin|mesh-list
20127081|NCT00020501|Fluorouracil|fluorouracil|mesh-list
20127082|NCT00020501|Floxuridine|floxuridine|mesh-list
20127083|NCT00020501|Irinotecan|irinotecan|mesh-list
20127084|NCT00020501|Melphalan|melphalan|mesh-list
20127085|NCT00020501|Calcium|calcium|mesh-list
20127086|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
20127087|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20127088|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127089|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
20127090|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127091|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127092|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127093|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127094|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
20127095|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20127096|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127097|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127098|NCT00020501|Antidotes|antidotes|mesh-ancestor
20127099|NCT00020501|Protective Agents|protective agents|mesh-ancestor
20127100|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127101|NCT00020501|Vitamins|vitamins|mesh-ancestor
20127102|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
20127103|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127104|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
19598874|NCT02574377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127105|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20127106|NCT00020527|Caspofungin|caspofungin|mesh-list
19598875|NCT02574221|Fluorides|fluorides|mesh-list
19598876|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
20127107|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
20127108|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127109|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173429|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
20127110|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127111|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
20127112|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20127113|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
20127114|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598877|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
19598878|NCT02574221|Protective Agents|protective agents|mesh-ancestor
19598879|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598880|NCT02574338|Alprostadil|alprostadil|mesh-list
19598881|NCT02574338|Misoprostol|misoprostol|mesh-list
19598882|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19598883|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
20127115|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20127116|NCT00020540|Protective Agents|protective agents|mesh-ancestor
20127117|NCT00020566|Dactinomycin|dactinomycin|mesh-list
20127118|NCT00020566|Doxorubicin|doxorubicin|mesh-list
20127119|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20127120|NCT00020566|Etoposide|etoposide|mesh-list
20127121|NCT00020566|Vincristine|vincristine|mesh-list
20127122|NCT00020566|Melphalan|melphalan|mesh-list
19598884|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20127123|NCT00020566|Busulfan|busulfan|mesh-list
20127124|NCT00020566|Ifosfamide|ifosfamide|mesh-list
20127125|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127126|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127127|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127128|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127129|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127130|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127131|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127132|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127133|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127134|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127135|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127136|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
20127137|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20127138|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127139|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
20127140|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127141|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20127142|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127143|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20127144|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20127145|NCT00020579|Entinostat|entinostat|mesh-list
20127146|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127147|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20127148|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127149|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127150|NCT00020605|Naloxone|naloxone|mesh-list
20127151|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20127152|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127153|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
20127154|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598885|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598886|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19598887|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19598888|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
19598889|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19598890|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
19598891|NCT02574338|Urological Agents|urological agents|mesh-ancestor
19658184|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19658185|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19658186|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127155|NCT00020618|Morphine|morphine|mesh-list
20127156|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20127157|NCT00020618|Narcotics|narcotics|mesh-ancestor
20127158|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20127159|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127160|NCT00020618|Analgesics|analgesics|mesh-ancestor
20127161|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
20127162|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127163|NCT00020631|Pirfenidone|pirfenidone|mesh-list
20127164|NCT00020631|Analgesics|analgesics|mesh-ancestor
20127165|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
20127166|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127167|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127168|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20127169|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20127170|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20127171|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19598892|NCT02574156|Insulin|insulin|mesh-list
19598893|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19598894|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598895|NCT02574130|Amikacin|amikacin|mesh-list
19598896|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19598897|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127172|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127173|NCT00020644|Gemcitabine|gemcitabine|mesh-list
20127174|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127175|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
20127176|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127177|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127178|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
20127179|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127180|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127181|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127182|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
20127183|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127184|NCT00020657|Ondansetron|ondansetron|mesh-list
20127185|NCT00020657|Granisetron|granisetron|mesh-list
20127186|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
20127187|NCT00020657|Dolasetron|dolasetron|mesh-list
20127188|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
20127189|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
20127190|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127191|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127192|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20127193|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
20127194|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
20127195|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20127196|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
20127197|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20127198|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127199|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20127200|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20127201|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20127202|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20127203|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20127204|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20127205|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
20127206|NCT00020670|Vaccines|vaccines|mesh-list
20127207|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
20127208|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127209|NCT00020696|Tirapazamine|tirapazamine|mesh-list
20127210|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127211|NCT00020709|Docetaxel|docetaxel|mesh-list
20127212|NCT00020709|Etoposide|etoposide|mesh-list
20127213|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
20127214|NCT00020709|Gefitinib|gefitinib|mesh-list
20127215|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127216|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127217|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127218|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127219|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127220|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127221|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127222|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127223|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127224|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20127225|NCT00020735|Toremifene|toremifene|mesh-list
19598898|NCT02573935|Clarithromycin|clarithromycin|mesh-list
19598899|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19598900|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19598901|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20127226|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127227|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127228|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20310598|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19598902|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127229|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20127230|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
20127231|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127232|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127233|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20127234|NCT00020748|Irinotecan|irinotecan|mesh-list
20127235|NCT00020748|Epirubicin|epirubicin|mesh-list
20127236|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20127237|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127238|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127239|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598903|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598904|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19598905|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19598906|NCT02573909|Oxycodone|oxycodone|mesh-list
19598907|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598908|NCT02573909|Narcotics|narcotics|mesh-ancestor
19598909|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598910|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598911|NCT02573909|Analgesics|analgesics|mesh-ancestor
19598912|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
19598913|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598914|NCT02573922|Oxycodone|oxycodone|mesh-list
19598915|NCT02573922|Naloxone|naloxone|mesh-list
19598916|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598917|NCT02573922|Narcotics|narcotics|mesh-ancestor
19598918|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598919|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598920|NCT02573922|Analgesics|analgesics|mesh-ancestor
19598921|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
19598922|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598923|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19598924|NCT02573987|Lidocaine|lidocaine|mesh-list
19598925|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
19598926|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
19598927|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
20127240|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127241|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127242|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127243|NCT00020761|Paclitaxel|paclitaxel|mesh-list
20127244|NCT00020761|Irinotecan|irinotecan|mesh-list
20127245|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127246|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127247|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127248|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127249|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127250|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127251|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20127252|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127253|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127254|NCT00020774|Gemcitabine|gemcitabine|mesh-list
20127255|NCT00020774|Lonafarnib|lonafarnib|mesh-list
20127256|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127257|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
20127258|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127259|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127260|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
20127261|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127262|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127263|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127264|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
20127265|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127266|NCT00020787|Cisplatin|cisplatin|mesh-list
20127267|NCT00020787|Fluorouracil|fluorouracil|mesh-list
20127268|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127269|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
20127270|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127271|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127272|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127273|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
20127274|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127275|NCT00020800|Rituximab|rituximab|mesh-list
20127276|NCT00020800|Fludarabine|fludarabine|mesh-list
19598928|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598929|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598930|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
20127277|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
20127278|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127279|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127280|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
20127281|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127282|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20127283|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127284|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
20127285|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127286|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127287|NCT00020839|Temozolomide|temozolomide|mesh-list
20127288|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127289|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
19598931|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598932|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19598933|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19598934|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19598935|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19598936|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598937|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19598938|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
19598939|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19598940|NCT02573987|Analgesics|analgesics|mesh-ancestor
19598941|NCT02573714|Ketamine|ketamine|mesh-list
19598942|NCT02573714|Analgesics|analgesics|mesh-ancestor
19598943|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
19598944|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598945|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598946|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19598947|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19598948|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
19598949|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
19598950|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20127290|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127291|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127292|NCT00020865|Levofloxacin|levofloxacin|mesh-list
20127293|NCT00020865|Ofloxacin|ofloxacin|mesh-list
20127294|NCT00020865|Cefepime|cefepime|mesh-list
20127295|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20127296|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127297|NCT00020865|Renal Agents|renal agents|mesh-ancestor
20127298|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20127299|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127300|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127301|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127302|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127303|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127304|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20127305|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20127306|NCT00020878|Celecoxib|celecoxib|mesh-list
20127307|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20127308|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20127309|NCT00020878|Analgesics|analgesics|mesh-ancestor
20127310|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
20127311|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127312|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127313|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20127314|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20127315|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20127316|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20127317|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127318|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127319|NCT00020917|Leucovorin|leucovorin|mesh-list
20127320|NCT00020917|Fluorouracil|fluorouracil|mesh-list
20127321|NCT00020917|Irinotecan|irinotecan|mesh-list
20127322|NCT00020917|Cetuximab|cetuximab|mesh-list
20127323|NCT00020917|Calcium|calcium|mesh-list
20127324|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
20127325|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20127326|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127327|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
20173430|NCT00161564|Rituximab|rituximab|mesh-list
20310599|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
19598951|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20127328|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127329|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127330|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127331|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127332|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
20127333|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20127334|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127335|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127336|NCT00020917|Antidotes|antidotes|mesh-ancestor
20127337|NCT00020917|Protective Agents|protective agents|mesh-ancestor
20127338|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127339|NCT00020917|Vitamins|vitamins|mesh-ancestor
20127340|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
20127341|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127342|NCT00020930|Cetuximab|cetuximab|mesh-list
20127343|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127344|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127345|NCT00020943|Leucovorin|leucovorin|mesh-list
20127346|NCT00020943|Cytarabine|cytarabine|mesh-list
20127347|NCT00020943|Prednisone|prednisone|mesh-list
20127348|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
20127349|NCT00020943|Carmustine|carmustine|mesh-list
20127350|NCT00020943|Rituximab|rituximab|mesh-list
20127351|NCT00020943|Doxorubicin|doxorubicin|mesh-list
20127352|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20127353|NCT00020943|Methotrexate|methotrexate|mesh-list
20127354|NCT00020943|Etoposide|etoposide|mesh-list
20127355|NCT00020943|Vincristine|vincristine|mesh-list
20127356|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
20127357|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127358|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
20127359|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127360|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20127361|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127362|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
20127363|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127364|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127365|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20127366|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127367|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127368|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127369|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127370|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127371|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20127372|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
20127373|NCT00020943|Hormones|hormones|mesh-ancestor
20127374|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127375|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127376|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20127377|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
20127378|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20127379|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127380|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
20127381|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
20127382|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20127383|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20127384|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127385|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
20608256|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20608257|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19598952|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20127386|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127387|NCT00020943|Antidotes|antidotes|mesh-ancestor
20127388|NCT00020943|Protective Agents|protective agents|mesh-ancestor
20608258|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20608259|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19598953|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598954|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598955|NCT02573701|Risperidone|risperidone|mesh-list
19598956|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
19598957|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19598958|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
19598959|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19598960|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598961|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598962|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19598963|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598964|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19598965|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19598966|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
19598967|NCT02573831|Oxycodone|oxycodone|mesh-list
19598968|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598969|NCT02573831|Narcotics|narcotics|mesh-ancestor
19598970|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598971|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598972|NCT02573831|Analgesics|analgesics|mesh-ancestor
19598973|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
19598974|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598975|NCT02573610|Levofloxacin|levofloxacin|mesh-list
19598976|NCT02573610|Ofloxacin|ofloxacin|mesh-list
19598977|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19598978|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127389|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127390|NCT00020943|Vitamins|vitamins|mesh-ancestor
19598979|NCT02573610|Renal Agents|renal agents|mesh-ancestor
19598980|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19598981|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19598982|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19598983|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19598984|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19598985|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19598986|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19598987|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19598988|NCT02573597|Sufentanil|sufentanil|mesh-list
19598989|NCT02573597|Bupivacaine|bupivacaine|mesh-list
19598990|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
19598991|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
19598992|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19598993|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19598994|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
19598995|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19598996|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19598997|NCT02573597|Narcotics|narcotics|mesh-ancestor
19598998|NCT02573597|Analgesics|analgesics|mesh-ancestor
19598999|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19599000|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599001|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
19599002|NCT02573519|Acetylcholine|acetylcholine|mesh-list
19599003|NCT02573519|Donepezil|donepezil|mesh-list
19599004|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19599005|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19599006|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599007|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599008|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
19599009|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599010|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599011|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
19599012|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
19599013|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19599014|NCT02573727|Terlipressin|terlipressin|mesh-list
19599015|NCT02573727|Epinephrine|epinephrine|mesh-list
19599016|NCT02573727|Racepinephrine|racepinephrine|mesh-list
19599017|NCT02573727|Norepinephrine|norepinephrine|mesh-list
19599018|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
19599019|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20127391|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
19599020|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599021|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
20127392|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
19599022|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20127393|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
19599023|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599024|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310600|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310601|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310602|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
20310603|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
20310604|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20310605|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20310606|NCT00674557|Growth Substances|growth substances|mesh-ancestor
20310607|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
19599025|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19599026|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19599027|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
19599028|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599029|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19599030|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
19599031|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
19599032|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
19599033|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19599034|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599035|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
19599036|NCT02573558|Propofol|propofol|mesh-list
19599037|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19599038|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599039|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599040|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599041|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
19599042|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
19599043|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599044|NCT02573558|Analgesics|analgesics|mesh-ancestor
19599045|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
19599046|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599047|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19599048|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19599049|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599050|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
19599051|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599052|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599053|NCT02573363|Cytarabine|cytarabine|mesh-list
20127394|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127395|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
20127396|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127397|NCT00021034|Taurolidine|taurolidine|mesh-list
20127398|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127399|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20127400|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127401|NCT00021047|Carboplatin|carboplatin|mesh-list
20127402|NCT00021047|Capecitabine|capecitabine|mesh-list
20127403|NCT00021047|Epirubicin|epirubicin|mesh-list
20127404|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127405|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127406|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
20127407|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127408|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127409|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127410|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127411|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310608|NCT00674596|Ramipril|ramipril|mesh-list
20310609|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20310610|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
20310611|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310612|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310613|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599054|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
19599055|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19599056|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
19599057|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599058|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127412|NCT00021060|Paclitaxel|paclitaxel|mesh-list
19599059|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
20127413|NCT00021060|Bevacizumab|bevacizumab|mesh-list
20127414|NCT00021060|Carboplatin|carboplatin|mesh-list
19599060|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599061|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599062|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
19599063|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599064|NCT02573363|Analgesics|analgesics|mesh-ancestor
19599065|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
19599066|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599067|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19599068|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19599069|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127415|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20127416|NCT00021060|Antibodies|antibodies|mesh-list
20127417|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
20127418|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20127419|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127420|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599070|NCT02573337|Lidocaine|lidocaine|mesh-list
19599071|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
19599072|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
19599073|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599074|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127421|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127422|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127423|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127424|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127425|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20127426|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20127427|NCT00021060|Growth Substances|growth substances|mesh-ancestor
20127428|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127429|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310614|NCT00674674|Topotecan|topotecan|mesh-list
20310615|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19599075|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
19599076|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599077|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19599078|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19599079|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19599080|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19599081|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599082|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
19599083|NCT02573064|Vancomycin|vancomycin|mesh-list
19599084|NCT02573064|Colistin|colistin|mesh-list
19599085|NCT02573064|Tigecycline|tigecycline|mesh-list
19599086|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19599087|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599088|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19599089|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599090|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599091|NCT02573220|Leucovorin|leucovorin|mesh-list
19599092|NCT02573220|Fluorouracil|fluorouracil|mesh-list
19599093|NCT02573220|Irinotecan|irinotecan|mesh-list
19599094|NCT02573220|Cetuximab|cetuximab|mesh-list
19599095|NCT02573220|Camptothecin|camptothecin|mesh-list
19599096|NCT02573220|Calcium|calcium|mesh-list
19599097|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
19599098|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19599099|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599100|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
19599101|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599102|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20310616|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310617|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310618|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310619|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310620|NCT00674687|Gabapentin|gabapentin|mesh-list
20310621|NCT00674687|Analgesics|analgesics|mesh-ancestor
20310622|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
19599103|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127430|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
20310623|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599104|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599105|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
19599106|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19599107|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19599108|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599109|NCT02573220|Antidotes|antidotes|mesh-ancestor
19599110|NCT02573220|Protective Agents|protective agents|mesh-ancestor
19599111|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
19599112|NCT02573220|Vitamins|vitamins|mesh-ancestor
20127431|NCT00021073|Leucovorin|leucovorin|mesh-list
20127432|NCT00021073|Fluorouracil|fluorouracil|mesh-list
19599113|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
19599114|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19599115|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19599116|NCT02573038|Aflibercept|aflibercept|mesh-list
19599117|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19599118|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19599119|NCT02573038|Growth Substances|growth substances|mesh-ancestor
19599120|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599121|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
19599122|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599123|NCT02573051|Isosorbide|isosorbide|mesh-list
19599124|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19599125|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19599126|NCT02573051|Misoprostol|misoprostol|mesh-list
19599127|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19599128|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
19599129|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19599130|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599131|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19599132|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19599133|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
19599134|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20310624|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310625|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
20310626|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20310627|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20310628|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310629|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310630|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20127433|NCT00021073|Irinotecan|irinotecan|mesh-list
20127434|NCT00021073|Alvocidib|alvocidib|mesh-list
20127435|NCT00021073|Calcium|calcium|mesh-list
20127436|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
20127437|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20127438|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127439|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
20127440|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127441|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127442|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127443|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127444|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
20127445|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20127446|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127447|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310631|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20310632|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310633|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599135|NCT02573051|Diuretics|diuretics|mesh-ancestor
19599136|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
19599137|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
19599138|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19599139|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599140|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19599141|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
19599142|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
19599143|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19599144|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
19599145|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599146|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
19599147|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310634|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
20608260|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599148|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599149|NCT02572986|Permethrin|permethrin|mesh-list
19599150|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666223|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20127448|NCT00021073|Antidotes|antidotes|mesh-ancestor
20310635|NCT00674713|Ondansetron|ondansetron|mesh-list
20127449|NCT00021073|Protective Agents|protective agents|mesh-ancestor
20127450|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127451|NCT00021073|Vitamins|vitamins|mesh-ancestor
20127452|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
20127453|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
20127454|NCT00021073|Growth Substances|growth substances|mesh-ancestor
20127455|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20127456|NCT00021099|Epothilones|epothilones|mesh-list
20127457|NCT00021099|Epothilone B|epothilone b|mesh-list
20127458|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127459|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127460|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127461|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127462|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127463|NCT00021112|Etoposide|etoposide|mesh-list
20127464|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127465|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127466|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127467|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19749596|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19749597|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749598|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127468|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127469|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127470|NCT00021138|Nicotine|nicotine|mesh-list
20127471|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20127472|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
20127473|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127474|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127475|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20127476|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20127477|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
20127478|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20127479|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127480|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
20127481|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127482|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127483|NCT00021164|Aldesleukin|aldesleukin|mesh-list
20127484|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
20127485|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127486|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127487|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127488|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
20127489|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127490|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20127491|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
20127492|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127493|NCT00021216|Bortezomib|bortezomib|mesh-list
20127494|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127495|NCT00021242|Docetaxel|docetaxel|mesh-list
20127496|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127497|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127498|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127499|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127500|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127501|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
20127502|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127503|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
20127504|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127505|NCT00021281|Leucovorin|leucovorin|mesh-list
20127506|NCT00021281|Fluorouracil|fluorouracil|mesh-list
20127507|NCT00021281|Irinotecan|irinotecan|mesh-list
20127508|NCT00021281|Calcium|calcium|mesh-list
20127509|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
20127510|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20127511|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127512|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
20127513|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127514|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127515|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127516|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127517|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
20127518|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20127519|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127520|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127521|NCT00021281|Antidotes|antidotes|mesh-ancestor
20127522|NCT00021281|Protective Agents|protective agents|mesh-ancestor
20127523|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127524|NCT00021281|Vitamins|vitamins|mesh-ancestor
19599151|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599152|NCT02572960|Vitamin D|vitamin d|mesh-list
19599153|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
19599154|NCT02572960|Valsartan|valsartan|mesh-list
19599155|NCT02572960|Vitamins|vitamins|mesh-ancestor
19599156|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
19599157|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599158|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19599159|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19599160|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20127525|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
20127526|NCT00021294|Eflornithine|eflornithine|mesh-list
20127527|NCT00021294|Triamcinolone|triamcinolone|mesh-list
20127528|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20127529|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
20127530|NCT00021294|Hormones|hormones|mesh-ancestor
20127531|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599161|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19599162|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19599163|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599164|NCT02572947|Dolutegravir|dolutegravir|mesh-list
19599165|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19599166|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19599167|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599168|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599169|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19599170|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19599171|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
20127532|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127533|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127534|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127535|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127536|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20127537|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19599172|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599173|NCT02572505|Tenofovir|tenofovir|mesh-list
19599174|NCT02572505|Emtricitabine|emtricitabine|mesh-list
19599175|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19599176|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
19599177|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599178|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19599179|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19599180|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599181|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599182|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19599183|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19599184|NCT02572583|Oseltamivir|oseltamivir|mesh-list
19599185|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
19599186|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599187|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599188|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599189|NCT02572687|Durvalumab|durvalumab|mesh-list
19599190|NCT02572687|Ramucirumab|ramucirumab|mesh-list
19599191|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19599192|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599193|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
19599194|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599195|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
19599196|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599197|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20127538|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19599198|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19599199|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
19599200|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599201|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599202|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20127539|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127540|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20127541|NCT00021307|Carboplatin|carboplatin|mesh-list
20127542|NCT00021307|Temozolomide|temozolomide|mesh-list
20127543|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127544|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127545|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
20127546|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127547|NCT00021320|Paclitaxel|paclitaxel|mesh-list
20127548|NCT00021320|Fluorouracil|fluorouracil|mesh-list
20127549|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127550|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127551|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127552|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127553|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127554|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127555|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
20127556|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127557|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127558|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
20127559|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127560|NCT00021333|Paclitaxel|paclitaxel|mesh-list
20127561|NCT00021333|Cisplatin|cisplatin|mesh-list
20127562|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127563|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127564|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127565|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127566|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127567|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127568|NCT00021346|Gemcitabine|gemcitabine|mesh-list
20127569|NCT00021346|Carboplatin|carboplatin|mesh-list
20127570|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127571|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127572|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
20127573|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127574|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
20127575|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127576|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127577|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127578|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
19658202|NCT03137966|Deferoxamine|deferoxamine|mesh-list
19658203|NCT03137966|Siderophores|siderophores|mesh-ancestor
19658204|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19658205|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
19658206|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
20127579|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127580|NCT00021359|Dexamethasone|dexamethasone|mesh-list
20127581|NCT00021359|Isotretinoin|isotretinoin|mesh-list
20127582|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20127583|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
20127584|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
20127585|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658207|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658208|NCT03114865|Dexamethasone|dexamethasone|mesh-list
19658209|NCT03114865|Blinatumomab|blinatumomab|mesh-list
19658210|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19658211|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19658212|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
19658213|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
19658214|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658215|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658216|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19658217|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
19658218|NCT03114865|Hormones|hormones|mesh-ancestor
19658219|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19658220|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127586|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127587|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19658221|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658222|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
20127588|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
19599203|NCT02572492|Dexamethasone|dexamethasone|mesh-list
19599204|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
19599205|NCT02572492|Melphalan|melphalan|mesh-list
19599206|NCT02572492|BB 1101|bb 1101|mesh-list
19599207|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599208|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
19599209|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
19599210|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599211|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599212|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19599213|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
19599214|NCT02572492|Hormones|hormones|mesh-ancestor
19599215|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599216|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19599217|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599218|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
19599219|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599220|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599221|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19599222|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
19599223|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19599224|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599225|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
19599226|NCT02572323|Tesamorelin|tesamorelin|mesh-list
19599227|NCT02572323|Growth Substances|growth substances|mesh-ancestor
19599228|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599229|NCT02572336|Plasminogen|plasminogen|mesh-list
19599230|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19599231|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19599232|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19599233|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599234|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
19599235|NCT02572375|Codeine|codeine|mesh-list
19599236|NCT02572375|Guaifenesin|guaifenesin|mesh-list
19599237|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19599238|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19599239|NCT02572375|Narcotics|narcotics|mesh-ancestor
19599240|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599241|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599242|NCT02572375|Analgesics|analgesics|mesh-ancestor
19599243|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
19599244|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599245|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
19599246|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
19599247|NCT02572375|Expectorants|expectorants|mesh-ancestor
19599248|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19599249|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599250|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
19599251|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599252|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599253|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
19599254|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20127589|NCT00021359|Hormones|hormones|mesh-ancestor
20127590|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127591|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127592|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127593|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
20127594|NCT00021372|Paclitaxel|paclitaxel|mesh-list
20127595|NCT00021372|Estramustine|estramustine|mesh-list
20127596|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127597|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127598|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
19599255|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
19599256|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
19599257|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
19599258|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19599259|NCT02572089|Naloxone|naloxone|mesh-list
19599260|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19599261|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599262|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
19599263|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599264|NCT02572141|Leucovorin|leucovorin|mesh-list
19599265|NCT02572141|Fluorouracil|fluorouracil|mesh-list
19599266|NCT02572141|Capecitabine|capecitabine|mesh-list
19599267|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
19599268|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
19599269|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
19599270|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599271|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19599272|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599273|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599274|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
19599275|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599276|NCT02572141|Antidotes|antidotes|mesh-ancestor
19599277|NCT02572141|Protective Agents|protective agents|mesh-ancestor
19599278|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
19599279|NCT02572141|Vitamins|vitamins|mesh-ancestor
19599280|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
19599281|NCT02571842|Prednisolone|prednisolone|mesh-list
20127599|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127600|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
19599282|NCT02571842|Rituximab|rituximab|mesh-list
19599283|NCT02571842|Enalapril|enalapril|mesh-list
19599284|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127601|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127602|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127603|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
20127604|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127605|NCT00021385|Squalamine|squalamine|mesh-list
20127606|NCT00021385|Carboplatin|carboplatin|mesh-list
20127607|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127608|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20127609|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127610|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20127611|NCT00021385|Protective Agents|protective agents|mesh-ancestor
20127612|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127613|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19599285|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599286|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
19599287|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127614|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20127615|NCT00021385|Growth Substances|growth substances|mesh-ancestor
20127616|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
20127617|NCT00021398|Leucovorin|leucovorin|mesh-list
20127618|NCT00021398|Fluorouracil|fluorouracil|mesh-list
20127619|NCT00021398|Calcium|calcium|mesh-list
20127620|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
20127621|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20127622|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127623|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
20127624|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127625|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127626|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127627|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127628|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
20127629|NCT00021398|Antidotes|antidotes|mesh-ancestor
20127630|NCT00021398|Protective Agents|protective agents|mesh-ancestor
20127631|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
20127632|NCT00021398|Vitamins|vitamins|mesh-ancestor
20127633|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
20127634|NCT00021450|Goserelin|goserelin|mesh-list
20127635|NCT00021450|Bicalutamide|bicalutamide|mesh-list
20127636|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127637|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599288|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19599289|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599290|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
19599291|NCT02571842|Hormones|hormones|mesh-ancestor
19599292|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599293|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19599294|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19599295|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
19599296|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599297|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127638|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
20127639|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
20127640|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127641|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127642|NCT00021463|Lamivudine|lamivudine|mesh-list
20127643|NCT00021463|Zidovudine|zidovudine|mesh-list
20127644|NCT00021463|Efavirenz|efavirenz|mesh-list
20127645|NCT00021463|Nevirapine|nevirapine|mesh-list
20127646|NCT00021463|Abacavir|abacavir|mesh-list
20127647|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
20127648|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20127649|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20127650|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127651|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127652|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
20127653|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127654|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127655|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127656|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
20127657|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20127658|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20127659|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20127660|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20127661|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20127662|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20127663|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
20127664|NCT00021489|Abacavir|abacavir|mesh-list
20127665|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127666|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127667|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20127668|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
20127669|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20127670|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127671|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127672|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599298|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599299|NCT02571959|Amoxicillin|amoxicillin|mesh-list
19599300|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
19599301|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
19599302|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19599303|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127673|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20127674|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20127675|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
20127676|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127677|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127678|NCT00021528|Mirtazapine|mirtazapine|mesh-list
20127679|NCT00021528|Buspirone|buspirone|mesh-list
20127680|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
20127681|NCT00021528|Sertraline|sertraline|mesh-list
20127682|NCT00021528|Citalopram|citalopram|mesh-list
20127683|NCT00021528|Nortriptyline|nortriptyline|mesh-list
20127684|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
20127685|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20127686|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20127687|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20127688|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20127689|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127690|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20127691|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
20127692|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127693|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127694|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20127695|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20127696|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20127697|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20127698|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
19599304|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599305|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599306|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19599307|NCT02571712|Timolol|timolol|mesh-list
19599308|NCT02571712|Bimatoprost|bimatoprost|mesh-list
19599309|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20127699|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
20127700|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20127701|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19599310|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19599311|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
19599312|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599313|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599314|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599315|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19599316|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599317|NCT02571881|Oxycodone|oxycodone|mesh-list
19599318|NCT02571881|Naloxone|naloxone|mesh-list
19599319|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19599320|NCT02571881|Narcotics|narcotics|mesh-ancestor
19599321|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599322|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599323|NCT02571881|Analgesics|analgesics|mesh-ancestor
20127702|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20127703|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20127704|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
20127705|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20127706|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20127707|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20310636|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20310637|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
20310638|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
20310639|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310640|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310641|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20310642|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
20310643|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
20127708|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20127709|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20127710|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20127711|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20127712|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
20127713|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20127714|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20127715|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127716|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127717|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127718|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
20127719|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127720|NCT00021567|Interferons|interferons|mesh-list
20127721|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
20127722|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127723|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
20127724|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127725|NCT00021645|Vitamin E|vitamin e|mesh-list
20127726|NCT00021645|Vitamins|vitamins|mesh-ancestor
20127727|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
20127728|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127729|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
20310644|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19599324|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
19599325|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599326|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19599327|NCT02571608|Metformin|metformin|mesh-list
19599328|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19599329|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599330|NCT02571283|Epinephrine|epinephrine|mesh-list
19599331|NCT02571283|Bupivacaine|bupivacaine|mesh-list
19599332|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
19599333|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
19599334|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599335|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599336|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
19599337|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599338|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599339|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
19599340|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19599341|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599342|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
19599343|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599344|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19599345|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20127730|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612304|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599346|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20127731|NCT00021645|Protective Agents|protective agents|mesh-ancestor
20127732|NCT00021671|Metronidazole|metronidazole|mesh-list
20127733|NCT00021671|Nevirapine|nevirapine|mesh-list
20127734|NCT00021671|Erythromycin|erythromycin|mesh-list
20127735|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
20127736|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20127737|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
20127738|NCT00021671|Ampicillin|ampicillin|mesh-list
20127739|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127740|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20127741|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20127742|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20127743|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20127744|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20127745|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127746|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127747|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
20127748|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20127749|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127750|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20127751|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20127752|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20127753|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20127754|NCT00021736|Bevacizumab|bevacizumab|mesh-list
20127755|NCT00021736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127756|NCT00021736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127757|NCT00021736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20127758|NCT00021736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20127759|NCT00021736|Growth Substances|growth substances|mesh-ancestor
20127760|NCT00021736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127761|NCT00021736|Growth Inhibitors|growth inhibitors|mesh-ancestor
20127762|NCT00021814|Doxazosin|doxazosin|mesh-list
20127763|NCT00021814|Finasteride|finasteride|mesh-list
19599347|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
19599348|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
19599349|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
19599350|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19599351|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
19599352|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19599353|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19599354|NCT02571517|Prednisolone|prednisolone|mesh-list
19599355|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
19599356|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19599357|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
19599358|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
19599359|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599360|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
19599361|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
19599362|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599363|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599364|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19599365|NCT02571517|Hormones|hormones|mesh-ancestor
19599366|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599367|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19599368|NCT02571517|Protective Agents|protective agents|mesh-ancestor
19599369|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19599370|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599371|NCT02571556|Dexamethasone|dexamethasone|mesh-list
19599372|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19599373|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19599374|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599375|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
19599376|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
20127764|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20127765|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20310645|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
20310646|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599377|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127766|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127767|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127768|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
20608261|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599378|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599379|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19599380|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
20173431|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20127769|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127770|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127771|NCT00021814|Urological Agents|urological agents|mesh-ancestor
20127772|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20127773|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20127774|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20127775|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20127776|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
20127777|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20127778|NCT00021827|Hormones|hormones|mesh-list
19599381|NCT02571556|Hormones|hormones|mesh-ancestor
19599382|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599383|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19599384|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599385|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19599386|NCT02571426|Propofol|propofol|mesh-list
19599387|NCT02571426|Sevoflurane|sevoflurane|mesh-list
19599388|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19599389|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599390|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599391|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599392|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
19599393|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
19599394|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19599395|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19599396|NCT02571361|Acetaminophen|acetaminophen|mesh-list
19599397|NCT02571361|Ibuprofen|ibuprofen|mesh-list
19599398|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599399|NCT02571361|Analgesics|analgesics|mesh-ancestor
19599400|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
19599401|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599402|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599403|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
19599404|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19599405|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599406|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19599407|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19599408|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599409|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599410|NCT02571543|Ibuprofen|ibuprofen|mesh-list
19599411|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19599412|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599413|NCT02571543|Analgesics|analgesics|mesh-ancestor
19599414|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
19599415|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599416|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599417|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599418|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20127779|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
20127780|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
20127781|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127782|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599419|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19599420|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599421|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599422|NCT02571205|Testosterone|testosterone|mesh-list
20127783|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20173432|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173433|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
19599423|NCT02571205|Androgens|androgens|mesh-ancestor
20173434|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173435|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173436|NCT00161577|Ketorolac|ketorolac|mesh-list
20173437|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20173438|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599424|NCT02571205|Hormones|hormones|mesh-ancestor
19599425|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127784|NCT00021983|Immunotoxins|immunotoxins|mesh-list
20127785|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
20127786|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127787|NCT00021996|Valdecoxib|valdecoxib|mesh-list
20127788|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20127789|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20127790|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127791|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127792|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20127793|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20127794|NCT00021996|Analgesics|analgesics|mesh-ancestor
20127795|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
20127796|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127797|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127798|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20127799|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20127800|NCT00022009|Gemcitabine|gemcitabine|mesh-list
20127801|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127802|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
20127803|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127804|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127805|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
20127806|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127807|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127808|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127809|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
20127810|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127811|NCT00022022|Docetaxel|docetaxel|mesh-list
20127812|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127813|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127814|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127815|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127816|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310647|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310648|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20310649|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20310650|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310651|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310652|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20127817|NCT00022048|Bevacizumab|bevacizumab|mesh-list
20310653|NCT00674752|Gabapentin|gabapentin|mesh-list
19599426|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599427|NCT02571296|Progesterone|progesterone|mesh-list
19599428|NCT02571296|Progestins|progestins|mesh-ancestor
19599429|NCT02571296|Hormones|hormones|mesh-ancestor
19599430|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599431|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599432|NCT02571192|Volixibat|volixibat|mesh-list
19599433|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19599434|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
19599435|NCT02571400|Analgesics|analgesics|mesh-list
19599436|NCT02571400|Narcotics|narcotics|mesh-ancestor
19599437|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599438|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599439|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
19599440|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599441|NCT02571491|Ketamine|ketamine|mesh-list
19599442|NCT02571491|Morphine|morphine|mesh-list
19599443|NCT02571491|Remifentanil|remifentanil|mesh-list
19599444|NCT02571491|Analgesics|analgesics|mesh-ancestor
19599445|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
19599446|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599447|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599448|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19599449|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599450|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
19599451|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
19599452|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599453|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19599454|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19599455|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20127818|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20310654|NCT00674752|Analgesics|analgesics|mesh-ancestor
19599456|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599457|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19599458|NCT02571491|Narcotics|narcotics|mesh-ancestor
19599459|NCT02571166|Valacyclovir|valacyclovir|mesh-list
19599460|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
19599461|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127819|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599462|NCT02571179|Fentanyl|fentanyl|mesh-list
19599463|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19599464|NCT02571179|Narcotics|narcotics|mesh-ancestor
19599465|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599466|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599467|NCT02571179|Analgesics|analgesics|mesh-ancestor
19599468|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
19599469|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599470|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19599471|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599472|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
19599473|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
19599474|NCT02570893|Paclitaxel|paclitaxel|mesh-list
20127820|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20127821|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20127822|NCT00022048|Growth Substances|growth substances|mesh-ancestor
20127823|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127824|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
19599475|NCT02570893|Carboplatin|carboplatin|mesh-list
19599476|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19599477|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599478|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
19599479|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
19599480|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
19599481|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599482|NCT02570971|Mannitol|mannitol|mesh-list
19599483|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19599484|NCT02570971|Diuretics|diuretics|mesh-ancestor
19599485|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
19599486|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599487|NCT02571140|Teriparatide|teriparatide|mesh-list
19599488|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
19599489|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19599490|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599491|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19599492|NCT02570841|Capsaicin|capsaicin|mesh-list
19599493|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
19599494|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
19599495|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
19599496|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599497|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127825|NCT00022074|Gabapentin|gabapentin|mesh-list
20127826|NCT00022074|Analgesics|analgesics|mesh-ancestor
20127827|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
20127828|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127829|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127830|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
20127831|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20127832|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20127833|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20127834|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20127835|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20127836|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20127837|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20127838|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127839|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
20127840|NCT00022087|Vitamin D|vitamin d|mesh-list
20127841|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
20127842|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
19599498|NCT02570789|Sunitinib|sunitinib|mesh-list
19599499|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599500|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19599501|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19599502|NCT02570789|Growth Substances|growth substances|mesh-ancestor
19599503|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599504|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
19599505|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19599506|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599507|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599508|NCT02570477|Vancomycin|vancomycin|mesh-list
19599509|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20127843|NCT00022087|Calcium|calcium|mesh-list
20127844|NCT00022087|Vitamins|vitamins|mesh-ancestor
20127845|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
20127846|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127847|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20127848|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20127849|NCT00022126|Cytarabine|cytarabine|mesh-list
20127850|NCT00022126|Cyclosporine|cyclosporine|mesh-list
20127851|NCT00022126|Dexamethasone|dexamethasone|mesh-list
20127852|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
19599510|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599511|NCT02570581|Acetaminophen|acetaminophen|mesh-list
19599512|NCT02570581|Ramipril|ramipril|mesh-list
19599513|NCT02570581|Furosemide|furosemide|mesh-list
19599514|NCT02570581|Memantine|memantine|mesh-list
20127853|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
20127854|NCT00022126|Doxorubicin|doxorubicin|mesh-list
20127855|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20127856|NCT00022126|Methotrexate|methotrexate|mesh-list
20127857|NCT00022126|Vincristine|vincristine|mesh-list
20127858|NCT00022126|Daunorubicin|daunorubicin|mesh-list
20127859|NCT00022126|Asparaginase|asparaginase|mesh-list
20127860|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
20127861|NCT00022126|Pegaspargase|pegaspargase|mesh-list
20127862|NCT00022126|Thioguanine|thioguanine|mesh-list
19599515|NCT02570581|Alprazolam|alprazolam|mesh-list
19599516|NCT02570581|Zopiclone|zopiclone|mesh-list
19599517|NCT02570581|Oxazepam|oxazepam|mesh-list
19599518|NCT02570581|Donepezil|donepezil|mesh-list
19599519|NCT02570581|Clopidogrel|clopidogrel|mesh-list
19599520|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19599521|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19599522|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19599523|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19599524|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
19599525|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599526|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599527|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599528|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599529|NCT02570581|Analgesics|analgesics|mesh-ancestor
19599530|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
19599531|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599532|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
19599533|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19599534|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599535|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19599536|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
19599537|NCT02570581|Diuretics|diuretics|mesh-ancestor
19599538|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
19599539|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19599540|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19599541|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19599542|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19599543|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
20127863|NCT00022126|Cyclosporins|cyclosporins|mesh-list
20127864|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599544|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19599545|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19599546|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19599547|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
20127865|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
20127866|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127867|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173439|NCT00161577|Analgesics|analgesics|mesh-ancestor
20127868|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127869|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
20127870|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127871|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127872|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20127873|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20127874|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
20127875|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
20127876|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20127877|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20127878|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
20127879|NCT00022126|Hormones|hormones|mesh-ancestor
20127880|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20127881|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20127882|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127883|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127884|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127885|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127886|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20127887|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
20127888|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20127889|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127890|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
20127891|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
20127892|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20127893|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20127894|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
20127895|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20127896|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127897|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127898|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127899|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127900|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
20127901|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20127902|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20127903|NCT00022126|Protective Agents|protective agents|mesh-ancestor
20127904|NCT00022139|Paclitaxel|paclitaxel|mesh-list
20127905|NCT00022139|Carboplatin|carboplatin|mesh-list
20127906|NCT00022139|Fluorouracil|fluorouracil|mesh-list
20127907|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127908|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127909|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127910|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127911|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127912|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127913|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
20127914|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127915|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127916|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
20127917|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127918|NCT00022152|Vinorelbine|vinorelbine|mesh-list
20127919|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19599548|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599549|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19599550|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599551|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19599552|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19599553|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19599554|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
19599555|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
19599556|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19599557|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
19599558|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599559|NCT02570230|Ketamine|ketamine|mesh-list
19599560|NCT02570230|Analgesics|analgesics|mesh-ancestor
19599561|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
19599562|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599563|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599564|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19599565|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599566|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
19599567|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
20127920|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127921|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
19599568|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599569|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20127922|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127923|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127924|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127925|NCT00022165|Selenium|selenium|mesh-list
20127926|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
20127927|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127928|NCT00022165|Protective Agents|protective agents|mesh-ancestor
20127929|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127930|NCT00022165|Trace Elements|trace elements|mesh-ancestor
20127931|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
20127932|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
20127933|NCT00022178|Doxorubicin|doxorubicin|mesh-list
20127934|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20127935|NCT00022178|Fluorouracil|fluorouracil|mesh-list
19599570|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19599571|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599572|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599573|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19599574|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
19599575|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599576|NCT02570243|Heparin|heparin|mesh-list
19599577|NCT02570243|Calcium heparin|calcium heparin|mesh-list
19599578|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
20127936|NCT00022178|Vincristine|vincristine|mesh-list
20127937|NCT00022178|Epirubicin|epirubicin|mesh-list
20127938|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127939|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
20127940|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127941|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20127942|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20127943|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
20127944|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127945|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127946|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20127947|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20127948|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20127949|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20127950|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127951|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
20127952|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127953|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127954|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127955|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127956|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127957|NCT00022191|Gemcitabine|gemcitabine|mesh-list
19599579|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19599580|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19599581|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599582|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19599583|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19599584|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599585|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19599586|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599587|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599588|NCT02569866|Cephalexin|cephalexin|mesh-list
19599589|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19599590|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599591|NCT02569879|Vaccines|vaccines|mesh-list
19599592|NCT02569879|Immunologic Factors|immunologic factors|mesh-ancestor
19599593|NCT02569879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599594|NCT02570035|Mirabegron|mirabegron|mesh-list
19599595|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19599596|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19599597|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599598|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
19599599|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599600|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599601|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599602|NCT02570035|Urological Agents|urological agents|mesh-ancestor
19599603|NCT02569970|Fluoxetine|fluoxetine|mesh-list
19599604|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20127958|NCT00022191|Paclitaxel|paclitaxel|mesh-list
20127959|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127960|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599605|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19599606|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19599607|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599608|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599609|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
19599610|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599611|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19599612|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
19599613|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19599614|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19599615|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19599616|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599617|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
19599618|NCT02569905|Parecoxib|parecoxib|mesh-list
19599619|NCT02569905|Analgesics|analgesics|mesh-ancestor
19599620|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
19599621|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599622|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599623|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20127961|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127962|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127963|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
20310655|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
20310656|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310657|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310658|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
20310659|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20310660|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20310661|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310662|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310663|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20310664|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20310665|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310666|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127964|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127965|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20127966|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
20127967|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
20127968|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310667|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
20310668|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
19599624|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599625|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599626|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19599627|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19599628|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599629|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599630|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19599631|NCT02569814|Amlodipine|amlodipine|mesh-list
19599632|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19599633|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599634|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19599635|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19599636|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599637|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19599638|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599639|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
19599640|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19599641|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19599642|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
19599643|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19599644|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19599645|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310669|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20310670|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310671|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20310672|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19599646|NCT02569489|Paclitaxel|paclitaxel|mesh-list
19599647|NCT02569489|Trastuzumab|trastuzumab|mesh-list
20127969|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127970|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20127971|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
20127972|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127973|NCT00022204|Vitamin E|vitamin e|mesh-list
20127974|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
20127975|NCT00022204|Vitamins|vitamins|mesh-ancestor
20127976|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
20310673|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310674|NCT00674921|Renal Agents|renal agents|mesh-ancestor
20310675|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310676|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
20310677|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20310678|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20310679|NCT00674999|Bacitracin|bacitracin|mesh-list
20310680|NCT00674999|Nystatin|nystatin|mesh-list
20310681|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20310682|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310683|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310684|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
20310685|NCT00674999|Ionophores|ionophores|mesh-ancestor
20310686|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20310687|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127977|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20127978|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
20127979|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127980|NCT00022204|Protective Agents|protective agents|mesh-ancestor
19599648|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127981|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20127982|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20127983|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20127984|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20127985|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
20127986|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20127987|NCT00022217|Paclitaxel|paclitaxel|mesh-list
20127988|NCT00022217|Carboplatin|carboplatin|mesh-list
20127989|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20127990|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20127991|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20127992|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20127993|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20127994|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20127995|NCT00022230|Aldesleukin|aldesleukin|mesh-list
20127996|NCT00022230|Paclitaxel|paclitaxel|mesh-list
20127997|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
19599649|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599650|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19599651|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19599652|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19599653|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599654|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19599655|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
19599656|NCT02569515|Hematinics|hematinics|mesh-ancestor
19599657|NCT02569463|Aldesleukin|aldesleukin|mesh-list
19599658|NCT02569463|Interleukin-2|interleukin-2|mesh-list
19599659|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599660|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599661|NCT02569463|Analgesics|analgesics|mesh-ancestor
19599662|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
19599663|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599664|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599665|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20310688|NCT00675012|Capecitabine|capecitabine|mesh-list
19599666|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20127998|NCT00022230|Doxorubicin|doxorubicin|mesh-list
20310689|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
19599667|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
19599668|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599669|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20127999|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20128000|NCT00022230|Sargramostim|sargramostim|mesh-list
20128001|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128002|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128003|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128004|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128005|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128006|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128007|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128008|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
20128009|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128010|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128011|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128012|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
20128013|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20128014|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128015|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128016|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128017|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128018|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20128019|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20128020|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
20128021|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128022|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
20128023|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128024|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20128025|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
20128026|NCT00022308|Irinotecan|irinotecan|mesh-list
20128027|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128028|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20128029|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128030|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128031|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599670|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19599671|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19599672|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
19599673|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128032|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
20128033|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20128034|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128035|NCT00022360|Taurolidine|taurolidine|mesh-list
20128036|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128037|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20128038|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128039|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
20128040|NCT00022386|Hematinics|hematinics|mesh-ancestor
20128041|NCT00022399|Celecoxib|celecoxib|mesh-list
20128042|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20128043|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20128044|NCT00022399|Analgesics|analgesics|mesh-ancestor
20128045|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
20128046|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128047|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128048|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128049|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128050|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20128051|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20128052|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128053|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128054|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20128055|NCT00022412|Vitamins|vitamins|mesh-ancestor
20128056|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
20128057|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128058|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20128059|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
19599674|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19599675|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19599676|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599677|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
19599678|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20128060|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128061|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128062|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128063|NCT00022438|Aldesleukin|aldesleukin|mesh-list
20128064|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
20128065|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128066|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20128067|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20128068|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
20128069|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128070|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20128071|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
20128072|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128073|NCT00022451|Tipifarnib|tipifarnib|mesh-list
20128074|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128075|NCT00022464|Sirolimus|sirolimus|mesh-list
20128076|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128077|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128078|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128079|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128080|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
20128081|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128082|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
20128083|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128084|NCT00022529|Trastuzumab|trastuzumab|mesh-list
20310690|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128085|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20128086|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128087|NCT00022542|Epothilones|epothilones|mesh-list
20128088|NCT00022542|Epothilone B|epothilone b|mesh-list
20128089|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128090|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128091|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128092|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310691|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
20310692|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310693|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310694|NCT00675181|Melatonin|melatonin|mesh-list
20310695|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
20310696|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310697|NCT00675181|Protective Agents|protective agents|mesh-ancestor
20310698|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310699|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310700|NCT00675194|Capecitabine|capecitabine|mesh-list
20310701|NCT00675194|Irinotecan|irinotecan|mesh-list
20310702|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310703|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128093|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128094|NCT00022555|Vincristine|vincristine|mesh-list
20128095|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
20128096|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128097|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128098|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128099|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128100|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128101|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128102|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20128103|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
20128104|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599679|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19599680|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599681|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19599682|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19599683|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
19599684|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599685|NCT02569554|Rabeprazole|rabeprazole|mesh-list
19599686|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19599687|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19599688|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19599689|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599690|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599691|NCT02569346|Triumeq|triumeq|mesh-list
19599692|NCT02569346|Lamivudine|lamivudine|mesh-list
19599693|NCT02569346|Abacavir|abacavir|mesh-list
19599694|NCT02569346|Dolutegravir|dolutegravir|mesh-list
20128105|NCT00022581|Thalidomide|thalidomide|mesh-list
20128106|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128107|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
19599695|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19599696|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19599697|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
19599698|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128108|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128109|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
20128110|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128111|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128112|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20128113|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20128114|NCT00022581|Growth Substances|growth substances|mesh-ancestor
20128115|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
20128116|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128117|NCT00022594|Lurtotecan|lurtotecan|mesh-list
20128118|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599699|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19599700|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128119|NCT00022607|Thalidomide|thalidomide|mesh-list
20128120|NCT00022607|Bevacizumab|bevacizumab|mesh-list
20128121|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20128122|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128123|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20128124|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20128125|NCT00022607|Growth Substances|growth substances|mesh-ancestor
20128126|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128127|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310704|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
19599701|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599702|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599703|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19599704|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19599705|NCT02569307|Minocycline|minocycline|mesh-list
19599706|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19599707|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599708|NCT02569073|Dronabinol|dronabinol|mesh-list
19599709|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
19599710|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599711|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19599712|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599713|NCT02569073|Analgesics|analgesics|mesh-ancestor
19599714|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
19599715|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599716|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19599717|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19599718|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599719|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599720|NCT02569073|Hormones|hormones|mesh-ancestor
19599721|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128128|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128129|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
20128130|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
20128131|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128132|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128133|NCT00022620|Paclitaxel|paclitaxel|mesh-list
20128134|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128135|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128136|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128137|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128138|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128139|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128140|NCT00022646|Gemcitabine|gemcitabine|mesh-list
20128141|NCT00022646|Pemetrexed|pemetrexed|mesh-list
20128142|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128143|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
20128144|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128145|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128146|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
20128147|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128148|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128149|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128150|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
20128151|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128152|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20608262|NCT02245269|Ritonavir|ritonavir|mesh-list
20128153|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19599722|NCT02569320|Dexamethasone|dexamethasone|mesh-list
19599723|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
19599724|NCT02569320|Pomalidomide|pomalidomide|mesh-list
19599725|NCT02569320|Ichthammol|ichthammol|mesh-list
19599726|NCT02569320|BB 1101|bb 1101|mesh-list
19599727|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19599728|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599729|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
19599730|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
19599731|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599732|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599733|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19599734|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
20128154|NCT00022685|Epratuzumab|epratuzumab|mesh-list
20128155|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20128156|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128157|NCT00022711|Temozolomide|temozolomide|mesh-list
20128158|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128159|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
20128160|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128161|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128162|NCT00022724|Sirolimus|sirolimus|mesh-list
20128163|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128164|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128165|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128166|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128167|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
20128168|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128169|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
20128170|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128171|NCT00022737|Leucovorin|leucovorin|mesh-list
20128172|NCT00022737|Cytarabine|cytarabine|mesh-list
20128173|NCT00022737|Cyclosporine|cyclosporine|mesh-list
20128174|NCT00022737|Dexamethasone|dexamethasone|mesh-list
20128175|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
20128176|NCT00022737|Ifosfamide|ifosfamide|mesh-list
20128177|NCT00022737|Methotrexate|methotrexate|mesh-list
20128178|NCT00022737|Etoposide|etoposide|mesh-list
20128179|NCT00022737|Vincristine|vincristine|mesh-list
20128180|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
20128181|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
20128182|NCT00022737|Daunorubicin|daunorubicin|mesh-list
20128183|NCT00022737|Asparaginase|asparaginase|mesh-list
20128184|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
20128185|NCT00022737|Pegaspargase|pegaspargase|mesh-list
20128186|NCT00022737|Cyclosporins|cyclosporins|mesh-list
20128187|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
20128188|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128189|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
20128190|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128191|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128192|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128193|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
20128194|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128195|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128196|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20128197|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128198|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
20128199|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
20128200|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128201|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20128202|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
20128203|NCT00022737|Hormones|hormones|mesh-ancestor
20128204|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128205|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20128206|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20128207|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
20128208|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19599735|NCT02569320|Hormones|hormones|mesh-ancestor
20128209|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128210|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
20128211|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
20128212|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128213|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20128214|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128215|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128216|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128217|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128218|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
20128219|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128220|NCT00022737|Antidotes|antidotes|mesh-ancestor
20128221|NCT00022737|Protective Agents|protective agents|mesh-ancestor
20128222|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
20310705|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310706|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20310707|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310708|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310709|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19599736|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599737|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19599738|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599739|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
19599740|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599741|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599742|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
19599743|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19599744|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19599745|NCT02569320|Growth Substances|growth substances|mesh-ancestor
19599746|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
19599747|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
19599748|NCT02569125|Everolimus|everolimus|mesh-list
19599749|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599750|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599751|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
19599752|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599753|NCT02568995|Ketorolac|ketorolac|mesh-list
19599754|NCT02568995|Epinephrine|epinephrine|mesh-list
19599755|NCT02568995|Racepinephrine|racepinephrine|mesh-list
19599756|NCT02568995|Ropivacaine|ropivacaine|mesh-list
19599757|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
19599758|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
19599759|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
19599760|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599761|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599762|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
19599763|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599764|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19599765|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599766|NCT02568995|Analgesics|analgesics|mesh-ancestor
19599767|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599768|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19599769|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19599770|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599771|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310710|NCT00675207|Dorzolamide|dorzolamide|mesh-list
20310711|NCT00675207|Brinzolamide|brinzolamide|mesh-list
20310712|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599772|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19599773|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599774|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
19599775|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599776|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19599777|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19599778|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
19599779|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19599780|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
19599781|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
19599782|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
19599783|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19599784|NCT02568943|Panobinostat|panobinostat|mesh-list
19599785|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599786|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19599787|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599788|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128223|NCT00022737|Vitamins|vitamins|mesh-ancestor
20128224|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
20608263|NCT02245269|Tipranavir|tipranavir|mesh-list
20608264|NCT02245269|Atorvastatin|atorvastatin|mesh-list
19599789|NCT02568839|Docetaxel|docetaxel|mesh-list
19599790|NCT02568839|Trastuzumab|trastuzumab|mesh-list
19599791|NCT02568839|Pertuzumab|pertuzumab|mesh-list
19599792|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599793|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
19599794|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19599795|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19599796|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599797|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19599798|NCT02568800|Cefepime|cefepime|mesh-list
19599799|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19599800|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599801|NCT02568709|Oxytocin|oxytocin|mesh-list
19599802|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
19599803|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19599804|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599805|NCT02568735|Etoricoxib|etoricoxib|mesh-list
19599806|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19599807|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19599808|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599809|NCT02568735|Analgesics|analgesics|mesh-ancestor
19599810|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
19599811|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599812|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599813|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599814|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19599815|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19599816|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19599817|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128225|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128226|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128227|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128228|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
20128229|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19599818|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599819|NCT02568618|Analgesics|analgesics|mesh-list
19599820|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
19599821|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599822|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128230|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128231|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128232|NCT00022841|Pamidronate|pamidronate|mesh-list
20128233|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20128234|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128235|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
20128236|NCT00022880|Antibodies|antibodies|mesh-list
20128237|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
20128238|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128239|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128240|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
20128241|NCT00022893|Antibodies|antibodies|mesh-list
20128242|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
20128243|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128244|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128245|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
20128246|NCT00022906|Antibodies|antibodies|mesh-list
20128247|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
20128248|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128249|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128250|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
20128251|NCT00022932|Antibodies|antibodies|mesh-list
20128252|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
20128253|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128254|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128255|NCT00022945|Prednisone|prednisone|mesh-list
20128256|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
20128257|NCT00022945|Doxorubicin|doxorubicin|mesh-list
20128258|NCT00022945|Vincristine|vincristine|mesh-list
20128259|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
20128260|NCT00022945|Antibodies|antibodies|mesh-list
20128261|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128262|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
19599823|NCT02568488|Metformin|metformin|mesh-list
20128263|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599824|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20128264|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128265|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128266|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
20128267|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128268|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128269|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20128270|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128271|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128272|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128273|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128274|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128275|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
20128276|NCT00022945|Hormones|hormones|mesh-ancestor
20128277|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128278|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20128279|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128280|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128281|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128282|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128283|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
20128284|NCT00022958|Antibodies|antibodies|mesh-list
20128285|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
20128286|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128287|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599825|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599826|NCT02568241|Interferons|interferons|mesh-list
19599827|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
19599828|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
19599829|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599830|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
19599831|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599832|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
19599833|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599834|NCT02568280|Insulin|insulin|mesh-list
19599835|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19599836|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
19599837|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
19599838|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19599839|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19599840|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599841|NCT02568176|Midazolam|midazolam|mesh-list
19599842|NCT02568176|Bupropion|bupropion|mesh-list
19599843|NCT02568176|Esketamine|esketamine|mesh-list
19599844|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19599845|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19599846|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599847|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599848|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19599849|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19599850|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19599851|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599852|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
19599853|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
19599854|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
19599855|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
19599856|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599857|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599858|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19599859|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
19599860|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19599861|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19599862|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19599863|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
19599864|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19599865|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19599866|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599867|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19599868|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19599869|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
19599870|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599871|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599872|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19599873|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
19599874|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19599875|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19599876|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599877|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
20128288|NCT00022971|Rituximab|rituximab|mesh-list
19599878|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19599879|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599880|NCT02567955|Vaccines|vaccines|mesh-list
20310713|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20310714|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20310715|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20310716|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
20310717|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310718|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310719|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599881|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
19599882|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599883|NCT02567942|Propofol|propofol|mesh-list
20128289|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20128290|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128291|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
20128292|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128293|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128294|NCT00023153|Adefovir|adefovir|mesh-list
20128295|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20310720|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20310721|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310722|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
20310723|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310724|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599884|NCT02567942|Sevoflurane|sevoflurane|mesh-list
19599885|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19599886|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599887|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599888|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599889|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
19599890|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
20310725|NCT00675246|Betamethasone|betamethasone|mesh-list
20310726|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
20310727|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20310728|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
20310729|NCT00675246|Hormones|hormones|mesh-ancestor
20310730|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310731|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599891|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19599892|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19599893|NCT02568423|Mirikizumab|mirikizumab|mesh-list
19599894|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19599895|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19599896|NCT02568423|Analgesics|analgesics|mesh-ancestor
19599897|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
19599898|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599899|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599900|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599901|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19599902|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19599903|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19599904|NCT02568111|Interferons|interferons|mesh-list
19599905|NCT02568111|Interferon-beta|interferon-beta|mesh-list
19599906|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
19599907|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19599908|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599909|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
19599910|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599911|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
19599912|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599913|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19599914|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19599915|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19599916|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19599917|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
19599918|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20128296|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
20128297|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128298|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20310732|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20612305|NCT02251041|Hematinics|hematinics|mesh-ancestor
19599919|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599920|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19599921|NCT02567981|Vitamin A|vitamin a|mesh-list
20128299|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128300|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128301|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128302|NCT00023166|Paclitaxel|paclitaxel|mesh-list
20128303|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128304|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128305|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128306|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128307|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128308|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128309|NCT00023218|Ritonavir|ritonavir|mesh-list
20128310|NCT00023218|Lopinavir|lopinavir|mesh-list
20128311|NCT00023218|Efavirenz|efavirenz|mesh-list
20128312|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20128313|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19599922|NCT02567981|Micronutrients|micronutrients|mesh-list
19599923|NCT02567981|Trace Elements|trace elements|mesh-list
19599924|NCT02567981|Vitamins|vitamins|mesh-ancestor
20310733|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
20310734|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20310735|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
20310736|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599925|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599926|NCT02568033|Paclitaxel|paclitaxel|mesh-list
19599927|NCT02568033|Docetaxel|docetaxel|mesh-list
20128314|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
20128315|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128316|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128317|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20128318|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20128319|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
20128320|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128321|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20128322|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20128323|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20128324|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128325|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20128326|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20128327|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20128328|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20128329|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20128330|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
20128331|NCT00023231|Sirolimus|sirolimus|mesh-list
20128332|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20128333|NCT00023231|Ganciclovir|ganciclovir|mesh-list
20128334|NCT00023231|Prednisone|prednisone|mesh-list
20128335|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
20128336|NCT00023231|Atorvastatin|atorvastatin|mesh-list
20128337|NCT00023231|Daclizumab|daclizumab|mesh-list
20128338|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128339|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
20128340|NCT00023231|Hormones|hormones|mesh-ancestor
19599928|NCT02568033|Carboplatin|carboplatin|mesh-list
19599929|NCT02568033|Pemetrexed|pemetrexed|mesh-list
19599930|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19599931|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599932|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
19599933|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
19599934|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19599935|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128341|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128342|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128343|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20128344|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310737|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
20310738|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19599936|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599937|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19599938|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19599939|NCT02567916|Propofol|propofol|mesh-list
19599940|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19599941|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599942|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599943|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599944|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
19599945|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
20128345|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128346|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128347|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
19599946|NCT02567929|Propofol|propofol|mesh-list
19599947|NCT02567929|Sevoflurane|sevoflurane|mesh-list
19599948|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19599949|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599950|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599951|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19599952|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
19599953|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
20128348|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128349|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128350|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128351|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128352|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
20310739|NCT00675285|Montelukast|montelukast|mesh-list
20310740|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20310741|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
20310742|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20310743|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
20310744|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310745|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310746|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20310747|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20310748|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599954|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19599955|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19599956|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19599957|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19599958|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599959|NCT02567838|Lidocaine|lidocaine|mesh-list
19599960|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
19599961|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
19599962|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599963|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599964|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
20310749|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
20310750|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20310751|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19599965|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599966|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19599967|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19599968|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19599969|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19599970|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599971|NCT02567773|Itraconazole|itraconazole|mesh-list
19599972|NCT02567773|GSK2881078|gsk2881078|mesh-list
19599973|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
19599974|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19599975|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19599976|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19599977|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19599978|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599979|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19599980|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
20310752|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20310753|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310754|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310755|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
20310756|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
20348575|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599981|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19599982|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599983|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19599984|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
19599985|NCT02567773|Hormones|hormones|mesh-ancestor
19599986|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
19599987|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
19599988|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
19599989|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19599990|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19599991|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
19599992|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19599993|NCT02567383|Docetaxel|docetaxel|mesh-list
19599994|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128353|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19599995|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128354|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
20128355|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
20128356|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
20128357|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128358|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20128359|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20128360|NCT00023231|Protective Agents|protective agents|mesh-ancestor
20128361|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20128362|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20128363|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
20310757|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20310758|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19599996|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
19599997|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
19599998|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19599999|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
19600000|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19600001|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19600002|NCT02567461|Aspirin|aspirin|mesh-list
19600003|NCT02567461|Edoxaban|edoxaban|mesh-list
19600004|NCT02567461|Clopidogrel|clopidogrel|mesh-list
19600005|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19600006|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19600007|NCT02567461|Analgesics|analgesics|mesh-ancestor
19600008|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
19600009|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600010|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600011|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19600012|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19600013|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19600014|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19600015|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600016|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19600017|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19600018|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600019|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
19600020|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19600021|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19600022|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19600023|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
19600024|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600025|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19600026|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
19600027|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19600028|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
19600029|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
19658265|NCT03085771|Deferoxamine|deferoxamine|mesh-list
19658266|NCT03085771|Siderophores|siderophores|mesh-ancestor
19658267|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19658268|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
19658269|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
19658270|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128364|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20128365|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20128366|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
20128367|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20128368|NCT00023231|Renal Agents|renal agents|mesh-ancestor
20128369|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
20128370|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20128371|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20128372|NCT00023244|Cyclosporine|cyclosporine|mesh-list
20128373|NCT00023244|Sirolimus|sirolimus|mesh-list
20128374|NCT00023244|Trimethoprim|trimethoprim|mesh-list
20310759|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310760|NCT00675545|Carboplatin|carboplatin|mesh-list
20310761|NCT00675545|Docetaxel|docetaxel|mesh-list
20128375|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
20310762|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128376|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20128377|NCT00023244|Prednisone|prednisone|mesh-list
20128378|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
20128379|NCT00023244|Tacrolimus|tacrolimus|mesh-list
20128380|NCT00023244|Cyclosporins|cyclosporins|mesh-list
20128381|NCT00023244|Basiliximab|basiliximab|mesh-list
20128382|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128383|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
20128384|NCT00023244|Hormones|hormones|mesh-ancestor
20128385|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128386|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128387|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20128388|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128389|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128390|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
20128391|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20128392|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128393|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128394|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
20128395|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128396|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
19600030|NCT02567396|Talazoparib|talazoparib|mesh-list
19600031|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19600032|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600033|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600034|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600035|NCT02567799|Paclitaxel|paclitaxel|mesh-list
19600036|NCT02567799|Carboplatin|carboplatin|mesh-list
19600037|NCT02567799|Genistein|genistein|mesh-list
19600038|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19600039|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600040|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
19600041|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
19600042|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
19600043|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600044|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19600045|NCT02567799|Protective Agents|protective agents|mesh-ancestor
19600046|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600047|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19600048|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600049|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
19600050|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19600051|NCT02567799|Estrogens|estrogens|mesh-ancestor
19600052|NCT02567799|Hormones|hormones|mesh-ancestor
19600053|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19600054|NCT02567331|Capecitabine|capecitabine|mesh-list
19600055|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19600056|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
19600057|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600058|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600059|NCT02567032|Oxytocin|oxytocin|mesh-list
19600060|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
19600061|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19600062|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600063|NCT02567149|Cidofovir|cidofovir|mesh-list
19600064|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
19600065|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600066|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600067|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600068|NCT02567253|Cisplatin|cisplatin|mesh-list
19600069|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600070|NCT02567279|Denosumab|denosumab|mesh-list
19600071|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19600072|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600073|NCT02567175|Domperidone|domperidone|mesh-list
20128397|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19600074|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
20128398|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128399|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128400|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
20128401|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
20128402|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128403|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20128404|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20128405|NCT00023244|Protective Agents|protective agents|mesh-ancestor
20128406|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20128407|NCT00023244|Renal Agents|renal agents|mesh-ancestor
20128408|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
20128409|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20128410|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20128411|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20128412|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20128413|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20128414|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20128415|NCT00023283|Buprenorphine|buprenorphine|mesh-list
20128416|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20128417|NCT00023283|Narcotics|narcotics|mesh-ancestor
20128418|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20128419|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128420|NCT00023283|Analgesics|analgesics|mesh-ancestor
20128421|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
20128422|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128423|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20128424|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
20128425|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20310763|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
20310764|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
19600075|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
19600076|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600077|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600078|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19600079|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19600080|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
19600081|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600082|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310765|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
20310766|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310767|NCT00675649|Golimumab|golimumab|mesh-list
20310768|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20310769|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20310770|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20310771|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
19600083|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
19600084|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
19600085|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600086|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
19600087|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600088|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600089|NCT02566967|Tofacitinib|tofacitinib|mesh-list
19600090|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19600091|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600092|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600093|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
19600094|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
19600095|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19600096|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
19600097|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600098|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600099|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19600100|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
19600101|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
19600102|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19600103|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
19600104|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600105|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600106|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19600107|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19600108|NCT02566824|Methylphenidate|methylphenidate|mesh-list
19600109|NCT02566824|Amphetamine|amphetamine|mesh-list
19600110|NCT02566824|Adderall|adderall|mesh-list
19600111|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
20310772|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600112|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20128426|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
20128427|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128428|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128429|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20128430|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
20128431|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20128432|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
20128433|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128434|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20128435|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20128436|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
20128437|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
20128438|NCT00023296|Protective Agents|protective agents|mesh-ancestor
20128439|NCT00023335|Isoniazid|isoniazid|mesh-list
20128440|NCT00023335|Rifapentine|rifapentine|mesh-list
20128441|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
20310773|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20310774|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
19600113|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600114|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19600115|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19600116|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600117|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600118|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
19600119|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600120|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
19600121|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
19600122|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600123|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
19600124|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19600125|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
19600126|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19600127|NCT02566928|Bacitracin|bacitracin|mesh-list
19600128|NCT02566928|Mupirocin|mupirocin|mesh-list
19600129|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19600130|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600131|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
19600132|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
19600133|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600134|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19600135|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600136|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600137|NCT02566707|Lamivudine|lamivudine|mesh-list
19600138|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19600139|NCT02566707|Dolutegravir|dolutegravir|mesh-list
19600140|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19600141|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19600142|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600143|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600144|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
19600145|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600146|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19600147|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19600148|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19600149|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19600150|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
19600151|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19600152|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19600153|NCT02566720|Amantadine|amantadine|mesh-list
19600154|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20128442|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310775|NCT00675688|Estrogens|estrogens|mesh-list
20310776|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20310777|NCT00675688|Hormones|hormones|mesh-ancestor
20310778|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310779|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310780|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20310781|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
20310782|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20310783|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20310784|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20310785|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
19600155|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19600156|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
19600157|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128443|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600158|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
19600159|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600160|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600161|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600162|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19600163|NCT02566720|Analgesics|analgesics|mesh-ancestor
19600164|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
19600165|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600166|NCT02566733|Remifentanil|remifentanil|mesh-list
19600167|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19600168|NCT02566733|Narcotics|narcotics|mesh-ancestor
19600169|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310786|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310787|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310788|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20310789|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310790|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310791|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310792|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310793|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
20310794|NCT00675714|Itraconazole|itraconazole|mesh-list
20310795|NCT00675714|Fluconazole|fluconazole|mesh-list
20310796|NCT00675714|Ketoconazole|ketoconazole|mesh-list
20310797|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
20310798|NCT00675714|Propranolol|propranolol|mesh-list
20310799|NCT00675714|Metoprolol|metoprolol|mesh-list
20310800|NCT00675714|Hormones|hormones|mesh-list
20310801|NCT00675714|Testosterone|testosterone|mesh-list
20310802|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
20310803|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
20310804|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20310805|NCT00675714|Oxandrolone|oxandrolone|mesh-list
20310806|NCT00675714|Nandrolone|nandrolone|mesh-list
20310807|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
20310808|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310809|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310810|NCT00675714|Androgens|androgens|mesh-ancestor
20310811|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20310812|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310813|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
20310814|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20310815|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20310816|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
20310817|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310818|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310819|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20310820|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20310821|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
20310822|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
20310823|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600170|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600171|NCT02566733|Analgesics|analgesics|mesh-ancestor
19600172|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
19600173|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600174|NCT02566356|Oxytocin|oxytocin|mesh-list
19600175|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
19600176|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19600177|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600178|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
19600179|NCT02566252|Albuterol|albuterol|mesh-list
19600180|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
19600181|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19600182|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
19600183|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600184|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310824|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20310825|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20128444|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20128445|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20128446|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
20128447|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128448|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20128449|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128450|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
20128451|NCT00023348|Isoniazid|isoniazid|mesh-list
20128452|NCT00023348|Rifabutin|rifabutin|mesh-list
20128453|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
20310826|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600185|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19600186|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
19600187|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
19600188|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19600189|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19600190|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19600191|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19600192|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
19600193|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600194|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600195|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19600196|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
19600197|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19600198|NCT02565979|Resveratrol|resveratrol|mesh-list
19600199|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
19600200|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600201|NCT02565979|Protective Agents|protective agents|mesh-ancestor
19600202|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600203|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600204|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19600205|NCT02565953|Paclitaxel|paclitaxel|mesh-list
19600206|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19600207|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600208|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19600209|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19600210|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
19600211|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600212|NCT02566187|Atorvastatin|atorvastatin|mesh-list
19600213|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19600214|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19600215|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
19600216|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600217|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19600218|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19600219|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600220|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
19600221|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19600222|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600223|NCT02566096|Morphine|morphine|mesh-list
19600224|NCT02566096|Bupivacaine|bupivacaine|mesh-list
19600225|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
19600226|NCT02566096|Anesthetics|anesthetics|mesh-list
19600227|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600228|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600229|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
19600230|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600231|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19600232|NCT02566096|Narcotics|narcotics|mesh-ancestor
19600233|NCT02566096|Analgesics|analgesics|mesh-ancestor
19600234|NCT02566226|Morphine|morphine|mesh-list
19600235|NCT02566226|Bupivacaine|bupivacaine|mesh-list
19600236|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
19600237|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
19600238|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600239|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600240|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
19600241|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600242|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19600243|NCT02566226|Narcotics|narcotics|mesh-ancestor
19600244|NCT02566226|Analgesics|analgesics|mesh-ancestor
19600245|NCT02565888|Ritonavir|ritonavir|mesh-list
19600246|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19600247|NCT02565888|Cobicistat|cobicistat|mesh-list
19600248|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19600249|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20310827|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19600250|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
19600251|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600252|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600253|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19600254|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19600255|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
19600256|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600257|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19600258|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19600259|NCT02565719|Interferons|interferons|mesh-list
19600260|NCT02565719|Tenofovir|tenofovir|mesh-list
19600261|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
19600262|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
19600263|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19600264|NCT02565719|REP 2139|rep 2139|mesh-list
19600265|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600266|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
19600267|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600268|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19600269|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19600270|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600271|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600272|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19600273|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19600274|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
19600275|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600276|NCT02565680|Prednisone|prednisone|mesh-list
19600277|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19600278|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
19600279|NCT02565680|Hormones|hormones|mesh-ancestor
19600280|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19600281|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600282|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19600283|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600284|NCT02565862|Metformin|metformin|mesh-list
19600285|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19600286|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600287|NCT02565836|Thrombin|thrombin|mesh-list
19600288|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
19600289|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
19600290|NCT02565836|Coagulants|coagulants|mesh-ancestor
19600291|NCT02565641|Gemcitabine|gemcitabine|mesh-list
19600292|NCT02565641|Capecitabine|capecitabine|mesh-list
19600293|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19600294|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
19600295|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600296|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600297|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
19600298|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600299|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600300|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19600301|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
19600302|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128454|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128455|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128456|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20128457|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20128458|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
20128459|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128460|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20128461|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128462|NCT00023361|Rifabutin|rifabutin|mesh-list
20128463|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128464|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128465|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128466|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
19658297|NCT03074045|Drospirenone|drospirenone|mesh-list
19658298|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
19658299|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20310828|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
20310829|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20310830|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
19658300|NCT03074045|Estradiol|estradiol|mesh-list
19658301|NCT03074045|Estrogens|estrogens|mesh-ancestor
19658302|NCT03074045|Hormones|hormones|mesh-ancestor
19658303|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128467|NCT00023374|Rifampin|rifampin|mesh-list
19600303|NCT02565693|Aspirin|aspirin|mesh-list
19600304|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
20128468|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
20128469|NCT00023374|Ethambutol|ethambutol|mesh-list
20128470|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128471|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
20128472|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128473|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128474|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
20128475|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128476|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128477|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128478|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20128479|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20128480|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20128481|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20128482|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20128483|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20128484|NCT00023387|Isoniazid|isoniazid|mesh-list
20128485|NCT00023387|Rifapentine|rifapentine|mesh-list
20128486|NCT00023387|Rifampin|rifampin|mesh-list
20128487|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
20128488|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128489|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128490|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20128491|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20128492|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
20128493|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128494|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20128495|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128496|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
20128497|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128498|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128499|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20128500|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20128501|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20128502|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20128503|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20128504|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20128505|NCT00023400|Nelfinavir|nelfinavir|mesh-list
20128506|NCT00023400|Rifabutin|rifabutin|mesh-list
20128507|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20128508|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20128509|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
20128510|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128511|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128512|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20128513|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20128514|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
20128515|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128516|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128517|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128518|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
19600305|NCT02565693|Dipyridamole|dipyridamole|mesh-list
19600306|NCT02565693|Apixaban|apixaban|mesh-list
20128519|NCT00023413|Efavirenz|efavirenz|mesh-list
20128520|NCT00023413|Rifabutin|rifabutin|mesh-list
20128521|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20128522|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128523|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128524|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128525|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
20128526|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128527|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20128528|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20128529|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19600307|NCT02565693|Clopidogrel|clopidogrel|mesh-list
19600308|NCT02565693|Calcium|calcium|mesh-list
20128530|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20128531|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20128532|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20128533|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128534|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128535|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
20128536|NCT00023426|Rifapentine|rifapentine|mesh-list
20128537|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20128538|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
20128539|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128540|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310831|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
20310832|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310833|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20310834|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20310835|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20310836|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20310837|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
20310838|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310839|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310840|NCT00675779|Atorvastatin|atorvastatin|mesh-list
20310841|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
20310842|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
20310843|NCT00675779|Dacuronium|dacuronium|mesh-list
20310844|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20310845|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20310846|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
20310847|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310848|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20310849|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19600309|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19600310|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600311|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19600312|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19600313|NCT02565693|Analgesics|analgesics|mesh-ancestor
19600314|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
19600315|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600316|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19600317|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19600318|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19600319|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19600320|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600321|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19600322|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19600323|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600324|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
19600325|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19600326|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19600327|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19600328|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
19600329|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600330|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19600331|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
19600332|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19600333|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
19600334|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
19600335|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19600336|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19600337|NCT02565602|Vitamin D|vitamin d|mesh-list
19600338|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
19600339|NCT02565602|Vitamins|vitamins|mesh-ancestor
19600340|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
19600341|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600342|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19600343|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19600344|NCT02565368|Metformin|metformin|mesh-list
19600345|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19600346|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600347|NCT02565212|Montelukast|montelukast|mesh-list
19600348|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19600349|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
19600350|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20310850|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600351|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
19600352|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19600353|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128541|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
20173440|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
20173441|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173442|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173443|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20173444|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173445|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20173446|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173447|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173448|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
20173449|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20173450|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173451|NCT00161655|Etanercept|etanercept|mesh-list
20173452|NCT00161655|Methotrexate|methotrexate|mesh-list
20173453|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20173454|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
20173455|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20173456|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173457|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20173458|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
20173459|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173460|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173461|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
20173462|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173463|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20173464|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173465|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
20173466|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173467|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20173468|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20173469|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20173470|NCT00161655|Analgesics|analgesics|mesh-ancestor
20173471|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
20173472|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173473|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20173474|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19600354|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19600355|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19600356|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600357|NCT02565303|Ropivacaine|ropivacaine|mesh-list
19600358|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
19600359|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
19600360|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600361|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600362|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
19600363|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600364|NCT02565316|Sertraline|sertraline|mesh-list
19600365|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
19600366|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19600367|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19600368|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19600369|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600370|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600371|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600372|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
19600373|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600374|NCT02565173|Timolol|timolol|mesh-list
19600375|NCT02565173|Adenosine|adenosine|mesh-list
19600376|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19600377|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19600378|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19600379|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600380|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600381|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600382|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19600383|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19600384|NCT02565173|Analgesics|analgesics|mesh-ancestor
19600385|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
19600386|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600387|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
19600388|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19600389|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
19600390|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
19600391|NCT02564536|Decitabine|decitabine|mesh-list
19600392|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19600393|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
19600394|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600395|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600396|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600397|NCT02564315|Nicotine|nicotine|mesh-list
19600398|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19600399|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
19600400|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600401|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600402|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19600403|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19600404|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
19600405|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600406|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600407|NCT02564237|Vaccines|vaccines|mesh-list
19600408|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
19600409|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600410|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
19600411|NCT02564094|Hematinics|hematinics|mesh-ancestor
19600412|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
19600413|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19600414|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600415|NCT02564146|Gemcitabine|gemcitabine|mesh-list
19600416|NCT02564146|Paclitaxel|paclitaxel|mesh-list
19600417|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19600418|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19600419|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600420|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
19600421|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
19600422|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
19600423|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600424|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19600425|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
19600426|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
19600427|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600428|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600429|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19600430|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
19600431|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600432|NCT02564003|Oxycodone|oxycodone|mesh-list
19600433|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19600434|NCT02564003|Narcotics|narcotics|mesh-ancestor
19600435|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600436|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600437|NCT02564003|Analgesics|analgesics|mesh-ancestor
19600438|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
19600439|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600440|NCT02563951|Granisetron|granisetron|mesh-list
19600441|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
19600442|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
19600443|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600444|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600445|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19600446|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19600447|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
19600448|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600449|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600450|NCT02563925|Durvalumab|durvalumab|mesh-list
19600451|NCT02563925|Tremelimumab|tremelimumab|mesh-list
19600452|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19600453|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600454|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
19600455|NCT02563782|Tacrolimus|tacrolimus|mesh-list
19600456|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19600457|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
19600458|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600459|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19600460|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600461|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600462|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19600463|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600464|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19600465|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
19600466|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600467|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600468|NCT02563795|Fentanyl|fentanyl|mesh-list
19600469|NCT02563795|Bupivacaine|bupivacaine|mesh-list
19600470|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
19600471|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
19600472|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600473|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600474|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
19600475|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600476|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19600477|NCT02563795|Narcotics|narcotics|mesh-ancestor
19600478|NCT02563795|Analgesics|analgesics|mesh-ancestor
19600479|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19600480|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19600481|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
19600482|NCT02563847|Erythritol|erythritol|mesh-list
19600483|NCT02563847|Tryptophan|tryptophan|mesh-list
19600484|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19600485|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
19600486|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19600487|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
19600488|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
19600489|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
19600490|NCT02563769|Cocaine|cocaine|mesh-list
19600491|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
19600492|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
19600493|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600494|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600495|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
19600496|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600497|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19600498|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19600499|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19600500|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600501|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600502|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
19600503|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600504|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600505|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600506|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600507|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19658304|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658305|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19658306|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
19658307|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19658308|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19658309|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19658310|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19658311|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19658312|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19658313|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
19658314|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19658315|NCT03074045|Diuretics|diuretics|mesh-ancestor
19658316|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
19658317|NCT03073980|Acetaminophen|acetaminophen|mesh-list
19658318|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19658319|NCT03073980|Analgesics|analgesics|mesh-ancestor
19658320|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
19658321|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658322|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658323|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
20128542|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20128543|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
20128544|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128545|NCT00023530|Thalidomide|thalidomide|mesh-list
20128546|NCT00023530|Fluconazole|fluconazole|mesh-list
20128547|NCT00023530|Voriconazole|voriconazole|mesh-list
20128548|NCT00023530|Dexamethasone|dexamethasone|mesh-list
20128549|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128550|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
20128551|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
20128552|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128553|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600508|NCT02563704|Artesunate|artesunate|mesh-list
19600509|NCT02563704|Quinine|quinine|mesh-list
19600510|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
19600511|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19600512|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19600513|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600514|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600515|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
19600516|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
19600517|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19600518|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
19600519|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19600520|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600521|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19600522|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600523|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19600524|NCT02563704|Analgesics|analgesics|mesh-ancestor
19600525|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
19600526|NCT02563821|Clonidine|clonidine|mesh-list
19600527|NCT02563821|Sufentanil|sufentanil|mesh-list
19600528|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
19600529|NCT02563821|Analgesics|analgesics|mesh-ancestor
19600530|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
19600531|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600532|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600533|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19600534|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
19600535|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
19600536|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19600537|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19600538|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19600539|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
19600540|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600541|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600542|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
19600543|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
19600544|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600545|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19600546|NCT02563821|Narcotics|narcotics|mesh-ancestor
19600547|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19600548|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19600549|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
19600550|NCT02563405|Doxazosin|doxazosin|mesh-list
19600551|NCT02563405|Nifedipine|nifedipine|mesh-list
19600552|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19600553|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600554|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600555|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19600556|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600557|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
19600558|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
19600559|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19600560|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19600561|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19600562|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19600563|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19600564|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
19600565|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600566|NCT02563340|Rituximab|rituximab|mesh-list
19600567|NCT02563340|Bortezomib|bortezomib|mesh-list
19600568|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19600569|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310851|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20310852|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310853|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20310854|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20310855|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20310856|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20310857|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310858|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20310859|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
19600570|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
19600571|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600572|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19600573|NCT02563353|Teriparatide|teriparatide|mesh-list
19600574|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20310860|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310861|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20310862|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20310863|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310864|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347191|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600575|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600576|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19600577|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
19600578|NCT02563288|Esmolol|esmolol|mesh-list
19600579|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
19600580|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
19600581|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
19600582|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
19600583|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19600584|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600585|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600586|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19600587|NCT02563288|Analgesics|analgesics|mesh-ancestor
19600588|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
19600589|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600590|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19600591|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600592|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600593|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19600594|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19600595|NCT02563327|Pyridoxine|pyridoxine|mesh-list
19600596|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
19600597|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
19600598|NCT02563327|Rifampin|rifampin|mesh-list
19600599|NCT02563327|Isoniazid|isoniazid|mesh-list
19600600|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
19600601|NCT02563327|Ethambutol|ethambutol|mesh-list
19600602|NCT02563327|Rifapentine|rifapentine|mesh-list
19600603|NCT02563327|Vitamins|vitamins|mesh-ancestor
19600604|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
19600605|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600606|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600607|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600608|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19600609|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19600610|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600611|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600612|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600613|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
19600614|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19600615|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
19600616|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
19600617|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19600618|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19600619|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19600620|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19600621|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19600622|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19600623|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19600624|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19600625|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19600626|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
19600627|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19600628|NCT02563054|Fluorouracil|fluorouracil|mesh-list
19600629|NCT02563054|Capecitabine|capecitabine|mesh-list
19600630|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600631|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
19600632|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600633|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19600634|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19600635|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
19600636|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600637|NCT02563041|Heparin|heparin|mesh-list
19600638|NCT02563041|Calcium heparin|calcium heparin|mesh-list
19600639|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
19600640|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347192|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347193|NCT00858377|Complement Factor H|complement factor h|mesh-list
19600641|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19600642|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19600643|NCT02562950|Midazolam|midazolam|mesh-list
19600644|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19600645|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19600646|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600647|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600648|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19600649|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19600650|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19600651|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19600652|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
19600653|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
19600654|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
20128554|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20128555|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
20128556|NCT00023530|Hormones|hormones|mesh-ancestor
20128557|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128558|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20128559|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310865|NCT00675961|Naltrexone|naltrexone|mesh-list
20310866|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20310867|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20310868|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310869|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
20310870|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310871|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20310872|NCT00676039|Citalopram|citalopram|mesh-list
20310873|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20310874|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19600655|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
19600656|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600657|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600658|NCT02562742|Ribavirin|ribavirin|mesh-list
19600659|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
19600660|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600661|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
19600662|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600663|NCT02562690|Thrombin|thrombin|mesh-list
19600664|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
19600665|NCT02562690|Coagulants|coagulants|mesh-ancestor
19600666|NCT02562417|Dexamethasone|dexamethasone|mesh-list
19600667|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19600668|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
19600669|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
19600670|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600671|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600672|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19600673|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
19600674|NCT02562417|Hormones|hormones|mesh-ancestor
19600675|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19600676|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19600677|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600678|NCT02562651|Doxycycline|doxycycline|mesh-list
19600679|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600680|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600681|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
19600682|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19600683|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19600684|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
19600685|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19600686|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600687|NCT02562664|Metformin|metformin|mesh-list
19600688|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19600689|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600690|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
19600691|NCT02562365|Carboplatin|carboplatin|mesh-list
19600692|NCT02562365|Etoposide|etoposide|mesh-list
20128560|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128561|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
20128562|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
20128563|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20128564|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310875|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600693|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19600694|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
19600695|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600696|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19600697|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19600698|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
19600699|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600700|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600701|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19600702|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19600703|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19600704|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19600705|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600706|NCT02562443|ON 01910|on 01910|mesh-list
19600707|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600708|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19600709|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128565|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20128566|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20128567|NCT00023530|Growth Substances|growth substances|mesh-ancestor
20128568|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
20128569|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
20128570|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20128571|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20128572|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310876|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310877|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310878|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600710|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600711|NCT02562508|Vaccines|vaccines|mesh-list
19600712|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
19600713|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600714|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
19600715|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19600716|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600717|NCT02562144|Lidocaine|lidocaine|mesh-list
19600718|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
19600719|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
19600720|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600721|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600722|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
19600723|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600724|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19600725|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19600726|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19600727|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600728|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600729|NCT02562300|Misoprostol|misoprostol|mesh-list
19600730|NCT02562300|Oxytocin|oxytocin|mesh-list
19600731|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
19600732|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19600733|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600734|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19600735|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
19600736|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19600737|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19600738|NCT02562118|Letrozole|letrozole|mesh-list
19600739|NCT02562118|Lenvatinib|lenvatinib|mesh-list
19600740|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600741|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19600742|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19600743|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600744|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600745|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19600746|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
19600747|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19600748|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600749|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19600750|NCT02562183|Kallikreins|kallikreins|mesh-list
20310879|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20310880|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
20310881|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310882|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19600751|NCT02562183|Coagulants|coagulants|mesh-ancestor
19600752|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
20128573|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600753|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
19600754|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19600755|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600756|NCT02562287|Olanzapine|olanzapine|mesh-list
19600757|NCT02562287|Risperidone|risperidone|mesh-list
19600758|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19600759|NCT02562287|Clozapine|clozapine|mesh-list
19600760|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19600761|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
19600762|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600763|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600764|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600765|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19600766|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19600767|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600768|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19600769|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19600770|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
20310883|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
20310884|NCT00676117|Loxoprofen|loxoprofen|mesh-list
20310885|NCT00676117|Esomeprazole|esomeprazole|mesh-list
20310886|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20310887|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20310888|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19600771|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
19600772|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
19600773|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600774|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19600775|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19600776|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19600777|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600778|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
19600779|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
19600780|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
19600781|NCT02562053|Fluoxetine|fluoxetine|mesh-list
19600782|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
19600783|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
19600784|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19600785|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19600786|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600787|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19600788|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19600789|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600790|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600791|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600792|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
19600793|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19600794|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
19600795|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19600796|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19600797|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19600798|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600799|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20128574|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20128575|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
20128576|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20128577|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20128578|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20128579|NCT00023621|Celecoxib|celecoxib|mesh-list
20128580|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20128581|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20128582|NCT00023621|Analgesics|analgesics|mesh-ancestor
20128583|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
20128584|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128585|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128586|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128587|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310889|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600800|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
19600801|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19600802|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600803|NCT02561936|Rilpivirine|rilpivirine|mesh-list
19600804|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19600805|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19600806|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600807|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600808|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
19600809|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600810|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19600811|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19600812|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
19600813|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
19600814|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19600815|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19600816|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600817|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
19600818|NCT02561923|Coagulants|coagulants|mesh-ancestor
19600819|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19600820|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
19600821|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19600822|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
19600823|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600824|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
19600825|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19600826|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19600827|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19600828|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19600829|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
19600830|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600831|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20128588|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20128589|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20310890|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600832|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19600833|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600834|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19600835|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19600836|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19600837|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19600838|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20310891|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20310892|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20310893|NCT00676117|Analgesics|analgesics|mesh-ancestor
20310894|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
20310895|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310896|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310897|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20310898|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310899|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
19600839|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19600840|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
19600841|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600842|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19600843|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19600844|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600845|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
19600846|NCT02561767|Tacrolimus|tacrolimus|mesh-list
19600847|NCT02561767|Basiliximab|basiliximab|mesh-list
19600848|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19600849|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
19600850|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128590|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128591|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128592|NCT00023634|Sargramostim|sargramostim|mesh-list
20128593|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
20128594|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128595|NCT00023660|Celecoxib|celecoxib|mesh-list
20128596|NCT00023660|Fluorouracil|fluorouracil|mesh-list
20310900|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
19600851|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19600852|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600853|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600854|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19600855|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600856|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19600857|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
19600858|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600859|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600860|NCT02561494|Nefopam|nefopam|mesh-list
19600861|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19600862|NCT02561494|Analgesics|analgesics|mesh-ancestor
19600863|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
19600864|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600865|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600866|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19600867|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19600868|NCT02561468|Nefopam|nefopam|mesh-list
19600869|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19600870|NCT02561468|Analgesics|analgesics|mesh-ancestor
19600871|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
19600872|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600873|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600874|NCT02561117|Metronidazole|metronidazole|mesh-list
19600875|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600876|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600877|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19600878|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19600879|NCT02561169|Oseltamivir|oseltamivir|mesh-list
19600880|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
19600881|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
19600882|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600883|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600884|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128597|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128598|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
20128599|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600885|NCT02561169|Antacids|antacids|mesh-ancestor
19600886|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20128600|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128601|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19600887|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
19600888|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19600889|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600890|NCT02561013|Monensin|monensin|mesh-list
19600891|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
19600892|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600893|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19600894|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19600895|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
19600896|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
19600897|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
19600898|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600899|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600900|NCT02561013|Ionophores|ionophores|mesh-ancestor
19600901|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19600902|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
19600903|NCT02560974|Capecitabine|capecitabine|mesh-list
19600904|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
19600905|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19600906|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
19600907|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600908|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600909|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
19600910|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600911|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
19600912|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600913|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600914|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19600915|NCT02560909|Vaccines|vaccines|mesh-list
19600916|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
19600917|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600918|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
19600919|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20128602|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
19600920|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19600921|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600922|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
19600923|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
19600924|NCT02560766|Gabapentin|gabapentin|mesh-list
19600925|NCT02560766|Analgesics|analgesics|mesh-ancestor
19600926|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
19600927|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19600928|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600929|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
19600930|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19600931|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19600932|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19600933|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19600934|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19600935|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19600936|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600937|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600938|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
19600939|NCT02560688|Clopidogrel|clopidogrel|mesh-list
19600940|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19600941|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19600942|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19600943|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19600944|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
19600945|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19600946|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600947|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600948|NCT02560649|Tenofovir|tenofovir|mesh-list
19600949|NCT02560649|Lamivudine|lamivudine|mesh-list
19600950|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19600951|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
19600952|NCT02560649|Entecavir|entecavir|mesh-list
19600953|NCT02560649|Adefovir|adefovir|mesh-list
19600954|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19600955|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
19600956|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600957|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19600958|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19600959|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600960|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600961|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19600962|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19600963|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
19600964|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600965|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
19600966|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19600967|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600968|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19600969|NCT02560376|Exenatide|exenatide|mesh-list
19600970|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19600971|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19600972|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19600973|NCT02560376|Incretins|incretins|mesh-ancestor
19600974|NCT02560376|Hormones|hormones|mesh-ancestor
19600975|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128603|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128604|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19658352|NCT03033446|Nivolumab|nivolumab|mesh-list
19658353|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658354|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658355|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19658356|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128605|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20128606|NCT00023660|Analgesics|analgesics|mesh-ancestor
20128607|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
20128608|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658361|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
19658362|NCT03025035|Olaparib|olaparib|mesh-list
19658363|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658364|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600976|NCT02560220|Mitomycins|mitomycins|mesh-list
19600977|NCT02560220|Mitomycin|mitomycin|mesh-list
19600978|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19600979|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600980|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
19600981|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600982|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19600983|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19600984|NCT02560207|Cefotaxime|cefotaxime|mesh-list
19600985|NCT02560207|Cefoxitin|cefoxitin|mesh-list
19600986|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600987|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600988|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
19600989|NCT02560155|Mupirocin|mupirocin|mesh-list
19600990|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19600991|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19600992|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
19600993|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19600994|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19600995|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310901|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310902|NCT00676156|Protective Agents|protective agents|mesh-ancestor
20310903|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310904|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
20310905|NCT00676156|Vitamins|vitamins|mesh-ancestor
20310906|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
20310907|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
20310908|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20310909|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19600996|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19600997|NCT02559973|Buprenorphine|buprenorphine|mesh-list
19600998|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19600999|NCT02559973|Naloxone|naloxone|mesh-list
19601000|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19601001|NCT02559973|Narcotics|narcotics|mesh-ancestor
19601002|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601003|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601004|NCT02559973|Analgesics|analgesics|mesh-ancestor
19601005|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
19601006|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601007|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19601008|NCT02559921|Vaccines|vaccines|mesh-list
19601009|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
19601010|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601011|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
19601012|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19601013|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
19601014|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601015|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
19601016|NCT02559908|Protective Agents|protective agents|mesh-ancestor
19601017|NCT02559791|Reslizumab|reslizumab|mesh-list
20128609|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128610|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20310910|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20310911|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
20310912|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310913|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310914|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310915|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310916|NCT00676260|Pioglitazone|pioglitazone|mesh-list
19601018|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20128611|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20128612|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20128613|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128614|NCT00023699|Gefitinib|gefitinib|mesh-list
20128615|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128616|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128617|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128618|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128619|NCT00023725|Semaxinib|semaxinib|mesh-list
19601019|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
19658365|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20128620|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20310917|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20310918|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310919|NCT00676286|Choline|choline|mesh-list
20310920|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
20310921|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20310922|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
20128621|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20128622|NCT00023725|Growth Substances|growth substances|mesh-ancestor
20128623|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128624|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
20128625|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128626|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128627|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128628|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128629|NCT00023738|Doxorubicin|doxorubicin|mesh-list
20128630|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20128631|NCT00023738|Ifosfamide|ifosfamide|mesh-list
20128632|NCT00023738|Dacarbazine|dacarbazine|mesh-list
20128633|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128634|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128635|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128636|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310923|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128637|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128638|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310924|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601020|NCT02559674|Gemcitabine|gemcitabine|mesh-list
19601021|NCT02559674|Paclitaxel|paclitaxel|mesh-list
19601022|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19601023|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601024|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
19601025|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19601026|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19601027|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601028|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19601029|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
19601030|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
19601031|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601032|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601033|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601034|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
19601035|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601036|NCT02559648|Denosumab|denosumab|mesh-list
19601037|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19601038|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601039|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
19601040|NCT02559440|Phenylephrine|phenylephrine|mesh-list
19601041|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
19601042|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601043|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
19601044|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19601045|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19601046|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19601047|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601048|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601049|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601050|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601051|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
19601052|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
19601053|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601054|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
19601055|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19601056|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
19601057|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19601058|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
19601059|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19601060|NCT02559440|Protective Agents|protective agents|mesh-ancestor
19601061|NCT02559388|Montelukast|montelukast|mesh-list
19601062|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19601063|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
19601064|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19601065|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
19601066|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601067|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601068|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19601069|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19601070|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601071|NCT02559297|Sevoflurane|sevoflurane|mesh-list
19601072|NCT02559297|Desflurane|desflurane|mesh-list
19601073|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19601074|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19601075|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
19601076|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
19601077|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601078|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601079|NCT02559232|Anticoagulants|anticoagulants|mesh-list
19601080|NCT02559154|Thalidomide|thalidomide|mesh-list
19601081|NCT02559154|Dexamethasone|dexamethasone|mesh-list
19601082|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
19601083|NCT02559154|Doxorubicin|doxorubicin|mesh-list
19601084|NCT02559154|Bortezomib|bortezomib|mesh-list
19601085|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601086|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
19601087|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601088|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19601089|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19601090|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
19601091|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601092|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601093|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19601094|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601095|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
19601096|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
19601097|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601098|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601099|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
19601100|NCT02559154|Hormones|hormones|mesh-ancestor
19601101|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601102|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19601103|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19601104|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19601105|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19601106|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601107|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
19601108|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601109|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601110|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19601111|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601112|NCT02559154|Growth Substances|growth substances|mesh-ancestor
19601113|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601114|NCT02559167|Cannabidiol|cannabidiol|mesh-list
19601115|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
19601116|NCT02559180|Aflibercept|aflibercept|mesh-list
19601117|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19601118|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601119|NCT02559180|Growth Substances|growth substances|mesh-ancestor
19601120|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601121|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601122|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601123|NCT02559141|Dobutamine|dobutamine|mesh-list
19601124|NCT02559141|Norepinephrine|norepinephrine|mesh-list
19601125|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19601126|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19601127|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601128|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601129|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601130|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601131|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
19601132|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
19601133|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601134|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19601135|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19601136|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19601137|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19601138|NCT02559141|Protective Agents|protective agents|mesh-ancestor
19601139|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
19601140|NCT02559102|Anesthetics|anesthetics|mesh-list
19601141|NCT02559102|Sevoflurane|sevoflurane|mesh-list
19601142|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601143|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601144|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19601145|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19601146|NCT02559102|Analgesics|analgesics|mesh-ancestor
19601147|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
19601148|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601149|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19601150|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19601151|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19601152|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601153|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601154|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601155|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19601156|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19601157|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
19601158|NCT02558972|Droxidopa|droxidopa|mesh-list
19601159|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19601160|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19601161|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19601162|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
19601163|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601164|NCT02558933|Protective Agents|protective agents|mesh-ancestor
19601165|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601166|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19601167|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19601168|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601169|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19601170|NCT02558959|Capecitabine|capecitabine|mesh-list
19601171|NCT02558959|Irinotecan|irinotecan|mesh-list
19601172|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19601173|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
19601174|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601175|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601176|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19601177|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19601178|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601179|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
19601180|NCT02558868|Irinotecan|irinotecan|mesh-list
19601181|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601182|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19601183|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19601184|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601185|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601186|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
19601187|NCT02558816|Venetoclax|venetoclax|mesh-list
19601188|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19601189|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601190|NCT02558751|Vaccines|vaccines|mesh-list
20128639|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128640|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
20128641|NCT00023751|Leucovorin|leucovorin|mesh-list
19601191|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19601192|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
20128642|NCT00023751|Fluorouracil|fluorouracil|mesh-list
20128643|NCT00023751|Calcium|calcium|mesh-list
20128644|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
20128645|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20128646|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128647|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
20128648|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128649|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128650|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128651|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128652|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
20128653|NCT00023751|Antidotes|antidotes|mesh-ancestor
20128654|NCT00023751|Protective Agents|protective agents|mesh-ancestor
20128655|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
20128656|NCT00023751|Vitamins|vitamins|mesh-ancestor
20128657|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
20128658|NCT00023777|Cytarabine|cytarabine|mesh-list
20128659|NCT00023777|Daunorubicin|daunorubicin|mesh-list
20128660|NCT00023777|Sargramostim|sargramostim|mesh-list
20128661|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128662|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
20128663|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601193|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128664|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608265|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19601194|NCT02558595|Niacinamide|niacinamide|mesh-list
19601195|NCT02558595|Niacin|niacin|mesh-list
20128665|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
20128666|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128667|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601196|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
19601197|NCT02558595|Vitamins|vitamins|mesh-ancestor
20128668|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
20128669|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128670|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20310925|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20310926|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
20310927|NCT00676377|Neostigmine|neostigmine|mesh-list
20310928|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20310929|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310930|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310931|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
20310932|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310933|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310934|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20310935|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
20310936|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20310937|NCT00676416|Propofol|propofol|mesh-list
20310938|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20310939|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310940|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310941|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20310942|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
20310943|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
20310944|NCT00676429|Ziprasidone|ziprasidone|mesh-list
19601198|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
19601199|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601200|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
19601201|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20128671|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20310945|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19601202|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
19601203|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601204|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19601205|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
19658366|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658367|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128672|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128673|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128674|NCT00023790|Silicon|silicon|mesh-list
20128675|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
20128676|NCT00023790|Trace Elements|trace elements|mesh-ancestor
20128677|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
20128678|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658375|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
19658376|NCT02998567|Guadecitabine|guadecitabine|mesh-list
19658377|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658378|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128679|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
20128680|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20128681|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19658379|NCT02985619|Triamcinolone|triamcinolone|mesh-list
19658380|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19658381|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19658382|NCT02985619|Bevacizumab|bevacizumab|mesh-list
19658383|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19658384|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658385|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658386|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19658387|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19658388|NCT02985619|Growth Substances|growth substances|mesh-ancestor
19658389|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658390|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
19658391|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19658392|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
19658393|NCT02985619|Hormones|hormones|mesh-ancestor
19658394|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19658395|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20310946|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
20310947|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19658396|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
20128682|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128683|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
20347194|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19601206|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
19601207|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
19601208|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
19601209|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601210|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601211|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
19601212|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601213|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
19601214|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19601215|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
19601216|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19601217|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
19601218|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601219|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601220|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
19601221|NCT02558517|Prednisone|prednisone|mesh-list
19601222|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601223|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
19601224|NCT02558517|Hormones|hormones|mesh-ancestor
19601225|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601226|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601227|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20128684|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20128685|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
20128686|NCT00023816|Carbendazim|carbendazim|mesh-list
20128687|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
20128688|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
20128689|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19601228|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601229|NCT02558452|Tacrolimus|tacrolimus|mesh-list
19601230|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601231|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
19601232|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601233|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19601234|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310948|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310949|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310950|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20310951|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20310952|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20310953|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20310954|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19601235|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601236|NCT02558387|Nintedanib|nintedanib|mesh-list
19601237|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601238|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19601239|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601240|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601241|NCT02558205|Liver Extracts|liver extracts|mesh-list
19601242|NCT02558205|Hematinics|hematinics|mesh-ancestor
19601243|NCT02558283|Lidocaine|lidocaine|mesh-list
19601244|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
19601245|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
19601246|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601247|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601248|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
19601249|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601250|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19601251|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19601252|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19601253|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20128690|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128691|NCT00023829|Bicalutamide|bicalutamide|mesh-list
20128692|NCT00023829|Flutamide|flutamide|mesh-list
20128693|NCT00023829|Hormones|hormones|mesh-list
20128694|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20128695|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128696|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
20128697|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
20128698|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128699|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20128700|NCT00023842|Mitomycins|mitomycins|mesh-list
20128701|NCT00023842|Mitomycin|mitomycin|mesh-list
20128702|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
20128703|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20310955|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
20128704|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128705|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
20128706|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601254|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601255|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
19601256|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19601257|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601258|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19601259|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601260|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19601261|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601262|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601263|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601264|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
19601265|NCT02558218|Hormones|hormones|mesh-ancestor
19601266|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601267|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601268|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19601269|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19601270|NCT02558361|Apremilast|apremilast|mesh-list
20128707|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128708|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128709|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20128710|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
20128711|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128712|NCT00023855|Doxorubicin|doxorubicin|mesh-list
20128713|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20128714|NCT00023855|Bortezomib|bortezomib|mesh-list
19658397|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128715|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128716|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128717|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128718|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128719|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128720|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128721|NCT00023868|Leucovorin|leucovorin|mesh-list
20128722|NCT00023868|Doxorubicin|doxorubicin|mesh-list
20128723|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20128724|NCT00023868|Fluorouracil|fluorouracil|mesh-list
20128725|NCT00023868|Irinotecan|irinotecan|mesh-list
20128726|NCT00023868|Mitomycins|mitomycins|mesh-list
20128727|NCT00023868|Mitomycin|mitomycin|mesh-list
20128728|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
20128729|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128730|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128731|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128732|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310956|NCT00676468|Montelukast|montelukast|mesh-list
20310957|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20128733|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128734|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128735|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128736|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
20128737|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128738|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128739|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
20128740|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20128741|NCT00023868|Antidotes|antidotes|mesh-ancestor
20128742|NCT00023868|Protective Agents|protective agents|mesh-ancestor
20128743|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
20128744|NCT00023868|Vitamins|vitamins|mesh-ancestor
20128745|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
20128746|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
20128747|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128748|NCT00023881|Bortezomib|bortezomib|mesh-list
20128749|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128750|NCT00023894|Alvocidib|alvocidib|mesh-list
20128751|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128752|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
20128753|NCT00023894|Growth Substances|growth substances|mesh-ancestor
20128754|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128755|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128756|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348576|NCT00864799|Misoprostol|misoprostol|mesh-list
20173475|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
20310958|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
20310959|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20310960|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
20310961|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20310962|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128757|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128758|NCT00023907|Paclitaxel|paclitaxel|mesh-list
20128759|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128760|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128761|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128762|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128763|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128764|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128765|NCT00023920|Cytarabine|cytarabine|mesh-list
19601271|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19601272|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19601273|NCT02558361|Analgesics|analgesics|mesh-ancestor
19601274|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
19601275|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20128766|NCT00023920|Bevacizumab|bevacizumab|mesh-list
20128767|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20128768|NCT00023920|Idarubicin|idarubicin|mesh-list
20128769|NCT00023920|Antibodies|antibodies|mesh-list
20128770|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
20128771|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20128772|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128773|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20128774|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20128775|NCT00023920|Growth Substances|growth substances|mesh-ancestor
20128776|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601276|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601277|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601278|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19601279|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19601280|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19601281|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601282|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601283|NCT02558153|Paclitaxel|paclitaxel|mesh-list
19601284|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19601285|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601286|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
19601287|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
19601288|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
19601289|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601290|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19601291|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19601292|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
19601293|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601294|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601295|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19601296|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
19601297|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19601298|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19601299|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19601300|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601301|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601302|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601303|NCT02558114|Ribavirin|ribavirin|mesh-list
19601304|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
19601305|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601306|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
19601307|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601308|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
19601309|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
19601310|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
19601311|NCT02558023|Nicardipine|nicardipine|mesh-list
19601312|NCT02558023|Urapidil|urapidil|mesh-list
19601313|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19601314|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19601315|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20608266|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20128777|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
20128778|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
20128779|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128780|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
20128781|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128782|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
20128783|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128784|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128785|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128786|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128787|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128788|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128789|NCT00023933|Antibodies|antibodies|mesh-list
20128790|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20128791|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
19601316|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601317|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19601318|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601319|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
19601320|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19601321|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
19601322|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601323|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19601324|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19601325|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20128792|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128793|NCT00023946|Epothilones|epothilones|mesh-list
20128794|NCT00023946|Epothilone B|epothilone b|mesh-list
20128795|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
19601326|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601327|NCT02557932|Bismuth|bismuth|mesh-list
19601328|NCT02557932|Antacids|antacids|mesh-ancestor
19601329|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601330|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601331|NCT02557984|Naltrexone|naltrexone|mesh-list
19601332|NCT02557984|Amisulpride|amisulpride|mesh-list
19601333|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19601334|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19601335|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601336|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
19601337|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601338|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19601339|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19601340|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601341|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19601342|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19601343|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
19601344|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601345|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601346|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19601347|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
19601348|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
19601349|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19601350|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19601351|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19601352|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19601353|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601354|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
19601355|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601356|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601357|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19601358|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601359|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
19601360|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19601361|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601362|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601363|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19601364|NCT02557867|Analgesics|analgesics|mesh-ancestor
19601365|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
19601366|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601367|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20128796|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128797|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
20608267|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
19601368|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19601369|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19601370|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601371|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601372|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601373|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
19601374|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19601375|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19601376|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19601377|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19601378|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601379|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
19601380|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601381|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601382|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19601383|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601384|NCT02557789|Lefamulin|lefamulin|mesh-list
19601385|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601386|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601387|NCT02557581|Terbutaline|terbutaline|mesh-list
19601388|NCT02557581|Clenbuterol|clenbuterol|mesh-list
19601389|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19601390|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
19601391|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601392|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601393|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19601394|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
19601395|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
20310963|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20310964|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20310965|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310966|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
20310967|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20310968|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20310969|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20310970|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20310971|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20310972|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310973|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310974|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20310975|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20310976|NCT00676559|Ranibizumab|ranibizumab|mesh-list
20310977|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20310978|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20310979|NCT00676559|Growth Substances|growth substances|mesh-ancestor
20310980|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601396|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
19601397|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19601398|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19601399|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19601400|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19601401|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601402|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601403|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601404|NCT02557958|Azithromycin|azithromycin|mesh-list
19601405|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601406|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601407|NCT02557854|Doxorubicin|doxorubicin|mesh-list
19601408|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19601409|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19601410|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601411|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20310981|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
20310982|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20310983|NCT00676637|Timolol|timolol|mesh-list
20310984|NCT00676637|Travoprost|travoprost|mesh-list
20310985|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20310986|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20310987|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19601412|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19601413|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601414|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310988|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19601415|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19601416|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601417|NCT02557451|Growth Substances|growth substances|mesh-ancestor
19601418|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601419|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601420|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601421|NCT02557594|Tenofovir|tenofovir|mesh-list
19601422|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
19601423|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128798|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128799|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128800|NCT00023959|Bevacizumab|bevacizumab|mesh-list
20128801|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20128802|NCT00023959|Fluorouracil|fluorouracil|mesh-list
20128803|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
19601424|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19601425|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19601426|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601427|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601428|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19601429|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19601430|NCT02557542|Polidocanol|polidocanol|mesh-list
19601431|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
19601432|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19601433|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19601434|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
19601435|NCT02557490|Raltitrexed|raltitrexed|mesh-list
19601436|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601437|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19601438|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
19601439|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601440|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19601441|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601442|NCT02557503|Fluorouracil|fluorouracil|mesh-list
19601443|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
19601444|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
19601445|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601446|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19601447|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601448|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601449|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
19601450|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601451|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
19601452|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
19601453|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
19601454|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601455|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601456|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
19601457|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601458|NCT02557373|Vitamins|vitamins|mesh-list
19601459|NCT02557373|Vitamin A|vitamin a|mesh-list
19601460|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
19601461|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
19601462|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601463|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
19601464|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601465|NCT02557373|Protective Agents|protective agents|mesh-ancestor
19601466|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19601467|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601468|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
19601469|NCT02557269|Azelastine|azelastine|mesh-list
19601470|NCT02557269|Prednisolone|prednisolone|mesh-list
19601471|NCT02557269|Xylometazoline|xylometazoline|mesh-list
19601472|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128804|NCT00023959|Antibodies|antibodies|mesh-list
20128805|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
20128806|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20128807|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128808|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20128809|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20128810|NCT00023959|Growth Substances|growth substances|mesh-ancestor
20128811|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128812|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
20128813|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
19601473|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
19601474|NCT02557269|Hormones|hormones|mesh-ancestor
20128814|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
19601475|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601476|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601477|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19601478|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601479|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
19601480|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601481|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
19601482|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19601483|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19601484|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19601485|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
19601486|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19601487|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601488|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601489|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19601490|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19601491|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
19601492|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
19601493|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601494|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
19601495|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19601496|NCT02557087|Meperidine|meperidine|mesh-list
19601497|NCT02557087|Scopolamine|scopolamine|mesh-list
19601498|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19601499|NCT02557087|Narcotics|narcotics|mesh-ancestor
19601500|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601501|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601502|NCT02557087|Analgesics|analgesics|mesh-ancestor
19601503|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
19601504|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601505|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19601506|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
19601507|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
19601508|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601509|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
19601510|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19601511|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
19601512|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601513|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601514|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19601515|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
19601516|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
19601517|NCT02556931|Fludarabine|fludarabine|mesh-list
19601518|NCT02556931|Tacrolimus|tacrolimus|mesh-list
19601519|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601520|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
19601521|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601522|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19601523|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19601524|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
19601525|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601526|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601527|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19601528|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19601529|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601530|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19601531|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19601532|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
19601533|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601534|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19658398|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128815|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128816|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128817|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128818|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
20128819|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128820|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128821|NCT00023972|Gemcitabine|gemcitabine|mesh-list
20128822|NCT00023972|Exatecan|exatecan|mesh-list
20128823|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128824|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
20128825|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128826|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128827|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
19601535|NCT02556905|Dexamethasone|dexamethasone|mesh-list
19601536|NCT02556905|Lenalidomide|lenalidomide|mesh-list
19601537|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601538|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
20128828|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128829|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128830|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128831|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
20128832|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128833|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20128834|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128835|NCT00023998|Leucovorin|leucovorin|mesh-list
20128836|NCT00023998|Doxorubicin|doxorubicin|mesh-list
20128837|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20128838|NCT00023998|Methotrexate|methotrexate|mesh-list
20128839|NCT00023998|Trastuzumab|trastuzumab|mesh-list
19601539|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
19601540|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601541|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601542|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601543|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
19601544|NCT02556905|Hormones|hormones|mesh-ancestor
19601545|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601546|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19601547|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601548|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
19601549|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19601550|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601551|NCT02556905|Growth Substances|growth substances|mesh-ancestor
19601552|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601553|NCT02556970|Acetaminophen|acetaminophen|mesh-list
19601554|NCT02556970|Diclofenac|diclofenac|mesh-list
19601555|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
19601556|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19601557|NCT02556970|Analgesics|analgesics|mesh-ancestor
19601558|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
19601559|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601560|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601561|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
19601562|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20128840|NCT00023998|Etoposide|etoposide|mesh-list
20128841|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
20128842|NCT00023998|Ifosfamide|ifosfamide|mesh-list
20128843|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
20128844|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128845|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128846|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128847|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128848|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128849|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128850|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128851|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20128852|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
20128853|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20128854|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128855|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
20128856|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
20128857|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20128858|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128859|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
20128860|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128861|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128862|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20128863|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20128864|NCT00023998|Antidotes|antidotes|mesh-ancestor
20128865|NCT00023998|Protective Agents|protective agents|mesh-ancestor
20128866|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
20128867|NCT00023998|Vitamins|vitamins|mesh-ancestor
20128868|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
20128869|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128870|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
20128871|NCT00024011|Bortezomib|bortezomib|mesh-list
20128872|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128873|NCT00024050|Cyclosporine|cyclosporine|mesh-list
19601563|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20128874|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
20128875|NCT00024050|Busulfan|busulfan|mesh-list
20128876|NCT00024050|Methotrexate|methotrexate|mesh-list
20128877|NCT00024050|Cyclosporins|cyclosporins|mesh-list
20310989|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
20310990|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20310991|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20310992|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20310993|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19601564|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19601565|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19601566|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601567|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601568|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
20310994|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20310995|NCT00676702|Vitamin K|vitamin k|mesh-list
20310996|NCT00676702|Pancrelipase|pancrelipase|mesh-list
20310997|NCT00676702|Pancreatin|pancreatin|mesh-list
20310998|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20310999|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20311000|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20311001|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311002|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
20311003|NCT00676702|Coagulants|coagulants|mesh-ancestor
20311004|NCT00676702|Vitamins|vitamins|mesh-ancestor
20311005|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
20311006|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311007|NCT00676741|Insulin|insulin|mesh-list
20311008|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20311009|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
20311010|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
20311011|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20311012|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
19601569|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
19601570|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601571|NCT02556879|Liver Extracts|liver extracts|mesh-list
19601572|NCT02556879|Antibodies|antibodies|mesh-list
19601573|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
19601574|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601575|NCT02556879|Hematinics|hematinics|mesh-ancestor
19601576|NCT02556866|Prednisone|prednisone|mesh-list
19601577|NCT02556866|Rituximab|rituximab|mesh-list
19601578|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19601579|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601580|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
19601581|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601582|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19601583|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601584|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
19601585|NCT02556866|Hormones|hormones|mesh-ancestor
19601586|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601587|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19601588|NCT02556723|Aflibercept|aflibercept|mesh-list
19601589|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19601590|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601591|NCT02556723|Growth Substances|growth substances|mesh-ancestor
19601592|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601593|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601594|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601595|NCT02556658|Anesthetics|anesthetics|mesh-list
19601596|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601597|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128878|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128879|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
20128880|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128881|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128882|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128883|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
20128884|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128885|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128886|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20128887|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20128888|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
20311013|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
20311014|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19601598|NCT02556814|Dexamethasone|dexamethasone|mesh-list
19601599|NCT02556814|Caffeic acid|caffeic acid|mesh-list
19601600|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601601|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
19601602|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
19601603|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601604|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601605|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601606|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
19601607|NCT02556814|Hormones|hormones|mesh-ancestor
19601608|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601609|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19601610|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601611|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
19601612|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601613|NCT02556814|Protective Agents|protective agents|mesh-ancestor
19601614|NCT02556840|Insulin|insulin|mesh-list
19601615|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19601616|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601617|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19601618|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601619|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19601620|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601621|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601622|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
19601623|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19601624|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19601625|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
19601626|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19601627|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601628|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19601629|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19601630|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19601631|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19601632|NCT02556411|Estrogens|estrogens|mesh-ancestor
19601633|NCT02556411|Hormones|hormones|mesh-ancestor
19601634|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311015|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20311016|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311017|NCT00676819|Insulin|insulin|mesh-list
20311018|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20311019|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
20311020|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20311021|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311022|NCT00676845|Olmesartan|olmesartan|mesh-list
20311023|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20311024|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20311025|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20311026|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20311027|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311028|NCT00676871|Blinatumomab|blinatumomab|mesh-list
19601635|NCT02556463|Durvalumab|durvalumab|mesh-list
19601636|NCT02556463|MEDI9197|medi9197|mesh-list
19601637|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19601638|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601639|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19601640|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
19601641|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601642|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
19601643|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19601644|NCT02556437|Antibodies|antibodies|mesh-list
19601645|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
19601646|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601647|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
19601648|NCT02556424|Dexamethasone|dexamethasone|mesh-list
19601649|NCT02556424|Triamcinolone|triamcinolone|mesh-list
19601650|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601651|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
19601652|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
19601653|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601654|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601655|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601656|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
19601657|NCT02556424|Hormones|hormones|mesh-ancestor
19601658|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19601659|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19601660|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601661|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19601662|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19601663|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19601664|NCT02556268|Triumeq|triumeq|mesh-list
19601665|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
19601666|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19601667|NCT02556268|Riociguat|riociguat|mesh-list
19601668|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
19601669|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
19601670|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601671|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
20311029|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311030|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
20311031|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20311032|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20311033|NCT00676936|Prednisolone|prednisolone|mesh-list
19601672|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601673|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19601674|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19601675|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601676|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19601677|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19601678|NCT02556229|Aflibercept|aflibercept|mesh-list
19601679|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20128889|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19601680|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601681|NCT02556229|Growth Substances|growth substances|mesh-ancestor
19601682|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128890|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128891|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
20128892|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
20128893|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128894|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20128895|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20128896|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
20128897|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128898|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20311034|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
19601683|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601684|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601685|NCT02556008|Cannabidiol|cannabidiol|mesh-list
19601686|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
19601687|NCT02556060|Lamotrigine|lamotrigine|mesh-list
19601688|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
19601689|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19601690|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19601691|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601692|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19601693|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601694|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19601695|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19601696|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601697|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19601698|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19601699|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
19601700|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
19601701|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601702|NCT02555943|Ritonavir|ritonavir|mesh-list
19601703|NCT02555943|Tenofovir|tenofovir|mesh-list
19601704|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
19601705|NCT02555943|Entecavir|entecavir|mesh-list
19601706|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19601707|NCT02555943|Ledipasvir|ledipasvir|mesh-list
19601708|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19601709|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19601710|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
19601711|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601712|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601713|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19601714|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19601715|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
19601716|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311035|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19601717|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20128899|NCT00024063|Orantinib|orantinib|mesh-list
20311036|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
20311037|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20311038|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
20311039|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
20311040|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311041|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601718|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19601719|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19601720|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19601721|NCT02555813|Gemcitabine|gemcitabine|mesh-list
19601722|NCT02555813|Paclitaxel|paclitaxel|mesh-list
19601723|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19601724|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19601725|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601726|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
19601727|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
19601728|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
19601729|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601730|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19601731|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
19601732|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
19601733|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601734|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601735|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601736|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
19601737|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311042|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20311043|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
20311044|NCT00676936|Hormones|hormones|mesh-ancestor
20311045|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311046|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19601738|NCT02555800|Cidofovir|cidofovir|mesh-list
20128900|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128901|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128902|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128903|NCT00024089|Gefitinib|gefitinib|mesh-list
20128904|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128905|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128906|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128907|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128908|NCT00024115|Antibodies|antibodies|mesh-list
20128909|NCT00024115|Immunotoxins|immunotoxins|mesh-list
20128910|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
20128911|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128912|NCT00024128|Cyclosporine|cyclosporine|mesh-list
20128913|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
19601739|NCT02555800|Bevacizumab|bevacizumab|mesh-list
19601740|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19601741|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601742|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19601743|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601744|NCT02555800|Growth Substances|growth substances|mesh-ancestor
19601745|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601746|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601747|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
19601748|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601749|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601750|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601751|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19601752|NCT02555852|Esomeprazole|esomeprazole|mesh-list
19601753|NCT02555852|Omeprazole|omeprazole|mesh-list
19601754|NCT02555852|Rabeprazole|rabeprazole|mesh-list
19601755|NCT02555852|Pantoprazole|pantoprazole|mesh-list
19601756|NCT02555852|Lansoprazole|lansoprazole|mesh-list
19601757|NCT02555852|Famotidine|famotidine|mesh-list
19601758|NCT02555852|Ranitidine|ranitidine|mesh-list
19601759|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19601760|NCT02555852|Cimetidine|cimetidine|mesh-list
20128914|NCT00024128|Cyclosporins|cyclosporins|mesh-list
20128915|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20128916|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311047|NCT00676936|Protective Agents|protective agents|mesh-ancestor
19601761|NCT02555852|Nizatidine|nizatidine|mesh-list
19601762|NCT02555852|Lafutidine|lafutidine|mesh-list
19601763|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
19601764|NCT02555852|Bismuth|bismuth|mesh-list
19601765|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19601766|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
19601767|NCT02555852|Histamine|histamine|mesh-list
19601768|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
19601769|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601770|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19601771|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19601772|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601773|NCT02555852|Antacids|antacids|mesh-ancestor
19601774|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
19601775|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
19601776|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601777|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601778|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
19601779|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19601780|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19601781|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601782|NCT02555696|Paclitaxel|paclitaxel|mesh-list
19601783|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19601784|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601785|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
19601786|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
19601787|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
19601788|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601789|NCT02555644|Cetuximab|cetuximab|mesh-list
19601790|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601791|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19601792|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19601793|NCT02555761|Alcaftadine|alcaftadine|mesh-list
19601794|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19601795|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19601796|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
19601797|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
19601798|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601799|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601800|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601801|NCT02555748|Sunitinib|sunitinib|mesh-list
19601802|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601803|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19601804|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19601805|NCT02555748|Growth Substances|growth substances|mesh-ancestor
19601806|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601807|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
19601808|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19601809|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601810|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601811|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
19601812|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19601813|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601814|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601815|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20311048|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20311049|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311050|NCT00677001|R 306465|r 306465|mesh-list
20311051|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20311052|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311053|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311054|NCT00677027|Lentinan|lentinan|mesh-list
20311055|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20311056|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
19601816|NCT02555605|Analgesics|analgesics|mesh-ancestor
19601817|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
20128917|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
20128918|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128919|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128920|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128921|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
20128922|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128923|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128924|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20128925|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311057|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128926|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
20311058|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311059|NCT00677118|Cisplatin|cisplatin|mesh-list
20311060|NCT00677118|Fluorouracil|fluorouracil|mesh-list
20311061|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311062|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
20311063|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128927|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20128928|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
20128929|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20128930|NCT00024141|Fluorouracil|fluorouracil|mesh-list
20128931|NCT00024141|Irinotecan|irinotecan|mesh-list
20128932|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
20128933|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128934|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20128935|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128936|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601818|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601819|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19601820|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19601821|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19601822|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
19601823|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601824|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601825|NCT02555488|Methylene Blue|methylene blue|mesh-list
19601826|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601827|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601828|NCT02555358|Docetaxel|docetaxel|mesh-list
19601829|NCT02555358|Capecitabine|capecitabine|mesh-list
20311064|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311065|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311066|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
20311067|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311068|NCT00677144|Capecitabine|capecitabine|mesh-list
20311069|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
20311070|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311071|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
20311072|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311073|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311074|NCT00677170|Pevonedistat|pevonedistat|mesh-list
20311075|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311076|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311077|NCT00677248|Ezetimibe|ezetimibe|mesh-list
20311078|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311079|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311080|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
20311081|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311082|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311083|NCT00677261|Anesthetics|anesthetics|mesh-list
20311084|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
20311085|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601830|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
19601831|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601832|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19601833|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19601834|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19601835|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601836|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19601837|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
19601838|NCT02555423|Anesthetics|anesthetics|mesh-list
19601839|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
19601840|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
19601841|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601842|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601843|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
19601844|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601845|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
19601846|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601847|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601848|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19601849|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19601850|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311086|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311087|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
20128937|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
19601851|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601852|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601853|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19601854|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20128938|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128939|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20128940|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128941|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128942|NCT00024154|Trastuzumab|trastuzumab|mesh-list
20128943|NCT00024154|Gefitinib|gefitinib|mesh-list
20128944|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20128945|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128946|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128947|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128948|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128949|NCT00024180|Romidepsin|romidepsin|mesh-list
19658415|NCT02960022|Prednisone|prednisone|mesh-list
19658416|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
19658417|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19658418|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
19658419|NCT02960022|Hormones|hormones|mesh-ancestor
19658420|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19658421|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658422|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19658423|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658424|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19658425|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658426|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658427|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
19658428|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20128950|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128951|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128952|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
20128953|NCT00024193|Melphalan|melphalan|mesh-list
20128954|NCT00024193|Busulfan|busulfan|mesh-list
19658434|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
19658435|NCT02912559|Leucovorin|leucovorin|mesh-list
19658436|NCT02912559|Folic Acid|folic acid|mesh-list
19658437|NCT02912559|Fluorouracil|fluorouracil|mesh-list
19658438|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
19658439|NCT02912559|Atezolizumab|atezolizumab|mesh-list
19658440|NCT02912559|Calcium|calcium|mesh-list
19658441|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19658442|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
19658443|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19658444|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658445|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19658446|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
19658447|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658448|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19658449|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658450|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19658451|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
19658452|NCT02912559|Antidotes|antidotes|mesh-ancestor
19658453|NCT02912559|Protective Agents|protective agents|mesh-ancestor
19658454|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
19658455|NCT02912559|Vitamins|vitamins|mesh-ancestor
19658456|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
19658457|NCT02912559|Hematinics|hematinics|mesh-ancestor
20128955|NCT00024193|Doxorubicin|doxorubicin|mesh-list
20128956|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20128957|NCT00024193|Etoposide|etoposide|mesh-list
20128958|NCT00024193|Vincristine|vincristine|mesh-list
20128959|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20128960|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
20128961|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128962|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128963|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20128964|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
20128965|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128966|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128967|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20128968|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20128969|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20128970|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20128971|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128972|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19601855|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
19601856|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19601857|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
19601858|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19601859|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
19601860|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601861|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601862|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
19601863|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19601864|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19601865|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601866|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19601867|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19601868|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19601869|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601870|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
19601871|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601872|NCT02555046|Anesthetics|anesthetics|mesh-list
19601873|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601874|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601875|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
19601876|NCT02554942|Hematinics|hematinics|mesh-ancestor
19601877|NCT02555007|Vinorelbine|vinorelbine|mesh-list
19601878|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19601879|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601880|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
19601881|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
19601882|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
19601883|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601884|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
19601885|NCT02554955|Daclizumab|daclizumab|mesh-list
19601886|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19601887|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601888|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19601889|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
19601890|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601891|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601892|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601893|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601894|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19601895|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
19601896|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601897|NCT02554864|Lidocaine|lidocaine|mesh-list
19601898|NCT02554864|Ropivacaine|ropivacaine|mesh-list
19601899|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
19601900|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
19601901|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601902|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601903|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
19601904|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601905|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19601906|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19601907|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19601908|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19601909|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601910|NCT02554851|Mitogens|mitogens|mesh-list
19601911|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128973|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
20128974|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
20128975|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
20128976|NCT00024206|Orantinib|orantinib|mesh-list
20128977|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20128978|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20128979|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20128980|NCT00024232|Antibodies|antibodies|mesh-list
20128981|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20128982|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
20128983|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20128984|NCT00024245|Probenecid|probenecid|mesh-list
20128985|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
20128986|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
20128987|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20128988|NCT00024245|Renal Agents|renal agents|mesh-ancestor
20128989|NCT00024271|Gemcitabine|gemcitabine|mesh-list
20128990|NCT00024271|Interferons|interferons|mesh-list
20311088|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311089|NCT00677300|Ritonavir|ritonavir|mesh-list
19601912|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601913|NCT02554812|Avelumab|avelumab|mesh-list
19601914|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19601915|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601916|NCT02554734|Levodopa|levodopa|mesh-list
19601917|NCT02554734|Carbidopa|carbidopa|mesh-list
19601918|NCT02554734|Entacapone|entacapone|mesh-list
19601919|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19601920|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19601921|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
19601922|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19601923|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601924|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601925|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19601926|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601927|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19601928|NCT02554695|Denosumab|denosumab|mesh-list
19601929|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20128991|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
20128992|NCT00024271|Doxorubicin|doxorubicin|mesh-list
20128993|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20128994|NCT00024271|Mitomycins|mitomycins|mesh-list
20128995|NCT00024271|Mitomycin|mitomycin|mesh-list
20128996|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20128997|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19601930|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601931|NCT02554318|Rifampin|rifampin|mesh-list
19601932|NCT02554318|Isoniazid|isoniazid|mesh-list
19601933|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
19601934|NCT02554318|Ethambutol|ethambutol|mesh-list
19601935|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19601936|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
19601937|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19601938|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19601939|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
19601940|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19601941|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601942|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601943|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19601944|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19601945|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19601946|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19601947|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19601948|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20128998|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
20128999|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129000|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
20129001|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129002|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129003|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129004|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
20129005|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129006|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129007|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129008|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129009|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
20129010|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129011|NCT00024284|Carboplatin|carboplatin|mesh-list
20129012|NCT00024284|Irinotecan|irinotecan|mesh-list
20311090|NCT00677300|Darunavir|darunavir|mesh-list
20129013|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311091|NCT00677300|Tenofovir|tenofovir|mesh-list
20311092|NCT00677300|Emtricitabine|emtricitabine|mesh-list
20311093|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
20311094|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20311095|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20311096|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
20311097|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311098|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311099|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20311100|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19601949|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19601950|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19601951|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
19601952|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19601953|NCT02554357|Bupivacaine|bupivacaine|mesh-list
19601954|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
19601955|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
19601956|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601957|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601958|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
19601959|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601960|NCT02554175|Propofol|propofol|mesh-list
19601961|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19601962|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19601963|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601964|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19601965|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
19601966|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
19601967|NCT02554344|Curcumin|curcumin|mesh-list
19601968|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19601969|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19601970|NCT02554344|Analgesics|analgesics|mesh-ancestor
19601971|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
19601972|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19601973|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601974|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19601975|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19601976|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19601977|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601978|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601979|NCT02554123|Vitamin E|vitamin e|mesh-list
19601980|NCT02554123|Petrolatum|petrolatum|mesh-list
19601981|NCT02554123|Vitamins|vitamins|mesh-ancestor
19601982|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
19601983|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19601984|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
19601985|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601986|NCT02554123|Protective Agents|protective agents|mesh-ancestor
19601987|NCT02554123|Emollients|emollients|mesh-ancestor
19601988|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
19601989|NCT02554045|Tadalafil|tadalafil|mesh-list
19601990|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
19601991|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19601992|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19601993|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19601994|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19601995|NCT02554045|Urological Agents|urological agents|mesh-ancestor
19601996|NCT02553824|Topiramate|topiramate|mesh-list
19601997|NCT02553824|Phentermine|phentermine|mesh-list
19601998|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
19601999|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19602000|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602001|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19602002|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
19602003|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19602004|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
19602005|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
19602006|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311101|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
19602007|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602008|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311102|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602009|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602010|NCT02553551|Vitamins|vitamins|mesh-list
19602011|NCT02553551|Ascorbic Acid|ascorbic acid|mesh-list
20311103|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20311104|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311105|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20311106|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20311107|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20311108|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20311109|NCT00677339|Vitamin D|vitamin d|mesh-list
20311110|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
20311111|NCT00677339|Vitamins|vitamins|mesh-list
20311112|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
20311113|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311114|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20311115|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602012|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
19602013|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602014|NCT02553551|Antioxidants|antioxidants|mesh-ancestor
19602015|NCT02553551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602016|NCT02553551|Protective Agents|protective agents|mesh-ancestor
19602017|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
19602018|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19602019|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602020|NCT02553603|Hormones|hormones|mesh-list
19602021|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19602022|NCT02553603|Tesamorelin|tesamorelin|mesh-list
19602023|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602024|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602025|NCT02553603|Growth Substances|growth substances|mesh-ancestor
19602026|NCT02553226|Oxytocin|oxytocin|mesh-list
19602027|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
19602028|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19602029|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129014|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20129015|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129016|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129017|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129018|NCT00024297|Warfarin|warfarin|mesh-list
20129019|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
20129020|NCT00024310|Folic Acid|folic acid|mesh-list
20129021|NCT00024310|Paclitaxel|paclitaxel|mesh-list
20129022|NCT00024310|Lometrexol|lometrexol|mesh-list
20129023|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129024|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129025|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129026|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129027|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129028|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129029|NCT00024310|Hematinics|hematinics|mesh-ancestor
20129030|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
20129031|NCT00024310|Vitamins|vitamins|mesh-ancestor
20129032|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
20129033|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129034|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129035|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
20129036|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19658491|NCT02879318|Gemcitabine|gemcitabine|mesh-list
19658492|NCT02879318|Paclitaxel|paclitaxel|mesh-list
19658493|NCT02879318|Durvalumab|durvalumab|mesh-list
19658494|NCT02879318|Tremelimumab|tremelimumab|mesh-list
19658495|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19658496|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658497|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
19658498|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
19658499|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
19658500|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658501|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19658502|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
19658503|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
20311116|NCT00677391|Sibutramine|sibutramine|mesh-list
19658504|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19658505|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658506|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129037|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129038|NCT00024323|Cisplatin|cisplatin|mesh-list
20129039|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602030|NCT02553083|Amoxicillin|amoxicillin|mesh-list
19602031|NCT02553083|Doxycycline|doxycycline|mesh-list
19602032|NCT02553083|Esomeprazole|esomeprazole|mesh-list
19602033|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19602034|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602035|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
19602036|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19602037|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19602038|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19602039|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602040|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19602041|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602042|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602043|NCT02553018|Methotrexate|methotrexate|mesh-list
19602044|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19602045|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
19602046|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19602047|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602048|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19602049|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
19602050|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602051|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602052|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
19602053|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602054|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19602055|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19602056|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
19602057|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602058|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19602059|NCT02552745|Parecoxib|parecoxib|mesh-list
19602060|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19602061|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19602062|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602063|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602064|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19602065|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602066|NCT02552745|Analgesics|analgesics|mesh-ancestor
19602067|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
19602068|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602069|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602070|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602071|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602072|NCT02553044|Vitamin D|vitamin d|mesh-list
19602073|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
19602074|NCT02553044|Vitamins|vitamins|mesh-ancestor
19602075|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
19602076|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602077|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19602078|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602079|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
19602080|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602081|NCT02552641|Amoxicillin|amoxicillin|mesh-list
19602082|NCT02552641|Clarithromycin|clarithromycin|mesh-list
19602083|NCT02552641|Esomeprazole|esomeprazole|mesh-list
19602084|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19602085|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602086|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19602087|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602088|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19602089|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602090|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602091|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19602092|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19602093|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19602094|NCT02552459|Sufentanil|sufentanil|mesh-list
19602095|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
19602096|NCT02552459|Dsuvia|dsuvia|mesh-list
19602097|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19602098|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602099|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602100|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602101|NCT02552459|Analgesics|analgesics|mesh-ancestor
20129040|NCT00024336|Tamoxifen|tamoxifen|mesh-list
19602102|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
19602103|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20129041|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19602104|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19602105|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19602106|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602107|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602108|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602109|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602110|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19602111|NCT02552459|Narcotics|narcotics|mesh-ancestor
19602112|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19602113|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19602114|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
19602115|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
19602116|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
19602117|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19602118|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19602119|NCT02552342|Prednisolone|prednisolone|mesh-list
19602120|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
19602121|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19602122|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
19602123|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602124|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
19602125|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
19602126|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602127|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602128|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602129|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
19602130|NCT02552342|Hormones|hormones|mesh-ancestor
19602131|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602132|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19602133|NCT02552342|Protective Agents|protective agents|mesh-ancestor
19602134|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19602135|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602136|NCT02552537|Mannitol|mannitol|mesh-list
19602137|NCT02552537|Omeprazole|omeprazole|mesh-list
19602138|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19602139|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602140|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19602141|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602142|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602143|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19602144|NCT02552537|Diuretics|diuretics|mesh-ancestor
19602145|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
19602146|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602147|NCT02552589|Fluorides|fluorides|mesh-list
19602148|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
19602149|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
19602150|NCT02552589|Protective Agents|protective agents|mesh-ancestor
19602151|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602152|NCT02551861|Ribavirin|ribavirin|mesh-list
19602153|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
19602154|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
19602155|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602156|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
19602157|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602158|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
19602159|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19602160|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19602161|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19602162|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19602163|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19602164|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602165|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
19602166|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602167|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602168|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19602169|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602170|NCT02551549|Rezafungin|rezafungin|mesh-list
19602171|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
19602172|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311117|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
20311118|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19602173|NCT02551523|Dolutegravir|dolutegravir|mesh-list
19602174|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19602175|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19602176|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19602177|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658507|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
19602178|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602179|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19602180|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
19602181|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602182|NCT02551536|Fexofenadine|fexofenadine|mesh-list
19602183|NCT02551536|Montelukast|montelukast|mesh-list
19602184|NCT02551536|Levocetirizine|levocetirizine|mesh-list
19602185|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19602186|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602187|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19602188|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
19602189|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602190|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602191|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19602192|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19602193|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602194|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19602195|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19602196|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19602197|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
19602198|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
19602199|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602200|NCT02551796|Levofloxacin|levofloxacin|mesh-list
19602201|NCT02551796|Ofloxacin|ofloxacin|mesh-list
19602202|NCT02551796|Tobramycin|tobramycin|mesh-list
19602203|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19602204|NCT02551796|Dexamethasone|dexamethasone|mesh-list
19602205|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
19602206|NCT02551796|BB 1101|bb 1101|mesh-list
19602207|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
19602208|NCT02551796|Dipivefrin|dipivefrin|mesh-list
19602209|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602210|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
19602211|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
19602212|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602213|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602214|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602215|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
19602216|NCT02551796|Hormones|hormones|mesh-ancestor
19602217|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602218|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19602219|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602220|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
19602221|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602222|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602223|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19602224|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602225|NCT02551796|Renal Agents|renal agents|mesh-ancestor
19602226|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19602227|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19602228|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19602229|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19602230|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19602231|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19602232|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
19602233|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
19602234|NCT02551796|Protective Agents|protective agents|mesh-ancestor
19602235|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602236|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602237|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602238|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19602239|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19602240|NCT02551276|Albuterol|albuterol|mesh-list
20129042|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
20129043|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20129044|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129045|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20129046|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129047|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20129048|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20129049|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20129050|NCT00024349|Fluorouracil|fluorouracil|mesh-list
20129051|NCT00024349|Mitomycins|mitomycins|mesh-list
19602241|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19602242|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
19602243|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602244|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602245|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19602246|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602247|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
20311119|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
20311120|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20311121|NCT00677443|Capecitabine|capecitabine|mesh-list
20311122|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
20311123|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311124|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
20311125|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311126|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311127|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
20311128|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311129|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311130|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
20311131|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311132|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311133|NCT00677521|Acarbose|acarbose|mesh-list
20311134|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20311135|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311136|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311137|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20311138|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311139|NCT00677586|Liver Extracts|liver extracts|mesh-list
20311140|NCT00677586|Hematinics|hematinics|mesh-ancestor
20311141|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
19602248|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19602249|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19602250|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19602251|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602252|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602253|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602254|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658508|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658509|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20129052|NCT00024349|Mitomycin|mitomycin|mesh-list
20129053|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
20129054|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129055|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129056|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129057|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129058|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
20129059|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129060|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129061|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
20129062|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129063|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129064|NCT00024362|BBR 3464|bbr 3464|mesh-list
20129065|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129066|NCT00024375|Paclitaxel|paclitaxel|mesh-list
20129067|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19658526|NCT02834013|Nivolumab|nivolumab|mesh-list
19658527|NCT02834013|Ipilimumab|ipilimumab|mesh-list
19658528|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658529|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658530|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19658531|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129068|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129069|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129070|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129071|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129072|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129073|NCT00024388|Paclitaxel|paclitaxel|mesh-list
20129074|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129075|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129076|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129077|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129078|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129079|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311142|NCT00677664|Mannitol|mannitol|mesh-list
20311143|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
20311144|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20311145|NCT00677664|Diuretics|diuretics|mesh-ancestor
20311146|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
20311147|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311148|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20311149|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
20311150|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311151|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20311152|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20311153|NCT00677729|Albuterol|albuterol|mesh-list
20311154|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20129080|NCT00024401|Paclitaxel|paclitaxel|mesh-list
20129081|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129082|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311155|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
20311156|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311157|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311158|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20311159|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
20311160|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
20311161|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20311162|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20129083|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129084|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129085|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129086|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129087|NCT00024414|Paclitaxel|paclitaxel|mesh-list
20129088|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129089|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129090|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129091|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129092|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
20311163|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20311164|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20311165|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
20311166|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311167|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311168|NCT00677755|Misoprostol|misoprostol|mesh-list
20311169|NCT00677755|Mifepristone|mifepristone|mesh-list
20311170|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20311171|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
20311172|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19602255|NCT02551367|Letrozole|letrozole|mesh-list
19602256|NCT02551367|Clomiphene|clomiphene|mesh-list
19602257|NCT02551367|Enclomiphene|enclomiphene|mesh-list
19602258|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
20311173|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311174|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20311175|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20311176|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
20311177|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19602259|NCT02551367|Hormones|hormones|mesh-list
19602260|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602261|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20129093|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129094|NCT00024427|Gemcitabine|gemcitabine|mesh-list
20129095|NCT00024427|Fluorouracil|fluorouracil|mesh-list
20129096|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129097|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
20129098|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129099|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129100|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
20129101|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129102|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602262|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602263|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602264|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19602265|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19602266|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602267|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20129103|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129104|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
20311178|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19602268|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
20129105|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602269|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19602270|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
19602271|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19602272|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20311179|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20311180|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20311181|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
20311182|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20311183|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20311184|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20311185|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311186|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
20311187|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19602273|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19602274|NCT02551042|Factor VIII|factor viii|mesh-list
19602275|NCT02551042|Coagulants|coagulants|mesh-ancestor
19602276|NCT02551029|Capsaicin|capsaicin|mesh-list
19602277|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
19602278|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
19602279|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
19602280|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602281|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602282|NCT02550977|Gestodene|gestodene|mesh-list
20129106|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
20129107|NCT00024440|Fludarabine|fludarabine|mesh-list
20129108|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
20129109|NCT00024440|Oblimersen|oblimersen|mesh-list
20129110|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129111|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
20129112|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129113|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129114|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129115|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
20129116|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129117|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129118|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129119|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129120|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
20129121|NCT00024453|Teicoplanin|teicoplanin|mesh-list
20129122|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20129123|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129124|NCT00024466|Vaccines|vaccines|mesh-list
20129125|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
19602283|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19602284|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19602285|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19602286|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
19602287|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19602288|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602289|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19602290|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19602291|NCT02550977|Progestins|progestins|mesh-ancestor
19602292|NCT02550977|Hormones|hormones|mesh-ancestor
20311188|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20347195|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347196|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
20347197|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347198|NCT00858429|Capecitabine|capecitabine|mesh-list
20347199|NCT00858429|Doxifluridine|doxifluridine|mesh-list
20347200|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20347201|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
20347202|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347203|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347204|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19602293|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602294|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
19602295|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19602296|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
19602297|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602298|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347205|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
19602299|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20129126|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129127|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
19602300|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602301|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19602302|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
19602303|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602304|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602305|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19602306|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
19602307|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
19602308|NCT02551107|Protective Agents|protective agents|mesh-ancestor
19602309|NCT02551133|Dexamethasone|dexamethasone|mesh-list
19602310|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602311|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
19602312|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
19602313|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311189|NCT00678106|Dalbavancin|dalbavancin|mesh-list
20311190|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20311191|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311192|NCT00678132|Gemcitabine|gemcitabine|mesh-list
20311193|NCT00678132|Olaparib|olaparib|mesh-list
20311194|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311195|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311196|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
20311197|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311198|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
20311199|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311200|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602314|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602315|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602316|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
19602317|NCT02551133|Hormones|hormones|mesh-ancestor
19602318|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602319|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20311201|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311202|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
20311203|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602320|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602321|NCT02550912|Vitamin D|vitamin d|mesh-list
19602322|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
19602323|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
19602324|NCT02550912|Vitamins|vitamins|mesh-list
19602325|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
19602326|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602327|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19602328|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602329|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
19602330|NCT02550782|Bupivacaine|bupivacaine|mesh-list
19602331|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
19602332|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
19602333|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602334|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602335|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
19602336|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602337|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19602338|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20129128|NCT00024492|Analgesics|analgesics|mesh-ancestor
20129129|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
20129130|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20129131|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129132|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129133|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129134|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129135|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129136|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129137|NCT00024518|Interferons|interferons|mesh-list
20129138|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
20129139|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129140|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
20129141|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129142|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
20129143|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129144|NCT00024531|Atorvastatin|atorvastatin|mesh-list
20129145|NCT00024531|Calcium|calcium|mesh-list
20311204|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19602339|NCT02550782|Analgesics|analgesics|mesh-ancestor
20129146|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20311205|NCT00678145|Epinephrine|epinephrine|mesh-list
19602340|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19602341|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19602342|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602343|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602344|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602345|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602346|NCT02550756|Capsaicin|capsaicin|mesh-list
19602347|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
19602348|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
19602349|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
19602350|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602351|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602352|NCT02550665|Donepezil|donepezil|mesh-list
19602353|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19602354|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602355|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602356|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
19602357|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602358|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602359|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
19602360|NCT02550483|Beta Carotene|beta carotene|mesh-list
19602361|NCT02550483|Lycopene|lycopene|mesh-list
19602362|NCT02550483|Carotenoids|carotenoids|mesh-list
19602363|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602364|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
19602365|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602366|NCT02550483|Protective Agents|protective agents|mesh-ancestor
19602367|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602368|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19602369|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19602370|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602371|NCT02550483|Provitamins|provitamins|mesh-ancestor
20129147|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129148|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20129149|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20129150|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
20129151|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129152|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20129153|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20129154|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129155|NCT00024544|Antibodies|antibodies|mesh-list
20129156|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20129157|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
20129158|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129159|NCT00024687|Immunotoxins|immunotoxins|mesh-list
20129160|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
20129161|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602372|NCT02550483|Vitamins|vitamins|mesh-ancestor
19602373|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
19602374|NCT02550717|Aspirin|aspirin|mesh-list
19602375|NCT02550717|Anticoagulants|anticoagulants|mesh-list
19602376|NCT02550717|Clopidogrel|clopidogrel|mesh-list
19602377|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19602378|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602379|NCT02550717|Analgesics|analgesics|mesh-ancestor
19602380|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
19602381|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602382|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311206|NCT00678145|Morphine|morphine|mesh-list
20311207|NCT00678145|Naloxone|naloxone|mesh-list
20311208|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311209|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20311210|NCT00678145|Narcotics|narcotics|mesh-ancestor
20311211|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20311212|NCT00678145|Analgesics|analgesics|mesh-ancestor
20311213|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
20311214|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311215|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20311216|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20311217|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
20311218|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311219|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311220|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20129162|NCT00024986|Tenofovir|tenofovir|mesh-list
20311221|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19602383|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602384|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129163|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
19602385|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19602386|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19602387|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602388|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19602389|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19602390|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602391|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
19602392|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19602393|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19602394|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19602395|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
19602396|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602397|NCT02550444|Clonidine|clonidine|mesh-list
19602398|NCT02550444|Analgesics|analgesics|mesh-ancestor
19602399|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
19602400|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602401|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602402|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19602403|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
19602404|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
19602405|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20129164|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129165|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20129166|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129167|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129168|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129169|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20129170|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20129171|NCT00025012|Isotretinoin|isotretinoin|mesh-list
20129172|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
20129173|NCT00025038|Cytarabine|cytarabine|mesh-list
20129174|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
20129175|NCT00025038|Fludarabine|fludarabine|mesh-list
20129176|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
19602406|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19602407|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602408|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602409|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602410|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602411|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19602412|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
19602413|NCT02550314|Coagulants|coagulants|mesh-ancestor
19602414|NCT02550119|Dexamethasone|dexamethasone|mesh-list
19602415|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
19602416|NCT02550119|Aprepitant|aprepitant|mesh-list
19602417|NCT02550119|Dolasetron|dolasetron|mesh-list
19602418|NCT02550119|Ichthammol|ichthammol|mesh-list
19602419|NCT02550119|BB 1101|bb 1101|mesh-list
19602420|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602421|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
19602422|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
19602423|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602424|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602425|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602426|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
19602427|NCT02550119|Hormones|hormones|mesh-ancestor
19602428|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602429|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19602430|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602431|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
19602432|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602433|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602434|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19602435|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602436|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
19602437|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19602438|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
19602439|NCT02550067|Copper|copper|mesh-list
19602440|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19602441|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
19602442|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
19602443|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20129177|NCT00025038|Tipifarnib|tipifarnib|mesh-list
20311222|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
19602444|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
19602445|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20129178|NCT00025038|Isotretinoin|isotretinoin|mesh-list
19602446|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602447|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19602448|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19602449|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19602450|NCT02550067|Trace Elements|trace elements|mesh-ancestor
19602451|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
19602452|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19602453|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19602454|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19602455|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602456|NCT02550262|Fentanyl|fentanyl|mesh-list
19602457|NCT02550262|Bupivacaine|bupivacaine|mesh-list
19602458|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
19602459|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
19602460|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602461|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602462|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
19602463|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602464|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19602465|NCT02550262|Narcotics|narcotics|mesh-ancestor
19602466|NCT02550262|Analgesics|analgesics|mesh-ancestor
19602467|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19602468|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19602469|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
19602470|NCT02550418|Budesonide|budesonide|mesh-list
19602471|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602472|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19602473|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
19602474|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602475|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602476|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19602477|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602478|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
19602479|NCT02550418|Hormones|hormones|mesh-ancestor
19602480|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602481|NCT02550080|Dapsone|dapsone|mesh-list
19602482|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602483|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
19602484|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19602485|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19602486|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19602487|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602488|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602489|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
19602490|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19602491|NCT02550249|Nivolumab|nivolumab|mesh-list
19602492|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19602493|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602494|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19602495|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602496|NCT02550028|Levetiracetam|levetiracetam|mesh-list
19602497|NCT02550028|Phenobarbital|phenobarbital|mesh-list
19602498|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
19602499|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
19602500|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19602501|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602502|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602503|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19602504|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20129179|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
20129180|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20129181|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
20129182|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129183|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
20129184|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129185|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129186|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129187|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
20129188|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129189|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129190|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129191|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311223|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19602505|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311224|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602506|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602507|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
20129192|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
20129193|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
19602508|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
19602509|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19602510|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19602511|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19602512|NCT02550327|Gemcitabine|gemcitabine|mesh-list
19602513|NCT02550327|Paclitaxel|paclitaxel|mesh-list
19602514|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19602515|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19602516|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602517|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
19602518|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
19602519|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
19602520|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602521|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19602522|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
19602523|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
19602524|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602525|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602526|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19602527|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
19602528|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602529|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602530|NCT02549846|Atorvastatin|atorvastatin|mesh-list
19602531|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19602532|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19602533|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19602534|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
19602535|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602536|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19602537|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19602538|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602539|NCT02549924|Resveratrol|resveratrol|mesh-list
19602540|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
19602541|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602542|NCT02549924|Protective Agents|protective agents|mesh-ancestor
19602543|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602544|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602545|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19602546|NCT02549742|Bleomycin|bleomycin|mesh-list
19602547|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19602548|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602549|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
19602550|NCT02549963|Anticoagulants|anticoagulants|mesh-list
19602551|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19602552|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
19602553|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19602554|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
19602555|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602556|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602557|NCT02550002|Aflibercept|aflibercept|mesh-list
19602558|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19602559|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19602560|NCT02550002|Growth Substances|growth substances|mesh-ancestor
19602561|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602562|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
19602563|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602564|NCT02549898|Cilostazol|cilostazol|mesh-list
19602565|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19602566|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19602567|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
20129194|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129195|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
20129196|NCT00025051|Celecoxib|celecoxib|mesh-list
20129197|NCT00025051|Mitogens|mitogens|mesh-list
20129198|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20129199|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20129200|NCT00025051|Analgesics|analgesics|mesh-ancestor
20129201|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
20129202|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602568|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20129203|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311225|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
19602569|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602570|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19602571|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602572|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19602573|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19602574|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602575|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19602576|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
19602577|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19602578|NCT02549898|Protective Agents|protective agents|mesh-ancestor
19602579|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19602580|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19602581|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602582|NCT02549898|Hematinics|hematinics|mesh-ancestor
19602583|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19602584|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19602585|NCT02549690|Testosterone|testosterone|mesh-list
19602586|NCT02549690|Androgens|androgens|mesh-ancestor
19602587|NCT02549690|Hormones|hormones|mesh-ancestor
19602588|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602589|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602590|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
19602591|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19602592|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602593|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602594|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602595|NCT02549768|Analgesics|analgesics|mesh-ancestor
19602596|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
19602597|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602598|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19602599|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19602600|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602601|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602602|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602603|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129204|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20129205|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129206|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20129207|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20129208|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129209|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129210|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129211|NCT00025064|Prednisolone|prednisolone|mesh-list
20129212|NCT00025064|Doxorubicin|doxorubicin|mesh-list
20129213|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20129214|NCT00025064|Etoposide|etoposide|mesh-list
20129215|NCT00025064|Vincristine|vincristine|mesh-list
20129216|NCT00025064|Melphalan|melphalan|mesh-list
20129217|NCT00025064|Ifosfamide|ifosfamide|mesh-list
20129218|NCT00025064|Dacarbazine|dacarbazine|mesh-list
20129219|NCT00025064|Bleomycin|bleomycin|mesh-list
20129220|NCT00025064|Vinblastine|vinblastine|mesh-list
20129221|NCT00025064|Procarbazine|procarbazine|mesh-list
20129222|NCT00025064|Chlorambucil|chlorambucil|mesh-list
20129223|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129224|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129225|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129226|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129227|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129228|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129229|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129230|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129231|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129232|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129233|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129234|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
20129235|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129236|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129237|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
20129238|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129239|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20129240|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
20129241|NCT00025064|Hormones|hormones|mesh-ancestor
20173476|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19602604|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
19602605|NCT02549677|Docetaxel|docetaxel|mesh-list
19602606|NCT02549677|Epirubicin|epirubicin|mesh-list
19602607|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19602608|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
19602609|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602610|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602611|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19602612|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
19602613|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602614|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602615|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19602616|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
19602617|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
19602618|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
19602619|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19602620|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19602621|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19602622|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602623|NCT02549651|Durvalumab|durvalumab|mesh-list
19602624|NCT02549651|Tremelimumab|tremelimumab|mesh-list
19602625|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19602626|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602627|NCT02549261|Etoposide|etoposide|mesh-list
19602628|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
19602629|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602630|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19602631|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19602632|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19602633|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602634|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602635|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19602636|NCT02549326|Vitamin D|vitamin d|mesh-list
19602637|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
19602638|NCT02549326|Vitamins|vitamins|mesh-ancestor
19602639|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
19602640|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602641|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19602642|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602643|NCT02549469|Naproxen|naproxen|mesh-list
19602644|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19602645|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602646|NCT02549469|Analgesics|analgesics|mesh-ancestor
19602647|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
19602648|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602649|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602650|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602651|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602652|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
19602653|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19602654|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602655|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602656|NCT02549391|Cinacalcet|cinacalcet|mesh-list
19602657|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602658|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602659|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19602660|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
19602661|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602662|NCT02549430|Letrozole|letrozole|mesh-list
19602663|NCT02549430|Fulvestrant|fulvestrant|mesh-list
19602664|NCT02549430|Palbociclib|palbociclib|mesh-list
19602665|NCT02549430|Anastrozole|anastrozole|mesh-list
19602666|NCT02549430|Exemestane|exemestane|mesh-list
19602667|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602668|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19602669|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19602670|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602671|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129242|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602672|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19602673|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
19602674|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602675|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602676|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19602677|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19602678|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19602679|NCT02549105|Lidocaine|lidocaine|mesh-list
19602680|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19602681|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
19602682|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
19602683|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602684|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602685|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
19602686|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602687|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19602688|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19602689|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19602690|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19602691|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602692|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19602693|NCT02549001|Amorolfine|amorolfine|mesh-list
19602694|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
19602695|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602696|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
19602697|NCT02548923|Propofol|propofol|mesh-list
19602698|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19602699|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602700|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602701|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19602702|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
19602703|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
19602704|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602705|NCT02548923|Analgesics|analgesics|mesh-ancestor
19602706|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
20129243|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20129244|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
20129245|NCT00025077|Thiotepa|thiotepa|mesh-list
19602707|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602708|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19602709|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19602710|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602711|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602712|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602713|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602714|NCT02549118|Tenoxicam|tenoxicam|mesh-list
19602715|NCT02549118|Meperidine|meperidine|mesh-list
19602716|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19602717|NCT02549118|Narcotics|narcotics|mesh-ancestor
19602718|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602719|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602720|NCT02549118|Analgesics|analgesics|mesh-ancestor
19602721|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
19602722|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602723|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19602724|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19602725|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602726|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602727|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602728|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19602729|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602730|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129246|NCT00025077|Carboplatin|carboplatin|mesh-list
20129247|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129248|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
20311226|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
20311227|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19602731|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19602732|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20129249|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129250|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129251|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129252|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
20129253|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311228|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20311229|NCT00678184|Atorvastatin|atorvastatin|mesh-list
19602733|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19602734|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19602735|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
19602736|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602737|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602738|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19602739|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19602740|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602741|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602742|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602743|NCT02549066|Milrinone|milrinone|mesh-list
19602744|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19602745|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19602746|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
19602747|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19602748|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19602749|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602750|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602751|NCT02549066|Protective Agents|protective agents|mesh-ancestor
19602752|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602753|NCT02548936|Simvastatin|simvastatin|mesh-list
19602754|NCT02548936|Ezetimibe|ezetimibe|mesh-list
19602755|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19602756|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19602757|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
19602758|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602759|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19602760|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19602761|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602762|NCT02548832|Magnesium Oxide|magnesium oxide|mesh-list
19602763|NCT02548832|Bezafibrate|bezafibrate|mesh-list
19602764|NCT02548832|Antacids|antacids|mesh-ancestor
19602765|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602766|NCT02548832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602767|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19602768|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
19602769|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19602770|NCT02548806|Clonidine|clonidine|mesh-list
19602771|NCT02548806|Analgesics|analgesics|mesh-ancestor
19602772|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
19602773|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20129254|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129255|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129256|NCT00025090|Fluorouracil|fluorouracil|mesh-list
20129257|NCT00025090|Mitomycins|mitomycins|mesh-list
20129258|NCT00025090|Mitomycin|mitomycin|mesh-list
20129259|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129260|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
20129261|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129262|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129263|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129264|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
20129265|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129266|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129267|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
20129268|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129269|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129270|NCT00025103|Dactinomycin|dactinomycin|mesh-list
20129271|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
20129272|NCT00025103|Melphalan|melphalan|mesh-list
20129273|NCT00025103|Carboplatin|carboplatin|mesh-list
20129274|NCT00025103|Doxorubicin|doxorubicin|mesh-list
19602774|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602775|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20129275|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20311230|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311231|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311232|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
19602776|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
19602777|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
19602778|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20129276|NCT00025103|Etoposide|etoposide|mesh-list
19602779|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19602780|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602781|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602782|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20129277|NCT00025103|Vincristine|vincristine|mesh-list
19602783|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602784|NCT02548741|Metformin|metformin|mesh-list
19602785|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
19602786|NCT02548741|Calcium|calcium|mesh-list
19602787|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19602788|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602789|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602790|NCT02548741|Antacids|antacids|mesh-ancestor
19602791|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602792|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19602793|NCT02548780|Doxorubicin|doxorubicin|mesh-list
19602794|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19602795|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602796|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19602797|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19602798|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602799|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602800|NCT02548468|Vidarabine|vidarabine|mesh-list
19602801|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
19602802|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
19602803|NCT02548468|Fludarabine|fludarabine|mesh-list
19602804|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
19602805|NCT02548468|Tacrolimus|tacrolimus|mesh-list
19602806|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19602807|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
19602808|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602809|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602810|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19602811|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
19602812|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602813|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602814|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19602815|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19602816|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
19602817|NCT02548468|Antiviral Agents|antiviral agents|mesh-ancestor
19602818|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602819|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19602820|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602821|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19602822|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19602823|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
19602824|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19602825|NCT02548611|Clopidogrel|clopidogrel|mesh-list
19602826|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19602827|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19602828|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19602829|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19602830|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19602831|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
19602832|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602833|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602834|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602835|NCT02548533|Lidocaine|lidocaine|mesh-list
19602836|NCT02548533|Epinephrine|epinephrine|mesh-list
19602837|NCT02548533|Prilocaine|prilocaine|mesh-list
19602838|NCT02548533|Carticaine|carticaine|mesh-list
19602839|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19602840|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
19602841|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
19602842|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602843|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602844|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
19602845|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602846|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19602847|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19602848|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19602849|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19602850|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602851|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19602852|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19602853|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602854|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602855|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19602856|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19602857|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
19602858|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19602859|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602860|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
19602861|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
19602862|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19602863|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19602864|NCT02548559|Cannabidiol|cannabidiol|mesh-list
19602865|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
19602866|NCT02548494|Insulin|insulin|mesh-list
19602867|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
19602868|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19602869|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602870|NCT02548403|Simethicone|simethicone|mesh-list
19602871|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
19602872|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602873|NCT02548403|Emollients|emollients|mesh-ancestor
19602874|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
19602875|NCT02548364|Vitamin D|vitamin d|mesh-list
19602876|NCT02548364|Calcifediol|calcifediol|mesh-list
19602877|NCT02548364|Vitamins|vitamins|mesh-ancestor
19602878|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
19602879|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602880|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19602881|NCT02548117|Finasteride|finasteride|mesh-list
19602882|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19602883|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19602884|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129278|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129279|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
20129280|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129281|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602885|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602886|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
19602887|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602888|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602889|NCT02548117|Urological Agents|urological agents|mesh-ancestor
19602890|NCT02548195|Gemcitabine|gemcitabine|mesh-list
19602891|NCT02548195|Capecitabine|capecitabine|mesh-list
19602892|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
19602893|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19602894|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
19602895|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602896|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19602897|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
19602898|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602899|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602900|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19602901|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
19602902|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602903|NCT02548286|Amlodipine|amlodipine|mesh-list
19602904|NCT02548286|Candesartan|candesartan|mesh-list
19602905|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19602906|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19602907|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19602908|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129282|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129283|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
20129284|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129285|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129286|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129287|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19602909|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602910|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602911|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
19602912|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19602913|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19602914|NCT02548052|Betamethasone|betamethasone|mesh-list
19602915|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
19602916|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19602917|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
19602918|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19602919|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602920|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
19602921|NCT02548052|Hormones|hormones|mesh-ancestor
20129288|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19602922|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19602923|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602924|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19602925|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
20129289|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129290|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129291|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129292|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129293|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129294|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129295|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20129296|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19658570|NCT02799602|Docetaxel|docetaxel|mesh-list
19658571|NCT02799602|Androgens|androgens|mesh-list
19658572|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658573|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
19658574|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
19658575|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
19658576|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311233|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311234|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311235|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311236|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311237|NCT00678236|Gentamicins|gentamicins|mesh-list
20311238|NCT00678236|Cimetidine|cimetidine|mesh-list
20311239|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20311240|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20129297|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20129298|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129299|NCT00025116|Gefitinib|gefitinib|mesh-list
20129300|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129301|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20129302|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129303|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658577|NCT02799602|Hormones|hormones|mesh-ancestor
19658578|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19658579|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129304|NCT00025142|Leucovorin|leucovorin|mesh-list
20129305|NCT00025142|Fluorouracil|fluorouracil|mesh-list
20311241|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20311242|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
20129306|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
20129307|NCT00025142|Gefitinib|gefitinib|mesh-list
20311243|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
20129308|NCT00025142|Calcium|calcium|mesh-list
20129309|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
20129310|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20129311|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129312|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
20129313|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129314|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129315|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129316|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129317|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
20129318|NCT00025142|Antidotes|antidotes|mesh-ancestor
20129319|NCT00025142|Protective Agents|protective agents|mesh-ancestor
20129320|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
20129321|NCT00025142|Vitamins|vitamins|mesh-ancestor
20129322|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
20129323|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20129324|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129325|NCT00025168|Gemcitabine|gemcitabine|mesh-list
20129326|NCT00025168|Irinotecan|irinotecan|mesh-list
20129327|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129328|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
20129329|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129330|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129331|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
20129332|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129333|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129334|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129335|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
20129336|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666224|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129337|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19602926|NCT02547597|Atenolol|atenolol|mesh-list
19602927|NCT02547597|Carvedilol|carvedilol|mesh-list
20311244|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311245|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311246|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311247|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20311248|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311249|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311250|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20311251|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311252|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20311253|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20311254|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
19602928|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19602929|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19602930|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
19602931|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19602932|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602933|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602934|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19602935|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
19602936|NCT02547597|Protective Agents|protective agents|mesh-ancestor
19602937|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19602938|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19602939|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19602940|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
19602941|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19602942|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19602943|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19602944|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
19602945|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
20311255|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311256|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311257|NCT00678314|Ropivacaine|ropivacaine|mesh-list
20311258|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
20311259|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
20311260|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20311261|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311262|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
20311263|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311264|NCT00678327|Prednisolone|prednisolone|mesh-list
20311265|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
19602946|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602947|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19602948|NCT02547792|Vaccines|vaccines|mesh-list
19602949|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
19602950|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602951|NCT02547870|Rilpivirine|rilpivirine|mesh-list
19602952|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19602953|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19602954|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602955|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602956|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
19602957|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602958|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19602959|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19602960|NCT02547896|Diclofenac|diclofenac|mesh-list
19602961|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19602962|NCT02547896|Codeine|codeine|mesh-list
19602963|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19602964|NCT02547896|Analgesics|analgesics|mesh-ancestor
19602965|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
19602966|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19602967|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602968|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19602969|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19602970|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19602971|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602972|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602973|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19602974|NCT02547896|Narcotics|narcotics|mesh-ancestor
19666225|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20311266|NCT00678327|Dacarbazine|dacarbazine|mesh-list
20311267|NCT00678327|Doxorubicin|doxorubicin|mesh-list
19602975|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19602976|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
19602977|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
19602978|NCT02547844|Tenofovir|tenofovir|mesh-list
19602979|NCT02547844|Efavirenz|efavirenz|mesh-list
19602980|NCT02547844|Emtricitabine|emtricitabine|mesh-list
19602981|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
19602982|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19602983|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19602984|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19602985|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19602986|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19602987|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19602988|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19602989|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19602990|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19602991|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19602992|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19602993|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19602994|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19602995|NCT02547519|Insulin|insulin|mesh-list
19602996|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19602997|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19602998|NCT02547350|Pirarubicin|pirarubicin|mesh-list
19602999|NCT02547350|Epirubicin|epirubicin|mesh-list
19603000|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603001|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19603002|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19603003|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19603004|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603005|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603006|NCT02547402|CXA-10|cxa-10|mesh-list
19603007|NCT02547402|Simvastatin|simvastatin|mesh-list
19603008|NCT02547402|Ezetimibe|ezetimibe|mesh-list
19603009|NCT02547402|Pravastatin|pravastatin|mesh-list
19603010|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19603011|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19603012|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19603013|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
19603014|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603015|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19603016|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19603017|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603018|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603019|NCT02547480|Irinotecan|irinotecan|mesh-list
19603020|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19603021|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19603022|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603023|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603024|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603025|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19603026|NCT02547025|Amoxicillin|amoxicillin|mesh-list
19603027|NCT02547025|Clarithromycin|clarithromycin|mesh-list
19603028|NCT02547025|Levofloxacin|levofloxacin|mesh-list
19603029|NCT02547025|Ofloxacin|ofloxacin|mesh-list
19603030|NCT02547025|Tetracycline|tetracycline|mesh-list
19603031|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19603032|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19603033|NCT02547025|Rabeprazole|rabeprazole|mesh-list
19603034|NCT02547025|Bismuth|bismuth|mesh-list
19603035|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603036|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
19603037|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19603038|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603039|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603040|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19603041|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19603042|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19603043|NCT02547025|Renal Agents|renal agents|mesh-ancestor
19603044|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19603045|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19603046|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129338|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20173477|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173478|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
20173479|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20173480|NCT00161681|Estradiol|estradiol|mesh-list
20173481|NCT00161681|Estrogens|estrogens|mesh-ancestor
20173482|NCT00161681|Hormones|hormones|mesh-ancestor
19603047|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19603048|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19603049|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603050|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19603051|NCT02547025|Antacids|antacids|mesh-ancestor
19603052|NCT02547155|Anesthetics|anesthetics|mesh-list
19603053|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603054|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603055|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
19603056|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19603057|NCT02547103|Mupirocin|mupirocin|mesh-list
19603058|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19603059|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603060|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
19603061|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
19603062|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19603063|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19603064|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603065|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603066|NCT02547116|Rifampin|rifampin|mesh-list
19603067|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19603068|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
19603069|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19603070|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603071|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
19603072|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19603073|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603074|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603075|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19603076|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19603077|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19603078|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19603079|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19603080|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19603081|NCT02546843|Rocuronium|rocuronium|mesh-list
19603082|NCT02546843|Atracurium|atracurium|mesh-list
19603083|NCT02546843|Cisatracurium|cisatracurium|mesh-list
19603084|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19603085|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19603086|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19603087|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603088|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603089|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19603090|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19603091|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
19603092|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603093|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603094|NCT02546791|Dasatinib|dasatinib|mesh-list
19603095|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603096|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19603097|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173483|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173484|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603098|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603099|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
19603100|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19603101|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603102|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
19603103|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
19603104|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19603105|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19603106|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19603107|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
19603108|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603109|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19603110|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19603111|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603112|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19603113|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19603114|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
19603115|NCT02546648|Coagulants|coagulants|mesh-ancestor
19603116|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
19603117|NCT02546583|Furosemide|furosemide|mesh-list
19603118|NCT02546583|Bumetanide|bumetanide|mesh-list
19603119|NCT02546583|Diuretics|diuretics|mesh-list
19603120|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19603121|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
19603122|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603123|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19603124|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603125|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19603126|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19603127|NCT02546531|Gemcitabine|gemcitabine|mesh-list
19603128|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
19603129|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19603130|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
19603131|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603132|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603133|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
19603134|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603135|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603136|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603137|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
19603138|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603139|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19603140|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19603141|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
19603142|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603143|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
19603144|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603145|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
19603146|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19603147|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603148|NCT02546141|Caseins|caseins|mesh-list
19603149|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
19603150|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
19603151|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603152|NCT02546349|Fluticasone|fluticasone|mesh-list
19603153|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
19603154|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19603155|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19603156|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603157|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19603158|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
19603159|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603160|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603161|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19603162|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
19603163|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
19603164|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19603165|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
19603166|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19603167|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
19603168|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603169|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603170|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19603171|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19603172|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19603173|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
19603174|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
19603175|NCT02546349|Hormones|hormones|mesh-ancestor
19603176|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603177|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
19603178|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19603179|NCT02546154|Hematinics|hematinics|mesh-ancestor
19603180|NCT02546232|Paclitaxel|paclitaxel|mesh-list
19603181|NCT02546232|Carboplatin|carboplatin|mesh-list
19603182|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19603183|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603184|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
19603185|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
19603186|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
19603187|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311268|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19603188|NCT02546297|Budesonide|budesonide|mesh-list
19603189|NCT02546297|Bromides|bromides|mesh-list
19603190|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
19603191|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
19603192|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19603193|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603194|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19603195|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
20311269|NCT00678327|Etoposide|etoposide|mesh-list
20311270|NCT00678327|Vincristine|vincristine|mesh-list
20311271|NCT00678327|Bleomycin|bleomycin|mesh-list
19603196|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603197|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603198|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19603199|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
19603200|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
19603201|NCT02546297|Hormones|hormones|mesh-ancestor
19603202|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603203|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19603204|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19603205|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19603206|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
19603207|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603208|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603209|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
19603210|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19603211|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
19603212|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
19603213|NCT02546050|Metformin|metformin|mesh-list
19603214|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19603215|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129339|NCT00025181|Ipilimumab|ipilimumab|mesh-list
20129340|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
20129341|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20129342|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129343|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20129344|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129345|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20129346|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
20129347|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129348|NCT00025194|Estramustine|estramustine|mesh-list
20129349|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129350|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
20129351|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129352|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129353|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20129354|NCT00025207|Gefitinib|gefitinib|mesh-list
20129355|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129356|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20129357|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129358|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658632|NCT02741323|Maraviroc|maraviroc|mesh-list
19658633|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20311272|NCT00678327|Vinblastine|vinblastine|mesh-list
19658634|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19658635|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311273|NCT00678327|Procarbazine|procarbazine|mesh-list
20311274|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311275|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
20612306|NCT02251041|Vitamins|vitamins|mesh-ancestor
19603216|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
20311276|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311277|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20311278|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20311279|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
20311280|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311281|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603217|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19603218|NCT02545751|Thymalfasin|thymalfasin|mesh-list
19603219|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19603220|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
19603221|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603222|NCT02545712|Ethanol|ethanol|mesh-list
19603223|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
19603224|NCT02545712|Sorbitol|sorbitol|mesh-list
19603225|NCT02545712|Glycerol|glycerol|mesh-list
19603226|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19603227|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603228|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603229|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603230|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19603231|NCT02545712|Protective Agents|protective agents|mesh-ancestor
19603232|NCT02545712|Cathartics|cathartics|mesh-ancestor
19603233|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603234|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
20129359|NCT00025220|Thalidomide|thalidomide|mesh-list
20129360|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129361|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
20129362|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129363|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
20129364|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20129365|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129366|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19603235|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
19603236|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
19603237|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603238|NCT02545777|Diclofenac|diclofenac|mesh-list
19603239|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19603240|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20311282|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20311283|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20311284|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20311285|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20311286|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311287|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20311288|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
20311289|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311290|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
20311291|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20311292|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
19603241|NCT02545777|Analgesics|analgesics|mesh-ancestor
19603242|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
19603243|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603244|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603245|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603246|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19603247|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19603248|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603249|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603250|NCT02545972|Tacrolimus|tacrolimus|mesh-list
19603251|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603252|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
20129367|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20129368|NCT00025220|Growth Substances|growth substances|mesh-ancestor
20129369|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
20129370|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129371|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
20129372|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129373|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20129374|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129375|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603253|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129376|NCT00025272|Carboplatin|carboplatin|mesh-list
19603254|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19603255|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658636|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19603256|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603257|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
19603258|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19603259|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19603260|NCT02545959|Prednisolone|prednisolone|mesh-list
19603261|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
19603262|NCT02545959|Rituximab|rituximab|mesh-list
19603263|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19603264|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
19603265|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19603266|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603267|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
19603268|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129377|NCT00025272|Etoposide|etoposide|mesh-list
20129378|NCT00025272|Topotecan|topotecan|mesh-list
19603269|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19603270|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603271|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
19603272|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
19603273|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603274|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603275|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
19603276|NCT02545959|Hormones|hormones|mesh-ancestor
19603277|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603278|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19603279|NCT02545959|Protective Agents|protective agents|mesh-ancestor
19603280|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19603281|NCT02545634|Sulfalene|sulfalene|mesh-list
19603282|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603283|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19603284|NCT02545634|Renal Agents|renal agents|mesh-ancestor
19603285|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
19603286|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19603287|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19603288|NCT02545738|Liraglutide|liraglutide|mesh-list
19603289|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19603290|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603291|NCT02545738|Incretins|incretins|mesh-ancestor
19603292|NCT02545738|Hormones|hormones|mesh-ancestor
20129379|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129380|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19603293|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603294|NCT02545465|Riociguat|riociguat|mesh-list
19603295|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
19603296|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603297|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
19603298|NCT02545426|Calcium|calcium|mesh-list
19603299|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19603300|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603301|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19603302|NCT02545530|Clonidine|clonidine|mesh-list
19603303|NCT02545530|Analgesics|analgesics|mesh-ancestor
19603304|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
19603305|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603306|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603307|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19603308|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
19603309|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
19603310|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19603311|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19603312|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19603313|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
19603314|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603315|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603316|NCT02545452|Anastrozole|anastrozole|mesh-list
19603317|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
19603318|NCT02545452|Nonoxynol|nonoxynol|mesh-list
19603319|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19603320|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603321|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19603322|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19603323|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603324|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603325|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19603326|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
20129381|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129382|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129383|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603327|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603328|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603329|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19603330|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
20311293|NCT00678327|Hormones|hormones|mesh-ancestor
20311294|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311295|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20311296|NCT00678431|Resveratrol|resveratrol|mesh-list
20311297|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
20311298|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311299|NCT00678431|Protective Agents|protective agents|mesh-ancestor
19603331|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19603332|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19603333|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19603334|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19603335|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19603336|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19603337|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19603338|NCT02545231|Pitavastatin|pitavastatin|mesh-list
19603339|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19603340|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19603341|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19603342|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
19603343|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603344|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603345|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19603346|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
19603347|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19603348|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603349|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
19603350|NCT02545010|Paclitaxel|paclitaxel|mesh-list
19603351|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19603352|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603353|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
19603354|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311300|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311301|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311302|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20311303|NCT00678457|Ondansetron|ondansetron|mesh-list
20311304|NCT00678457|Olanzapine|olanzapine|mesh-list
19603355|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
19603356|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603357|NCT02544919|SMOFlipid|smoflipid|mesh-list
19603358|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19603359|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19603360|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19603361|NCT02544906|Propofol|propofol|mesh-list
19603362|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19603363|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603364|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603365|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19603366|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
19603367|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
19603368|NCT02544880|Tadalafil|tadalafil|mesh-list
19603369|NCT02544880|Vaccines|vaccines|mesh-list
19603370|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
19603371|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603372|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
19603373|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19603374|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20129384|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129385|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20129386|NCT00025285|Thalidomide|thalidomide|mesh-list
20129387|NCT00025285|Carboplatin|carboplatin|mesh-list
20129388|NCT00025285|Irinotecan|irinotecan|mesh-list
20129389|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129390|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19603375|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603376|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603377|NCT02544880|Urological Agents|urological agents|mesh-ancestor
20129391|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129392|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129393|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129394|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129395|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
20129396|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129397|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
19603378|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
19603379|NCT02544893|Bupivacaine|bupivacaine|mesh-list
19603380|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
19603381|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
19603382|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603383|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603384|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
19603385|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603386|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19603387|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19603388|NCT02544893|Analgesics|analgesics|mesh-ancestor
19603389|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19603390|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19603391|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19603392|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
19603393|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603394|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603395|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19603396|NCT02545153|Aprotinin|aprotinin|mesh-list
19603397|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
19603398|NCT02545153|Coagulants|coagulants|mesh-ancestor
19603399|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19603400|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19603401|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
19603402|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603403|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603404|NCT02544815|Digoxin|digoxin|mesh-list
19603405|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19603406|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19603407|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603408|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603409|NCT02544815|Protective Agents|protective agents|mesh-ancestor
19603410|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603411|NCT02544932|Warfarin|warfarin|mesh-list
19603412|NCT02544932|Dabigatran|dabigatran|mesh-list
19603413|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
19603414|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
19603415|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19603416|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
19603417|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603418|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603419|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19603420|NCT02544828|Hematinics|hematinics|mesh-ancestor
19603421|NCT02544854|Propofol|propofol|mesh-list
19603422|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19603423|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603424|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603425|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19603426|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
19603427|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
19603428|NCT02545114|Tolvaptan|tolvaptan|mesh-list
19603429|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19603430|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603431|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
19603432|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603433|NCT02544776|Amlodipine|amlodipine|mesh-list
19603434|NCT02544776|Clomiphene|clomiphene|mesh-list
19603435|NCT02544776|Enclomiphene|enclomiphene|mesh-list
19603436|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
19603437|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603438|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19603439|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19603440|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19603441|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19603442|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603443|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
19603444|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20129398|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19603445|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
19603446|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603447|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19603448|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
19603449|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19603450|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19603451|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19603452|NCT02544750|Cannabidiol|cannabidiol|mesh-list
19603453|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
19603454|NCT02544659|Pamidronate|pamidronate|mesh-list
19603455|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19603456|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603457|NCT02544698|Vaccines|vaccines|mesh-list
19603458|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
19603459|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603460|NCT02544789|Clofarabine|clofarabine|mesh-list
19603461|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19603462|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
19603463|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603464|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603465|NCT02544737|Apatinib|apatinib|mesh-list
19603466|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603467|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19603468|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603469|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603470|NCT02544724|Interleukin-12|interleukin-12|mesh-list
19603471|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19603472|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
19603473|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603474|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19603475|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19603476|NCT02544724|Growth Substances|growth substances|mesh-ancestor
19603477|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
19603478|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603479|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19603480|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19603481|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19603482|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
19603483|NCT02544529|Laxatives|laxatives|mesh-ancestor
19603484|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603485|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19603486|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603487|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603488|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
19603489|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603490|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603491|NCT02544529|Miotics|miotics|mesh-ancestor
19603492|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
19603493|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603494|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19603495|NCT02544425|Dexamethasone|dexamethasone|mesh-list
19603496|NCT02544425|Etoposide|etoposide|mesh-list
19603497|NCT02544425|Melphalan|melphalan|mesh-list
19603498|NCT02544425|Busulfan|busulfan|mesh-list
19603499|NCT02544425|Asparaginase|asparaginase|mesh-list
19603500|NCT02544425|Ifosfamide|ifosfamide|mesh-list
20129399|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129400|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20129401|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20129402|NCT00025285|Growth Substances|growth substances|mesh-ancestor
20129403|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
19603501|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603502|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
19603503|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
19603504|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603505|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603506|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603507|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
19603508|NCT02544425|Hormones|hormones|mesh-ancestor
20129404|NCT00025298|Paclitaxel|paclitaxel|mesh-list
20129405|NCT00025298|Carboplatin|carboplatin|mesh-list
20129406|NCT00025298|Amifostine|amifostine|mesh-list
20129407|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129408|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129409|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
19603509|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603510|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20129410|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
19603511|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603512|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19603513|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19603514|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19603515|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603516|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603517|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19603518|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
19603519|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19603520|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603521|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
19658637|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19658638|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
19658639|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19658640|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20129411|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129412|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129413|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20129414|NCT00025298|Protective Agents|protective agents|mesh-ancestor
20129415|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129416|NCT00025311|Topotecan|topotecan|mesh-list
19658645|NCT02677922|Azacitidine|azacitidine|mesh-list
19658646|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19658647|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
19658648|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658649|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658650|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129417|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20129418|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129419|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129420|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129421|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129422|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
20129423|NCT00025324|Thiotepa|thiotepa|mesh-list
20129424|NCT00025324|Carboplatin|carboplatin|mesh-list
20129425|NCT00025324|Etoposide|etoposide|mesh-list
20129426|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129427|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
20129428|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129429|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129430|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129431|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
20129432|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129433|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129434|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129435|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129436|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19658671|NCT02624596|Midazolam|midazolam|mesh-list
19658672|NCT02624596|Ketamine|ketamine|mesh-list
19658673|NCT02624596|Analgesics|analgesics|mesh-ancestor
19658674|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
19658675|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658676|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658677|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19658678|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19658679|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
19658680|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
19658681|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19658682|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19658683|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19658684|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19658685|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658686|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19658687|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19658688|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19658689|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19658690|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19658691|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
19658692|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
20129437|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129438|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129439|NCT00025337|Leucovorin|leucovorin|mesh-list
20129440|NCT00025337|Bevacizumab|bevacizumab|mesh-list
19603522|NCT02544282|Acetaminophen|acetaminophen|mesh-list
19603523|NCT02544282|Sufentanil|sufentanil|mesh-list
19603524|NCT02544282|Tramadol|tramadol|mesh-list
19603525|NCT02544282|Pirinitramide|pirinitramide|mesh-list
19603526|NCT02544282|Propofol|propofol|mesh-list
19603527|NCT02544282|Sevoflurane|sevoflurane|mesh-list
19603528|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
19603529|NCT02544282|Atracurium|atracurium|mesh-list
19603530|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19603531|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603532|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603533|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19603534|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
19603535|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
19603536|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19603537|NCT02544282|Analgesics|analgesics|mesh-ancestor
19603538|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
19603539|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603540|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
19603541|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19603542|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19603543|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19603544|NCT02544282|Narcotics|narcotics|mesh-ancestor
19603545|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
19603546|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19603547|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19603548|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19603549|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19603550|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19603551|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19603552|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
19603553|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603554|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603555|NCT02544308|Dexamethasone|dexamethasone|mesh-list
19603556|NCT02544308|Lenalidomide|lenalidomide|mesh-list
19603557|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603558|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
19603559|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
19603560|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603561|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603562|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603563|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
19603564|NCT02544308|Hormones|hormones|mesh-ancestor
19603565|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603566|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19603567|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603568|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
20311305|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
20311306|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
20311307|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603569|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19603570|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19603571|NCT02544308|Growth Substances|growth substances|mesh-ancestor
19603572|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
19603573|NCT02544191|Goserelin|goserelin|mesh-list
19603574|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19603575|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603576|NCT02544165|Caffeine|caffeine|mesh-list
19603577|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19603578|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603579|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19603580|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603581|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603582|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20311308|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311309|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20311310|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
20311311|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
20311312|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20311313|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
19603583|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19603584|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
19603585|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603586|NCT02544243|Gemcitabine|gemcitabine|mesh-list
19603587|NCT02544243|Vinorelbine|vinorelbine|mesh-list
19603588|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311314|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612307|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
19603589|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19603590|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
19603591|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603592|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
19603593|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603594|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129441|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20129442|NCT00025337|Fluorouracil|fluorouracil|mesh-list
20129443|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
20129444|NCT00025337|Antibodies|antibodies|mesh-list
20129445|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
20129446|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19603595|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603596|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
19603597|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603598|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19603599|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19603600|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
19603601|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19603602|NCT02544269|Bupivacaine|bupivacaine|mesh-list
19603603|NCT02544269|Ropivacaine|ropivacaine|mesh-list
19603604|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
19603605|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
19603606|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603607|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603608|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
19603609|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603610|NCT02544061|Interleukin-12|interleukin-12|mesh-list
19603611|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19603612|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
19603613|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603614|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19603615|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19603616|NCT02544061|Growth Substances|growth substances|mesh-ancestor
19603617|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
19603618|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603619|NCT02543879|Azacitidine|azacitidine|mesh-list
19603620|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19603621|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
19603622|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603623|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603624|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603625|NCT05226923|Meropenem|meropenem|mesh-list
19603626|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19603627|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603628|NCT05226897|Metformin|metformin|mesh-list
19603629|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
19603630|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19603631|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603632|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19603633|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603634|NCT05226871|Cetuximab|cetuximab|mesh-list
19603635|NCT05226871|Letrozole|letrozole|mesh-list
19603636|NCT05226871|Fulvestrant|fulvestrant|mesh-list
19603637|NCT05226871|Palbociclib|palbociclib|mesh-list
19603638|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19603639|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603640|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19603641|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19603642|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603643|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603644|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19603645|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
19603646|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603647|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603648|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19603649|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19603650|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19603651|NCT05226832|Triamcinolone|triamcinolone|mesh-list
19603652|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603653|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
19603654|NCT05226832|Hormones|hormones|mesh-ancestor
19603655|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603656|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129447|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
19603657|NCT05226754|Diacetylrhein|diacetylrhein|mesh-list
19603658|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603659|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
19603660|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19603661|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603662|NCT05226663|Fluorides|fluorides|mesh-list
19603663|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
19603664|NCT05226663|Protective Agents|protective agents|mesh-ancestor
19603665|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603666|NCT05226429|Vaccines|vaccines|mesh-list
19603667|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
19603668|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603669|NCT05226299|Capsaicin|capsaicin|mesh-list
19603670|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
19603671|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
19603672|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
19603673|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603674|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603675|NCT05226013|Rasburicase|rasburicase|mesh-list
19603676|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
19603677|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19603678|NCT05225974|Liraglutide|liraglutide|mesh-list
19603679|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19603680|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603681|NCT05225974|Incretins|incretins|mesh-ancestor
19603682|NCT05225974|Hormones|hormones|mesh-ancestor
19603683|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603684|NCT05225961|Aspirin|aspirin|mesh-list
19603685|NCT05225961|Tirofiban|tirofiban|mesh-list
19603686|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19603687|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19603688|NCT05225961|Analgesics|analgesics|mesh-ancestor
19603689|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
19603690|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603691|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603692|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603693|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19603694|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19603695|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19603696|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603697|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19603698|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19603699|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603700|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
20129448|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129449|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20129450|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20129451|NCT00025337|Growth Substances|growth substances|mesh-ancestor
20129452|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129453|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
20129454|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
20129455|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
20129456|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129457|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129458|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129459|NCT00025337|Antidotes|antidotes|mesh-ancestor
20129460|NCT00025337|Protective Agents|protective agents|mesh-ancestor
20129461|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
20129462|NCT00025337|Vitamins|vitamins|mesh-ancestor
20129463|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
20129464|NCT00025350|Gefitinib|gefitinib|mesh-list
20129465|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129466|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20129467|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129468|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129469|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
20129470|NCT00025363|Ifosfamide|ifosfamide|mesh-list
20129471|NCT00025363|Doxorubicin|doxorubicin|mesh-list
20129472|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20129473|NCT00025363|Irinotecan|irinotecan|mesh-list
20129474|NCT00025363|Etoposide|etoposide|mesh-list
20129475|NCT00025363|Vincristine|vincristine|mesh-list
20129476|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
20129477|NCT00025363|Tirapazamine|tirapazamine|mesh-list
20129478|NCT00025363|Sargramostim|sargramostim|mesh-list
20129479|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129480|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
20129481|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603701|NCT05225844|Apatinib|apatinib|mesh-list
19603702|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603703|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19603704|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603705|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603706|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
19603707|NCT05225831|Fludarabine|fludarabine|mesh-list
19603708|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603709|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
19603710|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311315|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311316|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20311317|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20311318|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20311319|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20311320|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20311321|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20311322|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20129482|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129483|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129484|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
20129485|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129486|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129487|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129488|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129489|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129490|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129491|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129492|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20129493|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129494|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129495|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129496|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129497|NCT00025376|Bortezomib|bortezomib|mesh-list
20129498|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311323|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20311324|NCT00678483|Rimonabant|rimonabant|mesh-list
20311325|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19603711|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19603712|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19603713|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
19603714|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603715|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603716|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19603717|NCT05225766|Bupivacaine|bupivacaine|mesh-list
19603718|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
19603719|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
19603720|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603721|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129499|NCT00025389|Paclitaxel|paclitaxel|mesh-list
20129500|NCT00025389|Bevacizumab|bevacizumab|mesh-list
20129501|NCT00025389|Carboplatin|carboplatin|mesh-list
20129502|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129503|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129504|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129505|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129506|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129507|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129508|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20129509|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20129510|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19603722|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
19603723|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603724|NCT05224492|Sulforaphane|sulforaphane|mesh-list
19603725|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20129511|NCT00025389|Growth Substances|growth substances|mesh-ancestor
20129512|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129513|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
20129514|NCT00025402|Interferons|interferons|mesh-list
20129515|NCT00025402|Cytarabine|cytarabine|mesh-list
20129516|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
20129517|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
20129518|NCT00025402|Busulfan|busulfan|mesh-list
20129519|NCT00025402|Etoposide|etoposide|mesh-list
20311326|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20129520|NCT00025402|Idarubicin|idarubicin|mesh-list
20311327|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20311328|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311329|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311330|NCT00678483|Hormones|hormones|mesh-ancestor
20129521|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
20129522|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603726|NCT05224492|Protective Agents|protective agents|mesh-ancestor
19603727|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603728|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603729|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
19603730|NCT05202080|Narcotics|narcotics|mesh-ancestor
19603731|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603732|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603733|NCT05202080|Analgesics|analgesics|mesh-ancestor
19603734|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
20311331|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603735|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603736|NCT05171972|Ofatumumab|ofatumumab|mesh-list
19603737|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603738|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19603739|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19603740|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19603741|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19603742|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603743|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603744|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19603745|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19603746|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603747|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
19603748|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603749|NCT05162131|Ticagrelor|ticagrelor|mesh-list
19603750|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19603751|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19603752|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19603753|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19603754|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
19603755|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603756|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603757|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603758|NCT05157412|Doxycycline|doxycycline|mesh-list
19603759|NCT05157412|Prednisolone|prednisolone|mesh-list
19603760|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19603761|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
19603762|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19603763|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
19603764|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19603765|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
19603766|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603767|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
19603768|NCT05157412|Hormones|hormones|mesh-ancestor
19603769|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603770|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603771|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19603772|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129523|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
20129524|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129525|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129526|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129527|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
20129528|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129529|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603773|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
19603774|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
19603775|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603776|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603777|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19603778|NCT05157412|Protective Agents|protective agents|mesh-ancestor
19603779|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19603780|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603781|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
19603782|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20129530|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19603783|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19603784|NCT05155436|Amlodipine|amlodipine|mesh-list
19603785|NCT05155436|Telmisartan|telmisartan|mesh-list
19603786|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19603787|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19603788|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19603789|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603790|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19603791|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603792|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
19603793|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19603794|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19603795|NCT05151263|Aspirin|aspirin|mesh-list
19603796|NCT05151263|Salicylates|salicylates|mesh-list
19603797|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19603798|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19603799|NCT05151263|Analgesics|analgesics|mesh-ancestor
19603800|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
19603801|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603802|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603803|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603804|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19603805|NCT05151263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19603806|NCT05151263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19603807|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603808|NCT05151263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20129531|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129532|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129533|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129534|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129535|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
20129536|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129537|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129538|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
20129539|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129540|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
20129541|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129542|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
20129543|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129544|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20129545|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129546|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129547|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
19603809|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19603810|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603811|NCT05151263|Antipyretics|antipyretics|mesh-ancestor
19603812|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
19603813|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19603814|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603815|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603816|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19603817|NCT05139212|Analgesics|analgesics|mesh-ancestor
19603818|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
19603819|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603820|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19603821|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19603822|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19603823|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
19603824|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603825|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603826|NCT05127876|Ephedrine|ephedrine|mesh-list
19603827|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
19603828|NCT05127876|Ondansetron|ondansetron|mesh-list
19603829|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
19603830|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
19603831|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603832|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603833|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19603834|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
20129548|NCT00025428|Carboplatin|carboplatin|mesh-list
20129549|NCT00025428|Doxorubicin|doxorubicin|mesh-list
19256570|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603835|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
19603836|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19603837|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
19603838|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19603839|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603840|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19603841|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19603842|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19603843|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19603844|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19603845|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19603846|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
20129550|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20129551|NCT00025428|Etoposide|etoposide|mesh-list
20129552|NCT00025428|Vincristine|vincristine|mesh-list
20129553|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603847|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19603848|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
19603849|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19603850|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19603851|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
19603852|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
19603853|NCT05079230|Azacitidine|azacitidine|mesh-list
19603854|NCT05079230|Venetoclax|venetoclax|mesh-list
19603855|NCT05079230|Magrolimab|magrolimab|mesh-list
19603856|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19603857|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
19603858|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603859|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603860|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603861|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19603862|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19603863|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
19603864|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19603865|NCT05041907|Ivermectin|ivermectin|mesh-list
20129554|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
20129555|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129556|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129557|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129558|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
19603866|NCT05041907|Remdesivir|remdesivir|mesh-list
20129559|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129560|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129561|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129562|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129563|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129564|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19603867|NCT05041907|Favipiravir|favipiravir|mesh-list
19603868|NCT05041907|Antibodies|antibodies|mesh-list
19603869|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19603870|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
19603871|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129565|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129566|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129567|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129568|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129569|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129570|NCT00025441|Dactinomycin|dactinomycin|mesh-list
20129571|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
20129572|NCT00025441|Ifosfamide|ifosfamide|mesh-list
20129573|NCT00025441|Carboplatin|carboplatin|mesh-list
20129574|NCT00025441|Doxorubicin|doxorubicin|mesh-list
20129575|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19603872|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19603873|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603874|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
20129576|NCT00025441|Etoposide|etoposide|mesh-list
20129577|NCT00025441|Vincristine|vincristine|mesh-list
20129578|NCT00025441|Epirubicin|epirubicin|mesh-list
19603875|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603876|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
20129579|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129580|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
20129581|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129582|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129583|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129584|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
20129585|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129586|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129587|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129588|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129589|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129590|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129591|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603877|NCT04989699|Aflibercept|aflibercept|mesh-list
19603878|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19603879|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20129592|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129593|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129594|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19603880|NCT04989699|Growth Substances|growth substances|mesh-ancestor
19603881|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603882|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
19603883|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603884|NCT04861298|Quercetin|quercetin|mesh-list
19603885|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
19603886|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603887|NCT04861298|Protective Agents|protective agents|mesh-ancestor
19603888|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603889|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
19603890|NCT04859946|Busulfan|busulfan|mesh-list
19603891|NCT04859946|Thiotepa|thiotepa|mesh-list
19603892|NCT04859946|Fludarabine|fludarabine|mesh-list
19603893|NCT04859946|Tacrolimus|tacrolimus|mesh-list
19603894|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19603895|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
19603896|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603897|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19603898|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19603899|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
19603900|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603901|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603902|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19603903|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19603904|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129595|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129596|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20129597|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129598|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20129599|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129600|NCT00025454|Tipifarnib|tipifarnib|mesh-list
20129601|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129602|NCT00025467|Thalidomide|thalidomide|mesh-list
20129603|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129604|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
20129605|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129606|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
19603905|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19603906|NCT04846231|Red yeast rice|red yeast rice|mesh-list
19603907|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19603908|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19603909|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
19603910|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603911|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19603912|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19603913|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603914|NCT04844918|Tirzepatide|tirzepatide|mesh-list
19603915|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19603916|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603917|NCT04844918|Incretins|incretins|mesh-ancestor
19603918|NCT04844918|Hormones|hormones|mesh-ancestor
19603919|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603920|NCT04842708|Vaccines|vaccines|mesh-list
19603921|NCT04842708|Immunologic Factors|immunologic factors|mesh-ancestor
19603922|NCT04842708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603923|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
19603924|NCT04812366|Prednisone|prednisone|mesh-list
19603925|NCT04812366|Docetaxel|docetaxel|mesh-list
19603926|NCT04812366|Atezolizumab|atezolizumab|mesh-list
19603927|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
19603928|NCT04812366|Niraparib|niraparib|mesh-list
19603929|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603930|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
19603931|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
19603932|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
19603933|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603934|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19603935|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
19603936|NCT04812366|Hormones|hormones|mesh-ancestor
19603937|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603938|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603939|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19603940|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19603941|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603942|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
20129607|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20129608|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129609|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20129610|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20311332|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311333|NCT00678522|Atorvastatin|atorvastatin|mesh-list
20311334|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311335|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311336|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
20311337|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603943|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20129611|NCT00025467|Growth Substances|growth substances|mesh-ancestor
20129612|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
20129613|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129614|NCT00025480|Paclitaxel|paclitaxel|mesh-list
19603944|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19603945|NCT04771130|Posaconazole|posaconazole|mesh-list
19603946|NCT04771130|Azacitidine|azacitidine|mesh-list
19603947|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19603948|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
19603949|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603950|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603951|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603952|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
19603953|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603954|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19603955|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19603956|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19603957|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19603958|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19603959|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19603960|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
19603961|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19603962|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129615|NCT00025480|Carboplatin|carboplatin|mesh-list
20311338|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19603963|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
19603964|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19603965|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19603966|NCT04732208|Mydriatics|mydriatics|mesh-list
19603967|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
19603968|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19603969|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603970|NCT04731779|Cannabidiol|cannabidiol|mesh-list
19603971|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
19603972|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
19603973|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19603974|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
19603975|NCT04721626|Tetracycline|tetracycline|mesh-list
19603976|NCT04721626|Doxycycline|doxycycline|mesh-list
19603977|NCT04721626|Povidone|povidone|mesh-list
19603978|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19603979|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19603980|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
19603981|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
19603982|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
19603983|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
19603984|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19603985|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19603986|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19603987|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19603988|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
19603989|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19603990|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19603991|NCT04649203|Riboflavin|riboflavin|mesh-list
19603992|NCT04649203|Niacinamide|niacinamide|mesh-list
19603993|NCT04649203|Niacin|niacin|mesh-list
19603994|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
19603995|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
19603996|NCT04649203|Vitamins|vitamins|mesh-ancestor
19603997|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
19603998|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19603999|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19604000|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
19604001|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19604002|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
19604003|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604004|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19604005|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
19604006|NCT04638465|Cisplatin|cisplatin|mesh-list
19604007|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604008|NCT04634162|Cangrelor|cangrelor|mesh-list
19604009|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19604010|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19604011|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19604012|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19604013|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
19604014|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604015|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604016|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604017|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
19604018|NCT04633148|Fludarabine|fludarabine|mesh-list
19604019|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19604020|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
19604021|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604022|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604023|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19604024|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
19604025|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604026|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604027|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19604028|NCT04627753|Rituximab|rituximab|mesh-list
19604029|NCT04627753|Lenalidomide|lenalidomide|mesh-list
19604030|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19604031|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604032|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
20129616|NCT00025480|Tipifarnib|tipifarnib|mesh-list
20129617|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129618|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604033|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604034|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604035|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19604036|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20129619|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129620|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
19604037|NCT04627753|Growth Substances|growth substances|mesh-ancestor
19604038|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
19604039|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19604040|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19604041|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604042|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19604043|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19604044|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604045|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604046|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
19604047|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604048|NCT04599465|Ivacaftor|ivacaftor|mesh-list
19604049|NCT04599465|Elexacaftor|elexacaftor|mesh-list
19604050|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19604051|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604052|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604053|NCT04589676|Naloxone|naloxone|mesh-list
19604054|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19604055|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604056|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
19604057|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604058|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
19604059|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604060|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
19604061|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19604062|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19604063|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604064|NCT04565925|Urological Agents|urological agents|mesh-ancestor
19604065|NCT04545515|Ivacaftor|ivacaftor|mesh-list
19604066|NCT04545515|Elexacaftor|elexacaftor|mesh-list
19604067|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19604068|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604069|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604070|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
19604071|NCT04515615|Tegafur|tegafur|mesh-list
19604072|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604073|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19604074|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
19604075|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604076|NCT04489628|Vitamin D|vitamin d|mesh-list
19604077|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
19604078|NCT04489628|Vitamins|vitamins|mesh-ancestor
19604079|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
19604080|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604081|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19604082|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19604083|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19604084|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20129621|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129622|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129623|NCT00025493|Docetaxel|docetaxel|mesh-list
20129624|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129625|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129626|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
19604085|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604086|NCT04439318|Trametinib|trametinib|mesh-list
19604087|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19604088|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604089|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604090|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604091|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604092|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19604093|NCT04439318|Protective Agents|protective agents|mesh-ancestor
19604094|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604095|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19604096|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
19604097|NCT04439292|Trametinib|trametinib|mesh-list
19604098|NCT04439292|Dabrafenib|dabrafenib|mesh-list
19604099|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19604100|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604101|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604102|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129627|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
19604103|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604104|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19604105|NCT04439292|Protective Agents|protective agents|mesh-ancestor
19604106|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604107|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19604108|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
19604109|NCT04439279|Trametinib|trametinib|mesh-list
19604110|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19604111|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604112|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604113|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604114|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604115|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20129628|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129629|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
20129630|NCT00025519|Thalidomide|thalidomide|mesh-list
20129631|NCT00025519|Fludarabine|fludarabine|mesh-list
20129632|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
20129633|NCT00025519|Tacrolimus|tacrolimus|mesh-list
20311339|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311340|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311341|NCT00678613|Norfloxacin|norfloxacin|mesh-list
20311342|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20311343|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311344|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20311345|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20311346|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311347|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129634|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129635|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129636|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
20129637|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129638|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129639|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
20129640|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129641|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20129642|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604116|NCT04439279|Protective Agents|protective agents|mesh-ancestor
19604117|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604118|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19604119|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
19604120|NCT04439266|Crizotinib|crizotinib|mesh-list
19604121|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604122|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604123|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604124|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604125|NCT04439253|Crizotinib|crizotinib|mesh-list
19604126|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604127|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604128|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604129|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604130|NCT04439227|Adavosertib|adavosertib|mesh-list
19604131|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604132|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604133|NCT04439201|Palbociclib|palbociclib|mesh-list
19604134|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604135|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604136|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604137|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604138|NCT04439136|Afatinib|afatinib|mesh-list
19604139|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604140|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604141|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604142|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604143|NCT04439110|Trastuzumab|trastuzumab|mesh-list
19604144|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19604145|NCT04439110|Maytansine|maytansine|mesh-list
19604146|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
19604147|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19604148|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604149|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129643|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129644|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20129645|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
19604150|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
19604151|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19604152|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19604153|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604154|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
19604155|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604156|NCT04390581|Lidocaine|lidocaine|mesh-list
19604157|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
19604158|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
19604159|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604160|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604161|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
19604162|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604163|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19604164|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19604165|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19604166|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604167|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604168|NCT04379635|Paclitaxel|paclitaxel|mesh-list
19604169|NCT04379635|Carboplatin|carboplatin|mesh-list
19604170|NCT04379635|Pemetrexed|pemetrexed|mesh-list
19604171|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19604172|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604173|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
19604174|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
19604175|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
19604176|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604177|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604178|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19604179|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19604180|NCT04366115|Dexamethasone|dexamethasone|mesh-list
19604181|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
19604182|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19604183|NCT04366115|BB 1101|bb 1101|mesh-list
19604184|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604185|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
19604186|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
19604187|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604188|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604189|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604190|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
19604191|NCT04366115|Hormones|hormones|mesh-ancestor
19604192|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604193|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604194|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604195|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
19604196|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604197|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604198|NCT04362761|Ivacaftor|ivacaftor|mesh-list
19604199|NCT04362761|Elexacaftor|elexacaftor|mesh-list
19604200|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19604201|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604202|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604203|NCT04335201|Defibrotide|defibrotide|mesh-list
19604204|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19604205|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19604206|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604207|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19604208|NCT04313244|Vaccines|vaccines|mesh-list
19604209|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
19604210|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604211|NCT04294225|Letrozole|letrozole|mesh-list
19604212|NCT04294225|Anastrozole|anastrozole|mesh-list
19604213|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311348|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311349|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20311350|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311351|NCT00678626|Docetaxel|docetaxel|mesh-list
20311352|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311353|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
20311354|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311355|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
20311356|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604214|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19604215|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19604216|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604217|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604218|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19604219|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
19604220|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604221|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604222|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604223|NCT04292470|Amitriptyline|amitriptyline|mesh-list
19604224|NCT04292470|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19604225|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19604226|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
19604227|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20129646|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20129647|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129648|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
20129649|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20129650|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20129651|NCT00025519|Growth Substances|growth substances|mesh-ancestor
20129652|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
20129653|NCT00025532|Antibodies|antibodies|mesh-list
20129654|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20129655|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
19604228|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19604229|NCT04292470|Analgesics|analgesics|mesh-ancestor
19604230|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
19604231|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604232|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604233|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20129656|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129657|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
19604234|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19604235|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604236|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604237|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604238|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604239|NCT04292470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19604240|NCT04292470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19604241|NCT04292470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604242|NCT04209790|Temozolomide|temozolomide|mesh-list
19604243|NCT04209790|Benzolamide|benzolamide|mesh-list
19604244|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129658|NCT00025545|Methotrexate|methotrexate|mesh-list
20129659|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311357|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19604245|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
19604246|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604247|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604248|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19604249|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604250|NCT04183790|Ivacaftor|ivacaftor|mesh-list
19604251|NCT04183790|Elexacaftor|elexacaftor|mesh-list
19604252|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19604253|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604254|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604255|NCT04179396|Rucaparib|rucaparib|mesh-list
19604256|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19604257|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604258|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604259|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604260|NCT04140214|Carbocysteine|carbocysteine|mesh-list
19604261|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19604262|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604263|NCT04140214|Expectorants|expectorants|mesh-ancestor
19604264|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604265|NCT04115774|Diphosphonates|diphosphonates|mesh-list
19604266|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19604267|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604268|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
19604269|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19604270|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19604271|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
19604272|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604273|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19604274|NCT04034004|Naloxone|naloxone|mesh-list
19604275|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19604276|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604277|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
19604278|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604279|NCT04015622|Docetaxel|docetaxel|mesh-list
19604280|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604281|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
19604282|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
19604283|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129660|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
20129661|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604284|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604285|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
19604286|NCT04015115|Narcotics|narcotics|mesh-ancestor
20129662|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129663|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129664|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
20129665|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604287|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604288|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604289|NCT04015115|Analgesics|analgesics|mesh-ancestor
19604290|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
19604291|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604292|NCT04012138|Insulin|insulin|mesh-list
19604293|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19604294|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
19604295|NCT04012138|Albuterol|albuterol|mesh-list
19604296|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19604297|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604298|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19604299|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
19604300|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608268|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604301|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19604302|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604303|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
20129666|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608269|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20608270|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20608271|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608272|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19604304|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19604305|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19604306|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19604307|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604308|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604309|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604310|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604311|NCT03955861|Adalimumab|adalimumab|mesh-list
19604312|NCT03955861|Etanercept|etanercept|mesh-list
19604313|NCT03955861|Golimumab|golimumab|mesh-list
19604314|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
19604315|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604316|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20311358|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
20311359|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20311360|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20311361|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311362|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311363|NCT00678704|Urological Agents|urological agents|mesh-ancestor
20311364|NCT00678743|Simvastatin|simvastatin|mesh-list
19604317|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19604318|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20129667|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129668|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20129669|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
20129670|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20129671|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311365|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311366|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311367|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
20311368|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311369|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311370|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311371|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311372|NCT00678756|Ketoconazole|ketoconazole|mesh-list
20311373|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
20311374|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311375|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20311376|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311377|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311378|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311379|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20311380|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
20311381|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311382|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311383|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19604319|NCT03955861|Analgesics|analgesics|mesh-ancestor
19604320|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
19604321|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20129672|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
20129673|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
20129674|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129675|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20129676|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129677|NCT00025558|Carboplatin|carboplatin|mesh-list
20129678|NCT00025558|Temozolomide|temozolomide|mesh-list
20129679|NCT00025558|Thiotepa|thiotepa|mesh-list
20129680|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129681|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
20129682|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129683|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129684|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
20129685|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604322|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604323|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20311384|NCT00678769|Sirolimus|sirolimus|mesh-list
20311385|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20311386|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20311387|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311388|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20311389|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311390|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
20311391|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311392|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
20311393|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311394|NCT00678782|Etanercept|etanercept|mesh-list
20311395|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20311396|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20311397|NCT00678782|Analgesics|analgesics|mesh-ancestor
20311398|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
20311399|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311400|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311401|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20311402|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604324|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19604325|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
19604326|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19604327|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
19604328|NCT03912298|Narcotics|narcotics|mesh-ancestor
19604329|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604330|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604331|NCT03912298|Analgesics|analgesics|mesh-ancestor
19604332|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
20311403|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20311404|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311405|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
20311406|NCT00678964|Carboplatin|carboplatin|mesh-list
20311407|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20311408|NCT00678964|Vinorelbine|vinorelbine|mesh-list
19604333|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604334|NCT02543697|Epinephrine|epinephrine|mesh-list
19604335|NCT02543697|Racepinephrine|racepinephrine|mesh-list
19604336|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
19604337|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19604338|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604339|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604340|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604341|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604342|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604343|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19604344|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19604345|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
19604346|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604347|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19604348|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604349|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
19604350|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
19604351|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19604352|NCT02543944|Clonidine|clonidine|mesh-list
19604353|NCT02543944|Naltrexone|naltrexone|mesh-list
19604354|NCT02543944|Buprenorphine|buprenorphine|mesh-list
19604355|NCT02543944|Gabapentin|gabapentin|mesh-list
19604356|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19604357|NCT02543944|Narcotics|narcotics|mesh-ancestor
19604358|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604359|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604360|NCT02543944|Analgesics|analgesics|mesh-ancestor
19604361|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
19604362|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604363|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19604364|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19604365|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
20311409|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311410|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20311411|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311412|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604366|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19749599|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604367|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19604368|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19749600|NCT04857931|Colchicine|colchicine|mesh-list
20311413|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20311414|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
19604369|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19604370|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19604371|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604372|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604373|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
19604374|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19604375|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
19604376|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
19604377|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19604378|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19604379|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604380|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604381|NCT02543710|Taxane|taxane|mesh-list
19604382|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604383|NCT02543671|Vitamin D|vitamin d|mesh-list
19604384|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
19604385|NCT02543671|Vitamins|vitamins|mesh-ancestor
19604386|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
20311415|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311416|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
20311417|NCT00678977|Gemcitabine|gemcitabine|mesh-list
20311418|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311419|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311420|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
19604387|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604388|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19604389|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19604390|NCT02543645|Atezolizumab|atezolizumab|mesh-list
19604391|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604392|NCT02543411|Lidocaine|lidocaine|mesh-list
19604393|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
19604394|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
19604395|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604396|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604397|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
19604398|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604399|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19604400|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19604401|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19604402|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604403|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604404|NCT02543606|Esomeprazole|esomeprazole|mesh-list
19604405|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19604406|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604407|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19604408|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604409|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604410|NCT02543385|Ketamine|ketamine|mesh-list
19604411|NCT02543385|Esketamine|esketamine|mesh-list
19604412|NCT02543385|Analgesics|analgesics|mesh-ancestor
19604413|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
19604414|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604415|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604416|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19604417|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19604418|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
20129686|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129687|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129688|NCT00025584|Bortezomib|bortezomib|mesh-list
20129689|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129690|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
20129691|NCT00025597|Carboplatin|carboplatin|mesh-list
20129692|NCT00025597|Doxorubicin|doxorubicin|mesh-list
20129693|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20129694|NCT00025597|Etoposide|etoposide|mesh-list
20129695|NCT00025597|Vincristine|vincristine|mesh-list
20129696|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129697|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
20129698|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129699|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129700|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129701|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
20129702|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604419|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
20129703|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604420|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604421|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19604422|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19604423|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604424|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604425|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
19604426|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19604427|NCT02543034|Petrolatum|petrolatum|mesh-list
19604428|NCT02543034|Emollients|emollients|mesh-ancestor
19604429|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
19604430|NCT02543099|Policosanol|policosanol|mesh-list
19604431|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19604432|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19604433|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
19604434|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604435|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19604436|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19604437|NCT02543086|Piperaquine|piperaquine|mesh-list
19604438|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
19604439|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19604440|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19604441|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19658778|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
20129704|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129705|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129706|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129707|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129708|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129709|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129710|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
20311421|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311422|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
20311423|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311424|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311425|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311426|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
20311427|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311428|NCT00678990|Heparin|heparin|mesh-list
20311429|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
20311430|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20311431|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20311432|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311433|NCT00679068|Bosentan|bosentan|mesh-list
20311434|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20311435|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20311436|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311437|NCT00679120|Cimetidine|cimetidine|mesh-list
20311438|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20311439|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20311440|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20311441|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
20311442|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
19658779|NCT02443324|Ramucirumab|ramucirumab|mesh-list
19658780|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658781|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129711|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129712|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129713|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
20129714|NCT00025610|Carboplatin|carboplatin|mesh-list
20129715|NCT00025610|Doxorubicin|doxorubicin|mesh-list
20129716|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20129717|NCT00025610|Etoposide|etoposide|mesh-list
20129718|NCT00025610|Vincristine|vincristine|mesh-list
20129719|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129720|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
20129721|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604442|NCT02543229|Ranibizumab|ranibizumab|mesh-list
19604443|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19604444|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19604445|NCT02543229|Growth Substances|growth substances|mesh-ancestor
20129722|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129723|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129724|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
20129725|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129726|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129727|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129728|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129729|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129730|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129731|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129732|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129733|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129734|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129735|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129736|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
20129737|NCT00025623|Carboplatin|carboplatin|mesh-list
20129738|NCT00025623|Doxorubicin|doxorubicin|mesh-list
20129739|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20129740|NCT00025623|Etoposide|etoposide|mesh-list
20129741|NCT00025623|Vincristine|vincristine|mesh-list
20129742|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129743|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
19604446|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604447|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
19604448|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604449|NCT02543060|Fluorides|fluorides|mesh-list
19604450|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
19604451|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
19604452|NCT02543060|Protective Agents|protective agents|mesh-ancestor
19604453|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604454|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19604455|NCT02542969|Simvastatin|simvastatin|mesh-list
19604456|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19604457|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19604458|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
19604459|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604460|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19604461|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19604462|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604463|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
19604464|NCT02543073|Hormones|hormones|mesh-ancestor
19604465|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604466|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604467|NCT02542930|Thymalfasin|thymalfasin|mesh-list
19604468|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19604469|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
19604470|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604471|NCT02542852|Ritonavir|ritonavir|mesh-list
19604472|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19604473|NCT02542852|Dolutegravir|dolutegravir|mesh-list
19604474|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19604475|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19604476|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
19604477|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604478|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604479|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19604480|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19604481|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
19604482|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604483|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19604484|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19604485|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19604486|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19604487|NCT02542748|Norepinephrine|norepinephrine|mesh-list
19604488|NCT02542748|Ephedrine|ephedrine|mesh-list
20129744|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129745|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604489|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19604490|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604491|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604492|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20129746|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19604493|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604494|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604495|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
19604496|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
19604497|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604498|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19604499|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19604500|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
19604501|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19604502|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604503|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129747|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
20129748|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129749|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129750|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129751|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19604504|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
19604505|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604506|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604507|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
19604508|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19604509|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19604510|NCT02542592|Prednisolone|prednisolone|mesh-list
19604511|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
19604512|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19604513|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
19604514|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604515|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
19604516|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
19604517|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604518|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604519|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604520|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
19604521|NCT02542592|Hormones|hormones|mesh-ancestor
20129752|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129753|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129754|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129755|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129756|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129757|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129758|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
19604522|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604523|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19604524|NCT02542592|Protective Agents|protective agents|mesh-ancestor
20311443|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311444|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311445|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311446|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20311447|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311448|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311449|NCT00679146|Ketoprofen|ketoprofen|mesh-list
20311450|NCT00679146|Colchicine|colchicine|mesh-list
20311451|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19604525|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604526|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604527|NCT02542813|Oxytocin|oxytocin|mesh-list
19604528|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
19604529|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19604530|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604531|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19604532|NCT02542254|Albuterol|albuterol|mesh-list
20129759|NCT00025636|Cytarabine|cytarabine|mesh-list
20129760|NCT00025636|Dexamethasone|dexamethasone|mesh-list
20129761|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
20129762|NCT00025636|Melphalan|melphalan|mesh-list
20129763|NCT00025636|Carmustine|carmustine|mesh-list
20129764|NCT00025636|Methotrexate|methotrexate|mesh-list
20129765|NCT00025636|Etoposide|etoposide|mesh-list
20129766|NCT00025636|Vincristine|vincristine|mesh-list
20129767|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19604533|NCT02542254|Ipratropium|ipratropium|mesh-list
19604534|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20129768|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
20129769|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129770|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20311452|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19604535|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
19604536|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604537|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604538|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19604539|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604540|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
19604541|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19604542|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19604543|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19604544|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604545|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604546|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604547|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604548|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19604549|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
19604550|NCT02542137|Thymalfasin|thymalfasin|mesh-list
19604551|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19604552|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
19604553|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604554|NCT02542124|Interleukin-12|interleukin-12|mesh-list
19604555|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19604556|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
19604557|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604558|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19604559|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19604560|NCT02542124|Growth Substances|growth substances|mesh-ancestor
19604561|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
19604562|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604563|NCT02542111|Gemcitabine|gemcitabine|mesh-list
19604564|NCT02542111|Dexamethasone|dexamethasone|mesh-list
19604565|NCT02542111|Bortezomib|bortezomib|mesh-list
19604566|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604567|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604568|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
19604569|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
19604570|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604571|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604572|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604573|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
19604574|NCT02542111|Hormones|hormones|mesh-ancestor
19604575|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604576|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604577|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19604578|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
19604579|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604580|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
19604581|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604582|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604583|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19604584|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
19604585|NCT02542007|Sirolimus|sirolimus|mesh-list
19604586|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604587|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604588|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19604589|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604590|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
19604591|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19604592|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
19604593|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604594|NCT02542098|Hydrocodone|hydrocodone|mesh-list
19604595|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19604596|NCT02542098|Narcotics|narcotics|mesh-ancestor
19604597|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604598|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604599|NCT02542098|Analgesics|analgesics|mesh-ancestor
19604600|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
19604601|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604602|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
19604603|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604604|NCT02541734|Exenatide|exenatide|mesh-list
19604605|NCT02541734|Polygeline|polygeline|mesh-list
19749601|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
19749602|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604606|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19604607|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604608|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19604609|NCT02541734|Incretins|incretins|mesh-ancestor
19604610|NCT02541734|Hormones|hormones|mesh-ancestor
19604611|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604612|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
19604613|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
19604614|NCT02541786|Rabeprazole|rabeprazole|mesh-list
19604615|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
19604616|NCT02541786|Lansoprazole|lansoprazole|mesh-list
19604617|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19604618|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604619|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19604620|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604621|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604622|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
19604623|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604624|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
19604625|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19604626|NCT02541643|Elotuzumab|elotuzumab|mesh-list
19604627|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604628|NCT02541708|Folic Acid|folic acid|mesh-list
19604629|NCT02541708|Hematinics|hematinics|mesh-ancestor
19604630|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
19604631|NCT02541708|Vitamins|vitamins|mesh-ancestor
19604632|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
19604633|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604634|NCT02541526|Mirtazapine|mirtazapine|mesh-list
19604635|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
20311453|NCT00679146|Analgesics|analgesics|mesh-ancestor
20311454|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
20311455|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604636|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19604637|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19604638|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
19604639|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
19604640|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604641|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604642|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604643|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19604644|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20129771|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129772|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
19604645|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604646|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19604647|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19604648|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19604649|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604650|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19604651|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19604652|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
20129773|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129774|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129775|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129776|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20129777|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
20129778|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
20129779|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20129780|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20129781|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
20129782|NCT00025636|Hormones|hormones|mesh-ancestor
20129783|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20129784|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20129785|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20129786|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
20129787|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20129788|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129789|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
19604653|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19604654|NCT02541552|Ropivacaine|ropivacaine|mesh-list
19604655|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
19604656|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
19604657|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604658|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604659|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
19604660|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604661|NCT02541500|Minocycline|minocycline|mesh-list
19604662|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604663|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604664|NCT02541396|Ketamine|ketamine|mesh-list
19604665|NCT02541396|Oxycodone|oxycodone|mesh-list
19604666|NCT02541396|Analgesics|analgesics|mesh-ancestor
19604667|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
19604668|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604669|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604670|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19604671|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19604672|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
19604673|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
19604674|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604675|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19604676|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19604677|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604678|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604679|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19604680|NCT02541396|Narcotics|narcotics|mesh-ancestor
19604681|NCT02541383|Thalidomide|thalidomide|mesh-list
19604682|NCT02541383|Dexamethasone|dexamethasone|mesh-list
19604683|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
19604684|NCT02541383|Bortezomib|bortezomib|mesh-list
19604685|NCT02541383|Daratumumab|daratumumab|mesh-list
19604686|NCT02541383|BB 1101|bb 1101|mesh-list
19604687|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19604688|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604689|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
19604690|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
19604691|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604692|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604693|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604694|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
19604695|NCT02541383|Hormones|hormones|mesh-ancestor
19604696|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604697|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604698|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604699|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
19604700|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604701|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604702|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19604703|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
19604704|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
19604705|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604706|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604707|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19604708|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19604709|NCT02541383|Growth Substances|growth substances|mesh-ancestor
19604710|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
19604711|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
19604712|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19604713|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
19604714|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129790|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
20129791|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129792|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20129793|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20129794|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129795|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129796|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129797|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
20129798|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129799|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129800|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129801|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129802|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
20129803|NCT00025649|Melphalan|melphalan|mesh-list
20129804|NCT00025649|Busulfan|busulfan|mesh-list
20129805|NCT00025649|Carboplatin|carboplatin|mesh-list
20129806|NCT00025649|Doxorubicin|doxorubicin|mesh-list
20129807|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20129808|NCT00025649|Etoposide|etoposide|mesh-list
20129809|NCT00025649|Vincristine|vincristine|mesh-list
20129810|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20129811|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
20129812|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129813|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604715|NCT02541084|Aflibercept|aflibercept|mesh-list
19604716|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19604717|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19604718|NCT02541084|Growth Substances|growth substances|mesh-ancestor
19604719|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604720|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
19604721|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604722|NCT02541071|Clonidine|clonidine|mesh-list
20129814|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129815|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
20129816|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129817|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129818|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20129819|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20129820|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20129821|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129822|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604723|NCT02541071|Yohimbine|yohimbine|mesh-list
20129823|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129824|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129825|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129826|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129827|NCT00025675|Gefitinib|gefitinib|mesh-list
20311456|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311457|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20311458|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20311459|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19604724|NCT02541071|Analgesics|analgesics|mesh-ancestor
19604725|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
19604726|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604727|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604728|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19604729|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
19604730|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
19604731|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19604732|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19604733|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604734|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604735|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604736|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604737|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
19604738|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19604739|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19604740|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19604741|NCT02541071|Urological Agents|urological agents|mesh-ancestor
19604742|NCT02541045|Metadoxine|metadoxine|mesh-list
19604743|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19604744|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
19604745|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19604746|NCT02541227|Protective Agents|protective agents|mesh-ancestor
19604747|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604748|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
19604749|NCT02541032|Minocycline|minocycline|mesh-list
19604750|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604751|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604752|NCT02541019|Ondansetron|ondansetron|mesh-list
19604753|NCT02541019|Palonosetron|palonosetron|mesh-list
19604754|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
19604755|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
19604756|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604757|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604758|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604759|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
19604760|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
19604761|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19604762|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
19604763|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604764|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604765|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20129828|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604766|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20311460|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604767|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604768|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19604769|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19604770|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19604771|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
19604772|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604773|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604774|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
19604775|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19604776|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
19604777|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604778|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604779|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19604780|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604781|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
19604782|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19604783|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
19604784|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604785|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604786|NCT02540876|Ilorasertib|ilorasertib|mesh-list
19604787|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604788|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604789|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604790|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604791|NCT02540824|Apatinib|apatinib|mesh-list
19604792|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604793|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19604794|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604795|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604796|NCT02540837|Bupivacaine|bupivacaine|mesh-list
19604797|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
19604798|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
19604799|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604800|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604801|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
19604802|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604803|NCT02540785|Levofloxacin|levofloxacin|mesh-list
19604804|NCT02540785|Ofloxacin|ofloxacin|mesh-list
19604805|NCT02540785|Tobramycin|tobramycin|mesh-list
19604806|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19604807|NCT02540785|Dexamethasone|dexamethasone|mesh-list
19604808|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
19604809|NCT02540785|BB 1101|bb 1101|mesh-list
19604810|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
19604811|NCT02540785|Dipivefrin|dipivefrin|mesh-list
19604812|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604813|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
19604814|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
19604815|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604816|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604817|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604818|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
19604819|NCT02540785|Hormones|hormones|mesh-ancestor
19604820|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604821|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604822|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604823|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
19604824|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604825|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604826|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19604827|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604828|NCT02540785|Renal Agents|renal agents|mesh-ancestor
19604829|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604830|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19604831|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19604832|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19604833|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19604834|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19604835|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
19604836|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
20129829|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20311461|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311462|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
20311463|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
19604837|NCT02540785|Protective Agents|protective agents|mesh-ancestor
19604838|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604839|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604840|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604841|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19604842|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19604843|NCT02540720|Dexamethasone|dexamethasone|mesh-list
19604844|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
19604845|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19604846|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20129830|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129831|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129832|NCT00025688|Paclitaxel|paclitaxel|mesh-list
20129833|NCT00025688|Carboplatin|carboplatin|mesh-list
19604847|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604848|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
19604849|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
20311464|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311465|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
20311466|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311467|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19604850|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604851|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604852|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604853|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
19604854|NCT02540720|Hormones|hormones|mesh-ancestor
19604855|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604856|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604857|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604858|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
19604859|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
19604860|NCT02540642|Vitamins|vitamins|mesh-ancestor
19604861|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
19604862|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604863|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
19604864|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
19604865|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
20311468|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
20311469|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311470|NCT00679224|Ambrisentan|ambrisentan|mesh-list
20311471|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20311472|NCT00679237|Metformin|metformin|mesh-list
20311473|NCT00679237|Glimepiride|glimepiride|mesh-list
20311474|NCT00679237|Ezetimibe|ezetimibe|mesh-list
20311475|NCT00679237|Diuretics|diuretics|mesh-list
20311476|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20311477|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311478|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19604866|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19604867|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604868|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
19604869|NCT02540707|Mirabegron|mirabegron|mesh-list
19604870|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19604871|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19604872|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
19604873|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604874|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604875|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604876|NCT02540707|Urological Agents|urological agents|mesh-ancestor
19604877|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19604878|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19604879|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604880|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604881|NCT02540460|Delpazolid|delpazolid|mesh-list
20129834|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129835|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129836|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129837|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129838|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129839|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604882|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
19604883|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604884|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129840|NCT00025727|Ritonavir|ritonavir|mesh-list
19604885|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19604886|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604887|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604888|NCT02540512|Acetaminophen|acetaminophen|mesh-list
19604889|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19604890|NCT02540512|Hydrocodone|hydrocodone|mesh-list
19604891|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19604892|NCT02540512|Analgesics|analgesics|mesh-ancestor
19604893|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
19604894|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604895|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129841|NCT00025727|Lopinavir|lopinavir|mesh-list
20129842|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
20129843|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20129844|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20129845|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
20129846|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129847|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129848|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19604896|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
19604897|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19604898|NCT02540512|Narcotics|narcotics|mesh-ancestor
19604899|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604900|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
19604901|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604902|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20129849|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20129850|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
20129851|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129852|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20129853|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20129854|NCT00025740|Clonazepam|clonazepam|mesh-list
20129855|NCT00025740|Paroxetine|paroxetine|mesh-list
19604903|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604904|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604905|NCT02540239|Simethicone|simethicone|mesh-list
19604906|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
19604907|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604908|NCT02540239|Emollients|emollients|mesh-ancestor
19604909|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
19604910|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
19604911|NCT02540395|Prednisolone|prednisolone|mesh-list
19604912|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19604913|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
19604914|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19604915|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
19604916|NCT02540395|Tacrolimus|tacrolimus|mesh-list
19604917|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19604918|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
20311479|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311480|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
20311481|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311482|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311483|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20311484|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311485|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
20311486|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
20311487|NCT00679250|Cetirizine|cetirizine|mesh-list
20311488|NCT00679250|Levocetirizine|levocetirizine|mesh-list
20311489|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20311490|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20311491|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
20311492|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
20311493|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604919|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311494|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311495|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604920|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
19604921|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311496|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19604922|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19604923|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129856|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20311497|NCT00679315|Alfuzosin|alfuzosin|mesh-list
19604924|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604925|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19604926|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604927|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19604928|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
20129857|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20129858|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20129859|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129860|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20129861|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
20129862|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129863|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20129864|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
20129865|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20129866|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20129867|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20129868|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129869|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
20129870|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
19604929|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604930|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604931|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19604932|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
19604933|NCT02540395|Hormones|hormones|mesh-ancestor
19604934|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19604935|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19604936|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
19604937|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
19604938|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604939|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19604940|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19604941|NCT02540395|Protective Agents|protective agents|mesh-ancestor
19604942|NCT02540369|Aflibercept|aflibercept|mesh-list
19604943|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19604944|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19604945|NCT02540369|Growth Substances|growth substances|mesh-ancestor
19604946|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604947|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
19604948|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604949|NCT02540070|Ketorolac|ketorolac|mesh-list
19604950|NCT02540070|Epinephrine|epinephrine|mesh-list
19604951|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
19604952|NCT02540070|Morphine|morphine|mesh-list
19604953|NCT02540070|Ropivacaine|ropivacaine|mesh-list
19604954|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19604955|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19604956|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604957|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19604958|NCT02540070|Analgesics|analgesics|mesh-ancestor
19604959|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
19604960|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604961|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19604962|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19604963|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19604964|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
19604965|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19604966|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604967|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19604968|NCT02540070|Narcotics|narcotics|mesh-ancestor
19604969|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
19604970|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
19604971|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19604972|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19604973|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
19604974|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19604975|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
19604976|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
19604977|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
19604978|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20129871|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
20129872|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
19604979|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19604980|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20129873|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20129874|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129875|NCT00025779|Guanfacine|guanfacine|mesh-list
20129876|NCT00025779|Methylphenidate|methylphenidate|mesh-list
20129877|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20129878|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129879|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20129880|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20129881|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19604981|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19604982|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19604983|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19604984|NCT02539979|Acetaminophen|acetaminophen|mesh-list
19604985|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20311498|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20311499|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20311500|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19604986|NCT02539979|Analgesics|analgesics|mesh-ancestor
19604987|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
20311501|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
20311502|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311503|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19604988|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19604989|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19604990|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
19604991|NCT02539966|Sirolimus|sirolimus|mesh-list
19604992|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19604993|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19604994|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19604995|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19604996|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
19604997|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19604998|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
19604999|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605000|NCT02540018|Paclitaxel|paclitaxel|mesh-list
19605001|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20311504|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311505|NCT00679315|Urological Agents|urological agents|mesh-ancestor
20311506|NCT00679458|Buprenorphine|buprenorphine|mesh-list
20311507|NCT00679458|Naloxone|naloxone|mesh-list
20311508|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20311509|NCT00679458|Narcotics|narcotics|mesh-ancestor
20311510|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20311511|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311512|NCT00679458|Analgesics|analgesics|mesh-ancestor
20311513|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
20311514|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605002|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605003|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605004|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19605005|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19605006|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605007|NCT02539940|Paclitaxel|paclitaxel|mesh-list
19605008|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19605009|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605010|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605011|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
19605012|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
19605013|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605014|NCT02539849|Adalimumab|adalimumab|mesh-list
19605015|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605016|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605017|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
19605018|NCT02539706|Rocuronium|rocuronium|mesh-list
19605019|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19605020|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19605021|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19605022|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605023|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605024|NCT02539745|Vitamin D|vitamin d|mesh-list
19605025|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19605026|NCT02539745|Vitamins|vitamins|mesh-ancestor
19605027|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
20129882|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311515|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19605028|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749603|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605029|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20129883|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
20129884|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20129885|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19658801|NCT02408861|Nivolumab|nivolumab|mesh-list
19658802|NCT02408861|Ipilimumab|ipilimumab|mesh-list
19658803|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658804|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658805|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19658806|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129886|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20129887|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20129888|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20129889|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
20129890|NCT00025792|Pramipexole|pramipexole|mesh-list
19658812|NCT02386800|Panobinostat|panobinostat|mesh-list
19658813|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658814|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19658815|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658816|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129891|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
20129892|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129893|NCT00025792|Protective Agents|protective agents|mesh-ancestor
20129894|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129895|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20129896|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20129897|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
19658824|NCT02367040|Rituximab|rituximab|mesh-list
19658825|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19658826|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658827|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
19658828|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658829|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129898|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
20129899|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20129900|NCT00026039|Estrogens|estrogens|mesh-list
20129901|NCT00026039|Hormones|hormones|mesh-ancestor
20129902|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20129903|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129904|NCT00026052|Riluzole|riluzole|mesh-list
20129905|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
20129906|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20129907|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20129908|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20129909|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129910|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129911|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20129912|NCT00026052|Protective Agents|protective agents|mesh-ancestor
20129913|NCT00026078|Docetaxel|docetaxel|mesh-list
19658846|NCT02322099|Alendronate|alendronate|mesh-list
19658847|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
19658848|NCT02322099|Tenofovir|tenofovir|mesh-list
19658849|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
19658850|NCT02322099|Calcium|calcium|mesh-list
19658851|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19658852|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658853|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
19658854|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19658855|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19658856|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19658857|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19658858|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658859|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19658860|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19658861|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19658862|NCT02322099|Antacids|antacids|mesh-ancestor
20311516|NCT00679484|Candesartan|candesartan|mesh-list
20311517|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
20311518|NCT00679484|Olmesartan|olmesartan|mesh-list
20311519|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20311520|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20311521|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19658863|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19658864|NCT02322099|Vitamins|vitamins|mesh-ancestor
20129914|NCT00026078|Ifosfamide|ifosfamide|mesh-list
20129915|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605030|NCT02539641|Hormones|hormones|mesh-list
19605031|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605032|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605033|NCT02539628|Ropivacaine|ropivacaine|mesh-list
19605034|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
19605035|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
19605036|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605037|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605038|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
19605039|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605040|NCT02539316|SMOFlipid|smoflipid|mesh-list
19605041|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19605042|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19605043|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19605044|NCT02539199|Misoprostol|misoprostol|mesh-list
19605045|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19605046|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
19605047|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19605048|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605049|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19605050|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19605051|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
19605052|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
19605053|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19605054|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19605055|NCT02539394|Prednisolone|prednisolone|mesh-list
20129916|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129917|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129918|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129919|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129920|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19605056|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
19605057|NCT02539394|Hemostatics|hemostatics|mesh-list
19605058|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19605059|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
19605060|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605061|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
19605062|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
19605063|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605064|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605065|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19605066|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
19605067|NCT02539394|Hormones|hormones|mesh-ancestor
19605068|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605069|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19605070|NCT02539394|Protective Agents|protective agents|mesh-ancestor
19605071|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19605072|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605073|NCT02539394|Coagulants|coagulants|mesh-ancestor
19605074|NCT02538926|Prednisone|prednisone|mesh-list
19605075|NCT02538926|Cortisone|cortisone|mesh-list
19605076|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
19605077|NCT02538926|Rituximab|rituximab|mesh-list
19605078|NCT02538926|Doxorubicin|doxorubicin|mesh-list
19605079|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19605080|NCT02538926|Etoposide|etoposide|mesh-list
19605081|NCT02538926|Vincristine|vincristine|mesh-list
19605082|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
19605083|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
19605084|NCT02538926|Asparaginase|asparaginase|mesh-list
19605085|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
20129921|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
20129922|NCT00026091|Fenretinide|fenretinide|mesh-list
20129923|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129924|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20129925|NCT00026091|Protective Agents|protective agents|mesh-ancestor
20129926|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605086|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19605087|NCT02538926|Antibodies|antibodies|mesh-list
19605088|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
20129927|NCT00026104|Gemcitabine|gemcitabine|mesh-list
20129928|NCT00026104|Paclitaxel|paclitaxel|mesh-list
19605089|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19605090|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19605091|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
19605092|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605093|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605094|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20129929|NCT00026104|Tipifarnib|tipifarnib|mesh-list
20129930|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129931|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605095|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
19605096|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605097|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605098|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19605099|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19605100|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19605101|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19605102|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605103|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605104|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
20311522|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20311523|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311524|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20311525|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311526|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311527|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
20311528|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311529|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311530|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311531|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311532|NCT00679523|Tavaborole|tavaborole|mesh-list
20311533|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19605105|NCT02538926|Hormones|hormones|mesh-ancestor
19605106|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20129932|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129933|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
20129934|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129935|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129936|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19605107|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19605108|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20311534|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
20311535|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311536|NCT00679536|Fludarabine|fludarabine|mesh-list
20311537|NCT00679536|Busulfan|busulfan|mesh-list
20311538|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
20311539|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129937|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
20129938|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
20129939|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129940|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311540|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311541|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311542|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
20311543|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311544|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
20311545|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20311546|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20311547|NCT00679601|Tavaborole|tavaborole|mesh-list
20311548|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
20311549|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311550|NCT00679614|Acetaminophen|acetaminophen|mesh-list
20311551|NCT00679614|Tramadol|tramadol|mesh-list
20311552|NCT00679614|Naloxone|naloxone|mesh-list
20311553|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20311554|NCT00679614|Analgesics|analgesics|mesh-ancestor
20311555|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
20311556|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311557|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311558|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
19605109|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605110|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
19605111|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
19605112|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605113|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
19605114|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
19605115|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
19605116|NCT02538939|Antidotes|antidotes|mesh-ancestor
19605117|NCT02538939|Protective Agents|protective agents|mesh-ancestor
19605118|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129941|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311559|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20311560|NCT00679614|Narcotics|narcotics|mesh-ancestor
19605119|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
19605120|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605121|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
19605122|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20129942|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
20129943|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605123|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605124|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
19605125|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
19605126|NCT02538718|Ritodrine|ritodrine|mesh-list
19605127|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
19605128|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
19605129|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605130|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605131|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
19605132|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19605133|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19605134|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19605135|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19605136|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
19605137|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605138|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605139|NCT02538627|Trametinib|trametinib|mesh-list
19605140|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605141|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605142|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605143|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605144|NCT02538484|Letrozole|letrozole|mesh-list
19605145|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605146|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19605147|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19605148|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605149|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605150|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19605151|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
19605152|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605153|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605154|NCT02538367|Prucalopride|prucalopride|mesh-list
19605155|NCT02538367|YH12852|yh12852|mesh-list
19605156|NCT02538367|Laxatives|laxatives|mesh-ancestor
19605157|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19605158|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19605159|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19605160|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
19605161|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605162|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605163|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605164|NCT02538393|Sorafenib|sorafenib|mesh-list
19605165|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605166|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605167|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605168|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605169|NCT02538224|Doxycycline|doxycycline|mesh-list
19605170|NCT02538224|Ketoprofen|ketoprofen|mesh-list
19605171|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19605172|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605173|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
19605174|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19605175|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19605176|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19605177|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605178|NCT02538224|Analgesics|analgesics|mesh-ancestor
19605179|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
19605180|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605181|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605182|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605183|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605184|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19605185|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605186|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605187|NCT02538211|Vaccines|vaccines|mesh-list
19605188|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20129944|NCT00026130|Gemcitabine|gemcitabine|mesh-list
20311561|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605189|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
19605190|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605191|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19605192|NCT02538302|Oxybutynin|oxybutynin|mesh-list
19605193|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
19605194|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
19605195|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605196|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605197|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19605198|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19605199|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
19605200|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605201|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605202|NCT02538302|Urological Agents|urological agents|mesh-ancestor
19605203|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
19605204|NCT02538302|Coagulants|coagulants|mesh-ancestor
19605205|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19605206|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
19605207|NCT02538432|Gemcitabine|gemcitabine|mesh-list
19605208|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19605209|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
19605210|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311562|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20311563|NCT00679640|Candesartan|candesartan|mesh-list
20311564|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20311565|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20311566|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20311567|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311568|NCT00679653|Sibutramine|sibutramine|mesh-list
19605211|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605212|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
19605213|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605214|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605215|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19605216|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
19605217|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605218|NCT02538237|Ibuprofen|ibuprofen|mesh-list
19605219|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19605220|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605221|NCT02538237|Analgesics|analgesics|mesh-ancestor
19605222|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
19605223|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605224|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605225|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605226|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605227|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19605228|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605229|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605230|NCT02538198|Lenalidomide|lenalidomide|mesh-list
19605231|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
19605232|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605233|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19605234|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19605235|NCT02538198|Growth Substances|growth substances|mesh-ancestor
19605236|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
19605237|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605238|NCT02538172|Valganciclovir|valganciclovir|mesh-list
19605239|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
19605240|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605241|NCT02538003|Delpazolid|delpazolid|mesh-list
19605242|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
19605243|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19605244|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605245|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19605246|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605247|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605248|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
19605249|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
19605250|NCT02538146|Vitamins|vitamins|mesh-ancestor
19605251|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
19605252|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605253|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
19605254|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
19605255|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19605256|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19605257|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605258|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
19605259|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
19605260|NCT02538081|Risperidone|risperidone|mesh-list
19605261|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19605262|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
19605263|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605264|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605265|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605266|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19605267|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19605268|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605269|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19605270|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19605271|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
19658865|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
19658866|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
19658867|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19658868|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19658869|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658870|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19658871|NCT02316236|Analgesics|analgesics|mesh-ancestor
19658872|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
19658873|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658874|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19658875|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19658876|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19658877|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
19658878|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19658879|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658880|NCT02307812|Paclitaxel|paclitaxel|mesh-list
19658881|NCT02307812|Ramucirumab|ramucirumab|mesh-list
19658882|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19658883|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19658884|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
19658885|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
19658886|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
19658887|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658888|NCT02267252|Antibodies|antibodies|mesh-list
19658889|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
19658890|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19658891|NCT02246270|Heparin|heparin|mesh-list
19658892|NCT02246270|Calcium heparin|calcium heparin|mesh-list
19658893|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
19658894|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19658895|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19658896|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129945|NCT00026130|Fluorouracil|fluorouracil|mesh-list
20129946|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20129947|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
20129948|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129949|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129950|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
20129951|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129952|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129953|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749604|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
19749605|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19749606|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749607|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749608|NCT04857034|BMS-986165|bms-986165|mesh-list
19749609|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
19749610|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749611|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749612|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749613|NCT04844606|Mirikizumab|mirikizumab|mesh-list
19749614|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19658907|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
19658908|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19749615|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19749616|NCT04844606|Analgesics|analgesics|mesh-ancestor
19605272|NCT02537860|Fentanyl|fentanyl|mesh-list
19605273|NCT02537860|Bupivacaine|bupivacaine|mesh-list
19605274|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
19605275|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
19605276|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605277|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605278|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
19605279|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605280|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19605281|NCT02537860|Narcotics|narcotics|mesh-ancestor
19605282|NCT02537860|Analgesics|analgesics|mesh-ancestor
19605283|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19605284|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19605285|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
19605286|NCT02537847|Ertapenem|ertapenem|mesh-list
19605287|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
19605288|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
19605289|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19605290|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605291|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19605292|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605293|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605294|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19605295|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19605296|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605297|NCT02537925|Celecoxib|celecoxib|mesh-list
19605298|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19605299|NCT02537925|Nedaplatin|nedaplatin|mesh-list
19605300|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19605301|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605302|NCT02537925|Analgesics|analgesics|mesh-ancestor
19605303|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
19605304|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605305|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605306|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605307|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605308|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19605309|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605310|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605311|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605312|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
19605313|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19605314|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605315|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19605316|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605317|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
19605318|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19605319|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605320|NCT02537509|Vitamins|vitamins|mesh-ancestor
19605321|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
19605322|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19605323|NCT02537691|Theophylline|theophylline|mesh-list
19605324|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19605325|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
19605326|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605327|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605328|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19605329|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
19605330|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19605331|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605332|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605333|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
19605334|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19605335|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19605336|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
19605337|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605338|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
19605339|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19605340|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
19605341|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19605342|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
19605343|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749617|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
19605344|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605345|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
19605346|NCT02537353|Epinephrine|epinephrine|mesh-list
19605347|NCT02537353|Racepinephrine|racepinephrine|mesh-list
19605348|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
19605349|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19605350|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19605351|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
19605352|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605353|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605354|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605355|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19605356|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19605357|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
19605358|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605359|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19605360|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
19605361|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
19605362|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
19605363|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19605364|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
19605365|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19605366|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605367|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19605368|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605369|NCT02537561|Gemcitabine|gemcitabine|mesh-list
20129954|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
20129955|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129956|NCT00026143|Interferons|interferons|mesh-list
20129957|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
20129958|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
20129959|NCT00026143|Interleukin-12|interleukin-12|mesh-list
20129960|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129961|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
20129962|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20129963|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
20129964|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605370|NCT02537561|Cisplatin|cisplatin|mesh-list
19605371|NCT02537561|Talazoparib|talazoparib|mesh-list
20129965|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20129966|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20311569|NCT00679653|Metoprolol|metoprolol|mesh-list
19605372|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605373|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19605374|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
19605375|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605376|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
19605377|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605378|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605379|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311570|NCT00679653|Verapamil|verapamil|mesh-list
20311571|NCT00679653|Felodipine|felodipine|mesh-list
20311572|NCT00679653|Ramipril|ramipril|mesh-list
20311573|NCT00679653|Trandolapril|trandolapril|mesh-list
20311574|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19605380|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
19605381|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605382|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19605383|NCT02537600|Vemurafenib|vemurafenib|mesh-list
19605384|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605385|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605386|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605387|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605388|NCT02537379|Ribavirin|ribavirin|mesh-list
19605389|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
19605390|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605391|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
19605392|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605393|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
19605394|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19605395|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605396|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311575|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20129967|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20311576|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
19605397|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605398|NCT02537366|Analgesics|analgesics|mesh-ancestor
19605399|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
19605400|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605401|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19605402|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19605403|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19605404|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
19605405|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605406|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605407|NCT02537392|Folic Acid|folic acid|mesh-list
19605408|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
19605409|NCT02537392|Vitamins|vitamins|mesh-ancestor
19605410|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
19605411|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605412|NCT02537392|Hematinics|hematinics|mesh-ancestor
19605413|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
19605414|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19605415|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605416|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605417|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605418|NCT02537249|Analgesics|analgesics|mesh-ancestor
19605419|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
19605420|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605421|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19605422|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19605423|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19605424|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
19605425|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605426|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129968|NCT00026143|Growth Substances|growth substances|mesh-ancestor
20129969|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
20129970|NCT00026156|Docetaxel|docetaxel|mesh-list
20129971|NCT00026156|Vinorelbine|vinorelbine|mesh-list
19605427|NCT02537210|Mesalamine|mesalamine|mesh-list
19605428|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19605429|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605430|NCT02537210|Analgesics|analgesics|mesh-ancestor
19605431|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
20129972|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129973|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
20129974|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
19605432|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605433|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605434|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605435|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605436|NCT02537158|Sorafenib|sorafenib|mesh-list
19605437|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605438|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605439|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605440|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605441|NCT02537223|Cisplatin|cisplatin|mesh-list
19605442|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605443|NCT02537197|Naltrexone|naltrexone|mesh-list
19605444|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19605445|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19605446|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311577|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
20311578|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605447|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
19605448|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605449|NCT02537171|Apatinib|apatinib|mesh-list
19605450|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129975|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
20129976|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605451|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605452|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605453|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605454|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
19605455|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19605456|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605457|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19605458|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19605459|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605460|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605461|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605462|NCT02537080|Nimodipine|nimodipine|mesh-list
19605463|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19605464|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19605465|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19605466|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605467|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19605468|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605469|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
19605470|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
19605471|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19605472|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
20129977|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20129978|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
20129979|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129980|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20129981|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129982|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20129983|NCT00026182|Rituximab|rituximab|mesh-list
20129984|NCT00026182|Interleukin-12|interleukin-12|mesh-list
20129985|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20129986|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20129987|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
20129988|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20129989|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20129990|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20129991|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20129992|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20129993|NCT00026182|Growth Substances|growth substances|mesh-ancestor
20129994|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
20129995|NCT00026195|Irinotecan|irinotecan|mesh-list
20129996|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20129997|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20129998|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20129999|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130000|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130001|NCT00026234|Dexamethasone|dexamethasone|mesh-list
20130002|NCT00026234|Capecitabine|capecitabine|mesh-list
19605473|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19605474|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
20130003|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
20130004|NCT00026234|Floxuridine|floxuridine|mesh-list
20130005|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20130006|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
20130007|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
19605475|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605476|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605477|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
19605478|NCT02537054|Aflibercept|aflibercept|mesh-list
19605479|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19605480|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19605481|NCT02537054|Growth Substances|growth substances|mesh-ancestor
19605482|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605483|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
19605484|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605485|NCT02536989|Omeprazole|omeprazole|mesh-list
19605486|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19605487|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19605488|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20130008|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130009|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130010|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19605489|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605490|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605491|NCT02536859|Insulin|insulin|mesh-list
19605492|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19605493|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
19605494|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19605495|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605496|NCT02536937|Eliglustat|eliglustat|mesh-list
19605497|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605498|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605499|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
19605500|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19605501|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
19605502|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605503|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
19605504|NCT02536807|Protective Agents|protective agents|mesh-ancestor
19605505|NCT02536690|Midazolam|midazolam|mesh-list
19605506|NCT02536690|Remifentanil|remifentanil|mesh-list
19605507|NCT02536690|Propofol|propofol|mesh-list
19605508|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19605509|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605510|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605511|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19605512|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
19605513|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
19605514|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19605515|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19605516|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19605517|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19605518|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
19605519|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
19605520|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605521|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130011|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
20130012|NCT00026234|Hormones|hormones|mesh-ancestor
20130013|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605522|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19605523|NCT02536690|Narcotics|narcotics|mesh-ancestor
19605524|NCT02536690|Analgesics|analgesics|mesh-ancestor
19605525|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
19605526|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605527|NCT02536911|Eliglustat|eliglustat|mesh-list
19605528|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605529|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605530|NCT02536742|Fulvestrant|fulvestrant|mesh-list
19605531|NCT02536742|Palbociclib|palbociclib|mesh-list
19605532|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19605533|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605534|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19605535|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19605536|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
19605537|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605538|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605539|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605540|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605541|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605542|NCT02536755|Eliglustat|eliglustat|mesh-list
19605543|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605544|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605545|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19605546|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605547|NCT02536495|Docetaxel|docetaxel|mesh-list
19605548|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605549|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605550|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
19605551|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
19605552|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605553|NCT02536417|Melatonin|melatonin|mesh-list
19605554|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
20130014|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20130015|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130016|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130017|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
20608273|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19605555|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605556|NCT02536417|Protective Agents|protective agents|mesh-ancestor
19605557|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605558|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605559|NCT02536209|Oxycodone|oxycodone|mesh-list
19605560|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19605561|NCT02536209|Narcotics|narcotics|mesh-ancestor
19605562|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605563|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605564|NCT02536209|Analgesics|analgesics|mesh-ancestor
19605565|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
19605566|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19658909|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19658910|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19658911|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
19658912|NCT02229968|Coagulants|coagulants|mesh-ancestor
20130018|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130019|NCT00026260|Semaxinib|semaxinib|mesh-list
20130020|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130021|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130022|NCT00026260|Growth Substances|growth substances|mesh-ancestor
20130023|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130024|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130025|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130026|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20130027|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130028|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130029|NCT00026273|Leucovorin|leucovorin|mesh-list
20130030|NCT00026273|Fluorouracil|fluorouracil|mesh-list
20130031|NCT00026273|Irinotecan|irinotecan|mesh-list
20130032|NCT00026273|Calcium|calcium|mesh-list
20130033|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
20130034|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20130035|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130036|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
20130037|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130038|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130039|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130040|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130041|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
20130042|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20130043|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20130044|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130045|NCT00026273|Antidotes|antidotes|mesh-ancestor
20130046|NCT00026273|Protective Agents|protective agents|mesh-ancestor
20130047|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
20130048|NCT00026273|Vitamins|vitamins|mesh-ancestor
20130049|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
20130050|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20130051|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
20130052|NCT00026286|Estrogens|estrogens|mesh-list
20130053|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20130054|NCT00026286|Hormones|hormones|mesh-ancestor
20130055|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130056|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130057|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20130058|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20130059|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19605567|NCT02536430|Ketorolac|ketorolac|mesh-list
19605568|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19605569|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19605570|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605571|NCT02536430|Analgesics|analgesics|mesh-ancestor
19605572|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
19605573|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605574|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605575|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605576|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605577|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19605578|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605579|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605580|NCT02536352|Vitamins|vitamins|mesh-list
19605581|NCT02536352|Fluorides|fluorides|mesh-list
19605582|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
19605583|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605584|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
19605585|NCT02536352|Protective Agents|protective agents|mesh-ancestor
19605586|NCT02535988|Thymalfasin|thymalfasin|mesh-list
19605587|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19605588|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
19605589|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605590|NCT02535910|Vitamin D|vitamin d|mesh-list
20130060|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
20130061|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20130062|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20130063|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20130064|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19605591|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
19605592|NCT02535910|Calcifediol|calcifediol|mesh-list
19605593|NCT02535910|Vitamins|vitamins|mesh-ancestor
19605594|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
19605595|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605596|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19605597|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19605598|NCT02535975|Metformin|metformin|mesh-list
19605599|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19605600|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605601|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
19605602|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19605603|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605604|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130065|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20130066|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130067|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
19605605|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605606|NCT02536014|Analgesics|analgesics|mesh-ancestor
19605607|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
19605608|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605609|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19605610|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19605611|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19605612|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
19605613|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605614|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605615|NCT02535767|Primaquine|primaquine|mesh-list
19605616|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
20311579|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605617|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19605618|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19605619|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605620|NCT02535689|Tofacitinib|tofacitinib|mesh-list
19605621|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605622|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605623|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605624|NCT02535533|Selenium|selenium|mesh-list
19605625|NCT02535533|Axitinib|axitinib|mesh-list
19605626|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130068|NCT00026299|Gefitinib|gefitinib|mesh-list
20130069|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130070|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20130071|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605627|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605628|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605629|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605630|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
19605631|NCT02535533|Protective Agents|protective agents|mesh-ancestor
19605632|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605633|NCT02535533|Trace Elements|trace elements|mesh-ancestor
19605634|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
19605635|NCT02535351|Sunitinib|sunitinib|mesh-list
19605636|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605637|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19605638|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19605639|NCT02535351|Growth Substances|growth substances|mesh-ancestor
19605640|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605641|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
19605642|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605643|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605644|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605645|NCT02535299|Metformin|metformin|mesh-list
19605646|NCT02535299|Liraglutide|liraglutide|mesh-list
19605647|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19605648|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605649|NCT02535299|Incretins|incretins|mesh-ancestor
19605650|NCT02535299|Hormones|hormones|mesh-ancestor
19605651|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605652|NCT02535273|Lidocaine|lidocaine|mesh-list
19605653|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
19605654|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
19605655|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
19605656|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605657|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605658|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
19605659|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605660|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19605661|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19605662|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19605663|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19605664|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605665|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20311580|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20311581|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20311582|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20311583|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
20311584|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311585|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311586|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20311587|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
20311588|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311589|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20311590|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20311591|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19605666|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605667|NCT02535273|Analgesics|analgesics|mesh-ancestor
19605668|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19605669|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19605670|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19605671|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
19605672|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605673|NCT02535156|Risperidone|risperidone|mesh-list
19605674|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19605675|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
19605676|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605677|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605678|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605679|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19605680|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19605681|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605682|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19605683|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19605684|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
19605685|NCT05299203|Verapamil|verapamil|mesh-list
19605686|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19605687|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20311592|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
19605688|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19605689|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605690|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19605691|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605692|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
19605693|NCT05299164|Gemcitabine|gemcitabine|mesh-list
19605694|NCT05299164|Rituximab|rituximab|mesh-list
19605695|NCT05299164|Vinorelbine|vinorelbine|mesh-list
19605696|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
19605697|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19605698|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605699|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
19605700|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605701|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605702|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19605703|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
19605704|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605705|NCT05299164|Antiviral Agents|antiviral agents|mesh-ancestor
19605706|NCT05299164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605707|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605708|NCT05299164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19605709|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19605710|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605711|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311593|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
20311594|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20311595|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
19605712|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
19605713|NCT05299164|Analgesics|analgesics|mesh-ancestor
20311596|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20311597|NCT00679666|Riboflavin|riboflavin|mesh-list
20311598|NCT00679666|Vitamins|vitamins|mesh-ancestor
20311599|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
20311600|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311601|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
20311602|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20311603|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
20311604|NCT00679679|Metformin|metformin|mesh-list
20311605|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20311606|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311607|NCT00679705|Atosiban|atosiban|mesh-list
20311608|NCT00679705|Ritodrine|ritodrine|mesh-list
20311609|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
19605714|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
19605715|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605716|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19605717|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19605718|NCT05299125|Carboplatin|carboplatin|mesh-list
19605719|NCT05299125|Pemetrexed|pemetrexed|mesh-list
19605720|NCT05299125|Lazertinib|lazertinib|mesh-list
19605721|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605722|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605723|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605724|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19605725|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19605726|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605727|NCT05299086|Fluticasone|fluticasone|mesh-list
19605728|NCT05299086|Xhance|xhance|mesh-list
19605729|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605730|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19605731|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
19605732|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605733|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311610|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311611|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311612|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
20311613|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19605734|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19605735|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
19605736|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
20311614|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
19605737|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20311615|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
20608274|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
19605738|NCT05299073|Denosumab|denosumab|mesh-list
19605739|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19605740|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605741|NCT05298761|Lidocaine|lidocaine|mesh-list
19605742|NCT05298761|Nalbuphine|nalbuphine|mesh-list
19605743|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19605744|NCT05298761|Narcotics|narcotics|mesh-ancestor
19605745|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605746|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605747|NCT05298761|Analgesics|analgesics|mesh-ancestor
19605748|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
19605749|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605750|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
19605751|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
19605752|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19605753|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19605754|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19605755|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20130072|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130073|NCT00026338|Gemcitabine|gemcitabine|mesh-list
20130074|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20130075|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130076|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
19605756|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605757|NCT05298683|Acetaminophen|acetaminophen|mesh-list
19605758|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
19605759|NCT05298683|Promethazine|promethazine|mesh-list
19605760|NCT05298683|Dexamethasone|dexamethasone|mesh-list
19605761|NCT05298683|Pomalidomide|pomalidomide|mesh-list
19605762|NCT05298683|Ranitidine|ranitidine|mesh-list
19605763|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19605764|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605765|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
19605766|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
19605767|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605768|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605769|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19605770|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
19605771|NCT05298683|Hormones|hormones|mesh-ancestor
19605772|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605773|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19605774|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605775|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605776|NCT05298683|Analgesics|analgesics|mesh-ancestor
19605777|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
19605778|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
19605779|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
19605780|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19605781|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19605782|NCT05298683|Growth Substances|growth substances|mesh-ancestor
19605783|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
20311616|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311617|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20311618|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20311619|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20311620|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
20311621|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311622|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311623|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19605784|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19605785|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19605786|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605787|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
19605788|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
19605789|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19605790|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
20130077|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130078|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130079|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
20130080|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130081|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130082|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130083|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
20130084|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605791|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
19605792|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311624|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19605793|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605794|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19605795|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
19605796|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
19605797|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19605798|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19605799|NCT05298592|Nivolumab|nivolumab|mesh-list
19605800|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19605801|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605802|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19605803|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605804|NCT05298462|Antibodies|antibodies|mesh-list
19605805|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
19605806|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605807|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19605808|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19605809|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19605810|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605811|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605812|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19605813|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19605814|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605815|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
19605816|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130085|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20130086|NCT00026351|Rituximab|rituximab|mesh-list
20130087|NCT00026351|Pentostatin|pentostatin|mesh-list
20130088|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20130089|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130090|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
20130091|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130092|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130093|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20130094|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130095|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130096|NCT00026364|Leucovorin|leucovorin|mesh-list
20130097|NCT00026364|Fluorouracil|fluorouracil|mesh-list
19658983|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19658984|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130098|NCT00026364|Irinotecan|irinotecan|mesh-list
20130099|NCT00026364|Gefitinib|gefitinib|mesh-list
20130100|NCT00026364|Calcium|calcium|mesh-list
20130101|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
20130102|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20130103|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130104|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
20130105|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130106|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130107|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130108|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130109|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
20130110|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20130111|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20311625|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
19605817|NCT05298202|Capsaicin|capsaicin|mesh-list
19605818|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
19605819|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19605820|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
19605821|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605822|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605823|NCT05298176|Carboplatin|carboplatin|mesh-list
19605824|NCT05298176|Pemetrexed|pemetrexed|mesh-list
19605825|NCT05298176|Osimertinib|osimertinib|mesh-list
19605826|NCT05298176|Afatinib|afatinib|mesh-list
19605827|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605828|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605829|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605830|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19605831|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19605832|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19605833|NCT05298163|Calcitriol|calcitriol|mesh-list
19605834|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19605835|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605836|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19605837|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19605838|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605839|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19605840|NCT05298163|Vitamins|vitamins|mesh-ancestor
19605841|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
19605842|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19605843|NCT05298020|Gemcitabine|gemcitabine|mesh-list
19605844|NCT05298020|Paclitaxel|paclitaxel|mesh-list
19605845|NCT05298020|Endostar protein|endostar protein|mesh-list
19605846|NCT05298020|Endostatins|endostatins|mesh-list
19605847|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19605848|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605849|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605850|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
19605851|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
19605852|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605853|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19605854|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
19605855|NCT05298020|Antiviral Agents|antiviral agents|mesh-ancestor
19605856|NCT05298020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605857|NCT05298020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605858|NCT05298020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19605859|NCT05298020|Immunologic Factors|immunologic factors|mesh-ancestor
19605860|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605861|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130112|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130113|NCT00026364|Antidotes|antidotes|mesh-ancestor
20130114|NCT00026364|Protective Agents|protective agents|mesh-ancestor
20130115|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
20130116|NCT00026364|Vitamins|vitamins|mesh-ancestor
19605862|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19605863|NCT05298020|Growth Substances|growth substances|mesh-ancestor
19605864|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
19605865|NCT05297994|Vaccines|vaccines|mesh-list
19605866|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
19605867|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605868|NCT05297968|Oseltamivir|oseltamivir|mesh-list
19605869|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
19605870|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605871|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605872|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605873|NCT05297929|Irbesartan|irbesartan|mesh-list
19605874|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19605875|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19605876|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19605877|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605878|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
20130117|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
20130118|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20130119|NCT00026377|Leuprolide|leuprolide|mesh-list
20130120|NCT00026377|Goserelin|goserelin|mesh-list
20130121|NCT00026377|Flutamide|flutamide|mesh-list
20130122|NCT00026377|Bicalutamide|bicalutamide|mesh-list
19605879|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19605880|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19605881|NCT05297669|Analgesics|analgesics|mesh-ancestor
19605882|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
19605883|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19605884|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605885|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19605886|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19605887|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19605888|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19605889|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605890|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605891|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19605892|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
19605893|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605894|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605895|NCT05297578|Vaccines|vaccines|mesh-list
19605896|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19605897|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
19605898|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605899|NCT05297448|Rifaximin|rifaximin|mesh-list
19605900|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19605901|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605902|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19605903|NCT05297422|Ketamine|ketamine|mesh-list
20130123|NCT00026377|Semaxinib|semaxinib|mesh-list
20130124|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20130125|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
20130126|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20130127|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130128|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20130129|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130130|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
20130131|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
20130132|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130133|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130134|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130135|NCT00026377|Growth Substances|growth substances|mesh-ancestor
20130136|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130137|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20130138|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130139|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605904|NCT05297422|Ropivacaine|ropivacaine|mesh-list
19605905|NCT05297422|Analgesics|analgesics|mesh-ancestor
19605906|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
20311626|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
20311627|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20311628|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20311629|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311630|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20311631|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311632|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605907|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130140|NCT00026403|Gemcitabine|gemcitabine|mesh-list
20130141|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130142|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19605908|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605909|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19605910|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19605911|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
19605912|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
19605913|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605914|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19605915|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19605916|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19605917|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605918|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
19605919|NCT05297292|Ranibizumab|ranibizumab|mesh-list
20130143|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
20311633|NCT00679770|Tavaborole|tavaborole|mesh-list
19605920|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19605921|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19605922|NCT05297292|Growth Substances|growth substances|mesh-ancestor
19605923|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605924|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
19605925|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605926|NCT05297123|Tretinoin|tretinoin|mesh-list
19605927|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
19605928|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605929|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
19605930|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
19605931|NCT05281341|Hormones|hormones|mesh-list
19605932|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19605933|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605934|NCT05276102|Emollients|emollients|mesh-list
19605935|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
19605936|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
19605937|NCT05264168|Apixaban|apixaban|mesh-list
19605938|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19605939|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
19605940|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19605941|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
19605942|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605943|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605944|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
19605945|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
19605946|NCT05256797|Apixaban|apixaban|mesh-list
19605947|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19605948|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
19605949|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19605950|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
19605951|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19605952|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605953|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
19605954|NCT05227664|Paclitaxel|paclitaxel|mesh-list
19605955|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19605956|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19605957|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605958|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
19605959|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
19605960|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
19605961|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19605962|NCT05214664|Anesthetics|anesthetics|mesh-list
19605963|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19605964|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130144|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130145|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
20130146|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130147|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130148|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130149|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
20130150|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130151|NCT00026416|Interferons|interferons|mesh-list
20130152|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
20130153|NCT00026416|Thalidomide|thalidomide|mesh-list
20130154|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130155|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
20130156|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130157|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
20130158|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130159|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130160|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
20130161|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130162|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130163|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130164|NCT00026416|Growth Substances|growth substances|mesh-ancestor
20130165|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130166|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
20130167|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130168|NCT00026442|Capecitabine|capecitabine|mesh-list
20130169|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130170|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
20130171|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130172|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130173|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
20130174|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130175|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20130176|NCT00026468|Protective Agents|protective agents|mesh-ancestor
20130177|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130178|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20130179|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130180|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130181|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20130182|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20130183|NCT00026468|Analgesics|analgesics|mesh-ancestor
20130184|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
20130185|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130186|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20130187|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130188|NCT00026520|Interferons|interferons|mesh-list
20130189|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
20130190|NCT00026520|Thalidomide|thalidomide|mesh-list
20130191|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130192|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
20130193|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130194|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
19605985|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19605986|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19605987|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
19605988|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19605989|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19605990|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
19605991|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20130195|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130196|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130197|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
20130198|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19605992|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
19605993|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19605994|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19605995|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19605996|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19605997|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19605998|NCT05096884|Metoprolol|metoprolol|mesh-list
19605999|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19606000|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19606001|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
19606002|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
19606003|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606004|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130199|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130200|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130201|NCT00026520|Growth Substances|growth substances|mesh-ancestor
20130202|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
19606005|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19606006|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19606007|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19606008|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
20130203|NCT00026533|Thalidomide|thalidomide|mesh-list
20130204|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606009|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130205|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
20311634|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
19606010|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606011|NCT05068232|Carboplatin|carboplatin|mesh-list
20311635|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347206|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347207|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
20347208|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20347209|NCT00858455|Dolutegravir|dolutegravir|mesh-list
20347210|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20347211|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20347212|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347213|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347214|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20347215|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20347216|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
20347217|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347218|NCT00858624|Ketamine|ketamine|mesh-list
20347219|NCT00858624|Analgesics|analgesics|mesh-ancestor
19606012|NCT05068232|Etoposide|etoposide|mesh-list
19606013|NCT05068232|Durvalumab|durvalumab|mesh-list
19606014|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606015|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19606016|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19606017|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19606018|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606019|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606020|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606021|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19606022|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606023|NCT04992624|Dronabinol|dronabinol|mesh-list
19606024|NCT04992624|Cannabidiol|cannabidiol|mesh-list
19606025|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
19606026|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
19606027|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606028|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19606029|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19606030|NCT04992624|Analgesics|analgesics|mesh-ancestor
19606031|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
19606032|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606033|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19606034|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19606035|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606036|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606037|NCT04992624|Hormones|hormones|mesh-ancestor
19606038|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606039|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19606040|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19606041|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606042|NCT04967443|Prazosin|prazosin|mesh-list
19606043|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19606044|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19606045|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19606046|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19606047|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
19606048|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606049|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606050|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606051|NCT04959981|Osimertinib|osimertinib|mesh-list
19606052|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606053|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606054|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606055|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606056|NCT04949425|Adavosertib|adavosertib|mesh-list
19606057|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606058|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606059|NCT04946006|Oxytocin|oxytocin|mesh-list
19606060|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
19606061|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19606062|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606063|NCT04920149|Mesalamine|mesalamine|mesh-list
19606064|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19606065|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19606066|NCT04920149|Analgesics|analgesics|mesh-ancestor
19606067|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
20347220|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
19606068|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606069|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606070|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606071|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606072|NCT04910022|Lomustine|lomustine|mesh-list
19606073|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19606074|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
19606075|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606076|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606077|NCT04762381|Dexamethasone|dexamethasone|mesh-list
19606078|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
19606079|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19606080|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606081|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
19606082|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
19606083|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606084|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606085|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19606086|NCT04762381|Hormones|hormones|mesh-ancestor
19606087|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606088|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19606089|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606090|NCT04756804|Ethanol|ethanol|mesh-list
19606091|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
19606092|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19606093|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19606094|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606095|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19606096|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606097|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
19606098|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
19606099|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
19606100|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
19606101|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19606102|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19606103|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606104|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606105|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311636|NCT00679835|Daptomycin|daptomycin|mesh-list
20311637|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20311638|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311639|NCT00679900|SR 46349B|sr 46349b|mesh-list
20311640|NCT00679900|Lormetazepam|lormetazepam|mesh-list
20311641|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20311642|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20311643|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311644|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20311645|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20311646|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
19606106|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606107|NCT04697940|Decitabine|decitabine|mesh-list
19606108|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19606109|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
19606110|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606111|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606112|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606113|NCT04667078|Cangrelor|cangrelor|mesh-list
19606114|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19606115|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19606116|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19606117|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19606118|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
19606119|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606120|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606121|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606122|NCT04655157|Nivolumab|nivolumab|mesh-list
19606123|NCT04655157|Ipilimumab|ipilimumab|mesh-list
19606124|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606125|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606126|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19606127|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606128|NCT04639011|Norepinephrine|norepinephrine|mesh-list
19606129|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20311647|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606130|NCT04639011|Serotonin|serotonin|mesh-list
19606131|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19606132|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19606133|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19606134|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606135|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606136|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606137|NCT04639011|Analgesics|analgesics|mesh-ancestor
19606138|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
19606139|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606140|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
19606141|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19606142|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
19606143|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19606144|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19606145|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
19606146|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
19606147|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
19606148|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19606149|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19606150|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
19606151|NCT04585477|Durvalumab|durvalumab|mesh-list
19606152|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606153|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606154|NCT04578613|Rituximab|rituximab|mesh-list
19606155|NCT04578613|Chlorambucil|chlorambucil|mesh-list
19606156|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606157|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606158|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
19606159|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606160|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606161|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19606162|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
19606163|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606164|NCT04576546|Inositol|inositol|mesh-list
19606165|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
19606166|NCT04576546|Vitamins|vitamins|mesh-ancestor
19606167|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
19606168|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606169|NCT04566653|Calcium|calcium|mesh-list
19606170|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
19606171|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19606172|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606173|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
19606174|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
19606175|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606176|NCT04551677|Vaccines|vaccines|mesh-list
19606177|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
19606178|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606179|NCT04530058|Metformin|metformin|mesh-list
19606180|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606181|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606182|NCT04512235|Dexamethasone|dexamethasone|mesh-list
19606183|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
19606184|NCT04512235|Bortezomib|bortezomib|mesh-list
19606185|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606186|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
19606187|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606188|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606189|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19606190|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
19606191|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606192|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606193|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19606194|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606195|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
19606196|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
19606197|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606198|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19606199|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
19606200|NCT04512235|Hormones|hormones|mesh-ancestor
19606201|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606202|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19606203|NCT04498832|Vaccines|vaccines|mesh-list
19606204|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
19606205|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130206|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130207|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
20130208|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130209|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130210|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130211|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130212|NCT00026533|Growth Substances|growth substances|mesh-ancestor
20130213|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
19659028|NCT02065765|Ramucirumab|ramucirumab|mesh-list
19659029|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130214|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130215|NCT00026585|Tamoxifen|tamoxifen|mesh-list
19659030|NCT02061761|Nivolumab|nivolumab|mesh-list
19659031|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19659032|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659033|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19659034|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659035|NCT02037529|Paclitaxel|paclitaxel|mesh-list
19659036|NCT02037529|Halichondrin B|halichondrin b|mesh-list
19659037|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19659038|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19659039|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659040|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
19659041|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
19659042|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
19659043|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130216|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20130217|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
20130218|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130219|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130220|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20130221|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130222|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20130223|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20130224|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20130225|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19659054|NCT02003742|Tamsulosin|tamsulosin|mesh-list
19659055|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19659056|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19659057|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19659058|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
19659059|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659060|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659061|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659062|NCT02003742|Urological Agents|urological agents|mesh-ancestor
20130226|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20130227|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
20130228|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130229|NCT00026637|Sertraline|sertraline|mesh-list
20130230|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
20130231|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20130232|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20130233|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20130234|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20130235|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130236|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130237|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
20130238|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173485|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20173486|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
20173487|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20173488|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20173489|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20173490|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20173491|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20173492|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20173493|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
20173494|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20173495|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20173496|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
20173497|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606206|NCT04487925|Hormones|hormones|mesh-list
19606207|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19606208|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606209|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606210|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
19606211|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19606212|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606213|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606214|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606215|NCT04430036|Gemcitabine|gemcitabine|mesh-list
19606216|NCT04430036|Cisplatin|cisplatin|mesh-list
19606217|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606218|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19606219|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
19606220|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606221|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
19606222|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606223|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606224|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606225|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
19606226|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606227|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19606228|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19606229|NCT04397406|Fentanyl|fentanyl|mesh-list
19606230|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
19606231|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
19606232|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19606233|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19606234|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606235|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19606236|NCT04397406|Analgesics|analgesics|mesh-ancestor
19606237|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
19606238|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606239|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19606240|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19606241|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19606242|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
19606243|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606244|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606245|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19606246|NCT04397406|Narcotics|narcotics|mesh-ancestor
19606247|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19606248|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19606249|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
19606250|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
19606251|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
19606252|NCT04392921|Amiodarone|amiodarone|mesh-list
19606253|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19606254|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
19606255|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19606256|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19606257|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606258|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19606259|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19606260|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19606261|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606262|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19606263|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19606264|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19749618|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749619|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749620|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749621|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749622|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19749623|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19606265|NCT04342585|Progesterone|progesterone|mesh-list
19606266|NCT04342585|Progestins|progestins|mesh-ancestor
19606267|NCT04342585|Hormones|hormones|mesh-ancestor
19606268|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606269|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606270|NCT04326257|Nivolumab|nivolumab|mesh-list
19606271|NCT04326257|Ipilimumab|ipilimumab|mesh-list
19606272|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606273|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606274|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19606275|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606276|NCT04240626|Acetaminophen|acetaminophen|mesh-list
19606277|NCT04240626|Scopolamine|scopolamine|mesh-list
19606278|NCT04240626|Oxycodone|oxycodone|mesh-list
19606279|NCT04240626|Gabapentin|gabapentin|mesh-list
19606280|NCT04240626|Hydromorphone|hydromorphone|mesh-list
19606281|NCT04240626|Hydrocodone|hydrocodone|mesh-list
19606282|NCT04240626|Bupivacaine|bupivacaine|mesh-list
19606283|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
19606284|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19606285|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19606286|NCT04240626|Analgesics|analgesics|mesh-ancestor
19606287|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
19606288|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606289|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606290|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
19606291|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19606292|NCT04240626|Narcotics|narcotics|mesh-ancestor
19606293|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19606294|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
19606295|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19606296|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19606297|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19606298|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19606299|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19606300|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606301|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606302|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
19606303|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
19606304|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
19606305|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
19606306|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
19606307|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19606308|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
19606309|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
19606310|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19606311|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
19606312|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19606313|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
19606314|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19606315|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
19606316|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19606317|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
19606318|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19606319|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19606320|NCT04177810|Plerixafor|plerixafor|mesh-list
19606321|NCT04177810|Cemiplimab|cemiplimab|mesh-list
19606322|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19606323|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19606324|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
19606325|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606326|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606327|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606328|NCT04171700|Rucaparib|rucaparib|mesh-list
19606329|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19606330|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606331|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606332|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606333|NCT04126824|Triamcinolone|triamcinolone|mesh-list
19606334|NCT04126824|Bupivacaine|bupivacaine|mesh-list
19606335|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
19606336|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
19606337|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19606338|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606339|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
19606340|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606341|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606342|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
20130239|NCT00026819|Rofecoxib|rofecoxib|mesh-list
19606343|NCT04126824|Hormones|hormones|mesh-ancestor
20608275|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19606344|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606345|NCT04115956|Dexamethasone|dexamethasone|mesh-list
19606346|NCT04115956|Melphalan|melphalan|mesh-list
19606347|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606348|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
19606349|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
19606350|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606351|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606352|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19606353|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
19606354|NCT04115956|Hormones|hormones|mesh-ancestor
19606355|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606356|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19606357|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606358|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19606359|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
19606360|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606361|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19606362|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606363|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
19606364|NCT04109222|Vaccines|vaccines|mesh-list
19606365|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
19606366|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606367|NCT04108481|Durvalumab|durvalumab|mesh-list
19606368|NCT04108481|Methamphetamine|methamphetamine|mesh-list
19606369|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19606370|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606371|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606372|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
19606373|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130240|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20130241|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20130242|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130243|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130244|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20130245|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20130246|NCT00026819|Analgesics|analgesics|mesh-ancestor
20130247|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
20130248|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130249|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130250|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20130251|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130252|NCT00026962|Estradiol|estradiol|mesh-list
20130253|NCT00026962|Progesterone|progesterone|mesh-list
20130254|NCT00026962|Estrogens|estrogens|mesh-ancestor
20130255|NCT00026962|Hormones|hormones|mesh-ancestor
20130256|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130257|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130258|NCT00026962|Progestins|progestins|mesh-ancestor
20130259|NCT00027014|Fentanyl|fentanyl|mesh-list
20130260|NCT00027014|Oxycodone|oxycodone|mesh-list
20130261|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20130262|NCT00027014|Narcotics|narcotics|mesh-ancestor
20130263|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20130264|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130265|NCT00027014|Analgesics|analgesics|mesh-ancestor
20130266|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
20130267|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130268|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20130269|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20130270|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
20130271|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
20311648|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311649|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19606374|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19606375|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
19606376|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
19606377|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311650|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20311651|NCT00679965|Tavaborole|tavaborole|mesh-list
19606378|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
19606379|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606380|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130272|NCT00027040|Selegiline|selegiline|mesh-list
20130273|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
19606381|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
19606382|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19606383|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19606384|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19606385|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19606386|NCT04104646|Morphine|morphine|mesh-list
19606387|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19606388|NCT04104646|Narcotics|narcotics|mesh-ancestor
19606389|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19606390|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606391|NCT04104646|Analgesics|analgesics|mesh-ancestor
19606392|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
19606393|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606394|NCT04095689|Docetaxel|docetaxel|mesh-list
19606395|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
19606396|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606397|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
20130274|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20130275|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20130276|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20130277|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20130278|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130279|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130280|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20130281|NCT00027040|Protective Agents|protective agents|mesh-ancestor
20130282|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130283|NCT00027053|Trazodone|trazodone|mesh-list
20130284|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20130285|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20130286|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20130287|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130288|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20130289|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20130290|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20130291|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20130292|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130293|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130294|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
20130295|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20130296|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
20130297|NCT00027066|Aspirin|aspirin|mesh-list
20130298|NCT00027066|Warfarin|warfarin|mesh-list
20130299|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20311652|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
19606398|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
19606399|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
19606400|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606401|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606402|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
19606403|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606404|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606405|NCT04069312|Azithromycin|azithromycin|mesh-list
19606406|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19606407|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606408|NCT04046939|Pramipexole|pramipexole|mesh-list
19606409|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
19606410|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606411|NCT04046939|Protective Agents|protective agents|mesh-ancestor
19606412|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606413|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19606414|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19606415|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
19606416|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
19606417|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606418|NCT04038086|Insulin|insulin|mesh-list
19606419|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606420|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606421|NCT04036188|Vitamin D|vitamin d|mesh-list
19606422|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
19606423|NCT04036188|Triamcinolone|triamcinolone|mesh-list
19606424|NCT04036188|Vitamins|vitamins|mesh-ancestor
19606425|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
19606426|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606427|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19606428|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19606429|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20130300|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20130301|NCT00027066|Analgesics|analgesics|mesh-ancestor
20130302|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
20130303|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130304|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130305|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20130306|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130307|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20130308|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20130309|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130310|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19606430|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
19606431|NCT04036188|Hormones|hormones|mesh-ancestor
19606432|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606433|NCT04033263|Fluorides|fluorides|mesh-list
19606434|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
19606435|NCT04033263|Protective Agents|protective agents|mesh-ancestor
19606436|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606437|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
19606438|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19606439|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
19606440|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606441|NCT04013854|Nivolumab|nivolumab|mesh-list
19606442|NCT04013854|Ipilimumab|ipilimumab|mesh-list
19606443|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606444|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606445|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19606446|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606447|NCT03960125|Imipramine|imipramine|mesh-list
19606448|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19606449|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
19606450|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19606451|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19606452|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19606453|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19606454|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606455|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
19606456|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606457|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606458|NCT03955198|Durvalumab|durvalumab|mesh-list
19606459|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606460|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606461|NCT03940586|Letermovir|letermovir|mesh-list
19606462|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19606463|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606464|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606465|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606466|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
19606467|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606468|NCT03932162|Insulin|insulin|mesh-list
19606469|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19606470|NCT03932162|Mitogens|mitogens|mesh-list
19606471|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606472|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606473|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
19606474|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606475|NCT03930745|TOL-463|tol-463|mesh-list
19606476|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606477|NCT03912259|Emollients|emollients|mesh-list
19606478|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
19606479|NCT03890367|Vaccines|vaccines|mesh-list
19606480|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
19606481|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606482|NCT03799744|Durvalumab|durvalumab|mesh-list
19606483|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606484|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606485|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
19606486|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19606487|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606488|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
19606489|NCT03745352|Azacitidine|azacitidine|mesh-list
20130311|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19606490|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19606491|NCT03745352|Pevonedistat|pevonedistat|mesh-list
19606492|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19606493|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
19606494|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606495|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606496|NCT03724084|Cytarabine|cytarabine|mesh-list
19606497|NCT03724084|Daunorubicin|daunorubicin|mesh-list
19606498|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19606499|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
19606500|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606501|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606502|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
19606503|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606504|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606505|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
19606506|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606507|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19606508|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19606509|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19606510|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606511|NCT03715946|Nivolumab|nivolumab|mesh-list
19606512|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606513|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606514|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19606515|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130312|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130313|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
20130314|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
20130315|NCT00027079|Naltrexone|naltrexone|mesh-list
20130316|NCT00027079|Ondansetron|ondansetron|mesh-list
20130317|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20130318|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20130319|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130320|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
20130321|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130322|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
20130323|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
20130324|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20130325|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
20130326|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
20130327|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20130328|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
20130329|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130330|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130331|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20130332|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20130333|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20130334|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20130335|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20130336|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
20130337|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130338|NCT00027287|Vitamin E|vitamin e|mesh-list
20130339|NCT00027287|Vitamins|vitamins|mesh-ancestor
20311653|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311654|NCT00680095|Tavaborole|tavaborole|mesh-list
20311655|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
20311656|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130340|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
20130341|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130342|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
20130343|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130344|NCT00027287|Protective Agents|protective agents|mesh-ancestor
20130345|NCT00027300|Natalizumab|natalizumab|mesh-list
20130346|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
20130347|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130348|NCT00027339|Ritonavir|ritonavir|mesh-list
20130349|NCT00027339|Lopinavir|lopinavir|mesh-list
20130350|NCT00027339|Indinavir|indinavir|mesh-list
20130351|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
20130352|NCT00027339|Tenofovir|tenofovir|mesh-list
20130353|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20130354|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20130355|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
20130356|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130357|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130358|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20130359|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20311657|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19606516|NCT03653832|Clonidine|clonidine|mesh-list
19606517|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
19606518|NCT03653832|Propofol|propofol|mesh-list
19606519|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19606520|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19606521|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606522|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19606523|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
19606524|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
19606525|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19606526|NCT03653832|Analgesics|analgesics|mesh-ancestor
19606527|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
19606528|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606529|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19606530|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19606531|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19606532|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
19606533|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606534|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606535|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19606536|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
19606537|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
19606538|NCT03612960|Nicotine|nicotine|mesh-list
19606539|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19606540|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
19606541|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606542|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606543|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19606544|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19606545|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
19606546|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606547|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606548|NCT03609047|Paclitaxel|paclitaxel|mesh-list
19606549|NCT03609047|Docetaxel|docetaxel|mesh-list
19606550|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
19606551|NCT03609047|Doxorubicin|doxorubicin|mesh-list
19606552|NCT03609047|Epirubicin|epirubicin|mesh-list
19606553|NCT03609047|Palbociclib|palbociclib|mesh-list
19606554|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19606555|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606556|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
19606557|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
19606558|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
19606559|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606560|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606561|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
19606562|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606563|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606564|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19606565|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
19606566|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19606567|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19606568|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19606569|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19606570|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606571|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606572|NCT03607422|Upadacitinib|upadacitinib|mesh-list
19606573|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19606574|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606575|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606576|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606577|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606578|NCT03600805|Prednisone|prednisone|mesh-list
19606579|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606580|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
19606581|NCT03600805|Hormones|hormones|mesh-ancestor
19606582|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606583|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606584|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19606585|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606586|NCT03582176|Ketotifen|ketotifen|mesh-list
19606587|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
19606588|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
19606589|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19606590|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
19606591|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
19606592|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606593|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606594|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606595|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19606596|NCT03547427|Acetaminophen|acetaminophen|mesh-list
19606597|NCT03547427|Insulin|insulin|mesh-list
19606598|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19606599|NCT03547427|Pramlintide|pramlintide|mesh-list
19606600|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606601|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606602|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19606603|NCT03547427|Analgesics|analgesics|mesh-ancestor
19606604|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
19606605|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606606|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
19606607|NCT03502733|Nivolumab|nivolumab|mesh-list
20130360|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
20130361|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130362|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20130363|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20130364|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20130365|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20130366|NCT00027391|Albuterol|albuterol|mesh-list
20130367|NCT00027391|Oxandrolone|oxandrolone|mesh-list
20130368|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20130369|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
20130370|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130371|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130372|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20130373|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
20130374|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
20130375|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20130376|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20130377|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20130378|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20130379|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
20130380|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130381|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130382|NCT00027391|Androgens|androgens|mesh-ancestor
19606608|NCT03502733|Ipilimumab|ipilimumab|mesh-list
19606609|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606610|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606611|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19606612|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606613|NCT03489525|Antibodies|antibodies|mesh-list
19606614|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
19606615|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
19606616|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
19606617|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606618|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
19606619|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19606620|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19606621|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19606622|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19606623|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606624|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
19606625|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606626|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606627|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19606628|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606629|NCT03434119|Insulin|insulin|mesh-list
19606630|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19606631|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
19606632|NCT03434119|Lixisenatide|lixisenatide|mesh-list
19606633|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606634|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606635|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19606636|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
20130383|NCT00027391|Hormones|hormones|mesh-ancestor
19606637|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606638|NCT03323658|Bexarotene|bexarotene|mesh-list
19606639|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606640|NCT03278626|Paclitaxel|paclitaxel|mesh-list
19606641|NCT03278626|Carboplatin|carboplatin|mesh-list
19606642|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19606643|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606644|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
19606645|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
19606646|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
19606647|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606648|NCT03259165|Diuretics|diuretics|mesh-list
19606649|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19606650|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
19606651|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606652|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19606653|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606659|NCT03211858|Insulin|insulin|mesh-list
19606660|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19606661|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
19606662|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
20311658|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20311659|NCT00680134|Tavaborole|tavaborole|mesh-list
20311660|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
19606663|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
19606664|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19606665|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606666|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606667|NCT03191149|Osimertinib|osimertinib|mesh-list
19606668|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606669|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606670|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606671|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606672|NCT03113968|Ketamine|ketamine|mesh-list
19606673|NCT03113968|Analgesics|analgesics|mesh-ancestor
19606674|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
19606675|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606676|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606677|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19606678|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19606679|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
19606680|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
19606681|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19606682|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19606683|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19606684|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606685|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606686|NCT03093480|Factor VIII|factor viii|mesh-list
19606687|NCT03093480|Coagulants|coagulants|mesh-ancestor
19606688|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
19606689|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606690|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606691|NCT03077438|Vaccines|vaccines|mesh-list
19606692|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
19606693|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606694|NCT03045653|Tamoxifen|tamoxifen|mesh-list
19606695|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19606696|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
19606697|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19606698|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606699|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19606700|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606701|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19606702|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19606703|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19606704|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
19606705|NCT03007147|Leucovorin|leucovorin|mesh-list
19606706|NCT03007147|Folic Acid|folic acid|mesh-list
19606707|NCT03007147|Cytarabine|cytarabine|mesh-list
19606708|NCT03007147|Dexamethasone|dexamethasone|mesh-list
19606709|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
19606710|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
19606711|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19606712|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20130384|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130385|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
20130386|NCT00027404|Fluoxetine|fluoxetine|mesh-list
20130387|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20130388|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20130389|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20130390|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130391|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130392|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
20130393|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130394|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20130395|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
20130396|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20130397|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19606713|NCT03007147|Prednisolone|prednisolone|mesh-list
19606714|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
19606715|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
19606716|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19606717|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19606718|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19606719|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
19606720|NCT03007147|Ifosfamide|ifosfamide|mesh-list
19606721|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
19606722|NCT03007147|Doxorubicin|doxorubicin|mesh-list
19606723|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19606724|NCT03007147|Methotrexate|methotrexate|mesh-list
19606725|NCT03007147|Etoposide|etoposide|mesh-list
19606726|NCT03007147|Vincristine|vincristine|mesh-list
19606727|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
19606728|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
19606729|NCT03007147|Daunorubicin|daunorubicin|mesh-list
19606730|NCT03007147|Asparaginase|asparaginase|mesh-list
19606731|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
19606732|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
19606733|NCT03007147|Pegaspargase|pegaspargase|mesh-list
20311661|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311662|NCT00680160|Tavaborole|tavaborole|mesh-list
20311663|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
20311664|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606734|NCT03007147|Thioguanine|thioguanine|mesh-list
19606735|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
19606736|NCT03007147|Razoxane|razoxane|mesh-list
19606737|NCT03007147|Azathioprine|azathioprine|mesh-list
19606738|NCT03007147|Lenograstim|lenograstim|mesh-list
19606739|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19606740|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
19606741|NCT03007147|BB 1101|bb 1101|mesh-list
19606742|NCT03007147|Calcium|calcium|mesh-list
19606743|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
19606744|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
19606745|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130398|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20130399|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130400|NCT00027443|Cyclosporine|cyclosporine|mesh-list
20130401|NCT00027443|Cyclosporins|cyclosporins|mesh-list
19606746|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
19606747|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606748|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606749|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19606750|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
19606751|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606752|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606753|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19606754|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606755|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
19606756|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
19606757|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606758|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19606759|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
19606760|NCT03007147|Hormones|hormones|mesh-ancestor
19606761|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130402|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
20311665|NCT00680173|Interferons|interferons|mesh-list
19606762|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19606763|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
19606764|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606765|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19606766|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19606767|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19606768|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19606769|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19606770|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19606771|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
19606772|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19606773|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19606774|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
19606775|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
19606776|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19606777|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19606778|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19606779|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
19606780|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606781|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19606782|NCT03007147|Antidotes|antidotes|mesh-ancestor
19606783|NCT03007147|Protective Agents|protective agents|mesh-ancestor
19606784|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
19606785|NCT03007147|Vitamins|vitamins|mesh-ancestor
19606786|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
19606787|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
19606788|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
19606789|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
19606790|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19606791|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606792|NCT03007147|Hematinics|hematinics|mesh-ancestor
19606793|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
19606794|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19606795|NCT03003546|Paclitaxel|paclitaxel|mesh-list
19606796|NCT03003546|Rituximab|rituximab|mesh-list
19606797|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19606798|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606799|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
19606800|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
19606801|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
19606802|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606803|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606804|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
19606805|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606806|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606807|NCT02991365|Insulin|insulin|mesh-list
19606808|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606809|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606810|NCT02974621|Bevacizumab|bevacizumab|mesh-list
19606811|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19606812|NCT02974621|Olaparib|olaparib|mesh-list
19606813|NCT02974621|Cediranib|cediranib|mesh-list
19606814|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
19606815|NCT02974621|Antibodies|antibodies|mesh-list
19606816|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
19606817|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19606818|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
20130403|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130404|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130405|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606819|NCT02974621|Maleic acid|maleic acid|mesh-list
19606820|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606821|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19606822|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19606823|NCT02974621|Growth Substances|growth substances|mesh-ancestor
19606824|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606825|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
19606826|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
19606827|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606828|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19606829|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606830|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606831|NCT02893917|Olaparib|olaparib|mesh-list
19606832|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19606833|NCT02893917|Cediranib|cediranib|mesh-list
19606834|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606835|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606836|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130406|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
19606837|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606838|NCT02890069|Everolimus|everolimus|mesh-list
19606839|NCT02890069|Panobinostat|panobinostat|mesh-list
19606840|NCT02890069|Spartalizumab|spartalizumab|mesh-list
19606841|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606842|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606843|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
19606844|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606845|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19606846|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606847|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606848|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19606849|NCT02866747|Durvalumab|durvalumab|mesh-list
19606850|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606851|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606852|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
19606853|NCT02864407|Olodaterol|olodaterol|mesh-list
19606854|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19606855|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
19606856|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606857|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606858|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19606859|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
19606860|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
19606861|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19606862|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
19606863|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19606864|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606865|NCT02846532|Aspirin|aspirin|mesh-list
19606866|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
19606867|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19606868|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
19606869|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19606870|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
19606871|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606872|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606873|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
19606874|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19606875|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19606876|NCT02846532|Analgesics|analgesics|mesh-ancestor
19606877|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
19606878|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19606879|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606880|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606881|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606882|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19606883|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19606884|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19606885|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19606886|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
20311666|NCT00680173|Ribavirin|ribavirin|mesh-list
20311667|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
19606887|NCT02743806|Vedolizumab|vedolizumab|mesh-list
19606888|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19606889|NCT02688933|Insulin|insulin|mesh-list
19606890|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19606891|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
19606892|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606893|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606894|NCT02550197|Vaccines|vaccines|mesh-list
19606895|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
19606896|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606897|NCT02492165|Vaccines|vaccines|mesh-list
19606898|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
19606899|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606900|NCT02476006|Atorvastatin|atorvastatin|mesh-list
19606901|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19606902|NCT02476006|Simvastatin|simvastatin|mesh-list
19606903|NCT02476006|Ezetimibe|ezetimibe|mesh-list
19606904|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19606905|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19606906|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
19606907|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606908|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19606909|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311668|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
19606910|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606911|NCT02332590|Adalimumab|adalimumab|mesh-list
19606912|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20311669|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19606913|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606914|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
19606915|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606916|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606917|NCT02256865|Ketoconazole|ketoconazole|mesh-list
19606918|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
19606919|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19606920|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19606921|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19606922|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
19606923|NCT02256865|Testosterone|testosterone|mesh-list
19606924|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
19606925|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
20130407|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130408|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
20130409|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130410|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
20130411|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130412|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20130413|NCT00027495|Curcumin|curcumin|mesh-list
20130414|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20130415|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20130416|NCT00027495|Analgesics|analgesics|mesh-ancestor
20130417|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
20130418|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130419|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130420|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606926|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19606927|NCT02256865|Androgens|androgens|mesh-ancestor
19606928|NCT02256865|Hormones|hormones|mesh-ancestor
19606929|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130421|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130422|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130423|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130424|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130425|NCT00027508|Trabectedin|trabectedin|mesh-list
20130426|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19606930|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606931|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19606932|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606933|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
19606934|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606935|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
19606936|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606937|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19606938|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19606939|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606940|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606941|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19606942|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
19606943|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19606944|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
19606945|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606946|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659131|NCT01935128|Everolimus|everolimus|mesh-list
19659132|NCT01935128|Tacrolimus|tacrolimus|mesh-list
19659133|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19659134|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
19659135|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659136|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19659137|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659138|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659139|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659140|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19659141|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19659142|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659143|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19659144|NCT01896999|Nivolumab|nivolumab|mesh-list
19659145|NCT01896999|Ipilimumab|ipilimumab|mesh-list
19659146|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19659147|NCT01896999|Antibodies|antibodies|mesh-list
19659148|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
19659149|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20130427|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
20130428|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311670|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311671|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
20311672|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311673|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
20311674|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311675|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
20311676|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311677|NCT00680212|Beta Carotene|beta carotene|mesh-list
20311678|NCT00680212|Carotenoids|carotenoids|mesh-list
20311679|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
20311680|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311681|NCT00680212|Protective Agents|protective agents|mesh-ancestor
19606947|NCT01902173|Trametinib|trametinib|mesh-list
19606948|NCT01902173|Dabrafenib|dabrafenib|mesh-list
19606949|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19606950|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606951|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19606952|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606953|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606954|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19606955|NCT01902173|Protective Agents|protective agents|mesh-ancestor
19606956|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606957|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19606958|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
20311682|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311683|NCT00680212|Provitamins|provitamins|mesh-ancestor
20311684|NCT00680212|Vitamins|vitamins|mesh-ancestor
20311685|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
20311686|NCT00680277|Carotenoids|carotenoids|mesh-list
19606959|NCT01900444|Vaccines|vaccines|mesh-list
19606960|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
19606961|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606962|NCT01751126|Cyclosporine|cyclosporine|mesh-list
19606963|NCT01751126|Cyclosporins|cyclosporins|mesh-list
19606964|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19606965|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19606966|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19606967|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
19606968|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606969|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
19606970|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19606971|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
19606972|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19606973|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19606974|NCT01597414|Trastuzumab|trastuzumab|mesh-list
19606975|NCT01597414|Pertuzumab|pertuzumab|mesh-list
19606976|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19606977|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606978|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19606979|NCT01468896|Cetuximab|cetuximab|mesh-list
19606980|NCT01468896|Interleukin-12|interleukin-12|mesh-list
19606981|NCT01468896|Antibodies|antibodies|mesh-list
19606982|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
19606983|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19606984|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
19606985|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606986|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19606987|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19606988|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19606989|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19606990|NCT01468896|Growth Substances|growth substances|mesh-ancestor
19606991|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130429|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130430|NCT00027521|Bleomycin|bleomycin|mesh-list
20130431|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20130432|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130433|NCT00027534|Metronidazole|metronidazole|mesh-list
20130434|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130435|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130436|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20130437|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20130438|NCT00027547|Cytarabine|cytarabine|mesh-list
20130439|NCT00027547|Cyclosporine|cyclosporine|mesh-list
20311687|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
19606992|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
19606993|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19606994|NCT01307306|Metformin|metformin|mesh-list
20130440|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
20130441|NCT00027547|Methotrexate|methotrexate|mesh-list
19606995|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19606996|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19606997|NCT01299753|Propranolol|propranolol|mesh-list
19606998|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19606999|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19607000|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607001|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607002|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607003|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607004|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607005|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19607006|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
19607007|NCT01251861|Bicalutamide|bicalutamide|mesh-list
19607008|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
19607009|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
19607010|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607011|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607012|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607013|NCT01190228|Vaccines|vaccines|mesh-list
19607014|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
19607015|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311688|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311689|NCT00680277|Protective Agents|protective agents|mesh-ancestor
20311690|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311691|NCT00680329|Timolol|timolol|mesh-list
20311692|NCT00680329|Travoprost|travoprost|mesh-list
20311693|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20311694|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20311695|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20311696|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20311697|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
20311698|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311699|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311700|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607016|NCT01049035|Vaccines|vaccines|mesh-list
19607017|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19607018|NCT01049035|Immunoglobulins|immunoglobulins|mesh-list
20130442|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
20130443|NCT00027547|Fludarabine|fludarabine|mesh-list
20130444|NCT00027547|Cyclosporins|cyclosporins|mesh-list
20130445|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20130446|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
20130447|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20130448|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130449|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130450|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
20130451|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130452|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130453|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
20130454|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130455|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20130456|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311701|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607019|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
19607020|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607021|NCT00859781|Ketoconazole|ketoconazole|mesh-list
19607022|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
19607023|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607024|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
19607025|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607026|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19607027|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19607028|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607029|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607030|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19607031|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
19607032|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607033|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607034|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19607035|NCT00727090|Conivaptan|conivaptan|mesh-list
19607036|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19659150|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
19607037|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607038|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
19607039|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607040|NCT00658814|Azacitidine|azacitidine|mesh-list
19607041|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
19607042|NCT00658814|Calicheamicins|calicheamicins|mesh-list
19607043|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19607044|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
19607045|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607046|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607047|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607048|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607049|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19607050|NCT00569127|Interferons|interferons|mesh-list
19607051|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
19607052|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
20130457|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
20130458|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130459|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20130460|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
19607053|NCT00569127|Bevacizumab|bevacizumab|mesh-list
19607054|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19607055|NCT00569127|Octreotide|octreotide|mesh-list
19607056|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
19607057|NCT00569127|Antibodies|antibodies|mesh-list
19607058|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
19607059|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19607060|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
19607061|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607062|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19607063|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19607064|NCT00569127|Growth Substances|growth substances|mesh-ancestor
19607065|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607066|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
19607067|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
19607068|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
19607069|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607070|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19607071|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19607072|NCT05301608|Psilocybin|psilocybin|mesh-list
19607073|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19607074|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
19607075|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607076|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19607077|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19607078|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
19607079|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607080|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607081|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19607082|NCT05301530|Docetaxel|docetaxel|mesh-list
19607083|NCT05301530|Trastuzumab|trastuzumab|mesh-list
19607084|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607085|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607086|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607087|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607088|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607089|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607090|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
20130461|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130462|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
20130463|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20130464|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20130465|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19607091|NCT05301517|Hematinics|hematinics|mesh-ancestor
19607092|NCT05301361|Methylphenidate|methylphenidate|mesh-list
19607093|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19607094|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607095|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19607096|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19607097|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607098|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607099|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
20130466|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
19607100|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607101|NCT05301205|Gabapentin|gabapentin|mesh-list
20130467|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19607102|NCT05301205|Analgesics|analgesics|mesh-ancestor
19607103|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
19607104|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607105|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311702|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20311703|NCT00680355|Carotenoids|carotenoids|mesh-list
20311704|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
20311705|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311706|NCT00680355|Protective Agents|protective agents|mesh-ancestor
20311707|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311708|NCT00680394|Misoprostol|misoprostol|mesh-list
19607106|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
19607107|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19607108|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19607109|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607110|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19607111|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19607112|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19607113|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607114|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607115|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
19607116|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19607117|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19607118|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607119|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
19607120|NCT05301010|Docetaxel|docetaxel|mesh-list
19607121|NCT05301010|Trastuzumab|trastuzumab|mesh-list
19607122|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607123|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607124|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607125|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607126|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607127|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607128|NCT05300958|Deferoxamine|deferoxamine|mesh-list
19607129|NCT05300958|Siderophores|siderophores|mesh-ancestor
19607130|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19607131|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
19607132|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
19607133|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607134|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
19607135|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607136|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
19607137|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607138|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607139|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19607140|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
19607141|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607142|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607143|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19607144|NCT05300854|Anesthetics|anesthetics|mesh-list
19607145|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607146|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607147|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
19607148|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19607149|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607150|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607151|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607152|NCT05300802|Analgesics|analgesics|mesh-ancestor
19607153|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
19607154|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130468|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
20130469|NCT00027573|Methotrexate|methotrexate|mesh-list
20130470|NCT00027573|Fludarabine|fludarabine|mesh-list
20130471|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
20130472|NCT00027573|Tacrolimus|tacrolimus|mesh-list
20130473|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130474|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
20130475|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608276|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19607155|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19607156|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607157|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20130476|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607158|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607159|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607160|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607161|NCT05300555|Warfarin|warfarin|mesh-list
19607162|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
19607163|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
19607164|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20130477|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130478|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
20130479|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130480|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130481|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20130482|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20130483|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
20311709|NCT00680394|Mifepristone|mifepristone|mesh-list
20311710|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20311711|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
20311712|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20311713|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311714|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20311715|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19607165|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
19607166|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19607167|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
19607168|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607169|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607170|NCT05300490|Prednisolone|prednisolone|mesh-list
19607171|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607172|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
19607173|NCT05300490|Hormones|hormones|mesh-ancestor
19607174|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607175|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607176|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19607177|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607178|NCT05300477|Acetazolamide|acetazolamide|mesh-list
19607179|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
19607180|NCT05300477|Hematinics|hematinics|mesh-ancestor
19607181|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
19607182|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19607183|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607184|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130484|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20130485|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130486|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
20130487|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
20130488|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130489|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20130490|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20130491|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20130492|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
19607185|NCT05300477|Diuretics|diuretics|mesh-ancestor
19607186|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
19607187|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607188|NCT05300386|Citalopram|citalopram|mesh-list
19607189|NCT05300386|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19607190|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19607191|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607192|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607193|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607194|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
19607195|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607196|NCT05300386|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19607197|NCT05300386|Antidepressive Agents|antidepressive agents|mesh-ancestor
20130493|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608277|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
20608278|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608279|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20608280|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20608281|NCT02245295|Anesthetics|anesthetics|mesh-list
19607198|NCT05300386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19607199|NCT05300373|Adenosine|adenosine|mesh-list
19607200|NCT05300373|Analgesics|analgesics|mesh-ancestor
19607201|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
19607202|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607203|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607204|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607205|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
19607206|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19607207|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
19607208|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
19607209|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607210|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607211|NCT05300360|Adenosine|adenosine|mesh-list
19607212|NCT05300360|Analgesics|analgesics|mesh-ancestor
19607213|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
19607214|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607215|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607216|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607217|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
19607218|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19607219|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
19607220|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
19607221|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607222|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607223|NCT05300347|Adenosine|adenosine|mesh-list
19607224|NCT05300347|Analgesics|analgesics|mesh-ancestor
19607225|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
19607226|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607227|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607228|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607229|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
19607230|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19607231|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
19607232|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
19607233|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607234|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659151|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
19659152|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659153|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659154|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19659155|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659156|NCT01884259|Docetaxel|docetaxel|mesh-list
19659157|NCT01884259|Fluorouracil|fluorouracil|mesh-list
19659158|NCT01884259|Cetuximab|cetuximab|mesh-list
19659159|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659160|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
19659161|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
19659162|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
19659163|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659164|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
19659165|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19659166|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19659167|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
19659168|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659169|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20130494|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20130495|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130496|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130497|NCT00027599|Bevacizumab|bevacizumab|mesh-list
20130498|NCT00027599|Sargramostim|sargramostim|mesh-list
20130499|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20130500|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130501|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130502|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130503|NCT00027599|Growth Substances|growth substances|mesh-ancestor
20130504|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130505|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130506|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
20130507|NCT00027612|Irinotecan|irinotecan|mesh-list
20130508|NCT00027612|Carmustine|carmustine|mesh-list
20130509|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20130510|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20130511|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311716|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
19607235|NCT05300334|Adenosine|adenosine|mesh-list
20130512|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130513|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130514|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130515|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
20130516|NCT00027625|Temozolomide|temozolomide|mesh-list
20130517|NCT00027625|Gefitinib|gefitinib|mesh-list
20130518|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130519|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
20130520|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130521|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130522|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20130523|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130524|NCT00027638|Thalidomide|thalidomide|mesh-list
20130525|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130526|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
20130527|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130528|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
20130529|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130530|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130531|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130532|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130533|NCT00027638|Growth Substances|growth substances|mesh-ancestor
20130534|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130535|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130536|NCT00027664|Interferons|interferons|mesh-list
20130537|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
20130538|NCT00027664|Thalidomide|thalidomide|mesh-list
20130539|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130540|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
20130541|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130542|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
20130543|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130544|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130545|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
20130546|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130547|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130548|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130549|NCT00027664|Growth Substances|growth substances|mesh-ancestor
20130550|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130551|NCT00027677|Halofuginone|halofuginone|mesh-list
20130552|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130553|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
20311717|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20311718|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20311719|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19607236|NCT05300334|Analgesics|analgesics|mesh-ancestor
19607237|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
19607238|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607239|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607240|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607241|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
19607242|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19607243|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
19607244|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
19607245|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311720|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20311721|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
20311722|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19607246|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607247|NCT05300282|Gemcitabine|gemcitabine|mesh-list
19607248|NCT05300282|Atezolizumab|atezolizumab|mesh-list
19607249|NCT05300282|Vinorelbine|vinorelbine|mesh-list
19607250|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19607251|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19607252|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
19607253|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130554|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20130555|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19607254|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607255|NCT05300282|Antiviral Agents|antiviral agents|mesh-ancestor
20130556|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130557|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19607256|NCT05300282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607257|NCT05300282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607258|NCT05300282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607259|NCT05300282|Immunologic Factors|immunologic factors|mesh-ancestor
19607260|NCT05300282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607261|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607262|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607263|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607264|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607265|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19607266|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
19607267|NCT05300269|Capecitabine|capecitabine|mesh-list
19607268|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
19607269|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19607270|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
19607271|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607272|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607273|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
19607274|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19607275|NCT05300087|Albuterol|albuterol|mesh-list
19607276|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19607277|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
19607278|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607279|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607280|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20130558|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130559|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130560|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130561|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130562|NCT00027677|Growth Substances|growth substances|mesh-ancestor
20130563|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130564|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130565|NCT00027690|Gefitinib|gefitinib|mesh-list
20130566|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130567|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19607281|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
19607282|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
19607283|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19607284|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19607285|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19607286|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607287|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607288|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607289|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607290|NCT05300048|Serabelisib|serabelisib|mesh-list
19607291|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607292|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607293|NCT05300035|Antibodies|antibodies|mesh-list
19607294|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19607295|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
19607296|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607297|NCT05300009|Methotrexate|methotrexate|mesh-list
19607298|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19607299|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
19607300|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19607301|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607302|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19607303|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
19607304|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607305|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607306|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
19607307|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607308|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19607309|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607310|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
19607311|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607312|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19607313|NCT05299944|Cannabidiol|cannabidiol|mesh-list
19607314|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
19607315|NCT05299931|Ustekinumab|ustekinumab|mesh-list
19607316|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
19607317|NCT05299593|Timolol|timolol|mesh-list
19607318|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19607319|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19607320|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607321|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607322|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607323|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607324|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607325|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19607326|NCT05299580|Trametinib|trametinib|mesh-list
19607327|NCT05299580|Dabrafenib|dabrafenib|mesh-list
19607328|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607329|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19607330|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607331|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607332|NCT05299567|Azithromycin|azithromycin|mesh-list
19607333|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19607334|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607335|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
19607336|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607337|NCT05299476|Bevacizumab|bevacizumab|mesh-list
19607338|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607339|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607340|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19607341|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19607342|NCT05299476|Growth Substances|growth substances|mesh-ancestor
19607343|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607344|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130568|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130569|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130570|NCT00027703|Gemcitabine|gemcitabine|mesh-list
20130571|NCT00027703|Bevacizumab|bevacizumab|mesh-list
20130572|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20130573|NCT00027703|Antibodies|antibodies|mesh-list
20130574|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
20130575|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19607345|NCT05299398|Trazodone|trazodone|mesh-list
20130576|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607346|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19607347|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19607348|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607349|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607350|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19607351|NCT05299398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19607352|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19607353|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607354|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607355|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607356|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
19607357|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19607358|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
19607359|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
19607360|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19607361|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19607362|NCT05293249|Prednisolone|prednisolone|mesh-list
19607363|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
19607364|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19607365|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
19607366|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607367|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
19607368|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
19607369|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607370|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607371|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19607372|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
19607373|NCT05293249|Hormones|hormones|mesh-ancestor
19607374|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607375|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19607376|NCT05293249|Protective Agents|protective agents|mesh-ancestor
19607377|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19607378|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607379|NCT05291390|Pyronaridine|pyronaridine|mesh-list
19607380|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
19607381|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19607382|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19607383|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607384|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
19607385|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19607386|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
19607387|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607388|NCT05287724|Expectorants|expectorants|mesh-ancestor
19607389|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
19607390|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19607391|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
19607392|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607393|NCT05287724|Protective Agents|protective agents|mesh-ancestor
19607394|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607395|NCT05287724|Antidotes|antidotes|mesh-ancestor
19607396|NCT05280106|Citric Acid|citric acid|mesh-list
19607397|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
19607398|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
19607399|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
19607400|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19607401|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
19607402|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
19607403|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607404|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19607405|NCT05277480|Apatinib|apatinib|mesh-list
19607406|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607407|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19607408|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607409|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607410|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
19607411|NCT05277285|Antidotes|antidotes|mesh-ancestor
19607412|NCT05277285|Protective Agents|protective agents|mesh-ancestor
19607413|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607414|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
19607415|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607416|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
19607417|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19607418|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607419|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
19607420|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
19607421|NCT05271071|Lidocaine|lidocaine|mesh-list
19607422|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
19607423|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
19607424|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607425|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607426|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
19607427|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607428|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607429|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19607430|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19607431|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607432|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607433|NCT05259943|Psilocybin|psilocybin|mesh-list
19607434|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
19607435|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607436|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19607437|NCT05253287|Hormones|hormones|mesh-list
19607438|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607439|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130577|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130578|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130579|NCT00027703|Growth Substances|growth substances|mesh-ancestor
20130580|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130581|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130582|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
20130583|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130584|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
20130585|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130586|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
20130587|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130588|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130589|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130590|NCT00027716|Bortezomib|bortezomib|mesh-list
20130591|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130592|NCT00027742|Interferons|interferons|mesh-list
20130593|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
20130594|NCT00027742|Temozolomide|temozolomide|mesh-list
20130595|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130596|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
20130597|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130598|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130599|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
20130600|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130601|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
20130602|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130603|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
20130604|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130605|NCT00027807|Aldesleukin|aldesleukin|mesh-list
20130606|NCT00027807|Molgramostim|molgramostim|mesh-list
20130607|NCT00027807|Sargramostim|sargramostim|mesh-list
20130608|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
20130609|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130610|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130611|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20130612|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20130613|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
20130614|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130615|NCT00027820|Cyclosporine|cyclosporine|mesh-list
20130616|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
20130617|NCT00027820|Fludarabine|fludarabine|mesh-list
20130618|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
20130619|NCT00027820|Cyclosporins|cyclosporins|mesh-list
20130620|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130621|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130622|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
20130623|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130624|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130625|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
20130626|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130627|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130628|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
20130629|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130630|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
20130631|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130632|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20130633|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19607440|NCT05238649|Vaccines|vaccines|mesh-list
19607441|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
19607442|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607443|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
19607444|NCT05227716|Analgesics|analgesics|mesh-ancestor
19607445|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
19607446|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607447|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607448|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
19607449|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607450|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607451|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
19607452|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19607453|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607454|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607455|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19607456|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
19607457|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19607458|NCT05227300|Lidocaine|lidocaine|mesh-list
19607459|NCT05227300|Epinephrine|epinephrine|mesh-list
19607460|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
19607461|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
19607462|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607463|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607464|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
19607465|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607466|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607467|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19607468|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19607469|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607470|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607471|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607472|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607473|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607474|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607475|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19607476|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19607477|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
19607478|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19607479|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
19607480|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
19607481|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
19607482|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19607483|NCT05208190|Clozapine|clozapine|mesh-list
19607484|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19607485|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
19607486|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607487|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607488|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607489|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19607490|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19607491|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607492|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19607493|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
19607494|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
19607495|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
19607496|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607497|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607498|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19607499|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20130634|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20130635|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
20130636|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130637|NCT00027833|Leucovorin|leucovorin|mesh-list
20130638|NCT00027833|Fluorouracil|fluorouracil|mesh-list
20130639|NCT00027833|Irinotecan|irinotecan|mesh-list
20130640|NCT00027833|Calcium|calcium|mesh-list
20130641|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
20130642|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20130643|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130644|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
20130645|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607500|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130646|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311723|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19607501|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607502|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19607503|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607504|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607505|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
19607506|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607507|NCT05179239|Paclitaxel|paclitaxel|mesh-list
19607508|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19607509|NCT05179239|Cisplatin|cisplatin|mesh-list
19607510|NCT05179239|Carboplatin|carboplatin|mesh-list
19607511|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607512|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607513|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607514|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607515|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607516|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607517|NCT05178628|Gemcitabine|gemcitabine|mesh-list
19607518|NCT05178628|Paclitaxel|paclitaxel|mesh-list
19607519|NCT05178628|Tinzaparin|tinzaparin|mesh-list
19607520|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607521|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607522|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607523|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607524|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607525|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311724|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
20311725|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311726|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
20311727|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20311728|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20311729|NCT00680433|Ketamine|ketamine|mesh-list
20311730|NCT00680433|Analgesics|analgesics|mesh-ancestor
20311731|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
20311732|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311733|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311734|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20311735|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20311736|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
20311737|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
20311738|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20311739|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20311740|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20311741|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311742|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311743|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
20311744|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19607526|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19607527|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
19607528|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
19607529|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607530|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607531|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607532|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
19607533|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607534|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
19607535|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20130647|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130648|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130649|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
20130650|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20130651|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20130652|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130653|NCT00027833|Antidotes|antidotes|mesh-ancestor
20130654|NCT00027833|Protective Agents|protective agents|mesh-ancestor
20130655|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
20130656|NCT00027833|Vitamins|vitamins|mesh-ancestor
20130657|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
20130658|NCT00027859|Ketoconazole|ketoconazole|mesh-list
20130659|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
20130660|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20130661|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20311745|NCT00680446|Antibodies|antibodies|mesh-list
20130662|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20130663|NCT00027859|Docetaxel|docetaxel|mesh-list
19607536|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20130664|NCT00027859|Estramustine|estramustine|mesh-list
19607537|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19607538|NCT05178485|Bupivacaine|bupivacaine|mesh-list
19607539|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
19607540|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
19607541|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607542|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607543|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
19607544|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607545|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607546|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
19607547|NCT05178485|Hormones|hormones|mesh-ancestor
19607548|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607549|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607550|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
19607551|NCT05173324|Vaccines|vaccines|mesh-list
19607552|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
19607553|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607554|NCT05157672|Letrozole|letrozole|mesh-list
19607555|NCT05157672|Nicotine|nicotine|mesh-list
19607556|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19607557|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
19607558|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607559|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607560|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19607561|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19607562|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
19607563|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607564|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607565|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607566|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19607567|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19607568|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607569|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19607570|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
20130665|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130666|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
20130667|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
20130668|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
20130669|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130670|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20130671|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
20130672|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130673|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20130674|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20130675|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130676|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20130677|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
20130678|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130679|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130680|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20130681|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130682|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
20130683|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20130684|NCT00027872|Tipifarnib|tipifarnib|mesh-list
20130685|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130686|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
20130687|NCT00027885|Bevacizumab|bevacizumab|mesh-list
19607571|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607572|NCT05147493|Dexamethasone|dexamethasone|mesh-list
19607573|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
19607574|NCT05147493|Lenalidomide|lenalidomide|mesh-list
19607575|NCT05147493|Bortezomib|bortezomib|mesh-list
19607576|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607577|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
19607578|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607579|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607580|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19607581|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
19607582|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607583|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607584|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19607585|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607586|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
19607587|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
20130688|NCT00027885|Docetaxel|docetaxel|mesh-list
20311746|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
20311747|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
20311748|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311749|NCT00680485|Ketoconazole|ketoconazole|mesh-list
20311750|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
20311751|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311752|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20311753|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311754|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607588|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607589|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19607590|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
19607591|NCT05147493|Hormones|hormones|mesh-ancestor
19607592|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607593|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19607594|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19607595|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19607596|NCT05147493|Growth Substances|growth substances|mesh-ancestor
19607597|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
19607598|NCT05122182|Proxigermanium|proxigermanium|mesh-list
19607599|NCT05122182|Candesartan|candesartan|mesh-list
19607600|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
19607601|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19607602|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19607603|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19607604|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607605|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607606|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
19607607|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
19607608|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607609|NCT05072262|Dexamethasone|dexamethasone|mesh-list
19607610|NCT05072262|Nepafenac|nepafenac|mesh-list
19607611|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607612|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
19607613|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
19607614|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607615|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607616|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19607617|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
19607618|NCT05072262|Hormones|hormones|mesh-ancestor
19607619|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607620|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19607621|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607622|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19607623|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607624|NCT05072262|Analgesics|analgesics|mesh-ancestor
19607625|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
19607626|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607627|NCT05070754|Cantharidin|cantharidin|mesh-list
19607628|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607629|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607630|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
19607631|NCT05061017|Nivolumab|nivolumab|mesh-list
19607632|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607633|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
19607634|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607635|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607636|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19607637|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
19607638|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607639|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130689|NCT00027885|Doxorubicin|doxorubicin|mesh-list
20130690|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20130691|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130692|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
20130693|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130694|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130695|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130696|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
20130697|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130698|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130699|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20130700|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20311755|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311756|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20311757|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
20311758|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311759|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311760|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19607640|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19607641|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607642|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19607643|NCT05060549|Cariprazine|cariprazine|mesh-list
19607644|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19607645|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19607646|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607647|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607648|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19607649|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
19607650|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19607651|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20311761|NCT00680498|Ranibizumab|ranibizumab|mesh-list
20311762|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20311763|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19607652|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
19607653|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607654|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607655|NCT05046314|Vincristine|vincristine|mesh-list
19607656|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607657|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607658|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607659|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311764|NCT00680498|Growth Substances|growth substances|mesh-ancestor
20311765|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311766|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
20311767|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311768|NCT00680511|Methamphetamine|methamphetamine|mesh-list
20311769|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20311770|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311771|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
20311772|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
19607660|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607661|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607662|NCT05037812|Ketorolac|ketorolac|mesh-list
19607663|NCT05037812|Clonidine|clonidine|mesh-list
19607664|NCT05037812|Epinephrine|epinephrine|mesh-list
19607665|NCT05037812|Morphine|morphine|mesh-list
19607666|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19607667|NCT05037812|Narcotics|narcotics|mesh-ancestor
19607668|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607669|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607670|NCT05037812|Analgesics|analgesics|mesh-ancestor
19607671|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
19607672|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607673|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20130701|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130702|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130703|NCT00027885|Growth Substances|growth substances|mesh-ancestor
20130704|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
20130705|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
20130706|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
20130707|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
20130708|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20130709|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20130710|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20130711|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130712|NCT00027898|Carboplatin|carboplatin|mesh-list
20130713|NCT00027898|Etoposide|etoposide|mesh-list
20130714|NCT00027898|Bortezomib|bortezomib|mesh-list
20130715|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
20130716|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130717|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20130718|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19749660|NCT04790903|Prednisone|prednisone|mesh-list
20130719|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20130720|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130721|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130722|NCT00027911|Sargramostim|sargramostim|mesh-list
20130723|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
20130724|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130725|NCT00027924|Cyclosporine|cyclosporine|mesh-list
20130726|NCT00027924|Methotrexate|methotrexate|mesh-list
20130727|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
20130728|NCT00027924|Fludarabine|fludarabine|mesh-list
19607674|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607675|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607676|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607677|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607678|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19607679|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19607680|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
19607681|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19607682|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
19607683|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
19607684|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
19607685|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19607686|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19607687|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607688|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607689|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607690|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19607691|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607692|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19607693|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
19607694|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19607695|NCT05022654|Irinotecan|irinotecan|mesh-list
19607696|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19607697|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19607698|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607699|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607700|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607701|NCT05020457|Paclitaxel|paclitaxel|mesh-list
19607702|NCT05020457|Docetaxel|docetaxel|mesh-list
19607703|NCT05020457|Cisplatin|cisplatin|mesh-list
19607704|NCT05020457|Pemetrexed|pemetrexed|mesh-list
19607705|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607706|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607707|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607708|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607709|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607710|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607711|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607712|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19607713|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19607714|NCT05012943|Vaccines|vaccines|mesh-list
19607715|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
19607716|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607717|NCT05008354|Pyridoxine|pyridoxine|mesh-list
19607718|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
19607719|NCT05008354|Vitamins|vitamins|mesh-ancestor
19607720|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
19607721|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659222|NCT01841359|Pramlintide|pramlintide|mesh-list
19659223|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19659224|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659225|NCT01828697|Enoxaparin|enoxaparin|mesh-list
19659226|NCT01828697|Dalteparin|dalteparin|mesh-list
19659227|NCT01828697|Tinzaparin|tinzaparin|mesh-list
19659228|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19659229|NCT01828697|Nadroparin|nadroparin|mesh-list
20130729|NCT00027924|Busulfan|busulfan|mesh-list
20130730|NCT00027924|Cyclosporins|cyclosporins|mesh-list
20130731|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20130732|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
20130733|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20130734|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130735|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130736|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
20130737|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659230|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
19659231|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
19659232|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19659233|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19749661|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
19607722|NCT04988841|Nivolumab|nivolumab|mesh-list
19607723|NCT04988841|Ipilimumab|ipilimumab|mesh-list
19607724|NCT04988841|Laxatives|laxatives|mesh-list
19607725|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19607726|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607727|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130738|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130739|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
20130740|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130741|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20130742|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607728|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19607729|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130743|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
20130744|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130745|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20130746|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
20130747|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130748|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20130749|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
20130750|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130751|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19607730|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19607731|NCT04979377|Insulin|insulin|mesh-list
19607732|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19607733|NCT04979377|Hormones|hormones|mesh-list
19607734|NCT04979377|Testosterone|testosterone|mesh-list
19607735|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19607736|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19607737|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607738|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607739|NCT04979377|Androgens|androgens|mesh-ancestor
19607740|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19607741|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
19607742|NCT04974996|Prednisone|prednisone|mesh-list
19607743|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
19607744|NCT04974996|Rituximab|rituximab|mesh-list
19607745|NCT04974996|Doxorubicin|doxorubicin|mesh-list
19607746|NCT04974996|Vincristine|vincristine|mesh-list
19607747|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19607748|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607749|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
19607750|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607751|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19607752|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19607753|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
19607754|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607755|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607756|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19607757|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607758|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19607759|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19607760|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19607761|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607762|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607763|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
19607764|NCT04974996|Hormones|hormones|mesh-ancestor
19607765|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607766|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19607767|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607768|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607769|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607770|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607771|NCT04974398|Gemcitabine|gemcitabine|mesh-list
19607772|NCT04974398|Cisplatin|cisplatin|mesh-list
19607773|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130752|NCT00027937|Aldesleukin|aldesleukin|mesh-list
20130753|NCT00027937|Paclitaxel|paclitaxel|mesh-list
20130754|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
20130755|NCT00027937|Melphalan|melphalan|mesh-list
20130756|NCT00027937|Busulfan|busulfan|mesh-list
20130757|NCT00027937|Thiotepa|thiotepa|mesh-list
19607774|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130758|NCT00027937|Sargramostim|sargramostim|mesh-list
19607775|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
19607776|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607777|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
20130759|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607778|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19607779|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607780|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607781|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
19607782|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607783|NCT04972253|Infigratinib|infigratinib|mesh-list
19607784|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607785|NCT04959825|Melatonin|melatonin|mesh-list
19607786|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
19607787|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607788|NCT04959825|Protective Agents|protective agents|mesh-ancestor
19607789|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607790|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607791|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
19607792|NCT04955158|Ketamine|ketamine|mesh-list
19607793|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19607794|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607795|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607796|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607797|NCT04955158|Analgesics|analgesics|mesh-ancestor
19607798|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
19607799|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607800|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19607801|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607802|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607803|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607804|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607805|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607806|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19607807|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19607808|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
19607809|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
19607810|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19607811|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19607812|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
19607813|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
19607814|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19607815|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607816|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607817|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607818|NCT04953156|Analgesics|analgesics|mesh-ancestor
19607819|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
19607820|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607821|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19607822|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607823|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20130760|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130761|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
20130762|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20130763|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20130764|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607824|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607825|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607826|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607827|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
19607828|NCT04942184|Complement Factor H|complement factor h|mesh-list
19607829|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19607830|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19607831|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
20311773|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311774|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
20311775|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311776|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311777|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
20311778|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20311779|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20130765|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130766|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
20130767|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130768|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20311780|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607832|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607833|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
19607834|NCT04928391|Nalbuphine|nalbuphine|mesh-list
19607835|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19607836|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607837|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607838|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607839|NCT04928391|Analgesics|analgesics|mesh-ancestor
19607840|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
19607841|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607842|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19607843|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607844|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607845|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607846|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607847|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607848|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19607849|NCT04928391|Narcotics|narcotics|mesh-ancestor
19607850|NCT04928352|Bupivacaine|bupivacaine|mesh-list
19607851|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
19607852|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
19607853|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607854|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607855|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
19607856|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130769|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20130770|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
20130771|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20130772|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20130773|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20130774|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
20608282|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607857|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
20130775|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130776|NCT00027963|Gabapentin|gabapentin|mesh-list
20130777|NCT00027963|Analgesics|analgesics|mesh-ancestor
20130778|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
20130779|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130780|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130781|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
20130782|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20130783|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20130784|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607858|NCT04928300|Ketamine|ketamine|mesh-list
19607859|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19607860|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607861|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607862|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607863|NCT04928300|Analgesics|analgesics|mesh-ancestor
19607864|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
20130785|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20130786|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20130787|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20130788|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20130789|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130790|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
20130791|NCT00027976|Celecoxib|celecoxib|mesh-list
20130792|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20130793|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20130794|NCT00027976|Analgesics|analgesics|mesh-ancestor
20130795|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
20130796|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130797|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130798|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20130799|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20130800|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20130801|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20130802|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130803|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130804|NCT00027989|Gemcitabine|gemcitabine|mesh-list
20130805|NCT00027989|Doxorubicin|doxorubicin|mesh-list
19607865|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607866|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20130806|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20130807|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19607867|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607868|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607869|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607870|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607871|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607872|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19607873|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19607874|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
19607875|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
19607876|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19607877|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19607878|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19607879|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607880|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
19607881|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19607882|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19607883|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130808|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
20130809|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130810|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130811|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
20130812|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130813|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130814|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130815|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
20130816|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130817|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20130818|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20130819|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20130820|NCT00028028|Sirolimus|sirolimus|mesh-list
20130821|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130822|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130823|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20130824|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130825|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
20130826|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130827|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
20130828|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130829|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20130830|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130831|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130832|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130833|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20130834|NCT00028132|Tenofovir|tenofovir|mesh-list
20130835|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
20130836|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130837|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20130838|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20130839|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130840|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130841|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20130842|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20130843|NCT00028171|Tacrolimus|tacrolimus|mesh-list
20130844|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130845|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
20130846|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130847|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20130848|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130849|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130850|NCT00028275|Interferons|interferons|mesh-list
20130851|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
20130852|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130853|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
20130854|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130855|NCT00028288|Daclizumab|daclizumab|mesh-list
20130856|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130857|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
20130858|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130859|NCT00028314|Ritonavir|ritonavir|mesh-list
20130860|NCT00028314|Lopinavir|lopinavir|mesh-list
20130861|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20130862|NCT00028314|Nevirapine|nevirapine|mesh-list
20130863|NCT00028314|Abacavir|abacavir|mesh-list
20130864|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20130865|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19607884|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
19607885|NCT04910464|Coagulants|coagulants|mesh-ancestor
19607886|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
19607887|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19607888|NCT04910269|Antibodies|antibodies|mesh-list
19607889|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
19607890|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607891|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
19607892|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19607893|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19607894|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607895|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
19607896|NCT04905901|Coagulants|coagulants|mesh-ancestor
19607897|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
19607898|NCT04895735|Pemetrexed|pemetrexed|mesh-list
19607899|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19607900|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607901|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607902|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607903|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19607904|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19607905|NCT04868708|Paclitaxel|paclitaxel|mesh-list
19607906|NCT04868708|Bevacizumab|bevacizumab|mesh-list
19607907|NCT04868708|Carboplatin|carboplatin|mesh-list
19607908|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607909|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607910|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607911|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607912|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607913|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607914|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20130866|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
20130867|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130868|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130869|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19607915|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19607916|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19607917|NCT04868708|Growth Substances|growth substances|mesh-ancestor
19607918|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130870|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20130871|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
20130872|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130873|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20130874|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20130875|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20130876|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20130877|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20130878|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20130879|NCT00028327|Lamivudine|lamivudine|mesh-list
20130880|NCT00028327|Zidovudine|zidovudine|mesh-list
20130881|NCT00028327|Efavirenz|efavirenz|mesh-list
20130882|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20130883|NCT00028327|Nelfinavir|nelfinavir|mesh-list
20130884|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20130885|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19607919|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
19607920|NCT04858009|Paclitaxel|paclitaxel|mesh-list
19607921|NCT04858009|Cisplatin|cisplatin|mesh-list
19607922|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19607923|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607924|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607925|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607926|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607927|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607928|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130886|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130887|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130888|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
20130889|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130890|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20130891|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20130892|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
20311781|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19607929|NCT04855513|Metformin|metformin|mesh-list
19607930|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20311782|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
19607931|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607932|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
19607933|NCT04778787|Digoxin|digoxin|mesh-list
19607934|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19607935|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
19607936|NCT04778787|Diuretics|diuretics|mesh-list
19607937|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19607938|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19607939|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607940|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19607941|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607942|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19607943|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19607944|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19607945|NCT04778787|Protective Agents|protective agents|mesh-ancestor
19607946|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
19607947|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19607948|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
19607949|NCT04772222|Morphine|morphine|mesh-list
19607950|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19607951|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19607952|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607953|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607954|NCT04772222|Analgesics|analgesics|mesh-ancestor
19607955|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
19607956|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607957|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19607958|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607959|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607960|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607961|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607962|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607963|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19607964|NCT04772222|Narcotics|narcotics|mesh-ancestor
19607965|NCT04767256|Dexamethasone|dexamethasone|mesh-list
19607966|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
19607967|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19607968|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
19607969|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
19607970|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19607971|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19607972|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19607973|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
19607974|NCT04767256|Hormones|hormones|mesh-ancestor
19607975|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19607976|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19607977|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607978|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19607979|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20130893|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20130894|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20130895|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20130896|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20130897|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20130898|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20130899|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20130900|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20130901|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
20130902|NCT00028353|Toremifene|toremifene|mesh-list
20130903|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20130904|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130905|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20130906|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20130907|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
20130908|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20130909|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130910|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20130911|NCT00028366|Ritonavir|ritonavir|mesh-list
20130912|NCT00028366|Lopinavir|lopinavir|mesh-list
20130913|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
19607980|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19607981|NCT04767256|Analgesics|analgesics|mesh-ancestor
19607982|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
19607983|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19607984|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19607985|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19607986|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19607987|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19607988|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607989|NCT04754815|Paclitaxel|paclitaxel|mesh-list
19607990|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19607991|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
19607992|NCT04754815|Pemetrexed|pemetrexed|mesh-list
19607993|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19607994|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19607995|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
19607996|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
19607997|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
19607998|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19607999|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608000|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608001|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19608002|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19608003|NCT04740697|Tamoxifen|tamoxifen|mesh-list
19608004|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19608005|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
19608006|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608007|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608008|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19608009|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608010|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19608011|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19608012|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19659234|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130914|NCT00028366|Tenofovir|tenofovir|mesh-list
20130915|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20130916|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20130917|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
20130918|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130919|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130920|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20130921|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20130922|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
20130923|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130924|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20130925|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20130926|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20130927|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20130928|NCT00028405|Talaporfin|talaporfin|mesh-list
19659250|NCT01794793|Cabergoline|cabergoline|mesh-list
19659251|NCT01794793|Pasireotide|pasireotide|mesh-list
20130929|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130930|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20130931|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
20173498|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173499|NCT00161720|Protein C|protein c|mesh-list
20173500|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
20173501|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20173502|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20173503|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173504|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20173505|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
20173506|NCT00161733|Coagulants|coagulants|mesh-ancestor
20173507|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20173508|NCT00161759|Thrombin|thrombin|mesh-list
20173509|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
20173510|NCT00161759|Coagulants|coagulants|mesh-ancestor
20173511|NCT00161811|Vaccines|vaccines|mesh-list
20173512|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
20173513|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173514|NCT00161837|Vaccines|vaccines|mesh-list
20173515|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
20173516|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173517|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20173518|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
20173519|NCT00161902|Coagulants|coagulants|mesh-ancestor
20175102|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175103|NCT00167154|Risperidone|risperidone|mesh-list
19608013|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
19608014|NCT04696731|Fludarabine|fludarabine|mesh-list
19608015|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608016|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
19608017|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608018|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608019|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19608020|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
19608021|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608022|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608023|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19608024|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19608025|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19608026|NCT04654351|Icatibant|icatibant|mesh-list
19608027|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19608028|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19608029|NCT04654351|Analgesics|analgesics|mesh-ancestor
19608030|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
19608031|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608032|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608033|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19608034|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608035|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19608036|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19608037|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608038|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19608039|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608040|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
19608041|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19608042|NCT04642352|Bupivacaine|bupivacaine|mesh-list
19608043|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
19608044|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
19608045|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608046|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608047|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
19608048|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608049|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19608050|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
19608051|NCT04642352|Hormones|hormones|mesh-ancestor
19608052|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608053|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608054|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
19608055|NCT04614493|Temozolomide|temozolomide|mesh-list
19608056|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19608057|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
19608058|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608059|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608060|NCT04597268|Midazolam|midazolam|mesh-list
19608061|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
19608062|NCT04597268|Ketamine|ketamine|mesh-list
19608063|NCT04597268|Propofol|propofol|mesh-list
19608064|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19608065|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608066|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608067|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20130932|NCT00028418|Clofarabine|clofarabine|mesh-list
20130933|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20130934|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
19608068|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
19608069|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
19608070|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19608071|NCT04597268|Analgesics|analgesics|mesh-ancestor
19608072|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
19608073|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130935|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130936|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130937|NCT00028431|Ipilimumab|ipilimumab|mesh-list
20130938|NCT00028431|Antibodies|antibodies|mesh-list
20130939|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
20130940|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608074|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19608075|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19608076|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19608077|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
19608078|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608079|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608080|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19608081|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19608082|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19608083|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20130941|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20130942|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130943|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19608084|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19608085|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19608086|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608087|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
19608088|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
19608089|NCT04586985|Midazolam|midazolam|mesh-list
19608090|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19608091|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19608092|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608093|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608094|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20311783|NCT00680563|Hematinics|hematinics|mesh-ancestor
20311784|NCT00680602|Sertraline|sertraline|mesh-list
20311785|NCT00680602|Fluoxetine|fluoxetine|mesh-list
19608095|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19608096|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608097|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608098|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
19608099|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
19608100|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
20130944|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130945|NCT00028483|Docetaxel|docetaxel|mesh-list
20130946|NCT00028483|Doxorubicin|doxorubicin|mesh-list
20130947|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
20130948|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130949|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
20130950|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
20130951|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
20130952|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130953|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20130954|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20130955|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20130956|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20130957|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
20130958|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130959|NCT00028496|Metronidazole|metronidazole|mesh-list
20130960|NCT00028496|Molgramostim|molgramostim|mesh-list
20130961|NCT00028496|Vaccines|vaccines|mesh-list
20130962|NCT00028496|Sargramostim|sargramostim|mesh-list
20130963|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
20130964|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130965|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130966|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20130967|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20130968|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20130969|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20130970|NCT00028535|Paclitaxel|paclitaxel|mesh-list
20130971|NCT00028535|Trastuzumab|trastuzumab|mesh-list
20130972|NCT00028535|Interleukin-12|interleukin-12|mesh-list
20130973|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20130974|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130975|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
20130976|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
20130977|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
20130978|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130979|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20130980|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20130981|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
20130982|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20130983|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20130984|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20130985|NCT00028535|Growth Substances|growth substances|mesh-ancestor
20130986|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
19608101|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
20130987|NCT00028561|Carboplatin|carboplatin|mesh-list
20130988|NCT00028561|Epothilone B|epothilone b|mesh-list
19608102|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311786|NCT00680602|Paroxetine|paroxetine|mesh-list
20311787|NCT00680602|Citalopram|citalopram|mesh-list
19608103|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608104|NCT04573673|Emodin|emodin|mesh-list
19608105|NCT04573673|Cathartics|cathartics|mesh-ancestor
19608106|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19608107|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19608108|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608109|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608110|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
19608111|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19608112|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
19608113|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608114|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608115|NCT04522973|Ethanol|ethanol|mesh-list
19608116|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19608117|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608118|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608119|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608120|NCT04503252|Cefazolin|cefazolin|mesh-list
19608121|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19608122|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608123|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
19608124|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19608125|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608126|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19608127|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19608128|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
19608129|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608130|NCT04488159|Leucovorin|leucovorin|mesh-list
19608131|NCT04488159|Fluorouracil|fluorouracil|mesh-list
19608132|NCT04488159|Capecitabine|capecitabine|mesh-list
19608133|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
19608134|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
19608135|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608136|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19608137|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608138|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20130989|NCT00028561|Epothilones|epothilones|mesh-list
20130990|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20130991|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
20130992|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
20130993|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
20130994|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20130995|NCT00028574|Gabapentin|gabapentin|mesh-list
20130996|NCT00028574|Analgesics|analgesics|mesh-ancestor
20130997|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
20130998|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20130999|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131000|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
20131001|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20131002|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20131003|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20131004|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20131005|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20131006|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20131007|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131008|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131009|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
20131010|NCT00028587|Paclitaxel|paclitaxel|mesh-list
20131011|NCT00028587|Carboplatin|carboplatin|mesh-list
20131012|NCT00028587|Bortezomib|bortezomib|mesh-list
20131013|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131014|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131015|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131016|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131017|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131018|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131019|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
20131020|NCT00028600|Melphalan|melphalan|mesh-list
20131021|NCT00028600|Methotrexate|methotrexate|mesh-list
20131022|NCT00028600|Fludarabine|fludarabine|mesh-list
20131023|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
20131024|NCT00028600|Tacrolimus|tacrolimus|mesh-list
19608139|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
19608140|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608141|NCT04488159|Antidotes|antidotes|mesh-ancestor
20131025|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131026|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
19608142|NCT04488159|Protective Agents|protective agents|mesh-ancestor
19608143|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
19608144|NCT04488159|Vitamins|vitamins|mesh-ancestor
19608145|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
19608146|NCT04445246|Iloprost|iloprost|mesh-list
19608147|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19608148|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
19608149|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19608150|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
19608151|NCT04414761|Cetrorelix|cetrorelix|mesh-list
19608152|NCT04414761|Progesterone|progesterone|mesh-list
19608153|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
19608154|NCT04414761|Ganirelix|ganirelix|mesh-list
20131027|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131028|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608155|NCT04414761|Progestins|progestins|mesh-ancestor
19608156|NCT04414761|Hormones|hormones|mesh-ancestor
19608157|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608158|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608159|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19608160|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19608161|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19608162|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
19608163|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19608164|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19608165|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20131029|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131030|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
19608166|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19608167|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19608168|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608169|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
19608170|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19608171|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
19608172|NCT04414748|Cetrorelix|cetrorelix|mesh-list
19608173|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
19608174|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19608175|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
19608176|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20131031|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131032|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131033|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131034|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20131035|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
20131036|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20131037|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131038|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
20131039|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
20131040|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131041|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20131042|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20131043|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20131044|NCT00028613|Antibodies|antibodies|mesh-list
20131045|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20131046|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
20131047|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131048|NCT00028652|Interleukin-12|interleukin-12|mesh-list
20131049|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20131050|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
20131051|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131052|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20131053|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19608177|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608178|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
19608179|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608180|NCT04414748|Progestins|progestins|mesh-ancestor
19608181|NCT04414748|Hormones|hormones|mesh-ancestor
19608182|NCT04394182|Ritonavir|ritonavir|mesh-list
19608183|NCT04394182|Lopinavir|lopinavir|mesh-list
19608184|NCT04394182|Azithromycin|azithromycin|mesh-list
19608185|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
19749662|NCT04790903|Rituximab|rituximab|mesh-list
19608186|NCT04394182|Tazobactam|tazobactam|mesh-list
20131054|NCT00028652|Growth Substances|growth substances|mesh-ancestor
19608187|NCT04394182|Piperacillin|piperacillin|mesh-list
19608188|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19608189|NCT04394182|Heparin|heparin|mesh-list
19608190|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19608191|NCT04394182|Tinzaparin|tinzaparin|mesh-list
19608192|NCT04394182|Dalteparin|dalteparin|mesh-list
19608193|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19608194|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19608195|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
19608196|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608197|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131055|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
20131056|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131057|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
20131058|NCT00028665|Carmustine|carmustine|mesh-list
19608198|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19608199|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19608200|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
19608201|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608202|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19608203|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311788|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
20311789|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20311790|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20311791|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20311792|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20311793|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311794|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311795|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
20311796|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311797|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19608204|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
19608205|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19608206|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19608207|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19608208|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
19608209|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19608210|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19608211|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608212|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19608213|NCT04388319|Zonisamide|zonisamide|mesh-list
19608214|NCT04388319|Bupropion|bupropion|mesh-list
19608215|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19608216|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
19608217|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608218|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19608219|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19608220|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19608221|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608222|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
19608223|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608224|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608225|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19608226|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19608227|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608228|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
19608229|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19608230|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19608231|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
19608232|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20131059|NCT00028665|Rituximab|rituximab|mesh-list
20131060|NCT00028665|Etoposide|etoposide|mesh-list
20131061|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131062|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
20131063|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608233|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19608234|NCT04377503|Prednisolone|prednisolone|mesh-list
19608235|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
19608236|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19608237|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
19608238|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19608239|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
19608240|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
20131064|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608241|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608242|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608243|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20131065|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131066|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
20131067|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131068|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131069|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131070|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20131071|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131072|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131073|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131074|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131075|NCT00028678|Dalteparin|dalteparin|mesh-list
20131076|NCT00028678|Tinzaparin|tinzaparin|mesh-list
20131077|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20311798|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20311799|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20311800|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311801|NCT00680641|Simvastatin|simvastatin|mesh-list
20311802|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311803|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311804|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
20311805|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311806|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311807|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311808|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311809|NCT00680654|Riociguat|riociguat|mesh-list
20311810|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
19608244|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
19608245|NCT04377503|Hormones|hormones|mesh-ancestor
19608246|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608247|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19608248|NCT04377503|Protective Agents|protective agents|mesh-ancestor
19608249|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19608250|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608251|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
19608252|NCT04360473|Ketamine|ketamine|mesh-list
19608253|NCT04360473|Anesthetics|anesthetics|mesh-list
19608254|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608255|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608256|NCT04360473|Analgesics|analgesics|mesh-ancestor
19608257|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
19608258|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608259|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19608260|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608261|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
19608262|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19608263|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19608264|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608265|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131078|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
20131079|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20131080|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20131081|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131082|NCT00028691|Chlorambucil|chlorambucil|mesh-list
20131083|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20311811|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608266|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19608267|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
19608268|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19608269|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19608270|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19608271|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
20131084|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
20311812|NCT00680680|Dutasteride|dutasteride|mesh-list
19608272|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19608273|NCT04360070|Ketamine|ketamine|mesh-list
19608274|NCT04360070|Analgesics|analgesics|mesh-ancestor
19608275|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
20311813|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20311814|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20311815|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311816|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311817|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
19608276|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608277|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608278|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19608279|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608280|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
19608281|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
19608282|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608283|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19608284|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19608285|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608286|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608287|NCT04358549|Favipiravir|favipiravir|mesh-list
19608288|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
19608289|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608290|NCT04295486|Aspirin|aspirin|mesh-list
19608291|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19608292|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19608293|NCT04295486|Analgesics|analgesics|mesh-ancestor
19608294|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
20131085|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131086|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131087|NCT00028717|Prednisone|prednisone|mesh-list
20131088|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
20131089|NCT00028717|Rituximab|rituximab|mesh-list
20131090|NCT00028717|Doxorubicin|doxorubicin|mesh-list
20131091|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20131092|NCT00028717|Vincristine|vincristine|mesh-list
20131093|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131094|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
20131095|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131096|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131097|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131098|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
20131099|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131100|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131101|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131102|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20131103|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131104|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131105|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131106|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131107|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20131108|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
20131109|NCT00028717|Hormones|hormones|mesh-ancestor
20131110|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131111|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20131112|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131113|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131114|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131115|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131116|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
20131117|NCT00028730|Thiotepa|thiotepa|mesh-list
19608295|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608296|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608297|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20131118|NCT00028730|Fludarabine|fludarabine|mesh-list
20131119|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
20131120|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19608298|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608299|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19608300|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20131121|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131122|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
19608301|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608302|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19608303|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19608304|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608305|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
19659252|NCT01794793|Somatostatin|somatostatin|mesh-list
19659253|NCT01794793|Hormones|hormones|mesh-ancestor
19659254|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19659255|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659256|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19659257|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19659258|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
19659259|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
19659260|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659261|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659262|NCT01748149|Vemurafenib|vemurafenib|mesh-list
19659263|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659264|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131123|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131124|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131125|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131126|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
20131127|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131128|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131129|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131130|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131131|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
20131132|NCT00028743|Paclitaxel|paclitaxel|mesh-list
20131133|NCT00028743|Carboplatin|carboplatin|mesh-list
20131134|NCT00028743|Topotecan|topotecan|mesh-list
20131135|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131136|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131137|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131138|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131139|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131140|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131141|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20131142|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131143|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131144|NCT00028756|Gemcitabine|gemcitabine|mesh-list
20131145|NCT00028756|Doxorubicin|doxorubicin|mesh-list
20131146|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20131147|NCT00028756|Methotrexate|methotrexate|mesh-list
20131148|NCT00028756|Vinblastine|vinblastine|mesh-list
20131149|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131150|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131151|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
19659265|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659266|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131152|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131153|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
20131154|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131155|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131156|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131157|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
20131158|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131159|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131160|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131161|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131162|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20131163|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
20131164|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20131165|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
20131166|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20131167|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131168|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20131169|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131170|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131171|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131172|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131173|NCT00028782|Etanidazole|etanidazole|mesh-list
20311818|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20311819|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311820|NCT00680732|Folic Acid|folic acid|mesh-list
20131174|NCT00028782|Imidazole|imidazole|mesh-list
19608306|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
19608307|NCT04267887|Prednisone|prednisone|mesh-list
19608308|NCT04267887|Cortisone|cortisone|mesh-list
19608309|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
19608310|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
19608311|NCT04267887|Hormones|hormones|mesh-list
19608312|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19608313|NCT04267887|Androgens|androgens|mesh-list
19608314|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
19608315|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19608316|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
19608317|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608318|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608319|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19608320|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608321|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19608322|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131175|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131176|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131177|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131178|NCT00028795|Temozolomide|temozolomide|mesh-list
20131179|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131180|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
20131181|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131182|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131183|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
20131184|NCT00028821|Estradiol|estradiol|mesh-list
20131185|NCT00028821|Estrogens|estrogens|mesh-ancestor
20131186|NCT00028821|Hormones|hormones|mesh-ancestor
20131187|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131188|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131189|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131190|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131191|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131192|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131193|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131194|NCT00028834|Gemcitabine|gemcitabine|mesh-list
20131195|NCT00028834|Bevacizumab|bevacizumab|mesh-list
20131196|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20131197|NCT00028834|Antibodies|antibodies|mesh-list
20131198|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
20131199|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20131200|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131201|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20131202|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20131203|NCT00028834|Growth Substances|growth substances|mesh-ancestor
20131204|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131205|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
20131206|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
20131207|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131208|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
20131209|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131210|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
20131211|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131212|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131213|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608323|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608324|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
19749663|NCT04790903|Doxorubicin|doxorubicin|mesh-list
20131214|NCT00028847|Cytarabine|cytarabine|mesh-list
20311821|NCT00680732|Micronutrients|micronutrients|mesh-list
20311822|NCT00680732|Trace Elements|trace elements|mesh-list
19608325|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19608326|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
19608327|NCT04267887|Protective Agents|protective agents|mesh-ancestor
19608328|NCT04267887|Vitamins|vitamins|mesh-ancestor
19608329|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
19608330|NCT04267887|Estrogens|estrogens|mesh-ancestor
19608331|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
19608332|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
20131215|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
20131216|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131217|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
20131218|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608333|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608334|NCT04249596|Tianeptine|tianeptine|mesh-list
19608335|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19608336|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
19608337|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608338|NCT04248335|Midazolam|midazolam|mesh-list
19608339|NCT04248335|Pantoprazole|pantoprazole|mesh-list
19608340|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19608341|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19608342|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608343|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608344|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19608345|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19608346|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608347|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608348|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
19608349|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
19608350|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
19608351|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
19608352|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608353|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608354|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19608355|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19608356|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19608357|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608358|NCT04232358|Anesthetics|anesthetics|mesh-list
19608359|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608360|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608361|NCT04221828|Paclitaxel|paclitaxel|mesh-list
19608362|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19608363|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19608364|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608365|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
19608366|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131219|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608367|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131220|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
20131221|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131222|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131223|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
20131224|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131225|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131226|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131227|NCT00028860|Gemcitabine|gemcitabine|mesh-list
20131228|NCT00028860|Paclitaxel|paclitaxel|mesh-list
20131229|NCT00028860|Carboplatin|carboplatin|mesh-list
20131230|NCT00028860|Ifosfamide|ifosfamide|mesh-list
20131231|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131232|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311823|NCT00680732|Chloroquine|chloroquine|mesh-list
19608368|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608369|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19608370|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19608371|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608372|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
19608373|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608374|NCT04216953|Atezolizumab|atezolizumab|mesh-list
20131233|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131234|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131235|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131236|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131237|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131238|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
20131239|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
20131240|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131241|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131242|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131243|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
20131244|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131245|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131246|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
20131247|NCT00028873|Paclitaxel|paclitaxel|mesh-list
20131248|NCT00028873|Docetaxel|docetaxel|mesh-list
20131249|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131250|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131251|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131252|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131253|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131254|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131255|NCT00028886|Interferons|interferons|mesh-list
20131256|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
20131257|NCT00028886|Thalidomide|thalidomide|mesh-list
20131258|NCT00028886|Dexamethasone|dexamethasone|mesh-list
20131259|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
20131260|NCT00028886|Melphalan|melphalan|mesh-list
20131261|NCT00028886|Doxorubicin|doxorubicin|mesh-list
20131262|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20131263|NCT00028886|Vincristine|vincristine|mesh-list
20131264|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131265|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
20131266|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131267|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131268|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131269|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
20131270|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131271|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131272|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131273|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20131274|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
20131275|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
20131276|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131277|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20131278|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
20131279|NCT00028886|Hormones|hormones|mesh-ancestor
20131280|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131281|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20311824|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
19608375|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131282|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131283|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131284|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131285|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131286|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
20311825|NCT00680732|Hematinics|hematinics|mesh-ancestor
19608376|NCT04204343|Bupivacaine|bupivacaine|mesh-list
19608377|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
19608378|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
19608379|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608380|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131287|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311826|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
20311827|NCT00680732|Vitamins|vitamins|mesh-ancestor
20311828|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311829|NCT00680732|Amebicides|amebicides|mesh-ancestor
20311830|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20311831|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20311832|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311833|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
20311834|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20311835|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20311836|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311837|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311838|NCT00680758|Paclitaxel|paclitaxel|mesh-list
20311839|NCT00680758|Everolimus|everolimus|mesh-list
20311840|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20311841|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311842|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
20311843|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311844|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
20311845|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311846|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311847|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
20311848|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311849|NCT00680940|Paclitaxel|paclitaxel|mesh-list
20311850|NCT00680940|Cisplatin|cisplatin|mesh-list
20311851|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20311852|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311853|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
20311854|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
20311855|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
20311856|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311857|NCT00681005|Rabeprazole|rabeprazole|mesh-list
20311858|NCT00681005|Pantoprazole|pantoprazole|mesh-list
20311859|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20311860|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20311861|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20311862|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311863|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311864|NCT00681135|Olaflur|olaflur|mesh-list
19608381|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
20131288|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131289|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131290|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131291|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131292|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
20131293|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20131294|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20131295|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20131296|NCT00028886|Growth Substances|growth substances|mesh-ancestor
20131297|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
20131298|NCT00028899|Cytarabine|cytarabine|mesh-list
20131299|NCT00028899|Asparaginase|asparaginase|mesh-list
20131300|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
20131301|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
20131302|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131303|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
20131304|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131305|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131306|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
20131307|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131308|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131309|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
20131310|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131311|NCT00028899|Analgesics|analgesics|mesh-ancestor
20131312|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
20131313|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311865|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
20311866|NCT00681135|Protective Agents|protective agents|mesh-ancestor
20311867|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608382|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131314|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131315|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131316|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608383|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
19608384|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19608385|NCT04126538|Pirfenidone|pirfenidone|mesh-list
19608386|NCT04126538|Analgesics|analgesics|mesh-ancestor
19608387|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
19608388|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608389|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608390|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19608391|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19608392|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19608393|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608394|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608395|NCT04124601|Nivolumab|nivolumab|mesh-list
19608396|NCT04124601|Ipilimumab|ipilimumab|mesh-list
19608397|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608398|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608399|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19608400|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608401|NCT04118010|Vitamin D|vitamin d|mesh-list
19608402|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
19608403|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
19608404|NCT04118010|Vitamins|vitamins|mesh-list
19608405|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
19608406|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608407|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19608408|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19608409|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19608410|NCT04086212|Icodextrin|icodextrin|mesh-list
19608411|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
19608412|NCT05361447|Diazepam|diazepam|mesh-list
19608413|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19608414|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
19608415|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
19608416|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
19608417|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608418|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608419|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19608420|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20131317|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20131318|NCT00028912|Carboplatin|carboplatin|mesh-list
20131319|NCT00028912|Bortezomib|bortezomib|mesh-list
20131320|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131321|NCT00028925|Carboplatin|carboplatin|mesh-list
20131322|NCT00028925|Topotecan|topotecan|mesh-list
20131323|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131324|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20131325|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131326|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131327|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131328|NCT00028938|Paclitaxel|paclitaxel|mesh-list
20131329|NCT00028938|Carboplatin|carboplatin|mesh-list
20131330|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
20131331|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131332|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131333|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131334|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131335|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131336|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131337|NCT00028938|Hematinics|hematinics|mesh-ancestor
20131338|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20131339|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
20131340|NCT00028951|Coagulants|coagulants|mesh-ancestor
20131341|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
20131342|NCT00028964|Doxorubicin|doxorubicin|mesh-list
20131343|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20131344|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131345|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
20131346|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131347|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131348|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131349|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
19608421|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608422|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19608423|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20131350|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131351|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131352|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131353|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131354|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131355|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19608424|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19608425|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19608426|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608427|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608428|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
19608429|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
19608430|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
19608431|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
19608432|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608433|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608434|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
19608435|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19608436|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131356|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131357|NCT00028990|Paclitaxel|paclitaxel|mesh-list
20131358|NCT00028990|Bevacizumab|bevacizumab|mesh-list
19608437|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19608438|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608439|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
19608440|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19608441|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19608442|NCT05361278|Eusol|eusol|mesh-list
19608443|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19608444|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19608445|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608446|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
19608447|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
19608448|NCT05361057|Cytarabine|cytarabine|mesh-list
19608449|NCT05361057|Azacitidine|azacitidine|mesh-list
19608450|NCT05361057|Daunorubicin|daunorubicin|mesh-list
19608451|NCT05361057|Venetoclax|venetoclax|mesh-list
19749664|NCT04790903|Venetoclax|venetoclax|mesh-list
19749665|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749666|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
19749667|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749668|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749669|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19749670|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
19749671|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749672|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749673|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19749674|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749675|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19749676|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19749677|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19749678|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749679|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749680|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
19749681|NCT04790903|Hormones|hormones|mesh-ancestor
19749682|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749683|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749684|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
19749685|NCT04789408|Fludarabine|fludarabine|mesh-list
19749686|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749687|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
19749688|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749689|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749690|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19749691|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
19749692|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749693|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749694|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131359|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131360|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131361|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131362|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131363|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
19608452|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19608453|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
19608454|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608455|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608456|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
19608457|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608458|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608459|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
19608460|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608461|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608462|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19608463|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19608464|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19608465|NCT05360979|Endostatins|endostatins|mesh-list
19608466|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608467|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19608468|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19608469|NCT05360979|Growth Substances|growth substances|mesh-ancestor
19608470|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131364|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131365|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20131366|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20131367|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20131368|NCT00028990|Growth Substances|growth substances|mesh-ancestor
20131369|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131370|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20131371|NCT00029003|Gefitinib|gefitinib|mesh-list
20131372|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131373|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131374|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131375|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131376|NCT00029042|Infliximab|infliximab|mesh-list
20131377|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
20131378|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20131379|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131380|NCT00029159|Estrogens|estrogens|mesh-list
20131381|NCT00029159|Androgens|androgens|mesh-list
20131382|NCT00029159|Hormones|hormones|mesh-ancestor
20131383|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131384|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131385|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
20131386|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20131387|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131388|NCT00029250|Allicin|allicin|mesh-list
20131389|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131390|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20131391|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
20131392|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131393|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20131394|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
20131395|NCT00029250|Protective Agents|protective agents|mesh-ancestor
20131396|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131397|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20131398|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20131399|NCT00029315|Plasminogen|plasminogen|mesh-list
20131400|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20131401|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20131402|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20131403|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131404|NCT00029328|Etanercept|etanercept|mesh-list
20131405|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20131406|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20131407|NCT00029328|Analgesics|analgesics|mesh-ancestor
20131408|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
20131409|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131410|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131411|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20131412|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131413|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20131414|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131415|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
20131416|NCT00029380|Cyclosporine|cyclosporine|mesh-list
20131417|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
20131418|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
19608471|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
20131419|NCT00029380|Busulfan|busulfan|mesh-list
20131420|NCT00029380|Cyclosporins|cyclosporins|mesh-list
19608472|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19608473|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19608474|NCT05360953|Clonidine|clonidine|mesh-list
19608475|NCT05360953|Doxazosin|doxazosin|mesh-list
19608476|NCT05360953|Analgesics|analgesics|mesh-ancestor
19608477|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
19608478|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608479|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608480|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19608481|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
19608482|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
19608483|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19608484|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19608485|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19608486|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
20131421|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131422|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
20131423|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131424|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131425|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131426|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
20131427|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131428|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131429|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131430|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131431|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
20131432|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131433|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
20131434|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20131435|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131436|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20131437|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
20131438|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20131439|NCT00029458|Clozapine|clozapine|mesh-list
20131440|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20131441|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
20131442|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131443|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131444|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131445|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20131446|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20131447|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20131448|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20131449|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
20131450|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
20131451|NCT00029497|Amitriptyline|amitriptyline|mesh-list
20131452|NCT00029497|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20131453|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20131454|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
20131455|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20131456|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20131457|NCT00029497|Analgesics|analgesics|mesh-ancestor
20131458|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
20131459|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131460|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131461|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20131462|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20131463|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20131464|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131465|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
20131466|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131467|NCT00029497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20131468|NCT00029497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20131469|NCT00029497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20131470|NCT00029523|Cytarabine|cytarabine|mesh-list
20131471|NCT00029523|Methotrexate|methotrexate|mesh-list
20131472|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20131473|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
20131474|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20131475|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173520|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19608487|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608488|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131476|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131477|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
20131478|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131479|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608489|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19608490|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19608491|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19608492|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19608493|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19608494|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19608495|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19608496|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20131480|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
20131481|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131482|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20131483|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608497|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19608498|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19608499|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
19608500|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608501|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131484|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
20131485|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131486|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20131487|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
20131488|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131489|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20131490|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20131491|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20131492|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20131493|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131494|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
20131495|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131496|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131497|NCT00029627|Yohimbine|yohimbine|mesh-list
20131498|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
20131499|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
20131500|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131501|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131502|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20131503|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20131504|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20131505|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20131506|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131507|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131508|NCT00029627|Urological Agents|urological agents|mesh-ancestor
20131509|NCT00029679|Borage oil|borage oil|mesh-list
20131510|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131511|NCT00029757|Estrogens|estrogens|mesh-list
20131512|NCT00029757|Hormones|hormones|mesh-ancestor
20131513|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131514|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131515|NCT00029770|Acetaminophen|acetaminophen|mesh-list
20131516|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20131517|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20131518|NCT00029770|Codeine|codeine|mesh-list
20131519|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20131520|NCT00029770|Analgesics|analgesics|mesh-ancestor
20131521|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
20131522|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131523|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131524|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
20131525|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20131526|NCT00029770|Narcotics|narcotics|mesh-ancestor
20131527|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20131528|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
20131529|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
20131530|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131531|NCT00029822|Alfuzosin|alfuzosin|mesh-list
20131532|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20131533|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20311868|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20131534|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19608502|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131535|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
20131536|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131537|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131538|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131539|NCT00029822|Urological Agents|urological agents|mesh-ancestor
20131540|NCT00029835|Rimonabant|rimonabant|mesh-list
20131541|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20131542|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20131543|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20131544|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131545|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131546|NCT00029835|Hormones|hormones|mesh-ancestor
20131547|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131548|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131549|NCT00029848|Rimonabant|rimonabant|mesh-list
20131550|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20131551|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20131552|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20131553|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131554|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131555|NCT00029848|Hormones|hormones|mesh-ancestor
20131556|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131557|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131558|NCT00029861|Rimonabant|rimonabant|mesh-list
20131559|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20131560|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20131561|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20131562|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131563|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131564|NCT00029861|Hormones|hormones|mesh-ancestor
20131565|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131566|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131567|NCT00029874|Minocycline|minocycline|mesh-list
20131568|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20131569|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131570|NCT00030004|Midazolam|midazolam|mesh-list
20131571|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20131572|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20131573|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20131574|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131575|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20131576|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20131577|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20131578|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20131579|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
20131580|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
20131581|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
20131582|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
20131583|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131584|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131585|NCT00030030|Silymarin|silymarin|mesh-list
20131586|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
20131587|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131588|NCT00030030|Protective Agents|protective agents|mesh-ancestor
20131589|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173521|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
20173522|NCT00161915|Coagulants|coagulants|mesh-ancestor
20173523|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20173524|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
20173525|NCT00161980|Coagulants|coagulants|mesh-ancestor
20173526|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
20173527|NCT00161993|Antibodies|antibodies|mesh-list
20173528|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
20173529|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20173530|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20173531|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
20173532|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173533|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
20173534|NCT00162006|Antibodies|antibodies|mesh-list
20173535|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
20173536|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20311869|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20311870|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311871|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311872|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20311873|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20311874|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311875|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
20311876|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311877|NCT00681174|Acetaminophen|acetaminophen|mesh-list
20311878|NCT00681174|Morphine|morphine|mesh-list
20311879|NCT00681174|Remifentanil|remifentanil|mesh-list
20311880|NCT00681174|Oxycodone|oxycodone|mesh-list
20311881|NCT00681174|Propofol|propofol|mesh-list
20311882|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20311883|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20311884|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311885|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20311886|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
20311887|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
19608505|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
20131590|NCT00030056|Molgramostim|molgramostim|mesh-list
20131591|NCT00030056|Sargramostim|sargramostim|mesh-list
20131592|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
20131593|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131594|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131595|NCT00030069|Calcitriol|calcitriol|mesh-list
19608506|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
19608507|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608508|NCT05360602|Protective Agents|protective agents|mesh-ancestor
19608509|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608510|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
19608511|NCT05360602|Vitamins|vitamins|mesh-ancestor
19608512|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
19608513|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19608514|NCT05360576|Etonogestrel|etonogestrel|mesh-list
19608515|NCT05360576|NuvaRing|nuvaring|mesh-list
19608516|NCT05360576|Estradiol|estradiol|mesh-list
19608517|NCT05360576|Estrogens|estrogens|mesh-ancestor
20131596|NCT00030069|Dexamethasone|dexamethasone|mesh-list
20131597|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20131598|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
20131599|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
20131600|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131601|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131602|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20131603|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
20131604|NCT00030069|Hormones|hormones|mesh-ancestor
20131605|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131606|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20131607|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131608|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20131609|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20131610|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20131611|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131612|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20131613|NCT00030069|Vitamins|vitamins|mesh-ancestor
20131614|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
20131615|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20131616|NCT00030082|Melphalan|melphalan|mesh-list
20131617|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131618|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
20131619|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131620|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131621|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131622|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131623|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
20131624|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131625|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
20131626|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131627|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131628|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
19608518|NCT05360576|Hormones|hormones|mesh-ancestor
19608519|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131629|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
19608520|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173537|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20311888|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20311889|NCT00681174|Narcotics|narcotics|mesh-ancestor
19608521|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19608522|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
19608523|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19608524|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19608525|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19608526|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19608527|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
19608528|NCT05360537|Liraglutide|liraglutide|mesh-list
19608529|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19608530|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608531|NCT05360537|Incretins|incretins|mesh-ancestor
19608532|NCT05360537|Hormones|hormones|mesh-ancestor
19608533|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608534|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
19608535|NCT05360511|Hematinics|hematinics|mesh-ancestor
19608536|NCT05360433|Oxycodone|oxycodone|mesh-list
19608537|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19608538|NCT05360433|Narcotics|narcotics|mesh-ancestor
19608539|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608540|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131630|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131631|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
20131632|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
20131633|NCT00030173|Epothilones|epothilones|mesh-list
20131634|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
20131635|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131636|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131637|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131638|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131639|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131640|NCT00030238|Calcium|calcium|mesh-list
20131641|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20131642|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131643|NCT00030342|Interferons|interferons|mesh-list
20131644|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
20131645|NCT00030342|Fluorouracil|fluorouracil|mesh-list
20131646|NCT00030342|Sargramostim|sargramostim|mesh-list
20131647|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
20131648|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131649|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131650|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131651|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131652|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
20131653|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131654|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
20131655|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131656|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
20131657|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131658|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131659|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20131660|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131661|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131662|NCT00030368|Paclitaxel|paclitaxel|mesh-list
20131663|NCT00030368|Bortezomib|bortezomib|mesh-list
20131664|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131665|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131666|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131667|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131668|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131669|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131670|NCT00030381|Esorubicin|esorubicin|mesh-list
20131671|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131672|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131673|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
20131674|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131675|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131676|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131677|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131678|NCT00030407|Celecoxib|celecoxib|mesh-list
20131679|NCT00030407|Docetaxel|docetaxel|mesh-list
20131680|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608541|NCT05360433|Analgesics|analgesics|mesh-ancestor
20131681|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
19608542|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
20131682|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131683|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
19608543|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608544|NCT05360394|Paclitaxel|paclitaxel|mesh-list
19608545|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19608546|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19608547|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608548|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131684|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131685|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20131686|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20131687|NCT00030407|Analgesics|analgesics|mesh-ancestor
20131688|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
20131689|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131690|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131691|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20131692|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131693|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20131694|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20131695|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131696|NCT00030420|Celecoxib|celecoxib|mesh-list
20131697|NCT00030420|Docetaxel|docetaxel|mesh-list
20131698|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131699|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131700|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131701|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131702|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131703|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20131704|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20131705|NCT00030420|Analgesics|analgesics|mesh-ancestor
20131706|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
20131707|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131708|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131709|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20131710|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131711|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20131712|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20131713|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131714|NCT00030433|Gemcitabine|gemcitabine|mesh-list
20131715|NCT00030433|Irinotecan|irinotecan|mesh-list
20131716|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131717|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
20131718|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131719|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131720|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
20131721|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131722|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131723|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131724|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
20131725|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131726|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19608549|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
19608550|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
19608551|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608552|NCT05360342|Vitamins|vitamins|mesh-list
20131727|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131728|NCT00030446|Carboplatin|carboplatin|mesh-list
20131729|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20131730|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131731|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131732|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131733|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131734|NCT00030459|Vinorelbine|vinorelbine|mesh-list
20131735|NCT00030459|Mitomycins|mitomycins|mesh-list
20131736|NCT00030459|Mitomycin|mitomycin|mesh-list
20131737|NCT00030459|Vinblastine|vinblastine|mesh-list
20131738|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131739|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131740|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131741|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131742|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131743|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131744|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19608553|NCT05360342|Vitamin K|vitamin k|mesh-list
19608554|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
19608555|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
19608556|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608557|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19608558|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19608559|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608560|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
19608561|NCT05360342|Coagulants|coagulants|mesh-ancestor
19608562|NCT05360277|Capecitabine|capecitabine|mesh-list
19608563|NCT05360277|Antibodies|antibodies|mesh-list
19608564|NCT05360277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19608565|NCT05360277|Immunologic Factors|immunologic factors|mesh-ancestor
19608566|NCT05360277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608567|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131745|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
20131746|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20131747|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131748|NCT00030472|Doxorubicin|doxorubicin|mesh-list
20131749|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20131750|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131751|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131752|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131753|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131754|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131755|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131756|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20131757|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131758|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131759|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131760|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131761|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20131762|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131763|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131764|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131765|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131766|NCT00030511|Fluorouracil|fluorouracil|mesh-list
20131767|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
20131768|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131769|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131770|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131771|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131772|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
20131773|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131774|NCT00030524|Gefitinib|gefitinib|mesh-list
20131775|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131776|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131777|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131778|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131779|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20131780|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131781|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131782|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131783|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131784|NCT00030550|Thalidomide|thalidomide|mesh-list
20131785|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131786|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
20131787|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131788|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
20131789|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20131790|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131791|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20131792|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20131793|NCT00030550|Growth Substances|growth substances|mesh-ancestor
20131794|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
20131795|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131796|NCT00030563|Irinotecan|irinotecan|mesh-list
20131797|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20131798|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131799|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131800|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608568|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
19608569|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608570|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608571|NCT05360264|Decitabine|decitabine|mesh-list
19608572|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19608573|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
19608574|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608575|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608576|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608577|NCT05360160|Venetoclax|venetoclax|mesh-list
19608578|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608579|NCT05360147|Metformin|metformin|mesh-list
19608580|NCT05360147|Liraglutide|liraglutide|mesh-list
19608581|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19608582|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19608583|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608584|NCT05360147|Incretins|incretins|mesh-ancestor
19608585|NCT05360147|Hormones|hormones|mesh-ancestor
19608586|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608587|NCT05360030|Ketamine|ketamine|mesh-list
19608588|NCT05360030|Naloxone|naloxone|mesh-list
19608589|NCT05360030|Analgesics|analgesics|mesh-ancestor
19608590|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
19608591|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608592|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608593|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19608594|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608595|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
19608596|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
19608597|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608598|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19608599|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19608600|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608601|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608602|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19608603|NCT05359939|Choline|choline|mesh-list
19608604|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
19608605|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19608606|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
19608607|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608608|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19608609|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19608610|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
19608611|NCT05359874|Bevacizumab|bevacizumab|mesh-list
19608612|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608613|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608614|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19608615|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19608616|NCT05359874|Growth Substances|growth substances|mesh-ancestor
19608617|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608618|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
19608619|NCT05359861|Bevacizumab|bevacizumab|mesh-list
19608620|NCT05359861|Atezolizumab|atezolizumab|mesh-list
20131801|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131802|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20131803|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131804|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131805|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608621|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608622|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608623|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19608624|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19608625|NCT05359861|Growth Substances|growth substances|mesh-ancestor
19608626|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608627|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
19608628|NCT05359653|Clemastine|clemastine|mesh-list
19608629|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
19608630|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
19608631|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19608632|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
19608633|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
19608634|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608635|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608636|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608637|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19608638|NCT05359627|Polymyxins|polymyxins|mesh-list
19608639|NCT05359627|Polymyxin B|polymyxin b|mesh-list
20173538|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
19608640|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19608641|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608642|NCT05359497|Liver Extracts|liver extracts|mesh-list
19608643|NCT05359497|Hematinics|hematinics|mesh-ancestor
19608644|NCT05359432|Empagliflozin|empagliflozin|mesh-list
19608645|NCT05359432|Vildagliptin|vildagliptin|mesh-list
19608646|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19608647|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608648|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19608649|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608650|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19608651|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
19608652|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608653|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19608654|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19608655|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
19608656|NCT05359354|Vaccines|vaccines|mesh-list
19608657|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
19608658|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608659|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19608660|NCT05359341|Empagliflozin|empagliflozin|mesh-list
19608661|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19608662|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19608663|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19608664|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608665|NCT05359341|Incretins|incretins|mesh-ancestor
19608666|NCT05359341|Hormones|hormones|mesh-ancestor
19608667|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608668|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
19608669|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608670|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608671|NCT05359315|Interferons|interferons|mesh-list
19608672|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
19749695|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
19749696|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19749697|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749698|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19749699|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19749700|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749701|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749702|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311890|NCT00681174|Analgesics|analgesics|mesh-ancestor
20311891|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
19608673|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608674|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
19608675|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608676|NCT05359237|Vincristine|vincristine|mesh-list
20131806|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131807|NCT00030589|Bexarotene|bexarotene|mesh-list
20131808|NCT00030589|Methoxsalen|methoxsalen|mesh-list
20131809|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131810|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20131811|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
20131812|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
20131813|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20131814|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
20131815|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131816|NCT00030615|Decitabine|decitabine|mesh-list
19608677|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19608678|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608679|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
19608680|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
19608681|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
19608682|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608683|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
19608684|NCT05359211|Fludarabine|fludarabine|mesh-list
19608685|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608686|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
19608687|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608688|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608689|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19608690|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
19608691|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131817|NCT00030615|Azacitidine|azacitidine|mesh-list
20131818|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131819|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
20131820|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131821|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131822|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608692|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608693|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19608694|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
19608695|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19608696|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19608697|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608698|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
19608699|NCT05359172|Coagulants|coagulants|mesh-ancestor
20131823|NCT00030641|Docetaxel|docetaxel|mesh-list
20131824|NCT00030641|Oblimersen|oblimersen|mesh-list
20131825|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131826|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131827|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131828|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131829|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659295|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
19659296|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20131830|NCT00030654|Ketoconazole|ketoconazole|mesh-list
20131831|NCT00030654|Vinblastine|vinblastine|mesh-list
20131832|NCT00030654|Docetaxel|docetaxel|mesh-list
20131833|NCT00030654|Doxorubicin|doxorubicin|mesh-list
20131834|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20311892|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20311893|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20608283|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131835|NCT00030654|Bicalutamide|bicalutamide|mesh-list
20131836|NCT00030654|Flutamide|flutamide|mesh-list
20131837|NCT00030654|Estramustine|estramustine|mesh-list
20131838|NCT00030654|Hormones|hormones|mesh-list
20131839|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131840|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131841|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131842|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131843|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131844|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131845|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131846|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131847|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131848|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659316|NCT01500551|Tofacitinib|tofacitinib|mesh-list
19659317|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19659318|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659319|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131849|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20131850|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131851|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
20131852|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131853|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20131854|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20131855|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20131856|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
20131857|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20131858|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
20131859|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20608284|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
19659328|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19608700|NCT05359146|Edotreotide|edotreotide|mesh-list
19608701|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19608702|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311894|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
20311895|NCT00681213|Sirolimus|sirolimus|mesh-list
20311896|NCT00681213|Tacrolimus|tacrolimus|mesh-list
20311897|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311898|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
20311899|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311900|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20311901|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311902|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608703|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
19608704|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
19608705|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
19608706|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608707|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311903|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20311904|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20311905|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20311906|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311907|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
20311908|NCT00681226|Ramipril|ramipril|mesh-list
20311909|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20311910|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
20311911|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608708|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
19608709|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608710|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19608711|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19608712|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608713|NCT05359055|Itraconazole|itraconazole|mesh-list
19608714|NCT05359055|Rifampin|rifampin|mesh-list
19608715|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
19608716|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608717|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19608718|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19608719|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608720|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608721|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19608722|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
19608723|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608724|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608725|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19608726|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19608727|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
19608728|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19608729|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
19608730|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19608731|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19608732|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19608733|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19608734|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19608735|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19608736|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19608737|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19608738|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
19608739|NCT05358977|Coagulants|coagulants|mesh-ancestor
19608740|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19608741|NCT05358873|Antibodies|antibodies|mesh-list
19608742|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
19608743|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608744|NCT05358834|Melatonin|melatonin|mesh-list
19608745|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
19608746|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608747|NCT05358834|Protective Agents|protective agents|mesh-ancestor
20311912|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311913|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20311914|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
19608748|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608749|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20131860|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131861|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
20608285|NCT02245321|Hematinics|hematinics|mesh-ancestor
20608286|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
20608287|NCT02245334|Povidone|povidone|mesh-list
20131862|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
20131863|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131864|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131865|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131866|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131867|NCT00030693|Metronidazole|metronidazole|mesh-list
20131868|NCT00030693|Vaccines|vaccines|mesh-list
20131869|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
20131870|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131871|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131872|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20131873|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20311915|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
20311916|NCT00681343|Daclizumab|daclizumab|mesh-list
20131874|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20131875|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
20131876|NCT00030719|Melphalan|melphalan|mesh-list
20131877|NCT00030719|Busulfan|busulfan|mesh-list
20131878|NCT00030719|Carboplatin|carboplatin|mesh-list
20131879|NCT00030719|Etoposide|etoposide|mesh-list
20131880|NCT00030719|Vincristine|vincristine|mesh-list
20131881|NCT00030719|Dinutuximab|dinutuximab|mesh-list
20131882|NCT00030719|Isotretinoin|isotretinoin|mesh-list
20131883|NCT00030719|Antibodies|antibodies|mesh-list
20131884|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20131885|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131886|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
20131887|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131888|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20131889|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131890|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
19608750|NCT05358639|Olaparib|olaparib|mesh-list
20311917|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
20311918|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311919|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20311920|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20311921|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311922|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20311923|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19608751|NCT05358639|Navitoclax|navitoclax|mesh-list
19608752|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19608753|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608754|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608755|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608756|NCT05358548|Paclitaxel|paclitaxel|mesh-list
19608757|NCT05358548|Carboplatin|carboplatin|mesh-list
19608758|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
19608759|NCT05358548|Fluorouracil|fluorouracil|mesh-list
19608760|NCT05358548|Pemetrexed|pemetrexed|mesh-list
19608761|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19608762|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608763|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
19608764|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
19608765|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
19608766|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608767|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608768|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
19608769|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19608770|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608771|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
19608772|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608773|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608774|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19608775|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19608776|NCT05358535|Propofol|propofol|mesh-list
20131891|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311924|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19608777|NCT05358535|Etomidate|etomidate|mesh-list
19608778|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20131892|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311925|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
20608288|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
19608779|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608780|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608781|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20131893|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20131894|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20131895|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131896|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131897|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608782|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
19608783|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
19608784|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
19608785|NCT05358522|Narcotics|narcotics|mesh-ancestor
19608786|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608787|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608788|NCT05358522|Analgesics|analgesics|mesh-ancestor
19608789|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
19608790|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608791|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19608792|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
19608793|NCT05358509|Hematinics|hematinics|mesh-ancestor
19608794|NCT05358249|Cetuximab|cetuximab|mesh-list
19608795|NCT05358249|Trametinib|trametinib|mesh-list
19608796|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608797|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608798|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19608799|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608800|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608801|NCT05357885|Antibodies|antibodies|mesh-list
19608802|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
19608803|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311926|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311927|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311928|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311929|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311930|NCT00681460|Metformin|metformin|mesh-list
19608804|NCT05357872|Anesthetics|anesthetics|mesh-list
19608805|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608806|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608807|NCT05357859|Vitamin D|vitamin d|mesh-list
19608808|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
19608809|NCT05357859|Vitamins|vitamins|mesh-ancestor
19608810|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
19608811|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608812|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19608813|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19608814|NCT05357846|Paclitaxel|paclitaxel|mesh-list
19608815|NCT05357846|Cisplatin|cisplatin|mesh-list
19608816|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19608817|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608818|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19608819|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19608820|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19608821|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608826|NCT05357820|Itraconazole|itraconazole|mesh-list
19608827|NCT05357820|Rifampin|rifampin|mesh-list
19608828|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
19608829|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608830|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19608831|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19608832|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608833|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608834|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19608835|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
20131898|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131899|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131900|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
20131901|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
20131902|NCT00030732|Gemcitabine|gemcitabine|mesh-list
19659329|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20131903|NCT00030732|Capecitabine|capecitabine|mesh-list
20131904|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20311931|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19608836|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19608837|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608838|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19608839|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19608840|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
19608841|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19608842|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
19608843|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19608844|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19608845|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19608846|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19608847|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19608848|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19608849|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19608850|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19608851|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608852|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608853|NCT05357768|Formaldehyde|formaldehyde|mesh-list
19608854|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
19608855|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608856|NCT05357690|Bupivacaine|bupivacaine|mesh-list
19608857|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
19608858|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
19608859|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608860|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608861|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
19608862|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608863|NCT05357612|Pimavanserin|pimavanserin|mesh-list
19608864|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19608865|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19608866|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19608867|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19608868|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608869|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608870|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608871|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19608872|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19608873|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
19608874|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608875|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608876|NCT05357547|Buspirone|buspirone|mesh-list
19608877|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19608878|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19608879|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608880|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608881|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19608882|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19608883|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
19608884|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608885|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311932|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311933|NCT00681525|Atorvastatin|atorvastatin|mesh-list
20311934|NCT00681525|Ezetimibe|ezetimibe|mesh-list
20311935|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
20311936|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20311937|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20311938|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
20311939|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311940|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20311941|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20311942|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311943|NCT00681603|Bevacizumab|bevacizumab|mesh-list
20311944|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608886|NCT05357456|Epinephrine|epinephrine|mesh-list
19608887|NCT05357456|Racepinephrine|racepinephrine|mesh-list
19608888|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
19608889|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19608890|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20311945|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311946|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20311947|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20311948|NCT00681603|Growth Substances|growth substances|mesh-ancestor
20311949|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608891|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
19608892|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608893|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608894|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608895|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19608896|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19608897|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
19608898|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608899|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19608900|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
19608901|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
19608902|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
19608903|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19608904|NCT05357430|Propofol|propofol|mesh-list
19608905|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19608906|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608907|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608908|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608909|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
19608910|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
19608911|NCT05357417|Bevacizumab|bevacizumab|mesh-list
19608912|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19608913|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608914|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19608915|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19608916|NCT05357417|Growth Substances|growth substances|mesh-ancestor
19608917|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608918|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
19659330|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
19659331|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19659332|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19659333|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659334|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
19659335|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659336|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659337|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19659338|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19659339|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
19659340|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
20131905|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
20131906|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131907|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131908|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
20131909|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131910|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131911|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131912|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
20131913|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131914|NCT00030745|Gemcitabine|gemcitabine|mesh-list
20131915|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131916|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20131917|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
20131918|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131919|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
20131920|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131921|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131922|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20131923|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
20131924|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131925|NCT00030758|Lenograstim|lenograstim|mesh-list
20131926|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20131927|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
20131928|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131929|NCT00030784|Doxorubicin|doxorubicin|mesh-list
20131930|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20131931|NCT00030784|Ifosfamide|ifosfamide|mesh-list
20131932|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20131933|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131934|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20131935|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131936|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131937|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659374|NCT01398319|Ethanol|ethanol|mesh-list
19659375|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19659376|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608919|NCT05357326|Atropine|atropine|mesh-list
19608920|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19608921|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19608922|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19608923|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19608924|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19608925|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
20311950|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
20311951|NCT00681720|Flumazenil|flumazenil|mesh-list
20311952|NCT00681720|Antidotes|antidotes|mesh-ancestor
20311953|NCT00681720|Protective Agents|protective agents|mesh-ancestor
20311954|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311955|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
20311956|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
20311957|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311958|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347221|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347222|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347223|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20347224|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19608926|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608927|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608928|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19608929|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
19608930|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
19608931|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
19608932|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19608933|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19608934|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
19608935|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19608936|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608937|NCT05357196|Gemcitabine|gemcitabine|mesh-list
19608938|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19608939|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
19608940|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608941|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608942|NCT05357196|Antiviral Agents|antiviral agents|mesh-ancestor
20347225|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
20347226|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
20347227|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347228|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20347229|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20347230|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347231|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347232|NCT00858663|Everolimus|everolimus|mesh-list
20347233|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347234|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347235|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
20347236|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347237|NCT00858676|Acarbose|acarbose|mesh-list
19608943|NCT05357196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19608944|NCT05357196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608945|NCT05357196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608946|NCT05357196|Immunologic Factors|immunologic factors|mesh-ancestor
19608947|NCT05357196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608948|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
19608949|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19608950|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
19608951|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
19608952|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608953|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608954|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19608955|NCT05357066|Analgesics|analgesics|mesh-ancestor
19608956|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
19608957|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19608958|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
19608959|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19608960|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
19608961|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
19608962|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19608963|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347238|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19608964|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19608965|NCT05357040|Analgesics|analgesics|mesh-ancestor
19608966|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
19608967|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20131938|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20131939|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
20131940|NCT00030797|Irinotecan|irinotecan|mesh-list
20131941|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20131942|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131943|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131944|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131945|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131946|NCT00030810|Docetaxel|docetaxel|mesh-list
20131947|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311959|NCT00681733|Pioglitazone|pioglitazone|mesh-list
19608968|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
19608969|NCT05357027|Fludarabine|fludarabine|mesh-list
19608970|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19608971|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
19608972|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608973|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19608974|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19608975|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
19608976|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608977|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19608978|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19608979|NCT05356936|Vitamin D|vitamin d|mesh-list
19608980|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
20311960|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
20311961|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20311962|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311963|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20311964|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19608981|NCT05356936|Vitamins|vitamins|mesh-list
19608982|NCT05356936|Vitamin K|vitamin k|mesh-list
19608983|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
19608984|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
19608985|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19608986|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19608987|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19608988|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19608989|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19608990|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19608991|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
19608992|NCT05356936|Coagulants|coagulants|mesh-ancestor
19608993|NCT05356897|Trifluridine|trifluridine|mesh-list
19608994|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19608995|NCT05356897|Trastuzumab|trastuzumab|mesh-list
19608996|NCT05356897|Tucatinib|tucatinib|mesh-list
19608997|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19608998|NCT05356897|Antibodies|antibodies|mesh-list
19608999|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
19609000|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19609001|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
19609002|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609003|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609004|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
19609005|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609006|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
19609007|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609008|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609009|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609010|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19609011|NCT05356728|Hyaluronic Acid|hyaluronic acid|mesh-list
19609012|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19609013|NCT05356728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19609014|NCT05356728|Immunologic Factors|immunologic factors|mesh-ancestor
19609015|NCT05356728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609016|NCT05356728|Viscosupplements|viscosupplements|mesh-ancestor
19609017|NCT05356728|Protective Agents|protective agents|mesh-ancestor
19609018|NCT05356312|Vaccines|vaccines|mesh-list
20311965|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609019|NCT05356312|Immunologic Factors|immunologic factors|mesh-ancestor
19609020|NCT05356312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609021|NCT05356169|Venetoclax|venetoclax|mesh-list
19609022|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609023|NCT05356091|Sevoflurane|sevoflurane|mesh-list
19609024|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19609025|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19609026|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
19609027|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
19609028|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609029|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609030|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
19609031|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609032|NCT05355974|Norepinephrine|norepinephrine|mesh-list
19609033|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
19609034|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20131948|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20131949|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20131950|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
19609035|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19609036|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609037|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609038|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609039|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609040|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
19609041|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
19609042|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609043|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19609044|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19609045|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20131951|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131952|NCT00030849|Interferons|interferons|mesh-list
20131953|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
20131954|NCT00030849|Bexarotene|bexarotene|mesh-list
20131955|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131956|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
20131957|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131958|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
20311966|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20311967|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20311968|NCT00681733|Protective Agents|protective agents|mesh-ancestor
20311969|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
20311970|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20311971|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
20311972|NCT00681746|Flumazenil|flumazenil|mesh-list
20311973|NCT00681746|Antidotes|antidotes|mesh-ancestor
20311974|NCT00681746|Protective Agents|protective agents|mesh-ancestor
20311975|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20311976|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
19256571|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256572|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19256573|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
19256574|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
19256575|NCT04452383|Analgesics|analgesics|mesh-ancestor
19256576|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
19256577|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256578|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19256579|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19256580|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19256581|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256582|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256583|NCT04438824|Palbociclib|palbociclib|mesh-list
19609046|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19609047|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20131959|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131960|NCT00030862|Irinotecan|irinotecan|mesh-list
20131961|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131962|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20131963|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20131964|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131965|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131966|NCT00030875|Bortezomib|bortezomib|mesh-list
20131967|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609048|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609049|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19609050|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
19609051|NCT05355701|Cetuximab|cetuximab|mesh-list
19609052|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609053|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659377|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19659378|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131968|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20131969|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131970|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20131971|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20131972|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311977|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
20311978|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20311979|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311980|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20311981|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
20311982|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20131973|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20131974|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20131975|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
20131976|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20131977|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20131978|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19659390|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19659391|NCT01369199|Entecavir|entecavir|mesh-list
19659392|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
19659393|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19659394|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19659395|NCT01368497|Entecavir|entecavir|mesh-list
19659396|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
19659397|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20131979|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20131980|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20131981|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131982|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20131983|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
20131984|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20131985|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20131986|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20131987|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20131988|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
20131989|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20131990|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20131991|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20131992|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20131993|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20131994|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20131995|NCT00030966|Natalizumab|natalizumab|mesh-list
20131996|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
20131997|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20131998|NCT00030979|Donepezil|donepezil|mesh-list
20131999|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20132000|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609054|NCT05355610|Gentamicins|gentamicins|mesh-list
19609055|NCT05355610|Dexamethasone|dexamethasone|mesh-list
19609056|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
19609057|NCT05355610|BB 1101|bb 1101|mesh-list
19609058|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609059|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
19609060|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
19609061|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609062|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609063|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609064|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
19609065|NCT05355610|Hormones|hormones|mesh-ancestor
19609066|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609067|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19609068|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609069|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
19609070|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609071|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609072|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19609073|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609074|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19609075|NCT05355597|Clonidine|clonidine|mesh-list
19609076|NCT05355597|Epinephrine|epinephrine|mesh-list
19609077|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19609078|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19609079|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609080|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609081|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609082|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609083|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19609084|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20132001|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132002|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
20132003|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132004|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132005|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
20132006|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
20132007|NCT00031018|Donepezil|donepezil|mesh-list
20132008|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20132009|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132010|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132011|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
19609085|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
19609086|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609087|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19609088|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
19609089|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
19609090|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
19609091|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19609092|NCT05355597|Analgesics|analgesics|mesh-ancestor
19609093|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
19609094|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19609095|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
19609096|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19609097|NCT05355467|Tenofovir|tenofovir|mesh-list
19609098|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
19609099|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609100|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19609101|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20132012|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609102|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132013|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609103|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609104|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19609105|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19609106|NCT05355441|Analgesics|analgesics|mesh-list
19609107|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
19609108|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609109|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609110|NCT05355350|Meropenem|meropenem|mesh-list
19609111|NCT05355350|Tazobactam|tazobactam|mesh-list
19609112|NCT05355350|Piperacillin|piperacillin|mesh-list
19609113|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19609114|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19609115|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609116|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19609117|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609118|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132014|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
20132015|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
20132016|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132017|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132018|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
20132019|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20132020|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19609119|NCT05355337|Pramipexole|pramipexole|mesh-list
19609120|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
19609121|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609122|NCT05355337|Protective Agents|protective agents|mesh-ancestor
19609123|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609124|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19609125|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19609126|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
19609127|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
20132021|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132022|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20132023|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20132024|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
19609128|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609129|NCT05355272|Hormones|hormones|mesh-list
19609130|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609131|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609132|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
19609133|NCT05355051|Azacitidine|azacitidine|mesh-list
19609134|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609135|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609136|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19609137|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
19609138|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609139|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609140|NCT05354999|Caffeine|caffeine|mesh-list
19609141|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19609142|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609143|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19609144|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609145|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609146|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19609147|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19609148|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
20311983|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20311984|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20311985|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20311986|NCT00681772|Urological Agents|urological agents|mesh-ancestor
20311987|NCT00681785|Dalteparin|dalteparin|mesh-list
20311988|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20311989|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
20311990|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20311991|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19609149|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609150|NCT05354986|Povidone|povidone|mesh-list
19609151|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
19609152|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
19609153|NCT05354700|Carboplatin|carboplatin|mesh-list
20132025|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132026|NCT00031057|Riboflavin|riboflavin|mesh-list
20608289|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
20132027|NCT00031057|Thiamine|thiamine|mesh-list
19609154|NCT05354700|Etoposide|etoposide|mesh-list
19609155|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609156|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19609157|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19609158|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19609159|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609160|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609161|NCT05352516|Denosumab|denosumab|mesh-list
19609162|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19609163|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609164|NCT05351541|Zolpidem|zolpidem|mesh-list
19609165|NCT05351541|Modafinil|modafinil|mesh-list
19609166|NCT05351541|Psilocybin|psilocybin|mesh-list
19609167|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19609168|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19609169|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609170|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19609171|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19609172|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19609173|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609174|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19609175|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609176|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609177|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19609178|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
19609179|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
19609180|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609181|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
19609182|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609183|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19609184|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
19609185|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19609186|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19609187|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19609188|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19609189|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19609190|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609191|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609192|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609193|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609194|NCT05348200|Clobetasol|clobetasol|mesh-list
19609195|NCT05348200|Lidocaine|lidocaine|mesh-list
19609196|NCT05348200|Halobetasol|halobetasol|mesh-list
19609197|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
19609198|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
19609199|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609200|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609201|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
19609202|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609203|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19609204|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19609205|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19609206|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19609207|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609208|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19609209|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609210|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
19609211|NCT05348200|Hormones|hormones|mesh-ancestor
20311992|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609212|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609213|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
19609214|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19609215|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19609216|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609217|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19609218|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19609219|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
19609220|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19609221|NCT05347199|Amisulpride|amisulpride|mesh-list
19609222|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19609223|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19609224|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609225|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609226|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609227|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19609228|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
19609229|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609230|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609231|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19609232|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
19609233|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
20311993|NCT00681876|Bevacizumab|bevacizumab|mesh-list
20311994|NCT00681876|Cetuximab|cetuximab|mesh-list
20311995|NCT00681876|Irinotecan|irinotecan|mesh-list
20311996|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20311997|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20311998|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20311999|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20312000|NCT00681876|Growth Substances|growth substances|mesh-ancestor
20312001|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609234|NCT05347173|Nalbuphine|nalbuphine|mesh-list
19609235|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609236|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609237|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609238|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609239|NCT05347173|Analgesics|analgesics|mesh-ancestor
19609240|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
19609241|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609242|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19609243|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19609244|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19609245|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609246|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609247|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609248|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19609249|NCT05347173|Narcotics|narcotics|mesh-ancestor
19609250|NCT05347004|BI 425809|bi 425809|mesh-list
19609251|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
19609252|NCT05346393|Terlipressin|terlipressin|mesh-list
19609253|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19609254|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20132028|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
20132029|NCT00031057|Vitamins|vitamins|mesh-ancestor
20132030|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
20132031|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132032|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20132033|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132034|NCT00031070|Cyclosporine|cyclosporine|mesh-list
20132035|NCT00031070|Lamivudine|lamivudine|mesh-list
20132036|NCT00031070|Zidovudine|zidovudine|mesh-list
20132037|NCT00031070|Efavirenz|efavirenz|mesh-list
20132038|NCT00031070|Abacavir|abacavir|mesh-list
20132039|NCT00031070|Vaccines|vaccines|mesh-list
20132040|NCT00031070|Cyclosporins|cyclosporins|mesh-list
20132041|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20132042|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
20132043|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132044|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132045|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132046|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132047|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
20132048|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132049|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132050|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132051|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20132052|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20132053|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20132054|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
20132055|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20132056|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20132057|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
20132058|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20132059|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20132060|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20132061|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20132062|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20132063|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20132064|NCT00031083|Interferons|interferons|mesh-list
20132065|NCT00031083|Interferon-beta|interferon-beta|mesh-list
20312002|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
19609255|NCT05346224|Pertuzumab|pertuzumab|mesh-list
19609256|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609257|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609258|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19609259|NCT05345522|Antibodies|antibodies|mesh-list
19609260|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
19609261|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19609262|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
19609263|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609264|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609265|NCT05344404|Niacinamide|niacinamide|mesh-list
19609266|NCT05344404|Niacin|niacin|mesh-list
19609267|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
19609268|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
19609269|NCT05344404|Vitamins|vitamins|mesh-ancestor
19609270|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
19609271|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609272|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19609273|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
19609274|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609275|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19609276|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
19609277|NCT05343767|Metformin|metformin|mesh-list
19609278|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19609279|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609280|NCT05343260|Propofol|propofol|mesh-list
19609281|NCT05343260|Sevoflurane|sevoflurane|mesh-list
19609282|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609283|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609284|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609285|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19609286|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
19609287|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
19609288|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19609289|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19609290|NCT05342974|Misoprostol|misoprostol|mesh-list
19609291|NCT05342974|Atorvastatin|atorvastatin|mesh-list
19609292|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19609293|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19609294|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
19609295|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609296|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19609297|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19609298|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609299|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19609300|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
19609301|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19609302|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609303|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19609304|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609305|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
19609306|NCT05342467|Dinoprostone|dinoprostone|mesh-list
19609307|NCT05342467|Gemeprost|gemeprost|mesh-list
19609308|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
19609309|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19609310|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609311|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19609312|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
19609313|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19609314|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609315|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609316|NCT05340205|Misoprostol|misoprostol|mesh-list
19609317|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
19609318|NCT05340205|Oxytocin|oxytocin|mesh-list
19609319|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
19609320|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19609321|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609322|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19609323|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19609324|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609325|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
19609326|NCT05340205|Coagulants|coagulants|mesh-ancestor
19609327|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19609328|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
19609329|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19609330|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609331|NCT05338541|Etoposide|etoposide|mesh-list
19609332|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19609333|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609334|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19609335|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19609336|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609337|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609338|NCT05335317|Hormones|hormones|mesh-list
19609339|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609340|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609341|NCT05335148|Colchicine|colchicine|mesh-list
19609342|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
20132066|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132067|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
20132068|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132069|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
20132070|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132071|NCT00031096|Azelaic acid|azelaic acid|mesh-list
20132072|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132073|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132074|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20132075|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20132076|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
20132077|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132078|NCT00031109|Antacids|antacids|mesh-ancestor
20132079|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132080|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20132081|NCT00031135|Choline|choline|mesh-list
20132082|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
20132083|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19609343|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609344|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
19609345|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
19609346|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
19609347|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609348|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609349|NCT05334654|Enoxaparin|enoxaparin|mesh-list
19609350|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
19609351|NCT05334654|Bivalirudin|bivalirudin|mesh-list
19609352|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
19609353|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19609354|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19609355|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609356|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
19609357|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19609358|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
19609359|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609360|NCT05332587|Rituximab|rituximab|mesh-list
19609361|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609362|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609363|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
19609364|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609365|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609366|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
19609367|NCT05327686|Nivolumab|nivolumab|mesh-list
19609368|NCT05327686|Ipilimumab|ipilimumab|mesh-list
19609369|NCT05327686|Avelumab|avelumab|mesh-list
19609370|NCT05327686|Lenvatinib|lenvatinib|mesh-list
19609371|NCT05327686|Axitinib|axitinib|mesh-list
19609372|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19609373|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609374|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609375|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19609376|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609377|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609378|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609379|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
19609380|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609381|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
19609382|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609383|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609384|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609385|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312003|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19609386|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
19609387|NCT05325281|Gemcitabine|gemcitabine|mesh-list
19609388|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132084|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
19609389|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
19609390|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609391|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609392|NCT05325281|Antiviral Agents|antiviral agents|mesh-ancestor
19609393|NCT05325281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609394|NCT05325281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609395|NCT05325281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19609396|NCT05325281|Immunologic Factors|immunologic factors|mesh-ancestor
19609397|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609398|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
19609399|NCT05325281|Protective Agents|protective agents|mesh-ancestor
19609400|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
19609401|NCT05325281|Vitamins|vitamins|mesh-ancestor
19609402|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
19609403|NCT05325177|Ibuprofen|ibuprofen|mesh-list
19609404|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19609405|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609406|NCT05325177|Analgesics|analgesics|mesh-ancestor
19609407|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
19609408|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609409|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609410|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609411|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609412|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19609413|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609414|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609415|NCT05323019|Ketamine|ketamine|mesh-list
19609416|NCT05323019|Esketamine|esketamine|mesh-list
19609417|NCT05323019|Analgesics|analgesics|mesh-ancestor
19609418|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
19609419|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609420|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609421|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19609422|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19609423|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
19609424|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
20132085|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132086|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20132087|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20132088|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
20132089|NCT00031148|Mitogens|mitogens|mesh-list
20132090|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132091|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132092|NCT00031161|Nitisinone|nitisinone|mesh-list
19609425|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609426|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19609427|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19609428|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609429|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609430|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
19609431|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609432|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19609433|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609434|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
19609435|NCT05322070|Hormones|hormones|mesh-ancestor
19609436|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609437|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609438|NCT05320887|Nicotine|nicotine|mesh-list
19609439|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19609440|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
19609441|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609442|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609443|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19609444|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19609445|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
19609446|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609447|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609450|NCT05312385|Propofol|propofol|mesh-list
19609451|NCT05312385|Isoflurane|isoflurane|mesh-list
19609452|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609453|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609454|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609455|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20312004|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20312005|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312006|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312007|NCT00681902|Lidocaine|lidocaine|mesh-list
20312008|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
20312009|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
20312010|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312011|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312012|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
20312013|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312014|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20312015|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20312016|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20312017|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20312018|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312019|NCT00681928|Letrozole|letrozole|mesh-list
20312020|NCT00681928|Anastrozole|anastrozole|mesh-list
20312021|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312022|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20312023|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20312024|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312025|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312026|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20312027|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312028|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312029|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312030|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20312031|NCT00681941|Sevelamer|sevelamer|mesh-list
20312032|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
20312033|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
19609456|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
19609457|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
19609458|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19609459|NCT05310968|Aspirin|aspirin|mesh-list
19609460|NCT05310968|Tirofiban|tirofiban|mesh-list
19609461|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19609462|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609463|NCT05310968|Analgesics|analgesics|mesh-ancestor
19609464|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
19609465|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609466|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609467|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609468|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609469|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19609470|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19609471|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609472|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19609473|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19609474|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609475|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
19609476|NCT05307198|Capecitabine|capecitabine|mesh-list
19609477|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
19609478|NCT05307198|Antibodies|antibodies|mesh-list
19609479|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19609480|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
19609481|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609482|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19609483|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
19609484|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609485|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609486|NCT05305105|Psilocybin|psilocybin|mesh-list
19609487|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
19609488|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609489|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132093|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132094|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132095|NCT00031187|Docetaxel|docetaxel|mesh-list
20132096|NCT00031187|Doxorubicin|doxorubicin|mesh-list
20132097|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
20132098|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132099|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132100|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132101|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
20347239|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132102|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609490|NCT05303532|Durvalumab|durvalumab|mesh-list
19609491|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609492|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609493|NCT05303220|Branebrutinib|branebrutinib|mesh-list
19609494|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609495|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609496|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609497|NCT05294965|Fenoterol|fenoterol|mesh-list
19609498|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19609499|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
19609500|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609501|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609502|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19609503|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
19609504|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
19609505|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
19609506|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19609507|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19609508|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19609509|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19609510|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609511|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609512|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609513|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19609514|NCT05293938|Cathartics|cathartics|mesh-ancestor
19609515|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609516|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19609517|NCT05292872|Cathartics|cathartics|mesh-ancestor
19609518|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609519|NCT05290753|Erythromycin|erythromycin|mesh-list
19609520|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19609521|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609522|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609523|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19609524|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609525|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132103|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20132104|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20132105|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20132106|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609526|NCT05290220|Lenvatinib|lenvatinib|mesh-list
19609527|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609528|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609529|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609530|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609531|NCT05289440|Esketamine|esketamine|mesh-list
19609532|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
19609533|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609534|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19609535|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19609536|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
19609537|NCT05283408|Esketamine|esketamine|mesh-list
19609538|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609539|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609540|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132107|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
20312034|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312035|NCT00681967|Gefitinib|gefitinib|mesh-list
20312036|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608290|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20608291|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612137|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612138|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20132108|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132109|NCT00031278|Trastuzumab|trastuzumab|mesh-list
20132110|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20132111|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132112|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
20132113|NCT00031291|Antibodies|antibodies|mesh-list
20132114|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
20132115|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19609541|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609542|NCT05283408|Analgesics|analgesics|mesh-ancestor
20132116|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20132117|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
19609543|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
19609544|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609545|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19609546|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19609547|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19609548|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609549|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609550|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609551|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
19609552|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609553|NCT05282121|Empagliflozin|empagliflozin|mesh-list
19609554|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19609555|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609556|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19609557|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609558|NCT05281068|Danazol|danazol|mesh-list
19609559|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19609560|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
19609561|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609562|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609563|NCT05276284|Atezolizumab|atezolizumab|mesh-list
19609564|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
19609565|NCT05276284|Thioguanine|thioguanine|mesh-list
19609566|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609567|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
19609568|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609569|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19609570|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19609571|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
19609572|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609573|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19609574|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609575|NCT05276219|Furosemide|furosemide|mesh-list
19609576|NCT05276219|Isosorbide|isosorbide|mesh-list
19609577|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19609578|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19609579|NCT05276219|Diuretics|diuretics|mesh-ancestor
19609580|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
19609581|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609582|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19609583|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19609584|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609585|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19609586|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
19609587|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19609588|NCT05275010|Trastuzumab|trastuzumab|mesh-list
19609589|NCT05275010|Pertuzumab|pertuzumab|mesh-list
19609590|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609591|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609592|NCT05272605|Vaccines|vaccines|mesh-list
19609593|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
19609594|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609595|NCT05271292|Chiauranib|chiauranib|mesh-list
19609596|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609597|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609598|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609599|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609600|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19609601|NCT05270863|Carbachol|carbachol|mesh-list
19609602|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19609603|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19609604|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19609605|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19609606|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609607|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609608|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132118|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132119|NCT00031317|Clozapine|clozapine|mesh-list
20132120|NCT00031317|Paroxetine|paroxetine|mesh-list
20312037|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20312038|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312039|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312040|NCT00681980|Valproic Acid|valproic acid|mesh-list
20312041|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
20132121|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19609609|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609610|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20312042|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312043|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609611|NCT05270863|Miotics|miotics|mesh-ancestor
19609612|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
19609613|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609614|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19609615|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
19609616|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609617|NCT05270863|Analgesics|analgesics|mesh-ancestor
19609618|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
19609619|NCT05270863|Protective Agents|protective agents|mesh-ancestor
19609620|NCT05265910|Loratadine|loratadine|mesh-list
19609621|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19609622|NCT05265910|Dextrans|dextrans|mesh-list
19609623|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19609624|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19609625|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
19609626|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19609627|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19609628|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19609629|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19609630|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
19609631|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
19609632|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609633|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609634|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609635|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19609636|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609637|NCT05265910|Analgesics|analgesics|mesh-ancestor
20312044|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
20132122|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20132123|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20132124|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132125|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132126|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
20132127|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132128|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20132129|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
20132130|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132131|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20132132|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20132133|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132134|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19609638|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
19609639|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609640|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609641|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609642|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
19609643|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
19609644|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
19609645|NCT05262764|Empagliflozin|empagliflozin|mesh-list
19609646|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19609647|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609648|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19609649|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609650|NCT05262751|Nintedanib|nintedanib|mesh-list
19609651|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609652|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609653|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609654|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609655|NCT05260541|Pramoxine|pramoxine|mesh-list
20132135|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20132136|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20132137|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20132138|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
20132139|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
20132140|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20132141|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
20132142|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312045|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609656|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
19609657|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
19609658|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609659|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609660|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
19609661|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609662|NCT05255601|Nivolumab|nivolumab|mesh-list
19609663|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609664|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609665|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19609666|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609667|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
19609668|NCT05254548|Midazolam|midazolam|mesh-list
19609669|NCT05254548|Omeprazole|omeprazole|mesh-list
19609670|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19609671|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609672|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609673|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609674|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19609675|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19609676|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609677|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19609678|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
19609679|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
19609680|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
19609681|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
19609682|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609683|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609684|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19749711|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
19749712|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19749713|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19749714|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19749715|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19749716|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19749717|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749718|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
19749719|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749720|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749721|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19749722|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749723|NCT04762069|Lomustine|lomustine|mesh-list
19749724|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19749725|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
19749726|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749727|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749728|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
19749729|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19749730|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
19749731|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19749732|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
19749733|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749734|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749735|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
19749739|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19749740|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
19749741|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749742|NCT04680052|Rituximab|rituximab|mesh-list
19749743|NCT04680052|Lenalidomide|lenalidomide|mesh-list
19749744|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749745|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749746|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
19749747|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749748|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749749|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749750|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749751|NCT04680052|Growth Substances|growth substances|mesh-ancestor
19749752|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
19609685|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609686|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19609687|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609688|NCT05254548|Analgesics|analgesics|mesh-ancestor
19609689|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
19609690|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609691|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19609692|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609693|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609694|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609695|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19609696|NCT05253833|Allopurinol|allopurinol|mesh-list
19609697|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
19609698|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609699|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609700|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
19609701|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609702|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19609703|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
19609704|NCT05253833|Protective Agents|protective agents|mesh-ancestor
19609705|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609706|NCT05252442|Vaccines|vaccines|mesh-list
19609707|NCT05252442|Immunologic Factors|immunologic factors|mesh-ancestor
19609708|NCT05252442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609709|NCT05246982|Capecitabine|capecitabine|mesh-list
19609710|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
19609711|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19609712|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
19609713|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609714|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609715|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
19609716|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19609717|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19609718|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132143|NCT00031395|Clonidine|clonidine|mesh-list
20132144|NCT00031395|Methylphenidate|methylphenidate|mesh-list
20132145|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20132146|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132147|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20132148|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20132149|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20132150|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132151|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
20132152|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132153|NCT00031395|Analgesics|analgesics|mesh-ancestor
20132154|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
20132155|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132156|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20132157|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
20132158|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
20132159|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20132160|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20132161|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20132162|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
20132163|NCT00031434|Valganciclovir|valganciclovir|mesh-list
20132164|NCT00031434|Ganciclovir|ganciclovir|mesh-list
20132165|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20132166|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
20132167|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132168|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20132169|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609719|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
19609720|NCT05246943|Coagulants|coagulants|mesh-ancestor
19609721|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
19609722|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
20132170|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132171|NCT00031473|Ribavirin|ribavirin|mesh-list
20132172|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
19609726|NCT05243823|Estradiol|estradiol|mesh-list
19609727|NCT05243823|Estrogens|estrogens|mesh-ancestor
19609728|NCT05243823|Hormones|hormones|mesh-ancestor
19609729|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609730|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609731|NCT05241275|Xenon|xenon|mesh-list
19609732|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19609733|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
19609734|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
19609735|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609736|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609737|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
19609738|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609739|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132173|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132174|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
19659452|NCT01305889|Sertraline|sertraline|mesh-list
20132175|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132176|NCT00031499|Azithromycin|azithromycin|mesh-list
20132177|NCT00031499|Doxycycline|doxycycline|mesh-list
20132178|NCT00031499|Penicillins|penicillins|mesh-list
20132179|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20132180|NCT00031499|Penicillin G|penicillin g|mesh-list
20132181|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
20132182|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20132183|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132184|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
20132185|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20132186|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20132187|NCT00031564|Aldesleukin|aldesleukin|mesh-list
20132188|NCT00031564|Interleukin-2|interleukin-2|mesh-list
20132189|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132190|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132191|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19659453|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
19659454|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19659455|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19659456|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19659457|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19659458|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659459|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659460|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
19659461|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132192|NCT00031564|Analgesics|analgesics|mesh-ancestor
20132193|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
20132194|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132195|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20132196|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20132197|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
20132198|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312046|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312047|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
20312048|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20312049|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312050|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20312051|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
20312052|NCT00681993|Carboplatin|carboplatin|mesh-list
20312053|NCT00681993|Docetaxel|docetaxel|mesh-list
20312054|NCT00681993|Trastuzumab|trastuzumab|mesh-list
20132199|NCT00031577|Paclitaxel|paclitaxel|mesh-list
20132200|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20132201|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132202|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132203|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132204|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132205|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132206|NCT00031616|Brivudine|brivudine|mesh-list
20132207|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
20132208|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
20132209|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132210|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132211|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173539|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173540|NCT00162019|Factor VIII|factor viii|mesh-list
20173541|NCT00162019|Coagulants|coagulants|mesh-ancestor
20173542|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20173543|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20173544|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173545|NCT00162110|Cetuximab|cetuximab|mesh-list
20173546|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20173547|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173548|NCT00162149|Ritonavir|ritonavir|mesh-list
20173549|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20173550|NCT00162149|Nevirapine|nevirapine|mesh-list
20173551|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20173552|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20312055|NCT00681993|Doxorubicin|doxorubicin|mesh-list
20173553|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
20312056|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20312057|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19609740|NCT05233566|Ketamine|ketamine|mesh-list
19609741|NCT05233566|Analgesics|analgesics|mesh-ancestor
19609742|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
19609743|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609744|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609745|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19609746|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19609747|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
19609748|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
19609749|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609750|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19609751|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19609752|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609753|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609754|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
19609755|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19609756|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609757|NCT05231629|Dexamethasone|dexamethasone|mesh-list
19609758|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
19609759|NCT05231629|Melphalan|melphalan|mesh-list
19609760|NCT05231629|Lenalidomide|lenalidomide|mesh-list
19609761|NCT05231629|Bortezomib|bortezomib|mesh-list
19609762|NCT05231629|Daratumumab|daratumumab|mesh-list
19609763|NCT05231629|BB 1101|bb 1101|mesh-list
19609764|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19609765|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609766|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
19609767|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
20132212|NCT00031629|Gemcitabine|gemcitabine|mesh-list
20132213|NCT00031629|Docetaxel|docetaxel|mesh-list
20132214|NCT00031629|Lenograstim|lenograstim|mesh-list
20132215|NCT00031629|Sargramostim|sargramostim|mesh-list
20132216|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132217|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
20132218|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132219|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132220|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
20132221|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132222|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132223|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132224|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
20132225|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132226|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132227|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132228|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132229|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20132230|NCT00031642|Rituximab|rituximab|mesh-list
20132231|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20132232|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132233|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
20608292|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
20608293|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20608294|NCT02245438|Ritonavir|ritonavir|mesh-list
20608295|NCT02245438|Tipranavir|tipranavir|mesh-list
19609768|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609769|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609770|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609771|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
19609772|NCT05231629|Hormones|hormones|mesh-ancestor
19609773|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609774|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19609775|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609776|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
19609777|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609778|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609779|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19609780|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
19609781|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19609782|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19609783|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
19609784|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19609785|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19609786|NCT05231629|Growth Substances|growth substances|mesh-ancestor
20132234|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132235|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132236|NCT00031655|Cyclosporine|cyclosporine|mesh-list
20608296|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19609787|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
19609788|NCT05227937|Amikacin|amikacin|mesh-list
19609789|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19609790|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609791|NCT05227456|Etonogestrel|etonogestrel|mesh-list
19609792|NCT05227456|Desogestrel|desogestrel|mesh-list
19609793|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19609794|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
19609795|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19609796|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609797|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19609798|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19609799|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19609800|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19609801|NCT05227456|Progestins|progestins|mesh-ancestor
19609802|NCT05227456|Hormones|hormones|mesh-ancestor
19609803|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609804|NCT05226351|Dronabinol|dronabinol|mesh-list
19609805|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
19609806|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609807|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19609808|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19609809|NCT05226351|Analgesics|analgesics|mesh-ancestor
19609810|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
19609811|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609812|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19609813|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19609814|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609815|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609816|NCT05226351|Hormones|hormones|mesh-ancestor
19609817|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609818|NCT05225558|Vancomycin|vancomycin|mesh-list
19609819|NCT05225558|Delpazolid|delpazolid|mesh-list
19609820|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
19609821|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19609822|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609823|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19609824|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609825|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609826|NCT05222750|Vaccines|vaccines|mesh-list
19609827|NCT05222750|Immunologic Factors|immunologic factors|mesh-ancestor
19609828|NCT05222750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609829|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
19609830|NCT05222529|Bromides|bromides|mesh-list
19609831|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
19609832|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19609833|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19609834|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20312058|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
20312059|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312060|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312061|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20312062|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
20312063|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312064|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608297|NCT02245438|Norethindrone|norethindrone|mesh-list
20608298|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
20608299|NCT02245438|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20608300|NCT02245438|Norinyl|norinyl|mesh-list
20608301|NCT02245438|Estradiol|estradiol|mesh-list
20608302|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20608303|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20608304|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
20608305|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608306|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608307|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20608308|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20312065|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20312066|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19609835|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
19609836|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609837|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609838|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609839|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
19609840|NCT05220280|Infliximab|infliximab|mesh-list
19609841|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609842|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19609843|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609844|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609845|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
19609846|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609847|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609848|NCT05219435|Nivolumab|nivolumab|mesh-list
19609849|NCT05219435|Ipilimumab|ipilimumab|mesh-list
19609850|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19609851|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609852|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19609853|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609854|NCT05213208|Propofol|propofol|mesh-list
19609855|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609856|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609857|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609858|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19609859|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
19609860|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
19609861|NCT05211570|Azacitidine|azacitidine|mesh-list
19609862|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19609863|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
19609864|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609865|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609866|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609867|NCT05202353|Liraglutide|liraglutide|mesh-list
19609868|NCT05202353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19609869|NCT05202353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609870|NCT05202353|Incretins|incretins|mesh-ancestor
19609871|NCT05202353|Hormones|hormones|mesh-ancestor
19609872|NCT05202353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609873|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19609874|NCT05200481|Carboplatin|carboplatin|mesh-list
19609875|NCT05200481|Pemetrexed|pemetrexed|mesh-list
19609876|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609877|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608309|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
20608310|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608311|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20608312|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20608313|NCT02245438|Estrogens|estrogens|mesh-ancestor
20608314|NCT02245438|Hormones|hormones|mesh-ancestor
20608315|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608316|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608317|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20608318|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
20612139|NCT02249910|Metformin|metformin|mesh-list
20132237|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
20132238|NCT00031655|Fludarabine|fludarabine|mesh-list
19609878|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609879|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20312067|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312068|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19609880|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19609881|NCT05196815|Dobutamine|dobutamine|mesh-list
19609882|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19609883|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
19609884|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
19609885|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609886|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609887|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19609888|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19609889|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19609890|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
19609891|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19609892|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609893|NCT05196815|Protective Agents|protective agents|mesh-ancestor
19609894|NCT05189002|Dalteparin|dalteparin|mesh-list
19609895|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
19609896|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20132239|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
20132240|NCT00031655|Cyclosporins|cyclosporins|mesh-list
20132241|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312069|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20312070|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19609897|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19609898|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609899|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19609900|NCT05183139|Dexamethasone|dexamethasone|mesh-list
19609901|NCT05183139|Lenalidomide|lenalidomide|mesh-list
19609902|NCT05183139|Pomalidomide|pomalidomide|mesh-list
19609903|NCT05183139|Ixazomib|ixazomib|mesh-list
19609904|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609905|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
19609906|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
19609907|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609908|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609909|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609910|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
19609911|NCT05183139|Hormones|hormones|mesh-ancestor
19609912|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609913|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19609914|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609915|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
19609916|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19609917|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19609918|NCT05183139|Growth Substances|growth substances|mesh-ancestor
19609919|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
19609920|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
19609921|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609922|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609923|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
19609924|NCT05182073|Fludarabine|fludarabine|mesh-list
19609925|NCT05182073|Daratumumab|daratumumab|mesh-list
19609926|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19609927|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19609928|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
20312071|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20312072|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20312073|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312074|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
20312075|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19609929|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609930|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19609931|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19609932|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
19609933|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609934|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609935|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20132242|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132243|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
20132244|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132245|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132246|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
20132247|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132248|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132249|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
20132250|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132251|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132252|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132253|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20132254|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19659507|NCT01065454|Riociguat|riociguat|mesh-list
19659508|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
19659509|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132255|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20132256|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
20132257|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20132258|NCT00031681|Irinotecan|irinotecan|mesh-list
20132259|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20312076|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20312077|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19609936|NCT05177484|Ferric maltol|ferric maltol|mesh-list
19609937|NCT05177484|Hematinics|hematinics|mesh-ancestor
19609938|NCT05176964|Capecitabine|capecitabine|mesh-list
19609939|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
19609940|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19609941|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
19609942|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609943|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609944|NCT05173688|Propofol|propofol|mesh-list
19609945|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19609946|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19609947|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609948|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19609949|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
19609950|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
19609951|NCT05172908|Dexamethasone|dexamethasone|mesh-list
19609952|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609953|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
19609954|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
19609955|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609956|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609957|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609958|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
19609959|NCT05172908|Hormones|hormones|mesh-ancestor
19609960|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132260|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20132261|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20132262|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132263|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132264|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132265|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20132266|NCT00031707|Megestrol|megestrol|mesh-list
20132267|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
20132268|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20132269|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20312078|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
20312079|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
20312080|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20312081|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
20312082|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20312083|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20312084|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312085|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312086|NCT00682019|Urological Agents|urological agents|mesh-ancestor
20312087|NCT00682136|Ropivacaine|ropivacaine|mesh-list
20312088|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
19609961|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19609962|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609963|NCT05170789|Dexamethasone|dexamethasone|mesh-list
19609964|NCT05170789|Elotuzumab|elotuzumab|mesh-list
19609965|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19609966|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
19609967|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
19609968|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19609969|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609970|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19609971|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
19609972|NCT05170789|Hormones|hormones|mesh-ancestor
19609973|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609974|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19609975|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19609976|NCT05170230|Terlipressin|terlipressin|mesh-list
19609977|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19609978|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19609979|NCT05169905|Vaccines|vaccines|mesh-list
19609980|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
19609981|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609982|NCT05168566|Maleic acid|maleic acid|mesh-list
19609983|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609984|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609985|NCT05167513|Metformin|metformin|mesh-list
20132270|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19609986|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19609987|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19609988|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609989|NCT05167513|Incretins|incretins|mesh-ancestor
19609990|NCT05167513|Hormones|hormones|mesh-ancestor
20312089|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
20312090|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312091|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19609991|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19609992|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19609993|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
19609994|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609995|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19609996|NCT05162196|Niraparib|niraparib|mesh-list
19609997|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19609998|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19609999|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610000|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610001|NCT05161156|Bromides|bromides|mesh-list
19610002|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
19610003|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19610004|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
19610005|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610006|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610007|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19610008|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
19610009|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
19610010|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19610011|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
19610012|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610013|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610014|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
19610015|NCT05159050|Paclitaxel|paclitaxel|mesh-list
19610016|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19610017|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610018|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
19610019|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
19610020|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
19610021|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610022|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
19610023|NCT05157711|Phenylephrine|phenylephrine|mesh-list
19610024|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
19610025|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
19610026|NCT05157711|Bismuth|bismuth|mesh-list
19610027|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19610028|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
19610029|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
19610030|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610031|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610032|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
19610033|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19610034|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
19610035|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
19610036|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19610037|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19610038|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312092|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
20312093|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312094|NCT00682149|Ascorbic Acid|ascorbic acid|mesh-list
19610039|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
19610040|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610041|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610042|NCT05157711|Protective Agents|protective agents|mesh-ancestor
19610043|NCT05157711|Antacids|antacids|mesh-ancestor
19610044|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19610045|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
19610046|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
19610047|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19610048|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610049|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
19610050|NCT05157711|Coagulants|coagulants|mesh-ancestor
19610051|NCT05157685|Azithromycin|azithromycin|mesh-list
19610052|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19610053|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610054|NCT05154279|Terlipressin|terlipressin|mesh-list
19610055|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20312095|NCT00682149|Vitamins|vitamins|mesh-ancestor
19610056|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19610057|NCT05154136|Itraconazole|itraconazole|mesh-list
19610058|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
20312096|NCT00682149|Micronutrients|micronutrients|mesh-ancestor
19610059|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610060|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19610061|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19610062|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610063|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610064|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19610065|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
19610066|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610067|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610068|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19610069|NCT05152472|Atezolizumab|atezolizumab|mesh-list
19610070|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
19610071|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610072|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610073|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610074|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610075|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
19610076|NCT05147558|Lenvatinib|lenvatinib|mesh-list
19610077|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610078|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610079|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610080|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610081|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610082|NCT05145400|Dexamethasone|dexamethasone|mesh-list
19610083|NCT05145400|Lenalidomide|lenalidomide|mesh-list
19610084|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610085|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
19610086|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
19610087|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610088|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610089|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19610090|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
19610091|NCT05145400|Hormones|hormones|mesh-ancestor
19610092|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610093|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19610094|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610095|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
19610096|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19610097|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19610098|NCT05145400|Growth Substances|growth substances|mesh-ancestor
19610099|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
19610100|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
19610101|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19610102|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610103|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19610104|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610105|NCT05134974|Phentolamine|phentolamine|mesh-list
19610106|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19610107|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19610108|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19610109|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19610110|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
19610111|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610112|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610113|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610114|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19610115|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
19610116|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19610117|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
19610118|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610119|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
19610120|NCT05130814|Protective Agents|protective agents|mesh-ancestor
19610121|NCT05129722|Empagliflozin|empagliflozin|mesh-list
19610122|NCT05129722|Eplerenone|eplerenone|mesh-list
19610123|NCT05129722|Bumetanide|bumetanide|mesh-list
19610124|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19610125|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610126|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19610127|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608319|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19610128|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19610129|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
19610130|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610131|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19610132|NCT05129722|Diuretics|diuretics|mesh-ancestor
19610133|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
19610134|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19610135|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19610136|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19610137|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
19610138|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610139|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610148|NCT05125796|Acetaminophen|acetaminophen|mesh-list
19610149|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20132271|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
20132272|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20132273|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608320|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20608321|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19610150|NCT05125796|Ketoprofen|ketoprofen|mesh-list
19610151|NCT05125796|Lidocaine|lidocaine|mesh-list
19610152|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
19610153|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
19610154|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610155|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610156|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
19610157|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610158|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19610159|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19610160|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19610161|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19610162|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610163|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19610164|NCT05125796|Analgesics|analgesics|mesh-ancestor
19610165|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
19610166|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19610167|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610168|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610169|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19610170|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610171|NCT05120349|Osimertinib|osimertinib|mesh-list
19610172|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610173|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610174|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610175|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610176|NCT05111002|Doxycycline|doxycycline|mesh-list
20132274|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20132275|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20132276|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132277|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132278|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
20132279|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20132280|NCT00031720|Tamoxifen|tamoxifen|mesh-list
20132281|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20132282|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
20132283|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132284|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132285|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20608322|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19610177|NCT05111002|Lefamulin|lefamulin|mesh-list
19610178|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19610179|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312097|NCT00682149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312098|NCT00682149|Antioxidants|antioxidants|mesh-ancestor
20312099|NCT00682149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312100|NCT00682149|Protective Agents|protective agents|mesh-ancestor
19610180|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
19610181|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19610182|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19610183|NCT05109442|Atezolizumab|atezolizumab|mesh-list
19610184|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610185|NCT05107193|Afatinib|afatinib|mesh-list
19610186|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610187|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610188|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610189|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132286|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132287|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20132288|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20132289|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20132290|NCT00031733|Interleukin-12|interleukin-12|mesh-list
20132291|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20132292|NCT00031733|Sargramostim|sargramostim|mesh-list
20132293|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
20132294|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
20132295|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
20132296|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132297|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132298|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20132299|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20132300|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20132301|NCT00031733|Growth Substances|growth substances|mesh-ancestor
20132302|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
20132303|NCT00031733|Antacids|antacids|mesh-ancestor
20132304|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132305|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20132306|NCT00031746|Caseins|caseins|mesh-list
20132307|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
20132308|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
19659538|NCT00977574|Sirolimus|sirolimus|mesh-list
19659539|NCT00977574|Paclitaxel|paclitaxel|mesh-list
19659540|NCT00977574|Epothilones|epothilones|mesh-list
19659541|NCT00977574|Epothilone B|epothilone b|mesh-list
19659542|NCT00977574|Bevacizumab|bevacizumab|mesh-list
19659543|NCT00977574|Carboplatin|carboplatin|mesh-list
19659544|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19659545|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19659546|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
19659547|NCT00977574|Antibodies|antibodies|mesh-list
19659548|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
19659549|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19659550|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
19659551|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19659552|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659553|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
19659554|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
19659555|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312101|NCT00682214|Vitamin D|vitamin d|mesh-list
20312102|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
20312103|NCT00682214|Vitamins|vitamins|mesh-ancestor
19659556|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659557|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20312104|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
19659558|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19659559|NCT00977574|Growth Substances|growth substances|mesh-ancestor
19659560|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132309|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312105|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312106|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20312107|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20312108|NCT00682279|Topotecan|topotecan|mesh-list
20312109|NCT00682279|Lapatinib|lapatinib|mesh-list
20312110|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19610199|NCT05102552|Huperzine A|huperzine a|mesh-list
19610200|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19610201|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610202|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610203|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
19610204|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610205|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610206|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19610207|NCT05102552|Protective Agents|protective agents|mesh-ancestor
19610208|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
19610209|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610210|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610211|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
19610212|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19610213|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19610214|NCT05097976|Prednisolone|prednisolone|mesh-list
19610215|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
19610216|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19610217|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
19610218|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610219|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
19610220|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
19610221|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610222|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610223|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19610224|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
19610225|NCT05097976|Hormones|hormones|mesh-ancestor
19610226|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610227|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19610228|NCT05097976|Protective Agents|protective agents|mesh-ancestor
19610229|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19610230|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610231|NCT05091528|Capecitabine|capecitabine|mesh-list
19610232|NCT05091528|Trastuzumab|trastuzumab|mesh-list
19610233|NCT05091528|Tucatinib|tucatinib|mesh-list
19610234|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19610235|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
19610236|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610237|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610238|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610239|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610240|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610241|NCT05087992|Bevacizumab|bevacizumab|mesh-list
19610242|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610243|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610244|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19610245|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19610246|NCT05087992|Growth Substances|growth substances|mesh-ancestor
19610247|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610248|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19610249|NCT05086250|Ketamine|ketamine|mesh-list
19610250|NCT05086250|Analgesics|analgesics|mesh-ancestor
19610251|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
19610252|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610253|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610254|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20312111|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19610255|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19610256|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
19610257|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
19610258|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610259|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19610260|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19610261|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610262|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610263|NCT05084404|Guanabenz|guanabenz|mesh-list
19610264|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19610265|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19610266|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19610267|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19610268|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
19610269|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610270|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610271|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610272|NCT05081180|Lenvatinib|lenvatinib|mesh-list
19610273|NCT05081180|Avelumab|avelumab|mesh-list
19610274|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610275|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610276|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610277|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610278|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610279|NCT05076110|Acetaminophen|acetaminophen|mesh-list
19610280|NCT05076110|Ibuprofen|ibuprofen|mesh-list
20312112|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312113|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312114|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312115|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20312116|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
20312117|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20312118|NCT00682292|Daclizumab|daclizumab|mesh-list
20312119|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
20312120|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312121|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312122|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
20312123|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
20312124|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
20312125|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312126|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610281|NCT05076110|Oxycodone|oxycodone|mesh-list
19610282|NCT05076110|Gabapentin|gabapentin|mesh-list
19610283|NCT05076110|Methocarbamol|methocarbamol|mesh-list
20312127|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
20312128|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312129|NCT00682383|Docetaxel|docetaxel|mesh-list
20312130|NCT00682383|Etoposide|etoposide|mesh-list
20312131|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312132|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
20312133|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312134|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312135|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312136|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20312137|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20312138|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20312139|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312140|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
19610284|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19610285|NCT05076110|Analgesics|analgesics|mesh-ancestor
19610286|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
19610287|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610288|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610289|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
19610290|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19610291|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610292|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610293|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19610294|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610295|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610296|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19610297|NCT05076110|Narcotics|narcotics|mesh-ancestor
19610298|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610299|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
20312141|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20312142|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19610300|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19610301|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19610302|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19610303|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19610304|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19610305|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610306|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
19610307|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19610308|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19610309|NCT05074706|Antibodies|antibodies|mesh-list
19610310|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
19610311|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
19610312|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610313|NCT05071937|Talazoparib|talazoparib|mesh-list
19610314|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19610315|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610316|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610317|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610318|NCT05065216|Kallikreins|kallikreins|mesh-list
19610319|NCT05065216|Coagulants|coagulants|mesh-ancestor
19610320|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19610321|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
19610322|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19610323|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610324|NCT05065190|Nintedanib|nintedanib|mesh-list
19610325|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610326|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610327|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610328|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610329|NCT05065021|Paclitaxel|paclitaxel|mesh-list
19610330|NCT05065021|Bevacizumab|bevacizumab|mesh-list
19610331|NCT05065021|Niraparib|niraparib|mesh-list
19610332|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19610333|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610334|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
19610335|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
19610336|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
19610337|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610338|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610339|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19610340|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19610341|NCT05065021|Growth Substances|growth substances|mesh-ancestor
19610342|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610343|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
19610344|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19610345|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132310|NCT00031759|Imiquimod|imiquimod|mesh-list
20132311|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20132312|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
19610355|NCT05059535|Acetaminophen|acetaminophen|mesh-list
19610356|NCT05059535|Analgesics|analgesics|mesh-list
19610357|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19610358|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
19610359|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610360|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610361|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
19610362|NCT05056883|Ivermectin|ivermectin|mesh-list
19610363|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19610364|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610365|NCT05053087|Ropivacaine|ropivacaine|mesh-list
19610366|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
19610367|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
19610368|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610369|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612140|NCT02249910|Digoxin|digoxin|mesh-list
19610370|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
19610371|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610372|NCT05038410|Wobenzym|wobenzym|mesh-list
19610373|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19610374|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
19610375|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610376|NCT05035927|Psilocybin|psilocybin|mesh-list
19610377|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
19610378|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610379|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19610380|NCT05034627|Asparaginase|asparaginase|mesh-list
19610381|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610382|NCT05029999|Doxorubicin|doxorubicin|mesh-list
19610383|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19610384|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19610385|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610386|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19610387|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19610388|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610389|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610390|NCT05023980|Rituximab|rituximab|mesh-list
19610391|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19610392|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610393|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610394|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
20132313|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132314|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132315|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
20132316|NCT00031785|Megestrol|megestrol|mesh-list
19610395|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610396|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610397|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19610398|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
19610399|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610400|NCT05022784|Nintedanib|nintedanib|mesh-list
19610401|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610402|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610403|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610404|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610405|NCT05021900|Tenalisib|tenalisib|mesh-list
19610406|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
19610407|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132317|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
19610408|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659561|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
19659562|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
19659563|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19659564|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19659565|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19659566|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
19659567|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132318|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20132319|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20132320|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20132321|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
20132322|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20132323|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132324|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20132325|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20132326|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132327|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132328|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
20132329|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20132330|NCT00031798|Methylphenidate|methylphenidate|mesh-list
20132331|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20132332|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132333|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20132334|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20132335|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20132336|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132337|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
19659592|NCT00666237|Mitomycins|mitomycins|mesh-list
19610409|NCT05014542|Analgesics|analgesics|mesh-list
19610410|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
19610411|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610412|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132338|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132339|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20132340|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20132341|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
20132342|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132343|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132344|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20132345|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20132346|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20132347|NCT00031824|Cyclosporine|cyclosporine|mesh-list
20132348|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
20132349|NCT00031824|Prednisone|prednisone|mesh-list
20132350|NCT00031824|Tacrolimus|tacrolimus|mesh-list
20132351|NCT00031824|Cyclosporins|cyclosporins|mesh-list
20132352|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132353|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
19610429|NCT05003713|Prednisone|prednisone|mesh-list
19610430|NCT05003713|Cortisone|cortisone|mesh-list
19610431|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610432|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
19610433|NCT05003713|Hormones|hormones|mesh-ancestor
19610434|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610435|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610436|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19610437|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610438|NCT05002946|Naltrexone|naltrexone|mesh-list
19610439|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19610440|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19610441|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610442|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
19610443|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610444|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
19610445|NCT05000216|Methotrexate|methotrexate|mesh-list
19610446|NCT05000216|Vaccines|vaccines|mesh-list
19610447|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
19610448|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610449|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19610450|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
19610451|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19610452|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19610453|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
19610454|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610455|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610456|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
19610457|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610458|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19610459|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19610460|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610461|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19610462|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19610463|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19610464|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
19610465|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19610466|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610467|NCT04999969|Gemcitabine|gemcitabine|mesh-list
19610468|NCT04999969|Paclitaxel|paclitaxel|mesh-list
19610469|NCT04999969|Durvalumab|durvalumab|mesh-list
19610470|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19610471|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610472|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132354|NCT00031824|Hormones|hormones|mesh-ancestor
20132355|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132356|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132357|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132358|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132359|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19610473|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
19749753|NCT04666610|Brivaracetam|brivaracetam|mesh-list
19610474|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
19610475|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659593|NCT00666237|Mitomycin|mitomycin|mesh-list
19610476|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19610477|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
19610478|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
19610479|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610480|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610481|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19610482|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
19610483|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610484|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610485|NCT04996017|Atezolizumab|atezolizumab|mesh-list
19610486|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610487|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
19610488|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19610489|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
19610490|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19610491|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
19610492|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610493|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610494|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
20132360|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
20132361|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20132362|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132363|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132364|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
20132365|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132366|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132367|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132368|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
20132369|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20132370|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19610506|NCT04988217|Interferons|interferons|mesh-list
19610507|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
19610508|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
19610509|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610510|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
19610511|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610512|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
19610513|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610514|NCT04981509|Bevacizumab|bevacizumab|mesh-list
19610515|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19610516|NCT04981509|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19610517|NCT04981509|Atezolizumab|atezolizumab|mesh-list
19610518|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
19610519|NCT04981509|Antibodies|antibodies|mesh-list
19610520|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
19610521|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19610522|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
19610523|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610524|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19610525|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19610526|NCT04981509|Growth Substances|growth substances|mesh-ancestor
20312143|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20312144|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610527|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610528|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
19610529|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
19610530|NCT04981509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610531|NCT04981509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610532|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610533|NCT04980482|Interferons|interferons|mesh-list
19610534|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
19610535|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
19610536|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19610537|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610538|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
19610539|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610540|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
19610541|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610542|NCT04973163|Midazolam|midazolam|mesh-list
19610543|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19610544|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19610545|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610546|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610547|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19610548|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19610549|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19610550|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20132371|NCT00031837|Gemcitabine|gemcitabine|mesh-list
20608323|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19610551|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
19610552|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
19610553|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
19610554|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
19610555|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610556|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610557|NCT04966702|Ivermectin|ivermectin|mesh-list
19610558|NCT04966702|Albendazole|albendazole|mesh-list
19610559|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19610560|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610561|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
19610562|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
19610563|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19610564|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19610565|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
19610566|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
19610567|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
19610568|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610569|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132372|NCT00031837|Dalteparin|dalteparin|mesh-list
20132373|NCT00031837|Tinzaparin|tinzaparin|mesh-list
20132374|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20132375|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132376|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
20132377|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132378|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132379|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
20132380|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132381|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132382|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132383|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
20132384|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132385|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
20132386|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20132387|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20132388|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20132389|NCT00031850|Goserelin|goserelin|mesh-list
20132390|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132391|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132392|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20132393|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
20132394|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132395|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132396|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20132397|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20132398|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20132399|NCT00031863|Rofecoxib|rofecoxib|mesh-list
20132400|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20132401|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19610602|NCT04960202|Ritonavir|ritonavir|mesh-list
19610603|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19610604|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19610605|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
19610606|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610607|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610608|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19610609|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19610610|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
19610611|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610612|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19610613|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19610614|NCT04954599|Carboplatin|carboplatin|mesh-list
19610615|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
19610616|NCT04954599|Nivolumab|nivolumab|mesh-list
19610617|NCT04954599|Ipilimumab|ipilimumab|mesh-list
19610618|NCT04954599|Atezolizumab|atezolizumab|mesh-list
19610619|NCT04954599|Durvalumab|durvalumab|mesh-list
19610620|NCT04954599|Avelumab|avelumab|mesh-list
19610621|NCT04954599|Cemiplimab|cemiplimab|mesh-list
19610622|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19610623|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610624|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610625|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610626|NCT04952753|Leucovorin|leucovorin|mesh-list
19610627|NCT04952753|Bevacizumab|bevacizumab|mesh-list
19610628|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
19610629|NCT04952753|Irinotecan|irinotecan|mesh-list
19610630|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
19610631|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610632|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610633|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19610634|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19610635|NCT04952753|Growth Substances|growth substances|mesh-ancestor
19610636|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610637|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
19610638|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19610639|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19610640|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610641|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610642|NCT04952753|Antidotes|antidotes|mesh-ancestor
19610643|NCT04952753|Protective Agents|protective agents|mesh-ancestor
19610644|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
19610645|NCT04952753|Vitamins|vitamins|mesh-ancestor
19610646|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
19610647|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19610648|NCT04944888|Eliglustat|eliglustat|mesh-list
19610649|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610650|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610651|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610652|NCT04935359|Gemcitabine|gemcitabine|mesh-list
19610653|NCT04935359|Paclitaxel|paclitaxel|mesh-list
19610654|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19610655|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610656|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
19610657|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
19610658|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
19610659|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610660|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19610661|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
19610662|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
19610663|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610664|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610665|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19610666|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
19610667|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610668|NCT04930900|Epinephrine|epinephrine|mesh-list
19610669|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19610670|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19610671|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
19610672|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610673|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610674|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610675|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19610676|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19610677|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
19610678|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610679|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19610680|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
19610681|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
19610682|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
19610683|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19610684|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
19610685|NCT04930237|Bisacodyl|bisacodyl|mesh-list
19610686|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
20132402|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132403|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610687|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
19610688|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19610689|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19610690|NCT04930237|Calcium|calcium|mesh-list
20132404|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20132405|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20132406|NCT00031863|Analgesics|analgesics|mesh-ancestor
20132407|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
20132408|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132409|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132410|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610691|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19610692|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610693|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610694|NCT04930237|Cathartics|cathartics|mesh-ancestor
19610695|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19610696|NCT04930237|Laxatives|laxatives|mesh-ancestor
19610697|NCT04930237|Antacids|antacids|mesh-ancestor
19610698|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20312145|NCT00682500|Calfactant|calfactant|mesh-list
20312146|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20312147|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
20312148|NCT00682578|Artesunate|artesunate|mesh-list
19610699|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
19610700|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610701|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
19610702|NCT04928261|Trastuzumab|trastuzumab|mesh-list
19610703|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610704|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610705|NCT04922944|Vaccines|vaccines|mesh-list
19610706|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
19610707|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610708|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
19610709|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610710|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610711|NCT04907851|Denosumab|denosumab|mesh-list
19610712|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19610713|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659594|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19659595|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659596|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
19659597|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659598|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19659599|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659600|NCT00606346|Infliximab|infliximab|mesh-list
19659601|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
19659602|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19659603|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132411|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132412|NCT00031876|Paclitaxel|paclitaxel|mesh-list
20132413|NCT00031876|Capecitabine|capecitabine|mesh-list
20132414|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20132415|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132416|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132417|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132418|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132419|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132420|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132421|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
20132422|NCT00031889|Exemestane|exemestane|mesh-list
20132423|NCT00031889|Bicalutamide|bicalutamide|mesh-list
20132424|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132425|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20132426|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20132427|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659621|NCT00223171|Androgens|androgens|mesh-list
19659622|NCT00223171|Hormones|hormones|mesh-ancestor
19659623|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19659624|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132428|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132429|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20132430|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
20132431|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132432|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132433|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
20132434|NCT00031902|Prednisolone|prednisolone|mesh-list
20132435|NCT00031902|Rituximab|rituximab|mesh-list
20132436|NCT00031902|Vincristine|vincristine|mesh-list
20312149|NCT00682578|Chloroquine|chloroquine|mesh-list
20312150|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
20132437|NCT00031902|Bleomycin|bleomycin|mesh-list
20173554|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312151|NCT00682578|Piperaquine|piperaquine|mesh-list
20312152|NCT00682578|Artenimol|artenimol|mesh-list
19610714|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
19610715|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
19610716|NCT04904588|Melphalan|melphalan|mesh-list
20312153|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
19610717|NCT04904588|Busulfan|busulfan|mesh-list
19610718|NCT04904588|Fludarabine|fludarabine|mesh-list
19610719|NCT04904588|Tacrolimus|tacrolimus|mesh-list
19610720|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19610721|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
19610722|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610723|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610724|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19610725|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
19610726|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610727|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610728|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19610729|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19610730|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610731|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19610732|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19610733|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
19610734|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19610735|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610736|NCT04904536|Atorvastatin|atorvastatin|mesh-list
19610737|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19610738|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19610739|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
19610740|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610741|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19610742|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19610743|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610749|NCT04902859|Clonidine|clonidine|mesh-list
19610750|NCT04902859|Analgesics|analgesics|mesh-ancestor
19610751|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
20132438|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20132439|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132440|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
20132441|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132442|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132443|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19610752|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610753|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610754|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19610755|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
19610756|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
19610757|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19610758|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19610759|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19610760|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
19610761|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610762|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610763|NCT04902703|Molgramostim|molgramostim|mesh-list
19610764|NCT04902703|Sargramostim|sargramostim|mesh-list
20132444|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132445|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132446|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132447|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132448|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132449|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
20132450|NCT00031902|Hormones|hormones|mesh-ancestor
20132451|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132452|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132453|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20132454|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
20132455|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132456|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20132457|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312154|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19610765|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
19610766|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610767|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610768|NCT04900038|Lamivudine|lamivudine|mesh-list
19610769|NCT04900038|Dolutegravir|dolutegravir|mesh-list
19610770|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19610771|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19610772|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610773|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610774|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
19610775|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610776|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19610777|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19610778|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19610779|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19610780|NCT04899349|Metformin|metformin|mesh-list
19610781|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
19610782|NCT04899349|Fulvestrant|fulvestrant|mesh-list
19610783|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20132458|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132459|NCT00031928|Mafosfamide|mafosfamide|mesh-list
20132460|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20132461|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
20132462|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132463|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610784|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610785|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19610786|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610787|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19610788|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610789|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19610790|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19610791|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
19610792|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132464|NCT00031941|Lenalidomide|lenalidomide|mesh-list
20132465|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
20132466|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610812|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
19610813|NCT04895306|Testosterone|testosterone|mesh-list
19610814|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
19610815|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
19610816|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19610817|NCT04895306|Androgens|androgens|mesh-ancestor
19610818|NCT04895306|Hormones|hormones|mesh-ancestor
19610819|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610820|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610821|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132467|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20132468|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19610822|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610823|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
19610824|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
19610825|NCT04881240|Fludarabine|fludarabine|mesh-list
19610826|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132469|NCT00031941|Growth Substances|growth substances|mesh-ancestor
19610827|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
19610828|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610829|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610830|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19610831|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
19610832|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610833|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610834|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19610835|NCT04878107|Docetaxel|docetaxel|mesh-list
20312155|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20312156|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312157|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312158|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
20312159|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
20312160|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19610836|NCT04878107|Apatinib|apatinib|mesh-list
19610837|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610838|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19610839|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19610840|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19610841|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610842|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19610843|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610844|NCT04877522|Niacinamide|niacinamide|mesh-list
19610845|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
19610846|NCT04877522|Dasatinib|dasatinib|mesh-list
19610847|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610848|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20312161|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
20312162|NCT00682578|Amebicides|amebicides|mesh-ancestor
19610849|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610850|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610851|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
19610852|NCT04877522|Vitamins|vitamins|mesh-ancestor
19610853|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
20132470|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
20132471|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132472|NCT00031954|Gemcitabine|gemcitabine|mesh-list
19610854|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610855|NCT04873063|Beclomethasone|beclomethasone|mesh-list
19610856|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610857|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
19610858|NCT04873063|Hormones|hormones|mesh-ancestor
19610859|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610860|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610861|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19610862|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
19610863|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
19610864|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19610865|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610866|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19610867|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610868|NCT04856904|Trifarotene|trifarotene|mesh-list
19610869|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
19610870|NCT04854395|Bupivacaine|bupivacaine|mesh-list
19610871|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
19610872|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
19610873|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610874|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610875|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
20132473|NCT00031954|Paclitaxel|paclitaxel|mesh-list
20132474|NCT00031954|Carboplatin|carboplatin|mesh-list
20132475|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20132476|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132477|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132478|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132479|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132480|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132481|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132482|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
20312163|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610876|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610877|NCT04853043|Cetuximab|cetuximab|mesh-list
19610878|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610879|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610880|NCT04852887|Tamoxifen|tamoxifen|mesh-list
19610881|NCT04852887|Letrozole|letrozole|mesh-list
19610882|NCT04852887|Exemestane|exemestane|mesh-list
19610883|NCT04852887|Anastrozole|anastrozole|mesh-list
19610884|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610885|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19610886|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20132483|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
20132484|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132485|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132486|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132487|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
20132488|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132489|NCT00031967|Melatonin|melatonin|mesh-list
19610887|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610888|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610889|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19610890|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
19610891|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610892|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610893|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19610894|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19610895|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19610896|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19610897|NCT04851301|Naloxone|naloxone|mesh-list
19610898|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19610899|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610900|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
19610901|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610902|NCT04844866|Gemcitabine|gemcitabine|mesh-list
19610903|NCT04844866|Rituximab|rituximab|mesh-list
19610904|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
19610905|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19610906|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19610907|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
19610908|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610909|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610910|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
19610911|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610912|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610913|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19610914|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
19610915|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610916|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
19610917|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610918|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610919|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19610920|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19610921|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
19610922|NCT04840888|Itraconazole|itraconazole|mesh-list
19610923|NCT04840888|Carbamazepine|carbamazepine|mesh-list
19610924|NCT04840888|Omeprazole|omeprazole|mesh-list
19610925|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19610926|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19610927|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19610928|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19610929|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610930|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
19610931|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19610932|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19610933|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19610934|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19610935|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
20132490|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
20132491|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610936|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19610937|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610938|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19610939|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
19610940|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
19610941|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19610942|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610943|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19610944|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19610945|NCT04840888|Analgesics|analgesics|mesh-ancestor
19610946|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
19610947|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610948|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19610949|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20132492|NCT00031967|Protective Agents|protective agents|mesh-ancestor
20132493|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132494|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610950|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19610951|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19610952|NCT04840589|Nivolumab|nivolumab|mesh-list
19610953|NCT04840589|Ipilimumab|ipilimumab|mesh-list
19610954|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19610955|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610956|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19610957|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610958|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19610959|NCT04836429|Trioxsalen|trioxsalen|mesh-list
19610960|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610961|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
19610962|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19610963|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
19610964|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
19610965|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19610966|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610967|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610968|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
19610969|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
19610970|NCT04828694|Naltrexone|naltrexone|mesh-list
19610971|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19610972|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19610973|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610974|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
19610975|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610976|NCT04828083|Lidocaine|lidocaine|mesh-list
19610977|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
19610978|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
19610979|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19610980|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610981|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
19610982|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610983|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19610984|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19610985|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20132495|NCT00031980|Cyclosporine|cyclosporine|mesh-list
20132496|NCT00031980|Cyclosporins|cyclosporins|mesh-list
20132497|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132498|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132499|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19610986|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19610987|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19610988|NCT04823052|Sulindac|sulindac|mesh-list
19610989|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19610990|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19610991|NCT04823052|Analgesics|analgesics|mesh-ancestor
19610992|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
19610993|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19610994|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19610995|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19610996|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19610997|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19610998|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19610999|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611000|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132500|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
19611001|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
19611002|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611003|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611017|NCT04802759|Trastuzumab|trastuzumab|mesh-list
19611018|NCT04802759|Pertuzumab|pertuzumab|mesh-list
19611019|NCT04802759|Everolimus|everolimus|mesh-list
19611020|NCT04802759|Palbociclib|palbociclib|mesh-list
19611021|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611022|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611023|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611024|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
19611025|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611026|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611027|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611028|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611029|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
19611030|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611031|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132501|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132502|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
20132503|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132504|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132505|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132506|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20132507|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20132508|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132509|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20132510|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132511|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132512|NCT00032019|Prednisone|prednisone|mesh-list
19611032|NCT04795245|Afatinib|afatinib|mesh-list
19611033|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611034|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611035|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611036|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132513|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
20132514|NCT00032019|Rituximab|rituximab|mesh-list
20132515|NCT00032019|Doxorubicin|doxorubicin|mesh-list
20132516|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20132517|NCT00032019|Etoposide|etoposide|mesh-list
20132518|NCT00032019|Vincristine|vincristine|mesh-list
20132519|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132520|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
20132521|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132522|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132523|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19611048|NCT04789837|Cilostazol|cilostazol|mesh-list
19611049|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19611050|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
19611051|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611052|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132524|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
19611053|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20175104|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20175105|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
20175106|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175107|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175108|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175109|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20175110|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175111|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175112|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20312164|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20312165|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611054|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
19611055|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19611056|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19611057|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611058|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19611059|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
19611060|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19611061|NCT04789837|Protective Agents|protective agents|mesh-ancestor
19611062|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19611063|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19611064|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132525|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132526|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132527|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20132528|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20132529|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20132530|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20132531|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20132532|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132533|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132534|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
20132535|NCT00032019|Hormones|hormones|mesh-ancestor
20132536|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132537|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132538|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20132539|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132540|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132541|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132542|NCT00032032|Paclitaxel|paclitaxel|mesh-list
20132543|NCT00032032|Carboplatin|carboplatin|mesh-list
20132544|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20132545|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132546|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132547|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132548|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132549|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132550|NCT00032045|Ipilimumab|ipilimumab|mesh-list
20132551|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
20132552|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20132553|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132554|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20132555|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132556|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20132557|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
20132558|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132559|NCT00032084|Bupropion|bupropion|mesh-list
20132560|NCT00032084|Nicotine|nicotine|mesh-list
20132561|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20132562|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
20132563|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132564|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132565|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20132566|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20132567|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
20132568|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132569|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132570|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20132571|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
20132572|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132573|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20132574|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20132575|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20132576|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
20312166|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312167|NCT00682630|Artesunate|artesunate|mesh-list
19749754|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
19749755|NCT04665037|Posaconazole|posaconazole|mesh-list
20312168|NCT00682630|Pyronaridine|pyronaridine|mesh-list
20312169|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
20312170|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20312171|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20312172|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312173|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312174|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
20312175|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
19611065|NCT04789148|Oxytocin|oxytocin|mesh-list
19611066|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
19611067|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312176|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20312177|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
20312178|NCT00682656|Azithromycin|azithromycin|mesh-list
19611068|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611069|NCT04787835|Anesthetics|anesthetics|mesh-list
19611070|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
19611071|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611072|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611073|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
19611074|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611075|NCT04777357|Cariprazine|cariprazine|mesh-list
19611076|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19611077|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19611078|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611079|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611080|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19611081|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
19611082|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611083|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611084|NCT04767841|Metformin|metformin|mesh-list
19611085|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20312179|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19611086|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611087|NCT04763343|Ketamine|ketamine|mesh-list
19611088|NCT04763343|Analgesics|analgesics|mesh-ancestor
19611089|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
19611090|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611091|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611092|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19611093|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19611094|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
19611095|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
19611096|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611097|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19611098|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19611099|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611100|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611101|NCT04760288|Pralsetinib|pralsetinib|mesh-list
19611102|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611103|NCT04755764|Atenolol|atenolol|mesh-list
19611104|NCT04755764|Labetalol|labetalol|mesh-list
19611105|NCT04755764|Nifedipine|nifedipine|mesh-list
19611106|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19611107|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19611108|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611109|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19611110|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611111|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
19611112|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
19611113|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19611114|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19611115|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19611116|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
19611117|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
19611118|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175113|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20175114|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
20175115|NCT00167232|Naltrexone|naltrexone|mesh-list
20175116|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20175117|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20175118|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175119|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
20175120|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175121|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20312180|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20608324|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20608325|NCT02245438|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20608326|NCT02245451|Ritonavir|ritonavir|mesh-list
20608327|NCT02245451|Tipranavir|tipranavir|mesh-list
20608328|NCT02245451|Methadone|methadone|mesh-list
19611119|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19611120|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19611121|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19611122|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
19611123|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611124|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
19611125|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19611126|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19611127|NCT04754945|Dexamethasone|dexamethasone|mesh-list
19611128|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
19611129|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
19611130|NCT04754945|Bortezomib|bortezomib|mesh-list
19611131|NCT04754945|Ichthammol|ichthammol|mesh-list
19611132|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19611133|NCT04754945|BB 1101|bb 1101|mesh-list
19611134|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611135|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
19611136|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611137|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611138|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19611139|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
19611140|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611141|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611142|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19611143|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611144|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
19611145|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
19611146|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611147|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611148|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
19611149|NCT04754945|Hormones|hormones|mesh-ancestor
19611150|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611151|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19611152|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
19611153|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611154|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
19611155|NCT04750616|Niacinamide|niacinamide|mesh-list
19611156|NCT04750616|Niacin|niacin|mesh-list
19611157|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
19611158|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
19611159|NCT04750616|Vitamins|vitamins|mesh-ancestor
19611160|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
19611161|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611162|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19611163|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
19611164|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611165|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19611166|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
19611167|NCT04748848|Azacitidine|azacitidine|mesh-list
19611168|NCT04748848|Venetoclax|venetoclax|mesh-list
19611169|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
19611170|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19611171|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
19611172|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611173|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611174|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132577|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20132578|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20132579|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132580|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
20132581|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132582|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20132583|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132584|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20132585|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132586|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20132587|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608329|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20608330|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19611175|NCT04739150|Nintedanib|nintedanib|mesh-list
20132588|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132589|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20132590|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132591|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20132592|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132593|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132594|NCT00032136|Tamoxifen|tamoxifen|mesh-list
19611176|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611177|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611178|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611179|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611180|NCT04732182|Donepezil|donepezil|mesh-list
19611181|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19611182|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611183|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611184|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
19611185|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611186|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611187|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
19611188|NCT04732065|Dopamine|dopamine|mesh-list
19611189|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19611190|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
19611191|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
19611192|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611193|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611194|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
19611195|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611196|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611197|NCT04732065|Protective Agents|protective agents|mesh-ancestor
19611198|NCT04731974|Melatonin|melatonin|mesh-list
19611199|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
19611200|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611201|NCT04731974|Protective Agents|protective agents|mesh-ancestor
19611202|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611203|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611204|NCT04731467|Paclitaxel|paclitaxel|mesh-list
19611205|NCT04731467|Nivolumab|nivolumab|mesh-list
19611206|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19611207|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611208|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
19611209|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
19611210|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
19611211|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611212|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611213|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19611214|NCT04730362|Propofol|propofol|mesh-list
19611215|NCT04730362|Sevoflurane|sevoflurane|mesh-list
19611216|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
19611217|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611218|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611219|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19611220|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19611221|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
19611222|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19611223|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19611224|NCT04726085|Ibuprofen|ibuprofen|mesh-list
19611225|NCT04726085|Indomethacin|indomethacin|mesh-list
19611226|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19611227|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19611228|NCT04726085|Analgesics|analgesics|mesh-ancestor
19611229|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
19611230|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611231|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611232|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611233|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611234|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19611235|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611236|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611237|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
19611238|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
19611239|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19611240|NCT04725864|Progesterone|progesterone|mesh-list
19611241|NCT04725864|Progestins|progestins|mesh-ancestor
19611242|NCT04725864|Hormones|hormones|mesh-ancestor
19749756|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
19611243|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611244|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611245|NCT04721977|Capecitabine|capecitabine|mesh-list
19611246|NCT04721977|Trastuzumab|trastuzumab|mesh-list
19611247|NCT04721977|Tucatinib|tucatinib|mesh-list
19611248|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19611249|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
19611250|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611251|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611252|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611253|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611254|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611255|NCT04718220|Antibodies|antibodies|mesh-list
19611256|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
19611257|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611258|NCT04713709|Naloxone|naloxone|mesh-list
20132595|NCT00032136|Exemestane|exemestane|mesh-list
20132596|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132597|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20312181|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312182|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20312183|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20312184|NCT00682721|Valacyclovir|valacyclovir|mesh-list
20312185|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
20312186|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312187|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
20312188|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20312189|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20312190|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20312191|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20312192|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312193|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
20312194|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312195|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312196|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20312197|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312198|NCT00682825|Anesthetics|anesthetics|mesh-list
20312199|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
19611259|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19611260|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611261|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
19611262|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611263|NCT04712097|Rituximab|rituximab|mesh-list
19611264|NCT04712097|Lenalidomide|lenalidomide|mesh-list
19611265|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611266|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611267|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
19611268|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611269|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611270|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19611271|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19611272|NCT04712097|Growth Substances|growth substances|mesh-ancestor
19611273|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
19611274|NCT04711837|Propofol|propofol|mesh-list
19611275|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19611276|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611277|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611278|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19611279|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
19611280|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
19611281|NCT04702880|Carboplatin|carboplatin|mesh-list
19611282|NCT04702880|Nivolumab|nivolumab|mesh-list
19611283|NCT04702880|Etoposide|etoposide|mesh-list
19611284|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611285|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20132598|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
20132599|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132600|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132601|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132602|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608331|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
19611286|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19611287|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312200|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611288|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19611289|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19611290|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19611291|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611292|NCT04700176|Dexamethasone|dexamethasone|mesh-list
19611293|NCT04700176|Daratumumab|daratumumab|mesh-list
19611294|NCT04700176|Pomalidomide|pomalidomide|mesh-list
19611295|NCT04700176|Tretinoin|tretinoin|mesh-list
19611296|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611297|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
20312201|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312202|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
20312203|NCT00682955|Zinc|zinc|mesh-list
20312204|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
20312205|NCT00682955|Trace Elements|trace elements|mesh-ancestor
20312206|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
20312207|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611298|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
19611299|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611300|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611301|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611302|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
19611303|NCT04700176|Hormones|hormones|mesh-ancestor
19611304|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611305|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19611306|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611307|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
19611308|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19611309|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19611310|NCT04700176|Growth Substances|growth substances|mesh-ancestor
19611311|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
19611312|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
19611313|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
19611314|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
19611315|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611316|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611317|NCT04688788|Fexofenadine|fexofenadine|mesh-list
19611318|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
19611319|NCT04688788|Rituximab|rituximab|mesh-list
19611320|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
19611321|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611322|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611323|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
19611324|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611325|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132603|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20132604|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20132605|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20132606|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20132607|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20132608|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132609|NCT00032149|Prednisolone|prednisolone|mesh-list
20132610|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
20132611|NCT00032149|Etoposide|etoposide|mesh-list
20132612|NCT00032149|Vincristine|vincristine|mesh-list
20132613|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
20132614|NCT00032149|Bleomycin|bleomycin|mesh-list
19611326|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132615|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312208|NCT00682955|Astringents|astringents|mesh-ancestor
20312209|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
19611327|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
19611328|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
20132616|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
19611329|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611330|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611331|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
19611332|NCT04688788|Hormones|hormones|mesh-ancestor
19611333|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611334|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19611335|NCT04688788|Protective Agents|protective agents|mesh-ancestor
19611336|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19611337|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19611338|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19611339|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
19611340|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
19611341|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611342|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611343|NCT04685694|Misoprostol|misoprostol|mesh-list
19611344|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19611345|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
19611346|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19611347|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611348|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19611349|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611350|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
19611351|NCT04683614|Norepinephrine|norepinephrine|mesh-list
19611352|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19611353|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19611354|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
19611355|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611356|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611357|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611358|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
19611359|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
19611360|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611361|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20132617|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132618|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132619|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20132620|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
20132621|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132622|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132623|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20132624|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20132625|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20132626|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20132627|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132628|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132629|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132630|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132631|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132632|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
20132633|NCT00032149|Hormones|hormones|mesh-ancestor
20312210|NCT00683059|Paclitaxel|paclitaxel|mesh-list
20312211|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20312212|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312213|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
20312214|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312215|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132634|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132635|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132636|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132637|NCT00032149|Analgesics|analgesics|mesh-ancestor
20132638|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
20132639|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20132640|NCT00032162|Carboplatin|carboplatin|mesh-list
20132641|NCT00032162|Doxorubicin|doxorubicin|mesh-list
20312216|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611370|NCT04672005|Leucovorin|leucovorin|mesh-list
19611371|NCT04672005|Gemcitabine|gemcitabine|mesh-list
19611372|NCT04672005|Paclitaxel|paclitaxel|mesh-list
19611373|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19611374|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
19611375|NCT04672005|Irinotecan|irinotecan|mesh-list
19611376|NCT04672005|Folfirinox|folfirinox|mesh-list
19611377|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19611378|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611379|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19611380|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
19611381|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19611382|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611383|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19611384|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
19611385|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
19611386|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611387|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611388|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611389|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
19611390|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611391|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19611392|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19611393|NCT04672005|Antidotes|antidotes|mesh-ancestor
20132642|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20132643|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132644|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20132645|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19611394|NCT04672005|Protective Agents|protective agents|mesh-ancestor
19611395|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
19611396|NCT04672005|Vitamins|vitamins|mesh-ancestor
19611397|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
19611398|NCT04669288|Azithromycin|azithromycin|mesh-list
19611399|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19611400|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611401|NCT04651400|Antithrombins|antithrombins|mesh-list
19611402|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
19611403|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19611404|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
19611405|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611406|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611407|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
19611408|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19611409|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19611410|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611411|NCT04644627|Gentamicins|gentamicins|mesh-list
19611412|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19611413|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611414|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19611415|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611416|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611417|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19611418|NCT04635774|Insulin|insulin|mesh-list
19611419|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19611420|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611421|NCT04626596|Etonogestrel|etonogestrel|mesh-list
19611422|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20132646|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20132647|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132648|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132649|NCT00032175|Gemcitabine|gemcitabine|mesh-list
20132650|NCT00032175|Capecitabine|capecitabine|mesh-list
20132651|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132652|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
20132653|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132654|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132655|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
20132656|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132657|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132658|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611423|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
19611424|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19611425|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611426|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19611427|NCT04624828|Androgens|androgens|mesh-list
19611428|NCT04624828|Hormones|hormones|mesh-ancestor
19611429|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611430|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611431|NCT04622319|Trastuzumab|trastuzumab|mesh-list
19611432|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19611433|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611434|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611435|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
19611436|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
19611437|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
19611438|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611439|NCT04620733|Seladelpar|seladelpar|mesh-list
19611440|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19611441|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
19611442|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611443|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19611444|NCT04619979|Anesthetics|anesthetics|mesh-list
19611445|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611446|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611447|NCT04615624|Furosemide|furosemide|mesh-list
19611448|NCT04615624|Diuretics|diuretics|mesh-ancestor
19611449|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
19611450|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611451|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19611452|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19611453|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611454|NCT04614909|Temozolomide|temozolomide|mesh-list
19611455|NCT04614909|Olaparib|olaparib|mesh-list
19611456|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19611457|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
19611458|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611459|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611460|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19611461|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611465|NCT04603807|Crizotinib|crizotinib|mesh-list
19611466|NCT04603807|Entrectinib|entrectinib|mesh-list
19611467|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611468|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611469|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611470|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611471|NCT04602221|Lamotrigine|lamotrigine|mesh-list
19611472|NCT04602221|BI 425809|bi 425809|mesh-list
19611473|NCT04602221|BI 409306|bi 409306|mesh-list
20312217|NCT00683111|Esomeprazole|esomeprazole|mesh-list
20312218|NCT00683111|Famotidine|famotidine|mesh-list
19611474|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
19611475|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19611476|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19611477|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611478|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19611479|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611480|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19611481|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19611482|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611483|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19611484|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19611485|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19611486|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611487|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
19611488|NCT04589845|Trastuzumab|trastuzumab|mesh-list
19611489|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19611490|NCT04589845|Atezolizumab|atezolizumab|mesh-list
19611491|NCT04589845|Maytansine|maytansine|mesh-list
19611492|NCT04589845|Pralsetinib|pralsetinib|mesh-list
19611493|NCT04589845|Entrectinib|entrectinib|mesh-list
19611494|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611495|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611496|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19611497|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19611498|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
19611499|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312219|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19611500|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611501|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611502|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611505|NCT04580147|Aflibercept|aflibercept|mesh-list
19611506|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19611507|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19611508|NCT04580147|Growth Substances|growth substances|mesh-ancestor
19611509|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611510|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
19611511|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611512|NCT04570631|Dexamethasone|dexamethasone|mesh-list
19611513|NCT04570631|Bortezomib|bortezomib|mesh-list
19611514|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611515|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
19611516|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
19611517|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611518|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611519|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611520|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
19611521|NCT04570631|Hormones|hormones|mesh-ancestor
19611522|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611523|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19611524|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611527|NCT04559581|Nintedanib|nintedanib|mesh-list
19611528|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611529|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611530|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611531|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611532|NCT04557189|Ondansetron|ondansetron|mesh-list
19611533|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
19611534|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
19611535|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611536|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611537|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611538|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
19611539|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
19611540|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19611541|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
19611542|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611543|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611544|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19611545|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19611546|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611547|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19611548|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20132659|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
20132660|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132661|NCT00032188|Aldesleukin|aldesleukin|mesh-list
19611549|NCT04553133|Letrozole|letrozole|mesh-list
19611550|NCT04553133|Fulvestrant|fulvestrant|mesh-list
19611551|NCT04553133|Palbociclib|palbociclib|mesh-list
19611552|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611553|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19611554|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19611555|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611556|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611557|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19611558|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312220|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20312221|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20312222|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132662|NCT00032188|Interleukin-2|interleukin-2|mesh-list
20132663|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
20132664|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132665|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20132666|NCT00032188|Analgesics|analgesics|mesh-ancestor
19611559|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611560|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132667|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
19611561|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19611562|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19611563|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20132668|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132669|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132670|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20132671|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20132672|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
20132673|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132674|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20132675|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
20132676|NCT00032279|Visilizumab|visilizumab|mesh-list
20132677|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
20132678|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132679|NCT00032292|Visilizumab|visilizumab|mesh-list
20132680|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
20132681|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132682|NCT00032305|Visilizumab|visilizumab|mesh-list
20132683|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
20132684|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132685|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20132686|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132687|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
20132688|NCT00032396|Hormones|hormones|mesh-ancestor
20132689|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132690|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132691|NCT00032734|Satavaptan|satavaptan|mesh-list
20132692|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20132693|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132694|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
20132695|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132696|NCT00032747|Vasopressins|vasopressins|mesh-list
20132697|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
20132698|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
20132699|NCT00032747|Coagulants|coagulants|mesh-ancestor
20132700|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20132701|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20132702|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
20132703|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132704|NCT00032773|Pentostatin|pentostatin|mesh-list
20132705|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132706|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20132707|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132708|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665539|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19665540|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665541|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19665542|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
19665543|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665544|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19665545|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
19665546|NCT04894864|Anesthetics|anesthetics|mesh-list
19665547|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665548|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665549|NCT04894864|Narcotics|narcotics|mesh-ancestor
19665550|NCT04894864|Analgesics|analgesics|mesh-ancestor
19665551|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
19665552|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665553|NCT04787991|Gemcitabine|gemcitabine|mesh-list
19665554|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
19665555|NCT04787991|Paclitaxel|paclitaxel|mesh-list
19665556|NCT04787991|Nivolumab|nivolumab|mesh-list
19665557|NCT04787991|Ipilimumab|ipilimumab|mesh-list
19665558|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19665559|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665560|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19665561|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19665562|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665563|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665564|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19611564|NCT04547166|Bevacizumab|bevacizumab|mesh-list
19611565|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611566|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611567|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19611568|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19611569|NCT04547166|Growth Substances|growth substances|mesh-ancestor
19611570|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611571|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
19611572|NCT04545762|Vidarabine|vidarabine|mesh-list
19611573|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
19611574|NCT04545762|Fludarabine|fludarabine|mesh-list
19611575|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
19611576|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611577|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
19611578|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611579|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611580|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19611581|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
19611582|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611583|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611584|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19611585|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19611586|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
19611587|NCT04545762|Antiviral Agents|antiviral agents|mesh-ancestor
19611588|NCT04545762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611589|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
19611590|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
19611591|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
19611592|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19611593|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611594|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
19611595|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
19611596|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611597|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611598|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611599|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
19611600|NCT04544436|Hormones|hormones|mesh-ancestor
19611601|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611602|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19611603|NCT04544436|Protective Agents|protective agents|mesh-ancestor
19611604|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
19611605|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
19611606|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611607|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611608|NCT04542070|Rilpivirine|rilpivirine|mesh-list
19611609|NCT04542070|Cabotegravir|cabotegravir|mesh-list
19611610|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19611611|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19611612|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611613|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611614|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
19611615|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611616|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19611617|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19611618|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19611619|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19611620|NCT04541680|Nintedanib|nintedanib|mesh-list
19611621|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611622|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611623|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611624|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611625|NCT04539223|Evolocumab|evolocumab|mesh-list
19611626|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19611627|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19611628|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
19611629|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611630|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19611631|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
19611632|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19611633|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
19611634|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611635|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19611636|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611637|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
19611638|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611639|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
19611640|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19611641|NCT04535882|Protective Agents|protective agents|mesh-ancestor
19611642|NCT04532528|Dabigatran|dabigatran|mesh-list
19611643|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
19611644|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19611645|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
19611646|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611647|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611648|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
19611649|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19611650|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19611651|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611652|NCT04526899|Cemiplimab|cemiplimab|mesh-list
19611653|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611654|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611655|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19611656|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
19611657|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611658|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
19611659|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611660|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611661|NCT04514497|Irinotecan|irinotecan|mesh-list
19611662|NCT04514497|Topotecan|topotecan|mesh-list
19611663|NCT04514497|Camptothecin|camptothecin|mesh-list
19611664|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19611665|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19611666|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611667|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611668|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611669|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19611670|NCT04505410|Infliximab|infliximab|mesh-list
19611671|NCT04505410|Ustekinumab|ustekinumab|mesh-list
19611672|NCT04505410|Tofacitinib|tofacitinib|mesh-list
19611673|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
19611674|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611675|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611676|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611677|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611678|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611679|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
19611680|NCT04503616|Abatacept|abatacept|mesh-list
19611681|NCT04503616|Tacrolimus|tacrolimus|mesh-list
19611682|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611683|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
19611684|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611685|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611686|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19611687|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
19611688|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611689|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611690|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19611691|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19611692|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611693|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19611694|NCT04502095|Levofloxacin|levofloxacin|mesh-list
19611695|NCT04502095|Ofloxacin|ofloxacin|mesh-list
19611696|NCT04502095|Trimethoprim|trimethoprim|mesh-list
19611697|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19611698|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
19611699|NCT04502095|Clindamycin|clindamycin|mesh-list
19611700|NCT04502095|Ertapenem|ertapenem|mesh-list
19611701|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
19611702|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19611703|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611704|NCT04502095|Renal Agents|renal agents|mesh-ancestor
19611705|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19611706|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19611707|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19611708|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611709|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611710|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312223|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312224|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19611711|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19611712|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19611713|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19611714|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
19611715|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19611716|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19611717|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19611718|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19611719|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19611720|NCT04493216|Dolutegravir|dolutegravir|mesh-list
19611721|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19611722|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19611723|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611724|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611725|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19611726|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20132709|NCT00032786|Natalizumab|natalizumab|mesh-list
20132710|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
20132711|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132712|NCT00032799|Natalizumab|natalizumab|mesh-list
20132713|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
19611727|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
19611728|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611729|NCT04492254|Enoxaparin|enoxaparin|mesh-list
19611730|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
19611731|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19611732|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19611733|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611734|NCT04485130|Disulfiram|disulfiram|mesh-list
19611735|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19611736|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19611737|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611738|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611739|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
19611740|NCT04485013|Cetuximab|cetuximab|mesh-list
19611741|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611742|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611743|NCT04475835|Heparin|heparin|mesh-list
19611744|NCT04475835|Bivalirudin|bivalirudin|mesh-list
19611745|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
19611746|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19611747|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19611748|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611749|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
19611750|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19611751|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
19611752|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611753|NCT04474470|Cetuximab|cetuximab|mesh-list
19611754|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611755|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611756|NCT04471246|Cephalexin|cephalexin|mesh-list
19611757|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19611758|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611759|NCT04468984|Navitoclax|navitoclax|mesh-list
19611760|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132714|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132715|NCT00032812|Raclopride|raclopride|mesh-list
20132716|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20132717|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20132718|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20132719|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132720|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132721|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20132722|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
20132723|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132724|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132725|NCT00032825|Ketoconazole|ketoconazole|mesh-list
20132726|NCT00032825|Docetaxel|docetaxel|mesh-list
19611771|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19611772|NCT04466475|Melphalan|melphalan|mesh-list
19611773|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
19611774|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19611775|NCT04466475|Daratumumab|daratumumab|mesh-list
19611776|NCT04466475|Antibodies|antibodies|mesh-list
19611777|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
20132727|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611778|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19611779|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
19611780|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611781|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611782|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19611783|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
19611784|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611785|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19611786|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611787|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
19611788|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
19611789|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312225|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
20312226|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
20312227|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312228|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312229|NCT00683124|Losartan|losartan|mesh-list
20312230|NCT00683124|Nebivolol|nebivolol|mesh-list
20312231|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20312232|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20312233|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20312234|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20312235|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611790|NCT04463368|Nivolumab|nivolumab|mesh-list
19611791|NCT04463368|Ipilimumab|ipilimumab|mesh-list
19611792|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611793|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611794|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19611795|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611796|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
19611797|NCT04460456|Cemiplimab|cemiplimab|mesh-list
19611798|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611799|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611800|NCT04460326|Insulin|insulin|mesh-list
19611801|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19611802|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
19611803|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
19611804|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19611805|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611806|NCT04460066|Paclitaxel|paclitaxel|mesh-list
19611807|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19611808|NCT04460066|Antibodies|antibodies|mesh-list
19611809|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19611810|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611811|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
19611812|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
19611813|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
19611814|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611815|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
19611816|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611817|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
19611818|NCT04459416|Narcotics|narcotics|mesh-ancestor
19611819|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611820|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611821|NCT04459416|Analgesics|analgesics|mesh-ancestor
19611822|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
19611823|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611824|NCT04453137|Adalimumab|adalimumab|mesh-list
19611825|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611826|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611827|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
19611828|NCT04436926|Narcotics|narcotics|mesh-ancestor
19611829|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611830|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611831|NCT04436926|Analgesics|analgesics|mesh-ancestor
19611832|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
19611833|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132728|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
20132729|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19611836|NCT04428372|Mannitol|mannitol|mesh-list
20132730|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20132731|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132732|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
20132733|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132734|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20132735|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20132736|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132737|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20132738|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
20132739|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611837|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19611838|NCT04428372|Diuretics|diuretics|mesh-ancestor
19611839|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
19611840|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611841|NCT04420975|Nivolumab|nivolumab|mesh-list
19611842|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611843|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611844|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19611845|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611846|NCT04418856|Methamphetamine|methamphetamine|mesh-list
19611847|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19611848|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611849|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
19611850|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
19611851|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611852|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
19611853|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611854|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611855|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
19611856|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19611857|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19611858|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19611859|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19611860|NCT04417257|Fenretinide|fenretinide|mesh-list
19611861|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611862|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19611863|NCT04417257|Protective Agents|protective agents|mesh-ancestor
19611864|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659758|NCT04631393|Alfentanil|alfentanil|mesh-list
19659759|NCT04631393|Propofol|propofol|mesh-list
19659760|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19659761|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19659762|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659763|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19659764|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
19659765|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
19659766|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19659767|NCT04631393|Narcotics|narcotics|mesh-ancestor
19659768|NCT04631393|Analgesics|analgesics|mesh-ancestor
19659769|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
19659770|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312236|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
20312237|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20312238|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312239|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312240|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312241|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312242|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312243|NCT00683137|Valdecoxib|valdecoxib|mesh-list
20312244|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20312245|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20312246|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312247|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312248|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20312249|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20312250|NCT00683137|Analgesics|analgesics|mesh-ancestor
20312251|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
20312252|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312253|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312254|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312255|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312256|NCT00683176|Choline|choline|mesh-list
20312257|NCT00683176|Fenofibrate|fenofibrate|mesh-list
19659771|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
19659772|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19659773|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
19659774|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
19659775|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19659776|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19659777|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312258|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20312259|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
19659778|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659779|NCT04537923|Insulin|insulin|mesh-list
19659780|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19611865|NCT04408638|Gemcitabine|gemcitabine|mesh-list
19611866|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
19611867|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
19611868|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19611869|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
19611870|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611871|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611872|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
19611873|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611874|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611875|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611876|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
19611877|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611878|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611879|NCT04387240|Artesunate|artesunate|mesh-list
19611880|NCT04387240|Artemisinins|artemisinins|mesh-list
19611881|NCT04387240|Artemisinin|artemisinin|mesh-list
19611882|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
19611883|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19611884|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19611885|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611886|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611887|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
19611888|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
19611889|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19611890|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
19611891|NCT04381832|Docetaxel|docetaxel|mesh-list
19611892|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611893|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
19611894|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
19611895|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
19611896|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611897|NCT04378621|Adalimumab|adalimumab|mesh-list
19611898|NCT04378621|Etanercept|etanercept|mesh-list
19611899|NCT04378621|Golimumab|golimumab|mesh-list
19611900|NCT04378621|Infliximab|infliximab|mesh-list
19611901|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
19611902|NCT04378621|Tofacitinib|tofacitinib|mesh-list
19611903|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19611904|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611905|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19611906|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
19611907|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611908|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19611909|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19611910|NCT04378621|Analgesics|analgesics|mesh-ancestor
19611911|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
19611912|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611913|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611914|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611915|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
19611916|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611917|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611918|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611919|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19611920|NCT04375813|Sirolimus|sirolimus|mesh-list
19611921|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19611922|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19611923|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19611924|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611925|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
19611926|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19611927|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
19611928|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611929|NCT04373317|Pimavanserin|pimavanserin|mesh-list
19611930|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19611931|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
19611932|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19611933|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19611934|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19611935|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19611936|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611937|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19611938|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19611939|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19611940|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19611941|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
19611942|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19611943|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611944|NCT04364230|Poly ICLC|poly iclc|mesh-list
19611945|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
19611946|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611947|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
19611948|NCT04357457|Almitrine|almitrine|mesh-list
19611949|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
19611950|NCT04338659|Antibodies|antibodies|mesh-list
19611951|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19611952|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
19611953|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611954|NCT04335292|Pemetrexed|pemetrexed|mesh-list
20132740|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132741|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20132742|NCT00032838|Yohimbine|yohimbine|mesh-list
19611955|NCT04335292|Osimertinib|osimertinib|mesh-list
19611956|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611957|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611958|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611959|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19611960|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19611961|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611962|NCT04334330|Trastuzumab|trastuzumab|mesh-list
19611963|NCT04334330|Fulvestrant|fulvestrant|mesh-list
19611964|NCT04334330|Palbociclib|palbociclib|mesh-list
19611965|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19611966|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611967|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19611968|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19611969|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19611970|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
19611971|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19611972|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611973|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19611974|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19611975|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611976|NCT04333706|Capecitabine|capecitabine|mesh-list
19611977|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19611978|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
19611979|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19611980|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312260|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312261|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20312262|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
20312263|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611981|NCT04331717|Leuprolide|leuprolide|mesh-list
19611982|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19611983|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
19611984|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19611985|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611986|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19611987|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19611988|NCT04330690|Artesunate|artesunate|mesh-list
19611989|NCT04330690|Dexamethasone|dexamethasone|mesh-list
19611990|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
19611991|NCT04330690|Infliximab|infliximab|mesh-list
19611992|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19611993|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
19611994|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
19611995|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19611996|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19611997|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19611998|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
19611999|NCT04330690|Hormones|hormones|mesh-ancestor
19612000|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132743|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
20132744|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
20132745|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132746|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132747|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20312264|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
19612001|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20312265|NCT00683189|Warfarin|warfarin|mesh-list
19612002|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612003|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19612004|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612005|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612006|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
19612007|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612008|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
19612009|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19612010|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19612011|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132748|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20132749|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20132750|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
20132751|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612012|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
19612013|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
19612014|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19612015|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
19612016|NCT04329065|Paclitaxel|paclitaxel|mesh-list
19612017|NCT04329065|Trastuzumab|trastuzumab|mesh-list
19612018|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19612019|NCT04329065|Pertuzumab|pertuzumab|mesh-list
19612020|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19612021|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19612022|NCT04329065|Vaccines|vaccines|mesh-list
19612023|NCT04329065|Antibodies|antibodies|mesh-list
19612024|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
19612025|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19612026|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
19612027|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
19612028|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612029|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19612030|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612031|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
19612032|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
19612033|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
19612034|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612035|NCT04325217|Nintedanib|nintedanib|mesh-list
19612036|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612037|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19612038|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612039|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612040|NCT04314570|Ropivacaine|ropivacaine|mesh-list
19612041|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
19612042|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
19612043|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612044|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612045|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
19612046|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612047|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
19612048|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612049|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19612050|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19612051|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612052|NCT04311177|Losartan|losartan|mesh-list
19612053|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19612054|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19612055|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19612056|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19612057|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612058|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
19612059|NCT04303507|Chloroquine|chloroquine|mesh-list
19612060|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
19612061|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19612062|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19612063|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612064|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612065|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612066|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612067|NCT04303507|Amebicides|amebicides|mesh-ancestor
19612068|NCT04300647|Atezolizumab|atezolizumab|mesh-list
20132752|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132753|NCT00032838|Urological Agents|urological agents|mesh-ancestor
19612069|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612070|NCT04297332|Nicotine|nicotine|mesh-list
19612071|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20132754|NCT00032890|Celecoxib|celecoxib|mesh-list
20132755|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20132756|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20132757|NCT00032890|Analgesics|analgesics|mesh-ancestor
20132758|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
20132759|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132760|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132761|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132762|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132763|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20132764|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20132765|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132766|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132767|NCT00032929|Selegiline|selegiline|mesh-list
20312266|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
19612072|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
19612073|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612074|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612075|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19612076|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19612077|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
19612078|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612079|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612080|NCT04293562|Cytarabine|cytarabine|mesh-list
19612081|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
19612082|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19612083|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19612084|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19612085|NCT04293562|Methotrexate|methotrexate|mesh-list
19612086|NCT04293562|Etoposide|etoposide|mesh-list
20312267|NCT00683202|Aspirin|aspirin|mesh-list
20312268|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20312269|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20312270|NCT00683202|Analgesics|analgesics|mesh-ancestor
19612087|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
19612088|NCT04293562|Daunorubicin|daunorubicin|mesh-list
19612089|NCT04293562|Asparaginase|asparaginase|mesh-list
19612090|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
20312271|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
20312272|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312273|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312274|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312275|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312276|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20312277|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20312278|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312279|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20312280|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19612091|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
19612092|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
19612093|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
19612094|NCT04293562|Razoxane|razoxane|mesh-list
19612095|NCT04293562|Calicheamicins|calicheamicins|mesh-list
19612096|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19612097|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
19612098|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19612099|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612100|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132768|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
19612101|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
19659781|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
19612102|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612103|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612104|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
19612105|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612106|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19612107|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612108|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
19612109|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749757|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749758|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19749759|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19749760|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19749761|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19749762|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19749763|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749764|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749765|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19749766|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
19749767|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749768|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749769|NCT04662710|Leucovorin|leucovorin|mesh-list
19749770|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
19749771|NCT04662710|Capecitabine|capecitabine|mesh-list
19749772|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
19749773|NCT04662710|Lenvatinib|lenvatinib|mesh-list
19749774|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
19749775|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749776|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749777|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19749778|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
19749779|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749780|NCT04662710|Antidotes|antidotes|mesh-ancestor
19749781|NCT04662710|Protective Agents|protective agents|mesh-ancestor
19749782|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749783|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
19749784|NCT04662710|Vitamins|vitamins|mesh-ancestor
19749785|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
19749786|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749787|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749788|NCT04642820|Methamphetamine|methamphetamine|mesh-list
20132769|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132770|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20132771|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19749789|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19749790|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749791|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
19749792|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
19749793|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749794|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
19749795|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749796|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749797|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
19749798|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19749799|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19749800|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19749801|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19749802|NCT04642469|Durvalumab|durvalumab|mesh-list
19749803|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749804|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749805|NCT04640623|Gemcitabine|gemcitabine|mesh-list
19612110|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19612111|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19612112|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19612113|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19612114|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
19612115|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612116|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612117|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19612118|NCT04293562|Analgesics|analgesics|mesh-ancestor
19612119|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
19612120|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749806|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19612121|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
19749807|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
19612122|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
19612123|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
19612124|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
19612125|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612126|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19612127|NCT04293562|Protective Agents|protective agents|mesh-ancestor
19612128|NCT04286295|Nicotine|nicotine|mesh-list
19612129|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19612130|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
19612131|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612132|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612133|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19612134|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19612135|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
19612136|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612137|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612138|NCT04275713|Metformin|metformin|mesh-list
19612139|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19612140|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612141|NCT04271917|Acetaminophen|acetaminophen|mesh-list
19612142|NCT04271917|Ibuprofen|ibuprofen|mesh-list
19612143|NCT04271917|Cannabidiol|cannabidiol|mesh-list
19612144|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19612145|NCT04271917|Analgesics|analgesics|mesh-ancestor
19612146|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
19612147|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612148|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612149|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
19612150|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19612151|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612152|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612153|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19612154|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612155|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612156|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
19612157|NCT04266353|Resveratrol|resveratrol|mesh-list
19612158|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
19612159|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612160|NCT04266353|Protective Agents|protective agents|mesh-ancestor
19612161|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612162|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612163|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19612164|NCT04266275|Curcumin|curcumin|mesh-list
19612165|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19612166|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19612167|NCT04266275|Analgesics|analgesics|mesh-ancestor
19612168|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
19612169|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612170|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612171|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612172|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612173|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612174|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612175|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612176|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19612177|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
19612178|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612179|NCT04265105|Fluticasone|fluticasone|mesh-list
19612180|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612181|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19612182|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
19612183|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612184|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612185|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19612186|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
19612187|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
19612188|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19659782|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
19659783|NCT04537923|Tirzepatide|tirzepatide|mesh-list
19659784|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19659785|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312281|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659786|NCT04537923|Incretins|incretins|mesh-ancestor
19659787|NCT04537923|Hormones|hormones|mesh-ancestor
19659788|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19659789|NCT04513314|Valproic Acid|valproic acid|mesh-list
19612189|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
19612190|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612191|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612192|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19612193|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19612194|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19612195|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132772|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20132773|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132774|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132775|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20312282|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
20312283|NCT00683267|Capsaicin|capsaicin|mesh-list
20312284|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
20132776|NCT00032929|Protective Agents|protective agents|mesh-ancestor
20132777|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132778|NCT00032942|Lofexidine|lofexidine|mesh-list
19612203|NCT04250064|Bevacizumab|bevacizumab|mesh-list
19612204|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612205|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612206|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19612207|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19612208|NCT04250064|Growth Substances|growth substances|mesh-ancestor
19612209|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612210|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
19612211|NCT04249544|Pramipexole|pramipexole|mesh-list
19612212|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
19612213|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612214|NCT04249544|Protective Agents|protective agents|mesh-ancestor
19612215|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612216|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19612217|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19612218|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
19612219|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
19612220|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612221|NCT04248829|Gefitinib|gefitinib|mesh-list
19612222|NCT04248829|Lazertinib|lazertinib|mesh-list
19612223|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612224|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19612225|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612226|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612227|NCT04248595|Azacitidine|azacitidine|mesh-list
19612228|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
19612229|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19612230|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
19612231|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612232|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612233|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612234|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19612235|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19612236|NCT04246047|Dexamethasone|dexamethasone|mesh-list
19612237|NCT04246047|Bortezomib|bortezomib|mesh-list
19612238|NCT04246047|Daratumumab|daratumumab|mesh-list
19612239|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612240|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
19612241|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
19612242|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312285|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
20312286|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
20312287|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312288|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312289|NCT00683306|Gefitinib|gefitinib|mesh-list
20312290|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612243|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612244|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19612245|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
19256584|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132779|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20132780|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20132781|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132782|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
20132783|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132784|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20132785|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19612246|NCT04246047|Hormones|hormones|mesh-ancestor
19612247|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612248|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19612249|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612250|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
19612251|NCT04239092|Temozolomide|temozolomide|mesh-list
19612252|NCT04239092|Irinotecan|irinotecan|mesh-list
19612253|NCT04239092|Topotecan|topotecan|mesh-list
19612254|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612255|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
19612256|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312291|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19612257|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612258|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19612259|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
19612260|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612261|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612262|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19612263|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19612264|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19612265|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612266|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19612267|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612268|NCT04230499|Sirolimus|sirolimus|mesh-list
19612269|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19612270|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612271|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19612272|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612273|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
19612274|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612275|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
19612276|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612277|NCT04224272|Fulvestrant|fulvestrant|mesh-list
19612278|NCT04224272|Palbociclib|palbociclib|mesh-list
19612279|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19612280|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612281|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19612282|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19612283|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
19612284|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612285|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612286|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19612287|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612288|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612289|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
19612290|NCT04221035|Melphalan|melphalan|mesh-list
19612291|NCT04221035|Busulfan|busulfan|mesh-list
19612292|NCT04221035|Ifosfamide|ifosfamide|mesh-list
19612293|NCT04221035|Thiotepa|thiotepa|mesh-list
19612294|NCT04221035|Dacarbazine|dacarbazine|mesh-list
19612295|NCT04221035|Carboplatin|carboplatin|mesh-list
19612296|NCT04221035|Doxorubicin|doxorubicin|mesh-list
19612297|NCT04221035|Etoposide|etoposide|mesh-list
19612298|NCT04221035|Vincristine|vincristine|mesh-list
19612299|NCT04221035|Vindesine|vindesine|mesh-list
20132786|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20132787|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
20132788|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132789|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132790|NCT00032955|Buprenorphine|buprenorphine|mesh-list
20132791|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19612300|NCT04221035|Dinutuximab|dinutuximab|mesh-list
19612301|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612302|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
19612303|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612304|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132792|NCT00032955|Naloxone|naloxone|mesh-list
20132793|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19612305|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19612306|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
20132794|NCT00032955|Narcotics|narcotics|mesh-ancestor
19612307|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312292|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312293|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608332|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612308|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612309|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19612310|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19612311|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19612312|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19612313|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612314|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19612315|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
19612316|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
19612317|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
19612318|NCT04216316|Gemcitabine|gemcitabine|mesh-list
19612319|NCT04216316|Carboplatin|carboplatin|mesh-list
19612320|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
19612321|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612322|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19612323|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
19612324|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612325|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
19612326|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612327|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612328|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612329|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
19612330|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612331|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612332|NCT04207060|Indomethacin|indomethacin|mesh-list
19612333|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19612334|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19612335|NCT04207060|Analgesics|analgesics|mesh-ancestor
19612336|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
19612337|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612338|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612339|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612340|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612341|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
19612342|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
19612343|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19612344|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19612345|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612346|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612347|NCT04206787|Afatinib|afatinib|mesh-list
19612348|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612349|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19612350|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612351|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612352|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
19612353|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
19612354|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19612355|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
19612356|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612357|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
19612358|NCT04202692|Protective Agents|protective agents|mesh-ancestor
19612359|NCT04202692|Antacids|antacids|mesh-ancestor
19612360|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612361|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19612362|NCT04179864|Prednisone|prednisone|mesh-list
19612363|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612364|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
19612365|NCT04179864|Hormones|hormones|mesh-ancestor
19612366|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612367|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612368|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19612369|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612370|NCT04176705|Triamcinolone|triamcinolone|mesh-list
19612371|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19612372|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19612373|NCT04176705|Lidocaine|lidocaine|mesh-list
19612374|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19612375|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
19612376|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
19612377|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612378|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612379|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
19612380|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612381|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19612382|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19612383|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19612384|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19612385|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612386|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612387|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
19612388|NCT04176705|Hormones|hormones|mesh-ancestor
19612389|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612390|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612391|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
19612392|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132795|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20132796|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132797|NCT00032955|Analgesics|analgesics|mesh-ancestor
19612393|NCT04175912|Paclitaxel|paclitaxel|mesh-list
19612394|NCT04175912|Carboplatin|carboplatin|mesh-list
19612395|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19612396|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19612397|NCT04175912|Pevonedistat|pevonedistat|mesh-list
19612398|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19612399|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612400|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
19612401|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
20132798|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
20132799|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132800|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20132801|NCT00032968|Buprenorphine|buprenorphine|mesh-list
20132802|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20132803|NCT00032968|Naloxone|naloxone|mesh-list
20132804|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20132805|NCT00032968|Narcotics|narcotics|mesh-ancestor
20132806|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20132807|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132808|NCT00032968|Analgesics|analgesics|mesh-ancestor
19612402|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
19612403|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612404|NCT04174170|Sertraline|sertraline|mesh-list
19612405|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
19612406|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
19612407|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19612408|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19612409|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19612410|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19612411|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612412|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612413|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
19612414|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612415|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
19612416|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
19612417|NCT04168710|Bupivacaine|bupivacaine|mesh-list
19612418|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
19612419|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
19612420|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612421|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132809|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
20132810|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612422|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
19612423|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612424|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
20132811|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20132812|NCT00033033|Reserpine|reserpine|mesh-list
20132813|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20132814|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20132815|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20132816|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20132817|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132818|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132819|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19612425|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19612426|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19612427|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
20132820|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20132821|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20132822|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132823|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
19612428|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612429|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612430|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612431|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
19612432|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
19612433|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612434|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
19612435|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19612436|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19612437|NCT04165772|Capecitabine|capecitabine|mesh-list
19612438|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19612439|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
19612440|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612441|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612442|NCT04150458|Choline|choline|mesh-list
19612443|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
19612444|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19612445|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
19612446|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612447|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19612448|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19612449|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
19612450|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
19612451|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19612452|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19612453|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612454|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612455|NCT04145440|Felzartamab|felzartamab|mesh-list
19612456|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132824|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132825|NCT00033046|Modafinil|modafinil|mesh-list
20132826|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20132827|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132828|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20132829|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20132830|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20132831|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132832|NCT00033059|Tolcapone|tolcapone|mesh-list
20132833|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20132834|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20132835|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20132836|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132837|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132838|NCT00033072|Selegiline|selegiline|mesh-list
20608333|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608334|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20608335|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20608336|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
20612141|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20132839|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
20132840|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132841|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20312294|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
19612457|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
19612458|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612459|NCT04127578|Sirolimus|sirolimus|mesh-list
19612460|NCT04127578|Prednisone|prednisone|mesh-list
19612461|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
19612462|NCT04127578|Rituximab|rituximab|mesh-list
19612463|NCT04127578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20132842|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20132843|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20132844|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132845|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132846|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20132847|NCT00033072|Protective Agents|protective agents|mesh-ancestor
20132848|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312295|NCT00683319|Carboplatin|carboplatin|mesh-list
20312296|NCT00683319|Methotrexate|methotrexate|mesh-list
19612464|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612465|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
19612466|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612467|NCT04127578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612468|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612469|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
19612470|NCT04127578|Hormones|hormones|mesh-ancestor
19612471|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612472|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19612473|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19612474|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612475|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19612476|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
19612477|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612478|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
19612479|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
19612480|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612481|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19612482|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19612483|NCT04127578|Protective Agents|protective agents|mesh-ancestor
19612484|NCT04125563|Capsaicin|capsaicin|mesh-list
19612485|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
19612486|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
19612487|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
19612488|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612489|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612490|NCT04124614|Sertraline|sertraline|mesh-list
19612491|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
19612492|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
19612493|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19612494|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19612495|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19612496|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19612497|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612498|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612499|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
19612500|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612501|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
19612502|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
19612503|NCT04122625|Nivolumab|nivolumab|mesh-list
19612504|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612505|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612506|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19612507|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612508|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19612509|NCT04117945|Cetuximab|cetuximab|mesh-list
19612510|NCT04117945|Panitumumab|panitumumab|mesh-list
19612511|NCT04117945|Irinotecan|irinotecan|mesh-list
19612512|NCT04117945|Antibodies|antibodies|mesh-list
19612513|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
19612514|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19612515|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
19612516|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612517|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612518|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19612519|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19612520|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612521|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612522|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
19612523|NCT04106219|Topotecan|topotecan|mesh-list
19612524|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612525|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
19612526|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612527|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612528|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19612529|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
19612530|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612531|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612532|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19612533|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19612534|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19612535|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659790|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20132849|NCT00033085|Ondansetron|ondansetron|mesh-list
20312297|NCT00683319|Vincristine|vincristine|mesh-list
19659791|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
19659792|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19612536|NCT04104672|Gemcitabine|gemcitabine|mesh-list
19612537|NCT04104672|Paclitaxel|paclitaxel|mesh-list
19612538|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19612539|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612540|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
19612541|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
19612542|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
19612543|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612544|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19612545|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
19612546|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
19612547|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612548|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612549|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612550|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
19612551|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612552|NCT04102800|Benralizumab|benralizumab|mesh-list
19612553|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19612554|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
19612555|NCT04101461|Iron|iron|mesh-list
19612556|NCT04101461|Hepcidins|hepcidins|mesh-list
19612557|NCT04101461|Trace Elements|trace elements|mesh-ancestor
19612558|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
19612559|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612560|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612561|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
19612562|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19612563|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612564|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612565|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19612566|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19612567|NCT04094207|Protective Agents|protective agents|mesh-ancestor
19612568|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612569|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
19612570|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19612571|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
19612572|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
19612573|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
20132850|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
20132851|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
20132852|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132853|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612574|NCT04083560|Hematinics|hematinics|mesh-ancestor
19612575|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
19612576|NCT04083560|Vitamins|vitamins|mesh-ancestor
19612577|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
19612578|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612579|NCT04081688|Atezolizumab|atezolizumab|mesh-list
20132854|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20132855|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
20132856|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
20132857|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20132858|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
20132859|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132860|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132861|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20132862|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20132863|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20132864|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20132865|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20132866|NCT00033098|Metyrapone|metyrapone|mesh-list
20132867|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
20132868|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132869|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132870|NCT00033111|Cabergoline|cabergoline|mesh-list
20132871|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20132872|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20132873|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
20132874|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
20132875|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20132876|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132877|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132878|NCT00033163|Tenofovir|tenofovir|mesh-list
20132879|NCT00033163|Adefovir|adefovir|mesh-list
19612580|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19612581|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
19612582|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
20132880|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20132881|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
20132882|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132883|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19612583|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612584|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
19612585|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612586|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
19612587|NCT04081545|Analgesics|analgesics|mesh-list
19612588|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19612589|NCT04081545|Anesthetics|anesthetics|mesh-list
19612590|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612591|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612592|NCT04081545|Narcotics|narcotics|mesh-ancestor
19612593|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
19612594|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612595|NCT04078295|Nivolumab|nivolumab|mesh-list
19612596|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612597|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612598|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19612599|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612600|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
19612601|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
19612602|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612603|NCT04071769|Xenon|xenon|mesh-list
19612604|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19612605|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
19612606|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
19612607|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612608|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612609|NCT04069819|Cilostazol|cilostazol|mesh-list
19612610|NCT04069819|Citalopram|citalopram|mesh-list
19612611|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19612612|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19612613|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19612614|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612615|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612616|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
19612617|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612618|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19612619|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
19612620|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19612621|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
19612622|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612623|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19612624|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19612625|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
19612626|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19612627|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19612628|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19612629|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
19612630|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19612631|NCT04069819|Protective Agents|protective agents|mesh-ancestor
19612632|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19612633|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19612634|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612635|NCT04068246|Metformin|metformin|mesh-list
19612636|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19612637|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612638|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
19612639|NCT04068103|Leucovorin|leucovorin|mesh-list
19612640|NCT04068103|Folic Acid|folic acid|mesh-list
19612641|NCT04068103|Fluorouracil|fluorouracil|mesh-list
19612642|NCT04068103|Capecitabine|capecitabine|mesh-list
19612643|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
19612644|NCT04068103|Calcium|calcium|mesh-list
19612645|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
19612646|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19612647|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132884|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20132885|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612648|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19612649|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
20132886|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132887|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20132888|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20132889|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
20132890|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
20132891|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132892|NCT00033176|Protective Agents|protective agents|mesh-ancestor
20132893|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132894|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
20312298|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312299|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
20312300|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312301|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312302|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20312303|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
20312304|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612650|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612651|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19612652|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612653|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612654|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
19612655|NCT04068103|Antidotes|antidotes|mesh-ancestor
19612656|NCT04068103|Protective Agents|protective agents|mesh-ancestor
19612657|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
19612658|NCT04068103|Vitamins|vitamins|mesh-ancestor
19612659|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
19612660|NCT04068103|Hematinics|hematinics|mesh-ancestor
19612661|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
19612662|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19612663|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19612664|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
19612665|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612666|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612667|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612668|NCT04062123|Fentanyl|fentanyl|mesh-list
19612669|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
19612670|NCT04062123|Propofol|propofol|mesh-list
19612671|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19612672|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612673|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612674|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20312305|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312306|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20312307|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20312308|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
20312309|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19612675|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
19612676|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
19612677|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19749808|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749809|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749810|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
19749811|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749812|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312310|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20312311|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
20312312|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
20312313|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312314|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19612678|NCT04062123|Analgesics|analgesics|mesh-ancestor
19612679|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
19612680|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612681|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19612682|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19612683|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19612684|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
19612685|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749813|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749814|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
19749815|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749816|NCT04634604|Bevacizumab|bevacizumab|mesh-list
19612686|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612687|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20132895|NCT00033176|Vitamins|vitamins|mesh-ancestor
19612688|NCT04062123|Narcotics|narcotics|mesh-ancestor
19612689|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19612690|NCT04059484|Tamoxifen|tamoxifen|mesh-list
19612691|NCT04059484|Letrozole|letrozole|mesh-list
19612692|NCT04059484|Fulvestrant|fulvestrant|mesh-list
19612693|NCT04059484|Anastrozole|anastrozole|mesh-list
19612694|NCT04059484|Exemestane|exemestane|mesh-list
19612695|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612696|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19612697|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19612698|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612699|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612700|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19612701|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
19612702|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612703|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612704|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19612705|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19612706|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19612707|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20312315|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20312316|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20312317|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
20312318|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312319|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312320|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20312321|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312322|NCT00683436|Adipiplon|adipiplon|mesh-list
20312323|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312324|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312325|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
20312326|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
20312327|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312328|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312329|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20312330|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20312331|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20312332|NCT00683514|Cisplatin|cisplatin|mesh-list
20312333|NCT00683514|Vinorelbine|vinorelbine|mesh-list
20312334|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312335|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20312336|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
20312337|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312338|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312339|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347240|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347241|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20347242|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347243|NCT00858715|Aspirin|aspirin|mesh-list
20347244|NCT00858715|Clopidogrel|clopidogrel|mesh-list
20347245|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20347246|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20347247|NCT00858715|Analgesics|analgesics|mesh-ancestor
20347248|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
20347249|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347250|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347251|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347252|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20347253|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20347254|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20347255|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347256|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20347257|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19612708|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19612709|NCT04056624|Carotenoids|carotenoids|mesh-list
19612710|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
19612711|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347258|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612712|NCT04056624|Protective Agents|protective agents|mesh-ancestor
19612713|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132896|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
20132897|NCT00033189|Ubiquinone|ubiquinone|mesh-list
20132898|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
20132899|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
20132900|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132901|NCT00033189|Vitamins|vitamins|mesh-ancestor
20132902|NCT00033215|S 3304|s 3304|mesh-list
20132903|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
20132904|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
20132905|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132906|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132907|NCT00033241|Gemcitabine|gemcitabine|mesh-list
20132908|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20312340|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
20312341|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312342|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
20312343|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312344|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312345|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20312346|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
20312347|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312348|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312349|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20312350|NCT00683735|Metformin|metformin|mesh-list
19612732|NCT04034862|Lamivudine|lamivudine|mesh-list
19612733|NCT04034862|Dolutegravir|dolutegravir|mesh-list
19612734|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19612735|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19612736|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612737|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612738|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
19612739|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612740|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19612741|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19612742|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19612743|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19612744|NCT04025879|Paclitaxel|paclitaxel|mesh-list
19612745|NCT04025879|Docetaxel|docetaxel|mesh-list
19612746|NCT04025879|Carboplatin|carboplatin|mesh-list
19612747|NCT04025879|Nivolumab|nivolumab|mesh-list
19612748|NCT04025879|Pemetrexed|pemetrexed|mesh-list
19612749|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19612750|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612751|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
19612752|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
19612753|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
19612754|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612755|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612756|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19612757|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612758|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19612759|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19612760|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
19612761|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612762|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19612763|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612764|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612765|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
19612766|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612767|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612768|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19612769|NCT03993132|Empagliflozin|empagliflozin|mesh-list
19612770|NCT03993132|Glucagon|glucagon|mesh-list
19612771|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19612772|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19612773|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612774|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19612775|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612776|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19612777|NCT03993132|Hormones|hormones|mesh-ancestor
19612778|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612779|NCT03993132|Incretins|incretins|mesh-ancestor
19612780|NCT03989414|Dexamethasone|dexamethasone|mesh-list
19612781|NCT03989414|Bortezomib|bortezomib|mesh-list
19612782|NCT03989414|Daratumumab|daratumumab|mesh-list
19612783|NCT03989414|Elotuzumab|elotuzumab|mesh-list
19612784|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612785|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
19612786|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
19612787|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612788|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612789|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19612790|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
19612791|NCT03989414|Hormones|hormones|mesh-ancestor
19612792|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19612793|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19612794|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612795|NCT03987022|Acetaminophen|acetaminophen|mesh-list
19612796|NCT03987022|Ketorolac|ketorolac|mesh-list
19612797|NCT03987022|Oxycodone|oxycodone|mesh-list
19612798|NCT03987022|Hydromorphone|hydromorphone|mesh-list
19612799|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19612800|NCT03987022|Narcotics|narcotics|mesh-ancestor
19612801|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612802|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612803|NCT03987022|Analgesics|analgesics|mesh-ancestor
19612804|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
19612805|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612806|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19612807|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19612808|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612809|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612810|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19612811|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612812|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612813|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
19612814|NCT03984188|Theophylline|theophylline|mesh-list
19612815|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19612816|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
19612817|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612818|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612819|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19612820|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
19612821|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19612822|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612823|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612824|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
19612825|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19612826|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19612827|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
19612828|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612829|NCT03983876|Adalimumab|adalimumab|mesh-list
19612830|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612831|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612832|NCT03982082|Coal Tar|coal tar|mesh-list
19612833|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
19612834|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
19612835|NCT03949153|Nivolumab|nivolumab|mesh-list
19612836|NCT03949153|Ipilimumab|ipilimumab|mesh-list
19612837|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612838|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612839|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19612840|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612841|NCT03944044|Acetaminophen|acetaminophen|mesh-list
19612842|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19612843|NCT03944044|Analgesics|analgesics|mesh-ancestor
19612844|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
19612845|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612846|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612847|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
19612848|NCT03939182|Abexinostat|abexinostat|mesh-list
19612849|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19612850|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612851|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612852|NCT03934372|Ponatinib|ponatinib|mesh-list
19612853|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132909|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20132910|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
20132911|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132912|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132913|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
20132914|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132915|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132916|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612854|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19612855|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612856|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612857|NCT03926754|Mirabegron|mirabegron|mesh-list
19612858|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19612859|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19612860|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20132917|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
20132918|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132919|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20132920|NCT00033254|Thalidomide|thalidomide|mesh-list
19612861|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
19612862|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612863|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612864|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612865|NCT03926754|Urological Agents|urological agents|mesh-ancestor
19612873|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
19612874|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19612875|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659793|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19659794|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19659795|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19659796|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659797|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
19659798|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659799|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659800|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
19659801|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659802|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
19659803|NCT04447118|Docetaxel|docetaxel|mesh-list
19659804|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659805|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19659806|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19659807|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19659808|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659809|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
19659810|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19659811|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659812|NCT04409002|Niraparib|niraparib|mesh-list
19659813|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19659814|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659815|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659816|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659817|NCT04406415|Nafamostat|nafamostat|mesh-list
19659818|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19659819|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19659820|NCT04406415|Analgesics|analgesics|mesh-ancestor
19659821|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
19659822|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19659823|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659824|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19659825|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19659826|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
19659827|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
19659828|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132921|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612876|NCT03905928|Nicotine|nicotine|mesh-list
19612877|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19612878|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
19612879|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612880|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612881|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19612882|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19612883|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
19612884|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612885|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612886|NCT03899987|Aspirin|aspirin|mesh-list
19612887|NCT03899987|Interferons|interferons|mesh-list
19612888|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
19612889|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
19612890|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19612891|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612892|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
19612893|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612894|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19612895|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19612896|NCT03899987|Analgesics|analgesics|mesh-ancestor
19612897|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
19612898|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19612899|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612900|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612901|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612902|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19612903|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19612904|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612905|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20312351|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20132922|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
20132923|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132924|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
20132925|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20132926|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132927|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20132928|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20312352|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20312353|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312354|NCT00683735|Incretins|incretins|mesh-ancestor
20312355|NCT00683735|Hormones|hormones|mesh-ancestor
20312356|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312357|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20312358|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
20312359|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312360|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312361|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
20312362|NCT00683865|Ofloxacin|ofloxacin|mesh-list
20312363|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20312364|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20312365|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312366|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20312367|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19612906|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19612907|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612908|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
19612909|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
19612910|NCT03898986|Vaccines|vaccines|mesh-list
19612911|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
19612912|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612913|NCT03891264|Cannabidiol|cannabidiol|mesh-list
19612914|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
19612915|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
19612916|NCT03889418|Narcotics|narcotics|mesh-ancestor
19612917|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19612918|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612919|NCT03889418|Analgesics|analgesics|mesh-ancestor
19612920|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
19612921|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132929|NCT00033254|Growth Substances|growth substances|mesh-ancestor
20132930|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
20132931|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612922|NCT03881696|Omalizumab|omalizumab|mesh-list
19612923|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
20132932|NCT00033267|Sirolimus|sirolimus|mesh-list
19612924|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19612925|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612926|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19612927|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19612928|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
19612929|NCT03879694|Octreotide|octreotide|mesh-list
19612930|NCT03879694|Sargramostim|sargramostim|mesh-list
19612931|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
19612932|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
19612933|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612934|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612935|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19612936|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19612937|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19612938|NCT03877809|Sirolimus|sirolimus|mesh-list
20132933|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20132934|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132935|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20132936|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132937|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
20132938|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132939|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
20132940|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132941|NCT00033280|Temozolomide|temozolomide|mesh-list
20132942|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20132943|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
20132944|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132945|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132946|NCT00033306|Irinotecan|irinotecan|mesh-list
20132947|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20132948|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20132949|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132950|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132951|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132952|NCT00033319|Aspirin|aspirin|mesh-list
20312368|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312369|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612939|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19612940|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19612941|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19612942|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612943|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
19612944|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612945|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
19612946|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612947|NCT03875391|Oxytocin|oxytocin|mesh-list
19612948|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
19612949|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19612950|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612951|NCT03866421|Liver Extracts|liver extracts|mesh-list
19612952|NCT03866421|Hematinics|hematinics|mesh-ancestor
19612953|NCT03864926|Tacrolimus|tacrolimus|mesh-list
19612954|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19612955|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
19612956|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612957|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19612958|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612959|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612960|NCT03849313|Adalimumab|adalimumab|mesh-list
19612961|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19612962|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19612963|NCT03846310|Carboplatin|carboplatin|mesh-list
19612964|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
19612965|NCT03846310|Pemetrexed|pemetrexed|mesh-list
19612966|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612967|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612968|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19612969|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612970|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19612971|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19612972|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
19612973|NCT03840226|Antacids|antacids|mesh-ancestor
19612974|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132953|NCT00033319|Folic Acid|folic acid|mesh-list
19612975|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20132954|NCT00033319|Hematinics|hematinics|mesh-ancestor
20132955|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
19612976|NCT03836001|Serlopitant|serlopitant|mesh-list
19612977|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19612978|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19612979|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612980|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612981|NCT03834623|Nivolumab|nivolumab|mesh-list
19612982|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612983|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612984|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19612985|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612986|NCT03829436|Nivolumab|nivolumab|mesh-list
19612987|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19612988|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612989|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19612990|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19612991|NCT03823300|Aflibercept|aflibercept|mesh-list
19612992|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19612993|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19612994|NCT03823300|Growth Substances|growth substances|mesh-ancestor
19612995|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19612996|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
19612997|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19612998|NCT03823287|Aflibercept|aflibercept|mesh-list
19612999|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19613000|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19613001|NCT03823287|Growth Substances|growth substances|mesh-ancestor
19613002|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613003|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
19613004|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613005|NCT03815175|Aspirin|aspirin|mesh-list
19613006|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19613007|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19613008|NCT03815175|Analgesics|analgesics|mesh-ancestor
19613009|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
19613010|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613011|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613012|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613013|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613014|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19613015|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19613016|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613017|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19613018|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19613019|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613020|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
19613021|NCT03813147|Cytarabine|cytarabine|mesh-list
19613022|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
19613023|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19613024|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19613025|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19613026|NCT03813147|Methotrexate|methotrexate|mesh-list
19613027|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
19613028|NCT03813147|Azacitidine|azacitidine|mesh-list
19613029|NCT03813147|Fludarabine|fludarabine|mesh-list
19613030|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19613031|NCT03813147|Pevonedistat|pevonedistat|mesh-list
19613032|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20132956|NCT00033319|Vitamins|vitamins|mesh-ancestor
20132957|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
20132958|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132959|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20132960|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20132961|NCT00033319|Analgesics|analgesics|mesh-ancestor
20132962|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
20132963|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132964|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20132965|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20132966|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20132967|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20132968|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20132969|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19613033|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
19613034|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19613035|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613036|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613037|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
19613038|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613039|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613040|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
19613041|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19613042|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613043|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
19613044|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613045|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19613046|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
19613047|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613048|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613049|NCT03812224|Erenumab|erenumab|mesh-list
19613050|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19613051|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613052|NCT03812224|Analgesics|analgesics|mesh-ancestor
19613053|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
19613054|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613055|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613056|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
19613057|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613058|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613059|NCT03802058|Paclitaxel|paclitaxel|mesh-list
19613060|NCT03802058|Carboplatin|carboplatin|mesh-list
19613061|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613062|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613063|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613064|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613065|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613066|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613067|NCT03798054|Insulin|insulin|mesh-list
19613068|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19613069|NCT03798054|Metformin|metformin|mesh-list
19613070|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
19613071|NCT03798054|Lixisenatide|lixisenatide|mesh-list
19613072|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19613073|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19613074|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613075|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613076|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
19613077|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19613078|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
19613079|NCT03795194|Ampicillin|ampicillin|mesh-list
19613080|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19613081|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613082|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613083|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19613084|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613085|NCT03793478|Cytarabine|cytarabine|mesh-list
19613086|NCT03793478|Fludarabine|fludarabine|mesh-list
19613087|NCT03793478|Etoposide|etoposide|mesh-list
19613088|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613089|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613090|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
19665565|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
19665566|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
19665567|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665568|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665569|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665570|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
19665571|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665572|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665573|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19665574|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
19665575|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19665576|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19613091|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613092|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613093|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
19613094|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613095|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613096|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19613097|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19613098|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613099|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
19613100|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613101|NCT03783442|Paclitaxel|paclitaxel|mesh-list
19613102|NCT03783442|Fluorouracil|fluorouracil|mesh-list
19613103|NCT03783442|Capecitabine|capecitabine|mesh-list
19613104|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
19613105|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613106|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613107|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613108|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613109|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613110|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613111|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
19613112|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613113|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613114|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
19613115|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613116|NCT03781817|Ketamine|ketamine|mesh-list
20132970|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20132971|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20132972|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
20132973|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
20132974|NCT00033332|Pamidronate|pamidronate|mesh-list
20132975|NCT00033332|Thalidomide|thalidomide|mesh-list
20132976|NCT00033332|Dexamethasone|dexamethasone|mesh-list
20132977|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613117|NCT03781817|Analgesics|analgesics|mesh-ancestor
19613118|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
19613119|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613120|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613121|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19613122|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20132978|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
20132979|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
20132980|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20132981|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20132982|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20132983|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
20132984|NCT00033332|Hormones|hormones|mesh-ancestor
20132985|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20132986|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20132987|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20132988|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20132989|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
20132990|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
20132991|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20132992|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20132993|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20132994|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20132995|NCT00033332|Growth Substances|growth substances|mesh-ancestor
20132996|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
20132997|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20132998|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
20132999|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19613123|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
19613124|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
19613125|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19613126|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19613127|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19613128|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613129|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613130|NCT03778229|Osimertinib|osimertinib|mesh-list
19613131|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613132|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20133000|NCT00033345|Protective Agents|protective agents|mesh-ancestor
20133001|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133002|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133003|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20133004|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20133005|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
20133006|NCT00033358|Norgestrel|norgestrel|mesh-list
20133007|NCT00033358|Estradiol|estradiol|mesh-list
20133008|NCT00033358|Estrogens|estrogens|mesh-ancestor
20133009|NCT00033358|Hormones|hormones|mesh-ancestor
20312370|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312371|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20312372|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
20312373|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312374|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312375|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20312376|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20312377|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20312378|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20133010|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19613133|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613134|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613135|NCT03772925|Belinostat|belinostat|mesh-list
19613136|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19613137|NCT03772925|Pevonedistat|pevonedistat|mesh-list
19613138|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613139|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613140|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19613141|NCT03770455|Avelumab|avelumab|mesh-list
19613142|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20133011|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133012|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20133013|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
20133014|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20133015|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20133016|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20133017|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20133018|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20133019|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20133020|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20133021|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133022|NCT00033410|Paclitaxel|paclitaxel|mesh-list
20133023|NCT00033410|Carboplatin|carboplatin|mesh-list
20133024|NCT00033410|Tirapazamine|tirapazamine|mesh-list
19613143|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613144|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19613145|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19613146|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20312379|NCT00683865|Renal Agents|renal agents|mesh-ancestor
20133025|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133026|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312380|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20312381|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20312382|NCT00683891|Clozapine|clozapine|mesh-list
20312383|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20312384|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
20312385|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312386|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312387|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312388|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20312389|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20312390|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312391|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20312392|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
20312393|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
20312394|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
20312395|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
19613147|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
19613148|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613149|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19613150|NCT03762915|Minocycline|minocycline|mesh-list
19613151|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19613152|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133027|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613153|NCT03751436|Venetoclax|venetoclax|mesh-list
20133028|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613154|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613155|NCT03746275|Aspirin|aspirin|mesh-list
19613156|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
19613157|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19613158|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19613159|NCT03746275|Analgesics|analgesics|mesh-ancestor
19613160|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
19613161|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613162|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613163|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613164|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613165|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19613166|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19613167|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613168|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19613169|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19613170|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613171|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
19613172|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19613173|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
19613174|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19613175|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
19613176|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
19613177|NCT03746041|Abaloparatide|abaloparatide|mesh-list
19613178|NCT03746041|Bevacizumab|bevacizumab|mesh-list
19613179|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613180|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613181|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19613182|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19613183|NCT03746041|Growth Substances|growth substances|mesh-ancestor
19613184|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613185|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
19613186|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19613187|NCT03727061|Carboplatin|carboplatin|mesh-list
19613188|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
20312396|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20312397|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312398|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312399|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
20312400|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20312401|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312402|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312403|NCT00683956|Propofol|propofol|mesh-list
20312404|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
20312405|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608337|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133029|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133030|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133031|NCT00033423|Rituximab|rituximab|mesh-list
19613189|NCT03727061|Fluorouracil|fluorouracil|mesh-list
19613190|NCT03727061|Nivolumab|nivolumab|mesh-list
19613191|NCT03727061|Cetuximab|cetuximab|mesh-list
19613192|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19613193|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
19613194|NCT03727061|Trioxsalen|trioxsalen|mesh-list
19613195|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613196|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613197|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
19613198|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613199|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613200|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613201|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
20133032|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20133033|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133034|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
20133035|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133036|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20133037|NCT00033436|Niacinamide|niacinamide|mesh-list
19613202|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608338|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19613203|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20608339|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20608340|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19613204|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
19613205|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19613206|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19613207|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19613208|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19613209|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19613210|NCT03720990|Cholic Acids|cholic acids|mesh-list
19613211|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19613212|NCT03719326|Paclitaxel|paclitaxel|mesh-list
19613213|NCT03719326|Doxorubicin|doxorubicin|mesh-list
19613214|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19613215|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19613216|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613217|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613218|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613219|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613220|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613221|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613222|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19613223|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19613224|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19613225|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659829|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659830|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19659831|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19659832|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19659833|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19659834|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
19659835|NCT04215848|Budesonide|budesonide|mesh-list
19659836|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
19659837|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19659838|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19659839|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
19659840|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19659841|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659842|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19659843|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
19659844|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
19659845|NCT04215848|Hormones|hormones|mesh-ancestor
19659846|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19659847|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19659848|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19659849|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19659850|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
19659851|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659852|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659853|NCT04200534|Nicotine|nicotine|mesh-list
19659854|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19659855|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
19659856|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19659857|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659858|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19659859|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19659860|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
19659861|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659862|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659863|NCT04028388|Docetaxel|docetaxel|mesh-list
19659864|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659865|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
19659866|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
19659867|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
19659868|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659869|NCT04003506|Bupivacaine|bupivacaine|mesh-list
19659870|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
19659871|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
19659872|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19659873|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133038|NCT00033436|Niacin|niacin|mesh-list
20133039|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
20133040|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
20133041|NCT00033436|Vitamins|vitamins|mesh-ancestor
20133042|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
20133043|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133044|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20133045|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
20347259|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
19613226|NCT03712228|Antibodies|antibodies|mesh-list
19613227|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19613228|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
19613229|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613230|NCT03710824|Nintedanib|nintedanib|mesh-list
19613231|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613232|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19613233|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613234|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613235|NCT03705585|Vaccines|vaccines|mesh-list
19613236|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
19613237|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613238|NCT03697512|Rituximab|rituximab|mesh-list
19613239|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613240|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613241|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
19613242|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613243|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613244|NCT03689374|Insulin|insulin|mesh-list
19613245|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19613246|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
19613247|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
19613248|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19613249|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613250|NCT03685890|Nivolumab|nivolumab|mesh-list
19613251|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613252|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613253|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613254|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613255|NCT03674424|Avelumab|avelumab|mesh-list
19613256|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613257|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613258|NCT03671330|Letrozole|letrozole|mesh-list
19613259|NCT03671330|Goserelin|goserelin|mesh-list
19613260|NCT03671330|Anastrozole|anastrozole|mesh-list
19613261|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613262|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19613263|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19613264|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613265|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613266|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19613267|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
19613268|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133046|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133047|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19613269|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613270|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19613271|NCT03670355|Tenofovir|tenofovir|mesh-list
19613272|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
19613273|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613274|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19613275|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133048|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
20133049|NCT00033449|Gefitinib|gefitinib|mesh-list
20133050|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133051|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20133052|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133053|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133054|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20133055|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133056|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20133057|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133058|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133059|NCT00033553|Gemcitabine|gemcitabine|mesh-list
20133060|NCT00033553|Paclitaxel|paclitaxel|mesh-list
20133061|NCT00033553|Carboplatin|carboplatin|mesh-list
20133062|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613276|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613277|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613278|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19613279|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19613280|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
19613281|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19613282|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20133063|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613283|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19613284|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133064|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133065|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133066|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133067|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133068|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133069|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
19613285|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613286|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
19613287|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613288|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613289|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19613290|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613291|NCT03653364|Baloxavir|baloxavir|mesh-list
19613292|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
19613293|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613294|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133070|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
20133071|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133072|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133073|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133074|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
20133075|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133076|NCT00033566|S 3304|s 3304|mesh-list
20133077|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
19613295|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613296|NCT03641755|Olaparib|olaparib|mesh-list
20133078|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
20133079|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133080|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133081|NCT00033592|Bupropion|bupropion|mesh-list
20133082|NCT00033592|Nicotine|nicotine|mesh-list
20133083|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20133084|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
20133085|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133086|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133087|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20133088|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20133089|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
20133090|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133091|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133092|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20133093|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
20133094|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19613297|NCT03641755|Sapacitabine|sapacitabine|mesh-list
19613298|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19613299|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613300|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613301|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613302|NCT03631199|Paclitaxel|paclitaxel|mesh-list
19613303|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19613304|NCT03631199|Carboplatin|carboplatin|mesh-list
19613305|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
19613306|NCT03631199|Pemetrexed|pemetrexed|mesh-list
19613307|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19613308|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613309|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613310|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613311|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613312|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613313|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613314|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613315|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613316|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19613317|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19613318|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
19613319|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613320|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
19613321|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613322|NCT03594110|Empagliflozin|empagliflozin|mesh-list
19613323|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20133095|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20133096|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20133097|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133098|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
20133099|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20133100|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133101|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133102|NCT00033605|Octreotide|octreotide|mesh-list
20133103|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133104|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19613324|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613325|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19613326|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613327|NCT03587636|Bupivacaine|bupivacaine|mesh-list
19613328|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
19613329|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
19613330|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19613331|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613332|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
19613333|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613334|NCT03570697|Evolocumab|evolocumab|mesh-list
19613335|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19613336|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19613337|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
19613338|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613339|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19613340|NCT03567473|Dexamethasone|dexamethasone|mesh-list
19613341|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
19613342|NCT03567473|Epinephrine|epinephrine|mesh-list
19613343|NCT03567473|Racepinephrine|racepinephrine|mesh-list
19613344|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
19613345|NCT03567473|BB 1101|bb 1101|mesh-list
19613346|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20133105|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133106|NCT00033618|Epothilones|epothilones|mesh-list
20133107|NCT00033618|Epothilone B|epothilone b|mesh-list
20133108|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133109|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133110|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133111|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133112|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133113|NCT00033644|Doxorubicin|doxorubicin|mesh-list
20133114|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20133115|NCT00033644|Mitomycins|mitomycins|mesh-list
20133116|NCT00033644|Mitomycin|mitomycin|mesh-list
20133117|NCT00033644|Dacarbazine|dacarbazine|mesh-list
19613347|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
20133118|NCT00033644|Sargramostim|sargramostim|mesh-list
20133119|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133120|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20133121|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20133122|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20133123|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133124|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133125|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
20133126|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133127|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
20133128|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133129|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20133130|NCT00033683|Tamoxifen|tamoxifen|mesh-list
20133131|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
20133132|NCT00033683|Docetaxel|docetaxel|mesh-list
20133133|NCT00033683|Fluorouracil|fluorouracil|mesh-list
20133134|NCT00033683|Methotrexate|methotrexate|mesh-list
20133135|NCT00033683|Epirubicin|epirubicin|mesh-list
19613348|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
19613349|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613350|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613351|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19613352|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
19613353|NCT03567473|Hormones|hormones|mesh-ancestor
19613354|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19613355|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19613356|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133136|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613357|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
19613358|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133137|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
20133138|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133139|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613359|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613360|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20133140|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20133141|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
20133142|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133143|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133144|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19613361|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19613362|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
19613363|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613364|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19613365|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19613366|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19613367|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
20133145|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133146|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613368|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
19613369|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
19613370|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19613371|NCT03560531|Palbociclib|palbociclib|mesh-list
19613372|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613373|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19613374|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613375|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613376|NCT03557294|Varenicline|varenicline|mesh-list
19613377|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19613378|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19613379|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
19613380|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613381|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613382|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613383|NCT03540420|Atezolizumab|atezolizumab|mesh-list
19613384|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613385|NCT03537391|Fluorides|fluorides|mesh-list
19613386|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
19613387|NCT03537391|Protective Agents|protective agents|mesh-ancestor
19613388|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613393|NCT03527043|Citalopram|citalopram|mesh-list
19613394|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19613395|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19613396|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19613397|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613398|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613399|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
19613400|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613401|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19613402|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
19613403|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19613404|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
19613405|NCT03519997|Bavituximab|bavituximab|mesh-list
19613406|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613407|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613408|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
19613409|NCT03513406|Neostigmine|neostigmine|mesh-list
19613410|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19613411|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613412|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613413|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
19613414|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613415|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613416|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19613417|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
19613418|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613419|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19613420|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19613421|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20133147|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133148|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
20133149|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133150|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20133151|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
20133152|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20133153|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
20133154|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133155|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20133156|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133157|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20133158|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20133159|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20133160|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20133161|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
20133162|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133163|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20133164|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20133165|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20133166|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20133167|NCT00033696|Paclitaxel|paclitaxel|mesh-list
20133168|NCT00033696|Etoposide|etoposide|mesh-list
20133169|NCT00033696|Carboplatin|carboplatin|mesh-list
20133170|NCT00033696|Topotecan|topotecan|mesh-list
20133171|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133172|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133173|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133174|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133175|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133176|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133177|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19613425|NCT03503318|Risperidone|risperidone|mesh-list
19613426|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19613427|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
19613428|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613429|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613430|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613431|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19613432|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19613433|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19613434|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19613435|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19613436|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
19613437|NCT03498521|Gemcitabine|gemcitabine|mesh-list
19613438|NCT03498521|Bevacizumab|bevacizumab|mesh-list
19613439|NCT03498521|Carboplatin|carboplatin|mesh-list
19613440|NCT03498521|Trastuzumab|trastuzumab|mesh-list
19613441|NCT03498521|Atezolizumab|atezolizumab|mesh-list
19613442|NCT03498521|Olaparib|olaparib|mesh-list
19613443|NCT03498521|Pertuzumab|pertuzumab|mesh-list
19613444|NCT03498521|Vemurafenib|vemurafenib|mesh-list
19613445|NCT03498521|Ivosidenib|ivosidenib|mesh-list
19613446|NCT03498521|Entrectinib|entrectinib|mesh-list
19613447|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613448|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613449|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613450|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19613451|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19613452|NCT03498521|Growth Substances|growth substances|mesh-ancestor
19613453|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613454|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
19613455|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613456|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
19613457|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
19613458|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613459|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613460|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613461|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
19613462|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19613463|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19613464|NCT03495960|Rituximab|rituximab|mesh-list
19613465|NCT03495960|Methotrexate|methotrexate|mesh-list
19613466|NCT03495960|Lenalidomide|lenalidomide|mesh-list
20133178|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19613467|NCT03495960|Temozolomide|temozolomide|mesh-list
19613468|NCT03495960|Procarbazine|procarbazine|mesh-list
19665577|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613469|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613470|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613471|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
19613472|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613473|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613474|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19613475|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
19613476|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19613477|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613478|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
19613479|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613480|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
19613481|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613482|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19613483|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613484|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133179|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133180|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20133181|NCT00033709|Thalidomide|thalidomide|mesh-list
19613485|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19613486|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19613487|NCT03495960|Growth Substances|growth substances|mesh-ancestor
19613488|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
19613489|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19613490|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
19659874|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
19659875|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19659876|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
19659877|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19659878|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659879|NCT03955640|Olaparib|olaparib|mesh-list
19659880|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19659881|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659882|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659883|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659884|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
19659885|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19659886|NCT03910738|Testosterone|testosterone|mesh-list
19659887|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
19659888|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
19659889|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19659890|NCT03910738|Androgens|androgens|mesh-ancestor
19659891|NCT03910738|Hormones|hormones|mesh-ancestor
19659892|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19659893|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659894|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19659895|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659896|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
19659897|NCT03890744|Docetaxel|docetaxel|mesh-list
19659898|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659899|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
19659900|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
19659901|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133182|NCT00033709|Temozolomide|temozolomide|mesh-list
20133183|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20133184|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
20133185|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133186|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133187|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133188|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
20133189|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133190|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
20133191|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20133192|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133193|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20133194|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20133195|NCT00033709|Growth Substances|growth substances|mesh-ancestor
20133196|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
20133197|NCT00033722|Folic Acid|folic acid|mesh-list
20133198|NCT00033722|Lometrexol|lometrexol|mesh-list
19659902|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659903|NCT03885037|Infliximab|infliximab|mesh-list
20133199|NCT00033722|Hematinics|hematinics|mesh-ancestor
20133200|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
19613491|NCT03493854|Paclitaxel|paclitaxel|mesh-list
19613492|NCT03493854|Docetaxel|docetaxel|mesh-list
19613493|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
20133201|NCT00033722|Vitamins|vitamins|mesh-ancestor
20133202|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
20133203|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133204|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133205|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
20133206|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133207|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613494|NCT03493854|Doxorubicin|doxorubicin|mesh-list
19613495|NCT03493854|Trastuzumab|trastuzumab|mesh-list
19613496|NCT03493854|Pertuzumab|pertuzumab|mesh-list
19613497|NCT03493854|Hormones|hormones|mesh-list
19613498|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613499|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613500|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613501|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613502|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613503|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613504|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613505|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
19613506|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613507|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613508|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19613509|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
19613510|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19613511|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19613512|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19613513|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19613514|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613515|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613516|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19613517|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
19613518|NCT03476239|Blinatumomab|blinatumomab|mesh-list
19613519|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613520|NCT03469713|Nivolumab|nivolumab|mesh-list
19613521|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613522|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613523|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613524|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613525|NCT03464084|Melatonin|melatonin|mesh-list
19613526|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
19613527|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613528|NCT03464084|Protective Agents|protective agents|mesh-ancestor
19613529|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613530|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19613531|NCT03442556|Carboplatin|carboplatin|mesh-list
19613532|NCT03442556|Docetaxel|docetaxel|mesh-list
19613533|NCT03442556|Rucaparib|rucaparib|mesh-list
19613534|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613535|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613536|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613537|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613538|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613539|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19613540|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613541|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
19613542|NCT03440892|Methotrexate|methotrexate|mesh-list
19613543|NCT03440892|Abatacept|abatacept|mesh-list
19613544|NCT03440892|Tofacitinib|tofacitinib|mesh-list
19613545|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19613546|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
19613547|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19613548|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613549|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613550|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
19613551|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613552|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613553|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
19613554|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613555|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19613556|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613557|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
19613558|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20133208|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19613559|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19613560|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613561|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19613562|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613563|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19613564|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19613565|NCT03440892|Analgesics|analgesics|mesh-ancestor
19613566|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
19613567|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613568|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613569|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19613570|NCT03431168|Azithromycin|azithromycin|mesh-list
19613571|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19613572|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19613573|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613574|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19613575|NCT03431168|Renal Agents|renal agents|mesh-ancestor
19613576|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
19613577|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19613578|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19613579|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
19613580|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19613581|NCT03401749|Allantoin|allantoin|mesh-list
19613582|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19613583|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613584|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
19613585|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19613586|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
19613587|NCT03396575|Fludarabine|fludarabine|mesh-list
19613588|NCT03396575|Vaccines|vaccines|mesh-list
19613589|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
19613590|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613591|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613592|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613593|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19613594|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
19613595|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613596|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613597|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19613598|NCT03391284|Acetaminophen|acetaminophen|mesh-list
19613599|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19613600|NCT03391284|Analgesics|analgesics|mesh-ancestor
19613601|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
19613602|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613603|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613604|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
19613605|NCT03382561|Cisplatin|cisplatin|mesh-list
19613606|NCT03382561|Carboplatin|carboplatin|mesh-list
19613607|NCT03382561|Nivolumab|nivolumab|mesh-list
19613608|NCT03382561|Etoposide|etoposide|mesh-list
19613609|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
19613610|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
19613611|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613612|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613613|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613614|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613615|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613616|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19613617|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19613618|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613619|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
19613620|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
19613621|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613622|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613623|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613624|NCT03369223|Nivolumab|nivolumab|mesh-list
19613625|NCT03369223|Ipilimumab|ipilimumab|mesh-list
19613626|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613627|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613628|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613629|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613630|NCT03363464|Empagliflozin|empagliflozin|mesh-list
19613631|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19613632|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19613633|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613634|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19613635|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613636|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
19613637|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613638|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
19613639|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19613640|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19613641|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613642|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
19613643|NCT03361345|Coagulants|coagulants|mesh-ancestor
19613644|NCT03360916|Atorvastatin|atorvastatin|mesh-list
19613645|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19613646|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19613647|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
19613648|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613649|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19613650|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20133209|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133210|NCT00033735|Fluorouracil|fluorouracil|mesh-list
20133211|NCT00033735|Irofulven|irofulven|mesh-list
20133212|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
20133213|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133214|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133215|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133216|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133217|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
20133218|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133219|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20133220|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
20133221|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20133222|NCT00033748|Antibodies|antibodies|mesh-list
20133223|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
20133224|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20133225|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
20133226|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133227|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133228|NCT00033813|Oxatomide|oxatomide|mesh-list
19613651|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613652|NCT03359863|Pirfenidone|pirfenidone|mesh-list
19613653|NCT03359863|Analgesics|analgesics|mesh-ancestor
19613654|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
19613655|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613656|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613657|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19613658|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19613659|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613660|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613661|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613662|NCT03357419|Clindamycin|clindamycin|mesh-list
19613663|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
19613664|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
19613665|NCT03357419|Cephalexin|cephalexin|mesh-list
19613666|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19613667|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613668|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19613669|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613670|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613671|NCT03351998|Atorvastatin|atorvastatin|mesh-list
19613672|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19613673|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19613674|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
19613675|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613676|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19613677|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19613678|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133229|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20133230|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
20133231|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
20133232|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613679|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
19613680|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
20133233|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133234|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613681|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613682|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
19613683|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613684|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613685|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19613686|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
19613687|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613688|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613689|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19613690|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613691|NCT03334305|Vaccines|vaccines|mesh-list
19613692|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
19613693|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613694|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
19613695|NCT03331289|Exenatide|exenatide|mesh-list
19613696|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19613697|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613698|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19613699|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613700|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19613701|NCT03331289|Incretins|incretins|mesh-ancestor
19613702|NCT03331289|Hormones|hormones|mesh-ancestor
19613703|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19613704|NCT03324282|Avelumab|avelumab|mesh-list
19613705|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613706|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613707|NCT03323463|Carboplatin|carboplatin|mesh-list
19613708|NCT03323463|Fluorouracil|fluorouracil|mesh-list
19613709|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613710|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
19613711|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613712|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613713|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613714|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
19613715|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613716|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19613717|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613718|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613719|NCT03312738|Everolimus|everolimus|mesh-list
19613720|NCT03312738|Exemestane|exemestane|mesh-list
19613721|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613722|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613723|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
19613724|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613725|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19613726|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19613727|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613728|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613729|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19613730|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
19613731|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19613732|NCT03311958|Nivolumab|nivolumab|mesh-list
19613733|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613734|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613735|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613736|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613737|NCT03301506|Seladelpar|seladelpar|mesh-list
19613738|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19613739|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
19613740|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613741|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19613742|NCT03299049|Rilpivirine|rilpivirine|mesh-list
19613743|NCT03299049|Cabotegravir|cabotegravir|mesh-list
19613744|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19613745|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19613746|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613747|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613748|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
19613749|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613750|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19613751|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19613752|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19613753|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19613754|NCT03283007|Nintedanib|nintedanib|mesh-list
19613755|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613756|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20133235|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19613757|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613758|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613759|NCT03268057|Avelumab|avelumab|mesh-list
19613760|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613761|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613762|NCT03257631|Thalidomide|thalidomide|mesh-list
19613763|NCT03257631|Pomalidomide|pomalidomide|mesh-list
19613764|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
19613765|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613766|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19613767|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19613768|NCT03257631|Growth Substances|growth substances|mesh-ancestor
19613769|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
19613770|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613771|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613772|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
19613773|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19613774|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613775|NCT03253796|Golimumab|golimumab|mesh-list
19613776|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19613777|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613778|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613779|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
19613780|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659904|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
19659905|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19659906|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19659907|NCT03831503|Antibodies|antibodies|mesh-list
19659908|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
19659909|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659910|NCT03820817|Rifaximin|rifaximin|mesh-list
19659911|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19659912|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19659913|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19659914|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
19659915|NCT03789097|Poly ICLC|poly iclc|mesh-list
19659916|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19659917|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659918|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
19659919|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
19659920|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659921|NCT03745430|Ramucirumab|ramucirumab|mesh-list
19659922|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659923|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
19659924|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19659925|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19659926|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19659927|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
19659928|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659929|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659930|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659931|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
19659932|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19659933|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
19659934|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19659935|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659936|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19659937|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
19659938|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19659939|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
19659940|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659941|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19659942|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19659943|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
19659944|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
19659945|NCT03718793|Protective Agents|protective agents|mesh-ancestor
19659946|NCT03671967|Meropenem|meropenem|mesh-list
19659947|NCT03671967|Tazobactam|tazobactam|mesh-list
19659948|NCT03671967|Piperacillin|piperacillin|mesh-list
19659949|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19659950|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19659951|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19659952|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19659953|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312406|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659954|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613781|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
19613782|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613783|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613784|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
19613785|NCT03240211|Decitabine|decitabine|mesh-list
19613786|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613787|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613788|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613789|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
19613790|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613791|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613792|NCT03230565|Ropivacaine|ropivacaine|mesh-list
19613793|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
19613794|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
19613795|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19613796|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613797|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
19613798|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613799|NCT03205137|Amlodipine|amlodipine|mesh-list
19613800|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20312407|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20312408|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20312409|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
20312410|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
20133236|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20133237|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
20133238|NCT00033891|Infliximab|infliximab|mesh-list
20133239|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
20133240|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133241|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20133242|NCT00033982|Posaconazole|posaconazole|mesh-list
20312411|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20312412|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312413|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20312414|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
20312415|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20312416|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312417|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312418|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312419|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
19613801|NCT03205137|Telmisartan|telmisartan|mesh-list
20133243|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
19613802|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19613803|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
19613804|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19613805|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19613806|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19613807|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613808|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19613809|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613810|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
19613811|NCT03205137|Diuretics|diuretics|mesh-ancestor
19613812|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
20133244|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613813|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19613814|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19613815|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19613816|NCT03195478|Nivolumab|nivolumab|mesh-list
19613817|NCT03195478|Ipilimumab|ipilimumab|mesh-list
19613818|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613819|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613820|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613821|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613822|NCT03194906|Memantine|memantine|mesh-list
19613823|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19613824|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19613825|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
19613826|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19613827|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613828|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613829|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19613830|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19613831|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
19613832|NCT03192397|Sirolimus|sirolimus|mesh-list
19613833|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
19613834|NCT03192397|Melphalan|melphalan|mesh-list
19613835|NCT03192397|Fludarabine|fludarabine|mesh-list
19613836|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
19613837|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613838|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
19613839|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613840|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613841|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19613842|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
20133245|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20133246|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20133247|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20133248|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20133249|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133250|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133251|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133252|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19613843|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613844|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613845|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19613846|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613847|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
19613848|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19613849|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19613850|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
19613851|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19613852|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613853|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613854|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
20133253|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
20133254|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133255|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133256|NCT00034047|Nafarelin|nafarelin|mesh-list
20133257|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20133258|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
20133259|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20133260|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133261|NCT00034060|Etanercept|etanercept|mesh-list
20133262|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20133263|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20133264|NCT00034060|Analgesics|analgesics|mesh-ancestor
20133265|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
20133266|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133267|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133268|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20133269|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20133270|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133271|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133272|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
20133273|NCT00034086|Ritonavir|ritonavir|mesh-list
20133274|NCT00034086|Lopinavir|lopinavir|mesh-list
20133275|NCT00034086|Tenofovir|tenofovir|mesh-list
20133276|NCT00034086|Lamivudine|lamivudine|mesh-list
20133277|NCT00034086|Zidovudine|zidovudine|mesh-list
20133278|NCT00034086|Stavudine|stavudine|mesh-list
20133279|NCT00034086|Didanosine|didanosine|mesh-list
19613880|NCT03172936|Spartalizumab|spartalizumab|mesh-list
19613881|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613882|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613883|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613884|NCT03168464|Nivolumab|nivolumab|mesh-list
19613885|NCT03168464|Ipilimumab|ipilimumab|mesh-list
19613886|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613887|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613888|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19613889|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613890|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
19613891|NCT03160079|Blinatumomab|blinatumomab|mesh-list
19613892|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613893|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613894|NCT03158064|Durvalumab|durvalumab|mesh-list
19613895|NCT03158064|Tremelimumab|tremelimumab|mesh-list
19613896|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19613897|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613898|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
19613899|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613900|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
19613901|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613902|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613903|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
19613904|NCT03148457|Apixaban|apixaban|mesh-list
19613905|NCT03148457|Edoxaban|edoxaban|mesh-list
19613906|NCT03148457|Dabigatran|dabigatran|mesh-list
19613907|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19613908|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
19613909|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19613910|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
19613911|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613912|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613913|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
19613914|NCT03138252|Oxytocin|oxytocin|mesh-list
19613915|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
19613916|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19613917|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613918|NCT03122717|Gefitinib|gefitinib|mesh-list
20312420|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20312421|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312422|NCT00683995|Fentanyl|fentanyl|mesh-list
20312423|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20312424|NCT00683995|Narcotics|narcotics|mesh-ancestor
20312425|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312426|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312427|NCT00683995|Analgesics|analgesics|mesh-ancestor
20312428|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
20312429|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608341|NCT02245451|Narcotics|narcotics|mesh-ancestor
19613919|NCT03122717|Osimertinib|osimertinib|mesh-list
19613920|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613921|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19613922|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613923|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613924|NCT03117751|Cytarabine|cytarabine|mesh-list
19613925|NCT03117751|Dexamethasone|dexamethasone|mesh-list
19613926|NCT03117751|Prednisone|prednisone|mesh-list
19613927|NCT03117751|Prednisolone|prednisolone|mesh-list
19613928|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
19613929|NCT03117751|Doxorubicin|doxorubicin|mesh-list
19613930|NCT03117751|Methotrexate|methotrexate|mesh-list
19613931|NCT03117751|Etoposide|etoposide|mesh-list
19613932|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
19613933|NCT03117751|Vincristine|vincristine|mesh-list
19613934|NCT03117751|Bortezomib|bortezomib|mesh-list
19613935|NCT03117751|Daunorubicin|daunorubicin|mesh-list
19613936|NCT03117751|Asparaginase|asparaginase|mesh-list
19613937|NCT03117751|Dasatinib|dasatinib|mesh-list
19613938|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
19613939|NCT03117751|Vorinostat|vorinostat|mesh-list
19613940|NCT03117751|Idarubicin|idarubicin|mesh-list
19613941|NCT03117751|Clofarabine|clofarabine|mesh-list
19613942|NCT03117751|Pegaspargase|pegaspargase|mesh-list
20133280|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20133281|NCT00034086|Vaccines|vaccines|mesh-list
20133282|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20133283|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
20133284|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133285|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19613943|NCT03117751|Thioguanine|thioguanine|mesh-list
19613944|NCT03117751|Blinatumomab|blinatumomab|mesh-list
19613945|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19613946|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
19613947|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613948|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19613949|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19613950|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
19613951|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613952|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613953|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19613954|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19613955|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
19613956|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
19613957|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19613958|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19613959|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
19613960|NCT03117751|Hormones|hormones|mesh-ancestor
19613961|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19613962|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19613963|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19613964|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19613965|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19613966|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613967|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19613968|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
19613969|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19613970|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19613971|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
19613972|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
20133286|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20133287|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
20133288|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133289|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613973|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19613974|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19613975|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19613976|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
19613977|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19613978|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
19613979|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
19613980|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
19613981|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19613982|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19613983|NCT03099174|Letrozole|letrozole|mesh-list
19613984|NCT03099174|Fulvestrant|fulvestrant|mesh-list
19613985|NCT03099174|Anastrozole|anastrozole|mesh-list
19613986|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19613987|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19613988|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19613989|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19613990|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19613991|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19613992|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
19613993|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19613994|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19613995|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19613996|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19613997|NCT03081143|Paclitaxel|paclitaxel|mesh-list
19613998|NCT03081143|Ramucirumab|ramucirumab|mesh-list
19613999|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614000|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614001|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614002|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614003|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614004|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614005|NCT03064126|Paclitaxel|paclitaxel|mesh-list
19614006|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19614007|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614008|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614009|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614010|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614011|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614012|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614013|NCT03043053|Oxytocin|oxytocin|mesh-list
19614014|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
19614015|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19614016|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614017|NCT03038672|Nivolumab|nivolumab|mesh-list
19614018|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
19614019|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
19614020|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19614021|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20133290|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19614022|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614023|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614024|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614025|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
19614026|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614027|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
19614028|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19614029|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
19614030|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614031|NCT03032601|Expectorants|expectorants|mesh-ancestor
19614032|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
19614033|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19614034|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
19614035|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614036|NCT03032601|Protective Agents|protective agents|mesh-ancestor
19614037|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614038|NCT03032601|Antidotes|antidotes|mesh-ancestor
19614039|NCT03028350|Ifetroban|ifetroban|mesh-list
19614040|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19614041|NCT03011684|Tamoxifen|tamoxifen|mesh-list
19614042|NCT03011684|Letrozole|letrozole|mesh-list
19614043|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614044|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19614045|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19614046|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312430|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20312431|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20312432|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
20312433|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
20312434|NCT00684099|Docetaxel|docetaxel|mesh-list
20312435|NCT00684099|Pemetrexed|pemetrexed|mesh-list
19614047|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614048|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19614049|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
19614050|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614051|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614052|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614053|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19614054|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20133291|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19659955|NCT03524326|Cetuximab|cetuximab|mesh-list
20133292|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
20133293|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133294|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20133295|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133296|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20133297|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133298|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
20133299|NCT00034125|Tamoxifen|tamoxifen|mesh-list
20133300|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20312436|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614055|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19614056|NCT03002389|Fluticasone|fluticasone|mesh-list
19614057|NCT03002389|Xhance|xhance|mesh-list
19614058|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614059|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19614060|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
19614061|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614062|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614063|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19614064|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
19614065|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
19614066|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19614067|NCT02983045|Paclitaxel|paclitaxel|mesh-list
19614068|NCT02983045|Cisplatin|cisplatin|mesh-list
19614069|NCT02983045|Carboplatin|carboplatin|mesh-list
19614070|NCT02983045|Nivolumab|nivolumab|mesh-list
19614071|NCT02983045|Pemetrexed|pemetrexed|mesh-list
19614072|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614073|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614074|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614075|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614076|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614077|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614078|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614079|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614080|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614081|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19614082|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19614083|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
19614084|NCT02981069|Exenatide|exenatide|mesh-list
19614085|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19614086|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614087|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19614088|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614089|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19614090|NCT02981069|Incretins|incretins|mesh-ancestor
19614091|NCT02981069|Hormones|hormones|mesh-ancestor
19614092|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614093|NCT02978625|Nivolumab|nivolumab|mesh-list
19614094|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19614095|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614096|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614097|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614098|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614102|NCT02949700|Metformin|metformin|mesh-list
19614103|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19614104|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614105|NCT02943993|Edoxaban|edoxaban|mesh-list
19614106|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19614107|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
19614108|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19614109|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
19614110|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614111|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614112|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
19614113|NCT02939989|Ribavirin|ribavirin|mesh-list
19614114|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
19614115|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
19614116|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614117|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
19614118|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614119|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
19614120|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614121|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614122|NCT02917564|Triamcinolone|triamcinolone|mesh-list
19614123|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19614124|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20133301|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
20133302|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133303|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133304|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20133305|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133306|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20133307|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20133308|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19614125|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19614126|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614127|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
19614128|NCT02917564|Hormones|hormones|mesh-ancestor
19614129|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614130|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614131|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614132|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
19614133|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614134|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659956|NCT03524326|Lenvatinib|lenvatinib|mesh-list
19659957|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19659958|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659959|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19659960|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659961|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659962|NCT03512223|Dexamethasone|dexamethasone|mesh-list
19659963|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19659964|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
19659965|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
19659966|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133309|NCT00034138|Oregovomab|oregovomab|mesh-list
20133310|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20133311|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133312|NCT00034151|Paclitaxel|paclitaxel|mesh-list
20133313|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133314|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133315|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133316|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133317|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133318|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133319|NCT00034164|Paclitaxel|paclitaxel|mesh-list
20133320|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133321|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133322|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133323|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133324|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
19659967|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659968|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19659969|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
19659970|NCT03512223|Hormones|hormones|mesh-ancestor
19659971|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19659972|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19659973|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659974|NCT03441139|Analgesics|analgesics|mesh-list
19659975|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
19659976|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19659977|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659978|NCT03426254|Talazoparib|talazoparib|mesh-list
19659979|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19659980|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19659981|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19659982|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659983|NCT03359460|Lenalidomide|lenalidomide|mesh-list
19659984|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
19659985|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659986|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19659987|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19659988|NCT03359460|Growth Substances|growth substances|mesh-ancestor
19614135|NCT02903680|Dexamethasone|dexamethasone|mesh-list
19614136|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
19614137|NCT02903680|BB 1101|bb 1101|mesh-list
19614138|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614139|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
19614140|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
19614141|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614142|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614143|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19614144|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
19614145|NCT02903680|Hormones|hormones|mesh-ancestor
19614146|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614147|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614148|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614149|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
19614150|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614151|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614152|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
20133325|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133326|NCT00034177|Paclitaxel|paclitaxel|mesh-list
20133327|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20133328|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133329|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133330|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133331|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133332|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133333|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133334|NCT00034190|Paclitaxel|paclitaxel|mesh-list
20133335|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133336|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614153|NCT02890355|Leucovorin|leucovorin|mesh-list
19614154|NCT02890355|Folic Acid|folic acid|mesh-list
19614155|NCT02890355|Fluorouracil|fluorouracil|mesh-list
19614156|NCT02890355|Irinotecan|irinotecan|mesh-list
19614157|NCT02890355|Veliparib|veliparib|mesh-list
19614158|NCT02890355|Camptothecin|camptothecin|mesh-list
19614159|NCT02890355|Calcium|calcium|mesh-list
19614160|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
19614161|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19614162|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614163|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19614164|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
19614165|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614166|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614167|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614168|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614169|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
19614170|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19614171|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19614172|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614173|NCT02890355|Antidotes|antidotes|mesh-ancestor
19614174|NCT02890355|Protective Agents|protective agents|mesh-ancestor
19614175|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
19614176|NCT02890355|Vitamins|vitamins|mesh-ancestor
19614177|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
19614178|NCT02890355|Hematinics|hematinics|mesh-ancestor
19614179|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19614180|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614181|NCT02877134|Ustekinumab|ustekinumab|mesh-list
19614182|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
19614183|NCT02864914|Empagliflozin|empagliflozin|mesh-list
19614184|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19614185|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19614186|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614187|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19614188|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614189|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
19614190|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133337|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133338|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133339|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133340|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133341|NCT00034229|Felbamate|felbamate|mesh-list
20133342|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
19614195|NCT02817633|Carboplatin|carboplatin|mesh-list
19614196|NCT02817633|Docetaxel|docetaxel|mesh-list
19614197|NCT02817633|Nivolumab|nivolumab|mesh-list
19614198|NCT02817633|Pemetrexed|pemetrexed|mesh-list
19614199|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614200|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614201|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614202|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614203|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614204|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614205|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614206|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614207|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19614208|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19614209|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
19614210|NCT02811263|Hematinics|hematinics|mesh-ancestor
19614211|NCT02782104|Esketamine|esketamine|mesh-list
19614212|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
19614213|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133343|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20133344|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20133345|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133346|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133347|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133348|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
20133349|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19614237|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
19614238|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614239|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614240|NCT02763579|Carboplatin|carboplatin|mesh-list
19614241|NCT02763579|Etoposide|etoposide|mesh-list
19614242|NCT02763579|Atezolizumab|atezolizumab|mesh-list
19614243|NCT02763579|Antibodies|antibodies|mesh-list
19614244|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19614245|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
19614246|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614247|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614248|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614249|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19614250|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19614251|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614252|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614253|NCT02753283|Vitamin D|vitamin d|mesh-list
19614254|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
19614255|NCT02753283|Denosumab|denosumab|mesh-list
19614256|NCT02753283|Calcium|calcium|mesh-list
19614257|NCT02753283|Vitamins|vitamins|mesh-ancestor
19614258|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
19614259|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614260|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19614261|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20133350|NCT00034242|Antibodies|antibodies|mesh-list
19614262|NCT02743494|Nivolumab|nivolumab|mesh-list
20608342|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19614263|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614264|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614265|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20133351|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
20133352|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20133353|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
20133354|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133355|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
20133356|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20133357|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614266|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614267|NCT02741570|Cisplatin|cisplatin|mesh-list
19614268|NCT02741570|Carboplatin|carboplatin|mesh-list
19614269|NCT02741570|Fluorouracil|fluorouracil|mesh-list
19614270|NCT02741570|Nivolumab|nivolumab|mesh-list
19614271|NCT02741570|Cetuximab|cetuximab|mesh-list
19614272|NCT02741570|Ipilimumab|ipilimumab|mesh-list
19614273|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614274|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
19614275|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614276|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614277|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614278|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
19614279|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614280|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614281|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614282|NCT02732288|Melatonin|melatonin|mesh-list
19614283|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
19614284|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133358|NCT00034346|Paclitaxel|paclitaxel|mesh-list
20133359|NCT00034346|Carboplatin|carboplatin|mesh-list
20133360|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133361|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133362|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133363|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133364|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133365|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133366|NCT00034359|Lamivudine|lamivudine|mesh-list
20133367|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19614285|NCT02732288|Protective Agents|protective agents|mesh-ancestor
19614286|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133368|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20312437|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
20312438|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312439|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312440|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312441|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312442|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20312443|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20312444|NCT00684112|Gabapentin|gabapentin|mesh-list
20312445|NCT00684112|Analgesics|analgesics|mesh-ancestor
19614287|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19614288|NCT02726581|Dexamethasone|dexamethasone|mesh-list
19614289|NCT02726581|Nivolumab|nivolumab|mesh-list
19614290|NCT02726581|Pomalidomide|pomalidomide|mesh-list
19614291|NCT02726581|Elotuzumab|elotuzumab|mesh-list
19614292|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614293|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
19614294|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
20133369|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614295|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614296|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312446|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
19614297|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19614298|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
19614299|NCT02726581|Hormones|hormones|mesh-ancestor
19614300|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614301|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614302|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614303|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614304|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614305|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614306|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
19614307|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19614308|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19614309|NCT02726581|Growth Substances|growth substances|mesh-ancestor
19614310|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
19614311|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
19614312|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614313|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614314|NCT02672098|Carboplatin|carboplatin|mesh-list
19614315|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614316|NCT02667587|Nivolumab|nivolumab|mesh-list
19614317|NCT02667587|Temozolomide|temozolomide|mesh-list
19614318|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614319|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614320|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614321|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614322|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614323|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
19614324|NCT02649790|Dexamethasone|dexamethasone|mesh-list
19614325|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614326|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
19614327|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
19614328|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614329|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614330|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19614331|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
19614332|NCT02649790|Hormones|hormones|mesh-ancestor
19614333|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614334|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614335|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614336|NCT02642640|Melatonin|melatonin|mesh-list
19614337|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
19614338|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614339|NCT02642640|Protective Agents|protective agents|mesh-ancestor
19614340|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614341|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19614342|NCT02632721|Decitabine|decitabine|mesh-list
19614343|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614344|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
19614345|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614346|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312447|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312448|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312449|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
19614347|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614348|NCT02631759|Levetiracetam|levetiracetam|mesh-list
19614349|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
19614350|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
19614351|NCT02624518|Bombesin|bombesin|mesh-list
19614352|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133370|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133371|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
20133372|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133373|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20133374|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20133375|NCT00034372|Oregovomab|oregovomab|mesh-list
20133376|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20133377|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133378|NCT00034385|Valganciclovir|valganciclovir|mesh-list
20133379|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
20133380|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133381|NCT00034463|Folic Acid|folic acid|mesh-list
20133382|NCT00034463|Vitamins|vitamins|mesh-ancestor
20312450|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19614353|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133383|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
19614354|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614355|NCT02613507|Docetaxel|docetaxel|mesh-list
19614356|NCT02613507|Nivolumab|nivolumab|mesh-list
19614357|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614358|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614359|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614360|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614361|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614362|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614363|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614364|NCT02607722|Nintedanib|nintedanib|mesh-list
19614365|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614366|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19614367|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614368|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133384|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614374|NCT02594384|Rituximab|rituximab|mesh-list
19614375|NCT02594384|Atezolizumab|atezolizumab|mesh-list
19614376|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614377|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614378|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
19614379|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614380|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19614381|NCT02576717|Ozanimod|ozanimod|mesh-list
19614382|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19614383|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614384|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614385|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
19614386|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614387|NCT02568566|Vaccines|vaccines|mesh-list
19614388|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
19614389|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614390|NCT02568267|Entrectinib|entrectinib|mesh-list
19614391|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19614392|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614393|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614394|NCT02557945|Gabapentin|gabapentin|mesh-list
19614395|NCT02557945|Analgesics|analgesics|mesh-ancestor
19614396|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
19614397|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614398|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133385|NCT00034463|Hematinics|hematinics|mesh-ancestor
20133386|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
20133387|NCT00034489|Gemcitabine|gemcitabine|mesh-list
20133388|NCT00034489|Pemetrexed|pemetrexed|mesh-list
20133389|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133390|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
20133391|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133392|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133393|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
20133394|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133395|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133396|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133397|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
20133398|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133399|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20133400|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133401|NCT00034502|Irinotecan|irinotecan|mesh-list
19614399|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
19614400|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19614401|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19614402|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19614403|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19614404|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19614405|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19614406|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19614407|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133402|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19614408|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
19614409|NCT02525757|Paclitaxel|paclitaxel|mesh-list
19614410|NCT02525757|Carboplatin|carboplatin|mesh-list
19614411|NCT02525757|Atezolizumab|atezolizumab|mesh-list
19614412|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614413|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614414|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614415|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614416|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614417|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614418|NCT02524249|Caffeine|caffeine|mesh-list
19614419|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19614420|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614421|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19614422|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614423|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614424|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19614425|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19614426|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
19614427|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19614428|NCT02521493|Cytarabine|cytarabine|mesh-list
19614429|NCT02521493|Etoposide|etoposide|mesh-list
19614430|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
19614431|NCT02521493|Daunorubicin|daunorubicin|mesh-list
19614432|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
19614433|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
19614434|NCT02521493|Asparaginase|asparaginase|mesh-list
19614435|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
19614436|NCT02521493|Thioguanine|thioguanine|mesh-list
19614437|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
19614438|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614439|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614440|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19614441|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19614442|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614443|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614444|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614445|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
19614446|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
19614447|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614448|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614449|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
19614450|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614451|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19614452|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19614453|NCT02521493|Analgesics|analgesics|mesh-ancestor
19614454|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
19614455|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614456|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
19614457|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
19614458|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614459|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614460|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614461|NCT02501954|Paclitaxel|paclitaxel|mesh-list
19614462|NCT02501954|Carboplatin|carboplatin|mesh-list
19614463|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614464|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614465|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614466|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614467|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614468|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614469|NCT02500797|Nivolumab|nivolumab|mesh-list
19614470|NCT02500797|Ipilimumab|ipilimumab|mesh-list
19614471|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614472|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614473|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614474|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614475|NCT02488967|Paclitaxel|paclitaxel|mesh-list
19614476|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
19614477|NCT02488967|Carboplatin|carboplatin|mesh-list
19614478|NCT02488967|Doxorubicin|doxorubicin|mesh-list
19614479|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19659989|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
19614480|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19614481|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614482|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614483|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614484|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614485|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614486|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614487|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614488|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
19614489|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312451|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20312452|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312453|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20312454|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20312455|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20312456|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312457|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312458|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
20312459|NCT00684164|Conivaptan|conivaptan|mesh-list
20312460|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20312461|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312462|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
20312463|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312464|NCT00684190|Esomeprazole|esomeprazole|mesh-list
19614490|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19614491|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614492|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
19614493|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19614494|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19614495|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19614496|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20133403|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20133404|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133405|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133406|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133407|NCT00034528|Prednisone|prednisone|mesh-list
20133408|NCT00034528|Fludarabine|fludarabine|mesh-list
20133409|NCT00034528|Busulfan|busulfan|mesh-list
20133410|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20133411|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
20133412|NCT00034528|Hormones|hormones|mesh-ancestor
20133413|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133414|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133415|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20133416|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133417|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133418|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133419|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
20133420|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
20133421|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20133422|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20133423|NCT00034541|Paclitaxel|paclitaxel|mesh-list
20133424|NCT00034541|Carboplatin|carboplatin|mesh-list
20133425|NCT00034541|Cetuximab|cetuximab|mesh-list
20133426|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133427|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133428|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133429|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133430|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133431|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133432|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20133433|NCT00034580|Olanzapine|olanzapine|mesh-list
20133434|NCT00034580|Risperidone|risperidone|mesh-list
20133435|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20133436|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
20133437|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133438|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133439|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133440|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19614497|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133441|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20312465|NCT00684190|Lesogaberan|lesogaberan|mesh-list
20133442|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19614498|NCT02483585|Erenumab|erenumab|mesh-list
19614499|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19614500|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614501|NCT02483585|Analgesics|analgesics|mesh-ancestor
19614502|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
19614503|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614504|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614505|NCT02456740|Erenumab|erenumab|mesh-list
19614506|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19614507|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614508|NCT02456740|Analgesics|analgesics|mesh-ancestor
19614509|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
19614510|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614511|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614512|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
19614513|NCT02451982|Nivolumab|nivolumab|mesh-list
19614514|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
19614515|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614516|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614517|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19614518|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614519|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
19614520|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614521|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614522|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19614523|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614524|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19659990|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659991|NCT03227263|Bevacizumab|bevacizumab|mesh-list
19659992|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19659993|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19659994|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19659995|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19659996|NCT03227263|Growth Substances|growth substances|mesh-ancestor
19659997|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19659998|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
19659999|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
19660000|NCT03211416|Sorafenib|sorafenib|mesh-list
19660001|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660002|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660003|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19660004|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660005|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660006|NCT03150368|Docetaxel|docetaxel|mesh-list
19660007|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660008|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660009|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660010|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660011|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660012|NCT03147378|Docetaxel|docetaxel|mesh-list
19660013|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660014|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660015|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660016|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660017|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660018|NCT03136640|Docetaxel|docetaxel|mesh-list
19660019|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660020|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660021|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133443|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133444|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19660022|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660023|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660024|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
19660025|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19660026|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
19660027|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660028|NCT02972398|Expectorants|expectorants|mesh-ancestor
19660029|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
19660030|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19660031|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
19660032|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660033|NCT02972398|Protective Agents|protective agents|mesh-ancestor
19665578|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
19614525|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
19614526|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19614527|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
19614528|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614529|NCT02445651|Expectorants|expectorants|mesh-ancestor
19614530|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
19614531|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19614532|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
19614533|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614534|NCT02445651|Protective Agents|protective agents|mesh-ancestor
19614535|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614536|NCT02445651|Antidotes|antidotes|mesh-ancestor
19614537|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20133445|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
20133446|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
20133447|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
20133448|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133449|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19614538|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
19614539|NCT02445131|Idelalisib|idelalisib|mesh-list
19614540|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614541|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
19614542|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614543|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614544|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614545|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614546|NCT02435212|Deferasirox|deferasirox|mesh-list
19614547|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19614548|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
19614549|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
19614550|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614551|NCT02428192|Nivolumab|nivolumab|mesh-list
19614552|NCT02428192|Ipilimumab|ipilimumab|mesh-list
19614553|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614554|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614555|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614556|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614557|NCT02420717|Leucovorin|leucovorin|mesh-list
19614558|NCT02420717|Cytarabine|cytarabine|mesh-list
20133450|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20133451|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20133452|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133453|NCT00034593|Gemcitabine|gemcitabine|mesh-list
20133454|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133455|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
20133456|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133457|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133458|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
19614559|NCT02420717|Dexamethasone|dexamethasone|mesh-list
19614560|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
19614561|NCT02420717|Prednisone|prednisone|mesh-list
19614562|NCT02420717|Cortisone|cortisone|mesh-list
19614563|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
19614564|NCT02420717|Rituximab|rituximab|mesh-list
19614565|NCT02420717|Doxorubicin|doxorubicin|mesh-list
19614566|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19614567|NCT02420717|Methotrexate|methotrexate|mesh-list
19614568|NCT02420717|Vincristine|vincristine|mesh-list
19614569|NCT02420717|Daunorubicin|daunorubicin|mesh-list
19614570|NCT02420717|Dasatinib|dasatinib|mesh-list
19614571|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
19614572|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19614573|NCT02420717|Antibodies|antibodies|mesh-list
19614574|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
19614575|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19614576|NCT02420717|BB 1101|bb 1101|mesh-list
19614577|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614578|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
19614579|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614580|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19614581|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614582|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
20312466|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20312467|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19614583|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614584|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614585|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19614586|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614587|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
20133459|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614588|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
19614589|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614590|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19614591|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
19614592|NCT02420717|Hormones|hormones|mesh-ancestor
19614593|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614594|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614595|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
19614596|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614597|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20133460|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133461|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133462|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
20133463|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133464|NCT00034606|Gemcitabine|gemcitabine|mesh-list
20133465|NCT00034606|Pemetrexed|pemetrexed|mesh-list
20133466|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133467|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
20133468|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133469|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133470|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
20133471|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133472|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133473|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133474|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
20133475|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133476|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20133477|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133478|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
20133479|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133480|NCT00034632|Posaconazole|posaconazole|mesh-list
20133481|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
20133482|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133483|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20133484|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20133485|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20133486|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20133487|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19614598|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19614599|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19614600|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19614601|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
19614602|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19614603|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614604|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
19614605|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
19614606|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19614607|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19614608|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
19614609|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614610|NCT02420717|Antidotes|antidotes|mesh-ancestor
19614611|NCT02420717|Protective Agents|protective agents|mesh-ancestor
19614612|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
19614613|NCT02420717|Vitamins|vitamins|mesh-ancestor
19614614|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
19614615|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614616|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614617|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614618|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614619|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19614620|NCT02408068|Dexamethasone|dexamethasone|mesh-list
19614621|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
19614622|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19614623|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20133488|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614624|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19614625|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614626|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
19614627|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
20133489|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614628|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614629|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614630|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133490|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19614631|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
19614632|NCT02408068|Hormones|hormones|mesh-ancestor
19614633|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614634|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614635|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614636|NCT02407509|Everolimus|everolimus|mesh-list
19614637|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614638|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133491|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
20133492|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133493|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173555|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173556|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20173557|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20173558|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
20173559|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173560|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20173561|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19614639|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
19614640|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614641|NCT02403323|Etrolizumab|etrolizumab|mesh-list
19614642|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19614643|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
19614644|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173562|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20173563|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20173564|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20173565|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20173566|NCT00162188|Efavirenz|efavirenz|mesh-list
20173567|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20173568|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20173569|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173570|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173571|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
20173572|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173573|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19614645|NCT02397083|Everolimus|everolimus|mesh-list
19614646|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
19614647|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614648|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614649|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
19614650|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614651|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19614652|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
19614653|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19614654|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19614655|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19614656|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19614657|NCT02386826|Bevacizumab|bevacizumab|mesh-list
19614658|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614659|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614660|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19614661|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19614662|NCT02386826|Growth Substances|growth substances|mesh-ancestor
19614663|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614664|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
19614665|NCT02334865|Lenalidomide|lenalidomide|mesh-list
19614666|NCT02334865|Sargramostim|sargramostim|mesh-list
19614667|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
20173574|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20173575|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20173576|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20173577|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20173578|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19614668|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
19614669|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614670|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19614671|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19614672|NCT02334865|Growth Substances|growth substances|mesh-ancestor
19614673|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
19614674|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614675|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19614676|NCT02333370|Tamoxifen|tamoxifen|mesh-list
19614677|NCT02333370|Letrozole|letrozole|mesh-list
19614678|NCT02333370|Fulvestrant|fulvestrant|mesh-list
19614679|NCT02333370|Goserelin|goserelin|mesh-list
19614680|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614681|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19614682|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20133494|NCT00034645|Posaconazole|posaconazole|mesh-list
20133495|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
20312468|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19614683|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614684|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614685|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19614686|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
19614687|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614688|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614689|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614690|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19614691|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19614692|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19614693|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19614694|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19614695|NCT02324608|Cetuximab|cetuximab|mesh-list
19614696|NCT02324608|Antibodies|antibodies|mesh-list
19614697|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
19614698|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19614699|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
19614700|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614701|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614702|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19614703|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
19614704|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614705|NCT02288247|Prednisolone|prednisolone|mesh-list
19614706|NCT02288247|Docetaxel|docetaxel|mesh-list
19614707|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614708|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614709|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614710|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614711|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614712|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614713|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
19614714|NCT02288247|Hormones|hormones|mesh-ancestor
19614715|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614716|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614717|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614718|NCT02224781|Nivolumab|nivolumab|mesh-list
19614719|NCT02224781|Ipilimumab|ipilimumab|mesh-list
19614720|NCT02224781|Trametinib|trametinib|mesh-list
19614721|NCT02224781|Dabrafenib|dabrafenib|mesh-list
19614722|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19614723|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614724|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614725|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614726|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614727|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19614728|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614729|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19614730|NCT02224781|Protective Agents|protective agents|mesh-ancestor
19614731|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614732|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19614733|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
19614734|NCT02210559|Gemcitabine|gemcitabine|mesh-list
19614735|NCT02210559|Paclitaxel|paclitaxel|mesh-list
19614736|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614737|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614738|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614739|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614740|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614741|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614742|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614743|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
19614744|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
19614745|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614746|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133496|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312469|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312470|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133497|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20133498|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20133499|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20133500|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20133501|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133502|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133503|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133504|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20133505|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
20133506|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614747|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614748|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
19614749|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614750|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19614751|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19614752|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614765|NCT02193841|Calcium|calcium|mesh-list
19614766|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19614767|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614773|NCT02181413|Ixazomib|ixazomib|mesh-list
19614774|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614775|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614776|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
19614777|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614778|NCT02174861|Erenumab|erenumab|mesh-list
19614779|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19614780|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614781|NCT02174861|Analgesics|analgesics|mesh-ancestor
19614782|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
19614783|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614784|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614785|NCT02174549|Tirapazamine|tirapazamine|mesh-list
20133507|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133508|NCT00034658|Posaconazole|posaconazole|mesh-list
20133509|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
20133510|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133511|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20133512|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20133513|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19614786|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614787|NCT02164955|Pomalidomide|pomalidomide|mesh-list
19614788|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
19614789|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614790|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19614791|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19614792|NCT02164955|Growth Substances|growth substances|mesh-ancestor
19614793|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
19614794|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614795|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
19614796|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19614797|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
19614798|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614799|NCT02113163|Metformin|metformin|mesh-list
20133514|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20173579|NCT00162201|Abatacept|abatacept|mesh-list
19614800|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19614801|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19614802|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614803|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19614804|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19614805|NCT02109744|Decitabine|decitabine|mesh-list
19614806|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614807|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
19614808|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614809|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614810|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614811|NCT02107937|Paclitaxel|paclitaxel|mesh-list
19614812|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19614813|NCT02107937|Carboplatin|carboplatin|mesh-list
19614814|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133515|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133516|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133517|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133518|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20133519|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
20133520|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614815|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614816|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133521|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133522|NCT00034671|Posaconazole|posaconazole|mesh-list
20133523|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
20133524|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133525|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20133526|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20133527|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20133528|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19614817|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614818|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614819|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614820|NCT02095184|Letrozole|letrozole|mesh-list
19614821|NCT02095184|Anastrozole|anastrozole|mesh-list
19614822|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614823|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20133529|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133530|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133531|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133532|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20133533|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
20133534|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133535|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133536|NCT00034697|Temozolomide|temozolomide|mesh-list
20133537|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20133538|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
19614824|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19614825|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614826|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614827|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19614828|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
19614829|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614830|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614831|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614832|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
19614833|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19614834|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
19614835|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614836|NCT02094625|Expectorants|expectorants|mesh-ancestor
19614837|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
19614838|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19614839|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
19614840|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614841|NCT02094625|Protective Agents|protective agents|mesh-ancestor
19614842|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614843|NCT02094625|Antidotes|antidotes|mesh-ancestor
19614844|NCT02085265|Telmisartan|telmisartan|mesh-list
19614845|NCT02085265|Perindopril|perindopril|mesh-list
19614846|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19614847|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19614848|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19614849|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614850|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19614851|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
19614852|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614853|NCT02085148|Irinotecan|irinotecan|mesh-list
20133539|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133540|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133541|NCT00034710|Capsaicin|capsaicin|mesh-list
20133542|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
20133543|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
20133544|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
20133545|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19614854|NCT02085148|Vincristine|vincristine|mesh-list
19614855|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19614856|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19614857|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614858|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614859|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614860|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614861|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
19614862|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614863|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614864|NCT02052739|Brexanolone|brexanolone|mesh-list
19614865|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
20133546|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133547|NCT00034736|Levofloxacin|levofloxacin|mesh-list
20133548|NCT00034736|Ofloxacin|ofloxacin|mesh-list
20133549|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20133550|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133551|NCT00034736|Renal Agents|renal agents|mesh-ancestor
20133552|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20133553|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20133554|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20133555|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614866|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19614867|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614868|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614869|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
19614870|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
19614871|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
19614872|NCT02048813|Rituximab|rituximab|mesh-list
19614873|NCT02048813|Fludarabine|fludarabine|mesh-list
19614874|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
19614875|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19614876|NCT02048813|Antibodies|antibodies|mesh-list
19614877|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
19614878|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20133556|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133557|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133558|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20133559|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133560|NCT00034749|Risperidone|risperidone|mesh-list
20133561|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20133562|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
20133563|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133564|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133565|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133566|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20133567|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20133568|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133569|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133570|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20133571|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
19614879|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133572|NCT00034762|Risperidone|risperidone|mesh-list
20133573|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19614880|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
19614881|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614882|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19614883|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614884|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
19614885|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614886|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614887|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19614888|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614889|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
19614890|NCT02043587|Leucovorin|leucovorin|mesh-list
19614891|NCT02043587|Cytarabine|cytarabine|mesh-list
19614892|NCT02043587|Prednisone|prednisone|mesh-list
19614893|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
19614894|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19614895|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19614896|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19614897|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
19614898|NCT02043587|Rituximab|rituximab|mesh-list
19614899|NCT02043587|Methotrexate|methotrexate|mesh-list
19614900|NCT02043587|Etoposide|etoposide|mesh-list
19614901|NCT02043587|Vincristine|vincristine|mesh-list
19614902|NCT02043587|Daunorubicin|daunorubicin|mesh-list
19614903|NCT02043587|Asparaginase|asparaginase|mesh-list
19614904|NCT02043587|Dasatinib|dasatinib|mesh-list
19614905|NCT02043587|Pegaspargase|pegaspargase|mesh-list
19614906|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614907|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
19614908|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614909|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19614910|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614911|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
19614912|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614913|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614914|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19614915|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614916|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614917|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
19614918|NCT02043587|Hormones|hormones|mesh-ancestor
19614919|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614920|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614921|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19614922|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
19614923|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19614924|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19614925|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
19614926|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
19614927|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614928|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19614929|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19614930|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19614931|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19614932|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19614933|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
19614934|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19614935|NCT02043587|Antidotes|antidotes|mesh-ancestor
19614936|NCT02043587|Protective Agents|protective agents|mesh-ancestor
19614937|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
19614938|NCT02043587|Vitamins|vitamins|mesh-ancestor
19614939|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
19614940|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133574|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
19614941|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19614942|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
19614943|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19614944|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19614945|NCT02022098|Cisplatin|cisplatin|mesh-list
19614946|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614947|NCT01989585|Trametinib|trametinib|mesh-list
19614948|NCT01989585|Dabrafenib|dabrafenib|mesh-list
19614949|NCT01989585|Navitoclax|navitoclax|mesh-list
19614950|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614951|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20133575|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19614952|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614953|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614954|NCT01958021|Letrozole|letrozole|mesh-list
19614955|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173580|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19614956|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19614957|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19614958|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614959|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614960|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19614961|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
19614962|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614963|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614964|NCT01947023|Lapatinib|lapatinib|mesh-list
19614965|NCT01947023|Dabrafenib|dabrafenib|mesh-list
19614966|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614967|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19614968|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19614969|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19614970|NCT01933724|Prednisone|prednisone|mesh-list
20133576|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133577|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133578|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19614971|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
19614972|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19614973|NCT01933724|Hormones|hormones|mesh-ancestor
19614974|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19614975|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614976|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19614977|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614978|NCT01932125|Bevacizumab|bevacizumab|mesh-list
19614979|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19614980|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19614981|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19614982|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19614983|NCT01932125|Growth Substances|growth substances|mesh-ancestor
19614984|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614985|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
19614986|NCT01920932|Prednisone|prednisone|mesh-list
19614987|NCT01920932|Prednisolone|prednisolone|mesh-list
19614988|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
19614989|NCT01920932|Dacarbazine|dacarbazine|mesh-list
19614990|NCT01920932|Doxorubicin|doxorubicin|mesh-list
19614991|NCT01920932|Etoposide|etoposide|mesh-list
19614992|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19614993|NCT01920932|Imidazole|imidazole|mesh-list
19614994|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19614995|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
19614996|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19614997|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19614998|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19614999|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
19615000|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615001|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615002|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19615003|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19615004|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615005|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615006|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615007|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19615008|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
19615009|NCT01920932|Hormones|hormones|mesh-ancestor
19615010|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615011|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19615012|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615013|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615014|NCT01856478|Methotrexate|methotrexate|mesh-list
19615015|NCT01856478|Afatinib|afatinib|mesh-list
19615016|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19615017|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
19615018|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19615019|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615020|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615021|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
19615022|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615023|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615024|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19615025|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615026|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19615027|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133579|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20133580|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133581|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133582|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20133583|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
20133584|NCT00034775|Risperidone|risperidone|mesh-list
20133585|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20133586|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
20133587|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133588|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133589|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133590|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20133591|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20133592|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133593|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133594|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20133595|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
20133596|NCT00034788|Becaplermin|becaplermin|mesh-list
20133597|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
20133598|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20133599|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20133600|NCT00034788|Growth Substances|growth substances|mesh-ancestor
20133601|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133602|NCT00034801|Olanzapine|olanzapine|mesh-list
19615028|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
19615029|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615030|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19615031|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615032|NCT01844505|Nivolumab|nivolumab|mesh-list
19615033|NCT01844505|Ipilimumab|ipilimumab|mesh-list
19615034|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615035|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615036|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19615037|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615038|NCT01840592|Doxorubicin|doxorubicin|mesh-list
19615039|NCT01840592|Sorafenib|sorafenib|mesh-list
19615040|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19615041|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615042|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615043|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615044|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615045|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615046|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615047|NCT01757626|Molgramostim|molgramostim|mesh-list
19615048|NCT01757626|Sargramostim|sargramostim|mesh-list
19615049|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
19615050|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615051|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615052|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
19615053|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19615054|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
19615055|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615056|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19615057|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19615058|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
19615059|NCT01706939|Carboplatin|carboplatin|mesh-list
19615060|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615061|NCT01689519|Vemurafenib|vemurafenib|mesh-list
19615062|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615063|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615064|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133603|NCT00034801|Ziprasidone|ziprasidone|mesh-list
20133604|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
19615065|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615066|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
19615067|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19615068|NCT01682941|Estrogens|estrogens|mesh-ancestor
19615069|NCT01682941|Hormones|hormones|mesh-ancestor
19615070|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615071|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615072|NCT01628029|Melatonin|melatonin|mesh-list
19615073|NCT01628029|Methylphenidate|methylphenidate|mesh-list
19615074|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
19615075|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615076|NCT01628029|Protective Agents|protective agents|mesh-ancestor
19615077|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615078|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133605|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
20133606|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133607|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133608|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133609|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20133610|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20133611|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133612|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133613|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20133614|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20133615|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133616|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133617|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19615079|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19615080|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19615081|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19615082|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19615083|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
19615084|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19615085|NCT01622088|Pramipexole|pramipexole|mesh-list
19615086|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
19615087|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615088|NCT01622088|Protective Agents|protective agents|mesh-ancestor
19615089|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615090|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19615091|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19615092|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
19615093|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
19615094|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660034|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660035|NCT02972398|Antidotes|antidotes|mesh-ancestor
19660036|NCT02914470|Atezolizumab|atezolizumab|mesh-list
19660037|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660038|NCT02660710|Rituximab|rituximab|mesh-list
19660039|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660040|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660041|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
19660042|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660043|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660044|NCT02492711|Gemcitabine|gemcitabine|mesh-list
19660045|NCT02492711|Capecitabine|capecitabine|mesh-list
19660046|NCT02492711|Trastuzumab|trastuzumab|mesh-list
19660047|NCT02492711|Vinorelbine|vinorelbine|mesh-list
19660048|NCT02492711|Margetuximab|margetuximab|mesh-list
19660049|NCT02492711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19660050|NCT02492711|Antimetabolites|antimetabolites|mesh-ancestor
19660051|NCT02492711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660052|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660053|NCT02492711|Antiviral Agents|antiviral agents|mesh-ancestor
20133618|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
20133619|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20133620|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19660054|NCT02492711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660055|NCT02492711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660056|NCT02492711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133621|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
20133622|NCT00034840|Valsartan|valsartan|mesh-list
19615095|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
19615096|NCT01608451|Progesterone|progesterone|mesh-list
19615097|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19615098|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615099|NCT01608451|Vitamins|vitamins|mesh-ancestor
19615100|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
19615101|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19615102|NCT01608451|Progestins|progestins|mesh-ancestor
19615103|NCT01608451|Hormones|hormones|mesh-ancestor
19615104|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615105|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
19615106|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19615107|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19615108|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19615109|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19615110|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615111|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
19615112|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19615113|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615114|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19615115|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615116|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19615117|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615118|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615119|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615120|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19615121|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19615122|NCT01345175|Metronidazole|metronidazole|mesh-list
19615123|NCT01345175|Rifaximin|rifaximin|mesh-list
19615124|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19615125|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615126|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
19615127|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19615128|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19615129|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19615130|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19615131|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19615132|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615133|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615134|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
19615135|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133623|NCT00034840|Telmisartan|telmisartan|mesh-list
20133624|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20133625|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20133626|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20133627|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133628|NCT00034853|Naproxen|naproxen|mesh-list
20133629|NCT00034853|Meloxicam|meloxicam|mesh-list
20608343|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608344|NCT02245451|Analgesics|analgesics|mesh-ancestor
20608345|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
20608346|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133630|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20133631|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19615153|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
19615154|NCT01256398|Leucovorin|leucovorin|mesh-list
19615155|NCT01256398|Folic Acid|folic acid|mesh-list
19615156|NCT01256398|Cytarabine|cytarabine|mesh-list
19615157|NCT01256398|Dexamethasone|dexamethasone|mesh-list
19615158|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
19615159|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
19615160|NCT01256398|Melphalan|melphalan|mesh-list
19615161|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
19615162|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19615163|NCT01256398|Methotrexate|methotrexate|mesh-list
19615164|NCT01256398|Fludarabine|fludarabine|mesh-list
19615165|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
19615166|NCT01256398|Etoposide|etoposide|mesh-list
19615167|NCT01256398|Vincristine|vincristine|mesh-list
19615168|NCT01256398|Daunorubicin|daunorubicin|mesh-list
19615169|NCT01256398|Dasatinib|dasatinib|mesh-list
19615170|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
19615171|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
19615172|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
19615173|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20133632|NCT00034853|Analgesics|analgesics|mesh-ancestor
20133633|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
19615174|NCT01256398|Tacrolimus|tacrolimus|mesh-list
19615175|NCT01256398|Antibodies|antibodies|mesh-list
19615176|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
19615177|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19615178|NCT01256398|Lenograstim|lenograstim|mesh-list
19615179|NCT01256398|BB 1101|bb 1101|mesh-list
19615180|NCT01256398|Calcium|calcium|mesh-list
19615181|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
19615182|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615183|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
19615184|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615185|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615186|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19615187|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
19615188|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615189|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615190|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19615191|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19615192|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
19615193|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
19615194|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615195|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19615196|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
19615197|NCT01256398|Hormones|hormones|mesh-ancestor
19615198|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615199|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19615200|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
19615201|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615202|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19615203|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19615204|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19615205|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
19615206|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19615207|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615208|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
19615209|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
19615210|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19615211|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19615212|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615213|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615214|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615215|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
19615216|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615217|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19615218|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19615219|NCT01256398|Antidotes|antidotes|mesh-ancestor
19615220|NCT01256398|Protective Agents|protective agents|mesh-ancestor
20608347|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
19615221|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
19615222|NCT01256398|Vitamins|vitamins|mesh-ancestor
19615223|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
19615224|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615225|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
19615226|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615227|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19615228|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615229|NCT01256398|Hematinics|hematinics|mesh-ancestor
19615230|NCT01234532|Anastrozole|anastrozole|mesh-list
19615231|NCT01234532|Entinostat|entinostat|mesh-list
19615232|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19615233|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615234|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19615235|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19615236|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615237|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615238|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19615239|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
19615240|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615241|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615242|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19615243|NCT01217931|Bevacizumab|bevacizumab|mesh-list
19615244|NCT01217931|Everolimus|everolimus|mesh-list
19615245|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615246|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615247|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19615248|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19615249|NCT01217931|Growth Substances|growth substances|mesh-ancestor
19615250|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615251|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
19615252|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615253|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
19615254|NCT01196390|Paclitaxel|paclitaxel|mesh-list
19615255|NCT01196390|Carboplatin|carboplatin|mesh-list
19615256|NCT01196390|Trastuzumab|trastuzumab|mesh-list
19615257|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19615258|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19615259|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19615260|NCT01196390|Antibodies|antibodies|mesh-list
19615261|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
19615262|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19615263|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615264|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615265|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615266|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
19615267|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615268|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615269|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
19615270|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615271|NCT01154335|Everolimus|everolimus|mesh-list
19615272|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615273|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615274|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
19615275|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615276|NCT01145495|Rituximab|rituximab|mesh-list
19615277|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19615278|NCT01145495|Lenalidomide|lenalidomide|mesh-list
19615279|NCT01145495|Antibodies|antibodies|mesh-list
19615280|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
19615281|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19615282|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
19615283|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615284|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615285|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615286|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19615287|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19615288|NCT01145495|Growth Substances|growth substances|mesh-ancestor
19615289|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
19615290|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
19615291|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19615292|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615293|NCT01116648|Olaparib|olaparib|mesh-list
19615294|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19615295|NCT01116648|Cediranib|cediranib|mesh-list
19615296|NCT01116648|Maleic acid|maleic acid|mesh-list
19615297|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615298|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615299|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615300|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20133634|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133635|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133636|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20133637|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20133638|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
19615311|NCT01033032|Amrubicin|amrubicin|mesh-list
19615312|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615313|NCT01015833|Doxorubicin|doxorubicin|mesh-list
19615314|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19615315|NCT01015833|Sorafenib|sorafenib|mesh-list
19615316|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19615317|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615318|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615319|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615320|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615321|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615322|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615323|NCT00942331|Gemcitabine|gemcitabine|mesh-list
19615324|NCT00942331|Bevacizumab|bevacizumab|mesh-list
19615325|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19615326|NCT00942331|Cisplatin|cisplatin|mesh-list
19615327|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
19615328|NCT00942331|Antibodies|antibodies|mesh-list
19615329|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
19615330|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19615331|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
19615332|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615333|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19615334|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19615335|NCT00942331|Growth Substances|growth substances|mesh-ancestor
19615336|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615337|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
19615338|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
19615339|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615340|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
19615341|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615342|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
19615343|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615344|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615345|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615346|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
19615347|NCT00792948|Leucovorin|leucovorin|mesh-list
19615348|NCT00792948|Folic Acid|folic acid|mesh-list
20133639|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20133640|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133641|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133642|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20133643|NCT00034866|Tipranavir|tipranavir|mesh-list
20133644|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20133645|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
20133646|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20133647|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20133648|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
20133649|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615349|NCT00792948|Cytarabine|cytarabine|mesh-list
19615350|NCT00792948|Sirolimus|sirolimus|mesh-list
19615351|NCT00792948|Dexamethasone|dexamethasone|mesh-list
19615352|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
19615353|NCT00792948|Prednisone|prednisone|mesh-list
19615354|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
19615355|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19615356|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19615357|NCT00792948|Prednisolone|prednisolone|mesh-list
19615358|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
19615359|NCT00792948|Cortisone|cortisone|mesh-list
19615360|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
19615361|NCT00792948|Doxorubicin|doxorubicin|mesh-list
19615362|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19615363|NCT00792948|Methotrexate|methotrexate|mesh-list
19615364|NCT00792948|Etoposide|etoposide|mesh-list
19615365|NCT00792948|Vincristine|vincristine|mesh-list
19615366|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
20133650|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133651|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133652|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20133653|NCT00034879|Gefitinib|gefitinib|mesh-list
20133654|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133655|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20133656|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615367|NCT00792948|Dasatinib|dasatinib|mesh-list
19615368|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
19615369|NCT00792948|Tacrolimus|tacrolimus|mesh-list
19615370|NCT00792948|Lenograstim|lenograstim|mesh-list
19615371|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19615372|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
19615373|NCT00792948|BB 1101|bb 1101|mesh-list
19615374|NCT00792948|Calcium|calcium|mesh-list
19615375|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
19615376|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615377|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
19615378|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615379|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615380|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19615381|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
19615382|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615383|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615384|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19615385|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19615386|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
19615387|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
19615388|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615389|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19615390|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
19615391|NCT00792948|Hormones|hormones|mesh-ancestor
19615392|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615393|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19615394|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
19615395|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615396|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19615397|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615398|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615399|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19615400|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19615401|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19615402|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
20133657|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133658|NCT00034892|Olanzapine|olanzapine|mesh-list
20133659|NCT00034892|Risperidone|risperidone|mesh-list
20133660|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20133661|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
20133662|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133663|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615403|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19615404|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133664|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133665|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20133666|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20133667|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133668|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133669|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20133670|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
20133671|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
20133672|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
20133673|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615405|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
19615406|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
20133674|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133675|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20133676|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20133677|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133678|NCT00034905|Risperidone|risperidone|mesh-list
20133679|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20133680|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20133681|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
20133682|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133683|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133684|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133685|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20133686|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20133687|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133688|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133689|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20133690|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
20133691|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
20133692|NCT00034944|Aprepitant|aprepitant|mesh-list
20133693|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
20133694|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
20133695|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133696|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133697|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133698|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20133699|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133700|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133701|NCT00034983|Aprepitant|aprepitant|mesh-list
20133702|NCT00034983|Paroxetine|paroxetine|mesh-list
20133703|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19615407|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19615408|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19615409|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615410|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
19615411|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615412|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19615413|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19615414|NCT00792948|Antidotes|antidotes|mesh-ancestor
19615415|NCT00792948|Protective Agents|protective agents|mesh-ancestor
19615416|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
19615417|NCT00792948|Vitamins|vitamins|mesh-ancestor
19615418|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
19615419|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615420|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
19615421|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615422|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19615423|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
19615424|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19615425|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615426|NCT00792948|Hematinics|hematinics|mesh-ancestor
19615427|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
19615428|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
19615429|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20133704|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20133705|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133706|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133707|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133708|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
20133709|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133710|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20133711|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
20133712|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133713|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20133714|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133715|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133716|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
20133717|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
20133718|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133719|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133720|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20133721|NCT00035009|Aprepitant|aprepitant|mesh-list
20133722|NCT00035009|Paroxetine|paroxetine|mesh-list
20133723|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20133724|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19615430|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
19615431|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615432|NCT00775476|Expectorants|expectorants|mesh-ancestor
19615433|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
19615434|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19615435|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
19615436|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615437|NCT00775476|Protective Agents|protective agents|mesh-ancestor
19615438|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615439|NCT00775476|Antidotes|antidotes|mesh-ancestor
19615440|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19615441|NCT00769379|Trastuzumab|trastuzumab|mesh-list
19615442|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19615443|NCT00769379|Antibodies|antibodies|mesh-list
19615444|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
19615445|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19615446|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
19615447|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615448|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615449|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19615450|NCT00750698|Entinostat|entinostat|mesh-list
19615451|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615452|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615453|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615454|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615455|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19615456|NCT00655993|Simvastatin|simvastatin|mesh-list
19615457|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19615458|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19615459|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
19615460|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615461|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19615462|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19615463|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615464|NCT00608023|Tesamorelin|tesamorelin|mesh-list
19615465|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19615466|NCT00608023|Growth Substances|growth substances|mesh-ancestor
19615467|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615468|NCT00608023|Hormones|hormones|mesh-ancestor
19615469|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133725|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133726|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615470|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
19615471|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19615472|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
19615473|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19615474|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615475|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19615476|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19615477|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19615478|NCT00520767|Dexamethasone|dexamethasone|mesh-list
19615479|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
19615480|NCT00520767|Bortezomib|bortezomib|mesh-list
19615481|NCT00520767|Melphalan|melphalan|mesh-list
19615482|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19615483|NCT00520767|BB 1101|bb 1101|mesh-list
19615484|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19615485|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
19615486|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
19615487|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615488|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615489|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19615490|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
19615491|NCT00520767|Hormones|hormones|mesh-ancestor
19615492|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615493|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19615494|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615495|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
19615496|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615497|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133727|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133728|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
20133729|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615498|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19615499|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
19615500|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19615501|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615502|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
19615503|NCT00492050|Valacyclovir|valacyclovir|mesh-list
19615504|NCT00492050|Rituximab|rituximab|mesh-list
19615505|NCT00492050|Bortezomib|bortezomib|mesh-list
19615506|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615507|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615508|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
19615509|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615510|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615511|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
19615512|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615513|NCT00488072|Mirtazapine|mirtazapine|mesh-list
19615514|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
19615515|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19615516|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19615517|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
19615518|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
19615519|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19615520|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615521|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615522|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19615523|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19615524|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19615525|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19615526|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19615527|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19615528|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19615529|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19615530|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19615531|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
19615532|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19615533|NCT00456261|Gemcitabine|gemcitabine|mesh-list
19615534|NCT00456261|Bevacizumab|bevacizumab|mesh-list
19615535|NCT00456261|Carboplatin|carboplatin|mesh-list
19615536|NCT00456261|Pemetrexed|pemetrexed|mesh-list
19615537|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615538|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615539|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19615540|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19615541|NCT00456261|Growth Substances|growth substances|mesh-ancestor
19615542|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615543|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
19615544|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615545|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
19615546|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615547|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
19615548|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615549|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615550|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615551|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
19615552|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19615553|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19615554|NCT00362219|Morphine|morphine|mesh-list
19615555|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19615556|NCT00362219|Narcotics|narcotics|mesh-ancestor
19615557|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19615558|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133730|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20133731|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
20133732|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19615559|NCT00362219|Analgesics|analgesics|mesh-ancestor
19615560|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
19615561|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615562|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
19615563|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615564|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133733|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20133734|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133735|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133736|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
20133737|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
19615565|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19615566|NCT00215813|Poly I-C|poly i-c|mesh-list
19615567|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
19615568|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615569|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
19615570|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
19615571|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615572|NCT00127127|Vorinostat|vorinostat|mesh-list
19615573|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615574|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19615575|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615576|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615577|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19615578|NCT00110110|Cyclosporine|cyclosporine|mesh-list
19615579|NCT00110110|Carboplatin|carboplatin|mesh-list
19615580|NCT00110110|Etoposide|etoposide|mesh-list
19615581|NCT00110110|Vincristine|vincristine|mesh-list
19615582|NCT00110110|Cyclosporins|cyclosporins|mesh-list
19615583|NCT00110110|Lenograstim|lenograstim|mesh-list
19615584|NCT00110110|Sargramostim|sargramostim|mesh-list
19615585|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615586|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615587|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615588|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615589|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615590|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615591|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19615592|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
19615593|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615594|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615595|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19615596|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615597|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615598|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
19615599|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615600|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
19615601|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615602|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19615603|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
19615604|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
19615605|NCT00075387|Carboplatin|carboplatin|mesh-list
19615606|NCT00075387|Etoposide|etoposide|mesh-list
19615607|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
19615608|NCT00075387|Antidotes|antidotes|mesh-list
19615609|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615610|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
19615611|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615612|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615613|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19615614|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
19615615|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615616|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615617|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19615618|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615619|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615620|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615621|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615622|NCT00075387|Protective Agents|protective agents|mesh-ancestor
19615623|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
19615624|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
19615625|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19615626|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615627|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
19615628|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
19615629|NCT00061945|Leucovorin|leucovorin|mesh-list
19615630|NCT00061945|Cytarabine|cytarabine|mesh-list
19615631|NCT00061945|Acyclovir|acyclovir|mesh-list
19615632|NCT00061945|Trimethoprim|trimethoprim|mesh-list
19615633|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
19615634|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19615635|NCT00061945|Dexamethasone|dexamethasone|mesh-list
19615636|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
19615637|NCT00061945|Methotrexate|methotrexate|mesh-list
19615638|NCT00061945|Vincristine|vincristine|mesh-list
19615639|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
19615640|NCT00061945|Daunorubicin|daunorubicin|mesh-list
19615641|NCT00061945|Asparaginase|asparaginase|mesh-list
19615642|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
19615643|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
19615644|NCT00061945|Allopurinol|allopurinol|mesh-list
19615645|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
19615646|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615647|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
19615648|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615649|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615650|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19615651|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
19615652|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615653|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615654|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19615655|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19615656|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
19615657|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
19615658|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615659|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19615660|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
19615661|NCT00061945|Hormones|hormones|mesh-ancestor
19615662|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615663|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19615664|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19615665|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
19615666|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19615667|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615668|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
19615669|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
19615670|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615671|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19615672|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19615673|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
19615674|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615675|NCT00061945|Antidotes|antidotes|mesh-ancestor
19615676|NCT00061945|Protective Agents|protective agents|mesh-ancestor
19615677|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
19615678|NCT00061945|Vitamins|vitamins|mesh-ancestor
19615679|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
19615680|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615681|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615682|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
19615683|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615684|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615685|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19615686|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615687|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615688|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20133738|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133739|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133740|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20133741|NCT00035035|Gemcitabine|gemcitabine|mesh-list
20133742|NCT00035035|Pemetrexed|pemetrexed|mesh-list
20133743|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133744|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
20133745|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133746|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133747|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
20133748|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133749|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133750|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133751|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
20133752|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133753|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20133754|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133755|NCT00035048|Aprepitant|aprepitant|mesh-list
20133756|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
20133757|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
20133758|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133759|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133760|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19615689|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
19615690|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19615691|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
19615692|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19615693|NCT00061945|Renal Agents|renal agents|mesh-ancestor
19615694|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
20133761|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19615695|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19615696|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19615697|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19615698|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19615699|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19615700|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19615701|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
19615702|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19615703|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
19615704|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19615705|NCT00004494|Protective Agents|protective agents|mesh-ancestor
19615706|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615707|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19615708|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615709|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19615710|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
19615711|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615712|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19615713|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
19615714|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19615715|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615716|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19615717|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19615718|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19615719|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19615720|NCT04045665|Anticoagulants|anticoagulants|mesh-list
19615721|NCT04018612|Acetaminophen|acetaminophen|mesh-list
19615722|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19615723|NCT04018612|Analgesics|analgesics|mesh-ancestor
19615724|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
19615725|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615726|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615727|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
19615728|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
19615729|NCT03968393|Apixaban|apixaban|mesh-list
19615730|NCT03968393|Edoxaban|edoxaban|mesh-list
19615731|NCT03968393|Dabigatran|dabigatran|mesh-list
19615732|NCT03968393|Anticoagulants|anticoagulants|mesh-list
19615733|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19615734|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
19615735|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20133762|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133763|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133764|NCT00035061|Pemetrexed|pemetrexed|mesh-list
20133765|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615736|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
19615737|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615738|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615739|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
19615740|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615741|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615742|NCT03933215|Cladribine|cladribine|mesh-list
19615743|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615744|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615745|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
19615746|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660057|NCT02492711|Immunologic Factors|immunologic factors|mesh-ancestor
19660058|NCT02492711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660059|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660060|NCT02492711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19660061|NCT02492711|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660062|NCT02492711|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660063|NCT02492711|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660064|NCT02484716|Timolol|timolol|mesh-list
19660065|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19660066|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19660067|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
19660068|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660069|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660070|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660071|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19660072|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19660073|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19660074|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19660075|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19660076|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
19615747|NCT03904381|Fluorouracil|fluorouracil|mesh-list
19615748|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
19615749|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615750|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615751|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615752|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615753|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
19615754|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615755|NCT03876873|Anesthetics|anesthetics|mesh-list
19615756|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19615757|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615758|NCT03856437|Vaccines|vaccines|mesh-list
19615759|NCT03856437|Immunologic Factors|immunologic factors|mesh-ancestor
19615760|NCT03856437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615761|NCT03819660|Amifampridine|amifampridine|mesh-list
19615762|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19615763|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615764|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615765|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19615766|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19615767|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615768|NCT03810794|Donepezil|donepezil|mesh-list
19615769|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20133766|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133767|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133768|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20133769|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133770|NCT00035074|Methotrexate|methotrexate|mesh-list
20133771|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20133772|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
20133773|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20133774|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133775|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20133776|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
20133777|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615770|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615771|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615772|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
19615773|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19615774|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615775|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
19615776|NCT03800381|Rifampin|rifampin|mesh-list
19615777|NCT03800381|Isoniazid|isoniazid|mesh-list
19615778|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
19615779|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19615780|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
19615781|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19615782|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615783|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
19615784|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19615785|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615786|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615787|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19615788|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19615789|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19615790|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19615791|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19615792|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19615793|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19615794|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19615795|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
19615796|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19615797|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19615798|NCT03755973|Hormones|hormones|mesh-ancestor
19615799|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615800|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615801|NCT03747159|Belimumab|belimumab|mesh-list
19615802|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615803|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
19615804|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615805|NCT03732495|Denosumab|denosumab|mesh-list
20133778|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133779|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
20133780|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133781|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20133782|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133783|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
20133784|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20133785|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20133786|NCT00035087|Epothilones|epothilones|mesh-list
20133787|NCT00035087|Epothilone B|epothilone b|mesh-list
20133788|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133789|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133790|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133791|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133792|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133793|NCT00035100|Epothilones|epothilones|mesh-list
20133794|NCT00035100|Epothilone B|epothilone b|mesh-list
20133795|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133796|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133797|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133798|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133799|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133800|NCT00035113|Epothilones|epothilones|mesh-list
20133801|NCT00035113|Epothilone B|epothilone b|mesh-list
19615806|NCT03732495|Lenvatinib|lenvatinib|mesh-list
19615807|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615808|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615809|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615810|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615811|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19615812|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615813|NCT03728426|Letermovir|letermovir|mesh-list
19615814|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19615815|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615816|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615817|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615818|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
19615819|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615820|NCT03715166|Bumetanide|bumetanide|mesh-list
19615821|NCT03715166|Diuretics|diuretics|mesh-ancestor
19615822|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
19615823|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615824|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19615825|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19615826|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615827|NCT03680053|Cetrorelix|cetrorelix|mesh-list
19615828|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
19615829|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19615830|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
19615831|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19615832|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615833|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
19615834|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615835|NCT03680053|Progestins|progestins|mesh-ancestor
19615836|NCT03680053|Hormones|hormones|mesh-ancestor
19615837|NCT03666559|Azacitidine|azacitidine|mesh-list
19615838|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615839|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
19615840|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615841|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615842|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615843|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19615844|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19615845|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
19615846|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133802|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133803|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133804|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133805|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133806|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133807|NCT00035126|Epothilones|epothilones|mesh-list
20133808|NCT00035126|Epothilone B|epothilone b|mesh-list
20133809|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133810|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133811|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133812|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133813|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133814|NCT00035139|Methylphenidate|methylphenidate|mesh-list
19615847|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
19615848|NCT03636152|Chloroquine|chloroquine|mesh-list
19615849|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
19615850|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19615851|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19615852|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615853|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615854|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615855|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615856|NCT03636152|Amebicides|amebicides|mesh-ancestor
19615857|NCT03617523|Vaccines|vaccines|mesh-list
19615858|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
19615859|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615860|NCT03586284|Valganciclovir|valganciclovir|mesh-list
19615861|NCT03586284|Ganciclovir|ganciclovir|mesh-list
19615862|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19615863|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
19615864|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19615865|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19615866|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133815|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20133816|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133817|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20133818|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20133819|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19615867|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615868|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
19615869|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615870|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19615871|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615872|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133820|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133821|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
20133822|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133823|NCT00035152|Paclitaxel|paclitaxel|mesh-list
20133824|NCT00035152|Carboplatin|carboplatin|mesh-list
20133825|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133826|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133827|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133828|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133829|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133830|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133831|NCT00035165|Epothilones|epothilones|mesh-list
20133832|NCT00035165|Epothilone B|epothilone b|mesh-list
20133833|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133834|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133835|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615873|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
19615874|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615875|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615876|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19615877|NCT03563157|Leucovorin|leucovorin|mesh-list
19615878|NCT03563157|Paclitaxel|paclitaxel|mesh-list
19615879|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
19615880|NCT03563157|Fluorouracil|fluorouracil|mesh-list
19615881|NCT03563157|Capecitabine|capecitabine|mesh-list
19615882|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
19615883|NCT03563157|Cetuximab|cetuximab|mesh-list
19615884|NCT03563157|Avelumab|avelumab|mesh-list
19615885|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615886|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615887|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615888|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
19615889|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615890|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615891|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19615892|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
19615893|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615894|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615895|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19615896|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
19615897|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19615898|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
19615899|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19615900|NCT03563157|Antidotes|antidotes|mesh-ancestor
19615901|NCT03563157|Protective Agents|protective agents|mesh-ancestor
19615902|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
19615903|NCT03563157|Vitamins|vitamins|mesh-ancestor
19615904|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
19615905|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615906|NCT03546192|Vaccines|vaccines|mesh-list
19615907|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
19615908|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615909|NCT03528902|Tamoxifen|tamoxifen|mesh-list
19615910|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19615911|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
19615912|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615913|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615914|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19615915|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615916|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19615917|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19615918|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19615919|NCT03517449|Paclitaxel|paclitaxel|mesh-list
19615920|NCT03517449|Doxorubicin|doxorubicin|mesh-list
19615921|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
19615922|NCT03517449|Lenvatinib|lenvatinib|mesh-list
19615923|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615924|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615925|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615926|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
19615927|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615928|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615929|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19615930|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19615931|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19615932|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615933|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615934|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19615935|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19615936|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615937|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615938|NCT03490292|Paclitaxel|paclitaxel|mesh-list
19615939|NCT03490292|Carboplatin|carboplatin|mesh-list
19615940|NCT03490292|Avelumab|avelumab|mesh-list
19615941|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19615942|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615943|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615944|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133836|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133837|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133838|NCT00035178|Argatroban|argatroban|mesh-list
20133839|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
20133840|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20133841|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
20133842|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133843|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133844|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
20133845|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20133846|NCT00035191|Galantamine|galantamine|mesh-list
19615945|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
19615946|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615947|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615948|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
19615949|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19615950|NCT03480698|Protective Agents|protective agents|mesh-ancestor
19615951|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615952|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
19615953|NCT03474744|Rituximab|rituximab|mesh-list
19615954|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615955|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615956|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
19615957|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615958|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19615959|NCT03474094|Atezolizumab|atezolizumab|mesh-list
19615960|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19615961|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615962|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
19615963|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19615964|NCT03470922|Nivolumab|nivolumab|mesh-list
19615965|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19615966|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615967|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19615968|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615969|NCT03438318|Atezolizumab|atezolizumab|mesh-list
19615970|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660077|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660078|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19660079|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19660080|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660081|NCT05088330|Daratumumab|daratumumab|mesh-list
19660082|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660083|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19660084|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660085|NCT05088174|Cyclosporine|cyclosporine|mesh-list
19660086|NCT05088174|Cyclosporins|cyclosporins|mesh-list
19660087|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660088|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660089|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19660090|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
19660091|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660092|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
19660093|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660094|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
19660095|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660096|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19660097|NCT05088083|Paclitaxel|paclitaxel|mesh-list
19660098|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19660099|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660100|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660101|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660102|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660103|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133847|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20133848|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133849|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133850|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
20133851|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660104|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
19660105|NCT05088057|Docetaxel|docetaxel|mesh-list
19660106|NCT05088057|Doxorubicin|doxorubicin|mesh-list
19660107|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19660108|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
19660109|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660110|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660111|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19660112|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
19660113|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660114|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660115|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19660116|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660117|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660118|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660119|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19660120|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19660121|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19660122|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660123|NCT05087797|Nicorandil|nicorandil|mesh-list
19660124|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19660125|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19660126|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
19660127|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
19660128|NCT05087797|Vitamins|vitamins|mesh-ancestor
19660129|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
19660130|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660131|NCT05087706|Bicalutamide|bicalutamide|mesh-list
19660132|NCT05087706|Leuprolide|leuprolide|mesh-list
20133852|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133853|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20133854|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
19660133|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
19660134|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
19615971|NCT03387852|Fluticasone|fluticasone|mesh-list
20133855|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133856|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
20133857|NCT00035204|Galantamine|galantamine|mesh-list
20133858|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20133859|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19615972|NCT03387852|Xhance|xhance|mesh-list
19615973|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19615974|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19615975|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19615976|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19615977|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19615978|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
19615979|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19615980|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133860|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312471|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20312472|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
20312473|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
20133861|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
20133862|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133863|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133864|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20133865|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
20133866|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133867|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
20133868|NCT00035230|Topiramate|topiramate|mesh-list
20133869|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
20133870|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20312474|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312475|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312476|NCT00684216|Tamoxifen|tamoxifen|mesh-list
20312477|NCT00684216|Capecitabine|capecitabine|mesh-list
20312478|NCT00684216|Letrozole|letrozole|mesh-list
20312479|NCT00684216|Anastrozole|anastrozole|mesh-list
20312480|NCT00684216|Exemestane|exemestane|mesh-list
20312481|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20312482|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
20312483|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615981|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19615982|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
19615983|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
19615984|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19615985|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19615986|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20133871|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133872|NCT00035243|Epothilones|epothilones|mesh-list
20133873|NCT00035243|Epothilone B|epothilone b|mesh-list
20133874|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19615987|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19615988|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
19615989|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19615990|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19615991|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
19615992|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
19615993|NCT03387852|Hormones|hormones|mesh-ancestor
19615994|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19615995|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
19615996|NCT03387085|Leucovorin|leucovorin|mesh-list
19615997|NCT03387085|Paclitaxel|paclitaxel|mesh-list
19615998|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
20133875|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133876|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
20133877|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133878|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20133879|NCT00035256|Teriparatide|teriparatide|mesh-list
20133880|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20133881|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20133882|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133883|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20133884|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20312484|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19615999|NCT03387085|Bevacizumab|bevacizumab|mesh-list
19616000|NCT03387085|Fluorouracil|fluorouracil|mesh-list
20133885|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312485|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20312486|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20312487|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133886|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20133887|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20133888|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20133889|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20133890|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133891|NCT00035282|Aprepitant|aprepitant|mesh-list
20133892|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
20133893|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
20133894|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133895|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616001|NCT03387085|Capecitabine|capecitabine|mesh-list
19616002|NCT03387085|Avelumab|avelumab|mesh-list
19616003|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19616004|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616005|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
19616006|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
19616007|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
19616008|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616009|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616010|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
20133896|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133897|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20133898|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133899|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133900|NCT00035295|Aprepitant|aprepitant|mesh-list
20133901|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
20133902|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
20133903|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133904|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133905|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616011|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616012|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616013|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616014|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
19616015|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19616016|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616017|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19616018|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19616019|NCT03387085|Growth Substances|growth substances|mesh-ancestor
19616020|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
19616021|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
19616022|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616023|NCT03387085|Antidotes|antidotes|mesh-ancestor
19616024|NCT03387085|Protective Agents|protective agents|mesh-ancestor
19616025|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
19616026|NCT03387085|Vitamins|vitamins|mesh-ancestor
19616027|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
19616028|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
19616029|NCT03338972|Fludarabine|fludarabine|mesh-list
19616030|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616031|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
19616032|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616033|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616034|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616035|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
19616036|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616037|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616038|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19616039|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19616040|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19616041|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616042|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19616043|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19616044|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19616045|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616046|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
19616047|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616048|NCT03334318|Allopurinol|allopurinol|mesh-list
19616049|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
19616050|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616051|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616052|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
19616053|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616054|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19616055|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
19616056|NCT03334318|Protective Agents|protective agents|mesh-ancestor
19616057|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616058|NCT03308825|Vaccines|vaccines|mesh-list
19616059|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
19616060|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616061|NCT03292250|Durvalumab|durvalumab|mesh-list
19616062|NCT03292250|Tremelimumab|tremelimumab|mesh-list
20133906|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20133907|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133908|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133909|NCT00035308|Abetimus|abetimus|mesh-list
20133910|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20133911|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
20133912|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133913|NCT00035321|Olanzapine|olanzapine|mesh-list
20133914|NCT00035321|Fluoxetine|fluoxetine|mesh-list
20133915|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
20133916|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
20133917|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133918|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133919|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20133920|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20133921|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20133922|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20133923|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20133924|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20133925|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20133926|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133927|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133928|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133929|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
20133930|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20133931|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
20133932|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20133933|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133934|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133935|NCT00035347|Azithromycin|azithromycin|mesh-list
20133936|NCT00035347|Levofloxacin|levofloxacin|mesh-list
20133937|NCT00035347|Ofloxacin|ofloxacin|mesh-list
20133938|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
20133939|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20133940|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133941|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20133942|NCT00035347|Renal Agents|renal agents|mesh-ancestor
20312488|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20312489|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312490|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312491|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616063|NCT03292250|Nintedanib|nintedanib|mesh-list
20312492|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20312493|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20312494|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20312495|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20312496|NCT00684229|Anesthetics|anesthetics|mesh-list
20312497|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616064|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616065|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616066|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19616067|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616068|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616069|NCT03239340|Osimertinib|osimertinib|mesh-list
19616070|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616071|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19616072|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616073|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616074|NCT03224507|Dexamethasone|dexamethasone|mesh-list
19616075|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
19616076|NCT03224507|Lenalidomide|lenalidomide|mesh-list
20133943|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20133944|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19616077|NCT03224507|Daratumumab|daratumumab|mesh-list
19616078|NCT03224507|BB 1101|bb 1101|mesh-list
19616079|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19616080|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616081|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
19616082|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
19616083|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616084|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616085|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616086|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
19616087|NCT03224507|Hormones|hormones|mesh-ancestor
19616088|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616089|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616090|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616091|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
19616092|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616093|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616094|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
19616095|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19616096|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19616097|NCT03224507|Growth Substances|growth substances|mesh-ancestor
19616098|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
19616099|NCT03218085|Tenofovir|tenofovir|mesh-list
19616100|NCT03218085|Emtricitabine|emtricitabine|mesh-list
19616101|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
19616102|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616103|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20312498|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312499|NCT00684268|Silybin|silybin|mesh-list
20312500|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20133945|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133946|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133947|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312501|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312502|NCT00684268|Protective Agents|protective agents|mesh-ancestor
19616104|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19616105|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616106|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616107|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19616108|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19616109|NCT03123029|Venetoclax|venetoclax|mesh-list
19616110|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616111|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
19616112|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19616113|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
19616114|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616115|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
19616116|NCT03101163|Protective Agents|protective agents|mesh-ancestor
19616117|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
19616118|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616119|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616120|NCT03012581|Nivolumab|nivolumab|mesh-list
19616121|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616122|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616123|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19616124|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616125|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
19616126|NCT02981628|Leucovorin|leucovorin|mesh-list
19616127|NCT02981628|Folic Acid|folic acid|mesh-list
19616128|NCT02981628|Cytarabine|cytarabine|mesh-list
19616129|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
19616130|NCT02981628|Methotrexate|methotrexate|mesh-list
19616131|NCT02981628|Vincristine|vincristine|mesh-list
19616132|NCT02981628|Asparaginase|asparaginase|mesh-list
20133948|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20133949|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20133950|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20133951|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
20133952|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616133|NCT02981628|Mercaptopurine|mercaptopurine|mesh-list
19616134|NCT02981628|Pegaspargase|pegaspargase|mesh-list
19616135|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19616136|NCT02981628|Calcium|calcium|mesh-list
19616137|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
19616138|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616139|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
19616140|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616141|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616142|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616143|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
19616144|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616145|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616146|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19616147|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19616148|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19616149|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19616150|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
19616151|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19616152|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616153|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
19616154|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
19616155|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616156|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20133953|NCT00035425|Vancomycin|vancomycin|mesh-list
20133954|NCT00035425|Linezolid|linezolid|mesh-list
20133955|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20133956|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20133957|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20133958|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20133959|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133960|NCT00035451|Sotalol|sotalol|mesh-list
20133961|NCT00035451|Azimilide|azimilide|mesh-list
20133962|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20133963|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20133964|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
20133965|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20133966|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133967|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133968|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20133969|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
20133970|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
20133971|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20133972|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20133973|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133974|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20133975|NCT00035464|Azimilide|azimilide|mesh-list
20133976|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20133977|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20133978|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133979|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133980|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20133981|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133982|NCT00035477|Azimilide|azimilide|mesh-list
20133983|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20133984|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20133985|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20133986|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20133987|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20133988|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133989|NCT00035490|Azimilide|azimilide|mesh-list
20133990|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20133991|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20133992|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19616157|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19616158|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
19616159|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616160|NCT02981628|Antidotes|antidotes|mesh-ancestor
19616161|NCT02981628|Protective Agents|protective agents|mesh-ancestor
19616162|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
19616163|NCT02981628|Vitamins|vitamins|mesh-ancestor
19616164|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
19616165|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19616166|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
19616167|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
19616168|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
19616169|NCT02981628|Hematinics|hematinics|mesh-ancestor
19616170|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616171|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19616172|NCT02915302|Vaccines|vaccines|mesh-list
19616173|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
19665579|NCT04719065|Analgesics|analgesics|mesh-ancestor
20133993|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616174|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616175|NCT02914405|Nivolumab|nivolumab|mesh-list
19616176|NCT02914405|Dinutuximab|dinutuximab|mesh-list
19616177|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
19616178|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
19616179|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616180|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616181|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19616182|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616183|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
19616184|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616185|NCT02908269|Vaccines|vaccines|mesh-list
19616186|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
19616187|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616188|NCT02900664|Trametinib|trametinib|mesh-list
19616189|NCT02900664|Spartalizumab|spartalizumab|mesh-list
19616190|NCT02900664|Nazartinib|nazartinib|mesh-list
19616191|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616192|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19616193|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616194|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616195|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19616196|NCT02859012|Axitinib|axitinib|mesh-list
19616197|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616198|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19616199|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616200|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616201|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
19616202|NCT02807467|Propofol|propofol|mesh-list
19616203|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19616204|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616205|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616206|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19616207|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
19616208|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
19616209|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19616210|NCT02807467|Analgesics|analgesics|mesh-ancestor
19616211|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
19616212|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616213|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19616214|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19616215|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19616216|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
19616217|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616218|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616219|NCT02756897|Venetoclax|venetoclax|mesh-list
19616220|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616221|NCT02688790|Dalbavancin|dalbavancin|mesh-list
19616222|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19616223|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616224|NCT02617589|Nivolumab|nivolumab|mesh-list
19616225|NCT02617589|Temozolomide|temozolomide|mesh-list
19616226|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616227|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616228|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19616229|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749817|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749818|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749819|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749820|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749821|NCT04634604|Growth Substances|growth substances|mesh-ancestor
19749822|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749823|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749824|NCT04634578|Bevacizumab|bevacizumab|mesh-list
19616230|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616231|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
19616232|NCT02614859|Metformin|metformin|mesh-list
19616233|NCT02614859|Bicalutamide|bicalutamide|mesh-list
19616234|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19616235|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616236|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
19616237|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
19616238|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616239|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616240|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
19616241|NCT02614066|Fludarabine|fludarabine|mesh-list
19616242|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616243|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
19616244|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616245|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616246|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20608348|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
20608349|NCT02245464|Telmisartan|telmisartan|mesh-list
20608350|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20608351|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20608352|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20133994|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20133995|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20133996|NCT00035516|Epothilones|epothilones|mesh-list
20133997|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
20133998|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
20133999|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134000|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134001|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608353|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616247|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
19616248|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616249|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616250|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19616251|NCT02519348|Bevacizumab|bevacizumab|mesh-list
19616252|NCT02519348|Durvalumab|durvalumab|mesh-list
19616253|NCT02519348|Tremelimumab|tremelimumab|mesh-list
19616254|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616255|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616256|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19616257|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20134002|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20134003|NCT00035581|Poly I-C|poly i-c|mesh-list
20134004|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
20134005|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134006|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
20134007|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
20134008|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134009|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
20134010|NCT00035607|Hematinics|hematinics|mesh-ancestor
20134011|NCT00035620|Lenograstim|lenograstim|mesh-list
20134012|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20134013|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
20134014|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134015|NCT00035802|Topiramate|topiramate|mesh-list
20134016|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
20134017|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20134018|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134019|NCT00035854|Linezolid|linezolid|mesh-list
20134020|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19616258|NCT02519348|Growth Substances|growth substances|mesh-ancestor
20134021|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134022|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20134023|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608354|NCT02245477|Mitogens|mitogens|mesh-list
19616259|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616260|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
19616261|NCT02502747|Sargramostim|sargramostim|mesh-list
19616262|NCT02502747|Immunologic Factors|immunologic factors|mesh-ancestor
19616263|NCT02502747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616264|NCT02473276|Morphine|morphine|mesh-list
19616265|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19616266|NCT02473276|Narcotics|narcotics|mesh-ancestor
19616267|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616268|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616269|NCT02473276|Analgesics|analgesics|mesh-ancestor
19616270|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
19616271|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616272|NCT02457702|Glycerol|glycerol|mesh-list
19616273|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20134024|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134025|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20134026|NCT00035893|Poly I-C|poly i-c|mesh-list
20134027|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
20134028|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616274|NCT02457702|Protective Agents|protective agents|mesh-ancestor
19616275|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616276|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
19616277|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19616278|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
19616279|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616280|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
19616281|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616282|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19616283|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
19616284|NCT02309645|Coagulants|coagulants|mesh-ancestor
19616285|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
19616286|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
19616287|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616288|NCT02286414|Vitamins|vitamins|mesh-list
19616289|NCT02286414|Vitamin K|vitamin k|mesh-list
19616290|NCT02286414|Warfarin|warfarin|mesh-list
19616291|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
20134029|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
20134030|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
20134031|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134032|NCT00035958|Prednisone|prednisone|mesh-list
20134033|NCT00035958|Etanercept|etanercept|mesh-list
20134034|NCT00035958|Methotrexate|methotrexate|mesh-list
20134035|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134036|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
20134037|NCT00035958|Hormones|hormones|mesh-ancestor
20134038|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616292|NCT02286414|Dabigatran|dabigatran|mesh-list
19616293|NCT02286414|Apixaban|apixaban|mesh-list
19616294|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
19616295|NCT02286414|Fluindione|fluindione|mesh-list
19616296|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
19616297|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616298|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
19616299|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19616300|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
19616301|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19616302|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
19616303|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616304|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616305|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19616306|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19616307|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
19616308|NCT02286414|Coagulants|coagulants|mesh-ancestor
19616309|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
19616310|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616311|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616312|NCT02258659|Paclitaxel|paclitaxel|mesh-list
19616313|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20134039|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134040|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616314|NCT02258659|Carboplatin|carboplatin|mesh-list
19616315|NCT02258659|Fluorouracil|fluorouracil|mesh-list
19616316|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
19616317|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19616318|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616319|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
19616320|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
19616321|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134041|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616322|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616323|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
19616324|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616325|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616326|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
19616327|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616328|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
19616329|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616330|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19616331|NCT02143388|Cisplatin|cisplatin|mesh-list
19616332|NCT02143388|Capecitabine|capecitabine|mesh-list
19616333|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616334|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616335|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
19616336|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616337|NCT02111850|Aldesleukin|aldesleukin|mesh-list
19616338|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
19616339|NCT02111850|Fludarabine|fludarabine|mesh-list
19616340|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616341|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
19616342|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616343|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616344|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616345|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
19616346|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616347|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616348|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19616349|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19616350|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19616351|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
19616352|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660135|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660136|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660137|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660138|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19660139|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
19660140|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19660141|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660142|NCT05087693|Albuterol|albuterol|mesh-list
19660143|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19660144|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
19660145|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660146|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660147|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19660148|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
19660149|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
19660150|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19660151|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19660152|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19660153|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19660154|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
19660155|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660156|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660157|NCT05087368|Vaccines|vaccines|mesh-list
19660158|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
19660159|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660160|NCT05087134|Choline|choline|mesh-list
19660161|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
19660162|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19256585|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19660163|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
19660164|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660165|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660166|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19660167|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
19665580|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
19665581|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665582|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665583|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665584|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19665585|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19665586|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665587|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134042|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20134043|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
20134044|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20134045|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134046|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
20134047|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134048|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134049|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134050|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20134051|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134052|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
19256586|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616353|NCT02049905|Gemcitabine|gemcitabine|mesh-list
19616354|NCT02049905|Docetaxel|docetaxel|mesh-list
19616355|NCT02049905|Doxorubicin|doxorubicin|mesh-list
19616356|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19616357|NCT02049905|Ifosfamide|ifosfamide|mesh-list
19616358|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
19616359|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616360|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
19616361|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616362|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616363|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
19616364|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616365|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616366|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616367|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
19616368|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616369|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
19616370|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
19616371|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
19616372|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19616373|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19616374|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19616375|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616376|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
19616377|NCT01472562|Rituximab|rituximab|mesh-list
19616378|NCT01472562|Lenalidomide|lenalidomide|mesh-list
19616379|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616380|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616381|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
19616382|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616383|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616384|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19616385|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19616386|NCT01472562|Growth Substances|growth substances|mesh-ancestor
19616387|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
19616388|NCT01362998|Fentanyl|fentanyl|mesh-list
19616389|NCT01362998|Morphine|morphine|mesh-list
19616390|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19616391|NCT01362998|Narcotics|narcotics|mesh-ancestor
19616392|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616393|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616394|NCT01362998|Analgesics|analgesics|mesh-ancestor
19616395|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
19616396|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616397|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19616398|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19616399|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
19616400|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
19616401|NCT01302327|Exenatide|exenatide|mesh-list
19616402|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19616403|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616404|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19616405|NCT01302327|Incretins|incretins|mesh-ancestor
19616406|NCT01302327|Hormones|hormones|mesh-ancestor
19616407|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616408|NCT01259648|Remifentanil|remifentanil|mesh-list
19616409|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19616410|NCT01259648|Narcotics|narcotics|mesh-ancestor
19616411|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616412|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616413|NCT01259648|Analgesics|analgesics|mesh-ancestor
19616414|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
20134053|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616415|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616416|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
19616417|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616418|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
19616419|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616420|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616421|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616422|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
19616423|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616424|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616425|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19616426|NCT00819546|Everolimus|everolimus|mesh-list
19616427|NCT00819546|Midostaurin|midostaurin|mesh-list
19616428|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616429|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616430|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
19616431|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616432|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20134054|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134055|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20134056|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20134057|NCT00035958|Analgesics|analgesics|mesh-ancestor
20134058|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
20134059|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134060|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134061|NCT00035971|Alendronate|alendronate|mesh-list
19616433|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616434|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616435|NCT00762554|Fentanyl|fentanyl|mesh-list
19616436|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19616437|NCT00762554|Narcotics|narcotics|mesh-ancestor
19616438|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616439|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616440|NCT00762554|Analgesics|analgesics|mesh-ancestor
19616441|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
19616442|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616443|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19616444|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19616445|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
19616446|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
19616447|NCT00590187|Sapacitabine|sapacitabine|mesh-list
19616448|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616449|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
19616450|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616451|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19616452|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
19616453|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616454|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
19616455|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616456|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616457|NCT02535104|Ranpirnase|ranpirnase|mesh-list
19616458|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616459|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19616460|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616461|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616462|NCT02535130|Amikacin|amikacin|mesh-list
19616463|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19616464|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616465|NCT02534961|Cefazolin|cefazolin|mesh-list
19616466|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19616467|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616468|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
19616469|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19616470|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19616471|NCT02535039|Prednisolone|prednisolone|mesh-list
19616472|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
19616473|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19616474|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
19616475|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616476|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
19616477|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
19616478|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616479|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616480|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616481|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
19616482|NCT02535039|Hormones|hormones|mesh-ancestor
19660168|NCT05086848|Leucovorin|leucovorin|mesh-list
20134062|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19616483|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134063|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20134064|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134065|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20134066|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
19616484|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19616485|NCT02535039|Protective Agents|protective agents|mesh-ancestor
19616486|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616487|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616488|NCT02534870|Ritonavir|ritonavir|mesh-list
19616489|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19616490|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19616491|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
19616492|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616493|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616494|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19616495|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19616496|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
19616497|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616498|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19616499|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19616500|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
19616501|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
19616502|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616503|NCT02534753|Protective Agents|protective agents|mesh-ancestor
19616504|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616505|NCT02534753|Vitamins|vitamins|mesh-ancestor
19616506|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
19616507|NCT02534571|Epinephrine|epinephrine|mesh-list
19616508|NCT02534571|Hemostatics|hemostatics|mesh-list
19616509|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19616510|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19616511|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
20134067|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134068|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19616512|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616513|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616514|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616515|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19616516|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19616517|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
19616518|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616519|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19616520|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
19616521|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
19616522|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
19616523|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19616524|NCT02534571|Coagulants|coagulants|mesh-ancestor
19616525|NCT02534506|Nivolumab|nivolumab|mesh-list
19616526|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616527|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616528|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19616529|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616530|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
19616531|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19616532|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
19616533|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616534|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
19616535|NCT02534415|Protective Agents|protective agents|mesh-ancestor
19616536|NCT02534610|Etoricoxib|etoricoxib|mesh-list
19616537|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19616538|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19616539|NCT02534610|Analgesics|analgesics|mesh-ancestor
19616540|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
19616541|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616542|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616543|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616544|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616545|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19616546|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19616547|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616548|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616549|NCT02534363|Aripiprazole|aripiprazole|mesh-list
19616550|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19616551|NCT02534363|Ziprasidone|ziprasidone|mesh-list
19616552|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
19616553|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19616554|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19616555|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19616556|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616557|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616558|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
19616559|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
19616560|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616561|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616562|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19616563|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19616564|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
19616565|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19616566|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19616567|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19616568|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19616569|NCT02534376|Simvastatin|simvastatin|mesh-list
19616570|NCT02534376|Ezetimibe|ezetimibe|mesh-list
19616571|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19616572|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19616573|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
19616574|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616575|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19616576|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19616577|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616578|NCT02534636|Interferons|interferons|mesh-list
19616579|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
19616580|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
20134069|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20134070|NCT00035984|Exenatide|exenatide|mesh-list
20134071|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20134072|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134073|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19616581|NCT02534636|BMS-986165|bms-986165|mesh-list
19616582|NCT02534636|Famotidine|famotidine|mesh-list
19616583|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616584|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
19616585|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616586|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
19616587|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616588|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19616589|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616590|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19616591|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
19616592|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
19616593|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616594|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616595|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
19616596|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19616597|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616598|NCT02534467|Montelukast|montelukast|mesh-list
19616599|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19616600|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
19616601|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19616602|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
19616603|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616604|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616605|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19616606|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19616607|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616608|NCT02534337|Leucovorin|leucovorin|mesh-list
19616609|NCT02534337|Gemcitabine|gemcitabine|mesh-list
19616610|NCT02534337|Fluorouracil|fluorouracil|mesh-list
19616611|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
19616612|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616613|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
19616614|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616615|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616616|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
19616617|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134074|NCT00035984|Incretins|incretins|mesh-ancestor
19616618|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616619|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616620|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
19616621|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616622|NCT02534337|Antidotes|antidotes|mesh-ancestor
19616623|NCT02534337|Protective Agents|protective agents|mesh-ancestor
19616624|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
19616625|NCT02534337|Vitamins|vitamins|mesh-ancestor
19616626|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
19616627|NCT02534623|Fentanyl|fentanyl|mesh-list
19616628|NCT02534623|Bupivacaine|bupivacaine|mesh-list
19616629|NCT02534623|Anesthetics|anesthetics|mesh-list
19616630|NCT02534623|Propofol|propofol|mesh-list
19616631|NCT02534623|Sevoflurane|sevoflurane|mesh-list
19616632|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
19616633|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616634|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616635|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
19616636|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616637|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19616638|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19616639|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
19616640|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19616641|NCT02534623|Narcotics|narcotics|mesh-ancestor
19616642|NCT02534623|Analgesics|analgesics|mesh-ancestor
19616643|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19616644|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19616645|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19616646|NCT02534454|Nicotine|nicotine|mesh-list
19616647|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19616648|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
19616649|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616650|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616651|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19616652|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19616653|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
19616654|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134075|NCT00035984|Hormones|hormones|mesh-ancestor
20134076|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134077|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
20134078|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20134079|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134080|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
20134081|NCT00036023|Hematinics|hematinics|mesh-ancestor
20134082|NCT00036062|Sivelestat|sivelestat|mesh-list
20134083|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20134084|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
20134085|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134086|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134087|NCT00036088|Olanzapine|olanzapine|mesh-list
20134088|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
20134089|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
20134090|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134091|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134092|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134093|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20134094|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20134095|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20134096|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134097|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20134098|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19616655|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616656|NCT02534402|Prednisone|prednisone|mesh-list
19616657|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616658|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
19616659|NCT02534402|Hormones|hormones|mesh-ancestor
19616660|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616661|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616662|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616663|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660169|NCT05086848|Fluorouracil|fluorouracil|mesh-list
19660170|NCT05086848|Irinotecan|irinotecan|mesh-list
19660171|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
20134099|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20134100|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660172|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616664|NCT02533908|Fentanyl|fentanyl|mesh-list
19616665|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19616666|NCT02533908|Narcotics|narcotics|mesh-ancestor
19616667|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616668|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616669|NCT02533908|Analgesics|analgesics|mesh-ancestor
19616670|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
19616671|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616672|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19616673|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19616674|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
19616675|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
19616676|NCT02533973|Calcipotriene|calcipotriene|mesh-list
19616677|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
19616678|NCT02533791|Vaccines|vaccines|mesh-list
19616679|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
20134101|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134102|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
19616680|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616681|NCT02533648|Allopurinol|allopurinol|mesh-list
19616682|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
19616683|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616684|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616685|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
19616686|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616687|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19616688|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
19616689|NCT02533648|Protective Agents|protective agents|mesh-ancestor
19616690|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616691|NCT02533440|Anesthetics|anesthetics|mesh-list
19616692|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
19616693|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616694|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616695|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
19616696|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616697|NCT02533765|Olaparib|olaparib|mesh-list
19616698|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19616699|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134103|NCT00036101|Aripiprazole|aripiprazole|mesh-list
20134104|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134105|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134106|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20134107|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20134108|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20134109|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134110|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
19616700|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616701|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616702|NCT02533557|Lidocaine|lidocaine|mesh-list
19616703|NCT02533557|Epinephrine|epinephrine|mesh-list
19616704|NCT02533557|Racepinephrine|racepinephrine|mesh-list
19616705|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
19616706|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
19616707|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
19616708|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616709|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616710|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
19616711|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616712|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19616713|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19616714|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19616715|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19616716|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616717|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19616718|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19616719|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
19616720|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616721|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19616722|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19616723|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
19616724|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19616725|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
19616726|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
19616727|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
20608355|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
19616728|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19616729|NCT02533544|Tenofovir|tenofovir|mesh-list
19616730|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
19616731|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616732|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19616733|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19616734|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616735|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616736|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19616737|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19616738|NCT02533492|Triclosan|triclosan|mesh-list
19616739|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19616740|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616741|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19616742|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19616743|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
19616744|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616745|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19616746|NCT02533323|Gemcitabine|gemcitabine|mesh-list
19616747|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
19616748|NCT02533323|Pegaspargase|pegaspargase|mesh-list
19616749|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616750|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
19616751|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616752|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616753|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
19616754|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616755|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616756|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616757|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
19616758|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616759|NCT02533336|Abamectin|abamectin|mesh-list
19616760|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
19616761|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19616762|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616763|NCT02533349|Pantoprazole|pantoprazole|mesh-list
19616764|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19616765|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616766|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19616767|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616768|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616769|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
19616770|NCT02533284|Analgesics|analgesics|mesh-ancestor
19616771|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
19616772|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616773|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616774|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
19616775|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616776|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19616777|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
19616778|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19616779|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19616780|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616781|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19616782|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
19616783|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19616784|NCT02533141|Simvastatin|simvastatin|mesh-list
19616785|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19616786|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20134111|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
20134112|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134113|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134114|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20134115|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20134116|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
20134117|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19616787|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
19616788|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616789|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19616790|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19616791|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134118|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20134119|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19616792|NCT02533011|Heparin|heparin|mesh-list
19616793|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
19616794|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19616795|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19616796|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616797|NCT02533076|Capsaicin|capsaicin|mesh-list
19616798|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
19616799|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
19616800|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
19616801|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616802|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616803|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19616804|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
19616805|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616806|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616807|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616808|NCT02532660|Dexetimide|dexetimide|mesh-list
19616809|NCT02532660|Citalopram|citalopram|mesh-list
19616810|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19616811|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19616812|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19616813|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616814|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616815|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
19616816|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616817|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19616818|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
19616819|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19616820|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19616821|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19616822|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
19616823|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
19616824|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616825|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19616826|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19616827|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
19616828|NCT02532790|Prednisone|prednisone|mesh-list
19616829|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616830|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
19616831|NCT02532790|Hormones|hormones|mesh-ancestor
19616832|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616833|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616834|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616835|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134120|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20134121|NCT00036114|Aripiprazole|aripiprazole|mesh-list
20134122|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134123|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134124|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20134125|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20134126|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616836|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
19616837|NCT02532777|Prednisone|prednisone|mesh-list
19616838|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
19616839|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
19616840|NCT02532777|Leflunomide|leflunomide|mesh-list
19616841|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19616842|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19616843|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19616844|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
19616845|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134127|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134128|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
20134129|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
20134130|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134131|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134132|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20134133|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20134134|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
20134135|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20134136|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20134137|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20134138|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19616846|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616847|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19616848|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
19616849|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616850|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616851|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19616852|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616853|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
19616854|NCT02532777|Hormones|hormones|mesh-ancestor
19616855|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616856|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616857|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19616858|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19616859|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
19616860|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19616861|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616862|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
19616863|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
19616864|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616865|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616866|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19616867|NCT02532777|Protective Agents|protective agents|mesh-ancestor
19616868|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
19616869|NCT02532413|Entecavir|entecavir|mesh-list
19616870|NCT02532413|Poly I-C|poly i-c|mesh-list
19616871|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
19616872|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616873|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
19616874|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
19616875|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134139|NCT00036127|Aripiprazole|aripiprazole|mesh-list
20134140|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134141|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134142|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20134143|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20134144|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616876|NCT02532634|Dexamethasone|dexamethasone|mesh-list
19616877|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
19616878|NCT02532634|Aprepitant|aprepitant|mesh-list
19616879|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
19616880|NCT02532634|Palonosetron|palonosetron|mesh-list
19616881|NCT02532634|Ramosetron|ramosetron|mesh-list
19616882|NCT02532634|BB 1101|bb 1101|mesh-list
19616883|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616884|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
19616885|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
19616886|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616887|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616888|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616889|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
19616890|NCT02532634|Hormones|hormones|mesh-ancestor
19616891|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616892|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616893|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616894|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
19616895|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616896|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616897|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19616898|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616899|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20134145|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134146|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
20134147|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
20134148|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134149|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134150|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20134151|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20134152|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
20134153|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20134154|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20134155|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20134156|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20134157|NCT00036153|Methotrexate|methotrexate|mesh-list
20134158|NCT00036153|Tacrolimus|tacrolimus|mesh-list
19616900|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19616901|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
19616902|NCT02532400|Goserelin|goserelin|mesh-list
19616903|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616904|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134159|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20134160|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
20134161|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20134162|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616905|NCT02532491|Risperidone|risperidone|mesh-list
19616906|NCT02532491|Aripiprazole|aripiprazole|mesh-list
19616907|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19616908|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
19616909|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616910|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616911|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616912|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19616913|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19616914|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19616915|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19616916|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19616917|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
19616918|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
19616919|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
19616920|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19616921|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19616922|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19616923|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19660173|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19660174|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660175|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19660176|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
19660177|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660178|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19660179|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19660180|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660181|NCT05086848|Antidotes|antidotes|mesh-ancestor
19660182|NCT05086848|Protective Agents|protective agents|mesh-ancestor
19660183|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
19660184|NCT05086848|Vitamins|vitamins|mesh-ancestor
20134163|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134164|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
20134165|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134166|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134167|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134168|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134169|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20134170|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134171|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
20134172|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134173|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134174|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20134175|NCT00036166|Micafungin|micafungin|mesh-list
20134176|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
20134177|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134178|NCT00036179|Micafungin|micafungin|mesh-list
20134179|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
20134180|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134181|NCT00036218|Ropinirole|ropinirole|mesh-list
20312503|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312504|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19660185|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
19660186|NCT05086822|Irinotecan|irinotecan|mesh-list
19660187|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19660188|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19660189|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660190|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660191|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660192|NCT05086627|Capecitabine|capecitabine|mesh-list
19660193|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
19660194|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19660195|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
19660196|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660197|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660198|NCT05086614|Thymalfasin|thymalfasin|mesh-list
20134182|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20134183|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19660199|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20312505|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19616924|NCT02532569|Vaccines|vaccines|mesh-list
19616925|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
19616926|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616927|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19616928|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19616929|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19616930|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
19616931|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616932|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19616933|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19616934|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19616935|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19616936|NCT02532335|Cathartics|cathartics|mesh-ancestor
19616937|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616938|NCT02532114|Niclosamide|niclosamide|mesh-list
19616939|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
19616940|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19616941|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
19616942|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19616943|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616944|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
20134184|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
20134185|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
20134186|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616945|NCT02532270|Phenylephrine|phenylephrine|mesh-list
19616946|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
19616947|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19616948|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
19616949|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
19616950|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19616951|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616952|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
19616953|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19616954|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
19616955|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
19616956|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19616957|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19616958|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19616959|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
19616960|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19616961|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19616962|NCT02532270|Protective Agents|protective agents|mesh-ancestor
19616963|NCT02532062|Vitamin D|vitamin d|mesh-list
19616964|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
19616965|NCT02532062|Vitamins|vitamins|mesh-ancestor
19616966|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
19616967|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616968|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19616969|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19616970|NCT02531984|Azithromycin|azithromycin|mesh-list
19616971|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19616972|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616973|NCT02532140|Cefepime|cefepime|mesh-list
19616974|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19616975|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19616976|NCT02532192|Cytarabine|cytarabine|mesh-list
19616977|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
19616978|NCT02532192|Fluconazole|fluconazole|mesh-list
19616979|NCT02532192|Dexamethasone|dexamethasone|mesh-list
19616980|NCT02532192|Cisplatin|cisplatin|mesh-list
19616981|NCT02532192|Rituximab|rituximab|mesh-list
19616982|NCT02532192|Belinostat|belinostat|mesh-list
19616983|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19616984|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19616985|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
19616986|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616987|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19616988|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19616989|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
20134187|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134188|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134189|NCT00036231|Secretin|secretin|mesh-list
20134190|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134191|NCT00036231|Hormones|hormones|mesh-ancestor
20134192|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134193|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19616990|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
19616991|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134194|NCT00036244|Secretin|secretin|mesh-list
20134195|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134196|NCT00036244|Hormones|hormones|mesh-ancestor
20134197|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134198|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134199|NCT00036283|Celecoxib|celecoxib|mesh-list
19616992|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19616993|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
19616994|NCT02532192|Hormones|hormones|mesh-ancestor
19616995|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19616996|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19616997|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19616998|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
19616999|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617000|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
19617001|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617002|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617003|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19617004|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19617005|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617006|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312506|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312507|NCT00684372|Leflunomide|leflunomide|mesh-list
20312508|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312509|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312510|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312511|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
20312512|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312513|NCT00684385|Gefitinib|gefitinib|mesh-list
20312514|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312515|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20312516|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312517|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312518|NCT00684450|Protamines|protamines|mesh-list
20312519|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
20312520|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312521|NCT00684450|Coagulants|coagulants|mesh-ancestor
20312522|NCT00684463|Palonosetron|palonosetron|mesh-list
19617007|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19617008|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19749825|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749826|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617009|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
19617010|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19617011|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19617012|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
19617013|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19749827|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19749828|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19749829|NCT04634578|Growth Substances|growth substances|mesh-ancestor
19749830|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749831|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
19749832|NCT04632992|Paclitaxel|paclitaxel|mesh-list
19749833|NCT04632992|Maytansine|maytansine|mesh-list
19749834|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19749835|NCT04632992|Trastuzumab|trastuzumab|mesh-list
19749836|NCT04632992|Atezolizumab|atezolizumab|mesh-list
19749837|NCT04632992|Pertuzumab|pertuzumab|mesh-list
19749838|NCT04632992|Tucatinib|tucatinib|mesh-list
19749839|NCT04632992|Pralsetinib|pralsetinib|mesh-list
19749840|NCT04632992|Entrectinib|entrectinib|mesh-list
19749841|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19749842|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749843|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749844|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19749845|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19749846|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749847|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20134200|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20134201|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20134202|NCT00036283|Analgesics|analgesics|mesh-ancestor
20134203|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
20134204|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749848|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20312523|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
20312524|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
20312525|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312526|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617014|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19617015|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19617016|NCT02532153|Ketamine|ketamine|mesh-list
19617017|NCT02532153|Analgesics|analgesics|mesh-ancestor
19617018|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
19617019|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617020|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312527|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20312528|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20312529|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20312530|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
20312531|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347260|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19617021|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19617022|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19617023|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
19617024|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
19617025|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20134205|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134206|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134207|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134208|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20134209|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20134210|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134211|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134212|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20134213|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20134214|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20134215|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20134216|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134217|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134218|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134219|NCT00036309|Analgesics|analgesics|mesh-ancestor
20134220|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
20134221|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134222|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134223|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134224|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
20134225|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20134226|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20134227|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20134228|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20134229|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134230|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134231|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134232|NCT00036335|Analgesics|analgesics|mesh-ancestor
20134233|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
20134234|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134235|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134236|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20608356|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134237|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
20134238|NCT00036348|Aripiprazole|aripiprazole|mesh-list
20134239|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134240|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134241|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20134242|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20134243|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20134244|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134245|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
19617026|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19617027|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19617028|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617029|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617030|NCT02532322|Acetaminophen|acetaminophen|mesh-list
19617031|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617032|NCT02532322|Analgesics|analgesics|mesh-ancestor
19617033|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
19617034|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617035|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617036|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
19617037|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19617038|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617039|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617040|NCT02532023|Curcumin|curcumin|mesh-list
19617041|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19617042|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617043|NCT02532023|Analgesics|analgesics|mesh-ancestor
19617044|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
19617045|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617046|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617047|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617048|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617049|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617050|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617051|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617052|NCT02531906|Oxycodone|oxycodone|mesh-list
19617053|NCT02531906|Methadone|methadone|mesh-list
19617054|NCT02531906|Gabapentin|gabapentin|mesh-list
19617055|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19617056|NCT02531906|Narcotics|narcotics|mesh-ancestor
19617057|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617058|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617059|NCT02531906|Analgesics|analgesics|mesh-ancestor
20134246|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
20134247|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134248|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134249|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20134250|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19617060|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
19617061|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617062|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
19617063|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19617064|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19617065|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19617066|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19617067|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19617068|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617069|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617070|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
19617071|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
19617072|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
19617073|NCT02531854|Pemetrexed|pemetrexed|mesh-list
19617074|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617075|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617076|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617077|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19617078|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19617079|NCT02531490|Labetalol|labetalol|mesh-list
19617080|NCT02531490|Methyldopa|methyldopa|mesh-list
19617081|NCT02531490|Nifedipine|nifedipine|mesh-list
19617082|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19617083|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19617084|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617085|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19617086|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617087|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
19617088|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
19617089|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19617090|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19617091|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19617092|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19617093|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617094|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19617095|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
19617096|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
20134251|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
20134252|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20134253|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20134254|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20134255|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20134256|NCT00036361|Aripiprazole|aripiprazole|mesh-list
19617097|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617098|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19617099|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19617100|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
19617101|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19617102|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19617103|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19617104|NCT02531581|Furosemide|furosemide|mesh-list
19617105|NCT02531581|Diuretics|diuretics|mesh-list
19617106|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
19617107|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617108|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19617109|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19617110|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617111|NCT02531672|Choline|choline|mesh-list
19617112|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
19617113|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19617114|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
19617115|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617116|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19617117|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19617118|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
19617119|NCT02531568|Warfarin|warfarin|mesh-list
19617120|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
19617121|NCT02531451|Aspirin|aspirin|mesh-list
19617122|NCT02531451|Ibuprofen|ibuprofen|mesh-list
19617123|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19617124|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617125|NCT02531451|Analgesics|analgesics|mesh-ancestor
19617126|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
19617127|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617128|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617129|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617130|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617131|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19617132|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617133|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617134|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19617135|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19617136|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20134257|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134258|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134259|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20134260|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20134261|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20134262|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134263|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
20134264|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
20134265|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134266|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134267|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20134268|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20134269|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
20134270|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19617137|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
19617138|NCT02531529|Fentanyl|fentanyl|mesh-list
19617139|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19617140|NCT02531529|Narcotics|narcotics|mesh-ancestor
19617141|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617142|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617143|NCT02531529|Analgesics|analgesics|mesh-ancestor
19617144|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
19617145|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617146|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19617147|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19617148|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
19617149|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
19617150|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
19617151|NCT02531841|Dexamethasone|dexamethasone|mesh-list
19617152|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
19617153|NCT02531841|Etoposide|etoposide|mesh-list
19617154|NCT02531841|Ifosfamide|ifosfamide|mesh-list
19617155|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
19617156|NCT02531841|Thiotepa|thiotepa|mesh-list
19617157|NCT02531841|Carmustine|carmustine|mesh-list
19617158|NCT02531841|Busulfan|busulfan|mesh-list
19617159|NCT02531841|BB 1101|bb 1101|mesh-list
19617160|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617161|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
19617162|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
19617163|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617164|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617165|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19617166|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
19617167|NCT02531841|Hormones|hormones|mesh-ancestor
19617168|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617169|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19617170|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617171|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
19617172|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617173|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617174|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19617175|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19617176|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617177|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19617178|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
19617179|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19617180|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617181|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
19617182|NCT02531737|Docetaxel|docetaxel|mesh-list
19617183|NCT02531737|Nintedanib|nintedanib|mesh-list
19617184|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617185|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
19617186|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
19617187|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
19617188|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617189|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19617190|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617191|NCT02531412|Spironolactone|spironolactone|mesh-list
19617192|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19617193|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
19617194|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617195|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617196|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19617197|NCT02531412|Diuretics|diuretics|mesh-ancestor
19617198|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
19617199|NCT02531477|Propofol|propofol|mesh-list
19617200|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19617201|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617202|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617203|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19617204|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
19617205|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
19617206|NCT02531724|Simendan|simendan|mesh-list
19617207|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19617208|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
19617209|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19617210|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19617211|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617212|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617213|NCT02531724|Protective Agents|protective agents|mesh-ancestor
19617214|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617215|NCT02531165|Aspirin|aspirin|mesh-list
19617216|NCT02531165|Heparin|heparin|mesh-list
19617217|NCT02531165|Fentanyl|fentanyl|mesh-list
19617218|NCT02531165|Morphine|morphine|mesh-list
19617219|NCT02531165|Ticagrelor|ticagrelor|mesh-list
19617220|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19617221|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617222|NCT02531165|Analgesics|analgesics|mesh-ancestor
19617223|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
19617224|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617225|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617226|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134271|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20134272|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20134273|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20134274|NCT00036374|Infliximab|infliximab|mesh-list
20134275|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134276|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134277|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608357|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617227|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617228|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19617229|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19617230|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617231|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19617232|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19617233|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617234|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
19617235|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19617236|NCT02531165|Narcotics|narcotics|mesh-ancestor
19617237|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617238|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19617239|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19617240|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
19617241|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
19617242|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
19617243|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19617244|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19617245|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19617246|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
19617247|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617248|NCT02531191|Peficitinib|peficitinib|mesh-list
19617249|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617250|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617251|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617252|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
19617253|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617254|NCT02531152|Latanoprost|latanoprost|mesh-list
19617255|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19617256|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19617257|NCT02530918|Ranibizumab|ranibizumab|mesh-list
19617258|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19617259|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19617260|NCT02530918|Growth Substances|growth substances|mesh-ancestor
19617261|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617262|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
19617263|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617264|NCT02530788|Selenium|selenium|mesh-list
19617265|NCT02530788|Selenious Acid|selenious acid|mesh-list
19617266|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
19617267|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
19617268|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617269|NCT02530788|Protective Agents|protective agents|mesh-ancestor
19617270|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617271|NCT02530788|Trace Elements|trace elements|mesh-ancestor
19617272|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
19617273|NCT02530801|Bevacizumab|bevacizumab|mesh-list
19617274|NCT02530801|Fluorouracil|fluorouracil|mesh-list
19617275|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19617276|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617277|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19617278|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19617279|NCT02530801|Growth Substances|growth substances|mesh-ancestor
19617280|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617281|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
19617282|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
19617283|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617284|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617285|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617286|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
19617287|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
20134278|NCT00036387|Infliximab|infliximab|mesh-list
20134279|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134280|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134281|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134282|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
20134283|NCT00036400|Hematinics|hematinics|mesh-ancestor
20134284|NCT00036439|Infliximab|infliximab|mesh-list
20134285|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134286|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134287|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134288|NCT00036452|Ritonavir|ritonavir|mesh-list
20134289|NCT00036452|Lopinavir|lopinavir|mesh-list
19617288|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
20134290|NCT00036452|Tenofovir|tenofovir|mesh-list
20134291|NCT00036452|Emtricitabine|emtricitabine|mesh-list
20134292|NCT00036452|Stavudine|stavudine|mesh-list
20134293|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19617289|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617290|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19617291|NCT02530879|Esomeprazole|esomeprazole|mesh-list
19617292|NCT02530879|Omeprazole|omeprazole|mesh-list
19617293|NCT02530879|Lansoprazole|lansoprazole|mesh-list
19617294|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
19617295|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19617296|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19617297|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19617298|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617299|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134294|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20134295|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
20134296|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134297|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134298|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20134299|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134300|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
20134301|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134302|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20134303|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20134304|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20134305|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134306|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
20134307|NCT00036491|Rituximab|rituximab|mesh-list
20134308|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20134309|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134310|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
20134311|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660200|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
19660201|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134312|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134313|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
20134314|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20134315|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134316|NCT00036543|Atrasentan|atrasentan|mesh-list
20134317|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134318|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20134319|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20134320|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134321|NCT00036556|Atrasentan|atrasentan|mesh-list
20134322|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134323|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20134324|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20134325|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134326|NCT00036582|Clozapine|clozapine|mesh-list
20134327|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19660214|NCT05086107|Rifabutin|rifabutin|mesh-list
19660215|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19660216|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660217|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19660218|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
19660219|NCT05086081|Ticagrelor|ticagrelor|mesh-list
19660220|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19660221|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19660222|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19660223|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19660224|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19660225|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
19660226|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660227|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660228|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660229|NCT05085912|Ethanol|ethanol|mesh-list
19660230|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19660231|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660232|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660233|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660234|NCT05085665|Ivermectin|ivermectin|mesh-list
19660235|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660236|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660237|NCT05085652|Anesthetics|anesthetics|mesh-list
19660238|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660239|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617318|NCT02530632|Propofol|propofol|mesh-list
19617319|NCT02530632|Sevoflurane|sevoflurane|mesh-list
19617320|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
19617321|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617322|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617323|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19617324|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19617325|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
19617326|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19617327|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19617328|NCT02530411|Fulvestrant|fulvestrant|mesh-list
19617329|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19617330|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617331|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19617332|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19617333|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
19617334|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617335|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617336|NCT02530424|Trastuzumab|trastuzumab|mesh-list
19617337|NCT02530424|Pertuzumab|pertuzumab|mesh-list
19617338|NCT02530424|Fulvestrant|fulvestrant|mesh-list
19617339|NCT02530424|Palbociclib|palbociclib|mesh-list
19617340|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19617341|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617342|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19617343|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19617344|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19617345|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
19617346|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617347|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617348|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19617349|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617350|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617351|NCT02530463|Nivolumab|nivolumab|mesh-list
19617352|NCT02530463|Ipilimumab|ipilimumab|mesh-list
19617353|NCT02530463|Azacitidine|azacitidine|mesh-list
19617354|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19617355|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617356|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19617357|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617358|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617359|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
19617360|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617361|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
19617362|NCT02530502|Temozolomide|temozolomide|mesh-list
19617363|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19617364|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617365|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19617366|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
19617367|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617368|NCT02530489|Paclitaxel|paclitaxel|mesh-list
19617369|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19617370|NCT02530489|Atezolizumab|atezolizumab|mesh-list
19617371|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19617372|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19617373|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617374|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19617375|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19617376|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19617377|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617378|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
19617379|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617380|NCT02530359|Pirfenidone|pirfenidone|mesh-list
19617381|NCT02530359|Analgesics|analgesics|mesh-ancestor
19617382|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
19617383|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617384|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312532|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312533|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
19617385|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19617386|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617387|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617388|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617389|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617390|NCT02530320|Palbociclib|palbociclib|mesh-list
19617391|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134328|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
20134329|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134330|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134331|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134332|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20134333|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20134334|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617392|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19617393|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617394|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617395|NCT02529982|Curcumin|curcumin|mesh-list
19617396|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19617397|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617398|NCT02529982|Analgesics|analgesics|mesh-ancestor
19617399|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
19617400|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617401|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617402|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617403|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134335|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134336|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
20134337|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
20134338|NCT00036634|Tenofovir|tenofovir|mesh-list
20134339|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
20134340|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134341|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20134342|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134343|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617404|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617405|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617406|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617407|NCT02530060|Tenofovir|tenofovir|mesh-list
19617408|NCT02530060|Emtricitabine|emtricitabine|mesh-list
19617409|NCT02530060|Rilpivirine|rilpivirine|mesh-list
19617410|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
19617411|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617412|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19617413|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19617414|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617415|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617416|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19617417|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19617418|NCT02530047|Interferons|interferons|mesh-list
19617419|NCT02530047|Interferon-beta|interferon-beta|mesh-list
19617420|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617421|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
19617422|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617423|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
19617424|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617425|NCT02529969|Curcumin|curcumin|mesh-list
19617426|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19617427|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617428|NCT02529969|Analgesics|analgesics|mesh-ancestor
19617429|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
19617430|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617431|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617432|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617433|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134344|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134345|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20134346|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134347|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20134348|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134349|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20134350|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617434|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134351|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617435|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617436|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617437|NCT02529878|Paclitaxel|paclitaxel|mesh-list
19617438|NCT02529878|Apatinib|apatinib|mesh-list
19617439|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19617440|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617441|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
19617442|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
19617443|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
19617444|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617445|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19617446|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617447|NCT02529852|Prednisone|prednisone|mesh-list
19617448|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
19617449|NCT02529852|Doxorubicin|doxorubicin|mesh-list
19617450|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19617451|NCT02529852|Vincristine|vincristine|mesh-list
19617452|NCT02529852|Lenalidomide|lenalidomide|mesh-list
19617453|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
19617454|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617455|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
19617456|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617457|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617458|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19617459|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
19617460|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617461|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617462|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19617463|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19617464|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19617465|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617466|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617467|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312534|NCT00684489|Coal Tar|coal tar|mesh-list
20312535|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
20312536|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
20312537|NCT00684528|Metformin|metformin|mesh-list
20312538|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20312539|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312540|NCT00684606|Oxytocin|oxytocin|mesh-list
20312541|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
20312542|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312543|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312544|NCT00684632|Fentanyl|fentanyl|mesh-list
20312545|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19617468|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
19617469|NCT02529852|Hormones|hormones|mesh-ancestor
19617470|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617471|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19617472|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19617473|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
19617474|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
19617475|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
19617476|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19617477|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19617478|NCT02529852|Growth Substances|growth substances|mesh-ancestor
20312546|NCT00684632|Narcotics|narcotics|mesh-ancestor
20312547|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617479|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
19617480|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19617481|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
19617482|NCT02529839|Fludarabine|fludarabine|mesh-list
19617483|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
19617484|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617485|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
19617486|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617487|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617488|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20312548|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617489|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
20312549|NCT00684632|Analgesics|analgesics|mesh-ancestor
20134352|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
20134353|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134354|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20134355|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617490|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617491|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617492|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19617493|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19617494|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
19617495|NCT02529787|Lansoprazole|lansoprazole|mesh-list
19617496|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19617497|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19617498|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19617499|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617500|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617501|NCT02529774|Leucovorin|leucovorin|mesh-list
19617502|NCT02529774|Dexamethasone|dexamethasone|mesh-list
19617503|NCT02529774|Capecitabine|capecitabine|mesh-list
19617504|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
19617505|NCT02529774|Fluorouracil|fluorouracil|mesh-list
19617506|NCT02529774|Floxuridine|floxuridine|mesh-list
19617507|NCT02529774|Heparin|heparin|mesh-list
19617508|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
19617509|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617510|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
19617511|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
19617512|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617513|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617514|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19617515|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
19617516|NCT02529774|Hormones|hormones|mesh-ancestor
19617517|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617518|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19617519|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617520|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617521|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
19617522|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617523|NCT02529774|Antidotes|antidotes|mesh-ancestor
19617524|NCT02529774|Protective Agents|protective agents|mesh-ancestor
19617525|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
19617526|NCT02529774|Vitamins|vitamins|mesh-ancestor
19617527|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
19617528|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617529|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
19617530|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
19617531|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19617532|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19617533|NCT02529514|Baclofen|baclofen|mesh-list
19617534|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19617535|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617536|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19617537|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617538|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20134356|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134357|NCT00036764|Epothilones|epothilones|mesh-list
20134358|NCT00036764|Epothilone B|epothilone b|mesh-list
20134359|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
20134360|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
20134361|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134362|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134363|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134364|NCT00036777|Carboplatin|carboplatin|mesh-list
19617539|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
19617540|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
19617541|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617542|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617543|NCT02529579|Gemcitabine|gemcitabine|mesh-list
19617544|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617545|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
19617546|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617547|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617548|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
19617549|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617550|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617551|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617552|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
19660240|NCT05085587|Fluticasone|fluticasone|mesh-list
19617553|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617554|NCT02529540|Methamphetamine|methamphetamine|mesh-list
19617555|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19617556|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617557|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
19617558|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
19617559|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617560|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
19617561|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617562|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617563|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
19617564|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19617565|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19617566|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20134365|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20134366|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134367|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20134368|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134369|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617567|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19617568|NCT02529631|Orlistat|orlistat|mesh-list
19617569|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617570|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617571|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19617572|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19617573|NCT02529670|Lidocaine|lidocaine|mesh-list
19617574|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
19617575|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
19617576|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617577|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617578|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
19617579|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617580|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19617581|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19617582|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19617583|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19617584|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617585|NCT02529683|NuvaRing|nuvaring|mesh-list
19617586|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19617587|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
19617588|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19617589|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617590|NCT02529761|Sorafenib|sorafenib|mesh-list
19617591|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617592|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19617593|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617594|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617595|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
19617596|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19617597|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617598|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19617599|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617600|NCT02529124|Caseins|caseins|mesh-list
19617601|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
19617602|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
19617603|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617604|NCT02529059|Tenofovir|tenofovir|mesh-list
20134370|NCT00036790|Doxorubicin|doxorubicin|mesh-list
20134371|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20134372|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
20134373|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19617605|NCT02529059|Emtricitabine|emtricitabine|mesh-list
19617606|NCT02529059|Rilpivirine|rilpivirine|mesh-list
19617607|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
19617608|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617609|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19617610|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19617611|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617612|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617613|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19617614|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134374|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608358|NCT02245477|Growth Substances|growth substances|mesh-ancestor
19617615|NCT02529241|Delpazolid|delpazolid|mesh-list
19617616|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
19617617|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19617618|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617619|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19617620|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617621|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617622|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
19617623|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19617624|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617625|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617626|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617627|NCT02529202|Analgesics|analgesics|mesh-ancestor
19617628|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
19617629|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617630|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19617631|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19617632|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19617633|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
19617634|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617635|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617636|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
19617637|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19617638|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660241|NCT05085587|Xhance|xhance|mesh-list
19660242|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19660243|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19660244|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660245|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19660246|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
19660247|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660248|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660249|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19660250|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
19660251|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
19660252|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19660253|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19660254|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19660255|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19660256|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
19660257|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660258|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660259|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
19660260|NCT05085587|Hormones|hormones|mesh-ancestor
19660261|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660262|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
19660263|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
19660264|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19660265|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19660266|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19660267|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19660268|NCT05085106|Analgesics|analgesics|mesh-ancestor
19660269|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
19660270|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660271|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660272|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660273|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660274|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
19660275|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660276|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660277|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
19660278|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
19660279|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19660280|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660281|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660282|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660283|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660284|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660285|NCT05084573|Bupivacaine|bupivacaine|mesh-list
19660286|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
19660287|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
19660288|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20134375|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20608359|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617639|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19617640|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617641|NCT02528877|Sirolimus|sirolimus|mesh-list
19617642|NCT02528877|Fludarabine|fludarabine|mesh-list
19617643|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
19617644|NCT02528877|Melphalan|melphalan|mesh-list
19617645|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
19617646|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19617647|NCT02528877|Tacrolimus|tacrolimus|mesh-list
19617648|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617649|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617650|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
19617651|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617652|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617653|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
19617654|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617655|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19617656|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617657|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19617658|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617659|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19617660|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
19617661|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19617662|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
19617663|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19617664|NCT02528682|Vaccines|vaccines|mesh-list
19617665|NCT02528682|Immunologic Factors|immunologic factors|mesh-ancestor
19617666|NCT02528682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617667|NCT02528825|Remifentanil|remifentanil|mesh-list
20134376|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20134377|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134378|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134379|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20134380|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134381|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
19617668|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19617669|NCT02528825|Narcotics|narcotics|mesh-ancestor
19617670|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617671|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617672|NCT02528825|Analgesics|analgesics|mesh-ancestor
19617673|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
19617674|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617675|NCT02528760|Erythromycin|erythromycin|mesh-list
19617676|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
19617677|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19617678|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
19617679|NCT02528760|Metoclopramide|metoclopramide|mesh-list
19617680|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
19617681|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
19617682|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617683|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617684|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19617685|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19617686|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19617687|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
19617688|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617689|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617690|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19617691|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617692|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19617693|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617694|NCT02528526|Inositol|inositol|mesh-list
19617695|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
19617696|NCT02528526|Vitamins|vitamins|mesh-ancestor
20134382|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134383|NCT00036855|Rituximab|rituximab|mesh-list
20134384|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20134385|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20134386|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134387|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
20134388|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617697|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
19617698|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617699|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
19617700|NCT02528461|Liver Extracts|liver extracts|mesh-list
19617701|NCT02528461|Hematinics|hematinics|mesh-ancestor
19617702|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
19617703|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134389|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134390|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
20134391|NCT00036868|Fluorouracil|fluorouracil|mesh-list
20134392|NCT00036868|Methotrexate|methotrexate|mesh-list
20134393|NCT00036868|Trastuzumab|trastuzumab|mesh-list
20134394|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134395|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
20134396|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134397|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134398|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20134399|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
20134400|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134401|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134402|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20134403|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
20134404|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134405|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20134406|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
19617704|NCT02528513|Fentanyl|fentanyl|mesh-list
19617705|NCT02528513|Midazolam|midazolam|mesh-list
19617706|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
19617707|NCT02528513|Propofol|propofol|mesh-list
19617708|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19617709|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617710|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617711|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20134407|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20134408|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134409|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134410|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20134411|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134412|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20134413|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
20134414|NCT00036881|Astringents|astringents|mesh-ancestor
20134415|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134416|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134417|NCT00036894|Lenalidomide|lenalidomide|mesh-list
20134418|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
20134419|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134420|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20134421|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20134422|NCT00036894|Growth Substances|growth substances|mesh-ancestor
20134423|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
20134424|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134425|NCT00036946|Aflibercept|aflibercept|mesh-list
20134426|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19617712|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
19617713|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
19617714|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617715|NCT02528513|Analgesics|analgesics|mesh-ancestor
19617716|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
19617717|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617718|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19617719|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19617720|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19617721|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
19617722|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617723|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617724|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19617725|NCT02528513|Narcotics|narcotics|mesh-ancestor
19617726|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19617727|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19617728|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19617729|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19617730|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
19617731|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
20134427|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19617732|NCT02528175|Capecitabine|capecitabine|mesh-list
19617733|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617734|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
19617735|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617736|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134428|NCT00036946|Growth Substances|growth substances|mesh-ancestor
20134429|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134430|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
20134431|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134432|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
20134433|NCT00036985|Doxorubicin|doxorubicin|mesh-list
20134434|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20134435|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134436|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
20134437|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134438|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134439|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19617737|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
19617738|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19617739|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617740|NCT02528201|Celecoxib|celecoxib|mesh-list
19617741|NCT02528201|Diclofenac|diclofenac|mesh-list
19617742|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19617743|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617744|NCT02528201|Analgesics|analgesics|mesh-ancestor
19617745|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
19617746|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617747|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617748|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19617749|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617750|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19617751|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19617752|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617753|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617754|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19617755|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19617756|NCT02528383|Estradiol|estradiol|mesh-list
19617757|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19617758|NCT02528383|Estrogens|estrogens|mesh-ancestor
19617759|NCT02528383|Hormones|hormones|mesh-ancestor
19617760|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617761|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617762|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19617763|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
19617764|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19617765|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19617766|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19617767|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
19617768|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19617769|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19617770|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617771|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
19617772|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20134440|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
20134441|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134442|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134443|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20134444|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20134445|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20134446|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20134447|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134448|NCT00037011|Antibodies|antibodies|mesh-list
20134449|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20134450|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
20134451|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134452|NCT00037037|Sargramostim|sargramostim|mesh-list
20134453|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
20134454|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134455|NCT00037050|Vancomycin|vancomycin|mesh-list
20134456|NCT00037050|Linezolid|linezolid|mesh-list
20134457|NCT00037050|Oxacillin|oxacillin|mesh-list
20134458|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
20134459|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134460|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617773|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20134461|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20134462|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608360|NCT02245490|Tamsulosin|tamsulosin|mesh-list
19617774|NCT02528136|Oxytocin|oxytocin|mesh-list
19617775|NCT02528136|Carbetocin|carbetocin|mesh-list
19617776|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
19617777|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19617778|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617779|NCT02528123|Tobramycin|tobramycin|mesh-list
19617780|NCT02528123|Ofloxacin|ofloxacin|mesh-list
19617781|NCT02528123|Dexamethasone|dexamethasone|mesh-list
19617782|NCT02528123|Benoxinate|benoxinate|mesh-list
19617783|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
19617784|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134463|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134464|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
20134465|NCT00037063|Vitamin E|vitamin e|mesh-list
20134466|NCT00037063|Riboflavin|riboflavin|mesh-list
19617785|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
19617786|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
19617787|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617788|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617789|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134467|NCT00037063|Thiamine|thiamine|mesh-list
20134468|NCT00037063|Vitamins|vitamins|mesh-ancestor
20134469|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
20134470|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134471|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
20134472|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134473|NCT00037063|Protective Agents|protective agents|mesh-ancestor
19617790|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
19617791|NCT02528123|Hormones|hormones|mesh-ancestor
19617792|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617793|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19617794|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617795|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19617796|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617797|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19617798|NCT02528123|Renal Agents|renal agents|mesh-ancestor
19617799|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19617800|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617801|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617802|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617803|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19617804|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19617805|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
19617806|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
19617807|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617808|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
19617809|NCT02528019|Glimepiride|glimepiride|mesh-list
19617810|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19617811|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19617812|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19617813|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617814|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617815|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
19617816|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617817|NCT02527941|Metronidazole|metronidazole|mesh-list
19617818|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617819|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19617820|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19617821|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19617822|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19617823|NCT02527993|Liraglutide|liraglutide|mesh-list
19749849|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134474|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
19617824|NCT02527993|Acarbose|acarbose|mesh-list
19617825|NCT02527993|Verapamil|verapamil|mesh-list
20134475|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19617826|NCT02527993|Pasireotide|pasireotide|mesh-list
19617827|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19617828|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617829|NCT02527993|Incretins|incretins|mesh-ancestor
19617830|NCT02527993|Hormones|hormones|mesh-ancestor
19617831|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19617832|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19617833|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
19617834|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617835|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617836|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19617837|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19617838|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19617839|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19617840|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19617841|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
19617842|NCT02527733|Ranibizumab|ranibizumab|mesh-list
19617843|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19617844|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19617845|NCT02527733|Growth Substances|growth substances|mesh-ancestor
19617846|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617847|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
19617848|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617849|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
19617850|NCT02527746|Epirubicin|epirubicin|mesh-list
19617851|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617852|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
19617853|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617854|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617855|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19617856|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
19617857|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617858|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617859|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19617860|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19617861|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19617862|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617863|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617864|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
19617865|NCT02527785|Irinotecan|irinotecan|mesh-list
19617866|NCT02527785|Tegafur|tegafur|mesh-list
19617867|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617868|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19617869|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617870|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617871|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617872|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617873|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
19617874|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
19617875|NCT02527824|Irinotecan|irinotecan|mesh-list
19617876|NCT02527824|Tegafur|tegafur|mesh-list
19617877|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617878|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19617879|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20312550|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
20312551|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312552|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20312553|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20312554|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
20312555|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
20312556|NCT00684827|Albuterol|albuterol|mesh-list
19617880|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617881|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617882|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617883|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
19617884|NCT02527811|Urinastatin|urinastatin|mesh-list
19617885|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
19617886|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19617887|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
19617888|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617889|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617890|NCT02527863|Tolvaptan|tolvaptan|mesh-list
19617891|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19617892|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617893|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
20312557|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20134476|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134477|NCT00037089|Tegafur|tegafur|mesh-list
20134478|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134479|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
20134480|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134481|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134482|NCT00037102|Interferons|interferons|mesh-list
20134483|NCT00037102|Interferon-beta|interferon-beta|mesh-list
20134484|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
20134485|NCT00037102|Methotrexate|methotrexate|mesh-list
20134486|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20134487|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
20134488|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20134489|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134490|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134491|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
20134492|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134493|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617894|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617895|NCT02527772|Leucovorin|leucovorin|mesh-list
20134494|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134495|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134496|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20134497|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134498|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
20134499|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134500|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19617896|NCT02527772|Gemcitabine|gemcitabine|mesh-list
19617897|NCT02527772|Fluorouracil|fluorouracil|mesh-list
19617898|NCT02527772|Doxorubicin|doxorubicin|mesh-list
19617899|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19617900|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
19617901|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617902|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
19617903|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617904|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617905|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
19617906|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617907|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617908|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617909|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
19617910|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617911|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19617912|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19617913|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617914|NCT02527772|Antidotes|antidotes|mesh-ancestor
19617915|NCT02527772|Protective Agents|protective agents|mesh-ancestor
19617916|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
19617917|NCT02527772|Vitamins|vitamins|mesh-ancestor
19617918|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
19617919|NCT02527668|Vitamin D|vitamin d|mesh-list
19617920|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
19617921|NCT02527668|Calcifediol|calcifediol|mesh-list
19617922|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19617923|NCT02527668|Vitamins|vitamins|mesh-ancestor
20134501|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
20134502|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134503|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20134504|NCT00037115|Interferons|interferons|mesh-list
20134505|NCT00037115|Interferon-beta|interferon-beta|mesh-list
20134506|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
20134507|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
20134508|NCT00037115|Methotrexate|methotrexate|mesh-list
20134509|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20134510|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
20134511|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19617924|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
19617925|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617926|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19617927|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19617928|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19617929|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19617930|NCT02527603|Analgesics|analgesics|mesh-ancestor
19617931|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
19617932|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617933|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134512|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134513|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617934|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19617935|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19617936|NCT02527564|Suvorexant|suvorexant|mesh-list
19617937|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19617938|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19617939|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617940|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617941|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19617942|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19617943|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617944|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19617945|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660289|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660290|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
19660291|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660292|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
19660293|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19660294|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660295|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660296|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19660297|NCT05079672|Analgesics|analgesics|mesh-ancestor
19660298|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
19660299|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660300|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19660301|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19660302|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19660303|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
19660304|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660305|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660306|NCT05073939|Oxytocin|oxytocin|mesh-list
19660307|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
19660308|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19660309|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660310|NCT05068206|Bevacizumab|bevacizumab|mesh-list
19660311|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660312|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660313|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19660314|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19660315|NCT05068206|Growth Substances|growth substances|mesh-ancestor
19660316|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660317|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
19665588|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
19665589|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665590|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665591|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
19665592|NCT04610476|Prednisolone|prednisolone|mesh-list
19665593|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19665594|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
19665595|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19665596|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
19665597|NCT04610476|Adalimumab|adalimumab|mesh-list
19665598|NCT04610476|Etanercept|etanercept|mesh-list
19665599|NCT04610476|Apremilast|apremilast|mesh-list
19665600|NCT04610476|Golimumab|golimumab|mesh-list
19665601|NCT04610476|Methotrexate|methotrexate|mesh-list
19665602|NCT04610476|Abatacept|abatacept|mesh-list
19665603|NCT04610476|Infliximab|infliximab|mesh-list
19665604|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
19665605|NCT04610476|Ustekinumab|ustekinumab|mesh-list
19665606|NCT04610476|Ixekizumab|ixekizumab|mesh-list
19665607|NCT04610476|Tofacitinib|tofacitinib|mesh-list
19665608|NCT04610476|Leflunomide|leflunomide|mesh-list
19665609|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19665610|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
19665611|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19665612|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
19665613|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20134514|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
19665614|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665615|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617946|NCT02527577|Ropivacaine|ropivacaine|mesh-list
19617947|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
19617948|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
19617949|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19617950|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617951|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
19617952|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19617953|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
19617954|NCT02527213|Antidotes|antidotes|mesh-ancestor
19617955|NCT02527213|Protective Agents|protective agents|mesh-ancestor
20134515|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134516|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617956|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617957|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
19617958|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617959|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
19617960|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19617961|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617962|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
19617963|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
19617964|NCT02527174|Cytarabine|cytarabine|mesh-list
19617965|NCT02527174|Idarubicin|idarubicin|mesh-list
19617966|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19617967|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
19617968|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617969|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19617970|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
19617971|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617972|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19617973|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
19617974|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617975|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19617976|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19617977|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19617978|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617979|NCT02527109|Nifedipine|nifedipine|mesh-list
19617980|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19617981|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19617982|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617983|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19617984|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19617985|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
19617986|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
19617987|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19617988|NCT02527096|Lamivudine|lamivudine|mesh-list
19617989|NCT02527096|Dolutegravir|dolutegravir|mesh-list
19617990|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19617991|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19617992|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19617993|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19617994|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
19617995|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19617996|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19617997|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19617998|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19617999|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19618000|NCT02527083|Ketamine|ketamine|mesh-list
19618001|NCT02527083|Remifentanil|remifentanil|mesh-list
19618002|NCT02527083|Propofol|propofol|mesh-list
19618003|NCT02527083|Sevoflurane|sevoflurane|mesh-list
19618004|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19618005|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618006|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618007|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19618008|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
19618009|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
19618010|NCT02527083|Analgesics|analgesics|mesh-ancestor
19618011|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
19618012|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618013|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19618014|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19618015|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19618016|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618017|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618018|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19618019|NCT02527083|Narcotics|narcotics|mesh-ancestor
19618020|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19618021|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19618022|NCT02526888|Diltiazem|diltiazem|mesh-list
19618023|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19618024|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19618025|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618026|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618027|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19618028|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618029|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
19618030|NCT02526914|Vasopressins|vasopressins|mesh-list
19618031|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
19618032|NCT02526914|Oxytocin|oxytocin|mesh-list
19618033|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
19618034|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19618035|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312558|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
20312559|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312560|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312561|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20312562|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
20312563|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
20312564|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312565|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20312566|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312567|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312568|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312569|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312570|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312571|NCT00684853|Bevacizumab|bevacizumab|mesh-list
20312572|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20312573|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618036|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
19618037|NCT02526914|Coagulants|coagulants|mesh-ancestor
19618038|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19618039|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19618040|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
19618041|NCT02527005|Azithromycin|azithromycin|mesh-list
19618042|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
19618043|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
19618044|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19618045|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19618046|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618047|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
19618048|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19618049|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19618050|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19618051|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618052|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618053|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19618054|NCT02527005|Renal Agents|renal agents|mesh-ancestor
19618055|NCT02526953|Paclitaxel|paclitaxel|mesh-list
19618056|NCT02526953|Capecitabine|capecitabine|mesh-list
19618057|NCT02526953|Mitomycins|mitomycins|mesh-list
19618058|NCT02526953|Mitomycin|mitomycin|mesh-list
19618059|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19618060|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618061|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19618062|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19618063|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
19618064|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618065|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19618066|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
19618067|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19618068|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
19618069|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19618070|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618071|NCT02526979|Mirabegron|mirabegron|mesh-list
19618072|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19618073|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19618074|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19618075|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618076|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660318|NCT05063370|Simendan|simendan|mesh-list
20134517|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134518|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134519|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20134520|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134521|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
20134522|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134523|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134524|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
19618077|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618078|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618079|NCT02526979|Urological Agents|urological agents|mesh-ancestor
19618080|NCT02526875|Amlodipine|amlodipine|mesh-list
19618081|NCT02526875|Telmisartan|telmisartan|mesh-list
19618082|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19618083|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19618084|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618085|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618086|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19618087|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618088|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
19618089|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19618090|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19618091|NCT02526810|Insulin|insulin|mesh-list
19618092|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19618093|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
19618094|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
19618095|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618096|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618097|NCT02526758|Budesonide|budesonide|mesh-list
19618098|NCT02526758|Beclomethasone|beclomethasone|mesh-list
19618099|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
20134525|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134526|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134527|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
20134528|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
20134529|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134530|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134531|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
20134532|NCT00037115|Hormones|hormones|mesh-ancestor
19618100|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618101|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19618102|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
19618103|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618104|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618105|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19618106|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
19618107|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
19618108|NCT02526758|Hormones|hormones|mesh-ancestor
19618109|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618110|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19618111|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19618112|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19618113|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618114|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618115|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618116|NCT02526615|Metformin|metformin|mesh-list
19618117|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
19618118|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618119|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618120|NCT02526745|Vaccines|vaccines|mesh-list
19618121|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
19618122|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618123|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
19618124|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19618125|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
19618126|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618127|NCT02526303|Nadroparin|nadroparin|mesh-list
19618128|NCT02526303|Warfarin|warfarin|mesh-list
19618129|NCT02526303|Calcium|calcium|mesh-list
19618130|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20134533|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134534|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19618131|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618132|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
20134535|NCT00037115|Protective Agents|protective agents|mesh-ancestor
19618133|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20134536|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19618134|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19618135|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618136|NCT02526394|Vaccines|vaccines|mesh-list
19618137|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
19618138|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618139|NCT02526004|Tobramycin|tobramycin|mesh-list
19618140|NCT02526004|Ceftazidime|ceftazidime|mesh-list
19618141|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19618142|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134537|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
20134538|NCT00037154|Urological Agents|urological agents|mesh-ancestor
20134539|NCT00037180|Leucovorin|leucovorin|mesh-list
20134540|NCT00037180|Celecoxib|celecoxib|mesh-list
20134541|NCT00037180|Fluorouracil|fluorouracil|mesh-list
20134542|NCT00037180|Irinotecan|irinotecan|mesh-list
20134543|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
20134544|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134545|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134546|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312574|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19618143|NCT02525991|Loxapine|loxapine|mesh-list
19618144|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19618145|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19618146|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618147|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618148|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19618149|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19618150|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
19618151|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618152|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618153|NCT02526199|Dexamethasone|dexamethasone|mesh-list
19618154|NCT02526199|Epinephrine|epinephrine|mesh-list
19618155|NCT02526199|Bupivacaine|bupivacaine|mesh-list
19618156|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618157|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
20134547|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134548|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
20134549|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134550|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20134551|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20134552|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134553|NCT00037180|Antidotes|antidotes|mesh-ancestor
20134554|NCT00037180|Protective Agents|protective agents|mesh-ancestor
20134555|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
20134556|NCT00037180|Vitamins|vitamins|mesh-ancestor
20134557|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
20134558|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20134559|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20134560|NCT00037180|Analgesics|analgesics|mesh-ancestor
20134561|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
20134562|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134563|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134564|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134565|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20134566|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20134567|NCT00037206|Anidulafungin|anidulafungin|mesh-list
20134568|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
19618158|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
19618159|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618160|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134569|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312575|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20312576|NCT00684853|Growth Substances|growth substances|mesh-ancestor
20312577|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312578|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
20312579|NCT00684866|Albuterol|albuterol|mesh-list
20312580|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20312581|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
20312582|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312583|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312584|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20134570|NCT00037219|Anidulafungin|anidulafungin|mesh-list
20134571|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
20312585|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
20608361|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20134572|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134573|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
20134574|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134575|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134576|NCT00037518|Cinacalcet|cinacalcet|mesh-list
20134577|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20134578|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134579|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20134580|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
20134581|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134582|NCT00037531|Sirolimus|sirolimus|mesh-list
20134583|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134584|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134585|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20134586|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134587|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
20134588|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134589|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
20134590|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134591|NCT00037544|Factor VIII|factor viii|mesh-list
19618161|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618162|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
19618163|NCT02526199|Hormones|hormones|mesh-ancestor
19618164|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618165|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19618166|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618167|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
19618168|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
19618169|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618170|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
19618171|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19618172|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19618173|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618174|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618175|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618176|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20134592|NCT00037544|Coagulants|coagulants|mesh-ancestor
20134593|NCT00037570|Pantoprazole|pantoprazole|mesh-list
20134594|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20134595|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134596|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19618177|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19618178|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19618179|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
19618180|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
19618181|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
19618182|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19618183|NCT02526030|Aripiprazole|aripiprazole|mesh-list
19618184|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19618185|NCT02526030|Ziprasidone|ziprasidone|mesh-list
19618186|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
19618187|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19618188|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19618189|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19618190|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618191|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134597|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134598|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173581|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173582|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173583|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173584|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
19618192|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
19618193|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
19618194|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618195|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618196|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19618197|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19618198|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
19618199|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19618200|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19618201|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19618202|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19618203|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
19618204|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20173585|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618205|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19618206|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
19618207|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618208|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19618209|NCT02525848|Dexamethasone|dexamethasone|mesh-list
19618210|NCT02525848|Gabapentin|gabapentin|mesh-list
19618211|NCT02525848|Aprepitant|aprepitant|mesh-list
19618212|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618213|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
19618214|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
19618215|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618216|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618217|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618218|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
19618219|NCT02525848|Hormones|hormones|mesh-ancestor
19618220|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618221|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19618222|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618223|NCT02525848|Analgesics|analgesics|mesh-ancestor
19618224|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
19618225|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
19618226|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19618227|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19618228|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618229|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19618230|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19618231|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19618232|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618233|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618234|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
19618235|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19618236|NCT02525822|Tazarotene|tazarotene|mesh-list
19618237|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
19618238|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
19660319|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19660320|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
19660321|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19660322|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19660323|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660324|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660325|NCT05063370|Protective Agents|protective agents|mesh-ancestor
19660326|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660327|NCT05063006|Methamphetamine|methamphetamine|mesh-list
20134599|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
20134600|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660328|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19660329|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660330|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
19660331|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
19660332|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660333|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
19660334|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660335|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660336|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
19660337|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19660338|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19660339|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19660340|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19660341|NCT05028257|Vaccines|vaccines|mesh-list
19660342|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
19660343|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660344|NCT05020392|Vidarabine|vidarabine|mesh-list
19660345|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
19660346|NCT05020392|Fludarabine|fludarabine|mesh-list
19660347|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
19660348|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19660349|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
19660350|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660351|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660352|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19660353|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
19660354|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660355|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660356|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19665616|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
20134601|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134602|NCT00037596|Cytarabine|cytarabine|mesh-list
19618239|NCT02525484|Pirfenidone|pirfenidone|mesh-list
19618240|NCT02525484|Analgesics|analgesics|mesh-ancestor
19618241|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
19618242|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618243|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618244|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19618245|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618246|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618247|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618248|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618249|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19618250|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
19618251|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618252|NCT02525211|Ropivacaine|ropivacaine|mesh-list
19618253|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
19618254|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
19618255|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618256|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618257|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
19618258|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618259|NCT02525172|Rituximab|rituximab|mesh-list
19618260|NCT02525172|Methotrexate|methotrexate|mesh-list
19618261|NCT02525172|Bortezomib|bortezomib|mesh-list
19618262|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
19618263|NCT02525172|Antibodies|antibodies|mesh-list
19618264|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
19618265|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19618266|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19618267|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19618268|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618269|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
19618270|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134603|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
20134604|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134605|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
20134606|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134607|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134608|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
20134609|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134610|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134611|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
20134612|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618271|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134613|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20134614|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
20134615|NCT00037609|Capecitabine|capecitabine|mesh-list
20134616|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134617|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
20134618|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134619|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134620|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20134621|NCT00037609|Protective Agents|protective agents|mesh-ancestor
20134622|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134623|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20134624|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134625|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20134626|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20134627|NCT00037609|Analgesics|analgesics|mesh-ancestor
20134628|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
20312586|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
20608362|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19618272|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19749863|NCT04601883|Colchicine|colchicine|mesh-list
19749864|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
19749865|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749866|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
19749867|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
20608363|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19618273|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
19618274|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19749868|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173586|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618275|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19618276|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
19618277|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618278|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
19618279|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618280|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19618281|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19618282|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19618283|NCT02525250|Lenalidomide|lenalidomide|mesh-list
19618284|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
19618285|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618286|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19618287|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19618288|NCT02525250|Growth Substances|growth substances|mesh-ancestor
19618289|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
19618290|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618291|NCT02525237|Apatinib|apatinib|mesh-list
19618292|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618293|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19618294|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618295|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618296|NCT02525276|Hormones|hormones|mesh-list
19618297|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134629|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134630|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134631|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134632|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
20134633|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20134634|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134635|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312587|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312588|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20312589|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312590|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312591|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312592|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312593|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618298|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618299|NCT02525302|Halofuginone|halofuginone|mesh-list
19618300|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618301|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
19618302|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19618303|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19618304|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618305|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19618306|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618307|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618308|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19618309|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19618310|NCT02525302|Growth Substances|growth substances|mesh-ancestor
19618311|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618312|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
19618313|NCT02525081|Ramipril|ramipril|mesh-list
19618314|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19618315|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
19618316|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618317|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618318|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19618319|NCT02525016|Lidocaine|lidocaine|mesh-list
19618320|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
19618321|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
19618322|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618323|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618324|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
19618325|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618326|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618327|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19618328|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20312594|NCT00684905|Leuprolide|leuprolide|mesh-list
20312595|NCT00684905|Bicalutamide|bicalutamide|mesh-list
19618329|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173587|NCT00162214|Ketoconazole|ketoconazole|mesh-list
20312596|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19618330|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618331|NCT02525003|Vitamin D|vitamin d|mesh-list
19618332|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
19618333|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
19618334|NCT02525003|Vitamins|vitamins|mesh-list
19618335|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
19618336|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618337|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19618338|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19618339|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19618340|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
19618341|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19618342|NCT02525458|Protective Agents|protective agents|mesh-ancestor
19618343|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618344|NCT02524899|Guanfacine|guanfacine|mesh-list
19618345|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19618346|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19618347|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19618348|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19618349|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618350|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618351|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618352|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618353|NCT02524964|Tanshinone|tanshinone|mesh-list
19618354|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618355|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19618356|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618357|NCT02524964|Analgesics|analgesics|mesh-ancestor
19618358|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
19618359|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618360|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618361|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618362|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618363|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
19618364|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19618365|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618366|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19618367|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
19618368|NCT02524821|Metformin|metformin|mesh-list
19618369|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618370|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618371|NCT02524743|Acetaminophen|acetaminophen|mesh-list
19618372|NCT02524743|Lidocaine|lidocaine|mesh-list
19618373|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
20312597|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
20312598|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312599|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312600|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20312601|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312602|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
20312603|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312604|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312605|NCT00684957|Hormones|hormones|mesh-list
19618374|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
19618375|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618376|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618377|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
19618378|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618379|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618380|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19618381|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19618382|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618383|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618384|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618385|NCT02524743|Analgesics|analgesics|mesh-ancestor
19618386|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
19618387|NCT02524652|Ropivacaine|ropivacaine|mesh-list
19618388|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
19618389|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
19618390|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618391|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618392|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
19835542|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347261|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19618393|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618394|NCT02524639|Sirolimus|sirolimus|mesh-list
19618395|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19618396|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618397|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19618398|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618399|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
19618400|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19618401|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
19618402|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618403|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
19618404|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
19618405|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19618406|NCT02524444|Mefloquine|mefloquine|mesh-list
19618407|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
19618408|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19618409|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19618410|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618411|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19618412|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618413|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618414|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19618415|NCT02524444|Renal Agents|renal agents|mesh-ancestor
19618416|NCT02524405|Corticosterone|corticosterone|mesh-list
19618417|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618418|NCT02524379|Glyburide|glyburide|mesh-list
19618419|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618420|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618421|NCT02524301|Diprenorphine|diprenorphine|mesh-list
19618422|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19618423|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618424|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
19618425|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618426|NCT02524210|Omeprazole|omeprazole|mesh-list
19618427|NCT02524210|Rabeprazole|rabeprazole|mesh-list
19618428|NCT02524210|Dabigatran|dabigatran|mesh-list
19618429|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19618430|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618431|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19618432|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618433|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618434|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
19618435|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19618436|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
19618437|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
19618438|NCT02523820|Fluticasone|fluticasone|mesh-list
20134636|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134637|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
20134638|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618439|NCT02523820|Xhance|xhance|mesh-list
20134639|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20134640|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134641|NCT00037635|Cinacalcet|cinacalcet|mesh-list
20134642|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20134643|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134644|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20134645|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
19618440|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618441|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19618442|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
19618443|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618444|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618445|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19618446|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
19618447|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
19618448|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19618449|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
19618450|NCT02523911|Simethicone|simethicone|mesh-list
19618451|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
19618452|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19618453|NCT02523911|Analgesics|analgesics|mesh-ancestor
19618454|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
19618455|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618456|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173588|NCT00162214|Dasatinib|dasatinib|mesh-list
19618457|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
19618458|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618459|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618460|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
19618461|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19618462|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618463|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618464|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19618465|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
19618466|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19618467|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
19618468|NCT02523911|Emollients|emollients|mesh-ancestor
19618469|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
19618470|NCT02523911|Cathartics|cathartics|mesh-ancestor
19618471|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618472|NCT02523898|Metformin|metformin|mesh-list
19618473|NCT02523898|Clomiphene|clomiphene|mesh-list
19618474|NCT02523898|Enclomiphene|enclomiphene|mesh-list
19618475|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
19618476|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618477|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618478|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19618479|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
19618480|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618481|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19618482|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
19618483|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19618484|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19618485|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19618486|NCT02523768|Basiliximab|basiliximab|mesh-list
19618487|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19618488|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
19618489|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618490|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
19618491|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
19618492|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19618493|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19618494|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618495|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618496|NCT02524184|Urological Agents|urological agents|mesh-ancestor
19618497|NCT02523833|Albuterol|albuterol|mesh-list
19618498|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19618499|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
19618500|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618501|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618502|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19618503|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
19618504|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
19618505|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19618506|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20134646|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134647|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20134648|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134649|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19618507|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19618508|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19618509|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618510|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618511|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660357|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19660358|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
19660359|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
20134650|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20134651|NCT00037674|Topiramate|topiramate|mesh-list
20134652|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
20134653|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20134654|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134655|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20134656|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134657|NCT00037752|Sibutramine|sibutramine|mesh-list
20134658|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
20134659|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20134660|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
19618512|NCT02523859|Propofol|propofol|mesh-list
19618513|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19618514|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618515|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618516|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19618517|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
19618518|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
19618519|NCT02523846|Morphine|morphine|mesh-list
19618520|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19618521|NCT02523846|Narcotics|narcotics|mesh-ancestor
19618522|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256587|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256588|NCT04418401|Antibodies|antibodies|mesh-list
19256589|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
19256590|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256591|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19256592|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19256593|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19256594|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19256595|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19256596|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256597|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
19256598|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19256599|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256600|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256601|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259133|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19618523|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618524|NCT02523846|Analgesics|analgesics|mesh-ancestor
19618525|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
19618526|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618527|NCT02523976|Cytarabine|cytarabine|mesh-list
19618528|NCT02523976|Dexamethasone|dexamethasone|mesh-list
20134661|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20134662|NCT00037804|Irinotecan|irinotecan|mesh-list
20134663|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20134664|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20134665|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134666|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134667|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134668|NCT00037817|Celecoxib|celecoxib|mesh-list
20134669|NCT00037817|Decitabine|decitabine|mesh-list
20134670|NCT00037817|Romidepsin|romidepsin|mesh-list
20134671|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20134672|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20134673|NCT00037817|Analgesics|analgesics|mesh-ancestor
20134674|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
19618529|NCT02523976|Prednisone|prednisone|mesh-list
19618530|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
19618531|NCT02523976|Methotrexate|methotrexate|mesh-list
19618532|NCT02523976|Etoposide|etoposide|mesh-list
19618533|NCT02523976|Vincristine|vincristine|mesh-list
19618534|NCT02523976|Daunorubicin|daunorubicin|mesh-list
19618535|NCT02523976|Dasatinib|dasatinib|mesh-list
19618536|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
19618537|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
19618538|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19618539|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
19618540|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618541|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618542|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19618543|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
19618544|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618545|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618546|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19618547|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618548|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
19618549|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
19618550|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134675|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618551|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134676|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618552|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
19618553|NCT02523976|Hormones|hormones|mesh-ancestor
19618554|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618555|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19618556|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19618557|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
19618558|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19618559|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19618560|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
19618561|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
19618562|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618563|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19618564|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19618565|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19618566|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19618567|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19618568|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
19618569|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618570|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
19618571|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
19618572|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
19618573|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19618574|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19618575|NCT02523976|Analgesics|analgesics|mesh-ancestor
19618576|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
19618577|NCT02523755|Ropivacaine|ropivacaine|mesh-list
19618578|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
19618579|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
19618580|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618581|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618582|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
19618583|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618584|NCT02523547|Entecavir|entecavir|mesh-list
19618585|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
19618586|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618587|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
19618588|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19618589|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19618590|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618591|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618592|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618593|NCT02523638|Interferons|interferons|mesh-list
19618594|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
19618595|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
19618596|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618597|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
19618598|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618599|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
19618600|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618601|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
19618602|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618603|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
19618604|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
19618605|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618606|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
19618607|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
19618608|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618609|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618610|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618611|NCT02523300|Hormones|hormones|mesh-ancestor
19618612|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618613|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19618614|NCT02523300|Protective Agents|protective agents|mesh-ancestor
19618615|NCT02523131|Insulin|insulin|mesh-list
19618616|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618617|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618618|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
19618619|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
19618620|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19618621|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618622|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618623|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618624|NCT02523144|Analgesics|analgesics|mesh-ancestor
19618625|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
20134677|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618626|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618627|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19618628|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19618629|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19618630|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618631|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618632|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618633|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19618634|NCT02523092|Hormones|hormones|mesh-ancestor
19618635|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618636|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618637|NCT02523053|Fluorouracil|fluorouracil|mesh-list
19618638|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
19618639|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618640|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19618641|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618642|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19618643|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
19618644|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618645|NCT02522897|Ranibizumab|ranibizumab|mesh-list
19618646|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19618647|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19618648|NCT02522897|Growth Substances|growth substances|mesh-ancestor
19618649|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618650|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
19618651|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618652|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
19618653|NCT02522975|Hematinics|hematinics|mesh-ancestor
19618654|NCT02522910|Docetaxel|docetaxel|mesh-list
19618655|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618656|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
19618657|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
19618658|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
19618659|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618660|NCT02522858|Atropine|atropine|mesh-list
19618661|NCT02522858|Ephedrine|ephedrine|mesh-list
19618662|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
19618663|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19618664|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618665|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618666|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618667|NCT02522858|Analgesics|analgesics|mesh-ancestor
19618668|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
19618669|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618670|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19618671|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19618672|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19618673|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618674|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618675|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618676|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19618677|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618678|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19618679|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
19618680|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19618681|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
19618682|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
19618683|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
19618684|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19618685|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19618686|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
19618687|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19618688|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
19618689|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19618690|NCT02522754|Vaccines|vaccines|mesh-list
19618691|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
19618692|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618693|NCT02522936|Muramidase|muramidase|mesh-list
19618694|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618695|NCT02522650|Amiloride|amiloride|mesh-list
19618696|NCT02522650|Triamterene|triamterene|mesh-list
19618697|NCT02522650|Diuretics|diuretics|mesh-ancestor
19618698|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
19618699|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618700|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20134678|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618701|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19618702|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618703|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618704|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19618705|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19618706|NCT02522572|Plerixafor|plerixafor|mesh-list
19618707|NCT02522572|Bortezomib|bortezomib|mesh-list
19618708|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618709|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19618710|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19618711|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
19618712|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618713|NCT02522234|Lenograstim|lenograstim|mesh-list
19618714|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19618715|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
19618716|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618717|NCT02522221|Warfarin|warfarin|mesh-list
19618718|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
19618719|NCT02522169|Infliximab|infliximab|mesh-list
19618720|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
19618721|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134679|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20134680|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20134681|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134682|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618722|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618723|NCT02522208|Hydralazine|hydralazine|mesh-list
19618724|NCT02522208|Isosorbide|isosorbide|mesh-list
19618725|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19618726|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19618727|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19618728|NCT02522208|Diuretics|diuretics|mesh-ancestor
19618729|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
19618730|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618731|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
19618732|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19618733|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618734|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19660360|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660361|NCT05018221|Vitamins|vitamins|mesh-list
19660362|NCT05018221|Vitamin K|vitamin k|mesh-list
19660363|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
20312606|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312607|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312608|NCT00685009|Hormones|hormones|mesh-list
19660364|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
19660365|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
19660366|NCT05018221|Citric Acid|citric acid|mesh-list
19660367|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
19660368|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
19660369|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660370|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
19660371|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19660372|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
19660373|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
19660374|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660375|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19660376|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19660377|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
19660378|NCT05018221|Coagulants|coagulants|mesh-ancestor
19660379|NCT05018221|Antidotes|antidotes|mesh-ancestor
19660380|NCT05018221|Protective Agents|protective agents|mesh-ancestor
19660381|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
19660382|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
19660383|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134683|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134684|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
20134685|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134686|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20134687|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20134688|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134689|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660384|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660385|NCT05018221|Cathartics|cathartics|mesh-ancestor
19660386|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660387|NCT05016947|Dexamethasone|dexamethasone|mesh-list
19660388|NCT05016947|Venetoclax|venetoclax|mesh-list
19660389|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19660390|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618735|NCT02522078|Misoprostol|misoprostol|mesh-list
19618736|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19618737|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
19618738|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19618739|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618740|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19618741|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618742|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
19618743|NCT02522117|Atorvastatin|atorvastatin|mesh-list
19618744|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19618745|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19618746|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
19618747|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618748|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19618749|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19618750|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618751|NCT02522130|Naproxen|naproxen|mesh-list
19618752|NCT02522130|Lidocaine|lidocaine|mesh-list
19618753|NCT02522130|Misoprostol|misoprostol|mesh-list
19618754|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
19618755|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
19618756|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618757|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618758|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
19618759|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618760|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618761|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19618762|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20134690|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134691|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20134692|NCT00037882|Interferons|interferons|mesh-list
19618763|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618764|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618765|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19618766|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
19618767|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19618768|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19618769|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618770|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
19618771|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19618772|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618773|NCT02522130|Analgesics|analgesics|mesh-ancestor
19618774|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618775|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618776|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
19618777|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19618778|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618779|NCT02522039|Timolol|timolol|mesh-list
19618780|NCT02522039|Dorzolamide|dorzolamide|mesh-list
19618781|NCT02522039|Latanoprost|latanoprost|mesh-list
19618782|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19618783|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19618784|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618785|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20134693|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
20134694|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
20134695|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20134696|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134697|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
20134698|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134699|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
20134700|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134701|NCT00037999|Testosterone|testosterone|mesh-list
20134702|NCT00037999|Androgens|androgens|mesh-ancestor
20134703|NCT00037999|Hormones|hormones|mesh-ancestor
20134704|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134705|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134706|NCT00038012|Carboplatin|carboplatin|mesh-list
20134707|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134708|NCT00038025|Pentostatin|pentostatin|mesh-list
20134709|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134710|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20134711|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618786|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660391|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
19660392|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
20134712|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312609|NCT00685009|Progesterone|progesterone|mesh-list
20312610|NCT00685009|Estrogens|estrogens|mesh-list
20312611|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312612|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312613|NCT00685009|Progestins|progestins|mesh-ancestor
20312614|NCT00685022|Albuterol|albuterol|mesh-list
20312615|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20312616|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
20312617|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618787|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134713|NCT00038051|Lintuzumab|lintuzumab|mesh-list
20134714|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20134715|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134716|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
20134717|NCT00038064|Hematinics|hematinics|mesh-ancestor
20134718|NCT00038077|Metoprolol|metoprolol|mesh-list
20134719|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20134720|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20134721|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
20134722|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
20134723|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618788|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618789|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19618790|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19618791|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19618792|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19618793|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618794|NCT02522013|Aminophylline|aminophylline|mesh-list
19618795|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19618796|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
19618797|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618798|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618799|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19618800|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
19618801|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19618802|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19618803|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618804|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618805|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19618806|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19618807|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
19618808|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618809|NCT02522013|Protective Agents|protective agents|mesh-ancestor
19618810|NCT02521831|Bupivacaine|bupivacaine|mesh-list
19618811|NCT02521831|Anesthetics|anesthetics|mesh-list
19618812|NCT02521831|Isoflurane|isoflurane|mesh-list
19618813|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
19618814|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618815|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618816|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
19618817|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618818|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19618819|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
19618820|NCT02521714|Lenalidomide|lenalidomide|mesh-list
19618821|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
19618822|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134724|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134725|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20134726|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20134727|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19618823|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19618824|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19618825|NCT02521714|Growth Substances|growth substances|mesh-ancestor
19618826|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
19618827|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618828|NCT02521753|Metformin|metformin|mesh-list
19618829|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618830|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618831|NCT02521662|Nicotine|nicotine|mesh-list
19618832|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20134728|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608364|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19618833|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
19618834|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134729|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618835|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618836|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19618837|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19618838|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
19618839|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618840|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618841|NCT02521441|Lenograstim|lenograstim|mesh-list
19618842|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19618843|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
19618844|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618845|NCT02521415|Acetaminophen|acetaminophen|mesh-list
19618846|NCT02521415|Ibuprofen|ibuprofen|mesh-list
19618847|NCT02521415|Fentanyl|fentanyl|mesh-list
19618848|NCT02521415|Ketamine|ketamine|mesh-list
19618849|NCT02521415|Analgesics|analgesics|mesh-list
19618850|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
19618851|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618852|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618853|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19618854|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19618855|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
19618856|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
19618857|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19618858|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19618859|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19618860|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618861|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618862|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19618863|NCT02521415|Narcotics|narcotics|mesh-ancestor
19618864|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19618865|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618866|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
19618867|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19618868|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618869|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618870|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19618871|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618872|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19618873|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618874|NCT02521363|Taxane|taxane|mesh-list
19618875|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618876|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19618877|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
19618878|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19618879|NCT02521298|Prednisolone|prednisolone|mesh-list
19618880|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
19618881|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19618882|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
19618883|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618884|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
19618885|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
19618886|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618887|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618888|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19618889|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
19618890|NCT02521298|Hormones|hormones|mesh-ancestor
19618891|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618892|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19618893|NCT02521298|Protective Agents|protective agents|mesh-ancestor
19618894|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19618895|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618896|NCT02521246|Losartan|losartan|mesh-list
19618897|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19618898|NCT02521246|Candesartan|candesartan|mesh-list
19618899|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
19618900|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
19618901|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618902|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19618903|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19618904|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19618905|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618906|NCT02521246|Diuretics|diuretics|mesh-ancestor
20312618|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618907|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
19618908|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618909|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20134730|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134731|NCT00038090|Thalidomide|thalidomide|mesh-list
20134732|NCT00038090|Dexamethasone|dexamethasone|mesh-list
20134733|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134734|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
20134735|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
20134736|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134737|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134738|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20134739|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
20134740|NCT00038090|Hormones|hormones|mesh-ancestor
20134741|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20134742|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19618910|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618911|NCT02521233|Losartan|losartan|mesh-list
19618912|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19618913|NCT02521233|Candesartan|candesartan|mesh-list
19618914|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
19618915|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
19618916|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19618917|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19618918|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19618919|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19618920|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618921|NCT02521233|Diuretics|diuretics|mesh-ancestor
19618922|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
19618923|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618924|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19618925|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19618926|NCT02521207|Ibuprofen|ibuprofen|mesh-list
19618927|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19618928|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618929|NCT02521207|Analgesics|analgesics|mesh-ancestor
19618930|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
19618931|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618932|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618933|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618934|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618935|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19618936|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618937|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618938|NCT02521051|Bevacizumab|bevacizumab|mesh-list
19618939|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19618940|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618941|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19618942|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19618943|NCT02521051|Growth Substances|growth substances|mesh-ancestor
19618944|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618945|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
19618946|NCT02521155|Fenbendazole|fenbendazole|mesh-list
19618947|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
19618948|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
19618949|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20134743|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134744|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19618950|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618951|NCT02521064|Prednisone|prednisone|mesh-list
19618952|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618953|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
19618954|NCT02521064|Hormones|hormones|mesh-ancestor
19618955|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19618956|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618957|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19618958|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19618959|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
19618960|NCT02521077|Vitamins|vitamins|mesh-ancestor
19618961|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
19618962|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618963|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
19618964|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618965|NCT02521077|Protective Agents|protective agents|mesh-ancestor
19618966|NCT02521038|Ticagrelor|ticagrelor|mesh-list
19618967|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19618968|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19618969|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19618970|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19618971|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
19618972|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19618973|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618974|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618975|NCT02520934|Miglustat|miglustat|mesh-list
19618976|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19618977|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618978|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19618979|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19618980|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
19618981|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19618982|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19618983|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19618984|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618985|NCT02520921|Aspirin|aspirin|mesh-list
19618986|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19618987|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19618988|NCT02520921|Analgesics|analgesics|mesh-ancestor
19618989|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
19618990|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19618991|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19618992|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19618993|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19618994|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19618995|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19618996|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19618997|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19618998|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19618999|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619000|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
19619001|NCT02521012|Vitamin D|vitamin d|mesh-list
19619002|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
19619003|NCT02521012|Vitamins|vitamins|mesh-list
20134745|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
20134746|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
20134747|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134748|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134749|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20134750|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20134751|NCT00038090|Growth Substances|growth substances|mesh-ancestor
20134752|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
20134753|NCT00038116|Dopamine|dopamine|mesh-list
20134754|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20134755|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
20134756|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
20134757|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134758|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134759|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
19619004|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
19619005|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619006|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19619007|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19619008|NCT02520635|Temozolomide|temozolomide|mesh-list
19619009|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19619010|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
19619011|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619012|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619013|NCT02520752|Midazolam|midazolam|mesh-list
19619014|NCT02520752|Caffeine|caffeine|mesh-list
19619015|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19619016|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19619017|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619018|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619019|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19619020|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19619021|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19619022|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19749869|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134760|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312619|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19619023|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
19619024|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
19619025|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
19619026|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
19619027|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619028|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619029|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19619030|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19619031|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619032|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19619033|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19619034|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
19619035|NCT02520570|Urinastatin|urinastatin|mesh-list
19619036|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
19619037|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19619038|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
19619039|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619040|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660393|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20134761|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134762|NCT00038116|Protective Agents|protective agents|mesh-ancestor
20134763|NCT00038168|Paclitaxel|paclitaxel|mesh-list
20134764|NCT00038168|Estramustine|estramustine|mesh-list
20134765|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20134766|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134767|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
20134768|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660394|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660395|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660396|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
19660397|NCT05016947|Hormones|hormones|mesh-ancestor
20134769|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134770|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134771|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19660398|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660399|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660400|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660401|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660402|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19660403|NCT05013242|Goserelin|goserelin|mesh-list
19660404|NCT05013242|Dienogest|dienogest|mesh-list
19660405|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660406|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660407|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19660408|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
19660409|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19660410|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660411|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19660412|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19660413|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19660414|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19660415|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
19660416|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660417|NCT05008510|Camptothecin|camptothecin|mesh-list
19660418|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
19660419|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19660420|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660421|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19660422|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19660423|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660424|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660425|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
19660426|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660427|NCT04978298|Phenelzine|phenelzine|mesh-list
19660428|NCT04978298|Ozanimod|ozanimod|mesh-list
19660429|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19660430|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660431|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19660432|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
19660433|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660434|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
19660435|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19619041|NCT02520479|Pegaspargase|pegaspargase|mesh-list
19619042|NCT02520479|Asparaginase|asparaginase|mesh-list
19619043|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619044|NCT02520947|Desflurane|desflurane|mesh-list
19619045|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20134772|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
20134773|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20134774|NCT00038181|Thalidomide|thalidomide|mesh-list
20134775|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134776|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
20134777|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134778|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
20134779|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134780|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134781|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20134782|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20134783|NCT00038181|Growth Substances|growth substances|mesh-ancestor
20134784|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
19619046|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
19619047|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
19619048|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619049|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619050|NCT02520505|Citric Acid|citric acid|mesh-list
19619051|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
19619052|NCT02520505|Clomiphene|clomiphene|mesh-list
19619053|NCT02520505|Enclomiphene|enclomiphene|mesh-list
19619054|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
19619055|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
19619056|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19619057|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
19619058|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
19619059|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619060|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19619061|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
19619062|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619063|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619064|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19619065|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
19619066|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19619067|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19619068|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19619069|NCT02520453|Durvalumab|durvalumab|mesh-list
19619070|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619071|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619072|NCT02520817|Vitamins|vitamins|mesh-list
19619073|NCT02520817|Ascorbic Acid|ascorbic acid|mesh-list
19619074|NCT02520817|Vitamin E|vitamin e|mesh-list
19619075|NCT02520817|Vitamin A|vitamin a|mesh-list
19619076|NCT02520817|Lactulose|lactulose|mesh-list
19619077|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
19619078|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619079|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
19619080|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619081|NCT02520817|Protective Agents|protective agents|mesh-ancestor
19619082|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619083|NCT02520219|Endostar protein|endostar protein|mesh-list
19619084|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19619085|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19619086|NCT02520219|Growth Substances|growth substances|mesh-ancestor
19619087|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619088|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
19619089|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619090|NCT02520245|Cemiplimab|cemiplimab|mesh-list
19619091|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619092|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619093|NCT02520180|Everolimus|everolimus|mesh-list
19619094|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619095|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19619096|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
19619097|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619098|NCT02520115|Dexamethasone|dexamethasone|mesh-list
19619099|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
19619100|NCT02520115|Valproic Acid|valproic acid|mesh-list
19619101|NCT02520115|Ichthammol|ichthammol|mesh-list
19619102|NCT02520115|BB 1101|bb 1101|mesh-list
19619103|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619104|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
19619105|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
19619106|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619107|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619108|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619109|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
19619110|NCT02520115|Hormones|hormones|mesh-ancestor
19619111|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619112|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19619113|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619114|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
19619115|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619116|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619117|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
19619118|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
19619119|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619120|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
19619121|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19619122|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619123|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19619124|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
19619125|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
19619126|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19619127|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19619128|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19619129|NCT02520141|Ramucirumab|ramucirumab|mesh-list
19619130|NCT02520141|Antibodies|antibodies|mesh-list
19619131|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
19619132|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19619133|NCT02520141|Lexatumumab|lexatumumab|mesh-list
19619134|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
19619135|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619136|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619137|NCT02520102|Sargramostim|sargramostim|mesh-list
19619138|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
19619139|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619140|NCT02519543|Metformin|metformin|mesh-list
19619141|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19619142|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619143|NCT02519582|Niclosamide|niclosamide|mesh-list
19619144|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
19619145|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19619146|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
19619147|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19619148|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619149|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
19619150|NCT02519699|Norepinephrine|norepinephrine|mesh-list
19619151|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19619152|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19619153|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
19619154|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619155|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619156|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619157|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
20134785|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134786|NCT00038194|Docetaxel|docetaxel|mesh-list
20134787|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
20134788|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134789|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
20134790|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
19619158|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
19619159|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619160|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19619161|NCT02519608|Aspirin|aspirin|mesh-list
19619162|NCT02519608|Clopidogrel|clopidogrel|mesh-list
19619163|NCT02519608|Ticagrelor|ticagrelor|mesh-list
19619164|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19619165|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19619166|NCT02519608|Analgesics|analgesics|mesh-ancestor
19619167|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
19619168|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619169|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619170|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619171|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19619172|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19619173|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19619174|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619175|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20134791|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
19619176|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19619177|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619178|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
19619179|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19619180|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19619181|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19619182|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
19619183|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619184|NCT02519660|Lidocaine|lidocaine|mesh-list
19619185|NCT02519660|Tetracaine|tetracaine|mesh-list
19619186|NCT02519660|Prilocaine|prilocaine|mesh-list
19619187|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19619188|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
19619189|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
19619190|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619191|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619192|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
19619193|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619194|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19619195|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19619196|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19619197|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19619198|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619199|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19619200|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19619201|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
19619202|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19619203|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
19619204|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619205|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
19619206|NCT02519335|Razoxane|razoxane|mesh-list
19619207|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619208|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19619209|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19619210|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19619211|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619212|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619213|NCT02519335|Protective Agents|protective agents|mesh-ancestor
19619214|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619215|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
19619216|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
19619217|NCT02519322|Nivolumab|nivolumab|mesh-list
19619218|NCT02519322|Ipilimumab|ipilimumab|mesh-list
19619219|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
19619220|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
19619221|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619222|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619223|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19619224|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619225|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
19619226|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619227|NCT02519400|Amitriptyline|amitriptyline|mesh-list
19619228|NCT02519400|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19619229|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19619230|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
19619231|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19619232|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19619233|NCT02519400|Analgesics|analgesics|mesh-ancestor
19619234|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
19619235|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619236|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619237|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19619238|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19619239|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19619240|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619241|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
19619242|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619243|NCT02519400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19619244|NCT02519400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19619245|NCT02519400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619246|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
19619247|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
19619248|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19619249|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19619250|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619251|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619252|NCT02519153|Urological Agents|urological agents|mesh-ancestor
19619253|NCT02519010|Amlodipine|amlodipine|mesh-list
19619254|NCT02519010|Valsartan|valsartan|mesh-list
19619255|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19619256|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19619257|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19619258|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19619259|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619260|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19619261|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619262|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
19619263|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19619264|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19619265|NCT02518802|Pemetrexed|pemetrexed|mesh-list
19619266|NCT02518802|Gefitinib|gefitinib|mesh-list
19619267|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619268|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619269|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619270|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20134792|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134793|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20134794|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134795|NCT00038207|Vincristine|vincristine|mesh-list
20134796|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20134797|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619271|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19619272|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19619273|NCT02518945|Liraglutide|liraglutide|mesh-list
19619274|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
19619275|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20134798|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
20134799|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
20134800|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134801|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134802|NCT00038220|Ritonavir|ritonavir|mesh-list
20134803|NCT00038220|Lopinavir|lopinavir|mesh-list
20134804|NCT00038220|Tenofovir|tenofovir|mesh-list
20134805|NCT00038220|Lamivudine|lamivudine|mesh-list
20134806|NCT00038220|Efavirenz|efavirenz|mesh-list
20134807|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20134808|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20134809|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
19619276|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619277|NCT02518945|Incretins|incretins|mesh-ancestor
19619278|NCT02518945|Hormones|hormones|mesh-ancestor
19619279|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619280|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19619281|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619282|NCT02518763|Vitamin D|vitamin d|mesh-list
19619283|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
19619284|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
19619285|NCT02518763|Vitamins|vitamins|mesh-list
19619286|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
19619287|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619288|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19619289|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19619290|NCT02518789|Fentanyl|fentanyl|mesh-list
19619291|NCT02518789|Midazolam|midazolam|mesh-list
19619292|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
19619293|NCT02518789|Remifentanil|remifentanil|mesh-list
19619294|NCT02518789|Propofol|propofol|mesh-list
19619295|NCT02518789|Etomidate|etomidate|mesh-list
19619296|NCT02518789|Atracurium|atracurium|mesh-list
19619297|NCT02518789|Rocuronium|rocuronium|mesh-list
19619298|NCT02518789|Cisatracurium|cisatracurium|mesh-list
19619299|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19619300|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20134810|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134811|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619301|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619302|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19619303|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
19619304|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
19619305|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20134812|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19619306|NCT02518789|Analgesics|analgesics|mesh-ancestor
19619307|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
19619308|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619309|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19619310|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19619311|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19619312|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
20134813|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134814|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
20134815|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134816|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20134817|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20134818|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20134819|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134820|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20134821|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20134822|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20134823|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20134824|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20134825|NCT00038233|Thalidomide|thalidomide|mesh-list
20134826|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134827|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
20134828|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134829|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
20134830|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134831|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134832|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20312620|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
20312621|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
20312622|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312623|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20312624|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312625|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19619313|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619314|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619315|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19619316|NCT02518789|Narcotics|narcotics|mesh-ancestor
19619317|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19619318|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19619319|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19619320|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19619321|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
19619322|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
19619323|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19619324|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19619325|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19619326|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19619327|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19619328|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
20134833|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20134834|NCT00038233|Growth Substances|growth substances|mesh-ancestor
20134835|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
20134836|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134837|NCT00038246|Thalidomide|thalidomide|mesh-list
20134838|NCT00038246|Paclitaxel|paclitaxel|mesh-list
20134839|NCT00038246|Estramustine|estramustine|mesh-list
20134840|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20134841|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134842|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
20134843|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
20134844|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134845|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134846|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134847|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
20134848|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134849|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
20134850|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134851|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312626|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312627|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312628|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134852|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19619329|NCT02518958|Nivolumab|nivolumab|mesh-list
19619330|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619331|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134853|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20134854|NCT00038246|Growth Substances|growth substances|mesh-ancestor
20134855|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
20134856|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20134857|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
20134858|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20134859|NCT00038259|Aldesleukin|aldesleukin|mesh-list
20134860|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134861|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19619332|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19619333|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660436|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19660437|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660438|NCT04976595|Testosterone|testosterone|mesh-list
19660439|NCT04976595|Androgens|androgens|mesh-ancestor
19660440|NCT04976595|Hormones|hormones|mesh-ancestor
19660441|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660442|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660443|NCT04951050|Sirolimus|sirolimus|mesh-list
19660444|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19660445|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660446|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20312629|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
20312630|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
19660447|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660448|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
19660449|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20134862|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134863|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
20134864|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134865|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
20134866|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20134867|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134868|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20134869|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
20134870|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134871|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134872|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134873|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134874|NCT00038376|Interferons|interferons|mesh-list
20134875|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
20312631|NCT00685061|Daclizumab|daclizumab|mesh-list
20312632|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
20312633|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312634|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312635|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20312636|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312637|NCT00685100|Triamcinolone|triamcinolone|mesh-list
20312638|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660450|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
19660451|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660452|NCT04934072|Denosumab|denosumab|mesh-list
19660453|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19660454|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660455|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
19660456|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19660457|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660458|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19660459|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660460|NCT04912856|Ezogabine|ezogabine|mesh-list
19660461|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
19660462|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19660463|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660464|NCT04880863|Docetaxel|docetaxel|mesh-list
19660465|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
19660466|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660467|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660468|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660469|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660470|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660471|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660472|NCT04880577|Tenofovir|tenofovir|mesh-list
20134876|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
20312639|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
20312640|NCT00685100|Hormones|hormones|mesh-ancestor
19619334|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19619335|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134877|NCT00038376|Isotretinoin|isotretinoin|mesh-list
20134878|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134879|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
20134880|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134881|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
19619336|NCT02518503|Atorvastatin|atorvastatin|mesh-list
19619337|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19619338|NCT02518503|Simvastatin|simvastatin|mesh-list
19619339|NCT02518503|Pravastatin|pravastatin|mesh-list
19619340|NCT02518503|Lovastatin|lovastatin|mesh-list
19619341|NCT02518503|L 647318|l 647318|mesh-list
19619342|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
19619343|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19619344|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19619345|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
19619346|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619347|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19619348|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19619349|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619350|NCT02518594|Progesterone|progesterone|mesh-list
19619351|NCT02518594|Progestins|progestins|mesh-ancestor
19619352|NCT02518594|Hormones|hormones|mesh-ancestor
19619353|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619354|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619355|NCT02518451|Valsartan|valsartan|mesh-list
19619356|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19619357|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19619358|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19619359|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619360|NCT02518373|Omeprazole|omeprazole|mesh-list
19619361|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19619362|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619363|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19619364|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619365|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619366|NCT02518516|Atorvastatin|atorvastatin|mesh-list
20134882|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134883|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
20134884|NCT00038389|Rofecoxib|rofecoxib|mesh-list
20134885|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19619367|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19619368|NCT02518516|Simvastatin|simvastatin|mesh-list
19619369|NCT02518516|Pravastatin|pravastatin|mesh-list
19619370|NCT02518516|Lovastatin|lovastatin|mesh-list
19619371|NCT02518516|L 647318|l 647318|mesh-list
19619372|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
19619373|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19619374|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19619375|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
19619376|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619377|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19619378|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19619379|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619380|NCT02518438|Tramadol|tramadol|mesh-list
19619381|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19619382|NCT02518438|Narcotics|narcotics|mesh-ancestor
19619383|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619384|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619385|NCT02518438|Analgesics|analgesics|mesh-ancestor
19619386|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
19619387|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619388|NCT02518295|Sulfalene|sulfalene|mesh-list
19619389|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134886|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20134887|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134888|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134889|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20134890|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20134891|NCT00038389|Analgesics|analgesics|mesh-ancestor
20134892|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
19619390|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19619391|NCT02518295|Renal Agents|renal agents|mesh-ancestor
20134893|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619392|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
19619393|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19619394|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19619395|NCT02518152|Alendronate|alendronate|mesh-list
19619396|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19619397|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619398|NCT02518022|Insulin|insulin|mesh-list
19619399|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
19619400|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
19619401|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19619402|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619403|NCT02518009|Estrogens|estrogens|mesh-list
19619404|NCT02518009|Androgens|androgens|mesh-list
19619405|NCT02518009|Hormones|hormones|mesh-ancestor
20134894|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134895|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20134896|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134897|NCT00038402|Paclitaxel|paclitaxel|mesh-list
20134898|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
20134899|NCT00038402|Fluorouracil|fluorouracil|mesh-list
20134900|NCT00038402|Trastuzumab|trastuzumab|mesh-list
20134901|NCT00038402|Epirubicin|epirubicin|mesh-list
20134902|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20134903|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134904|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
20134905|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
20134906|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
20134907|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619406|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619407|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619408|NCT02517814|Vitamin D|vitamin d|mesh-list
19619409|NCT02517814|Vitamins|vitamins|mesh-ancestor
19619410|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
19619411|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619412|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19619413|NCT02517827|Paclitaxel|paclitaxel|mesh-list
19619414|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19619415|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619416|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
20134908|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312641|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312642|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312643|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19619417|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312644|NCT00685126|Albuterol|albuterol|mesh-list
20312645|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20312646|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
20312647|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312648|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312649|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20312650|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
20312651|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
20312652|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312653|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20312654|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312655|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312656|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312657|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619418|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
19619419|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619420|NCT02517788|Interferons|interferons|mesh-list
19619421|NCT02517788|Interferon-beta|interferon-beta|mesh-list
19619422|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
19619423|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619424|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
19619425|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619426|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
19619427|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619428|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19619429|NCT02517957|Loperamide|loperamide|mesh-list
19619430|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
19619431|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619432|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
19619433|NCT02517918|Sirolimus|sirolimus|mesh-list
19619434|NCT02517918|Methotrexate|methotrexate|mesh-list
19619435|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19619436|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
20134909|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
20134910|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619437|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19619438|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619439|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19619440|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
19619441|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619442|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619443|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
19619444|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619445|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19619446|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19619447|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
19619448|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19619449|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19619450|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19619451|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619452|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19619453|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
19619454|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19619455|NCT02517736|Sorafenib|sorafenib|mesh-list
19619456|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619457|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19619458|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619459|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619460|NCT02517684|Prednisolone|prednisolone|mesh-list
19619461|NCT02517684|Azathioprine|azathioprine|mesh-list
19619462|NCT02517684|Infliximab|infliximab|mesh-list
19619463|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619464|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
19619465|NCT02517684|Hormones|hormones|mesh-ancestor
19619466|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619467|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619468|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19619469|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619470|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619471|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
19619472|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134911|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20134912|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20134913|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
20134914|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20134915|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
19619473|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
19619474|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619475|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19619476|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19619477|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
19619478|NCT02517619|Dexamethasone|dexamethasone|mesh-list
19619479|NCT02517619|Prednisolone|prednisolone|mesh-list
19619480|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19619481|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
19619482|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19619483|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
19619484|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19619485|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19619486|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
19619487|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19619488|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619489|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
19619490|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
20134916|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20134917|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20134918|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20134919|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20134920|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20134921|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134922|NCT00038480|Ritonavir|ritonavir|mesh-list
20134923|NCT00038480|Lopinavir|lopinavir|mesh-list
20134924|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20134925|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19619491|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619492|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619493|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619494|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
19619495|NCT02517619|Hormones|hormones|mesh-ancestor
20134926|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
19619496|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619497|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19619498|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619499|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19619500|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19619501|NCT02517619|Protective Agents|protective agents|mesh-ancestor
19619502|NCT02517372|Pemirolast|pemirolast|mesh-list
19619503|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
19619504|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
19619505|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619506|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619507|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619508|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
20134927|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134928|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134929|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20134930|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134931|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
20134932|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619509|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619510|NCT02517424|Dronabinol|dronabinol|mesh-list
19619511|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
19619512|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619513|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19619514|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19619515|NCT02517424|Analgesics|analgesics|mesh-ancestor
19619516|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
19619517|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619518|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19619519|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19619520|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619521|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619522|NCT02517424|Hormones|hormones|mesh-ancestor
19619523|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619524|NCT02517307|Heparin|heparin|mesh-list
19619525|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19619526|NCT02517307|Glycerol|glycerol|mesh-list
19619527|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
19619528|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20134933|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20134934|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20134935|NCT00038493|Temozolomide|temozolomide|mesh-list
20134936|NCT00038493|Lonafarnib|lonafarnib|mesh-list
19619529|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19619530|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619531|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19619532|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19619533|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19619534|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19619535|NCT02517307|Protective Agents|protective agents|mesh-ancestor
19619536|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619537|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19619538|NCT02517164|Calcifediol|calcifediol|mesh-list
19619539|NCT02517164|Vitamins|vitamins|mesh-ancestor
19619540|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
19619541|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619542|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19660473|NCT04880577|Rituximab|rituximab|mesh-list
19660474|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
19660475|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660476|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660477|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
19660478|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660479|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660480|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
19660481|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134937|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19660482|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20312658|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312659|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
20312660|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19660483|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134938|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
20312661|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19619543|NCT02516826|Olmesartan|olmesartan|mesh-list
19619544|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19619545|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19619546|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19619547|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19619548|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
19619549|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619550|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19619551|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19619552|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619553|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19619554|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19619555|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19619556|NCT02517099|Azithromycin|azithromycin|mesh-list
20134939|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134940|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619557|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19619558|NCT02517099|Beclomethasone|beclomethasone|mesh-list
19619559|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19619560|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619561|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19619562|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619563|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619564|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619565|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
19619566|NCT02517099|Hormones|hormones|mesh-ancestor
19619567|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619568|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619569|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19619570|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
19619571|NCT02516774|Adalimumab|adalimumab|mesh-list
19619572|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619573|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19619574|NCT02516618|Fasinumab|fasinumab|mesh-list
19619575|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19619576|NCT02516618|Analgesics|analgesics|mesh-ancestor
19619577|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
19619578|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619579|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134941|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134942|NCT00038506|Tenofovir|tenofovir|mesh-list
20134943|NCT00038506|Lamivudine|lamivudine|mesh-list
20134944|NCT00038506|Zidovudine|zidovudine|mesh-list
20134945|NCT00038506|Abacavir|abacavir|mesh-list
20134946|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20134947|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
20134948|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134949|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20134950|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20134951|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134952|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619592|NCT02516904|Rezafungin|rezafungin|mesh-list
19619593|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
19619594|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619595|NCT02516631|Misoprostol|misoprostol|mesh-list
19619596|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20134953|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20134954|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20134955|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
20134956|NCT00038519|Ritonavir|ritonavir|mesh-list
20134957|NCT00038519|Saquinavir|saquinavir|mesh-list
20134958|NCT00038519|Amprenavir|amprenavir|mesh-list
20134959|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20134960|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20134961|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
20134962|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134963|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20134964|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20134965|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19619597|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
19619598|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19619599|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619600|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19619601|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619602|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
19619603|NCT02516527|Ipilimumab|ipilimumab|mesh-list
19619604|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619605|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619606|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19619607|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619608|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
19619609|NCT02516475|Astringents|astringents|mesh-ancestor
19619610|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619611|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19619612|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
19619613|NCT02516423|Dexamethasone|dexamethasone|mesh-list
19619614|NCT02516423|Lenalidomide|lenalidomide|mesh-list
19619615|NCT02516423|Ixazomib|ixazomib|mesh-list
19619616|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619617|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
19619618|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
19619619|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619620|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619621|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619622|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
19619623|NCT02516423|Hormones|hormones|mesh-ancestor
20134966|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
19619624|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619625|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19619626|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619627|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
19619628|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19619629|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19619630|NCT02516423|Growth Substances|growth substances|mesh-ancestor
19619631|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
19619632|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19619633|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
19619634|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619635|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619636|NCT02516436|Buprenorphine|buprenorphine|mesh-list
19619637|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19619638|NCT02516436|Narcotics|narcotics|mesh-ancestor
19619639|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619640|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619641|NCT02516436|Analgesics|analgesics|mesh-ancestor
19619642|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
19619643|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619644|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19619645|NCT02516462|Hormones|hormones|mesh-list
19619646|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19619647|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619648|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619649|NCT02516085|Metformin|metformin|mesh-list
19619650|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19619651|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619652|NCT02516059|Oxycodone|oxycodone|mesh-list
19619653|NCT02516059|Naloxone|naloxone|mesh-list
19619654|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19619655|NCT02516059|Narcotics|narcotics|mesh-ancestor
19619656|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619657|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619658|NCT02516059|Analgesics|analgesics|mesh-ancestor
19619659|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
19619660|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619661|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19619662|NCT02515968|Propofol|propofol|mesh-list
19619663|NCT02515968|Desflurane|desflurane|mesh-list
19619664|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
19619665|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619666|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20134967|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256602|NCT04363840|Aspirin|aspirin|mesh-list
19619667|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19619668|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19619669|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
19619670|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19619671|NCT02515955|Minocycline|minocycline|mesh-list
20134968|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20134969|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20134970|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20134971|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
20134972|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134973|NCT00038532|Ritonavir|ritonavir|mesh-list
20134974|NCT00038532|Saquinavir|saquinavir|mesh-list
19619672|NCT02515955|Amphetamine|amphetamine|mesh-list
19619673|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
19619674|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19619675|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619676|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19619677|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619678|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
19619679|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
19619680|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619681|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
19619682|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619683|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619684|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
19619685|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19619686|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19619687|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19619688|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19619689|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
19619690|NCT02515929|Procyanidin|procyanidin|mesh-list
19619691|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
19619692|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619693|NCT02515929|Protective Agents|protective agents|mesh-ancestor
19619694|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619695|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19619696|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19619697|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619698|NCT02515877|Carboplatin|carboplatin|mesh-list
19619699|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619700|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
19619701|NCT02515864|Dotinurad|dotinurad|mesh-list
19619702|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19619703|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19619704|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619705|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19619706|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20134975|NCT00038532|Amprenavir|amprenavir|mesh-list
20134976|NCT00038532|Efavirenz|efavirenz|mesh-list
20134977|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20134978|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19619707|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619708|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619709|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619710|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19619711|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
19619712|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19619713|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619714|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19619715|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19619716|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19619717|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
19619718|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
19619719|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19619720|NCT02515864|Renal Agents|renal agents|mesh-ancestor
19619721|NCT02515682|Equol|equol|mesh-list
19619722|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
19619723|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20134979|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
20134980|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134981|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619724|NCT02515682|Estrogens|estrogens|mesh-ancestor
19619725|NCT02515682|Hormones|hormones|mesh-ancestor
19660484|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20134982|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20134983|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19619726|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619727|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619728|NCT02515695|Interferons|interferons|mesh-list
19619729|NCT02515695|Interferon-beta|interferon-beta|mesh-list
19619730|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
19619731|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619732|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
19619733|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619734|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
19619735|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619736|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19619737|NCT02515734|Leucovorin|leucovorin|mesh-list
19619738|NCT02515734|Bevacizumab|bevacizumab|mesh-list
19619739|NCT02515734|Cetuximab|cetuximab|mesh-list
19619740|NCT02515734|Fluorouracil|fluorouracil|mesh-list
19619741|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
19619742|NCT02515734|Irinotecan|irinotecan|mesh-list
19619743|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619744|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619745|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19619746|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19619747|NCT02515734|Growth Substances|growth substances|mesh-ancestor
19619748|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619749|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19619750|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
19619751|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619752|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19619753|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19619754|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
19619755|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19619756|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19619757|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619758|NCT02515734|Antidotes|antidotes|mesh-ancestor
19619759|NCT02515734|Protective Agents|protective agents|mesh-ancestor
19619760|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
19619761|NCT02515734|Vitamins|vitamins|mesh-ancestor
19619762|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
19619763|NCT02515604|Misoprostol|misoprostol|mesh-list
19619764|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19619765|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
19619766|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312662|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
20312663|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312664|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20312665|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20312666|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312667|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619767|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619768|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19619769|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619770|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
19619771|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19619772|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19619773|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619774|NCT02515526|Tolbutamide|tolbutamide|mesh-list
19619775|NCT02515526|Ethanol|ethanol|mesh-list
19619776|NCT02515526|Digoxin|digoxin|mesh-list
19619777|NCT02515526|Midazolam|midazolam|mesh-list
19619778|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
19619779|NCT02515526|Caffeine|caffeine|mesh-list
19619780|NCT02515526|Omeprazole|omeprazole|mesh-list
19619781|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19619782|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19619783|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619784|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619785|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19619786|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19619787|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19619788|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19619789|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
19619790|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
19619791|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
19619792|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
19619793|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619794|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619795|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19619796|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619797|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19619798|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619799|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20134984|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
20134985|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20134986|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20134987|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19619800|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19619801|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19619802|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19619803|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
19619804|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19619805|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619806|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19619807|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19619808|NCT02515526|Protective Agents|protective agents|mesh-ancestor
19619809|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
19619810|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
19619811|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19619812|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19619813|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19619814|NCT02515448|Gentamicins|gentamicins|mesh-list
19619815|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19619816|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619817|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19619818|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619819|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619820|NCT02515435|Apatinib|apatinib|mesh-list
19619821|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619822|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19619823|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619824|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619825|NCT02515565|Erythromycin|erythromycin|mesh-list
19619826|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
19619827|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19619828|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
19619829|NCT02515565|Cephalosporins|cephalosporins|mesh-list
19619830|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19619831|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619832|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19619833|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19619834|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619835|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619836|NCT02515201|Taurolidine|taurolidine|mesh-list
19619837|NCT02515201|Heparin|heparin|mesh-list
19619838|NCT02515201|Calcium heparin|calcium heparin|mesh-list
19619839|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
19619840|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19619841|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19619842|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619843|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619844|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19619845|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20134988|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20134989|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20312668|NCT00685230|Antivenins|antivenins|mesh-list
19619846|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19619847|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
19619848|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619849|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
19619850|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619851|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619852|NCT02515422|Ketamine|ketamine|mesh-list
19619853|NCT02515422|Bupivacaine|bupivacaine|mesh-list
19619854|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
19619855|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
19619856|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619857|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619858|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
19619859|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619860|NCT02515422|Analgesics|analgesics|mesh-ancestor
19619861|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19619862|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19619863|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
19619864|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19619865|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19619866|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619867|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660485|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660486|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19660487|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19660488|NCT04861558|Fluorouracil|fluorouracil|mesh-list
19660489|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
19660490|NCT04861558|Irinotecan|irinotecan|mesh-list
19660491|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
19660492|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660493|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19660494|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660495|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19660496|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
19660497|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660498|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19660499|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19660500|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660501|NCT04837235|Hemay005|hemay005|mesh-list
19660502|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
19660503|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19660504|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19660505|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660506|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660507|NCT04775550|Dexamethasone|dexamethasone|mesh-list
19660508|NCT04775550|Lenalidomide|lenalidomide|mesh-list
19660509|NCT04775550|Bortezomib|bortezomib|mesh-list
19660510|NCT04775550|Daratumumab|daratumumab|mesh-list
19660511|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660512|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
20134990|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20134991|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20134992|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20134993|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20134994|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20134995|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20134996|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
20134997|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20134998|NCT00038545|Paclitaxel|paclitaxel|mesh-list
20134999|NCT00038545|Topotecan|topotecan|mesh-list
20135000|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135001|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135002|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135003|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135004|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135005|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135006|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20135007|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135008|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135009|NCT00038558|Doxorubicin|doxorubicin|mesh-list
20135010|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20312669|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
20312670|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312671|NCT00685269|Eszopiclone|eszopiclone|mesh-list
19660513|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
19660514|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660515|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660516|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660517|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
19660518|NCT04775550|Hormones|hormones|mesh-ancestor
19660519|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660520|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660521|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660522|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
19660523|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19660524|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19660525|NCT04775550|Growth Substances|growth substances|mesh-ancestor
19660526|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
19660527|NCT04771962|Sevoflurane|sevoflurane|mesh-list
19660528|NCT04771962|Desflurane|desflurane|mesh-list
19660529|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19660530|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19660531|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
19660532|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
19619868|NCT02515188|Acetaminophen|acetaminophen|mesh-list
19619869|NCT02515188|Propacetamol|propacetamol|mesh-list
19619870|NCT02515188|Analgesics|analgesics|mesh-ancestor
19619871|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
19619872|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619873|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619874|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19619875|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19619876|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19619877|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19619878|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
19619879|NCT02514941|Acetaminophen|acetaminophen|mesh-list
19619880|NCT02514941|Amoxicillin|amoxicillin|mesh-list
19619881|NCT02514941|Talinolol|talinolol|mesh-list
19619882|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19619883|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619884|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20135011|NCT00038558|Bleomycin|bleomycin|mesh-list
20135012|NCT00038558|Dacarbazine|dacarbazine|mesh-list
20135013|NCT00038558|Vinblastine|vinblastine|mesh-list
20135014|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135015|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619885|NCT02514941|Analgesics|analgesics|mesh-ancestor
19619886|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
19619887|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619888|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135016|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20135017|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135018|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135019|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135020|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135021|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
20135022|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135023|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
20312672|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20312673|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312674|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312675|NCT00685347|Albuterol|albuterol|mesh-list
20312676|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20312677|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
20312678|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619889|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
19619890|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19619891|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19619892|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
19619893|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619894|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619895|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19619896|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19619897|NCT02514980|Ketamine|ketamine|mesh-list
19619898|NCT02514980|Bupivacaine|bupivacaine|mesh-list
19619899|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
19619900|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
19619901|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619902|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619903|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
19619904|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619905|NCT02514980|Analgesics|analgesics|mesh-ancestor
19619906|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19619907|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19619908|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
19619909|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19619910|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20312679|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619911|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135024|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135025|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135026|NCT00038571|Bortezomib|bortezomib|mesh-list
20135027|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135028|NCT00038584|Lonafarnib|lonafarnib|mesh-list
20135029|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135030|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312680|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19619912|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312681|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
20135031|NCT00038597|Lonafarnib|lonafarnib|mesh-list
19619913|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
19619914|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19619915|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619916|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
19619917|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19619918|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619919|NCT02514681|Gemcitabine|gemcitabine|mesh-list
19619920|NCT02514681|Paclitaxel|paclitaxel|mesh-list
19619921|NCT02514681|Vinorelbine|vinorelbine|mesh-list
19619922|NCT02514681|Docetaxel|docetaxel|mesh-list
19619923|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20135032|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135033|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135034|NCT00038623|Rituximab|rituximab|mesh-list
20135035|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135036|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135037|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
20135038|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619924|NCT02514681|Capecitabine|capecitabine|mesh-list
19619925|NCT02514681|Trastuzumab|trastuzumab|mesh-list
19619926|NCT02514681|Pertuzumab|pertuzumab|mesh-list
19619927|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19619928|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619929|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
19619930|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
19619931|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
19619932|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619933|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19619934|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
19619935|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
19619936|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19619937|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19619938|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19619939|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
19619940|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619941|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19619942|NCT02514642|Clopidogrel|clopidogrel|mesh-list
19619943|NCT02514642|Ticagrelor|ticagrelor|mesh-list
19619944|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19619945|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19619946|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19619947|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19619948|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
19619949|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19619950|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619951|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619952|NCT02514629|Metformin|metformin|mesh-list
19619953|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
19619954|NCT02514629|Testosterone|testosterone|mesh-list
19619955|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
19619956|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
19619957|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19619958|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19619959|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619960|NCT02514629|Androgens|androgens|mesh-ancestor
19619961|NCT02514629|Hormones|hormones|mesh-ancestor
19619962|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19619963|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19619964|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619965|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
19619966|NCT02514538|Acetaminophen|acetaminophen|mesh-list
19619967|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19619968|NCT02514538|Analgesics|analgesics|mesh-ancestor
19619969|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
19619970|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619971|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619972|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
19619973|NCT02514278|Capecitabine|capecitabine|mesh-list
19619974|NCT02514278|Folfirinox|folfirinox|mesh-list
19619975|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19619976|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
19619977|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135039|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135040|NCT00038636|Ritonavir|ritonavir|mesh-list
20135041|NCT00038636|Lopinavir|lopinavir|mesh-list
19619978|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19619979|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
20312682|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
20135042|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20135043|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20135044|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
20135045|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135046|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135047|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20135048|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19619980|NCT02514343|Bupivacaine|bupivacaine|mesh-list
19619981|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
19619982|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
19619983|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19619984|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19619985|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
19619986|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19619987|NCT02514343|Analgesics|analgesics|mesh-ancestor
19619988|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19619989|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
19619990|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19619991|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19619992|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19619993|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19619994|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
19619995|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19619996|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
19619997|NCT02514330|Vitamins|vitamins|mesh-ancestor
19619998|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
19619999|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620000|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19620001|NCT02514421|Gemcitabine|gemcitabine|mesh-list
19620002|NCT02514421|Paclitaxel|paclitaxel|mesh-list
19620003|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19620004|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620005|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
19620006|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
19620007|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
19620008|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620009|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19620010|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
19620011|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
19620012|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620013|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620014|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19620015|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
19620016|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620017|NCT02514200|Riboflavin|riboflavin|mesh-list
19620018|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
19620019|NCT02514200|Vitamins|vitamins|mesh-ancestor
19620020|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
19620021|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620022|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19620023|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
20135049|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
20135050|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135051|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20135052|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20135053|NCT00038662|Atrasentan|atrasentan|mesh-list
20135054|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135055|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20135056|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20135057|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135058|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
20135059|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135060|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620024|NCT02514018|Vaccines|vaccines|mesh-list
19620025|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
19620026|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620027|NCT02513875|Vitamin D|vitamin d|mesh-list
19620028|NCT02513875|Vitamins|vitamins|mesh-ancestor
19620029|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
19620030|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620031|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19620032|NCT02513849|Tamoxifen|tamoxifen|mesh-list
19620033|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19620034|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
19620035|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19620036|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620037|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19620038|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620039|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19620040|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19620041|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19620042|NCT02513862|Heparin|heparin|mesh-list
19620043|NCT02513862|Protamines|protamines|mesh-list
19620044|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
19620045|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19620046|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19620047|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620048|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
19620049|NCT02513862|Coagulants|coagulants|mesh-ancestor
19620050|NCT02513927|Metoprolol|metoprolol|mesh-list
19620051|NCT02513927|Nifedipine|nifedipine|mesh-list
19620052|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19620053|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19620054|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
19620055|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
19620056|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620057|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620058|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19620059|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19620060|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19620061|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620062|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620063|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620064|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19620065|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19620066|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19620067|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
19620068|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
19620069|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19620070|NCT02513654|Lamotrigine|lamotrigine|mesh-list
19620071|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
19620072|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19620073|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19620074|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620075|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19620076|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620077|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19620078|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19620079|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20135061|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20135062|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20135063|NCT00038701|Growth Substances|growth substances|mesh-ancestor
19620080|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19620081|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19620082|NCT02513888|Vitamin D|vitamin d|mesh-list
19620083|NCT02513888|Vitamins|vitamins|mesh-ancestor
19620084|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
19620085|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620086|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19620087|NCT02513693|Rocuronium|rocuronium|mesh-list
19620088|NCT02513693|Neostigmine|neostigmine|mesh-list
19620089|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19620090|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19620091|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19620092|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620093|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620094|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19620095|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620096|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620097|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
19620098|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620099|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19620100|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
19620101|NCT02513433|Bupivacaine|bupivacaine|mesh-list
20135064|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135065|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
20135066|NCT00038766|Semapimod|semapimod|mesh-list
20135067|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20312683|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20135068|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20135069|NCT00038766|Analgesics|analgesics|mesh-ancestor
19620102|NCT02513433|Ropivacaine|ropivacaine|mesh-list
19620103|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
19620104|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
19620105|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
19620106|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620107|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620108|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
19620109|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620110|NCT02513381|Vitamin D|vitamin d|mesh-list
19620111|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
19620112|NCT02513381|Vitamins|vitamins|mesh-ancestor
19620113|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
19620114|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620115|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19620116|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19620117|NCT02513394|Palbociclib|palbociclib|mesh-list
19620118|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620119|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19620120|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620121|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620122|NCT02513355|Cisplatin|cisplatin|mesh-list
19620123|NCT02513355|Endostar protein|endostar protein|mesh-list
19620124|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620125|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19620126|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19620127|NCT02513355|Growth Substances|growth substances|mesh-ancestor
19620128|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620129|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
19660533|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660534|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660535|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
19660536|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19660537|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660538|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19660539|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660540|NCT04726098|Dexamethasone|dexamethasone|mesh-list
19660541|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
19660542|NCT04726098|BB 1101|bb 1101|mesh-list
19660543|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660544|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
19660545|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
19660546|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660547|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660548|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660549|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
19660550|NCT04726098|Hormones|hormones|mesh-ancestor
19660551|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660552|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660553|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660554|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
19660555|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660556|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665617|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665618|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665619|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665620|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665621|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19665622|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665623|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
20135070|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
20135071|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135072|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135073|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20135074|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135075|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135076|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
20135077|NCT00038792|Mitogens|mitogens|mesh-list
20135078|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135079|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665624|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665625|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20135080|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
19620130|NCT02513290|Loratadine|loratadine|mesh-list
19620131|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
19620132|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
19620133|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19620134|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19620135|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19620136|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
19620137|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
19620138|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620139|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620140|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620141|NCT02513342|Docetaxel|docetaxel|mesh-list
19620142|NCT02513342|Endostar protein|endostar protein|mesh-list
19620143|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620144|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
19620145|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
19620146|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
19620147|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620148|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19620149|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19620150|NCT02513342|Growth Substances|growth substances|mesh-ancestor
19620151|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620152|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
19620153|NCT02513004|Clopidogrel|clopidogrel|mesh-list
19620154|NCT02513004|Ticagrelor|ticagrelor|mesh-list
19620155|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19620156|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19620157|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19620158|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19620159|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
20135081|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135082|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135083|NCT00038831|Vidarabine|vidarabine|mesh-list
20135084|NCT00038831|Fludarabine|fludarabine|mesh-list
20135085|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
20135086|NCT00038831|Melphalan|melphalan|mesh-list
20135087|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
20135088|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20135089|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
20135090|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135091|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135092|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
20135093|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620160|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620161|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620162|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620163|NCT02513147|Lopinavir|lopinavir|mesh-list
19620164|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19620165|NCT02513147|Darunavir|darunavir|mesh-list
19620166|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
19620167|NCT02513147|Dolutegravir|dolutegravir|mesh-list
19620168|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19620169|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19620170|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
19620171|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620172|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620173|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19620174|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19620175|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
19620176|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620177|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19620178|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19620179|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19620180|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19620181|NCT02513069|Nicotine|nicotine|mesh-list
19620182|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
19620183|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19620184|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
19620185|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620186|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620187|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19620188|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20135094|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135095|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
20135096|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135097|NCT00038831|Antiviral Agents|antiviral agents|mesh-ancestor
19620189|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
19620190|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620191|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620192|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
19620193|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
19620194|NCT02512887|Anesthetics|anesthetics|mesh-list
19620195|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620196|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620197|NCT02512562|Simeprevir|simeprevir|mesh-list
19620198|NCT02512562|Odalasvir|odalasvir|mesh-list
19620199|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
19620200|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620201|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
19620202|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620203|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620204|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
19620205|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19620206|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19620207|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19620208|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19620209|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620210|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
19620211|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620212|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620213|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19620214|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620215|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19620216|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19620217|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19620218|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19620219|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19620220|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
19620221|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19620222|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
19620223|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620224|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19620225|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19620226|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19620227|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19620228|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620229|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
19620230|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19620231|NCT02512471|Ropivacaine|ropivacaine|mesh-list
19620232|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
19620233|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
19620234|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620235|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620236|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
19620237|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620238|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19620239|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19620240|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620241|NCT02512523|Incretins|incretins|mesh-ancestor
19620242|NCT02512523|Hormones|hormones|mesh-ancestor
19620243|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19620244|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19620245|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
19620246|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620247|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620248|NCT02512380|Docetaxel|docetaxel|mesh-list
19620249|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
19620250|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620251|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
19620252|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135098|NCT00038831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608365|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608366|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608367|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608368|NCT02245490|Urological Agents|urological agents|mesh-ancestor
20608369|NCT02245503|Tamsulosin|tamsulosin|mesh-list
19620253|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135099|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135100|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
19660557|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
19620254|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620255|NCT02512315|Cisplatin|cisplatin|mesh-list
19620256|NCT02512315|Docetaxel|docetaxel|mesh-list
19620257|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620258|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
19620259|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
19620260|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
19620261|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620262|NCT02512055|Atropine|atropine|mesh-list
19620263|NCT02512055|Ketamine|ketamine|mesh-list
19620264|NCT02512055|Analgesics|analgesics|mesh-ancestor
19620265|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
19620266|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620267|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620268|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19620269|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19620270|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
19620271|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
19620272|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620273|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19620274|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19620275|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620276|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620277|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19620278|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19620279|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19620280|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
19620281|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19620282|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
20135101|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135102|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135103|NCT00038844|Vidarabine|vidarabine|mesh-list
20135104|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
20135105|NCT00038844|Rituximab|rituximab|mesh-list
19620283|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
19620284|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
19620285|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19620286|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19620287|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
19620288|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
19620289|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19620290|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620291|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620292|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620293|NCT02511795|Olaparib|olaparib|mesh-list
19620294|NCT02511795|Adavosertib|adavosertib|mesh-list
19620295|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19620296|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620297|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620298|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620299|NCT02511613|Squalamine|squalamine|mesh-list
19620300|NCT02511613|Ranibizumab|ranibizumab|mesh-list
19620301|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19620302|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19620303|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19620304|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19620305|NCT02511613|Growth Substances|growth substances|mesh-ancestor
19620306|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620307|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
19620308|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620309|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19620310|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135106|NCT00038844|Fludarabine|fludarabine|mesh-list
19256603|NCT04363840|Vitamin D|vitamin d|mesh-list
19620311|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20135107|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
19620312|NCT02511613|Protective Agents|protective agents|mesh-ancestor
19620313|NCT02511665|Metformin|metformin|mesh-list
19620314|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19620315|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620316|NCT02511847|Afatinib|afatinib|mesh-list
19620317|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620318|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19620319|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620320|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620321|NCT02511639|Everolimus|everolimus|mesh-list
19620322|NCT02511639|Letrozole|letrozole|mesh-list
19620323|NCT02511639|Anastrozole|anastrozole|mesh-list
19620324|NCT02511639|Exemestane|exemestane|mesh-list
19620325|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19620326|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620327|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19620328|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
19620329|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620330|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19620331|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620332|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620333|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19620334|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
19620335|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20135108|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
19620336|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19620337|NCT02511483|Propranolol|propranolol|mesh-list
19620338|NCT02511483|Morphine|morphine|mesh-list
19620339|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19620340|NCT02511483|Narcotics|narcotics|mesh-ancestor
19620341|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620342|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620343|NCT02511483|Analgesics|analgesics|mesh-ancestor
19620344|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
19620345|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620346|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19620347|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19620348|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620349|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620350|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620351|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19620352|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19620353|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
19620354|NCT02511704|Nicotine|nicotine|mesh-list
19620355|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19620356|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
19620357|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620358|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620359|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19620360|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19620361|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
19620362|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620363|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620364|NCT02511574|Progesterone|progesterone|mesh-list
19620365|NCT02511574|Progestins|progestins|mesh-ancestor
19620366|NCT02511574|Hormones|hormones|mesh-ancestor
19620367|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19620368|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660558|NCT04699071|Lenvatinib|lenvatinib|mesh-list
19660559|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660560|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660561|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19660562|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135109|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135110|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
20135111|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135112|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660563|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660564|NCT04648189|Cetuximab|cetuximab|mesh-list
19660565|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19620369|NCT02511405|Bevacizumab|bevacizumab|mesh-list
19620370|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19620371|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620372|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19620373|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19620374|NCT02511405|Growth Substances|growth substances|mesh-ancestor
19620375|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620376|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
19620377|NCT02511353|Ivermectin|ivermectin|mesh-list
19620378|NCT02511353|Piperaquine|piperaquine|mesh-list
19620379|NCT02511353|Artenimol|artenimol|mesh-list
19620380|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19620381|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620382|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
19620383|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19620384|NCT02511418|Simvastatin|simvastatin|mesh-list
19620385|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19620386|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19620387|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
19620388|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620389|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19620390|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19620391|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620392|NCT02511366|Caseins|caseins|mesh-list
19620393|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
19620394|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
19620395|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620396|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
19620397|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135113|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135114|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
20135115|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620398|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620399|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620400|NCT02511327|Vaccines|vaccines|mesh-list
19620401|NCT02511327|Immunologic Factors|immunologic factors|mesh-ancestor
20135116|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135117|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135118|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135119|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135120|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
20135121|NCT00038844|Antiviral Agents|antiviral agents|mesh-ancestor
20135122|NCT00038844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620402|NCT02511327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620403|NCT02511223|Olaparib|olaparib|mesh-list
19620404|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19620405|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620406|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135123|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
20135124|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19620407|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620408|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19620409|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19620410|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
19620411|NCT02511210|Anesthetics|anesthetics|mesh-list
19620412|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620413|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620414|NCT02511054|Chloroquine|chloroquine|mesh-list
19620415|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
19620416|NCT02511054|Amebicides|amebicides|mesh-ancestor
19620417|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19620418|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19620419|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620420|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
19620421|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19620422|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19620423|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620424|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620425|NCT02511067|Ranibizumab|ranibizumab|mesh-list
19620426|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19620427|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20135125|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135126|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19620428|NCT02511067|Growth Substances|growth substances|mesh-ancestor
19620429|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620430|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
19620431|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620432|NCT02511132|Irinotecan|irinotecan|mesh-list
19620433|NCT02511132|Temozolomide|temozolomide|mesh-list
19620434|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19620435|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19620436|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620437|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620438|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620439|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19620440|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
19620441|NCT02510976|Prucalopride|prucalopride|mesh-list
19620442|NCT02510976|Laxatives|laxatives|mesh-ancestor
19620443|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620444|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19620445|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19620446|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
19620447|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620448|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620449|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620450|NCT02510781|Carboplatin|carboplatin|mesh-list
19620451|NCT02510781|Docetaxel|docetaxel|mesh-list
19620452|NCT02510781|Trastuzumab|trastuzumab|mesh-list
19620453|NCT02510781|Epirubicin|epirubicin|mesh-list
20135127|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20135128|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20135129|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20135130|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135131|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135132|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135133|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20135134|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
20135135|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20135136|NCT00038922|Oprelvekin|oprelvekin|mesh-list
20135137|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135138|NCT00038935|Factor VIII|factor viii|mesh-list
20135139|NCT00038935|Coagulants|coagulants|mesh-ancestor
20135140|NCT00038961|PENTA|penta|mesh-list
20135141|NCT00038961|Fondaparinux|fondaparinux|mesh-list
20135142|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20135143|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
20312684|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20312685|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312686|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312687|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312688|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312689|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312690|NCT00685425|Albuterol|albuterol|mesh-list
20312691|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20135144|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20135145|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
20135146|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135147|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135148|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
20135149|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19620454|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620455|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
19620456|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
19620457|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
19620458|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620459|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135150|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20135151|NCT00038974|Ribavirin|ribavirin|mesh-list
20135152|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20135153|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
20135154|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135155|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
20135156|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135157|NCT00039013|Exenatide|exenatide|mesh-list
20135158|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20312692|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
19620460|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135159|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135160|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20135161|NCT00039013|Incretins|incretins|mesh-ancestor
20312693|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135162|NCT00039013|Hormones|hormones|mesh-ancestor
20135163|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20135164|NCT00039026|Exenatide|exenatide|mesh-list
20135165|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20135166|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312694|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312695|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19620461|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19620462|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19620463|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620464|NCT02510911|Caffeine|caffeine|mesh-list
19620465|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19620466|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620467|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19620468|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620469|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620470|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19620471|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19620472|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
19620473|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620474|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19620475|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19620476|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620477|NCT02510950|Temozolomide|temozolomide|mesh-list
19620478|NCT02510950|Poly ICLC|poly iclc|mesh-list
19620479|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19620480|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
19620481|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620482|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620483|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
19620484|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
19620485|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620486|NCT02510586|Sevoflurane|sevoflurane|mesh-list
19620487|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19620488|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19620489|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
19620490|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
19620491|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620492|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620493|NCT02510534|Menotropins|menotropins|mesh-list
19620494|NCT02510534|Progesterone|progesterone|mesh-list
19620495|NCT02510534|Progestins|progestins|mesh-ancestor
19620496|NCT02510534|Hormones|hormones|mesh-ancestor
19620497|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20135167|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20135168|NCT00039026|Incretins|incretins|mesh-ancestor
20135169|NCT00039026|Hormones|hormones|mesh-ancestor
20135170|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20135171|NCT00039039|Paclitaxel|paclitaxel|mesh-list
20135172|NCT00039039|Carboplatin|carboplatin|mesh-list
20135173|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135174|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135175|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135176|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135177|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135178|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173589|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173590|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19620498|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620499|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19620500|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
19620501|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19620502|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
19620503|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19620504|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620505|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620506|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19620507|NCT02510612|Analgesics|analgesics|mesh-ancestor
19620508|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
19620509|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620510|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20173591|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312696|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
19620511|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19620512|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19620513|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620514|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620515|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620516|NCT02510963|Tenofovir|tenofovir|mesh-list
19620517|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
19620518|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620519|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19620520|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19620521|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620522|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620523|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19620524|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20135179|NCT00039052|Interleukin-4|interleukin-4|mesh-list
20135180|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20135181|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
20135182|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135183|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135184|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135185|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20135186|NCT00039091|Ipilimumab|ipilimumab|mesh-list
20135187|NCT00039091|Antibodies|antibodies|mesh-list
20135188|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
19620525|NCT02510287|Lidocaine|lidocaine|mesh-list
19620526|NCT02510287|Fentanyl|fentanyl|mesh-list
19620527|NCT02510287|Bupivacaine|bupivacaine|mesh-list
19620528|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
19620529|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
19620530|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620531|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620532|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
19620533|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620534|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19620535|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19620536|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19620537|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19620538|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620539|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19620540|NCT02510287|Narcotics|narcotics|mesh-ancestor
19620541|NCT02510287|Analgesics|analgesics|mesh-ancestor
19620542|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19620543|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19620544|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
19620545|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
19620546|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620547|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620548|NCT02510469|Apatinib|apatinib|mesh-list
19620549|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620550|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19620551|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620552|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620553|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
19620554|NCT02510222|Analgesics|analgesics|mesh-ancestor
19620555|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
19620556|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620557|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620558|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
19620559|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620560|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20135189|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20135190|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
20135191|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135192|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135193|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20312697|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
19620561|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
19620562|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19620563|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19620564|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620565|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20135194|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135195|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
20135196|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20135197|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135198|NCT00039117|Cytarabine|cytarabine|mesh-list
20135199|NCT00039117|Daunorubicin|daunorubicin|mesh-list
20312698|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19620566|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
19620567|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19620568|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
19620569|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19620570|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
19620571|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620572|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
19620573|NCT02510235|Protective Agents|protective agents|mesh-ancestor
19620574|NCT02510157|Dexamethasone|dexamethasone|mesh-list
19620575|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19620576|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
19620577|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
19620578|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620579|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620580|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620581|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
19620582|NCT02510157|Hormones|hormones|mesh-ancestor
19620583|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19620584|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19620585|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620586|NCT02510053|Caspofungin|caspofungin|mesh-list
19620587|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
19620588|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620589|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620590|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620591|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
19620592|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19620593|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620594|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620595|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19620596|NCT02509949|Analgesics|analgesics|mesh-ancestor
19620597|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
19620598|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620599|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19620600|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19620601|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19620602|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620603|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620604|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620605|NCT02509923|Rabeprazole|rabeprazole|mesh-list
19620606|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19620607|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620608|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19620609|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620610|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620611|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
19620612|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19620613|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19620614|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19620615|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620616|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620617|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620618|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660566|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660567|NCT04643249|Repaglinide|repaglinide|mesh-list
19660568|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
19660569|NCT04643249|Midazolam|midazolam|mesh-list
19660570|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
19660571|NCT04643249|Caffeine|caffeine|mesh-list
19660572|NCT04643249|Bupropion|bupropion|mesh-list
19660573|NCT04643249|Omeprazole|omeprazole|mesh-list
20135200|NCT00039117|Oblimersen|oblimersen|mesh-list
20135201|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135202|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
20135203|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135204|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660574|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19660575|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20135205|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
20135206|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620619|NCT02509806|Apatinib|apatinib|mesh-list
19620620|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620621|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19620622|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620623|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620624|NCT02509728|Choline|choline|mesh-list
19620625|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
19620626|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19620627|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
19620628|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620629|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620630|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19620631|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
19620632|NCT02509429|Insulin|insulin|mesh-list
19620633|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19620634|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
19620635|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
19620636|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19620637|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
19620638|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19620639|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620640|NCT02509273|Clonidine|clonidine|mesh-list
19620641|NCT02509273|Midazolam|midazolam|mesh-list
19620642|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19620643|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19620644|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620645|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620646|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19620647|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19620648|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19620649|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19620650|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
19620651|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
19620652|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
19620653|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
19620654|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620655|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620656|NCT02509273|Analgesics|analgesics|mesh-ancestor
19620657|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
20135207|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135208|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
20135209|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135210|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135211|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20135212|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19620658|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620659|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19620660|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
19620661|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
19620662|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19620663|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19620664|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19620665|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620666|NCT02509468|Sirolimus|sirolimus|mesh-list
19620667|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19620668|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620669|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19620670|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620671|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
19620672|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19620673|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
19620674|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620675|NCT02509559|Propranolol|propranolol|mesh-list
19620676|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19620677|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19620678|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620679|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620680|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620681|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135213|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135214|NCT00039156|IDN 5109|idn 5109|mesh-list
20135215|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135216|NCT00039169|IDN 5109|idn 5109|mesh-list
19620682|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20135217|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620683|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20135218|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19620684|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
19620685|NCT02509312|Ketorolac|ketorolac|mesh-list
19620686|NCT02509312|Morphine|morphine|mesh-list
19620687|NCT02509312|Hydromorphone|hydromorphone|mesh-list
19620688|NCT02509312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19620689|NCT02509312|Narcotics|narcotics|mesh-ancestor
19620690|NCT02509312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620691|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620692|NCT02509312|Analgesics|analgesics|mesh-ancestor
19620693|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
19620694|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620695|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20135219|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135220|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135221|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135222|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135223|NCT00039208|Leucovorin|leucovorin|mesh-list
20135224|NCT00039208|Fluorouracil|fluorouracil|mesh-list
20135225|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
20135226|NCT00039208|Irinotecan|irinotecan|mesh-list
20135227|NCT00039208|Calcium|calcium|mesh-list
20135228|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
20135229|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20135230|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135231|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
20135232|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135233|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135234|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135235|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135236|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
20135237|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20135238|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135239|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135240|NCT00039208|Antidotes|antidotes|mesh-ancestor
20135241|NCT00039208|Protective Agents|protective agents|mesh-ancestor
20135242|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
20135243|NCT00039208|Vitamins|vitamins|mesh-ancestor
20135244|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
20135245|NCT00039234|Aldesleukin|aldesleukin|mesh-list
20135246|NCT00039234|Histamine|histamine|mesh-list
20135247|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
20135248|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135249|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19620696|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19620697|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19620698|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19620699|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19620700|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620701|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620702|NCT02509351|Misoprostol|misoprostol|mesh-list
19620703|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20135250|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19620704|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
19620705|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20135251|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
20135252|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135253|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
20135254|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
20135255|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620706|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620707|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19620708|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620709|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
19620710|NCT02509286|Leucovorin|leucovorin|mesh-list
19620711|NCT02509286|Paclitaxel|paclitaxel|mesh-list
20135256|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135257|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135258|NCT00039273|Panitumumab|panitumumab|mesh-list
20135259|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19620712|NCT02509286|Docetaxel|docetaxel|mesh-list
19620713|NCT02509286|Carboplatin|carboplatin|mesh-list
19620714|NCT02509286|Fluorouracil|fluorouracil|mesh-list
19620715|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
19620716|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19620717|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620718|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
19620719|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
19620720|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
19620721|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620722|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
19620723|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19620724|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19620725|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
19620726|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620727|NCT02509286|Antidotes|antidotes|mesh-ancestor
19620728|NCT02509286|Protective Agents|protective agents|mesh-ancestor
19620729|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
19620730|NCT02509286|Vitamins|vitamins|mesh-ancestor
19620731|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
19620732|NCT02509234|Irinotecan|irinotecan|mesh-list
19620733|NCT02509234|Trabectedin|trabectedin|mesh-list
19620734|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19620735|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19620736|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620737|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620738|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620739|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19620740|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
19620741|NCT02509208|Hemostatics|hemostatics|mesh-list
19620742|NCT02509208|Coagulants|coagulants|mesh-ancestor
19620743|NCT02509195|Lamivudine|lamivudine|mesh-list
19620744|NCT02509195|Abacavir|abacavir|mesh-list
19620745|NCT02509195|Dolutegravir|dolutegravir|mesh-list
19620746|NCT02509195|Triumeq|triumeq|mesh-list
19620747|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19620748|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19620749|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749870|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832518|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19832519|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19835422|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835423|NCT00602797|Paclitaxel|paclitaxel|mesh-list
19835424|NCT00602797|Vinorelbine|vinorelbine|mesh-list
19835425|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19835426|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19835427|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835428|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
19835429|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
19835430|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
19835431|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835432|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
19835433|NCT00602836|Rituximab|rituximab|mesh-list
19835434|NCT00602836|Lenalidomide|lenalidomide|mesh-list
19835435|NCT00602836|Pentostatin|pentostatin|mesh-list
19835436|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835437|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
19835438|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835439|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835440|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19835441|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
19835442|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620750|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620751|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
19620752|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620753|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19620754|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19620755|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19620756|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19620757|NCT02509143|Ramosetron|ramosetron|mesh-list
19620758|NCT02509143|Antiemetics|antiemetics|mesh-list
19620759|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
19620760|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620761|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620762|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620763|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19620764|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
19620765|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620766|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620767|NCT02508870|Azacitidine|azacitidine|mesh-list
19620768|NCT02508870|Atezolizumab|atezolizumab|mesh-list
19620769|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19620770|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
19620771|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620772|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620773|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620774|NCT02509091|Amikacin|amikacin|mesh-list
19620775|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19620776|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620777|NCT02509052|Leflunomide|leflunomide|mesh-list
19620778|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620779|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620780|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19620781|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
19620782|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620783|NCT02508857|Ketorolac|ketorolac|mesh-list
19620784|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
19620785|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19620786|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19620787|NCT02508857|Analgesics|analgesics|mesh-ancestor
19620788|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
19620789|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620790|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620791|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19620792|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19620793|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19620794|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620795|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620796|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
19620797|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620798|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19620799|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
19620800|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19620801|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19620802|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19620803|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
19620804|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19620805|NCT02508922|Vitamin D|vitamin d|mesh-list
19620806|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
19620807|NCT02508922|Vitamins|vitamins|mesh-ancestor
19620808|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
19620809|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620810|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19620811|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19620812|NCT02508805|Diclofenac|diclofenac|mesh-list
19620813|NCT02508805|Tizanidine|tizanidine|mesh-list
19620814|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19620815|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19620816|NCT02508805|Analgesics|analgesics|mesh-ancestor
19620817|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
19620818|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620819|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620820|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19620821|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19620822|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19620823|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620824|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620825|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
19620826|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19620827|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19620828|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
20135260|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135261|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20312699|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20312700|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312701|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312702|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312703|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312704|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312705|NCT00685464|Abciximab|abciximab|mesh-list
20312706|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
20312707|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20312708|NCT00685503|Ranibizumab|ranibizumab|mesh-list
20312709|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20312710|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20312711|NCT00685503|Growth Substances|growth substances|mesh-ancestor
20312712|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312713|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
20312714|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312715|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
20312716|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19620829|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
19620830|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19620831|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19620832|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19620833|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620834|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620835|NCT02509104|Tamsulosin|tamsulosin|mesh-list
19620836|NCT02509104|Dutasteride|dutasteride|mesh-list
19620837|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19620838|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19620839|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19620840|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620841|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620842|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135262|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20135263|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135264|NCT00039338|Cisplatin|cisplatin|mesh-list
20135265|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135266|NCT00039351|Prednisone|prednisone|mesh-list
20135267|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
20135268|NCT00039351|Vincristine|vincristine|mesh-list
20135269|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312717|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
20312718|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312719|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620843|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620844|NCT02509104|Urological Agents|urological agents|mesh-ancestor
19620845|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19620846|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19620847|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620848|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
19620849|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19620850|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
19620851|NCT02508753|Tazobactam|tazobactam|mesh-list
19620852|NCT02508753|Ceftolozane|ceftolozane|mesh-list
19620853|NCT02508753|Cephalosporins|cephalosporins|mesh-list
19620854|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19620855|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620856|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20135270|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
20135271|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135272|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135273|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135274|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
20135275|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135276|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312720|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19620857|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19620858|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620859|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620860|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620861|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19620862|NCT02508623|Rifaximin|rifaximin|mesh-list
19620863|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19620864|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620865|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620866|NCT02508584|Antibodies|antibodies|mesh-list
19620867|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
19620868|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620869|NCT02508402|Dexamethasone|dexamethasone|mesh-list
19620870|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19620871|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
19620872|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
19620873|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620874|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620875|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19620876|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
19620877|NCT02508402|Hormones|hormones|mesh-ancestor
19620878|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19620879|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19620880|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620881|NCT02508311|Albuterol|albuterol|mesh-list
19620882|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19620883|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
19620884|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620885|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620886|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19620887|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
19620888|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
19620889|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19620890|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19620891|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19620892|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19620893|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
19620894|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620895|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620896|NCT02508350|Daptomycin|daptomycin|mesh-list
19620897|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19620898|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620899|NCT02508168|Metformin|metformin|mesh-list
19620900|NCT02508168|Alogliptin|alogliptin|mesh-list
19620901|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20135277|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135278|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20135279|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
19620902|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620903|NCT02508168|Incretins|incretins|mesh-ancestor
19620904|NCT02508168|Hormones|hormones|mesh-ancestor
19620905|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19620906|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19620907|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
19620908|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620909|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620910|NCT02508246|Cisplatin|cisplatin|mesh-list
19620911|NCT02508246|Docetaxel|docetaxel|mesh-list
19620912|NCT02508246|Adavosertib|adavosertib|mesh-list
19620913|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620914|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
19620915|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
19620916|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
19620917|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620918|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620919|NCT02508142|Scopolamine|scopolamine|mesh-list
19620920|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19620921|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19620922|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
19620923|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
19620924|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620925|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620926|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20312721|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
19620927|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
19620928|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20135280|NCT00039351|Hormones|hormones|mesh-ancestor
20135281|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20135282|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20135283|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135284|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135285|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135286|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135287|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
19620929|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
19620930|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620931|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620932|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19620933|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
19620934|NCT02508220|Oxytocin|oxytocin|mesh-list
19620935|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
19620936|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19620937|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620938|NCT02508064|Fostemsavir|fostemsavir|mesh-list
19620939|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19620940|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19620941|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
19620942|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620943|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19620944|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19620945|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660576|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660577|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660578|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19660579|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19660580|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19660581|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19660582|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
19660583|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
19660584|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
19660585|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
19660586|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660587|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660588|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19660589|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660590|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19660591|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660592|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19660593|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19660594|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19660595|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19660596|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
19660597|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19660598|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
19660599|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19660600|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19660601|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19660602|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
19660603|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19660604|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19660605|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
19660606|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
19660607|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19660608|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19660609|NCT04643249|Analgesics|analgesics|mesh-ancestor
19660610|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
19660611|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660612|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19660613|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19660614|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660615|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660616|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20135288|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135289|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135290|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135291|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135292|NCT00039390|Capecitabine|capecitabine|mesh-list
20135293|NCT00039390|Gefitinib|gefitinib|mesh-list
19660617|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20135294|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135295|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
19620946|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
19620947|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19620948|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
19620949|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620950|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
19620951|NCT02507934|Protective Agents|protective agents|mesh-ancestor
19620952|NCT02507843|Vitamin D|vitamin d|mesh-list
19620953|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
19620954|NCT02507843|Vitamins|vitamins|mesh-ancestor
19620955|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
19620956|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620957|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19620958|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19620959|NCT02507583|Insulin|insulin|mesh-list
19620960|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19620961|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620962|NCT02507648|Oseltamivir|oseltamivir|mesh-list
19620963|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
19620964|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19620965|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19620966|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620967|NCT02507635|Levocetirizine|levocetirizine|mesh-list
19620968|NCT02507635|Desloratadine|desloratadine|mesh-list
19620969|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19620970|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19620971|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
19620972|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
19620973|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19620974|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620975|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620976|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19620977|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
19620978|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19620979|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620980|NCT02507479|Thiotepa|thiotepa|mesh-list
19620981|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19620982|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
19620983|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19620984|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19620985|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19620986|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19620987|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
19620988|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620989|NCT02507700|Bupivacaine|bupivacaine|mesh-list
19620990|NCT02507700|Sevoflurane|sevoflurane|mesh-list
20135296|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135297|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135298|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19620991|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
19620992|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
19620993|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19620994|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19620995|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
19620996|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19620997|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19620998|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19620999|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
19621000|NCT02507609|Rocuronium|rocuronium|mesh-list
19621001|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621002|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19621003|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19621004|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20135299|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135300|NCT00039403|Gemcitabine|gemcitabine|mesh-list
20135301|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20135302|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135303|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
20135304|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135305|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621005|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621006|NCT02507440|Lidocaine|lidocaine|mesh-list
19621007|NCT02507440|Propofol|propofol|mesh-list
19621008|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
19621009|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
19621010|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621011|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621012|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
19621013|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621014|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19621015|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19621016|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19621017|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621018|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621019|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19621020|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621021|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
19621022|NCT02507362|Riboflavin|riboflavin|mesh-list
19621023|NCT02507362|Dextrans|dextrans|mesh-list
19621024|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
19621025|NCT02507362|Vitamins|vitamins|mesh-ancestor
19621026|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
19621027|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621028|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19621029|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
19621030|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
19621031|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
19621032|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
19621033|NCT02507336|Thalidomide|thalidomide|mesh-list
19621034|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621035|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
19621036|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621037|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
19621038|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621039|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621040|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19621041|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19621042|NCT02507336|Growth Substances|growth substances|mesh-ancestor
19621043|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
19621044|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621045|NCT02507323|Ticagrelor|ticagrelor|mesh-list
19621046|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19621047|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19621048|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19621049|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19621050|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19621051|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
19621052|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621053|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621054|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621055|NCT02507245|Hormones|hormones|mesh-list
19621056|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20312722|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19621057|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621058|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621059|NCT02507232|Temozolomide|temozolomide|mesh-list
19621060|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19621061|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
19621062|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621063|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621064|NCT02507284|SRX246|srx246|mesh-list
19621065|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19660618|NCT04558294|Ketanserin|ketanserin|mesh-list
20135306|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
20135307|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135308|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135309|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135310|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
20135311|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312723|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312724|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312725|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20135312|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135313|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
20312726|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621066|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621067|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
19621068|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621069|NCT02506998|Histamine|histamine|mesh-list
19621070|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
19621071|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19621072|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
19621073|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
19621074|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
19621075|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621076|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621077|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621078|NCT02507167|Rifampin|rifampin|mesh-list
19621079|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19621080|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
19621081|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621082|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621083|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
19621084|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19621085|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621086|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621087|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19621088|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19621089|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19621090|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19621091|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19621092|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19621093|NCT02507076|Melphalan|melphalan|mesh-list
19621094|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19621095|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
19621096|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621097|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621098|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19621099|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621100|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
19621101|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621102|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
20135314|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135315|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135316|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135317|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135318|NCT00039429|Atrasentan|atrasentan|mesh-list
20135319|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135320|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20135321|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19621103|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
20135322|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135323|NCT00039442|Capecitabine|capecitabine|mesh-list
20135324|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135325|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
20135326|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135327|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135328|NCT00039455|Trastuzumab|trastuzumab|mesh-list
20135329|NCT00039455|Alvocidib|alvocidib|mesh-list
20135330|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135331|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135332|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
20135333|NCT00039455|Growth Substances|growth substances|mesh-ancestor
20135334|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135335|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135336|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135337|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135338|NCT00039468|Thalidomide|thalidomide|mesh-list
20135339|NCT00039468|Irinotecan|irinotecan|mesh-list
20135340|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20135341|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135342|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135343|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135344|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312727|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312728|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
19621104|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
20312729|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312730|NCT00685568|Celecoxib|celecoxib|mesh-list
20312731|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20312732|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20312733|NCT00685568|Analgesics|analgesics|mesh-ancestor
20312734|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
19621105|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621106|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621107|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621108|NCT02507128|Liraglutide|liraglutide|mesh-list
19621109|NCT02507128|Glucagon|glucagon|mesh-list
19621110|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19621111|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621112|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621113|NCT02507128|Incretins|incretins|mesh-ancestor
19621114|NCT02507128|Hormones|hormones|mesh-ancestor
19621115|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621116|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19621117|NCT02506803|Gemcitabine|gemcitabine|mesh-list
19621118|NCT02506803|Paclitaxel|paclitaxel|mesh-list
19621119|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19621120|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621121|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
19621122|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
19621123|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
19621124|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621125|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19621126|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
19621127|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
19621128|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621129|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621130|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135345|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135346|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
20135347|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135348|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
20135349|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20135350|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135351|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20135352|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20135353|NCT00039468|Growth Substances|growth substances|mesh-ancestor
20135354|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
20135355|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
20135356|NCT00039481|Doxorubicin|doxorubicin|mesh-list
19621131|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
19621132|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621133|NCT02507154|Cetuximab|cetuximab|mesh-list
19621134|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19621135|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621136|NCT02506842|Leucovorin|leucovorin|mesh-list
19621137|NCT02506842|Folic Acid|folic acid|mesh-list
19621138|NCT02506842|Gemcitabine|gemcitabine|mesh-list
19621139|NCT02506842|Fluorouracil|fluorouracil|mesh-list
19621140|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
19621141|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
19621142|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621143|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621144|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19621145|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
19621146|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
19621147|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621148|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621149|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621150|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
19621151|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621152|NCT02506842|Antidotes|antidotes|mesh-ancestor
19621153|NCT02506842|Protective Agents|protective agents|mesh-ancestor
19621154|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
19621155|NCT02506842|Vitamins|vitamins|mesh-ancestor
19621156|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
19621157|NCT02506842|Hematinics|hematinics|mesh-ancestor
20135357|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20312735|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621158|NCT02506699|Analgesics|analgesics|mesh-list
20135358|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
19621159|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
19621160|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621161|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621162|NCT02506777|Metformin|metformin|mesh-list
19621163|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
19621164|NCT02506777|Doxorubicin|doxorubicin|mesh-list
19621165|NCT02506777|Fluorouracil|fluorouracil|mesh-list
19621166|NCT02506777|Melatonin|melatonin|mesh-list
19621167|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621168|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
19621169|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621170|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19621171|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19621172|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
19621173|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621174|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621175|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19621176|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621177|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19621178|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19621179|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19621180|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621181|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
19621182|NCT02506777|Protective Agents|protective agents|mesh-ancestor
19621183|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621184|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
19621185|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19621186|NCT02506647|Insulin|insulin|mesh-list
19621187|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19621188|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
19621189|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621190|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621191|NCT02506790|Toremifene|toremifene|mesh-list
20135359|NCT00039481|Razoxane|razoxane|mesh-list
20135360|NCT00039481|Oblimersen|oblimersen|mesh-list
20135361|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135362|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
20135363|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135364|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135365|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135366|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
20135367|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135368|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621192|NCT02506790|Metformin|metformin|mesh-list
19621193|NCT02506790|Melatonin|melatonin|mesh-list
19621194|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621195|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621196|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
19621197|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621198|NCT02506790|Protective Agents|protective agents|mesh-ancestor
19621199|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621200|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19621201|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621202|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19621203|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19621204|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
19621205|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621206|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19621207|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
19621208|NCT02506894|Analgesics|analgesics|mesh-ancestor
19621209|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
19621210|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621211|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621212|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
19621213|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621214|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19621215|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
20135369|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135370|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19621216|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19621217|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621218|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621219|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19621220|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
19621221|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19621222|NCT02506829|Nicotine|nicotine|mesh-list
19621223|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19621224|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
19621225|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621226|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621227|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20608370|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608371|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608372|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608373|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608374|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608375|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608376|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608377|NCT02245503|Urological Agents|urological agents|mesh-ancestor
19621228|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19621229|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
19621230|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621231|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621232|NCT02506686|Meropenem|meropenem|mesh-list
19621233|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621234|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621235|NCT02506855|Ropivacaine|ropivacaine|mesh-list
19621236|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
19621237|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
19621238|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621239|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621240|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
20135371|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20135372|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135373|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135374|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19621241|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621242|NCT02506348|Diclofenac|diclofenac|mesh-list
19621243|NCT02506348|Nepafenac|nepafenac|mesh-list
19621244|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19621245|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20135375|NCT00039481|Protective Agents|protective agents|mesh-ancestor
20135376|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135377|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
19621246|NCT02506348|Analgesics|analgesics|mesh-ancestor
19621247|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
20135378|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20135379|NCT00039494|Temozolomide|temozolomide|mesh-list
20608378|NCT02245529|Tamsulosin|tamsulosin|mesh-list
19621248|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621249|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621250|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19621251|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19621252|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19621253|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621254|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621255|NCT02506439|Vitamin D|vitamin d|mesh-list
19621256|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
19621257|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
19621258|NCT02506439|Vitamins|vitamins|mesh-list
19621259|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
19621260|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621261|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19621262|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19660619|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
20135380|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135381|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19621263|NCT02506231|Leucovorin|leucovorin|mesh-list
19621264|NCT02506231|Folic Acid|folic acid|mesh-list
19621265|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
19621266|NCT02506231|Antidotes|antidotes|mesh-ancestor
19621267|NCT02506231|Protective Agents|protective agents|mesh-ancestor
19621268|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621269|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
19621270|NCT02506231|Vitamins|vitamins|mesh-ancestor
19621271|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
19621272|NCT02506231|Hematinics|hematinics|mesh-ancestor
19621273|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19621274|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
19621275|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621276|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621277|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621278|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621279|NCT02506140|Aspirin|aspirin|mesh-list
19621280|NCT02506140|Clopidogrel|clopidogrel|mesh-list
20135382|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135383|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135384|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135385|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
20135386|NCT00039520|Sulindac|sulindac|mesh-list
20135387|NCT00039520|Docetaxel|docetaxel|mesh-list
20135388|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135389|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135390|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135391|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135392|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135393|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20135394|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20135395|NCT00039520|Analgesics|analgesics|mesh-ancestor
20135396|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
19621281|NCT02506140|Ticagrelor|ticagrelor|mesh-list
19621282|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19621283|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19621284|NCT02506140|Analgesics|analgesics|mesh-ancestor
19621285|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
19621286|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621287|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621288|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19621289|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19621290|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19621291|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20135397|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135398|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135399|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20135400|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135401|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20135402|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135403|NCT00039546|Gemcitabine|gemcitabine|mesh-list
20135404|NCT00039546|Paclitaxel|paclitaxel|mesh-list
20135405|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
20135406|NCT00039546|Epirubicin|epirubicin|mesh-list
20135407|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135408|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135409|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135410|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135411|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
19621292|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621293|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19621294|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19621295|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135412|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621296|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
19621297|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19621298|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19621299|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19621300|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
19621301|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621302|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19621303|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
19621304|NCT02506023|Coagulants|coagulants|mesh-ancestor
19621305|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19621306|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
19621307|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621308|NCT02505997|Midazolam|midazolam|mesh-list
19621309|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19621310|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19621311|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621312|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621313|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19621314|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19621315|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19621316|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621317|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
19621318|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
19621319|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
19621320|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
19621321|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621322|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621323|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
19621324|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19621325|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
19621326|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19621327|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19621328|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621329|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621330|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
19621331|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621332|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621333|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19621334|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621335|NCT02505841|Ropivacaine|ropivacaine|mesh-list
19621336|NCT02505841|Succinylcholine|succinylcholine|mesh-list
19621337|NCT02505841|Curare|curare|mesh-list
19621338|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
19621339|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
19621340|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621341|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621342|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
19621343|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621344|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19621345|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19621346|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19621347|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19621348|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19621349|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19621350|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
19621351|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621352|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621353|NCT02505776|Bimatoprost|bimatoprost|mesh-list
19621354|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19621355|NCT02505893|Sirolimus|sirolimus|mesh-list
19621356|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621357|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621358|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19621359|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621360|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
19621361|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621362|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
19621363|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621364|NCT02505971|Propranolol|propranolol|mesh-list
19621365|NCT02505971|Nadolol|nadolol|mesh-list
19621366|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19621367|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19621368|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
19621369|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621370|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621371|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621372|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19621373|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19621374|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
19621375|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
19621376|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
19621377|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621378|NCT02505880|Anesthetics|anesthetics|mesh-list
19621379|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
19621380|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621381|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621382|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
19621383|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621384|NCT02505633|Lidocaine|lidocaine|mesh-list
19621385|NCT02505633|Epinephrine|epinephrine|mesh-list
19621386|NCT02505633|Racepinephrine|racepinephrine|mesh-list
19621387|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
19621388|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
19621389|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
19621390|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621391|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621392|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
19621393|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621394|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19621395|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19621396|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19621397|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621398|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621399|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19621400|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19621401|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
19621402|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621403|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19621404|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19621405|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
19621406|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19621407|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
19621408|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
19621409|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
19621410|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19621411|NCT02505451|Dobutamine|dobutamine|mesh-list
19621412|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19621413|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
19621414|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
19621415|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621416|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621417|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19621418|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19621419|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19621420|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
19621421|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621422|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621423|NCT02505451|Protective Agents|protective agents|mesh-ancestor
19621424|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
19621425|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19621426|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
19621427|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621428|NCT02505477|Expectorants|expectorants|mesh-ancestor
20135413|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135414|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
20135415|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135416|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135417|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135418|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
20135419|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135420|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19621429|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
19621430|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19621431|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
19621432|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621433|NCT02505477|Protective Agents|protective agents|mesh-ancestor
19621434|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135421|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
19621435|NCT02505477|Antidotes|antidotes|mesh-ancestor
19621436|NCT02505516|Metformin|metformin|mesh-list
19621437|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621438|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621439|NCT02505568|Infliximab|infliximab|mesh-list
19621440|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
19621441|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19621442|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19621443|NCT02505581|Metronidazole|metronidazole|mesh-list
19621444|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
19621445|NCT02505581|Cefuroxime|cefuroxime|mesh-list
19621446|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
19621447|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621448|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621449|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19621450|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19621451|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19621452|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135422|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
20135423|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135424|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135425|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19621453|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621454|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621455|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621456|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19621457|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19621458|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
19621459|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19621460|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
19621461|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621462|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
19621463|NCT02505360|Protective Agents|protective agents|mesh-ancestor
19621464|NCT02505295|Selenium|selenium|mesh-list
19621465|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
19621466|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621467|NCT02505295|Protective Agents|protective agents|mesh-ancestor
19621468|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621469|NCT02505295|Trace Elements|trace elements|mesh-ancestor
19621470|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
19621471|NCT02505282|Vitamin K|vitamin k|mesh-list
19621472|NCT02505282|Vitamins|vitamins|mesh-ancestor
19621473|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
19621474|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621475|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19621476|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19621477|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621478|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
19621479|NCT02505282|Coagulants|coagulants|mesh-ancestor
19621480|NCT02505399|Clopidogrel|clopidogrel|mesh-list
19621481|NCT02505399|Ticagrelor|ticagrelor|mesh-list
19621482|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19621483|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19621484|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19621485|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19621486|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
19621487|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621488|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621489|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621490|NCT02505386|Ertapenem|ertapenem|mesh-list
19621491|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621492|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621493|NCT02505009|Tenofovir|tenofovir|mesh-list
19621494|NCT02505009|Entecavir|entecavir|mesh-list
19621495|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
19621496|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621497|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19621498|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19621499|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621500|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621501|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19621502|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19621503|NCT02505048|Rucaparib|rucaparib|mesh-list
19621504|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19621505|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621506|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621507|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135426|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20135427|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135428|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
20135429|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135430|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135431|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135432|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135433|NCT00039611|Leucovorin|leucovorin|mesh-list
20135434|NCT00039611|Fluorouracil|fluorouracil|mesh-list
19621508|NCT02505113|Montelukast|montelukast|mesh-list
19621509|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19621510|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
19621511|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19621512|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
19621513|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621514|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135435|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
20135436|NCT00039611|Calcium|calcium|mesh-list
20135437|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
20135438|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20135439|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135440|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
20135441|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135442|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135443|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621515|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19621516|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19621517|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621518|NCT02504944|Propranolol|propranolol|mesh-list
19621519|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19621520|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19621521|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19621522|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19621523|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
19621524|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621525|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621526|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621527|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20135444|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135445|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
20135446|NCT00039611|Antidotes|antidotes|mesh-ancestor
20135447|NCT00039611|Protective Agents|protective agents|mesh-ancestor
20135448|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
20135449|NCT00039611|Vitamins|vitamins|mesh-ancestor
20135450|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
19621528|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20135451|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
20135452|NCT00039663|Pravastatin|pravastatin|mesh-list
20135453|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
20135454|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20312736|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312737|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312738|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312739|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20312740|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20312741|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312742|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135455|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135456|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20135457|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20135458|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
20135459|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135460|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20135461|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20135462|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135463|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20135464|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20135465|NCT00039767|Lepirudin|lepirudin|mesh-list
20135466|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
20135467|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20135468|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
20135469|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135470|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621529|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
19621530|NCT02504996|Acetaminophen|acetaminophen|mesh-list
19621531|NCT02504996|Morphine|morphine|mesh-list
19621532|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19621533|NCT02504996|Narcotics|narcotics|mesh-ancestor
19621534|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621535|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621536|NCT02504996|Analgesics|analgesics|mesh-ancestor
19621537|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
19621538|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621539|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19621540|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
19621541|NCT02504983|Sorafenib|sorafenib|mesh-list
19621542|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621543|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19621544|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621545|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621546|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
19621547|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19621548|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
19621549|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621550|NCT02505087|Expectorants|expectorants|mesh-ancestor
19621551|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
20135471|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
20135472|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20135473|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20135474|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
20135475|NCT00039780|Protective Agents|protective agents|mesh-ancestor
20135476|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135477|NCT00039832|Reteplase|reteplase|mesh-list
20135478|NCT00039832|Abciximab|abciximab|mesh-list
20135479|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
20135480|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20135481|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20135482|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20135483|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135484|NCT00039858|Argatroban|argatroban|mesh-list
20135485|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
20135486|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19621552|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19621553|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
19621554|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621555|NCT02505087|Protective Agents|protective agents|mesh-ancestor
19621556|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621557|NCT02505087|Antidotes|antidotes|mesh-ancestor
19621558|NCT02504801|Budesonide|budesonide|mesh-list
19621559|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20135487|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
20135488|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135489|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135490|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
20135491|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20135492|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
20135493|NCT00039884|Hematinics|hematinics|mesh-ancestor
20135494|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20135495|NCT00039962|Thymalfasin|thymalfasin|mesh-list
20135496|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
20135497|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135498|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19621560|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19621561|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
19621562|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621563|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621564|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19621565|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
19621566|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
19621567|NCT02504801|Hormones|hormones|mesh-ancestor
19621568|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621569|NCT02504450|Haloperidol|haloperidol|mesh-list
19621570|NCT02504450|Ziprasidone|ziprasidone|mesh-list
19621571|NCT02504450|Loxapine|loxapine|mesh-list
19621572|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
19621573|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
20135499|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
19621574|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621575|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621576|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20135500|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621577|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19621578|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19621579|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621580|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19621581|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19621582|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
19621583|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621584|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621585|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19621586|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19621587|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
19621588|NCT02504489|Docetaxel|docetaxel|mesh-list
19621589|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621590|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19621591|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19621592|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19621593|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660620|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
19660621|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660622|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19660623|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19660624|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
19660625|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660626|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660627|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19660628|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19660629|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19660630|NCT04551222|Probenecid|probenecid|mesh-list
19660631|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
19660632|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
19660633|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660634|NCT04551222|Renal Agents|renal agents|mesh-ancestor
19660635|NCT04537897|Midazolam|midazolam|mesh-list
19660636|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19660637|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19660638|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660639|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660640|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19660641|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19660642|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19660643|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19660644|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
20135501|NCT00039975|Ritonavir|ritonavir|mesh-list
20135502|NCT00039975|Indinavir|indinavir|mesh-list
20135503|NCT00039975|Amlodipine|amlodipine|mesh-list
20135504|NCT00039975|Diltiazem|diltiazem|mesh-list
20135505|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20135506|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19660645|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
19660646|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
19660647|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
19660648|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660649|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660650|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
19660651|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19660652|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19660653|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660654|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
19660655|NCT04521881|Coagulants|coagulants|mesh-ancestor
19660656|NCT04507581|Anesthetics|anesthetics|mesh-list
19660657|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660658|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660659|NCT04507438|Donepezil|donepezil|mesh-list
19660660|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19660661|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660662|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660663|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
19660664|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135507|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
20135508|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135509|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135510|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20135511|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19660665|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660666|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
19660667|NCT04505670|Donepezil|donepezil|mesh-list
20135512|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
20135513|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135514|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20312743|NCT00685594|Vitamin D|vitamin d|mesh-list
20312744|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
20312745|NCT00685594|Vitamins|vitamins|mesh-ancestor
20312746|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
20312747|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312748|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20312749|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20312750|NCT00685607|Simethicone|simethicone|mesh-list
19621594|NCT02504476|Midazolam|midazolam|mesh-list
19621595|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19621596|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19621597|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20312751|NCT00685607|Loperamide|loperamide|mesh-list
20312752|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
20312753|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20312754|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
19621598|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621599|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19621600|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19621601|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19621602|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621603|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
19621604|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
19621605|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
19621606|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
19621607|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621608|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621609|NCT02504463|Naltrexone|naltrexone|mesh-list
19621610|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19621611|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19621612|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621613|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
19621614|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621615|NCT02504398|Methamphetamine|methamphetamine|mesh-list
19621616|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19621617|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621618|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
19621619|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
19621620|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621621|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
19621622|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621623|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621624|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
19621625|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19621626|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19621627|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621628|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19621629|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
19621630|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19621631|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621632|NCT02504359|Cytarabine|cytarabine|mesh-list
20135515|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20312755|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621633|NCT02504359|Methotrexate|methotrexate|mesh-list
19621634|NCT02504359|Etoposide|etoposide|mesh-list
19621635|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
20135516|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20135517|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20135518|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20135519|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20135520|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135521|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
20135522|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
20312756|NCT00685607|Emollients|emollients|mesh-ancestor
19621636|NCT02504359|Melphalan|melphalan|mesh-list
20312757|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
20312758|NCT00685633|Bicalutamide|bicalutamide|mesh-list
19621637|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
19621638|NCT02504359|Carmustine|carmustine|mesh-list
19621639|NCT02504359|Ixazomib|ixazomib|mesh-list
19621640|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
19621641|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19621642|NCT02504359|Tacrolimus|tacrolimus|mesh-list
19621643|NCT02504359|Glycine|glycine|mesh-list
19621644|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19621645|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
19621646|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19621647|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621648|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19621649|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
19621650|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621651|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621652|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
19621653|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621654|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19621655|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621656|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
19621657|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19621658|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19621659|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19621660|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19621661|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19621662|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
19621663|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621664|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19621665|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19621666|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
19621667|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19621668|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
19621669|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
19621670|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
19621671|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
19621672|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
19621673|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
19621674|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621675|NCT02504307|Sirolimus|sirolimus|mesh-list
19621676|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621677|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621678|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19621679|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621680|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
19621681|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621682|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
19621683|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621684|NCT02504346|Osimertinib|osimertinib|mesh-list
19621685|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621686|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19621687|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621688|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621689|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
19621690|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621691|NCT02504333|Gemcitabine|gemcitabine|mesh-list
19621692|NCT02504333|Paclitaxel|paclitaxel|mesh-list
19621693|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19621694|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19621695|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621696|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
19621697|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
19621698|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
19621699|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621700|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19621701|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
19621702|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
19621703|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749871|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
20135523|NCT00039988|Albuterol|albuterol|mesh-list
20135524|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
19749872|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135525|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20135526|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
20135527|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135528|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135529|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20135530|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
19256604|NCT04363840|Vitamins|vitamins|mesh-ancestor
20135531|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
20135532|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20135533|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20135534|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20135535|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19621704|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621705|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621706|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
19621707|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621708|NCT02504177|Anticoagulants|anticoagulants|mesh-list
19621709|NCT02504164|Midazolam|midazolam|mesh-list
19621710|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19621711|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19621712|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621713|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621714|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19621715|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19621716|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19621717|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621718|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
19621719|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
19621720|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
19621721|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
19621722|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621723|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621724|NCT02504138|Anesthetics|anesthetics|mesh-list
19621725|NCT02504138|Propofol|propofol|mesh-list
19621726|NCT02504138|Desflurane|desflurane|mesh-list
19621727|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621728|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621729|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19621730|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621731|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
19621732|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19621733|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
19621734|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19621735|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19621736|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621737|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
19621738|NCT02504125|Coagulants|coagulants|mesh-ancestor
19621739|NCT02503826|Midazolam|midazolam|mesh-list
19621740|NCT02503826|Sufentanil|sufentanil|mesh-list
19621741|NCT02503826|Dsuvia|dsuvia|mesh-list
19621742|NCT02503826|Propofol|propofol|mesh-list
19621743|NCT02503826|Cisatracurium|cisatracurium|mesh-list
19621744|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19621745|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621746|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621747|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621748|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
19621749|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
19621750|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19621751|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19621752|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19621753|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19621754|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
19621755|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
19621756|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621757|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621758|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19621759|NCT02503826|Narcotics|narcotics|mesh-ancestor
19621760|NCT02503826|Analgesics|analgesics|mesh-ancestor
19621761|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
19621762|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621763|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19621764|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19621765|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
19621766|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19621767|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621768|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20135536|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
20135537|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135538|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621769|NCT02503904|Metronidazole|metronidazole|mesh-list
19621770|NCT02503904|Lidocaine|lidocaine|mesh-list
19621771|NCT02503904|Epinephrine|epinephrine|mesh-list
19621772|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
19621773|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
19621774|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621775|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621776|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
19621777|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621778|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19621779|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19621780|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19621781|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621782|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621783|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621784|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19621785|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19621786|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19621787|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621788|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19621789|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19621790|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
19621791|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19621792|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
19621793|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
19621794|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
19621795|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19621796|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19621797|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19621798|NCT02503943|Metformin|metformin|mesh-list
19621799|NCT02503943|Liraglutide|liraglutide|mesh-list
20135539|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20135540|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
20135541|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135542|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135543|NCT00040014|Exemestane|exemestane|mesh-list
20135544|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135545|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19621800|NCT02503943|Mitiglinide|mitiglinide|mesh-list
19621801|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621802|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621803|NCT02503943|Incretins|incretins|mesh-ancestor
19621804|NCT02503943|Hormones|hormones|mesh-ancestor
19621805|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621806|NCT02503761|Meropenem|meropenem|mesh-list
19621807|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19621808|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621809|NCT02503462|Ritonavir|ritonavir|mesh-list
19621810|NCT02503462|Darunavir|darunavir|mesh-list
19621811|NCT02503462|Cobicistat|cobicistat|mesh-list
19621812|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19621813|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19621814|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
19621815|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621816|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621817|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19621818|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19621819|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
19621820|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621821|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19621822|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19621823|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
19621824|NCT02503319|Oxytocin|oxytocin|mesh-list
19621825|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
19621826|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19621827|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621828|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19621829|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19621830|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621831|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
19621832|NCT02503319|Coagulants|coagulants|mesh-ancestor
19621833|NCT02503358|Paclitaxel|paclitaxel|mesh-list
19621834|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19621835|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19621836|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135546|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20135547|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135548|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135549|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19621837|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19621838|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19621839|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19621840|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621841|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19621842|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19621843|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20135550|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
20135551|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621844|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19621845|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19621846|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19621847|NCT02502968|Cytarabine|cytarabine|mesh-list
19621848|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19621849|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
19621850|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621851|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621852|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
19621853|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621854|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621855|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
19621856|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621857|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
20135552|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135553|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20135554|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
20135555|NCT00040027|Thymalfasin|thymalfasin|mesh-list
20135556|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
20135557|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135558|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
19621858|NCT02502981|Spironolactone|spironolactone|mesh-list
19621859|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19621860|NCT02502981|Diuretics|diuretics|mesh-list
19621861|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
19621862|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
19621863|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
19621864|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19621865|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621866|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19621867|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
19621868|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19621869|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621870|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621871|NCT02502981|Hormones|hormones|mesh-ancestor
19621872|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
19621873|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19621874|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19621875|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19621876|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
19621877|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
19621878|NCT02502643|Picibanil|picibanil|mesh-list
19621879|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621880|NCT02502565|Uric Acid|uric acid|mesh-list
19621881|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
19621882|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621883|NCT02502565|Protective Agents|protective agents|mesh-ancestor
19621884|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621885|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
19621886|NCT02502825|Miotics|miotics|mesh-ancestor
19621887|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
19621888|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621889|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621890|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19621891|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19621892|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
19621893|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19621894|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19621895|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
19621896|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621897|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660668|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
19660669|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19660670|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660671|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660672|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
19660673|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660674|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660675|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
19621898|NCT02502799|Methylphenidate|methylphenidate|mesh-list
19621899|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19621900|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621901|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19621902|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19621903|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19621904|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621905|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
19621906|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621907|NCT02502877|Midazolam|midazolam|mesh-list
19621908|NCT02502877|Propofol|propofol|mesh-list
20135559|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135560|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19621909|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19621910|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621911|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621912|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621913|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
19621914|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
19621915|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19621916|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19621917|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19621918|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19621919|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
19621920|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
19621921|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19621922|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621923|NCT02502500|Celecoxib|celecoxib|mesh-list
19621924|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19621925|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19621926|NCT02502500|Analgesics|analgesics|mesh-ancestor
19621927|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
19621928|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621929|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621930|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19621931|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19621932|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19621933|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19621934|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621935|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621936|NCT02502253|Resveratrol|resveratrol|mesh-list
19621937|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
19621938|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621939|NCT02502253|Protective Agents|protective agents|mesh-ancestor
19621940|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621941|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621942|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19621943|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19621944|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19621945|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19621946|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
19621947|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621948|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20135561|NCT00040040|Bupropion|bupropion|mesh-list
20135562|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20135563|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
20135564|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20135565|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20135566|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20135567|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20135568|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135569|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
19621949|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19621950|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621951|NCT02502344|Metformin|metformin|mesh-list
19621952|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19621953|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621954|NCT02502175|Methadone|methadone|mesh-list
19749873|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
19621955|NCT02502175|Opium|opium|mesh-list
19621956|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19621957|NCT02502175|Narcotics|narcotics|mesh-ancestor
19621958|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19621959|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621960|NCT02502175|Analgesics|analgesics|mesh-ancestor
19621961|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
19621962|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621963|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
19621964|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
19621965|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
19621966|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19621967|NCT02502032|Cisatracurium|cisatracurium|mesh-list
19621968|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19621969|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19621970|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621971|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621972|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
19621973|NCT02502708|Temozolomide|temozolomide|mesh-list
19621974|NCT02502708|Etoposide|etoposide|mesh-list
19621975|NCT02502708|Tryptophan|tryptophan|mesh-list
19621976|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19621977|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
19621978|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621979|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19621980|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19621981|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
19621982|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19621983|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19621984|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19621985|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19621986|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19621987|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19621988|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19621989|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19621990|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
19621991|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19621992|NCT02501941|Ketamine|ketamine|mesh-list
19621993|NCT02501941|Analgesics|analgesics|mesh-ancestor
19621994|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
19621995|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19621996|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19621997|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19621998|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19621999|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
19622000|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
19622001|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622002|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19622003|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19622004|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622005|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622006|NCT02501837|Oxytocin|oxytocin|mesh-list
19622007|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
19622008|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19622009|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622010|NCT02501863|Fentanyl|fentanyl|mesh-list
19622011|NCT02501863|Ropivacaine|ropivacaine|mesh-list
19622012|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
19622013|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
19622014|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622015|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622016|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
19622017|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622018|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19622019|NCT02501863|Narcotics|narcotics|mesh-ancestor
19622020|NCT02501863|Analgesics|analgesics|mesh-ancestor
19622021|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20135570|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135571|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622022|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19622023|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
19622024|NCT02501798|Methylphenidate|methylphenidate|mesh-list
19622025|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19622026|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622027|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19256605|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
19622028|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19622029|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622030|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622031|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
19622032|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622033|NCT02501850|Metformin|metformin|mesh-list
19622034|NCT02501850|Liraglutide|liraglutide|mesh-list
19622035|NCT02501850|Exenatide|exenatide|mesh-list
19622036|NCT02501850|Lixisenatide|lixisenatide|mesh-list
19622037|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19622038|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622039|NCT02501850|Incretins|incretins|mesh-ancestor
19622040|NCT02501850|Hormones|hormones|mesh-ancestor
19622041|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622042|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19622043|NCT02501564|Naproxen|naproxen|mesh-list
19622044|NCT02501564|Codeine|codeine|mesh-list
19622045|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19622046|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19622047|NCT02501564|Analgesics|analgesics|mesh-ancestor
19622048|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
19622049|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622050|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622051|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622052|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622053|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
19622054|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19622055|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622056|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622057|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19622058|NCT02501564|Narcotics|narcotics|mesh-ancestor
19622059|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622060|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
19622061|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
19622062|NCT02501616|Metformin|metformin|mesh-list
19622063|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
19622064|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19622065|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622066|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19622067|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622068|NCT02501603|Paclitaxel|paclitaxel|mesh-list
19622069|NCT02501603|Afatinib|afatinib|mesh-list
19622070|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19622071|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622072|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
19622073|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
19622074|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
19622075|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622076|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19622077|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622078|NCT02501213|Furosemide|furosemide|mesh-list
19622079|NCT02501213|Spironolactone|spironolactone|mesh-list
19622080|NCT02501213|Diuretics|diuretics|mesh-ancestor
19622081|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
19622082|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622083|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19622084|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622085|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622086|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19622087|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
19622088|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622089|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19622090|NCT02501200|Ezetimibe|ezetimibe|mesh-list
19622091|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19622092|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19622093|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
19622094|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622095|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19622096|NCT02501291|Thalidomide|thalidomide|mesh-list
19622097|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135572|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20135573|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20135574|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135575|NCT00040053|Ondansetron|ondansetron|mesh-list
20135576|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
20135577|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
20135578|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135579|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135580|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20135581|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
19622098|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
19622099|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622100|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
19622101|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19622102|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622103|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19622104|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19622105|NCT02501291|Growth Substances|growth substances|mesh-ancestor
19622106|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
19622107|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622108|NCT02501278|Cisplatin|cisplatin|mesh-list
19622109|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622110|NCT02501109|Aripiprazole|aripiprazole|mesh-list
19622111|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
19622112|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19622113|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19622114|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19622115|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622116|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622117|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
19622118|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
19622119|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622120|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622121|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19622122|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19622123|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
19622124|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19622125|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19622126|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19622127|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19622128|NCT02500927|Naquotinib|naquotinib|mesh-list
19622129|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622130|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19622131|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622132|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660676|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19660677|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
19660678|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19660679|NCT04505670|Protective Agents|protective agents|mesh-ancestor
20135582|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
20135583|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20135584|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
20135585|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135586|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135587|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20135588|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20135589|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20135590|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20135591|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20135592|NCT00040066|Cocaine|cocaine|mesh-list
20135593|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
19660680|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
19660681|NCT04474002|Cathartics|cathartics|mesh-ancestor
19660682|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660683|NCT04470622|Aprepitant|aprepitant|mesh-list
19660684|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
19660685|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
19660686|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19749874|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749875|NCT04588727|Aspirin|aspirin|mesh-list
20135594|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
20135595|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20135596|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660687|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660688|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622133|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
19622134|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19622135|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
19622136|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622137|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622138|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20135597|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
20135598|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135599|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20135600|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20135601|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20135602|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20135603|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135604|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
20135605|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312759|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
20312760|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312761|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312762|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312763|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312764|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
20312765|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
20312766|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20312767|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312768|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
19749876|NCT04588727|Ticagrelor|ticagrelor|mesh-list
19749877|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19749878|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19622139|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
19622140|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19622141|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19622142|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19622143|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
19622144|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622145|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622146|NCT02500940|Leucovorin|leucovorin|mesh-list
19622147|NCT02500940|Fluorouracil|fluorouracil|mesh-list
19622148|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622149|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622150|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
19622151|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622152|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19622153|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622154|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
19622155|NCT02500940|Antidotes|antidotes|mesh-ancestor
19622156|NCT02500940|Protective Agents|protective agents|mesh-ancestor
19622157|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
19622158|NCT02500940|Vitamins|vitamins|mesh-ancestor
19622159|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
19622160|NCT02500667|Rifampin|rifampin|mesh-list
19622161|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19622162|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
19622163|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19622164|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622165|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
19622166|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20135606|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
20312769|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622167|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622168|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622169|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19622170|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19622171|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19622172|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19622173|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19622174|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19622175|NCT02500680|Vaccines|vaccines|mesh-list
19622176|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
19622177|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622178|NCT02500446|Dolutegravir|dolutegravir|mesh-list
19622179|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20312770|NCT00685672|Epinephrine|epinephrine|mesh-list
20135607|NCT00040105|Tipifarnib|tipifarnib|mesh-list
20135608|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135609|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135610|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135611|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135612|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
20135613|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20135614|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20135615|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312771|NCT00685672|Racepinephrine|racepinephrine|mesh-list
20312772|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
20312773|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20312774|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20135616|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135617|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
20135618|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135619|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20135620|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20135621|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
20135622|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20135623|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20135624|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135625|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135626|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
20135627|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135628|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20135629|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19622180|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19622181|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622182|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622183|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19622184|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19622185|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
19622186|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622187|NCT02500576|Aldesleukin|aldesleukin|mesh-list
19622188|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
19622189|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
19622190|NCT02500576|Fludarabine|fludarabine|mesh-list
19622191|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
19622192|NCT02500576|Interleukin-2|interleukin-2|mesh-list
19622193|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622194|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
19622195|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622196|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622197|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19622198|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
19622199|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622200|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622201|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19622202|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622203|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19622204|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
19622205|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19622206|NCT02500576|Analgesics|analgesics|mesh-ancestor
19622207|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
19622208|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622209|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19622210|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19622211|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
19622212|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622213|NCT02500524|Permethrin|permethrin|mesh-list
19622214|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622215|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622216|NCT02500563|Caseins|caseins|mesh-list
19622217|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
19622218|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
19622219|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622220|NCT02500511|Vaccines|vaccines|mesh-list
19622221|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
19622222|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622223|NCT02500498|Abatacept|abatacept|mesh-list
19622224|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19622225|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135630|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20312775|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
19622226|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622227|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622228|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
19622229|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622230|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622231|NCT02500459|Topotecan|topotecan|mesh-list
19622232|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19622233|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19622234|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622235|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622236|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622237|NCT02500329|Acarbose|acarbose|mesh-list
19622238|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19622239|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622240|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622241|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19622242|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622243|NCT02500225|Sevoflurane|sevoflurane|mesh-list
19622244|NCT02500225|Etomidate|etomidate|mesh-list
19622245|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19622246|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19622247|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
19622248|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
19622249|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622250|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622251|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19622252|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19622253|NCT02500147|Metformin|metformin|mesh-list
19622254|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19622255|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622256|NCT02500212|Tacrolimus|tacrolimus|mesh-list
19622257|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622258|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
19622259|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622260|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19622261|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622262|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622263|NCT02500017|Melatonin|melatonin|mesh-list
19622264|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
19622265|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622266|NCT02500017|Protective Agents|protective agents|mesh-ancestor
19622267|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622268|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622269|NCT02500108|Domperidone|domperidone|mesh-list
19622270|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
19622271|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
19622272|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622273|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622274|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622275|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19622276|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
19622277|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622278|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622279|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
19622280|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
19622281|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622282|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
19622283|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622284|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622285|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
20135631|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135632|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135633|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135634|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135635|NCT00040209|Levodopa|levodopa|mesh-list
20135636|NCT00040209|Apomorphine|apomorphine|mesh-list
20135637|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20135638|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20135639|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
20135640|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135641|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622286|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622287|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135642|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622288|NCT02500251|Rituximab|rituximab|mesh-list
19622289|NCT02500251|Bortezomib|bortezomib|mesh-list
19622290|NCT02500251|Belimumab|belimumab|mesh-list
19622291|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622292|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622293|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
19622294|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622295|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312776|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312777|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312778|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312779|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20312780|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20312781|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
20312782|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312783|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20312784|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
20312785|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
20312786|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
20312787|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20312788|NCT00685776|Anacetrapib|anacetrapib|mesh-list
20312789|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20312790|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19622296|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622297|NCT02500069|Caseins|caseins|mesh-list
19622298|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
19622299|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
19622300|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622301|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19622302|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19622303|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622304|NCT02499874|Tenofovir|tenofovir|mesh-list
19622305|NCT02499874|Lamivudine|lamivudine|mesh-list
19622306|NCT02499874|Zidovudine|zidovudine|mesh-list
19622307|NCT02499874|Emtricitabine|emtricitabine|mesh-list
19622308|NCT02499874|Efavirenz|efavirenz|mesh-list
19622309|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19622310|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
19622311|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622312|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19622313|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19622314|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622315|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622316|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19622317|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19622318|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
19622319|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19622320|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19622321|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19622322|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19622323|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19622324|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19622325|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
19622326|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
19622327|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
19622328|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622329|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622330|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
19622331|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622332|NCT02499978|Darunavir|darunavir|mesh-list
19622333|NCT02499978|Dolutegravir|dolutegravir|mesh-list
19622334|NCT02499978|Cobicistat|cobicistat|mesh-list
19622335|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19622336|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20135643|NCT00040209|Emetics|emetics|mesh-ancestor
20135644|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
20135645|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135646|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20135647|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
20135648|NCT00040248|Daclizumab|daclizumab|mesh-list
20135649|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622337|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
20312791|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
19622338|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312792|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135650|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
20135651|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312793|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20312794|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
20312795|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312796|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20312797|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312798|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622339|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622340|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19622341|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19622342|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
19622343|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622344|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19622345|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19622346|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19622347|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19622348|NCT02499965|Anesthetics|anesthetics|mesh-list
19622349|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
19622350|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622351|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622352|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
19622353|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
19622354|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622355|NCT02499861|Decitabine|decitabine|mesh-list
19622356|NCT02499861|Genistein|genistein|mesh-list
19622357|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19622358|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
19622359|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622360|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622361|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622362|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19622363|NCT02499861|Protective Agents|protective agents|mesh-ancestor
19622364|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622365|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19622366|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
19622367|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19622368|NCT02499861|Estrogens|estrogens|mesh-ancestor
19622369|NCT02499861|Hormones|hormones|mesh-ancestor
19622370|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622371|NCT02499822|Ramipril|ramipril|mesh-list
19622372|NCT02499822|Nifedipine|nifedipine|mesh-list
19622373|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20135652|NCT00040261|Memantine|memantine|mesh-list
20135653|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20135654|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20135655|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
20135656|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135657|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135658|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135659|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20135660|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20135661|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
20135662|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20135663|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20135664|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135665|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135666|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
20135667|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135668|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20135669|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20135670|NCT00040300|Racivir|racivir|mesh-list
20135671|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
20312799|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20312800|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
20312801|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20312802|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20312803|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
20312804|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20312805|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312806|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20312807|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
20312808|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20312809|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19622374|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
19622375|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135672|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135673|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
20135674|NCT00040378|Vitamins|vitamins|mesh-list
20135675|NCT00040378|Vitamin E|vitamin e|mesh-list
20135676|NCT00040378|Tocopherols|tocopherols|mesh-list
20135677|NCT00040378|Tocotrienols|tocotrienols|mesh-list
20135678|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
20135679|NCT00040378|Selenium|selenium|mesh-list
20135680|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
20135681|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135682|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
20135683|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135684|NCT00040378|Protective Agents|protective agents|mesh-ancestor
20135685|NCT00040378|Trace Elements|trace elements|mesh-ancestor
20135686|NCT00040391|Leucovorin|leucovorin|mesh-list
20135687|NCT00040391|Fluorouracil|fluorouracil|mesh-list
20135688|NCT00040391|Irinotecan|irinotecan|mesh-list
20135689|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
20135690|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135691|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135692|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135693|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135694|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
20135695|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135696|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20135697|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135698|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135699|NCT00040391|Antidotes|antidotes|mesh-ancestor
20135700|NCT00040391|Protective Agents|protective agents|mesh-ancestor
20135701|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
19622376|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622377|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19622378|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19622379|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622380|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19622381|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622382|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
19622383|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
19622384|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19622385|NCT02499757|Nicotine|nicotine|mesh-list
19622386|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19622387|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
19622388|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622389|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622390|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19622391|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19622392|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
19622393|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622394|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622395|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19622396|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20135702|NCT00040391|Vitamins|vitamins|mesh-ancestor
20135703|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
20135704|NCT00040417|Fludarabine|fludarabine|mesh-list
20135705|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
20135706|NCT00040417|Sargramostim|sargramostim|mesh-list
20135707|NCT00040417|Lenograstim|lenograstim|mesh-list
20135708|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135709|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
19622397|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19622398|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
19622399|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622400|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622401|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622402|NCT02499614|Crizotinib|crizotinib|mesh-list
19622403|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622404|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19622405|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622406|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622407|NCT02499562|Entecavir|entecavir|mesh-list
19622408|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
19622409|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622410|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
19622411|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
20135710|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135711|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20135712|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622412|NCT02499445|Sufentanil|sufentanil|mesh-list
19622413|NCT02499445|Remifentanil|remifentanil|mesh-list
19622414|NCT02499445|Propofol|propofol|mesh-list
19622415|NCT02499445|Sevoflurane|sevoflurane|mesh-list
19622416|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19622417|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622418|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622419|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19622420|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
19622421|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
19622422|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19622423|NCT02499445|Narcotics|narcotics|mesh-ancestor
19622424|NCT02499445|Analgesics|analgesics|mesh-ancestor
19622425|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
19622426|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622427|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19622428|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19622429|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19622430|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
19622431|NCT02499237|Denosumab|denosumab|mesh-list
19622432|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19622433|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622434|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
19622435|NCT02499393|Analgesics|analgesics|mesh-ancestor
19622436|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
19622437|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622438|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622439|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
19622440|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622441|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19622442|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
19622443|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19622444|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622445|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622446|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19622447|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
19622448|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19622449|NCT02499341|Ketamine|ketamine|mesh-list
19622450|NCT02499341|Tramadol|tramadol|mesh-list
19622451|NCT02499341|Analgesics|analgesics|mesh-ancestor
19622452|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
19622453|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622454|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622455|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19622456|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19622457|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
19622458|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
19622459|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622460|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19622461|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19622462|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622463|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622464|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19622465|NCT02499341|Narcotics|narcotics|mesh-ancestor
19622466|NCT02499354|Iron|iron|mesh-list
19622467|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19622468|NCT02499354|Trace Elements|trace elements|mesh-ancestor
19622469|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
19622470|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622471|NCT02499354|Hematinics|hematinics|mesh-ancestor
19622472|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19622473|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19660689|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19660690|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660691|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135713|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
19622474|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
19622475|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622476|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622477|NCT02498977|Cyclosporine|cyclosporine|mesh-list
19622478|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
19622479|NCT02498977|Azathioprine|azathioprine|mesh-list
19622480|NCT02498977|Tacrolimus|tacrolimus|mesh-list
19622481|NCT02498977|Cyclosporins|cyclosporins|mesh-list
19622482|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622483|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
19622484|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622485|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19622486|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622487|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622488|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
19622489|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622490|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
19622491|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622492|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19622493|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622494|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19622495|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
19622496|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19622497|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
19622498|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19622499|NCT02498756|Ipilimumab|ipilimumab|mesh-list
19622500|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622501|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622502|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19622503|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622504|NCT02498860|Pemetrexed|pemetrexed|mesh-list
19622505|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622506|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622507|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622508|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19622509|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19622510|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
19622511|NCT02498496|Analgesics|analgesics|mesh-ancestor
19622512|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
19622513|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622514|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622515|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
19622516|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622517|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19622518|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
19622519|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19622520|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622521|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622522|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19622523|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
19622524|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19622525|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
19622526|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19622527|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
19622528|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622529|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622530|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19622531|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
19622532|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19622533|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
19622534|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622535|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622536|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19622537|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
19622538|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
19622539|NCT02498535|Protective Agents|protective agents|mesh-ancestor
19622540|NCT02498457|Calcium|calcium|mesh-list
19622541|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19622542|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135714|NCT00040469|Busulfan|busulfan|mesh-list
20135715|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
19622543|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
19622544|NCT02498509|Levocabastine|levocabastine|mesh-list
19622545|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622546|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
19622547|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19622548|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19622549|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19622550|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
19622551|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
19622552|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622553|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622554|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622555|NCT02498301|Rifaximin|rifaximin|mesh-list
19622556|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19622557|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135716|NCT00040469|Phenytoin|phenytoin|mesh-list
20312810|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20312811|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
20312812|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312813|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312814|NCT00685854|Ranibizumab|ranibizumab|mesh-list
20312815|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19622558|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622559|NCT02498288|Isotretinoin|isotretinoin|mesh-list
19622560|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
19622561|NCT02498171|Fentanyl|fentanyl|mesh-list
19622562|NCT02498171|Morphine|morphine|mesh-list
19622563|NCT02498171|Bupivacaine|bupivacaine|mesh-list
19622564|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
19622565|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
19622566|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622567|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622568|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
19622569|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622570|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19622571|NCT02498171|Narcotics|narcotics|mesh-ancestor
19622572|NCT02498171|Analgesics|analgesics|mesh-ancestor
19622573|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19622574|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19622575|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
19622576|NCT02498145|Nicotine|nicotine|mesh-list
19622577|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19622578|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
19622579|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622580|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622581|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19622582|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19622583|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
19622584|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622585|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622586|NCT02497911|Bupivacaine|bupivacaine|mesh-list
19622587|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
19622588|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
19622589|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622590|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622591|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
19622592|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622593|NCT02498015|Ribavirin|ribavirin|mesh-list
19622594|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
19622595|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622596|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
19622597|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622598|NCT02498002|Lidocaine|lidocaine|mesh-list
20135717|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135718|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
20135719|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135720|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135721|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135722|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
20135723|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135724|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135725|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135726|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135727|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
20312816|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19622599|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
19622600|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
19622601|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20135728|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20135729|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20135730|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20135731|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20135732|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20135733|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
20135734|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135735|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
20135736|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135737|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135738|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135739|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
20135740|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135741|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135742|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135743|NCT00040495|Pantoprazole|pantoprazole|mesh-list
20135744|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19622602|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622603|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
19622604|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622605|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19622606|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19622607|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19622608|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622609|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622610|NCT02497833|Tretinoin|tretinoin|mesh-list
19622611|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622612|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
19622613|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
19622614|NCT02497820|Aspirin|aspirin|mesh-list
19622615|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19622616|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19622617|NCT02497820|Analgesics|analgesics|mesh-ancestor
19622618|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
19622619|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622620|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622621|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622622|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622623|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19622624|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19622625|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622626|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19622627|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19622628|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622629|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
19622630|NCT02497638|Metformin|metformin|mesh-list
19622631|NCT02497638|Biguanides|biguanides|mesh-list
19622632|NCT02497638|Atorvastatin|atorvastatin|mesh-list
19622633|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19622634|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622635|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19622636|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19622637|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
19622638|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622639|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19622640|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19622641|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622642|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
19622643|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19622644|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
19622645|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19622646|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
19622647|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622648|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622649|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
19622650|NCT02497547|Oxytocin|oxytocin|mesh-list
19622651|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
19622652|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19622653|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135745|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622654|NCT02497508|Nivolumab|nivolumab|mesh-list
20135746|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19622655|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622656|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622657|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19622658|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135747|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135748|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135749|NCT00040508|Sirolimus|sirolimus|mesh-list
20135750|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20135751|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135752|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135753|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135754|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
20135755|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135756|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
20135757|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135758|NCT00040521|Oprelvekin|oprelvekin|mesh-list
20135759|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135760|NCT00040586|Interleukin-2|interleukin-2|mesh-list
20135761|NCT00040586|Antibodies|antibodies|mesh-list
20135762|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20135763|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
20135764|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135765|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622659|NCT02497313|Metformin|metformin|mesh-list
19622660|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
19622661|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19622662|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622663|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19622664|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622665|NCT02497378|Dexamethasone|dexamethasone|mesh-list
19622666|NCT02497378|Bortezomib|bortezomib|mesh-list
19622667|NCT02497378|Daratumumab|daratumumab|mesh-list
19622668|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622669|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
19622670|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
19622671|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622672|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622673|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622674|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
19622675|NCT02497378|Hormones|hormones|mesh-ancestor
19622676|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622677|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19622678|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660692|NCT04405063|Paclitaxel|paclitaxel|mesh-list
19660693|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19660694|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660695|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19660696|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19660697|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19660698|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660699|NCT04362566|Bupivacaine|bupivacaine|mesh-list
19660700|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
19660701|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
19660702|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660703|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660704|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
19660705|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660706|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
19660707|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
19660708|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19660709|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660710|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660711|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660712|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660713|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19660714|NCT04335084|Vitamin D|vitamin d|mesh-list
19660715|NCT04335084|Vitamins|vitamins|mesh-list
19660716|NCT04335084|Ascorbic Acid|ascorbic acid|mesh-list
19660717|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
19660718|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
19660719|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660720|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19660721|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
19660722|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19660723|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20135766|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19660724|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660725|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749879|NCT04588727|Analgesics|analgesics|mesh-ancestor
20135767|NCT00040586|Analgesics|analgesics|mesh-ancestor
20135768|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
20135769|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622679|NCT02497326|Heparin|heparin|mesh-list
19622680|NCT02497326|Tramadol|tramadol|mesh-list
20135770|NCT00040599|Labetuzumab|labetuzumab|mesh-list
20135771|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622681|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
19622682|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19622683|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19622684|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622685|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19622686|NCT02497326|Narcotics|narcotics|mesh-ancestor
19622687|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20135772|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135773|NCT00040625|Pemetrexed|pemetrexed|mesh-list
20135774|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135775|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135776|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135777|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20135778|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20135779|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
20135780|NCT00040651|Fludarabine|fludarabine|mesh-list
20135781|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
20135782|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20312817|NCT00685854|Growth Substances|growth substances|mesh-ancestor
20312818|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312819|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
20312820|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622688|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622689|NCT02497326|Analgesics|analgesics|mesh-ancestor
19622690|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
19622691|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622692|NCT02497300|Amiloride|amiloride|mesh-list
19622693|NCT02497300|Spironolactone|spironolactone|mesh-list
19622694|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19622695|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
19622696|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622697|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622698|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19622699|NCT02497300|Diuretics|diuretics|mesh-ancestor
19622700|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
19622701|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19622702|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19622703|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622704|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622705|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19622706|NCT02497118|Vinorelbine|vinorelbine|mesh-list
19622707|NCT02497118|Endostatins|endostatins|mesh-list
19622708|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622709|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19622710|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19622711|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19622712|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19622713|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622714|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19622715|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19622716|NCT02497118|Growth Substances|growth substances|mesh-ancestor
19622717|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622718|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
19622719|NCT02497222|RNS60|rns60|mesh-list
19622720|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19622721|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19622722|NCT02497222|Analgesics|analgesics|mesh-ancestor
19622723|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
19622724|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135783|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
20135784|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135785|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135786|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135787|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
20312821|NCT00685906|Ticagrelor|ticagrelor|mesh-list
20312822|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
20135788|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312823|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19622725|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622726|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622727|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622728|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19622729|NCT02497157|Leucovorin|leucovorin|mesh-list
19622730|NCT02497157|Bevacizumab|bevacizumab|mesh-list
19622731|NCT02497157|Fluorouracil|fluorouracil|mesh-list
19622732|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
19622733|NCT02497157|Irinotecan|irinotecan|mesh-list
19622734|NCT02497157|Calcium|calcium|mesh-list
19622735|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
19622736|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622737|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622738|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19622739|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19622740|NCT02497157|Growth Substances|growth substances|mesh-ancestor
19622741|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622742|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
20135789|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135790|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135791|NCT00040690|Leucovorin|leucovorin|mesh-list
19622743|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19622744|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
19622745|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622746|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19622747|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622748|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
19622749|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19622750|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19622751|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622752|NCT02497157|Antidotes|antidotes|mesh-ancestor
19622753|NCT02497157|Protective Agents|protective agents|mesh-ancestor
19622754|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
19622755|NCT02497157|Vitamins|vitamins|mesh-ancestor
19622756|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
19622757|NCT02497365|Cefazolin|cefazolin|mesh-list
19622758|NCT02497365|Tobramycin|tobramycin|mesh-list
19622759|NCT02497365|Besifloxacin|besifloxacin|mesh-list
19622760|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19622761|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622762|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19622763|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19622764|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135792|NCT00040690|Cytarabine|cytarabine|mesh-list
20135793|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
20135794|NCT00040690|Ifosfamide|ifosfamide|mesh-list
19622765|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622766|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622767|NCT02497079|Formaldehyde|formaldehyde|mesh-list
19622768|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
19622769|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622770|NCT02497053|Pemetrexed|pemetrexed|mesh-list
19622771|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622772|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622773|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622774|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19622775|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19622776|NCT02496988|Temozolomide|temozolomide|mesh-list
19622777|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19622778|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
19622779|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622780|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622781|NCT02496962|Atorvastatin|atorvastatin|mesh-list
19622782|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19622783|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19622784|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
19622785|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622786|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19622787|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19622788|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622789|NCT02496975|Cyclosporine|cyclosporine|mesh-list
19622790|NCT02496975|Cyclosporins|cyclosporins|mesh-list
19622791|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622792|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135795|NCT00040690|Doxorubicin|doxorubicin|mesh-list
19622793|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622794|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
20135796|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19622795|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622796|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
19622797|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622798|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
20135797|NCT00040690|Methotrexate|methotrexate|mesh-list
20135798|NCT00040690|Etoposide|etoposide|mesh-list
20135799|NCT00040690|Vincristine|vincristine|mesh-list
20135800|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
20135801|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135802|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
20135803|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135804|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135805|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20135806|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
20135807|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135808|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135809|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135810|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135811|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19622799|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622800|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19622801|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19622802|NCT02496754|Hormones|hormones|mesh-ancestor
19622803|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622804|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135812|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135813|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312824|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20312825|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20312826|NCT00685906|Estradiol|estradiol|mesh-list
20312827|NCT00685906|Estrogens|estrogens|mesh-ancestor
20312828|NCT00685906|Hormones|hormones|mesh-ancestor
20312829|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312830|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312831|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20312832|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
20312833|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20312834|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20312835|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20312836|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20312837|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20312838|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20312839|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20312840|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20312841|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20312842|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
19622805|NCT02496910|Amlodipine|amlodipine|mesh-list
19622806|NCT02496910|Telmisartan|telmisartan|mesh-list
19622807|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
19622808|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19622809|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19622810|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19622811|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622812|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622813|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19749880|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
20135814|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20135815|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
20135816|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20135817|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135818|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
20135819|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
20135820|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20135821|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20135822|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19622814|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622815|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
19622816|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19622817|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20135823|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
20135824|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135825|NCT00040690|Antidotes|antidotes|mesh-ancestor
19622818|NCT02496910|Diuretics|diuretics|mesh-ancestor
19622819|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
20135826|NCT00040690|Protective Agents|protective agents|mesh-ancestor
20135827|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
20135828|NCT00040690|Vitamins|vitamins|mesh-ancestor
20135829|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
20135830|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135831|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135832|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173592|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173593|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
20173594|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173595|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20173596|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19622820|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19622821|NCT02496741|Metformin|metformin|mesh-list
20312843|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312844|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312845|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20312846|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20312847|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20312848|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20312849|NCT00685958|Enoxaparin|enoxaparin|mesh-list
20312850|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
20312851|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20312852|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19622822|NCT02496741|Chloroquine|chloroquine|mesh-list
19622823|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19622824|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622825|NCT02496741|Amebicides|amebicides|mesh-ancestor
19622826|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19622827|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19622828|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622829|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
19622830|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622831|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19622832|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19622833|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622834|NCT02496715|Fluticasone|fluticasone|mesh-list
19622835|NCT02496715|Xhance|xhance|mesh-list
19622836|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19622837|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622838|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19622839|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
19622840|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622841|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622842|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19622843|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
19622844|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
19622845|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19622846|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19622847|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20173597|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20173598|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312853|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173599|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622848|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19622849|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
19622850|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622851|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622852|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
19622853|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19622854|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622855|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622856|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19622857|NCT02496650|Analgesics|analgesics|mesh-ancestor
19622858|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
19622859|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622860|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19622861|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19622862|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19622863|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19622864|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622865|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622866|NCT02496494|Tacrolimus|tacrolimus|mesh-list
19622867|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622868|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
19622869|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622870|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19622871|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622872|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622873|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
19622874|NCT02496377|Glycine|glycine|mesh-list
19622875|NCT02496377|Hematinics|hematinics|mesh-ancestor
19622876|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
19622877|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19622878|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622879|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622880|NCT02496455|Tramadol|tramadol|mesh-list
19622881|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19622882|NCT02496455|Narcotics|narcotics|mesh-ancestor
19622883|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622884|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622885|NCT02496455|Analgesics|analgesics|mesh-ancestor
19622886|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
19622887|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622888|NCT02496299|Dexamethasone|dexamethasone|mesh-list
20135833|NCT00040768|Bortezomib|bortezomib|mesh-list
20135834|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135835|NCT00040781|Gefitinib|gefitinib|mesh-list
20135836|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135837|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135838|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622889|NCT02496299|Bupivacaine|bupivacaine|mesh-list
19622890|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622891|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
19622892|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
19622893|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622894|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622895|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622896|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
19622897|NCT02496299|Hormones|hormones|mesh-ancestor
19622898|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622899|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19622900|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622901|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
19622902|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
19622903|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622904|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
19622905|NCT02496286|Bevacizumab|bevacizumab|mesh-list
19622906|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19622907|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622908|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19622909|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19622910|NCT02496286|Growth Substances|growth substances|mesh-ancestor
19622911|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749881|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135839|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135840|NCT00040794|Paclitaxel|paclitaxel|mesh-list
19622912|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
19622913|NCT02496182|Pirfenidone|pirfenidone|mesh-list
19622914|NCT02496182|Analgesics|analgesics|mesh-ancestor
19622915|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
19622916|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622917|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622918|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19622919|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19622920|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622921|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19622922|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622923|NCT02496078|Asunaprevir|asunaprevir|mesh-list
19622924|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
19622925|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622926|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622927|NCT02495896|Gemcitabine|gemcitabine|mesh-list
19622928|NCT02495896|Paclitaxel|paclitaxel|mesh-list
19622929|NCT02495896|Docetaxel|docetaxel|mesh-list
19622930|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19622931|NCT02495896|Cisplatin|cisplatin|mesh-list
19622932|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19622933|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622934|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
19622935|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
19622936|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
19622937|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19622938|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19622939|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
19622940|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
19622941|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19622942|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622943|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19622944|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
19622945|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622946|NCT02495922|Dexamethasone|dexamethasone|mesh-list
19622947|NCT02495922|Lenalidomide|lenalidomide|mesh-list
19622948|NCT02495922|Bortezomib|bortezomib|mesh-list
19622949|NCT02495922|Elotuzumab|elotuzumab|mesh-list
19622950|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622951|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
19622952|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
19622953|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135841|NCT00040794|Carboplatin|carboplatin|mesh-list
20135842|NCT00040794|Gefitinib|gefitinib|mesh-list
20135843|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135844|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135845|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135846|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135847|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135848|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135849|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19622954|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622955|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19622956|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
19622957|NCT02495922|Hormones|hormones|mesh-ancestor
19622958|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19622959|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19622960|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622961|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
19622962|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19622963|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19622964|NCT02495922|Growth Substances|growth substances|mesh-ancestor
19622965|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
19622966|NCT02495688|Anesthetics|anesthetics|mesh-list
19622967|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622968|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622969|NCT02495584|Vitamin D|vitamin d|mesh-list
19622970|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
19622971|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
19622972|NCT02495584|Vitamins|vitamins|mesh-list
20135850|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135851|NCT00040807|Docetaxel|docetaxel|mesh-list
20135852|NCT00040807|Irinotecan|irinotecan|mesh-list
20135853|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622973|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
20135854|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135855|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
19622974|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832520|NCT03793439|Prednisone|prednisone|mesh-list
19622975|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19622976|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20312854|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
20312855|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20312856|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312857|NCT00685971|Vitamins|vitamins|mesh-ancestor
19622977|NCT02495636|Atezolizumab|atezolizumab|mesh-list
19622978|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622979|NCT02495818|Lidocaine|lidocaine|mesh-list
19622980|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
19622981|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
20135856|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135857|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135858|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20135859|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135860|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19622982|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19622983|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19622984|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
20135861|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
20135862|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19622985|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19622986|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19622987|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19622988|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19622989|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19622990|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135863|NCT00040859|Capecitabine|capecitabine|mesh-list
20135864|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
20135865|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135866|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
20135867|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135868|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135869|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
20135870|NCT00040872|Thiotepa|thiotepa|mesh-list
20135871|NCT00040872|Carboplatin|carboplatin|mesh-list
20135872|NCT00040872|Doxorubicin|doxorubicin|mesh-list
20135873|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20135874|NCT00040872|Etoposide|etoposide|mesh-list
20135875|NCT00040872|Vincristine|vincristine|mesh-list
20135876|NCT00040872|Topotecan|topotecan|mesh-list
20135877|NCT00040872|Isotretinoin|isotretinoin|mesh-list
20135878|NCT00040872|Antibodies|antibodies|mesh-list
20135879|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20135880|NCT00040872|Sargramostim|sargramostim|mesh-list
20608379|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608380|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608381|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608382|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608383|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608384|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608385|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608386|NCT02245529|Urological Agents|urological agents|mesh-ancestor
20608387|NCT02245555|Tamsulosin|tamsulosin|mesh-list
20608388|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608389|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608390|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608391|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608392|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660726|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135881|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135882|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
20312858|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
19622991|NCT02495662|Prednisolone|prednisolone|mesh-list
19622992|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19622993|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
19622994|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19622995|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
19622996|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19622997|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
19622998|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19622999|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
19623000|NCT02495662|Hormones|hormones|mesh-ancestor
19623001|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623002|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623003|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19623004|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623005|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
19623006|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
19623007|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623008|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623009|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19623010|NCT02495662|Protective Agents|protective agents|mesh-ancestor
19623011|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19623012|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19623013|NCT02496052|Estradiol|estradiol|mesh-list
19623014|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19623015|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
19623016|NCT02496052|Estrogens|estrogens|mesh-ancestor
19623017|NCT02496052|Hormones|hormones|mesh-ancestor
19623018|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623019|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623020|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19623021|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
19623022|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19623023|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19623024|NCT02496052|Progestins|progestins|mesh-ancestor
19623025|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19623026|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
20312859|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20312860|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
20312861|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20312862|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20312863|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
20312864|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312865|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20312866|NCT00686114|Paclitaxel|paclitaxel|mesh-list
20312867|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20312868|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20312869|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312870|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
20312871|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312872|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312873|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312874|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19623027|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623028|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19623029|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660727|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312875|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749882|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749883|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749884|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749885|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19749886|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19749887|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623030|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623031|NCT02495181|Aflibercept|aflibercept|mesh-list
19623032|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19623033|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19623034|NCT02495181|Growth Substances|growth substances|mesh-ancestor
19623035|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623036|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
19623037|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623038|NCT02495324|Valsartan|valsartan|mesh-list
19623039|NCT02495324|Olmesartan|olmesartan|mesh-list
19623040|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19623041|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19623042|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20608393|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135883|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135884|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135885|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19623043|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19623044|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623045|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
19623046|NCT02495220|Bupivacaine|bupivacaine|mesh-list
19623047|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
20135886|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
19623048|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
19623049|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623050|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623051|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
19623052|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623053|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19623054|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623055|NCT02495220|Analgesics|analgesics|mesh-ancestor
19623056|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19623057|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19623058|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19623059|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
19623060|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623061|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623062|NCT02495285|Polygeline|polygeline|mesh-list
19623063|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
19623064|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
19623065|NCT02495272|Oxytocin|oxytocin|mesh-list
19623066|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
19623067|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19623068|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623069|NCT02495415|Fenretinide|fenretinide|mesh-list
19623070|NCT02495415|Retinamide|retinamide|mesh-list
19623071|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623072|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19623073|NCT02495415|Protective Agents|protective agents|mesh-ancestor
19623074|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623075|NCT02495363|Bupivacaine|bupivacaine|mesh-list
19623076|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
19623077|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
19623078|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20135887|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135888|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135889|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20135890|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135891|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20135892|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135893|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135894|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19623079|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623080|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
19623081|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623082|NCT02494882|Dexamethasone|dexamethasone|mesh-list
19623083|NCT02494882|Dasatinib|dasatinib|mesh-list
19623084|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623085|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
19623086|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
19623087|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623088|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623089|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623090|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
19623091|NCT02494882|Hormones|hormones|mesh-ancestor
19623092|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623093|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19623094|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623095|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19623096|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623097|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623098|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19623099|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
19623100|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623101|NCT02494830|Ketamine|ketamine|mesh-list
19623102|NCT02494830|Analgesics|analgesics|mesh-ancestor
19623103|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
19623104|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623105|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623106|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19623107|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19623108|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
19623109|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
19623110|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623111|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19623112|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19623113|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623114|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623115|NCT02494804|Temozolomide|temozolomide|mesh-list
19623116|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19623117|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
19623118|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623119|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623120|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
19623121|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623122|NCT02495077|Acetaminophen|acetaminophen|mesh-list
19623123|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
19623124|NCT02495077|Promethazine|promethazine|mesh-list
19623125|NCT02495077|Loratadine|loratadine|mesh-list
19623126|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
19623127|NCT02495077|Prednisone|prednisone|mesh-list
19623128|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
19623129|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19623130|NCT02495077|Infliximab|infliximab|mesh-list
19623131|NCT02495077|Tacrolimus|tacrolimus|mesh-list
19623132|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
19623133|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20135895|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135896|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
19623134|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623135|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
19623136|NCT02495077|Hormones|hormones|mesh-ancestor
19623137|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623138|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623139|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19623140|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623141|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623142|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
19623143|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19623144|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623145|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623146|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623147|NCT02495077|Analgesics|analgesics|mesh-ancestor
19623148|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
19623149|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623150|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
19749888|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19623151|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19623152|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19623153|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
19623154|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19623155|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135897|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135898|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20135899|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
20135900|NCT00040885|Docetaxel|docetaxel|mesh-list
20135901|NCT00040885|Infliximab|infliximab|mesh-list
20135902|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135903|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135904|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135905|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
19623156|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
19623157|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
19623158|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623159|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19623160|NCT02495077|Protective Agents|protective agents|mesh-ancestor
20135906|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135907|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
20135908|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20135909|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135910|NCT00040950|Rituximab|rituximab|mesh-list
19623161|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
19623162|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623163|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19623164|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19623165|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623166|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
19623167|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
19623168|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19623169|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
19623170|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
19623171|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623172|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19623173|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
19623174|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19623175|NCT02494895|Aspirin|aspirin|mesh-list
19623176|NCT02494895|Ticagrelor|ticagrelor|mesh-list
19623177|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623178|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623179|NCT02494895|Analgesics|analgesics|mesh-ancestor
19623180|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
19623181|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623182|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623183|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623184|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623185|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19623186|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19623187|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623188|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19623189|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19623190|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623191|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
19623192|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19623193|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19623194|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19623195|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
19623196|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20135911|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20135912|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135913|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
20135914|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135915|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135916|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20135917|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135918|NCT00041015|Etoposide|etoposide|mesh-list
20135919|NCT00041015|Topotecan|topotecan|mesh-list
20135920|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623197|NCT02494856|Naproxen|naproxen|mesh-list
19623198|NCT02494856|Esomeprazole|esomeprazole|mesh-list
19623199|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20135921|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135922|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19623200|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623201|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19623202|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623203|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623204|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623205|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623206|NCT02494856|Analgesics|analgesics|mesh-ancestor
19623207|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
19623208|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623209|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623210|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623211|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623212|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
19623213|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19623214|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
19623215|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623216|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
19623217|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19623218|NCT02494687|Domperidone|domperidone|mesh-list
19623219|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
19623220|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
19623221|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623222|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623223|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623224|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19623225|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
19623226|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623227|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623228|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19623229|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
19623230|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
19623231|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19623232|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623233|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19623234|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19623235|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623236|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19623237|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19623238|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19623239|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623240|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
19623241|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19623242|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623243|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19623244|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
19623245|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19623246|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623247|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623248|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623249|NCT02494466|Montelukast|montelukast|mesh-list
19623250|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19623251|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
19623252|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19623253|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
19623254|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623255|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623256|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19623257|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19623258|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623259|NCT02494349|Tamsulosin|tamsulosin|mesh-list
19623260|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
19623261|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19623262|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19623263|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19623264|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
19623265|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623266|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623267|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623268|NCT02494349|Urological Agents|urological agents|mesh-ancestor
19623269|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19623270|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19623271|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
19623272|NCT02494284|Aspirin|aspirin|mesh-list
19623273|NCT02494284|Clopidogrel|clopidogrel|mesh-list
19623274|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623275|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623276|NCT02494284|Analgesics|analgesics|mesh-ancestor
19623277|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
19623278|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623279|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623280|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623281|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623282|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19623283|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19623284|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623285|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19623286|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19623287|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623288|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
19623289|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19623290|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19623291|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19623292|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
19623293|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623294|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
19623295|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19623296|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
19623297|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
19623298|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623299|NCT02493933|Expectorants|expectorants|mesh-ancestor
19623300|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
19623301|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19623302|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
19623303|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623304|NCT02493933|Protective Agents|protective agents|mesh-ancestor
19623305|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623306|NCT02493933|Antidotes|antidotes|mesh-ancestor
19623307|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19623308|NCT02493933|Estrogens|estrogens|mesh-ancestor
19623309|NCT02493933|Hormones|hormones|mesh-ancestor
19623310|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623311|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19623312|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19623313|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623314|NCT02493959|Incretins|incretins|mesh-ancestor
19623315|NCT02493959|Hormones|hormones|mesh-ancestor
19623316|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623317|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19623318|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
19623319|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623320|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660728|NCT04335084|Antioxidants|antioxidants|mesh-ancestor
19660729|NCT04335084|Protective Agents|protective agents|mesh-ancestor
19660730|NCT04316871|Morphine|morphine|mesh-list
19660731|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19660732|NCT04316871|Narcotics|narcotics|mesh-ancestor
19660733|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660734|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135923|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135924|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135925|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135926|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20135927|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
20135928|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135929|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135930|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135931|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135932|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
20135933|NCT00041054|Carboplatin|carboplatin|mesh-list
19660735|NCT04316871|Analgesics|analgesics|mesh-ancestor
19660736|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
19660737|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660738|NCT04295941|Trazodone|trazodone|mesh-list
19256606|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135934|NCT00041054|Etoposide|etoposide|mesh-list
19623321|NCT02493894|Cefazolin|cefazolin|mesh-list
19623322|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19623323|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623324|NCT02493725|Eculizumab|eculizumab|mesh-list
19623325|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19623326|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623327|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
19623328|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623329|NCT02493738|Itraconazole|itraconazole|mesh-list
19623330|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
19623331|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623332|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19623333|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19623334|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623335|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623336|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19623337|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
19623338|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623339|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623340|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19623341|NCT02493582|Apatinib|apatinib|mesh-list
19623342|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623343|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19623344|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623345|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623346|NCT02493504|Heparin|heparin|mesh-list
19623347|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
19623348|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19623349|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19623350|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623351|NCT02493465|Everolimus|everolimus|mesh-list
19623352|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312876|NCT00686140|Celecoxib|celecoxib|mesh-list
20312877|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20312878|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20312879|NCT00686140|Analgesics|analgesics|mesh-ancestor
20312880|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
20135935|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623353|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623354|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
19623355|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623356|NCT02493335|Budesonide|budesonide|mesh-list
19623357|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623358|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19623359|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
19623360|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623361|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623362|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19623363|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
19623364|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
19623365|NCT02493335|Hormones|hormones|mesh-ancestor
19623366|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623367|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
19623368|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623369|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623370|NCT02493179|Analgesics|analgesics|mesh-ancestor
19623371|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
19623372|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623373|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623374|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623375|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623376|NCT02493192|Meperidine|meperidine|mesh-list
19623377|NCT02493192|Haloperidol|haloperidol|mesh-list
20135936|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20135937|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20135938|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135939|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135940|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135941|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20135942|NCT00041054|Protective Agents|protective agents|mesh-ancestor
20135943|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312881|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623378|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
19623379|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
20135944|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19623380|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
19623381|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623382|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623383|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623384|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19623385|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19623386|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623387|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19623388|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19623389|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
19623390|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623391|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623392|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19623393|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19623394|NCT02493192|Narcotics|narcotics|mesh-ancestor
19623395|NCT02493192|Analgesics|analgesics|mesh-ancestor
19623396|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
19623397|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19623398|NCT02493283|Dapsone|dapsone|mesh-list
19623399|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623400|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
19623401|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19623402|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19623403|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19623404|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623405|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623406|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
19623407|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19623408|NCT02493231|Ketamine|ketamine|mesh-list
19623409|NCT02493231|Nefopam|nefopam|mesh-list
19623410|NCT02493231|Analgesics|analgesics|mesh-ancestor
19623411|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
19623412|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623413|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623414|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19623415|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19623416|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
19623417|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
20135945|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20135946|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20135947|NCT00041054|Analgesics|analgesics|mesh-ancestor
20135948|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
20135949|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135950|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20135951|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135952|NCT00041093|Docetaxel|docetaxel|mesh-list
20135953|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623418|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623419|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19623420|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19623421|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623422|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623423|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623424|NCT02493049|Domperidone|domperidone|mesh-list
19623425|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623426|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
19623427|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
19623428|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623429|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623430|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623431|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20135954|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135955|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135956|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135957|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135958|NCT00041106|Gemcitabine|gemcitabine|mesh-list
20135959|NCT00041106|Gefitinib|gefitinib|mesh-list
20135960|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135961|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20135962|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
19623432|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
19660739|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19660740|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20135963|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135964|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
20135965|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20135966|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623433|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623434|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19623435|NCT02493322|Olmesartan|olmesartan|mesh-list
19623436|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19623437|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
19623438|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19623439|NCT02493322|Diuretics|diuretics|mesh-ancestor
19623440|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
19623441|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623442|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19623443|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19623444|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623445|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19623446|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19623447|NCT02492945|Lidocaine|lidocaine|mesh-list
19623448|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19623449|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
19623450|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
19623451|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623452|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623453|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
19623454|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623455|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19623456|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19623457|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19623458|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19623459|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623460|NCT02492776|Omeprazole|omeprazole|mesh-list
19623461|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19623462|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623463|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19623464|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623465|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623466|NCT02492503|Paclitaxel|paclitaxel|mesh-list
19623467|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19623468|NCT02492503|Carboplatin|carboplatin|mesh-list
19623469|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19623470|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623471|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
19623472|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
19623473|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
19623474|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623475|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19623476|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19623477|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19623478|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623479|NCT02492464|Red yeast rice|red yeast rice|mesh-list
19623480|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19623481|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19623482|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19623483|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
19623484|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623485|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623486|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19623487|NCT02492412|Cyclosporine|cyclosporine|mesh-list
19623488|NCT02492412|Cyclosporins|cyclosporins|mesh-list
19623489|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623490|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623491|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623492|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
19623493|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623494|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
19623495|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623496|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
19623497|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20135967|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623498|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20135968|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
19623499|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
19623500|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19623501|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623502|NCT02492386|Everolimus|everolimus|mesh-list
19623503|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623504|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623505|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
19623506|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623507|NCT02492438|Vaccines|vaccines|mesh-list
19623508|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
19623509|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623510|NCT02492581|Nalmefene|nalmefene|mesh-list
19623511|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19623512|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623513|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
19623514|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20135969|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135970|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135971|NCT00041171|Docetaxel|docetaxel|mesh-list
20135972|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623515|NCT02492373|Clobetasol|clobetasol|mesh-list
19623516|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623517|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
19623518|NCT02492373|Hormones|hormones|mesh-ancestor
19623519|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623520|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623521|NCT02492490|Basiliximab|basiliximab|mesh-list
19623522|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623523|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
19623524|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623525|NCT02492308|Basiliximab|basiliximab|mesh-list
19623526|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20135973|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
20135974|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
20135975|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
20135976|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135977|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
20135978|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135979|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20135980|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135981|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135982|NCT00041210|Prednisone|prednisone|mesh-list
20135983|NCT00041210|Doxorubicin|doxorubicin|mesh-list
20135984|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20135985|NCT00041210|Bleomycin|bleomycin|mesh-list
20135986|NCT00041210|Etoposide|etoposide|mesh-list
20135987|NCT00041210|Vincristine|vincristine|mesh-list
20135988|NCT00041210|Dacarbazine|dacarbazine|mesh-list
20135989|NCT00041210|Vinblastine|vinblastine|mesh-list
19623527|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
19623528|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20135990|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
20135991|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20135992|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20135993|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19623529|NCT02492360|Cisplatin|cisplatin|mesh-list
19623530|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623531|NCT02492282|Remifentanil|remifentanil|mesh-list
19623532|NCT02492282|Propofol|propofol|mesh-list
19623533|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19623534|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623535|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623536|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19623537|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
19623538|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
19623539|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20135994|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20135995|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20135996|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20135997|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20135998|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
20135999|NCT00041210|Hormones|hormones|mesh-ancestor
20136000|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136001|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136002|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19623540|NCT02492282|Narcotics|narcotics|mesh-ancestor
19623541|NCT02492282|Analgesics|analgesics|mesh-ancestor
19623542|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
19623543|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623544|NCT02492126|Citric Acid|citric acid|mesh-list
19623545|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
19623546|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
19623547|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19623548|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
19623549|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
19623550|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623551|NCT02492230|Warfarin|warfarin|mesh-list
19623552|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
19623553|NCT02492178|Artesunate|artesunate|mesh-list
19623554|NCT02492178|Quinine|quinine|mesh-list
19623555|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
19623556|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19623557|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19623558|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623559|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623560|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
19623561|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
19623562|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19623563|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
19623564|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19623565|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623566|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19623567|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623568|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623569|NCT02492178|Analgesics|analgesics|mesh-ancestor
19623570|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
19623571|NCT02492217|Adalimumab|adalimumab|mesh-list
19623572|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623573|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623574|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
19623575|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19623576|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19623577|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623578|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
19623579|NCT02492087|Coagulants|coagulants|mesh-ancestor
19660741|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660742|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660743|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19660744|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19660745|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19660746|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19660747|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660748|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660749|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
19660750|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19660751|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
19660752|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
19660753|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
19660754|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
19660755|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19660756|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19660757|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660758|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
19665626|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19665627|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
19665628|NCT04610476|Hormones|hormones|mesh-ancestor
19665629|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19665630|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19665631|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
19665632|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
19665633|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665634|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19665635|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19665636|NCT04610476|Protective Agents|protective agents|mesh-ancestor
19665637|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19665638|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19665639|NCT04610476|Analgesics|analgesics|mesh-ancestor
19665640|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
19665641|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19665642|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665643|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19665644|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19665645|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19665646|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623580|NCT02492074|Dronabinol|dronabinol|mesh-list
19623581|NCT02492074|Cannabidiol|cannabidiol|mesh-list
19623582|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
19623583|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
19623584|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623585|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19623586|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623587|NCT02492074|Analgesics|analgesics|mesh-ancestor
19623588|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
20136003|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20136004|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136005|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136006|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
20136007|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20136008|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
20136009|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
19623589|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623590|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19623591|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19623592|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136010|NCT00041223|Procyanidin|procyanidin|mesh-list
20136011|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
20136012|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136013|NCT00041223|Protective Agents|protective agents|mesh-ancestor
19623593|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623594|NCT02492074|Hormones|hormones|mesh-ancestor
19623595|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623596|NCT02491983|Letrozole|letrozole|mesh-list
19623597|NCT02491983|Fulvestrant|fulvestrant|mesh-list
19623598|NCT02491983|Palbociclib|palbociclib|mesh-list
19623599|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623600|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19623601|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19623602|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623603|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623604|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19623605|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
19623606|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623607|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623608|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19623609|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19623610|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19623611|NCT02491697|Capecitabine|capecitabine|mesh-list
19623612|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19623613|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
19623614|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623615|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623616|NCT02491749|Anesthetics|anesthetics|mesh-list
19623617|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623618|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623619|NCT02491736|Ketoprofen|ketoprofen|mesh-list
19623620|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623621|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623622|NCT02491736|Analgesics|analgesics|mesh-ancestor
19623623|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
19623624|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623625|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623626|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623627|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623628|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19623629|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623630|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623631|NCT02491970|Fluticasone|fluticasone|mesh-list
19623632|NCT02491970|Xhance|xhance|mesh-list
19623633|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
19623634|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19623635|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19623636|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623637|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19623638|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
19623639|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832521|NCT03793439|Tofacitinib|tofacitinib|mesh-list
20136014|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623640|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623641|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19623642|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
19623643|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
19623644|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19623645|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19623646|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19623647|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19623648|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
19623649|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623650|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623651|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
19623652|NCT02491970|Hormones|hormones|mesh-ancestor
19623653|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623654|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
19623655|NCT02491879|Ketoprofen|ketoprofen|mesh-list
19623656|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623657|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623658|NCT02491879|Analgesics|analgesics|mesh-ancestor
19623659|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
19623660|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623661|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623662|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623663|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623664|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19623665|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623666|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623667|NCT02491723|Azithromycin|azithromycin|mesh-list
19623668|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19623669|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623670|NCT02491320|Letrozole|letrozole|mesh-list
19623671|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623672|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19623673|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19623674|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623675|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623676|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19623677|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
19623678|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623679|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623680|NCT02491242|Dolutegravir|dolutegravir|mesh-list
19623681|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19623682|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20136015|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19623683|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623684|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623685|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19623686|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19623687|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
19623688|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623689|NCT02491268|Cilostazol|cilostazol|mesh-list
19623690|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19623691|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
19623692|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623693|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623694|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19623695|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
19623696|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19623697|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19623698|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623699|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19623700|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
19623701|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19623702|NCT02491268|Protective Agents|protective agents|mesh-ancestor
19623703|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19623704|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19623705|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623706|NCT02491606|Tafenoquine|tafenoquine|mesh-list
19623707|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
19623708|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19623709|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19623710|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623711|NCT02491515|Denosumab|denosumab|mesh-list
19623712|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19623713|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136016|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20136017|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136018|NCT00041236|Exatecan|exatecan|mesh-list
20136019|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20136020|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20136021|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623714|NCT02491398|Rituximab|rituximab|mesh-list
19623715|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19623716|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19623717|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136022|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136023|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136024|NCT00041262|Fluorouracil|fluorouracil|mesh-list
20136025|NCT00041262|Epirubicin|epirubicin|mesh-list
20136026|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136027|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
20136028|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136029|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136030|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136031|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
20136032|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136033|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20136034|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136035|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19623718|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
19623719|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623720|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623721|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19623722|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
19623723|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623724|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
19623725|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
19623726|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623727|NCT02491528|Insulin|insulin|mesh-list
19623728|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19623729|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
19623730|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
19623731|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19623732|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19623733|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623734|NCT02491086|Nicotine|nicotine|mesh-list
19623735|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19623736|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
19623737|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623738|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623739|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19623740|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20136036|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136037|NCT00041275|Megestrol|megestrol|mesh-list
20136038|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
20136039|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20136040|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20136041|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20136042|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
20136043|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20136044|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623741|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
19623742|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623743|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623744|NCT02490982|Teriflunomide|teriflunomide|mesh-list
19623745|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623746|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623747|NCT02490982|Analgesics|analgesics|mesh-ancestor
19623748|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
20136045|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20136046|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20136047|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20136048|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136049|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
20136050|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19623749|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623750|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623751|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312882|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623752|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623753|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623754|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
19623755|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19623756|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19623757|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623758|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623759|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
19623760|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623761|NCT02490904|Eplerenone|eplerenone|mesh-list
19623762|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19623763|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
19623764|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623765|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623766|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19623767|NCT02490904|Diuretics|diuretics|mesh-ancestor
19623768|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
19623769|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19623770|NCT02490657|Iloprost|iloprost|mesh-list
19623771|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19623772|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
19623773|NCT02490592|Fluorides|fluorides|mesh-list
19623774|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
19623775|NCT02490592|Protective Agents|protective agents|mesh-ancestor
19623776|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623777|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
19623778|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19623779|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
19623780|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19623781|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623782|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19623783|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19623784|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19623785|NCT02490865|RNS60|rns60|mesh-list
19623786|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623787|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623788|NCT02490865|Analgesics|analgesics|mesh-ancestor
19623789|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
19623790|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623791|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623792|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623793|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623794|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19623795|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19623796|NCT02490839|Amoxicillin|amoxicillin|mesh-list
19623797|NCT02490839|Metronidazole|metronidazole|mesh-list
19623798|NCT02490839|Tetracycline|tetracycline|mesh-list
19623799|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19623800|NCT02490839|Rabeprazole|rabeprazole|mesh-list
19623801|NCT02490839|Bismuth|bismuth|mesh-list
19623802|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19623803|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623804|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
19623805|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20136051|NCT00041288|Cyclosporine|cyclosporine|mesh-list
20136052|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
20136053|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
20136054|NCT00041288|Methotrexate|methotrexate|mesh-list
20136055|NCT00041288|Fludarabine|fludarabine|mesh-list
20136056|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
20136057|NCT00041288|Tacrolimus|tacrolimus|mesh-list
20136058|NCT00041288|Cyclosporins|cyclosporins|mesh-list
20136059|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136060|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
20136061|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136062|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136063|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20136064|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
20136065|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623806|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19623807|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20136066|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136067|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20136068|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20136069|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
20136070|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20136071|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136072|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
20136073|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
20136074|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136075|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20136076|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20136077|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20136078|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
20136079|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623808|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623809|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623810|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623811|NCT02490839|Antacids|antacids|mesh-ancestor
19623812|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19623813|NCT02490527|Simvastatin|simvastatin|mesh-list
19623814|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19623815|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19623816|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
20136080|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19623817|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623818|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19623819|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19623820|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623821|NCT02490540|Sufentanil|sufentanil|mesh-list
19623822|NCT02490540|Dsuvia|dsuvia|mesh-list
19623823|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19623824|NCT02490540|Narcotics|narcotics|mesh-ancestor
20136081|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20136082|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
20136083|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20136084|NCT00041314|Gemcitabine|gemcitabine|mesh-list
20136085|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
20136086|NCT00041314|Carboplatin|carboplatin|mesh-list
20136087|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136088|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136089|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
20136090|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136091|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
20136092|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136093|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136094|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136095|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
19623825|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623826|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623827|NCT02490540|Analgesics|analgesics|mesh-ancestor
19623828|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
19623829|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623830|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19623831|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19623832|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
19623833|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
19623834|NCT02490436|Cetuximab|cetuximab|mesh-list
19623835|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19623836|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660759|NCT04122196|Pregabalin|pregabalin|mesh-list
19660760|NCT04122196|Analgesics|analgesics|mesh-ancestor
19660761|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
19660762|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136096|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136097|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20136098|NCT00041314|Protective Agents|protective agents|mesh-ancestor
19660763|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623837|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
19623838|NCT02490449|Lansoprazole|lansoprazole|mesh-list
19623839|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19623840|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623841|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19623842|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623843|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623844|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
19623845|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623846|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
19623847|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
19623848|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
19623849|NCT02490345|Gabapentin|gabapentin|mesh-list
19623850|NCT02490345|Analgesics|analgesics|mesh-ancestor
19623851|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
19623852|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623853|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623854|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
19623855|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19623856|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20136099|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20136100|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20136101|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20136102|NCT00041314|Analgesics|analgesics|mesh-ancestor
20136103|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
20136104|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136105|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623857|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623858|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20136106|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136107|NCT00041327|Interferons|interferons|mesh-list
20136108|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
19623859|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19623860|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19623861|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623862|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623863|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
19623864|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
19623865|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19623866|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623867|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623868|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20136109|NCT00041327|Lamivudine|lamivudine|mesh-list
20136110|NCT00041327|Zidovudine|zidovudine|mesh-list
20136111|NCT00041327|Prednisone|prednisone|mesh-list
20136112|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
20136113|NCT00041327|Doxorubicin|doxorubicin|mesh-list
20136114|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20136115|NCT00041327|Etoposide|etoposide|mesh-list
20136116|NCT00041327|Vincristine|vincristine|mesh-list
20136117|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136118|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
20136119|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623869|NCT02490072|Analgesics|analgesics|mesh-ancestor
19623870|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
19623871|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623872|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19623873|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19623874|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19623875|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19623876|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19623877|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623878|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
19623879|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
19623880|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19623881|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623882|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623883|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
19623884|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19623885|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19623886|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623887|NCT02490085|Insulin|insulin|mesh-list
19623888|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20136120|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136121|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20136122|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
19623889|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19623890|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623891|NCT02489955|Tobramycin|tobramycin|mesh-list
19623892|NCT02489955|Amikacin|amikacin|mesh-list
19623893|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19623894|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623895|NCT02490176|Liraglutide|liraglutide|mesh-list
19623896|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19623897|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623898|NCT02490176|Incretins|incretins|mesh-ancestor
19623899|NCT02490176|Hormones|hormones|mesh-ancestor
19623900|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623901|NCT02490098|Insulin|insulin|mesh-list
19623902|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20136123|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312883|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312884|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136124|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623903|NCT02490098|Glucagon|glucagon|mesh-list
19623904|NCT02490098|Hormones|hormones|mesh-list
19623905|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20136125|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20136126|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20136127|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136128|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20136129|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136130|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20136131|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
20136132|NCT00041327|Hormones|hormones|mesh-ancestor
20136133|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136134|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20136135|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20136136|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
20136137|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136138|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136139|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136140|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
20136141|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20136142|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20136143|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20136144|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20136145|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
20136146|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
20136147|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136148|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20136149|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136150|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136151|NCT00041431|Hormones|hormones|mesh-list
20136152|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136153|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136154|NCT00041483|Anecortave|anecortave|mesh-list
20136155|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20136156|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20136157|NCT00041483|Growth Substances|growth substances|mesh-ancestor
20136158|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136159|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
20136160|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136161|NCT00041535|Miglustat|miglustat|mesh-list
20136162|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136163|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136164|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20136165|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20136166|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
20136167|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136168|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19623906|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623907|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19623908|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623909|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19623910|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19660764|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
20136169|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20136170|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136171|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
20136172|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20136173|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
19623911|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623912|NCT02489695|Axitinib|axitinib|mesh-list
19623913|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623914|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19623915|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623916|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623917|NCT02489786|Digoxin|digoxin|mesh-list
19623918|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19623919|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19623920|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623921|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623922|NCT02489786|Protective Agents|protective agents|mesh-ancestor
19623923|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623924|NCT02489760|Adalimumab|adalimumab|mesh-list
19623925|NCT02489760|Etanercept|etanercept|mesh-list
19623926|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19623927|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623928|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19623929|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19623930|NCT02489760|Analgesics|analgesics|mesh-ancestor
19623931|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
19623932|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19623933|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623934|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19623935|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623936|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
19623937|NCT02489929|Azacitidine|azacitidine|mesh-list
19623938|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19623939|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
19623940|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623941|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623942|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623943|NCT02489864|Terlipressin|terlipressin|mesh-list
19623944|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19623945|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19623946|NCT02489240|Vitamin D|vitamin d|mesh-list
19623947|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
19623948|NCT02489240|Vitamins|vitamins|mesh-ancestor
19623949|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
20136174|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136175|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136176|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20136177|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
20136178|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20136179|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
20136180|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623950|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623951|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19623952|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19623953|NCT02489461|Efavirenz|efavirenz|mesh-list
19623954|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
19623955|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19623956|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19623957|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19623958|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623959|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623960|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
19623961|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623962|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19623963|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19623964|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19623965|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19623966|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19623967|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19623968|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19623969|NCT02489487|Ritonavir|ritonavir|mesh-list
19623970|NCT02489487|Darunavir|darunavir|mesh-list
19623971|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
19623972|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19623973|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19623974|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
19623975|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19623976|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623977|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19623978|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19623979|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
19623980|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19623981|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19623982|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19623983|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19623984|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19623985|NCT02489266|Aldesleukin|aldesleukin|mesh-list
19623986|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
19623987|NCT02489266|Fludarabine|fludarabine|mesh-list
19623988|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19623989|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
19623990|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19623991|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19623992|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19623993|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
19623994|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19623995|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19623996|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19623997|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19623998|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19623999|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
19624000|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624001|NCT02489513|Ivosidenib|ivosidenib|mesh-list
19624002|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624003|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624004|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624005|NCT02489409|Gemcitabine|gemcitabine|mesh-list
19624006|NCT02489409|Vinorelbine|vinorelbine|mesh-list
20136181|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136182|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20136183|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
20136184|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
20136185|NCT00041548|Protective Agents|protective agents|mesh-ancestor
20136186|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
20136187|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20136188|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
19624007|NCT02489409|Endostatins|endostatins|mesh-list
19624008|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19624009|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
19624010|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624011|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624012|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
19624013|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624014|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624015|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19624016|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
19624017|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624018|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19624019|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
19624020|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
19624021|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
19624022|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19624023|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19624024|NCT02489409|Growth Substances|growth substances|mesh-ancestor
19624025|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
19624026|NCT02489019|Fentanyl|fentanyl|mesh-list
19624027|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20608394|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624028|NCT02489019|Narcotics|narcotics|mesh-ancestor
19665647|NCT04565574|Rifampin|rifampin|mesh-list
19259134|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608395|NCT02245555|Urological Agents|urological agents|mesh-ancestor
20608396|NCT02245789|Remifentanil|remifentanil|mesh-list
20608397|NCT02245789|Propofol|propofol|mesh-list
20608398|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
20608399|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608400|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608401|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20608402|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20608403|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
19624029|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624030|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624031|NCT02489019|Analgesics|analgesics|mesh-ancestor
19624032|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
19624033|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624034|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19624035|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19624036|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
19624037|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
19624038|NCT02488889|Ethanol|ethanol|mesh-list
19624039|NCT02488889|Varenicline|varenicline|mesh-list
19624040|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19624041|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624042|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624043|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624044|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19624045|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19624046|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
19624047|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624048|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624049|NCT02488902|Mefloquine|mefloquine|mesh-list
19624050|NCT02488902|Tafenoquine|tafenoquine|mesh-list
19624051|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
19624052|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19624053|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19624054|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624055|NCT02488993|Rifaximin|rifaximin|mesh-list
19624056|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19624057|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624058|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624059|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
19624060|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19624061|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
19624062|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
19624063|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624064|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624065|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19624066|NCT02489097|Analgesics|analgesics|mesh-ancestor
19624067|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
19624068|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624069|NCT02488694|Pemetrexed|pemetrexed|mesh-list
19624070|NCT02488694|Afatinib|afatinib|mesh-list
19624071|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624072|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624073|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624074|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19624075|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19624076|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19624077|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
19624078|NCT02488473|Ropivacaine|ropivacaine|mesh-list
19624079|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19624080|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624081|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624082|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19624083|NCT02488473|Analgesics|analgesics|mesh-ancestor
19624084|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
19624085|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624086|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19624087|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19624088|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19624089|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
19624090|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624091|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624092|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
19624093|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
19660765|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19660766|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19660767|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660768|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19660769|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19660770|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19660771|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660772|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19660773|NCT04094012|Isoniazid|isoniazid|mesh-list
19660774|NCT04094012|Rifapentine|rifapentine|mesh-list
19660775|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
19624094|NCT02488512|Edotreotide|edotreotide|mesh-list
19624095|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19624096|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624097|NCT02488564|Metformin|metformin|mesh-list
19624098|NCT02488564|Docetaxel|docetaxel|mesh-list
19624099|NCT02488564|Doxorubicin|doxorubicin|mesh-list
19624100|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20136189|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136190|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136191|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20136192|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
20136193|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20136194|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
20136195|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136196|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136197|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19624101|NCT02488564|Trastuzumab|trastuzumab|mesh-list
19624102|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19624103|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624104|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624105|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
19624106|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
19624107|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
19624108|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624109|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19624110|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19624111|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19624112|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624113|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19624114|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
19624115|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
19624116|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624117|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136198|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
20136199|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
20136200|NCT00041561|Protective Agents|protective agents|mesh-ancestor
20136201|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
19624118|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19624119|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
19624120|NCT02488603|Tamoxifen|tamoxifen|mesh-list
19624121|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19624122|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
19624123|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624124|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624125|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19624126|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624127|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19624128|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19624129|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19624130|NCT02488538|Fluoxetine|fluoxetine|mesh-list
19624131|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
19624132|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
19624133|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19624134|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624135|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624136|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19624137|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19624138|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19624139|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624140|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136202|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20136203|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
20136204|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136205|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136206|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20136207|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
19624141|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
19624142|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19624143|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
20136208|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20136209|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
20312885|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20312886|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19624144|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19624145|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19624146|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19624147|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624148|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19624149|NCT02488616|Insulin|insulin|mesh-list
19624150|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19624151|NCT02488616|Hormones|hormones|mesh-list
19624152|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19624153|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624154|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624155|NCT02488642|Isosorbide|isosorbide|mesh-list
19624156|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19624157|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19624158|NCT02488642|Misoprostol|misoprostol|mesh-list
19624159|NCT02488642|Oxytocin|oxytocin|mesh-list
19624160|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
19624161|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624162|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624163|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19624164|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
19624165|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19624166|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624167|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19624168|NCT02488642|Diuretics|diuretics|mesh-ancestor
19624169|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
19624170|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624171|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19624172|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624173|NCT02488486|Remifentanil|remifentanil|mesh-list
19624174|NCT02488486|Propofol|propofol|mesh-list
19624175|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19624176|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624177|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624178|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19624179|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
19624180|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
19624181|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19624182|NCT02488486|Narcotics|narcotics|mesh-ancestor
19624183|NCT02488486|Analgesics|analgesics|mesh-ancestor
20136210|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136211|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136212|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20136213|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
20136214|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
19624184|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
19624185|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624186|NCT02488057|Liraglutide|liraglutide|mesh-list
19624187|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19624188|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136215|NCT00041574|Protective Agents|protective agents|mesh-ancestor
20136216|NCT00041639|Labetuzumab|labetuzumab|mesh-list
20136217|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136218|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136219|NCT00041652|Labetuzumab|labetuzumab|mesh-list
20136220|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136221|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136222|NCT00041665|Mitogens|mitogens|mesh-list
20136223|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
20136224|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136225|NCT00041678|Aripiprazole|aripiprazole|mesh-list
20136226|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
20136227|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20136228|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20312887|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312888|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312889|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
20312890|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20312891|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312892|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20312893|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20312894|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624189|NCT02488057|Incretins|incretins|mesh-ancestor
19624190|NCT02488057|Hormones|hormones|mesh-ancestor
20136229|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19624191|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136230|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20136231|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136232|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
20136233|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
20136234|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136235|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136236|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20136237|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20136238|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
20136239|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20136240|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20136241|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20136242|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20136243|NCT00041691|Labetuzumab|labetuzumab|mesh-list
20136244|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136245|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136246|NCT00041704|Anidulafungin|anidulafungin|mesh-list
20136247|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
20136248|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136249|NCT00041782|Dalteparin|dalteparin|mesh-list
20136250|NCT00041782|Tinzaparin|tinzaparin|mesh-list
20136251|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20136252|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
20136253|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20136254|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20136255|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136256|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
19624192|NCT02488291|Sufentanil|sufentanil|mesh-list
19624193|NCT02488291|Dsuvia|dsuvia|mesh-list
19624194|NCT02488291|Ropivacaine|ropivacaine|mesh-list
20312895|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312896|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624195|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
19624196|NCT02488291|Anesthetics|anesthetics|mesh-list
19624197|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624198|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624199|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
19624200|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624201|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19624202|NCT02488291|Narcotics|narcotics|mesh-ancestor
19624203|NCT02488291|Analgesics|analgesics|mesh-ancestor
20312897|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
19624204|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19624205|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19624206|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
19624207|NCT02488135|Hemostatics|hemostatics|mesh-list
19624208|NCT02488135|Coagulants|coagulants|mesh-ancestor
19624209|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19624210|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19624211|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19624212|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19624213|NCT02487953|Nicotine|nicotine|mesh-list
19624214|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19624215|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
19624216|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624217|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624218|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19624219|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19624220|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19624221|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624222|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624223|NCT02487914|Lidocaine|lidocaine|mesh-list
19624224|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
19624225|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
19624226|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624227|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624228|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
19624229|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624230|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20136257|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20312898|NCT00686192|Calcium|calcium|mesh-list
20136258|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
20608404|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19624231|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19624232|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19624233|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19624234|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624235|NCT02487680|Chromium|chromium|mesh-list
19624236|NCT02487680|Picolinic acid|picolinic acid|mesh-list
19624237|NCT02487680|Trace Elements|trace elements|mesh-ancestor
19624238|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
19624239|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624240|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19624241|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
19624242|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
19624243|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624244|NCT02487706|Dolutegravir|dolutegravir|mesh-list
19624245|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19624246|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19624247|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624248|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624249|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19624250|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19624251|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
19624252|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624253|NCT02487732|Ticagrelor|ticagrelor|mesh-list
19624254|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19624255|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19624256|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19624257|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19624258|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19624259|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
19624260|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624261|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624262|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624263|NCT02487823|Bicalutamide|bicalutamide|mesh-list
19624264|NCT02487823|Buserelin|buserelin|mesh-list
19624265|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
19624266|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
19624267|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136259|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20136260|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624268|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624269|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136261|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19624270|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19624271|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
19624272|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624273|NCT02487719|Teferrol|teferrol|mesh-list
19624274|NCT02487719|Hematinics|hematinics|mesh-ancestor
19624275|NCT02487433|Tofacitinib|tofacitinib|mesh-list
19624276|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19624277|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624278|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624279|NCT02487407|Simendan|simendan|mesh-list
19624280|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19624281|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624282|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19624283|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19624284|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624285|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136262|NCT00041977|Doxycycline|doxycycline|mesh-list
20136263|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19624286|NCT02487407|Protective Agents|protective agents|mesh-ancestor
19624287|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624288|NCT02487381|Dronabinol|dronabinol|mesh-list
19624289|NCT02487381|Cannabidiol|cannabidiol|mesh-list
19624290|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
19624291|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
19624292|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624293|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19624294|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19624295|NCT02487381|Analgesics|analgesics|mesh-ancestor
19624296|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
19624297|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624298|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19624299|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19624300|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624301|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624302|NCT02487381|Hormones|hormones|mesh-ancestor
19624303|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624304|NCT02487849|Carboplatin|carboplatin|mesh-list
19624305|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624306|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
19624307|NCT02487329|Calcium|calcium|mesh-list
19624308|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19624309|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624310|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19624311|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
19624312|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
19624313|NCT02487355|Bupivacaine|bupivacaine|mesh-list
19624314|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
19624315|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
19624316|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624317|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624318|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
19624319|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624320|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19624321|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20136264|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624322|NCT02487355|Analgesics|analgesics|mesh-ancestor
20136265|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
19624323|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19624324|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19624325|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19624326|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
19624327|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624328|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624329|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19624330|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
19624331|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19624332|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19624333|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19624334|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
19624335|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624336|NCT02487316|Crizotinib|crizotinib|mesh-list
19624337|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624338|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19624339|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624340|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624341|NCT02487212|Clobetasol|clobetasol|mesh-list
19624342|NCT02487212|Petrolatum|petrolatum|mesh-list
19624343|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19624344|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
19624345|NCT02487212|Hormones|hormones|mesh-ancestor
19624346|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624347|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624348|NCT02487212|Emollients|emollients|mesh-ancestor
19624349|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
19624350|NCT02487069|Cyclosporine|cyclosporine|mesh-list
19624351|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
19624352|NCT02487069|Methotrexate|methotrexate|mesh-list
19624353|NCT02487069|Cyclosporins|cyclosporins|mesh-list
19624354|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19624355|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19624356|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
19624357|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624358|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624359|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19624360|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
19624361|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624362|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624363|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
19624364|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624365|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19624366|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19624367|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
19624368|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19624369|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19624370|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
19624371|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624372|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19624373|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19624374|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19624375|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
19624376|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19624377|NCT02487082|Melatonin|melatonin|mesh-list
19624378|NCT02487082|Donepezil|donepezil|mesh-list
19624379|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
19624380|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624381|NCT02487082|Protective Agents|protective agents|mesh-ancestor
19624382|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624383|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624384|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19624385|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624386|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
19624387|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136266|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20136267|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20136268|NCT00041990|Decitabine|decitabine|mesh-list
20136269|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136270|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
20136271|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136272|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136273|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136274|NCT00042003|Decitabine|decitabine|mesh-list
20136275|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136276|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
20136277|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136278|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136279|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136280|NCT00042016|Decitabine|decitabine|mesh-list
20136281|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136282|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
19624388|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
19624389|NCT02486822|Oxytocin|oxytocin|mesh-list
19624390|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
19624391|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624392|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660776|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19660777|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660778|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19660779|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19660780|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
19660781|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660782|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19660783|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19660784|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
19660785|NCT04076761|Trifluridine|trifluridine|mesh-list
19660786|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
19660787|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660788|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
19660789|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660790|NCT04062266|Azacitidine|azacitidine|mesh-list
19660791|NCT04062266|Venetoclax|venetoclax|mesh-list
19660792|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19660793|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
19660794|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660795|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660796|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136283|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660797|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
19660798|NCT04021381|Cathartics|cathartics|mesh-ancestor
20136284|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624393|NCT02486848|Minoxidil|minoxidil|mesh-list
19624394|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19624395|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19624396|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624397|NCT02486926|Remifentanil|remifentanil|mesh-list
19624398|NCT02486926|Alfentanil|alfentanil|mesh-list
19624399|NCT02486926|Thiopental|thiopental|mesh-list
19624400|NCT02486926|Sevoflurane|sevoflurane|mesh-list
19624401|NCT02486926|Rocuronium|rocuronium|mesh-list
19624402|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19624403|NCT02486926|Narcotics|narcotics|mesh-ancestor
19624404|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624405|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624406|NCT02486926|Analgesics|analgesics|mesh-ancestor
19624407|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
19624408|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624409|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19624410|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19624411|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
20136285|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136286|NCT00042029|Aprepitant|aprepitant|mesh-list
20136287|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
19624412|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
19624413|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19624414|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19624415|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19624416|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19624417|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
19624418|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20136288|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
20136289|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136290|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136291|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20136292|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20136293|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136294|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136295|NCT00042068|Meloxicam|meloxicam|mesh-list
20136296|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20136297|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19624419|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
19624420|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
19624421|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624422|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624423|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19624424|NCT02486744|Hormones|hormones|mesh-ancestor
19624425|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624426|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624427|NCT02486432|Levodopa|levodopa|mesh-list
19624428|NCT02486432|Carbidopa|carbidopa|mesh-list
19624429|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19624430|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19624431|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19624432|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
19624433|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624434|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624435|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624436|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19624437|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624438|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19624439|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
19624440|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
19624441|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
19624442|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19624443|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
19624444|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19624445|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
19624446|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624447|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624448|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
19624449|NCT02486510|Maraviroc|maraviroc|mesh-list
20136298|NCT00042068|Analgesics|analgesics|mesh-ancestor
19624450|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19624451|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19624452|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136299|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
20136300|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136301|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624453|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19624454|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19624455|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
19624456|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624457|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19624458|NCT02486549|Bupivacaine|bupivacaine|mesh-list
19624459|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
19624460|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
19624461|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624462|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624463|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
19624464|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136302|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20136303|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136304|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19624465|NCT02486601|Paclitaxel|paclitaxel|mesh-list
19624466|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19624467|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624468|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
19624469|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
19624470|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
19624471|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624472|NCT02486640|Interferons|interferons|mesh-list
19624473|NCT02486640|Interferon-beta|interferon-beta|mesh-list
20136305|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20136306|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136307|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136308|NCT00042146|Zolpidem|zolpidem|mesh-list
20136309|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20136310|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20312899|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19624474|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
19624475|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624476|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
19624477|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624478|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
19624479|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624480|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19624481|NCT02486458|Listerine|listerine|mesh-list
19624482|NCT02486458|Fluorides|fluorides|mesh-list
19624483|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
19624484|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
19624485|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
19624486|NCT02486458|Protective Agents|protective agents|mesh-ancestor
19624487|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624488|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19624489|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624490|NCT02486484|Aflibercept|aflibercept|mesh-list
19624491|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19624492|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19624493|NCT02486484|Growth Substances|growth substances|mesh-ancestor
19624494|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624495|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
19624496|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624497|NCT02486367|Clopidogrel|clopidogrel|mesh-list
19624498|NCT02486367|Ticagrelor|ticagrelor|mesh-list
19624499|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19624500|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19624501|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19624502|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19624503|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
19624504|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624505|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624506|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624507|NCT02486341|Insulin|insulin|mesh-list
20312900|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312901|NCT00686192|Antacids|antacids|mesh-ancestor
20312902|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312903|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624508|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19624509|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624510|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
20312904|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
20312905|NCT00686218|Panobinostat|panobinostat|mesh-list
20136311|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20136312|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136313|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20136314|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
19624511|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624512|NCT02486133|Ritonavir|ritonavir|mesh-list
19624513|NCT02486133|Darunavir|darunavir|mesh-list
19624514|NCT02486133|Tenofovir|tenofovir|mesh-list
19624515|NCT02486133|Lamivudine|lamivudine|mesh-list
19624516|NCT02486133|Emtricitabine|emtricitabine|mesh-list
19624517|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19624518|NCT02486133|Abacavir|abacavir|mesh-list
19624519|NCT02486133|Dolutegravir|dolutegravir|mesh-list
19624520|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19624521|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20312906|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20312907|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312908|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19624522|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
19624523|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624524|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624525|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19624526|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19624527|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
19749889|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19749890|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749891|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
19749892|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19624528|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624529|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19624530|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19624531|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19624532|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19624533|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19624534|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19624535|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
19624536|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
19624537|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624538|NCT02486055|Vitamins|vitamins|mesh-ancestor
19624539|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
19624540|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
19624541|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
19624542|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624543|NCT02486276|Cilostazol|cilostazol|mesh-list
19624544|NCT02486276|Sumatriptan|sumatriptan|mesh-list
19624545|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19749893|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19749894|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19749895|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
19749896|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19749897|NCT04586426|Daratumumab|daratumumab|mesh-list
19749898|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749899|NCT04577833|Prednisone|prednisone|mesh-list
19749900|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
19749901|NCT04577833|Niraparib|niraparib|mesh-list
19749902|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19749903|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
19749904|NCT04577833|Hormones|hormones|mesh-ancestor
19749905|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749906|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749907|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19749908|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136315|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
20136316|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136317|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136318|NCT00042172|Donepezil|donepezil|mesh-list
20136319|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20136320|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173600|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624546|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19624547|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19749909|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20608405|NCT02245789|Narcotics|narcotics|mesh-ancestor
19624548|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
20136321|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624549|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624550|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624551|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624552|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19624553|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
19624554|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624555|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19624556|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
19624557|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19624558|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19624559|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19624560|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624561|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19624562|NCT02486276|Protective Agents|protective agents|mesh-ancestor
19624563|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19624564|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19624565|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624566|NCT02485990|Olaparib|olaparib|mesh-list
19624567|NCT02485990|Tremelimumab|tremelimumab|mesh-list
19624568|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19624569|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624570|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624571|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624572|NCT02485821|Misoprostol|misoprostol|mesh-list
19624573|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19624574|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19624575|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19624576|NCT02485821|Estradiol|estradiol|mesh-list
19624577|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19624578|NCT02485821|Estrogens|estrogens|mesh-ancestor
19624579|NCT02485821|Hormones|hormones|mesh-ancestor
19624580|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624581|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624582|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19624583|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
19624584|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624585|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19624586|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19624587|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
19624588|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19624589|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624590|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
19624591|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20136322|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
20136323|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136324|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136325|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
20136326|NCT00042289|Ritonavir|ritonavir|mesh-list
20136327|NCT00042289|Lopinavir|lopinavir|mesh-list
19624592|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19624593|NCT02485873|Vitamin K|vitamin k|mesh-list
19624594|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
19624595|NCT02485873|Vitamins|vitamins|mesh-ancestor
19624596|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
19624597|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624598|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19624599|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
19624600|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19624601|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
19624602|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624603|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624604|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
19624605|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19624606|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19624607|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
19624608|NCT02485873|Coagulants|coagulants|mesh-ancestor
19624609|NCT02485548|Fluorouracil|fluorouracil|mesh-list
19624610|NCT02485548|Raltitrexed|raltitrexed|mesh-list
19624611|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624612|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
19624613|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136328|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20136329|NCT00042289|Darunavir|darunavir|mesh-list
20136330|NCT00042289|Tenofovir|tenofovir|mesh-list
19624614|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19624615|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19624616|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
19624617|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624618|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19624619|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624620|NCT02485613|Dexamethasone|dexamethasone|mesh-list
19624621|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19624622|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
19624623|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
19624624|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624625|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624626|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624627|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
19624628|NCT02485613|Hormones|hormones|mesh-ancestor
19624629|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624630|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19624631|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624632|NCT02485431|Deflazacort|deflazacort|mesh-list
19624633|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19624634|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19624635|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
19624636|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624637|NCT02485444|Oxytocin|oxytocin|mesh-list
19624638|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
19624639|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19624640|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624641|NCT02485340|Isosorbide|isosorbide|mesh-list
19624642|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19624643|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19624644|NCT02485340|Sumatriptan|sumatriptan|mesh-list
19624645|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19624646|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19624647|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19624648|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
19624649|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624650|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624651|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624652|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19624653|NCT02485340|Diuretics|diuretics|mesh-ancestor
19624654|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
19624655|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624656|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19624657|NCT02485327|Insulin|insulin|mesh-list
19624658|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19624659|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19624660|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624661|NCT02485249|Dexamethasone|dexamethasone|mesh-list
19624662|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
19624663|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19624664|NCT02485249|BB 1101|bb 1101|mesh-list
19624665|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19624666|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
19624667|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
19624668|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624669|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136331|NCT00042289|Nevirapine|nevirapine|mesh-list
19624670|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624671|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
19624672|NCT02485249|Hormones|hormones|mesh-ancestor
19624673|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624674|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19624675|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624676|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
19624677|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624678|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624679|NCT02485145|Diclofenac|diclofenac|mesh-list
19624680|NCT02485145|Orphenadrine|orphenadrine|mesh-list
19624681|NCT02485145|Bupivacaine|bupivacaine|mesh-list
19624682|NCT02485145|Baclofen|baclofen|mesh-list
19624683|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
19624684|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
19624685|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20136332|NCT00042289|Dolutegravir|dolutegravir|mesh-list
19624686|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624687|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
19665648|NCT04565574|Rabeprazole|rabeprazole|mesh-list
19624688|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624689|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19624690|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19624691|NCT02485145|Analgesics|analgesics|mesh-ancestor
19624692|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19624693|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19624694|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19624695|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624696|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624697|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19624698|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19624699|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19624700|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
19624701|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
19624702|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624703|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19624704|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19624705|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
19624706|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
19624707|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19624708|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19624709|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
19624710|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
19624711|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19624712|NCT02485041|Mirodenafil|mirodenafil|mesh-list
19624713|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20136333|NCT00042289|Cobicistat|cobicistat|mesh-list
20136334|NCT00042289|Elvitegravir|elvitegravir|mesh-list
19624714|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19624715|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624716|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660799|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660800|NCT03970304|Vaccines|vaccines|mesh-list
19660801|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
19660802|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660803|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
19660804|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
19660805|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
19660806|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660807|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660808|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660809|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19660810|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19660811|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19660812|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19660813|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19660814|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
19660815|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19660816|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660817|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19660818|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660819|NCT03911505|Miglustat|miglustat|mesh-list
19660820|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660821|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136335|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
19624717|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
19624718|NCT02485262|Simeprevir|simeprevir|mesh-list
19624719|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
19624720|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624721|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
19624722|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624723|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624724|NCT02484885|Xenon|xenon|mesh-list
19624725|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19624726|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
19624727|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
19624728|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624729|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624730|NCT02484963|Zolpidem|zolpidem|mesh-list
19624731|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19624732|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19624733|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624734|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624735|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19624736|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
19624737|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
19624738|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624739|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624740|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19749910|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749911|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749912|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
19749913|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19749914|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19749915|NCT04538664|Carboplatin|carboplatin|mesh-list
19749916|NCT04538664|Pemetrexed|pemetrexed|mesh-list
19749917|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19749918|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749919|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749920|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749921|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19749922|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19749923|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749924|NCT04533750|Peposertib|peposertib|mesh-list
19749925|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749926|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749927|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749928|NCT04524611|Ustekinumab|ustekinumab|mesh-list
19749929|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19749930|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
19749931|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
19749932|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749933|NCT04523207|Relugolix|relugolix|mesh-list
19749934|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
19749935|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
19749936|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19749937|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19749938|NCT04521803|Rifampin|rifampin|mesh-list
19749939|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19749940|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
19749941|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19749942|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749943|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
19749944|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19749945|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749946|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749947|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19749948|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19749949|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20136336|NCT00042289|Efavirenz|efavirenz|mesh-list
20136337|NCT00042289|Levofloxacin|levofloxacin|mesh-list
20136338|NCT00042289|Ofloxacin|ofloxacin|mesh-list
20136339|NCT00042289|Rifampin|rifampin|mesh-list
20136340|NCT00042289|Isoniazid|isoniazid|mesh-list
20136341|NCT00042289|Linezolid|linezolid|mesh-list
20136342|NCT00042289|Cycloserine|cycloserine|mesh-list
20136343|NCT00042289|Amikacin|amikacin|mesh-list
19624741|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19624742|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20136344|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
20136345|NCT00042289|Ethambutol|ethambutol|mesh-list
20136346|NCT00042289|Bedaquiline|bedaquiline|mesh-list
19624743|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
19624744|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624745|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624746|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624747|NCT02485067|Urological Agents|urological agents|mesh-ancestor
19624748|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
20136347|NCT00042289|Etravirine|etravirine|mesh-list
20136348|NCT00042289|Clofazimine|clofazimine|mesh-list
20136349|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20136350|NCT00042289|Kanamycin|kanamycin|mesh-list
20136351|NCT00042289|Ethionamide|ethionamide|mesh-list
20136352|NCT00042289|Capreomycin|capreomycin|mesh-list
20136353|NCT00042289|Prothionamide|prothionamide|mesh-list
20136354|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20136355|NCT00042289|Etonogestrel|etonogestrel|mesh-list
20136356|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-list
19624749|NCT02485080|Simeprevir|simeprevir|mesh-list
19624750|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
19624751|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136357|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-list
20136358|NCT00042289|Estradiol|estradiol|mesh-list
20136359|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20136360|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20136361|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
20136362|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136363|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624752|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
19624753|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624754|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624755|NCT02485184|Propranolol|propranolol|mesh-list
19624756|NCT02485184|Warfarin|warfarin|mesh-list
19624757|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19624758|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
19624759|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19624760|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
19624761|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624762|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624763|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136364|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20136365|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20136366|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
19624764|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19624765|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19624766|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624767|NCT02485106|Rifaximin|rifaximin|mesh-list
19624768|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
19624769|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19624770|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624771|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624772|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19624773|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624774|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136367|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136368|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20136369|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20136370|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20136371|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20136372|NCT00042289|Estrogens|estrogens|mesh-ancestor
20136373|NCT00042289|Hormones|hormones|mesh-ancestor
20136374|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19624775|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20136375|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136376|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20136377|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20136378|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20136379|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19624776|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19624777|NCT02485106|Protective Agents|protective agents|mesh-ancestor
20136380|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136381|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19624778|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624779|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624780|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19624781|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
19624782|NCT02485028|Mirodenafil|mirodenafil|mesh-list
19624783|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19624784|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19624785|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624786|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624787|NCT02485015|Apatinib|apatinib|mesh-list
19624788|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624789|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19624790|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624791|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624792|NCT02484924|Clopidogrel|clopidogrel|mesh-list
19624793|NCT02484924|Ticagrelor|ticagrelor|mesh-list
20136382|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136383|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20136384|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20136385|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20136386|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20136387|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20136388|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20136389|NCT00042289|Renal Agents|renal agents|mesh-ancestor
20136390|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20136391|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20136392|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20136393|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
20136394|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
20136395|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20136396|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20136397|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20136398|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20136399|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20136400|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
20136401|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20136402|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19624794|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19624795|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19624796|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19624797|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19624798|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
19624799|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624800|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136403|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20136404|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20136405|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20136406|NCT00042302|Paclitaxel|paclitaxel|mesh-list
20136407|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20136408|NCT00042302|Carboplatin|carboplatin|mesh-list
20136409|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19624801|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624802|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19624803|NCT02484768|Hematinics|hematinics|mesh-ancestor
19624804|NCT02484833|Cetuximab|cetuximab|mesh-list
20136410|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136411|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136412|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136413|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
20136414|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136415|NCT00042315|Vinorelbine|vinorelbine|mesh-list
20136416|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20136417|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624805|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19624806|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624807|NCT02484677|Docetaxel|docetaxel|mesh-list
19624808|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624809|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
19624810|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
19624811|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
19624812|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624813|NCT02484573|Propranolol|propranolol|mesh-list
19624814|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19624815|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19624816|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
19624817|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624818|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624819|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624820|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19624821|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19624822|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
19624823|NCT02484755|Gefitinib|gefitinib|mesh-list
19624824|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624825|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19624826|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624827|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624828|NCT02484248|Ketotifen|ketotifen|mesh-list
19624829|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
19624830|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
19624831|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19624832|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
19624833|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
19624834|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136418|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136419|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
19624835|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624836|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624837|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19624838|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19624839|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624840|NCT02484300|Melatonin|melatonin|mesh-list
19624841|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
19624842|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624843|NCT02484300|Protective Agents|protective agents|mesh-ancestor
19624844|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624845|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624846|NCT02484352|Oxycodone|oxycodone|mesh-list
19624847|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19624848|NCT02484352|Narcotics|narcotics|mesh-ancestor
19624849|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624850|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624851|NCT02484352|Analgesics|analgesics|mesh-ancestor
19624852|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
19624853|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624854|NCT02484170|Mannitol|mannitol|mesh-list
19624855|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19624856|NCT02484170|Diuretics|diuretics|mesh-ancestor
19624857|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
19624858|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624859|NCT02484209|Metformin|metformin|mesh-list
19624860|NCT02484209|Glimepiride|glimepiride|mesh-list
19624861|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19624862|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624863|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19624864|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19624865|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
19624866|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19624867|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624868|NCT02484261|Bortezomib|bortezomib|mesh-list
19624869|NCT02484261|Pravastatin|pravastatin|mesh-list
19624870|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624871|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19624872|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19624873|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
19624874|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624875|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19624876|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19624877|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624878|NCT02484053|Rituximab|rituximab|mesh-list
19624879|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19624880|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624881|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
19624882|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624883|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19624884|NCT02483767|Goserelin|goserelin|mesh-list
19624885|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20136420|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
19624886|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624887|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19624888|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19624889|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19624890|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
19624891|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624892|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19624893|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19624894|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136421|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136422|NCT00042328|Valacyclovir|valacyclovir|mesh-list
20136423|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
20136424|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136425|NCT00042354|Clofarabine|clofarabine|mesh-list
20136426|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136427|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
20136428|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136429|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136430|NCT00042367|Mafosfamide|mafosfamide|mesh-list
20136431|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
20136432|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19624895|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19624896|NCT02483715|Amoxicillin|amoxicillin|mesh-list
19624897|NCT02483715|Metronidazole|metronidazole|mesh-list
19624898|NCT02483715|Tetracycline|tetracycline|mesh-list
19624899|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19624900|NCT02483715|Rabeprazole|rabeprazole|mesh-list
19624901|NCT02483715|Bismuth|bismuth|mesh-list
19624902|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19624903|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19624904|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
20312909|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312910|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312911|NCT00686322|Paclitaxel|paclitaxel|mesh-list
20312912|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20312913|NCT00686322|Cisplatin|cisplatin|mesh-list
20312914|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19624905|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19624906|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19624907|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19624908|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19624909|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624910|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624911|NCT02483715|Antacids|antacids|mesh-ancestor
19624912|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19624913|NCT02483793|Tamsulosin|tamsulosin|mesh-list
19624914|NCT02483793|Oxybutynin|oxybutynin|mesh-list
19624915|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19624916|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19624917|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19624918|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
19624919|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624920|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624921|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624922|NCT02483793|Urological Agents|urological agents|mesh-ancestor
19624923|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
19624924|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
19624925|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624926|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19624927|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19624928|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
19624929|NCT02483897|Tetracaine|tetracaine|mesh-list
19624930|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19624931|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
19624932|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
19624933|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624934|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624935|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
20312915|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19624936|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624937|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19624938|NCT02483845|Natalizumab|natalizumab|mesh-list
19624939|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
19624940|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624941|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19624942|NCT02483936|Olmesartan|olmesartan|mesh-list
19624943|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19624944|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
19624945|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19624946|NCT02483936|Diuretics|diuretics|mesh-ancestor
19624947|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
19624948|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624949|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19624950|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19624951|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624952|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19624953|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19624954|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19624955|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
19624956|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19624957|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19624958|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19624959|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624960|NCT02483923|Ropivacaine|ropivacaine|mesh-list
19624961|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
19624962|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
19624963|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624964|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624965|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
19624966|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624967|NCT02483884|Bombesin|bombesin|mesh-list
19624968|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624969|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624970|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624971|NCT02483689|Bupivacaine|bupivacaine|mesh-list
19624972|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
19624973|NCT02483689|Anesthetics|anesthetics|mesh-list
19624974|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624975|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624976|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
19624977|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19624978|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19624979|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19624980|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19624981|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
19624982|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624983|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19624984|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19624985|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19624986|NCT02483598|Buspirone|buspirone|mesh-list
19624987|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19624988|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19624989|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19624990|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19624991|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19624992|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19624993|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
19624994|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19624995|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19624996|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
19624997|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19624998|NCT02483624|Protective Agents|protective agents|mesh-ancestor
19624999|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625000|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660822|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19660823|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19660824|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
19660825|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660826|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19660827|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19660828|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660829|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
19660830|NCT03898180|Lenvatinib|lenvatinib|mesh-list
19660831|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660832|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660833|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19625001|NCT02483325|Fludarabine|fludarabine|mesh-list
19625002|NCT02483325|Busulfan|busulfan|mesh-list
19625003|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
19625004|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625005|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625006|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625007|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
19625008|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625009|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
19625010|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19625011|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19625012|NCT02483299|Metformin|metformin|mesh-list
19625013|NCT02483299|Liraglutide|liraglutide|mesh-list
19625014|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19625015|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625016|NCT02483299|Incretins|incretins|mesh-ancestor
19625017|NCT02483299|Hormones|hormones|mesh-ancestor
19625018|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625019|NCT02483182|Acyclovir|acyclovir|mesh-list
19625020|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
19625021|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625022|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
19625023|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19625024|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
19625025|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625026|NCT02483130|Expectorants|expectorants|mesh-ancestor
19625027|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625028|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19625029|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
19625030|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625031|NCT02483130|Protective Agents|protective agents|mesh-ancestor
19625032|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625033|NCT02483130|Antidotes|antidotes|mesh-ancestor
19625034|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
19625035|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
19625036|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625037|NCT02483143|Expectorants|expectorants|mesh-ancestor
19625038|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625039|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19625040|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
19625041|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625042|NCT02483143|Protective Agents|protective agents|mesh-ancestor
19625043|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625044|NCT02483169|Aspirin|aspirin|mesh-list
19625045|NCT02483169|Cilostazol|cilostazol|mesh-list
19625046|NCT02483169|Probucol|probucol|mesh-list
19625047|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19625048|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19625049|NCT02483169|Analgesics|analgesics|mesh-ancestor
19625050|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
19625051|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136433|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
20136434|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136435|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136436|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136437|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136438|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20136439|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
20136440|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136441|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20173601|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20173602|NCT00162227|Efavirenz|efavirenz|mesh-list
20173603|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20173604|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20173605|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173606|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173607|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
19625052|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625053|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625054|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625055|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19625056|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19625057|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625058|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19625059|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19625060|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625061|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
19625062|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19625063|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
19625064|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19625065|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625066|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
19625067|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19749950|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19749951|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19749952|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19749953|NCT04502706|Rituximab|rituximab|mesh-list
19749954|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749955|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749956|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
19749957|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136442|NCT00042393|Adefovir|adefovir|mesh-list
20136443|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20136444|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
20136445|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136446|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20136447|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20136448|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749958|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19749959|NCT04487145|Piperaquine|piperaquine|mesh-list
19749960|NCT04487145|Artenimol|artenimol|mesh-list
19749961|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
19749962|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19749963|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19749964|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19749965|NCT04487080|Osimertinib|osimertinib|mesh-list
19749966|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19749967|NCT04487080|Lazertinib|lazertinib|mesh-list
19749968|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19749969|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19749970|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19749971|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749972|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19749973|NCT04435600|Ustekinumab|ustekinumab|mesh-list
19749974|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
19749992|NCT04405102|Ozanimod|ozanimod|mesh-list
19749993|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19749994|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19749995|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19749996|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
19749997|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136449|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136450|NCT00042406|Zanolimumab|zanolimumab|mesh-list
20136451|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136452|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312916|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
20608406|NCT02245789|Analgesics|analgesics|mesh-ancestor
19749998|NCT04396574|Lasmiditan|lasmiditan|mesh-list
19749999|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19750000|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
19625068|NCT02483169|Protective Agents|protective agents|mesh-ancestor
19625069|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19625070|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19625071|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19625072|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19625073|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
19625074|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19625075|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
19625076|NCT02483156|Ribavirin|ribavirin|mesh-list
19625077|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
19625078|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
19625079|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625080|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
19625081|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625082|NCT02483221|Morphine|morphine|mesh-list
19625083|NCT02483221|Hydromorphone|hydromorphone|mesh-list
19625084|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19625085|NCT02483221|Narcotics|narcotics|mesh-ancestor
19625086|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625087|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625088|NCT02483221|Analgesics|analgesics|mesh-ancestor
19625089|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
19625090|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625091|NCT02483195|Minoxidil|minoxidil|mesh-list
19625092|NCT02483195|Spironolactone|spironolactone|mesh-list
19625093|NCT02483195|Finasteride|finasteride|mesh-list
20136453|NCT00042458|Pramlintide|pramlintide|mesh-list
20136454|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20136455|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136456|NCT00042471|Pramlintide|pramlintide|mesh-list
20136457|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20136458|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20136459|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136460|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
20136461|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20136462|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
19625094|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19625095|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
19625096|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625097|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625098|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19625099|NCT02483195|Diuretics|diuretics|mesh-ancestor
19625100|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
19625101|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19625102|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
19625103|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19625104|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19625105|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625106|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625107|NCT02483195|Urological Agents|urological agents|mesh-ancestor
19625108|NCT02483026|Vitamin D|vitamin d|mesh-list
19625109|NCT02483026|Vitamins|vitamins|mesh-list
19625110|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
19625111|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625112|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19625113|NCT02483078|Leronlimab|leronlimab|mesh-list
19625114|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19625115|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19625116|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625117|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19625118|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19625119|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
20136463|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625120|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625121|NCT02483104|Paclitaxel|paclitaxel|mesh-list
19625122|NCT02483104|Carboplatin|carboplatin|mesh-list
19625123|NCT02483104|Veliparib|veliparib|mesh-list
19625124|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20136464|NCT00042536|Naltrexone|naltrexone|mesh-list
20136465|NCT00042536|Yohimbine|yohimbine|mesh-list
20136466|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20136467|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20136468|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136469|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
20136470|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625125|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625126|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
19625127|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
19625128|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
19625129|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625130|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19625131|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625132|NCT02482740|Tamoxifen|tamoxifen|mesh-list
19625133|NCT02482740|Letrozole|letrozole|mesh-list
19625134|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625135|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19625136|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19625137|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625138|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625139|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19625140|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
19625141|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625142|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625143|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625144|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19625145|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19625146|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19625147|NCT02482766|Poractant alfa|poractant alfa|mesh-list
19625148|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19625149|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625150|NCT02482857|Aspirin|aspirin|mesh-list
19625151|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20136471|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
20136472|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
20136473|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20312917|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312918|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
19625152|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19625153|NCT02482857|Analgesics|analgesics|mesh-ancestor
19625154|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
19625155|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625156|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625157|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625158|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625159|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19625160|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19625161|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625162|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19625163|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19625164|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625165|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
19625166|NCT02482961|Colistin|colistin|mesh-list
19625167|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625168|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625169|NCT02482818|Pregabalin|pregabalin|mesh-list
19625170|NCT02482818|Analgesics|analgesics|mesh-ancestor
19625171|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
20312919|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312920|NCT00686361|Choline|choline|mesh-list
20312921|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
20312922|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20312923|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
20312924|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625172|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660834|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136474|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20136475|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20136476|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
20136477|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136478|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136479|NCT00042536|Urological Agents|urological agents|mesh-ancestor
20136480|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20312925|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20312926|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20312927|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
20312928|NCT00686374|Adalimumab|adalimumab|mesh-list
19625173|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625174|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
19625175|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19625176|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19625177|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625178|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19625179|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19625180|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20136481|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20136482|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20136483|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20136484|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20136485|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20136486|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20136487|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136488|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20312929|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312930|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312931|NCT00686439|Adalimumab|adalimumab|mesh-list
20312932|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20312933|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20312934|NCT00686478|Interferons|interferons|mesh-list
20312935|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
19625181|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625182|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19625183|NCT02482649|Methylphenidate|methylphenidate|mesh-list
19625184|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19625185|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19625186|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625187|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19625188|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19625189|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19625190|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625191|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
19625192|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625193|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19625194|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
19625195|NCT02482636|Vaccines|vaccines|mesh-list
19625196|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19625197|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
19625198|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625199|NCT02482311|Adavosertib|adavosertib|mesh-list
19625200|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625201|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625202|NCT02482272|Lamivudine|lamivudine|mesh-list
19625203|NCT02482272|Adefovir|adefovir|mesh-list
19625204|NCT02482272|Entecavir|entecavir|mesh-list
19625205|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19625206|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19625207|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625208|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625209|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
19625210|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625211|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19625212|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19625213|NCT02482402|Iloprost|iloprost|mesh-list
19625214|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19625215|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
19625216|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
19625217|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
19625218|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312936|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
20312937|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625219|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19625220|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19625221|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19625222|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
19625223|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625224|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19625225|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19625226|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625227|NCT02482155|Ibuprofen|ibuprofen|mesh-list
19625228|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19625229|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19625230|NCT02482155|Analgesics|analgesics|mesh-ancestor
19625231|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
19625232|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625233|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625234|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625235|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625236|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19625237|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625238|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625239|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
19625240|NCT02482090|Fludarabine|fludarabine|mesh-list
19625241|NCT02482090|Interleukin-2|interleukin-2|mesh-list
19625242|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625243|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
19625244|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625245|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625246|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19625247|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
19625248|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625249|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625250|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19625251|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19625252|NCT02482090|Analgesics|analgesics|mesh-ancestor
19625253|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
19625254|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625255|NCT02482324|Ibuprofen|ibuprofen|mesh-list
19625256|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19625257|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19625258|NCT02482324|Analgesics|analgesics|mesh-ancestor
19625259|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
19625260|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625261|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625262|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625263|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625264|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19625265|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625266|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625267|NCT02481960|Irinotecan|irinotecan|mesh-list
19625268|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19625269|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19625270|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625271|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625272|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625273|NCT02481791|Remifentanil|remifentanil|mesh-list
19625274|NCT02481791|Propofol|propofol|mesh-list
19625275|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19625276|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625277|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625278|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19625279|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
19625280|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
19625281|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19625282|NCT02481791|Narcotics|narcotics|mesh-ancestor
19625283|NCT02481791|Analgesics|analgesics|mesh-ancestor
19625284|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
19625285|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660835|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660836|NCT03898154|Dexamethasone|dexamethasone|mesh-list
19660837|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
19660838|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19660839|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19660840|NCT03898154|Prednisolone|prednisolone|mesh-list
19660841|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
19665649|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19625286|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19625287|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19625288|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625289|NCT02481635|Gemcitabine|gemcitabine|mesh-list
19625290|NCT02481635|Paclitaxel|paclitaxel|mesh-list
19625291|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19625292|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625293|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
19625294|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
19625295|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
19625296|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625297|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19625298|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
20312938|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
20312939|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136489|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136490|NCT00042562|Analgesics|analgesics|mesh-ancestor
20136491|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
20136492|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136493|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
19625299|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
19625300|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625301|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625302|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625303|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
19625304|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625305|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
19625306|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19625307|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
19625308|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625309|NCT02481609|Expectorants|expectorants|mesh-ancestor
19625310|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625311|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19625312|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
19625313|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625314|NCT02481609|Protective Agents|protective agents|mesh-ancestor
19625315|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625316|NCT02481609|Antidotes|antidotes|mesh-ancestor
19625317|NCT02481453|Sirolimus|sirolimus|mesh-list
19625318|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625319|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625320|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19625321|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625322|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
19625323|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625324|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
19625325|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625326|NCT02481323|Cilostazol|cilostazol|mesh-list
19625327|NCT02481323|Isosorbide|isosorbide|mesh-list
19625328|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19625329|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19625330|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19625331|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
19625332|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625333|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625334|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19625335|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625336|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20312940|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
20312941|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625337|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19625338|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625339|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19750001|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750002|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750003|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750004|NCT04396236|Lasmiditan|lasmiditan|mesh-list
19750005|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19750006|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
19750007|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136494|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20136495|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
20136496|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20136497|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19625340|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
19625341|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19625342|NCT02481323|Protective Agents|protective agents|mesh-ancestor
19625343|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19625344|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19625345|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625346|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19625347|NCT02481323|Diuretics|diuretics|mesh-ancestor
19625348|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
19625349|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19625350|NCT02481479|Saxagliptin|saxagliptin|mesh-list
19625351|NCT02481479|Incretins|incretins|mesh-ancestor
19625352|NCT02481479|Hormones|hormones|mesh-ancestor
19625353|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625354|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625355|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19625356|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
19625357|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625358|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625359|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19625360|NCT02481193|Cisatracurium|cisatracurium|mesh-list
19625361|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19625362|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19625363|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625364|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625365|NCT02481180|T0001|t0001|mesh-list
19625366|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19625367|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625368|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625369|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
19625370|NCT02480946|Methotrexate|methotrexate|mesh-list
19625371|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19625372|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
19625373|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19625374|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625375|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19625376|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
19625377|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625378|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625379|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
20136498|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20136499|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20136500|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625380|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625381|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19625382|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625383|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
19625384|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625385|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19625386|NCT02481076|Monensin|monensin|mesh-list
19625387|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
19625388|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625389|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19625390|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19625391|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
19625392|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
19625393|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
19625394|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625395|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625396|NCT02481076|Ionophores|ionophores|mesh-ancestor
19625397|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19625398|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
19625399|NCT02480894|Maraviroc|maraviroc|mesh-list
19625400|NCT02480894|Fostemsavir|fostemsavir|mesh-list
19625401|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19625402|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20136501|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136502|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136503|NCT00042575|Analgesics|analgesics|mesh-ancestor
20136504|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
20136505|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136506|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
20136507|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19625403|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625404|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19625405|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19625406|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
19625407|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625408|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19625409|NCT02480881|Fostemsavir|fostemsavir|mesh-list
19625410|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
19625411|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19625412|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
19625413|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19625414|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625415|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19625416|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19625417|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19625418|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
19625419|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625420|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19625421|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19625422|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625423|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19625424|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19625425|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20136508|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
20136509|NCT00042588|Antibodies|antibodies|mesh-list
20136510|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20136511|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
20136512|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136513|NCT00042601|Pramlintide|pramlintide|mesh-list
20136514|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20136515|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136516|NCT00042653|Cinacalcet|cinacalcet|mesh-list
20136517|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136518|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136519|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20136520|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
20136521|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625426|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19625427|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19625428|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
19625429|NCT02480647|Etonogestrel|etonogestrel|mesh-list
19625430|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19625431|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
19625432|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19625433|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625434|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19625435|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19625436|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19625437|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
19625438|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
19625439|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625440|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19625441|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136522|NCT00042679|Gemcitabine|gemcitabine|mesh-list
20136523|NCT00042679|Carboplatin|carboplatin|mesh-list
20136524|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136525|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136526|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
20136527|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136528|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
20136529|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136530|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136531|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625442|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625443|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
19625444|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19625445|NCT02480543|Misoprostol|misoprostol|mesh-list
19625446|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19625447|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
19625448|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19625449|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625450|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19625451|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625452|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
20136532|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
19625453|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
19625454|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
19625455|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625456|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
19625457|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19625458|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625459|NCT02480751|Beraprost|beraprost|mesh-list
19625460|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19625461|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
19625462|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19625463|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19625464|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625465|NCT02480465|Incretins|incretins|mesh-ancestor
19625466|NCT02480465|Hormones|hormones|mesh-ancestor
19625467|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625468|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19625469|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
19625470|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625471|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625472|NCT02480400|Dexetimide|dexetimide|mesh-list
19625473|NCT02480400|Citalopram|citalopram|mesh-list
19625474|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19625475|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19625476|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19625477|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625478|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625479|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
19625480|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625481|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19625482|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
19625483|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19625484|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19625485|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19625486|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
19625487|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
19625488|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625489|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19625490|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19625491|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
19625492|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
19625493|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19625494|NCT02480387|Ledipasvir|ledipasvir|mesh-list
19625495|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
19625496|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625497|NCT02480088|Palonosetron|palonosetron|mesh-list
19625498|NCT02480088|Ramosetron|ramosetron|mesh-list
19625499|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
19625500|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
19625501|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625502|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625503|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625504|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19625505|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19625506|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
19625507|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625508|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660842|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19660843|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
19660844|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660845|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
19660846|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
19660847|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19660848|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660849|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660850|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
19660851|NCT03898154|Hormones|hormones|mesh-ancestor
19660852|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660853|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660854|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660855|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19660856|NCT03898154|Protective Agents|protective agents|mesh-ancestor
19660857|NCT03857087|Edetic Acid|edetic acid|mesh-list
19660858|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19660859|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
19660860|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
20312942|NCT00686556|Cyclosporine|cyclosporine|mesh-list
19625509|NCT02480335|Bosentan|bosentan|mesh-list
19625510|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19625511|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19625512|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136533|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136534|NCT00042718|Amoxicillin|amoxicillin|mesh-list
19625513|NCT02480049|Montelukast|montelukast|mesh-list
19625514|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19625515|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625516|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19625517|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
19625518|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625519|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625520|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19625521|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19625522|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625523|NCT02479971|Clindamycin|clindamycin|mesh-list
19625524|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
19625525|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
19625526|NCT02479971|Gentamicins|gentamicins|mesh-list
19625527|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625528|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625529|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19625530|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625531|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625532|NCT02479854|Montelukast|montelukast|mesh-list
19625533|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19625534|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625535|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19625536|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
19625537|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625538|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625539|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19625540|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19625541|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625542|NCT02479867|Cefadroxil|cefadroxil|mesh-list
19625543|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625544|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625545|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
19625546|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
19625547|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19625548|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19625549|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
19625550|NCT02479789|Lidocaine|lidocaine|mesh-list
19625551|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
19625552|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
19625553|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625554|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625555|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
19625556|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625557|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19625558|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19625559|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19625560|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19625561|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625562|NCT02479815|Micronutrients|micronutrients|mesh-list
19625563|NCT02479815|Trace Elements|trace elements|mesh-list
19625564|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625565|NCT02479828|Ropivacaine|ropivacaine|mesh-list
19625566|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
19625567|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
19625568|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625569|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625570|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
19625571|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625572|NCT02479711|Methamphetamine|methamphetamine|mesh-list
19625573|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19625574|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625575|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
19625576|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
20136535|NCT00042718|Azithromycin|azithromycin|mesh-list
19625577|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625578|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
19625579|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625580|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625581|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
19625582|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19625583|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19625584|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19625585|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19625586|NCT02479620|Dexamethasone|dexamethasone|mesh-list
19625587|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
19625588|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19625589|NCT02479620|BB 1101|bb 1101|mesh-list
19625590|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625591|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
19625592|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
19625593|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625594|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625595|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625596|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
19625597|NCT02479620|Hormones|hormones|mesh-ancestor
19625598|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625599|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750008|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750009|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750010|NCT04394858|Temozolomide|temozolomide|mesh-list
19750011|NCT04394858|Olaparib|olaparib|mesh-list
19750012|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19750013|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19750014|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
19750015|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750016|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750017|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136536|NCT00042718|Levofloxacin|levofloxacin|mesh-list
19750038|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
19750039|NCT04379596|Fluorouracil|fluorouracil|mesh-list
19750040|NCT04379596|Capecitabine|capecitabine|mesh-list
19750041|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
19750042|NCT04379596|Trastuzumab|trastuzumab|mesh-list
19750043|NCT04379596|Durvalumab|durvalumab|mesh-list
19750044|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750045|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136537|NCT00042718|Ofloxacin|ofloxacin|mesh-list
20136538|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
20136539|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
20136540|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20136541|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20136542|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136543|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20136544|NCT00042718|Renal Agents|renal agents|mesh-ancestor
20136545|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136546|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19625600|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750046|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
19750047|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136547|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136548|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136549|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136550|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20136551|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20136552|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20136553|NCT00042731|Lycopene|lycopene|mesh-list
20136554|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20136555|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
20136556|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136557|NCT00042731|Protective Agents|protective agents|mesh-ancestor
20136558|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136559|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20136560|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20136561|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136562|NCT00042796|Decitabine|decitabine|mesh-list
20136563|NCT00042796|Azacitidine|azacitidine|mesh-list
20136564|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136565|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
20136566|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136567|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136568|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625601|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
19625602|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625603|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625604|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19625605|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625606|NCT02479490|Prednisone|prednisone|mesh-list
19625607|NCT02479490|Everolimus|everolimus|mesh-list
19625608|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625609|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
19625610|NCT02479490|Hormones|hormones|mesh-ancestor
19625611|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625612|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625613|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625614|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625615|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625616|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
19625617|NCT02479204|Atenolol|atenolol|mesh-list
19625618|NCT02479204|Diltiazem|diltiazem|mesh-list
19625619|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19625620|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19625621|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
19625622|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
19625623|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625624|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625625|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19625626|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19625627|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19625628|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
19625629|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625630|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625631|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19625632|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19625633|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19625634|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
20136569|NCT00042809|Paclitaxel|paclitaxel|mesh-list
20136570|NCT00042809|Trastuzumab|trastuzumab|mesh-list
20136571|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20136572|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20136573|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136574|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136575|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136576|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
20136577|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312943|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
20312944|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
20312945|NCT00686556|Fludarabine|fludarabine|mesh-list
20312946|NCT00686556|Cyclosporins|cyclosporins|mesh-list
20312947|NCT00686556|Sargramostim|sargramostim|mesh-list
20312948|NCT00686556|Lenograstim|lenograstim|mesh-list
20312949|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625635|NCT02479581|Floxacillin|floxacillin|mesh-list
19625636|NCT02479581|Dexamethasone|dexamethasone|mesh-list
19625637|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
20312950|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
20312951|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625638|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19625639|NCT02479581|Scopolamine|scopolamine|mesh-list
19625640|NCT02479581|Morphine|morphine|mesh-list
19625641|NCT02479581|Anesthetics|anesthetics|mesh-list
19625642|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625643|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
19625644|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
19625645|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625646|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625647|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625648|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
19625649|NCT02479581|Hormones|hormones|mesh-ancestor
19625650|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625651|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625652|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625653|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625654|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625655|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19625656|NCT02479581|Narcotics|narcotics|mesh-ancestor
19625657|NCT02479581|Analgesics|analgesics|mesh-ancestor
19625658|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
19625659|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19625660|NCT02479581|Protective Agents|protective agents|mesh-ancestor
19625661|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19625662|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
19625663|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19625664|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19625665|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625666|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19625667|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625668|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625669|NCT02479256|Tamoxifen|tamoxifen|mesh-list
19625670|NCT02479256|Citric Acid|citric acid|mesh-list
19625671|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
19625672|NCT02479256|Clomiphene|clomiphene|mesh-list
19625673|NCT02479256|Enclomiphene|enclomiphene|mesh-list
19625674|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
19625675|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
19625676|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19625677|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
19625678|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
19625679|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625680|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19625681|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
19625682|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625683|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312952|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625684|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625685|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625686|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19625687|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19625688|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19625689|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19625690|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
19625691|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19625692|NCT02479451|Theophylline|theophylline|mesh-list
19625693|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19625694|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
19625695|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625696|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625697|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19625698|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625699|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19625700|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625701|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625702|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
19625703|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19625704|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20312953|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19625705|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
19625706|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625707|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
19625708|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625709|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625710|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19625711|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19625712|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625713|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625714|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625715|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
19625716|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
20136578|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19625717|NCT02479347|Povidone|povidone|mesh-list
19625718|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19625719|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625720|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
19625721|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
19625722|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
19625723|NCT02479555|Dexamethasone|dexamethasone|mesh-list
19625724|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
19625725|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19625726|NCT02479555|BB 1101|bb 1101|mesh-list
19625727|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625728|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
19625729|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
19625730|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625731|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625732|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625733|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
19625734|NCT02479555|Hormones|hormones|mesh-ancestor
19625735|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625736|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625737|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625738|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
19625739|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625740|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136579|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20136580|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136581|NCT00042822|Romidepsin|romidepsin|mesh-list
20136582|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20136583|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136584|NCT00042835|Paclitaxel|paclitaxel|mesh-list
20136585|NCT00042835|Etoposide|etoposide|mesh-list
19625741|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
19625742|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19625743|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625744|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19625745|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625746|NCT02479178|Docetaxel|docetaxel|mesh-list
19625747|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625748|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136586|NCT00042835|Docetaxel|docetaxel|mesh-list
19625749|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136587|NCT00042835|Carboplatin|carboplatin|mesh-list
20136588|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19625750|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
19625751|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625752|NCT02479230|Gemcitabine|gemcitabine|mesh-list
19625753|NCT02479230|Vaccines|vaccines|mesh-list
19625754|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
19625755|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625756|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19625757|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
19625758|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625759|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625760|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
19625761|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625762|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625763|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625764|NCT02479217|Docetaxel|docetaxel|mesh-list
20136589|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
20136590|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19750048|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19750049|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750050|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
19750051|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750052|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19750053|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
19750054|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750055|NCT04341779|Tenofovir|tenofovir|mesh-list
19750056|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
19750057|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750058|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19750059|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19750060|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750061|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750062|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19750063|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19750064|NCT04340193|Nivolumab|nivolumab|mesh-list
19750065|NCT04340193|Ipilimumab|ipilimumab|mesh-list
19750066|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750067|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750068|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19750069|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750070|NCT04328844|Pemetrexed|pemetrexed|mesh-list
19750071|NCT04328844|Avelumab|avelumab|mesh-list
19750072|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750073|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750074|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750075|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19750076|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19750077|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750078|NCT04310995|Nicorandil|nicorandil|mesh-list
19750079|NCT04310995|Diltiazem|diltiazem|mesh-list
19750080|NCT04310995|Isosorbide|isosorbide|mesh-list
19750081|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19750082|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19750083|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19750084|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19750085|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19750086|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750087|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19750088|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750089|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
19750090|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19750091|NCT04310995|Diuretics|diuretics|mesh-ancestor
19750092|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
19750093|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19750094|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19750095|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
20136591|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136592|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136593|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136594|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
19625765|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750096|NCT04310995|Vitamins|vitamins|mesh-ancestor
19750097|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
19750098|NCT04310059|Folic Acid|folic acid|mesh-list
19625766|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
19750099|NCT04310059|Hematinics|hematinics|mesh-ancestor
20312954|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
20136595|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136596|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136597|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20136598|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136599|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20136600|NCT00042848|Modafinil|modafinil|mesh-list
20136601|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20136602|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136603|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20136604|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20136605|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20136606|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136607|NCT00042861|Leucovorin|leucovorin|mesh-list
20136608|NCT00042861|Fluorouracil|fluorouracil|mesh-list
20136609|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20136610|NCT00042861|Calcium|calcium|mesh-list
20136611|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
20136612|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136613|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136614|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
20136615|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136616|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19625767|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
19625768|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
19625769|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625770|NCT02479529|Norepinephrine|norepinephrine|mesh-list
19625771|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19625772|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19625773|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
19625774|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625775|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625776|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625777|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
19625778|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
19625779|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625780|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19625781|NCT02479165|Oxycodone|oxycodone|mesh-list
19625782|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19625783|NCT02479165|Narcotics|narcotics|mesh-ancestor
19625784|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625785|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625786|NCT02479165|Analgesics|analgesics|mesh-ancestor
19625787|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
19625788|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625789|NCT02479022|Insulin|insulin|mesh-list
19625790|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19625791|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
19625792|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19625793|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625794|NCT02479074|Prednisolone|prednisolone|mesh-list
19625795|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19625796|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
19625797|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19625798|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
19625799|NCT02479074|Montelukast|montelukast|mesh-list
19625800|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19625801|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
19625802|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625803|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
19625804|NCT02479074|Hormones|hormones|mesh-ancestor
19625805|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625806|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625807|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625808|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625809|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
19625810|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
19625811|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625812|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625813|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19625814|NCT02479074|Protective Agents|protective agents|mesh-ancestor
19625815|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19625816|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
19625817|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20136617|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625818|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
19625819|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19625820|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19625821|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625822|NCT02478879|Teriparatide|teriparatide|mesh-list
19625823|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
19625824|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625825|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19625826|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19625827|NCT02478645|Ramosetron|ramosetron|mesh-list
19625828|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
19625829|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
19625830|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625831|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625832|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625833|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19625834|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
19625835|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625836|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660861|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660862|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
19660863|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19660864|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19660865|NCT03845140|Praziquantel|praziquantel|mesh-list
19660866|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
19660867|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660868|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660869|NCT03827447|Vancomycin|vancomycin|mesh-list
19660870|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19660871|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660872|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
19660873|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19660874|NCT03821857|Corticosterone|corticosterone|mesh-list
19660875|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19660876|NCT03727724|Cetuximab|cetuximab|mesh-list
20136618|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136619|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
20136620|NCT00042861|Antidotes|antidotes|mesh-ancestor
20136621|NCT00042861|Protective Agents|protective agents|mesh-ancestor
19660877|NCT03727724|Afatinib|afatinib|mesh-list
19660878|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660879|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660880|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19660881|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660882|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660883|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19660884|NCT03697031|Hormones|hormones|mesh-ancestor
19660885|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660886|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660887|NCT03672487|Benzonidazole|benzonidazole|mesh-list
19660888|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19660889|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
19660890|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660891|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19660892|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19660893|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660894|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660895|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
19660896|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660897|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
19660898|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660899|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660900|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19660901|NCT03630835|Annexin A5|annexin a5|mesh-list
19660902|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660903|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660904|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
19660905|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
19660906|NCT03541850|Hormones|hormones|mesh-list
19660907|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19660908|NCT03541850|Androgens|androgens|mesh-list
19660909|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
19660910|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19660911|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750100|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
19750101|NCT04310059|Vitamins|vitamins|mesh-ancestor
19625837|NCT02478515|Ranibizumab|ranibizumab|mesh-list
19625838|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19625839|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19625840|NCT02478515|Growth Substances|growth substances|mesh-ancestor
19625841|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625842|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
19625843|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625844|NCT02478424|Cyclosporine|cyclosporine|mesh-list
19625845|NCT02478424|Methotrexate|methotrexate|mesh-list
19625846|NCT02478424|Cannabidiol|cannabidiol|mesh-list
19625847|NCT02478424|Cyclosporins|cyclosporins|mesh-list
19625848|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19625849|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
19625850|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19625851|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625852|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19625853|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
19625854|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625855|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625856|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
19625857|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625858|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20136622|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
20136623|NCT00042861|Vitamins|vitamins|mesh-ancestor
20136624|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
19625859|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625860|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
19625861|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625862|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19625863|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
19625864|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625865|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19625866|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
19625867|NCT02478710|Vancomycin|vancomycin|mesh-list
19625868|NCT02478710|Tobramycin|tobramycin|mesh-list
19625869|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625870|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625876|NCT02478294|Warfarin|warfarin|mesh-list
19625877|NCT02478294|Anticoagulants|anticoagulants|mesh-list
19625878|NCT02478281|Methylene Blue|methylene blue|mesh-list
19625879|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625880|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625881|NCT02478268|Xenon|xenon|mesh-list
19625882|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19625883|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
19625884|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
19625885|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19625886|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625887|NCT02478125|Docetaxel|docetaxel|mesh-list
19625888|NCT02478125|Sargramostim|sargramostim|mesh-list
19625889|NCT02478125|Lenograstim|lenograstim|mesh-list
19625890|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625891|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19625892|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
19625893|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19625894|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625895|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
19750102|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
19750103|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750104|NCT04309409|Nivolumab|nivolumab|mesh-list
19750105|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750106|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136625|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20136626|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136627|NCT00042874|Leucovorin|leucovorin|mesh-list
20136628|NCT00042874|Fluorouracil|fluorouracil|mesh-list
20136629|NCT00042874|Irinotecan|irinotecan|mesh-list
19750107|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20136630|NCT00042874|Alvocidib|alvocidib|mesh-list
19625896|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625897|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19625898|NCT02478047|Dexamethasone|dexamethasone|mesh-list
20136631|NCT00042874|Calcium|calcium|mesh-list
19625899|NCT02478047|Ramosetron|ramosetron|mesh-list
20136632|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
20136633|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136634|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136635|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
20136636|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136637|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136638|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136639|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136640|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
20136641|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20136642|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20136643|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136644|NCT00042874|Antidotes|antidotes|mesh-ancestor
19625900|NCT02478047|Antiemetics|antiemetics|mesh-list
19625901|NCT02478047|Tropisetron|tropisetron|mesh-list
19625902|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625903|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
19625904|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625905|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625906|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19625907|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
19625908|NCT02478047|Hormones|hormones|mesh-ancestor
19625909|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19625910|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625911|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625912|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19625913|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
19625914|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19625915|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625916|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19625917|NCT02478242|Nafamostat|nafamostat|mesh-list
19625918|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19625919|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19625920|NCT02478242|Analgesics|analgesics|mesh-ancestor
19625921|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
19625922|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19625923|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625924|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625925|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19625926|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
19625927|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
19625928|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625929|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625930|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19625931|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19625932|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19625933|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19625934|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
19625935|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
19625936|NCT02478229|Ledipasvir|ledipasvir|mesh-list
19625937|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
19625938|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625939|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
19625940|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625941|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
19625942|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19625943|NCT02477956|Vitamin D|vitamin d|mesh-list
19625944|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
19625945|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
19625946|NCT02477956|Vitamins|vitamins|mesh-list
19625947|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
19625948|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625949|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19625950|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19625951|NCT02477969|Metformin|metformin|mesh-list
19625952|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19625953|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625954|NCT02477995|Vaccines|vaccines|mesh-list
19625955|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
19625956|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625957|NCT02477891|Daratumumab|daratumumab|mesh-list
20136645|NCT00042874|Protective Agents|protective agents|mesh-ancestor
19625958|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625959|NCT02477852|Rifampin|rifampin|mesh-list
19625960|NCT02477852|Isoniazid|isoniazid|mesh-list
19625961|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
19625962|NCT02477852|Ethambutol|ethambutol|mesh-list
19625963|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19625964|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
19625965|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19625966|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19625967|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
19625968|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19625969|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19625970|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625971|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19625972|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19625973|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19625974|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19625975|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19625976|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19625977|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19625978|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19625979|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
19625980|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19625981|NCT02477813|Temozolomide|temozolomide|mesh-list
19625982|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19625983|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
19625984|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19625985|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625986|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19625987|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
19625988|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19625989|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
19625990|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19625991|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19625992|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20136646|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
20136647|NCT00042874|Vitamins|vitamins|mesh-ancestor
20136648|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
20136649|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
20136650|NCT00042874|Growth Substances|growth substances|mesh-ancestor
20136651|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20136652|NCT00042887|Mitomycins|mitomycins|mesh-list
20136653|NCT00042887|Mitomycin|mitomycin|mesh-list
20136654|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20136655|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136656|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
20136657|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136658|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20136659|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136660|NCT00042913|Epratuzumab|epratuzumab|mesh-list
20136661|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136662|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625993|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19625994|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19625995|NCT02477631|Deferiprone|deferiprone|mesh-list
19625996|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19625997|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
19625998|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
19625999|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626000|NCT02477514|Tedizolid|tedizolid|mesh-list
19626001|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
19626002|NCT02477514|Midazolam|midazolam|mesh-list
19626003|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19626004|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19626005|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19626006|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626007|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626008|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19626009|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19626010|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19626011|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19626012|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
19626013|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
20136663|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19626014|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
19626015|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
19626016|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626017|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626018|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19626019|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19626020|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
19626021|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19626022|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19626023|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626024|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19626025|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626026|NCT02477501|Norepinephrine|norepinephrine|mesh-list
19626027|NCT02477501|Ephedrine|ephedrine|mesh-list
19626028|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19626029|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19626030|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
19626031|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626032|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626033|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626034|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
19626035|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
19626036|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626037|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19626038|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19626039|NCT02477488|Allopurinol|allopurinol|mesh-list
19626040|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
19626041|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626042|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626043|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
19626044|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19626045|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19626046|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
19626047|NCT02477488|Protective Agents|protective agents|mesh-ancestor
19626048|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626049|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19626050|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19626051|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626052|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626053|NCT02477397|Fluticasone|fluticasone|mesh-list
19626054|NCT02477397|Xhance|xhance|mesh-list
20136664|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20136665|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136666|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
20136667|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136668|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20136669|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136670|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136671|NCT00042965|Gemcitabine|gemcitabine|mesh-list
20136672|NCT00042965|Capecitabine|capecitabine|mesh-list
19626055|NCT02477397|Budesonide|budesonide|mesh-list
19626056|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
19626057|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19626058|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20136673|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136674|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
20136675|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136676|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136677|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
20136678|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136679|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136680|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136681|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
20136682|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136683|NCT00042978|Carboplatin|carboplatin|mesh-list
20136684|NCT00042978|Etoposide|etoposide|mesh-list
20136685|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
20136686|NCT00042978|Oblimersen|oblimersen|mesh-list
20136687|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136688|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20136689|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136690|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19626059|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19626060|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626061|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19626062|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
19626063|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626064|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626065|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19626066|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
19626067|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
19626068|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19626069|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
20136691|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136692|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136693|NCT00043004|Leucovorin|leucovorin|mesh-list
20136694|NCT00043004|Bevacizumab|bevacizumab|mesh-list
20136695|NCT00043004|Fluorouracil|fluorouracil|mesh-list
20136696|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
20136697|NCT00043004|Calcium|calcium|mesh-list
20136698|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
20136699|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136700|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136701|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20136702|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20136703|NCT00043004|Growth Substances|growth substances|mesh-ancestor
20136704|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136705|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
20312955|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312956|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312957|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20312958|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20312959|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
20312960|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312961|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
20312962|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20312963|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20312964|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20136706|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136707|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
20136708|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136709|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20312965|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
19626070|NCT02477397|Hormones|hormones|mesh-ancestor
19626071|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626072|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19626073|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19626074|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19626075|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
19626076|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626077|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626078|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
19626079|NCT02477267|Buprenorphine|buprenorphine|mesh-list
19626080|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19626081|NCT02477267|Naloxone|naloxone|mesh-list
19626082|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19626083|NCT02477267|Narcotics|narcotics|mesh-ancestor
19626084|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626085|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626086|NCT02477267|Analgesics|analgesics|mesh-ancestor
19626087|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
19626088|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626089|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19626090|NCT02477280|Methylphenidate|methylphenidate|mesh-list
19626091|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19626092|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626093|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19626094|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19626095|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19626096|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626097|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
19626098|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626099|NCT02477306|Rabeprazole|rabeprazole|mesh-list
19626100|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19626101|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626102|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19626103|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136710|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19626104|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626105|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
19626106|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19626107|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
19626108|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19626109|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626110|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19626111|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19626112|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19626113|NCT02477254|Vaccines|vaccines|mesh-list
20136711|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
20136712|NCT00043004|Antidotes|antidotes|mesh-ancestor
20136713|NCT00043004|Protective Agents|protective agents|mesh-ancestor
20136714|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
20136715|NCT00043004|Vitamins|vitamins|mesh-ancestor
20136716|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
20136717|NCT00043043|Celecoxib|celecoxib|mesh-list
19626114|NCT02477254|Immunologic Factors|immunologic factors|mesh-ancestor
19626115|NCT02477254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626116|NCT02476955|Paclitaxel|paclitaxel|mesh-list
19626117|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19626118|NCT02476955|Carboplatin|carboplatin|mesh-list
19626119|NCT02476955|Anastrozole|anastrozole|mesh-list
19626120|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19626121|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626122|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
19626123|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136718|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20136719|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20136720|NCT00043043|Analgesics|analgesics|mesh-ancestor
20136721|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
20136722|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136723|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136724|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20136725|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136726|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20136727|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20136728|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136729|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312966|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20312967|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20312968|NCT00686621|Posaconazole|posaconazole|mesh-list
20312969|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
20312970|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20312971|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20312972|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20312973|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20312974|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20312975|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20312976|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626124|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
19626125|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626126|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19626127|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19626128|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19626129|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626130|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20312977|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312978|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20312979|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
20312980|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20312981|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312982|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
19626131|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
19626132|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626133|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626134|NCT02477007|Acetaminophen|acetaminophen|mesh-list
20312983|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20312984|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19626135|NCT02477007|Ibuprofen|ibuprofen|mesh-list
19626136|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20136730|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
20136731|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
20312985|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
20136732|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
19626137|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626138|NCT02477007|Analgesics|analgesics|mesh-ancestor
19626139|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
19626140|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626141|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626142|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626143|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19626144|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19626145|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136733|NCT00043069|Estrogens|estrogens|mesh-list
20136734|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
20136735|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
20136736|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136737|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136738|NCT00043069|Vitamins|vitamins|mesh-ancestor
20136739|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
20136740|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20136741|NCT00043069|Hormones|hormones|mesh-ancestor
20136742|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136743|NCT00043069|Antacids|antacids|mesh-ancestor
20136744|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136745|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20136746|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20136747|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20136748|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
20136749|NCT00043082|Carboplatin|carboplatin|mesh-list
20136750|NCT00043082|Doxorubicin|doxorubicin|mesh-list
20136751|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20136752|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136753|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20136754|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136755|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20136756|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136757|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136758|NCT00043095|Gemcitabine|gemcitabine|mesh-list
20136759|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136760|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
20136761|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136762|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136763|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
20136764|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136765|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136766|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136767|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
20136768|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136769|NCT00043121|Leucovorin|leucovorin|mesh-list
20136770|NCT00043121|Fluorouracil|fluorouracil|mesh-list
20136771|NCT00043121|Capecitabine|capecitabine|mesh-list
20136772|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
20136773|NCT00043121|Calcium|calcium|mesh-list
20136774|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
20136775|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136776|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136777|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
20136778|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136779|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136780|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136781|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136782|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
20312986|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312987|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19256607|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19256608|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19256609|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626146|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626147|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
19626148|NCT02476799|Ketorolac|ketorolac|mesh-list
19626149|NCT02476799|Fentanyl|fentanyl|mesh-list
19626150|NCT02476799|Ropivacaine|ropivacaine|mesh-list
19626151|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
19626152|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
20136783|NCT00043121|Antidotes|antidotes|mesh-ancestor
19626153|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626154|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626155|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
19626156|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626157|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19626158|NCT02476799|Narcotics|narcotics|mesh-ancestor
20136784|NCT00043121|Protective Agents|protective agents|mesh-ancestor
20136785|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
20136786|NCT00043121|Vitamins|vitamins|mesh-ancestor
20136787|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
20136788|NCT00043134|Decitabine|decitabine|mesh-list
20136789|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136790|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
19626159|NCT02476799|Analgesics|analgesics|mesh-ancestor
19626160|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19626161|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19626162|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
19626163|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19626164|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626165|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20136791|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136792|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136793|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626166|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19626167|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19626168|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626169|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626170|NCT02477098|Ropivacaine|ropivacaine|mesh-list
19626171|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
19626172|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
19626173|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626174|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626175|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
19626176|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626177|NCT02477072|Heparin|heparin|mesh-list
19626178|NCT02477072|Calcium heparin|calcium heparin|mesh-list
19626179|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
19626180|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19626181|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19626182|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626183|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
19626184|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19626185|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
19626186|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
19626187|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626188|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626189|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626190|NCT02476929|Analgesics|analgesics|mesh-ancestor
19626191|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
19626192|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626193|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
19626194|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19626195|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
20136794|NCT00043147|Prednisone|prednisone|mesh-list
20136795|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
20136796|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20136797|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20136798|NCT00043147|Prednisolone|prednisolone|mesh-list
20136799|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
20136800|NCT00043147|Beclomethasone|beclomethasone|mesh-list
20136801|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20136802|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
20136803|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20136804|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
20136805|NCT00043147|Hormones|hormones|mesh-ancestor
20136806|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136807|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136808|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20136809|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136810|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
20136811|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
20136812|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136813|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20136814|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20136815|NCT00043147|Protective Agents|protective agents|mesh-ancestor
20136816|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19626196|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626197|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
19626198|NCT02476903|Protective Agents|protective agents|mesh-ancestor
19626199|NCT02476864|Macitentan|macitentan|mesh-list
19626200|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19626201|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19626202|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626203|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19626204|NCT02476981|Ephedrine|ephedrine|mesh-list
19626205|NCT02476981|Midazolam|midazolam|mesh-list
19626206|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
19626207|NCT02476981|Remifentanil|remifentanil|mesh-list
19750108|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750109|NCT04291885|Avelumab|avelumab|mesh-list
19750110|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750111|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750112|NCT04287062|Suvorexant|suvorexant|mesh-list
19750113|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19750114|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19750115|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19750116|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750117|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19750118|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750119|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750120|NCT04264806|Azacitidine|azacitidine|mesh-list
19750121|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19750122|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
19750123|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750124|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750125|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750126|NCT04263831|Aldesleukin|aldesleukin|mesh-list
19750127|NCT04263831|Interleukin-2|interleukin-2|mesh-list
19750128|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750129|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19750130|NCT04263831|Analgesics|analgesics|mesh-ancestor
19750131|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
19750132|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750133|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750134|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19750135|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19750136|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
19750137|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750138|NCT04261049|Triamcinolone|triamcinolone|mesh-list
19750139|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19750140|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19750141|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19750142|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750143|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
19750144|NCT04261049|Hormones|hormones|mesh-ancestor
19750145|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750146|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750147|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750148|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
19750149|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750150|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750151|NCT04249362|Durvalumab|durvalumab|mesh-list
19750152|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750153|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750161|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
19750162|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750163|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750164|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
19750165|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750166|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
19626208|NCT02476981|Propofol|propofol|mesh-list
19626209|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19626210|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626211|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136817|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
20136818|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
20136819|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136820|NCT00043264|Azithromycin|azithromycin|mesh-list
20136821|NCT00043264|Rifampin|rifampin|mesh-list
20136822|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20136823|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136824|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20136825|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
20136826|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
20136827|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20136828|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136829|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136830|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20136831|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20136832|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20136833|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20136834|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20136835|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19626212|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19626213|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
19626214|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
19626215|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626216|NCT02476981|Analgesics|analgesics|mesh-ancestor
19626217|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
19626218|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626219|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19626220|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19626221|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19626222|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
19626223|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626224|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626225|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19626226|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19626227|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19626228|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20136836|NCT00043277|Bivalirudin|bivalirudin|mesh-list
20136837|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
20136838|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20136839|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
20136840|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626229|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
19626230|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
19626231|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19626232|NCT02476981|Narcotics|narcotics|mesh-ancestor
19626233|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19626234|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
19626235|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
19626236|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19626237|NCT02476825|Fluticasone|fluticasone|mesh-list
19626238|NCT02476825|Xhance|xhance|mesh-list
19626239|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626240|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19626241|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
20136841|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136842|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
20136843|NCT00043303|Interferons|interferons|mesh-list
20136844|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
20136845|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136846|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
20136847|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136848|NCT00043316|Interferons|interferons|mesh-list
20312988|NCT00686868|Ofatumumab|ofatumumab|mesh-list
20312989|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626242|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626243|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20312990|NCT00686985|Carboplatin|carboplatin|mesh-list
19626244|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19626245|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
19626246|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
19626247|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19660912|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
19660913|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660914|NCT03541850|Protective Agents|protective agents|mesh-ancestor
19660915|NCT03541850|Vitamins|vitamins|mesh-ancestor
19660916|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
19660917|NCT03541850|Estrogens|estrogens|mesh-ancestor
19660918|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660919|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660920|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
19660921|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
19665650|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19665651|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19665652|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665653|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665654|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19665655|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
19665656|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19665657|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665658|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
19665659|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19665660|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19665661|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19665662|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20136849|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
20136850|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665663|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19665664|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19665665|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19665666|NCT04560634|Norepinephrine|norepinephrine|mesh-list
19665667|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19665668|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19665669|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19665670|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665671|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665672|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665673|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
19665674|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
19665675|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665676|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19665677|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
19665678|NCT04483544|Olaparib|olaparib|mesh-list
19665679|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665680|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665681|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19665682|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665683|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665684|NCT04474353|Temozolomide|temozolomide|mesh-list
19665685|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665686|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
19665687|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665688|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665689|NCT04433845|Psilocybin|psilocybin|mesh-list
19665690|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
19665691|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665692|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19665693|NCT04364776|Durvalumab|durvalumab|mesh-list
19665694|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665695|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665696|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
19665697|NCT04357587|Capecitabine|capecitabine|mesh-list
19665698|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136851|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
20136852|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136853|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
20136854|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
20136855|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136856|NCT00043342|Interferons|interferons|mesh-list
20136857|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
20136858|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136859|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
20136860|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136861|NCT00043355|Interferons|interferons|mesh-list
20136862|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
20608407|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
20608408|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608409|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20608410|NCT02245841|Hormones|hormones|mesh-ancestor
20312991|NCT00686985|Docetaxel|docetaxel|mesh-list
20312992|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20312993|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
19626248|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
19626249|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19626250|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
19626251|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626252|NCT02476526|Expectorants|expectorants|mesh-ancestor
19626253|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
19626254|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19626255|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
19626256|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626257|NCT02476526|Protective Agents|protective agents|mesh-ancestor
19626258|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626259|NCT02476526|Antidotes|antidotes|mesh-ancestor
19626260|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19626261|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19626262|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
19626263|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626264|NCT02476773|Antacids|antacids|mesh-ancestor
19626265|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626266|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626267|NCT02476708|Curcumin|curcumin|mesh-list
19626268|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19626269|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626270|NCT02476708|Analgesics|analgesics|mesh-ancestor
19626271|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
19626272|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626273|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626274|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626275|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19626276|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626277|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626278|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626279|NCT02476760|Insulin|insulin|mesh-list
19626280|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19626281|NCT02476760|Metformin|metformin|mesh-list
19626282|NCT02476760|Pioglitazone|pioglitazone|mesh-list
19626283|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19626284|NCT02476760|Liraglutide|liraglutide|mesh-list
19626285|NCT02476760|Exenatide|exenatide|mesh-list
19626286|NCT02476760|Glimepiride|glimepiride|mesh-list
19626287|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
19626288|NCT02476760|Vildagliptin|vildagliptin|mesh-list
19626289|NCT02476760|Saxagliptin|saxagliptin|mesh-list
19626290|NCT02476760|Acarbose|acarbose|mesh-list
19626291|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19626292|NCT02476760|Repaglinide|repaglinide|mesh-list
19626293|NCT02476760|Gliclazide|gliclazide|mesh-list
19626294|NCT02476760|Glipizide|glipizide|mesh-list
19626295|NCT02476760|Biguanides|biguanides|mesh-list
19626296|NCT02476760|Tolbutamide|tolbutamide|mesh-list
19626297|NCT02476760|Voglibose|voglibose|mesh-list
20608411|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608412|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608413|NCT02245867|Antibodies|antibodies|mesh-list
20608414|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20608415|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
20608416|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608417|NCT02245932|Resveratrol|resveratrol|mesh-list
20608418|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
20612142|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626298|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19626299|NCT02476760|Nateglinide|nateglinide|mesh-list
19626300|NCT02476760|Miglitol|miglitol|mesh-list
19626301|NCT02476760|Troglitazone|troglitazone|mesh-list
19256610|NCT04363840|Analgesics|analgesics|mesh-ancestor
19626302|NCT02476760|Meglitinide|meglitinide|mesh-list
19626303|NCT02476760|Acetohexamide|acetohexamide|mesh-list
19626304|NCT02476760|Phenformin|phenformin|mesh-list
19626305|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
19626306|NCT02476760|Buformin|buformin|mesh-list
19626307|NCT02476760|Glibornuride|glibornuride|mesh-list
19626308|NCT02476760|Tolazamide|tolazamide|mesh-list
19626309|NCT02476760|Carbutamide|carbutamide|mesh-list
19626310|NCT02476760|Gliquidone|gliquidone|mesh-list
20136863|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136864|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
20608419|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608420|NCT02245932|Protective Agents|protective agents|mesh-ancestor
20136865|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136866|NCT00043381|Decitabine|decitabine|mesh-list
20136867|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136868|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
20136869|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136870|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136871|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136872|NCT00043394|Trastuzumab|trastuzumab|mesh-list
20136873|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136874|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136875|NCT00043537|Fluoxetine|fluoxetine|mesh-list
20136876|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20136877|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20136878|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20136879|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136880|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136881|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
20136882|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136883|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20136884|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
20312994|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
20312995|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
20312996|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20312997|NCT00687011|Dexamethasone|dexamethasone|mesh-list
20312998|NCT00687011|Palonosetron|palonosetron|mesh-list
20312999|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626311|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19626312|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
19626313|NCT02476760|Incretins|incretins|mesh-list
19626314|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313000|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
20313001|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
19626315|NCT02476760|Hormones|hormones|mesh-ancestor
19626316|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626317|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
19626318|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626319|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626320|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20313002|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313003|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313004|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20313005|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
20313006|NCT00687011|Hormones|hormones|mesh-ancestor
20313007|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20313008|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20313009|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313010|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20313011|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20313012|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
20313013|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313014|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313015|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
20313016|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20313017|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313018|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
20313019|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313020|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313021|NCT00687206|Valsartan|valsartan|mesh-list
19626321|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19626322|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19626323|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
19626324|NCT02476552|Niraparib|niraparib|mesh-list
19626325|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19626326|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626327|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626328|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626329|NCT02476279|Indomethacin|indomethacin|mesh-list
19626330|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19626331|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20313022|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19626332|NCT02476279|Analgesics|analgesics|mesh-ancestor
19626333|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
19626334|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626335|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626336|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626337|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136885|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20136886|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20136887|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20136888|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136889|NCT00043576|Calcitriol|calcitriol|mesh-list
20136890|NCT00043576|Docetaxel|docetaxel|mesh-list
20136891|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136892|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
20136893|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
20136894|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
20136895|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136896|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136897|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136898|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20136899|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20136900|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20136901|NCT00043576|Vitamins|vitamins|mesh-ancestor
20136902|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
20136903|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20136904|NCT00043589|Donepezil|donepezil|mesh-list
20136905|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20136906|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626338|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
19626339|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
19626340|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19626341|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19626342|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626343|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626344|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19626345|NCT02476136|Fluoxetine|fluoxetine|mesh-list
19626346|NCT02476136|Paroxetine|paroxetine|mesh-list
19626347|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19626348|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19626349|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19626350|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19626351|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626352|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626353|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626354|NCT02476136|Analgesics|analgesics|mesh-ancestor
19626355|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
19626356|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626357|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
19626358|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19626359|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
19626360|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19626361|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
19626362|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19626363|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19626364|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19626365|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626366|NCT02476123|Nivolumab|nivolumab|mesh-list
19626367|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
19626368|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19626369|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626370|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19626371|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626372|NCT02476045|Leucovorin|leucovorin|mesh-list
19626373|NCT02476045|Fluorouracil|fluorouracil|mesh-list
19626374|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
19626375|NCT02476045|Panitumumab|panitumumab|mesh-list
19626376|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
19626377|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
19626378|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626379|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19626380|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626381|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19626382|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
20136907|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626383|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626384|NCT02476045|Antidotes|antidotes|mesh-ancestor
19626385|NCT02476045|Protective Agents|protective agents|mesh-ancestor
19626386|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
19626387|NCT02476045|Vitamins|vitamins|mesh-ancestor
19626388|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
19626389|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19626390|NCT02475876|Clindamycin|clindamycin|mesh-list
19626391|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
19626392|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
19626393|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19626394|NCT02475876|Trimethoprim|trimethoprim|mesh-list
19626395|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
19626396|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19626397|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626398|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19626399|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626400|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626401|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19626402|NCT02475876|Renal Agents|renal agents|mesh-ancestor
19626403|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
19626404|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19626405|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19626406|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19626407|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19626408|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19626409|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19626410|NCT02475863|Warfarin|warfarin|mesh-list
19626411|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
19626412|NCT02475915|Tenofovir|tenofovir|mesh-list
19626413|NCT02475915|Emtricitabine|emtricitabine|mesh-list
19626414|NCT02475915|Efavirenz|efavirenz|mesh-list
19626415|NCT02475915|Maraviroc|maraviroc|mesh-list
19626416|NCT02475915|Darunavir|darunavir|mesh-list
19750167|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750168|NCT04223856|Gemcitabine|gemcitabine|mesh-list
19750169|NCT04223856|Carboplatin|carboplatin|mesh-list
19750170|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
19750171|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750172|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19750173|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
19750174|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750175|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
19750176|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750177|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750178|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750179|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
19750180|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750181|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750182|NCT04218851|Posaconazole|posaconazole|mesh-list
19750183|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
19750184|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750185|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19750186|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19750187|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19750188|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19750189|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19750190|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750191|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750192|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20136908|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
20136909|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20136910|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136911|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
20136912|NCT00043654|Mifepristone|mifepristone|mesh-list
19626417|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
19626418|NCT02475915|Vorinostat|vorinostat|mesh-list
19626419|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
19626420|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626421|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19626422|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19626423|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626424|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750193|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
19626425|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19626426|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19626427|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
19626428|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19626429|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19626430|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19626431|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19626432|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19626433|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19626434|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19626435|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19626436|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19626437|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626438|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19626439|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19626440|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19626441|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19626442|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19626443|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19626444|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
19626445|NCT02475772|Cisplatin|cisplatin|mesh-list
19626446|NCT02475772|Doxorubicin|doxorubicin|mesh-list
19626447|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19626448|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626449|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19626450|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20136913|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20136914|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
20136915|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20136916|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136917|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20136918|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20136919|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20136920|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
20136921|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20136922|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20136923|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
20136924|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20136925|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
20136926|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20136927|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20136928|NCT00043667|Daclizumab|daclizumab|mesh-list
20136929|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136930|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
20136931|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136932|NCT00043680|Celecoxib|celecoxib|mesh-list
20136933|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20136934|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626451|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19626452|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626453|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626454|NCT02475824|Midazolam|midazolam|mesh-list
19626455|NCT02475824|Meperidine|meperidine|mesh-list
19626456|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
19626457|NCT02475824|Propofol|propofol|mesh-list
19626458|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19626459|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626460|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626461|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20136935|NCT00043680|Analgesics|analgesics|mesh-ancestor
20136936|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
19626462|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
19626463|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
19626464|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626465|NCT02475824|Analgesics|analgesics|mesh-ancestor
19626466|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
19626467|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626468|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19626469|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19626470|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19626471|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
19626472|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626473|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626474|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19626475|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19626476|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19626477|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19626478|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
20136937|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20136938|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136939|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626479|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
19626480|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19626481|NCT02475824|Narcotics|narcotics|mesh-ancestor
19626482|NCT02475746|Itraconazole|itraconazole|mesh-list
19626483|NCT02475746|PF-06372865|pf-06372865|mesh-list
19626484|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
19626485|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626486|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19626487|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19626488|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626489|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626490|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19626491|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
19626492|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626493|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626494|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19626495|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
19626496|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
19626497|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626498|NCT02475499|Metformin|metformin|mesh-list
19626499|NCT02475499|Pioglitazone|pioglitazone|mesh-list
19626500|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19626501|NCT02475499|Liraglutide|liraglutide|mesh-list
19626502|NCT02475499|Exenatide|exenatide|mesh-list
19626503|NCT02475499|Glimepiride|glimepiride|mesh-list
19626504|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
19626505|NCT02475499|Vildagliptin|vildagliptin|mesh-list
19626506|NCT02475499|Saxagliptin|saxagliptin|mesh-list
19626507|NCT02475499|Acarbose|acarbose|mesh-list
19626508|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19626509|NCT02475499|Repaglinide|repaglinide|mesh-list
19626510|NCT02475499|Gliclazide|gliclazide|mesh-list
19626511|NCT02475499|Glipizide|glipizide|mesh-list
19626512|NCT02475499|Biguanides|biguanides|mesh-list
19626513|NCT02475499|Tolbutamide|tolbutamide|mesh-list
19626514|NCT02475499|Voglibose|voglibose|mesh-list
19626515|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19626516|NCT02475499|Nateglinide|nateglinide|mesh-list
19626517|NCT02475499|Miglitol|miglitol|mesh-list
19626518|NCT02475499|Troglitazone|troglitazone|mesh-list
19626519|NCT02475499|Meglitinide|meglitinide|mesh-list
19626520|NCT02475499|Acetohexamide|acetohexamide|mesh-list
19626521|NCT02475499|Phenformin|phenformin|mesh-list
19626522|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
19626523|NCT02475499|Buformin|buformin|mesh-list
19626524|NCT02475499|Glibornuride|glibornuride|mesh-list
19626525|NCT02475499|Tolazamide|tolazamide|mesh-list
19626526|NCT02475499|Carbutamide|carbutamide|mesh-list
19626527|NCT02475499|Gliquidone|gliquidone|mesh-list
19626528|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19626529|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
19626530|NCT02475499|Incretins|incretins|mesh-list
19626531|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626532|NCT02475499|Hormones|hormones|mesh-ancestor
19626533|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626534|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
19626535|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626536|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626537|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19626538|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19626539|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19626540|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
19626541|NCT02475421|Glucagon|glucagon|mesh-list
19626542|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626543|NCT02475421|Hormones|hormones|mesh-ancestor
19626544|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626545|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626546|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
19626547|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
19626548|NCT02475681|Chlorambucil|chlorambucil|mesh-list
19626549|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19626550|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626551|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19626552|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
19626553|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626554|NCT02475382|Nivolumab|nivolumab|mesh-list
19626555|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19626556|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626557|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19626558|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626559|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19626560|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
19626561|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19626562|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
19626563|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626564|NCT02475343|Riboflavin|riboflavin|mesh-list
19626565|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
19626566|NCT02475343|Vitamins|vitamins|mesh-ancestor
19626567|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
19626568|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626569|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19626570|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
19626571|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
19626572|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19626573|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
19626574|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19626575|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136940|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20136941|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20136942|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19626576|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19626577|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19626578|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19626579|NCT02475135|Tenofovir|tenofovir|mesh-list
19626580|NCT02475135|Emtricitabine|emtricitabine|mesh-list
19626581|NCT02475135|Darunavir|darunavir|mesh-list
19626582|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19626583|NCT02475135|Cobicistat|cobicistat|mesh-list
19626584|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19626585|NCT02475135|Elvitegravir|elvitegravir|mesh-list
19626586|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
19626587|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626588|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19626589|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19626590|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626591|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626592|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19626593|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19626594|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19626595|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19626596|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
19626597|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19626598|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19626599|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19626600|NCT02475161|Rabeprazole|rabeprazole|mesh-list
19626601|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19626602|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626603|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19626604|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626605|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626606|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
19626607|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19626608|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626609|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19626610|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19626611|NCT02475317|Volixibat|volixibat|mesh-list
20136943|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136944|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136945|NCT00043706|Antibodies|antibodies|mesh-list
20136946|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20136947|NCT00043706|Mitogens|mitogens|mesh-list
20136948|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
20136949|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136950|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
20136951|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136952|NCT00043719|Vitamin D|vitamin d|mesh-list
19626612|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19626613|NCT02474953|Curcumin|curcumin|mesh-list
19660922|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
20136953|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
20136954|NCT00043719|Calcium|calcium|mesh-list
19626614|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19626615|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626616|NCT02474953|Analgesics|analgesics|mesh-ancestor
19626617|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
19626618|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626619|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626620|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626621|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313023|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20313024|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20313025|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313026|NCT00687245|Esomeprazole|esomeprazole|mesh-list
20313027|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20313028|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20313029|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20313030|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313031|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313032|NCT00687258|Vitamin E|vitamin e|mesh-list
20313033|NCT00687258|Vitamins|vitamins|mesh-ancestor
20313034|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
20313035|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313036|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
20313037|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313038|NCT00687258|Protective Agents|protective agents|mesh-ancestor
20313039|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
20313040|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313041|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313042|NCT00687388|Celecoxib|celecoxib|mesh-list
20313043|NCT00687388|Doxazosin|doxazosin|mesh-list
20136955|NCT00043719|Vitamins|vitamins|mesh-ancestor
20136956|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
20136957|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136958|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20136959|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20136960|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
20313044|NCT00687388|Prazosin|prazosin|mesh-list
20313045|NCT00687388|Tamsulosin|tamsulosin|mesh-list
20313046|NCT00687388|Alfuzosin|alfuzosin|mesh-list
20313047|NCT00687388|Terazosin|terazosin|mesh-list
20313048|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19626622|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626623|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136961|NCT00043758|Tolvaptan|tolvaptan|mesh-list
20136962|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20136963|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136964|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
20136965|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136966|NCT00043771|Tolvaptan|tolvaptan|mesh-list
20136967|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20136968|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136969|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
20136970|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136971|NCT00043784|Enoxaparin|enoxaparin|mesh-list
20136972|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
20136973|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20136974|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20136975|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136976|NCT00043810|Vidarabine|vidarabine|mesh-list
20136977|NCT00043810|Fludarabine|fludarabine|mesh-list
20313049|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20313050|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20313051|NCT00687388|Analgesics|analgesics|mesh-ancestor
20313052|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
19660923|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136978|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
20136979|NCT00043810|Busulfan|busulfan|mesh-list
20136980|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
20136981|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20136982|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20136983|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
20136984|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20136985|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20136986|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
20313053|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626624|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660924|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660925|NCT03469050|Rifaximin|rifaximin|mesh-list
19660926|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19660927|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660928|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660929|NCT03415061|Insulin|insulin|mesh-list
19660930|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19660931|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19660932|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660933|NCT03403621|Pentamidine|pentamidine|mesh-list
20136987|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20136988|NCT00043810|Antiviral Agents|antiviral agents|mesh-ancestor
20136989|NCT00043810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20136990|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
20136991|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20136992|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20136993|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20136994|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20136995|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20136996|NCT00043823|Bevacizumab|bevacizumab|mesh-list
20136997|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20136998|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20136999|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137000|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20608421|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608422|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608423|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20608424|NCT02246023|Propofol|propofol|mesh-list
20608425|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20608426|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137001|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20137002|NCT00043823|Growth Substances|growth substances|mesh-ancestor
20137003|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137004|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
19660934|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
19660935|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660936|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19660937|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660938|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19660939|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
19660940|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19660941|NCT03327844|Metronidazole|metronidazole|mesh-list
19660942|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
19660943|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19660944|NCT03327844|Calcium|calcium|mesh-list
19660945|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19660946|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660947|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19660948|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660949|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
19660950|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19660951|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660952|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19660953|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19660954|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660955|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660956|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660957|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19660958|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19660959|NCT03189706|Irinotecan|irinotecan|mesh-list
19660960|NCT03189706|Temozolomide|temozolomide|mesh-list
19660961|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19660962|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19660963|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660964|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660965|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660966|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19660967|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
19660968|NCT03158883|Avelumab|avelumab|mesh-list
19660969|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19660970|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19660971|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
19660972|NCT03113994|Vitamin D|vitamin d|mesh-list
19660973|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
19626625|NCT02474914|Octreotide|octreotide|mesh-list
19626626|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626627|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20137005|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137006|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137007|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137008|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20137009|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137010|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137011|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20313054|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626628|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626629|NCT02475057|Hormones|hormones|mesh-list
19626630|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19626631|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626632|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626633|NCT02474667|Mitogens|mitogens|mesh-list
19626634|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
19626635|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626636|NCT02474654|Ketorolac|ketorolac|mesh-list
19626637|NCT02474654|Epinephrine|epinephrine|mesh-list
19626638|NCT02474654|Racepinephrine|racepinephrine|mesh-list
19626639|NCT02474654|Fentanyl|fentanyl|mesh-list
19626640|NCT02474654|Bupivacaine|bupivacaine|mesh-list
19626641|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
19626642|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
19626643|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
19626644|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626645|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626646|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
19626647|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313055|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313056|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313057|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19626648|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19626649|NCT02474654|Narcotics|narcotics|mesh-ancestor
19626650|NCT02474654|Analgesics|analgesics|mesh-ancestor
19626651|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19626652|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19626653|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
19626654|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19626655|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19626656|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
19626657|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626658|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626659|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19626660|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19626661|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
19626662|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19626663|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
19626664|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
19626665|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
19626666|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19626667|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19626668|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626669|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626670|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19626671|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19626672|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626673|NCT02474706|Imipenem|imipenem|mesh-list
19626674|NCT02474706|Cefoxitin|cefoxitin|mesh-list
19626675|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19626676|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626677|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19626678|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19626679|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19626680|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626681|NCT02474563|Prednisone|prednisone|mesh-list
19626682|NCT02474563|Bortezomib|bortezomib|mesh-list
19626683|NCT02474563|Melphalan|melphalan|mesh-list
19626684|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626685|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
19626686|NCT02474563|Hormones|hormones|mesh-ancestor
19626687|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137012|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19626688|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626689|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19626690|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626691|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19626692|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
19626693|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626694|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19626695|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19626696|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
19626697|NCT02474511|Anesthetics|anesthetics|mesh-list
19626698|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626699|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626700|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
19626701|NCT02474628|Calcium|calcium|mesh-list
19626702|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19626703|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626704|NCT02474628|Antacids|antacids|mesh-ancestor
19626705|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626706|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626707|NCT02474433|Misoprostol|misoprostol|mesh-list
20137013|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137014|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137015|NCT00043862|Topotecan|topotecan|mesh-list
20137016|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20137017|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137018|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137019|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137020|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137021|NCT00043875|Lamotrigine|lamotrigine|mesh-list
20137022|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
20137023|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20137024|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137025|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137026|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137027|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137028|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20137029|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20137030|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137031|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20313058|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19626708|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19626709|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
19626710|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19626711|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626712|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19626713|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626714|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
20137032|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20313059|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313060|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313061|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20313062|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20313063|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
20313064|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313065|NCT00687388|Urological Agents|urological agents|mesh-ancestor
20313066|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20313067|NCT00687466|Insulin|insulin|mesh-list
20313068|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313069|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313070|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
20313071|NCT00687518|Hematinics|hematinics|mesh-ancestor
20313072|NCT00687622|Trametinib|trametinib|mesh-list
20313073|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313074|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20313075|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313076|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626715|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19626716|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19626717|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19626718|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660974|NCT03113994|Ubiquinone|ubiquinone|mesh-list
20313077|NCT00687648|Prednisolone|prednisolone|mesh-list
20608427|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626719|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626720|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
19626721|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626722|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19626723|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19626724|NCT02474290|Sorafenib|sorafenib|mesh-list
19626725|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626726|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19626727|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626728|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626729|NCT02474212|Enoxaparin|enoxaparin|mesh-list
19626730|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
19626731|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19626732|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19626733|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626734|NCT02474225|Bevacizumab|bevacizumab|mesh-list
19626735|NCT02474225|Ranibizumab|ranibizumab|mesh-list
19626736|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
19626737|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19626738|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626739|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19626740|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19626741|NCT02474225|Growth Substances|growth substances|mesh-ancestor
19626742|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626743|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
19626744|NCT02474446|Vitamin D|vitamin d|mesh-list
19626745|NCT02474446|Vitamins|vitamins|mesh-ancestor
19626746|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
19626747|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626748|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19626749|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19626750|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
19626751|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626752|NCT02474420|Amlodipine|amlodipine|mesh-list
19626753|NCT02474420|Deferasirox|deferasirox|mesh-list
19626754|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19626755|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19626756|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19626757|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626758|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137033|NCT00043888|Ritonavir|ritonavir|mesh-list
20137034|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
20137035|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20137036|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20137037|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20137038|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
20137039|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137040|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137041|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137042|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19626759|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626760|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
19626761|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19626762|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
20137043|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
20137044|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137045|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20137046|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137047|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20137048|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20137049|NCT00043901|Lamotrigine|lamotrigine|mesh-list
20137050|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
20137051|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20137052|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137053|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137054|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137055|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137056|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20313078|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
20313079|NCT00687648|Methotrexate|methotrexate|mesh-list
20313080|NCT00687648|Letrozole|letrozole|mesh-list
20313081|NCT00687648|Anastrozole|anastrozole|mesh-list
20313082|NCT00687648|Exemestane|exemestane|mesh-list
19626763|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
19626764|NCT02474134|Interferons|interferons|mesh-list
19626765|NCT02474134|Interferon-beta|interferon-beta|mesh-list
19626766|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
19626767|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626768|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
19626769|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626770|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
19626771|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626772|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19626773|NCT02474186|Paclitaxel|paclitaxel|mesh-list
19626774|NCT02474186|Docetaxel|docetaxel|mesh-list
19626775|NCT02474186|Capecitabine|capecitabine|mesh-list
19626776|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20313083|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313084|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
20313085|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313086|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313087|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20313088|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
20313089|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313090|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626777|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626778|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
19626779|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
19626780|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
19626781|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626782|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19626783|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
19626784|NCT02473900|Oseltamivir|oseltamivir|mesh-list
19626785|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
19626786|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626787|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626788|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626789|NCT02473887|Ondansetron|ondansetron|mesh-list
19626790|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
19626791|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
19626792|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626793|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626794|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626795|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
19626796|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
19626797|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19626798|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
19626799|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626800|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626801|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19626802|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19626803|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626804|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19626805|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19626806|NCT02473809|Liraglutide|liraglutide|mesh-list
19626807|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19626808|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626809|NCT02473809|Incretins|incretins|mesh-ancestor
19626810|NCT02473809|Hormones|hormones|mesh-ancestor
19626811|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626812|NCT02473562|Varenicline|varenicline|mesh-list
19626813|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19626814|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19626815|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
19626816|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626817|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626818|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626819|NCT02473575|Caffeine|caffeine|mesh-list
19626820|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19626821|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626822|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19626823|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626824|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626825|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19626826|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19626827|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
19626828|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626829|NCT02473627|Pioglitazone|pioglitazone|mesh-list
19626830|NCT02473627|Tolbutamide|tolbutamide|mesh-list
19626831|NCT02473627|Midazolam|midazolam|mesh-list
20313091|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19626832|NCT02473627|Omeprazole|omeprazole|mesh-list
19626833|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19626834|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19626835|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626836|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626837|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19626838|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20608428|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20608429|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
20608430|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
19626839|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19626840|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19626841|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
19626842|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
19626843|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
19626844|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
19626845|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626846|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626847|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19626848|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19626849|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19626850|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19626851|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626852|NCT02473601|Mivacurium|mivacurium|mesh-list
19626853|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19626854|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19626855|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19626856|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626857|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626858|NCT02473328|Ritonavir|ritonavir|mesh-list
19626859|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19626860|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19626861|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19626862|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
19626863|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626864|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626865|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19626866|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19626867|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
19626868|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626869|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19626870|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19626871|NCT02473302|Tocopherols|tocopherols|mesh-list
19626872|NCT02473302|Vitamin E|vitamin e|mesh-list
19626873|NCT02473302|Tocotrienols|tocotrienols|mesh-list
19626874|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
19626875|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
19626876|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626877|NCT02473302|Protective Agents|protective agents|mesh-ancestor
19626878|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626879|NCT02473302|Vitamins|vitamins|mesh-ancestor
19626880|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
19626881|NCT02473406|Thymalfasin|thymalfasin|mesh-list
19626882|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19626883|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
19626884|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626885|NCT02473354|Remifentanil|remifentanil|mesh-list
19626886|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19626887|NCT02473354|Narcotics|narcotics|mesh-ancestor
19626888|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626889|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626890|NCT02473354|Analgesics|analgesics|mesh-ancestor
19626891|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
19626892|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626893|NCT02473263|Tazobactam|tazobactam|mesh-list
19626894|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
19626895|NCT02473263|Piperacillin|piperacillin|mesh-list
19626896|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19626897|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
19626898|NCT02473263|Norepinephrine|norepinephrine|mesh-list
19626899|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626900|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19626901|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19626902|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
19626903|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626904|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626905|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626906|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
19626907|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
19626908|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626909|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20137057|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20137058|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137059|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137060|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20137061|NCT00043914|Lamotrigine|lamotrigine|mesh-list
20137062|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
20137063|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20137064|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137065|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137066|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137067|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137068|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20137069|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20137070|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137071|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137072|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20137073|NCT00043927|Cisplatin|cisplatin|mesh-list
20137074|NCT00043927|Etoposide|etoposide|mesh-list
20137075|NCT00043927|Topotecan|topotecan|mesh-list
20137076|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137077|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20137078|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20137079|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137080|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137081|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137082|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20173608|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173609|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20173610|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20173611|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20173612|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20173613|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20313092|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19626910|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19626911|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19626912|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19626913|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626914|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
19626915|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19626916|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
19626917|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626918|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626919|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19626920|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
19626921|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
19626922|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20313093|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
20313094|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20313095|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20313096|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
20313097|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
20313098|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313099|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20313100|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20313101|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313102|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
20313103|NCT00687648|Hormones|hormones|mesh-ancestor
20313104|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626923|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
19626924|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626925|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626926|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
19626927|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
19626928|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660975|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
19660976|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19660977|NCT03113994|Calcium|calcium|mesh-list
19660978|NCT03113994|Vitamins|vitamins|mesh-ancestor
20313105|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19660979|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
20137083|NCT00043940|Bivalirudin|bivalirudin|mesh-list
20137084|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
20137085|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20137086|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
20137087|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137088|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137089|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
20137090|NCT00043953|Ritonavir|ritonavir|mesh-list
20137091|NCT00043953|Lopinavir|lopinavir|mesh-list
20137092|NCT00043953|Saquinavir|saquinavir|mesh-list
20137093|NCT00043953|Lamivudine|lamivudine|mesh-list
20137094|NCT00043953|Zidovudine|zidovudine|mesh-list
20137095|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20137096|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20137097|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19626929|NCT02473185|Methylphenidate|methylphenidate|mesh-list
19626930|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19626931|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626932|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19626933|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19626934|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137098|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
20137099|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137100|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137101|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20313106|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19626935|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626936|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
19626937|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19626938|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19626939|NCT02473198|Morphine|morphine|mesh-list
19626940|NCT02473198|Bupivacaine|bupivacaine|mesh-list
19626941|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
19626942|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
19626943|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626944|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626945|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
19626946|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19626947|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19626948|NCT02473198|Narcotics|narcotics|mesh-ancestor
19626949|NCT02473198|Analgesics|analgesics|mesh-ancestor
19626950|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19626951|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19626952|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19626953|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19626954|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19626955|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19626956|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137102|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137103|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
20137104|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137105|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20137106|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137107|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20137108|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19626957|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
19626958|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19626959|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626960|NCT02472873|Ethanol|ethanol|mesh-list
19626961|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19626962|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137109|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
20313107|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19626963|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19626964|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626965|NCT02473094|Metformin|metformin|mesh-list
19626966|NCT02473094|Capecitabine|capecitabine|mesh-list
19626967|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19626968|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626969|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19626970|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
19626971|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19626972|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626973|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19626974|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
19626975|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750194|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750195|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750196|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19750197|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19750198|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
19750199|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750200|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750201|NCT04214288|Fulvestrant|fulvestrant|mesh-list
19750202|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750203|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750204|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19750205|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19750206|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750207|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750208|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750209|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
19750210|NCT04199104|Lenvatinib|lenvatinib|mesh-list
19750211|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750212|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750213|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19750214|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137110|NCT00043966|Ritonavir|ritonavir|mesh-list
20137111|NCT00043966|Lopinavir|lopinavir|mesh-list
20137112|NCT00043966|Tenofovir|tenofovir|mesh-list
20137113|NCT00043966|Emtricitabine|emtricitabine|mesh-list
20137114|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20137115|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19750215|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750216|NCT04192019|Glucagon|glucagon|mesh-list
19750217|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19750218|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750219|NCT04192019|Hormones|hormones|mesh-ancestor
19750220|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750221|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750222|NCT04192019|Incretins|incretins|mesh-ancestor
19750223|NCT04188548|Trastuzumab|trastuzumab|mesh-list
19750224|NCT04188548|Pertuzumab|pertuzumab|mesh-list
19750225|NCT04188548|Everolimus|everolimus|mesh-list
19750226|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19750227|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750228|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750229|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750230|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
19750231|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750232|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19750233|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750234|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750235|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19750236|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750237|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750238|NCT04181827|Dexamethasone|dexamethasone|mesh-list
19750239|NCT04181827|Bortezomib|bortezomib|mesh-list
19750240|NCT04181827|Daratumumab|daratumumab|mesh-list
19750241|NCT04181827|Pomalidomide|pomalidomide|mesh-list
19750242|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20137116|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
20137117|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137118|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750243|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
19750244|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
20137119|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137120|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20313108|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20313109|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
20313110|NCT00687661|Diphosphonates|diphosphonates|mesh-list
20313111|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20313112|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313113|NCT00687700|Propranolol|propranolol|mesh-list
20313114|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19626976|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
19626977|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626978|NCT02472782|Teriparatide|teriparatide|mesh-list
19626979|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19626980|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626981|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19626982|NCT02472717|Liraglutide|liraglutide|mesh-list
19626983|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19626984|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626985|NCT02472717|Incretins|incretins|mesh-ancestor
19626986|NCT02472717|Hormones|hormones|mesh-ancestor
19626987|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19626988|NCT02472691|Lenalidomide|lenalidomide|mesh-list
19626989|NCT02472691|Azacitidine|azacitidine|mesh-list
19626990|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
19626991|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19626992|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19626993|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19626994|NCT02472691|Growth Substances|growth substances|mesh-ancestor
19626995|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
19626996|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19626997|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19626998|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
19626999|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627000|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627001|NCT02472613|Fluoxetine|fluoxetine|mesh-list
19627002|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19627003|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19627004|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19627005|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627006|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627007|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
19627008|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627009|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19627010|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
19627011|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19627012|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19627013|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19627014|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627015|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19627016|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19627017|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627018|NCT02472600|Colistin|colistin|mesh-list
19627019|NCT02472600|Polymyxins|polymyxins|mesh-list
19627020|NCT02472600|Neomycin|neomycin|mesh-list
19627021|NCT02472600|Omeprazole|omeprazole|mesh-list
19627022|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19627023|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627024|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19627025|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627026|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627027|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19627028|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627029|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19627030|NCT02472574|Plasminogen|plasminogen|mesh-list
19627031|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19627032|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19627033|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19627034|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627035|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
19627036|NCT02472626|Cytarabine|cytarabine|mesh-list
19627037|NCT02472626|Daunorubicin|daunorubicin|mesh-list
19627038|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19627039|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
19627040|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627041|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627042|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
19750245|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627043|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137121|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
20137122|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137123|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20137124|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137125|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20137126|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20137127|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20137128|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20137129|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20137130|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137131|NCT00044135|Clevudine|clevudine|mesh-list
20137132|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
20137133|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137134|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
20137135|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137136|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137137|NCT00044187|Sibutramine|sibutramine|mesh-list
20137138|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137139|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137140|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
20137141|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19627044|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627045|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
19627046|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627047|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19627048|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19627049|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19627050|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627051|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
19627052|NCT02472626|Protective Agents|protective agents|mesh-ancestor
20313115|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20313116|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
20313117|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313118|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313119|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313120|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20313121|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19627053|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
19627054|NCT02472626|Vitamins|vitamins|mesh-ancestor
19627055|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
19627056|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
19627057|NCT02472392|Melphalan|melphalan|mesh-list
19627058|NCT02472392|Busulfan|busulfan|mesh-list
19627059|NCT02472392|Fludarabine|fludarabine|mesh-list
19627060|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
19627061|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19627062|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627063|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
19627064|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137142|NCT00044265|Ramipril|ramipril|mesh-list
20137143|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20137144|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
19627065|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19627066|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19627067|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
19627068|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627069|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627070|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19627071|NCT02472054|Cyclosporine|cyclosporine|mesh-list
19627072|NCT02472054|Prednisolone|prednisolone|mesh-list
19627073|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19627074|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
19627075|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19627076|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
19627077|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
19627078|NCT02472054|Cyclosporins|cyclosporins|mesh-list
19627079|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19627080|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
19627081|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137145|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137146|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627082|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137147|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19627083|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627084|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
19627085|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627086|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
19627087|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627088|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
19627089|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19627090|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19627091|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19627092|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
19627093|NCT02472054|Hormones|hormones|mesh-ancestor
19627094|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627095|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19627096|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627097|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
19627098|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
19627099|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627100|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627101|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19627102|NCT02472054|Protective Agents|protective agents|mesh-ancestor
19627103|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19627104|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
19627105|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19627106|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627107|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
19627108|NCT02472080|Gemcitabine|gemcitabine|mesh-list
19627109|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
19627110|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19627111|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
19627112|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627113|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627114|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
19627115|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627116|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627117|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627118|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
19627119|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627120|NCT02472249|Norepinephrine|norepinephrine|mesh-list
19627121|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19627122|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19627123|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
19627124|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627125|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627126|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627127|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
19627128|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
19627129|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627130|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19627131|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
19627132|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19627133|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19627134|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627135|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
19627136|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627137|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627138|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
19627139|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
19627140|NCT02472275|Hormones|hormones|mesh-list
19627141|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19627142|NCT02472275|Androgens|androgens|mesh-list
19627143|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
19627144|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627145|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627146|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
19627147|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627148|NCT02472275|Protective Agents|protective agents|mesh-ancestor
19627149|NCT02472275|Vitamins|vitamins|mesh-ancestor
19627150|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
19627151|NCT02472275|Estrogens|estrogens|mesh-ancestor
19627152|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19627153|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627154|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
20137148|NCT00044278|Lamotrigine|lamotrigine|mesh-list
20137149|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
20137150|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20137151|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137152|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137153|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137154|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137155|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20137156|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20137157|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137158|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20313122|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
20347262|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20347263|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
20347264|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347265|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
20347266|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20347267|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347268|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
20347269|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347270|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
20347271|NCT00858767|Vitamin K|vitamin k|mesh-list
20137159|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20137160|NCT00044291|Toremifene|toremifene|mesh-list
20137161|NCT00044291|Letrozole|letrozole|mesh-list
20137162|NCT00044291|Hormones|hormones|mesh-list
20137163|NCT00044291|Atamestane|atamestane|mesh-list
20347272|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
20347273|NCT00858767|Caseins|caseins|mesh-list
20347274|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
19627155|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
19627156|NCT02472236|Digoxin|digoxin|mesh-list
19627157|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19627158|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19627159|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627160|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627161|NCT02472236|Protective Agents|protective agents|mesh-ancestor
19627162|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627163|NCT02471963|Empagliflozin|empagliflozin|mesh-list
19627164|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19627165|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627166|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627167|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627168|NCT02471833|Telmisartan|telmisartan|mesh-list
19627169|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19750246|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750247|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750248|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
19750249|NCT04181827|Hormones|hormones|mesh-ancestor
19750250|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750251|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750252|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750253|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
19750254|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19750255|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750256|NCT04181827|Growth Substances|growth substances|mesh-ancestor
20137164|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
20137165|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
20137166|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
20137167|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137168|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137169|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137170|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20137171|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20137172|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137173|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347275|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
20347276|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347277|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19627170|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19627171|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19627172|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627173|NCT02471820|Dexamethasone|dexamethasone|mesh-list
19627174|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
19627175|NCT02471820|Doxorubicin|doxorubicin|mesh-list
19627176|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19627177|NCT02471820|Lenalidomide|lenalidomide|mesh-list
19627178|NCT02471820|BB 1101|bb 1101|mesh-list
19627179|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19627180|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
19627181|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
19627182|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137174|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
20313123|NCT00687765|Temozolomide|temozolomide|mesh-list
20313124|NCT00687765|Iniparib|iniparib|mesh-list
20313125|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19627183|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627184|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627185|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
19627186|NCT02471820|Hormones|hormones|mesh-ancestor
19627187|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627188|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19627189|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627190|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
19627191|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627192|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627193|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19627194|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19627195|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19627196|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
19627197|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19627198|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19627199|NCT02471820|Growth Substances|growth substances|mesh-ancestor
19627200|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
19627201|NCT02471950|Isoflurane|isoflurane|mesh-list
19627202|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19627203|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
19627204|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
19627205|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627206|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627207|NCT02471690|Oritavancin|oritavancin|mesh-list
19627208|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19627209|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627210|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19627211|NCT02471677|Hormones|hormones|mesh-ancestor
19627212|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627213|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627214|NCT02471846|Atezolizumab|atezolizumab|mesh-list
19627215|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627216|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19627217|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
19627218|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627219|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
19627220|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627221|NCT02471547|Mitomycins|mitomycins|mesh-list
19750257|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832522|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832523|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
19832524|NCT03793439|Hormones|hormones|mesh-ancestor
19832525|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19832526|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832527|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19832528|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832529|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19832530|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832531|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832532|NCT03729401|Aspirin|aspirin|mesh-list
19832533|NCT03729401|Clopidogrel|clopidogrel|mesh-list
19832534|NCT03729401|Ticagrelor|ticagrelor|mesh-list
19832535|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19832536|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20313126|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
19627222|NCT02471547|Mitomycin|mitomycin|mesh-list
19627223|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19832537|NCT03729401|Analgesics|analgesics|mesh-ancestor
19627224|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627225|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
19627226|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627227|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19627228|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627229|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19627230|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19627231|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627232|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627233|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660980|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19660981|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19660982|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19660983|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19660984|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19660985|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
19660986|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19660987|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19660988|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19660989|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19660990|NCT03113994|Antacids|antacids|mesh-ancestor
19660991|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19660992|NCT02960568|Primaquine|primaquine|mesh-list
19660993|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
19660994|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19660995|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19660996|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19660997|NCT02958865|PF-06700841|pf-06700841|mesh-list
19660998|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19660999|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661000|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661001|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19661002|NCT02954510|Hematinics|hematinics|mesh-ancestor
20347278|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20137175|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20137176|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20137177|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20137178|NCT00044343|Lapatinib|lapatinib|mesh-list
19661003|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19661004|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19661005|NCT02953665|Liraglutide|liraglutide|mesh-list
19661006|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19661007|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661008|NCT02953665|Incretins|incretins|mesh-ancestor
19661009|NCT02953665|Hormones|hormones|mesh-ancestor
19661010|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661011|NCT02864004|Apomorphine|apomorphine|mesh-list
19661012|NCT02864004|Emetics|emetics|mesh-ancestor
19661013|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661014|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
19661015|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661016|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661017|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
19661018|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
19661019|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661020|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661021|NCT02834403|Aspirin|aspirin|mesh-list
19661022|NCT02834403|Docetaxel|docetaxel|mesh-list
19661023|NCT02834403|Amlodipine|amlodipine|mesh-list
19661024|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19661025|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661026|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
19661027|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
19661028|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
19661029|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661030|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19661031|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20137179|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137180|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137181|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137182|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137183|NCT00044382|Lenalidomide|lenalidomide|mesh-list
20137184|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
20137185|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137186|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20137187|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19627234|NCT02471430|Interferons|interferons|mesh-list
19627235|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
19627236|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
19627237|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19627238|NCT02471430|Panobinostat|panobinostat|mesh-list
19627239|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627240|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
19627241|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313127|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313128|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313129|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20313130|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313131|NCT00687817|Paclitaxel|paclitaxel|mesh-list
20313132|NCT00687817|Carboplatin|carboplatin|mesh-list
20313133|NCT00687817|Bavituximab|bavituximab|mesh-list
20313134|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20313135|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313136|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
20313137|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
20313138|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
20313139|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313140|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313141|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
20313142|NCT00687843|Tegafur|tegafur|mesh-list
19627242|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
19627243|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627244|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19627245|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627246|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627247|NCT02471209|Sevoflurane|sevoflurane|mesh-list
19627248|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
19627249|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627250|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627251|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19627252|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19627253|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
19627254|NCT02471105|Bimatoprost|bimatoprost|mesh-list
19627255|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20137188|NCT00044382|Growth Substances|growth substances|mesh-ancestor
20137189|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
20137190|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627256|NCT02470832|Itraconazole|itraconazole|mesh-list
19627257|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
19627258|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627259|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19627260|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19627261|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627262|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627263|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19627264|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
19627265|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627266|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627267|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19627268|NCT02470923|Nicotine|nicotine|mesh-list
19627269|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19627270|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
19627271|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627272|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627273|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19627274|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19627275|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
19627276|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627277|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137191|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
20137192|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137193|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137194|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
20137195|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173614|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20313143|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20137196|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137197|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
20137198|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313144|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
20313145|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313146|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313147|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20313148|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
20313149|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627278|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
19627279|NCT02470858|Asunaprevir|asunaprevir|mesh-list
19627280|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
19627281|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627282|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
19627283|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627284|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627285|NCT02470780|Rifaximin|rifaximin|mesh-list
19627286|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19627287|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627288|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627289|NCT02470767|Anticoagulants|anticoagulants|mesh-list
19627290|NCT02470611|Alendronate|alendronate|mesh-list
19627291|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19627292|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627293|NCT02470559|Aldesleukin|aldesleukin|mesh-list
19627294|NCT02470559|Interleukin-2|interleukin-2|mesh-list
19627295|NCT02470559|Sargramostim|sargramostim|mesh-list
19627296|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19627297|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627298|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19627299|NCT02470559|Analgesics|analgesics|mesh-ancestor
19627300|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
19627301|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627302|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313150|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20313151|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
20313152|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313153|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
20313154|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19627303|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
19627304|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20313155|NCT00687843|Protective Agents|protective agents|mesh-ancestor
20313156|NCT00687999|Interferons|interferons|mesh-list
20313157|NCT00687999|Ribavirin|ribavirin|mesh-list
20313158|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
20313159|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313160|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
19627305|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19627306|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
19627307|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627308|NCT02470637|Insulin|insulin|mesh-list
19627309|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19627310|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
19627311|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627312|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627313|NCT02470650|Ritonavir|ritonavir|mesh-list
19627314|NCT02470650|Darunavir|darunavir|mesh-list
19627315|NCT02470650|Tenofovir|tenofovir|mesh-list
20137199|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137200|NCT00044434|Bupropion|bupropion|mesh-list
20137201|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20137202|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137203|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137204|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20137205|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137206|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137207|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137208|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
20137209|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137210|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137211|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20137212|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137213|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313161|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627316|NCT02470650|Lamivudine|lamivudine|mesh-list
19627317|NCT02470650|Emtricitabine|emtricitabine|mesh-list
19627318|NCT02470650|Abacavir|abacavir|mesh-list
19627319|NCT02470650|Cobicistat|cobicistat|mesh-list
20137214|NCT00044447|Glimepiride|glimepiride|mesh-list
20608431|NCT02246049|Leucovorin|leucovorin|mesh-list
20608432|NCT02246049|Bevacizumab|bevacizumab|mesh-list
20608433|NCT02246049|Fluorouracil|fluorouracil|mesh-list
20137215|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20137216|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20137217|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137218|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20137219|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
20137220|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
20137221|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20137222|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137223|NCT00044473|Levofloxacin|levofloxacin|mesh-list
20137224|NCT00044473|Ofloxacin|ofloxacin|mesh-list
20137225|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20137226|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137227|NCT00044473|Renal Agents|renal agents|mesh-ancestor
20137228|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20137229|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20137230|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137231|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137232|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137233|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313162|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
20313163|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313164|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
20313165|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313166|NCT00688077|Calcitonin|calcitonin|mesh-list
20313167|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
20313168|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20313169|NCT00688077|Katacalcin|katacalcin|mesh-list
19627320|NCT02470650|Rilpivirine|rilpivirine|mesh-list
19627321|NCT02470650|Elvitegravir|elvitegravir|mesh-list
19627322|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19627323|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19627324|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
19627325|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627326|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627327|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19627328|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19627329|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
19627330|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627331|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19627332|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19627333|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19627334|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19627335|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19627336|NCT02470702|Oritavancin|oritavancin|mesh-list
19627337|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19627338|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627339|NCT02470676|Progesterone|progesterone|mesh-list
19627340|NCT02470676|Progestins|progestins|mesh-ancestor
19627341|NCT02470676|Hormones|hormones|mesh-ancestor
19627342|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627343|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627344|NCT02470442|Sevoflurane|sevoflurane|mesh-list
19627345|NCT02470442|Desflurane|desflurane|mesh-list
19627346|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19627347|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19627348|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
19627349|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
19627350|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627351|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627352|NCT02470455|Atorvastatin|atorvastatin|mesh-list
19627353|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19627354|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19627355|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
19627356|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627357|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19627358|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20137234|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20137235|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137236|NCT00044486|Posaconazole|posaconazole|mesh-list
20313170|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20608434|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
19627359|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627360|NCT02470546|Metformin|metformin|mesh-list
19627361|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627362|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627363|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
19627364|NCT02470663|Calcium|calcium|mesh-list
19627365|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19627366|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627367|NCT02470663|Antacids|antacids|mesh-ancestor
19627368|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627369|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627370|NCT02470299|Ketorolac|ketorolac|mesh-list
19627371|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20313171|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313172|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20313173|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
20313174|NCT00688194|Letrozole|letrozole|mesh-list
20313175|NCT00688194|Fulvestrant|fulvestrant|mesh-list
20313176|NCT00688194|Lapatinib|lapatinib|mesh-list
20313177|NCT00688194|Anastrozole|anastrozole|mesh-list
20313178|NCT00688194|Exemestane|exemestane|mesh-list
20313179|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313180|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20313181|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20313182|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313183|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313184|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19627372|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19627373|NCT02470299|Analgesics|analgesics|mesh-ancestor
19627374|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
19627375|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627376|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627377|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750258|NCT04166474|Dolutegravir|dolutegravir|mesh-list
19750259|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20137237|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
20313185|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
20313186|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20313187|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627378|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19627379|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19627380|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627381|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627382|NCT02470117|Antacids|antacids|mesh-list
19627383|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627384|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627385|NCT02470065|Afatinib|afatinib|mesh-list
19627386|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750260|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20137238|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137239|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20313188|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20313189|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20313190|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137240|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20137241|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20137242|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20137243|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137244|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313191|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
20313192|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313193|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313194|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
20137245|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137246|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20313195|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20313196|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313197|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20137247|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
20137248|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137249|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137250|NCT00044525|Taxane|taxane|mesh-list
20137251|NCT00044525|IDN 5109|idn 5109|mesh-list
20137252|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137253|NCT00044538|Taxane|taxane|mesh-list
20137254|NCT00044538|IDN 5109|idn 5109|mesh-list
20313198|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313199|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313200|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313201|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313202|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20347279|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
19627387|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19627388|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627389|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627390|NCT02470026|Yohimbine|yohimbine|mesh-list
19627391|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
19627392|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
19627393|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627394|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627395|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19627396|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19627397|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19627398|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
19627399|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627400|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627401|NCT02470026|Urological Agents|urological agents|mesh-ancestor
19627402|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
19627403|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19627404|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19627405|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20137255|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137256|NCT00044551|Taxane|taxane|mesh-list
20137257|NCT00044551|IDN 5109|idn 5109|mesh-list
20137258|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137259|NCT00044564|IDN 5109|idn 5109|mesh-list
20137260|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137261|NCT00044577|Tenofovir|tenofovir|mesh-list
20137262|NCT00044577|Lamivudine|lamivudine|mesh-list
20137263|NCT00044577|Abacavir|abacavir|mesh-list
20137264|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
20137265|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
20137266|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137267|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20137268|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20137269|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137270|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627406|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19627407|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627408|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
19627409|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627410|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627411|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19627412|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627413|NCT02469974|Busulfan|busulfan|mesh-list
19627414|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
19627415|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627416|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
19627417|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627418|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627419|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19627420|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627421|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19627422|NCT02469831|Rocuronium|rocuronium|mesh-list
19627423|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19627424|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19627425|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20137271|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137272|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137273|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
19627426|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627427|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627428|NCT02469740|Clopidogrel|clopidogrel|mesh-list
19627429|NCT02469740|Ticagrelor|ticagrelor|mesh-list
19627430|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19627431|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19627432|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19627433|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19627434|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
19627435|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627436|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627437|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661032|NCT02834403|Analgesics|analgesics|mesh-ancestor
19661033|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
19661034|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661035|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661036|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661037|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661038|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19661039|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19661040|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19661041|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19661042|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661043|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
19661044|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19661045|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19661046|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661047|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661048|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
19661049|NCT02770040|Infliximab|infliximab|mesh-list
19661050|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
19661051|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661052|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661053|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
19661054|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19661055|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19661056|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
19661057|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661058|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19661059|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661060|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661061|NCT02701088|Mitomycins|mitomycins|mesh-list
19661062|NCT02701088|Mitomycin|mitomycin|mesh-list
19661063|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19661064|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661065|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
19661066|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661067|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19661068|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661069|NCT02675465|Miglustat|miglustat|mesh-list
19661070|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137274|NCT00044616|Fluoxetine|fluoxetine|mesh-list
20137275|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19661071|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661072|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19661073|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19661074|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
19661075|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661076|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19661077|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19661078|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661079|NCT02663908|Leuprolide|leuprolide|mesh-list
19661080|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19661081|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
19661082|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19661083|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661084|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19661085|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137276|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137277|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137278|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137279|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137280|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
19750261|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627438|NCT02469545|Citalopram|citalopram|mesh-list
19627439|NCT02469545|Sertraline|sertraline|mesh-list
19627440|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19627441|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19627442|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19627443|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627444|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627445|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
19627446|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627447|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19627448|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
19627449|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19627450|NCT02469259|Oxytocin|oxytocin|mesh-list
19627451|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
19627452|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19627453|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627454|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
19627455|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19627456|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19627457|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627458|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
19627459|NCT02468999|Insulin|insulin|mesh-list
19627460|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19627461|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627462|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627463|NCT02469012|Ribavirin|ribavirin|mesh-list
19627464|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
19627465|NCT02469012|Ledipasvir|ledipasvir|mesh-list
19627466|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
19627467|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627468|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
19627469|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627470|NCT02468856|Modafinil|modafinil|mesh-list
19627471|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19627472|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627473|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19627474|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19627475|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19627476|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627477|NCT02468908|Molgramostim|molgramostim|mesh-list
19627478|NCT02468908|Sargramostim|sargramostim|mesh-list
19627479|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
19627480|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627481|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627482|NCT02468791|Rituximab|rituximab|mesh-list
19627483|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19627484|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627485|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
20137281|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137282|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20137283|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137284|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137285|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19627486|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627487|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19627488|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19627489|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627490|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19627491|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627492|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627493|NCT02468518|Vitamin E|vitamin e|mesh-list
19627494|NCT02468518|Vitamins|vitamins|mesh-ancestor
19627495|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
19627496|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750262|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137286|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137287|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137288|NCT00044629|Zolpidem|zolpidem|mesh-list
20137289|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19627497|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
20137290|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20137291|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137292|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627498|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627499|NCT02468518|Protective Agents|protective agents|mesh-ancestor
19627500|NCT02468531|Xenon|xenon|mesh-list
19627501|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20137293|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20137294|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
20137295|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
20137296|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137297|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137298|NCT00044642|Lorazepam|lorazepam|mesh-list
20137299|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
20137300|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
20137301|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
20137302|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137303|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137304|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20137305|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20137306|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137307|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20137308|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20137309|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137310|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
20137311|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
20137312|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627502|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
19627503|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
20137313|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137314|NCT00044668|Exenatide|exenatide|mesh-list
20137315|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20137316|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137317|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20313203|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20313204|NCT00688298|Imidacloprid|imidacloprid|mesh-list
20313205|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
20313206|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313207|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313208|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313209|NCT00688402|Lesogaberan|lesogaberan|mesh-list
20313210|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20313211|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20313212|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
20313213|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
20313214|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627504|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627505|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627506|NCT02468323|Ondansetron|ondansetron|mesh-list
19627507|NCT02468323|Palonosetron|palonosetron|mesh-list
19627508|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
19627509|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
19627510|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627511|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627512|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627513|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
19627514|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
19627515|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20313215|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313216|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313217|NCT00688428|Aspirin|aspirin|mesh-list
20313218|NCT00688428|Esomeprazole|esomeprazole|mesh-list
20313219|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20313220|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20313221|NCT00688428|Analgesics|analgesics|mesh-ancestor
20313222|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
20313223|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313224|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313225|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313226|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313227|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20313228|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20347280|NCT00858767|Coagulants|coagulants|mesh-ancestor
19627516|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
19627517|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137318|NCT00044668|Incretins|incretins|mesh-ancestor
20137319|NCT00044668|Hormones|hormones|mesh-ancestor
19627518|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313229|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313230|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20313231|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20313232|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627519|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19627520|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19627521|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627522|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19627523|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19627524|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19627525|NCT02468297|Ibuprofen|ibuprofen|mesh-list
19627526|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19627527|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19627528|NCT02468297|Analgesics|analgesics|mesh-ancestor
19627529|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
19627530|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627531|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627532|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19627533|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19627534|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19627535|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627536|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627537|NCT02468375|Mirabegron|mirabegron|mesh-list
19627538|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19627539|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19627540|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19627541|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
19627542|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627543|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627544|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627545|NCT02468375|Urological Agents|urological agents|mesh-ancestor
19627546|NCT02468232|Enalapril|enalapril|mesh-list
19627547|NCT02468232|Enalaprilat|enalaprilat|mesh-list
19627548|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19627549|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19627550|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
19627551|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627552|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627553|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19627554|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19627555|NCT02468206|Polidocanol|polidocanol|mesh-list
19627556|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19627557|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20313233|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
20313234|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20313235|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20313236|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20137320|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137321|NCT00044681|Risperidone|risperidone|mesh-list
20137322|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20313237|NCT00688480|Allopurinol|allopurinol|mesh-list
20313238|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
20313239|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313240|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313241|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
19627558|NCT02468128|Nalbuphine|nalbuphine|mesh-list
19627559|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20313242|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313243|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20313244|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
20313245|NCT00688480|Protective Agents|protective agents|mesh-ancestor
19750263|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19750264|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19750265|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
19750266|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137323|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
20137324|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137325|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137326|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137327|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20313246|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313247|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
19627560|NCT02468128|Narcotics|narcotics|mesh-ancestor
19627561|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627562|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627563|NCT02468128|Analgesics|analgesics|mesh-ancestor
19627564|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
19627565|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627566|NCT02468089|Sargramostim|sargramostim|mesh-list
19627567|NCT02468089|Immunologic Factors|immunologic factors|mesh-ancestor
19627568|NCT02468089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627569|NCT02468063|Terlipressin|terlipressin|mesh-list
19627570|NCT02468063|Norepinephrine|norepinephrine|mesh-list
19627571|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19627572|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19627573|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19627574|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19627575|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
19627576|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627577|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627578|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627579|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
19627580|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
19627581|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313248|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
19627582|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
19627583|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19627584|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
19627585|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19627586|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
19627587|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627588|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627589|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
19627590|NCT02468167|Polidocanol|polidocanol|mesh-list
19627591|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19627592|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19627593|NCT02467907|Paclitaxel|paclitaxel|mesh-list
19627594|NCT02467907|Bevacizumab|bevacizumab|mesh-list
19627595|NCT02467907|Carboplatin|carboplatin|mesh-list
19627596|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19627597|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627598|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
19627599|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
19627600|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
19627601|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627602|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19627603|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19627604|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19627605|NCT02467907|Growth Substances|growth substances|mesh-ancestor
19627606|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627607|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
19627608|NCT02467920|Exenatide|exenatide|mesh-list
19627609|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627610|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627611|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19627612|NCT02467920|Incretins|incretins|mesh-ancestor
19627613|NCT02467920|Hormones|hormones|mesh-ancestor
19627614|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627615|NCT02467647|Thalidomide|thalidomide|mesh-list
19627616|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627617|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
19627618|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627619|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
19627620|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19627621|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627622|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19627623|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19627624|NCT02467647|Growth Substances|growth substances|mesh-ancestor
19627625|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
19627626|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661086|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19661087|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19661088|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661089|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
19661090|NCT02624765|Digoxin|digoxin|mesh-list
19661091|NCT02624765|Sotalol|sotalol|mesh-list
20347281|NCT00858767|Vitamins|vitamins|mesh-ancestor
19627627|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
19627628|NCT02467426|Analgesics|analgesics|mesh-ancestor
20137328|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20137329|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137330|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137331|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20137332|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
20137333|NCT00044694|Exenatide|exenatide|mesh-list
20137334|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20137335|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137336|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20137337|NCT00044694|Incretins|incretins|mesh-ancestor
20137338|NCT00044694|Hormones|hormones|mesh-ancestor
20137339|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137340|NCT00044707|Pramlintide|pramlintide|mesh-list
20313249|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20313250|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20313251|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313252|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20313253|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19627629|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
19627630|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627631|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627632|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627633|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19627634|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19627635|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627636|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627637|NCT02467478|Linagliptin|linagliptin|mesh-list
19627638|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627639|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627640|NCT02467478|Incretins|incretins|mesh-ancestor
19627641|NCT02467478|Hormones|hormones|mesh-ancestor
19627642|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627643|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19627644|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
19627645|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627646|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627647|NCT02467556|Morphine|morphine|mesh-list
19627648|NCT02467556|Memantine|memantine|mesh-list
19627649|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19627650|NCT02467556|Narcotics|narcotics|mesh-ancestor
19627651|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627652|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313254|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313255|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313256|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313257|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20313258|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
20313259|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20313260|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313261|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19627653|NCT02467556|Analgesics|analgesics|mesh-ancestor
19627654|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
19627655|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627656|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19627657|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19627658|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
19627659|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627660|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627661|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19627662|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19627663|NCT02467595|Fentanyl|fentanyl|mesh-list
19627664|NCT02467595|Bromides|bromides|mesh-list
19627665|NCT02467595|Propofol|propofol|mesh-list
19627666|NCT02467595|Sevoflurane|sevoflurane|mesh-list
19627667|NCT02467595|Rocuronium|rocuronium|mesh-list
19627668|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19627669|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627670|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137341|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19627671|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19627672|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
19627673|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
20137342|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627674|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20137343|NCT00044720|Sirolimus|sirolimus|mesh-list
20137344|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20137345|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137346|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20137347|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137348|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
19627675|NCT02467595|Narcotics|narcotics|mesh-ancestor
19627676|NCT02467595|Analgesics|analgesics|mesh-ancestor
19627677|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
19627678|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627679|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20137349|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20137350|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
20137351|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137352|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
20137353|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20137354|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137355|NCT00044746|Tazobactam|tazobactam|mesh-list
20137356|NCT00044746|Piperacillin|piperacillin|mesh-list
20313262|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20313263|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20313264|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19627680|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19627681|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19627682|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
19627683|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19627684|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19627685|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19627686|NCT02467543|Ethanol|ethanol|mesh-list
19627687|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19627688|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627689|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627690|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627691|NCT02467686|Tamoxifen|tamoxifen|mesh-list
19627692|NCT02467686|Exemestane|exemestane|mesh-list
19627693|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19627694|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19627695|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
19627696|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627697|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627698|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19627699|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627700|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19627701|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19627702|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19627703|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19627704|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627705|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627706|NCT02467335|Fostemsavir|fostemsavir|mesh-list
19627707|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19627708|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19627709|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
19627710|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627711|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19627712|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19627713|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627714|NCT02467400|Propranolol|propranolol|mesh-list
19627715|NCT02467400|Atenolol|atenolol|mesh-list
19627716|NCT02467400|Nebivolol|nebivolol|mesh-list
20313265|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313266|NCT00688558|Simvastatin|simvastatin|mesh-list
20313267|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
20313268|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20313269|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19627717|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19627718|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19627719|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
20137357|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20137358|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20313270|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
20347282|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
20137359|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627720|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627721|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627722|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627723|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19627724|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19627725|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
19627726|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
19627727|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
19627728|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627729|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19627730|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19627731|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19627732|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19627733|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
19627734|NCT02467517|Ketamine|ketamine|mesh-list
19627735|NCT02467517|Analgesics|analgesics|mesh-ancestor
19627736|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
19627737|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627738|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627739|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19627740|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19627741|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
19627742|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
19627743|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627744|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19627745|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19627746|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627747|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627748|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19627749|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
19627750|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19627751|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19627752|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19627753|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
19627754|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19627755|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19627756|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19627757|NCT02467673|Estradiol|estradiol|mesh-list
19627758|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19627759|NCT02467673|Progesterone|progesterone|mesh-list
19627760|NCT02467673|Estrogens|estrogens|mesh-ancestor
19627761|NCT02467673|Hormones|hormones|mesh-ancestor
19627762|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627763|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137360|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19627764|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19627765|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
19627766|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19627767|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19627768|NCT02467673|Progestins|progestins|mesh-ancestor
19627769|NCT02467608|Isoniazid|isoniazid|mesh-list
19627770|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
19627771|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19627772|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627773|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20137361|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137362|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137363|NCT00044759|Tazobactam|tazobactam|mesh-list
20137364|NCT00044759|Piperacillin|piperacillin|mesh-list
20137365|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20137366|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20137367|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137368|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20137369|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137370|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137371|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20137372|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20137373|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137374|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137375|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137376|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627774|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19627775|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
19627776|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627777|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19627778|NCT02467023|Lidocaine|lidocaine|mesh-list
19627779|NCT02467023|Fentanyl|fentanyl|mesh-list
19627780|NCT02467023|Midazolam|midazolam|mesh-list
19627781|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
19627782|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
19627783|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19627784|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627785|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
19627786|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627787|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19627788|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19627789|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19627790|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19627791|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627792|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19627793|NCT02467023|Narcotics|narcotics|mesh-ancestor
19627794|NCT02467023|Analgesics|analgesics|mesh-ancestor
19627795|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19627796|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19627797|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
19627798|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19627799|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19627800|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19627801|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19627802|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
19627803|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
19627804|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627805|NCT02467127|Vitamin D|vitamin d|mesh-list
19627806|NCT02467127|Vitamins|vitamins|mesh-ancestor
19627807|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
19627808|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627809|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19627810|NCT02466984|Metoclopramide|metoclopramide|mesh-list
19627811|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
19627812|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
19627813|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627814|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627815|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627816|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19627817|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19627818|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
19627819|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627820|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627821|NCT02466997|Tacrolimus|tacrolimus|mesh-list
19627822|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627823|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
19627824|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627825|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19627826|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627827|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627828|NCT02467010|Dexamethasone|dexamethasone|mesh-list
19627829|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
20137377|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137378|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20137379|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137380|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19627830|NCT02467010|Bortezomib|bortezomib|mesh-list
19627831|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627832|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
19627833|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627834|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19627835|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19627836|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
19627837|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627838|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627839|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19627840|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19627841|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
19627842|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
20137381|NCT00044785|Leucovorin|leucovorin|mesh-list
19627843|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627844|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627845|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
20137382|NCT00044785|Fluorouracil|fluorouracil|mesh-list
20137383|NCT00044785|Irinotecan|irinotecan|mesh-list
19627846|NCT02467010|Hormones|hormones|mesh-ancestor
19627847|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627848|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19627849|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19627850|NCT02466828|Hematinics|hematinics|mesh-ancestor
20137384|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
20137385|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137386|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20137387|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137388|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627851|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19627852|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19627853|NCT02466919|Amoxicillin|amoxicillin|mesh-list
19627854|NCT02466919|Metronidazole|metronidazole|mesh-list
19627855|NCT02466919|Clarithromycin|clarithromycin|mesh-list
19627856|NCT02466919|Levofloxacin|levofloxacin|mesh-list
19627857|NCT02466919|Ofloxacin|ofloxacin|mesh-list
19627858|NCT02466919|Pantoprazole|pantoprazole|mesh-list
19627859|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19627860|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627861|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19627862|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19627863|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19627864|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627865|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627866|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19627867|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19627868|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19627869|NCT02466919|Renal Agents|renal agents|mesh-ancestor
19627870|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19627871|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19627872|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627873|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19627874|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19627875|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627876|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19627877|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
19627878|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627879|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
19627880|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19627881|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19627882|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627883|NCT02466802|Urological Agents|urological agents|mesh-ancestor
19627884|NCT02466503|Fluticasone|fluticasone|mesh-list
19627885|NCT02466503|Xhance|xhance|mesh-list
19627886|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19627887|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19627888|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19627889|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
19627890|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627891|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627892|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19627893|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
19627894|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
19627895|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19627896|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19627897|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19627898|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19627899|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19627900|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627901|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137389|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
20137390|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137391|NCT00044785|Antidotes|antidotes|mesh-ancestor
20137392|NCT00044785|Protective Agents|protective agents|mesh-ancestor
20137393|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
20137394|NCT00044785|Vitamins|vitamins|mesh-ancestor
20137395|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
20137396|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20137397|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19627902|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
19627903|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
20137398|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137399|NCT00044798|Citalopram|citalopram|mesh-list
19627904|NCT02466581|Prednisolone|prednisolone|mesh-list
19627905|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19627906|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
19627907|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19627908|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
19627909|NCT02466581|Abatacept|abatacept|mesh-list
19627910|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
19627911|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19627912|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
19627913|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19627914|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
19627915|NCT02466581|Hormones|hormones|mesh-ancestor
19627916|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19627917|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627918|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19627919|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627920|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
19627921|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
19627922|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627923|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627924|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20313271|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313272|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19627925|NCT02466581|Protective Agents|protective agents|mesh-ancestor
19627926|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
19627927|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19627928|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19627929|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627930|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19627931|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627932|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19627933|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19627934|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19627935|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
19627936|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19627937|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19627938|NCT02466581|Analgesics|analgesics|mesh-ancestor
19627939|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
19627940|NCT02466568|Nivolumab|nivolumab|mesh-list
19627941|NCT02466568|Vaccines|vaccines|mesh-list
19627942|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
19627943|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627944|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19627945|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19627946|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19627947|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627948|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19627949|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19627950|NCT02466490|Diuretics|diuretics|mesh-ancestor
19627951|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
19627952|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627953|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19627954|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19627955|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627956|NCT02466542|Esmolol|esmolol|mesh-list
19627957|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19627958|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19627959|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19627960|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
19627961|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19627962|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627963|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627964|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20137400|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20137401|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137402|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137403|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137404|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137405|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
20137406|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137407|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20137408|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137409|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137410|NCT00044811|Fexofenadine|fexofenadine|mesh-list
20137411|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20137412|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20137413|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20137414|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
20137415|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
20137416|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137417|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627965|NCT02466698|Metronidazole|metronidazole|mesh-list
19627966|NCT02466698|Vancomycin|vancomycin|mesh-list
19627967|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19627968|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19627969|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19627970|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
19627971|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19627972|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19627973|NCT02466698|Laxatives|laxatives|mesh-ancestor
19627974|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19627975|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
19750267|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19750268|NCT04163458|Menotropins|menotropins|mesh-list
19750269|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19750270|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
19750271|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19750272|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750273|NCT04150887|Azacitidine|azacitidine|mesh-list
19750274|NCT04150887|Venetoclax|venetoclax|mesh-list
19750275|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19750276|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
19750277|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750278|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750279|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750280|NCT04150042|Vitamins|vitamins|mesh-list
19750281|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
19750282|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
19750283|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
19750284|NCT04150042|Ethanol|ethanol|mesh-list
19750285|NCT04150042|Melphalan|melphalan|mesh-list
19750286|NCT04150042|Carmustine|carmustine|mesh-list
19750287|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
19750288|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750289|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19750290|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
19750291|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750292|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750293|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19750294|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750295|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
19750296|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
19750297|NCT04150042|Protective Agents|protective agents|mesh-ancestor
19750298|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
19750299|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19750300|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750301|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19750302|NCT04150042|Hematinics|hematinics|mesh-ancestor
19750303|NCT04149574|Nivolumab|nivolumab|mesh-list
19750304|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
19750305|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750306|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313273|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20137418|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137419|NCT00044824|Fexofenadine|fexofenadine|mesh-list
20137420|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20137421|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20137422|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20137423|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
20137424|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
20137425|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137426|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137427|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750307|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19750308|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19627976|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
19627977|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
19750309|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19750310|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
19627978|NCT02466464|Coagulants|coagulants|mesh-ancestor
19627979|NCT02466334|Calcitonin|calcitonin|mesh-list
19627980|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
19627981|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19627982|NCT02466334|Katacalcin|katacalcin|mesh-list
19627983|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19627984|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627985|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19627986|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
19627987|NCT02466373|Clonidine|clonidine|mesh-list
19627988|NCT02466373|Analgesics|analgesics|mesh-ancestor
19627989|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
19627990|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19627991|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19627992|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19627993|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
19627994|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
19627995|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19627996|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19627997|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19627998|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
19627999|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628000|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628001|NCT02466347|Fluticasone|fluticasone|mesh-list
19628002|NCT02466347|Xhance|xhance|mesh-list
19628003|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19628004|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313274|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313275|NCT00688805|Propranolol|propranolol|mesh-list
20313276|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20313277|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20313278|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
20313279|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628005|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19628006|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
19628007|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628008|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628009|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19628010|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
19628011|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628012|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19628013|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19628014|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19628015|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19628016|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
19628017|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628018|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628019|NCT02466438|Tazobactam|tazobactam|mesh-list
19628020|NCT02466438|Piperacillin|piperacillin|mesh-list
19628021|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19628022|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20137428|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20137429|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
20137430|NCT00044837|Estradiol|estradiol|mesh-list
20137431|NCT00044837|Estrogens|estrogens|mesh-ancestor
20137432|NCT00044837|Hormones|hormones|mesh-ancestor
20137433|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137434|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137435|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19628023|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628024|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19628025|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628026|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628027|NCT02466191|Gabapentin|gabapentin|mesh-list
19628028|NCT02466191|Memantine|memantine|mesh-list
19628029|NCT02466191|Analgesics|analgesics|mesh-ancestor
19628030|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
19628031|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628032|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628033|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
20137436|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
20137437|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20137438|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20313280|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628034|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19628035|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19628036|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628037|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628038|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19628039|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19628040|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628041|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137439|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20137440|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20137441|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20137442|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20137443|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20137444|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137445|NCT00044863|Cetuximab|cetuximab|mesh-list
20137446|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19628042|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
19628043|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19628044|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19628045|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
19628046|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19628047|NCT02466204|Hormones|hormones|mesh-ancestor
19628048|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137447|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137448|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
20137449|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20137450|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
20137451|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20137452|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628049|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628050|NCT02466022|Fentanyl|fentanyl|mesh-list
19628051|NCT02466022|Midazolam|midazolam|mesh-list
19628052|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
19628053|NCT02466022|Bupivacaine|bupivacaine|mesh-list
19628054|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628055|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
19628056|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628057|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628058|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
19628059|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628060|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19628061|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19628062|NCT02466022|Analgesics|analgesics|mesh-ancestor
19628063|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19628064|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19628065|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19628066|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
19628067|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628068|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628069|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628070|NCT02466022|Narcotics|narcotics|mesh-ancestor
19628071|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19628072|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19628073|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
19628074|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19628075|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19628076|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628077|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
19628078|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
19628079|NCT02466035|Caseins|caseins|mesh-list
19628080|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
19628081|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
19628082|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137453|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20137454|NCT00044889|Clofarabine|clofarabine|mesh-list
20137455|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20137456|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
20137457|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137458|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137459|NCT00044902|Epratuzumab|epratuzumab|mesh-list
20137460|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661092|NCT02624765|Flecainide|flecainide|mesh-list
19661093|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19661094|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20137461|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661095|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661096|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137462|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
20137463|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20137464|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20137465|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
20137466|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137467|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137468|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137469|NCT00044928|Tazobactam|tazobactam|mesh-list
20137470|NCT00044928|Piperacillin|piperacillin|mesh-list
20137471|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20137472|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20137473|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137474|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19628091|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
19628092|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19628093|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
19628094|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19628095|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628096|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19628097|NCT02465827|Ropivacaine|ropivacaine|mesh-list
19628098|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628099|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
19628100|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628101|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628102|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
19628103|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628104|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
19628105|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628106|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
19628107|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628108|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628109|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19628110|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
19628111|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628112|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628113|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19628114|NCT02465749|Vitamins|vitamins|mesh-list
19628115|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
19628116|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628117|NCT02465736|Cisplatin|cisplatin|mesh-list
19628118|NCT02465736|Docetaxel|docetaxel|mesh-list
19628119|NCT02465736|Vinorelbine|vinorelbine|mesh-list
19628120|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628121|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
19628122|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
19628123|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
19628124|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628125|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19628126|NCT02465801|Lenograstim|lenograstim|mesh-list
19628127|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19628128|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
19628129|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628130|NCT02465645|Carvedilol|carvedilol|mesh-list
19628131|NCT02465645|Simvastatin|simvastatin|mesh-list
19628132|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19628133|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19628134|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
19628135|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628136|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19628137|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19628138|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628139|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19628140|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19628141|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
20137475|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137476|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137477|NCT00044954|Cyclosporine|cyclosporine|mesh-list
20137478|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
20137479|NCT00044954|Fludarabine|fludarabine|mesh-list
20137480|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
20137481|NCT00044954|Cyclosporins|cyclosporins|mesh-list
20137482|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628142|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628143|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137483|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19628144|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19628145|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
20137484|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
20137485|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137486|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20137487|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
20137488|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137489|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137490|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
20137491|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137492|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
20137493|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628146|NCT02465645|Protective Agents|protective agents|mesh-ancestor
19628147|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19628148|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137494|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20137495|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20137496|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20137497|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
20137498|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19628149|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19628150|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
19628151|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19628152|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19628153|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
19628154|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19628155|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
19628156|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628157|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
19628158|NCT02465853|Protective Agents|protective agents|mesh-ancestor
19628159|NCT02465385|Linaclotide|linaclotide|mesh-list
19628160|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19628161|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
19628162|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628163|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628164|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
19628165|NCT02465359|Antibodies|antibodies|mesh-list
19628166|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
20137499|NCT00044993|Docetaxel|docetaxel|mesh-list
20137500|NCT00044993|Doxorubicin|doxorubicin|mesh-list
20137501|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19628167|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19628168|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19628169|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
19628170|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628171|NCT02465320|Lidocaine|lidocaine|mesh-list
20313281|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313282|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20313283|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20313284|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
19628172|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628173|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
19628174|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628175|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628176|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
19628177|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137502|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137503|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
20137504|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
20137505|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
20137506|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137507|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19628178|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19628179|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19628180|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19628181|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628182|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628183|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
20137508|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20137509|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137510|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137511|NCT00045006|Vorinostat|vorinostat|mesh-list
20137512|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137513|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20137514|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628184|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628185|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
19628186|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628187|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
19628188|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628189|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628190|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
19628191|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628192|NCT02465164|Oxytocin|oxytocin|mesh-list
19628193|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
19628194|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19628195|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628196|NCT02465255|Acetaminophen|acetaminophen|mesh-list
19628197|NCT02465255|Ketorolac|ketorolac|mesh-list
19628198|NCT02465255|Tramadol|tramadol|mesh-list
19628199|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19628200|NCT02465255|Analgesics|analgesics|mesh-ancestor
19628201|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
19628202|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628203|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628204|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
19628205|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19628206|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628207|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628208|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19628209|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628210|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628211|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628212|NCT02465255|Narcotics|narcotics|mesh-ancestor
19628213|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628214|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19628215|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19628216|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19628217|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628218|NCT02464722|Epinephrine|epinephrine|mesh-list
19628219|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
19628220|NCT02464722|Remifentanil|remifentanil|mesh-list
19628221|NCT02464722|Propofol|propofol|mesh-list
19628222|NCT02464722|Rocuronium|rocuronium|mesh-list
19628223|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19628224|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628225|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628226|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19628227|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
19628228|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
19628229|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19628230|NCT02464722|Analgesics|analgesics|mesh-ancestor
19628231|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
19628232|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628233|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19628234|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19628235|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19628236|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
19628237|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628238|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628239|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628240|NCT02464722|Narcotics|narcotics|mesh-ancestor
19628241|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19628242|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19628243|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
19628244|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19628245|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
19628246|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
19628247|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
19628248|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19628249|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19628250|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19628251|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19628252|NCT02464761|Verteporfin|verteporfin|mesh-list
19628253|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19628254|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628255|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
19628256|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19628257|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19628258|NCT02464696|Prednisolone|prednisolone|mesh-list
19628259|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
19628260|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19628261|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
20313285|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20313286|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
20313287|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20313288|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20313289|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20313290|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313291|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313292|NCT00688857|Diazoxide|diazoxide|mesh-list
20313293|NCT00688857|Choline|choline|mesh-list
20313294|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
20313295|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20313296|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
20313297|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313298|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628262|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628263|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
19628264|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
19628265|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628266|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628267|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628268|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
19628269|NCT02464696|Hormones|hormones|mesh-ancestor
19628270|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628271|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19628272|NCT02464696|Protective Agents|protective agents|mesh-ancestor
19628273|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19628274|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628275|NCT02464865|Thiamine|thiamine|mesh-list
19628276|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
19628277|NCT02464865|Vitamins|vitamins|mesh-ancestor
19628278|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
19628279|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628280|NCT02464813|Pregabalin|pregabalin|mesh-list
19628281|NCT02464813|Oxycodone|oxycodone|mesh-list
19628282|NCT02464813|Analgesics|analgesics|mesh-ancestor
19628283|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
19628284|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628285|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628286|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
19628287|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19628288|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628289|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628290|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19628291|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19628292|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19628293|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628294|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628295|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628296|NCT02464813|Narcotics|narcotics|mesh-ancestor
19628297|NCT02464631|Ribavirin|ribavirin|mesh-list
19628298|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
19628299|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
19628300|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628301|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
19628302|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628303|NCT02464683|Vitamin D|vitamin d|mesh-list
19628304|NCT02464683|Vitamins|vitamins|mesh-ancestor
19628305|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
19628306|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628307|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19628308|NCT02464501|Paclitaxel|paclitaxel|mesh-list
19628309|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19628310|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750311|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750312|NCT04141501|Psilocybin|psilocybin|mesh-list
19750313|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
19750314|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750315|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628311|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
19628312|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
19628313|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
19628314|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750316|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20313299|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19628315|NCT02464228|Tipifarnib|tipifarnib|mesh-list
19628316|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628317|NCT02464462|Vitamin D|vitamin d|mesh-list
19628318|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
19628319|NCT02464462|Calcium|calcium|mesh-list
19628320|NCT02464462|Vitamins|vitamins|mesh-ancestor
19628321|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
19628322|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628323|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19628324|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19628325|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
19628326|NCT02464410|Narcotics|narcotics|mesh-ancestor
19628327|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628328|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628329|NCT02464410|Analgesics|analgesics|mesh-ancestor
19628330|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
19628331|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628332|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
19628333|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19628334|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661097|NCT02624765|Protective Agents|protective agents|mesh-ancestor
19661098|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661099|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19661100|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20137515|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137516|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20137517|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20137518|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137519|NCT00045136|Melphalan|melphalan|mesh-list
20137520|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19661101|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
19661102|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661103|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
19661104|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
19661105|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661106|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19661107|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19661108|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661109|NCT02554383|Amoxicillin|amoxicillin|mesh-list
19661110|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
19661111|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
19661112|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19661113|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19661114|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661115|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19661116|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661117|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661118|NCT05090449|Losartan|losartan|mesh-list
19661119|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
19661120|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19661121|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19661122|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19661123|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19661124|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661125|NCT05090449|Diuretics|diuretics|mesh-ancestor
20313300|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
19661126|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
19661127|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661128|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19661129|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137521|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
20137522|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665699|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665700|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20137523|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137524|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20137525|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20137526|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
20173615|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
20313301|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20313302|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
19665701|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
19665702|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665703|NCT04351295|Chloroquine|chloroquine|mesh-list
19628335|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
19628336|NCT02463929|Promethazine|promethazine|mesh-list
19628337|NCT02463929|Ketamine|ketamine|mesh-list
19628338|NCT02463929|Bupivacaine|bupivacaine|mesh-list
20137527|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137528|NCT00045149|Aldesleukin|aldesleukin|mesh-list
20137529|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137530|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137531|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137532|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
19628339|NCT02463929|Sevoflurane|sevoflurane|mesh-list
19628340|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628341|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
19628342|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628343|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628344|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
19628345|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628346|NCT02463929|Analgesics|analgesics|mesh-ancestor
19628347|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19628348|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19628349|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
19628350|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19628351|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19628352|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628353|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628354|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19628355|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19628356|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19628357|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19628358|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
19628359|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
19628360|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628361|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19628362|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
19628363|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
19628364|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19628365|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
19628366|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628367|NCT02463825|Pimozide|pimozide|mesh-list
19628368|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19628369|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19628370|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628371|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628372|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628373|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19628374|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
19628375|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628376|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628377|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19628378|NCT02463994|Atezolizumab|atezolizumab|mesh-list
19628379|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628380|NCT02464020|Vancomycin|vancomycin|mesh-list
19628381|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19628382|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628383|NCT02463747|Vancomycin|vancomycin|mesh-list
20137533|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137534|NCT00045175|Topotecan|topotecan|mesh-list
20137535|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20137536|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20137537|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137538|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137539|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137540|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137541|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137542|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
20137543|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137544|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137545|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137546|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137547|NCT00045227|Docetaxel|docetaxel|mesh-list
20137548|NCT00045227|Vaccines|vaccines|mesh-list
20137549|NCT00045227|Sargramostim|sargramostim|mesh-list
20313303|NCT00688883|Fludarabine|fludarabine|mesh-list
19628384|NCT02463747|Meropenem|meropenem|mesh-list
19628385|NCT02463747|Tazobactam|tazobactam|mesh-list
19628386|NCT02463747|Piperacillin|piperacillin|mesh-list
20137550|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
20137551|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137552|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137553|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
20137554|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
20137555|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
20137556|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137557|NCT00045266|Aflibercept|aflibercept|mesh-list
20137558|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19628387|NCT02463747|Ceftazidime|ceftazidime|mesh-list
19628388|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19628389|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19628390|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628391|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20137559|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20137560|NCT00045266|Growth Substances|growth substances|mesh-ancestor
20137561|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137562|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
20137563|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137564|NCT00045279|Interferons|interferons|mesh-list
20137565|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
20137566|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
20137567|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20137568|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137569|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
19628392|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628393|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628394|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
19628395|NCT02464124|Lactulose|lactulose|mesh-list
19628396|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628397|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19628398|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628399|NCT02463591|Thrombin|thrombin|mesh-list
19628400|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
19628401|NCT02463591|Coagulants|coagulants|mesh-ancestor
19628402|NCT02463552|Naproxen|naproxen|mesh-list
19628403|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19628404|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19628405|NCT02463552|Analgesics|analgesics|mesh-ancestor
19628406|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
19628407|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628408|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628409|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628410|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628411|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
19628412|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19628413|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628414|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628415|NCT02463643|Rabeprazole|rabeprazole|mesh-list
19628416|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19628417|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628418|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19628419|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628420|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628421|NCT02463682|Insulin|insulin|mesh-list
19628422|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19628423|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628424|NCT02463942|Doxycycline|doxycycline|mesh-list
19628425|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19628426|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628427|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
19628428|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19628429|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19628430|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19628431|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19628432|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19628433|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19628434|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
19628435|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628436|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
19628437|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20137570|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137571|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
19628438|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20137572|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137573|NCT00045292|Valacyclovir|valacyclovir|mesh-list
19628439|NCT02463383|Ibuprofen|ibuprofen|mesh-list
19661130|NCT05090176|Povidone|povidone|mesh-list
20137574|NCT00045292|Acyclovir|acyclovir|mesh-list
19628440|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19628441|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19628442|NCT02463383|Analgesics|analgesics|mesh-ancestor
19628443|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
19628444|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628445|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628446|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628447|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628448|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19628449|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628450|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628451|NCT02463513|Vitamins|vitamins|mesh-list
19628452|NCT02463513|Riboflavin|riboflavin|mesh-list
19628453|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
19628454|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
19628455|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628456|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19628457|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628458|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19628459|NCT02463318|Melatonin|melatonin|mesh-list
19628460|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
19628461|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628462|NCT02463318|Protective Agents|protective agents|mesh-ancestor
19628463|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628464|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628465|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19628466|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628467|NCT02463110|Sertraline|sertraline|mesh-list
19628468|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
19628469|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628470|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19628471|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19628472|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628473|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628474|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628475|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
19628476|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628477|NCT02462772|Cabotegravir|cabotegravir|mesh-list
19628478|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19628479|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19628480|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19628481|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19628482|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19628483|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19628484|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628485|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628486|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19628487|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19628488|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
19628489|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628490|NCT02462889|Aflibercept|aflibercept|mesh-list
19628491|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19628492|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19628493|NCT02462889|Growth Substances|growth substances|mesh-ancestor
19628494|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628495|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19628496|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628497|NCT02463019|Tenofovir|tenofovir|mesh-list
19628498|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
19628499|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628500|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19628501|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19628502|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628503|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628504|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19628505|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19628506|NCT02463006|Methamphetamine|methamphetamine|mesh-list
19628507|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19628508|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628509|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
19628510|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
19628511|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628512|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
19628513|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628514|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628515|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
19628516|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19628517|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19628518|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628519|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19628520|NCT02462941|Adenosine|adenosine|mesh-list
19628521|NCT02462941|Analgesics|analgesics|mesh-ancestor
19628522|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
19628523|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628524|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628525|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19628526|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
19628527|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19628528|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
19628529|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
19628530|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628531|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628532|NCT02462915|Lidocaine|lidocaine|mesh-list
19628533|NCT02462915|Fentanyl|fentanyl|mesh-list
19628534|NCT02462915|Propofol|propofol|mesh-list
19628535|NCT02462915|Cisatracurium|cisatracurium|mesh-list
19628536|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628537|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
19628538|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628539|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750317|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
19750318|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750319|NCT04133636|Dexamethasone|dexamethasone|mesh-list
19750320|NCT04133636|Lenalidomide|lenalidomide|mesh-list
20137575|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
20137576|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750321|NCT04133636|Bortezomib|bortezomib|mesh-list
19750322|NCT04133636|Daratumumab|daratumumab|mesh-list
19750323|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750324|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
19750325|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
19750326|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750327|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750328|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750329|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
19750330|NCT04133636|Hormones|hormones|mesh-ancestor
19750331|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750332|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750333|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750334|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
19750335|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19750336|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750337|NCT04133636|Growth Substances|growth substances|mesh-ancestor
19750338|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
19750346|NCT04121260|Daratumumab|daratumumab|mesh-list
19750347|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750348|NCT04116541|Trametinib|trametinib|mesh-list
19750349|NCT04116541|Dabrafenib|dabrafenib|mesh-list
19750350|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750351|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19750352|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750353|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750354|NCT04108208|Androgens|androgens|mesh-list
19750355|NCT04108208|Hormones|hormones|mesh-ancestor
19750356|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750357|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750358|NCT04077463|Carboplatin|carboplatin|mesh-list
20137577|NCT00045318|Exatecan|exatecan|mesh-list
19628540|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
19628541|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750359|NCT04077463|Pemetrexed|pemetrexed|mesh-list
19750360|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19750361|NCT04077463|Lazertinib|lazertinib|mesh-list
19750362|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628542|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19628543|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19628544|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19628545|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628546|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628547|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19628548|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19628549|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
19628550|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628551|NCT02462915|Narcotics|narcotics|mesh-ancestor
19628552|NCT02462915|Analgesics|analgesics|mesh-ancestor
19628553|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19628554|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19628555|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19628556|NCT02462837|Mirabegron|mirabegron|mesh-list
19628557|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19628558|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19628559|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19628560|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
19628561|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628562|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628563|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628564|NCT02462837|Urological Agents|urological agents|mesh-ancestor
20137578|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20137579|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137580|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137581|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137582|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137583|NCT00045370|Interferons|interferons|mesh-list
20137584|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
20137585|NCT00045370|Sirolimus|sirolimus|mesh-list
20137586|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137587|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
20137588|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137589|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
19628565|NCT02462525|Dexamethasone|dexamethasone|mesh-list
19628566|NCT02462525|Pomalidomide|pomalidomide|mesh-list
19628567|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628568|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
19628569|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
19628570|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628571|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628572|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20137590|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137591|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20137592|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19628573|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
20137593|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
20137594|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20137595|NCT00045396|Tipifarnib|tipifarnib|mesh-list
19628574|NCT02462525|Hormones|hormones|mesh-ancestor
19628575|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628576|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19628577|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628578|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
19628579|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19628580|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19628581|NCT02462525|Growth Substances|growth substances|mesh-ancestor
19628582|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
19628583|NCT02462577|Morphine|morphine|mesh-list
19628584|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628585|NCT02462577|Narcotics|narcotics|mesh-ancestor
19628586|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628587|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628588|NCT02462577|Analgesics|analgesics|mesh-ancestor
19628589|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
19628590|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628591|NCT02462447|Choline|choline|mesh-list
19628592|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
19628593|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19628594|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
19628595|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628596|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628597|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19628598|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
20137596|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628599|NCT02462681|Ketamine|ketamine|mesh-list
19628600|NCT02462681|Analgesics|analgesics|mesh-ancestor
19628601|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
19628602|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628603|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628604|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19628605|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19628606|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
19628607|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
19628608|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628609|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19628610|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19628611|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628612|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628613|NCT02462499|Eplerenone|eplerenone|mesh-list
19628614|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19628615|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
19628616|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628617|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628618|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19628619|NCT02462499|Diuretics|diuretics|mesh-ancestor
20608435|NCT02246049|Irinotecan|irinotecan|mesh-list
20608436|NCT02246049|Calcium|calcium|mesh-list
20608437|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
20608438|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608439|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608440|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20608441|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20137597|NCT00045422|Interferons|interferons|mesh-list
20137598|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
20137599|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
19628620|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
19628621|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19661131|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
19661132|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
19661133|NCT05090137|Diuretics|diuretics|mesh-list
19661134|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
19661135|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661136|NCT05090124|Adalimumab|adalimumab|mesh-list
19661137|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661138|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661139|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
19661140|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19661141|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
19661142|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661143|NCT05089981|Expectorants|expectorants|mesh-ancestor
19661144|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
19661145|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19661146|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
19661147|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661148|NCT05089981|Protective Agents|protective agents|mesh-ancestor
19661149|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661150|NCT05089981|Antidotes|antidotes|mesh-ancestor
19661151|NCT05089604|Tacrolimus|tacrolimus|mesh-list
19661152|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19661153|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
19661154|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661155|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19661156|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661157|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661158|NCT05089539|Valsartan|valsartan|mesh-list
19661159|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19661160|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19661161|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19661162|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661163|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
19661164|NCT05089461|Analgesics|analgesics|mesh-ancestor
19661165|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
19661166|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661167|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661168|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661169|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19661170|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137600|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137601|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
20608442|NCT02246049|Growth Substances|growth substances|mesh-ancestor
19628622|NCT02462369|Glimepiride|glimepiride|mesh-list
19628623|NCT02462369|Saxagliptin|saxagliptin|mesh-list
19628624|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19628625|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19628626|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137602|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137603|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
20137604|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137605|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19628627|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628628|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
19628629|NCT02462369|Incretins|incretins|mesh-ancestor
19628630|NCT02462369|Hormones|hormones|mesh-ancestor
19628631|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628632|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19628633|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
19628634|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628635|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628636|NCT02462304|Bevacizumab|bevacizumab|mesh-list
19628637|NCT02462304|Ranibizumab|ranibizumab|mesh-list
19628638|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19628639|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628640|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19628641|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19628642|NCT02462304|Growth Substances|growth substances|mesh-ancestor
19628643|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628644|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
19628645|NCT02462317|Baclofen|baclofen|mesh-list
19628646|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19628647|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19628648|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19628649|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628650|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19628651|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628652|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19628653|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
19628654|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
19628655|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628656|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628657|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19628658|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628659|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
20137606|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137607|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137608|NCT00045448|Docetaxel|docetaxel|mesh-list
20137609|NCT00045448|Alvocidib|alvocidib|mesh-list
20137610|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137611|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
20137612|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
19628660|NCT02462109|Lorazepam|lorazepam|mesh-list
19628661|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
19628662|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
19628663|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
19628664|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628665|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628666|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628667|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19628668|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628669|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19628670|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19628671|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628672|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
19628673|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
20137613|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
19628674|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628675|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628676|NCT02462161|Insulin|insulin|mesh-list
19628677|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19628678|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
19628679|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
19628680|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19628681|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19628682|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137614|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137615|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
20137616|NCT00045448|Growth Substances|growth substances|mesh-ancestor
20137617|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137618|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137619|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137620|NCT00045461|Carboplatin|carboplatin|mesh-list
20137621|NCT00045461|Ifosfamide|ifosfamide|mesh-list
20137622|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137623|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20137624|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
20137625|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137626|NCT00045500|Prednisone|prednisone|mesh-list
20137627|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20137628|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20137629|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
20137630|NCT00045500|Hormones|hormones|mesh-ancestor
20137631|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628683|NCT02462174|Ketamine|ketamine|mesh-list
19628684|NCT02462174|Bupivacaine|bupivacaine|mesh-list
19628685|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628686|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
19628687|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628688|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628689|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
20137632|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137633|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20137634|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137635|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137636|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137637|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137638|NCT00045513|Fludarabine|fludarabine|mesh-list
20137639|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
20137640|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20137641|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137642|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20137643|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
20313304|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
20313305|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313306|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20313307|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
20313308|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313309|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313310|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
20608443|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628690|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628691|NCT02462174|Analgesics|analgesics|mesh-ancestor
19628692|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19628693|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19628694|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
19628695|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19628696|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19628697|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628698|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628699|NCT02462252|Cyclosporine|cyclosporine|mesh-list
19628700|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
19628701|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19628702|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19628703|NCT02462252|Cyclosporins|cyclosporins|mesh-list
19628704|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19628705|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137644|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137645|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628706|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628707|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628708|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
19628709|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628710|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
19628711|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628712|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628713|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628714|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19628715|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628716|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
19628717|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
19628718|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628719|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628720|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
19628721|NCT02462252|Hormones|hormones|mesh-ancestor
19628722|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628723|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19628724|NCT02462252|Protective Agents|protective agents|mesh-ancestor
19628725|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19628726|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628727|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
19628728|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
19628729|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628730|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628731|NCT02462265|Analgesics|analgesics|mesh-ancestor
19628732|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
19628733|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628734|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19628735|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19628736|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628737|NCT02462044|Iodine|iodine|mesh-list
19628738|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
19628739|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19628740|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628741|NCT02462044|Trace Elements|trace elements|mesh-ancestor
19628742|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
19628743|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628744|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
19628745|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628746|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19628747|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628748|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628749|NCT02461706|Cannabidiol|cannabidiol|mesh-list
19628750|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
19628751|NCT02461836|Gemcitabine|gemcitabine|mesh-list
19628752|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19628753|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
19628754|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628755|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628756|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
19628757|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628758|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628759|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628760|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
19628761|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628762|NCT02461888|Dexamethasone|dexamethasone|mesh-list
19750363|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750364|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750365|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19750366|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19750367|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19750368|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750369|NCT04075396|Lazertinib|lazertinib|mesh-list
19750370|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19750371|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750372|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750373|NCT04062448|Rituximab|rituximab|mesh-list
19750374|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750375|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750376|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
19628763|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
19628764|NCT02461888|Ixazomib|ixazomib|mesh-list
19628765|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628766|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
19628767|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628768|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628769|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19628770|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
19628771|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628772|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628773|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19628774|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628775|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
19628776|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
19628777|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628778|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19628779|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
19628780|NCT02461888|Hormones|hormones|mesh-ancestor
19628781|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628782|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19628783|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
19628784|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628785|NCT02461875|Cabergoline|cabergoline|mesh-list
19628786|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19628787|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19628788|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
19628789|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
19628790|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628791|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628792|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628793|NCT02461719|Cyclosporine|cyclosporine|mesh-list
20137646|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
19628794|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19628795|NCT02461719|Cyclosporins|cyclosporins|mesh-list
19628796|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628797|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628798|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628799|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
19628800|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628801|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
19628802|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628803|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628804|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628805|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19628806|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19628807|NCT02461927|Midazolam|midazolam|mesh-list
19628808|NCT02461927|Naltrexone|naltrexone|mesh-list
19628809|NCT02461927|Ketamine|ketamine|mesh-list
19628810|NCT02461927|Analgesics|analgesics|mesh-ancestor
19628811|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
19628812|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628813|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628814|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19628815|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19628816|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
19628817|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
19628818|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628819|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19628820|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19628821|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628822|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628823|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19628824|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20137647|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137648|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137649|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137650|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19628825|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19628826|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19628827|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19750377|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750378|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750379|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
19750380|NCT04059458|Calcium|calcium|mesh-list
19750381|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19750382|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750383|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19750384|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
19628828|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
19628829|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
19628830|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19628831|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20137651|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137652|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137653|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137654|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137655|NCT00045539|Leucovorin|leucovorin|mesh-list
20137656|NCT00045539|Methotrexate|methotrexate|mesh-list
20137657|NCT00045539|Thiotepa|thiotepa|mesh-list
19628832|NCT02461914|Warfarin|warfarin|mesh-list
19628833|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
19628834|NCT02461667|Alendronate|alendronate|mesh-list
19628835|NCT02461667|Metformin|metformin|mesh-list
20137658|NCT00045539|Calcium|calcium|mesh-list
20137659|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
20137660|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137661|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137662|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20137663|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
20137664|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20137665|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20137666|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
20137667|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137668|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137669|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
20137670|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137671|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20137672|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20137673|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
20137674|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20137675|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20137676|NCT00045539|Antidotes|antidotes|mesh-ancestor
20137677|NCT00045539|Protective Agents|protective agents|mesh-ancestor
19628836|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19628837|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628838|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20137678|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
20137679|NCT00045539|Vitamins|vitamins|mesh-ancestor
20137680|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
20137681|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20137682|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
20137683|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20137684|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
20137685|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137686|NCT00045591|Celecoxib|celecoxib|mesh-list
20137687|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20137688|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20137689|NCT00045591|Analgesics|analgesics|mesh-ancestor
20137690|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
20137691|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137692|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137693|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20137694|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20137695|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20137696|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20137697|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628839|NCT02461329|Polygeline|polygeline|mesh-list
19628840|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
19628841|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
20137698|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137699|NCT00045604|Irinotecan|irinotecan|mesh-list
20137700|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
20137701|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608444|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
19628842|NCT02461368|Triamcinolone|triamcinolone|mesh-list
19628843|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19628844|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19628845|NCT02461368|Lidocaine|lidocaine|mesh-list
19628846|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19628847|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628848|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
19628849|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628850|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137702|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20137703|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137704|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628851|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
19628852|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628853|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19628854|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19628855|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19628856|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628857|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628858|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628859|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
19628860|NCT02461368|Hormones|hormones|mesh-ancestor
19628861|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628862|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750385|NCT04059445|Calcium|calcium|mesh-list
19750386|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19750387|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750388|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19750389|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
19750390|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19750391|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19750392|NCT04051203|Prednisolone|prednisolone|mesh-list
19750393|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
19750394|NCT04051203|Lidocaine|lidocaine|mesh-list
19750395|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19750396|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
19750397|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
19750398|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
19750399|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19750400|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750401|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
19750402|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750403|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19750404|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19750405|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19750406|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19750407|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750408|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750409|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
19750410|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
19750411|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750412|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
19750413|NCT04051203|Hormones|hormones|mesh-ancestor
19750414|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750415|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19750416|NCT04051203|Protective Agents|protective agents|mesh-ancestor
19750417|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750418|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750419|NCT04034095|Prednisolone|prednisolone|mesh-list
19750420|NCT04034095|Docetaxel|docetaxel|mesh-list
19750421|NCT04034095|Bicalutamide|bicalutamide|mesh-list
19750422|NCT04034095|Androgens|androgens|mesh-list
19750423|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750424|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
19750425|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
19750426|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
19750427|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750428|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750429|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
19750430|NCT04034095|Hormones|hormones|mesh-ancestor
19750431|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750432|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750433|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750434|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
19750435|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750436|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20137705|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137706|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137707|NCT00045617|Etoposide|etoposide|mesh-list
20137708|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20137709|NCT00045617|Vaccines|vaccines|mesh-list
20137710|NCT00045617|Antibodies|antibodies|mesh-list
20137711|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
19750437|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
19750438|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137712|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19750439|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19750440|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
19750441|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137713|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20137714|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
20137715|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137716|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137717|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20137718|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20137719|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137720|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137721|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137722|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
20313311|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750442|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750443|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19750444|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19750445|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19750446|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
19750447|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
19750448|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19750449|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
19750450|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19750451|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750452|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19750453|NCT04023526|Azacitidine|azacitidine|mesh-list
19750454|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19750455|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
19750456|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750457|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750458|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750459|NCT03993535|Serotonin|serotonin|mesh-list
19750460|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19750461|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19750462|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
19750463|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750464|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750465|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750466|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137723|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137724|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137725|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750467|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19750468|NCT03986424|Memantine|memantine|mesh-list
19750469|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19750470|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19750471|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
19750472|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750473|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750474|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750475|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19750476|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19750477|NCT03961516|Pancrelipase|pancrelipase|mesh-list
20137726|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137727|NCT00045682|Paclitaxel|paclitaxel|mesh-list
20137728|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20137729|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20137730|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20137731|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137732|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
20137733|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
20137734|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
20137735|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137736|NCT00045695|Bortezomib|bortezomib|mesh-list
20137737|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173616|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20173617|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173618|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20173619|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173620|NCT00162318|Cetuximab|cetuximab|mesh-list
20173621|NCT00162318|Gefitinib|gefitinib|mesh-list
19750478|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750479|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
19750480|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19750481|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19750482|NCT03942887|Prednisolone|prednisolone|mesh-list
19750483|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
19750484|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
19750485|NCT03942887|Rituximab|rituximab|mesh-list
19750486|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19750487|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
19750488|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750489|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
19750490|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750491|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750492|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19750493|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
19750494|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750495|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750496|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19750497|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750498|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750499|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
19750500|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
19750501|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750502|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750503|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
19750504|NCT03942887|Hormones|hormones|mesh-ancestor
19750505|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750506|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19750507|NCT03942887|Protective Agents|protective agents|mesh-ancestor
19750508|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750509|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
19750510|NCT03918798|Procaine|procaine|mesh-list
19750511|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19750512|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
19750513|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
19750514|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19750515|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313312|NCT00688896|Pravastatin|pravastatin|mesh-list
20313313|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
20313314|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20313315|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20313316|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
20313317|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313318|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19750516|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
19750517|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750518|NCT03901963|Lenalidomide|lenalidomide|mesh-list
19750519|NCT03901963|Daratumumab|daratumumab|mesh-list
19750520|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
19750521|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750522|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19750523|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750524|NCT03901963|Growth Substances|growth substances|mesh-ancestor
20137738|NCT00045721|Carmustine|carmustine|mesh-list
20137739|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20137740|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20137741|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
20137742|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137743|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137744|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137745|NCT00045747|Fluorouracil|fluorouracil|mesh-list
20137746|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20137747|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
20137748|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137749|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20137750|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137751|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750525|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
19750526|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750527|NCT03895203|Adalimumab|adalimumab|mesh-list
19750528|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313319|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19750529|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750530|NCT03887624|Ethosuximide|ethosuximide|mesh-list
20137752|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
19628863|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
19750531|NCT03887624|Citalopram|citalopram|mesh-list
19750532|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19750533|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19750534|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19750535|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628864|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628865|NCT02461186|Piperaquine|piperaquine|mesh-list
19628866|NCT02461186|Artenimol|artenimol|mesh-list
19750536|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750537|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
19750538|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137753|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137754|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20137755|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137756|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20137757|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750539|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19750540|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
19750541|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19750542|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
19750543|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19750544|NCT03876119|Plasminogen|plasminogen|mesh-list
19750545|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19750546|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19750547|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750548|NCT03874286|Liver Extracts|liver extracts|mesh-list
19750549|NCT03874286|Hematinics|hematinics|mesh-ancestor
19750550|NCT03871829|Dexamethasone|dexamethasone|mesh-list
19750551|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
19750552|NCT03871829|BB 1101|bb 1101|mesh-list
19750553|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750554|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
19750555|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
19750556|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750557|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750558|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750559|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
19750560|NCT03871829|Hormones|hormones|mesh-ancestor
19750561|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750562|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750563|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750564|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
19750565|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750566|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750567|NCT03857139|Nicotine|nicotine|mesh-list
19750568|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19750569|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
19750570|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750571|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750572|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19750573|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19750574|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
19750575|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750576|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750577|NCT03834519|Prednisone|prednisone|mesh-list
19750578|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
19750579|NCT03834519|Olaparib|olaparib|mesh-list
19750580|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
19750581|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750582|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750583|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750584|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
20137758|NCT00045773|Sertraline|sertraline|mesh-list
19628867|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
19628868|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19628869|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19628870|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628871|NCT02461004|Ezetimibe|ezetimibe|mesh-list
20137759|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137760|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137761|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20137762|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137763|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137764|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628872|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19750585|NCT03834519|Hormones|hormones|mesh-ancestor
19750586|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750587|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750588|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750589|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19750590|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750591|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750592|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19750593|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750594|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19750595|NCT03833154|Durvalumab|durvalumab|mesh-list
19750596|NCT03833154|Osimertinib|osimertinib|mesh-list
19750597|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20137765|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137766|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
20137767|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137768|NCT00045799|Omeprazole|omeprazole|mesh-list
20137769|NCT00045799|Cimetidine|cimetidine|mesh-list
20137770|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20137771|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20137772|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20137773|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137774|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313320|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313321|NCT00688922|Pravastatin|pravastatin|mesh-list
19750598|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750599|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19750600|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750601|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750602|NCT03829501|Atezolizumab|atezolizumab|mesh-list
19750603|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750604|NCT03821545|Lidocaine|lidocaine|mesh-list
19750605|NCT03821545|Ketamine|ketamine|mesh-list
19750606|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
19750607|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
19750608|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19750609|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750610|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
19750611|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750612|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19750613|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19750614|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19750615|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19750616|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750617|NCT03821545|Analgesics|analgesics|mesh-ancestor
19750618|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19750619|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19750620|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
19750621|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19750622|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19750623|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750624|NCT03778957|Bevacizumab|bevacizumab|mesh-list
19750625|NCT03778957|Durvalumab|durvalumab|mesh-list
19750626|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750627|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750628|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19750629|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750630|NCT03778957|Growth Substances|growth substances|mesh-ancestor
19750631|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750632|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
19750633|NCT03778294|Temozolomide|temozolomide|mesh-list
19750634|NCT03778294|Levodopa|levodopa|mesh-list
19750635|NCT03778294|Fluorides|fluorides|mesh-list
19750636|NCT03778294|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19750637|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19750638|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
19750639|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750640|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750641|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
19750642|NCT03778294|Protective Agents|protective agents|mesh-ancestor
19750643|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750644|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
20608445|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137775|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20313322|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20313323|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20313324|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
19628873|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19628874|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
19628875|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628876|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19628877|NCT02461056|Ibuprofen|ibuprofen|mesh-list
19628878|NCT02461056|Hydromorphone|hydromorphone|mesh-list
19628879|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19628880|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19628881|NCT02461056|Analgesics|analgesics|mesh-ancestor
19628882|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
19628883|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628884|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628885|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628886|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628887|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19628888|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628889|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628890|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628891|NCT02461056|Narcotics|narcotics|mesh-ancestor
19628892|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628893|NCT02461121|Cyclosporine|cyclosporine|mesh-list
19628894|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
19628895|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
19628896|NCT02461121|Fludarabine|fludarabine|mesh-list
19628897|NCT02461121|Cyclosporins|cyclosporins|mesh-list
19628898|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19628899|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628900|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
19628901|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628902|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628903|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19628904|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
19628905|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628906|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628907|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19628908|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19628909|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
19628910|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628911|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628912|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19628913|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19628914|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19628915|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
19628916|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19628917|NCT02461043|Paclitaxel|paclitaxel|mesh-list
19628918|NCT02461043|Cisplatin|cisplatin|mesh-list
19628919|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19628920|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628921|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
19628922|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
19628923|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
19628924|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628925|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19628926|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
19628927|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628928|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
19628929|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628930|NCT02461030|Listerine|listerine|mesh-list
19628931|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
19628932|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
19628933|NCT02461030|Protective Agents|protective agents|mesh-ancestor
19628934|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628935|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19628936|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19628937|NCT02460913|Morphine|morphine|mesh-list
19628938|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19628939|NCT02460913|Narcotics|narcotics|mesh-ancestor
20313325|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628940|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608446|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
19628941|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313326|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20313327|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20313328|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137776|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
19750645|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750646|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19750647|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19832538|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
19832539|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832540|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832541|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832542|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832543|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19832544|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19832545|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832546|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19832547|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19832548|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832549|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
19832550|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19832551|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19832552|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19832553|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
19832554|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832555|NCT03725436|Paclitaxel|paclitaxel|mesh-list
19832556|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19832557|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19832558|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832559|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
19832560|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
19832561|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
19832562|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832563|NCT03722966|Nicotine|nicotine|mesh-list
19832564|NCT03722966|Varenicline|varenicline|mesh-list
19832565|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19832566|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
19832567|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832568|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832569|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19832570|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19832571|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
19832572|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832573|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832574|NCT03708354|Tocotrienols|tocotrienols|mesh-list
19832575|NCT03708354|Vitamin E|vitamin e|mesh-list
19832576|NCT03708354|Tocopherols|tocopherols|mesh-list
19832577|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
19832578|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832579|NCT03708354|Protective Agents|protective agents|mesh-ancestor
19832580|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832581|NCT03708354|Vitamins|vitamins|mesh-ancestor
19832582|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
19832583|NCT03571191|Denosumab|denosumab|mesh-list
19832584|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19832585|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832586|NCT03527472|Memantine|memantine|mesh-list
19832587|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19832588|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19832589|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
19832590|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832591|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832592|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832593|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19832594|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19832595|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19832596|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20137777|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
19832597|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
19832598|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137778|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137779|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137780|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20137781|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19750648|NCT03768960|Daratumumab|daratumumab|mesh-list
19750649|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750650|NCT03759288|Adalimumab|adalimumab|mesh-list
19750651|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750652|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750653|NCT03755765|Amoxicillin|amoxicillin|mesh-list
19750654|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
19750655|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
19750656|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19750657|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19750658|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750659|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19750660|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750661|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750662|NCT03751709|Blinatumomab|blinatumomab|mesh-list
19750663|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750664|NCT03748641|Prednisone|prednisone|mesh-list
19750665|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
19750666|NCT03748641|Niraparib|niraparib|mesh-list
19750667|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750668|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
20137782|NCT00045812|Ezetimibe|ezetimibe|mesh-list
20137783|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20137784|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20137785|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
20137786|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137787|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20137788|NCT00045864|Aldesleukin|aldesleukin|mesh-list
20137789|NCT00045864|Rituximab|rituximab|mesh-list
20137790|NCT00045864|Interleukin-2|interleukin-2|mesh-list
20137791|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20137792|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137793|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
20137794|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137795|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20137796|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20137797|NCT00045864|Analgesics|analgesics|mesh-ancestor
20137798|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
20137799|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137800|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137801|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137802|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
20137803|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137804|NCT00045877|Aldesleukin|aldesleukin|mesh-list
20313329|NCT00688948|Alfuzosin|alfuzosin|mesh-list
20313330|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20313331|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20313332|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19750669|NCT03748641|Hormones|hormones|mesh-ancestor
19750670|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750671|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750672|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750673|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750674|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19750675|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750676|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750677|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750678|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137805|NCT00045877|Rituximab|rituximab|mesh-list
20313333|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
20313334|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313335|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313336|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313337|NCT00688948|Urological Agents|urological agents|mesh-ancestor
20313338|NCT00688961|Aspirin|aspirin|mesh-list
20313339|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20313340|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20313341|NCT00688961|Analgesics|analgesics|mesh-ancestor
19750679|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20137806|NCT00045877|Interleukin-2|interleukin-2|mesh-list
20137807|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20137808|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137809|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
20137810|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313342|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
19750685|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19750686|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19750687|NCT03739814|Blinatumomab|blinatumomab|mesh-list
19750688|NCT03739814|Antibodies|antibodies|mesh-list
19750689|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
19750690|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19750691|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
19750692|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19750693|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
19750694|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750695|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750696|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750697|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19750698|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
19750699|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19750700|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20137811|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20137812|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19750701|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19750702|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19750703|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750704|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
19750705|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750706|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750707|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19750708|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750709|NCT03706365|Prednisone|prednisone|mesh-list
19750710|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
19750711|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750712|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
19750713|NCT03706365|Hormones|hormones|mesh-ancestor
19750714|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750715|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750716|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750717|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750718|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19750719|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750720|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750721|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750722|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19750723|NCT03652064|Dexamethasone|dexamethasone|mesh-list
19750724|NCT03652064|Lenalidomide|lenalidomide|mesh-list
19750725|NCT03652064|Bortezomib|bortezomib|mesh-list
19750726|NCT03652064|Daratumumab|daratumumab|mesh-list
19750727|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750728|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
19750729|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
19750730|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750731|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750732|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750733|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
19750734|NCT03652064|Hormones|hormones|mesh-ancestor
19750735|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750736|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750737|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750738|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
19750739|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19750740|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750741|NCT03652064|Growth Substances|growth substances|mesh-ancestor
19750742|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
19750743|NCT03640377|Praziquantel|praziquantel|mesh-list
19750744|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
19750745|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19750746|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750747|NCT03632187|Abatacept|abatacept|mesh-list
19750748|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19750749|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750750|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750751|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750752|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
20137813|NCT00045877|Analgesics|analgesics|mesh-ancestor
20137814|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
20137815|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137816|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137817|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137818|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
20137819|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137820|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20137821|NCT00045916|Nortriptyline|nortriptyline|mesh-list
20137822|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
19628942|NCT02460913|Analgesics|analgesics|mesh-ancestor
19628943|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
19628944|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628945|NCT02460874|Glyburide|glyburide|mesh-list
19628946|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19628947|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628948|NCT02460497|Minoxidil|minoxidil|mesh-list
19628949|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19628950|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
19628951|NCT02460510|Mannitol|mannitol|mesh-list
19628952|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19628953|NCT02460510|Diuretics|diuretics|mesh-ancestor
19628954|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
19661171|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661172|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661173|NCT05089448|Amlodipine|amlodipine|mesh-list
19661174|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19661175|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19661176|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661177|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661178|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661179|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661180|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
19661181|NCT05089383|Progesterone|progesterone|mesh-list
19661182|NCT05089383|Progestins|progestins|mesh-ancestor
19661183|NCT05089383|Hormones|hormones|mesh-ancestor
19661184|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661185|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661186|NCT05089344|Clomiphene|clomiphene|mesh-list
19661187|NCT05089344|Enclomiphene|enclomiphene|mesh-list
19661188|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
19661189|NCT05089344|Hormones|hormones|mesh-list
19661190|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661191|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661192|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19661193|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
19661194|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19661195|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
19661196|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19661197|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19661198|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19661199|NCT05088889|Nivolumab|nivolumab|mesh-list
19661200|NCT05088889|Ipilimumab|ipilimumab|mesh-list
19661201|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661202|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661203|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19661204|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661205|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19661206|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
19661207|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661208|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661209|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661210|NCT05088720|Misoprostol|misoprostol|mesh-list
19661211|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19661212|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
19661213|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19661214|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661215|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19661216|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661217|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
19661218|NCT05088707|Misoprostol|misoprostol|mesh-list
19661219|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19661220|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
19661221|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665704|NCT04351295|Favipiravir|favipiravir|mesh-list
20137823|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137824|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137825|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137826|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20137827|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137828|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137829|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137830|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20137831|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20137832|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20137833|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
19628955|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628956|NCT02460588|Prednisolone|prednisolone|mesh-list
19628957|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
19628958|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19628959|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
19628960|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628961|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19628962|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19628963|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
19628964|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628965|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19628966|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19628967|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19628968|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
19628969|NCT02460588|Hormones|hormones|mesh-ancestor
19628970|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628971|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19661222|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661223|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19661224|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661225|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
19661226|NCT05084118|Landiolol|landiolol|mesh-list
19661227|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19661228|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19661229|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
19661230|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661231|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661232|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661233|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19661234|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
19661235|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661236|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
19661237|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661238|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661239|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19661240|NCT05077540|Misoprostol|misoprostol|mesh-list
19661241|NCT05077540|Oxytocin|oxytocin|mesh-list
19661242|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
19661243|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19661244|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661245|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19661246|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
19661247|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19661248|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661249|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
19661250|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19661251|NCT05057468|Cyclosporine|cyclosporine|mesh-list
19661252|NCT05057468|Rituximab|rituximab|mesh-list
19661253|NCT05057468|Cyclosporins|cyclosporins|mesh-list
19661254|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661255|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661256|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
19661257|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661258|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661259|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661260|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661261|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19661262|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
19661263|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137834|NCT00045955|Fexofenadine|fexofenadine|mesh-list
20137835|NCT00045955|Montelukast|montelukast|mesh-list
20137836|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20137837|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
20137838|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20137839|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
20137840|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137841|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137842|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20137843|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20137844|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137845|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20137846|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20612143|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19628972|NCT02460627|Lidocaine|lidocaine|mesh-list
19750753|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750754|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750755|NCT03587142|Buspirone|buspirone|mesh-list
19750756|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19750757|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19750758|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19750759|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750760|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19750761|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19750762|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
19628973|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
19628974|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
19628975|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19628976|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628977|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
19628978|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628979|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19628980|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19628981|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19628982|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19628983|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628984|NCT02460692|Dronabinol|dronabinol|mesh-list
19628985|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
19628986|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19628987|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19628988|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19628989|NCT02460692|Analgesics|analgesics|mesh-ancestor
19628990|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
19628991|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19628992|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19628993|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19628994|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19628995|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19628996|NCT02460692|Hormones|hormones|mesh-ancestor
19628997|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19628998|NCT02460640|Morphine|morphine|mesh-list
19628999|NCT02460640|Ropivacaine|ropivacaine|mesh-list
19629000|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19629001|NCT02460640|Narcotics|narcotics|mesh-ancestor
19629002|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629003|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629004|NCT02460640|Analgesics|analgesics|mesh-ancestor
19629005|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
19629006|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629007|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
19629008|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
19629009|NCT02460419|Capecitabine|capecitabine|mesh-list
19629010|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19629011|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
19629012|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629013|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629014|NCT02460276|Rituximab|rituximab|mesh-list
19629015|NCT02460276|Lenalidomide|lenalidomide|mesh-list
19629016|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19629017|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629018|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
19629019|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629020|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629021|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19629022|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750763|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750764|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750765|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
19750766|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19750767|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19750768|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750769|NCT03582917|Vitamins|vitamins|mesh-ancestor
19750770|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
19750771|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
19750772|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750773|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750774|NCT03558724|Bevacizumab|bevacizumab|mesh-list
19750775|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750776|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750777|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19750778|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750779|NCT03558724|Growth Substances|growth substances|mesh-ancestor
19629023|NCT02460276|Growth Substances|growth substances|mesh-ancestor
20313343|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629024|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
19629025|NCT02460432|Paclitaxel|paclitaxel|mesh-list
19750780|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750781|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
19750782|NCT03506360|Dexamethasone|dexamethasone|mesh-list
19750783|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
19750784|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
19750785|NCT03506360|Ixazomib|ixazomib|mesh-list
19750786|NCT03506360|Ichthammol|ichthammol|mesh-list
19750787|NCT03506360|BB 1101|bb 1101|mesh-list
19750788|NCT03506360|Glycine|glycine|mesh-list
19750789|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750790|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
19750791|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
19750792|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750793|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750794|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750795|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
19750796|NCT03506360|Hormones|hormones|mesh-ancestor
19750797|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750798|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750799|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750800|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
19750801|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750802|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750803|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750804|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
19750805|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
19750806|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750807|NCT03473743|Carboplatin|carboplatin|mesh-list
19750808|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750809|NCT03462719|Venetoclax|venetoclax|mesh-list
19750810|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
19750811|NCT03462719|Chlorambucil|chlorambucil|mesh-list
19750812|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750813|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750814|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20313344|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629026|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19629027|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629028|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
19629029|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
19629030|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
19629031|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629032|NCT02460289|Minoxidil|minoxidil|mesh-list
19629033|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19629034|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
19629035|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19629036|NCT02460393|Antibodies|antibodies|mesh-list
19629037|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
19629038|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19629039|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
19629040|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750815|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
20612144|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19750816|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750817|NCT03452930|Benzimidazole|benzimidazole|mesh-list
19750818|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
19750819|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19750820|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750821|NCT03451851|Etanercept|etanercept|mesh-list
19750822|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19750823|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19750824|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19750825|NCT03451851|Analgesics|analgesics|mesh-ancestor
19750826|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
19750827|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750828|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750829|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750830|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750831|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750832|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750833|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
19750834|NCT03431350|Prednisone|prednisone|mesh-list
19750835|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
19750836|NCT03431350|Niraparib|niraparib|mesh-list
19750837|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750838|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
19750839|NCT03431350|Hormones|hormones|mesh-ancestor
19750840|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750841|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750842|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750843|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750844|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19750845|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750846|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750847|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750848|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19750849|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19750850|NCT03418649|Eplerenone|eplerenone|mesh-list
19750851|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19750852|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750853|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750854|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750855|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19750856|NCT03418649|Diuretics|diuretics|mesh-ancestor
19750857|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
19750858|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19750859|NCT03412565|Dexamethasone|dexamethasone|mesh-list
19750860|NCT03412565|Prednisone|prednisone|mesh-list
20137847|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20137848|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
20137849|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
20137850|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137851|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20137852|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20137853|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137854|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137855|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137856|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750861|NCT03412565|Lenalidomide|lenalidomide|mesh-list
19750862|NCT03412565|Bortezomib|bortezomib|mesh-list
19750863|NCT03412565|Melphalan|melphalan|mesh-list
19750864|NCT03412565|Daratumumab|daratumumab|mesh-list
19750865|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750866|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
19750867|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
19750868|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750869|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750870|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19750871|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
19750872|NCT03412565|Hormones|hormones|mesh-ancestor
19750873|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750874|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750875|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750876|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
19750877|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19750878|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19750879|NCT03412565|Growth Substances|growth substances|mesh-ancestor
19750880|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
19750881|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19750882|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
19750883|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750884|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19750885|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750886|NCT03404791|Gemcitabine|gemcitabine|mesh-list
19750887|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19750888|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
19750889|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750890|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750891|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
19750892|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750893|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750894|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750895|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
19750896|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750897|NCT03387475|Deferasirox|deferasirox|mesh-list
19750898|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19750899|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
19750900|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
19750901|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750902|NCT03384654|Cytarabine|cytarabine|mesh-list
19750903|NCT03384654|Prednisone|prednisone|mesh-list
19750904|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
19750905|NCT03384654|Doxorubicin|doxorubicin|mesh-list
19750906|NCT03384654|Methotrexate|methotrexate|mesh-list
19750907|NCT03384654|Vincristine|vincristine|mesh-list
19750908|NCT03384654|Asparaginase|asparaginase|mesh-list
19750909|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
19750910|NCT03384654|Daratumumab|daratumumab|mesh-list
19750911|NCT03384654|Pegaspargase|pegaspargase|mesh-list
19750912|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19750913|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
19750914|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750915|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750916|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19750917|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
19750918|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750919|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750920|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19750921|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19629041|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629042|NCT02460354|Metformin|metformin|mesh-list
19629043|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19629044|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629045|NCT02460367|Docetaxel|docetaxel|mesh-list
19629046|NCT02460367|Tryptophan|tryptophan|mesh-list
19629047|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629048|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
19629049|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
19629050|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
19629051|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629052|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19629053|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
19629054|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19629055|NCT02460211|Vitamin D|vitamin d|mesh-list
19629056|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
19629057|NCT02460211|Vitamins|vitamins|mesh-ancestor
19629058|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
19629059|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629060|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19629061|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19629062|NCT02460341|Ondansetron|ondansetron|mesh-list
19629063|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
19629064|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
19629065|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629066|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629067|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19629068|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
19629069|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
19629070|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19750922|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19750923|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19750924|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750925|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629071|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
19750926|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
19629072|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629073|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629074|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19629075|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19629076|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629077|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19629078|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19629079|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
19629080|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19629081|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20137857|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137858|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20137859|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137860|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137861|NCT00046033|Ritonavir|ritonavir|mesh-list
20137862|NCT00046033|Lopinavir|lopinavir|mesh-list
20137863|NCT00046033|Saquinavir|saquinavir|mesh-list
20137864|NCT00046033|Amprenavir|amprenavir|mesh-list
20137865|NCT00046033|Tenofovir|tenofovir|mesh-list
20137866|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20137867|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20137868|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
20137869|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137870|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629082|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19629083|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19629084|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629085|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
19629086|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629087|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629088|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19629089|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629090|NCT02460133|Ritonavir|ritonavir|mesh-list
19629091|NCT02460133|Ribavirin|ribavirin|mesh-list
19629092|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19629093|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19629094|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
19629095|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629096|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750927|NCT03384654|Hormones|hormones|mesh-ancestor
19750928|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19750929|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19750930|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19750931|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
19750932|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19750933|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19750934|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
19750935|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
19750936|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19750937|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19750938|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
19750939|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750940|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19750941|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
19750942|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
19750943|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
19750944|NCT03365362|Varenicline|varenicline|mesh-list
19750945|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19750946|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19750947|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
19750948|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750949|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750950|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750951|NCT03363503|Fluticasone|fluticasone|mesh-list
20137871|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137872|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137873|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
19629097|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19629098|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19629099|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
19629100|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612145|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137874|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137875|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19629101|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20137876|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137877|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20137878|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20137879|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20137880|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
20137881|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20137882|NCT00046111|Topotecan|topotecan|mesh-list
20137883|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20137884|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20137885|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137886|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137887|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137888|NCT00046137|Teriparatide|teriparatide|mesh-list
19750952|NCT03363503|Xhance|xhance|mesh-list
19750953|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19750954|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750955|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19750956|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
19750957|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19750958|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750959|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19750960|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
19750961|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
19750962|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19750963|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19750964|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19750965|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19750966|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19750967|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19750968|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750969|NCT03332589|Dabrafenib|dabrafenib|mesh-list
19750970|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137889|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20137890|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20137891|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137892|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20137893|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20137894|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
19750971|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19750972|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750973|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750974|NCT03317392|Olaparib|olaparib|mesh-list
19750975|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19750976|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19750977|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19750978|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19750979|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750980|NCT03301415|Valganciclovir|valganciclovir|mesh-list
19750981|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
19750982|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19750983|NCT03301220|Daratumumab|daratumumab|mesh-list
19750984|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20137895|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20137896|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20137897|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20137898|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
20137899|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20137900|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137901|NCT00046163|Midodrine|midodrine|mesh-list
20137902|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
20137903|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
20137904|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137905|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137906|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20137907|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20137908|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20137909|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19750985|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
19750986|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19750987|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19750988|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19750989|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750990|NCT03246906|Cyclosporine|cyclosporine|mesh-list
19750991|NCT03246906|Sirolimus|sirolimus|mesh-list
19750992|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
19750993|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
19750994|NCT03246906|Cyclosporins|cyclosporins|mesh-list
19750995|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313345|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313346|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313347|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20313348|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20313349|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313350|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20313351|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20313352|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313353|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
20137910|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
20137911|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137912|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137913|NCT00046176|Lamivudine|lamivudine|mesh-list
20137914|NCT00046176|Abacavir|abacavir|mesh-list
19629102|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20313354|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
20137915|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
20608447|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608448|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20608449|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608450|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
20608451|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20313355|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313356|NCT00689000|Tosedostat|tosedostat|mesh-list
20313357|NCT00689000|Glycine|glycine|mesh-list
20313358|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313359|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313360|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
20313361|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313362|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313363|NCT00689143|Sargramostim|sargramostim|mesh-list
20313364|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
20313365|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313366|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
19629103|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
19629104|NCT02460146|CXA-10|cxa-10|mesh-list
19629105|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19750996|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
19750997|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19750998|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19750999|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20608452|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20608453|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137916|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20137917|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20313367|NCT00689156|Docetaxel|docetaxel|mesh-list
19629106|NCT02460302|Progesterone|progesterone|mesh-list
19629107|NCT02460302|Progestins|progestins|mesh-ancestor
19629108|NCT02460302|Hormones|hormones|mesh-ancestor
19629109|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629110|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629111|NCT02460068|Nivolumab|nivolumab|mesh-list
20313368|NCT00689156|Epirubicin|epirubicin|mesh-list
20313369|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313370|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
19629112|NCT02460068|Ipilimumab|ipilimumab|mesh-list
19751000|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
20313371|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608454|NCT02246049|Antidotes|antidotes|mesh-ancestor
19751001|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751002|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751003|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751004|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751005|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
19751006|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751007|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19751008|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19751009|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19751010|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19751011|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
19751012|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19751013|NCT03234972|Dexamethasone|dexamethasone|mesh-list
19751014|NCT03234972|Bortezomib|bortezomib|mesh-list
19751015|NCT03234972|Daratumumab|daratumumab|mesh-list
19751016|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751017|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
19751018|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
20137918|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137919|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137920|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
20137921|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137922|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19751019|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751020|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751021|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751022|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
19751023|NCT03234972|Hormones|hormones|mesh-ancestor
19751024|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751025|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751026|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751027|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
19751028|NCT03233854|Fludarabine|fludarabine|mesh-list
19751029|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
19751030|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751031|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
19751032|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751033|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751034|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751035|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
19751036|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751037|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751038|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751039|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19751040|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
19751041|NCT03217812|Prednisone|prednisone|mesh-list
19751042|NCT03217812|Bortezomib|bortezomib|mesh-list
19751043|NCT03217812|Melphalan|melphalan|mesh-list
19751044|NCT03217812|Daratumumab|daratumumab|mesh-list
19751045|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751046|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
19751047|NCT03217812|Hormones|hormones|mesh-ancestor
19751048|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751049|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751050|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751051|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751052|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751053|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
19751054|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751055|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751056|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751057|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
19751058|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
19629113|NCT02460068|Fotemustine|fotemustine|mesh-list
19629114|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19629115|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629116|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19629117|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629118|NCT02459977|Basiliximab|basiliximab|mesh-list
19629119|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629120|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
19629121|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629122|NCT02459938|Glucagon|glucagon|mesh-list
19751059|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19751060|NCT03210688|Prednisone|prednisone|mesh-list
19751061|NCT03210688|Prednisolone|prednisolone|mesh-list
19751062|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751063|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
19751064|NCT03210688|Hormones|hormones|mesh-ancestor
19751065|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751066|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751067|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751068|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751069|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19751070|NCT03210688|Vitamins|vitamins|mesh-ancestor
19751071|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
19751072|NCT03201965|Dexamethasone|dexamethasone|mesh-list
19751073|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
19751074|NCT03201965|Bortezomib|bortezomib|mesh-list
19751075|NCT03201965|Daratumumab|daratumumab|mesh-list
19751076|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751077|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
19751078|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751079|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751080|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751081|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
19751082|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751083|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751084|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751085|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751086|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
19751087|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
19751088|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751089|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751090|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
19751091|NCT03201965|Hormones|hormones|mesh-ancestor
19751092|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751093|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751094|NCT03174847|Eplerenone|eplerenone|mesh-list
19751095|NCT03174847|Amiloride|amiloride|mesh-list
19751096|NCT03174847|Spironolactone|spironolactone|mesh-list
19751097|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19751098|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
19751099|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751100|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751101|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751102|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19751103|NCT03174847|Diuretics|diuretics|mesh-ancestor
19751104|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
19751105|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19751106|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19751107|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19751108|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19751109|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751110|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19751111|NCT03174847|Hormones|hormones|mesh-ancestor
19751112|NCT03120624|Iodine|iodine|mesh-list
19751113|NCT03120624|Interferons|interferons|mesh-list
19751114|NCT03120624|Interferon-beta|interferon-beta|mesh-list
19751115|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19751116|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
19751117|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751118|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
19751119|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751120|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
19751121|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751122|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19751123|NCT03120624|Trace Elements|trace elements|mesh-ancestor
19751124|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
19751125|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19751126|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751127|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751128|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19832599|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832600|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832601|NCT03497975|Nalbuphine|nalbuphine|mesh-list
19832602|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19832603|NCT03497975|Narcotics|narcotics|mesh-ancestor
19832604|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20137923|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137924|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
20137925|NCT00046241|Bupropion|bupropion|mesh-list
20137926|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20137927|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137928|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137929|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20137930|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20137931|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20137932|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137933|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
20313372|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313373|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20313374|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
20313375|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313376|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313377|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19629123|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19629124|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19629125|NCT02459938|Hormones|hormones|mesh-ancestor
19629126|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629127|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629128|NCT02459938|Incretins|incretins|mesh-ancestor
19629129|NCT02460055|Dexamethasone|dexamethasone|mesh-list
19629130|NCT02460055|Fentanyl|fentanyl|mesh-list
19629131|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
19629132|NCT02460055|Ondansetron|ondansetron|mesh-list
19629133|NCT02460055|Propofol|propofol|mesh-list
19629134|NCT02460055|Sevoflurane|sevoflurane|mesh-list
19629135|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629136|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
19629137|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
19629138|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629139|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629140|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19629141|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
19629142|NCT02460055|Hormones|hormones|mesh-ancestor
19661264|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
19661265|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19661266|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
19661267|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19661268|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661269|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19661270|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19661271|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661272|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661273|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661274|NCT05043077|Phenylephrine|phenylephrine|mesh-list
19661275|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
19661276|NCT05043077|Tropicamide|tropicamide|mesh-list
19661277|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19661278|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
19661279|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
19661280|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661281|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661282|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
19661283|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19661284|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
19661285|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
19661286|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19661287|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19661288|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19661289|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
19661290|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661291|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661292|NCT05043077|Protective Agents|protective agents|mesh-ancestor
19661293|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19661294|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19661295|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
19661296|NCT04991103|Dexamethasone|dexamethasone|mesh-list
19661297|NCT04991103|Lenalidomide|lenalidomide|mesh-list
19661298|NCT04991103|Bortezomib|bortezomib|mesh-list
19661299|NCT04991103|Daratumumab|daratumumab|mesh-list
19661300|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661301|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
19661302|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
19661303|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751129|NCT03091192|Sunitinib|sunitinib|mesh-list
19629143|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629144|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19629145|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629146|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19629147|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629148|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19629149|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
19629150|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
19629151|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19629152|NCT02460055|Narcotics|narcotics|mesh-ancestor
19629153|NCT02460055|Analgesics|analgesics|mesh-ancestor
19629154|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
20137934|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20137935|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137936|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19629155|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19629156|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19751130|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751131|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20137937|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20137938|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137939|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
20137940|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20137941|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137942|NCT00046267|Niacin|niacin|mesh-list
20137943|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20137944|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
20313378|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
19751132|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19751133|NCT03091192|Growth Substances|growth substances|mesh-ancestor
19751134|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751135|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
20313379|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
20313380|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
20313381|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20313382|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20313383|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313384|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313385|NCT00689169|Cytarabine|cytarabine|mesh-list
20313386|NCT00689169|Rituximab|rituximab|mesh-list
19751136|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19751137|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751138|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751139|NCT03089983|Isoniazid|isoniazid|mesh-list
19751140|NCT03089983|Rifapentine|rifapentine|mesh-list
20608455|NCT02246049|Protective Agents|protective agents|mesh-ancestor
19751141|NCT03089983|Buprenorphine|buprenorphine|mesh-list
19751142|NCT03089983|Methadone|methadone|mesh-list
20137945|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137946|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20137947|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
20608456|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
20608457|NCT02246049|Vitamins|vitamins|mesh-ancestor
20608458|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
20608459|NCT02246127|Everolimus|everolimus|mesh-list
20608460|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608461|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608462|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
19629157|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20137948|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
20137949|NCT00046267|Vitamins|vitamins|mesh-ancestor
20137950|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
20137951|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137952|NCT00046293|Abciximab|abciximab|mesh-list
20137953|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
19751143|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20313387|NCT00689169|Etoposide|etoposide|mesh-list
20608463|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751144|NCT03089983|Naloxone|naloxone|mesh-list
20313388|NCT00689169|Melphalan|melphalan|mesh-list
20608464|NCT02246179|Lidocaine|lidocaine|mesh-list
20608465|NCT02246179|Epinephrine|epinephrine|mesh-list
20137954|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20137955|NCT00046306|Antioxidants|antioxidants|mesh-list
19629158|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
19629159|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
19629160|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19629161|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
19629162|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629163|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629164|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19629165|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19629166|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137956|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137957|NCT00046306|Protective Agents|protective agents|mesh-ancestor
20137958|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137959|NCT00046319|Ambrisentan|ambrisentan|mesh-list
20137960|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20137961|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20137962|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20137963|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20137964|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
20137965|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137966|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137967|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20137968|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20137969|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
20137970|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20137971|NCT00046358|Ibuprofen|ibuprofen|mesh-list
20137972|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20137973|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20137974|NCT00046358|Analgesics|analgesics|mesh-ancestor
20137975|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
20137976|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20137977|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137978|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20137979|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20137980|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20137981|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20137982|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137983|NCT00046384|Aripiprazole|aripiprazole|mesh-list
20137984|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
20137985|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20137986|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20608466|NCT02246179|Prilocaine|prilocaine|mesh-list
20608467|NCT02246179|Carticaine|carticaine|mesh-list
19629167|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20313389|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313390|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313391|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
19629168|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19629169|NCT02460042|Paclitaxel|paclitaxel|mesh-list
19629170|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19629171|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629172|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
19629173|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
19629174|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
20137987|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20137988|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665705|NCT04351295|Amebicides|amebicides|mesh-ancestor
20137989|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20137990|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
20608468|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20608469|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
20608470|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
20608471|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608472|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608473|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
20137991|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
20137992|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313392|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313393|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313394|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20313395|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20313396|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313397|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313398|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313399|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20313400|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
20313401|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20313402|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313403|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19629175|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629176|NCT02459782|Anesthetics|anesthetics|mesh-list
19629177|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629178|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629179|NCT02460016|Ziresovir|ziresovir|mesh-list
19629180|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
19629181|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313404|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
20313405|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
20313406|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629182|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
19629183|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
19751145|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19751146|NCT03089983|Narcotics|narcotics|mesh-ancestor
20313407|NCT00689195|Curcumin|curcumin|mesh-list
20313408|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20313409|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20313410|NCT00689195|Analgesics|analgesics|mesh-ancestor
20313411|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
20313412|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313413|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313414|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313415|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313416|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313417|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313418|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313419|NCT00689208|Atropine|atropine|mesh-list
20313420|NCT00689208|Physostigmine|physostigmine|mesh-list
19751147|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19751148|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751149|NCT03089983|Analgesics|analgesics|mesh-ancestor
19751150|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
19751151|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751152|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19751153|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
19751154|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
19751155|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
19751156|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19751157|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751158|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19751159|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19751160|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
19751161|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751162|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20137993|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20137994|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20137995|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20137996|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
20137997|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20137998|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20137999|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20138000|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20138001|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20138002|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138003|NCT00046462|Metformin|metformin|mesh-list
20138004|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
20138005|NCT00046462|Glyburide|glyburide|mesh-list
20138006|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20313421|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19629184|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
20138007|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20138008|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138009|NCT00046501|Insulin|insulin|mesh-list
20313422|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20313423|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20313424|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
20313425|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313426|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313427|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20313428|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
20138010|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
20138011|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20138012|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
20138013|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
20138014|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20138015|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138016|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20138017|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138018|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20138019|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313429|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
20313430|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
20313431|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20313432|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20313433|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
20313434|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313435|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313436|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20313437|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629185|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751163|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19751164|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
19751165|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19751166|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
19751167|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
19751168|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751169|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
19751170|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19751171|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751172|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
19751173|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629186|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629187|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
20138020|NCT00046553|Mifepristone|mifepristone|mesh-list
20138021|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20138022|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
20138023|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20138024|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138025|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20138026|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20138027|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20138028|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
20138029|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20138030|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20138031|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
20138032|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20138033|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
20138034|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20138035|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20138036|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
20138037|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19629188|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19629189|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19629190|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
19629191|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629192|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629193|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
19629194|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19629195|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629196|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629197|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19629198|NCT02459509|Analgesics|analgesics|mesh-ancestor
20138038|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138039|NCT00046735|Lenalidomide|lenalidomide|mesh-list
20138040|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
20138041|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138042|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138043|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138044|NCT00046735|Growth Substances|growth substances|mesh-ancestor
20138045|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138046|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138047|NCT00046748|Omalizumab|omalizumab|mesh-list
20138048|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20138049|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20138050|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
20138051|NCT00046787|Lurtotecan|lurtotecan|mesh-list
20138052|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138053|NCT00046800|Lurtotecan|lurtotecan|mesh-list
20138054|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138055|NCT00046813|Nicotine|nicotine|mesh-list
20138056|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20138057|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
20138058|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138059|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138060|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20138061|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20138062|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
20138063|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138064|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138065|NCT00046826|Thalidomide|thalidomide|mesh-list
20138066|NCT00046826|Docetaxel|docetaxel|mesh-list
20138067|NCT00046826|Estramustine|estramustine|mesh-list
19629199|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
19629200|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751174|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751175|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751176|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
19751177|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751178|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751179|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751180|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19751181|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
19751182|NCT02953145|Coagulants|coagulants|mesh-ancestor
19751183|NCT02927769|Nivolumab|nivolumab|mesh-list
19751184|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19751185|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19751186|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751187|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751188|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19751189|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751190|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751191|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
19751192|NCT02925195|Vitamin D|vitamin d|mesh-list
19751193|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
19751194|NCT02925195|Vitamins|vitamins|mesh-ancestor
19751195|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
19629201|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19629202|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19629203|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19629204|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
19629205|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19751196|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751197|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19751198|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19629206|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629207|NCT02459613|Annexin A5|annexin a5|mesh-list
19751199|NCT02916979|Methotrexate|methotrexate|mesh-list
19751200|NCT02916979|Fludarabine|fludarabine|mesh-list
19751201|NCT02916979|Busulfan|busulfan|mesh-list
19751202|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
20138068|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313438|NCT00689208|Miotics|miotics|mesh-ancestor
20313439|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20313440|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19751203|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19751204|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
20138069|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138070|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138071|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
19751205|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19751206|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751207|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138072|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138073|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138074|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
20138075|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138076|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
20138077|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138078|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138079|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138080|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138081|NCT00046826|Growth Substances|growth substances|mesh-ancestor
20138082|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
19751208|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
19751209|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751210|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751211|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
19751212|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751213|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20138083|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138084|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
20138085|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19629208|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629209|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629210|NCT02459756|Ascorbic Acid|ascorbic acid|mesh-list
19629211|NCT02459756|Citric Acid|citric acid|mesh-list
19751214|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751215|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
19751216|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751217|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19751218|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
19751219|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751220|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751221|NCT02908477|Docetaxel|docetaxel|mesh-list
19751222|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751223|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
19751224|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
19751225|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
19751226|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751227|NCT02902029|Atezolizumab|atezolizumab|mesh-list
19751228|NCT02902029|Vemurafenib|vemurafenib|mesh-list
19751229|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751230|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19751231|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751232|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751233|NCT02899052|Dexamethasone|dexamethasone|mesh-list
19751234|NCT02899052|Venetoclax|venetoclax|mesh-list
19751235|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751236|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
19751237|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
19751238|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751239|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751240|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751241|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
19629212|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
19629213|NCT02459756|Vitamins|vitamins|mesh-ancestor
19629214|NCT02459756|Micronutrients|micronutrients|mesh-ancestor
19629215|NCT02459756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629216|NCT02459756|Antioxidants|antioxidants|mesh-ancestor
19629217|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629218|NCT02459756|Protective Agents|protective agents|mesh-ancestor
19629219|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
20138086|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
20138087|NCT00046852|Melphalan|melphalan|mesh-list
20138088|NCT00046852|Carmustine|carmustine|mesh-list
20138089|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20138090|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138091|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
20138092|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138093|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138094|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138095|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
19751242|NCT02899052|Hormones|hormones|mesh-ancestor
20138096|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138097|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138098|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20138099|NCT00046878|Carmustine|carmustine|mesh-list
20138100|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20138101|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138102|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
20138103|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751243|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751244|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751245|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751246|NCT02858037|Dapivirine|dapivirine|mesh-list
19751247|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19751248|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19751249|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
19751250|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751251|NCT02854696|Insulin|insulin|mesh-list
19751252|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19751253|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751254|NCT02752035|Azacitidine|azacitidine|mesh-list
20313441|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20313442|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
20313443|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313444|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20313445|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20313446|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313447|NCT00689442|Atorvastatin|atorvastatin|mesh-list
20313448|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
20313449|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20138104|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138105|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138106|NCT00046904|Etanercept|etanercept|mesh-list
20138107|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20138108|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20138109|NCT00046904|Analgesics|analgesics|mesh-ancestor
20138110|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
20138111|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313450|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20313451|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
20313452|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629220|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19629221|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
19629222|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
19629223|NCT02459574|Amiodarone|amiodarone|mesh-list
19629224|NCT02459574|Sotalol|sotalol|mesh-list
19629225|NCT02459574|Flecainide|flecainide|mesh-list
19629226|NCT02459574|Propafenone|propafenone|mesh-list
19629227|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19629228|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
19629229|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19629230|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629231|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
19629232|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19629233|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19629234|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629235|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19629236|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19629237|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19629238|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629239|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19629240|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19629241|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19629242|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19629243|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19629244|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
19629245|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629246|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
19629247|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
19629248|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629249|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19629250|NCT02459288|Clopidogrel|clopidogrel|mesh-list
19751255|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19751256|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
20138112|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313453|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20313454|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20313455|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313456|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
20313457|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20313458|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
20313459|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20313460|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313461|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20313462|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19751257|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751258|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751259|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751260|NCT02748018|Insulin|insulin|mesh-list
19751261|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19751262|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751263|NCT02741128|Vaccines|vaccines|mesh-list
19751264|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
19751265|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751266|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
19751267|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751268|NCT02658981|Nivolumab|nivolumab|mesh-list
19751269|NCT02658981|Antibodies|antibodies|mesh-list
19751270|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19751271|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
19751272|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751273|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751274|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751275|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19751276|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751277|NCT02609776|Carboplatin|carboplatin|mesh-list
19751278|NCT02609776|Pemetrexed|pemetrexed|mesh-list
19751279|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19751280|NCT02609776|Lazertinib|lazertinib|mesh-list
19751281|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19751282|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751283|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751284|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751285|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19751286|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19751287|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19751288|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751289|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
19751290|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751291|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
19751292|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751293|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19751294|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751295|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751296|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751297|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751298|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751299|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19751300|NCT02592317|Pioglitazone|pioglitazone|mesh-list
19751301|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19751302|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19751303|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19751304|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
19751305|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751306|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19751307|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19751308|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751309|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20138113|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138114|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138115|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138116|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138117|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
20138118|NCT00046917|Irinotecan|irinotecan|mesh-list
20138119|NCT00046917|Alvocidib|alvocidib|mesh-list
20138120|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138121|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20138122|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313463|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19751310|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751341|NCT02546661|Durvalumab|durvalumab|mesh-list
19751342|NCT02546661|Olaparib|olaparib|mesh-list
19751343|NCT02546661|Adavosertib|adavosertib|mesh-list
19751344|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751345|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751346|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19751347|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751348|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751349|NCT02519452|Daratumumab|daratumumab|mesh-list
19751350|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751351|NCT02489318|Androgens|androgens|mesh-list
19751352|NCT02489318|Hormones|hormones|mesh-ancestor
19751353|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751354|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751355|NCT02408549|Lacosamide|lacosamide|mesh-list
19751356|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
19751357|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19751358|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19751359|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19751360|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751361|NCT02365597|Metformin|metformin|mesh-list
19751362|NCT02365597|Midazolam|midazolam|mesh-list
19751363|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19751364|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751365|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19751366|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19751367|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19751368|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19751369|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19751370|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19751371|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19751372|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
19751373|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
19751374|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
19751375|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
19751376|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19751377|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751378|NCT02316106|Daratumumab|daratumumab|mesh-list
19751379|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19751380|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751381|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
20138123|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138124|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751382|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751383|NCT02310269|Pasireotide|pasireotide|mesh-list
19751384|NCT02310269|Hormones|hormones|mesh-ancestor
20138125|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138126|NCT00046917|Growth Substances|growth substances|mesh-ancestor
19751385|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751386|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751387|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19751388|NCT02296125|Gefitinib|gefitinib|mesh-list
19751389|NCT02296125|Osimertinib|osimertinib|mesh-list
19751390|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751391|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20313464|NCT00689520|Vitamin K|vitamin k|mesh-list
20313465|NCT00689520|Tinzaparin|tinzaparin|mesh-list
20313466|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19751392|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751393|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751394|NCT02277444|Golimumab|golimumab|mesh-list
19751395|NCT02277444|Methotrexate|methotrexate|mesh-list
19751396|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19751397|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
19751398|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19751399|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751400|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19751401|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
19751402|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751403|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751404|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
19751405|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751406|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19751407|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751408|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
19751409|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138127|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313467|NCT00689520|Dalteparin|dalteparin|mesh-list
19751410|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20138128|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138129|NCT00046943|Atrasentan|atrasentan|mesh-list
20138130|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138131|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20138132|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20138133|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138134|NCT00046969|Cisplatin|cisplatin|mesh-list
20138135|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138136|NCT00046995|Leucovorin|leucovorin|mesh-list
20138137|NCT00046995|Carboplatin|carboplatin|mesh-list
20138138|NCT00046995|Fluorouracil|fluorouracil|mesh-list
20138139|NCT00046995|Calcium|calcium|mesh-list
20138140|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
20138141|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138142|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20138143|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138144|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
20138145|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138146|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138147|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138148|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
20138149|NCT00046995|Antidotes|antidotes|mesh-ancestor
20138150|NCT00046995|Protective Agents|protective agents|mesh-ancestor
20138151|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
20138152|NCT00046995|Vitamins|vitamins|mesh-ancestor
20138153|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
20138154|NCT00047021|Cytarabine|cytarabine|mesh-list
20138155|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
20138156|NCT00047021|Sargramostim|sargramostim|mesh-list
20138157|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138158|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
20138159|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138160|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138161|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
20138162|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138163|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138164|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
20138165|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138166|NCT00047021|Analgesics|analgesics|mesh-ancestor
20138167|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
20138168|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138169|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20313468|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
20313469|NCT00689520|Vitamins|vitamins|mesh-ancestor
20313470|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
20313471|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313472|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20313473|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20138170|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138171|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138172|NCT00047047|Gemcitabine|gemcitabine|mesh-list
20138173|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138174|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138175|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
20138176|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138177|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
20138178|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138179|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138180|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138181|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
20138182|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138183|NCT00047073|Sirolimus|sirolimus|mesh-list
20138184|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138185|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313474|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313475|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
20313476|NCT00689520|Coagulants|coagulants|mesh-ancestor
20313477|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
20313478|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20313479|NCT00689559|Aripiprazole|aripiprazole|mesh-list
20313480|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
20313481|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20313482|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20313483|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20313484|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313485|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313486|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
20313487|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
20313488|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313489|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629251|NCT02459288|Ticagrelor|ticagrelor|mesh-list
19629252|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19629253|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20138186|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20138187|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138188|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
20313490|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20313491|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20313492|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
20313493|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19751411|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19751412|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751413|NCT02261636|Mesalamine|mesalamine|mesh-list
19751414|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19751415|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19751416|NCT02261636|Analgesics|analgesics|mesh-ancestor
19751417|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
19751418|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751419|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751420|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751421|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751422|NCT02257736|Prednisone|prednisone|mesh-list
19751423|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
19751424|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751425|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
19751426|NCT02257736|Hormones|hormones|mesh-ancestor
19751427|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751428|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138189|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313494|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19629254|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19629255|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19629256|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
19629257|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629258|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629259|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629260|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
19751429|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751430|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751431|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19751432|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751433|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751434|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751435|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19751436|NCT02256696|Rifampin|rifampin|mesh-list
19751437|NCT02256696|Rifabutin|rifabutin|mesh-list
19751438|NCT02256696|Isoniazid|isoniazid|mesh-list
19751439|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
19751440|NCT02256696|Ethambutol|ethambutol|mesh-list
19751441|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19751442|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
19751443|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19751444|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751445|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
19751446|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19751447|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751448|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751449|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19751450|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19751451|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19751452|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19751453|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19751454|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19751455|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19751456|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19751457|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
19751458|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19751459|NCT02252172|Dexamethasone|dexamethasone|mesh-list
19751460|NCT02252172|Lenalidomide|lenalidomide|mesh-list
19751461|NCT02252172|Daratumumab|daratumumab|mesh-list
19751462|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19751463|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751464|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
19751465|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
19751466|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751467|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751468|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751469|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
19751470|NCT02252172|Hormones|hormones|mesh-ancestor
19751471|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751472|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751473|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751474|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
19751475|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19751476|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19751477|NCT02252172|Growth Substances|growth substances|mesh-ancestor
19751478|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
19751479|NCT02195479|Dexamethasone|dexamethasone|mesh-list
19751480|NCT02195479|Prednisone|prednisone|mesh-list
19751481|NCT02195479|Melphalan|melphalan|mesh-list
19751482|NCT02195479|Bortezomib|bortezomib|mesh-list
19751483|NCT02195479|Daratumumab|daratumumab|mesh-list
19751484|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19629261|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19629262|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629263|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19629264|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629265|NCT02458963|Menotropins|menotropins|mesh-list
19629266|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19629267|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
19629268|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19629269|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629270|NCT02458742|Morphine|morphine|mesh-list
19629271|NCT02458742|Bupivacaine|bupivacaine|mesh-list
20138190|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
20138191|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138192|NCT00047099|Tamoxifen|tamoxifen|mesh-list
20138193|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
20138194|NCT00047099|Docetaxel|docetaxel|mesh-list
20138195|NCT00047099|Fluorouracil|fluorouracil|mesh-list
20138196|NCT00047099|Epirubicin|epirubicin|mesh-list
20138197|NCT00047099|Goserelin|goserelin|mesh-list
20138198|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751485|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138199|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
20138200|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751486|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
19751487|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
19751488|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751489|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751490|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751491|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
19751492|NCT02195479|Hormones|hormones|mesh-ancestor
19751493|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751494|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20138201|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138202|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138203|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
20138204|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138205|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138206|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20138207|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138208|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138209|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138210|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
20138211|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138212|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20138213|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20138214|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138215|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138216|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20138217|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
20138218|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20138219|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20138220|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20138221|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20138222|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20138223|NCT00047112|Fluorouracil|fluorouracil|mesh-list
20138224|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138225|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
19629272|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
19629273|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
20138226|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138227|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138228|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138229|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
20138230|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138231|NCT00047138|Dactinomycin|dactinomycin|mesh-list
20138232|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
20138233|NCT00047138|Carboplatin|carboplatin|mesh-list
20138234|NCT00047138|Doxorubicin|doxorubicin|mesh-list
20138235|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20138236|NCT00047138|Etoposide|etoposide|mesh-list
20138237|NCT00047138|Vincristine|vincristine|mesh-list
20138238|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138239|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
20138240|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138241|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138242|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138243|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
19629274|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629275|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629276|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
19629277|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629278|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19629279|NCT02458742|Narcotics|narcotics|mesh-ancestor
19629280|NCT02458742|Analgesics|analgesics|mesh-ancestor
19661304|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661305|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661306|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
19661307|NCT04991103|Hormones|hormones|mesh-ancestor
19661308|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661309|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19661310|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661311|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
19661312|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19661313|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19661314|NCT04991103|Growth Substances|growth substances|mesh-ancestor
19661315|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
19661316|NCT04945213|Biperiden|biperiden|mesh-list
20138244|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138245|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138246|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751495|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751496|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751497|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
19751498|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751499|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751500|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751501|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
20313495|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20313496|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20313497|NCT00689585|Ethosuximide|ethosuximide|mesh-list
20313498|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
20313499|NCT00689598|Spironolactone|spironolactone|mesh-list
20313500|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19751502|NCT02172651|Vitamin D|vitamin d|mesh-list
19751503|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
19751504|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
19751505|NCT02172651|Vitamins|vitamins|mesh-list
19751506|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
20138247|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20138248|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19751507|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751508|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19751509|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19751510|NCT02136134|Dexamethasone|dexamethasone|mesh-list
20138249|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138250|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138251|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20138252|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138253|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138254|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138255|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138256|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138257|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20138258|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20138259|NCT00047164|Ipilimumab|ipilimumab|mesh-list
20138260|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20138261|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138262|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20138263|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138264|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
20138265|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138266|NCT00047190|Tipifarnib|tipifarnib|mesh-list
20138267|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608474|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608475|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20608476|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20608477|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20608478|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19751511|NCT02136134|Bortezomib|bortezomib|mesh-list
19751512|NCT02136134|Daratumumab|daratumumab|mesh-list
19751513|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138268|NCT00047203|Alvocidib|alvocidib|mesh-list
20138269|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138270|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138271|NCT00047203|Growth Substances|growth substances|mesh-ancestor
20138272|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138273|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138274|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138275|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138276|NCT00047216|Tipifarnib|tipifarnib|mesh-list
19751514|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
19751515|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
19751516|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751517|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138277|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138278|NCT00047229|Doxorubicin|doxorubicin|mesh-list
20313501|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
20313502|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751518|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751519|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
19751520|NCT02136134|Hormones|hormones|mesh-ancestor
19751521|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751522|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751523|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751524|NCT02123758|Prednisone|prednisone|mesh-list
19751525|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
19751526|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751527|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
19751528|NCT02123758|Hormones|hormones|mesh-ancestor
19751529|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751530|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751531|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751532|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751533|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19751534|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751535|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751536|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751537|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19751538|NCT02087423|Durvalumab|durvalumab|mesh-list
19751539|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751540|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751541|NCT02076009|Dexamethasone|dexamethasone|mesh-list
19751542|NCT02076009|Lenalidomide|lenalidomide|mesh-list
19751543|NCT02076009|Daratumumab|daratumumab|mesh-list
19751544|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751545|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
19751546|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
19751547|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608479|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608480|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20608481|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20608482|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608483|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608484|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20608485|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20608486|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
19751548|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751549|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751550|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
19751551|NCT02076009|Hormones|hormones|mesh-ancestor
19751552|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751553|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751554|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751555|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
19751556|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19751557|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19751558|NCT02076009|Growth Substances|growth substances|mesh-ancestor
19751559|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
19751560|NCT02028338|Dapivirine|dapivirine|mesh-list
19751561|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19751562|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19751563|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
19751564|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751565|NCT01998971|Acetaminophen|acetaminophen|mesh-list
19751566|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
19751567|NCT01998971|Promethazine|promethazine|mesh-list
19751568|NCT01998971|Thalidomide|thalidomide|mesh-list
19751569|NCT01998971|Dexamethasone|dexamethasone|mesh-list
20138279|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20138280|NCT00047229|Oblimersen|oblimersen|mesh-list
19751570|NCT01998971|Prednisone|prednisone|mesh-list
20608487|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19751571|NCT01998971|Lenalidomide|lenalidomide|mesh-list
19751572|NCT01998971|Melphalan|melphalan|mesh-list
19751573|NCT01998971|Bortezomib|bortezomib|mesh-list
19751574|NCT01998971|Daratumumab|daratumumab|mesh-list
19751575|NCT01998971|Pomalidomide|pomalidomide|mesh-list
19751576|NCT01998971|Montelukast|montelukast|mesh-list
19751577|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751578|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
19751579|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
19751580|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751581|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751582|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751583|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
19751584|NCT01998971|Hormones|hormones|mesh-ancestor
19751585|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751586|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751587|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751588|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
19751589|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19751590|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19751591|NCT01998971|Growth Substances|growth substances|mesh-ancestor
19751592|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
19751593|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19751594|NCT01998971|Analgesics|analgesics|mesh-ancestor
19751595|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
19751596|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
19751597|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751598|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
19751599|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751600|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751601|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138281|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20138282|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138283|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20138284|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138285|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138286|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138287|NCT00047242|Irinotecan|irinotecan|mesh-list
20138288|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20138289|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20138290|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138291|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138292|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138293|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138294|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138295|NCT00047255|Carboplatin|carboplatin|mesh-list
20138296|NCT00047255|Docetaxel|docetaxel|mesh-list
20138297|NCT00047255|Trastuzumab|trastuzumab|mesh-list
20138298|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138299|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138300|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138301|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138302|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138303|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20138304|NCT00047268|Cytarabine|cytarabine|mesh-list
20138305|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
19629281|NCT02458755|Atorvastatin|atorvastatin|mesh-list
19629282|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19629283|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19629284|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19629285|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
19629286|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629287|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19629288|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19629289|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629290|NCT02458924|Niacin|niacin|mesh-list
19751602|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
20138306|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19751603|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19751604|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751605|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19751606|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
19751607|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19751608|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751609|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19751610|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19751611|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19751612|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19751613|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19751614|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
19751615|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
19751616|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19751617|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
19751618|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
19751619|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19751620|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19751621|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
19751622|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
19751623|NCT01974440|Prednisone|prednisone|mesh-list
19751624|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
19751625|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19751626|NCT01974440|Rituximab|rituximab|mesh-list
19751627|NCT01974440|Doxorubicin|doxorubicin|mesh-list
19751628|NCT01974440|Vincristine|vincristine|mesh-list
19629291|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19629292|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
19629293|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629294|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19629295|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
19629296|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
19629297|NCT02458924|Vitamins|vitamins|mesh-ancestor
19629298|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
19751629|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751630|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
19751631|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751632|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751633|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751634|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
19751635|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751636|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751637|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751638|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751639|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19751640|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19751641|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19751642|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751643|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751644|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
19751645|NCT01974440|Hormones|hormones|mesh-ancestor
19751646|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751647|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751648|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19751649|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
19751650|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138307|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
20138308|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138309|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138310|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
20138311|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138312|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138313|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
20138314|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138315|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20138316|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138317|NCT00047281|Thalidomide|thalidomide|mesh-list
20138318|NCT00047281|Celecoxib|celecoxib|mesh-list
20138319|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
20138320|NCT00047281|Etoposide|etoposide|mesh-list
20138321|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138322|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
19629299|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138323|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629300|NCT02459158|Arbekacin|arbekacin|mesh-list
19751651|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138324|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138325|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138326|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
20138327|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138328|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138329|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20138330|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20138331|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20138332|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138333|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138334|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20138335|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20138336|NCT00047281|Analgesics|analgesics|mesh-ancestor
20138337|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
20138338|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138339|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138340|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20138341|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20138342|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
20138343|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138344|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138345|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138346|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138347|NCT00047281|Growth Substances|growth substances|mesh-ancestor
20138348|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138349|NCT00047294|Thalidomide|thalidomide|mesh-list
20138350|NCT00047294|Celecoxib|celecoxib|mesh-list
20138351|NCT00047294|Temozolomide|temozolomide|mesh-list
20138352|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138353|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
20138354|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138355|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138356|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20138357|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20138358|NCT00047294|Analgesics|analgesics|mesh-ancestor
20138359|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
20138360|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138361|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138362|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138363|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138364|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20138365|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20138366|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138367|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138368|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
20138369|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
20138370|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138371|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138372|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19629301|NCT02459158|Dibekacin|dibekacin|mesh-list
19629302|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19629303|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629304|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19629305|NCT02458716|Leuprolide|leuprolide|mesh-list
19629306|NCT02458716|Bicalutamide|bicalutamide|mesh-list
19629307|NCT02458716|Androgens|androgens|mesh-list
19629308|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
19629309|NCT02458716|Hormones|hormones|mesh-ancestor
19629310|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629311|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629312|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19629313|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
19629314|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19629315|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19629316|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629317|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
19629318|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
19629319|NCT02458911|Paclitaxel|paclitaxel|mesh-list
20138373|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138374|NCT00047294|Growth Substances|growth substances|mesh-ancestor
20138375|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138376|NCT00047307|Gemcitabine|gemcitabine|mesh-list
20138377|NCT00047307|Alvocidib|alvocidib|mesh-list
20138378|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20313503|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751652|NCT01918397|Levofloxacin|levofloxacin|mesh-list
19751653|NCT01918397|Ofloxacin|ofloxacin|mesh-list
19751654|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19751655|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751656|NCT01918397|Renal Agents|renal agents|mesh-ancestor
19751657|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19751658|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19751659|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19751660|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751661|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751662|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751663|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19751664|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20138379|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
20138380|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138381|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138382|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
19751665|NCT01900574|Golimumab|golimumab|mesh-list
19751666|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19751667|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751668|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751669|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
19751670|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751671|NCT01815359|Leucovorin|leucovorin|mesh-list
19751672|NCT01815359|Mitomycins|mitomycins|mesh-list
19751673|NCT01815359|Mitomycin|mitomycin|mesh-list
19751674|NCT01815359|Antidotes|antidotes|mesh-ancestor
19751675|NCT01815359|Protective Agents|protective agents|mesh-ancestor
19751676|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751677|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
19751678|NCT01815359|Vitamins|vitamins|mesh-ancestor
19751679|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
19751680|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19751681|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751682|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
20313504|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20313505|NCT00689598|Diuretics|diuretics|mesh-ancestor
20313506|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
20313507|NCT00689624|Leucovorin|leucovorin|mesh-list
20313508|NCT00689624|Fluorouracil|fluorouracil|mesh-list
20313509|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
20313510|NCT00689624|Irinotecan|irinotecan|mesh-list
19751683|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751684|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19751685|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751686|NCT01792687|Prednisone|prednisone|mesh-list
19751687|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
19751688|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138383|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138384|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138385|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138386|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
20138387|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138388|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138389|NCT00047307|Growth Substances|growth substances|mesh-ancestor
20138390|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138391|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20138392|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138393|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138394|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138395|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138396|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20138397|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138398|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138399|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138400|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173622|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313511|NCT00689624|Cetuximab|cetuximab|mesh-list
19629320|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19629321|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629322|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
19629323|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
19629324|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
19629325|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629326|NCT02458781|Metronidazole|metronidazole|mesh-list
19629327|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
19751689|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
19751690|NCT01792687|Hormones|hormones|mesh-ancestor
19751691|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751692|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751693|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751694|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751695|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19751696|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751697|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751698|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751699|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19751700|NCT01776840|Rituximab|rituximab|mesh-list
19751701|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19751702|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751703|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751704|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
19751705|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751706|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751707|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751708|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
19751709|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751710|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
19751711|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
19751712|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19751713|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19751714|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751715|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751716|NCT01757782|Urological Agents|urological agents|mesh-ancestor
19751717|NCT01615029|Dexamethasone|dexamethasone|mesh-list
19751718|NCT01615029|Lenalidomide|lenalidomide|mesh-list
20138401|NCT00047450|Citalopram|citalopram|mesh-list
20138402|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20313512|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
19751719|NCT01615029|Daratumumab|daratumumab|mesh-list
19751720|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19751721|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751722|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
19751723|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
19751724|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751725|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313513|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313514|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20313515|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313516|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313517|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
20313518|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751726|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751727|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
19751728|NCT01615029|Hormones|hormones|mesh-ancestor
19751729|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751730|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751731|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751732|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
19751733|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138403|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138404|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138405|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138406|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138407|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
20138408|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138409|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20138410|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
20138411|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138412|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
20138413|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20138414|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138415|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20138416|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138417|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138418|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138419|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
19751734|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19751735|NCT01615029|Growth Substances|growth substances|mesh-ancestor
19751736|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
19751737|NCT01612351|Paclitaxel|paclitaxel|mesh-list
19751738|NCT01612351|Cisplatin|cisplatin|mesh-list
19751739|NCT01612351|Carboplatin|carboplatin|mesh-list
19751740|NCT01612351|Lapatinib|lapatinib|mesh-list
19751741|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19751742|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751743|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
19751744|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
19751745|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
19751746|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751747|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138420|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138421|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
20138422|NCT00047502|Lonafarnib|lonafarnib|mesh-list
20138423|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138424|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138425|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138426|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138427|NCT00047554|Travoprost|travoprost|mesh-list
20138428|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20138429|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20138430|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20138431|NCT00047567|Zonisamide|zonisamide|mesh-list
20138432|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
20138433|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20138434|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138435|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138436|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20138437|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138438|NCT00047580|Tizanidine|tizanidine|mesh-list
20138439|NCT00047580|Analgesics|analgesics|mesh-ancestor
20138440|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
20138441|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138442|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138443|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
20138444|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20138445|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20138446|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
20138447|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
20138448|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20138449|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20138450|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20138451|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
20138452|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138453|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138454|NCT00047632|Interferons|interferons|mesh-list
20138455|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
20138456|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138457|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
20138458|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138459|NCT00047645|Interferons|interferons|mesh-list
20138460|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
20138461|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138462|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
20138463|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138464|NCT00047658|Interferons|interferons|mesh-list
20138465|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
20138466|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138467|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
19751748|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751749|NCT01572480|Dexamethasone|dexamethasone|mesh-list
19751750|NCT01572480|Lenalidomide|lenalidomide|mesh-list
19751751|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751752|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
19751753|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
19751754|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751755|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751756|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751757|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
19751758|NCT01572480|Hormones|hormones|mesh-ancestor
19751759|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751760|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20138468|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138469|NCT00047671|Citalopram|citalopram|mesh-list
19751761|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751762|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
19751763|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19751764|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19751765|NCT01572480|Growth Substances|growth substances|mesh-ancestor
19751766|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
19751767|NCT01314118|Prednisone|prednisone|mesh-list
19751768|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
19751769|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751770|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
19751771|NCT01314118|Hormones|hormones|mesh-ancestor
19751772|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751773|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751774|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751775|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138470|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20138471|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138472|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138473|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138474|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138475|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
20313519|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20313520|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313521|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313522|NCT00689624|Antidotes|antidotes|mesh-ancestor
20313523|NCT00689624|Protective Agents|protective agents|mesh-ancestor
20313524|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
20313525|NCT00689624|Vitamins|vitamins|mesh-ancestor
20313526|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
20313527|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313528|NCT00689637|Warfarin|warfarin|mesh-list
20313529|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
19629328|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
19629329|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138476|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138477|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20138478|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
20138479|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138480|NCT00047710|Bevacizumab|bevacizumab|mesh-list
20138481|NCT00047710|Capecitabine|capecitabine|mesh-list
20138482|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20138483|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138484|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138485|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138486|NCT00047710|Growth Substances|growth substances|mesh-ancestor
20138487|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138488|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138489|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138490|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
20138491|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138492|NCT00047723|Minocycline|minocycline|mesh-list
20138493|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138494|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138495|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20138496|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138497|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138498|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347283|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347284|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
19629330|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19629331|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19629332|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19629333|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19629334|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19629335|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629336|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629337|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629338|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19629339|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19629340|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19629341|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
19629342|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
19629343|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
19629344|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20138499|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138500|NCT00047749|Ziconotide|ziconotide|mesh-list
20138501|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20138502|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20313530|NCT00689702|Capecitabine|capecitabine|mesh-list
19751776|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19751777|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751778|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751779|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751780|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19832605|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832606|NCT03497975|Analgesics|analgesics|mesh-ancestor
19832607|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
19832608|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832609|NCT03480971|Tempol|tempol|mesh-list
19832610|NCT03480971|TEMPO|tempo|mesh-list
19832611|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
19832612|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832613|NCT03480971|Protective Agents|protective agents|mesh-ancestor
19832614|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832615|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19832616|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832617|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19832618|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19832619|NCT03433833|Digoxin|digoxin|mesh-list
19832620|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19832621|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19832622|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832623|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832624|NCT03433833|Protective Agents|protective agents|mesh-ancestor
19832625|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832626|NCT03376646|Paclitaxel|paclitaxel|mesh-list
19832627|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19832628|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832629|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
19832630|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
19832631|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
19832632|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832633|NCT03359811|Bupivacaine|bupivacaine|mesh-list
19832634|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
19832635|NCT03359811|Anesthetics|anesthetics|mesh-list
19832636|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832637|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832638|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
19832639|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832640|NCT03297684|Aflibercept|aflibercept|mesh-list
19832641|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19832642|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19832643|NCT03297684|Growth Substances|growth substances|mesh-ancestor
19832644|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832645|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832646|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832647|NCT03262662|Varenicline|varenicline|mesh-list
19832648|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19832649|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19629345|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19629346|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629347|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
19629348|NCT02458729|Coagulants|coagulants|mesh-ancestor
19629349|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19629350|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
19629351|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19629352|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
19629353|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629354|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
19629355|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
19629356|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19629357|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19832650|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
19832651|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629358|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19629359|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19629360|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832652|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832653|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751781|NCT00002931|Paclitaxel|paclitaxel|mesh-list
19751782|NCT00002931|Etoposide|etoposide|mesh-list
19751783|NCT00002931|Carboplatin|carboplatin|mesh-list
19751784|NCT00002931|Ifosfamide|ifosfamide|mesh-list
19751785|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19751786|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751787|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
19751788|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
19751789|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19751790|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751791|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19751792|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19751793|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751794|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751795|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
19751796|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
19629361|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751797|NCT00003138|Lenograstim|lenograstim|mesh-list
19751798|NCT00003138|Sargramostim|sargramostim|mesh-list
20138503|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138504|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20138505|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138506|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20138507|NCT00047749|Protective Agents|protective agents|mesh-ancestor
20138508|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20138509|NCT00047749|Analgesics|analgesics|mesh-ancestor
20138510|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
20138511|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138512|NCT00047762|Bevacizumab|bevacizumab|mesh-list
20138513|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20138514|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20138515|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138516|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138517|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138518|NCT00047762|Growth Substances|growth substances|mesh-ancestor
20138519|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138520|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138521|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138522|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138523|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138524|NCT00047801|Docetaxel|docetaxel|mesh-list
20138525|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138526|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138527|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138528|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138529|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138530|NCT00047827|Amphotericin B|amphotericin b|mesh-list
20138531|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20138532|NCT00047827|Micafungin|micafungin|mesh-list
20138533|NCT00047827|Amebicides|amebicides|mesh-ancestor
20138534|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20138535|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20138536|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138537|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138538|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
20138539|NCT00047840|Docetaxel|docetaxel|mesh-list
20138540|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138541|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138542|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138543|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138544|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138545|NCT00048087|Docetaxel|docetaxel|mesh-list
19629362|NCT02458547|Bupivacaine|bupivacaine|mesh-list
19629363|NCT02458547|Propofol|propofol|mesh-list
19629364|NCT02458547|Desflurane|desflurane|mesh-list
19629365|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
19629366|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
19629367|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629368|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629369|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
19629370|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629371|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19751799|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19629372|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19751800|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
19751801|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138546|NCT00048087|Gefitinib|gefitinib|mesh-list
20138547|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138548|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138549|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138550|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138551|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138552|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138553|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138554|NCT00048113|Alicaforsen|alicaforsen|mesh-list
20138555|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138556|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138557|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
20138558|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138559|NCT00048126|Capecitabine|capecitabine|mesh-list
20138560|NCT00048126|Irinotecan|irinotecan|mesh-list
20138561|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138562|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
20138563|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138564|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138565|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20138566|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138567|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138568|NCT00048139|Capecitabine|capecitabine|mesh-list
20138569|NCT00048139|Irinotecan|irinotecan|mesh-list
20138570|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138571|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
20138572|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629373|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
19629374|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19629375|NCT02458625|Iron|iron|mesh-list
19629376|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19629377|NCT02458625|Trace Elements|trace elements|mesh-ancestor
20313531|NCT00689702|Cetuximab|cetuximab|mesh-list
20313532|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20313533|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
20138573|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138574|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20138575|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138576|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138577|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
20138578|NCT00048152|Cyclosporine|cyclosporine|mesh-list
20138579|NCT00048152|Cyclosporins|cyclosporins|mesh-list
20138580|NCT00048152|Daclizumab|daclizumab|mesh-list
20138581|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20138582|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608488|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
20608489|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
20608490|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
19629378|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
20138583|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20138584|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
20138585|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138586|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138587|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138588|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138589|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
20138590|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
20138591|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138592|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
20138593|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138594|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138595|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20138596|NCT00048204|Paroxetine|paroxetine|mesh-list
20138597|NCT00048204|Vestipitant|vestipitant|mesh-list
20138598|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20608491|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19629379|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629380|NCT02458625|Hematinics|hematinics|mesh-ancestor
19629381|NCT02458482|Albuterol|albuterol|mesh-list
19629382|NCT02458482|Ipratropium|ipratropium|mesh-list
19629383|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19629384|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
19629385|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629386|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629387|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19661317|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19661318|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19661319|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
19661320|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
19751802|NCT00003138|Hematinics|hematinics|mesh-ancestor
19751803|NCT00003199|Tamoxifen|tamoxifen|mesh-list
19751804|NCT00003199|Aldesleukin|aldesleukin|mesh-list
19751805|NCT00003199|Melphalan|melphalan|mesh-list
19751806|NCT00003199|Busulfan|busulfan|mesh-list
19629388|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
19629389|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
19629390|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19629391|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19629392|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19629393|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19629394|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
19629395|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629396|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629397|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19629398|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
19629399|NCT02458339|Methotrexate|methotrexate|mesh-list
19629400|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19629401|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
19629402|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19751807|NCT00003199|Thiotepa|thiotepa|mesh-list
19751808|NCT00003199|Interleukin-2|interleukin-2|mesh-list
20138599|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138600|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138601|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138602|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138603|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
20138604|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629403|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629404|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19629405|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
19629406|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629407|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629408|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
19629409|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629410|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19629411|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629412|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
19629413|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629414|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19751809|NCT00003199|Sargramostim|sargramostim|mesh-list
19751810|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751811|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751812|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
19751813|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751814|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751815|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751816|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
19751817|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751818|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19751819|NCT00003199|Analgesics|analgesics|mesh-ancestor
19751820|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
19751821|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751822|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19751823|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
19751824|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751825|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19751826|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19751827|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19832654|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19751828|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20138605|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20138606|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
20138607|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138608|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20138609|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20138610|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629415|NCT02458209|Bococizumab|bococizumab|mesh-list
19629416|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19629417|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19629418|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
19629419|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751829|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19751830|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19751831|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
19751832|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751833|NCT00003222|Aldesleukin|aldesleukin|mesh-list
19751834|NCT00003222|Interleukin-2|interleukin-2|mesh-list
19751835|NCT00003222|Sargramostim|sargramostim|mesh-list
19751836|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
19751837|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751838|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19751839|NCT00003222|Analgesics|analgesics|mesh-ancestor
19751840|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
19751841|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751842|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751843|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
19751844|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19751845|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19629420|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19629421|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20313534|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313535|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629422|NCT02458014|Blinatumomab|blinatumomab|mesh-list
19629423|NCT02458014|Antibodies|antibodies|mesh-list
19629424|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
19629425|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20138611|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20138612|NCT00048230|Bortezomib|bortezomib|mesh-list
20138613|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138614|NCT00048295|Alicaforsen|alicaforsen|mesh-list
20138615|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138616|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138617|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
20138618|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138619|NCT00048334|Romidepsin|romidepsin|mesh-list
20138620|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20138621|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138622|NCT00048360|Bupropion|bupropion|mesh-list
20138623|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20138624|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
20138625|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138626|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20138627|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138628|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138629|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138630|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
20138631|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138632|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138633|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20138634|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20138635|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138636|NCT00048373|Etanercept|etanercept|mesh-list
20138637|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20138638|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20138639|NCT00048373|Analgesics|analgesics|mesh-ancestor
20138640|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
20138641|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629426|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
19751846|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
19751847|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751848|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19751849|NCT00003224|Vaccines|vaccines|mesh-list
19751850|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
19751851|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
20313536|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313537|NCT00689715|Ethanol|ethanol|mesh-list
20313538|NCT00689715|Paclitaxel|paclitaxel|mesh-list
20313539|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20313540|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20313541|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313542|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
20313543|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
20313544|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
20313545|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313546|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20313547|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751852|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751853|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19751854|NCT00003270|Cyclosporine|cyclosporine|mesh-list
19751855|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
19751856|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
19751857|NCT00003270|Busulfan|busulfan|mesh-list
19751858|NCT00003270|Cyclosporins|cyclosporins|mesh-list
19751859|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19751860|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751861|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
19751862|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751863|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751864|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751865|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
19751866|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751867|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138642|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138643|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138644|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138645|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138646|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138647|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
19629427|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19629428|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
19629429|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138648|NCT00048399|Fludarabine|fludarabine|mesh-list
20138649|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
20138650|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138651|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20138652|NCT00048412|Fludarabine|fludarabine|mesh-list
20138653|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
20138654|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138655|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20138656|NCT00048425|Simendan|simendan|mesh-list
20138657|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20138658|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
20138659|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20138660|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20313548|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313549|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629430|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629431|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629432|NCT02458183|Vaccines|vaccines|mesh-list
19629433|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
19629434|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751868|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751869|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751870|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
19751871|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751872|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
19751873|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19751874|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751875|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
19751876|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
19751877|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751878|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19751879|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
19751880|NCT00003270|Hormones|hormones|mesh-ancestor
19751881|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751882|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19751883|NCT00003270|Protective Agents|protective agents|mesh-ancestor
19751884|NCT05235100|Apatinib|apatinib|mesh-list
19751885|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751886|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138661|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138662|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138663|NCT00048425|Protective Agents|protective agents|mesh-ancestor
20138664|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138665|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20138666|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138667|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138668|NCT00048503|Tipifarnib|tipifarnib|mesh-list
20138669|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138670|NCT00048555|Galiximab|galiximab|mesh-list
20138671|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138672|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138673|NCT00048594|Aprepitant|aprepitant|mesh-list
20138674|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
20138675|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
20138676|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138677|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138678|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138679|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19629435|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
19629436|NCT02458196|Prednisone|prednisone|mesh-list
19629437|NCT02458196|Prednisolone|prednisolone|mesh-list
19629438|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629439|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
19629440|NCT02458196|Hormones|hormones|mesh-ancestor
19629441|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629442|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629443|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19629444|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629445|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19629446|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19629447|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
19629448|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19629449|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629450|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629451|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629452|NCT02458157|Furosemide|furosemide|mesh-list
19629453|NCT02458157|Diuretics|diuretics|mesh-ancestor
19629454|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
19629455|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629456|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19629457|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19665706|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19665707|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19665708|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665709|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
19665710|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665711|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
19665712|NCT04337177|Temozolomide|temozolomide|mesh-list
19665713|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665714|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
19665715|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665716|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665717|NCT04316143|Zamicastat|zamicastat|mesh-list
19665718|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665719|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665720|NCT04308330|Vorinostat|vorinostat|mesh-list
19665721|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665722|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19665723|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665724|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665730|NCT04271293|Edoxaban|edoxaban|mesh-list
19665731|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19665732|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
19665733|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19665734|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
19665735|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665736|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751887|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751888|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751889|NCT05234840|Triamcinolone|triamcinolone|mesh-list
19751890|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751891|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
19751892|NCT05234840|Hormones|hormones|mesh-ancestor
20138680|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138681|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138682|NCT00048607|Aprepitant|aprepitant|mesh-list
20138683|NCT00048607|Paroxetine|paroxetine|mesh-list
20138684|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20138685|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138686|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138687|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138688|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138689|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
20138690|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138691|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20138692|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
20138693|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138694|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20138695|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20138696|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138697|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
20138698|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
20138699|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138700|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138701|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20138702|NCT00048646|Progesterone|progesterone|mesh-list
20138703|NCT00048646|Progestins|progestins|mesh-ancestor
20138704|NCT00048646|Hormones|hormones|mesh-ancestor
20138705|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20138706|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138707|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
20138708|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20138709|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138710|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
20138711|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138712|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138713|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138714|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138715|NCT00048750|Micafungin|micafungin|mesh-list
20138716|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
20138717|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138718|NCT00048763|Cilostazol|cilostazol|mesh-list
20138719|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20138720|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
20138721|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138722|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138723|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20138724|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
20138725|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20138726|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20138727|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138728|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20138729|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
20138730|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20138731|NCT00048763|Protective Agents|protective agents|mesh-ancestor
20138732|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20138733|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20138734|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138735|NCT00048776|Cilostazol|cilostazol|mesh-list
20138736|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20138737|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
20138738|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138739|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138740|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20138741|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
20138742|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20138743|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20173623|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313550|NCT00689780|Midazolam|midazolam|mesh-list
20138744|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138745|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20138746|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
20138747|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20138748|NCT00048776|Protective Agents|protective agents|mesh-ancestor
20138749|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20138750|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20138751|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138752|NCT00048802|Valproic Acid|valproic acid|mesh-list
20138753|NCT00048802|Olanzapine|olanzapine|mesh-list
20138754|NCT00048802|Risperidone|risperidone|mesh-list
20138755|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20138756|NCT00048802|Ziprasidone|ziprasidone|mesh-list
20138757|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20138758|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
20138759|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138760|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138761|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138762|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20138763|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20138764|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20138765|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138766|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20138767|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
20138768|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
20138769|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
20138770|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138771|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138772|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20138773|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138774|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138775|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
20138776|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138777|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
20138778|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
20138779|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
20138780|NCT00048828|Olanzapine|olanzapine|mesh-list
20138781|NCT00048828|Clozapine|clozapine|mesh-list
20138782|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
20138783|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
20138784|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20138785|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138786|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138787|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20138788|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20138789|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20138790|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138791|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20138792|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138793|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138794|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138795|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138796|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
20138797|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20138798|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
20138799|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
20138800|NCT00048841|Alendronate|alendronate|mesh-list
20138801|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20138802|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138803|NCT00048854|Sertraline|sertraline|mesh-list
20138804|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
20138805|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20138806|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20138807|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20138808|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20138809|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138810|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20138811|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
19629458|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629459|NCT02457975|Ranibizumab|ranibizumab|mesh-list
19629460|NCT02457975|Aflibercept|aflibercept|mesh-list
19629461|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138812|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138813|NCT00048880|Antibodies|antibodies|mesh-list
20138814|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20138815|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
19751893|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751894|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751895|NCT05234684|Prednisone|prednisone|mesh-list
19751896|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
19751897|NCT05234684|Vincristine|vincristine|mesh-list
19751898|NCT05234684|Rituximab|rituximab|mesh-list
19751899|NCT05234684|Doxorubicin|doxorubicin|mesh-list
19751900|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751901|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
19751902|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751903|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751904|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19751905|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
19751906|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751907|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751908|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19751909|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20138816|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138817|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20313551|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20313552|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20313553|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313554|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313555|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19629462|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19629463|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138818|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
20138819|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138820|NCT00049023|Octreotide|octreotide|mesh-list
20138821|NCT00049023|Edotreotide|edotreotide|mesh-list
20138822|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20138823|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20138824|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138825|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20138826|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138827|NCT00049062|Gefitinib|gefitinib|mesh-list
20138828|NCT00049062|Anastrozole|anastrozole|mesh-list
20138829|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138830|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138831|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138832|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138833|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20138834|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20138835|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20138836|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20138837|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
20138838|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20138839|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138840|NCT00049075|Fludarabine|fludarabine|mesh-list
20138841|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
20138842|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138843|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138844|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
20138845|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138846|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138847|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
20138848|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138849|NCT00049088|Bevacizumab|bevacizumab|mesh-list
19629464|NCT02457975|Growth Substances|growth substances|mesh-ancestor
19629465|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629466|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19629467|NCT02458118|Secretin|secretin|mesh-list
19629468|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19629469|NCT02458118|Hormones|hormones|mesh-ancestor
19629470|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629471|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629472|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
19629473|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19751910|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
19751911|NCT05234684|Hormones|hormones|mesh-ancestor
19751912|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751913|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19629474|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629475|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629476|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20138850|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20138851|NCT00049088|Docetaxel|docetaxel|mesh-list
20138852|NCT00049088|Antibodies|antibodies|mesh-list
20138853|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
20138854|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20138855|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138856|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138857|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138858|NCT00049088|Growth Substances|growth substances|mesh-ancestor
20138859|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138860|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138861|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
20138862|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138863|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138864|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138865|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138866|NCT00049101|Leucovorin|leucovorin|mesh-list
20138867|NCT00049101|Fluorouracil|fluorouracil|mesh-list
20138868|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
20138869|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20138870|NCT00049101|Calcium|calcium|mesh-list
20138871|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
20138872|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20138873|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138874|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
20138875|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138876|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138877|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138878|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138879|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
20138880|NCT00049101|Antidotes|antidotes|mesh-ancestor
20138881|NCT00049101|Protective Agents|protective agents|mesh-ancestor
20138882|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
20138883|NCT00049101|Vitamins|vitamins|mesh-ancestor
20138884|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
20138885|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138886|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173624|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20173625|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173626|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173627|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20173628|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20173629|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173630|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20173631|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20173632|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173633|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20173634|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20173635|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173636|NCT00162383|Dapsone|dapsone|mesh-list
20173637|NCT00162383|Debrisoquin|debrisoquin|mesh-list
20173638|NCT00162383|Mephenytoin|mephenytoin|mesh-list
20173639|NCT00162383|Caffeine|caffeine|mesh-list
20173640|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20173641|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173642|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20173643|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313556|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19629477|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19629478|NCT02458079|Protective Agents|protective agents|mesh-ancestor
19629479|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629480|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
19629481|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19629482|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
19629483|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
19629484|NCT02457650|Fludarabine|fludarabine|mesh-list
19629485|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629486|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
19665737|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
19665738|NCT04260477|Rifampin|rifampin|mesh-list
19665739|NCT04260477|Isoniazid|isoniazid|mesh-list
19665740|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
19665741|NCT04260477|Ethambutol|ethambutol|mesh-list
19665742|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19665743|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
19751914|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19751915|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
19751916|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
19751917|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
19751918|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751919|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19751920|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19751921|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19751922|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751923|NCT05234619|Ketorolac|ketorolac|mesh-list
19751924|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19751925|NCT05234619|Lidocaine|lidocaine|mesh-list
20138887|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
20138888|NCT00049114|Doxorubicin|doxorubicin|mesh-list
20138889|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20138890|NCT00049114|Tipifarnib|tipifarnib|mesh-list
20138891|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138892|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
20138893|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138894|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20138895|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138896|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
20138897|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138898|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138899|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20138900|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20138901|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20138902|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138903|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138904|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20138905|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138906|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138907|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138908|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138909|NCT00049179|Cytarabine|cytarabine|mesh-list
20138910|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
20138911|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138912|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
20138913|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138914|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138915|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
20138916|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138917|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138918|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
20138919|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138920|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20138921|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
20138922|NCT00049192|Oblimersen|oblimersen|mesh-list
20138923|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138924|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138925|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138926|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138927|NCT00049218|Carboplatin|carboplatin|mesh-list
20138928|NCT00049218|Etoposide|etoposide|mesh-list
20138929|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629487|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629488|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629489|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19629490|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
19629491|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629492|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629493|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19629494|NCT02457806|Phenylephrine|phenylephrine|mesh-list
19629495|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
19629496|NCT02457806|Tetracaine|tetracaine|mesh-list
19629497|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
19629498|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
20138930|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20138931|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20138932|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20138933|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138934|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629499|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19751926|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
20138935|NCT00049244|Capecitabine|capecitabine|mesh-list
20138936|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138937|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
20138938|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138939|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138940|NCT00049283|Docetaxel|docetaxel|mesh-list
20138941|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20138942|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138943|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138944|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138945|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138946|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138947|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20138948|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138949|NCT00049296|Thalidomide|thalidomide|mesh-list
20138950|NCT00049296|Docetaxel|docetaxel|mesh-list
20138951|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138952|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
20138953|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
20138954|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
20138955|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138956|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138957|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
20138958|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20138959|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
20138960|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138961|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138962|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138963|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138964|NCT00049296|Growth Substances|growth substances|mesh-ancestor
20138965|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
20138966|NCT00049335|Capecitabine|capecitabine|mesh-list
20138967|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138968|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
20138969|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138970|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138971|NCT00049348|Gemcitabine|gemcitabine|mesh-list
20138972|NCT00049348|Fluorouracil|fluorouracil|mesh-list
20138973|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
20138974|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138975|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20138976|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
20138977|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138978|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
20138979|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138980|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20138981|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138982|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
20138983|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629500|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629501|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
19629502|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629503|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19629504|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19629505|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
20138984|NCT00049348|Hematinics|hematinics|mesh-ancestor
20138985|NCT00049361|Thalidomide|thalidomide|mesh-list
20138986|NCT00049361|Temozolomide|temozolomide|mesh-list
19751927|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
19751928|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19751929|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751930|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
19751931|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751932|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19751933|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20138987|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20138988|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
20138989|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20138990|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20138991|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20138992|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
20138993|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751934|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20313557|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20313558|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20313559|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
20138994|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
20138995|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20138996|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20138997|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20138998|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20138999|NCT00049361|Growth Substances|growth substances|mesh-ancestor
20139000|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
20139001|NCT00049374|Thalidomide|thalidomide|mesh-list
20139002|NCT00049374|Dexamethasone|dexamethasone|mesh-list
20139003|NCT00049374|Oblimersen|oblimersen|mesh-list
20139004|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139005|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
20139006|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
20139007|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139008|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139009|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20139010|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
20139011|NCT00049374|Hormones|hormones|mesh-ancestor
20139012|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20139013|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20139014|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139015|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139016|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
20139017|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
20139018|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20139019|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139020|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20139021|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20139022|NCT00049374|Growth Substances|growth substances|mesh-ancestor
20139023|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
20139024|NCT00049387|Temozolomide|temozolomide|mesh-list
20139025|NCT00049387|Tipifarnib|tipifarnib|mesh-list
20139026|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139027|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
20139028|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139029|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139030|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
20139031|NCT00049413|Rituximab|rituximab|mesh-list
20139032|NCT00049413|Pentostatin|pentostatin|mesh-list
20139033|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139034|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
20139035|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139036|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139037|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139038|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
20139039|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139040|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139041|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20139042|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20139043|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20139044|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139045|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
20139046|NCT00049439|Lomustine|lomustine|mesh-list
20139047|NCT00049439|Etoposide|etoposide|mesh-list
20139048|NCT00049439|Procarbazine|procarbazine|mesh-list
20139049|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139050|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
20313560|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
20313561|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
20313562|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
20313563|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19751935|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19751936|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751937|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19751938|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19751939|NCT05234619|Analgesics|analgesics|mesh-ancestor
19751940|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751941|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19751942|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19751943|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19751944|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19751945|NCT05234307|Nivolumab|nivolumab|mesh-list
19751946|NCT05234307|Adenosine|adenosine|mesh-list
19751947|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
19751948|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19751949|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751950|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20139051|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139052|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139053|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139054|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
20139055|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139056|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139057|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20139058|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139059|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139060|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20139061|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139062|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
20139063|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20139064|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139065|NCT00049556|Gefitinib|gefitinib|mesh-list
20139066|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139067|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20139068|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139069|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139070|NCT00049569|Leucovorin|leucovorin|mesh-list
20139071|NCT00049569|Cytarabine|cytarabine|mesh-list
20139072|NCT00049569|Prednisone|prednisone|mesh-list
20139073|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
20139074|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20139075|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20139076|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20139077|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
20139078|NCT00049569|Doxorubicin|doxorubicin|mesh-list
20139079|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20139080|NCT00049569|Methotrexate|methotrexate|mesh-list
20139081|NCT00049569|Etoposide|etoposide|mesh-list
20139082|NCT00049569|Vincristine|vincristine|mesh-list
20139083|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
20139084|NCT00049569|Asparaginase|asparaginase|mesh-list
20139085|NCT00049569|Pegaspargase|pegaspargase|mesh-list
20139086|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
20139087|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139088|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
20139089|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139090|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139091|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139092|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
20139093|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139094|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139095|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20139096|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20139097|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139098|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20139099|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139100|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139101|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
20139102|NCT00049569|Hormones|hormones|mesh-ancestor
20139103|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20139104|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20313564|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751951|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139105|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20139106|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
20139107|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20139108|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139109|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
20139110|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
20139111|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20139112|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139113|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139114|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
20139115|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139116|NCT00049569|Antidotes|antidotes|mesh-ancestor
20139117|NCT00049569|Protective Agents|protective agents|mesh-ancestor
20139118|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
20139119|NCT00049569|Vitamins|vitamins|mesh-ancestor
20139120|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
20139121|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139122|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139123|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139124|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20139125|NCT00049582|Decitabine|decitabine|mesh-list
20139126|NCT00049582|Azacitidine|azacitidine|mesh-list
20139127|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139128|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
20139129|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139130|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139131|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139132|NCT00049595|Prednisone|prednisone|mesh-list
20139133|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
20139134|NCT00049595|Dacarbazine|dacarbazine|mesh-list
20139135|NCT00049595|Doxorubicin|doxorubicin|mesh-list
20139136|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20139137|NCT00049595|Etoposide|etoposide|mesh-list
20139138|NCT00049595|Vincristine|vincristine|mesh-list
20139139|NCT00049595|Bleomycin|bleomycin|mesh-list
20139140|NCT00049595|Vinblastine|vinblastine|mesh-list
20139141|NCT00049595|Procarbazine|procarbazine|mesh-list
20139142|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139143|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
20139144|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139145|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139146|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139147|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
20139148|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139149|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139150|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20313565|NCT00689806|Lovastatin|lovastatin|mesh-list
20313566|NCT00689806|L 647318|l 647318|mesh-list
20313567|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
20313568|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20313569|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20313570|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
20313571|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313572|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20313573|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20139151|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20139152|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139153|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20139154|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139155|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139156|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
20139157|NCT00049595|Hormones|hormones|mesh-ancestor
20139158|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20139159|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20139160|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139161|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139162|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139163|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139164|NCT00049608|Gemcitabine|gemcitabine|mesh-list
20139165|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139166|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
20313574|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256611|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
20139167|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139168|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139169|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
20139170|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751952|NCT05234307|Analgesics|analgesics|mesh-ancestor
19751953|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
19751954|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313575|NCT00689832|Fluticasone|fluticasone|mesh-list
20313576|NCT00689832|Tacrolimus|tacrolimus|mesh-list
20313577|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313578|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
20313579|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313580|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20313581|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313582|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313583|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313584|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20313585|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
20313586|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313587|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20313588|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
20313589|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
20313590|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20313591|NCT00689845|Cytarabine|cytarabine|mesh-list
20313592|NCT00689845|Prednisone|prednisone|mesh-list
19751955|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751956|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19751957|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
19751958|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19751959|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
19751960|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
19751961|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19751962|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19751963|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19751964|NCT05234112|Acetic Acid|acetic acid|mesh-list
19751965|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19751966|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751967|NCT05233735|Betamethasone|betamethasone|mesh-list
19751968|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19751969|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
19751970|NCT05233735|Hormones|hormones|mesh-ancestor
19751971|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19751972|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751973|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19751974|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
19751975|NCT05233722|Sirolimus|sirolimus|mesh-list
19751976|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751977|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19751978|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19751979|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19751980|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19751981|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
19751982|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19751983|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
19751984|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
19751985|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19751986|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19751987|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19751988|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19751989|NCT05233605|Analgesics|analgesics|mesh-ancestor
19751990|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
19751991|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19751992|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19751993|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19751994|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19751995|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
19751996|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19751997|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19751998|NCT05233579|Sulforaphane|sulforaphane|mesh-list
19751999|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19752000|NCT05233579|Protective Agents|protective agents|mesh-ancestor
19752001|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752002|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752003|NCT05233514|Metformin|metformin|mesh-list
19752004|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19752005|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752006|NCT05233462|Bupivacaine|bupivacaine|mesh-list
19752007|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
19752008|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
20313593|NCT00689845|Prednisolone|prednisolone|mesh-list
19752009|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752010|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752011|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
20139171|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139172|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139173|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
20139174|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629506|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629507|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629508|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
19629509|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
19752012|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752013|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
19752014|NCT05233358|Nivolumab|nivolumab|mesh-list
19752015|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19752016|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752017|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752018|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752019|NCT05233332|Vemurafenib|vemurafenib|mesh-list
19752020|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752021|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19752022|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752023|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752024|NCT05233228|Nicotine|nicotine|mesh-list
19752025|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19752026|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
19752027|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752028|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752029|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19752030|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19752031|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752032|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752033|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752034|NCT05233202|Simendan|simendan|mesh-list
19752035|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19752036|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
19752037|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19752038|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19752039|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752040|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752041|NCT05233202|Protective Agents|protective agents|mesh-ancestor
19752042|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629510|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
19629511|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19629512|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
19629513|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19629514|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
19629515|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19629516|NCT02457806|Protective Agents|protective agents|mesh-ancestor
19629517|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19629518|NCT02457585|Infliximab|infliximab|mesh-list
19629519|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
20139175|NCT00049634|Cyclosporine|cyclosporine|mesh-list
20139176|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
19752043|NCT05233124|Aspirin|aspirin|mesh-list
19752044|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
20139177|NCT00049634|Busulfan|busulfan|mesh-list
20139178|NCT00049634|Methotrexate|methotrexate|mesh-list
19752045|NCT05233124|Clopidogrel|clopidogrel|mesh-list
19752046|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19752047|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752048|NCT05233124|Analgesics|analgesics|mesh-ancestor
19752049|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
19752050|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752051|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752052|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139179|NCT00049634|Cyclosporins|cyclosporins|mesh-list
20139180|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139181|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
20139182|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139183|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139184|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139185|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
19752053|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139186|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752054|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19752055|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19752056|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752057|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19752058|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19752059|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752060|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
19752061|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19752062|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19752063|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19752064|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
19752065|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752066|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19752067|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
19752068|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19752069|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
19752070|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
19832655|NCT03179163|Enalapril|enalapril|mesh-list
19832656|NCT03179163|Captopril|captopril|mesh-list
19832657|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19832658|NCT03179163|Diuretics|diuretics|mesh-ancestor
19832659|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
19832660|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832661|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19832662|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832663|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832664|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19832665|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
19832666|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832667|NCT03177122|Inositol|inositol|mesh-list
19832668|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
19832669|NCT03177122|Vitamins|vitamins|mesh-ancestor
19832670|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
19629520|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19629521|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629522|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629523|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
19629524|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
19629525|NCT02457507|Vitamins|vitamins|mesh-ancestor
19629526|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
19629527|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313594|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
20313595|NCT00689845|Ifosfamide|ifosfamide|mesh-list
20313596|NCT00689845|Rituximab|rituximab|mesh-list
19629528|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
19629529|NCT02457507|Hematinics|hematinics|mesh-ancestor
19629530|NCT02457286|Metformin|metformin|mesh-list
19629531|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19629532|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629533|NCT02457351|Itraconazole|itraconazole|mesh-list
19629534|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
19629535|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629536|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19629537|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20313597|NCT00689845|Doxorubicin|doxorubicin|mesh-list
20313598|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20313599|NCT00689845|Methotrexate|methotrexate|mesh-list
20313600|NCT00689845|Etoposide|etoposide|mesh-list
20313601|NCT00689845|Vincristine|vincristine|mesh-list
20313602|NCT00689845|Bleomycin|bleomycin|mesh-list
20313603|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
20313604|NCT00689845|Vindesine|vindesine|mesh-list
20313605|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313606|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
20313607|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629538|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629539|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629540|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19629541|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
19629542|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629543|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629544|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19629545|NCT02457442|Remifentanil|remifentanil|mesh-list
19629546|NCT02457442|Propofol|propofol|mesh-list
20313608|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313609|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20313610|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
19629547|NCT02457442|Sevoflurane|sevoflurane|mesh-list
20313611|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313612|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313613|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19629548|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19629549|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629550|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629551|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20139187|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139188|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20139189|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20139190|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
20139191|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20139192|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139193|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
20139194|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
20139195|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139196|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20139197|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139198|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
20139199|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139200|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20139201|NCT00049660|Capecitabine|capecitabine|mesh-list
20139202|NCT00049660|Vinorelbine|vinorelbine|mesh-list
20139203|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139204|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
20139205|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139206|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139207|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139208|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139209|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139210|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139211|NCT00049725|Daclizumab|daclizumab|mesh-list
20139212|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139213|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
20139214|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139215|NCT00049751|Adalimumab|adalimumab|mesh-list
20139216|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139217|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139218|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20139219|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139220|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20139221|NCT00049777|Heparin|heparin|mesh-list
20139222|NCT00049777|Calcium heparin|calcium heparin|mesh-list
20139223|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20139224|NCT00049777|Tinzaparin|tinzaparin|mesh-list
20139225|NCT00049777|Dalteparin|dalteparin|mesh-list
20139226|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
20139227|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20139228|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20139229|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139230|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139231|NCT00049790|Paclitaxel|paclitaxel|mesh-list
20139232|NCT00049790|Carboplatin|carboplatin|mesh-list
20139233|NCT00049790|Angiostatins|angiostatins|mesh-list
20139234|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139235|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313614|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608492|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20608493|NCT02246244|Citalopram|citalopram|mesh-list
19629552|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
19629553|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
19629554|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19629555|NCT02457442|Narcotics|narcotics|mesh-ancestor
19629556|NCT02457442|Analgesics|analgesics|mesh-ancestor
19629557|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
19629558|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629559|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19629560|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19661321|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661322|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661323|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19661324|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19661325|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
19661326|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661327|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665744|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20139236|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139237|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139238|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139239|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139240|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20139241|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20139242|NCT00049790|Growth Substances|growth substances|mesh-ancestor
19629561|NCT02457312|Letrozole|letrozole|mesh-list
19629562|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629563|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19629564|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19629565|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629566|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629567|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19629568|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
19629569|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629570|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629571|NCT02457208|Rifampin|rifampin|mesh-list
19629572|NCT02457208|Isoniazid|isoniazid|mesh-list
20139243|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139244|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
20139245|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
20139246|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20139247|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20139248|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
19629573|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
19629574|NCT02457208|Ethambutol|ethambutol|mesh-list
19629575|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19629576|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
19629577|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19629578|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629579|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
19629580|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19629581|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629582|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629583|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19629584|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19629585|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19629586|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20139249|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
20139250|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629587|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19629588|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19629589|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19629590|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19629591|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
19629592|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19629593|NCT02456961|Riboflavin|riboflavin|mesh-list
19629594|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
19629595|NCT02456961|Vitamins|vitamins|mesh-ancestor
19629596|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
19629597|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629598|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19629599|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
19629600|NCT02456974|Amoxicillin|amoxicillin|mesh-list
19629601|NCT02456974|Vancomycin|vancomycin|mesh-list
19629602|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
19629603|NCT02456974|Meropenem|meropenem|mesh-list
19629604|NCT02456974|Tazobactam|tazobactam|mesh-list
19629605|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
19629606|NCT02456974|Amikacin|amikacin|mesh-list
19629607|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19629608|NCT02456974|Teicoplanin|teicoplanin|mesh-list
19629609|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19629610|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139251|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139252|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
20139253|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19629611|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19629612|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19629613|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629614|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629615|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629616|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19629617|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19629618|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19629619|NCT02457130|Clopidogrel|clopidogrel|mesh-list
19629620|NCT02457130|Ticagrelor|ticagrelor|mesh-list
19629621|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20139254|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139255|NCT00049946|Risperidone|risperidone|mesh-list
20139256|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20139257|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
20139258|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139259|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139260|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139261|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20139262|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20139263|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139264|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20139265|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20139266|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
20139267|NCT00049972|Paroxetine|paroxetine|mesh-list
20139268|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20139269|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20139270|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139271|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139272|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139273|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
20313615|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20313616|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139274|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139275|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20139276|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
20313617|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313618|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313619|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139277|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20139278|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20139279|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20313620|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
20313621|NCT00689845|Hormones|hormones|mesh-ancestor
19752092|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
19752093|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752094|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313622|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20313623|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20313624|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20313625|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
20313626|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20313627|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20313628|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
20313629|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
20139280|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139281|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
20139282|NCT00049985|Hematinics|hematinics|mesh-ancestor
20139283|NCT00049998|Topotecan|topotecan|mesh-list
19752095|NCT05232370|Losartan|losartan|mesh-list
19752096|NCT05232370|Enalapril|enalapril|mesh-list
19752097|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19752098|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19752099|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19752100|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19752101|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19629622|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19629623|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19629624|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19629625|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
19629626|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752102|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19752103|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752104|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
19752105|NCT05232227|Primaquine|primaquine|mesh-list
19752106|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
19752107|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19752108|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19752109|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752110|NCT05232123|Cannabidiol|cannabidiol|mesh-list
19752111|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
19752112|NCT05232084|Fentanyl|fentanyl|mesh-list
19752113|NCT05232084|Bupivacaine|bupivacaine|mesh-list
19752114|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
19752115|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
19752116|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752117|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752118|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
19752119|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752120|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19752121|NCT05232084|Narcotics|narcotics|mesh-ancestor
19752122|NCT05232084|Analgesics|analgesics|mesh-ancestor
19752123|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19752124|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19752125|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
19752126|NCT05231330|Fluorides|fluorides|mesh-list
19752127|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
19752128|NCT05231330|Protective Agents|protective agents|mesh-ancestor
20139284|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20139285|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19752129|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752130|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19752131|NCT05231148|Calcium|calcium|mesh-list
19752132|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19752133|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752134|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752135|NCT05230901|Dihydralazine|dihydralazine|mesh-list
19752136|NCT05230901|Spironolactone|spironolactone|mesh-list
19752137|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19752138|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
19752139|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752140|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752141|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19752142|NCT05230901|Diuretics|diuretics|mesh-ancestor
19752143|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
19752144|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19752145|NCT05230797|Zinc|zinc|mesh-list
19752146|NCT05230797|Propolis|propolis|mesh-list
19752147|NCT05230797|Eugenol|eugenol|mesh-list
19752148|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
19629627|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629628|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629629|NCT02456935|Esomeprazole|esomeprazole|mesh-list
19629630|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19752149|NCT05230797|Trace Elements|trace elements|mesh-ancestor
20139286|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139287|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752150|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
19752151|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752152|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752153|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
19752154|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
20139288|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139289|NCT00050063|Vaccines|vaccines|mesh-list
20139290|NCT00050063|Immunologic Factors|immunologic factors|mesh-ancestor
20139291|NCT00050063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139292|NCT00050141|Tipifarnib|tipifarnib|mesh-list
20139293|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139294|NCT00050154|Tipifarnib|tipifarnib|mesh-list
20139295|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139296|NCT00050180|Indinavir|indinavir|mesh-list
20139297|NCT00050180|Saquinavir|saquinavir|mesh-list
20139298|NCT00050180|Midazolam|midazolam|mesh-list
20139299|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20139300|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20139301|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139302|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139303|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20139304|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20139305|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20139306|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20139307|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
20139308|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
20139309|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
20139310|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
20139311|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139312|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139313|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20139314|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20139315|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
20139316|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139317|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20139318|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19629631|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19629632|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19629633|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629634|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629635|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
19629636|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629637|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
19629638|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629639|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629640|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19629641|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
19752155|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20139319|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
20139320|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139321|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20139322|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20139323|NCT00050206|Olanzapine|olanzapine|mesh-list
20139324|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
20139325|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
20139326|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752156|NCT05230797|Protective Agents|protective agents|mesh-ancestor
19752157|NCT05230758|Metformin|metformin|mesh-list
20139327|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139328|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20139329|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20139330|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20139331|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139332|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19752158|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19752159|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752160|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
19752161|NCT05230654|Aprepitant|aprepitant|mesh-list
19752162|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
19752163|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
19752164|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752165|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752166|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19752167|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19752168|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752169|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832671|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832672|NCT03004443|Infliximab|infliximab|mesh-list
20139333|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20139334|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20139335|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139336|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752170|NCT05230472|Simvastatin|simvastatin|mesh-list
19752171|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19752172|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19752173|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
19752174|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752175|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19752176|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19752177|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752178|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
19752179|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752180|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
19752181|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
19752182|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
19752183|NCT05211154|Diclofenac|diclofenac|mesh-list
19752184|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19752185|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752186|NCT05211154|Analgesics|analgesics|mesh-ancestor
19752187|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
19752188|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752189|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752190|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19752191|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19752192|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19752193|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752194|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752195|NCT05209555|Pilocarpine|pilocarpine|mesh-list
19752196|NCT05209555|Miotics|miotics|mesh-ancestor
19752197|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
19752198|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752199|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752200|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19752201|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19752202|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752203|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752204|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752205|NCT05209074|Ivosidenib|ivosidenib|mesh-list
19752206|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752207|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752208|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752209|NCT05208034|Methotrexate|methotrexate|mesh-list
19752210|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19752211|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
19752212|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19752213|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752214|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19752215|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
19752216|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752217|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752218|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
19752219|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752220|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19752221|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629642|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629643|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629644|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19629645|NCT02457026|Triamcinolone|triamcinolone|mesh-list
19752222|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
20139337|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139338|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
20139339|NCT00050245|Rituximab|rituximab|mesh-list
19629646|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19629647|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19629648|NCT02457026|Aflibercept|aflibercept|mesh-list
19629649|NCT02457026|Verteporfin|verteporfin|mesh-list
19629650|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19629651|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629652|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
19629653|NCT02457026|Hormones|hormones|mesh-ancestor
19629654|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629655|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629656|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629657|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
19629658|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629659|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752223|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19752224|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19752225|NCT05203276|Endostar protein|endostar protein|mesh-list
19752226|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19752227|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19752228|NCT05203276|Growth Substances|growth substances|mesh-ancestor
19752229|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752230|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
19752231|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752232|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19752233|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752234|NCT05202158|Gentamicins|gentamicins|mesh-list
19752235|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19752236|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752237|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19752238|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752239|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752240|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
19752241|NCT05199493|Giapreza|giapreza|mesh-list
19752242|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
19752243|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19752244|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19752245|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
19752246|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752247|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752248|NCT05188170|Niclosamide|niclosamide|mesh-list
19752249|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
19752250|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19752251|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
19752252|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19752253|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752254|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
19752255|NCT05184777|Estradiol|estradiol|mesh-list
19752256|NCT05184777|Progesterone|progesterone|mesh-list
20608494|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20608495|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20608496|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20608497|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608498|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608499|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
20608500|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608501|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20608502|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
20608503|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19752257|NCT05184777|Estrogens|estrogens|mesh-ancestor
19752258|NCT05184777|Hormones|hormones|mesh-ancestor
19752259|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752260|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752261|NCT05184777|Progestins|progestins|mesh-ancestor
19752262|NCT05174455|Niraparib|niraparib|mesh-list
19752263|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19752264|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752265|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752266|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752267|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19752268|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
19752269|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752270|NCT05124171|Vaccines|vaccines|mesh-list
19752271|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
19752272|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752273|NCT05120895|Pravastatin|pravastatin|mesh-list
19752274|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19629660|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19629661|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19629662|NCT02457026|Growth Substances|growth substances|mesh-ancestor
19629663|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
19629664|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629665|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19629666|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
19752275|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19752276|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
20608504|NCT02246595|Vilobelimab|vilobelimab|mesh-list
19629667|NCT02456948|Minocycline|minocycline|mesh-list
19832673|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
19752277|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752278|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19752279|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19752280|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832674|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19832675|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832676|NCT02959775|Vaccines|vaccines|mesh-list
19629668|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19629669|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629670|NCT02456844|Leucovorin|leucovorin|mesh-list
19629671|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
19629672|NCT02456844|Methotrexate|methotrexate|mesh-list
19629673|NCT02456844|Digoxin|digoxin|mesh-list
19629674|NCT02456844|Midazolam|midazolam|mesh-list
19832677|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
19832678|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832679|NCT02954406|Gemcitabine|gemcitabine|mesh-list
19832680|NCT02954406|Rituximab|rituximab|mesh-list
19832681|NCT02954406|Lenalidomide|lenalidomide|mesh-list
19832682|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19832683|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313630|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20313631|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20313632|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19832684|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832685|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
19832686|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832687|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832688|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832689|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
19832690|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832691|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
19832692|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832693|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832694|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832695|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19832696|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19832697|NCT02954406|Growth Substances|growth substances|mesh-ancestor
19832698|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832699|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19832700|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
19832701|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
20139340|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20139341|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629675|NCT02456844|Pravastatin|pravastatin|mesh-list
19832702|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832703|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19832704|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832705|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832706|NCT02910583|Venetoclax|venetoclax|mesh-list
19832707|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832708|NCT02829268|Dantrolene|dantrolene|mesh-list
19832709|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19832710|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832711|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19832712|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832713|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19832714|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19832715|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19832716|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832717|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832718|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
20139342|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
19629676|NCT02456844|Montelukast|montelukast|mesh-list
20139343|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139344|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139345|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
20139346|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
20139347|NCT00050271|Vitamins|vitamins|mesh-ancestor
20139348|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
20139349|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629677|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19629678|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
19629679|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19629680|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752281|NCT05093296|Naltrexone|naltrexone|mesh-list
19752282|NCT05093296|Oxytocin|oxytocin|mesh-list
19752283|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
19752284|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19752285|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752286|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19752287|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19752288|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
19752289|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752290|NCT05075876|Granisetron|granisetron|mesh-list
19752291|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
19752292|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
19752293|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752294|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752295|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19752296|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19752297|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
19752298|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752299|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752300|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
19752301|NCT05045170|Propofol|propofol|mesh-list
19752302|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
19752303|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752304|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752305|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20313633|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
20313634|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313635|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
20313636|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139350|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
20139351|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
20139352|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20139353|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313637|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
20313638|NCT00689858|Cilostazol|cilostazol|mesh-list
19752306|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19752307|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
20139354|NCT00050336|Lonafarnib|lonafarnib|mesh-list
20139355|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139356|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139357|NCT00050349|Epothilones|epothilones|mesh-list
20139358|NCT00050349|Epothilone B|epothilone b|mesh-list
20139359|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139360|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
19752308|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752309|NCT05045170|Analgesics|analgesics|mesh-ancestor
19752310|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
19752311|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752312|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19752313|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19752314|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19752315|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752316|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752317|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752318|NCT05042934|Irinotecan|irinotecan|mesh-list
19752319|NCT05042934|Camptothecin|camptothecin|mesh-list
19752320|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19752321|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19752322|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752323|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752324|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752325|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19752326|NCT05027204|Docetaxel|docetaxel|mesh-list
19752327|NCT05027204|Nivolumab|nivolumab|mesh-list
19752328|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139361|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139362|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139363|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139364|NCT00050362|Rofecoxib|rofecoxib|mesh-list
20139365|NCT00050362|Bupivacaine|bupivacaine|mesh-list
19752329|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
19752330|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
19752331|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
19752332|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139366|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
19752333|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752334|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19752335|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
19752336|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19752337|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752338|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752339|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752340|NCT05025605|Analgesics|analgesics|mesh-ancestor
19752341|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
19752342|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752343|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19752344|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19752345|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19752346|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752347|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752348|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752349|NCT05023070|Cannabidiol|cannabidiol|mesh-list
19752350|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
19752351|NCT05018273|Atezolizumab|atezolizumab|mesh-list
20313639|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20313640|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
20313641|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629681|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19629682|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
19752352|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752353|NCT05014282|Nicotine|nicotine|mesh-list
19752354|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19752355|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
19752356|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752357|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752358|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19752359|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19752360|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752361|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752362|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752363|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
19752364|NCT05014230|Narcotics|narcotics|mesh-ancestor
19752365|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752366|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313642|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313643|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19629683|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629684|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629685|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
19629686|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629687|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19629688|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629689|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
19629690|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629691|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19629692|NCT02456844|Antidotes|antidotes|mesh-ancestor
19629693|NCT02456844|Protective Agents|protective agents|mesh-ancestor
19629694|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
19752367|NCT05014230|Analgesics|analgesics|mesh-ancestor
19752368|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
20313644|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
20313645|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20313646|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20313647|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313648|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20313649|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
20313650|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20313651|NCT00689858|Protective Agents|protective agents|mesh-ancestor
20313652|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19752369|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752370|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19752371|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19752372|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19752373|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752374|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752375|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19752376|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19752377|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752378|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752379|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752380|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19752381|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19752382|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752383|NCT05005507|Tenofovir|tenofovir|mesh-list
19752384|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19752385|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
19752386|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752387|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19752388|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19752389|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752390|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752391|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20313653|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20313654|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313655|NCT00689949|Folic Acid|folic acid|mesh-list
20313656|NCT00689949|Hematinics|hematinics|mesh-ancestor
20313657|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
20313658|NCT00689949|Vitamins|vitamins|mesh-ancestor
20313659|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
20313660|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313661|NCT00690014|Probenecid|probenecid|mesh-list
20313662|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
20313663|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
19629695|NCT02456844|Vitamins|vitamins|mesh-ancestor
20139367|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
20139368|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139369|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139370|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
20139371|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139372|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20139373|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20139374|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139375|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139376|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20139377|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20139378|NCT00050362|Analgesics|analgesics|mesh-ancestor
20139379|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139380|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139381|NCT00050375|Oregovomab|oregovomab|mesh-list
20139382|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19629696|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
19629697|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19629698|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19629699|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629700|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19629701|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19629702|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19629703|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19629704|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
19629705|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
19629706|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
19752392|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19752393|NCT05004987|Dexetimide|dexetimide|mesh-list
19752394|NCT05004987|Citalopram|citalopram|mesh-list
19752395|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19752396|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19752397|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19752398|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752399|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752400|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
19752401|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313664|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629707|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
20313665|NCT00690014|Renal Agents|renal agents|mesh-ancestor
20313666|NCT00690105|Fluticasone|fluticasone|mesh-list
20313667|NCT00690105|Tacrolimus|tacrolimus|mesh-list
19752402|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19752403|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
19752404|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19752405|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19752406|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19752407|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
19752408|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
19752409|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752410|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19752411|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19752412|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752413|NCT05004805|Methylene Blue|methylene blue|mesh-list
19752414|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752415|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752416|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20313668|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313669|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
20313670|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313671|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20139383|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139384|NCT00050401|Vancomycin|vancomycin|mesh-list
20139385|NCT00050401|Tobramycin|tobramycin|mesh-list
20139386|NCT00050401|Meropenem|meropenem|mesh-list
20139387|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20139388|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139389|NCT00050414|Dexamethasone|dexamethasone|mesh-list
20139390|NCT00050414|Trabectedin|trabectedin|mesh-list
20139391|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139392|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
20139393|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
20313672|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139394|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139395|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139396|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20139397|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
20139398|NCT00050414|Hormones|hormones|mesh-ancestor
20139399|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752417|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19752418|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
19752419|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752420|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19752421|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
19752422|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752423|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752424|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19752425|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19752426|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19752427|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752428|NCT04965220|Trametinib|trametinib|mesh-list
19752429|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752430|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19752431|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752432|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139400|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20139401|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139402|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139403|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
20139404|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139405|NCT00050427|Trabectedin|trabectedin|mesh-list
20139406|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139407|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
20139408|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139409|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139410|NCT00050440|Dexamethasone|dexamethasone|mesh-list
20139411|NCT00050440|Trabectedin|trabectedin|mesh-list
20139412|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139413|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
20139414|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
20139415|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139416|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139417|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20139418|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
19752433|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
20139419|NCT00050440|Hormones|hormones|mesh-ancestor
20139420|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20139421|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20139422|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752434|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19752435|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752436|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20139423|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139424|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
20139425|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139426|NCT00050479|Celecoxib|celecoxib|mesh-list
20139427|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19752437|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752438|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19752439|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19752440|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752441|NCT04945655|Vaccines|vaccines|mesh-list
19752442|NCT04945655|Immunologic Factors|immunologic factors|mesh-ancestor
19752443|NCT04945655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752444|NCT04937166|Azacitidine|azacitidine|mesh-list
19752445|NCT04937166|Venetoclax|venetoclax|mesh-list
19752446|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19752447|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
19752448|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752449|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752450|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752451|NCT04928950|Charcoal|charcoal|mesh-list
19752452|NCT04928950|Antidotes|antidotes|mesh-ancestor
19752453|NCT04928950|Protective Agents|protective agents|mesh-ancestor
19752454|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752455|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
19752456|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19752457|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19752458|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19752459|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752460|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752461|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752462|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139428|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19629708|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139429|NCT00050479|Analgesics|analgesics|mesh-ancestor
20139430|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
20139431|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139432|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629709|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19629710|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
19629711|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19629712|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
19629713|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629714|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19629715|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19629716|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19629717|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19752463|NCT04920539|Dronabinol|dronabinol|mesh-list
19752464|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
19752465|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752466|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19752467|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752468|NCT04920539|Analgesics|analgesics|mesh-ancestor
19752469|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
19752470|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752471|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19752472|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19752473|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752474|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752475|NCT04920539|Hormones|hormones|mesh-ancestor
19752476|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752477|NCT04919382|Temozolomide|temozolomide|mesh-list
20139433|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139434|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139435|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20139436|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20139437|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629718|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19629719|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19629720|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20139438|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139439|NCT00050505|Vaccines|vaccines|mesh-list
20139440|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
20139441|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752478|NCT04919382|Atezolizumab|atezolizumab|mesh-list
19752479|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19752480|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19752481|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
19752482|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752483|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752484|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
19752485|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752486|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
19752487|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19752488|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
19752489|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752490|NCT05370729|Expectorants|expectorants|mesh-ancestor
19752491|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
19752492|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19752493|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
19752494|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752495|NCT05370729|Protective Agents|protective agents|mesh-ancestor
19752496|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752497|NCT05370729|Antidotes|antidotes|mesh-ancestor
20139442|NCT00050531|Interferons|interferons|mesh-list
20139443|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
20139444|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
20139445|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20139446|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20139447|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
20139448|NCT00050531|Molgramostim|molgramostim|mesh-list
20139449|NCT00050531|Sargramostim|sargramostim|mesh-list
20139450|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139451|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
20139452|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139453|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
20139454|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139455|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19629721|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19629722|NCT02456844|Analgesics|analgesics|mesh-ancestor
19832719|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832720|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832721|NCT02776605|Prednisone|prednisone|mesh-list
19832722|NCT02776605|Methotrexate|methotrexate|mesh-list
19832723|NCT02776605|Vincristine|vincristine|mesh-list
19832724|NCT02776605|Daunorubicin|daunorubicin|mesh-list
19832725|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
19832726|NCT02776605|Ponatinib|ponatinib|mesh-list
19832727|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629723|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
19629724|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629725|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19629726|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19629727|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629728|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19832728|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
19832729|NCT02776605|Hormones|hormones|mesh-ancestor
19832730|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20139456|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752512|NCT05370599|Losartan|losartan|mesh-list
19752513|NCT05370599|Amlodipine|amlodipine|mesh-list
19752514|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
19752515|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
19752516|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19752517|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19752518|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752519|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19752520|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752521|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
19752522|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19752523|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19752524|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19752525|NCT05370599|Diuretics|diuretics|mesh-ancestor
19752526|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
19752527|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19752528|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
20139457|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139458|NCT00050596|Docetaxel|docetaxel|mesh-list
20139459|NCT00050596|Ipilimumab|ipilimumab|mesh-list
20139460|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139461|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139462|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139463|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139464|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139465|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20139466|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20139467|NCT00050609|Tadalafil|tadalafil|mesh-list
20139468|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
20139469|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20139470|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20313673|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139471|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139472|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139473|NCT00050609|Urological Agents|urological agents|mesh-ancestor
19629729|NCT02456532|Zolpidem|zolpidem|mesh-list
19629730|NCT02456532|Eszopiclone|eszopiclone|mesh-list
19629731|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19629732|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19629733|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139474|NCT00050635|Octreotide|octreotide|mesh-list
20139475|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20139476|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20139477|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139478|NCT00050648|Cyclosporine|cyclosporine|mesh-list
20139479|NCT00050648|Cyclosporins|cyclosporins|mesh-list
20139480|NCT00050648|Daclizumab|daclizumab|mesh-list
20139481|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139482|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139483|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139484|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
20139485|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139486|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
20139487|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139488|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
19629734|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629735|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19752529|NCT05370547|Fludarabine|fludarabine|mesh-list
19752530|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19752531|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
19752532|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752533|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19752534|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19752535|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
19752536|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752537|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752538|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19752539|NCT05370417|Fluorides|fluorides|mesh-list
19752540|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
19752541|NCT05370417|Protective Agents|protective agents|mesh-ancestor
19752542|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139489|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629736|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
19752543|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
20139490|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20139491|NCT00050661|Daclizumab|daclizumab|mesh-list
20139492|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139493|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
20139494|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139495|NCT00050674|Lenograstim|lenograstim|mesh-list
20139496|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20139497|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
20139498|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139499|NCT00050713|Sirolimus|sirolimus|mesh-list
20139500|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20139501|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139502|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20139503|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139504|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
20139505|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139506|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
20139507|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139508|NCT00050726|Interleukin-2|interleukin-2|mesh-list
20139509|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139510|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20139511|NCT00050726|Analgesics|analgesics|mesh-ancestor
20139512|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
20139513|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139514|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139515|NCT00050804|Sertraline|sertraline|mesh-list
20139516|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
20139517|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20139518|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20313674|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629737|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
19629738|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629739|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629740|NCT02456597|Lidocaine|lidocaine|mesh-list
19629741|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
19629742|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
19629743|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629744|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629745|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
19629746|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629747|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19629748|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19629749|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19629750|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19629751|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629752|NCT02456714|Folfirinox|folfirinox|mesh-list
19629753|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629754|NCT02456454|Valproic Acid|valproic acid|mesh-list
19629755|NCT02456454|Risperidone|risperidone|mesh-list
19629756|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19629757|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
19629758|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629759|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629760|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629761|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19629762|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19629763|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629764|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19629765|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19629766|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
19629767|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
19629768|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629769|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
19629770|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
19629771|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19629772|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
19629773|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19629774|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
19629775|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19629776|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629777|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19629778|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19629779|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19629780|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139519|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20313675|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20313676|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
20139520|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139521|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139522|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139523|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
20139524|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173644|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173645|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20173646|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20173647|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
20173648|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173649|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173650|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
20173651|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20173652|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20173653|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20173654|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
20173655|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20173656|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20173657|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
20173658|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
20173659|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173660|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
20173661|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
20173662|NCT00162396|Albuterol|albuterol|mesh-list
20173663|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20173664|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
20313677|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313678|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20313679|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
20313680|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
20313681|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20313682|NCT00690118|Pioglitazone|pioglitazone|mesh-list
20313683|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313684|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313685|NCT00690170|Ketamine|ketamine|mesh-list
20313686|NCT00690170|Nicotine|nicotine|mesh-list
20313687|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20313688|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
20313689|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313690|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313691|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20313692|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20313693|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
20313694|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313695|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313696|NCT00690170|Analgesics|analgesics|mesh-ancestor
20313697|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
20313698|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20313699|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20313700|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
20313701|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
20313702|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313703|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20313704|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20313705|NCT00690222|Mydriatics|mydriatics|mesh-list
20313706|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
20313707|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313708|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313709|NCT00690300|Docetaxel|docetaxel|mesh-list
20313710|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
20313711|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629781|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19629782|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19629783|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19629784|NCT02456701|Vemurafenib|vemurafenib|mesh-list
19629785|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629786|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19629787|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629788|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752544|NCT05370326|Narcotics|narcotics|mesh-ancestor
20173665|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313712|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
20313713|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
19752545|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752546|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752547|NCT05370326|Analgesics|analgesics|mesh-ancestor
19752548|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
19752549|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752550|NCT05370313|Nicotine|nicotine|mesh-list
19752551|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19752552|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
19752553|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752554|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752555|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19752556|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19752557|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752558|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752559|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752560|NCT05370235|Afamelanotide|afamelanotide|mesh-list
19752561|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
19752562|NCT05369832|Ozanimod|ozanimod|mesh-list
19752563|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19752564|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752565|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19752566|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
19752567|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313714|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
20313715|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752568|NCT05369819|Midazolam|midazolam|mesh-list
19752569|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19752570|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19752571|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752572|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752573|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19752574|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19752575|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19752576|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19752577|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
19752578|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
19752579|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
19752580|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
19752581|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752582|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752583|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
19752584|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
19752585|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752586|NCT05369793|Protective Agents|protective agents|mesh-ancestor
19752587|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752588|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
19752589|NCT05369793|Vitamins|vitamins|mesh-ancestor
20139525|NCT00050817|Clopidogrel|clopidogrel|mesh-list
20139526|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20139527|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20139528|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20139529|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20139530|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
20139531|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139532|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139533|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139534|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
20139535|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
20139536|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
20139537|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139538|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139539|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
20139540|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752590|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
19752591|NCT05369650|Lidocaine|lidocaine|mesh-list
19752592|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
20139541|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139542|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20139543|NCT00050830|Protective Agents|protective agents|mesh-ancestor
20139544|NCT00050843|Thalidomide|thalidomide|mesh-list
20139545|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19752593|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
19752594|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313716|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
19752595|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629789|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19629790|NCT02456558|Deferiprone|deferiprone|mesh-list
19629791|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19629792|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
19752596|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
19752597|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752598|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19752599|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19752600|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19752601|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19752602|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752603|NCT05369481|Minoxidil|minoxidil|mesh-list
19752604|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
19752605|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
19752606|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19752607|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19752608|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752609|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752610|NCT05369481|Urological Agents|urological agents|mesh-ancestor
19752611|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19752612|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
19752613|NCT05369468|Bupivacaine|bupivacaine|mesh-list
19752614|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
19752615|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
19752616|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752617|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752618|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
19752619|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752620|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19752621|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752622|NCT05369468|Analgesics|analgesics|mesh-ancestor
19752623|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19752624|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19752625|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19752626|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752627|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752628|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752629|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
19752630|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608505|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20608506|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19752631|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19752632|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752633|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752634|NCT05369364|Dexamethasone|dexamethasone|mesh-list
19752635|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
19752636|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19752637|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
19752638|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
19752639|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752640|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752641|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19752642|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
19752643|NCT05369364|Hormones|hormones|mesh-ancestor
19752644|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608507|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
20608508|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608509|NCT02246621|Letrozole|letrozole|mesh-list
20608510|NCT02246621|Anastrozole|anastrozole|mesh-list
20139546|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
20139547|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139548|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
20139549|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20139550|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629793|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
19629794|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629795|NCT02456428|Insulin|insulin|mesh-list
19629796|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19629797|NCT02456428|Metformin|metformin|mesh-list
19629798|NCT02456428|Pioglitazone|pioglitazone|mesh-list
19629799|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20608511|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139551|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20608512|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19629800|NCT02456428|Liraglutide|liraglutide|mesh-list
19752645|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19752646|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752647|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19752648|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752649|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313717|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20313718|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20313719|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313720|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20313721|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19752650|NCT05369351|Mirabegron|mirabegron|mesh-list
19752651|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19752652|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19752653|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19752654|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752655|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139552|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20139553|NCT00050843|Growth Substances|growth substances|mesh-ancestor
20139554|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
20139555|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139556|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
20139557|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20139558|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20139559|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139560|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20139561|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19752656|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752657|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752658|NCT05369351|Urological Agents|urological agents|mesh-ancestor
19752659|NCT05369234|Sucralfate|sucralfate|mesh-list
19752660|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19752661|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19752662|NCT05369091|Simvastatin|simvastatin|mesh-list
19752663|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19752664|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20139562|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
20139563|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139564|NCT00050895|Ritonavir|ritonavir|mesh-list
20139565|NCT00050895|Lopinavir|lopinavir|mesh-list
20139566|NCT00050895|Tenofovir|tenofovir|mesh-list
20139567|NCT00050895|Lamivudine|lamivudine|mesh-list
20139568|NCT00050895|Zidovudine|zidovudine|mesh-list
20139569|NCT00050895|Stavudine|stavudine|mesh-list
20139570|NCT00050895|Efavirenz|efavirenz|mesh-list
20139571|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20139572|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20139573|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
20139574|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139575|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139576|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20139577|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20139578|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
20139579|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139580|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20139581|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20139582|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20139583|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139584|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
20139585|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20139586|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20139587|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20139588|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20139589|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20139590|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20139591|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20139592|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
20139593|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139594|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
20139595|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
20139596|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20139597|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19752665|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
20139598|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139599|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139600|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20139601|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20139602|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
20139603|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
20139604|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20139605|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20139606|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139607|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139608|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20139609|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20139610|NCT00050973|Bexarotene|bexarotene|mesh-list
20139611|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139612|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
20139613|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
20313722|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313723|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313724|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313725|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20313726|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
20313727|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20313728|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313729|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20313730|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20313731|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20313732|NCT00690417|Vitamin D|vitamin d|mesh-list
20313733|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
20313734|NCT00690417|Vitamins|vitamins|mesh-ancestor
20313735|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
20313736|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313737|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20313738|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20313739|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20313740|NCT00690521|Metolazone|metolazone|mesh-list
20313741|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20313742|NCT00690521|Diuretics|diuretics|mesh-ancestor
20313743|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
20313744|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313745|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20313746|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20313747|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313748|NCT00690534|Insulin|insulin|mesh-list
20313749|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20313750|NCT00690534|Nitroprusside|nitroprusside|mesh-list
20313751|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313752|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313753|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20313754|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
20608513|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19629801|NCT02456428|Exenatide|exenatide|mesh-list
19629802|NCT02456428|Glimepiride|glimepiride|mesh-list
19629803|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
19629804|NCT02456428|Vildagliptin|vildagliptin|mesh-list
19629805|NCT02456428|Saxagliptin|saxagliptin|mesh-list
19629806|NCT02456428|Acarbose|acarbose|mesh-list
19629807|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19629808|NCT02456428|Repaglinide|repaglinide|mesh-list
19629809|NCT02456428|Gliclazide|gliclazide|mesh-list
19629810|NCT02456428|Glipizide|glipizide|mesh-list
19629811|NCT02456428|Biguanides|biguanides|mesh-list
19629812|NCT02456428|Tolbutamide|tolbutamide|mesh-list
19629813|NCT02456428|Voglibose|voglibose|mesh-list
19629814|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19629815|NCT02456428|Nateglinide|nateglinide|mesh-list
19629816|NCT02456428|Miglitol|miglitol|mesh-list
19629817|NCT02456428|Troglitazone|troglitazone|mesh-list
19629818|NCT02456428|Meglitinide|meglitinide|mesh-list
19629819|NCT02456428|Acetohexamide|acetohexamide|mesh-list
19629820|NCT02456428|Phenformin|phenformin|mesh-list
19629821|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
19629822|NCT02456428|Buformin|buformin|mesh-list
19629823|NCT02456428|Glibornuride|glibornuride|mesh-list
19629824|NCT02456428|Tolazamide|tolazamide|mesh-list
19629825|NCT02456428|Carbutamide|carbutamide|mesh-list
19629826|NCT02456428|Gliquidone|gliquidone|mesh-list
19629827|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19629828|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
19629829|NCT02456428|Incretins|incretins|mesh-list
19629830|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752666|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752667|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19752668|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19752669|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752670|NCT05369052|Linezolid|linezolid|mesh-list
19752671|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19752672|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752673|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19752674|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752675|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832731|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832732|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19832733|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832734|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19832735|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
19832736|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19832737|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832738|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
20139614|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
20139615|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139616|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139617|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
20139618|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139619|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139620|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20139621|NCT00051051|Protective Agents|protective agents|mesh-ancestor
20139622|NCT00051077|Ribavirin|ribavirin|mesh-list
20139623|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20139624|NCT00051077|Adefovir|adefovir|mesh-list
20139625|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20139626|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
20139627|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139628|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
20139629|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139630|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20139631|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139632|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139633|NCT00051090|Lamivudine|lamivudine|mesh-list
20139634|NCT00051090|Efavirenz|efavirenz|mesh-list
20139635|NCT00051090|Abacavir|abacavir|mesh-list
19832739|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832740|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
19832741|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832742|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19832743|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832744|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
19832745|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832746|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19832747|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19832748|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
19832749|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
19832750|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
19832751|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19832752|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19832753|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19832754|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19832755|NCT02697227|Nicotine|nicotine|mesh-list
19832756|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19832757|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
19832758|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832759|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832760|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19832761|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20139636|NCT00051090|Didanosine|didanosine|mesh-list
19832762|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
19832763|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832764|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832765|NCT02664155|Vitamin K|vitamin k|mesh-list
19832766|NCT02664155|Heparin|heparin|mesh-list
19832767|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
19832768|NCT02664155|Apixaban|apixaban|mesh-list
19832769|NCT02664155|Vitamins|vitamins|mesh-ancestor
19832770|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
20139637|NCT00051090|Telbivudine|telbivudine|mesh-list
20139638|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20313755|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19752676|NCT05369039|Prednisolone|prednisolone|mesh-list
19752677|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139639|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139640|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139641|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629831|NCT02456428|Hormones|hormones|mesh-ancestor
19629832|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629833|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
20139642|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
20139643|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139644|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19752678|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
19752679|NCT05369039|Hormones|hormones|mesh-ancestor
19752680|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752681|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752682|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19752683|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752684|NCT05366283|Sargramostim|sargramostim|mesh-list
19752685|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
19752686|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752687|NCT05364515|Clobetasol|clobetasol|mesh-list
19752688|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19752689|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
19752690|NCT05364515|Hormones|hormones|mesh-ancestor
20139645|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20139646|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20139647|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20139648|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20139649|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20139650|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20139651|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20139652|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
20139653|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
20139654|NCT00051116|Lenalidomide|lenalidomide|mesh-list
20139655|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
20139656|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139657|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19629834|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139658|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19629835|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752691|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752692|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752693|NCT05363670|Albuterol|albuterol|mesh-list
19752694|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19752695|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
19752696|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752697|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752698|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19752699|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
19752700|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
19752701|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19752702|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19752703|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19752704|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19752705|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752706|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752707|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752708|NCT05363592|Metformin|metformin|mesh-list
19752709|NCT05363592|Alogliptin|alogliptin|mesh-list
19752710|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19752711|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752712|NCT05363592|Incretins|incretins|mesh-ancestor
19752713|NCT05363592|Hormones|hormones|mesh-ancestor
19752714|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752715|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19752716|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
19752717|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752718|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752719|NCT05363514|Naltrexone|naltrexone|mesh-list
19629836|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19629837|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19629838|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19752720|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19752721|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19752722|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752723|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
19752724|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752725|NCT05363384|Metformin|metformin|mesh-list
19752726|NCT05363384|Alogliptin|alogliptin|mesh-list
19752727|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19752728|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752729|NCT05363384|Incretins|incretins|mesh-ancestor
19752730|NCT05363384|Hormones|hormones|mesh-ancestor
19752731|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752732|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19752733|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
19752734|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752735|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752736|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
19752737|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19752738|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752739|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19752740|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313756|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313757|NCT00690560|Prednisone|prednisone|mesh-list
20313758|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
20313759|NCT00690560|Rituximab|rituximab|mesh-list
20313760|NCT00690560|Doxorubicin|doxorubicin|mesh-list
20313761|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19752741|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
19752742|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752743|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752744|NCT05355155|Bevacizumab|bevacizumab|mesh-list
19752745|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752746|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752747|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19752748|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19752749|NCT05355155|Growth Substances|growth substances|mesh-ancestor
19752750|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752751|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
19752752|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
19752753|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19752754|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752755|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752756|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752757|NCT05342376|Analgesics|analgesics|mesh-ancestor
19752758|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
19752759|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752760|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19752761|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19752762|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19752763|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752764|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752765|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752766|NCT05339256|Buprenorphine|buprenorphine|mesh-list
19752767|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19752768|NCT05339256|Narcotics|narcotics|mesh-ancestor
19752769|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19752770|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752771|NCT05339256|Analgesics|analgesics|mesh-ancestor
19752772|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
19752773|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313762|NCT00690560|Vincristine|vincristine|mesh-list
19629839|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
19629840|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
19629841|NCT02456350|Fludarabine|fludarabine|mesh-list
19752774|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19752775|NCT05334485|Bromides|bromides|mesh-list
20313763|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629842|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629843|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
19629844|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629845|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629846|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19629847|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
19629848|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629849|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752776|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19752777|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
19752778|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19752779|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752780|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752781|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
19752782|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752783|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752784|NCT05324163|Celecoxib|celecoxib|mesh-list
19752785|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19752786|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19752787|NCT05324163|Analgesics|analgesics|mesh-ancestor
19752788|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
19752789|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752790|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752791|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313764|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
20313765|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752792|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19752793|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19752794|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19752795|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752796|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752797|NCT05309655|Adenosine|adenosine|mesh-list
19752798|NCT05309655|Analgesics|analgesics|mesh-ancestor
19752799|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
19752800|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752801|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752802|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19752803|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
19752804|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19752805|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
19752806|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
19752807|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19752808|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752809|NCT05302297|Cemiplimab|cemiplimab|mesh-list
19752810|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752811|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752812|NCT05301842|Durvalumab|durvalumab|mesh-list
19752813|NCT05301842|Lenvatinib|lenvatinib|mesh-list
19752814|NCT05301842|Tremelimumab|tremelimumab|mesh-list
19752815|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752816|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752817|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19752818|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752819|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752820|NCT05271240|Bevacizumab|bevacizumab|mesh-list
19752821|NCT05271240|Temozolomide|temozolomide|mesh-list
19752822|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752823|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752824|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19752825|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19752826|NCT05271240|Growth Substances|growth substances|mesh-ancestor
19752827|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752828|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
19752829|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19752830|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
19752831|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752832|NCT05269030|Ivermectin|ivermectin|mesh-list
19752833|NCT05269030|Budesonide|budesonide|mesh-list
19752834|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19752835|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19752836|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
19752837|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313766|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313767|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20313768|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
20313769|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313770|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313771|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20313772|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752838|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752839|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19752840|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
19752841|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
20139659|NCT00051116|Growth Substances|growth substances|mesh-ancestor
20139660|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
19752842|NCT05269030|Hormones|hormones|mesh-ancestor
19752843|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752844|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19752845|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752846|NCT05269017|Vitamin D|vitamin d|mesh-list
19752847|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
19752848|NCT05269017|Budesonide|budesonide|mesh-list
19752849|NCT05269017|Vitamins|vitamins|mesh-ancestor
19752850|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
19752851|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752852|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19752853|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19752854|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19752855|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19752856|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
19752857|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19752858|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19752859|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
19752860|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
19752861|NCT05269017|Hormones|hormones|mesh-ancestor
19752862|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752863|NCT05245786|Copper|copper|mesh-list
19752864|NCT05245786|Antibodies|antibodies|mesh-list
19752865|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19752866|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
19752867|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752868|NCT05245786|Trace Elements|trace elements|mesh-ancestor
19752869|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
19752870|NCT05225064|Vaccines|vaccines|mesh-list
19752871|NCT05225064|Immunologic Factors|immunologic factors|mesh-ancestor
19752872|NCT05225064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832771|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832772|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
19832773|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19832774|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19832775|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832776|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19832777|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
19832778|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19832779|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
19832780|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832781|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19832782|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
19832783|NCT02664155|Coagulants|coagulants|mesh-ancestor
19832784|NCT02592356|Lenvatinib|lenvatinib|mesh-list
19832785|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832786|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19832787|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832788|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832789|NCT02506933|Vaccines|vaccines|mesh-list
19832790|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
19832791|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832792|NCT02493751|Avelumab|avelumab|mesh-list
19832793|NCT02493751|Axitinib|axitinib|mesh-list
19832794|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19832795|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832796|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19832797|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832798|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832799|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
19832800|NCT02461537|Analgesics|analgesics|mesh-ancestor
19832801|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
19832802|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832803|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832804|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832805|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19832806|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19832807|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832808|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832809|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
19832810|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
19832811|NCT02446964|Fludarabine|fludarabine|mesh-list
19832812|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
19629850|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19629851|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
19629852|NCT02456363|Adalimumab|adalimumab|mesh-list
19629853|NCT02456363|Etanercept|etanercept|mesh-list
19629854|NCT02456363|Golimumab|golimumab|mesh-list
19752873|NCT05201066|Azacitidine|azacitidine|mesh-list
19752874|NCT05201066|Decitabine|decitabine|mesh-list
19752875|NCT05201066|Venetoclax|venetoclax|mesh-list
19752876|NCT05201066|Spartalizumab|spartalizumab|mesh-list
19752877|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139661|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139662|NCT00051142|Travoprost|travoprost|mesh-list
20139663|NCT00051142|Latanoprost|latanoprost|mesh-list
20139664|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20139665|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20139666|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20139667|NCT00051155|Timolol|timolol|mesh-list
20139668|NCT00051155|Travoprost|travoprost|mesh-list
20139669|NCT00051155|Latanoprost|latanoprost|mesh-list
20139670|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20139671|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20139672|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
19752878|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
19752879|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752880|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752881|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752882|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19752883|NCT05178862|Fluconazole|fluconazole|mesh-list
19752884|NCT05178862|Caspofungin|caspofungin|mesh-list
19752885|NCT05178862|Micafungin|micafungin|mesh-list
19752886|NCT05178862|Anidulafungin|anidulafungin|mesh-list
19752887|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
19752888|NCT05178862|Echinocandins|echinocandins|mesh-list
19752889|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
19752890|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752891|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19752892|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19752893|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139673|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139674|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139675|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139676|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20139677|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19752894|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752895|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19752896|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
19752897|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752898|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752899|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19752900|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19752901|NCT05178407|Micronutrients|micronutrients|mesh-list
19752902|NCT05178407|Trace Elements|trace elements|mesh-list
19752903|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752904|NCT05169944|Magrolimab|magrolimab|mesh-list
19752905|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19752906|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752907|NCT05130463|Empagliflozin|empagliflozin|mesh-list
19752908|NCT05130463|Linagliptin|linagliptin|mesh-list
19629855|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139678|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20139679|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20139680|NCT00051181|Travoprost|travoprost|mesh-list
20139681|NCT00051181|Latanoprost|latanoprost|mesh-list
20139682|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19629856|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629857|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19629858|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19629859|NCT02456363|Analgesics|analgesics|mesh-ancestor
19629860|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
19629861|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629862|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629863|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19752909|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19832813|NCT02446964|Tacrolimus|tacrolimus|mesh-list
20139683|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20139684|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20139685|NCT00051259|Bupropion|bupropion|mesh-list
20139686|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20139687|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
19752910|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752911|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19752912|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752913|NCT05130463|Incretins|incretins|mesh-ancestor
19752914|NCT05130463|Hormones|hormones|mesh-ancestor
19752915|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19752916|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19752917|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
19752918|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752919|NCT05123599|Tenofovir|tenofovir|mesh-list
19752920|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
19752921|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752922|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19752923|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19752924|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752925|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752926|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19752927|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19752928|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
20139688|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20139689|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20139690|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20139691|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139692|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139693|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
19629864|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629865|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
19629866|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19629867|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313773|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20313774|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20313775|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313776|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313777|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313778|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
20313779|NCT00690560|Hormones|hormones|mesh-ancestor
19629868|NCT02456142|Morphine|morphine|mesh-list
19629869|NCT02456142|Bupivacaine|bupivacaine|mesh-list
19629870|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
20139694|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139695|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139696|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20139697|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20139698|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139699|NCT00051272|Bupropion|bupropion|mesh-list
20139700|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20139701|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
20139702|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20139703|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20139704|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20139705|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139706|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139707|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
20139708|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313780|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608514|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629871|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
19629872|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19629873|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629874|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
19629875|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629876|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19629877|NCT02456142|Narcotics|narcotics|mesh-ancestor
19629878|NCT02456142|Analgesics|analgesics|mesh-ancestor
19629879|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19629880|NCT02456194|Calcium|calcium|mesh-list
19629881|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19629882|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629883|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629884|NCT02456129|Itraconazole|itraconazole|mesh-list
19629885|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
20139709|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139710|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20139711|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20139712|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139713|NCT00051285|Enoximone|enoximone|mesh-list
20139714|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20139715|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
20139716|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20139717|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20139718|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139719|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139720|NCT00051285|Protective Agents|protective agents|mesh-ancestor
20139721|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139722|NCT00051298|Olanzapine|olanzapine|mesh-list
20139723|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
20139724|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
20139725|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139726|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139727|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20139728|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20139729|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20139730|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20139731|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20139732|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20139733|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19752929|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19752930|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
19752931|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752932|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19752933|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19752934|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
20139734|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139735|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139736|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139737|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
20139738|NCT00051389|Fosinopril|fosinopril|mesh-list
20139739|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20139740|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
20139741|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139742|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139743|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20139744|NCT00051441|Benzydamine|benzydamine|mesh-list
20139745|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20139746|NCT00051493|Carboplatin|carboplatin|mesh-list
20139747|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139748|NCT00051506|Carboplatin|carboplatin|mesh-list
20139749|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139750|NCT00051532|Seocalcitol|seocalcitol|mesh-list
20139751|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139752|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139753|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
20139754|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139755|NCT00051545|Seocalcitol|seocalcitol|mesh-list
20139756|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139757|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139758|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
20139759|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313781|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20313782|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20313783|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
20313784|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
19752935|NCT05006794|Gemcitabine|gemcitabine|mesh-list
19752936|NCT05006794|Docetaxel|docetaxel|mesh-list
19752937|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19752938|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
19752939|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752940|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752941|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
19752942|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19752943|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752944|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313785|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
20313786|NCT00690677|Panobinostat|panobinostat|mesh-list
20313787|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752945|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
19752946|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752947|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
19752948|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
19752949|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
19752950|NCT05006573|Benralizumab|benralizumab|mesh-list
19752951|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19752952|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
19752953|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
19752954|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19752955|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752956|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752957|NCT04994808|Fludarabine|fludarabine|mesh-list
19752958|NCT04994808|Clofarabine|clofarabine|mesh-list
19752959|NCT04994808|Treosulfan|treosulfan|mesh-list
19752960|NCT04994808|Busulfan|busulfan|mesh-list
19752961|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752962|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19752963|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
19752964|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752965|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19752966|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
19752967|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752968|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19752969|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
19752970|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19752971|NCT04991025|Gemcitabine|gemcitabine|mesh-list
19752972|NCT04991025|Carboplatin|carboplatin|mesh-list
19752973|NCT04991025|Pemetrexed|pemetrexed|mesh-list
19752974|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
20313788|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20313789|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313790|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313791|NCT00690768|Bevacizumab|bevacizumab|mesh-list
20313792|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313793|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752975|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752976|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19752977|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
19752978|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752979|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
19752980|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313794|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20313795|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20313796|NCT00690768|Growth Substances|growth substances|mesh-ancestor
19752981|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752982|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19752983|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
19752984|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19752985|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19752986|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19752987|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313797|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313798|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
20313799|NCT00690781|Caseins|caseins|mesh-list
19752988|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
19752989|NCT04971226|Dasatinib|dasatinib|mesh-list
19752990|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752991|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20139760|NCT00051571|Docetaxel|docetaxel|mesh-list
20139761|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139762|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139763|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139764|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139765|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139766|NCT00051584|Gemcitabine|gemcitabine|mesh-list
20139767|NCT00051584|Doxorubicin|doxorubicin|mesh-list
20139768|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
20139769|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139770|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
20139771|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139772|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313800|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
20313801|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
19752992|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19752993|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19752994|NCT04968106|Doxorubicin|doxorubicin|mesh-list
19752995|NCT04968106|Ifosfamide|ifosfamide|mesh-list
19752996|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19629886|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629887|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19629888|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19629889|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629890|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629891|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19629892|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
19629893|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629894|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139773|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
20139774|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139775|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139776|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139777|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
20139778|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139779|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20139780|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139781|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20139782|NCT00051597|Antibodies|antibodies|mesh-list
19752997|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19752998|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19752999|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19753000|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753001|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753002|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20313802|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313803|NCT00690846|Adalimumab|adalimumab|mesh-list
20313804|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313805|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629895|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19753003|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
19753004|NCT04965064|Capecitabine|capecitabine|mesh-list
19753005|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753006|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
19753007|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753008|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753009|NCT04947527|Fluorides|fluorides|mesh-list
19753010|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
19753011|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
20139783|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20139784|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
20139785|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139786|NCT00051623|Infliximab|infliximab|mesh-list
20139787|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
20139788|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20139789|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139790|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
20139791|NCT00051688|Tezacitabine|tezacitabine|mesh-list
20139792|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629896|NCT02456207|Rituximab|rituximab|mesh-list
19753012|NCT04947527|Protective Agents|protective agents|mesh-ancestor
19753013|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753014|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19753015|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19753016|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19753017|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753018|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753019|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
19753020|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753021|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19753022|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19753023|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
19753024|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19753025|NCT04891770|Tenofovir|tenofovir|mesh-list
20139793|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139794|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139795|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
20139796|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753026|NCT04891770|Nivolumab|nivolumab|mesh-list
19753027|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20139797|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139798|NCT00051753|Amoxicillin|amoxicillin|mesh-list
19753028|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753029|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753030|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753031|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
19753032|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753033|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20313806|NCT00690872|Gemcitabine|gemcitabine|mesh-list
20313807|NCT00690872|Carboplatin|carboplatin|mesh-list
20313808|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313809|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20313810|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
20313811|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313812|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
20313813|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313814|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313815|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313816|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
20313817|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313818|NCT00690885|Interferons|interferons|mesh-list
20313819|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
20313820|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
20313821|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20313822|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753034|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19753035|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753036|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19753037|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19753038|NCT04854499|Carboplatin|carboplatin|mesh-list
19753039|NCT04854499|Docetaxel|docetaxel|mesh-list
19753040|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
19753041|NCT04854499|Magrolimab|magrolimab|mesh-list
19753042|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753043|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
19753044|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
19753045|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753046|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753047|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753048|NCT04848662|Budesonide|budesonide|mesh-list
19753049|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753050|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19753051|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
19753052|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753053|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753054|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19753055|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
19753056|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
19753057|NCT04848662|Hormones|hormones|mesh-ancestor
19753058|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753059|NCT04813926|Riociguat|riociguat|mesh-list
19753060|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
19753061|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753062|NCT04812548|Azacitidine|azacitidine|mesh-list
19753063|NCT04812548|Venetoclax|venetoclax|mesh-list
20139799|NCT00051753|Levofloxacin|levofloxacin|mesh-list
20139800|NCT00051753|Ofloxacin|ofloxacin|mesh-list
20139801|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
20139802|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
20139803|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20139804|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20139805|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139806|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19753064|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753065|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
19753066|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753067|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753068|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753069|NCT04749628|Cannabidiol|cannabidiol|mesh-list
19753070|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
19753071|NCT04733534|Dasatinib|dasatinib|mesh-list
19753072|NCT04733534|Quercetin|quercetin|mesh-list
19753073|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753074|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19753075|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753076|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753077|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
20139807|NCT00051753|Renal Agents|renal agents|mesh-ancestor
19753078|NCT04733534|Protective Agents|protective agents|mesh-ancestor
19753079|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832814|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832815|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
19832816|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832817|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832818|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20139808|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139809|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20139810|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313823|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
20313824|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313825|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
20313826|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313827|NCT00690911|Adalimumab|adalimumab|mesh-list
19832819|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
19832820|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313828|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20313829|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20313830|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20313831|NCT00690937|Sevelamer|sevelamer|mesh-list
20313832|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
20313833|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
20139811|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139812|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139813|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20139814|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20139815|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20139816|NCT00051831|Ritonavir|ritonavir|mesh-list
20139817|NCT00051831|Saquinavir|saquinavir|mesh-list
20139818|NCT00051831|Tenofovir|tenofovir|mesh-list
20139819|NCT00051831|Emtricitabine|emtricitabine|mesh-list
20139820|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
20139821|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20139822|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20139823|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
20139824|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139825|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313834|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313835|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19832821|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139826|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20139827|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20139828|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
20139829|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139830|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20139831|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20139832|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20139833|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139834|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20139835|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19832822|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19832823|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832824|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
19832825|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19832826|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832827|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19832828|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19832829|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
19832830|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19832831|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832832|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
20139836|NCT00051844|Capravirine|capravirine|mesh-list
20139837|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20139838|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139839|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139840|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139841|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
20139842|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139843|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20139844|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20139845|NCT00051896|Vanoxerine|vanoxerine|mesh-list
20313836|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20313837|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
20313838|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19832833|NCT02394834|Leucovorin|leucovorin|mesh-list
19753080|NCT04732286|Bevacizumab|bevacizumab|mesh-list
19753081|NCT04732286|Atezolizumab|atezolizumab|mesh-list
19753082|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753083|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753084|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753085|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753086|NCT04732286|Growth Substances|growth substances|mesh-ancestor
19753087|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753088|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753089|NCT04726618|Xenon|xenon|mesh-list
20139846|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20139847|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19753090|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19753091|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
19753092|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
19753093|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753094|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753095|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19753096|NCT04697693|Citalopram|citalopram|mesh-list
19753097|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19753098|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19753099|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19753100|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753101|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19753102|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
19753103|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753104|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19753105|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
19753106|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19753107|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753108|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19753109|NCT04697693|Analgesics|analgesics|mesh-ancestor
19753110|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
19753111|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
19753112|NCT04695847|Antibodies|antibodies|mesh-list
19753113|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
19753114|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
19753115|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19753116|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
20139848|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139849|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139850|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
20139851|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139852|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139853|NCT00051974|Bortezomib|bortezomib|mesh-list
20139854|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139855|NCT00051987|Bortezomib|bortezomib|mesh-list
20139856|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139857|NCT00052000|Antibodies|antibodies|mesh-list
19753117|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753118|NCT04663750|Aflibercept|aflibercept|mesh-list
19753119|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20139858|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20139859|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
20139860|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753120|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753121|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753122|NCT04663750|Growth Substances|growth substances|mesh-ancestor
19753123|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753124|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753125|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753126|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19753127|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19753128|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139861|NCT00052013|Vatalanib|vatalanib|mesh-list
20139862|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20139863|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139864|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313839|NCT00690950|Dutasteride|dutasteride|mesh-list
20313840|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20313841|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20139865|NCT00052026|Carvedilol|carvedilol|mesh-list
20313842|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753135|NCT04610736|Temozolomide|temozolomide|mesh-list
19753136|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19753137|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
19753138|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313843|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313844|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
20313845|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20139866|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20139867|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20139868|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
20139869|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20139870|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139871|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139872|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20139873|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
20139874|NCT00052026|Protective Agents|protective agents|mesh-ancestor
20313846|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313847|NCT00691067|Mifepristone|mifepristone|mesh-list
20313848|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20313849|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
20313850|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20313851|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313852|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20313853|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20313854|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20313855|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
20313856|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20313857|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20608515|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608516|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20608517|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
19753139|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753140|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
19753141|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19753142|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608518|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608519|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608520|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20608521|NCT02246712|Tramadol|tramadol|mesh-list
20608522|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20608523|NCT02246712|Narcotics|narcotics|mesh-ancestor
20608524|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608525|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608526|NCT02246712|Analgesics|analgesics|mesh-ancestor
20608527|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
20313858|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
20313859|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20313860|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
20313861|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20313862|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20313863|NCT00691145|Tacrolimus|tacrolimus|mesh-list
19753143|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753144|NCT04609046|Rituximab|rituximab|mesh-list
19753145|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19753146|NCT04609046|Nivolumab|nivolumab|mesh-list
19753147|NCT04609046|Methotrexate|methotrexate|mesh-list
20313864|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313865|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
20313866|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753148|NCT04609046|Lenalidomide|lenalidomide|mesh-list
19753149|NCT04609046|Antibodies|antibodies|mesh-list
19753150|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
19753151|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19753152|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
19753153|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753154|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753155|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19753156|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20139875|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20139876|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20139877|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20139878|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
19629897|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19629898|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629899|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
19629900|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629901|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629902|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20313867|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20313868|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313869|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313870|NCT00691158|Pramlintide|pramlintide|mesh-list
20313871|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20313872|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20313873|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629903|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20139879|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20139880|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20139881|NCT00052039|Interferons|interferons|mesh-list
20139882|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
20139883|NCT00052039|Azathioprine|azathioprine|mesh-list
19753157|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
19753158|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19753159|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753160|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
19753161|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753162|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
19753163|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753164|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19753165|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753166|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19753167|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753168|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753169|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753170|NCT04609046|Growth Substances|growth substances|mesh-ancestor
19753171|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753172|NCT04592809|Midazolam|midazolam|mesh-list
19753173|NCT04592809|Ketamine|ketamine|mesh-list
19753174|NCT04592809|Analgesics|analgesics|mesh-ancestor
19753175|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
20139884|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139885|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
20139886|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753176|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753177|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753178|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19753179|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19753180|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
19753181|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
19753182|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753183|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20139887|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
20139888|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139889|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139890|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139891|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
20139892|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753184|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20139893|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20139894|NCT00052052|Interferons|interferons|mesh-list
20139895|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
20139896|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139897|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
20139898|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139899|NCT00052117|Capravirine|capravirine|mesh-list
20139900|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139901|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139902|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20139903|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19629904|NCT02456116|Analgesics|analgesics|mesh-ancestor
19753185|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313874|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
20139904|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
20139905|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20139906|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20139907|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20139908|NCT00052169|Docetaxel|docetaxel|mesh-list
20139909|NCT00052169|Gefitinib|gefitinib|mesh-list
20139910|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139911|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139912|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139913|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139914|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139915|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19753186|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753187|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20313875|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20313876|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
19753188|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19753189|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19753190|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19753191|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19753192|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
19753193|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
19753194|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
19753195|NCT04581382|Nivolumab|nivolumab|mesh-list
19753196|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753197|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753198|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753199|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753200|NCT04557735|Ravulizumab|ravulizumab|mesh-list
19753201|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19753202|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753203|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
19753204|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753205|NCT04551482|Oxytocin|oxytocin|mesh-list
20139916|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139917|NCT00052208|Gefitinib|gefitinib|mesh-list
20139918|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139919|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20139920|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139921|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139922|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
20139923|NCT00052221|Hematinics|hematinics|mesh-ancestor
20139924|NCT00052273|Capecitabine|capecitabine|mesh-list
20139925|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139926|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
19753206|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
19753207|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19753208|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753209|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
19753210|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19753211|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753212|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19753213|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753214|NCT04529772|Prednisone|prednisone|mesh-list
19753215|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
19753216|NCT04529772|Rituximab|rituximab|mesh-list
19753217|NCT04529772|Doxorubicin|doxorubicin|mesh-list
19753218|NCT04529772|Vincristine|vincristine|mesh-list
19753219|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
19753220|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753221|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
19753222|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753223|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19753224|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19753225|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
19753226|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753227|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753228|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19753229|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753230|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19753231|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139927|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139928|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753232|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20139929|NCT00052286|Modafinil|modafinil|mesh-list
19753233|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753234|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753235|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
19753236|NCT04529772|Hormones|hormones|mesh-ancestor
19753237|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753238|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753239|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19753240|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
19753241|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
19753242|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753243|NCT04519619|Aflibercept|aflibercept|mesh-list
19753244|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753245|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753246|NCT04519619|Growth Substances|growth substances|mesh-ancestor
19753247|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753248|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753249|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753250|NCT04496453|Vaccines|vaccines|mesh-list
19753251|NCT04496453|Immunologic Factors|immunologic factors|mesh-ancestor
19753252|NCT04496453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753253|NCT04482309|Trastuzumab|trastuzumab|mesh-list
19753254|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753255|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753256|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
19753257|NCT04456296|Testosterone|testosterone|mesh-list
19753258|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
19753259|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
19753260|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19753261|NCT04456296|Androgens|androgens|mesh-ancestor
19753262|NCT04456296|Hormones|hormones|mesh-ancestor
19753263|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753264|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753265|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753266|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753267|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
19753268|NCT04444492|Ranibizumab|ranibizumab|mesh-list
19753269|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753270|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753271|NCT04444492|Growth Substances|growth substances|mesh-ancestor
19753272|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753273|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753274|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753275|NCT04429425|Anesthetics|anesthetics|mesh-list
19753276|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753277|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753278|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
19753279|NCT04420884|Fluorouracil|fluorouracil|mesh-list
20608528|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608529|NCT02246816|Opium|opium|mesh-list
20608530|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20608531|NCT02246816|Narcotics|narcotics|mesh-ancestor
20608532|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608533|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753280|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753281|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753282|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
19753283|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753284|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753285|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753286|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
19753287|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753288|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
19753289|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753290|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629905|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
19629906|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629907|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629908|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629909|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19629910|NCT02456025|Tacrolimus|tacrolimus|mesh-list
19629911|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19629912|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
19753291|NCT04411550|Pertuzumab|pertuzumab|mesh-list
19753292|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608534|NCT02246816|Analgesics|analgesics|mesh-ancestor
20139930|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20139931|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139932|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19753293|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753294|NCT04410796|Carboplatin|carboplatin|mesh-list
20139933|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20139934|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20139935|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139936|NCT00052299|Cytarabine|cytarabine|mesh-list
20139937|NCT00052299|Etoposide|etoposide|mesh-list
20139938|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
20139939|NCT00052299|Idarubicin|idarubicin|mesh-list
20139940|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
20139941|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139942|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139943|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139944|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19753295|NCT04410796|Pemetrexed|pemetrexed|mesh-list
19753296|NCT04410796|Osimertinib|osimertinib|mesh-list
20139945|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139946|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139947|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139948|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
20139949|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
20313877|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313878|NCT00691184|Terbinafine|terbinafine|mesh-list
20313879|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
20313880|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313881|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313882|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313883|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
20313884|NCT00691236|Doxorubicin|doxorubicin|mesh-list
20313885|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19753297|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753298|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753299|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753300|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19753301|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19753302|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19753326|NCT04350463|Nivolumab|nivolumab|mesh-list
19753327|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
19753328|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753329|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753330|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753331|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753332|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753333|NCT04347434|Atorvastatin|atorvastatin|mesh-list
19753334|NCT04347434|Ezetimibe|ezetimibe|mesh-list
19753335|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19753336|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20139950|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753337|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
19753338|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753339|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19753340|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19753341|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753342|NCT04346914|Carboplatin|carboplatin|mesh-list
19753343|NCT04346914|Etoposide|etoposide|mesh-list
19753344|NCT04346914|Antibodies|antibodies|mesh-list
19753345|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19753346|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
19753347|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753348|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753349|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19753350|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19753351|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19753352|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753353|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753354|NCT04345718|Buprenorphine|buprenorphine|mesh-list
19753355|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
19753356|NCT04345718|Narcotics|narcotics|mesh-ancestor
19753357|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753358|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753359|NCT04345718|Analgesics|analgesics|mesh-ancestor
19753360|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
19753361|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753362|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19753363|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
19753364|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
19753365|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19753366|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19753367|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753368|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753369|NCT04325243|Urological Agents|urological agents|mesh-ancestor
19753370|NCT04303390|Cefazolin|cefazolin|mesh-list
19753371|NCT04303390|Cefuroxime|cefuroxime|mesh-list
19753372|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
19753373|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19753374|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753375|NCT04294459|Acetaminophen|acetaminophen|mesh-list
19753376|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
19753377|NCT04294459|Promethazine|promethazine|mesh-list
19753378|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
19753379|NCT04294459|Ranitidine|ranitidine|mesh-list
19753380|NCT04294459|Montelukast|montelukast|mesh-list
19753381|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19753382|NCT04294459|Analgesics|analgesics|mesh-ancestor
19753383|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
19753384|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753385|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753386|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
19753387|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753388|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
19753389|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
19753390|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753391|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
19753392|NCT04294459|Hormones|hormones|mesh-ancestor
19753393|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753394|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19753395|NCT04294459|Protective Agents|protective agents|mesh-ancestor
19753396|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19753397|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
19753398|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19753399|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
19753400|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19753401|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19753402|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753403|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19753404|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19753405|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753406|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
19753407|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
19753408|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19753409|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
19753410|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
19753411|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19753412|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19753413|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
20139951|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139952|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
20139953|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753414|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
19753415|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19753416|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19753417|NCT04287790|Naltrexone|naltrexone|mesh-list
19753418|NCT04287790|Disulfiram|disulfiram|mesh-list
19753419|NCT04287790|Acamprosate|acamprosate|mesh-list
19753420|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19753421|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19753422|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753423|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
19753424|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753425|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19753426|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753427|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753428|NCT04267939|Niraparib|niraparib|mesh-list
19753429|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19753430|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139954|NCT00052299|Analgesics|analgesics|mesh-ancestor
20139955|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
20139956|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20139957|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20139958|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753431|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753432|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753433|NCT04266977|Dexamethasone|dexamethasone|mesh-list
19753434|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753435|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
20313886|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313887|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20313888|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313889|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753436|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
19753437|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753438|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753439|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753440|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
19753441|NCT04266977|Hormones|hormones|mesh-ancestor
19753442|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753443|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753444|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753445|NCT04266340|Midazolam|midazolam|mesh-list
19753446|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
19753447|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19753448|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753449|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753450|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19753451|NCT04266340|Analgesics|analgesics|mesh-ancestor
19753452|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
19753453|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753454|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19753455|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19753456|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19753457|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
19753458|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19753459|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753460|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19753461|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19753462|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19753463|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19753464|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20139959|NCT00052312|Paclitaxel|paclitaxel|mesh-list
20139960|NCT00052312|Doxorubicin|doxorubicin|mesh-list
20139961|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20139962|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139963|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753465|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
20139964|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139965|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139966|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
20139967|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753466|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
19753467|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
19753468|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
19753469|NCT04263051|Nivolumab|nivolumab|mesh-list
19753470|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753471|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753472|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753473|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753474|NCT04255927|Triclosan|triclosan|mesh-list
19753475|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19753476|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753477|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19753478|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19753479|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
19753480|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753481|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19832834|NCT02394834|Bevacizumab|bevacizumab|mesh-list
19832835|NCT02394834|Panitumumab|panitumumab|mesh-list
19832836|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
19832837|NCT02394834|Fluorouracil|fluorouracil|mesh-list
19832838|NCT02394834|Calcium|calcium|mesh-list
19832839|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
19832840|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20139968|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20139969|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20139970|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20139971|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139972|NCT00052338|Gemcitabine|gemcitabine|mesh-list
20139973|NCT00052338|Carboplatin|carboplatin|mesh-list
20139974|NCT00052338|Bortezomib|bortezomib|mesh-list
20139975|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139976|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20139977|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
20313890|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313891|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20139978|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20139979|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
20139980|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832841|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832842|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19832843|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19832844|NCT02394834|Growth Substances|growth substances|mesh-ancestor
19832845|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832846|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832847|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19832848|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19832849|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
19832850|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832851|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832852|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832853|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
19832854|NCT02394834|Antidotes|antidotes|mesh-ancestor
19832855|NCT02394834|Protective Agents|protective agents|mesh-ancestor
19832856|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
19832857|NCT02394834|Vitamins|vitamins|mesh-ancestor
19832858|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
19832859|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
19832860|NCT02394795|Leucovorin|leucovorin|mesh-list
19832861|NCT02394795|Bevacizumab|bevacizumab|mesh-list
19832862|NCT02394795|Panitumumab|panitumumab|mesh-list
19832863|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
19832864|NCT02394795|Fluorouracil|fluorouracil|mesh-list
19832865|NCT02394795|Calcium|calcium|mesh-list
20139981|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20139982|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20139983|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
20139984|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173666|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173667|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20173668|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
20173669|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
20173670|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20173671|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19832866|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
20173672|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19832867|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19832868|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20139985|NCT00052351|Metronidazole|metronidazole|mesh-list
20139986|NCT00052351|Paclitaxel|paclitaxel|mesh-list
20139987|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
20313892|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629913|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753482|NCT04208178|Trastuzumab|trastuzumab|mesh-list
19753483|NCT04208178|Pertuzumab|pertuzumab|mesh-list
19753484|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753485|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629914|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19629915|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753486|NCT04108195|Daratumumab|daratumumab|mesh-list
19753487|NCT04108195|Pomalidomide|pomalidomide|mesh-list
19753488|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753489|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
19753490|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753491|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753492|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753493|NCT04108195|Growth Substances|growth substances|mesh-ancestor
19753494|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753495|NCT04085458|Factor VIII|factor viii|mesh-list
19753496|NCT04085458|Coagulants|coagulants|mesh-ancestor
19753497|NCT04039464|Bosentan|bosentan|mesh-list
19753498|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
19753499|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
19753500|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19753501|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20139988|NCT00052351|Doxorubicin|doxorubicin|mesh-list
20139989|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19753502|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753503|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753504|NCT04039464|Urological Agents|urological agents|mesh-ancestor
19753505|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19753506|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19753507|NCT04028245|Spartalizumab|spartalizumab|mesh-list
19753508|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753509|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753510|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753511|NCT03976245|Etanercept|etanercept|mesh-list
19753512|NCT03976245|Tofacitinib|tofacitinib|mesh-list
19753513|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19753514|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19753515|NCT03976245|Analgesics|analgesics|mesh-ancestor
19753516|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
19753517|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753518|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753519|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753520|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19753521|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753522|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753523|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
19753524|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19753525|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753526|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753527|NCT03974854|Gemcitabine|gemcitabine|mesh-list
19753528|NCT03974854|Capecitabine|capecitabine|mesh-list
19753529|NCT03974854|Irinotecan|irinotecan|mesh-list
19753530|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753531|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
20139990|NCT00052351|Vaccines|vaccines|mesh-list
20139991|NCT00052351|Sargramostim|sargramostim|mesh-list
20139992|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
20139993|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20139994|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20139995|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629916|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629917|NCT02455726|Pregabalin|pregabalin|mesh-list
19629918|NCT02455726|Oxycodone|oxycodone|mesh-list
19629919|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
19629920|NCT02455726|Analgesics|analgesics|mesh-ancestor
19629921|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
19629922|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629923|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629924|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
19629925|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20139996|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
20139997|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
20139998|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753532|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753533|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753534|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
19753535|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753536|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753537|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753538|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
20139999|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140000|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140001|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140002|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140003|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
20140004|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140005|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20140006|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140007|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140008|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140009|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753539|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753540|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20140010|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140011|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20140012|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20140013|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
20140014|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753541|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19753542|NCT03929666|Leucovorin|leucovorin|mesh-list
19753543|NCT03929666|Gemcitabine|gemcitabine|mesh-list
19753544|NCT03929666|Bevacizumab|bevacizumab|mesh-list
19753545|NCT03929666|Fluorouracil|fluorouracil|mesh-list
19753546|NCT03929666|Capecitabine|capecitabine|mesh-list
19753547|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
19753548|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753549|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753550|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753551|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753552|NCT03929666|Growth Substances|growth substances|mesh-ancestor
19753553|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753554|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753555|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753556|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
19753557|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753558|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
19753559|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753560|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753561|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753562|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
19753563|NCT03929666|Antidotes|antidotes|mesh-ancestor
19753564|NCT03929666|Protective Agents|protective agents|mesh-ancestor
19753565|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
20140015|NCT00052377|Aldesleukin|aldesleukin|mesh-list
20140016|NCT00052377|Interleukin-2|interleukin-2|mesh-list
19753566|NCT03929666|Vitamins|vitamins|mesh-ancestor
19753567|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
19753568|NCT03907969|AZD7648|azd7648|mesh-list
19753569|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19753570|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753571|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140017|NCT00052377|Interleukin-12|interleukin-12|mesh-list
20140018|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140019|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20140020|NCT00052377|Analgesics|analgesics|mesh-ancestor
20140021|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
20140022|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753572|NCT03850067|Carboplatin|carboplatin|mesh-list
19753573|NCT03850067|Nivolumab|nivolumab|mesh-list
19753574|NCT03850067|Etoposide|etoposide|mesh-list
19753575|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
19753576|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140023|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140024|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19753577|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753578|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753579|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753580|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20313893|NCT00691262|Tacrolimus|tacrolimus|mesh-list
19753581|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19753582|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19753583|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753584|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
19753585|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753586|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
19753587|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
19753588|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
19753589|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
19753590|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19753591|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
19753592|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
19753593|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753594|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753595|NCT03813108|Lumefantrine|lumefantrine|mesh-list
19753596|NCT03813108|Artemether|artemether|mesh-list
19753597|NCT03813108|Mefloquine|mefloquine|mesh-list
19753598|NCT03813108|Atovaquone|atovaquone|mesh-list
19753599|NCT03813108|Proguanil|proguanil|mesh-list
19753600|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19753601|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19753602|NCT03813108|Vaccines|vaccines|mesh-list
19753603|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
19753604|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19753605|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19753606|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753607|NCT03813108|Immunologic Factors|immunologic factors|mesh-ancestor
19753608|NCT03813108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753609|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753610|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753611|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
19753612|NCT03809611|Choline|choline|mesh-list
19753613|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
19753614|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19753615|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
19753616|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753617|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20140025|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20140026|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
20140027|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629926|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19629927|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753618|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19753619|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
19753620|NCT03800602|Metformin|metformin|mesh-list
20140028|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20140029|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
20140030|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140031|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140032|NCT00052377|Growth Substances|growth substances|mesh-ancestor
20140033|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140034|NCT00052390|Bevacizumab|bevacizumab|mesh-list
20140035|NCT00052390|Doxorubicin|doxorubicin|mesh-list
20313894|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20313895|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
20313896|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313897|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19629928|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19629929|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19629930|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19629931|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20140036|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20140037|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140038|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140039|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20313898|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629932|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19629933|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19629934|NCT02455726|Narcotics|narcotics|mesh-ancestor
19629935|NCT02455726|Antacids|antacids|mesh-ancestor
19629936|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19629937|NCT02455908|Aldesleukin|aldesleukin|mesh-list
19629938|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19629939|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19629940|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19753621|NCT03800602|Nivolumab|nivolumab|mesh-list
19753622|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19753623|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140040|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19629941|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
19629942|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629943|NCT02455869|Alendronate|alendronate|mesh-list
19629944|NCT02455869|Atorvastatin|atorvastatin|mesh-list
19629945|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19629946|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19629947|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
19629948|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629949|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19629950|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19629951|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629952|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19629953|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629954|NCT02455856|Itraconazole|itraconazole|mesh-list
19629955|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
19629956|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19629957|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19629958|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19629959|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629960|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629961|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19629962|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
19661328|NCT04908592|Dexamethasone|dexamethasone|mesh-list
19661329|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661330|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
19661331|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
19661332|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661333|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661334|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661335|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
19661336|NCT04908592|Hormones|hormones|mesh-ancestor
19661337|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661338|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19661339|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661340|NCT04895930|Aflutinib|aflutinib|mesh-list
19661341|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19661342|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661343|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661344|NCT04870424|Colchicine|colchicine|mesh-list
19661345|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
19661346|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661347|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
19661348|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
19661349|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
19661350|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661351|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661352|NCT04850651|Fluconazole|fluconazole|mesh-list
19661353|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
20140041|NCT00052390|Growth Substances|growth substances|mesh-ancestor
20140042|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140043|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140044|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20140045|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140046|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140047|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140048|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753624|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753625|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753626|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753627|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753628|NCT03775629|Tramadol|tramadol|mesh-list
19753629|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20313899|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313900|NCT00691275|Ondansetron|ondansetron|mesh-list
20313901|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
20313902|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
20313903|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313904|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753630|NCT03775629|Narcotics|narcotics|mesh-ancestor
19753631|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753632|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753633|NCT03775629|Analgesics|analgesics|mesh-ancestor
19753634|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
19753635|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753636|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
19753637|NCT03765229|Entinostat|entinostat|mesh-list
19753638|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753639|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753640|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19753641|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753642|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753643|NCT03763305|Fentanyl|fentanyl|mesh-list
19753644|NCT03763305|Remifentanil|remifentanil|mesh-list
19629963|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629964|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629965|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19629966|NCT02455921|Atropine|atropine|mesh-list
19753645|NCT03763305|Propofol|propofol|mesh-list
19753646|NCT03763305|Sevoflurane|sevoflurane|mesh-list
19753647|NCT03763305|Desflurane|desflurane|mesh-list
19753648|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19753649|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19753650|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753651|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753652|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19753653|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
19753654|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
19753655|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19753656|NCT03763305|Narcotics|narcotics|mesh-ancestor
19753657|NCT03763305|Analgesics|analgesics|mesh-ancestor
19753658|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
20140049|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20140050|NCT00052403|Antibodies|antibodies|mesh-list
20140051|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
20140052|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20140053|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
20140054|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
20140055|NCT00052403|Mitogens|mitogens|mesh-list
20140056|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140057|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140058|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173673|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19629967|NCT02455921|Neostigmine|neostigmine|mesh-list
19629968|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19629969|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19629970|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19629971|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
19629972|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629973|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629974|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19629975|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
19629976|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
19629977|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
19753659|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753660|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19753661|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19753662|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19753663|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19753664|NCT03739996|Cabotegravir|cabotegravir|mesh-list
19753665|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19753666|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753667|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753668|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
19753669|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753670|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19753671|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19753672|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19753673|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19753674|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
19753675|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753676|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753677|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
19753678|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753679|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753680|NCT03689699|Nivolumab|nivolumab|mesh-list
19753681|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753682|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753683|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753684|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753685|NCT03673462|Vaccines|vaccines|mesh-list
19753686|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
19753687|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753688|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
19753689|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753690|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753691|NCT03628391|Haloperidol|haloperidol|mesh-list
19753692|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
19753693|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
19753694|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
20140059|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140060|NCT00052416|Thalidomide|thalidomide|mesh-list
20140061|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140062|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
20140063|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140064|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
20140065|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140066|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140067|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140068|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140069|NCT00052416|Growth Substances|growth substances|mesh-ancestor
20140070|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140071|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140072|NCT00052455|Vincristine|vincristine|mesh-list
20140073|NCT00052455|Temozolomide|temozolomide|mesh-list
20140074|NCT00052455|Lomustine|lomustine|mesh-list
20140075|NCT00052455|Procarbazine|procarbazine|mesh-list
20140076|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140077|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140078|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140079|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140080|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753695|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753696|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753697|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753698|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19753699|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19753700|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753701|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19753702|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19753703|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
19753704|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19753705|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753706|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19753707|NCT03617666|Avelumab|avelumab|mesh-list
20140081|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140082|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140083|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
20140084|NCT00052468|Gemcitabine|gemcitabine|mesh-list
19753708|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753709|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832869|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19832870|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19832871|NCT02394795|Growth Substances|growth substances|mesh-ancestor
19832872|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832873|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832874|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19832875|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19832876|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
19832877|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832878|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832879|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832880|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
19832881|NCT02394795|Antidotes|antidotes|mesh-ancestor
19832882|NCT02394795|Protective Agents|protective agents|mesh-ancestor
20140085|NCT00052468|Paclitaxel|paclitaxel|mesh-list
20140086|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20140087|NCT00052468|Carboplatin|carboplatin|mesh-list
20140088|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140089|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140090|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140091|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140092|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140093|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140094|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19629978|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19629979|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19629980|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
19629981|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19629982|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19629983|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19629984|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19629985|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19661354|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661355|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19661356|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19661357|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661358|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661359|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19661360|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
19661361|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661362|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661363|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19661364|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19661365|NCT04828005|Naloxone|naloxone|mesh-list
19661366|NCT04828005|Nalmefene|nalmefene|mesh-list
19661367|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19661368|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661369|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
19661370|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661371|NCT04788550|Listerine|listerine|mesh-list
19661372|NCT04788550|Fluorides|fluorides|mesh-list
19661373|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
19661374|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
19661375|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
19661376|NCT04788550|Protective Agents|protective agents|mesh-ancestor
19661377|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661378|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19661379|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661380|NCT04759768|Naltrexone|naltrexone|mesh-list
19661381|NCT04759768|Nalmefene|nalmefene|mesh-list
19661382|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19661383|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661384|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
20140095|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
20140096|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
20140097|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140098|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140099|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140100|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
20140101|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140102|NCT00052494|Irinotecan|irinotecan|mesh-list
20313905|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20313906|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
20313907|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
20313908|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20313909|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
20313910|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313911|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313912|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20313913|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20313914|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313915|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20313916|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20313917|NCT00691379|Paclitaxel|paclitaxel|mesh-list
19629986|NCT02455687|Budesonide|budesonide|mesh-list
19629987|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
19629988|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19629989|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19629990|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
19629991|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19629992|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19629993|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19629994|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
19629995|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
19629996|NCT02455687|Hormones|hormones|mesh-ancestor
19629997|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19629998|NCT02455687|Analgesics|analgesics|mesh-ancestor
19629999|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
19630000|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
19630001|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630002|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19630003|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
19630004|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19630005|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630006|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630007|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19630008|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
19630009|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19630010|NCT02455362|Morphine|morphine|mesh-list
19630011|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19630012|NCT02455362|Narcotics|narcotics|mesh-ancestor
19630013|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630014|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630015|NCT02455362|Analgesics|analgesics|mesh-ancestor
19630016|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
19630017|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630018|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
19630019|NCT02455609|Ketamine|ketamine|mesh-list
19630020|NCT02455609|Bupivacaine|bupivacaine|mesh-list
19630021|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
19630022|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
19630023|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630024|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630025|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
19630026|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630027|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19630028|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19630029|NCT02455609|Analgesics|analgesics|mesh-ancestor
19630030|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19630031|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19630032|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19630033|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630034|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20140103|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
20313918|NCT00691379|Bevacizumab|bevacizumab|mesh-list
19661385|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661386|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20140104|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140105|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20140106|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19630035|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630036|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19630037|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19630038|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
19630039|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19630040|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19630041|NCT02455401|Remifentanil|remifentanil|mesh-list
19753710|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19753711|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
19753712|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753713|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19753714|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
19753715|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19753716|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753717|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19753718|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19753719|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19753720|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
19753721|NCT03602261|Calcifediol|calcifediol|mesh-list
19753722|NCT03602261|Vitamins|vitamins|mesh-ancestor
19753723|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
19753724|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753725|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19753726|NCT03571945|Anesthetics|anesthetics|mesh-list
19753727|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753728|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753729|NCT03569085|Sevoflurane|sevoflurane|mesh-list
19753730|NCT03569085|Isoflurane|isoflurane|mesh-list
19753731|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19753732|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19753733|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
19753734|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
19753735|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753736|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753737|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
19753738|NCT03547973|Avelumab|avelumab|mesh-list
19753739|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753740|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753741|NCT03511963|Bevacizumab|bevacizumab|mesh-list
19753742|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753743|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753744|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753745|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753746|NCT03511963|Growth Substances|growth substances|mesh-ancestor
19753747|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753748|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753749|NCT03505021|Simendan|simendan|mesh-list
19753750|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19753751|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
19753752|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19753753|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19753754|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753755|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753756|NCT03505021|Protective Agents|protective agents|mesh-ancestor
19753757|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753758|NCT03493152|Everolimus|everolimus|mesh-list
19753759|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753760|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753761|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
20140107|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140108|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140109|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140110|NCT00052507|Bortezomib|bortezomib|mesh-list
20140111|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140112|NCT00052559|Bevacizumab|bevacizumab|mesh-list
20140113|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19630042|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19630043|NCT02455401|Narcotics|narcotics|mesh-ancestor
19753762|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753763|NCT03483649|Bevacizumab|bevacizumab|mesh-list
20140114|NCT00052559|Fluorouracil|fluorouracil|mesh-list
19753764|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140115|NCT00052559|Antibodies|antibodies|mesh-list
19630044|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630045|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630046|NCT02455401|Analgesics|analgesics|mesh-ancestor
20140116|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
20140117|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20140118|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140119|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140120|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140121|NCT00052559|Growth Substances|growth substances|mesh-ancestor
20140122|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140123|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140124|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
20140125|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
20140126|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140127|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140128|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140129|NCT00052585|Leucovorin|leucovorin|mesh-list
20140130|NCT00052585|Fluorouracil|fluorouracil|mesh-list
20140131|NCT00052585|Irinotecan|irinotecan|mesh-list
20140132|NCT00052585|Gefitinib|gefitinib|mesh-list
20140133|NCT00052585|Calcium|calcium|mesh-list
19753765|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753766|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753767|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753768|NCT03483649|Growth Substances|growth substances|mesh-ancestor
19753769|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753770|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753771|NCT03405714|Brivaracetam|brivaracetam|mesh-list
20140134|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
20140135|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20313919|NCT00691379|Carboplatin|carboplatin|mesh-list
20313920|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20313921|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313922|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
20313923|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
20313924|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
20313925|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313926|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313927|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140136|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630047|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
19630048|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630049|NCT02455596|Interferons|interferons|mesh-list
19630050|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630051|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
19630052|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630053|NCT02455440|Propofol|propofol|mesh-list
19630054|NCT02455440|Sevoflurane|sevoflurane|mesh-list
19630055|NCT02455440|Esmolol|esmolol|mesh-list
19630056|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19630057|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630058|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140137|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
20140138|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140139|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19630059|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19630060|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
19630061|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
19753772|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
19753773|NCT03361436|Halichondrin B|halichondrin b|mesh-list
20140140|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630062|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19753774|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
20313928|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20313929|NCT00691379|Growth Substances|growth substances|mesh-ancestor
20313930|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313931|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
20313932|NCT00691392|Linezolid|linezolid|mesh-list
19753775|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
19753776|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753777|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753778|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753779|NCT03282344|Nivolumab|nivolumab|mesh-list
19753780|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753781|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753782|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753783|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753784|NCT03272139|Bupivacaine|bupivacaine|mesh-list
19753785|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
19753786|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
19753787|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753788|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753789|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
19753790|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753791|NCT03248479|Azacitidine|azacitidine|mesh-list
19753792|NCT03248479|Magrolimab|magrolimab|mesh-list
19753793|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753794|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
19753795|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753796|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140141|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140142|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
20140143|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20140144|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20313933|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20313934|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20313935|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20313936|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20313937|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313938|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20313939|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
20313940|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20313941|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
20313942|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313943|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313944|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20313945|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
20313946|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20313947|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20313948|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20313949|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
20313950|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313951|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313952|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
20140145|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140146|NCT00052585|Antidotes|antidotes|mesh-ancestor
20140147|NCT00052585|Protective Agents|protective agents|mesh-ancestor
20140148|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
20140149|NCT00052585|Vitamins|vitamins|mesh-ancestor
20140150|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
20140151|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140152|NCT00052611|Celecoxib|celecoxib|mesh-list
20140153|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20140154|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20140155|NCT00052611|Analgesics|analgesics|mesh-ancestor
20140156|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
20313953|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20313954|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
20313955|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140157|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313956|NCT00691470|Warfarin|warfarin|mesh-list
20313957|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
20347285|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753797|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753798|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753799|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19753800|NCT03233347|Nivolumab|nivolumab|mesh-list
19753801|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19753802|NCT03233347|Doxorubicin|doxorubicin|mesh-list
19753803|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19753804|NCT03233347|Daunorubicin|daunorubicin|mesh-list
19753805|NCT03233347|Dacarbazine|dacarbazine|mesh-list
19753806|NCT03233347|Vinblastine|vinblastine|mesh-list
19753807|NCT03233347|Antibodies|antibodies|mesh-list
19753808|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
19753809|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19753810|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
19753811|NCT03233347|Imidazole|imidazole|mesh-list
19753812|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
19753813|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753814|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753815|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19753816|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19753817|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19753818|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753819|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753820|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753821|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19753822|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
19753823|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19753824|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140158|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140159|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140160|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140161|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20140162|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20140163|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140164|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140165|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20140166|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20140167|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140168|NCT00052689|Gemcitabine|gemcitabine|mesh-list
20140169|NCT00052689|Bortezomib|bortezomib|mesh-list
20140170|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140171|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
20140172|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140173|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140174|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
20140175|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140176|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140177|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140178|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
20140179|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140180|NCT00052728|Tamoxifen|tamoxifen|mesh-list
20140181|NCT00052728|Tipifarnib|tipifarnib|mesh-list
20140182|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20140183|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
20140184|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753825|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
19753826|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753827|NCT03232918|Oxytocin|oxytocin|mesh-list
19753828|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
19753829|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19753830|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753831|NCT03215030|Dexamethasone|dexamethasone|mesh-list
19753832|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753833|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
19753834|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
19753835|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753836|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753837|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753838|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
19753839|NCT03215030|Hormones|hormones|mesh-ancestor
19753840|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753841|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753842|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140185|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140186|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140187|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140188|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20140189|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20140190|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20140191|NCT00052754|Gefitinib|gefitinib|mesh-list
20140192|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753843|NCT03213158|Ixazomib|ixazomib|mesh-list
19753844|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753845|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
19753846|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140193|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140194|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140195|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140196|NCT00052780|Temozolomide|temozolomide|mesh-list
20140197|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20140198|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140199|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
20140200|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20313958|NCT00691548|Cetuximab|cetuximab|mesh-list
20313959|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313960|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313961|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
20313962|NCT00691613|Hematinics|hematinics|mesh-ancestor
20313963|NCT00691795|Clonidine|clonidine|mesh-list
20313964|NCT00691795|Fentanyl|fentanyl|mesh-list
20313965|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20313966|NCT00691795|Narcotics|narcotics|mesh-ancestor
20313967|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313968|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313969|NCT00691795|Analgesics|analgesics|mesh-ancestor
20313970|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
20313971|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313972|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20313973|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20313974|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
20313975|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
20313976|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20313977|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
20313978|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
20313979|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20313980|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20313981|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20313982|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
20313983|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20313984|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753847|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753848|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
19753849|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753850|NCT03203473|Nivolumab|nivolumab|mesh-list
19753851|NCT03203473|Ipilimumab|ipilimumab|mesh-list
19753852|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753853|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753854|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19753855|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753856|NCT03180736|Dexamethasone|dexamethasone|mesh-list
19753857|NCT03180736|Daratumumab|daratumumab|mesh-list
19753858|NCT03180736|Pomalidomide|pomalidomide|mesh-list
19753859|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753860|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
19753861|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
19753862|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753863|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753864|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753865|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
19753866|NCT03180736|Hormones|hormones|mesh-ancestor
19753867|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753868|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753869|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140201|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20313985|NCT00691873|Omalizumab|omalizumab|mesh-list
19753870|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
20313986|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19753871|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19753872|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19753873|NCT03180736|Growth Substances|growth substances|mesh-ancestor
19753874|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
19753875|NCT03096080|XL647|xl647|mesh-list
19753876|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753877|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19753878|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753879|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753880|NCT03080883|Apixaban|apixaban|mesh-list
19753881|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19753882|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
19753883|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19753884|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
19753885|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753886|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753887|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
19753888|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
19753889|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753890|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753891|NCT03009981|Prednisone|prednisone|mesh-list
19753892|NCT03009981|Leuprolide|leuprolide|mesh-list
19753893|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
19753894|NCT03009981|Bicalutamide|bicalutamide|mesh-list
19753895|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753896|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
19753897|NCT03009981|Hormones|hormones|mesh-ancestor
19753898|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753899|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753900|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753901|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753902|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19753903|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
19753904|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19753905|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19753906|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753907|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753908|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
19753909|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19753910|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
19753911|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
19753912|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753913|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753914|NCT02926586|Cytarabine|cytarabine|mesh-list
19753915|NCT02926586|Fludarabine|fludarabine|mesh-list
19753916|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753917|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753918|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
19753919|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753920|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753921|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
19753922|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753923|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
19753924|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753925|NCT02884206|Valsartan|valsartan|mesh-list
19753926|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19753927|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19753928|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19753929|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19753930|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140202|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140203|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20140204|NCT00052832|Vitamins|vitamins|mesh-ancestor
20140205|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
20140206|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140207|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20140208|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
20140209|NCT00052845|Docetaxel|docetaxel|mesh-list
20140210|NCT00052845|Estramustine|estramustine|mesh-list
20140211|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140212|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19753931|NCT02861573|Dexamethasone|dexamethasone|mesh-list
19753932|NCT02861573|Prednisone|prednisone|mesh-list
19753933|NCT02861573|Carboplatin|carboplatin|mesh-list
20140213|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140214|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753934|NCT02861573|Docetaxel|docetaxel|mesh-list
19753935|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
19753936|NCT02861573|Etoposide|etoposide|mesh-list
19753937|NCT02861573|Olaparib|olaparib|mesh-list
19753938|NCT02861573|Lenvatinib|lenvatinib|mesh-list
19753939|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
19753940|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753941|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
19753942|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
19753943|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753944|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753945|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753946|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
19753947|NCT02861573|Hormones|hormones|mesh-ancestor
19753948|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753949|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753950|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753951|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
19753952|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
19753953|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
19753954|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753955|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19753956|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19753957|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19753958|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19753959|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19753960|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19753961|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19753962|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19753963|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
19753964|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19753965|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19753966|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
19753967|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19753968|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19753969|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19753970|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19753971|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753972|NCT02773030|Dexamethasone|dexamethasone|mesh-list
19753973|NCT02773030|Bortezomib|bortezomib|mesh-list
19753974|NCT02773030|Daratumumab|daratumumab|mesh-list
19753975|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19753976|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
19753977|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
19753978|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19753979|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753980|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19753981|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
19753982|NCT02773030|Hormones|hormones|mesh-ancestor
19753983|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19753984|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19753985|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630063|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19630064|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19630065|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19630066|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19630067|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630068|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630069|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630070|NCT02455271|Eszopiclone|eszopiclone|mesh-list
19630071|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19630072|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630073|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630074|NCT02455232|Lidocaine|lidocaine|mesh-list
19630075|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
19630076|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
20313987|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20313988|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
19630077|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630078|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630079|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
19630080|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630081|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19753986|NCT02756962|Cytarabine|cytarabine|mesh-list
19630082|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19630083|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19630084|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630085|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630086|NCT02455245|Carboplatin|carboplatin|mesh-list
19630087|NCT02455245|Vincristine|vincristine|mesh-list
19630088|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630089|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19630090|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630091|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
19630092|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
19630093|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630094|NCT02454894|Lidocaine|lidocaine|mesh-list
19630095|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
19630096|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
19630097|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630098|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630099|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
19630100|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630101|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19630102|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19630103|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19630104|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630105|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630106|NCT02455154|Letrozole|letrozole|mesh-list
19630107|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630108|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20140215|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140216|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140217|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
20140218|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140219|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19753987|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19753988|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
20608535|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
19753989|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19753990|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19753991|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
19753992|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19753993|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19753994|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
19753995|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19753996|NCT02753686|Tamoxifen|tamoxifen|mesh-list
19753997|NCT02753686|Everolimus|everolimus|mesh-list
19753998|NCT02753686|Letrozole|letrozole|mesh-list
19753999|NCT02753686|Fulvestrant|fulvestrant|mesh-list
19754000|NCT02753686|Anastrozole|anastrozole|mesh-list
19754001|NCT02753686|Exemestane|exemestane|mesh-list
19754002|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754003|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754004|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
19754005|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754006|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19754007|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19754008|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754009|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754010|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19754011|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
19754012|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140220|NCT00052845|Protective Agents|protective agents|mesh-ancestor
20140221|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140222|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20140223|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140224|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20140225|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20140226|NCT00052845|Analgesics|analgesics|mesh-ancestor
20140227|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
20140228|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140229|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140230|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140231|NCT00052884|Melphalan|melphalan|mesh-list
20140232|NCT00052884|Amifostine|amifostine|mesh-list
19754013|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19754014|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19754015|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19754016|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19754017|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19754018|NCT02740985|Docetaxel|docetaxel|mesh-list
19754019|NCT02740985|Durvalumab|durvalumab|mesh-list
19754020|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
19754021|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754022|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
19754023|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
19754024|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
19754025|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754026|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140233|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
20140234|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140235|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140236|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
20140237|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140238|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140239|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140240|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140241|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20140242|NCT00052884|Protective Agents|protective agents|mesh-ancestor
19754027|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19754028|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754029|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
19754030|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754031|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754032|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19754033|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19754034|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
19754035|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754036|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
19754037|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754038|NCT02677324|Venetoclax|venetoclax|mesh-list
19754039|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754040|NCT02573896|Lenalidomide|lenalidomide|mesh-list
20140243|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
20140244|NCT00052923|Carmustine|carmustine|mesh-list
19754041|NCT02573896|Dinutuximab|dinutuximab|mesh-list
19754042|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
19754043|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754044|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19754045|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19754046|NCT02573896|Growth Substances|growth substances|mesh-ancestor
19754047|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
19754048|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754049|NCT02553642|Nivolumab|nivolumab|mesh-list
19754050|NCT02553642|Ipilimumab|ipilimumab|mesh-list
19754051|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20313989|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
20313990|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20313991|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20313992|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20313993|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20313994|NCT00691886|Analgesics|analgesics|mesh-ancestor
20313995|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
20313996|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20313997|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20313998|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20313999|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20314000|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20314001|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754052|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754053|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19754054|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754055|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
19754056|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754057|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
19754058|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754059|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832883|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
19832884|NCT02394795|Vitamins|vitamins|mesh-ancestor
19832885|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
20140245|NCT00052923|Rituximab|rituximab|mesh-list
20140246|NCT00052923|Etoposide|etoposide|mesh-list
20140247|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314002|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314003|NCT00691912|Paclitaxel|paclitaxel|mesh-list
20314004|NCT00691912|Doxorubicin|doxorubicin|mesh-list
20314005|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20314006|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20314007|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314008|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
20314009|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
20314010|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
20314011|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140248|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
20140249|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140250|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140251|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140252|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
20140253|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140254|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140255|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140256|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140257|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140258|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19630109|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19630110|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630111|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630112|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19630113|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
19630114|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630115|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630116|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
19630117|NCT02455180|Vitamins|vitamins|mesh-ancestor
19630118|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
19630119|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630120|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
19630121|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630122|NCT02455180|Protective Agents|protective agents|mesh-ancestor
19630123|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
19630124|NCT02454881|Oxycodone|oxycodone|mesh-list
19630125|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19630126|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630127|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630128|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19630129|NCT02454881|Analgesics|analgesics|mesh-ancestor
19630130|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
19630131|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754060|NCT02428985|Riociguat|riociguat|mesh-list
19754061|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
20140259|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140260|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140261|NCT00052936|Prednisone|prednisone|mesh-list
20140262|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
20140263|NCT00052936|Rituximab|rituximab|mesh-list
20140264|NCT00052936|Doxorubicin|doxorubicin|mesh-list
20140265|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20140266|NCT00052936|Vincristine|vincristine|mesh-list
20140267|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140268|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
20140269|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140270|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173674|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
19754062|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754063|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19754064|NCT02411448|Gefitinib|gefitinib|mesh-list
19754065|NCT02411448|Osimertinib|osimertinib|mesh-list
19754066|NCT02411448|Ramucirumab|ramucirumab|mesh-list
19754067|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754068|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754069|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754070|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754071|NCT02215265|Cisplatin|cisplatin|mesh-list
19754072|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754073|NCT02138955|Curcumin|curcumin|mesh-list
19754074|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19754075|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19754076|NCT02138955|Analgesics|analgesics|mesh-ancestor
19754077|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
19754078|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754079|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314012|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314013|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20314014|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20314015|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314016|NCT00691951|Budesonide|budesonide|mesh-list
20314017|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
20314018|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314019|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20314020|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
19754080|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754081|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754082|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754083|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754084|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754085|NCT02121405|Capecitabine|capecitabine|mesh-list
19754086|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
19754087|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19754088|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
19630132|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19630133|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19630134|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19630135|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
19754089|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754090|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754091|NCT01929915|Fentanyl|fentanyl|mesh-list
19754092|NCT01929915|Morphine|morphine|mesh-list
19754093|NCT01929915|Bupivacaine|bupivacaine|mesh-list
19754094|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
19754095|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
19754096|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754097|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754098|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
19754099|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140271|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140272|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
20140273|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140274|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140275|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140276|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140277|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20140278|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140279|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140280|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140281|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140282|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
19754100|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20140283|NCT00052936|Hormones|hormones|mesh-ancestor
20140284|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314021|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314022|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630136|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630137|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630138|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19630139|NCT02454881|Narcotics|narcotics|mesh-ancestor
19630140|NCT02455115|Chromium|chromium|mesh-list
19630141|NCT02455115|Norepinephrine|norepinephrine|mesh-list
19630142|NCT02455115|Edetic Acid|edetic acid|mesh-list
19754101|NCT01929915|Narcotics|narcotics|mesh-ancestor
19754102|NCT01929915|Analgesics|analgesics|mesh-ancestor
19754103|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19754104|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19754105|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
19754106|NCT01849783|Thalidomide|thalidomide|mesh-list
19754107|NCT01849783|Dexamethasone|dexamethasone|mesh-list
19754108|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
19754109|NCT01849783|Melphalan|melphalan|mesh-list
19754110|NCT01849783|Doxorubicin|doxorubicin|mesh-list
19754111|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19754112|NCT01849783|Etoposide|etoposide|mesh-list
19754113|NCT01849783|Bortezomib|bortezomib|mesh-list
19754114|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
19754115|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754116|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
19754117|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754118|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754119|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19754120|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
19754121|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754122|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754123|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19754124|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754125|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
19754126|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
19754127|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754128|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19754129|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
19754130|NCT01849783|Hormones|hormones|mesh-ancestor
19754131|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754132|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19754133|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19754134|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19754135|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19754136|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754137|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19754138|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
19754139|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19754140|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754141|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19754142|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19754143|NCT01849783|Growth Substances|growth substances|mesh-ancestor
19754144|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
19754145|NCT01744912|Lenalidomide|lenalidomide|mesh-list
19754146|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
19754147|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754148|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19754149|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19754150|NCT01744912|Growth Substances|growth substances|mesh-ancestor
19754151|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
19754152|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754153|NCT01505465|Melatonin|melatonin|mesh-list
19754154|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
20140285|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140286|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140287|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140288|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140289|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140290|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
20140291|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140292|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140293|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140294|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140295|NCT00053001|Thalidomide|thalidomide|mesh-list
19630143|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
19630144|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19630145|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19630146|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630147|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630148|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630149|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630150|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
19630151|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
19630152|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630153|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19630154|NCT02455115|Trace Elements|trace elements|mesh-ancestor
19630155|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
19630156|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
19630157|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19630158|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
20314023|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20314024|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
19630159|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
19630160|NCT02455115|Antidotes|antidotes|mesh-ancestor
19630161|NCT02455115|Protective Agents|protective agents|mesh-ancestor
19630162|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19630163|NCT02455011|Volagidemab|volagidemab|mesh-list
19630164|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19754155|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754156|NCT01505465|Protective Agents|protective agents|mesh-ancestor
19754157|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754158|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20140296|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
20140297|NCT00053001|Hematinics|hematinics|mesh-ancestor
20140298|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140299|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
20140300|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140301|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
19754159|NCT00980538|Etravirine|etravirine|mesh-list
19754160|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19754161|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19754162|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754163|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754164|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
19754165|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754166|NCT00676663|Exemestane|exemestane|mesh-list
19754167|NCT00676663|Entinostat|entinostat|mesh-list
19754168|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754169|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19754170|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19754171|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754172|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754173|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19754174|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
19754175|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754176|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754177|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19754178|NCT00573131|Paclitaxel|paclitaxel|mesh-list
19754179|NCT00573131|Cisplatin|cisplatin|mesh-list
19754180|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19754181|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754182|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
19754183|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
19754184|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
19754185|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754186|NCT00555555|Factor VIII|factor viii|mesh-list
19754187|NCT00555555|Coagulants|coagulants|mesh-ancestor
20140302|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140303|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140304|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140305|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140306|NCT00053001|Growth Substances|growth substances|mesh-ancestor
20314025|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
19630165|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630166|NCT02454868|Remifentanil|remifentanil|mesh-list
19630167|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19630168|NCT02454868|Narcotics|narcotics|mesh-ancestor
19630169|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630170|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630171|NCT02454868|Analgesics|analgesics|mesh-ancestor
19630172|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
19630173|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630174|NCT02454764|Interferons|interferons|mesh-list
19630175|NCT02454764|Tenofovir|tenofovir|mesh-list
19630176|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
19630177|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
19630178|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630179|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
20140307|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140308|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140309|NCT00053027|Rituximab|rituximab|mesh-list
20140310|NCT00053027|Cladribine|cladribine|mesh-list
20140311|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140312|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140313|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
20140314|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630180|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630181|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19630182|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19630183|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754188|NCT00479765|Paclitaxel|paclitaxel|mesh-list
20140315|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20314026|NCT00691951|Hormones|hormones|mesh-ancestor
20314027|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314028|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20314029|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19661387|NCT04757493|Prucalopride|prucalopride|mesh-list
19661388|NCT04757493|Laxatives|laxatives|mesh-ancestor
19661389|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661390|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19661391|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19661392|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
19661393|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661394|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661395|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661396|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
19661397|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19661398|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19661399|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19661400|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661401|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661402|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
19661403|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661404|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661405|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19661406|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661407|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
19661408|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661409|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661410|NCT04723134|Leucovorin|leucovorin|mesh-list
19661411|NCT04723134|Folic Acid|folic acid|mesh-list
19661412|NCT04723134|Calcium|calcium|mesh-list
19661413|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
19661414|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661415|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661416|NCT04723134|Antidotes|antidotes|mesh-ancestor
19661417|NCT04723134|Protective Agents|protective agents|mesh-ancestor
19661418|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
19661419|NCT04723134|Vitamins|vitamins|mesh-ancestor
19661420|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
19661421|NCT04723134|Hematinics|hematinics|mesh-ancestor
19661422|NCT04713319|Calcium|calcium|mesh-list
19661423|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661424|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661425|NCT04691986|Niacinamide|niacinamide|mesh-list
19661426|NCT04691986|Niacin|niacin|mesh-list
19661427|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
19661428|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
19661429|NCT04691986|Vitamins|vitamins|mesh-ancestor
19661430|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
19661431|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661432|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19661433|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
19661434|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661435|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19661436|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
19661437|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
19661438|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19661439|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20314030|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20314031|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
20314032|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314033|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314034|NCT00692016|Naproxen|naproxen|mesh-list
20314035|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19754189|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19754190|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754191|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
19754192|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
19754193|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
19754194|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754195|NCT04864743|Factor VIII|factor viii|mesh-list
19754196|NCT04864743|Coagulants|coagulants|mesh-ancestor
19754197|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19754198|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
19754199|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
19754200|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754201|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754202|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
19754203|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754204|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19754205|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
19754206|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754207|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754208|NCT04852003|Morphine|morphine|mesh-list
19754209|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19754210|NCT04852003|Narcotics|narcotics|mesh-ancestor
19754211|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754212|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754213|NCT04852003|Analgesics|analgesics|mesh-ancestor
19754214|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
19754215|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754216|NCT04810598|Venetoclax|venetoclax|mesh-list
19754217|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754218|NCT04796922|Rituximab|rituximab|mesh-list
19754219|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
19754220|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754221|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754222|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
19754223|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754224|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754225|NCT04790513|Evolocumab|evolocumab|mesh-list
19754226|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19754227|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19754228|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
19754229|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754230|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19754231|NCT04786210|Triamcinolone|triamcinolone|mesh-list
19754232|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19754233|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19754234|NCT04786210|Fluorouracil|fluorouracil|mesh-list
19754235|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20140316|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140317|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
20140318|NCT00053092|Rituximab|rituximab|mesh-list
20140319|NCT00053092|Fludarabine|fludarabine|mesh-list
20140320|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
19754236|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
19754237|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754238|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19754239|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754240|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754241|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
19754242|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754243|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140321|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140322|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
20140323|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140324|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140325|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140326|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
20140327|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754244|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
19754245|NCT04786210|Hormones|hormones|mesh-ancestor
19754246|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754247|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754248|NCT04782778|Bupivacaine|bupivacaine|mesh-list
19754249|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
19754250|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
19754251|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754252|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754253|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
19754254|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754255|NCT04763512|Caseins|caseins|mesh-list
19754256|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
19754257|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
19754258|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754259|NCT04761861|Vildagliptin|vildagliptin|mesh-list
19754260|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19754261|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754262|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19754263|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
19754264|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754265|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754266|NCT04761094|Insulin|insulin|mesh-list
19754267|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19754268|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754269|NCT04756271|Antibodies|antibodies|mesh-list
19754270|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
19754271|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
19754272|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832886|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
19832887|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
19832888|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832889|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19832890|NCT02202772|Gemcitabine|gemcitabine|mesh-list
19832891|NCT02202772|Cisplatin|cisplatin|mesh-list
19832892|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832893|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832894|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
19832895|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832896|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
19832897|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140328|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630184|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630185|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19630186|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19630187|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
19630188|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630189|NCT02454751|Fentanyl|fentanyl|mesh-list
19630190|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19630191|NCT02454751|Narcotics|narcotics|mesh-ancestor
19630192|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630193|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630194|NCT02454751|Analgesics|analgesics|mesh-ancestor
19630195|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
19630196|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630197|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19630198|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19630199|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
20140329|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140330|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140331|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140332|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
20140333|NCT00053105|Cytarabine|cytarabine|mesh-list
20140334|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
20140335|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20140336|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20140337|NCT00053105|Prednisolone|prednisolone|mesh-list
20140338|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
20140339|NCT00053105|Pixantrone|pixantrone|mesh-list
20140340|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20140341|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
20140342|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140343|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140344|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
20140345|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314036|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20314037|NCT00692016|Analgesics|analgesics|mesh-ancestor
20314038|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
20314039|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314040|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630200|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
19630201|NCT02454712|Naltrexone|naltrexone|mesh-list
19630202|NCT02454712|Oxycodone|oxycodone|mesh-list
19630203|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19630204|NCT02454712|Narcotics|narcotics|mesh-ancestor
19630205|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630206|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630207|NCT02454712|Analgesics|analgesics|mesh-ancestor
19630208|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
20314041|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314042|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20314043|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
20314044|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20314045|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314046|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314047|NCT00692055|Naproxen|naproxen|mesh-list
20314048|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19754273|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
19754274|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754275|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754276|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19754277|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19754278|NCT04729023|Temazepam|temazepam|mesh-list
19754279|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19754280|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754281|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140346|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
20140347|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140348|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140349|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
20140350|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140351|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314049|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20314050|NCT00692055|Analgesics|analgesics|mesh-ancestor
20314051|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
19630209|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754282|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19754283|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19754284|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19754285|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
19754286|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
19754287|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754288|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754289|NCT04718350|Simendan|simendan|mesh-list
19754290|NCT04718350|Milrinone|milrinone|mesh-list
19754291|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19754292|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
19754293|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19754294|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19754295|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754296|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754297|NCT04718350|Protective Agents|protective agents|mesh-ancestor
19754298|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754299|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19754300|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
19754301|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19754302|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
19754303|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754304|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754305|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19754306|NCT04714710|Diuretics|diuretics|mesh-ancestor
19754307|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
20140352|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
20140353|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
20140354|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630210|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19754308|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19754309|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
20140355|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314052|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140356|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
20140357|NCT00053105|Hormones|hormones|mesh-ancestor
20140358|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140359|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20140360|NCT00053105|Protective Agents|protective agents|mesh-ancestor
20140361|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140362|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140363|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140364|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140365|NCT00053118|Carboplatin|carboplatin|mesh-list
20314053|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314054|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630211|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19630212|NCT02454491|Verapamil|verapamil|mesh-list
19630213|NCT02454491|Heparin|heparin|mesh-list
19630214|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
19630215|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19630216|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19630217|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630218|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19630219|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19630220|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630221|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19630222|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754310|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754311|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19754312|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19754313|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
19754314|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754315|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754316|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19754317|NCT04698434|Esketamine|esketamine|mesh-list
19754318|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
19754319|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19754320|NCT04696575|Lamivudine|lamivudine|mesh-list
19754321|NCT04696575|Carboplatin|carboplatin|mesh-list
19754322|NCT04696575|Etoposide|etoposide|mesh-list
19754323|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
19754324|NCT04696575|Atezolizumab|atezolizumab|mesh-list
19754325|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
19754326|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19754327|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754328|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19754329|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19754330|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19754331|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754332|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754333|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19754334|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19754335|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
19754336|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754337|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19754338|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19754339|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
19754340|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754341|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
19754342|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
19754343|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
19754344|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
19754345|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
19754346|NCT04681430|Gabexate|gabexate|mesh-list
19754347|NCT04681430|Camostat|camostat|mesh-list
19754348|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
19754349|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754350|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754351|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19754352|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19754353|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
19754354|NCT04677816|Vitamin D|vitamin d|mesh-list
19754355|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
19754356|NCT04677816|Vitamins|vitamins|mesh-ancestor
19754357|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
19754358|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754359|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19754360|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19754361|NCT04674774|Lansoprazole|lansoprazole|mesh-list
19754362|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
19754363|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19754364|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19754365|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19754366|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754367|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754368|NCT04672512|Prednisone|prednisone|mesh-list
19754369|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754370|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
19754371|NCT04672512|Hormones|hormones|mesh-ancestor
19754372|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754373|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754374|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19754375|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754376|NCT04650217|Levodopa|levodopa|mesh-list
19754377|NCT04650217|Carbidopa|carbidopa|mesh-list
19754378|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19754379|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19754380|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19754381|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
19754382|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754383|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754384|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754385|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19754386|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754387|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19754388|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
19754389|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
19754390|NCT04641195|Vitamin D|vitamin d|mesh-list
19754391|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
19754392|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
19754393|NCT04641195|Vitamins|vitamins|mesh-list
19754394|NCT04641195|Zinc|zinc|mesh-list
19754395|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
19754396|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754397|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19754398|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19754399|NCT04641195|Trace Elements|trace elements|mesh-ancestor
19754400|NCT04634539|Gemcitabine|gemcitabine|mesh-list
19754401|NCT04634539|Paclitaxel|paclitaxel|mesh-list
19754402|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19754403|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754404|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
19754405|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
19754406|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
19754407|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754408|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19754409|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
19754410|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
19754411|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754412|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754413|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754414|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
19754415|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754416|NCT04618523|Artesunate|artesunate|mesh-list
19754417|NCT04618523|Lumefantrine|lumefantrine|mesh-list
19754418|NCT04618523|Artemether|artemether|mesh-list
19754419|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19754420|NCT04618523|Amodiaquine|amodiaquine|mesh-list
19754421|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
19754422|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19754423|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19754424|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754425|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754426|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
19754427|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
19754428|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19754429|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
19754430|NCT04608266|Camostat|camostat|mesh-list
19754431|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
19754432|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754433|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754434|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19754435|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19754436|NCT04599816|Simendan|simendan|mesh-list
19754437|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19754438|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
19754439|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20140366|NCT00053118|Etoposide|etoposide|mesh-list
20140367|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140368|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140369|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140370|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140371|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314055|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754440|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19754441|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754442|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754443|NCT04599816|Protective Agents|protective agents|mesh-ancestor
19754444|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754445|NCT04599777|Sorafenib|sorafenib|mesh-list
19754446|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754447|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754448|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754449|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754450|NCT04582669|Triamcinolone|triamcinolone|mesh-list
19754451|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19754452|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19754453|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19754454|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754455|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
19754456|NCT04582669|Hormones|hormones|mesh-ancestor
19754457|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754458|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754459|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754460|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
19754461|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754462|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754463|NCT04567407|Ropivacaine|ropivacaine|mesh-list
19754464|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
19754465|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
19754466|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754467|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754468|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
19754469|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754470|NCT04562285|Antibodies|antibodies|mesh-list
19754471|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
19754472|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754473|NCT04562246|Antibodies|antibodies|mesh-list
19754474|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
19754475|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754476|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19754477|NCT04541290|Tacrolimus|tacrolimus|mesh-list
19754478|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754479|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
19754480|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754481|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19754482|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754483|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754484|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
19754485|NCT04539808|Leucovorin|leucovorin|mesh-list
19754486|NCT04539808|Folic Acid|folic acid|mesh-list
19754487|NCT04539808|Fluorouracil|fluorouracil|mesh-list
19754488|NCT04539808|Capecitabine|capecitabine|mesh-list
19754489|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
19754490|NCT04539808|Irinotecan|irinotecan|mesh-list
19754491|NCT04539808|Camptothecin|camptothecin|mesh-list
19754492|NCT04539808|Losartan|losartan|mesh-list
19754493|NCT04539808|Calcium|calcium|mesh-list
19754494|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
19754495|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19754496|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754497|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19754498|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
19754499|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754500|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19754501|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314056|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
20314057|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20314058|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754502|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754503|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
19754504|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20140372|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754505|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19754506|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754507|NCT04539808|Antidotes|antidotes|mesh-ancestor
19754508|NCT04539808|Protective Agents|protective agents|mesh-ancestor
19754509|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
19754510|NCT04539808|Vitamins|vitamins|mesh-ancestor
19754511|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
19754512|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19754513|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19754514|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19754515|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19754516|NCT04539808|Hematinics|hematinics|mesh-ancestor
19754517|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19754518|NCT04535505|Erythromycin|erythromycin|mesh-list
20314059|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630223|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
19630224|NCT02454504|Neostigmine|neostigmine|mesh-list
19630225|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19630226|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630227|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630228|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
19630229|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754519|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
19754520|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19754521|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
19754522|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19754523|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754524|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19754525|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19754526|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754527|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832898|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832899|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832900|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
19832901|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832902|NCT02192359|Irinotecan|irinotecan|mesh-list
19832903|NCT02192359|Camptothecin|camptothecin|mesh-list
19832904|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19832905|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19832906|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832907|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832908|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832909|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19832910|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19832911|NCT02174822|Paroxetine|paroxetine|mesh-list
19832912|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19832913|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19832914|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832915|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832916|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314060|NCT00692120|Vitamin D|vitamin d|mesh-list
20314061|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
20314062|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
20314063|NCT00692120|Vitamins|vitamins|mesh-list
20314064|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
20314065|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314066|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20314067|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20314068|NCT00692159|Pemetrexed|pemetrexed|mesh-list
20314069|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314070|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314071|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314072|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20314073|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19630230|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630231|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19630232|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
19630233|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314074|NCT00692172|Alefacept|alefacept|mesh-list
20314075|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
20314076|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
20314077|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630234|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19630235|NCT02454556|Hormones|hormones|mesh-ancestor
20140373|NCT00053131|Cytarabine|cytarabine|mesh-list
20140374|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
20140375|NCT00053131|Sargramostim|sargramostim|mesh-list
20140376|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314078|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20314079|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20314080|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20314081|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
20314082|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314083|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20314084|NCT00692263|Tramadol|tramadol|mesh-list
20314085|NCT00692263|Citalopram|citalopram|mesh-list
20314086|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19630236|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754528|NCT04527393|Morphine|morphine|mesh-list
19754529|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19754530|NCT04527393|Narcotics|narcotics|mesh-ancestor
19754531|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754532|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754533|NCT04527393|Analgesics|analgesics|mesh-ancestor
19754534|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
19754535|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754536|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
19754537|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754538|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
19754539|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754540|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
19754541|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754542|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754543|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
19754544|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754545|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754546|NCT04504864|Aspirin|aspirin|mesh-list
19754547|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19754548|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19754549|NCT04504864|Analgesics|analgesics|mesh-ancestor
19754550|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
19754551|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754552|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754553|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754554|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754555|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19754556|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19754557|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754558|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19754559|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19754560|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754561|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
19754562|NCT04497155|Norepinephrine|norepinephrine|mesh-list
20140377|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
20140378|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140379|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140380|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
20140381|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140382|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140383|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
20314087|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19630237|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630238|NCT02454426|Vortioxetine|vortioxetine|mesh-list
19630239|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
19630240|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19630241|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19630242|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19630243|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630244|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630245|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19630246|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19630247|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630248|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630249|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20140384|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140385|NCT00053131|Analgesics|analgesics|mesh-ancestor
19754563|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19754564|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19754565|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
19754566|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754567|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754568|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754569|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
19754570|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
19754571|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754572|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19754573|NCT04496999|Midostaurin|midostaurin|mesh-list
19754574|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754575|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754576|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754577|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754578|NCT04493320|Levodopa|levodopa|mesh-list
19754579|NCT04493320|Carbidopa|carbidopa|mesh-list
19754580|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19754581|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19754582|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19754583|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
19754584|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754585|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754586|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754587|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19754588|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754589|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19754590|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
19754591|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
19754592|NCT04491968|Methadone|methadone|mesh-list
19754593|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19754594|NCT04491968|Narcotics|narcotics|mesh-ancestor
19754595|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20140386|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
20140387|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140388|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140389|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140390|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140391|NCT00053144|Cytarabine|cytarabine|mesh-list
20140392|NCT00053144|Irinotecan|irinotecan|mesh-list
19754596|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754597|NCT04491968|Analgesics|analgesics|mesh-ancestor
19754598|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
19754599|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754600|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
19754601|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
19754602|NCT04483505|Fulvestrant|fulvestrant|mesh-list
19754603|NCT04483505|Palbociclib|palbociclib|mesh-list
19754604|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19754605|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754606|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19754607|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19754608|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
19754609|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754610|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754611|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754612|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754613|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754614|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
19754615|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754616|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754617|NCT04443348|Paclitaxel|paclitaxel|mesh-list
19754618|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
19754619|NCT04443348|Carboplatin|carboplatin|mesh-list
19754620|NCT04443348|Doxorubicin|doxorubicin|mesh-list
20140393|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20140394|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140395|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140396|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140397|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140398|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140399|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
20140400|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
19754621|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
20140401|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754622|NCT04443348|Capecitabine|capecitabine|mesh-list
19754623|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19754624|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754625|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
19754626|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
19754627|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
19754628|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754629|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754630|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
19754631|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754632|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754633|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19754634|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
19754635|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19754636|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19754637|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19754638|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19754639|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754640|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754641|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19754642|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
19754643|NCT04437303|Anticoagulants|anticoagulants|mesh-list
19754644|NCT04413786|Oxytocin|oxytocin|mesh-list
19754645|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
19754646|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19754647|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754648|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
19754649|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19754650|NCT04400383|Antibodies|antibodies|mesh-list
19754651|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
19754652|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19754653|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
19754654|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754655|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754656|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
19630250|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
19630251|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19630252|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19630253|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19630254|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19630255|NCT02454348|Vasopressins|vasopressins|mesh-list
19630256|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
19630257|NCT02454348|Norepinephrine|norepinephrine|mesh-list
19630258|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19754657|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754658|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754659|NCT04378959|Lidocaine|lidocaine|mesh-list
19754660|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
19754661|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
19754662|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754663|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754664|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
19754665|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754666|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19754667|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19754668|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19754669|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19754670|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754671|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
19754672|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754673|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754674|NCT04358393|Azacitidine|azacitidine|mesh-list
19754675|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19754676|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
19754677|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754678|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754679|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754680|NCT04347486|Atropine|atropine|mesh-list
19754681|NCT04347486|Neostigmine|neostigmine|mesh-list
19754682|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19754683|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19754684|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19754685|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
19754686|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630259|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19754687|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754688|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19754689|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
19754690|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
19754691|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
19754692|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19754693|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19754694|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
19754695|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754696|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754697|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19754698|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754699|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19754700|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
19754701|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
19754702|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19754703|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19754704|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754705|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754706|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754707|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754708|NCT04338698|Azithromycin|azithromycin|mesh-list
19754709|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
19754710|NCT04338698|Oseltamivir|oseltamivir|mesh-list
19754711|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19754712|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754713|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
19754714|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19754715|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19754716|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754717|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754718|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754719|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
19754720|NCT04331938|Anesthetics|anesthetics|mesh-list
19754721|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754722|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754723|NCT04326738|Midazolam|midazolam|mesh-list
19754724|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19754725|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19754726|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754727|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754728|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19754729|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19754730|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19754731|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19754732|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
19754733|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
19754734|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
19754735|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
19754736|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754737|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754738|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
19754739|NCT04305041|Lenvatinib|lenvatinib|mesh-list
19754740|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754741|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754742|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754743|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754744|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754745|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
19754746|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754747|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754748|NCT04288427|Finasteride|finasteride|mesh-list
19754749|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19754750|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20140402|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754751|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754752|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754753|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
19754754|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754755|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754756|NCT04288427|Urological Agents|urological agents|mesh-ancestor
19754757|NCT04282668|Tretinoin|tretinoin|mesh-list
19754758|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754759|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
20140403|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
19754760|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
19754761|NCT04274894|Testosterone|testosterone|mesh-list
19754762|NCT04274894|Androgens|androgens|mesh-ancestor
19754763|NCT04274894|Hormones|hormones|mesh-ancestor
19754764|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754765|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754766|NCT04263090|Nivolumab|nivolumab|mesh-list
19754767|NCT04263090|ON 01910|on 01910|mesh-list
19754768|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754769|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754770|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19754771|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754772|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754773|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140404|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140405|NCT00053157|Sargramostim|sargramostim|mesh-list
20140406|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
20140407|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754774|NCT04258852|Nicotine|nicotine|mesh-list
19754775|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19754776|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
19754777|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754778|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754779|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19754780|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19754781|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
19754782|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754783|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754784|NCT04255381|Pancrelipase|pancrelipase|mesh-list
19754785|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19754786|NCT04236141|Rituximab|rituximab|mesh-list
19754787|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19754788|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754789|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754790|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
19754791|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754792|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754793|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19754794|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
19754795|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754796|NCT04229381|Coal Tar|coal tar|mesh-list
19754797|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
19754798|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
19832917|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832918|NCT02174822|Analgesics|analgesics|mesh-ancestor
19832919|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
19630260|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630261|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630262|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832920|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832921|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
19832922|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19832923|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
19832924|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19832925|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
19832926|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19832927|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19832928|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19832929|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832930|NCT01961063|Busulfan|busulfan|mesh-list
19832931|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
19832932|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140408|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
20140409|NCT00053196|Methotrexate|methotrexate|mesh-list
19630263|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630264|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
19630265|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
19630266|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630267|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19630268|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
19630269|NCT02454348|Coagulants|coagulants|mesh-ancestor
19630270|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20140410|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
20140411|NCT00053196|Fludarabine|fludarabine|mesh-list
19832933|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754799|NCT04203927|Empagliflozin|empagliflozin|mesh-list
19754800|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19754801|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754802|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19754803|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754804|NCT04200066|Tamoxifen|tamoxifen|mesh-list
19754805|NCT04200066|Temozolomide|temozolomide|mesh-list
19754806|NCT04200066|Maprotiline|maprotiline|mesh-list
19754807|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19754808|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
19754809|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754810|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754811|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19754812|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
19754813|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754814|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754815|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19754816|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19754817|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19754818|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19754819|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19754820|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
19754821|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19754822|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19754823|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19754824|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19754825|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
19754826|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754827|NCT04183712|Gemcitabine|gemcitabine|mesh-list
19754828|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
19754829|NCT04183712|Afatinib|afatinib|mesh-list
19754830|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19754831|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
20140412|NCT00053196|Busulfan|busulfan|mesh-list
20140413|NCT00053196|Allopurinol|allopurinol|mesh-list
20140414|NCT00053196|Tacrolimus|tacrolimus|mesh-list
20140415|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20140416|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19754832|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754833|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140417|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
20140418|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20140419|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754834|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
19754835|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754836|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754837|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19754838|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
19754839|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754840|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754841|NCT04180813|Linagliptin|linagliptin|mesh-list
19754842|NCT04180813|Acarbose|acarbose|mesh-list
19754843|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19754844|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754845|NCT04180813|Incretins|incretins|mesh-ancestor
19754846|NCT04180813|Hormones|hormones|mesh-ancestor
19754847|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754848|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19754849|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
19754850|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754851|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754852|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19754853|NCT04171167|Fluticasone|fluticasone|mesh-list
19754854|NCT04171167|Xhance|xhance|mesh-list
19754855|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754856|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19754857|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
19754858|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140420|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140421|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
20173675|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754859|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754860|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19754861|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
19754862|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
19754863|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19754864|NCT04160546|Aspirin|aspirin|mesh-list
19754865|NCT04160546|Ponatinib|ponatinib|mesh-list
19754866|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19754867|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19754868|NCT04160546|Analgesics|analgesics|mesh-ancestor
19754869|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
19754870|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754871|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754872|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754873|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19754874|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19754875|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19754876|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754877|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19754878|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19754879|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754880|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
20140422|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140423|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140424|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
20140425|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140426|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20140427|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140428|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
19754881|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754882|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19754883|NCT04134000|Atezolizumab|atezolizumab|mesh-list
19754884|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754885|NCT04017468|Vancomycin|vancomycin|mesh-list
19754886|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19754887|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754888|NCT04015739|Bevacizumab|bevacizumab|mesh-list
19754889|NCT04015739|Durvalumab|durvalumab|mesh-list
19754890|NCT04015739|Olaparib|olaparib|mesh-list
19754891|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754892|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754893|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19754894|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19754895|NCT04015739|Growth Substances|growth substances|mesh-ancestor
19754896|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754897|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
19754898|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19754899|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754900|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754901|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
19754902|NCT03952299|Oxybutynin|oxybutynin|mesh-list
19754903|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
19754904|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
19754905|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754906|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754907|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19754908|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19754909|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
19754910|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754911|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754912|NCT03952299|Urological Agents|urological agents|mesh-ancestor
19754913|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19754914|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754915|NCT03952299|Renal Agents|renal agents|mesh-ancestor
19754916|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
19754917|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754918|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754919|NCT03948464|Morphine|morphine|mesh-list
19754920|NCT03948464|Methadone|methadone|mesh-list
19754921|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19754922|NCT03948464|Narcotics|narcotics|mesh-ancestor
20140429|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140430|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19754923|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19754924|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754925|NCT03948464|Analgesics|analgesics|mesh-ancestor
20140431|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20140432|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20140433|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20140434|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
20140435|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140436|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630271|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
19630272|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
19630273|NCT02454205|Levofloxacin|levofloxacin|mesh-list
19754926|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
19754927|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754928|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
19754929|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
19754930|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19754931|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19754932|NCT03941730|Estradiol|estradiol|mesh-list
19754933|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19754934|NCT03941730|Estrogens|estrogens|mesh-ancestor
19754935|NCT03941730|Hormones|hormones|mesh-ancestor
19754936|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754937|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754938|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19754939|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
19754940|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19754941|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19630274|NCT02454205|Ofloxacin|ofloxacin|mesh-list
19630275|NCT02454205|Isoniazid|isoniazid|mesh-list
19630276|NCT02454205|Linezolid|linezolid|mesh-list
19630277|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
19630278|NCT02454205|Bedaquiline|bedaquiline|mesh-list
19630279|NCT02454205|Kanamycin|kanamycin|mesh-list
19630280|NCT02454205|Ethionamide|ethionamide|mesh-list
19630281|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19754942|NCT03933384|Tenofovir|tenofovir|mesh-list
19754943|NCT03933384|Entecavir|entecavir|mesh-list
19754944|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
19754945|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19754946|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19754947|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19754948|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754949|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754950|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19754951|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19754952|NCT03901469|Talazoparib|talazoparib|mesh-list
19630282|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630283|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19630284|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19630285|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630286|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630287|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630288|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20140437|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
20140438|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140439|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19630289|NCT02454205|Renal Agents|renal agents|mesh-ancestor
19630290|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19754953|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19754954|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19754955|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630291|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19630292|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
19754956|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754957|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
19754958|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19754959|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19754960|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19754961|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754962|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
19754963|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754964|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754965|NCT03882047|Fluticasone|fluticasone|mesh-list
19754966|NCT03882047|Xhance|xhance|mesh-list
19754967|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
19754968|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754969|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19754970|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
19754971|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19754972|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754973|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20140440|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
20140441|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19754974|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
19754975|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
19754976|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19754977|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
19754978|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
19754979|NCT03879772|Beclomethasone|beclomethasone|mesh-list
19754980|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19754981|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19754982|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
19754983|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19754984|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
19754985|NCT03879772|Hormones|hormones|mesh-ancestor
19754986|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19754987|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19754988|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19754989|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
19754990|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
19754991|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19754992|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
19754993|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
19754994|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19754995|NCT03873402|Nivolumab|nivolumab|mesh-list
20140442|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
20140443|NCT00053196|Protective Agents|protective agents|mesh-ancestor
20140444|NCT00053209|Gemcitabine|gemcitabine|mesh-list
20140445|NCT00053209|Pemetrexed|pemetrexed|mesh-list
20140446|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140447|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
19630293|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19630294|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19630295|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
19630296|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19630297|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19754996|NCT03873402|Ipilimumab|ipilimumab|mesh-list
19754997|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19754998|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19754999|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19755000|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755001|NCT03871465|Triamcinolone|triamcinolone|mesh-list
19755002|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19755003|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20140448|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630298|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
19630299|NCT02454088|Triamcinolone|triamcinolone|mesh-list
19630300|NCT02454088|Calcium|calcium|mesh-list
19630301|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19630302|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630303|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19755004|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19755005|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755006|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
19755007|NCT03871465|Hormones|hormones|mesh-ancestor
19755008|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630304|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630305|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
19630306|NCT02454088|Hormones|hormones|mesh-ancestor
19630307|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630308|NCT02453867|Tacrolimus|tacrolimus|mesh-list
19630309|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19630310|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
19630311|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630312|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19630313|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630314|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755009|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755010|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755011|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
19755012|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755013|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755014|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
20140449|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140450|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
20140451|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140452|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140453|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140454|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
20140455|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140456|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20140457|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20140458|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
20140459|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140460|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
20140461|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
20140462|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140463|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140464|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140465|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140466|NCT00053287|Thalidomide|thalidomide|mesh-list
20140467|NCT00053287|Carboplatin|carboplatin|mesh-list
19755015|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755016|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755017|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19755018|NCT03860233|Oxytocin|oxytocin|mesh-list
19755019|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
19755020|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755021|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755022|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
19755023|NCT03855228|Loratadine|loratadine|mesh-list
19755024|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755025|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755026|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19755027|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
19755028|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19755029|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19755030|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
19755031|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
19755032|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755033|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755034|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755035|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
19755036|NCT03855189|Beclomethasone|beclomethasone|mesh-list
19755037|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755038|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755039|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19755040|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
19755041|NCT03855189|Hormones|hormones|mesh-ancestor
19755042|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755043|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755044|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19755045|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
20140468|NCT00053287|Fludarabine|fludarabine|mesh-list
19755046|NCT03845543|Paclitaxel|paclitaxel|mesh-list
20140469|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
20140470|NCT00053287|Topotecan|topotecan|mesh-list
19755047|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19755048|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755049|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
19755050|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140471|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140472|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314088|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20314089|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314090|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314091|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
19755051|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755052|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755053|NCT03840200|Rucaparib|rucaparib|mesh-list
19755054|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19755055|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755056|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755057|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755058|NCT03830918|Temozolomide|temozolomide|mesh-list
19755059|NCT03830918|Atezolizumab|atezolizumab|mesh-list
19755060|NCT03830918|Niraparib|niraparib|mesh-list
19755061|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19755062|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19755063|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
19755064|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755065|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755066|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
19755067|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755068|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19755069|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755070|NCT03828292|Dexamethasone|dexamethasone|mesh-list
19755071|NCT03828292|Bortezomib|bortezomib|mesh-list
19755072|NCT03828292|Pomalidomide|pomalidomide|mesh-list
19755073|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755074|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
19755075|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
19755076|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755077|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755078|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755079|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
19755080|NCT03828292|Hormones|hormones|mesh-ancestor
19755081|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755082|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755083|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755084|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
19755085|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19755086|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19755087|NCT03828292|Growth Substances|growth substances|mesh-ancestor
19755088|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140473|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
20140474|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140475|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140476|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
20140477|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140478|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20140479|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140480|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140481|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
20140482|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140483|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140484|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140485|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140486|NCT00053287|Growth Substances|growth substances|mesh-ancestor
20140487|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140488|NCT00053300|Thalidomide|thalidomide|mesh-list
20140489|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140490|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
20140491|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140492|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
20140493|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140494|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755089|NCT03769285|Niacinamide|niacinamide|mesh-list
19755090|NCT03769285|Niacin|niacin|mesh-list
19755091|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
19755092|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
19755093|NCT03769285|Vitamins|vitamins|mesh-ancestor
19755094|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
19755095|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755096|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19755097|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
19755098|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755099|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19755100|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
19755101|NCT03768492|Caffeine|caffeine|mesh-list
19755102|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19755103|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755104|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19755105|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755106|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755107|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19755108|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19755109|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
19755110|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755111|NCT03764631|Empagliflozin|empagliflozin|mesh-list
19755112|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19755113|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19755114|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755115|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19630315|NCT02453932|Donepezil|donepezil|mesh-list
19630316|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19630317|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630318|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630319|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
19630320|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630321|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630322|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
19630323|NCT02453698|Methylphenidate|methylphenidate|mesh-list
19630324|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19630325|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755116|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755117|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
19755118|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755119|NCT03761030|Levodopa|levodopa|mesh-list
20140495|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140496|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140497|NCT00053300|Growth Substances|growth substances|mesh-ancestor
19755120|NCT03761030|Carbidopa|carbidopa|mesh-list
19755121|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19755122|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19755123|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19755124|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
19755125|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755126|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755127|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755128|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19755129|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755130|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19755131|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
19755132|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
19755133|NCT03747120|Paclitaxel|paclitaxel|mesh-list
19755134|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
19755135|NCT03747120|Trastuzumab|trastuzumab|mesh-list
19755136|NCT03747120|Pertuzumab|pertuzumab|mesh-list
19755137|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19630326|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19630327|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19755138|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755139|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
19755140|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755141|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755142|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755143|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755144|NCT03745144|Cladribine|cladribine|mesh-list
20140498|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832934|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
19755145|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19755146|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19755147|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755148|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755149|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
19755150|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755151|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19755152|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
19755153|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755154|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20140499|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140500|NCT00053326|Fenretinide|fenretinide|mesh-list
20140501|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140502|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20140503|NCT00053326|Protective Agents|protective agents|mesh-ancestor
20140504|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140505|NCT00053339|Tamoxifen|tamoxifen|mesh-list
20140506|NCT00053339|Trastuzumab|trastuzumab|mesh-list
20140507|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140508|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140509|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20140510|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
20140511|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140512|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140513|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140514|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20140515|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20140516|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20140517|NCT00053378|Calcium|calcium|mesh-list
20140518|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19755155|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20140519|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140520|NCT00053430|Thalidomide|thalidomide|mesh-list
20140521|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140522|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
20140523|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140524|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
20140525|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140526|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140527|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140528|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140529|NCT00053430|Growth Substances|growth substances|mesh-ancestor
20140530|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140531|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630328|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630329|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630330|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
19630331|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661440|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661441|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
19661442|NCT04595786|Coagulants|coagulants|mesh-ancestor
19661443|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
19661444|NCT04569461|Androgens|androgens|mesh-list
19661445|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661446|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661447|NCT04569461|Hormones|hormones|mesh-ancestor
19661448|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661449|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661450|NCT04565483|Benralizumab|benralizumab|mesh-list
20140532|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20140533|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20140534|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
20140535|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140536|NCT00053599|Simvastatin|simvastatin|mesh-list
20140537|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19755156|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19755157|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19755158|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19755159|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19755160|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19755161|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19755162|NCT03736720|Leucovorin|leucovorin|mesh-list
19755163|NCT03736720|Fluorouracil|fluorouracil|mesh-list
19755164|NCT03736720|Irinotecan|irinotecan|mesh-list
19755165|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
19755166|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755167|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755168|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755169|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755170|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
19755171|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755172|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19755173|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19755174|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755175|NCT03736720|Antidotes|antidotes|mesh-ancestor
19755176|NCT03736720|Protective Agents|protective agents|mesh-ancestor
19755177|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
19755178|NCT03736720|Vitamins|vitamins|mesh-ancestor
19755179|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
19755180|NCT03703375|Gemcitabine|gemcitabine|mesh-list
19755181|NCT03703375|Azacitidine|azacitidine|mesh-list
19755182|NCT03703375|Romidepsin|romidepsin|mesh-list
19755183|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755184|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
20140538|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20140539|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
20140540|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140541|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20140542|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20140543|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140544|NCT00053612|Vitamin A|vitamin a|mesh-list
20140545|NCT00053612|Vitamins|vitamins|mesh-ancestor
19630332|NCT02453659|Nicotine|nicotine|mesh-list
19630333|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19630334|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
19630335|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630336|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630337|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20140546|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
20140547|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140548|NCT00053638|Tenofovir|tenofovir|mesh-list
20140549|NCT00053638|Lamivudine|lamivudine|mesh-list
20140550|NCT00053638|Efavirenz|efavirenz|mesh-list
20140551|NCT00053638|Abacavir|abacavir|mesh-list
20140552|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
20140553|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140554|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20140555|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20140556|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140557|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140558|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20140559|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20140560|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20140561|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20140562|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19630338|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19755185|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755186|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755187|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
19630339|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
19630340|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630341|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755188|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755189|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140563|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19755190|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755191|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
19755192|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755193|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19755194|NCT03656081|Itraconazole|itraconazole|mesh-list
19755195|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20140564|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20140565|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20140566|NCT00053716|Alprostadil|alprostadil|mesh-list
20140567|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20140568|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
20314092|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314093|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20314094|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
20314095|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20314096|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314097|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20314098|NCT00692263|Narcotics|narcotics|mesh-ancestor
20314099|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755196|NCT03656081|Amphotericin B|amphotericin b|mesh-list
19755197|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
19755198|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755199|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19755200|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19755201|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755202|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755203|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19755204|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
19755205|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755206|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755207|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19630342|NCT02453893|Risperidone|risperidone|mesh-list
19630343|NCT02453893|Iloperidone|iloperidone|mesh-list
19630344|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19630345|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
19630346|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755208|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19755209|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19755210|NCT03656081|Amebicides|amebicides|mesh-ancestor
19755211|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19755212|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19630347|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630348|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630349|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19630350|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19630351|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630352|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19755213|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19755214|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755215|NCT03645408|Exenatide|exenatide|mesh-list
19755216|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20140569|NCT00053716|Urological Agents|urological agents|mesh-ancestor
20140570|NCT00053768|Prednisone|prednisone|mesh-list
20140571|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
20140572|NCT00053768|Doxorubicin|doxorubicin|mesh-list
20140573|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20140574|NCT00053768|Etoposide|etoposide|mesh-list
19755217|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755218|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19755219|NCT03645408|Incretins|incretins|mesh-ancestor
19755220|NCT03645408|Hormones|hormones|mesh-ancestor
19755221|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755222|NCT03639935|Nivolumab|nivolumab|mesh-list
19755223|NCT03639935|Rucaparib|rucaparib|mesh-list
19755224|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755225|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755226|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19755227|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755228|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19755229|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755230|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
19755231|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19755232|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
19755233|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19755234|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
19755235|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755236|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755237|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
19755238|NCT03623828|Apomorphine|apomorphine|mesh-list
19755239|NCT03623828|Emetics|emetics|mesh-ancestor
19755240|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755241|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
19755242|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755243|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755244|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
19755245|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
19755246|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755247|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755248|NCT03586609|Cytarabine|cytarabine|mesh-list
19755249|NCT03586609|Azacitidine|azacitidine|mesh-list
19755250|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19755251|NCT03586609|Venetoclax|venetoclax|mesh-list
19755252|NCT03586609|Cladribine|cladribine|mesh-list
19755253|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755254|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
19755255|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755256|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755257|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
19755258|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140575|NCT00053768|Vincristine|vincristine|mesh-list
20140576|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140577|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
19755259|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755260|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
19755261|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755262|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755263|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19755264|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19755265|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755266|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
19755267|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
19755268|NCT03565913|Calcium|calcium|mesh-list
19755269|NCT03565913|Calcium acetate|calcium acetate|mesh-list
19755270|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19755271|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755272|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19755273|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
19755274|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
19755275|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755276|NCT03565913|Cathartics|cathartics|mesh-ancestor
19755277|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755278|NCT03546686|Nivolumab|nivolumab|mesh-list
19755279|NCT03546686|Ipilimumab|ipilimumab|mesh-list
19755280|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755281|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755282|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20140578|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140579|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19755283|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140580|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140581|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
20140582|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755284|NCT03528642|Temozolomide|temozolomide|mesh-list
19755285|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19755286|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
19755287|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755288|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755289|NCT03523156|Azithromycin|azithromycin|mesh-list
19755290|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19755291|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755292|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19755293|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19755294|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19755295|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755296|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630353|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19630354|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
19755297|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19755298|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19755299|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755300|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
19755301|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755302|NCT03497689|Treprostinil|treprostinil|mesh-list
20140583|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140584|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140585|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20140586|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140587|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140588|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140589|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140590|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
20140591|NCT00053768|Hormones|hormones|mesh-ancestor
20140592|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140593|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140594|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140595|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140596|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140597|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140598|NCT00053807|Interferons|interferons|mesh-list
20140599|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
20140600|NCT00053807|Aldesleukin|aldesleukin|mesh-list
19630355|NCT02453776|Infliximab|infliximab|mesh-list
19630356|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
19630357|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630358|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630359|NCT02453607|Infliximab|infliximab|mesh-list
19630360|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
19630361|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20140601|NCT00053807|Fluorouracil|fluorouracil|mesh-list
20140602|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
20140603|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140604|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140605|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140606|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140607|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
20140608|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140609|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
19630362|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630363|NCT02453529|Nafithromycin|nafithromycin|mesh-list
19630364|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19630365|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630366|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19630367|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630368|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630369|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
19630370|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
19630371|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
19630372|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19630373|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19630374|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630375|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
19630376|NCT02453802|Coagulants|coagulants|mesh-ancestor
19630377|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19630378|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
19630379|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19630380|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
19630381|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630382|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
20140610|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140611|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20140612|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20140613|NCT00053820|Interferons|interferons|mesh-list
20140614|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
20140615|NCT00053820|Aldesleukin|aldesleukin|mesh-list
20140616|NCT00053820|Fluorouracil|fluorouracil|mesh-list
20140617|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
20140618|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140619|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140620|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140621|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140622|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
20140623|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140624|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
20140625|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140626|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20140627|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20140628|NCT00053833|Irinotecan|irinotecan|mesh-list
20140629|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20140630|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140631|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755303|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19755304|NCT03476317|Vancomycin|vancomycin|mesh-list
19755305|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
19755306|NCT03476317|Neomycin|neomycin|mesh-list
19755307|NCT03476317|Fluconazole|fluconazole|mesh-list
19755308|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19755309|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140632|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140633|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140634|NCT00053872|Vincristine|vincristine|mesh-list
20140635|NCT00053872|Lomustine|lomustine|mesh-list
19755310|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755311|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19755312|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19755313|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755314|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755315|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755316|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19755317|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19755318|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
19755319|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19755320|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19755321|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
19755322|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755323|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755324|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20314100|NCT00692263|Analgesics|analgesics|mesh-ancestor
20314101|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
20314102|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
20140636|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140637|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140638|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140639|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140640|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140641|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140642|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140643|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
20140644|NCT00053885|Vatalanib|vatalanib|mesh-list
19755325|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19755326|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19755327|NCT03476317|Laxatives|laxatives|mesh-ancestor
19755328|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755329|NCT03472274|Durvalumab|durvalumab|mesh-list
19755330|NCT03472274|Tremelimumab|tremelimumab|mesh-list
19755331|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755332|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755333|NCT03434158|Olaparib|olaparib|mesh-list
19755334|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19755335|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755336|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140645|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140646|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314103|NCT00692315|Vitamins|vitamins|mesh-ancestor
19755337|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755338|NCT03425201|Niraparib|niraparib|mesh-list
19755339|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19755340|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755341|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755342|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755343|NCT03416153|Paclitaxel|paclitaxel|mesh-list
19755344|NCT03416153|Carboplatin|carboplatin|mesh-list
19755345|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19755346|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755347|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
19755348|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755349|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755350|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755351|NCT03408340|Fentanyl|fentanyl|mesh-list
19755352|NCT03408340|Ketamine|ketamine|mesh-list
19755353|NCT03408340|Propofol|propofol|mesh-list
19755354|NCT03408340|Sevoflurane|sevoflurane|mesh-list
19755355|NCT03408340|Rocuronium|rocuronium|mesh-list
19755356|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
19755357|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755358|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755359|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
19755360|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755361|NCT03408340|Analgesics|analgesics|mesh-ancestor
19755362|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19755363|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19755364|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
20140647|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755365|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19755366|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19755367|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755368|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755369|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19755370|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19755371|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19755372|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19755373|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19755374|NCT03408340|Narcotics|narcotics|mesh-ancestor
19755375|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19755376|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19755377|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19755378|NCT03397004|Doxycycline|doxycycline|mesh-list
19755379|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19755380|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755381|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
19755382|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19755383|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19755384|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19755385|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
19755386|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755387|NCT03362190|Ranibizumab|ranibizumab|mesh-list
19755388|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19755389|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19755390|NCT03362190|Growth Substances|growth substances|mesh-ancestor
19755391|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755392|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
19755393|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755394|NCT03346668|Gabapentin|gabapentin|mesh-list
19755395|NCT03346668|Analgesics|analgesics|mesh-ancestor
19755396|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
19755397|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755398|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755399|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
19755400|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19755401|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19755402|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755403|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19755404|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19755405|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19755406|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20140648|NCT00053911|Tamoxifen|tamoxifen|mesh-list
19755407|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755408|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
19755409|NCT03309150|Paclitaxel|paclitaxel|mesh-list
19630383|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
19630384|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19755410|NCT03309150|Carboplatin|carboplatin|mesh-list
19755411|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19755412|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755413|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
19755414|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755415|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755416|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755417|NCT03304717|Tenofovir|tenofovir|mesh-list
19755418|NCT03304717|Emtricitabine|emtricitabine|mesh-list
19755419|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
19755420|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755421|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19755422|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19755423|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755424|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755425|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19755426|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19755427|NCT03289299|Dexamethasone|dexamethasone|mesh-list
19755428|NCT03289299|Lenalidomide|lenalidomide|mesh-list
19755429|NCT03289299|Daratumumab|daratumumab|mesh-list
19755430|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755431|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
19755432|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
19755433|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755434|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755435|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755436|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
19755437|NCT03289299|Hormones|hormones|mesh-ancestor
19755438|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755439|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755440|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755441|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
19755442|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19755443|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19755444|NCT03289299|Growth Substances|growth substances|mesh-ancestor
19755445|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832935|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832936|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19832937|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832938|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19835443|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835444|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19835445|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835446|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835447|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835448|NCT00602836|Growth Substances|growth substances|mesh-ancestor
19835449|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835450|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19835451|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835452|NCT00602927|Varenicline|varenicline|mesh-list
19835453|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19835454|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19835455|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
19835456|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835457|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835458|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630385|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19630386|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19630387|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19630388|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630389|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630390|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
19630391|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19630392|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835459|NCT00603018|Fluoxetine|fluoxetine|mesh-list
19835460|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19835461|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19755446|NCT03272685|Nicotine|nicotine|mesh-list
19755447|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19755448|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
19755449|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755450|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755451|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19755452|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19755453|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
19755454|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755455|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755456|NCT03252522|Micronutrients|micronutrients|mesh-list
20140649|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
20140650|NCT00053911|Docetaxel|docetaxel|mesh-list
20140651|NCT00053911|Fluorouracil|fluorouracil|mesh-list
20140652|NCT00053911|Epirubicin|epirubicin|mesh-list
20140653|NCT00053911|Anastrozole|anastrozole|mesh-list
20140654|NCT00053911|Goserelin|goserelin|mesh-list
20140655|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140656|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
20140657|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140658|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140659|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140660|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
20140661|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755457|NCT03252522|Trace Elements|trace elements|mesh-list
19755458|NCT03252522|Antioxidants|antioxidants|mesh-list
19755459|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755460|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755461|NCT03252522|Protective Agents|protective agents|mesh-ancestor
19755462|NCT03223155|Nivolumab|nivolumab|mesh-list
20140662|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140663|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140664|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630393|NCT02453516|Epinephrine|epinephrine|mesh-list
19630394|NCT02453516|Ropivacaine|ropivacaine|mesh-list
19630395|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
20140665|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140666|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140667|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
20140668|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140669|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20140670|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140671|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19630396|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
19630397|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630398|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140672|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140673|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20140674|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
20140675|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140676|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140677|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20140678|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20140679|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20140680|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20140681|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20314104|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
20314105|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630399|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
19630400|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630401|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19630402|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19630403|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630404|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630405|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630406|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19630407|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19755463|NCT03223155|Ipilimumab|ipilimumab|mesh-list
20140682|NCT00053937|Pirfenidone|pirfenidone|mesh-list
20140683|NCT00053937|Analgesics|analgesics|mesh-ancestor
20314106|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
19755464|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755465|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755466|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19755467|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755468|NCT03217201|Methamphetamine|methamphetamine|mesh-list
19755469|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19755470|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755471|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
19755472|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
19755473|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755474|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
19755475|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755476|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755477|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
19755478|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19755479|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19755480|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19755481|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19755482|NCT03182179|Ondansetron|ondansetron|mesh-list
20314107|NCT00692328|Levodopa|levodopa|mesh-list
20314108|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20314109|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20314110|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
20314111|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755483|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
19755484|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
19755485|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755486|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314112|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314113|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314114|NCT00692354|Tosedostat|tosedostat|mesh-list
20314115|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314116|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314117|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
20314118|NCT00692510|Midazolam|midazolam|mesh-list
20314119|NCT00692510|Caffeine|caffeine|mesh-list
20314120|NCT00692510|Bupropion|bupropion|mesh-list
20314121|NCT00692510|Omeprazole|omeprazole|mesh-list
20314122|NCT00692510|Bilirubin|bilirubin|mesh-list
20314123|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19755487|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755488|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
19755489|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755490|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19755491|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
19755492|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755493|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755494|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19755495|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19755496|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755497|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19755498|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19755499|NCT03167242|Lumefantrine|lumefantrine|mesh-list
19755500|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19755501|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
19755502|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19755503|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19755504|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140684|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
20140685|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140686|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755505|NCT03164473|Rituximab|rituximab|mesh-list
19755506|NCT03164473|Azathioprine|azathioprine|mesh-list
20140687|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20140688|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20140689|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140690|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140691|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140692|NCT00053950|NSC 366140|nsc 366140|mesh-list
20140693|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140694|NCT00053963|Romidepsin|romidepsin|mesh-list
20140695|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20140696|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314124|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20314125|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20140697|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
20140698|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20140699|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20140700|NCT00053976|Prednisolone|prednisolone|mesh-list
20140701|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
20140702|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20140703|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
20140704|NCT00053976|Daclizumab|daclizumab|mesh-list
20140705|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140706|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
20140707|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
20140708|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140709|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140710|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20140711|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
20140712|NCT00053976|Hormones|hormones|mesh-ancestor
20140713|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140714|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19755507|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755508|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755509|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
20140715|NCT00053976|Protective Agents|protective agents|mesh-ancestor
20140716|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140717|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140718|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140719|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
20140720|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20140721|NCT00054002|Trioxsalen|trioxsalen|mesh-list
20140722|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140723|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
20140724|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20140725|NCT00054041|Vaccines|vaccines|mesh-list
20140726|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
20140727|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140728|NCT00054054|Docetaxel|docetaxel|mesh-list
20140729|NCT00054054|Fluorouracil|fluorouracil|mesh-list
20140730|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140731|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140732|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140733|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140734|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140735|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
20140736|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140737|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140738|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
20140739|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140740|NCT00054067|Cisplatin|cisplatin|mesh-list
20140741|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140742|NCT00054106|Flutamide|flutamide|mesh-list
20140743|NCT00054106|Buserelin|buserelin|mesh-list
20140744|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
20140745|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
20140746|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140747|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140748|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140749|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140750|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20140751|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
20140752|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20140753|NCT00054158|Thalidomide|thalidomide|mesh-list
20140754|NCT00054158|Dexamethasone|dexamethasone|mesh-list
19755510|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755511|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19755512|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
19755513|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755514|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755515|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755516|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
19755517|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755518|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755519|NCT03153280|Capecitabine|capecitabine|mesh-list
19755520|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
19755521|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755522|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
20140755|NCT00054158|Doxorubicin|doxorubicin|mesh-list
20140756|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20314126|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140757|NCT00054158|Vincristine|vincristine|mesh-list
20140758|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140759|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
20140760|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
20140761|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140762|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140763|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20140764|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
20140765|NCT00054158|Hormones|hormones|mesh-ancestor
20140766|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630408|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
19630409|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19755523|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630410|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
19630411|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
19630412|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
19630413|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20140767|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140768|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140769|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19755524|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755525|NCT03147612|Cytarabine|cytarabine|mesh-list
19755526|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
19755527|NCT03147612|Rituximab|rituximab|mesh-list
19755528|NCT03147612|Methotrexate|methotrexate|mesh-list
19755529|NCT03147612|Vincristine|vincristine|mesh-list
19755530|NCT03147612|Blinatumomab|blinatumomab|mesh-list
19755531|NCT03147612|Ponatinib|ponatinib|mesh-list
19755532|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19755533|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
19755534|NCT03147612|Antibodies|antibodies|mesh-list
19755535|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
19755536|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19755537|NCT03147612|Lenograstim|lenograstim|mesh-list
19755538|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19755539|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755540|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
19755541|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755542|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19755543|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19755544|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
19755545|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755546|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755547|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19755548|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19755549|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
19755550|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755551|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755552|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
19755553|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755554|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755555|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19755556|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19755557|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
19755558|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140770|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20140771|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140772|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140773|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140774|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140775|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140776|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140777|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
19630414|NCT02453503|Triamcinolone|triamcinolone|mesh-list
19630415|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19630416|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19630417|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19630418|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630419|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
19630420|NCT02453503|Hormones|hormones|mesh-ancestor
19630421|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630422|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630423|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755559|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20140778|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755560|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19755561|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19755562|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755563|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755564|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755565|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
19755566|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19755567|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19755568|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755569|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
19755570|NCT03113253|Coagulants|coagulants|mesh-ancestor
19755571|NCT03111992|Spartalizumab|spartalizumab|mesh-list
20140779|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
20140780|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
20140781|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20140782|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140783|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140784|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140785|NCT00054158|Growth Substances|growth substances|mesh-ancestor
20140786|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140787|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20140788|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20140789|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
20140790|NCT00054184|Paclitaxel|paclitaxel|mesh-list
19755572|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19755573|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755574|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755575|NCT03101046|Docetaxel|docetaxel|mesh-list
19755576|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755577|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
19755578|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755579|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755580|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755581|NCT03059173|Inositol|inositol|mesh-list
19755582|NCT03059173|Clomiphene|clomiphene|mesh-list
19755583|NCT03059173|Enclomiphene|enclomiphene|mesh-list
19755584|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
19755585|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20140791|NCT00054184|Docetaxel|docetaxel|mesh-list
20140792|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20140793|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140794|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140795|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140796|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755586|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
19755587|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755588|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755589|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19755590|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
19755591|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755592|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19755593|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19755594|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
19755595|NCT03059173|Vitamins|vitamins|mesh-ancestor
19755596|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
19755597|NCT03057106|Durvalumab|durvalumab|mesh-list
20140797|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140798|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140799|NCT00054197|Gemcitabine|gemcitabine|mesh-list
20140800|NCT00054197|Paclitaxel|paclitaxel|mesh-list
19630424|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
19630425|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630426|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630427|NCT02453490|Fluorouracil|fluorouracil|mesh-list
19630428|NCT02453490|Raltitrexed|raltitrexed|mesh-list
19630429|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
19630430|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630431|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19630432|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630433|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19630434|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
19630435|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630436|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19630437|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630438|NCT02453464|Leucovorin|leucovorin|mesh-list
19630439|NCT02453464|Irinotecan|irinotecan|mesh-list
19630440|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19630441|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19755598|NCT03057106|Tremelimumab|tremelimumab|mesh-list
20140801|NCT00054197|Vinorelbine|vinorelbine|mesh-list
20140802|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20140803|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140804|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140805|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140806|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140807|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140808|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140809|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140810|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
20140811|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
20140812|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140813|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140814|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140815|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
20140816|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140817|NCT00054210|Paclitaxel|paclitaxel|mesh-list
20140818|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20140819|NCT00054210|Carboplatin|carboplatin|mesh-list
20140820|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20140821|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140822|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608536|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608537|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
20608538|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314127|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20314128|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20314129|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20314130|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20314131|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
20314132|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
20314133|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
20314134|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
20314135|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314136|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314137|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20314138|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20608539|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
20140823|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140824|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140825|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755599|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755600|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755601|NCT03015129|Durvalumab|durvalumab|mesh-list
19755602|NCT03015129|Tremelimumab|tremelimumab|mesh-list
19755603|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755604|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755605|NCT03013491|Ipilimumab|ipilimumab|mesh-list
19755606|NCT03013491|Vemurafenib|vemurafenib|mesh-list
19755607|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755608|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755609|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19755610|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755611|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755612|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755613|NCT03008369|Lenvatinib|lenvatinib|mesh-list
19755614|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755615|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755616|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755617|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755618|NCT02963493|Dexamethasone|dexamethasone|mesh-list
19755619|NCT02963493|Melphalan|melphalan|mesh-list
19755620|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755621|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
19755622|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
19755623|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755624|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755625|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755626|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
19755627|NCT02963493|Hormones|hormones|mesh-ancestor
19755628|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755629|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140826|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755630|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314139|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20608540|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
19630442|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630443|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630444|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630445|NCT02453464|Antidotes|antidotes|mesh-ancestor
19755631|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19755632|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
19755633|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755634|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19755635|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755636|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
19755637|NCT02947503|Metformin|metformin|mesh-list
19755638|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19755639|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755640|NCT02930902|Gemcitabine|gemcitabine|mesh-list
19755641|NCT02930902|Paclitaxel|paclitaxel|mesh-list
19755642|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19755643|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
19755644|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19755645|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755646|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630446|NCT02453464|Protective Agents|protective agents|mesh-ancestor
19630447|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630448|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
19630449|NCT02453464|Vitamins|vitamins|mesh-ancestor
19630450|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
19630451|NCT02453425|Norepinephrine|norepinephrine|mesh-list
19630452|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19630453|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19630454|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630455|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630456|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630457|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755647|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755648|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755649|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755650|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755651|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
19755652|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
19755653|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755654|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630458|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
19630459|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
19630460|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630461|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19630462|NCT02453087|Rituximab|rituximab|mesh-list
19630463|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
19630464|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19630465|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630466|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
19630467|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630468|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630469|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
19630470|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19630471|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630472|NCT02453022|Omeprazole|omeprazole|mesh-list
19630473|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19630474|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630475|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19630476|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630477|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630478|NCT02452970|Gemcitabine|gemcitabine|mesh-list
19630479|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630480|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19630481|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
19630482|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630483|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
19630484|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630485|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630486|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19630487|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
19630488|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630489|NCT02452918|Oritavancin|oritavancin|mesh-list
19630490|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19755655|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755656|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
20314140|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314141|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19755657|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755658|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140827|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
20140828|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
20140829|NCT00054236|Fludarabine|fludarabine|mesh-list
20140830|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
20314142|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20314143|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20314144|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20314145|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
20314146|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20314147|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
20314148|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20314149|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20314150|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20314151|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
20314152|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20314153|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20314154|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20314155|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
20314156|NCT00692510|Protective Agents|protective agents|mesh-ancestor
20314157|NCT00692601|Capsaicin|capsaicin|mesh-list
19755659|NCT02921555|Prednisone|prednisone|mesh-list
19755660|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
19755661|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19755662|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19755663|NCT02921555|Prednisolone|prednisolone|mesh-list
19755664|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
19755665|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19755666|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
19755667|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755668|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
19755669|NCT02921555|Hormones|hormones|mesh-ancestor
19755670|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755671|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755672|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755673|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755674|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
19755675|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
19755676|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755677|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755678|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19755679|NCT02921555|Protective Agents|protective agents|mesh-ancestor
20314158|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
20314159|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755680|NCT02899078|Nivolumab|nivolumab|mesh-list
19755681|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755682|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755683|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19755684|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755685|NCT02895373|Alprostadil|alprostadil|mesh-list
19755686|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19755687|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
19755688|NCT02895373|Urological Agents|urological agents|mesh-ancestor
19755689|NCT02861417|Vidarabine|vidarabine|mesh-list
19755690|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
19755691|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
19755692|NCT02861417|Busulfan|busulfan|mesh-list
19755693|NCT02861417|Thiotepa|thiotepa|mesh-list
20608541|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
20608542|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20608543|NCT02246842|Antibodies|antibodies|mesh-list
20608544|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20608545|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
20140831|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20140832|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140833|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
20140834|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140835|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140836|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19755694|NCT02861417|Fludarabine|fludarabine|mesh-list
19755695|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
19755696|NCT02861417|Tacrolimus|tacrolimus|mesh-list
20140837|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
20140838|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140839|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140840|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140841|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140842|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
20140843|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140844|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
20140845|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
20140846|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140847|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20140848|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
20140849|NCT00054236|Hormones|hormones|mesh-ancestor
20140850|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140851|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20140852|NCT00054236|Protective Agents|protective agents|mesh-ancestor
20173676|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314160|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
20314161|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314162|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755697|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755698|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
19755699|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755700|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19755701|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20314163|NCT00692614|Triamcinolone|triamcinolone|mesh-list
20314164|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20314165|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20314166|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20314167|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755702|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
19755703|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755704|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173677|NCT00162409|Folic Acid|folic acid|mesh-list
20173678|NCT00162409|Hematinics|hematinics|mesh-ancestor
20173679|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
20173680|NCT00162409|Vitamins|vitamins|mesh-ancestor
20173681|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
19755705|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19755706|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755707|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
19755708|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
19755709|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19755710|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19755711|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755712|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19755713|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19755714|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
19755715|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19755716|NCT02788591|Esomeprazole|esomeprazole|mesh-list
19755717|NCT02788591|Omeprazole|omeprazole|mesh-list
19755718|NCT02788591|Pantoprazole|pantoprazole|mesh-list
19755719|NCT02788591|Lansoprazole|lansoprazole|mesh-list
19755720|NCT02788591|Sucralfate|sucralfate|mesh-list
19755721|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19755722|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19755723|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19755724|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755725|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755726|NCT02772588|Leuprolide|leuprolide|mesh-list
19755727|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19755728|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
19755729|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755730|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173682|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173683|NCT00162422|Albuterol|albuterol|mesh-list
20173684|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20173685|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
20173686|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173687|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173688|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20173689|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
19755731|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755732|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755733|NCT02766478|Genistein|genistein|mesh-list
20173690|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
19755734|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20140853|NCT00054288|Gemcitabine|gemcitabine|mesh-list
20140854|NCT00054288|Irinotecan|irinotecan|mesh-list
20140855|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140856|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
20140857|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140858|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140859|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
20140860|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140861|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140862|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140863|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
19630491|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630492|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
19755735|NCT02766478|Protective Agents|protective agents|mesh-ancestor
19755736|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755737|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755738|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755739|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755740|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755741|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
19755742|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19755743|NCT02766478|Estrogens|estrogens|mesh-ancestor
19755744|NCT02766478|Hormones|hormones|mesh-ancestor
19755745|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755746|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19755747|NCT02748057|Ezetimibe|ezetimibe|mesh-list
19755748|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19755749|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19755750|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
19755751|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755752|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19755753|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19755754|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755755|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
19755756|NCT02741271|Prednisone|prednisone|mesh-list
19755757|NCT02741271|Prednisolone|prednisolone|mesh-list
19630493|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19630494|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19630495|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
19630496|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755758|NCT02741271|Albuterol|albuterol|mesh-list
19755759|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755760|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
19755761|NCT02741271|Hormones|hormones|mesh-ancestor
19755762|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755763|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755764|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755765|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755766|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
19755767|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314168|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
20314169|NCT00692614|Hormones|hormones|mesh-ancestor
20314170|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314171|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314172|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314173|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
20314174|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314175|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314176|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20314177|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314178|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20314179|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314180|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314181|NCT00692731|Caffeine|caffeine|mesh-list
20314182|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20314183|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314184|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19755768|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20140864|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630497|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630498|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140865|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20314185|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314186|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314187|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20314188|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20314189|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
19755769|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19755770|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
19755771|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
20140866|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140867|NCT00054314|IDN 5109|idn 5109|mesh-list
20140868|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140869|NCT00054340|Cyclosporine|cyclosporine|mesh-list
20140870|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
20140871|NCT00054340|Busulfan|busulfan|mesh-list
20140872|NCT00054340|Methotrexate|methotrexate|mesh-list
20140873|NCT00054340|Cyclosporins|cyclosporins|mesh-list
20140874|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20140875|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140876|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
20140877|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140878|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20140879|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20140880|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
20140881|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140882|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140883|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20140884|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20140885|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
20140886|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20140887|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140888|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
20140889|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
20140890|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140891|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20140892|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20314190|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314191|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
20314192|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20314193|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314194|NCT00692900|Docetaxel|docetaxel|mesh-list
20314195|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
20314196|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314197|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
20314198|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20314199|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
20314200|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314201|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
20314202|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
20314203|NCT00692952|Nonoxynol|nonoxynol|mesh-list
19755772|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755773|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19755774|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19755775|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19755776|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
20140893|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
20140894|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140895|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19630499|NCT02452879|Urological Agents|urological agents|mesh-ancestor
19630500|NCT02452983|Sertraline|sertraline|mesh-list
19630501|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
19630502|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19630503|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19630504|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19630505|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630506|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140896|NCT00054392|Gemcitabine|gemcitabine|mesh-list
20140897|NCT00054392|Paclitaxel|paclitaxel|mesh-list
20140898|NCT00054392|Carboplatin|carboplatin|mesh-list
20140899|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140900|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140901|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140902|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140903|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
19755777|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20140904|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140905|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140906|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
20140907|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
20140908|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140909|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140910|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20140911|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
20140912|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755778|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755779|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
19755780|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19755781|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20140913|NCT00054405|Aldesleukin|aldesleukin|mesh-list
20140914|NCT00054405|Interleukin-2|interleukin-2|mesh-list
20140915|NCT00054405|Interleukin-12|interleukin-12|mesh-list
20140916|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140917|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20140918|NCT00054405|Analgesics|analgesics|mesh-ancestor
20140919|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
20140920|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140921|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140922|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20140923|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20140924|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
20140925|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140926|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20140927|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
20140928|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20140929|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20140930|NCT00054405|Growth Substances|growth substances|mesh-ancestor
20140931|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
20140932|NCT00054418|Vitamin D|vitamin d|mesh-list
20140933|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
20140934|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
20140935|NCT00054418|Calcium|calcium|mesh-list
20140936|NCT00054418|Vitamins|vitamins|mesh-ancestor
20140937|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
20140938|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140939|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20140940|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20140941|NCT00054418|Antacids|antacids|mesh-ancestor
20140942|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140943|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20140944|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20140945|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20140946|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
20140947|NCT00054431|Decitabine|decitabine|mesh-list
20140948|NCT00054431|Azacitidine|azacitidine|mesh-list
19755782|NCT02741245|Ezetimibe|ezetimibe|mesh-list
19755783|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19755784|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19755785|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
19755786|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755787|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19755788|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19755789|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755790|NCT02728050|Cytarabine|cytarabine|mesh-list
20140949|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140950|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140951|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140952|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140953|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755791|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19755792|NCT02728050|Sorafenib|sorafenib|mesh-list
19755793|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
19755794|NCT02728050|Cladribine|cladribine|mesh-list
19755795|NCT02728050|Lenograstim|lenograstim|mesh-list
19755796|NCT02728050|Sargramostim|sargramostim|mesh-list
19755797|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19755798|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
19755799|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755800|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755801|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
20140954|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
20140955|NCT00054444|Topotecan|topotecan|mesh-list
19755802|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20140956|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140957|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19755803|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19755804|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
19755805|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755806|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19755807|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755808|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755809|NCT02728050|Analgesics|analgesics|mesh-ancestor
19755810|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
19755811|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755812|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19755813|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19755814|NCT02705963|Trametinib|trametinib|mesh-list
20314204|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20314205|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314206|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20314207|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314208|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20314209|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20314210|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20314211|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20314212|NCT00693004|Donepezil|donepezil|mesh-list
20314213|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20314214|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314215|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314216|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
19755815|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19755816|NCT02705963|Norethindrone|norethindrone|mesh-list
19755817|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
19755818|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
19755819|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
19755820|NCT02705963|Estradiol|estradiol|mesh-list
19755821|NCT02705963|Estrogens|estrogens|mesh-ancestor
19755822|NCT02705963|Hormones|hormones|mesh-ancestor
19755823|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755824|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140958|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20140959|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140960|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140961|NCT00054457|Docetaxel|docetaxel|mesh-list
20140962|NCT00054457|Capecitabine|capecitabine|mesh-list
20140963|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140964|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
20140965|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
20140966|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
20140967|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140968|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20140969|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
20140970|NCT00054470|Trastuzumab|trastuzumab|mesh-list
20140971|NCT00054470|Tipifarnib|tipifarnib|mesh-list
20140972|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20140973|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314217|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314218|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314219|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
20314220|NCT00693030|Sirolimus|sirolimus|mesh-list
20314221|NCT00693030|Paclitaxel|paclitaxel|mesh-list
19630507|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630508|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
19630509|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630510|NCT02453009|Prednisone|prednisone|mesh-list
19630511|NCT02453009|Docetaxel|docetaxel|mesh-list
19630512|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630513|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630514|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
19630515|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
19630516|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630517|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630518|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
19630519|NCT02453009|Hormones|hormones|mesh-ancestor
19630520|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630521|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630522|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755825|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20314222|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20140974|NCT00054483|Bortezomib|bortezomib|mesh-list
20140975|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140976|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20140977|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140978|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20140979|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20140980|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140981|NCT00054522|Calcitriol|calcitriol|mesh-list
20140982|NCT00054522|Dexamethasone|dexamethasone|mesh-list
20140983|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20140984|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
20140985|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
20140986|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20140987|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20140988|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20140989|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
20140990|NCT00054522|Hormones|hormones|mesh-ancestor
20140991|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20140992|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20140993|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20140994|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20140995|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20140996|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20140997|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20140998|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20140999|NCT00054522|Vitamins|vitamins|mesh-ancestor
20141000|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
20141001|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19755826|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755827|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19755828|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755829|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755830|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755831|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755832|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20141002|NCT00054535|Aldesleukin|aldesleukin|mesh-list
20141003|NCT00054535|Vaccines|vaccines|mesh-list
20314223|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755833|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19755834|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
19755835|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755836|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755837|NCT02675231|Trastuzumab|trastuzumab|mesh-list
19755838|NCT02675231|Fulvestrant|fulvestrant|mesh-list
19755839|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755840|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755841|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755842|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19755843|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19755844|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
19755845|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755846|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755847|NCT02662257|Propofol|propofol|mesh-list
19755848|NCT02662257|Sevoflurane|sevoflurane|mesh-list
19755849|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19755850|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755851|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755852|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19755853|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
19755854|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
19755855|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19755856|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19755857|NCT02650401|Entrectinib|entrectinib|mesh-list
19755858|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755859|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755860|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755861|NCT02648477|Doxorubicin|doxorubicin|mesh-list
19755862|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19755863|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
19755864|NCT02648477|Letrozole|letrozole|mesh-list
19755865|NCT02648477|Anastrozole|anastrozole|mesh-list
19755866|NCT02648477|Exemestane|exemestane|mesh-list
20141004|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
20141005|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141006|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141007|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20141008|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20141009|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
20141010|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141011|NCT00054548|Paclitaxel|paclitaxel|mesh-list
20141012|NCT00054548|Oblimersen|oblimersen|mesh-list
20141013|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20141014|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141015|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141016|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
20141017|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141018|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141019|NCT00054561|Vitamin E|vitamin e|mesh-list
20141020|NCT00054561|Interferons|interferons|mesh-list
20141021|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
19755867|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19755868|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755869|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19755870|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19755871|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755872|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755873|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755874|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19755875|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19755876|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19755877|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
19755878|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755879|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755880|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755881|NCT02626507|Fulvestrant|fulvestrant|mesh-list
20141022|NCT00054561|Isotretinoin|isotretinoin|mesh-list
20141023|NCT00054561|Vitamins|vitamins|mesh-ancestor
20141024|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
19755882|NCT02626507|Goserelin|goserelin|mesh-list
19755883|NCT02626507|Palbociclib|palbociclib|mesh-list
19755884|NCT02626507|Gedatolisib|gedatolisib|mesh-list
20141025|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141026|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141027|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
20141028|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141029|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
20141030|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
20141031|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141032|NCT00054561|Protective Agents|protective agents|mesh-ancestor
19630523|NCT02452775|Poly ICLC|poly iclc|mesh-list
20141033|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141034|NCT00054574|Panitumumab|panitumumab|mesh-list
20141035|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141036|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141037|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
20141038|NCT00054587|Docetaxel|docetaxel|mesh-list
20141039|NCT00054587|Fluorouracil|fluorouracil|mesh-list
20141040|NCT00054587|Trastuzumab|trastuzumab|mesh-list
20141041|NCT00054587|Epirubicin|epirubicin|mesh-list
20141042|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141043|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
20141044|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141045|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141046|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20141047|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
20141048|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141049|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141050|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20608546|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
19630524|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
19630525|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
19630526|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630527|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
19630528|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19630529|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630530|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19630531|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630532|NCT02452515|Fulacimstat|fulacimstat|mesh-list
19630533|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141051|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141052|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755885|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19755886|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755887|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19755888|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19755889|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
19755890|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19755891|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755892|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755893|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755894|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755895|NCT02605967|Spartalizumab|spartalizumab|mesh-list
19755896|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19755897|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755898|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755899|NCT02584634|Avelumab|avelumab|mesh-list
19755900|NCT02584634|Crizotinib|crizotinib|mesh-list
19755901|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755902|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755903|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19755904|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755905|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755906|NCT02581137|Metformin|metformin|mesh-list
19755907|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19755908|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832939|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19832940|NCT01909245|Gastrins|gastrins|mesh-list
19832941|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
19832942|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832943|NCT01909245|Hormones|hormones|mesh-ancestor
19832944|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19832945|NCT01885689|Sirolimus|sirolimus|mesh-list
19832946|NCT01885689|Melphalan|melphalan|mesh-list
19832947|NCT01885689|Clofarabine|clofarabine|mesh-list
19832948|NCT01885689|Tacrolimus|tacrolimus|mesh-list
19832949|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832950|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
19832951|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832952|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19832953|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832954|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832955|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19832956|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832957|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19832958|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832959|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
19832960|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19832961|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
19832962|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19832963|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832964|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
19832965|NCT01872260|Letrozole|letrozole|mesh-list
19832966|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832967|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19832968|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19832969|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832970|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832971|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19832972|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
19832973|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19832974|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832975|NCT01740648|Fluorouracil|fluorouracil|mesh-list
19832976|NCT01740648|Trametinib|trametinib|mesh-list
19832977|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
19832978|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630534|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630535|NCT02452684|Eszopiclone|eszopiclone|mesh-list
19630536|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19630537|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630538|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630539|NCT02452437|Oxycodone|oxycodone|mesh-list
19630540|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19630541|NCT02452437|Narcotics|narcotics|mesh-ancestor
19630542|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755909|NCT02570503|Ketorolac|ketorolac|mesh-list
19755910|NCT02570503|Clonidine|clonidine|mesh-list
19755911|NCT02570503|Epinephrine|epinephrine|mesh-list
19755912|NCT02570503|Ropivacaine|ropivacaine|mesh-list
20141053|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141054|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
20141055|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141056|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141057|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20141058|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20141059|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20141060|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141061|NCT00054600|Methoxsalen|methoxsalen|mesh-list
20141062|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20141063|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141064|NCT00054613|Methoxsalen|methoxsalen|mesh-list
20141065|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20141066|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141067|NCT00054626|Gemcitabine|gemcitabine|mesh-list
20141068|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141069|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141070|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
20141071|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141072|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
20141073|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141074|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141075|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141076|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
20141077|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141078|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
20141079|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141080|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20141081|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141082|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
20141083|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20141084|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141085|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141086|NCT00054834|Epratuzumab|epratuzumab|mesh-list
20141087|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141088|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141089|NCT00054873|Fluorouracil|fluorouracil|mesh-list
20141090|NCT00054873|Tezacitabine|tezacitabine|mesh-list
20141091|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
20141092|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141093|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141094|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141095|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314224|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630543|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630544|NCT02452437|Analgesics|analgesics|mesh-ancestor
19630545|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
19630546|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630547|NCT02452606|Levodopa|levodopa|mesh-list
19630548|NCT02452606|Carbidopa|carbidopa|mesh-list
19630549|NCT02452606|Entacapone|entacapone|mesh-list
19630550|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19630551|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19630552|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
19630553|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630554|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630555|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630556|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19630557|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630558|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19630559|NCT02452502|Atorvastatin|atorvastatin|mesh-list
19630560|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19630561|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19630562|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
19630563|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630564|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20141096|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
20141097|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630565|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19755913|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
19755914|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
20141098|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141099|NCT00054886|Sunitinib|sunitinib|mesh-list
20141100|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141101|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141102|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141103|NCT00054886|Growth Substances|growth substances|mesh-ancestor
20141104|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630566|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630567|NCT02452385|Vorolanib|vorolanib|mesh-list
19755915|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755916|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755917|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
19755918|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755919|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19755920|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19755921|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19755922|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755923|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755924|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19755925|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19755926|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
19755927|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19755928|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
19755929|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
19755930|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
19755931|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19755932|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19755933|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19755934|NCT02570503|Analgesics|analgesics|mesh-ancestor
19630568|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19630569|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630570|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630571|NCT02452450|Acetaminophen|acetaminophen|mesh-list
19630572|NCT02452450|Ibuprofen|ibuprofen|mesh-list
19630573|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19630574|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19630575|NCT02452450|Analgesics|analgesics|mesh-ancestor
19630576|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
19630577|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630578|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630579|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630580|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630581|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19630582|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630583|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630584|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
19630585|NCT02452281|Ipilimumab|ipilimumab|mesh-list
19630586|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19630587|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630588|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19630589|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755935|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314225|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
19755936|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19755937|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19755938|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755939|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19755940|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
19755941|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19755942|NCT02564068|Oxytocin|oxytocin|mesh-list
19755943|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
19755944|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19755945|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755946|NCT02553265|Carbidopa|carbidopa|mesh-list
19755947|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19755948|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19755949|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
19755950|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755951|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755952|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755953|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19755954|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755955|NCT02550288|Atorvastatin|atorvastatin|mesh-list
19755956|NCT02550288|Ezetimibe|ezetimibe|mesh-list
19755957|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19755958|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19755959|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
19755960|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755961|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19755962|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19755963|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19755964|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
20141105|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141106|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20141107|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141108|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141109|NCT00054938|Aspirin|aspirin|mesh-list
20141110|NCT00054938|Ramipril|ramipril|mesh-list
20141111|NCT00054938|Pravastatin|pravastatin|mesh-list
20141112|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141113|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20141114|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20141115|NCT00054938|Analgesics|analgesics|mesh-ancestor
20141116|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
20141117|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141118|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141119|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141120|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20141121|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20141122|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141123|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19755965|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19755966|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19755967|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755968|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
19755969|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755970|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755971|NCT02499328|Durvalumab|durvalumab|mesh-list
19755972|NCT02499328|Tremelimumab|tremelimumab|mesh-list
19755973|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19755974|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19755975|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
19755976|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19755977|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19755978|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755979|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19755980|NCT02492269|Analgesics|analgesics|mesh-ancestor
19755981|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
19755982|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755983|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19755984|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19755985|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19755986|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
19755987|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19755988|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19755989|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19755990|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19755991|NCT02469753|Analgesics|analgesics|mesh-ancestor
19755992|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
19755993|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19755994|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19755995|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19755996|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19755997|NCT02467153|Vitamin D|vitamin d|mesh-list
19755998|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
19755999|NCT02467153|Vitamins|vitamins|mesh-ancestor
19756000|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
20141124|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20141125|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141126|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
20141127|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19630590|NCT02452125|Nicotine|nicotine|mesh-list
19630591|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19630592|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
19630593|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630594|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630595|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20141128|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
20141129|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20141130|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20141131|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20141132|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
20141133|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20141134|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20141135|NCT00054977|Fluorouracil|fluorouracil|mesh-list
20141136|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
20141137|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141138|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141139|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314226|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
20314227|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314228|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314229|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314230|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314231|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
20314232|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314233|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
20314234|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314235|NCT00693043|Lidocaine|lidocaine|mesh-list
20314236|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
19630596|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19630597|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
19630598|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630599|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630600|NCT02452307|Imiquimod|imiquimod|mesh-list
19630601|NCT02452307|Molgramostim|molgramostim|mesh-list
19630602|NCT02452307|Protamines|protamines|mesh-list
19630603|NCT02452307|Sargramostim|sargramostim|mesh-list
19630604|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
19630605|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630606|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19630607|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630608|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
19630609|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
19630610|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630611|NCT02452307|Coagulants|coagulants|mesh-ancestor
19630612|NCT02452151|Infliximab|infliximab|mesh-list
19630613|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19630614|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630615|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141140|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19630616|NCT02452177|Vitamin D|vitamin d|mesh-list
20314237|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
19630617|NCT02452177|Vitamins|vitamins|mesh-ancestor
19630618|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
20141141|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
20141142|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141143|NCT00055042|Vitamin E|vitamin e|mesh-list
20141144|NCT00055042|Vitamins|vitamins|mesh-ancestor
20141145|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
20141146|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141147|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
20141148|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141149|NCT00055042|Protective Agents|protective agents|mesh-ancestor
20141150|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
20141151|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20141152|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141153|NCT00055120|Ritonavir|ritonavir|mesh-list
20141154|NCT00055120|Lopinavir|lopinavir|mesh-list
20141155|NCT00055120|Tenofovir|tenofovir|mesh-list
20141156|NCT00055120|Emtricitabine|emtricitabine|mesh-list
20141157|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20141158|NCT00055120|Stavudine|stavudine|mesh-list
20141159|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20141160|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20141161|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
20141162|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141163|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141164|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20141165|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20141166|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
20141167|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141168|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20141169|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20141170|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20141171|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20141172|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
20141173|NCT00055133|Paclitaxel|paclitaxel|mesh-list
20141174|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20141175|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141176|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141177|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
19756001|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756002|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19756003|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19756004|NCT02460224|Spartalizumab|spartalizumab|mesh-list
19756005|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19756006|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756007|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756008|NCT02459457|Paclitaxel|paclitaxel|mesh-list
19756009|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19756010|NCT02459457|Carboplatin|carboplatin|mesh-list
19756011|NCT02459457|Fluorouracil|fluorouracil|mesh-list
19756012|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20141178|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141179|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141180|NCT00055159|Plasminogen|plasminogen|mesh-list
20141181|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19756013|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756014|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141182|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20141183|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20141184|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141185|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
20141186|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
20141187|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141188|NCT00055198|Daptomycin|daptomycin|mesh-list
20141189|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20141190|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141191|NCT00055250|Gemcitabine|gemcitabine|mesh-list
20141192|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141193|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
20141194|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141195|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141196|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
20141197|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141198|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141199|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141200|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
20141201|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141202|NCT00055302|Anastrozole|anastrozole|mesh-list
19630619|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630620|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19630621|NCT02452255|Propranolol|propranolol|mesh-list
19630622|NCT02452255|Metoprolol|metoprolol|mesh-list
19630623|NCT02452255|Fenofibrate|fenofibrate|mesh-list
19630624|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19630625|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19630626|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630627|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630628|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630629|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630630|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19630631|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19630632|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
19630633|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
20141203|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20141204|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141205|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19630634|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
19630635|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630636|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20141206|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20141207|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141208|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141209|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20141210|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
20141211|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756015|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
19756016|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
19756017|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630637|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19630638|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
19630639|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19630640|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19630641|NCT02452216|Hematinics|hematinics|mesh-ancestor
19630642|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19630643|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19630644|NCT02452112|Lidocaine|lidocaine|mesh-list
19630645|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
20141212|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141213|NCT00055341|Ribavirin|ribavirin|mesh-list
20141214|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20141215|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
20141216|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141217|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
19756018|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
19756019|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19756020|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756021|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
19756022|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756023|NCT02407236|Ustekinumab|ustekinumab|mesh-list
19756024|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756025|NCT02386774|Benoxinate|benoxinate|mesh-list
19756026|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19756027|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19756028|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
19756029|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
19756030|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756031|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756032|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
19756033|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756034|NCT02320396|Desloratadine|desloratadine|mesh-list
19756035|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756036|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756037|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756038|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756039|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756040|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756041|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756042|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
19630646|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
19756043|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
19756044|NCT02299505|Ceritinib|ceritinib|mesh-list
20141218|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141219|NCT00055367|Natalizumab|natalizumab|mesh-list
20141220|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
20141221|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141222|NCT00055393|Bupropion|bupropion|mesh-list
20141223|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20141224|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
20141225|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20141226|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20141227|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20141228|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20141229|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141230|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
20141231|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20141232|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141233|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20141234|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20141235|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141236|NCT00055419|Cetuximab|cetuximab|mesh-list
20141237|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141238|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141239|NCT00055432|Gemcitabine|gemcitabine|mesh-list
20141240|NCT00055432|Pemetrexed|pemetrexed|mesh-list
20141241|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141242|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
20141243|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141244|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314238|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314239|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314240|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
20314241|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314242|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19630647|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630648|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630649|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
19630650|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630651|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19630652|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19630653|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19630654|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630655|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630656|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19630657|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19630658|NCT02452099|Protective Agents|protective agents|mesh-ancestor
19630659|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630660|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19630661|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
19630662|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661451|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19661452|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
19661453|NCT04536194|Dopamine|dopamine|mesh-list
19661454|NCT04536194|Norepinephrine|norepinephrine|mesh-list
19661455|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19661456|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19661457|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
19661458|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661459|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661460|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661461|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
19661462|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
19661463|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661464|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19661465|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19661466|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
19661467|NCT04536194|Protective Agents|protective agents|mesh-ancestor
19661468|NCT04449042|Anesthetics|anesthetics|mesh-list
19661469|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661470|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661471|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
19661472|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661473|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661474|NCT04341090|Apatinib|apatinib|mesh-list
20141245|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
20141246|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141247|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141248|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756045|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756046|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19756047|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141249|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
20141250|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141251|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20141252|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20141253|NCT00055484|Zonisamide|zonisamide|mesh-list
20141254|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
20141255|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20141256|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20141257|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141258|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20141259|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141260|NCT00055523|Adalimumab|adalimumab|mesh-list
20141261|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141262|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141263|NCT00055536|Natalizumab|natalizumab|mesh-list
20141264|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
20141265|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141266|NCT00055549|Lorazepam|lorazepam|mesh-list
19756048|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756049|NCT02282345|Talazoparib|talazoparib|mesh-list
19756050|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19756051|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756052|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756053|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141267|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
20141268|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
20141269|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
20141270|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20141271|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20141272|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314243|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20314244|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20314245|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20314246|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756054|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19756055|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19756056|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756057|NCT02250014|Sargramostim|sargramostim|mesh-list
19756058|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
19756059|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756060|NCT02235701|Ifosfamide|ifosfamide|mesh-list
19756061|NCT02235701|Doxorubicin|doxorubicin|mesh-list
19756062|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19756063|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
20141273|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141274|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141275|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
20141276|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
20141277|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
20141278|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756064|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756065|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756066|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19756067|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19756068|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19756069|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141279|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20141280|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20141281|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20141282|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20314247|NCT00693056|beta-Lactams|beta-lactams|mesh-list
20314248|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314249|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314250|NCT00693069|Clopidogrel|clopidogrel|mesh-list
20141283|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756070|NCT02235688|Gemcitabine|gemcitabine|mesh-list
20314251|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20314252|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20314253|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20314254|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20314255|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
20314256|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314257|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756071|NCT02235688|Doxorubicin|doxorubicin|mesh-list
20141284|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20141285|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
20141286|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
20141287|NCT00055562|Lenalidomide|lenalidomide|mesh-list
20141288|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
20141289|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141290|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141291|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141292|NCT00055562|Growth Substances|growth substances|mesh-ancestor
20141293|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141294|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141295|NCT00055614|Topotecan|topotecan|mesh-list
20141296|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20141297|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20314258|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314259|NCT00693108|Testosterone|testosterone|mesh-list
20314260|NCT00693108|Androgens|androgens|mesh-ancestor
20314261|NCT00693108|Hormones|hormones|mesh-ancestor
20314262|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20141298|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141299|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141300|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608547|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608548|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
20314263|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314264|NCT00693121|Amantadine|amantadine|mesh-list
20314265|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20314266|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20314267|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
20314268|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314269|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
20314270|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314271|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608549|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20608550|NCT02246855|Antibodies|antibodies|mesh-list
19630663|NCT02451956|Paclitaxel|paclitaxel|mesh-list
19630664|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19630665|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630666|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630667|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
19630668|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
19630669|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630670|NCT02451865|Docetaxel|docetaxel|mesh-list
19630671|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630672|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630673|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
19630674|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
19630675|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630676|NCT02451787|Vitamin D|vitamin d|mesh-list
19630677|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
19630678|NCT02451787|Vitamins|vitamins|mesh-ancestor
19630679|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
19630680|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630681|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19630682|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19630683|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
19630684|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19630685|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630686|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630687|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19756072|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141301|NCT00055640|Prednisone|prednisone|mesh-list
20608551|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
19756073|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
19756074|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756075|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756076|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
19756077|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19756078|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756079|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756080|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
19756081|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756082|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19756083|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20141302|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
20141303|NCT00055640|Rituximab|rituximab|mesh-list
20141304|NCT00055640|Doxorubicin|doxorubicin|mesh-list
20141305|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20141306|NCT00055640|Vincristine|vincristine|mesh-list
19756084|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19756085|NCT02115074|Celecoxib|celecoxib|mesh-list
19756086|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756087|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756088|NCT02115074|Analgesics|analgesics|mesh-ancestor
19756089|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
20141307|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141308|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
20141309|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141310|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141311|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20141312|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
20141313|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141314|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141315|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20141316|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141317|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20141318|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20141319|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20141320|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141321|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141322|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
20141323|NCT00055640|Hormones|hormones|mesh-ancestor
20141324|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20141325|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20141326|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20141327|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141328|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
20141329|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141330|NCT00055653|Cyclosporine|cyclosporine|mesh-list
20141331|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
20141332|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
20141333|NCT00055653|Melphalan|melphalan|mesh-list
20141334|NCT00055653|Busulfan|busulfan|mesh-list
20141335|NCT00055653|Fludarabine|fludarabine|mesh-list
20141336|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
20141337|NCT00055653|Cyclosporins|cyclosporins|mesh-list
19756090|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756091|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756092|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756093|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756094|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756095|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756096|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756097|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756098|NCT02070549|Trametinib|trametinib|mesh-list
19756099|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756100|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19756101|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756102|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756103|NCT02066636|Nivolumab|nivolumab|mesh-list
19756104|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19756105|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141338|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20141339|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141340|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
19756106|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19756107|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756108|NCT02053246|Nebivolol|nebivolol|mesh-list
20314272|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141341|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141342|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141343|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20141344|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
20141345|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141346|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141347|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20141348|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141349|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
20141350|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141351|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
19756109|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19756110|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
19756111|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19756112|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19756113|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19756114|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
19756115|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756116|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756117|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756118|NCT01980940|Etoricoxib|etoricoxib|mesh-list
19756119|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19756120|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756121|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756122|NCT01980940|Analgesics|analgesics|mesh-ancestor
20141352|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141353|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141354|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20141355|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141356|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
20141357|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
20141358|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141359|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20141360|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
20141361|NCT00055653|Hormones|hormones|mesh-ancestor
20314273|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20314274|NCT00693121|Analgesics|analgesics|mesh-ancestor
20314275|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
20314276|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347286|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20347287|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347288|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630688|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19630689|NCT02451774|Protective Agents|protective agents|mesh-ancestor
19756123|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
19756124|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756125|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756126|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756127|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756128|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756129|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756130|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756131|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756132|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19756133|NCT01980940|Protective Agents|protective agents|mesh-ancestor
19756134|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19756135|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
19630690|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630691|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
19630692|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19630693|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
19630694|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
19630695|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19630696|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
19630697|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19630698|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630699|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19630700|NCT02451852|Osimertinib|osimertinib|mesh-list
19630701|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756136|NCT01923298|Estradiol|estradiol|mesh-list
19756137|NCT01923298|Estrogens|estrogens|mesh-ancestor
20141362|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20141363|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19756138|NCT01923298|Hormones|hormones|mesh-ancestor
19756139|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756140|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756141|NCT01918033|Desloratadine|desloratadine|mesh-list
19756142|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756143|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756144|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756145|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756146|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756147|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756148|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756149|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756150|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
19756151|NCT01916980|Desloratadine|desloratadine|mesh-list
19756152|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756153|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756154|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630702|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19630703|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630704|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630705|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
19630706|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
19630707|NCT02451748|Prednisone|prednisone|mesh-list
19630708|NCT02451748|Triamcinolone|triamcinolone|mesh-list
19630709|NCT02451748|Naproxen|naproxen|mesh-list
19630710|NCT02451748|Methotrexate|methotrexate|mesh-list
19630711|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
19630712|NCT02451748|Leflunomide|leflunomide|mesh-list
19630713|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630714|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
19630715|NCT02451748|Hormones|hormones|mesh-ancestor
19630716|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630717|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630718|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19630719|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630720|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19756155|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756156|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756157|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756158|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756159|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756160|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
19756161|NCT01916967|Desloratadine|desloratadine|mesh-list
19756162|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756163|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756164|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756165|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756166|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756167|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756168|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756169|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756170|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
20141364|NCT00055653|Protective Agents|protective agents|mesh-ancestor
20141365|NCT00055666|Beclomethasone|beclomethasone|mesh-list
20141366|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141367|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
20141368|NCT00055666|Hormones|hormones|mesh-ancestor
19756171|NCT01910402|Ritonavir|ritonavir|mesh-list
19756172|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19630721|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
19630722|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19630723|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19630724|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
19630725|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630726|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
19630727|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756173|NCT01910402|Tenofovir|tenofovir|mesh-list
19756174|NCT01910402|Lamivudine|lamivudine|mesh-list
19756175|NCT01910402|Emtricitabine|emtricitabine|mesh-list
19756176|NCT01910402|Abacavir|abacavir|mesh-list
19756177|NCT01910402|Dolutegravir|dolutegravir|mesh-list
19630728|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19630729|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19630730|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
19756178|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20141369|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756179|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19756180|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
19756181|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756182|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756183|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19756184|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19756185|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
20141370|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141371|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20141372|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
20141373|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
20141374|NCT00055679|Fluorouracil|fluorouracil|mesh-list
20141375|NCT00055679|Epirubicin|epirubicin|mesh-list
20141376|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141377|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
20141378|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141379|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141380|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20141381|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
20141382|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141383|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141384|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20141385|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
20314277|NCT00693199|Amlodipine|amlodipine|mesh-list
19756186|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19756187|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19756188|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19756189|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19756190|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19756191|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19756192|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20314278|NCT00693199|Prazosin|prazosin|mesh-list
20314279|NCT00693199|Terazosin|terazosin|mesh-list
20314280|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20314281|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20314282|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20314283|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314284|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20314285|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314286|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
20314287|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20314288|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20314289|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19630731|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630732|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19756193|NCT01893320|Decitabine|decitabine|mesh-list
19756194|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19630733|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
19630734|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19630735|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19630736|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630737|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19630738|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756195|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
19756196|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756197|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756198|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756199|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
19756200|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19756201|NCT01867606|Antibodies|antibodies|mesh-list
19756202|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
19756203|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756204|NCT01857063|Montelukast|montelukast|mesh-list
19756205|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756206|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756207|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19756208|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756209|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756210|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756211|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19756212|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20141386|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314290|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
20141387|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20141388|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20141389|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20141390|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630739|NCT02451748|Analgesics|analgesics|mesh-ancestor
19630740|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
19630741|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630742|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
19630743|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19630744|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630745|NCT02451527|Digoxin|digoxin|mesh-list
19630746|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19630747|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19630748|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630749|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630750|NCT02451527|Protective Agents|protective agents|mesh-ancestor
19630751|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630752|NCT02451605|Analgesics|analgesics|mesh-list
19630753|NCT02451605|Ropivacaine|ropivacaine|mesh-list
19630754|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
19630755|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630756|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630757|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
19630758|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
19630759|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630760|NCT02451579|Cetirizine|cetirizine|mesh-list
19630761|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
19630762|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19630763|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19630764|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19630765|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
19630766|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630767|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630768|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630769|NCT02451475|Amitriptyline|amitriptyline|mesh-list
19630770|NCT02451475|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19630771|NCT02451475|Paroxetine|paroxetine|mesh-list
19630772|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19630773|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19630774|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19630775|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630776|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630777|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630778|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
19630779|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630780|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19630781|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
19630782|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19630783|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19630784|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19630785|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630786|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19630787|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19630788|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19630789|NCT02451475|Analgesics|analgesics|mesh-ancestor
19630790|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
19630791|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141391|NCT00055718|Silymarin|silymarin|mesh-list
19256612|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141392|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
19756213|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756214|NCT01854268|Capsaicin|capsaicin|mesh-list
19756215|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
19756216|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756217|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
19756218|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756219|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756220|NCT01852812|Montelukast|montelukast|mesh-list
19756221|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756222|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756223|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19756224|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756225|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756226|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756227|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19756228|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19756229|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756230|NCT01828021|Margetuximab|margetuximab|mesh-list
19756231|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756232|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19756233|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19756234|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19756235|NCT01709318|Etonogestrel|etonogestrel|mesh-list
19756236|NCT01709318|Estradiol|estradiol|mesh-list
19756237|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20141393|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141394|NCT00055718|Protective Agents|protective agents|mesh-ancestor
20141395|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141396|NCT00055757|Gemcitabine|gemcitabine|mesh-list
20141397|NCT00055757|Tipifarnib|tipifarnib|mesh-list
19756238|NCT01709318|Estrogens|estrogens|mesh-ancestor
19756239|NCT01709318|Hormones|hormones|mesh-ancestor
19756240|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756241|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756242|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19756243|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
20141398|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141399|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141400|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
20141401|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141402|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
20141403|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141404|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141405|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141406|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
20141407|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141408|NCT00055770|Docetaxel|docetaxel|mesh-list
20141409|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20141410|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141411|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141412|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
20141413|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141414|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141415|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20141416|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141417|NCT00055809|Interferons|interferons|mesh-list
20141418|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
20141419|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
20141420|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20141421|NCT00055809|Bevacizumab|bevacizumab|mesh-list
20141422|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20141423|NCT00055809|Antibodies|antibodies|mesh-list
20141424|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
20141425|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20141426|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314291|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314292|NCT00693199|Urological Agents|urological agents|mesh-ancestor
20314293|NCT00693212|Methylphenidate|methylphenidate|mesh-list
20314294|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20314295|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314296|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20314297|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20314298|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20314299|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314300|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
20314301|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314302|NCT00693251|Sirolimus|sirolimus|mesh-list
20314303|NCT00693251|Paclitaxel|paclitaxel|mesh-list
20314304|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20314305|NCT00693251|Everolimus|everolimus|mesh-list
20314306|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20314307|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314308|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
20314309|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
20314310|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
20314311|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314312|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141427|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141428|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141429|NCT00055809|Growth Substances|growth substances|mesh-ancestor
20141430|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141431|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141432|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
20141433|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
20141434|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314313|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
20314314|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141435|NCT00055822|Leucovorin|leucovorin|mesh-list
20141436|NCT00055822|Fluorouracil|fluorouracil|mesh-list
20141437|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
20141438|NCT00055822|Oblimersen|oblimersen|mesh-list
20141439|NCT00055822|Calcium|calcium|mesh-list
20141440|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
20141441|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20141442|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141443|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
20314315|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314316|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314317|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314318|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
20314319|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
20314320|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
20314321|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314322|NCT00693355|Butyric Acid|butyric acid|mesh-list
20314323|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
20314324|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
20314325|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314326|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314327|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314328|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
20141444|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141445|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141446|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141447|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141448|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
20141449|NCT00055822|Antidotes|antidotes|mesh-ancestor
19630792|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19630793|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
19630794|NCT02451475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19630795|NCT02451475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19630796|NCT02451475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630797|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
19630798|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19630799|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141450|NCT00055822|Protective Agents|protective agents|mesh-ancestor
20141451|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
20141452|NCT00055822|Vitamins|vitamins|mesh-ancestor
20141453|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
20141454|NCT00055835|Gemcitabine|gemcitabine|mesh-list
20141455|NCT00055835|Paclitaxel|paclitaxel|mesh-list
20141456|NCT00055835|Carboplatin|carboplatin|mesh-list
19756244|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19756245|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19756246|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19756247|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20141457|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20141458|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141459|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141460|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20141461|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141462|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141463|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141464|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
20141465|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
20314329|NCT00693381|Prednisone|prednisone|mesh-list
20314330|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
19756248|NCT01698918|Dexamethasone|dexamethasone|mesh-list
19756249|NCT01698918|Everolimus|everolimus|mesh-list
19756250|NCT01698918|Letrozole|letrozole|mesh-list
19756251|NCT01698918|Exemestane|exemestane|mesh-list
19756252|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756253|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
19756254|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
19756255|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756256|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756257|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19756258|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
19756259|NCT01698918|Hormones|hormones|mesh-ancestor
19756260|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756261|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19756262|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756263|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756264|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
19756265|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19756266|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19756267|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756268|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756269|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19756270|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756271|NCT01673620|Loratadine|loratadine|mesh-list
20141466|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141467|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141468|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141469|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
20141470|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141471|NCT00055861|Bevacizumab|bevacizumab|mesh-list
20314331|NCT00693381|Tacrolimus|tacrolimus|mesh-list
19630802|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19630803|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
19630804|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19630805|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19630806|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19630807|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630808|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630809|NCT02451293|Melatonin|melatonin|mesh-list
19630810|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
19630811|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630812|NCT02451293|Protective Agents|protective agents|mesh-ancestor
19630813|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630814|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630815|NCT02451072|Ketanserin|ketanserin|mesh-list
19630816|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19630817|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
20141472|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19756272|NCT01673620|Montelukast|montelukast|mesh-list
19756273|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756274|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756275|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19756276|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
19630818|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756277|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756278|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756279|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20141473|NCT00055861|Docetaxel|docetaxel|mesh-list
20314332|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141474|NCT00055861|Antibodies|antibodies|mesh-list
20141475|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
20141476|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20141477|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141478|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141479|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141480|NCT00055861|Growth Substances|growth substances|mesh-ancestor
20141481|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630819|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19630820|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19630821|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
19630822|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630823|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630824|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19630825|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19630826|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19630827|NCT02451111|Rituximab|rituximab|mesh-list
19630828|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141482|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141483|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
20141484|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141485|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
20141486|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141487|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314333|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
20314334|NCT00693381|Hormones|hormones|mesh-ancestor
20141488|NCT00055874|Interferons|interferons|mesh-list
20141489|NCT00055874|Cytarabine|cytarabine|mesh-list
19630829|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630830|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
19630831|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630832|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630833|NCT02451033|Hormones|hormones|mesh-list
19630834|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630835|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630836|NCT02450994|Dexamethasone|dexamethasone|mesh-list
19630837|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630838|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
20314335|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314336|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314337|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20314338|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314339|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314340|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
20314341|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20314342|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314343|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314344|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314345|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20314346|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
20314347|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314348|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314349|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
20314350|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
19630839|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
19630840|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630841|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141490|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
19630842|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630843|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
19630844|NCT02450994|Hormones|hormones|mesh-ancestor
19630845|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630846|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19630847|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630848|NCT02450981|Bevacizumab|bevacizumab|mesh-list
19630849|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19630850|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630851|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19630852|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19630853|NCT02450981|Growth Substances|growth substances|mesh-ancestor
19630854|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630855|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141491|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
20141492|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
20141493|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141494|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
20141495|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19630856|NCT02450968|Dexamethasone|dexamethasone|mesh-list
19630857|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19630858|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
19630859|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
19630860|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756280|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19756281|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756282|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
19756283|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756284|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756285|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756286|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756287|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756288|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
19756289|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756290|NCT01617187|Olanzapine|olanzapine|mesh-list
19756291|NCT01617187|Asenapine|asenapine|mesh-list
19756292|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
19756293|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
19756294|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756295|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756296|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19756297|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19756298|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756299|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756300|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19756301|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19756302|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19756303|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19756304|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756305|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756306|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
19630861|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630862|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630863|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
19630864|NCT02450968|Hormones|hormones|mesh-ancestor
19630865|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756307|NCT01611883|Ezetimibe|ezetimibe|mesh-list
19756308|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756309|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20141496|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141497|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
20141498|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141499|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141500|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
19756310|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
19756311|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756312|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756313|NCT01572675|Celecoxib|celecoxib|mesh-list
19756314|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756315|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756316|NCT01572675|Analgesics|analgesics|mesh-ancestor
19756317|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
19756318|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756319|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756320|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756321|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630866|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19630867|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630868|NCT02451098|Atorvastatin|atorvastatin|mesh-list
19630869|NCT02451098|Ezetimibe|ezetimibe|mesh-list
19630870|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19630871|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19630872|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
19630873|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630874|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19630875|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19630876|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630877|NCT02450786|Donepezil|donepezil|mesh-list
20141501|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630878|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19630879|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630880|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630881|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
19630882|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630883|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630884|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
20314351|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314352|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630885|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19630886|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19630887|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
19630888|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630889|NCT02450838|Antacids|antacids|mesh-ancestor
19630890|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141502|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20141503|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141504|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
20141505|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20141506|NCT00055887|Gemcitabine|gemcitabine|mesh-list
20141507|NCT00055887|Paclitaxel|paclitaxel|mesh-list
19630891|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19630892|NCT02450773|Furosemide|furosemide|mesh-list
19630893|NCT02450773|Diuretics|diuretics|mesh-ancestor
19630894|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
19630895|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141508|NCT00055887|Vinorelbine|vinorelbine|mesh-list
19630896|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19630897|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19630898|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630899|NCT02450877|Azacitidine|azacitidine|mesh-list
19630900|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141509|NCT00055887|Carboplatin|carboplatin|mesh-list
20141510|NCT00055887|Efaproxiral|efaproxiral|mesh-list
20141511|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20141512|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141513|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
20141514|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
20141515|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
19630901|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
19630902|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630903|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630904|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141516|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141517|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141518|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
20141519|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
20141520|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141521|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141522|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141523|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
20141524|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141525|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
19630905|NCT02450682|Warfarin|warfarin|mesh-list
20141526|NCT00055913|Bevacizumab|bevacizumab|mesh-list
20141527|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20347289|NCT00858897|Insulin|insulin|mesh-list
19630906|NCT02450682|Apixaban|apixaban|mesh-list
19630907|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
19630908|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19630909|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
19630910|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19630911|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
20608552|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608553|NCT02246868|Factor VIII|factor viii|mesh-list
20608554|NCT02246868|Coagulants|coagulants|mesh-ancestor
20608555|NCT02246881|Factor VIII|factor viii|mesh-list
20608556|NCT02246881|Coagulants|coagulants|mesh-ancestor
20608557|NCT02246894|Factor VIII|factor viii|mesh-list
20608558|NCT02246894|Coagulants|coagulants|mesh-ancestor
20608559|NCT02246920|Fluticasone|fluticasone|mesh-list
19630912|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630913|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630914|NCT02450656|Docetaxel|docetaxel|mesh-list
19630915|NCT02450656|Afatinib|afatinib|mesh-list
19630916|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630917|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
19630918|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
19630919|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
19630920|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630921|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19630922|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630923|NCT02450513|Adalimumab|adalimumab|mesh-list
19630924|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141528|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20141529|NCT00055913|Antibodies|antibodies|mesh-list
20141530|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
20141531|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20141532|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141533|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141534|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141535|NCT00055913|Growth Substances|growth substances|mesh-ancestor
20141536|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141537|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141538|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
20141539|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20141540|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141541|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141542|NCT00055939|Exatecan|exatecan|mesh-list
20608560|NCT02246920|Xhance|xhance|mesh-list
20608561|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608562|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20608563|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
19630925|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661475|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661476|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19661477|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661478|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661479|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19661480|NCT04263896|Laxatives|laxatives|mesh-ancestor
19661481|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661482|NCT04254731|Methadone|methadone|mesh-list
19661483|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19661484|NCT04254731|Narcotics|narcotics|mesh-ancestor
19661485|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661486|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661487|NCT04254731|Analgesics|analgesics|mesh-ancestor
19661488|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
19661489|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661490|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
19661491|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
19661492|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
19661493|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661494|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665745|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665746|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
19665747|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19665748|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665749|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665750|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19665751|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19665752|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19665753|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19756322|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756323|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756324|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756325|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756326|NCT01554163|Celecoxib|celecoxib|mesh-list
19756327|NCT01554163|Etoricoxib|etoricoxib|mesh-list
20608564|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608565|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608566|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20608567|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
20608568|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756328|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756329|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756330|NCT01554163|Analgesics|analgesics|mesh-ancestor
19756331|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
19756332|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756333|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756334|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756335|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756336|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756337|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756338|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756339|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756340|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
19756341|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756342|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756343|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756344|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19756345|NCT01490190|Etonogestrel|etonogestrel|mesh-list
19756346|NCT01490190|NuvaRing|nuvaring|mesh-list
19756347|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19756348|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19756349|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19756350|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
19756351|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19756352|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756353|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19756354|NCT01490190|Estrogens|estrogens|mesh-ancestor
19756355|NCT01490190|Hormones|hormones|mesh-ancestor
19756356|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756357|NCT01473108|Eplerenone|eplerenone|mesh-list
19756358|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19756359|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756360|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756361|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756362|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19756363|NCT01473108|Diuretics|diuretics|mesh-ancestor
19756364|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
19756365|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19756366|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
19756367|NCT01471340|Prednisone|prednisone|mesh-list
19756368|NCT01471340|Prednisolone|prednisolone|mesh-list
19756369|NCT01471340|Albuterol|albuterol|mesh-list
19756370|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
19756371|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
19756372|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756373|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
19756374|NCT01471340|Hormones|hormones|mesh-ancestor
19756375|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756376|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756377|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19756378|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756379|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
19756380|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756381|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19756382|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20608569|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20612146|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756383|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756384|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19756385|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19756386|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19756387|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
19756388|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756389|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756390|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
19756391|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19756392|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756393|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756394|NCT01462370|Acetaminophen|acetaminophen|mesh-list
19756395|NCT01462370|Ibuprofen|ibuprofen|mesh-list
19756396|NCT01462370|Etoricoxib|etoricoxib|mesh-list
19756397|NCT01462370|Caffeine|caffeine|mesh-list
19756398|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756399|NCT01462370|Analgesics|analgesics|mesh-ancestor
19756400|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
19756401|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756402|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756403|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
19756404|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756405|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756406|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756407|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756408|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756409|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756410|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19756411|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19756412|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19756413|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19756414|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
19756415|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756416|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20141543|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20141544|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20141545|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141546|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141547|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141548|NCT00055952|Exatecan|exatecan|mesh-list
20141549|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20141550|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20141551|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141552|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608570|NCT02247128|Aspirin|aspirin|mesh-list
20608571|NCT02247128|Clopidogrel|clopidogrel|mesh-list
19756417|NCT01381679|Ezetimibe|ezetimibe|mesh-list
19756418|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756419|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756420|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
20608572|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20608573|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20608574|NCT02247128|Analgesics|analgesics|mesh-ancestor
20608575|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
20608576|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608577|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608578|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608579|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19630926|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19630927|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
19630928|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19630929|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19630930|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630931|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630932|NCT02450188|Urological Agents|urological agents|mesh-ancestor
19630933|NCT02450253|Tadalafil|tadalafil|mesh-list
19630934|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
19630935|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19630936|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19630937|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630938|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630939|NCT02450253|Urological Agents|urological agents|mesh-ancestor
19630940|NCT02450214|Ketamine|ketamine|mesh-list
19630941|NCT02450214|Analgesics|analgesics|mesh-ancestor
19630942|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
19630943|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19630944|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832979|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20608580|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20608581|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20608582|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608583|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20608584|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20608585|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608586|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
20608587|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20608588|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20612147|NCT02249910|Protective Agents|protective agents|mesh-ancestor
20314353|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20314354|NCT00693381|Protective Agents|protective agents|mesh-ancestor
20314355|NCT00693407|Capsaicin|capsaicin|mesh-list
20314356|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
20314357|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
20314358|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
20314359|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314360|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314361|NCT00693433|Sirolimus|sirolimus|mesh-list
20314362|NCT00693433|Dexamethasone|dexamethasone|mesh-list
20314363|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314364|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
20314365|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
20314366|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314367|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314368|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314369|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
20314370|NCT00693433|Hormones|hormones|mesh-ancestor
20314371|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314372|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20314373|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314374|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314375|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314376|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314377|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
20314378|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314379|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
20314380|NCT00693446|Sirolimus|sirolimus|mesh-list
20314381|NCT00693446|Tacrolimus|tacrolimus|mesh-list
20314382|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756421|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756422|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756423|NCT01379989|Carboplatin|carboplatin|mesh-list
19756424|NCT01379989|Doxorubicin|doxorubicin|mesh-list
19756425|NCT01379989|Trabectedin|trabectedin|mesh-list
19756426|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756427|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19756428|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19756429|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19756430|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756431|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756432|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19756433|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
19756434|NCT01370603|Atorvastatin|atorvastatin|mesh-list
19756435|NCT01370603|Ezetimibe|ezetimibe|mesh-list
19756436|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20141553|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141554|NCT00055965|Gemcitabine|gemcitabine|mesh-list
20141555|NCT00055965|Carboplatin|carboplatin|mesh-list
20141556|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141557|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20141558|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
20141559|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141560|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
20141561|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141562|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141563|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141564|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
20314383|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
20314384|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314385|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20314386|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756437|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756438|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
20141565|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314387|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314388|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19756439|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756440|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756441|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19756442|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756443|NCT01370590|Atorvastatin|atorvastatin|mesh-list
19756444|NCT01370590|Ezetimibe|ezetimibe|mesh-list
19756445|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756446|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756447|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
19756448|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756449|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756450|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19756451|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756452|NCT01349907|Asenapine|asenapine|mesh-list
19756453|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19756454|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756455|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756456|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756457|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19756458|NCT01345656|Spironolactone|spironolactone|mesh-list
19756459|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19756460|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756461|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756462|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756463|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19756464|NCT01345656|Diuretics|diuretics|mesh-ancestor
19756465|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
19756466|NCT01277822|Losartan|losartan|mesh-list
19756467|NCT01277822|Amlodipine|amlodipine|mesh-list
19756468|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20314389|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314390|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314391|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314392|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
20314393|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
20314394|NCT00693524|Prednisone|prednisone|mesh-list
20314395|NCT00693524|Tacrolimus|tacrolimus|mesh-list
20314396|NCT00693524|Daclizumab|daclizumab|mesh-list
20314397|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756469|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19756470|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832980|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314398|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
20314399|NCT00693524|Hormones|hormones|mesh-ancestor
20314400|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314401|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347290|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19630945|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19630946|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19630947|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
19630948|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
19630949|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630950|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19630951|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19630952|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19630953|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630954|NCT02450175|Everolimus|everolimus|mesh-list
19630955|NCT02450175|Letrozole|letrozole|mesh-list
19630956|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630957|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19630958|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
19630959|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630960|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19630961|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19630962|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630963|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630964|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19630965|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
19630966|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19630967|NCT02450279|Edetic Acid|edetic acid|mesh-list
19630968|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
19630969|NCT02450279|Antidotes|antidotes|mesh-ancestor
19630970|NCT02450279|Protective Agents|protective agents|mesh-ancestor
19630971|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141566|NCT00055978|Celecoxib|celecoxib|mesh-list
20141567|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20141568|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20141569|NCT00055978|Analgesics|analgesics|mesh-ancestor
20141570|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
20141571|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141572|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141573|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141574|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141575|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20141576|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20141577|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141578|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608589|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20608590|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
20608591|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608592|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
20608593|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20608594|NCT02247141|Antibodies|antibodies|mesh-list
20608595|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
19630972|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
19630973|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
19630974|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630975|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19630976|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
19630977|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19630978|NCT02450149|Sorafenib|sorafenib|mesh-list
19630979|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630980|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20608596|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630981|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630982|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630983|NCT02450123|Sunitinib|sunitinib|mesh-list
19630984|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19630985|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19661495|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
19661496|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661497|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661498|NCT04089150|Leucovorin|leucovorin|mesh-list
19661499|NCT04089150|Gemcitabine|gemcitabine|mesh-list
19661500|NCT04089150|Paclitaxel|paclitaxel|mesh-list
19661501|NCT04089150|Fluorouracil|fluorouracil|mesh-list
19661502|NCT04089150|Capecitabine|capecitabine|mesh-list
19661503|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
19661504|NCT04089150|Irinotecan|irinotecan|mesh-list
19661505|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19661506|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661507|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
19661508|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
19661509|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
19661510|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661511|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19661512|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
19661513|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
19661514|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661515|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661516|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19661517|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
19661518|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661519|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19661520|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19661521|NCT04089150|Antidotes|antidotes|mesh-ancestor
19661522|NCT04089150|Protective Agents|protective agents|mesh-ancestor
19661523|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
19661524|NCT04089150|Vitamins|vitamins|mesh-ancestor
19661525|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
19661526|NCT04082780|Rifamycins|rifamycins|mesh-list
19661527|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
19661528|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19661529|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661530|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661531|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19661532|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19661533|NCT03925350|Niraparib|niraparib|mesh-list
20608597|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
20608598|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20608599|NCT02247154|Antibodies|antibodies|mesh-list
20608600|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
20608601|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608602|NCT02247258|Azathioprine|azathioprine|mesh-list
20608603|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
20608604|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608605|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20608606|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608607|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756471|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756472|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19756473|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756474|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
19756475|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19756476|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19756477|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19756478|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19756479|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19756480|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
19756481|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832981|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832982|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
20141579|NCT00055991|Bexarotene|bexarotene|mesh-list
20141580|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608608|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
20608609|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608610|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608611|NCT02247310|Interferons|interferons|mesh-list
20314402|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20314403|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314404|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314405|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
20141581|NCT00056004|Zileuton|zileuton|mesh-list
20141582|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20314406|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20141583|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20141584|NCT00056004|Analgesics|analgesics|mesh-ancestor
20141585|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
20141586|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141587|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141588|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314407|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832983|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832984|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19832985|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832986|NCT01685424|Etoricoxib|etoricoxib|mesh-list
19832987|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19832988|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19832989|NCT01685424|Analgesics|analgesics|mesh-ancestor
19832990|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
20347291|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19630986|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19630987|NCT02450123|Growth Substances|growth substances|mesh-ancestor
19630988|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630989|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
19630990|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19630991|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19630992|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19630993|NCT02450084|Fentanyl|fentanyl|mesh-list
19630994|NCT02450084|Ropivacaine|ropivacaine|mesh-list
20141589|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141590|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20347292|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347293|NCT00859079|Insulin|insulin|mesh-list
20347294|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20347295|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20347296|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20347297|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347298|NCT00859079|Incretins|incretins|mesh-ancestor
20347299|NCT00859079|Hormones|hormones|mesh-ancestor
20347300|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347301|NCT00859105|Imiquimod|imiquimod|mesh-list
20347302|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19756482|NCT01208207|Naproxen|naproxen|mesh-list
19756483|NCT01208207|Etoricoxib|etoricoxib|mesh-list
19756484|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20314408|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314409|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314410|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20314411|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
20314412|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314413|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608612|NCT02247310|Interferon-beta|interferon-beta|mesh-list
19630995|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
19630996|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
19630997|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19630998|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19630999|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
19631000|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631001|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19631002|NCT02450084|Narcotics|narcotics|mesh-ancestor
19631003|NCT02450084|Analgesics|analgesics|mesh-ancestor
19631004|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19631005|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19631006|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
19631007|NCT02450045|Bupivacaine|bupivacaine|mesh-list
19631008|NCT02450045|Ropivacaine|ropivacaine|mesh-list
19631009|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
19631010|NCT02450045|Anesthetics|anesthetics|mesh-list
19631011|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631012|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631013|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
19631014|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631015|NCT02449954|Ketorolac|ketorolac|mesh-list
19756485|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756486|NCT01208207|Analgesics|analgesics|mesh-ancestor
19756487|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
19756488|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756489|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756490|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756491|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141591|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141592|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141593|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19756492|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
19756493|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756494|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756495|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756496|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756497|NCT01208181|Etoricoxib|etoricoxib|mesh-list
19756498|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756499|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756500|NCT01208181|Analgesics|analgesics|mesh-ancestor
19756501|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
19756502|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756503|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756504|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756505|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141594|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
20141595|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20141596|NCT00056030|Leucovorin|leucovorin|mesh-list
20141597|NCT00056030|Fluorouracil|fluorouracil|mesh-list
20141598|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
20141599|NCT00056030|Cetuximab|cetuximab|mesh-list
20141600|NCT00056030|Calcium|calcium|mesh-list
19756506|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20608613|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
20608614|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608615|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
19631016|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20141601|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
20141602|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20141603|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141604|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
20141605|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141606|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20608616|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631017|NCT02449954|Morphine|morphine|mesh-list
19631018|NCT02449954|Tramadol|tramadol|mesh-list
20141607|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141608|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141609|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
20141610|NCT00056030|Antidotes|antidotes|mesh-ancestor
20141611|NCT00056030|Protective Agents|protective agents|mesh-ancestor
20141612|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
20141613|NCT00056030|Vitamins|vitamins|mesh-ancestor
20141614|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
20141615|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141616|NCT00056056|Bexarotene|bexarotene|mesh-list
20141617|NCT00056056|Methoxsalen|methoxsalen|mesh-list
20141618|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141619|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20141620|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141621|NCT00056082|Celecoxib|celecoxib|mesh-list
20141622|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19631019|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19631020|NCT02449954|Narcotics|narcotics|mesh-ancestor
19631021|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631022|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631023|NCT02449954|Analgesics|analgesics|mesh-ancestor
19631024|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
19631025|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665754|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19665755|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19665756|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19665757|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19665758|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
19665759|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19665760|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19665761|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665762|NCT04141020|Sirolimus|sirolimus|mesh-list
19665763|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19665764|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665765|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19665766|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665767|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
19665768|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665769|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
19665770|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665771|NCT04140721|Moxonidine|moxonidine|mesh-list
19665772|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19665773|NCT04138875|Rituximab|rituximab|mesh-list
19665774|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19665775|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19665776|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665777|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665778|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
19665779|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665780|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665781|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665782|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
19665783|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665784|NCT04059562|Irinotecan|irinotecan|mesh-list
19665785|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19665786|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19665787|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665788|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665789|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665790|NCT04046107|Cemiplimab|cemiplimab|mesh-list
19665791|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665792|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665793|NCT04019834|Bupivacaine|bupivacaine|mesh-list
19665794|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
19665795|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
19665796|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665797|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665798|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
19665799|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665800|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
19665801|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
19665802|NCT03959241|Methotrexate|methotrexate|mesh-list
19665803|NCT03959241|Tacrolimus|tacrolimus|mesh-list
19665804|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665805|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
20141623|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20141624|NCT00056082|Analgesics|analgesics|mesh-ancestor
20141625|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
20141626|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141627|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141628|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141629|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141630|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20141631|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20141632|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141633|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141634|NCT00056095|Cyclosporine|cyclosporine|mesh-list
20141635|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
20141636|NCT00056095|Fludarabine|fludarabine|mesh-list
20141637|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
20141638|NCT00056095|Cyclosporins|cyclosporins|mesh-list
20141639|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756507|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756508|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314414|NCT00693576|Simvastatin|simvastatin|mesh-list
20314415|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20314416|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20314417|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
20314418|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314419|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20314420|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20314421|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314422|NCT00693589|Folic Acid|folic acid|mesh-list
20314423|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
20314424|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
20314425|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19756509|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756510|NCT01206517|Asenapine|asenapine|mesh-list
19756511|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19756512|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756513|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756514|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756515|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19756516|NCT01190267|Asenapine|asenapine|mesh-list
19756517|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19756518|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756519|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756520|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756521|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19756522|NCT01190254|Asenapine|asenapine|mesh-list
19756523|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19756524|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756525|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756526|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756527|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19756528|NCT01154036|Atorvastatin|atorvastatin|mesh-list
19756529|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19756530|NCT01154036|Ezetimibe|ezetimibe|mesh-list
19756531|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756532|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756533|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
19756534|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756535|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756536|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20314426|NCT00693589|Vitamins|vitamins|mesh-ancestor
20314427|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
20314428|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314429|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20314430|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756537|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756538|NCT01101464|Asenapine|asenapine|mesh-list
19756539|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20141640|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
20141641|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314431|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
20347303|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
20141642|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141643|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631026|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19631027|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19631028|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631029|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631030|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19631031|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631032|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631033|NCT02449941|Rabeprazole|rabeprazole|mesh-list
19631034|NCT02449941|Pantoprazole|pantoprazole|mesh-list
19631035|NCT02449941|Lansoprazole|lansoprazole|mesh-list
20314432|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314433|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20314434|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20314435|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631036|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
19631037|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19631038|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19631039|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19756540|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756541|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756542|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756543|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19756544|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
20141644|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
20141645|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141646|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314436|NCT00693589|Hematinics|hematinics|mesh-ancestor
20314437|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
20314438|NCT00693602|Asparaginase|asparaginase|mesh-list
20314439|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314440|NCT00693615|Vaccines|vaccines|mesh-list
19631040|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631041|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631042|NCT02449811|Amlodipine|amlodipine|mesh-list
19631043|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19631044|NCT02449811|Olmesartan|olmesartan|mesh-list
19631045|NCT02449811|Perindopril|perindopril|mesh-list
20314441|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
20314442|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631046|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20141647|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20141648|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19756545|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756546|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756547|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756548|NCT01030341|Insulin|insulin|mesh-list
19756549|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19756550|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19756551|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756552|NCT00979901|Loratadine|loratadine|mesh-list
19756553|NCT00979901|Montelukast|montelukast|mesh-list
19756554|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756555|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756556|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19756557|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756558|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756559|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756560|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19756561|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19756562|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756563|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
19756564|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756565|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756566|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20314443|NCT00693680|Imipramine|imipramine|mesh-list
20314444|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19756567|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20314445|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
20314446|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20608617|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
19631047|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19631048|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19756568|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
20141649|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
20141650|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141651|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
20314447|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20314448|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20314449|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20314450|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314451|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
20314452|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314453|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314454|NCT00693732|Citalopram|citalopram|mesh-list
20314455|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20314456|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19631049|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141652|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141653|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141654|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20141655|NCT00056225|Vitamins|vitamins|mesh-list
20141656|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
20141657|NCT00056225|Hydroxocobalamin|hydroxocobalamin|mesh-list
20141658|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
20141659|NCT00056225|Pyridoxal|pyridoxal|mesh-list
20141660|NCT00056225|Pyridoxine|pyridoxine|mesh-list
19631050|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19631051|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631052|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
20141661|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
20141662|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
20141663|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141664|NCT00056225|Hematinics|hematinics|mesh-ancestor
20141665|NCT00056264|Infliximab|infliximab|mesh-list
20141666|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141667|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20141668|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141669|NCT00056277|Lamotrigine|lamotrigine|mesh-list
19631053|NCT02449811|Diuretics|diuretics|mesh-ancestor
19631054|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
19631055|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19631056|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19631057|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19631058|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19631059|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
19631060|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631061|NCT02449733|Tenofovir|tenofovir|mesh-list
19631062|NCT02449733|Emtricitabine|emtricitabine|mesh-list
19631063|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19631064|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
19631065|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631066|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19631067|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19631068|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631069|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631070|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19631071|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19631072|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
19631073|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19631074|NCT02449746|Antibodies|antibodies|mesh-list
19631075|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
19631076|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19631077|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
19631078|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631079|NCT02449538|Everolimus|everolimus|mesh-list
19631080|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631081|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631082|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
19631083|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631084|NCT02449564|Sirolimus|sirolimus|mesh-list
19631085|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19631086|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631087|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20141670|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
20141671|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20141672|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173691|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19756569|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
19756570|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756571|NCT00963599|Loratadine|loratadine|mesh-list
19756572|NCT00963599|Montelukast|montelukast|mesh-list
19756573|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756574|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
20141673|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141674|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20141675|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141676|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20141677|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20141678|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20141679|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20141680|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20141681|NCT00056329|Vitamin E|vitamin e|mesh-list
20141682|NCT00056329|Tocopherols|tocopherols|mesh-list
20141683|NCT00056329|Vitamins|vitamins|mesh-ancestor
20141684|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
20141685|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141686|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
20141687|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141688|NCT00056329|Protective Agents|protective agents|mesh-ancestor
20141689|NCT00056368|Fluconazole|fluconazole|mesh-list
20141690|NCT00056368|Anidulafungin|anidulafungin|mesh-list
20141691|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
20141692|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141693|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20141694|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20141695|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141696|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141697|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20141698|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
20141699|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20141700|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141701|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20141702|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20314457|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19631088|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141703|NCT00056381|Anidulafungin|anidulafungin|mesh-list
20141704|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
20141705|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141706|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
20141707|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
20141708|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
19631089|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
19631090|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631091|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
19631092|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631093|NCT02449720|Ropivacaine|ropivacaine|mesh-list
19631094|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
19631095|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
19631096|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631097|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631098|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
20314458|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631099|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631100|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
19631101|NCT02449603|Exenatide|exenatide|mesh-list
19631102|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
19631103|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19631104|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19631105|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631106|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19631107|NCT02449603|Incretins|incretins|mesh-ancestor
19631108|NCT02449603|Hormones|hormones|mesh-ancestor
19631109|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631110|NCT02450058|Paclitaxel|paclitaxel|mesh-list
19631111|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
19631112|NCT02450058|Fluorouracil|fluorouracil|mesh-list
19631113|NCT02450058|Epirubicin|epirubicin|mesh-list
19631114|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631115|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631116|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
19756575|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20314459|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314460|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
20314461|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314462|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19631117|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631118|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631119|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631120|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631121|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
19631122|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631123|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631124|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631125|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
19631126|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631127|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
19631128|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19631129|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19631130|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19631131|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19631132|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631133|NCT02449655|Paclitaxel|paclitaxel|mesh-list
19631134|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19631135|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631136|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631137|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631138|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631139|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665806|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665807|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665808|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665809|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
19665810|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665811|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665812|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19665813|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19665814|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
19665815|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665816|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665817|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
19665818|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665819|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665820|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19665821|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19665822|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19665823|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19665824|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19665825|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
19665826|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19665827|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666226|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666227|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
19666228|NCT05103020|Bevacizumab|bevacizumab|mesh-list
19666229|NCT05103020|Cetuximab|cetuximab|mesh-list
19666230|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
19666231|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666232|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666233|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19666234|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19666235|NCT05103020|Growth Substances|growth substances|mesh-ancestor
19666236|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666237|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
19666238|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
19666239|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19666240|NCT05103007|Estrogens|estrogens|mesh-ancestor
19666241|NCT05103007|Hormones|hormones|mesh-ancestor
19666242|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666243|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666244|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666245|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666246|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
19666247|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19666248|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19756576|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756577|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756578|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756579|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19756580|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19756581|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756582|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
19756583|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
20141709|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20141710|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20141711|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141712|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141713|NCT00056433|Urological Agents|urological agents|mesh-ancestor
19756584|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756585|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756586|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756587|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756588|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
19756589|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756590|NCT00953680|Losartan|losartan|mesh-list
19756591|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19756592|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19756593|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19756594|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19756595|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19756596|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756597|NCT00953680|Diuretics|diuretics|mesh-ancestor
19756598|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
19756599|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756600|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19756601|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19756602|NCT00945035|Etoricoxib|etoricoxib|mesh-list
19756603|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756604|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756605|NCT00945035|Analgesics|analgesics|mesh-ancestor
19756606|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
19756607|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756608|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756609|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756610|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756611|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756612|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756613|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756614|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756615|NCT00943852|Losartan|losartan|mesh-list
19756616|NCT00943852|Isosorbide|isosorbide|mesh-list
20141714|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141715|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
20141716|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20141717|NCT00056446|Vatalanib|vatalanib|mesh-list
20141718|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20141719|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141720|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141721|NCT00056459|Vatalanib|vatalanib|mesh-list
20141722|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19631140|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631141|NCT02449486|Ropivacaine|ropivacaine|mesh-list
19631142|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
19631143|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
19631144|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631145|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631146|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
19631147|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631148|NCT02449265|Prednisone|prednisone|mesh-list
19631149|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
19631150|NCT02449265|Doxorubicin|doxorubicin|mesh-list
19631151|NCT02449265|Vincristine|vincristine|mesh-list
19631152|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631153|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
19631154|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141723|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612148|NCT02249936|Omeprazole|omeprazole|mesh-list
19631155|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631156|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631157|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
19631158|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631159|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631160|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631161|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20141724|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314463|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
20314464|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20314465|NCT00693758|Adenosine|adenosine|mesh-list
19631162|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19631163|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19631164|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631165|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631166|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
19631167|NCT02449265|Hormones|hormones|mesh-ancestor
19631168|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631169|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631170|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631171|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631172|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631173|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631174|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
19631175|NCT02449187|Metformin|metformin|mesh-list
19631176|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19631177|NCT02449187|Calcium|calcium|mesh-list
19631178|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19631179|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631180|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19631181|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19631182|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19631183|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19631184|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
19631185|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631186|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19631187|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19631188|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631189|NCT02449369|Acetaminophen|acetaminophen|mesh-list
19631190|NCT02449369|Oxycodone|oxycodone|mesh-list
19631191|NCT02449369|Hydromorphone|hydromorphone|mesh-list
19631192|NCT02449369|Orphenadrine|orphenadrine|mesh-list
19631193|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19631194|NCT02449369|Analgesics|analgesics|mesh-ancestor
19631195|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
19631196|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631197|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631198|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
19631199|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19631200|NCT02449369|Narcotics|narcotics|mesh-ancestor
19631201|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631202|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19631203|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19631204|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19631205|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19631206|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
19631207|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
19631208|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19631209|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19631210|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
19631211|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631212|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631213|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
19665828|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
19756617|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19756618|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20141725|NCT00056576|Zonisamide|zonisamide|mesh-list
20141726|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
20141727|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20141728|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20141729|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141730|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20141731|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141732|NCT00056641|Ritonavir|ritonavir|mesh-list
20141733|NCT00056641|Lopinavir|lopinavir|mesh-list
20141734|NCT00056641|Saquinavir|saquinavir|mesh-list
20141735|NCT00056641|Amprenavir|amprenavir|mesh-list
20141736|NCT00056641|Tipranavir|tipranavir|mesh-list
20141737|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20141738|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20141739|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
20141740|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141741|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141742|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20141743|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20141744|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
20141745|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141746|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20141747|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20141748|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20141749|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
20141750|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20141751|NCT00056654|Leuprolide|leuprolide|mesh-list
20141752|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20141753|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
20141754|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20141755|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141756|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20141757|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141758|NCT00056693|Sunitinib|sunitinib|mesh-list
20141759|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141760|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141761|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141762|NCT00056693|Growth Substances|growth substances|mesh-ancestor
20141763|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141764|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141765|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20141766|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756619|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19756620|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19756621|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19756622|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19756623|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756624|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19756625|NCT00943852|Diuretics|diuretics|mesh-ancestor
19756626|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
19756627|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756628|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
20141767|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141768|NCT00056758|Vaccines|vaccines|mesh-list
20141769|NCT00056758|Immunologic Factors|immunologic factors|mesh-ancestor
20141770|NCT00056758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141771|NCT00056797|Interleukin-2|interleukin-2|mesh-list
20141772|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141773|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20141774|NCT00056797|Analgesics|analgesics|mesh-ancestor
20141775|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
20141776|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141777|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141778|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
20141779|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20141780|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19756629|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19756630|NCT00909389|Simvastatin|simvastatin|mesh-list
19756631|NCT00909389|Ezetimibe|ezetimibe|mesh-list
20141781|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756632|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20141782|NCT00056823|Ranibizumab|ranibizumab|mesh-list
20141783|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141784|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141785|NCT00056823|Growth Substances|growth substances|mesh-ancestor
20141786|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141787|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141788|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141789|NCT00056836|Ranibizumab|ranibizumab|mesh-list
20141790|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141791|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141792|NCT00056836|Growth Substances|growth substances|mesh-ancestor
20141793|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141794|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141795|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141796|NCT00056875|Mitogens|mitogens|mesh-list
20141797|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
20141798|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141799|NCT00056966|Fludarabine|fludarabine|mesh-list
20141800|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
19756633|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756634|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756635|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
19756636|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756637|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756638|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19756639|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756640|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19756641|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
19756642|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19756643|NCT00820027|Ibuprofen|ibuprofen|mesh-list
19756644|NCT00820027|Etoricoxib|etoricoxib|mesh-list
19756645|NCT00820027|Morphine|morphine|mesh-list
19756646|NCT00820027|Oxycodone|oxycodone|mesh-list
19756647|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19756648|NCT00820027|Narcotics|narcotics|mesh-ancestor
19756649|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756650|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756651|NCT00820027|Analgesics|analgesics|mesh-ancestor
20141801|NCT00056966|Tacrolimus|tacrolimus|mesh-list
20141802|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141803|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756652|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
19756653|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756654|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756655|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20141804|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141805|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
20141806|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141807|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20141808|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141809|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141810|NCT00056979|Fludarabine|fludarabine|mesh-list
20141811|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
20141812|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141813|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141814|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
20141815|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
20141816|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141817|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
20141818|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141819|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141820|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20141821|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
20141822|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141823|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141824|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20141825|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141826|NCT00057031|Calcitriol|calcitriol|mesh-list
20141827|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20141828|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141829|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20141830|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20141831|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141832|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20141833|NCT00057031|Vitamins|vitamins|mesh-ancestor
20141834|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
20141835|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20141836|NCT00057122|Rifampin|rifampin|mesh-list
20141837|NCT00057122|Rifapentine|rifapentine|mesh-list
20141838|NCT00057122|Isoniazid|isoniazid|mesh-list
20141839|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20141840|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
20141841|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20141842|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141843|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
20141844|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20141845|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141846|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141847|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20141848|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19631214|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19631215|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631216|NCT02449252|Prednisone|prednisone|mesh-list
19631217|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
20141849|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20141850|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20141851|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20141852|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20141853|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19631218|NCT02449252|Doxorubicin|doxorubicin|mesh-list
19631219|NCT02449252|Vincristine|vincristine|mesh-list
19631220|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631221|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
19631222|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141854|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20141855|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
20141856|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20141857|NCT00057265|Lamivudine|lamivudine|mesh-list
20141858|NCT00057265|Telbivudine|telbivudine|mesh-list
20141859|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20141860|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20141861|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141862|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141863|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
20141864|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631223|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665829|NCT03882177|Pyridoxal|pyridoxal|mesh-list
19665830|NCT03882177|Pyridoxine|pyridoxine|mesh-list
19665831|NCT03882177|Pravastatin|pravastatin|mesh-list
19665832|NCT03882177|Vitamins|vitamins|mesh-ancestor
19665833|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
19665834|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665835|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
19665836|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19665837|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19665838|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
19665839|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665840|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19665841|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19665842|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665843|NCT03863184|Rituximab|rituximab|mesh-list
19665844|NCT03863184|Lenalidomide|lenalidomide|mesh-list
19665845|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
19665846|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665847|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665848|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
19665849|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665850|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665851|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19665852|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19665853|NCT03863184|Growth Substances|growth substances|mesh-ancestor
19665854|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
19665855|NCT03838744|Olaparib|olaparib|mesh-list
19665856|NCT03838744|Trabectedin|trabectedin|mesh-list
19665857|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19665858|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665859|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665860|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665861|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665862|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
19665863|NCT03736629|Azithromycin|azithromycin|mesh-list
19665864|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19631224|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631225|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
19631226|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631227|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631228|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631229|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19631230|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19631231|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19631232|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756656|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756657|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756658|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756659|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756660|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756661|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756662|NCT00788710|Etoricoxib|etoricoxib|mesh-list
20141865|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20141866|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20141867|NCT00057278|Gabapentin|gabapentin|mesh-list
20141868|NCT00057278|Analgesics|analgesics|mesh-ancestor
20141869|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
20141870|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141871|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141872|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
20141873|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20141874|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20141875|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20141876|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20141877|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19756663|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756664|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756665|NCT00788710|Analgesics|analgesics|mesh-ancestor
19756666|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
19756667|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756668|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756669|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756670|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756671|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756672|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756673|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756674|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756675|NCT00783224|Fluticasone|fluticasone|mesh-list
19756676|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
19756677|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756678|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19756679|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
19756680|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756681|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756682|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756683|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756684|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756685|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756686|NCT00780403|Cetirizine|cetirizine|mesh-list
19756687|NCT00780403|Desloratadine|desloratadine|mesh-list
19631233|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631234|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
19631235|NCT02449252|Hormones|hormones|mesh-ancestor
19756688|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756689|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756690|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19631236|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631237|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631238|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631239|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631240|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631241|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631242|NCT02449070|Nicorandil|nicorandil|mesh-list
19631243|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19631244|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19631245|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
19756691|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
19631246|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
19756692|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
19756693|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631247|NCT02449070|Vitamins|vitamins|mesh-ancestor
19756694|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756695|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756696|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756697|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756698|NCT00779116|Cetirizine|cetirizine|mesh-list
19756699|NCT00779116|Desloratadine|desloratadine|mesh-list
19756700|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756701|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756702|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756703|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
20141878|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20141879|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20141880|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141881|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
20141882|NCT00057304|Insulin|insulin|mesh-list
20141883|NCT00057304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20141884|NCT00057304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756704|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
19756705|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756706|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756707|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756708|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756709|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756710|NCT00764478|Asenapine|asenapine|mesh-list
19756711|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20141885|NCT00057343|Rituximab|rituximab|mesh-list
20314466|NCT00693758|Analgesics|analgesics|mesh-ancestor
20314467|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
19631248|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
19631249|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631250|NCT02449278|Prednisone|prednisone|mesh-list
19631251|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
19631252|NCT02449278|Doxorubicin|doxorubicin|mesh-list
19631253|NCT02449278|Vincristine|vincristine|mesh-list
19631254|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631255|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
19631256|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631257|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631258|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19756712|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756713|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756714|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756715|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19756716|NCT00761527|Desloratadine|desloratadine|mesh-list
19756717|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756718|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756719|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756720|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756721|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756722|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756723|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756724|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756725|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
19756726|NCT00757627|Etoricoxib|etoricoxib|mesh-list
19756727|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756728|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756729|NCT00757627|Analgesics|analgesics|mesh-ancestor
19756730|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
19756731|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756732|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756733|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756734|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756735|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756736|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756737|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756738|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756739|NCT00756938|Losartan|losartan|mesh-list
19756740|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19756741|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19756742|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19756743|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19756744|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612149|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19631259|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
20141886|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141887|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756745|NCT00746590|Tretazicar|tretazicar|mesh-list
19756746|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756747|NCT00730132|Ezetimibe|ezetimibe|mesh-list
19756748|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756749|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756750|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
19756751|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141888|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
20141889|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141890|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141891|NCT00057356|Conivaptan|conivaptan|mesh-list
20141892|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20141893|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141894|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
20141895|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141896|NCT00057369|Dalbavancin|dalbavancin|mesh-list
20141897|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20141898|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141899|NCT00057382|Doxorubicin|doxorubicin|mesh-list
20141900|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20141901|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141902|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20141903|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20141904|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141905|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141906|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
20141907|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141908|NCT00057408|Olanzapine|olanzapine|mesh-list
20141909|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
20141910|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
20141911|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
20141912|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141913|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141914|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20141915|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19756752|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756753|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
20141916|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20141917|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20141918|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20141919|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19756754|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756755|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756756|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756757|NCT00723736|Desloratadine|desloratadine|mesh-list
19756758|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756759|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756760|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756761|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756762|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756763|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756764|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756765|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756766|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
19756767|NCT00705081|Ezetimibe|ezetimibe|mesh-list
19756768|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756769|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756770|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
20141920|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20141921|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141922|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20141923|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
19631260|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631261|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631262|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631263|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19631264|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19631265|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19631266|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631267|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631268|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
19631269|NCT02449278|Hormones|hormones|mesh-ancestor
19756771|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756772|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756773|NCT00704769|Desloratadine|desloratadine|mesh-list
19756774|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19631270|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631271|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20141924|NCT00057421|Prednisolone|prednisolone|mesh-list
20141925|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141926|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
20141927|NCT00057421|Hormones|hormones|mesh-ancestor
20141928|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20141929|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141930|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20141931|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141932|NCT00057447|Interferons|interferons|mesh-list
20141933|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
19756775|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756776|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756777|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756778|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141934|NCT00057447|Rituximab|rituximab|mesh-list
20141935|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20141936|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141937|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
20141938|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141939|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20141940|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
20141941|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141942|NCT00057512|Masoprocol|masoprocol|mesh-list
20141943|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
20141944|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141945|NCT00057512|Protective Agents|protective agents|mesh-ancestor
20141946|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141947|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20141948|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141949|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20141950|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20141951|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20141952|NCT00057512|Analgesics|analgesics|mesh-ancestor
20141953|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
20141954|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141955|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141956|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173692|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20173693|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20173694|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20173695|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
20173696|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631272|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631273|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631274|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631275|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631276|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19631277|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
19631278|NCT02449005|Coagulants|coagulants|mesh-ancestor
19631279|NCT02448797|Vinorelbine|vinorelbine|mesh-list
19631280|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631281|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631282|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631283|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631284|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631285|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631286|NCT02448784|Donepezil|donepezil|mesh-list
19756779|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756780|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756781|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756782|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
19756783|NCT00704535|Ezetimibe|ezetimibe|mesh-list
19756784|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756785|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756786|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
19756787|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756788|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756789|NCT00694369|Acetaminophen|acetaminophen|mesh-list
19756790|NCT00694369|Ibuprofen|ibuprofen|mesh-list
19756791|NCT00694369|Etoricoxib|etoricoxib|mesh-list
19756792|NCT00694369|Codeine|codeine|mesh-list
19756793|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19756794|NCT00694369|Analgesics|analgesics|mesh-ancestor
19756795|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
19756796|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141957|NCT00057564|Thalidomide|thalidomide|mesh-list
20141958|NCT00057564|Dexamethasone|dexamethasone|mesh-list
20141959|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
20141960|NCT00057564|BB 1101|bb 1101|mesh-list
20141961|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20141962|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
20141963|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
20141964|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20141965|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141966|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20141967|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
20141968|NCT00057564|Hormones|hormones|mesh-ancestor
20141969|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20141970|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20141971|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141972|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
20141973|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20141974|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20141975|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20141976|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
19756797|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756798|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
20141977|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
20141978|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20141979|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20141980|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141981|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141982|NCT00057564|Growth Substances|growth substances|mesh-ancestor
20141983|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141984|NCT00057616|Lenalidomide|lenalidomide|mesh-list
20141985|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
20141986|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20141987|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20141988|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20141989|NCT00057616|Growth Substances|growth substances|mesh-ancestor
20141990|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
20141991|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20141992|NCT00057642|Sertraline|sertraline|mesh-list
20141993|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20141994|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
20314468|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314469|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314470|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20314471|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
20314472|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20314473|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
20314474|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
20314475|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314476|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314477|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
20314478|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20141995|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20141996|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20141997|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20141998|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20141999|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142000|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142001|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
20142002|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142003|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20142004|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20142005|NCT00057707|Modafinil|modafinil|mesh-list
20142006|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20142007|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142008|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20142009|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20142010|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19631287|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19631288|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631289|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631290|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
19631291|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631292|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631293|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
19631294|NCT02448901|Edoxaban|edoxaban|mesh-list
19631295|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19631296|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
19631297|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19631298|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
19631299|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631300|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631301|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
19661534|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19661535|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661536|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661537|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661538|NCT03906526|Nivolumab|nivolumab|mesh-list
19661539|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661540|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661541|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19661542|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661543|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
19661544|NCT03829332|Lenvatinib|lenvatinib|mesh-list
19661545|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661546|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661547|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19661548|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661549|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142011|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142012|NCT00057720|Doxorubicin|doxorubicin|mesh-list
20142013|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20142014|NCT00057720|Topotecan|topotecan|mesh-list
20142015|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20142016|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142017|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142018|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142019|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142020|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142021|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19631302|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
19631303|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19631304|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
20142022|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
20142023|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756799|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756800|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756801|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19756802|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19756803|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756804|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756805|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756806|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19756807|NCT00694369|Narcotics|narcotics|mesh-ancestor
19756808|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19756809|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
19756810|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756811|NCT00671528|Gentamicins|gentamicins|mesh-list
19756812|NCT00671528|Clotrimazole|clotrimazole|mesh-list
19756813|NCT00671528|Miconazole|miconazole|mesh-list
19756814|NCT00671528|Betamethasone|betamethasone|mesh-list
19756815|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
19756816|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19756817|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
19756818|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19756819|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756820|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
19756821|NCT00671528|Hormones|hormones|mesh-ancestor
19756822|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756823|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756824|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756825|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756826|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19756827|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19756828|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19756829|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756830|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756831|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19756832|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
19756833|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19756834|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20142024|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
20142025|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20142026|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20142027|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142028|NCT00057759|Urological Agents|urological agents|mesh-ancestor
20142029|NCT00057798|Gemcitabine|gemcitabine|mesh-list
20142030|NCT00057798|Vinorelbine|vinorelbine|mesh-list
20142031|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142032|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
19631305|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756835|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19756836|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756837|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19756838|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19756839|NCT00667823|Macitentan|macitentan|mesh-list
20142033|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631306|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
19631307|NCT02448407|Protective Agents|protective agents|mesh-ancestor
19631308|NCT02448550|Heparin|heparin|mesh-list
19631309|NCT02448550|Calcium heparin|calcium heparin|mesh-list
19631310|NCT02448550|Bivalirudin|bivalirudin|mesh-list
19756840|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19631311|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
19631312|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19631313|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19631314|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631315|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
19631316|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19631317|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
19631318|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631319|NCT02448329|Paclitaxel|paclitaxel|mesh-list
19631320|NCT02448329|Adavosertib|adavosertib|mesh-list
19631321|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631322|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631323|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631324|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631325|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631326|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756841|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19756842|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756843|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19756844|NCT00652327|Atorvastatin|atorvastatin|mesh-list
19756845|NCT00652327|Simvastatin|simvastatin|mesh-list
19756846|NCT00652327|Ezetimibe|ezetimibe|mesh-list
19756847|NCT00652327|Pravastatin|pravastatin|mesh-list
19756848|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19756849|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756850|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756851|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
19756852|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756853|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756854|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756855|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
19756856|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
19756857|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19756858|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
19756859|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756860|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756861|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756862|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756863|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19756864|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19756865|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19756866|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
19756867|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756868|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756869|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756870|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756871|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756872|NCT00568178|Losartan|losartan|mesh-list
19756873|NCT00568178|Amlodipine|amlodipine|mesh-list
19756874|NCT00568178|Enalapril|enalapril|mesh-list
19756875|NCT00568178|Enalaprilat|enalaprilat|mesh-list
19756876|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19756877|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19756878|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19756879|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756880|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20142034|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142035|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
20314479|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314480|NCT00693849|Citalopram|citalopram|mesh-list
20314481|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20314482|NCT00693849|Sertraline|sertraline|mesh-list
20314483|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20142036|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142037|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142038|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142039|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
20142040|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142041|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142042|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142043|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142044|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142045|NCT00057850|Cisplatin|cisplatin|mesh-list
20142046|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314484|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20314485|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142047|NCT00057889|Ipilimumab|ipilimumab|mesh-list
20142048|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142049|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142050|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20142051|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142052|NCT00057928|Gemcitabine|gemcitabine|mesh-list
20142053|NCT00057928|Paclitaxel|paclitaxel|mesh-list
20142054|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19756881|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756882|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
19756883|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19756884|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19756885|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19756886|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756887|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19756888|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
19756889|NCT00545844|Montelukast|montelukast|mesh-list
19756890|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19756891|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
19756892|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19756893|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
19756894|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756895|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756896|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19756897|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19756898|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756899|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
19756900|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19756901|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19756902|NCT00511355|Estradiol|estradiol|mesh-list
19756903|NCT00511355|Estrogens|estrogens|mesh-ancestor
19756904|NCT00511355|Hormones|hormones|mesh-ancestor
19756905|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756906|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142055|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142056|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142057|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142058|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142059|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142060|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142061|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
20142062|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
20142063|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142064|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314486|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314487|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19756907|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20142065|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19756908|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
19756909|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19756910|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19756911|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19756912|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20142066|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
20142067|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142068|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
20142069|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142070|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314488|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
20314489|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314490|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20314491|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
20314492|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142071|NCT00058006|Celecoxib|celecoxib|mesh-list
20142072|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20142073|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20142074|NCT00058006|Analgesics|analgesics|mesh-ancestor
20142075|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
20142076|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142077|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142078|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142079|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142080|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19756913|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19756914|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19756915|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
19756916|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756917|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756918|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756919|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
19756920|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756921|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756922|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756923|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
19756924|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756925|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756926|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756927|NCT00447603|Losartan|losartan|mesh-list
19756928|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20314493|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20314494|NCT00693862|Levodopa|levodopa|mesh-list
20142081|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20142082|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142083|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142084|NCT00058045|Aldesleukin|aldesleukin|mesh-list
20142085|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142086|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20142087|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20142088|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
20142089|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631327|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631328|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19631329|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
19631330|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19631331|NCT02448316|Prednisolone|prednisolone|mesh-list
19631332|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
19631333|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19631334|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
19631335|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631336|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
19631337|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
19631338|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631339|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142090|NCT00058071|Amifostine|amifostine|mesh-list
20142091|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19631340|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20142092|NCT00058071|Protective Agents|protective agents|mesh-ancestor
20314495|NCT00693862|Carbidopa|carbidopa|mesh-list
20314496|NCT00693862|Entacapone|entacapone|mesh-list
19756929|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19756930|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19756931|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19756932|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19756933|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756934|NCT00447603|Diuretics|diuretics|mesh-ancestor
19756935|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
19756936|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756937|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19756938|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19756939|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
20142093|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142094|NCT00058084|Prednisone|prednisone|mesh-list
20142095|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
20142096|NCT00058084|Epothilone B|epothilone b|mesh-list
20142097|NCT00058084|Epothilones|epothilones|mesh-list
20142098|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142099|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
20142100|NCT00058084|Hormones|hormones|mesh-ancestor
20142101|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20142102|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314497|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20314498|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19756940|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756941|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756942|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756943|NCT00423488|Simvastatin|simvastatin|mesh-list
19756944|NCT00423488|Ezetimibe|ezetimibe|mesh-list
19756945|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756946|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756947|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
19756948|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756949|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756950|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19756951|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756952|NCT00413972|Simvastatin|simvastatin|mesh-list
19756953|NCT00413972|Ezetimibe|ezetimibe|mesh-list
19756954|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19756955|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19756956|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
19756957|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756958|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19756959|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19756960|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142103|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20142104|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142105|NCT00058084|Analgesics|analgesics|mesh-ancestor
20142106|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
20142107|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142108|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142109|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19756961|NCT00391170|Dexamethasone|dexamethasone|mesh-list
19756962|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142110|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142111|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142112|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142113|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142114|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142115|NCT00058097|Tipifarnib|tipifarnib|mesh-list
20142116|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142117|NCT00058149|Gemcitabine|gemcitabine|mesh-list
19631341|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
19631342|NCT02448316|Hormones|hormones|mesh-ancestor
19631343|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631344|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19631345|NCT02448316|Protective Agents|protective agents|mesh-ancestor
19631346|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631347|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631348|NCT02448264|Berotralstat|berotralstat|mesh-list
19631349|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631350|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631351|NCT02448290|Docetaxel|docetaxel|mesh-list
19631352|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631353|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
20314499|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
20142118|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
20142119|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142120|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
19756963|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
19756964|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
19756965|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19756966|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756967|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19756968|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
19756969|NCT00391170|Hormones|hormones|mesh-ancestor
19756970|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756971|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19756972|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19756973|NCT00359138|Cetirizine|cetirizine|mesh-list
19756974|NCT00359138|Loratadine|loratadine|mesh-list
19756975|NCT00359138|Levocetirizine|levocetirizine|mesh-list
19756976|NCT00359138|Desloratadine|desloratadine|mesh-list
19756977|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19756978|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19756979|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
19756980|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
19756981|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142121|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142122|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142123|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
20142124|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142125|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142126|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142127|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
20142128|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142129|NCT00058201|Leucovorin|leucovorin|mesh-list
20142130|NCT00058201|Gemcitabine|gemcitabine|mesh-list
20142131|NCT00058201|Fluorouracil|fluorouracil|mesh-list
20142132|NCT00058201|Calcium|calcium|mesh-list
20142133|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
20142134|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142135|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
20142136|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142137|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142138|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
20142139|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142140|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142141|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142142|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
19756982|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19756983|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756984|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19756985|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19756986|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
19756987|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
20142143|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142144|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20142145|NCT00058201|Antidotes|antidotes|mesh-ancestor
20142146|NCT00058201|Protective Agents|protective agents|mesh-ancestor
20142147|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
20142148|NCT00058201|Vitamins|vitamins|mesh-ancestor
19631354|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631355|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631356|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631357|NCT02448251|Abivertinib|abivertinib|mesh-list
20142149|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
20142150|NCT00058227|Rituximab|rituximab|mesh-list
20142151|NCT00058227|Fludarabine|fludarabine|mesh-list
20142152|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
20142153|NCT00058227|Alvocidib|alvocidib|mesh-list
19631358|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19631359|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631360|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631361|NCT02448199|Meloxicam|meloxicam|mesh-list
19631362|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
19631363|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19756988|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
19756989|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
20142154|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19631364|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20142155|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142156|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
19631365|NCT02448199|Analgesics|analgesics|mesh-ancestor
19631366|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
19631367|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631368|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631369|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19756990|NCT00350701|Testosterone|testosterone|mesh-list
19756991|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
19756992|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
19756993|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19756994|NCT00350701|Androgens|androgens|mesh-ancestor
20142157|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142158|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142159|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142160|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
20142161|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142162|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142163|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
20142164|NCT00058227|Growth Substances|growth substances|mesh-ancestor
20142165|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20142166|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19756995|NCT00350701|Hormones|hormones|mesh-ancestor
19756996|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19756997|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19756998|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19756999|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757000|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
19631370|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19631371|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19631372|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631373|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631374|NCT02448082|Ichthammol|ichthammol|mesh-list
19631375|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
19631376|NCT02448069|Argatroban|argatroban|mesh-list
19631377|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
19631378|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19631379|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
19631380|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631381|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757001|NCT00335816|Leucovorin|leucovorin|mesh-list
19757002|NCT00335816|Fluorouracil|fluorouracil|mesh-list
19757003|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
19757004|NCT00335816|Calcium|calcium|mesh-list
19757005|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
19757006|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20142167|NCT00058253|Docetaxel|docetaxel|mesh-list
20142168|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142169|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142170|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142171|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631382|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
19631383|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19631384|NCT02447965|Bupivacaine|bupivacaine|mesh-list
19631385|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
19631386|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
19631387|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631388|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631389|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
19631390|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631391|NCT02447939|Trametinib|trametinib|mesh-list
19631392|NCT02447939|Dabrafenib|dabrafenib|mesh-list
19631393|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757007|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314500|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757008|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
20142172|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142173|NCT00058279|Aldesleukin|aldesleukin|mesh-list
20142174|NCT00058279|Ipilimumab|ipilimumab|mesh-list
20142175|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142176|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142177|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20142178|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142179|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20142180|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20142181|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
20142182|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142183|NCT00058292|Cytarabine|cytarabine|mesh-list
20142184|NCT00058292|Rituximab|rituximab|mesh-list
20142185|NCT00058292|Etoposide|etoposide|mesh-list
20142186|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
20142187|NCT00058292|Melphalan|melphalan|mesh-list
19757009|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757010|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757011|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757012|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757013|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
19757014|NCT00335816|Antidotes|antidotes|mesh-ancestor
19757015|NCT00335816|Protective Agents|protective agents|mesh-ancestor
19757016|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
19757017|NCT00335816|Vitamins|vitamins|mesh-ancestor
19757018|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
19757019|NCT00319449|Atorvastatin|atorvastatin|mesh-list
19757020|NCT00319449|Ezetimibe|ezetimibe|mesh-list
19757021|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20142188|NCT00058292|Carmustine|carmustine|mesh-list
20142189|NCT00058292|Lenograstim|lenograstim|mesh-list
20142190|NCT00058292|Sargramostim|sargramostim|mesh-list
20142191|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142192|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757022|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19757023|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
19757024|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757025|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19757026|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19757027|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757028|NCT00305344|Vaccines|vaccines|mesh-list
19757029|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
19757030|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757031|NCT00289887|Losartan|losartan|mesh-list
19757032|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19757033|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19757034|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19757035|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19757036|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757037|NCT00281320|Asenapine|asenapine|mesh-list
19757038|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19757039|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20142193|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
20142194|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757040|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19757041|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757042|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19757043|NCT00276016|Phenylephrine|phenylephrine|mesh-list
19757044|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
19757045|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
19757046|NCT00276016|Ephedrine|ephedrine|mesh-list
19757047|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19757048|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
19757049|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
19757050|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757051|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757052|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
20142195|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142196|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142197|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142198|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757053|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19757054|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
20142199|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142200|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142201|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19631394|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19631395|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631396|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631397|NCT02447809|Aspirin|aspirin|mesh-list
19757055|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
19757056|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19757057|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19757058|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19757059|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
19757060|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757061|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757062|NCT00276016|Protective Agents|protective agents|mesh-ancestor
19757063|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20142202|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
20142203|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
20142204|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142205|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142206|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20142207|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631398|NCT02447809|Clopidogrel|clopidogrel|mesh-list
19757064|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20142208|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
20142209|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20142210|NCT00058305|Vincristine|vincristine|mesh-list
20142211|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
20142212|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142213|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142214|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142215|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142216|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142217|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142218|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20142219|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
20142220|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142221|NCT00058318|Gemcitabine|gemcitabine|mesh-list
20142222|NCT00058318|Capecitabine|capecitabine|mesh-list
20142223|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142224|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
20142225|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142226|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142227|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
20142228|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142229|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142230|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142231|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
20142232|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142233|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
20142234|NCT00058331|Hematinics|hematinics|mesh-ancestor
20142235|NCT00058357|Lidocaine|lidocaine|mesh-list
20142236|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
20142237|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
20142238|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314501|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631399|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19631400|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19631401|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19631402|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19631403|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
19631404|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631405|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631406|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631407|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19631408|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19631409|NCT02447809|Analgesics|analgesics|mesh-ancestor
19631410|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
19631411|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631412|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142239|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142240|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
19757065|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19757066|NCT00265343|Olanzapine|olanzapine|mesh-list
19757067|NCT00265343|Asenapine|asenapine|mesh-list
19757068|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
19757069|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
19757070|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757071|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142241|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142242|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20142243|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20142244|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20142245|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142246|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142247|NCT00058435|Abagovomab|abagovomab|mesh-list
20142248|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142249|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142250|NCT00058448|Docetaxel|docetaxel|mesh-list
20142251|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142252|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142253|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142254|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142255|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142256|NCT00058461|Cytarabine|cytarabine|mesh-list
20142257|NCT00058461|Rituximab|rituximab|mesh-list
20142258|NCT00058461|Carboplatin|carboplatin|mesh-list
20142259|NCT00058461|Methotrexate|methotrexate|mesh-list
20142260|NCT00058461|Etoposide|etoposide|mesh-list
20142261|NCT00058461|Ifosfamide|ifosfamide|mesh-list
20142262|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142263|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142264|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
19757072|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19757073|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19757074|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19757075|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631413|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631414|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19631415|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19631416|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19631417|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631418|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
19631419|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
19631420|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
19631421|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631422|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631423|NCT02447757|Remifentanil|remifentanil|mesh-list
19631424|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19631425|NCT02447757|Narcotics|narcotics|mesh-ancestor
19631426|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19757076|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19757077|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19757078|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19757079|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19757080|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757081|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757082|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
20142265|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631427|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142266|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142267|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19757083|NCT00264147|Diclofenac|diclofenac|mesh-list
19757084|NCT00264147|Etoricoxib|etoricoxib|mesh-list
19757085|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19757086|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19757087|NCT00264147|Analgesics|analgesics|mesh-ancestor
19757088|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
19757089|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757090|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757091|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19757092|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757093|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19757094|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757095|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757096|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19757097|NCT00202878|Simvastatin|simvastatin|mesh-list
19757098|NCT00202878|Ezetimibe|ezetimibe|mesh-list
19757099|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19757100|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19757101|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19757102|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
19757103|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757104|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19757105|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19757106|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757107|NCT00174265|Olanzapine|olanzapine|mesh-list
19757108|NCT00174265|Asenapine|asenapine|mesh-list
20142268|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
20142269|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20142270|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142271|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
20142272|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142273|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
20142274|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757109|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
19757110|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
19757111|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757112|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757113|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19757114|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19757115|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19757116|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19757117|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19757118|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19757119|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19757120|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19757121|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757122|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757123|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
19757124|NCT00159783|Olanzapine|olanzapine|mesh-list
19757125|NCT00159783|Asenapine|asenapine|mesh-list
19757126|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
19757127|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
19757128|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757129|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757130|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19757131|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19757132|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19757133|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19757134|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19757135|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19757136|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19757137|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19757138|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757139|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757140|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
19757141|NCT00114101|Lenalidomide|lenalidomide|mesh-list
19757142|NCT00114101|Melphalan|melphalan|mesh-list
19757143|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
19757144|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19757145|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
19757146|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757147|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19757148|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20314502|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142275|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20142276|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142277|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20314503|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20314504|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314505|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20314506|NCT00693927|Fludarabine|fludarabine|mesh-list
20314507|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757149|NCT00114101|Growth Substances|growth substances|mesh-ancestor
19757150|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
19757151|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757152|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757153|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
19757154|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757155|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757156|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757157|NCT00092677|Simvastatin|simvastatin|mesh-list
20142278|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142279|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142280|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142281|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
20142282|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142283|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142284|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
20142285|NCT00058474|Fluorouracil|fluorouracil|mesh-list
20142286|NCT00058474|Capecitabine|capecitabine|mesh-list
20142287|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
20142288|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
20142289|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142290|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142291|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142292|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142293|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
20142294|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142295|NCT00058487|Thalidomide|thalidomide|mesh-list
20142296|NCT00058487|Epirubicin|epirubicin|mesh-list
20142297|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20142298|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142299|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20314508|NCT00693966|Vaccines|vaccines|mesh-list
19757158|NCT00092677|Ezetimibe|ezetimibe|mesh-list
19757159|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19757160|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19757161|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
19757162|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757163|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19757164|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19757165|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757166|NCT00090259|Losartan|losartan|mesh-list
19757167|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19757168|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19757169|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19757170|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19757171|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314509|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
20314510|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314511|NCT00693979|Paclitaxel|paclitaxel|mesh-list
20314512|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631428|NCT02447757|Analgesics|analgesics|mesh-ancestor
19631429|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
19631430|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631431|NCT02447705|Telbivudine|telbivudine|mesh-list
19631432|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
19631433|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314513|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314514|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757172|NCT00003298|Leucovorin|leucovorin|mesh-list
19757173|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
20314515|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631434|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19631435|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631436|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631437|NCT02447835|Olanzapine|olanzapine|mesh-list
19631438|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
20314516|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142300|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142301|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142302|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142303|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314517|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314518|NCT00694005|Sirolimus|sirolimus|mesh-list
20314519|NCT00694005|Paclitaxel|paclitaxel|mesh-list
20314520|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20314521|NCT00694005|Everolimus|everolimus|mesh-list
20314522|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20314523|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314524|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757174|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19757175|NCT00003298|Paclitaxel|paclitaxel|mesh-list
19757176|NCT00003298|Cisplatin|cisplatin|mesh-list
20314525|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20314526|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
20314527|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314528|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314529|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
20314530|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314531|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314532|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314533|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314534|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
20314535|NCT00694044|Varenicline|varenicline|mesh-list
20314536|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20314537|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20314538|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
20314539|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314540|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142304|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
20142305|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142306|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
20142307|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20142308|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757177|NCT00003298|Fluorouracil|fluorouracil|mesh-list
19757178|NCT00003298|Calcium|calcium|mesh-list
19757179|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
19757180|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757181|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757182|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757183|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757184|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757185|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757186|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19757187|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757188|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
19757189|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757190|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142309|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19631439|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
19631440|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631441|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631442|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19631443|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19631444|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19631445|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631446|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19631447|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19631448|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19631449|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19631450|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631451|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631452|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
20142310|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19631453|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
19631454|NCT02447796|Propofol|propofol|mesh-list
20142311|NCT00058487|Growth Substances|growth substances|mesh-ancestor
20142312|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
20314541|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631455|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19757191|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
20314542|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19631456|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631457|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631458|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19631459|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
19757192|NCT00003298|Antidotes|antidotes|mesh-ancestor
19757193|NCT00003298|Protective Agents|protective agents|mesh-ancestor
19757194|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
19757195|NCT00003298|Vitamins|vitamins|mesh-ancestor
19757196|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
19757197|NCT00003377|Paclitaxel|paclitaxel|mesh-list
19757198|NCT00003377|Cisplatin|cisplatin|mesh-list
19757199|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757200|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757201|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757202|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757203|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757204|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757205|NCT00003389|Prednisone|prednisone|mesh-list
19757206|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
19757207|NCT00003389|Dacarbazine|dacarbazine|mesh-list
19757208|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
19757209|NCT00003389|Doxorubicin|doxorubicin|mesh-list
19757210|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757211|NCT00003389|Etoposide|etoposide|mesh-list
19757212|NCT00003389|Vincristine|vincristine|mesh-list
19757213|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
19757214|NCT00003389|Bleomycin|bleomycin|mesh-list
19757215|NCT00003389|Vinblastine|vinblastine|mesh-list
19757216|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
19757217|NCT00003389|Imidazole|imidazole|mesh-list
19757218|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757219|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
19757220|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757221|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757222|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142313|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
20142314|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142315|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
20142316|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142317|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142318|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142319|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
20142320|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142321|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142322|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20142323|NCT00058682|Anidulafungin|anidulafungin|mesh-list
20142324|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
20142325|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142326|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
20142327|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142328|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20142329|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142330|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142331|NCT00058890|Gabapentin|gabapentin|mesh-list
20314543|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20142332|NCT00058890|Analgesics|analgesics|mesh-ancestor
20142333|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
20142334|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142335|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142336|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
20142337|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20142338|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20142339|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631460|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
19631461|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19631462|NCT02447796|Analgesics|analgesics|mesh-ancestor
19631463|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
19631464|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757223|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
19757224|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757225|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757226|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757227|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757228|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142340|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142341|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20142342|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20142343|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142344|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142345|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
20142346|NCT00058903|Sertraline|sertraline|mesh-list
20142347|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
20142348|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142349|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20142350|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20142351|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142352|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142353|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142354|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
20142355|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142356|NCT00058929|Treprostinil|treprostinil|mesh-list
20142357|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20142358|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
20142359|NCT00058955|Triazolam|triazolam|mesh-list
20142360|NCT00058955|Pentobarbital|pentobarbital|mesh-list
20142361|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20314544|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314545|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314546|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20314547|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19631465|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19631466|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19631467|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19631468|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
19631469|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631470|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631471|NCT02447666|Azacitidine|azacitidine|mesh-list
19631472|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19631473|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
19631474|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631475|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631476|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631477|NCT02447679|Tegafur|tegafur|mesh-list
19631478|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19631479|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
19631480|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631481|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631482|NCT02447601|Simvastatin|simvastatin|mesh-list
19631483|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19631484|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19631485|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
19631486|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631487|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19631488|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19631489|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631490|NCT02447393|Cetirizine|cetirizine|mesh-list
19631491|NCT02447393|Levocetirizine|levocetirizine|mesh-list
20314548|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314549|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
20314550|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314551|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20314552|NCT00694187|Zaleplon|zaleplon|mesh-list
20314553|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
20314554|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20314555|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314556|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314557|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
20314558|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
20314559|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314560|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314561|NCT00694200|Bevacizumab|bevacizumab|mesh-list
20314562|NCT00694200|Vinorelbine|vinorelbine|mesh-list
20314563|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20314564|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314565|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20314566|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19631492|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20314567|NCT00694200|Growth Substances|growth substances|mesh-ancestor
19631493|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19757229|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757230|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757231|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19757232|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
19757233|NCT00003389|Hormones|hormones|mesh-ancestor
19757234|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757235|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757236|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757237|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757238|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757239|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757240|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
19757241|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
19832991|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832992|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832993|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832994|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832995|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19832996|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19832997|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832998|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832999|NCT01587235|Simvastatin|simvastatin|mesh-list
19833000|NCT01587235|Ezetimibe|ezetimibe|mesh-list
19833001|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20142362|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20142363|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
20142364|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
20142365|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20142366|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142367|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20142368|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20142369|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142370|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
20142371|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
20142372|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142373|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142374|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20142375|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20142376|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20142377|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20142378|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142379|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142380|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142381|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142382|NCT00058968|Analgesics|analgesics|mesh-ancestor
20142383|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
20142384|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142385|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
20142386|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19833002|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833003|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20142387|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
19631494|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19631495|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
19631496|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
19631497|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631498|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631499|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631500|NCT02447406|Docetaxel|docetaxel|mesh-list
19631501|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631502|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631503|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631504|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631505|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631506|NCT02447510|Mitogens|mitogens|mesh-list
19631507|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142388|NCT00058994|Anecortave|anecortave|mesh-list
20142389|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20142390|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20142391|NCT00058994|Growth Substances|growth substances|mesh-ancestor
20142392|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142393|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
20142394|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142395|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
20142396|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142397|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142398|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20142399|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20142400|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20142401|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142402|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314568|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314569|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
20314570|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20314571|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631508|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631509|NCT02447289|Midazolam|midazolam|mesh-list
19631510|NCT02447289|Ketamine|ketamine|mesh-list
19631511|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19631512|NCT02447289|Analgesics|analgesics|mesh-ancestor
19631513|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
19631514|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631515|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631516|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19631517|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19631518|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
19631519|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
19631520|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631521|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19631522|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19631523|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631524|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631525|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19631526|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19631527|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19631528|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19631529|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19631530|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
19631531|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
19631532|NCT02447380|Docetaxel|docetaxel|mesh-list
19631533|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631534|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631535|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631536|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631537|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631538|NCT02447315|Pilocarpine|pilocarpine|mesh-list
19631539|NCT02447315|Miotics|miotics|mesh-ancestor
19631540|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
19631541|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631542|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631543|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19631544|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19631545|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
19631546|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631547|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631548|NCT02447224|Metronidazole|metronidazole|mesh-list
19631549|NCT02447224|Ertapenem|ertapenem|mesh-list
19631550|NCT02447224|Cefdinir|cefdinir|mesh-list
19631551|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631552|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19631553|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19631554|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19631555|NCT02447419|Gefitinib|gefitinib|mesh-list
19631556|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142403|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
20142404|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142405|NCT00059306|Aspirin|aspirin|mesh-list
20314572|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631557|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19631558|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631559|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631560|NCT02447211|Doxepin|doxepin|mesh-list
20142406|NCT00059306|Clopidogrel|clopidogrel|mesh-list
20142407|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20142408|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20142409|NCT00059306|Analgesics|analgesics|mesh-ancestor
20142410|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
20142411|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142412|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142413|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142414|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142415|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20142416|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20142417|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142418|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20142419|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20142420|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314573|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20314574|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314575|NCT00694252|Lapatinib|lapatinib|mesh-list
20314576|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314577|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20142421|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
20142422|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20142423|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20142424|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20142425|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
20142426|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142427|NCT00059358|Interferons|interferons|mesh-list
20142428|NCT00059358|Ribavirin|ribavirin|mesh-list
20142429|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
20142430|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
20142431|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20142432|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757242|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
19757243|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757244|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
19757245|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757246|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142433|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
20142434|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142435|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
20142436|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142437|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
20142438|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142439|NCT00059462|Interleukin-2|interleukin-2|mesh-list
20142440|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142441|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20142442|NCT00059462|Analgesics|analgesics|mesh-ancestor
20142443|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
20142444|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142445|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173697|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173698|NCT00162435|Warfarin|warfarin|mesh-list
20173699|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
20173700|NCT00162461|Phenytoin|phenytoin|mesh-list
20173701|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
20173702|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20173703|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20173704|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173705|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173706|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20173707|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20173708|NCT00162474|Phenytoin|phenytoin|mesh-list
20173709|NCT00162474|Warfarin|warfarin|mesh-list
20173710|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
20173711|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
20173712|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20173713|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20173714|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173715|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173716|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20173717|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20173718|NCT00162487|Albuterol|albuterol|mesh-list
20173719|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19757247|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757248|NCT00003631|Cytarabine|cytarabine|mesh-list
19757249|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
19757250|NCT00003631|Melphalan|melphalan|mesh-list
20314578|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314579|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314580|NCT00694291|Sorafenib|sorafenib|mesh-list
20314581|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314582|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20314583|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314584|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631561|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19757251|NCT00003631|Ifosfamide|ifosfamide|mesh-list
19757252|NCT00003631|Carmustine|carmustine|mesh-list
19757253|NCT00003631|Carboplatin|carboplatin|mesh-list
20314585|NCT00694317|Zaleplon|zaleplon|mesh-list
20314586|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
20314587|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20314588|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314589|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314590|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
20314591|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
20314592|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314593|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314594|NCT00694330|Vaccines|vaccines|mesh-list
20314595|NCT00694330|Immunologic Factors|immunologic factors|mesh-ancestor
20142446|NCT00059592|Valacyclovir|valacyclovir|mesh-list
20142447|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
20142448|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142449|NCT00059618|Carboplatin|carboplatin|mesh-list
20142450|NCT00059618|Bortezomib|bortezomib|mesh-list
20142451|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142452|NCT00059631|Bortezomib|bortezomib|mesh-list
20142453|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
20142454|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142455|NCT00059631|Analgesics|analgesics|mesh-ancestor
20142456|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
20142457|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142458|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142459|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142460|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142461|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142462|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142463|NCT00059722|Gefitinib|gefitinib|mesh-list
20142464|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142465|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20142466|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142467|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142468|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20142469|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142470|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20142471|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142472|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142473|NCT00059761|Irinotecan|irinotecan|mesh-list
20142474|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142475|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20142476|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142477|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142478|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142479|NCT00059800|Boron|boron|mesh-list
20142480|NCT00059800|Trace Elements|trace elements|mesh-ancestor
20142481|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
20142482|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142483|NCT00059813|Interferons|interferons|mesh-list
20142484|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
19631562|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19631563|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631564|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631565|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19631566|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
19631567|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19631568|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
19631569|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
19631570|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757254|NCT00003631|Etoposide|etoposide|mesh-list
19757255|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142485|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
19757256|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
20142486|NCT00059813|Oblimersen|oblimersen|mesh-list
20142487|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142488|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
20142489|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142490|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
19757257|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757258|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757259|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757260|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
19757261|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757262|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757263|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757264|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757265|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757266|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757267|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757268|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757269|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
19757270|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
20142491|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142492|NCT00059826|Interferons|interferons|mesh-list
20142493|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
20142494|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
20142495|NCT00059826|Fluorouracil|fluorouracil|mesh-list
19757271|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757272|NCT00003641|Interferons|interferons|mesh-list
19757273|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
19757274|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
19757275|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757276|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
20142496|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142497|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
20142498|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142499|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142500|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142501|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
20142502|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142503|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
20142504|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142505|NCT00059852|Gemcitabine|gemcitabine|mesh-list
20142506|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19757277|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757278|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
20142507|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757279|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757280|NCT00003644|Paclitaxel|paclitaxel|mesh-list
19757281|NCT00003644|Carboplatin|carboplatin|mesh-list
19757282|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142508|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
20142509|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142510|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142511|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
20142512|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142513|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142514|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142515|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
20142516|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142517|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20142518|NCT00059865|Gemcitabine|gemcitabine|mesh-list
20142519|NCT00059865|Pemetrexed|pemetrexed|mesh-list
20142520|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142521|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
20142522|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142523|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142524|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
20142525|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142526|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142527|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142528|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
20142529|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142530|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20142531|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757283|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142532|NCT00059878|Interferons|interferons|mesh-list
20142533|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
20142534|NCT00059878|Voriconazole|voriconazole|mesh-list
20142535|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142536|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
20142537|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142538|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
20142539|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20142540|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20142541|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142542|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142543|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20142544|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
20142545|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20142546|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142547|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19757284|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757285|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757286|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757287|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757288|NCT00003645|Leuprolide|leuprolide|mesh-list
19757289|NCT00003645|Goserelin|goserelin|mesh-list
19757290|NCT00003645|Flutamide|flutamide|mesh-list
19757291|NCT00003645|Bicalutamide|bicalutamide|mesh-list
19757292|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20142548|NCT00059904|Aldesleukin|aldesleukin|mesh-list
19631571|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631572|NCT02447185|Triamcinolone|triamcinolone|mesh-list
19631573|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19631574|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19631575|NCT02447185|Ranibizumab|ranibizumab|mesh-list
19631576|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19631577|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19631578|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19631579|NCT02447185|Growth Substances|growth substances|mesh-ancestor
19631580|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631581|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
19631582|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631583|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631584|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
20142549|NCT00059904|Rituximab|rituximab|mesh-list
20142550|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142551|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142552|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
20142553|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142554|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142555|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20142556|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20142557|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
20142558|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757293|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
19757294|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757295|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757296|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757297|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757298|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
19757299|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
19757300|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757301|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
19757302|NCT00003659|Rituximab|rituximab|mesh-list
19757303|NCT00003659|Fludarabine|fludarabine|mesh-list
19757304|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
20142559|NCT00059917|Camptothecin|camptothecin|mesh-list
20142560|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142561|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142562|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20142563|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142564|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314596|NCT00694330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314597|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20142565|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631585|NCT02447185|Hormones|hormones|mesh-ancestor
20142566|NCT00059930|Leucovorin|leucovorin|mesh-list
20142567|NCT00059930|Dexamethasone|dexamethasone|mesh-list
20142568|NCT00059930|Fluorouracil|fluorouracil|mesh-list
20142569|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
20142570|NCT00059930|Floxuridine|floxuridine|mesh-list
20142571|NCT00059930|Calcium|calcium|mesh-list
20142572|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
19631586|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631587|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631588|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
19631589|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631590|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631591|NCT02446977|Riboflavin|riboflavin|mesh-list
19631592|NCT02446977|Vitamins|vitamins|mesh-ancestor
19631593|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
19631594|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631595|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
19631596|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19631597|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
19631598|NCT02447016|Tenofovir|tenofovir|mesh-list
19631599|NCT02447016|Emtricitabine|emtricitabine|mesh-list
19631600|NCT02447016|Efavirenz|efavirenz|mesh-list
19631601|NCT02447016|Rilpivirine|rilpivirine|mesh-list
19631602|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
19631603|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631604|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19631605|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19631606|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631607|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631608|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19631609|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19631610|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19631611|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19631612|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19631613|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19631614|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19631615|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19631616|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
19631617|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
19631618|NCT02447055|Melphalan|melphalan|mesh-list
19631619|NCT02447055|Fludarabine|fludarabine|mesh-list
19631620|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
19631621|NCT02447055|Tacrolimus|tacrolimus|mesh-list
19631622|NCT02447055|Lenograstim|lenograstim|mesh-list
19631623|NCT02447055|Sargramostim|sargramostim|mesh-list
19631624|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631625|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
19631626|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142573|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142574|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
20142575|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
19631627|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631628|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142576|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142577|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142578|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314598|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
20314599|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20314600|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19631629|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
19631630|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314601|NCT00694408|Prednisolone|prednisolone|mesh-list
20314602|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
20314603|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
20314604|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20142579|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
20142580|NCT00059930|Hormones|hormones|mesh-ancestor
20142581|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20142582|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20142583|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142584|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20142585|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
20142586|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142587|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142588|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314605|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20314606|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20314607|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20314608|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
20314609|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314610|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
20314611|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
20314612|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631631|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142589|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
20142590|NCT00059930|Antidotes|antidotes|mesh-ancestor
20142591|NCT00059930|Protective Agents|protective agents|mesh-ancestor
20142592|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
20142593|NCT00059930|Vitamins|vitamins|mesh-ancestor
20142594|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
20142595|NCT00059943|Docetaxel|docetaxel|mesh-list
19631632|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631633|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19631634|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
19631635|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20142596|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142597|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142598|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142599|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142600|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142601|NCT00060112|Gemcitabine|gemcitabine|mesh-list
20142602|NCT00060112|Oblimersen|oblimersen|mesh-list
20142603|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314613|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142604|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
20142605|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142606|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142607|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
20142608|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142609|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314614|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314615|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
20142610|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142611|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
20142612|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142613|NCT00060125|Tipifarnib|tipifarnib|mesh-list
20142614|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142615|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
20142616|NCT00060138|Antibodies|antibodies|mesh-list
20142617|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20142618|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
20142619|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142620|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20314616|NCT00694408|Hormones|hormones|mesh-ancestor
20314617|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314618|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20314619|NCT00694408|Protective Agents|protective agents|mesh-ancestor
20314620|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631636|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19631637|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631638|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19631639|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19631640|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
20314621|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314622|NCT00694460|Vaccines|vaccines|mesh-list
20314623|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
20314624|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314625|NCT00694590|Plerixafor|plerixafor|mesh-list
20314626|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20142621|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
20314627|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19631641|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19631642|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142622|NCT00060242|Combretastatin|combretastatin|mesh-list
20142623|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142624|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142625|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142626|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142627|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142628|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142629|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
20142630|NCT00060255|Melphalan|melphalan|mesh-list
20142631|NCT00060255|Busulfan|busulfan|mesh-list
20142632|NCT00060255|Thiotepa|thiotepa|mesh-list
20142633|NCT00060255|Carmustine|carmustine|mesh-list
20142634|NCT00060255|Carboplatin|carboplatin|mesh-list
20142635|NCT00060255|Etoposide|etoposide|mesh-list
20142636|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142637|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
20142638|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142639|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142640|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142641|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
20142642|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142643|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142644|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20142645|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20608618|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608619|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19631643|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19631644|NCT02447094|Plasminogen|plasminogen|mesh-list
19631645|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20142646|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142647|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142648|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142649|NCT00060294|Rituximab|rituximab|mesh-list
20142650|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142651|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757305|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757306|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
19757307|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757308|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757309|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757310|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
19757311|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757312|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757313|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757314|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19757315|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757316|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
19757317|NCT00003702|Dactinomycin|dactinomycin|mesh-list
19757318|NCT00003702|Cactinomycin|cactinomycin|mesh-list
19757319|NCT00003702|Methotrexate|methotrexate|mesh-list
19757320|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19757321|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
19757322|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757323|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757324|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19631646|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19631647|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631648|NCT02446860|Nivolumab|nivolumab|mesh-list
19631649|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19631650|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631651|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19757325|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
20142652|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
20142653|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608620|NCT02247362|Vaccines|vaccines|mesh-list
20608621|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
20608622|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
20608623|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608624|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
20608625|NCT02247414|Aspirin|aspirin|mesh-list
20608626|NCT02247414|Heparin|heparin|mesh-list
20608627|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20608628|NCT02247414|Tinzaparin|tinzaparin|mesh-list
20608629|NCT02247414|Dalteparin|dalteparin|mesh-list
20608630|NCT02247414|Dipyridamole|dipyridamole|mesh-list
20608631|NCT02247414|Warfarin|warfarin|mesh-list
20608632|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20608633|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19757326|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757327|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757328|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
20142654|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142655|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20142656|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142657|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20142658|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142659|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142660|NCT00060359|Paclitaxel|paclitaxel|mesh-list
20142661|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19757329|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757330|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19757331|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757332|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
19757333|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608634|NCT02247414|Analgesics|analgesics|mesh-ancestor
20608635|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
20608636|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608637|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608638|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608639|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608640|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20608641|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19757334|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757335|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19757336|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757337|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757338|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19631652|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631653|NCT02446730|Clopidogrel|clopidogrel|mesh-list
19757339|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
19757340|NCT00003782|Docetaxel|docetaxel|mesh-list
19757341|NCT00003782|Doxorubicin|doxorubicin|mesh-list
19757342|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757343|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
19757344|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757345|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142662|NCT00060359|Carboplatin|carboplatin|mesh-list
20142663|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20142664|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142665|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142666|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142667|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142668|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142669|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142670|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20142671|NCT00060372|Ipilimumab|ipilimumab|mesh-list
20142672|NCT00060372|Antibodies|antibodies|mesh-list
20142673|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
20142674|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20142675|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
20142676|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142677|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142678|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20142679|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142680|NCT00060385|Prednisone|prednisone|mesh-list
20142681|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
20142682|NCT00060385|Doxorubicin|doxorubicin|mesh-list
20142683|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20142684|NCT00060385|Etoposide|etoposide|mesh-list
19631654|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19631655|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19631656|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19631657|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19631658|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
19631659|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142685|NCT00060385|Vincristine|vincristine|mesh-list
20142686|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142687|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
20142688|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142689|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608642|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608643|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19757346|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142690|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142691|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
19757347|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
19757348|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142692|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142693|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142694|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20314628|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
20314629|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314630|NCT00694629|Rifampin|rifampin|mesh-list
20314631|NCT00694629|Rifapentine|rifapentine|mesh-list
20314632|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20314633|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
20314634|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314635|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314636|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
20314637|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20608644|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19757349|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757350|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757351|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757352|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757353|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757354|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757355|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757356|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757357|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757358|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
19757359|NCT00003816|Melphalan|melphalan|mesh-list
19757360|NCT00003816|Busulfan|busulfan|mesh-list
19757361|NCT00003816|Thiotepa|thiotepa|mesh-list
19757362|NCT00003816|Carboplatin|carboplatin|mesh-list
19757363|NCT00003816|Fludarabine|fludarabine|mesh-list
19757364|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
19757365|NCT00003816|Etoposide|etoposide|mesh-list
19757366|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20142695|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20142696|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142697|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142698|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631660|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631661|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142699|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142700|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
20142701|NCT00060385|Hormones|hormones|mesh-ancestor
19757367|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757368|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
19757369|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757370|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757371|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757372|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
19757373|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757374|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757375|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20142702|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20142703|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20142704|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142705|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
20142706|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142707|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142708|NCT00060398|Dexamethasone|dexamethasone|mesh-list
20142709|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
20142710|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142711|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
20142712|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
20142713|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314638|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142714|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631662|NCT02446652|Paclitaxel|paclitaxel|mesh-list
19631663|NCT02446652|Carboplatin|carboplatin|mesh-list
19631664|NCT02446652|Hydralazine|hydralazine|mesh-list
19631665|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631666|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631667|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631668|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631669|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631670|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631671|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19631672|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
19631673|NCT02446782|Clindamycin|clindamycin|mesh-list
19631674|NCT02446782|Cefazolin|cefazolin|mesh-list
19631675|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19631676|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631677|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19631678|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631679|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631680|NCT02446795|Sunitinib|sunitinib|mesh-list
19631681|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631682|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19631683|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19631684|NCT02446795|Growth Substances|growth substances|mesh-ancestor
19631685|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631686|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19631687|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19631688|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631689|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631690|NCT02446834|Metformin|metformin|mesh-list
19631691|NCT02446834|Acarbose|acarbose|mesh-list
19631692|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19631693|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631694|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19631695|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631696|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631697|NCT02446574|Paclitaxel|paclitaxel|mesh-list
19631698|NCT02446574|Cisplatin|cisplatin|mesh-list
19631699|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631700|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608645|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631701|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631702|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631703|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
20142715|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20142716|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
20142717|NCT00060398|Hormones|hormones|mesh-ancestor
19631704|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631705|NCT02446704|Temozolomide|temozolomide|mesh-list
19631706|NCT02446704|Olaparib|olaparib|mesh-list
19631707|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631708|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
19631709|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631710|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631711|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19631712|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631713|NCT02446548|Losartan|losartan|mesh-list
19631714|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19631715|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19631716|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19631717|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19631718|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142718|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631719|NCT02446457|Rituximab|rituximab|mesh-list
20142719|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20142720|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142721|NCT00060398|Hematinics|hematinics|mesh-ancestor
20608646|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
19631720|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19631721|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
19631722|NCT02446457|Lenalidomide|lenalidomide|mesh-list
20142722|NCT00060411|Leucovorin|leucovorin|mesh-list
20142723|NCT00060411|Bevacizumab|bevacizumab|mesh-list
20142724|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20142725|NCT00060411|Fluorouracil|fluorouracil|mesh-list
20142726|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
19631723|NCT02446457|Antibodies|antibodies|mesh-list
19631724|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
19631725|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19631726|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
19631727|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631728|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631729|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631730|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19631731|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19631732|NCT02446457|Growth Substances|growth substances|mesh-ancestor
19631733|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
19631734|NCT02446431|Sirolimus|sirolimus|mesh-list
19631735|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
19631736|NCT02446431|Bevacizumab|bevacizumab|mesh-list
19631737|NCT02446431|Valproic Acid|valproic acid|mesh-list
19631738|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631739|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
19631740|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631741|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631742|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631743|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
19631744|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631745|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631746|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631747|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19631748|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19631749|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19631750|NCT02446431|Growth Substances|growth substances|mesh-ancestor
20142727|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20142728|NCT00060411|Antibodies|antibodies|mesh-list
20142729|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
20142730|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20142731|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
20142732|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142733|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20142734|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19757376|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757377|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
19757378|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757379|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142735|NCT00060411|Growth Substances|growth substances|mesh-ancestor
20142736|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142737|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
20142738|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
20142739|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
20142740|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142741|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142742|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142743|NCT00060411|Antidotes|antidotes|mesh-ancestor
20142744|NCT00060411|Protective Agents|protective agents|mesh-ancestor
20142745|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
20142746|NCT00060411|Vitamins|vitamins|mesh-ancestor
20142747|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
20142748|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20142749|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142750|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
19757380|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757381|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757382|NCT00003820|Rituximab|rituximab|mesh-list
19757383|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19757384|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757385|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
19757386|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142751|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19757387|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757388|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
19757389|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142752|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
20142753|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631751|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
20142754|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757390|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19757391|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19757392|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142755|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19631752|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19631753|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631754|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19631755|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
19631756|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
19631757|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631758|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
19631759|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631760|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
19631761|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20142756|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
20142757|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20142758|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
20142759|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142760|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142761|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20142762|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
20142763|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
20142764|NCT00060450|Protective Agents|protective agents|mesh-ancestor
20142765|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
20142766|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
20142767|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20142768|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142769|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20142770|NCT00060476|Rofecoxib|rofecoxib|mesh-list
20142771|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20142772|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20142773|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142774|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757393|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20142775|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20142776|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20142777|NCT00060476|Analgesics|analgesics|mesh-ancestor
19757394|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757395|NCT00003875|Aldesleukin|aldesleukin|mesh-list
19757396|NCT00003875|Etoposide|etoposide|mesh-list
19757397|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
19757398|NCT00003875|Busulfan|busulfan|mesh-list
19757399|NCT00003875|Interleukin-2|interleukin-2|mesh-list
19757400|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757401|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314639|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314640|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20314641|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20314642|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20314643|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20314644|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19757402|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757403|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757404|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631762|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20142778|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
20142779|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142780|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142781|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142782|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142783|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20142784|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
20142785|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142786|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19631763|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19631764|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19757405|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142787|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20142788|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20142789|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142790|NCT00060502|Gemcitabine|gemcitabine|mesh-list
20142791|NCT00060502|Infliximab|infliximab|mesh-list
20142792|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20142793|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
20142794|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142795|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142796|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
20142797|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142798|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142799|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142800|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
20142801|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142802|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
20142803|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19631765|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19757406|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
19757407|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757408|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
19757409|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757410|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757411|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20314645|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20314646|NCT00694694|Azithromycin|azithromycin|mesh-list
20608647|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
19757412|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19757413|NCT00003875|Analgesics|analgesics|mesh-ancestor
19757414|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
19757415|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142804|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142805|NCT00060554|Heparin|heparin|mesh-list
20142806|NCT00060554|PENTA|penta|mesh-list
20142807|NCT00060554|Fondaparinux|fondaparinux|mesh-list
20142808|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
20142809|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20142810|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20142811|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142812|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20142813|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
20142814|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20142815|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
20142816|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142817|NCT00060567|Irinotecan|irinotecan|mesh-list
20142818|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20608648|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20608649|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
19631766|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631767|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
19631768|NCT02446353|Megestrol|megestrol|mesh-list
20142819|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19757416|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19757417|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19757418|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
19757419|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757420|NCT00003896|Paclitaxel|paclitaxel|mesh-list
19757421|NCT00003896|Doxorubicin|doxorubicin|mesh-list
19757422|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20142820|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142821|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142822|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142823|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142824|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20142825|NCT00060632|Sirolimus|sirolimus|mesh-list
20142826|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20142827|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631769|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631770|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631771|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
20142828|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19631772|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19631773|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631774|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19631775|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19757423|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20142829|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142830|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
20142831|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142832|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
20314647|NCT00694694|Artesunate|artesunate|mesh-list
19631776|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19631777|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
19631778|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757424|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757425|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757426|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757427|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757428|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757429|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757430|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757431|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757432|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757433|NCT00003907|Cisplatin|cisplatin|mesh-list
19757434|NCT00003907|Doxorubicin|doxorubicin|mesh-list
19757435|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757436|NCT00003907|Mitomycins|mitomycins|mesh-list
19757437|NCT00003907|Mitomycin|mitomycin|mesh-list
19757438|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757439|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19631779|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19631780|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19631781|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
19631782|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19631783|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19631784|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631785|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
20142833|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142834|NCT00060645|Sirolimus|sirolimus|mesh-list
20142835|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20142836|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20142837|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20142838|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142839|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
20142840|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20142841|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
19631786|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
19757440|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757441|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757442|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757443|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757444|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
19757445|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757446|NCT00003910|Prednisone|prednisone|mesh-list
20142842|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142843|NCT00060671|Rituximab|rituximab|mesh-list
20142844|NCT00060671|Pixantrone|pixantrone|mesh-list
19757447|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
19757448|NCT00003910|Methotrexate|methotrexate|mesh-list
19757449|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757450|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
19757451|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757452|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757453|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757454|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
19757455|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757456|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142845|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142846|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142847|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
19757457|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631787|NCT02446301|Nalbuphine|nalbuphine|mesh-list
19631788|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19631789|NCT02446301|Narcotics|narcotics|mesh-ancestor
19631790|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631791|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631792|NCT02446301|Analgesics|analgesics|mesh-ancestor
19631793|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
19631794|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631795|NCT02445976|Seviteronel|seviteronel|mesh-list
19631796|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631797|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19631798|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757458|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19757459|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
19631799|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173720|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
19757460|NCT00003910|Hormones|hormones|mesh-ancestor
19757461|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757462|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757463|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19757464|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
19757465|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757466|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757467|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
19757468|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19757469|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757470|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19757471|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757472|NCT00004031|Prednisone|prednisone|mesh-list
19757473|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
19757474|NCT00004031|Carmustine|carmustine|mesh-list
19757475|NCT00004031|Rituximab|rituximab|mesh-list
19757476|NCT00004031|Doxorubicin|doxorubicin|mesh-list
19757477|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757478|NCT00004031|Etoposide|etoposide|mesh-list
19757479|NCT00004031|Vincristine|vincristine|mesh-list
19757480|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757481|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
19757482|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757483|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757484|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757485|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
19757486|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142848|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142849|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142850|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142851|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142852|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142853|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142854|NCT00060684|Dexamethasone|dexamethasone|mesh-list
20142855|NCT00060684|Rituximab|rituximab|mesh-list
20142856|NCT00060684|Fludarabine|fludarabine|mesh-list
20142857|NCT00060684|Pixantrone|pixantrone|mesh-list
20142858|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20142859|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142860|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
20142861|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142862|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20142863|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20142864|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
20142865|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
20142866|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142867|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20142868|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
20142869|NCT00060684|Hormones|hormones|mesh-ancestor
20142870|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20142871|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20142872|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142873|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20142874|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20142875|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142876|NCT00060866|Propranolol|propranolol|mesh-list
19631800|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
19631801|NCT02445989|NuvaRing|nuvaring|mesh-list
19631802|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19631803|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631804|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19631805|NCT02446002|Lofexidine|lofexidine|mesh-list
19631806|NCT02446002|Clonidine|clonidine|mesh-list
19631807|NCT02446002|Naltrexone|naltrexone|mesh-list
19631808|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19631809|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19631810|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631811|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
19631812|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631813|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19631814|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19631815|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19631816|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19631817|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
19757487|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757488|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631818|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631819|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631820|NCT02446002|Analgesics|analgesics|mesh-ancestor
19631821|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
19631822|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
20142877|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20142878|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20142879|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
20142880|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142881|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142882|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142883|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20142884|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20142885|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
20142886|NCT00060905|Valproic Acid|valproic acid|mesh-list
20142887|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
20142888|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142889|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142890|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
20142891|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142892|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142893|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
20142894|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20142895|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20142896|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142897|NCT00060918|Metoprolol|metoprolol|mesh-list
20142898|NCT00060918|Carvedilol|carvedilol|mesh-list
20142899|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20142900|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20142901|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
20142902|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
20142903|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142904|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142905|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20142906|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19757489|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19757490|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757491|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757492|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757493|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757494|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19757495|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
19757496|NCT00004031|Hormones|hormones|mesh-ancestor
19757497|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757498|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757499|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757500|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757501|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20142907|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20142908|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
20142909|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314648|NCT00694694|Lumefantrine|lumefantrine|mesh-list
20314649|NCT00694694|Artemether|artemether|mesh-list
20314650|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19631823|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
19631824|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19631825|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19631826|NCT02445898|Prednisolone|prednisolone|mesh-list
19631827|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
19631828|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19631829|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
19631830|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631831|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
19631832|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
19631833|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631834|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631835|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19631836|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
19631837|NCT02445898|Hormones|hormones|mesh-ancestor
19631838|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631839|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19631840|NCT02445898|Protective Agents|protective agents|mesh-ancestor
19631841|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20314651|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20142910|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142911|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
20142912|NCT00060918|Protective Agents|protective agents|mesh-ancestor
20142913|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20142914|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142915|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20142916|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
20142917|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20142918|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20142919|NCT00060931|Metoprolol|metoprolol|mesh-list
20142920|NCT00060931|Carvedilol|carvedilol|mesh-list
19757502|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757503|NCT00004054|Paclitaxel|paclitaxel|mesh-list
19757504|NCT00004054|Etoposide|etoposide|mesh-list
19757505|NCT00004054|Bicalutamide|bicalutamide|mesh-list
19757506|NCT00004054|Flutamide|flutamide|mesh-list
19757507|NCT00004054|Estramustine|estramustine|mesh-list
19757508|NCT00004054|Warfarin|warfarin|mesh-list
19757509|NCT00004054|Hormones|hormones|mesh-list
20142921|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20142922|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20142923|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
20142924|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
20142925|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142926|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142927|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20142928|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20142929|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19757510|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19757511|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757512|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757513|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757514|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757515|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757516|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757517|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757518|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757519|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757520|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757521|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757522|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
19757523|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
19757524|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
19757525|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757526|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757527|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
19757528|NCT00004088|Pamidronate|pamidronate|mesh-list
19757529|NCT00004088|Interferons|interferons|mesh-list
19757530|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
19757531|NCT00004088|Thalidomide|thalidomide|mesh-list
19757532|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
19757533|NCT00004088|Melphalan|melphalan|mesh-list
19757534|NCT00004088|Busulfan|busulfan|mesh-list
19757535|NCT00004088|Lenograstim|lenograstim|mesh-list
19757536|NCT00004088|Sargramostim|sargramostim|mesh-list
19757537|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757538|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
20142930|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
20142931|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142932|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142933|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
20142934|NCT00060931|Protective Agents|protective agents|mesh-ancestor
20142935|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20142936|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142937|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20142938|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
19757539|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757540|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757541|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20142939|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20142940|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20142941|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
20142942|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19757542|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
19757543|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757544|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20142943|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20142944|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20142945|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142946|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142947|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
20142948|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142949|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142950|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20142951|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142952|NCT00060996|Treprostinil|treprostinil|mesh-list
20142953|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20142954|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
20142955|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
20142956|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142957|NCT00061022|Protective Agents|protective agents|mesh-ancestor
20142958|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142959|NCT00061035|Vaccines|vaccines|mesh-list
20142960|NCT00061035|Immunologic Factors|immunologic factors|mesh-ancestor
20142961|NCT00061035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142962|NCT00061074|Nicotine|nicotine|mesh-list
20142963|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20142964|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
20142965|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20142966|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142967|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20142968|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20142969|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
20142970|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142971|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142972|NCT00061087|Methylphenidate|methylphenidate|mesh-list
20142973|NCT00061087|Bupropion|bupropion|mesh-list
20142974|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20314652|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314653|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
20314654|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20314655|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20314656|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314657|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
20314658|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
20314659|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20314660|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
20314661|NCT00694733|Anastrozole|anastrozole|mesh-list
20314662|NCT00694733|Leuprolide|leuprolide|mesh-list
20608650|NCT02247505|Tadalafil|tadalafil|mesh-list
19757545|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20142975|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142976|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20142977|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20142978|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142979|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142980|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
20142981|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142982|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20142983|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
20142984|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142985|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19757546|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
19757547|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757548|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19757549|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
19757550|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19757551|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19757552|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19757553|NCT00004088|Growth Substances|growth substances|mesh-ancestor
19757554|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
19757555|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19757556|NCT00004092|Paclitaxel|paclitaxel|mesh-list
19757557|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
19757558|NCT00004092|Carboplatin|carboplatin|mesh-list
19757559|NCT00004092|Doxorubicin|doxorubicin|mesh-list
20142986|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20142987|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20142988|NCT00061113|Fluoxetine|fluoxetine|mesh-list
20142989|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20314663|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
19757560|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20142990|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20142991|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20142992|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20142993|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20142994|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
20142995|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20142996|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20142997|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
20142998|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20142999|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20143000|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20143001|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143002|NCT00061126|Panitumumab|panitumumab|mesh-list
19757561|NCT00004092|Thiotepa|thiotepa|mesh-list
19757562|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20143003|NCT00061126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143004|NCT00061126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143005|NCT00061152|Capsaicin|capsaicin|mesh-list
20143006|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
20143007|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
20143008|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
20143009|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143010|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314664|NCT00694733|Estradiol|estradiol|mesh-list
20314665|NCT00694733|Estrogens|estrogens|mesh-list
19631842|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631843|NCT02445872|Dexamethasone|dexamethasone|mesh-list
19631844|NCT02445872|Aprepitant|aprepitant|mesh-list
19631845|NCT02445872|Palonosetron|palonosetron|mesh-list
19631846|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143011|NCT00061178|Bevacizumab|bevacizumab|mesh-list
20143012|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19631847|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
20143013|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143014|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20143015|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20143016|NCT00061178|Growth Substances|growth substances|mesh-ancestor
20143017|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143018|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
20173721|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173722|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173723|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20173724|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
20173725|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
20173726|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20173727|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20173728|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20173729|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20173730|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
20173731|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173732|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173733|NCT00162526|Tocopherols|tocopherols|mesh-list
20173734|NCT00162526|Vitamin E|vitamin e|mesh-list
20314666|NCT00694733|Testosterone|testosterone|mesh-list
19631848|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
19631849|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631850|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631851|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19631852|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
19631853|NCT02445872|Hormones|hormones|mesh-ancestor
19631854|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631855|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631856|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173735|NCT00162526|Tocotrienols|tocotrienols|mesh-list
20173736|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
19631857|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20314667|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
20143019|NCT00061243|Vaccines|vaccines|mesh-list
20143020|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
20143021|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143022|NCT00061256|Vitamin D|vitamin d|mesh-list
20143023|NCT00061256|Alendronate|alendronate|mesh-list
20143024|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
20143025|NCT00061256|Calcium|calcium|mesh-list
20143026|NCT00061256|Vitamins|vitamins|mesh-ancestor
20143027|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
20143028|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143029|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20143030|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20314668|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
20314669|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20314670|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20314671|NCT00694733|Hormones|hormones|mesh-ancestor
20314672|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314673|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314674|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20314675|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20314676|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314677|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20143031|NCT00061256|Antacids|antacids|mesh-ancestor
20143032|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143033|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20143034|NCT00061282|Clotrimazole|clotrimazole|mesh-list
20143035|NCT00061282|Miconazole|miconazole|mesh-list
20143036|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20314678|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314679|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631858|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19631859|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631860|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19631861|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19631862|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
19631863|NCT02446093|Valacyclovir|valacyclovir|mesh-list
19631864|NCT02446093|Antiviral Agents|antiviral agents|mesh-ancestor
19631865|NCT02446093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19631866|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
19631867|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19631868|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19631869|NCT02445599|Dipyrone|dipyrone|mesh-list
19631870|NCT02445599|Diclofenac|diclofenac|mesh-list
19631871|NCT02445599|Atropine|atropine|mesh-list
19631872|NCT02445599|Fentanyl|fentanyl|mesh-list
19631873|NCT02445599|Midazolam|midazolam|mesh-list
19631874|NCT02445599|Tramadol|tramadol|mesh-list
19631875|NCT02445599|Nalbuphine|nalbuphine|mesh-list
20143037|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143038|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
19757563|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757564|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
20143039|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20143040|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19631876|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19631877|NCT02445599|Narcotics|narcotics|mesh-ancestor
19631878|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19631879|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631880|NCT02445599|Analgesics|analgesics|mesh-ancestor
19631881|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
19631882|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631883|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19631884|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19631885|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
19631886|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
19631887|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19631888|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19631889|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19631890|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19631891|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
19631892|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
19631893|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143041|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757565|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757566|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631894|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143042|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757567|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143043|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20143044|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
20143045|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20143046|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143047|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20143048|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20143049|NCT00061308|Gemcitabine|gemcitabine|mesh-list
20143050|NCT00061308|Topotecan|topotecan|mesh-list
20143051|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143052|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
20143053|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143054|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143055|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
20143056|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143057|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143058|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143059|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
20143060|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143061|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143062|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143063|NCT00061321|Nevirapine|nevirapine|mesh-list
20143064|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20143065|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20143066|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143067|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757568|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757569|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
19757570|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757571|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757572|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757573|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
19757574|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757575|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757576|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757577|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143068|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
20143069|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143070|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20143071|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19757578|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757579|NCT00004124|Prednisone|prednisone|mesh-list
19757580|NCT00004124|Goserelin|goserelin|mesh-list
19757581|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
19757582|NCT00004124|Bicalutamide|bicalutamide|mesh-list
19757583|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19757584|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
19757585|NCT00004124|Hormones|hormones|mesh-ancestor
19757586|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757587|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757588|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757589|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757590|NCT00004124|Analgesics|analgesics|mesh-ancestor
19757591|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
19757592|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757593|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757594|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757595|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757596|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757597|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
19757598|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
19757599|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
19757600|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19757601|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757602|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
20143072|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20143073|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20143074|NCT00061360|Cyclosporine|cyclosporine|mesh-list
19757603|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143075|NCT00061360|Sirolimus|sirolimus|mesh-list
20143076|NCT00061360|Cyclosporins|cyclosporins|mesh-list
19757604|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19757605|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19833004|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
19757606|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757607|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19757608|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143077|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143078|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143079|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143080|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
20143081|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143082|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
20143083|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143084|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
20143085|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143086|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20143087|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19757609|NCT00004228|Leucovorin|leucovorin|mesh-list
19757610|NCT00004228|Cytarabine|cytarabine|mesh-list
19757611|NCT00004228|Dexamethasone|dexamethasone|mesh-list
19757612|NCT00004228|Prednisone|prednisone|mesh-list
19757613|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
19757614|NCT00004228|Doxorubicin|doxorubicin|mesh-list
19757615|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757616|NCT00004228|Methotrexate|methotrexate|mesh-list
19757617|NCT00004228|Vincristine|vincristine|mesh-list
19757618|NCT00004228|Daunorubicin|daunorubicin|mesh-list
19757619|NCT00004228|Asparaginase|asparaginase|mesh-list
20143088|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143089|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143090|NCT00061425|Epratuzumab|epratuzumab|mesh-list
20143091|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19631895|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19631896|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19631897|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631898|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143092|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143093|NCT00061438|Meropenem|meropenem|mesh-list
20143094|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20143095|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143096|NCT00061451|Gemcitabine|gemcitabine|mesh-list
20143097|NCT00061451|Pemetrexed|pemetrexed|mesh-list
20143098|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143099|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
20143100|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143101|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143102|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
20143103|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143104|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631899|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19631900|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631901|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20143105|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143106|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
20143107|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143108|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20143109|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20143110|NCT00061464|Gemcitabine|gemcitabine|mesh-list
20143111|NCT00061464|Pemetrexed|pemetrexed|mesh-list
20143112|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143113|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
20143114|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143115|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631902|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19631903|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
19631904|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20143116|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
20143117|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143118|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143119|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143120|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
20143121|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143122|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19631905|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
19631906|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
19631907|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
19757620|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
19757621|NCT00004228|Thioguanine|thioguanine|mesh-list
19757622|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
19757623|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173737|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
19631908|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19631909|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19631910|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
19631911|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
19631912|NCT02445703|Vaccines|vaccines|mesh-list
19631913|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
19631914|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631915|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
19631916|NCT02445716|Testosterone|testosterone|mesh-list
19631917|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
19631918|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
19631919|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19631920|NCT02445716|Androgens|androgens|mesh-ancestor
19631921|NCT02445716|Hormones|hormones|mesh-ancestor
19631922|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631923|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631924|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631925|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631926|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
19631927|NCT02445547|Hormones|hormones|mesh-list
19631928|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631929|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631930|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
19631931|NCT02445508|Sevelamer|sevelamer|mesh-list
19631932|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
19631933|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
20143123|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20143124|NCT00061477|Gemcitabine|gemcitabine|mesh-list
20143125|NCT00061477|Pemetrexed|pemetrexed|mesh-list
20143126|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143127|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
20143128|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143129|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143130|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
20143131|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143132|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143133|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143134|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
20143135|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143136|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19757624|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
19757625|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757626|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757627|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757628|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
19757629|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143137|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20143138|NCT00061503|Travoprost|travoprost|mesh-list
20143139|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20143140|NCT00061516|Brinzolamide|brinzolamide|mesh-list
20143141|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20143142|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757630|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757631|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757632|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19757633|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
19757634|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
19757635|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757636|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19757637|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
19757638|NCT00004228|Hormones|hormones|mesh-ancestor
19631934|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631935|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19631936|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19631937|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19631938|NCT02445352|Ezetimibe|ezetimibe|mesh-list
19631939|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19631940|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20143143|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757639|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757640|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20143144|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20143145|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20143146|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20143147|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20143148|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20143149|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20143150|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20143151|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20143152|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143153|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143154|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143155|NCT00061542|Timolol|timolol|mesh-list
20143156|NCT00061542|Betaxolol|betaxolol|mesh-list
20143157|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20143158|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20143159|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
20143160|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143161|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143162|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143163|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20143164|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20143165|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
20314680|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20314681|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
20314682|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20314683|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
20314684|NCT00694733|Androgens|androgens|mesh-ancestor
20314685|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
20314686|NCT00694759|Metformin|metformin|mesh-list
20314687|NCT00694759|Pioglitazone|pioglitazone|mesh-list
20314688|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20314689|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314690|NCT00694837|Nelfinavir|nelfinavir|mesh-list
20314691|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20314692|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20314693|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
20314694|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314695|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314696|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20314697|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20314698|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
20314699|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314700|NCT00694863|Cosyntropin|cosyntropin|mesh-list
20314701|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
20314702|NCT00694863|Hormones|hormones|mesh-ancestor
20314703|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314704|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314705|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
20314706|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20314707|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
20314708|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347304|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347305|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757641|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757642|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20347306|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
20347307|NCT00859118|Axitinib|axitinib|mesh-list
20347308|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347309|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20347310|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347311|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347312|NCT00859183|Sirolimus|sirolimus|mesh-list
20347313|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347314|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347315|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20347316|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347317|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
20347318|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347319|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
20608651|NCT02247505|Tamsulosin|tamsulosin|mesh-list
19757643|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757644|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347320|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757645|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19757646|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
19757647|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757648|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757649|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
19757650|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
19757651|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19757652|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757653|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
19757654|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757655|NCT00004228|Antidotes|antidotes|mesh-ancestor
19757656|NCT00004228|Protective Agents|protective agents|mesh-ancestor
19757657|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
19757658|NCT00004228|Vitamins|vitamins|mesh-ancestor
19757659|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
19757660|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20143166|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
20143167|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143168|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20143169|NCT00061594|Ranibizumab|ranibizumab|mesh-list
20143170|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20143171|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20143172|NCT00061594|Growth Substances|growth substances|mesh-ancestor
20143173|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631941|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
19631942|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631943|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19631944|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19631945|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631946|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19631947|NCT02445300|Laxatives|laxatives|mesh-ancestor
20143174|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
19757661|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757662|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757663|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757664|NCT00004259|Carmustine|carmustine|mesh-list
19757665|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20143175|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143176|NCT00061620|Tezacitabine|tezacitabine|mesh-list
20143177|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757666|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
19757667|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143178|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143179|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143180|NCT00061646|Carboplatin|carboplatin|mesh-list
20143181|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143182|NCT00061711|Hormones|hormones|mesh-list
20143183|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
20143184|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20143185|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143186|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20143187|NCT00061711|Estrogens|estrogens|mesh-ancestor
20143188|NCT00061750|Deferasirox|deferasirox|mesh-list
20143189|NCT00061750|Deferoxamine|deferoxamine|mesh-list
20143190|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20143191|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
20143192|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
20143193|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143194|NCT00061750|Siderophores|siderophores|mesh-ancestor
20143195|NCT00061763|Deferasirox|deferasirox|mesh-list
20143196|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20143197|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
20143198|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
20143199|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757668|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757669|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
19757670|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757671|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19757672|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
19757673|NCT00004547|Paclitaxel|paclitaxel|mesh-list
19757674|NCT00004547|Cisplatin|cisplatin|mesh-list
19757675|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757676|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757677|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
20143200|NCT00061776|Capsaicin|capsaicin|mesh-list
20143201|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
20143202|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
19631948|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19631949|NCT02445339|Naltrexone|naltrexone|mesh-list
19631950|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20143203|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
20143204|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143205|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143206|NCT00061789|Acetylcholine|acetylcholine|mesh-list
20143207|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
19757678|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757679|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757680|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757681|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19757682|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19757683|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19757684|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19757685|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
19757686|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
19757687|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757688|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757689|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757690|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
19757691|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
19757692|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757693|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
19757694|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757695|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757696|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757697|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
19757698|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143208|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19757699|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757700|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757701|NCT00004635|Thalidomide|thalidomide|mesh-list
19757702|NCT00004635|Leuprolide|leuprolide|mesh-list
19757703|NCT00004635|Goserelin|goserelin|mesh-list
19757704|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757705|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
19757706|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757707|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
19757708|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19757709|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757710|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19757711|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19757712|NCT00004635|Growth Substances|growth substances|mesh-ancestor
20143209|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
20143210|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143211|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143212|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143213|NCT00061802|Risperidone|risperidone|mesh-list
20143214|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20143215|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20143216|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
20143217|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143218|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143219|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143220|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20143221|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20143222|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20143223|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20143224|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20143225|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
20143226|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
20143227|NCT00061815|Leucovorin|leucovorin|mesh-list
20143228|NCT00061815|Fluorouracil|fluorouracil|mesh-list
20143229|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
20143230|NCT00061815|Cetuximab|cetuximab|mesh-list
19631951|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19631952|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631953|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
19631954|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631955|NCT02445404|Dexamethasone|dexamethasone|mesh-list
19631956|NCT02445404|Prednisone|prednisone|mesh-list
19631957|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
19631958|NCT02445404|Ifosfamide|ifosfamide|mesh-list
20143231|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
20143232|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143233|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143234|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143235|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143236|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
20143237|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143238|NCT00061815|Antidotes|antidotes|mesh-ancestor
20143239|NCT00061815|Protective Agents|protective agents|mesh-ancestor
20143240|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
20143241|NCT00061815|Vitamins|vitamins|mesh-ancestor
20143242|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
20143243|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143244|NCT00061854|Soblidotin|soblidotin|mesh-list
20143245|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143246|NCT00061867|Doxorubicin|doxorubicin|mesh-list
20143247|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20143248|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143249|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143250|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20143251|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143252|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143253|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143254|NCT00061906|Celecoxib|celecoxib|mesh-list
20143255|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20143256|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143257|NCT00061906|Analgesics|analgesics|mesh-ancestor
20143258|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
20143259|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143260|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143261|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143262|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143263|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20143264|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20143265|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143266|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143267|NCT00061919|Thalidomide|thalidomide|mesh-list
20143268|NCT00061919|Carboplatin|carboplatin|mesh-list
20143269|NCT00061919|Etoposide|etoposide|mesh-list
20143270|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
20143271|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143272|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20143273|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20143274|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143275|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143276|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143277|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143278|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
20143279|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757713|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
19757714|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757715|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19757716|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
20143280|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
20143281|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20143282|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143283|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20143284|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20143285|NCT00061919|Growth Substances|growth substances|mesh-ancestor
20143286|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
20143287|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
20143288|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143289|NCT00061984|Doxorubicin|doxorubicin|mesh-list
20143290|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757717|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757718|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757719|NCT00004859|Thalidomide|thalidomide|mesh-list
19757720|NCT00004859|Paclitaxel|paclitaxel|mesh-list
19757721|NCT00004859|Carboplatin|carboplatin|mesh-list
19757722|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757723|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757724|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757725|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757726|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757727|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143291|NCT00061984|Ifosfamide|ifosfamide|mesh-list
20143292|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143293|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143294|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20143295|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143296|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757728|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757729|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
19757730|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757731|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
19757732|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19757733|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757734|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19757735|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19757736|NCT00004859|Growth Substances|growth substances|mesh-ancestor
19757737|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
19757738|NCT00004888|Docetaxel|docetaxel|mesh-list
19757739|NCT00004888|Doxorubicin|doxorubicin|mesh-list
19757740|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757741|NCT00004888|Trastuzumab|trastuzumab|mesh-list
19757742|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757743|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757744|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757745|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757746|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143297|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143298|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20143299|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
20143300|NCT00061997|Inositol|inositol|mesh-list
20143301|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
20143302|NCT00061997|Vitamins|vitamins|mesh-ancestor
20143303|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
20143304|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143305|NCT00062023|Aspirin|aspirin|mesh-list
20143306|NCT00062023|Sulindac|sulindac|mesh-list
20143307|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20143308|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20143309|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143310|NCT00062023|Analgesics|analgesics|mesh-ancestor
20143311|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
20143312|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143313|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143314|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143315|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143316|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20143317|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20143318|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314709|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19757747|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757748|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757749|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757750|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757751|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19757752|NCT00004978|Aldesleukin|aldesleukin|mesh-list
19757753|NCT00004978|Interleukin-2|interleukin-2|mesh-list
19757754|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757755|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19757756|NCT00004978|Analgesics|analgesics|mesh-ancestor
19757757|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
19757758|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757759|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757760|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19757761|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19757762|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
19757763|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757764|NCT00005044|Bicalutamide|bicalutamide|mesh-list
19757765|NCT00005044|Flutamide|flutamide|mesh-list
19757766|NCT00005044|Hormones|hormones|mesh-list
19757767|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19757768|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757769|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757770|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
19757771|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
19757772|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143319|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19757773|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757774|NCT00005047|Doxorubicin|doxorubicin|mesh-list
20143320|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20143321|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143322|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
20143323|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20143324|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20143325|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143326|NCT00062036|Aldesleukin|aldesleukin|mesh-list
20143327|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
20143328|NCT00062036|Fludarabine|fludarabine|mesh-list
20143329|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
20143330|NCT00062036|Interleukin-2|interleukin-2|mesh-list
20143331|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
20143332|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757775|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757776|NCT00005047|Methotrexate|methotrexate|mesh-list
19757777|NCT00005047|Vinblastine|vinblastine|mesh-list
19757778|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757779|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757780|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757781|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143333|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
20143334|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143335|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143336|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20143337|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
20143338|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143339|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143340|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20143341|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143342|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
20143343|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20314710|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20314711|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20314712|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
20314713|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314714|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314715|NCT00694967|Progestins|progestins|mesh-ancestor
20314716|NCT00694967|Hormones|hormones|mesh-ancestor
20143344|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143345|NCT00062036|Analgesics|analgesics|mesh-ancestor
20143346|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
20143347|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143348|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20143349|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20143350|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
19757782|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757783|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757784|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19757785|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
19757786|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757787|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757788|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757789|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
19757790|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
19757791|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19757792|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143351|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143352|NCT00062062|Paclitaxel|paclitaxel|mesh-list
20143353|NCT00062062|Carboplatin|carboplatin|mesh-list
20143354|NCT00062062|Gefitinib|gefitinib|mesh-list
20143355|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20143356|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143357|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
20143358|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
20143359|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
20143360|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143361|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143362|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143363|NCT00062075|Romidepsin|romidepsin|mesh-list
20143364|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143365|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314717|NCT00694980|Etrolizumab|etrolizumab|mesh-list
20314718|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20143366|NCT00062101|Celecoxib|celecoxib|mesh-list
20143367|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20143368|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143369|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143370|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143371|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143372|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20143373|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143374|NCT00062101|Analgesics|analgesics|mesh-ancestor
20143375|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
20143376|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143377|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143378|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143379|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143380|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20143381|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20143382|NCT00062114|Rituximab|rituximab|mesh-list
20143383|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143384|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143385|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
20143386|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143387|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143388|NCT00062127|Thalidomide|thalidomide|mesh-list
20143389|NCT00062127|Irinotecan|irinotecan|mesh-list
20143390|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143391|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143392|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143393|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143394|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143395|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143396|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
20143397|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143398|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
20143399|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20143400|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143401|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20143402|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20143403|NCT00062127|Growth Substances|growth substances|mesh-ancestor
20143404|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
20143405|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
20143406|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143407|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
20143408|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143409|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143410|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20143411|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
20143412|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143413|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143414|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757793|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
19757794|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757795|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757796|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757797|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757798|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757799|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757800|NCT00005669|Metformin|metformin|mesh-list
19757801|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19757802|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757803|NCT00005803|Cytarabine|cytarabine|mesh-list
19757804|NCT00005803|Cyclosporine|cyclosporine|mesh-list
19757805|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
19757806|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
19757807|NCT00005803|Melphalan|melphalan|mesh-list
19757808|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
19757809|NCT00005803|Carmustine|carmustine|mesh-list
20143415|NCT00062179|Celecoxib|celecoxib|mesh-list
20143416|NCT00062179|Paclitaxel|paclitaxel|mesh-list
20143417|NCT00062179|Carboplatin|carboplatin|mesh-list
20143418|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757810|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19757811|NCT00005803|Fludarabine|fludarabine|mesh-list
19757812|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
19757813|NCT00005803|Etoposide|etoposide|mesh-list
19757814|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
19757815|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
19757816|NCT00005803|Cyclosporins|cyclosporins|mesh-list
19757817|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757818|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
19757819|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757820|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757821|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757822|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
19757823|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143419|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143420|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
20143421|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
20143422|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
20143423|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143424|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20314719|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
20314720|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143425|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143426|NCT00062179|Analgesics|analgesics|mesh-ancestor
20143427|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
20143428|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143429|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143430|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143431|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143432|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20143433|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20143434|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143435|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
20143436|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143437|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143438|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143439|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143440|NCT00062231|Amoxicillin|amoxicillin|mesh-list
20143441|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
20143442|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
20143443|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
20143444|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
20143445|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20143446|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20143447|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20143448|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143449|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20143450|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143451|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143452|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143453|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143454|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20143455|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
20143456|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20314721|NCT00695032|Ifosfamide|ifosfamide|mesh-list
20347321|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
19631959|NCT02445404|Carboplatin|carboplatin|mesh-list
19631960|NCT02445404|Etoposide|etoposide|mesh-list
19631961|NCT02445404|Vincristine|vincristine|mesh-list
19631962|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19631963|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
19631964|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631965|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19631966|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19631967|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
19631968|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631969|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631970|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19631971|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19631972|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
19631973|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
19631974|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19631975|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19631976|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
19631977|NCT02445404|Hormones|hormones|mesh-ancestor
19631978|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19631979|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19631980|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19631981|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19631982|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19631983|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757824|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143457|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314722|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314723|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20314724|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
20314725|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314726|NCT00695045|Morphine|morphine|mesh-list
20314727|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19631984|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
19631985|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
19631986|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
19631987|NCT02445391|Cisplatin|cisplatin|mesh-list
19631988|NCT02445391|Carboplatin|carboplatin|mesh-list
20143458|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20143459|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20143460|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20143461|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20143462|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20143463|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20143464|NCT00062244|Oblimersen|oblimersen|mesh-list
20143465|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143466|NCT00062257|Irofulven|irofulven|mesh-list
20143467|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20143468|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
20143469|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143470|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143471|NCT00062270|Gemcitabine|gemcitabine|mesh-list
20143472|NCT00062270|Docetaxel|docetaxel|mesh-list
20143473|NCT00062270|Gefitinib|gefitinib|mesh-list
20143474|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143475|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143476|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
20314728|NCT00695045|Narcotics|narcotics|mesh-ancestor
20314729|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314730|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314731|NCT00695045|Analgesics|analgesics|mesh-ancestor
20314732|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
20314733|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314734|NCT00695071|Itraconazole|itraconazole|mesh-list
20314735|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
20314736|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314737|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20314738|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20314739|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314740|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314741|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20314742|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
19631989|NCT02445391|Capecitabine|capecitabine|mesh-list
19631990|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19631991|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19631992|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
19631993|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19631994|NCT02445066|Vitamin D|vitamin d|mesh-list
19631995|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
19631996|NCT02445066|Vitamins|vitamins|mesh-ancestor
19631997|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
19631998|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19631999|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19661582|NCT03789604|Antibodies|antibodies|mesh-list
19661583|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19661584|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
19661585|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661586|NCT03522064|Carboplatin|carboplatin|mesh-list
19661587|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
19661588|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19661589|NCT03522064|Testosterone|testosterone|mesh-list
19661590|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
19661591|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
20143477|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143478|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
20143479|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143480|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143481|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143482|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
20143483|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143484|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
20143485|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757825|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757826|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757827|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
19757828|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757829|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757830|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757831|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757832|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
19632000|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19632001|NCT02444949|Cisplatin|cisplatin|mesh-list
20143486|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
20143487|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143488|NCT00062283|Alanosine|alanosine|mesh-list
20143489|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143490|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143491|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
20143492|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
20143493|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143494|NCT00062296|Rituximab|rituximab|mesh-list
20143495|NCT00062296|Epirubicin|epirubicin|mesh-list
20143496|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143497|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143498|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
20143499|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143500|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143501|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143502|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20143503|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143504|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143505|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757833|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757834|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
19632002|NCT02444949|Endostar protein|endostar protein|mesh-list
19632003|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632004|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19632005|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19632006|NCT02444949|Growth Substances|growth substances|mesh-ancestor
19632007|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143506|NCT00062322|Irinotecan|irinotecan|mesh-list
20143507|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632008|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
19632009|NCT02445053|Ivacaftor|ivacaftor|mesh-list
19632010|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19632011|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632012|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661592|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19661593|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661594|NCT03522064|Androgens|androgens|mesh-ancestor
19757835|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
19757836|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20143508|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143509|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143510|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143511|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143512|NCT00062426|Leucovorin|leucovorin|mesh-list
20143513|NCT00062426|Bevacizumab|bevacizumab|mesh-list
20143514|NCT00062426|Fluorouracil|fluorouracil|mesh-list
19661595|NCT03522064|Hormones|hormones|mesh-ancestor
19661596|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661597|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661598|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757837|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143515|NCT00062426|Capecitabine|capecitabine|mesh-list
19661599|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
19661600|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
20143516|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
20143517|NCT00062426|Calcium|calcium|mesh-list
19757838|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19757839|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
19757840|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19757841|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
19757842|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757843|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
20143518|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
20314743|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314744|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314745|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20314746|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
20314747|NCT00695201|Irinotecan|irinotecan|mesh-list
19632013|NCT02444767|Bimatoprost|bimatoprost|mesh-list
19632014|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19632015|NCT02444897|Fentanyl|fentanyl|mesh-list
19632016|NCT02444897|Nefopam|nefopam|mesh-list
19632017|NCT02444897|Ramosetron|ramosetron|mesh-list
19632018|NCT02444897|Ropivacaine|ropivacaine|mesh-list
19632019|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
19632020|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
20143519|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143520|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143521|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20143522|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20143523|NCT00062426|Growth Substances|growth substances|mesh-ancestor
19757844|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757845|NCT00005901|Pamidronate|pamidronate|mesh-list
19757846|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19757847|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757848|NCT00005906|Octreotide|octreotide|mesh-list
19757849|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19757850|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20143524|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143525|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
20143526|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20143527|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
19632021|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632022|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314748|NCT00695201|Floxuridine|floxuridine|mesh-list
20314749|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314750|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20314751|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20314752|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314753|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314754|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314755|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
20314756|NCT00695240|Bupivacaine|bupivacaine|mesh-list
20314757|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
20143528|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632023|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
19632024|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632025|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19632026|NCT02444897|Narcotics|narcotics|mesh-ancestor
19632027|NCT02444897|Analgesics|analgesics|mesh-ancestor
19632028|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20143529|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314758|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
20314759|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314760|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314761|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
20314762|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314763|NCT00695331|Misoprostol|misoprostol|mesh-list
20314764|NCT00695331|Oxytocin|oxytocin|mesh-list
20314765|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
20314766|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20314767|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608652|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
19632029|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19632030|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
20608653|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19632031|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
19632032|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
19757851|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608654|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19632033|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19632034|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19632035|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
19632036|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632037|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143530|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143531|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
20143532|NCT00062426|Antidotes|antidotes|mesh-ancestor
20143533|NCT00062426|Protective Agents|protective agents|mesh-ancestor
20143534|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
20143535|NCT00062426|Vitamins|vitamins|mesh-ancestor
20143536|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
20143537|NCT00062478|Camptothecin|camptothecin|mesh-list
20143538|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20143539|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143540|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143541|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143542|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143543|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143544|NCT00062556|Niacin|niacin|mesh-list
20143545|NCT00062556|Lovastatin|lovastatin|mesh-list
20143546|NCT00062556|L 647318|l 647318|mesh-list
20143547|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
20143548|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20143549|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
20143550|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143551|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20143552|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
20143553|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
20143554|NCT00062556|Vitamins|vitamins|mesh-ancestor
20143555|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
20143556|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632038|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632039|NCT02444611|Vaccines|vaccines|mesh-list
19632040|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
19632041|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
19632042|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143557|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20143558|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20143559|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143560|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
20143561|NCT00062595|Vitamin K|vitamin k|mesh-list
20143562|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19757852|NCT00005908|Tamoxifen|tamoxifen|mesh-list
19757853|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
19757854|NCT00005908|Docetaxel|docetaxel|mesh-list
19757855|NCT00005908|Doxorubicin|doxorubicin|mesh-list
19757856|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757857|NCT00005908|Capecitabine|capecitabine|mesh-list
19757858|NCT00005908|Anastrozole|anastrozole|mesh-list
19757859|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757860|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
19757861|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757862|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757863|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757864|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
19757865|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757866|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757867|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20143563|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20143564|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143565|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
19632043|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632044|NCT02444637|Rivastigmine|rivastigmine|mesh-list
19632045|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19632046|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632047|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632048|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
19632049|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632050|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143566|NCT00062595|Coagulants|coagulants|mesh-ancestor
20143567|NCT00062595|Vitamins|vitamins|mesh-ancestor
20143568|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
19757868|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757869|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
20143569|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143570|NCT00062660|Tipranavir|tipranavir|mesh-list
20143571|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20143572|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19757870|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757871|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757872|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757873|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757874|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757875|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143573|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
20143574|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143575|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20143576|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20143577|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20143578|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20143579|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143580|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143581|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143582|NCT00062673|Analgesics|analgesics|mesh-ancestor
20143583|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
20143584|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143585|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
20143586|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20143587|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
20143588|NCT00062686|Lapatinib|lapatinib|mesh-list
20143589|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143590|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143591|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143592|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143593|NCT00062699|Calcitriol|calcitriol|mesh-list
20143594|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20143595|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143596|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20143597|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20143598|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143599|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20143600|NCT00062699|Vitamins|vitamins|mesh-ancestor
20143601|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
20143602|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19757876|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
19757877|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19757878|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
20143603|NCT00062712|Sirolimus|sirolimus|mesh-list
20143604|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20143605|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20143606|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143607|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20143608|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143609|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
19632051|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19632052|NCT02444637|Protective Agents|protective agents|mesh-ancestor
19632053|NCT02444585|Denosumab|denosumab|mesh-list
19632054|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19632055|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143610|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143611|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
19757879|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19757880|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19757881|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19757882|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19757883|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20143612|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143613|NCT00062790|Dutasteride|dutasteride|mesh-list
20143614|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20143615|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20143616|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632056|NCT02444507|Esomeprazole|esomeprazole|mesh-list
19632057|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19632058|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19632059|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19632060|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632061|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757884|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19757885|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19757886|NCT00005937|Cyclosporine|cyclosporine|mesh-list
19757887|NCT00005937|Cyclosporins|cyclosporins|mesh-list
19757888|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19757889|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757890|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757891|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757892|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
19757893|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143617|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143618|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
20143619|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20143620|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143621|NCT00062803|Heparin|heparin|mesh-list
20143622|NCT00062803|Warfarin|warfarin|mesh-list
20143623|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
20143624|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
20143625|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20143626|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20314768|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19632062|NCT02444481|Polymyxins|polymyxins|mesh-list
19632063|NCT02444481|Nystatin|nystatin|mesh-list
19632064|NCT02444481|Neomycin|neomycin|mesh-list
19632065|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19632066|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143627|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143628|NCT00062816|Ribavirin|ribavirin|mesh-list
20143629|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
20143630|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143631|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
20143632|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314769|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
19632067|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
19632068|NCT02444481|Ionophores|ionophores|mesh-ancestor
19632069|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632070|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632071|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19632072|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632073|NCT02444572|Enoxaparin|enoxaparin|mesh-list
19632074|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
19632075|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19632076|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19632077|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632078|NCT02444546|Sargramostim|sargramostim|mesh-list
19632079|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
19632080|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632081|NCT02444559|Clonidine|clonidine|mesh-list
19632082|NCT02444559|Ropivacaine|ropivacaine|mesh-list
19632083|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
19632084|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
19632085|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19757894|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
19757895|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757896|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
19757897|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757898|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19757899|NCT00006011|Paclitaxel|paclitaxel|mesh-list
19757900|NCT00006011|Doxorubicin|doxorubicin|mesh-list
19757901|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757902|NCT00006011|Lenograstim|lenograstim|mesh-list
19757903|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757904|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757905|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757906|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757907|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757908|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757909|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757910|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757911|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757912|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757913|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19757914|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
19757915|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757916|NCT00006046|Antibodies|antibodies|mesh-list
19757917|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19757918|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
19757919|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757920|NCT00006099|Antibodies|antibodies|mesh-list
20143633|NCT00062842|Irinotecan|irinotecan|mesh-list
20143634|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143635|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143636|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143637|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143638|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173738|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173739|NCT00162526|Protective Agents|protective agents|mesh-ancestor
20173740|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173741|NCT00162526|Vitamins|vitamins|mesh-ancestor
20173742|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
20173743|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
20173744|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20173745|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173746|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173747|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19757921|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19757922|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
19757923|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757924|NCT00006101|Eflornithine|eflornithine|mesh-list
19757925|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173748|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20173749|NCT00162552|Protective Agents|protective agents|mesh-ancestor
20173750|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173751|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
20173752|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20173753|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
20173754|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20173755|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20173756|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
20173757|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173758|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173759|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173760|NCT00162591|Remifentanil|remifentanil|mesh-list
20173761|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20173762|NCT00162591|Narcotics|narcotics|mesh-ancestor
20173763|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19757926|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19757927|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19632086|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632087|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
19632088|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19757928|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19757929|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757930|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19757931|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757932|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757933|NCT00006110|Paclitaxel|paclitaxel|mesh-list
19757934|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
20173764|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173765|NCT00162591|Analgesics|analgesics|mesh-ancestor
20173766|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
20173767|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173768|NCT00162604|Cefuroxime|cefuroxime|mesh-list
20173769|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
20173770|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20173771|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173772|NCT00162643|Ritonavir|ritonavir|mesh-list
20173773|NCT00162643|Lopinavir|lopinavir|mesh-list
19632089|NCT02444559|Analgesics|analgesics|mesh-ancestor
19632090|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19632091|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
19632092|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
19632093|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20173774|NCT00162643|Lamivudine|lamivudine|mesh-list
20173775|NCT00162643|Zidovudine|zidovudine|mesh-list
20173776|NCT00162643|Efavirenz|efavirenz|mesh-list
20173777|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20173778|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20173779|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
20173780|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173781|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173782|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20173783|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20173784|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
20173785|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757935|NCT00006110|Doxorubicin|doxorubicin|mesh-list
20314770|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20143639|NCT00062881|Mafosfamide|mafosfamide|mesh-list
20143640|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19757936|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19757937|NCT00006110|Trastuzumab|trastuzumab|mesh-list
19757938|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19757939|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757940|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
19757941|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19757942|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19757943|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757944|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757945|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
19757946|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143641|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
20143642|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143643|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143644|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
20143645|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314771|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314772|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
20314773|NCT00695344|Everolimus|everolimus|mesh-list
20314774|NCT00695344|Azathioprine|azathioprine|mesh-list
20143646|NCT00062946|Fallypride|fallypride|mesh-list
20143647|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20143648|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20143649|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
20143650|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143651|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143652|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143653|NCT00062972|Donepezil|donepezil|mesh-list
20143654|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20143655|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143656|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143657|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
20143658|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143659|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143660|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
20143661|NCT00063011|Calcium|calcium|mesh-list
20143662|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20143663|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143664|NCT00063024|Calcium|calcium|mesh-list
20143665|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20143666|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143667|NCT00063076|Bexarotene|bexarotene|mesh-list
20143668|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143669|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
20143670|NCT00063089|Antibodies|antibodies|mesh-list
20143671|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
20143672|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20143673|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20143674|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
20143675|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143676|NCT00063128|Insulin|insulin|mesh-list
20143677|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20143678|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20143679|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143680|NCT00063141|Irinotecan|irinotecan|mesh-list
20143681|NCT00063141|Cetuximab|cetuximab|mesh-list
20143682|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143683|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20314775|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632094|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19632095|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19632096|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
19632097|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632098|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632099|NCT03840239|Capecitabine|capecitabine|mesh-list
19632100|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
19632101|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632102|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
20143684|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632103|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143685|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143686|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314776|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314777|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
20143687|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143688|NCT00063193|Minocycline|minocycline|mesh-list
20314778|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314779|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20314780|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20143689|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20143690|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143691|NCT00063310|Leuprolide|leuprolide|mesh-list
20143692|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20143693|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
20143694|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20143695|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143696|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20143697|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143698|NCT00063323|Bupropion|bupropion|mesh-list
20143699|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20143700|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
20143701|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20143702|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20143703|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20143704|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19757947|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757948|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19757949|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
19757950|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19757951|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19757952|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19757953|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19757954|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757955|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19757956|NCT00006164|Ribavirin|ribavirin|mesh-list
19757957|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19757958|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
19757959|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
19757960|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757961|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
20143705|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143706|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
20143707|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143708|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143709|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20143710|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20143711|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143712|NCT00063388|Cetuximab|cetuximab|mesh-list
20143713|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143714|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143715|NCT00063401|Paclitaxel|paclitaxel|mesh-list
20143716|NCT00063401|Carboplatin|carboplatin|mesh-list
20143717|NCT00063401|Cetuximab|cetuximab|mesh-list
20143718|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20143719|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143720|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
20143721|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
20143722|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
20143723|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143724|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143725|NCT00063414|Alicaforsen|alicaforsen|mesh-list
20143726|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20143727|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143728|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
20143729|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143730|NCT00063453|Vitamins|vitamins|mesh-list
20143731|NCT00063453|Vitamin E|vitamin e|mesh-list
20143732|NCT00063453|Tocopherols|tocopherols|mesh-list
20143733|NCT00063453|Tocotrienols|tocotrienols|mesh-list
20143734|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
20143735|NCT00063453|Selenium|selenium|mesh-list
20143736|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
20143737|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143738|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
20143739|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314781|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
20143740|NCT00063453|Protective Agents|protective agents|mesh-ancestor
20143741|NCT00063453|Trace Elements|trace elements|mesh-ancestor
19757962|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19757963|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
19757964|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757965|NCT00006170|Bupropion|bupropion|mesh-list
19757966|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20143742|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
20143743|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20143744|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143745|NCT00063583|Pirfenidone|pirfenidone|mesh-list
20143746|NCT00063583|Analgesics|analgesics|mesh-ancestor
20143747|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
20143748|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143749|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143750|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20143751|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143752|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143753|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143754|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143755|NCT00063596|Vitamin A|vitamin a|mesh-list
20143756|NCT00063596|Vitamins|vitamins|mesh-ancestor
20143757|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
19757967|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
19757968|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19757969|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19757970|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19757971|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19757972|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757973|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
19757974|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19757975|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757976|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19757977|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19757978|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757979|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19757980|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
19757981|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757982|NCT05347641|Cytarabine|cytarabine|mesh-list
19757983|NCT05347641|Methotrexate|methotrexate|mesh-list
19757984|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19757985|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
19757986|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19757987|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19757988|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19757989|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
19757990|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19757991|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19757992|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
19757993|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19757994|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
19757995|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19757996|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19757997|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19757998|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19757999|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
19758000|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833005|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833006|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833007|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833008|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833009|NCT01583322|Nintedanib|nintedanib|mesh-list
19833010|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833011|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19833012|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833013|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833014|NCT01571128|Tenofovir|tenofovir|mesh-list
19833015|NCT01571128|Emtricitabine|emtricitabine|mesh-list
19833016|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
19833017|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833018|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19833019|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19833020|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833021|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608655|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143758|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143759|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
19758001|NCT05347498|Febuxostat|febuxostat|mesh-list
19758002|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
19758003|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758004|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19758005|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
19758006|NCT05347459|Empagliflozin|empagliflozin|mesh-list
19758007|NCT05347459|Linagliptin|linagliptin|mesh-list
19758008|NCT05347459|Vildagliptin|vildagliptin|mesh-list
19758009|NCT05347459|Saxagliptin|saxagliptin|mesh-list
19758010|NCT05347459|Canagliflozin|canagliflozin|mesh-list
19758011|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19758012|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758013|NCT05347459|Incretins|incretins|mesh-ancestor
19758014|NCT05347459|Hormones|hormones|mesh-ancestor
19758015|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758016|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19758017|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
20314782|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314783|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314784|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314785|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314786|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
19758018|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758019|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758020|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19758021|NCT05347381|Dexamethasone|dexamethasone|mesh-list
19758022|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758023|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
19758024|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
19758025|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143760|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20143761|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143762|NCT00063687|Oxypurinol|oxypurinol|mesh-list
20143763|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143764|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143765|NCT00063713|Bortezomib|bortezomib|mesh-list
20143766|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143767|NCT00063726|Bortezomib|bortezomib|mesh-list
20143768|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143769|NCT00063791|Bortezomib|bortezomib|mesh-list
20143770|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143771|NCT00063804|Ritonavir|ritonavir|mesh-list
20143772|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20143773|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20143774|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
20143775|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632104|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632105|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
20143776|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758026|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758027|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758028|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
19758029|NCT05347381|Hormones|hormones|mesh-ancestor
19758030|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20143777|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20143778|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19632106|NCT03810911|Hematinics|hematinics|mesh-ancestor
19632107|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
19632108|NCT03808025|Narcotics|narcotics|mesh-ancestor
19632109|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632110|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632111|NCT03808025|Analgesics|analgesics|mesh-ancestor
19632112|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
19632113|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632114|NCT03757715|Dexamethasone|dexamethasone|mesh-list
19632115|NCT03757715|Bupivacaine|bupivacaine|mesh-list
19632116|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632117|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
19632118|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
19632119|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632120|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758031|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19758032|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758033|NCT05347238|Dopamine|dopamine|mesh-list
19758034|NCT05347238|Norepinephrine|norepinephrine|mesh-list
20143779|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
20143780|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143781|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20143782|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20143783|NCT00063830|Alicaforsen|alicaforsen|mesh-list
20143784|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20143785|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143786|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
20143787|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143788|NCT00063869|Etanercept|etanercept|mesh-list
20143789|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20143790|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143791|NCT00063869|Analgesics|analgesics|mesh-ancestor
20143792|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
20143793|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143794|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143795|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143796|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143797|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20143798|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143799|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
20314787|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314788|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20314789|NCT00695604|Fluticasone|fluticasone|mesh-list
20314790|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314791|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20143800|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20143801|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143802|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143803|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143804|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143805|NCT00063947|Gemcitabine|gemcitabine|mesh-list
20143806|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20143807|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143808|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
20143809|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143810|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143811|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
20143812|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143813|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143814|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632121|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19632122|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
19632123|NCT03757715|Hormones|hormones|mesh-ancestor
19632124|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632125|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19632126|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758035|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20143815|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
20143816|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143817|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143818|NCT00063960|Irinotecan|irinotecan|mesh-list
20143819|NCT00063960|Floxuridine|floxuridine|mesh-list
19758036|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19758037|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
19758038|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758039|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758040|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758041|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
20143820|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143821|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143822|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143823|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143824|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143825|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143826|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
20143827|NCT00064012|Docetaxel|docetaxel|mesh-list
20143828|NCT00064012|Bortezomib|bortezomib|mesh-list
20143829|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143830|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
20143831|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
20143832|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
20143833|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758042|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
19758043|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758044|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19758045|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19758046|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
19758047|NCT05347238|Protective Agents|protective agents|mesh-ancestor
19758048|NCT05347212|Nivolumab|nivolumab|mesh-list
19758049|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758050|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758051|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19758052|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758053|NCT05347160|Calcium|calcium|mesh-list
19758054|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20143834|NCT00064051|Gemcitabine|gemcitabine|mesh-list
20143835|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143836|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
20143837|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143838|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143839|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
20143840|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143841|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143842|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143843|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
20143844|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143845|NCT00064064|Gemcitabine|gemcitabine|mesh-list
20143846|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758055|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758056|NCT05347134|Gemcitabine|gemcitabine|mesh-list
20143847|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
20143848|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143849|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143850|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
20143851|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143852|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143853|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143854|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
20143855|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143856|NCT00064090|Cytarabine|cytarabine|mesh-list
20143857|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143858|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
20143859|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143860|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143861|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
20143862|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143863|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143864|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
19758057|NCT05347134|Capecitabine|capecitabine|mesh-list
19758058|NCT05347134|Vinorelbine|vinorelbine|mesh-list
19758059|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758060|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
19758061|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758062|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758063|NCT05347134|Antiviral Agents|antiviral agents|mesh-ancestor
19758064|NCT05347134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758065|NCT05347134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758066|NCT05347134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143865|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143866|NCT00064116|Rituximab|rituximab|mesh-list
20143867|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143868|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143869|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
20143870|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143871|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143872|NCT00064129|Ipilimumab|ipilimumab|mesh-list
20143873|NCT00064129|Sargramostim|sargramostim|mesh-list
20143874|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143875|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143876|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20143877|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143878|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
20143879|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143880|NCT00064142|Halofuginone|halofuginone|mesh-list
20143881|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314792|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
20314793|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314794|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314795|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20314796|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
20314797|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
20143882|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
20314798|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20314799|NCT00695630|Flumazenil|flumazenil|mesh-list
19758067|NCT05347134|Immunologic Factors|immunologic factors|mesh-ancestor
19758068|NCT05347134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758069|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19758070|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758071|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758072|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758073|NCT05346952|Carboplatin|carboplatin|mesh-list
19758074|NCT05346952|Pemetrexed|pemetrexed|mesh-list
19758075|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758076|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758077|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758078|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20143883|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20143884|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20143885|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143886|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20143887|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143888|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143889|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20143890|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20143891|NCT00064142|Growth Substances|growth substances|mesh-ancestor
20143892|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143893|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
20143894|NCT00064181|Leucovorin|leucovorin|mesh-list
20143895|NCT00064181|Celecoxib|celecoxib|mesh-list
20143896|NCT00064181|Fluorouracil|fluorouracil|mesh-list
20143897|NCT00064181|Capecitabine|capecitabine|mesh-list
20143898|NCT00064181|Irinotecan|irinotecan|mesh-list
20143899|NCT00064181|Calcium|calcium|mesh-list
20143900|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
20143901|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20314800|NCT00695630|Antidotes|antidotes|mesh-ancestor
20314801|NCT00695630|Protective Agents|protective agents|mesh-ancestor
20314802|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314803|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
20314804|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
20314805|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314806|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143902|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143903|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
20143904|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143905|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143906|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143907|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143908|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
20143909|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20143910|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20143911|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143912|NCT00064181|Antidotes|antidotes|mesh-ancestor
20143913|NCT00064181|Protective Agents|protective agents|mesh-ancestor
20143914|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
20143915|NCT00064181|Vitamins|vitamins|mesh-ancestor
20143916|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
20143917|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20143918|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20143919|NCT00064181|Analgesics|analgesics|mesh-ancestor
20143920|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
20143921|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143922|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20143923|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143924|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20143925|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20143926|NCT00064194|Vitamin E|vitamin e|mesh-list
20143927|NCT00064194|Selenium|selenium|mesh-list
20143928|NCT00064194|Vitamins|vitamins|mesh-ancestor
20143929|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
20143930|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314807|NCT00695643|Mesalamine|mesalamine|mesh-list
20143931|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
20143932|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143933|NCT00064194|Protective Agents|protective agents|mesh-ancestor
20143934|NCT00064194|Trace Elements|trace elements|mesh-ancestor
20143935|NCT00064207|Gemcitabine|gemcitabine|mesh-list
20143936|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20143937|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
20143938|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143939|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143940|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
20143941|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20143942|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143943|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20143944|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
20143945|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143946|NCT00064220|Soblidotin|soblidotin|mesh-list
20143947|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143948|NCT00064233|Dasatinib|dasatinib|mesh-list
20143949|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20143950|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143951|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143952|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143953|NCT00064246|Rituximab|rituximab|mesh-list
20143954|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20143955|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20143956|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314808|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20314809|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20314810|NCT00695643|Analgesics|analgesics|mesh-ancestor
20314811|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
20314812|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314813|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314814|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314815|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20314816|NCT00695682|Infliximab|infliximab|mesh-list
20314817|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
20314818|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314819|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20314820|NCT00695929|Simendan|simendan|mesh-list
20314821|NCT00695929|Milrinone|milrinone|mesh-list
20314822|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20314823|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
20314824|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20314825|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20143957|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
20143958|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143959|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20143960|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
20143961|NCT00064285|Alvocidib|alvocidib|mesh-list
20143962|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314826|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314827|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314828|NCT00695929|Protective Agents|protective agents|mesh-ancestor
20143963|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20143964|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20143965|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143966|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
20143967|NCT00064285|Growth Substances|growth substances|mesh-ancestor
20143968|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143969|NCT00064389|Albuterol|albuterol|mesh-list
20143970|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20143971|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
20143972|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143973|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143974|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20143975|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
20143976|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
20143977|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20143978|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20314829|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314830|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20314831|NCT00695994|Gemcitabine|gemcitabine|mesh-list
19758079|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20143979|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20143980|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20143981|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
20143982|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143983|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143984|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20143985|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
20143986|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20143987|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20143988|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
20143989|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20143990|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20143991|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20143992|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
19758080|NCT05346926|Calpastatin|calpastatin|mesh-list
19758081|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19758082|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
19758083|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758084|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758085|NCT05346861|Trastuzumab|trastuzumab|mesh-list
19758086|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758087|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758088|NCT05346731|Dexamethasone|dexamethasone|mesh-list
19758089|NCT05346731|Ondansetron|ondansetron|mesh-list
19758090|NCT05346731|Olanzapine|olanzapine|mesh-list
20143993|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20143994|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20143995|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20314832|NCT00695994|Carboplatin|carboplatin|mesh-list
20314833|NCT00695994|Docetaxel|docetaxel|mesh-list
20314834|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314835|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314836|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
19632127|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
19632128|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
19632129|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314837|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758091|NCT05346731|Aprepitant|aprepitant|mesh-list
19758092|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758093|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
19758094|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
19758095|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758096|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758097|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758098|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
19758099|NCT05346731|Hormones|hormones|mesh-ancestor
19758100|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758101|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19758102|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758103|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
19758104|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
19758105|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19758106|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
19758107|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758108|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758109|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19758110|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19758111|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758112|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19758113|NCT05346731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19632130|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
19758114|NCT05346731|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19758115|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19758116|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19758117|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19758118|NCT05346666|Midazolam|midazolam|mesh-list
19758119|NCT05346666|Phenobarbital|phenobarbital|mesh-list
19758120|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19758121|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19758122|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632131|NCT03737604|Bupivacaine|bupivacaine|mesh-list
19632132|NCT03737604|Ropivacaine|ropivacaine|mesh-list
19632133|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
19632134|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
19632135|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632136|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632137|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
20143996|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
20143997|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20143998|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20143999|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
20144000|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20144001|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20144002|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
20144003|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144004|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144005|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20144006|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
20144007|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20144008|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20144009|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20144010|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
20144011|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144012|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144013|NCT00064428|PENTA|penta|mesh-list
20144014|NCT00064428|Fondaparinux|fondaparinux|mesh-list
20144015|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19758123|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758124|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19758125|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19758126|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19758127|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19758128|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
20144016|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
20144017|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20144018|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
20144019|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144020|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144021|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
20314838|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
20314839|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314840|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314841|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144022|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20144023|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20144024|NCT00064467|Bupropion|bupropion|mesh-list
20144025|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19632138|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632139|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19632140|NCT03651804|Acetaminophen|acetaminophen|mesh-list
19632141|NCT03651804|Diphosphonates|diphosphonates|mesh-list
20144026|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
20144027|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144028|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20144029|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20144030|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144031|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144032|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
20144033|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144034|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144035|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20144036|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20144037|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173786|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20173787|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20173788|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20173789|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20314842|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
20314843|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314844|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
20314845|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
19632142|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19632143|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19632144|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632145|NCT03651804|Analgesics|analgesics|mesh-ancestor
19632146|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
19632147|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314846|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
20314847|NCT00696007|Gemcitabine|gemcitabine|mesh-list
20314848|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758129|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
20144038|NCT00064610|Bortezomib|bortezomib|mesh-list
20144039|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314849|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314850|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
20314851|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144040|NCT00064623|Capsaicin|capsaicin|mesh-list
20144041|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
20144042|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
20144043|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
20144044|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144045|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144046|NCT00064636|Bortezomib|bortezomib|mesh-list
20144047|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144048|NCT00064649|Finasteride|finasteride|mesh-list
20144049|NCT00064649|Alfuzosin|alfuzosin|mesh-list
20144050|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20144051|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20144052|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144053|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144054|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144055|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144056|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632148|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632149|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
19632150|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19632151|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632152|NCT03608163|Diazoxide|diazoxide|mesh-list
19632153|NCT03608163|Naloxone|naloxone|mesh-list
19632154|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19632155|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632156|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
19632157|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632158|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19632159|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
19632160|NCT03578367|Niacinamide|niacinamide|mesh-list
19632161|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
19632162|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632163|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19632164|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632165|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632166|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
19632167|NCT03578367|Vitamins|vitamins|mesh-ancestor
19632168|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
19632169|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632170|NCT03578198|Rituximab|rituximab|mesh-list
20144057|NCT00064649|Urological Agents|urological agents|mesh-ancestor
20314852|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
20144058|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20144059|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20144060|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20144061|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20144062|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144063|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
20144064|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20144065|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144066|NCT00064766|Doxycycline|doxycycline|mesh-list
20144067|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20144068|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144069|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
20144070|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19758130|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
19758131|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
19758132|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758133|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144071|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20144072|NCT00064857|Pycnogenols|pycnogenols|mesh-list
20144073|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20144074|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
20144075|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144076|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
20144077|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144078|NCT00064857|Protective Agents|protective agents|mesh-ancestor
19632171|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632172|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144079|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20144080|NCT00064974|Lenalidomide|lenalidomide|mesh-list
19758134|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
19758135|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19758136|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19758137|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19758138|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19758139|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19758140|NCT05346601|Chiauranib|chiauranib|mesh-list
19758141|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758142|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19758143|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758144|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144081|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
20144082|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144083|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20144084|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20144085|NCT00064974|Growth Substances|growth substances|mesh-ancestor
19758145|NCT05346588|Propofol|propofol|mesh-list
19758146|NCT05346588|Anesthetics|anesthetics|mesh-list
19758147|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19758148|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758149|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758150|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20144086|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
20144087|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144088|NCT00065117|Leucovorin|leucovorin|mesh-list
20144089|NCT00065117|Fluorouracil|fluorouracil|mesh-list
20144090|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
20314853|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314854|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758151|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
19758152|NCT05346562|Cannabidiol|cannabidiol|mesh-list
19758153|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
19758154|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
19758155|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758156|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758157|NCT05346445|Fluoxetine|fluoxetine|mesh-list
19758158|NCT05346445|Citalopram|citalopram|mesh-list
19758159|NCT05346445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19758160|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19758161|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19758162|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758163|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758164|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
19758165|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758166|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19758167|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
19758168|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19758169|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19758170|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19758171|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758172|NCT05346419|Vitamin D|vitamin d|mesh-list
19758173|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
19758174|NCT05346419|Vitamins|vitamins|mesh-ancestor
19758175|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
20144091|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
20144092|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144093|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20144094|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144095|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144096|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
20144097|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758176|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758177|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19758178|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19758179|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19758180|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758181|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19758182|NCT05346354|Ravulizumab|ravulizumab|mesh-list
20144098|NCT00065117|Antidotes|antidotes|mesh-ancestor
20144099|NCT00065117|Protective Agents|protective agents|mesh-ancestor
20144100|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
19758183|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20144101|NCT00065117|Vitamins|vitamins|mesh-ancestor
20144102|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
20144103|NCT00065130|Insulin|insulin|mesh-list
20144104|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20144105|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
20144106|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
20144107|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
20144108|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
19758184|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758185|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
19758186|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758187|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19758188|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
19758189|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758190|NCT05346211|Curcumin|curcumin|mesh-list
19758191|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19758192|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19758193|NCT05346211|Analgesics|analgesics|mesh-ancestor
19758194|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
19758195|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758196|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144109|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20144110|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144111|NCT00065143|Clofarabine|clofarabine|mesh-list
20144112|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20144113|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
20144114|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144115|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144116|NCT00065169|Celecoxib|celecoxib|mesh-list
20144117|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20144118|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20144119|NCT00065169|Analgesics|analgesics|mesh-ancestor
20144120|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
20144121|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144122|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144123|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20144124|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144125|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20144126|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20144127|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144128|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144129|NCT00065273|Olanzapine|olanzapine|mesh-list
20144130|NCT00065273|Risperidone|risperidone|mesh-list
20144131|NCT00065273|Clozapine|clozapine|mesh-list
20144132|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19758197|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758198|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758199|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758200|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758201|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758202|NCT05346159|Androgens|androgens|mesh-list
19758203|NCT05346159|Hormones|hormones|mesh-ancestor
19758204|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758205|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758206|NCT05346146|Gemcitabine|gemcitabine|mesh-list
19758207|NCT05346146|Paclitaxel|paclitaxel|mesh-list
20144133|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
20144134|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144135|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758208|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19758209|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758210|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758211|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758212|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
19833022|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20144136|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144137|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20144138|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20144139|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20314855|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20314856|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
20314857|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314858|NCT00696033|Diazepam|diazepam|mesh-list
20314859|NCT00696033|Lorazepam|lorazepam|mesh-list
20144140|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144141|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20144142|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
20314860|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
20314861|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
20314862|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
20144143|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
20144144|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
20144145|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144146|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144147|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20144148|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20144149|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144150|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
20314863|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314864|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314865|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20314866|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20314867|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20144151|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
20144152|NCT00065325|Fulvestrant|fulvestrant|mesh-list
20144153|NCT00065325|Exemestane|exemestane|mesh-list
20144154|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20144155|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314868|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20314869|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20314870|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144156|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20144157|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20144158|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144159|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144160|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314871|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
20314872|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
19632173|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
19632174|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144161|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20144162|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20144163|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144164|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144165|NCT00065351|Lenalidomide|lenalidomide|mesh-list
20144166|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
20144167|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144168|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20144169|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20144170|NCT00065351|Growth Substances|growth substances|mesh-ancestor
20144171|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
20144172|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144173|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
20144174|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
20144175|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20144176|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20144177|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144178|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20144179|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144180|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632175|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632176|NCT03575793|Nivolumab|nivolumab|mesh-list
19632177|NCT03575793|Ipilimumab|ipilimumab|mesh-list
19632178|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632179|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144181|NCT00065455|Vitamin A|vitamin a|mesh-list
20144182|NCT00065455|Vitamins|vitamins|mesh-ancestor
20144183|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
20144184|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144185|NCT00065533|Pemetrexed|pemetrexed|mesh-list
20144186|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144187|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144188|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144189|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20144190|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20144191|NCT00065546|Choline|choline|mesh-list
20144192|NCT00065546|Estrogens|estrogens|mesh-list
20144193|NCT00065546|Hormones|hormones|mesh-ancestor
20144194|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144195|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144196|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
19632180|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20314873|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144197|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20144198|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
20144199|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144200|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144201|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20144202|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
20144203|NCT00065559|Celecoxib|celecoxib|mesh-list
20144204|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20144205|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20144206|NCT00065559|Analgesics|analgesics|mesh-ancestor
20144207|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
20144208|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144209|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144210|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20144211|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144212|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20144213|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20144214|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144215|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144216|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
20144217|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
20144218|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144219|NCT00065624|Protective Agents|protective agents|mesh-ancestor
20144220|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632181|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632182|NCT03572283|Bethanechol|bethanechol|mesh-list
19632183|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19632184|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
19632185|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632186|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632187|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19632188|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19632189|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
20144221|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
20144222|NCT00065624|Vitamins|vitamins|mesh-ancestor
20144223|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
20144224|NCT00065637|Teriparatide|teriparatide|mesh-list
20144225|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144226|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144227|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20144228|NCT00065741|Silymarin|silymarin|mesh-list
20144229|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
20144230|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632190|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758213|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758214|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758215|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
19758216|NCT05346146|Antiviral Agents|antiviral agents|mesh-ancestor
19758217|NCT05346146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758218|NCT05346146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758219|NCT05346146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758220|NCT05346146|Immunologic Factors|immunologic factors|mesh-ancestor
19758221|NCT05346146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758222|NCT05346107|Paclitaxel|paclitaxel|mesh-list
19758223|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
19758224|NCT05346107|Doxorubicin|doxorubicin|mesh-list
19758225|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19758226|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19758227|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758228|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758229|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758230|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758231|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758232|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758233|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
19758234|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758235|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758236|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19758237|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
19758238|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19758239|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19758240|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19758241|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19758242|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758243|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
20144231|NCT00065741|Protective Agents|protective agents|mesh-ancestor
20144232|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144233|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20144234|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20144235|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144236|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144237|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144238|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20144239|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20144240|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20144241|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
20144242|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20144243|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144244|NCT00065884|Valproic Acid|valproic acid|mesh-list
20144245|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
20144246|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144247|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144248|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
20144249|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144250|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144251|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
20144252|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20144253|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20144254|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19758244|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19758245|NCT05345990|Antibodies|antibodies|mesh-list
19758246|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
19758247|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758248|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
19758249|NCT05345938|Analgesics|analgesics|mesh-ancestor
19758250|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
19758251|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758252|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758253|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758254|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19758255|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19758256|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758257|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758258|NCT05345899|Ascorbic Acid|ascorbic acid|mesh-list
19758259|NCT05345899|Vitamins|vitamins|mesh-ancestor
19758260|NCT05345899|Micronutrients|micronutrients|mesh-ancestor
19758261|NCT05345899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758262|NCT05345899|Antioxidants|antioxidants|mesh-ancestor
19758263|NCT05345899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758264|NCT05345899|Protective Agents|protective agents|mesh-ancestor
19758265|NCT05345808|Triamcinolone|triamcinolone|mesh-list
19758266|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19758267|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19758268|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19758269|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758270|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
19758271|NCT05345808|Hormones|hormones|mesh-ancestor
19758272|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758273|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758274|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758275|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
19758276|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758277|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758278|NCT05345782|Bupivacaine|bupivacaine|mesh-list
19758279|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
19758280|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
19758281|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758282|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758283|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
20144255|NCT00065923|Topiramate|topiramate|mesh-list
20144256|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
20144257|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20144258|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144259|NCT00065936|Naltrexone|naltrexone|mesh-list
20144260|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20144261|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19758284|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833023|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19833024|NCT01429168|Etoricoxib|etoricoxib|mesh-list
20144262|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144263|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
20144264|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144265|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
20144266|NCT00065949|Analgesics|analgesics|mesh-ancestor
20144267|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
20144268|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144269|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144270|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
20144271|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758285|NCT05345678|Durvalumab|durvalumab|mesh-list
19758286|NCT05345678|Tremelimumab|tremelimumab|mesh-list
19758287|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20144272|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20144273|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
20144274|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20144275|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144276|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144277|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144278|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
20144279|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20144280|NCT00065962|Secretin|secretin|mesh-list
20144281|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144282|NCT00065962|Hormones|hormones|mesh-ancestor
20144283|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144284|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144285|NCT00066001|Metronidazole|metronidazole|mesh-list
20144286|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144287|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20144288|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20144289|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20144290|NCT00066027|Doxycycline|doxycycline|mesh-list
20144291|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20144292|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144293|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
20144294|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19758288|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758289|NCT05345639|Ropivacaine|ropivacaine|mesh-list
19758290|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
19758291|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758292|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758293|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
19758294|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
19758295|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758296|NCT05345613|Epinephrine|epinephrine|mesh-list
19758297|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
20144295|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20144296|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
20144297|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
20144298|NCT00066040|Fluorides|fluorides|mesh-list
20144299|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
20144300|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
20144301|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
20144302|NCT00066040|Protective Agents|protective agents|mesh-ancestor
20144303|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144304|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20144305|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144306|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
20144307|NCT00066092|Lenograstim|lenograstim|mesh-list
20144308|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20144309|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
20144310|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144311|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20144312|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20144313|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20144314|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
20144315|NCT00066157|Estradiol|estradiol|mesh-list
20144316|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20144317|NCT00066157|Estrogens|estrogens|mesh-list
20144318|NCT00066157|Progesterone|progesterone|mesh-list
20144319|NCT00066157|Hormones|hormones|mesh-ancestor
20144320|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144321|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144322|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20144323|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
20144324|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20144325|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20144326|NCT00066157|Progestins|progestins|mesh-ancestor
20144327|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20144328|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20144329|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20144330|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20144331|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20144332|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144333|NCT00066196|Dacarbazine|dacarbazine|mesh-list
20144334|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20144335|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
20144336|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144337|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173790|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
20173791|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20173792|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20173793|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20173794|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20173795|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20173796|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
20173797|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173798|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
20173799|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173800|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758298|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19758299|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19758300|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
19758301|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758302|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758303|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758304|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19758305|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19758306|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
19758307|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758308|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19758309|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
19758310|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
19758311|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
19758312|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19758313|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19758314|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19758315|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
19758316|NCT05345613|Coagulants|coagulants|mesh-ancestor
19758317|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
19758318|NCT05345574|Remifentanil|remifentanil|mesh-list
19758319|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19758320|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758321|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758322|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19758323|NCT05345574|Analgesics|analgesics|mesh-ancestor
19758324|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
19758325|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758326|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19758327|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19758328|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19758329|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
19758330|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758331|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758332|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19758333|NCT05345574|Narcotics|narcotics|mesh-ancestor
19758334|NCT05345509|Donepezil|donepezil|mesh-list
19758335|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19758336|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758337|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758338|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
19758339|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758340|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758341|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
19758342|NCT05345457|Amoxicillin|amoxicillin|mesh-list
19758343|NCT05345457|Azithromycin|azithromycin|mesh-list
19758344|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19758345|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758346|NCT05343117|Palbociclib|palbociclib|mesh-list
19758347|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758348|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19758349|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758350|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758351|NCT05334433|Anesthetics|anesthetics|mesh-list
20144338|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
20144339|NCT00066248|Megestrol|megestrol|mesh-list
20144340|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
20144341|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20144342|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20144343|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20144344|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
20144345|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20144346|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144347|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20144348|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20144349|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20144350|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144351|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
20144352|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20144353|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
20144354|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
20144355|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144356|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20144357|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
20144358|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
20144359|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144360|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144361|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20144362|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
20144363|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20144364|NCT00066274|Leucovorin|leucovorin|mesh-list
20144365|NCT00066274|Fluorouracil|fluorouracil|mesh-list
19632191|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632192|NCT03512197|Midostaurin|midostaurin|mesh-list
19632193|NCT03512197|Staurosporine|staurosporine|mesh-list
20144366|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
20144367|NCT00066274|Irinotecan|irinotecan|mesh-list
20144368|NCT00066274|Calcium|calcium|mesh-list
20144369|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
20144370|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144371|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144372|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
20144373|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144374|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314874|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632194|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632195|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19632196|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632197|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632198|NCT03471611|Sargramostim|sargramostim|mesh-list
20144375|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144376|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144377|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
20144378|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19758352|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758353|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632199|NCT03471611|Lenograstim|lenograstim|mesh-list
20144379|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20144380|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144381|NCT00066274|Antidotes|antidotes|mesh-ancestor
20144382|NCT00066274|Protective Agents|protective agents|mesh-ancestor
20144383|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
20144384|NCT00066274|Vitamins|vitamins|mesh-ancestor
19632200|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
19758354|NCT05334056|Cocaine|cocaine|mesh-list
19758355|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
19758356|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
19758357|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20144385|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
20144386|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
20144387|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144388|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20144389|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144390|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758358|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758359|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
19758360|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758361|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19758362|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19758363|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19758364|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19758365|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758366|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
19758367|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758368|NCT05333549|Istradefylline|istradefylline|mesh-list
19758369|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
19758370|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19758371|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19758372|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
19758373|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758374|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758375|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758376|NCT05333458|Atezolizumab|atezolizumab|mesh-list
19758377|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19758378|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758379|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
19758380|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758381|NCT05326373|Fluorides|fluorides|mesh-list
19758382|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
19758383|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
19758384|NCT05326373|Protective Agents|protective agents|mesh-ancestor
19758385|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758386|NCT05320133|Bismuth|bismuth|mesh-list
19758387|NCT05320133|Antacids|antacids|mesh-ancestor
19758388|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758389|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758390|NCT05315336|Antibodies|antibodies|mesh-list
20144391|NCT00066339|Gefitinib|gefitinib|mesh-list
20144392|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144393|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20144394|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758391|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
19758392|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144395|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144396|NCT00066352|Bortezomib|bortezomib|mesh-list
20144397|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144398|NCT00066378|Gefitinib|gefitinib|mesh-list
19632201|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144399|NCT00066378|Anastrozole|anastrozole|mesh-list
20144400|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144401|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20144402|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144403|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144404|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20144405|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20144406|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20144407|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20144408|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144409|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144410|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144411|NCT00066391|Irinotecan|irinotecan|mesh-list
20144412|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144413|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20144414|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20144415|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632202|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632203|NCT03388788|CGP 12177|cgp 12177|mesh-list
19632204|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19632205|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19632206|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
19632207|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632208|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632209|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632210|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19632211|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19632212|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
20144416|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144417|NCT00066417|Cyclosporine|cyclosporine|mesh-list
20144418|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
20144419|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
20144420|NCT00066417|Thiotepa|thiotepa|mesh-list
20144421|NCT00066417|Fludarabine|fludarabine|mesh-list
20144422|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
20144423|NCT00066417|Cyclosporins|cyclosporins|mesh-list
20144424|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144425|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
20144426|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144427|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144428|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20144429|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
20144430|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144431|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144432|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20144433|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758393|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19758394|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19758395|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
19758396|NCT05294835|Ketamine|ketamine|mesh-list
19758397|NCT05294835|Analgesics|analgesics|mesh-ancestor
19758398|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
19758399|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758400|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758401|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19758402|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19758403|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
19758404|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
19758405|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758406|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19758407|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19758408|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758409|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758410|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19758411|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
19758412|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19758413|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20314875|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20314876|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20314877|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20314878|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20314879|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
20314880|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
20314881|NCT00696059|Adalimumab|adalimumab|mesh-list
20314882|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314883|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20314884|NCT00696098|Butyric Acid|butyric acid|mesh-list
20314885|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
20314886|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
20314887|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314888|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314889|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314890|NCT00696111|Leuprolide|leuprolide|mesh-list
20314891|NCT00696111|Progesterone|progesterone|mesh-list
20314892|NCT00696111|Estrogens|estrogens|mesh-list
20314893|NCT00696111|Progestins|progestins|mesh-ancestor
19758414|NCT05292755|Laxatives|laxatives|mesh-ancestor
19758415|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144434|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
20144435|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144436|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
20144437|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144438|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
20608656|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608657|NCT02247505|Urological Agents|urological agents|mesh-ancestor
20608658|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608659|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608660|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20144439|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20144440|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20314894|NCT00696111|Hormones|hormones|mesh-ancestor
20144441|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
20144442|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
20314895|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20314896|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758416|NCT05277896|Ketamine|ketamine|mesh-list
19758417|NCT05277896|Etomidate|etomidate|mesh-list
19758418|NCT05277896|Analgesics|analgesics|mesh-ancestor
19758419|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
19758420|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758421|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758422|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19758423|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19758424|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
19758425|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
19758426|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758427|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19758428|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19758429|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758430|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758431|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19758432|NCT05254184|Nivolumab|nivolumab|mesh-list
20144443|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144444|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144445|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
20144446|NCT00066417|Hormones|hormones|mesh-ancestor
20144447|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144448|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20144449|NCT00066417|Protective Agents|protective agents|mesh-ancestor
20144450|NCT00066443|Docetaxel|docetaxel|mesh-list
20144451|NCT00066443|Epirubicin|epirubicin|mesh-list
20144452|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144453|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
20144454|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
20144455|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
20144456|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144457|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19758433|NCT05254184|Ipilimumab|ipilimumab|mesh-list
19758434|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758435|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758436|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19758437|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758438|NCT05253794|Colchicine|colchicine|mesh-list
19758439|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
19758440|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758441|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758442|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
20144458|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20144459|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20144460|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144461|NCT00066456|Docetaxel|docetaxel|mesh-list
20144462|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144463|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
20144464|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758443|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758444|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758445|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758446|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
19758447|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758448|NCT05221840|Durvalumab|durvalumab|mesh-list
20144465|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
20144466|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144467|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
20144468|NCT00066482|Cisplatin|cisplatin|mesh-list
20144469|NCT00066482|Etoposide|etoposide|mesh-list
20144470|NCT00066482|Bleomycin|bleomycin|mesh-list
20144471|NCT00066482|Lenograstim|lenograstim|mesh-list
20144472|NCT00066482|Sargramostim|sargramostim|mesh-list
20144473|NCT00066482|Mesna|mesna|mesh-list
20144474|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144475|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
20144476|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144477|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144478|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20144479|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
20144480|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144481|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144482|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20314897|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19758449|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758450|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314898|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
20144483|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20144484|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19632213|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19632214|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
19632215|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19632216|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632217|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632218|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19632219|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144485|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19758451|NCT05185024|Iron|iron|mesh-list
19758452|NCT05185024|Trace Elements|trace elements|mesh-ancestor
19758453|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
19758454|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758455|NCT05168865|Letrozole|letrozole|mesh-list
19758456|NCT05168865|Estradiol|estradiol|mesh-list
19758457|NCT05168865|Progesterone|progesterone|mesh-list
19758458|NCT05168865|Estrogens|estrogens|mesh-ancestor
19758459|NCT05168865|Hormones|hormones|mesh-ancestor
19758460|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758461|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758462|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758463|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19758464|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20144486|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144487|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20144488|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20144489|NCT00066482|Protective Agents|protective agents|mesh-ancestor
20144490|NCT00066508|Bortezomib|bortezomib|mesh-list
20144491|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144492|NCT00066547|Antibodies|antibodies|mesh-list
20144493|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20144494|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
20144495|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144496|NCT00066586|Exemestane|exemestane|mesh-list
20144497|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144498|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20144499|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20144500|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144501|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144502|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20144503|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144504|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144505|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144506|NCT00066599|Voriconazole|voriconazole|mesh-list
20144507|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
20144508|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144509|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20144510|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20144511|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144512|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144513|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20144514|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144515|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758465|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758466|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758467|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19758468|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144516|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608661|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
19632220|NCT03365908|Ropivacaine|ropivacaine|mesh-list
19758469|NCT05168865|Progestins|progestins|mesh-ancestor
19758470|NCT05167734|Dextrans|dextrans|mesh-list
20608662|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758471|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
19758472|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
19758473|NCT05167734|Hematinics|hematinics|mesh-ancestor
20608663|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608664|NCT02247518|Tadalafil|tadalafil|mesh-list
20608665|NCT02247518|Tamsulosin|tamsulosin|mesh-list
20608666|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
19758474|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
19758475|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
19758476|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
20144517|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20144518|NCT00066612|Irinotecan|irinotecan|mesh-list
20144519|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20144520|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20144521|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144522|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144523|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632221|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
19632222|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
20144524|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
20144525|NCT00066625|Bortezomib|bortezomib|mesh-list
20144526|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144527|NCT00066638|Romidepsin|romidepsin|mesh-list
20144528|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20144529|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144530|NCT00066651|Immunotoxins|immunotoxins|mesh-list
20144531|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
20144532|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144533|NCT00066716|Celecoxib|celecoxib|mesh-list
20144534|NCT00066716|Paclitaxel|paclitaxel|mesh-list
20144535|NCT00066716|Carboplatin|carboplatin|mesh-list
20144536|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20144537|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144538|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
20144539|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
20144540|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
20144541|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144542|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20144543|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20144544|NCT00066716|Analgesics|analgesics|mesh-ancestor
20144545|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
20144546|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144547|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144548|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20144549|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144550|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20144551|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20144552|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314899|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20314900|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20314901|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314902|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
19632223|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632224|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632225|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
19632226|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144553|NCT00066768|Gemcitabine|gemcitabine|mesh-list
20144554|NCT00066768|Suramin|suramin|mesh-list
20144555|NCT00066768|Docetaxel|docetaxel|mesh-list
20144556|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20144557|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
20144558|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144559|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144560|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
20144561|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758477|NCT05163041|Nivolumab|nivolumab|mesh-list
19758478|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758479|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758480|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19758481|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758482|NCT05160363|Piperaquine|piperaquine|mesh-list
19758483|NCT05160363|Pyronaridine|pyronaridine|mesh-list
19758484|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
19758485|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19632227|NCT03335540|Nivolumab|nivolumab|mesh-list
19632228|NCT03335540|Ipilimumab|ipilimumab|mesh-list
20144562|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144563|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632229|NCT03335540|Linrodostat|linrodostat|mesh-list
19632230|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758486|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20144564|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
20144565|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144566|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758487|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758488|NCT05158062|Paclitaxel|paclitaxel|mesh-list
19758489|NCT05158062|Docetaxel|docetaxel|mesh-list
19758490|NCT05158062|Bevacizumab|bevacizumab|mesh-list
19758491|NCT05158062|Carboplatin|carboplatin|mesh-list
19758492|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
20144567|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
20144568|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
20144569|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
20144570|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
20144571|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20144572|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20144573|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20144574|NCT00066794|Cytarabine|cytarabine|mesh-list
20144575|NCT00066794|Cyclosporine|cyclosporine|mesh-list
20144576|NCT00066794|Daunorubicin|daunorubicin|mesh-list
20144577|NCT00066794|Cyclosporins|cyclosporins|mesh-list
20144578|NCT00066794|Sargramostim|sargramostim|mesh-list
20144579|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20144580|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
20144581|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144582|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144583|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
20144584|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144585|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144586|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
20144587|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144588|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144589|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
20144590|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
20144591|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144592|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20144593|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20144594|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20144595|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20144596|NCT00066846|Leucovorin|leucovorin|mesh-list
20144597|NCT00066846|Bevacizumab|bevacizumab|mesh-list
20144598|NCT00066846|Fluorouracil|fluorouracil|mesh-list
20144599|NCT00066846|Calcium|calcium|mesh-list
20144600|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
20144601|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20144602|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144603|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20144604|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20144605|NCT00066846|Growth Substances|growth substances|mesh-ancestor
20144606|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144607|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
20144608|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144609|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
20144610|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144611|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20144612|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144613|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
20144614|NCT00066846|Antidotes|antidotes|mesh-ancestor
20144615|NCT00066846|Protective Agents|protective agents|mesh-ancestor
20144616|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
20144617|NCT00066846|Vitamins|vitamins|mesh-ancestor
20144618|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
20144619|NCT00066859|Sertraline|sertraline|mesh-list
20144620|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
20144621|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144622|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20144623|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20144624|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144625|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144626|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144627|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
20144628|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144629|NCT00066872|Imiquimod|imiquimod|mesh-list
20144630|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20144631|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
20144632|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144633|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144634|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
20144635|NCT00066885|Calcitriol|calcitriol|mesh-list
19758493|NCT05158062|Olaparib|olaparib|mesh-list
19758494|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19758495|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144636|NCT00066885|Docetaxel|docetaxel|mesh-list
20314903|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
20144637|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632231|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632232|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19632233|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632234|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632235|NCT03295240|Rituximab|rituximab|mesh-list
19632236|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20144638|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
20144639|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
20144640|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
20144641|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144642|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144643|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144644|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20144645|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144646|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20144647|NCT00066885|Vitamins|vitamins|mesh-ancestor
20144648|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
20144649|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20144650|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
20144651|NCT00066989|Antibodies|antibodies|mesh-list
20144652|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
20144653|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20144654|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20144655|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
20144656|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144657|NCT00067015|Goserelin|goserelin|mesh-list
20144658|NCT00067015|Bicalutamide|bicalutamide|mesh-list
20144659|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20144660|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144661|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
20144662|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144663|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144664|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144665|NCT00067041|Treprostinil|treprostinil|mesh-list
20144666|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20144667|NCT00067080|Deferasirox|deferasirox|mesh-list
20144668|NCT00067080|Deferoxamine|deferoxamine|mesh-list
20144669|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20144670|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
20314904|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20314905|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20314906|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314907|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
20144671|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
20144672|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144673|NCT00067080|Siderophores|siderophores|mesh-ancestor
20144674|NCT00067093|Vitamin K|vitamin k|mesh-list
20144675|NCT00067093|Heparin|heparin|mesh-list
20144676|NCT00067093|Calcium heparin|calcium heparin|mesh-list
20144677|NCT00067093|Idraparinux|idraparinux|mesh-list
20144678|NCT00067093|Vitamins|vitamins|mesh-ancestor
20144679|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
20144680|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144681|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
20144682|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20144683|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20144684|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144685|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20144686|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
20144687|NCT00067093|Coagulants|coagulants|mesh-ancestor
20144688|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20144689|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
20144690|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20144691|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
20144692|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144693|NCT00067119|Aspirin|aspirin|mesh-list
20144694|NCT00067119|Dipyridamole|dipyridamole|mesh-list
20144695|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20144696|NCT00067119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20144697|NCT00067119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20144698|NCT00067119|Analgesics|analgesics|mesh-ancestor
20144699|NCT00067119|Sensory System Agents|sensory system agents|mesh-ancestor
20144700|NCT00067119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144701|NCT00067119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144702|NCT00067119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20144703|NCT00067119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758496|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758497|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758498|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758499|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758500|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758501|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19758502|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19758503|NCT05158062|Growth Substances|growth substances|mesh-ancestor
19758504|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758505|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
19758506|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19758507|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833025|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833026|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833027|NCT01429168|Analgesics|analgesics|mesh-ancestor
19833028|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
19833029|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833030|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833031|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833032|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833033|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19833034|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833035|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833036|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833037|NCT01327638|Etoricoxib|etoricoxib|mesh-list
19833038|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
20144704|NCT00067119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20144705|NCT00067119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20144706|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144707|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20144708|NCT00067119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20144709|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144710|NCT00067119|Antipyretics|antipyretics|mesh-ancestor
20144711|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20144712|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
19833039|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833040|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833041|NCT01327638|Analgesics|analgesics|mesh-ancestor
19833042|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
19833043|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833044|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833045|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833046|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833047|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833048|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833049|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833050|NCT01077843|Etoricoxib|etoricoxib|mesh-list
19833051|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19833052|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19833053|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833054|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20144713|NCT00067158|Nicotine|nicotine|mesh-list
19833055|NCT01077843|Analgesics|analgesics|mesh-ancestor
19833056|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
19833057|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833058|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833059|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833060|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833061|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833062|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833063|NCT00771160|Montelukast|montelukast|mesh-list
19833064|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19833065|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833066|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20144714|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20144715|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
20144716|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144717|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144718|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20144719|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20144720|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
19758508|NCT05125016|Cemiplimab|cemiplimab|mesh-list
19758509|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758510|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758511|NCT05111353|Poly ICLC|poly iclc|mesh-list
19758512|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
19758513|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
19758514|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144721|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144722|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144723|NCT00067262|Valproic Acid|valproic acid|mesh-list
20144724|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
20144725|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144726|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144727|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
20144728|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144729|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758515|NCT05098938|Acyclovir|acyclovir|mesh-list
19758516|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
19758517|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758518|NCT05079360|Everolimus|everolimus|mesh-list
19758519|NCT05079360|Exemestane|exemestane|mesh-list
19758520|NCT05079360|Estrogens|estrogens|mesh-list
20144730|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
20144731|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20144732|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20144733|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20314908|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20314909|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
20314910|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20314911|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314912|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20314913|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20314914|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20144734|NCT00067301|Citalopram|citalopram|mesh-list
20144735|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20144736|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20144737|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144738|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314915|NCT00696215|Rasagiline|rasagiline|mesh-list
20314916|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20314917|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314918|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144739|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144740|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
20144741|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144742|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20144743|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
20144744|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144745|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
20144746|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20144747|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144748|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
20144749|NCT00067353|Fluorides|fluorides|mesh-list
20144750|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
20144751|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
20144752|NCT00067353|Protective Agents|protective agents|mesh-ancestor
20144753|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144754|NCT00067405|Micronutrients|micronutrients|mesh-list
20144755|NCT00067405|Trace Elements|trace elements|mesh-list
20314919|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20314920|NCT00696215|Protective Agents|protective agents|mesh-ancestor
20314921|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314922|NCT00696475|Diazoxide|diazoxide|mesh-list
20314923|NCT00696475|Choline|choline|mesh-list
20314924|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
20144756|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144757|NCT00067431|Valproic Acid|valproic acid|mesh-list
20144758|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
20144759|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144760|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144761|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
20144762|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314925|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20314926|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
20347322|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19758521|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
20144763|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144764|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
19758522|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
19758523|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758524|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758525|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
19758526|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758527|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19758528|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19758529|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758530|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758531|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19758532|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
19758533|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144765|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20144766|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20144767|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144768|NCT00067444|Paroxetine|paroxetine|mesh-list
20144769|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20144770|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20144771|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144772|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144773|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144774|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
20144775|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144776|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19758534|NCT05079360|Hormones|hormones|mesh-ancestor
19758535|NCT05078827|Fluorouracil|fluorouracil|mesh-list
19758536|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
20144777|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
20144778|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144779|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20144780|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20144781|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144782|NCT00067457|Alosetron|alosetron|mesh-list
20144783|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144784|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20144785|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
20144786|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144787|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144788|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144789|NCT00067496|Modafinil|modafinil|mesh-list
20144790|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20144791|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144792|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20144793|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20144794|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20144795|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144796|NCT00067509|Progesterone|progesterone|mesh-list
20144797|NCT00067509|Estrogens|estrogens|mesh-list
20144798|NCT00067509|Progestins|progestins|mesh-ancestor
20144799|NCT00067509|Hormones|hormones|mesh-ancestor
20144800|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144801|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144802|NCT00067535|Cocaine|cocaine|mesh-list
20144803|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
20144804|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
20144805|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20144806|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632237|NCT03295240|Venetoclax|venetoclax|mesh-list
19632238|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632239|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632240|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
19632241|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632242|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632243|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19632244|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
20144807|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
19833067|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
20144808|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144809|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20144810|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19632245|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144811|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20144812|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144813|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144814|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
20144815|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144816|NCT00067548|EKB 569|ekb 569|mesh-list
20144817|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144818|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20144819|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144820|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144821|NCT00067561|Alosetron|alosetron|mesh-list
20144822|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144823|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20144824|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
20144825|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144826|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144827|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144828|NCT00067600|Calcium|calcium|mesh-list
20144829|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144830|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144831|NCT00067626|Chromium|chromium|mesh-list
20144832|NCT00067626|Trace Elements|trace elements|mesh-ancestor
19758537|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758538|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758539|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758540|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758541|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
19758542|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758543|NCT05051566|Esomeprazole|esomeprazole|mesh-list
19758544|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19758545|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758546|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19758547|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758548|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758549|NCT05050084|Leuprolide|leuprolide|mesh-list
19758550|NCT05050084|Goserelin|goserelin|mesh-list
19758551|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20144833|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
20144834|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144835|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20144836|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144837|NCT00067743|Lenalidomide|lenalidomide|mesh-list
19758552|NCT05050084|Flutamide|flutamide|mesh-list
19758553|NCT05050084|Bicalutamide|bicalutamide|mesh-list
19758554|NCT05050084|Tryptophan|tryptophan|mesh-list
19758555|NCT05050084|Buserelin|buserelin|mesh-list
19758556|NCT05050084|Hormones|hormones|mesh-list
19758557|NCT05050084|Relugolix|relugolix|mesh-list
19758558|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758559|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758560|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19758561|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
19758562|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19758563|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20314927|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144838|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
20144839|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144840|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20144841|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20314928|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758564|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144842|NCT00067743|Growth Substances|growth substances|mesh-ancestor
20144843|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
20144844|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144845|NCT00067756|Butyric Acid|butyric acid|mesh-list
20144846|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
20144847|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
20144848|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758565|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
19758566|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
19758567|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
19758568|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19758569|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
19758570|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20144849|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144850|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144851|NCT00067860|Hormones|hormones|mesh-list
20144852|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144853|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144854|NCT00067899|Vitamins|vitamins|mesh-list
20144855|NCT00067899|Ascorbic Acid|ascorbic acid|mesh-list
20144856|NCT00067899|Vitamin E|vitamin e|mesh-list
20144857|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
20144858|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144859|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
20144860|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144861|NCT00067899|Protective Agents|protective agents|mesh-ancestor
20144862|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20144863|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20144864|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20144865|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20144866|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144867|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144868|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20144869|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314929|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20314930|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
19758571|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19758572|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
19758573|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144870|NCT00067912|Analgesics|analgesics|mesh-ancestor
20144871|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
20144872|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144873|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
20144874|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144875|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
20144876|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20144877|NCT00067925|Calcium|calcium|mesh-list
20144878|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19758574|NCT05048797|Carboplatin|carboplatin|mesh-list
19758575|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
19758576|NCT05048797|Trastuzumab|trastuzumab|mesh-list
19758577|NCT05048797|Pemetrexed|pemetrexed|mesh-list
19758578|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758579|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758580|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758581|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758582|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19758583|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20144879|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144880|NCT00067938|Lamotrigine|lamotrigine|mesh-list
20144881|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
19758628|NCT05016310|Vitamin D|vitamin d|mesh-list
19758629|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
19758630|NCT05016310|Vitamins|vitamins|mesh-list
19758631|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
19758632|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758633|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19758634|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19758635|NCT05010122|Decitabine|decitabine|mesh-list
19758636|NCT05010122|Venetoclax|venetoclax|mesh-list
19758637|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758638|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
19758639|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758640|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758641|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758642|NCT05007392|Febuxostat|febuxostat|mesh-list
19758643|NCT05007392|Dotinurad|dotinurad|mesh-list
19758644|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
19758645|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758646|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
20144882|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20144883|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20144884|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144885|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144886|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144887|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20144888|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20144889|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20144890|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20144891|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20173801|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20173802|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
20173803|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173804|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173805|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20173806|NCT00162669|Bevacizumab|bevacizumab|mesh-list
20173807|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758647|NCT05007392|Renal Agents|renal agents|mesh-ancestor
19758648|NCT04980222|Prednisone|prednisone|mesh-list
19758649|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
19758650|NCT04980222|Rituximab|rituximab|mesh-list
19758651|NCT04980222|Doxorubicin|doxorubicin|mesh-list
19758652|NCT04980222|Vincristine|vincristine|mesh-list
19758653|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758654|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
19758655|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758656|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758657|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19758658|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
19758659|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758660|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758661|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19758662|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758663|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19758664|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19758665|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19758666|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758667|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758668|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
19758669|NCT04980222|Hormones|hormones|mesh-ancestor
19835462|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19758670|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758671|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19758672|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19758673|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758674|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758675|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758676|NCT04939272|Venetoclax|venetoclax|mesh-list
19758677|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758678|NCT04935229|Nivolumab|nivolumab|mesh-list
19758679|NCT04935229|Ipilimumab|ipilimumab|mesh-list
19758680|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758681|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758682|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19758683|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758684|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
19758685|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19758686|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758687|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758688|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19758689|NCT04916197|Analgesics|analgesics|mesh-ancestor
19758690|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
19758691|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758692|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19758693|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19758694|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19758695|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
19758696|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758697|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758698|NCT04912063|Azacitidine|azacitidine|mesh-list
19758699|NCT04912063|Venetoclax|venetoclax|mesh-list
19758700|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758701|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
19758702|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758703|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758704|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144892|NCT00067951|Metformin|metformin|mesh-list
20144893|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
20144894|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20144895|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144896|NCT00068029|Octreotide|octreotide|mesh-list
20144897|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144898|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20144899|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144900|NCT00068042|Octreotide|octreotide|mesh-list
20144901|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20144902|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20144903|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144904|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
20144905|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20144906|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20144907|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
20144908|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144909|NCT00068068|Talaporfin|talaporfin|mesh-list
20144910|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144911|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20144912|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
20144913|NCT00068081|Capsaicin|capsaicin|mesh-list
20144914|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
20144915|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
20144916|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
20144917|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144918|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144919|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
20144920|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144921|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144922|NCT00068276|Vitamins|vitamins|mesh-ancestor
20144923|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
20144924|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20144925|NCT00068289|Bortezomib|bortezomib|mesh-list
20144926|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144927|NCT00068302|Sirolimus|sirolimus|mesh-list
20144928|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20144929|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144930|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20144931|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144932|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
20144933|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144934|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
20144935|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144936|NCT00068315|Rituximab|rituximab|mesh-list
20144937|NCT00068315|Fludarabine|fludarabine|mesh-list
20144938|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
20144939|NCT00068315|Bortezomib|bortezomib|mesh-list
20144940|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20144941|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144942|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
20144943|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144944|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144945|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20144946|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
20144947|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144948|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144949|NCT00068432|Gemcitabine|gemcitabine|mesh-list
20144950|NCT00068432|Celecoxib|celecoxib|mesh-list
20144951|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20144952|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
20144953|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314931|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20314932|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
20314933|NCT00696514|Vitamin D|vitamin d|mesh-list
20314934|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
20314935|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
20144954|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144955|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
20314936|NCT00696514|Vitamins|vitamins|mesh-list
20314937|NCT00696514|Folic Acid|folic acid|mesh-list
20314938|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
20314939|NCT00696514|Hydroxocobalamin|hydroxocobalamin|mesh-list
20314940|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
20314941|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314942|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20314943|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20314944|NCT00696514|Hematinics|hematinics|mesh-ancestor
20314945|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
20314946|NCT00696540|Albuterol|albuterol|mesh-list
20314947|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20314948|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
20314949|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20314950|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314951|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20314952|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
20314953|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
20314954|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20314955|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20314956|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20314957|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20314958|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
20314959|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314960|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314961|NCT00696566|Rifampin|rifampin|mesh-list
19758717|NCT04853355|Spironolactone|spironolactone|mesh-list
19758718|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19758719|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
19758720|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20144956|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144957|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314962|NCT00696566|Clopidogrel|clopidogrel|mesh-list
20314963|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20314964|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19632246|NCT03279471|Sertraline|sertraline|mesh-list
19632247|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
19632248|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19632249|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19632250|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19758721|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758722|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19758723|NCT04853355|Diuretics|diuretics|mesh-ancestor
19758724|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
19758725|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
20144958|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144959|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
20144960|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144961|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20144962|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20144963|NCT00068432|Analgesics|analgesics|mesh-ancestor
20144964|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
20144965|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20144966|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20144967|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20144968|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20144969|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19632251|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632252|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632253|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632254|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
19632255|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632256|NCT03277729|Vidarabine|vidarabine|mesh-list
19632257|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
19632258|NCT03277729|Fludarabine|fludarabine|mesh-list
19632259|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
19632260|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632261|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
19632262|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632263|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632264|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20144970|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
20144971|NCT00068458|Calcium|calcium|mesh-list
20144972|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20144973|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20144974|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20144975|NCT00068471|Anidulafungin|anidulafungin|mesh-list
20144976|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
20144977|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20144978|NCT00068484|Bortezomib|bortezomib|mesh-list
20144979|NCT00068484|Topotecan|topotecan|mesh-list
20144980|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144981|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20144982|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20144983|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144984|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144985|NCT00068497|Gefitinib|gefitinib|mesh-list
20144986|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20144987|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20144988|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20144989|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20144990|NCT00068523|Cyclosporine|cyclosporine|mesh-list
20144991|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
20144992|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
20144993|NCT00068523|Fludarabine|fludarabine|mesh-list
20144994|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
20144995|NCT00068523|Cyclosporins|cyclosporins|mesh-list
20144996|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20144997|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20144998|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
20144999|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145000|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145001|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145002|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
20145003|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145004|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145005|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145006|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632265|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
20145007|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
20145008|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145009|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
20145010|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145011|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
20145012|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20145013|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145014|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
20145015|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
20145016|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145017|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20145018|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
20145019|NCT00068523|Hormones|hormones|mesh-ancestor
20145020|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145021|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20145022|NCT00068523|Protective Agents|protective agents|mesh-ancestor
20145023|NCT00068549|Gemcitabine|gemcitabine|mesh-list
20145024|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145025|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145026|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
20145027|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145028|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
20145029|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145030|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145031|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145032|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
20145033|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145034|NCT00068653|Celecoxib|celecoxib|mesh-list
20145035|NCT00068653|Gefitinib|gefitinib|mesh-list
20145036|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20145037|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20145038|NCT00068653|Analgesics|analgesics|mesh-ancestor
20145039|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
20145040|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145041|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145042|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145043|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145044|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20145045|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20145046|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145047|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145048|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145049|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20145050|NCT00068666|Temozolomide|temozolomide|mesh-list
20145051|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145052|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
20145053|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145054|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145055|NCT00068731|Lycopene|lycopene|mesh-list
20145056|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145057|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
20145058|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145059|NCT00068731|Protective Agents|protective agents|mesh-ancestor
20145060|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145061|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19632266|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632267|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632268|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19632269|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632270|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
19632271|NCT03277729|Antiviral Agents|antiviral agents|mesh-ancestor
19632272|NCT03277729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632273|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
20145062|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20145063|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145064|NCT00068744|Fluorouracil|fluorouracil|mesh-list
20145065|NCT00068744|Mitomycins|mitomycins|mesh-list
20145066|NCT00068744|Mitomycin|mitomycin|mesh-list
20145067|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145068|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
20145069|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145070|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145071|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145072|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
20145073|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314965|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20145074|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145075|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
20145076|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20145077|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145078|NCT00068757|Paclitaxel|paclitaxel|mesh-list
20145079|NCT00068757|Trastuzumab|trastuzumab|mesh-list
20145080|NCT00068757|Lonafarnib|lonafarnib|mesh-list
20145081|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145082|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145083|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145084|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145085|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145086|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145087|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145088|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145089|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
20145090|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145091|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20145092|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145093|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145094|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20145095|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
20145096|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145097|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
20145098|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
20145099|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20145100|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145101|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20145102|NCT00068861|Metformin|metformin|mesh-list
20145103|NCT00068861|Clomiphene|clomiphene|mesh-list
20145104|NCT00068861|Enclomiphene|enclomiphene|mesh-list
20145105|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
20145106|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20145107|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145108|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20145109|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
20145110|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145111|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19758726|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758727|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
19758728|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758729|NCT04813991|Ibuprofen|ibuprofen|mesh-list
19758730|NCT04813991|Oxycodone|oxycodone|mesh-list
19758731|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19758732|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19758733|NCT04813991|Analgesics|analgesics|mesh-ancestor
19758734|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
19758735|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758736|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758737|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758738|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19758739|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19758740|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758741|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758742|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19758743|NCT04813991|Narcotics|narcotics|mesh-ancestor
19758744|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758745|NCT04797767|Cytarabine|cytarabine|mesh-list
19758746|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19758747|NCT04797767|Venetoclax|venetoclax|mesh-list
19758748|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
19758749|NCT04797767|Cladribine|cladribine|mesh-list
19758750|NCT04797767|Sargramostim|sargramostim|mesh-list
20145112|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
20145113|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20145114|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20145115|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20145116|NCT00068952|Temozolomide|temozolomide|mesh-list
20145117|NCT00068952|Carmustine|carmustine|mesh-list
20145118|NCT00068952|Lomustine|lomustine|mesh-list
20145119|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145120|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
20145121|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145122|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145123|NCT00069251|Bupropion|bupropion|mesh-list
20145124|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20145125|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
20145126|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20145127|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19758751|NCT04797767|Lenograstim|lenograstim|mesh-list
19758752|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758753|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
19758754|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758755|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758756|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
19758757|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758758|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758759|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
19758760|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758761|NCT04797767|Analgesics|analgesics|mesh-ancestor
19758762|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
19758763|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758764|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19758765|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19758766|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758767|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19758768|NCT04745689|Carboplatin|carboplatin|mesh-list
19758769|NCT04745689|Etoposide|etoposide|mesh-list
19758770|NCT04745689|Durvalumab|durvalumab|mesh-list
19758771|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758772|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19758773|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19758774|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19758775|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758776|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758777|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758778|NCT04721015|Docetaxel|docetaxel|mesh-list
19758779|NCT04721015|Osimertinib|osimertinib|mesh-list
19758780|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758781|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145128|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20145129|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20145130|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145131|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
20145132|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145133|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145134|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20314966|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20314967|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
20314968|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20314969|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314970|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314971|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20314972|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
20314973|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20314974|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20314975|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
20314976|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20314977|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314978|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20314979|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20314980|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20314981|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19758782|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758783|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145135|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19758784|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758785|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19758786|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758787|NCT04661358|Fenofibrate|fenofibrate|mesh-list
19758788|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19758789|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
19758790|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758791|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19758792|NCT04658784|Cyclopropane|cyclopropane|mesh-list
19758793|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
19758794|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758795|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758796|NCT04572295|Fulvestrant|fulvestrant|mesh-list
19758797|NCT04572295|Exemestane|exemestane|mesh-list
19758798|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19758799|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758800|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19758801|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19758802|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
19758803|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758804|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758805|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19758806|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19758807|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758808|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758809|NCT04504669|Durvalumab|durvalumab|mesh-list
19758810|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758811|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758812|NCT04373785|Temozolomide|temozolomide|mesh-list
19758813|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19758814|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
19758815|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758816|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145136|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145137|NCT00069355|Propranolol|propranolol|mesh-list
20145138|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20145139|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20145140|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
20145141|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145142|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145143|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145144|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20145145|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20145146|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
20145147|NCT00069446|Bevacizumab|bevacizumab|mesh-list
20145148|NCT00069446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20314982|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19632274|NCT03241940|Fludarabine|fludarabine|mesh-list
19632275|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
19632276|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632277|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
19632278|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632279|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632280|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19632281|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
19632282|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632283|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632284|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145149|NCT00069446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758825|NCT04218565|Golimumab|golimumab|mesh-list
19758826|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19758827|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758828|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758829|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
19758830|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758831|NCT04197986|Infigratinib|infigratinib|mesh-list
19758832|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758833|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
19758834|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758835|NCT04161599|Metronidazole|metronidazole|mesh-list
19758836|NCT04161599|Cefuroxime|cefuroxime|mesh-list
19758837|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
19758838|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
19758839|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
19758840|NCT04161599|Citric Acid|citric acid|mesh-list
19758841|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
19758842|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758843|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19758844|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19758845|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19758846|NCT04161599|Cathartics|cathartics|mesh-ancestor
19758847|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758848|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
19758849|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19758850|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
19758851|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
19758852|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758853|NCT04161599|Antacids|antacids|mesh-ancestor
19758854|NCT04148911|Paclitaxel|paclitaxel|mesh-list
19758855|NCT04148911|Atezolizumab|atezolizumab|mesh-list
20145150|NCT00069446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20145151|NCT00069446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20145152|NCT00069446|Growth Substances|growth substances|mesh-ancestor
20145153|NCT00069446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145154|NCT00069446|Growth Inhibitors|growth inhibitors|mesh-ancestor
20145155|NCT00069459|Bupropion|bupropion|mesh-list
20145156|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20145157|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
20145158|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20145159|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19758856|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19758857|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758858|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758859|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758860|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758861|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758862|NCT04134936|Lenalidomide|lenalidomide|mesh-list
19758863|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
19758864|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758865|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19758866|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19758867|NCT04134936|Growth Substances|growth substances|mesh-ancestor
19758868|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
19758869|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758870|NCT04110145|Linaclotide|linaclotide|mesh-list
20314983|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20314984|NCT00696579|Gemcitabine|gemcitabine|mesh-list
20314985|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20314986|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
20314987|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20314988|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314989|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
20314990|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758871|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19758872|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
19758873|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758874|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758875|NCT04109391|Trastuzumab|trastuzumab|mesh-list
19758876|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20314991|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20314992|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758877|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145160|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20608667|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19758878|NCT04100018|Prednisone|prednisone|mesh-list
19758879|NCT04100018|Docetaxel|docetaxel|mesh-list
19758880|NCT04100018|Nivolumab|nivolumab|mesh-list
20145161|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20145162|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145163|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
20145164|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145165|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145166|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20145167|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20145168|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632285|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145169|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20145170|NCT00069498|Mesalamine|mesalamine|mesh-list
20145171|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
20145172|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20145173|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145174|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20145175|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632286|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
19632287|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
19632288|NCT03126630|Maytansine|maytansine|mesh-list
19632289|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632290|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632291|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19632292|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
19632293|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
19632294|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
19632295|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661601|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661602|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661603|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
19661604|NCT03408652|Denosumab|denosumab|mesh-list
19661605|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19661606|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661607|NCT03372941|Dalbavancin|dalbavancin|mesh-list
19661608|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19661609|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661610|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
19661611|NCT03292861|Sirolimus|sirolimus|mesh-list
19661612|NCT03292861|Tacrolimus|tacrolimus|mesh-list
19661613|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
19661614|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19661615|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
19661616|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661617|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19661618|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661619|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661620|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19661621|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661622|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19661623|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
19661624|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19661625|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661626|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
19661627|NCT03263117|Anesthetics|anesthetics|mesh-list
19661628|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661629|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661630|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19661631|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19661632|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661633|NCT03030261|Dexamethasone|dexamethasone|mesh-list
19661634|NCT03030261|Pomalidomide|pomalidomide|mesh-list
19661635|NCT03030261|Elotuzumab|elotuzumab|mesh-list
19661636|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661637|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
19661638|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
19661639|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661640|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661641|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661642|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
19661643|NCT03030261|Hormones|hormones|mesh-ancestor
19661644|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661645|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19661646|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661647|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
20314993|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
20314994|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20314995|NCT00696592|Bevacizumab|bevacizumab|mesh-list
20314996|NCT00696592|Verteporfin|verteporfin|mesh-list
20314997|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20314998|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20314999|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20315000|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19758881|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758882|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758883|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758884|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758885|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758886|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19758887|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
19758888|NCT04100018|Hormones|hormones|mesh-ancestor
19758889|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19758890|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758891|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19758892|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758893|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19758894|NCT04088305|Vancomycin|vancomycin|mesh-list
19758895|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19758896|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758897|NCT04073784|Gemcitabine|gemcitabine|mesh-list
19758898|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758899|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
19758900|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758901|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758902|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
19758903|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758904|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758905|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758906|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
19758907|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758908|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19758909|NCT03970330|Naltrexone|naltrexone|mesh-list
19758910|NCT03970330|Norethindrone|norethindrone|mesh-list
19758911|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
19758912|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19758913|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19758914|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758915|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
19758916|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758917|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19758918|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19758919|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19758920|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
19758921|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19758922|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19758923|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19758924|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
19758925|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19758926|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19758927|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758928|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19758929|NCT03933306|Analgesics|analgesics|mesh-ancestor
19758930|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
19758931|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19758932|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19758933|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19758934|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19758935|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
19758936|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19758937|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758938|NCT03898934|Vitamin D|vitamin d|mesh-list
19758939|NCT03898934|Vitamins|vitamins|mesh-ancestor
19758940|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
19758941|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758942|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19758943|NCT03884556|Gemcitabine|gemcitabine|mesh-list
19758944|NCT03884556|Paclitaxel|paclitaxel|mesh-list
19758945|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
19758946|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145176|NCT00069498|Analgesics|analgesics|mesh-ancestor
20145177|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
20145178|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145179|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145180|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145181|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145182|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
20145183|NCT00069550|Donepezil|donepezil|mesh-list
20145184|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20145185|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145186|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145187|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
20145188|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145189|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758947|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758948|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758949|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758950|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19758951|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758952|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19758953|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
19758954|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
19758955|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19758956|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758957|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19758958|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
19758959|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19758960|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758961|NCT03859869|Pancrelipase|pancrelipase|mesh-list
19758962|NCT03859869|Pancreatin|pancreatin|mesh-list
19758963|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19758964|NCT03851588|Dolutegravir|dolutegravir|mesh-list
19758965|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19758966|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19758967|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19758968|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758969|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20145190|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
20145191|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
20145192|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
20145193|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20145194|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20145195|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20145196|NCT00069706|Latanoprost|latanoprost|mesh-list
20145197|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20145198|NCT00069836|Metformin|metformin|mesh-list
20145199|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
20145200|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20145201|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145202|NCT00069875|Gemcitabine|gemcitabine|mesh-list
20145203|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145204|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145205|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
20145206|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145207|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
20145208|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632296|NCT03109964|Hemostatics|hemostatics|mesh-list
19632297|NCT03109964|Surgiflo|surgiflo|mesh-list
19632298|NCT03109964|Coagulants|coagulants|mesh-ancestor
19632299|NCT03099486|Leucovorin|leucovorin|mesh-list
19632300|NCT03099486|Antidotes|antidotes|mesh-ancestor
19632301|NCT03099486|Protective Agents|protective agents|mesh-ancestor
19632302|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632303|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
19632304|NCT03099486|Vitamins|vitamins|mesh-ancestor
19632305|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
19632306|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19632307|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19632308|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
19632309|NCT03017820|Iodine|iodine|mesh-list
19632310|NCT03017820|Interferons|interferons|mesh-list
19758970|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19632311|NCT03017820|Interferon-beta|interferon-beta|mesh-list
19632312|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
19632313|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632314|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
19758971|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
19758972|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632315|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632316|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632317|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19632318|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
19632319|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632320|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632321|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19632322|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
19632323|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632324|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19758973|NCT03836105|Cemiplimab|cemiplimab|mesh-list
19758974|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758975|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145209|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145210|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145211|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
20145212|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145213|NCT00069888|Docetaxel|docetaxel|mesh-list
20145214|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145215|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145216|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
19758976|NCT03798639|Nivolumab|nivolumab|mesh-list
19758977|NCT03798639|Ipilimumab|ipilimumab|mesh-list
19758978|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19758979|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758980|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19758981|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758982|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
19758983|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19758984|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19758985|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19758986|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
19758987|NCT03780894|Coagulants|coagulants|mesh-ancestor
19758988|NCT03775486|Gemcitabine|gemcitabine|mesh-list
19758989|NCT03775486|Paclitaxel|paclitaxel|mesh-list
19758990|NCT03775486|Cisplatin|cisplatin|mesh-list
19758991|NCT03775486|Carboplatin|carboplatin|mesh-list
19758992|NCT03775486|Pemetrexed|pemetrexed|mesh-list
19758993|NCT03775486|Durvalumab|durvalumab|mesh-list
19758994|NCT03775486|Olaparib|olaparib|mesh-list
19758995|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19758996|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145217|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145218|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145219|NCT00069901|Paclitaxel|paclitaxel|mesh-list
20145220|NCT00069901|Carboplatin|carboplatin|mesh-list
20145221|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19758997|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19758998|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
19758999|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759000|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759001|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759002|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759003|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
19759004|NCT03775486|Antiviral Agents|antiviral agents|mesh-ancestor
19759005|NCT03775486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759006|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759007|NCT03775486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759008|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
19759009|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759010|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19759011|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20145222|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20315001|NCT00696592|Growth Substances|growth substances|mesh-ancestor
19759012|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759013|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19759014|NCT03769090|Budesonide|budesonide|mesh-list
19759015|NCT03769090|Albuterol|albuterol|mesh-list
19759016|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759017|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19759018|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
19759019|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759020|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759021|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20145223|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145224|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145225|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145226|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145227|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632325|NCT03017820|Trace Elements|trace elements|mesh-ancestor
20173808|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173809|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20173810|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20608668|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19632326|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
19632327|NCT02991482|Gemcitabine|gemcitabine|mesh-list
19632328|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
19632329|NCT02991482|Vinorelbine|vinorelbine|mesh-list
19632330|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632331|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
19632332|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632333|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632334|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
19632335|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632336|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632337|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632338|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
19632339|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632340|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632341|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19632342|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
19632343|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
19632344|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
19632345|NCT02952534|Rucaparib|rucaparib|mesh-list
19632346|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19632347|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632348|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632349|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759022|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
19759023|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
19759024|NCT03769090|Hormones|hormones|mesh-ancestor
19759025|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759026|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
19759027|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19759028|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19759029|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19759030|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19759031|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
19759032|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759033|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759034|NCT03763162|Dexamethasone|dexamethasone|mesh-list
19759035|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
19759036|NCT03763162|Bortezomib|bortezomib|mesh-list
19759037|NCT03763162|Daratumumab|daratumumab|mesh-list
19759038|NCT03763162|Ixazomib|ixazomib|mesh-list
19759039|NCT03763162|Ichthammol|ichthammol|mesh-list
19759040|NCT03763162|BB 1101|bb 1101|mesh-list
19759041|NCT03763162|Glycine|glycine|mesh-list
19759042|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759043|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
19759044|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
19759045|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759046|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759047|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19759048|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
19759049|NCT03763162|Hormones|hormones|mesh-ancestor
19759050|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759051|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759052|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759053|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
19632350|NCT02906761|Aspirin|aspirin|mesh-list
19759054|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608669|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608670|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608671|NCT02247518|Urological Agents|urological agents|mesh-ancestor
20608672|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20608673|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20608674|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20608675|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
20608676|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145228|NCT00069927|Methylphenidate|methylphenidate|mesh-list
20145229|NCT00069927|Amphetamine|amphetamine|mesh-list
20145230|NCT00069927|Adderall|adderall|mesh-list
20145231|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
20145232|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20145233|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145234|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20145235|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20145236|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20145237|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145238|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
20145239|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145240|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
20145241|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
20145242|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145243|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
20145244|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19759055|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759056|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
19759057|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
19759058|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759059|NCT03752216|Niraparib|niraparib|mesh-list
19759060|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19759061|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759062|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759063|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759064|NCT03751124|Norethindrone|norethindrone|mesh-list
19759065|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
19759066|NCT03751124|Estradiol|estradiol|mesh-list
19759067|NCT03751124|Relugolix|relugolix|mesh-list
19759068|NCT03751124|Estrogens|estrogens|mesh-ancestor
19759069|NCT03751124|Hormones|hormones|mesh-ancestor
19759070|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759071|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759072|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19759073|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
19759074|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19759075|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19759076|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19759077|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19759078|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19759079|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
19759080|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
19759081|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19759082|NCT03735095|Trioxsalen|trioxsalen|mesh-list
19759083|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145245|NCT00069940|Sargramostim|sargramostim|mesh-list
20145246|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
20145247|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145248|NCT00069966|Cytarabine|cytarabine|mesh-list
20145249|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
20145250|NCT00069966|Rituximab|rituximab|mesh-list
20145251|NCT00069966|Pixantrone|pixantrone|mesh-list
20315002|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315003|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
20315004|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20315005|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315006|NCT00696631|Dronedarone|dronedarone|mesh-list
20315007|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315008|NCT00696644|Teriparatide|teriparatide|mesh-list
20315009|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20315010|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315011|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19759084|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315012|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19759085|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20145252|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315013|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19759086|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19759087|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19759088|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759089|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
19759090|NCT03629483|Ropivacaine|ropivacaine|mesh-list
19759091|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19759092|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19759093|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759094|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19759095|NCT03629483|Analgesics|analgesics|mesh-ancestor
19759096|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
19759097|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759098|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19759099|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19759100|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19759101|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
19759102|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759103|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759104|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
19759105|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
19759106|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
19759107|NCT03622788|Fludarabine|fludarabine|mesh-list
19759108|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20315014|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20315015|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
20315016|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315017|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315018|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20315019|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20145253|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145254|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
20145255|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145256|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145257|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145258|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
20145259|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145260|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
20145261|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145262|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145263|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145264|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
20145265|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
20145266|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315020|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
20315021|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315022|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
20315023|NCT00696748|Testosterone|testosterone|mesh-list
20315024|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
20315025|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
20315026|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20315027|NCT00696748|Androgens|androgens|mesh-ancestor
20315028|NCT00696748|Hormones|hormones|mesh-ancestor
20315029|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315030|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315031|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20315032|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315033|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
20315034|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20315035|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315036|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632351|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19759109|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145267|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19632352|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632353|NCT02906761|Analgesics|analgesics|mesh-ancestor
19632354|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
19632355|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632356|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632357|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632358|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632359|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19632360|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19632361|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145268|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
19759110|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
20145269|NCT00069966|Hormones|hormones|mesh-ancestor
20145270|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145271|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20145272|NCT00069966|Protective Agents|protective agents|mesh-ancestor
20145273|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20145274|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145275|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759111|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759112|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759113|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759114|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
19759115|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759116|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145276|NCT00069992|Fludarabine|fludarabine|mesh-list
20145277|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
20145278|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145279|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145280|NCT00070057|Celecoxib|celecoxib|mesh-list
20145281|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20145282|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20145283|NCT00070057|Analgesics|analgesics|mesh-ancestor
20145284|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
20145285|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145286|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145287|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145288|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145289|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20145290|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20145291|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145292|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145293|NCT00070083|Prednisone|prednisone|mesh-list
19632362|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19632363|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19632364|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632365|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
19632366|NCT02883062|Paclitaxel|paclitaxel|mesh-list
19632367|NCT02883062|Carboplatin|carboplatin|mesh-list
19632368|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19632369|NCT02883062|Atezolizumab|atezolizumab|mesh-list
19632370|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19632371|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19632372|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632373|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19632374|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
19632375|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19632376|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632377|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
19632378|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632379|NCT02725567|Ivacaftor|ivacaftor|mesh-list
19632380|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19632381|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632382|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632383|NCT02709655|Vortioxetine|vortioxetine|mesh-list
19632384|NCT02709655|Fluoxetine|fluoxetine|mesh-list
19632385|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19632386|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19632387|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632388|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632389|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632390|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
19632391|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632392|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19632393|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
19632394|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19632395|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19632396|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19632397|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632398|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19632399|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19632400|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19759117|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145294|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
20145295|NCT00070083|Rituximab|rituximab|mesh-list
20145296|NCT00070083|Doxorubicin|doxorubicin|mesh-list
20145297|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20145298|NCT00070083|Vincristine|vincristine|mesh-list
20145299|NCT00070083|Oblimersen|oblimersen|mesh-list
20145300|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145301|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
20145302|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145303|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145304|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145305|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
20145306|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145307|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145308|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145309|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145310|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145311|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20145312|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145313|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145314|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145315|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
20145316|NCT00070083|Hormones|hormones|mesh-ancestor
20145317|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145318|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759118|NCT03595059|Paclitaxel|paclitaxel|mesh-list
19759119|NCT03595059|Docetaxel|docetaxel|mesh-list
19759120|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759121|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759122|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759123|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759124|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759125|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759126|NCT03553810|Valsartan|valsartan|mesh-list
19759127|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19759128|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19759129|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19759130|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19759131|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759132|NCT03527264|Nivolumab|nivolumab|mesh-list
19759133|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759134|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759135|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19759136|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145319|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20315037|NCT00696826|Incretins|incretins|mesh-ancestor
20315038|NCT00696826|Hormones|hormones|mesh-ancestor
20315039|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632401|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19632402|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19632403|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19632404|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19632405|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19632406|NCT02648698|Levofloxacin|levofloxacin|mesh-list
19632407|NCT02648698|Tinidazole|tinidazole|mesh-list
19632408|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632409|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19632410|NCT02648698|Renal Agents|renal agents|mesh-ancestor
19632411|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19632412|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19632413|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632414|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632415|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632416|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19632417|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19833068|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833069|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145320|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145321|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145322|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145323|NCT00070122|Leucovorin|leucovorin|mesh-list
20145324|NCT00070122|Bevacizumab|bevacizumab|mesh-list
20173811|NCT00162669|Growth Substances|growth substances|mesh-ancestor
19759137|NCT03519308|Gemcitabine|gemcitabine|mesh-list
19759138|NCT03519308|Paclitaxel|paclitaxel|mesh-list
19759139|NCT03519308|Nivolumab|nivolumab|mesh-list
19759140|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759141|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759142|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759143|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759144|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759145|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759146|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759147|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
19759148|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
19759149|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759150|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759151|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759152|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
19759153|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759154|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759155|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19759156|NCT03483038|Irinotecan|irinotecan|mesh-list
19759157|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19759158|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19759159|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759160|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759161|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759162|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
19759163|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19759164|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19759165|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759166|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
19759167|NCT03475342|Coagulants|coagulants|mesh-ancestor
19759168|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
19759169|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759170|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759171|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19759172|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19759173|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19759174|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19759175|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759176|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145325|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20145326|NCT00070122|Fluorouracil|fluorouracil|mesh-list
20145327|NCT00070122|Capecitabine|capecitabine|mesh-list
20145328|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
20145329|NCT00070122|Antibodies|antibodies|mesh-list
20145330|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
20145331|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20145332|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
19759177|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759178|NCT03271151|Analgesics|analgesics|mesh-ancestor
19759179|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
19759180|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759181|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
19759182|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19759183|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
19759184|NCT03265405|Prednisolone|prednisolone|mesh-list
19759185|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19759186|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
19759187|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19759188|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
19759189|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19759190|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
20145333|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145334|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20145335|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20145336|NCT00070122|Growth Substances|growth substances|mesh-ancestor
20145337|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145338|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
20145339|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
20145340|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
20145341|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145342|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759191|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145343|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145344|NCT00070122|Antidotes|antidotes|mesh-ancestor
19759192|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
19632418|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
19632419|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19632420|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19759193|NCT03265405|Hormones|hormones|mesh-ancestor
19759194|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759195|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759196|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759197|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759198|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
19759199|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
19759200|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759201|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19759202|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19759203|NCT03265405|Protective Agents|protective agents|mesh-ancestor
19759204|NCT03228537|Cisplatin|cisplatin|mesh-list
19759205|NCT03228537|Pemetrexed|pemetrexed|mesh-list
19759206|NCT03228537|Atezolizumab|atezolizumab|mesh-list
19759207|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19759208|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759209|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759210|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759211|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19759212|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19759213|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
19759214|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145345|NCT00070122|Protective Agents|protective agents|mesh-ancestor
20145346|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
20145347|NCT00070122|Vitamins|vitamins|mesh-ancestor
20145348|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
20145349|NCT00070148|Megestrol|megestrol|mesh-list
20145350|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
20145351|NCT00070148|Oxandrolone|oxandrolone|mesh-list
20145352|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20145353|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20145354|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20145355|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
20145356|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20145357|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145358|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20145359|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20145360|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20145361|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145362|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
20145363|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20145364|NCT00070148|Androgens|androgens|mesh-ancestor
20145365|NCT00070148|Hormones|hormones|mesh-ancestor
20315040|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19759215|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
19759216|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19759217|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19759218|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759219|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19759220|NCT03172897|Analgesics|analgesics|mesh-ancestor
19759221|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
19759222|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759223|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19632421|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19632422|NCT02600897|Rituximab|rituximab|mesh-list
19632423|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
19632424|NCT02600897|Lenalidomide|lenalidomide|mesh-list
19632425|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632426|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632427|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
19632428|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632429|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632430|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19632431|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19632432|NCT02600897|Growth Substances|growth substances|mesh-ancestor
19632433|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
20145366|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315041|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
19632434|NCT02532257|Rituximab|rituximab|mesh-list
19632435|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19632436|NCT02532257|Lenalidomide|lenalidomide|mesh-list
20145367|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
19632437|NCT02532257|Antibodies|antibodies|mesh-list
19759224|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19759225|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19632438|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
19632439|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19632440|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
19632441|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632442|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632443|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632444|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19632445|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19632446|NCT02532257|Growth Substances|growth substances|mesh-ancestor
19632447|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
19632448|NCT02340676|Interleukin-2|interleukin-2|mesh-list
19632449|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632450|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632451|NCT02340676|Analgesics|analgesics|mesh-ancestor
19632452|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
19632453|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632454|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632455|NCT02320292|Rituximab|rituximab|mesh-list
19632456|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19632457|NCT02320292|Antibodies|antibodies|mesh-list
19632458|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
19632459|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19632460|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
19632461|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632462|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632463|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632464|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
19632465|NCT02317783|Flutemetamol|flutemetamol|mesh-list
19632466|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
19632467|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632468|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
19632469|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632470|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19632471|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19632472|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
19632473|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632474|NCT02144584|Memantine|memantine|mesh-list
19632475|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19632476|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19632477|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
19632478|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632479|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632480|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632481|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19632482|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19632483|NCT02008656|Leucovorin|leucovorin|mesh-list
19632484|NCT02008656|Fluorouracil|fluorouracil|mesh-list
19632485|NCT02008656|Capecitabine|capecitabine|mesh-list
19632486|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
19632487|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
19632488|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632489|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632490|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632491|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632492|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
19632493|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632494|NCT02008656|Antidotes|antidotes|mesh-ancestor
19632495|NCT02008656|Protective Agents|protective agents|mesh-ancestor
19632496|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
19632497|NCT02008656|Vitamins|vitamins|mesh-ancestor
19632498|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
19632499|NCT02000882|Capecitabine|capecitabine|mesh-list
19632500|NCT02000882|Trastuzumab|trastuzumab|mesh-list
19632501|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632502|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
19632503|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632504|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632505|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759226|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
20145368|NCT00070161|Donepezil|donepezil|mesh-list
20145369|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20145370|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145371|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145372|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
20145373|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145374|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145375|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
20145376|NCT00070174|Cytarabine|cytarabine|mesh-list
19759227|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759228|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145377|NCT00070174|Cyclosporine|cyclosporine|mesh-list
20145378|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
20145379|NCT00070174|Busulfan|busulfan|mesh-list
20315042|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759229|NCT03141177|Nivolumab|nivolumab|mesh-list
19759230|NCT03141177|Ipilimumab|ipilimumab|mesh-list
20315043|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759231|NCT03141177|Sunitinib|sunitinib|mesh-list
19759232|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759233|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759234|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19759235|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759236|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19759237|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759238|NCT03141177|Growth Substances|growth substances|mesh-ancestor
19759239|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759240|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759241|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19759242|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759243|NCT03117049|Paclitaxel|paclitaxel|mesh-list
19759244|NCT03117049|Bevacizumab|bevacizumab|mesh-list
19759245|NCT03117049|Carboplatin|carboplatin|mesh-list
19759246|NCT03117049|Nivolumab|nivolumab|mesh-list
19759247|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759248|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759249|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759250|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759251|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759252|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759253|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759254|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19759255|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759256|NCT03117049|Growth Substances|growth substances|mesh-ancestor
19759257|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759258|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759259|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19759260|NCT03102723|Cangrelor|cangrelor|mesh-list
19759261|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20347323|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19759262|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19759263|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19759264|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19759265|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
19759266|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759267|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759268|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145380|NCT00070174|Methotrexate|methotrexate|mesh-list
20145381|NCT00070174|Etoposide|etoposide|mesh-list
20145382|NCT00070174|Daunorubicin|daunorubicin|mesh-list
20145383|NCT00070174|Asparaginase|asparaginase|mesh-list
20145384|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
20145385|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
20145386|NCT00070174|Cyclosporins|cyclosporins|mesh-list
20145387|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145388|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
20145389|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145390|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145391|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145392|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
20315044|NCT00696930|Edotreotide|edotreotide|mesh-list
20145393|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145394|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145395|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145396|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20145397|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
20145398|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20145399|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145400|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
20145401|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
20145402|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145403|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20145404|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20145405|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145406|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20145407|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145408|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
20145409|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145410|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
20145411|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20145412|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145413|NCT00070174|Analgesics|analgesics|mesh-ancestor
19759278|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
19759279|NCT03012984|Morphine|morphine|mesh-list
19759280|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19759281|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19759282|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759283|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19759284|NCT03012984|Analgesics|analgesics|mesh-ancestor
19759285|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
19632525|NCT01877837|Vidarabine|vidarabine|mesh-list
19632526|NCT01877837|Fludarabine|fludarabine|mesh-list
19632527|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
19632528|NCT01877837|Melphalan|melphalan|mesh-list
19759286|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759287|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19759288|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19759289|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19759290|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
19759291|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759292|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759293|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19759294|NCT03012984|Narcotics|narcotics|mesh-ancestor
20145414|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
20145415|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632529|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
20145416|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632530|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632531|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759295|NCT02993822|Maleic acid|maleic acid|mesh-list
19759296|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759297|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759298|NCT02972840|Rituximab|rituximab|mesh-list
19759299|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19759300|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
19759301|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759302|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759303|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
19759304|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759305|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759306|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759307|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
19759308|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759309|NCT02957019|Rituximab|rituximab|mesh-list
19759310|NCT02957019|Interleukin-2|interleukin-2|mesh-list
19759311|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759312|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759313|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
19759314|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759315|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759316|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19759317|NCT02957019|Analgesics|analgesics|mesh-ancestor
19759318|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
19759319|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759333|NCT02942355|Palbociclib|palbociclib|mesh-list
19759334|NCT02942355|Anastrozole|anastrozole|mesh-list
19632532|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
19632533|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632534|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632535|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
19632536|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632537|NCT01877837|Antiviral Agents|antiviral agents|mesh-ancestor
19759335|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759336|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19759337|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759338|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759339|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759340|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19759341|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19759342|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19759343|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
19759344|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759345|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759346|NCT02938793|Durvalumab|durvalumab|mesh-list
19759347|NCT02938793|Tremelimumab|tremelimumab|mesh-list
19759348|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759349|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759350|NCT02924441|Lidocaine|lidocaine|mesh-list
19759351|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
19759352|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
19759353|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19759354|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632538|NCT01877837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632539|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19632540|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
19632541|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19632542|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632543|NCT01812252|Azacitidine|azacitidine|mesh-list
19632544|NCT01812252|Decitabine|decitabine|mesh-list
19759355|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
19759356|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145417|NCT00070187|Interferons|interferons|mesh-list
19759357|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19759358|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19759359|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19759360|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19759361|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759362|NCT02924324|Propofol|propofol|mesh-list
19759363|NCT02924324|Ropivacaine|ropivacaine|mesh-list
20145418|NCT00070187|Cytarabine|cytarabine|mesh-list
20145419|NCT00070187|Aldesleukin|aldesleukin|mesh-list
19759364|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19759365|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20145420|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
20145421|NCT00070187|Cyclosporine|cyclosporine|mesh-list
20145422|NCT00070187|Etoposide|etoposide|mesh-list
20145423|NCT00070187|Melphalan|melphalan|mesh-list
20145424|NCT00070187|Interleukin-2|interleukin-2|mesh-list
20145425|NCT00070187|Carmustine|carmustine|mesh-list
20145426|NCT00070187|Cyclosporins|cyclosporins|mesh-list
19632545|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632546|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
19632547|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632548|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632549|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145427|NCT00070187|Lenograstim|lenograstim|mesh-list
20145428|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759366|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759367|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19759368|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
19759369|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
19759370|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
20145429|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145430|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20145431|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145432|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145433|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145434|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
20145435|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145436|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145437|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
20145438|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145439|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
19632550|NCT01748175|Triamcinolone|triamcinolone|mesh-list
19759371|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
19759372|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759373|NCT02901041|Zonisamide|zonisamide|mesh-list
19759374|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
19759375|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19759376|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19759377|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759378|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19759379|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759380|NCT02807454|Dexamethasone|dexamethasone|mesh-list
19759381|NCT02807454|Durvalumab|durvalumab|mesh-list
19759382|NCT02807454|Daratumumab|daratumumab|mesh-list
19759383|NCT02807454|Pomalidomide|pomalidomide|mesh-list
19759384|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759385|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
19759386|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
19759387|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759388|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759389|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19759390|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
19632551|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19632552|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19632553|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19632554|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632555|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
19632556|NCT01748175|Hormones|hormones|mesh-ancestor
19632557|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632558|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759391|NCT02807454|Hormones|hormones|mesh-ancestor
19759392|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145440|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145441|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20145442|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
20145443|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
20145444|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145445|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20145446|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145447|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
20145448|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145449|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20145450|NCT00070187|Analgesics|analgesics|mesh-ancestor
20145451|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
20145452|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608677|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608678|NCT02247544|Trabectedin|trabectedin|mesh-list
20145453|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20145454|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20145455|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
20145456|NCT00070200|Melphalan|melphalan|mesh-list
20145457|NCT00070200|Doxorubicin|doxorubicin|mesh-list
20145458|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20145459|NCT00070200|Etoposide|etoposide|mesh-list
20145460|NCT00070200|Vincristine|vincristine|mesh-list
20145461|NCT00070200|Topotecan|topotecan|mesh-list
20145462|NCT00070200|Isotretinoin|isotretinoin|mesh-list
20145463|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145464|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
20145465|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145466|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145467|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145468|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
20145469|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632559|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632560|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
19632561|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632562|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632563|NCT01642004|Docetaxel|docetaxel|mesh-list
19632564|NCT01642004|Nivolumab|nivolumab|mesh-list
19632565|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632566|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19632567|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19632568|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19632569|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632570|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19632571|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19632572|NCT01453179|Diclofenac|diclofenac|mesh-list
19632573|NCT01453179|Imiquimod|imiquimod|mesh-list
19632574|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19632575|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632576|NCT01453179|Analgesics|analgesics|mesh-ancestor
19632577|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
19632578|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632579|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632580|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632581|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632582|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19632583|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632584|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632585|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632586|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
19632587|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145470|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145471|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145472|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145473|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20315045|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19759393|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759394|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759395|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759396|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
19759397|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19759398|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759399|NCT02807454|Growth Substances|growth substances|mesh-ancestor
19759400|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759401|NCT02753127|Leucovorin|leucovorin|mesh-list
19759402|NCT02753127|Bevacizumab|bevacizumab|mesh-list
19759403|NCT02753127|Fluorouracil|fluorouracil|mesh-list
19759404|NCT02753127|Irinotecan|irinotecan|mesh-list
19759405|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759406|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759407|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19759408|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759409|NCT02753127|Growth Substances|growth substances|mesh-ancestor
19759410|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759411|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759412|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
19759413|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759414|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759415|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759416|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
20315046|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315047|NCT00696956|Paclitaxel|paclitaxel|mesh-list
20315048|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20315049|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315050|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315051|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
20315052|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
20315053|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315054|NCT00696969|Amphotericin B|amphotericin b|mesh-list
20315055|NCT00696969|Paromomycin|paromomycin|mesh-list
20315056|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20315057|NCT00696969|Miltefosine|miltefosine|mesh-list
20315058|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
19632588|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
19632589|NCT01366092|Interleukin-2|interleukin-2|mesh-list
19759417|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19759418|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19759419|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759420|NCT02753127|Antidotes|antidotes|mesh-ancestor
19759421|NCT02753127|Protective Agents|protective agents|mesh-ancestor
19759422|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
19759423|NCT02753127|Vitamins|vitamins|mesh-ancestor
19759424|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
19759425|NCT02744430|Mirabegron|mirabegron|mesh-list
19759426|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19759427|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19759428|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20145474|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145475|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145476|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145477|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145478|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145479|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145480|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20145481|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
20145482|NCT00070213|Leucovorin|leucovorin|mesh-list
20145483|NCT00070213|Fluorouracil|fluorouracil|mesh-list
20145484|NCT00070213|Capecitabine|capecitabine|mesh-list
19632590|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632591|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632592|NCT01366092|Analgesics|analgesics|mesh-ancestor
19632593|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
19632594|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632595|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632596|NCT01336530|Oxethazaine|oxethazaine|mesh-list
19632597|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19632598|NCT01336530|Antacids|antacids|mesh-list
19632599|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19632600|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632601|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
19632602|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145485|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
20145486|NCT00070213|Calcium|calcium|mesh-list
20145487|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
20315059|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
20315060|NCT00696969|Amebicides|amebicides|mesh-ancestor
20315061|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20315062|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20315063|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315064|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20315065|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
20315066|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315067|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20145488|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20145489|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145490|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
20145491|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145492|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145493|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145494|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145495|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
20145496|NCT00070213|Antidotes|antidotes|mesh-ancestor
20145497|NCT00070213|Protective Agents|protective agents|mesh-ancestor
20145498|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
20145499|NCT00070213|Vitamins|vitamins|mesh-ancestor
19759429|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19759430|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759431|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759432|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759433|NCT02744430|Urological Agents|urological agents|mesh-ancestor
19759434|NCT02674958|Aspirin|aspirin|mesh-list
19759435|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19759436|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20145500|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
19759437|NCT02674958|Analgesics|analgesics|mesh-ancestor
19759438|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
19759439|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759440|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759441|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759442|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759443|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19759444|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19759445|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759446|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19759447|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19759448|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759449|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
19759450|NCT02668562|Ticagrelor|ticagrelor|mesh-list
19759451|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19759452|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19759453|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19759454|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19759455|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
19759456|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759457|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759458|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759459|NCT02659241|Adavosertib|adavosertib|mesh-list
19759460|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759461|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145501|NCT00070239|Alvocidib|alvocidib|mesh-list
20145502|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20145503|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20145504|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145505|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145506|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145507|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
20145508|NCT00070239|Growth Substances|growth substances|mesh-ancestor
20145509|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20145510|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145511|NCT00070252|Docetaxel|docetaxel|mesh-list
19759462|NCT02538744|Doxazosin|doxazosin|mesh-list
19759463|NCT02538744|Cocaine|cocaine|mesh-list
19759464|NCT02538744|Modafinil|modafinil|mesh-list
19759465|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19759466|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759467|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19759468|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19759469|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19759470|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759471|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
19759472|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
19759473|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19759474|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
19759475|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759476|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19759477|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19759478|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19759479|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19759480|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
19759481|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759482|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19759483|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19759484|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19759485|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19759486|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
19759487|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
19759488|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759489|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759490|NCT02308202|Perindopril|perindopril|mesh-list
19759491|NCT02308202|Doxazosin|doxazosin|mesh-list
19759492|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19759493|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
19759494|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759495|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759496|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19759497|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19759498|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19759499|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19759500|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
19759501|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759502|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759503|NCT02297698|Trastuzumab|trastuzumab|mesh-list
19759504|NCT02297698|Sargramostim|sargramostim|mesh-list
19759505|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759506|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759507|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
19759508|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759509|NCT02207712|Ranibizumab|ranibizumab|mesh-list
19759510|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19759511|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759512|NCT02207712|Growth Substances|growth substances|mesh-ancestor
19759513|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759514|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759515|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759516|NCT02119468|Dexamethasone|dexamethasone|mesh-list
19759517|NCT02119468|Pomalidomide|pomalidomide|mesh-list
19759518|NCT02119468|Ixazomib|ixazomib|mesh-list
19759519|NCT02119468|Glycine|glycine|mesh-list
19759520|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19759521|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759522|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
19759523|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
20145512|NCT00070252|Capecitabine|capecitabine|mesh-list
20145513|NCT00070252|Tipifarnib|tipifarnib|mesh-list
20145514|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145515|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759524|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759525|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759526|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19759527|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
19759528|NCT02119468|Hormones|hormones|mesh-ancestor
20145516|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759529|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145517|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145518|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145519|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145520|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
20145521|NCT00070265|Capecitabine|capecitabine|mesh-list
20145522|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
20145523|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145524|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
20145525|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145526|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145527|NCT00070278|Gemcitabine|gemcitabine|mesh-list
20145528|NCT00070278|Paclitaxel|paclitaxel|mesh-list
20145529|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
20145530|NCT00070278|Epirubicin|epirubicin|mesh-list
20145531|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145532|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145533|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145534|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145535|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145536|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145537|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759530|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759531|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759532|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759533|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
19759534|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19759535|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759536|NCT02119468|Growth Substances|growth substances|mesh-ancestor
19759537|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759538|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
19759539|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759540|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
19759541|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759542|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
19759543|NCT02106572|Mitomycins|mitomycins|mesh-list
19759544|NCT02106572|Mitomycin|mitomycin|mesh-list
19759545|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19759546|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759547|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
19759548|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759549|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19759550|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759551|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20145538|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
20145539|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145540|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145541|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145542|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
20145543|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145544|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145545|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
20145546|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
20145547|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145548|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145549|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145550|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20145551|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145552|NCT00070304|Gemcitabine|gemcitabine|mesh-list
20145553|NCT00070304|Vinorelbine|vinorelbine|mesh-list
20145554|NCT00070304|Lenograstim|lenograstim|mesh-list
20145555|NCT00070304|Sargramostim|sargramostim|mesh-list
20145556|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145557|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
20145558|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145559|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145560|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
20145561|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145562|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145563|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145564|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
20145565|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315068|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20145566|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20145567|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145568|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315069|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20315070|NCT00696982|Glyburide|glyburide|mesh-list
20315071|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315072|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315073|NCT00696982|Incretins|incretins|mesh-ancestor
20315074|NCT00696982|Hormones|hormones|mesh-ancestor
20315075|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315076|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20315077|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
20315078|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315079|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315080|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
20315081|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
20315082|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20315083|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315084|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315085|NCT00697021|Aspirin|aspirin|mesh-list
20315086|NCT00697021|Clopidogrel|clopidogrel|mesh-list
20315087|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20315088|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19256613|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19256614|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256615|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19256616|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19256617|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145569|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145570|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145571|NCT00070343|Dacarbazine|dacarbazine|mesh-list
20145572|NCT00070343|Oblimersen|oblimersen|mesh-list
20145573|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145574|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
20145575|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145576|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145577|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
20315089|NCT00697021|Analgesics|analgesics|mesh-ancestor
19256618|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19256619|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19256620|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256621|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
20315090|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
20315091|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315092|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315093|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20315094|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315095|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20315096|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20315097|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315098|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20315099|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20315100|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315101|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
20315102|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19256622|NCT04337060|Lidocaine|lidocaine|mesh-list
19759552|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19759553|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
19759554|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759555|NCT01960530|Dexamethasone|dexamethasone|mesh-list
19759556|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
19759557|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19759558|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19759559|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19759560|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759561|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
19759562|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
19759563|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759564|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759565|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20145578|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
19759566|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
19759567|NCT01960530|Hormones|hormones|mesh-ancestor
19256623|NCT04337060|Morphine|morphine|mesh-list
19759568|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759569|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759570|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759571|NCT01892722|Interferons|interferons|mesh-list
19759572|NCT01892722|Interferon-beta|interferon-beta|mesh-list
19759573|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
19759574|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19759575|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759576|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
19759577|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759578|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
19759579|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759580|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19759581|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19759582|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759583|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759584|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19759585|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
19759586|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833070|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19833071|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833072|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833073|NCT00756418|Theophylline|theophylline|mesh-list
19833074|NCT00756418|Montelukast|montelukast|mesh-list
19833075|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19833076|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833077|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19833078|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
19833079|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833080|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833081|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19833082|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833083|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833084|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19833085|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
20145579|NCT00070382|Hematinics|hematinics|mesh-ancestor
20145580|NCT00070434|Leucovorin|leucovorin|mesh-list
20145581|NCT00070434|Pyridoxine|pyridoxine|mesh-list
20145582|NCT00070434|Fluorouracil|fluorouracil|mesh-list
20145583|NCT00070434|Capecitabine|capecitabine|mesh-list
20145584|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
20145585|NCT00070434|Irinotecan|irinotecan|mesh-list
20145586|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
20145587|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145588|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
19632603|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632604|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19632605|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
19632606|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
19632607|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20145589|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145590|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145591|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145592|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145593|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
20145594|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20145595|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145596|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145597|NCT00070434|Antidotes|antidotes|mesh-ancestor
20145598|NCT00070434|Protective Agents|protective agents|mesh-ancestor
20145599|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
20145600|NCT00070434|Vitamins|vitamins|mesh-ancestor
20145601|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
20145602|NCT00070447|Prednisone|prednisone|mesh-list
19632608|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
19632609|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632610|NCT01305499|Azacitidine|azacitidine|mesh-list
19632611|NCT01305499|Entinostat|entinostat|mesh-list
19632612|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632613|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
19632614|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632615|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632616|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632617|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19759587|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
19759588|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759589|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19759590|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759591|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759592|NCT01716806|Nivolumab|nivolumab|mesh-list
19759593|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19759594|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19759595|NCT01716806|Dacarbazine|dacarbazine|mesh-list
19759596|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759597|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759598|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19759599|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759600|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759601|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
19759602|NCT01516216|Vitamin D|vitamin d|mesh-list
19759603|NCT01516216|Leucovorin|leucovorin|mesh-list
19759604|NCT01516216|Bevacizumab|bevacizumab|mesh-list
19759605|NCT01516216|Fluorouracil|fluorouracil|mesh-list
19759606|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
19759607|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759608|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759609|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19759610|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759611|NCT01516216|Growth Substances|growth substances|mesh-ancestor
19759612|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759613|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759614|NCT01516216|Vitamins|vitamins|mesh-ancestor
19759615|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
19759616|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19759617|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
19759618|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759619|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759620|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759621|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
19759622|NCT01516216|Antidotes|antidotes|mesh-ancestor
19759623|NCT01516216|Protective Agents|protective agents|mesh-ancestor
19759624|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
19759625|NCT01062451|Candesartan|candesartan|mesh-list
19759626|NCT01062451|Perindopril|perindopril|mesh-list
19759627|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19759628|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19759629|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19759630|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759631|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19759632|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
19759633|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759634|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
20145603|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
20145604|NCT00070447|Rituximab|rituximab|mesh-list
20145605|NCT00070447|Doxorubicin|doxorubicin|mesh-list
20145606|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20145607|NCT00070447|Vincristine|vincristine|mesh-list
20145608|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145609|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
20145610|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145611|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145612|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145613|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
20145614|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145615|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145616|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145617|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145618|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19759635|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19759636|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19759637|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19759638|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759639|NCT00381641|Sunitinib|sunitinib|mesh-list
19759640|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759641|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20145619|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20145620|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19759642|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19759643|NCT00381641|Growth Substances|growth substances|mesh-ancestor
19759644|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759645|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
19759646|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19759647|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759648|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759649|NCT00006178|Sirolimus|sirolimus|mesh-list
19759650|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
19759651|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19759652|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759653|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19759654|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759655|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
19759656|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759657|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
19759658|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759659|NCT00006184|Cyclosporine|cyclosporine|mesh-list
19759660|NCT00006184|Prednisone|prednisone|mesh-list
19759661|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
19759662|NCT00006184|Doxorubicin|doxorubicin|mesh-list
19759663|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19759664|NCT00006184|Methotrexate|methotrexate|mesh-list
19759665|NCT00006184|Fludarabine|fludarabine|mesh-list
19759666|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
19759667|NCT00006184|Etoposide|etoposide|mesh-list
19759668|NCT00006184|Vincristine|vincristine|mesh-list
19759669|NCT00006184|Bortezomib|bortezomib|mesh-list
19759670|NCT00006184|Molgramostim|molgramostim|mesh-list
19759671|NCT00006184|Cyclosporins|cyclosporins|mesh-list
19759672|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
19759673|NCT00006184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19759674|NCT00006184|Antibodies|antibodies|mesh-list
19759675|NCT00006184|Sargramostim|sargramostim|mesh-list
19759676|NCT00006184|Lenograstim|lenograstim|mesh-list
19759677|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
19759678|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759679|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
19759680|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759681|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759682|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145621|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145622|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145623|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
20145624|NCT00070447|Hormones|hormones|mesh-ancestor
20145625|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145626|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20145627|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145628|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145629|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145630|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145631|NCT00070473|Pemetrexed|pemetrexed|mesh-list
20145632|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145633|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145634|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145635|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20145636|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20145637|NCT00070486|Gemcitabine|gemcitabine|mesh-list
20145638|NCT00070486|Celecoxib|celecoxib|mesh-list
20145639|NCT00070486|Zileuton|zileuton|mesh-list
20145640|NCT00070486|Carboplatin|carboplatin|mesh-list
20145641|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145642|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145643|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
20145644|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759683|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
19759684|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759685|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759686|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19759687|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19759688|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19759689|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19759690|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759691|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759692|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
20145645|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
19759693|NCT00006184|Hormones|hormones|mesh-ancestor
19759694|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759695|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20145646|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145647|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145648|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145649|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
20145650|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145651|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20145652|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20145653|NCT00070486|Analgesics|analgesics|mesh-ancestor
20145654|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
20145655|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145656|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759696|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19759697|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
19759698|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19759699|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759700|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
19759701|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
19759702|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19759703|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19759704|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759705|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759706|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759707|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759708|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
19759709|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759710|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19759711|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19759712|NCT00006227|Paclitaxel|paclitaxel|mesh-list
19759713|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759714|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759715|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759716|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19632618|NCT01244815|Asenapine|asenapine|mesh-list
19632619|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19632620|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19759717|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759718|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759719|NCT00006237|Interferons|interferons|mesh-list
19759720|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
19759721|NCT00006237|Aldesleukin|aldesleukin|mesh-list
19759722|NCT00006237|Interleukin-2|interleukin-2|mesh-list
19759723|NCT00006237|Dacarbazine|dacarbazine|mesh-list
19759724|NCT00006237|Vinblastine|vinblastine|mesh-list
19759725|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759726|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
19759727|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759728|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
19759729|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759730|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19759731|NCT00006237|Analgesics|analgesics|mesh-ancestor
20145657|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145658|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20145659|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20145660|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20145661|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20145662|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
19632621|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632622|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759732|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
19759733|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759734|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19632623|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19632624|NCT01194622|Fluticasone|fluticasone|mesh-list
19632625|NCT01194622|Xhance|xhance|mesh-list
19632626|NCT01194622|Azelastine|azelastine|mesh-list
19632627|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632628|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19632629|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
19632630|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632631|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759735|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19759736|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759737|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
19759738|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759739|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759740|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759741|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145663|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145664|NCT00070525|Tipifarnib|tipifarnib|mesh-list
20145665|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145666|NCT00070538|Cytarabine|cytarabine|mesh-list
20145667|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145668|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
20145669|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145670|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145671|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
20145672|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145673|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315103|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20315104|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20315105|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
20315106|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315107|NCT00697034|Capsaicin|capsaicin|mesh-list
20315108|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
20315109|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315110|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
20315111|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759742|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759743|NCT00006244|Interferons|interferons|mesh-list
19759744|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
19759745|NCT00006244|Aldesleukin|aldesleukin|mesh-list
19759746|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
19759747|NCT00006244|Melphalan|melphalan|mesh-list
19759748|NCT00006244|Interleukin-2|interleukin-2|mesh-list
19759749|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759750|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
19759751|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759752|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759753|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
19759754|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759755|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19759756|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759757|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
19759758|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759759|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19759760|NCT00006244|Analgesics|analgesics|mesh-ancestor
19759761|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
19759762|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759763|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19759764|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19759765|NCT00006289|Neurotropin|neurotropin|mesh-list
19759766|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19759767|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
19759768|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759769|NCT00006289|Analgesics|analgesics|mesh-ancestor
19759770|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
19759771|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759772|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
19759773|NCT00006305|Biguanides|biguanides|mesh-list
19759774|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19759775|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
19759776|NCT00006305|Calcium|calcium|mesh-list
19759777|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19759778|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19759779|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19759780|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19759781|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759782|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19759783|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19759784|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
19759785|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19759786|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759787|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
19759788|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759789|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19759790|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
20315112|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759791|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759792|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19759793|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
19759794|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759795|NCT00006392|Vitamins|vitamins|mesh-list
19759796|NCT00006392|Vitamin E|vitamin e|mesh-list
19759797|NCT00006392|Tocopherols|tocopherols|mesh-list
19759798|NCT00006392|Tocotrienols|tocotrienols|mesh-list
19759799|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
19759800|NCT00006392|Selenium|selenium|mesh-list
19759801|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
19759802|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759803|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
19759804|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759805|NCT00006392|Protective Agents|protective agents|mesh-ancestor
19759806|NCT00006392|Trace Elements|trace elements|mesh-ancestor
19759807|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
19759808|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759809|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
19759810|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759811|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759812|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19759813|NCT00006489|Naltrexone|naltrexone|mesh-list
19759814|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19759815|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19759816|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759817|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
19759818|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759819|NCT00006604|Ritonavir|ritonavir|mesh-list
19759820|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19759821|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19759822|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
19759823|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759824|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759825|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19759826|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19759827|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
19759828|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759829|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19759830|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19759831|NCT00006721|Prednisone|prednisone|mesh-list
19759832|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
19759833|NCT00006721|Rituximab|rituximab|mesh-list
19759834|NCT00006721|Doxorubicin|doxorubicin|mesh-list
19759835|NCT00006721|Vincristine|vincristine|mesh-list
19759836|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759837|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
19759838|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759839|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759840|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759841|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
19759842|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759843|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759844|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145674|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
20145675|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145676|NCT00070551|Cytarabine|cytarabine|mesh-list
20145677|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145678|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
19759845|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759846|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19759847|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19759848|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19759849|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759850|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19759851|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
19759852|NCT00006721|Hormones|hormones|mesh-ancestor
19759853|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759854|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759855|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759856|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759857|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759858|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759859|NCT00006903|Fulvestrant|fulvestrant|mesh-list
19759860|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19759861|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759862|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19759863|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19759864|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
19833086|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19759865|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19759866|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759867|NCT00007020|Cholic Acids|cholic acids|mesh-list
19759868|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19759869|NCT00007345|Romidepsin|romidepsin|mesh-list
19759870|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19759871|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759872|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
19759873|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759874|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
20145679|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145680|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145681|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
20315113|NCT00697060|Docetaxel|docetaxel|mesh-list
19759875|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759876|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759877|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759878|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
19759879|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759880|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759881|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19759882|NCT00008138|Paclitaxel|paclitaxel|mesh-list
19759883|NCT00008138|Carboplatin|carboplatin|mesh-list
19759884|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759885|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759886|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759887|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759888|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759889|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759890|NCT00008385|Selenium|selenium|mesh-list
19759891|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
19759892|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759893|NCT00008385|Protective Agents|protective agents|mesh-ancestor
19759894|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759895|NCT00008385|Trace Elements|trace elements|mesh-ancestor
19759896|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
19759897|NCT00009737|Leucovorin|leucovorin|mesh-list
19759898|NCT00009737|Fluorouracil|fluorouracil|mesh-list
19759899|NCT00009737|Capecitabine|capecitabine|mesh-list
19759900|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
19759901|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759902|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759903|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759904|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759905|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
19759906|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759907|NCT00009737|Antidotes|antidotes|mesh-ancestor
19759908|NCT00009737|Protective Agents|protective agents|mesh-ancestor
19759909|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
19759910|NCT00009737|Vitamins|vitamins|mesh-ancestor
19759911|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
19759912|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
19759913|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19759914|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759915|NCT00010257|Paclitaxel|paclitaxel|mesh-list
19759916|NCT00010257|Carboplatin|carboplatin|mesh-list
19759917|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759918|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759919|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759920|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759921|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759922|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759923|NCT00010439|Alendronate|alendronate|mesh-list
19759924|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19759925|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759926|NCT00011986|Gemcitabine|gemcitabine|mesh-list
19759927|NCT00011986|Paclitaxel|paclitaxel|mesh-list
19759928|NCT00011986|Carboplatin|carboplatin|mesh-list
19759929|NCT00011986|Doxorubicin|doxorubicin|mesh-list
19759930|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19759931|NCT00011986|Topotecan|topotecan|mesh-list
19759932|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759933|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759934|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759935|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759936|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
19833087|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19759937|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759938|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19759939|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
19759940|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
19759941|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759942|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759943|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145682|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145683|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145684|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
20145685|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145686|NCT00070629|Paclitaxel|paclitaxel|mesh-list
20145687|NCT00070629|Docetaxel|docetaxel|mesh-list
20145688|NCT00070629|Cisplatin|cisplatin|mesh-list
20145689|NCT00070629|Carboplatin|carboplatin|mesh-list
20145690|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145691|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145692|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145693|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145694|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145695|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145696|NCT00070642|Dacarbazine|dacarbazine|mesh-list
19759944|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
19759945|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759946|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19759947|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19759948|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19759949|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19759950|NCT00012012|Amifostine|amifostine|mesh-list
19759951|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19759952|NCT00012012|Protective Agents|protective agents|mesh-ancestor
19759953|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632632|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19632633|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
19632634|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
19632635|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19632636|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19632637|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632638|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632639|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19632640|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19632641|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
19632642|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
19632643|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632644|NCT01190852|Fluticasone|fluticasone|mesh-list
19759954|NCT00012298|Rituximab|rituximab|mesh-list
19759955|NCT00012298|Oprelvekin|oprelvekin|mesh-list
19759956|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19759957|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19759958|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759959|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
19759960|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759961|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759962|NCT00013611|Aldesleukin|aldesleukin|mesh-list
19759963|NCT00013611|Interleukin-2|interleukin-2|mesh-list
19759964|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759965|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19759966|NCT00013611|Analgesics|analgesics|mesh-ancestor
19759967|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
19759968|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632645|NCT01190852|Azelastine|azelastine|mesh-list
19632646|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632647|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19632648|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
19632649|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632650|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632651|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19759969|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145697|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145698|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
19759970|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19759971|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20173812|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759972|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
20145699|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145700|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145701|NCT00070655|Vitamin K|vitamin k|mesh-list
20145702|NCT00070655|Warfarin|warfarin|mesh-list
20145703|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
20145704|NCT00070655|Idraparinux|idraparinux|mesh-list
20145705|NCT00070655|Vitamins|vitamins|mesh-ancestor
20145706|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
20145707|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759973|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19759974|NCT00014222|Paclitaxel|paclitaxel|mesh-list
19759975|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
19759976|NCT00014222|Doxorubicin|doxorubicin|mesh-list
19759977|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19759978|NCT00014222|Fluorouracil|fluorouracil|mesh-list
19759979|NCT00014222|Epirubicin|epirubicin|mesh-list
19759980|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
19759981|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19759982|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19759983|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
19759984|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
19759985|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
19759986|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759987|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19759988|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
19759989|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19759990|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19759991|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19759992|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
19759993|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19759994|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145708|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
20145709|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20145710|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20145711|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19759995|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19759996|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19759997|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19759998|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
19759999|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760000|NCT00014222|Hematinics|hematinics|mesh-ancestor
19760001|NCT00014495|Cytarabine|cytarabine|mesh-list
19760002|NCT00014495|Bismuth|bismuth|mesh-list
19760003|NCT00014495|Antibodies|antibodies|mesh-list
19760004|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19760005|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
19760006|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760007|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760008|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
19760009|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760010|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760011|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
19760012|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760013|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760014|NCT00014495|Antacids|antacids|mesh-ancestor
19760015|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19760016|NCT00014911|Sirolimus|sirolimus|mesh-list
19760017|NCT00014911|Pentamidine|pentamidine|mesh-list
19760018|NCT00014911|Trimethoprim|trimethoprim|mesh-list
19760019|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
19760020|NCT00014911|Ganciclovir|ganciclovir|mesh-list
19760021|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19760022|NCT00014911|Tacrolimus|tacrolimus|mesh-list
19760023|NCT00014911|Daclizumab|daclizumab|mesh-list
19760024|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760025|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
19760026|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760027|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19760028|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760029|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760030|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20145712|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
19760031|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760032|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760033|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145713|NCT00070655|Coagulants|coagulants|mesh-ancestor
19760034|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
19760035|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19760036|NCT00014911|Renal Agents|renal agents|mesh-ancestor
19760037|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
19760038|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20315114|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315115|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315116|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
20315117|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
20315118|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315119|NCT00697086|Dronedarone|dronedarone|mesh-list
20608679|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20608680|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
20608681|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608682|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760039|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19760040|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19760041|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19760042|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19760043|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19760044|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
19760045|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19760046|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19760047|NCT00015457|Amlodipine|amlodipine|mesh-list
19760048|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
20145714|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20145715|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
20145716|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20145717|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
20145718|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145719|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
20145720|NCT00070733|Testosterone|testosterone|mesh-list
20145721|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
20145722|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
20145723|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20145724|NCT00070733|Androgens|androgens|mesh-ancestor
20145725|NCT00070733|Hormones|hormones|mesh-ancestor
20145726|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145727|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145728|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760049|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19760050|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19760051|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760052|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
19760053|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19760054|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760055|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19760056|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19760057|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19760058|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
19760059|NCT00015847|Interferons|interferons|mesh-list
19760060|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
19760061|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
19760062|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760063|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
19760064|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145729|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145730|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
20145731|NCT00070759|Daclizumab|daclizumab|mesh-list
20145732|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145733|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
20145734|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608683|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20608684|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20608685|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20608686|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608687|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608688|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19760065|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
20145735|NCT00070837|Antibodies|antibodies|mesh-list
19760066|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833088|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145736|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19760067|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760068|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760069|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760070|NCT00016718|Emtricitabine|emtricitabine|mesh-list
20145737|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
20145738|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145739|NCT00071071|Zanolimumab|zanolimumab|mesh-list
20145740|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145741|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145742|NCT00071084|Zanolimumab|zanolimumab|mesh-list
19760071|NCT00016718|Efavirenz|efavirenz|mesh-list
19760072|NCT00016718|Didanosine|didanosine|mesh-list
19760073|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
19760074|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760075|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19760076|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20145743|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760077|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760078|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760079|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19760080|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19760081|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19760082|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19760083|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19760084|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19760085|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19760086|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19760087|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
19760088|NCT00016913|Paclitaxel|paclitaxel|mesh-list
19760089|NCT00016913|Carboplatin|carboplatin|mesh-list
19760090|NCT00016913|Leuprolide|leuprolide|mesh-list
19760091|NCT00016913|Goserelin|goserelin|mesh-list
19760092|NCT00016913|Estramustine|estramustine|mesh-list
19760093|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760094|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760095|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760096|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760097|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760098|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760099|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19760100|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
19760101|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19760102|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760103|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760104|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760105|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
19760106|NCT00017563|Docetaxel|docetaxel|mesh-list
19760107|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
19760108|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760109|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760110|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760111|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760112|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760113|NCT00017563|Analgesics|analgesics|mesh-ancestor
19760114|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
19760115|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760116|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760117|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760118|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145744|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315120|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19760119|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315121|NCT00697125|Vaccines|vaccines|mesh-list
20145745|NCT00071097|Darunavir|darunavir|mesh-list
20145746|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20145747|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20145748|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
20145749|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145750|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145751|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20145752|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20145753|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
20145754|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145755|NCT00071136|Gemcitabine|gemcitabine|mesh-list
20145756|NCT00071136|Pemetrexed|pemetrexed|mesh-list
19760120|NCT00018031|Ribavirin|ribavirin|mesh-list
19760121|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19760122|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
19760123|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
19760124|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760125|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
19760126|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760127|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
19760128|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760129|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19760130|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19760131|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760132|NCT00019682|Aldesleukin|aldesleukin|mesh-list
20145757|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20145758|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
20145759|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145760|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145761|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
20145762|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145763|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145764|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145765|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
20145766|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145767|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20145768|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20145769|NCT00071188|Paclitaxel|paclitaxel|mesh-list
20145770|NCT00071188|Carboplatin|carboplatin|mesh-list
20145771|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145772|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145773|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145774|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145775|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145776|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145777|NCT00071201|Adefovir|adefovir|mesh-list
20145778|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20145779|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
20315122|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
20315123|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315124|NCT00697138|Amphetamine|amphetamine|mesh-list
20315125|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
19632652|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
19632653|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
19632654|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19632655|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19632656|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632657|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632658|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19632659|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19632660|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
19632661|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
19632662|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632663|NCT01142596|Asenapine|asenapine|mesh-list
19632664|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19632665|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20145780|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760133|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145781|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20315126|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19760134|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19760135|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19760136|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
19760137|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760138|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
19760139|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145782|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20145783|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145784|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760140|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760141|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760142|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760143|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
19760144|NCT00021255|Carboplatin|carboplatin|mesh-list
19760145|NCT00021255|Docetaxel|docetaxel|mesh-list
19760146|NCT00021255|Doxorubicin|doxorubicin|mesh-list
19760147|NCT00021255|Trastuzumab|trastuzumab|mesh-list
19760148|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760149|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
19760150|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760151|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760152|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760153|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
19760154|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760155|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760156|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19760157|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760158|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145785|NCT00071227|Triamcinolone|triamcinolone|mesh-list
20145786|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20145787|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20145788|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20145789|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145790|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
20145791|NCT00071227|Hormones|hormones|mesh-ancestor
20145792|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632666|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19760159|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760160|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760161|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760162|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760163|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760164|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760165|NCT00021541|Tipifarnib|tipifarnib|mesh-list
19760166|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760167|NCT00022490|Cytarabine|cytarabine|mesh-list
19760168|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
19760169|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760170|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
19632667|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632668|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19632669|NCT01098110|Asenapine|asenapine|mesh-list
19632670|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19632671|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19632672|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632673|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632674|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19632675|NCT01028716|Vidarabine|vidarabine|mesh-list
19632676|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
19632677|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
19632678|NCT01028716|Fludarabine|fludarabine|mesh-list
19632679|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
19632680|NCT01028716|Tacrolimus|tacrolimus|mesh-list
19632681|NCT01028716|Lenograstim|lenograstim|mesh-list
19632682|NCT01028716|Sargramostim|sargramostim|mesh-list
19632683|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632684|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
19632685|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632686|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632687|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19632688|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
19632689|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760171|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760172|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760173|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
19833089|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
19632690|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632691|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19632692|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760174|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760175|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760176|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
19760177|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760178|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760179|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760180|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
19760181|NCT00022516|Methotrexate|methotrexate|mesh-list
19760182|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760183|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
19760184|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760185|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760186|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760187|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
19760188|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760189|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760190|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19760191|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19760192|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
19760193|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19760194|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760195|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
19760196|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760197|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760198|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19760199|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19760200|NCT00022633|Gemcitabine|gemcitabine|mesh-list
19760201|NCT00022633|Paclitaxel|paclitaxel|mesh-list
19760202|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760203|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760204|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760205|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760206|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760207|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760208|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760209|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
19760210|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
19760211|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760212|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145793|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145794|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145795|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
20145796|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145797|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145798|NCT00071240|Hormones|hormones|mesh-list
19632693|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
19632694|NCT01028716|Antiviral Agents|antiviral agents|mesh-ancestor
19632695|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632696|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632697|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19632698|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632699|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19632700|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19632701|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
19632702|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19632703|NCT01006265|Ponesimod|ponesimod|mesh-list
19632704|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19632705|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632706|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632707|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
19632708|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632709|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
19632710|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
19632711|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632712|NCT00977483|Protective Agents|protective agents|mesh-ancestor
19632713|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632714|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
19632715|NCT00977483|Vitamins|vitamins|mesh-ancestor
19760213|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632716|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
19632717|NCT00972309|Vaccines|vaccines|mesh-list
19760214|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
19760215|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760216|NCT00022659|Bevacizumab|bevacizumab|mesh-list
19760217|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19760218|NCT00022659|Antibodies|antibodies|mesh-list
19760219|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
19760220|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19760221|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760222|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19760223|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19760224|NCT00022659|Growth Substances|growth substances|mesh-ancestor
19760225|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760226|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
19760227|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
19760228|NCT00022672|Trastuzumab|trastuzumab|mesh-list
19760229|NCT00022672|Anastrozole|anastrozole|mesh-list
19760230|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760231|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760232|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760233|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19760234|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19760235|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760236|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760237|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19760238|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
19760239|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760240|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760241|NCT00022698|Capecitabine|capecitabine|mesh-list
19760242|NCT00022698|Irinotecan|irinotecan|mesh-list
19760243|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760244|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
19760245|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760246|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760247|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19760248|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760249|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760250|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
19760251|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19760252|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19760253|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760254|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19760255|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19760256|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
19760257|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760258|NCT00023309|Lamivudine|lamivudine|mesh-list
19760259|NCT00023309|Adefovir|adefovir|mesh-list
19760260|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19760261|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19760262|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19760263|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760264|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760265|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
19760266|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760267|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19760268|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19760269|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19760270|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
19760271|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145799|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145800|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145801|NCT00071253|Valproic Acid|valproic acid|mesh-list
19632718|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
19632719|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632720|NCT00777348|Reproterol|reproterol|mesh-list
19632721|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19632722|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19632723|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
19632724|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632725|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632726|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760272|NCT00023452|Isoniazid|isoniazid|mesh-list
19760273|NCT00023452|Rifapentine|rifapentine|mesh-list
19760274|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
19760275|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19632727|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19632728|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
19632729|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632730|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19632731|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
19632732|NCT00777127|Diclofenac|diclofenac|mesh-list
19632733|NCT00777127|Imiquimod|imiquimod|mesh-list
19632734|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19632735|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19632736|NCT00777127|Analgesics|analgesics|mesh-ancestor
19632737|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
19632738|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632739|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632740|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632741|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632742|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19632743|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632744|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632745|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632746|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
19632747|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632748|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
19632749|NCT00761371|Imiquimod|imiquimod|mesh-list
19632750|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632751|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
19632752|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632753|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632754|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
19632755|NCT00591227|Insulin|insulin|mesh-list
19632756|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19632757|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
19632758|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
19632759|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19632760|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632761|NCT00534976|Montelukast|montelukast|mesh-list
19632762|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19632763|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
19632764|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19632765|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
19632766|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632767|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632768|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19760276|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19632769|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19632770|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760277|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19760278|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19760279|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
19760280|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760281|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19760282|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19760283|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
19760284|NCT00023673|Paclitaxel|paclitaxel|mesh-list
19760285|NCT00023673|Carboplatin|carboplatin|mesh-list
19760286|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760287|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760288|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760289|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760290|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145802|NCT00071253|Olanzapine|olanzapine|mesh-list
20145803|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
20145804|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
20145805|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145806|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760291|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760292|NCT00023712|Bortezomib|bortezomib|mesh-list
19760293|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760294|NCT00023764|Bortezomib|bortezomib|mesh-list
19760295|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760296|NCT00024102|Doxorubicin|doxorubicin|mesh-list
19760297|NCT00024102|Capecitabine|capecitabine|mesh-list
19760298|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760299|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760300|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760301|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760302|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760303|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760304|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760305|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
19760306|NCT00024167|Ketoconazole|ketoconazole|mesh-list
19760307|NCT00024167|Dexamethasone|dexamethasone|mesh-list
19760308|NCT00024167|Prednisone|prednisone|mesh-list
19760309|NCT00024167|Estramustine|estramustine|mesh-list
19760310|NCT00024167|Docetaxel|docetaxel|mesh-list
19760311|NCT00024167|Doxorubicin|doxorubicin|mesh-list
19760312|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19760313|NCT00024167|Vinblastine|vinblastine|mesh-list
19760314|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760315|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
19760316|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
19760317|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760318|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760319|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19760320|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
19760321|NCT00024167|Hormones|hormones|mesh-ancestor
19760322|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145807|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20145808|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20145809|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20145810|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20145811|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19760323|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760324|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760325|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760326|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760327|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760328|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145812|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20145813|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20145814|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20145815|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145816|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145817|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
20145818|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
20145819|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145820|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
19760329|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760330|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760331|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760332|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760333|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
20145821|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
20145822|NCT00071266|Niacin|niacin|mesh-list
20145823|NCT00071266|Lovastatin|lovastatin|mesh-list
19760334|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760335|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19760336|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19760337|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19760338|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
19760339|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19760340|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760341|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760342|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
19760343|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
19760344|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760345|NCT00025155|Epothilones|epothilones|mesh-list
19760346|NCT00025155|Epothilone B|epothilone b|mesh-list
19760347|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760348|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145824|NCT00071266|L 647318|l 647318|mesh-list
20145825|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
20145826|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20145827|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
20315127|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20315128|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20315129|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20315130|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760349|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760350|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760351|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760352|NCT00025233|Bevacizumab|bevacizumab|mesh-list
19760353|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19760354|NCT00025233|Antibodies|antibodies|mesh-list
19760355|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
19760356|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19760357|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760358|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19760359|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19760360|NCT00025233|Growth Substances|growth substances|mesh-ancestor
19760361|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760362|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
19760363|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
19760364|NCT00025259|Cytarabine|cytarabine|mesh-list
19760365|NCT00025259|Dexamethasone|dexamethasone|mesh-list
19760366|NCT00025259|Prednisone|prednisone|mesh-list
19760367|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
19760368|NCT00025259|Cortisone|cortisone|mesh-list
19760369|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
19760370|NCT00025259|Cisplatin|cisplatin|mesh-list
19760371|NCT00025259|Doxorubicin|doxorubicin|mesh-list
19760372|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19760373|NCT00025259|Etoposide|etoposide|mesh-list
19760374|NCT00025259|Vincristine|vincristine|mesh-list
20315131|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
20145828|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145829|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20145830|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
20145831|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
19760375|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
19760376|NCT00025259|Bleomycin|bleomycin|mesh-list
19760377|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
19760378|NCT00025259|Lenograstim|lenograstim|mesh-list
19760379|NCT00025259|BB 1101|bb 1101|mesh-list
20145832|NCT00071266|Vitamins|vitamins|mesh-ancestor
20145833|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
19760380|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760381|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
19760382|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760383|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760384|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760385|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
19760386|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760387|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760388|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19760389|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760390|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
20145834|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760391|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
19760392|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760393|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19760394|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
19760395|NCT00025259|Hormones|hormones|mesh-ancestor
19632771|NCT00492999|Leucovorin|leucovorin|mesh-list
19632772|NCT00492999|Dexamethasone|dexamethasone|mesh-list
19632773|NCT00492999|Fluorouracil|fluorouracil|mesh-list
19632774|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
19632775|NCT00492999|Irinotecan|irinotecan|mesh-list
19760396|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760397|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760398|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760399|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760400|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760401|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760402|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760403|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760404|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
19760405|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
19760406|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760407|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19760408|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760409|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760410|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760411|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
19760412|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
19760413|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760414|NCT00025506|Thalidomide|thalidomide|mesh-list
19760415|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760416|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
19760417|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145835|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20145836|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20145837|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145838|NCT00071279|Idraparinux|idraparinux|mesh-list
20145839|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20145840|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
19632776|NCT00492999|Floxuridine|floxuridine|mesh-list
19632777|NCT00492999|Calcium|calcium|mesh-list
19760418|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
19760419|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19760420|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760421|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19760422|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19760423|NCT00025506|Growth Substances|growth substances|mesh-ancestor
19760424|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
19760425|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760426|NCT00025662|Interleukin-2|interleukin-2|mesh-list
19760427|NCT00025662|Immunotoxins|immunotoxins|mesh-list
19760428|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760429|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19760430|NCT00025662|Analgesics|analgesics|mesh-ancestor
19760431|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
19760432|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760433|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760434|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
19760435|NCT00026208|Prednisone|prednisone|mesh-list
19760436|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
19760437|NCT00026208|Doxorubicin|doxorubicin|mesh-list
19760438|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19760439|NCT00026208|Etoposide|etoposide|mesh-list
19760440|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
19760441|NCT00026208|Vincristine|vincristine|mesh-list
19760442|NCT00026208|Bleomycin|bleomycin|mesh-list
19760443|NCT00026208|Vinblastine|vinblastine|mesh-list
19760444|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760445|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
19760446|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760447|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760448|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760449|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
19760450|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145841|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19632778|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
19632779|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760451|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632780|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
19632781|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
19632782|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632783|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760452|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145842|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
20145843|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760453|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760454|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760455|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760456|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760457|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760458|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
19760459|NCT00026208|Hormones|hormones|mesh-ancestor
19760460|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760461|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760462|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760463|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760464|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760465|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760466|NCT00026221|Interferons|interferons|mesh-list
19760467|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
19760468|NCT00026221|Bevacizumab|bevacizumab|mesh-list
19760469|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760470|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760471|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19760472|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19760473|NCT00026221|Growth Substances|growth substances|mesh-ancestor
19760474|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760475|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
19760476|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
19760477|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760478|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
19760479|NCT00026494|Temozolomide|temozolomide|mesh-list
19760480|NCT00026494|Vinorelbine|vinorelbine|mesh-list
19760481|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760482|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
19760483|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760484|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760485|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760486|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145844|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145845|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
20145846|NCT00071331|Tolvaptan|tolvaptan|mesh-list
20145847|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20145848|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145849|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
20145850|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145851|NCT00071448|Insulin|insulin|mesh-list
20145852|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20145853|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
20145854|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
20145855|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20145856|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145857|NCT00071539|Immunotoxins|immunotoxins|mesh-list
20145858|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
20145859|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256624|NCT04337060|Bupivacaine|bupivacaine|mesh-list
19632784|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19632785|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
19632786|NCT00492999|Hormones|hormones|mesh-ancestor
19632787|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632788|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19632789|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632790|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19632791|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
19632792|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632793|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632794|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632795|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
19632796|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19632797|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19632798|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632799|NCT00492999|Antidotes|antidotes|mesh-ancestor
19632800|NCT00492999|Protective Agents|protective agents|mesh-ancestor
19632801|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
19632802|NCT00492999|Vitamins|vitamins|mesh-ancestor
19760487|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760488|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145860|NCT00071643|Citalopram|citalopram|mesh-list
19760489|NCT00027027|Pertuzumab|pertuzumab|mesh-list
19760490|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760491|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760492|NCT00027378|Fluoxetine|fluoxetine|mesh-list
19760493|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19760494|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19760495|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19760496|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760497|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19760498|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
19760499|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760500|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19760501|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
19760502|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19760503|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19760504|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19760505|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760506|NCT00027560|Cyclosporine|cyclosporine|mesh-list
19760507|NCT00027560|Fludarabine|fludarabine|mesh-list
19760508|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
19760509|NCT00027560|Melphalan|melphalan|mesh-list
19760510|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
19760511|NCT00027560|Cyclosporins|cyclosporins|mesh-list
19760512|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760513|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760514|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
19760515|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760516|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760517|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
19760518|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760519|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760520|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
19760521|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760522|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760523|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760524|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19760525|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760526|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
19760527|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19760528|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760529|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
19760530|NCT00027846|Carboplatin|carboplatin|mesh-list
19760531|NCT00027846|Etoposide|etoposide|mesh-list
19760532|NCT00027846|Vincristine|vincristine|mesh-list
19760533|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
19760534|NCT00027846|Lenograstim|lenograstim|mesh-list
19760535|NCT00027846|Sargramostim|sargramostim|mesh-list
19760536|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760537|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
19760538|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760539|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760540|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760541|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
19760542|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760543|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632803|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
19632804|NCT00408473|Flecainide|flecainide|mesh-list
19632805|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19632806|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19632807|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19632808|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632809|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632810|NCT00337675|Montelukast|montelukast|mesh-list
19632811|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19632812|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
19760544|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20145861|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20145862|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20145863|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20145864|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145865|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632813|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19632814|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
19632815|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632816|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632817|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19632818|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19632819|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632820|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
19632821|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
19661648|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19661649|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19661650|NCT03030261|Growth Substances|growth substances|mesh-ancestor
19661651|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
19661652|NCT02969850|Vitamin D|vitamin d|mesh-list
19661653|NCT02969850|Calcium|calcium|mesh-list
19661654|NCT02969850|Vitamins|vitamins|mesh-ancestor
19661655|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
19661656|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661657|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661658|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19661659|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
19661660|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19661661|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19661662|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19661663|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661664|NCT02349867|Gemcitabine|gemcitabine|mesh-list
19661665|NCT02349867|Sorafenib|sorafenib|mesh-list
19661666|NCT02349867|Vorinostat|vorinostat|mesh-list
19661667|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19661668|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
19661669|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661670|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661671|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
19661672|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661673|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661674|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19661675|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
19661676|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661677|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19661678|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19661679|NCT02339766|Morphine|morphine|mesh-list
19661680|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19661681|NCT02339766|Narcotics|narcotics|mesh-ancestor
19661682|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661683|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661684|NCT02339766|Analgesics|analgesics|mesh-ancestor
19661685|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
19661686|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661687|NCT05092386|Vaccines|vaccines|mesh-list
19661688|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
19661689|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665865|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665866|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
19665867|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19665868|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
19665869|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665870|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665871|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19665872|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19665873|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19665874|NCT03524898|Gemcitabine|gemcitabine|mesh-list
19665875|NCT03524898|Paclitaxel|paclitaxel|mesh-list
19665876|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19632822|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632823|NCT00328601|Protective Agents|protective agents|mesh-ancestor
19632824|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632825|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
19632826|NCT00328601|Vitamins|vitamins|mesh-ancestor
19632827|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
19632828|NCT00317772|Topotecan|topotecan|mesh-list
19632829|NCT00317772|Gefitinib|gefitinib|mesh-list
19632830|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19632831|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19632832|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632833|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145866|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
20145867|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145868|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20145869|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
19632834|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632835|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19632836|NCT00294320|Imiquimod|imiquimod|mesh-list
19632837|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19760545|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760546|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760547|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760548|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760549|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19760550|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760551|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760552|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760553|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
19760554|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760555|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
19760556|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760557|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760558|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760559|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760560|NCT00028093|Ribavirin|ribavirin|mesh-list
19760561|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19760562|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
19760563|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
19760564|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760565|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
19760566|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760567|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
19760568|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760569|NCT00028262|Cysteamine|cysteamine|mesh-list
19760570|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19760571|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760572|NCT00028769|Paclitaxel|paclitaxel|mesh-list
19760573|NCT00028769|Etoposide|etoposide|mesh-list
19760574|NCT00028769|Leuprolide|leuprolide|mesh-list
19760575|NCT00028769|Goserelin|goserelin|mesh-list
19632838|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
19632839|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632840|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632841|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
19632842|NCT00291486|Capecitabine|capecitabine|mesh-list
19760576|NCT00028769|Bicalutamide|bicalutamide|mesh-list
20145870|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19256625|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
19760577|NCT00028769|Flutamide|flutamide|mesh-list
19760578|NCT00028769|Estramustine|estramustine|mesh-list
19760579|NCT00028769|Nilutamide|nilutamide|mesh-list
19760580|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760581|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145871|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20145872|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20145873|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20145874|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20145875|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19760582|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760583|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760584|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760585|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760586|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760587|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760588|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760589|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19760590|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
19760591|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19760592|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760593|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760594|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
19760595|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
19760596|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760597|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760598|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
19760599|NCT00029107|Rituximab|rituximab|mesh-list
19760600|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760601|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760602|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
19760603|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760604|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833090|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19833091|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20145876|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145877|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20145878|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145879|NCT00071695|Analgesics|analgesics|mesh-ancestor
20145880|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
20145881|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145882|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
20145883|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20145884|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
20145885|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20145886|NCT00071747|Lamotrigine|lamotrigine|mesh-list
20145887|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
20145888|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20145889|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20145890|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145891|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20145892|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145893|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20145894|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20145895|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20145896|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20145897|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20145898|NCT00071838|Daclizumab|daclizumab|mesh-list
20145899|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19833092|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
19833093|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833094|NCT00755794|Montelukast|montelukast|mesh-list
19833095|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19833096|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833097|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19833098|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
19833099|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833100|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833101|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19833102|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833103|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833104|NCT00700661|Montelukast|montelukast|mesh-list
19833105|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19833106|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833107|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19760605|NCT00029536|Progesterone|progesterone|mesh-list
19760606|NCT00029536|Progestins|progestins|mesh-ancestor
19760607|NCT00029536|Hormones|hormones|mesh-ancestor
19760608|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760609|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760610|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19760611|NCT00030147|Estradiol|estradiol|mesh-list
19760612|NCT00030147|Estrogens|estrogens|mesh-ancestor
19760613|NCT00030147|Hormones|hormones|mesh-ancestor
19760614|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760615|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760616|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19760617|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
19760618|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19760619|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19760620|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19760621|NCT00030264|Methotrexate|methotrexate|mesh-list
19760622|NCT00030264|Vinblastine|vinblastine|mesh-list
19760623|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19760624|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
19760625|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19760626|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760627|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760628|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
19760629|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760630|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760631|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760632|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760633|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19760634|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760635|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
19760636|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760637|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19760638|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760639|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760640|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760641|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760642|NCT00030901|Selenium|selenium|mesh-list
19760643|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
19760644|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760645|NCT00030901|Protective Agents|protective agents|mesh-ancestor
19760646|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760647|NCT00030901|Trace Elements|trace elements|mesh-ancestor
19760648|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
19760649|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
19760650|NCT00030992|Promethazine|promethazine|mesh-list
19760651|NCT00030992|Ranitidine|ranitidine|mesh-list
19760652|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19760653|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19760654|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19760655|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19760656|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760657|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
19760658|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
19760659|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
19760660|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760661|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
19760662|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
19760663|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19632843|NCT00291486|Antibodies|antibodies|mesh-list
19632844|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19632845|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
19632846|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632847|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632848|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
19632849|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632850|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632851|NCT00284856|Fluticasone|fluticasone|mesh-list
19632852|NCT00284856|Montelukast|montelukast|mesh-list
19632853|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632854|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19632855|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
19632856|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632857|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760664|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20145900|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
20145901|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145902|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
20145903|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145904|NCT00071942|Metronidazole|metronidazole|mesh-list
20145905|NCT00071942|Vaccines|vaccines|mesh-list
20145906|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
20145907|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145908|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760665|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
19760666|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
19760667|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19760668|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760669|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19760670|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
19760671|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760672|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19760673|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19760674|NCT00031447|Acyclovir|acyclovir|mesh-list
19760675|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
19760676|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760677|NCT00031460|Acyclovir|acyclovir|mesh-list
19760678|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
19760679|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760680|NCT00031486|Valacyclovir|valacyclovir|mesh-list
19760681|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
19760682|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760683|NCT00031551|Etanercept|etanercept|mesh-list
19760684|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19760685|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20145909|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20145910|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20145911|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20145912|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
20145913|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20145914|NCT00071955|Antibodies|antibodies|mesh-list
20145915|NCT00071955|Sargramostim|sargramostim|mesh-list
20145916|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20145917|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
20145918|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145919|NCT00071968|Sirolimus|sirolimus|mesh-list
20145920|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20145921|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145922|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145923|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760686|NCT00031551|Analgesics|analgesics|mesh-ancestor
19760687|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
19760688|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760689|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760690|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760691|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760692|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19760693|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760694|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
19760695|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
19760696|NCT00031590|Lomustine|lomustine|mesh-list
19760697|NCT00031590|Etoposide|etoposide|mesh-list
19760698|NCT00031590|Vincristine|vincristine|mesh-list
19760699|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760700|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
19760701|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145924|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
20145925|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145926|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
20145927|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760702|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760703|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760704|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
19760705|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760706|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760707|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19760708|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760709|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760710|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760711|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760712|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145928|NCT00071994|Gefitinib|gefitinib|mesh-list
20145929|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760713|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760714|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760715|NCT00031694|Paclitaxel|paclitaxel|mesh-list
19760716|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
20145930|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20145931|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145932|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145933|NCT00072007|Prednisone|prednisone|mesh-list
20145934|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
20145935|NCT00072007|Rituximab|rituximab|mesh-list
20145936|NCT00072007|Doxorubicin|doxorubicin|mesh-list
20145937|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20145938|NCT00072007|Vincristine|vincristine|mesh-list
20145939|NCT00072007|Cladribine|cladribine|mesh-list
20145940|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20145941|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
20145942|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145943|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20145944|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20145945|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
19760717|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760718|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760719|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760720|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760721|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760722|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760723|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19760724|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
19760725|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760726|NCT00032487|Metformin|metformin|mesh-list
19760727|NCT00032487|Glimepiride|glimepiride|mesh-list
19760728|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
19760729|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19760730|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760731|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19760732|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760733|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
19760734|NCT00032591|Thrombin|thrombin|mesh-list
19760735|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
19760736|NCT00032591|Coagulants|coagulants|mesh-ancestor
19760737|NCT00033371|Eflornithine|eflornithine|mesh-list
19760738|NCT00033371|Celecoxib|celecoxib|mesh-list
19760739|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19760740|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19760741|NCT00033371|Analgesics|analgesics|mesh-ancestor
19760742|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
19760743|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760744|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760745|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760746|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760747|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19760748|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19760749|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760750|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760751|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760752|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20145946|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145947|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632858|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19632859|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
19632860|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
19632861|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19632862|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19632863|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
19632864|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632865|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19632866|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19632867|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632868|NCT00189319|Flecainide|flecainide|mesh-list
19632869|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19632870|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19760753|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19760754|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19760755|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20145948|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20173813|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
19760756|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19760757|NCT00033514|Trastuzumab|trastuzumab|mesh-list
19760758|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19760759|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19760760|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760761|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760762|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760763|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760764|NCT00033540|Gemcitabine|gemcitabine|mesh-list
19760765|NCT00033540|Capecitabine|capecitabine|mesh-list
19760766|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760767|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
19760768|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760769|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760770|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
19760771|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760772|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760773|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760774|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
19760775|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760776|NCT00033657|Paclitaxel|paclitaxel|mesh-list
19760777|NCT00033657|Camptothecin|camptothecin|mesh-list
19760778|NCT00033657|Cisplatin|cisplatin|mesh-list
19760779|NCT00033657|Irinotecan|irinotecan|mesh-list
19760780|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760781|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760782|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760783|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760784|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760785|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760786|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19760787|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760788|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760789|NCT00033917|Indomethacin|indomethacin|mesh-list
19760790|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19760791|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19760792|NCT00033917|Analgesics|analgesics|mesh-ancestor
19760793|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
19760794|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760795|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760796|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760797|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760798|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
19760799|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
19760800|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19760801|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19760802|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760803|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760804|NCT00035555|Cyclosporine|cyclosporine|mesh-list
19760805|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
19760806|NCT00035555|Abatacept|abatacept|mesh-list
19760807|NCT00035555|Cyclosporins|cyclosporins|mesh-list
19760808|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145949|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145950|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20145951|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760809|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760810|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760811|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
19760812|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760813|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
19760814|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760815|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760816|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760817|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19760818|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760819|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760820|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19760821|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
19760822|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20145952|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20145953|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145954|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20145955|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
19760823|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19760824|NCT00035815|Mitogens|mitogens|mesh-list
19760825|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760826|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760827|NCT00035932|Ritonavir|ritonavir|mesh-list
19760828|NCT00035932|Lopinavir|lopinavir|mesh-list
19760829|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19760830|NCT00035932|Saquinavir|saquinavir|mesh-list
19760831|NCT00035932|Tenofovir|tenofovir|mesh-list
19760832|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19760833|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19760834|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
19760835|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760836|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760837|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19760838|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19760839|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
19760840|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760841|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19760842|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19760843|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19760844|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19760845|NCT00036270|Tamoxifen|tamoxifen|mesh-list
19760846|NCT00036270|Exemestane|exemestane|mesh-list
19760847|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19760848|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
19760849|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760850|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760851|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760852|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760853|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19760854|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19760855|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19760856|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19760857|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19760858|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760859|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760860|NCT00036569|Interferons|interferons|mesh-list
19760861|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
19760862|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760863|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
19760864|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760865|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
19760866|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760867|NCT00036738|Cyclosporine|cyclosporine|mesh-list
19760868|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
19760869|NCT00036738|Fludarabine|fludarabine|mesh-list
19760870|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
19760871|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
19760872|NCT00036738|Dasatinib|dasatinib|mesh-list
19760873|NCT00036738|Cyclosporins|cyclosporins|mesh-list
19760874|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760875|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760876|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
19760877|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760878|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760879|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
19760880|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760881|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760882|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
19760883|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760884|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
19760885|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760886|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19760887|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760888|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19760889|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
19760890|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19760891|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760892|NCT00038103|Celecoxib|celecoxib|mesh-list
19760893|NCT00038103|Exemestane|exemestane|mesh-list
19760894|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19760895|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19760896|NCT00038103|Analgesics|analgesics|mesh-ancestor
19760897|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
20145956|NCT00072007|Hormones|hormones|mesh-ancestor
19760898|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760899|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760900|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760901|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760902|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19760903|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19760904|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20145957|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20145958|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20145959|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20145960|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145961|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145962|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145963|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
20145964|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19760905|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760906|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760907|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19760908|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19760909|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19760910|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
19760911|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760912|NCT00038467|Tamoxifen|tamoxifen|mesh-list
19760913|NCT00038467|Exemestane|exemestane|mesh-list
19760914|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19760915|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
19760916|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760917|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760918|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760919|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760920|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19760921|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19760922|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19760923|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19760924|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19760925|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760926|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760927|NCT00038610|Cytarabine|cytarabine|mesh-list
19760928|NCT00038610|Dexamethasone|dexamethasone|mesh-list
19760929|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
19760930|NCT00038610|Doxorubicin|doxorubicin|mesh-list
19760931|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19760932|NCT00038610|Methotrexate|methotrexate|mesh-list
19760933|NCT00038610|Vincristine|vincristine|mesh-list
19760934|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
19760935|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760936|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
19760937|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760938|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19760939|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760940|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
19760941|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760942|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760943|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19760944|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19760945|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
19760946|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
19760947|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19760948|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19760949|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
19760950|NCT00038610|Hormones|hormones|mesh-ancestor
19760951|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19760952|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19760953|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19760954|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19760955|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19760956|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760957|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19760958|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
19760959|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19760960|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760961|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
19760962|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315132|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19760963|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19760964|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19760965|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
19760966|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760967|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19760968|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19760969|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
19760970|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
19760971|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760972|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
19760973|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19760974|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19760975|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19760976|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760977|NCT00038857|Vidarabine|vidarabine|mesh-list
19760978|NCT00038857|Fludarabine|fludarabine|mesh-list
19760979|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
19760980|NCT00038857|Melphalan|melphalan|mesh-list
19760981|NCT00038857|Thiotepa|thiotepa|mesh-list
19760982|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
19760983|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19760984|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145965|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145966|NCT00072033|Docetaxel|docetaxel|mesh-list
20145967|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145968|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
20145969|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
20145970|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145971|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145972|NCT00072046|Interferons|interferons|mesh-list
19760985|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19760986|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
19760987|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19760988|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19760989|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
19760990|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19760991|NCT00038857|Antiviral Agents|antiviral agents|mesh-ancestor
19760992|NCT00038857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19760993|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19760994|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
19760995|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19760996|NCT00038948|Cyclosporine|cyclosporine|mesh-list
19760997|NCT00038948|Sirolimus|sirolimus|mesh-list
19760998|NCT00038948|Tacrolimus|tacrolimus|mesh-list
19760999|NCT00038948|Cyclosporins|cyclosporins|mesh-list
19761000|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761001|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
19761002|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761003|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19761004|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761005|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761006|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
19761007|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761008|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761009|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761010|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761011|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761012|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761013|NCT00039130|Leucovorin|leucovorin|mesh-list
19761014|NCT00039130|Cytarabine|cytarabine|mesh-list
19761015|NCT00039130|Dexamethasone|dexamethasone|mesh-list
19761016|NCT00039130|Prednisone|prednisone|mesh-list
19761017|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
19761018|NCT00039130|Ifosfamide|ifosfamide|mesh-list
19761019|NCT00039130|Rituximab|rituximab|mesh-list
19761020|NCT00039130|Doxorubicin|doxorubicin|mesh-list
19761021|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19761022|NCT00039130|Methotrexate|methotrexate|mesh-list
19761023|NCT00039130|Etoposide|etoposide|mesh-list
19761024|NCT00039130|Vincristine|vincristine|mesh-list
19761025|NCT00039130|Allopurinol|allopurinol|mesh-list
19761026|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
19761027|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761028|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
19761029|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761030|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761031|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761032|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
20145973|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
19833108|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
20145974|NCT00072046|Bevacizumab|bevacizumab|mesh-list
20145975|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20145976|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20145977|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20145978|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20145979|NCT00072046|Growth Substances|growth substances|mesh-ancestor
20145980|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145981|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
20145982|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
20145983|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761033|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761034|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761035|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761036|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761037|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761038|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
19761039|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
19761040|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761041|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19761042|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
19761043|NCT00039130|Hormones|hormones|mesh-ancestor
19761044|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761045|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19761046|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761047|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20145984|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
20145985|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
20145986|NCT00072059|Hematinics|hematinics|mesh-ancestor
19761048|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761049|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761050|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19761051|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
19761052|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19761053|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761054|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
20145987|NCT00072072|Celecoxib|celecoxib|mesh-list
20315133|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315134|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20315135|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
20315136|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
20315137|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761055|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761056|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19761057|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19761058|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761059|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
19761060|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761061|NCT00039130|Antidotes|antidotes|mesh-ancestor
19761062|NCT00039130|Protective Agents|protective agents|mesh-ancestor
19761063|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
19761064|NCT00039130|Vitamins|vitamins|mesh-ancestor
19761065|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
19761066|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315138|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
20315139|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20315140|NCT00697151|Aspirin|aspirin|mesh-list
20315141|NCT00697151|Warfarin|warfarin|mesh-list
20315142|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20315143|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315144|NCT00697151|Analgesics|analgesics|mesh-ancestor
19761067|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761068|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
20145988|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20315145|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
20145989|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315146|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761069|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
20145990|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20145991|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761070|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19761071|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
19761072|NCT00039195|Prednisone|prednisone|mesh-list
19761073|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
20145992|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20145993|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20145994|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20145995|NCT00072072|Analgesics|analgesics|mesh-ancestor
20145996|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
20145997|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20145998|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20145999|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146000|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146001|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19761074|NCT00039195|Ifosfamide|ifosfamide|mesh-list
19761075|NCT00039195|Rituximab|rituximab|mesh-list
19761076|NCT00039195|Carboplatin|carboplatin|mesh-list
19761077|NCT00039195|Doxorubicin|doxorubicin|mesh-list
19761078|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19761079|NCT00039195|Etoposide|etoposide|mesh-list
19761080|NCT00039195|Vincristine|vincristine|mesh-list
19761081|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761082|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
19761083|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761084|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761085|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761086|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
19761087|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761088|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761089|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761090|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761091|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761092|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761093|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761094|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761095|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761096|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
19761097|NCT00039195|Hormones|hormones|mesh-ancestor
19761098|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761099|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19761100|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761101|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761102|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761103|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761104|NCT00039377|Leucovorin|leucovorin|mesh-list
19761105|NCT00039377|Cytarabine|cytarabine|mesh-list
19761106|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
19761107|NCT00039377|Methotrexate|methotrexate|mesh-list
19761108|NCT00039377|Etoposide|etoposide|mesh-list
19761109|NCT00039377|Vincristine|vincristine|mesh-list
19632871|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19632872|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632873|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632874|NCT00189293|Imiquimod|imiquimod|mesh-list
19632875|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632876|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
19632877|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632878|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632879|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
19761110|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
20146002|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20146003|NCT00072085|Aldesleukin|aldesleukin|mesh-list
20146004|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
20173814|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19632880|NCT00189267|Imiquimod|imiquimod|mesh-list
19632881|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632882|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
19761111|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
19761112|NCT00039377|Tacrolimus|tacrolimus|mesh-list
19761113|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
19761114|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761115|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
19761116|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761117|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761118|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761119|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
19761120|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761121|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761122|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761123|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19761124|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
19761125|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19761126|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761127|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
19761128|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761129|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146005|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146006|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20146007|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20146008|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
20146009|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146010|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20146011|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
20146012|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761130|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19761131|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19761132|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761133|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761134|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761135|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
19761136|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146013|NCT00072098|Interleukin-12|interleukin-12|mesh-list
20146014|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20146015|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
20146016|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146017|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20146018|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20146019|NCT00072098|Growth Substances|growth substances|mesh-ancestor
20146020|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
20146021|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146022|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20146023|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146024|NCT00072124|Dacarbazine|dacarbazine|mesh-list
20146025|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146026|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146027|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
20146028|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146029|NCT00072137|Metronidazole|metronidazole|mesh-list
20146030|NCT00072137|Molgramostim|molgramostim|mesh-list
20146031|NCT00072137|Vaccines|vaccines|mesh-list
20146032|NCT00072137|Sargramostim|sargramostim|mesh-list
20146033|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
20146034|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146035|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146036|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146037|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20146038|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20146039|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20146040|NCT00072150|Bortezomib|bortezomib|mesh-list
20146041|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146042|NCT00072163|Thalidomide|thalidomide|mesh-list
20146043|NCT00072163|Temozolomide|temozolomide|mesh-list
20146044|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146045|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
20146046|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146047|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146048|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146049|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
20146050|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146051|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
20146052|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20146053|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146054|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20146055|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20146056|NCT00072163|Growth Substances|growth substances|mesh-ancestor
20146057|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
20146058|NCT00072215|Paclitaxel|paclitaxel|mesh-list
20146059|NCT00072215|Vinblastine|vinblastine|mesh-list
19761137|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19761138|NCT00039377|Antidotes|antidotes|mesh-ancestor
20146060|NCT00072215|Ifosfamide|ifosfamide|mesh-list
20146061|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20146062|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146063|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146064|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146065|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146066|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146067|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146068|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
20146069|NCT00072228|Gemcitabine|gemcitabine|mesh-list
20146070|NCT00072228|Soblidotin|soblidotin|mesh-list
20146071|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19632883|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632884|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632885|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
19632886|NCT00189254|Imiquimod|imiquimod|mesh-list
20146072|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
19632887|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632888|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
19632889|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632890|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632891|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
19632892|NCT00189241|Imiquimod|imiquimod|mesh-list
19632893|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632894|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
19632895|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632896|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632897|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
19632898|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
19632899|NCT00070707|Albuterol|albuterol|mesh-list
19632900|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19632901|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
19632902|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632903|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632904|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19632905|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
19632906|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
19632907|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19632908|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19632909|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19761139|NCT00039377|Protective Agents|protective agents|mesh-ancestor
19632910|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20146073|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761140|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
19761141|NCT00039377|Vitamins|vitamins|mesh-ancestor
19761142|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
19761143|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761144|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761145|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761146|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761147|NCT00039871|Ribavirin|ribavirin|mesh-list
19761148|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19761149|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
19761150|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
19761151|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761152|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
19761153|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146074|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146075|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
20146076|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146077|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146078|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146079|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
20146080|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146081|NCT00072267|Topotecan|topotecan|mesh-list
20146082|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20146083|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20146084|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146085|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146086|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146087|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146088|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20146089|NCT00072319|Paclitaxel|paclitaxel|mesh-list
20146090|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
20146091|NCT00072319|Epirubicin|epirubicin|mesh-list
20146092|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20146093|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146094|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146095|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146096|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
20315147|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315148|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20315149|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315150|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20315151|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20315152|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315153|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20315154|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20315155|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315156|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
20315157|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
20315158|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
20315159|NCT00697164|Hematinics|hematinics|mesh-ancestor
20315160|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
20315161|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20608689|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19256626|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
19632911|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
19632912|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632913|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632914|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19632915|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19632916|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19632917|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
19632918|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19761154|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
20146097|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173815|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
20315162|NCT00697281|Growth Substances|growth substances|mesh-ancestor
20608690|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608691|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
20608692|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608693|NCT02247596|Resveratrol|resveratrol|mesh-list
20608694|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
20608695|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608696|NCT02247596|Protective Agents|protective agents|mesh-ancestor
19761155|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761156|NCT00040365|Amifostine|amifostine|mesh-list
19761157|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19761158|NCT00040365|Protective Agents|protective agents|mesh-ancestor
19761159|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761160|NCT00040664|Ritonavir|ritonavir|mesh-list
19761161|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
19761162|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19761163|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19761164|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
19761165|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761166|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761167|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19761168|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19761169|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
19761170|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761171|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19761172|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19761173|NCT00040846|Cyclosporine|cyclosporine|mesh-list
19761174|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
19761175|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19761176|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
19761177|NCT00040846|Fludarabine|fludarabine|mesh-list
19761178|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
19761179|NCT00040846|Antibodies|antibodies|mesh-list
19761180|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
19761181|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19761182|NCT00040846|Cyclosporins|cyclosporins|mesh-list
19761183|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
19761184|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761185|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761186|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761187|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
19761188|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761189|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761190|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761191|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
19761192|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761193|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761194|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761195|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19761196|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761197|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19761198|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
19761199|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761200|NCT00040937|Thalidomide|thalidomide|mesh-list
19761201|NCT00040937|Dexamethasone|dexamethasone|mesh-list
19761202|NCT00040937|Prednisone|prednisone|mesh-list
19761203|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
19761204|NCT00040937|Melphalan|melphalan|mesh-list
19761205|NCT00040937|Sargramostim|sargramostim|mesh-list
19761206|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761207|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
19761208|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146098|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632919|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
19632920|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632921|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
19632922|NCT02444169|Protective Agents|protective agents|mesh-ancestor
19661690|NCT05091775|Mesalamine|mesalamine|mesh-list
19661691|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19661692|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19661693|NCT05091775|Analgesics|analgesics|mesh-ancestor
19661694|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
19661695|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661696|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661697|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661698|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19661699|NCT05091606|Anesthetics|anesthetics|mesh-list
19661700|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661701|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661702|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
19661703|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19761209|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761210|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761211|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
20146099|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
19761212|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761213|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315163|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315164|NCT00697372|Sirolimus|sirolimus|mesh-list
20315165|NCT00697372|Everolimus|everolimus|mesh-list
20315166|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315167|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315168|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
20315169|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315170|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20315171|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315172|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20315173|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
20315174|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
20315175|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20315176|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20315177|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315178|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
20315179|NCT00697385|Coagulants|coagulants|mesh-ancestor
20315180|NCT00697437|Ketoconazole|ketoconazole|mesh-list
20315181|NCT00697437|Docetaxel|docetaxel|mesh-list
20315182|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315183|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315184|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761214|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761215|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761216|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
20146100|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146101|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146102|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146103|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
20146104|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20146105|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20146106|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20315185|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761217|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
19761218|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761219|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19761220|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
19761221|NCT00040937|Hormones|hormones|mesh-ancestor
19761222|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761223|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19761224|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
19761225|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761226|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761227|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19761228|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19761229|NCT00040937|Growth Substances|growth substances|mesh-ancestor
19761230|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
19761231|NCT00041067|Docetaxel|docetaxel|mesh-list
19761232|NCT00041067|Trastuzumab|trastuzumab|mesh-list
19761233|NCT00041067|Vinorelbine|vinorelbine|mesh-list
19761234|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761235|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761236|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761237|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761238|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761239|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761240|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761241|NCT00041080|Tamoxifen|tamoxifen|mesh-list
19761242|NCT00041080|Thalidomide|thalidomide|mesh-list
19761243|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19761244|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
19761245|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761246|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761247|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19761248|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761249|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19761250|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19761251|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19761252|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761253|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
20146107|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20315186|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761254|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
19761255|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761256|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761257|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19761258|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19761259|NCT00041080|Growth Substances|growth substances|mesh-ancestor
19761260|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
19761261|NCT00041119|Paclitaxel|paclitaxel|mesh-list
19761262|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
19761263|NCT00041119|Doxorubicin|doxorubicin|mesh-list
19761264|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19761265|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761266|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761267|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761268|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761269|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761270|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761271|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761272|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
19761273|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761274|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761275|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761276|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
19632923|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19632924|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19632925|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632926|NCT02444364|Incretins|incretins|mesh-ancestor
19632927|NCT02444364|Hormones|hormones|mesh-ancestor
19632928|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19632929|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19632930|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
19632931|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632932|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632933|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
19632934|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19761277|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761278|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761279|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761280|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761281|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761282|NCT00041132|Leucovorin|leucovorin|mesh-list
19761283|NCT00041132|Cytarabine|cytarabine|mesh-list
19761284|NCT00041132|Dexamethasone|dexamethasone|mesh-list
19761285|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
19761286|NCT00041132|Rituximab|rituximab|mesh-list
19761287|NCT00041132|Doxorubicin|doxorubicin|mesh-list
19761288|NCT00041132|Methotrexate|methotrexate|mesh-list
19761289|NCT00041132|Vincristine|vincristine|mesh-list
19761290|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
19761291|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761292|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
19761293|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761294|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761295|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761296|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
19761297|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761298|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761299|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761300|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761301|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761302|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
19761303|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
19761304|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761305|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19761306|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
20146108|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315187|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
19632935|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19761307|NCT00041132|Hormones|hormones|mesh-ancestor
19761308|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761309|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19761310|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761311|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761312|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146109|NCT00072332|Cisplatin|cisplatin|mesh-list
19632936|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19632937|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632938|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632939|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
19632940|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19632941|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146110|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146111|NCT00072345|Thalidomide|thalidomide|mesh-list
20146112|NCT00072345|Temozolomide|temozolomide|mesh-list
19761313|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761314|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19761315|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
19761316|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19761317|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761318|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
19761319|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761320|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20146113|NCT00072345|Lomustine|lomustine|mesh-list
20146114|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146115|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
20146116|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146117|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146118|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146119|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
20146120|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146121|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
20146122|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20146123|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146124|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20146125|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20146126|NCT00072345|Growth Substances|growth substances|mesh-ancestor
20146127|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
20146128|NCT00072436|Gemcitabine|gemcitabine|mesh-list
20146129|NCT00072436|Alvocidib|alvocidib|mesh-list
20146130|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146131|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
20146132|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146133|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632942|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19632943|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632944|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
19632945|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632946|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
19632947|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632948|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19632949|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19632950|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
19761321|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19761322|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
19761323|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761324|NCT00041132|Antidotes|antidotes|mesh-ancestor
19761325|NCT00041132|Protective Agents|protective agents|mesh-ancestor
19761326|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
19761327|NCT00041132|Vitamins|vitamins|mesh-ancestor
19761328|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
19761329|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761330|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761331|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761332|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761333|NCT00041470|Paclitaxel|paclitaxel|mesh-list
19761334|NCT00041470|Vinorelbine|vinorelbine|mesh-list
19761335|NCT00041470|Trastuzumab|trastuzumab|mesh-list
19761336|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761337|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761338|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761339|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761340|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761341|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761342|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761343|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
19761344|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19761345|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19761346|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146134|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
20146135|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761347|NCT00041938|Aspirin|aspirin|mesh-list
19761348|NCT00041938|Warfarin|warfarin|mesh-list
19761349|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19761350|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19761351|NCT00041938|Analgesics|analgesics|mesh-ancestor
19761352|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
19761353|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761354|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761355|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761356|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761357|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19761358|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19761359|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761360|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19761361|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19761362|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761363|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
19761364|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
19761365|NCT00042224|Clozapine|clozapine|mesh-list
19761366|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19761367|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
19761368|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761369|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761370|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761371|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19761372|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19761373|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19761374|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19761375|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
19761376|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
19761377|NCT00042432|Cinacalcet|cinacalcet|mesh-list
19761378|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19761379|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761380|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19761381|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
19761382|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761383|NCT00042939|Docetaxel|docetaxel|mesh-list
19761384|NCT00042939|Irinotecan|irinotecan|mesh-list
19761385|NCT00042939|Cetuximab|cetuximab|mesh-list
19761386|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761387|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761388|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761389|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761390|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761391|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19761392|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146136|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146137|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146138|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
20146139|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146140|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
20146141|NCT00072436|Growth Substances|growth substances|mesh-ancestor
20146142|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20146143|NCT00072462|Tamoxifen|tamoxifen|mesh-list
20146144|NCT00072462|Anastrozole|anastrozole|mesh-list
20146145|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146146|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20146147|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
20146148|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315188|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315189|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20315190|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19661704|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
19661705|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661706|NCT05091359|Calcium|calcium|mesh-list
19661707|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661708|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661709|NCT05091203|Vitamin D|vitamin d|mesh-list
19661710|NCT05091203|Vitamins|vitamins|mesh-ancestor
19661711|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
19661712|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661713|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19661714|NCT05091177|Acetylcholine|acetylcholine|mesh-list
19661715|NCT05091177|Antibodies|antibodies|mesh-list
19661716|NCT05091177|Neostigmine|neostigmine|mesh-list
19761393|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761394|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761395|NCT00042991|Gefitinib|gefitinib|mesh-list
19761396|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761397|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761398|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761399|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761400|NCT00043186|Denosumab|denosumab|mesh-list
19761401|NCT00043186|Alendronate|alendronate|mesh-list
19761402|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19761403|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761404|NCT00043550|Sertraline|sertraline|mesh-list
19761405|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19761406|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
19761407|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19761408|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19761409|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20146149|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146150|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20146151|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146152|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20146153|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20146154|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20146155|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20146156|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20146157|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146158|NCT00072527|Carboplatin|carboplatin|mesh-list
20146159|NCT00072527|Irinotecan|irinotecan|mesh-list
20146160|NCT00072527|Etoposide|etoposide|mesh-list
20146161|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146162|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20146163|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146164|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146165|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146166|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20146167|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20146168|NCT00072540|Celecoxib|celecoxib|mesh-list
20146169|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20146170|NCT00072540|Mitogens|mitogens|mesh-list
20146171|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20146172|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20146173|NCT00072540|Analgesics|analgesics|mesh-ancestor
20146174|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
20146175|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146176|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146177|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146178|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146179|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20146180|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20146181|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146182|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146183|NCT00072553|Leucovorin|leucovorin|mesh-list
20146184|NCT00072553|Celecoxib|celecoxib|mesh-list
20146185|NCT00072553|Fluorouracil|fluorouracil|mesh-list
20146186|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
20146187|NCT00072553|Calcium|calcium|mesh-list
20146188|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
20146189|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20146190|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632951|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632952|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632953|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19632954|NCT02444260|Lidocaine|lidocaine|mesh-list
19632955|NCT02444260|Midazolam|midazolam|mesh-list
19632956|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19632957|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19632958|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19632959|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632960|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19632961|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19632962|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19632963|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19761410|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632964|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
19632965|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
19632966|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
20146191|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
20146192|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146193|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146194|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146195|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146196|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
20146197|NCT00072553|Antidotes|antidotes|mesh-ancestor
20146198|NCT00072553|Protective Agents|protective agents|mesh-ancestor
20146199|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
20146200|NCT00072553|Vitamins|vitamins|mesh-ancestor
20146201|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
20146202|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20146203|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20146204|NCT00072553|Analgesics|analgesics|mesh-ancestor
20146205|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
20146206|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146207|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146208|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146209|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19761411|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761412|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761413|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
19761414|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761415|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19761416|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19761417|NCT00043979|Cyclosporine|cyclosporine|mesh-list
19761418|NCT00043979|Sirolimus|sirolimus|mesh-list
19761419|NCT00043979|Prednisone|prednisone|mesh-list
19761420|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
19761421|NCT00043979|Melphalan|melphalan|mesh-list
19761422|NCT00043979|Doxorubicin|doxorubicin|mesh-list
19761423|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19761424|NCT00043979|Fludarabine|fludarabine|mesh-list
19761425|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
19761426|NCT00043979|Etoposide|etoposide|mesh-list
19761427|NCT00043979|Vincristine|vincristine|mesh-list
19761428|NCT00043979|Tacrolimus|tacrolimus|mesh-list
19761429|NCT00043979|Cyclosporins|cyclosporins|mesh-list
19761430|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19761431|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761432|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
20146210|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20146211|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146212|NCT00072579|Sargramostim|sargramostim|mesh-list
19632967|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
19632968|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761433|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761434|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761435|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761436|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
19761437|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761438|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761439|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761440|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761441|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761442|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761443|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761444|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761445|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
19761446|NCT00043979|Hormones|hormones|mesh-ancestor
19761447|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761448|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19761449|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761450|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
20146213|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
19632969|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19632970|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
19632971|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
19632972|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19632973|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19761451|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761452|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20146214|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146215|NCT00072592|Rituximab|rituximab|mesh-list
20146216|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761453|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761454|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761455|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761456|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
19761457|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761458|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761459|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19632974|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19632975|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19632976|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19632977|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
20146217|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146218|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
20146219|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146220|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146221|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
20146222|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146223|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20146224|NCT00072618|Protective Agents|protective agents|mesh-ancestor
20146225|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146226|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20146227|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146228|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146229|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20146230|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20146231|NCT00072618|Analgesics|analgesics|mesh-ancestor
20146232|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
20146233|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146234|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146235|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146236|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20146237|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761460|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19761461|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19761462|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19761463|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19761464|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19761465|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761466|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19761467|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19761468|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19761469|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19761470|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
19761471|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761472|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761473|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19761474|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20146238|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20146239|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19632978|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19632979|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
19632980|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632981|NCT02443727|Oxytocin|oxytocin|mesh-list
19632982|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
19761475|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
19761476|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19761477|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19761478|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
19761479|NCT00044044|Haloperidol|haloperidol|mesh-list
19761480|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
19761481|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19761482|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
19761483|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
19761484|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761485|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761486|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19761487|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19632983|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19632984|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632985|NCT02443818|Sirolimus|sirolimus|mesh-list
19761488|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19632986|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19632987|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761489|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19761490|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19761491|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19761492|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
19761493|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761494|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761495|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19632988|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19632989|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19632990|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
19632991|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19632992|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
19632993|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19632994|NCT02444013|Folic Acid|folic acid|mesh-list
19632995|NCT02444013|Uric Acid|uric acid|mesh-list
19632996|NCT02444013|Hematinics|hematinics|mesh-ancestor
19632997|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
19632998|NCT02444013|Vitamins|vitamins|mesh-ancestor
19632999|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
19633000|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633001|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
19633002|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633003|NCT02444013|Protective Agents|protective agents|mesh-ancestor
19633004|NCT02443844|Tamsulosin|tamsulosin|mesh-list
19633005|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19633006|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19633007|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19633008|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
19633009|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633010|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633011|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633012|NCT02443844|Urological Agents|urological agents|mesh-ancestor
19633013|NCT02443922|Metformin|metformin|mesh-list
19633014|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19633015|NCT02443922|Glimepiride|glimepiride|mesh-list
19633016|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633017|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633018|NCT02443922|Incretins|incretins|mesh-ancestor
19633019|NCT02443922|Hormones|hormones|mesh-ancestor
19633020|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633021|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19633022|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
19761496|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19761497|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19761498|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19761499|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
19761500|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19761501|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19761502|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
19633023|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633024|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633025|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19633026|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633027|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
19633028|NCT02443714|Insulin|insulin|mesh-list
19761503|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19761504|NCT00044083|Tolcapone|tolcapone|mesh-list
19761505|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19761506|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19761507|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19761508|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761509|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761510|NCT00044213|Vitamins|vitamins|mesh-list
19761511|NCT00044213|Edetic Acid|edetic acid|mesh-list
19761512|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
19761513|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
19761514|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761515|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
19761516|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19761517|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
20146240|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633029|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19633030|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
19761518|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
19761519|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761520|NCT00044213|Antidotes|antidotes|mesh-ancestor
19761521|NCT00044213|Protective Agents|protective agents|mesh-ancestor
19761522|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19761523|NCT00044512|Sorafenib|sorafenib|mesh-list
19761524|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761525|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761526|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761527|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761528|NCT00044655|Olanzapine|olanzapine|mesh-list
19761529|NCT00044655|Risperidone|risperidone|mesh-list
19761530|NCT00044655|Aripiprazole|aripiprazole|mesh-list
19761531|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19761532|NCT00044655|Ziprasidone|ziprasidone|mesh-list
19761533|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19761534|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
19761535|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761536|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761537|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761538|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19761539|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19761540|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19761541|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19761542|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19761543|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
19761544|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
19761545|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
20146241|NCT00072670|Trabectedin|trabectedin|mesh-list
20146242|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146243|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
20146244|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146245|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146246|NCT00072683|Tolvaptan|tolvaptan|mesh-list
20146247|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20146248|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146249|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
20146250|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146251|NCT00072722|Pomalidomide|pomalidomide|mesh-list
20146252|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
20146253|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146254|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20146255|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19761546|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761547|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19761548|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19761549|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19761550|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19761551|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
19761552|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
19633031|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633032|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146256|NCT00072722|Growth Substances|growth substances|mesh-ancestor
20146257|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
20146258|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146259|NCT00072748|EKB 569|ekb 569|mesh-list
20146260|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146261|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19633033|NCT02443623|Vaccines|vaccines|mesh-list
19633034|NCT02443623|Immunologic Factors|immunologic factors|mesh-ancestor
19633035|NCT02443623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633036|NCT02443545|Deferiprone|deferiprone|mesh-list
19633037|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19633038|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
19633039|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
19633040|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633041|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
19633042|NCT02443285|Cefotaxime|cefotaxime|mesh-list
19633043|NCT02443285|Cefoxitin|cefoxitin|mesh-list
19633044|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19633045|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633046|NCT02443246|Vitamin D|vitamin d|mesh-list
19633047|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
20146262|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173816|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633048|NCT02443246|Vitamins|vitamins|mesh-ancestor
19761553|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19761554|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19633049|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
19761555|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19761556|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19761557|NCT00045032|Trastuzumab|trastuzumab|mesh-list
19761558|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761559|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761560|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19761561|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761562|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761563|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761564|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761565|NCT00045162|Irinotecan|irinotecan|mesh-list
19761566|NCT00045162|Etoposide|etoposide|mesh-list
19761567|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761568|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19761569|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761570|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761571|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761572|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761573|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761574|NCT00045305|Cyclosporine|cyclosporine|mesh-list
19761575|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
19761576|NCT00045305|Methotrexate|methotrexate|mesh-list
19761577|NCT00045305|Pentostatin|pentostatin|mesh-list
19761578|NCT00045305|Methoxsalen|methoxsalen|mesh-list
19761579|NCT00045305|Cyclosporins|cyclosporins|mesh-list
19761580|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19761581|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
19761582|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19761583|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761584|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761585|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
19761586|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761587|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761588|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761589|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761590|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19761591|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761592|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
19761593|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761594|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19761595|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
19761596|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761597|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19761598|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761599|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19761600|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
19761601|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761602|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19761603|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19761604|NCT00045435|Cyclosporine|cyclosporine|mesh-list
19761605|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
19761606|NCT00045435|Fludarabine|fludarabine|mesh-list
19761607|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
20146263|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146264|NCT00072787|Cisplatin|cisplatin|mesh-list
20146265|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146266|NCT00072826|Acetylcholine|acetylcholine|mesh-list
19633050|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633051|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20146267|NCT00072826|Oxypurinol|oxypurinol|mesh-list
20146268|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
20146269|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19633052|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19633053|NCT02443311|Betamethasone|betamethasone|mesh-list
19633054|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
19633055|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19633056|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
19633057|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
19761608|NCT00045435|Cyclosporins|cyclosporins|mesh-list
19761609|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761610|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146270|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
20146271|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146272|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146273|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146274|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146275|NCT00072839|Teduglutide|teduglutide|mesh-list
20146276|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20146277|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20146278|NCT00072839|Protective Agents|protective agents|mesh-ancestor
20146279|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146280|NCT00072852|Irinotecan|irinotecan|mesh-list
20146281|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20146282|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146283|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146284|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146285|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146286|NCT00072865|Carboplatin|carboplatin|mesh-list
20146287|NCT00072865|Pemetrexed|pemetrexed|mesh-list
20146288|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146289|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146290|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146291|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19761611|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
19761612|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761613|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761614|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
19761615|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761616|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761617|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
19761618|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761619|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761620|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761621|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19761622|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761623|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19761624|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
19761625|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20146292|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20146293|NCT00072904|Repaglinide|repaglinide|mesh-list
20146294|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20146295|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146296|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
20146297|NCT00072930|Prednisone|prednisone|mesh-list
20146298|NCT00072930|Docetaxel|docetaxel|mesh-list
20146299|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146300|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146301|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146302|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146303|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146304|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146305|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
19761626|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19761627|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146306|NCT00072930|Hormones|hormones|mesh-ancestor
20146307|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20146308|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761628|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761629|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761630|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761631|NCT00045630|Gemcitabine|gemcitabine|mesh-list
19761632|NCT00045630|Paclitaxel|paclitaxel|mesh-list
19761633|NCT00045630|Carboplatin|carboplatin|mesh-list
19761634|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761635|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761636|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761637|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761638|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761639|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146309|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20146310|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20146311|NCT00072943|Interferons|interferons|mesh-list
20146312|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
19761640|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761641|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
19761642|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
19761643|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761644|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761645|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761646|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
19761647|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761648|NCT00045708|Epothilones|epothilones|mesh-list
19761649|NCT00045708|Epothilone B|epothilone b|mesh-list
19761650|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
19761651|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761652|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761653|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761654|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761655|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761656|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
19761657|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761658|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761659|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761660|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761661|NCT00045942|Itraconazole|itraconazole|mesh-list
19761662|NCT00045942|Midostaurin|midostaurin|mesh-list
19761663|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
19761664|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761665|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19761666|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19761667|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761668|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761669|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19761670|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
19761671|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761672|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761673|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19761674|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761675|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761676|NCT00046228|Reteplase|reteplase|mesh-list
19761677|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19761678|NCT00046228|Abciximab|abciximab|mesh-list
19761679|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
19761680|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19761681|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19761682|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19761683|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761684|NCT00046475|Midodrine|midodrine|mesh-list
19761685|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
19761686|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
19761687|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761688|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761689|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19761690|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19761691|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19761692|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19761693|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
19761694|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146313|NCT00072943|Antibodies|antibodies|mesh-list
20146314|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20146315|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
20146316|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146317|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146318|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
20146319|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146320|NCT00072969|Daclizumab|daclizumab|mesh-list
20146321|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633058|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19633059|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633060|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
19633061|NCT02443311|Hormones|hormones|mesh-ancestor
19633062|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633063|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633064|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19633065|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
19633066|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20146322|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
20146323|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146324|NCT00072982|Borage oil|borage oil|mesh-list
20146325|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146326|NCT00073047|Daclizumab|daclizumab|mesh-list
20146327|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146328|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
20146329|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146330|NCT00073164|Valproic Acid|valproic acid|mesh-list
20146331|NCT00073164|Olanzapine|olanzapine|mesh-list
20146332|NCT00073164|Risperidone|risperidone|mesh-list
20146333|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19633067|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633068|NCT02443311|Analgesics|analgesics|mesh-ancestor
19633069|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
20146334|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
20146335|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173817|NCT00162695|Etoposide|etoposide|mesh-list
19633070|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633071|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633072|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
19633073|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633074|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
19633075|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19633076|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633077|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633078|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19633079|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19633080|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19633081|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19633082|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633083|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633084|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633085|NCT02443194|Analgesics|analgesics|mesh-ancestor
19633086|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
19633087|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633088|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
19633089|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19633090|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
19633091|NCT02443012|Nepafenac|nepafenac|mesh-list
19661717|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
19661718|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661719|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19661720|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661721|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661722|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
19661723|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661724|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19661725|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
19661726|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661727|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
19661728|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19661729|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
19661730|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19661731|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661732|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661733|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19661734|NCT05091151|Analgesics|analgesics|mesh-ancestor
19661735|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
19661736|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661737|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19661738|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19661739|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19661740|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
19661741|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661742|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661743|NCT05091138|Buprenorphine|buprenorphine|mesh-list
19661744|NCT05091138|Bupivacaine|bupivacaine|mesh-list
19661745|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
19661746|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
19661747|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661748|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661749|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
19661750|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761695|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761696|NCT00046566|Caseins|caseins|mesh-list
19761697|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
19761698|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
19761699|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761700|NCT00046839|Celecoxib|celecoxib|mesh-list
20146336|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146337|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146338|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20146339|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20146340|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19761701|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19761702|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19761703|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19761704|NCT00046839|Analgesics|analgesics|mesh-ancestor
19761705|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
19761706|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761707|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146341|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20146342|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20146343|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
20146344|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
20315191|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315192|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20315193|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
20315194|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315195|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315196|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20315197|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
20315198|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633092|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20146345|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
20146346|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146347|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20146348|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20146349|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20146350|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146351|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
20146352|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146353|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
20146354|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
20146355|NCT00073203|Paroxetine|paroxetine|mesh-list
20146356|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20146357|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20146358|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146359|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146360|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146361|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
20146362|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146363|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20146364|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
20146365|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20146366|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20146367|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20146368|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146369|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19633093|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633094|NCT02443012|Analgesics|analgesics|mesh-ancestor
19633095|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
19633096|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633097|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633098|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633099|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633100|NCT02443064|Vancomycin|vancomycin|mesh-list
19633101|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19633102|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633103|NCT02443142|Acetaminophen|acetaminophen|mesh-list
19633104|NCT02443142|Ibuprofen|ibuprofen|mesh-list
19633105|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633106|NCT02443142|Analgesics|analgesics|mesh-ancestor
19633107|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
19761708|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761709|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761710|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19761711|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761712|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761713|NCT00046930|Cytarabine|cytarabine|mesh-list
19761714|NCT00046930|Daunorubicin|daunorubicin|mesh-list
19761715|NCT00046930|Molgramostim|molgramostim|mesh-list
19761716|NCT00046930|Lenograstim|lenograstim|mesh-list
19761717|NCT00046930|Sargramostim|sargramostim|mesh-list
19761718|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761719|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
19761720|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761721|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761722|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
19761723|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761724|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761725|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
19761726|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761727|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19761728|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761729|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761730|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761731|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761732|NCT00047008|Cisplatin|cisplatin|mesh-list
19761733|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761734|NCT00047060|Cyclosporine|cyclosporine|mesh-list
19761735|NCT00047060|Fludarabine|fludarabine|mesh-list
19761736|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
19761737|NCT00047060|Cyclosporins|cyclosporins|mesh-list
19761738|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761739|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761740|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761741|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
19761742|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761743|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761744|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
19761745|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761746|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761747|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761748|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19761749|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761750|NCT00047320|Carboplatin|carboplatin|mesh-list
19761751|NCT00047320|Etoposide|etoposide|mesh-list
19761752|NCT00047320|Ifosfamide|ifosfamide|mesh-list
19761753|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
19761754|NCT00047320|Thiotepa|thiotepa|mesh-list
19761755|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761756|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761757|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761758|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761759|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761760|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761761|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761762|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
19761763|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761764|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761765|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
20146370|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20146371|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20146372|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20146373|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146374|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20146375|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20146376|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20146377|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
20146378|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146379|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146380|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20146381|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20146382|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
20146383|NCT00073372|Abciximab|abciximab|mesh-list
20146384|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
20146385|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20146386|NCT00073385|Docetaxel|docetaxel|mesh-list
20146387|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761766|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761767|NCT00047697|Donepezil|donepezil|mesh-list
19761768|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19761769|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761770|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761771|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
19761772|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761773|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761774|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
19761775|NCT00047879|Interferons|interferons|mesh-list
19761776|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
19761777|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
19761778|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19761779|NCT00047879|Thalidomide|thalidomide|mesh-list
19761780|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761781|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
19761782|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761783|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
19761784|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761785|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761786|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
19761787|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761788|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19761789|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19761790|NCT00047879|Growth Substances|growth substances|mesh-ancestor
19761791|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
19761792|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
19761793|NCT00048035|Hematinics|hematinics|mesh-ancestor
19761794|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
19761795|NCT00048048|Hematinics|hematinics|mesh-ancestor
19761796|NCT00048061|Vitamin D|vitamin d|mesh-list
19761797|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
20146388|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146389|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146390|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146391|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146392|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20146393|NCT00073411|Citalopram|citalopram|mesh-list
20146394|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20146395|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20146396|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146397|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146398|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146399|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
19761798|NCT00048061|Calcium|calcium|mesh-list
19761799|NCT00048061|Vitamins|vitamins|mesh-ancestor
19761800|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
19761801|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761802|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19761803|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19761804|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
19761805|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19761806|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761807|NCT00048165|Cyclosporine|cyclosporine|mesh-list
19761808|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
19633108|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633109|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761809|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
19761810|NCT00048165|Cyclosporins|cyclosporins|mesh-list
19761811|NCT00048165|Daclizumab|daclizumab|mesh-list
19761812|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146400|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146401|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20146402|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
20146403|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20146404|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146405|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20146406|NCT00073411|Analgesics|analgesics|mesh-ancestor
19633110|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
19633111|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633112|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633113|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633114|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19633115|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633116|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633117|NCT02442921|Colchicine|colchicine|mesh-list
19633118|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
19633119|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633120|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146407|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
19761813|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761814|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761815|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
19761816|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761817|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
19761818|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761819|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
20146408|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
19761820|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761821|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19761822|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761823|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761824|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19761825|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
19761826|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761827|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761828|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
19761829|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
19761830|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761831|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19761832|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
19761833|NCT00048165|Hormones|hormones|mesh-ancestor
19761834|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761835|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19761836|NCT00048165|Protective Agents|protective agents|mesh-ancestor
19761837|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
19761838|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19761839|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
19761840|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761841|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761842|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
19761843|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761844|NCT00048542|Adalimumab|adalimumab|mesh-list
19761845|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761846|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833109|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833110|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833111|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19833112|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833113|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833114|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19833115|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19833116|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833117|NCT00659711|Incretins|incretins|mesh-ancestor
19833118|NCT00659711|Hormones|hormones|mesh-ancestor
19833119|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833120|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19833121|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
19833122|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833123|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833124|NCT00653276|Cyclosporine|cyclosporine|mesh-list
19833125|NCT00653276|Ezetimibe|ezetimibe|mesh-list
19833126|NCT00653276|Cyclosporins|cyclosporins|mesh-list
19833127|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833128|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833129|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19833130|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
19833131|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833132|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
19833133|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833134|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
19833135|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833136|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19833137|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833138|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833139|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
20146409|NCT00073437|Infliximab|infliximab|mesh-list
20146410|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20146411|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20146412|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173818|NCT00162695|Vincristine|vincristine|mesh-list
20173819|NCT00162695|Epirubicin|epirubicin|mesh-list
20173820|NCT00162695|Ifosfamide|ifosfamide|mesh-list
20173821|NCT00162695|Carboplatin|carboplatin|mesh-list
20146413|NCT00073580|Hirudins|hirudins|mesh-list
20146414|NCT00073580|Anticoagulants|anticoagulants|mesh-list
20146415|NCT00073580|Bivalirudin|bivalirudin|mesh-list
20146416|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
20146417|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20146418|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
20146419|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146420|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146421|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20146422|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20146423|NCT00073593|Heparin|heparin|mesh-list
20146424|NCT00073593|Bivalirudin|bivalirudin|mesh-list
20146425|NCT00073593|Protamines|protamines|mesh-list
20146426|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
20146427|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20146428|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20146429|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146430|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
20146431|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20146432|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
20146433|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146434|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
20146435|NCT00073593|Coagulants|coagulants|mesh-ancestor
20146436|NCT00073658|Risperidone|risperidone|mesh-list
20146437|NCT00073658|Citalopram|citalopram|mesh-list
19633121|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
19633122|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
19633123|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633124|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633125|NCT02442791|Exenatide|exenatide|mesh-list
19633126|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633127|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633128|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19633129|NCT02442791|Incretins|incretins|mesh-ancestor
19633130|NCT02442791|Hormones|hormones|mesh-ancestor
19633131|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633132|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
19633133|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19633134|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19633135|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633136|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633137|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19633138|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19633139|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19661751|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19661752|NCT05091138|Narcotics|narcotics|mesh-ancestor
19661753|NCT05091138|Analgesics|analgesics|mesh-ancestor
19661754|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19661755|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
19661756|NCT05091099|Alendronate|alendronate|mesh-list
19661757|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19661758|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661759|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
19661760|NCT05091086|Denosumab|denosumab|mesh-list
19661761|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19661762|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661763|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
19661764|NCT05091008|Ledipasvir|ledipasvir|mesh-list
19661765|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19661766|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
19661767|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661768|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
19661769|NCT05090761|Buprenorphine|buprenorphine|mesh-list
19661770|NCT05090761|Bupivacaine|bupivacaine|mesh-list
19661771|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19661772|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
19661773|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
19661774|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661775|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661776|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
19661777|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661778|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19661779|NCT05090761|Narcotics|narcotics|mesh-ancestor
19661780|NCT05090761|Analgesics|analgesics|mesh-ancestor
19661781|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19661782|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19661783|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
19661784|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19761847|NCT00048568|Methotrexate|methotrexate|mesh-list
19761848|NCT00048568|Abatacept|abatacept|mesh-list
19761849|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19761850|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
19761851|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19761852|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761853|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761854|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
19761855|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146438|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20146439|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
20146440|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146441|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146442|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146443|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19761856|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761857|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
19761858|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761859|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19761860|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761861|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
19761862|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761863|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19761864|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19761865|NCT00048581|Abatacept|abatacept|mesh-list
19761866|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19761867|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761868|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761869|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761870|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
20146444|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20146445|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20146446|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20146447|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20146448|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
20146449|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20146450|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20146451|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146452|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20146453|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
20146454|NCT00073697|Dexetimide|dexetimide|mesh-list
20146455|NCT00073697|Citalopram|citalopram|mesh-list
20146456|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20146457|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20146458|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146459|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146460|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146461|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
19761871|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761872|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761873|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19761874|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
19761875|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761876|NCT00048737|Vidarabine|vidarabine|mesh-list
19761877|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
19761878|NCT00048737|Rituximab|rituximab|mesh-list
19761879|NCT00048737|Fludarabine|fludarabine|mesh-list
19761880|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
19761881|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761882|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
19761883|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761884|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761885|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761886|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
19761887|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761888|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761889|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761890|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761891|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146462|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146463|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19761892|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
19761893|NCT00048737|Antiviral Agents|antiviral agents|mesh-ancestor
19761894|NCT00048737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761895|NCT00048815|Citalopram|citalopram|mesh-list
19761896|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19761897|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19761898|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146464|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
20146465|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20315199|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315200|NCT00697476|Topotecan|topotecan|mesh-list
19761899|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761900|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19761901|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
19761902|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761903|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19761904|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
19761905|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19761906|NCT00048893|Metronidazole|metronidazole|mesh-list
19761907|NCT00048893|Paclitaxel|paclitaxel|mesh-list
19761908|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
19761909|NCT00048893|Doxorubicin|doxorubicin|mesh-list
19761910|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19761911|NCT00048893|Fludarabine|fludarabine|mesh-list
19761912|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
19761913|NCT00048893|Vaccines|vaccines|mesh-list
19761914|NCT00048893|Sargramostim|sargramostim|mesh-list
19761915|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
19761916|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761917|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761918|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315201|NCT00697476|Vorinostat|vorinostat|mesh-list
20315202|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20315203|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20315204|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315205|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315206|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315207|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20315208|NCT00697502|Capecitabine|capecitabine|mesh-list
20315209|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20315210|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
19761919|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761920|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761921|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761922|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761923|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761924|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761925|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19761926|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
19761927|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761928|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761929|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761930|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761931|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761932|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19761933|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
19761934|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19761935|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19761936|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19761937|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19761938|NCT00048932|Abatacept|abatacept|mesh-list
19761939|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19761940|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761941|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761942|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761943|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
19761944|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761945|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146466|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20146467|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20146468|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
20146469|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
20146470|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19761946|NCT00049036|Prednisone|prednisone|mesh-list
20146471|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20146472|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20146473|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
20146474|NCT00073710|Calcitriol|calcitriol|mesh-list
20146475|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20146476|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146477|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20146478|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146479|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146480|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20146481|NCT00073710|Vitamins|vitamins|mesh-ancestor
20146482|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
20146483|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20146484|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20146485|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146486|NCT00073736|Cytarabine|cytarabine|mesh-list
20146487|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146488|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
20146489|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146490|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146491|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
20146492|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146493|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146494|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
20146495|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761947|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
19761948|NCT00049036|Rituximab|rituximab|mesh-list
19761949|NCT00049036|Doxorubicin|doxorubicin|mesh-list
19761950|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19761951|NCT00049036|Etoposide|etoposide|mesh-list
19761952|NCT00049036|Vincristine|vincristine|mesh-list
19761953|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
19761954|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19761955|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
19761956|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761957|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19761958|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20315211|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315212|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315213|NCT00697554|Vaccines|vaccines|mesh-list
20315214|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
20315215|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761959|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
19761960|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761961|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761962|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19761963|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761964|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19761965|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19761966|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19761967|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761968|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19761969|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
19761970|NCT00049036|Hormones|hormones|mesh-ancestor
19761971|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19761972|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19761973|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761974|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
19761975|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
19761976|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
19761977|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
19761978|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761979|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19761980|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19761981|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761982|NCT00049257|Paclitaxel|paclitaxel|mesh-list
19761983|NCT00049257|Carboplatin|carboplatin|mesh-list
19761984|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19761985|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761986|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315216|NCT00697567|Vaccines|vaccines|mesh-list
20315217|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
20315218|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315219|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20315220|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19761987|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
20315221|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19761988|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146496|NCT00073814|Albuterol|albuterol|mesh-list
20146497|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20146498|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
20146499|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146500|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146501|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20146502|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
20146503|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
20146504|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20146505|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20146506|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20146507|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20146508|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
20146509|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146510|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146511|NCT00073827|Albuterol|albuterol|mesh-list
20146512|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20146513|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
20146514|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146515|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146516|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20146517|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
20146518|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
20146519|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20146520|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20146521|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20146522|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20146523|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
20146524|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146525|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146526|NCT00073840|Albuterol|albuterol|mesh-list
20146527|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20146528|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
20146529|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146530|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315222|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633140|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19633141|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633142|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633143|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
19633144|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19633145|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
19633146|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19633147|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19633148|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633149|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19633150|NCT02442817|Linagliptin|linagliptin|mesh-list
19633151|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633152|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633153|NCT02442817|Incretins|incretins|mesh-ancestor
19633154|NCT02442817|Hormones|hormones|mesh-ancestor
19661785|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661786|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661787|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661788|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
19661789|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19661790|NCT05090592|Atropine|atropine|mesh-list
19661791|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19661792|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19661793|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19661794|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
19661795|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661796|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661797|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19661798|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
19661799|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
19661800|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
19661801|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19661802|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19761989|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19761990|NCT00049322|Bevacizumab|bevacizumab|mesh-list
19761991|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19761992|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761993|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19761994|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19761995|NCT00049322|Growth Substances|growth substances|mesh-ancestor
19761996|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19761997|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
19761998|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
20146531|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20146532|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
20146533|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
20146534|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20146535|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20146536|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20146537|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20146538|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
20146539|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146540|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146541|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
20146542|NCT00073879|Fludarabine|fludarabine|mesh-list
20146543|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
20146544|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
20146545|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146546|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
20146547|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146548|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146549|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146550|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
20146551|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146552|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19761999|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
19762000|NCT00049504|Fludarabine|fludarabine|mesh-list
19762001|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
19762002|NCT00049504|Tacrolimus|tacrolimus|mesh-list
19762003|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762004|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
19762005|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762006|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762007|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762008|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
19762009|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762010|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762011|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762012|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762013|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
19762014|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19762015|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762016|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762017|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19762018|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
19762019|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19762020|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762021|NCT00049517|Cytarabine|cytarabine|mesh-list
19762022|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
19762023|NCT00049517|Busulfan|busulfan|mesh-list
19762024|NCT00049517|Daunorubicin|daunorubicin|mesh-list
19762025|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
19762026|NCT00049517|Sargramostim|sargramostim|mesh-list
19762027|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762028|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
19762029|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762030|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762031|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762032|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
19762033|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762034|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762035|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762036|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146553|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20146554|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146555|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
19762037|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
19762038|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
19762039|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762040|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762041|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762042|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762043|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762044|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762045|NCT00049530|Interferons|interferons|mesh-list
19762046|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
19762047|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
19762048|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19762049|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762050|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
19762051|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762052|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
19762053|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762054|NCT00049543|Gefitinib|gefitinib|mesh-list
19762055|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762056|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19762057|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762058|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762059|NCT00049673|Thalidomide|thalidomide|mesh-list
19762060|NCT00049673|Prednisone|prednisone|mesh-list
19762061|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19762062|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
19633155|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633156|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19762063|NCT00049673|Hormones|hormones|mesh-ancestor
19762064|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762065|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762066|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19762067|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762068|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762069|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
19762070|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
19762071|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19762072|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762073|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19762074|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19762075|NCT00049673|Growth Substances|growth substances|mesh-ancestor
19762076|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19762077|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19762078|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
19762079|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762080|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
19762081|NCT00050011|Letrozole|letrozole|mesh-list
19762082|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762083|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19762084|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19762085|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762086|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762087|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19762088|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
19762089|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762090|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762091|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19762092|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20146556|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20146557|NCT00073905|Gemcitabine|gemcitabine|mesh-list
20146558|NCT00073905|Capecitabine|capecitabine|mesh-list
20146559|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19633157|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
19633158|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633159|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633160|NCT02442674|Tolvaptan|tolvaptan|mesh-list
19633161|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19633162|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633163|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
19633164|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633165|NCT02442648|Rituximab|rituximab|mesh-list
19633166|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19633167|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633168|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
20146560|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
20146561|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146562|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146563|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
20146564|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146565|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146566|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146567|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
20146568|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146569|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
20146570|NCT00073931|Sargramostim|sargramostim|mesh-list
20146571|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
20146572|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762093|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
19762094|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762095|NCT00050167|Paclitaxel|paclitaxel|mesh-list
19762096|NCT00050167|Docetaxel|docetaxel|mesh-list
19762097|NCT00050167|Capecitabine|capecitabine|mesh-list
19762098|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762099|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762100|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762101|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762102|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762103|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762104|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762105|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
19762106|NCT00050622|Methylphenidate|methylphenidate|mesh-list
19762107|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19762108|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762109|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19762110|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19762111|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19762112|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762113|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
19762114|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762115|NCT00050778|Interferons|interferons|mesh-list
19762116|NCT00050778|Interferon-beta|interferon-beta|mesh-list
19762117|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
19762118|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
19762119|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762120|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
19762121|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762122|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762123|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
19762124|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762125|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19762126|NCT00050960|Paclitaxel|paclitaxel|mesh-list
19762127|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19762128|NCT00050960|Carboplatin|carboplatin|mesh-list
20146573|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146574|NCT00073970|Celecoxib|celecoxib|mesh-list
20146575|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20146576|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20146577|NCT00073970|Analgesics|analgesics|mesh-ancestor
19762129|NCT00050960|Bexarotene|bexarotene|mesh-list
19762130|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762131|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762132|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762133|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762134|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762135|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762136|NCT00050986|Temozolomide|temozolomide|mesh-list
19762137|NCT00050986|Tipifarnib|tipifarnib|mesh-list
19762138|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762139|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
19762140|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762141|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762142|NCT00051168|Travoprost|travoprost|mesh-list
19762143|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19762144|NCT00051311|Cyclosporine|cyclosporine|mesh-list
19762145|NCT00051311|Prednisone|prednisone|mesh-list
20146578|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
20146579|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762146|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
19762147|NCT00051311|Doxorubicin|doxorubicin|mesh-list
19762148|NCT00051311|Methotrexate|methotrexate|mesh-list
19762149|NCT00051311|Fludarabine|fludarabine|mesh-list
19762150|NCT00051311|Etoposide|etoposide|mesh-list
19633169|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633170|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633171|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
19633172|NCT02442752|Lansoprazole|lansoprazole|mesh-list
19633173|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19633174|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633175|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19633176|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661803|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
19661804|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661805|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661806|NCT05081583|Midazolam|midazolam|mesh-list
19661807|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19661808|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19661809|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661810|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661811|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19661812|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19661813|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19661814|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19661815|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
19661816|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
19661817|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
19661818|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
19661819|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661820|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661821|NCT05081336|Ezetimibe|ezetimibe|mesh-list
19661822|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19661823|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19661824|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
19661825|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661826|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19661827|NCT05077839|Trifluridine|trifluridine|mesh-list
19661828|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
19661829|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661830|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
19661831|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661832|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
19661833|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19661834|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
19661835|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19661836|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
19661837|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661838|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661839|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
19661840|NCT05077085|Vancomycin|vancomycin|mesh-list
19661841|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19661842|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661843|NCT05069129|Vaccines|vaccines|mesh-list
19661844|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
19661845|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661846|NCT05067985|Anesthetics|anesthetics|mesh-list
19661847|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661848|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661849|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19661850|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19661851|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661852|NCT04985136|Sorafenib|sorafenib|mesh-list
19661853|NCT04985136|Apatinib|apatinib|mesh-list
19661854|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661855|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19661856|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661857|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661858|NCT04952350|Atorvastatin|atorvastatin|mesh-list
19661859|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19661860|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19661861|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
19661862|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661863|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19661864|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19661865|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661866|NCT04899492|Nicotine|nicotine|mesh-list
19661867|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19661868|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
19762151|NCT00051311|Vincristine|vincristine|mesh-list
20146580|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146581|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146582|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146583|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20146584|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20146585|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146586|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146587|NCT00074009|Bortezomib|bortezomib|mesh-list
20146588|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146589|NCT00074022|Docetaxel|docetaxel|mesh-list
20146590|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146591|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633177|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661869|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661870|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661871|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19661872|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19661873|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
19661874|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661875|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661876|NCT04866017|Durvalumab|durvalumab|mesh-list
19661877|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19661878|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661879|NCT04850144|Bromides|bromides|mesh-list
19661880|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
19661881|NCT04850144|Charcoal|charcoal|mesh-list
19661882|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19661883|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
19661884|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661885|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661886|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19661887|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
19661888|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
19661889|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19661890|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
19661891|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661892|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661893|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
19661894|NCT04850144|Antidotes|antidotes|mesh-ancestor
19661895|NCT04850144|Protective Agents|protective agents|mesh-ancestor
19665877|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665878|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
19665879|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
19665880|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665881|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665882|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665883|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
19665884|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
19665885|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665886|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665887|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665888|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
19665889|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665890|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19665891|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19665892|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
19665893|NCT03522753|Hormones|hormones|mesh-ancestor
19665894|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19665895|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665896|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665897|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665898|NCT03435939|Losartan|losartan|mesh-list
19762152|NCT00051311|Cyclosporins|cyclosporins|mesh-list
19762153|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762154|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
19762155|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762156|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762157|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762158|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
19762159|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762160|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762161|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762162|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762163|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762164|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762165|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762166|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19762167|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
19762168|NCT00051311|Hormones|hormones|mesh-ancestor
19762169|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762170|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19762171|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19762172|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
19762173|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19762174|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762175|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
19762176|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
19762177|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19762178|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19762179|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762180|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762181|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762182|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762183|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
19762184|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762185|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19762186|NCT00051558|Alendronate|alendronate|mesh-list
19762187|NCT00051558|Teriparatide|teriparatide|mesh-list
19762188|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19762189|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762190|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19762191|NCT00051636|Vitamin D|vitamin d|mesh-list
19762192|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
19762193|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
19762194|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
19762195|NCT00051636|Calcium|calcium|mesh-list
19762196|NCT00051636|Vitamins|vitamins|mesh-ancestor
19762197|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
19762198|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762199|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19762200|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19762201|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19762202|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19762203|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762204|NCT00052078|Sertraline|sertraline|mesh-list
19762205|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
19762206|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19762207|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19762208|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19762209|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19762210|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762211|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762212|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
19762213|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762214|NCT00052429|Fluorouracil|fluorouracil|mesh-list
19762215|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762216|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
19762217|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762218|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762219|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146592|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146593|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762220|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
19762221|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762222|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19762223|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762224|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19762225|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762226|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762227|NCT00052715|Poly ICLC|poly iclc|mesh-list
19762228|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
19762229|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
19762230|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762231|NCT00052910|Leucovorin|leucovorin|mesh-list
19762232|NCT00052910|Fluorouracil|fluorouracil|mesh-list
19762233|NCT00052910|Epirubicin|epirubicin|mesh-list
19762234|NCT00052910|Calcium|calcium|mesh-list
19762235|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
19762236|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762237|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19762238|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762239|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
19762240|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762241|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762242|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762243|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
19762244|NCT00052910|Antidotes|antidotes|mesh-ancestor
19762245|NCT00052910|Protective Agents|protective agents|mesh-ancestor
19762246|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
19762247|NCT00052910|Vitamins|vitamins|mesh-ancestor
19762248|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
19762249|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762250|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762251|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762252|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762253|NCT00053014|Cyclosporine|cyclosporine|mesh-list
19762254|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
19762255|NCT00053014|Fludarabine|fludarabine|mesh-list
19762256|NCT00053014|Cyclosporins|cyclosporins|mesh-list
19762257|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762258|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762259|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762260|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
19762261|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762262|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762263|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
19762264|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762265|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
19762266|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762267|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19762268|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762269|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19762270|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
19762271|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19762272|NCT00053352|Etoposide|etoposide|mesh-list
19762273|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
19762274|NCT00053352|Bleomycin|bleomycin|mesh-list
19762275|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762276|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762277|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762278|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762279|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762280|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762281|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762282|NCT00053365|Irofulven|irofulven|mesh-list
19762283|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762284|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
19762285|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762286|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762287|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
19762288|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19762289|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19762290|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762291|NCT00053482|Vaccines|vaccines|mesh-list
19762292|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
19762293|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762294|NCT00053677|Naltrexone|naltrexone|mesh-list
19762295|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19762296|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20146594|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146595|NCT00074074|Infliximab|infliximab|mesh-list
19762297|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762298|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
19762299|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762300|NCT00053703|Olanzapine|olanzapine|mesh-list
19762301|NCT00053703|Risperidone|risperidone|mesh-list
19762302|NCT00053703|Molindone|molindone|mesh-list
19762303|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19762304|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
19762305|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762306|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762307|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762308|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19762309|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19762310|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19762311|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19762312|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19762313|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
19762314|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
19762315|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
19762316|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762317|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19762318|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19762319|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19762320|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19762321|NCT00053846|Buspirone|buspirone|mesh-list
19762322|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19762323|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19762324|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19762325|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762326|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19762327|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19762328|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
19762329|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762330|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762331|NCT00053898|Tamoxifen|tamoxifen|mesh-list
19762332|NCT00053898|Anastrozole|anastrozole|mesh-list
19762333|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762334|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19762335|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
19762336|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762337|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762338|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19762339|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762340|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19762341|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19762342|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19762343|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19762344|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19762345|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762346|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
19762347|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
19762348|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
19762349|NCT00053989|Fludarabine|fludarabine|mesh-list
19762350|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
19762351|NCT00053989|Tacrolimus|tacrolimus|mesh-list
20146596|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
20146597|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20146598|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762352|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19762353|NCT00053989|Sargramostim|sargramostim|mesh-list
19762354|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762355|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
19762356|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762357|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762358|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762359|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
19762360|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762361|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762362|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762363|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762364|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
20146599|NCT00074087|Doxorubicin|doxorubicin|mesh-list
20146600|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19762365|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19762366|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762367|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762368|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19762369|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
19762370|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19762371|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762372|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19762373|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
19762374|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
19762375|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762376|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19762377|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
19762378|NCT00053989|Hormones|hormones|mesh-ancestor
20146601|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20146602|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633178|NCT02442362|Paclitaxel|paclitaxel|mesh-list
19633179|NCT02442362|Fluorouracil|fluorouracil|mesh-list
20146603|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20146604|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146605|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146606|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146607|NCT00074100|Amonafide|amonafide|mesh-list
20146608|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146609|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
20146610|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146611|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146612|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633180|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
19633181|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19633182|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633183|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633184|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
19633185|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
19633186|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633187|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
19633188|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19633189|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633190|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
19633191|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633192|NCT02442739|Ketamine|ketamine|mesh-list
19633193|NCT02442739|Analgesics|analgesics|mesh-ancestor
20146613|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
20146614|NCT00074139|Docetaxel|docetaxel|mesh-list
20146615|NCT00074139|Doxorubicin|doxorubicin|mesh-list
20146616|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20146617|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146618|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
20146619|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146620|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146621|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146622|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
20146623|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633194|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
19633195|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633196|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633197|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19633198|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19762379|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762380|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19762381|NCT00053989|Protective Agents|protective agents|mesh-ancestor
19762382|NCT00054028|Suramin|suramin|mesh-list
19762383|NCT00054028|Paclitaxel|paclitaxel|mesh-list
19762384|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762385|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633199|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
19762386|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762387|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146624|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146625|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20146626|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146627|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146628|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146629|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19633200|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
19633201|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633202|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19633203|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19633204|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633205|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315223|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762388|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762389|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762390|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
19762391|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
19762392|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19762393|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762394|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19762395|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19762396|NCT00054132|Bevacizumab|bevacizumab|mesh-list
19762397|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19762398|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19762399|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
19762400|NCT00054132|Antibodies|antibodies|mesh-list
19762401|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
19762402|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19762403|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
19762404|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762405|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19762406|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20146630|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20146631|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146632|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146633|NCT00074178|Cytarabine|cytarabine|mesh-list
20146634|NCT00074178|Dexamethasone|dexamethasone|mesh-list
20146635|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
20146636|NCT00074178|Methotrexate|methotrexate|mesh-list
20146637|NCT00074178|Etoposide|etoposide|mesh-list
20146638|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
20146639|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146640|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
20146641|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146642|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146643|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146644|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
20146645|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315224|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20315225|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19762407|NCT00054132|Growth Substances|growth substances|mesh-ancestor
19762408|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762409|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
19762410|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
19762411|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19762412|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762413|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762414|NCT00054275|Docetaxel|docetaxel|mesh-list
19762415|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19762416|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762417|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762418|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762419|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
19633206|NCT02442453|Turmeric extract|turmeric extract|mesh-list
19633207|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
19633208|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633209|NCT02442453|Protective Agents|protective agents|mesh-ancestor
19633210|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633211|NCT02442531|Docetaxel|docetaxel|mesh-list
19633212|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633213|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633214|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
19633215|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
19633216|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833140|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19633217|NCT02442466|BQ 788|bq 788|mesh-list
19762420|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762421|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20146646|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146647|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20146648|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146649|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
20146650|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
20146651|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146652|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20146653|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
20146654|NCT00074178|Hormones|hormones|mesh-ancestor
20146655|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762422|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762423|NCT00054327|Cytarabine|cytarabine|mesh-list
19762424|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
19762425|NCT00054327|Busulfan|busulfan|mesh-list
19762426|NCT00054327|Etoposide|etoposide|mesh-list
19762427|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
19762428|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762429|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
19762430|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762431|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762432|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762433|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
19762434|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762435|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762436|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762437|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762438|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762439|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762440|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762441|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762442|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
19762443|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
19762444|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762445|NCT00054353|Cyclosporine|cyclosporine|mesh-list
19762446|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
19762447|NCT00054353|Fludarabine|fludarabine|mesh-list
19762448|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
19762449|NCT00054353|Melphalan|melphalan|mesh-list
19762450|NCT00054353|Cyclosporins|cyclosporins|mesh-list
19762451|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762452|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762453|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
19762454|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762455|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146656|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20146657|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20146658|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
20146659|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20146660|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146661|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
20146662|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
20146663|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146664|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20146665|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20146666|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20146667|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20146668|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146669|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
19762456|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
19762457|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762458|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762459|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
19762460|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762461|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
19762462|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762463|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19762464|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762465|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19762466|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
19762467|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20146670|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146671|NCT00074191|Cytarabine|cytarabine|mesh-list
20146672|NCT00074191|Dexamethasone|dexamethasone|mesh-list
19762468|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762469|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
19762470|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762471|NCT00054639|Rituximab|rituximab|mesh-list
19762472|NCT00054639|Oblimersen|oblimersen|mesh-list
19762473|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762474|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762475|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
20146673|NCT00074191|Methotrexate|methotrexate|mesh-list
20146674|NCT00074191|Lomustine|lomustine|mesh-list
20146675|NCT00074191|Procarbazine|procarbazine|mesh-list
20146676|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146677|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
20146678|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
20146679|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20146680|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146681|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20146682|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
20146683|NCT00074191|Hormones|hormones|mesh-ancestor
20146684|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20146685|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20146686|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146687|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20146688|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
20146689|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20146690|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146691|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
20146692|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146693|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
20146694|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146695|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20146696|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146697|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
20146698|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146699|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20146700|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
20146701|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146702|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762476|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762477|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762478|NCT00054665|Prednisone|prednisone|mesh-list
19762479|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
19762480|NCT00054665|Doxorubicin|doxorubicin|mesh-list
19762481|NCT00054665|Etoposide|etoposide|mesh-list
19762482|NCT00054665|Vincristine|vincristine|mesh-list
19762483|NCT00054665|Bortezomib|bortezomib|mesh-list
19762484|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762485|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
19762486|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762487|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762488|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762489|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
19762490|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146703|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
19661896|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
19661897|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19661898|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19661899|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
19661900|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19661901|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661902|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19661903|NCT04710199|Maraviroc|maraviroc|mesh-list
19661904|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19661905|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19661906|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661907|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19661908|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19762491|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762492|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762493|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762494|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762495|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762496|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762497|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19762498|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
19762499|NCT00054665|Hormones|hormones|mesh-ancestor
19762500|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762501|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19762502|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762503|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762504|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762505|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762506|NCT00054691|Gefitinib|gefitinib|mesh-list
19762507|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146704|NCT00074204|Gemcitabine|gemcitabine|mesh-list
20146705|NCT00074204|Carboplatin|carboplatin|mesh-list
20146706|NCT00074204|Docetaxel|docetaxel|mesh-list
20146707|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762508|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19762509|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762510|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762511|NCT00054704|Riluzole|riluzole|mesh-list
19762512|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
19762513|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19762514|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19762515|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762516|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762517|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762518|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19762519|NCT00054704|Protective Agents|protective agents|mesh-ancestor
19762520|NCT00054717|Ritonavir|ritonavir|mesh-list
19762521|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19762522|NCT00054717|Tipranavir|tipranavir|mesh-list
19762523|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
19762524|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19762525|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762526|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762527|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19762528|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19762529|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
19762530|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762531|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19762532|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19762533|NCT00054756|Hormones|hormones|mesh-list
19762534|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
19762535|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762536|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762537|NCT00055237|Bevacizumab|bevacizumab|mesh-list
19762538|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762539|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762540|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19762541|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19762542|NCT00055237|Growth Substances|growth substances|mesh-ancestor
19762543|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762544|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
19762545|NCT00055497|Adalimumab|adalimumab|mesh-list
19762546|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146708|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19633218|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19633219|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19633220|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19633221|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633222|NCT02442440|Anisodamine|anisodamine|mesh-list
19633223|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19633224|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19633225|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
19633226|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633227|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633228|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146709|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
19762547|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762548|NCT00055601|Gemcitabine|gemcitabine|mesh-list
19762549|NCT00055601|Paclitaxel|paclitaxel|mesh-list
19762550|NCT00055601|Fluorouracil|fluorouracil|mesh-list
19762551|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762552|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762553|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762554|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762555|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762556|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762557|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762558|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
19762559|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
19762560|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762561|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762562|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762563|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
19762564|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762565|NCT00055692|Bevacizumab|bevacizumab|mesh-list
19762566|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19762567|NCT00055692|Antibodies|antibodies|mesh-list
19762568|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
19762569|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19762570|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762571|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19762572|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19762573|NCT00055692|Growth Substances|growth substances|mesh-ancestor
19762574|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762575|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
19762576|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
19762577|NCT00056160|Dexamethasone|dexamethasone|mesh-list
19762578|NCT00056160|Lenalidomide|lenalidomide|mesh-list
19762579|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19762580|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
19762581|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
19762582|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762583|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762584|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19762585|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
19762586|NCT00056160|Hormones|hormones|mesh-ancestor
19762587|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762588|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19762589|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762590|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
19762591|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19762592|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19762593|NCT00056160|Growth Substances|growth substances|mesh-ancestor
19762594|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
19762595|NCT00056407|Dutasteride|dutasteride|mesh-list
19661909|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
19661910|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661911|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19661912|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19661913|NCT04648696|Vancomycin|vancomycin|mesh-list
19661914|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19661915|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19661916|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
19661917|NCT04639310|Ezogabine|ezogabine|mesh-list
19661918|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
19661919|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661920|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661921|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
19661922|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
19661923|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661924|NCT04604548|Protective Agents|protective agents|mesh-ancestor
19661925|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661926|NCT04590794|Plasminogen|plasminogen|mesh-list
19661927|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19661928|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19661929|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661930|NCT04543643|Carvedilol|carvedilol|mesh-list
19661931|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19661932|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19661933|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
19661934|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762596|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19762597|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19762598|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762599|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762600|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
19762601|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762602|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762603|NCT00056472|Olanzapine|olanzapine|mesh-list
19762604|NCT00056472|Sertraline|sertraline|mesh-list
19762605|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
20146710|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146711|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
20146712|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146713|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146714|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146715|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
19762606|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
19762607|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762608|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762609|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19762610|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19762611|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19762612|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19762613|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19762614|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19762615|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19762616|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19762617|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762618|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762619|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
19762620|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
19762621|NCT00056498|Risperidone|risperidone|mesh-list
19762622|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19762623|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
19762624|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762625|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762626|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762627|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19762628|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19762629|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19762630|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19762631|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19762632|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
19762633|NCT00056550|Antithrombins|antithrombins|mesh-list
19762634|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
19762635|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19762636|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
19762637|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762638|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762639|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
19762640|NCT00056862|Ribavirin|ribavirin|mesh-list
19762641|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19762642|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
19762643|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
19762644|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762645|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
19762646|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762647|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
19762648|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762649|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
19762650|NCT00057330|Vaccines|vaccines|mesh-list
19762651|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
19762652|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
19762653|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762654|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19762655|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762656|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762657|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
19762658|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762659|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
19762660|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20146716|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762661|NCT00057330|Protective Agents|protective agents|mesh-ancestor
20146717|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762662|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
19762663|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19762664|NCT00057681|Valproic Acid|valproic acid|mesh-list
19762665|NCT00057681|Risperidone|risperidone|mesh-list
19762666|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
19762667|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19762668|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
19762669|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762670|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762671|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762672|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20146718|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146719|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146720|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
19762673|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19762674|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19762675|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19762676|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19762677|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
19762678|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
19762679|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762680|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
19762681|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
19762682|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
19762683|NCT00057785|Fluorouracil|fluorouracil|mesh-list
19762684|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762685|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
19762686|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762687|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762688|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762689|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
19762690|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762691|NCT00057811|Leucovorin|leucovorin|mesh-list
19762692|NCT00057811|Cytarabine|cytarabine|mesh-list
19762693|NCT00057811|Prednisone|prednisone|mesh-list
19762694|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
20146721|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20146722|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
20146723|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146724|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146725|NCT00074321|Capecitabine|capecitabine|mesh-list
20146726|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
20146727|NCT00074321|Irinotecan|irinotecan|mesh-list
20146728|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146729|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
20146730|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146731|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146732|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20146733|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146734|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146735|NCT00074334|Immunotoxins|immunotoxins|mesh-list
20146736|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
19762695|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19762696|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19762697|NCT00057811|Prednisolone|prednisolone|mesh-list
19762698|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
19762699|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
19762700|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19762701|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19762702|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19762703|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
19762704|NCT00057811|Rituximab|rituximab|mesh-list
19762705|NCT00057811|Doxorubicin|doxorubicin|mesh-list
19762706|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20146737|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146738|NCT00074399|Nevirapine|nevirapine|mesh-list
20146739|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20146740|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20146741|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146742|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146743|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
19762707|NCT00057811|Methotrexate|methotrexate|mesh-list
20146744|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146745|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19762708|NCT00057811|Etoposide|etoposide|mesh-list
19762709|NCT00057811|Vincristine|vincristine|mesh-list
19762710|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
19762711|NCT00057811|Rasburicase|rasburicase|mesh-list
19762712|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20146746|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20146747|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20146748|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20146749|NCT00074438|Rituximab|rituximab|mesh-list
20146750|NCT00074438|Methotrexate|methotrexate|mesh-list
20146751|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20315226|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20315227|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
20315228|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315229|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315230|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20315231|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20315232|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
20315233|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
20315234|NCT00697671|Etoposide|etoposide|mesh-list
19633229|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19633230|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633231|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633232|NCT02442440|Analgesics|analgesics|mesh-ancestor
19633233|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
19633234|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633235|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633236|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633237|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19633238|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633239|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
19633240|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
19633241|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
19762713|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
19762714|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
19762715|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762716|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
19762717|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762718|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762719|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19762720|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
19762721|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762722|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762723|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762724|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762725|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762726|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762727|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762728|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762729|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19762730|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
19762731|NCT00057811|Hormones|hormones|mesh-ancestor
19762732|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762733|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20146752|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146753|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
20146754|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146755|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146756|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20146757|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
20146758|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20146759|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146760|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
20146761|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146762|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
20146763|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146764|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20146765|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146766|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20146767|NCT00074607|Gemcitabine|gemcitabine|mesh-list
20146768|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146769|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
20146770|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146771|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146772|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
20146773|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315235|NCT00697671|Interleukin-2|interleukin-2|mesh-list
20315236|NCT00697671|Clofarabine|clofarabine|mesh-list
19633242|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19633243|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
20146774|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146775|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146776|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
20146777|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146778|NCT00074620|Hirudins|hirudins|mesh-list
20146779|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
20146780|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20146781|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
20146782|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146783|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146784|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
20146785|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20146786|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20146787|NCT00074737|Cytarabine|cytarabine|mesh-list
20146788|NCT00074737|Idarubicin|idarubicin|mesh-list
20146789|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146790|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
20146791|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146792|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146793|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
20146794|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146795|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146796|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
20146797|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146798|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20146799|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20146800|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146801|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146802|NCT00074750|Molgramostim|molgramostim|mesh-list
20146803|NCT00074750|Sargramostim|sargramostim|mesh-list
20146804|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
20146805|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146806|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146807|NCT00074776|Lamotrigine|lamotrigine|mesh-list
19633244|NCT02442440|Protective Agents|protective agents|mesh-ancestor
19633245|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
19633246|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
19633247|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19633248|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19633249|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633250|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633251|NCT02442492|Urological Agents|urological agents|mesh-ancestor
19633252|NCT02442063|Paclitaxel|paclitaxel|mesh-list
19633253|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19633254|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19633255|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633256|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633257|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19633258|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665899|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19665900|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19665901|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19665902|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19665903|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665904|NCT03430791|Nivolumab|nivolumab|mesh-list
19665905|NCT03430791|Ipilimumab|ipilimumab|mesh-list
19665906|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665907|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665908|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19665909|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665910|NCT03383224|Nicotine|nicotine|mesh-list
19665911|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19665912|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
19665913|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665914|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665915|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19665916|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19665917|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
19665918|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665919|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665920|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
19665921|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665922|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
19665923|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19762734|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19762735|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
19762736|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19762737|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762738|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
20146808|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20146809|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146810|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20146811|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20146812|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146813|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
20146814|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20146815|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20146816|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20146817|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20146818|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20146819|NCT00074828|Enoxaparin|enoxaparin|mesh-list
20146820|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
20146821|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20146822|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20146823|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146824|NCT00074841|Azithromycin|azithromycin|mesh-list
20146825|NCT00074841|Chloroquine|chloroquine|mesh-list
20146826|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20146827|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
20146828|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
20146829|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20146830|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20146831|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146832|NCT00074841|Amebicides|amebicides|mesh-ancestor
20146833|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20146834|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20146835|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
20146836|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146837|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20146838|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20146839|NCT00074841|Analgesics|analgesics|mesh-ancestor
19633259|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762739|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19762740|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19762741|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19762742|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762743|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
19762744|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762745|NCT00057811|Antidotes|antidotes|mesh-ancestor
19762746|NCT00057811|Protective Agents|protective agents|mesh-ancestor
19762747|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
19762748|NCT00057811|Vitamins|vitamins|mesh-ancestor
19762749|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
19762750|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762751|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762752|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762753|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
19762754|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
19762755|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762756|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19762757|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19762758|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
20146840|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
19633260|NCT02442427|Palivizumab|palivizumab|mesh-list
19633261|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
19633262|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633263|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
19633264|NCT02442180|Prednisolone|prednisolone|mesh-list
19633265|NCT02442180|Lenograstim|lenograstim|mesh-list
19633266|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19633267|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
19633268|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633269|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633270|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
19633271|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
19633272|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633273|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633274|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
20146841|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762759|NCT00057837|Cisplatin|cisplatin|mesh-list
20146842|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762760|NCT00057837|Irinotecan|irinotecan|mesh-list
19762761|NCT00057837|Etoposide|etoposide|mesh-list
19762762|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
19762763|NCT00057837|Topotecan|topotecan|mesh-list
19762764|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
19762765|NCT00057837|Camptothecin|camptothecin|mesh-list
19762766|NCT00057837|Sargramostim|sargramostim|mesh-list
19762767|NCT00057837|Lenograstim|lenograstim|mesh-list
19762768|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315237|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315238|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
20315239|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315240|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315241|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20315242|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
20315243|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315244|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762769|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19762770|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762771|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762772|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762773|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20146843|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20146844|NCT00074841|Filaricides|filaricides|mesh-ancestor
20146845|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
19762774|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762775|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
19762776|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762777|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19762778|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
19762779|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
19762780|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762781|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762782|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762783|NCT00057863|Paclitaxel|paclitaxel|mesh-list
19762784|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
19762785|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762786|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762787|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762788|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762789|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762790|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762791|NCT00057876|Gemcitabine|gemcitabine|mesh-list
19762792|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762793|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
19762794|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762795|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762796|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
19762797|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762798|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762799|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762800|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
19762801|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762802|NCT00057941|Fulvestrant|fulvestrant|mesh-list
19762803|NCT00057941|Anastrozole|anastrozole|mesh-list
19762804|NCT00057941|Gefitinib|gefitinib|mesh-list
20146846|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
20146847|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20146848|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146849|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762805|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20146850|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19762806|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762807|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19762808|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19762809|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
19762810|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762811|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762812|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19762813|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762814|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762815|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19762816|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20146851|NCT00074841|Renal Agents|renal agents|mesh-ancestor
20146852|NCT00075010|Decitabine|decitabine|mesh-list
20146853|NCT00075010|Valproic Acid|valproic acid|mesh-list
20146854|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146855|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
20146856|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146857|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146858|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146859|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
20146860|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
20146861|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146862|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146863|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
20146864|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20146865|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20146866|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20146867|NCT00075075|Infliximab|infliximab|mesh-list
20146868|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
20146869|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20146870|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20146871|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19762817|NCT00057954|Cyclosporine|cyclosporine|mesh-list
19762818|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
19762819|NCT00057954|Methotrexate|methotrexate|mesh-list
19762820|NCT00057954|Pentostatin|pentostatin|mesh-list
19762821|NCT00057954|Cyclosporins|cyclosporins|mesh-list
19762822|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19762823|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
19762824|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19762825|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762826|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19762827|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
19762828|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762829|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762830|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
19762831|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762832|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19762833|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762834|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
19762835|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762836|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19762837|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
19762838|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762839|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19762840|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762841|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19762842|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
20146872|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20146873|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146874|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146875|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
20146876|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146877|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146878|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20146879|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
20146880|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762843|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20146881|NCT00075192|Leuprolide|leuprolide|mesh-list
20146882|NCT00075192|Bicalutamide|bicalutamide|mesh-list
20146883|NCT00075192|Tremelimumab|tremelimumab|mesh-list
20146884|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20146885|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
20146886|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20146887|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146888|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20146889|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146890|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
20146891|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
20146892|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20146893|NCT00075205|Rimonabant|rimonabant|mesh-list
20146894|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20146895|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20146896|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20315245|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20315246|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20315247|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20315248|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762844|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20146897|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20146898|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146899|NCT00075205|Hormones|hormones|mesh-ancestor
20146900|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762845|NCT00058019|Epothilones|epothilones|mesh-list
19762846|NCT00058019|Epothilone B|epothilone b|mesh-list
19762847|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762848|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762849|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762850|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762851|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762852|NCT00058123|Poly ICLC|poly iclc|mesh-list
19762853|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
19762854|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
19762855|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762856|NCT00058240|Alvocidib|alvocidib|mesh-list
19762857|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762858|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
19762859|NCT00058240|Growth Substances|growth substances|mesh-ancestor
19762860|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762861|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19762862|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762863|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762864|NCT00058370|Vincristine|vincristine|mesh-list
19762865|NCT00058370|Lomustine|lomustine|mesh-list
19762866|NCT00058370|Antibodies|antibodies|mesh-list
19762867|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19762868|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
19762869|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762870|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762871|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762872|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762873|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762874|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762875|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762876|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19633275|NCT02442180|Hormones|hormones|mesh-ancestor
19633276|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633277|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19633278|NCT02442180|Protective Agents|protective agents|mesh-ancestor
19633279|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19633280|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146901|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146902|NCT00075231|Ritonavir|ritonavir|mesh-list
20146903|NCT00075231|Lopinavir|lopinavir|mesh-list
20146904|NCT00075231|Lamivudine|lamivudine|mesh-list
20146905|NCT00075231|Zidovudine|zidovudine|mesh-list
20146906|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20146907|NCT00075231|Efavirenz|efavirenz|mesh-list
20146908|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20146909|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20146910|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
20146911|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146912|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146913|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20146914|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20146915|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
19762877|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
19762878|NCT00058422|Prednisone|prednisone|mesh-list
19762879|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
19762880|NCT00058422|Rituximab|rituximab|mesh-list
19762881|NCT00058422|Doxorubicin|doxorubicin|mesh-list
19762882|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19762883|NCT00058422|Vincristine|vincristine|mesh-list
19762884|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
19762885|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19762886|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762887|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
19762888|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762889|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762890|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20146916|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633281|NCT02442128|Fentanyl|fentanyl|mesh-list
19633282|NCT02442128|Propofol|propofol|mesh-list
19633283|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19633284|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19762891|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
19762892|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762893|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762894|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19762895|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762896|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762897|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19762898|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19762899|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762900|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19762901|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
20146917|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20146918|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20146919|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20146920|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20146921|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
20146922|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20146923|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20146924|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20146925|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20146926|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20173822|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20173823|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173824|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20173825|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20173826|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173827|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173828|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20173829|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
20173830|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
20173831|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
20173832|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173833|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20173834|NCT00162721|Doxorubicin|doxorubicin|mesh-list
20173835|NCT00162721|Ifosfamide|ifosfamide|mesh-list
20173836|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173837|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20173838|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20173839|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20173840|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173841|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173842|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20173843|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
20173844|NCT00162734|Interferons|interferons|mesh-list
20173845|NCT00162734|Ribavirin|ribavirin|mesh-list
20173846|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
20173847|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173848|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
20173849|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173850|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
20173851|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173852|NCT00162760|Thalidomide|thalidomide|mesh-list
20173853|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173854|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
20173855|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173856|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
20173857|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20173858|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173859|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20173860|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20173861|NCT00162760|Growth Substances|growth substances|mesh-ancestor
20315249|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633285|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633286|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19633287|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
19633288|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
19633289|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19633290|NCT02442128|Narcotics|narcotics|mesh-ancestor
19633291|NCT02442128|Analgesics|analgesics|mesh-ancestor
19633292|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
19633293|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633294|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19633295|NCT02441933|Carboplatin|carboplatin|mesh-list
19633296|NCT02441933|Taxane|taxane|mesh-list
19762902|NCT00058422|Hormones|hormones|mesh-ancestor
19762903|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762904|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19762905|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19762906|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762907|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762908|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146927|NCT00075374|Docetaxel|docetaxel|mesh-list
20146928|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146929|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
20608697|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633297|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146930|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
19633298|NCT02441907|Aflibercept|aflibercept|mesh-list
19633299|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19633300|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19762909|NCT00058422|Hematinics|hematinics|mesh-ancestor
19762910|NCT00058539|Pertuzumab|pertuzumab|mesh-list
19762911|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762912|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762913|NCT00058552|Pertuzumab|pertuzumab|mesh-list
19762914|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19762915|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762916|NCT00058825|Cyclosporine|cyclosporine|mesh-list
19762917|NCT00058825|Fludarabine|fludarabine|mesh-list
19762918|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
20146931|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146932|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146933|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
20146934|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146935|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
20146936|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146937|NCT00075439|Gefitinib|gefitinib|mesh-list
20146938|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146939|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20146940|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146941|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146942|NCT00075452|Gemcitabine|gemcitabine|mesh-list
20146943|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
20146944|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146945|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
20315250|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315251|NCT00697671|Analgesics|analgesics|mesh-ancestor
20315252|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
20315253|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762919|NCT00058825|Tacrolimus|tacrolimus|mesh-list
19762920|NCT00058825|Cyclosporins|cyclosporins|mesh-list
19762921|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315254|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20315255|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
20315256|NCT00697775|Vaccines|vaccines|mesh-list
19762922|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762923|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19762924|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
19762925|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762926|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19762927|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762928|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
19762929|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762930|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
19762931|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19762932|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20315257|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
20315258|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315259|NCT00697814|Clomiphene|clomiphene|mesh-list
20608698|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633301|NCT02441907|Growth Substances|growth substances|mesh-ancestor
19633302|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633303|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
19633304|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633305|NCT02441842|Atenolol|atenolol|mesh-list
19762933|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19762934|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20146946|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633306|NCT02441842|Lisinopril|lisinopril|mesh-list
20315260|NCT00697814|Enclomiphene|enclomiphene|mesh-list
19762935|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315261|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
19762936|NCT00059215|Clopidogrel|clopidogrel|mesh-list
19762937|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19762938|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19762939|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19762940|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19762941|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19762942|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
19762943|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19762944|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762945|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762946|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19762947|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19762948|NCT00059228|Estradiol|estradiol|mesh-list
19762949|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19762950|NCT00059228|Estrogens|estrogens|mesh-ancestor
19762951|NCT00059228|Hormones|hormones|mesh-ancestor
20146947|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146948|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
20146949|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146950|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146951|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146952|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
20146953|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146954|NCT00075465|Docetaxel|docetaxel|mesh-list
19762952|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19762953|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762954|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19762955|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
19762956|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19762957|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19762958|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
19762959|NCT00059332|Analgesics|analgesics|mesh-ancestor
19762960|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
19762961|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762962|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762963|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
19762964|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19762965|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19762966|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
19762967|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19762968|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19762969|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19762970|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19762971|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
19762972|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19833141|NCT00652847|Ezetimibe|ezetimibe|mesh-list
19833142|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833143|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833144|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
19833145|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833146|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833147|NCT00652717|Simvastatin|simvastatin|mesh-list
19833148|NCT00652717|Ezetimibe|ezetimibe|mesh-list
19833149|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833150|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833151|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
19833152|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833153|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833154|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833155|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833156|NCT00652444|Simvastatin|simvastatin|mesh-list
19833157|NCT00652444|Ezetimibe|ezetimibe|mesh-list
19833158|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20146955|NCT00075465|Epirubicin|epirubicin|mesh-list
20315262|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20146956|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146957|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146958|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146959|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146960|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146961|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20146962|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19833159|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20146963|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20146964|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19762973|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
19762974|NCT00059475|Interleukin-2|interleukin-2|mesh-list
19762975|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762976|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19762977|NCT00059475|Analgesics|analgesics|mesh-ancestor
19762978|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
19762979|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19762980|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762981|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19762982|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
19762983|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762984|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
19762985|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19762986|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
19762987|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19762988|NCT00059475|Protective Agents|protective agents|mesh-ancestor
19762989|NCT00059787|Paclitaxel|paclitaxel|mesh-list
19762990|NCT00059787|Carboplatin|carboplatin|mesh-list
19762991|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19762992|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20146965|NCT00075491|Fenretinide|fenretinide|mesh-list
20146966|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146967|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20146968|NCT00075491|Protective Agents|protective agents|mesh-ancestor
20146969|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146970|NCT00075517|Gemcitabine|gemcitabine|mesh-list
20146971|NCT00075517|Docetaxel|docetaxel|mesh-list
20146972|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146973|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
20146974|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146975|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146976|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
20146977|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20146978|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20146979|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20146980|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
20146981|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20146982|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315263|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
20315264|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315265|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315266|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20315267|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
20608699|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20146983|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146984|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
20315268|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20315269|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20608700|NCT02247648|Tramadol|tramadol|mesh-list
20608701|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20608702|NCT02247648|Narcotics|narcotics|mesh-ancestor
20608703|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633307|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19633308|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
19633309|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633310|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633311|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19633312|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19633313|NCT02441842|Protective Agents|protective agents|mesh-ancestor
19633314|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633315|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19633316|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
19633317|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
19633318|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633319|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19633320|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19633321|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19633322|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
19633323|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633324|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
19633325|NCT02441894|Promethazine|promethazine|mesh-list
19633326|NCT02441894|Dexamethasone|dexamethasone|mesh-list
19633327|NCT02441894|Prednisolone|prednisolone|mesh-list
19633328|NCT02441894|Ondansetron|ondansetron|mesh-list
19633329|NCT02441894|Metoclopramide|metoclopramide|mesh-list
20146985|NCT00075543|Docetaxel|docetaxel|mesh-list
20146986|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
20146987|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146988|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
20146989|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
20146990|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
20146991|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20146992|NCT00075556|Capecitabine|capecitabine|mesh-list
20146993|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20146994|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
20146995|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833160|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
20146996|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20146997|NCT00075595|Leucovorin|leucovorin|mesh-list
20146998|NCT00075595|Fluorouracil|fluorouracil|mesh-list
20146999|NCT00075595|Irinotecan|irinotecan|mesh-list
20147000|NCT00075595|Calcium|calcium|mesh-list
20147001|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
20147002|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20147003|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147004|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
20147005|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147006|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147007|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147008|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147009|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
20147010|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20147011|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147012|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147013|NCT00075595|Antidotes|antidotes|mesh-ancestor
20147014|NCT00075595|Protective Agents|protective agents|mesh-ancestor
20147015|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
20147016|NCT00075595|Vitamins|vitamins|mesh-ancestor
20147017|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
20147018|NCT00075621|Melphalan|melphalan|mesh-list
20147019|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
20147020|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147021|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20147022|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
20147023|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147024|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147025|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20147026|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147027|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
20147028|NCT00075634|Doxorubicin|doxorubicin|mesh-list
20147029|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20147030|NCT00075634|Decitabine|decitabine|mesh-list
20147031|NCT00075634|Azacitidine|azacitidine|mesh-list
20147032|NCT00075634|Lenograstim|lenograstim|mesh-list
20147033|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147034|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
20147035|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147036|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173862|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
19633330|NCT02441894|Granisetron|granisetron|mesh-list
19633331|NCT02441894|Ranitidine|ranitidine|mesh-list
19633332|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
19633333|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633334|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
19633335|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
19633336|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633337|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633338|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633339|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
19633340|NCT02441894|Hormones|hormones|mesh-ancestor
19665924|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19665925|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665926|NCT03229512|Urological Agents|urological agents|mesh-ancestor
19665927|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19665928|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19665929|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665930|NCT03033914|Doxorubicin|doxorubicin|mesh-list
19665931|NCT03033914|Bleomycin|bleomycin|mesh-list
19665932|NCT03033914|Nivolumab|nivolumab|mesh-list
19665933|NCT03033914|Dacarbazine|dacarbazine|mesh-list
19665934|NCT03033914|Vinblastine|vinblastine|mesh-list
19665935|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19762993|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19762994|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
19762995|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
19762996|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
19762997|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147037|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20147038|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
20147039|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147040|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147041|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20147042|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147043|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20147044|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147045|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147046|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20147047|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147048|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
20147049|NCT00075647|Sirolimus|sirolimus|mesh-list
20147050|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20147051|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147052|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147053|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147054|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
20147055|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147056|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
20147057|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19762998|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19762999|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763000|NCT00059839|Prednisone|prednisone|mesh-list
19763001|NCT00059839|Doxorubicin|doxorubicin|mesh-list
19763002|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19763003|NCT00059839|Methotrexate|methotrexate|mesh-list
19763004|NCT00059839|Vincristine|vincristine|mesh-list
20147058|NCT00075673|Celecoxib|celecoxib|mesh-list
20147059|NCT00075673|Vinorelbine|vinorelbine|mesh-list
20147060|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20147061|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20147062|NCT00075673|Analgesics|analgesics|mesh-ancestor
20147063|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
20147064|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20147065|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147066|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20147067|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763005|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
19763006|NCT00059839|Vinblastine|vinblastine|mesh-list
19763007|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763008|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763009|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763010|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763011|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763012|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763013|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763014|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
19763015|NCT00059839|Hormones|hormones|mesh-ancestor
19763016|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763017|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763018|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147068|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20315270|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19633341|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633342|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19633343|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763019|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19633344|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
19633345|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
19633346|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19633347|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
19633348|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633349|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633350|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19763020|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
19763021|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19763022|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20315271|NCT00697866|Vaccines|vaccines|mesh-list
19763023|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
19763024|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
19763025|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19763026|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763027|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
19763028|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763029|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19763030|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763031|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633351|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19633352|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633353|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19633354|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19633355|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19633356|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19633357|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
19633358|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
19633359|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
19633360|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19633361|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
19763032|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763033|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763034|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19763035|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19763036|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763037|NCT00060346|Prednisone|prednisone|mesh-list
19763038|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
19763039|NCT00060346|Rituximab|rituximab|mesh-list
19763040|NCT00060346|Doxorubicin|doxorubicin|mesh-list
19763041|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19763042|NCT00060346|Vincristine|vincristine|mesh-list
19763043|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763044|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
19763045|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763046|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763047|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763048|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
19763049|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763050|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763051|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19763052|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763053|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763054|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763055|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763056|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763057|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763058|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
19763059|NCT00060346|Hormones|hormones|mesh-ancestor
19763060|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763061|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763062|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763063|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763064|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763065|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763066|NCT00060424|Cyclosporine|cyclosporine|mesh-list
19763067|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
19763068|NCT00060424|Fludarabine|fludarabine|mesh-list
19763069|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
19763070|NCT00060424|Cyclosporins|cyclosporins|mesh-list
19763071|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147069|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20147070|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147071|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147072|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147073|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147074|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147075|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147076|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147077|NCT00075686|Gemcitabine|gemcitabine|mesh-list
20147078|NCT00075686|Cetuximab|cetuximab|mesh-list
20147079|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147080|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
20147081|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763072|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763073|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
20147082|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763074|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763075|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763076|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
19763077|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763078|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763079|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
19763080|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763081|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
19763082|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763083|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20147083|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
20147084|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147085|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147086|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147087|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
20147088|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147089|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20147090|NCT00075699|Vincristine|vincristine|mesh-list
20147091|NCT00075699|Vinorelbine|vinorelbine|mesh-list
20147092|NCT00075699|Mitomycins|mitomycins|mesh-list
20147093|NCT00075699|Mitomycin|mitomycin|mesh-list
20147094|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147095|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147096|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763084|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763085|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19763086|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
19763087|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763088|NCT00060528|Metronidazole|metronidazole|mesh-list
19763089|NCT00060528|Molgramostim|molgramostim|mesh-list
19763090|NCT00060528|Sargramostim|sargramostim|mesh-list
19763091|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
19763092|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763093|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763094|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763095|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763096|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19763097|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19763098|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
19763099|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19763100|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
19763101|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763102|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763103|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19763104|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
19763105|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19763106|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
19763107|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763108|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19763109|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19763110|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
19763111|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
19763112|NCT00060840|Protective Agents|protective agents|mesh-ancestor
19763113|NCT00060944|Dexamethasone|dexamethasone|mesh-list
19763114|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
19763115|NCT00060944|Trabectedin|trabectedin|mesh-list
19763116|NCT00060944|BB 1101|bb 1101|mesh-list
19763117|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763118|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
19763119|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
19763120|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763121|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763122|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19763123|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
19763124|NCT00060944|Hormones|hormones|mesh-ancestor
19763125|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763126|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147097|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147098|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147099|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147100|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763127|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147101|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
20147102|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19763128|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20147103|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763129|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763130|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763131|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763132|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
19763133|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
19763134|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763135|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763136|NCT00061373|Aspirin|aspirin|mesh-list
19763137|NCT00061373|Tinzaparin|tinzaparin|mesh-list
19763138|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19763139|NCT00061373|Dalteparin|dalteparin|mesh-list
19763140|NCT00061373|Eptifibatide|eptifibatide|mesh-list
19763141|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19763142|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19763143|NCT00061373|Analgesics|analgesics|mesh-ancestor
19763144|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
19763145|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763146|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763147|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763148|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763149|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19763150|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19763151|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763152|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19763153|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19763154|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763155|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
19763156|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
19763157|NCT00061633|Vancomycin|vancomycin|mesh-list
19763158|NCT00061633|Penicillins|penicillins|mesh-list
19763159|NCT00061633|Telavancin|telavancin|mesh-list
19763160|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763161|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763162|NCT00061893|Celecoxib|celecoxib|mesh-list
19763163|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
19763164|NCT00061893|Ifosfamide|ifosfamide|mesh-list
19763165|NCT00061893|Doxorubicin|doxorubicin|mesh-list
19763166|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19763167|NCT00061893|Etoposide|etoposide|mesh-list
19763168|NCT00061893|Vincristine|vincristine|mesh-list
19763169|NCT00061893|Vinblastine|vinblastine|mesh-list
19763170|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763171|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
19763172|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763173|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763174|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763175|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
19763176|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763177|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763178|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19763179|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763180|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763181|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763182|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763183|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147104|NCT00075712|Paclitaxel|paclitaxel|mesh-list
20147105|NCT00075712|Carboplatin|carboplatin|mesh-list
20147106|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763184|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763185|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763186|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763187|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19763188|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19763189|NCT00061893|Analgesics|analgesics|mesh-ancestor
19763190|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
20147107|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147108|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147109|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147110|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147111|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147112|NCT00075738|Leucovorin|leucovorin|mesh-list
20147113|NCT00075738|Fluorouracil|fluorouracil|mesh-list
19763191|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763192|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763193|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19763194|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20147114|NCT00075738|Irinotecan|irinotecan|mesh-list
20147115|NCT00075738|Calcium|calcium|mesh-list
19763195|NCT00061932|Irinotecan|irinotecan|mesh-list
19763196|NCT00061932|Bortezomib|bortezomib|mesh-list
19763197|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19763198|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763199|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763200|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763201|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763202|NCT00062010|Interferons|interferons|mesh-list
19763203|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
19763204|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
19763205|NCT00062010|Paclitaxel|paclitaxel|mesh-list
19763206|NCT00062010|Tretinoin|tretinoin|mesh-list
19763207|NCT00062010|Isotretinoin|isotretinoin|mesh-list
19763208|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763209|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763210|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763211|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763212|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763213|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763214|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
19763215|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763216|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
19763217|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763218|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
19763219|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
19763220|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
19763221|NCT00062374|Alovudine|alovudine|mesh-list
19763222|NCT00062374|Cisplatin|cisplatin|mesh-list
19763223|NCT00062374|Irinotecan|irinotecan|mesh-list
19763224|NCT00062374|Camptothecin|camptothecin|mesh-list
19763225|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19763226|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763227|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19763228|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763229|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763230|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763231|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19763232|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763233|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
19763234|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
19763235|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763236|NCT00062439|Docetaxel|docetaxel|mesh-list
19763237|NCT00062439|Etoposide|etoposide|mesh-list
19763238|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763239|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763240|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763241|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147116|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
19633362|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
19633363|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19633364|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19633365|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20147117|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147118|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20147119|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147120|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
20147121|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147122|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147123|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633366|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
19633367|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19633368|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19633369|NCT02441660|Capsaicin|capsaicin|mesh-list
19633370|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
19633371|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
19633372|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
19633373|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633374|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633375|NCT02441673|Ephedrine|ephedrine|mesh-list
19633376|NCT02441673|Meperidine|meperidine|mesh-list
19763242|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763243|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763244|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763245|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147124|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
20147125|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19633377|NCT02441673|Tramadol|tramadol|mesh-list
19633378|NCT02441673|Nefopam|nefopam|mesh-list
19633379|NCT02441673|Metoclopramide|metoclopramide|mesh-list
20147126|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147127|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147128|NCT00075738|Antidotes|antidotes|mesh-ancestor
20147129|NCT00075738|Protective Agents|protective agents|mesh-ancestor
20147130|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
20147131|NCT00075738|Vitamins|vitamins|mesh-ancestor
20147132|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
20147133|NCT00075751|Gemcitabine|gemcitabine|mesh-list
20147134|NCT00075751|Carboplatin|carboplatin|mesh-list
19763246|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763247|NCT00062647|Vancomycin|vancomycin|mesh-list
19763248|NCT00062647|Cloxacillin|cloxacillin|mesh-list
19763249|NCT00062647|Oxacillin|oxacillin|mesh-list
19763250|NCT00062647|Telavancin|telavancin|mesh-list
19763251|NCT00062647|Nafcillin|nafcillin|mesh-list
19763252|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763253|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147135|NCT00075751|Bortezomib|bortezomib|mesh-list
20147136|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147137|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147138|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
20147139|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147140|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
20147141|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147142|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147143|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147144|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
20147145|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147146|NCT00075777|Valproic Acid|valproic acid|mesh-list
20147147|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
20147148|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147149|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147150|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
20147151|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147152|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147153|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
20147154|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20147155|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20147156|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20147157|NCT00075855|Testosterone|testosterone|mesh-list
19763254|NCT00062738|Paroxetine|paroxetine|mesh-list
19763255|NCT00062738|Nortriptyline|nortriptyline|mesh-list
19763256|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19763257|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19763258|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19763259|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763260|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19763261|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
19763262|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763263|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19763264|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
19763265|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19763266|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19763267|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19763268|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763269|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19763270|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19763271|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
19763272|NCT00062764|Pioglitazone|pioglitazone|mesh-list
19763273|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20147158|NCT00075855|Androgens|androgens|mesh-ancestor
20147159|NCT00075855|Hormones|hormones|mesh-ancestor
20147160|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315272|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
19633380|NCT02441673|Ranitidine|ranitidine|mesh-list
19633381|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19633382|NCT02441673|Oxytocin|oxytocin|mesh-list
19633383|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
19633384|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19633385|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633386|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19633387|NCT02441673|Narcotics|narcotics|mesh-ancestor
19633388|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633389|NCT02441673|Analgesics|analgesics|mesh-ancestor
19633390|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
19633391|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633392|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
19633393|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
19763274|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763275|NCT00063154|Pertuzumab|pertuzumab|mesh-list
19763276|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763277|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763278|NCT00063232|Metformin|metformin|mesh-list
19763279|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19763280|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763281|NCT00063258|Paclitaxel|paclitaxel|mesh-list
19763282|NCT00063258|Carboplatin|carboplatin|mesh-list
19763283|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19763284|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763285|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763286|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763287|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763288|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763289|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763290|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19763291|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763292|NCT00063362|Lamotrigine|lamotrigine|mesh-list
19763293|NCT00063362|Valproic Acid|valproic acid|mesh-list
19763294|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
19763295|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
19763296|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19763297|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763298|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763299|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
19633394|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633395|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19633396|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19633397|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
19633398|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633399|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633400|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19633401|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
19633402|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19633403|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
19763300|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19763301|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19763302|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763303|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
19763304|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19763305|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19763306|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20147161|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147162|NCT00075868|Octreotide|octreotide|mesh-list
20147163|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633404|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19633405|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19633406|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
19633407|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
19763307|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19763308|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19763309|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
19763310|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19763311|NCT00063570|Gemcitabine|gemcitabine|mesh-list
19763312|NCT00063570|Pemetrexed|pemetrexed|mesh-list
19763313|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763314|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
19763315|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763316|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763317|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
19763318|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763319|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763320|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763321|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
19763322|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763323|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19763324|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19763325|NCT00063622|Vitamin E|vitamin e|mesh-list
20147164|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147165|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147166|NCT00075894|Alanosine|alanosine|mesh-list
20147167|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763326|NCT00063622|Pioglitazone|pioglitazone|mesh-list
19763327|NCT00063622|Vitamins|vitamins|mesh-ancestor
19763328|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
19763329|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763330|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19763331|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
19763332|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763333|NCT00063622|Protective Agents|protective agents|mesh-ancestor
19763334|NCT00063635|Vitamin E|vitamin e|mesh-list
19763335|NCT00063635|Metformin|metformin|mesh-list
19763336|NCT00063635|Vitamins|vitamins|mesh-ancestor
19763337|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
19763338|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763339|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19763340|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
19763341|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763342|NCT00063635|Protective Agents|protective agents|mesh-ancestor
19763343|NCT00063934|Docetaxel|docetaxel|mesh-list
19763344|NCT00063934|Doxorubicin|doxorubicin|mesh-list
19763345|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19763346|NCT00063934|Oblimersen|oblimersen|mesh-list
19763347|NCT00063934|Lenograstim|lenograstim|mesh-list
19763348|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763349|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763350|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763351|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763352|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763353|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763354|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20147168|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147169|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
20147170|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
20147171|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147172|NCT00075907|Ritonavir|ritonavir|mesh-list
20147173|NCT00075907|Lopinavir|lopinavir|mesh-list
20147174|NCT00075907|Efavirenz|efavirenz|mesh-list
19763355|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763356|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763357|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19763358|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
19763359|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763360|NCT00063999|Paclitaxel|paclitaxel|mesh-list
19763361|NCT00063999|Cisplatin|cisplatin|mesh-list
19763362|NCT00063999|Carboplatin|carboplatin|mesh-list
19763363|NCT00063999|Doxorubicin|doxorubicin|mesh-list
19763364|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19763365|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19763366|NCT00063999|Lenograstim|lenograstim|mesh-list
19763367|NCT00063999|Sargramostim|sargramostim|mesh-list
19763368|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763369|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763370|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763371|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763372|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763373|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763374|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763375|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763376|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763377|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763378|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19763379|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
19763380|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763381|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19763382|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
19763383|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19763384|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19763385|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19763386|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
19763387|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19763388|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763389|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19763390|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19763391|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20147175|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20147176|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20315273|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763392|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147177|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19763393|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763394|NCT00064038|Dexamethasone|dexamethasone|mesh-list
20147178|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147179|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147180|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20147181|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20147182|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
20147183|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147184|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20147185|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20147186|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20147187|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20147188|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20147189|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20147190|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20147191|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20147192|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20147193|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
20147194|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147195|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20147196|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20147197|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173863|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315274|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20315275|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315276|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315277|NCT00697892|Ritonavir|ritonavir|mesh-list
20315278|NCT00697892|Lopinavir|lopinavir|mesh-list
20315279|NCT00697892|Efavirenz|efavirenz|mesh-list
20315280|NCT00697892|Lumefantrine|lumefantrine|mesh-list
20315281|NCT00697892|Artemether|artemether|mesh-list
20315282|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20315283|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19633408|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19633409|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633410|NCT02441803|Cytarabine|cytarabine|mesh-list
19633411|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
19633412|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
19633413|NCT02441803|Busulfan|busulfan|mesh-list
19763395|NCT00064038|Lenalidomide|lenalidomide|mesh-list
19763396|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763397|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
19763398|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
19763399|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763400|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763401|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19763402|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
19763403|NCT00064038|Hormones|hormones|mesh-ancestor
19763404|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763405|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763406|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763407|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
19763408|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19763409|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19763410|NCT00064038|Growth Substances|growth substances|mesh-ancestor
19763411|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
19763412|NCT00064077|Gemcitabine|gemcitabine|mesh-list
19763413|NCT00064077|Paclitaxel|paclitaxel|mesh-list
19763414|NCT00064077|Vinorelbine|vinorelbine|mesh-list
19763415|NCT00064077|Cisplatin|cisplatin|mesh-list
20315284|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19633414|NCT02441803|Fludarabine|fludarabine|mesh-list
19633415|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
19633416|NCT02441803|Decitabine|decitabine|mesh-list
19633417|NCT02441803|Idarubicin|idarubicin|mesh-list
19633418|NCT02441803|Clofarabine|clofarabine|mesh-list
19633419|NCT02441803|Tacrolimus|tacrolimus|mesh-list
19633420|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
19633421|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19633422|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633423|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
19633424|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633425|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633426|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19633427|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
19633428|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633429|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763416|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19763417|NCT00064077|Topotecan|topotecan|mesh-list
20147198|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147199|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
19763418|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763419|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763420|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763421|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763422|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763423|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763424|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763425|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
19763426|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
19763427|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763428|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763429|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763430|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
19763431|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763432|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19763433|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763434|NCT00064259|Fluorouracil|fluorouracil|mesh-list
19763435|NCT00064259|Oblimersen|oblimersen|mesh-list
19763436|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763437|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
20147200|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
20147201|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
20147202|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147203|NCT00075959|Protective Agents|protective agents|mesh-ancestor
20147204|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147205|NCT00075972|Nicotine|nicotine|mesh-list
20147206|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19763438|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763439|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763440|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763441|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
19763442|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763443|NCT00064337|Thalidomide|thalidomide|mesh-list
19763444|NCT00064337|Dexamethasone|dexamethasone|mesh-list
19763445|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
19763446|NCT00064337|Melphalan|melphalan|mesh-list
19763447|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763448|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
19763449|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763450|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763451|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763452|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
19763453|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763454|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763455|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19763456|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763457|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
19763458|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
19763459|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763460|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20147207|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
20147208|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20147209|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147210|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19763461|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
19763462|NCT00064337|Hormones|hormones|mesh-ancestor
19763463|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763464|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763465|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
19763466|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763467|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763468|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19763469|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19763470|NCT00064337|Growth Substances|growth substances|mesh-ancestor
19763471|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
19763472|NCT00064350|Sorafenib|sorafenib|mesh-list
19763473|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763474|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19763475|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763476|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147211|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20147212|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
20147213|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19763477|NCT00064701|Cyclosporine|cyclosporine|mesh-list
19763478|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
19763479|NCT00064701|Tacrolimus|tacrolimus|mesh-list
19763480|NCT00064701|Cyclosporins|cyclosporins|mesh-list
19763481|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763482|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
19763483|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763484|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19763485|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763486|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763487|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
19763488|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763489|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
19763490|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763491|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763492|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763493|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19633430|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19763494|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
19633431|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763495|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763496|NCT00064792|Simvastatin|simvastatin|mesh-list
19763497|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19763498|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19763499|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
19763500|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763501|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19763502|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19763503|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763504|NCT00064844|Nicotine|nicotine|mesh-list
19763505|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19763506|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
19763507|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763508|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763509|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19763510|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19763511|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
19763512|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19763513|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763514|NCT00064987|Hormones|hormones|mesh-list
19763515|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19763516|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763517|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763518|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
19763519|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19763520|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763521|NCT00065156|Lenalidomide|lenalidomide|mesh-list
19763522|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
19763523|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763524|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19763525|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19763526|NCT00065156|Growth Substances|growth substances|mesh-ancestor
19763527|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
19763528|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763529|NCT00065182|Docetaxel|docetaxel|mesh-list
19763530|NCT00065182|Topotecan|topotecan|mesh-list
19763531|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763532|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633432|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
19633433|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
19633434|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633435|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19633436|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633437|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19633438|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19633439|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
19763533|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
19633440|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763534|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173864|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
19763535|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763536|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19763537|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763538|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763539|NCT00065260|Cyclosporine|cyclosporine|mesh-list
19763540|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
19763541|NCT00065260|Cyclosporins|cyclosporins|mesh-list
19763542|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
19763543|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19763544|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763545|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763546|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763547|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
19763548|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763549|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
19763550|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763551|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
19763552|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763553|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19763554|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763555|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763556|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
19763557|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763558|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763559|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763560|NCT00065468|Interferons|interferons|mesh-list
19763561|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
19763562|NCT00065468|Sirolimus|sirolimus|mesh-list
19763563|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763564|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
19763565|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763566|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
19763567|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763568|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763569|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763570|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
19763571|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763572|NCT00065507|Entecavir|entecavir|mesh-list
19763573|NCT00065507|Adefovir|adefovir|mesh-list
19763574|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
19763575|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763576|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19763577|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20147214|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633441|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19633442|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763578|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763579|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763580|NCT00065611|Dexamethasone|dexamethasone|mesh-list
19763581|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763582|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
19763583|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
19763584|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763585|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763586|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19763587|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
19763588|NCT00065611|Hormones|hormones|mesh-ancestor
19633443|NCT02441816|Aflibercept|aflibercept|mesh-list
19633444|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19633445|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19633446|NCT02441816|Growth Substances|growth substances|mesh-ancestor
19633447|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633448|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
19633449|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633450|NCT02441439|Iron|iron|mesh-list
19633451|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19633452|NCT02441439|Trace Elements|trace elements|mesh-ancestor
19633453|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
19763589|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763590|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147215|NCT00075998|Interferons|interferons|mesh-list
20147216|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
20147217|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633454|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763591|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147218|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
20147219|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147220|NCT00076115|Risperidone|risperidone|mesh-list
20147221|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20147222|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
20147223|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147224|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147225|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147226|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20147227|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20147228|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315285|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
19633455|NCT02441439|Hematinics|hematinics|mesh-ancestor
19633456|NCT02441465|Vemurafenib|vemurafenib|mesh-list
19633457|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633458|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19633459|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633460|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633461|NCT02441530|Vitamin D|vitamin d|mesh-list
19633462|NCT02441530|Vitamins|vitamins|mesh-list
19633463|NCT02441530|Vitamin E|vitamin e|mesh-list
19633464|NCT02441530|Ibuprofen|ibuprofen|mesh-list
19633465|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
19633466|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633467|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19633468|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633469|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633470|NCT02441530|Analgesics|analgesics|mesh-ancestor
19633471|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
19633472|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633473|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633474|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633475|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19633476|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315286|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315287|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315288|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20315289|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20315290|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
20315291|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315292|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20315293|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20315294|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19633477|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633478|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
19633479|NCT02441530|Protective Agents|protective agents|mesh-ancestor
19633480|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
19633481|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19633482|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
19633483|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633484|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
19633485|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633486|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633487|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19633488|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
19633489|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633490|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633491|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19633492|NCT02441075|Ethanol|ethanol|mesh-list
19633493|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19633494|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633495|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633496|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633497|NCT02441088|Octreotide|octreotide|mesh-list
19633498|NCT02441088|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
19633499|NCT02441088|Edotreotide|edotreotide|mesh-list
19633500|NCT02441088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20147229|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19763592|NCT00065806|Atorvastatin|atorvastatin|mesh-list
19763593|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19763594|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19763595|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
19763596|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763597|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19763598|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19763599|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763600|NCT00066066|Amoxicillin|amoxicillin|mesh-list
19763601|NCT00066066|Metronidazole|metronidazole|mesh-list
19763602|NCT00066066|Doxycycline|doxycycline|mesh-list
19763603|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19763604|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763605|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19763606|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19763607|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
19763608|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
19763609|NCT00066170|Modafinil|modafinil|mesh-list
19763610|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19763611|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763612|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19763613|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19763614|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19763615|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763616|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19763617|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19763618|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
19763619|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
19763620|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19763621|NCT00066222|Etoposide|etoposide|mesh-list
19763622|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763623|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763624|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763625|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763626|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763627|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763628|NCT00066365|Molgramostim|molgramostim|mesh-list
19633501|NCT02441088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19633502|NCT02441088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633503|NCT02441088|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19633504|NCT02441088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633505|NCT02441088|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19633506|NCT02441088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20147230|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20147231|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
20147232|NCT00076206|Sirolimus|sirolimus|mesh-list
19633507|NCT02440880|Dexamethasone|dexamethasone|mesh-list
19633508|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
19633509|NCT02440880|BB 1101|bb 1101|mesh-list
19633510|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633511|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
19633512|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
19633513|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633514|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633515|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633516|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
19633517|NCT02440880|Hormones|hormones|mesh-ancestor
19633518|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633519|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19633520|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633521|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
19633522|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633523|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633524|NCT02440750|Dienogest|dienogest|mesh-list
19633525|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
19633526|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19633527|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
19633528|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19633529|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633530|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19633531|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19633532|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19633533|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20147233|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20147234|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147235|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147236|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147237|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
20147238|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147239|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
20147240|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147241|NCT00076232|Acyclovir|acyclovir|mesh-list
20147242|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
20147243|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147244|NCT00076284|Aplaviroc|aplaviroc|mesh-list
20147245|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20147246|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20147247|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147248|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20147249|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20147250|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
20147251|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147252|NCT00076310|Cisplatin|cisplatin|mesh-list
20147253|NCT00076310|Docetaxel|docetaxel|mesh-list
20147254|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20147255|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147256|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147257|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147258|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147259|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147260|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20147261|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147262|NCT00076323|Primaquine|primaquine|mesh-list
20147263|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
20147264|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19633534|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
19633535|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633536|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147265|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20147266|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147267|NCT00076349|Rituximab|rituximab|mesh-list
20147268|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20147269|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20315295|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20315296|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20147270|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147271|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
19633537|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661935|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147272|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147273|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147274|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20147275|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
20147276|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147277|NCT00076362|Octreotide|octreotide|mesh-list
20315297|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20315298|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20315299|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20315300|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20315301|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
20315302|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20315303|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19661936|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661937|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19661938|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
19661939|NCT04543643|Protective Agents|protective agents|mesh-ancestor
19661940|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19661941|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661942|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19661943|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
19661944|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19661945|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19661946|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
19661947|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19661948|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661949|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661950|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633538|NCT02440958|Folfirinox|folfirinox|mesh-list
19633539|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633540|NCT02440841|Itraconazole|itraconazole|mesh-list
19633541|NCT02440841|Rifampin|rifampin|mesh-list
19763629|NCT00066365|Sargramostim|sargramostim|mesh-list
19763630|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
19763631|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763632|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763633|NCT00066469|Prednisone|prednisone|mesh-list
19763634|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
19763635|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19763636|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19763637|NCT00066469|Prednisolone|prednisolone|mesh-list
20147278|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20147279|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147280|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147281|NCT00076388|Docetaxel|docetaxel|mesh-list
19763638|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
19763639|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
19763640|NCT00066469|Rituximab|rituximab|mesh-list
19763641|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19763642|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
19763643|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763644|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
19763645|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763646|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763647|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763648|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
19763649|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763650|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763651|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19763652|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763653|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763654|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
19763655|NCT00066469|Hormones|hormones|mesh-ancestor
19763656|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763657|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763658|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
19763659|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
19763660|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20147282|NCT00076388|Gefitinib|gefitinib|mesh-list
20147283|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147284|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147285|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147286|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147287|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633542|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
19633543|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633544|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19633545|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19633546|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633547|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633548|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19633549|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
19633550|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633551|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633552|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19633553|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19633554|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
19633555|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19633556|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
19633557|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19633558|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19633559|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19633560|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19633561|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19633562|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19633563|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19633564|NCT02440581|Alendronate|alendronate|mesh-list
19633565|NCT02440581|Teriparatide|teriparatide|mesh-list
19633566|NCT02440581|Cinacalcet|cinacalcet|mesh-list
19763661|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19763662|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20147288|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20147289|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147290|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
20147291|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147292|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20147293|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
20147294|NCT00076414|Acetylcholine|acetylcholine|mesh-list
19763663|NCT00066469|Protective Agents|protective agents|mesh-ancestor
19763664|NCT00066573|Anastrozole|anastrozole|mesh-list
19763665|NCT00066573|Exemestane|exemestane|mesh-list
20147295|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
19633567|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19633568|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633569|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19763666|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763667|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763668|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19763669|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19763670|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763671|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763672|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19763673|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
19763674|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763675|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763676|NCT00066677|Docetaxel|docetaxel|mesh-list
19763677|NCT00066677|Bevacizumab|bevacizumab|mesh-list
19763678|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763679|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763680|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763681|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763682|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763683|NCT00066677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763684|NCT00066677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19763685|NCT00066677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19763686|NCT00066677|Growth Substances|growth substances|mesh-ancestor
19763687|NCT00066677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763688|NCT00066677|Growth Inhibitors|growth inhibitors|mesh-ancestor
19763689|NCT00066690|Tamoxifen|tamoxifen|mesh-list
19763690|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19763691|NCT00066690|Exemestane|exemestane|mesh-list
19763692|NCT00066690|Tryptophan|tryptophan|mesh-list
19763693|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763694|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763695|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763696|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19763697|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
19763698|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147296|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19633570|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19633571|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
19633572|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633573|NCT02440828|Tobramycin|tobramycin|mesh-list
19633574|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19633575|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633576|NCT02440347|Anesthetics|anesthetics|mesh-list
19633577|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633578|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633579|NCT02440230|Anastrozole|anastrozole|mesh-list
19633580|NCT02440230|Exemestane|exemestane|mesh-list
19633581|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19633582|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633583|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19633584|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19633585|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633586|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633587|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19633588|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
19633589|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633590|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763699|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147297|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
20147298|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19763700|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19763701|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19763702|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19763703|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19763704|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19763705|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763706|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
19763707|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19763708|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
19763709|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19763710|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19763711|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19763712|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
19763713|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19763714|NCT00066703|Tamoxifen|tamoxifen|mesh-list
19763715|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19763716|NCT00066703|Exemestane|exemestane|mesh-list
19763717|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19763718|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
19763719|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763720|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763721|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763722|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763723|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19763724|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19763725|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19763726|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19763727|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19763728|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147299|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147300|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147301|NCT00076440|Leuprolide|leuprolide|mesh-list
20147302|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20147303|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
20147304|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20147305|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147306|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147307|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147308|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
20147309|NCT00076492|Vitamins|vitamins|mesh-ancestor
20147310|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
20147311|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147312|NCT00076518|Fenofibrate|fenofibrate|mesh-list
20147313|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20315304|NCT00697905|Gemcitabine|gemcitabine|mesh-list
20315305|NCT00697905|Carboplatin|carboplatin|mesh-list
19633591|NCT02440399|Acetaminophen|acetaminophen|mesh-list
19633592|NCT02440399|Diclofenac|diclofenac|mesh-list
19633593|NCT02440399|Morphine|morphine|mesh-list
19633594|NCT02440399|Oxycodone|oxycodone|mesh-list
19633595|NCT02440399|Tramadol|tramadol|mesh-list
19633596|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19633597|NCT02440399|Narcotics|narcotics|mesh-ancestor
19633598|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633599|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633600|NCT02440399|Analgesics|analgesics|mesh-ancestor
19633601|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
19633602|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633603|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633604|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
19633605|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633606|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633607|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633608|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19763729|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763730|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
19763731|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19763732|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
19763733|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19763734|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20315306|NCT00697905|Fluorouracil|fluorouracil|mesh-list
20315307|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633609|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633610|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633611|NCT02440243|Vaccines|vaccines|mesh-list
20315308|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20315309|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
20315310|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633612|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
19633613|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633614|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
20147314|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
20147315|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147316|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20147317|NCT00076531|Leuprolide|leuprolide|mesh-list
20147318|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20147319|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
20147320|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20147321|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633615|NCT02440256|Narcotics|narcotics|mesh-ancestor
19633616|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633617|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633618|NCT02440256|Analgesics|analgesics|mesh-ancestor
19633619|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
19633620|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633621|NCT02440100|Midazolam|midazolam|mesh-list
19633622|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19633623|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19633624|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633625|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633626|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19633627|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19633628|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19633629|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19633630|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
19633631|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
19633632|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
19633633|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
19633634|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633635|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633636|NCT02439944|Nicotine|nicotine|mesh-list
19633637|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19633638|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
19633639|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633640|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633641|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19633642|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19633643|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
19633644|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633645|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633646|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
19633647|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19633648|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633649|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633650|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633651|NCT02439905|Analgesics|analgesics|mesh-ancestor
19633652|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
19633653|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633654|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19633655|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19633656|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19633657|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
19633658|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147322|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147323|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147324|NCT00076544|Ziconotide|ziconotide|mesh-list
20147325|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20147326|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20147327|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147328|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20147329|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147330|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20147331|NCT00076544|Protective Agents|protective agents|mesh-ancestor
19633659|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315311|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
20608704|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608705|NCT02247648|Analgesics|analgesics|mesh-ancestor
19633660|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
19763735|NCT00066742|Etoposide|etoposide|mesh-list
19763736|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
19763737|NCT00066742|Tirapazamine|tirapazamine|mesh-list
19763738|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763739|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763740|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763741|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763742|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763743|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763744|NCT00066781|Gemcitabine|gemcitabine|mesh-list
19763745|NCT00066781|Irinotecan|irinotecan|mesh-list
19763746|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763747|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
19763748|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147332|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20147333|NCT00076544|Analgesics|analgesics|mesh-ancestor
20315312|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315313|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315314|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315315|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
20315316|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315317|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20315318|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
20315319|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315320|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20315321|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20315322|NCT00697996|Rituximab|rituximab|mesh-list
20315323|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20315324|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315325|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
20315326|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315327|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315328|NCT00698126|Insulin|insulin|mesh-list
20315329|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20315330|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
20315331|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
20315332|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315333|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763749|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763750|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
19763751|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763752|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763753|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763754|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
19763755|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763756|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19763757|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763758|NCT00066937|Benztropine|benztropine|mesh-list
19763759|NCT00066937|Nortriptyline|nortriptyline|mesh-list
19763760|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19763761|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
20147334|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
20147335|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20147336|NCT00076609|Capecitabine|capecitabine|mesh-list
20315334|NCT00698269|Insulin|insulin|mesh-list
19633661|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19633662|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19633663|NCT02439866|Prednisolone|prednisolone|mesh-list
19633664|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
19633665|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19633666|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
19633667|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633668|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
20147337|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147338|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
20147339|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315335|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20315336|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
20315337|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
19633669|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
19763762|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19763763|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20147340|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315338|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19633670|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633671|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633672|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633673|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
19633674|NCT02439866|Hormones|hormones|mesh-ancestor
19633675|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633676|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19633677|NCT02439866|Protective Agents|protective agents|mesh-ancestor
19633678|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763764|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19763765|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19763766|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763767|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
19763768|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19763769|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763770|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19763771|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19763772|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
19763773|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
19763774|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763775|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19763776|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19763777|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
19763778|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19763779|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
19763780|NCT00067002|Vidarabine|vidarabine|mesh-list
19763781|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
19763782|NCT00067002|Melphalan|melphalan|mesh-list
19763783|NCT00067002|Thiotepa|thiotepa|mesh-list
19763784|NCT00067002|Rituximab|rituximab|mesh-list
19763785|NCT00067002|Fludarabine|fludarabine|mesh-list
19763786|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
19763787|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763788|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
19763789|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763790|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763791|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763792|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
19763793|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763794|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763795|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20147341|NCT00076635|Interferons|interferons|mesh-list
20147342|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
20147343|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147344|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
20147345|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147346|NCT00076674|Levodopa|levodopa|mesh-list
20147347|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20147348|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20147349|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
20147350|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147351|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147352|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147353|NCT00076726|Infliximab|infliximab|mesh-list
20147354|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315339|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
20315340|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
20315341|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20315342|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315343|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315344|NCT00698334|Rifampin|rifampin|mesh-list
20315345|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
20315346|NCT00698334|Ethambutol|ethambutol|mesh-list
20315347|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20315348|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
20315349|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20315350|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315351|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
20315352|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20315353|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315354|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315355|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19763796|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763797|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763798|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
19633679|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633680|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19633681|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
19633682|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19633683|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
19633684|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633685|NCT02440009|Itraconazole|itraconazole|mesh-list
19633686|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
19633687|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
19633688|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633689|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19633690|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19633691|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633692|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633693|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19633694|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
19633695|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20147355|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20147356|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147357|NCT00076791|Tenofovir|tenofovir|mesh-list
20147358|NCT00076791|Emtricitabine|emtricitabine|mesh-list
20147359|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20147360|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
20147361|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147362|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20147363|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20147364|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147365|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147366|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20147367|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20147368|NCT00076856|Temozolomide|temozolomide|mesh-list
20147369|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20147370|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
20147371|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147372|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147373|NCT00076869|Amphotericin B|amphotericin b|mesh-list
20147374|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20147375|NCT00076869|Caspofungin|caspofungin|mesh-list
19763799|NCT00067002|Antiviral Agents|antiviral agents|mesh-ancestor
19763800|NCT00067002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763801|NCT00067028|Cytarabine|cytarabine|mesh-list
19763802|NCT00067028|Clofarabine|clofarabine|mesh-list
19763803|NCT00067028|Idarubicin|idarubicin|mesh-list
19763804|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763805|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
19763806|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763807|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763808|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
19763809|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763810|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763811|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
19763812|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763813|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763814|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763815|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763816|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763817|NCT00067808|Decitabine|decitabine|mesh-list
19763818|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763819|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
19763820|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763821|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763822|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763823|NCT00067990|Losartan|losartan|mesh-list
19763824|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19763825|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19763826|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19763827|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19763828|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763829|NCT00068250|Rituximab|rituximab|mesh-list
19763830|NCT00068250|Methotrexate|methotrexate|mesh-list
19763831|NCT00068250|Temozolomide|temozolomide|mesh-list
20147376|NCT00076869|Amebicides|amebicides|mesh-ancestor
19763832|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20147377|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19763833|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763834|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
19763835|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763836|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763837|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19763838|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
19763839|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19763840|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763841|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
19763842|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763843|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19763844|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763845|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19763846|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763847|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19763848|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763849|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
19763850|NCT00068341|Carboplatin|carboplatin|mesh-list
19763851|NCT00068341|Docetaxel|docetaxel|mesh-list
19763852|NCT00068341|Trastuzumab|trastuzumab|mesh-list
20315356|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20315357|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20315358|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20315359|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20315360|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20315361|NCT00698425|Citric Acid|citric acid|mesh-list
20315362|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
20315363|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
20315364|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20315365|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
20315366|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
20315367|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315368|NCT00698464|Pasireotide|pasireotide|mesh-list
20315369|NCT00698464|Hormones|hormones|mesh-ancestor
20315370|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315371|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347324|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608706|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
20608707|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608708|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
20608709|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20608710|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
20347325|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
20347326|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
20347327|NCT00859274|Budesonide|budesonide|mesh-list
20347328|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347329|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20347330|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
20347331|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347332|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347333|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20608711|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19633696|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633697|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19633698|NCT02440009|Hormones|hormones|mesh-ancestor
19633699|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
19633700|NCT02439788|Fludarabine|fludarabine|mesh-list
19633701|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633702|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
19633703|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633704|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633705|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19633706|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
19633707|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633708|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633709|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19633710|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
19633711|NCT02439697|Hematinics|hematinics|mesh-ancestor
19633712|NCT02439632|Levofloxacin|levofloxacin|mesh-list
19633713|NCT02439632|Ofloxacin|ofloxacin|mesh-list
19633714|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
19633715|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
19633716|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19633717|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763853|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763854|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
19763855|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
19763856|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
19763857|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763858|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763859|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19763860|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763861|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19763862|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763863|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763864|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
19763865|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763866|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19763867|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763868|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763869|NCT00068393|Gemcitabine|gemcitabine|mesh-list
19763870|NCT00068393|Doxorubicin|doxorubicin|mesh-list
19763871|NCT00068393|Sargramostim|sargramostim|mesh-list
19763872|NCT00068393|Lenograstim|lenograstim|mesh-list
20608712|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20608713|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
19633718|NCT02439632|Renal Agents|renal agents|mesh-ancestor
19633719|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19633720|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19633721|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19633722|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633723|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633724|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633725|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19633726|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19633727|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19633728|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
19633729|NCT02439450|Nivolumab|nivolumab|mesh-list
19633730|NCT02439450|Pemetrexed|pemetrexed|mesh-list
19633731|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19633732|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608714|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608715|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20608716|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20608717|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608718|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608719|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20608720|NCT02247986|Methylphenidate|methylphenidate|mesh-list
20315372|NCT00698607|Sirolimus|sirolimus|mesh-list
20315373|NCT00698607|Everolimus|everolimus|mesh-list
20315374|NCT00698607|Clopidogrel|clopidogrel|mesh-list
19633733|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19763873|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763874|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
19763875|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763876|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763877|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
19763878|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763879|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763880|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763881|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
19763882|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763883|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19763884|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19763885|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763886|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19763887|NCT00068406|Cisplatin|cisplatin|mesh-list
20147378|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20147379|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147380|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20147381|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
20147382|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147383|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147384|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20147385|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147386|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147387|NCT00076986|Carmustine|carmustine|mesh-list
20147388|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20315375|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633734|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633735|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147389|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
20147390|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147391|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147392|NCT00077025|Gefitinib|gefitinib|mesh-list
20147393|NCT00077025|Anastrozole|anastrozole|mesh-list
20147394|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147395|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20147396|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147397|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147398|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147399|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20147400|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20147401|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20147402|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
20147403|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315376|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315377|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
20315378|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315379|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20315380|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20315381|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20315382|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19633736|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19633737|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19633738|NCT02439489|Carboplatin|carboplatin|mesh-list
19633739|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633740|NCT02439190|Aspirin|aspirin|mesh-list
19633741|NCT02439190|Clopidogrel|clopidogrel|mesh-list
19633742|NCT02439190|BMS-986120|bms-986120|mesh-list
19633743|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633744|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633745|NCT02439190|Analgesics|analgesics|mesh-ancestor
20147404|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147405|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
20147406|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
20147407|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147408|NCT00077077|Capecitabine|capecitabine|mesh-list
20147409|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147410|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
20147411|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147412|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147413|NCT00077103|Doxorubicin|doxorubicin|mesh-list
20147414|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20147415|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
20147416|NCT00077103|Combretastatin|combretastatin|mesh-list
20147417|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147418|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147419|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20147420|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147421|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147422|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147423|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147424|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147425|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
20315383|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
20315384|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147426|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147427|NCT00077116|Cytarabine|cytarabine|mesh-list
19633746|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
20147428|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
19661951|NCT04526652|Analgesics|analgesics|mesh-ancestor
19633747|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633748|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633749|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633750|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633751|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19633752|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19633753|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633754|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19633755|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19633756|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633757|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
20147429|NCT00077116|Busulfan|busulfan|mesh-list
19763888|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763889|NCT00068419|Tamoxifen|tamoxifen|mesh-list
19763890|NCT00068419|Sulindac|sulindac|mesh-list
19763891|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763892|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19763893|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
19763894|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19763895|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763896|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763897|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763898|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19763899|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19763900|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19763901|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19763902|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19763903|NCT00068419|Analgesics|analgesics|mesh-ancestor
19763904|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
19633758|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19633759|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19633760|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19763905|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763906|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763907|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763908|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19763909|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763910|NCT00068445|Lamotrigine|lamotrigine|mesh-list
19763911|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
19763912|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19763913|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19763914|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763915|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19763916|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763917|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19763918|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19763919|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19763920|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19763921|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19763922|NCT00068575|Interferons|interferons|mesh-list
19763923|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
19763924|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
19763925|NCT00068575|Cisplatin|cisplatin|mesh-list
19633761|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
19633762|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661952|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
19661953|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661954|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19661955|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19661956|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19661957|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
19661958|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147430|NCT00077116|Idarubicin|idarubicin|mesh-list
20147431|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
20147432|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147433|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
20147434|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147435|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147436|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20147437|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
20147438|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147439|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147440|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19763926|NCT00068575|Fluorouracil|fluorouracil|mesh-list
19763927|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763928|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
19763929|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763930|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763931|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763932|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
19763933|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763934|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
19763935|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19763936|NCT00068588|Capecitabine|capecitabine|mesh-list
19763937|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763938|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
19763939|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763940|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763941|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
19763942|NCT00068601|Goserelin|goserelin|mesh-list
19763943|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763944|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
19763945|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763946|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763947|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19763948|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
19763949|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763950|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763951|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19763952|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19763953|NCT00068692|Leucovorin|leucovorin|mesh-list
19763954|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
20147441|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147442|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
20147443|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
20147444|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147445|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147446|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20147447|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147448|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147449|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608721|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20608722|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608723|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20608724|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20608725|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20608726|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608727|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
20608728|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608729|NCT02248012|Everolimus|everolimus|mesh-list
20608730|NCT02248012|Temozolomide|temozolomide|mesh-list
20608731|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608732|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608733|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
20608734|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608735|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20608736|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
20612150|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633763|NCT02439411|Trametinib|trametinib|mesh-list
19633764|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633765|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19633766|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633767|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633768|NCT02439125|Eltoprazine|eltoprazine|mesh-list
19633769|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19633770|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
19633771|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633772|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633773|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633774|NCT02439034|Acetaminophen|acetaminophen|mesh-list
19633775|NCT02439034|Ketoprofen|ketoprofen|mesh-list
19633776|NCT02439034|Codeine|codeine|mesh-list
19633777|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19633778|NCT02439034|Analgesics|analgesics|mesh-ancestor
19633779|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
19633780|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763955|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19763956|NCT00068692|Fluorouracil|fluorouracil|mesh-list
19763957|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
19763958|NCT00068692|Irinotecan|irinotecan|mesh-list
19763959|NCT00068692|Camptothecin|camptothecin|mesh-list
19633781|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633782|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
19633783|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633784|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608737|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608738|NCT02248051|CXA-10|cxa-10|mesh-list
20608739|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608740|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20608741|NCT02248129|Telmisartan|telmisartan|mesh-list
20608742|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19763960|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
19763961|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633785|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633786|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19763962|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
19763963|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763964|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19763965|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19763966|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19763967|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
19763968|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19763969|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19763970|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763971|NCT00068692|Antidotes|antidotes|mesh-ancestor
19763972|NCT00068692|Protective Agents|protective agents|mesh-ancestor
19763973|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
19763974|NCT00068692|Vitamins|vitamins|mesh-ancestor
19763975|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
19763976|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19763977|NCT00068770|Celecoxib|celecoxib|mesh-list
19763978|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19763979|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19763980|NCT00068770|Analgesics|analgesics|mesh-ancestor
19763981|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
19763982|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19763983|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19763984|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19763985|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19763986|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19763987|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19763988|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19763989|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19763990|NCT00069095|Leucovorin|leucovorin|mesh-list
19763991|NCT00069095|Bevacizumab|bevacizumab|mesh-list
19763992|NCT00069095|Fluorouracil|fluorouracil|mesh-list
20147450|NCT00077129|Paclitaxel|paclitaxel|mesh-list
20147451|NCT00077129|Carboplatin|carboplatin|mesh-list
20147452|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147453|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147454|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147455|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147456|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147457|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147458|NCT00077168|Tamoxifen|tamoxifen|mesh-list
20147459|NCT00077168|Anastrozole|anastrozole|mesh-list
19633787|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633788|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633789|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19633790|NCT02439034|Narcotics|narcotics|mesh-ancestor
19633791|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633792|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
19633793|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
19633794|NCT02438982|Rituximab|rituximab|mesh-list
19633795|NCT02438982|Tacrolimus|tacrolimus|mesh-list
19633796|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20608743|NCT02248129|Diuretics|diuretics|mesh-ancestor
20608744|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
19763993|NCT00069095|Capecitabine|capecitabine|mesh-list
19633797|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19633798|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633799|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
19763994|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
19763995|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19763996|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147460|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147461|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20147462|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
20147463|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20147464|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147465|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147466|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147467|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20147468|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20147469|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20147470|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20147471|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20147472|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147473|NCT00077181|Cytarabine|cytarabine|mesh-list
20147474|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147475|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
19763997|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19763998|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19763999|NCT00069095|Growth Substances|growth substances|mesh-ancestor
19764000|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633800|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764001|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
19764002|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
19764003|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633801|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633802|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633803|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633804|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147476|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147477|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633805|NCT02438709|Etoricoxib|etoricoxib|mesh-list
19633806|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19633807|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633808|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19764004|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764005|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764006|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
19764007|NCT00069095|Antidotes|antidotes|mesh-ancestor
20347334|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
20347335|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
19633809|NCT02438709|Analgesics|analgesics|mesh-ancestor
19633810|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
20347336|NCT00859274|Hormones|hormones|mesh-ancestor
19764008|NCT00069095|Protective Agents|protective agents|mesh-ancestor
19764009|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
19764010|NCT00069095|Vitamins|vitamins|mesh-ancestor
20347337|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347338|NCT00859352|Midazolam|midazolam|mesh-list
20347339|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20347340|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20347341|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347342|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347343|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20347344|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20347345|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20347346|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20347347|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
20347348|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
20347349|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
20347350|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
20347351|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347352|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347353|NCT00859534|Afamelanotide|afamelanotide|mesh-list
20347354|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
20608745|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608746|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20608747|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20608748|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608749|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20608750|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20608751|NCT02248142|Pramipexole|pramipexole|mesh-list
20608752|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
20608753|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608754|NCT02248142|Protective Agents|protective agents|mesh-ancestor
20608755|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608756|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20608757|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20608758|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
20608759|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
20608760|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608761|NCT02248155|Pramipexole|pramipexole|mesh-list
20608762|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
20608763|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608764|NCT02248155|Protective Agents|protective agents|mesh-ancestor
20608765|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608766|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20608767|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20608768|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
20608769|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
20608770|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608771|NCT02248168|Pramipexole|pramipexole|mesh-list
20608772|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
20608773|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764011|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
19764012|NCT00069108|Leucovorin|leucovorin|mesh-list
19764013|NCT00069108|Capecitabine|capecitabine|mesh-list
19764014|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
19764015|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764016|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
19764017|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764018|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608774|NCT02248168|Protective Agents|protective agents|mesh-ancestor
20608775|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608776|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20608777|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20608778|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
20608779|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
20608780|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608781|NCT02248181|Pramipexole|pramipexole|mesh-list
20608782|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
20608783|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608784|NCT02248181|Protective Agents|protective agents|mesh-ancestor
20608785|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608786|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20608787|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20608788|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
20608789|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
20608790|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608791|NCT02248207|Pramipexole|pramipexole|mesh-list
20608792|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
20608793|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608794|NCT02248207|Protective Agents|protective agents|mesh-ancestor
20608795|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608796|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20608797|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20608798|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
20608799|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
20608800|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608801|NCT02248220|Pramipexole|pramipexole|mesh-list
20608802|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
20608803|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608804|NCT02248220|Protective Agents|protective agents|mesh-ancestor
20608805|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764019|NCT00069108|Antidotes|antidotes|mesh-ancestor
20608806|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19256627|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19764020|NCT00069108|Protective Agents|protective agents|mesh-ancestor
19764021|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764022|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
19764023|NCT00069108|Vitamins|vitamins|mesh-ancestor
19764024|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
19764025|NCT00069121|Leucovorin|leucovorin|mesh-list
19764026|NCT00069121|Fluorouracil|fluorouracil|mesh-list
19764027|NCT00069121|Capecitabine|capecitabine|mesh-list
19764028|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
19764029|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
19764030|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764031|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764032|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764033|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764034|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
19764035|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764036|NCT00069121|Antidotes|antidotes|mesh-ancestor
19764037|NCT00069121|Protective Agents|protective agents|mesh-ancestor
19764038|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
19764039|NCT00069121|Vitamins|vitamins|mesh-ancestor
19764040|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
19764041|NCT00069160|Docetaxel|docetaxel|mesh-list
19764042|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19764043|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764044|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633811|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764045|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764046|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764047|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764048|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19833161|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833162|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833163|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833164|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833165|NCT00652301|Simvastatin|simvastatin|mesh-list
19833166|NCT00652301|Ezetimibe|ezetimibe|mesh-list
19833167|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833168|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833169|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
20147478|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
20147479|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147480|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147481|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
20147482|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147483|NCT00077194|Romidepsin|romidepsin|mesh-list
20147484|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147485|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173865|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
20173866|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
20173867|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20173868|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
20173869|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
20173870|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173871|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173872|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173873|NCT00162799|Triflusal|triflusal|mesh-list
20173874|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20173875|NCT00162812|Epirubicin|epirubicin|mesh-list
20173876|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20347355|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
19633812|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633813|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633814|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633815|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19633816|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633817|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633818|NCT02438761|Gedatolisib|gedatolisib|mesh-list
19633819|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19633820|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633821|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633822|NCT02438683|BI 409306|bi 409306|mesh-list
19633823|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19633824|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633825|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633826|NCT02438852|Ropivacaine|ropivacaine|mesh-list
19633827|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
19633828|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
19633829|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633830|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633831|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
19633832|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633833|NCT02438657|Lidocaine|lidocaine|mesh-list
19633834|NCT02438657|Epinephrine|epinephrine|mesh-list
19764049|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19764050|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764051|NCT00069784|Insulin|insulin|mesh-list
20147486|NCT00077220|Paclitaxel|paclitaxel|mesh-list
20147487|NCT00077220|Carboplatin|carboplatin|mesh-list
20147488|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147489|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147490|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147491|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147492|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147493|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147494|NCT00077233|Leucovorin|leucovorin|mesh-list
20147495|NCT00077233|Fluorouracil|fluorouracil|mesh-list
20147496|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
20147497|NCT00077233|Irinotecan|irinotecan|mesh-list
20147498|NCT00077233|Cetuximab|cetuximab|mesh-list
20147499|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147500|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
20147501|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147502|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147503|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147504|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147505|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
20147506|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20147507|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147508|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147509|NCT00077233|Antidotes|antidotes|mesh-ancestor
20147510|NCT00077233|Protective Agents|protective agents|mesh-ancestor
20147511|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
20147512|NCT00077233|Vitamins|vitamins|mesh-ancestor
20147513|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
20147514|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20147515|NCT00077246|Paclitaxel|paclitaxel|mesh-list
20147516|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20147517|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147518|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147519|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147520|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147521|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147522|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147523|NCT00077259|Epothilones|epothilones|mesh-list
20147524|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
20147525|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147526|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147527|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147528|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147529|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147530|NCT00077298|Bevacizumab|bevacizumab|mesh-list
20147531|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20147532|NCT00077298|Cetuximab|cetuximab|mesh-list
20147533|NCT00077298|Irinotecan|irinotecan|mesh-list
20147534|NCT00077298|Antibodies|antibodies|mesh-list
20147535|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
20147536|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20147537|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147538|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20147539|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20147540|NCT00077298|Growth Substances|growth substances|mesh-ancestor
20147541|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147542|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
20147543|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
19633835|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
19764052|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20147544|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20147545|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20147546|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147547|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147548|NCT00077311|Docetaxel|docetaxel|mesh-list
20147549|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
20147550|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
19633836|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
19633837|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633838|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315385|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315386|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20315387|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315388|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20315389|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
20315390|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
20315391|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20315392|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
20315393|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20147551|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764053|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
19764054|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19764055|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764056|NCT00069823|Esomeprazole|esomeprazole|mesh-list
19764057|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19764058|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19764059|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19764060|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764061|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764062|NCT00069953|Paclitaxel|paclitaxel|mesh-list
19764063|NCT00069953|Fluorouracil|fluorouracil|mesh-list
19764064|NCT00069953|Lenograstim|lenograstim|mesh-list
19764065|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764066|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764067|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764068|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764069|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20315394|NCT00698724|Prednisolone|prednisolone|mesh-list
20315395|NCT00698724|Bromfenac|bromfenac|mesh-list
20315396|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20315397|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
20315398|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20315399|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
20315400|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
20315401|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315402|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315403|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315404|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
19764070|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764071|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
19764072|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764073|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764074|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
19764075|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764076|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19764077|NCT00070070|Sargramostim|sargramostim|mesh-list
19764078|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
19764079|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
19764080|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764081|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19764082|NCT00070109|Trabectedin|trabectedin|mesh-list
19764083|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20147552|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147553|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147554|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147555|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147556|NCT00077311|Hematinics|hematinics|mesh-ancestor
20315405|NCT00698724|Hormones|hormones|mesh-ancestor
20315406|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633839|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
19633840|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633841|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19633842|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19633843|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19633844|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19633845|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633846|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19633847|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20315407|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20315408|NCT00698724|Protective Agents|protective agents|mesh-ancestor
20315409|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19764084|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
19764085|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764086|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608807|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20608808|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
20608809|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
20608810|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608811|NCT02248233|Nimodipine|nimodipine|mesh-list
20608812|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20608813|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
20608814|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20608815|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20608816|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20147557|NCT00077311|Protective Agents|protective agents|mesh-ancestor
20147558|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147559|NCT00077337|Romidepsin|romidepsin|mesh-list
20315410|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315411|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20315412|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315413|NCT00698724|Analgesics|analgesics|mesh-ancestor
20315414|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
20315415|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315416|NCT00698763|Simendan|simendan|mesh-list
20147560|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147561|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147562|NCT00077350|Gemcitabine|gemcitabine|mesh-list
20147563|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147564|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
20147565|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147566|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147567|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
20147568|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147569|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147570|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147571|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
20147572|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147573|NCT00077363|Capecitabine|capecitabine|mesh-list
20147574|NCT00077363|Tipifarnib|tipifarnib|mesh-list
20147575|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147576|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
20147577|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633848|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
19633849|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315417|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20315418|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
20315419|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20315420|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20315421|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147578|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147579|NCT00077389|Carboplatin|carboplatin|mesh-list
20147580|NCT00077389|Doxorubicin|doxorubicin|mesh-list
20147581|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20147582|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315422|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315423|NCT00698763|Protective Agents|protective agents|mesh-ancestor
19633850|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19633851|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19633852|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
19633853|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19633854|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
19633855|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
19633856|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
19633857|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19633858|NCT02438865|Epirubicin|epirubicin|mesh-list
19633859|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147583|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147584|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20315424|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315425|NCT00698776|Lenalidomide|lenalidomide|mesh-list
20608817|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633860|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633861|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19633862|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20315426|NCT00698776|KRN 7000|krn 7000|mesh-list
20315427|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
20315428|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315429|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20315430|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20315431|NCT00698776|Growth Substances|growth substances|mesh-ancestor
20315432|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
20315433|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315434|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20315435|NCT00698802|Insulin|insulin|mesh-list
20315436|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20315437|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315438|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315439|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20315440|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315441|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20315442|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20315443|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20315444|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
19633863|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315445|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608818|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20608819|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608820|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
20608821|NCT02248259|Itraconazole|itraconazole|mesh-list
20608822|NCT02248259|BI 409306|bi 409306|mesh-list
20608823|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
19764087|NCT00070135|Methotrexate|methotrexate|mesh-list
19764088|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
19764089|NCT00070135|Fludarabine|fludarabine|mesh-list
19764090|NCT00070135|Busulfan|busulfan|mesh-list
19764091|NCT00070135|Tacrolimus|tacrolimus|mesh-list
19764092|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19764093|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19764094|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
19764095|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19764096|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764097|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764098|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
19764099|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764100|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764101|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
19764102|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764103|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19764104|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764105|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
19764106|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764107|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19764108|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19764109|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
19764110|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764111|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764112|NCT00070291|Cyclosporine|cyclosporine|mesh-list
19764113|NCT00070291|Cyclosporins|cyclosporins|mesh-list
19764114|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764115|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764116|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764117|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
19764118|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764119|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
19764120|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764121|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
19764122|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764123|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19764124|NCT00070317|Methylene Blue|methylene blue|mesh-list
19764125|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19764126|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764127|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764128|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19764129|NCT00070941|Citalopram|citalopram|mesh-list
19764130|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19764131|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20608824|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608825|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20608826|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20608827|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764132|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19764133|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764134|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19764135|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
19764136|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764137|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19764138|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
19764139|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19764140|NCT00071006|Axitinib|axitinib|mesh-list
19764141|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764142|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764143|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764144|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764145|NCT00071396|Rituximab|rituximab|mesh-list
19764146|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
19764147|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608828|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608829|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20608830|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
20608831|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608832|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608833|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20608834|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20608835|NCT02248415|Anesthetics|anesthetics|mesh-list
20608836|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608837|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608838|NCT02248428|Thalidomide|thalidomide|mesh-list
20608839|NCT02248428|Clarithromycin|clarithromycin|mesh-list
20608840|NCT02248428|Dexamethasone|dexamethasone|mesh-list
20608841|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
20608842|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608843|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
19764148|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764149|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
19764150|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764151|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764152|NCT00071487|Belimumab|belimumab|mesh-list
19764153|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608844|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608845|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608846|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20608847|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
20608848|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608849|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608850|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764154|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
19764155|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764156|NCT00071721|Valproic Acid|valproic acid|mesh-list
19764157|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
19764158|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764159|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764160|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
19764161|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19764162|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764163|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
19764164|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19764165|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20147585|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20608851|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608852|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
20608853|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
20608854|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608855|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20608856|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
20147586|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147587|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147588|NCT00077402|Fenretinide|fenretinide|mesh-list
20147589|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147590|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20147591|NCT00077402|Protective Agents|protective agents|mesh-ancestor
20147592|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147593|NCT00077415|Gemcitabine|gemcitabine|mesh-list
20147594|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764166|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20147595|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
20147596|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147597|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147598|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
20147599|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147600|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147601|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147602|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
20147603|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147604|NCT00077428|Doxorubicin|doxorubicin|mesh-list
20147605|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20147606|NCT00077428|Bortezomib|bortezomib|mesh-list
19764167|NCT00071760|Ritonavir|ritonavir|mesh-list
19764168|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
19764169|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20147607|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147608|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147609|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20147610|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20315446|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315447|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315448|NCT00699023|Simvastatin|simvastatin|mesh-list
20315449|NCT00699023|Ezetimibe|ezetimibe|mesh-list
20315450|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20315451|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20315452|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
20315453|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315454|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20315455|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19764170|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19764171|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
19764172|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147611|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147612|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147613|NCT00077441|Bortezomib|bortezomib|mesh-list
20147614|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147615|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20147616|NCT00077454|Temozolomide|temozolomide|mesh-list
20147617|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315456|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315457|NCT00699036|Metformin|metformin|mesh-list
20315458|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
20147618|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20147619|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147620|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147621|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20315459|NCT00699036|Losartan|losartan|mesh-list
19633864|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633865|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
19633866|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19633867|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19633868|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633869|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
19633870|NCT02438566|Coagulants|coagulants|mesh-ancestor
19633871|NCT02438345|Leronlimab|leronlimab|mesh-list
19633872|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19633873|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19764173|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764174|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19764175|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19764176|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
19764177|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764178|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19764179|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19764180|NCT00071799|Cytarabine|cytarabine|mesh-list
19764181|NCT00071799|Azacitidine|azacitidine|mesh-list
19764182|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147622|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
20147623|NCT00077467|Bortezomib|bortezomib|mesh-list
20147624|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147625|NCT00077493|Antibodies|antibodies|mesh-list
20147626|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
20147627|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20147628|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
20147629|NCT00077493|Immunotoxins|immunotoxins|mesh-list
20147630|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
19764183|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
19764184|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764185|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764186|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
19764187|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764188|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764189|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
19764190|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764191|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764192|NCT00071812|Belimumab|belimumab|mesh-list
19764193|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764194|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
19764195|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764196|NCT00071890|Aldesleukin|aldesleukin|mesh-list
19764197|NCT00071890|Interleukin-2|interleukin-2|mesh-list
20315460|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315461|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764198|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315462|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315463|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315464|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20315465|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20315466|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315467|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
20315468|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
20315469|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20315470|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20315471|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
20315472|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315473|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315474|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147631|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147632|NCT00077519|Tipifarnib|tipifarnib|mesh-list
20147633|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315475|NCT00699049|Urological Agents|urological agents|mesh-ancestor
20315476|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20315477|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
20315478|NCT00699062|Montelukast|montelukast|mesh-list
20315479|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20608857|NCT02248428|Hormones|hormones|mesh-ancestor
19764199|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19764200|NCT00071890|Analgesics|analgesics|mesh-ancestor
19764201|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
19764202|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764203|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764204|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19764205|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19764206|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
19764207|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764208|NCT00071981|Molgramostim|molgramostim|mesh-list
19764209|NCT00071981|Vaccines|vaccines|mesh-list
19764210|NCT00071981|Sargramostim|sargramostim|mesh-list
19764211|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
19764212|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
19764213|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147634|NCT00077532|Ipilimumab|ipilimumab|mesh-list
19764214|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147635|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
20608858|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608859|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20608860|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
19764215|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19764216|NCT00072176|Sirolimus|sirolimus|mesh-list
19764217|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764218|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764219|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19764220|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764221|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
19764222|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764223|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
19764224|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764225|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
19764226|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764227|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764228|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764229|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764230|NCT00072280|Dactinomycin|dactinomycin|mesh-list
20147636|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20147637|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147638|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20147639|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764231|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
19764232|NCT00072280|Ifosfamide|ifosfamide|mesh-list
19764233|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
19764234|NCT00072280|Etoposide|etoposide|mesh-list
19764235|NCT00072280|Vincristine|vincristine|mesh-list
19764236|NCT00072280|Lenograstim|lenograstim|mesh-list
19764237|NCT00072280|Sargramostim|sargramostim|mesh-list
19764238|NCT00072280|Mesna|mesna|mesh-list
19764239|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764240|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
19764241|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764242|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764243|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764244|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
19764245|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764246|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764247|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764248|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764249|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19764250|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19764251|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315480|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
20315481|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20315482|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
20315483|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315484|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608861|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764252|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19764253|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764254|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764255|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764256|NCT00072280|Protective Agents|protective agents|mesh-ancestor
20147640|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20147641|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
20147642|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147643|NCT00077545|Cisplatin|cisplatin|mesh-list
20147644|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147645|NCT00077558|Fludarabine|fludarabine|mesh-list
20147646|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
20147647|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147648|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147649|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
20147650|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147651|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147652|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
20147653|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147654|NCT00077584|Bosentan|bosentan|mesh-list
20147655|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20147656|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19764257|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764258|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764259|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19764260|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19764261|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19764262|NCT00072384|Carboplatin|carboplatin|mesh-list
20608862|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608863|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20608864|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20608865|NCT02248428|Growth Substances|growth substances|mesh-ancestor
20608866|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
19764263|NCT00072384|Etoposide|etoposide|mesh-list
19764264|NCT00072384|Vincristine|vincristine|mesh-list
19764265|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
20608867|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20608868|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608869|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20608870|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20608871|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
20608872|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20608873|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608874|NCT02248493|Acetaminophen|acetaminophen|mesh-list
20608875|NCT02248493|Ketoprofen|ketoprofen|mesh-list
20608876|NCT02248493|Morphine|morphine|mesh-list
20608877|NCT02248493|Tramadol|tramadol|mesh-list
20608878|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20608879|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20608880|NCT02248493|Narcotics|narcotics|mesh-ancestor
20608881|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315485|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20315486|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20315487|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315488|NCT00699114|Acetaminophen|acetaminophen|mesh-list
20315489|NCT00699114|Ibuprofen|ibuprofen|mesh-list
20315490|NCT00699114|Codeine|codeine|mesh-list
20315491|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315492|NCT00699114|Analgesics|analgesics|mesh-ancestor
20315493|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
20315494|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315495|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315496|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
20315497|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20315498|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20315499|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315500|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20608882|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608883|NCT02248493|Analgesics|analgesics|mesh-ancestor
20608884|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
20147657|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147658|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
20147659|NCT00077597|Hematinics|hematinics|mesh-ancestor
20147660|NCT00077688|Paclitaxel|paclitaxel|mesh-list
20147661|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20147662|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147663|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
20147664|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
20147665|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
20147666|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147667|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20147668|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20147669|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20147670|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20147671|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147672|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20147673|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20147674|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20147675|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
20147676|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147677|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147678|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20147679|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20147680|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
20147681|NCT00077727|Galantamine|galantamine|mesh-list
20315501|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147682|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20147683|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608885|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608886|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315502|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315503|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20315504|NCT00699114|Narcotics|narcotics|mesh-ancestor
20315505|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315506|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
20315507|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
20315508|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
20315509|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
20315510|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20315511|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315512|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315513|NCT00699244|Anesthetics|anesthetics|mesh-list
20147684|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147685|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
20147686|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147687|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608887|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
20608888|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20315514|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315515|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608889|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20608890|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608891|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20608892|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764266|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764267|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764268|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19764269|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19764270|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764271|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764272|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764273|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764274|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764275|NCT00072449|Rituximab|rituximab|mesh-list
20147688|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20147689|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
20147690|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764276|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764277|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764278|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
19764279|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147691|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
20147692|NCT00077753|Enoxaparin|enoxaparin|mesh-list
20147693|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
20147694|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
20147695|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20147696|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20608893|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633874|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633875|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19633876|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19633877|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
19633878|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633879|NCT02438397|Insulin|insulin|mesh-list
19633880|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19633881|NCT02438397|Metformin|metformin|mesh-list
19633882|NCT02438397|Acarbose|acarbose|mesh-list
19633883|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633884|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633885|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19633886|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633887|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608894|NCT02248506|Clotrimazole|clotrimazole|mesh-list
19633888|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
19633889|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19633890|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
19633891|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19633892|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
19633893|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608895|NCT02248506|Miconazole|miconazole|mesh-list
20608896|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20608897|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608898|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
20608899|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20608900|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20608901|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608902|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608903|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20608904|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
20608905|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20608906|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608907|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20608908|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20608909|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
20608910|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20608911|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612151|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20147697|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612152|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612153|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612154|NCT02250118|Bevacizumab|bevacizumab|mesh-list
20612155|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20612156|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612157|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20147698|NCT00077779|Adalimumab|adalimumab|mesh-list
20147699|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20147700|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147701|NCT00077792|Enoxaparin|enoxaparin|mesh-list
20147702|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
20612158|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20612159|NCT02250118|Growth Substances|growth substances|mesh-ancestor
20612160|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612161|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
20612162|NCT02250209|Capecitabine|capecitabine|mesh-list
20612163|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
20612164|NCT02250209|Trastuzumab|trastuzumab|mesh-list
20612165|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20612166|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
20612167|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612168|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147703|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
19633894|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633895|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
19633896|NCT02437825|Octreotide|octreotide|mesh-list
19633897|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633898|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147704|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20147705|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20147706|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147707|NCT00077805|Enoxaparin|enoxaparin|mesh-list
20147708|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
20147709|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
20147710|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20147711|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20147712|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147713|NCT00077818|Enoxaparin|enoxaparin|mesh-list
20147714|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
20147715|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
20147716|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20147717|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20147718|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147719|NCT00077844|Enoxaparin|enoxaparin|mesh-list
20147720|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
20147721|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
20147722|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20147723|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20315516|NCT00699296|Panobinostat|panobinostat|mesh-list
19633899|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764280|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608912|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20608913|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608914|NCT05354479|Acetaminophen|acetaminophen|mesh-list
20608915|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20608916|NCT05354479|Analgesics|analgesics|mesh-ancestor
20608917|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
20608918|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19633900|NCT02438072|Fexofenadine|fexofenadine|mesh-list
19633901|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
19633902|NCT02438072|Midazolam|midazolam|mesh-list
19764281|NCT00072475|Vatalanib|vatalanib|mesh-list
19764282|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764283|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764284|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764285|NCT00072514|Gemcitabine|gemcitabine|mesh-list
19764286|NCT00072514|Dexamethasone|dexamethasone|mesh-list
19633903|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
19633904|NCT02438072|Caffeine|caffeine|mesh-list
19633905|NCT02438072|Bupropion|bupropion|mesh-list
19633906|NCT02438072|Omeprazole|omeprazole|mesh-list
19633907|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19633908|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19633909|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19633910|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764287|NCT00072514|Rituximab|rituximab|mesh-list
19764288|NCT00072514|Carboplatin|carboplatin|mesh-list
19764289|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764290|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764291|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
19764292|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764293|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764294|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19764295|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
19764296|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
19764297|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764298|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19764299|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
19764300|NCT00072514|Hormones|hormones|mesh-ancestor
19764301|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764302|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19764303|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764304|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
19764305|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764306|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
19633911|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19633912|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19633913|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19633914|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19633915|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
19633916|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
19633917|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
19633918|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
19633919|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19633920|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633921|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19633922|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19633923|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19633924|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19633925|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19633926|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19633927|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19633928|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19633929|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
19764307|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147724|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147725|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
20147726|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
20147727|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147728|NCT00077883|Cisplatin|cisplatin|mesh-list
20147729|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147730|NCT00077948|Metoprolol|metoprolol|mesh-list
20147731|NCT00077948|Enoximone|enoximone|mesh-list
20147732|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20147733|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19764308|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147734|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
19764309|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608919|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608920|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
20608921|NCT05354466|Neostigmine|neostigmine|mesh-list
19633930|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19764310|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
19764311|NCT00072566|Bevacizumab|bevacizumab|mesh-list
19764312|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19764313|NCT00072566|Antibodies|antibodies|mesh-list
19764314|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
19764315|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19764316|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
19764317|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
19764318|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764319|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
19764320|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608922|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20608923|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608924|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608925|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
20608926|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20608927|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608928|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20608929|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
20608930|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608931|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
20608932|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
20315517|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315518|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20315519|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315520|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315521|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20608933|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19633931|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
20608934|NCT05354258|Amodiaquine|amodiaquine|mesh-list
19764321|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764322|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764323|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
19764324|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764325|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764326|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764327|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19764328|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19764329|NCT00072566|Growth Substances|growth substances|mesh-ancestor
19764330|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
19764331|NCT00073008|Lapatinib|lapatinib|mesh-list
19764332|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764333|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764334|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764335|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764336|NCT00073021|Mesalamine|mesalamine|mesh-list
19764337|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20608935|NCT05354258|Albendazole|albendazole|mesh-list
20608936|NCT05354258|Praziquantel|praziquantel|mesh-list
20608937|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
20608938|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19633932|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19633933|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19633934|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19633935|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
19633936|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19633937|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19633938|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
19633939|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
19633940|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19633941|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19633942|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19633943|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20608939|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20608940|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20608941|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20608942|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608943|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608944|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20315522|NCT00699322|Glimepiride|glimepiride|mesh-list
20315523|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315524|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315525|NCT00699322|Incretins|incretins|mesh-ancestor
20315526|NCT00699322|Hormones|hormones|mesh-ancestor
20608945|NCT05354258|Renal Agents|renal agents|mesh-ancestor
20608946|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
20608947|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
19764338|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19764339|NCT00073021|Analgesics|analgesics|mesh-ancestor
19764340|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
19764341|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764342|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764343|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19764344|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764345|NCT00073073|Vitamin D|vitamin d|mesh-list
19764346|NCT00073073|Exemestane|exemestane|mesh-list
19764347|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
19764348|NCT00073073|Calcium|calcium|mesh-list
19764349|NCT00073073|Vitamins|vitamins|mesh-ancestor
19764350|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
19764351|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608948|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20608949|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
20608950|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
20608951|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
20608952|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764352|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19764353|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19764354|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764355|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19764356|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19764357|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764358|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764359|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19764360|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
19764361|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764362|NCT00073073|Antacids|antacids|mesh-ancestor
19764363|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19764364|NCT00073307|Sorafenib|sorafenib|mesh-list
19764365|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764366|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764367|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764368|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764369|NCT00073528|Letrozole|letrozole|mesh-list
19764370|NCT00073528|Lapatinib|lapatinib|mesh-list
19764371|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764372|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19764373|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19764374|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764375|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764376|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19764377|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
19764378|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764379|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764380|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19633944|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19633945|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
19633946|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
19633947|NCT02438072|Analgesics|analgesics|mesh-ancestor
19633948|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
19633949|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315527|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315528|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20315529|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
20315530|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315531|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608953|NCT05354102|Nivolumab|nivolumab|mesh-list
19633950|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19633951|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19764381|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19764382|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764383|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764384|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19764385|NCT00073918|Iodine|iodine|mesh-list
19764386|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
19764387|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
19764388|NCT00073918|Etoposide|etoposide|mesh-list
19764389|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
19764390|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
19764391|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19764392|NCT00073918|Antibodies|antibodies|mesh-list
19764393|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
19764394|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19764395|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764396|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
19764397|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633952|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633953|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19633954|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19633955|NCT02438020|Metformin|metformin|mesh-list
19633956|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633957|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633958|NCT02437812|Metformin|metformin|mesh-list
19633959|NCT02437812|Paclitaxel|paclitaxel|mesh-list
19633960|NCT02437812|Carboplatin|carboplatin|mesh-list
19633961|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19633962|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633963|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
19633964|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
19633965|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
19633966|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633967|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19764398|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764399|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764400|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
19764401|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764402|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764403|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764404|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19633968|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633969|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
19633970|NCT02437955|Trace Elements|trace elements|mesh-ancestor
19633971|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
20608954|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20608955|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764405|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19764406|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19764407|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764408|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19764409|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764410|NCT00073918|Trace Elements|trace elements|mesh-ancestor
19764411|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
19764412|NCT00073957|Cytarabine|cytarabine|mesh-list
19764413|NCT00073957|Rituximab|rituximab|mesh-list
19764414|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764415|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764416|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
20608956|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20608957|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764417|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764418|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764419|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764420|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
19764421|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764422|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
19764423|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764424|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764425|NCT00073983|Gemcitabine|gemcitabine|mesh-list
19764426|NCT00073983|Docetaxel|docetaxel|mesh-list
19764427|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764428|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
19764429|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608958|NCT05354076|Doxorubicin|doxorubicin|mesh-list
20608959|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19633972|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764430|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608960|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20315532|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315533|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315534|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
20315535|NCT00699361|Pantoprazole|pantoprazole|mesh-list
20315536|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20315537|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315538|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20315539|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147735|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
20147736|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764431|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
20315540|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315541|NCT00699387|Benzonidazole|benzonidazole|mesh-list
20315542|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315543|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
20315544|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315545|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20315546|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20315547|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20315548|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764432|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764433|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764434|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764435|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
19764436|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315549|NCT00699426|Esomeprazole|esomeprazole|mesh-list
20608961|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19633973|NCT02437461|Triamcinolone|triamcinolone|mesh-list
19633974|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19633975|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19633976|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19633977|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19633978|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
19633979|NCT02437461|Hormones|hormones|mesh-ancestor
19633980|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19633981|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633982|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19633983|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
19633984|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764437|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764438|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764439|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
20608962|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20608963|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20608964|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608965|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608966|NCT05353829|Methotrexate|methotrexate|mesh-list
20608967|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20608968|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
20608969|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20608970|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608971|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20608972|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
20608973|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608974|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20608975|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
20608976|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608977|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20608978|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20608979|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
19633985|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19633986|NCT02437721|Folic Acid|folic acid|mesh-list
20147737|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147738|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19764440|NCT00074035|Pentostatin|pentostatin|mesh-list
19764441|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764442|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20147739|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20147740|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20147741|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
20147742|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315550|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20315551|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315552|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20315553|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315554|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315555|NCT00699452|Candesartan|candesartan|mesh-list
20315556|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315557|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20315558|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20315559|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315560|NCT00699465|Enoxaparin|enoxaparin|mesh-list
20315561|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
20315562|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
20315563|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20315564|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20315565|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315566|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
20608980|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20608981|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20608982|NCT05353816|Heparin|heparin|mesh-list
20608983|NCT05353816|Anticoagulants|anticoagulants|mesh-ancestor
20608984|NCT05353816|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20315567|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
20315568|NCT00699478|Vitamins|vitamins|mesh-ancestor
20315569|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
20315570|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315571|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
20315572|NCT00699504|Cangrelor|cangrelor|mesh-list
20315573|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20315574|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315575|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20315576|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20315577|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20608985|NCT05353816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20608986|NCT05353816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20608987|NCT05353764|Ropivacaine|ropivacaine|mesh-list
20608988|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
20608989|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
20608990|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20608991|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608992|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
20608993|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20608994|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20608995|NCT05353673|Danazol|danazol|mesh-list
20608996|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19633987|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
19633988|NCT02437721|Hematinics|hematinics|mesh-ancestor
19633989|NCT02437721|Vitamins|vitamins|mesh-ancestor
19633990|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
19633991|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19633992|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
19633993|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19633994|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
19633995|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
19633996|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
19661959|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661960|NCT04516993|Tenecteplase|tenecteplase|mesh-list
19661961|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19661962|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19661963|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661964|NCT04401800|Lenvatinib|lenvatinib|mesh-list
19661965|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19661966|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19661967|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19661968|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661969|NCT04341467|Olanzapine|olanzapine|mesh-list
19661970|NCT04341467|Amisulpride|amisulpride|mesh-list
19661971|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
19661972|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
19661973|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661974|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661975|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661976|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19661977|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19661978|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19661979|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19661980|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19661981|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20608997|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20608998|NCT05353673|Incretins|incretins|mesh-ancestor
20608999|NCT05353673|Hormones|hormones|mesh-ancestor
20609000|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609001|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20609002|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
20609003|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609004|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609005|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20609006|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
20609007|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
20609008|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20609009|NCT05353361|Paclitaxel|paclitaxel|mesh-list
20609010|NCT05353361|Pertuzumab|pertuzumab|mesh-list
20609011|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20609012|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609013|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
20609014|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609015|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
20609016|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764443|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764444|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764445|NCT00074165|Cytarabine|cytarabine|mesh-list
19764446|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
19764447|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
19764448|NCT00074165|Rituximab|rituximab|mesh-list
19764449|NCT00074165|Carboplatin|carboplatin|mesh-list
19764450|NCT00074165|Etoposide|etoposide|mesh-list
19764451|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
19764452|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764453|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
19764454|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764455|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764456|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20315578|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315579|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315580|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315581|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20315582|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20315583|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20315584|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20315585|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
20609017|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609018|NCT05353348|Vitamins|vitamins|mesh-list
20609019|NCT05353348|Folic Acid|folic acid|mesh-list
20609020|NCT05353348|Hydroxocobalamin|hydroxocobalamin|mesh-list
20609021|NCT05353348|Vitamin B 12|vitamin b 12|mesh-list
20609022|NCT05353348|Vitamin B Complex|vitamin b complex|mesh-list
20609023|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
20609024|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20609025|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
20609026|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609027|NCT05353348|Hematinics|hematinics|mesh-ancestor
20609028|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
20609029|NCT05353283|Tenofovir|tenofovir|mesh-list
20609030|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
20609031|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609032|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20609033|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20609034|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147743|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147744|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20147745|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
20147746|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20147747|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20147748|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147749|NCT00077948|Protective Agents|protective agents|mesh-ancestor
20147750|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
20147751|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20147752|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147753|NCT00077987|Sunitinib|sunitinib|mesh-list
19764457|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
20147754|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609035|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609036|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20147755|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20147756|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20147757|NCT00077987|Growth Substances|growth substances|mesh-ancestor
20147758|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147759|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
20147760|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20147761|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147762|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147763|NCT00078000|Sunitinib|sunitinib|mesh-list
20147764|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147765|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20147766|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20315586|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315587|NCT00699530|Cabergoline|cabergoline|mesh-list
20315588|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20315589|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20315590|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
20609037|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20147767|NCT00078000|Growth Substances|growth substances|mesh-ancestor
20147768|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147769|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
20147770|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20147771|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147772|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147773|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20147774|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20147775|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20147776|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19764458|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764459|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764460|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764461|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764462|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764463|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19764464|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19764465|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764466|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764467|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
19764468|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
19764469|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764470|NCT00074165|Antidotes|antidotes|mesh-ancestor
19764471|NCT00074165|Protective Agents|protective agents|mesh-ancestor
19764472|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
19764473|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
19764474|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764475|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
19764476|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
19764477|NCT00074269|Cyclosporine|cyclosporine|mesh-list
19764478|NCT00074269|Methotrexate|methotrexate|mesh-list
19764479|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
19764480|NCT00074269|Fludarabine|fludarabine|mesh-list
19764481|NCT00074269|Melphalan|melphalan|mesh-list
19764482|NCT00074269|Cyclosporins|cyclosporins|mesh-list
19764483|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19764484|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19764485|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
19764486|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19764487|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764488|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764489|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
19764490|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764491|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764492|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
19764493|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764494|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19764495|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764496|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
19764497|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764498|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19764499|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
20315591|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
20609038|NCT05353257|Carboplatin|carboplatin|mesh-list
20609039|NCT05353257|Etoposide|etoposide|mesh-list
20609040|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609041|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20609042|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20609043|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20609044|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609045|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764500|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764501|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19764502|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764503|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
19764504|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764505|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
19764506|NCT00074282|Rituximab|rituximab|mesh-list
19764507|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
19764508|NCT00074282|Pentostatin|pentostatin|mesh-list
19764509|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764510|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
19764511|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609046|NCT05353205|HH-GV-678|hh-gv-678|mesh-list
20609047|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20609048|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609049|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609050|NCT05353192|Hormones|hormones|mesh-list
20609051|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609052|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609053|NCT05353140|Aspirin|aspirin|mesh-list
20609054|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
20609055|NCT05353140|Clopidogrel|clopidogrel|mesh-list
20609056|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20609057|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19764512|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764513|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764514|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
19764515|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764516|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764517|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764518|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20315592|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315593|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315594|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609058|NCT05353140|Analgesics|analgesics|mesh-ancestor
20609059|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
20609060|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609061|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764519|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19764520|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764521|NCT00074308|Bevacizumab|bevacizumab|mesh-list
19764522|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19764523|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
19764524|NCT00074308|Antibodies|antibodies|mesh-list
19764525|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
19764526|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19764527|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764528|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19764529|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19764530|NCT00074308|Growth Substances|growth substances|mesh-ancestor
19633997|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
19633998|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20147777|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147778|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19633999|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634000|NCT02437656|Metformin|metformin|mesh-list
19634001|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19634002|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634003|NCT02437045|Meropenem|meropenem|mesh-list
20147779|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20147780|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20147781|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
20147782|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20147783|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147784|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20147785|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20147786|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
19634004|NCT02437045|Tazobactam|tazobactam|mesh-list
19634005|NCT02437045|Piperacillin|piperacillin|mesh-list
20315595|NCT00699634|Nabilone|nabilone|mesh-list
19634006|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19634007|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634008|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634009|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19634010|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634011|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609062|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609063|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609064|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20609065|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20609066|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609067|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20609068|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20609069|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609070|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
20609071|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20609072|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20609073|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19764531|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764532|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
19764533|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
19764534|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764535|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764536|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764537|NCT00074412|Nevirapine|nevirapine|mesh-list
19764538|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20609074|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
20609075|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609076|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20609077|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
20315596|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
20315597|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
20315598|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315599|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315600|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315601|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20315602|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20315603|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315604|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20315605|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
20315606|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
20315607|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315608|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315609|NCT00699764|Vaccines|vaccines|mesh-list
19634012|NCT02436993|Paclitaxel|paclitaxel|mesh-list
19634013|NCT02436993|Bevacizumab|bevacizumab|mesh-list
19634014|NCT02436993|Carboplatin|carboplatin|mesh-list
19634015|NCT02436993|Trastuzumab|trastuzumab|mesh-list
19634016|NCT02436993|Pertuzumab|pertuzumab|mesh-list
19634017|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19634018|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634019|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19634020|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
19634021|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19634022|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634023|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19634024|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20315610|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
20315611|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315612|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
19764539|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20609078|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20609079|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
19764540|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764541|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764542|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
19764543|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315613|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
20609080|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
20609081|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19764544|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19764545|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19764546|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19764547|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19764548|NCT00074490|Prednisone|prednisone|mesh-list
19764549|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
19764550|NCT00074490|Rituximab|rituximab|mesh-list
19764551|NCT00074490|Doxorubicin|doxorubicin|mesh-list
20147787|NCT00078117|Buprenorphine|buprenorphine|mesh-list
20147788|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20147789|NCT00078117|Narcotics|narcotics|mesh-ancestor
20147790|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20147791|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147792|NCT00078117|Analgesics|analgesics|mesh-ancestor
20609082|NCT05353101|Cyclosporine|cyclosporine|mesh-list
20609083|NCT05353101|Tobramycin|tobramycin|mesh-list
20609084|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20609085|NCT05353101|Cyclosporins|cyclosporins|mesh-list
20315614|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20315615|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20315616|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315617|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20315618|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315619|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20315620|NCT00699881|Cetuximab|cetuximab|mesh-list
20315621|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20315622|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315623|NCT00699894|Ondansetron|ondansetron|mesh-list
20147793|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
20147794|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315624|NCT00699894|Aprepitant|aprepitant|mesh-list
20315625|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
20315626|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
20315627|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315628|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764552|NCT00074490|Fludarabine|fludarabine|mesh-list
19764553|NCT00074490|Etoposide|etoposide|mesh-list
19764554|NCT00074490|Vincristine|vincristine|mesh-list
19764555|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764556|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
20609086|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609087|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609088|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609089|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
20609090|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609091|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
20609092|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609093|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
20609094|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609095|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20609096|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20609097|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20609098|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20609099|NCT05353010|Tacrolimus|tacrolimus|mesh-list
20609100|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609101|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
20609102|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609103|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20609104|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609105|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612169|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20612170|NCT02250300|Ixazomib|ixazomib|mesh-list
20612171|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612172|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612173|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612174|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612175|NCT02250482|Factor VIII|factor viii|mesh-list
20612176|NCT02250482|Coagulants|coagulants|mesh-ancestor
20612177|NCT02250508|Factor VIII|factor viii|mesh-list
20612178|NCT02250508|Coagulants|coagulants|mesh-ancestor
20612179|NCT02250534|Nicotine|nicotine|mesh-list
19764557|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764558|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764559|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764560|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
20612180|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20612181|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
20612182|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609106|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19764561|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764562|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764563|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764564|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764565|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19764566|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19764567|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19764568|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609107|NCT05352854|Pilocarpine|pilocarpine|mesh-list
20609108|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20609109|NCT05352854|Miotics|miotics|mesh-ancestor
20315629|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315630|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
20315631|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315632|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20315633|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
20609110|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
20609111|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609112|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609113|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20609114|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20609115|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
20609116|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609117|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609118|NCT05352828|Nivolumab|nivolumab|mesh-list
20609119|NCT05352828|Fludarabine|fludarabine|mesh-list
20315634|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609120|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20609121|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609122|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609123|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20609124|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634025|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20609125|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20609126|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
20609127|NCT05352815|Insulin|insulin|mesh-list
20609128|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315635|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315636|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20315637|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20315638|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315639|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20315640|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20315641|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20315642|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20315643|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
19634026|NCT02436993|Growth Substances|growth substances|mesh-ancestor
19634027|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634028|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
19634029|NCT02436980|Midazolam|midazolam|mesh-list
19634030|NCT02436980|Tramadol|tramadol|mesh-list
19634031|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19634032|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19634033|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634034|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634035|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19634036|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19634037|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634038|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19634039|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
19634040|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
19634041|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
19634042|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
19634043|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634044|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634045|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19634046|NCT02436980|Narcotics|narcotics|mesh-ancestor
19634047|NCT02436980|Analgesics|analgesics|mesh-ancestor
19634048|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
19634049|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315644|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20609129|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315645|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20315646|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634050|NCT02437032|Menotropins|menotropins|mesh-list
19634051|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19634052|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
19634053|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19634054|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634055|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
19634056|NCT02437136|Entinostat|entinostat|mesh-list
19764569|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609130|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
20609131|NCT05352672|Cemiplimab|cemiplimab|mesh-list
20609132|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609133|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315647|NCT00699946|Olanzapine|olanzapine|mesh-list
20315648|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
20315649|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
20315650|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315651|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315652|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315653|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20609134|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
20609135|NCT05351489|Bupivacaine|bupivacaine|mesh-list
20609136|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
20609137|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
20609138|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609139|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609140|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
19764570|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
19764571|NCT00074490|Hormones|hormones|mesh-ancestor
19764572|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764573|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19764574|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764575|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764576|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609141|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609142|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20609143|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315654|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20609144|NCT05351489|Analgesics|analgesics|mesh-ancestor
19634057|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764577|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764578|NCT00074581|Ritonavir|ritonavir|mesh-list
19764579|NCT00074581|Lopinavir|lopinavir|mesh-list
20147795|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20147796|NCT00078130|Buprenorphine|buprenorphine|mesh-list
20147797|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19634058|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147798|NCT00078130|Naloxone|naloxone|mesh-list
20147799|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19634059|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19634060|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634061|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634062|NCT02436928|Vaccines|vaccines|mesh-list
19634063|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
19764580|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19764581|NCT00074581|Tenofovir|tenofovir|mesh-list
19764582|NCT00074581|Lamivudine|lamivudine|mesh-list
19764583|NCT00074581|Zidovudine|zidovudine|mesh-list
19764584|NCT00074581|Emtricitabine|emtricitabine|mesh-list
19764585|NCT00074581|Nevirapine|nevirapine|mesh-list
19764586|NCT00074581|Stavudine|stavudine|mesh-list
19764587|NCT00074581|Didanosine|didanosine|mesh-list
20147800|NCT00078130|Narcotics|narcotics|mesh-ancestor
20147801|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20147802|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147803|NCT00078130|Analgesics|analgesics|mesh-ancestor
20147804|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
20147805|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20147806|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20147807|NCT00078182|Tenofovir|tenofovir|mesh-list
20147808|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
20147809|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315655|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315656|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20147810|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20147811|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20315657|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20609145|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20315658|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20315659|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20315660|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315661|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315662|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
20147812|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147813|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147814|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20147815|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20147816|NCT00078195|Omalizumab|omalizumab|mesh-list
20147817|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
20147818|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
20147819|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20147820|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147821|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20147822|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20147823|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
20147824|NCT00078234|Rituximab|rituximab|mesh-list
20147825|NCT00078234|Fludarabine|fludarabine|mesh-list
20147826|NCT00078234|Oblimersen|oblimersen|mesh-list
20147827|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764588|NCT00074581|Efavirenz|efavirenz|mesh-list
19764589|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19764590|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19764591|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
20315663|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
20315664|NCT00700024|Testosterone|testosterone|mesh-list
20147828|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147829|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
20147830|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147831|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147832|NCT00078247|Lamivudine|lamivudine|mesh-list
20147833|NCT00078247|Zidovudine|zidovudine|mesh-list
19634064|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764592|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147834|NCT00078247|Abacavir|abacavir|mesh-list
20147835|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19764593|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764594|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19764595|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19764596|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
19764597|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147836|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20147837|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147838|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147839|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
20147840|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147841|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20147842|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20147843|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
20147844|NCT00078260|Pemetrexed|pemetrexed|mesh-list
20147845|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147846|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147847|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315665|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
20315666|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
20315667|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20315668|NCT00700024|Androgens|androgens|mesh-ancestor
20315669|NCT00700024|Hormones|hormones|mesh-ancestor
20315670|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609146|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19634065|NCT02436902|Sorafenib|sorafenib|mesh-list
19634066|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
19634067|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634068|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19634069|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634070|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634071|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19634072|NCT02436902|Estrogens|estrogens|mesh-ancestor
19634073|NCT02436902|Hormones|hormones|mesh-ancestor
20147848|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20147849|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20147850|NCT00078351|Hylan|hylan|mesh-list
20147851|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
20315671|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315672|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20315673|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315674|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
20315675|NCT00700037|Atorvastatin|atorvastatin|mesh-list
19634074|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634075|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634076|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19634077|NCT02436538|Hormones|hormones|mesh-list
19634078|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315676|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20315677|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20315678|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
20315679|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315680|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20315681|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20315682|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315683|NCT00700128|Frovatriptan|frovatriptan|mesh-list
20315684|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19634079|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634080|NCT02436798|Ondansetron|ondansetron|mesh-list
19634081|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
19634082|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
19634083|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634084|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634085|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634086|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
19634087|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
19634088|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20315685|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
20315686|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315687|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315688|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315689|NCT00700154|Insulin|insulin|mesh-list
20315690|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20315691|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
19634089|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
19634090|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634091|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634092|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19634093|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19634094|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634095|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634096|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19634097|NCT02436694|Dexamethasone|dexamethasone|mesh-list
19634098|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
19634099|NCT02436694|Ropivacaine|ropivacaine|mesh-list
19634100|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
19764598|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20315692|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315693|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315694|NCT00700193|Vaccines|vaccines|mesh-list
20315695|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
20315696|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315697|NCT00700284|Dapivirine|dapivirine|mesh-list
20315698|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20315699|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20315700|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
20315701|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315702|NCT00700297|Colchicine|colchicine|mesh-list
20315703|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
20315704|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315705|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764599|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19764600|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19764601|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19764602|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
19764603|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19764604|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19764605|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19764606|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20315706|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
20315707|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
20315708|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147852|NCT00078351|Protective Agents|protective agents|mesh-ancestor
20147853|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147854|NCT00078390|S 3304|s 3304|mesh-list
20147855|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
20147856|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
20147857|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147858|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147859|NCT00078442|Interferons|interferons|mesh-list
20147860|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
20147861|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
20147862|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20147863|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147864|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
20315709|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315710|NCT00700362|Insulin|insulin|mesh-list
20315711|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315712|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315713|NCT00700466|Metoprolol|metoprolol|mesh-list
20315714|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20315715|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315716|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315717|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
20315718|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
20315719|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315720|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315721|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20315722|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20315723|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
20147865|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147866|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
20147867|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147868|NCT00078481|Idebenone|idebenone|mesh-list
20147869|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
20147870|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147871|NCT00078481|Protective Agents|protective agents|mesh-ancestor
20147872|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315724|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315725|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315726|NCT00700492|Progesterone|progesterone|mesh-list
20315727|NCT00700492|Progestins|progestins|mesh-ancestor
20315728|NCT00700492|Hormones|hormones|mesh-ancestor
20315729|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634101|NCT02436694|Anesthetics|anesthetics|mesh-list
19634102|NCT02436694|BB 1101|bb 1101|mesh-list
19634103|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634104|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
19634105|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
19634106|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634107|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634108|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634109|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
19634110|NCT02436694|Hormones|hormones|mesh-ancestor
19661982|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19661983|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19661984|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19661985|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
19661986|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19661987|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
19661988|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19661989|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
19661990|NCT04287660|Clarithromycin|clarithromycin|mesh-list
19661991|NCT04287660|Dexamethasone|dexamethasone|mesh-list
19661992|NCT04287660|Lenalidomide|lenalidomide|mesh-list
19661993|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19661994|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
19661995|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
19661996|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19661997|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19661998|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19661999|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
19662000|NCT04287660|Hormones|hormones|mesh-ancestor
19662001|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315730|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315731|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
20315732|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
20315733|NCT00700544|Norethandrolone|norethandrolone|mesh-list
20315734|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
20315735|NCT00700544|Hormones|hormones|mesh-ancestor
20315736|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315737|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315738|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20315739|NCT00700583|Terazosin|terazosin|mesh-list
20315740|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315741|NCT00700583|Diuretics|diuretics|mesh-ancestor
20315742|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
20315743|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147873|NCT00078546|Antibodies|antibodies|mesh-list
20147874|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20147875|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
20147876|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147877|NCT00078572|Capecitabine|capecitabine|mesh-list
20147878|NCT00078572|Lapatinib|lapatinib|mesh-list
20315744|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20315745|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20315746|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315747|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20315748|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20315749|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20315750|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
20315751|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315752|NCT00700583|Urological Agents|urological agents|mesh-ancestor
20347356|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20347357|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347358|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347359|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20347360|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347361|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20347362|NCT00859807|Amodiaquine|amodiaquine|mesh-list
20347363|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
20347364|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20347365|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20609147|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20147879|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147880|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
20147881|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147882|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147883|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20147884|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147885|NCT00078598|Rituximab|rituximab|mesh-list
20147886|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
20147887|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20147888|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147889|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
20147890|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147891|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147892|NCT00078611|Natalizumab|natalizumab|mesh-list
20147893|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
20147894|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147895|NCT00078689|Daclizumab|daclizumab|mesh-list
20147896|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147897|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
20147898|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147899|NCT00078793|Etanercept|etanercept|mesh-list
20147900|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20147901|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315753|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
20315754|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315755|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315756|NCT00700687|Aspirin|aspirin|mesh-list
20147902|NCT00078793|Analgesics|analgesics|mesh-ancestor
20147903|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
20147904|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315757|NCT00700687|Celecoxib|celecoxib|mesh-list
20315758|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20315759|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20147905|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147906|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20147907|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147908|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20147909|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147910|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
20147911|NCT00078806|Etanercept|etanercept|mesh-list
20147912|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20147913|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20315760|NCT00700687|Analgesics|analgesics|mesh-ancestor
20315761|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
20315762|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315763|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315764|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20315765|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20315766|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19634111|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634112|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19634113|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634114|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
19634115|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634116|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315767|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20315768|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315769|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20315770|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20315771|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315772|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
20315773|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20315774|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
20315775|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315776|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634117|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19764607|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19764608|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
19764609|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
19764610|NCT00074711|Calcium|calcium|mesh-list
19764611|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19764612|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764613|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19764614|NCT00074711|Antacids|antacids|mesh-ancestor
19764615|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764616|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19764617|NCT00074802|Paroxetine|paroxetine|mesh-list
19764618|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19764619|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19764620|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19764621|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764622|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19764623|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
19764624|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764625|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19764626|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
19764627|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19764628|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19764629|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19764630|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147914|NCT00078806|Analgesics|analgesics|mesh-ancestor
20147915|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
19634118|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
20315777|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
20315778|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315779|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634119|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
19634120|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634121|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764631|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
19764632|NCT00074815|Citalopram|citalopram|mesh-list
19764633|NCT00074815|Fluoxetine|fluoxetine|mesh-list
19764634|NCT00074815|Paroxetine|paroxetine|mesh-list
19764635|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19764636|NCT00074815|Sertraline|sertraline|mesh-list
19764637|NCT00074815|Clomipramine|clomipramine|mesh-list
19764638|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19764639|NCT00074815|Serotonin|serotonin|mesh-list
20609148|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
20609149|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609150|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609151|NCT05345002|Tretinoin|tretinoin|mesh-list
20609152|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147916|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20147917|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147918|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20147919|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147920|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20147921|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147922|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
20147923|NCT00078832|Anastrozole|anastrozole|mesh-list
20147924|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20147925|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147926|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20147927|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20147928|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609153|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
20609154|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
20609158|NCT05340452|Clarithromycin|clarithromycin|mesh-list
20609159|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20147929|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147930|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20609160|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609161|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20609162|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609163|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609164|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19764640|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19764641|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20147931|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
20147932|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20147933|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147934|NCT00078845|Amifostine|amifostine|mesh-list
20147935|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20147936|NCT00078845|Protective Agents|protective agents|mesh-ancestor
20147937|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147938|NCT00078858|Cyclosporine|cyclosporine|mesh-list
20147939|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
20147940|NCT00078858|Fludarabine|fludarabine|mesh-list
20147941|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
20147942|NCT00078858|Cyclosporins|cyclosporins|mesh-list
20147943|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147944|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147945|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
20147946|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147947|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147948|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
20147949|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315780|NCT00700856|Pioglitazone|pioglitazone|mesh-list
19634122|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19634123|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19634124|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634125|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634126|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634127|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
19634128|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19764642|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764643|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19764644|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
20147950|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634129|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19634130|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19634131|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19634132|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764645|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764646|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19764647|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
19634133|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
19634134|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19764648|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19764649|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19764650|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19764651|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764652|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19764653|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19764654|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19764655|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19764656|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19764657|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19764658|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19764659|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19764660|NCT00075023|Thalidomide|thalidomide|mesh-list
19764661|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764662|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
19764663|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764664|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
19764665|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764666|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764667|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19764668|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19764669|NCT00075023|Growth Substances|growth substances|mesh-ancestor
19634135|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634136|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19634137|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634138|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
19634139|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19634140|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
19634141|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634142|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634143|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19634144|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
19634145|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19634146|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
19634147|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634148|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634149|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19634150|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
19634151|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
19634152|NCT02436512|Protective Agents|protective agents|mesh-ancestor
19764670|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
19764671|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764672|NCT00075218|Sunitinib|sunitinib|mesh-list
19764673|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764674|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19764675|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19764676|NCT00075218|Growth Substances|growth substances|mesh-ancestor
19764677|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147951|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
20147952|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609165|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20609166|NCT05339399|Oxytocin|oxytocin|mesh-list
20609167|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
20609168|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20147953|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
20147954|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147955|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20147956|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147957|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20609169|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764678|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
19764679|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764680|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764681|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764682|NCT00075270|Paclitaxel|paclitaxel|mesh-list
19764683|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19764684|NCT00075270|Lapatinib|lapatinib|mesh-list
19764685|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764686|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764687|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764688|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764689|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764690|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764691|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764692|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764693|NCT00075335|Plerixafor|plerixafor|mesh-list
19764694|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19764695|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19764696|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
19764697|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764698|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
19764699|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764700|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764701|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147958|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
20147959|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20147960|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
19634153|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
19634154|NCT02436395|Povidone|povidone|mesh-list
19634155|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
19634156|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
19634157|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19634158|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634159|NCT02436226|Citric Acid|citric acid|mesh-list
19634160|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
20147961|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147962|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20147963|NCT00078910|Protective Agents|protective agents|mesh-ancestor
20147964|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634161|NCT02436226|Clomiphene|clomiphene|mesh-list
19634162|NCT02436226|Enclomiphene|enclomiphene|mesh-list
19634163|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
20147965|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19764702|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764703|NCT00075478|Cyclosporine|cyclosporine|mesh-list
19764704|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
19764705|NCT00075478|Fludarabine|fludarabine|mesh-list
19764706|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
19764707|NCT00075478|Cyclosporins|cyclosporins|mesh-list
19764708|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764709|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764710|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
19764711|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764712|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764713|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
19764714|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764715|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764716|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
20147966|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634164|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19634165|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
19634166|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19634167|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
19634168|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
19634169|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634170|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19634171|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
19634172|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634173|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147967|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634174|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19634175|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
19764717|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20147968|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20147969|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20147970|NCT00078910|Analgesics|analgesics|mesh-ancestor
20609170|NCT05338983|Anesthetics|anesthetics|mesh-list
20609171|NCT05338983|Mepivacaine|mepivacaine|mesh-list
20609172|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
20609173|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609174|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609175|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
20609176|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609177|NCT05337566|Azithromycin|azithromycin|mesh-list
20609178|NCT05337566|Cefuroxime|cefuroxime|mesh-list
20609179|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
20609180|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20609181|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609182|NCT05335954|Norepinephrine|norepinephrine|mesh-list
20609183|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20609184|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20609185|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
20609186|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609187|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609188|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609189|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
20609190|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
20609191|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634176|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20147971|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
20147972|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20147973|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20147974|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20147975|NCT00078962|Gemcitabine|gemcitabine|mesh-list
20147976|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147977|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
19634177|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19764718|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19764719|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764720|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19634178|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19634179|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19634180|NCT02436083|Cefuroxime|cefuroxime|mesh-list
19634181|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
19634182|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634183|NCT02436044|Leucovorin|leucovorin|mesh-list
19634184|NCT02436044|Fluorouracil|fluorouracil|mesh-list
19764721|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19764722|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19764723|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
19764724|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764725|NCT00075504|Gemcitabine|gemcitabine|mesh-list
20147978|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634185|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
19634186|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
19634187|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
19634188|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634189|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19634190|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634191|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634192|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
19764726|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20609192|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20609193|NCT05330364|Cladribine|cladribine|mesh-list
19764727|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
19764728|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609194|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609195|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609196|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
20609197|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609198|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
20609199|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
20609200|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20609201|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20609202|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
20609203|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609204|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609205|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609206|NCT05327270|Nivolumab|nivolumab|mesh-list
20609207|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609208|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609209|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20609210|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764729|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764730|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
19764731|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609211|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
20609212|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20609213|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20609214|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609215|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764732|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764733|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764734|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
19764735|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764736|NCT00075582|Dactinomycin|dactinomycin|mesh-list
19764737|NCT00075582|Cactinomycin|cactinomycin|mesh-list
19764738|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
19764739|NCT00075582|Vincristine|vincristine|mesh-list
19764740|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764741|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
19764742|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764743|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764744|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764745|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
19764746|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764747|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764748|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764749|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764750|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
19764751|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764752|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764753|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764754|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764755|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19764756|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19764757|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764758|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19764759|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
19764760|NCT00075725|Leucovorin|leucovorin|mesh-list
19764761|NCT00075725|Folic Acid|folic acid|mesh-list
19764762|NCT00075725|Cytarabine|cytarabine|mesh-list
19764763|NCT00075725|Dexamethasone|dexamethasone|mesh-list
19764764|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
19764765|NCT00075725|Prednisone|prednisone|mesh-list
19764766|NCT00075725|Cortisone|cortisone|mesh-list
19764767|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
19764768|NCT00075725|Doxorubicin|doxorubicin|mesh-list
19764769|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19764770|NCT00075725|Methotrexate|methotrexate|mesh-list
19764771|NCT00075725|Vincristine|vincristine|mesh-list
19764772|NCT00075725|Daunorubicin|daunorubicin|mesh-list
19764773|NCT00075725|Asparaginase|asparaginase|mesh-list
19764774|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
19764775|NCT00075725|Pegaspargase|pegaspargase|mesh-list
20609216|NCT05299242|Adalimumab|adalimumab|mesh-list
20609217|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19764776|NCT00075725|Thioguanine|thioguanine|mesh-list
19764777|NCT00075725|BB 1101|bb 1101|mesh-list
19764778|NCT00075725|Calcium|calcium|mesh-list
19764779|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
19764780|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
20147979|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147980|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
20147981|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609218|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609219|NCT05298696|Cilostazol|cilostazol|mesh-list
20609220|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20609221|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
20609222|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609223|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764781|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764782|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
19764783|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764784|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764785|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764786|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
19764787|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764788|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764789|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764790|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19764791|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
19764792|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
19764793|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764794|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19764795|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
19764796|NCT00075725|Hormones|hormones|mesh-ancestor
19764797|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609224|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20609225|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
20609226|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19764798|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19764799|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
19764800|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764801|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20147982|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609227|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20609228|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147983|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20147984|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
20147985|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147986|NCT00078975|Gemcitabine|gemcitabine|mesh-list
20147987|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20147988|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
20147989|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20147990|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20147991|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
20147992|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634193|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634194|NCT02436044|Antidotes|antidotes|mesh-ancestor
19634195|NCT02436044|Protective Agents|protective agents|mesh-ancestor
19634196|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
19634197|NCT02436044|Vitamins|vitamins|mesh-ancestor
19634198|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
19634199|NCT02435927|Leucovorin|leucovorin|mesh-list
19634200|NCT02435927|Fluorouracil|fluorouracil|mesh-list
19634201|NCT02435927|Capecitabine|capecitabine|mesh-list
19634202|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
19634203|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
19634204|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634205|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19634206|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634207|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634208|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
19634209|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634210|NCT02435927|Antidotes|antidotes|mesh-ancestor
19634211|NCT02435927|Protective Agents|protective agents|mesh-ancestor
19634212|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
19634213|NCT02435927|Vitamins|vitamins|mesh-ancestor
19634214|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
19634215|NCT02435797|Nicorandil|nicorandil|mesh-list
19634216|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19634217|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19634218|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
19634219|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
19634220|NCT02435797|Vitamins|vitamins|mesh-ancestor
19634221|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
19634222|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147993|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20147994|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609229|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20609230|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
20609231|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20609232|NCT05298696|Protective Agents|protective agents|mesh-ancestor
20609233|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19764802|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19764803|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19764804|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19764805|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20147995|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
20147996|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20147997|NCT00078988|Carboplatin|carboplatin|mesh-list
20147998|NCT00078988|Etoposide|etoposide|mesh-list
20147999|NCT00078988|Thiotepa|thiotepa|mesh-list
20148000|NCT00078988|Isotretinoin|isotretinoin|mesh-list
20148001|NCT00078988|Lenograstim|lenograstim|mesh-list
20148002|NCT00078988|Sargramostim|sargramostim|mesh-list
20148003|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148004|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148005|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148006|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148007|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148008|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148009|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20148010|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
20148011|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148012|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148013|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
20148014|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20609234|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20609235|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609236|NCT05298670|Metformin|metformin|mesh-list
20609237|NCT05298670|Interferons|interferons|mesh-list
20148015|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148016|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
20148017|NCT00079014|Doxorubicin|doxorubicin|mesh-list
20148018|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20148019|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148020|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148021|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148022|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148023|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148024|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148025|NCT00079027|Doxorubicin|doxorubicin|mesh-list
20148026|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20148027|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148028|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148029|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148030|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148031|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148032|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148033|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20148034|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148035|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148036|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148037|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148038|NCT00079066|Cetuximab|cetuximab|mesh-list
20315781|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20609238|NCT05298670|Interferon-beta|interferon-beta|mesh-list
20609239|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
19634223|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
19634224|NCT02435771|Vitamin D|vitamin d|mesh-list
19634225|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19634226|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634227|NCT02435771|Vitamins|vitamins|mesh-ancestor
19634228|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
19634229|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19634230|NCT02435732|Heparin|heparin|mesh-list
19634231|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
19634232|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19634233|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19634234|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634235|NCT02435654|Olanzapine|olanzapine|mesh-list
19764806|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19764807|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
19764808|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19764809|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764810|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
19764811|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
19764812|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20148039|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148040|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173877|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173878|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20173879|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20173880|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173881|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173882|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
19764813|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19764814|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
19764815|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764816|NCT00075725|Antidotes|antidotes|mesh-ancestor
19764817|NCT00075725|Protective Agents|protective agents|mesh-ancestor
19764818|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
19764819|NCT00075725|Vitamins|vitamins|mesh-ancestor
19764820|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
19764821|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19764822|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315782|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315783|NCT00700895|Warfarin|warfarin|mesh-list
20315784|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
20315785|NCT00700921|Lovastatin|lovastatin|mesh-list
20315786|NCT00700921|L 647318|l 647318|mesh-list
20315787|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
20173883|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20173884|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764823|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
19764824|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764825|NCT00075725|Hematinics|hematinics|mesh-ancestor
19764826|NCT00075764|Fulvestrant|fulvestrant|mesh-list
19764827|NCT00075764|Anastrozole|anastrozole|mesh-list
19764828|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19764829|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764830|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19764831|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19764832|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
20173885|NCT00162864|Montelukast|montelukast|mesh-list
20173886|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20173887|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
19764833|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764834|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764835|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19764836|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19764837|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764838|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764839|NCT00075803|Fluconazole|fluconazole|mesh-list
19764840|NCT00075803|Voriconazole|voriconazole|mesh-list
19764841|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
19764842|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764843|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19764844|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19764845|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764846|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764847|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19764848|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
20173888|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20173889|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
20173890|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173891|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173892|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20173893|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20173894|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173895|NCT00162877|Esomeprazole|esomeprazole|mesh-list
20173896|NCT00162877|Rabeprazole|rabeprazole|mesh-list
20173897|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20315788|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833170|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148041|NCT00079079|Gemcitabine|gemcitabine|mesh-list
20148042|NCT00079079|Carboplatin|carboplatin|mesh-list
20148043|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148044|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148045|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
20148046|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609240|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20609241|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609242|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609243|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
20609244|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609245|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
20609246|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20609247|NCT05289323|Neostigmine|neostigmine|mesh-list
20609248|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20609249|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609250|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609251|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
20609252|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609253|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609254|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20609255|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
20609256|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612183|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612184|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20612185|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20612186|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
20612187|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612188|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612189|NCT02250599|Paclitaxel|paclitaxel|mesh-list
20612190|NCT02250599|Bevacizumab|bevacizumab|mesh-list
20612191|NCT02250599|Carboplatin|carboplatin|mesh-list
20612192|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20612193|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612194|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612195|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
20612196|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
20612197|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612198|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20612199|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20612200|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20612201|NCT02250599|Growth Substances|growth substances|mesh-ancestor
20612202|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612203|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
20612204|NCT02250664|Nicotine|nicotine|mesh-list
20612205|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20612206|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
20612207|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612208|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612209|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20612210|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20612211|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
19634236|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
19634237|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
19634238|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634239|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634240|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634241|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19634242|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19634243|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634244|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634245|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19634246|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19634247|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20148047|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
20148048|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148049|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148050|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148051|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
20148052|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148053|NCT00079092|Thalidomide|thalidomide|mesh-list
20148054|NCT00079092|Procarbazine|procarbazine|mesh-list
20609257|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
20609258|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20609259|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764849|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764850|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764851|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19764852|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19764853|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19764854|NCT00075829|Thalidomide|thalidomide|mesh-list
19764855|NCT00075829|Dexamethasone|dexamethasone|mesh-list
19764856|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148055|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148056|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
20148057|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148058|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
20148059|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764857|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
19764858|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
19764859|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764860|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764861|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19764862|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
19764863|NCT00075829|Hormones|hormones|mesh-ancestor
19634248|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634249|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634250|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
19634251|NCT02435563|Ritonavir|ritonavir|mesh-list
19634252|NCT02435563|Ticagrelor|ticagrelor|mesh-list
19764864|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764865|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19764866|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764867|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764868|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
19764869|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
19764870|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764871|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634253|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19634254|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19634255|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
19634256|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634257|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148060|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148061|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20148062|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20148063|NCT00079092|Growth Substances|growth substances|mesh-ancestor
20148064|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
20148065|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148066|NCT00079105|Prednisolone|prednisolone|mesh-list
19634258|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19634259|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19634260|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
19634261|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634262|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19634263|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20148067|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
20148068|NCT00079105|Etoposide|etoposide|mesh-list
20609260|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20609261|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
20148069|NCT00079105|Vincristine|vincristine|mesh-list
20148070|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
20148071|NCT00079105|Bleomycin|bleomycin|mesh-list
20148072|NCT00079105|Vinblastine|vinblastine|mesh-list
20148073|NCT00079105|Procarbazine|procarbazine|mesh-list
20148074|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
20148075|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148076|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
20148077|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148078|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148079|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148080|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
20148081|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609262|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20609263|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609264|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634264|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19634265|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19634266|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19634267|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19634268|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
19634269|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634270|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662002|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19662003|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609265|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609266|NCT05254626|Pioglitazone|pioglitazone|mesh-list
20609267|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
20609268|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20609269|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609270|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20609271|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609272|NCT05248633|Dexamethasone|dexamethasone|mesh-list
20609273|NCT05248633|Lenalidomide|lenalidomide|mesh-list
20609274|NCT05248633|Bortezomib|bortezomib|mesh-list
20609275|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609276|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
19662004|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
19662005|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19662006|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19662007|NCT04287660|Growth Substances|growth substances|mesh-ancestor
19662008|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
19662009|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19662010|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662011|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19662012|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662013|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662014|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19662015|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19662016|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
19662017|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
19662018|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19662019|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19662020|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
19662021|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
19662022|NCT04255277|Charcoal|charcoal|mesh-list
19662023|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19662024|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662025|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19662026|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19662027|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662028|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662029|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764872|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19764873|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19764874|NCT00075829|Growth Substances|growth substances|mesh-ancestor
19764875|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
19764876|NCT00075881|Bortezomib|bortezomib|mesh-list
19764877|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764878|NCT00075946|Rituximab|rituximab|mesh-list
19764879|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764880|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609277|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
20609278|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609279|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609280|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609281|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
20609282|NCT05248633|Hormones|hormones|mesh-ancestor
20609283|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148082|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148083|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20148084|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19634271|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
19634272|NCT02435537|Morphine|morphine|mesh-list
19634273|NCT02435537|Bupivacaine|bupivacaine|mesh-list
19634274|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
19634275|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
19634276|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634277|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634278|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
19634279|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634280|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19634281|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19634282|NCT02435537|Analgesics|analgesics|mesh-ancestor
19634283|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19634284|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19634285|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19634286|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
19634287|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634288|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634289|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20148085|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148086|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148087|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148088|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148089|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148090|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148091|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148092|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
20609284|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20609285|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609286|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
20609287|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20609288|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20609289|NCT05248633|Growth Substances|growth substances|mesh-ancestor
20609290|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
20609291|NCT05229965|Acetaminophen|acetaminophen|mesh-list
20609292|NCT05229965|Codeine|codeine|mesh-list
19764881|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
19764882|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764883|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764884|NCT00076011|Mitogens|mitogens|mesh-list
19764885|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
19764886|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764887|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764888|NCT00076011|Growth Substances|growth substances|mesh-ancestor
19764889|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764890|NCT00076024|Docetaxel|docetaxel|mesh-list
19764891|NCT00076024|Axitinib|axitinib|mesh-list
19764892|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764893|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148093|NCT00079105|Hormones|hormones|mesh-ancestor
20148094|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764894|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148095|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20315789|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19634290|NCT02435537|Narcotics|narcotics|mesh-ancestor
19764895|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
19764896|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764897|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764898|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764899|NCT00076102|Pirfenidone|pirfenidone|mesh-list
19764900|NCT00076102|Analgesics|analgesics|mesh-ancestor
20148096|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20148097|NCT00079105|Analgesics|analgesics|mesh-ancestor
20148098|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
20148099|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148100|NCT00079118|Docetaxel|docetaxel|mesh-list
20148101|NCT00079118|Irinotecan|irinotecan|mesh-list
20148102|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148103|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148104|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148105|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148106|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148107|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20148108|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148109|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148110|NCT00079131|Oblimersen|oblimersen|mesh-list
20148111|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315790|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
20148112|NCT00079144|Aldesleukin|aldesleukin|mesh-list
20609293|NCT05229965|Caffeine|caffeine|mesh-list
20609294|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20609295|NCT05229965|Analgesics|analgesics|mesh-ancestor
20609296|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
20609297|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609298|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609299|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
20148113|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
20148114|NCT00079144|Fludarabine|fludarabine|mesh-list
20148115|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
20148116|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
20609300|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20609301|NCT05229965|Narcotics|narcotics|mesh-ancestor
20609302|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609303|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
20609304|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
19634291|NCT02435459|Calcium|calcium|mesh-list
20148117|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148118|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
20315791|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315792|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20315793|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20315794|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315795|NCT00700947|Metoprolol|metoprolol|mesh-list
19634292|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19634293|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634294|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
19634295|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19634296|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634297|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19634298|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
19634299|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634300|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634301|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634302|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634303|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
19634304|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
19634305|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19634306|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19634307|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634308|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634309|NCT02435303|Urological Agents|urological agents|mesh-ancestor
19634310|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
19634311|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19634312|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634313|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634314|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634315|NCT02435186|Paclitaxel|paclitaxel|mesh-list
20148119|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634316|NCT02435186|Cisplatin|cisplatin|mesh-list
19764901|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
20148120|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148121|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20609305|NCT05229965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20148122|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
20148123|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148124|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148125|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20148126|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148127|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
20148128|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20148129|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20148130|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20148131|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
20148132|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148133|NCT00079157|Sargramostim|sargramostim|mesh-list
19634317|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19634318|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634319|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
20609306|NCT05229965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20609307|NCT05229965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609308|NCT05229965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609309|NCT05229965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20148134|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
20148135|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
20148136|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634320|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609310|NCT05229965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20609311|NCT05229965|Purinergic Agents|purinergic agents|mesh-ancestor
20609312|NCT05229965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609313|NCT05223582|Prednisone|prednisone|mesh-list
20609314|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
20609315|NCT05223582|Androgens|androgens|mesh-list
20609316|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609317|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
20609318|NCT05223582|Hormones|hormones|mesh-ancestor
20609319|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764902|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764903|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764904|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19764905|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19764906|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19764907|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764908|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764909|NCT00076336|Lamivudine|lamivudine|mesh-list
19764910|NCT00076336|Telbivudine|telbivudine|mesh-list
19764911|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19764912|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19764913|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764914|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764915|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
19764916|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764917|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19764918|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19764919|NCT00076570|Sirolimus|sirolimus|mesh-list
19764920|NCT00076570|Tacrolimus|tacrolimus|mesh-list
19764921|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634321|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
19634322|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634323|NCT02435108|Crizotinib|crizotinib|mesh-list
19634324|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634325|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19634326|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634327|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634328|NCT02434952|Piperaquine|piperaquine|mesh-list
19764922|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
19764923|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148137|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20148138|NCT00079170|Docetaxel|docetaxel|mesh-list
20148139|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315796|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20315797|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20315798|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
20315799|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315800|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315801|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315802|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315803|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315804|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
20609320|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609321|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20609322|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609323|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20609324|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609325|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609326|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
20609327|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20609328|NCT05214287|Nitrox|nitrox|mesh-list
20609329|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20609330|NCT05214287|Protective Agents|protective agents|mesh-ancestor
20609331|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609332|NCT05212610|Vaccines|vaccines|mesh-list
20609333|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
20609334|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609335|NCT05197062|Aticaprant|aticaprant|mesh-list
20315805|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
20315806|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315807|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19764924|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19764925|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315808|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
20609336|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20609337|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764926|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609338|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
20609339|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609340|NCT05172245|Cisplatin|cisplatin|mesh-list
20609341|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609342|NCT05153408|Carboplatin|carboplatin|mesh-list
20609343|NCT05153408|Pemetrexed|pemetrexed|mesh-list
20609344|NCT05153408|Osimertinib|osimertinib|mesh-list
20609345|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609346|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609347|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609348|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20609349|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20609350|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19764927|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19764928|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19764929|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19764930|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764931|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
19764932|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
19764933|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19764934|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
19764935|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19764936|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19764937|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19764938|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19764939|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764940|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
19764941|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19764942|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764943|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19764944|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764945|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
19764946|NCT00076752|Promethazine|promethazine|mesh-list
19764947|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
19764948|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
19764949|NCT00076752|Rituximab|rituximab|mesh-list
20315809|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315810|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315811|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
20609351|NCT05147233|Dexamethasone|dexamethasone|mesh-list
19764950|NCT00076752|Fludarabine|fludarabine|mesh-list
20315812|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315813|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315814|NCT00701220|Atorvastatin|atorvastatin|mesh-list
20315815|NCT00701220|Calcium|calcium|mesh-list
20315816|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20315817|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315818|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20315819|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20148140|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148141|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148142|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148143|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148144|NCT00079222|Itraconazole|itraconazole|mesh-list
20148145|NCT00079222|Voriconazole|voriconazole|mesh-list
20148146|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
20148147|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148148|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20148149|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20148150|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148151|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315820|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
20315821|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148152|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20148153|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
20148154|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148155|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609352|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609353|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
20609354|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
20609355|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609356|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315822|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20315823|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20315824|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315825|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
19764951|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
19764952|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19764953|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
19764954|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764955|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19764956|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19764957|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
19764958|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764959|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19764960|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19764961|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19764962|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19764963|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
19764964|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19764965|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
19764966|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
20315826|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20315827|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20315828|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609357|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609358|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
20609359|NCT05147233|Hormones|hormones|mesh-ancestor
19764967|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19764968|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19764969|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
19764970|NCT00076752|Hormones|hormones|mesh-ancestor
19764971|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19764972|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19764973|NCT00076752|Protective Agents|protective agents|mesh-ancestor
19764974|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19764975|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19764976|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19764977|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
20148156|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20609360|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609361|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148157|NCT00079235|Sirolimus|sirolimus|mesh-list
20609362|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609363|NCT05124457|Insulin|insulin|mesh-list
20609364|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20609365|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
20609366|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
20609367|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
20609368|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
20609369|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20609370|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609371|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
20609372|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609373|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20609374|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20609375|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19634329|NCT02434952|Primaquine|primaquine|mesh-list
19634330|NCT02434952|Artenimol|artenimol|mesh-list
20609376|NCT05096663|Vitamins|vitamins|mesh-list
19764978|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
19764979|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
19764980|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19764981|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
19764982|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
20315829|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
20315830|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315831|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19764983|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19764984|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19764985|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
20315832|NCT00701246|Folic Acid|folic acid|mesh-list
20315833|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
20315834|NCT00701246|Hematinics|hematinics|mesh-ancestor
20315835|NCT00701246|Vitamins|vitamins|mesh-ancestor
20315836|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
20315837|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315838|NCT00701259|Lansoprazole|lansoprazole|mesh-list
20315839|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
20315840|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20315841|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20315842|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20315843|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634331|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
19634332|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19764986|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
19764987|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19764988|NCT00077064|Captopril|captopril|mesh-list
19764989|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19764990|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
19764991|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764992|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19764993|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19764994|NCT00077207|Carboplatin|carboplatin|mesh-list
19764995|NCT00077207|Vincristine|vincristine|mesh-list
19764996|NCT00077207|Temozolomide|temozolomide|mesh-list
19764997|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609377|NCT05096663|Folic Acid|folic acid|mesh-list
20609378|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
20609379|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
20609380|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
19634333|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20148158|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20148159|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148160|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148161|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148162|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
20148163|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148164|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
20315844|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634334|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634335|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
19634336|NCT02434861|Digoxin|digoxin|mesh-list
19634337|NCT02434861|Rolapitant|rolapitant|mesh-list
19634338|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315845|NCT00701285|Pravastatin|pravastatin|mesh-list
20609381|NCT05096663|Gemcitabine|gemcitabine|mesh-list
19634339|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19634340|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19764998|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20315846|NCT00701285|Pitavastatin|pitavastatin|mesh-list
20148165|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609382|NCT05096663|Dexamethasone|dexamethasone|mesh-list
20609383|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
20609384|NCT05096663|Docetaxel|docetaxel|mesh-list
20315847|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20315848|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20315849|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
20315850|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315851|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20315852|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20609385|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
20609386|NCT05096663|Pemetrexed|pemetrexed|mesh-list
19634341|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634342|NCT02434861|Protective Agents|protective agents|mesh-ancestor
19634343|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634344|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634345|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19634346|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19634347|NCT02434861|Analgesics|analgesics|mesh-ancestor
19634348|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
19634349|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634350|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634351|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19634352|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634353|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19634354|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634355|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19634356|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19634357|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19634358|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634359|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
19634360|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634361|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634362|NCT02434822|Vaccines|vaccines|mesh-list
19634363|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
19634364|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634365|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20609387|NCT05096663|Ramucirumab|ramucirumab|mesh-list
20609388|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20609389|NCT05096663|Antibodies|antibodies|mesh-list
20609390|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
20609391|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20609392|NCT05096663|BB 1101|bb 1101|mesh-list
20609393|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
20609394|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609395|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
20609396|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609397|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
20315853|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315854|NCT00701298|Interferons|interferons|mesh-list
20315855|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
20315856|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
20315857|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20315858|NCT00701298|Decitabine|decitabine|mesh-list
20315859|NCT00701298|Azacitidine|azacitidine|mesh-list
20609398|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
20609399|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609400|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609401|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
20609402|NCT05096663|Hormones|hormones|mesh-ancestor
20609403|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609404|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19634366|NCT02434757|Hormones|hormones|mesh-ancestor
19662030|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19662031|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19662032|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662033|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19662034|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19662035|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19662036|NCT04255277|Estrogens|estrogens|mesh-ancestor
19662037|NCT04255277|Hormones|hormones|mesh-ancestor
19662038|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662039|NCT04255277|Antidotes|antidotes|mesh-ancestor
19662040|NCT04255277|Protective Agents|protective agents|mesh-ancestor
19662041|NCT04218539|Psilocybin|psilocybin|mesh-list
19662042|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
19662043|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662044|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19662045|NCT04149587|Brodalumab|brodalumab|mesh-list
19764999|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765000|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765001|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765002|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765003|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19765004|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
19765005|NCT00077376|Carboplatin|carboplatin|mesh-list
19765006|NCT00077376|Trastuzumab|trastuzumab|mesh-list
20609405|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609406|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
20315860|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315861|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
20609407|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609408|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609409|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20609410|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
20609411|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
20609412|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609413|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609414|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
20609415|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609416|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
20609417|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20609418|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20609419|NCT05096663|Hematinics|hematinics|mesh-ancestor
20609420|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
20609421|NCT05087381|Niclosamide|niclosamide|mesh-list
20609422|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
20609423|NCT05087381|Bromhexine|bromhexine|mesh-list
20609424|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609425|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148166|NCT00079248|Progesterone|progesterone|mesh-list
20148167|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20148168|NCT00079248|Estrogens|estrogens|mesh-list
20148169|NCT00079248|Progestins|progestins|mesh-ancestor
20148170|NCT00079248|Hormones|hormones|mesh-ancestor
20148171|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148172|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148173|NCT00079261|Gemcitabine|gemcitabine|mesh-list
20609426|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20148174|NCT00079261|Prednisone|prednisone|mesh-list
20148175|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
19765007|NCT00077376|Epothilone B|epothilone b|mesh-list
19765008|NCT00077376|Epothilones|epothilones|mesh-list
19765009|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765010|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765011|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765012|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765013|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765014|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765015|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
19765016|NCT00077610|Hematinics|hematinics|mesh-ancestor
19765017|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
19765018|NCT00077623|Hematinics|hematinics|mesh-ancestor
19765019|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19765020|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
19765021|NCT00077636|Ribavirin|ribavirin|mesh-list
19765022|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
19765023|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765024|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
19765025|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765026|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
19765027|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765028|NCT00077649|Ribavirin|ribavirin|mesh-list
19765029|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19765030|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
19765031|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
19765032|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19765033|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
19765034|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765035|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
19765036|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765037|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
19765038|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765039|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765040|NCT00077675|Vancomycin|vancomycin|mesh-list
19765041|NCT00077675|Penicillins|penicillins|mesh-list
19765042|NCT00077675|Telavancin|telavancin|mesh-list
19765043|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765044|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765045|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
20609427|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20609428|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609429|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609430|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20609431|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20609432|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20609433|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20609434|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609435|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
20609436|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20609437|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
20609438|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20609439|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20609440|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20609441|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
19765046|NCT00077766|Hematinics|hematinics|mesh-ancestor
19765047|NCT00077857|Docetaxel|docetaxel|mesh-list
19765048|NCT00077857|Capecitabine|capecitabine|mesh-list
19765049|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765050|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765051|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765052|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765053|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765054|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765055|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
19833171|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833172|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833173|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833174|NCT00651963|Ezetimibe|ezetimibe|mesh-list
19833175|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833176|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833177|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
19833178|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833179|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833180|NCT00651560|Simvastatin|simvastatin|mesh-list
20609442|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20609443|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
19765056|NCT00077974|Sunitinib|sunitinib|mesh-list
19765057|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765058|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765059|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765060|NCT00077974|Growth Substances|growth substances|mesh-ancestor
19765061|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765062|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765063|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19765064|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765065|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765066|NCT00078286|Sertraline|sertraline|mesh-list
19765067|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
19765068|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19765069|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19765070|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19765071|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19765072|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765073|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19765074|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
19765075|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765076|NCT00078312|Modafinil|modafinil|mesh-list
19765077|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19765078|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765079|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20609444|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20609445|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634367|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765080|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19765081|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19765082|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765083|NCT00078325|Modafinil|modafinil|mesh-list
19765084|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19833181|NCT00651560|Ezetimibe|ezetimibe|mesh-list
20148176|NCT00079261|Doxorubicin|doxorubicin|mesh-list
20148177|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19634368|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634369|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
19634370|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
19634371|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634372|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
19634373|NCT02434614|Cisplatin|cisplatin|mesh-list
19634374|NCT02434614|Docetaxel|docetaxel|mesh-list
19634375|NCT02434614|Fluorouracil|fluorouracil|mesh-list
19634376|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634377|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
19634378|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
19634379|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
19634380|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634381|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
19634382|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19634383|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634384|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
19634385|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634386|NCT02433860|Nicotine|nicotine|mesh-list
19634387|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19634388|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
19634389|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634390|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634391|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19634392|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19634393|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
19634394|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634395|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634396|NCT02433847|Mosapride|mosapride|mesh-list
20148178|NCT00079261|Vincristine|vincristine|mesh-list
20148179|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148180|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
20148181|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148182|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148183|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148184|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
19634397|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20148185|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148186|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148187|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20148188|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148189|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
20148190|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
20148191|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148192|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148193|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148194|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148195|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20315862|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609446|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
20609447|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
20609448|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
20609449|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609450|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20609451|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
20609452|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
20609453|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20609454|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20609455|NCT05087381|Expectorants|expectorants|mesh-ancestor
20609456|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
20315863|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
20315864|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315865|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20315866|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
20315867|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315868|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315869|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20609457|NCT05062980|Docetaxel|docetaxel|mesh-list
20609458|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
20609459|NCT05062980|Ramucirumab|ramucirumab|mesh-list
20609460|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609461|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
20609462|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609463|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
20609464|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609465|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609466|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
20609467|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
20609468|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20609469|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20609470|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
20609471|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609472|NCT05050162|Cisplatin|cisplatin|mesh-list
20609473|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
20609474|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609475|NCT05020327|Amoxicillin|amoxicillin|mesh-list
19634398|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20609476|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634399|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
19634400|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634401|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634402|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634403|NCT02433808|Neostigmine|neostigmine|mesh-list
19634404|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19634405|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634406|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634407|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
19634408|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634409|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634410|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19634411|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
19634412|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634413|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
19634414|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19634415|NCT02433899|Dexamethasone|dexamethasone|mesh-list
19634416|NCT02433899|Epinephrine|epinephrine|mesh-list
19634417|NCT02433899|Mepivacaine|mepivacaine|mesh-list
19634418|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634419|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
19634420|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
19634421|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634422|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765085|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765086|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19765087|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19765088|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19765089|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765090|NCT00078338|Interferons|interferons|mesh-list
19765091|NCT00078338|Interferon-beta|interferon-beta|mesh-list
19765092|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
19765093|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
19765094|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
19765095|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765096|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
20609477|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609478|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20609479|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20609480|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
20609481|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609482|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609483|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609484|NCT05000736|Fulvestrant|fulvestrant|mesh-list
20609485|NCT05000736|Palbociclib|palbociclib|mesh-list
20609486|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20609487|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20609488|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609489|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20609490|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20609491|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
20609492|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148196|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148197|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
20148198|NCT00079261|Hormones|hormones|mesh-ancestor
20148199|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148200|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148201|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20609493|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609494|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20609495|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609496|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609497|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20609498|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
20609499|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20609500|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20609501|NCT04976868|Analgesics|analgesics|mesh-ancestor
20609502|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
20609503|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20148202|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148203|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148204|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148205|NCT00079287|Gemcitabine|gemcitabine|mesh-list
20148206|NCT00079287|Paclitaxel|paclitaxel|mesh-list
20148207|NCT00079287|Vinorelbine|vinorelbine|mesh-list
20148208|NCT00079287|Docetaxel|docetaxel|mesh-list
20148209|NCT00079287|Carboplatin|carboplatin|mesh-list
20148210|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148211|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148212|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148213|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609504|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765097|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765098|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
19765099|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765100|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19765101|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148214|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148215|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148216|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20315870|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20315871|NCT00701337|Estradiol|estradiol|mesh-list
20315872|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20315873|NCT00701337|Estrogens|estrogens|mesh-ancestor
20315874|NCT00701337|Hormones|hormones|mesh-ancestor
19765102|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765103|NCT00078377|Modafinil|modafinil|mesh-list
20148217|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
20148218|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
20315875|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315876|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315877|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20315878|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
20315879|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19634423|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634424|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
19634425|NCT02433899|Hormones|hormones|mesh-ancestor
19634426|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634427|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19634428|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634429|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19634430|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634431|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
19765104|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20609505|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609506|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609507|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
20609508|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609509|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
19765105|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765106|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19765107|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19765108|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19765109|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765110|NCT00078403|Ribavirin|ribavirin|mesh-list
19765111|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19765112|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
19765113|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765114|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
19765115|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765116|NCT00078559|Acetaminophen|acetaminophen|mesh-list
19765117|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
19765118|NCT00078559|Promethazine|promethazine|mesh-list
19765119|NCT00078559|Sirolimus|sirolimus|mesh-list
19765120|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19765121|NCT00078559|Nystatin|nystatin|mesh-list
19765122|NCT00078559|Clotrimazole|clotrimazole|mesh-list
19765123|NCT00078559|Miconazole|miconazole|mesh-list
19765124|NCT00078559|Pentamidine|pentamidine|mesh-list
19765125|NCT00078559|Trimethoprim|trimethoprim|mesh-list
20315880|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20315881|NCT00701428|Losartan|losartan|mesh-list
19765126|NCT00078559|Valganciclovir|valganciclovir|mesh-list
19765127|NCT00078559|Acyclovir|acyclovir|mesh-list
19765128|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
19765129|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
20148219|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609510|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20609511|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609512|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612212|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148220|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148221|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148222|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
20148223|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148224|NCT00079300|Imiquimod|imiquimod|mesh-list
20148225|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20148226|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
20315882|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315883|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19634432|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315884|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20612213|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612214|NCT02250729|Pholcodine|pholcodine|mesh-list
20612215|NCT02250729|Analgesics|analgesics|mesh-ancestor
19765130|NCT00078559|Tacrolimus|tacrolimus|mesh-list
19765131|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315885|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20315886|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315887|NCT00701493|Topiramate|topiramate|mesh-list
20315888|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
20315889|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20315890|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315891|NCT00701532|Modafinil|modafinil|mesh-list
19765132|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
20315892|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20315893|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315894|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20315895|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20315896|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20315897|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609513|NCT04928664|Bupivacaine|bupivacaine|mesh-list
20609514|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
20609515|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
20609516|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609517|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609518|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
20609519|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609520|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
20609521|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
20609522|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609523|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
20609524|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609525|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609526|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20609527|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
20609528|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609529|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609530|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20609531|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609532|NCT04910503|Dexamethasone|dexamethasone|mesh-list
20609533|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20609534|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609535|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
20609536|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
20609537|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609538|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609539|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609540|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
20609541|NCT04910503|Hormones|hormones|mesh-ancestor
20609542|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20315898|NCT00701597|Bosentan|bosentan|mesh-list
20315899|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315900|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20315901|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315902|NCT00701623|Heparin|heparin|mesh-list
20315903|NCT00701623|Calcium heparin|calcium heparin|mesh-list
19765133|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765134|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19765135|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765136|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765137|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19765138|NCT00078559|Analgesics|analgesics|mesh-ancestor
19765139|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
20609543|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20609544|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609545|NCT04893109|Paclitaxel|paclitaxel|mesh-list
20609546|NCT04893109|Maytansine|maytansine|mesh-list
20315904|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
20315905|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20609547|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20609548|NCT04893109|Trastuzumab|trastuzumab|mesh-list
20609549|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20609550|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609551|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
20609552|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609553|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
20609554|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609555|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609556|NCT04876066|Ketamine|ketamine|mesh-list
19765140|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765141|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
19765142|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765143|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765144|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19765145|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765146|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
20609557|NCT04876066|Analgesics|analgesics|mesh-ancestor
20609558|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
19765147|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765148|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
19765149|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
19765150|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19765151|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
20315906|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20315907|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315908|NCT00701740|Isotretinoin|isotretinoin|mesh-list
20315909|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
20315910|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
20315911|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
20315912|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20315913|NCT00701740|Protective Agents|protective agents|mesh-ancestor
20315914|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765152|NCT00078559|Hormones|hormones|mesh-ancestor
19765153|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765154|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19765155|NCT00078559|Protective Agents|protective agents|mesh-ancestor
19765156|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765157|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19765158|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19765159|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19765160|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
19765161|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
19765162|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19765163|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
19765164|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
19765165|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19765166|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19765167|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
19765168|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
19765169|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19765170|NCT00078559|Renal Agents|renal agents|mesh-ancestor
19765171|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
19765172|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19765173|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19765174|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19765175|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19765176|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19765177|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19765178|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
19765179|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19765180|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19765181|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19765182|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
19765183|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20315915|NCT00701792|Liver Extracts|liver extracts|mesh-list
20315916|NCT00701792|Hematinics|hematinics|mesh-ancestor
20315917|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
19765184|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20148227|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148228|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148229|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
20148230|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
20148231|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765185|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19765186|NCT00078559|Ionophores|ionophores|mesh-ancestor
19765187|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20148232|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148233|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148234|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148235|NCT00079352|Gemcitabine|gemcitabine|mesh-list
20148236|NCT00079352|Irinotecan|irinotecan|mesh-list
20148237|NCT00079352|Alvocidib|alvocidib|mesh-list
20148238|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148239|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
20148240|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148241|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148242|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
20148243|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148244|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148245|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148246|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
20315918|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19765188|NCT00078715|Yohimbine|yohimbine|mesh-list
20148247|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148248|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19765189|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
20609559|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609560|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609561|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20609562|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20609563|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
20609564|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
20609565|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609566|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20609567|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20609568|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609569|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609570|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
20609571|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20609572|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
20609573|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609574|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
20609575|NCT04866706|Protective Agents|protective agents|mesh-ancestor
20609576|NCT04856007|Metformin|metformin|mesh-list
20609577|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
20609578|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20609579|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609580|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20609581|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609582|NCT04849715|Rituximab|rituximab|mesh-list
20609583|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20609584|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609585|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609586|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
20609587|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609588|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609589|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19634433|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19634434|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19634435|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
19634436|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634437|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634438|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19634439|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19634440|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19634441|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
19634442|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
19634443|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
19634444|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19634445|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
19634446|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
19634447|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634448|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
19662046|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
19662047|NCT04058158|Eculizumab|eculizumab|mesh-list
19662048|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19662049|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662050|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
19662051|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662052|NCT03966807|Nicotine|nicotine|mesh-list
19662053|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19662054|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
19662055|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662056|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662057|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19662058|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19662059|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
19662060|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19765190|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
20148249|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148250|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
20148251|NCT00079352|Growth Substances|growth substances|mesh-ancestor
20148252|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148253|NCT00079365|Gemcitabine|gemcitabine|mesh-list
20148254|NCT00079365|Fluorouracil|fluorouracil|mesh-list
20148255|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148256|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
20148257|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148258|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148259|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
20148260|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148261|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765191|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609590|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
20609591|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609601|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
20609602|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609603|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609604|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
20609605|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609606|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609607|NCT04793958|Cetuximab|cetuximab|mesh-list
20609608|NCT04793958|Adagrasib|adagrasib|mesh-list
20609609|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609610|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609611|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20609612|NCT04792580|Lifitegrast|lifitegrast|mesh-list
20609613|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20609614|NCT04768101|Corticosterone|corticosterone|mesh-list
20609615|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609616|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20609617|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20609618|NCT04745026|Cannabidiol|cannabidiol|mesh-list
19765192|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765193|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19765194|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19765195|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19765196|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
20609619|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
20609620|NCT04736979|Amoxicillin|amoxicillin|mesh-list
20609621|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
20148262|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20315919|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315920|NCT00701857|Pemetrexed|pemetrexed|mesh-list
20315921|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315922|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315923|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315924|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20315925|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20609622|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
20609623|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20609624|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20609625|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609626|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19634449|NCT02434029|Budesonide|budesonide|mesh-list
19634450|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634451|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19634452|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
19634453|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634454|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634455|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19634456|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
20148263|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
20315926|NCT00701909|Ketamine|ketamine|mesh-list
20609627|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315927|NCT00701909|Morphine|morphine|mesh-list
20315928|NCT00701909|Analgesics|analgesics|mesh-ancestor
20315929|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
20315930|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315931|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315932|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20315933|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20315934|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
20315935|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
20609628|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609629|NCT04710030|Valacyclovir|valacyclovir|mesh-list
20609630|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
20315936|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20315937|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20315938|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20315939|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315940|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609631|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609632|NCT04704050|Dronedarone|dronedarone|mesh-list
20609633|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20609634|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
20609635|NCT04700072|Lenvatinib|lenvatinib|mesh-list
20609636|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609637|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609638|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20609639|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609640|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609641|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
20609642|NCT04697576|Nivolumab|nivolumab|mesh-list
20609643|NCT04697576|Ipilimumab|ipilimumab|mesh-list
20609644|NCT04697576|Vaccines|vaccines|mesh-list
20609645|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
20609646|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609647|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609648|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148264|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148265|NCT00079378|Decitabine|decitabine|mesh-list
20148266|NCT00079378|Azacitidine|azacitidine|mesh-list
20148267|NCT00079378|Valproic Acid|valproic acid|mesh-list
20148268|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148269|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
20148270|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148271|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148272|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609649|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20609650|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609651|NCT04683627|Diclofenac|diclofenac|mesh-list
20609652|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20609653|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20609654|NCT04683627|Analgesics|analgesics|mesh-ancestor
20609655|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
19765197|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19765198|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765199|NCT00078715|Urological Agents|urological agents|mesh-ancestor
19765200|NCT00078754|Valproic Acid|valproic acid|mesh-list
19765201|NCT00078754|Fluoxetine|fluoxetine|mesh-list
19765202|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20148273|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
20315941|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20315942|NCT00701909|Narcotics|narcotics|mesh-ancestor
20315943|NCT00701961|Artesunate|artesunate|mesh-list
20315944|NCT00701961|Mefloquine|mefloquine|mesh-list
20315945|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
20315946|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20315947|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20315948|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20315949|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315950|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
20315951|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
20315952|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20315953|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
20315954|NCT00702091|Ramipril|ramipril|mesh-list
20315955|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20315956|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
20148274|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
20315957|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609656|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315958|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315959|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315960|NCT00702117|Flecainide|flecainide|mesh-list
20315961|NCT00702117|Procainamide|procainamide|mesh-list
20609657|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609658|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609659|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609660|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20609661|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609662|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609663|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20609664|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20609665|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609666|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
20609667|NCT04666038|Rituximab|rituximab|mesh-list
20609668|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20609669|NCT04666038|Idelalisib|idelalisib|mesh-list
20609670|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609671|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609672|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
19765203|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19765204|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19765205|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765206|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19765207|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
19765208|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765209|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20609673|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609674|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609675|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20609676|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
20609677|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609678|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609679|NCT04659369|Nivolumab|nivolumab|mesh-list
20609680|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765210|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
19765211|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19765212|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19765213|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19765214|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765215|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
19765216|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
19765217|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
20609681|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609682|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20609683|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609684|NCT04644237|Trastuzumab|trastuzumab|mesh-list
20609685|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20609686|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609687|NCT04636034|Anesthetics|anesthetics|mesh-list
20609688|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
20609689|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609690|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609691|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
20609692|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765218|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19765219|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19765220|NCT00078767|Sertraline|sertraline|mesh-list
19765221|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
19765222|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20315962|NCT00702117|Ajmaline|ajmaline|mesh-list
20609693|NCT04631029|Carboplatin|carboplatin|mesh-list
20609694|NCT04631029|Etoposide|etoposide|mesh-list
20609695|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
20609696|NCT04631029|Atezolizumab|atezolizumab|mesh-list
20609697|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
20609698|NCT04631029|Entinostat|entinostat|mesh-list
20609699|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20609700|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20609701|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609702|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20609703|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20609704|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20609705|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609706|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609707|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
20609708|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765223|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19765224|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19765225|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19765226|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765227|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19765228|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
19765229|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765230|NCT00078819|Etanercept|etanercept|mesh-list
19765231|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19765232|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19765233|NCT00078819|Analgesics|analgesics|mesh-ancestor
19765234|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
19765235|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765236|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765237|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765238|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765239|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19765240|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765241|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
19765242|NCT00078897|Selenium|selenium|mesh-list
20315963|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20315964|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20315965|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20315966|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20315967|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315968|NCT00702130|Pravastatin|pravastatin|mesh-list
20315969|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20315970|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20315971|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
20315972|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315973|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20609709|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
19765243|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
19765244|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765245|NCT00078897|Protective Agents|protective agents|mesh-ancestor
19765246|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765247|NCT00078897|Trace Elements|trace elements|mesh-ancestor
19765248|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
19765249|NCT00078949|Gemcitabine|gemcitabine|mesh-list
19765250|NCT00078949|Cytarabine|cytarabine|mesh-list
19765251|NCT00078949|Dexamethasone|dexamethasone|mesh-list
19765252|NCT00078949|Rituximab|rituximab|mesh-list
19765253|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765254|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765255|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
19765256|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765257|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765258|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765259|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
19765260|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
19765261|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765262|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19765263|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
19765264|NCT00078949|Hormones|hormones|mesh-ancestor
19765265|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148275|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148276|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609710|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
20609711|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148277|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
20148278|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20148279|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20148280|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20148281|NCT00079430|Paclitaxel|paclitaxel|mesh-list
20148282|NCT00079430|Bevacizumab|bevacizumab|mesh-list
20148283|NCT00079430|Carboplatin|carboplatin|mesh-list
20148284|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20148285|NCT00079430|Antibodies|antibodies|mesh-list
20148286|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
20148287|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20148288|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148289|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20315974|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20315975|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315976|NCT00702156|Bisoprolol|bisoprolol|mesh-list
20315977|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20315978|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
20315979|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
20315980|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20315981|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315982|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20315983|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20315984|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20315985|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
20315986|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20315987|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315988|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20315989|NCT00702182|Vinorelbine|vinorelbine|mesh-list
20315990|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609712|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609713|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
20609714|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
20609715|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609716|NCT04586023|Teriflunomide|teriflunomide|mesh-list
20609717|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20609718|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20609719|NCT04586023|Analgesics|analgesics|mesh-ancestor
19765266|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19765267|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765268|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
19765269|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609720|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
20609721|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609722|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609723|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609724|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609725|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609726|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
20612216|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
20612217|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634457|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
19634458|NCT02434029|Hormones|hormones|mesh-ancestor
19634459|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634460|NCT02433925|Resveratrol|resveratrol|mesh-list
19634461|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
19634462|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634463|NCT02433925|Protective Agents|protective agents|mesh-ancestor
19634464|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634465|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634466|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19634467|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19634468|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19634469|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19634470|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634471|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634472|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634473|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19634474|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19634475|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
19634476|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634477|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634478|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19634479|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19634480|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
19634481|NCT02433652|Vaccines|vaccines|mesh-list
19634482|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
20612218|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612219|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
19256628|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20315991|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20315992|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20315993|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20315994|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20315995|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
20315996|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
20315997|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
20609727|NCT04586010|Teriflunomide|teriflunomide|mesh-list
20609728|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20609729|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20609730|NCT04586010|Analgesics|analgesics|mesh-ancestor
20609731|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
20609732|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609733|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609734|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609735|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609736|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609737|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
20609738|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
20609739|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
20609740|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609741|NCT04574713|Candesartan|candesartan|mesh-list
20609742|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
20609743|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20609744|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20609745|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20609746|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609747|NCT04560686|Atezolizumab|atezolizumab|mesh-list
20609748|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609749|NCT04557956|Trametinib|trametinib|mesh-list
20609750|NCT04557956|Dabrafenib|dabrafenib|mesh-list
20609751|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20609752|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609753|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20609754|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609755|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609756|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20609757|NCT04557956|Protective Agents|protective agents|mesh-ancestor
20609758|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609759|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20609760|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
20609761|NCT04553770|Trastuzumab|trastuzumab|mesh-list
20609762|NCT04553770|Anastrozole|anastrozole|mesh-list
19634483|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634484|NCT02433626|Cisplatin|cisplatin|mesh-list
19634485|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634486|NCT02433587|Aspirin|aspirin|mesh-list
19634487|NCT02433587|Clopidogrel|clopidogrel|mesh-list
19634488|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19634489|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19634490|NCT02433587|Analgesics|analgesics|mesh-ancestor
19634491|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
19634492|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634493|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634494|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634495|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19634496|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19634497|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19634498|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634499|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19634500|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20315998|NCT00702260|Ramipril|ramipril|mesh-list
20315999|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20316000|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
20316001|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316002|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316003|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20316004|NCT00702416|Acetaminophen|acetaminophen|mesh-list
20316005|NCT00702416|Fentanyl|fentanyl|mesh-list
20316006|NCT00702416|Morphine|morphine|mesh-list
20316007|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
20316008|NCT00702416|Narcotics|narcotics|mesh-list
20316009|NCT00702416|Analgesics|analgesics|mesh-list
20609763|NCT04553770|Camptothecin|camptothecin|mesh-list
20316010|NCT00702416|Anesthetics|anesthetics|mesh-list
20316011|NCT00702416|Ropivacaine|ropivacaine|mesh-list
20609764|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
20609765|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765270|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
19765271|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765272|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765273|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765274|NCT00079001|Vitamin D|vitamin d|mesh-list
19765275|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
19765276|NCT00079001|Calcium|calcium|mesh-list
19765277|NCT00079001|Androgens|androgens|mesh-list
19765278|NCT00079001|Vitamins|vitamins|mesh-ancestor
19765279|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
19765280|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765281|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19765282|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20316012|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
20316013|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19765283|NCT00079001|Hormones|hormones|mesh-ancestor
19765284|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765285|NCT00079040|Bevacizumab|bevacizumab|mesh-list
19765286|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19765287|NCT00079040|Etoposide|etoposide|mesh-list
19765288|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
19765289|NCT00079040|Antibodies|antibodies|mesh-list
19765290|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
19765291|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19765292|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765293|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765294|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765295|NCT00079040|Growth Substances|growth substances|mesh-ancestor
19765296|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765297|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765298|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
19765299|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19765300|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19765301|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765302|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148290|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148291|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148292|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148293|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148294|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20148295|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20148296|NCT00079430|Growth Substances|growth substances|mesh-ancestor
20148297|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148298|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
20148299|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
19765303|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765304|NCT00079183|Sirolimus|sirolimus|mesh-list
19765305|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765306|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765307|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19765308|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765309|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
19765310|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765311|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
19765312|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634501|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634502|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
19634503|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19634504|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19634505|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19634506|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
19634507|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634508|NCT02433704|Cefazolin|cefazolin|mesh-list
19634509|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634510|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634511|NCT02433457|Omeprazole|omeprazole|mesh-list
19634512|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19634513|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634514|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19634515|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634516|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634517|NCT02433535|Simvastatin|simvastatin|mesh-list
19634518|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19634519|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19765313|NCT00079274|Leucovorin|leucovorin|mesh-list
19634520|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
20148300|NCT00079443|Rituximab|rituximab|mesh-list
19634521|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634522|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19634523|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19634524|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634525|NCT02433522|Rituximab|rituximab|mesh-list
19634526|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19634527|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634528|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
19634529|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765314|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20609766|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316014|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316015|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
20316016|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316017|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20316018|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20609767|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20609768|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20609769|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20609770|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609771|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765315|NCT00079274|Cetuximab|cetuximab|mesh-list
19765316|NCT00079274|Fluorouracil|fluorouracil|mesh-list
19765317|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
19765318|NCT00079274|Irinotecan|irinotecan|mesh-list
19765319|NCT00079274|Antibodies|antibodies|mesh-list
20609772|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20609773|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
20609774|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609775|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609776|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20609777|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20609778|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20609779|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
20609780|NCT04553666|Vitamins|vitamins|mesh-list
20609781|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
20609782|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20609783|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
20609784|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609785|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
20316019|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
20316020|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20316021|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
20316022|NCT00702442|Droperidol|droperidol|mesh-list
20316023|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20316024|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
20316025|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
20316026|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316027|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634530|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19634531|NCT02433418|Diclofenac|diclofenac|mesh-list
19634532|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19634533|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20609786|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609787|NCT04553666|Protective Agents|protective agents|mesh-ancestor
20609788|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20609789|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20609790|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609791|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20609792|NCT04553003|Prednisone|prednisone|mesh-list
20609793|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
20609794|NCT04553003|Choline|choline|mesh-list
20609795|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
20609796|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
20609797|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609798|NCT04553003|Hormones|hormones|mesh-ancestor
20609799|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609800|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609801|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20609802|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609803|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
20609804|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
20316028|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609805|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609806|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316029|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20316030|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20609807|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20609808|NCT04553003|Protective Agents|protective agents|mesh-ancestor
20609809|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
20609810|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20609811|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
20609812|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609813|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20609814|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
20609815|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
20316031|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20316032|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20316033|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20316034|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20316035|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
20316036|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316037|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316038|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
20316039|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316040|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316041|NCT00702572|Paclitaxel|paclitaxel|mesh-list
20316042|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20316043|NCT00702572|Bevacizumab|bevacizumab|mesh-list
20316044|NCT00702572|Carboplatin|carboplatin|mesh-list
20316045|NCT00702572|Vorinostat|vorinostat|mesh-list
20148301|NCT00079443|Fludarabine|fludarabine|mesh-list
20316046|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20316047|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316048|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316049|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316050|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316051|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316052|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316053|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20316054|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20316055|NCT00702572|Growth Substances|growth substances|mesh-ancestor
20316056|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316057|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316058|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20316059|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316060|NCT00702637|Modafinil|modafinil|mesh-list
20316061|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20609816|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
20609817|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148302|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
20148303|NCT00079443|Romidepsin|romidepsin|mesh-list
20609818|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20609819|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20609820|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
20316062|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609821|NCT04539366|Fludarabine|fludarabine|mesh-list
20609822|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
20609823|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
20609824|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609825|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609826|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609827|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20609828|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
19765320|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
19765321|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19765322|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
20148304|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148305|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148306|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
20148307|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148308|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148309|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148310|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
19765323|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
19765324|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765325|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765326|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
20173898|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316063|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20612220|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
20609829|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609830|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609831|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20609832|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20609833|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
20609834|NCT04509336|Orphenadrine|orphenadrine|mesh-list
20609835|NCT04509336|Baclofen|baclofen|mesh-list
20609836|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20609837|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609838|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20609839|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609840|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20609841|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
20609842|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
20609843|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609844|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609845|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20609846|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20609847|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
20609848|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
20609849|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20609850|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20609851|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
20609852|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
20609853|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20609854|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609855|NCT04491942|Gemcitabine|gemcitabine|mesh-list
20609856|NCT04491942|Cisplatin|cisplatin|mesh-list
20609857|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609858|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20609859|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
20609860|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765327|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765328|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765329|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765330|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19765331|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765332|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765333|NCT00079274|Antidotes|antidotes|mesh-ancestor
19765334|NCT00079274|Protective Agents|protective agents|mesh-ancestor
19765335|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
19765336|NCT00079274|Vitamins|vitamins|mesh-ancestor
19765337|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
19765338|NCT00079326|Trastuzumab|trastuzumab|mesh-list
19765339|NCT00079326|Epothilone B|epothilone b|mesh-list
19765340|NCT00079326|Epothilones|epothilones|mesh-list
19765341|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765342|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765343|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765344|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609861|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
20609862|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765345|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765346|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765347|NCT00079339|Tipifarnib|tipifarnib|mesh-list
20609863|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609864|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609865|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
20609866|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609867|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
20609868|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609869|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20609870|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609871|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609872|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
20609873|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609874|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609875|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20609876|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20609877|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
20609878|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609879|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20609880|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
19765348|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765349|NCT00079417|Iodine|iodine|mesh-list
20609881|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609882|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609883|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19765350|NCT00079417|Carboplatin|carboplatin|mesh-list
19765351|NCT00079417|Vincristine|vincristine|mesh-list
19765352|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765353|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19765354|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765355|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
20609884|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20609885|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20609886|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
20609887|NCT04435795|Ciclesonide|ciclesonide|mesh-list
20609888|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
20609889|NCT04435795|Hormones|hormones|mesh-ancestor
20609890|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609891|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609892|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20609893|NCT04429555|Ibudilast|ibudilast|mesh-list
20609894|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20609895|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
20609896|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316064|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20609897|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148311|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148312|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148313|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148314|NCT00079456|Sirolimus|sirolimus|mesh-list
20148315|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20148316|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148317|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148318|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148319|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
20148320|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20609898|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20609899|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
20609900|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20609901|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609902|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609903|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20609904|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
20609905|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
20609906|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
20609907|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
20609908|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609909|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609910|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
20609911|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609912|NCT04368533|Fluorides|fluorides|mesh-list
19765356|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765357|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765358|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19765359|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148321|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
20148322|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148323|NCT00079469|Bupropion|bupropion|mesh-list
20148324|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20148325|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
20148326|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20148327|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20148328|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20148329|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20148330|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148331|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
20148332|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148333|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148334|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20148335|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20148336|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148337|NCT00079508|Bivalirudin|bivalirudin|mesh-list
20148338|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
19765360|NCT00079417|Trace Elements|trace elements|mesh-ancestor
19765361|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
19765362|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765363|NCT00079677|Modafinil|modafinil|mesh-list
19765364|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19765365|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765366|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19765367|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19765368|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19765369|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609913|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
20609914|NCT04368533|Protective Agents|protective agents|mesh-ancestor
20609915|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609916|NCT04280562|Acetaminophen|acetaminophen|mesh-list
20609917|NCT04280562|Analgesics|analgesics|mesh-list
20609918|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20609919|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
20609920|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609921|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609922|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
20609923|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20609924|NCT04270682|Cathartics|cathartics|mesh-ancestor
20316065|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20316066|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316067|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20316068|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
20316069|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20316070|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20316071|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20316072|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20316073|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316074|NCT00702728|Furosemide|furosemide|mesh-list
20316075|NCT00702728|Diuretics|diuretics|mesh-ancestor
20316076|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
20316077|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316078|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20316079|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20609925|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609926|NCT04199728|Liraglutide|liraglutide|mesh-list
20609927|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19765370|NCT00079937|Fluticasone|fluticasone|mesh-list
19765371|NCT00079937|Omalizumab|omalizumab|mesh-list
19765372|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765373|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19765374|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
19765375|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765376|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765377|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19765378|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19765379|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
19765380|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20609928|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609929|NCT04199728|Incretins|incretins|mesh-ancestor
20609930|NCT04199728|Hormones|hormones|mesh-ancestor
20609931|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609932|NCT04167813|Ondansetron|ondansetron|mesh-list
20609933|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
20609934|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
20609935|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609936|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609937|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609938|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
20148339|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20148340|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
20148341|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148342|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148343|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
20148344|NCT00079560|Dronabinol|dronabinol|mesh-list
20148345|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
20148346|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148347|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20148348|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20148349|NCT00079560|Analgesics|analgesics|mesh-ancestor
20148350|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
20148351|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20148352|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20609939|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
20609940|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20609941|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
20609942|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20609943|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609944|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20609945|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20609946|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609947|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20609948|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20609949|NCT04123067|Pioglitazone|pioglitazone|mesh-list
20609950|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20609951|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609952|NCT04120246|Acetic Acid|acetic acid|mesh-list
19765381|NCT00080119|Isoniazid|isoniazid|mesh-list
19765382|NCT00080119|Trimethoprim|trimethoprim|mesh-list
19765383|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
19765384|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
19765385|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765386|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765387|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19765388|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19765389|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
19765390|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765391|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19765392|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19765393|NCT00080119|Renal Agents|renal agents|mesh-ancestor
19634534|NCT02433418|Analgesics|analgesics|mesh-ancestor
19634535|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
19634536|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634537|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634538|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634539|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19634540|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19634541|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634542|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634543|NCT02433314|Brexanolone|brexanolone|mesh-list
19634544|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
19765394|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
19765395|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19765396|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20148353|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20148354|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148355|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609953|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20609954|NCT04120246|Trastuzumab|trastuzumab|mesh-list
20609955|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20609956|NCT04120246|Antibodies|antibodies|mesh-list
20609957|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
20609958|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20609959|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
20609960|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609961|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609962|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20609963|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20609964|NCT04110080|Anesthetics|anesthetics|mesh-list
20609965|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20609966|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609967|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20609968|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20609969|NCT04092270|Doxorubicin|doxorubicin|mesh-list
20609970|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20609971|NCT04092270|Peposertib|peposertib|mesh-list
19765397|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19765398|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148356|NCT00079560|Hormones|hormones|mesh-ancestor
20148357|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148358|NCT00079586|Heparin|heparin|mesh-list
20148359|NCT00079586|Bivalirudin|bivalirudin|mesh-list
20148360|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
20148361|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20148362|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20148363|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148364|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
20148365|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20148366|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
20148367|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148368|NCT00079612|Sorafenib|sorafenib|mesh-list
20148369|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148370|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148371|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148372|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148373|NCT00079638|Niacin|niacin|mesh-list
20148374|NCT00079638|Atorvastatin|atorvastatin|mesh-list
20148375|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20316080|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316081|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20316082|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20316083|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19634545|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634546|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634547|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634548|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
19634549|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
19634550|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19634551|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19634552|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19634553|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19634554|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634555|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634556|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634557|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19634558|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
19634559|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634560|NCT02433730|Testosterone|testosterone|mesh-list
19634561|NCT02433730|Androgens|androgens|mesh-ancestor
19634562|NCT02433730|Hormones|hormones|mesh-ancestor
19634563|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634564|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634565|NCT02433912|Acetaminophen|acetaminophen|mesh-list
19634566|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
19634567|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19634568|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19634569|NCT02433912|Analgesics|analgesics|mesh-ancestor
19634570|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
19634571|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634572|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634573|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
19634574|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19634575|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634576|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
19634577|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19634578|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
19634579|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
19634580|NCT02433184|Etanercept|etanercept|mesh-list
19634581|NCT02433184|Methotrexate|methotrexate|mesh-list
19634582|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19634583|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
19634584|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20609972|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20609973|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609974|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20609975|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19634585|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634586|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19634587|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
19634588|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609976|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20609977|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20609978|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20609979|NCT04091126|Dexamethasone|dexamethasone|mesh-list
20609980|NCT04091126|Lenalidomide|lenalidomide|mesh-list
20609981|NCT04091126|Bortezomib|bortezomib|mesh-list
20609982|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20609983|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
20609984|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
20609985|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20609986|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20609987|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20609988|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
20609989|NCT04091126|Hormones|hormones|mesh-ancestor
20609990|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20609991|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20609992|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20609993|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
20609994|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20609995|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20609996|NCT04091126|Growth Substances|growth substances|mesh-ancestor
20609997|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
20609998|NCT04079621|Primaquine|primaquine|mesh-list
20609999|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
20610000|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20610001|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20610002|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612221|NCT02250781|TIC10 compound|tic10 compound|mesh-list
20612222|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612223|NCT02250794|Insulin|insulin|mesh-list
20612224|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20612225|NCT02250794|Metformin|metformin|mesh-list
20612226|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
20612227|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20612228|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
20612229|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20612230|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612231|NCT02250794|Incretins|incretins|mesh-ancestor
20612232|NCT02250794|Hormones|hormones|mesh-ancestor
20612233|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612234|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20612235|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612236|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612237|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612301|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612302|NCT02251041|Protective Agents|protective agents|mesh-ancestor
20148376|NCT00079638|Simvastatin|simvastatin|mesh-list
20148377|NCT00079638|Ezetimibe|ezetimibe|mesh-list
20148378|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20148379|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20148380|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
20612303|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610003|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
20610004|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20610005|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20610006|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148381|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148382|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20610007|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20610008|NCT04042727|Analgesics|analgesics|mesh-ancestor
20610009|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
20610010|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610011|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20610012|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20610013|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20610014|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
20610015|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148383|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20148384|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148385|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
20148386|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
20148387|NCT00079638|Vitamins|vitamins|mesh-ancestor
20148388|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
20148389|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148390|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
20148391|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148392|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148393|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20148394|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148395|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148396|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
20148397|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316084|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20316085|NCT00702793|Varenicline|varenicline|mesh-list
20610016|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610017|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
20610018|NCT04042155|Apixaban|apixaban|mesh-list
20610019|NCT04042155|Edoxaban|edoxaban|mesh-list
20610020|NCT04042155|Dabigatran|dabigatran|mesh-list
20610021|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20610022|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
20610023|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20610024|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
20610025|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610026|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610027|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
20610028|NCT04014387|Zolpidem|zolpidem|mesh-list
20610029|NCT04014387|Suvorexant|suvorexant|mesh-list
20610030|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20316086|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20610031|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20610032|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20610033|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610034|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20610035|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
20610036|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
20610037|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610038|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610039|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20610040|NCT03993912|Dexamethasone|dexamethasone|mesh-list
20610041|NCT03993912|Lenalidomide|lenalidomide|mesh-list
20610042|NCT03993912|Daratumumab|daratumumab|mesh-list
20148398|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610043|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316087|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20610044|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
20610045|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
20610046|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610047|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610048|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20610049|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
20610050|NCT03993912|Hormones|hormones|mesh-ancestor
19765399|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19765400|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19765401|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19765402|NCT00080223|Pirfenidone|pirfenidone|mesh-list
19765403|NCT00080223|Analgesics|analgesics|mesh-ancestor
19765404|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
19765405|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765406|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765407|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19765408|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19765409|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765410|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765411|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765412|NCT00080288|Modafinil|modafinil|mesh-list
19765413|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19765414|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765415|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19765416|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19765417|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19765418|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765419|NCT00080301|Capecitabine|capecitabine|mesh-list
19765420|NCT00080301|Epothilones|epothilones|mesh-list
19765421|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765422|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
19765423|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765424|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765425|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765426|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765427|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765428|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
19765429|NCT00080483|Testosterone|testosterone|mesh-list
19765430|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
19765431|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
19765432|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19765433|NCT00080483|Androgens|androgens|mesh-ancestor
20316088|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
20316089|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316090|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316091|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316092|NCT00702819|Bevacizumab|bevacizumab|mesh-list
20316093|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316094|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316095|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765434|NCT00080483|Hormones|hormones|mesh-ancestor
19833182|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20148399|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
20148400|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
20148401|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148402|NCT00079807|Protective Agents|protective agents|mesh-ancestor
20148403|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148404|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
20148405|NCT00079807|Vitamins|vitamins|mesh-ancestor
20148406|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
20148407|NCT00079820|Vaccines|vaccines|mesh-list
20148408|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
20148409|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148410|NCT00079833|Esomeprazole|esomeprazole|mesh-list
20148411|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20148412|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20148413|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20148414|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610051|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610052|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148415|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148416|NCT00079872|Pemetrexed|pemetrexed|mesh-list
20148417|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148418|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148419|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148420|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20148421|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20148422|NCT00079885|Tigecycline|tigecycline|mesh-list
20316096|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20316097|NCT00702819|Growth Substances|growth substances|mesh-ancestor
20316098|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316099|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765435|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765436|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347366|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347367|NCT00859872|Haloperidol|haloperidol|mesh-list
20347368|NCT00859872|Risperidone|risperidone|mesh-list
19634589|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610053|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634590|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
19634591|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634592|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19765437|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148423|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20148424|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148425|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20148426|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148427|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148428|NCT00079911|Valacyclovir|valacyclovir|mesh-list
20148429|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
20148430|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148431|NCT00079924|Teriparatide|teriparatide|mesh-list
20148432|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20148433|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20148434|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148435|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20148436|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20148437|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
20148438|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148439|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20148440|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20148441|NCT00079963|Vitamins|vitamins|mesh-list
20148442|NCT00079963|Ascorbic Acid|ascorbic acid|mesh-list
19765438|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765439|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
19765440|NCT00080899|Fenretinide|fenretinide|mesh-list
19765441|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765442|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19765443|NCT00080899|Protective Agents|protective agents|mesh-ancestor
19765444|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148443|NCT00079963|Vitamin E|vitamin e|mesh-list
20148444|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
20148445|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148446|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
20148447|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634593|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634594|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
19634595|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19634596|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19634597|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
19634598|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19634599|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19765445|NCT00080938|Temozolomide|temozolomide|mesh-list
20148448|NCT00079963|Protective Agents|protective agents|mesh-ancestor
20148449|NCT00079976|Tigecycline|tigecycline|mesh-list
20148450|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347369|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
20347370|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20347371|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
20347372|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347373|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347374|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347375|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20347376|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20347377|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347378|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19765446|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19765447|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
19765448|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765449|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765450|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
19765451|NCT00081159|Doxorubicin|doxorubicin|mesh-list
19765452|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19765453|NCT00081159|Leuprolide|leuprolide|mesh-list
19765454|NCT00081159|Goserelin|goserelin|mesh-list
19765455|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19765456|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634600|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634601|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19634602|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19634603|NCT02433184|Analgesics|analgesics|mesh-ancestor
19634604|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
19634605|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634606|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765457|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19765458|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765459|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610054|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
20610055|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20610056|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20610057|NCT03993912|Growth Substances|growth substances|mesh-ancestor
20610058|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
20610059|NCT03970096|Cyclosporine|cyclosporine|mesh-list
20610060|NCT03970096|Sirolimus|sirolimus|mesh-list
20610061|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
20610062|NCT03970096|Busulfan|busulfan|mesh-list
19765460|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765461|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20610063|NCT03970096|Thiotepa|thiotepa|mesh-list
20610064|NCT03970096|Methotrexate|methotrexate|mesh-list
20610065|NCT03970096|Fludarabine|fludarabine|mesh-list
20610066|NCT03970096|Tacrolimus|tacrolimus|mesh-list
19634607|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634608|NCT02432885|Enalapril|enalapril|mesh-list
19634609|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19765462|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765463|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19765464|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
19765465|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19765466|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19765467|NCT00081263|Celecoxib|celecoxib|mesh-list
20148451|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148452|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20148453|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148454|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148455|NCT00079989|Tigecycline|tigecycline|mesh-list
20148456|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20148457|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148458|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20316100|NCT00702871|Ranitidine|ranitidine|mesh-list
20316101|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20316102|NCT00702871|Sucralfate|sucralfate|mesh-list
20316103|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20316104|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316105|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20316106|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
20316107|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
19634610|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
19634611|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634612|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634613|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19634614|NCT02432911|Cytarabine|cytarabine|mesh-list
19634615|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
19634616|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19634617|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
19634618|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765468|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
19833183|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20316108|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347379|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20347380|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
20347381|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
20347382|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
20347383|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765469|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19765470|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19765471|NCT00081263|Analgesics|analgesics|mesh-ancestor
19765472|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
19765473|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765474|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765475|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765476|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765477|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19765478|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19765479|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765480|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765481|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20610067|NCT03970096|Cyclosporins|cyclosporins|mesh-list
20610068|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610069|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
20610070|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610071|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765482|NCT00081289|Leucovorin|leucovorin|mesh-list
20316109|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316110|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316111|NCT00702936|Telmisartan|telmisartan|mesh-list
20316112|NCT00702936|Ramipril|ramipril|mesh-list
20316113|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20316114|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20316115|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20316116|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316117|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20316118|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
20316119|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316120|NCT00702975|Paclitaxel|paclitaxel|mesh-list
20316121|NCT00702975|Bevacizumab|bevacizumab|mesh-list
20316122|NCT00702975|Carboplatin|carboplatin|mesh-list
20316123|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19634619|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765483|NCT00081289|Folic Acid|folic acid|mesh-list
19765484|NCT00081289|Fluorouracil|fluorouracil|mesh-list
19765485|NCT00081289|Capecitabine|capecitabine|mesh-list
19765486|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
19765487|NCT00081289|Irinotecan|irinotecan|mesh-list
19765488|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
19765489|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
19765490|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765491|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765492|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765493|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765494|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
19765495|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765496|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19765497|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765498|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765499|NCT00081289|Antidotes|antidotes|mesh-ancestor
19765500|NCT00081289|Protective Agents|protective agents|mesh-ancestor
19765501|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
19765502|NCT00081289|Vitamins|vitamins|mesh-ancestor
19765503|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
19765504|NCT00081289|Hematinics|hematinics|mesh-ancestor
19765505|NCT00081328|Metformin|metformin|mesh-list
19765506|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
19765507|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19765508|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316124|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19634620|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
19634621|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634622|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634623|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
19634624|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634625|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19634626|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19634627|NCT02433041|Ketamine|ketamine|mesh-list
19634628|NCT02433041|Haloperidol|haloperidol|mesh-list
19634629|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
19634630|NCT02433041|Analgesics|analgesics|mesh-ancestor
19765509|NCT00081458|Teduglutide|teduglutide|mesh-list
19634631|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
19765510|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316125|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316126|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316127|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316128|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316129|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316130|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316131|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20316132|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20610072|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20610073|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
20610074|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610075|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610076|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20316133|NCT00702975|Growth Substances|growth substances|mesh-ancestor
20316134|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316135|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316136|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20316137|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316138|NCT00703066|Vaccines|vaccines|mesh-list
20316139|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
20316140|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316141|NCT00703079|Octreotide|octreotide|mesh-list
20316142|NCT00703079|Lanreotide|lanreotide|mesh-list
20316143|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316144|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610077|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20610078|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
20610079|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20610080|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610081|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
20610082|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
20610083|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610084|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20610085|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20610086|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20610087|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
20610088|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610089|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610090|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20610091|NCT03965689|Paclitaxel|paclitaxel|mesh-list
20610092|NCT03965689|Carboplatin|carboplatin|mesh-list
20610093|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20610094|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20610095|NCT03965689|Pevonedistat|pevonedistat|mesh-list
20610096|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610097|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610098|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
20610099|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610100|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610101|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610102|NCT03954379|Dexamethasone|dexamethasone|mesh-list
20610103|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
20610104|NCT03954379|Analgesics|analgesics|mesh-list
20610105|NCT03954379|Anesthetics|anesthetics|mesh-list
20610106|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
20610107|NCT03954379|BB 1101|bb 1101|mesh-list
20148459|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148460|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148461|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
20148462|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148463|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20148464|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
20148465|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
20148466|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148467|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20148468|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
20148469|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
20148470|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148471|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20610108|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20610109|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
20610110|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
19765511|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19765512|NCT00081458|Protective Agents|protective agents|mesh-ancestor
19765513|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765514|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
19765515|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19765516|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765517|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
19765518|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19765519|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19765520|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19765521|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765522|NCT00081770|Ribavirin|ribavirin|mesh-list
19765523|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19765524|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
19765525|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19765526|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
19765527|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765528|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
19765529|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765530|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
19765531|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765532|NCT00081861|Bevacizumab|bevacizumab|mesh-list
19765533|NCT00081861|Rituximab|rituximab|mesh-list
19765534|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765535|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765536|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20610111|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610112|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610113|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20610114|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
20610115|NCT03954379|Hormones|hormones|mesh-ancestor
20610116|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610117|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610118|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610119|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
20610120|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610121|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610122|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20610123|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
20610124|NCT03910387|Gemcitabine|gemcitabine|mesh-list
20148472|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
20148473|NCT00080080|Docetaxel|docetaxel|mesh-list
19634632|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765537|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765538|NCT00081861|Growth Substances|growth substances|mesh-ancestor
19765539|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765540|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765541|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
19765542|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765543|NCT00081939|Thalidomide|thalidomide|mesh-list
19765544|NCT00081939|Bortezomib|bortezomib|mesh-list
19765545|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148474|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148475|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148476|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148477|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148478|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148479|NCT00080145|Risperidone|risperidone|mesh-list
20148480|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20148481|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
20148482|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148483|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148484|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148485|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20148486|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20148487|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20148488|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634633|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634634|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19634635|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19634636|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
19634637|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
19634638|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19765546|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765547|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
19765548|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765549|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
19765550|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610125|NCT03910387|Paclitaxel|paclitaxel|mesh-list
20610126|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20610127|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610128|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610129|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
20610130|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610131|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610132|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610133|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610134|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
20610135|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
20610136|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610137|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610138|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610139|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
20610140|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765551|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765552|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765553|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765554|NCT00081939|Growth Substances|growth substances|mesh-ancestor
19765555|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
19634639|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19634640|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19634641|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634642|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634643|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
19634644|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
19634645|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634646|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19765556|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
19765557|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765558|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19765559|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765560|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610141|NCT03878095|Olaparib|olaparib|mesh-list
20610142|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20610143|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610144|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610145|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610146|NCT03865212|Interferons|interferons|mesh-list
20148489|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20148490|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
20148491|NCT00080158|Mirtazapine|mirtazapine|mesh-list
20148492|NCT00080158|Citalopram|citalopram|mesh-list
20148493|NCT00080158|Bupropion|bupropion|mesh-list
20148494|NCT00080158|Fluoxetine|fluoxetine|mesh-list
20148495|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19634647|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19634648|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634649|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20610147|NCT03865212|Interferon-beta|interferon-beta|mesh-list
20610148|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610149|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
20610150|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610151|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
20610152|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610153|NCT03843463|Dexetimide|dexetimide|mesh-list
20610154|NCT03843463|Citalopram|citalopram|mesh-list
20610155|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20610156|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20610157|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20610158|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610159|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610160|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
20610161|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610162|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19765561|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
19765562|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20148496|NCT00080158|Sertraline|sertraline|mesh-list
19634650|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
20148497|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19634651|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19634652|NCT02432846|Sunitinib|sunitinib|mesh-list
19634653|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634654|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19634655|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19634656|NCT02432846|Growth Substances|growth substances|mesh-ancestor
19634657|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634658|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
19634659|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19634660|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634661|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634662|NCT02432807|Vancomycin|vancomycin|mesh-list
19634663|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634664|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634665|NCT02432976|Insulin|insulin|mesh-list
19634666|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19634667|NCT02432976|Exenatide|exenatide|mesh-list
19765563|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765564|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19765565|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20610163|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
20610164|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20610165|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20610166|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20610167|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
20610168|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
20610169|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610170|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19634668|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
19634669|NCT02432976|Incretins|incretins|mesh-list
20148498|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20148499|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20148500|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148501|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148502|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
20148503|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148504|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20148505|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
20148506|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20148507|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20148508|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
20148509|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20148510|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20148511|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148512|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20148513|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634670|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20610171|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20148514|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20148515|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20148516|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
20148517|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
20148518|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20148519|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20148520|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20148521|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20148522|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
20148523|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20148524|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20148525|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20148526|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20148527|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148528|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20148529|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148530|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148531|NCT00080275|Niacin|niacin|mesh-list
20148532|NCT00080275|Simvastatin|simvastatin|mesh-list
20148533|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20148534|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20148535|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
20148536|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634671|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765566|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148537|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20148538|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20148539|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148540|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
20610172|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
20610173|NCT03842709|Pramipexole|pramipexole|mesh-list
20610174|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
20610175|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610176|NCT03842709|Protective Agents|protective agents|mesh-ancestor
20610177|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610178|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20610179|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20610180|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
20610181|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
20610182|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19765567|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765568|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765569|NCT00082329|Plerixafor|plerixafor|mesh-list
19765570|NCT00082329|Lenograstim|lenograstim|mesh-list
19765571|NCT00082329|Sargramostim|sargramostim|mesh-list
19765572|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19765573|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
19765574|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765575|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19765576|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19765577|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
20610183|NCT03838484|Nicotine|nicotine|mesh-list
20610184|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20610185|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
20610186|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610187|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610188|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20610189|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20610190|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
20610191|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610192|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610193|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20610194|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
20610195|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610196|NCT03796650|Vancomycin|vancomycin|mesh-list
20610197|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610198|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610199|NCT03787602|Avelumab|avelumab|mesh-list
20610200|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610201|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610202|NCT03749460|Nivolumab|nivolumab|mesh-list
19765578|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148541|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
20148542|NCT00080275|Vitamins|vitamins|mesh-ancestor
20148543|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
19765579|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20148544|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148545|NCT00080314|Aripiprazole|aripiprazole|mesh-list
20148546|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
20148547|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20316145|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316146|NCT00703105|Vaccines|vaccines|mesh-list
20316147|NCT00703105|Immunologic Factors|immunologic factors|mesh-ancestor
20316148|NCT00703105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634672|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19634673|NCT02432976|Hormones|hormones|mesh-ancestor
19634674|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634675|NCT02432833|Tacrolimus|tacrolimus|mesh-list
19634676|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634677|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
19634678|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634679|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19634680|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634681|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634682|NCT02432872|Cytarabine|cytarabine|mesh-list
19634683|NCT02432872|Daunorubicin|daunorubicin|mesh-list
20148548|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19765580|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20148549|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20316149|NCT00703144|Tazobactam|tazobactam|mesh-list
20610203|NCT03749460|Ipilimumab|ipilimumab|mesh-list
19765581|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19765582|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765583|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
19765584|NCT00082381|Exenatide|exenatide|mesh-list
19765585|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19765586|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765587|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19765588|NCT00082381|Incretins|incretins|mesh-ancestor
19765589|NCT00082381|Hormones|hormones|mesh-ancestor
20610204|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610205|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610206|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610207|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610208|NCT03729102|Vaccines|vaccines|mesh-list
20610209|NCT03729102|Immunologic Factors|immunologic factors|mesh-ancestor
20148550|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20148551|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148552|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
20148553|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
20148554|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148555|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316150|NCT00703144|Piperacillin|piperacillin|mesh-list
20316151|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20316152|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316153|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316154|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20148556|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20148557|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20148558|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
20148559|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20148560|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20148561|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20148562|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20148563|NCT00080327|Aripiprazole|aripiprazole|mesh-list
20148564|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
20148565|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20148566|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20148567|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20316155|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316156|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316157|NCT00703170|Sirolimus|sirolimus|mesh-list
20316158|NCT00703170|Doxorubicin|doxorubicin|mesh-list
20316159|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20316160|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20316161|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148568|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20148569|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148570|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
20148571|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
20316162|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19634684|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148572|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148573|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148574|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20148575|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20148576|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
20316163|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20610210|NCT03729102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634685|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
19634686|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634687|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634688|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
19634689|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634690|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634691|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
19634692|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634693|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19634694|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19634695|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19634696|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765590|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610211|NCT03728361|Nivolumab|nivolumab|mesh-list
20610212|NCT03728361|Temozolomide|temozolomide|mesh-list
20316164|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316165|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316166|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316167|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316168|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
20316169|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316170|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
20316171|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316172|NCT00703196|Folic Acid|folic acid|mesh-list
20316173|NCT00703196|Hematinics|hematinics|mesh-ancestor
20316174|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
20316175|NCT00703196|Vitamins|vitamins|mesh-ancestor
20316176|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
20610213|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610214|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765591|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
19765592|NCT00082407|Exenatide|exenatide|mesh-list
19765593|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
19765594|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19765595|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765596|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19765597|NCT00082407|Incretins|incretins|mesh-ancestor
19765598|NCT00082407|Hormones|hormones|mesh-ancestor
19765599|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765600|NCT00082433|Capecitabine|capecitabine|mesh-list
19765601|NCT00082433|Epothilones|epothilones|mesh-list
19765602|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765603|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
19765604|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765605|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765606|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765607|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765608|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765609|NCT00082628|Hormones|hormones|mesh-list
19765610|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765611|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765612|NCT00082758|Interleukin-2|interleukin-2|mesh-list
19765613|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
19765614|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765615|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19765616|NCT00082758|Analgesics|analgesics|mesh-ancestor
19765617|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
19765618|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765619|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765620|NCT00082810|Fulvestrant|fulvestrant|mesh-list
19765621|NCT00082810|Tipifarnib|tipifarnib|mesh-list
19765622|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19765623|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765624|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19765625|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19765626|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
20610215|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610216|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316177|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316178|NCT00703235|Bevacizumab|bevacizumab|mesh-list
19765627|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765628|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765629|NCT00082888|Tipifarnib|tipifarnib|mesh-list
19765630|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765631|NCT00083122|Cisplatin|cisplatin|mesh-list
19765632|NCT00083122|Alvocidib|alvocidib|mesh-list
19765633|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765634|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765635|NCT00083122|Growth Substances|growth substances|mesh-ancestor
19765636|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765637|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20316179|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316180|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316181|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20316182|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20610217|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20610218|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
19765638|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765639|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765640|NCT00083174|Exemestane|exemestane|mesh-list
20316183|NCT00703235|Growth Substances|growth substances|mesh-ancestor
20610219|NCT03715127|Psilocybin|psilocybin|mesh-list
20610220|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
20610221|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610222|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20610223|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20610224|NCT03682289|Olaparib|olaparib|mesh-list
20610225|NCT03682289|Adenosine|adenosine|mesh-list
20610226|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20610227|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610228|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610229|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610230|NCT03682289|Analgesics|analgesics|mesh-ancestor
20610231|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
19765641|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765642|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19765643|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19765644|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765645|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765646|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19765647|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
19765648|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765649|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765650|NCT00083226|Doxorubicin|doxorubicin|mesh-list
19765651|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19765652|NCT00083226|Bortezomib|bortezomib|mesh-list
19765653|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19765654|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765655|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19765656|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765657|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610232|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610233|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610234|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20610235|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
20610236|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20610237|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
20610238|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
20610239|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610240|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
20610241|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
20610242|NCT03670966|Fludarabine|fludarabine|mesh-list
20610243|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
20610244|NCT03670966|Tacrolimus|tacrolimus|mesh-list
20610245|NCT03670966|Antibodies|antibodies|mesh-list
20610246|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610247|NCT03670966|Sargramostim|sargramostim|mesh-list
20610248|NCT03670966|Lenograstim|lenograstim|mesh-list
20610249|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765658|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765659|NCT00083382|Pamidronate|pamidronate|mesh-list
20148577|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20148578|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20148579|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20148580|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20148581|NCT00080340|Gefitinib|gefitinib|mesh-list
20148582|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148583|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148584|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148585|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610250|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
19634697|NCT02432781|Insulin|insulin|mesh-list
19634698|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19634699|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634700|NCT02432599|Choline|choline|mesh-list
19634701|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
19634702|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19634703|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
19634704|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634705|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634706|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19634707|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
19634708|NCT02432534|Atorvastatin|atorvastatin|mesh-list
19634709|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19634710|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19634711|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
20610251|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148586|NCT00080405|Bortezomib|bortezomib|mesh-list
20148587|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148588|NCT00080418|Paclitaxel|paclitaxel|mesh-list
20148589|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148590|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765660|NCT00083382|Thalidomide|thalidomide|mesh-list
19765661|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765662|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
20316184|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316185|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765663|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610252|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20610253|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20610254|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
19765664|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
19765665|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765666|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765667|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765668|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765669|NCT00083382|Growth Substances|growth substances|mesh-ancestor
19765670|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765671|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634712|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634713|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19634714|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20316186|NCT00703300|Bortezomib|bortezomib|mesh-list
20316187|NCT00703300|Decitabine|decitabine|mesh-list
20316188|NCT00703300|Azacitidine|azacitidine|mesh-list
20316189|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316190|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316191|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
20316192|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316193|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316194|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
20316195|NCT00703313|Levofloxacin|levofloxacin|mesh-list
19634715|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765672|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19765673|NCT00083551|Interferons|interferons|mesh-list
20610255|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610256|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610257|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20610258|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610259|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
20610260|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610261|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20148591|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316196|NCT00703313|Ofloxacin|ofloxacin|mesh-list
20316197|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
20316198|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20316199|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20316200|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20316201|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610262|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610263|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20610264|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20610265|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
20610266|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610267|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20610268|NCT03641313|Irinotecan|irinotecan|mesh-list
19765674|NCT00083551|Cytarabine|cytarabine|mesh-list
19765675|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
20148592|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148593|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148594|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148595|NCT00080431|Daclizumab|daclizumab|mesh-list
20148596|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148597|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
20148598|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765676|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
19765677|NCT00083551|Thalidomide|thalidomide|mesh-list
20612238|NCT02250820|Pentobarbital|pentobarbital|mesh-list
20148599|NCT00080444|Dexamethasone|dexamethasone|mesh-list
20316202|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765678|NCT00083551|Dexamethasone|dexamethasone|mesh-list
19765679|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
19765680|NCT00083551|Melphalan|melphalan|mesh-list
19765681|NCT00083551|Carmustine|carmustine|mesh-list
19765682|NCT00083551|Cisplatin|cisplatin|mesh-list
19765683|NCT00083551|Doxorubicin|doxorubicin|mesh-list
20610269|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20610270|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20610271|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610272|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765684|NCT00083551|Etoposide|etoposide|mesh-list
19765685|NCT00083551|Vincristine|vincristine|mesh-list
19765686|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765687|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
19765688|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765689|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20610273|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610274|NCT03637972|Nicotine|nicotine|mesh-list
20610275|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20610276|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
20610277|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610278|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610279|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19765690|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19765691|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
19765692|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765693|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765694|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19765695|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765696|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
19765697|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
19765698|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765699|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19765700|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
19765701|NCT00083551|Hormones|hormones|mesh-ancestor
19765702|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765703|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148600|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
20148601|NCT00080444|Ondansetron|ondansetron|mesh-list
20148602|NCT00080444|Aprepitant|aprepitant|mesh-list
20316203|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20316204|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20316205|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316206|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316207|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316208|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20316209|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
20316210|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20316211|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316212|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20316213|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20316214|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20316215|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20316216|NCT00703313|Renal Agents|renal agents|mesh-ancestor
20316217|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20316218|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20316219|NCT00703352|Eplerenone|eplerenone|mesh-list
20316220|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20316221|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
20316222|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765704|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148603|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
20148604|NCT00080444|BB 1101|bb 1101|mesh-list
20148605|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148606|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
20148607|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
20148608|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20148609|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148610|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20148611|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
20148612|NCT00080444|Hormones|hormones|mesh-ancestor
20148613|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765705|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19765706|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148614|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20316223|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316224|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20316225|NCT00703352|Diuretics|diuretics|mesh-ancestor
20316226|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
20316227|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20316228|NCT00703365|Gemcitabine|gemcitabine|mesh-list
20316229|NCT00703365|Sorafenib|sorafenib|mesh-list
20316230|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316231|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
20316232|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148615|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148616|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
20148617|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148618|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148619|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
20148620|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316233|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316234|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
19765707|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765708|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19765709|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
19765710|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765711|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765712|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
19765713|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765714|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765715|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610280|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20610281|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
20610282|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610283|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610284|NCT03623854|Nivolumab|nivolumab|mesh-list
20610285|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
20610286|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
20610287|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610288|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610289|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610290|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610291|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
20148621|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20148622|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
20148623|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148624|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20148625|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20148626|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20148627|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20148628|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20148629|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20148630|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
20148631|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20148632|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148633|NCT00080496|Imipenem|imipenem|mesh-list
20148634|NCT00080496|Tigecycline|tigecycline|mesh-list
20148635|NCT00080496|Cilastatin|cilastatin|mesh-list
20148636|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20148637|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148638|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20148639|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148640|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148641|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
20148642|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
20148643|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148644|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148645|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148646|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148647|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316235|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610292|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610293|NCT03617328|Poly ICLC|poly iclc|mesh-list
20610294|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
19765716|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
20148648|NCT00080522|Ritonavir|ritonavir|mesh-list
20610295|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610296|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
20610297|NCT03587311|Paclitaxel|paclitaxel|mesh-list
20610298|NCT03587311|Maytansine|maytansine|mesh-list
20610299|NCT03587311|Bevacizumab|bevacizumab|mesh-list
20610300|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20610301|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20610302|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
20610303|NCT03587311|Antibodies|antibodies|mesh-list
20610304|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
20610305|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610306|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
20610307|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610308|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610309|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
20610310|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148649|NCT00080522|Lopinavir|lopinavir|mesh-list
20148650|NCT00080522|Lamivudine|lamivudine|mesh-list
20148651|NCT00080522|Zidovudine|zidovudine|mesh-list
20148652|NCT00080522|Stavudine|stavudine|mesh-list
20148653|NCT00080522|Didanosine|didanosine|mesh-list
20148654|NCT00080522|Efavirenz|efavirenz|mesh-list
20148655|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19634723|NCT02432612|Nabiximols|nabiximols|mesh-list
19634724|NCT02432612|Analgesics|analgesics|mesh-ancestor
19634725|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
19634726|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634727|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634728|NCT02432677|Remifentanil|remifentanil|mesh-list
19634729|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19634730|NCT02432677|Narcotics|narcotics|mesh-ancestor
19634731|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634732|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634733|NCT02432677|Analgesics|analgesics|mesh-ancestor
19634734|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
20148656|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20148657|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
20148658|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148659|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148660|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20148661|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19634735|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610311|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148662|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
20148663|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148664|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20148665|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20148666|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20148667|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20148668|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
20148669|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20148670|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20148671|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20148672|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20148673|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20148674|NCT00080613|Exemestane|exemestane|mesh-list
20148675|NCT00080613|Hormones|hormones|mesh-list
20148676|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148677|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148678|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148679|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20148680|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20148681|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148682|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610312|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148683|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20610313|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20610314|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20610315|NCT03587311|Growth Substances|growth substances|mesh-ancestor
20610316|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634736|NCT02432651|Xanthohumol|xanthohumol|mesh-list
20610317|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
20610318|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
20610319|NCT03573947|Paclitaxel|paclitaxel|mesh-list
20610320|NCT03573947|Nivolumab|nivolumab|mesh-list
20610321|NCT03573947|Ipilimumab|ipilimumab|mesh-list
20148684|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
20148685|NCT00080626|Docetaxel|docetaxel|mesh-list
20148686|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148687|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148688|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148689|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148690|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148691|NCT00080665|Docetaxel|docetaxel|mesh-list
20148692|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
20148693|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148694|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148695|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148696|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148697|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148698|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148699|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148700|NCT00080678|Docetaxel|docetaxel|mesh-list
20148701|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
20148702|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148703|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148704|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148705|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148706|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148707|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148708|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173899|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20173900|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173901|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173902|NCT00162916|Citalopram|citalopram|mesh-list
20173903|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20173904|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20173905|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173906|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173907|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173908|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
20173909|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173910|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20173911|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
20173912|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20173913|NCT00162955|Valsartan|valsartan|mesh-list
20173914|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20173915|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20173916|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20173917|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173918|NCT00162968|Citalopram|citalopram|mesh-list
20173919|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20173920|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20173921|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173922|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173923|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173924|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
20173925|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173926|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20173927|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
20173928|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20173929|NCT00163046|Gabapentin|gabapentin|mesh-list
20173930|NCT00163046|Analgesics|analgesics|mesh-ancestor
20173931|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
20173932|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316236|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316237|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610322|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610323|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148709|NCT00080743|Tamoxifen|tamoxifen|mesh-list
20610324|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316238|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
20316239|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316240|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20316241|NCT00703378|Docetaxel|docetaxel|mesh-list
20316242|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316243|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316244|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316245|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316246|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316247|NCT00703430|Memantine|memantine|mesh-list
20316248|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20148710|NCT00080743|Gefitinib|gefitinib|mesh-list
20148711|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148712|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20148713|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
20148714|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148715|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148716|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148717|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148718|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20148719|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20148720|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20148721|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148722|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316249|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20316250|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
20316251|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316252|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316253|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316254|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20316255|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20316256|NCT00703469|Nivolumab|nivolumab|mesh-list
20316257|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316258|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316259|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20316260|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316261|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
20316262|NCT00703482|Ubiquinone|ubiquinone|mesh-list
20316263|NCT00703482|Fenofibrate|fenofibrate|mesh-list
20148723|NCT00080782|Celecoxib|celecoxib|mesh-list
20148724|NCT00080782|Doxorubicin|doxorubicin|mesh-list
20148725|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20148726|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148727|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148728|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148729|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148730|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148731|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148732|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20148733|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20148734|NCT00080782|Analgesics|analgesics|mesh-ancestor
20148735|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
20148736|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316264|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20316265|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
20610325|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610326|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610327|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610328|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610329|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610330|NCT03561870|Olaparib|olaparib|mesh-list
20610331|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20610332|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610333|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610334|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610335|NCT03530267|Aflibercept|aflibercept|mesh-list
20610336|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20610337|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765717|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765718|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765719|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765720|NCT00083551|Growth Substances|growth substances|mesh-ancestor
20148737|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316266|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148738|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148739|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148740|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20148741|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20148742|NCT00080795|Gemcitabine|gemcitabine|mesh-list
20148743|NCT00080795|Doxorubicin|doxorubicin|mesh-list
20148744|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20148745|NCT00080795|Ifosfamide|ifosfamide|mesh-list
20148746|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148747|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148748|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
20148749|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148750|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
20148751|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148752|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148753|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148754|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
20148755|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148756|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148757|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148758|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148759|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148760|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
20148761|NCT00080808|Phentolamine|phentolamine|mesh-list
20148762|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
20148763|NCT00080808|Alprostadil|alprostadil|mesh-list
20148764|NCT00080808|Papaverine|papaverine|mesh-list
20148765|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148766|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
20148767|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20148768|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20148769|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148770|NCT00080808|Urological Agents|urological agents|mesh-ancestor
20148771|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20316267|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20316268|NCT00703482|Vitamins|vitamins|mesh-ancestor
20316269|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
20316270|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316271|NCT00703586|Maraviroc|maraviroc|mesh-list
20316272|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20316273|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20316274|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316275|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20316276|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20316277|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
20148772|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20148773|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
20148774|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20148775|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148776|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20148777|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20148778|NCT00080847|Prednisone|prednisone|mesh-list
20148779|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
20148780|NCT00080847|Rituximab|rituximab|mesh-list
20148781|NCT00080847|Doxorubicin|doxorubicin|mesh-list
20148782|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20148783|NCT00080847|Vincristine|vincristine|mesh-list
20148784|NCT00080847|Oblimersen|oblimersen|mesh-list
19634737|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634738|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19634739|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19634740|NCT02432651|Growth Substances|growth substances|mesh-ancestor
19634741|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634742|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
19634743|NCT02433795|Rituximab|rituximab|mesh-list
19634744|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19634745|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148785|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148786|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
20316278|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316279|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20316280|NCT00703625|Sirolimus|sirolimus|mesh-list
20316281|NCT00703625|Docetaxel|docetaxel|mesh-list
20316282|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316283|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316284|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
19634746|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634747|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
19634748|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634749|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19634750|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19634751|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
19765721|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765722|NCT00083616|Panitumumab|panitumumab|mesh-list
19765723|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765724|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765725|NCT00083720|Cetuximab|cetuximab|mesh-list
19765726|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765727|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765728|NCT00083889|Interferons|interferons|mesh-list
19765729|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
19765730|NCT00083889|Sunitinib|sunitinib|mesh-list
19765731|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765732|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
19765733|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765734|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
19765735|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765736|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765737|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19765738|NCT00083889|Growth Substances|growth substances|mesh-ancestor
19765739|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19765740|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148787|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610338|NCT03530267|Growth Substances|growth substances|mesh-ancestor
20610339|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610340|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
20610341|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610342|NCT03529110|Trastuzumab|trastuzumab|mesh-list
20610343|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20610344|NCT03529110|Maytansine|maytansine|mesh-list
20610345|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610346|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610347|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610348|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
19634752|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148788|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148789|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148790|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
20148791|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148792|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148793|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20148794|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148795|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148796|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148797|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148798|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148799|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148800|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
20148801|NCT00080847|Hormones|hormones|mesh-ancestor
20148802|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148803|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148804|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148805|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148806|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148807|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316285|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
19634753|NCT02432664|Midazolam|midazolam|mesh-list
19634754|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19634755|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19634756|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19765741|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610349|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765742|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634757|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634758|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20610350|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610351|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610352|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
20610353|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20610354|NCT03524417|Antibodies|antibodies|mesh-list
20610355|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
20610356|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610357|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
20610358|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20610359|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610360|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20610361|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20610362|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
20610363|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610364|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20610365|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19634759|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19634760|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19634761|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19634762|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
19634763|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
19634764|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
19634765|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
19634766|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634767|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634768|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
19634769|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19634770|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634771|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20610366|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610367|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20610368|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20610369|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20610370|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610371|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
20610372|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634772|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
19634773|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634774|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634775|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634776|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634777|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19634778|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19634779|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
20610373|NCT03497156|Lercanidipine|lercanidipine|mesh-list
20610374|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20610375|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20148808|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20148809|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20148810|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148811|NCT00080886|Cytarabine|cytarabine|mesh-list
20148812|NCT00080886|Rituximab|rituximab|mesh-list
20148813|NCT00080886|Etoposide|etoposide|mesh-list
20148814|NCT00080886|Melphalan|melphalan|mesh-list
20148815|NCT00080886|Carmustine|carmustine|mesh-list
20148816|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148817|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148818|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
20148819|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148820|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148821|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148822|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148823|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148824|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634780|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316286|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316287|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316288|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316289|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148825|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148826|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148827|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
20148828|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
20148829|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148830|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148831|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148832|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
20148833|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20148834|NCT00080925|Cytarabine|cytarabine|mesh-list
20148835|NCT00080925|Cyclosporine|cyclosporine|mesh-list
20148836|NCT00080925|Prednisone|prednisone|mesh-list
20148837|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
20148838|NCT00080925|Rituximab|rituximab|mesh-list
20148839|NCT00080925|Doxorubicin|doxorubicin|mesh-list
20148840|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20148841|NCT00080925|Fludarabine|fludarabine|mesh-list
20148842|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
20148843|NCT00080925|Etoposide|etoposide|mesh-list
20148844|NCT00080925|Vincristine|vincristine|mesh-list
20148845|NCT00080925|Cyclosporins|cyclosporins|mesh-list
20148846|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148847|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
20148848|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148849|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148850|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148851|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
20148852|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148853|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148854|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20316290|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
20316291|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316292|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
20316293|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316294|NCT00703638|Pemetrexed|pemetrexed|mesh-list
20316295|NCT00703638|Sorafenib|sorafenib|mesh-list
20316296|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316297|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316298|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316299|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20316300|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20316301|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20316302|NCT00703651|Vaccines|vaccines|mesh-list
19634781|NCT02432365|Paclitaxel|paclitaxel|mesh-list
20148855|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148856|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20148857|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20148858|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148859|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148860|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148861|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
20148862|NCT00080925|Hormones|hormones|mesh-ancestor
20148863|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20148864|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20148865|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148866|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
20148867|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148868|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
20148869|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148870|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148871|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148872|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148873|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
20148874|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
20148875|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20148876|NCT00080951|Leucovorin|leucovorin|mesh-list
20148877|NCT00080951|Fluorouracil|fluorouracil|mesh-list
20148878|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
20148879|NCT00080951|Irinotecan|irinotecan|mesh-list
20148880|NCT00080951|Calcium|calcium|mesh-list
20148881|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
20148882|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20148883|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148884|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
20316303|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
20316304|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316305|NCT00703690|Fenofibrate|fenofibrate|mesh-list
20316306|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20316307|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
20316308|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316309|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20610376|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20610377|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610378|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20316310|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20316311|NCT00703703|Darifenacin|darifenacin|mesh-list
20316312|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20610379|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610380|NCT03497143|Lamotrigine|lamotrigine|mesh-list
20610381|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
20610382|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20610383|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20610384|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610385|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20610386|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610387|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20610388|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19765743|NCT00084136|Tenofovir|tenofovir|mesh-list
19765744|NCT00084136|Lamivudine|lamivudine|mesh-list
19765745|NCT00084136|Zidovudine|zidovudine|mesh-list
19765746|NCT00084136|Emtricitabine|emtricitabine|mesh-list
19765747|NCT00084136|Efavirenz|efavirenz|mesh-list
19765748|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19765749|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19765750|NCT00084136|Didanosine|didanosine|mesh-list
19765751|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20148885|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610389|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20610390|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20610391|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20610392|NCT03479684|Warfarin|warfarin|mesh-list
20610393|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
20610394|NCT03466151|Sirolimus|sirolimus|mesh-list
20610395|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610396|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610397|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20610398|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610399|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
20610400|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610401|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
20610402|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610403|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
20610404|NCT03463460|Sunitinib|sunitinib|mesh-list
20610405|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610406|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610407|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20610408|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20610409|NCT03463460|Growth Substances|growth substances|mesh-ancestor
20610410|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610411|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
20610412|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20610413|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610414|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612239|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
20612240|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20612241|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19765752|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
19765753|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148886|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148887|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148888|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148889|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
20148890|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20148891|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20148892|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316313|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20148893|NCT00080951|Antidotes|antidotes|mesh-ancestor
20316314|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
20610415|NCT03440190|Methylphenidate|methylphenidate|mesh-list
20610416|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20610417|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610418|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20610419|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20610420|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20610421|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610422|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
20610423|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610424|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
19765754|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19765755|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19765756|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765757|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148894|NCT00080951|Protective Agents|protective agents|mesh-ancestor
20148895|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
20148896|NCT00080951|Vitamins|vitamins|mesh-ancestor
20148897|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
20148898|NCT00080977|Aldesleukin|aldesleukin|mesh-list
20148899|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148900|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20148901|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20148902|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
20148903|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316315|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316316|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634782|NCT02432365|Cisplatin|cisplatin|mesh-list
20148904|NCT00080990|Leucovorin|leucovorin|mesh-list
20148905|NCT00080990|Fluorouracil|fluorouracil|mesh-list
20148906|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
20148907|NCT00080990|Alvocidib|alvocidib|mesh-list
20148908|NCT00080990|Calcium|calcium|mesh-list
20148909|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
20148910|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20148911|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148912|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
20148913|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148914|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148915|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148916|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148917|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
20148918|NCT00080990|Antidotes|antidotes|mesh-ancestor
20148919|NCT00080990|Protective Agents|protective agents|mesh-ancestor
20148920|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
20148921|NCT00080990|Vitamins|vitamins|mesh-ancestor
20148922|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
20148923|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20148924|NCT00080990|Growth Substances|growth substances|mesh-ancestor
20148925|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148926|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148927|NCT00081042|Paclitaxel|paclitaxel|mesh-list
20148928|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20148929|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20148930|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148931|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148932|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148933|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
19634783|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19634784|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634785|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
19634786|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
19634787|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
19634788|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148934|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610425|NCT03393845|Fulvestrant|fulvestrant|mesh-list
19634789|NCT02432053|Tacrolimus|tacrolimus|mesh-list
19634790|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634791|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
19634792|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634793|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19634794|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634795|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148935|NCT00081055|Cyclosporine|cyclosporine|mesh-list
20148936|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
20148937|NCT00081055|Busulfan|busulfan|mesh-list
20148938|NCT00081055|Methotrexate|methotrexate|mesh-list
19765758|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19765759|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19765760|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
20610426|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610427|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610428|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610429|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20610430|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20610431|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
20610432|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610433|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610434|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
20610435|NCT03391466|Fludarabine|fludarabine|mesh-list
19765761|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19765762|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19765763|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20148939|NCT00081055|Cyclosporins|cyclosporins|mesh-list
20148940|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20148941|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
20148942|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148943|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148944|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20148945|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
20148946|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148947|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148948|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20148949|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20148950|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
20148951|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20148952|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20148953|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
20148954|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
20148955|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148956|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20148957|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19765764|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19765765|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19765766|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19765767|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19765768|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19765769|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
20148958|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
20610436|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610437|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
20148959|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20148960|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20148961|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
20148962|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20148963|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148964|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20148965|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20148966|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148967|NCT00081107|Epothilones|epothilones|mesh-list
20148968|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
20148969|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
20148970|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
20148971|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
20148972|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148973|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148974|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
20148975|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
20148976|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148977|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20148978|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20148979|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148980|NCT00081172|Antibodies|antibodies|mesh-list
20148981|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20148982|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
20148983|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148984|NCT00081224|Celecoxib|celecoxib|mesh-list
20148985|NCT00081224|Capecitabine|capecitabine|mesh-list
20610438|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148986|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316317|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316318|NCT00703703|Urological Agents|urological agents|mesh-ancestor
20316319|NCT00703742|Citalopram|citalopram|mesh-list
20316320|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20316321|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20316322|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20316323|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316324|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316325|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
20316326|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316327|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20316328|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
20316329|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20316330|NCT00703755|Metformin|metformin|mesh-list
20610439|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20610440|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20610441|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
20148987|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
20148988|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20148989|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20148990|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20148991|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20148992|NCT00081224|Analgesics|analgesics|mesh-ancestor
20148993|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
20148994|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20148995|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20148996|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20148997|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20148998|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20148999|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20149000|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149001|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
20149002|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149003|NCT00081276|Cisplatin|cisplatin|mesh-list
20149004|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149005|NCT00081302|Paclitaxel|paclitaxel|mesh-list
20149006|NCT00081302|Carboplatin|carboplatin|mesh-list
20149007|NCT00081302|Cetuximab|cetuximab|mesh-list
20149008|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20149009|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149010|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20149011|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
20149012|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149013|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149014|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20149015|NCT00081315|Amifostine|amifostine|mesh-list
20149016|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20149017|NCT00081315|Protective Agents|protective agents|mesh-ancestor
20149018|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149019|NCT00081380|Valproic Acid|valproic acid|mesh-list
20149020|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20149021|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
20149022|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
20149023|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20149024|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20149025|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20149026|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316331|NCT00703755|Fenofibrate|fenofibrate|mesh-list
20610442|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610443|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610444|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20610445|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
20610446|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610447|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610448|NCT03367741|Nivolumab|nivolumab|mesh-list
20610449|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610450|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610451|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610452|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149027|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316332|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19765770|NCT00084149|Ritonavir|ritonavir|mesh-list
19765771|NCT00084149|Lopinavir|lopinavir|mesh-list
19765772|NCT00084149|Lamivudine|lamivudine|mesh-list
19765773|NCT00084149|Zidovudine|zidovudine|mesh-list
20149028|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149029|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
20149030|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
20149031|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
20149032|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149033|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
20149034|NCT00081471|Hematinics|hematinics|mesh-ancestor
19765774|NCT00084149|Abacavir|abacavir|mesh-list
20149035|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
20149036|NCT00081484|Hematinics|hematinics|mesh-ancestor
20149037|NCT00081536|Capecitabine|capecitabine|mesh-list
20149038|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149039|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
20149040|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149041|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149042|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
20149043|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149044|NCT00081575|Levofloxacin|levofloxacin|mesh-list
20149045|NCT00081575|Ofloxacin|ofloxacin|mesh-list
20149046|NCT00081575|Tigecycline|tigecycline|mesh-list
20149047|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20149048|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149049|NCT00081575|Renal Agents|renal agents|mesh-ancestor
20149050|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149051|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149052|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149053|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149054|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149055|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149056|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20149057|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20149058|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20149059|NCT00081588|Darunavir|darunavir|mesh-list
20149060|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20149061|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20149062|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
20149063|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149064|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149065|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20149066|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20149067|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
20149068|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149069|NCT00081614|Bevacizumab|bevacizumab|mesh-list
20149070|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20149071|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20149072|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149073|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149074|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149075|NCT00081614|Growth Substances|growth substances|mesh-ancestor
20149076|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149077|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149078|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20149079|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149080|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149081|NCT00081744|Tigecycline|tigecycline|mesh-list
20149082|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149083|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149084|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20149085|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149086|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149087|NCT00081757|Thalidomide|thalidomide|mesh-list
20149088|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149089|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
20149090|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149091|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149092|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149093|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149094|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19765775|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19765776|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19765777|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
19765778|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149095|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149096|NCT00081757|Growth Substances|growth substances|mesh-ancestor
20610453|NCT03360721|Prednisone|prednisone|mesh-list
20610454|NCT03360721|Cortisone|cortisone|mesh-list
20610455|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
20610456|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20610457|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
20610458|NCT03360721|Hormones|hormones|mesh-ancestor
20610459|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610460|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610461|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610462|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610463|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20610464|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610465|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610466|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
20610467|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20610468|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610469|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
20610470|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610471|NCT03347331|Befiradol|befiradol|mesh-list
20610472|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20149097|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149098|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149099|NCT00081796|Capecitabine|capecitabine|mesh-list
20149100|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149101|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
20149102|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149103|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149104|NCT00081822|Cytarabine|cytarabine|mesh-list
20149105|NCT00081822|Clofarabine|clofarabine|mesh-list
20149106|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149107|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
20149108|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149109|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149110|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
20149111|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149112|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149113|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
20149114|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149115|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
20149116|NCT00081835|Antibodies|antibodies|mesh-list
20149117|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
20149118|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20149119|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20149120|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
20149121|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149122|NCT00081848|Metronidazole|metronidazole|mesh-list
20149123|NCT00081848|Celecoxib|celecoxib|mesh-list
20149124|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20149125|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20149126|NCT00081848|Analgesics|analgesics|mesh-ancestor
20149127|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
20149128|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149129|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634796|NCT02432027|Betamethasone|betamethasone|mesh-list
19634797|NCT02432027|Calcipotriene|calcipotriene|mesh-list
19634798|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634799|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
19634800|NCT02432027|Hormones|hormones|mesh-ancestor
19634801|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634802|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634803|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19634804|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
19634805|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
19662061|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662062|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
19662063|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662064|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
19662065|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662066|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20610473|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20610474|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
19662067|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149130|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149131|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149132|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20149133|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20149134|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149135|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149136|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149137|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634806|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
19634807|NCT02432261|ST 1435|st 1435|mesh-list
19634808|NCT02432261|Testosterone|testosterone|mesh-list
19634809|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
19634810|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
19634811|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20149138|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20149139|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20149140|NCT00081874|Everolimus|everolimus|mesh-list
20149141|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149142|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149143|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
20149144|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149145|NCT00081887|Clofarabine|clofarabine|mesh-list
20149146|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149147|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
20149148|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149149|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149150|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
20149151|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20149152|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149153|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
20149154|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149155|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20149156|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149157|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149158|NCT00081978|Etravirine|etravirine|mesh-list
20149159|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20149160|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20149161|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149162|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149163|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
20149164|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149165|NCT00082043|Dutasteride|dutasteride|mesh-list
20149166|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20149167|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20149168|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149169|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149170|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
20149171|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149172|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149173|NCT00082082|Thymalfasin|thymalfasin|mesh-list
20149174|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20149175|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
20149176|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149177|NCT00082095|Doxorubicin|doxorubicin|mesh-list
20149178|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20149179|NCT00082095|Capecitabine|capecitabine|mesh-list
20149180|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20149181|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149182|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149183|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149184|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149185|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149186|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149187|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
20149188|NCT00082186|Bosentan|bosentan|mesh-list
20149189|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19634812|NCT02432261|Androgens|androgens|mesh-ancestor
19634813|NCT02432261|Hormones|hormones|mesh-ancestor
19634814|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634815|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634816|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149190|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19634817|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610475|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610476|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610477|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610478|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
20610479|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610480|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610481|NCT03300557|Exemestane|exemestane|mesh-list
20610482|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149191|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149192|NCT00082199|Aripiprazole|aripiprazole|mesh-list
20149193|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
20149194|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20149195|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20149196|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20149197|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20149198|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149199|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
20149200|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
20149201|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149202|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149203|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20149204|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20149205|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
20149206|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20149207|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20149208|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20149209|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20149210|NCT00082212|Cetuximab|cetuximab|mesh-list
20149211|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20149212|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149213|NCT00082225|Antibodies|antibodies|mesh-list
20149214|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
20149215|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149216|NCT00082251|Niacin|niacin|mesh-list
20149217|NCT00082251|Simvastatin|simvastatin|mesh-list
20149218|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20149219|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20149220|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
20149221|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149222|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20149223|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20149224|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149225|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
20149226|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
20149227|NCT00082251|Vitamins|vitamins|mesh-ancestor
20149228|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
20149229|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149230|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
20149231|NCT00082277|Anastrozole|anastrozole|mesh-list
20149232|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149233|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149234|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20149235|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20149236|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149237|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149238|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20610483|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20610484|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20610485|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610486|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610487|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20610488|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
20610489|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610490|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610491|NCT03298893|Nivolumab|nivolumab|mesh-list
20610492|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610493|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610494|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610495|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610496|NCT03298451|Sorafenib|sorafenib|mesh-list
20610497|NCT03298451|Durvalumab|durvalumab|mesh-list
20610498|NCT03298451|Tremelimumab|tremelimumab|mesh-list
20610499|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610500|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610501|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20610502|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610503|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610504|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610505|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
20610506|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610507|NCT03289351|Tazobactam|tazobactam|mesh-list
20610508|NCT03289351|Piperacillin|piperacillin|mesh-list
20610509|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20610510|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610511|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610512|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20610513|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610514|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610515|NCT03287908|Dexamethasone|dexamethasone|mesh-list
20610516|NCT03287908|Pomalidomide|pomalidomide|mesh-list
20610517|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20610518|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
20610519|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
20610520|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610521|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610522|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20610523|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
20610524|NCT03287908|Hormones|hormones|mesh-ancestor
20610525|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610526|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610527|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610528|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
20149239|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
20149240|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149241|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149242|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20149243|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20149244|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20149245|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20149246|NCT00082316|Capsaicin|capsaicin|mesh-list
20149247|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
20149248|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
20149249|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
20149250|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149251|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149252|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20149253|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20149254|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20149255|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20149256|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
20149257|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149258|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610529|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20610530|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20610531|NCT03287908|Growth Substances|growth substances|mesh-ancestor
20610532|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
20610533|NCT03283488|Megestrol|megestrol|mesh-list
20149259|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20149260|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20149261|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
20149262|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149263|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20149264|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20149265|NCT00082446|Vaccines|vaccines|mesh-list
20149266|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
20149267|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316333|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316334|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20316335|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
20316336|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316337|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20316338|NCT00703807|Everolimus|everolimus|mesh-list
20316339|NCT00703807|Topotecan|topotecan|mesh-list
20316340|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316341|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316342|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
20610534|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
20610535|NCT03283488|Mirtazapine|mirtazapine|mesh-list
20610536|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
20610537|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20610538|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20610539|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
20610540|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
20610541|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610542|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610543|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610544|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20610545|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20610546|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20610547|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20610548|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20610549|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20610550|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
20610551|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20610552|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20610553|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
20610554|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20610555|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20610556|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19765779|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149268|NCT00082472|Docetaxel|docetaxel|mesh-list
20149269|NCT00082472|Doxorubicin|doxorubicin|mesh-list
20149270|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20149271|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149272|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
20149273|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
20149274|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149275|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149276|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20149277|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149278|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149279|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149280|NCT00082485|Baclofen|baclofen|mesh-list
20149281|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20149282|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149283|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20149284|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149285|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20149286|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
20149287|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
20149288|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149289|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149290|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20149291|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20149292|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
20149293|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149294|NCT00082524|Caspofungin|caspofungin|mesh-list
20149295|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
20149296|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149297|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149298|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149299|NCT00082537|Caspofungin|caspofungin|mesh-list
20149300|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20149301|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
20149302|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149303|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149304|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149305|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20149306|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20149307|NCT00082563|Azithromycin|azithromycin|mesh-list
20149308|NCT00082563|Chloroquine|chloroquine|mesh-list
20149309|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20149310|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149311|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149312|NCT00082563|Amebicides|amebicides|mesh-ancestor
20149313|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20149314|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20149315|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
20149316|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765780|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20149317|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19634818|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
19634819|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19634820|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
20610557|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19634821|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19833184|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
20149318|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20149319|NCT00082563|Analgesics|analgesics|mesh-ancestor
20149320|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
20149321|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149322|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149323|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149324|NCT00082563|Filaricides|filaricides|mesh-ancestor
20149325|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
20149326|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
20149327|NCT00082576|Azithromycin|azithromycin|mesh-list
20149328|NCT00082576|Chloroquine|chloroquine|mesh-list
20149329|NCT00082576|Mefloquine|mefloquine|mesh-list
20149330|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149331|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149332|NCT00082576|Amebicides|amebicides|mesh-ancestor
20149333|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20149334|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20149335|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
20149336|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173933|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173934|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
20173935|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20173936|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20173937|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20173938|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20173939|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20173940|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20173941|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173942|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173943|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
20173944|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
20173945|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20173946|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173947|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
20173948|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20173949|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173950|NCT00163111|Amphotericin B|amphotericin b|mesh-list
20173951|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20173952|NCT00163111|Fluconazole|fluconazole|mesh-list
20173953|NCT00163111|Amebicides|amebicides|mesh-ancestor
20173954|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20173955|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20173956|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173957|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20173958|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
20173959|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20173960|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20173961|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173962|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173963|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20173964|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
20173965|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634822|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19634823|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
19634824|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19634825|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19634826|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
19634827|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634828|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634829|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634830|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
19634831|NCT02431988|Fludarabine|fludarabine|mesh-list
19634832|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19634833|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
19634834|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634835|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662068|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
20173966|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610558|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
20610559|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20610560|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20610561|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20610562|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610563|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765781|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19765782|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
19765783|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765784|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19765785|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19765786|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19765787|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19765788|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
19765789|NCT00084266|Vancomycin|vancomycin|mesh-list
19765790|NCT00084266|Linezolid|linezolid|mesh-list
19765791|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765792|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765793|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20149337|NCT00082589|Eplerenone|eplerenone|mesh-list
19765794|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765795|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765796|NCT00084318|Docetaxel|docetaxel|mesh-list
19765797|NCT00084318|Cetuximab|cetuximab|mesh-list
19765798|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765799|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765800|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
19765801|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765802|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149338|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20149339|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
20149340|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149341|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149342|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20149343|NCT00082589|Diuretics|diuretics|mesh-ancestor
20149344|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
20149345|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20149346|NCT00082602|Galantamine|galantamine|mesh-list
20149347|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19634836|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19634837|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
19634838|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634839|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634840|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19634841|NCT02431975|Ritonavir|ritonavir|mesh-list
19634842|NCT02431975|Lopinavir|lopinavir|mesh-list
19634843|NCT02431975|Lamivudine|lamivudine|mesh-list
19765803|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19765804|NCT00084409|Iloprost|iloprost|mesh-list
19765805|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19765806|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
19765807|NCT00084617|Capecitabine|capecitabine|mesh-list
19765808|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
19765809|NCT00084617|Irinotecan|irinotecan|mesh-list
19765810|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765811|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
19765812|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149348|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149349|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149350|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
20610564|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
20610565|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20610566|NCT03282916|Valacyclovir|valacyclovir|mesh-list
20610567|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
20610568|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610569|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
20149351|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149352|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149353|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20149354|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
20610570|NCT03257163|Capecitabine|capecitabine|mesh-list
20610571|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19634844|NCT02431975|Zidovudine|zidovudine|mesh-list
19634845|NCT02431975|Nevirapine|nevirapine|mesh-list
19634846|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19765813|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610572|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610573|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610574|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
20610575|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610576|NCT03250377|Brivaracetam|brivaracetam|mesh-list
20610577|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
20610578|NCT03249714|Ofatumumab|ofatumumab|mesh-list
20610579|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610580|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610581|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
20610582|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765814|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19765815|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765816|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765817|NCT00084682|Romidepsin|romidepsin|mesh-list
19765818|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19765819|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765820|NCT00084747|Bortezomib|bortezomib|mesh-list
19765821|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765822|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
19765823|NCT00084838|Leucovorin|leucovorin|mesh-list
19765824|NCT00084838|Cytarabine|cytarabine|mesh-list
19765825|NCT00084838|Dactinomycin|dactinomycin|mesh-list
19765826|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
19765827|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19765828|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19765829|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19765830|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
19765831|NCT00084838|Temozolomide|temozolomide|mesh-list
19765832|NCT00084838|Cisplatin|cisplatin|mesh-list
19765833|NCT00084838|Doxorubicin|doxorubicin|mesh-list
19765834|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19765835|NCT00084838|Methotrexate|methotrexate|mesh-list
19765836|NCT00084838|Etoposide|etoposide|mesh-list
19765837|NCT00084838|Vincristine|vincristine|mesh-list
19765838|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
19765839|NCT00084838|Razoxane|razoxane|mesh-list
19765840|NCT00084838|Lenograstim|lenograstim|mesh-list
19765841|NCT00084838|Calcium|calcium|mesh-list
19634847|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19634848|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
19634849|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634850|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765842|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
19765843|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765844|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
20149355|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149356|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
20610583|NCT03233711|Nivolumab|nivolumab|mesh-list
20610584|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19634851|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19634852|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19634853|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
19634854|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634855|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19634856|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19634857|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19634858|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19634859|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
19634860|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20610585|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765845|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149357|NCT00082667|Gefitinib|gefitinib|mesh-list
20149358|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149359|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20149360|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149361|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149362|NCT00082719|Interferons|interferons|mesh-list
20149363|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
20149364|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
20149365|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149366|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
19765846|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765847|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19765848|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
20149367|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149368|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
20610586|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610587|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610588|NCT03228069|Vaccines|vaccines|mesh-list
20610589|NCT03228069|Immunologic Factors|immunologic factors|mesh-ancestor
20610590|NCT03228069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610591|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
20610592|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
20610593|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610594|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610595|NCT03178149|Tacrolimus|tacrolimus|mesh-list
20610596|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610597|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
20610598|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610599|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20610600|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610601|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610602|NCT03176953|Topiramate|topiramate|mesh-list
20610603|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
20610604|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20610605|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610606|NCT03174197|Temozolomide|temozolomide|mesh-list
20610607|NCT03174197|Atezolizumab|atezolizumab|mesh-list
20610608|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610609|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20610610|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
20610611|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610612|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610613|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
20610614|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610615|NCT03170882|Dexamethasone|dexamethasone|mesh-list
20610616|NCT03170882|Pomalidomide|pomalidomide|mesh-list
19765849|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765850|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765851|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19765852|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19765853|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19765854|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765855|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765856|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19765857|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19765858|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19765859|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
20610617|NCT03170882|Ixazomib|ixazomib|mesh-list
20610618|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20610619|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
20610620|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
20610621|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610622|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610623|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20610624|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
20610625|NCT03170882|Hormones|hormones|mesh-ancestor
20610626|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765860|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19765861|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765862|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
19765863|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
19765864|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19765865|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20610627|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610628|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149369|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149370|NCT00082784|Bortezomib|bortezomib|mesh-list
20610629|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
20610630|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20610631|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20610632|NCT03170882|Growth Substances|growth substances|mesh-ancestor
20610633|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
20610634|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
20610635|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610636|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610637|NCT03165994|Paclitaxel|paclitaxel|mesh-list
20610638|NCT03165994|Carboplatin|carboplatin|mesh-list
20610639|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610640|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610641|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
20610642|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610643|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610644|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610645|NCT03126435|Gemcitabine|gemcitabine|mesh-list
20610646|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610647|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
20610648|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610649|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610650|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
20610651|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610652|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610653|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610654|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
20610655|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610656|NCT03092674|Cytarabine|cytarabine|mesh-list
20610657|NCT03092674|Nivolumab|nivolumab|mesh-list
20610658|NCT03092674|Azacitidine|azacitidine|mesh-list
20610659|NCT03092674|Decitabine|decitabine|mesh-list
20610660|NCT03092674|Midostaurin|midostaurin|mesh-list
20610661|NCT03092674|Staurosporine|staurosporine|mesh-list
20610662|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610663|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610664|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610665|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610666|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610667|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
20610668|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
20610669|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610670|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610671|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
20610672|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610673|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610674|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20610675|NCT03074318|Avelumab|avelumab|mesh-list
20610676|NCT03074318|Trabectedin|trabectedin|mesh-list
20610677|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610678|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316343|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316344|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20610679|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610680|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149371|NCT00082784|Alvocidib|alvocidib|mesh-list
20149372|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149373|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149374|NCT00082784|Growth Substances|growth substances|mesh-ancestor
20149375|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610681|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
20612242|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634861|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19634862|NCT02431936|Prazosin|prazosin|mesh-list
19634863|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20149376|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20316345|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20316346|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316347|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316348|NCT00703872|Interferons|interferons|mesh-list
20316349|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610682|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610683|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
20610684|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610690|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
20610691|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20610692|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20610693|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
20610694|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20610695|NCT03043924|Estradiol|estradiol|mesh-list
20610696|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20610697|NCT03043924|Cyproterone|cyproterone|mesh-list
20610698|NCT03043924|Estrogens|estrogens|mesh-ancestor
20610699|NCT03043924|Hormones|hormones|mesh-ancestor
20610700|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610701|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610702|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20610703|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
20610704|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20610705|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20610706|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20610707|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20610708|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20610709|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
20610710|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
20610711|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610712|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20610713|NCT03041740|Perflubron|perflubron|mesh-list
20610714|NCT03041740|Bromides|bromides|mesh-list
20610715|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
20610716|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20610717|NCT03033576|Nivolumab|nivolumab|mesh-list
20610718|NCT03033576|Ipilimumab|ipilimumab|mesh-list
20610719|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610720|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610721|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610722|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610723|NCT02991456|Ondansetron|ondansetron|mesh-list
20610724|NCT02991456|Rolapitant|rolapitant|mesh-list
20610725|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
20316350|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
20316351|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316352|NCT00703898|Nevirapine|nevirapine|mesh-list
20316353|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20610726|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
20610727|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610728|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610729|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19765866|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19765867|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
19765868|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149377|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149378|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149379|NCT00082797|Leucovorin|leucovorin|mesh-list
20149380|NCT00082797|Methotrexate|methotrexate|mesh-list
20149381|NCT00082797|Calcium|calcium|mesh-list
20149382|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
20149383|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20149384|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149385|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20149386|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
20149387|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20149388|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149389|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
20149390|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149391|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610730|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
20610731|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
20610732|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20610733|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
20610734|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610735|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610736|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20610737|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20610738|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20610739|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20610740|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20610741|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20610742|NCT02983578|Durvalumab|durvalumab|mesh-list
20610743|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
20610744|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610745|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
20610746|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610747|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610748|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
20610749|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610750|NCT02940548|Amlodipine|amlodipine|mesh-list
20610751|NCT02940548|Nifedipine|nifedipine|mesh-list
20610752|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20610753|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20610754|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20610755|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610756|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20610757|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610758|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
20610759|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
20610760|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19765869|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19765870|NCT00084838|Antidotes|antidotes|mesh-ancestor
19765871|NCT00084838|Protective Agents|protective agents|mesh-ancestor
19765872|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
19765873|NCT00084838|Vitamins|vitamins|mesh-ancestor
19765874|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
19765875|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
19765876|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610761|NCT02921256|Leucovorin|leucovorin|mesh-list
20610762|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
20610763|NCT02921256|Fluorouracil|fluorouracil|mesh-list
20610764|NCT02921256|Capecitabine|capecitabine|mesh-list
20610765|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
20610766|NCT02921256|Veliparib|veliparib|mesh-list
20610767|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610768|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610769|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
20610770|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610771|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610772|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316354|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20316355|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610773|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
20610774|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634864|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19634865|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19765877|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
19765878|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765879|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19765880|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19634866|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19634867|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
19634868|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634869|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634870|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634871|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19634872|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19634873|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634874|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19634875|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634876|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634877|NCT02431728|Melatonin|melatonin|mesh-list
19765881|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20610775|NCT02921256|Antidotes|antidotes|mesh-ancestor
20610776|NCT02921256|Protective Agents|protective agents|mesh-ancestor
20610777|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
20610778|NCT02921256|Vitamins|vitamins|mesh-ancestor
20610779|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
20610780|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20610781|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610782|NCT02915016|Vaccines|vaccines|mesh-list
20610783|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20610784|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
20610785|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610786|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20610787|NCT02888743|Durvalumab|durvalumab|mesh-list
20610788|NCT02888743|Ipilimumab|ipilimumab|mesh-list
19765882|NCT00084864|Calcitriol|calcitriol|mesh-list
19765883|NCT00084864|Dexamethasone|dexamethasone|mesh-list
19765884|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765885|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
19765886|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
19765887|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19765888|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765889|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19765890|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
19765891|NCT00084864|Hormones|hormones|mesh-ancestor
19765892|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19765893|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19765894|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765895|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19765896|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19765897|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19765898|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765899|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19765900|NCT00084864|Vitamins|vitamins|mesh-ancestor
19765901|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
19765902|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19765903|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
19765904|NCT00085098|Cisplatin|cisplatin|mesh-list
19765905|NCT00085098|Carboplatin|carboplatin|mesh-list
19765906|NCT00085098|Etoposide|etoposide|mesh-list
19765907|NCT00085098|Lenograstim|lenograstim|mesh-list
19765908|NCT00085098|Sargramostim|sargramostim|mesh-list
19765909|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765910|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
19765911|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610789|NCT02888743|Tremelimumab|tremelimumab|mesh-list
20610790|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
20610791|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20610792|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
20610793|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610794|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610795|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
20610796|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610797|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20610798|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610799|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
20610800|NCT02883049|Leucovorin|leucovorin|mesh-list
20610801|NCT02883049|Folic Acid|folic acid|mesh-list
20610802|NCT02883049|Cytarabine|cytarabine|mesh-list
20610803|NCT02883049|Dexamethasone|dexamethasone|mesh-list
20610804|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
20610805|NCT02883049|Prednisone|prednisone|mesh-list
20610806|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
20610807|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20610808|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20610809|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20610810|NCT02883049|Cortisone|cortisone|mesh-list
20610811|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
20610812|NCT02883049|Doxorubicin|doxorubicin|mesh-list
20610813|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20610814|NCT02883049|Methotrexate|methotrexate|mesh-list
20610815|NCT02883049|Etoposide|etoposide|mesh-list
20610816|NCT02883049|Vincristine|vincristine|mesh-list
20610817|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
20610818|NCT02883049|Daunorubicin|daunorubicin|mesh-list
20610819|NCT02883049|Asparaginase|asparaginase|mesh-list
19765912|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765913|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20610820|NCT02883049|Dasatinib|dasatinib|mesh-list
20610821|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
20610822|NCT02883049|Clofarabine|clofarabine|mesh-list
20610823|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
20610824|NCT02883049|Pegaspargase|pegaspargase|mesh-list
20610825|NCT02883049|Thioguanine|thioguanine|mesh-list
20610826|NCT02883049|BB 1101|bb 1101|mesh-list
20610827|NCT02883049|Calcium|calcium|mesh-list
20610828|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
20610829|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
20610830|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610831|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
19765914|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
19765915|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765916|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765917|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19765918|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19765919|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19765920|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19765921|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765922|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19765923|NCT00085254|Temozolomide|temozolomide|mesh-list
19765924|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20316356|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316357|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
20316358|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765925|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
19765926|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765927|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765928|NCT00085293|Decitabine|decitabine|mesh-list
19765929|NCT00085293|Azacitidine|azacitidine|mesh-list
19765930|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19765931|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765932|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
19765933|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765934|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765935|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19765936|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19765937|NCT00085410|Bortezomib|bortezomib|mesh-list
19765938|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765939|NCT00085423|Aldesleukin|aldesleukin|mesh-list
19765940|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
19765941|NCT00085423|Fludarabine|fludarabine|mesh-list
19765942|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
20316359|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20316360|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19765943|NCT00085423|Interleukin-2|interleukin-2|mesh-list
19765944|NCT00085423|Molgramostim|molgramostim|mesh-list
19765945|NCT00085423|Sargramostim|sargramostim|mesh-list
19765946|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765947|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
19765948|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765949|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765950|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19765951|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
19765952|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765953|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765954|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19765955|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149392|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
20149393|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149394|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20149395|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765956|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
19765957|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19765958|NCT00085423|Analgesics|analgesics|mesh-ancestor
19765959|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
19765960|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149396|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
20149397|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149398|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20149399|NCT00082797|Antidotes|antidotes|mesh-ancestor
20149400|NCT00082797|Protective Agents|protective agents|mesh-ancestor
20149401|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
20149402|NCT00082797|Vitamins|vitamins|mesh-ancestor
20149403|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
20149404|NCT00082823|Aflibercept|aflibercept|mesh-list
20149405|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149406|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149407|NCT00082823|Growth Substances|growth substances|mesh-ancestor
20149408|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316361|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20610832|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765961|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19765962|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19765963|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
19765964|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765965|NCT00085436|Interferons|interferons|mesh-list
19765966|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
19765967|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
19765968|NCT00085436|Aldesleukin|aldesleukin|mesh-list
19765969|NCT00085436|Vaccines|vaccines|mesh-list
19765970|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
19765971|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765972|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765973|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
19765974|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316362|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20316363|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
20316364|NCT00703989|Benphothiamine|benphothiamine|mesh-list
20316365|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
20316366|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316367|NCT00703989|Protective Agents|protective agents|mesh-ancestor
19634878|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
20316368|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316369|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
20316370|NCT00703989|Vitamins|vitamins|mesh-ancestor
20316371|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
19634879|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765975|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19765976|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19765977|NCT00085540|Romidepsin|romidepsin|mesh-list
19765978|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19765979|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765980|NCT00085566|Everolimus|everolimus|mesh-list
19765981|NCT00085566|Gefitinib|gefitinib|mesh-list
19765982|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765983|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19765984|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
19765985|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19765986|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19765987|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610833|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19634880|NCT02431728|Protective Agents|protective agents|mesh-ancestor
19634881|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634882|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634883|NCT02431663|Ketamine|ketamine|mesh-list
19634884|NCT02431663|Analgesics|analgesics|mesh-ancestor
19634885|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
19634886|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634887|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149409|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149410|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149411|NCT00082836|Rituximab|rituximab|mesh-list
20149412|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20149413|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149414|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
20149415|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149416|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149417|NCT00082862|Gemcitabine|gemcitabine|mesh-list
20149418|NCT00082862|Interferons|interferons|mesh-list
20149419|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
20316372|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20316373|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
19634888|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19634889|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19765988|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316374|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
20316375|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
20316376|NCT00704080|Temozolomide|temozolomide|mesh-list
20316377|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20316378|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
20316379|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316380|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316381|NCT00704106|Entecavir|entecavir|mesh-list
20316382|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
20316383|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19765989|NCT00085644|Adalimumab|adalimumab|mesh-list
20149420|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149421|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316384|NCT00704145|Paclitaxel|paclitaxel|mesh-list
20610834|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20610835|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
20610836|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610837|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149422|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
20149423|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149424|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
20149425|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149426|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634890|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
19634891|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
19634892|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634893|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19634894|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19634895|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634896|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634897|NCT02431429|Miltefosine|miltefosine|mesh-list
20610838|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19765990|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19765991|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19765992|NCT00085709|Cytarabine|cytarabine|mesh-list
19765993|NCT00085709|Daunorubicin|daunorubicin|mesh-list
19765994|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
19765995|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19765996|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
19765997|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19765998|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19765999|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
19766000|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610839|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20610840|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
20610841|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
20610842|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610843|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20610844|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
20610845|NCT02883049|Hormones|hormones|mesh-ancestor
20610846|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20610847|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20610848|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
20610849|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610850|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20610851|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20610852|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20610853|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20610854|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20610855|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20610856|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
20610857|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20610858|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610859|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
20610860|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
20610861|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20610862|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20610863|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610864|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
20610865|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610866|NCT02883049|Antidotes|antidotes|mesh-ancestor
20610867|NCT02883049|Protective Agents|protective agents|mesh-ancestor
20610868|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
20610869|NCT02883049|Vitamins|vitamins|mesh-ancestor
20610870|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
20610871|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
19634898|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
19634899|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634900|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634901|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19634902|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19766001|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149427|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149428|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
20149429|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149430|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
20149431|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610872|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610873|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610874|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20610875|NCT02883049|Hematinics|hematinics|mesh-ancestor
20610876|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
20610877|NCT02871401|Valganciclovir|valganciclovir|mesh-list
20610878|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
20610879|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610880|NCT02801656|Vancomycin|vancomycin|mesh-list
20610881|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610882|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610883|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
20610884|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610885|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610886|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
20610887|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
20610888|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20610889|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
19766002|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
19766003|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766004|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19766005|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19766006|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19766007|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766008|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766009|NCT00085839|Paclitaxel|paclitaxel|mesh-list
19766010|NCT00085839|Carboplatin|carboplatin|mesh-list
19766011|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19766012|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19766013|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766014|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766015|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766016|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766017|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610890|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610891|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
20610892|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610893|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610894|NCT02684162|Guadecitabine|guadecitabine|mesh-list
20610895|NCT02684162|Azacitidine|azacitidine|mesh-list
20610896|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610897|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610898|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
20610899|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610900|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610901|NCT02661971|Leucovorin|leucovorin|mesh-list
20610902|NCT02661971|Docetaxel|docetaxel|mesh-list
20610903|NCT02661971|Fluorouracil|fluorouracil|mesh-list
20610904|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
20610905|NCT02661971|Ramucirumab|ramucirumab|mesh-list
20610906|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610907|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
20610908|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610909|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610910|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610911|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
20610912|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610913|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610914|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
20610915|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610916|NCT02661971|Antidotes|antidotes|mesh-ancestor
20610917|NCT02661971|Protective Agents|protective agents|mesh-ancestor
20610918|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
20610919|NCT02661971|Vitamins|vitamins|mesh-ancestor
20610920|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
20610921|NCT02621398|Paclitaxel|paclitaxel|mesh-list
20610922|NCT02621398|Carboplatin|carboplatin|mesh-list
20610923|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
20610924|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20610925|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20610926|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610927|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
20610928|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
20610929|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610930|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610931|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20610932|NCT02590393|Nicotine|nicotine|mesh-list
20610933|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20610934|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
20316385|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20316386|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316387|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316388|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316389|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
20610935|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20610936|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610937|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20610938|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20610939|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
20610940|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20610941|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610942|NCT02588105|Leucovorin|leucovorin|mesh-list
20610943|NCT02588105|Folic Acid|folic acid|mesh-list
20610944|NCT02588105|Fluorouracil|fluorouracil|mesh-list
20610945|NCT02588105|Irinotecan|irinotecan|mesh-list
20610946|NCT02588105|Olaparib|olaparib|mesh-list
20610947|NCT02588105|AZD0156|azd0156|mesh-list
20610948|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
20610949|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
20610950|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610951|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610952|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610953|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610954|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
20610955|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610956|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20610957|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20610958|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610959|NCT02588105|Antidotes|antidotes|mesh-ancestor
20610960|NCT02588105|Protective Agents|protective agents|mesh-ancestor
20610961|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
20610962|NCT02588105|Vitamins|vitamins|mesh-ancestor
20610963|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
20610964|NCT02588105|Hematinics|hematinics|mesh-ancestor
20610965|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20610966|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20610967|NCT02567422|Cisplatin|cisplatin|mesh-list
20610968|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610969|NCT02567409|Gemcitabine|gemcitabine|mesh-list
20610970|NCT02567409|Cisplatin|cisplatin|mesh-list
20610971|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610972|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610973|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
19634903|NCT02431416|Hormones|hormones|mesh-list
19766018|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19766019|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766020|NCT00085917|Interferons|interferons|mesh-list
19766021|NCT00085917|Ribavirin|ribavirin|mesh-list
19766022|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
19766023|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19766024|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766025|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
19766026|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766027|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
19766028|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766029|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
19766030|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316390|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634904|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634905|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634906|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
19634907|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634908|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19634909|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634910|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634911|NCT02431325|Teduglutide|teduglutide|mesh-list
19634912|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634913|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19634914|NCT02431325|Protective Agents|protective agents|mesh-ancestor
19634915|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766031|NCT00086138|Sertraline|sertraline|mesh-list
19766032|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
20316391|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
19766033|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20610974|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610975|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
19766034|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19766035|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19766036|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766037|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766038|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766039|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
19766040|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766041|NCT00086190|Paroxetine|paroxetine|mesh-list
19766042|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19766043|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19766044|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19766045|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766046|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766047|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766048|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
19766049|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766050|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19766051|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
19766052|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766053|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20316392|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
20316393|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20316394|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316395|NCT00704249|Nevirapine|nevirapine|mesh-list
20316396|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19766054|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19766055|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766056|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19766057|NCT00086281|Zolpidem|zolpidem|mesh-list
19766058|NCT00086281|Modafinil|modafinil|mesh-list
19766059|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19766060|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766061|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19766062|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19766063|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19766064|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766065|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19766066|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19766067|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19766068|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19766069|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
19766070|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
19766071|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634916|NCT02431286|Dexamethasone|dexamethasone|mesh-list
19833185|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833186|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833187|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833188|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833189|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
20316397|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19634917|NCT02431286|Aprepitant|aprepitant|mesh-list
19634918|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634919|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
19634920|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
19634921|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634922|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634923|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634924|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
19634925|NCT02431286|Hormones|hormones|mesh-ancestor
19634926|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634927|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19634928|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766072|NCT00086307|Pramipexole|pramipexole|mesh-list
19766073|NCT00086307|Citalopram|citalopram|mesh-list
19766074|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19766075|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19766076|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766077|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766078|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766079|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
19766080|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766081|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19766082|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
19766083|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766084|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19766085|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19766086|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
19766087|NCT00086307|Protective Agents|protective agents|mesh-ancestor
19766088|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
19766089|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
19766090|NCT00086346|Cyclosporine|cyclosporine|mesh-list
19766091|NCT00086346|Sirolimus|sirolimus|mesh-list
19766092|NCT00086346|Tacrolimus|tacrolimus|mesh-list
19766093|NCT00086346|Cyclosporins|cyclosporins|mesh-list
19766094|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766095|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
19766096|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766097|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19766098|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766099|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766100|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
19766101|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766102|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
19766103|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19766104|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19766105|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19766106|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766107|NCT00086385|Bupropion|bupropion|mesh-list
19766108|NCT00086385|Nicotine|nicotine|mesh-list
19766109|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19766110|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
19766111|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19766112|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766113|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19766114|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20149432|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
20149433|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20149434|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149435|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
20149436|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149437|NCT00082966|Bortezomib|bortezomib|mesh-list
20149438|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316398|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766115|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
19766116|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766117|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316399|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316400|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
20316401|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316402|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20316403|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19256629|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
20149439|NCT00083005|Thalidomide|thalidomide|mesh-list
20149440|NCT00083005|Docetaxel|docetaxel|mesh-list
20149441|NCT00083005|Estramustine|estramustine|mesh-list
20149442|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149443|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
20149444|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20149445|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149446|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149447|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149448|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
20149449|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149450|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
19766118|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20149451|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19766119|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
20316404|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19766120|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766121|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19766122|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19766123|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766124|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
19766125|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19766126|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19766127|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766128|NCT00086411|Bupropion|bupropion|mesh-list
19766129|NCT00086411|Nicotine|nicotine|mesh-list
19766130|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19766131|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
19766132|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19766133|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766134|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19766135|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19766136|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
20149452|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149453|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149454|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149455|NCT00083005|Growth Substances|growth substances|mesh-ancestor
20149456|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149457|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19766137|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766138|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766139|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19766140|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
19766141|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766142|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19766143|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19766144|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766145|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
19766146|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19766147|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19766148|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766149|NCT00086502|Metformin|metformin|mesh-list
19766150|NCT00086502|Pioglitazone|pioglitazone|mesh-list
19766151|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19766152|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19766153|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766154|NCT00086502|Incretins|incretins|mesh-ancestor
19766155|NCT00086502|Hormones|hormones|mesh-ancestor
19766156|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766157|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19766158|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
19766159|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766160|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766161|NCT00086515|Metformin|metformin|mesh-list
19766162|NCT00086515|Pioglitazone|pioglitazone|mesh-list
19766163|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19766164|NCT00086515|Glipizide|glipizide|mesh-list
19766165|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19766166|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766167|NCT00086515|Incretins|incretins|mesh-ancestor
19766168|NCT00086515|Hormones|hormones|mesh-ancestor
19766169|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766170|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19766171|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
19766172|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766173|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634929|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19634930|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634931|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634932|NCT02431221|Perhexiline|perhexiline|mesh-list
19634933|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19634934|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19634935|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634936|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19634937|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634938|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
19634939|NCT02431208|Dexamethasone|dexamethasone|mesh-list
19634940|NCT02431208|Lenalidomide|lenalidomide|mesh-list
19766174|NCT00086580|Vidarabine|vidarabine|mesh-list
19766175|NCT00086580|Fludarabine|fludarabine|mesh-list
19766176|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
19766177|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
19766178|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766179|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766180|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
19766181|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766182|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766183|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
19766184|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766185|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
19766186|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766187|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766188|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
19766189|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766190|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19766191|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
19766192|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
19766193|NCT00086957|Docetaxel|docetaxel|mesh-list
19766194|NCT00086957|Trastuzumab|trastuzumab|mesh-list
19766195|NCT00086957|Gefitinib|gefitinib|mesh-list
19766196|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766197|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766198|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766199|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766200|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766201|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766202|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19766203|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766204|NCT00086996|Fluorouracil|fluorouracil|mesh-list
19256630|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256631|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19256632|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19256633|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19256634|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19256635|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256636|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19256637|NCT04337060|Narcotics|narcotics|mesh-ancestor
19256638|NCT04337060|Analgesics|analgesics|mesh-ancestor
19766205|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
19766206|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
19766207|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766208|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766209|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766210|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766211|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
19766212|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766213|NCT00087126|Topotecan|topotecan|mesh-list
19766214|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19256639|NCT04330183|Ketamine|ketamine|mesh-list
19256640|NCT04330183|Analgesics|analgesics|mesh-ancestor
20316405|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20316406|NCT00704275|Cyclosporine|cyclosporine|mesh-list
20316407|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20316408|NCT00704275|Cyclosporins|cyclosporins|mesh-list
20316409|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316410|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316411|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316412|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
20316413|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316414|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
20316415|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316416|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316417|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316418|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20316419|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20316420|NCT00704301|Rivastigmine|rivastigmine|mesh-list
20316421|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20316422|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766215|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19766216|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316423|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316424|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
20316425|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316426|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316427|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20316428|NCT00704301|Protective Agents|protective agents|mesh-ancestor
20316429|NCT00704314|Simvastatin|simvastatin|mesh-list
20316430|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20316431|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20316432|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
20316433|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316434|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20316435|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20316436|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316437|NCT00704366|Saracatinib|saracatinib|mesh-list
20316438|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316439|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766217|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766218|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766219|NCT00087139|Epothilones|epothilones|mesh-list
19766220|NCT00087139|Epothilone B|epothilone b|mesh-list
19766221|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766222|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766223|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766224|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766225|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766226|NCT00087152|Capecitabine|capecitabine|mesh-list
19766227|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
19766228|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149458|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
20149459|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149460|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
20149461|NCT00083031|Bevacizumab|bevacizumab|mesh-list
20149462|NCT00083031|Methotrexate|methotrexate|mesh-list
20149463|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149464|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
20149465|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766229|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
19766230|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766231|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766232|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19766233|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766234|NCT00087490|Vancomycin|vancomycin|mesh-list
19766235|NCT00087490|Linezolid|linezolid|mesh-list
19766236|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19766237|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766238|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19766239|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766240|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766241|NCT00087516|Metformin|metformin|mesh-list
19766242|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19766243|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19766244|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766245|NCT00087516|Incretins|incretins|mesh-ancestor
19766246|NCT00087516|Hormones|hormones|mesh-ancestor
19766247|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766248|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19766249|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
19766250|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766251|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149466|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316440|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316441|NCT00704392|XL647|xl647|mesh-list
20316442|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766252|NCT00087529|Rituximab|rituximab|mesh-list
19766253|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316443|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19634941|NCT02431208|Atezolizumab|atezolizumab|mesh-list
19634942|NCT02431208|Daratumumab|daratumumab|mesh-list
19634943|NCT02431208|Pomalidomide|pomalidomide|mesh-list
19766254|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766255|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
19766256|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766257|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19766258|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
19766259|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19766260|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19766261|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19766262|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
19766263|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
19766264|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19766265|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766266|NCT00087568|Ribavirin|ribavirin|mesh-list
19766267|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19766268|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
19766269|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766270|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
19766271|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766272|NCT00087594|Ribavirin|ribavirin|mesh-list
19766273|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19766274|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
19766275|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766276|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
19766277|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766278|NCT00087607|Ribavirin|ribavirin|mesh-list
19766279|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19766280|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19766281|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
19766282|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766283|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
19766284|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766285|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19766286|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
19766287|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766288|NCT00087646|Ribavirin|ribavirin|mesh-list
19766289|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19766290|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
19766291|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
19766292|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766293|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
19766294|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766295|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
19766296|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766297|NCT00087672|Lenalidomide|lenalidomide|mesh-list
19766298|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
19766299|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766300|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19766301|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19766302|NCT00087672|Growth Substances|growth substances|mesh-ancestor
19766303|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
19766304|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766305|NCT00087685|Everolimus|everolimus|mesh-list
19766306|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766307|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766308|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
19766309|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766310|NCT00087698|Pemetrexed|pemetrexed|mesh-list
19766311|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766312|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634944|NCT02431208|Antibodies|antibodies|mesh-list
20316444|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19634945|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19634946|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
19634947|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634948|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19634949|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
19634950|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
19634951|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634952|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20347384|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19634953|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
19634954|NCT02431208|Hormones|hormones|mesh-ancestor
19766313|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766314|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19766315|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19766316|NCT00088153|Progesterone|progesterone|mesh-list
19766317|NCT00088153|Estrogens|estrogens|mesh-list
19634955|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19634956|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19634957|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766318|NCT00088153|Progestins|progestins|mesh-ancestor
19766319|NCT00088153|Hormones|hormones|mesh-ancestor
19766320|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766321|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766322|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
19766323|NCT00088166|Hormones|hormones|mesh-ancestor
19766324|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766325|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766326|NCT00088218|Cytarabine|cytarabine|mesh-list
19766327|NCT00088218|Clofarabine|clofarabine|mesh-list
19766328|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766329|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
19766330|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766331|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766332|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
19766333|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149467|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149468|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
20149469|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149470|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149471|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19766334|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766335|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
19766336|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766337|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19766338|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19766339|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766340|NCT00088413|Molgramostim|molgramostim|mesh-list
20149472|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20149473|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19766341|NCT00088413|Sargramostim|sargramostim|mesh-list
19766342|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
19766343|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766344|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766345|NCT00088452|Lamotrigine|lamotrigine|mesh-list
19766346|NCT00088452|Valproic Acid|valproic acid|mesh-list
19766347|NCT00088452|Ethosuximide|ethosuximide|mesh-list
19766348|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
19766349|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19766350|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766351|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766352|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19766353|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766354|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19766355|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20149474|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149475|NCT00083031|Growth Substances|growth substances|mesh-ancestor
20149476|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149477|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20149478|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
19634958|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19634959|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19634960|NCT02431208|Growth Substances|growth substances|mesh-ancestor
19634961|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
19634962|NCT02431143|Miltefosine|miltefosine|mesh-list
19766356|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19766357|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766358|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19766359|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149479|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20149480|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149481|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
20149482|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
20149483|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149484|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20149485|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19766360|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
19766361|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766362|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
19766363|NCT00088465|Olanzapine|olanzapine|mesh-list
19766364|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
19766365|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
20149486|NCT00083057|Paclitaxel|paclitaxel|mesh-list
20149487|NCT00083057|Gefitinib|gefitinib|mesh-list
20149488|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20149489|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149490|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
20149491|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
20149492|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149493|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149494|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20149495|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149496|NCT00083070|Temozolomide|temozolomide|mesh-list
20149497|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149498|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
20149499|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149500|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149501|NCT00083083|Paclitaxel|paclitaxel|mesh-list
20149502|NCT00083083|Etoposide|etoposide|mesh-list
20149503|NCT00083083|Vinorelbine|vinorelbine|mesh-list
20149504|NCT00083083|Vinblastine|vinblastine|mesh-list
20149505|NCT00083083|Docetaxel|docetaxel|mesh-list
20149506|NCT00083083|Carboplatin|carboplatin|mesh-list
20149507|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20149508|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20149509|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149510|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
20149511|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
20149512|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149513|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149514|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149515|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149516|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149517|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20149518|NCT00083096|Temozolomide|temozolomide|mesh-list
20149519|NCT00083096|Lonafarnib|lonafarnib|mesh-list
20149520|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149521|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
20149522|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149523|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149524|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149525|NCT00083109|Suramin|suramin|mesh-list
20149526|NCT00083109|Fluorouracil|fluorouracil|mesh-list
20149527|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
20149528|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149529|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149530|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149531|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149532|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
19634963|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
19634964|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634965|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19634966|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19634967|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19634968|NCT02431013|Cilostazol|cilostazol|mesh-list
19634969|NCT02431013|Simvastatin|simvastatin|mesh-list
19634970|NCT02431013|Pravastatin|pravastatin|mesh-list
19634971|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19634972|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19634973|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
19634974|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634975|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19634976|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19766366|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19766367|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766368|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19766369|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19766370|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19766371|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19766372|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766373|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19634977|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316445|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316446|NCT00704431|Darapladib|darapladib|mesh-list
20316447|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20316448|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316449|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316450|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20316451|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
20316452|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20316453|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20316454|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20316455|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20316456|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766374|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19766375|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766376|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766377|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766378|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
19766379|NCT00088530|Gemcitabine|gemcitabine|mesh-list
19766380|NCT00088530|Prednisone|prednisone|mesh-list
19766381|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
19766382|NCT00088530|Rituximab|rituximab|mesh-list
19766383|NCT00088530|Etoposide|etoposide|mesh-list
19766384|NCT00088530|Vincristine|vincristine|mesh-list
19766385|NCT00088530|Vinorelbine|vinorelbine|mesh-list
20149533|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149534|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
20149535|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
20149536|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20149537|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149538|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20149539|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20149540|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20149541|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149542|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149543|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149544|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20149545|NCT00083148|Capecitabine|capecitabine|mesh-list
20149546|NCT00083148|Irinotecan|irinotecan|mesh-list
20316457|NCT00704548|Simvastatin|simvastatin|mesh-list
20316458|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20316459|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20316460|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
20316461|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316462|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20316463|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20316464|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316465|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
20316466|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20316467|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316468|NCT00704600|Nelfinavir|nelfinavir|mesh-list
20610976|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20610977|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610978|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20610979|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
20610980|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634978|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19634979|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
19634980|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19634981|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634982|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19634983|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
19634984|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19634985|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19634986|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19634987|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
19634988|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19766386|NCT00088530|Pixantrone|pixantrone|mesh-list
19766387|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766388|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
19766389|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766390|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19766391|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19766392|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
19766393|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766394|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766395|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19766396|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766397|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766398|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
19766399|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
19766400|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766401|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766402|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19766403|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
19766404|NCT00088530|Hormones|hormones|mesh-ancestor
19766405|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766406|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19766407|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19766408|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19766409|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19766410|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766411|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766412|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766413|NCT00088595|Pasireotide|pasireotide|mesh-list
19766414|NCT00088595|Hormones|hormones|mesh-ancestor
19766415|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766416|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766417|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19766418|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20316469|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20316470|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20316471|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
20316472|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316473|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19634989|NCT02431013|Protective Agents|protective agents|mesh-ancestor
19766419|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19766420|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19766421|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766422|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766423|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19766424|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19766425|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19766426|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
19766427|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19634990|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19634991|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19634992|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19634993|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19634994|NCT02431065|Ropivacaine|ropivacaine|mesh-list
19634995|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
19634996|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19634997|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19634998|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
19634999|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
19635000|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635001|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
19766428|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766429|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19766430|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19766431|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
19766432|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19766433|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19766434|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
19766435|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19766436|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19766437|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19766438|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20316474|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20316475|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19766439|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766440|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766441|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19766442|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19766443|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19766444|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19766445|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766446|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766447|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19766448|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19766449|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
19766450|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19766451|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19766452|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
19766453|NCT00088699|Ketamine|ketamine|mesh-list
19766454|NCT00088699|Analgesics|analgesics|mesh-ancestor
19766455|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
19766456|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19766457|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766458|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19766459|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19766460|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
19766461|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
19766462|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19766463|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19766464|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19766465|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766466|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766467|NCT00088881|Prednisone|prednisone|mesh-list
19766468|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
19766469|NCT00088881|Rituximab|rituximab|mesh-list
19766470|NCT00088881|Doxorubicin|doxorubicin|mesh-list
19766471|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19766472|NCT00088881|Vincristine|vincristine|mesh-list
19766473|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766474|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
19766475|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766476|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19766477|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19766478|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
19766479|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766480|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766481|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19766482|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766483|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19766484|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19766485|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19766486|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766487|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19766488|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
19766489|NCT00088881|Hormones|hormones|mesh-ancestor
19766490|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766491|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19766492|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19766493|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766494|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766495|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766496|NCT00088907|Docetaxel|docetaxel|mesh-list
20149547|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149548|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
20149549|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766497|NCT00088907|Gefitinib|gefitinib|mesh-list
19766498|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766499|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766500|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766501|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766502|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766503|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20149550|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149551|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20149552|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149553|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316476|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
20149554|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
19766504|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766505|NCT00088985|Trastuzumab|trastuzumab|mesh-list
19766506|NCT00088985|Vinorelbine|vinorelbine|mesh-list
19766507|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766508|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766509|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19766510|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766511|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766512|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766513|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766514|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
19766515|NCT00089011|Fludarabine|fludarabine|mesh-list
19766516|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
19766517|NCT00089011|Tacrolimus|tacrolimus|mesh-list
19766518|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766519|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766520|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
19766521|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766522|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766523|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
19766524|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766525|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19766526|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766527|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19766528|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19766529|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
19766530|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19766531|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766532|NCT00089024|Leucovorin|leucovorin|mesh-list
19766533|NCT00089024|Gemcitabine|gemcitabine|mesh-list
19766534|NCT00089024|Fluorouracil|fluorouracil|mesh-list
19766535|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
19766536|NCT00089024|Calcium|calcium|mesh-list
19766537|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
19766538|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766539|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
19766540|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766541|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766542|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
19766543|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149555|NCT00083161|Etoposide|etoposide|mesh-list
20149556|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149557|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
20149558|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149559|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20610981|NCT02535312|Cisplatin|cisplatin|mesh-list
19635002|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635003|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
19635004|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635005|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635006|NCT02430714|Lenvatinib|lenvatinib|mesh-list
19635007|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635008|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19635009|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635010|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635011|NCT02430896|Methylphenidate|methylphenidate|mesh-list
19766544|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766545|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766546|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
19766547|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766548|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19766549|NCT00089024|Antidotes|antidotes|mesh-ancestor
19766550|NCT00089024|Protective Agents|protective agents|mesh-ancestor
19766551|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
19766552|NCT00089024|Vitamins|vitamins|mesh-ancestor
20149560|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149561|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
20149562|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149563|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149564|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19766553|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
19766554|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20149565|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20149566|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19766555|NCT00089076|Ipilimumab|ipilimumab|mesh-list
19766556|NCT00089076|Antibodies|antibodies|mesh-list
19766557|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
19635012|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19635013|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19635014|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766558|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19766559|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
19766560|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766561|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766562|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19766563|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766564|NCT00089102|Gemcitabine|gemcitabine|mesh-list
19766565|NCT00089102|Irinotecan|irinotecan|mesh-list
19766566|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766567|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
19766568|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766569|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766570|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
19766571|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766572|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766573|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766574|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
19766575|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766576|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19766577|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19635015|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19635016|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19635017|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635018|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635019|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
19635020|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635021|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19635022|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635023|NCT02430545|Rifampin|rifampin|mesh-list
19635024|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19766578|NCT00089284|Rituximab|rituximab|mesh-list
19766579|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
19766580|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766581|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766582|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
19766583|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149567|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149568|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149569|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
20149570|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149571|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
20149572|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149573|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149574|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20149575|NCT00083213|Aflibercept|aflibercept|mesh-list
20149576|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149577|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149578|NCT00083213|Growth Substances|growth substances|mesh-ancestor
20149579|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149580|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149581|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149582|NCT00083252|Cisplatin|cisplatin|mesh-list
20149583|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149584|NCT00083278|Ipilimumab|ipilimumab|mesh-list
20149585|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20149586|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149587|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20149588|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149589|NCT00083304|Efaproxiral|efaproxiral|mesh-list
20149590|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
20149591|NCT00083343|Caspofungin|caspofungin|mesh-list
20149592|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
20149593|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149594|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149595|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149596|NCT00083408|Pamidronate|pamidronate|mesh-list
20149597|NCT00083408|Thalidomide|thalidomide|mesh-list
20149598|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635025|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
19635026|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149599|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
20316477|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316478|NCT00704639|Carboplatin|carboplatin|mesh-list
20316479|NCT00704639|Cetuximab|cetuximab|mesh-list
19766584|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19766585|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19766586|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
19766587|NCT00089297|Paclitaxel|paclitaxel|mesh-list
19766588|NCT00089297|Carboplatin|carboplatin|mesh-list
19766589|NCT00089297|Cetuximab|cetuximab|mesh-list
19766590|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19766591|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766592|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766593|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766594|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766595|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766596|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766597|NCT00089479|Capecitabine|capecitabine|mesh-list
19766598|NCT00089479|Docetaxel|docetaxel|mesh-list
19766599|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766600|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
19766601|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766602|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766603|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766604|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766605|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766606|NCT00089505|Ritonavir|ritonavir|mesh-list
19766607|NCT00089505|Lopinavir|lopinavir|mesh-list
19766608|NCT00089505|Tenofovir|tenofovir|mesh-list
19766609|NCT00089505|Emtricitabine|emtricitabine|mesh-list
19766610|NCT00089505|Nevirapine|nevirapine|mesh-list
19766611|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19766612|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19766613|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19766614|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
19766615|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766616|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766617|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19766618|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19766619|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
19766620|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766621|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19766622|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19766623|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19766624|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19766625|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19766626|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19766627|NCT00089544|Thalidomide|thalidomide|mesh-list
19766628|NCT00089544|Doxorubicin|doxorubicin|mesh-list
19766629|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19766630|NCT00089544|Ifosfamide|ifosfamide|mesh-list
19766631|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
19766632|NCT00089544|Dacarbazine|dacarbazine|mesh-list
19766633|NCT00089544|Imidazole|imidazole|mesh-list
19766634|NCT00089544|Lenograstim|lenograstim|mesh-list
19766635|NCT00089544|Sargramostim|sargramostim|mesh-list
19766636|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19766637|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766638|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19766639|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19766640|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766641|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766642|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19766643|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
19766644|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766645|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19766646|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
19766647|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766648|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
19766649|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149600|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149601|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149602|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149603|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149604|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149605|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149606|NCT00083408|Growth Substances|growth substances|mesh-ancestor
20149607|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316480|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316481|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316482|NCT00704665|Methocarbamol|methocarbamol|mesh-list
20316483|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20316484|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316485|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20316486|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316487|NCT00704678|Sevelamer|sevelamer|mesh-list
20316488|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
20316489|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
20316490|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316491|NCT00704691|Lenalidomide|lenalidomide|mesh-list
20316492|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
20316493|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316494|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19635027|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635028|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
19766650|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766651|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19766652|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19766653|NCT00089544|Growth Substances|growth substances|mesh-ancestor
19766654|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
19766655|NCT00089583|Ritonavir|ritonavir|mesh-list
19766656|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
19766657|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19766658|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19766659|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
19766660|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766661|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766662|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19766663|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19766664|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
19766665|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766666|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19766667|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19766668|NCT00089609|Thalidomide|thalidomide|mesh-list
19766669|NCT00089609|Prednisone|prednisone|mesh-list
19766670|NCT00089609|Bevacizumab|bevacizumab|mesh-list
19766671|NCT00089609|Docetaxel|docetaxel|mesh-list
19766672|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766673|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766674|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19766675|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19766676|NCT00089609|Growth Substances|growth substances|mesh-ancestor
19766677|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766678|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
19766679|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766680|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766681|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766682|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766683|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19766684|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
19766685|NCT00089609|Hormones|hormones|mesh-ancestor
19766686|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766687|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19766688|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766689|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
19635029|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19635030|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635031|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635032|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19635033|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19635034|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19635035|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19635036|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19635037|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19635038|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
19635039|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19766690|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
19766691|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19766692|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766693|NCT00089635|Panitumumab|panitumumab|mesh-list
19766694|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316495|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20316496|NCT00704691|Growth Substances|growth substances|mesh-ancestor
20316497|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
19635040|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19635041|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19635042|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
19635043|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635044|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635045|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635046|NCT02430298|Melatonin|melatonin|mesh-list
19635047|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
19635048|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635049|NCT02430298|Protective Agents|protective agents|mesh-ancestor
19635050|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635051|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635052|NCT02430259|Isoniazid|isoniazid|mesh-list
19635053|NCT02430259|Rifapentine|rifapentine|mesh-list
19635054|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
19635055|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19635056|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635057|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19635058|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19635059|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
19635060|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635061|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19635062|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19635063|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
19635064|NCT02430181|Interferons|interferons|mesh-list
19635065|NCT02430181|Ritonavir|ritonavir|mesh-list
19635066|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
19635067|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19635068|NCT02430181|Lonafarnib|lonafarnib|mesh-list
19635069|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635070|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
19635071|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635072|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19635073|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19635074|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
19635075|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635076|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635077|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19635078|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19635079|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19635080|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19635081|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
19635082|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662069|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662070|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662071|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19662072|NCT03924986|Gemcitabine|gemcitabine|mesh-list
19662073|NCT03924986|Cisplatin|cisplatin|mesh-list
19662074|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662075|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19662076|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
19662077|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662078|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
19662079|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662080|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662081|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662082|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
19662083|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766695|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766696|NCT00089648|Sunitinib|sunitinib|mesh-list
19766697|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766698|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19766699|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19766700|NCT00089648|Growth Substances|growth substances|mesh-ancestor
19766701|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766702|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
19766703|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19662084|NCT03922620|Bupivacaine|bupivacaine|mesh-list
20316498|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316499|NCT00704704|Thalidomide|thalidomide|mesh-list
19766704|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766705|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766706|NCT00089661|Denosumab|denosumab|mesh-list
19766707|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19635083|NCT02430194|Interferons|interferons|mesh-list
19635084|NCT02430194|Ritonavir|ritonavir|mesh-list
19635085|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
19635086|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
19635087|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19635088|NCT02430194|Lonafarnib|lonafarnib|mesh-list
19635089|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635090|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
19635091|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635092|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19635093|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19635094|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
19635095|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766708|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766709|NCT00089674|Denosumab|denosumab|mesh-list
19766710|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19766711|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766712|NCT00089778|Aldesleukin|aldesleukin|mesh-list
19766713|NCT00089778|Interleukin-2|interleukin-2|mesh-list
19766714|NCT00089778|Mitogens|mitogens|mesh-list
19766715|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316500|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316501|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
20316502|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316503|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
20316504|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316505|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316506|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20316507|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20316508|NCT00704704|Growth Substances|growth substances|mesh-ancestor
20316509|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316510|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766716|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19766717|NCT00089778|Analgesics|analgesics|mesh-ancestor
19766718|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
19766719|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19766720|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766721|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766722|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766723|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19766724|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19766725|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
19766726|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766727|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
19766728|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
19766729|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
19766730|NCT00089843|Testosterone|testosterone|mesh-list
19766731|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
19766732|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
19766733|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19766734|NCT00089843|Androgens|androgens|mesh-ancestor
19766735|NCT00089843|Hormones|hormones|mesh-ancestor
19766736|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766737|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766738|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19766739|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766740|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
19766741|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19766742|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766743|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766744|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19766745|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20316511|NCT00704743|Calpastatin|calpastatin|mesh-list
20316512|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20316513|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
20316514|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316515|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316516|NCT00704756|Ribavirin|ribavirin|mesh-list
20610982|NCT02535312|Pemetrexed|pemetrexed|mesh-list
19635096|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635097|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19766746|NCT00089999|Lapatinib|lapatinib|mesh-list
19766747|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766748|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19766749|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766750|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766751|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
19766752|NCT00090051|Rituximab|rituximab|mesh-list
19766753|NCT00090051|Fludarabine|fludarabine|mesh-list
19766754|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
19766755|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766756|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
19766757|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610983|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20610984|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20610985|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20610986|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20610987|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20610988|NCT02533232|Minocycline|minocycline|mesh-list
20610989|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20610990|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766758|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19766759|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19766760|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
19766761|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766762|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766763|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19766764|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766765|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766766|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
20316517|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20316518|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
20316519|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
20316520|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316521|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
20316522|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316523|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
20316524|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20610991|NCT02506959|Gemcitabine|gemcitabine|mesh-list
20610992|NCT02506959|Melphalan|melphalan|mesh-list
19635098|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19635099|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19635100|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19635101|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
19635102|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635103|NCT02430350|Edaravone|edaravone|mesh-list
19635104|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19635105|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
19635106|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635107|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19635108|NCT02430350|Protective Agents|protective agents|mesh-ancestor
19635109|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635110|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
19635111|NCT02430363|Dactolisib|dactolisib|mesh-list
19635112|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19635113|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766767|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19766768|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
19766769|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766770|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19766771|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
20149608|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149609|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20149610|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
20149611|NCT00083434|Hematinics|hematinics|mesh-ancestor
20149612|NCT00083460|Thalidomide|thalidomide|mesh-list
20149613|NCT00083460|Dexamethasone|dexamethasone|mesh-list
20149614|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149615|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
19635114|NCT02430233|Progesterone|progesterone|mesh-list
19766772|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149616|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
20149617|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149618|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149619|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20149620|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
20149621|NCT00083460|Hormones|hormones|mesh-ancestor
20610993|NCT02506959|Busulfan|busulfan|mesh-list
19635115|NCT02430233|Progestins|progestins|mesh-ancestor
20610994|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
20610995|NCT02506959|Panobinostat|panobinostat|mesh-list
20610996|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20610997|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20610998|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
19635116|NCT02430233|Hormones|hormones|mesh-ancestor
19635117|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766773|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766774|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19766775|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19766776|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19766777|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
19766778|NCT00090103|Tamsulosin|tamsulosin|mesh-list
19766779|NCT00090103|Dutasteride|dutasteride|mesh-list
19766780|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20610999|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611000|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611001|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
20611002|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611003|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611004|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611005|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
20611006|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611007|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611008|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
20316525|NCT00704821|Docetaxel|docetaxel|mesh-list
20611009|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20611010|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19766781|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19766782|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19766783|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
19766784|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766785|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766786|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766787|NCT00090103|Urological Agents|urological agents|mesh-ancestor
19766788|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19766789|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19766790|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766791|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
19766792|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766793|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
19766794|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
19635118|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635119|NCT02430103|Goserelin|goserelin|mesh-list
19635120|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635121|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635122|NCT02429973|Gemcitabine|gemcitabine|mesh-list
19635123|NCT02429973|Sirolimus|sirolimus|mesh-list
19635124|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635125|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
19635126|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635127|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635128|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
19766795|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766796|NCT00090402|Protective Agents|protective agents|mesh-ancestor
19766797|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766798|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
19766799|NCT00090402|Vitamins|vitamins|mesh-ancestor
19766800|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
19766801|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
19766802|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316526|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635129|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766803|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766804|NCT00090545|Sorafenib|sorafenib|mesh-list
19766805|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766806|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19766807|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766808|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766809|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19766810|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19766811|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19766812|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
19766813|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19766814|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766815|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766816|NCT00090584|Urological Agents|urological agents|mesh-ancestor
19766817|NCT00090610|Carboplatin|carboplatin|mesh-list
19766818|NCT00090610|Docetaxel|docetaxel|mesh-list
19766819|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766820|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766821|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766822|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766823|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766824|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
19766825|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
19766826|NCT00090753|Hematinics|hematinics|mesh-ancestor
19766827|NCT00090766|Valganciclovir|valganciclovir|mesh-list
19766828|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
19766829|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766830|NCT00090779|Ritonavir|ritonavir|mesh-list
19766831|NCT00090779|Lopinavir|lopinavir|mesh-list
19766832|NCT00090779|Tenofovir|tenofovir|mesh-list
19766833|NCT00090779|Emtricitabine|emtricitabine|mesh-list
19766834|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19766835|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19766836|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19766837|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
19766838|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766839|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766840|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19766841|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19766842|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
19766843|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766844|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19766845|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19766846|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19766847|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19766848|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19766849|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
19766850|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19766851|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
19766852|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19766853|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766854|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19766855|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19766856|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766857|NCT00090857|Letrozole|letrozole|mesh-list
19766858|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766859|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19766860|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19766861|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766862|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766863|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19766864|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19766865|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766866|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766867|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
19766868|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766869|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19766870|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766871|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766872|NCT00091026|Gemcitabine|gemcitabine|mesh-list
19766873|NCT00091026|Bevacizumab|bevacizumab|mesh-list
19766874|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19766875|NCT00091026|Cetuximab|cetuximab|mesh-list
19766876|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20316527|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316528|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316529|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316530|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316531|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
20316532|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20347385|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20348577|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20348578|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
20348579|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20348580|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348581|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20348582|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20348583|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
20348584|NCT00864812|Fluticasone|fluticasone|mesh-list
20348585|NCT00864812|Xhance|xhance|mesh-list
20348586|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
20348587|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20348588|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19635130|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635131|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635132|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
19635133|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635134|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19635135|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19635136|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
20348589|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348590|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20348591|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
20348592|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635137|NCT02429960|Remifentanil|remifentanil|mesh-list
19635138|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19766877|NCT00091026|Antibodies|antibodies|mesh-list
19766878|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
19766879|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19766880|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766881|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19766882|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19766883|NCT00091026|Growth Substances|growth substances|mesh-ancestor
19766884|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766885|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
19766886|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
19766887|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766888|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
19766889|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766890|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
19766891|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766892|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766893|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766894|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19766895|NCT00091260|Dexamethasone|dexamethasone|mesh-list
19766896|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
19766897|NCT00091260|Lenalidomide|lenalidomide|mesh-list
19766898|NCT00091260|BB 1101|bb 1101|mesh-list
19766899|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19766900|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
20348593|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611011|NCT02506153|Interferons|interferons|mesh-list
19635139|NCT02429960|Narcotics|narcotics|mesh-ancestor
19635140|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635141|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635142|NCT02429960|Analgesics|analgesics|mesh-ancestor
19635143|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
19635144|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635145|NCT02429921|Selenium|selenium|mesh-list
19635146|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
19635147|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635148|NCT02429921|Protective Agents|protective agents|mesh-ancestor
19635149|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766901|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
19766902|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19766903|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766904|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19766905|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
19766906|NCT00091260|Hormones|hormones|mesh-ancestor
19766907|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19766908|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19766909|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766910|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
19766911|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766912|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766913|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
19766914|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19766915|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19766916|NCT00091260|Growth Substances|growth substances|mesh-ancestor
19766917|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
19766918|NCT00091273|Sargramostim|sargramostim|mesh-list
19766919|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
19766920|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
19766921|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766922|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19766923|NCT00091442|Docetaxel|docetaxel|mesh-list
19766924|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19766925|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766926|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766927|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766928|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766929|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766930|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19766931|NCT00091507|Insulin|insulin|mesh-list
19766932|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19766933|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766934|NCT00091572|Temozolomide|temozolomide|mesh-list
19766935|NCT00091572|Dacarbazine|dacarbazine|mesh-list
19766936|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19766937|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
19766938|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766939|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766940|NCT00091793|Denosumab|denosumab|mesh-list
19766941|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19766942|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766943|NCT00091819|Vancomycin|vancomycin|mesh-list
19766944|NCT00091819|Telavancin|telavancin|mesh-list
20149622|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149623|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149624|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149625|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149626|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
20149627|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149628|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149629|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149630|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149631|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149632|NCT00083460|Growth Substances|growth substances|mesh-ancestor
20149633|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149634|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
19766945|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19766946|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766947|NCT00091832|Denosumab|denosumab|mesh-list
19766948|NCT00091832|Diphosphonates|diphosphonates|mesh-list
19766949|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19766950|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766951|NCT00091949|Pioglitazone|pioglitazone|mesh-list
19766952|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19766953|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766954|NCT00092417|Vaccines|vaccines|mesh-list
19766955|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
19766956|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833190|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833191|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
19833192|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19833193|NCT00551876|Simvastatin|simvastatin|mesh-list
19833194|NCT00551876|Ezetimibe|ezetimibe|mesh-list
19833195|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833196|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833197|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
19833198|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149635|NCT00083486|Hematinics|hematinics|mesh-ancestor
20149636|NCT00083525|Capecitabine|capecitabine|mesh-list
20149637|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20149638|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
20149639|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149640|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149641|NCT00083538|Thalidomide|thalidomide|mesh-list
20149642|NCT00083538|Dexamethasone|dexamethasone|mesh-list
20149643|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
20316533|NCT00704899|Amitriptyline|amitriptyline|mesh-list
20316534|NCT00704899|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20316535|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20316536|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
20316537|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20316538|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20316539|NCT00704899|Analgesics|analgesics|mesh-ancestor
20316540|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
20316541|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316542|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316543|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20316544|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20316545|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20316546|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316547|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
20316548|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316549|NCT00704899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19766957|NCT00092534|Vaccines|vaccines|mesh-list
19766958|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
19766959|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766960|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
19766961|NCT00093015|Hematinics|hematinics|mesh-ancestor
19766962|NCT00093041|Zalutumumab|zalutumumab|mesh-list
19766963|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766964|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766965|NCT00093145|Paclitaxel|paclitaxel|mesh-list
19766966|NCT00093145|Carboplatin|carboplatin|mesh-list
19766967|NCT00093145|Trastuzumab|trastuzumab|mesh-list
19766968|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19766969|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19766970|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766971|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
19766972|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
19766973|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
19766974|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766975|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19766976|NCT00093379|Capecitabine|capecitabine|mesh-list
19766977|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
19766978|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766979|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
19766980|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766981|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766982|NCT00093470|Tipifarnib|tipifarnib|mesh-list
19766983|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766984|NCT00093496|Gemcitabine|gemcitabine|mesh-list
19766985|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19766986|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
19766987|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19766988|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19766989|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
19766990|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19766991|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19766992|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19766993|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
19766994|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19766995|NCT00093756|Paclitaxel|paclitaxel|mesh-list
19766996|NCT00093756|Carboplatin|carboplatin|mesh-list
19766997|NCT00093756|Bortezomib|bortezomib|mesh-list
19766998|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19766999|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767000|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767001|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767002|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149644|NCT00083538|Etoposide|etoposide|mesh-list
20149645|NCT00083538|Doxorubicin|doxorubicin|mesh-list
19767003|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611012|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
20149646|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20611013|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
19767004|NCT00093782|Sirolimus|sirolimus|mesh-list
19767005|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19767006|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767007|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767008|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767009|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
19767010|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767011|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
19767012|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767013|NCT00093795|Gemcitabine|gemcitabine|mesh-list
19767014|NCT00093795|Paclitaxel|paclitaxel|mesh-list
19767015|NCT00093795|Docetaxel|docetaxel|mesh-list
19767016|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
19767017|NCT00093795|Doxorubicin|doxorubicin|mesh-list
19767018|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767019|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767020|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767021|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767022|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767023|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767024|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767025|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
19767026|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767027|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767028|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767029|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
19767030|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19767031|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767032|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
19767033|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
20149647|NCT00083538|Cisplatin|cisplatin|mesh-list
20149648|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149649|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
20149650|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149651|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149652|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149653|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
20149654|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149655|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149656|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20149657|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149658|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
20149659|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
20149660|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149661|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20149662|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
20149663|NCT00083538|Hormones|hormones|mesh-ancestor
20149664|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149665|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149666|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20149667|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149668|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149669|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149670|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20149671|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149672|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149673|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149674|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149675|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149676|NCT00083538|Growth Substances|growth substances|mesh-ancestor
20149677|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149678|NCT00083577|Thalidomide|thalidomide|mesh-list
20149679|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149680|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
20149681|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149682|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149683|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149684|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767034|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767035|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767036|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767037|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149685|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149686|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19767038|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767039|NCT00093808|Capecitabine|capecitabine|mesh-list
19767040|NCT00093808|Trastuzumab|trastuzumab|mesh-list
19767041|NCT00093808|Vinorelbine|vinorelbine|mesh-list
19767042|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767043|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
19767044|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767045|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767046|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767047|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767048|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767049|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767050|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767051|NCT00094055|Axitinib|axitinib|mesh-list
19767052|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767053|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767054|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767055|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767056|NCT00094094|Axitinib|axitinib|mesh-list
19767057|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767058|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767059|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767060|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767061|NCT00094107|Axitinib|axitinib|mesh-list
19767062|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767063|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767064|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767065|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767066|NCT00094172|Atorvastatin|atorvastatin|mesh-list
19767067|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19767068|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19767069|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
19767070|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767071|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19767072|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19767073|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767074|NCT00094302|Spironolactone|spironolactone|mesh-list
19767075|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19767076|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
19767077|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767078|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767079|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19767080|NCT00094302|Diuretics|diuretics|mesh-ancestor
19767081|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
19767082|NCT00094328|Anastrozole|anastrozole|mesh-list
19767083|NCT00094328|Bicalutamide|bicalutamide|mesh-list
19767084|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19767085|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767086|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19767087|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19767088|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767089|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767090|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19767091|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
19767092|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767093|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767094|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
19767095|NCT00094445|Curcumin|curcumin|mesh-list
19767096|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19767097|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19767098|NCT00094445|Analgesics|analgesics|mesh-ancestor
19767099|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
19767100|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767101|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767102|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19767103|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767104|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767105|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767106|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316550|NCT00704899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20316551|NCT00704899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20316552|NCT00704925|Amifampridine|amifampridine|mesh-list
20316553|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20316554|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316555|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316556|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20316557|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19767107|NCT00094458|Azathioprine|azathioprine|mesh-list
19767108|NCT00094458|Infliximab|infliximab|mesh-list
19767109|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767110|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19767111|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767112|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
19767113|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767114|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767115|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767116|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767117|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
19767118|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767119|NCT00094497|Doxorubicin|doxorubicin|mesh-list
19767120|NCT00094497|Etoposide|etoposide|mesh-list
20316558|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316559|NCT00704951|Posaconazole|posaconazole|mesh-list
20316560|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
20316561|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316562|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20316563|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20316564|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20316565|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20316566|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20316567|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316568|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316569|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20316570|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
20316571|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316572|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316573|NCT00704990|Vitamins|vitamins|mesh-list
20316574|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
20316575|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
20316576|NCT00704990|Pyridoxal|pyridoxal|mesh-list
19767121|NCT00094497|Mitotane|mitotane|mesh-list
19767122|NCT00094497|Streptozocin|streptozocin|mesh-list
19767123|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767124|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767125|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19767126|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767127|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767128|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767129|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767130|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19767131|NCT00094653|Ipilimumab|ipilimumab|mesh-list
20149687|NCT00083577|Growth Substances|growth substances|mesh-ancestor
20149688|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149689|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149690|NCT00083590|Huperzine A|huperzine a|mesh-list
20149691|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20149692|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149693|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149694|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
20316577|NCT00704990|Pyridoxine|pyridoxine|mesh-list
19767132|NCT00094653|Vaccines|vaccines|mesh-list
19767133|NCT00094653|Antibodies|antibodies|mesh-list
19767134|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19767135|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
19767136|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767137|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767138|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767139|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19767140|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767141|NCT00094757|Pioglitazone|pioglitazone|mesh-list
19767142|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19767143|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19767144|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767145|NCT00094757|Incretins|incretins|mesh-ancestor
19767146|NCT00094757|Hormones|hormones|mesh-ancestor
20149695|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19767147|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767148|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19767149|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
19767150|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767151|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767152|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19767153|NCT00094770|Glipizide|glipizide|mesh-list
19767154|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19767155|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767156|NCT00094770|Incretins|incretins|mesh-ancestor
19767157|NCT00094770|Hormones|hormones|mesh-ancestor
19767158|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767159|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19767160|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
19767161|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767162|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316578|NCT00704990|Zinc|zinc|mesh-list
20316579|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
20316580|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
20149696|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149697|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20149698|NCT00083590|Protective Agents|protective agents|mesh-ancestor
20149699|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20149700|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20149701|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20149702|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20149703|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149704|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20149705|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20149706|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20149707|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
20149708|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149709|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149710|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20149711|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20149712|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
20149713|NCT00083681|Thalidomide|thalidomide|mesh-list
20149714|NCT00083681|Dexamethasone|dexamethasone|mesh-list
20149715|NCT00083681|Etoposide|etoposide|mesh-list
20149716|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
20149717|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149718|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149719|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
20149720|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
20149721|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149722|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149723|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20149724|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
20149725|NCT00083681|Hormones|hormones|mesh-ancestor
20149726|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316581|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316582|NCT00704990|Trace Elements|trace elements|mesh-ancestor
19767163|NCT00094835|Paclitaxel|paclitaxel|mesh-list
19767164|NCT00094835|Carboplatin|carboplatin|mesh-list
19767165|NCT00094835|Panitumumab|panitumumab|mesh-list
19767166|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
19767167|NCT00094835|Imetelstat|imetelstat|mesh-list
19767168|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767169|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767170|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767171|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767172|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767173|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767174|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767175|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767176|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767177|NCT00094861|Paclitaxel|paclitaxel|mesh-list
19767178|NCT00094861|Carboplatin|carboplatin|mesh-list
19767179|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767180|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767181|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767182|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316583|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
19767183|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149727|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149728|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611014|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
19767184|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767185|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
19767186|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19767187|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
19767188|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767189|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767190|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19635150|NCT02429921|Trace Elements|trace elements|mesh-ancestor
19635151|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
19635152|NCT02429804|Listerine|listerine|mesh-list
19767191|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
19767192|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19767193|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
19767194|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767195|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19767196|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19767197|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
19767198|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
19767199|NCT00094887|Protective Agents|protective agents|mesh-ancestor
19767200|NCT00094900|Rilonacept|rilonacept|mesh-list
19767201|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19767202|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19767203|NCT00095056|Glipizide|glipizide|mesh-list
19767204|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19767205|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767206|NCT00095056|Incretins|incretins|mesh-ancestor
19767207|NCT00095056|Hormones|hormones|mesh-ancestor
19767208|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767209|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19767210|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
19767211|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767212|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767213|NCT00095121|Lamivudine|lamivudine|mesh-list
19767214|NCT00095121|Adefovir|adefovir|mesh-list
19767215|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19767216|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19767217|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767218|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767219|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767220|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
19767221|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767222|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19767223|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767224|NCT00095147|Methotrexate|methotrexate|mesh-list
19767225|NCT00095147|Abatacept|abatacept|mesh-list
19767226|NCT00095147|Infliximab|infliximab|mesh-list
19767227|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19767228|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
19767229|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19767230|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767231|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767232|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
19767233|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767234|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767235|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767236|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767237|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19635153|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
19635154|NCT02429804|Fluorides|fluorides|mesh-list
19635155|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
19635156|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19767238|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767239|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
19767240|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767241|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767242|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19767243|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19767244|NCT00095173|Abatacept|abatacept|mesh-list
19767245|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20149729|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149730|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20149731|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635157|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
19635158|NCT02429804|Protective Agents|protective agents|mesh-ancestor
19635159|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635160|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19767246|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767247|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767248|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767249|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
19767250|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767251|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767252|NCT00095199|Docetaxel|docetaxel|mesh-list
19767253|NCT00095199|Pemetrexed|pemetrexed|mesh-list
19767254|NCT00095199|Cetuximab|cetuximab|mesh-list
19767255|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767256|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767257|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767258|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767259|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767260|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767261|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19767262|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767263|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767264|NCT00095212|Testosterone|testosterone|mesh-list
19767265|NCT00095212|Androgens|androgens|mesh-ancestor
19767266|NCT00095212|Hormones|hormones|mesh-ancestor
19767267|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767268|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767269|NCT00095238|Irbesartan|irbesartan|mesh-list
19767270|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19767271|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19767272|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19767273|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149732|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149733|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149734|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
20149735|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149736|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20149737|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
20149738|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20149739|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149740|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149741|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149742|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19767274|NCT00095498|Denosumab|denosumab|mesh-list
19767275|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19767276|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767277|NCT00095563|Lapatinib|lapatinib|mesh-list
19767278|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767279|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767280|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767281|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767282|NCT00095836|Gefitinib|gefitinib|mesh-list
19767283|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767284|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767285|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767286|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767287|NCT00095875|Carboplatin|carboplatin|mesh-list
19767288|NCT00095875|Docetaxel|docetaxel|mesh-list
19767289|NCT00095875|Fluorouracil|fluorouracil|mesh-list
19767290|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767291|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767292|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767293|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767294|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767295|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
19767296|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767297|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767298|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
19767299|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767300|NCT00095940|Lapatinib|lapatinib|mesh-list
19767301|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767302|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767303|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767304|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149743|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149744|NCT00083681|Growth Substances|growth substances|mesh-ancestor
19767305|NCT00095979|Epothilones|epothilones|mesh-list
19767306|NCT00095979|Epothilone B|epothilone b|mesh-list
19767307|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767308|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767309|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767310|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767311|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767312|NCT00096018|Thalidomide|thalidomide|mesh-list
19767313|NCT00096018|Fludarabine|fludarabine|mesh-list
20149745|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149746|NCT00083694|Thalidomide|thalidomide|mesh-list
20316584|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767314|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
19767315|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767316|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767317|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
19767318|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767319|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767320|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
19767321|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767322|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
19767323|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19767324|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767325|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19767326|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19767327|NCT00096018|Growth Substances|growth substances|mesh-ancestor
19767328|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767329|NCT00096031|Cetuximab|cetuximab|mesh-list
19767330|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767331|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767332|NCT00096044|Rituximab|rituximab|mesh-list
19635161|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635162|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19635163|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767333|NCT00096044|Lenalidomide|lenalidomide|mesh-list
19767334|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767335|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767336|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
19767337|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767338|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767339|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20316585|NCT00704990|Protective Agents|protective agents|mesh-ancestor
20316586|NCT00705042|Etanercept|etanercept|mesh-list
20316587|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19767340|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19767341|NCT00096044|Growth Substances|growth substances|mesh-ancestor
19767342|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767343|NCT00096122|Cytarabine|cytarabine|mesh-list
19767344|NCT00096122|Idarubicin|idarubicin|mesh-list
19767345|NCT00096122|Tipifarnib|tipifarnib|mesh-list
19767346|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767347|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
19767348|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767349|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767350|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
19767351|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767352|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767353|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
19767354|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767355|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767356|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19767357|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767358|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149747|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149748|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
20149749|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149750|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149751|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149752|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149753|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149754|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149755|NCT00083694|Growth Substances|growth substances|mesh-ancestor
19635164|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
19635165|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
19635166|NCT02429726|Cisplatin|cisplatin|mesh-list
19635167|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635168|NCT02429700|Paclitaxel|paclitaxel|mesh-list
19767359|NCT00096135|Leucovorin|leucovorin|mesh-list
19767360|NCT00096135|Cytarabine|cytarabine|mesh-list
19767361|NCT00096135|Dexamethasone|dexamethasone|mesh-list
19767362|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
19767363|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19767364|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19767365|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19767366|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
19767367|NCT00096135|Methotrexate|methotrexate|mesh-list
19767368|NCT00096135|Etoposide|etoposide|mesh-list
19767369|NCT00096135|Vincristine|vincristine|mesh-list
19767370|NCT00096135|Daunorubicin|daunorubicin|mesh-list
19767371|NCT00096135|Asparaginase|asparaginase|mesh-list
19767372|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
19767373|NCT00096135|Pegaspargase|pegaspargase|mesh-list
19767374|NCT00096135|Lenograstim|lenograstim|mesh-list
19767375|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
19767376|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767377|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
19767378|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767379|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767380|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767381|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
19767382|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767383|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767384|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19767385|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19767386|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
19767387|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
19767388|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767389|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19767390|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
19767391|NCT00096135|Hormones|hormones|mesh-ancestor
19767392|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767393|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19767394|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19767395|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
19767396|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19767397|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767398|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
19767399|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767400|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767401|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19767402|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767403|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767404|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19767405|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767406|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
19767407|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767408|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19767409|NCT00096135|Antidotes|antidotes|mesh-ancestor
19767410|NCT00096135|Protective Agents|protective agents|mesh-ancestor
19767411|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
19767412|NCT00096135|Vitamins|vitamins|mesh-ancestor
19767413|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
19767414|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767415|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767416|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767417|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767418|NCT00096161|Cyclosporine|cyclosporine|mesh-list
19767419|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
19767420|NCT00096161|Vidarabine|vidarabine|mesh-list
19767421|NCT00096161|Pentostatin|pentostatin|mesh-list
19767422|NCT00096161|Cyclosporins|cyclosporins|mesh-list
19767423|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767424|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767425|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767426|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
19767427|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767428|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
19767429|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767430|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767431|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767432|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19767433|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767434|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767435|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19767436|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
19767437|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316588|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20316589|NCT00705042|Analgesics|analgesics|mesh-ancestor
20316590|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
20316591|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316592|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316593|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316594|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316595|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316596|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316597|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
19767438|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19767439|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
19767440|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
19767441|NCT00096174|Cisplatin|cisplatin|mesh-list
19767442|NCT00096174|Cetuximab|cetuximab|mesh-list
19767443|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767444|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767445|NCT00096226|Paclitaxel|paclitaxel|mesh-list
19767446|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19767447|NCT00096226|Carboplatin|carboplatin|mesh-list
19767448|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767449|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767450|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767451|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767452|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767453|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767454|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19767455|NCT00096265|Temozolomide|temozolomide|mesh-list
19767456|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767457|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767458|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767459|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767460|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767461|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
19767462|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
19767463|NCT00096278|Leucovorin|leucovorin|mesh-list
19767464|NCT00096278|Folic Acid|folic acid|mesh-list
19767465|NCT00096278|Bevacizumab|bevacizumab|mesh-list
19767466|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19767467|NCT00096278|Fluorouracil|fluorouracil|mesh-list
19767468|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
19767469|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
19767470|NCT00096278|Antibodies|antibodies|mesh-list
19767471|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
19767472|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19767473|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
19767474|NCT00096278|Calcium|calcium|mesh-list
19767475|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
20149756|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149757|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149758|NCT00083707|Thalidomide|thalidomide|mesh-list
20149759|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149760|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
20149761|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149762|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149763|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149764|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149765|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149766|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149767|NCT00083707|Growth Substances|growth substances|mesh-ancestor
20149768|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
20149769|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149770|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20149771|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
20149772|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316598|NCT00705120|Cyclosporine|cyclosporine|mesh-list
19767476|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767477|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19767478|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19767479|NCT00096278|Growth Substances|growth substances|mesh-ancestor
19767480|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767481|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767482|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
19767483|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19767484|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19767485|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
20149773|NCT00083785|Talaporfin|talaporfin|mesh-list
20316599|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
20316600|NCT00705120|Busulfan|busulfan|mesh-list
19767486|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767487|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767488|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767489|NCT00096278|Antidotes|antidotes|mesh-ancestor
19767490|NCT00096278|Protective Agents|protective agents|mesh-ancestor
19767491|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
19767492|NCT00096278|Vitamins|vitamins|mesh-ancestor
19767493|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
19767494|NCT00096278|Hematinics|hematinics|mesh-ancestor
19767495|NCT00096356|Vitamins|vitamins|mesh-list
19767496|NCT00096356|Vitamin E|vitamin e|mesh-list
19767497|NCT00096356|Tocopherols|tocopherols|mesh-list
19767498|NCT00096356|Tocotrienols|tocotrienols|mesh-list
19767499|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
19767500|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
19767501|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767502|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
19767503|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767504|NCT00096356|Protective Agents|protective agents|mesh-ancestor
19767505|NCT00096382|Aldesleukin|aldesleukin|mesh-list
19767506|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
19767507|NCT00096382|Fludarabine|fludarabine|mesh-list
19767508|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
19767509|NCT00096382|Interleukin-2|interleukin-2|mesh-list
19767510|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767511|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
19767512|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767513|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767514|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767515|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
19767516|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767517|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767518|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19767519|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767520|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
19767521|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19767522|NCT00096382|Analgesics|analgesics|mesh-ancestor
19767523|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
19767524|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767525|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19767526|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767527|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
19767528|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767529|NCT00096447|Lapatinib|lapatinib|mesh-list
19767530|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767531|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767532|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767533|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767534|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
19767535|NCT00096460|Carmustine|carmustine|mesh-list
19767536|NCT00096460|Rituximab|rituximab|mesh-list
19767537|NCT00096460|Methotrexate|methotrexate|mesh-list
19767538|NCT00096460|Fludarabine|fludarabine|mesh-list
19767539|NCT00096460|Etoposide|etoposide|mesh-list
19767540|NCT00096460|Tacrolimus|tacrolimus|mesh-list
19767541|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767542|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
19767543|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767544|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767545|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767546|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
19767547|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767548|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767549|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19767550|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767551|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19767552|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
19767553|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19767554|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767555|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
19767556|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767557|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767558|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19767559|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767560|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767561|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19767562|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20316601|NCT00705120|Cyclosporins|cyclosporins|mesh-list
19635169|NCT02429700|Etoposide|etoposide|mesh-list
19635170|NCT02429700|Carboplatin|carboplatin|mesh-list
19635171|NCT02429700|Bleomycin|bleomycin|mesh-list
19767563|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19767564|NCT00096486|Everolimus|everolimus|mesh-list
19767565|NCT00096486|Gefitinib|gefitinib|mesh-list
19767566|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767567|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149774|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149775|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20149776|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767568|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
19767569|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767570|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767571|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767572|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767573|NCT00096538|Valganciclovir|valganciclovir|mesh-list
19767574|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
19767575|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767576|NCT00096785|Entecavir|entecavir|mesh-list
19767577|NCT00096785|Adefovir|adefovir|mesh-list
19767578|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
19767579|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767580|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19767581|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767582|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767583|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767584|NCT00096941|Pertuzumab|pertuzumab|mesh-list
19767585|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767586|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149777|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20149778|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
20149779|NCT00083824|Estrogens|estrogens|mesh-list
20149780|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20149781|NCT00083824|Hormones|hormones|mesh-ancestor
20149782|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149783|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149784|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20149785|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20316602|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316603|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
20316604|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316605|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316606|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20316607|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
20316608|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316609|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316610|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20316611|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635172|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19635173|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635174|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
19635175|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
19635176|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
19635177|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635178|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19635179|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19635180|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635181|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19635182|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
19635183|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19635184|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19635185|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635186|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635187|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635188|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635189|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
19635190|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
19635191|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635192|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
19767587|NCT00096954|Omalizumab|omalizumab|mesh-list
20316612|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
19635193|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19635194|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
19767588|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19635195|NCT02429817|Edetic Acid|edetic acid|mesh-list
19767589|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19767590|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
19767591|NCT00096993|Gemcitabine|gemcitabine|mesh-list
19767592|NCT00096993|Pertuzumab|pertuzumab|mesh-list
19767593|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767594|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
19767595|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767596|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767597|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
19767598|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767599|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767600|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767601|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
19767602|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767603|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767604|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19767605|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767606|NCT00097448|Prednisone|prednisone|mesh-list
19767607|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
19767608|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19767609|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19767610|NCT00097448|Prednisolone|prednisolone|mesh-list
19767611|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
19767612|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19767613|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
19767614|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19767615|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
19767616|NCT00097448|Hormones|hormones|mesh-ancestor
19767617|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767618|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767619|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19767620|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767621|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
20149786|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20149787|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
20149788|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20149789|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20149790|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20149791|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20149792|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149793|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149794|NCT00083876|Thalidomide|thalidomide|mesh-list
20149795|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149796|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
20149797|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149798|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
20316613|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316614|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316615|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20316616|NCT00705198|Temozolomide|temozolomide|mesh-list
20316617|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20316618|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
20316619|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635196|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
19635197|NCT02429817|Antidotes|antidotes|mesh-ancestor
19635198|NCT02429817|Protective Agents|protective agents|mesh-ancestor
19635199|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635200|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
19635201|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
19635202|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635203|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19635204|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
19635205|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19635206|NCT02429882|Brodalumab|brodalumab|mesh-list
19635207|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
19635208|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
19635209|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19767622|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
19767623|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767624|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19635210|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
19767625|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19767626|NCT00097448|Protective Agents|protective agents|mesh-ancestor
19635211|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767627|NCT00097500|Metformin|metformin|mesh-list
19767628|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
19767629|NCT00097500|Exenatide|exenatide|mesh-list
19767630|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19767631|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767632|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19767633|NCT00097500|Incretins|incretins|mesh-ancestor
19767634|NCT00097500|Hormones|hormones|mesh-ancestor
19767635|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767636|NCT00097591|Clopidogrel|clopidogrel|mesh-list
19767637|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19767638|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19767639|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19767640|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19767641|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19767642|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
19767643|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19767644|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767645|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767646|NCT00097669|Folic Acid|folic acid|mesh-list
19767647|NCT00097669|Hematinics|hematinics|mesh-ancestor
19767648|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
19767649|NCT00097669|Vitamins|vitamins|mesh-ancestor
19767650|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
19767651|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767652|NCT00097695|Icatibant|icatibant|mesh-list
19767653|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19767654|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19767655|NCT00097695|Analgesics|analgesics|mesh-ancestor
19767656|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
19767657|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767658|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767659|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19767660|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767661|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19767662|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19767663|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767664|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19767665|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767666|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
19767667|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
19767668|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19767669|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19767670|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767671|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19767672|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
19767673|NCT00097773|Tobramycin|tobramycin|mesh-list
19767674|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19767675|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767676|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19767677|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767678|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767679|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767680|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316620|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635212|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635213|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19635214|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
19635215|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19635216|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19635217|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19635218|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635219|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635220|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635221|NCT02429687|Paclitaxel|paclitaxel|mesh-list
19635222|NCT02429687|Etoposide|etoposide|mesh-list
19635223|NCT02429687|Carboplatin|carboplatin|mesh-list
19635224|NCT02429687|Bleomycin|bleomycin|mesh-list
19635225|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19635226|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635227|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767681|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19635228|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316621|NCT00705315|Bevacizumab|bevacizumab|mesh-list
20316622|NCT00705315|Docetaxel|docetaxel|mesh-list
20316623|NCT00705315|Epirubicin|epirubicin|mesh-list
20316624|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20316625|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316626|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19767682|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19767683|NCT00097786|Nateglinide|nateglinide|mesh-list
19767684|NCT00097786|Valsartan|valsartan|mesh-list
19767685|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19767686|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19767687|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19767688|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767689|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19767690|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767691|NCT00097981|Thalidomide|thalidomide|mesh-list
19767692|NCT00097981|Dexamethasone|dexamethasone|mesh-list
19767693|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19767694|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
19767695|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
19767696|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767697|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767698|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19767699|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
20316627|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20316628|NCT00705315|Growth Substances|growth substances|mesh-ancestor
20316629|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316630|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316631|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316632|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316633|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316634|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316635|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20316636|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20316637|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20316638|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767700|NCT00097981|Hormones|hormones|mesh-ancestor
19767701|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767702|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19767703|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767704|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767705|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
19767706|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
19767707|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19767708|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767709|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19767710|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19767711|NCT00097981|Growth Substances|growth substances|mesh-ancestor
19767712|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767713|NCT00098020|Isotretinoin|isotretinoin|mesh-list
19767714|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767715|NCT00098059|Famciclovir|famciclovir|mesh-list
19767716|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
19767717|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316639|NCT00705354|Bacitracin|bacitracin|mesh-list
20316640|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20316641|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316642|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316643|NCT00705419|Tenofovir|tenofovir|mesh-list
20316644|NCT00705419|Emtricitabine|emtricitabine|mesh-list
20316645|NCT00705419|Maleic acid|maleic acid|mesh-list
20316646|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
19635229|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
19635230|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635231|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19635232|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19635233|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635234|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19635235|NCT02429622|Paclitaxel|paclitaxel|mesh-list
19635236|NCT02429622|Nedaplatin|nedaplatin|mesh-list
19635237|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19635238|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635239|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
19635240|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
19635241|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
19635242|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635243|NCT02429596|Lamotrigine|lamotrigine|mesh-list
19635244|NCT02429596|Carbamazepine|carbamazepine|mesh-list
20149799|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149800|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149801|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149802|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149803|NCT00083876|Growth Substances|growth substances|mesh-ancestor
19767718|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767719|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767720|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767721|NCT00098254|Sorafenib|sorafenib|mesh-list
19767722|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767723|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767724|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767725|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767726|NCT00098293|Lamivudine|lamivudine|mesh-list
19767727|NCT00098293|Zidovudine|zidovudine|mesh-list
19767728|NCT00098293|Efavirenz|efavirenz|mesh-list
19767729|NCT00098293|Maraviroc|maraviroc|mesh-list
19767730|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19767731|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767732|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767733|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767734|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
19767735|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767736|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19767737|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767738|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
19767739|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19767740|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19767741|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19767742|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19767743|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19767744|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19767745|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19767746|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19767747|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19767748|NCT00098306|Maraviroc|maraviroc|mesh-list
19767749|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19767750|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19767751|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767752|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19767753|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767754|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
19767755|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767756|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19767757|NCT00098371|Alvocidib|alvocidib|mesh-list
19767758|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767759|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767760|NCT00098371|Growth Substances|growth substances|mesh-ancestor
19767761|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767762|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767763|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767764|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767765|NCT00098670|Rituximab|rituximab|mesh-list
19767766|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19767767|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
19767768|NCT00098670|Fludarabine|fludarabine|mesh-list
19767769|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
19767770|NCT00098670|Antibodies|antibodies|mesh-list
19767771|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
19767772|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19767773|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
19767774|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767775|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767776|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767777|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767778|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
19767779|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767780|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767781|NCT00098722|Maraviroc|maraviroc|mesh-list
19767782|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19767783|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19767784|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767785|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20149804|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767786|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767787|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
19767788|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316647|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316648|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20316649|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20316650|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316651|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316652|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20611015|NCT02506153|Ipilimumab|ipilimumab|mesh-list
20611016|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20611017|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611018|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
20611019|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611020|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20316653|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767789|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19767790|NCT00098748|Maraviroc|maraviroc|mesh-list
19767791|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19767792|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19767793|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767794|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19767795|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767796|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
19767797|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767798|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19767799|NCT00098774|Leucovorin|leucovorin|mesh-list
19767800|NCT00098774|Cytarabine|cytarabine|mesh-list
19767801|NCT00098774|Rituximab|rituximab|mesh-list
19767802|NCT00098774|Methotrexate|methotrexate|mesh-list
19767803|NCT00098774|Etoposide|etoposide|mesh-list
19767804|NCT00098774|Temozolomide|temozolomide|mesh-list
19767805|NCT00098774|Calcium|calcium|mesh-list
19767806|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
19767807|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767808|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767809|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
19767810|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767811|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767812|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19767813|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19767814|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
19767815|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19767816|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767817|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
19767818|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767819|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767820|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767821|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19767822|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767823|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767824|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767825|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19767826|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767827|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
19767828|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149805|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149806|NCT00083902|Thalidomide|thalidomide|mesh-list
20149807|NCT00083902|Dexamethasone|dexamethasone|mesh-list
20149808|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149809|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
20149810|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
20149811|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149812|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149813|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20149814|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
20149815|NCT00083902|Hormones|hormones|mesh-ancestor
20149816|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149817|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20149818|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767829|NCT00098774|Antidotes|antidotes|mesh-ancestor
19767830|NCT00098774|Protective Agents|protective agents|mesh-ancestor
19767831|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
20149819|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767832|NCT00098774|Vitamins|vitamins|mesh-ancestor
19767833|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
19767834|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767835|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
19767836|NCT00098787|Leucovorin|leucovorin|mesh-list
19767837|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
19767838|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19767839|NCT00098787|Bevacizumab|bevacizumab|mesh-list
19767840|NCT00098787|Fluorouracil|fluorouracil|mesh-list
19767841|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
19767842|NCT00098787|Irinotecan|irinotecan|mesh-list
19767843|NCT00098787|Camptothecin|camptothecin|mesh-list
19767844|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
19767845|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767846|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767847|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19767848|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19767849|NCT00098787|Growth Substances|growth substances|mesh-ancestor
19767850|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767851|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767852|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
19767853|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767854|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767855|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316654|NCT00705445|Zinc|zinc|mesh-list
20611021|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611022|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
20611023|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611024|NCT02389946|Sirolimus|sirolimus|mesh-list
20611025|NCT02389946|Everolimus|everolimus|mesh-list
20316655|NCT00705445|Trace Elements|trace elements|mesh-list
20316656|NCT00705445|Micronutrients|micronutrients|mesh-list
20316657|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316658|NCT00705471|Infliximab|infliximab|mesh-list
20316659|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316660|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19767856|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
19767857|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19767858|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767859|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767860|NCT00098787|Antidotes|antidotes|mesh-ancestor
19767861|NCT00098787|Protective Agents|protective agents|mesh-ancestor
19767862|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
19767863|NCT00098787|Vitamins|vitamins|mesh-ancestor
19767864|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
19767865|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19833199|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833200|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833201|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833202|NCT00551447|Simvastatin|simvastatin|mesh-list
19833203|NCT00551447|Ezetimibe|ezetimibe|mesh-list
19833204|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833205|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833206|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
20149820|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
20316661|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316662|NCT00705510|Cyclosporine|cyclosporine|mesh-list
20316663|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19635245|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
19635246|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19635247|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635248|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635249|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19635250|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635251|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19635252|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19635253|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635254|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19635255|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19635256|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
19635257|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19635258|NCT02429596|Analgesics|analgesics|mesh-ancestor
19635259|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
19635260|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635261|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19635262|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19635263|NCT02429219|Ethanol|ethanol|mesh-list
19635264|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19767866|NCT00098813|Romidepsin|romidepsin|mesh-list
19767867|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767868|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767869|NCT00098839|Leucovorin|leucovorin|mesh-list
19767870|NCT00098839|Cytarabine|cytarabine|mesh-list
19767871|NCT00098839|Prednisone|prednisone|mesh-list
19767872|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
19767873|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19767874|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19767875|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19767876|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
19767877|NCT00098839|Doxorubicin|doxorubicin|mesh-list
19767878|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19767879|NCT00098839|Methotrexate|methotrexate|mesh-list
19767880|NCT00098839|Etoposide|etoposide|mesh-list
19767881|NCT00098839|Vincristine|vincristine|mesh-list
20316664|NCT00705510|Cyclosporins|cyclosporins|mesh-list
19635265|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767882|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
19767883|NCT00098839|Asparaginase|asparaginase|mesh-list
19767884|NCT00098839|Pegaspargase|pegaspargase|mesh-list
19767885|NCT00098839|Epratuzumab|epratuzumab|mesh-list
19767886|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
19767887|NCT00098839|Razoxane|razoxane|mesh-list
19635266|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635267|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635268|NCT02429193|Prednisone|prednisone|mesh-list
19635269|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
19635270|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19635271|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
19635272|NCT02429193|Hormones|hormones|mesh-ancestor
19635273|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767888|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
19767889|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767890|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
19767891|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767892|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767893|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767894|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
19767895|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767896|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767897|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19767898|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19767899|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19767900|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767901|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316665|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635274|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635275|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635276|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635277|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19635278|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635279|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635280|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
19635281|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19635282|NCT02429271|Clopidogrel|clopidogrel|mesh-list
19635283|NCT02429271|Ticagrelor|ticagrelor|mesh-list
19635284|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19635285|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19635286|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19635287|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19635288|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
19635289|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635290|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635291|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635292|NCT02429466|Guadecitabine|guadecitabine|mesh-list
19635293|NCT02429466|Azacitidine|azacitidine|mesh-list
19635294|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635295|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635296|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
19635297|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767902|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347386|NCT00859885|Aspirin|aspirin|mesh-list
19767903|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
19767904|NCT00098839|Hormones|hormones|mesh-ancestor
19767905|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19767906|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19767907|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19767908|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
19767909|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19767910|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19767911|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
19767912|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
19767913|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19767914|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767915|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19767916|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
19767917|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767918|NCT00098839|Antidotes|antidotes|mesh-ancestor
19767919|NCT00098839|Protective Agents|protective agents|mesh-ancestor
19767920|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
19767921|NCT00098839|Vitamins|vitamins|mesh-ancestor
19767922|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
20316666|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316667|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316668|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
20316669|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316670|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
20316671|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316672|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316673|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635298|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635299|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19635300|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
19635301|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635302|NCT02429505|Miltefosine|miltefosine|mesh-list
19767923|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
19767924|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19767925|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19767926|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19767927|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19767928|NCT00098865|Thalidomide|thalidomide|mesh-list
19767929|NCT00098865|Temozolomide|temozolomide|mesh-list
19767930|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19767931|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
19767932|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767933|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767934|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19767935|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
19767936|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767937|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
19767938|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19767939|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767940|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19767941|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19767942|NCT00098865|Growth Substances|growth substances|mesh-ancestor
19767943|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
19767944|NCT00098956|Topotecan|topotecan|mesh-list
19767945|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
19767946|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19767947|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19767948|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149821|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
20149822|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149823|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149824|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20149825|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20149826|NCT00083902|Growth Substances|growth substances|mesh-ancestor
20149827|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
19635303|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
19635304|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635305|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635306|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19635307|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19635308|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
19635309|NCT02429388|Spironolactone|spironolactone|mesh-list
19635310|NCT02429388|Diuretics|diuretics|mesh-list
19635311|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
19767949|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149828|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20149829|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
19767950|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19767951|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19767952|NCT00099021|Pioglitazone|pioglitazone|mesh-list
19767953|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19767954|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767955|NCT00099047|Celecoxib|celecoxib|mesh-list
19767956|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19767957|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19767958|NCT00099047|Analgesics|analgesics|mesh-ancestor
19767959|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
19767960|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19767961|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767962|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19767963|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19767964|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19767965|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19767966|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767967|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767968|NCT00099268|Levodopa|levodopa|mesh-list
19767969|NCT00099268|Carbidopa|carbidopa|mesh-list
19767970|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19767971|NCT00099268|Entacapone|entacapone|mesh-list
19767972|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19767973|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19767974|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
19767975|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149830|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20149831|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20149832|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20149833|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635312|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19635313|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
19635314|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635315|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635316|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
19635317|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635318|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635319|NCT02429232|Pioglitazone|pioglitazone|mesh-list
19767976|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767977|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19767978|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19767979|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767980|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19767981|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
19767982|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
19767983|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19767984|NCT00099359|Lamivudine|lamivudine|mesh-list
19767985|NCT00099359|Zidovudine|zidovudine|mesh-list
19767986|NCT00099359|Nevirapine|nevirapine|mesh-list
19767987|NCT00099359|Nelfinavir|nelfinavir|mesh-list
19767988|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19767989|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19767990|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19767991|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19767992|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
19767993|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19767994|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19767995|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19767996|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
19767997|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19767998|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19767999|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19768000|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19768001|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
19768002|NCT00099632|Ritonavir|ritonavir|mesh-list
19768003|NCT00099632|Lopinavir|lopinavir|mesh-list
19768004|NCT00099632|Tenofovir|tenofovir|mesh-list
19768005|NCT00099632|Lamivudine|lamivudine|mesh-list
19768006|NCT00099632|Zidovudine|zidovudine|mesh-list
19635320|NCT02429232|Linagliptin|linagliptin|mesh-list
19768007|NCT00099632|Emtricitabine|emtricitabine|mesh-list
19768008|NCT00099632|Nevirapine|nevirapine|mesh-list
19635321|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19768009|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19768010|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19768011|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19768012|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19768013|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
19768014|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768015|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768016|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768017|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19768018|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
19768019|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768020|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19768021|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19768022|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19768023|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768024|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
19768025|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19768026|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19768027|NCT00099983|Risperidone|risperidone|mesh-list
19768028|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19768029|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
19768030|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768031|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768032|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768033|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19768034|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19768035|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19768036|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768037|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19768038|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
19768039|NCT00100048|Tenofovir|tenofovir|mesh-list
19768040|NCT00100048|Lamivudine|lamivudine|mesh-list
19768041|NCT00100048|Efavirenz|efavirenz|mesh-list
19768042|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
19768043|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
19768044|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768045|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19768046|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768047|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768048|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768049|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768050|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19768051|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19768052|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19768053|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19768054|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19768055|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19768056|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19768057|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19768058|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19768059|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
19768060|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19768061|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19768062|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
19768063|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768064|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768065|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768066|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
19768067|NCT00100178|Daclizumab|daclizumab|mesh-list
19768068|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768069|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768070|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19768071|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
19768072|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19768073|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768074|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768075|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768076|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768077|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
19768078|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768079|NCT00100659|Interferons|interferons|mesh-list
19768080|NCT00100659|Ribavirin|ribavirin|mesh-list
19768081|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768082|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
19768083|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768084|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
19768085|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768086|NCT00100698|Hormones|hormones|mesh-list
20316674|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20316675|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20316676|NCT00705549|Gemcitabine|gemcitabine|mesh-list
20316677|NCT00705549|Cisplatin|cisplatin|mesh-list
20316678|NCT00705549|Docetaxel|docetaxel|mesh-list
20316679|NCT00705549|Vinorelbine|vinorelbine|mesh-list
20316680|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316681|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316682|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
20316683|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316684|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
20316685|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316686|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316687|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316688|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
20316689|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316690|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316691|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316692|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316693|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20316694|NCT00705562|Caseins|caseins|mesh-list
20316695|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
20316696|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
20316697|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316698|NCT00705588|Tadalafil|tadalafil|mesh-list
20316699|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20316700|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
20316701|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20316702|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20316703|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316704|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768087|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768088|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768089|NCT00100789|Gemcitabine|gemcitabine|mesh-list
19768090|NCT00100789|Paclitaxel|paclitaxel|mesh-list
19768091|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19768092|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768093|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
19768094|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
19768095|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
19768096|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768097|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768098|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
19768099|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
19768100|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768101|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768102|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768103|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
19768104|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768105|NCT00100802|Temozolomide|temozolomide|mesh-list
19768106|NCT00100802|Lomustine|lomustine|mesh-list
19768107|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19768108|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
19768109|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768110|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768111|NCT00100815|Gemcitabine|gemcitabine|mesh-list
19768112|NCT00100815|Bevacizumab|bevacizumab|mesh-list
19768113|NCT00100815|Capecitabine|capecitabine|mesh-list
19768114|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768115|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768116|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19768117|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19768118|NCT00100815|Growth Substances|growth substances|mesh-ancestor
19768119|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768120|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316705|NCT00705588|Urological Agents|urological agents|mesh-ancestor
19768121|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768122|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
20149834|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149835|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20149836|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20149837|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20149838|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20149839|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149840|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20149841|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149842|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20149843|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
20149844|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20149845|NCT00083993|Sirolimus|sirolimus|mesh-list
20149846|NCT00083993|Letrozole|letrozole|mesh-list
20316706|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
20316707|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20149847|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149848|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20316708|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
20316709|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768123|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768124|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
19768125|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768126|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768127|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768128|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
19768129|NCT00100841|Leucovorin|leucovorin|mesh-list
19768130|NCT00100841|Bevacizumab|bevacizumab|mesh-list
19768131|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19768132|NCT00100841|Cetuximab|cetuximab|mesh-list
19768133|NCT00100841|Fluorouracil|fluorouracil|mesh-list
19768134|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
19768135|NCT00100841|Antibodies|antibodies|mesh-list
19768136|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
19768137|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19768138|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
19768139|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768140|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19768141|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19768142|NCT00100841|Growth Substances|growth substances|mesh-ancestor
19768143|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768144|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
19768145|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
19768146|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
19768147|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768148|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316710|NCT00705692|Levamisole|levamisole|mesh-list
20316711|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20316712|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
20316713|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316714|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
20316715|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
20316716|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20316717|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316718|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316719|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
20316720|NCT00705770|Anecortave|anecortave|mesh-list
20316721|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20316722|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20316723|NCT00705770|Growth Substances|growth substances|mesh-ancestor
20316724|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316725|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316726|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316727|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316728|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
19768149|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768150|NCT00100841|Antidotes|antidotes|mesh-ancestor
19768151|NCT00100841|Protective Agents|protective agents|mesh-ancestor
19768152|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
19768153|NCT00100841|Vitamins|vitamins|mesh-ancestor
19768154|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
19768155|NCT00101010|Prednisone|prednisone|mesh-list
19768156|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
20316729|NCT00705796|Testosterone|testosterone|mesh-list
20316730|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
19768157|NCT00101010|Rituximab|rituximab|mesh-list
19768158|NCT00101010|Doxorubicin|doxorubicin|mesh-list
19768159|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19768160|NCT00101010|Vincristine|vincristine|mesh-list
19768161|NCT00101010|Lenograstim|lenograstim|mesh-list
19768162|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768163|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
19768164|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768165|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768166|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19768167|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
19768168|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768169|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768170|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19768171|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768172|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768173|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19768174|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768175|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768176|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19768177|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
19768178|NCT00101010|Hormones|hormones|mesh-ancestor
19768179|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768180|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19768181|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19768182|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19768183|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
19768184|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
19768185|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
19768186|NCT00101036|Lapatinib|lapatinib|mesh-list
19768187|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768188|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768189|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768190|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768191|NCT00101101|Aldesleukin|aldesleukin|mesh-list
19768192|NCT00101101|Dexamethasone|dexamethasone|mesh-list
19768193|NCT00101101|Prednisone|prednisone|mesh-list
19768194|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
19635322|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635323|NCT02429232|Incretins|incretins|mesh-ancestor
19635324|NCT02429232|Hormones|hormones|mesh-ancestor
19768195|NCT00101101|Doxorubicin|doxorubicin|mesh-list
19768196|NCT00101101|Vincristine|vincristine|mesh-list
19768197|NCT00101101|Interleukin-2|interleukin-2|mesh-list
19768198|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768199|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
19768200|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768201|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768202|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19768203|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
19768204|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768205|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768206|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19768207|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19768208|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
19768209|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
19768210|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19768211|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19768212|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
19768213|NCT00101101|Hormones|hormones|mesh-ancestor
19768214|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768215|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19768216|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19635325|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635326|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19635327|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
19635328|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635329|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635330|NCT02429323|Sevoflurane|sevoflurane|mesh-list
19635331|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19635332|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19635333|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
19635334|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
19635335|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635336|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768217|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19768218|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768219|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768220|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19768221|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
19768222|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
19768223|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
19768224|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19768225|NCT00101101|Analgesics|analgesics|mesh-ancestor
19768226|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
19768227|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768228|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19768229|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
19768230|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768231|NCT00101166|Vaccines|vaccines|mesh-list
19768232|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
19768233|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768234|NCT00101192|Cetuximab|cetuximab|mesh-list
19768235|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768236|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768237|NCT00101283|Gemcitabine|gemcitabine|mesh-list
19768238|NCT00101283|Carboplatin|carboplatin|mesh-list
19768239|NCT00101283|Pemetrexed|pemetrexed|mesh-list
19768240|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768241|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768242|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
19768243|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768244|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
19768245|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768246|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768247|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768248|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
19768249|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768250|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19768251|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768252|NCT00101361|Oxandrolone|oxandrolone|mesh-list
19768253|NCT00101361|Androgens|androgens|mesh-ancestor
19768254|NCT00101361|Hormones|hormones|mesh-ancestor
19768255|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768256|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768257|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
19768258|NCT00101400|Sorafenib|sorafenib|mesh-list
19768259|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768260|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768261|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768262|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768263|NCT00101413|Sorafenib|sorafenib|mesh-list
19768264|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768265|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768266|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768267|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768268|NCT00101452|Citalopram|citalopram|mesh-list
19768269|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19768270|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19768271|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768272|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768273|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768274|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
19768275|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768276|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19768277|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
19768278|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768279|NCT00101582|Cisplatin|cisplatin|mesh-list
19768280|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768281|NCT00101647|Dasatinib|dasatinib|mesh-list
19768282|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768283|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768284|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768285|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768286|NCT00101660|Dasatinib|dasatinib|mesh-list
19768287|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768288|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768289|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768290|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768291|NCT00101686|Bevacizumab|bevacizumab|mesh-list
19768292|NCT00101686|Capecitabine|capecitabine|mesh-list
19768293|NCT00101686|Irinotecan|irinotecan|mesh-list
19768294|NCT00101686|Fluorouracil|fluorouracil|mesh-list
19768295|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768296|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768297|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19768298|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19768299|NCT00101686|Growth Substances|growth substances|mesh-ancestor
19768300|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768301|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
19768302|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768303|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
19768304|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768305|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19768306|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768307|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768308|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768309|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
19768310|NCT00101816|Dasatinib|dasatinib|mesh-list
19768311|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768312|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768313|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768314|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768315|NCT00101907|Gemcitabine|gemcitabine|mesh-list
19768316|NCT00101907|Panitumumab|panitumumab|mesh-list
19768317|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
19768318|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768319|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768320|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
19768321|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768322|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
19768323|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768324|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768325|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149849|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20149850|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149851|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149852|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20149853|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
20149854|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149855|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149856|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149857|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149858|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20149859|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
20149860|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149861|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
20149862|NCT00084019|Ritonavir|ritonavir|mesh-list
20149863|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20149864|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20149865|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20149866|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
20149867|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149868|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149869|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20149870|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20149871|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
20149872|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149873|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20149874|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20149875|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20149876|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
20149877|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149878|NCT00084058|Ritonavir|ritonavir|mesh-list
20149879|NCT00084058|Lopinavir|lopinavir|mesh-list
20149880|NCT00084058|Saquinavir|saquinavir|mesh-list
20149881|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20149882|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20149883|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
20149884|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149885|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149886|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768326|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
19768327|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149887|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20149888|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
19768328|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768329|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768330|NCT00102063|Aripiprazole|aripiprazole|mesh-list
19768331|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
19768332|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768333|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19768334|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19768335|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19768336|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768337|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
19768338|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
19768339|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768340|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768341|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19768342|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19768343|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
19768344|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19768345|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19768346|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19768347|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19768348|NCT00102440|Allopurinol|allopurinol|mesh-list
19768349|NCT00102440|Febuxostat|febuxostat|mesh-list
19768350|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
19768351|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768352|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768353|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
19768354|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768355|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19768356|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
19768357|NCT00102440|Protective Agents|protective agents|mesh-ancestor
19768358|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768359|NCT00102518|Aripiprazole|aripiprazole|mesh-list
19768360|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
19768361|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768362|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19768363|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19768364|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19768365|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768366|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
19768367|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
19768368|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768369|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768370|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19768371|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19768372|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
19768373|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19768374|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19768375|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19768376|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19768377|NCT00102531|Cisplatin|cisplatin|mesh-list
19768378|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768379|NCT00102687|Azacitidine|azacitidine|mesh-list
19768380|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768381|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
19768382|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768383|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768384|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768385|NCT00102804|Pemetrexed|pemetrexed|mesh-list
19768386|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768387|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768388|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768389|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19768390|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768391|NCT00102960|Ritonavir|ritonavir|mesh-list
19768392|NCT00102960|Lopinavir|lopinavir|mesh-list
19768393|NCT00102960|Lamivudine|lamivudine|mesh-list
19768394|NCT00102960|Zidovudine|zidovudine|mesh-list
19768395|NCT00102960|Nevirapine|nevirapine|mesh-list
19768396|NCT00102960|Abacavir|abacavir|mesh-list
19768397|NCT00102960|Didanosine|didanosine|mesh-list
19768398|NCT00102960|Efavirenz|efavirenz|mesh-list
19768399|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19768400|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19768401|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
19768402|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768403|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768404|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768405|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19768406|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
19768407|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768408|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20316731|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
20316732|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20316733|NCT00705796|Androgens|androgens|mesh-ancestor
20316734|NCT00705796|Hormones|hormones|mesh-ancestor
20316735|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316736|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316737|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20316738|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768409|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19768410|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19768411|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768412|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
19768413|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19768414|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19768415|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19768416|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19768417|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19768418|NCT00103116|Vaccines|vaccines|mesh-list
19768419|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
19768420|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768421|NCT00103142|Sargramostim|sargramostim|mesh-list
19768422|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
19768423|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768424|NCT00103194|Lapatinib|lapatinib|mesh-list
19768425|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768426|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768427|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768428|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768429|NCT00103207|Cetuximab|cetuximab|mesh-list
19768430|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768431|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768432|NCT00103259|Irinotecan|irinotecan|mesh-list
19768433|NCT00103259|Bortezomib|bortezomib|mesh-list
19768434|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19768435|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768436|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768437|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768438|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768439|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
19768440|NCT00103285|Leucovorin|leucovorin|mesh-list
19768441|NCT00103285|Folic Acid|folic acid|mesh-list
19768442|NCT00103285|Cytarabine|cytarabine|mesh-list
19768443|NCT00103285|Dexamethasone|dexamethasone|mesh-list
19768444|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
19768445|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
19768446|NCT00103285|Doxorubicin|doxorubicin|mesh-list
19768447|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19768448|NCT00103285|Methotrexate|methotrexate|mesh-list
19768449|NCT00103285|Vincristine|vincristine|mesh-list
19768450|NCT00103285|Asparaginase|asparaginase|mesh-list
19768451|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
20316739|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
20316740|NCT00705822|Prednisone|prednisone|mesh-list
19635337|NCT02429440|Molgramostim|molgramostim|mesh-list
19635338|NCT02429440|Sargramostim|sargramostim|mesh-list
19635339|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
19635340|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635341|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635342|NCT02429453|Thrombin|thrombin|mesh-list
19635343|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
19635344|NCT02429453|Coagulants|coagulants|mesh-ancestor
19635345|NCT02429518|Miltefosine|miltefosine|mesh-list
19635346|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
19635347|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635348|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635349|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19635350|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19768452|NCT00103285|Pegaspargase|pegaspargase|mesh-list
19768453|NCT00103285|Thioguanine|thioguanine|mesh-list
19768454|NCT00103285|BB 1101|bb 1101|mesh-list
19635351|NCT02428751|Prednisone|prednisone|mesh-list
19635352|NCT02428751|Rituximab|rituximab|mesh-list
19768455|NCT00103285|Calcium|calcium|mesh-list
19768456|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
19768457|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
20316741|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
19768458|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768459|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
19768460|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768461|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768462|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19768463|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
19768464|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768465|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768466|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19768467|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19768468|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
19768469|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
19768470|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19768471|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19768472|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
19768473|NCT00103285|Hormones|hormones|mesh-ancestor
19768474|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768475|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19768476|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
19768477|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768478|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768479|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19768480|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768481|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19768482|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19768483|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19768484|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
19768485|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19768486|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768487|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
19768488|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
19768489|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19768490|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768491|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
19768492|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768493|NCT00103285|Antidotes|antidotes|mesh-ancestor
19768494|NCT00103285|Protective Agents|protective agents|mesh-ancestor
19768495|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
19768496|NCT00103285|Vitamins|vitamins|mesh-ancestor
19768497|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
19768498|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19768499|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
19768500|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
19768501|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
19768502|NCT00103285|Hematinics|hematinics|mesh-ancestor
19768503|NCT00103376|Bortezomib|bortezomib|mesh-list
19768504|NCT00103376|Androgens|androgens|mesh-list
19768505|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
19768506|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768507|NCT00103376|Hormones|hormones|mesh-ancestor
19768508|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768509|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768510|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
19768511|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
19768512|NCT00103402|Alfuzosin|alfuzosin|mesh-list
19768513|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19768514|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19768515|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19768516|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
19768517|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768518|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768519|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768520|NCT00103402|Urological Agents|urological agents|mesh-ancestor
19768521|NCT00103506|Doxorubicin|doxorubicin|mesh-list
19768522|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19768523|NCT00103506|Bortezomib|bortezomib|mesh-list
19768524|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768525|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768526|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19768527|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768528|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768529|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149889|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768530|NCT00103610|Plerixafor|plerixafor|mesh-list
19768531|NCT00103610|Sargramostim|sargramostim|mesh-list
20149890|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20149891|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20149892|NCT00084097|Omalizumab|omalizumab|mesh-list
20611026|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611027|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768532|NCT00103610|Lenograstim|lenograstim|mesh-list
19768533|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
19768534|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768535|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19768536|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768537|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20611028|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
19768538|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
19768539|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768540|NCT00103662|Plerixafor|plerixafor|mesh-list
19768541|NCT00103662|Sargramostim|sargramostim|mesh-list
19768542|NCT00103662|Lenograstim|lenograstim|mesh-list
19768543|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
19768544|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768545|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19768546|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768547|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19768548|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
19768549|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768550|NCT00103740|Vitamin D|vitamin d|mesh-list
20149893|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20149894|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20149895|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
20149896|NCT00084201|Amoxicillin|amoxicillin|mesh-list
20149897|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19768551|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
19768552|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
19768553|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
19768554|NCT00103740|Calcium|calcium|mesh-list
19768555|NCT00103740|Vitamins|vitamins|mesh-ancestor
19768556|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
19768557|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768558|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19768559|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19768560|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19768561|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768562|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768563|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
19768564|NCT00103844|Dasatinib|dasatinib|mesh-list
19768565|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768566|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768567|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768568|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768569|NCT00103857|Metformin|metformin|mesh-list
19768570|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19768571|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19768572|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768573|NCT00103857|Incretins|incretins|mesh-ancestor
19768574|NCT00103857|Hormones|hormones|mesh-ancestor
19768575|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768576|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19768577|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
19768578|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768579|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768580|NCT00104052|Ribavirin|ribavirin|mesh-list
19768581|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19768582|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
19768583|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
19768584|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768585|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
19768586|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768587|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
19768588|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768589|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
19768590|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19768591|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768592|NCT00104247|Verapamil|verapamil|mesh-list
19768593|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19768594|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19768595|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768596|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149898|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768597|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19768598|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768599|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
19768600|NCT00104299|Prednisone|prednisone|mesh-list
19768601|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
19768602|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
19768603|NCT00104299|Rituximab|rituximab|mesh-list
19768604|NCT00104299|Azathioprine|azathioprine|mesh-list
19768605|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
19768606|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316742|NCT00705822|Docetaxel|docetaxel|mesh-list
20316743|NCT00705822|Estramustine|estramustine|mesh-list
20316744|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768607|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
19768608|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768609|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768610|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19768611|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
19768612|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768613|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768614|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19768615|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768616|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19768617|NCT00104299|Hormones|hormones|mesh-ancestor
19768618|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768619|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19768620|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
19768621|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
19768622|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19768623|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19768624|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19768625|NCT00104299|Protective Agents|protective agents|mesh-ancestor
19768626|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
19768627|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768628|NCT00104416|Lamotrigine|lamotrigine|mesh-list
19768629|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
20149899|NCT00084214|Paclitaxel|paclitaxel|mesh-list
20149900|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20149901|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149902|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
20149903|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
20149904|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149905|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149906|NCT00084227|Azithromycin|azithromycin|mesh-list
20149907|NCT00084227|Chloroquine|chloroquine|mesh-list
20149908|NCT00084227|Atovaquone|atovaquone|mesh-list
20149909|NCT00084227|Proguanil|proguanil|mesh-list
20149910|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19635353|NCT02428751|Doxorubicin|doxorubicin|mesh-list
19635354|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20316745|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316746|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
19635355|NCT02428751|Vincristine|vincristine|mesh-list
19635356|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19635357|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635358|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
19635359|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635360|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635361|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19635362|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20149911|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149912|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149913|NCT00084227|Amebicides|amebicides|mesh-ancestor
20149914|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20316747|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
19768630|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20149915|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19768631|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768632|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768633|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19768634|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768635|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19768636|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19768637|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19768638|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768639|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19768640|NCT00104572|Vitamin D|vitamin d|mesh-list
19768641|NCT00104572|Anastrozole|anastrozole|mesh-list
19768642|NCT00104572|Calcium|calcium|mesh-list
19768643|NCT00104572|Testosterone|testosterone|mesh-list
19768644|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19768645|NCT00104572|Vitamins|vitamins|mesh-ancestor
19768646|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
19768647|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768648|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19768649|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19768650|NCT00104572|Androgens|androgens|mesh-ancestor
19768651|NCT00104572|Hormones|hormones|mesh-ancestor
19768652|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768653|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19768654|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768655|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19768656|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768657|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768658|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19768659|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
19768660|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
19768661|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768662|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
19768663|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19768664|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19768665|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768666|NCT00104637|Urological Agents|urological agents|mesh-ancestor
19768667|NCT00104650|Diphosphonates|diphosphonates|mesh-list
19768668|NCT00104650|Denosumab|denosumab|mesh-list
19768669|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19768670|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768671|NCT00104676|Paclitaxel|paclitaxel|mesh-list
19768672|NCT00104676|Etoposide|etoposide|mesh-list
19768673|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
19768674|NCT00104676|Ifosfamide|ifosfamide|mesh-list
19768675|NCT00104676|Bleomycin|bleomycin|mesh-list
19768676|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19768677|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768678|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
19768679|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
19768680|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
19768681|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768682|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19768683|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768684|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768685|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19768686|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
19768687|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768688|NCT00104858|Cyclosporine|cyclosporine|mesh-list
19768689|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
19768690|NCT00104858|Rituximab|rituximab|mesh-list
19768691|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19768692|NCT00104858|Fludarabine|fludarabine|mesh-list
19768693|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
19768694|NCT00104858|Antibodies|antibodies|mesh-list
19768695|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
19768696|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19768697|NCT00104858|Cyclosporins|cyclosporins|mesh-list
19768698|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
19768699|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768700|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768701|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768702|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768703|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
19768704|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768705|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20149916|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
19635363|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768706|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768707|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
19768708|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768709|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
19768710|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19768711|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768712|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19768713|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
19768714|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19768715|NCT00104871|Bortezomib|bortezomib|mesh-list
19768716|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768717|NCT00104884|Romidepsin|romidepsin|mesh-list
19768718|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768719|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768720|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
19768721|NCT00105001|Sirolimus|sirolimus|mesh-list
19768722|NCT00105001|Fludarabine|fludarabine|mesh-list
19768723|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
19768724|NCT00105001|Tacrolimus|tacrolimus|mesh-list
19768725|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768726|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768727|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
20149917|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149918|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149919|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768728|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768729|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768730|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
19768731|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768732|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19768733|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149920|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
20149921|NCT00084240|Azithromycin|azithromycin|mesh-list
20149922|NCT00084240|Chloroquine|chloroquine|mesh-list
20149923|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20149924|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
20149925|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
20149926|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19635364|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635365|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635366|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19635367|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
20149927|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20149928|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149929|NCT00084240|Amebicides|amebicides|mesh-ancestor
20149930|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20149931|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20149932|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
20316748|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316749|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316750|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
20316751|NCT00705822|Hormones|hormones|mesh-ancestor
20316752|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635368|NCT02428751|Hormones|hormones|mesh-ancestor
19635369|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635370|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635371|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19635372|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
19635373|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
19635374|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
19635375|NCT02428764|Gemcitabine|gemcitabine|mesh-list
19635376|NCT02428764|Carboplatin|carboplatin|mesh-list
19635377|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
19635378|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635379|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635380|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
19635381|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635382|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
19768734|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768735|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20149933|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149934|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19768736|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
19768737|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19768738|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768739|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
19768740|NCT00105027|Triamcinolone|triamcinolone|mesh-list
20149935|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20149936|NCT00084240|Analgesics|analgesics|mesh-ancestor
20149937|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
20149938|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20149939|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149940|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149941|NCT00084240|Filaricides|filaricides|mesh-ancestor
20149942|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
20149943|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
19768741|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19768742|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19768743|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19768744|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19768745|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
19768746|NCT00105027|Hormones|hormones|mesh-ancestor
19768747|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768748|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768749|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768750|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
19768751|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768752|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768753|NCT00105066|Metformin|metformin|mesh-list
19768754|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19768755|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768756|NCT00105079|Ritonavir|ritonavir|mesh-list
19768757|NCT00105079|Lopinavir|lopinavir|mesh-list
19768758|NCT00105079|Saquinavir|saquinavir|mesh-list
20316753|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316754|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20316755|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20316756|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
20316757|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19768759|NCT00105079|Tenofovir|tenofovir|mesh-list
19768760|NCT00105079|Emtricitabine|emtricitabine|mesh-list
19768761|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19768762|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19768763|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19768764|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
19768765|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768766|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768767|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768768|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19768769|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
19768770|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768771|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19768772|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19768773|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19768774|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768775|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
19768776|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19768777|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19768778|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
20149944|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20316758|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20316759|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
20316760|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635383|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635384|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635385|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635386|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
19635387|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635388|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19635389|NCT02428933|Bromocriptine|bromocriptine|mesh-list
19635390|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19635391|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19635392|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
19635393|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316761|NCT00705835|Antacids|antacids|mesh-ancestor
20316762|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768779|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768780|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19768781|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20316763|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316764|NCT00705900|Calcipotriene|calcipotriene|mesh-list
20316765|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316766|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20316767|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
20316768|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316769|NCT00705978|Pancreatin|pancreatin|mesh-list
20316770|NCT00705978|Pancrelipase|pancrelipase|mesh-list
20316771|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316772|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
19768782|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768783|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635394|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768784|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
19768785|NCT00105183|Antibodies|antibodies|mesh-list
19768786|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
19768787|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19768788|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19768789|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
19768790|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19768791|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
19768792|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768793|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768794|NCT00105196|Aripiprazole|aripiprazole|mesh-list
19768795|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
19768796|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768797|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19768798|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19768799|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19768800|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768801|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
19768802|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
19768803|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768804|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768805|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19768806|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19768807|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
19768808|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19768809|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19768810|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19768811|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19768812|NCT00105235|Cyclosporine|cyclosporine|mesh-list
19768813|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
19768814|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
19768815|NCT00105235|Tacrolimus|tacrolimus|mesh-list
19768816|NCT00105235|Cyclosporins|cyclosporins|mesh-list
19768817|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768818|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
19768819|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768820|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19768821|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768822|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768823|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
19768824|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768825|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316773|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19635395|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
19635396|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
19635397|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635398|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635399|NCT02428777|Diclofenac|diclofenac|mesh-list
19635400|NCT02428777|Tramadol|tramadol|mesh-list
19635401|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19635402|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19635403|NCT02428777|Analgesics|analgesics|mesh-ancestor
19635404|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
19635405|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635406|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768826|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635407|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19635408|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316774|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768827|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20316775|NCT00706069|Capecitabine|capecitabine|mesh-list
19768828|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768829|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19768830|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
19768831|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19768832|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768833|NCT00105443|Sorafenib|sorafenib|mesh-list
19768834|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768835|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768836|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768837|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768838|NCT00105469|Tobramycin|tobramycin|mesh-list
19768839|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316776|NCT00706069|Vinorelbine|vinorelbine|mesh-list
20316777|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316778|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
20316779|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316780|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316781|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20316782|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
20316783|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316784|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316785|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
20316786|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316787|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
20316788|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20316789|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19768840|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768841|NCT00105482|Naltrexone|naltrexone|mesh-list
19768842|NCT00105482|Nicotine|nicotine|mesh-list
19768843|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19768844|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
19768845|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19768846|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768847|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19768848|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19768849|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
19768850|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768851|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768852|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19768853|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19768854|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
19768855|NCT00105534|Azithromycin|azithromycin|mesh-list
19768856|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19768857|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768858|NCT00105586|Citalopram|citalopram|mesh-list
19768859|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19768860|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19768861|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768862|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768863|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768864|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
19768865|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768866|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19768867|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
19768868|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768869|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19768870|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19768871|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20316790|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
20316791|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
19662085|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
19662086|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
19662087|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662088|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662089|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
19662090|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662091|NCT03901573|Atezolizumab|atezolizumab|mesh-list
19662092|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662093|NCT03841110|Aldesleukin|aldesleukin|mesh-list
19662094|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
19662095|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
19662096|NCT03841110|Nivolumab|nivolumab|mesh-list
19662097|NCT03841110|Fludarabine|fludarabine|mesh-list
19662098|NCT03841110|Atezolizumab|atezolizumab|mesh-list
19662099|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768872|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768873|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768874|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768875|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768876|NCT00105989|Analgesics|analgesics|mesh-ancestor
19768877|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
19768878|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19768879|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
19768880|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768881|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
19768882|NCT00106002|Pemetrexed|pemetrexed|mesh-list
19768883|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768884|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768885|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768886|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19768887|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768888|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
19768889|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19768890|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768891|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768892|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19768893|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768894|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19768895|NCT00106106|Acamprosate|acamprosate|mesh-list
19768896|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19768897|NCT00106184|Rituximab|rituximab|mesh-list
19768898|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19768899|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768900|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
19768901|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149945|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149946|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635409|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19635410|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635411|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635412|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19635413|NCT02428777|Narcotics|narcotics|mesh-ancestor
19635414|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635415|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
19635416|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
19768902|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833207|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833208|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833209|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833210|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833211|NCT00542087|Diclofenac|diclofenac|mesh-list
19833212|NCT00542087|Etoricoxib|etoricoxib|mesh-list
19833213|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833214|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833215|NCT00542087|Analgesics|analgesics|mesh-ancestor
19833216|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
19833217|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833218|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833219|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833220|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833221|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833222|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833223|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833224|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19833225|NCT00541697|Atorvastatin|atorvastatin|mesh-list
19833226|NCT00541697|Simvastatin|simvastatin|mesh-list
19833227|NCT00541697|Ezetimibe|ezetimibe|mesh-list
19833228|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833229|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833230|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
19833231|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833232|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833233|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833234|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833235|NCT00489346|Fluticasone|fluticasone|mesh-list
19833236|NCT00489346|Xhance|xhance|mesh-list
19833237|NCT00489346|Montelukast|montelukast|mesh-list
19635417|NCT02429037|Cisplatin|cisplatin|mesh-list
20316792|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20316793|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316794|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
19768903|NCT00106353|Sirolimus|sirolimus|mesh-list
19768904|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19768905|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768906|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768907|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768908|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
19768909|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635418|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635419|NCT02429076|Propofol|propofol|mesh-list
19768910|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
19768911|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768912|NCT00106392|Tacrolimus|tacrolimus|mesh-list
19768913|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768914|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
19768915|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768916|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20316795|NCT00706225|Estrogens|estrogens|mesh-list
20316796|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20316797|NCT00706225|Hormones|hormones|mesh-ancestor
20316798|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316799|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316800|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19768917|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635420|NCT02429076|Sevoflurane|sevoflurane|mesh-list
19768918|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768919|NCT00106431|Romidepsin|romidepsin|mesh-list
19768920|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768921|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768922|NCT00106535|Methotrexate|methotrexate|mesh-list
19635421|NCT02429076|Methylphenidate|methylphenidate|mesh-list
19635422|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19635423|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635424|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635425|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19635426|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
19635427|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
19635428|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19768923|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19768924|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
20316801|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19768925|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19768926|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768927|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19768928|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
19768929|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768930|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768931|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
19768932|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768933|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19768934|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768935|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
19768936|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768937|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19768938|NCT00106639|Tacrolimus|tacrolimus|mesh-list
19768939|NCT00106639|Tofacitinib|tofacitinib|mesh-list
20316802|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
19662100|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
19662101|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662102|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662103|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19662104|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
19662105|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662106|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662107|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19662108|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662109|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19662110|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19662111|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19662112|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
19662113|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19768940|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768941|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
19768942|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768943|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19768944|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768945|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768946|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19768947|NCT00106704|Pioglitazone|pioglitazone|mesh-list
19768948|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19768949|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19768950|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768951|NCT00106704|Incretins|incretins|mesh-ancestor
19768952|NCT00106704|Hormones|hormones|mesh-ancestor
19768953|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768954|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19768955|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
19768956|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768957|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768958|NCT00107120|Citalopram|citalopram|mesh-list
19768959|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19768960|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19768961|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19768962|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768963|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19768964|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
19768965|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768966|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19768967|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
19768968|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19768969|NCT00107198|Prednisone|prednisone|mesh-list
19768970|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
19768971|NCT00107198|Doxorubicin|doxorubicin|mesh-list
19768972|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19768973|NCT00107198|Vincristine|vincristine|mesh-list
19768974|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768975|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
19768976|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19768977|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19768978|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19768979|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
19768980|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19768981|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19768982|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19768983|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19768984|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19768985|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19768986|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19768987|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19768988|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
19768989|NCT00107198|Hormones|hormones|mesh-ancestor
19768990|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19768991|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19768992|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19768993|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
19768994|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
19768995|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
19768996|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
19768997|NCT00107276|Capecitabine|capecitabine|mesh-list
19768998|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19768999|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
19769000|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769001|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769002|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769003|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
19769004|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769005|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769006|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19769007|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769008|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
19769009|NCT00107380|Prednisone|prednisone|mesh-list
19769010|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
19769011|NCT00107380|Rituximab|rituximab|mesh-list
19769012|NCT00107380|Doxorubicin|doxorubicin|mesh-list
19769013|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19769014|NCT00107380|Vincristine|vincristine|mesh-list
19769015|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
19769016|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769017|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
19769018|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635429|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19635430|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19635431|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19635432|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19635433|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635434|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769019|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769020|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769021|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
19769022|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769023|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769024|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19769025|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769026|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769027|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20316803|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20316804|NCT00706277|Fentanyl|fentanyl|mesh-list
20316805|NCT00706277|Remifentanil|remifentanil|mesh-list
20149947|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20149948|NCT00084240|Renal Agents|renal agents|mesh-ancestor
20149949|NCT00084279|Interferons|interferons|mesh-list
20149950|NCT00084279|Ribavirin|ribavirin|mesh-list
20149951|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
20149952|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
20316806|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
19769028|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769029|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769030|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769031|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
19769032|NCT00107380|Hormones|hormones|mesh-ancestor
19769033|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769034|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769035|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769036|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769037|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769038|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769039|NCT00107536|Lapatinib|lapatinib|mesh-list
19769040|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769041|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769042|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769043|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769044|NCT00107653|Ribavirin|ribavirin|mesh-list
19769045|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19769046|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
19769047|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
19769048|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769049|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
19769050|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769051|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
19769052|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769053|NCT00107744|Caseins|caseins|mesh-list
19769054|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
19769055|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
20316807|NCT00706277|Propofol|propofol|mesh-list
20316808|NCT00706277|Sevoflurane|sevoflurane|mesh-list
20316809|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20316810|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20316811|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316812|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19635435|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
19635436|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635437|NCT02429050|Morphine|morphine|mesh-list
19769056|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769057|NCT00107783|Nitisinone|nitisinone|mesh-list
19769058|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149953|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
20149954|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149955|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
20149956|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149957|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
20173967|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19769059|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769060|NCT00107900|Edoxaban|edoxaban|mesh-list
19769061|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19769062|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
19769063|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19769064|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
19769065|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769066|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769067|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
19769068|NCT00107952|Vancomycin|vancomycin|mesh-list
19769069|NCT00107952|Telavancin|telavancin|mesh-list
19769070|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769071|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769072|NCT00107978|Vancomycin|vancomycin|mesh-list
19769073|NCT00107978|Telavancin|telavancin|mesh-list
19769074|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769075|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769076|NCT00107991|Etanercept|etanercept|mesh-list
19769077|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19769078|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19769079|NCT00107991|Analgesics|analgesics|mesh-ancestor
19769080|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
19769081|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769082|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769083|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769084|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769085|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769086|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769087|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
19769088|NCT00108069|Tamoxifen|tamoxifen|mesh-list
19769089|NCT00108069|Bortezomib|bortezomib|mesh-list
19769090|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769091|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19769092|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
19769093|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769094|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769095|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769096|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19769097|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19769098|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19769099|NCT00108082|Atenolol|atenolol|mesh-list
19769100|NCT00108082|Carvedilol|carvedilol|mesh-list
19769101|NCT00108082|Lisinopril|lisinopril|mesh-list
19769102|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19769103|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19769104|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
19769105|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19769106|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769107|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769108|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19769109|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
19769110|NCT00108082|Protective Agents|protective agents|mesh-ancestor
19769111|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19769112|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19769113|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19769114|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
19769115|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19769116|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19769117|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19769118|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
19769119|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769120|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19769121|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19769122|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
19769123|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
19769124|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769125|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19769126|NCT00108160|Mupirocin|mupirocin|mesh-list
19769127|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769128|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769129|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19769130|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769131|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769132|NCT00108355|Octreotide|octreotide|mesh-list
19769133|NCT00108355|Midodrine|midodrine|mesh-list
20316813|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
19769134|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769135|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769136|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769137|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
19769138|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
19769139|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769140|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769141|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19769142|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19769143|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19769144|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19769145|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
19769146|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19769147|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769148|NCT00108485|Niacin|niacin|mesh-list
19769149|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19769150|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
19769151|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769152|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19769153|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
19769154|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
19769155|NCT00108485|Vitamins|vitamins|mesh-ancestor
19769156|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
19769157|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769158|NCT00108524|Orlistat|orlistat|mesh-list
19769159|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769160|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769161|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19769162|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19769163|NCT00108550|Gabapentin|gabapentin|mesh-list
19769164|NCT00108550|Analgesics|analgesics|mesh-ancestor
19769165|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
19769166|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769167|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769168|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
19769169|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19769170|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19769171|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19769172|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19769173|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19769174|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19769175|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19769176|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769177|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
19769178|NCT00108732|Metronidazole|metronidazole|mesh-list
19769179|NCT00108732|Goserelin|goserelin|mesh-list
19769180|NCT00108732|Bicalutamide|bicalutamide|mesh-list
19769181|NCT00108732|Vaccines|vaccines|mesh-list
19769182|NCT00108732|Sargramostim|sargramostim|mesh-list
19769183|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
19769184|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769185|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769186|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769187|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
19769188|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
19769189|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769190|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769191|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769192|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19769193|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19769194|NCT00108745|Paclitaxel|paclitaxel|mesh-list
20316814|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
20316815|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20316816|NCT00706277|Narcotics|narcotics|mesh-ancestor
20316817|NCT00706277|Analgesics|analgesics|mesh-ancestor
19769195|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19769196|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19769197|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769198|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769199|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769200|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769201|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769202|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769203|NCT00108953|Doxorubicin|doxorubicin|mesh-list
19769204|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20316818|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
19769205|NCT00108953|Sorafenib|sorafenib|mesh-list
19769206|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769207|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769208|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19769209|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769210|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769211|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769212|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769213|NCT00109005|Lenalidomide|lenalidomide|mesh-list
19769214|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
19769215|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769216|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769217|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769218|NCT00109005|Growth Substances|growth substances|mesh-ancestor
19769219|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769220|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769221|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
19769222|NCT00109031|Etoposide|etoposide|mesh-list
19769223|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769224|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
19769225|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769226|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769227|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769228|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
19769229|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769230|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769231|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19769232|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769233|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19769234|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769235|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769236|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19769237|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
19769238|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769239|NCT00109473|Prednisone|prednisone|mesh-list
19769240|NCT00109473|Hormones|hormones|mesh-list
19769241|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769242|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
19769243|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769244|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769245|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769246|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769247|NCT00109590|Ritonavir|ritonavir|mesh-list
19769248|NCT00109590|Lopinavir|lopinavir|mesh-list
19769249|NCT00109590|Zidovudine|zidovudine|mesh-list
19769250|NCT00109590|Nevirapine|nevirapine|mesh-list
19769251|NCT00109590|Didanosine|didanosine|mesh-list
19769252|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19769253|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19769254|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
19769255|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769256|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769257|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19769258|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19769259|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
19769260|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769261|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19769262|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19769263|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
19769264|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19769265|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19769266|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19769267|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19769268|NCT00109733|Hormones|hormones|mesh-list
19769269|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769270|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769271|NCT00109772|Lenalidomide|lenalidomide|mesh-list
19769272|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
19769273|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769274|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769275|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769276|NCT00109772|Growth Substances|growth substances|mesh-ancestor
20316819|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769277|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
20316820|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20149958|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149959|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
20149960|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149961|NCT00084370|Celecoxib|celecoxib|mesh-list
20149962|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19769278|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769279|NCT00109837|Leucovorin|leucovorin|mesh-list
19769280|NCT00109837|Cytarabine|cytarabine|mesh-list
19769281|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19769282|NCT00109837|Dexamethasone|dexamethasone|mesh-list
19769283|NCT00109837|Prednisone|prednisone|mesh-list
19769284|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
19769285|NCT00109837|Doxorubicin|doxorubicin|mesh-list
19769286|NCT00109837|Methotrexate|methotrexate|mesh-list
19769287|NCT00109837|Vincristine|vincristine|mesh-list
19769288|NCT00109837|Daunorubicin|daunorubicin|mesh-list
19769289|NCT00109837|Asparaginase|asparaginase|mesh-list
19769290|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
19769291|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
19769292|NCT00109837|Thioguanine|thioguanine|mesh-list
19769293|NCT00109837|Allopurinol|allopurinol|mesh-list
19769294|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769295|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
19769296|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769297|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769298|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769299|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
19769300|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769301|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769302|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19769303|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769304|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
19769305|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
19769306|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769307|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769308|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
19769309|NCT00109837|Hormones|hormones|mesh-ancestor
19769310|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769311|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769312|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769313|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19769314|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769315|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769316|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19769317|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
19769318|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19769319|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769320|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
19769321|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
19769322|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19769323|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19769324|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
19769325|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20149963|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20149964|NCT00084370|Analgesics|analgesics|mesh-ancestor
20149965|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
20149966|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316821|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20316822|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20316823|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20316824|NCT00706576|Mitogens|mitogens|mesh-list
20316825|NCT00706576|Enkephalin, Methionine|enkephalin, methionine|mesh-list
20316826|NCT00706576|Enkephalins|enkephalins|mesh-list
20316827|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316828|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
20316829|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316830|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316831|NCT00706680|Cyclosporine|cyclosporine|mesh-list
20316832|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
20316833|NCT00706680|Prednisone|prednisone|mesh-list
20316834|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19769326|NCT00109837|Antidotes|antidotes|mesh-ancestor
19769327|NCT00109837|Protective Agents|protective agents|mesh-ancestor
20316835|NCT00706680|Cyclosporins|cyclosporins|mesh-list
19769328|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
19769329|NCT00109837|Vitamins|vitamins|mesh-ancestor
20316836|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
19769330|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
20316837|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316838|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
20316839|NCT00706680|Hormones|hormones|mesh-ancestor
20316840|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316841|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769331|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769332|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769333|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769334|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769335|NCT00109837|Analgesics|analgesics|mesh-ancestor
19769336|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
19769337|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
19769338|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19769339|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
19769340|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19769341|NCT00109837|Renal Agents|renal agents|mesh-ancestor
19769342|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769343|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
19769344|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19769345|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19769346|NCT00109850|Irinotecan|irinotecan|mesh-list
19769347|NCT00109850|Cetuximab|cetuximab|mesh-list
19769348|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769349|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19769350|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769351|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769352|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769353|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769354|NCT00109928|Gemcitabine|gemcitabine|mesh-list
19769355|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
19769356|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19769357|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19769358|NCT00109928|Prednisolone|prednisolone|mesh-list
19769359|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
19769360|NCT00109928|Etoposide|etoposide|mesh-list
19769361|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19769362|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
19769363|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769364|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769365|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
19769366|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769367|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
19769368|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769369|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769370|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769371|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
19769372|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769373|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769374|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19769375|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769376|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769377|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
19769378|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
19769379|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769380|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769381|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
19769382|NCT00109928|Hormones|hormones|mesh-ancestor
19769383|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769384|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20316842|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769385|NCT00109928|Protective Agents|protective agents|mesh-ancestor
19769386|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769387|NCT00109967|Sirolimus|sirolimus|mesh-list
20316843|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769388|NCT00109967|Rituximab|rituximab|mesh-list
19769389|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769390|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769391|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
19769392|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769393|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769394|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769395|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769396|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769397|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
19769398|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769399|NCT00110019|Paclitaxel|paclitaxel|mesh-list
19769400|NCT00110019|Carboplatin|carboplatin|mesh-list
20611029|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611030|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19635438|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19635439|NCT02429050|Narcotics|narcotics|mesh-ancestor
19635440|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19769401|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19769402|NCT00110019|Sorafenib|sorafenib|mesh-list
19769403|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769404|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769405|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769406|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769407|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769408|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769409|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769410|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769411|NCT00110084|Gemcitabine|gemcitabine|mesh-list
19769412|NCT00110084|Paclitaxel|paclitaxel|mesh-list
19769413|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19769414|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769415|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769416|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769417|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769418|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769419|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769420|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769421|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
19769422|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
19769423|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769424|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769425|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769426|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
19769427|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769428|NCT00110149|Rituximab|rituximab|mesh-list
19635441|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635442|NCT02429050|Analgesics|analgesics|mesh-ancestor
19635443|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
19635444|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635445|NCT02428972|Propofol|propofol|mesh-list
19635446|NCT02428972|Sevoflurane|sevoflurane|mesh-list
20316844|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316845|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316846|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316847|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
20316848|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
20316849|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316850|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316851|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316852|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20316853|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20316854|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20316855|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
20316856|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316857|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20316858|NCT00706680|Protective Agents|protective agents|mesh-ancestor
19635447|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19635448|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635449|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635450|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19635451|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
19769429|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769430|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316859|NCT00706862|Lactoferrin|lactoferrin|mesh-list
19769431|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
19769432|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769433|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769434|NCT00110214|Prednisone|prednisone|mesh-list
19769435|NCT00110214|Bevacizumab|bevacizumab|mesh-list
19769436|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19769437|NCT00110214|Docetaxel|docetaxel|mesh-list
19769438|NCT00110214|Antibodies|antibodies|mesh-list
19769439|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
19769440|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19769441|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769442|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769443|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769444|NCT00110214|Growth Substances|growth substances|mesh-ancestor
19769445|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769446|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769447|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
19769448|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769449|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769450|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769451|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769452|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769453|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
19769454|NCT00110214|Hormones|hormones|mesh-ancestor
19769455|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769456|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769457|NCT00110266|Deferasirox|deferasirox|mesh-list
19769458|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19769459|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
19769460|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
19769461|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769462|NCT00110305|Efavirenz|efavirenz|mesh-list
19769463|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19769464|NCT00110305|Rilpivirine|rilpivirine|mesh-list
19769465|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19769466|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769467|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769468|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
19769469|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769470|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19769471|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19769472|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19769473|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19769474|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19769475|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19769476|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19769477|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19769478|NCT00110357|Irinotecan|irinotecan|mesh-list
19769479|NCT00110357|Cetuximab|cetuximab|mesh-list
19769480|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19769481|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769482|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769483|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769484|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769485|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769486|NCT00110396|Interferons|interferons|mesh-list
19769487|NCT00110396|Interferon-beta|interferon-beta|mesh-list
19769488|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
19769489|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769490|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
19769491|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769492|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
20149967|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20149968|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20149969|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20149970|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20149971|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20149972|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149973|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149974|NCT00084396|Letrozole|letrozole|mesh-list
20149975|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149976|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20149977|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19769493|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769494|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19769495|NCT00110461|Aripiprazole|aripiprazole|mesh-list
19769496|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
19769497|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19769498|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19769499|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19769500|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19769501|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769502|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
19769503|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
19769504|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635452|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
19769505|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769506|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19769507|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19769508|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
19769509|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19769510|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19769511|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19769512|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19769513|NCT00110513|Antithrombins|antithrombins|mesh-list
19769514|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
19769515|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19769516|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
19769517|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769518|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769519|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
19769520|NCT00110617|Deferasirox|deferasirox|mesh-list
19769521|NCT00110617|Deferoxamine|deferoxamine|mesh-list
19769522|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19769523|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
19769524|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
19769525|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769526|NCT00110617|Siderophores|siderophores|mesh-ancestor
19769527|NCT00110812|Aldesleukin|aldesleukin|mesh-list
19769528|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769529|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19769530|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19769531|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
19769532|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769533|NCT00110890|Cinacalcet|cinacalcet|mesh-list
19769534|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19769535|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769536|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19769537|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
19769538|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769539|NCT00110994|Sorafenib|sorafenib|mesh-list
19769540|NCT00110994|Dacarbazine|dacarbazine|mesh-list
19769541|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769542|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769543|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769544|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149978|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20149979|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149980|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20149981|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
20149982|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20149983|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173968|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19635453|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19635454|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19635455|NCT02428946|Bromocriptine|bromocriptine|mesh-list
19635456|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19635457|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19635458|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
19635459|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635460|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635461|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
19635462|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
19635463|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635464|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769545|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19635465|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20316860|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
20316861|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635466|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19635467|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19635468|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635469|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635470|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19635471|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635472|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635473|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
19635474|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662114|NCT03713294|Dexamethasone|dexamethasone|mesh-list
19662115|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
19662116|NCT03713294|Pomalidomide|pomalidomide|mesh-list
19662117|NCT03713294|Elotuzumab|elotuzumab|mesh-list
19662118|NCT03713294|Ichthammol|ichthammol|mesh-list
19662119|NCT03713294|BB 1101|bb 1101|mesh-list
19662120|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19662121|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
19662122|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
19662123|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662124|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662125|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662126|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
19662127|NCT03713294|Hormones|hormones|mesh-ancestor
19662128|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662129|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19662130|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662131|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
19662132|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662133|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662134|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
19662135|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19662136|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19662137|NCT03713294|Growth Substances|growth substances|mesh-ancestor
19662138|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
19662139|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
19662140|NCT03663205|Cisplatin|cisplatin|mesh-list
19662141|NCT03663205|Carboplatin|carboplatin|mesh-list
19662142|NCT03663205|Pemetrexed|pemetrexed|mesh-list
19662143|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662144|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662145|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662146|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19662147|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19662148|NCT03597581|Bevacizumab|bevacizumab|mesh-list
19662149|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662150|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662151|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19662152|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19662153|NCT03597581|Growth Substances|growth substances|mesh-ancestor
19662154|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662155|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
19662156|NCT03593915|Azacitidine|azacitidine|mesh-list
19662157|NCT03593915|Decitabine|decitabine|mesh-list
19662158|NCT03593915|Alvocidib|alvocidib|mesh-list
19662159|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19662160|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
19662161|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662162|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662163|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662164|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
19662165|NCT03593915|Growth Substances|growth substances|mesh-ancestor
19662166|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662167|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19662168|NCT03472586|Nivolumab|nivolumab|mesh-list
19662169|NCT03472586|Ipilimumab|ipilimumab|mesh-list
19662170|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662171|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662172|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19662173|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662174|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
19662175|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662176|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316862|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316863|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
20316864|NCT00706888|Pyridoxal|pyridoxal|mesh-list
20316865|NCT00706888|Pyridoxine|pyridoxine|mesh-list
20316866|NCT00706888|Vitamins|vitamins|mesh-ancestor
20316867|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
20316868|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316869|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
20316870|NCT00706927|Timolol|timolol|mesh-list
20316871|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20316872|NCT00706927|Latanoprost|latanoprost|mesh-list
20316873|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20316874|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20316875|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
20316876|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19769546|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
19769547|NCT00111007|Paclitaxel|paclitaxel|mesh-list
19769548|NCT00111007|Carboplatin|carboplatin|mesh-list
19769549|NCT00111007|Sorafenib|sorafenib|mesh-list
19769550|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769551|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769552|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769553|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
19635475|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
19635476|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19635477|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20316877|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316878|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316879|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20316880|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20316881|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19635478|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635479|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
19635480|NCT02428868|Coagulants|coagulants|mesh-ancestor
19635481|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
19635482|NCT02428686|Hematinics|hematinics|mesh-ancestor
19635483|NCT02428543|Cytarabine|cytarabine|mesh-list
19635484|NCT02428543|Ponatinib|ponatinib|mesh-list
19635485|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635486|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
19769554|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769555|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769556|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769557|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769558|NCT00111241|Letrozole|letrozole|mesh-list
19769559|NCT00111241|Anastrozole|anastrozole|mesh-list
19769560|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19769561|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769562|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19769563|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769564|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769565|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19769566|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
19769567|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769568|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769569|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769570|NCT00111657|Rasburicase|rasburicase|mesh-list
19769571|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
19769572|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769573|NCT00111761|Leucovorin|leucovorin|mesh-list
19769574|NCT00111761|Fluorouracil|fluorouracil|mesh-list
19769575|NCT00111761|Irinotecan|irinotecan|mesh-list
19769576|NCT00111761|Panitumumab|panitumumab|mesh-list
19769577|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
19769578|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769579|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769580|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769581|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769582|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
19769583|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769584|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19769585|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19769586|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635487|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769587|NCT00111761|Antidotes|antidotes|mesh-ancestor
20316882|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20316883|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19769588|NCT00111761|Protective Agents|protective agents|mesh-ancestor
19769589|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
19769590|NCT00111761|Vitamins|vitamins|mesh-ancestor
19769591|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
19769592|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769593|NCT00111813|Bortezomib|bortezomib|mesh-list
19769594|NCT00111813|Vorinostat|vorinostat|mesh-list
19769595|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769596|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19769597|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769598|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769599|NCT00111839|Pemetrexed|pemetrexed|mesh-list
19769600|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769601|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316884|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20316885|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20316886|NCT00706953|Doxorubicin|doxorubicin|mesh-list
20316887|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20316888|NCT00706953|Bortezomib|bortezomib|mesh-list
20316889|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20316890|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316891|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19769602|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769603|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19769604|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19769605|NCT00111917|Infliximab|infliximab|mesh-list
19769606|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
19769607|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769608|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769609|NCT00112047|Tenofovir|tenofovir|mesh-list
19769610|NCT00112047|Lamivudine|lamivudine|mesh-list
19769611|NCT00112047|Zidovudine|zidovudine|mesh-list
19769612|NCT00112047|Emtricitabine|emtricitabine|mesh-list
19769613|NCT00112047|Efavirenz|efavirenz|mesh-list
19769614|NCT00112047|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19769615|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19769616|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
19635488|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149984|NCT00084435|Docetaxel|docetaxel|mesh-list
19769617|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769618|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19769619|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19769620|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769621|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769622|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19769623|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19769624|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
20149985|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149986|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
20149987|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
20149988|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149989|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149990|NCT00084448|Celecoxib|celecoxib|mesh-list
20149991|NCT00084448|Paclitaxel|paclitaxel|mesh-list
20149992|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20149993|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20149994|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
19635489|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
19635490|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635491|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635492|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
19635493|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635494|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19635495|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635496|NCT02428439|Lamotrigine|lamotrigine|mesh-list
19635497|NCT02428439|Bupropion|bupropion|mesh-list
19635498|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19635499|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
19635500|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19635501|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19635502|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19635503|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19769625|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20149995|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
20316892|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20316893|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635504|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635505|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
19769626|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19769627|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19769628|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19769629|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19769630|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19769631|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
19769632|NCT00112151|Testosterone|testosterone|mesh-list
19769633|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
19769634|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
19769635|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19769636|NCT00112151|Androgens|androgens|mesh-ancestor
19769637|NCT00112151|Hormones|hormones|mesh-ancestor
20316894|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316895|NCT00707070|Acitretin|acitretin|mesh-list
20316896|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20316897|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
20316898|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769638|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769639|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769640|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769641|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769642|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
19769643|NCT00112294|Paclitaxel|paclitaxel|mesh-list
19769644|NCT00112294|Docetaxel|docetaxel|mesh-list
19769645|NCT00112294|Carboplatin|carboplatin|mesh-list
19769646|NCT00112294|Cetuximab|cetuximab|mesh-list
19769647|NCT00112294|Taxane|taxane|mesh-list
19769648|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769649|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769650|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769651|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769652|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769653|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769654|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769655|NCT00112385|Etanercept|etanercept|mesh-list
19769656|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19769657|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19769658|NCT00112385|Analgesics|analgesics|mesh-ancestor
19769659|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
19769660|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769661|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769662|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769663|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769664|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769665|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769666|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
19769667|NCT00112437|Vitamin D|vitamin d|mesh-list
19769668|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
19769669|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
19769670|NCT00112437|Calcium|calcium|mesh-list
19769671|NCT00112437|Vitamins|vitamins|mesh-ancestor
19769672|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
19769673|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769674|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19769675|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19769676|NCT00112437|Antacids|antacids|mesh-ancestor
19635506|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635507|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635508|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19635509|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19635510|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635511|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
19635512|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19769677|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769678|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769679|NCT00112463|Romidepsin|romidepsin|mesh-list
19769680|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769681|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316899|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
20316900|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316901|NCT00707083|Dexamethasone|dexamethasone|mesh-list
20316902|NCT00707083|Methotrexate|methotrexate|mesh-list
20316903|NCT00707083|Vincristine|vincristine|mesh-list
20316904|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
20316905|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316906|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
20316907|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
20316908|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316909|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316910|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20316911|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
20316912|NCT00707083|Hormones|hormones|mesh-ancestor
20316913|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316914|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20316915|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769682|NCT00112489|Paclitaxel|paclitaxel|mesh-list
19769683|NCT00112489|Carboplatin|carboplatin|mesh-list
19769684|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769685|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769686|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769687|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769688|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769689|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769690|NCT00112502|Thalidomide|thalidomide|mesh-list
19769691|NCT00112502|Celecoxib|celecoxib|mesh-list
19769692|NCT00112502|Temozolomide|temozolomide|mesh-list
19769693|NCT00112502|Isotretinoin|isotretinoin|mesh-list
19769694|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769695|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
19769696|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769697|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769698|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19769699|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19769700|NCT00112502|Analgesics|analgesics|mesh-ancestor
19769701|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
19769702|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769703|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769704|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769705|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769706|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19769707|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19769708|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769709|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769710|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
19769711|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
19769712|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769713|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769714|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769715|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769716|NCT00112502|Growth Substances|growth substances|mesh-ancestor
19769717|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769718|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
19769719|NCT00112580|Ipilimumab|ipilimumab|mesh-list
19769720|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769721|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769722|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20149996|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
20149997|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20149998|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20149999|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20150000|NCT00084448|Analgesics|analgesics|mesh-ancestor
19769723|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150001|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
20150002|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150003|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150004|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150005|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150006|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20150007|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20150008|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150009|NCT00084461|Romidepsin|romidepsin|mesh-list
20150010|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769724|NCT00112593|Cyclosporine|cyclosporine|mesh-list
19769725|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
19769726|NCT00112593|Fludarabine|fludarabine|mesh-list
19769727|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
19769728|NCT00112593|Cyclosporins|cyclosporins|mesh-list
19769729|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769730|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150011|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150012|NCT00084513|Trastuzumab|trastuzumab|mesh-list
20150013|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
20150014|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150015|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150016|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150017|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150018|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150019|NCT00084565|Paclitaxel|paclitaxel|mesh-list
20150020|NCT00084565|Topotecan|topotecan|mesh-list
20150021|NCT00084565|Estramustine|estramustine|mesh-list
20150022|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20150023|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150024|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150025|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150026|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150027|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150028|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20150029|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150030|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150031|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769731|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
19769732|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769733|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769734|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
19769735|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769736|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769737|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
19769738|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769739|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
19769740|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769741|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19769742|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769743|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19769744|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
19769745|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769746|NCT00112671|Sorafenib|sorafenib|mesh-list
19769747|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769748|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769749|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769750|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769751|NCT00112723|Alvocidib|alvocidib|mesh-list
19769752|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769753|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769754|NCT00112723|Growth Substances|growth substances|mesh-ancestor
19769755|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769756|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769757|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769758|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769759|NCT00112736|Sirolimus|sirolimus|mesh-list
19769760|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19769761|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769762|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769763|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769764|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769765|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769766|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769767|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769768|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
19769769|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769770|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
19769771|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769772|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
19769773|NCT00112827|Melphalan|melphalan|mesh-list
19769774|NCT00112827|Lenalidomide|lenalidomide|mesh-list
19769775|NCT00112827|Lenograstim|lenograstim|mesh-list
19769776|NCT00112827|Sargramostim|sargramostim|mesh-list
19769777|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769778|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
19769779|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769780|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769781|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769782|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
19769783|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769784|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769785|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19769786|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19769787|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769788|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769789|NCT00112827|Growth Substances|growth substances|mesh-ancestor
19769790|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769791|NCT00112905|Sorafenib|sorafenib|mesh-list
19769792|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769793|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769794|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769795|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150032|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
20150033|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20150034|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
20150035|NCT00084578|Celecoxib|celecoxib|mesh-list
20150036|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20150037|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20150038|NCT00084578|Analgesics|analgesics|mesh-ancestor
20150039|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
20150040|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150041|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150042|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20611031|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611032|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769796|NCT00112918|Leucovorin|leucovorin|mesh-list
19769797|NCT00112918|Bevacizumab|bevacizumab|mesh-list
20150043|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20611033|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
20611034|NCT02317874|Paclitaxel|paclitaxel|mesh-list
20150044|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20150045|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20150046|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150047|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150048|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20150049|NCT00084591|Capecitabine|capecitabine|mesh-list
20150050|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150051|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
20150052|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150053|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150054|NCT00084604|Bevacizumab|bevacizumab|mesh-list
19635513|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19635514|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19635515|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19635516|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635517|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19635518|NCT02428374|Clopidogrel|clopidogrel|mesh-list
19635519|NCT02428374|Ticagrelor|ticagrelor|mesh-list
19635520|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19635521|NCT02428374|Simvastatin|simvastatin|mesh-list
19635522|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19635523|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19769798|NCT00112918|Fluorouracil|fluorouracil|mesh-list
19769799|NCT00112918|Capecitabine|capecitabine|mesh-list
19769800|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
19769801|NCT00112918|Calcium|calcium|mesh-list
20611035|NCT02317874|Carboplatin|carboplatin|mesh-list
20611036|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20150055|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20150056|NCT00084604|Irinotecan|irinotecan|mesh-list
20150057|NCT00084604|Antibodies|antibodies|mesh-list
20150058|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
20150059|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20150060|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150061|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20150062|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20150063|NCT00084604|Growth Substances|growth substances|mesh-ancestor
20150064|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150065|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
20150066|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
20150067|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20150068|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150069|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150070|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150071|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
20150072|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150073|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150074|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150075|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150076|NCT00084643|Capecitabine|capecitabine|mesh-list
20150077|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
20150078|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150079|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
20150080|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150081|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150082|NCT00084669|Zolpidem|zolpidem|mesh-list
20150083|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20150084|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20150085|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20150086|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20150087|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150088|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150089|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150090|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20150091|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
20150092|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150093|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20150094|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20150095|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150096|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20150097|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
20150098|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
20150099|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
20150100|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
20150101|NCT00084695|Melphalan|melphalan|mesh-list
20150102|NCT00084695|Busulfan|busulfan|mesh-list
20150103|NCT00084695|Fludarabine|fludarabine|mesh-list
20150104|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
20150105|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20150106|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150107|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
20150108|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150109|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150110|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150111|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
20150112|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635524|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19635525|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19635526|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
19635527|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635528|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635529|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635530|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19635531|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19635532|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
19635533|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20150113|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150114|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20347387|NCT00859885|Clopidogrel|clopidogrel|mesh-list
19769802|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
19769803|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769804|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769805|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769806|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769807|NCT00112918|Growth Substances|growth substances|mesh-ancestor
19769808|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769809|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769810|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19769811|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
19769812|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769813|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769814|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769815|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
19769816|NCT00112918|Antidotes|antidotes|mesh-ancestor
19769817|NCT00112918|Protective Agents|protective agents|mesh-ancestor
19769818|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
19769819|NCT00112918|Vitamins|vitamins|mesh-ancestor
20150115|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150116|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
19769820|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
19769821|NCT00112957|Vaccines|vaccines|mesh-list
19769822|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
19769823|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833238|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833239|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19833240|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
19833241|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833242|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833243|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19833244|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833245|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
19833246|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19833247|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833248|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19833249|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
20316916|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20316917|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
20316918|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20316919|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316920|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
20316921|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316922|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
20316923|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316924|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20316925|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316926|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
20316927|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316928|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20316929|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20316930|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19833250|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833251|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20150117|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150118|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
20150119|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
20150120|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150121|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20150122|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
20150123|NCT00084695|Hormones|hormones|mesh-ancestor
20150124|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150125|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19833252|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833253|NCT00395603|Atorvastatin|atorvastatin|mesh-list
19833254|NCT00395603|Simvastatin|simvastatin|mesh-list
19833255|NCT00395603|Ezetimibe|ezetimibe|mesh-list
19833256|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833257|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833258|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
20150126|NCT00084695|Protective Agents|protective agents|mesh-ancestor
20316931|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19833259|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833260|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20150127|NCT00084708|Calcitriol|calcitriol|mesh-list
20316932|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769824|NCT00113087|Enalapril|enalapril|mesh-list
19769825|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19769826|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
19769827|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769828|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769829|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19769830|NCT00113217|Bevacizumab|bevacizumab|mesh-list
19769831|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769832|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769833|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769834|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769835|NCT00113217|Growth Substances|growth substances|mesh-ancestor
19769836|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769837|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769838|NCT00113230|Bevacizumab|bevacizumab|mesh-list
19769839|NCT00113230|Capecitabine|capecitabine|mesh-list
19769840|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769841|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769842|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769843|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769844|NCT00113230|Growth Substances|growth substances|mesh-ancestor
19769845|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769846|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
20150128|NCT00084708|Dexamethasone|dexamethasone|mesh-list
20150129|NCT00084708|Gefitinib|gefitinib|mesh-list
20150130|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150131|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
19769847|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769848|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
19769849|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769850|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
19769851|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
19769852|NCT00113269|Tacrolimus|tacrolimus|mesh-list
19769853|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
19769854|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19769855|NCT00113269|Basiliximab|basiliximab|mesh-list
19769856|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769857|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
19769858|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769859|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20316933|NCT00707135|Sirolimus|sirolimus|mesh-list
20316934|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769860|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769861|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769862|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19769863|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769864|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19769865|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
19769866|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19769867|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769868|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150132|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
20150133|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150134|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150135|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20150136|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
20150137|NCT00084708|Hormones|hormones|mesh-ancestor
20150138|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150139|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20150140|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150141|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150142|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150143|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150144|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20150145|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20150146|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20150147|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20150148|NCT00084708|Vitamins|vitamins|mesh-ancestor
20150149|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
20150150|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20150151|NCT00084721|Celecoxib|celecoxib|mesh-list
20150152|NCT00084721|Irinotecan|irinotecan|mesh-list
20150153|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20611037|NCT02317874|Talazoparib|talazoparib|mesh-list
19769869|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19769870|NCT00113295|Paroxetine|paroxetine|mesh-list
19769871|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
19769872|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19769873|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19769874|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19769875|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19769876|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769877|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19769878|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19769879|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19769880|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769881|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19769882|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
19769883|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19769884|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19769885|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19769886|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769887|NCT00113321|Decitabine|decitabine|mesh-list
19769888|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19769889|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
19769890|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769891|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769892|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769893|NCT00113360|Everolimus|everolimus|mesh-list
19769894|NCT00113360|Octreotide|octreotide|mesh-list
19769895|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769896|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19769897|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
19769898|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769899|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769900|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769901|NCT00113373|Lapatinib|lapatinib|mesh-list
19769902|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769903|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150154|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150155|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150156|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150157|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150158|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19769904|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769905|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769906|NCT00113490|Palivizumab|palivizumab|mesh-list
19769907|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
19769908|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19769909|NCT00113516|Paclitaxel|paclitaxel|mesh-list
19769910|NCT00113516|Carboplatin|carboplatin|mesh-list
19769911|NCT00113516|Sunitinib|sunitinib|mesh-list
19769912|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19769913|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769914|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
19769915|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
19769916|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
19769917|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769918|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769919|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769920|NCT00113516|Growth Substances|growth substances|mesh-ancestor
19769921|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769922|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769923|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769924|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769925|NCT00113529|Sunitinib|sunitinib|mesh-list
19769926|NCT00113529|Gefitinib|gefitinib|mesh-list
19769927|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769928|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19769929|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19769930|NCT00113529|Growth Substances|growth substances|mesh-ancestor
19769931|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769932|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
19769933|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19769934|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150159|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20150160|NCT00084721|Analgesics|analgesics|mesh-ancestor
19769935|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769936|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
19769937|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19769938|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19769939|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769940|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
19769941|NCT00113568|Coagulants|coagulants|mesh-ancestor
19769942|NCT00113607|Dexamethasone|dexamethasone|mesh-list
19769943|NCT00113607|Trabectedin|trabectedin|mesh-list
19769944|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769945|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
19769946|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
19769947|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769948|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769949|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19769950|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
19769951|NCT00113607|Hormones|hormones|mesh-ancestor
19769952|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769953|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769954|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769955|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769956|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
19769957|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769958|NCT00113763|Panitumumab|panitumumab|mesh-list
19769959|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19769960|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769961|NCT00113841|Curcumin|curcumin|mesh-list
19769962|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19769963|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19769964|NCT00113841|Analgesics|analgesics|mesh-ancestor
19769965|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
19769966|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769967|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769968|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19769969|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19769970|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769971|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19769972|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769973|NCT00114114|Goserelin|goserelin|mesh-list
19769974|NCT00114114|Testosterone|testosterone|mesh-list
19769975|NCT00114114|Androgens|androgens|mesh-ancestor
19769976|NCT00114114|Hormones|hormones|mesh-ancestor
19769977|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19769978|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769979|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19769980|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769981|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19769982|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19769983|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19769984|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19769985|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769986|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19769987|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19769988|NCT00114127|Analgesics|analgesics|mesh-ancestor
19769989|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
19769990|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19769991|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
19769992|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19769993|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
19769994|NCT00114140|Temozolomide|temozolomide|mesh-list
19769995|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19769996|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
19769997|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19769998|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19769999|NCT00114166|Topotecan|topotecan|mesh-list
19770000|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19770001|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19770002|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150161|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
20150162|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150163|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150164|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150165|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150166|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19770003|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770004|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770005|NCT00114218|Gemcitabine|gemcitabine|mesh-list
19770006|NCT00114218|Docetaxel|docetaxel|mesh-list
19770007|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770008|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
19770009|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770010|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770011|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
19770012|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770013|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770014|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770015|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
19770016|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770017|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770018|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770019|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
19770020|NCT00114231|Capecitabine|capecitabine|mesh-list
19770021|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
19770022|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770023|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
19770024|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770025|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770026|NCT00114244|Gemcitabine|gemcitabine|mesh-list
19770027|NCT00114244|Sorafenib|sorafenib|mesh-list
19770028|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770029|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
19770030|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770031|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770032|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
19770033|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770034|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770035|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770036|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
19770037|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770038|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770039|NCT00114504|Simvastatin|simvastatin|mesh-list
19770040|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19635534|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19635535|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635536|NCT02428322|Vitamin D|vitamin d|mesh-list
19635537|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
19635538|NCT02428322|Vitamins|vitamins|mesh-ancestor
19635539|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
19635540|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635541|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19635542|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19635543|NCT02428257|Ephedrine|ephedrine|mesh-list
19635544|NCT02428257|Bupivacaine|bupivacaine|mesh-list
19635545|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
19770041|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19770042|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
19770043|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770044|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19770045|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19770046|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770047|NCT00114517|Estradiol|estradiol|mesh-list
19770048|NCT00114517|Estrogens|estrogens|mesh-list
19770049|NCT00114517|Hormones|hormones|mesh-ancestor
19770050|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770051|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770052|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
19770053|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770054|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
19770055|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770056|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770057|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770058|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
19770059|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770060|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770061|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770062|NCT00114738|Rituximab|rituximab|mesh-list
19770063|NCT00114738|Bortezomib|bortezomib|mesh-list
19635546|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
19770064|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770065|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770066|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
19770067|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770068|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770069|NCT00114777|Cyclosporine|cyclosporine|mesh-list
19770070|NCT00114777|Abatacept|abatacept|mesh-list
19770071|NCT00114777|Cyclosporins|cyclosporins|mesh-list
19770072|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770073|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770074|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770075|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
19770076|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770077|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
19770078|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770079|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770080|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770081|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19770082|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19770083|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770084|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
19770085|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
19770086|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770087|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770088|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770089|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770090|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19770091|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19770092|NCT00114972|Paclitaxel|paclitaxel|mesh-list
19770093|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19770094|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19770095|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770096|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770097|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770098|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
19770099|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770100|NCT00115037|Naltrexone|naltrexone|mesh-list
19770101|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19770102|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19770103|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770104|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
19770105|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770106|NCT00115063|Orlistat|orlistat|mesh-list
19770107|NCT00115063|Sibutramine|sibutramine|mesh-list
19770108|NCT00115063|Diethylpropion|diethylpropion|mesh-list
19770109|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770110|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770111|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19770112|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19770113|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
19770114|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19770115|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
19770116|NCT00115297|Montelukast|montelukast|mesh-list
19770117|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19770118|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
19770119|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19770120|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
19770121|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770122|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770123|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19770124|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19770125|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770126|NCT00115336|Ibuprofen|ibuprofen|mesh-list
19770127|NCT00115336|Ketorolac|ketorolac|mesh-list
19770128|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770129|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770130|NCT00115336|Analgesics|analgesics|mesh-ancestor
19770131|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
19770132|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770133|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770134|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770135|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770136|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19770137|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770138|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770139|NCT00115349|Deferiprone|deferiprone|mesh-list
19770140|NCT00115349|Deferoxamine|deferoxamine|mesh-list
19770141|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19770142|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
19770143|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
19770144|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770145|NCT00115349|Siderophores|siderophores|mesh-ancestor
19770146|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
19770147|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770148|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770149|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770150|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770151|NCT00115765|Bevacizumab|bevacizumab|mesh-list
19770152|NCT00115765|Panitumumab|panitumumab|mesh-list
19770153|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
19770154|NCT00115765|Irinotecan|irinotecan|mesh-list
19770155|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770156|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770157|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19770158|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19770159|NCT00115765|Growth Substances|growth substances|mesh-ancestor
19770160|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150167|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20150168|NCT00084734|Docetaxel|docetaxel|mesh-list
19770161|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
19770162|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19770163|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19770164|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770165|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770166|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
19770167|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19770168|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
19770169|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19770170|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
19770171|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770172|NCT00115804|Fluoxetine|fluoxetine|mesh-list
19770173|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19770174|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19770175|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19770176|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611038|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611039|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611040|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770177|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19770178|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
19770179|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770180|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19770181|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
19770182|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19770183|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19770184|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19770185|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770186|NCT00116207|Niacinamide|niacinamide|mesh-list
19770187|NCT00116207|Allopurinol|allopurinol|mesh-list
19770188|NCT00116207|Antioxidants|antioxidants|mesh-list
19770189|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
19770190|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770191|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770192|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
19770193|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770194|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19770195|NCT00116207|Protective Agents|protective agents|mesh-ancestor
19770196|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770197|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
19770198|NCT00116207|Vitamins|vitamins|mesh-ancestor
19770199|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
19770200|NCT00116272|Etanercept|etanercept|mesh-list
19770201|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770202|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770203|NCT00116272|Analgesics|analgesics|mesh-ancestor
19770204|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
19770205|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770206|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770207|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770208|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770209|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20150169|NCT00084734|Capecitabine|capecitabine|mesh-list
19770210|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770211|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
19770212|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19770213|NCT00116649|Imiquimod|imiquimod|mesh-list
19770214|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19770215|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
19770216|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770217|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770218|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
19770219|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19770220|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19770221|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19770222|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770223|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770224|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770225|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
19770226|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770227|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19770228|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19770229|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
19770230|NCT00116831|Glipizide|glipizide|mesh-list
19770231|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19770232|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770233|NCT00116844|Valacyclovir|valacyclovir|mesh-list
19770234|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
19770235|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316935|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316936|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20316937|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316938|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
20316939|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316940|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
20316941|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316942|NCT00707187|Tadalafil|tadalafil|mesh-list
20316943|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
20316944|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20316945|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20316946|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316947|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316948|NCT00707187|Urological Agents|urological agents|mesh-ancestor
20316949|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20316950|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316951|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20316952|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316953|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316954|NCT00707278|Capecitabine|capecitabine|mesh-list
20316955|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
20316956|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20316957|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
20316958|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316959|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347388|NCT00859885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20347389|NCT00859885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770236|NCT00116857|Sertraline|sertraline|mesh-list
19770237|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
19770238|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19770239|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19770240|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19770241|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19770242|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770243|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19770244|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
19770245|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770246|NCT00117156|Rituximab|rituximab|mesh-list
19770247|NCT00117156|Fludarabine|fludarabine|mesh-list
19770248|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770249|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770250|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
19770251|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770252|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770253|NCT00117507|Deferasirox|deferasirox|mesh-list
19770254|NCT00117507|Chelating Agents|chelating agents|mesh-list
19770255|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19770256|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
20150170|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770257|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770258|NCT00117572|Docetaxel|docetaxel|mesh-list
19770259|NCT00117572|Fluorouracil|fluorouracil|mesh-list
19770260|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
19770261|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770262|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770263|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770264|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
19770265|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770266|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
19770267|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770268|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770269|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
19770270|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770271|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
19770272|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770273|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770274|NCT00117598|Sirolimus|sirolimus|mesh-list
19770275|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19770276|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770277|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770278|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770279|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
19770280|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770281|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
19770282|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770283|NCT00117637|Interferons|interferons|mesh-list
19770284|NCT00117637|Sorafenib|sorafenib|mesh-list
19770285|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770286|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
19770287|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770288|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770289|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770290|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770291|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20316960|NCT00707330|Clarithromycin|clarithromycin|mesh-list
20316961|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316962|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316963|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20316964|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316965|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316966|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20316967|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20316968|NCT00707369|Amoxicillin|amoxicillin|mesh-list
20316969|NCT00707369|Metronidazole|metronidazole|mesh-list
20316970|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20316971|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316972|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20316973|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20316974|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
20316975|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20316976|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770292|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19770293|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19770294|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770295|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770296|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770297|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
19770298|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770299|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19770300|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19770301|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
19770302|NCT00117715|Caffeine|caffeine|mesh-list
19770303|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19770304|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770305|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19770306|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770307|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770308|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19770309|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19770310|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
19770311|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20316977|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347390|NCT00859885|Analgesics|analgesics|mesh-ancestor
19770312|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
19770313|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
19770314|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19770315|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19770316|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
19770317|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770318|NCT00117962|Carboplatin|carboplatin|mesh-list
19770319|NCT00117962|Pemetrexed|pemetrexed|mesh-list
19770320|NCT00117962|Cetuximab|cetuximab|mesh-list
19770321|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770322|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770323|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770324|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19770325|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770326|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770327|NCT00118040|Genistein|genistein|mesh-list
19770328|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19770329|NCT00118040|Protective Agents|protective agents|mesh-ancestor
19770330|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770331|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770332|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770333|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770334|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770335|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
19770336|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19770337|NCT00118040|Estrogens|estrogens|mesh-ancestor
19770338|NCT00118040|Hormones|hormones|mesh-ancestor
19770339|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770340|NCT00118131|Docetaxel|docetaxel|mesh-list
19770341|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770342|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770343|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770344|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
19770345|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770346|NCT00118144|Bortezomib|bortezomib|mesh-list
19770347|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770348|NCT00118157|Tamoxifen|tamoxifen|mesh-list
19770349|NCT00118157|Lapatinib|lapatinib|mesh-list
19770350|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770351|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19770352|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
19770353|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770354|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770355|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19770356|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770357|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19770358|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19770359|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19770360|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770361|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770362|NCT00118209|Prednisone|prednisone|mesh-list
19770363|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
19770364|NCT00118209|Rituximab|rituximab|mesh-list
19770365|NCT00118209|Doxorubicin|doxorubicin|mesh-list
19770366|NCT00118209|Etoposide|etoposide|mesh-list
19770367|NCT00118209|Vincristine|vincristine|mesh-list
19770368|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316978|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770369|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
19770370|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770371|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150171|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150172|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150173|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150174|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150175|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150176|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
20150177|NCT00084773|Fluorouracil|fluorouracil|mesh-list
20150178|NCT00084773|Cetuximab|cetuximab|mesh-list
20150179|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
20150180|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150181|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150182|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150183|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20316979|NCT00707421|Fluorometholone|fluorometholone|mesh-list
19770372|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770373|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
19770374|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770375|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770376|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770377|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770378|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770379|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19770380|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19770381|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770382|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770383|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
19770384|NCT00118209|Hormones|hormones|mesh-ancestor
19770385|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770386|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19770387|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19770388|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770389|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770390|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
19770391|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
19770392|NCT00118274|Vaccines|vaccines|mesh-list
19770393|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
19770394|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
19770395|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770396|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770397|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770398|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770399|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
19770400|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770401|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770402|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770403|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19770404|NCT00118287|Etanercept|etanercept|mesh-list
19770405|NCT00118287|Azacitidine|azacitidine|mesh-list
19770406|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770407|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
19770408|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770409|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770410|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770411|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770412|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770413|NCT00118287|Analgesics|analgesics|mesh-ancestor
19770414|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
19770415|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770416|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770417|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770418|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770419|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19770420|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770421|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
19770422|NCT00118352|Cyclosporine|cyclosporine|mesh-list
19770423|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
19770424|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19770425|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
19770426|NCT00118352|Fludarabine|fludarabine|mesh-list
19770427|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
19770428|NCT00118352|Antibodies|antibodies|mesh-list
19770429|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
19770430|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19770431|NCT00118352|Cyclosporins|cyclosporins|mesh-list
19770432|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
19770433|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770434|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770435|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770436|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
19770437|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770438|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770439|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770440|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
19770441|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770442|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770443|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770444|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19770445|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770446|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19770447|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
19770448|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19770449|NCT00118365|Eflornithine|eflornithine|mesh-list
19770450|NCT00118365|Sulindac|sulindac|mesh-list
19770451|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770452|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19770453|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19770454|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19770455|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770456|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19770457|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770458|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770459|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770460|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770461|NCT00118365|Analgesics|analgesics|mesh-ancestor
19770462|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
19770463|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770464|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770465|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770466|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770467|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19770468|NCT00118378|Modafinil|modafinil|mesh-list
19770469|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19770470|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770471|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19770472|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19770473|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19770474|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770475|NCT00118404|Fluoxetine|fluoxetine|mesh-list
19770476|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19770477|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19770478|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19770479|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770480|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19770481|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
19770482|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770483|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19770484|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
19770485|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19770486|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19770487|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19770488|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770489|NCT00118417|Clonazepam|clonazepam|mesh-list
19770490|NCT00118417|Sertraline|sertraline|mesh-list
19770491|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
19770492|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19770493|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19770494|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19770495|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19770496|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770497|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19770498|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
19770499|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770500|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
19635547|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635548|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635549|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
19635550|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635551|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19635552|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
19635553|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
19635554|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19635555|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635556|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635557|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635558|NCT02428283|Remifentanil|remifentanil|mesh-list
19635559|NCT02428283|Ropivacaine|ropivacaine|mesh-list
19770501|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
19770502|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
19770503|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
20150184|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
20150185|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635560|NCT02428283|Sevoflurane|sevoflurane|mesh-list
19770504|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19770505|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
19770506|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770507|NCT00118716|Fluticasone|fluticasone|mesh-list
19770508|NCT00118716|Xhance|xhance|mesh-list
19770509|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19770510|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770511|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19770512|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
19770513|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770514|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770515|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19770516|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
19770517|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770518|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19770519|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19770520|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19770521|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19770522|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
19770523|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19770524|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770525|NCT00118742|Cyclosporine|cyclosporine|mesh-list
19770526|NCT00118742|Sirolimus|sirolimus|mesh-list
19770527|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
19770528|NCT00118742|Tacrolimus|tacrolimus|mesh-list
19770529|NCT00118742|Cyclosporins|cyclosporins|mesh-list
19770530|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770531|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
19770532|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770533|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19770534|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770535|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770536|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
19770537|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770538|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770539|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770540|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770541|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770542|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19770543|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
19770544|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19833261|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833262|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833263|NCT00395473|Ezetimibe|ezetimibe|mesh-list
19833264|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833265|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833266|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
19833267|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833268|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833269|NCT00393354|Etoricoxib|etoricoxib|mesh-list
19833270|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150186|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150187|NCT00084786|Docetaxel|docetaxel|mesh-list
20150188|NCT00084786|Gefitinib|gefitinib|mesh-list
19833271|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833272|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833273|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833274|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20150189|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150190|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150191|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150192|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150193|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150194|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150195|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150196|NCT00084812|Safingol|safingol|mesh-list
20150197|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150198|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150199|NCT00084825|Docetaxel|docetaxel|mesh-list
20150200|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
20150201|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150202|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150203|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150204|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
19833275|NCT00393354|Analgesics|analgesics|mesh-ancestor
19833276|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
19770545|NCT00118755|Bevacizumab|bevacizumab|mesh-list
19770546|NCT00118755|Capecitabine|capecitabine|mesh-list
19770547|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
19770548|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770549|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770550|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19770551|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19770552|NCT00118755|Growth Substances|growth substances|mesh-ancestor
19770553|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770554|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
19770555|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770556|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
19770557|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770558|NCT00118898|Ritonavir|ritonavir|mesh-list
19770559|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19770560|NCT00118898|Tenofovir|tenofovir|mesh-list
19770561|NCT00118898|Lamivudine|lamivudine|mesh-list
19770562|NCT00118898|Emtricitabine|emtricitabine|mesh-list
19770563|NCT00118898|Abacavir|abacavir|mesh-list
19770564|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19770565|NCT00118898|Efavirenz|efavirenz|mesh-list
19770566|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
19770567|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19770568|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19770569|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
19770570|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770571|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770572|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19770573|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19770574|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
19770575|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770576|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19770577|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19770578|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19770579|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770580|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19770581|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19770582|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19770583|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19770584|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19770585|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
19770586|NCT00119015|Fluticasone|fluticasone|mesh-list
19770587|NCT00119015|Xhance|xhance|mesh-list
19770588|NCT00119015|Montelukast|montelukast|mesh-list
19770589|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770590|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19770591|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
19770592|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770593|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770594|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19770595|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
19770596|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770597|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19770598|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19770599|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
19770600|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770601|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19770602|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19770603|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770604|NCT00119106|Tenofovir|tenofovir|mesh-list
19770605|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
19770606|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770607|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19770608|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770609|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770610|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770611|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19770612|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19770613|NCT00119158|Fluticasone|fluticasone|mesh-list
19770614|NCT00119158|Xhance|xhance|mesh-list
19770615|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
19770616|NCT00119158|Tacrolimus|tacrolimus|mesh-list
19770617|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770618|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19770619|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
19770620|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770621|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770622|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19770623|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
19770624|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770625|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19770626|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770627|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770628|NCT00119158|Analgesics|analgesics|mesh-ancestor
19770629|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
19770630|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770631|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770632|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
19635561|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
19635562|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
19635563|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635564|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635565|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
19635566|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635567|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19770633|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19770634|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770635|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770636|NCT00119262|Tamoxifen|tamoxifen|mesh-list
19770637|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
19770638|NCT00119262|Bevacizumab|bevacizumab|mesh-list
19770639|NCT00119262|Doxorubicin|doxorubicin|mesh-list
19770640|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19770641|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19770642|NCT00119262|Antibodies|antibodies|mesh-list
19770643|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
19770644|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19770645|NCT00119262|Lenograstim|lenograstim|mesh-list
19770646|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19770647|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770648|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770649|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770650|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
19770651|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770652|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316980|NCT00707421|Ketorolac|ketorolac|mesh-list
20316981|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770653|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770654|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
19770655|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770656|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19770657|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19770658|NCT00119262|Growth Substances|growth substances|mesh-ancestor
19770659|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
19770660|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770661|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19770662|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19770663|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20316982|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20316983|NCT00707421|Analgesics|analgesics|mesh-ancestor
20316984|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
20316985|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20316986|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20316987|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20316988|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20316989|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19635568|NCT02428283|Narcotics|narcotics|mesh-ancestor
19635569|NCT02428283|Analgesics|analgesics|mesh-ancestor
19635570|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19635571|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19635572|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
19635573|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19635574|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
19635575|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635576|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
19635577|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770664|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19770665|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19770666|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
20316990|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611041|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770667|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770668|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19770669|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19770670|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19770671|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19770672|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19770673|NCT00119379|Tenofovir|tenofovir|mesh-list
19770674|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
19770675|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770676|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19770677|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770678|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770679|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770680|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19770681|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19770682|NCT00119392|Cyclosporine|cyclosporine|mesh-list
19770683|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
19770684|NCT00119392|Rituximab|rituximab|mesh-list
19770685|NCT00119392|Fludarabine|fludarabine|mesh-list
19770686|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
19770687|NCT00119392|Cyclosporins|cyclosporins|mesh-list
19770688|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19770689|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770690|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770691|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
19770692|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770693|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770694|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770695|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
19770696|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770697|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770698|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770699|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
19770700|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770701|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
20150205|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150206|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150207|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150208|NCT00084877|Irinotecan|irinotecan|mesh-list
20150209|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20150210|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19770702|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19770703|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770704|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19770705|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
19770706|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19770707|NCT00119678|Prednisone|prednisone|mesh-list
19770708|NCT00119678|Abatacept|abatacept|mesh-list
19770709|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770710|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
19770711|NCT00119678|Hormones|hormones|mesh-ancestor
19770712|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770713|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770714|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19770715|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770716|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19770717|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770718|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770719|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
19770720|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770721|NCT00120250|Eszopiclone|eszopiclone|mesh-list
19770722|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19770723|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19770724|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770725|NCT00120289|Niacin|niacin|mesh-list
19770726|NCT00120289|Simvastatin|simvastatin|mesh-list
19770727|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19770728|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19770729|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
19770730|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770731|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20150211|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150212|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150213|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150214|NCT00084890|Carboplatin|carboplatin|mesh-list
20150215|NCT00084890|Docetaxel|docetaxel|mesh-list
20150216|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150217|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770732|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19770733|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770734|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
19770735|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
19770736|NCT00120289|Vitamins|vitamins|mesh-ancestor
19770737|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
19770738|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770739|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
19770740|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770741|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770742|NCT00120523|Analgesics|analgesics|mesh-ancestor
19770743|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
19770744|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770745|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770746|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770747|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770748|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770749|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770750|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
19770751|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19770752|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770753|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770754|NCT00120874|Memantine|memantine|mesh-list
19770755|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19770756|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20150218|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150219|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150220|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150221|NCT00084916|Sirolimus|sirolimus|mesh-list
20150222|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20150223|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20316991|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20316992|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
20316993|NCT00707421|Hormones|hormones|mesh-ancestor
20316994|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20316995|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20316996|NCT00707473|Cisplatin|cisplatin|mesh-list
20316997|NCT00707473|Carboplatin|carboplatin|mesh-list
19635578|NCT02428062|Phenylephrine|phenylephrine|mesh-list
19635579|NCT02428062|Dopamine|dopamine|mesh-list
19635580|NCT02428062|Epinephrine|epinephrine|mesh-list
19635581|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
19635582|NCT02428062|Norepinephrine|norepinephrine|mesh-list
19635583|NCT02428062|Ephedrine|ephedrine|mesh-list
20316998|NCT00707473|Docetaxel|docetaxel|mesh-list
20316999|NCT00707473|Fluorouracil|fluorouracil|mesh-list
20317000|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317001|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
20317002|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
20317003|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
20317004|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317005|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
20317006|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635584|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19635585|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635586|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19635587|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19635588|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635589|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635590|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635591|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19635592|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19635593|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
19635594|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635595|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19635596|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
19635597|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
19635598|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
19770757|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
20317007|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635599|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19635600|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
20150224|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770758|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19770759|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770760|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770761|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19770762|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19770763|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
19770764|NCT00121134|Bevacizumab|bevacizumab|mesh-list
19770765|NCT00121134|Capecitabine|capecitabine|mesh-list
19770766|NCT00121134|Methotrexate|methotrexate|mesh-list
19770767|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770768|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
19770769|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770770|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770771|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770772|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
19770773|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770774|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770775|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770776|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770777|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19770778|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19770779|NCT00121134|Growth Substances|growth substances|mesh-ancestor
19770780|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
19770781|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770782|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
19770783|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19770784|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
19770785|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19770786|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770787|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770788|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19770789|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770790|NCT00121186|Methotrexate|methotrexate|mesh-list
19770791|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
19770792|NCT00121186|Fludarabine|fludarabine|mesh-list
19770793|NCT00121186|Melphalan|melphalan|mesh-list
19770794|NCT00121186|Tacrolimus|tacrolimus|mesh-list
19770795|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19770796|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
19770797|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19770798|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770799|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770800|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
19770801|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770802|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770803|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770804|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770805|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19770806|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770807|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
19770808|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770809|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770810|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19770811|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770812|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
19770813|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770814|NCT00121199|Prednisone|prednisone|mesh-list
19770815|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
19770816|NCT00121199|Bevacizumab|bevacizumab|mesh-list
19770817|NCT00121199|Rituximab|rituximab|mesh-list
19770818|NCT00121199|Doxorubicin|doxorubicin|mesh-list
19770819|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19770820|NCT00121199|Vincristine|vincristine|mesh-list
19770821|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19770822|NCT00121199|Antibodies|antibodies|mesh-list
19770823|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
19770824|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20150225|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150226|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
20150227|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150228|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
20150229|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150230|NCT00084942|Gemcitabine|gemcitabine|mesh-list
19770825|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770826|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
19770827|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770828|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770829|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770830|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
19770831|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770832|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770833|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770834|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19770835|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19770836|NCT00121199|Growth Substances|growth substances|mesh-ancestor
19770837|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
19770838|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770839|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19770840|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19770841|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770842|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770843|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
20317008|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
19770844|NCT00121199|Hormones|hormones|mesh-ancestor
19770845|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770846|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19770847|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19770848|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770849|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770850|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
19770851|NCT00121225|Vorinostat|vorinostat|mesh-list
19770852|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770853|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19770854|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770855|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770856|NCT00121251|Gemcitabine|gemcitabine|mesh-list
19770857|NCT00121251|Capecitabine|capecitabine|mesh-list
19770858|NCT00121251|Sorafenib|sorafenib|mesh-list
19770859|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770860|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
19770861|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770862|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770863|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
19770864|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770865|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770866|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770867|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
19770868|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150231|NCT00084942|Capecitabine|capecitabine|mesh-list
20150232|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150233|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
20150234|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150235|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150236|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
20150237|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770869|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770870|NCT00121641|Metformin|metformin|mesh-list
19770871|NCT00121641|Saxagliptin|saxagliptin|mesh-list
19770872|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19770873|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770874|NCT00121641|Incretins|incretins|mesh-ancestor
19770875|NCT00121641|Hormones|hormones|mesh-ancestor
19770876|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770877|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19770878|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
19770879|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770880|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770881|NCT00121667|Metformin|metformin|mesh-list
19770882|NCT00121667|Pioglitazone|pioglitazone|mesh-list
19770883|NCT00121667|Saxagliptin|saxagliptin|mesh-list
19770884|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19770885|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150238|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150239|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150240|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
20150241|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150242|NCT00084981|Decitabine|decitabine|mesh-list
20150243|NCT00084981|Azacitidine|azacitidine|mesh-list
20317009|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150244|NCT00084981|Valproic Acid|valproic acid|mesh-list
19770886|NCT00121667|Incretins|incretins|mesh-ancestor
19770887|NCT00121667|Hormones|hormones|mesh-ancestor
19770888|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770889|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19770890|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
19770891|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770892|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770893|NCT00121719|Lenvatinib|lenvatinib|mesh-list
19770894|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770895|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770896|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770897|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770898|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
19770899|NCT00121810|Sirolimus|sirolimus|mesh-list
19770900|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19770901|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770902|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770903|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19770904|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
19770905|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19770906|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19770907|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770908|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770909|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
19770910|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770911|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
19770912|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635601|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19635602|NCT02428062|Protective Agents|protective agents|mesh-ancestor
19635603|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19635604|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
19635605|NCT02427932|Gentamicins|gentamicins|mesh-list
19635606|NCT02427932|Ampicillin|ampicillin|mesh-list
19635607|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19635608|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635609|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19635610|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635611|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635612|NCT02427893|Vemurafenib|vemurafenib|mesh-list
19635613|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770913|NCT00121836|Bevacizumab|bevacizumab|mesh-list
19770914|NCT00121836|Capecitabine|capecitabine|mesh-list
19770915|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19770916|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770917|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19770918|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19770919|NCT00121836|Growth Substances|growth substances|mesh-ancestor
19770920|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770921|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
19770922|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770923|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
19770924|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770925|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
19770926|NCT00121992|Docetaxel|docetaxel|mesh-list
19770927|NCT00121992|Doxorubicin|doxorubicin|mesh-list
19770928|NCT00121992|Fluorouracil|fluorouracil|mesh-list
19770929|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770930|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
19770931|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770932|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770933|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19770934|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
19770935|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770936|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150245|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150246|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
20150247|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150248|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150249|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150250|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
20150251|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
20150252|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635614|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19770937|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19770938|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19770939|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19770940|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19770941|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19770942|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19770943|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19770944|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770945|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
19770946|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19770947|NCT00122278|Dexamethasone|dexamethasone|mesh-list
19770948|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770949|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
19770950|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
19770951|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770952|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770953|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19770954|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
19770955|NCT00122278|Hormones|hormones|mesh-ancestor
19770956|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19770957|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19770958|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770959|NCT00122317|Eculizumab|eculizumab|mesh-list
19770960|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19770961|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770962|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
19770963|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770964|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20317010|NCT00707512|Natalizumab|natalizumab|mesh-list
20317011|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
20317012|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317013|NCT00707551|Ketoconazole|ketoconazole|mesh-list
20317014|NCT00707551|Verapamil|verapamil|mesh-list
20317015|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
20317016|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317017|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20317018|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20317019|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317020|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317021|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20317022|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
20317023|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317024|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770965|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19770966|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770967|NCT00122382|Methotrexate|methotrexate|mesh-list
19770968|NCT00122382|Abatacept|abatacept|mesh-list
19770969|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19770970|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
19770971|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19770972|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150253|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150254|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
20150255|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20150256|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150257|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150258|NCT00085020|Trastuzumab|trastuzumab|mesh-list
20150259|NCT00085020|Lapatinib|lapatinib|mesh-list
20150260|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150261|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150262|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150263|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150264|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150265|NCT00085111|Bevacizumab|bevacizumab|mesh-list
20150266|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20150267|NCT00085111|Antibodies|antibodies|mesh-list
20150268|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
20150269|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20150270|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150271|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20150272|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20150273|NCT00085111|Growth Substances|growth substances|mesh-ancestor
20150274|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150275|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
19770973|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150276|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
20150277|NCT00085124|Cytarabine|cytarabine|mesh-list
20150278|NCT00085124|Daunorubicin|daunorubicin|mesh-list
20150279|NCT00085124|Oblimersen|oblimersen|mesh-list
20150280|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150281|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
20150282|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150283|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150284|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
20150285|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150286|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150287|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
20150288|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770974|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
19770975|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770976|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19770977|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
19770978|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19770979|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19770980|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19770981|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
19770982|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770983|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19770984|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19770985|NCT00122447|Aspirin|aspirin|mesh-list
19770986|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
19770987|NCT00122447|Olmesartan|olmesartan|mesh-list
19770988|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19770989|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19770990|NCT00122447|Analgesics|analgesics|mesh-ancestor
19770991|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
19770992|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19770993|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19770994|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19770995|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19770996|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19770997|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19770998|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19770999|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19771000|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19771001|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771002|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
19771003|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19771004|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19771005|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19771006|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
19771007|NCT00122447|Protective Agents|protective agents|mesh-ancestor
19771008|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
19771009|NCT00122447|Vitamins|vitamins|mesh-ancestor
19771010|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
19771011|NCT00122460|Cisplatin|cisplatin|mesh-list
19771012|NCT00122460|Carboplatin|carboplatin|mesh-list
19771013|NCT00122460|Fluorouracil|fluorouracil|mesh-list
19771014|NCT00122460|Cetuximab|cetuximab|mesh-list
19771015|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771016|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
19771017|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771018|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19771019|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771020|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
19771021|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771022|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771023|NCT00122681|Vaccines|vaccines|mesh-list
19771024|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
19771025|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150289|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150290|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20150291|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150292|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150293|NCT00085150|Immunotoxins|immunotoxins|mesh-list
20150294|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
20150295|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150296|NCT00085163|Leucovorin|leucovorin|mesh-list
20150297|NCT00085163|Celecoxib|celecoxib|mesh-list
19771026|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
20150298|NCT00085163|Fluorouracil|fluorouracil|mesh-list
20150299|NCT00085163|Calcium|calcium|mesh-list
20150300|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
19771027|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771028|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
19771029|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771030|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771031|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19771032|NCT00123110|Metformin|metformin|mesh-list
19771033|NCT00123110|Leuprolide|leuprolide|mesh-list
19771034|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19771035|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771036|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19771037|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
19771038|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19771039|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19771040|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771041|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
19771042|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19771043|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19771044|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771045|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
19771046|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
19771047|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
19771048|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771049|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
19771050|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19771051|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19771052|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771053|NCT00123162|Urological Agents|urological agents|mesh-ancestor
19771054|NCT00123474|Dasatinib|dasatinib|mesh-list
19771055|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771056|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771057|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771058|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771059|NCT00123487|Dasatinib|dasatinib|mesh-list
19771060|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771061|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771062|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771063|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771064|NCT00123604|Metoprolol|metoprolol|mesh-list
19771065|NCT00123604|Carvedilol|carvedilol|mesh-list
19771066|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19771067|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19771068|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
19771069|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
19771070|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771071|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771072|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19771073|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19771074|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19771075|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
19771076|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771077|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771078|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
19771079|NCT00123604|Protective Agents|protective agents|mesh-ancestor
19771080|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19771081|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771082|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19771083|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
19771084|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19771085|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19771086|NCT00123630|Omalizumab|omalizumab|mesh-list
19771087|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19771088|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19771089|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
19771090|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
19771091|NCT00123643|Glyburide|glyburide|mesh-list
19771092|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19771093|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771094|NCT00123955|Spironolactone|spironolactone|mesh-list
19771095|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19771096|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
19771097|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19771098|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150301|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20611042|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771099|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19771100|NCT00123955|Diuretics|diuretics|mesh-ancestor
19771101|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
19771102|NCT00124020|Vancomycin|vancomycin|mesh-list
19771103|NCT00124020|Telavancin|telavancin|mesh-list
19771104|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19771105|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771106|NCT00124072|Folic Acid|folic acid|mesh-list
19771107|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
19771108|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
19771109|NCT00124072|Simvastatin|simvastatin|mesh-list
19771110|NCT00124072|Vitamins|vitamins|mesh-ancestor
19771111|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
19771112|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771113|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19771114|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19771115|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
19771116|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771117|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19771118|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19771119|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771120|NCT00124072|Hematinics|hematinics|mesh-ancestor
19771121|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
19771122|NCT00124176|Albuterol|albuterol|mesh-list
19771123|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19771124|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
19771125|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771126|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771127|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19771128|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19771129|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
19771130|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19771131|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19771132|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19771133|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19771134|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19771135|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771136|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771137|NCT00124449|Abatacept|abatacept|mesh-list
19771138|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19771139|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771140|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771141|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771142|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
19771143|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771144|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771145|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19771146|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
19771147|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19771148|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
19771149|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19771150|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771151|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19771152|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19771153|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771154|NCT00124579|Thalidomide|thalidomide|mesh-list
19771155|NCT00124579|Dexamethasone|dexamethasone|mesh-list
19771156|NCT00124579|Bortezomib|bortezomib|mesh-list
19771157|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19771158|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
19771159|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
19771160|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771161|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771162|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317025|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20317026|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20317027|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20317028|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20317029|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20317030|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317031|NCT00707642|Vaccines|vaccines|mesh-list
20317032|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
20317033|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317034|NCT00707707|Paclitaxel|paclitaxel|mesh-list
20317035|NCT00707707|Olaparib|olaparib|mesh-list
20317036|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20317037|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771163|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
19771164|NCT00124579|Hormones|hormones|mesh-ancestor
19771165|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19771166|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19771167|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771168|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771169|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
19771170|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
19771171|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19771172|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771173|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19771174|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771175|NCT00124579|Growth Substances|growth substances|mesh-ancestor
19771176|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771177|NCT00124618|Cetuximab|cetuximab|mesh-list
19771178|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771179|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771180|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19771181|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771182|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771183|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771184|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771185|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
19771186|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19771187|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19771188|NCT00124709|Analgesics|analgesics|mesh-ancestor
19771189|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
19771190|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771191|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771192|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19771193|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771194|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
19771195|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771196|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
19771197|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19771198|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771199|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771200|NCT00124735|Rocuronium|rocuronium|mesh-list
19771201|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19771202|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19771203|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19771204|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771205|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771206|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
19771207|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771208|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771209|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771210|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771211|NCT00124943|Paclitaxel|paclitaxel|mesh-list
19771212|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19771213|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19771214|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771215|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771216|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771217|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
19833277|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20317038|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612243|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20317039|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
20317040|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
20317041|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317042|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20317043|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317044|NCT00707772|Ribavirin|ribavirin|mesh-list
20317045|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19771218|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771219|NCT00124982|Abatacept|abatacept|mesh-list
19771220|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
19771221|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19771222|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771223|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771224|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771225|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
19771226|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771227|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
19771228|NCT00125034|Cetuximab|cetuximab|mesh-list
19771229|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771230|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771231|NCT00125138|Metylperon|metylperon|mesh-list
19771232|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19771233|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19771234|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19771235|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771236|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771237|NCT00125164|Mecasermin|mecasermin|mesh-list
19771238|NCT00125164|Growth Substances|growth substances|mesh-ancestor
19771239|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771240|NCT00125190|Mecasermin|mecasermin|mesh-list
19771241|NCT00125190|Growth Substances|growth substances|mesh-ancestor
19771242|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771243|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19771244|NCT00125359|Bexarotene|bexarotene|mesh-list
19771245|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317046|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
20317047|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
20317048|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317049|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
19771246|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771247|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771248|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771249|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19771250|NCT00125372|Bexarotene|bexarotene|mesh-list
19771251|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771252|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771253|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771254|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771255|NCT00125515|Naltrexone|naltrexone|mesh-list
19771256|NCT00125515|Memantine|memantine|mesh-list
19771257|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19771258|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19771259|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771260|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
19771261|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771262|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19771263|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19771264|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
19771265|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771266|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771267|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19771268|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19771269|NCT00125528|Cycloserine|cycloserine|mesh-list
19771270|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19771271|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771272|NCT00125528|Renal Agents|renal agents|mesh-ancestor
19771273|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20317050|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317051|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
20317052|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317053|NCT00707785|Vitamin A|vitamin a|mesh-list
19771274|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
20317054|NCT00707785|Vitamins|vitamins|mesh-ancestor
20317055|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
20317056|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612244|NCT02250820|Analgesics|analgesics|mesh-ancestor
20317057|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20317058|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
20317059|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317060|NCT00707824|Nalbuphine|nalbuphine|mesh-list
20317061|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20317062|NCT00707824|Narcotics|narcotics|mesh-ancestor
20317063|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317064|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317065|NCT00707824|Analgesics|analgesics|mesh-ancestor
20317066|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
20317067|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317068|NCT00707850|Ribavirin|ribavirin|mesh-list
20317069|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19635615|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771275|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19771276|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
19771277|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771278|NCT00125593|Simvastatin|simvastatin|mesh-list
19771279|NCT00125593|Ezetimibe|ezetimibe|mesh-list
19771280|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19771281|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19771282|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
19771283|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771284|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19771285|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19771286|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771287|NCT00125853|Atenolol|atenolol|mesh-list
19771288|NCT00125853|Nebivolol|nebivolol|mesh-list
19771289|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19771290|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19771291|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
19771292|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
19771293|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771294|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771295|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19771296|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19771297|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20150302|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150303|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
20150304|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150305|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150306|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150307|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150308|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
20150309|NCT00085163|Antidotes|antidotes|mesh-ancestor
20150310|NCT00085163|Protective Agents|protective agents|mesh-ancestor
20150311|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
20150312|NCT00085163|Vitamins|vitamins|mesh-ancestor
20150313|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
20150314|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20150315|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20150316|NCT00085163|Analgesics|analgesics|mesh-ancestor
20150317|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
20150318|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150319|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150320|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635616|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635617|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19635618|NCT02427880|Furosemide|furosemide|mesh-list
19635619|NCT02427880|Acetazolamide|acetazolamide|mesh-list
19635620|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19635621|NCT02427880|Diuretics|diuretics|mesh-ancestor
19635622|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
19635623|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635624|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19635625|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635626|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635627|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20150321|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20317070|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
19771298|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
19833278|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20317071|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
20150322|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20150323|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150324|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
20150325|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20150326|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
19771299|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771300|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771301|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
19771302|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19771303|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19771304|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19771305|NCT00125931|Pentazocine|pentazocine|mesh-list
19771306|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19771307|NCT00125931|Narcotics|narcotics|mesh-ancestor
19771308|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19771309|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771310|NCT00125931|Analgesics|analgesics|mesh-ancestor
19771311|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
19771312|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771313|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19771314|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19771315|NCT00125957|Bupropion|bupropion|mesh-list
19771316|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19771317|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
19771318|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771319|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19771320|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19771321|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771322|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771323|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
19771324|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771325|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771326|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19771327|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19771328|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771329|NCT00126191|Leucovorin|leucovorin|mesh-list
19771330|NCT00126191|Cytarabine|cytarabine|mesh-list
19771331|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
19771332|NCT00126191|Ifosfamide|ifosfamide|mesh-list
19771333|NCT00126191|Rituximab|rituximab|mesh-list
19771334|NCT00126191|Doxorubicin|doxorubicin|mesh-list
19771335|NCT00126191|Methotrexate|methotrexate|mesh-list
19771336|NCT00126191|Etoposide|etoposide|mesh-list
19771337|NCT00126191|Vincristine|vincristine|mesh-list
19771338|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771339|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
20317072|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317073|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
20317074|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317075|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
19635628|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
19635629|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19635630|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635631|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19635632|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19635633|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635634|NCT02427295|Octreotide|octreotide|mesh-list
19635635|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19635636|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635637|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635638|NCT02427334|Dienogest|dienogest|mesh-list
19635639|NCT02427334|Fluoxetine|fluoxetine|mesh-list
19635640|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19635641|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19635642|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771340|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150327|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150328|NCT00085228|Docetaxel|docetaxel|mesh-list
20150329|NCT00085228|Oblimersen|oblimersen|mesh-list
20150330|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771341|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771342|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19771343|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
20150331|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771344|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771345|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771346|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19771347|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771348|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19771349|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19771350|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19771351|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771352|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19771353|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
19771354|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19771355|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19771356|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
19771357|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19771358|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19771359|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19771360|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19771361|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
19771362|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771363|NCT00126191|Antidotes|antidotes|mesh-ancestor
19771364|NCT00126191|Protective Agents|protective agents|mesh-ancestor
19771365|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
19771366|NCT00126191|Vitamins|vitamins|mesh-ancestor
19771367|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
19771368|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771369|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771370|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771371|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19771372|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771373|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771374|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771375|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19771376|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19771377|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771378|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771379|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771380|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19771381|NCT00126490|Aldesleukin|aldesleukin|mesh-list
19771382|NCT00126490|Bevacizumab|bevacizumab|mesh-list
19771383|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19771384|NCT00126490|Interleukin-2|interleukin-2|mesh-list
19771385|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
19771386|NCT00126490|Antibodies|antibodies|mesh-list
19771387|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
19771388|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19771389|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
19771390|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771391|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19771392|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771393|NCT00126490|Growth Substances|growth substances|mesh-ancestor
19771394|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771395|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771396|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
19771397|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19771398|NCT00126490|Analgesics|analgesics|mesh-ancestor
19771399|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
19771400|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771401|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20317076|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317077|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20317078|NCT00707876|Hematinics|hematinics|mesh-ancestor
20317079|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20317080|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20317081|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
20317082|NCT00707902|Lidocaine|lidocaine|mesh-list
19771402|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19771403|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
19771404|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771405|NCT00126503|Bevacizumab|bevacizumab|mesh-list
19771406|NCT00126503|Sorafenib|sorafenib|mesh-list
20317083|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
19771407|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771408|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771409|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20150332|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771410|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771411|NCT00126503|Growth Substances|growth substances|mesh-ancestor
19771412|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771413|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771414|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771415|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771416|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771417|NCT00126555|Gefitinib|gefitinib|mesh-list
19771418|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771419|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771420|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317084|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
20317085|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317086|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317087|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
20317088|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317089|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19771421|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771422|NCT00126568|Sorafenib|sorafenib|mesh-list
19771423|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771424|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771425|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771426|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771427|NCT00126581|Paclitaxel|paclitaxel|mesh-list
19771428|NCT00126581|Carboplatin|carboplatin|mesh-list
19771429|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19771430|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19771431|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19771432|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771433|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771434|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771435|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771436|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317090|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20317091|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20317092|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20317093|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317094|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20317095|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317096|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
20317097|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
19771437|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19635643|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635644|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771438|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833279|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19833280|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833281|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833282|NCT00393211|Etoricoxib|etoricoxib|mesh-list
19833283|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833284|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833285|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833286|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833287|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833288|NCT00393211|Analgesics|analgesics|mesh-ancestor
19833289|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
19833290|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833291|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833292|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19833293|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19635645|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
19635646|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635647|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19635648|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
19635649|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19635650|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19635651|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19635652|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635653|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19635654|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
19635655|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19771439|NCT00126594|Interferons|interferons|mesh-list
19771440|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
19771441|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
19771442|NCT00126594|Sorafenib|sorafenib|mesh-list
19771443|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771444|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
19771445|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771446|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771447|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771448|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771449|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
19771450|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771451|NCT00127036|Bevacizumab|bevacizumab|mesh-list
19771452|NCT00127036|Capecitabine|capecitabine|mesh-list
19771453|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
19771454|NCT00127036|Irinotecan|irinotecan|mesh-list
19771455|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771456|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771457|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19771458|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771459|NCT00127036|Growth Substances|growth substances|mesh-ancestor
19771460|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771461|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771462|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19771463|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
19771464|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771465|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19771466|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19771467|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317098|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317099|NCT00707941|Oseltamivir|oseltamivir|mesh-list
20317100|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
20317101|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317102|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317103|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317104|NCT00708149|Lansoprazole|lansoprazole|mesh-list
20317105|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
20317106|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20317107|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317108|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20317109|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317110|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317111|NCT00708240|Citalopram|citalopram|mesh-list
20317112|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20317113|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20317114|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20317115|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317116|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317117|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
20317118|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317119|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19771468|NCT00127101|Vorinostat|vorinostat|mesh-list
19771469|NCT00127101|Bexarotene|bexarotene|mesh-list
19771470|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771471|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19771472|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771473|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771474|NCT00127166|Fluticasone|fluticasone|mesh-list
19771475|NCT00127166|Xhance|xhance|mesh-list
19771476|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19771477|NCT00127166|Montelukast|montelukast|mesh-list
20317120|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
20317121|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771478|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19771479|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19771480|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
19771481|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771482|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771483|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19771484|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
19771485|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
19771486|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19771487|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20317122|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19771488|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19635656|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19635657|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19771489|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19771490|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19771491|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771492|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771493|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19771494|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
20150333|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150334|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150335|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20150336|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150337|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771495|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19771496|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19771497|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19771498|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19771499|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19771500|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771501|NCT00127192|Incretins|incretins|mesh-ancestor
19771502|NCT00127192|Hormones|hormones|mesh-ancestor
19771503|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19771504|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19771505|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
19771506|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771507|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771508|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
19771509|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
19771510|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
19771511|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19771512|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771513|NCT00127218|Niacin|niacin|mesh-list
19771514|NCT00127218|Atorvastatin|atorvastatin|mesh-list
19771515|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19771516|NCT00127218|Simvastatin|simvastatin|mesh-list
19771517|NCT00127218|Pravastatin|pravastatin|mesh-list
19771518|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19771519|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19771520|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
19771521|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771522|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19771523|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19771524|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771525|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
19771526|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
20317123|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20317124|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20317125|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20317126|NCT00708318|Fentanyl|fentanyl|mesh-list
20150338|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771527|NCT00127218|Vitamins|vitamins|mesh-ancestor
19771528|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
19771529|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771530|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
19771531|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20150339|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150340|NCT00085306|Interferons|interferons|mesh-list
20150341|NCT00085306|Interferon-beta|interferon-beta|mesh-list
20317127|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19635658|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20317128|NCT00708318|Narcotics|narcotics|mesh-ancestor
19635659|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19635660|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
19635661|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635662|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635663|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635664|NCT02427308|Miltefosine|miltefosine|mesh-list
19635665|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
19635666|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635667|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635668|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19635669|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19635670|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
19635671|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19771532|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771533|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771534|NCT00127712|Amiodarone|amiodarone|mesh-list
19771535|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19771536|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
19771537|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20150342|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150343|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
20150344|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150345|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
19771538|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771539|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771540|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19771541|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19771542|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19771543|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771544|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19771545|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19771546|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19771547|NCT00127803|Vaccines|vaccines|mesh-list
19771548|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
19771549|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771550|NCT00127842|Etanercept|etanercept|mesh-list
19771551|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19771552|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19771553|NCT00127842|Analgesics|analgesics|mesh-ancestor
19771554|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
19771555|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771556|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771557|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19771558|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771559|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20150346|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150347|NCT00085332|Docetaxel|docetaxel|mesh-list
20150348|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150349|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150350|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771560|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771561|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
19771562|NCT00127855|Vaccines|vaccines|mesh-list
19771563|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19771564|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
19771565|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771566|NCT00127933|Capecitabine|capecitabine|mesh-list
19771567|NCT00127933|Docetaxel|docetaxel|mesh-list
19771568|NCT00127933|Trastuzumab|trastuzumab|mesh-list
20150351|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150352|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150353|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
20150354|NCT00085345|Melphalan|melphalan|mesh-list
20150355|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
20150356|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150357|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
20150358|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150359|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150360|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20150361|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150362|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
20150363|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150364|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
19635672|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19635673|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635674|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
19635675|NCT02427412|Coagulants|coagulants|mesh-ancestor
19635676|NCT02427386|Estradiol|estradiol|mesh-list
19635677|NCT02427386|Estrogens|estrogens|mesh-list
19635678|NCT02427386|Hormones|hormones|mesh-ancestor
19635679|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635680|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635681|NCT02427165|Albuterol|albuterol|mesh-list
19635682|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19635683|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
19833294|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150365|NCT00085345|Protective Agents|protective agents|mesh-ancestor
20150366|NCT00085345|Vitamins|vitamins|mesh-ancestor
19771569|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19771570|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
19771571|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771572|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771573|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771574|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150367|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
20150368|NCT00085358|Paclitaxel|paclitaxel|mesh-list
20150369|NCT00085358|Docetaxel|docetaxel|mesh-list
20150370|NCT00085358|Bevacizumab|bevacizumab|mesh-list
20150371|NCT00085358|Carboplatin|carboplatin|mesh-list
20150372|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20150373|NCT00085358|Antibodies|antibodies|mesh-list
20150374|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
20317129|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317130|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771575|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771576|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771577|NCT00128102|Vorinostat|vorinostat|mesh-list
19771578|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771579|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19771580|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771581|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771582|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
19771583|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19771584|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19771585|NCT00128180|Prednisolone|prednisolone|mesh-list
19771586|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
19771587|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19771588|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
19771589|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19771590|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
19771591|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
19771592|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771593|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771594|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19771595|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
19771596|NCT00128180|Hormones|hormones|mesh-ancestor
19771597|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19771598|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19771599|NCT00128180|Protective Agents|protective agents|mesh-ancestor
20317131|NCT00708318|Analgesics|analgesics|mesh-ancestor
20317132|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
20317133|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771600|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19771601|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771602|NCT00128206|Rifampin|rifampin|mesh-list
19771603|NCT00128206|Isoniazid|isoniazid|mesh-list
19771604|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19771605|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
19771606|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19771607|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771608|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
19771609|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19771610|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771611|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771612|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19771613|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19771614|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19771615|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19771616|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19771617|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19771618|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19771619|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19771620|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
19771621|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19771622|NCT00128401|Cycloserine|cycloserine|mesh-list
20150375|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20150376|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20150377|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150378|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150379|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150380|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150381|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150382|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19771623|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19662177|NCT03423680|Aripiprazole|aripiprazole|mesh-list
19771624|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771625|NCT00128401|Renal Agents|renal agents|mesh-ancestor
19771626|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19771627|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
19771628|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19771629|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
19771630|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771631|NCT00128661|Vaccines|vaccines|mesh-list
19771632|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
19771633|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771634|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19771635|NCT00128830|Etravirine|etravirine|mesh-list
19771636|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
19771637|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19771638|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
19771639|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19771640|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771641|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771642|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
19771643|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771644|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19771645|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19771646|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19771647|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19771648|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19771649|NCT00128921|Bortezomib|bortezomib|mesh-list
19771650|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771651|NCT00129116|Vaccines|vaccines|mesh-list
19771652|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
19771653|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771654|NCT00129129|Vaccines|vaccines|mesh-list
19771655|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
19771656|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771657|NCT00129220|Haloperidol|haloperidol|mesh-list
19771658|NCT00129220|Olanzapine|olanzapine|mesh-list
19771659|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
19771660|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
19771661|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
19771662|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771663|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771664|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19771665|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19662178|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
19662179|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19662180|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19662181|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19662182|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662183|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662184|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
19662185|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
19662186|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662187|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662188|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19662189|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19662190|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
19662191|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19662192|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19662193|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19662194|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19662195|NCT03393468|Dapivirine|dapivirine|mesh-list
19662196|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19771666|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19771667|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19771668|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771669|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19771670|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19771671|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771672|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771673|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771674|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
19771675|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19771676|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
19771677|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19771678|NCT00129246|Naltrexone|naltrexone|mesh-list
19771679|NCT00129246|Bupropion|bupropion|mesh-list
19771680|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19771681|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19771682|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150383|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20150384|NCT00085358|Growth Substances|growth substances|mesh-ancestor
20150385|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150386|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
20150387|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
19771683|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
19771684|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771685|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20150388|NCT00085384|Interferons|interferons|mesh-list
20150389|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
20150390|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
20150391|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20150392|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150393|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
20150394|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317134|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20317135|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20317136|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
20317137|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
20317138|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20317139|NCT00708344|Irbesartan|irbesartan|mesh-list
20317140|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20317141|NCT00708344|Diuretics|diuretics|mesh-ancestor
20317142|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
20150395|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
19635684|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635685|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150396|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150397|NCT00085449|Cyclosporine|cyclosporine|mesh-list
20150398|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
19635686|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19635687|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
19635688|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
19635689|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20317143|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635690|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19635691|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19771686|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
19256641|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
19771687|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771688|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20317144|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19771689|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19771690|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771691|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771692|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
20150399|NCT00085449|Fludarabine|fludarabine|mesh-list
20150400|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
20150401|NCT00085449|Melphalan|melphalan|mesh-list
20150402|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
20150403|NCT00085449|Cyclosporins|cyclosporins|mesh-list
20150404|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635692|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19635693|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635694|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635695|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635696|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20150405|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150406|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
20150407|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317145|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20317146|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635697|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
19771693|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771694|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19771695|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19771696|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771697|NCT00129259|Iron|iron|mesh-list
19771698|NCT00129259|Trace Elements|trace elements|mesh-ancestor
19771699|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
19771700|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771701|NCT00129272|Bupropion|bupropion|mesh-list
19771702|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19771703|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
19771704|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771705|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19771706|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19771707|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771708|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771709|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
19771710|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771711|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771712|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19771713|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19771714|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771715|NCT00129285|Modafinil|modafinil|mesh-list
19771716|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19771717|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771718|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19771719|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19771720|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19771721|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771722|NCT00129311|Selegiline|selegiline|mesh-list
19771723|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
19771724|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771725|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19771726|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19635698|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771727|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19771728|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771729|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771730|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19771731|NCT00129311|Protective Agents|protective agents|mesh-ancestor
19771732|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771733|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
20150408|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150409|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
19635699|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
19635700|NCT02426840|Vitamin D|vitamin d|mesh-list
19635701|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
19635702|NCT02426840|Vitamins|vitamins|mesh-list
19635703|NCT02426840|Calcium|calcium|mesh-list
19635704|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
19635705|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771734|NCT00129376|Docetaxel|docetaxel|mesh-list
19771735|NCT00129376|Doxorubicin|doxorubicin|mesh-list
19771736|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771737|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
19771738|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317147|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20317148|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19771739|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771740|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19771741|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
19771742|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771743|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771744|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19771745|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771746|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771747|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771748|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19771749|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19771750|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19771751|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771752|NCT00129389|Paclitaxel|paclitaxel|mesh-list
19771753|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
19771754|NCT00129389|Doxorubicin|doxorubicin|mesh-list
19771755|NCT00129389|Fluorouracil|fluorouracil|mesh-list
19771756|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19771757|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771758|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771759|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771760|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771761|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771762|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771763|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
19771764|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771765|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771766|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19771767|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
19771768|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19771769|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19771770|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19771771|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19771772|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771773|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
19771774|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19771775|NCT00129467|Methylphenidate|methylphenidate|mesh-list
19771776|NCT00129467|Serotonin|serotonin|mesh-list
19771777|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19771778|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19771779|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771780|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20150410|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771781|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19771782|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19771783|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150411|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150412|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
20150413|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150414|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
20150415|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150416|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19771784|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
19771785|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771786|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19771787|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
19771788|NCT00129545|Warfarin|warfarin|mesh-list
19771789|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
20150417|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150418|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20150419|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
20150420|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20150421|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150422|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
20150423|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20317149|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19771790|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
19771791|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19771792|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771793|NCT00129727|Paclitaxel|paclitaxel|mesh-list
19771794|NCT00129727|Bevacizumab|bevacizumab|mesh-list
19771795|NCT00129727|Carboplatin|carboplatin|mesh-list
19771796|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19771797|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771798|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771799|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771800|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771801|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771802|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771803|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19771804|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771805|NCT00129727|Growth Substances|growth substances|mesh-ancestor
19771806|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771807|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771808|NCT00129766|Palivizumab|palivizumab|mesh-list
19771809|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
19771810|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771811|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
19771812|NCT00129935|Docetaxel|docetaxel|mesh-list
19771813|NCT00129935|Capecitabine|capecitabine|mesh-list
19771814|NCT00129935|Epirubicin|epirubicin|mesh-list
19771815|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771816|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
19771817|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771818|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771819|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19771820|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
19771821|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771822|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771823|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19771824|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771825|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771826|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771827|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19771828|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
19771829|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19771830|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19771831|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19771832|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771833|NCT00129961|Cyclosporine|cyclosporine|mesh-list
19771834|NCT00129961|Sirolimus|sirolimus|mesh-list
19771835|NCT00129961|Tacrolimus|tacrolimus|mesh-list
19771836|NCT00129961|Cyclosporins|cyclosporins|mesh-list
19771837|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771838|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
19771839|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771840|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19771841|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150424|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150425|NCT00085462|Aldesleukin|aldesleukin|mesh-list
20317150|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317151|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150426|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
20150427|NCT00085462|Fludarabine|fludarabine|mesh-list
20150428|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
20150429|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150430|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
20150431|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150432|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150433|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150434|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
20150435|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150436|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150437|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20150438|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150439|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
20150440|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20150441|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20150442|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
19771842|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771843|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
19771844|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317152|NCT00708396|Citalopram|citalopram|mesh-list
20317153|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20317154|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19771845|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
19771846|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19771847|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19771848|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19771849|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771850|NCT00130039|Cilostazol|cilostazol|mesh-list
19771851|NCT00130039|Clopidogrel|clopidogrel|mesh-list
19771852|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19771853|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19771854|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19771855|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19771856|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
19771857|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771858|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771859|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771860|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19771861|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
19771862|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771863|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19771864|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
19771865|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19771866|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19771867|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
19771868|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19771869|NCT00130039|Protective Agents|protective agents|mesh-ancestor
19771870|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19771871|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19771872|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771873|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
19771874|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
19771875|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19771876|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19771877|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771878|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19771879|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19771880|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
19771881|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19771882|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
19771883|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771884|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19771885|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19771886|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19771887|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19771888|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771889|NCT00130247|Rifampin|rifampin|mesh-list
19771890|NCT00130247|Isoniazid|isoniazid|mesh-list
19771891|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
19771892|NCT00130247|Ethambutol|ethambutol|mesh-list
19771893|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19771894|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
19771895|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19771896|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19771897|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
19771898|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19771899|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771900|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771901|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19771902|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19771903|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19771904|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19771905|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19771906|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19771907|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19771908|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19771909|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
19771910|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19771911|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
19771912|NCT00130286|Hormones|hormones|mesh-list
19771913|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150443|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150444|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
20150445|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150446|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150447|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150448|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150449|NCT00085501|Paclitaxel|paclitaxel|mesh-list
20150450|NCT00085501|Carboplatin|carboplatin|mesh-list
20150451|NCT00085501|Cetuximab|cetuximab|mesh-list
20150452|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20150453|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150454|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
19635706|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19635707|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19635708|NCT02426905|Trientine|trientine|mesh-list
19771914|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771915|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19771916|NCT00130442|Dacarbazine|dacarbazine|mesh-list
19771917|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19771918|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
19771919|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771920|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771921|NCT00130520|Bevacizumab|bevacizumab|mesh-list
19771922|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19771923|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771924|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771925|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19635709|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
19635710|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
19635711|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635712|NCT02426866|Efavirenz|efavirenz|mesh-list
19635713|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19635714|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19635715|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635716|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635717|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
19635718|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635719|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19635720|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19635721|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19635722|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19635723|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19635724|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19635725|NCT02426697|Fentanyl|fentanyl|mesh-list
19635726|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19635727|NCT02426697|Narcotics|narcotics|mesh-ancestor
19771926|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771927|NCT00130520|Growth Substances|growth substances|mesh-ancestor
19771928|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771929|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771930|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771931|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771932|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771933|NCT00130533|Capecitabine|capecitabine|mesh-list
19771934|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19771935|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
19635728|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635729|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635730|NCT02426697|Analgesics|analgesics|mesh-ancestor
19635731|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
20150455|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150456|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150457|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317155|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635732|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771936|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771937|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771938|NCT00130637|Daclizumab|daclizumab|mesh-list
19771939|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19771940|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
19771941|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771942|NCT00130689|Cetuximab|cetuximab|mesh-list
19833295|NCT00328523|Ezetimibe|ezetimibe|mesh-list
19771943|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771944|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771945|NCT00130728|Bevacizumab|bevacizumab|mesh-list
19771946|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19771947|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771948|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771949|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19771950|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771951|NCT00130728|Growth Substances|growth substances|mesh-ancestor
19771952|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771953|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771954|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19771955|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19771956|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771957|NCT00130780|Bevacizumab|bevacizumab|mesh-list
19771958|NCT00130780|Docetaxel|docetaxel|mesh-list
19771959|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19771960|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19771961|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19771962|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19771963|NCT00130780|Growth Substances|growth substances|mesh-ancestor
19771964|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771965|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
19771966|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
19771967|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
19771968|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
19771969|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771970|NCT00130793|Vaccines|vaccines|mesh-list
20150458|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150459|NCT00085527|Romidepsin|romidepsin|mesh-list
20150460|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150461|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150462|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19771971|NCT00130793|Immunoglobulins|immunoglobulins|mesh-list
19771972|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
19771973|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771974|NCT00130832|Vaccines|vaccines|mesh-list
19771975|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
19771976|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771977|NCT00130923|Risperidone|risperidone|mesh-list
19771978|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19771979|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
19771980|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19771981|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19771982|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19771983|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19771984|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19771985|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19771986|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19771987|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19771988|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
19771989|NCT00131248|Metoclopramide|metoclopramide|mesh-list
19771990|NCT00131248|Ranitidine|ranitidine|mesh-list
19771991|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19771992|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
19771993|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
20150463|NCT00085553|Tipifarnib|tipifarnib|mesh-list
20150464|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150465|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150466|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150467|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150468|NCT00085579|Aldesleukin|aldesleukin|mesh-list
19635733|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19635734|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19635735|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
19635736|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
19635737|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
19635738|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
19635739|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
19635740|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19635741|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19771994|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19771995|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150469|NCT00085579|Sargramostim|sargramostim|mesh-list
20150470|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
19771996|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19771997|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19771998|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19771999|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
19772000|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772001|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772002|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19772003|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19772004|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
19772005|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
19772006|NCT00131352|Hylan|hylan|mesh-list
20317156|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317157|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317158|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
20317159|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317160|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20317161|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
20317162|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772007|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
19772008|NCT00131352|Protective Agents|protective agents|mesh-ancestor
19772009|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772010|NCT00131378|Hormones|hormones|mesh-list
19772011|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772012|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772013|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19772014|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19772015|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19772016|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19772017|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772018|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772019|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772020|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19772021|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
19772022|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772023|NCT00131469|Teriparatide|teriparatide|mesh-list
19772024|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19772025|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772026|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19772027|NCT00131664|Metformin|metformin|mesh-list
19772028|NCT00131664|Glimepiride|glimepiride|mesh-list
19772029|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
19772030|NCT00131664|Maleic acid|maleic acid|mesh-list
20317163|NCT00708539|Progesterone|progesterone|mesh-list
20317164|NCT00708539|Progestins|progestins|mesh-ancestor
20317165|NCT00708539|Hormones|hormones|mesh-ancestor
20317166|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772031|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19772032|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772033|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772034|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772035|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19772036|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772037|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
19772038|NCT00131677|Tenofovir|tenofovir|mesh-list
19772039|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
19772040|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772041|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19772042|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772043|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772044|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772045|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19772046|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19772047|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
19772048|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19772049|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
19772050|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19772051|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772052|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19772053|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19772054|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19772055|NCT00131911|Sorafenib|sorafenib|mesh-list
20317167|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317168|NCT00708565|Iloprost|iloprost|mesh-list
20317169|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20317170|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317171|NCT00708578|Metformin|metformin|mesh-list
20317172|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
20317173|NCT00708578|Glimepiride|glimepiride|mesh-list
20317174|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19635742|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635743|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635744|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662197|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19662198|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
19662199|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317175|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317176|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20317177|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662200|NCT03371667|Methotrexate|methotrexate|mesh-list
19662201|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19662202|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
19662203|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19662204|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662205|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19662206|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
19662207|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662208|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662209|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
19662210|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662211|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19662212|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662213|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
19662214|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662215|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19662216|NCT03318900|Aldesleukin|aldesleukin|mesh-list
19662217|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
19662218|NCT03318900|Interleukin-2|interleukin-2|mesh-list
19662219|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19662220|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
19662221|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662222|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
19662223|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662224|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662225|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19662226|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
19662227|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662228|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662229|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19662230|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19662231|NCT03318900|Analgesics|analgesics|mesh-ancestor
19662232|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
19662233|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662234|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19662235|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19662236|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
19662237|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662238|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
19662239|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19662240|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662241|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
19662242|NCT03121001|Sirolimus|sirolimus|mesh-list
19662243|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
19662244|NCT03121001|Fludarabine|fludarabine|mesh-list
19662245|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
19662246|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662247|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
19662248|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662249|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662250|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19662251|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
19662252|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662253|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662254|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19662255|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19662256|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19662257|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
19772056|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772057|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19772058|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772059|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772060|NCT00131937|Sorafenib|sorafenib|mesh-list
20150471|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150472|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150473|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20150474|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19635745|NCT02426723|Dexamethasone|dexamethasone|mesh-list
19772061|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772062|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19772063|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772064|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772065|NCT00132002|Vorinostat|vorinostat|mesh-list
20317178|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
20317179|NCT00708591|Sirolimus|sirolimus|mesh-list
20317180|NCT00708591|Ketoconazole|ketoconazole|mesh-list
20317181|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20317182|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317183|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19635746|NCT02426723|Lenalidomide|lenalidomide|mesh-list
19635747|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19635748|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
19635749|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
19635750|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635751|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635752|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19635753|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
19635754|NCT02426723|Hormones|hormones|mesh-ancestor
19635755|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635756|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635757|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635758|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
19635759|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19635760|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19635761|NCT02426723|Growth Substances|growth substances|mesh-ancestor
19635762|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
19635763|NCT02426736|Dexamethasone|dexamethasone|mesh-list
20317184|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317185|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
19772066|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772067|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20150475|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
20150476|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150477|NCT00085696|Rituximab|rituximab|mesh-list
20150478|NCT00085696|Bortezomib|bortezomib|mesh-list
20150479|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150480|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317186|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635764|NCT02426736|Bupivacaine|bupivacaine|mesh-list
20150481|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
20150482|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635765|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772068|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772069|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772070|NCT00132028|Vorinostat|vorinostat|mesh-list
19772071|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150483|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150484|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20150485|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19635766|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
19635767|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
19772072|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20150486|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20317187|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
20317188|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317189|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20317190|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20317191|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317192|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772073|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772074|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772075|NCT00132301|Prednisone|prednisone|mesh-list
19772076|NCT00132301|Docetaxel|docetaxel|mesh-list
20150487|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150488|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150489|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150490|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20150491|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20150492|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
20150493|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150494|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150495|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20150496|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20150497|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
20150498|NCT00085761|Capsaicin|capsaicin|mesh-list
20150499|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
20150500|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
20150501|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
20150502|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150503|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150504|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
20150505|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150506|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20150507|NCT00085826|Protective Agents|protective agents|mesh-ancestor
20317193|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19772077|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772078|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
19772079|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
19772080|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
19772081|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772082|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772083|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
19772084|NCT00132301|Hormones|hormones|mesh-ancestor
19772085|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772086|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772087|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772088|NCT00132314|Risperidone|risperidone|mesh-list
19772089|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
19772090|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20317194|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
20317195|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772091|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
19772092|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772093|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772094|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772095|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19772096|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772097|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20317196|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19772098|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19772099|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
19772100|NCT00132496|Rabeprazole|rabeprazole|mesh-list
19772101|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19772102|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772103|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19772104|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772105|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772106|NCT00132678|Risperidone|risperidone|mesh-list
19772107|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19772108|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
19772109|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772110|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772111|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772112|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19772113|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19772114|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772115|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772116|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19772117|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
20317197|NCT00708656|Mesalamine|mesalamine|mesh-list
20317198|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20317199|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772118|NCT00132691|Cyclosporine|cyclosporine|mesh-list
19772119|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
19772120|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19772121|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
19772122|NCT00132691|Chlorambucil|chlorambucil|mesh-list
19772123|NCT00132691|Methotrexate|methotrexate|mesh-list
19772124|NCT00132691|Azathioprine|azathioprine|mesh-list
19772125|NCT00132691|Infliximab|infliximab|mesh-list
19772126|NCT00132691|Tacrolimus|tacrolimus|mesh-list
19772127|NCT00132691|Cyclosporins|cyclosporins|mesh-list
19772128|NCT00132691|Daclizumab|daclizumab|mesh-list
19772129|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19772130|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
19772131|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
19772132|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772133|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772134|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19772135|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772136|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772137|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19772138|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19772139|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
19772140|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19772141|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19772142|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
19772143|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
19772144|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772145|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19772146|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772147|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19772148|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
19772149|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772150|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19772151|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19772152|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
19772153|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19772154|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772155|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772156|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
19772157|NCT00132691|Hormones|hormones|mesh-ancestor
19772158|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772159|NCT00132730|MK 0873|mk 0873|mesh-list
19772160|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19772161|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19772162|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772163|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772164|NCT00132769|MK 0873|mk 0873|mesh-list
19772165|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19772166|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19772167|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772168|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772169|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
19772170|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19772171|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772172|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
19772173|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19772174|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19772175|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
19772176|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
19772177|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772178|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772179|NCT00133575|Vaccines|vaccines|mesh-list
19772180|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
19772181|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772182|NCT00133705|Mifepristone|mifepristone|mesh-list
19772183|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20317200|NCT00708656|Analgesics|analgesics|mesh-ancestor
19772184|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
19772185|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19772186|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772187|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19772188|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19772189|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19772190|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
19772191|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19772192|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19772193|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
19772194|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772195|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
19772196|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19772197|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19833296|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833297|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833298|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
19833299|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833300|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833301|NCT00269191|Ibuprofen|ibuprofen|mesh-list
19833302|NCT00269191|Etoricoxib|etoricoxib|mesh-list
19833303|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833304|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833305|NCT00269191|Analgesics|analgesics|mesh-ancestor
19833306|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
19833307|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833308|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833309|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833310|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833311|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833312|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833313|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833314|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19833315|NCT00251576|Heparin|heparin|mesh-list
19833316|NCT00251576|Calcium heparin|calcium heparin|mesh-list
19833317|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19833318|NCT00251576|Tinzaparin|tinzaparin|mesh-list
19635768|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635769|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635770|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19635771|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
19635772|NCT02426736|Hormones|hormones|mesh-ancestor
19635773|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635774|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19833319|NCT00251576|Dalteparin|dalteparin|mesh-list
20317201|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
20317202|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317203|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317204|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20317205|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20317206|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
20317207|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20317208|NCT00708747|Antibodies|antibodies|mesh-list
20317209|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
20317210|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317211|NCT00708773|Irinotecan|irinotecan|mesh-list
19833320|NCT00251576|Tirofiban|tirofiban|mesh-list
19833321|NCT00251576|Simvastatin|simvastatin|mesh-list
19833322|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
19833323|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19833324|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19833325|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833326|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833327|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833328|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
19833329|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833330|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833331|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833332|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19833333|NCT00250445|Diclofenac|diclofenac|mesh-list
19833334|NCT00250445|Etoricoxib|etoricoxib|mesh-list
19833335|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833336|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833337|NCT00250445|Analgesics|analgesics|mesh-ancestor
19833338|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
19833339|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317212|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19772198|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
19772199|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772200|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772201|NCT00133978|Selenium|selenium|mesh-list
19772202|NCT00133978|Antioxidants|antioxidants|mesh-list
19772203|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772204|NCT00133978|Protective Agents|protective agents|mesh-ancestor
19772205|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772206|NCT00133978|Trace Elements|trace elements|mesh-ancestor
19772207|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
19772208|NCT00133991|Leucovorin|leucovorin|mesh-list
19772209|NCT00133991|Cytarabine|cytarabine|mesh-list
19772210|NCT00133991|Prednisone|prednisone|mesh-list
19772211|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
19772212|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
19772213|NCT00133991|Rituximab|rituximab|mesh-list
19772214|NCT00133991|Methotrexate|methotrexate|mesh-list
19772215|NCT00133991|Vincristine|vincristine|mesh-list
19772216|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772217|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
19772218|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772219|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772220|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19772221|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
19772222|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772223|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772224|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19772225|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772226|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772227|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
19772228|NCT00133991|Hormones|hormones|mesh-ancestor
19772229|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772230|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772231|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19772232|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
19772233|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19772234|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19772235|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
19772236|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
19772237|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772238|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19772239|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772240|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
19772241|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772242|NCT00133991|Antidotes|antidotes|mesh-ancestor
19772243|NCT00133991|Protective Agents|protective agents|mesh-ancestor
19772244|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
19772245|NCT00133991|Vitamins|vitamins|mesh-ancestor
19772246|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
19772247|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19772248|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19772249|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19772250|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19772251|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
19772252|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
19772253|NCT00134004|Fludarabine|fludarabine|mesh-list
19772254|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
19772255|NCT00134004|Tacrolimus|tacrolimus|mesh-list
19772256|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772257|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
19772258|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772259|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772260|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19772261|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
19772262|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772263|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772264|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19772265|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19772266|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
19772267|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19772268|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772269|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19772270|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19772271|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
19772272|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19772273|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772274|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
19635775|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635776|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
19635777|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
19635778|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635779|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
19635780|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19772275|NCT00134017|Busulfan|busulfan|mesh-list
19772276|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772277|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
19772278|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772279|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772280|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150508|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150509|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20150510|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150511|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635781|NCT02426619|Fluorides|fluorides|mesh-list
19635782|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
19635783|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
19635784|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
19635785|NCT02426619|Protective Agents|protective agents|mesh-ancestor
19635786|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635787|NCT02426502|Cyclosporine|cyclosporine|mesh-list
19635788|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
19635789|NCT02426502|Prednisone|prednisone|mesh-list
19635790|NCT02426502|Azathioprine|azathioprine|mesh-list
19635791|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
19635792|NCT02426502|Cyclosporins|cyclosporins|mesh-list
19635793|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19635794|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
19635795|NCT02426502|Hormones|hormones|mesh-ancestor
19635796|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635797|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635798|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635799|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635800|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635801|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635802|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635803|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
19635804|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
19635805|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635806|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
19635807|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635808|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19635809|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19635810|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19635811|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
19635812|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19635813|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
19635814|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635815|NCT02426281|Gemcitabine|gemcitabine|mesh-list
19635816|NCT02426281|Paclitaxel|paclitaxel|mesh-list
19635817|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19635818|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635819|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
19635820|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
19635821|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
19635822|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635823|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635824|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
19635825|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
19635826|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19635827|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635828|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635829|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
19635830|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635831|NCT02426463|Oxycodone|oxycodone|mesh-list
19635832|NCT02426463|Propofol|propofol|mesh-list
19635833|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19635834|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635835|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635836|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19772281|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
19772282|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772283|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772284|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19772285|NCT00134043|Vorinostat|vorinostat|mesh-list
19772286|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772287|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19772288|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772289|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772290|NCT00134056|Prednisone|prednisone|mesh-list
19772291|NCT00134056|Docetaxel|docetaxel|mesh-list
19772292|NCT00134056|Atrasentan|atrasentan|mesh-list
20317213|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20317214|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772293|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772294|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
19772295|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
19772296|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
19772297|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772298|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772299|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
19772300|NCT00134056|Hormones|hormones|mesh-ancestor
19772301|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772302|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772303|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772304|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19772305|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19772306|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
19772307|NCT00134082|Rituximab|rituximab|mesh-list
19772308|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772309|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
19772310|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772311|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772312|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19772313|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
19772314|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772315|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772316|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19772317|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772318|NCT00134563|Teriflunomide|teriflunomide|mesh-list
19772319|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19772320|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772321|NCT00134563|Analgesics|analgesics|mesh-ancestor
19772322|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
19772323|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772324|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772325|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772326|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635837|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
19635838|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
19635839|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19635840|NCT02426463|Narcotics|narcotics|mesh-ancestor
19635841|NCT02426463|Analgesics|analgesics|mesh-ancestor
19635842|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
19635843|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635844|NCT02426294|Pioglitazone|pioglitazone|mesh-list
19635845|NCT02426294|Glimepiride|glimepiride|mesh-list
19635846|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19635847|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635848|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19635849|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635850|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
19635851|NCT02426450|Leucovorin|leucovorin|mesh-list
19635852|NCT02426450|Fluorouracil|fluorouracil|mesh-list
19635853|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
19635854|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
19635855|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635856|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635857|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635858|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635859|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
19635860|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635861|NCT02426450|Antidotes|antidotes|mesh-ancestor
19635862|NCT02426450|Protective Agents|protective agents|mesh-ancestor
19635863|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
19635864|NCT02426450|Vitamins|vitamins|mesh-ancestor
19772327|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772328|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
19772329|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19772330|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
19772331|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772332|NCT00134901|Memantine|memantine|mesh-list
19772333|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19772334|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19772335|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
19772336|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772337|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772338|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772339|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19772340|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19772341|NCT00135226|Aspirin|aspirin|mesh-list
19772342|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19772343|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772344|NCT00135226|Analgesics|analgesics|mesh-ancestor
19772345|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
19772346|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772347|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772348|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772349|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772350|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19772351|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19772352|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772353|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19772354|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19772355|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772356|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
19772357|NCT00135330|Exenatide|exenatide|mesh-list
19772358|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
19772359|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19772360|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772361|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20150512|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20150513|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20150514|NCT00085826|Analgesics|analgesics|mesh-ancestor
20150515|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
20150516|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150517|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150518|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150519|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20150520|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
20150521|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150522|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19635865|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
19635866|NCT02426229|Dabigatran|dabigatran|mesh-list
19635867|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
19635868|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19635869|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
19635870|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635871|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772362|NCT00135330|Incretins|incretins|mesh-ancestor
19772363|NCT00135330|Hormones|hormones|mesh-ancestor
19772364|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772365|NCT00135356|Ritonavir|ritonavir|mesh-list
19772366|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19772367|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19772368|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20150523|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20150524|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150525|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150526|NCT00085943|Ritonavir|ritonavir|mesh-list
19772369|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
19772370|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19772371|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772372|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772373|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19772374|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19772375|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
19772376|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772377|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19772378|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19772379|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772380|NCT00135512|Bupropion|bupropion|mesh-list
19772381|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19772382|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
19772383|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772384|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19772385|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19772386|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19772387|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772388|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
19772389|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772390|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772391|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19772392|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19772393|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772394|NCT00135694|Prednisone|prednisone|mesh-list
19772395|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19772396|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772397|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
19772398|NCT00135694|Hormones|hormones|mesh-ancestor
19772399|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772400|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772401|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772402|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635872|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
19635873|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
19635874|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772403|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772404|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772405|NCT00135707|Vitamins|vitamins|mesh-list
19772406|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
19772407|NCT00135707|Vitamin E|vitamin e|mesh-list
19772408|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
19772409|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
19772410|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772411|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
19772412|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772413|NCT00135707|Protective Agents|protective agents|mesh-ancestor
19772414|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19635875|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19635876|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19635877|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635878|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
20150527|NCT00085943|Lopinavir|lopinavir|mesh-list
20150528|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
20150529|NCT00085943|Lamivudine|lamivudine|mesh-list
20150530|NCT00085943|Abacavir|abacavir|mesh-list
20150531|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20150532|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20150533|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
20150534|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150535|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150536|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20150537|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20150538|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
20150539|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150540|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19635879|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635880|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635881|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19635882|NCT02426177|Labetalol|labetalol|mesh-list
19635883|NCT02426177|Nifedipine|nifedipine|mesh-list
19772415|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
19772416|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772417|NCT00136084|Cytarabine|cytarabine|mesh-list
19772418|NCT00136084|Dexamethasone|dexamethasone|mesh-list
19772419|NCT00136084|Prednisone|prednisone|mesh-list
19772420|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
19772421|NCT00136084|Methotrexate|methotrexate|mesh-list
19772422|NCT00136084|Etoposide|etoposide|mesh-list
19772423|NCT00136084|Vincristine|vincristine|mesh-list
19772424|NCT00136084|Daunorubicin|daunorubicin|mesh-list
19772425|NCT00136084|Asparaginase|asparaginase|mesh-list
19772426|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
19772427|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
19772428|NCT00136084|Cladribine|cladribine|mesh-list
19772429|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
19772430|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772431|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
19772432|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772433|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772434|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19772435|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
19772436|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772437|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772438|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19772439|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772440|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
19772441|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
19772442|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772443|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772444|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
19772445|NCT00136084|Hormones|hormones|mesh-ancestor
19772446|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772447|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772448|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19772449|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
19772450|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19772451|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611043|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611044|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19772452|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
19772453|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
19772454|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772455|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19772456|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772457|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19772458|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19772459|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19772460|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
19772461|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772462|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
19772463|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
19772464|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
19772465|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19772466|NCT00136084|Analgesics|analgesics|mesh-ancestor
19772467|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
19772468|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772469|NCT00136318|Ribavirin|ribavirin|mesh-list
19772470|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19772471|NCT00136318|Citalopram|citalopram|mesh-list
19772472|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
19772473|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772474|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
19772475|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772476|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19772477|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20150541|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20150542|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20150543|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20150544|NCT00085969|Exenatide|exenatide|mesh-list
20150545|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20150546|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150547|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20150548|NCT00085969|Incretins|incretins|mesh-ancestor
19772478|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19772479|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772480|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
19772481|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772482|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19772483|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
19772484|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772485|NCT00136695|Anastrozole|anastrozole|mesh-list
19772486|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772487|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772488|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19772489|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19772490|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772491|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772492|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19772493|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
19772494|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772495|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772496|NCT00136760|Bupropion|bupropion|mesh-list
19772497|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19772498|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
19772499|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772500|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19772501|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19772502|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19772503|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772504|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
19772505|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772506|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772507|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19772508|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19772509|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772510|NCT00136916|Insulin|insulin|mesh-list
19772511|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19772512|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19772513|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772514|NCT00136955|Irinotecan|irinotecan|mesh-list
19772515|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19772516|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19772517|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772518|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772519|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772520|NCT00137046|Insulin|insulin|mesh-list
19772521|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19772522|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19772523|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772524|NCT00137111|Cytarabine|cytarabine|mesh-list
19772525|NCT00137111|Dexamethasone|dexamethasone|mesh-list
19635884|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19635885|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19635886|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635887|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19635888|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635889|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
19635890|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
19635891|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19772526|NCT00137111|Prednisone|prednisone|mesh-list
19772527|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
19772528|NCT00137111|Doxorubicin|doxorubicin|mesh-list
19772529|NCT00137111|Methotrexate|methotrexate|mesh-list
19772530|NCT00137111|Etoposide|etoposide|mesh-list
19772531|NCT00137111|Vincristine|vincristine|mesh-list
19772532|NCT00137111|Daunorubicin|daunorubicin|mesh-list
19772533|NCT00137111|Asparaginase|asparaginase|mesh-list
19772534|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
19772535|NCT00137111|Pegaspargase|pegaspargase|mesh-list
19772536|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772537|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
19772538|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772539|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635892|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19635893|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19635894|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635895|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635896|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19772540|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19772541|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
19772542|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772543|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772544|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19772545|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772546|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
19772547|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
19772548|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772549|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317215|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317216|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317217|NCT00708799|Azithromycin|azithromycin|mesh-list
20317218|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20317219|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317220|NCT00708812|Paclitaxel|paclitaxel|mesh-list
20317221|NCT00708812|Carboplatin|carboplatin|mesh-list
20317222|NCT00708812|Endostar protein|endostar protein|mesh-list
20317223|NCT00708812|Endostatins|endostatins|mesh-list
20317224|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20317225|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317226|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20317227|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20317228|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20317229|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317230|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20317231|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20317232|NCT00708812|Growth Substances|growth substances|mesh-ancestor
19772550|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
19772551|NCT00137111|Hormones|hormones|mesh-ancestor
19772552|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772553|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772554|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19772555|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19772556|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19772557|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772558|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19772559|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
19772560|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19772561|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19772562|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
19772563|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
20317233|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317234|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
19772564|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19772565|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772566|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19772567|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
19772568|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772569|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
19772570|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
19772571|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
19772572|NCT00137423|Sunitinib|sunitinib|mesh-list
19772573|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772574|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19772575|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19772576|NCT00137423|Growth Substances|growth substances|mesh-ancestor
19772577|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772578|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
19772579|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19772580|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772581|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772582|NCT00137436|Prednisone|prednisone|mesh-list
19772583|NCT00137436|Docetaxel|docetaxel|mesh-list
19772584|NCT00137436|Sunitinib|sunitinib|mesh-list
19772585|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772586|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
19772587|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
19772588|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
19772589|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772590|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772591|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
19772592|NCT00137436|Hormones|hormones|mesh-ancestor
19772593|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772594|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317235|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
19772595|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20317236|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19772596|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19772597|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19635897|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
19635898|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
19635899|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635900|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19635901|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19635902|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
19635903|NCT02426164|Epinephrine|epinephrine|mesh-list
19772598|NCT00137436|Growth Substances|growth substances|mesh-ancestor
19772599|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
19772600|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19772601|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772602|NCT00137449|Sunitinib|sunitinib|mesh-list
19772603|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772604|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19772605|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19772606|NCT00137449|Growth Substances|growth substances|mesh-ancestor
19772607|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772608|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
19772609|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19772610|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772611|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772612|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19772613|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772614|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150549|NCT00085969|Hormones|hormones|mesh-ancestor
20150550|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150551|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
20317237|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772615|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772616|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772617|NCT00137969|Acetaminophen|acetaminophen|mesh-list
19772618|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
19772619|NCT00137969|Promethazine|promethazine|mesh-list
19772620|NCT00137969|Prednisone|prednisone|mesh-list
19772621|NCT00137969|Rituximab|rituximab|mesh-list
19772622|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772623|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772624|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
19772625|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772626|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772627|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772628|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
19772629|NCT00137969|Hormones|hormones|mesh-ancestor
19772630|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772631|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772632|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772633|NCT00137969|Analgesics|analgesics|mesh-ancestor
19772634|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
19772635|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772636|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
19772637|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19772638|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19772639|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772640|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
19772641|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
19772642|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
19772643|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
19772644|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772645|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19772646|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
19772647|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
19772648|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772649|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772650|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19772651|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
19772652|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
19772653|NCT00138125|Trastuzumab|trastuzumab|mesh-list
19772654|NCT00138125|Fulvestrant|fulvestrant|mesh-list
19772655|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772656|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635904|NCT02426164|Morphine|morphine|mesh-list
19635905|NCT02426164|Bupivacaine|bupivacaine|mesh-list
19772657|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772658|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20317238|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20317239|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20317240|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317241|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317242|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317243|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19772659|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19772660|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
19772661|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772662|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772663|NCT00138203|Vorinostat|vorinostat|mesh-list
19772664|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772665|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19772666|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772667|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772668|NCT00138424|Cidofovir|cidofovir|mesh-list
19772669|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
19772670|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772671|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772672|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772673|NCT00138671|Insulin|insulin|mesh-list
19772674|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19772675|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19772676|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772677|NCT00139477|Metformin|metformin|mesh-list
19772678|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19772679|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772680|NCT00139659|Insulin|insulin|mesh-list
19772681|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19772682|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19772683|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772684|NCT00139737|Ziprasidone|ziprasidone|mesh-list
19772685|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19772686|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
19772687|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772688|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772689|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772690|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19772691|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19772692|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772693|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772694|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19772695|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
19772696|NCT00139776|Celecoxib|celecoxib|mesh-list
19772697|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19772698|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772699|NCT00139776|Analgesics|analgesics|mesh-ancestor
19772700|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
19772701|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772702|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772703|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772704|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772705|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19772706|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20317244|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
20317245|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317246|NCT00709046|Pantoprazole|pantoprazole|mesh-list
20317247|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20317248|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317249|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20317250|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317251|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317252|NCT00709137|Amiloride|amiloride|mesh-list
20317253|NCT00709137|Spironolactone|spironolactone|mesh-list
20317254|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20317255|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
20317256|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317257|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317258|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19772707|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772708|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772709|NCT00140140|Paclitaxel|paclitaxel|mesh-list
19772710|NCT00140140|Vinorelbine|vinorelbine|mesh-list
20317259|NCT00709137|Diuretics|diuretics|mesh-ancestor
20317260|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
19772711|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19635906|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
19635907|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
19635908|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19635909|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635910|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
19635911|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635912|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19635913|NCT02426164|Narcotics|narcotics|mesh-ancestor
19635914|NCT02426164|Analgesics|analgesics|mesh-ancestor
19635915|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19635916|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
19635917|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
19635918|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20150552|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635919|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
19635920|NCT02426164|Hormones|hormones|mesh-ancestor
19635921|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635922|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19635923|NCT02426164|Protective Agents|protective agents|mesh-ancestor
19772712|NCT00140140|Trastuzumab|trastuzumab|mesh-list
19772713|NCT00140140|Sargramostim|sargramostim|mesh-list
19772714|NCT00140140|Lenograstim|lenograstim|mesh-list
19772715|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19772716|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772717|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19772718|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19772719|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19772720|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772721|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772722|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
19772723|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772724|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19772725|NCT00140426|Risperidone|risperidone|mesh-list
19772726|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19772727|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
19772728|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772729|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772730|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772731|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19772732|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19772733|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772734|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772735|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19772736|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
19772737|NCT00140556|Bevacizumab|bevacizumab|mesh-list
19772738|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19772739|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772740|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772741|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19772742|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19772743|NCT00140556|Growth Substances|growth substances|mesh-ancestor
19772744|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772745|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
19772746|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19772747|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150553|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20150554|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
20150555|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
20150556|NCT00086086|Hematinics|hematinics|mesh-ancestor
20150557|NCT00086099|Amifostine|amifostine|mesh-list
20150558|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20150559|NCT00086099|Protective Agents|protective agents|mesh-ancestor
20150560|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150561|NCT00086112|Risperidone|risperidone|mesh-list
20150562|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20150563|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
20150564|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150565|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150566|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150567|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20150568|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20150569|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150570|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19635924|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19772748|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772749|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19772750|NCT00140855|Ipilimumab|ipilimumab|mesh-list
20317261|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20317262|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20317263|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20317264|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317265|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20317266|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20317267|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
20611045|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772751|NCT00140855|Antibodies|antibodies|mesh-list
19772752|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
19772753|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19772754|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
19772755|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772756|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772757|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19772758|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772759|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
19772760|NCT00141037|Trimethoprim|trimethoprim|mesh-list
19772761|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
19772762|NCT00141037|Valganciclovir|valganciclovir|mesh-list
19772763|NCT00141037|Ganciclovir|ganciclovir|mesh-list
19772764|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19772765|NCT00141037|Prednisone|prednisone|mesh-list
19772766|NCT00141037|Tacrolimus|tacrolimus|mesh-list
19772767|NCT00141037|Daclizumab|daclizumab|mesh-list
19772768|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772769|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
19772770|NCT00141037|Hormones|hormones|mesh-ancestor
19772771|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772772|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772773|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19772774|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772775|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772776|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
19772777|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19772778|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772779|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772780|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19772781|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19772782|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
19772783|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19772784|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772785|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19772786|NCT00141037|Renal Agents|renal agents|mesh-ancestor
19772787|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
19772788|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19772789|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19772790|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19772791|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19772792|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19772793|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19772794|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
19772795|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772796|NCT00141102|Celecoxib|celecoxib|mesh-list
19772797|NCT00141102|Diclofenac|diclofenac|mesh-list
19772798|NCT00141102|Omeprazole|omeprazole|mesh-list
19772799|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19772800|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19635925|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19635926|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
19635927|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635928|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635929|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19635930|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19635931|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19635932|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
19635933|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
19635934|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
19635935|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19635936|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
19635937|NCT02426099|Spironolactone|spironolactone|mesh-list
19635938|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19772801|NCT00141102|Analgesics|analgesics|mesh-ancestor
19772802|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
19772803|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772804|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772805|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772806|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772807|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19772808|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19772809|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772810|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772811|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19772812|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772813|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19772814|NCT00141115|Levetiracetam|levetiracetam|mesh-list
19772815|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
19772816|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
19772817|NCT00141219|Pregabalin|pregabalin|mesh-list
19772818|NCT00141219|Analgesics|analgesics|mesh-ancestor
19772819|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
19772820|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772821|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772822|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
19772823|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19772824|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19772825|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772826|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19772827|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19772828|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19772829|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772830|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772831|NCT00141271|Ziprasidone|ziprasidone|mesh-list
19772832|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19772833|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
19772834|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19772835|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772836|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772837|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19772838|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19772839|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19772840|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19772841|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19772842|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
19772843|NCT00141297|Palbociclib|palbociclib|mesh-list
19772844|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772845|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19772846|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772847|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772848|NCT00141453|Olmesartan|olmesartan|mesh-list
19772849|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19772850|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19772851|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19772852|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19772853|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772854|NCT00141518|Levodopa|levodopa|mesh-list
19772855|NCT00141518|Carbidopa|carbidopa|mesh-list
19772856|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19772857|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19772858|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19772859|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
19772860|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317268|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317269|NCT00709189|Folic Acid|folic acid|mesh-list
20317270|NCT00709189|Norgestimate|norgestimate|mesh-list
20317271|NCT00709189|Estradiol|estradiol|mesh-list
20317272|NCT00709189|Estrogens|estrogens|mesh-ancestor
19772861|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772862|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772863|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19772864|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772865|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19772866|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
19772867|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
19772868|NCT00141726|Etanercept|etanercept|mesh-list
20317273|NCT00709189|Hormones|hormones|mesh-ancestor
20317274|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772869|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19772870|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772871|NCT00141726|Analgesics|analgesics|mesh-ancestor
19772872|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
19635939|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
19635940|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635941|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635942|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19635943|NCT02426099|Diuretics|diuretics|mesh-ancestor
19772873|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772874|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772875|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772876|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772877|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317275|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317276|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20317277|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
20317278|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20317279|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20317280|NCT00709189|Hematinics|hematinics|mesh-ancestor
20317281|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
20317282|NCT00709189|Vitamins|vitamins|mesh-ancestor
20317283|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
20317284|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19635944|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
19635945|NCT02426060|Warfarin|warfarin|mesh-list
19772878|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772879|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
19772880|NCT00141739|Etanercept|etanercept|mesh-list
19772881|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19772882|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772883|NCT00141739|Analgesics|analgesics|mesh-ancestor
19772884|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
19772885|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772886|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772887|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772888|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772889|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772890|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772891|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
19772892|NCT00141778|Ramipril|ramipril|mesh-list
19772893|NCT00141778|Spironolactone|spironolactone|mesh-list
19772894|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19772895|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19772896|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19772897|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
19772898|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
19772899|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19772900|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772901|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19772902|NCT00141778|Diuretics|diuretics|mesh-ancestor
19772903|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
20150571|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20150572|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
20150573|NCT00086125|Sirolimus|sirolimus|mesh-list
20150574|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20150575|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150576|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150577|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150578|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
20150579|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150580|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
20150581|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150582|NCT00086177|Progesterone|progesterone|mesh-list
19635946|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
19635947|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19772904|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
19772905|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772906|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19772907|NCT00141778|Hormones|hormones|mesh-ancestor
19772908|NCT00141817|Pantoprazole|pantoprazole|mesh-list
20150583|NCT00086177|Progestins|progestins|mesh-ancestor
20317285|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19635948|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
20150584|NCT00086177|Hormones|hormones|mesh-ancestor
20317286|NCT00709215|Cordycepin|cordycepin|mesh-list
20173969|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19635949|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635950|NCT02426008|Mitogens|mitogens|mesh-list
19635951|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
19635952|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772909|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19772910|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772911|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19772912|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772913|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772914|NCT00141921|Etanercept|etanercept|mesh-list
19772915|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19772916|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19772917|NCT00141921|Analgesics|analgesics|mesh-ancestor
19772918|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
19772919|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772920|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772921|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19772922|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772923|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772924|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772925|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
19772926|NCT00142116|Thalidomide|thalidomide|mesh-list
19772927|NCT00142116|Rituximab|rituximab|mesh-list
19772928|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772929|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772930|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
19772931|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772932|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772933|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19772934|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
19772935|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19772936|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772937|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19772938|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19772939|NCT00142116|Growth Substances|growth substances|mesh-ancestor
19635953|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
19635954|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19635955|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19635956|NCT02425813|Prednisolone|prednisolone|mesh-list
19635957|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
19635958|NCT02425813|Budesonide|budesonide|mesh-list
19635959|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19635960|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
19635961|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19635962|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
19635963|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
19635964|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19635965|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635966|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19772940|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
19772941|NCT00142168|Rituximab|rituximab|mesh-list
19772942|NCT00142168|Lenalidomide|lenalidomide|mesh-list
19772943|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19772944|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772945|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
20150585|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150586|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150587|NCT00086203|Rituximab|rituximab|mesh-list
20150588|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150589|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150590|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
20150591|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150592|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150593|NCT00086255|Tiagabine|tiagabine|mesh-list
20150594|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
20150595|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20150596|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20150597|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20150598|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150599|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
19635967|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
19635968|NCT02425813|Hormones|hormones|mesh-ancestor
19772946|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772947|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19772948|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19772949|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19772950|NCT00142168|Growth Substances|growth substances|mesh-ancestor
19772951|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
19772952|NCT00142298|Telbivudine|telbivudine|mesh-list
19772953|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
19772954|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19772955|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19772956|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772957|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772958|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19772959|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
19772960|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
19772961|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772962|NCT00142454|Imiquimod|imiquimod|mesh-list
19772963|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19772964|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
19772965|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772966|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19772967|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
19772968|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
19772969|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772970|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
19772971|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19772972|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19772973|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19772974|NCT00142506|Urological Agents|urological agents|mesh-ancestor
19772975|NCT00142818|Naltrexone|naltrexone|mesh-list
19772976|NCT00142818|Modafinil|modafinil|mesh-list
19772977|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19772978|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19772979|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772980|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
19772981|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772982|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19772983|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19772984|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19772985|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19772986|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772987|NCT00142909|Lofexidine|lofexidine|mesh-list
19772988|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19772989|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19772990|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19772991|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
19772992|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19772993|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19772994|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19772995|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19772996|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
19772997|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19635969|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635970|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19635971|NCT02425813|Protective Agents|protective agents|mesh-ancestor
19635972|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635973|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635974|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19635975|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20150600|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150601|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150602|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
20150603|NCT00086268|Carboplatin|carboplatin|mesh-list
19635976|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
19635977|NCT02425852|Prednisolone|prednisolone|mesh-list
19635978|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
19635979|NCT02425852|Azathioprine|azathioprine|mesh-list
19635980|NCT02425852|Infliximab|infliximab|mesh-list
19635981|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150604|NCT00086268|Docetaxel|docetaxel|mesh-list
20150605|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150606|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150607|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150608|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150609|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173970|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19635982|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
20150610|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20150611|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150612|NCT00086294|Levodopa|levodopa|mesh-list
19772998|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19772999|NCT00143247|Insulin|insulin|mesh-list
19773000|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19773001|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317287|NCT00709215|Pentostatin|pentostatin|mesh-list
20317288|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317289|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20317290|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317291|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317292|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
20317293|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317294|NCT00709254|Fentanyl|fentanyl|mesh-list
20317295|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20317296|NCT00709254|Narcotics|narcotics|mesh-ancestor
20317297|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317298|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317299|NCT00709254|Analgesics|analgesics|mesh-ancestor
20317300|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
19635983|NCT02425852|Hormones|hormones|mesh-ancestor
19635984|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19635985|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19635986|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19635987|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19635988|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773002|NCT00143312|Voriconazole|voriconazole|mesh-list
19773003|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
19773004|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773005|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19773006|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19773007|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773008|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773009|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19773010|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
19773011|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773012|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773013|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19773014|NCT00143390|Anastrozole|anastrozole|mesh-list
19773015|NCT00143390|Exemestane|exemestane|mesh-list
19773016|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773017|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773018|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19773019|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19773020|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773021|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773022|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19773023|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
19773024|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150613|NCT00086294|Pimavanserin|pimavanserin|mesh-list
20150614|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20150615|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19635989|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
19635990|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19635991|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
19635992|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19635993|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19635994|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19635995|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
19635996|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
19635997|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19635998|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
19635999|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19636000|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636001|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19636002|NCT02425722|Linaclotide|linaclotide|mesh-list
20150616|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
20150617|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150618|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150619|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150620|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19773025|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773026|NCT00143403|Leucovorin|leucovorin|mesh-list
19773027|NCT00143403|Folic Acid|folic acid|mesh-list
19773028|NCT00143403|Irinotecan|irinotecan|mesh-list
19773029|NCT00143403|Fluorouracil|fluorouracil|mesh-list
19773030|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
19773031|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19773032|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19773033|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773034|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773035|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773036|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
19773037|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19773038|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773039|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
19773040|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773041|NCT00143403|Antidotes|antidotes|mesh-ancestor
19773042|NCT00143403|Protective Agents|protective agents|mesh-ancestor
19773043|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
19773044|NCT00143403|Vitamins|vitamins|mesh-ancestor
19773045|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
19773046|NCT00143403|Hematinics|hematinics|mesh-ancestor
19773047|NCT00143455|Cisplatin|cisplatin|mesh-list
19773048|NCT00143455|Irinotecan|irinotecan|mesh-list
19773049|NCT00143455|Etoposide|etoposide|mesh-list
19773050|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773051|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19773052|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19773053|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773054|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317301|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317302|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20317303|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20317304|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
20317305|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
20317306|NCT00709267|Folic Acid|folic acid|mesh-list
20317307|NCT00709267|Hematinics|hematinics|mesh-ancestor
19773055|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773056|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19773057|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19773058|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
19773059|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833340|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833341|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833342|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833343|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833344|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833345|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833346|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19833347|NCT00242489|Diclofenac|diclofenac|mesh-list
19833348|NCT00242489|Etoricoxib|etoricoxib|mesh-list
19833349|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19833350|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833351|NCT00242489|Analgesics|analgesics|mesh-ancestor
19833352|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
19833353|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833354|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833355|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833356|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833357|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19833358|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833359|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833360|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19833361|NCT00166530|Atorvastatin|atorvastatin|mesh-list
19833362|NCT00166530|Simvastatin|simvastatin|mesh-list
19833363|NCT00166530|Ezetimibe|ezetimibe|mesh-list
19833364|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833365|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833366|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
19833367|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833368|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833369|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833370|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317308|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
20317309|NCT00709267|Vitamins|vitamins|mesh-ancestor
19833371|NCT00092833|Ezetimibe|ezetimibe|mesh-list
20317310|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
20317311|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636003|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19636004|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
19636005|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636006|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636007|NCT02425774|Prucalopride|prucalopride|mesh-list
19636008|NCT02425774|Laxatives|laxatives|mesh-ancestor
19636009|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773060|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
19773061|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19773062|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19773063|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773064|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773065|NCT00144170|Ritonavir|ritonavir|mesh-list
19773066|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19773067|NCT00144170|Tipranavir|tipranavir|mesh-list
19773068|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
19773069|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19773070|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773071|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773072|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19773073|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19773074|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
19773075|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773076|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19773077|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19773078|NCT00144300|Pramipexole|pramipexole|mesh-list
19773079|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
19773080|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773081|NCT00144300|Protective Agents|protective agents|mesh-ancestor
19773082|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773083|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19773084|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19773085|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
19773086|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
19773087|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773088|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
20150621|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636010|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19636011|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19636012|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
19636013|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636014|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636015|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636016|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
19636017|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636018|NCT02425943|Mannitol|mannitol|mesh-list
19636019|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19636020|NCT02425943|Diuretics|diuretics|mesh-ancestor
19636021|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
19636022|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636023|NCT02425709|Diclofenac|diclofenac|mesh-list
19636024|NCT02425709|Tramadol|tramadol|mesh-list
19636025|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19636026|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636027|NCT02425709|Analgesics|analgesics|mesh-ancestor
19636028|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
19636029|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636030|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636031|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636032|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636033|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19636034|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636035|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636036|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19636037|NCT02425709|Narcotics|narcotics|mesh-ancestor
19636038|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636039|NCT02425566|Trimethaphan|trimethaphan|mesh-list
19636040|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
19636041|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
19636042|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
19636043|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19636044|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19636045|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19636046|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
19636047|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773089|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19773090|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
19773091|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773092|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317312|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20317313|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
20317314|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317315|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317316|NCT00709332|Folic Acid|folic acid|mesh-list
20317317|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20317318|NCT00709332|Norgestimate|norgestimate|mesh-list
20317319|NCT00709332|Estradiol|estradiol|mesh-list
19636048|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636049|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19636050|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19636051|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
19636052|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636053|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636054|NCT02425488|Coal Tar|coal tar|mesh-list
19636055|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
19636056|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
19636057|NCT02425605|Sorafenib|sorafenib|mesh-list
19636058|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636059|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19636060|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636061|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636062|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
19636063|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
19773093|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19773094|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
19773095|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
19773096|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19773097|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
19773098|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773099|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773100|NCT00144391|Testosterone|testosterone|mesh-list
19773101|NCT00144391|Androgens|androgens|mesh-ancestor
19773102|NCT00144391|Hormones|hormones|mesh-ancestor
19773103|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773104|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773105|NCT00144963|Dexamethasone|dexamethasone|mesh-list
19773106|NCT00144963|Vincristine|vincristine|mesh-list
19773107|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773108|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
19773109|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
19773110|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773111|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773112|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773113|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
19773114|NCT00144963|Hormones|hormones|mesh-ancestor
19773115|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773116|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773117|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773118|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773119|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
19773120|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773121|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773122|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773123|NCT00145041|Vincristine|vincristine|mesh-list
19773124|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773125|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773126|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
19773127|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773128|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773129|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773130|NCT00145249|Fluconazole|fluconazole|mesh-list
19773131|NCT00145249|Amphotericin B|amphotericin b|mesh-list
19773132|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19636064|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636065|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
19636066|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636067|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317320|NCT00709332|Estrogens|estrogens|mesh-ancestor
20317321|NCT00709332|Hormones|hormones|mesh-ancestor
19636068|NCT02426112|Azithromycin|azithromycin|mesh-list
20611046|NCT02314169|Nivolumab|nivolumab|mesh-list
19773133|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
19773134|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773135|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19773136|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19773137|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773138|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773139|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19773140|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
19773141|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773142|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773143|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19773144|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19773145|NCT00145249|Amebicides|amebicides|mesh-ancestor
19773146|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19773147|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19773148|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19773149|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
19773150|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19773151|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773152|NCT00145418|Docetaxel|docetaxel|mesh-list
19773153|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
19773154|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773155|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
19773156|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773157|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773158|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773159|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19773160|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19773161|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19773162|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
19773163|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773164|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19773165|NCT00145587|Antibodies|antibodies|mesh-list
19773166|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
19773167|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773168|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
19773169|NCT00145626|Melphalan|melphalan|mesh-list
19773170|NCT00145626|Thiotepa|thiotepa|mesh-list
19773171|NCT00145626|Fludarabine|fludarabine|mesh-list
19773172|NCT00145626|Antibodies|antibodies|mesh-list
19773173|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773174|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
20317322|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317323|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317324|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19773175|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773176|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773177|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773178|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
19773179|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773180|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773181|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19773182|NCT00145795|Ritonavir|ritonavir|mesh-list
19773183|NCT00145795|Lopinavir|lopinavir|mesh-list
19773184|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19773185|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19773186|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
19773187|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773188|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773189|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19773190|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19773191|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
19773192|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773193|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19773194|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19773195|NCT00145977|Vitamin D|vitamin d|mesh-list
19773196|NCT00145977|Alendronate|alendronate|mesh-list
19773197|NCT00145977|Calcium|calcium|mesh-list
19773198|NCT00145977|Vitamins|vitamins|mesh-ancestor
19773199|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
19773200|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773201|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19773202|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19773203|NCT00146328|Tipranavir|tipranavir|mesh-list
19773204|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19773205|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19773206|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
19773207|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773208|NCT00146640|Prednisone|prednisone|mesh-list
19773209|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773210|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
19773211|NCT00146640|Hormones|hormones|mesh-ancestor
19773212|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773213|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773214|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773215|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773216|NCT00147199|Treprostinil|treprostinil|mesh-list
19773217|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773218|NCT00147212|Trabectedin|trabectedin|mesh-list
19773219|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773220|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
19773221|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773222|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773223|NCT00147225|Carboplatin|carboplatin|mesh-list
19773224|NCT00147225|Doxorubicin|doxorubicin|mesh-list
19773225|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19773226|NCT00147225|Ifosfamide|ifosfamide|mesh-list
19773227|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773228|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20317325|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
20317326|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20317327|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20317328|NCT00709332|Hematinics|hematinics|mesh-ancestor
20317329|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
20317330|NCT00709332|Vitamins|vitamins|mesh-ancestor
19636069|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19636070|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636071|NCT02425865|Golimumab|golimumab|mesh-list
19636072|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19636073|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636074|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636075|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
19636076|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636077|NCT02425462|Dienogest|dienogest|mesh-list
19636078|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19636079|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
19636080|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19636081|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773229|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20317331|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
20317332|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20317333|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20317334|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20347391|NCT00859885|Sensory System Agents|sensory system agents|mesh-ancestor
20347392|NCT00859885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347393|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347394|NCT00859885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773230|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19773231|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773232|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773233|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773234|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
19773235|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19773236|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19773237|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19773238|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773239|NCT00147498|Tofacitinib|tofacitinib|mesh-list
19773240|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19773241|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773242|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773243|NCT00147537|Paclitaxel|paclitaxel|mesh-list
19773244|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19773245|NCT00147537|Carboplatin|carboplatin|mesh-list
19773246|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19773247|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19773248|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773249|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347395|NCT00859885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773250|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19636082|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19773251|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773252|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773253|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773254|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19773255|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773256|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
19773257|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773258|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
19773259|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19773260|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19773261|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773262|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19773263|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19773264|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
19773265|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773266|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19773267|NCT00147966|Rituximab|rituximab|mesh-list
19773268|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773269|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773270|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
19773271|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773272|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773273|NCT00148109|Cetuximab|cetuximab|mesh-list
19773274|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773275|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773276|NCT00148122|Docetaxel|docetaxel|mesh-list
19773277|NCT00148122|Capecitabine|capecitabine|mesh-list
19773278|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773279|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
19773280|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773281|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773282|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773283|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19773284|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
19773285|NCT00148317|Dexamethasone|dexamethasone|mesh-list
19773286|NCT00148317|Doxorubicin|doxorubicin|mesh-list
19773287|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19773288|NCT00148317|Bortezomib|bortezomib|mesh-list
19636083|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19636084|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19636085|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19636086|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
19636087|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636088|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19636089|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636090|NCT02425501|Aflibercept|aflibercept|mesh-list
19636091|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19636092|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19636093|NCT02425501|Growth Substances|growth substances|mesh-ancestor
19773289|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773290|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
19773291|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
19773292|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773293|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773294|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773295|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
19773296|NCT00148317|Hormones|hormones|mesh-ancestor
19773297|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773298|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773299|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773300|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19773301|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19773302|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19773303|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773304|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773305|NCT00148668|Carboplatin|carboplatin|mesh-list
19773306|NCT00148668|Docetaxel|docetaxel|mesh-list
19773307|NCT00148668|Trastuzumab|trastuzumab|mesh-list
19773308|NCT00148668|Vinorelbine|vinorelbine|mesh-list
19773309|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773310|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
19773311|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773312|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773313|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773314|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773315|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773316|NCT00148798|Cisplatin|cisplatin|mesh-list
19636094|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636095|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
20150622|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150623|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150624|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20150625|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20150626|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
20150627|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20150628|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20150629|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20150630|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150631|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773317|NCT00148798|Cetuximab|cetuximab|mesh-list
19773318|NCT00148798|Vinorelbine|vinorelbine|mesh-list
19773319|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773320|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773321|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773322|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
19773323|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773324|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773325|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773326|NCT00148941|Vaccines|vaccines|mesh-list
19773327|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
19773328|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773329|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
19773330|NCT00149214|Docetaxel|docetaxel|mesh-list
19773331|NCT00149214|Doxorubicin|doxorubicin|mesh-list
19773332|NCT00149214|Pemetrexed|pemetrexed|mesh-list
19773333|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773334|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
19773335|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773336|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773337|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773338|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
19773339|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773340|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773341|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19773342|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
19773343|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773344|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773345|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19773346|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19773347|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19636096|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662258|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19662259|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662260|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662261|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
19773348|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773349|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19773350|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19773351|NCT00149227|Valsartan|valsartan|mesh-list
19773352|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
19773353|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19773354|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19773355|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317335|NCT00709423|Moxaverine|moxaverine|mesh-list
19662262|NCT03073525|Atezolizumab|atezolizumab|mesh-list
19662263|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662264|NCT02965898|Vitamin D|vitamin d|mesh-list
19662265|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
19662266|NCT02965898|Vitamins|vitamins|mesh-list
19662267|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
19662268|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662269|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19662270|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19662271|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
19662272|NCT02952222|Propofol|propofol|mesh-list
19662273|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19773356|NCT00149630|Disulfiram|disulfiram|mesh-list
19773357|NCT00149630|Methadone|methadone|mesh-list
20317336|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
19662274|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662275|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317337|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
20317338|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317339|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317340|NCT00709436|Ketamine|ketamine|mesh-list
20317341|NCT00709436|Analgesics|analgesics|mesh-ancestor
20317342|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
20317343|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317344|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317345|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20317346|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19773358|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19773359|NCT00149630|Narcotics|narcotics|mesh-ancestor
19773360|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19773361|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773362|NCT00149630|Analgesics|analgesics|mesh-ancestor
19773363|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
19773364|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773365|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
19773366|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
19773367|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19773368|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20317347|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
20317348|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
20317349|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317350|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20317351|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20317352|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317353|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317354|NCT00709449|Papaverine|papaverine|mesh-list
20317355|NCT00709449|Moxaverine|moxaverine|mesh-list
20317356|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
20317357|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
20150632|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150633|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20150634|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20150635|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
20150636|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317358|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317359|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317360|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20317361|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317362|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317363|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317364|NCT00709449|Urological Agents|urological agents|mesh-ancestor
20317365|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
20317366|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20317367|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317368|NCT00709488|Talaporfin|talaporfin|mesh-list
20317369|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317370|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20317371|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
20317372|NCT00709553|Midazolam|midazolam|mesh-list
19773369|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773370|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773371|NCT00149643|Fluoxetine|fluoxetine|mesh-list
19773372|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20150637|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150638|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20317373|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20317374|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20317375|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317376|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317377|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20317378|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19773373|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19773374|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19773375|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773376|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150639|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20150640|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
20150641|NCT00086333|Docetaxel|docetaxel|mesh-list
20150642|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150643|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
20317379|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773377|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
19636097|NCT02425241|Vaccines|vaccines|mesh-list
19636098|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
19773378|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773379|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19773380|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
19773381|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773382|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19773383|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19773384|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773385|NCT00149734|Ondansetron|ondansetron|mesh-list
19773386|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
19773387|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
19773388|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773389|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773390|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773391|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
19773392|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773393|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19773394|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
19773395|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773396|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773397|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19773398|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19773399|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19773400|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773401|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19773402|NCT00149799|Citalopram|citalopram|mesh-list
19773403|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19773404|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19773405|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19773406|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773407|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773408|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
19773409|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773410|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19773411|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
19773412|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773413|NCT00149825|Dexetimide|dexetimide|mesh-list
19773414|NCT00149825|Citalopram|citalopram|mesh-list
19773415|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19773416|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19773417|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19773418|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773419|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773420|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
19773421|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773422|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19773423|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
19773424|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773425|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19773426|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19773427|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
19773428|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
19773429|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773430|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19773431|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20150644|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150645|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
19636099|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636100|NCT02425137|Gemcitabine|gemcitabine|mesh-list
19636101|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636102|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
19636103|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636104|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636105|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
19636106|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636107|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636108|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636109|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
19636110|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636111|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
19636112|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20173971|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
19773432|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
19773433|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
19773434|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773435|NCT00149890|Cyclosporine|cyclosporine|mesh-list
19773436|NCT00149890|Cyclosporins|cyclosporins|mesh-list
19773437|NCT00149890|Basiliximab|basiliximab|mesh-list
20150646|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150647|NCT00086359|Ritonavir|ritonavir|mesh-list
20150648|NCT00086359|Lopinavir|lopinavir|mesh-list
20150649|NCT00086359|Lamivudine|lamivudine|mesh-list
20150650|NCT00086359|Zidovudine|zidovudine|mesh-list
20150651|NCT00086359|Abacavir|abacavir|mesh-list
20150652|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20150653|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20150654|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20150655|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
20150656|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317380|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19773438|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773439|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773440|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773441|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
19773442|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773443|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
19773444|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773445|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773446|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773447|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19773448|NCT00149994|Cyclosporine|cyclosporine|mesh-list
19773449|NCT00149994|Prednisone|prednisone|mesh-list
19773450|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
19773451|NCT00149994|Tacrolimus|tacrolimus|mesh-list
19773452|NCT00149994|Cyclosporins|cyclosporins|mesh-list
19773453|NCT00149994|Basiliximab|basiliximab|mesh-list
19773454|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773455|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
19773456|NCT00149994|Hormones|hormones|mesh-ancestor
19773457|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773458|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773459|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773460|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773461|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773462|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
19773463|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19773464|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773465|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773466|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
19773467|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773468|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773469|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773470|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
19773471|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
19773472|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636113|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19636114|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19636115|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20317381|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
20317382|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
20317383|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
19636116|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19636117|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636118|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
19636119|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636120|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636121|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19773473|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773474|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19773475|NCT00149994|Protective Agents|protective agents|mesh-ancestor
19773476|NCT00150345|Voriconazole|voriconazole|mesh-list
19773477|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
19773478|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773479|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20150657|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773480|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20317384|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
19773481|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317385|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773482|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773483|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20317386|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317387|NCT00709644|Folic Acid|folic acid|mesh-list
20317388|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20317389|NCT00709644|Norgestimate|norgestimate|mesh-list
20317390|NCT00709644|Estradiol|estradiol|mesh-list
20317391|NCT00709644|Estrogens|estrogens|mesh-ancestor
20317392|NCT00709644|Hormones|hormones|mesh-ancestor
20317393|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317394|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317395|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20317396|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
20317397|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20317398|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20317399|NCT00709644|Hematinics|hematinics|mesh-ancestor
20317400|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
20317401|NCT00709644|Vitamins|vitamins|mesh-ancestor
20317402|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
20317403|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20317404|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20317405|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20317406|NCT00709657|Bevacizumab|bevacizumab|mesh-list
20317407|NCT00709657|Ranibizumab|ranibizumab|mesh-list
20150658|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20150659|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19773484|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
19773485|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773486|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773487|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19773488|NCT00150462|Dexamethasone|dexamethasone|mesh-list
19773489|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773490|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
19773491|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
19773492|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773493|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773494|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773495|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
19773496|NCT00150462|Hormones|hormones|mesh-ancestor
19773497|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150660|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
20150661|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150662|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20150663|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20150664|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20150665|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20150666|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
19636122|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636123|NCT02425202|Ketamine|ketamine|mesh-list
19636124|NCT02425202|Analgesics|analgesics|mesh-ancestor
19636125|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
20150667|NCT00086463|Iloprost|iloprost|mesh-list
20150668|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20150669|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
20150670|NCT00086489|Tremelimumab|tremelimumab|mesh-list
20150671|NCT00086489|Ipilimumab|ipilimumab|mesh-list
20150672|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150673|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150674|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20150675|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150676|NCT00086528|XL647|xl647|mesh-list
20150677|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150678|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150679|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150680|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173972|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173973|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317408|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20317409|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636126|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636127|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636128|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19636129|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20150681|NCT00086541|Interferons|interferons|mesh-list
20150682|NCT00086541|Ribavirin|ribavirin|mesh-list
20150683|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
19773498|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773499|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773500|NCT00150592|Guanfacine|guanfacine|mesh-list
19773501|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773502|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19773503|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19773504|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19773505|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
19773506|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773507|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773508|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773509|NCT00150618|Guanfacine|guanfacine|mesh-list
19773510|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773511|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19773512|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19773513|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19773514|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
19773515|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773516|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773517|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773518|NCT00150800|Brivaracetam|brivaracetam|mesh-list
19773519|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
19773520|NCT00150813|Levetiracetam|levetiracetam|mesh-list
19773521|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
19773522|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
19773523|NCT00150969|Vitamin K|vitamin k|mesh-list
19773524|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
19773525|NCT00150969|Vitamins|vitamins|mesh-ancestor
19773526|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
19773527|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773528|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19773529|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19773530|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773531|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
19773532|NCT00150969|Coagulants|coagulants|mesh-ancestor
19773533|NCT00151281|Thalidomide|thalidomide|mesh-list
19773534|NCT00151281|Prednisone|prednisone|mesh-list
19773535|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
19773536|NCT00151281|Rituximab|rituximab|mesh-list
19773537|NCT00151281|Etoposide|etoposide|mesh-list
19773538|NCT00151281|Procarbazine|procarbazine|mesh-list
19773539|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773540|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
19773541|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773542|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773543|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773544|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
19773545|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773546|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773547|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19773548|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773549|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773550|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
19773551|NCT00151281|Hormones|hormones|mesh-ancestor
19773552|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773553|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773554|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773555|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19773556|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19773557|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773558|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
19773559|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19773560|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773561|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19773562|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19773563|NCT00151281|Growth Substances|growth substances|mesh-ancestor
19773564|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
19773565|NCT00151320|Rituximab|rituximab|mesh-list
20150684|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150685|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
19773566|NCT00151320|Bortezomib|bortezomib|mesh-list
20150686|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773567|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773568|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773569|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
19773570|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773571|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773572|NCT00151411|Metformin|metformin|mesh-list
19773573|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19773574|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773575|NCT00151476|Celecoxib|celecoxib|mesh-list
19773576|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19773577|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19773578|NCT00151476|Analgesics|analgesics|mesh-ancestor
19773579|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
19773580|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773581|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773582|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773583|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773584|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19773585|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19773586|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773587|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150687|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
20150688|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150689|NCT00086593|Lamotrigine|lamotrigine|mesh-list
20150690|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
20150691|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20150692|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20150693|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150694|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20150695|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150696|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20150697|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636130|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
19773588|NCT00151775|Olmesartan|olmesartan|mesh-list
19773589|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19773590|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773591|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19773592|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19773593|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773594|NCT00151814|Olmesartan|olmesartan|mesh-list
19773595|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19773596|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773597|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19773598|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19773599|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773600|NCT00151892|Mesalamine|mesalamine|mesh-list
19773601|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19773602|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19773603|NCT00151892|Analgesics|analgesics|mesh-ancestor
19773604|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
19773605|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773606|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773607|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773608|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150698|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20150699|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636131|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
19636132|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636133|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19636134|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19773609|NCT00151996|Guanfacine|guanfacine|mesh-list
19773610|NCT00151996|Methylphenidate|methylphenidate|mesh-list
20150700|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20150701|NCT00086606|Omalizumab|omalizumab|mesh-list
19636135|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636136|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636137|NCT02425254|Acetaminophen|acetaminophen|mesh-list
19636138|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636139|NCT02425254|Analgesics|analgesics|mesh-ancestor
19636140|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
19636141|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773611|NCT00151996|Amphetamine|amphetamine|mesh-list
20150702|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19773612|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19773613|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773614|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19773615|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19773616|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19773617|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773618|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
19773619|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773620|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
19773621|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
19773622|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773623|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
19773624|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19773625|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773626|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19773627|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19773628|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19773629|NCT00152009|Guanfacine|guanfacine|mesh-list
19773630|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773631|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19773632|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19773633|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19773634|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
19773635|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773636|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773637|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773638|NCT00152464|Levocetirizine|levocetirizine|mesh-list
19773639|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19773640|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19773641|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
19773642|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
19773643|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773644|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773645|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773646|NCT00152516|Levetiracetam|levetiracetam|mesh-list
19773647|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
19773648|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
19773649|NCT00152971|Enoxaparin|enoxaparin|mesh-list
19773650|NCT00152971|Dabigatran|dabigatran|mesh-list
19773651|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
19773652|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19773653|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19773654|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773655|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
19773656|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19773657|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
19773658|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773659|NCT00153062|Telmisartan|telmisartan|mesh-list
19773660|NCT00153062|Clopidogrel|clopidogrel|mesh-list
19773661|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
19636142|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636143|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
19636144|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19636145|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19636146|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636147|NCT02424552|Vitamin D|vitamin d|mesh-list
19636148|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
19636149|NCT02424552|Vitamins|vitamins|mesh-ancestor
19636150|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
19636151|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636152|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19636153|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19636154|NCT02424695|Gabapentin|gabapentin|mesh-list
19636155|NCT02424695|Analgesics|analgesics|mesh-ancestor
19636156|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
19636157|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636158|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636159|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
19636160|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19636161|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636162|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636163|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773662|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19773663|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19773664|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19773665|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19773666|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
19773667|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773668|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773669|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150703|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19636164|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19636165|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19636166|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636167|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636168|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
19636169|NCT02424318|Topiramate|topiramate|mesh-list
19636170|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
19636171|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20150704|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
20150705|NCT00086632|Oregovomab|oregovomab|mesh-list
20150706|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150707|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636172|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773670|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20150708|NCT00086645|Dexetimide|dexetimide|mesh-list
20150709|NCT00086645|Citalopram|citalopram|mesh-list
20150710|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20150711|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20150712|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20150713|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773671|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19773672|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19773673|NCT00153101|Telmisartan|telmisartan|mesh-list
20150714|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150715|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
20150716|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150717|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20150718|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
20150719|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150720|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20150721|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20150722|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
20150723|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
20150724|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150725|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19773674|NCT00153101|Ramipril|ramipril|mesh-list
19773675|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773676|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19773677|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19773678|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150726|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19773679|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20150727|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
20150728|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
20317410|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20317411|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20317412|NCT00709657|Growth Substances|growth substances|mesh-ancestor
20317413|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317414|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
19773680|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
19773681|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773682|NCT00153166|Pioglitazone|pioglitazone|mesh-list
19773683|NCT00153166|Atorvastatin|atorvastatin|mesh-list
19773684|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19773685|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19773686|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
19773687|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150729|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20150730|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19773688|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19773689|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19773690|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317415|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
20317416|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
20317417|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20317418|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20317419|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317420|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
20317421|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20317422|NCT00709917|Repaglinide|repaglinide|mesh-list
20317423|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20317424|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317425|NCT00709969|Lumefantrine|lumefantrine|mesh-list
20317426|NCT00709969|Artemether|artemether|mesh-list
20317427|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19773691|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19773692|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773693|NCT00153179|Acipimox|acipimox|mesh-list
19636173|NCT02424214|Ionophores|ionophores|mesh-list
19636174|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19636175|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636176|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
19636177|NCT02424201|Misoprostol|misoprostol|mesh-list
19636178|NCT02424201|Vitamins|vitamins|mesh-ancestor
19636179|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
19636180|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317428|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
20317429|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19636181|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19636182|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
19773694|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19773695|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
19773696|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773697|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19773698|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19773699|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773700|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19773701|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773702|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773703|NCT00153816|Vitamin D|vitamin d|mesh-list
19773704|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
19773705|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
19773706|NCT00153816|Calcium|calcium|mesh-list
19773707|NCT00153816|Vitamins|vitamins|mesh-ancestor
19773708|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
19773709|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773710|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19773711|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19773712|NCT00153816|Antacids|antacids|mesh-ancestor
19773713|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773714|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773715|NCT00153842|Bexarotene|bexarotene|mesh-list
19773716|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773717|NCT00153920|Bortezomib|bortezomib|mesh-list
19773718|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773719|NCT00153985|Fludarabine|fludarabine|mesh-list
20317430|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20317431|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317432|NCT00709982|Folic Acid|folic acid|mesh-list
20317433|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20317434|NCT00709982|Norgestimate|norgestimate|mesh-list
20317435|NCT00709982|Estradiol|estradiol|mesh-list
19773720|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
20150731|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150732|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20150733|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20150734|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
20150735|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150736|NCT00086736|Eflornithine|eflornithine|mesh-list
20150737|NCT00086736|Bicalutamide|bicalutamide|mesh-list
20150738|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
19773721|NCT00153985|Busulfan|busulfan|mesh-list
20317436|NCT00709982|Estrogens|estrogens|mesh-ancestor
20317437|NCT00709982|Hormones|hormones|mesh-ancestor
20317438|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773722|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317439|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773723|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773724|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150739|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
20150740|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150741|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150742|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150743|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20150744|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20150745|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19636183|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19636184|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19636185|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636186|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
20150746|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150747|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20150748|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150749|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150750|NCT00086775|Rituximab|rituximab|mesh-list
20150751|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
20150752|NCT00086775|Fludarabine|fludarabine|mesh-list
20317440|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19773725|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
19773726|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773727|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773728|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
19773729|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773730|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19773731|NCT00154102|Leucovorin|leucovorin|mesh-list
19773732|NCT00154102|Folic Acid|folic acid|mesh-list
19773733|NCT00154102|Fluorouracil|fluorouracil|mesh-list
19773734|NCT00154102|Irinotecan|irinotecan|mesh-list
19773735|NCT00154102|Cetuximab|cetuximab|mesh-list
19773736|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
19773737|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
19773738|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773739|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19773740|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317441|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
20317442|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20317443|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20317444|NCT00709982|Hematinics|hematinics|mesh-ancestor
20317445|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
20317446|NCT00709982|Vitamins|vitamins|mesh-ancestor
20317447|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
20317448|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20317449|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20317450|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20317451|NCT00710086|Remifentanil|remifentanil|mesh-list
20317452|NCT00710086|Hydromorphone|hydromorphone|mesh-list
20317453|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20317454|NCT00710086|Narcotics|narcotics|mesh-ancestor
20317455|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317456|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317457|NCT00710086|Analgesics|analgesics|mesh-ancestor
20317458|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
20317459|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317460|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
20317461|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317462|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20317463|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20317464|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317465|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317466|NCT00710099|Urological Agents|urological agents|mesh-ancestor
20317467|NCT00710125|Doxorubicin|doxorubicin|mesh-list
20317468|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20317469|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317470|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19636187|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
19636188|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636189|NCT02424201|Protective Agents|protective agents|mesh-ancestor
19636190|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
19636191|NCT02424461|Ofloxacin|ofloxacin|mesh-list
19636192|NCT02424461|Levofloxacin|levofloxacin|mesh-list
19636193|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19773741|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636194|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773742|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
19773743|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773744|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19773745|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19773746|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773747|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773748|NCT00154102|Antidotes|antidotes|mesh-ancestor
19773749|NCT00154102|Protective Agents|protective agents|mesh-ancestor
19773750|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
19773751|NCT00154102|Vitamins|vitamins|mesh-ancestor
19773752|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
19773753|NCT00154102|Hematinics|hematinics|mesh-ancestor
19773754|NCT00154284|Cyclosporine|cyclosporine|mesh-list
19773755|NCT00154284|Prednisone|prednisone|mesh-list
19773756|NCT00154284|Everolimus|everolimus|mesh-list
19773757|NCT00154284|Cyclosporins|cyclosporins|mesh-list
19773758|NCT00154284|Basiliximab|basiliximab|mesh-list
19773759|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773760|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
19773761|NCT00154284|Hormones|hormones|mesh-ancestor
19773762|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150753|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
20150754|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773763|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773764|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773765|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773766|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773767|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773768|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773769|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
19773770|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
19773771|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773772|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773773|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773774|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19773775|NCT00154297|Everolimus|everolimus|mesh-list
19773776|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773777|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773778|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
20150755|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150756|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
20150757|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150758|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150759|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150760|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
20317471|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20317472|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317473|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317474|NCT00710138|Vitamins|vitamins|mesh-list
20317475|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
20317476|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
20317477|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
19636195|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19636196|NCT02424461|Renal Agents|renal agents|mesh-ancestor
19636197|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19636198|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19636199|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636200|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636201|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636202|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20150761|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150762|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150763|NCT00086801|Gemcitabine|gemcitabine|mesh-list
19636203|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19636204|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
19636205|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19773779|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150764|NCT00086801|Doxorubicin|doxorubicin|mesh-list
19773780|NCT00154310|Cyclosporine|cyclosporine|mesh-list
19773781|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
19773782|NCT00154310|Everolimus|everolimus|mesh-list
19773783|NCT00154310|Cyclosporins|cyclosporins|mesh-list
20317478|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
20347396|NCT00859885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19773784|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773785|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773786|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773787|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
19773788|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773789|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
19773790|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773791|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773792|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773793|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19773794|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773795|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19773796|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19773797|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
19773798|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19773799|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
19773800|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
19773801|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773802|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19773803|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773804|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773805|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
19773806|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19773807|NCT00156013|Clofarabine|clofarabine|mesh-list
19773808|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19773809|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
19773810|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773811|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833372|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833373|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19833374|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
19833375|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833376|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833377|NCT00092716|Atorvastatin|atorvastatin|mesh-list
19833378|NCT00092716|Ezetimibe|ezetimibe|mesh-list
19833379|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19833380|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20317479|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317480|NCT00710138|Hematinics|hematinics|mesh-ancestor
20317481|NCT00710216|Lamivudine|lamivudine|mesh-list
20317482|NCT00710216|Telbivudine|telbivudine|mesh-list
20317483|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20317484|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20317485|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317486|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317487|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
19833381|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
19833382|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833383|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833384|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19833385|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317488|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833386|NCT00588094|Rituximab|rituximab|mesh-list
19833387|NCT00588094|Carboplatin|carboplatin|mesh-list
19833388|NCT00588094|Etoposide|etoposide|mesh-list
19833389|NCT00588094|Ifosfamide|ifosfamide|mesh-list
19833390|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19833391|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833392|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
19833393|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833394|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833395|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19833396|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19833397|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19833398|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833399|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833400|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19833401|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
19833402|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
19833403|NCT00588159|Promethazine|promethazine|mesh-list
19833404|NCT00588159|Gabapentin|gabapentin|mesh-list
19833405|NCT00588159|Analgesics|analgesics|mesh-ancestor
19833406|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
20317489|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20317490|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20150765|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20150766|NCT00086801|Vinblastine|vinblastine|mesh-list
20150767|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20150768|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150769|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
20150770|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150771|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317491|NCT00710229|Bevacizumab|bevacizumab|mesh-list
20317492|NCT00710229|Ranibizumab|ranibizumab|mesh-list
20317493|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773812|NCT00156247|Acitretin|acitretin|mesh-list
19773813|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
19773814|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773815|NCT00156533|Zolpidem|zolpidem|mesh-list
19773816|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19773817|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19773818|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19773819|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773820|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19773821|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
19773822|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
19773823|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773824|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773825|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19773826|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
19773827|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773828|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19773829|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19773830|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19773831|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773832|NCT00156819|Fluticasone|fluticasone|mesh-list
20317494|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317495|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20317496|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20317497|NCT00710229|Growth Substances|growth substances|mesh-ancestor
20317498|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317499|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
20317500|NCT00710268|Bevacizumab|bevacizumab|mesh-list
20317501|NCT00710268|Olaparib|olaparib|mesh-list
20317502|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20317503|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317504|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20317505|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20317506|NCT00710268|Growth Substances|growth substances|mesh-ancestor
20317507|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317508|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
20317509|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20317510|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317511|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611047|NCT02314169|Ipilimumab|ipilimumab|mesh-list
20611048|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20611049|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773833|NCT00156819|Xhance|xhance|mesh-list
20150772|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
20150773|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150774|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150775|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150776|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
20150777|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150778|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150779|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20150780|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150781|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20150782|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20150783|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611050|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19773834|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20611051|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611052|NCT02296229|Androgens|androgens|mesh-list
20611053|NCT02296229|Hormones|hormones|mesh-ancestor
20611054|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611055|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611056|NCT02275533|Nivolumab|nivolumab|mesh-list
20611057|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19773835|NCT00156819|Montelukast|montelukast|mesh-list
19773836|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773837|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19773838|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
19773839|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773840|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773841|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19773842|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
19773843|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773844|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19773845|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19773846|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19773847|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19773848|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
19773849|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773850|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773851|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19773852|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
20611058|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611059|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20611060|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773853|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19773854|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19773855|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19773856|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
19773857|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19636206|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19636207|NCT02424435|Prednisolone|prednisolone|mesh-list
19636208|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
19636209|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20150784|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150785|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
19636210|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
19636211|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636212|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
19773858|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19773859|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19773860|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19773861|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773862|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
19773863|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773864|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773865|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19773866|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773867|NCT00156923|Naltrexone|naltrexone|mesh-list
19773868|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19773869|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19773870|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773871|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
19773872|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773873|NCT00156936|Naltrexone|naltrexone|mesh-list
19773874|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19773875|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19773876|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150786|NCT00086827|Romidepsin|romidepsin|mesh-list
20317512|NCT00710320|Anesthetics|anesthetics|mesh-list
19636213|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
20150787|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150788|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150789|NCT00086840|Sirolimus|sirolimus|mesh-list
20150790|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20150791|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150792|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150793|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150794|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
20150795|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317513|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611061|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20611062|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
20611063|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20611064|NCT02185417|Diuretics|diuretics|mesh-ancestor
20611065|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
20611066|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611067|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19773877|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
19773878|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773879|NCT00157014|Cyclosporine|cyclosporine|mesh-list
19773880|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
20317514|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317515|NCT00710359|Vitamins|vitamins|mesh-list
20317516|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
20317517|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
20317518|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
19773881|NCT00157014|Prednisone|prednisone|mesh-list
19773882|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
19773883|NCT00157014|Tacrolimus|tacrolimus|mesh-list
19773884|NCT00157014|Cyclosporins|cyclosporins|mesh-list
19773885|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19773886|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
19773887|NCT00157014|Hormones|hormones|mesh-ancestor
19773888|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317519|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
20317520|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317521|NCT00710359|Hematinics|hematinics|mesh-ancestor
20317522|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
20317523|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19773889|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773890|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19773891|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773892|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773893|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
19773894|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19773895|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773896|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773897|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
19773898|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773899|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
19773900|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773901|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19773902|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19773903|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
19773904|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19773905|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
19773906|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
19773907|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773908|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19773909|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19773910|NCT00157014|Protective Agents|protective agents|mesh-ancestor
19773911|NCT00157157|Factor VIII|factor viii|mesh-list
19773912|NCT00157157|Coagulants|coagulants|mesh-ancestor
19773913|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
19773914|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773915|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
19773916|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773917|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773918|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773919|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
19773920|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773921|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773922|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19636214|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636215|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636216|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636217|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
19636218|NCT02424435|Hormones|hormones|mesh-ancestor
19636219|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636220|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19636221|NCT02424435|Protective Agents|protective agents|mesh-ancestor
19636222|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19636223|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150796|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
19636224|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
19773923|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
20150797|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150798|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20150799|NCT00086879|Temozolomide|temozolomide|mesh-list
20150800|NCT00086879|Carmustine|carmustine|mesh-list
20150801|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150802|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150803|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150804|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773924|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19773925|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
19773926|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773927|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19773928|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19773929|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
19773930|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773931|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773932|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19773933|NCT00157248|Dabigatran|dabigatran|mesh-list
19773934|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
19773935|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19773936|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
19773937|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773938|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773939|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
20317524|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317525|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317526|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20317527|NCT00710437|Analgesics|analgesics|mesh-ancestor
20317528|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
20317529|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317530|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20317531|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20317532|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20317533|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
20317534|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317535|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317536|NCT00710528|Idelalisib|idelalisib|mesh-list
19773940|NCT00157573|Sargramostim|sargramostim|mesh-list
19773941|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
19773942|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773943|NCT00158184|Oxycodone|oxycodone|mesh-list
19773944|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19773945|NCT00158184|Narcotics|narcotics|mesh-ancestor
19773946|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19773947|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773948|NCT00158184|Analgesics|analgesics|mesh-ancestor
19773949|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
19773950|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19773951|NCT00158223|Pimozide|pimozide|mesh-list
19773952|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19773953|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19773954|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19773955|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773956|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19773957|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19773958|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
19773959|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773960|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773961|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19773962|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19773963|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
19773964|NCT00158262|Propranolol|propranolol|mesh-list
19773965|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19773966|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19773967|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
19773968|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19773969|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773970|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773971|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19773972|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19773973|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
20150805|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150806|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
20150807|NCT00086892|Carboplatin|carboplatin|mesh-list
20150808|NCT00086892|Cetuximab|cetuximab|mesh-list
20150809|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150810|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150811|NCT00086931|Capecitabine|capecitabine|mesh-list
20150812|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
20317537|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773974|NCT00158379|Paclitaxel|paclitaxel|mesh-list
19773975|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19773976|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19773977|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150813|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150814|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
20150815|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150816|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150817|NCT00086944|Rituximab|rituximab|mesh-list
20150818|NCT00086944|Carboplatin|carboplatin|mesh-list
20150819|NCT00086944|Etoposide|etoposide|mesh-list
20150820|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
20150821|NCT00086944|Ifosfamide|ifosfamide|mesh-list
20150822|NCT00086944|Oblimersen|oblimersen|mesh-list
20150823|NCT00086944|Lenograstim|lenograstim|mesh-list
19773978|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
19773979|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
19773980|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773981|NCT00158743|Digoxin|digoxin|mesh-list
19773982|NCT00158743|Antibodies|antibodies|mesh-list
19773983|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
19773984|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
19773985|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773986|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19773987|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19773988|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19773989|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19773990|NCT00158743|Protective Agents|protective agents|mesh-ancestor
19773991|NCT00158756|Vaccines|vaccines|mesh-list
19773992|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
19773993|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19773994|NCT00158860|Valacyclovir|valacyclovir|mesh-list
19636225|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
19636226|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19636227|NCT02424136|Antibodies|antibodies|mesh-list
19636228|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
19636229|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636230|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19636231|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
19636232|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636233|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19773995|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
19773996|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19773997|NCT00159263|Budesonide|budesonide|mesh-list
19773998|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
19773999|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774000|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19774001|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
19774002|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774003|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774004|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19774005|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
19774006|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
19774007|NCT00159263|Hormones|hormones|mesh-ancestor
19774008|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774009|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19774010|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19774011|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19774012|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
19774013|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774014|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774015|NCT00159419|Alendronate|alendronate|mesh-list
19774016|NCT00159419|Pamidronate|pamidronate|mesh-list
19774017|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19774018|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774019|NCT00159432|Bevacizumab|bevacizumab|mesh-list
19774020|NCT00159432|Capecitabine|capecitabine|mesh-list
19774021|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
20150824|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20150825|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150826|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
20150827|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150828|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150829|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20150830|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19636234|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
19636235|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20150831|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150832|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175122|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19774022|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774023|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774024|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19774025|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19774026|NCT00159432|Growth Substances|growth substances|mesh-ancestor
19774027|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774028|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
19774029|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19774030|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
19774031|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774032|NCT00159822|Voriconazole|voriconazole|mesh-list
19774033|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
19774034|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774035|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19774036|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20317538|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317539|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636236|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
19774037|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774038|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774039|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19774040|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
19774041|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774042|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774043|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19774044|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
19774045|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774046|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
19774047|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19774048|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19774049|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774050|NCT00159861|Urological Agents|urological agents|mesh-ancestor
19774051|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
19774052|NCT00159874|Citric Acid|citric acid|mesh-list
19774053|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
19774054|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
19774055|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19636237|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636238|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636239|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19636240|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
19774056|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
19774057|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
19774058|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774059|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
19774060|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19774061|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19774062|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774063|NCT00159874|Urological Agents|urological agents|mesh-ancestor
19774064|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
19774065|NCT00159913|Citric Acid|citric acid|mesh-list
19774066|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
19774067|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
19636241|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
19636242|NCT02424136|Protective Agents|protective agents|mesh-ancestor
19636243|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
19774068|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19774069|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
19774070|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
19774071|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774072|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
19774073|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19636244|NCT02423928|Ipilimumab|ipilimumab|mesh-list
19636245|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636246|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
19636247|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636248|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636249|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774074|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19774075|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774076|NCT00159913|Urological Agents|urological agents|mesh-ancestor
19774077|NCT00159965|Sertraline|sertraline|mesh-list
19774078|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
19774079|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774080|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19774081|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19774082|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774083|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774084|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774085|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
19774086|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774087|NCT00160199|Progesterone|progesterone|mesh-list
19774088|NCT00160199|Progestins|progestins|mesh-ancestor
19774089|NCT00160199|Hormones|hormones|mesh-ancestor
19774090|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774091|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774092|NCT00160251|Ribavirin|ribavirin|mesh-list
19774093|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19774094|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
19774095|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774096|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
19774097|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774098|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
19774099|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774100|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
19774101|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774102|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774103|NCT00160615|Levetiracetam|levetiracetam|mesh-list
19774104|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
19774105|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
19774106|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
19774107|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774108|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
19774109|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774110|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774111|NCT00160654|Levetiracetam|levetiracetam|mesh-list
19774112|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
19774113|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
19774114|NCT00160667|Brivaracetam|brivaracetam|mesh-list
19774115|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
20317540|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
20317541|NCT00710619|Coagulants|coagulants|mesh-ancestor
20317542|NCT00710736|Fluorouracil|fluorouracil|mesh-list
20317543|NCT00710736|Capecitabine|capecitabine|mesh-list
20317544|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
20317545|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317546|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150833|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150834|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20317547|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317548|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317549|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
20317550|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317551|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
20317552|NCT00710788|Calcium|calcium|mesh-list
20317553|NCT00710788|Sevelamer|sevelamer|mesh-list
20317554|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20317555|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317556|NCT00710788|Antacids|antacids|mesh-ancestor
20317557|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317558|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317559|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
19774116|NCT00160680|Levocetirizine|levocetirizine|mesh-list
19774117|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19774118|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19774119|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
19774120|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
19774121|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150835|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150836|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
20150837|NCT00086970|Ifosfamide|ifosfamide|mesh-list
20150838|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20150839|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150840|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
20150841|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774122|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774123|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774124|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
19774125|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774126|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
19774127|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774128|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774129|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
19774130|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774131|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
19774132|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774133|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774134|NCT00161213|Gemcitabine|gemcitabine|mesh-list
19774135|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
19774136|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19774137|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
19636250|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
19636251|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636252|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636253|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19636254|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19636255|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19636256|NCT02424071|Melatonin|melatonin|mesh-list
19636257|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
19636258|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150842|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150843|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150844|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
20150845|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150846|NCT00087009|Rituximab|rituximab|mesh-list
19774138|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774139|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774140|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
19774141|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774142|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774143|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774144|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
19774145|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774146|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19774147|NCT00161473|Prazosin|prazosin|mesh-list
19774148|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19774149|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19774150|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19774151|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19774152|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
19774153|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774154|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774155|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774156|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19774157|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19774158|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774159|NCT00162097|Efavirenz|efavirenz|mesh-list
19774160|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19774161|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19774162|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19774163|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774164|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774165|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
19774166|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774167|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19774168|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20150847|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774169|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19774170|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19774171|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19774172|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19774173|NCT00162123|Ipilimumab|ipilimumab|mesh-list
19774174|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774175|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774176|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19774177|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774178|NCT00162266|Abatacept|abatacept|mesh-list
19774179|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19774180|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774181|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774182|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774183|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
19774184|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774185|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774186|NCT00162981|Clobazam|clobazam|mesh-list
20317560|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
20317561|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
20317562|NCT00710827|Androgens|androgens|mesh-ancestor
20317563|NCT00710827|Hormones|hormones|mesh-ancestor
20317564|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317565|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317566|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
20317567|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20317568|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317569|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20317570|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20317571|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
19774187|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
19774188|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19774189|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19774190|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19774191|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774192|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774193|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19774194|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
19774195|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
19774196|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774197|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774198|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19774199|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19774200|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19774201|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
19774202|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774203|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774204|NCT00163020|Progestins|progestins|mesh-ancestor
19774205|NCT00163020|Hormones|hormones|mesh-ancestor
19774206|NCT00163293|Ciclesonide|ciclesonide|mesh-list
19774207|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
19774208|NCT00163293|Hormones|hormones|mesh-ancestor
19774209|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774210|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774211|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19774212|NCT00163657|Cyclosporine|cyclosporine|mesh-list
19774213|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
19774214|NCT00163657|Tacrolimus|tacrolimus|mesh-list
19774215|NCT00163657|Cyclosporins|cyclosporins|mesh-list
19774216|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774217|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
19774218|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774219|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19774220|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774221|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774222|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
19774223|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774224|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
19774225|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774226|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19774227|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774228|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19774229|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
19774230|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19774231|NCT00165646|Rabeprazole|rabeprazole|mesh-list
19774232|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19774233|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774234|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20317572|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317573|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
20317574|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20317575|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
20317576|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20317577|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20317578|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20317579|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20317580|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
20317581|NCT00711204|Donepezil|donepezil|mesh-list
20317582|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20317583|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774235|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774236|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774237|NCT00165672|Rabeprazole|rabeprazole|mesh-list
19774238|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19774239|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774240|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19774241|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774242|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774243|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
19774244|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19774245|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19774246|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774247|NCT00165698|Vitamins|vitamins|mesh-ancestor
19774248|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
19774249|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19774250|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
19774251|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19774252|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19774253|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19774254|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774255|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774256|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774257|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774258|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774259|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19774260|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774261|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19774262|NCT00165841|Rabeprazole|rabeprazole|mesh-list
19774263|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19774264|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774265|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19774266|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774267|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774268|NCT00166036|Atorvastatin|atorvastatin|mesh-list
19774269|NCT00166036|Pravastatin|pravastatin|mesh-list
19774270|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19774271|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20150848|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150849|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
20150850|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150851|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150852|NCT00087035|Docetaxel|docetaxel|mesh-list
20150853|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20150854|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150855|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150856|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150857|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150858|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150859|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150860|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150861|NCT00087048|Topotecan|topotecan|mesh-list
20150862|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20150863|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19774272|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
19774273|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150864|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317584|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774274|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19774275|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19774276|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774277|NCT00166114|Citalopram|citalopram|mesh-list
19774278|NCT00166114|Desipramine|desipramine|mesh-list
19774279|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19774280|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19774281|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774282|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774283|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774284|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
19774285|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774286|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19774287|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
19774288|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774289|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19774290|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774291|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19774292|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
19774293|NCT00166166|Fluconazole|fluconazole|mesh-list
19774294|NCT00166166|Nitroprusside|nitroprusside|mesh-list
19774295|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
20150865|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317585|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774296|NCT00166166|Acetylcholine|acetylcholine|mesh-list
19774297|NCT00166166|Bradykinin|bradykinin|mesh-list
19774298|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19774299|NCT00166166|Kininogens|kininogens|mesh-list
19774300|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
19774301|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774302|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19774303|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19774304|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317586|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317587|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317588|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
20317589|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
20317590|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19774305|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774306|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19774307|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
19774308|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774309|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774310|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19774311|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19774312|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19774313|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
19774314|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19774315|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19774316|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
20150866|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317591|NCT00711256|Protective Agents|protective agents|mesh-ancestor
20317592|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317593|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
20317594|NCT00711295|Vaccines|vaccines|mesh-list
20317595|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
20317596|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317597|NCT00711308|Vitamin K|vitamin k|mesh-list
20317598|NCT00711308|Tinzaparin|tinzaparin|mesh-list
20317599|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20317600|NCT00711308|Dalteparin|dalteparin|mesh-list
19774317|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150867|NCT00087074|Sirolimus|sirolimus|mesh-list
20150868|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20150869|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150870|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150871|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150872|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
20150873|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150874|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
20150875|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150876|NCT00087087|Pemetrexed|pemetrexed|mesh-list
20317601|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
20150877|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317602|NCT00711308|Vitamins|vitamins|mesh-ancestor
19774318|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19774319|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
19774320|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19774321|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774322|NCT00166296|Citalopram|citalopram|mesh-list
19774323|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19774324|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19774325|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774326|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774327|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774328|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
19774329|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774330|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19774331|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
19774332|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774333|NCT00166439|Cytarabine|cytarabine|mesh-list
19774334|NCT00166439|Dexamethasone|dexamethasone|mesh-list
19774335|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
19774336|NCT00166439|Rituximab|rituximab|mesh-list
19774337|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774338|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
19774339|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
19774340|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774341|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317603|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
20317604|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317605|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20317606|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20317607|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317608|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
20317609|NCT00711308|Coagulants|coagulants|mesh-ancestor
20317610|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
20317611|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20347397|NCT00859885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20347398|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347399|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20347400|NCT00859885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20347401|NCT00859885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347402|NCT00859885|Antipyretics|antipyretics|mesh-ancestor
20347403|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19774342|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774343|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
19774344|NCT00166439|Hormones|hormones|mesh-ancestor
19774345|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774346|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774347|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774348|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774349|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
19774350|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774351|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19774352|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
19774353|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774354|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
19774355|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774356|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774357|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
19774358|NCT00166712|Sirolimus|sirolimus|mesh-list
19774359|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
19774360|NCT00166712|Tacrolimus|tacrolimus|mesh-list
19774361|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774362|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
19774363|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774364|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19774365|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774366|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774367|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19774368|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774369|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19774370|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
19774371|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19774372|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774373|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
19774374|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774375|NCT00167102|Alefacept|alefacept|mesh-list
19774376|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
20317612|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20317613|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20317614|NCT00711620|Thymalfasin|thymalfasin|mesh-list
20317615|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20317616|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
20317617|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317618|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
19774377|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
19774378|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774379|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
19774380|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774381|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
19774382|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774383|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774384|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774385|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
19774386|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774387|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774388|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19774389|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
19774390|NCT00167206|Fludarabine|fludarabine|mesh-list
19774391|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774392|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
19774393|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317619|NCT00711698|Narcotics|narcotics|mesh-ancestor
20317620|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317621|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317622|NCT00711698|Analgesics|analgesics|mesh-ancestor
20611068|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611069|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611070|NCT02180867|Doxorubicin|doxorubicin|mesh-list
20611071|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20611072|NCT02180867|Daunorubicin|daunorubicin|mesh-list
20611073|NCT02180867|Ifosfamide|ifosfamide|mesh-list
20611074|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
20611075|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611076|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611077|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20611078|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19636259|NCT02424071|Protective Agents|protective agents|mesh-ancestor
19636260|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636261|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636262|NCT02423954|Sirolimus|sirolimus|mesh-list
19636263|NCT02423954|Capecitabine|capecitabine|mesh-list
19636264|NCT02423954|Nivolumab|nivolumab|mesh-list
19636265|NCT02423954|Irinotecan|irinotecan|mesh-list
19636266|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636267|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
19636268|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317623|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
20317624|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317625|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
20611079|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611080|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611081|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611082|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
19636269|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636270|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20317626|NCT00711789|Giapreza|giapreza|mesh-list
20317627|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
20317628|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20317629|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20317630|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
20317631|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317632|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317633|NCT00711841|Dexamethasone|dexamethasone|mesh-list
20317634|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
20317635|NCT00711841|BB 1101|bb 1101|mesh-list
20317636|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20317637|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
19636271|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20317638|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
20317639|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611083|NCT02176148|Fluocinonide|fluocinonide|mesh-list
19636272|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20317640|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317641|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317642|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
20317643|NCT00711841|Hormones|hormones|mesh-ancestor
20317644|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317645|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20317646|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317647|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
20317648|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317649|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317650|NCT00711854|Rifampin|rifampin|mesh-list
20317651|NCT00711854|Linezolid|linezolid|mesh-list
20317652|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20317653|NCT00711854|Trimethoprim|trimethoprim|mesh-list
19636273|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19636274|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636275|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19636276|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636277|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19636278|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
19636279|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636280|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
19636281|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636282|NCT02423915|Vidarabine|vidarabine|mesh-list
20317654|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
20611084|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774394|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774395|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774396|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
19774397|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774398|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774399|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19774400|NCT00167245|Topiramate|topiramate|mesh-list
19774401|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
19774402|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19774403|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774404|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
19774405|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774406|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
19774407|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774408|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774409|NCT00167934|Valproic Acid|valproic acid|mesh-list
19774410|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
19774411|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774412|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774413|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
19774414|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774415|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636283|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
19636284|NCT02423915|Sirolimus|sirolimus|mesh-list
19774416|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
19636285|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
19636286|NCT02423915|Rituximab|rituximab|mesh-list
19636287|NCT02423915|Fludarabine|fludarabine|mesh-list
19636288|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
19636289|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636290|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
19636291|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150878|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150879|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150880|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20150881|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20150882|NCT00087100|Pemetrexed|pemetrexed|mesh-list
20150883|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150884|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150885|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150886|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20150887|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20150888|NCT00087113|Pemetrexed|pemetrexed|mesh-list
20150889|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150890|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150891|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636292|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636293|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19636294|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
20150892|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20150893|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20150894|NCT00087165|Prednisone|prednisone|mesh-list
19774417|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19774418|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19774419|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774420|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
19774421|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19774422|NCT00168038|Antibodies|antibodies|mesh-list
19774423|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
19774424|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774425|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
19774426|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19774427|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
19774428|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774429|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774430|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774431|NCT00168103|Complement C1s|complement c1s|mesh-list
19774432|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19774433|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19774434|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
19774435|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774436|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19774437|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774438|NCT00168298|Dexamethasone|dexamethasone|mesh-list
19774439|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
19774440|NCT00168298|BB 1101|bb 1101|mesh-list
19774441|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774442|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
19774443|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
19774444|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774445|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774446|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774447|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
19774448|NCT00168298|Hormones|hormones|mesh-ancestor
19774449|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774450|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774451|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774452|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
20150895|NCT00087165|Docetaxel|docetaxel|mesh-list
20150896|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150897|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150898|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150899|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150900|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150901|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150902|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
20150903|NCT00087165|Hormones|hormones|mesh-ancestor
20150904|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20150905|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150906|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20150907|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
20150908|NCT00087178|Doxorubicin|doxorubicin|mesh-list
20150909|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20150910|NCT00087178|Fluorouracil|fluorouracil|mesh-list
20150911|NCT00087178|Epirubicin|epirubicin|mesh-list
20150912|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20150913|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
20150914|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150915|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150916|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20150917|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
20150918|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150919|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150920|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20150921|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150922|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20150923|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150924|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150925|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
20150926|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150927|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
20150928|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20150929|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
20150930|NCT00087217|Paclitaxel|paclitaxel|mesh-list
19774453|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774454|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774455|NCT00168324|Dexamethasone|dexamethasone|mesh-list
19774456|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
19774457|NCT00168324|BB 1101|bb 1101|mesh-list
19774458|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774459|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
19774460|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
19774461|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774462|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774463|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774464|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
19774465|NCT00168324|Hormones|hormones|mesh-ancestor
19774466|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774467|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774468|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774469|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
19774470|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774471|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774472|NCT00168337|Dexamethasone|dexamethasone|mesh-list
19774473|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774474|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
19774475|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
19774476|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774477|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774478|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774479|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
19774480|NCT00168337|Hormones|hormones|mesh-ancestor
19774481|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774482|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774483|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774484|NCT00168389|Dexamethasone|dexamethasone|mesh-list
19774485|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774486|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
19774487|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
19774488|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774489|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774490|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774491|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
19774492|NCT00168389|Hormones|hormones|mesh-ancestor
19774493|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774494|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774495|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774496|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
19774497|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19774498|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19774499|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19774500|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774501|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774502|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774503|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774504|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774505|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19774506|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833407|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833408|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833409|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
19833410|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19833411|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19833412|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833413|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19833414|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19833415|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19833416|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833417|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150931|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20150932|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150933|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20150934|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20150935|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150936|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150937|NCT00087256|Celecoxib|celecoxib|mesh-list
20611085|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
19774507|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
19774508|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19774509|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19774510|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19774511|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774512|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774513|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774514|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774515|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774516|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19774517|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774518|NCT00168805|Enoxaparin|enoxaparin|mesh-list
19774519|NCT00168805|Dabigatran|dabigatran|mesh-list
19774520|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
19774521|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19774522|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19774523|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774524|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
19774525|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19774526|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
19774527|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774528|NCT00168818|Enoxaparin|enoxaparin|mesh-list
19774529|NCT00168818|Dabigatran|dabigatran|mesh-list
19774530|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
19774531|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19774532|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19774533|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774534|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
19774535|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19774536|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19774537|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774538|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
19774539|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19774540|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
19774541|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774542|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774543|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19774544|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
19774545|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
19774546|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19774547|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774548|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20150938|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20150939|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20150940|NCT00087256|Analgesics|analgesics|mesh-ancestor
20150941|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
20150942|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774549|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774550|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
19774551|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19774552|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
19774553|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774554|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774555|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19774556|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
19774557|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
19774558|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19774559|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774560|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774561|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774562|NCT00169104|Trastuzumab|trastuzumab|mesh-list
19774563|NCT00169104|Vinorelbine|vinorelbine|mesh-list
19774564|NCT00169104|Lenograstim|lenograstim|mesh-list
19774565|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774566|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774567|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19774568|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
19774569|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774570|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19774571|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
19774572|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
19774573|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
20150943|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774574|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774575|NCT00170157|Ipilimumab|ipilimumab|mesh-list
19774576|NCT00170157|Leuprolide|leuprolide|mesh-list
19774577|NCT00170157|Goserelin|goserelin|mesh-list
19774578|NCT00170157|Bicalutamide|bicalutamide|mesh-list
19774579|NCT00170157|Flutamide|flutamide|mesh-list
19774580|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19774581|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774582|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19774583|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774584|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19774585|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
19774586|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19774587|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774588|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774589|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
19774590|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
19774591|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774592|NCT00170625|Topotecan|topotecan|mesh-list
19774593|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19774594|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19774595|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774596|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774597|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774598|NCT00170846|Everolimus|everolimus|mesh-list
19774599|NCT00170846|Azathioprine|azathioprine|mesh-list
19774600|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19774601|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774602|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774603|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
19774604|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774605|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774606|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774607|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
19774608|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19774609|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774610|NCT00170950|Amlodipine|amlodipine|mesh-list
19774611|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19774612|NCT00170950|Benazepril|benazepril|mesh-list
19774613|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19774614|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19774615|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774616|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774617|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19774618|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774619|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
19774620|NCT00170950|Diuretics|diuretics|mesh-ancestor
19774621|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
19774622|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19774623|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19774624|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
19774625|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774626|NCT00171054|Amlodipine|amlodipine|mesh-list
19774627|NCT00171054|Valsartan|valsartan|mesh-list
19774628|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19774629|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19774630|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19774631|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774632|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774633|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19774634|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774635|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317655|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20317656|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
20317657|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20150944|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20150945|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20150946|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20150947|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20150948|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150949|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150950|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20150951|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774636|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19774637|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19774638|NCT00171054|Diuretics|diuretics|mesh-ancestor
19774639|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
19774640|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19774641|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
19774642|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774643|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19774644|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774645|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774646|NCT00171210|Deferasirox|deferasirox|mesh-list
19774647|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19774648|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
19774649|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
19774650|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774651|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
19774652|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774653|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19774654|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774655|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774656|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
19774657|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774658|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19774659|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774660|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774661|NCT00171301|Deferasirox|deferasirox|mesh-list
19774662|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19774663|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
19774664|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
19774665|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774666|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
19774667|NCT00171314|Letrozole|letrozole|mesh-list
19774668|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774669|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19774670|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19774671|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774672|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774673|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19774674|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
19774675|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774676|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774677|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19774678|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
19774679|NCT00171340|Letrozole|letrozole|mesh-list
19774680|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774681|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19774682|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19774683|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774684|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774685|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19774686|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
19774687|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774688|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774689|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19774690|NCT00171704|Tamoxifen|tamoxifen|mesh-list
19774691|NCT00171704|Letrozole|letrozole|mesh-list
19774692|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774693|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19774694|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19774695|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317658|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317659|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
20317660|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20317661|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317662|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317663|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20317664|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20317665|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20317666|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20317667|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20317668|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20611086|NCT02176148|Hormones|hormones|mesh-ancestor
19774696|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774697|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19774698|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
19774699|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774700|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774701|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774702|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19774703|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20317669|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20317670|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20317671|NCT00711854|Renal Agents|renal agents|mesh-ancestor
20317672|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
20317673|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20317674|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20317675|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20317676|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20317677|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20317678|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20317679|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
20317680|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
20317681|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20317682|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20317683|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
20317684|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20317685|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20317686|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317687|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20317688|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317689|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611087|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611088|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774704|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19774705|NCT00171730|Pasireotide|pasireotide|mesh-list
19774706|NCT00171730|Hormones|hormones|mesh-ancestor
19774707|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774708|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774709|NCT00171834|Epothilones|epothilones|mesh-list
19774710|NCT00171834|Epothilone B|epothilone b|mesh-list
19774711|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
19774712|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
19774713|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
19774714|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774715|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774716|NCT00171873|Octreotide|octreotide|mesh-list
19774717|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774718|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774719|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774720|NCT00171925|Vitamin D|vitamin d|mesh-list
19774721|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
19774722|NCT00171925|Calcium|calcium|mesh-list
19774723|NCT00171925|Vitamins|vitamins|mesh-ancestor
19774724|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
19774725|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636295|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636296|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636297|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19636298|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19636299|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636300|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
19636301|NCT02423915|Antiviral Agents|antiviral agents|mesh-ancestor
19636302|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636303|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19636304|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19636305|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
19636306|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19774726|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19774727|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20611089|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20611090|NCT02166463|Prednisone|prednisone|mesh-list
19774728|NCT00171951|Pasireotide|pasireotide|mesh-list
19774729|NCT00171951|Hormones|hormones|mesh-ancestor
19774730|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774731|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774732|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
19774733|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19774734|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774735|NCT00172185|Teduglutide|teduglutide|mesh-list
19774736|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774737|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19774738|NCT00172185|Protective Agents|protective agents|mesh-ancestor
19774739|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774740|NCT00174382|Donepezil|donepezil|mesh-list
19774741|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20317690|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20317691|NCT00711906|Renal Agents|renal agents|mesh-ancestor
20317692|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20317693|NCT00711919|Pitavastatin|pitavastatin|mesh-list
20317694|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20317695|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20317696|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20317697|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
19774742|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774743|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774744|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774745|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774746|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774747|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
19774748|NCT00174447|Ziprasidone|ziprasidone|mesh-list
19774749|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19774750|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
19774751|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774752|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774753|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774754|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19774755|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19774756|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19774757|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774758|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19774759|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
19774760|NCT00174785|Dronedarone|dronedarone|mesh-list
19774761|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19774762|NCT00174915|Allopurinol|allopurinol|mesh-list
19774763|NCT00174915|Febuxostat|febuxostat|mesh-list
19774764|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
19774765|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774766|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774767|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
19774768|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774769|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19774770|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
19774771|NCT00174915|Protective Agents|protective agents|mesh-ancestor
19774772|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774773|NCT00174941|Febuxostat|febuxostat|mesh-list
19774774|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
19774775|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774776|NCT00174967|Febuxostat|febuxostat|mesh-list
19774777|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
19774778|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20317698|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317699|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317700|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19774779|NCT00175019|Allopurinol|allopurinol|mesh-list
19774780|NCT00175019|Febuxostat|febuxostat|mesh-list
19774781|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
19774782|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774783|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774784|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
19774785|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774786|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19774787|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
20317701|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
20317702|NCT00712049|Niacin|niacin|mesh-list
20611091|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
19774788|NCT00175019|Protective Agents|protective agents|mesh-ancestor
19774789|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774790|NCT00175825|Brivaracetam|brivaracetam|mesh-list
19774791|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
19774792|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
19774793|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774794|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
19774795|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774796|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774797|NCT00175916|Brivaracetam|brivaracetam|mesh-list
19774798|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
19774799|NCT00176202|Valproic Acid|valproic acid|mesh-list
19774800|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
19774801|NCT00176202|Risperidone|risperidone|mesh-list
19774802|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
19774803|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19774804|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
19774805|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774806|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774807|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774808|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19774809|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19774810|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774811|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19774812|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
19774813|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774814|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
19774815|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
19774816|NCT00176228|Lamotrigine|lamotrigine|mesh-list
19774817|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
19774818|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19774819|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19774820|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774821|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19774822|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774823|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19774824|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19774825|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19774826|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19774827|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19774828|NCT00176254|Paclitaxel|paclitaxel|mesh-list
19774829|NCT00176254|Carboplatin|carboplatin|mesh-list
19774830|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19774831|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774832|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
19774833|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
19774834|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
19774835|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774836|NCT00176306|Levofloxacin|levofloxacin|mesh-list
19774837|NCT00176306|Ofloxacin|ofloxacin|mesh-list
19774838|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19774839|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774840|NCT00176306|Renal Agents|renal agents|mesh-ancestor
19774841|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19774842|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19774843|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19774844|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774845|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774846|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774847|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19774848|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19774849|NCT00176423|Galantamine|galantamine|mesh-list
19774850|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20150952|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150953|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150954|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150955|NCT00087282|Irinotecan|irinotecan|mesh-list
20317703|NCT00712049|Niacinamide|niacinamide|mesh-list
20317704|NCT00712049|Simvastatin|simvastatin|mesh-list
20317705|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20150956|NCT00087282|Alvocidib|alvocidib|mesh-list
20150957|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20150958|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20150959|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150960|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317706|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19774851|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774852|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317707|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
19774853|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
19774854|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19774855|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774856|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19774857|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
19774858|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774859|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
19774860|NCT00176462|Leucovorin|leucovorin|mesh-list
19774861|NCT00176462|Cytarabine|cytarabine|mesh-list
19774862|NCT00176462|Dexamethasone|dexamethasone|mesh-list
19774863|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
19774864|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
19774865|NCT00176462|Methotrexate|methotrexate|mesh-list
19774866|NCT00176462|Vincristine|vincristine|mesh-list
19774867|NCT00176462|Asparaginase|asparaginase|mesh-list
19774868|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
19774869|NCT00176462|Thioguanine|thioguanine|mesh-list
19774870|NCT00176462|Daunorubicin|daunorubicin|mesh-list
19774871|NCT00176462|Aminopterin|aminopterin|mesh-list
19774872|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774873|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
20317708|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317709|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20317710|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20317711|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317712|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
20317713|NCT00712049|Vitamins|vitamins|mesh-ancestor
19636307|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636308|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
19636309|NCT02424045|Dexamethasone|dexamethasone|mesh-list
19636310|NCT02424045|Carboplatin|carboplatin|mesh-list
19636311|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19636312|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636313|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
19636314|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
19636315|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636316|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636317|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636318|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
19774874|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774875|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774876|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774877|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
19774878|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774879|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774880|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19774881|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19774882|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
19774883|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
19774884|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19774885|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19774886|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
19774887|NCT00176462|Hormones|hormones|mesh-ancestor
19774888|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774889|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19774890|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19774891|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
19774892|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19774893|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19774894|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
19774895|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
19774896|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774897|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19774898|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19774899|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
19774900|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774901|NCT00176462|Antidotes|antidotes|mesh-ancestor
19774902|NCT00176462|Protective Agents|protective agents|mesh-ancestor
19774903|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
19774904|NCT00176462|Vitamins|vitamins|mesh-ancestor
19774905|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
19774906|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19774907|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611092|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19636319|NCT02424045|Hormones|hormones|mesh-ancestor
19774908|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
19774909|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
19774910|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19774911|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19774912|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19774913|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
19774914|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
19774915|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
19774916|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19774917|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
19774918|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774919|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774920|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774921|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
19774922|NCT00176605|Etoposide|etoposide|mesh-list
19774923|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636320|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636321|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19636322|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636323|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19636324|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
19636325|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636326|NCT02423837|Rituximab|rituximab|mesh-list
19636327|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19636328|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19636329|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636330|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
19636331|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774924|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
19774925|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774926|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774927|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774928|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
19774929|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774930|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774931|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19774932|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19774933|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19774934|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19774935|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774936|NCT00176644|Estradiol|estradiol|mesh-list
19774937|NCT00176644|Estrogens|estrogens|mesh-ancestor
19774938|NCT00176644|Hormones|hormones|mesh-ancestor
19774939|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19774940|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774941|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19774942|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
19774943|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
19774944|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774945|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19774946|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19774947|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19774948|NCT00176800|Growth Substances|growth substances|mesh-ancestor
19774949|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774950|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19774951|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774952|NCT00176826|Busulfan|busulfan|mesh-list
19774953|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
19774954|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774955|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774956|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
19774957|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774958|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774959|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774960|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19774961|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
19774962|NCT00176839|Melphalan|melphalan|mesh-list
19774963|NCT00176839|Busulfan|busulfan|mesh-list
19774964|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19774965|NCT00176839|Sargramostim|sargramostim|mesh-list
20150961|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150962|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
20150963|NCT00087282|Growth Substances|growth substances|mesh-ancestor
20150964|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150965|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19636332|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774966|NCT00176839|Lenograstim|lenograstim|mesh-list
19636333|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19636334|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
19636335|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636336|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
19774967|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774968|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
19774969|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774970|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774971|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774972|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
19774973|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774974|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774975|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19774976|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19774977|NCT00176852|Vidarabine|vidarabine|mesh-list
19774978|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
19774979|NCT00176852|Busulfan|busulfan|mesh-list
19774980|NCT00176852|Fludarabine|fludarabine|mesh-list
19774981|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
19774982|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
19774983|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19774984|NCT00176852|Sargramostim|sargramostim|mesh-list
19774985|NCT00176852|Lenograstim|lenograstim|mesh-list
19774986|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19774987|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
19636337|NCT02423863|Nivolumab|nivolumab|mesh-list
19636338|NCT02423863|Durvalumab|durvalumab|mesh-list
19636339|NCT02423863|Cemiplimab|cemiplimab|mesh-list
19774988|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19774989|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19774990|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19774991|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
19774992|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19774993|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19774994|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19774995|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19774996|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
19774997|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
19636340|NCT02423863|Atezolizumab|atezolizumab|mesh-list
20317714|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
20317715|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317716|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317717|NCT00712062|Pemetrexed|pemetrexed|mesh-list
20317718|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317719|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317720|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317721|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19774998|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19774999|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19775000|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19775001|NCT00176865|Cyclosporine|cyclosporine|mesh-list
19775002|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
19775003|NCT00176865|Fludarabine|fludarabine|mesh-list
19775004|NCT00176865|Melphalan|melphalan|mesh-list
19775005|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
19775006|NCT00176865|Cyclosporins|cyclosporins|mesh-list
19775007|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19775008|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
19775009|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19775010|NCT00176865|Antibodies|antibodies|mesh-list
19775011|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
19775012|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19775013|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775014|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775015|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317722|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19636341|NCT02423863|Poly ICLC|poly iclc|mesh-list
19636342|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19775016|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
19775017|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317723|NCT00712101|Abciximab|abciximab|mesh-list
19636343|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636344|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20317724|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
19636345|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775018|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775019|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
19775020|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775021|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
19775022|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775023|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19775024|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775025|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19775026|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
19775027|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19775028|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19636346|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
19636347|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
19636348|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775029|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
19775030|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775031|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19775032|NCT00176878|Fludarabine|fludarabine|mesh-list
19775033|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
19775034|NCT00176878|Busulfan|busulfan|mesh-list
19775035|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19775036|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775037|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19775038|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
19775039|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775040|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775041|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
19775042|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775043|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
19775044|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19775045|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775046|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
19775047|NCT00176904|Busulfan|busulfan|mesh-list
19775048|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19775049|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775050|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
19775051|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775052|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775053|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19775054|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
19775055|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775056|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775057|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775058|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
19775059|NCT00176917|Busulfan|busulfan|mesh-list
19775060|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
19775061|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775062|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
19636349|NCT02423811|Fursultiamin|fursultiamin|mesh-list
19636350|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
19636351|NCT02423811|Vitamins|vitamins|mesh-ancestor
19636352|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
19636353|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636354|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
19775063|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775064|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775065|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20317725|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20317726|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19775066|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
19775067|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775068|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775069|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775070|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
19775071|NCT00176930|Busulfan|busulfan|mesh-list
19775072|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775073|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
19775074|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775075|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775076|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19775077|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
19775078|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775079|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775080|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775081|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
19636355|NCT02423759|Gentamicins|gentamicins|mesh-list
19775082|NCT00177047|Melphalan|melphalan|mesh-list
19775083|NCT00177047|Sargramostim|sargramostim|mesh-list
19775084|NCT00177047|Lenograstim|lenograstim|mesh-list
19775085|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775086|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
19775087|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775088|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775089|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19775090|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
19775091|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775092|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775093|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775094|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19775095|NCT00177164|Olanzapine|olanzapine|mesh-list
19775096|NCT00177164|Risperidone|risperidone|mesh-list
19775097|NCT00177164|Aripiprazole|aripiprazole|mesh-list
19775098|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19775099|NCT00177164|Ziprasidone|ziprasidone|mesh-list
19775100|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
19775101|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19775102|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
19775103|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775104|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775105|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775106|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775107|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775108|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775109|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19775110|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
19775111|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
19775112|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
19775113|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775114|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19775115|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775116|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775117|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775118|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775119|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
19775120|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19775121|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19775122|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19775123|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19775124|NCT00177216|Zolpidem|zolpidem|mesh-list
19775125|NCT00177216|Citalopram|citalopram|mesh-list
19775126|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775127|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775128|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775129|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775130|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775131|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
19775132|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775133|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19775134|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775135|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775136|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19775137|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19775138|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775139|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19775140|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
19775141|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
19775142|NCT00177255|Docetaxel|docetaxel|mesh-list
19775143|NCT00177255|Capecitabine|capecitabine|mesh-list
20317727|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20317728|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
20317729|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317730|NCT00712140|Trastuzumab|trastuzumab|mesh-list
19775144|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775145|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775146|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775147|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775148|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775149|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19775150|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
19775151|NCT00177294|Citalopram|citalopram|mesh-list
20317731|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20317732|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775152|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775153|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775154|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775155|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775156|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775157|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
19775158|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775159|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19775160|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775161|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775162|NCT00177307|Bevacizumab|bevacizumab|mesh-list
19775163|NCT00177307|Capecitabine|capecitabine|mesh-list
19775164|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
19775165|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19775166|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775167|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19775168|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19775169|NCT00177307|Growth Substances|growth substances|mesh-ancestor
19636356|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19636357|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636358|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19636359|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19636360|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636361|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636362|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636363|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19636364|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20150966|NCT00087295|Romidepsin|romidepsin|mesh-list
20150967|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20150968|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150969|NCT00087334|Capecitabine|capecitabine|mesh-list
20150970|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
20317733|NCT00712205|Calcitriol|calcitriol|mesh-list
20317734|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20317735|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317736|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20317737|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19636365|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19636366|NCT02423694|Dexetimide|dexetimide|mesh-list
19775170|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775171|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
19775172|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19775173|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
19775174|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775175|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19775176|NCT00177671|Donepezil|donepezil|mesh-list
19775177|NCT00177671|Citalopram|citalopram|mesh-list
19775178|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19775179|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775180|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775181|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775182|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775183|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775184|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
19775185|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775186|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19775187|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775188|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775189|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775190|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
19775191|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19775192|NCT00177671|Analgesics|analgesics|mesh-ancestor
20150971|NCT00087334|Gefitinib|gefitinib|mesh-list
20150972|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20150973|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
20150974|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150975|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20150976|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20150977|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20150978|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20150979|NCT00087347|Hematinics|hematinics|mesh-ancestor
20150980|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20150981|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20150982|NCT00087373|Metronidazole|metronidazole|mesh-list
19775193|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
19775194|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
19775195|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19775196|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775197|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
19775198|NCT00178178|Bupivacaine|bupivacaine|mesh-list
19775199|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
19775200|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
19775201|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775202|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775203|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
19775204|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775205|NCT00178256|Paclitaxel|paclitaxel|mesh-list
19775206|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19775207|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775208|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775209|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775210|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775211|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775212|NCT00178464|Aspirin|aspirin|mesh-list
19775213|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19775214|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19775215|NCT00178464|Analgesics|analgesics|mesh-ancestor
19775216|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
19775217|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775218|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775219|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19775220|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775221|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19775222|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19775223|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775224|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19775225|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19775226|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775227|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
19775228|NCT00178503|Methylphenidate|methylphenidate|mesh-list
19775229|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19775230|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775231|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19775232|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775233|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775234|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775235|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
20150983|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20150984|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20150985|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19775236|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775237|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
19775238|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19775239|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19775240|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19775241|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775242|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775243|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
19775244|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775245|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775246|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19775247|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775248|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
19775249|NCT00178841|Bexarotene|bexarotene|mesh-list
19775250|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19775251|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775252|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775253|NCT00178919|Trimethaphan|trimethaphan|mesh-list
19775254|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
19775255|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775256|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19775257|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19775258|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19775259|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
19775260|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775261|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150986|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19775262|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19775263|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19775264|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
19775265|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775266|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
19775267|NCT00179010|Adenosine|adenosine|mesh-list
19775268|NCT00179010|Analgesics|analgesics|mesh-ancestor
19775269|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
19775270|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775271|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775272|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19775273|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
19775274|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19775275|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
19775276|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
19775277|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775278|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775279|NCT00179309|Docetaxel|docetaxel|mesh-list
19775280|NCT00179309|Sargramostim|sargramostim|mesh-list
19775281|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775282|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775283|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775284|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775285|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775286|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
19775287|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775288|NCT00179413|Interferons|interferons|mesh-list
19775289|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
19775290|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
19775291|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19775292|NCT00179413|Colchicine|colchicine|mesh-list
19775293|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775294|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
19775295|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775296|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
19775297|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775298|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
19775299|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775300|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775301|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775302|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775303|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775304|NCT00179478|Interferons|interferons|mesh-list
19775305|NCT00179478|Interferon-beta|interferon-beta|mesh-list
19775306|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
19775307|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775308|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
19775309|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775310|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
19775311|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775312|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19775313|NCT00179517|Anastrozole|anastrozole|mesh-list
19775314|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19775315|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775316|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19775317|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19775318|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775319|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775320|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19775321|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
19775322|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19775323|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775324|NCT00179621|Lenalidomide|lenalidomide|mesh-list
19775325|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
20150987|NCT00087399|Gabapentin|gabapentin|mesh-list
20150988|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
20150989|NCT00087399|Analgesics|analgesics|mesh-ancestor
20150990|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
20150991|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20150992|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150993|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
20150994|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20150995|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775326|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20150996|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775327|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19833418|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
19775328|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19775329|NCT00179621|Growth Substances|growth substances|mesh-ancestor
19775330|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
19775331|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775332|NCT00179647|Dexamethasone|dexamethasone|mesh-list
19775333|NCT00179647|Lenalidomide|lenalidomide|mesh-list
19775334|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19775335|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
19775336|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
19775337|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775338|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775339|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19775340|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
19775341|NCT00179647|Hormones|hormones|mesh-ancestor
19775342|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19775343|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19775344|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775345|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
19775346|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19775347|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19775348|NCT00179647|Growth Substances|growth substances|mesh-ancestor
19775349|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
19775350|NCT00179660|Lenalidomide|lenalidomide|mesh-list
19775351|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
19775352|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775353|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19775354|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19775355|NCT00179660|Growth Substances|growth substances|mesh-ancestor
19775356|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
19775357|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775358|NCT00179673|Lenalidomide|lenalidomide|mesh-list
19775359|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
19775360|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775361|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19775362|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19775363|NCT00179673|Growth Substances|growth substances|mesh-ancestor
19775364|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19775365|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317738|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317739|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20317740|NCT00712205|Vitamins|vitamins|mesh-ancestor
20317741|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
20317742|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20317743|NCT00712257|Heparin|heparin|mesh-list
20317744|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
20317745|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20317746|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20317747|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775366|NCT00179959|Mupirocin|mupirocin|mesh-list
19775367|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19775368|NCT00179959|Eusol|eusol|mesh-list
19775369|NCT00179959|Petrolatum|petrolatum|mesh-list
19775370|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19775371|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775372|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19775373|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775374|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20150997|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20150998|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20150999|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20151000|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151001|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151002|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
20151003|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20151004|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151005|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151006|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151007|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151008|NCT00087425|Rituximab|rituximab|mesh-list
20151009|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
20151010|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20151011|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151012|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
20151013|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317748|NCT00712322|Darifenacin|darifenacin|mesh-list
19636367|NCT02423694|Citalopram|citalopram|mesh-list
19636368|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19636369|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19636370|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19636371|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636372|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636373|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
19636374|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636375|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19636376|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
19636377|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636378|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19775375|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
19775376|NCT00179959|Emollients|emollients|mesh-ancestor
19775377|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
19775378|NCT00180479|Paclitaxel|paclitaxel|mesh-list
19775379|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19775380|NCT00180479|Everolimus|everolimus|mesh-list
19775381|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19775382|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775383|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775384|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775385|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775386|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775387|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151014|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151015|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20151016|NCT00087451|Sirolimus|sirolimus|mesh-list
19775388|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
19775389|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775390|NCT00180674|Warfarin|warfarin|mesh-list
19775391|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
19833419|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19833420|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19833421|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
19833422|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
19833423|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
19833424|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
19833425|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19833426|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19833427|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
19833428|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
19833429|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19833430|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
19833431|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151017|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151018|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151019|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20151020|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151021|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
20151022|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611093|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20611094|NCT02166463|Prednisolone|prednisolone|mesh-list
20611095|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
20151023|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
20151024|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151025|NCT00087464|Tenofovir|tenofovir|mesh-list
20151026|NCT00087464|Emtricitabine|emtricitabine|mesh-list
20151027|NCT00087464|Nevirapine|nevirapine|mesh-list
20151028|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
20151029|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151030|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20151031|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20151032|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151033|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151034|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20151035|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20151036|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20151037|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20151038|NCT00087542|Pimavanserin|pimavanserin|mesh-list
20151039|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20151040|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19833432|NCT00588237|Paclitaxel|paclitaxel|mesh-list
19636379|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19833433|NCT00588237|Bevacizumab|bevacizumab|mesh-list
20611096|NCT02166463|Cortisone|cortisone|mesh-list
20151041|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151042|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151043|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151044|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151045|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151046|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20151047|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20151048|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
20151049|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151050|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775392|NCT00180687|Bupivacaine|bupivacaine|mesh-list
19775393|NCT00180687|Coal Tar|coal tar|mesh-list
19775394|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
19775395|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
19775396|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775397|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775398|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
19775399|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775400|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
19775401|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
19775402|NCT00180713|Simvastatin|simvastatin|mesh-list
19775403|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19775404|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19775405|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
19775406|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775407|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19775408|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19775409|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775410|NCT00181155|Allopurinol|allopurinol|mesh-list
19775411|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
19775412|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775413|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775414|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
19775415|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775416|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19775417|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
19775418|NCT00181155|Protective Agents|protective agents|mesh-ancestor
19775419|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775420|NCT00181714|Methylphenidate|methylphenidate|mesh-list
19775421|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19775422|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775423|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19775424|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775425|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775426|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775427|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
19775428|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775429|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19775430|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19775431|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775432|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775433|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775434|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
19775435|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775436|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775437|NCT00181844|Lamotrigine|lamotrigine|mesh-list
19775438|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
19775439|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19775440|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775441|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775442|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19775443|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775444|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19775445|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775446|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775447|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151051|NCT00087581|Cyclosporine|cyclosporine|mesh-list
20151052|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
20151053|NCT00087581|Tacrolimus|tacrolimus|mesh-list
20151054|NCT00087581|Cyclosporins|cyclosporins|mesh-list
20151055|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317749|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20317750|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19775448|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19775449|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19775450|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775451|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775452|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19775453|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775454|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775455|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775456|NCT00182000|Cycloserine|cycloserine|mesh-list
19775457|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19775458|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775459|NCT00182000|Renal Agents|renal agents|mesh-ancestor
19775460|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19775461|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
19775462|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19775463|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
19775464|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775465|NCT00182078|Sertraline|sertraline|mesh-list
19775466|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775467|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775468|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775469|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775470|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775471|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775472|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775473|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
19775474|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775475|NCT00182091|Hormones|hormones|mesh-list
19775476|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19775477|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775478|NCT00182689|Sorafenib|sorafenib|mesh-list
19775479|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775480|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19775481|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775482|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775483|NCT00182754|Octreotide|octreotide|mesh-list
19775484|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19775485|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19775486|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775487|NCT00182767|Doxorubicin|doxorubicin|mesh-list
19775488|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19775489|NCT00182767|Epothilone B|epothilone b|mesh-list
19775490|NCT00182767|Epothilones|epothilones|mesh-list
19775491|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775492|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775493|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19775494|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19775495|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775496|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775497|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775498|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775499|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775500|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
19775501|NCT00182793|Melphalan|melphalan|mesh-list
19775502|NCT00182793|Thiotepa|thiotepa|mesh-list
19775503|NCT00182793|Carboplatin|carboplatin|mesh-list
19775504|NCT00182793|Trastuzumab|trastuzumab|mesh-list
19775505|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775506|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
19775507|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775508|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775509|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19775510|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
19775511|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775512|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775513|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775514|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19775515|NCT00183092|Quinacrine|quinacrine|mesh-list
19775516|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
19775517|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19775518|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
19775519|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19775520|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775521|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
19775522|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19775523|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
19775524|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775525|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775526|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775527|NCT00183196|Naltrexone|naltrexone|mesh-list
19775528|NCT00183196|Gabapentin|gabapentin|mesh-list
19775529|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19775530|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19775531|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775532|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
19775533|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775534|NCT00183196|Analgesics|analgesics|mesh-ancestor
19775535|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
19775536|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19775537|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775538|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775539|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775540|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19775541|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19775542|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775543|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775544|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
19775545|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
19775546|NCT00183248|Sirolimus|sirolimus|mesh-list
19775547|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
19775548|NCT00183248|Tacrolimus|tacrolimus|mesh-list
19775549|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775550|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
19775551|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775552|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20151056|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
20151057|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151058|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20151059|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151060|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151061|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
20151062|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317751|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
20317752|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317753|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317754|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317755|NCT00712322|Urological Agents|urological agents|mesh-ancestor
19775553|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775554|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775555|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775556|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775557|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20151063|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151064|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151065|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775558|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
20151066|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151067|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20151068|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
19775559|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19775560|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775561|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
19775562|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19775563|NCT00183274|Norepinephrine|norepinephrine|mesh-list
19775564|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19775565|NCT00183274|Serotonin|serotonin|mesh-list
19775566|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
19775567|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19775568|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19775569|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
19775570|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775571|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151069|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151070|NCT00087620|Capecitabine|capecitabine|mesh-list
20151071|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151072|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
20151073|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317756|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
20317757|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
19775572|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775573|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
19775574|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
19775575|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775576|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19775577|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775578|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775579|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19775580|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775581|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775582|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19775583|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
19775584|NCT00183339|Fluoxetine|fluoxetine|mesh-list
19775585|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775586|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775587|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775588|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775589|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775590|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
19775591|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775592|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19775593|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775594|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151074|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151075|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
20151076|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20151077|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151078|NCT00087711|Gemcitabine|gemcitabine|mesh-list
20151079|NCT00087711|Pemetrexed|pemetrexed|mesh-list
20151080|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151081|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151082|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
20151083|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317758|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19775595|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19775596|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19775597|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775598|NCT00183391|Methylphenidate|methylphenidate|mesh-list
19775599|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19775600|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19775601|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775602|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19775603|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775604|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775605|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775606|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
19775607|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775608|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19775609|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
19775610|NCT00183430|Prazosin|prazosin|mesh-list
19775611|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19775612|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19775613|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19775614|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19775615|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19775616|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775617|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775618|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775619|NCT00183443|Valproic Acid|valproic acid|mesh-list
19775620|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19775621|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775622|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775623|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19775624|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775625|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775626|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775627|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775628|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775629|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
19775630|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
20151084|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
19636380|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
19636381|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
19775631|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
19775632|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775633|NCT00183469|Lamotrigine|lamotrigine|mesh-list
19775634|NCT00183469|Valproic Acid|valproic acid|mesh-list
19775635|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
19775636|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19775637|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775638|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775639|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19775640|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775641|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19775642|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775643|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775644|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775645|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19775646|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636382|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636383|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19636384|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19636385|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
19636386|NCT02423590|Gemcitabine|gemcitabine|mesh-list
19636387|NCT02423590|Carboplatin|carboplatin|mesh-list
19636388|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636389|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636390|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
19636391|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636392|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
19636393|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636394|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636395|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775647|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
19775648|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775649|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
19775650|NCT00183625|Olanzapine|olanzapine|mesh-list
19775651|NCT00183625|Risperidone|risperidone|mesh-list
19775652|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19775653|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
19775654|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775655|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775656|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775657|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19775658|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775659|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775660|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775661|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19775662|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
19775663|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
20151085|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151086|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636396|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
19636397|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636398|NCT02423642|Heparin|heparin|mesh-list
19636399|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
19636400|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636401|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19775664|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
20151087|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151088|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
20151089|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151090|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20151091|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20151092|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20151093|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20151094|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20317759|NCT00712374|Amodiaquine|amodiaquine|mesh-list
19636402|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19636403|NCT02423603|Paclitaxel|paclitaxel|mesh-list
19636404|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19636405|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636406|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
19636407|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
19636408|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
19636409|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662276|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19662277|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
19662278|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
19775665|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775666|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19775667|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775668|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775669|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775670|NCT00183677|Citalopram|citalopram|mesh-list
19775671|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775672|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775673|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775674|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775675|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775676|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
19775677|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775678|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19775679|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775680|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775681|NCT00183729|Memantine|memantine|mesh-list
19775682|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19775683|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19775684|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
19775685|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775686|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775687|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775688|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19775689|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19775690|NCT00183794|Gemcitabine|gemcitabine|mesh-list
19775691|NCT00183794|Docetaxel|docetaxel|mesh-list
19775692|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19775693|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
19775694|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775695|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775696|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
19775697|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775698|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775699|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775700|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
19662279|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19775701|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775702|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775703|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775704|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775705|NCT00183872|Docetaxel|docetaxel|mesh-list
19775706|NCT00183872|Irinotecan|irinotecan|mesh-list
19775707|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775708|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775709|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775710|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775711|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775712|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19775713|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19775714|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775715|NCT00184002|Prednisone|prednisone|mesh-list
19775716|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
19775717|NCT00184002|Doxorubicin|doxorubicin|mesh-list
19662280|NCT02952222|Analgesics|analgesics|mesh-ancestor
19662281|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
19662282|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662283|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19662284|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19662285|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19662286|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
19662287|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775718|NCT00184002|Vincristine|vincristine|mesh-list
19775719|NCT00184002|Rituximab|rituximab|mesh-list
19775720|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775721|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
19775722|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775723|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775724|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19775725|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
19775726|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775727|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775728|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19636410|NCT02423824|Liraglutide|liraglutide|mesh-list
19636411|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19636412|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636413|NCT02423824|Incretins|incretins|mesh-ancestor
19636414|NCT02423824|Hormones|hormones|mesh-ancestor
19636415|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636416|NCT02423395|Orphenadrine|orphenadrine|mesh-list
19636417|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636418|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19636419|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19636420|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19636421|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19636422|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775729|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775730|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20317760|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
20317761|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20317762|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20317763|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317764|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20317765|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775731|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19775732|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775733|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19775734|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
19775735|NCT00184002|Hormones|hormones|mesh-ancestor
19775736|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19775737|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19775738|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19775739|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775740|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775741|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775742|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19775743|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
19775744|NCT00184028|Docetaxel|docetaxel|mesh-list
19775745|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775746|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
19775747|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
19775748|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
19775749|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775750|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
19775751|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
19775752|NCT00184054|Vitamins|vitamins|mesh-ancestor
19775753|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
19775754|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775755|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
19775756|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775757|NCT00184054|Protective Agents|protective agents|mesh-ancestor
19775758|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775759|NCT00184093|Gemcitabine|gemcitabine|mesh-list
19775760|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19775761|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
19775762|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775763|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775764|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
19775765|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775766|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775767|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775768|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
19775769|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775770|NCT00184600|Insulin|insulin|mesh-list
19775771|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19636423|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
19636424|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
19775772|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
19775773|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
20347404|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20317766|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317767|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20317768|NCT00712374|Renal Agents|renal agents|mesh-ancestor
20317769|NCT00712400|Latanoprost|latanoprost|mesh-list
20317770|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20317771|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20317772|NCT00712439|Gabapentin|gabapentin|mesh-list
20317773|NCT00712439|Analgesics|analgesics|mesh-ancestor
20317774|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
19775774|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19775775|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
19775776|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
19775777|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19775778|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775779|NCT00185211|Interferons|interferons|mesh-list
19775780|NCT00185211|Interferon-beta|interferon-beta|mesh-list
19775781|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
19775782|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775783|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
19775784|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775785|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
19775786|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775787|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19775788|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
19775789|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19775790|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
19775791|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19775792|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775793|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19775794|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19775795|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19775796|NCT00185588|Gemcitabine|gemcitabine|mesh-list
19775797|NCT00185588|Vatalanib|vatalanib|mesh-list
19775798|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19775799|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
19775800|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775801|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775802|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
19775803|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775804|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775805|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775806|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
19775807|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151095|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20151096|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151097|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775808|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19775809|NCT00185614|Cyclosporine|cyclosporine|mesh-list
19775810|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
19775811|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
19775812|NCT00185614|Melphalan|melphalan|mesh-list
19775813|NCT00185614|Cyclosporins|cyclosporins|mesh-list
19775814|NCT00185614|Lenograstim|lenograstim|mesh-list
19775815|NCT00185614|Sargramostim|sargramostim|mesh-list
19775816|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775817|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
19775818|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775819|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775820|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19775821|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
19775822|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775823|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775824|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19775825|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19775826|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151098|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151099|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20151100|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151101|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151102|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20317775|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775827|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
20611097|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
19775828|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775829|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
19775830|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19775831|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775832|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20317776|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317777|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
20317778|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20317779|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20317780|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317781|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20317782|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20317783|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20317784|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317785|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317786|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
20317787|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
20317788|NCT00712452|Vinblastine|vinblastine|mesh-list
20317789|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317790|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
20317791|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317792|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20317793|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20317794|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
20317795|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775833|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
19775834|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611098|NCT02166463|Doxorubicin|doxorubicin|mesh-list
20611099|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20611100|NCT02166463|Etoposide|etoposide|mesh-list
20611101|NCT02166463|Vincristine|vincristine|mesh-list
19775835|NCT00185640|Cyclosporine|cyclosporine|mesh-list
20317796|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317797|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20317798|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20317799|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
20317800|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
20317801|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
20317802|NCT00712465|Digoxin|digoxin|mesh-list
20317803|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19775836|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
19775837|NCT00185640|Lenograstim|lenograstim|mesh-list
19775838|NCT00185640|Cyclosporins|cyclosporins|mesh-list
19775839|NCT00185640|Sargramostim|sargramostim|mesh-list
19775840|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
19775841|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19775842|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19775843|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
19775844|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775845|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775846|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775847|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775848|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
19775849|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20317804|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20317805|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317806|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317807|NCT00712465|Protective Agents|protective agents|mesh-ancestor
20317808|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317809|NCT00712478|Insulin|insulin|mesh-list
20317810|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20317811|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317812|NCT00712491|Sirolimus|sirolimus|mesh-list
20611102|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
19775850|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
19775851|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775852|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19775853|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775854|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775855|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20611103|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20611104|NCT02166463|Bleomycin|bleomycin|mesh-list
20611105|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
19775856|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
19775857|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19775858|NCT00185692|Acetaminophen|acetaminophen|mesh-list
19775859|NCT00185692|Cyclosporine|cyclosporine|mesh-list
20317813|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20317814|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611106|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19636425|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19636426|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19775860|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
19775861|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
19636427|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
19636428|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636429|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636430|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
19636431|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19636432|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775862|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19775863|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19775864|NCT00185692|Prednisolone|prednisolone|mesh-list
19775865|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
19775866|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
19775867|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19775868|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19775869|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19775870|NCT00185692|Cyclosporins|cyclosporins|mesh-list
19775871|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19775872|NCT00185692|Lenograstim|lenograstim|mesh-list
19775873|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19775874|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
19775875|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775876|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775877|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19775878|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
19775879|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775880|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
19775881|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19775882|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
19775883|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19775884|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19775885|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19775886|NCT00185692|Analgesics|analgesics|mesh-ancestor
19775887|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
19775888|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775889|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
19775890|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19775891|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19775892|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19775893|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
19775894|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19775895|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636433|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
19636434|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636435|NCT02423265|Ranolazine|ranolazine|mesh-list
19636436|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19636437|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19636438|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775896|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
19775897|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
20151103|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151104|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151105|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19636439|NCT02423239|Gemcitabine|gemcitabine|mesh-list
19636440|NCT02423239|Paclitaxel|paclitaxel|mesh-list
19636441|NCT02423239|Sorafenib|sorafenib|mesh-list
19636442|NCT02423239|HU 211|hu 211|mesh-list
19636443|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19636444|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636445|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
19636446|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
19636447|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
19636448|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775898|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19775899|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
20151106|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151107|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151108|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151109|NCT00087802|Gemcitabine|gemcitabine|mesh-list
20151110|NCT00087802|Paclitaxel|paclitaxel|mesh-list
20611107|NCT02166463|Antibodies|antibodies|mesh-list
19775900|NCT00185692|Hormones|hormones|mesh-ancestor
19775901|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151111|NCT00087802|Carboplatin|carboplatin|mesh-list
20611108|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
19775902|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19775903|NCT00185692|Protective Agents|protective agents|mesh-ancestor
19775904|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19775905|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19775906|NCT00185731|Atorvastatin|atorvastatin|mesh-list
19775907|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19775908|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19775909|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
19775910|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775911|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19775912|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19775913|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775914|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
19775915|NCT00185900|Nifedipine|nifedipine|mesh-list
19775916|NCT00185900|Analgesics|analgesics|mesh-ancestor
19775917|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
19775918|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775919|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775920|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
19775921|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775922|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19775923|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
19775924|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19775925|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775926|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775927|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19775928|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
19775929|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19775930|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
19775931|NCT00186017|Olanzapine|olanzapine|mesh-list
19775932|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
19775933|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
20611109|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20611110|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
20317815|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20317816|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317817|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
20317818|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317819|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
20317820|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317821|NCT00712504|Docetaxel|docetaxel|mesh-list
20317822|NCT00712504|Sunitinib|sunitinib|mesh-list
20317823|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317824|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
20317825|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
20317826|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
20317827|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611111|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19775934|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775935|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775936|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317828|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20317829|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19636449|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636450|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
19636451|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
19636452|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636453|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636454|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636455|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
19636456|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636457|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19636458|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19636459|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
19636460|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
19636461|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636462|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636463|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19636464|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19636465|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317830|NCT00712504|Growth Substances|growth substances|mesh-ancestor
20317831|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636466|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19636467|NCT02423239|Protective Agents|protective agents|mesh-ancestor
20611112|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
19775937|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19775938|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775939|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775940|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775941|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19775942|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19775943|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775944|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775945|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19775946|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
19775947|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19775948|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
19775949|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19775950|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19775951|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19775952|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775953|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775954|NCT00186056|Mifepristone|mifepristone|mesh-list
19636468|NCT02422784|Vitamin D|vitamin d|mesh-list
19636469|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
19636470|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
19636471|NCT02422784|Vitamins|vitamins|mesh-list
19636472|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
19636473|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636474|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19636475|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19636476|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
19636477|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19636478|NCT02422836|Protective Agents|protective agents|mesh-ancestor
19636479|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636480|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
19636481|NCT02422901|Ascorbic Acid|ascorbic acid|mesh-list
19636482|NCT02422901|Vitamins|vitamins|mesh-ancestor
19636483|NCT02422901|Micronutrients|micronutrients|mesh-ancestor
19636484|NCT02422901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636485|NCT02422901|Antioxidants|antioxidants|mesh-ancestor
19636486|NCT02422901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636487|NCT02422901|Protective Agents|protective agents|mesh-ancestor
19636488|NCT02422966|Acetaminophen|acetaminophen|mesh-list
19636489|NCT02422966|Ibuprofen|ibuprofen|mesh-list
19636490|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636491|NCT02422966|Analgesics|analgesics|mesh-ancestor
19636492|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
19775955|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19775956|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
19775957|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19775958|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775959|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19775960|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19775961|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19775962|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
19775963|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19775964|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19775965|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
19775966|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19775967|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
19775968|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19775969|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19775970|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
19775971|NCT00186069|Analgesics|analgesics|mesh-ancestor
19775972|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
19775973|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19775974|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317832|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
20317833|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20317834|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317835|NCT00712517|Propofol|propofol|mesh-list
20317836|NCT00712517|Sevoflurane|sevoflurane|mesh-list
19775975|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
19775976|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19775977|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20317837|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19636493|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636494|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636495|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
20317838|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317839|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317840|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20317841|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
19636496|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20317842|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
20317843|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20317844|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20317845|NCT00712556|Fluorides|fluorides|mesh-list
20317846|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
19775978|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
19775979|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19775980|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19775981|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775982|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19775983|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
19775984|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19775985|NCT00186121|Anastrozole|anastrozole|mesh-list
19775986|NCT00186121|Goserelin|goserelin|mesh-list
19775987|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19775988|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317847|NCT00712556|Protective Agents|protective agents|mesh-ancestor
20317848|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317849|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
20317850|NCT00712582|Ifosfamide|ifosfamide|mesh-list
20317851|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
20317852|NCT00712582|Carmustine|carmustine|mesh-list
20317853|NCT00712582|Rituximab|rituximab|mesh-list
20317854|NCT00712582|Carboplatin|carboplatin|mesh-list
20317855|NCT00712582|Etoposide|etoposide|mesh-list
20317856|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
20317857|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
20317858|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317859|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
20317860|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317861|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20317862|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20317863|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
20317864|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317865|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317866|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20317867|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20317868|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20317869|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20317870|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20317871|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317872|NCT00712582|Analgesics|analgesics|mesh-ancestor
19636497|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636498|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636499|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19636500|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636501|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636502|NCT02422953|Micronutrients|micronutrients|mesh-list
19636503|NCT02422953|Trace Elements|trace elements|mesh-list
19636504|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636505|NCT02422888|Ticagrelor|ticagrelor|mesh-list
19636506|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19636507|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19636508|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19636509|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19775989|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20317873|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
20317874|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317875|NCT00712595|Mifepristone|mifepristone|mesh-list
20317876|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20317877|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
20317878|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19775990|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19775991|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19775992|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19775993|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19775994|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
19775995|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19775996|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19775997|NCT00186186|Valproic Acid|valproic acid|mesh-list
19775998|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
19775999|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776000|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776001|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
19776002|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776003|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776004|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
19776005|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776006|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776007|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776008|NCT00186446|Bupropion|bupropion|mesh-list
19776009|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19776010|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
19776011|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776012|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19776013|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19776014|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776015|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776016|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
19776017|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776018|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776019|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19776020|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19776021|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776022|NCT00186498|Memantine|memantine|mesh-list
19776023|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19776024|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19776025|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
19776026|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317879|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317880|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20317881|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20317882|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20317883|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
20317884|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20317885|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19776027|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776028|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776029|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19776030|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19776031|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
19776032|NCT00186537|Fenofibrate|fenofibrate|mesh-list
19776033|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19776034|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776035|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19776036|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
19776037|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776038|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19776039|NCT00186628|Acetaminophen|acetaminophen|mesh-list
19776040|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
19776041|NCT00186628|Promethazine|promethazine|mesh-list
19776042|NCT00186628|Cyclosporine|cyclosporine|mesh-list
19776043|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
19776044|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
19776045|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19776046|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19776047|NCT00186628|Prednisolone|prednisolone|mesh-list
19776048|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
19776049|NCT00186628|Rituximab|rituximab|mesh-list
19776050|NCT00186628|Granisetron|granisetron|mesh-list
19776051|NCT00186628|Lenograstim|lenograstim|mesh-list
19776052|NCT00186628|Cyclosporins|cyclosporins|mesh-list
19776053|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
19776054|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20317886|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
20317887|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20317888|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
20317889|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20317890|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20317891|NCT00712647|Beta Carotene|beta carotene|mesh-list
20317892|NCT00712647|Vitamin A|vitamin a|mesh-list
20317893|NCT00712647|Carotenoids|carotenoids|mesh-list
20317894|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
20317895|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317896|NCT00712647|Protective Agents|protective agents|mesh-ancestor
20317897|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636510|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19636511|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
19636512|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636513|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636514|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636515|NCT02422823|Epinephrine|epinephrine|mesh-list
20317898|NCT00712647|Provitamins|provitamins|mesh-ancestor
20317899|NCT00712647|Vitamins|vitamins|mesh-ancestor
20317900|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
20317901|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
20317902|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20317903|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317904|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317905|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20317906|NCT00712686|Olanzapine|olanzapine|mesh-list
20317907|NCT00712686|Aripiprazole|aripiprazole|mesh-list
20317908|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
20317909|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
20317910|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776055|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19776056|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
19776057|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776058|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776059|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
19776060|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776061|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776062|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19776063|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317911|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317912|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20317913|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19776064|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776065|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776066|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
19776067|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776068|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
19776069|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19776070|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19776071|NCT00186628|Analgesics|analgesics|mesh-ancestor
19776072|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
19776073|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776074|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
19776075|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19776076|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
19776077|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
19776078|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19776079|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
19776080|NCT00186628|Hormones|hormones|mesh-ancestor
19776081|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19776082|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19776083|NCT00186628|Protective Agents|protective agents|mesh-ancestor
19776084|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19776085|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19776086|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19776087|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20317914|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20317915|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636516|NCT02422823|Carticaine|carticaine|mesh-list
19636517|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19776088|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
19776089|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
20317916|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636518|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20317917|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19776090|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19776091|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
19776092|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
19776093|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776094|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19776095|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
19776096|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19776097|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
19776098|NCT00186875|Cytarabine|cytarabine|mesh-list
19776099|NCT00186875|Dexamethasone|dexamethasone|mesh-list
19776100|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
19776101|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
19776102|NCT00186875|Methotrexate|methotrexate|mesh-list
19776103|NCT00186875|Etoposide|etoposide|mesh-list
19776104|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
19776105|NCT00186875|Vincristine|vincristine|mesh-list
19776106|NCT00186875|Asparaginase|asparaginase|mesh-list
19776107|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
19776108|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
19776109|NCT00186875|Vinblastine|vinblastine|mesh-list
19776110|NCT00186875|Pegaspargase|pegaspargase|mesh-list
19776111|NCT00186875|Teniposide|teniposide|mesh-list
19776112|NCT00186875|BB 1101|bb 1101|mesh-list
19776113|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776114|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
19776115|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776116|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776117|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19776118|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
19776119|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776120|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776121|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19776122|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19776123|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
19776124|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
19776125|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776126|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19776127|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
19776128|NCT00186875|Hormones|hormones|mesh-ancestor
19776129|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19776130|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19776131|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
19776132|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776133|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19776134|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
19776135|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19776136|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776137|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
19776138|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
19776139|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776140|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20151112|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
20151113|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20151114|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151115|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151116|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151117|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151118|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151119|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776141|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776142|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776143|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776144|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
19776145|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776146|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776147|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151120|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
20151121|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
20151122|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151123|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151124|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151125|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
20151126|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776148|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776149|NCT00186875|Analgesics|analgesics|mesh-ancestor
19776150|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
19776151|NCT00186901|Vitamin D|vitamin d|mesh-list
20151127|NCT00087815|Dexamethasone|dexamethasone|mesh-list
19776152|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
19776153|NCT00186901|Calcium|calcium|mesh-list
20151128|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20151129|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
20151130|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
20151131|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151132|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151133|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151134|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
20151135|NCT00087815|Hormones|hormones|mesh-ancestor
20151136|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151137|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19776154|NCT00186901|Vitamins|vitamins|mesh-ancestor
19776155|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
19776156|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776157|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19776158|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19776159|NCT00186901|Antacids|antacids|mesh-ancestor
20317918|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20317919|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776160|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776161|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19776162|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
19776163|NCT00187096|Fludarabine|fludarabine|mesh-list
19776164|NCT00187096|Etoposide|etoposide|mesh-list
19776165|NCT00187096|Interleukin-2|interleukin-2|mesh-list
19776166|NCT00187096|Clofarabine|clofarabine|mesh-list
19776167|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776168|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
19776169|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776170|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776171|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19776172|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
19776173|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776174|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776175|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19776176|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776177|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
19776178|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776179|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776180|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776181|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776182|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19776183|NCT00187096|Analgesics|analgesics|mesh-ancestor
19776184|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
19776185|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151138|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151139|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20151140|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151141|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151142|NCT00087854|Amonafide|amonafide|mesh-list
20151143|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151144|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
19776186|NCT00187135|Fentanyl|fentanyl|mesh-list
20151145|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151146|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151147|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151148|NCT00087867|Bortezomib|bortezomib|mesh-list
20151149|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151150|NCT00087880|Bupropion|bupropion|mesh-list
20151151|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20151152|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151153|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151154|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20151155|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151156|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20151157|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151158|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
20151159|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151160|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151161|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20151162|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19776187|NCT00187135|Propofol|propofol|mesh-list
19776188|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19776189|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776190|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776191|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19776192|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
19776193|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
19776194|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20317920|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611113|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611114|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
19776195|NCT00187135|Narcotics|narcotics|mesh-ancestor
19776196|NCT00187135|Analgesics|analgesics|mesh-ancestor
19776197|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
19776198|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776199|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19776200|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19776201|NCT00187486|Temozolomide|temozolomide|mesh-list
19776202|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776203|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19776204|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776205|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776206|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19776207|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
19636519|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
19636520|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20611115|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636521|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636522|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636523|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19776208|NCT00187655|Cefotaxime|cefotaxime|mesh-list
19776209|NCT00187655|Cefoxitin|cefoxitin|mesh-list
19776210|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19776211|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776212|NCT00187681|Metformin|metformin|mesh-list
19776213|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19776214|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776215|NCT00187720|Metformin|metformin|mesh-list
19776216|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19776217|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776218|NCT00187889|Eplerenone|eplerenone|mesh-list
19776219|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19776220|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
19776221|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19776222|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776223|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19776224|NCT00187889|Diuretics|diuretics|mesh-ancestor
19776225|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
19776226|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19776227|NCT00189098|Trimethoprim|trimethoprim|mesh-list
19776228|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19776229|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
20151163|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151164|NCT00087945|Lamivudine|lamivudine|mesh-list
20151165|NCT00087945|Zidovudine|zidovudine|mesh-list
20151166|NCT00087945|Abacavir|abacavir|mesh-list
20151167|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
19776230|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19776231|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776232|NCT00189098|Renal Agents|renal agents|mesh-ancestor
19776233|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
19776234|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19776235|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19776236|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776237|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776238|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151168|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20151169|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20151170|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151171|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151172|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
20151173|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151174|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19636524|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20151175|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19636525|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
19636526|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776239|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19776240|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19776241|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19776242|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19776243|NCT00189137|Gemcitabine|gemcitabine|mesh-list
19776244|NCT00189137|Docetaxel|docetaxel|mesh-list
19776245|NCT00189137|Doxorubicin|doxorubicin|mesh-list
19776246|NCT00189137|Ifosfamide|ifosfamide|mesh-list
19776247|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776248|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
19776249|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776250|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776251|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
19776252|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776253|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776254|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776255|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
19776256|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776257|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776258|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776259|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776260|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19776261|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776262|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776263|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19776264|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
19776265|NCT00189202|Sirolimus|sirolimus|mesh-list
19776266|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19776267|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776268|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19776269|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776270|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
20151176|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
20151177|NCT00088036|Olanzapine|olanzapine|mesh-list
19776271|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776272|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
19776273|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776274|NCT00189228|Omalizumab|omalizumab|mesh-list
19776275|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19776276|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19776277|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
19776278|NCT00189306|Imiquimod|imiquimod|mesh-list
19776279|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19776280|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
19776281|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776282|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776283|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
19776284|NCT00189436|Budesonide|budesonide|mesh-list
19776285|NCT00189436|Albuterol|albuterol|mesh-list
19776286|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19776287|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19776288|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
19776289|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776290|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776291|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19776292|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
19776293|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
19776294|NCT00189436|Hormones|hormones|mesh-ancestor
19776295|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19776296|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
19776297|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19776298|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19776299|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19776300|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19776301|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
19776302|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776303|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776304|NCT00189462|Montelukast|montelukast|mesh-list
19776305|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19776306|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
19776307|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19776308|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
19776309|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151178|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
20151179|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
19776310|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776311|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19776312|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19776313|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776314|NCT00189475|Montelukast|montelukast|mesh-list
19776315|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19776316|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
19776317|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19776318|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
19776319|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151180|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151181|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151182|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151183|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151184|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776320|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776321|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19776322|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19776323|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776324|NCT00189488|Methotrexate|methotrexate|mesh-list
19776325|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19776326|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
19776327|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19776328|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776329|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776330|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
19776331|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776332|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776333|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
19776334|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776335|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776336|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776337|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
19776338|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776339|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19776340|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
19776341|NCT00190671|Pemetrexed|pemetrexed|mesh-list
19776342|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776343|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
19776344|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776345|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776346|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19776347|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
19776348|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776349|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776350|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19776351|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776352|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776353|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19776354|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19776355|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19776356|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19776357|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776358|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776359|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
19776360|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776361|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776362|NCT00190749|Olanzapine|olanzapine|mesh-list
19776363|NCT00190749|Risperidone|risperidone|mesh-list
20151185|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151186|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636527|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19636528|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
19636529|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
19636530|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
19636531|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19636532|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
19636533|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
19636534|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636535|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
19636536|NCT02423096|Haloperidol|haloperidol|mesh-list
19636537|NCT02423096|Olanzapine|olanzapine|mesh-list
19636538|NCT02423096|Risperidone|risperidone|mesh-list
19636539|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19636540|NCT02423096|Sulpiride|sulpiride|mesh-list
19636541|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19636542|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
19636543|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636544|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636545|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776364|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19776365|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
19776366|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776367|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776368|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776369|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19776370|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776371|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776372|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776373|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19776374|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
19776375|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
20151187|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20317921|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776376|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
19776377|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776378|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19776379|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19776380|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19776381|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776382|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19776383|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19776384|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19776385|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776386|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776387|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
19776388|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776389|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776390|NCT00190983|Pemetrexed|pemetrexed|mesh-list
19776391|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776392|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776393|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776394|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776395|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19776396|NCT00191100|Gemcitabine|gemcitabine|mesh-list
19776397|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776398|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776399|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
20317922|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
20317923|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
19776400|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776401|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
19776402|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776403|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776404|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776405|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
19636546|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19776406|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776407|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19776408|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19776409|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
19776410|NCT00191113|Estradiol|estradiol|mesh-list
19776411|NCT00191113|Hormones|hormones|mesh-ancestor
19776412|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151188|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151189|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20151190|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151191|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151192|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
20151193|NCT00088049|Olanzapine|olanzapine|mesh-list
20151194|NCT00088049|Aripiprazole|aripiprazole|mesh-list
20151195|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
20317924|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
20317925|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
19636547|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636548|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776413|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776414|NCT00191113|Estrogens|estrogens|mesh-ancestor
19776415|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19636549|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636550|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19636551|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
19636552|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
20317926|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20317927|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20317928|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20317929|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20317930|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20317931|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20317932|NCT00712738|Nifedipine|nifedipine|mesh-list
20317933|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19776416|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
19776417|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19776418|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19776419|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19776420|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19776421|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19776422|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19776423|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19776424|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776425|NCT00191139|Gemcitabine|gemcitabine|mesh-list
19776426|NCT00191139|Cisplatin|cisplatin|mesh-list
19776427|NCT00191139|Docetaxel|docetaxel|mesh-list
19776428|NCT00191139|Etoposide|etoposide|mesh-list
19776429|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
19776430|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776431|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776432|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
19776433|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776434|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
19776435|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776436|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776437|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776438|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
19776439|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776440|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776441|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776442|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776443|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776444|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20317934|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20317935|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317936|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20317937|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317938|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
19636553|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
19636554|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776445|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776446|NCT00191152|Gemcitabine|gemcitabine|mesh-list
19776447|NCT00191152|Capecitabine|capecitabine|mesh-list
19776448|NCT00191152|Docetaxel|docetaxel|mesh-list
19776449|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776450|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
19776451|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776452|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776453|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
19776454|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776455|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776456|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776457|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
19776458|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776459|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776460|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
19636555|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636556|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19636557|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19636558|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776461|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
19833434|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19833435|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776462|NCT00191191|Pemetrexed|pemetrexed|mesh-list
19776463|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776464|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776465|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776466|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776467|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19776468|NCT00191269|Gemcitabine|gemcitabine|mesh-list
19776469|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776470|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
19776471|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776472|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776473|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
19776474|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776475|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776476|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776477|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
19776478|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776479|NCT00191282|Insulin|insulin|mesh-list
19776480|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19776481|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
19776482|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
19776483|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
19776484|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
19776485|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
19776486|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19776487|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776488|NCT00191308|Pemetrexed|pemetrexed|mesh-list
19776489|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776490|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776491|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776492|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776493|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19776494|NCT00191334|Gemcitabine|gemcitabine|mesh-list
19776495|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776496|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776497|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
19776498|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776499|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
19776500|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776501|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776502|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317939|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
20317940|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20317941|NCT00712764|Adenosine|adenosine|mesh-list
20317942|NCT00712764|Analgesics|analgesics|mesh-ancestor
20317943|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
20317944|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20317945|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776503|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
19776504|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776505|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19776506|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19776507|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19776508|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776509|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776510|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
19776511|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776512|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776513|NCT00191451|Gemcitabine|gemcitabine|mesh-list
19776514|NCT00191451|Carboplatin|carboplatin|mesh-list
19776515|NCT00191451|Trastuzumab|trastuzumab|mesh-list
19776516|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776517|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776518|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
19776519|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776520|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
19776521|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776522|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776523|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776524|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
19776525|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776526|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776527|NCT00191477|Gemcitabine|gemcitabine|mesh-list
19776528|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20317946|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19776529|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
19776530|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776531|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776532|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
19776533|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776534|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776535|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776536|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
19776537|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776538|NCT00191646|Gemcitabine|gemcitabine|mesh-list
19776539|NCT00191646|Paclitaxel|paclitaxel|mesh-list
19776540|NCT00191646|Carboplatin|carboplatin|mesh-list
19776541|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776542|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776543|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776544|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776545|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776546|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776547|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776548|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
19776549|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
19776550|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776551|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776552|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776553|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
19776554|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776555|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19776556|NCT00191724|Enoxaparin|enoxaparin|mesh-list
19776557|NCT00191724|Protein C|protein c|mesh-list
19776558|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
20317947|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
20317948|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20317949|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
20317950|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
20317951|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317952|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317953|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20317954|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20317955|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20317956|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20317957|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20317958|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
20317959|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20317960|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317961|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317962|NCT00712790|Sorafenib|sorafenib|mesh-list
20317963|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317964|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20317965|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317966|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317967|NCT00712855|Sorafenib|sorafenib|mesh-list
20317968|NCT00712855|Mapatumumab|mapatumumab|mesh-list
19636559|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
19636560|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19636561|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19636562|NCT02423018|Pregabalin|pregabalin|mesh-list
19636563|NCT02423018|Analgesics|analgesics|mesh-ancestor
19636564|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
19636565|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636566|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636567|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
19636568|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19636569|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19636570|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636571|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19636572|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19636573|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636574|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636575|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636576|NCT02423083|Guanabenz|guanabenz|mesh-list
19636577|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19636578|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19776559|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19776560|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19776561|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776562|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776563|NCT00191789|Gemcitabine|gemcitabine|mesh-list
20317969|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20317970|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20317971|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20317972|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317973|NCT00712894|Verapamil|verapamil|mesh-list
20317974|NCT00712894|Diltiazem|diltiazem|mesh-list
20317975|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
20317976|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
19776564|NCT00191789|Doxorubicin|doxorubicin|mesh-list
19776565|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776566|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776567|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
19776568|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776569|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
19776570|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776571|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776572|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776573|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
19776574|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776575|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19776576|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776577|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776578|NCT00191815|Gemcitabine|gemcitabine|mesh-list
19776579|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776580|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776581|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
19776582|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776583|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
19776584|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776585|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776586|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776587|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
19776588|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776589|NCT00191854|Gemcitabine|gemcitabine|mesh-list
19776590|NCT00191854|Paclitaxel|paclitaxel|mesh-list
19776591|NCT00191854|Carboplatin|carboplatin|mesh-list
19776592|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776593|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776594|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776595|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776596|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776597|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776598|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776599|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
19776600|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
19776601|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776602|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776603|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776604|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
19776605|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776606|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19776607|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19776608|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151196|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
20151197|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151198|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151199|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151200|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151201|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151202|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151203|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151204|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20151205|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151206|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20151207|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151208|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151209|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
20151210|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151211|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
20317977|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20317978|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20317979|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20317980|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317981|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20317982|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317983|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20317984|NCT00712907|Ascorbic Acid|ascorbic acid|mesh-list
20317985|NCT00712907|Vitamins|vitamins|mesh-ancestor
19776609|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776610|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317986|NCT00712907|Micronutrients|micronutrients|mesh-ancestor
20317987|NCT00712907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317988|NCT00712907|Antioxidants|antioxidants|mesh-ancestor
19776611|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
19776612|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776613|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636579|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19636580|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19636581|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
19636582|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636583|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636584|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636585|NCT02422563|Paclitaxel|paclitaxel|mesh-list
19636586|NCT02422563|Carboplatin|carboplatin|mesh-list
19776614|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19776615|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19776616|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19776617|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776618|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776619|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
19776620|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776621|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776622|NCT00191984|Irinotecan|irinotecan|mesh-list
19776623|NCT00191984|Pemetrexed|pemetrexed|mesh-list
19776624|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19776625|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776626|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776627|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776628|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776629|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776630|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19776631|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19776632|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19776633|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19776634|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776635|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776636|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
19636587|NCT02422563|Ifosfamide|ifosfamide|mesh-list
19636588|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19636589|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776637|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776638|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776639|NCT00192036|Gemcitabine|gemcitabine|mesh-list
19776640|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776641|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776642|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
19776643|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776644|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
19776645|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776646|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776647|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776648|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
20151212|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
20151213|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20151214|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20151215|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20151216|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20151217|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20151218|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20151219|NCT00088075|Risperidone|risperidone|mesh-list
20151220|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20151221|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
19636590|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776649|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776650|NCT00192075|Leucovorin|leucovorin|mesh-list
19776651|NCT00192075|Folic Acid|folic acid|mesh-list
19776652|NCT00192075|Gemcitabine|gemcitabine|mesh-list
19776653|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
19776654|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
19776655|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776656|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
19776657|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776658|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776659|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
19776660|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776661|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776662|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776663|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
19776664|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776665|NCT00192075|Antidotes|antidotes|mesh-ancestor
19636591|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
19636592|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
19636593|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636594|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19636595|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
19636596|NCT02422706|Metronidazole|metronidazole|mesh-list
19636597|NCT02422706|Clarithromycin|clarithromycin|mesh-list
19636598|NCT02422706|Levofloxacin|levofloxacin|mesh-list
19636599|NCT02422706|Ofloxacin|ofloxacin|mesh-list
19636600|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
19636601|NCT02422706|Doxycycline|doxycycline|mesh-list
19636602|NCT02422706|Omeprazole|omeprazole|mesh-list
19636603|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636604|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19636605|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19636606|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19636607|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19636608|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19776666|NCT00192075|Protective Agents|protective agents|mesh-ancestor
19776667|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
19776668|NCT00192075|Vitamins|vitamins|mesh-ancestor
19636609|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19636610|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636611|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776669|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
19776670|NCT00192075|Hematinics|hematinics|mesh-ancestor
19776671|NCT00192647|Ribavirin|ribavirin|mesh-list
19776672|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19776673|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
19776674|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
19776675|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776676|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
19776677|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776678|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776679|NCT00193037|Docetaxel|docetaxel|mesh-list
19776680|NCT00193037|Doxorubicin|doxorubicin|mesh-list
19776681|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19776682|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776683|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776684|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776685|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776686|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776687|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19776688|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776689|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776690|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776691|NCT00193050|Gemcitabine|gemcitabine|mesh-list
19776692|NCT00193050|Docetaxel|docetaxel|mesh-list
19776693|NCT00193050|Epirubicin|epirubicin|mesh-list
19776694|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776695|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
19776696|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776697|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776698|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
20151222|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151223|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151224|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151225|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151226|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636612|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19776699|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776700|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776701|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776702|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
19776703|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776704|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776705|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776706|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776707|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19776708|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776709|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776710|NCT00193063|Gemcitabine|gemcitabine|mesh-list
19776711|NCT00193063|Trastuzumab|trastuzumab|mesh-list
19776712|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776713|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
19776714|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776715|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776716|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
19776717|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776718|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776719|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776720|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
20317989|NCT00712907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317990|NCT00712907|Protective Agents|protective agents|mesh-ancestor
20317991|NCT00712933|Belimumab|belimumab|mesh-list
20317992|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20317993|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
20317994|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20317995|NCT00713011|Nifedipine|nifedipine|mesh-list
20317996|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20317997|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776721|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776722|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776723|NCT00193128|Docetaxel|docetaxel|mesh-list
19776724|NCT00193128|Capecitabine|capecitabine|mesh-list
19776725|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
19776726|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776727|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776728|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776729|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776730|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776731|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776732|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
19776733|NCT00193180|Docetaxel|docetaxel|mesh-list
19776734|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
19776735|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776736|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776737|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776738|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776739|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776740|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19776741|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776742|NCT00193206|Gemcitabine|gemcitabine|mesh-list
19776743|NCT00193206|Paclitaxel|paclitaxel|mesh-list
19776744|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19776745|NCT00193206|Epirubicin|epirubicin|mesh-list
19776746|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776747|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776748|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776749|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
20317998|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20317999|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20318000|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318001|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
20318002|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
20318003|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20318004|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
20611116|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776750|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776751|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776752|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776753|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
19776754|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
19776755|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776756|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776757|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776758|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
19776759|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151227|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151228|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151229|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20151230|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
19776760|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19776761|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776762|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776763|NCT00193258|Bevacizumab|bevacizumab|mesh-list
19776764|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19776765|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
19776766|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776767|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776768|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19776769|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19776770|NCT00193258|Growth Substances|growth substances|mesh-ancestor
19776771|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776772|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
19776773|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19776774|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776775|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776776|NCT00193375|Bevacizumab|bevacizumab|mesh-list
19776777|NCT00193375|Carboplatin|carboplatin|mesh-list
19776778|NCT00193375|Irinotecan|irinotecan|mesh-list
19776779|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776780|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776781|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19776782|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19776783|NCT00193375|Growth Substances|growth substances|mesh-ancestor
20318005|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20318006|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318007|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
20318008|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318009|NCT00713167|Protective Agents|protective agents|mesh-ancestor
20318010|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318011|NCT00713193|Cyclosporine|cyclosporine|mesh-list
20318012|NCT00713193|Prednisone|prednisone|mesh-list
19776784|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776785|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
19776786|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19776787|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776788|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776789|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776790|NCT00193453|Gemcitabine|gemcitabine|mesh-list
19776791|NCT00193453|Docetaxel|docetaxel|mesh-list
19776792|NCT00193453|Cetuximab|cetuximab|mesh-list
19776793|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776794|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
20151231|NCT00088088|Paclitaxel|paclitaxel|mesh-list
20151232|NCT00088088|Carboplatin|carboplatin|mesh-list
20151233|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20151234|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151235|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151236|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151237|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20318013|NCT00713193|Cyclosporins|cyclosporins|mesh-list
19776795|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776796|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776797|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
19776798|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776799|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776800|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776801|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
19776802|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776803|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776804|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776805|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776806|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776807|NCT00193492|Bevacizumab|bevacizumab|mesh-list
19776808|NCT00193492|Rituximab|rituximab|mesh-list
19776809|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776810|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776811|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19776812|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611117|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19776813|NCT00193492|Growth Substances|growth substances|mesh-ancestor
20318014|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636613|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19636614|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20318015|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
20318016|NCT00713193|Hormones|hormones|mesh-ancestor
20318017|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318018|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318019|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20318020|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318021|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318022|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318023|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318024|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
20318025|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
20318026|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318027|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611118|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
19636615|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19636616|NCT02422706|Renal Agents|renal agents|mesh-ancestor
19636617|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776814|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776815|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
19776816|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
19776817|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776818|NCT00193596|Gemcitabine|gemcitabine|mesh-list
19776819|NCT00193596|Paclitaxel|paclitaxel|mesh-list
19776820|NCT00193596|Etoposide|etoposide|mesh-list
19776821|NCT00193596|Carboplatin|carboplatin|mesh-list
19776822|NCT00193596|Irinotecan|irinotecan|mesh-list
19776823|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776824|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776825|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776826|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776827|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776828|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776829|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776830|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
19776831|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
19776832|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19776833|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776834|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776835|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
19776836|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776837|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19776838|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776839|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776840|NCT00193609|Capecitabine|capecitabine|mesh-list
19776841|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
19776842|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776843|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
19776844|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776845|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776846|NCT00194012|Aripiprazole|aripiprazole|mesh-list
19776847|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
19776848|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776849|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19776850|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776851|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636618|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19636619|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636620|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19636621|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
19636622|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19636623|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19636624|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636625|NCT02422485|Analgesics|analgesics|mesh-ancestor
19636626|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
19636627|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636628|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636629|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636630|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776852|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776853|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
19776854|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
20318028|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20318029|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19776855|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776856|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776857|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19776858|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19776859|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
19776860|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19776861|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19776862|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19776863|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19776864|NCT00194025|Valproic Acid|valproic acid|mesh-list
19776865|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
19776866|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776867|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776868|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
19776869|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776870|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776871|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
19776872|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776873|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776874|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776875|NCT00194077|Aripiprazole|aripiprazole|mesh-list
19776876|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
19776877|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776878|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19776879|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776880|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776881|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776882|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
19776883|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
19776884|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776885|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776886|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19776887|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19776888|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
19776889|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19776890|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19776891|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19776892|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19776893|NCT00194116|Valproic Acid|valproic acid|mesh-list
19776894|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
19776895|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776896|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776897|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
19776898|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776899|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776900|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
19776901|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776902|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776903|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776904|NCT00194129|Valproic Acid|valproic acid|mesh-list
19776905|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
19776906|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
19776907|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19776908|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776909|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776910|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
19776911|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19776912|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776913|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776914|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
20347405|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20347406|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
20347407|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347408|NCT00859911|Micronutrients|micronutrients|mesh-list
20347409|NCT00859911|Trace Elements|trace elements|mesh-list
20347410|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347411|NCT00860119|Alprazolam|alprazolam|mesh-list
20347412|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20347413|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19776915|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
19776916|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776917|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
19776918|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
20347414|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776919|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
19636631|NCT02422589|Ceritinib|ceritinib|mesh-list
19636632|NCT02422589|Midazolam|midazolam|mesh-list
19636633|NCT02422589|Warfarin|warfarin|mesh-list
19636634|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19636635|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19636636|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636637|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636638|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19636639|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636640|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636641|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19636642|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
19636643|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
19636644|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
19636645|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
19636646|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636647|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636648|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
19636649|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776920|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151238|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776921|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151239|NCT00088114|Paclitaxel|paclitaxel|mesh-list
20151240|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20151241|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151242|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151243|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151244|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151245|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151246|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
20151247|NCT00088231|Vatalanib|vatalanib|mesh-list
20151248|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151249|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151250|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151251|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151252|NCT00088270|Leucovorin|leucovorin|mesh-list
20151253|NCT00088270|Fluorouracil|fluorouracil|mesh-list
20151254|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
20151255|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151256|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151257|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776922|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776923|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776924|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776925|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776926|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776927|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19776928|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19776929|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
19776930|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19776931|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19776932|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19776933|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776934|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
19776935|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19776936|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776937|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19776938|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19776939|NCT00194675|Testosterone|testosterone|mesh-list
19776940|NCT00194675|Dutasteride|dutasteride|mesh-list
19776941|NCT00194675|Androgens|androgens|mesh-ancestor
19776942|NCT00194675|Hormones|hormones|mesh-ancestor
19776943|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19776944|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776945|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19776946|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19776947|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776948|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151258|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151259|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
20612245|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
19636650|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19636651|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776949|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
19776950|NCT00194779|Tamoxifen|tamoxifen|mesh-list
19776951|NCT00194779|Vinorelbine|vinorelbine|mesh-list
19776952|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
19776953|NCT00194779|Doxorubicin|doxorubicin|mesh-list
19776954|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19776955|NCT00194779|Capecitabine|capecitabine|mesh-list
19776956|NCT00194779|Methotrexate|methotrexate|mesh-list
19776957|NCT00194779|Trastuzumab|trastuzumab|mesh-list
19776958|NCT00194779|Letrozole|letrozole|mesh-list
19776959|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19776960|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19776961|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
19776962|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
19776963|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
19776964|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19776965|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19776966|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
19776967|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19776968|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19776969|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19776970|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
19776971|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19776972|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19776973|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19776974|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19776975|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19776976|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19776977|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
19776978|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19776979|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
19776980|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19776981|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
19776982|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19776983|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19776984|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19776985|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19776986|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19776987|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19776988|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
19776989|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19776990|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19776991|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19776992|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19776993|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19776994|NCT00194792|Paclitaxel|paclitaxel|mesh-list
19776995|NCT00194792|Vinorelbine|vinorelbine|mesh-list
19776996|NCT00194792|Capecitabine|capecitabine|mesh-list
19776997|NCT00194792|Methotrexate|methotrexate|mesh-list
19636652|NCT02422498|Cisplatin|cisplatin|mesh-list
19636653|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151260|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151261|NCT00088270|Antidotes|antidotes|mesh-ancestor
20151262|NCT00088270|Protective Agents|protective agents|mesh-ancestor
20151263|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
20151264|NCT00088270|Vitamins|vitamins|mesh-ancestor
20151265|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
19636654|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
19636655|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19636656|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
19636657|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19636658|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
19636659|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636660|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636661|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
19636662|NCT02422654|Eliglustat|eliglustat|mesh-list
19636663|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636664|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636665|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
19636666|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19776998|NCT00194792|Exemestane|exemestane|mesh-list
20151266|NCT00088387|Valproic Acid|valproic acid|mesh-list
20151267|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636667|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19776999|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19777000|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20151268|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777001|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777002|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
19777003|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
19777004|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
19777005|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777006|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777007|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
19777008|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19777009|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
19777010|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777011|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777012|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777013|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777014|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19777015|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777016|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
19777017|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777018|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19777019|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19777020|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19777021|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19777022|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
19777023|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777024|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
19777025|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19777026|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
19777027|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19777028|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777029|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
19777030|NCT00194896|Glyburide|glyburide|mesh-list
19777031|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19777032|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318030|NCT00713271|AZD-3199|azd-3199|mesh-list
20318031|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20318032|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20318033|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20318034|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
19777033|NCT00194987|Prednisone|prednisone|mesh-list
19777034|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
19777035|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19777036|NCT00194987|Antibodies|antibodies|mesh-list
19777037|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
19777038|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19777039|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777040|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
19777041|NCT00194987|Hormones|hormones|mesh-ancestor
19777042|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151269|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151270|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
20151271|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151272|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151273|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151274|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
20151275|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
20151276|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777043|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777044|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777045|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777046|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
19777047|NCT00195039|Antibodies|antibodies|mesh-list
19777048|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19777049|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
19777050|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777051|NCT00195273|Cyclosporine|cyclosporine|mesh-list
19777052|NCT00195273|Sirolimus|sirolimus|mesh-list
19777053|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
19777054|NCT00195273|Cyclosporins|cyclosporins|mesh-list
19777055|NCT00195273|Daclizumab|daclizumab|mesh-list
19777056|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777057|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777058|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151277|NCT00088478|Olanzapine|olanzapine|mesh-list
20318035|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777059|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
19777060|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151278|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
20318036|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318037|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777061|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
19777062|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777063|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777064|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777065|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19777066|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19777067|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777068|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19777069|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
19777070|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19777071|NCT00195338|Etanercept|etanercept|mesh-list
19777072|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777073|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777074|NCT00195338|Analgesics|analgesics|mesh-ancestor
19777075|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
19777076|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777077|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777078|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777079|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777080|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777081|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777082|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
19777083|NCT00195351|Metronidazole|metronidazole|mesh-list
19777084|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
19777085|NCT00195351|Tigecycline|tigecycline|mesh-list
19777086|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777087|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19777088|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19777089|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19777090|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19777091|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777092|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777093|NCT00195403|Etanercept|etanercept|mesh-list
19777094|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777095|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777096|NCT00195403|Analgesics|analgesics|mesh-ancestor
19777097|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
19777098|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777099|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777100|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777101|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777102|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777103|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777104|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
19777105|NCT00195429|Sirolimus|sirolimus|mesh-list
19777106|NCT00195429|Prednisone|prednisone|mesh-list
19777107|NCT00195429|Tacrolimus|tacrolimus|mesh-list
19777108|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777109|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
19777110|NCT00195429|Hormones|hormones|mesh-ancestor
19777111|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318038|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
20318039|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20318040|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19636668|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636669|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
19636670|NCT02422056|Coagulants|coagulants|mesh-ancestor
19636671|NCT02422199|Capecitabine|capecitabine|mesh-list
19636672|NCT02422199|Lapatinib|lapatinib|mesh-list
19636673|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636674|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
19636675|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777112|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318041|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318042|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20318043|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318044|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318045|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318046|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777113|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777114|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777115|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636676|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777116|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
19777117|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19777118|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777119|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777120|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19777121|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777122|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19777123|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
19777124|NCT00195442|Factor VIII|factor viii|mesh-list
19777125|NCT00195442|Coagulants|coagulants|mesh-ancestor
19777126|NCT00195494|Etanercept|etanercept|mesh-list
19777127|NCT00195494|Methotrexate|methotrexate|mesh-list
19777128|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19777129|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
19777130|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777131|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777132|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777133|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
19777134|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777135|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777136|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777137|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777138|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19777139|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777140|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
19777141|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777142|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19636677|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19636678|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636679|NCT02422017|Timolol|timolol|mesh-list
19636680|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19636681|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19777143|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777144|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777145|NCT00195494|Analgesics|analgesics|mesh-ancestor
19777146|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
19777147|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777148|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777149|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777150|NCT00195507|Etanercept|etanercept|mesh-list
19777151|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777152|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777153|NCT00195507|Analgesics|analgesics|mesh-ancestor
19777154|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
19777155|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777156|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777157|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777158|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777159|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777160|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777161|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
19777162|NCT00195624|Cyclosporine|cyclosporine|mesh-list
19777163|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
19777164|NCT00195624|Cyclosporins|cyclosporins|mesh-list
19777165|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777166|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777167|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777168|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
19777169|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777170|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
19777171|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777172|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777173|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777174|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19777175|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19636682|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
19636683|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636684|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636685|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636686|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19636687|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19636688|NCT02422030|Atorvastatin|atorvastatin|mesh-list
19636689|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
19777176|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612246|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777177|NCT00195650|Adalimumab|adalimumab|mesh-list
19777178|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777179|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777180|NCT00195663|Adalimumab|adalimumab|mesh-list
19777181|NCT00195663|Methotrexate|methotrexate|mesh-list
19777182|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19777183|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
19777184|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777185|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777186|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777187|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
19777188|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777189|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777190|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777191|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777192|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19777193|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636690|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19636691|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19636692|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
19636693|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636694|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19636695|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19636696|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636697|NCT02422108|Denosumab|denosumab|mesh-list
19777194|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
19777195|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777196|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19777197|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777198|NCT00195676|Adalimumab|adalimumab|mesh-list
19777199|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777200|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777201|NCT00195702|Adalimumab|adalimumab|mesh-list
19777202|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777203|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777204|NCT00195715|Adalimumab|adalimumab|mesh-list
19777205|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777206|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777207|NCT00195819|Adalimumab|adalimumab|mesh-list
19777208|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777209|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777210|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
19777211|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19777212|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
19777213|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777214|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777215|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19777216|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19777217|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19777218|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
19777219|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19777220|NCT00196326|Estradiol|estradiol|mesh-list
19777221|NCT00196326|Estrogens|estrogens|mesh-ancestor
19777222|NCT00196326|Hormones|hormones|mesh-ancestor
19777223|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777224|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777225|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19777226|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
19777227|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777228|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19777229|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19777230|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19777231|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19777232|NCT00196976|Edetic Acid|edetic acid|mesh-list
19777233|NCT00196976|Vaccines|vaccines|mesh-list
19777234|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
19777235|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
19777236|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777237|NCT00196976|Antidotes|antidotes|mesh-ancestor
19777238|NCT00196976|Protective Agents|protective agents|mesh-ancestor
19636698|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19636699|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636700|NCT02421913|Ketamine|ketamine|mesh-list
19777239|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
19777240|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
19777241|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777242|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20318047|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19777243|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
19777244|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19777245|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19777246|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
19777247|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777248|NCT00197106|Fluticasone|fluticasone|mesh-list
19777249|NCT00197106|Xhance|xhance|mesh-list
19777250|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19777251|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777252|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19777253|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
19777254|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777255|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777256|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19777257|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
19777258|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777259|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19777260|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19777261|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19777262|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19777263|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
19777264|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777265|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777266|NCT00197145|Aplaviroc|aplaviroc|mesh-list
19777267|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19777268|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19777269|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777270|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19777271|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19777272|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
19777273|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777274|NCT00197184|Vaccines|vaccines|mesh-list
19777275|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
19777276|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777277|NCT00198029|Hylan|hylan|mesh-list
19777278|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
19777279|NCT00198029|Protective Agents|protective agents|mesh-ancestor
19777280|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777281|NCT00198081|Celecoxib|celecoxib|mesh-list
19777282|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19777283|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777284|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777285|NCT00198081|Analgesics|analgesics|mesh-ancestor
19777286|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
19777287|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777288|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777289|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777290|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777291|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19777292|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777293|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777294|NCT00198107|Cycloserine|cycloserine|mesh-list
19777295|NCT00198107|Aripiprazole|aripiprazole|mesh-list
19777296|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
20318048|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
20318049|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20318050|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318051|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20318052|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20318053|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20318054|NCT00713440|Acetaminophen|acetaminophen|mesh-list
20318055|NCT00713440|Prednisolone|prednisolone|mesh-list
20318056|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20318057|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
20318058|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20318059|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
20318060|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20318061|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
20318062|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318063|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
20318064|NCT00713440|Hormones|hormones|mesh-ancestor
19777297|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20318065|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318066|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777298|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151279|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
20151280|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151281|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151282|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151283|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151284|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20318067|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20318068|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318069|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
20318070|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
20318071|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318072|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318073|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20318074|NCT00713440|Protective Agents|protective agents|mesh-ancestor
20611119|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636701|NCT02421913|Analgesics|analgesics|mesh-ancestor
19636702|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
19636703|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636704|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636705|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19636706|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19636707|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
19636708|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
19636709|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636710|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19636711|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19636712|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636713|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662288|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662289|NCT02922764|Carboplatin|carboplatin|mesh-list
19662290|NCT02922764|Docetaxel|docetaxel|mesh-list
19662291|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
19662292|NCT02922764|Nivolumab|nivolumab|mesh-list
19662293|NCT02922764|Pemetrexed|pemetrexed|mesh-list
19662294|NCT02922764|Ipilimumab|ipilimumab|mesh-list
19662295|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662296|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
19662297|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
19662298|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
19662299|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662300|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662301|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19662302|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662303|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19662304|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19662305|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19662306|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19662307|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
19662308|NCT02563015|Vitamin D|vitamin d|mesh-list
19662309|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
19662310|NCT02563015|Vitamins|vitamins|mesh-ancestor
19662311|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
19662312|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662313|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19662314|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19662315|NCT02531932|Carboplatin|carboplatin|mesh-list
19662316|NCT02531932|Everolimus|everolimus|mesh-list
19662317|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662318|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662319|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
19662320|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662321|NCT02344290|Pitavastatin|pitavastatin|mesh-list
19662322|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19662323|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19662324|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19662325|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
19662326|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662327|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662328|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19662329|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19662330|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19662331|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
19662332|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777299|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19777300|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777301|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777302|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
19777303|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
19777304|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777305|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777306|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19777307|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19777308|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
19777309|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19777310|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19777311|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19777312|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19777313|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19777314|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777315|NCT00198107|Renal Agents|renal agents|mesh-ancestor
19777316|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19777317|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
19777318|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19777319|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
19777320|NCT00198133|Pemetrexed|pemetrexed|mesh-list
19777321|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777322|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777323|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777324|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19777325|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19777326|NCT00198822|Vitamin A|vitamin a|mesh-list
19777327|NCT00198822|Beta Carotene|beta carotene|mesh-list
19777328|NCT00198822|Carotenoids|carotenoids|mesh-list
19777329|NCT00198822|Vitamins|vitamins|mesh-ancestor
19777330|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
19777331|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777332|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
19777333|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777334|NCT00198822|Protective Agents|protective agents|mesh-ancestor
19777335|NCT00198822|Provitamins|provitamins|mesh-ancestor
19777336|NCT00199381|Istradefylline|istradefylline|mesh-list
19777337|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
19777338|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19777339|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19777340|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
19777341|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777342|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777343|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777344|NCT00199797|Leucovorin|leucovorin|mesh-list
19777345|NCT00199797|Fluorouracil|fluorouracil|mesh-list
19777346|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
19777347|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
19777348|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777349|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777350|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777351|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777352|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
19777353|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318075|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20318076|NCT00713440|Analgesics|analgesics|mesh-ancestor
20318077|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
20318078|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
20318079|NCT00713557|Tirofiban|tirofiban|mesh-list
20318080|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20318081|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20318082|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777354|NCT00199797|Antidotes|antidotes|mesh-ancestor
19777355|NCT00199797|Protective Agents|protective agents|mesh-ancestor
19777356|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
20318083|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20318084|NCT00713622|Zonisamide|zonisamide|mesh-list
19777357|NCT00199797|Vitamins|vitamins|mesh-ancestor
19777358|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
19777359|NCT00200161|Temozolomide|temozolomide|mesh-list
19777360|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20318085|NCT00713622|Valproic Acid|valproic acid|mesh-list
19777361|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
19777362|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318086|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
19777363|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833436|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
19833437|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
19833438|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
19833439|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833440|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19833441|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19636714|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
19636715|NCT02421926|Dasatinib|dasatinib|mesh-list
19636716|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636717|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19636718|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636719|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636720|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
19833442|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19833443|NCT00588237|Growth Substances|growth substances|mesh-ancestor
19833444|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833445|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
19833446|NCT00588341|Temozolomide|temozolomide|mesh-list
19833447|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19833448|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
19833449|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833450|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833451|NCT00588354|Triamcinolone|triamcinolone|mesh-list
19833452|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19833453|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19833454|NCT00588354|Lidocaine|lidocaine|mesh-list
19833455|NCT00588354|Clonidine|clonidine|mesh-list
19833456|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19833457|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
19833458|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
19833459|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833460|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833461|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
19833462|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833463|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19833464|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19833465|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19833466|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19833467|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833468|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833469|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
19833470|NCT00588354|Hormones|hormones|mesh-ancestor
19833471|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833472|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19833473|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
19833474|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833475|NCT00588354|Analgesics|analgesics|mesh-ancestor
19833476|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19833477|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
19833478|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
19833479|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20318087|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318088|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318089|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
20318090|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318091|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318092|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
20318093|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20318094|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318095|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20318096|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20318097|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20318098|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20318099|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20318100|NCT00713674|Mupirocin|mupirocin|mesh-list
20318101|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636721|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
19636722|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19636723|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19636724|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636725|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318102|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19833480|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19777364|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19636726|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636727|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777365|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19777366|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777367|NCT00200356|Ozagrel|ozagrel|mesh-list
19777368|NCT00200356|Edaravone|edaravone|mesh-list
19777369|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19777370|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
19777371|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777372|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19777373|NCT00200356|Protective Agents|protective agents|mesh-ancestor
20151285|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151286|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151287|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20151288|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151289|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777374|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777375|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777376|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19777377|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19777378|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
19777379|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
19777380|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777381|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19777382|NCT00200902|Citalopram|citalopram|mesh-list
19777383|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19777384|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19777385|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19777386|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777387|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777388|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777389|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
19777390|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777391|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20318103|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318104|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318105|NCT00713687|Gemcitabine|gemcitabine|mesh-list
20318106|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
20318107|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318108|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
20318109|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318110|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318111|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
20318112|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318113|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318114|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318115|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
20318116|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318117|NCT00713726|Fentanyl|fentanyl|mesh-list
20318118|NCT00713726|Tramadol|tramadol|mesh-list
20318119|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20318120|NCT00713726|Narcotics|narcotics|mesh-ancestor
20611120|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636728|NCT02421640|Cisplatin|cisplatin|mesh-list
19636729|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636730|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
19636731|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19636732|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
19636733|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19636734|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636735|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636736|NCT02422277|Urological Agents|urological agents|mesh-ancestor
19777392|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151290|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151291|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151292|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
20151293|NCT00088491|Olanzapine|olanzapine|mesh-list
20151294|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
20151295|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
20151296|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151297|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151298|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151299|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20318121|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318122|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318123|NCT00713726|Analgesics|analgesics|mesh-ancestor
20318124|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
19777393|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777394|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777395|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19777396|NCT00200902|Analgesics|analgesics|mesh-ancestor
19777397|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
19777398|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
19777399|NCT00200967|Beclomethasone|beclomethasone|mesh-list
19777400|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19777401|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19777402|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
19777403|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777404|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777405|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19777406|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
19777407|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19777408|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20151300|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151301|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151302|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777409|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19777410|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
19777411|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777412|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777413|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777414|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
19777415|NCT00200967|Hormones|hormones|mesh-ancestor
20151303|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20151304|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151305|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20318125|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318126|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20318127|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20318128|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
20318129|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
20318130|NCT00713739|Prazosin|prazosin|mesh-list
20318131|NCT00713739|Doxazosin|doxazosin|mesh-list
20318132|NCT00713739|Nifedipine|nifedipine|mesh-list
20318133|NCT00713739|Alfuzosin|alfuzosin|mesh-list
20318134|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20318135|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611121|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20151306|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151307|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151308|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
20151309|NCT00088504|Interferons|interferons|mesh-list
20151310|NCT00088504|Ribavirin|ribavirin|mesh-list
20151311|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
20151312|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
20151313|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20151314|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151315|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
20347415|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19636737|NCT02422121|RNS60|rns60|mesh-list
19636738|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19636739|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636740|NCT02422121|Analgesics|analgesics|mesh-ancestor
19636741|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
19636742|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636743|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636744|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636745|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636746|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19636747|NCT02421289|Efavirenz|efavirenz|mesh-list
19636748|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19636749|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19636750|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636751|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636752|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
19636753|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636754|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19636755|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19636756|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19777416|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777417|NCT00201123|Interferons|interferons|mesh-list
19777418|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
19777419|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777420|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
19777421|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777422|NCT00201448|Vaccines|vaccines|mesh-list
19777423|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
19777424|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777425|NCT00201643|Dexamethasone|dexamethasone|mesh-list
19777426|NCT00201643|Betamethasone|betamethasone|mesh-list
19777427|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777428|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
19777429|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
19777430|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777431|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777432|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777433|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
19777434|NCT00201643|Hormones|hormones|mesh-ancestor
19636757|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19636758|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19636759|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19777435|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777436|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777437|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777438|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19777439|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
19777440|NCT00201734|Paclitaxel|paclitaxel|mesh-list
19777441|NCT00201734|Carboplatin|carboplatin|mesh-list
19777442|NCT00201734|Capecitabine|capecitabine|mesh-list
19777443|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19777444|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777445|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19777446|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
19777447|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19777448|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777449|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777450|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
19777451|NCT00201760|Gemcitabine|gemcitabine|mesh-list
19777452|NCT00201760|Trastuzumab|trastuzumab|mesh-list
19777453|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777454|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777455|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
19777456|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777457|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
19777458|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777459|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777460|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777461|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
19777462|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777463|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19777464|NCT00201773|Celecoxib|celecoxib|mesh-list
19777465|NCT00201773|Exemestane|exemestane|mesh-list
19777466|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777467|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777468|NCT00201773|Analgesics|analgesics|mesh-ancestor
19777469|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
19777470|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777471|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777472|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777473|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777474|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19777475|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20347416|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19636760|NCT02420938|Rituximab|rituximab|mesh-list
19636761|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19636762|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636763|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
19636764|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777476|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777477|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777478|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777479|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19833481|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20318136|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318137|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20318138|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318139|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
20318140|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
20151316|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151317|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
20151318|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151319|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
20151320|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173974|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20173975|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20173976|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20173977|NCT00163150|Atorvastatin|atorvastatin|mesh-list
20318141|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777480|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19777481|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19777482|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
19777483|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777484|NCT00201825|Docetaxel|docetaxel|mesh-list
19777485|NCT00201825|Capecitabine|capecitabine|mesh-list
19777486|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777487|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
19777488|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19777489|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
19777490|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777491|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777492|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
19777493|NCT00201838|Gemcitabine|gemcitabine|mesh-list
19777494|NCT00201838|Etanercept|etanercept|mesh-list
19777495|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777496|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
19777497|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777498|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777499|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
19777500|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777501|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777502|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777503|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
19777504|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777505|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777506|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777507|NCT00201838|Analgesics|analgesics|mesh-ancestor
19777508|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
19777509|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777510|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777511|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777512|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777513|NCT00201851|Tamoxifen|tamoxifen|mesh-list
19777514|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19777515|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
19777516|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777517|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777518|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777519|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318142|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20318143|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20318144|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20318145|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20318146|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
20318147|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318148|NCT00713739|Urological Agents|urological agents|mesh-ancestor
20318149|NCT00713765|Donepezil|donepezil|mesh-list
20318150|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20318151|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347417|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777520|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19777521|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19777522|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19777523|NCT00201864|Fulvestrant|fulvestrant|mesh-list
19777524|NCT00201864|Exemestane|exemestane|mesh-list
19777525|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777526|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318152|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318153|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
20318154|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318155|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318156|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
20318157|NCT00713921|Fesoterodine|fesoterodine|mesh-list
20318158|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20318159|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20318160|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
20318161|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318162|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318163|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318164|NCT00713921|Urological Agents|urological agents|mesh-ancestor
20318165|NCT00713947|Amoxicillin|amoxicillin|mesh-list
20318166|NCT00713947|Metronidazole|metronidazole|mesh-list
20318167|NCT00713947|Clarithromycin|clarithromycin|mesh-list
20318168|NCT00713947|Pantoprazole|pantoprazole|mesh-list
20318169|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318170|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318171|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20318172|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20318173|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20318174|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777527|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19777528|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19777529|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
19777530|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777531|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777532|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19777533|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19777534|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777535|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777536|NCT00201877|Rituximab|rituximab|mesh-list
19777537|NCT00201877|Bortezomib|bortezomib|mesh-list
19777538|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19777539|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777540|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
19777541|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777542|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777543|NCT00202449|Prazosin|prazosin|mesh-list
19777544|NCT00202449|Paroxetine|paroxetine|mesh-list
19777545|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19777546|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19777547|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777548|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777549|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777550|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
19777551|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777552|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19777553|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
19777554|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777555|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19777556|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19777557|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777558|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19777559|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19777560|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19777561|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19777562|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
19777563|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
19777564|NCT00202644|Anagrelide|anagrelide|mesh-list
19777565|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777566|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
19777567|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151321|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
20151322|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20151323|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
20151324|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151325|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151326|NCT00088556|Paclitaxel|paclitaxel|mesh-list
20151327|NCT00088556|Carboplatin|carboplatin|mesh-list
20151328|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20151329|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833482|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
20151330|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151331|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151332|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151333|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777568|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777569|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19777570|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19777571|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19777572|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19777573|NCT00202722|Remifentanil|remifentanil|mesh-list
19777574|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19777575|NCT00202722|Narcotics|narcotics|mesh-ancestor
19777576|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777577|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777578|NCT00202722|Analgesics|analgesics|mesh-ancestor
19777579|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
19777580|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777581|NCT00202839|Ribavirin|ribavirin|mesh-list
19777582|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19777583|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
19636765|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636766|NCT02421042|Lenvatinib|lenvatinib|mesh-list
19636767|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636768|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19636769|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636770|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636771|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19636772|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19636773|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19636774|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
19636775|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777584|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
19777585|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777586|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
19777587|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777588|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
20318175|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318176|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20318177|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20318178|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20318179|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318180|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20318181|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
19777589|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777590|NCT00202930|Rituximab|rituximab|mesh-list
19777591|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19777592|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318182|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
20318183|NCT00713986|Protective Agents|protective agents|mesh-ancestor
20318184|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777593|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
19777594|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777595|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777596|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
19777597|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
19777598|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19777599|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
19777600|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777601|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777602|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777603|NCT00203047|Prednisone|prednisone|mesh-list
19777604|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
19777605|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
20151334|NCT00088582|Octreotide|octreotide|mesh-list
20151335|NCT00088582|Pasireotide|pasireotide|mesh-list
20151336|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151337|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20151338|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151339|NCT00088582|Hormones|hormones|mesh-ancestor
20151340|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636776|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19777606|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777607|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
19777608|NCT00203047|Hormones|hormones|mesh-ancestor
19777609|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777610|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777611|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777612|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777613|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19777614|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
19777615|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777616|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777617|NCT00203216|Levetiracetam|levetiracetam|mesh-list
19777618|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
19777619|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
19777620|NCT00203229|Lamotrigine|lamotrigine|mesh-list
20318185|NCT00713999|Praziquantel|praziquantel|mesh-list
20318186|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
20318187|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20318188|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318189|NCT00714025|Everolimus|everolimus|mesh-list
20318190|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318191|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318192|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
20318193|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318194|NCT00714064|Edetic Acid|edetic acid|mesh-list
20318195|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
20318196|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20318197|NCT00714064|Antidotes|antidotes|mesh-ancestor
20318198|NCT00714064|Protective Agents|protective agents|mesh-ancestor
20318199|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318200|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
20318201|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
20318202|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318203|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20318204|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
20318205|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20318206|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
20318207|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20318208|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19777621|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
19777622|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19777623|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777624|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777625|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19777626|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777627|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19777628|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20318209|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20318210|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20318211|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318212|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318213|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318214|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20318215|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
20318216|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20318217|NCT00714103|Adenosine|adenosine|mesh-list
20318218|NCT00714103|Analgesics|analgesics|mesh-ancestor
20318219|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
20318220|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318221|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318222|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20318223|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
20318224|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20318225|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
20318226|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
20318227|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636777|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19636778|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636779|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
19636780|NCT02421029|Edetic Acid|edetic acid|mesh-list
19636781|NCT02421029|Calcium|calcium|mesh-list
19636782|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
19636783|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19636784|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636785|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19636786|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
19636787|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19777629|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318228|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777630|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777631|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19777632|NCT00203242|Valproic Acid|valproic acid|mesh-list
19777633|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
19777634|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777635|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777636|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
19777637|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777638|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777639|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
19777640|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19777641|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777642|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777643|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
19777644|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19777645|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
19777646|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
19777647|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777648|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777649|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777650|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777651|NCT00203268|Analgesics|analgesics|mesh-ancestor
19777652|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
19777653|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777654|NCT00203294|Triamcinolone|triamcinolone|mesh-list
19777655|NCT00203294|Lidocaine|lidocaine|mesh-list
19777656|NCT00203294|Bupivacaine|bupivacaine|mesh-list
19777657|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
19777658|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
19777659|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777660|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777661|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
19777662|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777663|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19777664|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19777665|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19777666|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777667|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777668|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777669|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
19777670|NCT00203294|Hormones|hormones|mesh-ancestor
19777671|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777672|NCT00203307|Olanzapine|olanzapine|mesh-list
19777673|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
19777674|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
19777675|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777676|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777677|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777678|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19777679|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19777680|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777681|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777682|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19777683|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19777684|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777685|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777686|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777687|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
19777688|NCT00203411|Bevacizumab|bevacizumab|mesh-list
19777689|NCT00203411|Capecitabine|capecitabine|mesh-list
19636788|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
19636789|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
19636790|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636791|NCT02421029|Antidotes|antidotes|mesh-ancestor
19636792|NCT02421029|Protective Agents|protective agents|mesh-ancestor
19636793|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19636794|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19636795|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19636796|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19636797|NCT02420834|Laxatives|laxatives|mesh-ancestor
19636798|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636799|NCT02420665|Acetic Acid|acetic acid|mesh-list
19636800|NCT02420665|Proflavine|proflavine|mesh-list
19777690|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19636801|NCT02420665|Retinol acetate|retinol acetate|mesh-list
19777691|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777692|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19777693|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19777694|NCT00203411|Growth Substances|growth substances|mesh-ancestor
19777695|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777696|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
19777697|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19777698|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
19777699|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777700|NCT00203424|Bevacizumab|bevacizumab|mesh-list
19777701|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19777702|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19777703|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777704|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19777705|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19777706|NCT00203424|Growth Substances|growth substances|mesh-ancestor
19777707|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777708|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
19777709|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19777710|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777711|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777712|NCT00203476|Niacin|niacin|mesh-list
19777713|NCT00203476|Ezetimibe|ezetimibe|mesh-list
19777714|NCT00203476|Colestipol|colestipol|mesh-list
19777715|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19777716|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19777717|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
19777718|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777719|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19777720|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
19777721|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
19777722|NCT00203476|Vitamins|vitamins|mesh-ancestor
19777723|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
19777724|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777725|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
19777726|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
19777727|NCT00203502|Bevacizumab|bevacizumab|mesh-list
19777728|NCT00203502|Docetaxel|docetaxel|mesh-list
19777729|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318229|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
20318230|NCT00714181|Temozolomide|temozolomide|mesh-list
20318231|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20318232|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
20318233|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318234|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318235|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
20318236|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20318237|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20318238|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318239|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318240|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777730|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
19777731|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777732|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777733|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19777734|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
19777735|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777736|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777737|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19777738|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19777739|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19777740|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19777741|NCT00203502|Growth Substances|growth substances|mesh-ancestor
19777742|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
19777743|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
19777744|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
19777745|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
19777746|NCT00203931|Pemetrexed|pemetrexed|mesh-list
19777747|NCT00203931|Cetuximab|cetuximab|mesh-list
19777748|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777749|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777750|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777751|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19777752|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20318241|NCT00714246|Carboplatin|carboplatin|mesh-list
20318242|NCT00714246|Docetaxel|docetaxel|mesh-list
19777753|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19777754|NCT00203996|Pioglitazone|pioglitazone|mesh-list
19777755|NCT00203996|Leuprolide|leuprolide|mesh-list
19777756|NCT00203996|Estrogens|estrogens|mesh-list
19777757|NCT00203996|Progestins|progestins|mesh-list
19777758|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19777759|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777760|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19777761|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
19777762|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777763|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19777764|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777765|NCT00203996|Hormones|hormones|mesh-ancestor
19777766|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777767|NCT00204373|Lansoprazole|lansoprazole|mesh-list
19777768|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
19777769|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19777770|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777771|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19777772|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777773|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777774|NCT00205374|Cidofovir|cidofovir|mesh-list
19777775|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
19777776|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777777|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777778|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777779|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
19777780|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19777781|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19777782|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
19777783|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19777784|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777785|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19777786|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19777787|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19777788|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19777789|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777790|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19777791|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19777792|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777793|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151341|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151342|NCT00088608|Pasireotide|pasireotide|mesh-list
20151343|NCT00088608|Hormones|hormones|mesh-ancestor
20151344|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151345|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151346|NCT00088686|Capsaicin|capsaicin|mesh-list
20151347|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
20151348|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151349|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
20151350|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151351|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151352|NCT00088816|Tegafur|tegafur|mesh-list
20151353|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151354|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636802|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19636803|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636804|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19636805|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
19636806|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636807|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19636808|NCT02420665|Protective Agents|protective agents|mesh-ancestor
19636809|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636810|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19636811|NCT02420782|Itraconazole|itraconazole|mesh-list
19636812|NCT02420782|Midazolam|midazolam|mesh-list
19636813|NCT02420782|Pilocarpine|pilocarpine|mesh-list
19636814|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19636815|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19636816|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636817|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636818|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19636819|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19777794|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151355|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
20151356|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151357|NCT00088855|Doxorubicin|doxorubicin|mesh-list
20151358|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20151359|NCT00088855|Bortezomib|bortezomib|mesh-list
20151360|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20151361|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151362|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20318243|NCT00714246|Bortezomib|bortezomib|mesh-list
19777795|NCT00205699|Olanzapine|olanzapine|mesh-list
19777796|NCT00205699|Risperidone|risperidone|mesh-list
19777797|NCT00205699|Aripiprazole|aripiprazole|mesh-list
20318244|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318245|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
20318246|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
20318247|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
20318248|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318249|NCT00714376|Docetaxel|docetaxel|mesh-list
20318250|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777798|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19777799|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
19777800|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777801|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777802|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777803|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19777804|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19777805|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777806|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777807|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19777808|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
19777809|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
19777810|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
19777811|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777812|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777813|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19777814|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19777815|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777816|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
19777817|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
19777818|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19777819|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19777820|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19777821|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19777822|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
20318251|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
20318252|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
19777823|NCT00205712|Ketamine|ketamine|mesh-list
19777824|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19777825|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777826|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777827|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20151363|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318253|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
20318254|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318255|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
20318256|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20318257|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
20318258|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318259|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318260|NCT00714519|Castor Oil|castor oil|mesh-list
20318261|NCT00714519|Cathartics|cathartics|mesh-ancestor
20318262|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318263|NCT00714558|Fentanyl|fentanyl|mesh-list
20318264|NCT00714558|Naltrexone|naltrexone|mesh-list
20318265|NCT00714558|Naloxone|naloxone|mesh-list
19636820|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19636821|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19636822|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
19636823|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
19636824|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
19636825|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
19636826|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636827|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636828|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
19636829|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636830|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19636831|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19777828|NCT00205712|Analgesics|analgesics|mesh-ancestor
19777829|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
19777830|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777831|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19777832|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19777833|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19777834|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
19777835|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777836|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777837|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19777838|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19777839|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
19777840|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
19777841|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19777842|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19777843|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
19777844|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19777845|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19777846|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
19777847|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19777848|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777849|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19777850|NCT00205803|Vaccines|vaccines|mesh-list
19777851|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19777852|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
19777853|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777854|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
19777855|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19777856|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777857|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19777858|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
19777859|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19777860|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777861|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777862|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777863|NCT00206102|Risperidone|risperidone|mesh-list
19777864|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19777865|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19777866|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
19777867|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19777868|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777869|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777870|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19777871|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19777872|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19777873|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19777874|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19777875|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
19777876|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
19777877|NCT00206323|Topiramate|topiramate|mesh-list
19777878|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
19777879|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19777880|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777881|NCT00206336|Topiramate|topiramate|mesh-list
19777882|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
19777883|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19777884|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777885|NCT00206427|Lapatinib|lapatinib|mesh-list
19777886|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777887|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19777888|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777889|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777890|NCT00206440|Esomeprazole|esomeprazole|mesh-list
19777891|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19777892|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777893|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19777894|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777895|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777896|NCT00206518|Docetaxel|docetaxel|mesh-list
19777897|NCT00206518|Doxorubicin|doxorubicin|mesh-list
19777898|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19777899|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
19777900|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777901|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
19636832|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636833|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19636834|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
19636835|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636836|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19636837|NCT02420782|Miotics|miotics|mesh-ancestor
19777902|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
19777903|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
19777904|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777905|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19777906|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20318266|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20318267|NCT00714558|Narcotics|narcotics|mesh-ancestor
20318268|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318269|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318270|NCT00714558|Analgesics|analgesics|mesh-ancestor
19777907|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19777908|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777909|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777910|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
19777911|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777912|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777913|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19777914|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
19777915|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19777916|NCT00206726|Fludarabine|fludarabine|mesh-list
19777917|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
19777918|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19777919|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19777920|NCT00207090|Rifampin|rifampin|mesh-list
19777921|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20151364|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151365|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151366|NCT00088894|Gemcitabine|gemcitabine|mesh-list
20151367|NCT00088894|Bevacizumab|bevacizumab|mesh-list
20151368|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20151369|NCT00088894|Antibodies|antibodies|mesh-list
20151370|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
20151371|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20151372|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151373|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20151374|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19777922|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
19777923|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19777924|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777925|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
19777926|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19777927|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777928|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777929|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19777930|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19777931|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19777932|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19777933|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19777934|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19777935|NCT00207142|Ritonavir|ritonavir|mesh-list
19777936|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20151375|NCT00088894|Growth Substances|growth substances|mesh-ancestor
20151376|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151377|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
20151378|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
20151379|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151380|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
20151381|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318271|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
20318272|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318273|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19636838|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
19636839|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777937|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19777938|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19777939|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
20151382|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
19777940|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777941|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777942|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19777943|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19777944|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
19777945|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19777946|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19777947|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19777948|NCT00207714|Golimumab|golimumab|mesh-list
19777949|NCT00207714|Infliximab|infliximab|mesh-list
19777950|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777951|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19777952|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636840|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19636841|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19636842|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
19636843|NCT02420652|Aspirin|aspirin|mesh-list
19636844|NCT02420652|Metformin|metformin|mesh-list
19636845|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19636846|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318274|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20318275|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
20318276|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
19636847|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777953|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19777954|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777955|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777956|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
19777957|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777958|NCT00207727|Ustekinumab|ustekinumab|mesh-list
19777959|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777960|NCT00207740|Golimumab|golimumab|mesh-list
20151383|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151384|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151385|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151386|NCT00088933|Metronidazole|metronidazole|mesh-list
20151387|NCT00088933|Docetaxel|docetaxel|mesh-list
20151388|NCT00088933|Vaccines|vaccines|mesh-list
20151389|NCT00088933|Sargramostim|sargramostim|mesh-list
20151390|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
20151391|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151392|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151393|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151394|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
19777961|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19777962|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777963|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777964|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
19777965|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777966|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
19777967|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19777968|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777969|NCT00208026|Analgesics|analgesics|mesh-ancestor
19777970|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
19777971|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19777972|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19777973|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19777974|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19777975|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
19777976|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777977|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
19777978|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19777979|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19777980|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777981|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
19777982|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19777983|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19777984|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777985|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
19777986|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151395|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151396|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636848|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19777987|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318277|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20318278|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19777988|NCT00208767|Valsartan|valsartan|mesh-list
19777989|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19777990|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19777991|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19777992|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19777993|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
19777994|NCT00208975|Rituximab|rituximab|mesh-list
19777995|NCT00208975|Fludarabine|fludarabine|mesh-list
19777996|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
19777997|NCT00208975|Sargramostim|sargramostim|mesh-list
19777998|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19777999|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
19778000|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778001|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19778002|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19778003|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
19778004|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778005|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778006|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20151397|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151398|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151399|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19778007|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778008|NCT00208975|Analgesics|analgesics|mesh-ancestor
20151400|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20318279|NCT00714584|Naltrexone|naltrexone|mesh-list
20318280|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20318281|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20318282|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318283|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
20318284|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318285|NCT00714623|Sirolimus|sirolimus|mesh-list
20318286|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318287|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318288|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318289|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318290|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
20318291|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318292|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
20318293|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318294|NCT00714649|Cetuximab|cetuximab|mesh-list
20318295|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20318296|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318297|NCT00714740|Acetazolamide|acetazolamide|mesh-list
20318298|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
20318299|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20318300|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318301|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318302|NCT00714740|Diuretics|diuretics|mesh-ancestor
20318303|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
20318304|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318305|NCT00714779|Fluoxetine|fluoxetine|mesh-list
20318306|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20318307|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20318308|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20318309|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318310|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318311|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
20318312|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318313|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20318314|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
20318315|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20318316|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20318317|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20318318|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151401|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20151402|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151403|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151404|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151405|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151406|NCT00088959|Celecoxib|celecoxib|mesh-list
20151407|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20151408|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778009|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
19778010|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778011|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20151409|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151410|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151411|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778012|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778013|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778014|NCT00209092|Docetaxel|docetaxel|mesh-list
19778015|NCT00209092|Capecitabine|capecitabine|mesh-list
19778016|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778017|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
19778018|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778019|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778020|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778021|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19778022|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
19778023|NCT00209170|Citalopram|citalopram|mesh-list
19778024|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19778025|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19778026|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778027|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778028|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778029|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
19778030|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778031|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19778032|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778033|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778034|NCT00209560|Fospropofol|fospropofol|mesh-list
19778035|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19778036|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778037|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778038|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
19778039|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778040|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19778041|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778042|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778043|NCT00210184|Leucovorin|leucovorin|mesh-list
19778044|NCT00210184|Fluorouracil|fluorouracil|mesh-list
19778045|NCT00210184|Irinotecan|irinotecan|mesh-list
19778046|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
19778047|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778048|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19778049|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778050|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778051|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
19778052|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778053|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19778054|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778055|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778056|NCT00210184|Antidotes|antidotes|mesh-ancestor
19778057|NCT00210184|Protective Agents|protective agents|mesh-ancestor
19778058|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
19778059|NCT00210184|Vitamins|vitamins|mesh-ancestor
19778060|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
19778061|NCT00210353|Rituximab|rituximab|mesh-list
19778062|NCT00210353|Chlorambucil|chlorambucil|mesh-list
19778063|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778064|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778065|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
19778066|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778067|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19778068|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19778069|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
19778070|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778071|NCT00210470|Zinc|zinc|mesh-list
19778072|NCT00210470|Indomethacin|indomethacin|mesh-list
20151412|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20151413|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20151414|NCT00088959|Analgesics|analgesics|mesh-ancestor
20151415|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
20151416|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151417|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778073|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
19778074|NCT00210470|Omeprazole|omeprazole|mesh-list
19778075|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778076|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
19778077|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778078|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19778079|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19778080|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
19778081|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778082|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778083|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19778084|NCT00210470|Trace Elements|trace elements|mesh-ancestor
19778085|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
19778086|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19778087|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778088|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19778089|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778090|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19778091|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19778092|NCT00210470|Analgesics|analgesics|mesh-ancestor
19778093|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
19778094|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778095|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778096|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
19778097|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
19778098|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19778099|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19778100|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
19778101|NCT00210626|Hematinics|hematinics|mesh-ancestor
19636849|NCT02420652|Analgesics|analgesics|mesh-ancestor
19636850|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
19636851|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636852|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636853|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636854|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19636855|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19636856|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636857|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19636858|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19636859|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636860|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
19636861|NCT02420509|Leucovorin|leucovorin|mesh-list
19636862|NCT02420509|Capecitabine|capecitabine|mesh-list
19636863|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636864|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636865|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19636866|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
19636867|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636868|NCT02420509|Antidotes|antidotes|mesh-ancestor
19636869|NCT02420509|Protective Agents|protective agents|mesh-ancestor
19778102|NCT00211081|Spironolactone|spironolactone|mesh-list
19778103|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19778104|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
19778105|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778106|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778107|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19778108|NCT00211081|Diuretics|diuretics|mesh-ancestor
19778109|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
19778110|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19778111|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19778112|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
20611122|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611123|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20611124|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611125|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611126|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20611127|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
20611128|NCT02166463|Hormones|hormones|mesh-ancestor
20611129|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611130|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20611131|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611132|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611133|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611134|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611135|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
19636870|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
19636871|NCT02420509|Vitamins|vitamins|mesh-ancestor
20611136|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
20611137|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611138|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20611139|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19778113|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778114|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778115|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778116|NCT00211185|Prednisone|prednisone|mesh-list
19778117|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
19778118|NCT00211185|Doxorubicin|doxorubicin|mesh-list
19778119|NCT00211185|Vincristine|vincristine|mesh-list
19778120|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
19778121|NCT00211185|Sargramostim|sargramostim|mesh-list
19778122|NCT00211185|Lenograstim|lenograstim|mesh-list
19778123|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778124|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
19778125|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778126|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19778127|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19778128|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
19778129|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778130|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778131|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19778132|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19778133|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19778134|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778135|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778136|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778137|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
19778138|NCT00211185|Hormones|hormones|mesh-ancestor
19778139|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778140|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778141|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19778142|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
19778143|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778144|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778145|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19778146|NCT00211510|Insulin|insulin|mesh-list
19778147|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19778148|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778149|NCT00211536|Insulin|insulin|mesh-list
19778150|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19778151|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19778152|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778153|NCT00211692|Interferons|interferons|mesh-list
19778154|NCT00211692|Ribavirin|ribavirin|mesh-list
19778155|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
19778156|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
19778157|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778158|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
19778159|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778160|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
19778161|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778162|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
19778163|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778164|NCT00211757|Valproic Acid|valproic acid|mesh-list
19778165|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
19778166|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778167|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778168|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
19778169|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778170|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151418|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20151419|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151420|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20151421|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20151422|NCT00088998|Bevacizumab|bevacizumab|mesh-list
20151423|NCT00088998|Docetaxel|docetaxel|mesh-list
20151424|NCT00088998|Capecitabine|capecitabine|mesh-list
20151425|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778171|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
19778172|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778173|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151426|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611140|NCT02166463|Protective Agents|protective agents|mesh-ancestor
19778174|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778175|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19778176|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19778177|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19778178|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778179|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778180|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778181|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778182|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19778183|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778184|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778185|NCT00211887|Interferons|interferons|mesh-list
19778186|NCT00211887|Interferon-beta|interferon-beta|mesh-list
19778187|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
19778188|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
19778189|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
19778190|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778191|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
19778192|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778193|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
19778194|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778195|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19778196|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778197|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833483|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833484|NCT00588406|Prednisone|prednisone|mesh-list
19833485|NCT00588406|Budesonide|budesonide|mesh-list
19833486|NCT00588406|Bromides|bromides|mesh-list
19833487|NCT00588406|Albuterol|albuterol|mesh-list
19833488|NCT00588406|Ipratropium|ipratropium|mesh-list
19833489|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833490|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
19833491|NCT00588406|Hormones|hormones|mesh-ancestor
19833492|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833493|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833494|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19833495|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833496|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19833497|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
19833498|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833499|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19833500|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833501|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
19833502|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
19833503|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19833504|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19833505|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19833506|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19833507|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
19833508|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833509|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833510|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19833511|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
19833512|NCT00588445|Gefitinib|gefitinib|mesh-list
19833513|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636872|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
19636873|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19636874|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19636875|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19636876|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
19636877|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19636878|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636879|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19636880|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636881|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
19636882|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
19833514|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19833515|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778198|NCT00212134|Dipivefrin|dipivefrin|mesh-list
19778199|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19778200|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19778201|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778202|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778203|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778204|NCT00212758|Hormones|hormones|mesh-list
19778205|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778206|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778207|NCT00213135|Cladribine|cladribine|mesh-list
19778208|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778209|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778210|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
19778211|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778212|NCT00213148|Anastrozole|anastrozole|mesh-list
19778213|NCT00213148|Citric Acid|citric acid|mesh-list
19778214|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
19778215|NCT00213148|Clomiphene|clomiphene|mesh-list
19778216|NCT00213148|Enclomiphene|enclomiphene|mesh-list
19778217|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
19778218|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
19778219|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19778220|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
19778221|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
20151427|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20151428|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20151429|NCT00088998|Growth Substances|growth substances|mesh-ancestor
20151430|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151431|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
20151432|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151433|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151434|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151435|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151436|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151437|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
20151438|NCT00089037|Sirolimus|sirolimus|mesh-list
19778222|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778223|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778224|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778225|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19778226|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19778227|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778228|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19778229|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
19778230|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778231|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778232|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19778233|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
19778234|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19778235|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19778236|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19778237|NCT00213239|Remifentanil|remifentanil|mesh-list
19778238|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19778239|NCT00213239|Narcotics|narcotics|mesh-ancestor
19778240|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778241|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778242|NCT00213239|Analgesics|analgesics|mesh-ancestor
19778243|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
19778244|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778245|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
19778246|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19778247|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778248|NCT00214019|Fluticasone|fluticasone|mesh-list
19778249|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19778250|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19778251|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778252|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19778253|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
19778254|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778255|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778256|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19778257|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
19778258|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
19778259|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19778260|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19778261|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19778262|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19778263|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19778264|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778265|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778266|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
19778267|NCT00214019|Hormones|hormones|mesh-ancestor
19778268|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778269|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
19778270|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19778271|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778272|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778273|NCT00214461|Vaccines|vaccines|mesh-list
19778274|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
19636883|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636884|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19636885|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
19636886|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20151439|NCT00089037|Methotrexate|methotrexate|mesh-list
20151440|NCT00089037|Tacrolimus|tacrolimus|mesh-list
19778275|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778276|NCT00214890|Tenofovir|tenofovir|mesh-list
19778277|NCT00214890|Abacavir|abacavir|mesh-list
19778278|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
19778279|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778280|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19778281|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19636887|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
19636888|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19636889|NCT02420418|Expectorants|expectorants|mesh-ancestor
19636890|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
19636891|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19778282|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778283|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778284|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19778285|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20151441|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19778286|NCT00215137|Citalopram|citalopram|mesh-list
19778287|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19778288|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19778289|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778290|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778291|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778292|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
19778293|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151442|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
20151443|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20151444|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151445|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151446|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
20151447|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151448|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151449|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151450|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151451|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20151452|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151453|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
20151454|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151455|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20151456|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20151457|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19778294|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19778295|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778296|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778297|NCT00215150|Ziprasidone|ziprasidone|mesh-list
19778298|NCT00215150|Sertraline|sertraline|mesh-list
19778299|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778300|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778301|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19778302|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19778303|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778304|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778305|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778306|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
19778307|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778308|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19778309|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778310|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778311|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778312|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19778313|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
19778314|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19778315|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
19778316|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19778317|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
19778318|NCT00215644|Capecitabine|capecitabine|mesh-list
19778319|NCT00215644|Epirubicin|epirubicin|mesh-list
19778320|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778321|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19778322|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
19778323|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778324|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19778325|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19778326|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778327|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778328|NCT00215787|Lansoprazole|lansoprazole|mesh-list
19778329|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
19778330|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19778331|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778332|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19778333|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778334|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151458|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151459|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20151460|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
20151461|NCT00089050|Cyclosporine|cyclosporine|mesh-list
20151462|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
20151463|NCT00089050|Cyclosporins|cyclosporins|mesh-list
20151464|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151465|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151466|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151467|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
20151468|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151469|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
20151470|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151471|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151472|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151473|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20151474|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20151475|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151476|NCT00089063|Sargramostim|sargramostim|mesh-list
20151477|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
20151478|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
20318319|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
20318320|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20318321|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318322|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318323|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20318324|NCT00714857|Analgesics|analgesics|mesh-ancestor
20318325|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
20318326|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318327|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20318328|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20318329|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19778335|NCT00215930|Gemcitabine|gemcitabine|mesh-list
19778336|NCT00215930|Carboplatin|carboplatin|mesh-list
19778337|NCT00215930|Docetaxel|docetaxel|mesh-list
19778338|NCT00215930|Vinorelbine|vinorelbine|mesh-list
19778339|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778340|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19778341|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
19636892|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
19778342|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778343|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
19778344|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778345|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778346|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778347|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
19778348|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778349|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
19778350|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778351|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778352|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19778353|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
19778354|NCT00215943|Thalidomide|thalidomide|mesh-list
19778355|NCT00215943|Dexamethasone|dexamethasone|mesh-list
19778356|NCT00215943|Doxorubicin|doxorubicin|mesh-list
19778357|NCT00215943|Vincristine|vincristine|mesh-list
19778358|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19778359|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778360|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
19778361|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
19778362|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778363|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778364|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778365|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
19778366|NCT00215943|Hormones|hormones|mesh-ancestor
19778367|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778368|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778369|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778370|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19778371|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19636893|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636894|NCT02420418|Protective Agents|protective agents|mesh-ancestor
19636895|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636896|NCT02420418|Antidotes|antidotes|mesh-ancestor
19636897|NCT02420171|Insulin|insulin|mesh-list
19636898|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19636899|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636900|NCT02420132|Ranibizumab|ranibizumab|mesh-list
19636901|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19636902|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19636903|NCT02420132|Growth Substances|growth substances|mesh-ancestor
19636904|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636905|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
19636906|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636907|NCT02420080|Brincidofovir|brincidofovir|mesh-list
19636908|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
19636909|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778372|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778373|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778374|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318330|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
19778375|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19778376|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
19778377|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778378|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778379|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778380|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
19778381|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
19778382|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19778383|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778384|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19778385|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19778386|NCT00215943|Growth Substances|growth substances|mesh-ancestor
19778387|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
19778388|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19778389|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
19778390|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19778391|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778392|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778393|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19778394|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778395|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19778396|NCT00216086|Capecitabine|capecitabine|mesh-list
19778397|NCT00216086|Irinotecan|irinotecan|mesh-list
19778398|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318331|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318332|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318333|NCT00714883|Sirolimus|sirolimus|mesh-list
19778399|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
19778400|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778401|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778402|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19778403|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778404|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778405|NCT00216099|Folic Acid|folic acid|mesh-list
19778406|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
19778407|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
19778408|NCT00216099|Pemetrexed|pemetrexed|mesh-list
19778409|NCT00216099|Vitamins|vitamins|mesh-ancestor
19778410|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
19778411|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778412|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778413|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778414|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778415|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19778416|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19778417|NCT00216099|Hematinics|hematinics|mesh-ancestor
19778418|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
19778419|NCT00216125|Docetaxel|docetaxel|mesh-list
20318334|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318335|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318336|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19778420|NCT00216125|Etoposide|etoposide|mesh-list
19778421|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778422|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19778423|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778424|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778425|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778426|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19778427|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19778428|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778429|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778430|NCT00216203|Pemetrexed|pemetrexed|mesh-list
19778431|NCT00216203|Cetuximab|cetuximab|mesh-list
20151479|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151480|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20151481|NCT00089089|Decitabine|decitabine|mesh-list
20151482|NCT00089089|Azacitidine|azacitidine|mesh-list
20151483|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151484|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
20151485|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151486|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151487|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318337|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778432|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778433|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778434|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778435|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19778436|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19778437|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778438|NCT00216476|Risperidone|risperidone|mesh-list
19778439|NCT00216476|Aripiprazole|aripiprazole|mesh-list
19778440|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19778441|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19778442|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
19778443|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778444|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778445|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778446|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778447|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778448|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778449|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778450|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19778451|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
19778452|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778453|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
19778454|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19778455|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19778456|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19778457|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19778458|NCT00216671|Risperidone|risperidone|mesh-list
19778459|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19778460|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
19778461|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778462|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778463|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778464|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778465|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778466|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778467|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778468|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19778469|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
19778470|NCT00216736|Dexamethasone|dexamethasone|mesh-list
19778471|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778472|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
19778473|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
19778474|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778475|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778476|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778477|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
19778478|NCT00216736|Hormones|hormones|mesh-ancestor
19778479|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778480|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778481|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778482|NCT00217022|Budesonide|budesonide|mesh-list
19778483|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778484|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19778485|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
19778486|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151488|NCT00089115|Rituximab|rituximab|mesh-list
19636910|NCT02419742|Paclitaxel|paclitaxel|mesh-list
19636911|NCT02419742|Docetaxel|docetaxel|mesh-list
19636912|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
19636913|NCT02419742|Carboplatin|carboplatin|mesh-list
19636914|NCT02419742|Doxorubicin|doxorubicin|mesh-list
19636915|NCT02419742|Trastuzumab|trastuzumab|mesh-list
19636916|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19636917|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636918|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
19636919|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
19636920|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
19636921|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636922|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636923|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
19636924|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636925|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636926|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19636927|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
19636928|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19636929|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19778487|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778488|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19778489|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
19778490|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
19778491|NCT00217022|Hormones|hormones|mesh-ancestor
19778492|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778493|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19778494|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778495|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
19778496|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19778497|NCT00217399|Sorafenib|sorafenib|mesh-list
19778498|NCT00217399|Anastrozole|anastrozole|mesh-list
19778499|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778500|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19778501|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778502|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778503|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778504|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19778505|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19778506|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19778507|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
19778508|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778509|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778510|NCT00217425|Prednisone|prednisone|mesh-list
19778511|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
19778512|NCT00217425|Bevacizumab|bevacizumab|mesh-list
19778513|NCT00217425|Doxorubicin|doxorubicin|mesh-list
19778514|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19778515|NCT00217425|Vincristine|vincristine|mesh-list
19778516|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778517|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
19778518|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778519|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19778520|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19778521|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
19778522|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778523|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778524|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19778525|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778526|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19778527|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19778528|NCT00217425|Growth Substances|growth substances|mesh-ancestor
19778529|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
19778530|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19778531|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19778532|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778533|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778534|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778535|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
19778536|NCT00217425|Hormones|hormones|mesh-ancestor
19778537|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778538|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778539|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19778540|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
19778541|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778542|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778543|NCT00217438|Melphalan|melphalan|mesh-list
19778544|NCT00217438|Amifostine|amifostine|mesh-list
19778545|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19778546|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
19778547|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778548|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778549|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19778550|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778551|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
19778552|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778553|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19778554|NCT00217438|Protective Agents|protective agents|mesh-ancestor
19778555|NCT00217464|Fulvestrant|fulvestrant|mesh-list
19778556|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778557|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778558|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19778559|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19778560|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
20318338|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
20318339|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318340|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
20318341|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318342|NCT00714961|Clopidogrel|clopidogrel|mesh-list
19636930|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19636931|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19636932|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636933|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662333|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662334|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662335|NCT05094804|Pembrolizumab|pembrolizumab|mesh-list
19662336|NCT05094804|Nivolumab|nivolumab|mesh-list
20318343|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20318344|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20318345|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20318346|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20318347|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
20318348|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318349|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318350|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318351|NCT00715013|Epothilone B|epothilone b|mesh-list
20318352|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318353|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
20318354|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
20318355|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
20318356|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347418|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
20347419|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
19662337|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662338|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662339|NCT05094804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19662340|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662341|NCT05094596|Montelukast|montelukast|mesh-list
19662342|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19662343|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
19662344|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19662345|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
19662346|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662347|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662348|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19662349|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19662350|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662351|NCT05094492|Fluorides|fluorides|mesh-list
19662352|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
19662353|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
19662354|NCT05094492|Protective Agents|protective agents|mesh-ancestor
19662355|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662356|NCT05094414|Valacyclovir|valacyclovir|mesh-list
19662357|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
19662358|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662359|NCT05094375|Misoprostol|misoprostol|mesh-list
19662360|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19662361|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
19662362|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19662363|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662364|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19662365|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662366|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
19662367|NCT05093907|Capecitabine|capecitabine|mesh-list
19662368|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19662369|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
19662370|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662371|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662372|NCT05093478|Lidocaine|lidocaine|mesh-list
19662373|NCT05093478|Capsaicin|capsaicin|mesh-list
19662374|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
19662375|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
19662376|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662377|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662378|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
19662379|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778561|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778562|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778563|NCT00217581|Bevacizumab|bevacizumab|mesh-list
19778564|NCT00217581|Docetaxel|docetaxel|mesh-list
19778565|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
19778566|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778567|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778568|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19778569|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19778570|NCT00217581|Growth Substances|growth substances|mesh-ancestor
19778571|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778572|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
19778573|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
19778574|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778575|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778576|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778577|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
19778578|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778579|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778580|NCT00217620|Sorafenib|sorafenib|mesh-list
19778581|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778582|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19778583|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778584|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778585|NCT00217672|Bevacizumab|bevacizumab|mesh-list
19778586|NCT00217672|Docetaxel|docetaxel|mesh-list
20151489|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
20151490|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20151491|NCT00089115|Antibodies|antibodies|mesh-list
20151492|NCT00089115|Sargramostim|sargramostim|mesh-list
20151493|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20151494|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20151495|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151496|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
20611141|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
19636934|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
20151497|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151498|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151499|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20151500|NCT00089154|Antibodies|antibodies|mesh-list
20151501|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
20151502|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20151503|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
20151504|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151505|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151506|NCT00089167|Thalidomide|thalidomide|mesh-list
20151507|NCT00089167|Dexamethasone|dexamethasone|mesh-list
20151508|NCT00089167|Melphalan|melphalan|mesh-list
20151509|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20151510|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
20151511|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
20151512|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636935|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19636936|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
19778587|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778588|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778589|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19778590|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19778591|NCT00217672|Growth Substances|growth substances|mesh-ancestor
19778592|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778593|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
19778594|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151513|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318357|NCT00715039|Lorazepam|lorazepam|mesh-list
19636937|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
19636938|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636939|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636940|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636941|NCT02420002|Analgesics|analgesics|mesh-ancestor
20151514|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151515|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
20151516|NCT00089167|Hormones|hormones|mesh-ancestor
20151517|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636942|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
20151518|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20151519|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778595|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
19778596|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
19778597|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778598|NCT00217971|Dronabinol|dronabinol|mesh-list
19778599|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
19778600|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778601|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151520|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
20151521|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20151522|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
20151523|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151524|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20151525|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778602|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19778603|NCT00217971|Analgesics|analgesics|mesh-ancestor
19778604|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
19778605|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778606|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19778607|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19778608|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778609|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778610|NCT00217971|Hormones|hormones|mesh-ancestor
19778611|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778612|NCT00218023|Naltrexone|naltrexone|mesh-list
19778613|NCT00218023|Levodopa|levodopa|mesh-list
19778614|NCT00218023|Carbidopa|carbidopa|mesh-list
19778615|NCT00218023|Modafinil|modafinil|mesh-list
19778616|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19778617|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19778618|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778619|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
19778620|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778621|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19778622|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19778623|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
19778624|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778625|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778626|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19778627|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778628|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19778629|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19778630|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19778631|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19778632|NCT00218062|Modafinil|modafinil|mesh-list
19778633|NCT00218062|Amphetamine|amphetamine|mesh-list
19778634|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
19778635|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19778636|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778637|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19778638|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19778639|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19778640|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778641|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
19778642|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
19778643|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778644|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
19778645|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778646|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
20151526|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
20151527|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151528|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151529|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20151530|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20151531|NCT00089167|Growth Substances|growth substances|mesh-ancestor
20151532|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
20151533|NCT00089193|Sargramostim|sargramostim|mesh-list
20151534|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
20151535|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
20151536|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151537|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20151538|NCT00089206|Sargramostim|sargramostim|mesh-list
20151539|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
20151540|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
20318358|NCT00715039|Paroxetine|paroxetine|mesh-list
19778647|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19778648|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19778649|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778650|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19778651|NCT00218257|Progesterone|progesterone|mesh-list
19778652|NCT00218257|Progestins|progestins|mesh-ancestor
19778653|NCT00218257|Hormones|hormones|mesh-ancestor
19778654|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778655|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778656|NCT00218296|Lobeline|lobeline|mesh-list
19778657|NCT00218296|Nicotine|nicotine|mesh-list
19778658|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19778659|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
19778660|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778661|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778662|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19778663|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19778664|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
19778665|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778666|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778667|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
19778668|NCT00218387|Modafinil|modafinil|mesh-list
20151541|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151542|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20151543|NCT00089219|Sargramostim|sargramostim|mesh-list
19778669|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19778670|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778671|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19778672|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19778673|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19778674|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778675|NCT00218426|Naltrexone|naltrexone|mesh-list
19778676|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19778677|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19778678|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778679|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
19778680|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778681|NCT00218439|Paroxetine|paroxetine|mesh-list
19778682|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19778683|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19778684|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778685|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778686|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778687|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
19778688|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778689|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19778690|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778691|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778692|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19778693|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19778694|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778695|NCT00218465|Glycine|glycine|mesh-list
19778696|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
19778697|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778698|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778699|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778700|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
19778701|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19778702|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
19778703|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778704|NCT00218491|Expectorants|expectorants|mesh-ancestor
19778705|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
19778706|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19778707|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
19778708|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778709|NCT00218491|Protective Agents|protective agents|mesh-ancestor
19778710|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778711|NCT00218491|Antidotes|antidotes|mesh-ancestor
19778712|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19778713|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19778714|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151544|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
20151545|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
19778715|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778716|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778717|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
19778718|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778719|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778720|NCT00219141|Losartan|losartan|mesh-list
19778721|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19778722|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19778723|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19778724|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19778725|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778726|NCT00219284|Levodopa|levodopa|mesh-list
19778727|NCT00219284|Carbidopa|carbidopa|mesh-list
19778728|NCT00219284|Entacapone|entacapone|mesh-list
19636943|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636944|NCT02419729|Estrogens|estrogens|mesh-list
19636945|NCT02419729|Hormones|hormones|mesh-ancestor
19636946|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19636947|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636948|NCT02419651|Diclofenac|diclofenac|mesh-list
19636949|NCT02419651|Tramadol|tramadol|mesh-list
19636950|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19636951|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636952|NCT02419651|Analgesics|analgesics|mesh-ancestor
19778729|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19778730|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19778731|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19778732|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
19778733|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778734|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778735|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778736|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19778737|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778738|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19778739|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19778740|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
19778741|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
19636953|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
19778742|NCT00219349|Citalopram|citalopram|mesh-list
19778743|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19778744|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19778745|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778746|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778747|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778748|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
19778749|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778750|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19778751|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778752|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778753|NCT00219544|Pregabalin|pregabalin|mesh-list
19778754|NCT00219544|Analgesics|analgesics|mesh-ancestor
19778755|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
19778756|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778757|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778758|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
19778759|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19778760|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778761|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151546|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151547|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20151548|NCT00089258|Isotretinoin|isotretinoin|mesh-list
20151549|NCT00089258|Antibodies|antibodies|mesh-list
20151550|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20151551|NCT00089258|Sargramostim|sargramostim|mesh-list
20151552|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
20151553|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151554|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151555|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20151556|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
20151557|NCT00089349|Methotrexate|methotrexate|mesh-list
20151558|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
20151559|NCT00089349|Antibodies|antibodies|mesh-list
20151560|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
19636954|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778762|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19778763|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19778764|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778765|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778766|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778767|NCT00219557|Gemcitabine|gemcitabine|mesh-list
19778768|NCT00219557|Axitinib|axitinib|mesh-list
19778769|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19778770|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
19778771|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778772|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778773|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
19778774|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778775|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778776|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778777|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
19778778|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778779|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19778780|NCT00220636|Aripiprazole|aripiprazole|mesh-list
19778781|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778782|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778783|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778784|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778785|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778786|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778787|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
19778788|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
19778789|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778790|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778791|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19778792|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19778793|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
19778794|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19778795|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19778796|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19778797|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19778798|NCT00220701|Dexetimide|dexetimide|mesh-list
19778799|NCT00220701|Citalopram|citalopram|mesh-list
19778800|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19778801|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20318359|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19636955|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636956|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636957|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636958|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19636959|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636960|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318360|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20318361|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347420|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778802|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778803|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778804|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778805|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
19778806|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151561|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20151562|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
20151563|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151564|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19636961|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20151565|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20151566|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
20151567|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20151568|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151569|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
20151570|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151571|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151572|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636962|NCT02419651|Narcotics|narcotics|mesh-ancestor
19636963|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19636964|NCT02419820|Aspirin|aspirin|mesh-list
19636965|NCT02419820|Clopidogrel|clopidogrel|mesh-list
19636966|NCT02419820|APD791|apd791|mesh-list
19778807|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19778808|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
19778809|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778810|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19778811|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19778812|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
19778813|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
19778814|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778815|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19778816|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19778817|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
19778818|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
19778819|NCT00220727|Antibodies|antibodies|mesh-list
19778820|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
19778821|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19778822|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19778823|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
19778824|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
19778825|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778826|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
19778827|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19778828|NCT00220740|Antibodies|antibodies|mesh-list
19778829|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
19778830|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19778831|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
19778832|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
19778833|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778834|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
20318362|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318363|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318364|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
20318365|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318366|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20318367|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
20318368|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20318369|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20318370|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20318371|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778835|NCT00220779|Antibodies|antibodies|mesh-list
19778836|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
19778837|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19778838|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19778839|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
19778840|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
19778841|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151573|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20151574|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318372|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
20318373|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
20151575|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151576|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20151577|NCT00089401|Melphalan|melphalan|mesh-list
20151578|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20151579|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
20151580|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151581|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151582|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20151583|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19636967|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19636968|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19636969|NCT02419820|Analgesics|analgesics|mesh-ancestor
19636970|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
19636971|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19636972|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636973|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19636974|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19636975|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19636976|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19636977|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636978|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19636979|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19778842|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
19778843|NCT00220805|Antibodies|antibodies|mesh-list
19778844|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
19778845|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19778846|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19778847|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
19778848|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
20318374|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
20318375|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318376|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318377|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20318378|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318379|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19778849|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778850|NCT00220961|Pioglitazone|pioglitazone|mesh-list
19778851|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19778852|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778853|NCT00221104|Pravastatin|pravastatin|mesh-list
19778854|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19778855|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19778856|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
19778857|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778858|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19778859|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20318380|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20318381|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
20318382|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
20318383|NCT00715091|Diclofenac|diclofenac|mesh-list
20318384|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20318385|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20318386|NCT00715091|Analgesics|analgesics|mesh-ancestor
20318387|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
20318388|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318389|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318390|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318391|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20318392|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20318393|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636980|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19636981|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
19636982|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19636983|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19636984|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19636985|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
19636986|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19636987|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19636988|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19636989|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
19636990|NCT02419534|Diltiazem|diltiazem|mesh-list
19636991|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20318394|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318395|NCT00715273|Niacin|niacin|mesh-list
20318396|NCT00715273|Niacinamide|niacinamide|mesh-list
19636992|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19636993|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778860|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778861|NCT00221195|Thrombin|thrombin|mesh-list
19778862|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
19778863|NCT00221195|Coagulants|coagulants|mesh-ancestor
19778864|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
19778865|NCT00221299|Hormones|hormones|mesh-list
19778866|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
19778867|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778868|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778869|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19778870|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778871|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778872|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19636994|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19636995|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19636996|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19636997|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
19636998|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19636999|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637000|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637001|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
19778873|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20318397|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
20151584|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
20151585|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318398|NCT00715273|Atorvastatin|atorvastatin|mesh-list
19637002|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637003|NCT02419443|Gabapentin|gabapentin|mesh-list
19637004|NCT02419443|Analgesics|analgesics|mesh-ancestor
19637005|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
19778874|NCT00221338|Gabapentin|gabapentin|mesh-list
19778875|NCT00221338|Analgesics|analgesics|mesh-ancestor
19778876|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
19778877|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778878|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778879|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
19778880|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19778881|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778882|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778883|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778884|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19637006|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637007|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637008|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
19637009|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19637010|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778885|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19778886|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778887|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778888|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
20318399|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20318400|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20318401|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20318402|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
20318403|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318404|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20318405|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20318406|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318407|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
20318408|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
20318409|NCT00715273|Vitamins|vitamins|mesh-ancestor
20318410|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
20318411|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318412|NCT00715351|Insulin|insulin|mesh-list
20318413|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20318414|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
20318415|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
19778889|NCT00221403|Valproic Acid|valproic acid|mesh-list
19778890|NCT00221403|Risperidone|risperidone|mesh-list
19778891|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19778892|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19778893|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
19778894|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778895|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778896|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778897|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778898|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778899|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778900|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778901|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19778902|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
19778903|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
19778904|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778905|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
19778906|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
19778907|NCT00222105|Thalidomide|thalidomide|mesh-list
19778908|NCT00222105|Dexamethasone|dexamethasone|mesh-list
19778909|NCT00222105|Doxorubicin|doxorubicin|mesh-list
20151586|NCT00089427|Temozolomide|temozolomide|mesh-list
20151587|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20151588|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
20151589|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151590|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151591|NCT00089440|Aripiprazole|aripiprazole|mesh-list
20318416|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
19778910|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19778911|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19778912|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
19778913|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
19778914|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19778915|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778916|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778917|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
19778918|NCT00222105|Hormones|hormones|mesh-ancestor
19778919|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19778920|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19778921|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778922|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19778923|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19778924|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19778925|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778926|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778927|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19778928|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
19778929|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
19778930|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19778931|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19778932|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19778933|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19778934|NCT00222105|Growth Substances|growth substances|mesh-ancestor
19778935|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
19778936|NCT00222131|Esomeprazole|esomeprazole|mesh-list
19778937|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19778938|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778939|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19778940|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778941|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778942|NCT00222729|Bevacizumab|bevacizumab|mesh-list
19778943|NCT00222729|Pemetrexed|pemetrexed|mesh-list
19778944|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19778945|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19778946|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19778947|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19778948|NCT00222729|Growth Substances|growth substances|mesh-ancestor
19778949|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778950|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
19778951|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19778952|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778953|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19778954|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19778955|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19778956|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
19778957|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778958|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19778959|NCT00223080|Antacids|antacids|mesh-ancestor
19778960|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778961|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778962|NCT00223236|Choline|choline|mesh-list
19778963|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20151592|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151593|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151594|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778964|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
19778965|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19778966|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
19778967|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778968|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19778969|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19778970|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
19778971|NCT00223262|Lamotrigine|lamotrigine|mesh-list
19778972|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
19778973|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19778974|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19778975|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778976|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19778977|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778978|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778979|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778980|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778981|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778982|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19778983|NCT00223496|Aripiprazole|aripiprazole|mesh-list
19778984|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151595|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778985|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19778986|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19778987|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19778988|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19778989|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19778990|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
19778991|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
19778992|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19778993|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19778994|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19778995|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19778996|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
19778997|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19778998|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19778999|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19779000|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19779001|NCT00223665|Leuprolide|leuprolide|mesh-list
19779002|NCT00223665|Flutamide|flutamide|mesh-list
19779003|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19779004|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
19779005|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19779006|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318417|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
20318418|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20318419|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318420|NCT00715377|Benztropine|benztropine|mesh-list
19779007|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19779008|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779009|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
19779010|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
19779011|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19779012|NCT00223678|Sirolimus|sirolimus|mesh-list
19779013|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19779014|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779015|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19779016|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779017|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
19779018|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779019|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
19779020|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779021|NCT00223704|Icatibant|icatibant|mesh-list
19779022|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
19779023|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19779024|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19779025|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779026|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
19779027|NCT00223704|Coagulants|coagulants|mesh-ancestor
20318421|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20318422|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19779028|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19779029|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19779030|NCT00223704|Analgesics|analgesics|mesh-ancestor
19779031|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
19779032|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779033|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779034|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779035|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779036|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19779037|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19779038|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19779039|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779040|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
19779041|NCT00223821|Oxybutynin|oxybutynin|mesh-list
19779042|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
19779043|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
19779044|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779045|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779046|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19779047|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19779048|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
19779049|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779050|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318423|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
19779051|NCT00223821|Urological Agents|urological agents|mesh-ancestor
19833516|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833517|NCT00588536|Leucovorin|leucovorin|mesh-list
19833518|NCT00588536|Methotrexate|methotrexate|mesh-list
19833519|NCT00588536|Thioguanine|thioguanine|mesh-list
19833520|NCT00588536|Calcium|calcium|mesh-list
19833521|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
19833522|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20318424|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
20318425|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318426|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318427|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20318428|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20318429|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
20318430|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318431|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833523|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833524|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19833525|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
19833526|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19833527|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19833528|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
19833529|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833530|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833531|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
19833532|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833533|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19833534|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19833535|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
19833536|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833537|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19833538|NCT00588536|Antidotes|antidotes|mesh-ancestor
19833539|NCT00588536|Protective Agents|protective agents|mesh-ancestor
19833540|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
19833541|NCT00588536|Vitamins|vitamins|mesh-ancestor
19833542|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
19833543|NCT00588640|Methadone|methadone|mesh-list
19833544|NCT00588640|D-methadone|d-methadone|mesh-list
19833545|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19833546|NCT00588640|Narcotics|narcotics|mesh-ancestor
19833547|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833548|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318432|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20318433|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20318434|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20318435|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
20318436|NCT00715455|Heparin|heparin|mesh-list
20318437|NCT00715455|Calcium heparin|calcium heparin|mesh-list
20318438|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
20318439|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19833549|NCT00588640|Analgesics|analgesics|mesh-ancestor
19833550|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
20318440|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20318441|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318442|NCT00715637|Cytarabine|cytarabine|mesh-list
20318443|NCT00715637|Amonafide|amonafide|mesh-list
20318444|NCT00715637|Daunorubicin|daunorubicin|mesh-list
20318445|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318446|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
20318447|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318448|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318449|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
20318450|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151596|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151597|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151598|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
20151599|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
20151600|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151601|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151602|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20151603|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20151604|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
20318451|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19833551|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833552|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
19637011|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779052|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
19779053|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
19779054|NCT00223977|Hematinics|hematinics|mesh-ancestor
19779055|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
19779056|NCT00224016|Oxybutynin|oxybutynin|mesh-list
19779057|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
19779058|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
19779059|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779060|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779061|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19779062|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19637012|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19637013|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19637014|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19637015|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637016|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637017|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
19637018|NCT02419859|Insulin|insulin|mesh-list
19779063|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
19779064|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779065|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779066|NCT00224016|Urological Agents|urological agents|mesh-ancestor
19779067|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19779068|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779069|NCT00224016|Renal Agents|renal agents|mesh-ancestor
19779070|NCT00224029|Oxybutynin|oxybutynin|mesh-list
19779071|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
19779072|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
19779073|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779074|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779075|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19779076|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19779077|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
19779078|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779079|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779080|NCT00224029|Urological Agents|urological agents|mesh-ancestor
19779081|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
19779082|NCT00224042|Hematinics|hematinics|mesh-ancestor
19779083|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
19779084|NCT00224055|Hematinics|hematinics|mesh-ancestor
19779085|NCT00224107|Silodosin|silodosin|mesh-list
19779086|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19779087|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19779088|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19779089|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
19779090|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779091|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779092|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779093|NCT00224107|Urological Agents|urological agents|mesh-ancestor
19779094|NCT00224120|Silodosin|silodosin|mesh-list
19779095|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19779096|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19779097|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19779098|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
19779099|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779100|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779101|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779102|NCT00224120|Urological Agents|urological agents|mesh-ancestor
19779103|NCT00224133|Silodosin|silodosin|mesh-list
19779104|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19779105|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19779106|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20151605|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20151606|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19637019|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19637020|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19779107|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
20151607|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20151608|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20151609|NCT00089453|Dexamethasone|dexamethasone|mesh-list
20151610|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
20151611|NCT00089453|Melphalan|melphalan|mesh-list
19779108|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151612|NCT00089453|Fludarabine|fludarabine|mesh-list
20318452|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
19779109|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779110|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779111|NCT00224133|Urological Agents|urological agents|mesh-ancestor
19779112|NCT00224289|Latanoprost|latanoprost|mesh-list
19779113|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19779114|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19779115|NCT00224484|Vaccines|vaccines|mesh-list
19779116|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
19779117|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779118|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19779119|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19779120|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19779121|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779122|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
20318453|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318454|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318455|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20318456|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318457|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318458|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
20318459|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
20151613|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151614|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
20151615|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151616|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151617|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20151618|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
20151619|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151620|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637021|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637022|NCT02419352|Atropine|atropine|mesh-list
19637023|NCT02419352|Neostigmine|neostigmine|mesh-list
19637024|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19637025|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20151621|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20151622|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20151623|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
20151624|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
20151625|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151626|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151627|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
20151628|NCT00089453|Hormones|hormones|mesh-ancestor
20151629|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151630|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20151631|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
20151632|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20151633|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20318460|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20151634|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151635|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20151636|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20151637|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
20318461|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19779123|NCT00224874|Etanercept|etanercept|mesh-list
20318462|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318463|NCT00715689|Hormones|hormones|mesh-list
20318464|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318465|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318466|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
20318467|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20318468|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318469|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20318470|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20318471|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
20318472|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637026|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19637027|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
19637028|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637029|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637030|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19779124|NCT00224874|Pentostatin|pentostatin|mesh-list
19779125|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
19779126|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19779127|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779128|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19779129|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
19779130|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19779131|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779132|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779133|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779134|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19779135|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19779136|NCT00224874|Analgesics|analgesics|mesh-ancestor
19779137|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
19779138|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779139|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779140|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779141|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779142|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779143|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779144|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
19779145|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19779146|NCT00224952|Carbamazepine|carbamazepine|mesh-list
19779147|NCT00224952|Valproic Acid|valproic acid|mesh-list
19779148|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
19779149|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779150|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779151|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
19779152|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779153|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779154|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
20318473|NCT00715715|Prednisone|prednisone|mesh-list
20318474|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779155|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19779156|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779157|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779158|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19779159|NCT00224952|Analgesics|analgesics|mesh-ancestor
19779160|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
19779161|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779162|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19779163|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779164|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19779165|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19779166|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19779167|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19779168|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19779169|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19779170|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
19779171|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779172|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779173|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19779174|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
19779175|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779176|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19779177|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19779178|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779179|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
19779180|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779181|NCT00225212|Rituximab|rituximab|mesh-list
19779182|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779183|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779184|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
19779185|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779186|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779187|NCT00225251|Bupropion|bupropion|mesh-list
19779188|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19779189|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
19779190|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779191|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19779192|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19779193|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779194|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318475|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
20318476|NCT00715715|Hormones|hormones|mesh-ancestor
19637031|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
20151638|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637032|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
19637033|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
19779195|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
19779196|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779197|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779198|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19779199|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19779200|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779201|NCT00225277|Pioglitazone|pioglitazone|mesh-list
19779202|NCT00225277|Glimepiride|glimepiride|mesh-list
19779203|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19779204|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779205|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19779206|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779207|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
19779208|NCT00225420|Docetaxel|docetaxel|mesh-list
19779209|NCT00225420|Leuprolide|leuprolide|mesh-list
19779210|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779211|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779212|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779213|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19779214|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779215|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19779216|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
19779217|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19779218|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779219|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19779220|NCT00225498|Olanzapine|olanzapine|mesh-list
19779221|NCT00225498|Risperidone|risperidone|mesh-list
19779222|NCT00225498|Ziprasidone|ziprasidone|mesh-list
19779223|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19779224|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
19779225|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779226|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779227|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779228|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19779229|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19779230|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779231|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779232|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19779233|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
19779234|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
19779235|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
19779236|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779237|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779238|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19779239|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19779240|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779241|NCT00225732|Ibuprofen|ibuprofen|mesh-list
19779242|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19779243|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19779244|NCT00225732|Analgesics|analgesics|mesh-ancestor
19779245|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
19779246|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779247|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779248|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779249|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151639|NCT00089518|Valsartan|valsartan|mesh-list
20151640|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20151641|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20151642|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20151643|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151644|NCT00089557|Capsaicin|capsaicin|mesh-list
19637034|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20151645|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
19637035|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19637036|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
19637037|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637038|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637039|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19637040|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779250|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19779251|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637041|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19637042|NCT02419261|Analgesics|analgesics|mesh-list
19637043|NCT02419261|Ropivacaine|ropivacaine|mesh-list
19637044|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
19779252|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779253|NCT00225758|Lapatinib|lapatinib|mesh-list
19779254|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318477|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318478|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318479|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19779255|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779256|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779257|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779258|NCT00225784|Gemcitabine|gemcitabine|mesh-list
19779259|NCT00225784|Cetuximab|cetuximab|mesh-list
19779260|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318480|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318481|NCT00715780|Insulin|insulin|mesh-list
20318482|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20318483|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
20318484|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
20318485|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20318486|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
20318487|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
20318488|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
20318489|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
20318490|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
20318491|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20318492|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318493|NCT00715832|Vaccines|vaccines|mesh-list
20318494|NCT00715832|Immunologic Factors|immunologic factors|mesh-ancestor
20318495|NCT00715832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318496|NCT00715858|Doxycycline|doxycycline|mesh-list
20318497|NCT00715858|Rifampin|rifampin|mesh-list
20318498|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318499|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318500|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
20318501|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20318502|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19637045|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
19637046|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637047|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637048|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
19637049|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637050|NCT02419118|Dexamethasone|dexamethasone|mesh-list
19637051|NCT02419118|Lenalidomide|lenalidomide|mesh-list
19637052|NCT02419118|Daratumumab|daratumumab|mesh-list
19637053|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637054|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
19637055|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
19637056|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637057|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637058|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637059|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
19637060|NCT02419118|Hormones|hormones|mesh-ancestor
19637061|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637062|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19637063|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637064|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
19637065|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19637066|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19637067|NCT02419118|Growth Substances|growth substances|mesh-ancestor
19637068|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
19637069|NCT02419105|Vitamin D|vitamin d|mesh-list
19637070|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
19637071|NCT02419105|Testosterone|testosterone|mesh-list
19637072|NCT02419105|Vitamins|vitamins|mesh-ancestor
19637073|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
19637074|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637075|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19637076|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19637077|NCT02419105|Androgens|androgens|mesh-ancestor
19637078|NCT02419105|Hormones|hormones|mesh-ancestor
20318503|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20318504|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
20318505|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
20318506|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20318507|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318508|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318509|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20318510|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20318511|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20318512|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20318513|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20318514|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20318515|NCT00715871|Nicotine|nicotine|mesh-list
20318516|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20318517|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
20318518|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318519|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318520|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20318521|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20318522|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
20318523|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318524|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318525|NCT00715975|Clobetasol|clobetasol|mesh-list
20318526|NCT00715975|Halobetasol|halobetasol|mesh-list
20318527|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318528|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
20318529|NCT00715975|Hormones|hormones|mesh-ancestor
20318530|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318531|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779261|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
19779262|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779263|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779264|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
19779265|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779266|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779267|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779268|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
19779269|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779270|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779271|NCT00226239|Docetaxel|docetaxel|mesh-list
19779272|NCT00226239|Cetuximab|cetuximab|mesh-list
19779273|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318532|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20318533|NCT00715988|Methadone|methadone|mesh-list
20318534|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20318535|NCT00715988|Narcotics|narcotics|mesh-ancestor
19779274|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779275|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779276|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
19779277|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779278|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779279|NCT00226577|Gemcitabine|gemcitabine|mesh-list
19779280|NCT00226577|Pemetrexed|pemetrexed|mesh-list
19779281|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779282|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
19779283|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779284|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779285|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
19779286|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779287|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779288|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779289|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
19779290|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779291|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19779292|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19779293|NCT00226590|Gemcitabine|gemcitabine|mesh-list
20151646|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151647|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
19779294|NCT00226590|Paclitaxel|paclitaxel|mesh-list
20151648|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151649|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151650|NCT00089570|Terlipressin|terlipressin|mesh-list
20151651|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20151652|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20151653|NCT00089622|Levodopa|levodopa|mesh-list
19779295|NCT00226590|Carboplatin|carboplatin|mesh-list
19779296|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20151654|NCT00089622|Lisuride|lisuride|mesh-list
19779297|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779298|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779299|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779300|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
19779301|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779302|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779303|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
19779304|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
19779305|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779306|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779307|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779308|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
19779309|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318536|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779310|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
19779311|NCT00226655|Hormones|hormones|mesh-ancestor
19779312|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19779313|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779314|NCT00226811|Sunitinib|sunitinib|mesh-list
19779315|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779316|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19779317|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19779318|NCT00226811|Growth Substances|growth substances|mesh-ancestor
19779319|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779320|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
19779321|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779322|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779323|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779324|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
19779325|NCT00226941|Promethazine|promethazine|mesh-list
19779326|NCT00226941|Capecitabine|capecitabine|mesh-list
19779327|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
19779328|NCT00226941|Cetuximab|cetuximab|mesh-list
19779329|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779330|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
19779331|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779332|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779333|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779334|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19779335|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19779336|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779337|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779338|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
19779339|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
19779340|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
19779341|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779342|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
19779343|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
19779344|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779345|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19779346|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
19779347|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
19779348|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779349|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19779350|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
19779351|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
19779352|NCT00227019|Vitamins|vitamins|mesh-list
19779353|NCT00227019|Folic Acid|folic acid|mesh-list
19779354|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
19779355|NCT00227019|Hydroxocobalamin|hydroxocobalamin|mesh-list
19779356|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
19779357|NCT00227019|Dexamethasone|dexamethasone|mesh-list
19779358|NCT00227019|Bevacizumab|bevacizumab|mesh-list
19779359|NCT00227019|Pemetrexed|pemetrexed|mesh-list
19779360|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779361|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779362|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19779363|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19779364|NCT00227019|Growth Substances|growth substances|mesh-ancestor
19779365|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779366|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
19779367|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
19779368|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779369|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
19779370|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
19779371|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779372|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779373|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
19779374|NCT00227019|Hormones|hormones|mesh-ancestor
19779375|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19779376|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19779377|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779378|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779379|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19779380|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19779381|NCT00227019|Hematinics|hematinics|mesh-ancestor
19779382|NCT00227266|Valproic Acid|valproic acid|mesh-list
19779383|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
19779384|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779385|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779386|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
19779387|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779388|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779389|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
19779390|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19779391|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779392|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779393|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19779394|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
19779395|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779396|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19779397|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19779398|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779399|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779400|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19779401|NCT00227370|Valganciclovir|valganciclovir|mesh-list
19779402|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
19779403|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779404|NCT00227539|Pemetrexed|pemetrexed|mesh-list
19779405|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19779406|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779407|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779408|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779409|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19779410|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19779411|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19779412|NCT00227591|Prednisone|prednisone|mesh-list
19779413|NCT00227591|Lenalidomide|lenalidomide|mesh-list
19779414|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779415|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
19779416|NCT00227591|Hormones|hormones|mesh-ancestor
19779417|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19779418|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779419|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19779420|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779421|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
19779422|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19779423|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19779424|NCT00227591|Growth Substances|growth substances|mesh-ancestor
19637079|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637080|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
19637081|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779425|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
19779426|NCT00227617|Leucovorin|leucovorin|mesh-list
19779427|NCT00227617|Bevacizumab|bevacizumab|mesh-list
19779428|NCT00227617|Fluorouracil|fluorouracil|mesh-list
19779429|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
19779430|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779431|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779432|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19779433|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19637082|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
19637083|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637084|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637085|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637086|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
19637087|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637088|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779434|NCT00227617|Growth Substances|growth substances|mesh-ancestor
19779435|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779436|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
19779437|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
19779438|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779439|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779440|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779441|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
19779442|NCT00227617|Antidotes|antidotes|mesh-ancestor
19779443|NCT00227617|Protective Agents|protective agents|mesh-ancestor
19779444|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
19779445|NCT00227617|Vitamins|vitamins|mesh-ancestor
19779446|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
19779447|NCT00227721|Gemcitabine|gemcitabine|mesh-list
19779448|NCT00227721|Docetaxel|docetaxel|mesh-list
19779449|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779450|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
19779451|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779452|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318537|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318538|NCT00715988|Analgesics|analgesics|mesh-ancestor
20318539|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
20318540|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318541|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
19779453|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
19779454|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779455|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779456|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779457|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
19779458|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779459|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779460|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779461|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
19779462|NCT00227760|Cediranib|cediranib|mesh-list
19779463|NCT00227760|Maleic acid|maleic acid|mesh-list
19779464|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779465|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779466|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779467|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779468|NCT00227994|Donepezil|donepezil|mesh-list
20151655|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20151656|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20151657|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
20151658|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637089|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19637090|NCT02419235|Ethanol|ethanol|mesh-list
19637091|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19637092|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637093|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318542|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
20318543|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
20318544|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20318545|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
20318546|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318547|NCT00716001|Expectorants|expectorants|mesh-ancestor
20318548|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
20318549|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20318550|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
20318551|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318552|NCT00716001|Protective Agents|protective agents|mesh-ancestor
20318553|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637094|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151659|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151660|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318554|NCT00716001|Antidotes|antidotes|mesh-ancestor
20318555|NCT00716170|Glucagon|glucagon|mesh-list
20611142|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637095|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
19637096|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19637097|NCT02418988|Estrogens|estrogens|mesh-ancestor
19637098|NCT02418988|Hormones|hormones|mesh-ancestor
20151661|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20151662|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
19637099|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637100|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151663|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
20151664|NCT00089687|Vanoxerine|vanoxerine|mesh-list
19637101|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19779469|NCT00227994|Galantamine|galantamine|mesh-list
19779470|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19779471|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779472|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779473|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
19779474|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779475|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779476|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
19779477|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19779478|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
19779479|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779480|NCT00228423|Clopidogrel|clopidogrel|mesh-list
19779481|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19779482|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19779483|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19779484|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19779485|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
19779486|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779487|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779488|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779489|NCT00228553|Modafinil|modafinil|mesh-list
19779490|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19779491|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779492|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19779493|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19779494|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19779495|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779496|NCT00228566|Modafinil|modafinil|mesh-list
19779497|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19779498|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779499|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19779500|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19779501|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19779502|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779503|NCT00228813|Sargramostim|sargramostim|mesh-list
19779504|NCT00228813|Lenograstim|lenograstim|mesh-list
19779505|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
19779506|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779507|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19779508|NCT00228943|Tryptophan|tryptophan|mesh-list
19779509|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19779510|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
19779511|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779512|NCT00229619|Rituximab|rituximab|mesh-list
19779513|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779514|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779515|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
19779516|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779517|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20318556|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20318557|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20318558|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318559|NCT00716170|Hormones|hormones|mesh-ancestor
20318560|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318561|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318562|NCT00716170|Incretins|incretins|mesh-ancestor
20318563|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20318564|NCT00716183|Amoxicillin|amoxicillin|mesh-list
20318565|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
20318566|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
19779518|NCT00229658|Pramlintide|pramlintide|mesh-list
19779519|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19779520|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779521|NCT00229723|Gefitinib|gefitinib|mesh-list
19779522|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779523|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779524|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779525|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779526|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19779527|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779528|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779529|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779530|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779531|NCT00230178|Allopurinol|allopurinol|mesh-list
20318567|NCT00716183|Lactams|lactams|mesh-list
20318568|NCT00716183|beta-Lactams|beta-lactams|mesh-list
19637102|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637103|NCT02418572|Testosterone|testosterone|mesh-list
19637104|NCT02418572|Androgens|androgens|mesh-ancestor
19637105|NCT02418572|Hormones|hormones|mesh-ancestor
19637106|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637107|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637108|NCT02418702|Ketamine|ketamine|mesh-list
19637109|NCT02418702|Analgesics|analgesics|mesh-ancestor
19637110|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
19637111|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151665|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20151666|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151667|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20151668|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151669|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
19637112|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637113|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19637114|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19637115|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
19637116|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
19637117|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637118|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19637119|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19637120|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637121|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637122|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19637123|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19637124|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19637125|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
19637126|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637127|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19637128|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19637129|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637130|NCT02418624|Carboplatin|carboplatin|mesh-list
19637131|NCT02418624|Olaparib|olaparib|mesh-list
19637132|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637133|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19637134|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637135|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637136|NCT02418533|Menotropins|menotropins|mesh-list
19637137|NCT02418533|Hormones|hormones|mesh-list
19637138|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19637139|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637140|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637141|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19637142|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
19637143|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19637144|NCT02418273|Denosumab|denosumab|mesh-list
19637145|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19637146|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637147|NCT02418130|Inositol|inositol|mesh-list
19779532|NCT00230178|Rasburicase|rasburicase|mesh-list
19779533|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
19779534|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779535|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779536|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
19779537|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779538|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19779539|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
19779540|NCT00230178|Protective Agents|protective agents|mesh-ancestor
19779541|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779542|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
19779543|NCT00230282|Fludarabine|fludarabine|mesh-list
19779544|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
19779545|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779546|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
20151670|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151671|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151672|NCT00089700|Ibalizumab|ibalizumab|mesh-list
20151673|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20151674|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20151675|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
20151676|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779547|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779548|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779549|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19779550|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
19779551|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779552|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779553|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19779554|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779555|NCT00230737|Melatonin|melatonin|mesh-list
19779556|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
19779557|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779558|NCT00230737|Protective Agents|protective agents|mesh-ancestor
19779559|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318569|NCT00716183|Cloxacillin|cloxacillin|mesh-list
20318570|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318571|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318572|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318573|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20318574|NCT00716248|Bucillamine|bucillamine|mesh-list
20318575|NCT00716248|Methotrexate|methotrexate|mesh-list
20318576|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20318577|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
20318578|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20318579|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318580|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318581|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
20318582|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318583|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779560|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779561|NCT00230971|Metronidazole|metronidazole|mesh-list
19779562|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
19779563|NCT00230971|Tigecycline|tigecycline|mesh-list
19779564|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779565|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19779566|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19779567|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19779568|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19779569|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779570|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779571|NCT00231309|Sargramostim|sargramostim|mesh-list
19779572|NCT00231309|Lenograstim|lenograstim|mesh-list
19779573|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
19779574|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779575|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19779576|NCT00231465|Docetaxel|docetaxel|mesh-list
19779577|NCT00231465|Gefitinib|gefitinib|mesh-list
19779578|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779579|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779580|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779581|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
19779582|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779583|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779584|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779585|NCT00231478|Granisetron|granisetron|mesh-list
20318584|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
20318585|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318586|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20318587|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779586|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
19779587|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
19779588|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779589|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779590|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779591|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19779592|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
19779593|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779594|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779595|NCT00231777|Ondansetron|ondansetron|mesh-list
19779596|NCT00231777|Aprepitant|aprepitant|mesh-list
19779597|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
20318588|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
20318589|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779598|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
19779599|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779600|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779601|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20611143|NCT02152982|Temozolomide|temozolomide|mesh-list
19779602|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
19779603|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
19779604|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19779605|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
19779606|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779607|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779608|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19779609|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19779610|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637148|NCT02418130|Thiamine|thiamine|mesh-list
19637149|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19637150|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
19637151|NCT02418130|Vitamins|vitamins|mesh-ancestor
19637152|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
20151677|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
20151678|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151679|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
20151680|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151681|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151682|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20151683|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
20151684|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151685|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151686|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20151687|NCT00089765|Ranibizumab|ranibizumab|mesh-list
20151688|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20151689|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20151690|NCT00089765|Growth Substances|growth substances|mesh-ancestor
20151691|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779611|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779612|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19779613|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19779614|NCT00231842|Ifosfamide|ifosfamide|mesh-list
19779615|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779616|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19779617|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
19779618|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779619|NCT00231868|Paclitaxel|paclitaxel|mesh-list
19779620|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19779621|NCT00231868|Carboplatin|carboplatin|mesh-list
19779622|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19779623|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779624|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779625|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779626|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151692|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
20151693|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151694|NCT00089804|Abetimus|abetimus|mesh-list
20151695|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151696|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
20151697|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151698|NCT00089830|Squalamine|squalamine|mesh-list
20151699|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151700|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151701|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20151702|NCT00089830|Protective Agents|protective agents|mesh-ancestor
20151703|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151704|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151705|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20151706|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20151707|NCT00089830|Growth Substances|growth substances|mesh-ancestor
20151708|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
20151709|NCT00089856|Prednisone|prednisone|mesh-list
19637153|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637154|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19637155|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637156|NCT02417883|Furosemide|furosemide|mesh-list
19637157|NCT02417883|Diuretics|diuretics|mesh-ancestor
19637158|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
19637159|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637160|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19779627|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637161|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779628|NCT00231894|Pioglitazone|pioglitazone|mesh-list
20151710|NCT00089856|Docetaxel|docetaxel|mesh-list
20151711|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318590|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20318591|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20318592|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20318593|NCT00716248|Analgesics|analgesics|mesh-ancestor
19779629|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19779630|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779631|NCT00232180|Eplerenone|eplerenone|mesh-list
19779632|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19779633|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
19779634|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19779635|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779636|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19779637|NCT00232180|Diuretics|diuretics|mesh-ancestor
19779638|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
19779639|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19779640|NCT00232479|Carboplatin|carboplatin|mesh-list
19779641|NCT00232479|Docetaxel|docetaxel|mesh-list
19779642|NCT00232479|Trastuzumab|trastuzumab|mesh-list
19779643|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779644|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779645|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779646|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
19779647|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779648|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779649|NCT00232505|Carboplatin|carboplatin|mesh-list
19779650|NCT00232505|Cetuximab|cetuximab|mesh-list
19779651|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779652|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779653|NCT00232583|Metformin|metformin|mesh-list
20151712|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
20151713|NCT00089856|Hormones|hormones|mesh-ancestor
20151714|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19779654|NCT00232583|Pioglitazone|pioglitazone|mesh-list
19779655|NCT00232583|Glyburide|glyburide|mesh-list
19779656|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19779657|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779658|NCT00232596|Ezogabine|ezogabine|mesh-list
19779659|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
19779660|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779661|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779662|NCT00232739|Sirolimus|sirolimus|mesh-list
19779663|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19779664|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779665|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19779666|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779667|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
19779668|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151715|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151716|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20151717|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151718|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
20151719|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151720|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151721|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151722|NCT00089869|Olanzapine|olanzapine|mesh-list
20151723|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20151724|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
20151725|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
20151726|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151727|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151728|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637162|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662380|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19662381|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19662382|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19662383|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19662384|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662385|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
19662386|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665936|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665937|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19779669|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
19779670|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779671|NCT00233064|Palivizumab|palivizumab|mesh-list
19779672|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
19779673|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318594|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
20318595|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151729|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151730|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151731|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151732|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151733|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20151734|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151735|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20151736|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151737|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151738|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
20151739|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20151740|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
20151741|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
20151742|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20151743|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
20151744|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151745|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151746|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
20151747|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151748|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637163|NCT02417896|Spironolactone|spironolactone|mesh-list
19637164|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19637165|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
20151749|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151750|NCT00090012|Olanzapine|olanzapine|mesh-list
20151751|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19637166|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637167|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779674|NCT00233103|Sertraline|sertraline|mesh-list
19779675|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
19779676|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779677|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19779678|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19779679|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779680|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779681|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779682|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
19779683|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779684|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19779685|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
19779686|NCT00233363|Rebamipide|rebamipide|mesh-list
19779687|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19779688|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779689|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
19779690|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779691|NCT00233363|Protective Agents|protective agents|mesh-ancestor
19779692|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151752|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
20151753|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
19637168|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19637169|NCT02417896|Diuretics|diuretics|mesh-ancestor
19637170|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
19637171|NCT02418065|Testosterone|testosterone|mesh-list
19637172|NCT02418065|Androgens|androgens|mesh-ancestor
19637173|NCT02418065|Hormones|hormones|mesh-ancestor
19637174|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637175|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637176|NCT02418078|Anesthetics|anesthetics|mesh-list
19637177|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637178|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637179|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
19637180|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19637181|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
19779693|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779694|NCT00233389|Rebamipide|rebamipide|mesh-list
19779695|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20318596|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779696|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779697|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
19779698|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779699|NCT00233389|Protective Agents|protective agents|mesh-ancestor
19779700|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779701|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318597|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
20318598|NCT00716248|Protective Agents|protective agents|mesh-ancestor
20318599|NCT00716391|Cisplatin|cisplatin|mesh-list
20318600|NCT00716391|Cetuximab|cetuximab|mesh-list
20318601|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318602|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20318603|NCT00716469|Talaporfin|talaporfin|mesh-list
20318604|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318605|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19779702|NCT00233454|Midostaurin|midostaurin|mesh-list
19779703|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779704|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779705|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779706|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779707|NCT00233480|Atorvastatin|atorvastatin|mesh-list
19779708|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19779709|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19779710|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
19779711|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779712|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19779713|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19779714|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779715|NCT00233948|Nelfinavir|nelfinavir|mesh-list
19779716|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19779717|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19779718|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
19779719|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779720|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779721|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19779722|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19779723|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
19779724|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779725|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
19779726|NCT00233987|Melphalan|melphalan|mesh-list
19779727|NCT00233987|Carmustine|carmustine|mesh-list
19779728|NCT00233987|Etoposide|etoposide|mesh-list
19779729|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779730|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
19779731|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779732|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779733|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19779734|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
19779735|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779736|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779737|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19779738|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19779739|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19779740|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19779741|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779742|NCT00234039|Gemcitabine|gemcitabine|mesh-list
19779743|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779744|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
19779745|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779746|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779747|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
19779748|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779749|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151754|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151755|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151756|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151757|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151758|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151759|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151760|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151761|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20151762|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20151763|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20151764|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151765|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318606|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
19779750|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779751|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
19779752|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833553|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
20318607|NCT00716521|Zolpidem|zolpidem|mesh-list
20318608|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20318609|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20318610|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318611|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318612|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20318613|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
20318614|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
20318615|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318616|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833554|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833555|NCT00588666|Gemcitabine|gemcitabine|mesh-list
19833556|NCT00588666|Bevacizumab|bevacizumab|mesh-list
19833557|NCT00588666|Carboplatin|carboplatin|mesh-list
19833558|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19833559|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833560|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19833561|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19833562|NCT00588666|Growth Substances|growth substances|mesh-ancestor
19833563|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833564|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
19833565|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19833566|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
19833567|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833568|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
19833569|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833570|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833571|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19833572|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
19833573|NCT00588731|Cannabidiol|cannabidiol|mesh-list
19833574|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
19833575|NCT00588822|Rituximab|rituximab|mesh-list
19833576|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19833577|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833578|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
19833579|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833580|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833581|NCT00588900|Irinotecan|irinotecan|mesh-list
19833582|NCT00588900|Cediranib|cediranib|mesh-list
19833583|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19833584|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19833585|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833586|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833587|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833588|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19833589|NCT00588952|Ketamine|ketamine|mesh-list
19833590|NCT00588952|Analgesics|analgesics|mesh-ancestor
19833591|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
19833592|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833593|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833594|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19833595|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19833596|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
19833597|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
19833598|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833599|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19833600|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19833601|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833602|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833603|NCT00588965|Propranolol|propranolol|mesh-list
19833604|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19833605|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19833606|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
19833607|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833608|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833609|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833610|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19833611|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19833612|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
19833613|NCT00589056|Nelfinavir|nelfinavir|mesh-list
19833614|NCT00589056|Etoposide|etoposide|mesh-list
19779753|NCT00234052|Bevacizumab|bevacizumab|mesh-list
19779754|NCT00234052|Carboplatin|carboplatin|mesh-list
19779755|NCT00234052|Pemetrexed|pemetrexed|mesh-list
19779756|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779757|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779758|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19779759|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19779760|NCT00234052|Growth Substances|growth substances|mesh-ancestor
19779761|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779762|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
19779763|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779764|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779765|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19779766|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19779767|NCT00234065|Aspirin|aspirin|mesh-list
19779768|NCT00234065|Cilostazol|cilostazol|mesh-list
19779769|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19779770|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19779771|NCT00234065|Analgesics|analgesics|mesh-ancestor
19779772|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
19779773|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19779774|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779775|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779776|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779777|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19779778|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19779779|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779780|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19779781|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19779782|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779783|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
20318617|NCT00716547|Celecoxib|celecoxib|mesh-list
20318618|NCT00716547|Ketoprofen|ketoprofen|mesh-list
20318619|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20318620|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20318621|NCT00716547|Analgesics|analgesics|mesh-ancestor
20318622|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
20318623|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318624|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318625|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318626|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779784|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19779785|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
19779786|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19779787|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
19779788|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
19779789|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19779790|NCT00234065|Protective Agents|protective agents|mesh-ancestor
19779791|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19779792|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19779793|NCT00234078|Rebamipide|rebamipide|mesh-list
19779794|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19779795|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779796|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
19779797|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779798|NCT00234078|Protective Agents|protective agents|mesh-ancestor
19779799|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779800|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779801|NCT00234104|Tolvaptan|tolvaptan|mesh-list
19779802|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19779803|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779804|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
19779805|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779806|NCT00234494|Gemcitabine|gemcitabine|mesh-list
19779807|NCT00234494|Bevacizumab|bevacizumab|mesh-list
19779808|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779809|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779810|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19779811|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19779812|NCT00234494|Growth Substances|growth substances|mesh-ancestor
19779813|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779814|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
20318627|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19779815|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779816|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
19779817|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779818|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
19779819|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779820|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779821|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779822|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
19779823|NCT00234832|Sibutramine|sibutramine|mesh-list
19779824|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
19779825|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779826|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
19779827|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19779828|NCT00234884|Adalimumab|adalimumab|mesh-list
19779829|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779830|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779831|NCT00235391|Deferasirox|deferasirox|mesh-list
19779832|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19779833|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
19779834|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
19779835|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779836|NCT00235443|Lacosamide|lacosamide|mesh-list
19779837|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
19779838|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19779839|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19779840|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779841|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779842|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
19779843|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
19779844|NCT00235573|Vitamins|vitamins|mesh-ancestor
19779845|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
19779846|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779847|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
19779848|NCT00235573|Hematinics|hematinics|mesh-ancestor
19779849|NCT00235716|Vitamins|vitamins|mesh-list
19779850|NCT00235716|Vitamin E|vitamin e|mesh-list
19779851|NCT00235716|Tocopherols|tocopherols|mesh-list
19779852|NCT00235716|Tocotrienols|tocotrienols|mesh-list
19779853|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
19779854|NCT00235716|Memantine|memantine|mesh-list
19779855|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
19779856|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779857|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
19779858|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779859|NCT00235716|Protective Agents|protective agents|mesh-ancestor
19779860|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19779861|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19779862|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
19779863|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779864|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19779865|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19779866|NCT00235755|Ezogabine|ezogabine|mesh-list
19779867|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
19779868|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779869|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779870|NCT00235833|Adalimumab|adalimumab|mesh-list
19779871|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779872|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779873|NCT00235872|Adalimumab|adalimumab|mesh-list
19779874|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19779875|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19779876|NCT00235989|Interferons|interferons|mesh-list
19779877|NCT00235989|Interferon-beta|interferon-beta|mesh-list
19779878|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
19779879|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779880|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
19779881|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779882|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
19779883|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779884|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19779885|NCT00236080|Modafinil|modafinil|mesh-list
19779886|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19779887|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779888|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19779889|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19779890|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19779891|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779892|NCT00236184|Rabeprazole|rabeprazole|mesh-list
19779893|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19779894|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779895|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19779896|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779897|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779898|NCT00236197|Rabeprazole|rabeprazole|mesh-list
19779899|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19779900|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19779901|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19779902|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779903|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779904|NCT00236899|Gemcitabine|gemcitabine|mesh-list
19779905|NCT00236899|Paclitaxel|paclitaxel|mesh-list
19779906|NCT00236899|Docetaxel|docetaxel|mesh-list
19779907|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19779908|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318628|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20318629|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779909|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
19779910|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
19779911|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
20318630|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318631|NCT00716573|Everolimus|everolimus|mesh-list
20318632|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779912|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779913|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19779914|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
19779915|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
19779916|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19779917|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318633|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318634|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
20318635|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318636|NCT00716612|Ubiquinone|ubiquinone|mesh-list
20318637|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
20318638|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
20318639|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318640|NCT00716612|Vitamins|vitamins|mesh-ancestor
20318641|NCT00716755|Olanzapine|olanzapine|mesh-list
19779918|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19779919|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
19779920|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779921|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
20318642|NCT00716755|Risperidone|risperidone|mesh-list
20318643|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20318644|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
19779922|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19779923|NCT00236938|Hematinics|hematinics|mesh-ancestor
19779924|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
19779925|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19779926|NCT00236951|Hematinics|hematinics|mesh-ancestor
20318645|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637182|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637183|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
19637184|NCT02417610|Protective Agents|protective agents|mesh-ancestor
19637185|NCT02417506|Ibuprofen|ibuprofen|mesh-list
19637186|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19637187|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19637188|NCT02417506|Analgesics|analgesics|mesh-ancestor
19637189|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
19637190|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637191|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637192|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637193|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151766|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
20151767|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151768|NCT00090025|Leucovorin|leucovorin|mesh-list
20151769|NCT00090025|Fluorouracil|fluorouracil|mesh-list
20151770|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
20151771|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151772|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151773|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151774|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637194|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19779927|NCT00236977|Iron|iron|mesh-list
20151775|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
20318646|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637195|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779928|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20318647|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151776|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151777|NCT00090025|Antidotes|antidotes|mesh-ancestor
20151778|NCT00090025|Protective Agents|protective agents|mesh-ancestor
20151779|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
20151780|NCT00090025|Vitamins|vitamins|mesh-ancestor
20151781|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
20151782|NCT00090038|Rituximab|rituximab|mesh-list
20151783|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20151784|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151785|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
20151786|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151787|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151788|NCT00090090|Elsamicin A|elsamicin a|mesh-list
20151789|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318648|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19779929|NCT00236977|Trace Elements|trace elements|mesh-ancestor
19779930|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
19779931|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779932|NCT00236977|Hematinics|hematinics|mesh-ancestor
19779933|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
19779934|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19779935|NCT00237042|Estradiol|estradiol|mesh-list
19779936|NCT00237042|Estrogens|estrogens|mesh-ancestor
19779937|NCT00237042|Hormones|hormones|mesh-ancestor
19779938|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19779939|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779940|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19779941|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
19779942|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19779943|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19779944|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19779945|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19779946|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19779947|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
19779948|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318649|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20318650|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318651|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20318652|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20318653|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
20318654|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
20318655|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
20318656|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318657|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318658|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19637196|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637197|NCT02417493|Epinephrine|epinephrine|mesh-list
19637198|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19637199|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19637200|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
19637201|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637202|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637203|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637204|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19637205|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19637206|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
19637207|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637208|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19637209|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
19637210|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
19637211|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
19637212|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19637213|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
19637214|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19637215|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
19637216|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637217|NCT02417467|Nicotine|nicotine|mesh-list
19637218|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19637219|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
19637220|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637221|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637222|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19779949|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151790|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151791|NCT00090155|Ondansetron|ondansetron|mesh-list
19779950|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779951|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779952|NCT00237458|Lacosamide|lacosamide|mesh-list
19779953|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
19779954|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19779955|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19779956|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19779957|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779958|NCT00237666|Ziprasidone|ziprasidone|mesh-list
19779959|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19779960|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
19779961|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19779962|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779963|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779964|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19779965|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19779966|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779967|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19779968|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19779969|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
20318659|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20318660|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347421|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779970|NCT00237718|Vitamin E|vitamin e|mesh-list
19779971|NCT00237718|Tocopherols|tocopherols|mesh-list
19779972|NCT00237718|Tocotrienols|tocotrienols|mesh-list
19779973|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
19779974|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
19779975|NCT00237718|Vitamins|vitamins|mesh-ancestor
19779976|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
19779977|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779978|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
19779979|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779980|NCT00237718|Protective Agents|protective agents|mesh-ancestor
19779981|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
19779982|NCT00238108|Melatonin|melatonin|mesh-list
19779983|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
19779984|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779985|NCT00238108|Protective Agents|protective agents|mesh-ancestor
19779986|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779987|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19779988|NCT00238121|Sorafenib|sorafenib|mesh-list
19779989|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779990|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19779991|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19779992|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19779993|NCT00238238|Rituximab|rituximab|mesh-list
19779994|NCT00238238|Lenalidomide|lenalidomide|mesh-list
19779995|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19779996|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19779997|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
19779998|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19779999|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780000|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19780001|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19780002|NCT00238238|Growth Substances|growth substances|mesh-ancestor
19780003|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
19780004|NCT00238303|Vorinostat|vorinostat|mesh-list
19780005|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780006|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19780007|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780008|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780009|NCT00238355|Voriconazole|voriconazole|mesh-list
19780010|NCT00238355|Caspofungin|caspofungin|mesh-list
19780011|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
19780012|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780013|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19780014|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19780015|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780016|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780017|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19780018|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
20347422|NCT00860223|Digoxin|digoxin|mesh-list
19780019|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318661|NCT00716846|Atorvastatin|atorvastatin|mesh-list
20318662|NCT00716846|Simvastatin|simvastatin|mesh-list
20318663|NCT00716846|Pitavastatin|pitavastatin|mesh-list
20318664|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20318665|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20318666|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
20318667|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318668|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20318669|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20318670|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318671|NCT00716911|Ganciclovir|ganciclovir|mesh-list
20318672|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20318673|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
20318674|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780020|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780021|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19780022|NCT00238433|Melphalan|melphalan|mesh-list
19780023|NCT00238433|Busulfan|busulfan|mesh-list
19780024|NCT00238433|Thiotepa|thiotepa|mesh-list
19780025|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
19780026|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780027|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19780028|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
19780029|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780030|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780031|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19780032|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780033|NCT00238615|Carboplatin|carboplatin|mesh-list
19780034|NCT00238615|Docetaxel|docetaxel|mesh-list
19780035|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151792|NCT00090155|Aprepitant|aprepitant|mesh-list
20151793|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
20151794|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
20151795|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151796|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151797|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151798|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
20318675|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20318676|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318677|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318678|NCT00716924|Clopidogrel|clopidogrel|mesh-list
20318679|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19780036|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
19780037|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19780038|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
19780039|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780040|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
19780041|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19780042|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780043|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19780044|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
19780045|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19780046|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780047|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780048|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780049|NCT00239356|Aripiprazole|aripiprazole|mesh-list
19780050|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780051|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780052|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19780053|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780054|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780055|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780056|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
19780057|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
19780058|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780059|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780060|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20151799|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151800|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20151801|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
20151802|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318680|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19780061|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20151803|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780062|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
19780063|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19780064|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19637223|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19637224|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
19637225|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318681|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20318682|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20318683|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
20318684|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318685|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318686|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318687|NCT00716950|Losartan|losartan|mesh-list
20318688|NCT00716950|Valsartan|valsartan|mesh-list
20318689|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19780065|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19780066|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19780067|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
19780068|NCT00239590|Testosterone|testosterone|mesh-list
19780069|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
20151804|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20318690|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20318691|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20318692|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318693|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20318694|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
20318695|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
20318696|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20318697|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20318698|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151805|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151806|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318699|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20318700|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318701|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20318702|NCT00717210|Temozolomide|temozolomide|mesh-list
20318703|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20318704|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
20318705|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318706|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318707|NCT00717340|Paclitaxel|paclitaxel|mesh-list
20318708|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20318709|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318710|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
20318711|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
20318712|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
19637226|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637227|NCT02417389|Alendronate|alendronate|mesh-list
20318713|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318714|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
20318715|NCT00717379|Prednisone|prednisone|mesh-list
20318716|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
20318717|NCT00717379|Tacrolimus|tacrolimus|mesh-list
20318718|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318719|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
20318720|NCT00717379|Hormones|hormones|mesh-ancestor
20318721|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318722|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637228|NCT02417389|Cinacalcet|cinacalcet|mesh-list
19637229|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19637230|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637231|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19637232|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19780070|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
20151807|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151808|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20151809|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20151810|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
20151811|NCT00090194|Antibodies|antibodies|mesh-list
20151812|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
20151813|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19780071|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19637233|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
19637234|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318723|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20318724|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318725|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318726|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
20318727|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20318728|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318729|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318730|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318731|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20318732|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
20318733|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318734|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318735|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
20318736|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
20318737|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318738|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318739|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19637235|NCT02417090|Metformin|metformin|mesh-list
19637236|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19637237|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637238|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19637239|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19637240|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19637241|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637242|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637243|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19637244|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19637245|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637246|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
19637247|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637248|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19637249|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
19637250|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19637251|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19637252|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
19662387|NCT05093387|Carboplatin|carboplatin|mesh-list
19662388|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
19662389|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662390|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662391|NCT05093374|Bevacizumab|bevacizumab|mesh-list
19662392|NCT05093374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662393|NCT05093374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662394|NCT05093374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19662395|NCT05093374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19662396|NCT05093374|Growth Substances|growth substances|mesh-ancestor
19662397|NCT05093374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662398|NCT05093374|Growth Inhibitors|growth inhibitors|mesh-ancestor
19662399|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
19662400|NCT05093231|Olaparib|olaparib|mesh-list
19662401|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662402|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662403|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19662404|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662405|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662406|NCT05092984|Spironolactone|spironolactone|mesh-list
19662407|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19662408|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
19662409|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662410|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662411|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19662412|NCT05092984|Diuretics|diuretics|mesh-ancestor
19662413|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
19662414|NCT05092945|Niacin|niacin|mesh-list
19662415|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
19662416|NCT05092945|Niacinamide|niacinamide|mesh-list
19662417|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19662418|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
19662419|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662420|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19662421|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
19662422|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
19662423|NCT05092945|Vitamins|vitamins|mesh-ancestor
19780072|NCT00239590|Androgens|androgens|mesh-ancestor
19780073|NCT00239590|Hormones|hormones|mesh-ancestor
19780074|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780075|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780076|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780077|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780078|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
19780079|NCT00239642|Iron|iron|mesh-list
19780080|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19780081|NCT00239642|Trace Elements|trace elements|mesh-ancestor
19780082|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
19780083|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780084|NCT00239642|Hematinics|hematinics|mesh-ancestor
19780085|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19780086|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19780087|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19780088|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
19780089|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780090|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19780091|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19780092|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780093|NCT00240071|Tamoxifen|tamoxifen|mesh-list
19780094|NCT00240071|Bevacizumab|bevacizumab|mesh-list
19780095|NCT00240071|Letrozole|letrozole|mesh-list
19780096|NCT00240071|Exemestane|exemestane|mesh-list
19780097|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780098|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780099|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19780100|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19780101|NCT00240071|Growth Substances|growth substances|mesh-ancestor
19780102|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780103|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
19780104|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19780105|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19780106|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780107|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780108|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19780109|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
19637253|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637254|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
19637255|NCT02417116|Protective Agents|protective agents|mesh-ancestor
19637256|NCT02417298|Ketamine|ketamine|mesh-list
19637257|NCT02417298|Analgesics|analgesics|mesh-ancestor
19637258|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
19637259|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780110|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637260|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637261|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19637262|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19637263|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
19637264|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
19637265|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637266|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19637267|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19637268|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637269|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637270|NCT02417103|Liraglutide|liraglutide|mesh-list
19637271|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19637272|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637273|NCT02417103|Incretins|incretins|mesh-ancestor
19780111|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780112|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19780113|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20151814|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20151815|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
20151816|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151817|NCT00090207|Ondansetron|ondansetron|mesh-list
20151818|NCT00090207|Aprepitant|aprepitant|mesh-list
20151819|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
20151820|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
20151821|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151822|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780114|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20151823|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19780115|NCT00240097|Carboplatin|carboplatin|mesh-list
19780116|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
19780117|NCT00240097|Irinotecan|irinotecan|mesh-list
19780118|NCT00240097|Etoposide|etoposide|mesh-list
19780119|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780120|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19780121|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19780122|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780123|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780124|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19780125|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19780126|NCT00240110|Valproic Acid|valproic acid|mesh-list
19780127|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
19780128|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780129|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780130|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780131|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780132|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
19780133|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780134|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780135|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780136|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
19780137|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
19780138|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780139|NCT00240162|Vatalanib|vatalanib|mesh-list
19780140|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780141|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780142|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780143|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19780144|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19780145|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19780146|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
19780147|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780148|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19780149|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19780150|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780151|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
19780152|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19780153|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
19780154|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780155|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780156|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19780157|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
19780158|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19780159|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
19780160|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780161|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780162|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19780163|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
19780164|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
19780165|NCT00240487|Protective Agents|protective agents|mesh-ancestor
19780166|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
19780167|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19780168|NCT00240526|Antibodies|antibodies|mesh-list
19780169|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
19780170|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780171|NCT00240981|Testosterone|testosterone|mesh-list
19780172|NCT00240981|Androgens|androgens|mesh-ancestor
19780173|NCT00240981|Hormones|hormones|mesh-ancestor
19780174|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780175|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780176|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
19780177|NCT00240994|Sirolimus|sirolimus|mesh-list
19780178|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
19780179|NCT00240994|Tacrolimus|tacrolimus|mesh-list
19780180|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780181|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
19780182|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780183|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19780184|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780185|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780186|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19780187|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780188|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19780189|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
20318740|NCT00717379|Protective Agents|protective agents|mesh-ancestor
20318741|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
19780190|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19780191|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780192|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
19780193|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780194|NCT00241176|Aripiprazole|aripiprazole|mesh-list
20318742|NCT00717470|Prednisone|prednisone|mesh-list
20318743|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
20318744|NCT00717470|Tacrolimus|tacrolimus|mesh-list
20318745|NCT00717470|Basiliximab|basiliximab|mesh-list
20151824|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
20151825|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151826|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20151827|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
20151828|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151829|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151830|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151831|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780195|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780196|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780197|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19637274|NCT02417103|Hormones|hormones|mesh-ancestor
19637275|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780198|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780199|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780200|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780201|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
19780202|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
19780203|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780204|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780205|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19780206|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19780207|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
19780208|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19780209|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19780210|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19780211|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19780212|NCT00241358|Plerixafor|plerixafor|mesh-list
19780213|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19780214|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19780215|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
19780216|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780217|NCT00241631|Fluticasone|fluticasone|mesh-list
19780218|NCT00241631|Xhance|xhance|mesh-list
19780219|NCT00241631|Theophylline|theophylline|mesh-list
19780220|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780221|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19780222|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
19780223|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780224|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780225|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19780226|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
20151832|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318746|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318747|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
20318748|NCT00717470|Hormones|hormones|mesh-ancestor
20318749|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318750|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780227|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637276|NCT02417207|Entecavir|entecavir|mesh-list
19637277|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
19637278|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637279|NCT02416999|Bevacizumab|bevacizumab|mesh-list
19637280|NCT02416999|Temozolomide|temozolomide|mesh-list
19637281|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19637282|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637283|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19637284|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19780228|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20151833|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19637285|NCT02416999|Growth Substances|growth substances|mesh-ancestor
19780229|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19780230|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318751|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780231|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780232|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
19780233|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19780234|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19780235|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
19780236|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780237|NCT00241644|Vaccines|vaccines|mesh-list
19780238|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
19780239|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780240|NCT00241839|Allopurinol|allopurinol|mesh-list
19780241|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
19780242|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
19780243|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780244|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780245|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
19780246|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780247|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19780248|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
19780249|NCT00241839|Protective Agents|protective agents|mesh-ancestor
19780250|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780251|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19780252|NCT00241839|Diuretics|diuretics|mesh-ancestor
19780253|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
19780254|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19780255|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780256|NCT00241904|Propranolol|propranolol|mesh-list
19780257|NCT00241904|Metoprolol|metoprolol|mesh-list
19780258|NCT00241904|Atenolol|atenolol|mesh-list
19780259|NCT00241904|Lisinopril|lisinopril|mesh-list
19780260|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19780261|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19780262|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19780263|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19780264|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19780265|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780266|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780267|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151834|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20151835|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19637286|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637287|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
19637288|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637289|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
19637290|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637291|NCT02417337|Acetaminophen|acetaminophen|mesh-list
19637292|NCT02417337|Ibuprofen|ibuprofen|mesh-list
19637293|NCT02417337|Diclofenac|diclofenac|mesh-list
19637294|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
19637295|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19637296|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19637297|NCT02417337|Analgesics|analgesics|mesh-ancestor
19637298|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
19637299|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637300|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637301|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637302|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637303|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19780268|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20151836|NCT00090246|Ondansetron|ondansetron|mesh-list
20151837|NCT00090246|Aprepitant|aprepitant|mesh-list
20151838|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
20151839|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
20151840|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151841|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151842|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151843|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
20151844|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
20151845|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20151846|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
20151847|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20151848|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151849|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151850|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151851|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780269|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19637304|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318752|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318753|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318754|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
20318755|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20318756|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318757|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318758|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318759|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20318760|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
20318761|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318762|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318763|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
20318764|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
20318765|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318766|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20318767|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20318768|NCT00717470|Protective Agents|protective agents|mesh-ancestor
20318769|NCT00717561|Amoxicillin|amoxicillin|mesh-list
20318770|NCT00717561|Azithromycin|azithromycin|mesh-list
20318771|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
20318772|NCT00717561|Clarithromycin|clarithromycin|mesh-list
20318773|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
20318774|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
20318775|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
20318776|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20318777|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20318778|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318779|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318780|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20318781|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318782|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318783|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318784|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318785|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20318786|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
20611144|NCT02152982|Veliparib|veliparib|mesh-list
19637305|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637306|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
19637307|NCT02416817|Thrombin|thrombin|mesh-list
19637308|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
19637309|NCT02416817|Coagulants|coagulants|mesh-ancestor
19637310|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19637311|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
19637312|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637313|NCT02416752|Remifentanil|remifentanil|mesh-list
19637314|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19637315|NCT02416752|Narcotics|narcotics|mesh-ancestor
19637316|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637317|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637318|NCT02416752|Analgesics|analgesics|mesh-ancestor
19637319|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
19637320|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637321|NCT02416765|Glucagon|glucagon|mesh-list
19637322|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637323|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637324|NCT02416765|Hormones|hormones|mesh-ancestor
19662424|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
19662425|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662426|NCT05089526|Lidocaine|lidocaine|mesh-list
19662427|NCT05089526|Fentanyl|fentanyl|mesh-list
19662428|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
19662429|NCT05089526|Ketamine|ketamine|mesh-list
19662430|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
19662431|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
19662432|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662433|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662434|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
19662435|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662436|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19662437|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19662438|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19662439|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19662440|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662441|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19662442|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19780270|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
19637325|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780271|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
19780272|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
19780273|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780274|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19780275|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
19780276|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780277|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19780278|NCT00241904|Protective Agents|protective agents|mesh-ancestor
19780279|NCT00242216|Ritonavir|ritonavir|mesh-list
19780280|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19780281|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
19780282|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19780283|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19780284|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
19780285|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780286|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780287|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19780288|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19780289|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
19780290|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780291|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19637326|NCT02416804|Buprenorphine|buprenorphine|mesh-list
19637327|NCT02416804|Tramadol|tramadol|mesh-list
19637328|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19780292|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19780293|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
19780294|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19780295|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780296|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780297|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19780298|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19780299|NCT00242502|Bevacizumab|bevacizumab|mesh-list
20151852|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151853|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19637329|NCT02416804|Narcotics|narcotics|mesh-ancestor
19637330|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637331|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637332|NCT02416804|Analgesics|analgesics|mesh-ancestor
19637333|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
19780300|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19780301|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20151854|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20151855|NCT00090272|Ertapenem|ertapenem|mesh-list
20151856|NCT00090272|Cefotetan|cefotetan|mesh-list
20151857|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151858|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151859|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20151860|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151861|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151862|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151863|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151864|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20151865|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151866|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20151867|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
20151868|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20151869|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20151870|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20151871|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637334|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637335|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19637336|NCT02416687|Etonogestrel|etonogestrel|mesh-list
19637337|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19637338|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
19637339|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20151872|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151873|NCT00090428|Caseins|caseins|mesh-list
20151874|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
20318787|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19637340|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637341|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20151875|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
20151876|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637342|NCT02416869|Dexamethasone|dexamethasone|mesh-list
19637343|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
19637344|NCT02416869|BB 1101|bb 1101|mesh-list
19637345|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637346|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
19637347|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
19637348|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637349|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637350|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637351|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
20151877|NCT00090480|Vaccines|vaccines|mesh-list
20151878|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
20151879|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151880|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
20151881|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
20151882|NCT00090623|Ranibizumab|ranibizumab|mesh-list
19637352|NCT02416869|Hormones|hormones|mesh-ancestor
19662443|NCT05089526|Analgesics|analgesics|mesh-ancestor
19662444|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19662445|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19662446|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19662447|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19662448|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662449|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19662450|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19662451|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
19662452|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19662453|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19662454|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19662455|NCT05089526|Narcotics|narcotics|mesh-ancestor
19662456|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19662457|NCT05080218|Adalimumab|adalimumab|mesh-list
19662458|NCT05080218|Etanercept|etanercept|mesh-list
19662459|NCT05080218|Golimumab|golimumab|mesh-list
19662460|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19662461|NCT05080218|Abatacept|abatacept|mesh-list
19662462|NCT05080218|Upadacitinib|upadacitinib|mesh-list
19662463|NCT05080218|Tofacitinib|tofacitinib|mesh-list
19662464|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19662465|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662466|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19662467|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19662468|NCT05080218|Analgesics|analgesics|mesh-ancestor
19662469|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
19662470|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662471|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662472|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662473|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662474|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
19662475|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19662476|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662477|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662478|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19662479|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662480|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19662481|NCT05049616|Nifedipine|nifedipine|mesh-list
19662482|NCT05049616|Diuretics|diuretics|mesh-list
19662483|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19662484|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19662485|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19662486|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780302|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780303|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19780304|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19780305|NCT00242502|Growth Substances|growth substances|mesh-ancestor
19780306|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780307|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
19780308|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780309|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780310|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780311|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
19780312|NCT00242567|Androgens|androgens|mesh-list
19780313|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19780314|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780315|NCT00242567|Hormones|hormones|mesh-ancestor
19780316|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780317|NCT00242580|Triamcinolone|triamcinolone|mesh-list
19780318|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19780319|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19780320|NCT00242580|Verteporfin|verteporfin|mesh-list
19780321|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19780322|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780323|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
19780324|NCT00242580|Hormones|hormones|mesh-ancestor
19780325|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780326|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780327|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780328|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
19780329|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780330|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780331|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19780332|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
19780333|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
20318788|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318789|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19780334|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19780335|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780336|NCT00242632|Memantine|memantine|mesh-list
19780337|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19780338|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19780339|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
19780340|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780341|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780342|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780343|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19780344|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19780345|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
19780346|NCT00242710|Estrogens|estrogens|mesh-list
19780347|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19780348|NCT00242710|Hormones|hormones|mesh-ancestor
19780349|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780350|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780351|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19780352|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19780353|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
19780354|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20318790|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20318791|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20318792|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20318793|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20318794|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20318795|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19780355|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
19780356|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
19780357|NCT00243022|Vitamins|vitamins|mesh-ancestor
20151883|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20151884|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20151885|NCT00090623|Growth Substances|growth substances|mesh-ancestor
20151886|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151887|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
20151888|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151889|NCT00090675|Gefitinib|gefitinib|mesh-list
20151890|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151891|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780358|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
19780359|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780360|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
19780361|NCT00243022|Hematinics|hematinics|mesh-ancestor
19780362|NCT00243061|Cediranib|cediranib|mesh-list
19780363|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780364|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780365|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780366|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780367|NCT00243074|Cediranib|cediranib|mesh-list
19780368|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780369|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780370|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780371|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780372|NCT00243152|Lamotrigine|lamotrigine|mesh-list
19780373|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
19780374|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19780375|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780376|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780377|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19780378|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780379|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19780380|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780381|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780382|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780383|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19780384|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
19780385|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780386|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780387|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780388|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780389|NCT00243347|Cediranib|cediranib|mesh-list
19780390|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780391|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780392|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780393|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780394|NCT00243386|Factor VIII|factor viii|mesh-list
19780395|NCT00243386|Coagulants|coagulants|mesh-ancestor
19780396|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
19780397|NCT00243412|Rituximab|rituximab|mesh-list
19780398|NCT00243412|Methotrexate|methotrexate|mesh-list
19780399|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780400|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780401|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
19780402|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780403|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780404|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19780405|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
19780406|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19780407|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19780408|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
19780409|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780410|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
19780411|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780412|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19780413|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780414|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19780415|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780416|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
19780417|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
19780418|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780419|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19780420|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
19780421|NCT00243412|Hormones|hormones|mesh-ancestor
19780422|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780423|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19780424|NCT00243412|Protective Agents|protective agents|mesh-ancestor
19780425|NCT00243503|Trastuzumab|trastuzumab|mesh-list
19780426|NCT00243503|Sunitinib|sunitinib|mesh-list
19780427|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780428|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780429|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19780430|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20151892|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318796|NCT00717587|Sunitinib|sunitinib|mesh-list
20318797|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
20318798|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780431|NCT00243503|Growth Substances|growth substances|mesh-ancestor
19780432|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780433|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
19780434|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780435|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780436|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780437|NCT00243659|Factor VIII|factor viii|mesh-list
19780438|NCT00243659|Coagulants|coagulants|mesh-ancestor
19780439|NCT00243932|Ubiquinone|ubiquinone|mesh-list
19780440|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
19780441|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
19780442|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780443|NCT00243932|Vitamins|vitamins|mesh-ancestor
19780444|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19780445|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833615|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833616|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20318799|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20318800|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20318801|NCT00717587|Growth Substances|growth substances|mesh-ancestor
19833617|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19833618|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19833619|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833620|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833621|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19833622|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19833623|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
19833624|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19833625|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19833626|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
19833627|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833628|NCT00589290|Belinostat|belinostat|mesh-list
19833629|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833630|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19833631|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833632|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151893|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173978|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20173979|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20173980|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
20173981|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173982|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20173983|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20318802|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318803|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
20318804|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20318805|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318806|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318807|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20318808|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
20318809|NCT00717652|Triamcinolone|triamcinolone|mesh-list
20173984|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173985|NCT00163202|Atorvastatin|atorvastatin|mesh-list
20173986|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20173987|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20173988|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
20173989|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173990|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20173991|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19637353|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637354|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19637355|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637356|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
19637357|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637358|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637359|NCT02416739|Niacinamide|niacinamide|mesh-list
19637360|NCT02416739|Niacin|niacin|mesh-list
19637361|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
19637362|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
19833633|NCT00589303|Metoprolol|metoprolol|mesh-list
19833634|NCT00589303|Amiodarone|amiodarone|mesh-list
19780446|NCT00244374|Vaccines|vaccines|mesh-list
19780447|NCT00244374|Immunologic Factors|immunologic factors|mesh-ancestor
19780448|NCT00244374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780449|NCT00244621|Candesartan|candesartan|mesh-list
19780450|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
19780451|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19780452|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19780453|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19780454|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780455|NCT00244712|Tenofovir|tenofovir|mesh-list
19780456|NCT00244712|Lamivudine|lamivudine|mesh-list
19780457|NCT00244712|Emtricitabine|emtricitabine|mesh-list
19780458|NCT00244712|Abacavir|abacavir|mesh-list
19780459|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
19780460|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780461|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19780462|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19780463|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780464|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780465|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19780466|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20151894|NCT00090727|AQ4N|aq4n|mesh-list
20151895|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151896|NCT00090896|Ipilimumab|ipilimumab|mesh-list
20151897|NCT00090896|Antibodies|antibodies|mesh-list
20151898|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20151899|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
20151900|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151901|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20151902|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151903|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20151904|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151905|NCT00090909|Gemcitabine|gemcitabine|mesh-list
20151906|NCT00090909|Dexamethasone|dexamethasone|mesh-list
20151907|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151908|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20151909|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
20151910|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
20151911|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20151912|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151913|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151914|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
20151915|NCT00090909|Hormones|hormones|mesh-ancestor
20151916|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20151917|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20151918|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151919|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
20151920|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151921|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
20151922|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151923|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151924|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151925|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
20151926|NCT00091039|Metronidazole|metronidazole|mesh-list
20151927|NCT00091039|Paclitaxel|paclitaxel|mesh-list
20151928|NCT00091039|Carboplatin|carboplatin|mesh-list
20151929|NCT00091039|Vaccines|vaccines|mesh-list
20151930|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
19780467|NCT00244725|Warfarin|warfarin|mesh-list
19780468|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
19780469|NCT00244855|Dexamethasone|dexamethasone|mesh-list
19780470|NCT00244855|Rituximab|rituximab|mesh-list
19780471|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780472|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780473|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
19780474|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780475|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780476|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780477|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
19780478|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
19780479|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780480|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20151931|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151932|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19780481|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
20151933|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780482|NCT00244855|Hormones|hormones|mesh-ancestor
20151934|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
19780483|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780484|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780485|NCT00244881|Cediranib|cediranib|mesh-list
19780486|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780487|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780488|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780489|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780490|NCT00244933|Gemcitabine|gemcitabine|mesh-list
19780491|NCT00244933|Genistein|genistein|mesh-list
19780492|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19780493|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
19780494|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780495|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780496|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
19780497|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780498|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780499|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780500|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
19780501|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780502|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19780503|NCT00244933|Protective Agents|protective agents|mesh-ancestor
19780504|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780505|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
19780506|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19780507|NCT00244933|Estrogens|estrogens|mesh-ancestor
19780508|NCT00244933|Hormones|hormones|mesh-ancestor
19780509|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780510|NCT00244985|Rituximab|rituximab|mesh-list
19780511|NCT00244985|Doxorubicin|doxorubicin|mesh-list
19780512|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19780513|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780514|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780515|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
19780516|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780517|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780518|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19780519|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19780520|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19780521|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780522|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780523|NCT00245011|Ifosfamide|ifosfamide|mesh-list
19780524|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
19780525|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780526|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20318810|NCT00717652|Tretinoin|tretinoin|mesh-list
20318811|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318812|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
20318813|NCT00717652|Hormones|hormones|mesh-ancestor
19780527|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
19780528|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780529|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780530|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19780531|NCT00245011|Analgesics|analgesics|mesh-ancestor
19780532|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
19780533|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780534|NCT00245037|Cyclosporine|cyclosporine|mesh-list
19780535|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
20151935|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
20151936|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
20151937|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151938|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151939|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20151940|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20151941|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20151942|NCT00091052|Sargramostim|sargramostim|mesh-list
20151943|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
20151944|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151945|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
20151946|NCT00091078|Oblimersen|oblimersen|mesh-list
20151947|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151948|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151949|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151950|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151951|NCT00091104|Aldesleukin|aldesleukin|mesh-list
20347423|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19780536|NCT00245037|Methotrexate|methotrexate|mesh-list
19780537|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
19780538|NCT00245037|Fludarabine|fludarabine|mesh-list
19780539|NCT00245037|Busulfan|busulfan|mesh-list
19780540|NCT00245037|Phenytoin|phenytoin|mesh-list
20318814|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20318815|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318816|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318817|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
20318818|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
20318819|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
20318820|NCT00717678|Tacrolimus|tacrolimus|mesh-list
20318821|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20318822|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
20318823|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318824|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20318825|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318826|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318827|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19780541|NCT00245037|Cyclosporins|cyclosporins|mesh-list
19780542|NCT00245037|Sargramostim|sargramostim|mesh-list
19780543|NCT00245037|Lenograstim|lenograstim|mesh-list
19780544|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19780545|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
19780546|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19780547|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780548|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19780549|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
19780550|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780551|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780552|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
19780553|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780554|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19780555|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780556|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
19780557|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780558|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19780559|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
19780560|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780561|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19780562|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19780563|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19780564|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
19780565|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19780566|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
19780567|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19780568|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19780569|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19780570|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
19780571|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19780572|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19780573|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780574|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20318828|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318829|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20318830|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
20318831|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20318832|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318833|NCT00717704|Dasatinib|dasatinib|mesh-list
20318834|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318835|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780575|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19780576|NCT00245050|Pyridoxine|pyridoxine|mesh-list
19780577|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
19780578|NCT00245050|Doxorubicin|doxorubicin|mesh-list
19780579|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19780580|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19780581|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780582|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19780583|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318836|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780584|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780585|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780586|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
19780587|NCT00245050|Vitamins|vitamins|mesh-ancestor
19780588|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
20318837|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318838|NCT00717730|Vitamins|vitamins|mesh-list
20318839|NCT00717730|Folic Acid|folic acid|mesh-list
20318840|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
20318841|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
19780589|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780590|NCT00245063|Cediranib|cediranib|mesh-list
19780591|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780592|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780593|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780594|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780595|NCT00245102|Sorafenib|sorafenib|mesh-list
19780596|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780597|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780598|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780599|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780600|NCT00245557|Sertraline|sertraline|mesh-list
19780601|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780602|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780603|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19780604|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19780605|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780606|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780607|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780608|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
19780609|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780610|NCT00245583|Topiramate|topiramate|mesh-list
19780611|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
19780612|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19780613|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780614|NCT00245635|Fluoxetine|fluoxetine|mesh-list
19780615|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19780616|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19780617|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780618|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780619|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780620|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
19780621|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780622|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19780623|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780624|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780625|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19780626|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19780627|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780628|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
19780629|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780630|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
19780631|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780632|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780633|NCT00245856|Dalteparin|dalteparin|mesh-list
19780634|NCT00245856|Tinzaparin|tinzaparin|mesh-list
19780635|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19780636|NCT00245856|Warfarin|warfarin|mesh-list
19780637|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
19780638|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19780639|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19780640|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780641|NCT00246012|Dacarbazine|dacarbazine|mesh-list
19780642|NCT00246012|Intetumumab|intetumumab|mesh-list
19780643|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19780644|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
19780645|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780646|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780647|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20151952|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
20151953|NCT00091104|Fludarabine|fludarabine|mesh-list
20151954|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
20151955|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
20151956|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151957|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
20151958|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151959|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20151960|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20151961|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
20318842|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
19780648|NCT00246025|Dabigatran|dabigatran|mesh-list
19780649|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
19780650|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19780651|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
19780652|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780653|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780654|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
19780655|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
19780656|NCT00246129|Daclizumab|daclizumab|mesh-list
20318843|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
19780657|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780658|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780659|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151962|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780660|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
19780661|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780662|NCT00246259|Risperidone|risperidone|mesh-list
19780663|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
19780664|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19780665|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
19780666|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780667|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780668|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780669|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780670|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780671|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780672|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19780673|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
19780674|NCT00246324|Interferons|interferons|mesh-list
19780675|NCT00246324|Interferon-beta|interferon-beta|mesh-list
19780676|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
19780677|NCT00246324|Doxycycline|doxycycline|mesh-list
19780678|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780679|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
19780680|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780681|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19780682|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
19780683|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19780684|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19780685|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
19780686|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780687|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19780688|NCT00246337|Rizatriptan|rizatriptan|mesh-list
19780689|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19780690|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
19780691|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780692|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780693|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780694|NCT00246376|Niacin|niacin|mesh-list
19780695|NCT00246376|Fenofibrate|fenofibrate|mesh-list
20151963|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151964|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20151965|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151966|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
20151967|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20151968|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19780696|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19780697|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
19780698|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780699|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20151969|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19780700|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
20151970|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
20151971|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20151972|NCT00091117|Bortezomib|bortezomib|mesh-list
20151973|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151974|NCT00091130|Vaccines|vaccines|mesh-list
20151975|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
20151976|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151977|NCT00091143|Fludarabine|fludarabine|mesh-list
20151978|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
20151979|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
20151980|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20151981|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151982|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20151983|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
20151984|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151985|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20151986|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
19780701|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
19780702|NCT00246376|Vitamins|vitamins|mesh-ancestor
19780703|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
19780704|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780705|NCT00246441|Paroxetine|paroxetine|mesh-list
19780706|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19780707|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19780708|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780709|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780710|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780711|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
19780712|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780713|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19780714|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780715|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780716|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19780717|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19780718|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780719|NCT00246519|Atenolol|atenolol|mesh-list
19780720|NCT00246519|Metoprolol|metoprolol|mesh-list
19780721|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19780722|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
19780723|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19780724|NCT00246519|Diuretics|diuretics|mesh-ancestor
19780725|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
19780726|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780727|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19780728|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780729|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780730|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19780731|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
19780732|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
19780733|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780734|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20151987|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20151988|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20151989|NCT00091156|Gefitinib|gefitinib|mesh-list
20151990|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151991|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20151992|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20151993|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20151994|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
20151995|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151996|NCT00091195|Romidepsin|romidepsin|mesh-list
20151997|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20151998|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20151999|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
20318844|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318845|NCT00717730|Hematinics|hematinics|mesh-ancestor
20318846|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
20318847|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20318848|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347424|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19780735|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19780736|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19780737|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
19780738|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780739|NCT00246571|Sunitinib|sunitinib|mesh-list
19780740|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780741|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19780742|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19780743|NCT00246571|Growth Substances|growth substances|mesh-ancestor
19780744|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780745|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
19780746|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780747|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780748|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780749|NCT00246740|Doxycycline|doxycycline|mesh-list
19780750|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20152000|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20152001|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152002|NCT00091247|Tetracycline|tetracycline|mesh-list
20152003|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19780751|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780752|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
19780753|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19780754|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19780755|NCT00246753|Lapatinib|lapatinib|mesh-list
19780756|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780757|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780758|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780759|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780760|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
19780761|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
19780762|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19780763|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780764|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780765|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19780766|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780767|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19780768|NCT00247416|Gemcitabine|gemcitabine|mesh-list
19780769|NCT00247416|Dexamethasone|dexamethasone|mesh-list
19780770|NCT00247416|Carboplatin|carboplatin|mesh-list
19780771|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780772|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
19780773|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
19780774|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780775|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780776|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19780777|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
19780778|NCT00247416|Hormones|hormones|mesh-ancestor
19780779|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780780|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780781|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780782|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19780783|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
19780784|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780785|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
19780786|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780787|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780788|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780789|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
19780790|NCT00247624|Eszopiclone|eszopiclone|mesh-list
19780791|NCT00247624|Fluoxetine|fluoxetine|mesh-list
19780792|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19780793|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19780794|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780795|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780796|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780797|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
19780798|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780799|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19780800|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780801|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780802|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19780803|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19780804|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780805|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20318849|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318850|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
20318851|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318852|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318853|NCT00717808|Tranilast|tranilast|mesh-list
19833635|NCT00589303|Verapamil|verapamil|mesh-list
20152004|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152005|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20152006|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152007|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152008|NCT00091299|Warfarin|warfarin|mesh-list
20152009|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
20152010|NCT00091312|Leucovorin|leucovorin|mesh-list
20152011|NCT00091312|Fluorouracil|fluorouracil|mesh-list
20152012|NCT00091312|Irinotecan|irinotecan|mesh-list
20152013|NCT00091312|Calcium|calcium|mesh-list
20152014|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
20152015|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152016|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318854|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
20318855|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20318856|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20318857|NCT00717808|Analgesics|analgesics|mesh-ancestor
20318858|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
19637363|NCT02416739|Vitamins|vitamins|mesh-ancestor
19780806|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780807|NCT00247676|Sunitinib|sunitinib|mesh-list
19780808|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780809|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19780810|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19780811|NCT00247676|Growth Substances|growth substances|mesh-ancestor
19780812|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780813|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
19780814|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19780815|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780816|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780817|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
19780818|NCT00247962|Etanercept|etanercept|mesh-list
19780819|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19780820|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19780821|NCT00247962|Analgesics|analgesics|mesh-ancestor
19780822|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
19780823|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780824|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780825|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780826|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780827|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19780828|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780829|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
19780830|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780831|NCT00248170|Letrozole|letrozole|mesh-list
19780832|NCT00248170|Anastrozole|anastrozole|mesh-list
19780833|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780834|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20152017|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
20152018|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152019|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20152020|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152021|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152022|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
20152023|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20152024|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20152025|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152026|NCT00091312|Antidotes|antidotes|mesh-ancestor
20152027|NCT00091312|Protective Agents|protective agents|mesh-ancestor
20152028|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
20152029|NCT00091312|Vitamins|vitamins|mesh-ancestor
20152030|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
20152031|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20152032|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
20152033|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152034|NCT00091325|Protective Agents|protective agents|mesh-ancestor
20152035|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152036|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20152037|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20152038|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637364|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
19637365|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152039|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20152040|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
20152041|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20152042|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
20152043|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637366|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19637367|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
19637368|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637369|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19637370|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
19637371|NCT02416583|Oxytocin|oxytocin|mesh-list
19637372|NCT02416583|Dinoprostone|dinoprostone|mesh-list
19637373|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
19637374|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19637375|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637376|NCT02416427|Atorvastatin|atorvastatin|mesh-list
19637377|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19780835|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19780836|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780837|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780838|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20152044|NCT00091377|Paclitaxel|paclitaxel|mesh-list
20152045|NCT00091377|Cisplatin|cisplatin|mesh-list
20152046|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20152047|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152048|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
19637378|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19637379|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
19637380|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637381|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19637382|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20152049|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
20152050|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
20152051|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152052|NCT00091429|Ranolazine|ranolazine|mesh-list
20152053|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19780839|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
19780840|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780841|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780842|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780843|NCT00248495|Pemetrexed|pemetrexed|mesh-list
19780844|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780845|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780846|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780847|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19780848|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19780849|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
19780850|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19780851|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19780852|NCT00248534|Prednisolone|prednisolone|mesh-list
19780853|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
19780854|NCT00248534|Rituximab|rituximab|mesh-list
19780855|NCT00248534|Temozolomide|temozolomide|mesh-list
19780856|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19780857|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
19780858|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19780859|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780860|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
19780861|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780862|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19780863|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19780864|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
19780865|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780866|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780867|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
19780868|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
19780869|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780870|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19780871|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
19780872|NCT00248534|Hormones|hormones|mesh-ancestor
19780873|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780874|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19780875|NCT00248534|Protective Agents|protective agents|mesh-ancestor
19780876|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780877|NCT00248547|Dexamethasone|dexamethasone|mesh-list
19780878|NCT00248547|Ondansetron|ondansetron|mesh-list
19780879|NCT00248547|Aprepitant|aprepitant|mesh-list
19780880|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19780881|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
19780882|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
19780883|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780884|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152054|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152055|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152056|NCT00091468|Nicotine|nicotine|mesh-list
20152057|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20152058|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
20152059|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637383|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637384|NCT02416388|Cytarabine|cytarabine|mesh-list
19637385|NCT02416388|Cyclosporine|cyclosporine|mesh-list
19780885|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19780886|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
19780887|NCT00248547|Hormones|hormones|mesh-ancestor
19780888|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19780889|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19780890|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780891|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
19780892|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
19780893|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19780894|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
19780895|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780896|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780897|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19780898|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780899|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780900|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780901|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19780902|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19780903|NCT00248560|Gemcitabine|gemcitabine|mesh-list
19780904|NCT00248560|Docetaxel|docetaxel|mesh-list
19780905|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318859|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20318860|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318861|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20318862|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20318863|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19780906|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
19780907|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780908|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780909|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
19780910|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780911|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780912|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19780913|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
19780914|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780915|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
19780916|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
19780917|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
19780918|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19780919|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19780920|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19780921|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780922|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780923|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780924|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780925|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19780926|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780927|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780928|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
19780929|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19780930|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
19780931|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19780932|NCT00248625|Expectorants|expectorants|mesh-ancestor
19780933|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
19780934|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19780935|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
19780936|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780937|NCT00248625|Protective Agents|protective agents|mesh-ancestor
19780938|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780939|NCT00248625|Antidotes|antidotes|mesh-ancestor
20318864|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19637386|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
19637387|NCT02416388|Dexamethasone|dexamethasone|mesh-list
19637388|NCT02416388|Methotrexate|methotrexate|mesh-list
19637389|NCT02416388|Daunorubicin|daunorubicin|mesh-list
19637390|NCT02416388|Venetoclax|venetoclax|mesh-list
19637391|NCT02416388|Idarubicin|idarubicin|mesh-list
19637392|NCT02416388|Cyclosporins|cyclosporins|mesh-list
19637393|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637394|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
19637395|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
19637396|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637397|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637398|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637399|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
19780940|NCT00248651|Amitriptyline|amitriptyline|mesh-list
19780941|NCT00248651|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19780942|NCT00248651|Citalopram|citalopram|mesh-list
19780943|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19780944|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19780945|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19780946|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780947|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780948|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
19780949|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780950|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19780951|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
19780952|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19780953|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19780954|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19780955|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19780956|NCT00248651|Analgesics|analgesics|mesh-ancestor
19780957|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
19780958|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20611145|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611146|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
20611147|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611148|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611149|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20611150|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611151|NCT02135042|Gemcitabine|gemcitabine|mesh-list
20611152|NCT02135042|Paclitaxel|paclitaxel|mesh-list
20611153|NCT02135042|Cisplatin|cisplatin|mesh-list
20611154|NCT02135042|Fluorouracil|fluorouracil|mesh-list
20611155|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20611156|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611157|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780959|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
19780960|NCT00248651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19780961|NCT00248651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19780962|NCT00248651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19780963|NCT00248807|Enalaprilat|enalaprilat|mesh-list
19780964|NCT00248807|Enalapril|enalapril|mesh-list
19780965|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19780966|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
19780967|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318865|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318866|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20318867|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20318868|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
19780968|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780969|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19780970|NCT00248833|Vaccines|vaccines|mesh-list
19780971|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
19780972|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780973|NCT00249002|Paclitaxel|paclitaxel|mesh-list
19780974|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19780975|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19780976|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19780977|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
19780978|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
19780979|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
19780980|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19780981|NCT00249249|Atorvastatin|atorvastatin|mesh-list
19780982|NCT00249249|Pitavastatin|pitavastatin|mesh-list
19780983|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19780984|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20152060|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152061|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20152062|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20152063|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
20152064|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152065|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152066|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20152067|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
20318869|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
20173992|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318870|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19780985|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
19780986|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152068|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152069|NCT00091559|Vorinostat|vorinostat|mesh-list
20152070|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152071|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20152072|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780987|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19780988|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19780989|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19780990|NCT00249288|Folic Acid|folic acid|mesh-list
19780991|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
19780992|NCT00249288|Hematinics|hematinics|mesh-ancestor
19780993|NCT00249288|Vitamins|vitamins|mesh-ancestor
19780994|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
19780995|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19780996|NCT00249379|Acamprosate|acamprosate|mesh-list
19780997|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19780998|NCT00249444|Mirtazapine|mirtazapine|mesh-list
19780999|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
19781000|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781001|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19781002|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
19781003|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
19781004|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781005|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781006|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781007|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19781008|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20318871|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20318872|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20318873|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
20318874|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
20318875|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
19781009|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781010|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19781011|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19781012|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19781013|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
19781014|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19781015|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19781016|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
19781017|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20318876|NCT00717821|Hematinics|hematinics|mesh-ancestor
20318877|NCT00717834|Formaldehyde|formaldehyde|mesh-list
20318878|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
20318879|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318880|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20318881|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20318882|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318883|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318884|NCT00717938|Carboplatin|carboplatin|mesh-list
20318885|NCT00717938|Etoposide|etoposide|mesh-list
20318886|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
20318887|NCT00717938|Cisplatin|cisplatin|mesh-list
20318888|NCT00717938|Enoxaparin|enoxaparin|mesh-list
20318889|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
20318890|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318891|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20318892|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781018|NCT00249769|Vaccines|vaccines|mesh-list
20152073|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318893|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318894|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318895|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318896|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
20318897|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20318898|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20318899|NCT00717951|Capecitabine|capecitabine|mesh-list
20152074|NCT00091598|Ambrisentan|ambrisentan|mesh-list
20152075|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20318900|NCT00717951|Docetaxel|docetaxel|mesh-list
20611158|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
20152076|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
20318901|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781019|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
20318902|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318903|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
20318904|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318905|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
20318906|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
20318907|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
20318908|NCT00717990|Bevacizumab|bevacizumab|mesh-list
20318909|NCT00717990|Capecitabine|capecitabine|mesh-list
20318910|NCT00717990|Irinotecan|irinotecan|mesh-list
20318911|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20318912|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318913|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20318914|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20318915|NCT00717990|Growth Substances|growth substances|mesh-ancestor
20318916|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318917|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20318918|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20318919|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
20318920|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318921|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20318922|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318923|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318924|NCT00718146|Vaccines|vaccines|mesh-list
20318925|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
20318926|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318927|NCT00718172|Ribavirin|ribavirin|mesh-list
20318928|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
20318929|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318930|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
20318931|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20318932|NCT00718276|Vitamin D|vitamin d|mesh-list
20318933|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
20318934|NCT00718276|Vitamins|vitamins|mesh-ancestor
20318935|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
20318936|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611159|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
19781020|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781021|NCT00249795|Irbesartan|irbesartan|mesh-list
19781022|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19781023|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19781024|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19781025|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781026|NCT00249808|Antibodies|antibodies|mesh-list
19781027|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19781028|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
19781029|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781030|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19781031|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19781032|NCT00249834|Hormones|hormones|mesh-ancestor
19781033|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781034|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781035|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19781036|NCT00249873|Clopidogrel|clopidogrel|mesh-list
19781037|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19781038|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19781039|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19781040|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19781041|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
19781042|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781043|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781044|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781045|NCT00250432|Caspofungin|caspofungin|mesh-list
19781046|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
19781047|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781048|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152077|NCT00091611|Fludarabine|fludarabine|mesh-list
20152078|NCT00091611|Interleukin-2|interleukin-2|mesh-list
20152079|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152080|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
20152081|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152082|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152083|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152084|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
20152085|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152086|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781049|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781050|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
19781051|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19781052|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
19781053|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781054|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318937|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20318938|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20318939|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
20318940|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20318941|NCT00718354|Cisplatin|cisplatin|mesh-list
20318942|NCT00718354|Carboplatin|carboplatin|mesh-list
20318943|NCT00718354|Fluorouracil|fluorouracil|mesh-list
20318944|NCT00718354|Capecitabine|capecitabine|mesh-list
20318945|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
19781055|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19781056|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
19781057|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19781058|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19781059|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19781060|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
19781061|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781062|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781063|NCT00250705|Aripiprazole|aripiprazole|mesh-list
19781064|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
19781065|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781066|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19781067|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781068|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781069|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781070|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
19781071|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
19781072|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781073|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781074|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19781075|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19781076|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
19781077|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19781078|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19781079|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19781080|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19781081|NCT00250835|Celecoxib|celecoxib|mesh-list
19781082|NCT00250835|Capecitabine|capecitabine|mesh-list
19781083|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
20318946|NCT00718354|Epirubicin|epirubicin|mesh-list
20318947|NCT00718354|Enoxaparin|enoxaparin|mesh-list
20318948|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318949|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
19781084|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20152087|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20152088|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152089|NCT00091611|Analgesics|analgesics|mesh-ancestor
19781085|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
19833636|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20152090|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
20152091|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152092|NCT00091624|Lenalidomide|lenalidomide|mesh-list
20152093|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
20152094|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152095|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20152096|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20152097|NCT00091624|Growth Substances|growth substances|mesh-ancestor
20152098|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
20152099|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152100|NCT00091650|Olanzapine|olanzapine|mesh-list
20152101|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
20152102|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
20152103|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152104|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152105|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152106|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20152107|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20152108|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318950|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318951|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19781086|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781087|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781088|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19781089|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19781090|NCT00250835|Analgesics|analgesics|mesh-ancestor
19781091|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
19781092|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781093|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781094|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19781095|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781096|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19781097|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19781098|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781099|NCT00250926|Dexamethasone|dexamethasone|mesh-list
20152109|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20152110|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20152111|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20152112|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152113|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152114|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152115|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
20152116|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20152117|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152118|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152119|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781100|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
20152120|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152121|NCT00091702|Vaccines|vaccines|mesh-list
20152122|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
20152123|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781101|NCT00250926|Rituximab|rituximab|mesh-list
19781102|NCT00250926|Bortezomib|bortezomib|mesh-list
19781103|NCT00250926|BB 1101|bb 1101|mesh-list
19781104|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781105|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781106|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
19781107|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152124|NCT00091715|Bosentan|bosentan|mesh-list
20152125|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20152126|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20152127|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781108|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781109|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19781110|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
19781111|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
19781112|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781113|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781114|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
19781115|NCT00250926|Hormones|hormones|mesh-ancestor
19781116|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781117|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781118|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
19781119|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781120|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781121|NCT00251004|Cyclosporine|cyclosporine|mesh-list
19781122|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
19781123|NCT00251004|Everolimus|everolimus|mesh-list
20152128|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20152129|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
20152130|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
20152131|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
20152132|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20152133|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20152134|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152135|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20152136|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20152137|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20152138|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20152139|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20152140|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781124|NCT00251004|Cyclosporins|cyclosporins|mesh-list
19781125|NCT00251004|Basiliximab|basiliximab|mesh-list
19781126|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781127|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637400|NCT02416388|Hormones|hormones|mesh-ancestor
19637401|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637402|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19637403|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637404|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19637405|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
19637406|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19637407|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19637408|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
19637409|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637410|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637411|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637412|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19637413|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637414|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
19637415|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637416|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19637417|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
19637418|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781128|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781129|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
19781130|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781131|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
19781132|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781133|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
19781134|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781135|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19781136|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781137|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19781138|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19781139|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
19781140|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19781141|NCT00251225|Docetaxel|docetaxel|mesh-list
19781142|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
19781143|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781144|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
19781145|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
19781146|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
19781147|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781148|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19781149|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781150|NCT00251303|Riluzole|riluzole|mesh-list
19781151|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
19781152|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19781153|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19781154|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781155|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781156|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781157|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19781158|NCT00251303|Protective Agents|protective agents|mesh-ancestor
19781159|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
19781160|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
19781161|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781162|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781163|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781164|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
19781165|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781166|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781167|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781168|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19781169|NCT00251589|Vorinostat|vorinostat|mesh-list
19781170|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781171|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19781172|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781173|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152141|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152142|NCT00091741|Etanercept|etanercept|mesh-list
20152143|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152144|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152145|NCT00091741|Analgesics|analgesics|mesh-ancestor
20173993|NCT00163241|Celecoxib|celecoxib|mesh-list
19781174|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19781175|NCT00251641|Methotrexate|methotrexate|mesh-list
19781176|NCT00251641|Infliximab|infliximab|mesh-list
19781177|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19781178|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
19781179|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19781180|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781181|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19781182|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
19781183|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781184|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781185|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
19781186|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781187|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19781188|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781189|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
19781190|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781191|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19781192|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781193|NCT00251693|Lansoprazole|lansoprazole|mesh-list
19781194|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
19781195|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781196|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637419|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
19637420|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19637421|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19637422|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19637423|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19637424|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19637425|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
19637426|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19637427|NCT02416232|Trametinib|trametinib|mesh-list
19637428|NCT02416232|Dabrafenib|dabrafenib|mesh-list
19781197|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781198|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781199|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781200|NCT00251719|Lansoprazole|lansoprazole|mesh-list
19781201|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
19781202|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781203|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781204|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781205|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781206|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781207|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
19781208|NCT00251745|Lansoprazole|lansoprazole|mesh-list
19781209|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781210|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781211|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781212|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781213|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781214|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
19781215|NCT00251758|Lansoprazole|lansoprazole|mesh-list
19781216|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781217|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781218|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781219|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781220|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781221|NCT00251927|Esomeprazole|esomeprazole|mesh-list
19781222|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781223|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637429|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637430|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19637431|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637432|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637433|NCT02416271|Vitamin D|vitamin d|mesh-list
19781224|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781225|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781226|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781227|NCT00251979|Esomeprazole|esomeprazole|mesh-list
19781228|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781229|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781230|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781231|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637434|NCT02416271|Alendronate|alendronate|mesh-list
19637435|NCT02416271|Teriparatide|teriparatide|mesh-list
19781232|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781233|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19781234|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
19781235|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781236|NCT00252239|Plasminogen|plasminogen|mesh-list
19781237|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19781238|NCT00252239|Tenecteplase|tenecteplase|mesh-list
19781239|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19781240|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19781241|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611160|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611161|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611162|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19637436|NCT02416271|Calcium|calcium|mesh-list
19833637|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19833638|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
19833639|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
19833640|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833641|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833642|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19833643|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19833644|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19833645|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
19833646|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833647|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833648|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
19833649|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19833650|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19833651|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19833652|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19833653|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19833654|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833655|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19833656|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19833657|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19833658|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19833659|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19833660|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19833661|NCT00589329|Metronidazole|metronidazole|mesh-list
19833662|NCT00589329|Erythromycin|erythromycin|mesh-list
19833663|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
19833664|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19637437|NCT02416271|Vitamins|vitamins|mesh-ancestor
19637438|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
19637439|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637440|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19637441|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19662487|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19833665|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
19833666|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833667|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19833668|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19833669|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19833670|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19662488|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662489|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
19662490|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
19662491|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19662492|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
19662493|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
19662494|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662495|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
19833671|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833672|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833673|NCT00589472|Vorinostat|vorinostat|mesh-list
19833674|NCT00589472|Leuprolide|leuprolide|mesh-list
19833675|NCT00589472|Goserelin|goserelin|mesh-list
19833676|NCT00589472|Bicalutamide|bicalutamide|mesh-list
19833677|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833678|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19833679|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662496|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19781242|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
19781243|NCT00252499|Fenofibrate|fenofibrate|mesh-list
19781244|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19781245|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781246|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19781247|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
19781248|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781249|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19781250|NCT00252564|Leucovorin|leucovorin|mesh-list
19781251|NCT00252564|Bevacizumab|bevacizumab|mesh-list
19781252|NCT00252564|Cetuximab|cetuximab|mesh-list
19781253|NCT00252564|Fluorouracil|fluorouracil|mesh-list
19781254|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
19781255|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781256|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781257|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19781258|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19781259|NCT00252564|Growth Substances|growth substances|mesh-ancestor
19781260|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781261|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
19781262|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
19781263|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781264|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19781265|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781266|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
19781267|NCT00252564|Antidotes|antidotes|mesh-ancestor
19781268|NCT00252564|Protective Agents|protective agents|mesh-ancestor
19781269|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
19781270|NCT00252564|Vitamins|vitamins|mesh-ancestor
19781271|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
19781272|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
19781273|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
19781274|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781275|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781276|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781277|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
19781278|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781279|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781280|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781281|NCT00252694|Candesartan|candesartan|mesh-list
19781282|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19781283|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19781284|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19781285|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781286|NCT00252720|Candesartan|candesartan|mesh-list
19637442|NCT02416531|Clobetasol|clobetasol|mesh-list
19637443|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19781287|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19781288|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19781289|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19781290|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781291|NCT00252733|Candesartan|candesartan|mesh-list
19637444|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
19637445|NCT02416531|Hormones|hormones|mesh-ancestor
19637446|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637447|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637448|NCT02416258|Betamethasone|betamethasone|mesh-list
19637449|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
19637450|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19637451|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
19637452|NCT02416258|Calcipotriene|calcipotriene|mesh-list
19637453|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19637454|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637455|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
19637456|NCT02416258|Hormones|hormones|mesh-ancestor
19637457|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637458|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637459|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19637460|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
19637461|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637462|NCT02416245|Micronutrients|micronutrients|mesh-list
19637463|NCT02416245|Trace Elements|trace elements|mesh-list
19637464|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637465|NCT02416570|Clarithromycin|clarithromycin|mesh-list
19781292|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
19781293|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19781294|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19781295|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19781296|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781297|NCT00252967|Atorvastatin|atorvastatin|mesh-list
19781298|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19781299|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19781300|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
19781301|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781302|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19781303|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19781304|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781305|NCT00253370|Cisplatin|cisplatin|mesh-list
19781306|NCT00253370|Docetaxel|docetaxel|mesh-list
19781307|NCT00253370|Sorafenib|sorafenib|mesh-list
19781308|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637466|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19637467|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637468|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19637469|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637470|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637471|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19637472|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19781309|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
19781310|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
19781311|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
19781312|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637473|NCT02416141|Tramadol|tramadol|mesh-list
19637474|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19637475|NCT02416141|Narcotics|narcotics|mesh-ancestor
19637476|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637477|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637478|NCT02416141|Analgesics|analgesics|mesh-ancestor
19637479|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
19637480|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637481|NCT02416167|Dotinurad|dotinurad|mesh-list
19637482|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
19637483|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
19637484|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637485|NCT02416167|Renal Agents|renal agents|mesh-ancestor
19637486|NCT02416115|Morphine|morphine|mesh-list
19637487|NCT02416115|Ramosetron|ramosetron|mesh-list
19637488|NCT02416115|Naloxone|naloxone|mesh-list
19637489|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19637490|NCT02416115|Narcotics|narcotics|mesh-ancestor
19637491|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637492|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637493|NCT02416115|Analgesics|analgesics|mesh-ancestor
19781313|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19781314|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781315|NCT00253435|Carboplatin|carboplatin|mesh-list
19781316|NCT00253435|Etoposide|etoposide|mesh-list
19781317|NCT00253435|Melphalan|melphalan|mesh-list
19781318|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781319|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19781320|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781321|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781322|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781323|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781324|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
19781325|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781326|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781327|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
19781328|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781329|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781330|NCT00253513|Fludarabine|fludarabine|mesh-list
19781331|NCT00253513|Treosulfan|treosulfan|mesh-list
19781332|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781333|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637494|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
19781334|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152146|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
20152147|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152148|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318952|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781335|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
19781336|NCT00253630|Vorinostat|vorinostat|mesh-list
19781337|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781338|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20152149|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152150|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781339|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781340|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781341|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19781342|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
19781343|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781344|NCT00253643|Protective Agents|protective agents|mesh-ancestor
20318953|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
20318954|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318955|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318956|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20318957|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318958|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318959|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
20318960|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20318961|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19781345|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781346|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19781347|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19781348|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781349|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19781350|NCT00253747|Methylphenidate|methylphenidate|mesh-list
19781351|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19781352|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781353|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19781354|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19781355|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19781356|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781357|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
19781358|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781359|NCT00253890|Trazodone|trazodone|mesh-list
19781360|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19781361|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781362|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781363|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781364|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781365|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19781366|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19781367|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19781368|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781369|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781370|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
19781371|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19781372|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
19781373|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
19781374|NCT00254163|Rituximab|rituximab|mesh-list
19781375|NCT00254163|Fludarabine|fludarabine|mesh-list
19781376|NCT00254163|Pentostatin|pentostatin|mesh-list
19781377|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152151|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152152|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152153|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
20152154|NCT00091806|Panitumumab|panitumumab|mesh-list
20152155|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20152156|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152157|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
20152158|NCT00091858|Hematinics|hematinics|mesh-ancestor
20152159|NCT00091897|Rituximab|rituximab|mesh-list
20152160|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20152161|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152162|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
20152163|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152164|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152165|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
20152166|NCT00091910|Hematinics|hematinics|mesh-ancestor
20152167|NCT00091936|Lamivudine|lamivudine|mesh-list
20152168|NCT00091936|Efavirenz|efavirenz|mesh-list
20152169|NCT00091936|Didanosine|didanosine|mesh-list
20318962|NCT00718406|Metoprolol|metoprolol|mesh-list
20152170|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20152171|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20318963|NCT00718406|Morphine|morphine|mesh-list
20318964|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20318965|NCT00718406|Narcotics|narcotics|mesh-ancestor
20318966|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318967|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20318968|NCT00718406|Analgesics|analgesics|mesh-ancestor
20318969|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
20318970|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637495|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637496|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19637497|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
19637498|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
19637499|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637500|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19637501|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
19637502|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662497|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662498|NCT05022810|Acetaminophen|acetaminophen|mesh-list
19662499|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19662500|NCT05022810|Analgesics|analgesics|mesh-ancestor
19662501|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
19662502|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662503|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662504|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
19662505|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
19662506|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662507|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
19662508|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
19662509|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
19662510|NCT04993560|Vaccines|vaccines|mesh-list
19662511|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
19662512|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662513|NCT04947085|Ketamine|ketamine|mesh-list
19662514|NCT04947085|Analgesics|analgesics|mesh-ancestor
19662515|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
19662516|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662517|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662518|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19662519|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19662520|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
19662521|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
19662522|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662523|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19662524|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19662525|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662526|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662527|NCT04885816|Sirolimus|sirolimus|mesh-list
19662528|NCT04885816|Everolimus|everolimus|mesh-list
19662529|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662530|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662531|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
19662532|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662533|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19662534|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662535|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19662536|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
19662537|NCT04865614|Sevoflurane|sevoflurane|mesh-list
19662538|NCT04865614|Etomidate|etomidate|mesh-list
19662539|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19662540|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19662541|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
19662542|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
19662543|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662544|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662545|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19662546|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19662547|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
19662548|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19662549|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662550|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662551|NCT04770454|Buspirone|buspirone|mesh-list
19662552|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19662553|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19662554|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20318971|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20318972|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20318973|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
20318974|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
20318975|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20318976|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20318977|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20318978|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
20318979|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20318980|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318981|NCT00718471|Heparin|heparin|mesh-list
20318982|NCT00718471|Enoxaparin|enoxaparin|mesh-list
19781378|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
19781379|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781380|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781381|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781382|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
19781383|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781384|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781385|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20152172|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152173|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152174|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
19781386|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781387|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19781388|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781389|NCT00254293|Abatacept|abatacept|mesh-list
19781390|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19781391|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19781392|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781393|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781394|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781395|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
19781396|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781397|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781398|NCT00254397|Leuprolide|leuprolide|mesh-list
19781399|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19781400|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
19781401|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19781402|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781403|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781404|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781405|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
19781406|NCT00254410|Rituximab|rituximab|mesh-list
19781407|NCT00254410|Fludarabine|fludarabine|mesh-list
19781408|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
19781409|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781410|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
19781411|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781412|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781413|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781414|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
19781415|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781416|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781417|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781418|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781419|NCT00254410|Analgesics|analgesics|mesh-ancestor
19781420|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
19781421|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781422|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781423|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781424|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781425|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19781426|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20152175|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152176|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20152177|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20152178|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19781427|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19781428|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19781429|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781430|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
20318983|NCT00718471|Calcium heparin|calcium heparin|mesh-list
19781431|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781432|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781433|NCT00254488|Valproic Acid|valproic acid|mesh-list
19781434|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781435|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781436|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781437|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
19781438|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781439|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781440|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781441|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
19781442|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
19781443|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781444|NCT00254540|Sunitinib|sunitinib|mesh-list
19781445|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781446|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20318984|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
20318985|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20318986|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20318987|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318988|NCT00718484|Doxorubicin|doxorubicin|mesh-list
20318989|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20318990|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
20318991|NCT00718484|Ifosfamide|ifosfamide|mesh-list
19781447|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19781448|NCT00254540|Growth Substances|growth substances|mesh-ancestor
19781449|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781450|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
19781451|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19781452|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781453|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781454|NCT00254566|Azithromycin|azithromycin|mesh-list
19781455|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
19781456|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19781457|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19781458|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781459|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781460|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781461|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781462|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781463|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781464|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20318992|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20318993|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20318994|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20318995|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20318996|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20318997|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20318998|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637503|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637504|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
19637505|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20318999|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
20319000|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
20319001|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20319002|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20319003|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
20319004|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319005|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20319006|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20319007|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319008|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319009|NCT00718601|Imetelstat|imetelstat|mesh-list
20319010|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
20319011|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319012|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319013|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19637506|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637507|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637508|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19637509|NCT02416063|Analgesics|analgesics|mesh-ancestor
19781465|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
20319014|NCT00718705|Josamycin|josamycin|mesh-list
20319015|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319016|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319017|NCT00718757|Dexamethasone|dexamethasone|mesh-list
20319018|NCT00718757|Irinotecan|irinotecan|mesh-list
20319019|NCT00718757|Vincristine|vincristine|mesh-list
20319020|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319021|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
20319022|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
20319023|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319024|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781466|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19781467|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781468|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19781469|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19781470|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19781471|NCT00254592|Paclitaxel|paclitaxel|mesh-list
19781472|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19781473|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
19781474|NCT00254592|Bevacizumab|bevacizumab|mesh-list
19781475|NCT00254592|Carboplatin|carboplatin|mesh-list
19781476|NCT00254592|Doxorubicin|doxorubicin|mesh-list
19781477|NCT00254592|Trastuzumab|trastuzumab|mesh-list
20319025|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20319026|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
20319027|NCT00718757|Hormones|hormones|mesh-ancestor
20319028|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20319029|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20319030|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319031|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20319032|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319033|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319034|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319035|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20319036|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
20319037|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
20319038|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
20347425|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347426|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347427|NCT00860223|Protective Agents|protective agents|mesh-ancestor
20347428|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781478|NCT00254592|Sargramostim|sargramostim|mesh-list
19781479|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19781480|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781481|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
19781482|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
19781483|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
19781484|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781485|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781486|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
19781487|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781488|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781489|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781490|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
19781491|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781492|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781493|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19781494|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19781495|NCT00254592|Growth Substances|growth substances|mesh-ancestor
19781496|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
19781497|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19781498|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20152179|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20152180|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20152181|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20152182|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20152183|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20152184|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
20152185|NCT00092001|Sunitinib|sunitinib|mesh-list
20152186|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152187|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20152188|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20152189|NCT00092001|Growth Substances|growth substances|mesh-ancestor
20152190|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347429|NCT00860275|Fluconazole|fluconazole|mesh-list
20152191|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
20152192|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152193|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152194|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152195|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
20152196|NCT00092079|Alendronate|alendronate|mesh-list
20152197|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152198|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152199|NCT00092079|Vitamins|vitamins|mesh-ancestor
20152200|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
20152201|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20152202|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
20152203|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
20152204|NCT00092170|Ertapenem|ertapenem|mesh-list
20152205|NCT00092170|Ticarcillin|ticarcillin|mesh-list
20152206|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20319039|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
20319040|NCT00718796|Ubiquinone|ubiquinone|mesh-list
20319041|NCT00718796|Atorvastatin|atorvastatin|mesh-list
20319042|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20152207|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152208|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152209|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319043|NCT00718796|Simvastatin|simvastatin|mesh-list
20319044|NCT00718796|Pravastatin|pravastatin|mesh-list
20319045|NCT00718796|Lovastatin|lovastatin|mesh-list
20319046|NCT00718796|L 647318|l 647318|mesh-list
20319047|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
20319048|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
20319049|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20319050|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
20319051|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319052|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20319053|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20319054|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319055|NCT00718796|Vitamins|vitamins|mesh-ancestor
20319056|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
20319057|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319058|NCT00718913|Docetaxel|docetaxel|mesh-list
20319059|NCT00718913|Capecitabine|capecitabine|mesh-list
20319060|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319061|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
20319062|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
20319063|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
20319064|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319065|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19637510|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
19637511|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637512|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19637513|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19637514|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19637515|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
19637516|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662555|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662556|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19662557|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19662558|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
19662559|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662560|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662561|NCT04731025|Vancomycin|vancomycin|mesh-list
19662562|NCT04731025|Gentamicins|gentamicins|mesh-list
19662563|NCT04731025|Cefazolin|cefazolin|mesh-list
19662564|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19662565|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662566|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19662567|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662568|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662569|NCT04691128|Anesthetics|anesthetics|mesh-list
19662570|NCT04691128|Propofol|propofol|mesh-list
19662571|NCT04691128|Desflurane|desflurane|mesh-list
19662572|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662573|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662574|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19662575|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19662576|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
19662577|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19665938|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781499|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781500|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781501|NCT00254982|Infliximab|infliximab|mesh-list
19781502|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
19781503|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781504|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781505|NCT00255008|Ribavirin|ribavirin|mesh-list
19781506|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19781507|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
19781508|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
19781509|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781510|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
19781511|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781512|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
19781513|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781514|NCT00255034|Ribavirin|ribavirin|mesh-list
19781515|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19781516|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
19781517|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
19781518|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781519|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
19781520|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781521|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
19781522|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781523|NCT00255086|Memantine|memantine|mesh-list
19781524|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19781525|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19781526|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
19781527|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781528|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781529|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781530|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19781531|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19781532|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
19781533|NCT00255151|Lansoprazole|lansoprazole|mesh-list
19781534|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781535|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781536|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781537|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781538|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781539|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
19781540|NCT00255164|Lansoprazole|lansoprazole|mesh-list
20152210|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152211|NCT00092183|Ondansetron|ondansetron|mesh-list
20152212|NCT00092183|Aprepitant|aprepitant|mesh-list
20152213|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
20152214|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
20152215|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152216|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152217|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152218|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
20152219|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
20152220|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20152221|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
20152222|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152223|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319066|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
20319067|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20319068|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
20319069|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20319070|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20319071|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319072|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319073|NCT00718952|Urological Agents|urological agents|mesh-ancestor
20319074|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
20319075|NCT00719056|Lactams|lactams|mesh-list
20319076|NCT00719056|Cephalosporins|cephalosporins|mesh-list
19637517|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637518|NCT02416128|Prednisolone|prednisolone|mesh-list
19637519|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19637520|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
19637521|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19637522|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
19637523|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19637524|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
19637525|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637526|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
20319077|NCT00719056|Teicoplanin|teicoplanin|mesh-list
20319078|NCT00719056|beta-Lactams|beta-lactams|mesh-list
20319079|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319080|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319081|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20319082|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319083|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319084|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319085|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319086|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20319087|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319088|NCT00719095|Naltrexone|naltrexone|mesh-list
20319089|NCT00719095|Buprenorphine|buprenorphine|mesh-list
20319090|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20319091|NCT00719095|Narcotics|narcotics|mesh-ancestor
20319092|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20319093|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319094|NCT00719095|Analgesics|analgesics|mesh-ancestor
20319095|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
20319096|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319097|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20319098|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20319099|NCT00719108|Insulin|insulin|mesh-list
19637527|NCT02416128|Hormones|hormones|mesh-ancestor
19637528|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637529|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637530|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19637531|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637532|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
19637533|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
19662578|NCT04682522|Metronidazole|metronidazole|mesh-list
19662579|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662580|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19662581|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19662582|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19662583|NCT04657809|Insulin|insulin|mesh-list
19662584|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19662585|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662586|NCT04601584|Antibodies|antibodies|mesh-list
19662587|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
19662588|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
19662589|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662590|NCT04585854|Caffeine|caffeine|mesh-list
19662591|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19662592|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662593|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19662594|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662595|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662596|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19662597|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19662598|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
19662599|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662600|NCT04582981|Raltitrexed|raltitrexed|mesh-list
19662601|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19662602|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
19662603|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662604|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662605|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19662606|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662607|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
19662608|NCT04548661|Povidone|povidone|mesh-list
19662609|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
19662610|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
19662611|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19662612|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662613|NCT04504240|Famotidine|famotidine|mesh-list
19662614|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19662615|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662616|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19662617|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
19662618|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
19662619|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662620|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662621|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662622|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19781541|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781542|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781543|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781544|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781545|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781546|NCT00255177|Mifepristone|mifepristone|mesh-list
19781547|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19781548|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
19781549|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19781550|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781551|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19781552|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19781553|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19781554|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
19781555|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19781556|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19781557|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
19781558|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781559|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
19781560|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19781561|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19781562|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
19781563|NCT00255190|Lansoprazole|lansoprazole|mesh-list
19781564|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781565|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781566|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781567|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781568|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781569|NCT00255346|Dasatinib|dasatinib|mesh-list
19781570|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781571|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19781572|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781573|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781574|NCT00255684|Cyclosporine|cyclosporine|mesh-list
19781575|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
20152224|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20152225|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20152226|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20152227|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20152228|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20152229|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20152230|NCT00092196|Aprepitant|aprepitant|mesh-list
20152231|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
20152232|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
20152233|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152234|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152235|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152236|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20152237|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175123|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20175124|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175125|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175126|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
20175127|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175128|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175129|NCT00167375|Eszopiclone|eszopiclone|mesh-list
20175130|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20175131|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175132|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175133|NCT00167401|Docetaxel|docetaxel|mesh-list
20175134|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175135|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
20175136|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
20175137|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175138|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175139|NCT00167479|Risperidone|risperidone|mesh-list
20175140|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20175141|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
20175142|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175143|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175144|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175145|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19781576|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
19781577|NCT00255684|Fludarabine|fludarabine|mesh-list
19781578|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
19781579|NCT00255684|Cyclosporins|cyclosporins|mesh-list
19781580|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781581|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
19781582|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781583|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781584|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781585|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
19781586|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781587|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781588|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781589|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19781590|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
19781591|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781592|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
20319100|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20319101|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20319102|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319103|NCT00719121|Adapalene|adapalene|mesh-list
20319104|NCT00719121|R 115866|r 115866|mesh-list
20319105|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20319106|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20319107|NCT00719121|Analgesics|analgesics|mesh-ancestor
20319108|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
20319109|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319110|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637534|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637535|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637536|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19637537|NCT02416128|Protective Agents|protective agents|mesh-ancestor
19637538|NCT02415985|Lopinavir|lopinavir|mesh-list
19637539|NCT02415985|Rifabutin|rifabutin|mesh-list
19637540|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19637541|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19637542|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
19637543|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637544|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637545|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19637546|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19637547|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
19637548|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637549|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19637550|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19637551|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19637552|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19637553|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
19637554|NCT02415920|Oxytocin|oxytocin|mesh-list
19637555|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
19637556|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19637557|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637558|NCT02415829|Capecitabine|capecitabine|mesh-list
19637559|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
19637560|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19637561|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
19637562|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637563|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637564|NCT02415881|Panitumumab|panitumumab|mesh-list
19637565|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19637566|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152238|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152239|NCT00092274|Ofatumumab|ofatumumab|mesh-list
20152240|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152241|NCT00092287|Lanreotide|lanreotide|mesh-list
20152242|NCT00092287|Octreotide|octreotide|mesh-list
20152243|NCT00092287|Somatostatin|somatostatin|mesh-list
20152244|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152245|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152246|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20152247|NCT00092287|Hormones|hormones|mesh-ancestor
20152248|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20152249|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152250|NCT00092300|Valdecoxib|valdecoxib|mesh-list
20152251|NCT00092300|Rofecoxib|rofecoxib|mesh-list
20319111|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19781593|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781594|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
19781595|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19781596|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19781597|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19781598|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
19781599|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19781600|NCT00255723|Carboplatin|carboplatin|mesh-list
19781601|NCT00255723|Etoposide|etoposide|mesh-list
19781602|NCT00255723|Ifosfamide|ifosfamide|mesh-list
19781603|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781604|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19781605|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781606|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319112|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20319113|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
20319114|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319115|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319116|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319117|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
20319118|NCT00719173|Aprepitant|aprepitant|mesh-list
20319119|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319120|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
20319121|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319122|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637567|NCT02415712|Fomepizole|fomepizole|mesh-list
19781607|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781608|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781609|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781610|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
19781611|NCT00255801|Doxorubicin|doxorubicin|mesh-list
19781612|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19781613|NCT00255801|Bexarotene|bexarotene|mesh-list
19781614|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19781615|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781616|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781617|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781618|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781619|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781620|NCT00255840|Ritonavir|ritonavir|mesh-list
19781621|NCT00255840|Lopinavir|lopinavir|mesh-list
19781622|NCT00255840|Lamivudine|lamivudine|mesh-list
19781623|NCT00255840|Nevirapine|nevirapine|mesh-list
19781624|NCT00255840|Stavudine|stavudine|mesh-list
19781625|NCT00255840|Efavirenz|efavirenz|mesh-list
19781626|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19781627|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19781628|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
19781629|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781630|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781631|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19781632|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19781633|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
19781634|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781635|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19781636|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19781637|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19781638|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19781639|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19781640|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19781641|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19781642|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19637568|NCT02415712|Antidotes|antidotes|mesh-ancestor
19637569|NCT02415712|Protective Agents|protective agents|mesh-ancestor
19637570|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637571|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637572|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637573|NCT02415803|Clopidogrel|clopidogrel|mesh-list
19637574|NCT02415803|Ticagrelor|ticagrelor|mesh-list
19637575|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19781643|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19781644|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
19781645|NCT00256204|Rasagiline|rasagiline|mesh-list
20319123|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637576|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19781646|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20319124|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
20319125|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319126|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319127|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20319128|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
19637577|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19637578|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19637579|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
19637580|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637581|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637582|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637583|NCT02415777|Riboflavin|riboflavin|mesh-list
19637584|NCT02415777|Thiamine|thiamine|mesh-list
19637585|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19637586|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
19781647|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781648|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781649|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19781650|NCT00256204|Protective Agents|protective agents|mesh-ancestor
19637587|NCT02415777|Vitamins|vitamins|mesh-ancestor
19637588|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
19637589|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637590|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19637591|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637592|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19637593|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637594|NCT02415569|Bisacodyl|bisacodyl|mesh-list
19637595|NCT02415569|Cathartics|cathartics|mesh-ancestor
19637596|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781651|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781652|NCT00256217|Anastrozole|anastrozole|mesh-list
19781653|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781654|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637597|NCT02415569|Laxatives|laxatives|mesh-ancestor
19637598|NCT02415699|Leucovorin|leucovorin|mesh-list
19637599|NCT02415699|Fluorouracil|fluorouracil|mesh-list
19637600|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
19781655|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19781656|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19781657|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781658|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781659|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19781660|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
19781661|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781662|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781663|NCT00256243|Paclitaxel|paclitaxel|mesh-list
19781664|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
19781665|NCT00256243|Carboplatin|carboplatin|mesh-list
19781666|NCT00256243|Doxorubicin|doxorubicin|mesh-list
19781667|NCT00256243|Trastuzumab|trastuzumab|mesh-list
19781668|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19781669|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781670|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19781671|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
19781672|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19781673|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781674|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781675|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
19781676|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781677|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781678|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781679|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
20152252|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20152253|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20152254|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152255|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152256|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152257|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152258|NCT00092300|Analgesics|analgesics|mesh-ancestor
20152259|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
20319129|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
19637601|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
19637602|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637603|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19781680|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781681|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19781682|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781683|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781684|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781685|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781686|NCT00256282|Docetaxel|docetaxel|mesh-list
19781687|NCT00256282|Vinorelbine|vinorelbine|mesh-list
19781688|NCT00256282|Sargramostim|sargramostim|mesh-list
19781689|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781690|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
19781691|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
19781692|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
19781693|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781694|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19781695|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
19781696|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781697|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
19781698|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781699|NCT00256451|Ethanol|ethanol|mesh-list
19781700|NCT00256451|Naltrexone|naltrexone|mesh-list
19781701|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19781702|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781703|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781704|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781705|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19781706|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19781707|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
19781708|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781709|NCT00256698|Fulvestrant|fulvestrant|mesh-list
19781710|NCT00256698|Anastrozole|anastrozole|mesh-list
19781711|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781712|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781713|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19781714|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19781715|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
19781716|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781717|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781718|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19781719|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19781720|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781721|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781722|NCT00256750|Cyclosporine|cyclosporine|mesh-list
19781723|NCT00256750|Abatacept|abatacept|mesh-list
19781724|NCT00256750|Cyclosporins|cyclosporins|mesh-list
19781725|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781726|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781727|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781728|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
19781729|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781730|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
19781731|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781732|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
19781733|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781734|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19781735|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19781736|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781737|NCT00256776|Thalidomide|thalidomide|mesh-list
19781738|NCT00256776|Dexamethasone|dexamethasone|mesh-list
19781739|NCT00256776|Bortezomib|bortezomib|mesh-list
19781740|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19781741|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
19781742|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
19781743|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781744|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781745|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781746|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
19781747|NCT00256776|Hormones|hormones|mesh-ancestor
19781748|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781749|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781750|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781751|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781752|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
19781753|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
19781754|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19781755|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19781756|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19781757|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19781758|NCT00256776|Growth Substances|growth substances|mesh-ancestor
19781759|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
19781760|NCT00256854|Ropinirole|ropinirole|mesh-list
19781761|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19781762|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19781763|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
19781764|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
20319130|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319131|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20319132|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20319133|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20319134|NCT00719199|Cetuximab|cetuximab|mesh-list
20319135|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20319136|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319137|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
20319138|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20319139|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
20319140|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319141|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
20319142|NCT00719290|Protective Agents|protective agents|mesh-ancestor
20319143|NCT00719381|Pioglitazone|pioglitazone|mesh-list
20319144|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20319145|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319146|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
20319147|NCT00719407|Hematinics|hematinics|mesh-ancestor
20319148|NCT00719420|Amoxicillin|amoxicillin|mesh-list
20319149|NCT00719420|Metronidazole|metronidazole|mesh-list
20319150|NCT00719420|Clarithromycin|clarithromycin|mesh-list
20319151|NCT00719420|Omeprazole|omeprazole|mesh-list
20319152|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319153|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319154|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20319155|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20319156|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20319157|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20319158|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20319159|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319160|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781765|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781766|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781767|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781768|NCT00256997|Risperidone|risperidone|mesh-list
19781769|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
19781770|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19781771|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
19781772|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781773|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781774|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319161|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20319162|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20319163|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319164|NCT00719433|Armin|armin|mesh-list
20319165|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20319166|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319167|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319168|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
20319169|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781775|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781776|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781777|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781778|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19781779|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
19781780|NCT00257010|Almotriptan|almotriptan|mesh-list
19781781|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19781782|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
19781783|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781784|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781785|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781786|NCT00257166|Ziprasidone|ziprasidone|mesh-list
19781787|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20319170|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319171|NCT00719459|Iron|iron|mesh-list
19781788|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
20319172|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19781789|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781790|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781791|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781792|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19781793|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781794|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781795|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781796|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19781797|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
19781798|NCT00257192|Ziprasidone|ziprasidone|mesh-list
19781799|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19781800|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
19781801|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781802|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781803|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781804|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19781805|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19781806|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781807|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19781808|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19781809|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
19781810|NCT00257309|Tenecteplase|tenecteplase|mesh-list
19781811|NCT00257309|Clopidogrel|clopidogrel|mesh-list
19781812|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19781813|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19781814|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19781815|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19781816|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
19781817|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781818|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781819|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781820|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19781821|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19781822|NCT00257556|Menotropins|menotropins|mesh-list
19781823|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19781824|NCT00257556|Hormones|hormones|mesh-ancestor
19781825|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781826|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781827|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19781828|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
19781829|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19781830|NCT00257608|Bevacizumab|bevacizumab|mesh-list
19781831|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19781832|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781833|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781834|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19781835|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19781836|NCT00257608|Growth Substances|growth substances|mesh-ancestor
19781837|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781838|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
19781839|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19781840|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781841|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781842|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
19781843|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19781844|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19781845|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19781846|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152260|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152261|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152262|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152263|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152264|NCT00092313|Acetaminophen|acetaminophen|mesh-list
20152265|NCT00092313|Rofecoxib|rofecoxib|mesh-list
20152266|NCT00092313|Oxycodone|oxycodone|mesh-list
20152267|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152268|NCT00092313|Analgesics|analgesics|mesh-ancestor
20152269|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
20152270|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152271|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152272|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
20319173|NCT00719459|Trace Elements|trace elements|mesh-ancestor
20152273|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20152274|NCT00092313|Narcotics|narcotics|mesh-ancestor
19781847|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781848|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
19781849|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781850|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781851|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19781852|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781853|NCT00257686|Pravastatin|pravastatin|mesh-list
19781854|NCT00257686|Pitavastatin|pitavastatin|mesh-list
19781855|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19781856|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19781857|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
19781858|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781859|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19781860|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19781861|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781862|NCT00257725|Methylphenidate|methylphenidate|mesh-list
19781863|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19781864|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781865|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19781866|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19781867|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19781868|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781869|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
19781870|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781871|NCT00257894|Baclofen|baclofen|mesh-list
19781872|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781873|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19781874|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19781875|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781876|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19781877|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
19781878|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
19781879|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19781880|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781881|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
19781882|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781883|NCT00257920|Vitamins|vitamins|mesh-ancestor
19781884|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
19781885|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19781886|NCT00257933|Prednisolone|prednisolone|mesh-list
19781887|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19781888|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
19781889|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19781890|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
19781891|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19781892|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
19781893|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319174|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
20319175|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319176|NCT00719459|Hematinics|hematinics|mesh-ancestor
20319177|NCT00719602|Ritonavir|ritonavir|mesh-list
20319178|NCT00719602|Lopinavir|lopinavir|mesh-list
20319179|NCT00719602|Lamivudine|lamivudine|mesh-list
20319180|NCT00719602|Zidovudine|zidovudine|mesh-list
20319181|NCT00719602|Nevirapine|nevirapine|mesh-list
20319182|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20319183|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20319184|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
20319185|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319186|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319187|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20319188|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20319189|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
20319190|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319191|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20319192|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319193|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20319194|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20319195|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
20319196|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20319197|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20319198|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
19781894|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
19781895|NCT00257933|Hormones|hormones|mesh-ancestor
20319199|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20152275|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19781896|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781897|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781898|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781899|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781900|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
19781901|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
19781902|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781903|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781904|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19781905|NCT00257933|Protective Agents|protective agents|mesh-ancestor
19781906|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19781907|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19781908|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19781909|NCT00258128|Analgesics|analgesics|mesh-ancestor
19781910|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
19781911|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19781912|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781913|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19781914|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781915|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
19781916|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781917|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
19781918|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781919|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781920|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781921|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
19781922|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781923|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781924|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781925|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
19781926|NCT00258206|Rituximab|rituximab|mesh-list
19781927|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781928|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
19781929|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781930|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781931|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781932|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
19781933|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781934|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781935|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781936|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781937|NCT00258310|Capecitabine|capecitabine|mesh-list
19781938|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19781939|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
19781940|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781941|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781942|NCT00258349|Trastuzumab|trastuzumab|mesh-list
19781943|NCT00258349|Vorinostat|vorinostat|mesh-list
19781944|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781945|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781946|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19781947|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781948|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781949|NCT00258362|Carboplatin|carboplatin|mesh-list
19781950|NCT00258362|Docetaxel|docetaxel|mesh-list
19637604|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637605|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637606|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
19637607|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637608|NCT02415699|Antidotes|antidotes|mesh-ancestor
19637609|NCT02415699|Protective Agents|protective agents|mesh-ancestor
19637610|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
19637611|NCT02415699|Vitamins|vitamins|mesh-ancestor
19637612|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
19637613|NCT02415309|Melatonin|melatonin|mesh-list
19637614|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
19637615|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637616|NCT02415309|Protective Agents|protective agents|mesh-ancestor
19637617|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637618|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637619|NCT02415192|Amlodipine|amlodipine|mesh-list
19637620|NCT02415192|Valsartan|valsartan|mesh-list
19781951|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781952|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
19781953|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
20319200|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
20319201|NCT00719693|Fenofibrate|fenofibrate|mesh-list
20319202|NCT00719693|Calcium|calcium|mesh-list
20319203|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319204|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319205|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20319206|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19781954|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
19781955|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781956|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
19781957|NCT00258440|Hematinics|hematinics|mesh-ancestor
19781958|NCT00258817|Vaccines|vaccines|mesh-list
19781959|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
19781960|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781961|NCT00258830|Vaccines|vaccines|mesh-list
19781962|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
19781963|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781964|NCT00258856|Vaccines|vaccines|mesh-list
19781965|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
19781966|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781967|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
19781968|NCT00258960|Doxorubicin|doxorubicin|mesh-list
19781969|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19781970|NCT00258960|Trastuzumab|trastuzumab|mesh-list
19781971|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19781972|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
19781973|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19781974|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19781975|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19781976|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
19781977|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781978|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781979|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19781980|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19781981|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19781982|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19781983|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781984|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19781985|NCT00259012|Pantoprazole|pantoprazole|mesh-list
19781986|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19781987|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19781988|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19781989|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19781990|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19781991|NCT00259090|Fulvestrant|fulvestrant|mesh-list
19781992|NCT00259090|Anastrozole|anastrozole|mesh-list
19781993|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19781994|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19781995|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19781996|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19781997|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
19781998|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19781999|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782000|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19782001|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19782002|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782003|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782004|NCT00259272|Olanzapine|olanzapine|mesh-list
19782005|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
19782006|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
19782007|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782008|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782009|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19782010|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19782011|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782012|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782013|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782014|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19782015|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19782016|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782017|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782018|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20319207|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20319208|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
20319209|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782019|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
19782020|NCT00259285|Pemetrexed|pemetrexed|mesh-list
19782021|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782022|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782023|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782024|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19782025|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19833680|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833681|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19833682|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
19833683|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19833684|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833685|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19833686|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
19833687|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
19833688|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833689|NCT00589563|Sirolimus|sirolimus|mesh-list
19833690|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
19833691|NCT00589563|Melphalan|melphalan|mesh-list
19833692|NCT00589563|Methotrexate|methotrexate|mesh-list
19833693|NCT00589563|Fludarabine|fludarabine|mesh-list
19833694|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
19833695|NCT00589563|Etoposide|etoposide|mesh-list
19833696|NCT00589563|Tacrolimus|tacrolimus|mesh-list
19833697|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19833698|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19833699|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
19833700|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833701|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833702|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152276|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20152277|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20152278|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152279|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152280|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152281|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152282|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152283|NCT00092326|Acetaminophen|acetaminophen|mesh-list
20319210|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19833703|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
19833704|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833705|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833706|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19833707|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19833708|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
19833709|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19833710|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19833711|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
20152284|NCT00092326|Rofecoxib|rofecoxib|mesh-list
20319211|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20319212|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319213|NCT00719745|Tacrolimus|tacrolimus|mesh-list
20319214|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319215|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
20319216|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319217|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20319218|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637621|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19637622|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19637623|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19637624|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637625|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19637626|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637627|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
19637628|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20152285|NCT00092326|Oxycodone|oxycodone|mesh-list
20152286|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152287|NCT00092326|Analgesics|analgesics|mesh-ancestor
19782026|NCT00259298|Teriparatide|teriparatide|mesh-list
19782027|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19782028|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782029|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19782030|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
19782031|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
19782032|NCT00259610|Etanercept|etanercept|mesh-list
19782033|NCT00259610|Methotrexate|methotrexate|mesh-list
19782034|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19782035|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
19782036|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19782037|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782038|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782039|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
19782040|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782041|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782042|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782043|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782044|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20319219|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319220|NCT00719758|Beraprost|beraprost|mesh-list
20319221|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20319222|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
20152288|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
20152289|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152290|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152291|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
20152292|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20152293|NCT00092326|Narcotics|narcotics|mesh-ancestor
20152294|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20319223|NCT00719797|Leucovorin|leucovorin|mesh-list
20319224|NCT00719797|Bevacizumab|bevacizumab|mesh-list
20319225|NCT00719797|Fluorouracil|fluorouracil|mesh-list
20319226|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
20319227|NCT00719797|Irinotecan|irinotecan|mesh-list
20319228|NCT00719797|Calcium|calcium|mesh-list
19637629|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19782045|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782046|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
19782047|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782048|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19782049|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
19782050|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19782051|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19782052|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637630|NCT02415335|Dexamethasone|dexamethasone|mesh-list
19637631|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
19637632|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19637633|NCT02415335|BB 1101|bb 1101|mesh-list
19637634|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637635|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
19637636|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
19782053|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19782054|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19782055|NCT00259610|Analgesics|analgesics|mesh-ancestor
19782056|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
19782057|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782058|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782059|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19782060|NCT00259649|Eletriptan|eletriptan|mesh-list
19782061|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19782062|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
19782063|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782064|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782065|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782066|NCT00259740|Denosumab|denosumab|mesh-list
19782067|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19782068|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782069|NCT00259857|Alendronate|alendronate|mesh-list
19782070|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19782071|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152295|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20152296|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20319229|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
19637637|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319230|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782072|NCT00260065|Decitabine|decitabine|mesh-list
19782073|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782074|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
19782075|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782076|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782077|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782078|NCT00260208|Cyclosporine|cyclosporine|mesh-list
19782079|NCT00260208|Tacrolimus|tacrolimus|mesh-list
19782080|NCT00260208|Cyclosporins|cyclosporins|mesh-list
19782081|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782082|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
19782083|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782084|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19782085|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782086|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782087|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
19782088|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782089|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782090|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782091|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19782092|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19782093|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19782094|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782095|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319231|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319232|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20319233|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20319234|NCT00719797|Growth Substances|growth substances|mesh-ancestor
20319235|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319236|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
20319237|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319238|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
20319239|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319240|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782096|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19782097|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782098|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782099|NCT00260689|Cyclosporine|cyclosporine|mesh-list
19782100|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
20319241|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319242|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
20319243|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20319244|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319245|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319246|NCT00719797|Antidotes|antidotes|mesh-ancestor
20319247|NCT00719797|Protective Agents|protective agents|mesh-ancestor
20319248|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
20319249|NCT00719797|Vitamins|vitamins|mesh-ancestor
19637638|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637639|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637640|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
19637641|NCT02415335|Hormones|hormones|mesh-ancestor
19637642|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637643|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19637644|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637645|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
19637646|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637647|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637648|NCT02415413|Dexamethasone|dexamethasone|mesh-list
19782101|NCT00260689|Cyclosporins|cyclosporins|mesh-list
19782102|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20319250|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
19637649|NCT02415413|Lenalidomide|lenalidomide|mesh-list
19637650|NCT02415413|Melphalan|melphalan|mesh-list
19637651|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637652|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
19637653|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
19637654|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637655|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637656|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19637657|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
19637658|NCT02415413|Hormones|hormones|mesh-ancestor
19637659|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637660|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19637661|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637662|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
19637663|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19637664|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19637665|NCT02415413|Growth Substances|growth substances|mesh-ancestor
19637666|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
19637667|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637668|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
19665939|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665940|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665941|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665942|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19665943|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665944|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
19665945|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19665946|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
19665947|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
19665948|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665949|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
19665950|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
19665951|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19665952|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19665953|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665954|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665955|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665956|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665957|NCT03023124|Doxorubicin|doxorubicin|mesh-list
19665958|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19665959|NCT03023124|Dacarbazine|dacarbazine|mesh-list
19665960|NCT03023124|Trabectedin|trabectedin|mesh-list
19665961|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19665962|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665963|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19665964|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19665965|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665966|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665967|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665968|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
19665969|NCT02957968|Paclitaxel|paclitaxel|mesh-list
19665970|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
19665971|NCT02957968|Carboplatin|carboplatin|mesh-list
19665972|NCT02957968|Doxorubicin|doxorubicin|mesh-list
19665973|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
19665974|NCT02957968|Decitabine|decitabine|mesh-list
19665975|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19665976|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665977|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
19665978|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
19665979|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665980|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665981|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665982|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
19665983|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665984|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665985|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665986|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
19665987|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19665988|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19665989|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19665990|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19665991|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782103|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
19782104|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782105|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782106|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782107|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
19782108|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782109|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
19782110|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782111|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782112|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782113|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19637669|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782114|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782115|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782116|NCT00260832|Cytarabine|cytarabine|mesh-list
19782117|NCT00260832|Decitabine|decitabine|mesh-list
19782118|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782119|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
19782120|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782121|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782122|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
19782123|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782124|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782125|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
19782126|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782127|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782128|NCT00260962|Olanzapine|olanzapine|mesh-list
19782129|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
19782130|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
19782131|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782132|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152297|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637670|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19637671|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637672|NCT02415270|Menthol|menthol|mesh-list
19637673|NCT02415270|Nicotine|nicotine|mesh-list
19637674|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19637675|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
19637676|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637677|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637678|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19637679|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19637680|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
19637681|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637682|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637683|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
19637684|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637685|NCT02415257|Gentamicins|gentamicins|mesh-list
19637686|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19637687|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637688|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19637689|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782133|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152298|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152299|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152300|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152301|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152302|NCT00092339|Valdecoxib|valdecoxib|mesh-list
20152303|NCT00092339|Rofecoxib|rofecoxib|mesh-list
20152304|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20152305|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20152306|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637690|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175146|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175147|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782134|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20175148|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175149|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20175150|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
20175151|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
20175152|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19782135|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782136|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782137|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782138|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19782139|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19782140|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782141|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782142|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782143|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
19782144|NCT00261443|Valproic Acid|valproic acid|mesh-list
19782145|NCT00261443|Aripiprazole|aripiprazole|mesh-list
19782146|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
19782147|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
19782148|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782149|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19782150|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782151|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782152|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782153|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
19782154|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
19782155|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782156|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782157|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19782158|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19782159|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
19782160|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19782161|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19782162|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19782163|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19782164|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782165|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
19782166|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
19782167|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
19782168|NCT00261495|Oxycodone|oxycodone|mesh-list
19782169|NCT00261495|Hydromorphone|hydromorphone|mesh-list
19782170|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19782171|NCT00261495|Narcotics|narcotics|mesh-ancestor
19782172|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782173|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319251|NCT00719823|Maraviroc|maraviroc|mesh-list
20319252|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20319253|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20319254|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319255|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20319256|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20319257|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
20319258|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319259|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20319260|NCT00719875|Vorinostat|vorinostat|mesh-list
20319261|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20319262|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319263|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319264|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319265|NCT00720018|Sumatriptan|sumatriptan|mesh-list
20319266|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20319267|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20319268|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20319269|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
20319270|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637691|NCT02415179|Fluticasone|fluticasone|mesh-list
19637692|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
19637693|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
19637694|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19637695|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19637696|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637697|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19637698|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
19637699|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637700|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637701|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19637702|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
19782174|NCT00261495|Analgesics|analgesics|mesh-ancestor
19782175|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
20347430|NCT00860275|Ketoconazole|ketoconazole|mesh-list
19782176|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782177|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
19782178|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19782179|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782180|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782181|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19782182|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19782183|NCT00261950|Cinacalcet|cinacalcet|mesh-list
19782184|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19782185|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782186|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19782187|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
19782188|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19782189|NCT00262002|Vaccines|vaccines|mesh-list
19782190|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
19782191|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782192|NCT00262028|Vaccines|vaccines|mesh-list
19782193|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
19782194|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782195|NCT00262041|Vaccines|vaccines|mesh-list
19782196|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
19782197|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782198|NCT00262067|Bevacizumab|bevacizumab|mesh-list
19782199|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782200|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782201|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782202|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19782203|NCT00262067|Growth Substances|growth substances|mesh-ancestor
19782204|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782205|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782206|NCT00262080|Ecallantide|ecallantide|mesh-list
19782207|NCT00262080|Analgesics|analgesics|mesh-ancestor
19782208|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
19782209|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782210|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782211|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19782212|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19782213|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782214|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782215|NCT00262223|Sertraline|sertraline|mesh-list
19782216|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
19782217|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782218|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19782219|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19782220|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782221|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782222|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782223|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
19782224|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782225|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19782226|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19782227|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782228|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
19782229|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782230|NCT00262522|Ritonavir|ritonavir|mesh-list
19782231|NCT00262522|Lopinavir|lopinavir|mesh-list
19782232|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19782233|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20152307|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152308|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152309|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152310|NCT00092339|Analgesics|analgesics|mesh-ancestor
20152311|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
20152312|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152313|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152314|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152315|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152316|NCT00092352|Celecoxib|celecoxib|mesh-list
20152317|NCT00092352|Rofecoxib|rofecoxib|mesh-list
20152318|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152319|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152320|NCT00092352|Analgesics|analgesics|mesh-ancestor
20152321|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
20152322|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782234|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19782235|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
19782236|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782237|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782238|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19782239|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19782240|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
19782241|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782242|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19782243|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19782244|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19782245|NCT00262600|Warfarin|warfarin|mesh-list
19782246|NCT00262600|Dabigatran|dabigatran|mesh-list
19782247|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
19782248|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
19782249|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19782250|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
19782251|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782252|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782253|NCT00262639|Gabapentin|gabapentin|mesh-list
19782254|NCT00262639|Flumazenil|flumazenil|mesh-list
19782255|NCT00262639|Analgesics|analgesics|mesh-ancestor
19782256|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
19782257|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782258|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782259|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
19782260|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19782261|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782262|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782263|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782264|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19782265|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19782266|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782267|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782268|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
19782269|NCT00262639|Antidotes|antidotes|mesh-ancestor
19782270|NCT00262639|Protective Agents|protective agents|mesh-ancestor
19782271|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
19782272|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
19782273|NCT00262730|Temozolomide|temozolomide|mesh-list
19782274|NCT00262730|Poly ICLC|poly iclc|mesh-list
19782275|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19782276|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
19782277|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782278|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782279|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
19782280|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
19782281|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782282|NCT00262821|Tirapazamine|tirapazamine|mesh-list
19782283|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782284|NCT00262834|Vorinostat|vorinostat|mesh-list
19782285|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782286|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19782287|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782288|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782289|NCT00262847|Paclitaxel|paclitaxel|mesh-list
19782290|NCT00262847|Bevacizumab|bevacizumab|mesh-list
19782291|NCT00262847|Carboplatin|carboplatin|mesh-list
19637703|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637704|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19637705|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19637706|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19637707|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19637708|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
19637709|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637710|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637711|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
19637712|NCT02415179|Hormones|hormones|mesh-ancestor
19637713|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637714|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
19637715|NCT02415114|Resveratrol|resveratrol|mesh-list
19782292|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19637716|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
19782293|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19782294|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
19782295|NCT00262847|Antibodies|antibodies|mesh-list
19782296|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
19782297|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19782298|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
19782299|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19782300|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782301|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
19782302|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
19782303|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
19782304|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782305|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782306|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19782307|NCT00262847|Growth Substances|growth substances|mesh-ancestor
19782308|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637717|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637718|NCT02415114|Protective Agents|protective agents|mesh-ancestor
19637719|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637720|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152323|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152324|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152325|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152326|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20152327|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19637721|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19637722|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
19637723|NCT02414919|Etonogestrel|etonogestrel|mesh-list
19637724|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19782309|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782310|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
19782311|NCT00262860|Gemcitabine|gemcitabine|mesh-list
19782312|NCT00262860|Bortezomib|bortezomib|mesh-list
19782313|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782314|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
19782315|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782316|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782317|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
19782318|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637725|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
19782319|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782320|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782321|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
19782322|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782323|NCT00262873|Bortezomib|bortezomib|mesh-list
19782324|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782325|NCT00262925|Leucovorin|leucovorin|mesh-list
19782326|NCT00262925|Dexamethasone|dexamethasone|mesh-list
19782327|NCT00262925|Methotrexate|methotrexate|mesh-list
19782328|NCT00262925|Vincristine|vincristine|mesh-list
19782329|NCT00262925|Asparaginase|asparaginase|mesh-list
19782330|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
19782331|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
19782332|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19782333|NCT00262925|Antibodies|antibodies|mesh-list
19782334|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
19782335|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19782336|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
19782337|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
19782338|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782339|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782340|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
19782341|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
19782342|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782343|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19782344|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
19782345|NCT00262925|Hormones|hormones|mesh-ancestor
19782346|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19782347|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20152328|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347431|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
19782348|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782349|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19782350|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
19833712|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782351|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19782352|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782353|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
19782354|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782355|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782356|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782357|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19782358|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782359|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782360|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19637726|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19637727|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637728|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19637729|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19637730|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19637731|NCT02415023|Paclitaxel|paclitaxel|mesh-list
19637732|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19637733|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19637734|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637735|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
19637736|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
19637737|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
19637738|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637739|NCT02414880|Rocuronium|rocuronium|mesh-list
20319271|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319272|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319273|NCT00720135|Rituximab|rituximab|mesh-list
20319274|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20319275|NCT00720135|Interleukin-2|interleukin-2|mesh-list
20319276|NCT00720135|Antibodies|antibodies|mesh-list
19637740|NCT02414880|Neostigmine|neostigmine|mesh-list
19637741|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19637742|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19637743|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19637744|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637745|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637746|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19637747|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637748|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637749|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
19637750|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637751|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19637752|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
19637753|NCT02414984|Golimumab|golimumab|mesh-list
19782361|NCT00262925|Antidotes|antidotes|mesh-ancestor
19782362|NCT00262925|Protective Agents|protective agents|mesh-ancestor
19782363|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
19782364|NCT00262925|Vitamins|vitamins|mesh-ancestor
19782365|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
19782366|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19782367|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
19782368|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
19782369|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
19782370|NCT00262951|Interferons|interferons|mesh-list
19782371|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
19782372|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
19782373|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19782374|NCT00262951|Cisplatin|cisplatin|mesh-list
19782375|NCT00262951|Fluorouracil|fluorouracil|mesh-list
19782376|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782377|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
19782378|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782379|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782380|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782381|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
19782382|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782383|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
19782384|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637754|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19637755|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637756|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637757|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
19637758|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782385|NCT00262964|Niacin|niacin|mesh-list
19782386|NCT00262964|Fenofibrate|fenofibrate|mesh-list
19782387|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19782388|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
19782389|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782390|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19782391|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
19782392|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
19782393|NCT00262964|Vitamins|vitamins|mesh-ancestor
19782394|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
19782395|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782396|NCT00263211|Aspirin|aspirin|mesh-list
19782397|NCT00263211|Clopidogrel|clopidogrel|mesh-list
19782398|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19782399|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19637759|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
19637760|NCT02414945|Fludarabine|fludarabine|mesh-list
19637761|NCT02414945|Interleukin-2|interleukin-2|mesh-list
19637762|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637763|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
19637764|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637765|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637766|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637767|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
19637768|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637769|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637770|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19637771|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19637772|NCT02414945|Analgesics|analgesics|mesh-ancestor
19782400|NCT00263211|Analgesics|analgesics|mesh-ancestor
19782401|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
19782402|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782403|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782404|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782405|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782406|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19637773|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
19637774|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637775|NCT02415062|Donepezil|donepezil|mesh-list
19782407|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19782408|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782409|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19782410|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19782411|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782412|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
19637776|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19637777|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637778|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637779|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
19637780|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637781|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637782|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
19637783|NCT02415036|Melphalan|melphalan|mesh-list
19637784|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637785|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
19637786|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637787|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637788|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19637789|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637790|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
19637791|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637792|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
19637793|NCT02414802|Heparin|heparin|mesh-list
19637794|NCT02414802|Calcium heparin|calcium heparin|mesh-list
19637795|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19637796|NCT02414802|Tinzaparin|tinzaparin|mesh-list
19637797|NCT02414802|Dalteparin|dalteparin|mesh-list
19637798|NCT02414802|Calcium|calcium|mesh-list
19637799|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19637800|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637801|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19637802|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
19637803|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19637804|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19637805|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637806|NCT02414750|Vemurafenib|vemurafenib|mesh-list
19782413|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19782414|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19782415|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19782416|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
19782417|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782418|NCT00263328|Tacrolimus|tacrolimus|mesh-list
19782419|NCT00263328|Tofacitinib|tofacitinib|mesh-list
19782420|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782421|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
19782422|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782423|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20152329|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152330|NCT00092365|Celecoxib|celecoxib|mesh-list
20152331|NCT00092365|Rofecoxib|rofecoxib|mesh-list
19637807|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637808|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19637809|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319277|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
20319278|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20319279|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
20319280|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319281|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319282|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782424|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782425|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782426|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152332|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152333|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152334|NCT00092365|Analgesics|analgesics|mesh-ancestor
20152335|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
20152336|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152337|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319283|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20319284|NCT00720135|Analgesics|analgesics|mesh-ancestor
20319285|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
20319286|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319287|NCT00720148|Bortezomib|bortezomib|mesh-list
20319288|NCT00720148|Sunitinib|sunitinib|mesh-list
20319289|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319290|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20319291|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20319292|NCT00720148|Growth Substances|growth substances|mesh-ancestor
20319293|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319294|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
20319295|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20319296|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319297|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637810|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637811|NCT02414503|Oxytocin|oxytocin|mesh-list
19637812|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
19637813|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19637814|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637815|NCT02414555|Phenylephrine|phenylephrine|mesh-list
19637816|NCT02414555|Norepinephrine|norepinephrine|mesh-list
19637817|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19637818|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19637819|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
19637820|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
19637821|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637822|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637823|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
19637824|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
19637825|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
19637826|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19637827|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19637828|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19782427|NCT00263575|Fentanyl|fentanyl|mesh-list
19637829|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
19782428|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20319298|NCT00720161|Metformin|metformin|mesh-list
19637830|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637831|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637832|NCT02414555|Protective Agents|protective agents|mesh-ancestor
19637833|NCT02414568|Prednisone|prednisone|mesh-list
19782429|NCT00263575|Narcotics|narcotics|mesh-ancestor
19782430|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782431|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782432|NCT00263575|Analgesics|analgesics|mesh-ancestor
19782433|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
19782434|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782435|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19782436|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19782437|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
19782438|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
19782439|NCT00263588|Lapatinib|lapatinib|mesh-list
19782440|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782441|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19782442|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782443|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782444|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
19782445|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19782446|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782447|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782448|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19782449|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19782450|NCT00264004|Cediranib|cediranib|mesh-list
19782451|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782452|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19782453|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782454|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782455|NCT00264238|Memantine|memantine|mesh-list
19782456|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19782457|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19782458|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
19782459|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782460|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782461|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782462|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19782463|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19782464|NCT00264290|Valganciclovir|valganciclovir|mesh-list
19782465|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
19782466|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782467|NCT00264303|Levocetirizine|levocetirizine|mesh-list
19782468|NCT00264303|Desloratadine|desloratadine|mesh-list
19782469|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19782470|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19782471|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
19782472|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
20319299|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20319300|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319301|NCT00720174|Doxorubicin|doxorubicin|mesh-list
20319302|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20319303|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20319304|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20319305|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319306|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20319307|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319308|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637834|NCT02414568|Doxorubicin|doxorubicin|mesh-list
19637835|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19637836|NCT02414568|Vinblastine|vinblastine|mesh-list
19637837|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19637838|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637839|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19637840|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19637841|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637842|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637843|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19637844|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
19637845|NCT02414568|Hormones|hormones|mesh-ancestor
19637846|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19637847|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637848|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19782473|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782474|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782475|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782476|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19782477|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
19782478|NCT00264381|Dalteparin|dalteparin|mesh-list
19782479|NCT00264381|Tinzaparin|tinzaparin|mesh-list
19782480|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19782481|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
19782482|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19782483|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19782484|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782485|NCT00264498|Gemcitabine|gemcitabine|mesh-list
19782486|NCT00264498|Carboplatin|carboplatin|mesh-list
19782487|NCT00264498|Gefitinib|gefitinib|mesh-list
19782488|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782489|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782490|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
19782491|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782492|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
20152338|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152339|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152340|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20152341|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19782493|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782494|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782495|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782496|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
19782497|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782498|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19782499|NCT00264537|Golimumab|golimumab|mesh-list
19782500|NCT00264537|Methotrexate|methotrexate|mesh-list
19782501|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19782502|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19782503|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
19782504|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19782505|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782506|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782507|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
19782508|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782509|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782510|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782511|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782512|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19782513|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782514|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
19782515|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782516|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19782517|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19782518|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782519|NCT00264550|Golimumab|golimumab|mesh-list
19782520|NCT00264550|Methotrexate|methotrexate|mesh-list
19782521|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19782522|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19782523|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
19782524|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19782525|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782526|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782527|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
19782528|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782529|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782530|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782531|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782532|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19782533|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782534|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
19782535|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782536|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19782537|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19782538|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782539|NCT00264641|Insulin|insulin|mesh-list
19782540|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19782541|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19782542|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782543|NCT00264797|Methylphenidate|methylphenidate|mesh-list
19833713|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319309|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319310|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
20319311|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319312|NCT00720265|Tacrolimus|tacrolimus|mesh-list
19782544|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19782545|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782546|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19782547|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19782548|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782549|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782550|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
19782551|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782552|NCT00264849|Omalizumab|omalizumab|mesh-list
19782553|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19782554|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19782555|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
19782556|NCT00264875|Pregabalin|pregabalin|mesh-list
20319313|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319314|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
20319315|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782557|NCT00264875|Analgesics|analgesics|mesh-ancestor
19782558|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
19782559|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782560|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782561|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
19782562|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19782563|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782564|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782565|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19782566|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19782567|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782568|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782569|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782570|NCT00265083|Golimumab|golimumab|mesh-list
19782571|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19782572|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19782573|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782574|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782575|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
19782576|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782577|NCT00265096|Golimumab|golimumab|mesh-list
19782578|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19782579|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20319316|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20319317|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319318|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319319|NCT00720291|Metronidazole|metronidazole|mesh-list
20319320|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319321|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319322|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20319323|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20319324|NCT00720304|Docetaxel|docetaxel|mesh-list
19782580|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152342|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152343|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152344|NCT00092378|Diclofenac|diclofenac|mesh-list
20152345|NCT00092378|Rofecoxib|rofecoxib|mesh-list
20152346|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152347|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152348|NCT00092378|Analgesics|analgesics|mesh-ancestor
20152349|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
20152350|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152351|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152352|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152353|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152354|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20152355|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152356|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152357|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20152358|NCT00092391|Vaccines|vaccines|mesh-list
20152359|NCT00092391|Immunoglobulins|immunoglobulins|mesh-list
20152360|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
20152361|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152362|NCT00092404|Vaccines|vaccines|mesh-list
20152363|NCT00092404|Immunoglobulins|immunoglobulins|mesh-list
20152364|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
20152365|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152366|NCT00092508|Mesalamine|mesalamine|mesh-list
20152367|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152368|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152369|NCT00092508|Analgesics|analgesics|mesh-ancestor
20319325|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20319326|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319327|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
20319328|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
20319329|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
20319330|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319331|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19637849|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637850|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
19637851|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19637852|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
19637853|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
19637854|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
19637855|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
19637856|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
19637857|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19637858|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19637859|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637860|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637861|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637862|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662623|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19662624|NCT04492306|Protective Agents|protective agents|mesh-ancestor
19662625|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662626|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19662627|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
19662628|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662629|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
19662630|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19662631|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
19662632|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662633|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
19662634|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19662635|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
19662636|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662637|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
19662638|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19662639|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
19662640|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662641|NCT04459052|Expectorants|expectorants|mesh-ancestor
19662642|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
19662643|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19662644|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
19662645|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662646|NCT04459052|Protective Agents|protective agents|mesh-ancestor
19662647|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662648|NCT04459052|Antidotes|antidotes|mesh-ancestor
19662649|NCT04429802|Prucalopride|prucalopride|mesh-list
19662650|NCT04429802|Laxatives|laxatives|mesh-ancestor
19662651|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662652|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19662653|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19662654|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
19662655|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662656|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662657|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662658|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
19662659|NCT04387760|Favipiravir|favipiravir|mesh-list
19662660|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
19662661|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19662662|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19662663|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662664|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662665|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662666|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662667|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
19637863|NCT02414581|Ethanol|ethanol|mesh-list
19637864|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
20152370|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
20152371|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152372|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152373|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152374|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637865|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20152375|NCT00092846|Lovastatin|lovastatin|mesh-list
20152376|NCT00092846|L 647318|l 647318|mesh-list
20152377|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
20152378|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20152379|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20152380|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
20152381|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152382|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20152383|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20152384|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152385|NCT00092924|Mapatumumab|mapatumumab|mesh-list
20152386|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152387|NCT00092937|Busulfan|busulfan|mesh-list
20152388|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
20152389|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152390|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152391|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
20152392|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152393|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152394|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152395|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20152396|NCT00092976|Factor VIII|factor viii|mesh-list
20152397|NCT00092976|Coagulants|coagulants|mesh-ancestor
20152398|NCT00093002|Fulvestrant|fulvestrant|mesh-list
20152399|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20152400|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152401|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20152402|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19637866|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19637867|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637868|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637869|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637870|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
19637871|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
19637872|NCT02414529|Vitamin D|vitamin d|mesh-list
19637873|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
19637874|NCT02414529|Vitamins|vitamins|mesh-list
19637875|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
19637876|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637877|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19637878|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19637879|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
19662685|NCT04356534|Antibodies|antibodies|mesh-list
19662686|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
19662687|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662688|NCT04331756|Anesthetics|anesthetics|mesh-list
19662689|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662690|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662716|NCT04300244|Nivolumab|nivolumab|mesh-list
20152403|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
20152404|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20152405|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152406|NCT00093028|Bortezomib|bortezomib|mesh-list
20152407|NCT00093028|Lenalidomide|lenalidomide|mesh-list
20152408|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152409|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
19782581|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782582|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
19782583|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319332|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319333|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
20319334|NCT00720408|Tacrolimus|tacrolimus|mesh-list
20319335|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319336|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
20319337|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319338|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20319339|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319340|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319341|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20319342|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319343|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20319344|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
20319345|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19782584|NCT00265109|Levetiracetam|levetiracetam|mesh-list
19637880|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19637881|NCT02414490|Antibodies|antibodies|mesh-list
19637882|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
19637883|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19637884|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
19637885|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782585|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
19782586|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
19782587|NCT00265122|Ustekinumab|ustekinumab|mesh-list
19782588|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782589|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
19782590|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19782591|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782592|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
19782593|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19782594|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782595|NCT00265239|Edaravone|edaravone|mesh-list
19782596|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19782597|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
19782598|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782599|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19782600|NCT00265239|Protective Agents|protective agents|mesh-ancestor
19782601|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782602|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19637886|NCT02414685|Paclitaxel|paclitaxel|mesh-list
19637887|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19637888|NCT02414685|Cisplatin|cisplatin|mesh-list
19637889|NCT02414685|Ifosfamide|ifosfamide|mesh-list
19637890|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
19637891|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19637892|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637893|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
19637894|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
19637895|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
19637896|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637897|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637898|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
19637899|NCT02414724|Gemcitabine|gemcitabine|mesh-list
19637900|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19637901|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
19637902|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637903|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782603|NCT00265317|Sunitinib|sunitinib|mesh-list
19637904|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
19782604|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782605|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152410|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152411|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20152412|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20152413|NCT00093028|Growth Substances|growth substances|mesh-ancestor
20152414|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
20152415|NCT00093067|Daptomycin|daptomycin|mesh-list
20152416|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20152417|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152418|NCT00093093|Interferons|interferons|mesh-list
20152419|NCT00093093|Ribavirin|ribavirin|mesh-list
20152420|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
20152421|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
20152422|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19637905|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637906|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637907|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637908|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
19637909|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637910|NCT02414451|Propranolol|propranolol|mesh-list
19637911|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19637912|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19637913|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
19637914|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637915|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637916|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637917|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19637918|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19637919|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
19637920|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
19637921|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19637922|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19637923|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19662717|NCT04300244|Ipilimumab|ipilimumab|mesh-list
19662718|NCT04300244|Sargramostim|sargramostim|mesh-list
19662719|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662720|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662721|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19662722|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662723|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
19662724|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662725|NCT04298203|Topiramate|topiramate|mesh-list
19662726|NCT04298203|Phentermine|phentermine|mesh-list
19662727|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
19662728|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19662729|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662730|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19662731|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
19662732|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19662733|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
19662734|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
19662735|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662736|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
19662737|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662738|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662739|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
19662740|NCT04214418|Atezolizumab|atezolizumab|mesh-list
19662741|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662742|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
19662743|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19662744|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19662745|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662746|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662747|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662748|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662749|NCT04204967|Fentanyl|fentanyl|mesh-list
19662750|NCT04204967|Remifentanil|remifentanil|mesh-list
19662751|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19662752|NCT04204967|Narcotics|narcotics|mesh-ancestor
19662753|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662754|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662755|NCT04204967|Analgesics|analgesics|mesh-ancestor
19662756|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
19662757|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662758|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19662759|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19662760|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
19662761|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
19782606|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782607|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782608|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782609|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19782610|NCT00265317|Growth Substances|growth substances|mesh-ancestor
19782611|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782612|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782613|NCT00265330|Ziprasidone|ziprasidone|mesh-list
20152423|NCT00093093|Taribavirin|taribavirin|mesh-list
20152424|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152425|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
20152426|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152427|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
20152428|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152429|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
20152430|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152431|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19782614|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19782615|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
19782616|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782617|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782618|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782619|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19782620|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782621|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782622|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782623|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19782624|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
19782625|NCT00265382|Ziprasidone|ziprasidone|mesh-list
19782626|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19782627|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
19782628|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782629|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782630|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782631|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19782632|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782633|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782634|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782635|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19782636|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
19782637|NCT00265395|Interferons|interferons|mesh-list
19782638|NCT00265395|Ribavirin|ribavirin|mesh-list
19782639|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
19782640|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
19782641|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19782642|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782643|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
19782644|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782645|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
19782646|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782647|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
19782648|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782649|NCT00265616|Pentobarbital|pentobarbital|mesh-list
20319346|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319347|NCT00720421|Lorazepam|lorazepam|mesh-list
20319348|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
20319349|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
20319350|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
20319351|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319352|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782650|NCT00265616|Thiopental|thiopental|mesh-list
19782651|NCT00265616|Propofol|propofol|mesh-list
19782652|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19782653|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782654|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782655|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19782656|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
19782657|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
19782658|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
19782659|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
20319353|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152432|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319354|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20319355|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782660|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
19782661|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152433|NCT00093158|Anticoagulants|anticoagulants|mesh-list
19782662|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782663|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20319356|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20319357|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20319358|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782664|NCT00265759|Letrozole|letrozole|mesh-list
19782665|NCT00265759|Anastrozole|anastrozole|mesh-list
19782666|NCT00265759|Exemestane|exemestane|mesh-list
19782667|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782668|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19782669|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19782670|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782671|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782672|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19782673|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
19782674|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19782675|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782676|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19782677|NCT00265785|Pemetrexed|pemetrexed|mesh-list
19782678|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782679|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782680|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782681|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19782682|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19782683|NCT00265850|Leucovorin|leucovorin|mesh-list
19782684|NCT00265850|Folic Acid|folic acid|mesh-list
19782685|NCT00265850|Bevacizumab|bevacizumab|mesh-list
19782686|NCT00265850|Cetuximab|cetuximab|mesh-list
19782687|NCT00265850|Fluorouracil|fluorouracil|mesh-list
19782688|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
19782689|NCT00265850|Irinotecan|irinotecan|mesh-list
19782690|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
19782691|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782692|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782693|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782694|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19782695|NCT00265850|Growth Substances|growth substances|mesh-ancestor
19782696|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782697|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782698|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
19782699|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782700|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782701|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782702|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
19782703|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19782704|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19782705|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782706|NCT00265850|Antidotes|antidotes|mesh-ancestor
19782707|NCT00265850|Protective Agents|protective agents|mesh-ancestor
19782708|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
20319359|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
20319360|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
20319361|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20319362|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319363|NCT00720447|Cytarabine|cytarabine|mesh-list
19782709|NCT00265850|Vitamins|vitamins|mesh-ancestor
19782710|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
19782711|NCT00265850|Hematinics|hematinics|mesh-ancestor
19782712|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
19782713|NCT00265889|Melphalan|melphalan|mesh-list
19782714|NCT00265889|Busulfan|busulfan|mesh-list
19782715|NCT00265889|Etoposide|etoposide|mesh-list
19782716|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782717|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
19782718|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782719|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782720|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19782721|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
19782722|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782723|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319364|NCT00720447|Etoposide|etoposide|mesh-list
19782724|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19782725|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19782726|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19782727|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19782728|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319365|NCT00720447|Melphalan|melphalan|mesh-list
20319366|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
19782729|NCT00265941|Cetuximab|cetuximab|mesh-list
19782730|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782731|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782732|NCT00266032|Drospirenone|drospirenone|mesh-list
19782733|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19782734|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
19782735|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19782736|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782737|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19782738|NCT00266032|Diuretics|diuretics|mesh-ancestor
19782739|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
19782740|NCT00266110|Trastuzumab|trastuzumab|mesh-list
19782741|NCT00266110|Vinorelbine|vinorelbine|mesh-list
19782742|NCT00266110|Sargramostim|sargramostim|mesh-list
19782743|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782744|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782745|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19782746|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
19782747|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19782748|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19782749|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782750|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
19782751|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782752|NCT00266227|Rituximab|rituximab|mesh-list
19782753|NCT00266227|Methotrexate|methotrexate|mesh-list
19782754|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782755|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782756|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
19782757|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782758|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782759|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19782760|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
19782761|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19782762|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19637924|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782763|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
19782764|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782765|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
19782766|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319367|NCT00720447|Carmustine|carmustine|mesh-list
20319368|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20319369|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319370|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19637925|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782767|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19782768|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782769|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19782770|NCT00266279|Capecitabine|capecitabine|mesh-list
19782771|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
19782772|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782773|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
19782774|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782775|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782776|NCT00266409|Alprazolam|alprazolam|mesh-list
19782777|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19637926|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
19637927|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19637928|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637929|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19637930|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637931|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
19637932|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19637933|NCT02414464|Calcium|calcium|mesh-list
19637934|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19637935|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637936|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19637937|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19637938|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637939|NCT02414399|Azithromycin|azithromycin|mesh-list
19637940|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19637941|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637942|NCT02414256|Anesthetics|anesthetics|mesh-list
19637943|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782778|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782779|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782780|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19782781|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782782|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782783|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
19782784|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
19782785|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782786|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782787|NCT00266630|Carbamazepine|carbamazepine|mesh-list
19782788|NCT00266630|Valproic Acid|valproic acid|mesh-list
19782789|NCT00266630|Olanzapine|olanzapine|mesh-list
19782790|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
19782791|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
19782792|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782793|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782794|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19782795|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19782796|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19782797|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782798|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19782799|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19782800|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19637944|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637945|NCT02414373|Bupivacaine|bupivacaine|mesh-list
19637946|NCT02414373|Ropivacaine|ropivacaine|mesh-list
19637947|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
19637948|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
19637949|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19637950|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637951|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
19637952|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19637953|NCT02414165|Flucytosine|flucytosine|mesh-list
19637954|NCT02414165|Bevacizumab|bevacizumab|mesh-list
19637955|NCT02414165|Temozolomide|temozolomide|mesh-list
19637956|NCT02414165|Lomustine|lomustine|mesh-list
19637957|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19637958|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637959|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782801|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782802|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782803|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19782804|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
19782805|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782806|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
19782807|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
19782808|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
19782809|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19782810|NCT00266630|Analgesics|analgesics|mesh-ancestor
19782811|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
19782812|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19782813|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19782814|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19782815|NCT00266656|Hormones|hormones|mesh-list
19782816|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19782817|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782818|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
19782819|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152434|NCT00093158|Bivalirudin|bivalirudin|mesh-list
20152435|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
20152436|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20152437|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
20152438|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152439|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173994|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20173995|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20173996|NCT00163241|Analgesics|analgesics|mesh-ancestor
20173997|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
20173998|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173999|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174000|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319371|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19637960|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19637961|NCT02414165|Growth Substances|growth substances|mesh-ancestor
19782820|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782821|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
19782822|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
19782823|NCT00266708|Diphosphonates|diphosphonates|mesh-list
19782824|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19782825|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19782826|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782827|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19782828|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782829|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19782830|NCT00266799|Doxorubicin|doxorubicin|mesh-list
19782831|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19782832|NCT00266799|Capecitabine|capecitabine|mesh-list
19782833|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19782834|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637962|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637963|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
19637964|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637965|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
19637966|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782835|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19782836|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19782837|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782838|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782839|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782840|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
20319372|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319373|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319374|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20319375|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
20319376|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
20319377|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319378|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637967|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
19637968|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19637969|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
19637970|NCT02414009|Leucovorin|leucovorin|mesh-list
19637971|NCT02414009|Fluorouracil|fluorouracil|mesh-list
19637972|NCT02414009|Capecitabine|capecitabine|mesh-list
19637973|NCT02414009|Irinotecan|irinotecan|mesh-list
19782841|NCT00266812|Temozolomide|temozolomide|mesh-list
20319379|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
20319380|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319381|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20319382|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
20319383|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20319384|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20319385|NCT00720512|Leucovorin|leucovorin|mesh-list
19782842|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19782843|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
19782844|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782845|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782846|NCT00266851|Azithromycin|azithromycin|mesh-list
19782847|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19782848|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833714|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19833715|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19833716|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19833717|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19833718|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19833719|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19833720|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19833721|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833722|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19833723|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
19833724|NCT00589628|Infliximab|infliximab|mesh-list
19833725|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
19833726|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19833727|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637974|NCT02414009|Temozolomide|temozolomide|mesh-list
19637975|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
19637976|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637977|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19833728|NCT00589667|Gemcitabine|gemcitabine|mesh-list
20319386|NCT00720512|Bevacizumab|bevacizumab|mesh-list
19782849|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
19782850|NCT00266864|Testosterone|testosterone|mesh-list
19782851|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
19782852|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
19782853|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19782854|NCT00266864|Androgens|androgens|mesh-ancestor
19782855|NCT00266864|Hormones|hormones|mesh-ancestor
19782856|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19782857|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782858|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19782859|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782860|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
19782861|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
19782862|NCT00267007|Hematinics|hematinics|mesh-ancestor
19782863|NCT00267020|Gemcitabine|gemcitabine|mesh-list
19782864|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782865|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
19782866|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782867|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782868|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
19782869|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782870|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782871|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782872|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
19782873|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782874|NCT00267046|Doxorubicin|doxorubicin|mesh-list
19782875|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19782876|NCT00267046|Vincristine|vincristine|mesh-list
19782877|NCT00267046|Ifosfamide|ifosfamide|mesh-list
19782878|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782879|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19782880|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19782881|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19782882|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782883|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782884|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19782885|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
19782886|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
19782887|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
19782888|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19782889|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
19782890|NCT00267059|Lenalidomide|lenalidomide|mesh-list
19782891|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
19782892|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782893|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782894|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20152440|NCT00093184|Anticoagulants|anticoagulants|mesh-list
20152441|NCT00093184|Bivalirudin|bivalirudin|mesh-list
20152442|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
20152443|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20152444|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
20152445|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152446|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152447|NCT00093223|Paclitaxel|paclitaxel|mesh-list
20152448|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20152449|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20152450|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152451|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
20152452|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
20152453|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
20152454|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152455|NCT00093249|Clevidipine|clevidipine|mesh-list
20152456|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19637978|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19637979|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19637980|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
19637981|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19637982|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19637983|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19637984|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19637985|NCT02414009|Antidotes|antidotes|mesh-ancestor
19782895|NCT00267059|Growth Substances|growth substances|mesh-ancestor
19782896|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782897|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152457|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174001|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19637986|NCT02414009|Protective Agents|protective agents|mesh-ancestor
19637987|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
19637988|NCT02414009|Vitamins|vitamins|mesh-ancestor
19637989|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
20319387|NCT00720512|Fluorouracil|fluorouracil|mesh-list
20319388|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
20319389|NCT00720512|Irinotecan|irinotecan|mesh-list
20319390|NCT00720512|Calcium|calcium|mesh-list
20319391|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
19782898|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
19782899|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782900|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19782901|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782902|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782903|NCT00267111|Tetracaine|tetracaine|mesh-list
19782904|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
19782905|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
20319392|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20319393|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319394|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20319395|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20319396|NCT00720512|Growth Substances|growth substances|mesh-ancestor
20319397|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319398|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
20319399|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319400|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
20319401|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19637990|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19637991|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
19637992|NCT02413853|Leucovorin|leucovorin|mesh-list
19637993|NCT02413853|Bevacizumab|bevacizumab|mesh-list
19637994|NCT02413853|Fluorouracil|fluorouracil|mesh-list
19637995|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
19637996|NCT02413853|Calcium|calcium|mesh-list
19637997|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
19662762|NCT04182672|Triamcinolone|triamcinolone|mesh-list
19662763|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19662764|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19662765|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19662766|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19662767|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
19662768|NCT04182672|Hormones|hormones|mesh-ancestor
19662769|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662770|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662771|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662772|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
19662773|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662774|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662775|NCT04169373|Upadacitinib|upadacitinib|mesh-list
19662776|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19662777|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19662778|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662779|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662780|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662781|NCT04085445|Paclitaxel|paclitaxel|mesh-list
19662782|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19662783|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662784|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
19662785|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
19662786|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
19662787|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662788|NCT04069273|Paclitaxel|paclitaxel|mesh-list
19662789|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
19662790|NCT04069273|Ramucirumab|ramucirumab|mesh-list
19662791|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19662792|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662793|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
19662794|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
19662795|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
19662796|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662797|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662798|NCT04052568|Psilocybin|psilocybin|mesh-list
19662799|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
19662800|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662801|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20319402|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782906|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19782907|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782908|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
20319403|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319404|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
20319405|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20319406|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319407|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319408|NCT00720512|Antidotes|antidotes|mesh-ancestor
20319409|NCT00720512|Protective Agents|protective agents|mesh-ancestor
20319410|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
20319411|NCT00720512|Vitamins|vitamins|mesh-ancestor
20319412|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
20319413|NCT00720538|Thalidomide|thalidomide|mesh-list
20319414|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319415|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
20319416|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319417|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
20319418|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19782909|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782910|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
19782911|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19782912|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782913|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19782914|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
19782915|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19782916|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782917|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782918|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782919|NCT00267189|Cyclosporine|cyclosporine|mesh-list
19782920|NCT00267189|Everolimus|everolimus|mesh-list
19782921|NCT00267189|Azathioprine|azathioprine|mesh-list
19782922|NCT00267189|Tacrolimus|tacrolimus|mesh-list
19782923|NCT00267189|Cyclosporins|cyclosporins|mesh-list
19782924|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19782925|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782926|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152458|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152459|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152460|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152461|NCT00093262|Clevidipine|clevidipine|mesh-list
20152462|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20152463|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152464|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152465|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152466|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152467|NCT00093288|Bupropion|bupropion|mesh-list
20152468|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20152469|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
20152470|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20152471|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20152472|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20152473|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152474|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152475|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
20152476|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152477|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319419|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319420|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20319421|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19782927|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
19782928|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782929|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782930|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782931|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782932|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
19782933|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782934|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782935|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
19782936|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
20319422|NCT00720538|Growth Substances|growth substances|mesh-ancestor
20319423|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782937|NCT00267202|Omalizumab|omalizumab|mesh-list
20152478|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20152479|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19782938|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
19782939|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782940|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19782941|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19782942|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
19782943|NCT00267293|Acetaminophen|acetaminophen|mesh-list
19782944|NCT00267293|Ibuprofen|ibuprofen|mesh-list
19782945|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19782946|NCT00267293|Analgesics|analgesics|mesh-ancestor
19782947|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
19782948|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782949|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782950|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
19782951|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19782952|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19782953|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19782954|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19782955|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782956|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782957|NCT00267488|Topotecan|topotecan|mesh-list
19782958|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19782959|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19782960|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782961|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782962|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782963|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
19782964|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19782965|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782966|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19782967|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19782968|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19782969|NCT00267670|Protective Agents|protective agents|mesh-ancestor
20152480|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152481|NCT00093301|Simendan|simendan|mesh-list
20152482|NCT00093301|Dobutamine|dobutamine|mesh-list
20152483|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20152484|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
20152485|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20152486|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20152487|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152488|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152489|NCT00093301|Protective Agents|protective agents|mesh-ancestor
20152490|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152491|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
20152492|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
20152493|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152494|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20152495|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20152496|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20152497|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
20152498|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152499|NCT00093314|Ofatumumab|ofatumumab|mesh-list
20152500|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152501|NCT00093353|Cefixime|cefixime|mesh-list
20152502|NCT00093353|Irinotecan|irinotecan|mesh-list
20152503|NCT00093353|Temozolomide|temozolomide|mesh-list
20152504|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20152505|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20152506|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152507|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152508|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152509|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152510|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
20152511|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20152512|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152513|NCT00093366|Etanercept|etanercept|mesh-list
20152514|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
20152515|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152516|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152517|NCT00093366|Analgesics|analgesics|mesh-ancestor
20152518|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
20152519|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19782970|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782971|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
19782972|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19782973|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
19782974|NCT00267696|Gemcitabine|gemcitabine|mesh-list
19782975|NCT00267696|Bevacizumab|bevacizumab|mesh-list
19782976|NCT00267696|Carboplatin|carboplatin|mesh-list
19782977|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19782978|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782979|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782980|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19782981|NCT00267696|Growth Substances|growth substances|mesh-ancestor
19782982|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782983|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782984|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19782985|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
19782986|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152520|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152521|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319424|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319425|NCT00720564|Temozolomide|temozolomide|mesh-list
20319426|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
20319427|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20319428|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
20319429|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319430|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319431|NCT00720577|Pioglitazone|pioglitazone|mesh-list
20319432|NCT00720577|Losartan|losartan|mesh-list
20319433|NCT00720577|Simvastatin|simvastatin|mesh-list
20319434|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20319435|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20319436|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
20319437|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319438|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20319439|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20319440|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319441|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20319442|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319443|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20319444|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20319445|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20319446|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19782987|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
19782988|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19782989|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19782990|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19782991|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
19782992|NCT00267748|Sunitinib|sunitinib|mesh-list
19782993|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19782994|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19782995|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19782996|NCT00267748|Growth Substances|growth substances|mesh-ancestor
19782997|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19782998|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
19782999|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783000|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783001|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152522|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152523|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152524|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319447|NCT00720590|Ritonavir|ritonavir|mesh-list
20319448|NCT00720590|Lopinavir|lopinavir|mesh-list
20319449|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20319450|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20319451|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20319452|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20319453|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783002|NCT00267865|Leucovorin|leucovorin|mesh-list
20152525|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
20152526|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152527|NCT00093418|Tipifarnib|tipifarnib|mesh-list
19783003|NCT00267865|Rituximab|rituximab|mesh-list
19783004|NCT00267865|Methotrexate|methotrexate|mesh-list
20152528|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783005|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20152529|NCT00093444|Doxorubicin|doxorubicin|mesh-list
19783006|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783007|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
19783008|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783009|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783010|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19783011|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
19783012|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19783013|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783014|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
19783015|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783016|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
19783017|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783018|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19783019|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783020|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19783021|NCT00267865|Antidotes|antidotes|mesh-ancestor
19783022|NCT00267865|Protective Agents|protective agents|mesh-ancestor
19783023|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
19783024|NCT00267865|Vitamins|vitamins|mesh-ancestor
19783025|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
19783026|NCT00267956|Ustekinumab|ustekinumab|mesh-list
19783027|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
19783028|NCT00267969|Ustekinumab|ustekinumab|mesh-list
19783029|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
19783030|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
19783031|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783032|NCT00268242|Gemcitabine|gemcitabine|mesh-list
19783033|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
19783034|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783035|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
19783036|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783037|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783038|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
19783039|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783040|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783041|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783042|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
19783043|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783044|NCT00268242|Analgesics|analgesics|mesh-ancestor
19783045|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
19783046|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783047|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19783048|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19783049|NCT00268346|Gefitinib|gefitinib|mesh-list
19783050|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783051|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783052|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347432|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783053|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783054|NCT00268437|Carboplatin|carboplatin|mesh-list
19783055|NCT00268437|Pemetrexed|pemetrexed|mesh-list
19783056|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783057|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783058|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783059|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19783060|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19783061|NCT00268762|Argatroban|argatroban|mesh-list
19783062|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
19783063|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19783064|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
19783065|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783066|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783067|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
19783068|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19783069|NCT00268905|Carboplatin|carboplatin|mesh-list
19783070|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783071|NCT00268983|Iodine|iodine|mesh-list
19783072|NCT00268983|Rituximab|rituximab|mesh-list
19783073|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
19783074|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19783075|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20152530|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20152531|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20152532|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152533|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19783076|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783077|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
20152534|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20152535|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152536|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152537|NCT00093457|Sorafenib|sorafenib|mesh-list
20152538|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152539|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152540|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152541|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152542|NCT00093483|Cytarabine|cytarabine|mesh-list
20152543|NCT00093483|Idarubicin|idarubicin|mesh-list
20319454|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319455|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20319456|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20319457|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
20319458|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319459|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20319460|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319461|NCT00720603|Plerixafor|plerixafor|mesh-list
19637998|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19637999|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638000|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19638001|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19638002|NCT02413853|Growth Substances|growth substances|mesh-ancestor
19638003|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638004|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
19638005|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19638006|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
19638007|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662802|NCT03854032|Nivolumab|nivolumab|mesh-list
19662803|NCT03854032|Linrodostat|linrodostat|mesh-list
19662804|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662805|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662806|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19662807|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662808|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662809|NCT03818763|Factor VIII|factor viii|mesh-list
19662810|NCT03818763|Coagulants|coagulants|mesh-ancestor
19662811|NCT03710876|Gemcitabine|gemcitabine|mesh-list
19662812|NCT03710876|Celecoxib|celecoxib|mesh-list
19662813|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19662814|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
19662815|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662816|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662817|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
19662818|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662819|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662820|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662821|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
19662822|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662823|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19662824|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19662825|NCT03710876|Analgesics|analgesics|mesh-ancestor
19662826|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
19662827|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662828|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19662829|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662830|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19662831|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19662832|NCT03688828|Amoxicillin|amoxicillin|mesh-list
19662833|NCT03688828|Clarithromycin|clarithromycin|mesh-list
19662834|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
19662835|NCT03688828|Esomeprazole|esomeprazole|mesh-list
19662836|NCT03688828|Bismuth|bismuth|mesh-list
19662837|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662838|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19662839|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19662840|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19662841|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662842|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19662843|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662844|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19662845|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19662846|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20152544|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
20152545|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20152546|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
20152547|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152548|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152549|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
20152550|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152551|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152552|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
20152553|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152554|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20152555|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20152556|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20152557|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152558|NCT00093509|Doxorubicin|doxorubicin|mesh-list
20152559|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19783078|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783079|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783080|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19783081|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783082|NCT00268983|Trace Elements|trace elements|mesh-ancestor
19783083|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
19783084|NCT00269087|Fluticasone|fluticasone|mesh-list
19783085|NCT00269087|Xhance|xhance|mesh-list
19783086|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19783087|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783088|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19783089|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
19783090|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783091|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783092|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19783093|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
19783094|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
19783095|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19783096|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19783097|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19783098|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19783099|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
19783100|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783101|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783102|NCT00269113|Rituximab|rituximab|mesh-list
19783103|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783104|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783105|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
19783106|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783107|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783108|NCT00269152|Carboplatin|carboplatin|mesh-list
19783109|NCT00269152|Pemetrexed|pemetrexed|mesh-list
19783110|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783111|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783112|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783113|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19783114|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19783115|NCT00269399|Vancomycin|vancomycin|mesh-list
19783116|NCT00269399|Rifaximin|rifaximin|mesh-list
19783117|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19783118|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783119|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19783120|NCT00269919|Risperidone|risperidone|mesh-list
19783121|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20152560|NCT00093509|Ifosfamide|ifosfamide|mesh-list
20152561|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
20152562|NCT00093509|Mesna|mesna|mesh-list
20152563|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20152564|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152565|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20152566|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20152567|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783122|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
20152568|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152569|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152570|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
20152571|NCT00093509|Protective Agents|protective agents|mesh-ancestor
20152572|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783123|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152573|NCT00093522|Fludarabine|fludarabine|mesh-list
20152574|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
19638008|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19638009|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19638010|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
19638011|NCT02413853|Antidotes|antidotes|mesh-ancestor
19638012|NCT02413853|Protective Agents|protective agents|mesh-ancestor
19638013|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
19638014|NCT02413853|Vitamins|vitamins|mesh-ancestor
19638015|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
19638016|NCT02413658|Phenytoin|phenytoin|mesh-list
19638017|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
19638018|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19638019|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19638020|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19638021|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638022|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19638023|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19638024|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
19638025|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
19638026|NCT02413281|Buprenorphine|buprenorphine|mesh-list
19638027|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19638028|NCT02413281|Narcotics|narcotics|mesh-ancestor
19638029|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638030|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638031|NCT02413281|Analgesics|analgesics|mesh-ancestor
19638032|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
19638033|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638034|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19638035|NCT02413515|Nifedipine|nifedipine|mesh-list
19638036|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19638037|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19638038|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638039|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19638040|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638041|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
19638042|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
19638043|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638044|NCT02413554|Rivastigmine|rivastigmine|mesh-list
19638045|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19638046|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638047|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638048|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
19638049|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638050|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638051|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19638052|NCT02413554|Protective Agents|protective agents|mesh-ancestor
19638053|NCT02413541|Polymyxins|polymyxins|mesh-list
19638054|NCT02413541|Polymyxin B|polymyxin b|mesh-list
19638055|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19638056|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638057|NCT02413086|Chitosan|chitosan|mesh-list
19783124|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783125|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783126|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19783127|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19783128|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19783129|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19783130|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19783131|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
19783132|NCT00270205|Vaccines|vaccines|mesh-list
19783133|NCT00270205|Immunologic Factors|immunologic factors|mesh-ancestor
19783134|NCT00270205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783135|NCT00270231|Naltrexone|naltrexone|mesh-list
19783136|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19783137|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19783138|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783139|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
19783140|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783141|NCT00270257|Buprenorphine|buprenorphine|mesh-list
19783142|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19783143|NCT00270257|Naloxone|naloxone|mesh-list
19783144|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19638058|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19638059|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19783145|NCT00270257|Narcotics|narcotics|mesh-ancestor
19783146|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638060|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
20319462|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20319463|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20319464|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
20319465|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319466|NCT00720616|Insulin|insulin|mesh-list
20319467|NCT00720616|Hormones|hormones|mesh-list
20319468|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20319469|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319470|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20319471|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
20319472|NCT00720772|Antidotes|antidotes|mesh-ancestor
20319473|NCT00720772|Protective Agents|protective agents|mesh-ancestor
20319474|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319475|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
20319476|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319477|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
20319478|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319479|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319480|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
20319481|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
20347433|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20347434|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20347435|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347436|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347437|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20347438|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
20347439|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347440|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347441|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20347442|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20347443|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20347444|NCT00860340|Spironolactone|spironolactone|mesh-list
19783147|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783148|NCT00270257|Analgesics|analgesics|mesh-ancestor
19783149|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
19783150|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783151|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19783152|NCT00270296|Ritonavir|ritonavir|mesh-list
19783153|NCT00270296|Lopinavir|lopinavir|mesh-list
19783154|NCT00270296|Lamivudine|lamivudine|mesh-list
20347445|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20152575|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20152576|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152577|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20347446|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
20347447|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347448|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347449|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20347450|NCT00860340|Diuretics|diuretics|mesh-ancestor
20347451|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
20347452|NCT00860366|Uric Acid|uric acid|mesh-list
20347453|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
20347454|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347455|NCT00860366|Protective Agents|protective agents|mesh-ancestor
20347456|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347457|NCT00860496|Cyclosporine|cyclosporine|mesh-list
20347458|NCT00860496|Tacrolimus|tacrolimus|mesh-list
20347459|NCT00860496|Cyclosporins|cyclosporins|mesh-list
20347460|NCT00860496|Tofacitinib|tofacitinib|mesh-list
19783155|NCT00270296|Zidovudine|zidovudine|mesh-list
19783156|NCT00270296|Nevirapine|nevirapine|mesh-list
19783157|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19783158|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19638061|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638062|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19638063|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
19638064|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
19638065|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
19638066|NCT02413086|Coagulants|coagulants|mesh-ancestor
19638067|NCT02413138|Hormones|hormones|mesh-list
19638068|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638069|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638070|NCT02412930|Tramadol|tramadol|mesh-list
19638071|NCT02412930|Bupivacaine|bupivacaine|mesh-list
19783159|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19783160|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
19783161|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783162|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783163|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19783164|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19783165|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
19783166|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783167|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19783168|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19783169|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19783170|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19783171|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
19783172|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19783173|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19783174|NCT00270634|Tacrolimus|tacrolimus|mesh-list
19783175|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783176|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
19783177|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783178|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19783179|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783180|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783181|NCT00270790|Carboplatin|carboplatin|mesh-list
19783182|NCT00270790|Amifostine|amifostine|mesh-list
20319482|NCT00720811|Acetaminophen|acetaminophen|mesh-list
20319483|NCT00720811|Amoxicillin|amoxicillin|mesh-list
20319484|NCT00720811|Lumefantrine|lumefantrine|mesh-list
20319485|NCT00720811|Artemether|artemether|mesh-list
20319486|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20319487|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19783183|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783184|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19783185|NCT00270790|Protective Agents|protective agents|mesh-ancestor
19783186|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783187|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
19783188|NCT00270894|Docetaxel|docetaxel|mesh-list
19783189|NCT00270894|Trastuzumab|trastuzumab|mesh-list
19783190|NCT00270894|Epirubicin|epirubicin|mesh-list
19783191|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783192|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
19783193|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783194|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783195|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783196|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
19783197|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783198|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783199|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19783200|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783201|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
20319488|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319489|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20319490|NCT00720811|Analgesics|analgesics|mesh-ancestor
20319491|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
20319492|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783202|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783203|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783204|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19783205|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19783206|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19783207|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783208|NCT00271024|Naltrexone|naltrexone|mesh-list
19783209|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19783210|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19783211|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783212|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
19783213|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783214|NCT00271219|Buprenorphine|buprenorphine|mesh-list
19783215|NCT00271219|Methadone|methadone|mesh-list
19783216|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19783217|NCT00271219|Narcotics|narcotics|mesh-ancestor
19783218|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19783219|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783220|NCT00271219|Analgesics|analgesics|mesh-ancestor
19783221|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
19783222|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319493|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319494|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
20319495|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
20319496|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20319497|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20319498|NCT00720824|Anesthetics|anesthetics|mesh-list
20319499|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20319500|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
20319501|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20319502|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319503|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
20319504|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319505|NCT00720850|Lenalidomide|lenalidomide|mesh-list
20319506|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
20319507|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783223|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19783224|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
19783225|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
19783226|NCT00271505|Bevacizumab|bevacizumab|mesh-list
19783227|NCT00271505|Carboplatin|carboplatin|mesh-list
19783228|NCT00271505|Docetaxel|docetaxel|mesh-list
19783229|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783230|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319508|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20319509|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20319510|NCT00720850|Growth Substances|growth substances|mesh-ancestor
19783231|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19783232|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19783233|NCT00271505|Growth Substances|growth substances|mesh-ancestor
19783234|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783235|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
20152578|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
20152579|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152580|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152581|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
20152582|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152583|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20152584|NCT00093548|Vaccines|vaccines|mesh-list
20152585|NCT00093548|Sargramostim|sargramostim|mesh-list
20152586|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
20152587|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152588|NCT00093561|Lycopene|lycopene|mesh-list
20152589|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152590|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
20152591|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152592|NCT00093561|Protective Agents|protective agents|mesh-ancestor
20152593|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152594|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20152595|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20319511|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
20319512|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783236|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783237|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783238|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
20319513|NCT00720902|Hormones|hormones|mesh-list
20319514|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20319515|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20319516|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319517|NCT00720915|Anticoagulants|anticoagulants|mesh-list
20319518|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
20319519|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20319520|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20319521|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319522|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
20319523|NCT00720915|Coagulants|coagulants|mesh-ancestor
20319524|NCT00721032|Amiodarone|amiodarone|mesh-list
20319525|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20319526|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
20319527|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20319528|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20319529|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319530|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20319531|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20319532|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319533|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611163|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
19783239|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319534|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20319535|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20319536|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20319537|NCT00721201|Mifepristone|mifepristone|mesh-list
20319538|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20319539|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
20319540|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20319541|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319542|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20319543|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19638072|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638073|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
19638074|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638075|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638076|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
19638077|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638078|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19638079|NCT02412930|Narcotics|narcotics|mesh-ancestor
19783240|NCT00271570|Infliximab|infliximab|mesh-list
19783241|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
19783242|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19783243|NCT00271570|Antibodies|antibodies|mesh-list
19783244|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
19783245|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19783246|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
19783247|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783248|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
19783249|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19783250|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783251|NCT00271596|Citalopram|citalopram|mesh-list
19783252|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19783253|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19783254|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783255|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783256|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783257|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
19783258|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783259|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19783260|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
19783261|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19783262|NCT00271609|Bevacizumab|bevacizumab|mesh-list
19783263|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783264|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783265|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19783266|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19783267|NCT00271609|Growth Substances|growth substances|mesh-ancestor
19783268|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783269|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
19783270|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19783271|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783272|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783273|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783274|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783275|NCT00272311|Aspirin|aspirin|mesh-list
19783276|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19783277|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19783278|NCT00272311|Analgesics|analgesics|mesh-ancestor
19783279|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
19783280|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783281|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783282|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783283|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152596|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152597|NCT00093587|Cyclosporine|cyclosporine|mesh-list
20152598|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
20152599|NCT00093587|Busulfan|busulfan|mesh-list
20152600|NCT00093587|Cyclosporins|cyclosporins|mesh-list
20152601|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20152602|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152603|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
19638080|NCT02412930|Analgesics|analgesics|mesh-ancestor
19638081|NCT02413021|Cytarabine|cytarabine|mesh-list
20152604|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783284|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20152605|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783285|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19783286|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783287|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19783288|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20319544|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20319545|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
20319546|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20319547|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20319548|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
20319549|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20319550|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
20319551|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20319552|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20319553|NCT00721240|Montelukast|montelukast|mesh-list
20319554|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20319555|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
20319556|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20319557|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
19783289|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783290|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
20319558|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20319559|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611164|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
19783291|NCT00272337|Aspirin|aspirin|mesh-list
19783292|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19783293|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19783294|NCT00272337|Analgesics|analgesics|mesh-ancestor
19783295|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
19783296|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783297|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783298|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783299|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783300|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19783301|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19783302|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783303|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19783304|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19783305|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783306|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
19783307|NCT00272779|Emtricitabine|emtricitabine|mesh-list
19783308|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19783309|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
19783310|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783311|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19783312|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19783313|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783314|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783315|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19783316|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19783317|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19783318|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19783319|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
19783320|NCT00272792|Verapamil|verapamil|mesh-list
19783321|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20152606|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152607|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
20152608|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152609|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152610|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20152611|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152612|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
20152613|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152614|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
20152615|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20152616|NCT00093600|Cytarabine|cytarabine|mesh-list
20152617|NCT00093600|Daunorubicin|daunorubicin|mesh-list
20152618|NCT00093600|Midostaurin|midostaurin|mesh-list
20152619|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20152620|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
20152621|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152622|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152623|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
20152624|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152625|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152626|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
20152627|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152628|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20152629|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20152630|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19783322|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19783323|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783324|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783325|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19783326|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783327|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
19783328|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
19783329|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19783330|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19783331|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783332|NCT00272987|Paclitaxel|paclitaxel|mesh-list
19783333|NCT00272987|Trastuzumab|trastuzumab|mesh-list
19783334|NCT00272987|Lapatinib|lapatinib|mesh-list
19783335|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19783336|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783337|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783338|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783339|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783340|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783341|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783342|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783343|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783344|NCT00273052|Metoprolol|metoprolol|mesh-list
19783345|NCT00273052|Carvedilol|carvedilol|mesh-list
20319560|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20319561|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20319562|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319563|NCT00721305|Lovastatin|lovastatin|mesh-list
20319564|NCT00721305|L 647318|l 647318|mesh-list
20319565|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
20319566|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19638082|NCT02413021|Deferasirox|deferasirox|mesh-list
19638083|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19638084|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
20319567|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20319568|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
20319569|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319570|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20319571|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20152631|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152632|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152633|NCT00093613|Sorafenib|sorafenib|mesh-list
20152634|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152635|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783346|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19783347|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19783348|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
20152636|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152637|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152638|NCT00093626|Sorafenib|sorafenib|mesh-list
20152639|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152640|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152641|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152642|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152643|NCT00093639|Everolimus|everolimus|mesh-list
20152644|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
19638085|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638086|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638087|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
19638088|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638089|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152645|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152646|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152647|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
20152648|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783349|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
19783350|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783351|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783352|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19783353|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19783354|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19783355|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
19783356|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783357|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783358|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
19783359|NCT00273052|Protective Agents|protective agents|mesh-ancestor
19783360|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19783361|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783362|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19783363|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
19783364|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19783365|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19783366|NCT00273754|Caffeine|caffeine|mesh-list
19783367|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19783368|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783369|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19783370|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783371|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783372|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19783373|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19783374|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
19783375|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783376|NCT00273910|Imiquimod|imiquimod|mesh-list
19783377|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19783378|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
19783379|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783380|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783381|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
19783382|NCT00274261|Nonoxynol|nonoxynol|mesh-list
19783383|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19783384|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19783385|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783386|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19783387|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
19783388|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19783389|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19783390|NCT00274287|Sargramostim|sargramostim|mesh-list
19783391|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
19783392|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783393|NCT00274456|Paclitaxel|paclitaxel|mesh-list
19783394|NCT00274456|Docetaxel|docetaxel|mesh-list
19783395|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19783396|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19783397|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783398|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783399|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783400|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783401|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783402|NCT00274469|Fulvestrant|fulvestrant|mesh-list
19783403|NCT00274469|Anastrozole|anastrozole|mesh-list
19783404|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19783405|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783406|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19783407|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20319572|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638090|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
19638091|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638092|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19638093|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
19638094|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
19638095|NCT02412917|Valacyclovir|valacyclovir|mesh-list
19638096|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
20319573|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
19638097|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638098|NCT02412904|Menotropins|menotropins|mesh-list
19638099|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19638100|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
19638101|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638102|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319574|NCT00721331|Loratadine|loratadine|mesh-list
20319575|NCT00721331|Nortriptyline|nortriptyline|mesh-list
20319576|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319577|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
20319578|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20319579|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
20319580|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20319581|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20319582|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
20319583|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
20319584|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20319585|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319586|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319587|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19638103|NCT02412813|Cobalt|cobalt|mesh-list
19638104|NCT02412813|Trace Elements|trace elements|mesh-ancestor
19638105|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
19638106|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662847|NCT03688828|Antacids|antacids|mesh-ancestor
20319588|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
20319589|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20319590|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20319591|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20319592|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20319593|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
20319594|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
20319595|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319596|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319597|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20319598|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19662848|NCT03688828|Diuretics|diuretics|mesh-ancestor
19662849|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
19662850|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662851|NCT03688828|Expectorants|expectorants|mesh-ancestor
19662852|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
20319599|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662853|NCT03643822|Dexamethasone|dexamethasone|mesh-list
19662854|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
19662855|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
19662856|NCT03643822|BB 1101|bb 1101|mesh-list
19662857|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19662858|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
19662859|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
19662860|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662861|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662862|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662863|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
19662864|NCT03643822|Hormones|hormones|mesh-ancestor
19662865|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662866|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19662867|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662868|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
19662869|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662870|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662871|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19662872|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19662873|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19662874|NCT03643822|Analgesics|analgesics|mesh-ancestor
19662875|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
19662876|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19662877|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19662878|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19662879|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
19662880|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662881|NCT03634150|Doxorubicin|doxorubicin|mesh-list
19662882|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19662883|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662884|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19662885|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19662886|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662887|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662888|NCT03593759|Prednisone|prednisone|mesh-list
19662889|NCT03593759|Prednisolone|prednisolone|mesh-list
19662890|NCT03593759|Methotrexate|methotrexate|mesh-list
19662891|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19662892|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
19783408|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
19783409|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19783410|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783411|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19783412|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19783413|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783414|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783415|NCT00274651|Belinostat|belinostat|mesh-list
19783416|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638107|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
19638108|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638109|NCT02412566|SMOFlipid|smoflipid|mesh-list
19638110|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19638111|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19638112|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19638113|NCT02412475|Cytarabine|cytarabine|mesh-list
19638114|NCT02412475|Fludarabine|fludarabine|mesh-list
19638115|NCT02412475|Sorafenib|sorafenib|mesh-list
19783417|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19783418|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783419|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783420|NCT00274742|Blinatumomab|blinatumomab|mesh-list
19783421|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19783422|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783423|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
19783424|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783425|NCT00274768|Capecitabine|capecitabine|mesh-list
19783426|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783427|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
19783428|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783429|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783430|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
19783431|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
19783432|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783433|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783434|NCT00274846|Aldesleukin|aldesleukin|mesh-list
19783435|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
19783436|NCT00274846|Fludarabine|fludarabine|mesh-list
19783437|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
19783438|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783439|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
19783440|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783441|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783442|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783443|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
19783444|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783445|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783446|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19783447|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783448|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
19783449|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19783450|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19783451|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
19783452|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783453|NCT00274924|Prednisone|prednisone|mesh-list
19783454|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
19783455|NCT00274924|Ifosfamide|ifosfamide|mesh-list
19783456|NCT00274924|Rituximab|rituximab|mesh-list
19783457|NCT00274924|Carboplatin|carboplatin|mesh-list
19783458|NCT00274924|Doxorubicin|doxorubicin|mesh-list
19783459|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19783460|NCT00274924|Etoposide|etoposide|mesh-list
19783461|NCT00274924|Vincristine|vincristine|mesh-list
19783462|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
19783463|NCT00274924|Lenograstim|lenograstim|mesh-list
19783464|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783465|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
19783466|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783467|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783468|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783469|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
19783470|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783471|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783472|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20347461|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783473|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19638116|NCT02412475|Decitabine|decitabine|mesh-list
19638117|NCT02412475|Vorinostat|vorinostat|mesh-list
19783474|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19783475|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19783476|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19783477|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783478|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783479|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
19783480|NCT00274924|Hormones|hormones|mesh-ancestor
19783481|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19783482|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19783483|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19783484|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19783485|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783486|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
20152649|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152650|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152651|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152652|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
20152653|NCT00093652|Gefitinib|gefitinib|mesh-list
19783487|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783488|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
20319600|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319601|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319602|NCT00721448|Ticagrelor|ticagrelor|mesh-list
20319603|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20319604|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20319605|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20319606|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19783489|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
19783490|NCT00274937|Fluorouracil|fluorouracil|mesh-list
19783491|NCT00274937|Amifostine|amifostine|mesh-list
19783492|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783493|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
20319607|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
20319608|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783494|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783495|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783496|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783497|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
19783498|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783499|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19783500|NCT00274937|Protective Agents|protective agents|mesh-ancestor
19783501|NCT00275002|Temozolomide|temozolomide|mesh-list
19783502|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19783503|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783504|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
19783505|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783506|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783507|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783508|NCT00275028|Cediranib|cediranib|mesh-list
19783509|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783510|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783511|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783512|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783513|NCT00275262|Leuprolide|leuprolide|mesh-list
19783514|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19783515|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
19783516|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19783517|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783518|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19783519|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783520|NCT00275275|Pramipexole|pramipexole|mesh-list
19783521|NCT00275275|Ropinirole|ropinirole|mesh-list
19783522|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
19783523|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152654|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152655|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152656|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152657|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152658|NCT00093665|Fluorouracil|fluorouracil|mesh-list
20152659|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347462|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
19783524|NCT00275275|Protective Agents|protective agents|mesh-ancestor
19783525|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783526|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19783527|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19783528|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
19783529|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
19783530|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783531|NCT00275301|Olanzapine|olanzapine|mesh-list
19783532|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
19783533|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
19783534|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783535|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783536|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19783537|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19783538|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19783539|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19783540|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19783541|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19783542|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19783543|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783544|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783545|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783546|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
19783547|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
19783548|NCT00275509|Dexamethasone|dexamethasone|mesh-list
20319609|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319610|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319611|NCT00721487|Fluconazole|fluconazole|mesh-list
20319612|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
19638118|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638119|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783549|NCT00275509|Prednisone|prednisone|mesh-list
19783550|NCT00275509|Tacrolimus|tacrolimus|mesh-list
20152660|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
20152661|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152662|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20152663|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152664|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
20152665|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152666|NCT00093678|Celecoxib|celecoxib|mesh-list
20152667|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19783551|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
19783552|NCT00275509|Daclizumab|daclizumab|mesh-list
19783553|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783554|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
19783555|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
19783556|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783557|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783558|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19783559|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
19783560|NCT00275509|Hormones|hormones|mesh-ancestor
19783561|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19783562|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19783563|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783564|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783565|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
19783566|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19783567|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783568|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783569|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19783570|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19638120|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
19638121|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638122|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19638123|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
19638124|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638125|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
19638126|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638127|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19638128|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638129|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19638130|NCT02412449|Glycine|glycine|mesh-list
19638131|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
19638132|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783571|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
19783572|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20152668|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19783573|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783574|NCT00275561|Fluticasone|fluticasone|mesh-list
19783575|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783576|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19783577|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
20319613|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319614|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19638133|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638134|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638135|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
19783578|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783579|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783580|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19783581|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
19783582|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
19783583|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19783584|NCT00275821|Ranibizumab|ranibizumab|mesh-list
19783585|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19783586|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19783587|NCT00275821|Growth Substances|growth substances|mesh-ancestor
19783588|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783589|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
19783590|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783591|NCT00275834|Zonisamide|zonisamide|mesh-list
19783592|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
19783593|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19783594|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783595|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783596|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19783597|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783598|NCT00276094|Tamoxifen|tamoxifen|mesh-list
19783599|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19783600|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
19783601|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19783602|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783603|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19783604|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783605|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19783606|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19783607|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19833729|NCT00589667|Pemetrexed|pemetrexed|mesh-list
19833730|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20319615|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319616|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319617|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319618|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20319619|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
20319620|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638136|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19638137|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
19833731|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
19833732|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833733|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833734|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
19833735|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833736|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833737|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152669|NCT00093678|Analgesics|analgesics|mesh-ancestor
20152670|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
20152671|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152672|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152673|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152674|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152675|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19638138|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638139|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638140|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19638141|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
19833738|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
19833739|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152676|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20152677|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319621|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638142|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638143|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638144|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19638145|NCT02412345|Alprostadil|alprostadil|mesh-list
19638146|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19638147|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
19783608|NCT00276250|Abatacept|abatacept|mesh-list
19783609|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19783610|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783611|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783612|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783613|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
19783614|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783615|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783616|NCT00276380|Aspirin|aspirin|mesh-list
19783617|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19783618|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19783619|NCT00276380|Analgesics|analgesics|mesh-ancestor
19783620|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
19783621|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783622|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783623|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783624|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783625|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19638148|NCT02412345|Urological Agents|urological agents|mesh-ancestor
19638149|NCT02412267|Carboplatin|carboplatin|mesh-list
19638150|NCT02412267|Etoposide|etoposide|mesh-list
19638151|NCT02412267|Ifosfamide|ifosfamide|mesh-list
19638152|NCT02412267|Ofatumumab|ofatumumab|mesh-list
19638153|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638154|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19638155|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19638156|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19638157|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638158|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638159|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19638160|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
19783626|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19783627|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783628|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19783629|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19783630|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783631|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
19783632|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19783633|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19783634|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783635|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152678|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152679|NCT00093704|Ganciclovir|ganciclovir|mesh-list
20152680|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20152681|NCT00093704|Bortezomib|bortezomib|mesh-list
20152682|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152683|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
20152684|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152685|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20152686|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152687|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152688|NCT00093743|Cyclosporine|cyclosporine|mesh-list
20152689|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
20152690|NCT00093743|Fludarabine|fludarabine|mesh-list
20152691|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
20152692|NCT00093743|Cyclosporins|cyclosporins|mesh-list
20152693|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152694|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20152695|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
20152696|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152697|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152698|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
20152699|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152700|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152701|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
20319622|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20319623|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19783636|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
19783637|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783638|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783639|NCT00276549|Gemcitabine|gemcitabine|mesh-list
19783640|NCT00276549|Docetaxel|docetaxel|mesh-list
19783641|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20319624|NCT00721526|Disulfiram|disulfiram|mesh-list
20319625|NCT00721526|Lorazepam|lorazepam|mesh-list
19783642|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
19783643|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783644|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783645|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
19783646|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783647|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783648|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783649|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
19783650|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783651|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783652|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783653|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783654|NCT00276614|Bortezomib|bortezomib|mesh-list
19783655|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783656|NCT00276744|Gemcitabine|gemcitabine|mesh-list
19783657|NCT00276744|Sirolimus|sirolimus|mesh-list
19783658|NCT00276744|Capecitabine|capecitabine|mesh-list
19783659|NCT00276744|Docetaxel|docetaxel|mesh-list
19783660|NCT00276744|Irinotecan|irinotecan|mesh-list
20319626|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
20319627|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
20319628|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
20319629|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319630|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783661|NCT00276744|Cetuximab|cetuximab|mesh-list
19783662|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19783663|NCT00276744|Mitomycins|mitomycins|mesh-list
19783664|NCT00276744|Mitomycin|mitomycin|mesh-list
19783665|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783666|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
19783667|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783668|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783669|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
19783670|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783671|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783672|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783673|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
19783674|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783675|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783676|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783677|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783678|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19783679|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19783680|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783681|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783682|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19783683|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20319631|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20319632|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20319633|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20319634|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20319635|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20319636|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20319637|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
20319638|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
20319639|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783684|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
19783685|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
19783686|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19783687|NCT00276861|Gemcitabine|gemcitabine|mesh-list
19783688|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
19783689|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20319640|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319641|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20319642|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19783690|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
20319643|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783691|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783692|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319644|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20319645|NCT00721552|Prednisolone|prednisolone|mesh-list
20319646|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20319647|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
20319648|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20319649|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
20319650|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20319651|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
20319652|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319653|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
20319654|NCT00721552|Hormones|hormones|mesh-ancestor
20319655|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20319656|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319657|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20319658|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783693|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
19783694|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783695|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783696|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783697|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
19783698|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783699|NCT00277212|Lamotrigine|lamotrigine|mesh-list
19783700|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
19783701|NCT00277212|Aripiprazole|aripiprazole|mesh-list
19783702|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
19783703|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19783704|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19783705|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19783706|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19783707|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783708|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
19783709|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
19783710|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783711|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783712|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19783713|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19783714|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
19783715|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19783716|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19783717|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19783718|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19783719|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19783720|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783721|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19783722|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19783723|NCT00277355|Minocycline|minocycline|mesh-list
19783724|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19783725|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783726|NCT00277394|Heparin|heparin|mesh-list
19783727|NCT00277394|Tinzaparin|tinzaparin|mesh-list
19783728|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
19783729|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19783730|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19783731|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783732|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
19783733|NCT00278109|Doxorubicin|doxorubicin|mesh-list
19783734|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783735|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
20319659|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
20319660|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
20319661|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319662|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20319663|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20319664|NCT00721552|Protective Agents|protective agents|mesh-ancestor
20319665|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20319666|NCT00721552|Incretins|incretins|mesh-ancestor
20319667|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20319668|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
20319669|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319670|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319671|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20319672|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
20319673|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
19783736|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319674|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
20319675|NCT00721747|Docetaxel|docetaxel|mesh-list
20319676|NCT00721747|Doxorubicin|doxorubicin|mesh-list
20319677|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20319678|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319679|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
20319680|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319681|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783737|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783738|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783739|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
19783740|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783741|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783742|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19783743|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19783744|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19783745|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19783746|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783747|NCT00278148|Paclitaxel|paclitaxel|mesh-list
19783748|NCT00278148|Carboplatin|carboplatin|mesh-list
19783749|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19783750|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19783751|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783752|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783753|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783754|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783755|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783756|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783757|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783758|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
19783759|NCT00278161|Rituximab|rituximab|mesh-list
19783760|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783761|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
19783762|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783763|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783764|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783765|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
19783766|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783767|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783768|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19783769|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783770|NCT00278395|Vorinostat|vorinostat|mesh-list
19783771|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783772|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19783773|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783774|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783775|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
19783776|NCT00278512|Fludarabine|fludarabine|mesh-list
19783777|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
19783778|NCT00278512|Tacrolimus|tacrolimus|mesh-list
19783779|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
19783780|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783781|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
20152702|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152703|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
20152704|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152705|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20152706|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20152707|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20152708|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
20152709|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20152710|NCT00093769|Rituximab|rituximab|mesh-list
20152711|NCT00093769|Bortezomib|bortezomib|mesh-list
20152712|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20152713|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152714|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
20152715|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152716|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152717|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
20152718|NCT00093834|Doxorubicin|doxorubicin|mesh-list
20152719|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20152720|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152721|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
20152722|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319682|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20319683|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
19783782|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783783|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783784|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783785|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
19783786|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783787|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783788|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19783789|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19783790|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783791|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783792|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
19783793|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19783794|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19783795|NCT00278564|Prednisolone|prednisolone|mesh-list
19783796|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
19783797|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
19783798|NCT00278564|Rituximab|rituximab|mesh-list
19783799|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19783800|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
19783801|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783802|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
19783803|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783804|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783805|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783806|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
19783807|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783808|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783809|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19783810|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783811|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783812|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
19783813|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
19783814|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783815|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19783816|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
19783817|NCT00278564|Hormones|hormones|mesh-ancestor
19783818|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19783819|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19783820|NCT00278564|Protective Agents|protective agents|mesh-ancestor
19783821|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19783822|NCT00278863|Capecitabine|capecitabine|mesh-list
19783823|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783824|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
19783825|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783826|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783827|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
19783828|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783829|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783830|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783831|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783832|NCT00278889|Leucovorin|leucovorin|mesh-list
19783833|NCT00278889|Bevacizumab|bevacizumab|mesh-list
19783834|NCT00278889|Fluorouracil|fluorouracil|mesh-list
19783835|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
19783836|NCT00278889|Cediranib|cediranib|mesh-list
19783837|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783838|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783839|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19783840|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19783841|NCT00278889|Growth Substances|growth substances|mesh-ancestor
19783842|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783843|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19783844|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
19783845|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783846|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19783847|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783848|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
19783849|NCT00278889|Antidotes|antidotes|mesh-ancestor
19783850|NCT00278889|Protective Agents|protective agents|mesh-ancestor
20319684|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319685|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319686|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20319687|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
20319688|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783851|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
19783852|NCT00278889|Vitamins|vitamins|mesh-ancestor
20319689|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
20319690|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20319691|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20319692|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319693|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319694|NCT00721773|Valsartan|valsartan|mesh-list
20319695|NCT00721773|Benazepril|benazepril|mesh-list
20319696|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20319697|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20319698|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20319699|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319700|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20319701|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
20319702|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319703|NCT00721877|Resveratrol|resveratrol|mesh-list
19783853|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
19783854|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783855|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783856|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
19783857|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19783858|NCT00278954|Antibodies|antibodies|mesh-list
20152723|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152724|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783859|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
19783860|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19783861|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
19783862|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783863|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
19783864|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
19783865|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
19783866|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
19783867|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
19783868|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19783869|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783870|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19783871|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19783872|NCT00279305|Rituximab|rituximab|mesh-list
19783873|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783874|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783875|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
19783876|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783877|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783878|NCT00279708|Atorvastatin|atorvastatin|mesh-list
19783879|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19783880|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19783881|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
19783882|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783883|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19783884|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20152725|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
20152726|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152727|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152728|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20152729|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20152730|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20152731|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20152732|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152733|NCT00093860|Propranolol|propranolol|mesh-list
20152734|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20152735|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20152736|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
20152737|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152738|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152739|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152740|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20152741|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19783885|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152742|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
20152743|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
20319704|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
19783886|NCT00279812|Selenium|selenium|mesh-list
19783887|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
19783888|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319705|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783889|NCT00279812|Protective Agents|protective agents|mesh-ancestor
19783890|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783891|NCT00279812|Trace Elements|trace elements|mesh-ancestor
19783892|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
19783893|NCT00279916|Triamcinolone|triamcinolone|mesh-list
19783894|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19783895|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19783896|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19783897|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783898|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
19783899|NCT00279916|Hormones|hormones|mesh-ancestor
19783900|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19783901|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783902|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783903|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
19783904|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783905|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319706|NCT00721877|Protective Agents|protective agents|mesh-ancestor
20319707|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319708|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319709|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20319710|NCT00721916|Leucovorin|leucovorin|mesh-list
20319711|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
20319712|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319713|NCT00721916|Antidotes|antidotes|mesh-ancestor
20319714|NCT00721916|Protective Agents|protective agents|mesh-ancestor
20319715|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319716|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
20319717|NCT00721916|Vitamins|vitamins|mesh-ancestor
20319718|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
20319719|NCT00722033|Indomethacin|indomethacin|mesh-list
20319720|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20319721|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20319722|NCT00722033|Analgesics|analgesics|mesh-ancestor
20319723|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
20319724|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319725|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319726|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319727|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20319728|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
20319729|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
20319730|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20319731|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20319732|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319733|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319734|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
20319735|NCT00722098|Vaccines|vaccines|mesh-list
20319736|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
20319737|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319738|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319739|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20319740|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20319741|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
20319742|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319743|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319744|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20319745|NCT00722150|Artesunate|artesunate|mesh-list
20319746|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
20319747|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20319748|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20319749|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319750|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319751|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
19638161|NCT02412059|Prednisolone|prednisolone|mesh-list
19638162|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19638163|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
19638164|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19638165|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
19638166|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19638167|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
19638168|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19783906|NCT00280059|Pregabalin|pregabalin|mesh-list
19783907|NCT00280059|Lamotrigine|lamotrigine|mesh-list
19783908|NCT00280059|Analgesics|analgesics|mesh-ancestor
19783909|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
20319752|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
19783910|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783911|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783912|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
19783913|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19783914|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783915|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783916|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19783917|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19783918|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19783919|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19783920|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19783921|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19783922|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19783923|NCT00280150|Paclitaxel|paclitaxel|mesh-list
19783924|NCT00280150|Bevacizumab|bevacizumab|mesh-list
19783925|NCT00280150|Carboplatin|carboplatin|mesh-list
19783926|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19783927|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19783928|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783929|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
19783930|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
19783931|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
19783932|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783933|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783934|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19783935|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20319753|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20319754|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
20319755|NCT00722176|Risperidone|risperidone|mesh-list
20319756|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20319757|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
20319758|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20319759|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319760|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319761|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20319762|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20319763|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20319764|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20319765|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20319766|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
20319767|NCT00722215|Nifedipine|nifedipine|mesh-list
20319768|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
20319769|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20319770|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20319771|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319772|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319773|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319774|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
20319775|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
19783936|NCT00280150|Growth Substances|growth substances|mesh-ancestor
20319776|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20319777|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20319778|NCT00722293|Doxorubicin|doxorubicin|mesh-list
20319779|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20319780|NCT00722293|Epirubicin|epirubicin|mesh-list
20319781|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20319782|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319783|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20319784|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319785|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638169|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
19638170|NCT02412059|Hormones|hormones|mesh-ancestor
19638171|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638172|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638173|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19638174|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638175|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
19638176|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
19638177|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783937|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783938|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
19783939|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783940|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783941|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
19783942|NCT00280241|Rituximab|rituximab|mesh-list
19783943|NCT00280241|Fludarabine|fludarabine|mesh-list
19783944|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19783945|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
19783946|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783947|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19783948|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19783949|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
19783950|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783951|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783952|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19783953|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19783954|NCT00280293|Lamotrigine|lamotrigine|mesh-list
19783955|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
19783956|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19783957|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783958|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783959|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19783960|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783961|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19783962|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19783963|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19783964|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19783965|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19783966|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19783967|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
19783968|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19783969|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19783970|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19783971|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19783972|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783973|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
19783974|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783975|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783976|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19783977|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19783978|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19783979|NCT00280397|Lenvatinib|lenvatinib|mesh-list
19783980|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783981|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19783982|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19783983|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783984|NCT00280566|Ziprasidone|ziprasidone|mesh-list
19783985|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19783986|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
19783987|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19783988|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19783989|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19783990|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19783991|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19783992|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19783993|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19783994|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19783995|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
19783996|NCT00280735|Carboplatin|carboplatin|mesh-list
19783997|NCT00280735|Docetaxel|docetaxel|mesh-list
19783998|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19783999|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784000|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784001|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784002|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784003|NCT00280748|Pemetrexed|pemetrexed|mesh-list
19784004|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784005|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319786|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319787|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
20319788|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20319789|NCT00722475|Antibodies|antibodies|mesh-list
20319790|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
19784006|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784007|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19784008|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19784009|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19784010|NCT00281021|Digoxin|digoxin|mesh-list
19784011|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784012|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19784013|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784014|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784015|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19784016|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19784017|NCT00281021|Protective Agents|protective agents|mesh-ancestor
19784018|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784019|NCT00281528|Paclitaxel|paclitaxel|mesh-list
19784020|NCT00281528|Bevacizumab|bevacizumab|mesh-list
19784021|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19784022|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19784023|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784024|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784025|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784026|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784027|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784028|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784029|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784030|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784031|NCT00281528|Growth Substances|growth substances|mesh-ancestor
19784032|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784033|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
19638178|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638179|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19638180|NCT02412059|Protective Agents|protective agents|mesh-ancestor
19638181|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
19638182|NCT02412150|Remifentanil|remifentanil|mesh-list
19638183|NCT02412150|Desflurane|desflurane|mesh-list
19638184|NCT02412150|Anesthetics|anesthetics|mesh-list
19638185|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
19638186|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19638187|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638188|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784034|NCT00281580|Amlodipine|amlodipine|mesh-list
19784035|NCT00281580|Telmisartan|telmisartan|mesh-list
19784036|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19784037|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19784038|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784039|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784040|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19784041|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784042|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
19784043|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19784044|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19784045|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19784046|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
19784047|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784048|NCT00281697|Bevacizumab|bevacizumab|mesh-list
19784049|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20319791|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20319792|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
20319793|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319794|NCT00722488|Pevonedistat|pevonedistat|mesh-list
20319795|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319796|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319797|NCT00722579|Cobalt|cobalt|mesh-list
20319798|NCT00722579|Chromium|chromium|mesh-list
20319799|NCT00722579|Trace Elements|trace elements|mesh-ancestor
20319800|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
20319801|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319802|NCT00722631|Pioglitazone|pioglitazone|mesh-list
19784050|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784051|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784052|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20319803|NCT00722631|Glimepiride|glimepiride|mesh-list
20319804|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19638189|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638190|NCT02412150|Analgesics|analgesics|mesh-ancestor
20319805|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784053|NCT00281697|Growth Substances|growth substances|mesh-ancestor
19784054|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784055|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784056|NCT00281827|Gemcitabine|gemcitabine|mesh-list
19784057|NCT00281827|Thalidomide|thalidomide|mesh-list
19784058|NCT00281827|Carboplatin|carboplatin|mesh-list
19784059|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784060|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19784061|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
19784062|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784063|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
19784064|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784065|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784066|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319806|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20319807|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20319808|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
20347463|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347464|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20347465|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347466|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347467|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
20347468|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347469|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
20347470|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20347471|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19638191|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
19638192|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638193|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19638194|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19638195|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19638196|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
19638197|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638198|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784067|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
19784068|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784069|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
20152744|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152745|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152746|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152747|NCT00093886|Clevidipine|clevidipine|mesh-list
20152748|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
20152749|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
20152750|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20152751|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152752|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152753|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152754|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152755|NCT00093912|Nitroprusside|nitroprusside|mesh-list
20152756|NCT00093912|Clevidipine|clevidipine|mesh-list
20152757|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20152758|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
20152759|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20152760|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347472|NCT00860626|Interferons|interferons|mesh-list
20347473|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347474|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
19638199|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19638200|NCT02412150|Narcotics|narcotics|mesh-ancestor
19638201|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
19784070|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784071|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784072|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784073|NCT00281827|Growth Substances|growth substances|mesh-ancestor
19784074|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784075|NCT00281840|Bevacizumab|bevacizumab|mesh-list
19784076|NCT00281840|Docetaxel|docetaxel|mesh-list
19784077|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784078|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784079|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784080|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20152761|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20152762|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784081|NCT00281840|Growth Substances|growth substances|mesh-ancestor
19784082|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784083|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
20152763|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152764|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152765|NCT00093925|Nicardipine|nicardipine|mesh-list
20152766|NCT00093925|Clevidipine|clevidipine|mesh-list
20152767|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20152768|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20152769|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152770|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152771|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152772|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152773|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
20152774|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
20152775|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20152776|NCT00093951|Protective Agents|protective agents|mesh-ancestor
20152777|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152778|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
20152779|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
20152780|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152781|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152782|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
20319809|NCT00722709|Ropivacaine|ropivacaine|mesh-list
20319810|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
19784084|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784085|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784086|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784087|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784088|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
19784089|NCT00281918|Rituximab|rituximab|mesh-list
19784090|NCT00281918|Fludarabine|fludarabine|mesh-list
19784091|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
19784092|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784093|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
19784094|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784095|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784096|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19784097|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
19784098|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784099|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784100|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19784101|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784102|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19784103|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
19784104|NCT00281957|Sirolimus|sirolimus|mesh-list
19784105|NCT00281957|Sorafenib|sorafenib|mesh-list
19784106|NCT00281957|Tipifarnib|tipifarnib|mesh-list
19784107|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784108|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19784109|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784110|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784111|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784112|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784113|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784114|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
19784115|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784116|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
19784117|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784118|NCT00282048|Axitinib|axitinib|mesh-list
19784119|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784120|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19784121|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784122|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784123|NCT00282087|Gemcitabine|gemcitabine|mesh-list
19784124|NCT00282087|Docetaxel|docetaxel|mesh-list
19784125|NCT00282087|Doxorubicin|doxorubicin|mesh-list
19784126|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19784127|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
19784128|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784129|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784130|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
19784131|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319811|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
19784132|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784133|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784134|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
19784135|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784136|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784137|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784138|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784139|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784140|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19784141|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19784142|NCT00282243|Tacrolimus|tacrolimus|mesh-list
19784143|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784144|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
19784145|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784146|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19784147|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784148|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784149|NCT00282256|Tacrolimus|tacrolimus|mesh-list
19784150|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784151|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
19784152|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784153|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19784154|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784155|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784156|NCT00282282|Sirolimus|sirolimus|mesh-list
19784157|NCT00282282|Fludarabine|fludarabine|mesh-list
20319812|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20319813|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319814|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
20319815|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319816|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
20319817|NCT00722735|Finafloxacin|finafloxacin|mesh-list
20319818|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319819|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319820|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20319821|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319822|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319823|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319824|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319825|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20319826|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20319827|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20319828|NCT00722735|Renal Agents|renal agents|mesh-ancestor
19784158|NCT00282282|Busulfan|busulfan|mesh-list
19784159|NCT00282282|Tacrolimus|tacrolimus|mesh-list
19784160|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319829|NCT00722839|Vaccines|vaccines|mesh-list
20319830|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
19784161|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319831|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319832|NCT00722852|Ketoprofen|ketoprofen|mesh-list
20319833|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638202|NCT02412189|Norepinephrine|norepinephrine|mesh-list
19638203|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19638204|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19638205|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
19638206|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638207|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638208|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638209|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
19638210|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
19638211|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638212|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19638213|NCT02411942|Adapalene|adapalene|mesh-list
19638214|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638215|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638216|NCT02411942|Analgesics|analgesics|mesh-ancestor
19638217|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
19638218|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638219|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638220|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638221|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638222|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
19784162|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784163|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
19784164|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784165|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19784166|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784167|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784168|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784169|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784170|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
19784171|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
19784172|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19784173|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19784174|NCT00282308|Rituximab|rituximab|mesh-list
19784175|NCT00282308|Methotrexate|methotrexate|mesh-list
19784176|NCT00282308|Vaccines|vaccines|mesh-list
19784177|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19784178|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19784179|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
19784180|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784181|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784182|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784183|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784184|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19784185|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
19784186|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19784187|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19784188|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
19784189|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784190|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
19784191|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784192|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19784193|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784194|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19784195|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19784196|NCT00282347|Acetaminophen|acetaminophen|mesh-list
19784197|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
20319834|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20319835|NCT00722852|Analgesics|analgesics|mesh-ancestor
20319836|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
20319837|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319838|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784198|NCT00282347|Promethazine|promethazine|mesh-list
19784199|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
19784200|NCT00282347|Prednisone|prednisone|mesh-list
19784201|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
19784202|NCT00282347|Rituximab|rituximab|mesh-list
19784203|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784204|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784205|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
19784206|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784207|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784208|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784209|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
19784210|NCT00282347|Hormones|hormones|mesh-ancestor
19784211|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784212|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19784213|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19784214|NCT00282347|Analgesics|analgesics|mesh-ancestor
19784215|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
19784216|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784217|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
19784218|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784219|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19784220|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
19784221|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784222|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784223|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784224|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784225|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
19784226|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
19784227|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19784228|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19784229|NCT00282347|Protective Agents|protective agents|mesh-ancestor
19784230|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19784231|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19784232|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19784233|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
19784234|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
19784235|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19784236|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
19784237|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
19784238|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784239|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19784240|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
19784241|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
19784242|NCT00282412|Cyclosporine|cyclosporine|mesh-list
19784243|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
20319839|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319840|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20319841|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20319842|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319843|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319844|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20319845|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
20319846|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319847|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
20319848|NCT00722956|Atorvastatin|atorvastatin|mesh-list
20319849|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19784244|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
19784245|NCT00282412|Fludarabine|fludarabine|mesh-list
19784246|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
19784247|NCT00282412|Cyclosporins|cyclosporins|mesh-list
19784248|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784249|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
19784250|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784251|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784252|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19784253|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
19784254|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784255|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784256|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19784257|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784258|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
19784259|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784260|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
19784261|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19784262|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784263|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19784264|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
19784265|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784266|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784267|NCT00282464|Ziprasidone|ziprasidone|mesh-list
19784268|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19784269|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
19784270|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784271|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784272|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784273|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19784274|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19784275|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19784276|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784277|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19784278|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
19784279|NCT00282568|Tacrolimus|tacrolimus|mesh-list
19784280|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784281|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
19784282|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784283|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19784284|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784285|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784286|NCT00282828|Clonazepam|clonazepam|mesh-list
19784287|NCT00282828|Sertraline|sertraline|mesh-list
19784288|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19784289|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
19784290|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784291|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19784292|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19784293|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784294|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784295|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784296|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
20319850|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20319851|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
20319852|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319853|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20319854|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20319855|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784297|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784298|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19784299|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19784300|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
19784301|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
19784302|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
19784303|NCT00282919|Azithromycin|azithromycin|mesh-list
19784304|NCT00282919|Chloroquine|chloroquine|mesh-list
19784305|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784306|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784307|NCT00282919|Amebicides|amebicides|mesh-ancestor
19784308|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20319856|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20319857|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20319858|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20319859|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
20319860|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319861|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20319862|NCT00722969|Sorafenib|sorafenib|mesh-list
20319863|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319864|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20319865|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319866|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319867|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20319868|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
20319869|NCT00723047|Coagulants|coagulants|mesh-ancestor
20319870|NCT00723060|Citalopram|citalopram|mesh-list
20319871|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20319872|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20319873|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20319874|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784309|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19784310|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
19784311|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784312|NCT00282971|Insulin|insulin|mesh-list
19784313|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784314|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784315|NCT00282984|Varenicline|varenicline|mesh-list
19784316|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19784317|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19784318|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
19784319|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784320|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784321|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784322|NCT00283049|Insulin|insulin|mesh-list
19784323|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19784324|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
19784325|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
19784326|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784327|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784328|NCT00283062|Docetaxel|docetaxel|mesh-list
19784329|NCT00283062|Leuprolide|leuprolide|mesh-list
19784330|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784331|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784332|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784333|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784334|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784335|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20152783|NCT00093977|Hematinics|hematinics|mesh-ancestor
20152784|NCT00093990|Tipifarnib|tipifarnib|mesh-list
20152785|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784336|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
19784337|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19784338|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152786|NCT00094003|Poly I-C|poly i-c|mesh-list
20152787|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
20152788|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152789|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
20152790|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
20152791|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152792|NCT00094029|Sunitinib|sunitinib|mesh-list
20152793|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152794|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20152795|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784339|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19784340|NCT00283244|Gemcitabine|gemcitabine|mesh-list
19784341|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19784342|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19784343|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
19784344|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784345|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784346|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
19784347|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784348|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784349|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784350|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
19784351|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784352|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19784353|NCT00283387|Betaine|betaine|mesh-list
20319875|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20319876|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
20319877|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319878|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20319879|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
20319880|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784354|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19784355|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
19784356|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19784357|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
19784358|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784359|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19784360|NCT00283504|Omalizumab|omalizumab|mesh-list
19784361|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19784362|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19784363|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
19784364|NCT00283595|Hormones|hormones|mesh-list
19784365|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784366|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784367|NCT00283686|Telmisartan|telmisartan|mesh-list
19784368|NCT00283686|Lisinopril|lisinopril|mesh-list
19784369|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19784370|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19784371|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19784372|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19784373|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784374|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
19784375|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784376|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19784377|NCT00283686|Protective Agents|protective agents|mesh-ancestor
19784378|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784379|NCT00283712|Infliximab|infliximab|mesh-list
19784380|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
20319881|NCT00723086|Docetaxel|docetaxel|mesh-list
20319882|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319883|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
20319884|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
20319885|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
20319886|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319887|NCT00723164|Fentanyl|fentanyl|mesh-list
20319888|NCT00723164|Midazolam|midazolam|mesh-list
20319889|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20319890|NCT00723164|Narcotics|narcotics|mesh-ancestor
20319891|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19784381|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19784382|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19833740|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19833741|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19833742|NCT00589693|Imipenem|imipenem|mesh-list
19833743|NCT00589693|Doripenem|doripenem|mesh-list
19833744|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
19833745|NCT00589693|Cilastatin|cilastatin|mesh-list
19833746|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19833747|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152796|NCT00094029|Growth Substances|growth substances|mesh-ancestor
20152797|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152798|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
20319892|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319893|NCT00723164|Analgesics|analgesics|mesh-ancestor
20319894|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
20319895|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20319896|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20319897|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20319898|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
20319899|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
20319900|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20319901|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20319902|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20319903|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20319904|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
20319905|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
20319906|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20319907|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319908|NCT00723216|Enoxaparin|enoxaparin|mesh-list
20319909|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
20319910|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20319911|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20319912|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784383|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
19784384|NCT00283803|Hormones|hormones|mesh-list
19784385|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19784386|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
19784387|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784388|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784389|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784390|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
19784391|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19784392|NCT00283803|Protective Agents|protective agents|mesh-ancestor
19784393|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19784394|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784395|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784396|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19784397|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19784398|NCT00283803|Analgesics|analgesics|mesh-ancestor
19784399|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
19784400|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784401|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784402|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784403|NCT00283816|Metformin|metformin|mesh-list
19784404|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
19784405|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
19784406|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19784407|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784408|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784409|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19784410|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19784411|NCT00284050|Ranibizumab|ranibizumab|mesh-list
19784412|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784413|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784414|NCT00284050|Growth Substances|growth substances|mesh-ancestor
19784415|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784416|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784417|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784418|NCT00284089|Ranibizumab|ranibizumab|mesh-list
19784419|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784420|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784421|NCT00284089|Growth Substances|growth substances|mesh-ancestor
19784422|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784423|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784424|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784425|NCT00284141|Aflibercept|aflibercept|mesh-list
19784426|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784427|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784428|NCT00284141|Growth Substances|growth substances|mesh-ancestor
19784429|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784430|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784431|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784432|NCT00284180|Trastuzumab|trastuzumab|mesh-list
19784433|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784434|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784435|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
19784436|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19784437|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19784438|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19784439|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784440|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784441|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
19784442|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784443|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784444|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19784445|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784446|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19784447|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19784448|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19784449|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784450|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
19784451|NCT00284934|Prednisone|prednisone|mesh-list
19784452|NCT00284934|Tacrolimus|tacrolimus|mesh-list
19784453|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784454|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
19784455|NCT00284934|Hormones|hormones|mesh-ancestor
19784456|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784457|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784458|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19784459|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784460|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784461|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
19784462|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19784463|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784464|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784465|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784466|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19784467|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
19784468|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784469|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319913|NCT00723242|Ribavirin|ribavirin|mesh-list
20319914|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
20319915|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319916|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
20319917|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319918|NCT00723268|Prednisolone|prednisolone|mesh-list
19784470|NCT00285012|Varenicline|varenicline|mesh-list
19784471|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19784472|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19784473|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
19784474|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784475|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784476|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784477|NCT00285467|Vitamin D|vitamin d|mesh-list
19784478|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
19784479|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
19784480|NCT00285467|Vitamins|vitamins|mesh-ancestor
20319919|NCT00723268|Colchicine|colchicine|mesh-list
20319920|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20319921|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
20319922|NCT00723268|Hormones|hormones|mesh-ancestor
20319923|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20319924|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319925|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20319926|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319927|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
20319928|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20319929|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
20319930|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784481|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
19784482|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784483|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19784484|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319931|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
20319932|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319933|NCT00723307|Metformin|metformin|mesh-list
20319934|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20319935|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784485|NCT00285584|Bupropion|bupropion|mesh-list
19784486|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19784487|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
19784488|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784489|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19784490|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19784491|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784492|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784493|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
19784494|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784495|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784496|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19784497|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19784498|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784499|NCT00285779|Etanercept|etanercept|mesh-list
19784500|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19784501|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19784502|NCT00285779|Analgesics|analgesics|mesh-ancestor
19784503|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
19784504|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784505|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784506|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784507|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784508|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19784509|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784510|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
19784511|NCT00285818|Mifepristone|mifepristone|mesh-list
19784512|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19784513|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
19784514|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19784515|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784516|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19784517|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19784518|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19784519|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
19784520|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19784521|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19784522|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
19784523|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784524|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
19784525|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19784526|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19784527|NCT00285857|Lovastatin|lovastatin|mesh-list
20152799|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20152800|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152801|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152802|NCT00094081|Tirapazamine|tirapazamine|mesh-list
20152803|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784528|NCT00285857|L 647318|l 647318|mesh-list
19784529|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
19784530|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19784531|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
19784532|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784533|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19784534|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19784535|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19784536|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784537|NCT00286091|Denosumab|denosumab|mesh-list
19784538|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19784539|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784540|NCT00286156|Sirolimus|sirolimus|mesh-list
19784541|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784542|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784543|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784544|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784545|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
19784546|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784547|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
19784548|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152804|NCT00094120|Squalamine|squalamine|mesh-list
20152805|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20152806|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152807|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19784549|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
19784550|NCT00286182|Hematinics|hematinics|mesh-ancestor
19784551|NCT00286221|Fentanyl|fentanyl|mesh-list
20319936|NCT00723320|Atorvastatin|atorvastatin|mesh-list
19784552|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19784553|NCT00286221|Narcotics|narcotics|mesh-ancestor
19784554|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19784555|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784556|NCT00286221|Analgesics|analgesics|mesh-ancestor
19784557|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
19784558|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784559|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19784560|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19784561|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
19784562|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
19784563|NCT00286234|Niacin|niacin|mesh-list
19784564|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
19784565|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19784566|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
19784567|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784568|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19784569|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
19784570|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
19784571|NCT00286234|Vitamins|vitamins|mesh-ancestor
19784572|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
19784573|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784574|NCT00286325|Rituximab|rituximab|mesh-list
19784575|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784576|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784577|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
19784578|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784579|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20319937|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20319938|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20319939|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
20319940|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319941|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20319942|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20319943|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319944|NCT00723346|Asparaginase|asparaginase|mesh-list
20319945|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319946|NCT00723385|Vitamin D|vitamin d|mesh-list
20319947|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
20319948|NCT00723385|Vitamins|vitamins|mesh-ancestor
20319949|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
20319950|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319951|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20319952|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319953|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
20319954|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20319955|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
19784580|NCT00286429|Insulin|insulin|mesh-list
20319956|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20319957|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
20319958|NCT00723424|Digoxin|digoxin|mesh-list
20319959|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20319960|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20319961|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319962|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784581|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19784582|NCT00286429|Alogliptin|alogliptin|mesh-list
19784583|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784584|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784585|NCT00286429|Incretins|incretins|mesh-ancestor
19784586|NCT00286429|Hormones|hormones|mesh-ancestor
19784587|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784588|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19784589|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
19784590|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784591|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784592|NCT00286442|Metformin|metformin|mesh-list
19784593|NCT00286442|Alogliptin|alogliptin|mesh-list
19784594|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784595|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784596|NCT00286442|Incretins|incretins|mesh-ancestor
19784597|NCT00286442|Hormones|hormones|mesh-ancestor
19784598|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784599|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19784600|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
19784601|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784602|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784603|NCT00286455|Alogliptin|alogliptin|mesh-list
19784604|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784605|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784606|NCT00286455|Incretins|incretins|mesh-ancestor
19784607|NCT00286455|Hormones|hormones|mesh-ancestor
19784608|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784609|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19784610|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
19784611|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784612|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784613|NCT00286468|Alogliptin|alogliptin|mesh-list
19784614|NCT00286468|Glyburide|glyburide|mesh-list
19784615|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784616|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784617|NCT00286468|Incretins|incretins|mesh-ancestor
19784618|NCT00286468|Hormones|hormones|mesh-ancestor
19784619|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784620|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19784621|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
19784622|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784623|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784624|NCT00286494|Pioglitazone|pioglitazone|mesh-list
19784625|NCT00286494|Alogliptin|alogliptin|mesh-list
19784626|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784627|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784628|NCT00286494|Incretins|incretins|mesh-ancestor
19784629|NCT00286494|Hormones|hormones|mesh-ancestor
19784630|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784631|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19784632|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
19784633|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784634|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784635|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19784636|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19784637|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19784638|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784639|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784640|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
19784641|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784642|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784643|NCT00287053|Valproic Acid|valproic acid|mesh-list
19784644|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
19784645|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784646|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784647|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
19784648|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784649|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784650|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
19784651|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19784652|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19784653|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784654|NCT00287222|Bevacizumab|bevacizumab|mesh-list
19784655|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19784656|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784657|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784658|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784659|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784660|NCT00287222|Growth Substances|growth substances|mesh-ancestor
19784661|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784662|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784663|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19784664|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784665|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784666|NCT00287287|Lenalidomide|lenalidomide|mesh-list
19784667|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
19784668|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784669|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784670|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784671|NCT00287287|Growth Substances|growth substances|mesh-ancestor
19784672|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784673|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784674|NCT00287339|Esomeprazole|esomeprazole|mesh-list
19784675|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19784676|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19784677|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19784678|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784679|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784680|NCT00287586|Testosterone|testosterone|mesh-list
19784681|NCT00287586|Androgens|androgens|mesh-ancestor
19784682|NCT00287586|Hormones|hormones|mesh-ancestor
19784683|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784684|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784685|NCT00287690|Genistein|genistein|mesh-list
19784686|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19784687|NCT00287690|Protective Agents|protective agents|mesh-ancestor
19784688|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784689|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784690|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19784691|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784692|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784693|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
19784694|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19784695|NCT00287690|Estrogens|estrogens|mesh-ancestor
19784696|NCT00287690|Hormones|hormones|mesh-ancestor
19784697|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784698|NCT00287716|Pirfenidone|pirfenidone|mesh-list
19784699|NCT00287716|Analgesics|analgesics|mesh-ancestor
19784700|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
20319963|NCT00723424|Protective Agents|protective agents|mesh-ancestor
20319964|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784701|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784702|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784703|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152808|NCT00094120|Protective Agents|protective agents|mesh-ancestor
20152809|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152810|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784704|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19784705|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784706|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784707|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784708|NCT00287729|Pirfenidone|pirfenidone|mesh-list
19784709|NCT00287729|Analgesics|analgesics|mesh-ancestor
19784710|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
19784711|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784712|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784713|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19784714|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19784715|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784716|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784717|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784718|NCT00287872|Thalidomide|thalidomide|mesh-list
19784719|NCT00287872|Bortezomib|bortezomib|mesh-list
19784720|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784721|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784722|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
19784723|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784724|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
19784725|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19784726|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784727|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784728|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784729|NCT00287872|Growth Substances|growth substances|mesh-ancestor
19784730|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784731|NCT00287989|Paclitaxel|paclitaxel|mesh-list
19784732|NCT00287989|Carboplatin|carboplatin|mesh-list
20152811|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20152812|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20152813|NCT00094120|Growth Substances|growth substances|mesh-ancestor
20152814|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
20152815|NCT00094146|Octreotide|octreotide|mesh-list
20319965|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20319966|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19784733|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19784734|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19784735|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784736|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784737|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784738|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784739|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784740|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19784741|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784742|NCT00288015|Bevacizumab|bevacizumab|mesh-list
19784743|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784744|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784745|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19784746|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19784747|NCT00288015|Growth Substances|growth substances|mesh-ancestor
19784748|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784749|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
19784750|NCT00288054|Docetaxel|docetaxel|mesh-list
19784751|NCT00288054|Cetuximab|cetuximab|mesh-list
19784752|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784753|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784754|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784755|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784756|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784757|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784758|NCT00288067|Rituximab|rituximab|mesh-list
19784759|NCT00288067|Fenretinide|fenretinide|mesh-list
19784760|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784761|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784762|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
19784763|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784764|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784765|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19784766|NCT00288067|Protective Agents|protective agents|mesh-ancestor
19784767|NCT00288366|Aripiprazole|aripiprazole|mesh-list
19784768|NCT00288366|Ziprasidone|ziprasidone|mesh-list
19784769|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
19784770|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784771|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19784772|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19784773|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19784774|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784775|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
19784776|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
19784777|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784778|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784779|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19784780|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19784781|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
19784782|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19784783|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19784784|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19784785|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19784786|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
19784787|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19784788|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19784789|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19784790|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784791|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784792|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
19784793|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784794|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784795|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20152816|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152817|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20152818|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152819|NCT00094289|Disulfiram|disulfiram|mesh-list
20152820|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20152821|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20152822|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152823|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152824|NCT00094315|Cocaine|cocaine|mesh-list
20152825|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
20152826|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
19784796|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784797|NCT00288574|Fluoxetine|fluoxetine|mesh-list
19784798|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19784799|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19784800|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784801|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784802|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784803|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
19784804|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784805|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19784806|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
19784807|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784808|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19784809|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19784810|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784811|NCT00288587|Diuretics|diuretics|mesh-list
19784812|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19784813|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
19784814|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784815|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784816|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784817|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19784818|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
19784819|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19784820|NCT00288600|Antibodies|antibodies|mesh-list
19784821|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
19784822|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19784823|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
19784824|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784825|NCT00288626|Cytarabine|cytarabine|mesh-list
19784826|NCT00288626|Prednisone|prednisone|mesh-list
19784827|NCT00288626|Etoposide|etoposide|mesh-list
19784828|NCT00288626|Melphalan|melphalan|mesh-list
19784829|NCT00288626|Carmustine|carmustine|mesh-list
19784830|NCT00288626|Sargramostim|sargramostim|mesh-list
19784831|NCT00288626|Lenograstim|lenograstim|mesh-list
19784832|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784833|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
19784834|NCT00288626|Hormones|hormones|mesh-ancestor
19784835|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784836|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784837|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19784838|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784839|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19784840|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19784841|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19784842|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784843|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784844|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19784845|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
19784846|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
19784847|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784848|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784849|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
19784850|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19784851|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
19784852|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19784853|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19784854|NCT00288639|Pregabalin|pregabalin|mesh-list
19784855|NCT00288639|Analgesics|analgesics|mesh-ancestor
19784856|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
19784857|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784858|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784859|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
19784860|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19784861|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19784862|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784863|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319967|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20319968|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
20319969|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20319970|NCT00723437|Acitretin|acitretin|mesh-list
20319971|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
20319972|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
19784864|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19784865|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19784866|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20152827|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638223|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
19638224|NCT02411955|Tazarotene|tazarotene|mesh-list
19638225|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
19638226|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
19638227|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
19638228|NCT02411955|Vitamins|vitamins|mesh-ancestor
19638229|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
19638230|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638231|NCT02412085|Golimumab|golimumab|mesh-list
19638232|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19638233|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638234|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19638235|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
19638236|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152828|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152829|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
20152830|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152831|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20152832|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20152833|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20152834|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152835|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152836|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
20152837|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152838|NCT00094341|Etanercept|etanercept|mesh-list
19638237|NCT02412033|Misoprostol|misoprostol|mesh-list
19638238|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19638239|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
19638240|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638241|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638242|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19638243|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638244|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
19638245|NCT02411994|Artesunate|artesunate|mesh-list
19638246|NCT02411994|Lumefantrine|lumefantrine|mesh-list
19638247|NCT02411994|Artemether|artemether|mesh-list
19638248|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19638249|NCT02411994|Pyronaridine|pyronaridine|mesh-list
19638250|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
19638251|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19638252|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19638253|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638254|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638255|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
19638256|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
19638257|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19638258|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
19638259|NCT02411877|Clotrimazole|clotrimazole|mesh-list
19638260|NCT02411877|Miconazole|miconazole|mesh-list
19638261|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19638262|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638263|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
19638264|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19638265|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19638266|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638267|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638268|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19638269|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
19638270|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638271|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152839|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20152840|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20152841|NCT00094341|Analgesics|analgesics|mesh-ancestor
20152842|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
20152843|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638272|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19638273|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19638274|NCT02411903|Clopidogrel|clopidogrel|mesh-list
19638275|NCT02411903|Atorvastatin|atorvastatin|mesh-list
19784867|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784868|NCT00288704|Rilonacept|rilonacept|mesh-list
19784869|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784870|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19784871|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784872|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784873|NCT00289211|Complement C1s|complement c1s|mesh-list
19784874|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19784875|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19784876|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
19784877|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784878|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19784879|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784880|NCT00289536|Factor VIII|factor viii|mesh-list
19784881|NCT00289536|Coagulants|coagulants|mesh-ancestor
20152844|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152845|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20152846|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152847|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152848|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152849|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
20152850|NCT00094367|Lamivudine|lamivudine|mesh-list
20152851|NCT00094367|Abacavir|abacavir|mesh-list
20152852|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20152853|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19784882|NCT00289653|Nicotine|nicotine|mesh-list
19784883|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19784884|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
20152854|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152855|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152856|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
20152857|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152858|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20152859|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20152860|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
20152861|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152862|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
20152863|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152864|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20152865|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20152866|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
20152867|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152868|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152869|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20152870|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
20152871|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
20319973|NCT00723502|Amoxicillin|amoxicillin|mesh-list
20319974|NCT00723502|Finafloxacin|finafloxacin|mesh-list
19784885|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784886|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784887|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19784888|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19784889|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
19784890|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19784891|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784892|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19784893|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
19784894|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784895|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20319975|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
20319976|NCT00723502|Esomeprazole|esomeprazole|mesh-list
20319977|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20319978|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784896|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19784897|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784898|NCT00289848|Incretins|incretins|mesh-ancestor
19784899|NCT00289848|Hormones|hormones|mesh-ancestor
19784900|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784901|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19784902|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
19784903|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833748|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
20152872|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319979|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20152873|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
19784904|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784905|NCT00289900|Atorvastatin|atorvastatin|mesh-list
19784906|NCT00289900|Simvastatin|simvastatin|mesh-list
19784907|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19784908|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19784909|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
19784910|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784911|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19784912|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19784913|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784914|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19784915|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19784916|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638276|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19638277|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19638278|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19638279|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
19638280|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638281|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20319980|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20319981|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20319982|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20319983|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20319984|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20319985|NCT00723502|Renal Agents|renal agents|mesh-ancestor
20319986|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20319987|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20319988|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20319989|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20319990|NCT00723515|Listerine|listerine|mesh-list
20319991|NCT00723515|Calcium|calcium|mesh-list
20319992|NCT00723515|Fluorides|fluorides|mesh-list
20319993|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
20319994|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20319995|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611165|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611166|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611167|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611168|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
20319996|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
20319997|NCT00723515|Protective Agents|protective agents|mesh-ancestor
19638282|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19638283|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784917|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784918|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
20152874|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152875|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152876|NCT00094432|Aripiprazole|aripiprazole|mesh-list
20152877|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
20152878|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19784919|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784920|NCT00289991|Itraconazole|itraconazole|mesh-list
19784921|NCT00289991|Voriconazole|voriconazole|mesh-list
19784922|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
19784923|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20152879|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20152880|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20152881|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20319998|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20319999|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320000|NCT00723658|Cytarabine|cytarabine|mesh-list
19638284|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20611169|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611170|NCT02101775|Gemcitabine|gemcitabine|mesh-list
20611171|NCT02101775|Adavosertib|adavosertib|mesh-list
20611172|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611173|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
20320001|NCT00723658|Thalidomide|thalidomide|mesh-list
20320002|NCT00723658|Dexamethasone|dexamethasone|mesh-list
20320003|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
20320004|NCT00723658|Melphalan|melphalan|mesh-list
20320005|NCT00723658|Carmustine|carmustine|mesh-list
20320006|NCT00723658|Rituximab|rituximab|mesh-list
20320007|NCT00723658|Doxorubicin|doxorubicin|mesh-list
20320008|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20320009|NCT00723658|Etoposide|etoposide|mesh-list
20320010|NCT00723658|Bortezomib|bortezomib|mesh-list
20320011|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20320012|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
20320013|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320014|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320015|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20320016|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
20320017|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320018|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320019|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20320020|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19784924|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19784925|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19784926|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784927|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784928|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19784929|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
19784930|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784931|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784932|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19784933|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
19784934|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
19784935|NCT00290290|Povidone|povidone|mesh-list
19784936|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19784937|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784938|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
19784939|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
19784940|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
19784941|NCT00290329|Vaccines|vaccines|mesh-list
19784942|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
19784943|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784944|NCT00290342|Edetic Acid|edetic acid|mesh-list
19784945|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
19784946|NCT00290342|Antidotes|antidotes|mesh-ancestor
19784947|NCT00290342|Protective Agents|protective agents|mesh-ancestor
19784948|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784949|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
19784950|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
19784951|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784952|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19784953|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
19784954|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19833749|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833750|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833751|NCT00589784|Sunitinib|sunitinib|mesh-list
19833752|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
19833753|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320021|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320022|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
19833754|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19833755|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19833756|NCT00589784|Growth Substances|growth substances|mesh-ancestor
19833757|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833758|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
20320023|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
20320024|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320025|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320026|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
20320027|NCT00723658|Hormones|hormones|mesh-ancestor
20320028|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20320029|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19833759|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19833760|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833761|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320030|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20320031|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20320032|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20320033|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320034|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20320035|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20320036|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
20320037|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
20320038|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320039|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
19784955|NCT00290433|Cytarabine|cytarabine|mesh-list
19784956|NCT00290433|Dexamethasone|dexamethasone|mesh-list
19784957|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
19784958|NCT00290433|Doxorubicin|doxorubicin|mesh-list
19784959|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19784960|NCT00290433|Methotrexate|methotrexate|mesh-list
19784961|NCT00290433|Vincristine|vincristine|mesh-list
19784962|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19784963|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
19784964|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19784965|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19784966|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19784967|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
19784968|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19784969|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19784970|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19784971|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19784972|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
19784973|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
19784974|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19784975|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19784976|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
19784977|NCT00290433|Hormones|hormones|mesh-ancestor
19784978|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19784979|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19784980|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19784981|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19784982|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19784983|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19784984|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19784985|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
19784986|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19784987|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19784988|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
19784989|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
19784990|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19784991|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19784992|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
19784993|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19784994|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19784995|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
19784996|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
19784997|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
19784998|NCT00290472|Sirolimus|sirolimus|mesh-list
19784999|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20320040|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20320041|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20320042|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20320043|NCT00723658|Growth Substances|growth substances|mesh-ancestor
20320044|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
20320045|NCT00723775|Lopinavir|lopinavir|mesh-list
20320046|NCT00723775|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20320047|NCT00723775|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19638285|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19638286|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19638287|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19638288|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
19638289|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638290|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638291|NCT02411786|Molgramostim|molgramostim|mesh-list
19638292|NCT02411786|Sargramostim|sargramostim|mesh-list
19638293|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
19638294|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785000|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638295|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785001|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785002|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320048|NCT00723775|Protease Inhibitors|protease inhibitors|mesh-ancestor
19785003|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
19785004|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785005|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
19785006|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785007|NCT00290498|Cytarabine|cytarabine|mesh-list
19785008|NCT00290498|Dexamethasone|dexamethasone|mesh-list
19785009|NCT00290498|Prednisone|prednisone|mesh-list
19785010|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
19785011|NCT00290498|Rituximab|rituximab|mesh-list
19785012|NCT00290498|Doxorubicin|doxorubicin|mesh-list
19785013|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19785014|NCT00290498|Methotrexate|methotrexate|mesh-list
19785015|NCT00290498|Vincristine|vincristine|mesh-list
19785016|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785017|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
19785018|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785019|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785020|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19785021|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
20320049|NCT00723775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320050|NCT00723775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320051|NCT00723775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20320052|NCT00723775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20320053|NCT00723775|Antiviral Agents|antiviral agents|mesh-ancestor
20320054|NCT00723775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320055|NCT00723775|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20320056|NCT00723775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20320057|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20320058|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19785022|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785023|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785024|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19785025|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19785026|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785027|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
19785028|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
19785029|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785030|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785031|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
19785032|NCT00290498|Hormones|hormones|mesh-ancestor
20320059|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20320060|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320061|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320062|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20320063|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20320064|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320065|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
20320066|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320067|NCT00723879|Ribavirin|ribavirin|mesh-list
19638296|NCT02411825|Metformin|metformin|mesh-list
19785033|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785034|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785035|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785036|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19785037|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19785038|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785039|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19785040|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
19785041|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19785042|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19785043|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
19638297|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19638298|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638299|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
19638300|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
19638301|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638302|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638303|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638304|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
19638305|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
19638306|NCT02411604|Tacrolimus|tacrolimus|mesh-list
19638307|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19638308|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
19785044|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
19785045|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19785046|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19785047|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
19785048|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785049|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19785050|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
19785051|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
19785052|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
19785053|NCT00290537|Paclitaxel|paclitaxel|mesh-list
20320068|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20320069|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
20320070|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320071|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
19638309|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638310|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19638311|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152882|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152883|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
20152884|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
19638312|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638313|NCT02411149|Epinephrine|epinephrine|mesh-list
19638314|NCT02411149|Racepinephrine|racepinephrine|mesh-list
19638315|NCT02411149|Morphine|morphine|mesh-list
19785054|NCT00290537|Carboplatin|carboplatin|mesh-list
19785055|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19785056|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785057|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19785058|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19785059|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19785060|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785061|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
19785062|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19785063|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20152885|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152886|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785064|NCT00290589|Prednisolone|prednisolone|mesh-list
19785065|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
19785066|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19785067|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
19785068|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785069|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
19785070|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
19785071|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785072|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785073|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785074|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
19785075|NCT00290589|Hormones|hormones|mesh-ancestor
19785076|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785077|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19785078|NCT00290589|Protective Agents|protective agents|mesh-ancestor
19785079|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785080|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785081|NCT00290615|Bevacizumab|bevacizumab|mesh-list
19785082|NCT00290615|Cetuximab|cetuximab|mesh-list
19785083|NCT00290615|Capecitabine|capecitabine|mesh-list
19785084|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
19785085|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19785086|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20152887|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20152888|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20152889|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
20152890|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20152891|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20152892|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20152893|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20152894|NCT00094484|Cinacalcet|cinacalcet|mesh-list
20152895|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20152896|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152897|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20152898|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
20320072|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320073|NCT00723918|Methadone|methadone|mesh-list
19638316|NCT02411149|Ropivacaine|ropivacaine|mesh-list
19785087|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19785088|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20320074|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19638317|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
19785089|NCT00290615|Growth Substances|growth substances|mesh-ancestor
19785090|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785091|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
19785092|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19785093|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
19785094|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785095|NCT00290654|Tamoxifen|tamoxifen|mesh-list
19785096|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19785097|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785098|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785099|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785100|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785101|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785102|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19785103|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19785104|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19785105|NCT00290693|Docetaxel|docetaxel|mesh-list
19785106|NCT00290693|Capecitabine|capecitabine|mesh-list
19785107|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785108|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
19785109|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
19785110|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
19785111|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785112|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19785113|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
19785114|NCT00290706|Gemcitabine|gemcitabine|mesh-list
19785115|NCT00290706|Bortezomib|bortezomib|mesh-list
19785116|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19785117|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
19785118|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785119|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785120|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
19785121|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785122|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785123|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785124|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
19785125|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785126|NCT00290732|Doxorubicin|doxorubicin|mesh-list
19785127|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19785128|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785129|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785130|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19785131|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19785132|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785133|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785134|NCT00290745|Tamoxifen|tamoxifen|mesh-list
19785135|NCT00290745|Letrozole|letrozole|mesh-list
19785136|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785137|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785138|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19785139|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19785140|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785141|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19785142|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785143|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785144|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785145|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785146|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19785147|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19785148|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19785149|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
19785150|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
19785151|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785152|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19785153|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785154|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785155|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
19785156|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19785157|NCT00290810|Bevacizumab|bevacizumab|mesh-list
19785158|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19785159|NCT00290810|Antibodies|antibodies|mesh-list
19785160|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
19785161|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19785162|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785163|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19785164|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19785165|NCT00290810|Growth Substances|growth substances|mesh-ancestor
19785166|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785167|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
19785168|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
19785169|NCT00291135|Letrozole|letrozole|mesh-list
19785170|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785171|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19785172|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19785173|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785174|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785175|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19785176|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785177|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785178|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785179|NCT00291226|Glycine|glycine|mesh-list
19785180|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
20320075|NCT00723918|Narcotics|narcotics|mesh-ancestor
20320076|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320077|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320078|NCT00723918|Analgesics|analgesics|mesh-ancestor
20320079|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
20320080|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320081|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
20320082|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
20320083|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20320084|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
19785181|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785182|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785183|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785184|NCT00291330|Warfarin|warfarin|mesh-list
20320085|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320086|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20320087|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20320088|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320089|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320090|NCT00723983|Sumatriptan|sumatriptan|mesh-list
20320091|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20320092|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20320093|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20320094|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
20320095|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785185|NCT00291330|Dabigatran|dabigatran|mesh-list
19785186|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
19785187|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
19785188|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19785189|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
19785190|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785191|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785192|NCT00291577|Docetaxel|docetaxel|mesh-list
19785193|NCT00291577|Sunitinib|sunitinib|mesh-list
19785194|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785195|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
19785196|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
19785197|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
19785198|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785199|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20320096|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320097|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320098|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
20320099|NCT00724022|Prednisolone|prednisolone|mesh-list
20320100|NCT00724022|Tacrolimus|tacrolimus|mesh-list
20320101|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
20320102|NCT00724022|Basiliximab|basiliximab|mesh-list
20320103|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20320104|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
20320105|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320106|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20320107|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320108|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320109|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785200|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19785201|NCT00291577|Growth Substances|growth substances|mesh-ancestor
20320110|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
19785202|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785203|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
19785204|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19785205|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785206|NCT00291642|Cetirizine|cetirizine|mesh-list
19785207|NCT00291642|Levocetirizine|levocetirizine|mesh-list
19785208|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19785209|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19785210|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19785211|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
19785212|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
20320111|NCT00724022|Hormones|hormones|mesh-ancestor
20320112|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20320113|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785213|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785214|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785215|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785216|NCT00291655|Levetiracetam|levetiracetam|mesh-list
19785217|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
19785218|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
19785219|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
19785220|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785221|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
19785222|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785223|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785224|NCT00291694|Celecoxib|celecoxib|mesh-list
19785225|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19785226|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785227|NCT00291694|Analgesics|analgesics|mesh-ancestor
19785228|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
19785229|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785230|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785231|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785232|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785233|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20320114|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320115|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20320116|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20320117|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
20320118|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20320119|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320120|NCT00724035|Fentanyl|fentanyl|mesh-list
20320121|NCT00724035|Midazolam|midazolam|mesh-list
20320122|NCT00724035|Analgesics|analgesics|mesh-list
20320123|NCT00724035|Anesthetics|anesthetics|mesh-list
20320124|NCT00724035|Ropivacaine|ropivacaine|mesh-list
20320125|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
19785234|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19785235|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785236|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785237|NCT00292162|Metoprolol|metoprolol|mesh-list
19785238|NCT00292162|Carvedilol|carvedilol|mesh-list
19785239|NCT00292162|Ramipril|ramipril|mesh-list
19785240|NCT00292162|Enalapril|enalapril|mesh-list
19785241|NCT00292162|Lisinopril|lisinopril|mesh-list
19785242|NCT00292162|Bisoprolol|bisoprolol|mesh-list
19785243|NCT00292162|Perindopril|perindopril|mesh-list
19785244|NCT00292162|Captopril|captopril|mesh-list
19785245|NCT00292162|Spironolactone|spironolactone|mesh-list
19785246|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19785247|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20320126|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320127|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320128|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
20320129|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320130|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20320131|NCT00724035|Narcotics|narcotics|mesh-ancestor
20320132|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19785248|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20320133|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20320134|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
19785249|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19785250|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19785251|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
19785252|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
20320135|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20320136|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19785253|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785254|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785255|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19785256|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19785257|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
19785258|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785259|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785260|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785261|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785262|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19785263|NCT00292162|Diuretics|diuretics|mesh-ancestor
19785264|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
19785265|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
19785266|NCT00292162|Protective Agents|protective agents|mesh-ancestor
19785267|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19785268|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785269|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19785270|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
19785271|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19785272|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19785273|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
19785274|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785275|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19785276|NCT00292188|Pregabalin|pregabalin|mesh-list
19785277|NCT00292188|Analgesics|analgesics|mesh-ancestor
20320137|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20320138|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19785278|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
19785279|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785280|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785281|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
20152899|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20320139|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
19785282|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19785283|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785284|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785285|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19785286|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19785287|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19785288|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19785289|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19785290|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
19785291|NCT00292227|Rotigotine|rotigotine|mesh-list
19785292|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19785293|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785294|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19785295|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19785296|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785297|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785298|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785299|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785300|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
19785301|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
19785302|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785303|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20320140|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
20320141|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785304|NCT00292370|Paroxetine|paroxetine|mesh-list
19785305|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
19785306|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19785307|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19785308|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19785309|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19785310|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785311|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19785312|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19785313|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785314|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785315|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785316|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
19785317|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19785318|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19785319|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19785320|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785321|NCT00292461|Lamotrigine|lamotrigine|mesh-list
19785322|NCT00292461|Zonisamide|zonisamide|mesh-list
19785323|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
19785324|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19785325|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785326|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785327|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19785328|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785329|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19785330|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19785331|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19785332|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19785333|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19785334|NCT00292591|Vitamin D|vitamin d|mesh-list
19785335|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
19785336|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
19785337|NCT00292591|Vitamins|vitamins|mesh-list
19785338|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
19785339|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785340|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19785341|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19785342|NCT00292942|Artesunate|artesunate|mesh-list
19785343|NCT00292942|Mannitol|mannitol|mesh-list
19785344|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
19785345|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19785346|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19785347|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785348|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785349|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
19785350|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
19785351|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19785352|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
19785353|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19785354|NCT00292942|Diuretics|diuretics|mesh-ancestor
19785355|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
19785356|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785357|NCT00292981|Complement C1s|complement c1s|mesh-list
19785358|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19785359|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19785360|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
19785361|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785362|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19785363|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785364|NCT00293020|Fentanyl|fentanyl|mesh-list
19785365|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19785366|NCT00293020|Narcotics|narcotics|mesh-ancestor
19785367|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19785368|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785369|NCT00293020|Analgesics|analgesics|mesh-ancestor
19785370|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
19785371|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320142|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638318|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19638319|NCT02411149|Narcotics|narcotics|mesh-ancestor
19638320|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638321|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638322|NCT02411149|Analgesics|analgesics|mesh-ancestor
19638323|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
20320143|NCT00724074|Bupivacaine|bupivacaine|mesh-list
20320144|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
20320145|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
20320146|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320147|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320148|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
19638324|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638325|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638326|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
19638327|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19638328|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19638329|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
19638330|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638331|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785372|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19785373|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19638332|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19638333|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19638334|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
19638335|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19638336|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
19638337|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
19638338|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
19638339|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19638340|NCT02411526|Risperidone|risperidone|mesh-list
20320149|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320150|NCT00724113|Lidocaine|lidocaine|mesh-list
20320151|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
20320152|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
20320153|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320154|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320155|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
20320156|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320157|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20320158|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20320159|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20320160|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20320161|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320162|NCT00724178|Vitamin D|vitamin d|mesh-list
20320163|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
20320164|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
20320165|NCT00724178|Calcium|calcium|mesh-list
20320166|NCT00724178|Vitamins|vitamins|mesh-ancestor
20320167|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
20320168|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320169|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20320170|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20320171|NCT00724178|Antacids|antacids|mesh-ancestor
20320172|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320173|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638341|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19638342|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
19662893|NCT03593759|Hormones|hormones|mesh-ancestor
19662894|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662895|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662896|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19662897|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662898|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19662899|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
19662900|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19662901|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19662902|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
19662903|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662904|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
19662905|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662906|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19662907|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662908|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
19662909|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662910|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19662911|NCT03564821|Ivosidenib|ivosidenib|mesh-list
19662912|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662913|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662914|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662915|NCT03329378|Paclitaxel|paclitaxel|mesh-list
19662916|NCT03329378|Docetaxel|docetaxel|mesh-list
19662917|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19662918|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
19662919|NCT03329378|Carboplatin|carboplatin|mesh-list
19662920|NCT03329378|Doxorubicin|doxorubicin|mesh-list
19662921|NCT03329378|Trastuzumab|trastuzumab|mesh-list
19662922|NCT03329378|Pertuzumab|pertuzumab|mesh-list
19662923|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19662924|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662925|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
19662926|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
19662927|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
19662928|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662929|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19662930|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
19785374|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
19785375|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
19785376|NCT00293033|Fentanyl|fentanyl|mesh-list
19785377|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19785378|NCT00293033|Narcotics|narcotics|mesh-ancestor
19785379|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19785380|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785381|NCT00293033|Analgesics|analgesics|mesh-ancestor
19785382|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
19785383|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785384|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19785385|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19785386|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
19785387|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
19785388|NCT00293059|Dienogest|dienogest|mesh-list
19785389|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19785390|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19785391|NCT00293059|Estradiol|estradiol|mesh-list
19785392|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19638343|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638344|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638345|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638346|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19638347|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19638348|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638349|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19638350|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19638351|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
19638352|NCT02411630|Tenofovir|tenofovir|mesh-list
19638353|NCT02411630|Emtricitabine|emtricitabine|mesh-list
19638354|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
19638355|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785393|NCT00293059|Estrogens|estrogens|mesh-ancestor
19785394|NCT00293059|Hormones|hormones|mesh-ancestor
19785395|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785396|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785397|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19785398|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
19785399|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19785400|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19785401|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20320174|NCT00724230|Ribavirin|ribavirin|mesh-list
20320175|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20320176|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
20320177|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
20320178|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320179|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
20320180|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320181|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
20320182|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320183|NCT00724256|Ceftibuten|ceftibuten|mesh-list
20320184|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20320185|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320186|NCT00724295|Ribavirin|ribavirin|mesh-list
20320187|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20320188|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
20320189|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320190|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
20320191|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320192|NCT00724321|Iloprost|iloprost|mesh-list
20320193|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20320194|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
20320195|NCT00724360|Trastuzumab|trastuzumab|mesh-list
20320196|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320197|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320198|NCT00724386|Paclitaxel|paclitaxel|mesh-list
20320199|NCT00724386|Vinorelbine|vinorelbine|mesh-list
20320200|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20320201|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320202|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
20320203|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
20320204|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
20320205|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785402|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19638356|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19785403|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20320206|NCT00724529|Infliximab|infliximab|mesh-list
20320207|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
19785404|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785405|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785406|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785407|NCT00293202|Etanercept|etanercept|mesh-list
19785408|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19785409|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785410|NCT00293202|Analgesics|analgesics|mesh-ancestor
19785411|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
19785412|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785413|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785414|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785415|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785416|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785417|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785418|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
19785419|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
19785420|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19785421|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19785422|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
19785423|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785424|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19785425|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19785426|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785427|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785428|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
19785429|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19785430|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20320208|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320209|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320210|NCT00724542|Voglibose|voglibose|mesh-list
20320211|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320212|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320213|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20320214|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785431|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
19785432|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785433|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19785434|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19785435|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785436|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785437|NCT00293293|Taxane|taxane|mesh-list
19785438|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785439|NCT00293384|Dexamethasone|dexamethasone|mesh-list
20320215|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320216|NCT00724581|Amiodarone|amiodarone|mesh-list
20320217|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20320218|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
20320219|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20320220|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785440|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
19785441|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
19785442|NCT00293384|Aprepitant|aprepitant|mesh-list
19785443|NCT00293384|Granisetron|granisetron|mesh-list
19785444|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19785445|NCT00293384|BB 1101|bb 1101|mesh-list
19785446|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785447|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
19785448|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785449|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785450|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19785451|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
19785452|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785453|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785454|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19785455|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785456|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
19785457|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
20320221|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320222|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20320223|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20320224|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19785458|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785459|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785460|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
19785461|NCT00293384|Hormones|hormones|mesh-ancestor
19833762|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19785462|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785463|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785464|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
19638357|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19638358|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638359|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638360|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19638361|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19638362|NCT02411318|Ethanol|ethanol|mesh-list
19638363|NCT02411318|Caffeine|caffeine|mesh-list
19638364|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20152900|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
20152901|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20152902|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20152903|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
19638365|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638366|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19638367|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785465|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785466|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19785467|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785468|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19785469|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
19785470|NCT00293397|Doxorubicin|doxorubicin|mesh-list
19785471|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19785472|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785473|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785474|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19785475|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19785476|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785477|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785478|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
19785479|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19785480|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
19785481|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785482|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785483|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785484|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
19785485|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785486|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
19785487|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19785488|NCT00293423|Protective Agents|protective agents|mesh-ancestor
19785489|NCT00293462|Sargramostim|sargramostim|mesh-list
19785490|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
19785491|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785492|NCT00293540|Tamoxifen|tamoxifen|mesh-list
19785493|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19785494|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785495|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785496|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785497|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785498|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785499|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20320225|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320226|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20320227|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20320228|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20320229|NCT00724620|Ribavirin|ribavirin|mesh-list
20320230|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19785500|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20152904|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152905|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152906|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20320231|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
19785501|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19785502|NCT00293579|Pemetrexed|pemetrexed|mesh-list
19785503|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785504|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785505|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785506|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20152907|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20152908|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
20152909|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785507|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19785508|NCT00293709|Etanercept|etanercept|mesh-list
19785509|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19785510|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785511|NCT00293709|Analgesics|analgesics|mesh-ancestor
19785512|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
19785513|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785514|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785515|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785516|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785517|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785518|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785519|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
19785520|NCT00293722|Etanercept|etanercept|mesh-list
20320232|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320233|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
20320234|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320235|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
20320236|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20320237|NCT00724672|Adalimumab|adalimumab|mesh-list
20320238|NCT00724672|Etanercept|etanercept|mesh-list
19785521|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19785522|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785523|NCT00293722|Analgesics|analgesics|mesh-ancestor
19785524|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
19785525|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785526|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785527|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785528|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785529|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785530|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152910|NCT00094549|Valproic Acid|valproic acid|mesh-list
20152911|NCT00094549|Olanzapine|olanzapine|mesh-list
20152912|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
20152913|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
20152914|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152915|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152916|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152917|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20152918|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20152919|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20152920|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20152921|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20152922|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20152923|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20152924|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152925|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152926|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
20152927|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
20152928|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20152929|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
20320239|NCT00724672|Infliximab|infliximab|mesh-list
20320240|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785531|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
19785532|NCT00293813|Denosumab|denosumab|mesh-list
19785533|NCT00293813|Alendronate|alendronate|mesh-list
19785534|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19785535|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785536|NCT00294398|Fluticasone|fluticasone|mesh-list
19785537|NCT00294398|Xhance|xhance|mesh-list
19785538|NCT00294398|Budesonide|budesonide|mesh-list
19785539|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785540|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19785541|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
19785542|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785543|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785544|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19785545|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
19785546|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
19785547|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19785548|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
19785549|NCT00294398|Hormones|hormones|mesh-ancestor
20320241|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785550|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785551|NCT00294515|Valganciclovir|valganciclovir|mesh-list
19785552|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
20152930|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
20152931|NCT00094614|Atropine|atropine|mesh-list
20152932|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20152933|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20152934|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20152935|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
20152936|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152937|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152938|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20152939|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
20152940|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
20152941|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
20152942|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20152943|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20152944|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
20152945|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152946|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152947|NCT00094627|Gaboxadol|gaboxadol|mesh-list
19785553|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785554|NCT00294554|Memantine|memantine|mesh-list
19785555|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19785556|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19785557|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
19785558|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785559|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785560|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785561|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19785562|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19785563|NCT00294632|Rituximab|rituximab|mesh-list
19785564|NCT00294632|Lenalidomide|lenalidomide|mesh-list
19785565|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19785566|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785567|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
19785568|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785569|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785570|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19785571|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19785572|NCT00294632|Growth Substances|growth substances|mesh-ancestor
19785573|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
19785574|NCT00294658|Prednisone|prednisone|mesh-list
19785575|NCT00294658|Prednisolone|prednisolone|mesh-list
19785576|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785577|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
19785578|NCT00294658|Hormones|hormones|mesh-ancestor
19785579|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785580|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785581|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785582|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785583|NCT00294671|Diflunisal|diflunisal|mesh-list
19785584|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19785585|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785586|NCT00294671|Analgesics|analgesics|mesh-ancestor
19785587|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
19785588|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785589|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785590|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785591|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785592|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19785593|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785594|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785595|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
19785596|NCT00294684|Prednisolone|prednisolone|mesh-list
19785597|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785598|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
19785599|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
19785600|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785601|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785602|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785603|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
19785604|NCT00294684|Hormones|hormones|mesh-ancestor
19785605|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785606|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20152948|NCT00094627|Analgesics|analgesics|mesh-ancestor
20152949|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
20152950|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152951|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638368|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638369|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19785607|NCT00294684|Protective Agents|protective agents|mesh-ancestor
19785608|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785609|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785610|NCT00294723|Liraglutide|liraglutide|mesh-list
19785611|NCT00294723|Glimepiride|glimepiride|mesh-list
19785612|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19785613|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785614|NCT00294723|Incretins|incretins|mesh-ancestor
19785615|NCT00294723|Hormones|hormones|mesh-ancestor
19785616|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785617|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19785618|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785619|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
19785620|NCT00294762|Paclitaxel|paclitaxel|mesh-list
19785621|NCT00294762|Carboplatin|carboplatin|mesh-list
19785622|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19785623|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19638370|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19638371|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
19638372|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638373|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19638374|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785624|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785625|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
19785626|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
19785627|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
19785628|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785629|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19785630|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785631|NCT00295022|Montelukast|montelukast|mesh-list
19785632|NCT00295022|Levocetirizine|levocetirizine|mesh-list
19785633|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19785634|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
19785635|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19785636|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785637|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785638|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785639|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19785640|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19785641|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785642|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19785643|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19785644|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
19785645|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
19785646|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785647|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
19785648|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19785649|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
19785650|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785651|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152952|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
20152953|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
20152954|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
19785652|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20152955|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152956|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152957|NCT00094640|Olanzapine|olanzapine|mesh-list
20152958|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
20152959|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
20152960|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785653|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19785654|NCT00295503|Bevacizumab|bevacizumab|mesh-list
19785655|NCT00295503|Pemetrexed|pemetrexed|mesh-list
19785656|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19785657|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785658|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19785659|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19785660|NCT00295503|Growth Substances|growth substances|mesh-ancestor
19785661|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785662|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
19785663|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785664|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785665|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19785666|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19785667|NCT00295620|Anastrozole|anastrozole|mesh-list
19785668|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785669|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785670|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19785671|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19785672|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785673|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785674|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20320242|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
20320243|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785675|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785676|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785677|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785678|NCT00295633|Metformin|metformin|mesh-list
19785679|NCT00295633|Pioglitazone|pioglitazone|mesh-list
19785680|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
19785681|NCT00295633|Saxagliptin|saxagliptin|mesh-list
19785682|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320244|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638375|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638376|NCT02411175|Ethanol|ethanol|mesh-list
19638377|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19638378|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638379|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638380|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638381|NCT02411331|Ethanol|ethanol|mesh-list
19638382|NCT02411331|Enoxaparin|enoxaparin|mesh-list
19638383|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
19638384|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19638385|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19638386|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638387|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19638388|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638389|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638390|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638391|NCT02411344|Pertuzumab|pertuzumab|mesh-list
19638392|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19638393|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662931|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662932|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19662933|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19662934|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
19662935|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19662936|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19662937|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19662938|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19662939|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662940|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19662941|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19662942|NCT03270059|Hematinics|hematinics|mesh-ancestor
19662943|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19662944|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19662945|NCT03268083|Vaccines|vaccines|mesh-list
19662946|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
19662947|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662948|NCT03170817|Regadenoson|regadenoson|mesh-list
19662949|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19662950|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20320245|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785683|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785684|NCT00295633|Incretins|incretins|mesh-ancestor
19785685|NCT00295633|Hormones|hormones|mesh-ancestor
19785686|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785687|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19785688|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
19785689|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785690|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785691|NCT00295750|Leuprolide|leuprolide|mesh-list
19785692|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19785693|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
19785694|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19785695|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785696|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785697|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785698|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
19785699|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19785700|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785701|NCT00295932|Prednisone|prednisone|mesh-list
19785702|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
19785703|NCT00295932|Rituximab|rituximab|mesh-list
19785704|NCT00295932|Bortezomib|bortezomib|mesh-list
19785705|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785706|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
19785707|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785708|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785709|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19785710|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
19785711|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785712|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785713|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19785714|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19785715|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785716|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
19785717|NCT00295932|Hormones|hormones|mesh-ancestor
19785718|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785719|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785720|NCT00296036|Pyridoxine|pyridoxine|mesh-list
19785721|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
19785722|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
20320246|NCT00724672|Analgesics|analgesics|mesh-ancestor
20320247|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
20320248|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320249|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320250|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20320251|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
20320252|NCT00724685|Ropivacaine|ropivacaine|mesh-list
20320253|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638394|NCT02410863|Trametinib|trametinib|mesh-list
19638395|NCT02410863|Dabrafenib|dabrafenib|mesh-list
19638396|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638397|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19638398|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638399|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638400|NCT02410980|Tretinoin|tretinoin|mesh-list
19638401|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638402|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
19638403|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
19638404|NCT02410759|Carbetocin|carbetocin|mesh-list
19638405|NCT02410759|Ergonovine|ergonovine|mesh-list
19638406|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
19638407|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638408|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638409|NCT02410694|Thalidomide|thalidomide|mesh-list
19638410|NCT02410694|Dexamethasone|dexamethasone|mesh-list
19638411|NCT02410694|Ixazomib|ixazomib|mesh-list
19638412|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638413|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
19638414|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
19638415|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638416|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638417|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638418|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
19638419|NCT02410694|Hormones|hormones|mesh-ancestor
19638420|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638421|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20320254|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
20320255|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320256|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320257|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
20320258|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320259|NCT00724724|Aspirin|aspirin|mesh-list
20320260|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
20320261|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20320262|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785723|NCT00296036|Vitamins|vitamins|mesh-ancestor
19785724|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
19785725|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785726|NCT00296192|Rotigotine|rotigotine|mesh-list
19785727|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
19785728|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
19785729|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785730|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785731|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785732|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
19785733|NCT00296244|Prednisone|prednisone|mesh-list
19785734|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
19785735|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19785736|NCT00296244|Tacrolimus|tacrolimus|mesh-list
19785737|NCT00296244|Basiliximab|basiliximab|mesh-list
19785738|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785739|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
19785740|NCT00296244|Hormones|hormones|mesh-ancestor
19785741|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785742|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785743|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19785744|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785745|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785746|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
19785747|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19785748|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320263|NCT00724724|Analgesics|analgesics|mesh-ancestor
20320264|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
20320265|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320266|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320267|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320268|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320269|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20320270|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20320271|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320272|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20320273|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20320274|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320275|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
20320276|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20320277|NCT00724724|Protective Agents|protective agents|mesh-ancestor
20320278|NCT00724802|Triacetin|triacetin|mesh-list
20320279|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
20320280|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320281|NCT00724880|Clopidogrel|clopidogrel|mesh-list
20320282|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20320283|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19785749|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785750|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
19785751|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
19785752|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785753|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19785754|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19785755|NCT00296244|Protective Agents|protective agents|mesh-ancestor
19785756|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785757|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19785758|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
19785759|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19785760|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785761|NCT00296296|Cyclosporine|cyclosporine|mesh-list
19785762|NCT00296296|Tacrolimus|tacrolimus|mesh-list
19785763|NCT00296296|Cyclosporins|cyclosporins|mesh-list
19785764|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785765|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
19785766|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785767|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20320284|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19785768|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785769|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785770|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
19785771|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785772|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
19785773|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785774|NCT00296322|Mitomycins|mitomycins|mesh-list
19785775|NCT00296322|Mitomycin|mitomycin|mesh-list
19785776|NCT00296322|Doxifluridine|doxifluridine|mesh-list
19785777|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785778|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785779|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
19785780|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785781|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19785782|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785783|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19785784|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
19785785|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785786|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
19785787|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785788|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
19785789|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19785790|NCT00296335|Mitomycins|mitomycins|mesh-list
20320285|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20320286|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
20320287|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320288|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320289|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347475|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347476|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
19785791|NCT00296335|Mitomycin|mitomycin|mesh-list
19785792|NCT00296335|Doxifluridine|doxifluridine|mesh-list
19785793|NCT00296335|Floxuridine|floxuridine|mesh-list
19785794|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785795|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19785796|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
19785797|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785798|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19785799|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785800|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19785801|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
20347477|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20347478|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347479|NCT00860899|Clonidine|clonidine|mesh-list
20347480|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
20347481|NCT00860899|Analgesics|analgesics|mesh-ancestor
20347482|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
19638422|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638423|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19638424|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
19638425|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
19638426|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19638427|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638428|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19638429|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19638430|NCT02410694|Growth Substances|growth substances|mesh-ancestor
19638431|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
19638432|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
19638433|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638434|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638435|NCT02410746|Ibuprofen|ibuprofen|mesh-list
19785802|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785803|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
19785804|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347483|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638436|NCT02410746|Morphine|morphine|mesh-list
20320290|NCT00725036|Insulin|insulin|mesh-list
20320291|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20320292|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
20320293|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
20320294|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
20320295|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
20320296|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320297|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320298|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
20320299|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
20320300|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
20320301|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320302|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320303|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
20320304|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320305|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20320306|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20320307|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320308|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
20320309|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
20320310|NCT00725218|Analgesics|analgesics|mesh-ancestor
20320311|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
20320312|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320313|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320314|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20320315|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20320316|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320317|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320318|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20320319|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638437|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
19638438|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19785805|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
19785806|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19785807|NCT00296374|Atorvastatin|atorvastatin|mesh-list
19785808|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19785809|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19785810|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19785811|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
19785812|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785813|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19785814|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19785815|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785816|NCT00296400|Atorvastatin|atorvastatin|mesh-list
19785817|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19785818|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20320320|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320321|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
20320322|NCT00725231|Doxorubicin|doxorubicin|mesh-list
20320323|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20320324|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320325|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320326|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20320327|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19638439|NCT02410746|Narcotics|narcotics|mesh-ancestor
19638440|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19785819|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19785820|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
19785821|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638441|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638442|NCT02410746|Analgesics|analgesics|mesh-ancestor
19638443|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
19638444|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638445|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638446|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638447|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638448|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638449|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19638450|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638451|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785822|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20320328|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20320329|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785823|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19785824|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785825|NCT00296491|Fluticasone|fluticasone|mesh-list
19785826|NCT00296491|Xhance|xhance|mesh-list
19785827|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19785828|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19785829|NCT00296491|Montelukast|montelukast|mesh-list
19785830|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785831|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19785832|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
19785833|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785834|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785835|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19785836|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
19785837|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
19785838|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19785839|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19785840|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20320330|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638452|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638453|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
19638454|NCT02410590|Atropine|atropine|mesh-list
19638455|NCT02410590|Rocuronium|rocuronium|mesh-list
19638456|NCT02410590|Cisatracurium|cisatracurium|mesh-list
19638457|NCT02410590|Succinylcholine|succinylcholine|mesh-list
19638458|NCT02410590|Neostigmine|neostigmine|mesh-list
19785841|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19785842|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
19785843|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785844|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638459|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19638460|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19638461|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19638462|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638463|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638464|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19638465|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19638466|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19638467|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
19638468|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19638469|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
19638470|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
19638471|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
19638472|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19638473|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19638474|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
20320331|NCT00725348|R 115866|r 115866|mesh-list
20320332|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20320333|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638475|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638476|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638477|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19785845|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19785846|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
19785847|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19785848|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19785849|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19785850|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
19785851|NCT00296491|Hormones|hormones|mesh-ancestor
20320334|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638478|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785852|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
20152961|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152962|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20152963|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20152964|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20152965|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20152966|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20152967|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20152968|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20152969|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174002|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19785853|NCT00296504|Ritonavir|ritonavir|mesh-list
19785854|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
19785855|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19785856|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19785857|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
19638479|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19638480|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19638481|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
19638482|NCT02410720|Cathartics|cathartics|mesh-ancestor
19638483|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638484|NCT02410655|Oxytocin|oxytocin|mesh-list
19638485|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
19638486|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638487|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638488|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19638489|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
19638490|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638491|NCT02410460|Lidocaine|lidocaine|mesh-list
19638492|NCT02410460|Clonidine|clonidine|mesh-list
19785858|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785859|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785860|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19785861|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19785862|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
19785863|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19785864|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19785865|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19785866|NCT00296517|Bupropion|bupropion|mesh-list
19785867|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19785868|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
19785869|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19785870|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19785871|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19785872|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785873|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785874|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
19785875|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785876|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785877|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19785878|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19785879|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785880|NCT00296647|Bupropion|bupropion|mesh-list
19785881|NCT00296647|Nicotine|nicotine|mesh-list
19785882|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19785883|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
19785884|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785885|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785886|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19785887|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19785888|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
19785889|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785890|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785891|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19638493|NCT02410460|Midazolam|midazolam|mesh-list
19638494|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
19638495|NCT02410460|Scopolamine|scopolamine|mesh-list
19638496|NCT02410460|Ketamine|ketamine|mesh-list
19638497|NCT02410460|Ondansetron|ondansetron|mesh-list
20152970|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785892|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
19785893|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19785894|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19785895|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19785896|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785897|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
20152971|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152972|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
20152973|NCT00094666|Gaboxadol|gaboxadol|mesh-list
19638498|NCT02410460|Metoclopramide|metoclopramide|mesh-list
19638499|NCT02410460|Bupivacaine|bupivacaine|mesh-list
20152974|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152975|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152976|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152977|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638500|NCT02410460|Propofol|propofol|mesh-list
19638501|NCT02410460|Sevoflurane|sevoflurane|mesh-list
19638502|NCT02410460|Desflurane|desflurane|mesh-list
19638503|NCT02410460|Famotidine|famotidine|mesh-list
19785898|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19785899|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19785900|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785901|NCT00296725|Fluoxetine|fluoxetine|mesh-list
19785902|NCT00296725|Imipramine|imipramine|mesh-list
19785903|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19785904|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19785905|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785906|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785907|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785908|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
19785909|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785910|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19785911|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
19785912|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19785913|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19785914|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19785915|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785916|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19785917|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19785918|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
19785919|NCT00296816|Bevacizumab|bevacizumab|mesh-list
19785920|NCT00296816|Docetaxel|docetaxel|mesh-list
19785921|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
19785922|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19785923|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785924|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19785925|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19785926|NCT00296816|Growth Substances|growth substances|mesh-ancestor
19785927|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785928|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
19785929|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
19785930|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
19785931|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
19785932|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785933|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
19785934|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19785935|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19785936|NCT00297037|Analgesics|analgesics|mesh-ancestor
19785937|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
19785938|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785939|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785940|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19785941|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785942|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
20152978|NCT00094666|Analgesics|analgesics|mesh-ancestor
20152979|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
20152980|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
20152981|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
20152982|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
20152983|NCT00094692|Atropine|atropine|mesh-list
20152984|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20152985|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20152986|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20152987|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
20152988|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20152989|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20152990|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20152991|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
20152992|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
19638504|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19638505|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638506|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
19638507|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638508|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638509|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
19638510|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638511|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19638512|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19638513|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19638514|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19785943|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20152993|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
20152994|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19785944|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
19785945|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19785946|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19785947|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833763|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19833764|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19833765|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19833766|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19833767|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19833768|NCT00589914|Risperidone|risperidone|mesh-list
19833769|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19833770|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19833771|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833772|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833773|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19833774|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19833775|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19638515|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638516|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19638517|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19638518|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
19638519|NCT02410460|Analgesics|analgesics|mesh-ancestor
19638520|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19638521|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19638522|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19638523|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833776|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
19833777|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833778|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833779|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19833780|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19833781|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
19833782|NCT00589979|Lidocaine|lidocaine|mesh-list
19833783|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
20152995|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20152996|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
20152997|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20152998|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20152999|NCT00094848|Mapatumumab|mapatumumab|mesh-list
20153000|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153001|NCT00094926|Risperidone|risperidone|mesh-list
20153002|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153003|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
19833784|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
19833785|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833786|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833787|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
19833788|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833789|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19638524|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19638525|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19638526|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19638527|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19833790|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19833791|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19833792|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19833793|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833794|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
19833795|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833796|NCT00590031|Irinotecan|irinotecan|mesh-list
19833797|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833798|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19833799|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19833800|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833801|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833802|NCT00590044|Insulin|insulin|mesh-list
19833803|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19833804|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
19833805|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
19833806|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19833807|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833808|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
20153004|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153005|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638528|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
19638529|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
19638530|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20153006|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153007|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153008|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153009|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153010|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19638531|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19638532|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
19638533|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
19638534|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638535|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
19638536|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19638537|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19638538|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
19638539|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19638540|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19638541|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
19785948|NCT00297232|Natalizumab|natalizumab|mesh-list
19785949|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
19785950|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785951|NCT00297479|Nicotine|nicotine|mesh-list
19785952|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19785953|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
19785954|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785955|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785956|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19785957|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19785958|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
19785959|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785960|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785961|NCT00297492|Nicotine|nicotine|mesh-list
19785962|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19785963|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
19785964|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19785965|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785966|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19785967|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19785968|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
19785969|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785970|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785971|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
19785972|NCT00297596|Trastuzumab|trastuzumab|mesh-list
19785973|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19785974|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19785975|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
19785976|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19785977|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
19785978|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785979|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19785980|NCT00297778|Pramipexole|pramipexole|mesh-list
19785981|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
19785982|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19785983|NCT00297778|Protective Agents|protective agents|mesh-ancestor
19785984|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785985|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19785986|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19785987|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
19785988|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
19785989|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19785990|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
19785991|NCT00297830|Alendronate|alendronate|mesh-list
19785992|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19785993|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19785994|NCT00297882|Artesunate|artesunate|mesh-list
19785995|NCT00297882|Lumefantrine|lumefantrine|mesh-list
19785996|NCT00297882|Artemether|artemether|mesh-list
19785997|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19785998|NCT00297882|Amodiaquine|amodiaquine|mesh-list
19785999|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
19786000|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20153011|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20320335|NCT00725400|Cetuximab|cetuximab|mesh-list
19638542|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19638543|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19786001|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20153012|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
19786002|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786003|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786004|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
19786005|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
19786006|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19786007|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
19786008|NCT00298038|Rifaximin|rifaximin|mesh-list
19786009|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19786010|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786011|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786012|NCT00298155|Ketoconazole|ketoconazole|mesh-list
20153013|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
20153014|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153015|NCT00094978|Alvocidib|alvocidib|mesh-list
20153016|NCT00094978|Romidepsin|romidepsin|mesh-list
20153017|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153018|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
20153019|NCT00094978|Growth Substances|growth substances|mesh-ancestor
20153020|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786013|NCT00298155|Goserelin|goserelin|mesh-list
19786014|NCT00298155|Bicalutamide|bicalutamide|mesh-list
19786015|NCT00298155|Dutasteride|dutasteride|mesh-list
19786016|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19786017|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786018|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
19786019|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786020|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19786021|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19786022|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786023|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786024|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19786025|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
19786026|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786027|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786028|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19786029|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
19786030|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19786031|NCT00298233|Oseltamivir|oseltamivir|mesh-list
19786032|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
19786033|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786034|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786035|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786036|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
19786037|NCT00298272|Adalimumab|adalimumab|mesh-list
19786038|NCT00298272|Etanercept|etanercept|mesh-list
19786039|NCT00298272|Rituximab|rituximab|mesh-list
19786040|NCT00298272|Methotrexate|methotrexate|mesh-list
19786041|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786042|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786043|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
19786044|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786045|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786046|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19786047|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
19786048|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19786049|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786050|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
19786051|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786052|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786053|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786054|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19786055|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786056|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19786057|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786058|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
19786059|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
19786060|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786061|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786062|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
19786063|NCT00298272|Hormones|hormones|mesh-ancestor
19786064|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786065|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19786066|NCT00298272|Protective Agents|protective agents|mesh-ancestor
19786067|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20153021|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153022|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153023|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786068|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19786069|NCT00298272|Analgesics|analgesics|mesh-ancestor
19786070|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
19786071|NCT00298363|Tenofovir|tenofovir|mesh-list
19786072|NCT00298363|Emtricitabine|emtricitabine|mesh-list
19786073|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19786074|NCT00298363|Entecavir|entecavir|mesh-list
19786075|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
19786076|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786077|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19786078|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19786079|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786080|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786081|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19786082|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19786083|NCT00298610|Artesunate|artesunate|mesh-list
19786084|NCT00298610|Atovaquone|atovaquone|mesh-list
19786085|NCT00298610|Proguanil|proguanil|mesh-list
19786086|NCT00298610|Quinidine|quinidine|mesh-list
19786087|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19786088|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
19786089|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19786090|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19786091|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786092|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786093|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
19786094|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
19786095|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19786096|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
19786097|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786098|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786099|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
19786100|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19786101|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19786102|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
19786103|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786104|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786105|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19786106|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19786107|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19786108|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
19786109|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19786110|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19786111|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786112|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19786113|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19786114|NCT00298766|Bortezomib|bortezomib|mesh-list
19786115|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786116|NCT00298831|Rocuronium|rocuronium|mesh-list
19786117|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20153024|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153025|NCT00095043|Gaboxadol|gaboxadol|mesh-list
19786118|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19786119|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20153026|NCT00095043|Analgesics|analgesics|mesh-ancestor
20153027|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
20153028|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153029|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153030|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
20153031|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
20153032|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
19786120|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786121|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153033|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786122|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
19786123|NCT00299104|Rituximab|rituximab|mesh-list
19786124|NCT00299104|Methotrexate|methotrexate|mesh-list
19786125|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786126|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786127|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
19786128|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786129|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786130|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19786131|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
19786132|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19786133|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786134|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
19786135|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786136|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786137|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786138|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19786139|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786140|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19786141|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786142|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
19786143|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
19786144|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786145|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786146|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
19786147|NCT00299104|Hormones|hormones|mesh-ancestor
20320336|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320337|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320338|NCT00725439|R 115866|r 115866|mesh-list
20320339|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20320340|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320341|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320342|NCT00725478|Piribedil|piribedil|mesh-list
20320343|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20320344|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20320345|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
20320346|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
20320347|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320348|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320349|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320350|NCT00725517|Icodextrin|icodextrin|mesh-list
19638544|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19638545|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
19638546|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19786148|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786149|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19786150|NCT00299104|Protective Agents|protective agents|mesh-ancestor
19786151|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
19786152|NCT00299130|Rituximab|rituximab|mesh-list
19786153|NCT00299130|Methotrexate|methotrexate|mesh-list
19786154|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786155|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786156|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
19786157|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786158|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786159|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19638547|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19638548|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
20320351|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
19786160|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
19786161|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19786162|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786163|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
19786164|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786165|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786166|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638549|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19638550|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19638551|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
19638552|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19638553|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19638554|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
19638555|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
19638556|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
19638557|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
19786167|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19786168|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786169|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19786170|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786171|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
19786172|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
19786173|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786174|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786175|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
19786176|NCT00299130|Hormones|hormones|mesh-ancestor
19786177|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786178|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19786179|NCT00299130|Protective Agents|protective agents|mesh-ancestor
19786180|NCT00299156|Clofarabine|clofarabine|mesh-list
19786181|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786182|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
19786183|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786184|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786185|NCT00299182|Cytarabine|cytarabine|mesh-list
19786186|NCT00299182|Dexamethasone|dexamethasone|mesh-list
19786187|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
19786188|NCT00299182|Rituximab|rituximab|mesh-list
19786189|NCT00299182|Doxorubicin|doxorubicin|mesh-list
19786190|NCT00299182|Methotrexate|methotrexate|mesh-list
19786191|NCT00299182|Vincristine|vincristine|mesh-list
19786192|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786193|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
19786194|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786195|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786196|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786197|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
19786198|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786199|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786200|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19786201|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786202|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786203|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
19786204|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
19786205|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786206|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786207|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
19786208|NCT00299182|Hormones|hormones|mesh-ancestor
19786209|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786210|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19786211|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786212|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19786213|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20153034|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153035|NCT00095069|Gaboxadol|gaboxadol|mesh-list
20153036|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153037|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153038|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153039|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153040|NCT00095069|Analgesics|analgesics|mesh-ancestor
19786214|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786215|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19786216|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
19786217|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19786218|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786219|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
19786220|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786221|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19786222|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19786223|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
19786224|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786225|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19786226|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
19786227|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
19786228|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
19786229|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
19786230|NCT00299221|Tacrolimus|tacrolimus|mesh-list
19786231|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786232|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
19786233|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786234|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19786235|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786236|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786237|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786238|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786239|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19786240|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
19638558|NCT02410226|Anesthetics|anesthetics|mesh-list
19638559|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638560|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638561|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
19638562|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19638563|NCT02410031|Cyproterone|cyproterone|mesh-list
19638564|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
19638565|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19638566|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19638567|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19638568|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
19638569|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638570|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638571|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19786241|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19786242|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786243|NCT00299494|Rituximab|rituximab|mesh-list
19786244|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19786245|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786246|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786247|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
19786248|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320352|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20320353|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20320354|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20320355|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320356|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20320357|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320358|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320359|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
20320360|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320361|NCT00725777|Lumefantrine|lumefantrine|mesh-list
20320362|NCT00725777|Artemether|artemether|mesh-list
20320363|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19786249|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786250|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786251|NCT00299546|Golimumab|golimumab|mesh-list
19786252|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19786253|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19786254|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786255|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153041|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
20153042|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
19638572|NCT02410031|Estrogens|estrogens|mesh-ancestor
19638573|NCT02410031|Hormones|hormones|mesh-ancestor
20153043|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
20153044|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
20174003|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20174004|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174005|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174006|NCT00163254|Abciximab|abciximab|mesh-list
20320364|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
20320365|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20320366|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20320367|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638574|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638575|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
19638576|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
19638577|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638578|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19638579|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
19638580|NCT02410096|Miotics|miotics|mesh-ancestor
19638581|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
19638582|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638583|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320368|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19638584|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19638585|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19638586|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
19786256|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
19786257|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786258|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
19786259|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786260|NCT00299702|Aripiprazole|aripiprazole|mesh-list
19786261|NCT00299702|Risperidone|risperidone|mesh-list
19786262|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
19786263|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19638587|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19638588|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19638589|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
19638590|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638591|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638592|NCT02410317|Morphine|morphine|mesh-list
19638593|NCT02410317|Ropivacaine|ropivacaine|mesh-list
19638594|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19786264|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19786265|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19786266|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19786267|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786268|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
19786269|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
19786270|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786271|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786272|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19786273|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19786274|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
19786275|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19786276|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19786277|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19786278|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19786279|NCT00299741|Sunitinib|sunitinib|mesh-list
19786280|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786281|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19786282|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19786283|NCT00299741|Growth Substances|growth substances|mesh-ancestor
19786284|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786285|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
19786286|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19786287|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786288|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786289|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
19786290|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19786291|NCT00299988|Antibodies|antibodies|mesh-list
19786292|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
19786293|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19786294|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
19786295|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786296|NCT00300053|Lenograstim|lenograstim|mesh-list
19786297|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19786298|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
19786299|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786300|NCT00300274|Cyclosporine|cyclosporine|mesh-list
19786301|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
19786302|NCT00300274|Everolimus|everolimus|mesh-list
19786303|NCT00300274|Cyclosporins|cyclosporins|mesh-list
19786304|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153045|NCT00095082|Insulin|insulin|mesh-list
20153046|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20153047|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
20153048|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
20153049|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
20153050|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153051|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153052|NCT00095134|Risperidone|risperidone|mesh-list
20153053|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153054|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
20153055|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153056|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786305|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153057|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786306|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153058|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19786307|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
19786308|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786309|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
19786310|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786311|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786312|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786313|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19786314|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786315|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786316|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19786317|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
19786318|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19786319|NCT00300365|Aspirin|aspirin|mesh-list
19786320|NCT00300365|Niacin|niacin|mesh-list
19786321|NCT00300365|Pioglitazone|pioglitazone|mesh-list
19786322|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19786323|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19786324|NCT00300365|Analgesics|analgesics|mesh-ancestor
19786325|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
19786326|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786327|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786328|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786329|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638595|NCT02410317|Narcotics|narcotics|mesh-ancestor
19638596|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638597|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638598|NCT02410317|Analgesics|analgesics|mesh-ancestor
19786330|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19786331|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19786332|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786333|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19786334|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19786335|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786336|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
19786337|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19786338|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19786339|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
19786340|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19786341|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
19786342|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
19786343|NCT00300365|Vitamins|vitamins|mesh-ancestor
19786344|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
19786345|NCT00300391|Haloperidol|haloperidol|mesh-list
19786346|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
19786347|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
19786348|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
19786349|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786350|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786351|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320369|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
20320370|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20320371|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19786352|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19786353|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19786354|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19786355|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19786356|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19786357|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
19786358|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786359|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786360|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19786361|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
19786362|NCT00300430|Atorvastatin|atorvastatin|mesh-list
19786363|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19786364|NCT00300430|Simvastatin|simvastatin|mesh-list
19786365|NCT00300430|Fenofibrate|fenofibrate|mesh-list
19786366|NCT00300430|Calcium|calcium|mesh-list
19786367|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19786368|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638599|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
19638600|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638601|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638602|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
19638603|NCT02410083|Aspirin|aspirin|mesh-list
19638604|NCT02410083|Clopidogrel|clopidogrel|mesh-list
19638605|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638606|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19786369|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19786370|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19786371|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19786372|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
19786373|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786374|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19786375|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19786376|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786377|NCT00300456|Simvastatin|simvastatin|mesh-list
19638607|NCT02410083|Analgesics|analgesics|mesh-ancestor
19638608|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
19638609|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638610|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638611|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638612|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638613|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20320372|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320373|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320374|NCT00725790|Urological Agents|urological agents|mesh-ancestor
20320375|NCT00725829|Simvastatin|simvastatin|mesh-list
20320376|NCT00725829|Ezetimibe|ezetimibe|mesh-list
20320377|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20320378|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20320379|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
20320380|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320381|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20320382|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20320383|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320384|NCT00725946|Iodine|iodine|mesh-list
20320385|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
20320386|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20320387|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320388|NCT00725946|Trace Elements|trace elements|mesh-ancestor
20320389|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
20320390|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320391|NCT00725985|Cladribine|cladribine|mesh-list
20320392|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320393|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786378|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19786379|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19786380|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
19786381|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786382|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19786383|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19786384|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786385|NCT00300469|Atorvastatin|atorvastatin|mesh-list
19786386|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19786387|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19786388|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
19786389|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786390|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19786391|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19786392|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786393|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19786394|NCT00300482|Calcium|calcium|mesh-list
20320394|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
20320395|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320396|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
20320397|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
20320398|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
20320399|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320400|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638614|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19638615|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786395|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19786396|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786397|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19786398|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19786399|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
19786400|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786401|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19786402|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19786403|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786404|NCT00300495|Amiodarone|amiodarone|mesh-list
19786405|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19786406|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
19786407|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19786408|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786409|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786410|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19786411|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19786412|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19786413|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786414|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19786415|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19786416|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19786417|NCT00300677|Voriconazole|voriconazole|mesh-list
19786418|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
19786419|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786420|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19786421|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19786422|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786423|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786424|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19786425|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
19786426|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786427|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786428|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20320401|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
20320402|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320403|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20320404|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20320405|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320406|NCT00726258|Ketamine|ketamine|mesh-list
20320407|NCT00726258|Analgesics|analgesics|mesh-ancestor
20320408|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
20320409|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320410|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320411|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20320412|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19786429|NCT00300742|Topiramate|topiramate|mesh-list
19786430|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
19786431|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19786432|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320413|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
20320414|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
20320415|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320416|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20320417|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20320418|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347484|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786433|NCT00300755|Pantoprazole|pantoprazole|mesh-list
20153059|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153060|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153061|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153062|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153063|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
20153064|NCT00095186|Lactoferrin|lactoferrin|mesh-list
20153065|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153066|NCT00095225|Bevacizumab|bevacizumab|mesh-list
20153067|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20153068|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20153069|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153070|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153071|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20153072|NCT00095225|Growth Substances|growth substances|mesh-ancestor
20153073|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153074|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
20320419|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320420|NCT00726466|Ranibizumab|ranibizumab|mesh-list
20320421|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20320422|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20320423|NCT00726466|Growth Substances|growth substances|mesh-ancestor
20320424|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320425|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
20320426|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786434|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19786435|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786436|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19786437|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786438|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786439|NCT00300885|Paclitaxel|paclitaxel|mesh-list
19786440|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19786441|NCT00300885|Carboplatin|carboplatin|mesh-list
19786442|NCT00300885|Sorafenib|sorafenib|mesh-list
19786443|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19786444|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786445|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
19786446|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
19786447|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
19786448|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786449|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19786450|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786451|NCT00301028|Paclitaxel|paclitaxel|mesh-list
19786452|NCT00301028|Carboplatin|carboplatin|mesh-list
19786453|NCT00301028|Cetuximab|cetuximab|mesh-list
19786454|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19786455|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786456|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
19786457|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
19786458|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
19786459|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786460|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786461|NCT00301067|Calcitriol|calcitriol|mesh-list
19786462|NCT00301067|Temozolomide|temozolomide|mesh-list
19786463|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786464|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
19786465|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786466|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786467|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19786468|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786469|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19786470|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786471|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19786472|NCT00301067|Vitamins|vitamins|mesh-ancestor
19786473|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
19786474|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19786475|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
19786476|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19786477|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153075|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153076|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153077|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153078|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
20153079|NCT00095251|Lorazepam|lorazepam|mesh-list
20153080|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20153081|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153082|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153083|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20153084|NCT00095251|Analgesics|analgesics|mesh-ancestor
20153085|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
20153086|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153087|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20153088|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20153089|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20153090|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
19786478|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153091|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786479|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19786480|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19786481|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19786482|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786483|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19786484|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786485|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786486|NCT00301756|Belinostat|belinostat|mesh-list
19786487|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786488|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19786489|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786490|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786491|NCT00301808|Docetaxel|docetaxel|mesh-list
19786492|NCT00301808|Pemetrexed|pemetrexed|mesh-list
19786493|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786494|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
19786495|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
19786496|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
19786497|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786498|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786499|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19786500|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19786501|NCT00301821|Prednisone|prednisone|mesh-list
19786502|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
19786503|NCT00301821|Rituximab|rituximab|mesh-list
19786504|NCT00301821|Doxorubicin|doxorubicin|mesh-list
19786505|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19786506|NCT00301821|Vincristine|vincristine|mesh-list
19786507|NCT00301821|Epratuzumab|epratuzumab|mesh-list
19786508|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786509|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
19786510|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320427|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
20320428|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20320429|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320430|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320431|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320432|NCT00726570|Heparin|heparin|mesh-list
20320433|NCT00726570|Calcium heparin|calcium heparin|mesh-list
20320434|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20320435|NCT00726570|Tinzaparin|tinzaparin|mesh-list
20320436|NCT00726570|Dalteparin|dalteparin|mesh-list
20320437|NCT00726570|Anticoagulants|anticoagulants|mesh-list
20320438|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19786511|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786512|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786513|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
19786514|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786515|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786516|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19786517|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786518|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786519|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19786520|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19786521|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786522|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786523|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
19786524|NCT00301821|Hormones|hormones|mesh-ancestor
20320439|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20320440|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320441|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
19638616|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19786525|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786526|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19786527|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19786528|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
19786529|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
20320442|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
20320443|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19638617|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19638618|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638619|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
19638620|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19638621|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19638622|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19786530|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
19786531|NCT00301834|Cyclosporine|cyclosporine|mesh-list
19786532|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
19786533|NCT00301834|Methotrexate|methotrexate|mesh-list
19786534|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
19786535|NCT00301834|Fludarabine|fludarabine|mesh-list
19786536|NCT00301834|Busulfan|busulfan|mesh-list
19786537|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
19786538|NCT00301834|Cyclosporins|cyclosporins|mesh-list
19786539|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19786540|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
19786541|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19786542|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786543|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786544|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
19786545|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786546|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786547|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786548|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786549|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19786550|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786551|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
19786552|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786553|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19786554|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
19786555|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786556|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19786557|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786558|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
19786559|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
19786560|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786561|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786562|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
19786563|NCT00301834|Hormones|hormones|mesh-ancestor
19786564|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786565|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19786566|NCT00301834|Protective Agents|protective agents|mesh-ancestor
19786567|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
19786568|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786569|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19786570|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320444|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20320445|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786571|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
19786572|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19786573|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786574|NCT00301964|Bevacizumab|bevacizumab|mesh-list
19786575|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19786576|NCT00301964|Antibodies|antibodies|mesh-list
19786577|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
19786578|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19786579|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786580|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19786581|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19786582|NCT00301964|Growth Substances|growth substances|mesh-ancestor
19786583|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786584|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
19786585|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
19786586|NCT00302003|Cytarabine|cytarabine|mesh-list
19786587|NCT00302003|Dexamethasone|dexamethasone|mesh-list
19786588|NCT00302003|Prednisone|prednisone|mesh-list
19786589|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
19786590|NCT00302003|Ifosfamide|ifosfamide|mesh-list
19786591|NCT00302003|Doxorubicin|doxorubicin|mesh-list
19786592|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19786593|NCT00302003|Etoposide|etoposide|mesh-list
19786594|NCT00302003|Vincristine|vincristine|mesh-list
19786595|NCT00302003|Vinorelbine|vinorelbine|mesh-list
19786596|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
19786597|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786598|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
19786599|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786600|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786601|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786602|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
19786603|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786604|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786605|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20320446|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320447|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320448|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320449|NCT00726687|Capecitabine|capecitabine|mesh-list
20320450|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20320451|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
20320452|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320453|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786606|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19786607|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
19786608|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
19786609|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786610|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786611|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
19786612|NCT00302003|Hormones|hormones|mesh-ancestor
19786613|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786614|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19786615|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786616|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19786617|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19786618|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786619|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19786620|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786621|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
19786622|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
19786623|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786624|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
19786625|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
19786626|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
19786627|NCT00302068|Sertraline|sertraline|mesh-list
19786628|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
19786629|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19786630|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19786631|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20320454|NCT00726700|Prednisone|prednisone|mesh-list
20320455|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
20320456|NCT00726700|Rituximab|rituximab|mesh-list
20320457|NCT00726700|Doxorubicin|doxorubicin|mesh-list
20320458|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19786632|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786633|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786634|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786635|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
19786636|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786637|NCT00302081|Ribavirin|ribavirin|mesh-list
19786638|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19786639|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
19786640|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
19786641|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786642|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
19786643|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786644|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
19786645|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786646|NCT00302107|Mirtazapine|mirtazapine|mesh-list
19786647|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
19786648|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19786649|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19786650|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
19786651|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
19786652|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786653|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786654|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786655|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19786656|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19786657|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19786658|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19786659|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19786660|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19786661|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
19786662|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19786663|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19786664|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
20320459|NCT00726700|Vincristine|vincristine|mesh-list
19786665|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20320460|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786666|NCT00302133|Naltrexone|naltrexone|mesh-list
19786667|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19786668|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19786669|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786670|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
19786671|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786672|NCT00302159|Temozolomide|temozolomide|mesh-list
19786673|NCT00302159|Valproic Acid|valproic acid|mesh-list
19786674|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786675|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
19786676|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786677|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786678|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
19786679|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786680|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
19786681|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786682|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786683|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
19786684|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19786685|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19786686|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19786687|NCT00302211|Bosentan|bosentan|mesh-list
19786688|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
19786689|NCT00302211|Iloprost|iloprost|mesh-list
19786690|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
19786691|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19786692|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19786693|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638623|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
19638624|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638625|NCT02410005|Calcitriol|calcitriol|mesh-list
19638626|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19638627|NCT02410005|Losartan|losartan|mesh-list
19638628|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19638629|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19638630|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19638631|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19638632|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786694|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786695|NCT00302211|Urological Agents|urological agents|mesh-ancestor
19786696|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19786697|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19786698|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19786699|NCT00302458|Methylphenidate|methylphenidate|mesh-list
19786700|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19786701|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786702|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19786703|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19786704|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786705|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786706|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
19786707|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786708|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19786709|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19786710|NCT00302731|Hormones|hormones|mesh-list
19786711|NCT00302731|Estradiol|estradiol|mesh-list
19786712|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19786713|NCT00302731|Progesterone|progesterone|mesh-list
19786714|NCT00302731|Estrogens|estrogens|mesh-list
19786715|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786716|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786717|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19786718|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
19786719|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19786720|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19786721|NCT00302731|Progestins|progestins|mesh-ancestor
19786722|NCT00302848|Drospirenone|drospirenone|mesh-list
19786723|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
19786724|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
19786725|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
19786726|NCT00302848|Progestins|progestins|mesh-list
19786727|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19786728|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320461|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
19786729|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19786730|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19786731|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19786732|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19786733|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
19786734|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786735|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19786736|NCT00302848|Diuretics|diuretics|mesh-ancestor
19786737|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
19786738|NCT00302848|Hormones|hormones|mesh-ancestor
19786739|NCT00302952|Lovastatin|lovastatin|mesh-list
19786740|NCT00302952|L 647318|l 647318|mesh-list
19786741|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
19786742|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19786743|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19786744|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
19786745|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786746|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19786747|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19786748|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786749|NCT00303108|Carboplatin|carboplatin|mesh-list
19786750|NCT00303108|Doxorubicin|doxorubicin|mesh-list
19786751|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19786752|NCT00303108|Trastuzumab|trastuzumab|mesh-list
19786753|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786754|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786755|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19786756|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19786757|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786758|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786759|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786760|NCT00303316|Vaccines|vaccines|mesh-list
19786761|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
20320462|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320463|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320464|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20320465|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
20320466|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786762|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786763|NCT00303329|Deferasirox|deferasirox|mesh-list
19786764|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19786765|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
19786766|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
19786767|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786768|NCT00303446|Dutasteride|dutasteride|mesh-list
20320467|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320468|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20320469|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320470|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20320471|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20320472|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20320473|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320474|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320475|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
20320476|NCT00726700|Hormones|hormones|mesh-ancestor
20320477|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20320478|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20320479|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20320480|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
20320481|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
20320482|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
20320483|NCT00726726|Vitamin K|vitamin k|mesh-list
20320484|NCT00726726|Midazolam|midazolam|mesh-list
20320485|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
19786769|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19786770|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19786771|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153092|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153093|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
20153094|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
20153095|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
20153096|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20153097|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20153098|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153099|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153100|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
20153101|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
19786772|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153102|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
20153103|NCT00095264|Hematinics|hematinics|mesh-ancestor
20153104|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
20153105|NCT00095277|Hematinics|hematinics|mesh-ancestor
20153106|NCT00095316|Caspofungin|caspofungin|mesh-list
19786773|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
19786774|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638633|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19638634|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638635|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19638636|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19638637|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19638638|NCT02410005|Vitamins|vitamins|mesh-ancestor
19638639|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
19638640|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19638641|NCT02410135|Mirabegron|mirabegron|mesh-list
19638642|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19638643|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19638644|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19638645|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
19638646|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786775|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786776|NCT00303459|Bosentan|bosentan|mesh-list
19786777|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19786778|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19786779|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786780|NCT00303485|Vitamin D|vitamin d|mesh-list
19786781|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
19786782|NCT00303485|Calcium|calcium|mesh-list
19786783|NCT00303485|Vitamins|vitamins|mesh-ancestor
19786784|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
19786785|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786786|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19786787|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19786788|NCT00303602|Olanzapine|olanzapine|mesh-list
19786789|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
19786790|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
19786791|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786792|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786793|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786794|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19786795|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153107|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
20153108|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153109|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153110|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153111|NCT00095329|Sirolimus|sirolimus|mesh-list
20153112|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20153113|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153114|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153115|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153116|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
20153117|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153118|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
20153119|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153120|NCT00095355|Valproic Acid|valproic acid|mesh-list
20153121|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153122|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153123|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153124|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
20153125|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153126|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153127|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153128|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
20153129|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
20320486|NCT00726726|Caffeine|caffeine|mesh-list
20320487|NCT00726726|Omeprazole|omeprazole|mesh-list
20320488|NCT00726726|Warfarin|warfarin|mesh-list
20320489|NCT00726726|Vitamins|vitamins|mesh-ancestor
19786796|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19786797|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19786798|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19786799|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19786800|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786801|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786802|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786803|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
19786804|NCT00303628|Leucovorin|leucovorin|mesh-list
19786805|NCT00303628|Bevacizumab|bevacizumab|mesh-list
19786806|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19786807|NCT00303628|Fluorouracil|fluorouracil|mesh-list
19786808|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
19786809|NCT00303628|Antibodies|antibodies|mesh-list
19786810|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
19786811|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19786812|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
19786813|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786814|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20320490|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
20320491|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320492|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20320493|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20320494|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19786815|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19786816|NCT00303628|Growth Substances|growth substances|mesh-ancestor
20320495|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20320496|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20320497|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320498|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20320499|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
20320500|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
20320501|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
20320502|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
19786817|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786818|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
19786819|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
19786820|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
19786821|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786822|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19786823|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786824|NCT00303628|Antidotes|antidotes|mesh-ancestor
19786825|NCT00303628|Protective Agents|protective agents|mesh-ancestor
19786826|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
19786827|NCT00303628|Vitamins|vitamins|mesh-ancestor
19786828|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
19786829|NCT00303667|Vidarabine|vidarabine|mesh-list
19786830|NCT00303667|Aldesleukin|aldesleukin|mesh-list
19786831|NCT00303667|Cyclosporine|cyclosporine|mesh-list
19786832|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
19786833|NCT00303667|Fludarabine|fludarabine|mesh-list
19786834|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
19786835|NCT00303667|Interleukin-2|interleukin-2|mesh-list
20320503|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320504|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320505|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
20320506|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20320507|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320508|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20320509|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320510|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20320511|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20320512|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19786836|NCT00303667|Cyclosporins|cyclosporins|mesh-list
19786837|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
19786838|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786839|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
19786840|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786841|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786842|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786843|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
19833809|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20320513|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20320514|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
20153130|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153131|NCT00095368|Amoxicillin|amoxicillin|mesh-list
20153132|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20153133|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153134|NCT00095433|Ranibizumab|ranibizumab|mesh-list
20153135|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153136|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20320515|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19638647|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638648|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638649|NCT02410135|Urological Agents|urological agents|mesh-ancestor
19638650|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
19786844|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786845|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786846|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19786847|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19638651|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19638652|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320516|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20320517|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
20320518|NCT00726726|Coagulants|coagulants|mesh-ancestor
20320519|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
20320520|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
20320521|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19638653|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638654|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638655|NCT02409810|Analgesics|analgesics|mesh-ancestor
19638656|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
20320522|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20320523|NCT05373901|Tretinoin|tretinoin|mesh-list
20320524|NCT05373901|Dinutuximab|dinutuximab|mesh-list
20320525|NCT05373901|Isotretinoin|isotretinoin|mesh-list
19638657|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638658|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19638659|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19638660|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19786848|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
19786849|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
19786850|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786851|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786852|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
19786853|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786854|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19786855|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19786856|NCT00303667|Analgesics|analgesics|mesh-ancestor
19786857|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
19786858|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19786859|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19786860|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19786861|NCT00303719|Cyclosporine|cyclosporine|mesh-list
19786862|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
19786863|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
19786864|NCT00303719|Fludarabine|fludarabine|mesh-list
19786865|NCT00303719|Cyclosporins|cyclosporins|mesh-list
20320526|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320527|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
20320528|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
20347485|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20347486|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
20347487|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
20347488|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20347489|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20347490|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20347491|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347492|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347493|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347494|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638661|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
19786866|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19786867|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19786868|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
20153137|NCT00095433|Growth Substances|growth substances|mesh-ancestor
20153138|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786869|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153139|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
20347495|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
19786870|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19786871|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786872|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
19786873|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786874|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786875|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19786876|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786877|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
19786878|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786879|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19786880|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19786881|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786882|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19786883|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
19786884|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19786885|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19786886|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
19786887|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786888|NCT00303823|Protective Agents|protective agents|mesh-ancestor
19786889|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786890|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19786891|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19786892|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786893|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19786894|NCT00303862|Cediranib|cediranib|mesh-list
19786895|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786896|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786897|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786898|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19786899|NCT00303953|Belinostat|belinostat|mesh-list
19786900|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786901|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19786902|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786903|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786904|NCT00303966|Sorafenib|sorafenib|mesh-list
19786905|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786906|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19786907|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786908|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786909|NCT00304031|Temozolomide|temozolomide|mesh-list
19786910|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786911|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
19786912|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786913|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833810|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833811|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833812|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19833813|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19833814|NCT00590161|Protective Agents|protective agents|mesh-ancestor
19833815|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833816|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
19833817|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20320529|NCT05373680|Metformin|metformin|mesh-list
20320530|NCT05373680|Empagliflozin|empagliflozin|mesh-list
20320531|NCT05373680|Biguanides|biguanides|mesh-list
20320532|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320533|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320534|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19638662|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638663|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638664|NCT02409849|Octreotide|octreotide|mesh-list
19638665|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638666|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19638667|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638668|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
19638669|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19638670|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638671|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638672|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19638673|NCT02409862|Oxytocin|oxytocin|mesh-list
19638674|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
19638675|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638676|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638677|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19638678|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19638679|NCT02409498|Bupivacaine|bupivacaine|mesh-list
19786914|NCT00304083|Doxorubicin|doxorubicin|mesh-list
19786915|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19786916|NCT00304083|Etoposide|etoposide|mesh-list
19786917|NCT00304083|Ifosfamide|ifosfamide|mesh-list
19786918|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19786919|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786920|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19786921|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19786922|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786923|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786924|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19786925|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19786926|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
19786927|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19786928|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20320535|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320536|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
20320537|NCT05373303|Hematinics|hematinics|mesh-ancestor
19786929|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19786930|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786931|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786932|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
19786933|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786934|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786935|NCT00304187|Erythromycin|erythromycin|mesh-list
19786936|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
19786937|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19786938|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
19786939|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19786940|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786941|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19786942|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19786943|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786944|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786945|NCT00304278|Cisplatin|cisplatin|mesh-list
19786946|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19786947|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786948|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19786949|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786950|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786951|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
19786952|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19786953|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19786954|NCT00304707|Bupropion|bupropion|mesh-list
19786955|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19786956|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
19786957|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19786958|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19786959|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19786960|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19786961|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786962|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
19786963|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19786964|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786965|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19786966|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19786967|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786968|NCT00304746|Testosterone|testosterone|mesh-list
19786969|NCT00304746|Androgens|androgens|mesh-ancestor
19786970|NCT00304746|Hormones|hormones|mesh-ancestor
20320538|NCT05373277|Ticagrelor|ticagrelor|mesh-list
19638680|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638681|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
19638682|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638683|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638684|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
19638685|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833818|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
20320539|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19638686|NCT02409537|Resveratrol|resveratrol|mesh-list
19638687|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
20320540|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20320541|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20320542|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
19786971|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19786972|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786973|NCT05267847|Anesthetics|anesthetics|mesh-list
19786974|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19786975|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786976|NCT05267457|Vanadium|vanadium|mesh-list
19786977|NCT05267457|Trace Elements|trace elements|mesh-ancestor
19786978|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
19786979|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19786980|NCT05267392|Durvalumab|durvalumab|mesh-list
19786981|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786982|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786983|NCT05267366|Bevacizumab|bevacizumab|mesh-list
19786984|NCT05267366|Carboplatin|carboplatin|mesh-list
20320543|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320544|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20320545|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20320546|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320547|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20320548|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20320549|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20320550|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20320551|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
20320552|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320553|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320554|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20320555|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20320556|NCT05373264|Diuretics|diuretics|mesh-ancestor
20320557|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
20320558|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320559|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20320560|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20320561|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320562|NCT05373225|Acetic Acid|acetic acid|mesh-list
20320563|NCT05373225|Retinol acetate|retinol acetate|mesh-list
20320564|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20320565|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320566|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20320567|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
20320568|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320569|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20320570|NCT05373225|Protective Agents|protective agents|mesh-ancestor
20320571|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320572|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
20320573|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20320574|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320575|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320576|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20320577|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20320578|NCT05373134|Protective Agents|protective agents|mesh-ancestor
20320579|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320580|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
20320581|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19786985|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19786986|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19786987|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786988|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19786989|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19786990|NCT05267366|Growth Substances|growth substances|mesh-ancestor
19786991|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320582|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
20320583|NCT05373108|Macitentan|macitentan|mesh-list
20320584|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20320585|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20320586|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320587|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20320588|NCT05373004|Empagliflozin|empagliflozin|mesh-list
20320589|NCT05373004|Enalapril|enalapril|mesh-list
20320590|NCT05373004|Enalaprilat|enalaprilat|mesh-list
19786992|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
19786993|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786994|NCT05267288|Afatinib|afatinib|mesh-list
19786995|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19786996|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19786997|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19786998|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19786999|NCT05266937|Paclitaxel|paclitaxel|mesh-list
19787000|NCT05266937|Carboplatin|carboplatin|mesh-list
19787001|NCT05266937|Atezolizumab|atezolizumab|mesh-list
19787002|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19787003|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787004|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787005|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
19787006|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
19787007|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787008|NCT05266924|Hormones|hormones|mesh-list
19787009|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19787010|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19787011|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787012|NCT05266859|Calcium|calcium|mesh-list
19787013|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19787014|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787015|NCT05266820|Thalidomide|thalidomide|mesh-list
19787016|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787017|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
19787018|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787019|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
19787020|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787021|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787022|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19787023|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19787024|NCT05266820|Growth Substances|growth substances|mesh-ancestor
19787025|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
19787026|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787027|NCT05266807|Vancomycin|vancomycin|mesh-list
19787028|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
19787029|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787030|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787031|NCT05266794|Selenium|selenium|mesh-list
19787032|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
19787033|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
19787034|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787035|NCT05266794|Protective Agents|protective agents|mesh-ancestor
19787036|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638688|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638689|NCT02409537|Protective Agents|protective agents|mesh-ancestor
19638690|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638691|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638692|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19638693|NCT02409407|Alprostadil|alprostadil|mesh-list
19638694|NCT02409407|Misoprostol|misoprostol|mesh-list
19638695|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19787037|NCT05266794|Trace Elements|trace elements|mesh-ancestor
19787038|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
19787039|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
19787040|NCT05266794|Vitamins|vitamins|mesh-ancestor
19787041|NCT05266716|Methamphetamine|methamphetamine|mesh-list
19787042|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19787043|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787044|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
19787045|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
19787046|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787047|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
19787048|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787049|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787050|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
19787051|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19787052|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19787053|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19787054|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19787055|NCT05266690|Dextrans|dextrans|mesh-list
19787056|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
19638696|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
19638697|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638698|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787057|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
19787058|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
19787059|NCT05266651|Tadalafil|tadalafil|mesh-list
19787060|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
19787061|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19787062|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19787063|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787064|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787065|NCT05266651|Urological Agents|urological agents|mesh-ancestor
20320591|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20320592|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320593|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320594|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320595|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787066|NCT05266560|Propofol|propofol|mesh-list
19787067|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19787068|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787069|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787070|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19787071|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
19787072|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
19787073|NCT05266534|Terlipressin|terlipressin|mesh-list
19787074|NCT05266534|Carbetocin|carbetocin|mesh-list
19787075|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19787076|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19787077|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
19787078|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19787079|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787080|NCT05266274|Azacitidine|azacitidine|mesh-list
19787081|NCT05266274|Antibodies|antibodies|mesh-list
19787082|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19787083|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
19787084|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787085|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19787086|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
19787087|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787088|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787089|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787090|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
19787091|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
19787092|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
19787093|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19787094|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787095|NCT05266261|Vitamins|vitamins|mesh-ancestor
19787096|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
19787097|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19787098|NCT05266261|Antacids|antacids|mesh-ancestor
19787099|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787100|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19787101|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
19787102|NCT05266196|Topotecan|topotecan|mesh-list
19787103|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787104|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
19787105|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787106|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787107|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19787108|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
19787109|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787110|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787111|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19787112|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19787113|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787114|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787115|NCT05266105|Palbociclib|palbociclib|mesh-list
20320596|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20320597|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
20320598|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20320599|NCT05372939|Adalimumab|adalimumab|mesh-list
20320600|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320601|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320602|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
20320603|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19787116|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787117|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19787118|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320604|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
19787119|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787120|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19787121|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19787122|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787123|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
19787124|NCT05266040|Valacyclovir|valacyclovir|mesh-list
19787125|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
19787126|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833819|NCT00590226|Insulin|insulin|mesh-list
19833820|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19833821|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
20320605|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320606|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20320607|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320608|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20320609|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320610|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20320611|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320612|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
20320613|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320614|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
20320615|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320616|NCT05372614|Trastuzumab|trastuzumab|mesh-list
19833822|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
19833823|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
19833824|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
19833825|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19833826|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835463|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835464|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835465|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
19835466|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835467|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20320617|NCT05372614|Camptothecin|camptothecin|mesh-list
20320618|NCT05372614|Maleic acid|maleic acid|mesh-list
20320619|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
20320620|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320621|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835468|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835469|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835470|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19835471|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19835472|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835473|NCT00603044|Fluticasone|fluticasone|mesh-list
19835474|NCT00603044|Xhance|xhance|mesh-list
19835475|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835476|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19835477|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
19835478|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835479|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835480|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19835481|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
20320622|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320623|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320624|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20320625|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20320626|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20320627|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
20320628|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638699|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19638700|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638701|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
19638702|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19638703|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
19638704|NCT02409407|Urological Agents|urological agents|mesh-ancestor
19638705|NCT02409563|Budesonide|budesonide|mesh-list
19638706|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638707|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19638708|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
19638709|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638710|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638711|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19638712|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
19638713|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
19835482|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
20320629|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20320630|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20320631|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
20320632|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320633|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20320634|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20320635|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
20320636|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
20320637|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320638|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320639|NCT05366621|Denosumab|denosumab|mesh-list
20320640|NCT05366621|Diphosphonates|diphosphonates|mesh-list
20320641|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320642|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20320643|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
20320644|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
20320645|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20320646|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
20320647|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320648|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320649|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20320650|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
20320651|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638714|NCT02409563|Hormones|hormones|mesh-ancestor
19638715|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638716|NCT02409433|Lacosamide|lacosamide|mesh-list
19638717|NCT02409433|Phenytoin|phenytoin|mesh-list
19638718|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
19638719|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19638720|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19638721|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19638722|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638723|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19638724|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19638725|NCT02409017|Insulin|insulin|mesh-list
19638726|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19638727|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638728|NCT02409004|Rifampin|rifampin|mesh-list
19662951|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
19662952|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
19662953|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662954|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662955|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662956|NCT03148275|Trametinib|trametinib|mesh-list
19662957|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662958|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19662959|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662960|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662961|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
19662962|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19662963|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19662964|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
19662965|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19662966|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662967|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662968|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
19662969|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
19662970|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662971|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
19662972|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19662973|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
19662974|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
19662975|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19662976|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19662977|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662978|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
19662979|NCT02926651|Coagulants|coagulants|mesh-ancestor
19662980|NCT02896335|Palbociclib|palbociclib|mesh-list
19662981|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662982|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19662983|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662984|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19662985|NCT02843074|Dexamethasone|dexamethasone|mesh-list
19787127|NCT05266027|Nalbuphine|nalbuphine|mesh-list
19787128|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19787129|NCT05266027|Narcotics|narcotics|mesh-ancestor
19787130|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787131|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787132|NCT05266027|Analgesics|analgesics|mesh-ancestor
19787133|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
19787134|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787135|NCT05265975|Rituximab|rituximab|mesh-list
19787136|NCT05265975|Lenalidomide|lenalidomide|mesh-list
19787137|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787138|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787139|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
19787140|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787141|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787142|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19787143|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19787144|NCT05265975|Growth Substances|growth substances|mesh-ancestor
19787145|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19787146|NCT05265962|Decitabine|decitabine|mesh-list
19787147|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19787148|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
19787149|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787150|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787151|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787152|NCT05265819|Hormones|hormones|mesh-list
19787153|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19787154|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787155|NCT05265793|Apatinib|apatinib|mesh-list
19787156|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787157|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19787158|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787159|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787160|NCT05240781|Sirolimus|sirolimus|mesh-list
19787161|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787162|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787163|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19787164|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787165|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
19787166|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787167|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
19787168|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787169|NCT05237596|Acetaminophen|acetaminophen|mesh-list
19787170|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19787171|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19787172|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19787173|NCT05237596|Analgesics|analgesics|mesh-ancestor
19787174|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
19787175|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787176|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787177|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
19787178|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787179|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
19787180|NCT05236036|Temozolomide|temozolomide|mesh-list
19787181|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19787182|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787183|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19787184|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
19787185|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787186|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787187|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787188|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787189|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19787190|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
19787191|NCT05217498|Istradefylline|istradefylline|mesh-list
19787192|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
19787193|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19787194|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19787195|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
19787196|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787197|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787198|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787199|NCT05211804|Ranibizumab|ranibizumab|mesh-list
19787200|NCT05211804|Aflibercept|aflibercept|mesh-list
19787201|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787202|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19787203|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19787204|NCT05211804|Growth Substances|growth substances|mesh-ancestor
19787205|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787206|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
19787207|NCT05206435|Nicotine|nicotine|mesh-list
19787208|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19787209|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
19787210|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787211|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787212|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19787213|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19787214|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
19787215|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787216|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787217|NCT05201430|Capecitabine|capecitabine|mesh-list
19787218|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
19787219|NCT05201430|Irinotecan|irinotecan|mesh-list
19787220|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19787221|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
19787222|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787223|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787224|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19787225|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787226|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787227|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
19787228|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787229|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787230|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19787231|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787232|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787233|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787234|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787235|NCT05185973|Micronutrients|micronutrients|mesh-list
19787236|NCT05185973|Trace Elements|trace elements|mesh-list
19787237|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787238|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
19787239|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19787240|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
19787241|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787242|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787243|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19787244|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
19787245|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
19787246|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19787247|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
19787248|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787249|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787250|NCT05156060|Ketamine|ketamine|mesh-list
19787251|NCT05156060|Gabapentin|gabapentin|mesh-list
19787252|NCT05156060|Analgesics|analgesics|mesh-ancestor
19787253|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
19787254|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787255|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787256|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19787257|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19787258|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
19787259|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
20320652|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320653|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20320654|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320655|NCT05364073|Aflutinib|aflutinib|mesh-list
19638729|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19638730|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
19638731|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19638732|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638733|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
19638734|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19638735|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638736|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638737|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19638738|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19638739|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19787260|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787261|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19787262|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19787263|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787264|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787265|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
19787266|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19787267|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19787268|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19787269|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
19787270|NCT05117034|Morphine|morphine|mesh-list
19787271|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19787272|NCT05117034|Narcotics|narcotics|mesh-ancestor
19787273|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787274|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787275|NCT05117034|Analgesics|analgesics|mesh-ancestor
19787276|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
19787277|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787278|NCT05092360|Gemcitabine|gemcitabine|mesh-list
19787279|NCT05092360|Paclitaxel|paclitaxel|mesh-list
19787280|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19787281|NCT05092360|Doxorubicin|doxorubicin|mesh-list
19787282|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19787283|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
19787284|NCT05092360|Topotecan|topotecan|mesh-list
19787285|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19787286|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787287|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787288|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
19787289|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
19787290|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787291|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19787292|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
19787293|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
19787294|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787295|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787296|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787297|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
19787298|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787299|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19787300|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19787301|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787302|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787303|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19787304|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19787305|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19787306|NCT05018091|Dexamethasone|dexamethasone|mesh-list
19787307|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
19787308|NCT05018091|BB 1101|bb 1101|mesh-list
19787309|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19787310|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
19787311|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
19638740|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19638741|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19638742|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19638743|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
19638744|NCT02409290|Levofloxacin|levofloxacin|mesh-list
19638745|NCT02409290|Isoniazid|isoniazid|mesh-list
19638746|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
19787312|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787313|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787314|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19787315|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
19787316|NCT05018091|Hormones|hormones|mesh-ancestor
19787317|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19787318|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19787319|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787320|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
19787321|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787322|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787323|NCT04974216|Rituximab|rituximab|mesh-list
19787324|NCT04974216|Lenalidomide|lenalidomide|mesh-list
19787325|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19638747|NCT02409290|Ethambutol|ethambutol|mesh-list
19638748|NCT02409290|Bedaquiline|bedaquiline|mesh-list
19638749|NCT02409290|Clofazimine|clofazimine|mesh-list
19638750|NCT02409290|Kanamycin|kanamycin|mesh-list
19638751|NCT02409290|Prothionamide|prothionamide|mesh-list
19638752|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787326|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787327|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
19787328|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787329|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787330|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19638753|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638754|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19638755|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787331|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19787332|NCT04974216|Growth Substances|growth substances|mesh-ancestor
20320656|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20320657|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320658|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320659|NCT05358587|Anesthetics|anesthetics|mesh-list
20320660|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
20320661|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20320662|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320663|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320664|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
20320665|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320666|NCT05350202|Empagliflozin|empagliflozin|mesh-list
20320667|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20320668|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787333|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
19787334|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
19787335|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19787336|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19787337|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19787338|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19787339|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787340|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
19787341|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787342|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787343|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19787344|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787345|NCT04786964|Folic Acid|folic acid|mesh-list
19787346|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
19787347|NCT04786964|Hydroxocobalamin|hydroxocobalamin|mesh-list
19787348|NCT04786964|Dexamethasone|dexamethasone|mesh-list
19787349|NCT04786964|Carboplatin|carboplatin|mesh-list
19787350|NCT04786964|Pemetrexed|pemetrexed|mesh-list
19787351|NCT04786964|Vitamins|vitamins|mesh-ancestor
19787352|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
19787353|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787354|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787355|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19787356|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
19787357|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
19787358|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153140|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153141|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
20153142|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153143|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153144|NCT00095459|Bevacizumab|bevacizumab|mesh-list
20153145|NCT00095459|Sorafenib|sorafenib|mesh-list
20153146|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20153147|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153148|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153149|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20153150|NCT00095459|Growth Substances|growth substances|mesh-ancestor
20153151|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153152|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
20153153|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153154|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153155|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153156|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19638756|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638757|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638758|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638759|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19638760|NCT02409290|Renal Agents|renal agents|mesh-ancestor
19787359|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20153157|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787360|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
19787361|NCT04786964|Hormones|hormones|mesh-ancestor
19787362|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19787363|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19787364|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787365|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787366|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19787367|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19787368|NCT04786964|Hematinics|hematinics|mesh-ancestor
19787369|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
19787370|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
19787371|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787372|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787373|NCT04750226|Levodopa|levodopa|mesh-list
19787374|NCT04750226|Carbidopa|carbidopa|mesh-list
19787375|NCT04750226|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19787376|NCT04750226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19787377|NCT04750226|Dopamine Agents|dopamine agents|mesh-ancestor
19787378|NCT04750226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320669|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320670|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347496|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347497|NCT00860925|Clonidine|clonidine|mesh-list
20347498|NCT00860925|Analgesics|analgesics|mesh-ancestor
20347499|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
19787379|NCT04750226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787380|NCT04750226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787381|NCT04750226|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20347500|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347501|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347502|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20347503|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
20347504|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
20347505|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20347506|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20347507|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20347508|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347509|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347510|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347511|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20347512|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20347513|NCT00860964|Estradiol|estradiol|mesh-list
20347514|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19638761|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19787382|NCT04750226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787383|NCT04641507|Tadalafil|tadalafil|mesh-list
19787384|NCT04641507|Tamsulosin|tamsulosin|mesh-list
19787385|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
19787386|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19787387|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19787388|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787389|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787390|NCT04641507|Urological Agents|urological agents|mesh-ancestor
19787391|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20153158|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153159|NCT00095511|Aripiprazole|aripiprazole|mesh-list
20153160|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
20153161|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153162|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153163|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153164|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153165|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638762|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19638763|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
19638764|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19638765|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19638766|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
19638767|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19638768|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638769|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
19638770|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19638771|NCT02409199|Docetaxel|docetaxel|mesh-list
19638772|NCT02409199|Apatinib|apatinib|mesh-list
19638773|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638774|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
19638775|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
19638776|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
19638777|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638778|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19638779|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19662986|NCT02843074|Lenalidomide|lenalidomide|mesh-list
19662987|NCT02843074|Elotuzumab|elotuzumab|mesh-list
19662988|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19662989|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
19662990|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
19662991|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19662992|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19662993|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19662994|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
19787392|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19787393|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19787394|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
19787395|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787396|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787397|NCT04618744|Insulin|insulin|mesh-list
19787398|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19787399|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19662995|NCT02843074|Hormones|hormones|mesh-ancestor
19662996|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19662997|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19662998|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19662999|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
19663000|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19663001|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19663002|NCT02843074|Growth Substances|growth substances|mesh-ancestor
19787400|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787401|NCT04617457|Leucovorin|leucovorin|mesh-list
19787402|NCT04617457|Folic Acid|folic acid|mesh-list
19787403|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
19787404|NCT04617457|Irinotecan|irinotecan|mesh-list
19787405|NCT04617457|Fluorouracil|fluorouracil|mesh-list
19787406|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
19787407|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787408|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19787409|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787410|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787411|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787412|NCT04617457|Antidotes|antidotes|mesh-ancestor
19787413|NCT04617457|Protective Agents|protective agents|mesh-ancestor
19787414|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787415|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
19787416|NCT04617457|Vitamins|vitamins|mesh-ancestor
19787417|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
19787418|NCT04617457|Hematinics|hematinics|mesh-ancestor
19787419|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
19787420|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19787421|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787422|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
19787423|NCT04586660|Denosumab|denosumab|mesh-list
19787424|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20153166|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153167|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
20153168|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320671|NCT05328908|Trifluridine|trifluridine|mesh-list
20320672|NCT05328908|Nivolumab|nivolumab|mesh-list
20320673|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320674|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153169|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153170|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20153171|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153172|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
20153173|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20153174|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153175|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153176|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153177|NCT00095524|Aripiprazole|aripiprazole|mesh-list
20320675|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20320676|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787425|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787426|NCT04564846|Insulin|insulin|mesh-list
19787427|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19787428|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787429|NCT04528212|Glimepiride|glimepiride|mesh-list
19787430|NCT04528212|Curcumin|curcumin|mesh-list
19787431|NCT04528212|Fenofibrate|fenofibrate|mesh-list
19787432|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19787433|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19787434|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787435|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787436|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
19787437|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19787438|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19787439|NCT04528212|Analgesics|analgesics|mesh-ancestor
20320677|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
20320678|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
20320679|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320680|NCT05328388|Lycopene|lycopene|mesh-list
20320681|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320682|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
20320683|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320684|NCT05328388|Protective Agents|protective agents|mesh-ancestor
20320685|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787440|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
19787441|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787442|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19787443|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787444|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787445|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787446|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787447|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19787448|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
19787449|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19787450|NCT04493931|Rifampin|rifampin|mesh-list
19787451|NCT04493931|Digoxin|digoxin|mesh-list
19787452|NCT04493931|Midazolam|midazolam|mesh-list
19787453|NCT04493931|Cimetidine|cimetidine|mesh-list
19787454|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19787455|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19787456|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787457|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787458|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19787459|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19787460|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19787461|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19787462|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
19787463|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
19787464|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
20320686|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20320687|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20320688|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320689|NCT05292001|Dextrans|dextrans|mesh-list
20320690|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
20320691|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
20320692|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
20320693|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
20320694|NCT05292001|Hematinics|hematinics|mesh-ancestor
20320695|NCT05261139|Ritonavir|ritonavir|mesh-list
20320696|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20320697|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20320698|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
19787465|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
19787466|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787467|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787468|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19787469|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
19787470|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787471|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787472|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
19787473|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19787474|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787475|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19787476|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19787477|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20320699|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787478|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19833827|NCT00590317|Ondansetron|ondansetron|mesh-list
20320700|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787479|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19787480|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19787481|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20320701|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20320702|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20320703|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
20320704|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320705|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20320706|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20320707|NCT05253131|Durvalumab|durvalumab|mesh-list
20320708|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320709|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320710|NCT05251909|Benralizumab|benralizumab|mesh-list
20320711|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20320712|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
20320713|NCT05232994|Metformin|metformin|mesh-list
20320714|NCT05232994|Esomeprazole|esomeprazole|mesh-list
20320715|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20320716|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320717|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20320718|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320719|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20320720|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787482|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19787483|NCT04493931|Protective Agents|protective agents|mesh-ancestor
19787484|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19787485|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19787486|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19787487|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
19787488|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
19787489|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19787490|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19787491|NCT04489173|Trifluridine|trifluridine|mesh-list
19787492|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
19787493|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787494|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
19787495|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19833828|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
19833829|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
19833830|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
19833831|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833832|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833833|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19833834|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
19833835|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
19833836|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19833837|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
19833838|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833839|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833840|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19833841|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19833842|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833843|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19833844|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19833845|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19833846|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
19833847|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19833848|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19833849|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833850|NCT00590460|Fludarabine|fludarabine|mesh-list
19833851|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
19833852|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833853|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19833854|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19833855|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19833856|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19833857|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833858|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833859|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320721|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320722|NCT05228613|Vaccines|vaccines|mesh-list
20320723|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
20320724|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833860|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19833861|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19787496|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
19787497|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19787498|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787499|NCT04476511|Vitamins|vitamins|mesh-ancestor
19787500|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
19787501|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19787502|NCT04445662|Varenicline|varenicline|mesh-list
19787503|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19787504|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19787505|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
19787506|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787507|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320725|NCT05227742|Psilocybin|psilocybin|mesh-list
20320726|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
20320727|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787508|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787509|NCT04413617|Tofacitinib|tofacitinib|mesh-list
19787510|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19787511|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787512|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787513|NCT04342572|Melphalan|melphalan|mesh-list
19787514|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19787515|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
19787516|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787517|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787518|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19787519|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787520|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
19787521|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787522|NCT04339426|Azithromycin|azithromycin|mesh-list
19787523|NCT04339426|Atovaquone|atovaquone|mesh-list
19787524|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787525|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787526|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
19787527|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19787528|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19787529|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787530|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787531|NCT04338204|Tofacitinib|tofacitinib|mesh-list
19787532|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19787533|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787534|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787535|NCT04312503|Olanzapine|olanzapine|mesh-list
19787536|NCT04312503|Risperidone|risperidone|mesh-list
19787537|NCT04312503|Aripiprazole|aripiprazole|mesh-list
19787538|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19787539|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20320728|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320729|NCT05209308|Rituximab|rituximab|mesh-list
20320730|NCT05209308|Venetoclax|venetoclax|mesh-list
20320731|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787540|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19787541|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
19787542|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787543|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787544|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787545|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19787546|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19787547|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787548|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19787549|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19787550|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
19787551|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
19787552|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
19787553|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787554|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19787555|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19787556|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19787557|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19787558|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
19787559|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
19787560|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19787561|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19787562|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20320732|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787563|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19787564|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19787565|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19787566|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19787567|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19787568|NCT04298463|Vancomycin|vancomycin|mesh-list
20320733|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
20320734|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320735|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787569|NCT04298463|Daptomycin|daptomycin|mesh-list
19787570|NCT04298463|Teicoplanin|teicoplanin|mesh-list
19787571|NCT04298463|Dalbavancin|dalbavancin|mesh-list
19787572|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787573|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787574|NCT04260854|Bupivacaine|bupivacaine|mesh-list
19787575|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
19787576|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
19787577|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153178|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
20153179|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153180|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19787578|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787579|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
19787580|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787581|NCT04251351|Acetaminophen|acetaminophen|mesh-list
19787582|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19787583|NCT04251351|Analgesics|analgesics|mesh-ancestor
19787584|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
19787585|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787586|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787587|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
19787588|NCT04248569|Nivolumab|nivolumab|mesh-list
19787589|NCT04248569|Ipilimumab|ipilimumab|mesh-list
19787590|NCT04248569|Poly ICLC|poly iclc|mesh-list
19787591|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20153181|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153182|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153183|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153184|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153185|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
20153186|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153187|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153188|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20153189|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153190|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
20153191|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20153192|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153193|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153194|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19638780|NCT02409147|Aspirin|aspirin|mesh-list
19638781|NCT02409147|Nystatin|nystatin|mesh-list
20153195|NCT00095641|Capecitabine|capecitabine|mesh-list
20320736|NCT05206877|Insulin|insulin|mesh-list
20320737|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20320738|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153196|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153197|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
20174007|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
20320739|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320740|NCT05205382|Nicotine|nicotine|mesh-list
19638782|NCT02409147|Prednisone|prednisone|mesh-list
19638783|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
19638784|NCT02409147|Basiliximab|basiliximab|mesh-list
19638785|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638786|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
19638787|NCT02409147|Hormones|hormones|mesh-ancestor
19638788|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638789|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638790|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19638791|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638792|NCT02409147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638793|NCT02409147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638794|NCT02409147|Analgesics|analgesics|mesh-ancestor
19638795|NCT02409147|Sensory System Agents|sensory system agents|mesh-ancestor
19787592|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787593|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19833862|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
20347515|NCT00860964|Estrogens|estrogens|mesh-ancestor
19638796|NCT02409147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787594|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787595|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
19787596|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
19787597|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787598|NCT04221750|Metformin|metformin|mesh-list
19787599|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19787600|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787601|NCT04220125|Midazolam|midazolam|mesh-list
19787602|NCT04220125|Ketamine|ketamine|mesh-list
19787603|NCT04220125|Analgesics|analgesics|mesh-ancestor
19787604|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
19787605|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787606|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787607|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19787608|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19787609|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
19787610|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
19787611|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787612|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19787613|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20153198|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153199|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153200|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
20153201|NCT00095654|Ramipril|ramipril|mesh-list
20153202|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153203|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153204|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20153205|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
20153206|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153207|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153208|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20153209|NCT00095667|Lapatinib|lapatinib|mesh-list
20153210|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153211|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153212|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787614|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787615|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787616|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19787617|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19787618|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19787619|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19787620|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19787621|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
20153213|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320741|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20320742|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
19638797|NCT02409147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638798|NCT02409147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19638799|NCT02409147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19638800|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638801|NCT02409147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19638802|NCT02409147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19638803|NCT02409147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638804|NCT02409147|Antipyretics|antipyretics|mesh-ancestor
19638805|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19638806|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
19638807|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19638808|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638809|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
19638810|NCT02409147|Ionophores|ionophores|mesh-ancestor
19638811|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19638812|NCT02409186|Paclitaxel|paclitaxel|mesh-list
19638813|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19638814|NCT02409186|Cisplatin|cisplatin|mesh-list
19638815|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
19638816|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19638817|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638818|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
19638819|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
19638820|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
19787622|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
20153214|NCT00095680|Bortezomib|bortezomib|mesh-list
19787623|NCT04209686|Paclitaxel|paclitaxel|mesh-list
19787624|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
19787625|NCT04209686|Olaparib|olaparib|mesh-list
19787626|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19787627|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787628|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787629|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
20320743|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320744|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320745|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20320746|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20320747|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
20320748|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320749|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320750|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
20320751|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320752|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320753|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
20153215|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153216|NCT00095693|Sorafenib|sorafenib|mesh-list
20153217|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20320754|NCT05203445|Olaparib|olaparib|mesh-list
20320755|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320756|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320757|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19787630|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
19787631|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787632|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787633|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19787634|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787635|NCT04207944|Sulindac|sulindac|mesh-list
19787636|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19787637|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19787638|NCT04207944|Analgesics|analgesics|mesh-ancestor
19787639|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
19787640|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787641|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787642|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19787643|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787644|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787645|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19787646|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787647|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787648|NCT04177758|Vitamin D|vitamin d|mesh-list
19787649|NCT04177758|Vitamins|vitamins|mesh-ancestor
19787650|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
19787651|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787652|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19787653|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19787654|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19787655|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19787656|NCT04157153|Sirolimus|sirolimus|mesh-list
19787657|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787658|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787659|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19787660|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787661|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
20320758|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787662|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787663|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
19787664|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153218|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153219|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153220|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153221|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153222|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20153223|NCT00095706|Bevacizumab|bevacizumab|mesh-list
20320759|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320760|NCT05199311|Dexamethasone|dexamethasone|mesh-list
20320761|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320762|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
20320763|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
20320764|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347516|NCT00860964|Hormones|hormones|mesh-ancestor
20153224|NCT00095706|Trastuzumab|trastuzumab|mesh-list
20153225|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787665|NCT04145700|Gemcitabine|gemcitabine|mesh-list
19787666|NCT04145700|Docetaxel|docetaxel|mesh-list
19787667|NCT04145700|Ramucirumab|ramucirumab|mesh-list
19787668|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19787669|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
19787670|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787671|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787672|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
19787673|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787674|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787675|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787676|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
19787677|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787678|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787679|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
19787680|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
19787681|NCT04129619|Ether|ether|mesh-list
19787682|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19787683|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
19787684|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
19787685|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19787686|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787687|NCT04128722|Sirolimus|sirolimus|mesh-list
19787688|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787689|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787690|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19787691|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787692|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
19787693|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787694|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
19787695|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787696|NCT04123873|Acetaminophen|acetaminophen|mesh-list
20320765|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320766|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320767|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
20320768|NCT05199311|Hormones|hormones|mesh-ancestor
20320769|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20320770|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20320771|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320772|NCT05190770|Triamcinolone|triamcinolone|mesh-list
20320773|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20320774|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20320775|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20320776|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20320777|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
19638821|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787697|NCT04123873|Dexamethasone|dexamethasone|mesh-list
19787698|NCT04123873|Ibuprofen|ibuprofen|mesh-list
19787699|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19787700|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
19787701|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
19787702|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153226|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153227|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153228|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20153229|NCT00095706|Growth Substances|growth substances|mesh-ancestor
20153230|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153231|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
20153232|NCT00095719|Aripiprazole|aripiprazole|mesh-list
20153233|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
20320778|NCT05190770|Hormones|hormones|mesh-ancestor
19638822|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19638823|NCT02408978|Naproxen|naproxen|mesh-list
19638824|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638825|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638826|NCT02408978|Analgesics|analgesics|mesh-ancestor
19638827|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
19638828|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638829|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638830|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638831|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638832|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
19787703|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787704|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638833|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19638834|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638835|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638836|NCT02409238|Metformin|metformin|mesh-list
19638837|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153234|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153235|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153236|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153237|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153238|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153239|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153240|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
20153241|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153242|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153243|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20153244|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153245|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
20153246|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20153247|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153248|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153249|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153250|NCT00095745|Aripiprazole|aripiprazole|mesh-list
20153251|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
20153252|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153253|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153254|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153255|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153256|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153257|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153258|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
19638838|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638839|NCT02408679|Vitamin D|vitamin d|mesh-list
19638840|NCT02408679|Vitamins|vitamins|mesh-ancestor
19638841|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
19638842|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638843|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20153259|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787705|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
19787706|NCT04123873|Hormones|hormones|mesh-ancestor
19787707|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19787708|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19787709|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787710|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20320779|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19787711|NCT04123873|Analgesics|analgesics|mesh-ancestor
19787712|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
19787713|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
19787714|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19787715|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787716|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19787717|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787718|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787719|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
19787720|NCT04098068|Antibodies|antibodies|mesh-list
19787721|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
19787722|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787723|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787724|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787725|NCT04061590|Cisplatin|cisplatin|mesh-list
19787726|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
19787727|NCT04061590|Pemetrexed|pemetrexed|mesh-list
19787728|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787729|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787730|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787731|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787732|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19787733|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19787734|NCT04031833|Amphotericin B|amphotericin b|mesh-list
20320780|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320781|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20320782|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
20320783|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638844|NCT02408705|Acetaminophen|acetaminophen|mesh-list
19787735|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19787736|NCT04031833|Amebicides|amebicides|mesh-ancestor
19787737|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19787738|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19787739|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787740|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787741|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
19787742|NCT04016142|Paclitaxel|paclitaxel|mesh-list
19787743|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19787744|NCT04016142|Carboplatin|carboplatin|mesh-list
19787745|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19787746|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787747|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787748|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
19787749|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
19787750|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787751|NCT04005287|Pirenzepine|pirenzepine|mesh-list
19787752|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19787753|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19787754|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19787755|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19787756|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
19787757|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787758|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787759|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787760|NCT03999554|Vaccines|vaccines|mesh-list
19787761|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
19787762|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787763|NCT03977467|Atezolizumab|atezolizumab|mesh-list
19787764|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320784|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320785|NCT05180357|Benralizumab|benralizumab|mesh-list
20320786|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20320787|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
19787765|NCT03934567|Abexinostat|abexinostat|mesh-list
19638845|NCT02408705|Liraglutide|liraglutide|mesh-list
19638846|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638847|NCT02408705|Analgesics|analgesics|mesh-ancestor
19638848|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
19638849|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638850|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638851|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
19638852|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19638853|NCT02408705|Incretins|incretins|mesh-ancestor
19638854|NCT02408705|Hormones|hormones|mesh-ancestor
19638855|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19638856|NCT02408744|Pirfenidone|pirfenidone|mesh-list
19638857|NCT02408744|Analgesics|analgesics|mesh-ancestor
19638858|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
19638859|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638860|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638861|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638862|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638863|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638864|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638865|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638866|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
19638867|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19638868|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638869|NCT02408926|Vaccines|vaccines|mesh-list
19638870|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
19638871|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638872|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
19638873|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19787766|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19787767|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787768|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787769|NCT03917966|Docetaxel|docetaxel|mesh-list
19787770|NCT03917966|Apatinib|apatinib|mesh-list
19787771|NCT03917966|Nedaplatin|nedaplatin|mesh-list
19787772|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320788|NCT05171777|Atezolizumab|atezolizumab|mesh-list
20320789|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19638874|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
19638875|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19787773|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787774|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
19787775|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
20320790|NCT05169684|Docetaxel|docetaxel|mesh-list
19787776|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787777|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19787778|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787779|NCT03879798|Irinotecan|irinotecan|mesh-list
19787780|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19787781|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787782|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787783|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787784|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833863|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833864|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833865|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19833866|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19833867|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
19833868|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
19833869|NCT00590590|Promethazine|promethazine|mesh-list
19833870|NCT00590590|Lidocaine|lidocaine|mesh-list
19833871|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
19833872|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
19833873|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833874|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833875|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
19833876|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833877|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19833878|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19833879|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19833880|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19833881|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833882|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19833883|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19833884|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
19833885|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
19833886|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19833887|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19833888|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
19833889|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
19833890|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833891|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19833892|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
19833893|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
19833894|NCT00590681|Bevacizumab|bevacizumab|mesh-list
19833895|NCT00590681|Temozolomide|temozolomide|mesh-list
19833896|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19833897|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833898|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19833899|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19833900|NCT00590681|Growth Substances|growth substances|mesh-ancestor
19833901|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833902|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19833903|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19833904|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
19833905|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833906|NCT00590772|Montelukast|montelukast|mesh-list
19833907|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19833908|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
19833909|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19833910|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
19833911|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19833912|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833913|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19833914|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833915|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833916|NCT00590824|Interleukin-2|interleukin-2|mesh-list
19833917|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833918|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19833919|NCT00590824|Analgesics|analgesics|mesh-ancestor
19833920|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
19833921|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833922|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833923|NCT00590863|Dexetimide|dexetimide|mesh-list
19833924|NCT00590863|Mirtazapine|mirtazapine|mesh-list
19833925|NCT00590863|Citalopram|citalopram|mesh-list
19833926|NCT00590863|Bupropion|bupropion|mesh-list
19833927|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20320791|NCT05169684|Nivolumab|nivolumab|mesh-list
20320792|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320793|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153260|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153261|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20153262|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153263|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
20153264|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20153265|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153266|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153267|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153268|NCT00095758|Aripiprazole|aripiprazole|mesh-list
20153269|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
19638876|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638877|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19638878|NCT02408562|Becaplermin|becaplermin|mesh-list
19638879|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
19638880|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
19638881|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19638882|NCT02408562|Growth Substances|growth substances|mesh-ancestor
20153270|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153271|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153272|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20320794|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
20320795|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
20320796|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320797|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320798|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20320799|NCT05162014|Empagliflozin|empagliflozin|mesh-list
20320800|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19638883|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638884|NCT02408393|Ropivacaine|ropivacaine|mesh-list
19638885|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638886|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
19663003|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
19663004|NCT02805504|Bupivacaine|bupivacaine|mesh-list
19663005|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
19663006|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
19663007|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663008|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663009|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
19663010|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663011|NCT02605148|Vitamin D|vitamin d|mesh-list
19663012|NCT02605148|Vitamins|vitamins|mesh-ancestor
19663013|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
19663014|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663015|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19663016|NCT02505750|Capecitabine|capecitabine|mesh-list
19663017|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663018|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
19663019|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663020|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663021|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
19663022|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663023|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663024|NCT02395640|Capecitabine|capecitabine|mesh-list
19663025|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
19663026|NCT02395640|Epirubicin|epirubicin|mesh-list
19663027|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663028|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
19663029|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663030|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663031|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19663032|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19663033|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19663034|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663035|NCT02381535|Cisplatin|cisplatin|mesh-list
19663036|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663037|NCT05096715|Bevacizumab|bevacizumab|mesh-list
19663038|NCT05096715|Atezolizumab|atezolizumab|mesh-list
19663039|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663040|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663041|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20320801|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20320802|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320803|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320804|NCT05145296|Daratumumab|daratumumab|mesh-list
20320805|NCT05145296|Abatacept|abatacept|mesh-list
20320806|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320807|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20320808|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320809|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20320810|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
20320811|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320812|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320813|NCT05139225|Daratumumab|daratumumab|mesh-list
19787785|NCT03867487|Empagliflozin|empagliflozin|mesh-list
19787786|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19787787|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787788|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19787789|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787790|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19787791|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19787792|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19787793|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787794|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787795|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
19787796|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787797|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19787798|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19787799|NCT03792841|Etanercept|etanercept|mesh-list
19787800|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
19787801|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19787802|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787803|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787804|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19787805|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19787806|NCT03792841|Analgesics|analgesics|mesh-ancestor
19787807|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
19787808|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787809|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787810|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19787811|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787812|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19787813|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787814|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
19787815|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787816|NCT03783416|Ixazomib|ixazomib|mesh-list
19787817|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787818|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
19787819|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787820|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787821|NCT03765983|Trastuzumab|trastuzumab|mesh-list
19787822|NCT03765983|GDC-0084|gdc-0084|mesh-list
19787823|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787824|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787825|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787826|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787827|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
20320814|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320815|NCT05124275|Pilocarpine|pilocarpine|mesh-list
20320816|NCT05124275|Miotics|miotics|mesh-ancestor
20320817|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
19638887|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638888|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638889|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
19638890|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638891|NCT02408354|Glycerol|glycerol|mesh-list
19638892|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19638893|NCT02408354|Protective Agents|protective agents|mesh-ancestor
19638894|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638895|NCT02408185|Colistin|colistin|mesh-list
19638896|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19638897|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638898|NCT02408302|Midazolam|midazolam|mesh-list
19638899|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20320818|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320819|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320820|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20320821|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20320822|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
20320823|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320824|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320825|NCT05119920|Pilocarpine|pilocarpine|mesh-list
20320826|NCT05119920|Miotics|miotics|mesh-ancestor
20320827|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
20320828|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320829|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320830|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20320831|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20320832|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
20320833|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320834|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638900|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19638901|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638902|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638903|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19638904|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19638905|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19638906|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19638907|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
19638908|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
19638909|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
19638910|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
19638911|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787828|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
19787829|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787830|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
19787831|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787832|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787833|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19787834|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
19787835|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787836|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787837|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19787838|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787839|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19638912|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320835|NCT05092828|Morphine|morphine|mesh-list
20320836|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20320837|NCT05092828|Narcotics|narcotics|mesh-ancestor
20320838|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320839|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320840|NCT05092828|Analgesics|analgesics|mesh-ancestor
20320841|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
20320842|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320843|NCT05089734|Docetaxel|docetaxel|mesh-list
20320844|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787840|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
19787841|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787842|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787843|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
19787844|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638913|NCT02408328|Caffeine|caffeine|mesh-list
19638914|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
19638915|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638916|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19638917|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638918|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19638919|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638920|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19638921|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19638922|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
19787845|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
19787846|NCT03732352|Osimertinib|osimertinib|mesh-list
20320845|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787847|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19787848|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19787849|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787850|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787851|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19787852|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787853|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
19787854|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
19787855|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787856|NCT03709914|Fosfomycin|fosfomycin|mesh-list
19787857|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19787858|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787859|NCT03706053|Midodrine|midodrine|mesh-list
19787860|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
19787861|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
19787862|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787863|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787864|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19787865|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19787866|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19787867|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19787868|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
19787869|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787870|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787871|NCT03638141|Durvalumab|durvalumab|mesh-list
19787872|NCT03638141|Ipilimumab|ipilimumab|mesh-list
19787873|NCT03638141|Tremelimumab|tremelimumab|mesh-list
19787874|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19787875|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787876|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787877|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
19787878|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153273|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153274|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153275|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153276|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
20153277|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153278|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153279|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20153280|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153281|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
19638923|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638924|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
19638925|NCT02408289|Procyanidin|procyanidin|mesh-list
19638926|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
19638927|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638928|NCT02408289|Protective Agents|protective agents|mesh-ancestor
19638929|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638930|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19638931|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19638932|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638933|NCT02408419|Bupivacaine|bupivacaine|mesh-list
19638934|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
19638935|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
19638936|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638937|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638938|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
19638939|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638940|NCT02408172|Metoprolol|metoprolol|mesh-list
19638941|NCT02408172|Amlodipine|amlodipine|mesh-list
19638942|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19638943|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19638944|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19638945|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638946|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19787879|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19787880|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787881|NCT03617172|Misoprostol|misoprostol|mesh-list
19787882|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19787883|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
19787884|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19638947|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638948|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
19638949|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19638950|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
19638951|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
19638952|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787885|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787886|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19787887|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19787888|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
19787889|NCT03587272|Sirolimus|sirolimus|mesh-list
19787890|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
19787891|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20153282|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19638953|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19638954|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19638955|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19638956|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
19638957|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638958|NCT02408146|Celecoxib|celecoxib|mesh-list
19638959|NCT02408146|Parecoxib|parecoxib|mesh-list
19638960|NCT02408146|Fentanyl|fentanyl|mesh-list
19638961|NCT02408146|Ondansetron|ondansetron|mesh-list
19638962|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19638963|NCT02408146|Narcotics|narcotics|mesh-ancestor
19638964|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19638965|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19638966|NCT02408146|Analgesics|analgesics|mesh-ancestor
19638967|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
19638968|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19638969|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19638970|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19638971|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
19638972|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
19638973|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19638974|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19638975|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19638976|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19638977|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19638978|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19638979|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19638980|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19638981|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
19638982|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
19638983|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19638984|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
19638985|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
20153283|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153284|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153285|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153286|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
20153287|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153288|NCT00095810|Aripiprazole|aripiprazole|mesh-list
20153289|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
20153290|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153291|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153292|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153293|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153294|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153295|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153296|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
20153297|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153298|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153299|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19638986|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19787892|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19638987|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
19787893|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19638988|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19638989|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19638990|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19638991|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320846|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
20320847|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19638992|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19638993|NCT02407899|Vitamin D|vitamin d|mesh-list
19638994|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
19638995|NCT02407899|Insulin|insulin|mesh-list
19638996|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19638997|NCT02407899|Metformin|metformin|mesh-list
19638998|NCT02407899|Saxagliptin|saxagliptin|mesh-list
19638999|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19639000|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19787894|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787895|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
19787896|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787897|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
19787898|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787899|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787900|NCT03563716|Atezolizumab|atezolizumab|mesh-list
19787901|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787902|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
19787903|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
19787904|NCT03518034|Testosterone|testosterone|mesh-list
19787905|NCT03518034|Androgens|androgens|mesh-ancestor
19787906|NCT03518034|Hormones|hormones|mesh-ancestor
19787907|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19787908|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787909|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
19787910|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19787911|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19787912|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787913|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
19787914|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
19787915|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787916|NCT03366415|Gemcitabine|gemcitabine|mesh-list
19787917|NCT03366415|Cisplatin|cisplatin|mesh-list
19787918|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787919|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19787920|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
19787921|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787922|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
19787923|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19787924|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787925|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787926|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
19787927|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787928|NCT03315910|Nicotine|nicotine|mesh-list
19787929|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19787930|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
19787931|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19787932|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787933|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19787934|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19787935|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
19787936|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19787937|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787938|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
19787939|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787940|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787941|NCT03239015|Trastuzumab|trastuzumab|mesh-list
20153300|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153301|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
19639001|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639002|NCT02407899|Vitamins|vitamins|mesh-ancestor
19787942|NCT03239015|Everolimus|everolimus|mesh-list
20153302|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20153303|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153304|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153305|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153306|NCT00095823|Aripiprazole|aripiprazole|mesh-list
20153307|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
19787943|NCT03239015|Olaparib|olaparib|mesh-list
20320848|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787944|NCT03239015|Gefitinib|gefitinib|mesh-list
19639003|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
19787945|NCT03239015|Palbociclib|palbociclib|mesh-list
19787946|NCT03239015|Afatinib|afatinib|mesh-list
20320849|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
19787947|NCT03239015|Vemurafenib|vemurafenib|mesh-list
19787948|NCT03239015|Dabrafenib|dabrafenib|mesh-list
19787949|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19787950|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787951|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639004|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19639005|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19639006|NCT02407899|Incretins|incretins|mesh-ancestor
19639007|NCT02407899|Hormones|hormones|mesh-ancestor
19639008|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639009|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
19639010|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639011|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787952|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787953|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
19787954|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787955|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19787956|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787957|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787958|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19787959|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19787960|NCT03239015|Growth Substances|growth substances|mesh-ancestor
19787961|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
19787962|NCT03197935|Paclitaxel|paclitaxel|mesh-list
19787963|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
19787964|NCT03197935|Doxorubicin|doxorubicin|mesh-list
19787965|NCT03197935|Atezolizumab|atezolizumab|mesh-list
19787966|NCT03197935|Antibodies|antibodies|mesh-list
19787967|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19787968|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787969|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
19787970|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
19787971|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
19787972|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787973|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787974|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
19787975|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787976|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787977|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19787978|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
19787979|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19787980|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19787981|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19639012|NCT02408042|Rituximab|rituximab|mesh-list
19639013|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
19787982|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19787983|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19787984|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
19787985|NCT03161379|Nivolumab|nivolumab|mesh-list
19787986|NCT03161379|Pancrelipase|pancrelipase|mesh-list
19787987|NCT03161379|Vaccines|vaccines|mesh-list
19787988|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
19787989|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19787990|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19787991|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19787992|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19787993|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
19787994|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19787995|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19787996|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19787997|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19787998|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19787999|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19788000|NCT03120780|Fentanyl|fentanyl|mesh-list
19788001|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19788002|NCT03120780|Narcotics|narcotics|mesh-ancestor
19788003|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788004|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788005|NCT03120780|Analgesics|analgesics|mesh-ancestor
19788006|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
19788007|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788008|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19788009|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19639014|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19788010|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
20153308|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153309|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153310|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153311|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153312|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153313|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153314|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
20153315|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153316|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153317|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20320850|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20320851|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320852|NCT05072236|Lidocaine|lidocaine|mesh-list
20320853|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
20320854|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
20320855|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639015|NCT02408042|Carboplatin|carboplatin|mesh-list
19639016|NCT02408042|Etoposide|etoposide|mesh-list
19639017|NCT02408042|Ifosfamide|ifosfamide|mesh-list
19639018|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19639019|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639020|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
19639021|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639022|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19639023|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19639024|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19639025|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19639026|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639027|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639028|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19639029|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
19639030|NCT02408003|Simendan|simendan|mesh-list
19639031|NCT02408003|Milrinone|milrinone|mesh-list
19639032|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19639033|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
19639034|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19639035|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19639036|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663042|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19663043|NCT05096715|Growth Substances|growth substances|mesh-ancestor
19663044|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663045|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
19663046|NCT05096676|Oxytocin|oxytocin|mesh-list
19663047|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
19663048|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19663049|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663050|NCT05096520|Lidocaine|lidocaine|mesh-list
19663051|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
19663052|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
19663053|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663054|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663055|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
19663056|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663057|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19663058|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19663059|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19663060|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663061|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665992|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665993|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665994|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
19665995|NCT02733614|SRX246|srx246|mesh-list
19665996|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19788011|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
19788012|NCT03079921|Propranolol|propranolol|mesh-list
19788013|NCT03079921|Phentolamine|phentolamine|mesh-list
19788014|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19788015|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19788016|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
19788017|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19788018|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788019|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788020|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19788021|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19788022|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
19788023|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19788024|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
19788025|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788026|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320856|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320857|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
20320858|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320859|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20320860|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20320861|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19788027|NCT03017131|Aldesleukin|aldesleukin|mesh-list
19788028|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
19788029|NCT03017131|Decitabine|decitabine|mesh-list
19788030|NCT03017131|Interleukin-2|interleukin-2|mesh-list
19788031|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788032|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
19788033|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639037|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639038|NCT02408003|Protective Agents|protective agents|mesh-ancestor
19639039|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639040|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19639041|NCT02407821|Citalopram|citalopram|mesh-list
19639042|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20320862|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19639043|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19639044|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19639045|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639046|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639047|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
19639048|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639049|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19639050|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
19639051|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19639052|NCT02407912|Cisplatin|cisplatin|mesh-list
19639053|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639054|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19639055|NCT02407834|Eusol|eusol|mesh-list
19639056|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
19639057|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639058|NCT02407782|Ivermectin|ivermectin|mesh-list
19639059|NCT02407782|Permethrin|permethrin|mesh-list
19639060|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19639061|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639062|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639063|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788034|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788035|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788036|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
19788037|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788038|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788039|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19788040|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19788041|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
19788042|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788043|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19788044|NCT03017131|Analgesics|analgesics|mesh-ancestor
19788045|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
19788046|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788047|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19639064|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19788048|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19788049|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
19788050|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788051|NCT03013933|Cyclosporine|cyclosporine|mesh-list
19788052|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19788053|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19788054|NCT03013933|Verapamil|verapamil|mesh-list
19788055|NCT03013933|Antibodies|antibodies|mesh-list
19788056|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
19788057|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19788058|NCT03013933|Cyclosporins|cyclosporins|mesh-list
19788059|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
19788060|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
19788061|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788062|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788063|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788064|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788065|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788066|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
19788067|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788068|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
19788069|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788070|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19788071|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19788072|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19788073|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19788074|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19788075|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
19788076|NCT03007238|Aldesleukin|aldesleukin|mesh-list
19788077|NCT03007238|Interleukin-2|interleukin-2|mesh-list
19788078|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788079|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20153318|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153319|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
20153320|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20153321|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153322|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153323|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153324|NCT00095862|Interferons|interferons|mesh-list
20153325|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
20320863|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320864|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
20320865|NCT05068791|Psilocybin|psilocybin|mesh-list
20320866|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
20320867|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
20320868|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20320869|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20320870|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320871|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320872|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320873|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
19639065|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
19639066|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639067|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663062|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
19663063|NCT05096390|Axitinib|axitinib|mesh-list
19663064|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663065|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663066|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19663067|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663068|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663069|NCT05096312|Zinc|zinc|mesh-list
19663070|NCT05096312|Adapalene|adapalene|mesh-list
19663071|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19663072|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19663073|NCT05096312|Trace Elements|trace elements|mesh-ancestor
19663074|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
19663075|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663076|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
19663077|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19663078|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19663079|NCT05096312|Analgesics|analgesics|mesh-ancestor
19663080|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
19663081|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663082|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19663083|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788080|NCT03007238|Analgesics|analgesics|mesh-ancestor
20153326|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
20153327|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788081|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
19788082|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788083|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788084|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19788085|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19788086|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
19788087|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788088|NCT02823002|Lidocaine|lidocaine|mesh-list
19788089|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
19788090|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
19788091|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788092|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788093|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
19788094|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788095|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19788096|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19788097|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19788098|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20320874|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320875|NCT05065567|Droperidol|droperidol|mesh-list
20320876|NCT05065567|Haloperidol|haloperidol|mesh-list
20320877|NCT05065567|Ondansetron|ondansetron|mesh-list
19639068|NCT02407600|Aprepitant|aprepitant|mesh-list
19639069|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
19788099|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788100|NCT02779257|Diazoxide|diazoxide|mesh-list
19788101|NCT02779257|Pasireotide|pasireotide|mesh-list
19788102|NCT02779257|Hormones|hormones|mesh-ancestor
19788103|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788104|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788105|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19788106|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
19788107|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19788108|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19788109|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788110|NCT02660411|Propofol|propofol|mesh-list
19788111|NCT02660411|Sevoflurane|sevoflurane|mesh-list
19788112|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19788113|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788114|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788115|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19788116|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
19788117|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
19788118|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19788119|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19788120|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
19788121|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
19788122|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
19788123|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788124|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788125|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788126|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788127|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
19788128|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788129|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788130|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19788131|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788132|NCT02633137|Cytarabine|cytarabine|mesh-list
19788133|NCT02633137|Lenalidomide|lenalidomide|mesh-list
19639070|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
19639071|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
19639072|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639073|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639074|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639075|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19639076|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639077|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639078|NCT02407626|Propofol|propofol|mesh-list
19639079|NCT02407626|Sevoflurane|sevoflurane|mesh-list
19639080|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19639081|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639082|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639083|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19788134|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20320878|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
19788135|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
19788136|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788137|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788138|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
19788139|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788140|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788141|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
19788142|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788143|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19788144|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19788145|NCT02633137|Growth Substances|growth substances|mesh-ancestor
19639084|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
19788146|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
19788147|NCT02578732|Leucovorin|leucovorin|mesh-list
19788148|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
19788149|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788150|NCT02578732|Antidotes|antidotes|mesh-ancestor
19788151|NCT02578732|Protective Agents|protective agents|mesh-ancestor
19788152|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788153|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
19788154|NCT02578732|Vitamins|vitamins|mesh-ancestor
19788155|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
19788156|NCT02530437|Paclitaxel|paclitaxel|mesh-list
19788157|NCT02530437|Carboplatin|carboplatin|mesh-list
19788158|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19788159|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19788160|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788161|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
19788162|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
19639085|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
19639086|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19639087|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19788163|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788164|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788165|NCT02501434|Heparin|heparin|mesh-list
19788166|NCT02501434|Calcium heparin|calcium heparin|mesh-list
19788167|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
19788168|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19788169|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19788170|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788171|NCT02478255|Xenon|xenon|mesh-list
19788172|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19788173|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
19788174|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
19788175|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788176|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788177|NCT02462421|Canagliflozin|canagliflozin|mesh-list
19788178|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19788179|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788180|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788181|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788182|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
19788183|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788184|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788185|NCT02272790|Gemcitabine|gemcitabine|mesh-list
19788186|NCT02272790|Paclitaxel|paclitaxel|mesh-list
19639088|NCT02407392|Acetic Acid|acetic acid|mesh-list
19639089|NCT02407392|Retinol acetate|retinol acetate|mesh-list
19639090|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19639091|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639092|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19639093|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
19639094|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639095|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19639096|NCT02407392|Protective Agents|protective agents|mesh-ancestor
19639097|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639098|NCT02407366|Carboplatin|carboplatin|mesh-list
19639099|NCT02407366|Pemetrexed|pemetrexed|mesh-list
19639100|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639101|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639102|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639103|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19788187|NCT02272790|Carboplatin|carboplatin|mesh-list
19639104|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19788188|NCT02272790|Adavosertib|adavosertib|mesh-list
19788189|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153328|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
20153329|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153330|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20153331|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20153332|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
20153333|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153334|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153335|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20153336|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
20153337|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153338|NCT00095888|Gemcitabine|gemcitabine|mesh-list
20153339|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153340|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
20153341|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153342|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153343|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
20320879|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
20320880|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
20320881|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320882|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320883|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320884|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
20153344|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153345|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153346|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153347|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
20153348|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153349|NCT00095901|Capecitabine|capecitabine|mesh-list
20153350|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153351|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
20153352|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153353|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153354|NCT00095914|Paclitaxel|paclitaxel|mesh-list
20153355|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20153356|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153357|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320885|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
20320886|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20320887|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
20320888|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20320889|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320890|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20320891|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20320892|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320893|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20320894|NCT05065567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20320895|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20320896|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
20320897|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20320898|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20320899|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20320900|NCT05056974|UB-421|ub-421|mesh-list
20320901|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20320902|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
20320903|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320904|NCT05036408|Coal Tar|coal tar|mesh-list
20320905|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
20320906|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
20320907|NCT05030298|Temozolomide|temozolomide|mesh-list
20320908|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20320909|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
20320910|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320911|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347517|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639105|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19639106|NCT02407340|Oxytocin|oxytocin|mesh-list
19639107|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
19639108|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19639109|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639110|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19639111|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347518|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639112|NCT02407548|Vitamin E|vitamin e|mesh-list
19639113|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
19788190|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788191|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
19788192|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
19788193|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788194|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788195|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19788196|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
19788197|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
19788198|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639114|NCT02407548|Ubiquinone|ubiquinone|mesh-list
19639115|NCT02407548|Vitamins|vitamins|mesh-ancestor
19639116|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
19788199|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788200|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788201|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
19788202|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833928|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19833929|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19833930|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19833931|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833932|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19833933|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
19833934|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833935|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19833936|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
19833937|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19833938|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19833939|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19833940|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
19833941|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
19833942|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19833943|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19833944|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19833945|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
19833946|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19833947|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
19833948|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19833949|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19833950|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833951|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19833952|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19833953|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
19833954|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
19833955|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20611174|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833956|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19833957|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19833958|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19833959|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20153358|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153359|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153360|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
20153361|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153362|NCT00095927|Paclitaxel|paclitaxel|mesh-list
20153363|NCT00095927|Carboplatin|carboplatin|mesh-list
20153364|NCT00095927|Amifostine|amifostine|mesh-list
20153365|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153366|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639117|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833960|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19833961|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
19639118|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
19639119|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639120|NCT02407548|Protective Agents|protective agents|mesh-ancestor
19639121|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
19639122|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19639123|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639124|NCT02407210|Olmesartan|olmesartan|mesh-list
19639125|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19639126|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20153367|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153368|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153369|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
20320912|NCT05023473|Morphine|morphine|mesh-list
20320913|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20320914|NCT05023473|Narcotics|narcotics|mesh-ancestor
20320915|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20320916|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320917|NCT05023473|Analgesics|analgesics|mesh-ancestor
20320918|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
20320919|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320920|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
20320921|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20320922|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20320923|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
20320924|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320925|NCT05018585|Antacids|antacids|mesh-ancestor
20320926|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320927|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320928|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20320929|NCT05018585|Vitamins|vitamins|mesh-ancestor
20320930|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
19788203|NCT02178410|Vitamin D|vitamin d|mesh-list
19788204|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
19788205|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
19788206|NCT02178410|Vitamins|vitamins|mesh-list
19788207|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
19788208|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788209|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19788210|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19788211|NCT01880541|Anesthetics|anesthetics|mesh-list
19788212|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788213|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788214|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
19788215|NCT01852890|Gemcitabine|gemcitabine|mesh-list
19788216|NCT01852890|Vitamins|vitamins|mesh-ancestor
19788217|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
19788218|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788219|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20320931|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20320935|NCT04984811|Atezolizumab|atezolizumab|mesh-list
20320936|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788220|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
19788221|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788222|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788223|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
19788224|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788225|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788226|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788227|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
19788228|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
19788229|NCT01852890|Protective Agents|protective agents|mesh-ancestor
19788230|NCT01650350|Naltrexone|naltrexone|mesh-list
19788231|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19788232|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19788233|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788234|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
19788235|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788236|NCT01595321|Leucovorin|leucovorin|mesh-list
19788237|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
19788238|NCT01595321|Fluorouracil|fluorouracil|mesh-list
19788239|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
19788240|NCT01595321|Irinotecan|irinotecan|mesh-list
19788241|NCT01595321|Folfirinox|folfirinox|mesh-list
20320937|NCT04961528|Terlipressin|terlipressin|mesh-list
20320938|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
20320939|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20320940|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19788242|NCT01595321|Vaccines|vaccines|mesh-list
19788243|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
19788244|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788245|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788246|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20320941|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788247|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788248|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
20320942|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
20320943|NCT04961528|Coagulants|coagulants|mesh-ancestor
19788249|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788250|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788251|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19788252|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
19788253|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19788254|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19788255|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19788256|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788257|NCT01595321|Antidotes|antidotes|mesh-ancestor
19788258|NCT01595321|Protective Agents|protective agents|mesh-ancestor
19788259|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
19788260|NCT01595321|Vitamins|vitamins|mesh-ancestor
19788261|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
19788262|NCT01552590|Tolvaptan|tolvaptan|mesh-list
19788263|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19788264|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788265|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
19788266|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788267|NCT01345136|Everolimus|everolimus|mesh-list
19788268|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788269|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788270|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
19788271|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788272|NCT01158417|Resveratrol|resveratrol|mesh-list
19788273|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
19788274|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788275|NCT01158417|Protective Agents|protective agents|mesh-ancestor
19788276|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788277|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788278|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19788279|NCT01000467|Probucol|probucol|mesh-list
19788280|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19788281|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19788282|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
19788283|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788284|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19788285|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
19788286|NCT01000467|Protective Agents|protective agents|mesh-ancestor
19788287|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788288|NCT00743197|Aspirin|aspirin|mesh-list
19788289|NCT00743197|Lisinopril|lisinopril|mesh-list
19788290|NCT00743197|Simvastatin|simvastatin|mesh-list
19788291|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19788292|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20320944|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20320945|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20320946|NCT04956627|Itraconazole|itraconazole|mesh-list
20320947|NCT04956627|Phenytoin|phenytoin|mesh-list
20320948|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
20320949|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
20320950|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20320951|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20320952|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20320953|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320954|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320955|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20320956|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
19788293|NCT00743197|Analgesics|analgesics|mesh-ancestor
19788294|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
19788295|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788296|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788297|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19788298|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788299|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19788300|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19788301|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788302|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19788303|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19788304|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788305|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
19788306|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19788307|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19788308|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
19788309|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19788310|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19788311|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19788312|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
19788313|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19788314|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19788315|NCT00743197|Protective Agents|protective agents|mesh-ancestor
19788316|NCT00549978|Cilostazol|cilostazol|mesh-list
19788317|NCT00549978|Probucol|probucol|mesh-list
19788318|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19788319|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
19788320|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788321|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788322|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19788323|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
19788324|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19788325|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19788326|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788327|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19788328|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
19788329|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19788330|NCT00549978|Protective Agents|protective agents|mesh-ancestor
19788331|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19788332|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19788333|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788334|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19788335|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19788336|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
19788337|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19788338|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
19788339|NCT00198328|Bleomycin|bleomycin|mesh-list
19788340|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788341|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788342|NCT00198315|Bleomycin|bleomycin|mesh-list
19788343|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788344|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788345|NCT00304954|Sirolimus|sirolimus|mesh-list
19788346|NCT00304954|Infliximab|infliximab|mesh-list
19788347|NCT00304954|Daclizumab|daclizumab|mesh-list
19788348|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19788349|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788350|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788351|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788352|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
19788353|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788354|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
19788355|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788356|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
19788357|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20320957|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20320958|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20320959|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20320960|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
20320961|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20320962|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20320963|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20320964|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20320965|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20320966|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20320967|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
20320968|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20320969|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20320970|NCT04926285|Venetoclax|venetoclax|mesh-list
19788358|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788359|NCT00305058|Morphine|morphine|mesh-list
19788360|NCT00305058|Hydromorphone|hydromorphone|mesh-list
20153370|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153371|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20153372|NCT00095927|Protective Agents|protective agents|mesh-ancestor
20153373|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153374|NCT00095966|Gemcitabine|gemcitabine|mesh-list
20153375|NCT00095966|Sorafenib|sorafenib|mesh-list
20153376|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19788361|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19788362|NCT00305058|Narcotics|narcotics|mesh-ancestor
19788363|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788364|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788365|NCT00305058|Analgesics|analgesics|mesh-ancestor
19788366|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
20320971|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
20320972|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320973|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20320974|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20320975|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20320976|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320977|NCT04921371|Listerine|listerine|mesh-list
20320978|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19788367|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788368|NCT00305084|Doxorubicin|doxorubicin|mesh-list
19788369|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788370|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788371|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19788372|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19788373|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788374|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788375|NCT00305110|Hydromorphone|hydromorphone|mesh-list
19788376|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19788377|NCT00305110|Narcotics|narcotics|mesh-ancestor
19788378|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788379|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788380|NCT00305110|Analgesics|analgesics|mesh-ancestor
19788381|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
19788382|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788383|NCT00305162|Clopidogrel|clopidogrel|mesh-list
19788384|NCT00305162|Cangrelor|cangrelor|mesh-list
19788385|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19788386|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19788387|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19788388|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19788389|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
19788390|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19788391|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788392|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788393|NCT00305448|Fulvestrant|fulvestrant|mesh-list
19788394|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19788395|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788396|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19788397|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20153377|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
20153378|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20320979|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788398|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
19788399|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788400|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788401|NCT00305578|Memantine|memantine|mesh-list
19788402|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19788403|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19788404|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
19788405|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19788406|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788407|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788408|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19788409|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19788410|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19788411|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153379|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153380|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
20153381|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153382|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153383|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153384|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
20153385|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788412|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788413|NCT00305604|Incretins|incretins|mesh-ancestor
19788414|NCT00305604|Hormones|hormones|mesh-ancestor
19788415|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788416|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19788417|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
19788418|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835483|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20320980|NCT04897217|Megestrol|megestrol|mesh-list
20320981|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
20153386|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153387|NCT00096005|Bortezomib|bortezomib|mesh-list
19639127|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19639128|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19639129|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20153388|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153389|NCT00096057|Antibodies|antibodies|mesh-list
20153390|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20153391|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
20153392|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153393|NCT00096070|Gemcitabine|gemcitabine|mesh-list
20153394|NCT00096070|Fluorouracil|fluorouracil|mesh-list
20153395|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
20153396|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20320982|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
20320983|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20320984|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
20320985|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20320986|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639130|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639131|NCT02407314|Aspirin|aspirin|mesh-list
19639132|NCT02407314|Ticagrelor|ticagrelor|mesh-list
19639133|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19639134|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19639135|NCT02407314|Analgesics|analgesics|mesh-ancestor
19639136|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
19639137|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639138|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639139|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639140|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19639141|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19639142|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19639143|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639144|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19639145|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19639146|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639147|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
19663084|NCT05095714|Liver Extracts|liver extracts|mesh-list
19663085|NCT05095714|Hematinics|hematinics|mesh-ancestor
19663086|NCT05095636|Apatinib|apatinib|mesh-list
19663087|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663088|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19663089|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663090|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663091|NCT05095571|Niacinamide|niacinamide|mesh-list
19663092|NCT05095571|Niacin|niacin|mesh-list
19663093|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
19663094|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
19663095|NCT05095571|Vitamins|vitamins|mesh-ancestor
19663096|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
19663097|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663098|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19663099|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
19663100|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663101|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19663102|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
19663103|NCT05095480|Red yeast rice|red yeast rice|mesh-list
19663104|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19663105|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19663106|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19663107|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
19663108|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663109|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663110|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19663111|NCT05095467|Paclitaxel|paclitaxel|mesh-list
19663112|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19663113|NCT05095467|Tegafur|tegafur|mesh-list
19663114|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19663115|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663116|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
19663117|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
20320987|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20320988|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20320989|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19788419|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788420|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
19788421|NCT00305682|Sirolimus|sirolimus|mesh-list
19788422|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
19788423|NCT00305682|Fludarabine|fludarabine|mesh-list
19788424|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19788425|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788426|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
19788427|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788428|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788429|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788430|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
19788431|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788432|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788433|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19788434|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788435|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19788436|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
19788437|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19788438|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788439|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788440|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
19788441|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
19788442|NCT00305695|Imidazole|imidazole|mesh-list
19788443|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19788444|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788445|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788446|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788447|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
19788448|NCT00305760|Cetuximab|cetuximab|mesh-list
19788449|NCT00305760|Vaccines|vaccines|mesh-list
19788450|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
19788451|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788452|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788453|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788454|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788455|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
19788456|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788457|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788458|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19788459|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788460|NCT00305773|Vorinostat|vorinostat|mesh-list
19788461|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788462|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19788463|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788464|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788465|NCT00305864|Temozolomide|temozolomide|mesh-list
19788466|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
19788467|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788468|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
19788469|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788470|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788471|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19788472|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
19788473|NCT00305877|Gemcitabine|gemcitabine|mesh-list
19788474|NCT00305877|Bevacizumab|bevacizumab|mesh-list
19788475|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19788476|NCT00305877|Cetuximab|cetuximab|mesh-list
19788477|NCT00305877|Capecitabine|capecitabine|mesh-list
19788478|NCT00305877|Antibodies|antibodies|mesh-list
19788479|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
19788480|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19788481|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788482|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19788483|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19788484|NCT00305877|Growth Substances|growth substances|mesh-ancestor
19788485|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788486|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
19788487|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
19788488|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19788489|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
19788490|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788491|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
19788492|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788493|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788494|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788495|NCT00305942|Carboplatin|carboplatin|mesh-list
19788496|NCT00305942|Topotecan|topotecan|mesh-list
19788497|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788498|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19788499|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19788500|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788501|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788502|NCT00306163|Fluticasone|fluticasone|mesh-list
19788503|NCT00306163|Ciclesonide|ciclesonide|mesh-list
19788504|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19788505|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19788506|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
19788507|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20320990|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20320991|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20320992|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20320993|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
20320994|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20320995|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
20320996|NCT04892277|Fludarabine|fludarabine|mesh-list
20320997|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20320998|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
20320999|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321000|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321001|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20321002|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
20321003|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321004|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788508|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788509|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19788510|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
19788511|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
20321005|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20321006|NCT04844814|Prednisone|prednisone|mesh-list
20321007|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20321008|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321009|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
20321010|NCT04844814|Hormones|hormones|mesh-ancestor
19788512|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19788513|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
19788514|NCT00306163|Hormones|hormones|mesh-ancestor
19788515|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788516|NCT00306189|Denosumab|denosumab|mesh-list
19788517|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19788518|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788519|NCT00306202|Dasatinib|dasatinib|mesh-list
19788520|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788521|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19788522|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788523|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788524|NCT00306293|Valacyclovir|valacyclovir|mesh-list
19788525|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
19788526|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788527|NCT00306384|Alogliptin|alogliptin|mesh-list
19788528|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788529|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153397|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
20153398|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153399|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153400|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
20153401|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153402|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153403|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153404|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
19663118|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
19663119|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663120|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663121|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
19663122|NCT05095259|Insulin|insulin|mesh-list
19663123|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19663124|NCT05095259|Epinephrine|epinephrine|mesh-list
19663125|NCT05095259|Glucagon|glucagon|mesh-list
20321011|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321012|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321013|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321014|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321015|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321016|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20321017|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321018|NCT04814446|Vaccines|vaccines|mesh-list
20321019|NCT04814446|Immunologic Factors|immunologic factors|mesh-ancestor
20321020|NCT04814446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788530|NCT00306384|Incretins|incretins|mesh-ancestor
19788531|NCT00306384|Hormones|hormones|mesh-ancestor
19788532|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788533|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19788534|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
19788535|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788536|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788537|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19788538|NCT00306488|Antioxidants|antioxidants|mesh-list
19788539|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19788540|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788541|NCT00306488|Protective Agents|protective agents|mesh-ancestor
19788542|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788543|NCT00306527|Vaccines|vaccines|mesh-list
19788544|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
19788545|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788546|NCT00306592|Natalizumab|natalizumab|mesh-list
19788547|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
19788548|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788549|NCT00306670|Prednisone|prednisone|mesh-list
19788550|NCT00306670|Rituximab|rituximab|mesh-list
19788551|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788552|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788553|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
19788554|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788555|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788556|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19788557|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
19788558|NCT00306670|Hormones|hormones|mesh-ancestor
19788559|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788560|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19788561|NCT00306787|Valacyclovir|valacyclovir|mesh-list
19788562|NCT00306787|Famciclovir|famciclovir|mesh-list
19788563|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
19788564|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788565|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19788566|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788567|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788568|NCT00306852|Mitomycins|mitomycins|mesh-list
19788569|NCT00306852|Mitomycin|mitomycin|mesh-list
19788570|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788571|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788572|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
19788573|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788574|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20321021|NCT04806919|Progesterone|progesterone|mesh-list
20321022|NCT04806919|Progestins|progestins|mesh-ancestor
20321023|NCT04806919|Hormones|hormones|mesh-ancestor
20321024|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788575|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788576|NCT00306891|Cediranib|cediranib|mesh-list
19788577|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788578|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19788579|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788580|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788581|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19788582|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
19788583|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788584|NCT00307047|Paclitaxel|paclitaxel|mesh-list
19788585|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19788586|NCT00307047|Everolimus|everolimus|mesh-list
19788587|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19788588|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321025|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788589|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
19788590|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
19788591|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788592|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788593|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788594|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
19788595|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788596|NCT00307086|Bortezomib|bortezomib|mesh-list
19788597|NCT00307086|Melphalan|melphalan|mesh-list
19788598|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788599|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788600|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
19788601|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788602|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19788603|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788604|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
19788605|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788606|NCT00307125|Rituximab|rituximab|mesh-list
19788607|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788608|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788609|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
19788610|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788611|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788612|NCT00307151|Ritonavir|ritonavir|mesh-list
20321026|NCT04800224|Propolis|propolis|mesh-list
20321027|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321028|NCT04786340|Pirenzepine|pirenzepine|mesh-list
20321029|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20321030|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20321031|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321032|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20321033|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20321034|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
20321035|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20321036|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321037|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321038|NCT04781972|Methylphenidate|methylphenidate|mesh-list
19788613|NCT00307151|Lopinavir|lopinavir|mesh-list
19788614|NCT00307151|Lamivudine|lamivudine|mesh-list
19788615|NCT00307151|Zidovudine|zidovudine|mesh-list
19788616|NCT00307151|Nevirapine|nevirapine|mesh-list
19788617|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19788618|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19788619|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
19788620|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788621|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788622|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19788623|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19788624|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
19788625|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788626|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19788627|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19788628|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19788629|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19788630|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
19788631|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19788632|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19788633|NCT00307294|Thalidomide|thalidomide|mesh-list
19788634|NCT00307294|Doxorubicin|doxorubicin|mesh-list
19788635|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788636|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788637|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19788638|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19788639|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788640|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788641|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788642|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
19788643|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788644|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
19788645|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19788646|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321039|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19788647|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19788648|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19788649|NCT00307294|Growth Substances|growth substances|mesh-ancestor
20321040|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321041|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20321042|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20321043|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20321044|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321045|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
20153405|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153406|NCT00096083|Melphalan|melphalan|mesh-list
20153407|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20153408|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
20153409|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321046|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20321047|NCT04779307|Vedolizumab|vedolizumab|mesh-list
20321048|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321049|NCT04778397|Cytarabine|cytarabine|mesh-list
20321050|NCT04778397|Azacitidine|azacitidine|mesh-list
20321051|NCT04778397|Daunorubicin|daunorubicin|mesh-list
20321052|NCT04778397|Venetoclax|venetoclax|mesh-list
20321053|NCT04778397|Idarubicin|idarubicin|mesh-list
20321054|NCT04778397|Magrolimab|magrolimab|mesh-list
20321055|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19639148|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19639149|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19639150|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20321056|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321057|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
20321058|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321059|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639151|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
19788650|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
19788651|NCT00307437|Ustekinumab|ustekinumab|mesh-list
19788652|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
19788653|NCT00307489|Tenofovir|tenofovir|mesh-list
19788654|NCT00307489|Emtricitabine|emtricitabine|mesh-list
20321060|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
20321061|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321062|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788655|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
19788656|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788657|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19788658|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19788659|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788660|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788661|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19788662|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19788663|NCT00307684|Methylphenidate|methylphenidate|mesh-list
20153410|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153411|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20153412|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153413|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
20153414|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153415|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
20153416|NCT00096096|Tacrolimus|tacrolimus|mesh-list
20153417|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153418|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
20153419|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153420|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20153421|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153422|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321063|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
20321064|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639152|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639153|NCT02407080|Interferons|interferons|mesh-list
19639154|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
19639155|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
19639156|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19639157|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639158|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
19639159|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639160|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
19788664|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19788665|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788666|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19788667|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19788668|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19639161|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639162|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19639163|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19639164|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639165|NCT02406950|Incretins|incretins|mesh-ancestor
19639166|NCT02406950|Hormones|hormones|mesh-ancestor
19639167|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639168|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19788669|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788670|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
19788671|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19788672|NCT00307736|Bevacizumab|bevacizumab|mesh-list
19788673|NCT00307736|Fluorouracil|fluorouracil|mesh-list
19788674|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19788675|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788676|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788677|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19788678|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19788679|NCT00307736|Growth Substances|growth substances|mesh-ancestor
19788680|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788681|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
19788682|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
19788683|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788684|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19788685|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788686|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
19788687|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19788688|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788689|NCT00307801|Dienogest|dienogest|mesh-list
19788690|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19788691|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19788692|NCT00307801|Estradiol|estradiol|mesh-list
19788693|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19788694|NCT00307801|Estrogens|estrogens|mesh-ancestor
19788695|NCT00307801|Hormones|hormones|mesh-ancestor
19788696|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788697|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788698|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19788699|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
19788700|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19788701|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19788702|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19788703|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19788704|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19788705|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
19788706|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19788707|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788708|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
20153423|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153424|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153425|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20321065|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321066|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20321067|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321068|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19639169|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
20153426|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
20153427|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20153428|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153429|NCT00096148|Cytarabine|cytarabine|mesh-list
20153430|NCT00096148|Bevacizumab|bevacizumab|mesh-list
20153431|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20153432|NCT00096148|Idarubicin|idarubicin|mesh-list
20153433|NCT00096148|Antibodies|antibodies|mesh-list
19639170|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639171|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788709|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788710|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
19788711|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788712|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20153434|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
20153435|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20153436|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153437|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19788713|NCT00308074|Aripiprazole|aripiprazole|mesh-list
19788714|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
19788715|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19788716|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19788717|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20321069|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20321070|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321071|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
20321072|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321073|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
19788718|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19788719|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788720|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
19788721|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
19788722|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19788723|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788724|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20153438|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20153439|NCT00096148|Growth Substances|growth substances|mesh-ancestor
20153440|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153441|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
20153442|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
20153443|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321074|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321083|NCT04713098|Coal Tar|coal tar|mesh-list
20321084|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
20321085|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
20321086|NCT04700124|Gemcitabine|gemcitabine|mesh-list
19639172|NCT02406911|Ticagrelor|ticagrelor|mesh-list
20153444|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
20153445|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153446|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
20153447|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153448|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153449|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153450|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20153451|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20321087|NCT04700124|Cisplatin|cisplatin|mesh-list
19639173|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19639174|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19639175|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19639176|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19639177|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
19639178|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639179|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639180|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639181|NCT02406872|Propofol|propofol|mesh-list
19639182|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19639183|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639184|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639185|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19639186|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
19639187|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
19639188|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
19639189|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
19639190|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19639191|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639192|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19639193|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
19639194|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639195|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19639196|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788725|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20321088|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
20321089|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788726|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
19788727|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19788728|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19788729|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19788730|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19788731|NCT00308087|Rituximab|rituximab|mesh-list
19639197|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
19639198|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639199|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19639200|NCT02406508|Sorafenib|sorafenib|mesh-list
19639201|NCT02406508|Melphalan|melphalan|mesh-list
19639202|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639203|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19639204|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788732|NCT00308087|Molgramostim|molgramostim|mesh-list
19788733|NCT00308087|Sargramostim|sargramostim|mesh-list
19788734|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19788735|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788736|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
19788737|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788738|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788739|NCT00308139|Exenatide|exenatide|mesh-list
19788740|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788741|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788742|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19788743|NCT00308139|Incretins|incretins|mesh-ancestor
19788744|NCT00308139|Hormones|hormones|mesh-ancestor
19788745|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788746|NCT00308308|Insulin|insulin|mesh-list
19788747|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788748|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788749|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
19788750|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788751|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
19788752|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788753|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788754|NCT00308620|Chloroquine|chloroquine|mesh-list
19788755|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19788756|NCT00308620|Amebicides|amebicides|mesh-ancestor
19788757|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19788758|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20153452|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153453|NCT00096187|Pemetrexed|pemetrexed|mesh-list
20153454|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153455|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153456|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153457|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20153458|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20153459|NCT00096291|Paclitaxel|paclitaxel|mesh-list
20153460|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20153461|NCT00096291|Doxorubicin|doxorubicin|mesh-list
20153462|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20153463|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153464|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153465|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153466|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153467|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20153468|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153469|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153470|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20153471|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20153472|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153473|NCT00096304|Docetaxel|docetaxel|mesh-list
20153474|NCT00096304|Epirubicin|epirubicin|mesh-list
20153475|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153476|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153477|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153478|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
20153479|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153480|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153481|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20153482|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20153483|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153484|NCT00096317|Ketoconazole|ketoconazole|mesh-list
19788759|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788760|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
19788761|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19639205|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639206|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19639207|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
19639208|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19639209|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788762|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19788763|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19788764|NCT00308620|Analgesics|analgesics|mesh-ancestor
19788765|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
19788766|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788767|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788768|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20153485|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
20153486|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153487|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20153488|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20153489|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153490|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153491|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20153492|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
20153493|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20153494|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153495|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19788769|NCT00308620|Filaricides|filaricides|mesh-ancestor
19788770|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
19788771|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
19788772|NCT00308711|Misoprostol|misoprostol|mesh-list
19788773|NCT00308711|Dinoprostone|dinoprostone|mesh-list
19788774|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19788775|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
19788776|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19788777|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788778|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19788779|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19788780|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
19788781|NCT00308737|Insulin|insulin|mesh-list
19788782|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788783|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788784|NCT00308750|Carboplatin|carboplatin|mesh-list
19788785|NCT00308750|Docetaxel|docetaxel|mesh-list
19788786|NCT00308750|Pemetrexed|pemetrexed|mesh-list
20153496|NCT00096330|Folic Acid|folic acid|mesh-list
20153497|NCT00096330|Hematinics|hematinics|mesh-ancestor
20153498|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
20153499|NCT00096330|Vitamins|vitamins|mesh-ancestor
20153500|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
20153501|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153502|NCT00096343|Paclitaxel|paclitaxel|mesh-list
20153503|NCT00096343|Carboplatin|carboplatin|mesh-list
20153504|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153505|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153506|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
19639210|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
19639211|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639212|NCT02406690|Leuprolide|leuprolide|mesh-list
19639213|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19639214|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19639215|NCT02406690|Estradiol|estradiol|mesh-list
19639216|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19639217|NCT02406690|Progesterone|progesterone|mesh-list
19639218|NCT02406690|Estrogens|estrogens|mesh-ancestor
19639219|NCT02406690|Hormones|hormones|mesh-ancestor
19639220|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639221|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639222|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19639223|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
19639224|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19639225|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19639226|NCT02406690|Progestins|progestins|mesh-ancestor
19639227|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19639228|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
20153507|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153508|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788787|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788788|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
19788789|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
20321090|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321091|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
20321092|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321093|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
20321094|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321095|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321096|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19639229|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19788790|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788791|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788792|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788793|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19788794|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19833962|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19833963|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19833964|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19833965|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19833966|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833967|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19833968|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19833969|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833970|NCT00590967|Cisplatin|cisplatin|mesh-list
19833971|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833972|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
19833973|NCT00591006|Phenytoin|phenytoin|mesh-list
19833974|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19833975|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
19833976|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19833977|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19833978|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19833979|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833980|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19833981|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833982|NCT00591019|Modafinil|modafinil|mesh-list
19833983|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19833984|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833985|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19833986|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19833987|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19833988|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19833989|NCT00591123|Leucovorin|leucovorin|mesh-list
19833990|NCT00591123|Fluorouracil|fluorouracil|mesh-list
19833991|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
19833992|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19833993|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
19833994|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19833995|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
19833996|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153509|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153510|NCT00096369|Tamoxifen|tamoxifen|mesh-list
20153511|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20153512|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
20153513|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20153514|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153515|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20153516|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153517|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20153518|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20321097|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
19639230|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639231|NCT02406703|Mepivacaine|mepivacaine|mesh-list
19639232|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
19639233|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
19639234|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
19639235|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639236|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639237|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
19639238|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639239|NCT02406521|Sorafenib|sorafenib|mesh-list
19639240|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19639241|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639242|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19788795|NCT00309166|Vaccines|vaccines|mesh-list
19788796|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
19788797|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788798|NCT00309244|Insulin|insulin|mesh-list
19788799|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19788800|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
19788801|NCT00309244|Protamines|protamines|mesh-list
19788802|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788803|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788804|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
19788805|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788806|NCT00309244|Coagulants|coagulants|mesh-ancestor
19788807|NCT00309465|Insulin|insulin|mesh-list
19788808|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19788809|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
19788810|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788811|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788812|NCT00309608|Glimepiride|glimepiride|mesh-list
19788813|NCT00309608|Linagliptin|linagliptin|mesh-list
19788814|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19788815|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19788816|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788817|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788818|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
19788819|NCT00309608|Incretins|incretins|mesh-ancestor
19788820|NCT00309608|Hormones|hormones|mesh-ancestor
19788821|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788822|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19788823|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
19788824|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788825|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788826|NCT00309738|Simvastatin|simvastatin|mesh-list
19788827|NCT00309738|Pitavastatin|pitavastatin|mesh-list
19788828|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19788829|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19788830|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
19788831|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788832|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19788833|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19788834|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788835|NCT00309751|Atorvastatin|atorvastatin|mesh-list
19788836|NCT00309751|Pitavastatin|pitavastatin|mesh-list
19788837|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19788838|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19788839|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
19788840|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788841|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19788842|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19788843|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639243|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639244|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639245|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19639246|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20153519|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20153520|NCT00096395|Gemcitabine|gemcitabine|mesh-list
20153521|NCT00096395|Sorafenib|sorafenib|mesh-list
20153522|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153523|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
20153524|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153525|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153526|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
20153527|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153528|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788844|NCT00309777|Simvastatin|simvastatin|mesh-list
20153529|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153530|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
20153531|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153532|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153533|NCT00096434|Sorafenib|sorafenib|mesh-list
20153534|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153535|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20153536|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153537|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788845|NCT00309777|Pitavastatin|pitavastatin|mesh-list
19788846|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20153538|NCT00096473|Donepezil|donepezil|mesh-list
20153539|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20153540|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153541|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153542|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
20153543|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153544|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153545|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
20153546|NCT00096512|Sorafenib|sorafenib|mesh-list
20153547|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153548|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19788847|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19788848|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
19788849|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788850|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19788851|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19788852|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788853|NCT00309842|Cyclosporine|cyclosporine|mesh-list
20153549|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153550|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153551|NCT00096525|Lenalidomide|lenalidomide|mesh-list
20153552|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
20153553|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153554|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153555|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20153556|NCT00096525|Growth Substances|growth substances|mesh-ancestor
20153557|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
20153558|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153559|NCT00096551|Metronidazole|metronidazole|mesh-list
20153560|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153561|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19788854|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
19788855|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
19788856|NCT00309842|Fludarabine|fludarabine|mesh-list
19788857|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
19788858|NCT00309842|Cyclosporins|cyclosporins|mesh-list
19788859|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788860|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
19788861|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788862|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788863|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19788864|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
19788865|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788866|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788867|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19788868|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19788869|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
19788870|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788871|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
20321098|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321099|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321100|NCT04663997|Docetaxel|docetaxel|mesh-list
20321101|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
19788872|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788873|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
19788874|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19788875|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19788876|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19788877|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
19788878|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19788879|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
19788880|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19788881|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19788882|NCT00309907|Prednisolone|prednisolone|mesh-list
19788883|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
19788884|NCT00309907|Etanercept|etanercept|mesh-list
19788885|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19788886|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
19788887|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19788888|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
19788889|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
20153562|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20153563|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20153564|NCT00096616|Albuterol|albuterol|mesh-list
20153565|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19835484|NCT00603187|Acyline|acyline|mesh-list
20153566|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
19788890|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788891|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788892|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19788893|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
19788894|NCT00309907|Hormones|hormones|mesh-ancestor
19788895|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788896|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19788897|NCT00309907|Protective Agents|protective agents|mesh-ancestor
19788898|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19788899|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788900|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19788901|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19788902|NCT00309907|Analgesics|analgesics|mesh-ancestor
19788903|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
19788904|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19788905|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153567|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153568|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153569|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20153570|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
20153571|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
20153572|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20153573|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20153574|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20153575|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20153576|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
20153577|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153578|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153579|NCT00096629|Vaccines|vaccines|mesh-list
20153580|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
20153581|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153582|NCT00096655|Infliximab|infliximab|mesh-list
20153583|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
20153584|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20153585|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20153586|NCT00096668|Paclitaxel|paclitaxel|mesh-list
20153587|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153588|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153589|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153590|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153591|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
20153592|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153593|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
20153594|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20153595|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
20153596|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20153597|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153598|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20153599|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20153600|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20153601|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
20153602|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
20153603|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153604|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
20153605|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153606|NCT00096720|Levodopa|levodopa|mesh-list
20153607|NCT00096720|Pramipexole|pramipexole|mesh-list
20153608|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20153609|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20153610|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
19788906|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
19788907|NCT00309946|Cediranib|cediranib|mesh-list
19788908|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788909|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788910|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788911|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19788912|NCT00309959|Paclitaxel|paclitaxel|mesh-list
19788913|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19788914|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19788915|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788916|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153611|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153612|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788917|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153613|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153614|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
20153615|NCT00096720|Protective Agents|protective agents|mesh-ancestor
20153616|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153617|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20153618|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20153619|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20153620|NCT00096811|Entecavir|entecavir|mesh-list
20153621|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
20153622|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153623|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
20153624|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153625|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20153626|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
20153627|NCT00096850|Ritonavir|ritonavir|mesh-list
20153628|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20153629|NCT00096850|Rifampin|rifampin|mesh-list
20153630|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20153631|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20153632|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
20153633|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153634|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153635|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20153636|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20153637|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
20153638|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153639|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20153640|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20153641|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20153642|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
20153643|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20153644|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
20153645|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20153646|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20153647|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20153648|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20153649|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20153650|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20153651|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20153652|NCT00096863|Haloperidol|haloperidol|mesh-list
20153653|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
20153654|NCT00096863|Ziprasidone|ziprasidone|mesh-list
20153655|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
20153656|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
20153657|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153658|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153659|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20153660|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153661|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153662|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153663|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153664|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153665|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
20153666|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153667|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153668|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20153669|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153670|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
20153671|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
20153672|NCT00096915|Hematinics|hematinics|mesh-ancestor
20153673|NCT00096967|Bevacizumab|bevacizumab|mesh-list
20153674|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663126|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19663127|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663128|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19663129|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19663130|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
19663131|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663132|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663133|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19663134|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19663135|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
19663136|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663137|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19663138|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
20321102|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321103|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
20321104|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153675|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153676|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153677|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20153678|NCT00096967|Growth Substances|growth substances|mesh-ancestor
20153679|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153680|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
19639272|NCT02406300|Bupivacaine|bupivacaine|mesh-list
19639273|NCT02406300|Ropivacaine|ropivacaine|mesh-list
19639274|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
19639275|NCT02406300|Sevoflurane|sevoflurane|mesh-list
19788918|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788919|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788920|NCT00310037|Bortezomib|bortezomib|mesh-list
19639276|NCT02406300|Desflurane|desflurane|mesh-list
19639277|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
19639278|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
19639279|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639280|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788921|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174008|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20174009|NCT00163267|Clopidogrel|clopidogrel|mesh-list
20174010|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20174011|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20174012|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20174013|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20174014|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
20174015|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174016|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174017|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174018|NCT00163306|Pantoprazole|pantoprazole|mesh-list
20174019|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20174020|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20174021|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20174022|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174023|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174024|NCT00163319|Ciclesonide|ciclesonide|mesh-list
20174025|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
20174026|NCT00163319|Hormones|hormones|mesh-ancestor
20174027|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174028|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174029|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174030|NCT00163332|Ciclesonide|ciclesonide|mesh-list
20174031|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
20174032|NCT00163332|Hormones|hormones|mesh-ancestor
20174033|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174034|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174035|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174036|NCT00163345|Ciclesonide|ciclesonide|mesh-list
20174037|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
20174038|NCT00163345|Hormones|hormones|mesh-ancestor
20174039|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174040|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174041|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174042|NCT00163358|Ciclesonide|ciclesonide|mesh-list
20174043|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
20174044|NCT00163358|Hormones|hormones|mesh-ancestor
20174045|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174046|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174047|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174048|NCT00163371|Ciclesonide|ciclesonide|mesh-list
20174049|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
20321105|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788922|NCT00310050|Pemetrexed|pemetrexed|mesh-list
19788923|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788924|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19788925|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788926|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19788927|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19788928|NCT00310076|Thalidomide|thalidomide|mesh-list
19639281|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
20174050|NCT00163371|Hormones|hormones|mesh-ancestor
20321106|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321107|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20321108|NCT04652076|Paclitaxel|paclitaxel|mesh-list
20321109|NCT04652076|Carboplatin|carboplatin|mesh-list
20321110|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
20321111|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19788929|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19788930|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
19788931|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788932|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
19788933|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19788934|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19788935|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19788936|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19788937|NCT00310076|Growth Substances|growth substances|mesh-ancestor
19788938|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
19788939|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788940|NCT00310375|Ezogabine|ezogabine|mesh-list
19788941|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
20153681|NCT00097019|Bevacizumab|bevacizumab|mesh-list
20153682|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20153683|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153684|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153685|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20153686|NCT00097019|Growth Substances|growth substances|mesh-ancestor
20153687|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153688|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
20153689|NCT00097032|Risperidone|risperidone|mesh-list
20153690|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20153691|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20153692|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
20153693|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153694|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153695|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153696|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153697|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153698|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153699|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153700|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153701|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
20153702|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
20153703|NCT00097045|Interferons|interferons|mesh-list
20153704|NCT00097045|Ribavirin|ribavirin|mesh-list
20153705|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
20153706|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639282|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639283|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19639284|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19639285|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
19639286|NCT02406183|Ipilimumab|ipilimumab|mesh-list
19639287|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19639288|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639289|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19639290|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639291|NCT02406144|Dexamethasone|dexamethasone|mesh-list
19639292|NCT02406144|Lenalidomide|lenalidomide|mesh-list
19639293|NCT02406144|Ixazomib|ixazomib|mesh-list
20153707|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
20153708|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153709|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
20153710|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153711|NCT00097071|Insulin|insulin|mesh-list
20153712|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20321112|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19788942|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20153713|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
20321113|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
20321114|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
20321115|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
19788943|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153714|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
19788944|NCT00310401|Albuterol|albuterol|mesh-list
19788945|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19788946|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
19788947|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19788948|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788949|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19788950|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
19788951|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
19788952|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19788953|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19788954|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19788955|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19788956|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
19788957|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19788958|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788959|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
19788960|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20153715|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153716|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153717|NCT00097084|Insulin|insulin|mesh-list
20153718|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20153719|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
20153720|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
20153721|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
20153722|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153723|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153724|NCT00097110|Ascorbic Acid|ascorbic acid|mesh-list
20153725|NCT00097110|Vitamins|vitamins|mesh-ancestor
20153726|NCT00097110|Micronutrients|micronutrients|mesh-ancestor
20153727|NCT00097110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153728|NCT00097110|Antioxidants|antioxidants|mesh-ancestor
20153729|NCT00097110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153730|NCT00097110|Protective Agents|protective agents|mesh-ancestor
20153731|NCT00097123|Misoprostol|misoprostol|mesh-list
20153732|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20153733|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
20153734|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20153735|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153736|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20153737|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639294|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639295|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
19639296|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
19639297|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639298|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788961|NCT00310791|Hormones|hormones|mesh-list
19788962|NCT00310791|Estradiol|estradiol|mesh-list
19788963|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19788964|NCT00310791|Estrogens|estrogens|mesh-list
20321116|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321117|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321118|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
20321119|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321120|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
20153738|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
20153739|NCT00097188|Rituximab|rituximab|mesh-list
20153740|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20153741|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153742|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
20153743|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153744|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20153745|NCT00097214|Carboplatin|carboplatin|mesh-list
20153746|NCT00097214|Cetuximab|cetuximab|mesh-list
20153747|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321121|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321122|NCT04620304|UB-421|ub-421|mesh-list
20321123|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19639299|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639300|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
19639301|NCT02406144|Hormones|hormones|mesh-ancestor
19639302|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639303|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19788965|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19788966|NCT00310791|Progestins|progestins|mesh-list
19833997|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153748|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20153749|NCT00097227|Paclitaxel|paclitaxel|mesh-list
20153750|NCT00097227|Carboplatin|carboplatin|mesh-list
19788967|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19788968|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788969|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19788970|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
19788971|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19788972|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19788973|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19788974|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19788975|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19788976|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19788977|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
19788978|NCT00310804|Vaccines|vaccines|mesh-list
19788979|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
19788980|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788981|NCT00310817|Vaccines|vaccines|mesh-list
19788982|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
19788983|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788984|NCT00310856|Vaccines|vaccines|mesh-list
19788985|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
19788986|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788987|NCT00311155|Amlodipine|amlodipine|mesh-list
19788988|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19788989|NCT00311155|Olmesartan|olmesartan|mesh-list
19788990|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19788991|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20153751|NCT00097227|Cetuximab|cetuximab|mesh-list
20153752|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153753|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153754|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153755|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153756|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
20153757|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153758|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20153759|NCT00097266|Haloperidol|haloperidol|mesh-list
20153760|NCT00097266|Aripiprazole|aripiprazole|mesh-list
20153761|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
20153762|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
20153763|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153764|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20153765|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20153766|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20153767|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153768|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
20153769|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
20153770|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153771|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153772|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20153773|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20153774|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
20153775|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19788992|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19788993|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20153776|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19788994|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19788995|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19788996|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19788997|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
19788998|NCT00311155|Diuretics|diuretics|mesh-ancestor
19788999|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
20153777|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20153778|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20153779|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
20153780|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
20153781|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153782|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20153783|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20153784|NCT00097279|Metformin|metformin|mesh-list
20153785|NCT00097279|Pioglitazone|pioglitazone|mesh-list
20153786|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
20153787|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
20153788|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153789|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153790|NCT00097318|Interferons|interferons|mesh-list
20153791|NCT00097318|Interferon-beta|interferon-beta|mesh-list
20321124|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
20321125|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321126|NCT04620291|UB-421|ub-421|mesh-list
20321127|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19639304|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639305|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
19639306|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20153792|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
20153793|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153794|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
20153795|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153796|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
20153797|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153798|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20153799|NCT00097344|Toremifene|toremifene|mesh-list
20153800|NCT00097344|Letrozole|letrozole|mesh-list
20153801|NCT00097344|Hormones|hormones|mesh-list
20153802|NCT00097344|Atamestane|atamestane|mesh-list
20153803|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
20153804|NCT00097344|Estrogens|estrogens|mesh-list
20153805|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
20153806|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
20153807|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20153808|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153809|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153810|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20153811|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20153812|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153813|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153814|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
20153815|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20153816|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20153817|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20153818|NCT00097383|Epirubicin|epirubicin|mesh-list
20153819|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153820|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153821|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20153822|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20153823|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153824|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153825|NCT00097435|Ribavirin|ribavirin|mesh-list
19639307|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19639308|NCT02406144|Growth Substances|growth substances|mesh-ancestor
19639309|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
19639310|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
19639311|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639312|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639313|NCT02406170|Paclitaxel|paclitaxel|mesh-list
19639314|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19639315|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639316|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
20321128|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
19639317|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153826|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
20321129|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321130|NCT04616963|Tenofovir|tenofovir|mesh-list
19789000|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19789001|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19789002|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19789003|NCT00311246|Adalimumab|adalimumab|mesh-list
19789004|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789005|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789006|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
19789007|NCT00311311|Sirolimus|sirolimus|mesh-list
19789008|NCT00311311|Prednisone|prednisone|mesh-list
19789009|NCT00311311|Tacrolimus|tacrolimus|mesh-list
19789010|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789011|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
19789012|NCT00311311|Hormones|hormones|mesh-ancestor
19789013|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789014|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789015|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19789016|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789017|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789018|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
19789019|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19789020|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789021|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789022|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19789023|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19789024|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
19789025|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19789026|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789027|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
20153827|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153828|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
20153829|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153830|NCT00097734|Ertapenem|ertapenem|mesh-list
20153831|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20153832|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153833|NCT00097760|Natalizumab|natalizumab|mesh-list
20153834|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
20153835|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153836|NCT00097799|Ritonavir|ritonavir|mesh-list
20153837|NCT00097799|Tipranavir|tipranavir|mesh-list
20153838|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20321131|NCT04616963|Emtricitabine|emtricitabine|mesh-list
20321132|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20321133|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
19789028|NCT00311363|Gabapentin|gabapentin|mesh-list
19789029|NCT00311363|Analgesics|analgesics|mesh-ancestor
19789030|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
19789031|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153839|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20321134|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153840|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
20153841|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153842|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153843|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20153844|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20153845|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
20153846|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153847|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20153848|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20153849|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
20153850|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20153851|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153852|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
20153853|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20153854|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153855|NCT00097851|Docetaxel|docetaxel|mesh-list
20153856|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153857|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
20153858|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
20153859|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
20153860|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153861|NCT00097877|Insulin|insulin|mesh-list
20153862|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20153863|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
20321135|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19789032|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789033|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
19789034|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19789035|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19789036|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789037|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789038|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19789039|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20153864|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
20153865|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
20153866|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20153867|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153868|NCT00097903|Camptothecin|camptothecin|mesh-list
20153869|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20153870|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153871|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20153872|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20153873|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153874|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153875|NCT00097916|Memantine|memantine|mesh-list
20153876|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20153877|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20153878|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
20153879|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153880|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153881|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153882|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20153883|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20153884|NCT00097929|Vorinostat|vorinostat|mesh-list
20153885|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153886|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20153887|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153888|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153889|NCT00097942|Memantine|memantine|mesh-list
20153890|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20153891|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20153892|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
20153893|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153894|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153895|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153896|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20153897|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20153898|NCT00097968|Everolimus|everolimus|mesh-list
20153899|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153900|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153901|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
20153902|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153903|NCT00098007|Everolimus|everolimus|mesh-list
20153904|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153905|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153906|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
20153907|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153908|NCT00098033|Clofarabine|clofarabine|mesh-list
20153909|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153910|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
20153911|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153912|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153913|NCT00098046|Famciclovir|famciclovir|mesh-list
20153914|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
20153915|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153916|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20153917|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153918|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639318|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
19639319|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639320|NCT02406014|Diclofenac|diclofenac|mesh-list
19639321|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19639322|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19639323|NCT02406014|Analgesics|analgesics|mesh-ancestor
19639324|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
19639325|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639326|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789040|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789041|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153919|NCT00098111|Azathioprine|azathioprine|mesh-list
19789042|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
19789043|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
19789044|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19789045|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19789046|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19789047|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789048|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789049|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
19789050|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789051|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789052|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19789053|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789054|NCT00311402|Aspirin|aspirin|mesh-list
19789055|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
19789056|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19789057|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19789058|NCT00311402|Analgesics|analgesics|mesh-ancestor
19789059|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
20153920|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
20153921|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153922|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153923|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153924|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153925|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
20153926|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153927|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20153928|NCT00098124|Milnacipran|milnacipran|mesh-list
20153929|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
20153930|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20153931|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20153932|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20153933|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153934|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20153935|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153936|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20153937|NCT00098124|Analgesics|analgesics|mesh-ancestor
20153938|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
20153939|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20153940|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
20153941|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20153942|NCT00098137|Olmesartan|olmesartan|mesh-list
20153943|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20153944|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20153945|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20153946|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153947|NCT00098241|Everolimus|everolimus|mesh-list
20153948|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153949|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153950|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
20153951|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153952|NCT00098280|Eculizumab|eculizumab|mesh-list
20153953|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20153954|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153955|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
20153956|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153957|NCT00098319|Folic Acid|folic acid|mesh-list
20153958|NCT00098319|Hematinics|hematinics|mesh-ancestor
20153959|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
20153960|NCT00098319|Vitamins|vitamins|mesh-ancestor
20153961|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
20153962|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153963|NCT00098358|Zileuton|zileuton|mesh-list
20153964|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20153965|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20153966|NCT00098358|Analgesics|analgesics|mesh-ancestor
20153967|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
20321136|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20321137|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321138|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153968|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789060|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789061|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153969|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789062|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789063|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789064|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19789065|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19789066|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789067|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19789068|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19789069|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789070|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
20153970|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20153971|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20153972|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20153973|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20153974|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153975|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20153976|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
20153977|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20153978|NCT00098384|Rifaximin|rifaximin|mesh-list
20153979|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20153980|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153981|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20153982|NCT00098397|Romidepsin|romidepsin|mesh-list
20153983|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20153984|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153985|NCT00098423|Cytarabine|cytarabine|mesh-list
20153986|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20153987|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
20153988|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153989|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20153990|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
20153991|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20153992|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20153993|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
20153994|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20153995|NCT00098436|Temozolomide|temozolomide|mesh-list
20153996|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20153997|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
20153998|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20153999|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154000|NCT00098462|Sirolimus|sirolimus|mesh-list
20154001|NCT00098462|Gefitinib|gefitinib|mesh-list
20154002|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20154003|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154004|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154005|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154006|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
20321139|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20321140|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20347519|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20347520|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
20347521|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20347522|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20347523|NCT00860977|Valacyclovir|valacyclovir|mesh-list
20347524|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
20347525|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347526|NCT00861016|Metoprolol|metoprolol|mesh-list
20347527|NCT00861016|Felodipine|felodipine|mesh-list
20347528|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20347529|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20347530|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
20347531|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
20347532|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347533|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347534|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19789071|NCT00311584|Irinotecan|irinotecan|mesh-list
19789072|NCT00311584|Temozolomide|temozolomide|mesh-list
19789073|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19789074|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789075|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789076|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789077|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789078|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19789079|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
20347535|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20347536|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19789080|NCT00311623|Sirolimus|sirolimus|mesh-list
19789081|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19789082|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789083|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19789084|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789085|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
19789086|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789087|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
19789088|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789089|NCT00312195|Buprenorphine|buprenorphine|mesh-list
19789090|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789091|NCT00312195|Narcotics|narcotics|mesh-ancestor
19789092|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789093|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789094|NCT00312195|Analgesics|analgesics|mesh-ancestor
19789095|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
19789096|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789097|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789098|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
19789099|NCT00312208|Docetaxel|docetaxel|mesh-list
19789100|NCT00312208|Doxorubicin|doxorubicin|mesh-list
19789101|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19789102|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789103|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
19789104|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789105|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789106|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19789107|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
19789108|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789109|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789110|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19789111|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
19789112|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
19789113|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789114|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19789115|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19789116|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789117|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789118|NCT00312221|Oxycodone|oxycodone|mesh-list
19789119|NCT00312221|Buprenorphine|buprenorphine|mesh-list
19789120|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789121|NCT00312221|Narcotics|narcotics|mesh-ancestor
19789122|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789123|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789124|NCT00312221|Analgesics|analgesics|mesh-ancestor
19789125|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
19789126|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789127|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789128|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
19789129|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19789130|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19789131|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789132|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19789133|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789134|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789135|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789136|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789137|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19789138|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
19789139|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19789140|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789141|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19789142|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19789143|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19789144|NCT00312377|Docetaxel|docetaxel|mesh-list
19789145|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789146|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
19789147|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
19789148|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789149|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789150|NCT00312494|Ziprasidone|ziprasidone|mesh-list
19789151|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19789152|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
19789153|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789154|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789155|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789156|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19789157|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19789158|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789159|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789160|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19789161|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
19789162|NCT00312572|Buprenorphine|buprenorphine|mesh-list
19789163|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789164|NCT00312572|Narcotics|narcotics|mesh-ancestor
19789165|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789166|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789167|NCT00312572|Analgesics|analgesics|mesh-ancestor
19789168|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
19789169|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789170|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789171|NCT00312728|Bevacizumab|bevacizumab|mesh-list
19789172|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19789173|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789174|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19789175|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19789176|NCT00312728|Growth Substances|growth substances|mesh-ancestor
19789177|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789178|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
19789179|NCT00312845|Rituximab|rituximab|mesh-list
19789180|NCT00312845|Bortezomib|bortezomib|mesh-list
19789181|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19789182|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789183|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
19789184|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789185|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321141|NCT04577404|Edaravone|edaravone|mesh-list
20321142|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19639327|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639328|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19639329|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19639330|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639331|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639332|NCT02405910|Gemcitabine|gemcitabine|mesh-list
20321143|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
20321144|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321145|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20321146|NCT04577404|Protective Agents|protective agents|mesh-ancestor
20321147|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321148|NCT04567615|Nivolumab|nivolumab|mesh-list
20321149|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321150|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321151|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321152|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321153|NCT04541407|Temozolomide|temozolomide|mesh-list
20321154|NCT04541407|Osimertinib|osimertinib|mesh-list
20321155|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19639333|NCT02405910|Paclitaxel|paclitaxel|mesh-list
19639334|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19639335|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789186|NCT00312858|Vaccines|vaccines|mesh-list
19789187|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19789188|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
19789189|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789190|NCT00312923|Policosanol|policosanol|mesh-list
19789191|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19789192|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19789193|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
19789194|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789195|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19639336|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
19639337|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
19639338|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
19639339|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639340|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19639341|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
19789196|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19789197|NCT00313014|Oxycodone|oxycodone|mesh-list
19789198|NCT00313014|Buprenorphine|buprenorphine|mesh-list
19789199|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20321156|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
20321157|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321158|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154007|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154008|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
20154009|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154010|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154011|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154012|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154013|NCT00098488|Rituximab|rituximab|mesh-list
19789200|NCT00313014|Narcotics|narcotics|mesh-ancestor
19789201|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789202|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789203|NCT00313014|Analgesics|analgesics|mesh-ancestor
19789204|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
19789205|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789206|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789207|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
19789208|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19789209|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789210|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789211|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19789212|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19789213|NCT00313170|Fulvestrant|fulvestrant|mesh-list
19789214|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19789215|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789216|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19789217|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19789218|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
19789219|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789220|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789221|NCT00313300|Apixaban|apixaban|mesh-list
19789222|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19789223|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
19789224|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19789225|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
19789226|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789227|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789228|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
19789229|NCT00313313|Metformin|metformin|mesh-list
19789230|NCT00313313|Saxagliptin|saxagliptin|mesh-list
19789231|NCT00313313|Glyburide|glyburide|mesh-list
19789232|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19789233|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789234|NCT00313313|Incretins|incretins|mesh-ancestor
19789235|NCT00313313|Hormones|hormones|mesh-ancestor
19789236|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789237|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19789238|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
19789239|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789240|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321159|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20321160|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789241|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19789242|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789243|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19789244|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154014|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321161|NCT04500548|Nivolumab|nivolumab|mesh-list
20321162|NCT04500548|Ipilimumab|ipilimumab|mesh-list
19639342|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
19639343|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639344|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639345|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19639346|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
19639347|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639348|NCT02406066|Oxazepam|oxazepam|mesh-list
19639349|NCT02406066|Metyrapone|metyrapone|mesh-list
19639350|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
19639351|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639352|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154015|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639353|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19789245|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789246|NCT00313586|Azacitidine|azacitidine|mesh-list
19789247|NCT00313586|Entinostat|entinostat|mesh-list
19789248|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19789249|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19789250|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
19789251|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789252|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789253|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789254|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
19789255|NCT00313612|Topotecan|topotecan|mesh-list
19789256|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789257|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19789258|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789259|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789260|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789261|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
19789262|NCT00313716|Hematinics|hematinics|mesh-ancestor
19789263|NCT00313729|Temozolomide|temozolomide|mesh-list
19789264|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19789265|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
19789266|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789267|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789268|NCT00313781|Prednisone|prednisone|mesh-list
19789269|NCT00313781|Docetaxel|docetaxel|mesh-list
19789270|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789271|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
19789272|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
19789273|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789274|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789275|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789276|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
19789277|NCT00313781|Hormones|hormones|mesh-ancestor
19789278|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789279|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789280|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19789281|NCT00313820|Pregabalin|pregabalin|mesh-list
19789282|NCT00313820|Analgesics|analgesics|mesh-ancestor
19789283|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
19789284|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789285|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789286|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
19789287|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19789288|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789289|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789290|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19789291|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19789292|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19789293|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789294|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789295|NCT00313846|Buprenorphine|buprenorphine|mesh-list
19789296|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789297|NCT00313846|Narcotics|narcotics|mesh-ancestor
19789298|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789299|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789300|NCT00313846|Analgesics|analgesics|mesh-ancestor
19789301|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
19789302|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789303|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789304|NCT00314106|Aldesleukin|aldesleukin|mesh-list
19789305|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
19789306|NCT00314106|Fludarabine|fludarabine|mesh-list
19789307|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789308|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
19789309|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154016|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
20154017|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154018|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154019|NCT00098501|Sirolimus|sirolimus|mesh-list
20154020|NCT00098501|EKB 569|ekb 569|mesh-list
20154021|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20154022|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789310|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789311|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20154023|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19789312|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
19789313|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789314|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789315|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19789316|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19789317|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19789318|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
19789319|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154024|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154025|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
20154026|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154027|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
20154028|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154029|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154030|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154031|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154032|NCT00098527|Romidepsin|romidepsin|mesh-list
19789320|NCT00314249|Milnacipran|milnacipran|mesh-list
19789321|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
19789322|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19789323|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19789324|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789325|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789326|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789327|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789328|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19789329|NCT00314249|Analgesics|analgesics|mesh-ancestor
19789330|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
19789331|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154033|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154034|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154035|NCT00098540|Sorafenib|sorafenib|mesh-list
19639354|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639355|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639356|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19639357|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19639358|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19639359|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
19639360|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
19639361|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154036|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154037|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154038|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789332|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
19789333|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789334|NCT00314262|Celecoxib|celecoxib|mesh-list
19789335|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19789336|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789337|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19789338|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789339|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789340|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19789341|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19789342|NCT00314262|Analgesics|analgesics|mesh-ancestor
19789343|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
19789344|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789345|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789346|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789347|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789348|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19789349|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19789350|NCT00314340|Acetaminophen|acetaminophen|mesh-list
19789351|NCT00314340|Morphine|morphine|mesh-list
19789352|NCT00314340|Hydrocodone|hydrocodone|mesh-list
19789353|NCT00314340|Phenobarbital|phenobarbital|mesh-list
19789354|NCT00314340|Amphetamine|amphetamine|mesh-list
19789355|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789356|NCT00314340|Narcotics|narcotics|mesh-ancestor
20154039|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154040|NCT00098553|Everolimus|everolimus|mesh-list
20154041|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154042|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154043|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
19639362|NCT02406092|Prednisone|prednisone|mesh-list
19639363|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
19639364|NCT02406092|Rituximab|rituximab|mesh-list
19789357|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789358|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789359|NCT00314340|Analgesics|analgesics|mesh-ancestor
19789360|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
19789361|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789362|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19789363|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
19789364|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
19789365|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
19789366|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19789367|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
19789368|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
19789369|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
19789370|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789371|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789372|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
19789373|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19789374|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19789375|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789376|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19789377|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
19789378|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19789379|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19789380|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19789381|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
19789382|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
19789383|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19789384|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19789385|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19789386|NCT00314574|Omalizumab|omalizumab|mesh-list
19789387|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19789388|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19789389|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
19789390|NCT00314808|Dronabinol|dronabinol|mesh-list
19789391|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
19789392|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789393|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789394|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19789395|NCT00314808|Analgesics|analgesics|mesh-ancestor
19789396|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
19789397|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789398|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19789399|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19789400|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789401|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789402|NCT00314808|Hormones|hormones|mesh-ancestor
19789403|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789404|NCT00314951|Vancomycin|vancomycin|mesh-list
19789405|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
19789406|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19789407|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789408|NCT00315055|Vaccines|vaccines|mesh-list
19789409|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
19789410|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789411|NCT00315146|Pioglitazone|pioglitazone|mesh-list
19789412|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19789413|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789414|NCT00315302|Atropine|atropine|mesh-list
19639365|NCT02406092|Doxorubicin|doxorubicin|mesh-list
19639366|NCT02406092|Fludarabine|fludarabine|mesh-list
19789415|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19789416|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19639367|NCT02406092|Vincristine|vincristine|mesh-list
19639368|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19639369|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
19639370|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639371|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19639372|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19639373|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
19639374|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639375|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639376|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19639377|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19639378|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19789417|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19789418|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
19789419|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789420|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789421|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19789422|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
19789423|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
19789424|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
19789425|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19789426|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19789427|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
19789428|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789429|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639379|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19639380|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19639381|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789430|NCT00315328|Atropine|atropine|mesh-list
19789431|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19789432|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19789433|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19789434|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
19789435|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789436|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789437|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19789438|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
19789439|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
19789440|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
19789441|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19789442|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19789443|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
19789444|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789445|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639382|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789446|NCT00315341|Buprenorphine|buprenorphine|mesh-list
19789447|NCT00315341|Methadone|methadone|mesh-list
20321163|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321164|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321165|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321166|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321167|NCT04484623|Dexamethasone|dexamethasone|mesh-list
20321168|NCT04484623|Bortezomib|bortezomib|mesh-list
20321169|NCT04484623|Pomalidomide|pomalidomide|mesh-list
20321170|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321171|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
20321172|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
19639383|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
19639384|NCT02406092|Hormones|hormones|mesh-ancestor
19639385|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639386|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639387|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19639388|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
19639389|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19639390|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789448|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20321173|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639391|NCT02405988|Remifentanil|remifentanil|mesh-list
19789449|NCT00315341|Naloxone|naloxone|mesh-list
19789450|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789451|NCT00315341|Narcotics|narcotics|mesh-ancestor
19789452|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789453|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789454|NCT00315341|Analgesics|analgesics|mesh-ancestor
19789455|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
19789456|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789457|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789458|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
19789459|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
20154044|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154045|NCT00098579|Doxorubicin|doxorubicin|mesh-list
20154046|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20154047|NCT00098579|Alvocidib|alvocidib|mesh-list
20154048|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154049|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789460|NCT00315445|Acetaminophen|acetaminophen|mesh-list
19789461|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19789462|NCT00315445|Oxycodone|oxycodone|mesh-list
19789463|NCT00315445|Buprenorphine|buprenorphine|mesh-list
19789464|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19789465|NCT00315445|Analgesics|analgesics|mesh-ancestor
19789466|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
19789467|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789468|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789469|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
19789470|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789471|NCT00315445|Narcotics|narcotics|mesh-ancestor
19789472|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789473|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789474|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19789475|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789476|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789477|NCT00315458|Buprenorphine|buprenorphine|mesh-list
19789478|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789479|NCT00315458|Narcotics|narcotics|mesh-ancestor
19789480|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789481|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789482|NCT00315458|Analgesics|analgesics|mesh-ancestor
19789483|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
19789484|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789485|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789486|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
19789487|NCT00315705|Etoposide|etoposide|mesh-list
19789488|NCT00315705|Clofarabine|clofarabine|mesh-list
19789489|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789490|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
19789491|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789492|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789493|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19789494|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
19789495|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789496|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789497|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19789498|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19789499|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19789500|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789501|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789502|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19789503|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
19789504|NCT00316004|Dextrans|dextrans|mesh-list
19789505|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
19789506|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
19789507|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
19789508|NCT00316017|Dextrans|dextrans|mesh-list
19789509|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
19789510|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
19789511|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
19833998|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19833999|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154050|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20154051|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20154052|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154053|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834000|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
19834001|NCT00591123|Antidotes|antidotes|mesh-ancestor
19834002|NCT00591123|Protective Agents|protective agents|mesh-ancestor
19789512|NCT00316082|Metformin|metformin|mesh-list
19789513|NCT00316082|Saxagliptin|saxagliptin|mesh-list
19789514|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19789515|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789516|NCT00316082|Incretins|incretins|mesh-ancestor
19789517|NCT00316082|Hormones|hormones|mesh-ancestor
19789518|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789519|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19789520|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
19789521|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789522|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789523|NCT00316173|Carboplatin|carboplatin|mesh-list
19789524|NCT00316173|Topotecan|topotecan|mesh-list
19789525|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789526|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19789527|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789528|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789529|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789530|NCT00316186|Carboplatin|carboplatin|mesh-list
19789531|NCT00316186|Topotecan|topotecan|mesh-list
19789532|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789533|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19789534|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789535|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789536|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789537|NCT00316199|Gemcitabine|gemcitabine|mesh-list
19789538|NCT00316199|Paclitaxel|paclitaxel|mesh-list
19789539|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19789540|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789541|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
19789542|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
19789543|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789544|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789545|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19789546|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
19789547|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
19789548|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789549|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789550|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789551|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
19789552|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789553|NCT00316225|Pemetrexed|pemetrexed|mesh-list
19789554|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789555|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789556|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789557|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19789558|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19789559|NCT00316264|Palivizumab|palivizumab|mesh-list
19789560|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
19789561|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789562|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
19789563|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789564|NCT00316277|Narcotics|narcotics|mesh-ancestor
19789565|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789566|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789567|NCT00316277|Analgesics|analgesics|mesh-ancestor
19789568|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
19789569|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789570|NCT00316719|Lamivudine|lamivudine|mesh-list
19789571|NCT00316719|Adefovir|adefovir|mesh-list
19789572|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19789573|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19789574|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19789575|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789576|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789577|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
19789578|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789579|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19789580|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19789581|NCT00316862|Irinotecan|irinotecan|mesh-list
20154054|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
20154055|NCT00098579|Growth Substances|growth substances|mesh-ancestor
19789582|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789583|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19789584|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19789585|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789586|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789587|NCT00316888|Cisplatin|cisplatin|mesh-list
19789588|NCT00316888|Fluorouracil|fluorouracil|mesh-list
19789589|NCT00316888|Cetuximab|cetuximab|mesh-list
19789590|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789591|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
19789592|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789593|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19789594|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789595|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
19789596|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789597|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19789598|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
19789599|NCT00316914|Calcium|calcium|mesh-list
19789600|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19789601|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789602|NCT00316914|Analgesics|analgesics|mesh-ancestor
19789603|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
19789604|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789605|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
19789606|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789607|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19789608|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
19639392|NCT02405988|Naloxone|naloxone|mesh-list
19639393|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19639394|NCT02405988|Narcotics|narcotics|mesh-ancestor
19639395|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639396|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639397|NCT02405988|Analgesics|analgesics|mesh-ancestor
19639398|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
19639399|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154056|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154057|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154058|NCT00098605|Lapatinib|lapatinib|mesh-list
20154059|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154060|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154061|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154062|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154063|NCT00098618|Interferons|interferons|mesh-list
20154064|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
20154065|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
20154066|NCT00098618|Sorafenib|sorafenib|mesh-list
20154067|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789609|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19789610|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789611|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789612|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
20154068|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
20154069|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639400|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19639401|NCT02406053|Antioxidants|antioxidants|mesh-list
19789613|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19789614|NCT00317044|Esomeprazole|esomeprazole|mesh-list
19789615|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19789616|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19789617|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19789618|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789619|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789620|NCT00317473|Vaccines|vaccines|mesh-list
19789621|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
19789622|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789623|NCT00317642|Cytarabine|cytarabine|mesh-list
19789624|NCT00317642|Clofarabine|clofarabine|mesh-list
19789625|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19789626|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
19789627|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154070|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154071|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639402|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639403|NCT02406053|Protective Agents|protective agents|mesh-ancestor
19639404|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789628|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154072|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639405|NCT02405858|Prednisolone|prednisolone|mesh-list
19789629|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
19789630|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789631|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789632|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
19789633|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789634|NCT00317720|Trastuzumab|trastuzumab|mesh-list
19789635|NCT00317720|Everolimus|everolimus|mesh-list
19789636|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19789637|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789638|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789639|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
19789640|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789641|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
19789642|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19789643|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
19789644|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789645|NCT00318136|Paclitaxel|paclitaxel|mesh-list
20321174|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321175|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321176|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
20154073|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
20154074|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154075|NCT00098631|Lapatinib|lapatinib|mesh-list
20321177|NCT04484623|Hormones|hormones|mesh-ancestor
20321178|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321179|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321180|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321181|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
20321182|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321183|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321184|NCT04484623|Growth Substances|growth substances|mesh-ancestor
20321185|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
19789646|NCT00318136|Bevacizumab|bevacizumab|mesh-list
19789647|NCT00318136|Carboplatin|carboplatin|mesh-list
19789648|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19789649|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789650|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
19789651|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
19789652|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789653|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789654|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19789655|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19789656|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19789657|NCT00318136|Growth Substances|growth substances|mesh-ancestor
19789658|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789659|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
19789660|NCT00318149|Vaccines|vaccines|mesh-list
19789661|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
19789662|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154076|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154077|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154078|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154079|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154080|NCT00098683|Amifostine|amifostine|mesh-list
20154081|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19789663|NCT00318292|Epinephrine|epinephrine|mesh-list
19789664|NCT00318292|Bupivacaine|bupivacaine|mesh-list
19789665|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
19789666|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
19789667|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789668|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789669|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
19789670|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789671|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19789672|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19789673|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
19789674|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154082|NCT00098683|Protective Agents|protective agents|mesh-ancestor
20154083|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154084|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20321186|NCT04480463|Aflibercept|aflibercept|mesh-list
19789675|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789676|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19789677|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20154085|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20321187|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321188|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321189|NCT04480463|Growth Substances|growth substances|mesh-ancestor
20321190|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321191|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
20321192|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321193|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
20321194|NCT04478019|Povidone|povidone|mesh-list
20321195|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
20321196|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
20321197|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20321198|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321199|NCT04458831|Dexamethasone|dexamethasone|mesh-list
20321200|NCT04458831|Pomalidomide|pomalidomide|mesh-list
20321201|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321202|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
20321203|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
20321204|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321205|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321206|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321207|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
20321208|NCT04458831|Hormones|hormones|mesh-ancestor
19789678|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
19789679|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19789680|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
19789681|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
19789682|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
19789683|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19789684|NCT00318370|Farletuzumab|farletuzumab|mesh-list
19789685|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789686|NCT00318409|Bupropion|bupropion|mesh-list
19789687|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19789688|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
19789689|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789690|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19789691|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19789692|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789693|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789694|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
19789695|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789696|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789697|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19789698|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19789699|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789700|NCT00318461|Metformin|metformin|mesh-list
19789701|NCT00318461|Liraglutide|liraglutide|mesh-list
20321209|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321210|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321211|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321212|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
20321213|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321214|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321215|NCT04458831|Growth Substances|growth substances|mesh-ancestor
20321216|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
19639406|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
19639407|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639408|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
19639409|NCT02405858|Hormones|hormones|mesh-ancestor
19639410|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639411|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639412|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639413|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789702|NCT00318461|Glimepiride|glimepiride|mesh-list
20321217|NCT04456699|Leucovorin|leucovorin|mesh-list
20321218|NCT04456699|Bevacizumab|bevacizumab|mesh-list
20321219|NCT04456699|Fluorouracil|fluorouracil|mesh-list
19789703|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20321220|NCT04456699|Capecitabine|capecitabine|mesh-list
20321221|NCT04456699|Olaparib|olaparib|mesh-list
20154086|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154087|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154088|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
20154089|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154090|NCT00098800|Fenretinide|fenretinide|mesh-list
20154091|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154092|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20154093|NCT00098800|Protective Agents|protective agents|mesh-ancestor
20154094|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154095|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
20154096|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19639414|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19639415|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639416|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639417|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
19639418|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19663139|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
19663140|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
19663141|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19663142|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19663143|NCT05095259|Hormones|hormones|mesh-ancestor
19663144|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663145|NCT05095207|Bicalutamide|bicalutamide|mesh-list
19663146|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
19663147|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
19663148|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663149|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663150|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663151|NCT05095077|Tadalafil|tadalafil|mesh-list
19663152|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
19663153|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19663154|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19663155|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663156|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663157|NCT05095077|Urological Agents|urological agents|mesh-ancestor
19663158|NCT05095025|Bupivacaine|bupivacaine|mesh-list
19663159|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
19663160|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
19663161|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663162|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663163|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
19663164|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663165|NCT05091619|Vaccines|vaccines|mesh-list
19663166|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
19663167|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663168|NCT05084027|Fludarabine|fludarabine|mesh-list
19663169|NCT05084027|Melphalan|melphalan|mesh-list
19663170|NCT05084027|Venetoclax|venetoclax|mesh-list
19663171|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663172|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663173|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663174|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
19663175|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663176|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19663177|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
19663178|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19663179|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19663180|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19663181|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19663182|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663183|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789704|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789705|NCT00318461|Incretins|incretins|mesh-ancestor
19789706|NCT00318461|Hormones|hormones|mesh-ancestor
19789707|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789708|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19789709|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789710|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
19789711|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
19789712|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19789713|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19789714|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19789715|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789716|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19789717|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
19789718|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19789719|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789720|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789721|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
19789722|NCT00318643|Mitomycins|mitomycins|mesh-list
19789723|NCT00318643|Mitomycin|mitomycin|mesh-list
19789724|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19789725|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789726|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
19789727|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789728|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19789729|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789730|NCT00318708|Fluticasone|fluticasone|mesh-list
19789731|NCT00318708|Xhance|xhance|mesh-list
19789732|NCT00318708|Clarithromycin|clarithromycin|mesh-list
19789733|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19789734|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20321222|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
20321223|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321224|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321225|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321226|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321227|NCT04456699|Growth Substances|growth substances|mesh-ancestor
19639419|NCT02405715|Oxytocin|oxytocin|mesh-list
19789735|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
19789736|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789737|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789738|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19639420|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
19639421|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19639422|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639423|NCT02405598|Albuterol|albuterol|mesh-list
19639424|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19639425|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
19789739|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
19789740|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
19789741|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19789742|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19789743|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789744|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19789745|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789746|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789747|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19789748|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19789749|NCT00318812|Iron|iron|mesh-list
19789750|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19789751|NCT00318812|Trace Elements|trace elements|mesh-ancestor
19789752|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
19789753|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789754|NCT00318812|Hematinics|hematinics|mesh-ancestor
19789755|NCT00318929|Valproic Acid|valproic acid|mesh-list
19789756|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
19789757|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789758|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789759|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
19639426|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639427|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639428|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19789760|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639429|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
19639430|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
20347537|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
19789761|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789762|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
19789763|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19789764|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789765|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20321228|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321229|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
20321230|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
20321231|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639431|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19639432|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19639433|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20321232|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321233|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321234|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
20321235|NCT04456699|Antidotes|antidotes|mesh-ancestor
20321236|NCT04456699|Protective Agents|protective agents|mesh-ancestor
20321237|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
20321238|NCT04456699|Vitamins|vitamins|mesh-ancestor
20321239|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
20321240|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20321241|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321242|NCT04429503|Aflibercept|aflibercept|mesh-list
20321243|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321244|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321245|NCT04429503|Growth Substances|growth substances|mesh-ancestor
20321246|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789766|NCT00319020|Bosentan|bosentan|mesh-list
19789767|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19789768|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19789769|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789770|NCT00319046|Miglustat|miglustat|mesh-list
19789771|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789772|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789773|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19789774|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19789775|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
19789776|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789777|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19789778|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19789779|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789780|NCT00319111|Bosentan|bosentan|mesh-list
19789781|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19789782|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19789783|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789784|NCT00319501|Diazepam|diazepam|mesh-list
19789785|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19789786|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
19789787|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
19789788|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
19789789|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789790|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789791|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19789792|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19789793|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789794|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19789795|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19789796|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19789797|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19789798|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789799|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19639434|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19639435|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
19639436|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639437|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639438|NCT02405793|Meloxicam|meloxicam|mesh-list
19639439|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19639440|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19639441|NCT02405793|Analgesics|analgesics|mesh-ancestor
19639442|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
19639443|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639444|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639445|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321247|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
19789800|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
19789801|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
19789802|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
19789803|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
19789804|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789805|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789806|NCT00319592|Vaccines|vaccines|mesh-list
19789807|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
19789808|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789809|NCT00319696|Bosentan|bosentan|mesh-list
19789810|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19789811|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19789812|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789813|NCT00319956|Azithromycin|azithromycin|mesh-list
19789814|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19789815|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789816|NCT00319982|Diltiazem|diltiazem|mesh-list
19789817|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19789818|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19789819|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789820|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789821|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19789822|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789823|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
19789824|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
19789825|NCT00320190|Dasatinib|dasatinib|mesh-list
19789826|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789827|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19789828|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789829|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789830|NCT00320216|Ustekinumab|ustekinumab|mesh-list
19789831|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
19789832|NCT00320255|Apixaban|apixaban|mesh-list
19789833|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19789834|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
19789835|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19789836|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
19789837|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789838|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789839|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
19639446|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19639447|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19639448|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19639449|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639450|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639451|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
19639452|NCT02405689|Remifentanil|remifentanil|mesh-list
19639453|NCT02405689|Sevoflurane|sevoflurane|mesh-list
19639454|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19639455|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639456|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639457|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19789840|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
19789841|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19789842|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20154097|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154098|NCT00098878|Carboplatin|carboplatin|mesh-list
20154099|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321248|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321249|NCT04426240|Cyclosporine|cyclosporine|mesh-list
20321250|NCT04426240|Cyclosporins|cyclosporins|mesh-list
20321251|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321252|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639458|NCT02405689|Analgesics|analgesics|mesh-ancestor
19789843|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20174051|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174052|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174053|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174054|NCT00163384|Ciclesonide|ciclesonide|mesh-list
20174055|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
20174056|NCT00163384|Hormones|hormones|mesh-ancestor
20321253|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321254|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
19639459|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
20174057|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19789844|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789845|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789846|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
19789847|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789848|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789849|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19789850|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789851|NCT00320385|Trastuzumab|trastuzumab|mesh-list
20321255|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321256|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
20321257|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321258|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
20321259|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19789852|NCT00320385|Lapatinib|lapatinib|mesh-list
19789853|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19789854|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789855|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19789856|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789857|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789858|NCT00320398|PENTA|penta|mesh-list
19789859|NCT00320398|Fondaparinux|fondaparinux|mesh-list
19789860|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19789861|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
19789862|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19789863|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
19789864|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789865|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789866|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
19789867|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19789868|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19789869|NCT00320411|Lapatinib|lapatinib|mesh-list
19789870|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789871|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19789872|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789873|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789874|NCT00320424|PENTA|penta|mesh-list
19789875|NCT00320424|Fondaparinux|fondaparinux|mesh-list
19789876|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19789877|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
19789878|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19789879|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
19789880|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789881|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789882|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
19789883|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19789884|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19789885|NCT00320489|Olanzapine|olanzapine|mesh-list
19789886|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
19789887|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
19789888|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789889|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789890|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19789891|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19789892|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19789893|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789894|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789895|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19789896|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19789897|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789898|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789899|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789900|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
19789901|NCT00320515|Pemetrexed|pemetrexed|mesh-list
19789902|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321260|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19639460|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639461|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19639462|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19639463|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19639464|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
19639465|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639466|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639467|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19639468|NCT02405689|Narcotics|narcotics|mesh-ancestor
20321261|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19789903|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789904|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789905|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19789906|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19789907|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19789908|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19789909|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19789910|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19789911|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789912|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
19789913|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789914|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789915|NCT00320541|Gemcitabine|gemcitabine|mesh-list
19789916|NCT00320541|Paclitaxel|paclitaxel|mesh-list
19789917|NCT00320541|Bevacizumab|bevacizumab|mesh-list
19789918|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19789919|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789920|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
19789921|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
19789922|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789923|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789924|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19789925|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19789926|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19789927|NCT00320541|Growth Substances|growth substances|mesh-ancestor
19789928|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789929|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
19789930|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19789931|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
20154100|NCT00098891|Entinostat|entinostat|mesh-list
20154101|NCT00098891|Isotretinoin|isotretinoin|mesh-list
20154102|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20154103|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
20154104|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154105|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154106|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154107|NCT00098917|Vaccines|vaccines|mesh-list
20154108|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
20154109|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154110|NCT00098969|Resveratrol|resveratrol|mesh-list
20154111|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
20154112|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154113|NCT00098969|Protective Agents|protective agents|mesh-ancestor
20154114|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154115|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154116|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20154117|NCT00098982|Leucovorin|leucovorin|mesh-list
20154118|NCT00098982|Fluorouracil|fluorouracil|mesh-list
20154119|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
20154120|NCT00098982|Bortezomib|bortezomib|mesh-list
20154121|NCT00098982|Calcium|calcium|mesh-list
20154122|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
20154123|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20154124|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154125|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
20154126|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154127|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20154128|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154129|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154130|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
20154131|NCT00098982|Antidotes|antidotes|mesh-ancestor
20154132|NCT00098982|Protective Agents|protective agents|mesh-ancestor
20154133|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
20154134|NCT00098982|Vitamins|vitamins|mesh-ancestor
20154135|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
20154136|NCT00098995|Tirapazamine|tirapazamine|mesh-list
20154137|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154138|NCT00099008|Genistein|genistein|mesh-list
20154139|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20154140|NCT00099008|Protective Agents|protective agents|mesh-ancestor
20154141|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154142|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154143|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154144|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321262|NCT04406727|UB-421|ub-421|mesh-list
19789932|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
19789933|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789934|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789935|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789936|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
19789937|NCT00320671|Risperidone|risperidone|mesh-list
19789938|NCT00320671|Aripiprazole|aripiprazole|mesh-list
19789939|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19789940|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
19789941|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789942|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789943|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789944|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19789945|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19789946|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789947|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19789948|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19789949|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
19789950|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
19789951|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
19789952|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19789953|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19789954|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19789955|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19789956|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
19789957|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19789958|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789959|NCT00320749|Gemcitabine|gemcitabine|mesh-list
19789960|NCT00320749|Capecitabine|capecitabine|mesh-list
19789961|NCT00320749|Docetaxel|docetaxel|mesh-list
19789962|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19789963|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
19789964|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19789965|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789966|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
19789967|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19789968|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19789969|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19789970|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
19789971|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789972|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
19789973|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
19789974|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
19789975|NCT00320788|Aflibercept|aflibercept|mesh-list
19789976|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19789977|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321263|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
20321264|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321265|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
20321266|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20321267|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20347538|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19789978|NCT00320788|Growth Substances|growth substances|mesh-ancestor
19789979|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789980|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
19789981|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789982|NCT00320801|Buprenorphine|buprenorphine|mesh-list
19789983|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19789984|NCT00320801|Narcotics|narcotics|mesh-ancestor
19789985|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19789986|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789987|NCT00320801|Analgesics|analgesics|mesh-ancestor
19789988|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
19789989|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19789990|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19789991|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
19789992|NCT00321464|Denosumab|denosumab|mesh-list
19789993|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19789994|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789995|NCT00321594|Belinostat|belinostat|mesh-list
19789996|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19789997|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20174058|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19789998|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174059|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174060|NCT00163397|Ciclesonide|ciclesonide|mesh-list
20174061|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
19789999|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790000|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
19790001|NCT00321620|Denosumab|denosumab|mesh-list
19790002|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19790003|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790004|NCT00321646|Bevacizumab|bevacizumab|mesh-list
19790005|NCT00321646|Docetaxel|docetaxel|mesh-list
19790006|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790007|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790008|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790009|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790010|NCT00321646|Growth Substances|growth substances|mesh-ancestor
19790011|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790012|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790013|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790014|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
19790015|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
19790016|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790017|NCT00321672|Capsaicin|capsaicin|mesh-list
19790018|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
19790019|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
20154145|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154146|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
20321268|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321269|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
20321270|NCT04390217|Coagulants|coagulants|mesh-ancestor
20321271|NCT04318210|Tenofovir|tenofovir|mesh-list
20321272|NCT04318210|Emtricitabine|emtricitabine|mesh-list
20321273|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
20321274|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321275|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20321276|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20321277|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321278|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321279|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20321280|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20321281|NCT04313881|Azacitidine|azacitidine|mesh-list
20321282|NCT04313881|Magrolimab|magrolimab|mesh-list
20321283|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321284|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
20321285|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321286|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321287|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321288|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321289|NCT04305405|Benralizumab|benralizumab|mesh-list
20321290|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20321291|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
20321292|NCT04303858|Atezolizumab|atezolizumab|mesh-list
20321293|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321294|NCT04303195|Metopimazine|metopimazine|mesh-list
20321295|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
20321296|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
20321297|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321298|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321299|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321300|NCT04286867|Ethanol|ethanol|mesh-list
20321301|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20321302|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321303|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20321304|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321305|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
20321306|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
20321307|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321308|NCT04254627|Etanercept|etanercept|mesh-list
20154147|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20154148|NCT00099008|Estrogens|estrogens|mesh-ancestor
20154149|NCT00099008|Hormones|hormones|mesh-ancestor
20154150|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154151|NCT00099060|Lapatinib|lapatinib|mesh-list
20154152|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154153|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20321309|NCT04254627|Mifepristone|mifepristone|mesh-list
20321310|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19790020|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
19790021|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321311|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19639469|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19639470|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19639471|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
19639472|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
19639473|NCT02405364|Dexamethasone|dexamethasone|mesh-list
19639474|NCT02405364|Lenalidomide|lenalidomide|mesh-list
20154154|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321312|NCT04254627|Analgesics|analgesics|mesh-ancestor
20321313|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
20321314|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321315|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321316|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321317|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321318|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639475|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639476|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
20154155|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154156|NCT00099125|Irinotecan|irinotecan|mesh-list
20154157|NCT00099125|Temozolomide|temozolomide|mesh-list
20154158|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20154159|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20154160|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154161|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154162|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154163|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20154164|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
20154165|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20154166|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20154167|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20154168|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
20154169|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154170|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154171|NCT00099164|Progestins|progestins|mesh-ancestor
20154172|NCT00099164|Hormones|hormones|mesh-ancestor
20154173|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
20154174|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
20154175|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20154176|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154177|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
20154178|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154179|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20154180|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20154181|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154182|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154183|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
20154184|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
20154185|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
20154186|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20154187|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154188|NCT00099216|Rivastigmine|rivastigmine|mesh-list
20154189|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20154190|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154191|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154192|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
20154193|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154194|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154195|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20154196|NCT00099216|Protective Agents|protective agents|mesh-ancestor
20154197|NCT00099242|Rivastigmine|rivastigmine|mesh-list
20154198|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20154199|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154200|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154201|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
20321319|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19639477|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
19639478|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639479|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639480|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639481|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
19639482|NCT02405364|Hormones|hormones|mesh-ancestor
19639483|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639484|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639485|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639486|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
19790022|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790023|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
19790024|NCT00321685|Leucovorin|leucovorin|mesh-list
19790025|NCT00321685|Folic Acid|folic acid|mesh-list
19790026|NCT00321685|Bevacizumab|bevacizumab|mesh-list
19790027|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19790028|NCT00321685|Fluorouracil|fluorouracil|mesh-list
19790029|NCT00321685|Capecitabine|capecitabine|mesh-list
19790030|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
19790031|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
19790032|NCT00321685|Antibodies|antibodies|mesh-list
19790033|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
19790034|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19790035|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
19790036|NCT00321685|Calcium|calcium|mesh-list
19790037|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
19790038|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790039|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790040|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790041|NCT00321685|Growth Substances|growth substances|mesh-ancestor
20321320|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
20321321|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19790042|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790043|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790044|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
19790045|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19790046|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19790047|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
19790048|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790049|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790050|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790051|NCT00321685|Antidotes|antidotes|mesh-ancestor
19790052|NCT00321685|Protective Agents|protective agents|mesh-ancestor
19790053|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
19790054|NCT00321685|Vitamins|vitamins|mesh-ancestor
19790055|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
19790056|NCT00321685|Hematinics|hematinics|mesh-ancestor
19790057|NCT00321711|Azacitidine|azacitidine|mesh-list
19790058|NCT00321711|Decitabine|decitabine|mesh-list
19790059|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790060|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
19790061|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790062|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790063|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790064|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
19790065|NCT00321737|Lansoprazole|lansoprazole|mesh-list
19790066|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19790067|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19790068|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19790069|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790070|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790071|NCT00321828|Leucovorin|leucovorin|mesh-list
19790072|NCT00321828|Bevacizumab|bevacizumab|mesh-list
19790073|NCT00321828|Fluorouracil|fluorouracil|mesh-list
19790074|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
19790075|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
19790076|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790077|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790078|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790079|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790080|NCT00321828|Growth Substances|growth substances|mesh-ancestor
19790081|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790082|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790083|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
19790084|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790085|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790086|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790087|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
19790088|NCT00321828|Antidotes|antidotes|mesh-ancestor
19790089|NCT00321828|Protective Agents|protective agents|mesh-ancestor
19790090|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
19790091|NCT00321828|Vitamins|vitamins|mesh-ancestor
19790092|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
19790093|NCT00321854|Pramipexole|pramipexole|mesh-list
20321322|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
19790094|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
19790095|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790096|NCT00321854|Protective Agents|protective agents|mesh-ancestor
19790097|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790098|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19790099|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19790100|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
19790101|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
19790102|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790103|NCT00321893|Budesonide|budesonide|mesh-list
19790104|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19790105|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19790106|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
19790107|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790108|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790109|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19790110|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
19790111|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
19790112|NCT00321893|Hormones|hormones|mesh-ancestor
19790113|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790114|NCT00321906|Sirolimus|sirolimus|mesh-list
19790115|NCT00321906|Azathioprine|azathioprine|mesh-list
19790116|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19790117|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790118|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19790119|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790120|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
19790121|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790122|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
19790123|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790124|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
19790125|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790126|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790127|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790128|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
19790129|NCT00321919|Hematinics|hematinics|mesh-ancestor
19834003|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
19834004|NCT00591123|Vitamins|vitamins|mesh-ancestor
19834005|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
19834006|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19834007|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834008|NCT00591149|Docetaxel|docetaxel|mesh-list
19834009|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
19834010|NCT00591149|Cetuximab|cetuximab|mesh-list
19834011|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834012|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
19834013|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
19834014|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834015|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834016|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834017|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19834018|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19834019|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19834020|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834021|NCT00591266|Amlodipine|amlodipine|mesh-list
19834022|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19834023|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19834024|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19834025|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834026|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834027|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19834028|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834029|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
19834030|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19834031|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20154202|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154203|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154204|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20154205|NCT00099242|Protective Agents|protective agents|mesh-ancestor
20154206|NCT00099320|Exenatide|exenatide|mesh-list
20154207|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154208|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154209|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20154210|NCT00099320|Incretins|incretins|mesh-ancestor
20154211|NCT00099320|Hormones|hormones|mesh-ancestor
20154212|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154213|NCT00099333|Exenatide|exenatide|mesh-list
20321323|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19834032|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
19639487|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19639488|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19639489|NCT02405364|Growth Substances|growth substances|mesh-ancestor
19639490|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790130|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
19790131|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
19790132|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
19790133|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
19790134|NCT00321932|Calcium|calcium|mesh-list
19790135|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19790136|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790137|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19790138|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790139|NCT00321932|Vitamins|vitamins|mesh-ancestor
19790140|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
19790141|NCT00321932|Antacids|antacids|mesh-ancestor
19790142|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19790143|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
19790144|NCT00321984|Lansoprazole|lansoprazole|mesh-list
19790145|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19790146|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19790147|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19639491|NCT02405156|Letrozole|letrozole|mesh-list
19639492|NCT02405156|Misoprostol|misoprostol|mesh-list
19639493|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639494|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19639495|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20154214|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154215|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154216|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20154217|NCT00099333|Incretins|incretins|mesh-ancestor
20154218|NCT00099333|Hormones|hormones|mesh-ancestor
20154219|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154220|NCT00099450|INS 50589|ins 50589|mesh-list
20154221|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19790148|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790149|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790150|NCT00322049|Vaccines|vaccines|mesh-list
19790151|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
20154222|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20154223|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
19790152|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790153|NCT00322101|Cyclosporine|cyclosporine|mesh-list
19790154|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
19790155|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
19790156|NCT00322101|Busulfan|busulfan|mesh-list
19790157|NCT00322101|Methotrexate|methotrexate|mesh-list
19790158|NCT00322101|Fludarabine|fludarabine|mesh-list
20154224|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154225|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154226|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790159|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
19790160|NCT00322101|Tacrolimus|tacrolimus|mesh-list
19790161|NCT00322101|Cyclosporins|cyclosporins|mesh-list
20154227|NCT00099489|Interferons|interferons|mesh-list
20154228|NCT00099489|Interferon-beta|interferon-beta|mesh-list
20154229|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
20154230|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154231|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
20154232|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154233|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
20154234|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154235|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20154236|NCT00099502|Interferons|interferons|mesh-list
20154237|NCT00099502|Interferon-beta|interferon-beta|mesh-list
20154238|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
20154239|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
20154240|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154241|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
20154242|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154243|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
20154244|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154245|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20154246|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154247|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790162|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790163|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
19790164|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154248|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
19790165|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790166|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19790167|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
19790168|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790169|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790170|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19790171|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19790172|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
19790173|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19790174|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790175|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
19790176|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
19790177|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790178|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19790179|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19790180|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19790181|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
19790182|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790183|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19790184|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19790185|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
19790186|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19790187|NCT00322153|Memantine|memantine|mesh-list
19790188|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19790189|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19790190|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
19790191|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790192|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790193|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790194|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19790195|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19790196|NCT00322309|Mirtazapine|mirtazapine|mesh-list
19790197|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
19790198|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19790199|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19790200|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
19790201|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
19790202|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790203|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790204|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790205|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19790206|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19790207|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19790208|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19790209|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19790210|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19790211|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
19790212|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19790213|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19790214|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
19790215|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19790216|NCT00322335|PENTA|penta|mesh-list
19790217|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
19790218|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19790219|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19790220|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790221|NCT00322348|Goserelin|goserelin|mesh-list
19790222|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19790223|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790224|NCT00322374|Epirubicin|epirubicin|mesh-list
19790225|NCT00322374|Epothilones|epothilones|mesh-list
19790226|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154249|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20154250|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639496|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639497|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639498|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19639499|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
19639500|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639501|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639502|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20154251|NCT00099554|Etanercept|etanercept|mesh-list
19790227|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790228|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19790229|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19790230|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790231|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790232|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790233|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
19790234|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
19790235|NCT00322387|Plerixafor|plerixafor|mesh-list
19790236|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19790237|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790238|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
19790239|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790240|NCT00322439|Etanercept|etanercept|mesh-list
19790241|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19790242|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19790243|NCT00322439|Analgesics|analgesics|mesh-ancestor
19790244|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
19790245|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790246|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790247|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19790248|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790249|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20154252|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20154253|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20154254|NCT00099554|Analgesics|analgesics|mesh-ancestor
19639503|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
19639504|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19790250|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790251|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
19790252|NCT00322452|Paclitaxel|paclitaxel|mesh-list
19790253|NCT00322452|Carboplatin|carboplatin|mesh-list
19790254|NCT00322452|Gefitinib|gefitinib|mesh-list
19790255|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19790256|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790257|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790258|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
19790259|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
19790260|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790261|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790262|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790263|NCT00322465|Azithromycin|azithromycin|mesh-list
19790264|NCT00322465|Doxycycline|doxycycline|mesh-list
19790265|NCT00322465|Tinidazole|tinidazole|mesh-list
19790266|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19790267|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790268|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
19790269|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19790270|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19790271|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
19790272|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790273|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19790274|NCT00322491|Plerixafor|plerixafor|mesh-list
19790275|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19790276|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790277|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
19790278|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790279|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
19790280|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19790281|NCT00322556|Antibodies|antibodies|mesh-list
19790282|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
20154255|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
19639505|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19639506|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639507|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
19639508|NCT02405130|Epinephrine|epinephrine|mesh-list
19639509|NCT02405130|Racepinephrine|racepinephrine|mesh-list
19639510|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
19639511|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19639512|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19639513|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
20154256|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790283|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639514|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790284|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19790285|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19790286|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20321324|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20321325|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19639515|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639516|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639517|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19639518|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19639519|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
19639520|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639521|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19790287|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19790288|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790289|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790290|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790291|NCT00322621|Analgesics|analgesics|mesh-ancestor
19790292|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
19790293|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790294|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
19790295|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19790296|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
19790297|NCT00322842|Plerixafor|plerixafor|mesh-list
19790298|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19790299|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790300|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
19790301|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790302|NCT00322868|Pioglitazone|pioglitazone|mesh-list
19790303|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790304|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790305|NCT00322881|Paclitaxel|paclitaxel|mesh-list
19790306|NCT00322881|Carboplatin|carboplatin|mesh-list
19790307|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19790308|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790309|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790310|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19790311|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
19790312|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790313|NCT00323063|Gemcitabine|gemcitabine|mesh-list
19790314|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
19790315|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790316|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
19790317|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790318|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790319|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
19790320|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790321|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790322|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790323|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
19790324|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790325|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790326|NCT00323115|Temozolomide|temozolomide|mesh-list
19790327|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19790328|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
19790329|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790330|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790331|NCT00323297|Bosentan|bosentan|mesh-list
19790332|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
19790333|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790334|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
19790335|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20154257|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154258|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20154259|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154260|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20154261|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154262|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
20154263|NCT00099606|Dasatinib|dasatinib|mesh-list
20154264|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154265|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154266|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154267|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639522|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
19639523|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
19639524|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
19639525|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19639526|NCT02405338|Vaccines|vaccines|mesh-list
19639527|NCT02405338|Immunologic Factors|immunologic factors|mesh-ancestor
19790336|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19790337|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321326|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20321327|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
20321328|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20321329|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20321330|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
20321331|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321332|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
20321333|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20321334|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20321335|NCT04252612|Pramlintide|pramlintide|mesh-list
20321336|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20321337|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790338|NCT00323297|Urological Agents|urological agents|mesh-ancestor
19790339|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19790340|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19790341|NCT00323362|Gemcitabine|gemcitabine|mesh-list
19790342|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
19790343|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790344|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
19790345|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790346|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790347|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
19790348|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790349|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790350|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790351|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
19790352|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790353|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790354|NCT00323479|Anastrozole|anastrozole|mesh-list
19790355|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321338|NCT04250883|Iodine|iodine|mesh-list
20321339|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20321340|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321341|NCT04250883|Trace Elements|trace elements|mesh-ancestor
20321342|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
20321343|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321344|NCT04237103|Methotrexate|methotrexate|mesh-list
20321345|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20321346|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
20321347|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20321348|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321349|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321350|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
20321351|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321352|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321353|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
20321354|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321355|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20321356|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321357|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
20321358|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321359|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20321360|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
20321361|NCT04213794|Cisplatin|cisplatin|mesh-list
20321362|NCT04213794|Doxorubicin|doxorubicin|mesh-list
20321363|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19639528|NCT02405338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639529|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
19639530|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19639531|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639532|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19639533|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639534|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
19639535|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19790356|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790357|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19790358|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19790359|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790360|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790361|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19790362|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
20321364|NCT04213794|Daunorubicin|daunorubicin|mesh-list
20154268|NCT00099619|Insulin|insulin|mesh-list
20154269|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20154270|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
20154271|NCT00099619|Exenatide|exenatide|mesh-list
20154272|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154273|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154274|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19790363|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790364|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790365|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19790366|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19790367|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19790368|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790369|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790370|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
19790371|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790372|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19790373|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790374|NCT00323557|Molgramostim|molgramostim|mesh-list
19790375|NCT00323557|Sargramostim|sargramostim|mesh-list
19790376|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19790377|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
19790378|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790379|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790380|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
19639536|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19639537|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639538|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
19639539|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
19639540|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639541|NCT02404844|Tamoxifen|tamoxifen|mesh-list
19639542|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19639543|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
19790381|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
19790382|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19790383|NCT00323622|Amodiaquine|amodiaquine|mesh-list
19790384|NCT00323622|Vaccines|vaccines|mesh-list
19790385|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
20154275|NCT00099619|Incretins|incretins|mesh-ancestor
20154276|NCT00099619|Hormones|hormones|mesh-ancestor
20154277|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154278|NCT00099645|Mifepristone|mifepristone|mesh-list
20154279|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20154280|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
20154281|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20154282|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154283|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20154284|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20154285|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20154286|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
20154287|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19639544|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639545|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639546|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639547|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154288|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20154289|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
20154290|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154291|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
19639548|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19639549|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19639550|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19639551|NCT02404779|Cisatracurium|cisatracurium|mesh-list
19639552|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20154292|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20154293|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20154294|NCT00099684|Ezetimibe|ezetimibe|mesh-list
20154295|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20154296|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20154297|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
20154298|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154299|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19639553|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19639554|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639555|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639556|NCT02405013|Ribavirin|ribavirin|mesh-list
19639557|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
19790386|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790387|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
19790388|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19790389|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19790390|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790391|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19790392|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790393|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790394|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19790395|NCT00323622|Renal Agents|renal agents|mesh-ancestor
19790396|NCT00323739|Bevacizumab|bevacizumab|mesh-list
19790397|NCT00323739|Everolimus|everolimus|mesh-list
19790398|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790399|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790400|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790401|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790402|NCT00323739|Growth Substances|growth substances|mesh-ancestor
19790403|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790404|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790405|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790406|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
19790407|NCT00323869|Gemcitabine|gemcitabine|mesh-list
19790408|NCT00323869|Bevacizumab|bevacizumab|mesh-list
19790409|NCT00323869|Carboplatin|carboplatin|mesh-list
19790410|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790411|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790412|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790413|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790414|NCT00323869|Growth Substances|growth substances|mesh-ancestor
19790415|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790416|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790417|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790418|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
19790419|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790420|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
19790421|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790422|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790423|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790424|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
19790425|NCT00323882|Ipilimumab|ipilimumab|mesh-list
19790426|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790427|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790428|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19790429|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790430|NCT00324038|Acetaminophen|acetaminophen|mesh-list
19790431|NCT00324038|Buprenorphine|buprenorphine|mesh-list
19790432|NCT00324038|Codeine|codeine|mesh-list
19790433|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19790434|NCT00324038|Analgesics|analgesics|mesh-ancestor
19790435|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
19790436|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790437|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790438|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
19790439|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19639558|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19639559|NCT02405013|Ledipasvir|ledipasvir|mesh-list
19639560|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
19639561|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639562|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
19639563|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639564|NCT02404688|Ethanol|ethanol|mesh-list
19639565|NCT02404688|Dronabinol|dronabinol|mesh-list
19639566|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19790440|NCT00324038|Narcotics|narcotics|mesh-ancestor
19790441|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19790442|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19639567|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639568|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19790443|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
19790444|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
19790445|NCT00324155|Ipilimumab|ipilimumab|mesh-list
19790446|NCT00324155|Dacarbazine|dacarbazine|mesh-list
19790447|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790448|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790449|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19790450|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790451|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19790452|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
19790453|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19790454|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790455|NCT00324259|Estradiol|estradiol|mesh-list
20321365|NCT04213794|Antidotes|antidotes|mesh-list
20321366|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321367|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321368|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20321369|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20321370|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321371|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321372|NCT04213794|Protective Agents|protective agents|mesh-ancestor
20321373|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321374|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
20321375|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
20321376|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19639569|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639570|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
19790456|NCT00324259|Estrogens|estrogens|mesh-ancestor
19790457|NCT00324259|Hormones|hormones|mesh-ancestor
19790458|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790459|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790460|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19790461|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
19790462|NCT00324272|Coagulants|coagulants|mesh-ancestor
19790463|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19790464|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19790465|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790466|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19790467|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19790468|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
19790469|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790470|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790471|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19790472|NCT00324415|Fluorouracil|fluorouracil|mesh-list
19790473|NCT00324415|Cetuximab|cetuximab|mesh-list
19790474|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790475|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
19790476|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790477|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790478|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790479|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
19790480|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790481|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790482|NCT00324649|Lamivudine|lamivudine|mesh-list
19790483|NCT00324649|Zidovudine|zidovudine|mesh-list
19790484|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19790485|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19790486|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19790487|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790488|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790489|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
19790490|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790491|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19639571|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19639572|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19639573|NCT02404688|Analgesics|analgesics|mesh-ancestor
19639574|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
19639575|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639576|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19639577|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19639578|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639579|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321377|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321378|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
20321379|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
20321380|NCT04209855|Paclitaxel|paclitaxel|mesh-list
20321381|NCT04209855|Maytansine|maytansine|mesh-list
20321382|NCT04209855|Doxorubicin|doxorubicin|mesh-list
20321383|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20321384|NCT04209855|Topotecan|topotecan|mesh-list
20321385|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20321386|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321387|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
20321388|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
20321389|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
20321390|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321391|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321392|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20321393|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20321394|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321395|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20321396|NCT04209543|Progesterone|progesterone|mesh-list
20321397|NCT04209543|Progestins|progestins|mesh-ancestor
20321398|NCT04209543|Hormones|hormones|mesh-ancestor
20321399|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321400|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321401|NCT04183062|Gemcitabine|gemcitabine|mesh-list
20321402|NCT04183062|Docetaxel|docetaxel|mesh-list
19790492|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790493|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
19790494|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
19790495|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790496|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790497|NCT00324740|Vorinostat|vorinostat|mesh-list
19790498|NCT00324740|Isotretinoin|isotretinoin|mesh-list
19790499|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790500|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19790501|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790502|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790503|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
19790504|NCT00324870|Bevacizumab|bevacizumab|mesh-list
19790505|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19790506|NCT00324870|Vorinostat|vorinostat|mesh-list
19790507|NCT00324870|Antibodies|antibodies|mesh-list
19790508|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
19790509|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19790510|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790511|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790512|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790513|NCT00324870|Growth Substances|growth substances|mesh-ancestor
19790514|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790515|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790516|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
19790517|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19790518|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790519|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790520|NCT00324896|Eszopiclone|eszopiclone|mesh-list
19790521|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19790522|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19790523|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790524|NCT00324961|Adefovir|adefovir|mesh-list
19790525|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19790526|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
19790527|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790528|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19790529|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19790530|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790531|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790532|NCT00324987|Bevacizumab|bevacizumab|mesh-list
19790533|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19790534|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
19790535|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
19790536|NCT00324987|Antibodies|antibodies|mesh-list
19790537|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
19790538|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20321403|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321404|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
20321405|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321406|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321407|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
19790539|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
19790540|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790541|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790542|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790543|NCT00324987|Growth Substances|growth substances|mesh-ancestor
19790544|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790545|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790546|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
19790547|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790548|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790549|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790550|NCT00325078|Infliximab|infliximab|mesh-list
19790551|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
19790552|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19790553|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790554|NCT00325143|Edetic Acid|edetic acid|mesh-list
19790555|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
19790556|NCT00325143|Antidotes|antidotes|mesh-ancestor
19790557|NCT00325143|Protective Agents|protective agents|mesh-ancestor
19790558|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790559|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
19790560|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
19790561|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790562|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19790563|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
19790564|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19790565|NCT00325234|Gemcitabine|gemcitabine|mesh-list
19790566|NCT00325234|Carboplatin|carboplatin|mesh-list
19790567|NCT00325234|Pemetrexed|pemetrexed|mesh-list
19790568|NCT00325234|Vinorelbine|vinorelbine|mesh-list
19790569|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790570|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790571|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
19790572|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321408|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321409|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321410|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321411|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
20321412|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321413|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790573|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
19790574|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790575|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790576|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790577|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
19790578|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790579|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19790580|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19790581|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19790582|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790583|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
19790584|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
19790585|NCT00325403|Treprostinil|treprostinil|mesh-list
19790586|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19790587|NCT00325416|Melphalan|melphalan|mesh-list
19790588|NCT00325416|Topotecan|topotecan|mesh-list
19790589|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19790590|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
19790591|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790592|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790593|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19790594|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790595|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
19790596|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790597|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19790598|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19790599|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790600|NCT00325442|Treprostinil|treprostinil|mesh-list
19790601|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19790602|NCT00325468|Denosumab|denosumab|mesh-list
19790603|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19790604|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790605|NCT00325780|Pitavastatin|pitavastatin|mesh-list
19790606|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19790607|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19790608|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20321414|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
20321415|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
20321416|NCT04176419|Acetaminophen|acetaminophen|mesh-list
20321417|NCT04176419|Celecoxib|celecoxib|mesh-list
20321418|NCT04176419|Lidocaine|lidocaine|mesh-list
20321419|NCT04176419|Ketamine|ketamine|mesh-list
20321420|NCT04176419|Gabapentin|gabapentin|mesh-list
20321421|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
20321422|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
20321423|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20321424|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790609|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
19790610|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321425|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
20321426|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321427|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20321428|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20321429|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19790611|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790612|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19790613|NCT00325819|Acetaminophen|acetaminophen|mesh-list
19790614|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19790615|NCT00325819|Analgesics|analgesics|mesh-ancestor
19790616|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
19790617|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790618|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790619|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
19790620|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19790621|NCT00325897|Azithromycin|azithromycin|mesh-list
19790622|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790623|NCT00326170|Azacitidine|azacitidine|mesh-list
19790624|NCT00326170|Tretinoin|tretinoin|mesh-list
19790625|NCT00326170|Valproic Acid|valproic acid|mesh-list
19790626|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790627|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
19790628|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790629|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790630|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790631|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
19790632|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
19790633|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
19790634|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
19790635|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790636|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790637|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
19790638|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19790639|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19790640|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19790641|NCT00326209|Mesalamine|mesalamine|mesh-list
19790642|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19790643|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19790644|NCT00326209|Analgesics|analgesics|mesh-ancestor
19790645|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
19790646|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790647|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790648|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19790649|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790650|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
19790651|NCT00326417|Fludarabine|fludarabine|mesh-list
19790652|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790653|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
19790654|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790655|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790656|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19790657|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
19790658|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790659|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790660|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19790661|NCT00326495|Cetuximab|cetuximab|mesh-list
19790662|NCT00326495|Sorafenib|sorafenib|mesh-list
19790663|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790664|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790665|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20321430|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348594|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19790666|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790667|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321431|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321432|NCT04176419|Analgesics|analgesics|mesh-ancestor
20321433|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20321434|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20321435|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
20321436|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19790668|NCT00326599|Gemcitabine|gemcitabine|mesh-list
19790669|NCT00326599|Carboplatin|carboplatin|mesh-list
19790670|NCT00326599|Cediranib|cediranib|mesh-list
19790671|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790672|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790673|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
19790674|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790675|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
19790676|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790677|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790678|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790679|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
19790680|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790681|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790682|NCT00326612|Midazolam|midazolam|mesh-list
19790683|NCT00326612|Diazepam|diazepam|mesh-list
19790684|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19790685|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19790686|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19790687|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790688|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19790689|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19790690|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19790691|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19790692|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
19790693|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
19790694|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
19790695|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
19790696|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790697|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790698|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
19790699|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
19790700|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
19790701|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790702|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19790703|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19790704|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19790705|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
19790706|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
19790707|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19790708|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
19790709|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790710|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790711|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790712|NCT00326716|Ritonavir|ritonavir|mesh-list
19790713|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19790714|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20321437|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20321438|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20321439|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19790715|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19790716|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19790717|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
19790718|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790719|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790720|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19790721|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790722|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
19790723|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790724|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19790725|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19790726|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19790727|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19790728|NCT00326781|Nicotine|nicotine|mesh-list
19790729|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19790730|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
19790731|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790732|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790733|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19790734|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19790735|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
19790736|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790737|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321440|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
20321441|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20321442|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321443|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321444|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20321445|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20321446|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321447|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
20321448|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20321449|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20321450|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20321451|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
20321452|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20321453|NCT04163952|Panitumumab|panitumumab|mesh-list
20321454|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20321455|NCT04163952|Antibodies|antibodies|mesh-list
20321456|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
20321457|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20321458|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
20321459|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321460|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321461|NCT04144465|Phenylephrine|phenylephrine|mesh-list
20321462|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
20321463|NCT04144465|Norepinephrine|norepinephrine|mesh-list
19790738|NCT00326872|Cediranib|cediranib|mesh-list
19790739|NCT00326872|Maleic acid|maleic acid|mesh-list
19790740|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790741|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790742|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790743|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790744|NCT00326885|Catumaxomab|catumaxomab|mesh-list
19790745|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19790746|NCT00326911|Gemcitabine|gemcitabine|mesh-list
19790747|NCT00326911|Bevacizumab|bevacizumab|mesh-list
19790748|NCT00326911|Cetuximab|cetuximab|mesh-list
19790749|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790750|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790751|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790752|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790753|NCT00326911|Growth Substances|growth substances|mesh-ancestor
19790754|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790755|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790756|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19790757|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
19790758|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790759|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
19790760|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790761|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790762|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321464|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19790763|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
19790764|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
19790765|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19790766|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19790767|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790768|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19790769|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790770|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
19790771|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154300|NCT00099710|Curcumin|curcumin|mesh-list
20154301|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20154302|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20154303|NCT00099710|Analgesics|analgesics|mesh-ancestor
20154304|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
20154305|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154306|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154307|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20154308|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154309|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321465|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
19790772|NCT00327015|Metformin|metformin|mesh-list
20154310|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321466|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
20321467|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790773|NCT00327015|Pioglitazone|pioglitazone|mesh-list
19790774|NCT00327015|Saxagliptin|saxagliptin|mesh-list
19790775|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790776|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790777|NCT00327015|Incretins|incretins|mesh-ancestor
19790778|NCT00327015|Hormones|hormones|mesh-ancestor
19790779|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790780|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19790781|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
19790782|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790783|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790784|NCT00327171|Aflibercept|aflibercept|mesh-list
19790785|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790786|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20154311|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154312|NCT00099736|Cyclosporine|cyclosporine|mesh-list
20154313|NCT00099736|Cyclosporins|cyclosporins|mesh-list
20154314|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20154315|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
20154316|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154317|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
20154318|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154319|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154320|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154321|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
20154322|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154323|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154324|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20154325|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20154326|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20154327|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20154328|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321468|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321469|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
20321470|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19639580|NCT02404688|Hormones|hormones|mesh-ancestor
19639581|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790787|NCT00327171|Growth Substances|growth substances|mesh-ancestor
19790788|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790789|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790790|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834033|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19834034|NCT00591305|Protective Agents|protective agents|mesh-ancestor
19834035|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834036|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834037|NCT00591370|Temozolomide|temozolomide|mesh-list
19834038|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834039|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
19834040|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834041|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834042|NCT00591565|Acamprosate|acamprosate|mesh-list
19834043|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19834044|NCT00591578|Valsartan|valsartan|mesh-list
19834045|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19639582|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
19639583|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19639584|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
19639585|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639586|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
19639587|NCT02404454|Protective Agents|protective agents|mesh-ancestor
19639588|NCT02404337|Betaine|betaine|mesh-list
19639589|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639590|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
19639591|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19639592|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
19639593|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639594|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19639595|NCT02404376|Exenatide|exenatide|mesh-list
19639596|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19639597|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639598|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19834046|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19639599|NCT02404376|Incretins|incretins|mesh-ancestor
19639600|NCT02404376|Hormones|hormones|mesh-ancestor
19790791|NCT00327340|Docetaxel|docetaxel|mesh-list
19790792|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
19790793|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790794|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790795|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
19790796|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
19790797|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790798|NCT00327340|Analgesics|analgesics|mesh-ancestor
19790799|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
19790800|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790801|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790802|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19790803|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19790804|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790805|NCT00327392|Fospropofol|fospropofol|mesh-list
19790806|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19790807|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19790808|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790809|NCT00327444|Aflibercept|aflibercept|mesh-list
19790810|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19790811|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19790812|NCT00327444|Growth Substances|growth substances|mesh-ancestor
19790813|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790814|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
19790815|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790816|NCT00327717|Zonisamide|zonisamide|mesh-list
19790817|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
19790818|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19790819|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19790820|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790821|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19790822|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790823|NCT00328094|Insulin|insulin|mesh-list
19790824|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19790825|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790826|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790827|NCT00328172|Metformin|metformin|mesh-list
19790828|NCT00328172|Linagliptin|linagliptin|mesh-list
19790829|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790830|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790831|NCT00328172|Incretins|incretins|mesh-ancestor
19790832|NCT00328172|Hormones|hormones|mesh-ancestor
19790833|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790834|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19790835|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
19790836|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790837|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790838|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
19790839|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790840|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790841|NCT00328562|Gefitinib|gefitinib|mesh-list
19790842|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790843|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790844|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790845|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790846|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
19790847|NCT00328614|Goserelin|goserelin|mesh-list
19790848|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
19790849|NCT00328614|Bicalutamide|bicalutamide|mesh-list
19790850|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
19790851|NCT00328614|Androgens|androgens|mesh-list
19790852|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19790853|NCT00328614|Ethylene|ethylene|mesh-list
19790854|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19790855|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790856|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
19790857|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
19790858|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154329|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154330|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
20154331|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154332|NCT00099775|Caspofungin|caspofungin|mesh-list
20154333|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
20154334|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154335|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835485|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
19790859|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790860|NCT00328614|Hormones|hormones|mesh-ancestor
19790861|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
19790862|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790863|NCT00328614|Protective Agents|protective agents|mesh-ancestor
19790864|NCT00328614|Vitamins|vitamins|mesh-ancestor
19790865|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
19790866|NCT00328614|Estrogens|estrogens|mesh-ancestor
19790867|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
19790868|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19790869|NCT00328614|Growth Substances|growth substances|mesh-ancestor
19790870|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19790871|NCT00328614|Analgesics|analgesics|mesh-ancestor
19790872|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
19790873|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19790874|NCT00328627|Pioglitazone|pioglitazone|mesh-list
19790875|NCT00328627|Alogliptin|alogliptin|mesh-list
19790876|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790877|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790878|NCT00328627|Incretins|incretins|mesh-ancestor
19790879|NCT00328627|Hormones|hormones|mesh-ancestor
19790880|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790881|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19790882|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
19790883|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321471|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
20321472|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
19639601|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639602|NCT02404623|Vitamin D|vitamin d|mesh-list
19639603|NCT02404623|Vitamins|vitamins|mesh-ancestor
19639604|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
19639605|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639606|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19639607|NCT02404363|Clopidogrel|clopidogrel|mesh-list
19639608|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19639609|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19790884|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790885|NCT00328770|Sirolimus|sirolimus|mesh-list
19790886|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19790887|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790888|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19790889|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790890|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
19790891|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790892|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
19790893|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790894|NCT00328861|Aldesleukin|aldesleukin|mesh-list
19790895|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
19790896|NCT00328861|Fludarabine|fludarabine|mesh-list
19790897|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790898|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
19790899|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639610|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19639611|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19639612|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
19639613|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639614|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639615|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639616|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
19639617|NCT02404519|Vitamin K|vitamin k|mesh-list
19639618|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
19639619|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19639620|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19639621|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639622|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
19639623|NCT02404519|Coagulants|coagulants|mesh-ancestor
19639624|NCT02404519|Vitamins|vitamins|mesh-ancestor
19639625|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
19639626|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639627|NCT02404259|Ritonavir|ritonavir|mesh-list
19639628|NCT02404259|Lopinavir|lopinavir|mesh-list
20321473|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19639629|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19790900|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790901|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19790902|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
19790903|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790904|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790905|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19790906|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19790907|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19790908|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
19790909|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154336|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154337|NCT00099788|Ranolazine|ranolazine|mesh-list
20154338|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20154339|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20154340|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154341|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20154342|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19790910|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19790911|NCT00328926|Hormones|hormones|mesh-list
19790912|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19790913|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19790914|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790915|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19790916|NCT00329030|Rituximab|rituximab|mesh-list
19790917|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
19790918|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19790919|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790920|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
19790921|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790922|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790923|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19790924|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19790925|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19790926|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
19790927|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790928|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19790929|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19790930|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790931|NCT00329238|Warfarin|warfarin|mesh-list
19790932|NCT00329238|Dabigatran|dabigatran|mesh-list
19790933|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
19790934|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
19790935|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19790936|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
19790937|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790938|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790939|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
20321474|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19639630|NCT02404259|Tenofovir|tenofovir|mesh-list
19639631|NCT02404259|Efavirenz|efavirenz|mesh-list
19639632|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19639633|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19639634|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
19639635|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639636|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790940|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790941|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
19790942|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639637|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19639638|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19639639|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
19639640|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639641|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19639642|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19639643|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19639644|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19639645|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19639646|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19639647|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19639648|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19639649|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19639650|NCT02404142|Atracurium|atracurium|mesh-list
19639651|NCT02404142|Curare|curare|mesh-list
19790943|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790944|NCT00329407|Topiramate|topiramate|mesh-list
19790945|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
20321475|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20611175|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611176|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
20611177|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611178|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611179|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611180|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
20154343|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154344|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154345|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
20154346|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154347|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20154348|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154349|NCT00099866|Metformin|metformin|mesh-list
20154350|NCT00099866|Vildagliptin|vildagliptin|mesh-list
20154351|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154352|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154353|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20154354|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154355|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154356|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154357|NCT00099892|Vildagliptin|vildagliptin|mesh-list
20154358|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790946|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790947|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790948|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
19790949|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790950|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
19790951|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790952|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19790953|NCT00329433|Heparin|heparin|mesh-list
19790954|NCT00329433|Desirudin|desirudin|mesh-list
19790955|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
19790956|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19790957|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19790958|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790959|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
19790960|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790961|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
20321476|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
20321477|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20321478|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321479|NCT04144465|Protective Agents|protective agents|mesh-ancestor
19790962|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790963|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154359|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154360|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20154361|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
20321489|NCT04130204|Colchicine|colchicine|mesh-list
20321490|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
20321491|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321492|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
20321493|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
20321494|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
20154362|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154363|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154364|NCT00099905|Vildagliptin|vildagliptin|mesh-list
20154365|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154366|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154367|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20321495|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321496|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790964|NCT00329602|Ropinirole|ropinirole|mesh-list
20321497|NCT04126317|Aflibercept|aflibercept|mesh-list
20611181|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790965|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19790966|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19790967|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
19790968|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
19790969|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19790970|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790971|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790972|NCT00329641|Paclitaxel|paclitaxel|mesh-list
19790973|NCT00329641|Carboplatin|carboplatin|mesh-list
19790974|NCT00329641|Sorafenib|sorafenib|mesh-list
19790975|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19790976|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154368|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154369|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154370|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154371|NCT00099918|Vildagliptin|vildagliptin|mesh-list
20154372|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19790977|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
19790978|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
19790979|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
19790980|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790981|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790982|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790983|NCT00329719|Sirolimus|sirolimus|mesh-list
19790984|NCT00329719|Sorafenib|sorafenib|mesh-list
19790985|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19790986|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19790987|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19790988|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19790989|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19790990|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19790991|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19790992|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
19790993|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19790994|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
19790995|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19790996|NCT00329797|Vitamin D|vitamin d|mesh-list
19790997|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
19790998|NCT00329797|Calcium|calcium|mesh-list
19790999|NCT00329797|Vitamins|vitamins|mesh-ancestor
19791000|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
19791001|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791002|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19791003|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19791004|NCT00329849|Vaccines|vaccines|mesh-list
19791005|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
19791006|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791007|NCT00329901|Vaccines|vaccines|mesh-list
19791008|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
19791009|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791010|NCT00330161|Vorinostat|vorinostat|mesh-list
19791011|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791012|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19791013|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791014|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791015|NCT00330174|Acamprosate|acamprosate|mesh-list
19791016|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19791017|NCT00330187|Bupropion|bupropion|mesh-list
19791018|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19791019|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
19791020|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19791021|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19791022|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20154373|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154374|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19639652|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19639653|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19639654|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19639655|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639656|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639657|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19639658|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19639659|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
19791023|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19791024|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791025|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
19791026|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791027|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791028|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19791029|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19791030|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791031|NCT00330343|Naloxone|naloxone|mesh-list
19791032|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19791033|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791034|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
19639660|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639661|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639662|NCT02404077|Clonidine|clonidine|mesh-list
19639663|NCT02404077|Analgesics|analgesics|mesh-ancestor
19639664|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
19639665|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639666|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639667|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19639668|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
19639669|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
19639670|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19639671|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19791035|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791036|NCT00330421|Sorafenib|sorafenib|mesh-list
19791037|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791038|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791039|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791040|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791041|NCT00330460|Denosumab|denosumab|mesh-list
19791042|NCT00330460|Alendronate|alendronate|mesh-list
19791043|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19791044|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791045|NCT00330551|Risperidone|risperidone|mesh-list
20321498|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321499|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321500|NCT04126317|Growth Substances|growth substances|mesh-ancestor
20321501|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321502|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
20321503|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321504|NCT04120636|Celecoxib|celecoxib|mesh-list
20321505|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20321506|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20321507|NCT04120636|Analgesics|analgesics|mesh-ancestor
20321508|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
20321509|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321510|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791046|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19791047|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
19791048|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791049|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791050|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791051|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19791052|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19791053|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19791054|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20154375|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154376|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154377|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154378|NCT00099931|Vildagliptin|vildagliptin|mesh-list
20154379|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154380|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154381|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20321511|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321512|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321513|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20154382|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154383|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154384|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154385|NCT00099944|Glimepiride|glimepiride|mesh-list
20154386|NCT00099944|Vildagliptin|vildagliptin|mesh-list
20154387|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20154388|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154389|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611182|NCT02003222|Cytarabine|cytarabine|mesh-list
20154390|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19639672|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19791055|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19791056|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
19791057|NCT00330564|Sunitinib|sunitinib|mesh-list
19791058|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791059|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19791060|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321514|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19639673|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
19639674|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639675|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639676|NCT02404233|Darunavir|darunavir|mesh-list
19639677|NCT02404233|Cobicistat|cobicistat|mesh-list
19639678|NCT02404233|Rilpivirine|rilpivirine|mesh-list
19639679|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19639680|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19639681|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
19639682|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791061|NCT00330564|Growth Substances|growth substances|mesh-ancestor
19791062|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791063|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
19791064|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791065|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791066|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791067|NCT00330668|Mecasermin|mecasermin|mesh-list
19791068|NCT00330668|Growth Substances|growth substances|mesh-ancestor
19791069|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791070|NCT00330681|Edaravone|edaravone|mesh-list
19791071|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19791072|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
19791073|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791074|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19791075|NCT00330681|Protective Agents|protective agents|mesh-ancestor
19791076|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791077|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19791078|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19791079|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19791080|NCT00330733|Analgesics|analgesics|mesh-ancestor
19639683|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639684|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19639685|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19639686|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
19639687|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19639688|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19639689|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19639690|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19639691|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19639692|NCT02404064|Metronidazole|metronidazole|mesh-list
19639693|NCT02404064|Cefotaxime|cefotaxime|mesh-list
19639694|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791081|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
19791082|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791083|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791084|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791085|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791086|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
19791087|NCT00330759|Denosumab|denosumab|mesh-list
19791088|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19791089|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791090|NCT00330863|Olanzapine|olanzapine|mesh-list
19791091|NCT00330863|Risperidone|risperidone|mesh-list
20154391|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
20154392|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20154393|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154394|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154395|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154396|NCT00099957|Vildagliptin|vildagliptin|mesh-list
20154397|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154398|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154399|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19791092|NCT00330863|Aripiprazole|aripiprazole|mesh-list
19791093|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19791094|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19791095|NCT00330863|Ziprasidone|ziprasidone|mesh-list
19791096|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20321515|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791097|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
19791098|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791099|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791100|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791101|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19791102|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19791103|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19791104|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19791105|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19791106|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
19791107|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
19791108|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
19791109|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791110|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791111|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19791112|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19791113|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19791114|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
19791115|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
19791116|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19791117|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19791118|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19791119|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19791120|NCT00330876|Pitavastatin|pitavastatin|mesh-list
19791121|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19791122|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19791123|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19791124|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
19791125|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791126|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791127|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19791128|NCT00330915|Pemetrexed|pemetrexed|mesh-list
19791129|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791130|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791131|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791132|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19639695|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19639696|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19639697|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19663184|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19663185|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663186|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663187|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
19663188|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791133|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19791134|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19791135|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19791136|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19791137|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19791138|NCT00331006|Rituximab|rituximab|mesh-list
19791139|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20154400|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154401|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154402|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154403|NCT00099970|Dacarbazine|dacarbazine|mesh-list
20154404|NCT00099970|Volociximab|volociximab|mesh-list
20154405|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20154406|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
20154407|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154408|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154409|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20154410|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20154411|NCT00099970|Growth Substances|growth substances|mesh-ancestor
20154412|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611183|NCT02003222|Dexamethasone|dexamethasone|mesh-list
19663192|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
19663193|NCT05057481|Rituximab|rituximab|mesh-list
19663194|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663195|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663196|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
19791140|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791141|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
19791142|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791143|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791144|NCT00331136|Artesunate|artesunate|mesh-list
19791145|NCT00331136|Pyronaridine|pyronaridine|mesh-list
19791146|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
19791147|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19791148|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19791149|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791150|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791151|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
19791152|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
19791153|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19791154|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
19791155|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
19791156|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19791157|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
19791158|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791159|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791160|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19639698|NCT02404038|NuvaRing|nuvaring|mesh-list
19639699|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19791161|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791162|NCT00331344|Prednisone|prednisone|mesh-list
19791163|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
19791164|NCT00331344|Epothilone B|epothilone b|mesh-list
19791165|NCT00331344|Epothilones|epothilones|mesh-list
19791166|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791167|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
19791168|NCT00331344|Hormones|hormones|mesh-ancestor
19791169|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791170|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791171|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19791172|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791173|NCT00331344|Analgesics|analgesics|mesh-ancestor
19791174|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
19791175|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791176|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19791177|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791178|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791179|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791180|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791181|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791182|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791183|NCT00331409|Everolimus|everolimus|mesh-list
19791184|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
19791185|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791186|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791187|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
19791188|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791189|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791190|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791191|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791192|NCT00331422|Paclitaxel|paclitaxel|mesh-list
19791193|NCT00331422|Carboplatin|carboplatin|mesh-list
19791194|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791195|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791196|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791197|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791198|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791199|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154413|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
20154414|NCT00099996|Ezetimibe|ezetimibe|mesh-list
20154415|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20154416|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19639700|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19639701|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
19639702|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19639703|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639704|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19639705|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19639706|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19639707|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19791200|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
19791201|NCT00331552|Doxorubicin|doxorubicin|mesh-list
20154417|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
19791202|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19791203|NCT00331552|Trastuzumab|trastuzumab|mesh-list
19791204|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19791205|NCT00331552|Antibodies|antibodies|mesh-list
19791206|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
20154418|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154419|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20154420|NCT00100009|Triamcinolone|triamcinolone|mesh-list
20154421|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20154422|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20154423|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20154424|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321516|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321517|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19791207|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19791208|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791209|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
19791210|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791211|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791212|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19791213|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
19791214|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791215|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791216|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19791217|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19639708|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19639709|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19639710|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20321518|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20321519|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20321520|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
20321521|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321522|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20321523|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20321524|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321525|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
20321526|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
19639711|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19791218|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19791219|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791220|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791221|NCT00331630|Paclitaxel|paclitaxel|mesh-list
19791222|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19791223|NCT00331630|Lapatinib|lapatinib|mesh-list
19791224|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791225|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791226|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791227|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791228|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791229|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791230|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791231|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791232|NCT00331682|Docetaxel|docetaxel|mesh-list
19791233|NCT00331682|Alvocidib|alvocidib|mesh-list
19791234|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791235|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
19639712|NCT02404051|Everolimus|everolimus|mesh-list
19639713|NCT02404051|Fulvestrant|fulvestrant|mesh-list
19639714|NCT02404051|Exemestane|exemestane|mesh-list
19639715|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639716|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19639717|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
19639718|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639719|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639720|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19639721|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19639722|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
19639723|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639724|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19639725|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19791236|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791237|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
20154425|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
20154426|NCT00100009|Hormones|hormones|mesh-ancestor
19791238|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791239|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
19791240|NCT00331682|Growth Substances|growth substances|mesh-ancestor
19791241|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791242|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791243|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791244|NCT00331760|Cisplatin|cisplatin|mesh-list
19791245|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791246|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20154427|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154428|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154429|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154430|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
20154431|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154432|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154433|NCT00100074|Lobeline|lobeline|mesh-list
20154434|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20154435|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
20154436|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154437|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154438|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20154439|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20154440|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
19791247|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19791248|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19791249|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19791250|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791251|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791252|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791253|NCT00331799|Analgesics|analgesics|mesh-ancestor
19791254|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
19791255|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791256|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
20321527|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321528|NCT04042935|Protective Agents|protective agents|mesh-ancestor
20321529|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321530|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
20321531|NCT04042935|Vitamins|vitamins|mesh-ancestor
20321532|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
20347539|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347540|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20347541|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347542|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20347543|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
20347544|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
20347545|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20154441|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154442|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154443|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
20154444|NCT00100100|Modafinil|modafinil|mesh-list
20154445|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20154446|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154447|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20154448|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20154449|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20154450|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347546|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347547|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347548|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20347549|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791257|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19791258|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
19791259|NCT00331864|Ranibizumab|ranibizumab|mesh-list
19791260|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19791261|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19791262|NCT00331864|Growth Substances|growth substances|mesh-ancestor
19791263|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791264|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
19791265|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154451|NCT00100113|Vanoxerine|vanoxerine|mesh-list
20347550|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791266|NCT00332163|Irinotecan|irinotecan|mesh-list
19791267|NCT00332163|Panitumumab|panitumumab|mesh-list
19791268|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19791269|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791270|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791271|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791272|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791273|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19791274|NCT00332189|Verapamil|verapamil|mesh-list
19791275|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19791276|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19791277|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19791278|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791279|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19791280|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791281|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
19791282|NCT00332241|Aripiprazole|aripiprazole|mesh-list
19791283|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
19791284|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19791285|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19791286|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19791287|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19791288|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791289|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
19791290|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
20154452|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20154453|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19791291|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791292|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791293|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19791294|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20321533|NCT03984448|Prednisone|prednisone|mesh-list
20321534|NCT03984448|Cortisone|cortisone|mesh-list
20321535|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
19791295|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
19791296|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19791297|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19791298|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19791299|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19791300|NCT00332332|Etanercept|etanercept|mesh-list
19791301|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19791302|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19791303|NCT00332332|Analgesics|analgesics|mesh-ancestor
19791304|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
19791305|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791306|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791307|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791308|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791309|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791310|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791311|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
19791312|NCT00332462|Cyclosporine|cyclosporine|mesh-list
19791313|NCT00332462|Cyclosporins|cyclosporins|mesh-list
20154454|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20154455|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154456|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
20154457|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154458|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321536|NCT03984448|Rituximab|rituximab|mesh-list
20321537|NCT03984448|Doxorubicin|doxorubicin|mesh-list
20321538|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20321539|NCT03984448|Etoposide|etoposide|mesh-list
20321540|NCT03984448|Vincristine|vincristine|mesh-list
19791314|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791315|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791316|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791317|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
19791318|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791319|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
19791320|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791321|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
19791322|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791323|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19791324|NCT00332488|Insulin|insulin|mesh-list
19791325|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19791326|NCT00332488|Metformin|metformin|mesh-list
19791327|NCT00332488|Secretagogues|secretagogues|mesh-list
19791328|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19791329|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791330|NCT00332579|Naltrexone|naltrexone|mesh-list
19791331|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19791332|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19791333|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791334|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
19791335|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791336|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
19791337|NCT00332605|Naltrexone|naltrexone|mesh-list
19791338|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19791339|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19791340|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19791341|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791342|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
19791343|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791344|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
19791345|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791346|NCT00332605|Expectorants|expectorants|mesh-ancestor
19791347|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
19791348|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19791349|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
19791350|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791351|NCT00332605|Protective Agents|protective agents|mesh-ancestor
19791352|NCT00332605|Antidotes|antidotes|mesh-ancestor
19791353|NCT00332644|Bupropion|bupropion|mesh-list
19791354|NCT00332644|Nicotine|nicotine|mesh-list
19791355|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19791356|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
19791357|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791358|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791359|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19791360|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19791361|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
19791362|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791363|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791364|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19791365|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
19791366|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19791367|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19791368|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19791369|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19791370|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
19791371|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19791372|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19791373|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791374|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
19791375|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19791376|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19791377|NCT00332696|Prednisolone|prednisolone|mesh-list
19791378|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
19791379|NCT00332696|Octreotide|octreotide|mesh-list
19791380|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19791381|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
19791382|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791383|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
19791384|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
19791385|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791386|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321541|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
20321542|NCT03984448|Venetoclax|venetoclax|mesh-list
19791387|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791388|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
19791389|NCT00332696|Hormones|hormones|mesh-ancestor
19791390|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791391|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19791392|NCT00332696|Protective Agents|protective agents|mesh-ancestor
19791393|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19791394|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791395|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
19791396|NCT00332709|Letrozole|letrozole|mesh-list
19791397|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791398|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19791399|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19791400|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791401|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791402|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19791403|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
19791404|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791405|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791406|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19791407|NCT00332839|Cyclosporine|cyclosporine|mesh-list
19791408|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
19791409|NCT00332839|Everolimus|everolimus|mesh-list
19791410|NCT00332839|Tacrolimus|tacrolimus|mesh-list
19791411|NCT00332839|Cyclosporins|cyclosporins|mesh-list
19791412|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791413|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
19791414|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791415|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19791416|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791417|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791418|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
19791419|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791420|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
19791421|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791422|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791423|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19791424|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19791425|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
19791426|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791427|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19791428|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19791429|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791430|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791431|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
19791432|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791433|NCT00333177|Risperidone|risperidone|mesh-list
19791434|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19791435|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
19791436|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791437|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639726|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639727|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639728|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
19639729|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19639730|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19639731|NCT02403856|Prednisolone|prednisolone|mesh-list
19639732|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
19639733|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19639734|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
19639735|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639736|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
19639737|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
19639738|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639739|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791438|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791439|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19791440|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19791441|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19791442|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19791443|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19791444|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
19791445|NCT00333359|Gabapentin|gabapentin|mesh-list
19791446|NCT00333359|Analgesics|analgesics|mesh-ancestor
19791447|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
19791448|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791449|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791450|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
20321543|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
20321544|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20321545|NCT03984448|Antibodies|antibodies|mesh-list
20321546|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
20321547|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20321548|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321549|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
20321550|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321551|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321552|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20321553|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
20321554|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321555|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791451|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19791452|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19791453|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19791454|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19791455|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19791456|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19791457|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791458|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791459|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
19791460|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
19791461|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19791462|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791463|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19791464|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
19791465|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791466|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791467|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791468|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791469|NCT00333775|Bevacizumab|bevacizumab|mesh-list
19791470|NCT00333775|Docetaxel|docetaxel|mesh-list
19791471|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19791472|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791473|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19791474|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321556|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20321557|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321558|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20321559|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20321560|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321561|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321562|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
20321563|NCT03984448|Hormones|hormones|mesh-ancestor
20321564|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321565|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321566|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20321567|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
19639740|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321568|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
19639741|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
19639742|NCT02403856|Hormones|hormones|mesh-ancestor
19639743|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639744|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19639745|NCT02403856|Protective Agents|protective agents|mesh-ancestor
19639746|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639747|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639748|NCT02403804|Betaine|betaine|mesh-list
19639749|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639750|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
19791475|NCT00333775|Growth Substances|growth substances|mesh-ancestor
19791476|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791477|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
19791478|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791479|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791480|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
20321569|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
20321570|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
20321571|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
20321572|NCT03970954|Interleukin-2|interleukin-2|mesh-list
20321573|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791481|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154459|NCT00100126|Amoxicillin|amoxicillin|mesh-list
20321574|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20321575|NCT03970954|Analgesics|analgesics|mesh-ancestor
20321576|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
20321577|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321578|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321579|NCT03969212|Baloxavir|baloxavir|mesh-list
20321580|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
20321581|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321582|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321583|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321584|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
19639751|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19639752|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
19639753|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639754|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19639755|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
19639756|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19639757|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20321585|NCT03958565|Denosumab|denosumab|mesh-list
20321586|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20321587|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20321588|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321589|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20611184|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
20611185|NCT02003222|Prednisone|prednisone|mesh-list
20611186|NCT02003222|Cortisone|cortisone|mesh-list
20611187|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
20611188|NCT02003222|Rituximab|rituximab|mesh-list
20611189|NCT02003222|Methotrexate|methotrexate|mesh-list
19639758|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639759|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
19639760|NCT02403596|Coagulants|coagulants|mesh-ancestor
19639761|NCT02403544|Capecitabine|capecitabine|mesh-list
19639762|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
19639763|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19639764|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
19639765|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639766|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639767|NCT02403687|Topiramate|topiramate|mesh-list
19639768|NCT02403687|Diclofenac|diclofenac|mesh-list
19639769|NCT02403687|Meloxicam|meloxicam|mesh-list
19639770|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
19639771|NCT02403687|Lidocaine|lidocaine|mesh-list
19639772|NCT02403687|Clonidine|clonidine|mesh-list
19639773|NCT02403687|Sumatriptan|sumatriptan|mesh-list
19639774|NCT02403687|Ketamine|ketamine|mesh-list
19639775|NCT02403687|Gabapentin|gabapentin|mesh-list
19639776|NCT02403687|Amitriptyline|amitriptyline|mesh-list
19639777|NCT02403687|Tizanidine|tizanidine|mesh-list
19639778|NCT02403687|Bupivacaine|bupivacaine|mesh-list
20154460|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20154461|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154462|NCT00100139|Paclitaxel|paclitaxel|mesh-list
20154463|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20154464|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20154465|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154466|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
20154467|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
20154468|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174062|NCT00163397|Hormones|hormones|mesh-ancestor
20611190|NCT02003222|Etoposide|etoposide|mesh-list
19639779|NCT02403687|Prilocaine|prilocaine|mesh-list
19639780|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
19639781|NCT02403687|Baclofen|baclofen|mesh-list
19639782|NCT02403687|Capsaicin|capsaicin|mesh-list
19639783|NCT02403687|Menthol|menthol|mesh-list
20321590|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
20321591|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611191|NCT02003222|Vincristine|vincristine|mesh-list
20611192|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
19639784|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
19639785|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
19639786|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639787|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639788|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
19639789|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639790|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19639791|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19791482|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
19791483|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791484|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
19791485|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791486|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791487|NCT00333814|Dexamethasone|dexamethasone|mesh-list
19791488|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
19791489|NCT00333814|BB 1101|bb 1101|mesh-list
19791490|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791491|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
19791492|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
19791493|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791494|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791495|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791496|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
19791497|NCT00333814|Hormones|hormones|mesh-ancestor
19791498|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791499|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19791500|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791501|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
19791502|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791503|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791504|NCT00333840|Interferons|interferons|mesh-list
19791505|NCT00333840|Cytarabine|cytarabine|mesh-list
19791506|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
19791507|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
19791508|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
19791509|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791510|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
19791511|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791512|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791513|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
19791514|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791515|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791516|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
19791517|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791518|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791519|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321592|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19791520|NCT00333866|Pregabalin|pregabalin|mesh-list
19791521|NCT00333866|Analgesics|analgesics|mesh-ancestor
19791522|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
19791523|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791524|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791525|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
19791526|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19791527|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19791528|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791529|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19791530|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19791531|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19791532|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19791533|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834047|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19834048|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20154469|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154470|NCT00100243|Abarelix|abarelix|mesh-list
20154471|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
20154472|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154473|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834049|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154474|NCT00100269|Antioxidants|antioxidants|mesh-list
20154475|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611193|NCT02003222|Daunorubicin|daunorubicin|mesh-list
20321593|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
20321594|NCT03914625|Leucovorin|leucovorin|mesh-list
20321595|NCT03914625|Folic Acid|folic acid|mesh-list
20321596|NCT03914625|Cytarabine|cytarabine|mesh-list
20321597|NCT03914625|Dexamethasone|dexamethasone|mesh-list
20321598|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
20321599|NCT03914625|Prednisone|prednisone|mesh-list
20321600|NCT03914625|Prednisolone|prednisolone|mesh-list
19791534|NCT00334074|Cytarabine|cytarabine|mesh-list
19791535|NCT00334074|Clofarabine|clofarabine|mesh-list
19791536|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791537|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
19791538|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791539|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791540|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
19791541|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791542|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791543|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
19791544|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791545|NCT00334295|Fulvestrant|fulvestrant|mesh-list
19791546|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19791547|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791548|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19791549|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19791550|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
19791551|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791552|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791553|NCT00334542|Simvastatin|simvastatin|mesh-list
19791554|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19791555|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19791556|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
19791557|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791558|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19791559|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20321601|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20321602|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
20321603|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19791560|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791561|NCT00334633|Metronidazole|metronidazole|mesh-list
19791562|NCT00334633|Tinidazole|tinidazole|mesh-list
19791563|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791564|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791565|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19791566|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19791567|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
19791568|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791569|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19791570|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
19791571|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
19791572|NCT00334737|Hematinics|hematinics|mesh-ancestor
19791573|NCT00334802|Gemcitabine|gemcitabine|mesh-list
19791574|NCT00334802|Paclitaxel|paclitaxel|mesh-list
19791575|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791576|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791577|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791578|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791579|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791580|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791581|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791582|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
19791583|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
19791584|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791585|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791586|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791587|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
19791588|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321604|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
20321605|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
20321606|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20321607|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20321608|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19791589|NCT00334958|Rufinamide|rufinamide|mesh-list
19791590|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
20321609|NCT03914625|Cortisone|cortisone|mesh-list
19791591|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20321610|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
20321611|NCT03914625|Doxorubicin|doxorubicin|mesh-list
19791592|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19791593|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19791594|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791595|NCT00335140|Leucovorin|leucovorin|mesh-list
19791596|NCT00335140|Cytarabine|cytarabine|mesh-list
19791597|NCT00335140|Dexamethasone|dexamethasone|mesh-list
19791598|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
19791599|NCT00335140|Rituximab|rituximab|mesh-list
19791600|NCT00335140|Methotrexate|methotrexate|mesh-list
19791601|NCT00335140|Vincristine|vincristine|mesh-list
19791602|NCT00335140|Procarbazine|procarbazine|mesh-list
19791603|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19791604|NCT00335140|BB 1101|bb 1101|mesh-list
19791605|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
19791606|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19791607|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791608|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
19791609|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791610|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791611|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791612|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
19791613|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
19791614|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791615|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791616|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
19791617|NCT00335140|Hormones|hormones|mesh-ancestor
19791618|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791619|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19791620|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
19791621|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791622|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791623|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19791624|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
19791625|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19791626|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791627|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
19791628|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
19791629|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20321612|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19791630|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791631|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19791632|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
19791633|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321613|NCT03914625|Methotrexate|methotrexate|mesh-list
20321614|NCT03914625|Vincristine|vincristine|mesh-list
20321615|NCT03914625|Asparaginase|asparaginase|mesh-list
20321616|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
20154476|NCT00100269|Protective Agents|protective agents|mesh-ancestor
20154477|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154478|NCT00100308|Heparin|heparin|mesh-list
20154479|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
20154480|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20154481|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20154482|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154483|NCT00100412|Phenylephrine|phenylephrine|mesh-list
20154484|NCT00100412|Dobutamine|dobutamine|mesh-list
20154485|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
20154486|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20154487|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
20154488|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
20154489|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154490|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154491|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
20154492|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20154493|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
20154494|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
20154495|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20154496|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20154497|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20154498|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
20154499|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154500|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154501|NCT00100412|Protective Agents|protective agents|mesh-ancestor
19791634|NCT00335140|Antidotes|antidotes|mesh-ancestor
20321617|NCT03914625|Pegaspargase|pegaspargase|mesh-list
19791635|NCT00335140|Protective Agents|protective agents|mesh-ancestor
20154502|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20321618|NCT03914625|Thioguanine|thioguanine|mesh-list
20154503|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20154504|NCT00100464|Paroxetine|paroxetine|mesh-list
20154505|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20154506|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20154507|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20154508|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154509|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154510|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
20154511|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154512|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20154513|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
20154514|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20154515|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19791636|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
19791637|NCT00335140|Vitamins|vitamins|mesh-ancestor
19791638|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
19791639|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791640|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791641|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791642|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791643|NCT00335153|Levodopa|levodopa|mesh-list
19791644|NCT00335153|Carbidopa|carbidopa|mesh-list
19791645|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19791646|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19791647|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19791648|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
19791649|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791650|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791651|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791652|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19791653|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791654|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19791655|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
19791656|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
20321619|NCT03914625|Blinatumomab|blinatumomab|mesh-list
19639792|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19639793|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19639794|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639795|NCT02403687|Analgesics|analgesics|mesh-ancestor
19639796|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19639797|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19639798|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
20321620|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20321621|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
20321622|NCT03914625|Antibodies|antibodies|mesh-list
20321623|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
19639799|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19639800|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19639801|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639802|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
19639803|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19639804|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19639805|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19639806|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
19639807|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19639808|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19639809|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639810|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791657|NCT00335283|Lansoprazole|lansoprazole|mesh-list
20321624|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19791658|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
19791659|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19791660|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791661|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19791662|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791663|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791664|NCT00335322|Ritonavir|ritonavir|mesh-list
19791665|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19791666|NCT00335322|Tenofovir|tenofovir|mesh-list
19791667|NCT00335322|Zidovudine|zidovudine|mesh-list
19791668|NCT00335322|Emtricitabine|emtricitabine|mesh-list
19791669|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19791670|NCT00335322|Abacavir|abacavir|mesh-list
19791671|NCT00335322|Efavirenz|efavirenz|mesh-list
19791672|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19791673|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19791674|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
19791675|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791676|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791677|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19791678|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19791679|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
19791680|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791681|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19791682|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19791683|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19791684|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19791685|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
19791686|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19791687|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20154516|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20154517|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174063|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174064|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174065|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174066|NCT00163410|Ciclesonide|ciclesonide|mesh-list
20174067|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
20174068|NCT00163410|Hormones|hormones|mesh-ancestor
20174069|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174070|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174071|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174072|NCT00163423|Ciclesonide|ciclesonide|mesh-list
20174073|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
20174074|NCT00163423|Hormones|hormones|mesh-ancestor
20174075|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174076|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174077|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20175153|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256642|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175154|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20175155|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
20175156|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175157|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175158|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175159|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175160|NCT00167518|Triamcinolone|triamcinolone|mesh-list
20175161|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20175162|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
20175163|NCT00167518|Hormones|hormones|mesh-ancestor
20175164|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175165|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175166|NCT00167557|Interferons|interferons|mesh-list
20175167|NCT00167557|Ribavirin|ribavirin|mesh-list
20321625|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20321626|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20321627|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
20321628|NCT03914625|BB 1101|bb 1101|mesh-list
20321629|NCT03914625|Calcium|calcium|mesh-list
20321630|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
20321631|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
20321632|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321633|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
20321634|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321635|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321636|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20321637|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
20321638|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321639|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321640|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20321641|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321642|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
20321643|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
20321644|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321645|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321646|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
20321647|NCT03914625|Hormones|hormones|mesh-ancestor
20321648|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321649|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321650|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
20321651|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321652|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321653|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20321654|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20321655|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20321656|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20321657|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20321658|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
19791688|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19791689|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19791690|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19791691|NCT00335452|Clopidogrel|clopidogrel|mesh-list
19791692|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19791693|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19791694|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19791695|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19791696|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
19791697|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791698|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791699|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791700|NCT00335478|Daptomycin|daptomycin|mesh-list
19791701|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791702|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791703|NCT00335504|Sulindac|sulindac|mesh-list
19791704|NCT00335504|Atorvastatin|atorvastatin|mesh-list
19791705|NCT00335504|Calcium|calcium|mesh-list
19791706|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20321659|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20321660|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321661|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
20321662|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
20321663|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20321664|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19639811|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19639812|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639813|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19639814|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
19791707|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791708|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19791709|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19639815|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
19639816|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19639817|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19639818|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19639819|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
19639820|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
19639821|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19639822|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19639823|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19639824|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
19639825|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19639826|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19639827|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
19791710|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
19791711|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791712|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19791713|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19791714|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791715|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19791716|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19791717|NCT00335504|Analgesics|analgesics|mesh-ancestor
19791718|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
20154518|NCT00100477|Etoposide|etoposide|mesh-list
20154519|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
20154520|NCT00100477|Topotecan|topotecan|mesh-list
20154521|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20154522|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154523|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20154524|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20154525|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154526|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154527|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20154528|NCT00100477|Analgesics|analgesics|mesh-ancestor
19791719|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791720|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791721|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791722|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791723|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19791724|NCT00335556|Dactinomycin|dactinomycin|mesh-list
19791725|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
19791726|NCT00335556|Carboplatin|carboplatin|mesh-list
19791727|NCT00335556|Doxorubicin|doxorubicin|mesh-list
19791728|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19791729|NCT00335556|Irinotecan|irinotecan|mesh-list
19791730|NCT00335556|Etoposide|etoposide|mesh-list
20154529|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
20154530|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154531|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639828|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19791731|NCT00335556|Vincristine|vincristine|mesh-list
19791732|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154532|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
20154533|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20154534|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154535|NCT00100568|Lamivudine|lamivudine|mesh-list
19791733|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
20154536|NCT00100568|Zidovudine|zidovudine|mesh-list
20154537|NCT00100568|Efavirenz|efavirenz|mesh-list
20174078|NCT00163436|Ciclesonide|ciclesonide|mesh-list
19791734|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791735|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791736|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19791737|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
19791738|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791739|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791740|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19791741|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19791742|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19791743|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791744|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791745|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19639829|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19639830|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
19639831|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
19639832|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
19791746|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791747|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791748|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791749|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791750|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791751|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791752|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19791753|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19639833|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19639834|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20321665|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
20321666|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321667|NCT03914625|Antidotes|antidotes|mesh-ancestor
20321668|NCT03914625|Protective Agents|protective agents|mesh-ancestor
20321669|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
20321670|NCT03914625|Vitamins|vitamins|mesh-ancestor
20321671|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
20321672|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20321673|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
20321674|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
20321675|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
20321676|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20321677|NCT03914625|Hematinics|hematinics|mesh-ancestor
20321678|NCT03900793|Sunitinib|sunitinib|mesh-list
20321679|NCT03900793|Losartan|losartan|mesh-list
20321680|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639835|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19639836|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19639837|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
19639838|NCT02403713|Fluticasone|fluticasone|mesh-list
19639839|NCT02403713|Xhance|xhance|mesh-list
19639840|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
19639841|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639842|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20154538|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20154539|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20174079|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
19639843|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
19639844|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639845|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639846|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19639847|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
19639848|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
19639849|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19639850|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19639851|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19639852|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19791754|NCT00335725|Hormones|hormones|mesh-list
20321681|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321682|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321683|NCT03900793|Growth Substances|growth substances|mesh-ancestor
19791755|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19791756|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791757|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791758|NCT00335738|Carboplatin|carboplatin|mesh-list
19791759|NCT00335738|Etoposide|etoposide|mesh-list
19791760|NCT00335738|Vincristine|vincristine|mesh-list
19791761|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
19791762|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791763|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791764|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19791765|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791766|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791767|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791768|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791769|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791770|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791771|NCT00335764|Sirolimus|sirolimus|mesh-list
19791772|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19791773|NCT00335764|Sorafenib|sorafenib|mesh-list
19791774|NCT00335764|Tipifarnib|tipifarnib|mesh-list
19791775|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791776|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791777|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791778|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791779|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791780|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791781|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19791782|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
19791783|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791784|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
19791785|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791786|NCT00335829|Bevacizumab|bevacizumab|mesh-list
19791787|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19791788|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791789|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19791790|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19791791|NCT00335829|Growth Substances|growth substances|mesh-ancestor
19791792|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791793|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
19791794|NCT00335959|Capecitabine|capecitabine|mesh-list
19791795|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
19791796|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791797|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
19791798|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791799|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791800|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
19791801|NCT00335972|Remifentanil|remifentanil|mesh-list
19791802|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19791803|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19791804|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791805|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19791806|NCT00335972|Analgesics|analgesics|mesh-ancestor
19791807|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
19791808|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154540|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20154541|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154542|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154543|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
20154544|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154545|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20154546|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20154547|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
20154548|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20154549|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20154550|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20154551|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20154552|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19791809|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19791810|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19791811|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19791812|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
19791813|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19791814|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791815|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19791816|NCT00335972|Narcotics|narcotics|mesh-ancestor
19791817|NCT00336024|Leucovorin|leucovorin|mesh-list
19791818|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
19791819|NCT00336024|Thiotepa|thiotepa|mesh-list
19791820|NCT00336024|Carboplatin|carboplatin|mesh-list
19791821|NCT00336024|Methotrexate|methotrexate|mesh-list
19791822|NCT00336024|Etoposide|etoposide|mesh-list
19791823|NCT00336024|Vincristine|vincristine|mesh-list
19791824|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
19791825|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
19791826|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791827|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
19791828|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791829|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791830|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19639853|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
19639854|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639855|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639856|NCT02403648|Glucagon|glucagon|mesh-list
19639857|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19639858|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639859|NCT02403648|Hormones|hormones|mesh-ancestor
19639860|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639861|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321684|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321685|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
19639862|NCT02403648|Incretins|incretins|mesh-ancestor
19639863|NCT02403531|Docetaxel|docetaxel|mesh-list
19639864|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639865|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
19639866|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
20154553|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20154554|NCT00100581|Interferons|interferons|mesh-list
20154555|NCT00100581|Ritonavir|ritonavir|mesh-list
20154556|NCT00100581|Tenofovir|tenofovir|mesh-list
20154557|NCT00100581|Ribavirin|ribavirin|mesh-list
20154558|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
20154559|NCT00100581|Lamivudine|lamivudine|mesh-list
20154560|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
20154561|NCT00100581|Efavirenz|efavirenz|mesh-list
20154562|NCT00100581|Lopinavir|lopinavir|mesh-list
20321686|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19639867|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
19639868|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639869|NCT02403349|Atenolol|atenolol|mesh-list
19639870|NCT02403349|Valsartan|valsartan|mesh-list
19639871|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19639872|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19639873|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19639874|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639875|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19639876|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
19639877|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
19639878|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639879|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639880|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19639881|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19639882|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19639883|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
19791831|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
19791832|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791833|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791834|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19791835|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19791836|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
19791837|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19791838|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791839|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
19791840|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
19791841|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154563|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20154564|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154565|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
19791842|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19791843|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19791844|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791845|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19791846|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791847|NCT00336024|Antidotes|antidotes|mesh-ancestor
19791848|NCT00336024|Protective Agents|protective agents|mesh-ancestor
19791849|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
19791850|NCT00336024|Vitamins|vitamins|mesh-ancestor
19791851|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
19791852|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
19791853|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
19791854|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
19791855|NCT00336232|Vitamin K|vitamin k|mesh-list
19791856|NCT00336232|Vitamins|vitamins|mesh-ancestor
19791857|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
19791858|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791859|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19791860|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19791861|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791862|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
19791863|NCT00336232|Coagulants|coagulants|mesh-ancestor
19791864|NCT00336323|Bevacizumab|bevacizumab|mesh-list
19791865|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19791866|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791867|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19791868|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19791869|NCT00336323|Growth Substances|growth substances|mesh-ancestor
19791870|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791871|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
19791872|NCT00336479|Interferons|interferons|mesh-list
19791873|NCT00336479|Ribavirin|ribavirin|mesh-list
19791874|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
19791875|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
20154566|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154567|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20154568|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20154569|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154570|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154571|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154572|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20154573|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20154574|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20154575|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20154576|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20154577|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20611194|NCT02003222|Asparaginase|asparaginase|mesh-list
20611195|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
20611196|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
20611197|NCT02003222|Pegaspargase|pegaspargase|mesh-list
20611198|NCT02003222|Blinatumomab|blinatumomab|mesh-list
20611199|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19639884|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639885|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
19639886|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19639887|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
19639888|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19639889|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639890|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19639891|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19639892|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19639893|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19639894|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
19639895|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19639896|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19639897|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19639898|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19639899|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639900|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
19639901|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639902|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639903|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19639904|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791876|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19791877|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791878|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
19791879|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791880|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
19791881|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791882|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
19791883|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791884|NCT00336492|Infliximab|infliximab|mesh-list
19791885|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
19791886|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791887|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19791888|NCT00336505|Clarithromycin|clarithromycin|mesh-list
19791889|NCT00336505|Cethromycin|cethromycin|mesh-list
19791890|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791891|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791892|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19791893|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791894|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791895|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19791896|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19791897|NCT00336544|Clarithromycin|clarithromycin|mesh-list
19791898|NCT00336544|Cethromycin|cethromycin|mesh-list
19791899|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791900|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791901|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19791902|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154578|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
20154579|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
19791903|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791904|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19791905|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19791906|NCT00336583|Cytarabine|cytarabine|mesh-list
19791907|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
19791908|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
19791909|NCT00336583|Etoposide|etoposide|mesh-list
19791910|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791911|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19791912|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19791913|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791914|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791915|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154580|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154581|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20154582|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20154583|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20154584|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20154585|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20154586|NCT00100594|Lamivudine|lamivudine|mesh-list
20154587|NCT00100594|Zidovudine|zidovudine|mesh-list
20154588|NCT00100594|Efavirenz|efavirenz|mesh-list
20154589|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20154590|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19639905|NCT02403284|Liraglutide|liraglutide|mesh-list
19639906|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19639907|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639908|NCT02403284|Incretins|incretins|mesh-ancestor
19639909|NCT02403284|Hormones|hormones|mesh-ancestor
19639910|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639911|NCT02403128|Aflibercept|aflibercept|mesh-list
19639912|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19639913|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19639914|NCT02403128|Growth Substances|growth substances|mesh-ancestor
19639915|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639916|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
19639917|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639918|NCT02403063|Neostigmine|neostigmine|mesh-list
19791916|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791917|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
19791918|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
19791919|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791920|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791921|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
19791922|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791923|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19791924|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
19791925|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
19791926|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19791927|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19791928|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
19791929|NCT00336583|Hormones|hormones|mesh-ancestor
20321687|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321688|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321689|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19791930|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19791931|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19791932|NCT00336583|Protective Agents|protective agents|mesh-ancestor
19791933|NCT00336700|Gemcitabine|gemcitabine|mesh-list
19791934|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19791935|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791936|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
19791937|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791938|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791939|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
19791940|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791941|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791942|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791943|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
19791944|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791945|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19791946|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
19791947|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321690|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20321691|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20321692|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20321693|NCT03899155|Nivolumab|nivolumab|mesh-list
20321694|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321695|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321696|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321697|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321698|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
20321699|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
20321700|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791948|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791949|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19791950|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
19791951|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791952|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791953|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791954|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791955|NCT00336856|Irinotecan|irinotecan|mesh-list
19791956|NCT00336856|Cetuximab|cetuximab|mesh-list
19791957|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19791958|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19791959|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791960|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791961|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791962|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321701|NCT03836209|Cytarabine|cytarabine|mesh-list
20321702|NCT03836209|Daunorubicin|daunorubicin|mesh-list
20321703|NCT03836209|Midostaurin|midostaurin|mesh-list
20321704|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321705|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
20321706|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321707|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321708|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
19791963|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
19791964|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19791965|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321709|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321710|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321711|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
20321712|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321713|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321714|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20321715|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20321716|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321717|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20321718|NCT03822468|Letrozole|letrozole|mesh-list
20321719|NCT03822468|Anastrozole|anastrozole|mesh-list
20321720|NCT03822468|Goserelin|goserelin|mesh-list
19791966|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19791967|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
19791968|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19791969|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791970|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791971|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791972|NCT00337103|Capecitabine|capecitabine|mesh-list
19791973|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791974|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
19791975|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791976|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19791977|NCT00337168|Cytarabine|cytarabine|mesh-list
19791978|NCT00337168|Clofarabine|clofarabine|mesh-list
19791979|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791980|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
19791981|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19791982|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321721|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321722|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20321723|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20321724|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19791983|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
19791984|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19791985|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19791986|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
19791987|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791988|NCT00337194|Gemcitabine|gemcitabine|mesh-list
19791989|NCT00337194|Doxorubicin|doxorubicin|mesh-list
19791990|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19791991|NCT00337194|Vinorelbine|vinorelbine|mesh-list
19791992|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19791993|NCT00337194|Antibodies|antibodies|mesh-list
19791994|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19791995|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
19791996|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19791997|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19791998|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
19791999|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792000|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792001|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
19792002|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792003|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639919|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19639920|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639921|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639922|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
19639923|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19639924|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639925|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19639926|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
19639927|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639928|NCT02403037|Dexamethasone|dexamethasone|mesh-list
19639929|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
19639930|NCT02403037|Antiemetics|antiemetics|mesh-list
19639931|NCT02403037|Emetics|emetics|mesh-list
19639932|NCT02403037|BB 1101|bb 1101|mesh-list
19639933|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639934|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
19639935|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639936|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639937|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321725|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639938|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
19639939|NCT02403037|Hormones|hormones|mesh-ancestor
19792004|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792005|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19792006|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19792007|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792008|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19792009|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
19792010|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
19792011|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
19792012|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792013|NCT00337207|Bevacizumab|bevacizumab|mesh-list
19792014|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792015|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792016|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19792017|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19792018|NCT00337207|Growth Substances|growth substances|mesh-ancestor
19792019|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792020|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
19792021|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19792022|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19792023|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792024|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19792025|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19792026|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792027|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792028|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
19792029|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792030|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
19792031|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19792032|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792033|NCT00337428|Vaccines|vaccines|mesh-list
19792034|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
19792035|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792036|NCT00337467|Ritonavir|ritonavir|mesh-list
19792037|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20321726|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20321727|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
20321728|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321729|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321730|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321731|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20321732|NCT03817125|Vancomycin|vancomycin|mesh-list
20321733|NCT03817125|Nivolumab|nivolumab|mesh-list
20321734|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792038|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19792039|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19792040|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
19792041|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792042|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792043|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19792044|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19792045|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
20321735|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321736|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321737|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321738|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321739|NCT03743376|UB-421|ub-421|mesh-list
20321740|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20321741|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
20321742|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321743|NCT03742102|Paclitaxel|paclitaxel|mesh-list
20321744|NCT03742102|Trastuzumab|trastuzumab|mesh-list
20321745|NCT03742102|Durvalumab|durvalumab|mesh-list
20321746|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20321747|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321748|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
20321749|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
20321750|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
20321751|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321752|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321753|NCT03734653|Testosterone|testosterone|mesh-list
20321754|NCT03734653|Androgens|androgens|mesh-ancestor
20321755|NCT03734653|Hormones|hormones|mesh-ancestor
20321756|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321757|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321758|NCT03728478|Etanercept|etanercept|mesh-list
20321759|NCT03728478|Methotrexate|methotrexate|mesh-list
20611200|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
20611201|NCT02003222|Antibodies|antibodies|mesh-list
20611202|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
20611203|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20321760|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20321761|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
20321762|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20321763|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321764|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321765|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
20321766|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321767|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321768|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
20321769|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321770|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20321771|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321772|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
20321773|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321774|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20321775|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20321776|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20321777|NCT03728478|Analgesics|analgesics|mesh-ancestor
20321778|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
20321779|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321780|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321781|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321782|NCT03702283|Penicillins|penicillins|mesh-list
20321783|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19639940|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639941|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639942|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639943|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154591|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20154592|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154593|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154594|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
20154595|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154596|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20154597|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20154598|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
20154599|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20154600|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20321784|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321785|NCT03655821|Pemetrexed|pemetrexed|mesh-list
20321786|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321787|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321788|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321789|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20611204|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19639944|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639945|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639946|NCT02402972|Leucovorin|leucovorin|mesh-list
19639947|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
19639948|NCT02402972|Floxuridine|floxuridine|mesh-list
19639949|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
19639950|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639951|NCT02402972|Antidotes|antidotes|mesh-ancestor
19639952|NCT02402972|Protective Agents|protective agents|mesh-ancestor
19639953|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792046|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792047|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19792048|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19792049|NCT00337571|Aripiprazole|aripiprazole|mesh-list
19792050|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
19792051|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20154601|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19792052|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20154602|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20154603|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20154604|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20321790|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20611205|NCT02003222|BB 1101|bb 1101|mesh-list
20321791|NCT03647774|Naltrexone|naltrexone|mesh-list
20321792|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20321793|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20321794|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321795|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
20321796|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321797|NCT03642132|Bevacizumab|bevacizumab|mesh-list
19792053|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792054|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792055|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792056|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
19792057|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
19792058|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792059|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792060|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20321798|NCT03642132|Avelumab|avelumab|mesh-list
20321799|NCT03642132|Talazoparib|talazoparib|mesh-list
19792061|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19792062|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
19792063|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19792064|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792065|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19792066|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19792067|NCT00337610|Metformin|metformin|mesh-list
19792068|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19792069|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19792070|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792071|NCT00337610|Incretins|incretins|mesh-ancestor
19792072|NCT00337610|Hormones|hormones|mesh-ancestor
19792073|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792074|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19792075|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
19792076|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792077|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792078|NCT00337662|Olanzapine|olanzapine|mesh-list
19792079|NCT00337662|Risperidone|risperidone|mesh-list
19792080|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792081|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
20321800|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321801|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321802|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321803|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19639954|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
19639955|NCT02402972|Vitamins|vitamins|mesh-ancestor
19792082|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792083|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792084|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792085|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19792086|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792087|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792088|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792089|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19792090|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
19792091|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
19792092|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
19792093|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792094|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792095|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19792096|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19792097|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792098|NCT00337727|Dexamethasone|dexamethasone|mesh-list
19792099|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
20321804|NCT03642132|Growth Substances|growth substances|mesh-ancestor
19639956|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
19639957|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19639958|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
19639959|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639960|NCT02402868|Ketamine|ketamine|mesh-list
19639961|NCT02402868|Analgesics|analgesics|mesh-ancestor
19639962|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
19639963|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639964|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792100|NCT00337727|Ondansetron|ondansetron|mesh-list
20321805|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792101|NCT00337727|Aprepitant|aprepitant|mesh-list
19792102|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
19792103|NCT00337727|BB 1101|bb 1101|mesh-list
19792104|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792105|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
19792106|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
19792107|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792108|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792109|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792110|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
19792111|NCT00337727|Hormones|hormones|mesh-ancestor
19792112|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792113|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19792114|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792115|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
19792116|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792117|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792118|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
19792119|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
19792120|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792121|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
19792122|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792123|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19792124|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792125|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639965|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19639966|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19639967|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
19639968|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
19639969|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19639970|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19639971|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19639972|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792126|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792127|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19792128|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19792129|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
19792130|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
19792131|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19792132|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
19792133|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792134|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792135|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792136|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
19639973|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639974|NCT02402725|Dexamethasone|dexamethasone|mesh-list
19639975|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
19639976|NCT02402725|BB 1101|bb 1101|mesh-list
19639977|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19639978|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
19639979|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
19639980|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19639981|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19639982|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19639983|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
19639984|NCT02402725|Hormones|hormones|mesh-ancestor
19639985|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19639986|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19639987|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639988|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
19639989|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19639990|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639991|NCT02402712|Docetaxel|docetaxel|mesh-list
19639992|NCT02402712|Trastuzumab|trastuzumab|mesh-list
19639993|NCT02402712|Pertuzumab|pertuzumab|mesh-list
19639994|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19639995|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
19639996|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
19639997|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
19639998|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19639999|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792137|NCT00337935|Hematinics|hematinics|mesh-ancestor
19792138|NCT00337987|Prednisone|prednisone|mesh-list
19792139|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
19640000|NCT02402621|Fentanyl|fentanyl|mesh-list
19792140|NCT00337987|Vincristine|vincristine|mesh-list
19792141|NCT00337987|Doxorubicin|doxorubicin|mesh-list
19792142|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19792143|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
19792144|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792145|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
19792146|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792147|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154605|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
20154606|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20154607|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154608|NCT00100646|Ritonavir|ritonavir|mesh-list
20154609|NCT00100646|Lopinavir|lopinavir|mesh-list
20154610|NCT00100646|Lamivudine|lamivudine|mesh-list
20154611|NCT00100646|Stavudine|stavudine|mesh-list
20154612|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20154613|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20154614|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
19640001|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19640002|NCT02402621|Narcotics|narcotics|mesh-ancestor
19640003|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640004|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640005|NCT02402621|Analgesics|analgesics|mesh-ancestor
19640006|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
20321806|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
20321807|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20321808|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321809|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321810|NCT03635164|Durvalumab|durvalumab|mesh-list
20321811|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20154615|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154616|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154617|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20154618|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20154619|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
20154620|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154621|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19792148|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19792149|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
19792150|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640007|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792151|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792152|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19792153|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792154|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
19792155|NCT00337987|Hormones|hormones|mesh-ancestor
19792156|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792157|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19792158|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19792159|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
19792160|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
19792161|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
19792162|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19792163|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19792164|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792165|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792166|NCT00338039|Gemcitabine|gemcitabine|mesh-list
19792167|NCT00338039|Capecitabine|capecitabine|mesh-list
19792168|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
19792169|NCT00338039|Cetuximab|cetuximab|mesh-list
19792170|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19792171|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
19792172|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792173|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792174|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
19792175|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154622|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19640008|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19640009|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19640010|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
19640011|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
19640012|NCT02402595|Itraconazole|itraconazole|mesh-list
19640013|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
19640014|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640015|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19792176|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640016|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19834050|NCT00591630|Cytarabine|cytarabine|mesh-list
19792177|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792178|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
19792179|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792180|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792181|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
19792182|NCT00338286|Hematinics|hematinics|mesh-ancestor
19792183|NCT00338598|Glycine|glycine|mesh-list
19792184|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
19792185|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792186|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792187|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792188|NCT00338728|Letrozole|letrozole|mesh-list
19792189|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
19792190|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792191|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19792192|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19792193|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321812|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321813|NCT03613116|Vitamin D|vitamin d|mesh-list
20321814|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
19792194|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792195|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19792196|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
19792197|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792198|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792199|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19792200|NCT00338884|Sunitinib|sunitinib|mesh-list
19792201|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792202|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19792203|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19792204|NCT00338884|Growth Substances|growth substances|mesh-ancestor
19792205|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792206|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
19792207|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19792208|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792209|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792210|NCT00338949|Olanzapine|olanzapine|mesh-list
19792211|NCT00338949|Risperidone|risperidone|mesh-list
19792212|NCT00338949|Ziprasidone|ziprasidone|mesh-list
19792213|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792214|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
19792215|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792216|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792217|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792218|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19792219|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792220|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792221|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792222|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19792223|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
19792224|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
19792225|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
19792226|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792227|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792228|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19792229|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19792230|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792231|NCT00338962|Naltrexone|naltrexone|mesh-list
19792232|NCT00338962|Paroxetine|paroxetine|mesh-list
19792233|NCT00338962|Desipramine|desipramine|mesh-list
19792234|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19792235|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19792236|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792237|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
19792238|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792239|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19792240|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20321815|NCT03613116|Vitamins|vitamins|mesh-ancestor
19792241|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20321816|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
20321817|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321818|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19792242|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792243|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792244|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
19792245|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19792246|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
19792247|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792248|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19792249|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19792250|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792251|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19792252|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19792253|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
19792254|NCT00338988|Capecitabine|capecitabine|mesh-list
19792255|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
19792256|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19792257|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
19792258|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792259|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792260|NCT00339079|Fluoxetine|fluoxetine|mesh-list
19792261|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19792262|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19792263|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792264|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792265|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792266|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
19792267|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792268|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19792269|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
19792270|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792271|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19792272|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19792273|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792274|NCT00339144|Dasatinib|dasatinib|mesh-list
19792275|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792276|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19792277|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792278|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792279|NCT00339183|Panitumumab|panitumumab|mesh-list
19792280|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792281|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792282|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19792283|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19792284|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19792285|NCT00339833|Analgesics|analgesics|mesh-ancestor
20321819|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20321820|NCT03586999|Nivolumab|nivolumab|mesh-list
20321821|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792286|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
19792287|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792288|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792289|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792290|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792291|NCT00340379|Haloperidol|haloperidol|mesh-list
19792292|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
19792293|NCT00340379|Ziprasidone|ziprasidone|mesh-list
19792294|NCT00340379|Sertraline|sertraline|mesh-list
19792295|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
19792296|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20154623|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20154624|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20154625|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
20154626|NCT00100685|Volociximab|volociximab|mesh-list
20154627|NCT00100685|Antibodies|antibodies|mesh-list
20154628|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20154629|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
20154630|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154631|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20154632|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20154633|NCT00100685|Growth Substances|growth substances|mesh-ancestor
20321822|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792297|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19792298|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19792299|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792300|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792301|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792302|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
19792303|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792304|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
19792305|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
19792306|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640017|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640018|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640019|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19640020|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
19640021|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640022|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640023|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19640024|NCT02402491|Aspirin|aspirin|mesh-list
19792307|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792308|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19792309|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792310|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792311|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19792312|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
19792313|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19792314|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792315|NCT00340678|Losartan|losartan|mesh-list
19792316|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19792317|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19792318|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19792319|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19792320|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792321|NCT00340704|Tamsulosin|tamsulosin|mesh-list
19792322|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19792323|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19792324|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19792325|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
19792326|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792327|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792328|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792329|NCT00340704|Urological Agents|urological agents|mesh-ancestor
19792330|NCT00340834|Interferons|interferons|mesh-list
19792331|NCT00340834|Interferon-beta|interferon-beta|mesh-list
19792332|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
19792333|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19792334|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792335|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
19792336|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792337|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19792338|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792339|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792340|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
19792341|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792342|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19792343|NCT00342355|Ritonavir|ritonavir|mesh-list
19792344|NCT00342355|Lopinavir|lopinavir|mesh-list
19792345|NCT00342355|Lamivudine|lamivudine|mesh-list
19792346|NCT00342355|Zidovudine|zidovudine|mesh-list
19792347|NCT00342355|Stavudine|stavudine|mesh-list
19792348|NCT00342355|Didanosine|didanosine|mesh-list
19792349|NCT00342355|Efavirenz|efavirenz|mesh-list
19792350|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19792351|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19792352|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
19792353|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792354|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792355|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19792356|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19792357|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
19640025|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
19640026|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19640027|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19792358|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834051|NCT00591630|Rituximab|rituximab|mesh-list
19792359|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19792360|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19792361|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19792362|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19792363|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
19792364|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19792365|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19792366|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19792367|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19792368|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19792369|NCT00342563|Mecamylamine|mecamylamine|mesh-list
19792370|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19792371|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19792372|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
19792373|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792374|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792375|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20321823|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321824|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321825|NCT03583957|Caffeine|caffeine|mesh-list
19792376|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19792377|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
19792378|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792379|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792380|NCT00342628|Vaccines|vaccines|mesh-list
19792381|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
19792382|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792383|NCT00343044|Bevacizumab|bevacizumab|mesh-list
19792384|NCT00343044|Topotecan|topotecan|mesh-list
19792385|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792386|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792387|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19792388|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19792389|NCT00343044|Growth Substances|growth substances|mesh-ancestor
19792390|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792391|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
19792392|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19792393|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792394|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792395|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792396|NCT00343083|Paclitaxel|paclitaxel|mesh-list
19792397|NCT00343083|Carboplatin|carboplatin|mesh-list
19792398|NCT00343083|Cetuximab|cetuximab|mesh-list
19792399|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19792400|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792401|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19792402|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19792403|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19792404|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792405|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792406|NCT00343252|Teriparatide|teriparatide|mesh-list
19792407|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
19792408|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
19792409|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19792410|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792411|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19792412|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20154634|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
20154635|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154636|NCT00100737|Rituximab|rituximab|mesh-list
20154637|NCT00100737|Interleukin-2|interleukin-2|mesh-list
20154638|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20154639|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154640|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
20154641|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154642|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154643|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20154644|NCT00100737|Analgesics|analgesics|mesh-ancestor
20154645|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
20154646|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321826|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20154647|NCT00100750|Gemcitabine|gemcitabine|mesh-list
20154648|NCT00100750|Tipifarnib|tipifarnib|mesh-list
20154649|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20321827|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321828|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20321829|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321830|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321831|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20321832|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20321833|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
20321834|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154650|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
20154651|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154652|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154653|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
20154654|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154655|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154656|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154657|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
20154658|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154659|NCT00100776|Olanzapine|olanzapine|mesh-list
20154660|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
20154661|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
20154662|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321853|NCT03527537|Insulin|insulin|mesh-list
20321854|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20321855|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321856|NCT03520569|Octreotide|octreotide|mesh-list
20321857|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321858|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321859|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321860|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20321861|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20321862|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20321863|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321864|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321865|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
20321866|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321867|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20321868|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20321869|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
20321870|NCT03504241|Sirolimus|sirolimus|mesh-list
20321871|NCT03504241|Prednisone|prednisone|mesh-list
20321872|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
20321873|NCT03504241|Abatacept|abatacept|mesh-list
20321874|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321875|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
20321876|NCT03504241|Hormones|hormones|mesh-ancestor
20321877|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321878|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321879|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321880|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321881|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20321882|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20321883|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
20321884|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20321885|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792413|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20154663|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154664|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20154665|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20154666|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20154667|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20154668|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20154669|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20154670|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19640028|NCT02402491|Analgesics|analgesics|mesh-ancestor
20154671|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20154672|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321886|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792414|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792415|NCT00343291|Paclitaxel|paclitaxel|mesh-list
19792416|NCT00343291|Bevacizumab|bevacizumab|mesh-list
19792417|NCT00343291|Carboplatin|carboplatin|mesh-list
19792418|NCT00343291|Cetuximab|cetuximab|mesh-list
19792419|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19792420|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792421|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
19792422|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
19792423|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
19792424|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792425|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792426|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19792427|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19792428|NCT00343291|Growth Substances|growth substances|mesh-ancestor
19792429|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792430|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
19792431|NCT00343382|Pilocarpine|pilocarpine|mesh-list
19792432|NCT00343382|Miotics|miotics|mesh-ancestor
19792433|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
19792434|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792435|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792436|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19792437|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19792438|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
19792439|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792440|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792441|NCT00343460|Dexamethasone|dexamethasone|mesh-list
19792442|NCT00343460|Palonosetron|palonosetron|mesh-list
19792443|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792444|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
19792445|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
19792446|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792447|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792448|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321887|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321888|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
20321889|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20321890|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
20321891|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321892|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321893|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321894|NCT03503058|Chloroquine|chloroquine|mesh-list
20321895|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20321896|NCT03503058|Amebicides|amebicides|mesh-ancestor
20321897|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20611206|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640029|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
19640030|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640031|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640032|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640033|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640034|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19640035|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19640036|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640037|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19640038|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19640039|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640040|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
19640041|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19792449|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
19792450|NCT00343460|Hormones|hormones|mesh-ancestor
19792451|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792452|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19792453|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792454|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19792455|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792456|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
19792457|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792458|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792459|NCT00343512|Docetaxel|docetaxel|mesh-list
19792460|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792461|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
19792462|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
19792463|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
20154673|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154674|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
20154675|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20154676|NCT00100854|Fulvestrant|fulvestrant|mesh-list
20154677|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154678|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19792464|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792465|NCT00343785|Cyclosporine|cyclosporine|mesh-list
20154679|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154680|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154681|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20154682|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20154683|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20154684|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
20154685|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154686|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154687|NCT00100880|Lenalidomide|lenalidomide|mesh-list
20321898|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20321899|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20321900|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
20321901|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20321902|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20321903|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20321904|NCT03503058|Analgesics|analgesics|mesh-ancestor
20321905|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
20321906|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321907|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321908|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20321909|NCT03503058|Filaricides|filaricides|mesh-ancestor
20321910|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
19792466|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
19792467|NCT00343785|Methotrexate|methotrexate|mesh-list
19792468|NCT00343785|Cyclosporins|cyclosporins|mesh-list
19792469|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
19792470|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19792471|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
19792472|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792473|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
19792474|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792475|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792476|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19792477|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
19792478|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792479|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792480|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19792481|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19792482|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
20321911|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
20321912|NCT03499899|Carboplatin|carboplatin|mesh-list
20321913|NCT03499899|Spartalizumab|spartalizumab|mesh-list
20321914|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321915|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321916|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321917|NCT03491540|Gentamicins|gentamicins|mesh-list
20321918|NCT03491540|Ornidazole|ornidazole|mesh-list
20321919|NCT03491540|Sennosides|sennosides|mesh-list
20321920|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19792483|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19834052|NCT00591630|Etoposide|etoposide|mesh-list
20321921|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792484|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19792485|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
19792486|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19792487|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792488|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19792489|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19792490|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
19792491|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792492|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19792493|NCT00343863|Dexamethasone|dexamethasone|mesh-list
19792494|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
19792495|NCT00343863|Doxorubicin|doxorubicin|mesh-list
19792496|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19792497|NCT00343863|Ondansetron|ondansetron|mesh-list
19792498|NCT00343863|Palonosetron|palonosetron|mesh-list
19792499|NCT00343863|Antiemetics|antiemetics|mesh-list
19792500|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792501|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
19792502|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792503|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792504|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19792505|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
19792506|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321922|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20321923|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321924|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321925|NCT03491540|Laxatives|laxatives|mesh-ancestor
20321926|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20321927|NCT03491540|Amebicides|amebicides|mesh-ancestor
20321928|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20321929|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20321930|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20321931|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20321932|NCT03479268|Pevonedistat|pevonedistat|mesh-list
20321933|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321934|NCT03475004|Bevacizumab|bevacizumab|mesh-list
20321935|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
20321936|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321937|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321938|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20321939|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20321940|NCT03475004|Growth Substances|growth substances|mesh-ancestor
19792507|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792508|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19792509|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792510|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
20321941|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321942|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640042|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19640043|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
19640044|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640045|NCT02402465|Fluticasone|fluticasone|mesh-list
19640046|NCT02402465|Xhance|xhance|mesh-list
19640047|NCT02402465|Azelastine|azelastine|mesh-list
19640048|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640049|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19640050|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
19640051|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640052|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640053|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19640054|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
19640055|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
19640056|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19640057|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19640058|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640059|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640060|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19640061|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19640062|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
19640063|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
19640064|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640065|NCT02402400|Ticagrelor|ticagrelor|mesh-list
19640066|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19640067|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19792511|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20321943|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
20321944|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321945|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321946|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
20321947|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20321948|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321949|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321950|NCT03436654|Prednisone|prednisone|mesh-list
20321951|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
20321952|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640068|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19640069|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19640070|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
19640071|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640072|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640073|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640074|NCT02402413|Androgens|androgens|mesh-list
19640075|NCT02402413|Hormones|hormones|mesh-ancestor
19640076|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640077|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640078|NCT02402283|Metronidazole|metronidazole|mesh-list
19640079|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640080|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19640081|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19640082|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19663197|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663198|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663199|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19663200|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19663201|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
20321953|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
20321954|NCT03436654|Hormones|hormones|mesh-ancestor
20321955|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20321956|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321957|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20321958|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321959|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20321960|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20321961|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321962|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
20321963|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20321964|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20321965|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19663202|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19663203|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19663204|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663205|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663206|NCT05001360|Nivolumab|nivolumab|mesh-list
19663207|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19663208|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663209|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663210|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663211|NCT04986839|Acetaminophen|acetaminophen|mesh-list
19663212|NCT04986839|Ibuprofen|ibuprofen|mesh-list
19663213|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19663214|NCT04986839|Analgesics|analgesics|mesh-ancestor
19663215|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
19663216|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663217|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663218|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
19663219|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19663220|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19663221|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663222|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19663223|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663224|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663225|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19663226|NCT04901299|Fulvestrant|fulvestrant|mesh-list
19663227|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19663228|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663229|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20154688|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
20154689|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154690|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640083|NCT02402231|Omalizumab|omalizumab|mesh-list
19640084|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19640085|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19640086|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
19640087|NCT02402543|Acetaminophen|acetaminophen|mesh-list
19640088|NCT02402543|Dexamethasone|dexamethasone|mesh-list
19640089|NCT02402543|Ketamine|ketamine|mesh-list
19640090|NCT02402543|Gabapentin|gabapentin|mesh-list
19640091|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640092|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
19640093|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
19640094|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640095|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640096|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640097|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
19640098|NCT02402543|Hormones|hormones|mesh-ancestor
19640099|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640100|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19640101|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640102|NCT02402543|Analgesics|analgesics|mesh-ancestor
19640103|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
19640104|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19640105|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19640106|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
19640107|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
19640108|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640109|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19640110|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19663230|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19663231|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
19256643|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663232|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663233|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663234|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
19663235|NCT04895761|Letrozole|letrozole|mesh-list
19663236|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663237|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
19663238|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663239|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663240|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19663241|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
19663242|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663243|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663244|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19663245|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19663246|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19663247|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663248|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19663249|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
19663250|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663251|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
19663252|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19663253|NCT04829383|Bevacizumab|bevacizumab|mesh-list
19663254|NCT04829383|Atezolizumab|atezolizumab|mesh-list
19663255|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663256|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663257|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19663258|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19663259|NCT04829383|Growth Substances|growth substances|mesh-ancestor
19663260|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663261|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
19663262|NCT04793100|Aflibercept|aflibercept|mesh-list
19663263|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20154691|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20154692|NCT00100880|Growth Substances|growth substances|mesh-ancestor
20154693|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
20154694|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154695|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
20154696|NCT00100893|Procyanidin|procyanidin|mesh-list
20154697|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
19792512|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792513|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
19792514|NCT00343863|Hormones|hormones|mesh-ancestor
19792515|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792516|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19792517|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19792518|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19792519|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792520|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792521|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
19792522|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
19792523|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792524|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
20154698|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154699|NCT00100893|Protective Agents|protective agents|mesh-ancestor
19640111|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640112|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640113|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19640114|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
19640115|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
19640116|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19640117|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20321980|NCT03355976|Nivolumab|nivolumab|mesh-list
20321981|NCT03355976|Ipilimumab|ipilimumab|mesh-list
20321982|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321983|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321984|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20321985|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321986|NCT03332797|Palbociclib|palbociclib|mesh-list
20321987|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321988|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19640118|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19640119|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
19640120|NCT02402348|Metformin|metformin|mesh-list
19640121|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19640122|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640123|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
19640124|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640125|NCT02402179|Tryptophan|tryptophan|mesh-list
19640126|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19640127|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
19640128|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19640129|NCT02401945|Aflibercept|aflibercept|mesh-list
20321989|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640130|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640131|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640132|NCT02401945|Growth Substances|growth substances|mesh-ancestor
19792525|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792526|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19792527|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792528|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792529|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792530|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19792531|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19792532|NCT00343889|Vaccines|vaccines|mesh-list
19792533|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
19792534|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792535|NCT00344032|Vaccines|vaccines|mesh-list
19792536|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
19792537|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792538|NCT00344175|Simvastatin|simvastatin|mesh-list
19792539|NCT00344175|Pitavastatin|pitavastatin|mesh-list
19792540|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19792541|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19792542|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
19792543|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792544|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19792545|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19792546|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792547|NCT00344305|Vaccines|vaccines|mesh-list
19792548|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
19792549|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792550|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19792551|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
19792552|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792553|NCT00344370|Atorvastatin|atorvastatin|mesh-list
19792554|NCT00344370|Pitavastatin|pitavastatin|mesh-list
19792555|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19792556|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19792557|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
19792558|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321990|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20321991|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19792559|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20321992|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20321993|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20321994|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20321995|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
20321996|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20321997|NCT03182244|Cytarabine|cytarabine|mesh-list
20321998|NCT03182244|Fludarabine|fludarabine|mesh-list
19792560|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19792561|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834053|NCT00591630|Melphalan|melphalan|mesh-list
19834054|NCT00591630|Carmustine|carmustine|mesh-list
19834055|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834056|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834057|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
19834058|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834059|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834060|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19834061|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19834062|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19834063|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834064|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834065|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611207|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
20611208|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611209|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834066|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
19834067|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
19834068|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834069|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834070|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834071|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
19834072|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834073|NCT00591734|Bevacizumab|bevacizumab|mesh-list
20321999|NCT03182244|Etoposide|etoposide|mesh-list
19834074|NCT00591734|Everolimus|everolimus|mesh-list
20322000|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
19792562|NCT00344461|Tenofovir|tenofovir|mesh-list
19792563|NCT00344461|Nevirapine|nevirapine|mesh-list
19792564|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
19792565|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792566|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19792567|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19792568|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792569|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792570|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19792571|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19792572|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19792573|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19792574|NCT00344682|Memantine|memantine|mesh-list
19792575|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19792576|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19792577|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
19792578|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792579|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792580|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792581|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20322001|NCT03182244|Sargramostim|sargramostim|mesh-list
20322002|NCT03182244|Lenograstim|lenograstim|mesh-list
20322003|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322004|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322005|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
20322006|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322007|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322008|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
20322009|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322010|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20322011|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20322012|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20322013|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322014|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
20322015|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322016|NCT03182244|Analgesics|analgesics|mesh-ancestor
19792582|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19792583|NCT00344773|Gefitinib|gefitinib|mesh-list
19792584|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792585|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19792586|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792587|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792588|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19792589|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792590|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
19792591|NCT00344968|Hormones|hormones|mesh-ancestor
19792592|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792593|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792594|NCT00345033|Aripiprazole|aripiprazole|mesh-list
19792595|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
19792596|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792597|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19792598|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792599|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792600|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792601|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
19792602|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
19792603|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792604|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792605|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19792606|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19792607|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
19792608|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19792609|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19792610|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19792611|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19792612|NCT00345046|Prednisolone|prednisolone|mesh-list
19792613|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19792614|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
19792615|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19792616|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
19792617|NCT00345046|Prednisone|prednisone|mesh-list
20322017|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
20322018|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792618|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19792619|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
19792620|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792621|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
19792622|NCT00345046|Hormones|hormones|mesh-ancestor
19792623|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792624|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792625|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19792626|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792627|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
19792628|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
19792629|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792630|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792631|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19792632|NCT00345046|Protective Agents|protective agents|mesh-ancestor
19792633|NCT00345371|Topiramate|topiramate|mesh-list
19792634|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
19792635|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19792636|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792637|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
19792638|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19792639|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792640|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792641|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19792642|NCT00345384|Analgesics|analgesics|mesh-ancestor
19792643|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
19792644|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792645|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19792646|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19792647|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19792648|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
19792649|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792650|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792651|NCT00345540|Carboplatin|carboplatin|mesh-list
19792652|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792653|NCT00345579|PENTA|penta|mesh-list
19792654|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
19792655|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19792656|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19792657|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792658|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19792659|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792660|NCT00345683|Vaccines|vaccines|mesh-list
19792661|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
19792662|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792663|NCT00345839|Cinacalcet|cinacalcet|mesh-list
19792664|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19792665|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792666|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19792667|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
19792668|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792669|NCT00345865|Cytarabine|cytarabine|mesh-list
19792670|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
19792671|NCT00345865|Carmustine|carmustine|mesh-list
19792672|NCT00345865|Etoposide|etoposide|mesh-list
19792673|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792674|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
19792675|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792676|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792677|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19792678|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
19792679|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792680|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154700|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154701|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20154702|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20154703|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154704|NCT00100906|Aldesleukin|aldesleukin|mesh-list
20154705|NCT00100906|Interleukin-2|interleukin-2|mesh-list
20154706|NCT00100906|Tretinoin|tretinoin|mesh-list
20154707|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154708|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19792681|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20322019|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19792682|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20154709|NCT00100906|Analgesics|analgesics|mesh-ancestor
19792683|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19792684|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792685|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792686|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19792687|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
19792688|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
19792689|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792690|NCT00345878|Vaccines|vaccines|mesh-list
19792691|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
19792692|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792693|NCT00345969|Testosterone|testosterone|mesh-list
19792694|NCT00345969|Androgens|androgens|mesh-ancestor
19792695|NCT00345969|Hormones|hormones|mesh-ancestor
19792696|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792697|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792698|NCT00346034|Pregabalin|pregabalin|mesh-list
19792699|NCT00346034|Analgesics|analgesics|mesh-ancestor
19792700|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
20154710|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
20154711|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154712|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154713|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19792701|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792702|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792703|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
19792704|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19792705|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792706|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792707|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19792708|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19792709|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19792710|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792711|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19792712|NCT00346151|Sirolimus|sirolimus|mesh-list
19792713|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
19792714|NCT00346151|Abatacept|abatacept|mesh-list
19792715|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
19792716|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19792717|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
19792718|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
19792719|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19792720|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792721|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19792722|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792723|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
20154714|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20154715|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
20154716|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154717|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
20322020|NCT03164447|UB-421|ub-421|mesh-list
20322021|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19640133|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640134|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640135|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640136|NCT02401971|Thalidomide|thalidomide|mesh-list
19640137|NCT02401971|Irinotecan|irinotecan|mesh-list
19640138|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19640139|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19640140|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640141|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640142|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640143|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640144|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
19640145|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640146|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
19640147|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19640148|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640149|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640150|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640151|NCT02401971|Growth Substances|growth substances|mesh-ancestor
19640152|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
19792724|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640153|NCT02401880|Empagliflozin|empagliflozin|mesh-list
19792725|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
19792726|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322022|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
19792727|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792728|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
19792729|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
19792730|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792731|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792732|NCT00346151|Hormones|hormones|mesh-ancestor
19792733|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792734|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19792735|NCT00346151|Protective Agents|protective agents|mesh-ancestor
19792736|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20322023|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347551|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347552|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347553|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20347554|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
20347555|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20347556|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347557|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20347558|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20347559|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20347560|NCT00861042|Lacosamide|lacosamide|mesh-list
20347561|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
20347562|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20347563|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20347564|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347565|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347566|NCT00861068|Lacosamide|lacosamide|mesh-list
20347567|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
20347568|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20347569|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20347570|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347571|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347572|NCT00861094|Leucovorin|leucovorin|mesh-list
20347573|NCT00861094|Folic Acid|folic acid|mesh-list
20347574|NCT00861094|Fluorouracil|fluorouracil|mesh-list
20347575|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
19792737|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792738|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792739|NCT00346216|Ibuprofen|ibuprofen|mesh-list
19792740|NCT00346216|Celecoxib|celecoxib|mesh-list
19792741|NCT00346216|Naproxen|naproxen|mesh-list
19792742|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19792743|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19792744|NCT00346216|Analgesics|analgesics|mesh-ancestor
19792745|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
19792746|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347576|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
20347577|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347578|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
20347579|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347580|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20347581|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347582|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
20347583|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792747|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792748|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792749|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792750|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19792751|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792752|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792753|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19792754|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
19792755|NCT00346268|Parecoxib|parecoxib|mesh-list
19792756|NCT00346268|Morphine|morphine|mesh-list
19792757|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19792758|NCT00346268|Narcotics|narcotics|mesh-ancestor
19792759|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19792760|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792761|NCT00346268|Analgesics|analgesics|mesh-ancestor
19792762|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
19792763|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792764|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19792765|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19792766|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792767|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792768|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19792769|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19792770|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792771|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792772|NCT00346775|Beclomethasone|beclomethasone|mesh-list
19792773|NCT00346775|Flunisolide|flunisolide|mesh-list
19792774|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792775|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
19792776|NCT00346775|Hormones|hormones|mesh-ancestor
19792777|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792778|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792779|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20322024|NCT03149211|UB-421|ub-421|mesh-list
20322025|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20322026|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
19792780|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
19792781|NCT00347009|Adefovir|adefovir|mesh-list
19792782|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20322027|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322028|NCT03083665|Brivaracetam|brivaracetam|mesh-list
20322029|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
20322030|NCT03068624|Aldesleukin|aldesleukin|mesh-list
20322031|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
20322032|NCT03068624|Ipilimumab|ipilimumab|mesh-list
20322033|NCT03068624|Interleukin-2|interleukin-2|mesh-list
20322034|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322035|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
20322036|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322037|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792783|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
19792784|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792785|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19792786|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19792787|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792788|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792789|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
19792790|NCT00347360|Carvedilol|carvedilol|mesh-list
19792791|NCT00347360|Lisinopril|lisinopril|mesh-list
19792792|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19792793|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19792794|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
19792795|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322038|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20322039|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
20322040|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322041|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322042|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20322043|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322044|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20322045|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20322046|NCT03068624|Analgesics|analgesics|mesh-ancestor
20322047|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
20322048|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322049|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20322050|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20322051|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
20322052|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792796|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792797|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792798|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19792799|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
19792800|NCT00347360|Protective Agents|protective agents|mesh-ancestor
19792801|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19792802|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792803|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19792804|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
19792805|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19792806|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19792807|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19792808|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
19792809|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792810|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19792811|NCT00347438|Capecitabine|capecitabine|mesh-list
19792812|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19792813|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
19792814|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792815|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792816|NCT00347776|Azithromycin|azithromycin|mesh-list
19792817|NCT00347776|Tetracycline|tetracycline|mesh-list
19792818|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19792819|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792820|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19792821|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792822|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792823|NCT00347919|Lapatinib|lapatinib|mesh-list
19792824|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792825|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19792826|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792827|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792828|NCT00347932|Besifloxacin|besifloxacin|mesh-list
19792829|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19792830|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792831|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19792832|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792833|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792834|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792835|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792836|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
19792837|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19792838|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792839|NCT00348283|Adalimumab|adalimumab|mesh-list
19792840|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792841|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792842|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
19792843|NCT00348309|Donepezil|donepezil|mesh-list
19792844|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19792845|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792846|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792847|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
19792848|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792849|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792850|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
19792851|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19792852|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
19792853|NCT00348348|Besifloxacin|besifloxacin|mesh-list
19792854|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19792855|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792856|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20154718|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
20154719|NCT00100945|Gefitinib|gefitinib|mesh-list
20154720|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154721|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154722|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154723|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154724|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
20154725|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20154726|NCT00100958|Protective Agents|protective agents|mesh-ancestor
20154727|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154728|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154729|NCT00100971|Vaccines|vaccines|mesh-list
19792857|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792858|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792859|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792860|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792861|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
19792862|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19792863|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792864|NCT00348595|Lenalidomide|lenalidomide|mesh-list
19792865|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
19792866|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792867|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19792868|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19792869|NCT00348595|Growth Substances|growth substances|mesh-ancestor
19792870|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
19792871|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792872|NCT00348686|Felodipine|felodipine|mesh-list
19792873|NCT00348686|Candesartan|candesartan|mesh-list
19792874|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
19792875|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19792876|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19792877|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20347584|NCT00861094|Antidotes|antidotes|mesh-ancestor
19792878|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792879|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19792880|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19792881|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19792882|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19792883|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792884|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
19792885|NCT00348790|Vatalanib|vatalanib|mesh-list
19792886|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19792887|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154730|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
19792888|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792889|NCT00348816|Prednisone|prednisone|mesh-list
19792890|NCT00348816|Docetaxel|docetaxel|mesh-list
19792891|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792892|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
19792893|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
19792894|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
19792895|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792896|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792897|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
19792898|NCT00348816|Hormones|hormones|mesh-ancestor
19792899|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19792900|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792901|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19792902|NCT00348881|Vaccines|vaccines|mesh-list
19792903|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
19792904|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792905|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
19792906|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
19792907|NCT00348933|Betaine|betaine|mesh-list
19792908|NCT00348933|Vitamins|vitamins|mesh-ancestor
19792909|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
19792910|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792911|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
19792912|NCT00348933|Hematinics|hematinics|mesh-ancestor
19792913|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19792914|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
20154731|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154732|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
20154733|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20154734|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20154735|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154736|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20154737|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20154738|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
20154739|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154740|NCT00101062|Celecoxib|celecoxib|mesh-list
20154741|NCT00101062|Letrozole|letrozole|mesh-list
19792915|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19792916|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
19792917|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792918|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19792919|NCT00348946|Androgens|androgens|mesh-list
19792920|NCT00348946|Oxandrolone|oxandrolone|mesh-list
19792921|NCT00348946|Hormones|hormones|mesh-ancestor
19792922|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154742|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154743|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20154744|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20154745|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154746|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154747|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20154748|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
20154749|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154750|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154751|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20154752|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20154753|NCT00101062|Analgesics|analgesics|mesh-ancestor
20154754|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
20154755|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154756|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20154757|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154758|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19792923|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792924|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
19792925|NCT00349336|Bevacizumab|bevacizumab|mesh-list
19792926|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19792927|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792928|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19792929|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19792930|NCT00349336|Growth Substances|growth substances|mesh-ancestor
19792931|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792932|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
19792933|NCT00349349|Ofatumumab|ofatumumab|mesh-list
19792934|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792935|NCT00349388|Mesalamine|mesalamine|mesh-list
19792936|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19792937|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19792938|NCT00349388|Analgesics|analgesics|mesh-ancestor
19792939|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
19792940|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792941|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792942|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19792943|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792944|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
19792945|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19792946|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19792947|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
19792948|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792949|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
19792950|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792951|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792952|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
19792953|NCT00349778|Melphalan|melphalan|mesh-list
19792954|NCT00349778|Carmustine|carmustine|mesh-list
19792955|NCT00349778|Etoposide|etoposide|mesh-list
19792956|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
19792957|NCT00349778|Lenograstim|lenograstim|mesh-list
19792958|NCT00349778|Sargramostim|sargramostim|mesh-list
19792959|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19792960|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
19792961|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792962|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19792963|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19792964|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
19792965|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792966|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19792967|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20154759|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19792968|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19792969|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19792970|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19792971|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19792972|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19792973|NCT00349921|Adenosine|adenosine|mesh-list
19792974|NCT00349921|Clonidine|clonidine|mesh-list
19792975|NCT00349921|Analgesics|analgesics|mesh-ancestor
19792976|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
19792977|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792978|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19792979|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19792980|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
19792981|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
19792982|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19792983|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19792984|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19792985|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
19792986|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19792987|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19792988|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19792989|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
19792990|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19792991|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
19792992|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
19792993|NCT00349973|Dipyridamole|dipyridamole|mesh-list
19792994|NCT00349973|Olanzapine|olanzapine|mesh-list
19792995|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
19792996|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
19792997|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19792998|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154760|NCT00101075|Capecitabine|capecitabine|mesh-list
20154761|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
20154762|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20154763|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
20154764|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154765|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154766|NCT00101088|Sirolimus|sirolimus|mesh-list
20322082|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
20322083|NCT02916862|Calcium|calcium|mesh-list
20322084|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20322085|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322086|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20322087|NCT02880982|Vitamin D|vitamin d|mesh-list
20154767|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
20154768|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154769|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154770|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322088|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
20322089|NCT02880982|Vitamins|vitamins|mesh-ancestor
20322090|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
20322091|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322092|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20322093|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20322094|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
20322095|NCT02816021|Azacitidine|azacitidine|mesh-list
20322096|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322097|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322098|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322099|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
20322100|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322101|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640154|NCT02401880|Linagliptin|linagliptin|mesh-list
19640155|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19640156|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640157|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19640158|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640159|NCT02401880|Incretins|incretins|mesh-ancestor
19640160|NCT02401880|Hormones|hormones|mesh-ancestor
19640161|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640162|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19640163|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
19792999|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19793000|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19793001|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20174080|NCT00163436|Hormones|hormones|mesh-ancestor
19793002|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793003|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793004|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19793005|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19793006|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19793007|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322102|NCT02766465|Sirolimus|sirolimus|mesh-list
20322103|NCT02766465|Methotrexate|methotrexate|mesh-list
20322104|NCT02766465|Fludarabine|fludarabine|mesh-list
20322105|NCT02766465|Melphalan|melphalan|mesh-list
20322106|NCT02766465|Busulfan|busulfan|mesh-list
20322107|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
20322108|NCT02766465|Tacrolimus|tacrolimus|mesh-list
20322109|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20322110|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
20322111|NCT02766465|Lenograstim|lenograstim|mesh-list
20322112|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19640164|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640165|NCT02401828|Dolutegravir|dolutegravir|mesh-list
19793008|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793009|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
19793010|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19793011|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793012|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19793013|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
19793014|NCT00350025|Paclitaxel|paclitaxel|mesh-list
19793015|NCT00350025|Cetuximab|cetuximab|mesh-list
19793016|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19793017|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793018|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
19793019|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
19793020|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
19793021|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793022|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793023|NCT00350142|Gemcitabine|gemcitabine|mesh-list
19793024|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793025|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
19793026|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793027|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793028|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
19793029|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793030|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793031|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793032|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
19793033|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793034|NCT00350207|Bromides|bromides|mesh-list
19793035|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
19793036|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19793037|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20154771|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154772|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20154773|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154774|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154775|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
20154776|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154777|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
20154778|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322113|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
19640166|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19640167|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19793038|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
19793039|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793040|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793041|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19793042|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
19640168|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640169|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640170|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19640171|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19640172|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
19793043|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
19640173|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793044|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19793045|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
20322114|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20322115|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793046|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793047|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793048|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19793049|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19793050|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19793051|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
19793052|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
19793053|NCT00350272|Tenofovir|tenofovir|mesh-list
19793054|NCT00350272|Lamivudine|lamivudine|mesh-list
19793055|NCT00350272|Efavirenz|efavirenz|mesh-list
19793056|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
19793057|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
19793058|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793059|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19793060|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19793061|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793062|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793063|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19793064|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19793065|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19793066|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19793067|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19793068|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19793069|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19793070|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19793071|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
19793072|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20322116|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322117|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
20322118|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322119|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322120|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
20322121|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322122|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20322123|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322124|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
20322125|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322126|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20322127|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20322128|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20322129|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322130|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20322131|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
20322132|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20322133|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
20322134|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20322135|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20322136|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322137|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
19793073|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793074|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19793075|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19793076|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19793077|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19793078|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793079|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793080|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793081|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
19793082|NCT00350519|Hematinics|hematinics|mesh-ancestor
19793083|NCT00350532|Clonidine|clonidine|mesh-list
19793084|NCT00350532|Analgesics|analgesics|mesh-ancestor
20154779|NCT00101114|Interferons|interferons|mesh-list
20154780|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
20154781|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
20154782|NCT00101114|Sorafenib|sorafenib|mesh-list
20154783|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154784|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
20154785|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154786|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154787|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322138|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19793085|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
19793086|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793087|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793088|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19640174|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19640175|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
19640176|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640177|NCT02401477|Amoxicillin|amoxicillin|mesh-list
19640178|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19640179|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640180|NCT02401594|Enoxaparin|enoxaparin|mesh-list
19640181|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
19640182|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19640183|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
19640184|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19793089|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
19793090|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
19793091|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19793092|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19793093|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19793094|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
19793095|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793096|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793097|NCT00350545|Cyclosporine|cyclosporine|mesh-list
19793098|NCT00350545|Prednisone|prednisone|mesh-list
19793099|NCT00350545|Rituximab|rituximab|mesh-list
19793100|NCT00350545|Tacrolimus|tacrolimus|mesh-list
19793101|NCT00350545|Cyclosporins|cyclosporins|mesh-list
19793102|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793103|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793104|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
19793105|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793106|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793107|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19793108|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
19793109|NCT00350545|Hormones|hormones|mesh-ancestor
19793110|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793111|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19793112|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793113|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19793114|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793115|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793116|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
19793117|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793118|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
19793119|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
19793120|NCT00350636|Oxybutynin|oxybutynin|mesh-list
19793121|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
19793122|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
19793123|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793124|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793125|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19793126|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19793127|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
19793128|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793129|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793130|NCT00350636|Urological Agents|urological agents|mesh-ancestor
19793131|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19793132|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793133|NCT00350636|Renal Agents|renal agents|mesh-ancestor
19793134|NCT00350727|Lapatinib|lapatinib|mesh-list
19793135|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793136|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19793137|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793138|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793139|NCT00350779|Metformin|metformin|mesh-list
19793140|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19793141|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
19793142|NCT00350779|Glipizide|glipizide|mesh-list
19793143|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19793144|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793145|NCT00350779|Incretins|incretins|mesh-ancestor
19793146|NCT00350779|Hormones|hormones|mesh-ancestor
19793147|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793148|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19793149|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
19793150|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834075|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19640185|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
19793151|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793152|NCT00350792|Carboplatin|carboplatin|mesh-list
19793153|NCT00350792|Pemetrexed|pemetrexed|mesh-list
19793154|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793155|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793156|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793157|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19793158|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19793159|NCT00350870|Disulfiram|disulfiram|mesh-list
19793160|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19793161|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19793162|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793163|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793164|NCT00351000|Ziprasidone|ziprasidone|mesh-list
19793165|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19793166|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
19793167|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793168|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793169|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793170|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19793171|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19793172|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793173|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793174|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19793175|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
19793176|NCT00351039|Bevacizumab|bevacizumab|mesh-list
19793177|NCT00351039|Pemetrexed|pemetrexed|mesh-list
19793178|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19793179|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793180|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793181|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19793182|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793183|NCT00351039|Growth Substances|growth substances|mesh-ancestor
19793184|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793185|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793186|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793187|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154788|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154789|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
20154790|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322139|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
20322140|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322141|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322142|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20322143|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
20322144|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20322145|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
20322146|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322147|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322148|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20322149|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
20322150|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
20322151|NCT02760329|Protective Agents|protective agents|mesh-ancestor
20322152|NCT02759185|Dronabinol|dronabinol|mesh-list
19640186|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640187|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640188|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
19640189|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19640190|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19640191|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
19640192|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19640193|NCT02401425|Letrozole|letrozole|mesh-list
19793188|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19793189|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20154791|NCT00101127|Gemcitabine|gemcitabine|mesh-list
20154792|NCT00101127|Docetaxel|docetaxel|mesh-list
20154793|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20154794|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
20154795|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154796|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154797|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
19793190|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154798|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793191|NCT00351273|Azithromycin|azithromycin|mesh-list
19793192|NCT00351273|Doxycycline|doxycycline|mesh-list
19793193|NCT00351273|Rifampin|rifampin|mesh-list
19793194|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793195|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793196|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
19793197|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19793198|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19793199|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19793200|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
19793201|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
19793202|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19793203|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793204|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793205|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19793206|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19793207|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19793208|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20322153|NCT02759185|Cannabidiol|cannabidiol|mesh-list
20322154|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
20322155|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
20322156|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322157|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20322158|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20322159|NCT02759185|Analgesics|analgesics|mesh-ancestor
20322160|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
20322161|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322162|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20322163|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20322164|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322165|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322166|NCT02759185|Hormones|hormones|mesh-ancestor
20322167|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20322168|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
20322169|NCT02730546|Leucovorin|leucovorin|mesh-list
20322170|NCT02730546|Folic Acid|folic acid|mesh-list
20322171|NCT02730546|Paclitaxel|paclitaxel|mesh-list
20322172|NCT02730546|Carboplatin|carboplatin|mesh-list
20322173|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
20322174|NCT02730546|Fluorouracil|fluorouracil|mesh-list
20322175|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
20322176|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20322177|NCT02730546|Calcium|calcium|mesh-list
20322178|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
19640194|NCT02401425|Misoprostol|misoprostol|mesh-list
19640195|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640196|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19640197|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19640198|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640199|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640200|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19640201|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
19640202|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640203|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640204|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19640205|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
19640206|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19640207|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19640208|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19793209|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20154799|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154800|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154801|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
20154802|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154803|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
20154804|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
20154805|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
20154806|NCT00101140|Fludarabine|fludarabine|mesh-list
20154807|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
20154808|NCT00101140|Thiotepa|thiotepa|mesh-list
20154809|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20154810|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154811|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793210|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19793211|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
19793212|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19793213|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793214|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793215|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19793216|NCT00351299|Analgesics|analgesics|mesh-ancestor
19793217|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
19793218|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793219|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19793220|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19793221|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19793222|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
19793223|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322179|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19793224|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793225|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
19793226|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19793227|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793228|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19793229|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
19793230|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793231|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793232|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793233|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793234|NCT00351416|Letrozole|letrozole|mesh-list
19793235|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19793236|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
19793237|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793238|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19793239|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793240|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793241|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19793242|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
19793243|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793244|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793245|NCT00351611|Pregabalin|pregabalin|mesh-list
19793246|NCT00351611|Analgesics|analgesics|mesh-ancestor
19793247|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
19793248|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793249|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793250|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
19793251|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19793252|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19793253|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793254|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19793255|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19793256|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19793257|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793258|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793259|NCT00351819|Testosterone|testosterone|mesh-list
19793260|NCT00351819|Androgens|androgens|mesh-ancestor
19793261|NCT00351819|Hormones|hormones|mesh-ancestor
19793262|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793263|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834076|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834077|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19834078|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19834079|NCT00591734|Growth Substances|growth substances|mesh-ancestor
19834080|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834081|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834082|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834083|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
19834084|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
19834085|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19834086|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19834087|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20154812|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
20154813|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154814|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154815|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
19793264|NCT00351936|Aripiprazole|aripiprazole|mesh-list
19793265|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
19793266|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793267|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19793268|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19793269|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793270|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793271|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
19793272|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
19793273|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793274|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793275|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19793276|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19793277|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
19793278|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19793279|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19793280|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19793281|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19793282|NCT00352001|Lenalidomide|lenalidomide|mesh-list
19793283|NCT00352001|Azacitidine|azacitidine|mesh-list
19793284|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
19793285|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793286|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20322180|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322181|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
20322182|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
20322183|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
20322184|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322185|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20322186|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322187|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20154816|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154817|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20154818|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
20154819|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20154820|NCT00101153|Cytarabine|cytarabine|mesh-list
20154821|NCT00101153|Daunorubicin|daunorubicin|mesh-list
20154822|NCT00101153|Tipifarnib|tipifarnib|mesh-list
20154823|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20154824|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
20154825|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154826|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322188|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793287|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793288|NCT00352001|Growth Substances|growth substances|mesh-ancestor
19793289|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793290|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793291|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793292|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
19793293|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793294|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793295|NCT00352053|Tenofovir|tenofovir|mesh-list
19793296|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
19793297|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322189|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
19793298|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19793299|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19793300|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793301|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793302|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19793303|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19793304|NCT00352105|Fluorouracil|fluorouracil|mesh-list
19793305|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793306|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
19793307|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793308|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793309|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793310|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
19793311|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793312|NCT00352365|Lenalidomide|lenalidomide|mesh-list
19793313|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
19793314|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322190|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793315|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19793316|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793317|NCT00352365|Growth Substances|growth substances|mesh-ancestor
19793318|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793319|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793320|NCT00352417|Atreleuton|atreleuton|mesh-list
19793321|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19793322|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793323|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793324|NCT00352612|Clindamycin|clindamycin|mesh-list
19793325|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
19793326|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
19793327|NCT00352612|Cephalexin|cephalexin|mesh-list
19793328|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793329|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793330|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19793331|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793332|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793333|NCT00352664|Donepezil|donepezil|mesh-list
19793334|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19793335|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793336|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793337|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
19793338|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640209|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
19640210|NCT02401347|Talazoparib|talazoparib|mesh-list
19640211|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19640212|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640213|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640214|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640215|NCT02401269|Aspirin|aspirin|mesh-list
19640216|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19640217|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19640218|NCT02401269|Analgesics|analgesics|mesh-ancestor
19640219|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
19640220|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640221|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640222|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640223|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640224|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19640225|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19640226|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640227|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19640228|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19640229|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640230|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
19640231|NCT02401295|Itraconazole|itraconazole|mesh-list
19793339|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793340|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
19793341|NCT00352690|Paclitaxel|paclitaxel|mesh-list
19793342|NCT00352690|Carboplatin|carboplatin|mesh-list
19793343|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19793344|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19793345|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793346|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
19793347|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19793348|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
19793349|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793350|NCT00352755|Leucovorin|leucovorin|mesh-list
19793351|NCT00352755|Fluorouracil|fluorouracil|mesh-list
19793352|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
19793353|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
19793354|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793355|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322191|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640232|NCT02401295|Celecoxib|celecoxib|mesh-list
19793356|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793357|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793358|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
19793359|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793360|NCT00352755|Antidotes|antidotes|mesh-ancestor
19640233|NCT02401295|Tretinoin|tretinoin|mesh-list
19640234|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19640235|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19793361|NCT00352755|Protective Agents|protective agents|mesh-ancestor
19793362|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
20322192|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
20322193|NCT02730546|Antidotes|antidotes|mesh-ancestor
20322194|NCT02730546|Protective Agents|protective agents|mesh-ancestor
20322195|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
20322196|NCT02730546|Vitamins|vitamins|mesh-ancestor
20322197|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
20322198|NCT02730546|Hematinics|hematinics|mesh-ancestor
19793363|NCT00352755|Vitamins|vitamins|mesh-ancestor
19793364|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
19793365|NCT00352781|Nicotine|nicotine|mesh-list
19793366|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19793367|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
19793368|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793369|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793370|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19793371|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20322199|NCT02704156|Gemcitabine|gemcitabine|mesh-list
20322200|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
20322201|NCT02704156|Trametinib|trametinib|mesh-list
20322202|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322203|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
20322204|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322205|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322206|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
20322207|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793372|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
19793373|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793374|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793375|NCT00352794|Prednisone|prednisone|mesh-list
19793376|NCT00352794|Lenalidomide|lenalidomide|mesh-list
19793377|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19793378|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
19793379|NCT00352794|Hormones|hormones|mesh-ancestor
19793380|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793381|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793382|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19793383|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793384|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
19793385|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19793386|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793387|NCT00352794|Growth Substances|growth substances|mesh-ancestor
19793388|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793389|NCT00352846|Vitamin D|vitamin d|mesh-list
19793390|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
19793391|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
19793392|NCT00352846|Calcium|calcium|mesh-list
19793393|NCT00352846|Vitamins|vitamins|mesh-ancestor
19793394|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
19793395|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793396|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19793397|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19793398|NCT00352846|Antacids|antacids|mesh-ancestor
19793399|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793400|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20154827|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
20154828|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154829|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154830|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
20154831|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154832|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154833|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20154834|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20154835|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154836|NCT00101179|Azacitidine|azacitidine|mesh-list
20154837|NCT00101179|Entinostat|entinostat|mesh-list
20154838|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20154839|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20154840|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
20154841|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154842|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154843|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154844|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
19793401|NCT00352885|Citalopram|citalopram|mesh-list
20154845|NCT00101205|Etoposide|etoposide|mesh-list
20322208|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322209|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322210|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
19793402|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19793403|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20322211|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322212|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322213|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20322214|NCT02688530|Dexamethasone|dexamethasone|mesh-list
20322215|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
20322216|NCT02688530|BB 1101|bb 1101|mesh-list
20322217|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322218|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
20322219|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
20322220|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793404|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19793405|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793406|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793407|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
19793408|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793409|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19793410|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
19793411|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793412|NCT00352911|Mifepristone|mifepristone|mesh-list
19793413|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19793414|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
19793415|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19793416|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793417|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19793418|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19793419|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19793420|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
19793421|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19793422|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19793423|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
19793424|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793425|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
19793426|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19793427|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19793428|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
19793429|NCT00352976|Sirolimus|sirolimus|mesh-list
19793430|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
19793431|NCT00352976|Fludarabine|fludarabine|mesh-list
19793432|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793433|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
19793434|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793435|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793436|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19793437|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
19793438|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793439|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793440|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19793441|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154846|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
20154847|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154848|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20154849|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20154850|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20154851|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154852|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154853|NCT00101231|Alvocidib|alvocidib|mesh-list
20154854|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154855|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
20154856|NCT00101231|Growth Substances|growth substances|mesh-ancestor
20154857|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154858|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154859|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154860|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154861|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
20154862|NCT00101270|Irinotecan|irinotecan|mesh-list
20154863|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154864|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20154865|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20154866|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154867|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322221|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322222|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322223|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
20322224|NCT02688530|Hormones|hormones|mesh-ancestor
20322225|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20322226|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20322227|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322228|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
20322229|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322230|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793442|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19793443|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
19793444|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793445|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793446|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793447|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
19793448|NCT00353119|Etanercept|etanercept|mesh-list
19793449|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19793450|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19793451|NCT00353119|Analgesics|analgesics|mesh-ancestor
19793452|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
19793453|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793454|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793455|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19793456|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793457|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19793458|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322231|NCT02657434|Carboplatin|carboplatin|mesh-list
20322232|NCT02657434|Pemetrexed|pemetrexed|mesh-list
20322233|NCT02657434|Atezolizumab|atezolizumab|mesh-list
20322234|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322235|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322236|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322237|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20322238|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20322239|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
20322240|NCT02625480|Fludarabine|fludarabine|mesh-list
19793459|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
19793460|NCT00353262|Capecitabine|capecitabine|mesh-list
19793461|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
19793462|NCT00353262|Bevacizumab|bevacizumab|mesh-list
19793463|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793464|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
19793465|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793466|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793467|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793468|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19793469|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793470|NCT00353262|Growth Substances|growth substances|mesh-ancestor
19793471|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793472|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793473|NCT00353301|Sirolimus|sirolimus|mesh-list
19793474|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19793475|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793476|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19793477|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793478|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793479|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793480|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793481|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19793482|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
19793483|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793484|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
19793485|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793486|NCT00353418|Ribavirin|ribavirin|mesh-list
19793487|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19793488|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
19793489|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793490|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
19793491|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793492|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
19793493|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19793494|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793495|NCT00353496|Lanreotide|lanreotide|mesh-list
19793496|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793497|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
19793498|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20322241|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793499|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19793500|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
19793501|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793502|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19793503|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
19793504|NCT00353652|Spironolactone|spironolactone|mesh-list
19793505|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19793506|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
19793507|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793508|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793509|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19793510|NCT00353652|Diuretics|diuretics|mesh-ancestor
19793511|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
19793512|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19793513|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19793514|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19793515|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793516|NCT00353704|Pregabalin|pregabalin|mesh-list
19793517|NCT00353704|Morphine|morphine|mesh-list
19793518|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19793519|NCT00353704|Narcotics|narcotics|mesh-ancestor
19793520|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793521|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793522|NCT00353704|Analgesics|analgesics|mesh-ancestor
19793523|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
19793524|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793525|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
19793526|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19793527|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19793528|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793529|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19793530|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19793531|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19793532|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793533|NCT00353834|Insulin|insulin|mesh-list
19793534|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19793535|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
19793536|NCT00353834|Exenatide|exenatide|mesh-list
19793537|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19793538|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793539|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19793540|NCT00353834|Incretins|incretins|mesh-ancestor
19793541|NCT00353834|Hormones|hormones|mesh-ancestor
19793542|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793543|NCT00353873|Fluticasone|fluticasone|mesh-list
19793544|NCT00353873|Xhance|xhance|mesh-list
19793545|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19793546|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19793547|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19793548|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
19793549|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793550|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793551|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19793552|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
20322242|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
20322243|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322244|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322245|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20322246|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
20322247|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793553|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
19793554|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19793555|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19793556|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19793557|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19793558|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
19793559|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793560|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793561|NCT00353977|Vaccines|vaccines|mesh-list
19793562|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
19793563|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793564|NCT00354029|Ketamine|ketamine|mesh-list
19793565|NCT00354029|Analgesics|analgesics|mesh-ancestor
19793566|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
19793567|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154868|NCT00101296|Tipifarnib|tipifarnib|mesh-list
20154869|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154870|NCT00101309|Aldesleukin|aldesleukin|mesh-list
20154871|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154872|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20154873|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19640236|NCT02401295|Analgesics|analgesics|mesh-ancestor
19793568|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793569|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19793570|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19640237|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
19640238|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640239|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640240|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640241|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640242|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19640243|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19793571|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
19793572|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
19793573|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793574|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19793575|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19793576|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793577|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793578|NCT00354107|Cytarabine|cytarabine|mesh-list
19793579|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
19793580|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19793581|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19793582|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19793583|NCT00354107|Carboplatin|carboplatin|mesh-list
19793584|NCT00354107|Methotrexate|methotrexate|mesh-list
19793585|NCT00354107|Etoposide|etoposide|mesh-list
19793586|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
19793587|NCT00354107|Ifosfamide|ifosfamide|mesh-list
19793588|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19793589|NCT00354107|Antibodies|antibodies|mesh-list
19793590|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19793591|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
19793592|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793593|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793594|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19793595|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
19793596|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19793597|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793598|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
19793599|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793600|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
19793601|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793602|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19793603|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793604|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793605|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19793606|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19793607|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19793608|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19793609|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
19793610|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793611|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19793612|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19793613|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
19793614|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793615|NCT00354172|Cyclosporine|cyclosporine|mesh-list
19793616|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
19793617|NCT00354172|Aldesleukin|aldesleukin|mesh-list
19793618|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
19793619|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19793620|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19793621|NCT00354172|Prednisolone|prednisolone|mesh-list
19793622|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
19793623|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
19793624|NCT00354172|Fludarabine|fludarabine|mesh-list
19793625|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
19793626|NCT00354172|Interleukin-2|interleukin-2|mesh-list
19793627|NCT00354172|Cyclosporins|cyclosporins|mesh-list
19793628|NCT00354172|Lenograstim|lenograstim|mesh-list
19793629|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20154874|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
19793630|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
19793631|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793632|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
20322248|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322249|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20322250|NCT02421939|Cytarabine|cytarabine|mesh-list
20322251|NCT02421939|Fludarabine|fludarabine|mesh-list
20322252|NCT02421939|Etoposide|etoposide|mesh-list
20322253|NCT02421939|Azacitidine|azacitidine|mesh-list
20322254|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
20322255|NCT02421939|Idarubicin|idarubicin|mesh-list
20322256|NCT02421939|Sargramostim|sargramostim|mesh-list
20322257|NCT02421939|Lenograstim|lenograstim|mesh-list
20322258|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322259|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322260|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
20322261|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322262|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322263|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
20322264|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322265|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20322266|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19640244|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793633|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793634|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793635|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19793636|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
19793637|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793638|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793639|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19793640|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793641|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
19793642|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19793643|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793644|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
19793645|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793646|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
19793647|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19793648|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19793649|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19793650|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
19793651|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793652|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19793653|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
19793654|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
19793655|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793656|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19793657|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
19793658|NCT00354172|Hormones|hormones|mesh-ancestor
19793659|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793660|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19793661|NCT00354172|Protective Agents|protective agents|mesh-ancestor
19793662|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19793663|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19793664|NCT00354172|Analgesics|analgesics|mesh-ancestor
19793665|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
19793666|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19793667|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19793668|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
19640245|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640246|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
19640247|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640248|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19640249|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19640250|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19640251|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
19640252|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640253|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19640254|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640255|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
19793669|NCT00354224|Capecitabine|capecitabine|mesh-list
20322267|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20322268|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322269|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
20322270|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322271|NCT02421939|Analgesics|analgesics|mesh-ancestor
20322272|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
20322273|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322274|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20322275|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20322276|NCT02383966|Carboplatin|carboplatin|mesh-list
20322277|NCT02383966|Fluorouracil|fluorouracil|mesh-list
20322278|NCT02383966|Cetuximab|cetuximab|mesh-list
20322279|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322280|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
20322281|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322282|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322283|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322284|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
20322285|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322286|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322294|NCT02227927|Domperidone|domperidone|mesh-list
20322295|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
20322296|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
20322297|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322298|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322299|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322300|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20322301|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
20322302|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322303|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322304|NCT02172872|Decitabine|decitabine|mesh-list
20322305|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322306|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
20322307|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322308|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322309|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322310|NCT02099058|Nivolumab|nivolumab|mesh-list
20322311|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20322312|NCT02099058|Osimertinib|osimertinib|mesh-list
20322313|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20322314|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322315|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322316|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20322317|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322318|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20322319|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322320|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
20322321|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322322|NCT02073565|Everolimus|everolimus|mesh-list
20322323|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322324|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322325|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
20322326|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322327|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
20322328|NCT02060487|Citric Acid|citric acid|mesh-list
20322329|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
20322330|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
20322331|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20322332|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
20322333|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
20322334|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322335|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
20322336|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20322337|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20322338|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322339|NCT02060487|Urological Agents|urological agents|mesh-ancestor
20322340|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
19640256|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
19640257|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19640258|NCT02401503|Venetoclax|venetoclax|mesh-list
19640259|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
19640260|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20322341|NCT02037126|Promethazine|promethazine|mesh-list
20322342|NCT02037126|Psilocybin|psilocybin|mesh-list
19793670|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
19793671|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793672|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
19793673|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793674|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793675|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
19793676|NCT00354341|Hematinics|hematinics|mesh-ancestor
19793677|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19793678|NCT00354432|Caseins|caseins|mesh-list
19793679|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19793680|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19793681|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19793682|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793683|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793684|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793685|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19793686|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
19793687|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793688|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
19793689|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
19793690|NCT00354601|Docetaxel|docetaxel|mesh-list
19793691|NCT00354601|Capecitabine|capecitabine|mesh-list
19793692|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322343|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20322344|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20322345|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322346|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322347|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
20322348|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
20322349|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
20322350|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322351|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
20322352|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
20322353|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322354|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20322355|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
20322356|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
20322357|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322358|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322359|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20322360|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
19793693|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
19793694|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
19793695|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
19793696|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793697|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793698|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
19793699|NCT00354640|Anastrozole|anastrozole|mesh-list
19793700|NCT00354640|Simvastatin|simvastatin|mesh-list
19793701|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19793702|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20322361|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
20322362|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
20322363|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20322364|NCT01951274|Serlopitant|serlopitant|mesh-list
20322365|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20322366|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322367|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322368|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793703|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
19793704|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793705|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19793706|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19793707|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793708|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19793709|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793710|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19793711|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19793712|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19793713|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
19793714|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793715|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793716|NCT00354679|Bevacizumab|bevacizumab|mesh-list
19793717|NCT00354679|Irinotecan|irinotecan|mesh-list
19793718|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793719|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154875|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154876|NCT00101335|Celecoxib|celecoxib|mesh-list
20154877|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20154878|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20154879|NCT00101335|Analgesics|analgesics|mesh-ancestor
19793720|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19793721|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793722|NCT00354679|Growth Substances|growth substances|mesh-ancestor
19793723|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793724|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793725|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19793726|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19793727|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793728|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793729|NCT00354744|Dactinomycin|dactinomycin|mesh-list
19793730|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
19793731|NCT00354744|Ifosfamide|ifosfamide|mesh-list
19793732|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
19793733|NCT00354744|Doxorubicin|doxorubicin|mesh-list
19793734|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19793735|NCT00354744|Irinotecan|irinotecan|mesh-list
19793736|NCT00354744|Etoposide|etoposide|mesh-list
19793737|NCT00354744|Vincristine|vincristine|mesh-list
19793738|NCT00354744|Camptothecin|camptothecin|mesh-list
19793739|NCT00354744|Lenograstim|lenograstim|mesh-list
19793740|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793741|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
19793742|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793743|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793744|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19793745|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
19793746|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793747|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793748|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19793749|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19793750|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19793751|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19793752|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793753|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19793754|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20154880|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
20154881|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154882|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154883|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20154884|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20154885|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20154886|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20154887|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154888|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154889|NCT00101348|Bevacizumab|bevacizumab|mesh-list
20154890|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20154891|NCT00101348|Cetuximab|cetuximab|mesh-list
20154892|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20154893|NCT00101348|Antibodies|antibodies|mesh-list
20154894|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
19793755|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19793756|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
19793757|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
19793758|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
19793759|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793760|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793761|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19793762|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19793763|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
19793764|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19793765|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
19793766|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793767|NCT00354770|Expectorants|expectorants|mesh-ancestor
19793768|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
19793769|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19793770|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
19793771|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793772|NCT00354770|Protective Agents|protective agents|mesh-ancestor
19793773|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793774|NCT00354770|Antidotes|antidotes|mesh-ancestor
19793775|NCT00354887|Capecitabine|capecitabine|mesh-list
19793776|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
19793777|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793778|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
19793779|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793780|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793781|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
19793782|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
19793783|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793784|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19793785|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793786|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793787|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
19793788|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19793789|NCT00354978|Leucovorin|leucovorin|mesh-list
19793790|NCT00354978|Bevacizumab|bevacizumab|mesh-list
19793791|NCT00354978|Fluorouracil|fluorouracil|mesh-list
19793792|NCT00354978|Irinotecan|irinotecan|mesh-list
19793793|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19640261|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
19640262|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640263|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640264|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19640265|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
19640266|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19640267|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640268|NCT02401035|Pantoprazole|pantoprazole|mesh-list
19640269|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19640270|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19793794|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793795|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640271|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19640272|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640273|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640274|NCT02401139|Ketamine|ketamine|mesh-list
19640275|NCT02401139|Analgesics|analgesics|mesh-ancestor
19640276|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
19640277|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640278|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640279|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19640280|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19640281|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
19640282|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
19793796|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793797|NCT00354978|Growth Substances|growth substances|mesh-ancestor
19793798|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793799|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793800|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
19793801|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793802|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19793803|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793804|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
19793805|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19793806|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19793807|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793808|NCT00354978|Antidotes|antidotes|mesh-ancestor
19793809|NCT00354978|Protective Agents|protective agents|mesh-ancestor
19793810|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
19793811|NCT00354978|Vitamins|vitamins|mesh-ancestor
19793812|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
19793813|NCT00355030|Leuprolide|leuprolide|mesh-list
19793814|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19793815|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
19640283|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640284|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19793816|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19793817|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793818|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19793819|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793820|NCT00355082|Lamotrigine|lamotrigine|mesh-list
19793821|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
19793822|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19793823|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19793824|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793825|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19793826|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793827|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19793828|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19793829|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793830|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793831|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19793832|NCT00355121|Vaccines|vaccines|mesh-list
19793833|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
20154895|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20154896|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154897|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20154898|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20154899|NCT00101348|Growth Substances|growth substances|mesh-ancestor
20154900|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154901|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
20154902|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
20154903|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20154904|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154905|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154906|NCT00101374|Leflunomide|leflunomide|mesh-list
19793834|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793835|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19793836|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19793837|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793838|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793839|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
19793840|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793841|NCT00355199|Rituximab|rituximab|mesh-list
19793842|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793843|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793844|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
19793845|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793846|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793847|NCT00355342|Fluticasone|fluticasone|mesh-list
19793848|NCT00355342|Xhance|xhance|mesh-list
19793849|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19793850|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19793851|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19793852|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
19793853|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793854|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793855|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19793856|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
19793857|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
19793858|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19793859|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19793860|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19793861|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19793862|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
19793863|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793864|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793865|NCT00355368|Rocuronium|rocuronium|mesh-list
19793866|NCT00355368|Succinylcholine|succinylcholine|mesh-list
19793867|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19793868|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19793869|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19793870|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793871|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793872|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19793873|NCT00355394|Metoclopramide|metoclopramide|mesh-list
19793874|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
19793875|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
19793876|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793877|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793878|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19793879|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19793880|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19793881|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
19793882|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793883|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793884|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
19793885|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793886|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19793887|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19793888|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19793889|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
20154907|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175168|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175169|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
20175170|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175171|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
20175172|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175173|NCT00167583|Interferons|interferons|mesh-list
20175174|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
20175175|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
20175176|NCT00167583|Cyclosporine|cyclosporine|mesh-list
20175177|NCT00167583|Cyclosporins|cyclosporins|mesh-list
20175178|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175179|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
20175180|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175181|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175182|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793890|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793891|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19793892|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19793893|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793894|NCT00355784|Hormones|hormones|mesh-list
19793895|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19793896|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793897|NCT00356031|Bevacizumab|bevacizumab|mesh-list
19793898|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793899|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793900|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19793901|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793902|NCT00356031|Growth Substances|growth substances|mesh-ancestor
19793903|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793904|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793905|NCT00356122|Bevacizumab|bevacizumab|mesh-list
19793906|NCT00356122|Docetaxel|docetaxel|mesh-list
19793907|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
19793908|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19793909|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793910|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19793911|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19793912|NCT00356122|Growth Substances|growth substances|mesh-ancestor
19793913|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793914|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
19793915|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
19793916|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
19793917|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
19793918|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793919|NCT00356135|Clopidogrel|clopidogrel|mesh-list
19793920|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19793921|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19793922|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19793923|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19793924|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19793925|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
19793926|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793927|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793928|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793929|NCT00356148|Ampicillin|ampicillin|mesh-list
19793930|NCT00356148|Sulbactam|sulbactam|mesh-list
19793931|NCT00356148|Sultamicillin|sultamicillin|mesh-list
19793932|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793933|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793934|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19793935|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19793936|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793937|NCT00356200|Fluphenazine|fluphenazine|mesh-list
19793938|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
19793939|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
19793940|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19793941|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19793942|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793943|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793944|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793945|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19793946|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
19793947|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793948|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793949|NCT00356265|Phenylephrine|phenylephrine|mesh-list
19793950|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
19793951|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19793952|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
19793953|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
19793954|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19793955|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793956|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
19793957|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19793958|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
19793959|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
19793960|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19793961|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19793962|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19793963|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
19793964|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793965|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793966|NCT00356265|Protective Agents|protective agents|mesh-ancestor
19793967|NCT00356278|Cycloserine|cycloserine|mesh-list
19793968|NCT00356278|Alprazolam|alprazolam|mesh-list
19793969|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19793970|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19793971|NCT00356278|Renal Agents|renal agents|mesh-ancestor
19793972|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19793973|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
19793974|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19793975|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
19793976|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793977|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19793978|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19793979|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793980|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19793981|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19793982|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19793983|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
19793984|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
19793985|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19793986|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
19793987|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19793988|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
19793989|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19793990|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19793991|NCT00356525|Gemcitabine|gemcitabine|mesh-list
19793992|NCT00356525|Carboplatin|carboplatin|mesh-list
19793993|NCT00356525|Pemetrexed|pemetrexed|mesh-list
19793994|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19793995|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322393|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20322394|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322395|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20322396|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322397|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322398|NCT00732212|Hemostatics|hemostatics|mesh-list
20322399|NCT00732212|Coagulants|coagulants|mesh-ancestor
19793996|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
19793997|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19793998|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
19793999|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794000|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794001|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794002|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
19794003|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794004|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20322400|NCT00522145|XL647|xl647|mesh-list
20322401|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154908|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154909|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154910|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
20154911|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174081|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174082|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174083|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174084|NCT00163449|Ciclesonide|ciclesonide|mesh-list
20174085|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
20174086|NCT00163449|Hormones|hormones|mesh-ancestor
20174087|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174088|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174089|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174090|NCT00163462|Ciclesonide|ciclesonide|mesh-list
20174091|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
20174092|NCT00163462|Hormones|hormones|mesh-ancestor
20174093|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794005|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19794006|NCT00356590|Etanercept|etanercept|mesh-list
19794007|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20322402|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20322403|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347585|NCT00861094|Protective Agents|protective agents|mesh-ancestor
19794008|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19794009|NCT00356590|Analgesics|analgesics|mesh-ancestor
19794010|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
19794011|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794012|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794013|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19794014|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794015|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794016|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794017|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
19794018|NCT00356603|Sumatriptan|sumatriptan|mesh-list
19794019|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19794020|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19794021|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19794022|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
19794023|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794024|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794025|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794026|NCT00356759|Warfarin|warfarin|mesh-list
19794027|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
19794028|NCT00356811|Paclitaxel|paclitaxel|mesh-list
19794029|NCT00356811|Lapatinib|lapatinib|mesh-list
19794030|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19794031|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794032|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
19794033|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
19794034|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
19794035|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794036|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19794037|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794038|NCT00356889|Bevacizumab|bevacizumab|mesh-list
19794039|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19794040|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19794041|NCT00356889|Antibodies|antibodies|mesh-list
19794042|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
19794043|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19794044|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794045|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19794046|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19794047|NCT00356889|Growth Substances|growth substances|mesh-ancestor
19794048|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154912|NCT00101426|Ranirestat|ranirestat|mesh-list
20154913|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154914|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154915|NCT00101569|Aripiprazole|aripiprazole|mesh-list
20154916|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
20154917|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19794049|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794050|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
19794051|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19794052|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794053|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794054|NCT00356915|Itraconazole|itraconazole|mesh-list
19794055|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19794056|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
19794057|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794058|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19794059|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19794060|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794061|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794062|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19794063|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
19794064|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154918|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20154919|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20154920|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20154921|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154922|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
20154923|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
20154924|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154925|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154926|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20154927|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20154928|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
20322404|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794065|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794066|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19794067|NCT00356993|Nicotine|nicotine|mesh-list
19794068|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19794069|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
19794070|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794071|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794072|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19794073|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19794074|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
19794075|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794076|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794077|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19794078|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19794079|NCT00357006|Estradiol|estradiol|mesh-list
19794080|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19794081|NCT00357006|Estrogens|estrogens|mesh-ancestor
19794082|NCT00357006|Hormones|hormones|mesh-ancestor
19794083|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794084|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794085|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19794086|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
19794087|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19794088|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19794089|NCT00357032|Belinostat|belinostat|mesh-list
19794090|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794091|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19794092|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794093|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794094|NCT00357097|Ropinirole|ropinirole|mesh-list
19794095|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19794096|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19794097|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
19794098|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
19794099|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794100|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794101|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794102|NCT00357110|Fulvestrant|fulvestrant|mesh-list
19794103|NCT00357110|Anastrozole|anastrozole|mesh-list
19794104|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19794105|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794106|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19794107|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19794108|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
19794109|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794110|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794111|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19794112|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19794113|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794114|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794115|NCT00357162|Belinostat|belinostat|mesh-list
19794116|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794117|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19794118|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794119|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794120|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
19794121|NCT00357331|Diuretics|diuretics|mesh-ancestor
19794122|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
19794123|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794124|NCT00357331|Expectorants|expectorants|mesh-ancestor
19794125|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
19794126|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
19794127|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19794128|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794129|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19794130|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794131|NCT00357396|Melphalan|melphalan|mesh-list
19794132|NCT00357396|Busulfan|busulfan|mesh-list
19794133|NCT00357396|Thiotepa|thiotepa|mesh-list
19794134|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19794135|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
19794136|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794137|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322405|NCT00364780|XL647|xl647|mesh-list
19794138|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19794139|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794140|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
20322406|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322407|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20322408|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322409|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322410|NCT00321698|Docetaxel|docetaxel|mesh-list
20322411|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322412|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
20322413|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
20322414|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
20322415|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322416|NCT00726804|Adalimumab|adalimumab|mesh-list
20322417|NCT00726804|Etanercept|etanercept|mesh-list
19794141|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794142|NCT00357500|Thalidomide|thalidomide|mesh-list
19794143|NCT00357500|Celecoxib|celecoxib|mesh-list
19794144|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
19794145|NCT00357500|Etoposide|etoposide|mesh-list
20322418|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322419|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322420|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20322421|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20322422|NCT00726804|Analgesics|analgesics|mesh-ancestor
20322423|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
20322424|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322425|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322426|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322427|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794146|NCT00357500|Fenofibrate|fenofibrate|mesh-list
19794147|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794148|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
19794149|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794150|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794151|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19794152|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
19794153|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794154|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794155|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19794156|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19794157|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19794158|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19794159|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794160|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19794161|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19794162|NCT00357500|Analgesics|analgesics|mesh-ancestor
20154929|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20154930|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20154931|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20154932|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20154933|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20154934|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20154935|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20154936|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20154937|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154938|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20154939|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20154940|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20154941|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
20154942|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20154943|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154944|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20154945|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20154946|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
20154947|NCT00101673|Vildagliptin|vildagliptin|mesh-list
20154948|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154949|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154950|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20154951|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154952|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154953|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154954|NCT00101712|Vildagliptin|vildagliptin|mesh-list
20154955|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154956|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154957|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20154958|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
20154959|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154960|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154961|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
20154962|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20154963|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154964|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20154965|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
20154966|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19794163|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
19794164|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794165|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20154967|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20154968|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154969|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154970|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
20154971|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
20154972|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154973|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154974|NCT00101764|Triamcinolone|triamcinolone|mesh-list
20154975|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20322428|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
20322429|NCT00726869|Elotuzumab|elotuzumab|mesh-list
19794166|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19794167|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19794168|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
19794169|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19794170|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794171|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19794172|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19794173|NCT00357500|Growth Substances|growth substances|mesh-ancestor
19794174|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794175|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19794176|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
19794177|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20322430|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322431|NCT00726960|Buprenorphine|buprenorphine|mesh-list
20322432|NCT00726960|Aprepitant|aprepitant|mesh-list
20322433|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20322434|NCT00726960|Narcotics|narcotics|mesh-ancestor
20322435|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322436|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794178|NCT00357552|Ritonavir|ritonavir|mesh-list
19794179|NCT00357552|Lopinavir|lopinavir|mesh-list
19794180|NCT00357552|Tenofovir|tenofovir|mesh-list
19794181|NCT00357552|Emtricitabine|emtricitabine|mesh-list
19794182|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19794183|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19794184|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19794185|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
19640285|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19640286|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640287|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640288|NCT02400931|Rocuronium|rocuronium|mesh-list
19640289|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19640290|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19640291|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19794186|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154976|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20322437|NCT00726960|Analgesics|analgesics|mesh-ancestor
20322438|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
20322439|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322440|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20322441|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
20322442|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
20322443|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322444|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20322445|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322446|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322447|NCT00726973|Ranibizumab|ranibizumab|mesh-list
20322448|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20322449|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20322450|NCT00726973|Growth Substances|growth substances|mesh-ancestor
20322451|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322452|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794187|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794188|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19794189|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19794190|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
19794191|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794192|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19794193|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19794194|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20154977|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20154978|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20154979|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
20154980|NCT00101764|Hormones|hormones|mesh-ancestor
20154981|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20154982|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154983|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20154984|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
20154985|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154986|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154987|NCT00101790|Pamidronate|pamidronate|mesh-list
20154988|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20322453|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322454|NCT00727038|Ranibizumab|ranibizumab|mesh-list
20322455|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20322456|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20322457|NCT00727038|Growth Substances|growth substances|mesh-ancestor
20322458|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322459|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
20322460|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640292|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640293|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640294|NCT02400879|Sufentanil|sufentanil|mesh-list
19640295|NCT02400879|Remifentanil|remifentanil|mesh-list
19640296|NCT02400879|Sevoflurane|sevoflurane|mesh-list
19640297|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19640298|NCT02400879|Narcotics|narcotics|mesh-ancestor
19640299|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640300|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640301|NCT02400879|Analgesics|analgesics|mesh-ancestor
19640302|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
19640303|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640304|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19640305|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19640306|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
19640307|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
19640308|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19640309|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19640310|NCT02400645|Ketorolac|ketorolac|mesh-list
19640311|NCT02400645|Bupivacaine|bupivacaine|mesh-list
20322461|NCT00727077|Interferons|interferons|mesh-list
20322462|NCT00727077|Ribavirin|ribavirin|mesh-list
20322463|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
20322464|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
20322465|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20154989|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154990|NCT00101803|Vildagliptin|vildagliptin|mesh-list
20154991|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20154992|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20154993|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20154994|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
19640312|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
19640313|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
19640314|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640315|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640316|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
19640317|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20154995|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20154996|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20154997|NCT00101829|Rituximab|rituximab|mesh-list
20322466|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
20322467|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322468|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
20322469|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322470|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
20322471|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322472|NCT00727103|Varenicline|varenicline|mesh-list
20322473|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20322474|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20322475|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
20322476|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322477|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322478|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322479|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20322480|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20322481|NCT00727129|Estradiol|estradiol|mesh-list
20322482|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20322483|NCT00727129|Estrogens|estrogens|mesh-ancestor
19640318|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20154998|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322484|NCT00727129|Hormones|hormones|mesh-ancestor
20322485|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640319|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19794195|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19794196|NCT00357656|Factor VIII|factor viii|mesh-list
19794197|NCT00357656|Coagulants|coagulants|mesh-ancestor
19794198|NCT00357734|Gefitinib|gefitinib|mesh-list
19794199|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794200|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19794201|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794202|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794203|NCT00357760|Aflibercept|aflibercept|mesh-list
19794204|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
19794205|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19794206|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19794207|NCT00357760|Growth Substances|growth substances|mesh-ancestor
19640320|NCT02400645|Analgesics|analgesics|mesh-ancestor
19640321|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640322|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794208|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794209|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640323|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19640324|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640325|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640326|NCT02400866|Olanzapine|olanzapine|mesh-list
19794210|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794211|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
19794212|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19794213|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19794214|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794215|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
19794216|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
19834088|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322486|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347586|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
20154999|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155000|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
20155001|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155002|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20155003|NCT00101842|Gemcitabine|gemcitabine|mesh-list
19640327|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
19640328|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
19640329|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322487|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20322488|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
20322489|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20322490|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20322491|NCT00727207|Everolimus|everolimus|mesh-list
19640330|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640331|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640332|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19640333|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19640334|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640335|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19640336|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19640337|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19640338|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19640339|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640340|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640341|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
19640342|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19640343|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19640344|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19640345|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640346|NCT02400788|Sorafenib|sorafenib|mesh-list
20155004|NCT00101842|Pemetrexed|pemetrexed|mesh-list
20155005|NCT00101842|Cisplatin|cisplatin|mesh-list
20155006|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155007|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
20322492|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322493|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640347|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640348|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19640349|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640350|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663264|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19663265|NCT04793100|Growth Substances|growth substances|mesh-ancestor
19663266|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322494|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
20322495|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322496|NCT00727233|Sorafenib|sorafenib|mesh-list
19663267|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
19663268|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663269|NCT04760028|Anesthetics|anesthetics|mesh-list
19663270|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663271|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665997|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665998|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
19665999|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666000|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
19666001|NCT02727387|Temozolomide|temozolomide|mesh-list
19666002|NCT02727387|Melphalan|melphalan|mesh-list
19666003|NCT02727387|Busulfan|busulfan|mesh-list
19666004|NCT02727387|Ifosfamide|ifosfamide|mesh-list
19666005|NCT02727387|Irinotecan|irinotecan|mesh-list
19666006|NCT02727387|Etoposide|etoposide|mesh-list
19666007|NCT02727387|Vincristine|vincristine|mesh-list
19666008|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794217|NCT00357903|Etanercept|etanercept|mesh-list
19794218|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19794219|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19794220|NCT00357903|Analgesics|analgesics|mesh-ancestor
20322497|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322498|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19666009|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
19666010|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794221|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
19666011|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666012|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20155008|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322499|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322500|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347587|NCT00861094|Vitamins|vitamins|mesh-ancestor
20347588|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
20347589|NCT00861094|Hematinics|hematinics|mesh-ancestor
20347590|NCT00861107|Vaccines|vaccines|mesh-list
20347591|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
20347592|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347593|NCT00861120|Doxorubicin|doxorubicin|mesh-list
20347594|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20347595|NCT00861120|Panitumumab|panitumumab|mesh-list
20347596|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20347597|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347598|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20347599|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20347600|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347601|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347602|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20347603|NCT00861250|Dexamethasone|dexamethasone|mesh-list
20347604|NCT00861250|Bortezomib|bortezomib|mesh-list
19794222|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794223|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794224|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19794225|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794226|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794227|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794228|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
19794229|NCT00357968|Clopidogrel|clopidogrel|mesh-list
19794230|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19794231|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19794232|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20155009|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155010|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
20155011|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155012|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794233|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19794234|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20347605|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347606|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
20347607|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
20347608|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640351|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19794235|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
19794236|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794237|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794238|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794239|NCT00357994|Levodopa|levodopa|mesh-list
19794240|NCT00357994|Carbidopa|carbidopa|mesh-list
19794241|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19794242|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19794243|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19794244|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
20155013|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155014|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
20155015|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155016|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20347609|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640352|NCT02400801|Dienogest|dienogest|mesh-list
19640353|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19640354|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
19640355|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19640356|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
19640357|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19640358|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640359|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19640360|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19640361|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640362|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19640363|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20347610|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640364|NCT02400801|Estrogens|estrogens|mesh-ancestor
19640365|NCT02400801|Hormones|hormones|mesh-ancestor
19794245|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347611|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
20347612|NCT00861250|Hormones|hormones|mesh-ancestor
20347613|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155017|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20322501|NCT00727493|Alendronate|alendronate|mesh-list
20322502|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20322503|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322504|NCT00727545|Chelating Agents|chelating agents|mesh-list
20322505|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
20322506|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322507|NCT00727727|Piribedil|piribedil|mesh-list
20322508|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20322509|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20322510|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
20322511|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
20322512|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322513|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322514|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322515|NCT00727753|Bevacizumab|bevacizumab|mesh-list
20322516|NCT00727753|Ranibizumab|ranibizumab|mesh-list
20322517|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322518|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322519|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20322520|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20322521|NCT00727753|Growth Substances|growth substances|mesh-ancestor
19640366|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794246|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794247|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794248|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19794249|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794250|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19794251|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
19794252|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
19794253|NCT00358150|Eliglustat|eliglustat|mesh-list
19794254|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794255|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155018|NCT00101894|Panitumumab|panitumumab|mesh-list
20155019|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
20155020|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155021|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155022|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155023|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155024|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155025|NCT00101920|Panitumumab|panitumumab|mesh-list
20155026|NCT00101920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155027|NCT00101920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155028|NCT00101998|Alvimopan|alvimopan|mesh-list
20155029|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155030|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
20155031|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155032|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155033|NCT00102115|Talaporfin|talaporfin|mesh-list
20155034|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155035|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20155036|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
20155037|NCT00102141|Drospirenone|drospirenone|mesh-list
20155038|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20155039|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20155040|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20155041|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20322522|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322523|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640367|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19640368|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
19794256|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
19794257|NCT00358215|Hematinics|hematinics|mesh-ancestor
19794258|NCT00358436|Bromides|bromides|mesh-list
19794259|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
19794260|NCT00358462|Azithromycin|azithromycin|mesh-list
19794261|NCT00358462|Doxycycline|doxycycline|mesh-list
19794262|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19640369|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
19640370|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19640371|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19640372|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19640373|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20155042|NCT00102141|Estradiol|estradiol|mesh-list
20155043|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19640374|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640375|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
19640376|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640377|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640378|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19640379|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640380|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19640381|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19640382|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640383|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
19640384|NCT02400151|Vitamin D|vitamin d|mesh-list
19640385|NCT02400151|Vitamins|vitamins|mesh-ancestor
19640386|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
19640387|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640388|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19794263|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794264|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
19794265|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19794266|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20322524|NCT00727766|Clofarabine|clofarabine|mesh-list
20322525|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322526|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
20322527|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322528|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322529|NCT00727831|Leucovorin|leucovorin|mesh-list
20322530|NCT00727831|Methotrexate|methotrexate|mesh-list
20322531|NCT00727831|Calcium|calcium|mesh-list
20322532|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
19794267|NCT00358501|Defibrotide|defibrotide|mesh-list
19794268|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19794269|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19794270|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794271|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19794272|NCT00358579|Vasopressins|vasopressins|mesh-list
19794273|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
19794274|NCT00358579|Epinephrine|epinephrine|mesh-list
19794275|NCT00358579|Racepinephrine|racepinephrine|mesh-list
19794276|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
19794277|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794278|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19794279|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19794280|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
19794281|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794282|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794283|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19794284|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19794285|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
19794286|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794287|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19794288|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
19794289|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
19794290|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
19794291|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19794292|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
19794293|NCT00358579|Coagulants|coagulants|mesh-ancestor
19794294|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19794295|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
19794296|NCT00358644|Decitabine|decitabine|mesh-list
19794297|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19794298|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
19794299|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794300|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794301|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794302|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
19794303|NCT00358657|Sirolimus|sirolimus|mesh-list
19794304|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
20155044|NCT00102141|Estrogens|estrogens|mesh-ancestor
20155045|NCT00102141|Hormones|hormones|mesh-ancestor
20155046|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155047|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155048|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20155049|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
20155050|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20155051|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20155052|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20322533|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20322534|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322535|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20322536|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
20322537|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20322538|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155053|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
20155054|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20155055|NCT00102141|Diuretics|diuretics|mesh-ancestor
20155056|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
20155057|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20155058|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20155059|NCT00102154|Gaboxadol|gaboxadol|mesh-list
20155060|NCT00102154|Analgesics|analgesics|mesh-ancestor
20155061|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
20155062|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155063|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155064|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
20155065|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
20155066|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
20155067|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155068|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155069|NCT00102167|Gaboxadol|gaboxadol|mesh-list
20155070|NCT00102167|Analgesics|analgesics|mesh-ancestor
20155071|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
20155072|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155073|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155074|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
20155075|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
20155076|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
20155077|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155078|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155079|NCT00102206|Ritonavir|ritonavir|mesh-list
20155080|NCT00102206|Lopinavir|lopinavir|mesh-list
19640389|NCT02400385|Nivolumab|nivolumab|mesh-list
19640390|NCT02400385|Sunitinib|sunitinib|mesh-list
19640391|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19640392|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640393|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20155081|NCT00102206|Saquinavir|saquinavir|mesh-list
20155082|NCT00102206|Tenofovir|tenofovir|mesh-list
20155083|NCT00102206|Lamivudine|lamivudine|mesh-list
20155084|NCT00102206|Zidovudine|zidovudine|mesh-list
20155085|NCT00102206|Emtricitabine|emtricitabine|mesh-list
20155086|NCT00102206|Abacavir|abacavir|mesh-list
19794305|NCT00358657|Fludarabine|fludarabine|mesh-list
19794306|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
19794307|NCT00358657|Tacrolimus|tacrolimus|mesh-list
19794308|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794309|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
19794310|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794311|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794312|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19794313|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
19794314|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794315|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794316|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19794317|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19794318|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
20155087|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20155088|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19640394|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640395|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640396|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640397|NCT02400385|Growth Substances|growth substances|mesh-ancestor
19640398|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640399|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640400|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19640401|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640402|NCT02400281|Cytarabine|cytarabine|mesh-list
19640403|NCT02400281|Fludarabine|fludarabine|mesh-list
19640404|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
20155089|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
19640405|NCT02400281|Etoposide|etoposide|mesh-list
19640406|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
19794319|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20155090|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155091|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155092|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20155093|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20155094|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
20155095|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155096|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20155097|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20322539|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
20322540|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155098|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20155099|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20155100|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
20155101|NCT00102219|Doxorubicin|doxorubicin|mesh-list
20155102|NCT00102219|Pemetrexed|pemetrexed|mesh-list
20155103|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20155104|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155105|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20155106|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20155107|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155108|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155109|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20155110|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20322541|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322542|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
20322543|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322544|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20322545|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322546|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
20322547|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322548|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20322549|NCT00727831|Antidotes|antidotes|mesh-ancestor
20322550|NCT00727831|Protective Agents|protective agents|mesh-ancestor
20322551|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
20322552|NCT00727831|Vitamins|vitamins|mesh-ancestor
20322553|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
20322554|NCT00727870|Glycerol|glycerol|mesh-list
20322555|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20322556|NCT00727870|Protective Agents|protective agents|mesh-ancestor
20322557|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322558|NCT00727935|Lidocaine|lidocaine|mesh-list
20322559|NCT00727935|Ropivacaine|ropivacaine|mesh-list
20322560|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
20322561|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
20322562|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322563|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322564|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
20322565|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322566|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20322567|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20322568|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20322569|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20322570|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322571|NCT00727948|Aspirin|aspirin|mesh-list
20322572|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20322573|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20322574|NCT00727948|Analgesics|analgesics|mesh-ancestor
20322575|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
20322576|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322577|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322578|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322579|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322580|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20322581|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20322582|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322583|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20322584|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20322585|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322586|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
20322587|NCT00727987|Golimumab|golimumab|mesh-list
19640407|NCT02400281|Azacitidine|azacitidine|mesh-list
19640408|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
19640409|NCT02400281|Idarubicin|idarubicin|mesh-list
19640410|NCT02400281|Crenolanib|crenolanib|mesh-list
19640411|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640412|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19640413|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
19640414|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322588|NCT00727987|Methotrexate|methotrexate|mesh-list
20322589|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20322590|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
20322591|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20322592|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322593|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322594|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
19794320|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794321|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19794322|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19794323|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
19794324|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19794325|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794326|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
19794327|NCT00358670|Infliximab|infliximab|mesh-list
19794328|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19794329|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794330|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794331|NCT00358735|Enoxaparin|enoxaparin|mesh-list
19794332|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
19794333|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19794334|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19794335|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794336|NCT00358826|Atreleuton|atreleuton|mesh-list
19794337|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19794338|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794339|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794340|NCT00358917|Ritonavir|ritonavir|mesh-list
19794341|NCT00358917|Lopinavir|lopinavir|mesh-list
19794342|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19794343|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19794344|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19794345|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
20155111|NCT00102258|Hormones|hormones|mesh-list
20155112|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155113|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174094|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174095|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174096|NCT00163488|Ciclesonide|ciclesonide|mesh-list
20174097|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
20174098|NCT00163488|Hormones|hormones|mesh-ancestor
20174099|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174100|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347614|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19794346|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794347|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794348|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19794349|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19794350|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
19794351|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794352|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19794353|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19794354|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19794355|NCT00359021|Etravirine|etravirine|mesh-list
19794356|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19794357|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19794358|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794359|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794360|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
19794361|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794362|NCT00359073|Montelukast|montelukast|mesh-list
19794363|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19794364|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
19794365|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19794366|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
19794367|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794368|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794369|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19794370|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19794371|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794372|NCT00359281|Niacin|niacin|mesh-list
19794373|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
19794374|NCT00359281|Atorvastatin|atorvastatin|mesh-list
19794375|NCT00359281|Simvastatin|simvastatin|mesh-list
20155114|NCT00102271|Oxypurinol|oxypurinol|mesh-list
20155115|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155116|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155117|NCT00102284|Levodopa|levodopa|mesh-list
20155118|NCT00102284|Modafinil|modafinil|mesh-list
19640415|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640416|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
19640417|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640418|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
19640419|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640420|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19640421|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19640422|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19640423|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155119|NCT00102284|Rivastigmine|rivastigmine|mesh-list
20155120|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20155121|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20155122|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
20155123|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155124|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155125|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155126|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20155127|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20155128|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20155129|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20155130|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20155131|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155132|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
20155133|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20155134|NCT00102284|Protective Agents|protective agents|mesh-ancestor
20155135|NCT00102310|Z 338|z 338|mesh-list
20155136|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20155137|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155138|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155139|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
20322595|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322596|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322597|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
20322598|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322599|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20322600|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322601|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
20322602|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322603|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19640424|NCT02400281|Analgesics|analgesics|mesh-ancestor
19640425|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
19640426|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663272|NCT04756505|Interleukin-12|interleukin-12|mesh-list
19663273|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
19663274|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19663275|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
19663276|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663277|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19663278|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19663279|NCT04756505|Growth Substances|growth substances|mesh-ancestor
19663280|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
19663281|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663282|NCT04737109|Androgens|androgens|mesh-list
19663283|NCT04737109|Hormones|hormones|mesh-ancestor
19663284|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663285|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663286|NCT04735354|Valsartan|valsartan|mesh-list
19663287|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19663288|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19663289|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19663290|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663291|NCT04603365|Temozolomide|temozolomide|mesh-list
19663292|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19663293|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19663294|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
19663295|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663296|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663297|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640427|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19640428|NCT02400255|Crenolanib|crenolanib|mesh-list
19640429|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155140|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155141|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155142|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155143|NCT00102375|Topotecan|topotecan|mesh-list
20155144|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20155145|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20155146|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155147|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155148|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155149|NCT00102388|Vildagliptin|vildagliptin|mesh-list
20155150|NCT00102388|Gliclazide|gliclazide|mesh-list
20155151|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20155152|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640430|NCT02400112|Vancomycin|vancomycin|mesh-list
19640431|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19640432|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640433|NCT02400021|Progesterone|progesterone|mesh-list
19640434|NCT02400021|Progestins|progestins|mesh-ancestor
19640435|NCT02400021|Hormones|hormones|mesh-ancestor
20322604|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19640436|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640437|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640438|NCT02400047|Dexamethasone|dexamethasone|mesh-list
19640439|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
19640440|NCT02400047|Ketoprofen|ketoprofen|mesh-list
20155153|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20155154|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
20155155|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155156|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155157|NCT00102414|Gemcitabine|gemcitabine|mesh-list
20155158|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155159|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
20155160|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155161|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155162|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
20155163|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155164|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155165|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155166|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
20155167|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155168|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
19640441|NCT02400047|BB 1101|bb 1101|mesh-list
19640442|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20155169|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20155170|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155171|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155172|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20155173|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20155174|NCT00102453|Protective Agents|protective agents|mesh-ancestor
20155175|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155176|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
20155177|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20155178|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
20155179|NCT00102479|Aripiprazole|aripiprazole|mesh-list
20155180|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
20155181|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155182|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20155183|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20155184|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20155185|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794376|NCT00359281|Ezetimibe|ezetimibe|mesh-list
19794377|NCT00359281|Fenofibrate|fenofibrate|mesh-list
19794378|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19794379|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19794380|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
20155186|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
20155187|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
20322605|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640443|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
19794381|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155188|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640444|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
19640445|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794382|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19794383|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20322606|NCT00728000|Gemcitabine|gemcitabine|mesh-list
20322607|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
20322608|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19640446|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794384|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794385|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
19794386|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
19794387|NCT00359281|Vitamins|vitamins|mesh-ancestor
19794388|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
19794389|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794390|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
19794391|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
19794392|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19794393|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19794394|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794395|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19794396|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19794397|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19794398|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155189|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155190|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20155191|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20155192|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
20155193|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20155194|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20155195|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20155196|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19794399|NCT00359632|Linezolid|linezolid|mesh-list
19794400|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19794401|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794402|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19794403|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155197|NCT00102492|Casopitant|casopitant|mesh-list
20155198|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
20155199|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
20155200|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155201|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155202|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155203|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20155204|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155205|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155206|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
20155207|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155208|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20155209|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
20155210|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
20155211|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
20155212|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20155213|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19794404|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794405|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
19794406|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
19640447|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640448|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
19640449|NCT02400047|Hormones|hormones|mesh-ancestor
19640450|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640451|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19640452|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640453|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
19640454|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640455|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640456|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19640457|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19640458|NCT02400047|Analgesics|analgesics|mesh-ancestor
19640459|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
19640460|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640461|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19794407|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19794408|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20155214|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322609|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155215|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155216|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155217|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20155218|NCT00102583|Cyclosporine|cyclosporine|mesh-list
20155219|NCT00102583|Cyclosporins|cyclosporins|mesh-list
20155220|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155221|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155222|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155223|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
20155224|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794409|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794410|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794411|NCT00359736|Urological Agents|urological agents|mesh-ancestor
19794412|NCT00359762|Exenatide|exenatide|mesh-list
19794413|NCT00359762|Glimepiride|glimepiride|mesh-list
19794414|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19794415|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322610|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
20322611|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322612|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322613|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
20322614|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322615|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794416|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20155225|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
20155226|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155227|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
20155228|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20155229|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20155230|NCT00102609|Dexamethasone|dexamethasone|mesh-list
19794417|NCT00359762|Incretins|incretins|mesh-ancestor
20155231|NCT00102609|Doxorubicin|doxorubicin|mesh-list
20155232|NCT00102609|Trabectedin|trabectedin|mesh-list
19640462|NCT02399800|Triamcinolone|triamcinolone|mesh-list
19640463|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19640464|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19640465|NCT02399800|Bupivacaine|bupivacaine|mesh-list
19640466|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19640467|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
19640468|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
19640469|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640470|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640471|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
20155233|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20155234|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
20155235|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
20155236|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322616|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322617|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
20322618|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322619|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20322620|NCT00728013|Atorvastatin|atorvastatin|mesh-list
19640472|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640473|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640474|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
19640475|NCT02399800|Hormones|hormones|mesh-ancestor
19640476|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640477|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640478|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
19640479|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640480|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640481|NCT02399566|Pemetrexed|pemetrexed|mesh-list
19640482|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19640483|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640484|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640485|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640486|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19640487|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19640488|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19640489|NCT02399592|Bevacizumab|bevacizumab|mesh-list
19640490|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19794418|NCT00359762|Hormones|hormones|mesh-ancestor
20155237|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155238|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155239|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
20155240|NCT00102609|Hormones|hormones|mesh-ancestor
20155241|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155242|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20155243|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155244|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20155245|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20155246|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20155247|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155248|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155249|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20155250|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
20155251|NCT00102622|Paclitaxel|paclitaxel|mesh-list
20155252|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20155253|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155254|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
20155255|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
20155256|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155257|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155258|NCT00102635|Fenretinide|fenretinide|mesh-list
20155259|NCT00102635|Lonafarnib|lonafarnib|mesh-list
19640491|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640492|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640493|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640494|NCT02399592|Growth Substances|growth substances|mesh-ancestor
19640495|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640496|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640497|NCT02399657|Dexamethasone|dexamethasone|mesh-list
19640498|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640499|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
19640500|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
19640501|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640502|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640503|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640504|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
19640505|NCT02399657|Hormones|hormones|mesh-ancestor
20155260|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322621|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20322622|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20322623|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
20322624|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322625|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20322626|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20322627|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322628|NCT00728078|Thalidomide|thalidomide|mesh-list
20322629|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322630|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
20322631|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322632|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
20322633|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20322634|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322635|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20322636|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20322637|NCT00728078|Growth Substances|growth substances|mesh-ancestor
20322638|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
20322639|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322640|NCT00728156|Clopidogrel|clopidogrel|mesh-list
20322641|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20322642|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20322643|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20155261|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20155262|NCT00102635|Protective Agents|protective agents|mesh-ancestor
20155263|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155264|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322644|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20322645|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
20611210|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611211|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
20612247|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19794419|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794420|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19794421|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640506|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794422|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
19794423|NCT00359788|Albuterol|albuterol|mesh-list
19794424|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
19794425|NCT00359788|Ipratropium|ipratropium|mesh-list
19794426|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19794427|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
19794428|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794429|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794430|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19794431|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
19794432|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
20155265|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155266|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
20155267|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155268|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155269|NCT00102674|Cangrelor|cangrelor|mesh-list
20155270|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20155271|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20155272|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20155273|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20155274|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
20155275|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155276|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155277|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155278|NCT00102700|Gemcitabine|gemcitabine|mesh-list
19794433|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19794434|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
19794435|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794436|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155279|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
20155280|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155281|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
20155282|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155283|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155284|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
20322646|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794437|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
19794438|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19794439|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19794440|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19794441|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19794442|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
20322647|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322648|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322649|NCT00728195|Olanzapine|olanzapine|mesh-list
20322650|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
20322651|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
20322652|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
19794443|NCT00359801|Insulin|insulin|mesh-list
19794444|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19794445|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19794446|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794447|NCT00360126|Lamotrigine|lamotrigine|mesh-list
19794448|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
20322653|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322654|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322655|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794449|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19794450|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794451|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794452|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19794453|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794454|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19794455|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19794456|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19794457|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19794458|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19794459|NCT00360230|Vaccines|vaccines|mesh-list
19794460|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
19794461|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794462|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19794463|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19794464|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19794465|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794466|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794467|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
19794468|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794469|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322656|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20322657|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20322658|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322659|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20322660|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20322661|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20322662|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19640507|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19640508|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640509|NCT02399709|Simvastatin|simvastatin|mesh-list
19640510|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19794470|NCT00360282|Rizatriptan|rizatriptan|mesh-list
19794471|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19794472|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
19794473|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794474|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794475|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794476|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
19794477|NCT00360334|Exenatide|exenatide|mesh-list
19794478|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19794479|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794480|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19794481|NCT00360334|Incretins|incretins|mesh-ancestor
19794482|NCT00360334|Hormones|hormones|mesh-ancestor
19794483|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794484|NCT00360360|Paclitaxel|paclitaxel|mesh-list
19794485|NCT00360360|Bevacizumab|bevacizumab|mesh-list
19794486|NCT00360360|Carboplatin|carboplatin|mesh-list
19794487|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19794488|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20155285|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640511|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19640512|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
19640513|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640514|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19640515|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19640516|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640517|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19640518|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19640519|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
19640520|NCT02399462|Hormones|hormones|mesh-ancestor
19640521|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640522|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640523|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640524|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640525|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
19640526|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
19640527|NCT02399449|Hematinics|hematinics|mesh-ancestor
19640528|NCT02399397|Fentanyl|fentanyl|mesh-list
19640529|NCT02399397|Midazolam|midazolam|mesh-list
19640530|NCT02399397|Anesthetics|anesthetics|mesh-list
19640531|NCT02399397|Propofol|propofol|mesh-list
19640532|NCT02399397|Rocuronium|rocuronium|mesh-list
19640533|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640534|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640535|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19640536|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20155286|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155287|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155288|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
20155289|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155290|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20155291|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20155292|NCT00102713|Valproic Acid|valproic acid|mesh-list
20155293|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
20155294|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155295|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155296|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
20155297|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155298|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155299|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
20155300|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20155301|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20155302|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155303|NCT00102752|Gemcitabine|gemcitabine|mesh-list
20155304|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155305|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
20155306|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322663|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322664|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322665|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
20322666|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20322667|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20322668|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
20322669|NCT00728273|Micronutrients|micronutrients|mesh-list
20322670|NCT00728273|Trace Elements|trace elements|mesh-list
20322671|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322672|NCT00728312|Aripiprazole|aripiprazole|mesh-list
20322673|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
20322674|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19640537|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
19640538|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19640539|NCT02399397|Narcotics|narcotics|mesh-ancestor
19640540|NCT02399397|Analgesics|analgesics|mesh-ancestor
19640541|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
19640542|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322675|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20322676|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20322677|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322678|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322679|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
20322680|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
20322681|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322682|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322683|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20322684|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20322685|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
20322686|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20322687|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20322688|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20322689|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20322690|NCT00728520|Azacitidine|azacitidine|mesh-list
20322691|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20322692|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
20322693|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322694|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322695|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640543|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19640544|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19640545|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19640546|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19640547|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
19640548|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
19640549|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640550|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640551|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19640552|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19640553|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19640554|NCT02399410|Bevacizumab|bevacizumab|mesh-list
19640555|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
19640556|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19640557|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640558|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640559|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640560|NCT02399410|Growth Substances|growth substances|mesh-ancestor
19640561|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640562|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640563|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20322696|NCT00728546|Isoniazid|isoniazid|mesh-list
20322697|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
19640564|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640565|NCT02399189|Methotrexate|methotrexate|mesh-list
20155307|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155308|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
20155309|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155310|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155311|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155312|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
20155313|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155314|NCT00102765|Fluticasone|fluticasone|mesh-list
20155315|NCT00102765|Xhance|xhance|mesh-list
20155316|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20155317|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20155318|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19794489|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794490|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
19794491|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
19794492|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
19794493|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794494|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19794495|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19794496|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19794497|NCT00360360|Growth Substances|growth substances|mesh-ancestor
19794498|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794499|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794500|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19794501|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794502|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19794503|NCT00360399|Citalopram|citalopram|mesh-list
20155319|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20155320|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
20155321|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155322|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322698|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19794504|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19794505|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19794506|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794507|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794508|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794509|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
19794510|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794511|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19794512|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
19794513|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19794514|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794515|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19794516|NCT00360399|Analgesics|analgesics|mesh-ancestor
19794517|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
19794518|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
19794519|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19794520|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
19794521|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
19794522|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19794523|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
19794524|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19794525|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794526|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19794527|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19794528|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19794529|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19794530|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19794531|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19794532|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794533|NCT00360568|Levodopa|levodopa|mesh-list
19794534|NCT00360568|Carbidopa|carbidopa|mesh-list
19794535|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19794536|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19794537|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19794538|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
20155323|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20322699|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322700|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20322701|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20155324|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
20322702|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
19794539|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794540|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794541|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794542|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19794543|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794544|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19794545|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
19794546|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
20155325|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
20155326|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20155327|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20155328|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20155329|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19794547|NCT00360672|Lenalidomide|lenalidomide|mesh-list
19794548|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
19794549|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794550|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19794551|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19794552|NCT00360672|Growth Substances|growth substances|mesh-ancestor
19794553|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794554|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794555|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
19794556|NCT00360685|Methotrexate|methotrexate|mesh-list
19794557|NCT00360685|Tacrolimus|tacrolimus|mesh-list
19794558|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19794559|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
19794560|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19794561|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794562|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19794563|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
19794564|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794565|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794566|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
19794567|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794568|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19794569|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794570|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
19794571|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794572|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19794573|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20155330|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
20322703|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322704|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20322705|NCT00728559|Bupivacaine|bupivacaine|mesh-list
20322706|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
20322707|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
20322708|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322709|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322710|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
20322711|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322712|NCT00728585|Mitogens|mitogens|mesh-list
20322713|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
20322714|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322715|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
20322716|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20322717|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
20322718|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322719|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
20322720|NCT00728611|Protective Agents|protective agents|mesh-ancestor
20322721|NCT00728663|Docetaxel|docetaxel|mesh-list
20322722|NCT00728663|Cetuximab|cetuximab|mesh-list
20322723|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322724|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
20322725|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
20322726|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155331|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155332|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155333|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
20155334|NCT00102765|Hormones|hormones|mesh-ancestor
20155335|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155336|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
20155337|NCT00102778|Ritonavir|ritonavir|mesh-list
20155338|NCT00102778|Lopinavir|lopinavir|mesh-list
19794574|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20155339|NCT00102778|Aplaviroc|aplaviroc|mesh-list
20322727|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322728|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322729|NCT00728715|Budesonide|budesonide|mesh-list
20322730|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
20322731|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322732|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20322733|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
20322734|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322735|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794575|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19794576|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
19794577|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20155340|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20155341|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20155342|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
20155343|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155344|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155345|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20155346|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20155347|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
20155348|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155349|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20155350|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20155351|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20155352|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20155353|NCT00102830|Trebananib|trebananib|mesh-list
20155354|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20155355|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20155356|NCT00102830|Growth Substances|growth substances|mesh-ancestor
20155357|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155358|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794578|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794579|NCT00360698|Insulin|insulin|mesh-list
20155359|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155360|NCT00102843|Folic Acid|folic acid|mesh-list
20155361|NCT00102843|Betaine|betaine|mesh-list
20155362|NCT00102843|Hematinics|hematinics|mesh-ancestor
20155363|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
20155364|NCT00102843|Vitamins|vitamins|mesh-ancestor
20155365|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
20155366|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155367|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155368|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
20155369|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20155370|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
20155371|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155372|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20155373|NCT00102856|Pramipexole|pramipexole|mesh-list
20155374|NCT00102856|Rivastigmine|rivastigmine|mesh-list
20155375|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
20155376|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155377|NCT00102856|Protective Agents|protective agents|mesh-ancestor
20155378|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640566|NCT02399189|Temozolomide|temozolomide|mesh-list
19640567|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640568|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
19640569|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640570|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640571|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19640572|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
19640573|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19640574|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19640575|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
19640576|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640577|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
19640578|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640579|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19640580|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640581|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19640582|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19640583|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
19640584|NCT02399215|Nintedanib|nintedanib|mesh-list
19640585|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640586|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155379|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20155380|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19794580|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19794581|NCT00360698|Metformin|metformin|mesh-list
19794582|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
19794583|NCT00360698|Glimepiride|glimepiride|mesh-list
19794584|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
19794585|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19794586|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794587|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19794588|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794589|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
19794590|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19794591|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19794592|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19794593|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794594|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794595|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794596|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794597|NCT00360724|Analgesics|analgesics|mesh-ancestor
19794598|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
19794599|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794600|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
19794601|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19794602|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
19794603|NCT00360828|Irinotecan|irinotecan|mesh-list
19794604|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20155381|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
19640587|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640588|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640589|NCT02399137|Gemcitabine|gemcitabine|mesh-list
19640590|NCT02399137|Paclitaxel|paclitaxel|mesh-list
19640591|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19640592|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640593|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
19640594|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19640595|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19640596|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155382|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
20155383|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155384|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20155385|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155386|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
20155387|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20155388|NCT00102869|Levodopa|levodopa|mesh-list
20155389|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20155390|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20155391|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
20155392|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155393|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155394|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155395|NCT00102882|Fluticasone|fluticasone|mesh-list
20155396|NCT00102882|Xhance|xhance|mesh-list
20155397|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20155398|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20155399|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20155400|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20155401|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
20155402|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155403|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155404|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20155405|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
20155406|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
20322736|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20322737|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
20322738|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
20322739|NCT00728715|Hormones|hormones|mesh-ancestor
20322740|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20322741|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20322742|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20322743|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19640597|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155407|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20155408|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20322744|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
20155409|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20155410|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19640598|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
19640599|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
20322745|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322746|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322747|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20322748|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20322749|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20322750|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
20322751|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322752|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20322753|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20322754|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322755|NCT00728832|Morphine|morphine|mesh-list
20322756|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20322757|NCT00728832|Narcotics|narcotics|mesh-ancestor
20322758|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322759|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322760|NCT00728832|Analgesics|analgesics|mesh-ancestor
20322761|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
20322762|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322763|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19640600|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640601|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640602|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640603|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
19640604|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640605|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
19640606|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
19640607|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19640608|NCT02398994|Antibodies|antibodies|mesh-list
19794605|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19794606|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794607|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794608|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794609|NCT00360971|Cisplatin|cisplatin|mesh-list
19794610|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794611|NCT00361140|Vidarabine|vidarabine|mesh-list
19794612|NCT00361140|Fludarabine|fludarabine|mesh-list
19640609|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
19640610|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19640611|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640612|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
19640613|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
19640614|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640615|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640616|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640617|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
19640618|NCT02398994|Hormones|hormones|mesh-ancestor
19640619|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640620|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19794613|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
19794614|NCT00361140|Busulfan|busulfan|mesh-list
19794615|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794616|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19794617|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
19794618|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794619|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794620|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
19794621|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794622|NCT00361140|Antiviral Agents|antiviral agents|mesh-ancestor
19794623|NCT00361140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794624|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
19794625|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19794626|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19794627|NCT00361218|Citalopram|citalopram|mesh-list
20155411|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
20155412|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155413|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155414|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
20155415|NCT00102882|Hormones|hormones|mesh-ancestor
20174101|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19640621|NCT02398994|Protective Agents|protective agents|mesh-ancestor
19794628|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19794629|NCT00361218|Serotonin|serotonin|mesh-list
19794630|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19794631|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794632|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794633|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794634|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
19794635|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794636|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19794637|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
19794638|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19794639|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19794640|NCT00361231|Gemcitabine|gemcitabine|mesh-list
19794641|NCT00361231|Bevacizumab|bevacizumab|mesh-list
19794642|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
19794643|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19794644|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794645|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19794646|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19794647|NCT00361231|Growth Substances|growth substances|mesh-ancestor
19794648|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794649|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794650|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19794651|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
19794652|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794653|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
20611212|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611213|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155416|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155417|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
20155418|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
20155419|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20155420|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155421|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
20155422|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20155423|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20155424|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794654|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794655|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794656|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794657|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
19794658|NCT00361257|Minocycline|minocycline|mesh-list
19794659|NCT00361257|Tetracycline|tetracycline|mesh-list
19794660|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19794661|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794662|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19794663|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155425|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20155426|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20155427|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
20155428|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155429|NCT00102947|Daptomycin|daptomycin|mesh-list
20155430|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20155431|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155432|NCT00102973|Carboplatin|carboplatin|mesh-list
20155433|NCT00102973|Doxorubicin|doxorubicin|mesh-list
19794664|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794665|NCT00361270|Complement Factor H|complement factor h|mesh-list
19794666|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19794667|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794668|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
19794669|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794670|NCT00361283|Atorvastatin|atorvastatin|mesh-list
19794671|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19794672|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19794673|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
19794674|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794675|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19794676|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19794677|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794678|NCT00361335|Golimumab|golimumab|mesh-list
19794679|NCT00361335|Methotrexate|methotrexate|mesh-list
19794680|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19794681|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
19794682|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19794683|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794684|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19794685|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
19794686|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794687|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794688|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
19794689|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794690|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19794691|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794692|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
19794693|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794694|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19794695|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19794696|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19794697|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
19794698|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19794699|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
19794700|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19794701|NCT00361504|Oxycodone|oxycodone|mesh-list
19794702|NCT00361504|Tapentadol|tapentadol|mesh-list
19794703|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19794704|NCT00361504|Narcotics|narcotics|mesh-ancestor
19794705|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19794706|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794707|NCT00361504|Analgesics|analgesics|mesh-ancestor
19794708|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
19794709|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794710|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19794711|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19794712|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794713|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794714|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
19794715|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794716|NCT00361569|Estrogens|estrogens|mesh-list
19794717|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19794718|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
19794719|NCT00361569|Hormones|hormones|mesh-ancestor
19794720|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794721|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794722|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
19794723|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20155434|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20155435|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155436|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20155437|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19794724|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794725|NCT00361634|Etanercept|etanercept|mesh-list
19794726|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19794727|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20155438|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20155439|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155440|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155441|NCT00102986|Ritonavir|ritonavir|mesh-list
20155442|NCT00102986|Lopinavir|lopinavir|mesh-list
19794728|NCT00361634|Analgesics|analgesics|mesh-ancestor
19794729|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
19794730|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794731|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155443|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20155444|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20155445|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
20155446|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155447|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155448|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19640622|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
19663298|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
19663299|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19663300|NCT04514302|Antibodies|antibodies|mesh-list
19663301|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
19663302|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663303|NCT04492891|Cyclosporine|cyclosporine|mesh-list
19663304|NCT04492891|Cyclosporins|cyclosporins|mesh-list
19663305|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155449|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19666013|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
20155450|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
20155451|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155452|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20155453|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20155454|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20155455|NCT00103038|Hematinics|hematinics|mesh-ancestor
20155456|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20155457|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20155458|NCT00103051|Gemcitabine|gemcitabine|mesh-list
20155459|NCT00103051|Gefitinib|gefitinib|mesh-list
19640623|NCT02398929|Bisoprolol|bisoprolol|mesh-list
20155460|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155461|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155462|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
20155463|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155464|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
20155465|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155466|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794732|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19794733|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794734|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794735|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794736|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
20155467|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155468|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
20155469|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155470|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155471|NCT00103103|Leucovorin|leucovorin|mesh-list
20155472|NCT00103103|Fluorouracil|fluorouracil|mesh-list
20155473|NCT00103103|Bortezomib|bortezomib|mesh-list
19794737|NCT00361842|Irinotecan|irinotecan|mesh-list
19794738|NCT00361842|Floxuridine|floxuridine|mesh-list
19794739|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19794740|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19794741|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155474|NCT00103103|Calcium|calcium|mesh-list
20155475|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
20155476|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20155477|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155478|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
20155479|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155480|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155481|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155482|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155483|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
20155484|NCT00103103|Antidotes|antidotes|mesh-ancestor
20155485|NCT00103103|Protective Agents|protective agents|mesh-ancestor
20155486|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
20155487|NCT00103103|Vitamins|vitamins|mesh-ancestor
20155488|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
20155489|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
20155490|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155491|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155492|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155493|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155494|NCT00103233|Trastuzumab|trastuzumab|mesh-list
20155495|NCT00103233|Vinorelbine|vinorelbine|mesh-list
20155496|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155497|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155498|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20322764|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
20322765|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322766|NCT00729118|Lenalidomide|lenalidomide|mesh-list
20322767|NCT00729118|Vorinostat|vorinostat|mesh-list
20322768|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
19640624|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19640625|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
19640626|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
19640627|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640628|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640629|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19640630|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20155499|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
20155500|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
20155501|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
20322769|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155502|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794742|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794743|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794744|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19794745|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
19794746|NCT00361972|Lansoprazole|lansoprazole|mesh-list
19794747|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
19794748|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19794749|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794750|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19794751|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794752|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794753|NCT00362115|Olmesartan|olmesartan|mesh-list
19794754|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19794755|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19794756|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19794757|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19794758|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794759|NCT00362180|Mipomersen|mipomersen|mesh-list
19794760|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19794761|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19794762|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
19794763|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794764|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19794765|NCT00362232|Enoxaparin|enoxaparin|mesh-list
19794766|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
19794767|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
19794768|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19794769|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
19794770|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19794771|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
19794772|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794773|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794774|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
19794775|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19794776|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19794777|NCT00362297|Valacyclovir|valacyclovir|mesh-list
19794778|NCT00362297|Acyclovir|acyclovir|mesh-list
20155503|NCT00103246|Silicon|silicon|mesh-list
20155504|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
20155505|NCT00103246|Trace Elements|trace elements|mesh-ancestor
19794779|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
19794780|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794781|NCT00362414|Mitogens|mitogens|mesh-list
19794782|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
19794783|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794784|NCT00362440|Metformin|metformin|mesh-list
20322770|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20322771|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20322772|NCT00729118|Growth Substances|growth substances|mesh-ancestor
20322773|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794785|NCT00362440|Pioglitazone|pioglitazone|mesh-list
19794786|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19794787|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794788|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
19794789|NCT00362466|Dasatinib|dasatinib|mesh-list
20322774|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322775|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20322776|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322777|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322778|NCT00729131|Etanercept|etanercept|mesh-list
20155506|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
20155507|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155508|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
20155509|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20155510|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20155511|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155512|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
20155513|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20155514|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
20155515|NCT00103272|Bortezomib|bortezomib|mesh-list
20155516|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155517|NCT00103298|Leucovorin|leucovorin|mesh-list
20155518|NCT00103298|Fluorouracil|fluorouracil|mesh-list
20155519|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
20155520|NCT00103298|Melphalan|melphalan|mesh-list
19794790|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794791|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155521|NCT00103298|Calcium|calcium|mesh-list
20155522|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
20322779|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19794792|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794793|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794794|NCT00362609|Pantoprazole|pantoprazole|mesh-list
19794795|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19794796|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794797|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19794798|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794799|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155523|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20155524|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155525|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
20155526|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155527|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155528|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155529|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155530|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
20155531|NCT00103298|Antidotes|antidotes|mesh-ancestor
20155532|NCT00103298|Protective Agents|protective agents|mesh-ancestor
20155533|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
20155534|NCT00103298|Vitamins|vitamins|mesh-ancestor
20155535|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
20155536|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20155537|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
20611214|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20611215|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20611216|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
20611217|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
20611218|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611219|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20611220|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
20611221|NCT02003222|Hormones|hormones|mesh-ancestor
20611222|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611223|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20611224|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
20611225|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611226|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20611227|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
20611228|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20611229|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611230|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
19794800|NCT00362817|Carboplatin|carboplatin|mesh-list
20155538|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20155539|NCT00103324|Lapatinib|lapatinib|mesh-list
20155540|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155541|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155542|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155543|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155544|NCT00103389|Docetaxel|docetaxel|mesh-list
19794801|NCT00362817|Temozolomide|temozolomide|mesh-list
19794802|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794803|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20322780|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20322781|NCT00729131|Analgesics|analgesics|mesh-ancestor
20322782|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
19794804|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
20155545|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155546|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
20155547|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
20155548|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155549|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155550|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
20155551|NCT00103519|Hormones|hormones|mesh-ancestor
20155552|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155553|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155554|NCT00103545|Abagovomab|abagovomab|mesh-list
20155555|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155556|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155557|NCT00103571|Olanzapine|olanzapine|mesh-list
20155558|NCT00103571|Aripiprazole|aripiprazole|mesh-list
20155559|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
20155560|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
20322783|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155561|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174102|NCT00163501|Ciclesonide|ciclesonide|mesh-list
20322784|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322785|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322786|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322787|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322788|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322789|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
20322790|NCT00729170|Calcium|calcium|mesh-list
20322791|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20322792|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322793|NCT00729222|Rolofylline|rolofylline|mesh-list
20322794|NCT00729222|Diuretics|diuretics|mesh-ancestor
20322795|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
20322796|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155562|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155563|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155564|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20155565|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20155566|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20155567|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155568|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20155569|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20155570|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20155571|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611231|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611232|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20155572|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155573|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
20155574|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
20155575|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
20155576|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
20155577|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20155578|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20155579|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19794805|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794806|NCT00362882|Docetaxel|docetaxel|mesh-list
19794807|NCT00362882|Bortezomib|bortezomib|mesh-list
19794808|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794809|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
19794810|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
19794811|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
19794812|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794813|NCT00363051|Everolimus|everolimus|mesh-list
19794814|NCT00363051|Octreotide|octreotide|mesh-list
19794815|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794816|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794817|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
19794818|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794819|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19794820|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19794821|NCT00363077|Vaccines|vaccines|mesh-list
19794822|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
19794823|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794824|NCT00363129|Vitamin E|vitamin e|mesh-list
19794825|NCT00363129|Vitamins|vitamins|mesh-ancestor
19794826|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
19794827|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794828|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
19794829|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794830|NCT00363129|Protective Agents|protective agents|mesh-ancestor
19794831|NCT00363142|Ritonavir|ritonavir|mesh-list
19794832|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
19794833|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19794834|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19794835|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
19794836|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794837|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794838|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19794839|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19794840|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
19794841|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794842|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19794843|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20322797|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20322798|NCT00729287|Selenium|selenium|mesh-list
20322799|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
20322800|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322801|NCT00729287|Protective Agents|protective agents|mesh-ancestor
19794844|NCT00363168|Ranibizumab|ranibizumab|mesh-list
19794845|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19794846|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19794847|NCT00363168|Growth Substances|growth substances|mesh-ancestor
19794848|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794849|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
19794850|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794851|NCT00363298|Caffeine|caffeine|mesh-list
19794852|NCT00363298|Amphetamine|amphetamine|mesh-list
19794853|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
19794854|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20155580|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20155581|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20155582|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20155583|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
20155584|NCT00103597|Domperidone|domperidone|mesh-list
20155585|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
20155586|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
20322802|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322803|NCT00729287|Trace Elements|trace elements|mesh-ancestor
20322804|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
20322805|NCT00729300|Disulfiram|disulfiram|mesh-list
20322806|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20322807|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20322808|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322809|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347615|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347616|NCT00861276|Nicotine|nicotine|mesh-list
20347617|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20347618|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
20155587|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155588|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155589|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155590|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20155591|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
20155592|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155593|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155594|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20155595|NCT00103623|Abarelix|abarelix|mesh-list
20155596|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
20155597|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155598|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794855|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794856|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19794857|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794858|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794859|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19794860|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20155599|NCT00103649|Xaliproden|xaliproden|mesh-list
20155600|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20155601|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20155602|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
20155603|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155604|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155605|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155606|NCT00103701|Dasatinib|dasatinib|mesh-list
20155607|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155608|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155609|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155610|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155611|NCT00103727|Risperidone|risperidone|mesh-list
20155612|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20155613|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
20155614|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155615|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155616|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347619|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347620|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347621|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19794861|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
20155617|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20155618|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20155619|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20155620|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155621|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20155622|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
20155623|NCT00103753|Deferiprone|deferiprone|mesh-list
20155624|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20155625|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
20155626|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
20155627|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155628|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20155629|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20155630|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20155631|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155632|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
20155633|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155634|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155635|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
20155636|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
19794862|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794863|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
20322810|NCT00729313|Lanreotide|lanreotide|mesh-list
19794864|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
19794865|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794866|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
19794867|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
19794868|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19794869|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19794870|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794871|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19794872|NCT00363311|Dutasteride|dutasteride|mesh-list
19794873|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19794874|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19794875|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794876|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794877|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
19794878|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794879|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794880|NCT00363415|Carboplatin|carboplatin|mesh-list
19794881|NCT00363415|Etoposide|etoposide|mesh-list
19794882|NCT00363415|Pemetrexed|pemetrexed|mesh-list
19794883|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794884|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19794885|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19794886|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19794887|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794888|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794889|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19794890|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19794891|NCT00363467|Busulfan|busulfan|mesh-list
19794892|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
19794893|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794894|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794895|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
19794896|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794897|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19794898|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794899|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19794900|NCT00363480|Fluticasone|fluticasone|mesh-list
19794901|NCT00363480|Albuterol|albuterol|mesh-list
20155637|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155638|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
20155639|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155640|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20155641|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20155642|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
20155643|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155644|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155645|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20155646|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20155647|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20155648|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
20155649|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20155650|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155651|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155652|NCT00103805|Levodopa|levodopa|mesh-list
20155653|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20155654|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20155655|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
20155656|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794902|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19794903|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19794904|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19794905|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
19794906|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794907|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794908|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19794909|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
19794910|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
19794911|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19794912|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19794913|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20322811|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322812|NCT00729339|Mosapride|mosapride|mesh-list
20322813|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322814|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20322815|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
19794914|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19794915|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
20155657|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155658|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155659|NCT00103818|Gaboxadol|gaboxadol|mesh-list
20155660|NCT00103818|Analgesics|analgesics|mesh-ancestor
20322816|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794916|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794917|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794918|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
20322817|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322818|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322819|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20322820|NCT00729404|Gestodene|gestodene|mesh-list
20322821|NCT00729404|Femovan|femovan|mesh-list
20322822|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20322823|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20322824|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20322825|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
20322826|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20322827|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794919|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19794920|NCT00363545|Vaccines|vaccines|mesh-list
19794921|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
19794922|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794923|NCT00363649|Interferons|interferons|mesh-list
20322828|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20322829|NCT00729404|Estrogens|estrogens|mesh-ancestor
20322830|NCT00729404|Hormones|hormones|mesh-ancestor
20322831|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20322832|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20322833|NCT00729404|Progestins|progestins|mesh-ancestor
20322834|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20322835|NCT00729495|Celecoxib|celecoxib|mesh-list
20322836|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20322837|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20322838|NCT00729495|Analgesics|analgesics|mesh-ancestor
20322839|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
20322840|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322841|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322842|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322843|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322844|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20322845|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20322846|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322847|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322848|NCT00729573|Tenofovir|tenofovir|mesh-list
19794924|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
19794925|NCT00363649|Sargramostim|sargramostim|mesh-list
19794926|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794927|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
20155661|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
19794928|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794929|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
19794930|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834089|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19834090|NCT00591773|Diuretics|diuretics|mesh-ancestor
19834091|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
19834092|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834093|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19834094|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834095|NCT00591825|Cycloserine|cycloserine|mesh-list
20322849|NCT00729573|Emtricitabine|emtricitabine|mesh-list
20322850|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20322851|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
20322852|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834096|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19834097|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834098|NCT00591825|Renal Agents|renal agents|mesh-ancestor
19834099|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19834100|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
19834101|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19834102|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
20322853|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20322854|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20322855|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322856|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322857|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20322858|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20611233|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20611234|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611235|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20611236|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611237|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
20611238|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611239|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611240|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611241|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611242|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611243|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
20611244|NCT01912625|Paclitaxel|paclitaxel|mesh-list
19834103|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834104|NCT00591851|Paclitaxel|paclitaxel|mesh-list
19834105|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
19834106|NCT00591851|Doxorubicin|doxorubicin|mesh-list
19834107|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19834108|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19834109|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155662|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155663|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155664|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
20611245|NCT01912625|Carboplatin|carboplatin|mesh-list
20611246|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20611247|NCT01912625|Trametinib|trametinib|mesh-list
19640631|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19640632|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
19640633|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640634|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640635|NCT02398838|Misoprostol|misoprostol|mesh-list
19640636|NCT02398838|Mifepristone|mifepristone|mesh-list
19640637|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19640638|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
19640639|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19640640|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640641|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19640642|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640643|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
19834110|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
19834111|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
20155665|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
20155666|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
20155667|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155668|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155669|NCT00103922|Cilomilast|cilomilast|mesh-list
20155670|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20155671|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20155672|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640644|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19640645|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19640646|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20322859|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
20322860|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20322861|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322862|NCT00729638|Lenalidomide|lenalidomide|mesh-list
20322863|NCT00729638|Everolimus|everolimus|mesh-list
20322864|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
20322865|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640647|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19794931|NCT00363779|Cyclosporine|cyclosporine|mesh-list
19794932|NCT00363779|Cyclosporins|cyclosporins|mesh-list
19794933|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794934|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794935|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19794936|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
19794937|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794938|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
19794939|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19794940|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
19794941|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19794942|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19794943|NCT00363883|Vorinostat|vorinostat|mesh-list
19794944|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794945|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19794946|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794947|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794948|NCT00363896|Bromides|bromides|mesh-list
19794949|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
19794950|NCT00364013|Panitumumab|panitumumab|mesh-list
19794951|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19794952|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611248|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19640648|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
19640649|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19794953|NCT00364156|Nicotine|nicotine|mesh-list
19794954|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19640650|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20611249|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611250|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611251|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611252|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611253|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611254|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611255|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611256|NCT01866111|Cenobamate|cenobamate|mesh-list
20611257|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
20611258|NCT01767194|Sirolimus|sirolimus|mesh-list
19640651|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
19640652|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640653|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
19794955|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
19794956|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794957|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794958|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19794959|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19794960|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
19794961|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794962|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794963|NCT00364286|Dasatinib|dasatinib|mesh-list
19794964|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794965|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19794966|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794967|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794968|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19794969|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19794970|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19794971|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794972|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794973|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19794974|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19794975|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611259|NCT01767194|Irinotecan|irinotecan|mesh-list
20611260|NCT01767194|Camptothecin|camptothecin|mesh-list
19794976|NCT00364377|Incretins|incretins|mesh-ancestor
19794977|NCT00364377|Hormones|hormones|mesh-ancestor
19794978|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19794979|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19794980|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
19794981|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19794982|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794983|NCT00364533|Oxycodone|oxycodone|mesh-list
19794984|NCT00364533|Tapentadol|tapentadol|mesh-list
19794985|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19794986|NCT00364533|Narcotics|narcotics|mesh-ancestor
19794987|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19794988|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19794989|NCT00364533|Analgesics|analgesics|mesh-ancestor
19794990|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
19794991|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19794992|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19794993|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19794994|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19794995|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19794996|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19794997|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19794998|NCT00364611|Bevacizumab|bevacizumab|mesh-list
19794999|NCT00364611|Trastuzumab|trastuzumab|mesh-list
19795000|NCT00364611|Docetaxel|docetaxel|mesh-list
19795001|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795002|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795003|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795004|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795005|NCT00364611|Growth Substances|growth substances|mesh-ancestor
19795006|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795007|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795008|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
19795009|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
19795010|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
19795011|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795012|NCT00364793|Emtricitabine|emtricitabine|mesh-list
19795013|NCT00364793|Efavirenz|efavirenz|mesh-list
19795014|NCT00364793|Didanosine|didanosine|mesh-list
19795015|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
19795016|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795017|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19795018|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19795019|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795020|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795021|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19795022|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19795023|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19795024|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19795025|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19795026|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19795027|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19795028|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20322866|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20322867|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20322868|NCT00729638|Growth Substances|growth substances|mesh-ancestor
19795029|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
19795030|NCT00364819|Rituximab|rituximab|mesh-list
19795031|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795032|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795033|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
19795034|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795035|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795036|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
19795037|NCT00364832|Hematinics|hematinics|mesh-ancestor
19795038|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
19795039|NCT00364845|Hematinics|hematinics|mesh-ancestor
19795040|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19795041|NCT00364923|Aminopterin|aminopterin|mesh-list
19795042|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19795043|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795044|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795045|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322869|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795046|NCT00365053|Belinostat|belinostat|mesh-list
19795047|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795048|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19795049|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795050|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795051|NCT00365105|Vitamin D|vitamin d|mesh-list
19795052|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
19640654|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19640655|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19640656|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
19640657|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
19640658|NCT02398682|Protective Agents|protective agents|mesh-ancestor
19640659|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640660|NCT02398448|Allopurinol|allopurinol|mesh-list
19640661|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
19795053|NCT00365105|Calcium|calcium|mesh-list
19795054|NCT00365105|Vitamins|vitamins|mesh-ancestor
19795055|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
19795056|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795057|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19795058|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19795059|NCT00365144|Bevacizumab|bevacizumab|mesh-list
19795060|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19795061|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795062|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795063|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795064|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795065|NCT00365144|Growth Substances|growth substances|mesh-ancestor
19795066|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795067|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795068|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19795069|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611261|NCT01767194|Temozolomide|temozolomide|mesh-list
20611262|NCT01767194|Dinutuximab|dinutuximab|mesh-list
20611263|NCT01767194|Sargramostim|sargramostim|mesh-list
20322870|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322871|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795070|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795071|NCT00365209|Curcumin|curcumin|mesh-list
19795072|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20322872|NCT00729664|Atezolizumab|atezolizumab|mesh-list
20611264|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20611265|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611266|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640662|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640663|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640664|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
19640665|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640666|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19640667|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
19640668|NCT02398448|Protective Agents|protective agents|mesh-ancestor
19640669|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640670|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19640671|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640672|NCT02398630|Hormones|hormones|mesh-list
19640673|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640674|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640675|NCT02398487|Nicotine|nicotine|mesh-list
19795073|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19795074|NCT00365209|Analgesics|analgesics|mesh-ancestor
19795075|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
20155673|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155674|NCT00103935|Exenatide|exenatide|mesh-list
20155675|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20155676|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155677|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20155678|NCT00103935|Incretins|incretins|mesh-ancestor
20155679|NCT00103935|Hormones|hormones|mesh-ancestor
20155680|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155681|NCT00103948|Donepezil|donepezil|mesh-list
20155682|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20155683|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155684|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155685|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
20155686|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322873|NCT00729664|BMS-936559|bms-936559|mesh-list
19795076|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795077|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795078|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322874|NCT00729664|Antibodies|antibodies|mesh-list
20322875|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
20322876|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20322877|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
20322878|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322879|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322880|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322881|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20322882|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322883|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20322884|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322885|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322886|NCT00729768|Cyclosporine|cyclosporine|mesh-list
20322887|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
20322888|NCT00729768|Cyclosporins|cyclosporins|mesh-list
20322889|NCT00729768|Basiliximab|basiliximab|mesh-list
20322890|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322891|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322892|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20322893|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
20322894|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322895|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
20322896|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20322897|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
20322898|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322899|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20322900|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20322901|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322902|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20322903|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
20322904|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20322905|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
20322906|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
20322907|NCT00729794|Vasopressins|vasopressins|mesh-list
20322908|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
20322909|NCT00729794|Epinephrine|epinephrine|mesh-list
20322910|NCT00729794|Racepinephrine|racepinephrine|mesh-list
20322911|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
20155687|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322912|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322913|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
20322914|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
20322915|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322916|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322917|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20322918|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
20322919|NCT00729794|Hormones|hormones|mesh-ancestor
20322920|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20322921|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20322922|NCT00729794|Protective Agents|protective agents|mesh-ancestor
19640676|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19640677|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
19640678|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640679|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640680|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19640681|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19640682|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
19640683|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640684|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640685|NCT02398552|Sunitinib|sunitinib|mesh-list
20155688|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
20155689|NCT00104013|Xaliproden|xaliproden|mesh-list
20155690|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20155691|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20155692|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
20155693|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155694|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155695|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174103|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
20322923|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20322924|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20322925|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
20322926|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322927|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322928|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20322929|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20322930|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20322931|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
20322932|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
19795079|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795080|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795081|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795082|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795083|NCT00365261|Eszopiclone|eszopiclone|mesh-list
19795084|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19795085|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795086|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795087|NCT00365274|Prednisone|prednisone|mesh-list
19795088|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
19795089|NCT00365274|Doxorubicin|doxorubicin|mesh-list
19795090|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20322933|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
20322934|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20322935|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
20322936|NCT00729794|Coagulants|coagulants|mesh-ancestor
20322937|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20322938|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
20322939|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
19640686|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20322940|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
20322941|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20322942|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20322943|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322944|NCT00729911|Amiodarone|amiodarone|mesh-list
20322945|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20322946|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
19640687|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19640688|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640689|NCT02398552|Growth Substances|growth substances|mesh-ancestor
19640690|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640691|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640692|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19640693|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640694|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640695|NCT02398357|Nadroparin|nadroparin|mesh-list
19640696|NCT02398357|Warfarin|warfarin|mesh-list
19640697|NCT02398357|Calcium|calcium|mesh-list
19795091|NCT00365274|Vincristine|vincristine|mesh-list
19795092|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19795093|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795094|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
19795095|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795096|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795097|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19795098|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
19795099|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795100|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795101|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19795102|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19795103|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19795104|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795105|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795106|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795107|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
19795108|NCT00365274|Hormones|hormones|mesh-ancestor
19795109|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795110|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19795111|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19795112|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
19795113|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
19795114|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
19795115|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795116|NCT00365300|Pantoprazole|pantoprazole|mesh-list
19795117|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19795118|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19795119|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20322947|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19795120|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322948|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20322949|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322950|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20322951|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20322952|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20322953|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322954|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20322955|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20322956|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19795121|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795122|NCT00365352|Gabapentin|gabapentin|mesh-list
19795123|NCT00365352|Analgesics|analgesics|mesh-ancestor
19795124|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
19795125|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155696|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
20155697|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
20155698|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
20155699|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155700|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155701|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155702|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
20155703|NCT00104169|Hematinics|hematinics|mesh-ancestor
20155704|NCT00104182|Insulin|insulin|mesh-list
20155705|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19795126|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795127|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
19795128|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19795129|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19795130|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20155706|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
20155707|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
20155708|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
20155709|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
19795131|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19795132|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19795133|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19795134|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795135|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795136|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
20155710|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20155711|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155712|NCT00104260|Verapamil|verapamil|mesh-list
20155713|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20155714|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20155715|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20155716|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322957|NCT00729950|Ipilimumab|ipilimumab|mesh-list
20322958|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20322959|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795137|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
19795138|NCT00365365|Bevacizumab|bevacizumab|mesh-list
19795139|NCT00365365|Carboplatin|carboplatin|mesh-list
19795140|NCT00365365|Docetaxel|docetaxel|mesh-list
19795141|NCT00365365|Doxorubicin|doxorubicin|mesh-list
19795142|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19795143|NCT00365365|Trastuzumab|trastuzumab|mesh-list
19795144|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795145|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
19795146|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795147|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795148|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19795149|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
19795150|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795151|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795152|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19795153|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795154|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20155717|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19256644|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19795155|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795156|NCT00365365|Growth Substances|growth substances|mesh-ancestor
20155718|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155719|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
19795157|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795158|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
19795159|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
19795160|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155720|NCT00104273|Rasagiline|rasagiline|mesh-list
20155721|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20155722|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155723|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155724|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20155725|NCT00104273|Protective Agents|protective agents|mesh-ancestor
20155726|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155727|NCT00104286|Troxacitabine|troxacitabine|mesh-list
20155728|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155729|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20155730|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20155731|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
20155732|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155733|NCT00104403|Dexamethasone|dexamethasone|mesh-list
20155734|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
20155735|NCT00104403|Ondansetron|ondansetron|mesh-list
20155736|NCT00104403|Casopitant|casopitant|mesh-list
20155737|NCT00104403|BB 1101|bb 1101|mesh-list
20155738|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20155739|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
20155740|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
20155741|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155742|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155743|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20155744|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
20322960|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20322961|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322962|NCT00729963|Sibutramine|sibutramine|mesh-list
20322963|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
20322964|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20322965|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
20322966|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20322967|NCT00729976|Ibuprofen|ibuprofen|mesh-list
20322968|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20322969|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20322970|NCT00729976|Analgesics|analgesics|mesh-ancestor
20322971|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
20322972|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322973|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20322974|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20322975|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20322976|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20155745|NCT00104403|Hormones|hormones|mesh-ancestor
20155746|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155747|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20155748|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155749|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
20155750|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155751|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155752|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
20322977|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20322978|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322979|NCT00730054|Clonidine|clonidine|mesh-list
20322980|NCT00730054|Remifentanil|remifentanil|mesh-list
20322981|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20322982|NCT00730054|Narcotics|narcotics|mesh-ancestor
20322983|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20322984|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640698|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19640699|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640700|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
19640701|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19640702|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19640703|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640704|NCT02398474|Ropivacaine|ropivacaine|mesh-list
19640705|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
19640706|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
19640707|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640708|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795161|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20155753|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
20155754|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20155755|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
20322985|NCT00730054|Analgesics|analgesics|mesh-ancestor
20322986|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
20322987|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20322988|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20322989|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
20322990|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
20322991|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20322992|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20322993|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19640709|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
19640710|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640711|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
19640712|NCT02398539|Triamcinolone|triamcinolone|mesh-list
19640713|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640714|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
20155756|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155757|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20155758|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20155759|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20155760|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155761|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20155762|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20155763|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20155764|NCT00104429|Aplaviroc|aplaviroc|mesh-list
20155765|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20155766|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20155767|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155768|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155769|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
20155770|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155771|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20155772|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20155773|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20155774|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20155775|NCT00104442|Rivastigmine|rivastigmine|mesh-list
19795162|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19795163|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795164|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795165|NCT00365391|Bevacizumab|bevacizumab|mesh-list
19795166|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19795167|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19795168|NCT00365391|Antibodies|antibodies|mesh-list
19795169|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
19795170|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19795171|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795172|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795173|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640715|NCT02398539|Hormones|hormones|mesh-ancestor
19640716|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640717|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795174|NCT00365391|Growth Substances|growth substances|mesh-ancestor
19795175|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155776|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19795176|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795177|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
19795178|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19795179|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795180|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795181|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
19795182|NCT00365417|Bevacizumab|bevacizumab|mesh-list
19795183|NCT00365417|Docetaxel|docetaxel|mesh-list
19795184|NCT00365417|Doxorubicin|doxorubicin|mesh-list
19795185|NCT00365417|Capecitabine|capecitabine|mesh-list
19795186|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795187|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
19795188|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795189|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795190|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19795191|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
19795192|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795193|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795194|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834112|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155777|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155778|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155779|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
20155780|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155781|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155782|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20155783|NCT00104442|Protective Agents|protective agents|mesh-ancestor
20155784|NCT00104468|Troxacitabine|troxacitabine|mesh-list
20155785|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155786|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20155787|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20155788|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
20155789|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155790|NCT00104546|Vitamin K|vitamin k|mesh-list
20155791|NCT00104546|Vitamins|vitamins|mesh-ancestor
20155792|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
20155793|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155794|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20155795|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20155796|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155797|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
20155798|NCT00104546|Coagulants|coagulants|mesh-ancestor
20155799|NCT00104598|Bupropion|bupropion|mesh-list
20155800|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20155801|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
20155802|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155803|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19795195|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795196|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795197|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795198|NCT00365417|Growth Substances|growth substances|mesh-ancestor
19795199|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795200|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
20155804|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20155805|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611267|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795201|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
19795202|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
19795203|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19795204|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19795205|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795206|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795207|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611268|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611269|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611270|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
20611271|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611272|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611273|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611274|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
20611275|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611276|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
19640718|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20322994|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
20322995|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20322996|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20322997|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
19640719|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640720|NCT02398201|Bezafibrate|bezafibrate|mesh-list
19640721|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19640722|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
19640723|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640724|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19640725|NCT02398123|Bupivacaine|bupivacaine|mesh-list
19640726|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
19640727|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
19640728|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640729|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640730|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
19640731|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640732|NCT02398136|Midazolam|midazolam|mesh-list
19640733|NCT02398136|Ketamine|ketamine|mesh-list
19795208|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
19795209|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
19795210|NCT00365456|Hormones|hormones|mesh-list
19795211|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
19795212|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795213|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795214|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19795215|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795216|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795217|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20322998|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
20322999|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20323000|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19795218|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19795219|NCT00365508|Nicotine|nicotine|mesh-list
19795220|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19795221|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
20323001|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323002|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323003|NCT00730067|Urological Agents|urological agents|mesh-ancestor
19795222|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795223|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795224|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19795225|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19795226|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19795227|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640734|NCT02398136|Analgesics|analgesics|mesh-ancestor
19640735|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
19640736|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640737|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640738|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19640739|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20323004|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
20323005|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
19640740|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
19640741|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
19640742|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640743|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19640744|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19640745|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640746|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795228|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795229|NCT00365547|Bevacizumab|bevacizumab|mesh-list
19640747|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19640748|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19640749|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19640750|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20323006|NCT00730093|Vitamins|vitamins|mesh-ancestor
20323007|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
20323008|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323009|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
20323010|NCT00730093|Hematinics|hematinics|mesh-ancestor
20323011|NCT00730197|Albuterol|albuterol|mesh-list
20323012|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20323013|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
20323014|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323015|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640751|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19640752|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
19640753|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
20611277|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611278|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611279|NCT01767129|Quinidine|quinidine|mesh-list
20611280|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
20611281|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
20611282|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
20611283|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19640754|NCT02397928|Carboplatin|carboplatin|mesh-list
19640755|NCT02397928|Pemetrexed|pemetrexed|mesh-list
19640756|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795230|NCT00365547|Topotecan|topotecan|mesh-list
19795231|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20323016|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19640757|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323017|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
20323018|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
20323019|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20323020|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20323021|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20323022|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20323023|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
20323024|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323025|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323026|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
20323027|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20323028|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323029|NCT00730223|Efavirenz|efavirenz|mesh-list
19640758|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640759|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20155806|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155807|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
20155808|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20155809|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155810|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20155811|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20155812|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155813|NCT00104624|Docetaxel|docetaxel|mesh-list
20155814|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155815|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
20155816|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
20155817|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155818|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155819|NCT00104663|Quinacrine|quinacrine|mesh-list
20155820|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
20155821|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20155822|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
20155823|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20155824|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155825|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
20155826|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20155827|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
20155828|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155829|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155830|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155831|NCT00104689|Capecitabine|capecitabine|mesh-list
20155832|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
20155833|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155834|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
19640760|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19640761|NCT02397720|Nivolumab|nivolumab|mesh-list
19640762|NCT02397720|Ipilimumab|ipilimumab|mesh-list
19640763|NCT02397720|Azacitidine|azacitidine|mesh-list
20155835|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155836|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155837|NCT00104715|Docetaxel|docetaxel|mesh-list
20155838|NCT00104715|Goserelin|goserelin|mesh-list
20155839|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
19795232|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795233|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795234|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795235|NCT00365547|Growth Substances|growth substances|mesh-ancestor
19795236|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795237|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795238|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19795239|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20155840|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155841|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
19640764|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19640765|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795240|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795241|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795242|NCT00365599|Tamoxifen|tamoxifen|mesh-list
20155842|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
20323030|NCT00730223|Nevirapine|nevirapine|mesh-list
19795243|NCT00365599|Vorinostat|vorinostat|mesh-list
20155843|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
20155844|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795244|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795245|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19795246|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
19795247|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795248|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795249|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19795250|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323031|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20323032|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20323033|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323034|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323035|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
20323036|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323037|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20155845|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20155846|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
20155847|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155848|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155849|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20155850|NCT00104741|Flutamide|flutamide|mesh-list
20155851|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
20155852|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20155853|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
20155854|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20155855|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795251|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19795252|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19795253|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19795254|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19795255|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795256|NCT00365716|Vaccines|vaccines|mesh-list
19795257|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
19795258|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155856|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20155857|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20155858|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155859|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
20155860|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
20155861|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155862|NCT00104767|Celecoxib|celecoxib|mesh-list
20155863|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20155864|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20155865|NCT00104767|Analgesics|analgesics|mesh-ancestor
20155866|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
20155867|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155868|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795259|NCT00365794|Testosterone|testosterone|mesh-list
19795260|NCT00365794|Androgens|androgens|mesh-ancestor
19795261|NCT00365794|Hormones|hormones|mesh-ancestor
19795262|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795263|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795264|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
19795265|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795266|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795267|NCT00365859|Aripiprazole|aripiprazole|mesh-list
19795268|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
19795269|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155869|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20155870|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795270|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19795271|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19795272|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795273|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795274|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
19795275|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
19795276|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795277|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795278|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19795279|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20155871|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20323038|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19795280|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
19795281|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19795282|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19795283|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19795284|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19795285|NCT00365976|Eszopiclone|eszopiclone|mesh-list
19795286|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20155872|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20155873|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155874|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155875|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
20155876|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20155877|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
20155878|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155879|NCT00104793|Carboplatin|carboplatin|mesh-list
20155880|NCT00104793|Irinotecan|irinotecan|mesh-list
20155881|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155882|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20155883|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20155884|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155885|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155886|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
20155887|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
20155888|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20611284|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19640766|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19640767|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795287|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795288|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795289|NCT00366106|Dexamethasone|dexamethasone|mesh-list
19795290|NCT00366106|Doxorubicin|doxorubicin|mesh-list
19795291|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19795292|NCT00366106|Bortezomib|bortezomib|mesh-list
19795293|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795294|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
19795295|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
19795296|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795297|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640768|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19640769|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
19640770|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640771|NCT02397772|Albendazole|albendazole|mesh-list
19640772|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
19640773|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19640774|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640775|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
19640776|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19640777|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19640778|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
19640779|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
19640780|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
19640781|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795298|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19795299|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
19795300|NCT00366106|Hormones|hormones|mesh-ancestor
19795301|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611285|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640782|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640783|NCT02397863|Cannabidiol|cannabidiol|mesh-list
19640784|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
19640785|NCT02398058|Olaparib|olaparib|mesh-list
20611286|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611287|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611288|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20611289|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20611290|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
20155889|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155890|NCT00104806|Vitamins|vitamins|mesh-ancestor
20155891|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
20155892|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19795302|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20155893|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155894|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
19640786|NCT02398058|Trabectedin|trabectedin|mesh-list
20323039|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20155895|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20155896|NCT00104819|Antibodies|antibodies|mesh-list
20155897|NCT00104819|Sargramostim|sargramostim|mesh-list
20155898|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20155899|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
20155900|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155901|NCT00104845|Vaccines|vaccines|mesh-list
20155902|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
20155903|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795303|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795304|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19795305|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19795306|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795307|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323040|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20323041|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20611291|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19795308|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795309|NCT00366249|Ertapenem|ertapenem|mesh-list
19795310|NCT00366249|Tigecycline|tigecycline|mesh-list
19795311|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20155904|NCT00104910|Cetuximab|cetuximab|mesh-list
20155905|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155906|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155907|NCT00104923|Fenretinide|fenretinide|mesh-list
20155908|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155909|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20155910|NCT00104923|Protective Agents|protective agents|mesh-ancestor
20155911|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640787|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19640788|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640789|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640790|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19640791|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19640792|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
19640793|NCT02397382|Midazolam|midazolam|mesh-list
20155912|NCT00104949|Trastuzumab|trastuzumab|mesh-list
20155913|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155914|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611292|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
20611293|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20611294|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20611295|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611296|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611297|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20611298|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20611299|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
20611300|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20611301|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20611302|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611303|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20611304|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20611305|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20611306|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611307|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611308|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611309|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640794|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
19640795|NCT02397382|Caffeine|caffeine|mesh-list
20155915|NCT00104962|Lenalidomide|lenalidomide|mesh-list
20155916|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
20155917|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155918|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20155919|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640796|NCT02397382|Omeprazole|omeprazole|mesh-list
20155920|NCT00104962|Growth Substances|growth substances|mesh-ancestor
20155921|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
20155922|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155923|NCT00104975|Fludarabine|fludarabine|mesh-list
20155924|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
20155925|NCT00104975|Melphalan|melphalan|mesh-list
20155926|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
20155927|NCT00104975|Thiotepa|thiotepa|mesh-list
19795312|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795313|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19795314|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795315|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795316|NCT00366301|Metformin|metformin|mesh-list
20155928|NCT00104975|Tacrolimus|tacrolimus|mesh-list
19640797|NCT02397382|Warfarin|warfarin|mesh-list
19640798|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19640799|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20155929|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155930|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20155931|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
20323042|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19795317|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
19795318|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19795319|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795320|NCT00366340|Vaccines|vaccines|mesh-list
19795321|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20323043|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20323044|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20323045|NCT00730249|Methylphenidate|methylphenidate|mesh-list
20323046|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20323047|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323048|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20323049|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20323050|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20323051|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323052|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
19795322|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
19795323|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795324|NCT00366444|Diclofenac|diclofenac|mesh-list
19795325|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19795326|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19795327|NCT00366444|Analgesics|analgesics|mesh-ancestor
19795328|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
20323053|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323054|NCT00730288|Vaccines|vaccines|mesh-list
20323055|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
20323056|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323057|NCT00730366|Chloroquine|chloroquine|mesh-list
20323058|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
20323059|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
20323060|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20323061|NCT00730366|Amebicides|amebicides|mesh-ancestor
19795329|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795330|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795331|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795332|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795333|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19795334|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795335|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795336|NCT00366457|Gemcitabine|gemcitabine|mesh-list
19795337|NCT00366457|Bevacizumab|bevacizumab|mesh-list
19795338|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19795339|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795340|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795341|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795342|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795343|NCT00366457|Growth Substances|growth substances|mesh-ancestor
20323062|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19640800|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20155932|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640801|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640802|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19640803|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19640804|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20155933|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155934|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
20323063|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20323064|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795344|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795345|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795346|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19795347|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
19795348|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795349|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
19795350|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795351|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795352|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795353|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
19795354|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20155935|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155936|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20155937|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155938|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20155939|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
20155940|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20611310|NCT01708941|Interferons|interferons|mesh-list
20611311|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
20611312|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
20611313|NCT01708941|Ipilimumab|ipilimumab|mesh-list
20611314|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611315|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
19795355|NCT00366535|Neurotropin|neurotropin|mesh-list
19795356|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19795357|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
19795358|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795359|NCT00366535|Analgesics|analgesics|mesh-ancestor
19795360|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
19795361|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795362|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
19795363|NCT00366548|Vaccines|vaccines|mesh-list
19795364|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19795365|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
19795366|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795367|NCT00366626|Naltrexone|naltrexone|mesh-list
19795368|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19795369|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19795370|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795371|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
19795372|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795373|NCT00366678|Vaccines|vaccines|mesh-list
19795374|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19795375|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
19795376|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795377|NCT00366899|Vaccines|vaccines|mesh-list
19795378|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19795379|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
19795380|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795381|NCT00367016|Omalizumab|omalizumab|mesh-list
19795382|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19795383|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20611316|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611317|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20611318|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20611319|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640805|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19640806|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
19640807|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
19640808|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
19640809|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
19640810|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640811|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640812|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
19640813|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19640814|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640815|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19640816|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640817|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19640818|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19640819|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19640820|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19640821|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
19795384|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20611320|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
20611321|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611322|NCT01659606|Cyclosporine|cyclosporine|mesh-list
20611323|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
20611324|NCT01659606|Fludarabine|fludarabine|mesh-list
20611325|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
20611326|NCT01659606|Tacrolimus|tacrolimus|mesh-list
19640822|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
19640823|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
19640824|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20323065|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
19795385|NCT00367055|Metformin|metformin|mesh-list
19795386|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
19795387|NCT00367055|Gliclazide|gliclazide|mesh-list
19795388|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19795389|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795390|NCT00367133|Triamcinolone|triamcinolone|mesh-list
19795391|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19795392|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19795393|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19795394|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795395|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
19795396|NCT00367133|Hormones|hormones|mesh-ancestor
19795397|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795398|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795399|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795400|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
19795401|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795402|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640825|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19640826|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
19640827|NCT02397603|Bupivacaine|bupivacaine|mesh-list
19640828|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
19640829|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
19640830|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640831|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640832|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
19795403|NCT00367237|Methotrexate|methotrexate|mesh-list
19795404|NCT00367237|Infliximab|infliximab|mesh-list
19795405|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19795406|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
19795407|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19795408|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795409|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19795410|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
19795411|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795412|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795413|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
19795414|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795415|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19795416|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795417|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
19795418|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795419|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19795420|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19795421|NCT00367341|Citalopram|citalopram|mesh-list
19795422|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19795423|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19795424|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20155941|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20155942|NCT00104988|Thalidomide|thalidomide|mesh-list
20155943|NCT00104988|Temozolomide|temozolomide|mesh-list
20155944|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20155945|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
20155946|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155947|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20155948|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20155949|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
20155950|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155951|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
20155952|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20155953|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155954|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20174104|NCT00163501|Hormones|hormones|mesh-ancestor
20611327|NCT01659606|Cyclosporins|cyclosporins|mesh-list
20611328|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795425|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795426|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795427|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
19795428|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640833|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640834|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19640835|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19795429|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19795430|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
19795431|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19795432|NCT00367432|Levetiracetam|levetiracetam|mesh-list
19795433|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
19795434|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
19795435|NCT00367458|Atorvastatin|atorvastatin|mesh-list
20323066|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323067|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20323068|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323069|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323070|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20323071|NCT00730366|Renal Agents|renal agents|mesh-ancestor
20323072|NCT00730392|Etanercept|etanercept|mesh-list
20323073|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20323074|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20323075|NCT00730392|Analgesics|analgesics|mesh-ancestor
20323076|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
20323077|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323078|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323079|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323080|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323081|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323082|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323083|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
20323084|NCT00730418|Doxazosin|doxazosin|mesh-list
20323085|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20323086|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20323087|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20323088|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20323089|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
20323090|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323091|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323092|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323093|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20323094|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323095|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323096|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323097|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20323098|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
20323099|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
20323100|NCT00730509|Vitamins|vitamins|mesh-ancestor
20323101|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
20323102|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323103|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
20323104|NCT00730509|Hematinics|hematinics|mesh-ancestor
20323105|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20323106|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20323107|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19640836|NCT02397603|Analgesics|analgesics|mesh-ancestor
19640837|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19640838|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19640839|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19640840|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
19640841|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640842|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640843|NCT02397395|Simeprevir|simeprevir|mesh-list
19640844|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
19640845|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640846|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
20323108|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
20323109|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347622|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19795436|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19795437|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19795438|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
19795439|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795440|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19795441|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20155955|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20155956|NCT00104988|Growth Substances|growth substances|mesh-ancestor
20155957|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
20155958|NCT00105040|Levetiracetam|levetiracetam|mesh-list
20155959|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
20155960|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
20155961|NCT00105105|Mifepristone|mifepristone|mesh-list
20155962|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20155963|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
20323110|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323111|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323112|NCT00730535|Urological Agents|urological agents|mesh-ancestor
20323113|NCT00730574|Vitamins|vitamins|mesh-list
20323114|NCT00730574|Folic Acid|folic acid|mesh-list
20323115|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
20323116|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
20323117|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
20155964|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19795442|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795443|NCT00367484|Interferons|interferons|mesh-list
19795444|NCT00367484|Interferon-beta|interferon-beta|mesh-list
19795445|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
19795446|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795447|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
19795448|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795449|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
19795450|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795451|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20155965|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155966|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20155967|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20155968|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20155969|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
20323118|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
20323119|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323120|NCT00730574|Hematinics|hematinics|mesh-ancestor
20611329|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611330|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611331|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
20611332|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611333|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20611334|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611335|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
20611336|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611337|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611338|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20611339|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19640847|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323121|NCT00730769|Valganciclovir|valganciclovir|mesh-list
19640848|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640849|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19640850|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19640851|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640852|NCT02397512|Lactulose|lactulose|mesh-list
19640853|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19640854|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
19640855|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19640856|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640857|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19640858|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640859|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19640860|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20323122|NCT00730769|Ganciclovir|ganciclovir|mesh-list
20323123|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20323124|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
19640861|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640862|NCT02397538|Amlodipine|amlodipine|mesh-list
19795452|NCT00367601|Bevacizumab|bevacizumab|mesh-list
20323125|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155970|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20323126|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19640863|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19640864|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19640865|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19640866|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795453|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19795454|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795455|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795456|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795457|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795458|NCT00367601|Growth Substances|growth substances|mesh-ancestor
19795459|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795460|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
19640867|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640868|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19640869|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795461|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19795462|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795463|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155971|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20155972|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
20155973|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20155974|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
20155975|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20155976|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20155977|NCT00105144|Caspofungin|caspofungin|mesh-list
20155978|NCT00105144|Micafungin|micafungin|mesh-list
20155979|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
20155980|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20155981|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155982|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155983|NCT00105209|Aspirin|aspirin|mesh-list
20155984|NCT00105209|Clopidogrel|clopidogrel|mesh-list
20323127|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323128|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640870|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
19640871|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19640872|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19640873|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
19640874|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19795464|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
19795465|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795466|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
19795467|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19795468|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795469|NCT00367770|Bosentan|bosentan|mesh-list
19795470|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19795471|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19795472|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795473|NCT00367835|Guanfacine|guanfacine|mesh-list
19795474|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19795475|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19640875|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19640876|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640877|NCT02397486|Vitamin E|vitamin e|mesh-list
19640878|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
19640879|NCT02397486|Vitamins|vitamins|mesh-ancestor
19640880|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
19640881|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640882|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
19640883|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640884|NCT02397486|Protective Agents|protective agents|mesh-ancestor
19640885|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19795476|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19795477|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20155985|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19795478|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
19640886|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640887|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19795479|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795480|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795481|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795482|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
20155986|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20155987|NCT00105209|Analgesics|analgesics|mesh-ancestor
20155988|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
20155989|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20155990|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20155991|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20155992|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640888|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19640889|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
19640890|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19640891|NCT02397590|Atorvastatin|atorvastatin|mesh-list
19640892|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19640893|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19640894|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
19640895|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155993|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20155994|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20155995|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20155996|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20155997|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20155998|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20155999|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
20156000|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20156001|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20156002|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20156003|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
20156004|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156005|NCT00105287|Fentanyl|fentanyl|mesh-list
20156006|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19795483|NCT00367991|Hematinics|hematinics|mesh-ancestor
19795484|NCT00368069|Levetiracetam|levetiracetam|mesh-list
19795485|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
19795486|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
19795487|NCT00368251|Brivaracetam|brivaracetam|mesh-list
19795488|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
19640896|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19640897|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19640898|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663306|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663307|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663308|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
19663309|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663310|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
20156007|NCT00105287|Narcotics|narcotics|mesh-ancestor
20156008|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156009|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663311|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19663312|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
19663313|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663314|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19663315|NCT04431635|Rituximab|rituximab|mesh-list
20156010|NCT00105287|Analgesics|analgesics|mesh-ancestor
20156011|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
20156012|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156013|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20156014|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20156015|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
20156016|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
20323129|NCT00730821|Nintedanib|nintedanib|mesh-list
20323130|NCT00730821|Afatinib|afatinib|mesh-list
19663316|NCT04431635|Nivolumab|nivolumab|mesh-list
19795489|NCT00368277|Amlodipine|amlodipine|mesh-list
19795490|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20323131|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323132|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19663317|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20156017|NCT00105300|Adalimumab|adalimumab|mesh-list
20156018|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795491|NCT00368277|Ramipril|ramipril|mesh-list
19795492|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20323133|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323134|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323135|NCT00730938|Cefuroxime|cefuroxime|mesh-list
19640899|NCT02397356|Ketamine|ketamine|mesh-list
19640900|NCT02397356|Analgesics|analgesics|mesh-ancestor
19640901|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
19640902|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640903|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640904|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19640905|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19640906|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
19640907|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
19640908|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640909|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19640910|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19640911|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640912|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640913|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19640914|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19640915|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
19640916|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640917|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640918|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19640919|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
19640920|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19640921|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19640922|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19640923|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
19640924|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19640925|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640926|NCT02397330|Morphine|morphine|mesh-list
19640927|NCT02397330|Bupivacaine|bupivacaine|mesh-list
19640928|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
19640929|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
19640930|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640931|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640932|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
19640933|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640934|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19640935|NCT02397330|Narcotics|narcotics|mesh-ancestor
19640936|NCT02397330|Analgesics|analgesics|mesh-ancestor
19795493|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19795494|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19640937|NCT02396979|Methadone|methadone|mesh-list
19640938|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19795495|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795496|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19795497|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795498|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
19795499|NCT00368277|Diuretics|diuretics|mesh-ancestor
19795500|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
19795501|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19795502|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19795503|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
20156019|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156020|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20156021|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20156022|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156023|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156024|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156025|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156026|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19640939|NCT02396979|Narcotics|narcotics|mesh-ancestor
19640940|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156027|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20156028|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
20156029|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323136|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
20323137|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20323138|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323139|NCT00730977|Mannitol|mannitol|mesh-list
20323140|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20323141|NCT00730977|Diuretics|diuretics|mesh-ancestor
19795504|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323142|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
20611340|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20611341|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
19795505|NCT00368290|Modafinil|modafinil|mesh-list
19795506|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19795507|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795508|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19795509|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19795510|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19795511|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795512|NCT00368355|Cytarabine|cytarabine|mesh-list
19795513|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
19795514|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
19795515|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795516|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
19795517|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795518|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20611342|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611343|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20323143|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323144|NCT00731003|Tryptophan|tryptophan|mesh-list
20323145|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
20323146|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20323147|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
20323148|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20323149|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
19640941|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640942|NCT02396979|Analgesics|analgesics|mesh-ancestor
19795519|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19795520|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
19640943|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
19640944|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611344|NCT01622868|Lapatinib|lapatinib|mesh-list
20611345|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611346|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611347|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256645|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20156030|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640945|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
19795521|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795522|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795523|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20156031|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20156032|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20156033|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
20156034|NCT00105352|Glucagon|glucagon|mesh-list
20156035|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20156036|NCT00105352|Hormones|hormones|mesh-ancestor
20156037|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156038|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156039|NCT00105404|Triamcinolone|triamcinolone|mesh-list
20156040|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20156041|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20156042|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20156043|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19640946|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
19640947|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
19640948|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640949|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
19640950|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
19640951|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
19640952|NCT02397213|Cyclosporine|cyclosporine|mesh-list
19640953|NCT02397213|Cyclosporins|cyclosporins|mesh-list
20323150|NCT00731016|Pravastatin|pravastatin|mesh-list
20323151|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20156044|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
20156045|NCT00105404|Hormones|hormones|mesh-ancestor
19795524|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19795525|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
19795526|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
19795527|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795528|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20156046|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156047|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156048|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156049|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
20156050|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156051|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795529|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19795530|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19795531|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
19795532|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795533|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795534|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19795535|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19795536|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19795537|NCT00368537|Ampicillin|ampicillin|mesh-list
19795538|NCT00368537|Tigecycline|tigecycline|mesh-list
19795539|NCT00368537|Sulbactam|sulbactam|mesh-list
19795540|NCT00368537|Sultamicillin|sultamicillin|mesh-list
19795541|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19795542|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795543|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19795544|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795545|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795546|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19795547|NCT00368550|Sertraline|sertraline|mesh-list
19795548|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
19795549|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19640954|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640955|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795550|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20156052|NCT00105495|Deferiprone|deferiprone|mesh-list
20156053|NCT00105495|Deferoxamine|deferoxamine|mesh-list
19640956|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19640957|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
19640958|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640959|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
19640960|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640961|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
19640962|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19640963|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19640964|NCT02396888|Insulin|insulin|mesh-list
19640965|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19640966|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640967|NCT02396563|Ropivacaine|ropivacaine|mesh-list
19640968|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
19640969|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
20323152|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323153|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20323154|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20323155|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
20323156|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323157|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20323158|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20323159|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323160|NCT00731068|Mitogens|mitogens|mesh-list
19795551|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19795552|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795553|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795554|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795555|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
19795556|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795557|NCT00368641|Icodextrin|icodextrin|mesh-list
19795558|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
20156054|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20156055|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
20323161|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323162|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323163|NCT00731146|Anesthetics|anesthetics|mesh-list
20323164|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323165|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156056|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
20156057|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156058|NCT00105495|Siderophores|siderophores|mesh-ancestor
20156059|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
20156060|NCT00105547|Analgesics|analgesics|mesh-ancestor
20156061|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
20156062|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640970|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19640971|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640972|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
19640973|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19640974|NCT02396862|Factor VIII|factor viii|mesh-list
19640975|NCT02396862|Coagulants|coagulants|mesh-ancestor
19640976|NCT02396225|Voriconazole|voriconazole|mesh-list
19640977|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
19640978|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640979|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19640980|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19640981|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19640982|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19640983|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19640984|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
19640985|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19640986|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795559|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19795560|NCT00368745|Pregabalin|pregabalin|mesh-list
19795561|NCT00368745|Analgesics|analgesics|mesh-ancestor
19795562|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
20156063|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795563|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795564|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156064|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20156065|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20156066|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20156067|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156068|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20156069|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156070|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174105|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174106|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174107|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174108|NCT00163514|Ciclesonide|ciclesonide|mesh-list
20174109|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
20174110|NCT00163514|Hormones|hormones|mesh-ancestor
20174111|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174112|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174113|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20156071|NCT00105937|Fentanyl|fentanyl|mesh-list
20156072|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20156073|NCT00105937|Narcotics|narcotics|mesh-ancestor
20156074|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156075|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156076|NCT00105937|Analgesics|analgesics|mesh-ancestor
20156077|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
20156078|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156079|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20156080|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20156081|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
20156082|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
20156083|NCT00105950|Lapatinib|lapatinib|mesh-list
20156084|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156085|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20323166|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
20323167|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
20323168|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20323169|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
20323170|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323171|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323172|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323173|NCT00731224|Rivastigmine|rivastigmine|mesh-list
20323174|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20323175|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323176|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323177|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
20323178|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323179|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323180|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20323181|NCT00731224|Protective Agents|protective agents|mesh-ancestor
20323182|NCT00731276|Irinotecan|irinotecan|mesh-list
20323183|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20323184|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20323185|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156086|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156087|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156088|NCT00106054|Leucovorin|leucovorin|mesh-list
20156089|NCT00106054|Bevacizumab|bevacizumab|mesh-list
20156090|NCT00106054|Irinotecan|irinotecan|mesh-list
20156091|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19640987|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19640988|NCT02396303|Carbetocin|carbetocin|mesh-list
19640989|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
19640990|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20156092|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156093|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20156094|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19640991|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19640992|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
19640993|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
19640994|NCT02396329|Povidone|povidone|mesh-list
19640995|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19640996|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19640997|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
19640998|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
19640999|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
19641000|NCT02396433|Carboplatin|carboplatin|mesh-list
19641001|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19641002|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641003|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663318|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663319|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
19663320|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663321|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663322|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19663323|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663324|NCT04430985|Leucovorin|leucovorin|mesh-list
19663325|NCT04430985|Fluorouracil|fluorouracil|mesh-list
19663326|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
19663327|NCT04430985|Nivolumab|nivolumab|mesh-list
19663328|NCT04430985|Ipilimumab|ipilimumab|mesh-list
19663329|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
19663330|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663331|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663332|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663333|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641004|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641005|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
19641006|NCT02396030|Analgesics|analgesics|mesh-ancestor
19641007|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
19641008|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641009|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323186|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323187|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323188|NCT00731289|Triamcinolone|triamcinolone|mesh-list
20323189|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20323190|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19641010|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
19641011|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641012|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19641013|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
19641014|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19641015|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641016|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641017|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19641018|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
19641019|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641020|NCT02396108|Paclitaxel|paclitaxel|mesh-list
19641021|NCT02396108|Carboplatin|carboplatin|mesh-list
20323191|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
20323192|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20323193|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323194|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
19641022|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19641023|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641024|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641025|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641026|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641027|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641028|NCT02396043|Cytarabine|cytarabine|mesh-list
19641029|NCT02396043|Dexamethasone|dexamethasone|mesh-list
20323195|NCT00731289|Hormones|hormones|mesh-ancestor
20323196|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323197|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323198|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323199|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
20323200|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323201|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323202|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20323203|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
20323204|NCT00731289|Protective Agents|protective agents|mesh-ancestor
20347623|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
20347624|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347625|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347626|NCT00861315|Amikacin|amikacin|mesh-list
20347627|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347628|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347629|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
20347630|NCT00861328|Irinotecan|irinotecan|mesh-list
20347631|NCT00861328|Camptothecin|camptothecin|mesh-list
20347632|NCT00861328|ON 01910|on 01910|mesh-list
20347633|NCT00861328|Glycine|glycine|mesh-list
20347634|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347635|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20347636|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20347637|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347638|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347639|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20347640|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20347641|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
19641030|NCT02396043|Prednisone|prednisone|mesh-list
19641031|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
19641032|NCT02396043|Methotrexate|methotrexate|mesh-list
19641033|NCT02396043|Vincristine|vincristine|mesh-list
19641034|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
19641035|NCT02396043|Pegaspargase|pegaspargase|mesh-list
19641036|NCT02396043|Asparaginase|asparaginase|mesh-list
19641037|NCT02396043|Pirarubicin|pirarubicin|mesh-list
19641038|NCT02396043|Doxorubicin|doxorubicin|mesh-list
19641039|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156095|NCT00106054|Growth Substances|growth substances|mesh-ancestor
20156096|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156097|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
20156098|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19795565|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
19795566|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20156099|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611348|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323205|NCT00731302|Aspirin|aspirin|mesh-list
20323206|NCT00731302|Meloxicam|meloxicam|mesh-list
20323207|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20323208|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20323209|NCT00731302|Analgesics|analgesics|mesh-ancestor
20323210|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
20323211|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323212|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323213|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323214|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323215|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20323216|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20323217|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323218|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20323219|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20323220|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323221|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
20323222|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20323223|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20611349|NCT01609790|Bevacizumab|bevacizumab|mesh-list
19641040|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
20156100|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156101|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156102|NCT00106054|Antidotes|antidotes|mesh-ancestor
19641041|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641042|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641043|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19641044|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
19641045|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641046|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641047|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19641048|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795567|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795568|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795569|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20156103|NCT00106054|Protective Agents|protective agents|mesh-ancestor
20156104|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
20156105|NCT00106054|Vitamins|vitamins|mesh-ancestor
20156106|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
20156107|NCT00106132|Triamcinolone|triamcinolone|mesh-list
20156108|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20156109|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20156110|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20156111|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20156112|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
20156113|NCT00106132|Hormones|hormones|mesh-ancestor
20156114|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156115|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156116|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156117|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
20156118|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156119|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156120|NCT00106158|Vaccines|vaccines|mesh-list
20156121|NCT00106158|Immunologic Factors|immunologic factors|mesh-ancestor
20156122|NCT00106158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156123|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20156124|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
20323224|NCT00731367|Laxatives|laxatives|mesh-ancestor
20323225|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323226|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20156125|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641049|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
20156126|NCT00106197|Bupropion|bupropion|mesh-list
20156127|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20156128|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156129|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19795570|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19795571|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19795572|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323227|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323228|NCT00731393|Vaccines|vaccines|mesh-list
20323229|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
20323230|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641050|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
19641051|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641052|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641053|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
19641054|NCT02396043|Hormones|hormones|mesh-ancestor
19641055|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19641056|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19641057|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795573|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19795574|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19795575|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19795576|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19795577|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795578|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795579|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
19795580|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795581|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795582|NCT00368875|Paclitaxel|paclitaxel|mesh-list
19795583|NCT00368875|Bevacizumab|bevacizumab|mesh-list
19795584|NCT00368875|Vorinostat|vorinostat|mesh-list
19795585|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19795586|NCT00368875|Antibodies|antibodies|mesh-list
19795587|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
19795588|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19795589|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19795590|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795591|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
19795592|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
19795593|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
19795594|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795595|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20156130|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20156131|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20156132|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641058|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19641059|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
19641060|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641061|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19641062|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
19641063|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
19641064|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19641065|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19641066|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
19641067|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641068|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19641069|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641070|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641071|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641072|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19641073|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19641074|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19641075|NCT02395783|Melatonin|melatonin|mesh-list
19641076|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
19641077|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641078|NCT02395783|Protective Agents|protective agents|mesh-ancestor
20156133|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156134|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
20156135|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156136|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156137|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20156138|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20323231|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20323232|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20323233|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323234|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323235|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
20611350|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20611351|NCT01609790|Trebananib|trebananib|mesh-list
19641079|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641080|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795596|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795597|NCT00368875|Growth Substances|growth substances|mesh-ancestor
19795598|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795599|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795600|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
19641081|NCT02395705|Paclitaxel|paclitaxel|mesh-list
19641082|NCT02395705|Cisplatin|cisplatin|mesh-list
19641083|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19641084|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641085|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641086|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641087|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641088|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641089|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
19641090|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19641091|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641092|NCT02395926|Choline|choline|mesh-list
19795601|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19795602|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795603|NCT00368927|Sulindac|sulindac|mesh-list
19795604|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19795605|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19795606|NCT00368927|Analgesics|analgesics|mesh-ancestor
19795607|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
19795608|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795609|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795610|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795611|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795612|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795613|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19795614|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795615|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795616|NCT00368966|Vaccines|vaccines|mesh-list
19795617|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19795618|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
19795619|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795620|NCT00368979|Dutasteride|dutasteride|mesh-list
20156139|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156140|NCT00106262|Irinotecan|irinotecan|mesh-list
20156141|NCT00106262|Bortezomib|bortezomib|mesh-list
20156142|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20156143|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20156144|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156145|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156146|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156147|NCT00106288|Amphotericin B|amphotericin b|mesh-list
20156148|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20156149|NCT00106288|Micafungin|micafungin|mesh-list
20156150|NCT00106288|Amebicides|amebicides|mesh-ancestor
20156151|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20156152|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20611352|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
20611353|NCT01609790|Antibodies|antibodies|mesh-list
20611354|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
20611355|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20611356|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
20611357|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611358|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611359|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611360|NCT01609790|Growth Substances|growth substances|mesh-ancestor
20611361|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611362|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611363|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
20611364|NCT01553149|Lenalidomide|lenalidomide|mesh-list
20611365|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
20611366|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611367|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795621|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19795622|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19795623|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795624|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795625|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
19795626|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795627|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795628|NCT00368992|Paclitaxel|paclitaxel|mesh-list
19795629|NCT00368992|Bevacizumab|bevacizumab|mesh-list
19795630|NCT00368992|Cetuximab|cetuximab|mesh-list
19795631|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19795632|NCT00368992|Antibodies|antibodies|mesh-list
19795633|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
19795634|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20611368|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611369|NCT01553149|Growth Substances|growth substances|mesh-ancestor
20611370|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611371|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156153|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156154|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20156155|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
20156156|NCT00106301|Romidepsin|romidepsin|mesh-list
20156157|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20156158|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156159|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20156160|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20156161|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
20323236|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641093|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
19641094|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19641095|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
19641096|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641097|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641098|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19795635|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19795636|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795637|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19795638|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19795639|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19795640|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795641|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795642|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795643|NCT00368992|Growth Substances|growth substances|mesh-ancestor
19795644|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795645|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795646|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
19795647|NCT00369122|Bevacizumab|bevacizumab|mesh-list
19795648|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19795649|NCT00369122|Cisplatin|cisplatin|mesh-list
19795650|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
19795651|NCT00369122|Antibodies|antibodies|mesh-list
19795652|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
19795653|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19795654|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
19795655|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795656|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795657|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795658|NCT00369122|Growth Substances|growth substances|mesh-ancestor
19795659|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795660|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
19641099|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
19641100|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19641101|NCT02395952|Laxatives|laxatives|mesh-ancestor
19641102|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641103|NCT02395744|Paclitaxel|paclitaxel|mesh-list
19641104|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19795661|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
19795662|NCT00369161|Everolimus|everolimus|mesh-list
19795663|NCT00369161|Tacrolimus|tacrolimus|mesh-list
19795664|NCT00369161|Basiliximab|basiliximab|mesh-list
19795665|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611372|NCT01371981|Cytarabine|cytarabine|mesh-list
19641105|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795666|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
20156162|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156163|NCT00106366|Insulin|insulin|mesh-list
19795667|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795668|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19795669|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795670|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795671|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795672|NCT00369226|Methotrexate|methotrexate|mesh-list
19795673|NCT00369226|Bortezomib|bortezomib|mesh-list
19795674|NCT00369226|Tacrolimus|tacrolimus|mesh-list
19795675|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19795676|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
19795677|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19795678|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795679|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19795680|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
19795681|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795682|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795683|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
19795684|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795685|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19795686|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795687|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
20323237|NCT00731562|Varenicline|varenicline|mesh-list
20323238|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20323239|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20323240|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
20323241|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323242|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795688|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795689|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19795690|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19795691|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
19795692|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19795693|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795694|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19795695|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
19795696|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19795697|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795698|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795699|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834113|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834114|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834115|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
19834116|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834117|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834118|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834119|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
19834120|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834121|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19834122|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19834123|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19834124|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834125|NCT00592072|Decanoic acid|decanoic acid|mesh-list
19834126|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
19834127|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323243|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323244|NCT00731575|Prednisolone|prednisolone|mesh-list
20323245|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20323246|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
20323247|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20323248|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
20323249|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20323250|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
20323251|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323252|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
20323253|NCT00731575|Hormones|hormones|mesh-ancestor
20323254|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323255|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323256|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20323257|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323258|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
20323259|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
20323260|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611373|NCT01371981|Etoposide|etoposide|mesh-list
19256646|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
20323261|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323262|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20323263|NCT00731575|Protective Agents|protective agents|mesh-ancestor
20323264|NCT00731601|Pantoprazole|pantoprazole|mesh-list
20323265|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20323266|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641106|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
19795700|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19795701|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19795702|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19641107|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641108|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641109|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663334|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
19663335|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663336|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663337|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19663338|NCT04430985|Antidotes|antidotes|mesh-ancestor
19663339|NCT04430985|Protective Agents|protective agents|mesh-ancestor
19795703|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795704|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795705|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795706|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795707|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
19795708|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19795709|NCT00369382|Cyclosporine|cyclosporine|mesh-list
19795710|NCT00369382|Sirolimus|sirolimus|mesh-list
19795711|NCT00369382|Tacrolimus|tacrolimus|mesh-list
19795712|NCT00369382|Cyclosporins|cyclosporins|mesh-list
19795713|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795714|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
19795715|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795716|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19795717|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795718|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795719|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
19795720|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795721|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156164|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20156165|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
19663340|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
19663341|NCT04430985|Vitamins|vitamins|mesh-ancestor
19663342|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
19663343|NCT04367311|Docetaxel|docetaxel|mesh-list
19663344|NCT04367311|Pemetrexed|pemetrexed|mesh-list
19663345|NCT04367311|Atezolizumab|atezolizumab|mesh-list
19663346|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663347|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
19663348|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
19663349|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20156166|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
20156167|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
20156168|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20156169|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156170|NCT00106379|Tenofovir|tenofovir|mesh-list
20156171|NCT00106379|Emtricitabine|emtricitabine|mesh-list
20156172|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20156173|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
20156174|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156175|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20156176|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20156177|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156178|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156179|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20156180|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20156181|NCT00106405|Memantine|memantine|mesh-list
20156182|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20156183|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20156184|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
20156185|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156186|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174114|NCT00163540|Formaldehyde|formaldehyde|mesh-list
20323267|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19663350|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663351|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663352|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20156187|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156188|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20156189|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20156190|NCT00106418|Romidepsin|romidepsin|mesh-list
19641110|NCT02395458|Amoxicillin|amoxicillin|mesh-list
19641111|NCT02395458|Metronidazole|metronidazole|mesh-list
19641112|NCT02395458|Clarithromycin|clarithromycin|mesh-list
19641113|NCT02395458|Omeprazole|omeprazole|mesh-list
19641114|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19641115|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641116|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20323268|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323269|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323270|NCT00731627|Simvastatin|simvastatin|mesh-list
20323271|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20323272|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20323273|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
20323274|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323275|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20323276|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20323277|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323278|NCT00731861|Paclitaxel|paclitaxel|mesh-list
20323279|NCT00731861|Vatalanib|vatalanib|mesh-list
20323280|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20323281|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641117|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19641118|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19641119|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641120|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19641121|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641122|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641123|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19641124|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19641125|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19641126|NCT02395510|Vortioxetine|vortioxetine|mesh-list
19641127|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156191|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20156192|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156193|NCT00106496|Tacrolimus|tacrolimus|mesh-list
20156194|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156195|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
20156196|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156197|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20156198|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156199|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156200|NCT00106522|Methotrexate|methotrexate|mesh-list
20156201|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20156202|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
20156203|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20323282|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641128|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19641129|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19641130|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19641131|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641132|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641133|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19641134|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19641135|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641136|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641137|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641138|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
19641139|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19641140|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19641141|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19641142|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19641143|NCT02395497|Antibodies|antibodies|mesh-list
19641144|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19641145|NCT02395497|Tacrolimus|tacrolimus|mesh-list
19641146|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
19641147|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256647|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
19641148|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795722|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323283|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
19834128|NCT00592124|Tenofovir|tenofovir|mesh-list
19641149|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19641150|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795723|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19795724|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19795725|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641151|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641152|NCT02395237|Glimepiride|glimepiride|mesh-list
19641153|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19641154|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19641155|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611374|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
20611375|NCT01371981|Daunorubicin|daunorubicin|mesh-list
19641156|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795726|NCT00369486|Triamcinolone|triamcinolone|mesh-list
19795727|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19795728|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19795729|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20156204|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156205|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156206|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
20156207|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156208|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156209|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156210|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156211|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20156212|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156213|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
20156214|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156215|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20156216|NCT00106548|Methotrexate|methotrexate|mesh-list
20156217|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20156218|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
20156219|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20156220|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156221|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156222|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
20156223|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156224|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611376|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
20156225|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611377|NCT01371981|Bortezomib|bortezomib|mesh-list
19641157|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
19641158|NCT02394847|Propofol|propofol|mesh-list
19641159|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19641160|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641161|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641162|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19641163|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
19641164|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
19641165|NCT02395068|Irinotecan|irinotecan|mesh-list
19641166|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
19641167|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19641168|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19641169|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795730|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19795731|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
19795732|NCT00369486|Hormones|hormones|mesh-ancestor
19795733|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795734|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795735|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19795736|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
19795737|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795738|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795739|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19795740|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795741|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19795742|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795743|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795744|NCT00369577|Loxapine|loxapine|mesh-list
19795745|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19795746|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19795747|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795748|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795749|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20611378|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
19795750|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19795751|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
19795752|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641170|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641171|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641172|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795753|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795754|NCT00369590|Aflibercept|aflibercept|mesh-list
19795755|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
19795756|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795757|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19795758|NCT00369590|Growth Substances|growth substances|mesh-ancestor
19795759|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795760|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
19795761|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795762|NCT00369629|Gemcitabine|gemcitabine|mesh-list
19795763|NCT00369629|Pemetrexed|pemetrexed|mesh-list
19641173|NCT02395016|Gemcitabine|gemcitabine|mesh-list
19641174|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
19641175|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19641176|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
19641177|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641178|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641179|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
20156226|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156227|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20156228|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156229|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
20156230|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156231|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20156232|NCT00106561|Irbesartan|irbesartan|mesh-list
20156233|NCT00106561|Spironolactone|spironolactone|mesh-list
20156234|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20156235|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
19641180|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641181|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156236|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156237|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156238|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20323284|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323285|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323286|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20323287|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323288|NCT00731926|Vitamins|vitamins|mesh-list
19795764|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156239|NCT00106561|Diuretics|diuretics|mesh-ancestor
20156240|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
20156241|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20156242|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20156243|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20156244|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156245|NCT00106587|Paclitaxel|paclitaxel|mesh-list
20156246|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20156247|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795765|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
19795766|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156248|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
20156249|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
20156250|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
20156251|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156252|NCT00106600|Pixantrone|pixantrone|mesh-list
20156253|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20156254|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20156255|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156256|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156257|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156258|NCT00106613|Romidepsin|romidepsin|mesh-list
20156259|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20156260|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156261|NCT00106691|Toremifene|toremifene|mesh-list
20156262|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20323289|NCT00731926|Ascorbic Acid|ascorbic acid|mesh-list
20323290|NCT00731926|Vitamin E|vitamin e|mesh-list
19795767|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156263|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156264|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20156265|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20156266|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
20156267|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156268|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156269|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20156270|NCT00106821|Bromides|bromides|mesh-list
20156271|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
19641182|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641183|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
19641184|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641185|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19641186|NCT02394821|Metronidazole|metronidazole|mesh-list
19641187|NCT02394821|Polihexanide|polihexanide|mesh-list
19641188|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156272|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20156273|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
20156274|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156275|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156276|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20156277|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
19641189|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19641190|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19641191|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19641192|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
19641193|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19641194|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19641195|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641196|NCT02394652|Metformin|metformin|mesh-list
19641197|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20156278|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
20156279|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20156280|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
20323291|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
20323292|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323293|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
20323294|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323295|NCT00731926|Protective Agents|protective agents|mesh-ancestor
20323296|NCT00731952|Bortezomib|bortezomib|mesh-list
20323297|NCT00731952|Vorinostat|vorinostat|mesh-list
20323298|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323299|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20323300|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323301|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323302|NCT00731965|Vaccines|vaccines|mesh-list
20323303|NCT00731965|Immunologic Factors|immunologic factors|mesh-ancestor
20323304|NCT00731965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323305|NCT00732082|Gemcitabine|gemcitabine|mesh-list
20156281|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156282|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641198|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19641199|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641200|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19641201|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641202|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
19641203|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641204|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19641205|NCT02394470|Protective Agents|protective agents|mesh-ancestor
19641206|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641207|NCT02394496|Fulvestrant|fulvestrant|mesh-list
19641208|NCT02394496|Lapatinib|lapatinib|mesh-list
19641209|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20323306|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611379|NCT01371981|Sorafenib|sorafenib|mesh-list
20611380|NCT01371981|Asparaginase|asparaginase|mesh-list
19641210|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19641211|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641212|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20611381|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611382|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641213|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19641214|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
19641215|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19641216|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641217|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611383|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20156283|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
20156284|NCT00106834|Infliximab|infliximab|mesh-list
20156285|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156286|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20156287|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323307|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
20323308|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323309|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323310|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
20323311|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323312|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323313|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611384|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20156288|NCT00106847|Infliximab|infliximab|mesh-list
20156289|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156290|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20156291|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156292|NCT00106886|Folic Acid|folic acid|mesh-list
20156293|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
20156294|NCT00106886|Pyridoxal|pyridoxal|mesh-list
20156295|NCT00106886|Pyridoxine|pyridoxine|mesh-list
20156296|NCT00106886|Vitamins|vitamins|mesh-ancestor
20156297|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
20156298|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156299|NCT00106886|Hematinics|hematinics|mesh-ancestor
20156300|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
20156301|NCT00107003|Lapatinib|lapatinib|mesh-list
20156302|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156303|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20156304|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156305|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156306|NCT00107016|Letrozole|letrozole|mesh-list
20156307|NCT00107016|Everolimus|everolimus|mesh-list
20156308|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156309|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20156310|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20156311|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156312|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156313|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20156314|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
20156315|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156316|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795768|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
19795769|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156317|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156318|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
20156319|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20156320|NCT00107081|Amoxicillin|amoxicillin|mesh-list
19795770|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795771|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156321|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
20156322|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641218|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641219|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641220|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19795772|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
20156323|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20156324|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20156325|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323314|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
20611385|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611386|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611387|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611388|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
20611389|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
20611390|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611391|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611392|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
20156326|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323315|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323316|NCT00732108|Topiramate|topiramate|mesh-list
20323317|NCT00732108|Lactulose|lactulose|mesh-list
20323318|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
20323319|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323320|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323321|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323322|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20323323|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323324|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323325|NCT00732121|Incretins|incretins|mesh-ancestor
20323326|NCT00732121|Hormones|hormones|mesh-ancestor
20323327|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323328|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20323329|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
20323330|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323331|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323332|NCT00732147|Pramlintide|pramlintide|mesh-list
20323333|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323334|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156327|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156328|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19641221|NCT02394483|Olorofim|olorofim|mesh-list
19641222|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
19641223|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641224|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
20156329|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20156330|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20156331|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156332|NCT00107107|Pramlintide|pramlintide|mesh-list
20156333|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20156334|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156335|NCT00107237|Everolimus|everolimus|mesh-list
20156336|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323335|NCT00732186|Ipilimumab|ipilimumab|mesh-list
20323336|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20323337|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323338|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20323339|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323340|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
20323341|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20323342|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20323343|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20323344|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323345|NCT00732290|Fluoxetine|fluoxetine|mesh-list
20323346|NCT00732290|Clopidogrel|clopidogrel|mesh-list
20323347|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20323348|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20323349|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20323350|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20323351|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
20156337|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156338|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
20156339|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156340|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
20156341|NCT00107263|Letrozole|letrozole|mesh-list
20156342|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156343|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20174115|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
20323352|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323353|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323354|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641225|NCT02394418|Propofol|propofol|mesh-list
20323355|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20323356|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20323357|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20323358|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
20323359|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20323360|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
20323361|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19641226|NCT02394418|Sevoflurane|sevoflurane|mesh-list
19641227|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19641228|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834129|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
19641229|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641230|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19641231|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
19641232|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
19641233|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19641234|NCT02394418|Analgesics|analgesics|mesh-ancestor
19641235|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
19641236|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611393|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611394|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611395|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611396|NCT01371981|Analgesics|analgesics|mesh-ancestor
20156344|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20156345|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156346|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156347|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20156348|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
20156349|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156350|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156351|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20156352|NCT00107341|Paclitaxel|paclitaxel|mesh-list
20156353|NCT00107341|Carboplatin|carboplatin|mesh-list
20156354|NCT00107341|Bortezomib|bortezomib|mesh-list
20156355|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20156356|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156357|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
20156358|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
20323362|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20323363|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19641237|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19641238|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19641239|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20323364|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323365|NCT00732407|Losartan|losartan|mesh-list
20323366|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20323367|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20323368|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20323369|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20323370|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611397|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
19641240|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
19641241|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641242|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641243|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19641244|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19641245|NCT02394145|Clopidogrel|clopidogrel|mesh-list
19641246|NCT02394145|Ticagrelor|ticagrelor|mesh-list
19641247|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19641248|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19641249|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19641250|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19641251|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
19641252|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641253|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641254|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641255|NCT02394158|Metformin|metformin|mesh-list
19641256|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19641257|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641258|NCT02394197|Chloroquine|chloroquine|mesh-list
19641259|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19641260|NCT02394197|Primaquine|primaquine|mesh-list
19641261|NCT02394197|Amebicides|amebicides|mesh-ancestor
19641262|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19641263|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19641264|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641265|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
19641266|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641267|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19641268|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19641269|NCT02394197|Analgesics|analgesics|mesh-ancestor
19641270|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
19641271|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795773|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795774|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19795775|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19795776|NCT00369655|Aflibercept|aflibercept|mesh-list
19795777|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
19795778|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19795779|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19641272|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641273|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641274|NCT02394197|Filaricides|filaricides|mesh-ancestor
19641275|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
19641276|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
20323371|NCT00732420|Topotecan|topotecan|mesh-list
20323372|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20323373|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20323374|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323375|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641277|NCT02394119|Rituximab|rituximab|mesh-list
19641278|NCT02394119|Ofatumumab|ofatumumab|mesh-list
19641279|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19641280|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641281|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
19641282|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641283|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641284|NCT02394106|Ofatumumab|ofatumumab|mesh-list
19641285|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641286|NCT02394015|Doxorubicin|doxorubicin|mesh-list
19641287|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19641288|NCT02394015|Trabectedin|trabectedin|mesh-list
19641289|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19641290|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641291|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19641292|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795780|NCT00369655|Growth Substances|growth substances|mesh-ancestor
19795781|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795782|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
19641293|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641294|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641295|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19641296|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
19795783|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795784|NCT00369681|Rituximab|rituximab|mesh-list
19795785|NCT00369681|Doxorubicin|doxorubicin|mesh-list
19795786|NCT00369681|Dacarbazine|dacarbazine|mesh-list
19795787|NCT00369681|Bleomycin|bleomycin|mesh-list
19795788|NCT00369681|Vinblastine|vinblastine|mesh-list
19795789|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795790|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795791|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
19795792|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795793|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795794|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19795795|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19795796|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795797|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795798|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795799|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19795800|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
20323376|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323377|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
19641297|NCT02393846|Ketoprofen|ketoprofen|mesh-list
19641298|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19641299|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19641300|NCT02393846|Analgesics|analgesics|mesh-ancestor
20323378|NCT00732446|Dexamethasone|dexamethasone|mesh-list
20323379|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
19641301|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
19641302|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641303|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795801|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19795802|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
19795803|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
19795804|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641304|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641305|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795805|NCT00369707|Rituximab|rituximab|mesh-list
19795806|NCT00369707|Bortezomib|bortezomib|mesh-list
19641306|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19641307|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641308|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641309|NCT02394093|Aspirin|aspirin|mesh-list
19641310|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19641311|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19641312|NCT02394093|Analgesics|analgesics|mesh-ancestor
19641313|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
19641314|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641315|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641316|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641317|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156359|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
19795807|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795808|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795809|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
19795810|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795811|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19795812|NCT00369746|Citalopram|citalopram|mesh-list
19795813|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20156360|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156361|NCT00107354|Cytarabine|cytarabine|mesh-list
20156362|NCT00107354|Aldesleukin|aldesleukin|mesh-list
20156363|NCT00107354|Etoposide|etoposide|mesh-list
20156364|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
20156365|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20156366|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156367|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20156368|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795814|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19795815|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795816|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795817|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795818|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
19795819|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795820|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19795821|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
19795822|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19795823|NCT00369785|Donepezil|donepezil|mesh-list
19795824|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19641318|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19641319|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19641320|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641321|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19641322|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19641323|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641324|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
19641325|NCT02393898|Paclitaxel|paclitaxel|mesh-list
19641326|NCT02393898|Bevacizumab|bevacizumab|mesh-list
19641327|NCT02393898|Carboplatin|carboplatin|mesh-list
19641328|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19641329|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641330|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641331|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641332|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641333|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795825|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795826|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795827|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
19795828|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795829|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795830|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
19795831|NCT00369915|Scopolamine|scopolamine|mesh-list
19795832|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19795833|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19795834|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
20156369|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156370|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156371|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156372|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
20156373|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
20156374|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156375|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156376|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
19641334|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19641335|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19641336|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19641337|NCT02393898|Growth Substances|growth substances|mesh-ancestor
19641338|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641339|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
19641340|NCT02394028|Etrolizumab|etrolizumab|mesh-list
19641341|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641342|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
19641343|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641344|NCT02394002|Propofol|propofol|mesh-list
19641345|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19641346|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641347|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641348|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19641349|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
19641350|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
19641351|NCT02394054|Vasopressins|vasopressins|mesh-list
19641352|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
19641353|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
19641354|NCT02394054|Coagulants|coagulants|mesh-ancestor
19641355|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19641356|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19641357|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
19641358|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641359|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
19641360|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19641361|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20156377|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156378|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20156379|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20156380|NCT00107354|Analgesics|analgesics|mesh-ancestor
20156381|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
20156382|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156383|NCT00107393|Capecitabine|capecitabine|mesh-list
20156384|NCT00107393|Trastuzumab|trastuzumab|mesh-list
20156385|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156386|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
20156387|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156388|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156389|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20156390|NCT00107419|Pemetrexed|pemetrexed|mesh-list
20156391|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156392|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156393|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156394|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20156395|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20156396|NCT00107432|Sorafenib|sorafenib|mesh-list
20156397|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156398|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20156399|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156400|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156401|NCT00107458|Valproic Acid|valproic acid|mesh-list
20156402|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
20156403|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641362|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641363|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
19641364|NCT02393963|Coagulants|coagulants|mesh-ancestor
19663353|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19663354|NCT04262869|Paclitaxel|paclitaxel|mesh-list
19663355|NCT04262869|Carboplatin|carboplatin|mesh-list
19663356|NCT04262869|Pemetrexed|pemetrexed|mesh-list
19663357|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19663358|NCT04262869|Durvalumab|durvalumab|mesh-list
19663359|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
19663360|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19663361|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
20156404|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156405|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
19663362|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19663363|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156406|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156407|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323380|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20323381|NCT00732446|BB 1101|bb 1101|mesh-list
20323382|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323383|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
20323384|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
20323385|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323386|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641365|NCT02393664|Bupivacaine|bupivacaine|mesh-list
19641366|NCT02393664|Propofol|propofol|mesh-list
19641367|NCT02393664|Sevoflurane|sevoflurane|mesh-list
20156408|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
20323387|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323388|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
20323389|NCT00732446|Hormones|hormones|mesh-ancestor
20156409|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156410|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156411|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156412|NCT00107471|Topotecan|topotecan|mesh-list
19795835|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
19795836|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795837|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795838|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323390|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323391|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20323392|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323393|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
20323394|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323395|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323396|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20323397|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611398|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641368|NCT02393664|Rocuronium|rocuronium|mesh-list
19641369|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
19641370|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
19641371|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641372|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641373|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
19795839|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
19795840|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19795841|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
19795842|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795843|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795844|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19795845|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
19795846|NCT00369941|Tenofovir|tenofovir|mesh-list
19795847|NCT00369941|Emtricitabine|emtricitabine|mesh-list
19795848|NCT00369941|Efavirenz|efavirenz|mesh-list
19795849|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
19795850|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19795851|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
20156413|NCT00107471|Lenograstim|lenograstim|mesh-list
19641374|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641375|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19641376|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19641377|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
19641378|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19795852|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795853|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19795854|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19795855|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795856|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795857|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19795858|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19795859|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20156414|NCT00107471|Sargramostim|sargramostim|mesh-list
20611399|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
20611400|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611401|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
20323398|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20323399|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20323400|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20323401|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
19795860|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19795861|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19795862|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19795863|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19795864|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19795865|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19795866|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19795867|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
19795868|NCT00369967|NuvaRing|nuvaring|mesh-list
19795869|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19795870|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795871|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19795872|NCT00370032|Alosetron|alosetron|mesh-list
19795873|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19795874|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19795875|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
19795876|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795877|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795878|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795879|NCT00370071|Interferons|interferons|mesh-list
19795880|NCT00370071|Interferon-beta|interferon-beta|mesh-list
19795881|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
19795882|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795883|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
19795884|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795885|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
19795886|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795887|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19795888|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19795889|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795890|NCT00370292|Pemetrexed|pemetrexed|mesh-list
19795891|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795892|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795893|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795894|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19795895|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19795896|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
19641379|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19641380|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19641381|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19641382|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19641383|NCT02393599|Cocaine|cocaine|mesh-list
19641384|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
19641385|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
19641386|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641387|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641388|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
19641389|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641390|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19641391|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19641392|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19641393|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641394|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641395|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
19641396|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641397|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
19641398|NCT02393482|Leuprolide|leuprolide|mesh-list
20156415|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20156416|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
20156417|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156418|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20156419|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20156420|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156421|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641399|NCT02393482|Tibolone|tibolone|mesh-list
19641400|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
19641401|NCT02393482|Hormones|hormones|mesh-list
19641402|NCT02393482|Estradiol|estradiol|mesh-list
19641403|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19641404|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323402|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641405|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19641406|NCT02393482|Estrogens|estrogens|mesh-ancestor
19641407|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641408|NCT02393482|Antacids|antacids|mesh-ancestor
19641409|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641410|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641411|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19641412|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
19641413|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19641414|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323403|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20323404|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20323405|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20323406|NCT00732485|Fenofibrate|fenofibrate|mesh-list
20323407|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20323408|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
20323409|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323410|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20323411|NCT00732511|Metoprolol|metoprolol|mesh-list
20323412|NCT00732511|Carvedilol|carvedilol|mesh-list
20323413|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20323414|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20323415|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
20323416|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
20323417|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323418|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641415|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
19641416|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
19641417|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19641418|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19641419|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
19641420|NCT02393482|Vitamins|vitamins|mesh-ancestor
19641421|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
19641422|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20156422|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156423|NCT00107510|Carboplatin|carboplatin|mesh-list
20156424|NCT00107510|Docetaxel|docetaxel|mesh-list
20156425|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156426|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
20156427|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
20156428|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
20156429|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156430|NCT00107523|Cytarabine|cytarabine|mesh-list
20156431|NCT00107523|Idarubicin|idarubicin|mesh-list
20156432|NCT00107523|Pravastatin|pravastatin|mesh-list
20156433|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156434|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
20156435|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156436|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641423|NCT02393573|Metformin|metformin|mesh-list
19641424|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19641425|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641426|NCT02393625|Nivolumab|nivolumab|mesh-list
19641427|NCT02393625|Ceritinib|ceritinib|mesh-list
20156437|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
20156438|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156439|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156440|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
20323419|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20323420|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20323421|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20323422|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
20323423|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323424|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323425|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
19641428|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19641429|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641430|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19641431|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641432|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19641433|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641434|NCT02393586|Amoxicillin|amoxicillin|mesh-list
19641435|NCT02393586|Rifampin|rifampin|mesh-list
20156441|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323426|NCT00732511|Protective Agents|protective agents|mesh-ancestor
20323427|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20323428|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20323429|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20323430|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
20323431|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20323432|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20323433|NCT00732524|Glipizide|glipizide|mesh-list
20323434|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323435|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323436|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
20323437|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20323438|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
20323439|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156442|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20156443|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19795897|NCT05288075|Charcoal|charcoal|mesh-list
19795898|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19795899|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19795900|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19795901|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
19795902|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156444|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795903|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795904|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156445|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156446|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20156447|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20156448|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20156449|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20156450|NCT00107601|Insulin|insulin|mesh-list
20156451|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323440|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641436|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19641437|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
19641438|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
19641439|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19641440|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641441|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19641442|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
19641443|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
19641444|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19641445|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641446|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641447|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19641448|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19641449|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19641450|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19641451|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19641452|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19641453|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19641454|NCT02393456|Oxytocin|oxytocin|mesh-list
19641455|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
19641456|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641457|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641458|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
19641459|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19641460|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20323441|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20323442|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
20323443|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20323444|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
20323445|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323446|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323447|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19641461|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641462|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19641463|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19641464|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
19641465|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641466|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641467|NCT02393430|Rebamipide|rebamipide|mesh-list
20156452|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323448|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
20323449|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
20323450|NCT00732537|Protective Agents|protective agents|mesh-ancestor
20323451|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20323452|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19641468|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19641469|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641470|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
19641471|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641472|NCT02393430|Protective Agents|protective agents|mesh-ancestor
20156453|NCT00107731|Valproic Acid|valproic acid|mesh-list
20156454|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20156455|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156456|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156457|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20156458|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156459|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156460|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156461|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323453|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323454|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
20323455|NCT00732576|Vitamin K|vitamin k|mesh-list
20323456|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
20323457|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20156462|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156463|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
20156464|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
20156465|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
20156466|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174116|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174117|NCT00163553|Meperidine|meperidine|mesh-list
20174118|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20174119|NCT00163553|Narcotics|narcotics|mesh-ancestor
20174120|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20174121|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323458|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20323459|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323460|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
20323461|NCT00732576|Coagulants|coagulants|mesh-ancestor
20323462|NCT00732576|Vitamins|vitamins|mesh-ancestor
20323463|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
20323464|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323465|NCT00732589|Lidocaine|lidocaine|mesh-list
19641473|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641474|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641475|NCT02393443|Oxytocin|oxytocin|mesh-list
19641476|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
19641477|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20323466|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
19641478|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641479|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
19663364|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
19663365|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
19663366|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
19663367|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663368|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663369|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19663370|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19663371|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663372|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
19663373|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663374|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
19663375|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663376|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663377|NCT04189952|Rituximab|rituximab|mesh-list
19663378|NCT04189952|Carboplatin|carboplatin|mesh-list
19663379|NCT04189952|Etoposide|etoposide|mesh-list
19663380|NCT04189952|Ifosfamide|ifosfamide|mesh-list
19663381|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
19663382|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663383|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663384|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
19663385|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663386|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663387|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19663388|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19663389|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20156467|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20156468|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156469|NCT00107796|Modafinil|modafinil|mesh-list
20156470|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20156471|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156472|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20156473|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20156474|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20156475|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156476|NCT00107809|Modafinil|modafinil|mesh-list
20156477|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20156478|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156479|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20156480|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20156481|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20156482|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156483|NCT00107822|Lidocaine|lidocaine|mesh-list
20156484|NCT00107822|Tetracaine|tetracaine|mesh-list
20156485|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
20156486|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
20156487|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156488|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323467|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
20323468|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323469|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323470|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
20323471|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323472|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20323473|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20323474|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20611402|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641480|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19641481|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19641482|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641483|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
19641484|NCT02393300|Coagulants|coagulants|mesh-ancestor
19641485|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
19641486|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19641487|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19641488|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
19641489|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
19641490|NCT02393144|Meperidine|meperidine|mesh-list
19641491|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
19641492|NCT02393144|Analgesics|analgesics|mesh-list
19641493|NCT02393144|Oxytocin|oxytocin|mesh-list
19641494|NCT02393144|Dinoprostone|dinoprostone|mesh-list
19641495|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
19641496|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19663390|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663391|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663392|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19663393|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
19663394|NCT04182360|Carbetocin|carbetocin|mesh-list
19663395|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
19663396|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19663397|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663398|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
19663399|NCT04064814|Flunarizine|flunarizine|mesh-list
19663400|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
19663401|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663402|NCT04064814|Protective Agents|protective agents|mesh-ancestor
19663403|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663404|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
19663405|NCT04064814|Vitamins|vitamins|mesh-ancestor
19663406|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
19663407|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
19663408|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19663409|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663410|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19663411|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19663412|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
19663413|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
19663414|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663415|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
19663416|NCT04039230|Talazoparib|talazoparib|mesh-list
20156489|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
20156490|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156491|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20156492|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19641497|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641498|NCT02393144|Narcotics|narcotics|mesh-ancestor
19641499|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795905|NCT05288075|Antidotes|antidotes|mesh-ancestor
19795906|NCT05288075|Protective Agents|protective agents|mesh-ancestor
19795907|NCT05287633|Esomeprazole|esomeprazole|mesh-list
19795908|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19795909|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19795910|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19641500|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
19641501|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641502|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19641503|NCT02393157|Carboplatin|carboplatin|mesh-list
19641504|NCT02393157|Etoposide|etoposide|mesh-list
19641505|NCT02393157|Ifosfamide|ifosfamide|mesh-list
19641506|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
19641507|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641508|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19641509|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19641510|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19641511|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641512|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641513|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19641514|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
19641515|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19641516|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19641517|NCT02392910|Hematinics|hematinics|mesh-ancestor
19641518|NCT02392845|Docetaxel|docetaxel|mesh-list
19641519|NCT02392845|Epirubicin|epirubicin|mesh-list
19641520|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641521|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641522|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641523|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641524|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641525|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19641526|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19641527|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19641528|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641529|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
19795911|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795912|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795913|NCT05287607|Bilirubin|bilirubin|mesh-list
19795914|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
19795915|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156493|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19641530|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19641531|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20156494|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20156495|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156496|NCT00107835|Lidocaine|lidocaine|mesh-list
20156497|NCT00107835|Tetracaine|tetracaine|mesh-list
20156498|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
20323475|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20323476|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323477|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20323478|NCT00732693|Norethindrone|norethindrone|mesh-list
20323479|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
20323480|NCT00732693|Estradiol|estradiol|mesh-list
20156499|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
20156500|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156501|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156502|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
20156503|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156504|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20156505|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20156506|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20156507|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174122|NCT00163553|Analgesics|analgesics|mesh-ancestor
19641532|NCT02392780|Prednisolone|prednisolone|mesh-list
19641533|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
20156508|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641534|NCT02392780|Cannabidiol|cannabidiol|mesh-list
19641535|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20156509|NCT00107848|Modafinil|modafinil|mesh-list
20156510|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20156511|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156512|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19641536|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
19641537|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19641538|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641539|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
19641540|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
19641541|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641542|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641543|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641544|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
19641545|NCT02392780|Hormones|hormones|mesh-ancestor
20156513|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19641546|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19641547|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19641548|NCT02392780|Protective Agents|protective agents|mesh-ancestor
19641549|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19641550|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641551|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
19641552|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641553|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641554|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
19641555|NCT02393066|Propofol|propofol|mesh-list
19641556|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19641557|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641558|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641559|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19641560|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
19641561|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
19641562|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19641563|NCT02393066|Analgesics|analgesics|mesh-ancestor
19641564|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
19641565|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641566|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20611403|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641567|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19641568|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19641569|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
19641570|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641571|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641572|NCT02392793|Irinotecan|irinotecan|mesh-list
19641573|NCT02392793|Temozolomide|temozolomide|mesh-list
19641574|NCT02392793|Talazoparib|talazoparib|mesh-list
19641575|NCT02392793|Lenograstim|lenograstim|mesh-list
19641576|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19641577|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19641578|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156514|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20156515|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156516|NCT00107874|Misoprostol|misoprostol|mesh-list
20156517|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20611404|NCT01366144|Paclitaxel|paclitaxel|mesh-list
20611405|NCT01366144|Carboplatin|carboplatin|mesh-list
20611406|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20611407|NCT01366144|Veliparib|veliparib|mesh-list
20611408|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611409|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611410|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611411|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611412|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641579|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611413|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641580|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641581|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19641582|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
19641583|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641584|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19641585|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
19641586|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19641587|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19641588|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19641589|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
19641590|NCT02392520|Cetrorelix|cetrorelix|mesh-list
19641591|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19641592|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
19641593|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641594|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641595|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
19641596|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19641597|NCT02392702|Ivacaftor|ivacaftor|mesh-list
19641598|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19641599|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611414|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20611415|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611416|NCT01309191|Minoxidil|minoxidil|mesh-list
20611417|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20611418|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
20611419|NCT01236560|Bevacizumab|bevacizumab|mesh-list
20611420|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19795916|NCT05287607|Protective Agents|protective agents|mesh-ancestor
19795917|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795918|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19795919|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795920|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795921|NCT05287503|Ambroxol|ambroxol|mesh-list
19795922|NCT05287503|Expectorants|expectorants|mesh-ancestor
19795923|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
20611421|NCT01236560|Temozolomide|temozolomide|mesh-list
20156518|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
20156519|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20156520|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156521|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20156522|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20156523|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
20156524|NCT00108004|Pramlintide|pramlintide|mesh-list
20156525|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19641600|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641601|NCT02392468|BI 409306|bi 409306|mesh-list
19641602|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19641603|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641604|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641605|NCT02392364|Aflibercept|aflibercept|mesh-list
19795924|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
19795925|NCT05287464|Nivolumab|nivolumab|mesh-list
19795926|NCT05287464|Ipilimumab|ipilimumab|mesh-list
19795927|NCT05287464|Avelumab|avelumab|mesh-list
19795928|NCT05287464|Atezolizumab|atezolizumab|mesh-list
19795929|NCT05287464|Lenvatinib|lenvatinib|mesh-list
19795930|NCT05287464|Axitinib|axitinib|mesh-list
19795931|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19795932|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19795933|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19795934|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795935|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19795936|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795937|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
19795938|NCT05287425|Gentamicins|gentamicins|mesh-list
19795939|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19795940|NCT05287425|Povidone|povidone|mesh-list
19795941|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19795942|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19795943|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19795944|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19795945|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156526|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795946|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156527|NCT00108017|Timolol|timolol|mesh-list
19795947|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611422|NCT01236560|Vorinostat|vorinostat|mesh-list
19641606|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19641607|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19641608|NCT02392364|Growth Substances|growth substances|mesh-ancestor
19641609|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641610|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
19641611|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641612|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19641613|NCT02392676|Olaparib|olaparib|mesh-list
19641614|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19641615|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641616|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641617|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641618|NCT02392117|Insulin|insulin|mesh-list
19641619|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19641620|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641621|NCT02392039|Loratadine|loratadine|mesh-list
19641622|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
19641623|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
19641624|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19641625|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19641626|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19641627|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
19641628|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
19641629|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641630|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641631|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641632|NCT02392130|Clobetasol|clobetasol|mesh-list
19795948|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19795949|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19795950|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19795951|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
19641633|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641634|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
19641635|NCT02392130|Hormones|hormones|mesh-ancestor
19641636|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19641637|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641638|NCT02392156|Factor VIII|factor viii|mesh-list
19641639|NCT02392156|Coagulants|coagulants|mesh-ancestor
19641640|NCT02392169|Methylphenidate|methylphenidate|mesh-list
19641641|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19641642|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641643|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19641644|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19641645|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641646|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641647|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
19641648|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663417|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19663418|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663419|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663420|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663421|NCT03998735|Lobeline|lobeline|mesh-list
19663422|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19663423|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
19663424|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663425|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663426|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19663427|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20156528|NCT00108017|Dorzolamide|dorzolamide|mesh-list
20156529|NCT00108017|Maleic acid|maleic acid|mesh-list
20156530|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19663428|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
19795952|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
19795953|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19795954|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
19795955|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
19795956|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19795957|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19795958|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19663429|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663430|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795959|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795960|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323481|NCT00732693|Progesterone|progesterone|mesh-list
20323482|NCT00732693|Estrogens|estrogens|mesh-ancestor
19795961|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641649|NCT02391844|Oxycodone|oxycodone|mesh-list
19795962|NCT05287256|Dronabinol|dronabinol|mesh-list
19795963|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
19795964|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795965|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19641650|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19641651|NCT02391844|Narcotics|narcotics|mesh-ancestor
19641652|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641653|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641654|NCT02391844|Analgesics|analgesics|mesh-ancestor
19641655|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
19641656|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641657|NCT02391883|Clopidogrel|clopidogrel|mesh-list
20156531|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19795966|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19795967|NCT05287256|Analgesics|analgesics|mesh-ancestor
19795968|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
19795969|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795970|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19795971|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19795972|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19795973|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19795974|NCT05287256|Hormones|hormones|mesh-ancestor
19795975|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19795976|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
20156532|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
20156533|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156534|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156535|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156536|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19641658|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19641659|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19641660|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19641661|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19641662|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
20156537|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20156538|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156539|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20156540|NCT00108095|Ondansetron|ondansetron|mesh-list
20156541|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
20156542|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
20156543|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156544|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156545|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20156546|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
20323483|NCT00732693|Hormones|hormones|mesh-ancestor
19641663|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641664|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641665|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641666|NCT02391805|Tenofovir|tenofovir|mesh-list
19641667|NCT02391805|Entecavir|entecavir|mesh-list
19641668|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
19641669|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641670|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19641671|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19641672|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641673|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641674|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19641675|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19641676|NCT02391662|Gemcitabine|gemcitabine|mesh-list
19641677|NCT02391662|Paclitaxel|paclitaxel|mesh-list
19641678|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19641679|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19641680|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641681|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641682|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641683|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641684|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641685|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19795977|NCT05287191|Digoxin|digoxin|mesh-list
19795978|NCT05287191|Amiodarone|amiodarone|mesh-list
20347642|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641686|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
19641687|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
19641688|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641689|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641690|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641691|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
19641692|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641693|NCT02391688|Fexofenadine|fexofenadine|mesh-list
19641694|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
19641695|NCT02391688|Midazolam|midazolam|mesh-list
19641696|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
19641697|NCT02391688|Caffeine|caffeine|mesh-list
19641698|NCT02391688|Bupropion|bupropion|mesh-list
19641699|NCT02391688|Omeprazole|omeprazole|mesh-list
19641700|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19641701|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19795979|NCT05287191|Analgesics|analgesics|mesh-ancestor
19795980|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
19641702|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641703|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641704|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19641705|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156547|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156548|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20156549|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
20156550|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156551|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156552|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20156553|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156554|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156555|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156556|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20156557|NCT00108186|Celecoxib|celecoxib|mesh-list
20156558|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20323484|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323485|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323486|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20323487|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
20323488|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20156559|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20156560|NCT00108186|Analgesics|analgesics|mesh-ancestor
20156561|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
20156562|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156563|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156564|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20156565|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156566|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20156567|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20156568|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156569|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156570|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20323489|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20156571|NCT00108238|Estradiol|estradiol|mesh-list
19795981|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19795982|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19795983|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
19795984|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19795985|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19795986|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
19795987|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19795988|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19795989|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323490|NCT00732693|Progestins|progestins|mesh-ancestor
20323491|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19641706|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19641707|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19641708|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
19795990|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19795991|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
19795992|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19795993|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20156572|NCT00108238|Progesterone|progesterone|mesh-list
20156573|NCT00108238|Estrogens|estrogens|mesh-ancestor
20156574|NCT00108238|Hormones|hormones|mesh-ancestor
20156575|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156576|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156577|NCT00108238|Progestins|progestins|mesh-ancestor
20156578|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20156579|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
20156580|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20156581|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20156582|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20156583|NCT00108251|Eplerenone|eplerenone|mesh-list
20156584|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20156585|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
20156586|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156587|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156588|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20156589|NCT00108251|Diuretics|diuretics|mesh-ancestor
20156590|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
20156591|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20156592|NCT00108316|Fluoxetine|fluoxetine|mesh-list
19795994|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19795995|NCT05287191|Protective Agents|protective agents|mesh-ancestor
19795996|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
19795997|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19795998|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19795999|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19796000|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19796001|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19796002|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19796003|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19796004|NCT05287100|Midodrine|midodrine|mesh-list
19796005|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
19796006|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
19796007|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796008|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796009|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19796010|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19796011|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19796012|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19796013|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
19796014|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796015|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796016|NCT05287035|Dexamethasone|dexamethasone|mesh-list
19796017|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
19796018|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796019|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
19796020|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
19796021|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796022|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796023|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19796024|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
19796025|NCT05287035|Hormones|hormones|mesh-ancestor
19796026|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796027|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19796028|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796029|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
19796030|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19796031|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796032|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19796033|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20156593|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20156594|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20156595|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19796034|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796035|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796036|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796037|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19641709|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
19796038|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19796039|NCT05286801|Atezolizumab|atezolizumab|mesh-list
19796040|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19796041|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796042|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
19796043|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834130|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834131|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19834132|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19641710|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
19641711|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
19641712|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641713|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641714|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19641715|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641716|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19641717|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641718|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19641719|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19641720|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19641721|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19641722|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
19641723|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19641724|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
19641725|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19641726|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19641727|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641728|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
19641729|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19641730|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19641731|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
19641732|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
19641733|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19641734|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19641735|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19641736|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19641737|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19641738|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
20156596|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156597|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156598|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
20156599|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156600|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20156601|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156602|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156603|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20156604|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19641739|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
19641740|NCT02391688|Analgesics|analgesics|mesh-ancestor
19834133|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834134|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834135|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19834136|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19834137|NCT00592176|Bevacizumab|bevacizumab|mesh-list
19641741|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
20156605|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156606|NCT00108368|Olanzapine|olanzapine|mesh-list
20156607|NCT00108368|Risperidone|risperidone|mesh-list
20156608|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19641742|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156609|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
20156610|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156611|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156612|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641743|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19641744|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19641745|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641746|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834138|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834139|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156613|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20156614|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156615|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156616|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156617|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19641747|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20156618|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
20156619|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
20156620|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
20156621|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156622|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20156623|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20156624|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20156625|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20156626|NCT00108394|Pamidronate|pamidronate|mesh-list
19641748|NCT02391636|Oxytocin|oxytocin|mesh-list
19641749|NCT02391636|Carbetocin|carbetocin|mesh-list
19641750|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
19641751|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641752|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641753|NCT02391480|Venetoclax|venetoclax|mesh-list
19641754|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641755|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19641756|NCT02391181|Hematinics|hematinics|mesh-ancestor
19641757|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19641758|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
19641759|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
19641760|NCT02391077|Povidone|povidone|mesh-list
19641761|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641762|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19641763|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
19641764|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
19641765|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
19641766|NCT02391142|Lidocaine|lidocaine|mesh-list
19641767|NCT02391142|Ropivacaine|ropivacaine|mesh-list
20156627|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20156628|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156629|NCT00108420|Prazosin|prazosin|mesh-list
20156630|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20156631|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20156632|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20156633|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20156634|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
20156635|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156636|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156637|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156638|NCT00108446|Lidocaine|lidocaine|mesh-list
20156639|NCT00108446|Fentanyl|fentanyl|mesh-list
20156640|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
20156641|NCT00108446|Naloxone|naloxone|mesh-list
20156642|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
20156643|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
20156644|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156645|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323492|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20323493|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20156646|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
19641768|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
19641769|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
19641770|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641771|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156647|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323494|NCT00732745|Docetaxel|docetaxel|mesh-list
19641772|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
19641773|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641774|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20323495|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
20156648|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19796044|NCT05286619|Gemcitabine|gemcitabine|mesh-list
19796045|NCT05286619|Carboplatin|carboplatin|mesh-list
19796046|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
19796047|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796048|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19796049|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
19796050|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796051|NCT05286619|Antiviral Agents|antiviral agents|mesh-ancestor
19796052|NCT05286619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796053|NCT05286619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796054|NCT05286619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796055|NCT05286619|Immunologic Factors|immunologic factors|mesh-ancestor
19796056|NCT05286619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796057|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796058|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
19796059|NCT05286528|Dasatinib|dasatinib|mesh-list
19796060|NCT05286528|Ponatinib|ponatinib|mesh-list
19796061|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796062|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20156649|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20156650|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19796063|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796064|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796065|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
19796066|NCT05286437|Letrozole|letrozole|mesh-list
19796067|NCT05286437|Lenvatinib|lenvatinib|mesh-list
19796068|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796069|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323496|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323497|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
20323498|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
20323499|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323500|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641775|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19641776|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19641777|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641778|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641779|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19641780|NCT02390921|Hematinics|hematinics|mesh-ancestor
19641781|NCT02390882|Tamsulosin|tamsulosin|mesh-list
20156651|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641782|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19641783|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19641784|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19641785|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
19641786|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641787|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641788|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641789|NCT02390882|Urological Agents|urological agents|mesh-ancestor
19641790|NCT02390700|Golimumab|golimumab|mesh-list
19641791|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19796070|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20156652|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156653|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20156654|NCT00108446|Narcotics|narcotics|mesh-ancestor
20156655|NCT00108446|Analgesics|analgesics|mesh-ancestor
20156656|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20156657|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19796071|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19796072|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796073|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796074|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19796075|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
19796076|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796077|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796078|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19796079|NCT05286346|Tenofovir|tenofovir|mesh-list
19796080|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
19796081|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796082|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19796083|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19796084|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796085|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796086|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19796087|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19796088|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
19796089|NCT05286320|Lenvatinib|lenvatinib|mesh-list
19796090|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796091|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796092|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19796093|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796094|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796095|NCT05286268|Plasminogen|plasminogen|mesh-list
19796096|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19796097|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19796098|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156658|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
20156659|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20323501|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
20323502|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
20323503|NCT00732784|Calcium|calcium|mesh-list
20323504|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19641792|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641793|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641794|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
19641795|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641796|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
19641797|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20323505|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323506|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156660|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
20156661|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
20156662|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20156663|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20156664|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156665|NCT00108498|Mirtazapine|mirtazapine|mesh-list
20156666|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156667|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156668|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20323507|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20323508|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323509|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641798|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19641799|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641800|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
19641801|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
19641802|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641803|NCT02390674|Cyclosporine|cyclosporine|mesh-list
19641804|NCT02390674|Cyclosporins|cyclosporins|mesh-list
19641805|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641806|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641807|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641808|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
19641809|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641810|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
19641811|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641812|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
19641813|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641814|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20323510|NCT00732784|Antacids|antacids|mesh-ancestor
20323511|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323512|NCT00732810|Capecitabine|capecitabine|mesh-list
20323513|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20323514|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20323515|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
20323516|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323517|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323518|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20323519|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323520|NCT00732836|Paclitaxel|paclitaxel|mesh-list
20323521|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20323522|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20323523|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323524|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
20323525|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
20323526|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323527|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323528|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
20323529|NCT00732888|Calcium|calcium|mesh-list
20323530|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20323531|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323532|NCT00732888|Antacids|antacids|mesh-ancestor
20323533|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323534|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323535|NCT00732914|Sorafenib|sorafenib|mesh-list
20323536|NCT00732914|Sunitinib|sunitinib|mesh-list
20323537|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323538|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20323539|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323540|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323541|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20323542|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20323543|NCT00732914|Growth Substances|growth substances|mesh-ancestor
20323544|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323545|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
20323546|NCT00732927|Aspirin|aspirin|mesh-list
20323547|NCT00732927|Parnaparin|parnaparin|mesh-list
20323548|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20323549|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20323550|NCT00732927|Analgesics|analgesics|mesh-ancestor
20323551|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
20323552|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323553|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323554|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796099|NCT05286008|Dexamethasone|dexamethasone|mesh-list
19796100|NCT05286008|Ropivacaine|ropivacaine|mesh-list
19796101|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796102|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
19796103|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
19796104|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796105|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796106|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19796107|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
19796108|NCT05286008|Hormones|hormones|mesh-ancestor
19796109|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796110|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19796111|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796112|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
19796113|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
20323555|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323556|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20323557|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19641815|NCT02390739|Aldesleukin|aldesleukin|mesh-list
19641816|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
19641817|NCT02390739|Fludarabine|fludarabine|mesh-list
19641818|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641819|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
19641820|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641821|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641822|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19641823|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
19641824|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641825|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641826|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19641827|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20156669|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
20156670|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
20156671|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156672|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156673|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156674|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20156675|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156676|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156677|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20156678|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20323558|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796114|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796115|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
19796116|NCT05285943|Betamethasone|betamethasone|mesh-list
19796117|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
19796118|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19796119|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
19796120|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19796121|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796122|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
19796123|NCT05285943|Hormones|hormones|mesh-ancestor
19796124|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796125|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796126|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19796127|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
19796128|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
19796129|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
19796130|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796131|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19796132|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19796133|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796134|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156679|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20156680|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
20323559|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20323560|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19641828|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19641829|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
19641830|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641831|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
19641832|NCT02390843|Topotecan|topotecan|mesh-list
19641833|NCT02390843|Simvastatin|simvastatin|mesh-list
19641834|NCT02390843|Sargramostim|sargramostim|mesh-list
19641835|NCT02390843|Lenograstim|lenograstim|mesh-list
19641836|NCT02390843|Mitogens|mitogens|mesh-list
19641837|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641838|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
19641839|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641840|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641841|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19641842|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
20323561|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323562|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
20323563|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
20323564|NCT00732953|Paclitaxel|paclitaxel|mesh-list
20323565|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20323566|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323567|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641843|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641844|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641845|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19641846|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19641847|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19641848|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
19641849|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19641850|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19641851|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641852|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19641853|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19641854|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641855|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19641856|NCT02390544|Melphalan|melphalan|mesh-list
19641857|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20323568|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19796135|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
19796136|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641858|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
19641859|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641860|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641861|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19641862|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641863|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
19641864|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323569|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323570|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156681|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20156682|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20156683|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
20156684|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20156685|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
20156686|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20156687|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
20156688|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156689|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20156690|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20156691|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20156692|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156693|NCT00108537|Bupropion|bupropion|mesh-list
20156694|NCT00108537|Nicotine|nicotine|mesh-list
20156695|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20156696|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
20156697|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156698|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156699|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20156700|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20156701|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
20156702|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156703|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156704|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20156705|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156706|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156707|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20156708|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20156709|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20156710|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
20156711|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20156712|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20156713|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156714|NCT00108563|Citalopram|citalopram|mesh-list
20156715|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20156716|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20156717|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20156718|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156719|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156720|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
20156721|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156722|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20156723|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156724|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156725|NCT00108576|Valproic Acid|valproic acid|mesh-list
20323571|NCT00732966|Losartan|losartan|mesh-list
20323572|NCT00732966|Valsartan|valsartan|mesh-list
20323573|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20323574|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20323575|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20323576|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323577|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20323578|NCT00733031|Gemcitabine|gemcitabine|mesh-list
20323579|NCT00733031|Pemetrexed|pemetrexed|mesh-list
20156726|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
20156727|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156728|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323580|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156729|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
20323581|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
20156730|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156731|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156732|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
20156733|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156734|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156735|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156736|NCT00108602|Acetazolamide|acetazolamide|mesh-list
20156737|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
20156738|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20156739|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156740|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156741|NCT00108602|Diuretics|diuretics|mesh-ancestor
20156742|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
20156743|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156744|NCT00108615|Metformin|metformin|mesh-list
20156745|NCT00108615|Pioglitazone|pioglitazone|mesh-list
20156746|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19796137|NCT05285787|Vitamin MK 7|vitamin mk 7|mesh-list
19796138|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
19796139|NCT05285787|Coagulants|coagulants|mesh-ancestor
19796140|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19796141|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19796142|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796143|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
19796144|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796145|NCT05250050|Amoxicillin|amoxicillin|mesh-list
19796146|NCT05250050|Metronidazole|metronidazole|mesh-list
19796147|NCT05250050|Clarithromycin|clarithromycin|mesh-list
19796148|NCT05250050|Levofloxacin|levofloxacin|mesh-list
19796149|NCT05250050|Tetracycline|tetracycline|mesh-list
19796150|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
19796151|NCT05250050|Esomeprazole|esomeprazole|mesh-list
19796152|NCT05250050|Bismuth|bismuth|mesh-list
19796153|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796154|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20156747|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156748|NCT00108667|Levodopa|levodopa|mesh-list
20156749|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20156750|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20156751|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
20156752|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156753|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156754|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156755|NCT00108706|Candesartan|candesartan|mesh-list
20156756|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20156757|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20156758|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20156759|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156760|NCT00108771|Fentanyl|fentanyl|mesh-list
20156761|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20156762|NCT00108771|Narcotics|narcotics|mesh-ancestor
20156763|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20156764|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156765|NCT00108771|Analgesics|analgesics|mesh-ancestor
20156766|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
20156767|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156768|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20156769|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20156770|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
20156771|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
20156772|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
20156773|NCT00108797|Coagulants|coagulants|mesh-ancestor
20156774|NCT00108849|Estradiol|estradiol|mesh-list
20156775|NCT00108849|Estrogens|estrogens|mesh-ancestor
20156776|NCT00108849|Hormones|hormones|mesh-ancestor
20156777|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156778|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156779|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
20156780|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20156781|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
20156782|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796155|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156783|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156784|NCT00108979|Citalopram|citalopram|mesh-list
20156785|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19796156|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19796157|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20323582|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323583|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323584|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
20323585|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641865|NCT02390817|Neostigmine|neostigmine|mesh-list
19641866|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20156786|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20156787|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20156788|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156789|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156790|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
20156791|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156792|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20156793|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156794|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156795|NCT00108992|Diclofenac|diclofenac|mesh-list
20156796|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20156797|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20156798|NCT00108992|Analgesics|analgesics|mesh-ancestor
20156799|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
19641867|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641868|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641869|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
19641870|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19641871|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641872|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19641873|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
19641874|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641875|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19641876|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641877|NCT02390505|Ascorbic Acid|ascorbic acid|mesh-list
19641878|NCT02390505|Vitamins|vitamins|mesh-ancestor
20156800|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156801|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156802|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20156803|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641879|NCT02390505|Micronutrients|micronutrients|mesh-ancestor
20156804|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20156805|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156806|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156807|NCT00109044|Citalopram|citalopram|mesh-list
19796158|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19796159|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641880|NCT02390505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796160|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19641881|NCT02390505|Antioxidants|antioxidants|mesh-ancestor
19641882|NCT02390505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641883|NCT02390505|Protective Agents|protective agents|mesh-ancestor
19641884|NCT02390440|Bupivacaine|bupivacaine|mesh-list
19641885|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
19641886|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
19641887|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641888|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641889|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
19641890|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641891|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19641892|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19641893|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19641894|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
19641895|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641896|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19641897|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19641898|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641899|NCT02390258|S66913|s66913|mesh-list
19641900|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19641901|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641902|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641903|NCT02390310|Lidocaine|lidocaine|mesh-list
19641904|NCT02390310|Prilocaine|prilocaine|mesh-list
19796161|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796162|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19641905|NCT02390310|Anesthetics|anesthetics|mesh-list
19641906|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
20323586|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323587|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323588|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
20323589|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323590|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20323591|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20323592|NCT00733057|Minocycline|minocycline|mesh-list
20323593|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20323594|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323595|NCT00733083|Dexamethasone|dexamethasone|mesh-list
20323596|NCT00733083|Morphine|morphine|mesh-list
20323597|NCT00733083|Oxycodone|oxycodone|mesh-list
20323598|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323599|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
20323600|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
20323601|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641907|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19641908|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641909|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
19641910|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641911|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19641912|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19641913|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19641914|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19641915|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663431|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
19663432|NCT03981952|Vaccines|vaccines|mesh-list
19663433|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
19663434|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663435|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
19663436|NCT03968939|Promethazine|promethazine|mesh-list
19663437|NCT03968939|Melatonin|melatonin|mesh-list
19663438|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
19663439|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663440|NCT03968939|Protective Agents|protective agents|mesh-ancestor
19663441|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663442|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663443|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19663444|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19663445|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
19663446|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
19663447|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
19663448|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663449|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
19663450|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
19663451|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19663452|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19663453|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
19663454|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
19663455|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663456|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19663457|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
19663458|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
19663459|NCT03959891|Letrozole|letrozole|mesh-list
19663460|NCT03959891|Fulvestrant|fulvestrant|mesh-list
19663461|NCT03959891|Palbociclib|palbociclib|mesh-list
19663462|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19663463|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663464|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19663465|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663466|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663467|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19663468|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
19663469|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663470|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663471|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19663472|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19663473|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19663474|NCT03950609|Everolimus|everolimus|mesh-list
19663475|NCT03950609|Lenvatinib|lenvatinib|mesh-list
19663476|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663477|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663478|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
19663479|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323602|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323603|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20323604|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
20323605|NCT00733083|Hormones|hormones|mesh-ancestor
20323606|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323607|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20323608|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323609|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20323610|NCT00733083|Narcotics|narcotics|mesh-ancestor
20323611|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323612|NCT00733083|Analgesics|analgesics|mesh-ancestor
20323613|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
20323614|NCT00733148|Insulin|insulin|mesh-list
20323615|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323616|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323617|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
20323618|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323619|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347643|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347644|NCT00861367|Aspirin|aspirin|mesh-list
20347645|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20347646|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20347647|NCT00861367|Analgesics|analgesics|mesh-ancestor
20347648|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
20347649|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347650|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347651|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347652|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20347653|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20347654|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20347655|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347656|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20347657|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20347658|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347659|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
20347660|NCT00861406|Interferons|interferons|mesh-list
20347661|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
20347662|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
20347663|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20347664|NCT00861406|Vaccines|vaccines|mesh-list
20347665|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
20347666|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347667|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347668|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
20347669|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19641916|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
19641917|NCT02390102|Hematinics|hematinics|mesh-ancestor
19641918|NCT02390089|Capsaicin|capsaicin|mesh-list
19641919|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
19641920|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
19641921|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
19641922|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641923|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641924|NCT02389842|Palbociclib|palbociclib|mesh-list
19641925|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641926|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19641927|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156808|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20156809|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20156810|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20156811|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156812|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156813|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
20156814|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156815|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20156816|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
20156817|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156818|NCT00109057|Bevacizumab|bevacizumab|mesh-list
20156819|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20156820|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156821|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20347670|NCT00861419|Niacinamide|niacinamide|mesh-list
20347671|NCT00861419|Bevacizumab|bevacizumab|mesh-list
19641928|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347672|NCT00861419|Sunitinib|sunitinib|mesh-list
20347673|NCT00861419|Trebananib|trebananib|mesh-list
19796163|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19796164|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19796165|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19796166|NCT05250050|Renal Agents|renal agents|mesh-ancestor
19796167|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19641929|NCT02389972|Dasatinib|dasatinib|mesh-list
19641930|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641931|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19641932|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641933|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641934|NCT02389751|Paclitaxel|paclitaxel|mesh-list
19641935|NCT02389751|Carboplatin|carboplatin|mesh-list
19641936|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19641937|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19641938|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796168|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19796169|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796170|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19796171|NCT05250050|Antacids|antacids|mesh-ancestor
19796172|NCT05250050|Diuretics|diuretics|mesh-ancestor
19796173|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
19796174|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796175|NCT05250050|Expectorants|expectorants|mesh-ancestor
19796176|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
19796177|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
19796178|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19796179|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19796180|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796181|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
19796182|NCT05248321|Coagulants|coagulants|mesh-ancestor
19796183|NCT05225805|Lefamulin|lefamulin|mesh-list
19796184|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19796185|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796186|NCT05220462|Midazolam|midazolam|mesh-list
19796187|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19796188|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19796189|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796190|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796191|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19796192|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19796193|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19796194|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19796195|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
19796196|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
19796197|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
19796198|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
19796199|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796200|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641939|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
19641940|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
19641941|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
19641942|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641943|NCT02389868|Lovastatin|lovastatin|mesh-list
19641944|NCT02389868|L 647318|l 647318|mesh-list
19641945|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
19641946|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19796201|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
19796202|NCT05219604|Promethazine|promethazine|mesh-list
19796203|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19796204|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19796205|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796206|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796207|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
19796208|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
19796209|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
19796210|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641947|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19796211|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
19796212|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
19796213|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19796214|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19796215|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
19641948|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
19796216|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
20323620|NCT00733239|Cycloserine|cycloserine|mesh-list
19796217|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796218|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796219|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19796220|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
19796221|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
19796222|NCT05206955|Tadalafil|tadalafil|mesh-list
19796223|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
19796224|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19796225|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19796226|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796227|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796228|NCT05206955|Urological Agents|urological agents|mesh-ancestor
19796229|NCT05189756|Aprepitant|aprepitant|mesh-list
19796230|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
19796231|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
19796232|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
19796233|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796234|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796235|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641949|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641950|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19641951|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19641952|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641953|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
19796236|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19796237|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796238|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796239|NCT05187286|Apixaban|apixaban|mesh-list
19796240|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19796241|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
19796242|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19796243|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
19796244|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796245|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796246|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
19796247|NCT05183035|Cytarabine|cytarabine|mesh-list
19796248|NCT05183035|Fludarabine|fludarabine|mesh-list
19796249|NCT05183035|Azacitidine|azacitidine|mesh-list
19796250|NCT05183035|Venetoclax|venetoclax|mesh-list
19796251|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
19796252|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796253|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19796254|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
19796255|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796256|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796257|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
19641954|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19641955|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
19641956|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641957|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19641958|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19641959|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
19641960|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641961|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641962|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19641963|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19641964|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19641965|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641966|NCT02389582|Enoxaparin|enoxaparin|mesh-list
19641967|NCT02389582|Dabigatran|dabigatran|mesh-list
19641968|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
20156822|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20156823|NCT00109057|Growth Substances|growth substances|mesh-ancestor
20156824|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156825|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
20156826|NCT00109070|Bevacizumab|bevacizumab|mesh-list
20156827|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19641969|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19641970|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19796258|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156828|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323621|NCT00733239|Verapamil|verapamil|mesh-list
19796259|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
19796260|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796261|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796262|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796263|NCT05171049|Apixaban|apixaban|mesh-list
19796264|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19796265|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
19796266|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19796267|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
19796268|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641971|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641972|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
19641973|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19641974|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
19641975|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19641976|NCT02389543|Dexamethasone|dexamethasone|mesh-list
19641977|NCT02389543|Lenalidomide|lenalidomide|mesh-list
19641978|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19641979|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
19641980|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
19796269|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19641981|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19641982|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641983|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19641984|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
19641985|NCT02389543|Hormones|hormones|mesh-ancestor
19796270|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
19796271|NCT05169957|Nivolumab|nivolumab|mesh-list
19796272|NCT05169957|Ipilimumab|ipilimumab|mesh-list
19796273|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796274|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796275|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19796276|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796277|NCT05165966|Vaccines|vaccines|mesh-list
19796278|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
19796279|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796280|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
19796281|NCT05156268|Olaparib|olaparib|mesh-list
19796282|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796283|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796284|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19796285|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796286|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796287|NCT05146739|Vidarabine|vidarabine|mesh-list
19796288|NCT05146739|Cytarabine|cytarabine|mesh-list
19796289|NCT05146739|Fludarabine|fludarabine|mesh-list
19796290|NCT05146739|Fludarabine phosphate|fludarabine phosphate|mesh-list
19796291|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796292|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19796293|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
19796294|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796295|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796296|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
19796297|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796298|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
19796299|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796300|NCT05143502|Fluticasone|fluticasone|mesh-list
19796301|NCT05143502|Xhance|xhance|mesh-list
19796302|NCT05143502|Prednisolone|prednisolone|mesh-list
19641986|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19641987|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19641988|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19641989|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
19641990|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19641991|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19641992|NCT02389543|Growth Substances|growth substances|mesh-ancestor
19796303|NCT05143502|Montelukast|montelukast|mesh-list
19796304|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796305|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19796306|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
20156829|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20156830|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20156831|NCT00109070|Growth Substances|growth substances|mesh-ancestor
20156832|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156833|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
20156834|NCT00109096|Pemetrexed|pemetrexed|mesh-list
20156835|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796307|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156836|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796308|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796309|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19796310|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
19796311|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
19796312|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19796313|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
19796314|NCT05143502|Hormones|hormones|mesh-ancestor
19796315|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796316|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19796317|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796318|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19796319|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
19796320|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19796321|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19796322|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796323|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
19796324|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
19796325|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19796326|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796327|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796328|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
19796329|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19796330|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796331|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834140|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19834141|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19834142|NCT00592176|Growth Substances|growth substances|mesh-ancestor
19834143|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834144|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834145|NCT00592319|Celecoxib|celecoxib|mesh-list
19834146|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19834147|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19834148|NCT00592319|Analgesics|analgesics|mesh-ancestor
19834149|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
19834150|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834151|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834152|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834153|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834154|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19834155|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19834156|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834157|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834158|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19834159|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19834160|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19834161|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834162|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834163|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834164|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19834165|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19834166|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
19834167|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834168|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834169|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19834170|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19834171|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
19834172|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19834173|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19834174|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19834175|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834176|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834177|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834178|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834179|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19834180|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
19834181|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834182|NCT00592475|Conivaptan|conivaptan|mesh-list
19834183|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19834184|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796332|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
19796333|NCT05109429|Narcotics|narcotics|mesh-ancestor
19796334|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796335|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796336|NCT05109429|Analgesics|analgesics|mesh-ancestor
19796337|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
19796338|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796339|NCT05081492|Antibodies|antibodies|mesh-list
19796340|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
19796341|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
19796342|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796343|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
19796344|NCT05075330|Narcotics|narcotics|mesh-ancestor
19796345|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796346|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796347|NCT05075330|Analgesics|analgesics|mesh-ancestor
20156837|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156838|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20156839|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20156840|NCT00109109|Vorinostat|vorinostat|mesh-list
19641993|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
19641994|NCT02389400|Methotrexate|methotrexate|mesh-list
19641995|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19641996|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
19641997|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19641998|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19641999|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19642000|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
19796348|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
20156841|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156842|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20156843|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323622|NCT00733239|Diltiazem|diltiazem|mesh-list
19796349|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796350|NCT05069038|Palbociclib|palbociclib|mesh-list
19796351|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796352|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19796353|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796354|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796355|NCT05059600|Pregnanolone|pregnanolone|mesh-list
19796356|NCT05059600|Brexanolone|brexanolone|mesh-list
19796357|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
19796358|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796359|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796360|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
19796361|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796362|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796363|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
19796364|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
19796365|NCT05025787|Celecoxib|celecoxib|mesh-list
19796366|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19796367|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19796368|NCT05025787|Analgesics|analgesics|mesh-ancestor
19796369|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
19796370|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796371|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796372|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796373|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796374|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19796375|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19796376|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796377|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796378|NCT04976283|Pioglitazone|pioglitazone|mesh-list
19796379|NCT04976283|Empagliflozin|empagliflozin|mesh-list
19796380|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19796381|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796382|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19796383|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796384|NCT04971187|Cisplatin|cisplatin|mesh-list
20156844|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323623|NCT00733239|Isradipine|isradipine|mesh-list
20323624|NCT00733239|Nifedipine|nifedipine|mesh-list
19796385|NCT04971187|Carboplatin|carboplatin|mesh-list
19796386|NCT04971187|Pemetrexed|pemetrexed|mesh-list
20323625|NCT00733239|Gabapentin|gabapentin|mesh-list
20323626|NCT00733239|Naloxone|naloxone|mesh-list
19796387|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796388|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796389|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796390|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19796391|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19796392|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
19796393|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
19796394|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19796395|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796396|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19796397|NCT04930783|Nivolumab|nivolumab|mesh-list
19796398|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796399|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796400|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19796401|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796402|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
19796403|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
19796404|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19796405|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
19796406|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796407|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796408|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
19796409|NCT04901975|Spironolactone|spironolactone|mesh-list
19796410|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19796411|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
19796412|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796413|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796414|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19796415|NCT04901975|Diuretics|diuretics|mesh-ancestor
19796416|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
19796417|NCT04899388|Fentanyl|fentanyl|mesh-list
19796418|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19796419|NCT04899388|Narcotics|narcotics|mesh-ancestor
20323627|NCT00733239|Analgesics|analgesics|mesh-ancestor
20323628|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
19796420|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796421|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796422|NCT04899388|Analgesics|analgesics|mesh-ancestor
19796423|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
19796424|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796425|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19796426|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20156845|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20156846|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20156847|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20156848|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156849|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156850|NCT00109135|Hormones|hormones|mesh-ancestor
20156851|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20156852|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156853|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20156854|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20156855|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20156856|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323629|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323630|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323631|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
20323632|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20323633|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20323634|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323635|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19796427|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
19796428|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
19796429|NCT04892186|Inositol|inositol|mesh-list
19796430|NCT04892186|Metformin|metformin|mesh-list
19796431|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19796432|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796433|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
19796434|NCT04892186|Vitamins|vitamins|mesh-ancestor
19796435|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
20323636|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20323637|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20323638|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323639|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323640|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
20323641|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20323642|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20323643|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642001|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642002|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642003|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
19642004|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642005|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19642006|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642007|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
19796436|NCT04884763|Erenumab|erenumab|mesh-list
20323644|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19796437|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19796438|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796439|NCT04884763|Analgesics|analgesics|mesh-ancestor
19796440|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
19796441|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796442|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796443|NCT04847453|Dexamethasone|dexamethasone|mesh-list
19796444|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
19796445|NCT04847453|Venetoclax|venetoclax|mesh-list
19796446|NCT04847453|Ixazomib|ixazomib|mesh-list
19796447|NCT04847453|Ichthammol|ichthammol|mesh-list
19796448|NCT04847453|BB 1101|bb 1101|mesh-list
19796449|NCT04847453|Glycine|glycine|mesh-list
19796450|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796451|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
19796452|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
19796453|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796454|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796455|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19796456|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
19796457|NCT04847453|Hormones|hormones|mesh-ancestor
19796458|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796459|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19796460|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796461|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
19796462|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796463|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796464|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
19796465|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
19796466|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796467|NCT04820673|Sarecycline|sarecycline|mesh-list
19796468|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19796469|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796470|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
19796471|NCT04802590|Venetoclax|venetoclax|mesh-list
19796472|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796473|NCT04781855|Nivolumab|nivolumab|mesh-list
19796474|NCT04781855|Ipilimumab|ipilimumab|mesh-list
19796475|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796476|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796477|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19796478|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796479|NCT04684238|Midazolam|midazolam|mesh-list
19796480|NCT04684238|Isoflurane|isoflurane|mesh-list
19796481|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19796482|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19796483|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796484|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796485|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19796486|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19796487|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19796488|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19796489|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
19642008|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642009|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19642010|NCT02389439|Artesunate|artesunate|mesh-list
19796490|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
19796491|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
19796492|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
19796493|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796494|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796495|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19796496|NCT04681443|Phenol|phenol|mesh-list
19796497|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19796498|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796499|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
19796500|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19796501|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19796502|NCT04666272|Trametinib|trametinib|mesh-list
19796503|NCT04666272|Dabrafenib|dabrafenib|mesh-list
19796504|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323645|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
20323646|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
20323647|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20323648|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20323649|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323650|NCT00733239|Renal Agents|renal agents|mesh-ancestor
20323651|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20323652|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
20323653|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20323654|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
20323655|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20323656|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20323657|NCT00733265|Ticagrelor|ticagrelor|mesh-list
20323658|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20323659|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20323660|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20323661|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20323662|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
20323663|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323664|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323665|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323666|NCT00733317|Budesonide|budesonide|mesh-list
20323667|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323668|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20323669|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
20323670|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323671|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323672|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20323673|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
20323674|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
19642011|NCT02389439|Pyronaridine|pyronaridine|mesh-list
19642012|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
19642013|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19642014|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19642015|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796505|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19796506|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796507|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642016|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642017|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
19642018|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
19642019|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19834185|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
19834186|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834187|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
19834188|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
19834189|NCT00592488|Vitamins|vitamins|mesh-ancestor
19834190|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
19834191|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834192|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
19834193|NCT00592501|Fluorouracil|fluorouracil|mesh-list
19834194|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834195|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
19834196|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834197|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19834198|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834199|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
19834200|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834201|NCT00592683|Aripiprazole|aripiprazole|mesh-list
19834202|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
19642020|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
20323675|NCT00733317|Hormones|hormones|mesh-ancestor
19642021|NCT02389426|Bosentan|bosentan|mesh-list
19642022|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19834203|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19642023|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19642024|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642025|NCT02389348|Artefenomel|artefenomel|mesh-list
20323676|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323677|NCT00733434|Alprostadil|alprostadil|mesh-list
20323678|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20323679|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
20323680|NCT00733434|Urological Agents|urological agents|mesh-ancestor
20323681|NCT00733473|Budesonide|budesonide|mesh-list
19642026|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
19642027|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19642028|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19642029|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323682|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323683|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20323684|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
20323685|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323686|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323687|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20323688|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
20323689|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
20323690|NCT00733473|Hormones|hormones|mesh-ancestor
20323691|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323692|NCT00733525|Fluoxetine|fluoxetine|mesh-list
20323693|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20323694|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20323695|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20323696|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323697|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323698|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
20323699|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323700|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20323701|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
20323702|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20323703|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20323704|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19642030|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
19642031|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19642032|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
19642033|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642034|NCT02389309|Sirolimus|sirolimus|mesh-list
19642035|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
19642036|NCT02389309|Dasatinib|dasatinib|mesh-list
19642037|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642038|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
19642039|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642040|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642041|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19642042|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
19642043|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642044|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642045|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19642046|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642047|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642048|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19796508|NCT04600141|Heparin|heparin|mesh-list
19796509|NCT04600141|Calcium heparin|calcium heparin|mesh-list
19642049|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
19796510|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
19796511|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19796512|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19796513|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796514|NCT04584255|Niraparib|niraparib|mesh-list
19796515|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19796516|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796517|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796518|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796519|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
19796520|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
19796521|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796522|NCT04555096|Protective Agents|protective agents|mesh-ancestor
19796523|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796524|NCT04551352|Adalimumab|adalimumab|mesh-list
19796525|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
19796526|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796527|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796528|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796529|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796530|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
19796531|NCT04541017|Magrolimab|magrolimab|mesh-list
19796532|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
19796533|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
19796534|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
19796535|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796536|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796537|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796538|NCT04526288|Cytarabine|cytarabine|mesh-list
19796539|NCT04526288|Daunorubicin|daunorubicin|mesh-list
19796540|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19642050|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19642051|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642052|NCT02389231|Interleukin-2|interleukin-2|mesh-list
19642053|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642054|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19796541|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
19796542|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796543|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796544|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
19796545|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796546|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796547|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
19796548|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796549|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19796550|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19642055|NCT02389231|Analgesics|analgesics|mesh-ancestor
19642056|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
19642057|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642058|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642059|NCT02389218|Sotalol|sotalol|mesh-list
20156857|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156858|NCT00109148|Hormones|hormones|mesh-ancestor
20156859|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642060|NCT02389218|Flecainide|flecainide|mesh-list
19642061|NCT02389218|Propafenone|propafenone|mesh-list
19642062|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19642063|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19642064|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
19642065|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642066|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642067|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642068|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19642069|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
19642070|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
19642071|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642072|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19642073|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20156860|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156861|NCT00109161|Antibodies|antibodies|mesh-list
20156862|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20156863|NCT00109161|Daclizumab|daclizumab|mesh-list
19796551|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19796552|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796553|NCT04522739|Spironolactone|spironolactone|mesh-list
20323705|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323706|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
20323707|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20323708|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323709|NCT00733564|Lidocaine|lidocaine|mesh-list
20323710|NCT00733564|Propofol|propofol|mesh-list
20323711|NCT00733564|Sevoflurane|sevoflurane|mesh-list
20323712|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
20323713|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
20323714|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323715|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323716|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
20323717|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323718|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19642074|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642075|NCT02389179|Vitamin D|vitamin d|mesh-list
19642076|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
19642077|NCT02389179|Vitamins|vitamins|mesh-ancestor
19642078|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
19642079|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642080|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19642081|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19642082|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19642083|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
19642084|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642085|NCT02388750|Palonosetron|palonosetron|mesh-list
19642086|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
19796554|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19796555|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
19642087|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
19642088|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642089|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796556|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796557|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796558|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19796559|NCT04522739|Diuretics|diuretics|mesh-ancestor
19796560|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
19796561|NCT04517799|Cannabidiol|cannabidiol|mesh-list
19796562|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
19796563|NCT04517396|Fenofibrate|fenofibrate|mesh-list
19796564|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
20156864|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
19642090|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642091|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19642092|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19642093|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
19642094|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642095|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642096|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
19642097|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642098|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
19642099|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642100|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642101|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19642102|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
19642103|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642104|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642105|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19642106|NCT02388581|Amoxicillin|amoxicillin|mesh-list
20156865|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156866|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156867|NCT00109187|Omalizumab|omalizumab|mesh-list
20156868|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20156869|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20156870|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
20156871|NCT00109200|Omalizumab|omalizumab|mesh-list
20156872|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20156873|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20156874|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
20156875|NCT00109226|Bevacizumab|bevacizumab|mesh-list
20156876|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20156877|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642107|NCT02388581|Metronidazole|metronidazole|mesh-list
20156878|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20323719|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19642108|NCT02388581|Clarithromycin|clarithromycin|mesh-list
19642109|NCT02388581|Lansoprazole|lansoprazole|mesh-list
19642110|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
19642111|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642112|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796565|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19796566|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
19796567|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796568|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19796569|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19796570|NCT04504318|Enoxaparin|enoxaparin|mesh-list
19796571|NCT04504318|Apixaban|apixaban|mesh-list
19796572|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
19796573|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19796574|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19796575|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796576|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19796577|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
19796578|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19796579|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
19796580|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796581|NCT04492553|Testosterone|testosterone|mesh-list
19796582|NCT04492553|Androgens|androgens|mesh-ancestor
19796583|NCT04492553|Hormones|hormones|mesh-ancestor
20156879|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20156880|NCT00109226|Growth Substances|growth substances|mesh-ancestor
20156881|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156882|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
20156883|NCT00109239|Bevacizumab|bevacizumab|mesh-list
20156884|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20156885|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156886|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20156887|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20156888|NCT00109239|Growth Substances|growth substances|mesh-ancestor
19642113|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19642114|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19642115|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19642116|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642117|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642118|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19642119|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19642120|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19642121|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642122|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19642123|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19642124|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19642125|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642126|NCT02388516|Vitamin D|vitamin d|mesh-list
19642127|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
20323720|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19796584|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796585|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796586|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19796587|NCT04422431|Choline|choline|mesh-list
19796588|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
19796589|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19796590|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
19796591|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796592|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19796593|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19796594|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
19796595|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
19796596|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
19642128|NCT02388516|Vitamins|vitamins|mesh-ancestor
19642129|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
20156889|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642130|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642131|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19642132|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19642133|NCT02388477|Doxycycline|doxycycline|mesh-list
19642134|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19796597|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642135|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796598|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19796599|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19642136|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
19642137|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19796600|NCT04422431|Growth Substances|growth substances|mesh-ancestor
20323721|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20323722|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323723|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20323724|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20323725|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
20323726|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20323727|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20323728|NCT00733616|Docetaxel|docetaxel|mesh-list
20323729|NCT00733616|Capecitabine|capecitabine|mesh-list
20323730|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
20323731|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323732|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
20323733|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
20323734|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323735|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323736|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20323737|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
20323738|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20323739|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
20323740|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20323741|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20323742|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20323743|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323744|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323745|NCT00733720|Naltrexone|naltrexone|mesh-list
19642138|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19796601|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796602|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
19796603|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796604|NCT04417179|Bupivacaine|bupivacaine|mesh-list
19796605|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
19796606|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
19796607|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796608|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796609|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
19796610|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796611|NCT04415151|Tofacitinib|tofacitinib|mesh-list
19796612|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19796613|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796614|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796615|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
19796616|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19796617|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642139|NCT02388373|Fluticasone|fluticasone|mesh-list
19642140|NCT02388373|Xhance|xhance|mesh-list
19642141|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
19642142|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19642143|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642144|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20156890|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
19796618|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19796619|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20156891|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20156892|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156893|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20156894|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156895|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156896|NCT00109278|Vaccines|vaccines|mesh-list
20156897|NCT00109278|Immunoglobulins|immunoglobulins|mesh-list
20156898|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
19642145|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
19642146|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642147|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642148|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19642149|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
20156899|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156900|NCT00109356|AQ4N|aq4n|mesh-list
20156901|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156902|NCT00109382|Aspirin|aspirin|mesh-list
20323746|NCT00733720|Buprenorphine|buprenorphine|mesh-list
20347674|NCT00861419|Sorafenib|sorafenib|mesh-list
19642150|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156903|NCT00109382|Clopidogrel|clopidogrel|mesh-list
20156904|NCT00109382|Simvastatin|simvastatin|mesh-list
19796620|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
19796621|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796622|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
19796623|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
19796624|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19796625|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19796626|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796627|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796628|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796629|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796630|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
19796631|NCT04314843|Fludarabine|fludarabine|mesh-list
19796632|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796633|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
19796634|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796635|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796636|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19796637|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
19796638|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796639|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796640|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19796641|NCT04294264|Trifluridine|trifluridine|mesh-list
19796642|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
19796643|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796644|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
19796645|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796646|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
19796647|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796648|NCT04288895|Vortioxetine|vortioxetine|mesh-list
19796649|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
19796650|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19796651|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19796652|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19796653|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796654|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796655|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19796656|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19796657|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19796658|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796659|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796660|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
19796661|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19796662|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19796663|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19796664|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19796665|NCT04271202|Erenumab|erenumab|mesh-list
19796666|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19796667|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796668|NCT04271202|Analgesics|analgesics|mesh-ancestor
19796669|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
19796670|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796671|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796672|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
20156905|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20156906|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20156907|NCT00109382|Analgesics|analgesics|mesh-ancestor
19796673|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
19796674|NCT04259060|Hematinics|hematinics|mesh-ancestor
19796675|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
19796676|NCT04259060|Vitamins|vitamins|mesh-ancestor
19796677|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
19796678|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796679|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
19796680|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19796681|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796682|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19796683|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796684|NCT04247126|Gemcitabine|gemcitabine|mesh-list
19796685|NCT04247126|Paclitaxel|paclitaxel|mesh-list
19796686|NCT04247126|Fulvestrant|fulvestrant|mesh-list
19796687|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20156908|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
19796688|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796689|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
20156909|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156910|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642151|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19642152|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19642153|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19642154|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19642155|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
19796690|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
19796691|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
19796692|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796693|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19642156|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642157|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663480|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19663481|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663482|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663483|NCT03866538|Budesonide|budesonide|mesh-list
19663484|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19663485|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19663486|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
19663487|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663488|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663489|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19663490|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
19663491|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
19663492|NCT03866538|Hormones|hormones|mesh-ancestor
19663493|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663494|NCT03856619|Teriflunomide|teriflunomide|mesh-list
19663495|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19663496|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19796694|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
19796695|NCT04247126|Antiviral Agents|antiviral agents|mesh-ancestor
19796696|NCT04247126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796697|NCT04247126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796698|NCT04247126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796699|NCT04247126|Immunologic Factors|immunologic factors|mesh-ancestor
19796700|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796701|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19796702|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19796703|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19796704|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
19796705|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796706|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
19796707|NCT04163107|Dexamethasone|dexamethasone|mesh-list
19796708|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19796709|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
19796710|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
19796711|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796712|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796713|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19796714|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
19796715|NCT04163107|Hormones|hormones|mesh-ancestor
19796716|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796717|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20156911|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19663497|NCT03856619|Analgesics|analgesics|mesh-ancestor
19663498|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
19663499|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663500|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663501|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19663502|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663503|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663504|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
19663505|NCT03821272|Vaccines|vaccines|mesh-list
19663506|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
19663507|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796718|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796719|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
19796720|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19796721|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19796722|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796723|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796724|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642158|NCT02388178|Fluorides|fluorides|mesh-list
19642159|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
19642160|NCT02388178|Protective Agents|protective agents|mesh-ancestor
19642161|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642162|NCT02388048|Ofatumumab|ofatumumab|mesh-list
19642163|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642164|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20156912|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156913|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20156914|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20156915|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156916|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20156917|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20156918|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642165|NCT02388061|Plasminogen|plasminogen|mesh-list
19642166|NCT02388061|Tenecteplase|tenecteplase|mesh-list
19642167|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19642168|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19642169|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642170|NCT02388035|Cefotaxime|cefotaxime|mesh-list
19642171|NCT02388035|Cefoxitin|cefoxitin|mesh-list
19642172|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642173|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156919|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
20156920|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20156921|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20156922|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20156923|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
19642174|NCT02387892|Vitamin D|vitamin d|mesh-list
19642175|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
19642176|NCT02387892|Vitamins|vitamins|mesh-ancestor
19642177|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
19642178|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156924|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156925|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20156926|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20156927|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
19642179|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19642180|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19642181|NCT02387931|Vitamin D|vitamin d|mesh-list
19642182|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
19642183|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
19642184|NCT02387931|Vitamins|vitamins|mesh-list
19796725|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796726|NCT04080284|Niraparib|niraparib|mesh-list
19796727|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19796728|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796729|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796730|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642185|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
19642186|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642187|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19834204|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19834205|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19834206|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834207|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834208|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
20156928|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19642188|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19642189|NCT02387918|Dexamethasone|dexamethasone|mesh-list
19642190|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642191|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
19642192|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
19642193|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642194|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642195|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642196|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
19834209|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
19642197|NCT02387918|Hormones|hormones|mesh-ancestor
19642198|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642199|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20323747|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20323748|NCT00733720|Naloxone|naloxone|mesh-list
20323749|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20323750|NCT00733720|Narcotics|narcotics|mesh-ancestor
20323751|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323752|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323753|NCT00733720|Analgesics|analgesics|mesh-ancestor
20323754|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
20323755|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323756|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20323757|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20323758|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
20323759|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323760|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323761|NCT00733811|Deferiprone|deferiprone|mesh-list
20323762|NCT00733811|Deferoxamine|deferoxamine|mesh-list
20323763|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19796731|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19796732|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19796733|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
19796734|NCT04072107|Capecitabine|capecitabine|mesh-list
19796735|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19796736|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
19796737|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796738|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796739|NCT03984240|Midazolam|midazolam|mesh-list
19796740|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
19796741|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19796742|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796743|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796744|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19796745|NCT03984240|Analgesics|analgesics|mesh-ancestor
19796746|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
19796747|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796748|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19796749|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20156929|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20156930|NCT00109395|Midazolam|midazolam|mesh-list
20156931|NCT00109395|Lorazepam|lorazepam|mesh-list
20156932|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20156933|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19796750|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19796751|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19796752|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156934|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323764|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
20323765|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
20323766|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323767|NCT00733811|Siderophores|siderophores|mesh-ancestor
20323768|NCT00733850|Gemcitabine|gemcitabine|mesh-list
20323769|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20323770|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
19642200|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642201|NCT02387619|Amlodipine|amlodipine|mesh-list
19642202|NCT02387619|Telmisartan|telmisartan|mesh-list
19642203|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19642204|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20156935|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156936|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20156937|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20156938|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20156939|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19642205|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19642206|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19642207|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19796753|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156940|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
20156941|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
20156942|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
20156943|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
20323771|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323772|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796754|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19796755|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19796756|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20323773|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
20323774|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323775|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323776|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323777|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
20323778|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323779|NCT00733889|Docetaxel|docetaxel|mesh-list
20323780|NCT00733889|Fluorouracil|fluorouracil|mesh-list
20323781|NCT00733889|Cetuximab|cetuximab|mesh-list
20323782|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323783|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
20323784|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
20323785|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323786|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323787|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
19796757|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19796758|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19796759|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
20156944|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156945|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156946|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
20156947|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
20156948|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
20156949|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20156950|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20156951|NCT00109408|Methotrexate|methotrexate|mesh-list
20156952|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20156953|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
20156954|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20156955|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156956|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20156957|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
20174123|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
20323788|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20323789|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323790|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
20323791|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347675|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
19642208|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642209|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19642210|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642211|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
19642212|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19642213|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19642214|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
19642215|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19663508|NCT03806309|Leucovorin|leucovorin|mesh-list
19663509|NCT03806309|Fluorouracil|fluorouracil|mesh-list
19663510|NCT03806309|Irinotecan|irinotecan|mesh-list
19663511|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
19663512|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663513|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663514|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663515|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663516|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
19663517|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663518|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19663519|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19663520|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663521|NCT03806309|Antidotes|antidotes|mesh-ancestor
19663522|NCT03806309|Protective Agents|protective agents|mesh-ancestor
19663523|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
19663524|NCT03806309|Vitamins|vitamins|mesh-ancestor
19663525|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
19663526|NCT03714815|Macitentan|macitentan|mesh-list
19663527|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19663528|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19663529|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663530|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20323792|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20611423|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
20611424|NCT01236560|Antibodies|antibodies|mesh-list
20611425|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
20156958|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156959|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20156960|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156961|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156962|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20156963|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20156964|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
20156965|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20156966|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20174124|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174125|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20174126|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
20174127|NCT00163566|Androgens|androgens|mesh-ancestor
20174128|NCT00163566|Hormones|hormones|mesh-ancestor
20174129|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174130|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174131|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20174132|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
20174133|NCT00163592|Coagulants|coagulants|mesh-ancestor
20174134|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20174135|NCT00163605|Thrombin|thrombin|mesh-list
20174136|NCT00163605|Calcium|calcium|mesh-list
20323793|NCT00733967|Varenicline|varenicline|mesh-list
19642216|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19642217|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323794|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20611426|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20611427|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
20611428|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642218|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19642219|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19642220|NCT02387307|Interferons|interferons|mesh-list
19642221|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642222|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
19642223|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642224|NCT02387567|Lidocaine|lidocaine|mesh-list
19642225|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
19642226|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
19642227|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642228|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642229|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
19642230|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642231|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19642232|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19642233|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19642234|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642235|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642236|NCT02387242|Rifampin|rifampin|mesh-list
19642237|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19642238|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
19642239|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642240|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642241|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
19642242|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19642243|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642244|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642245|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19642246|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19642247|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20174137|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20174138|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642248|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19642249|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19642250|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20156967|NCT00109551|Folic Acid|folic acid|mesh-list
20156968|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
19642251|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
20156969|NCT00109551|Hematinics|hematinics|mesh-ancestor
20156970|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
20156971|NCT00109551|Vitamins|vitamins|mesh-ancestor
20156972|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
20156973|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156974|NCT00109551|Astringents|astringents|mesh-ancestor
20156975|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
20156976|NCT00109564|Acetylcholine|acetylcholine|mesh-list
20156977|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
20156978|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
20156979|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20156980|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
20156981|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20156982|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156983|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156984|NCT00109603|Tenofovir|tenofovir|mesh-list
20156985|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
20323795|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20323796|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
20323797|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323798|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323799|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323800|NCT00734123|Aspirin|aspirin|mesh-list
20323801|NCT00734123|Rimonabant|rimonabant|mesh-list
20323802|NCT00734123|Enalapril|enalapril|mesh-list
19642252|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
20156986|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156987|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20156988|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20323803|NCT00734123|Clopidogrel|clopidogrel|mesh-list
20323804|NCT00734123|Atorvastatin|atorvastatin|mesh-list
20611429|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611430|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19642253|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19642254|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19642255|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642256|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642257|NCT02387450|Urological Agents|urological agents|mesh-ancestor
19642258|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
19642259|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19642260|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
19642261|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19642262|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
19642263|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663531|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
19663532|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19663533|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19663534|NCT03636165|Prednisolone|prednisolone|mesh-list
19663535|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
19663536|NCT03636165|Ropivacaine|ropivacaine|mesh-list
19663537|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19663538|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
19663539|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
19663540|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
19663541|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663542|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663543|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
19663544|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663545|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323805|NCT00734123|Simvastatin|simvastatin|mesh-list
20323806|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20323807|NCT00734123|Diuretics|diuretics|mesh-list
20323808|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19642264|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642265|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
19642266|NCT02387203|Amoxicillin|amoxicillin|mesh-list
19642267|NCT02387203|Clarithromycin|clarithromycin|mesh-list
19642268|NCT02387203|Lansoprazole|lansoprazole|mesh-list
19642269|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642270|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642271|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19642272|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642273|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663546|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
19663547|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
19663548|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19663549|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
19663550|NCT03636165|Hormones|hormones|mesh-ancestor
19663551|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663552|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19663553|NCT03636165|Protective Agents|protective agents|mesh-ancestor
19663554|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19663555|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663556|NCT03564873|Azacitidine|azacitidine|mesh-list
19663557|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
19663558|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663559|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
19663560|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663561|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663562|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663563|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19663564|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19663565|NCT03528408|Nivolumab|nivolumab|mesh-list
19663566|NCT03528408|Ipilimumab|ipilimumab|mesh-list
19663567|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663568|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663569|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19663570|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663571|NCT03521037|Rucaparib|rucaparib|mesh-list
19663572|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19663573|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663574|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663575|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663576|NCT03422094|Nivolumab|nivolumab|mesh-list
19663577|NCT03422094|Ipilimumab|ipilimumab|mesh-list
19663578|NCT03422094|Poly ICLC|poly iclc|mesh-list
19663579|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663580|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663581|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19663582|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663583|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
19663584|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
19663585|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796760|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
19796761|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
19796762|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
19796763|NCT03983226|Gemcitabine|gemcitabine|mesh-list
19796764|NCT03983226|Carboplatin|carboplatin|mesh-list
19796765|NCT03983226|Doxorubicin|doxorubicin|mesh-list
19796766|NCT03983226|Niraparib|niraparib|mesh-list
20611431|NCT01236560|Growth Substances|growth substances|mesh-ancestor
20611432|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20156989|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20156990|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20156991|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20156992|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20156993|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
20156994|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20156995|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20156996|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20156997|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20156998|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
20156999|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
20157000|NCT00109746|Chromium|chromium|mesh-list
20157001|NCT00109746|Picolinic acid|picolinic acid|mesh-list
19642274|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19642275|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20323809|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20323810|NCT00734123|Analgesics|analgesics|mesh-ancestor
20323811|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
20323812|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323813|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323814|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323815|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323816|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20323817|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19642276|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19642277|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642278|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19796767|NCT03983226|Taxane|taxane|mesh-list
19796768|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796769|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19642279|NCT02387086|Aspirin|aspirin|mesh-list
19642280|NCT02387086|Thalidomide|thalidomide|mesh-list
19642281|NCT02387086|Gefitinib|gefitinib|mesh-list
19642282|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19642283|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157002|NCT00109746|Trace Elements|trace elements|mesh-ancestor
19796770|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
19796771|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796772|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
19642284|NCT02387086|Analgesics|analgesics|mesh-ancestor
19642285|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
19642286|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642287|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642288|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642289|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642290|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19796773|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796774|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796775|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796776|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
19796777|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796778|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19796779|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20157003|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
20157004|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642291|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19642292|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642293|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19642294|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19642295|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642296|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
19642297|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642298|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
19642299|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
19796780|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19796781|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19796782|NCT03948347|Liraglutide|liraglutide|mesh-list
20157005|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19796783|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19796784|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323818|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323819|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20323820|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19642300|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642301|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796785|NCT03948347|Incretins|incretins|mesh-ancestor
19796786|NCT03948347|Hormones|hormones|mesh-ancestor
19796787|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796788|NCT03944434|Leuprolide|leuprolide|mesh-list
19796789|NCT03944434|Goserelin|goserelin|mesh-list
20157006|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
20157007|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
20157008|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642302|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19796790|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19796791|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19796792|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19796793|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
19796794|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19796795|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796796|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19796797|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796798|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19796799|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796800|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796801|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19796802|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
19796803|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796804|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
19796805|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19796806|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
19796807|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19642303|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19642304|NCT02387086|Growth Substances|growth substances|mesh-ancestor
19642305|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
19642306|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642307|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19642308|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
19642309|NCT02387138|Irinotecan|irinotecan|mesh-list
19642310|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642311|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19642312|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19642313|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642314|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642315|NCT02387060|Fentanyl|fentanyl|mesh-list
19642316|NCT02387060|Bupivacaine|bupivacaine|mesh-list
19642317|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
19642318|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
19642319|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642320|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642321|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
19642322|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642323|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19642324|NCT02387060|Narcotics|narcotics|mesh-ancestor
19642325|NCT02387060|Analgesics|analgesics|mesh-ancestor
19642326|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19796808|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
19796809|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796810|NCT03924401|Abatacept|abatacept|mesh-list
19796811|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19796812|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796813|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796814|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796815|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
20157009|NCT00109785|Idoxuridine|idoxuridine|mesh-list
20157010|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20157011|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20157012|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157013|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
20157014|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642327|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20157015|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20323821|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323822|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
20323823|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20323824|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20323825|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
20323826|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20323827|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20323828|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20323829|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20157016|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157017|NCT00109798|Temozolomide|temozolomide|mesh-list
20157018|NCT00109798|Topotecan|topotecan|mesh-list
20157019|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20157020|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
20157021|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157022|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323830|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20323831|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
20323832|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642328|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
19642329|NCT02387021|Ropivacaine|ropivacaine|mesh-list
19642330|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
19642331|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
19642332|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323833|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
20323834|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20323835|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
20323836|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19256648|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157023|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19796816|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796817|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796818|NCT03907475|Gemcitabine|gemcitabine|mesh-list
19796819|NCT03907475|Paclitaxel|paclitaxel|mesh-list
20157024|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20157025|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157026|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
20157027|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20157028|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
20157029|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157030|NCT00109824|Decitabine|decitabine|mesh-list
20157031|NCT00109824|Azacitidine|azacitidine|mesh-list
20157032|NCT00109824|Valproic Acid|valproic acid|mesh-list
20157033|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157034|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
20157035|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157036|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157037|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157038|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
20157039|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
20157040|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20157041|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642333|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642334|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
19642335|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642336|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19642337|NCT02386943|Saxagliptin|saxagliptin|mesh-list
19642338|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19642339|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642340|NCT02386943|Incretins|incretins|mesh-ancestor
19642341|NCT02386943|Hormones|hormones|mesh-ancestor
19642342|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642343|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19642344|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
19642345|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642346|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642347|NCT02386735|Prednisone|prednisone|mesh-list
19642348|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642349|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
19642350|NCT02386735|Hormones|hormones|mesh-ancestor
19642351|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642352|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157042|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
20157043|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20323837|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20347676|NCT00861419|Imetelstat|imetelstat|mesh-list
19642353|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642354|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663592|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
19663593|NCT03384836|Propranolol|propranolol|mesh-list
19663594|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663595|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663596|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19663597|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19663598|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
19663599|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663600|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323838|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20323839|NCT00734123|Hormones|hormones|mesh-ancestor
19663601|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796820|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19796821|NCT03907475|Carboplatin|carboplatin|mesh-list
19796822|NCT03907475|Doxorubicin|doxorubicin|mesh-list
19796823|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19796824|NCT03907475|Capecitabine|capecitabine|mesh-list
19796825|NCT03907475|Durvalumab|durvalumab|mesh-list
19796826|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
19796827|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19796828|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
19796829|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19796830|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796831|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
19796832|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
19796833|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
19796834|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796835|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19796836|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
19796837|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
19796838|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796839|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796840|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796841|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
19796842|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796843|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19796844|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19796845|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19796846|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796847|NCT03873805|Vidarabine|vidarabine|mesh-list
19796848|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
19796849|NCT03873805|Fludarabine|fludarabine|mesh-list
19796850|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
19796851|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796852|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
19796853|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796854|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796855|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19796856|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
20611433|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611434|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
20611435|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611436|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
20611437|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663602|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19663603|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19663604|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
19663605|NCT03311555|Docetaxel|docetaxel|mesh-list
19663606|NCT03311555|Androgens|androgens|mesh-list
19663607|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663608|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
19663609|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
19663610|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
19796857|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796858|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796859|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19642355|NCT02386358|Benzonidazole|benzonidazole|mesh-list
19642356|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642357|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
19642358|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642359|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19642360|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19642361|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19642362|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796860|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20347677|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19642363|NCT02386397|Gemcitabine|gemcitabine|mesh-list
19642364|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
19796861|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
19796862|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
19796863|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19796864|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
19796865|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19796866|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796867|NCT03859024|Acetaminophen|acetaminophen|mesh-list
19796868|NCT03859024|Dexamethasone|dexamethasone|mesh-list
19796869|NCT03859024|Ibuprofen|ibuprofen|mesh-list
19796870|NCT03859024|Celecoxib|celecoxib|mesh-list
19796871|NCT03859024|Oxycodone|oxycodone|mesh-list
19796872|NCT03859024|Gabapentin|gabapentin|mesh-list
19796873|NCT03859024|Bupivacaine|bupivacaine|mesh-list
19642365|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19642366|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
19642367|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642368|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642369|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
19642370|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642371|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642372|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642373|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
19642374|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796874|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642375|NCT02386488|Vortioxetine|vortioxetine|mesh-list
19642376|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
19642377|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19796875|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
19796876|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
19796877|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642378|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19642379|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19642380|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642381|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642382|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19642383|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20157044|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157045|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19642384|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642385|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642386|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642387|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
19642388|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19642389|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19642390|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19796878|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796879|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157046|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
20157047|NCT00109941|Mitogens|mitogens|mesh-list
20157048|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
20157049|NCT00109941|Narcotics|narcotics|mesh-ancestor
20157050|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157051|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157052|NCT00109941|Analgesics|analgesics|mesh-ancestor
20157053|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
20157054|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157055|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157056|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157057|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642391|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19642392|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
19642393|NCT02386462|Propofol|propofol|mesh-list
19642394|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19796880|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
19796881|NCT03859024|Hormones|hormones|mesh-ancestor
19796882|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796883|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19796884|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796885|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
19796886|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
19796887|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796888|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
19796889|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19796890|NCT03859024|Analgesics|analgesics|mesh-ancestor
19796891|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
19796892|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20157058|NCT00109954|Cisplatin|cisplatin|mesh-list
20157059|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157060|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
20157061|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20157062|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20157063|NCT00109993|Prednisolone|prednisolone|mesh-list
20157064|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
19796893|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19796894|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19796895|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796896|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796897|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19796898|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19796899|NCT03859024|Narcotics|narcotics|mesh-ancestor
19796900|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
20157065|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
20157066|NCT00109993|Tacrolimus|tacrolimus|mesh-list
20157067|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20157068|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
20611438|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19796901|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19796902|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19796903|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19642395|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642396|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642397|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19642398|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
19642399|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
19642400|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19642401|NCT02386462|Analgesics|analgesics|mesh-ancestor
19642402|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
19796904|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19796905|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19796906|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796907|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
19796908|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19796909|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
19796910|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796911|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
19796912|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796913|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
19796914|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796915|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796916|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19796917|NCT03818607|Eculizumab|eculizumab|mesh-list
19642403|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642404|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19642405|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19642406|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19642407|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
19642408|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642409|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642410|NCT02386449|Mannitol|mannitol|mesh-list
19642411|NCT02386449|Bisacodyl|bisacodyl|mesh-list
19642412|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
19642413|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
19642414|NCT02386449|Citric Acid|citric acid|mesh-list
19642415|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
19642416|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19642417|NCT02386449|Diuretics|diuretics|mesh-ancestor
19642418|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
19642419|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642420|NCT02386449|Cathartics|cathartics|mesh-ancestor
19642421|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157069|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642422|NCT02386449|Laxatives|laxatives|mesh-ancestor
19642423|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
19642424|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19642425|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
19642426|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
19642427|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642428|NCT02386449|Antacids|antacids|mesh-ancestor
19642429|NCT02386566|Natalizumab|natalizumab|mesh-list
19642430|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
19642431|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642432|NCT02386293|Irbesartan|irbesartan|mesh-list
20323840|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323841|NCT00734279|Leuprolide|leuprolide|mesh-list
20323842|NCT00734279|Ganirelix|ganirelix|mesh-list
20323843|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20323844|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
20323845|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20323846|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323847|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642433|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19642434|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19642435|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19642436|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642437|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
19642438|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19642439|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19642440|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642441|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
19642442|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
19642443|NCT02386475|Dexetimide|dexetimide|mesh-list
19642444|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19642445|NCT02386475|Citalopram|citalopram|mesh-list
19642446|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19642447|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19642448|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642449|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642450|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642451|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
19642452|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642453|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19642454|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
20157070|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
20157071|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157072|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20157073|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157074|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323848|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323849|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
20323850|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323851|NCT00734318|Fluticasone|fluticasone|mesh-list
20157075|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157076|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
20157077|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
20157078|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157079|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157080|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
20323852|NCT00734318|Xhance|xhance|mesh-list
20323853|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
20323854|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20323855|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
20323856|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20323857|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323858|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20323859|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
20323860|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19642455|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19642456|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19642457|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19642458|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
19642459|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
19642460|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642461|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19642462|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19642463|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
20323861|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20323862|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20323863|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
20611439|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611440|NCT01236547|Paclitaxel|paclitaxel|mesh-list
19642464|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19642465|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
19642466|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
20611441|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20323864|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20323865|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323866|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20323867|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
20323868|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20323869|NCT00734383|Propofol|propofol|mesh-list
20323870|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20323871|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323872|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323873|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20323874|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
20323875|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
20323876|NCT00734448|Inositol|inositol|mesh-list
20323877|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
20323878|NCT00734448|Vitamins|vitamins|mesh-ancestor
20323879|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
20323880|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611442|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611443|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611444|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611445|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611446|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611447|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611448|NCT01142388|Paclitaxel|paclitaxel|mesh-list
20611449|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20157081|NCT00109993|Hormones|hormones|mesh-ancestor
20157082|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157083|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20157084|NCT00109993|Protective Agents|protective agents|mesh-ancestor
20157085|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20157086|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157087|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157088|NCT00110006|Prednisone|prednisone|mesh-list
20157089|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
20323881|NCT00734526|Temozolomide|temozolomide|mesh-list
20323882|NCT00734526|Sorafenib|sorafenib|mesh-list
20323883|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20323884|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
20323885|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611450|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19642467|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
19642468|NCT02386150|Vaccines|vaccines|mesh-list
19642469|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
19642470|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642471|NCT02386111|Sunitinib|sunitinib|mesh-list
19642472|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642473|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19642474|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19642475|NCT02386111|Growth Substances|growth substances|mesh-ancestor
19642476|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642477|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
19642478|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19642479|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642480|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642481|NCT02386033|Atorvastatin|atorvastatin|mesh-list
19642482|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19796918|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19796919|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19796920|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
19796921|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796922|NCT03809000|Leuprolide|leuprolide|mesh-list
19796923|NCT03809000|Goserelin|goserelin|mesh-list
19796924|NCT03809000|Bicalutamide|bicalutamide|mesh-list
20157090|NCT00110006|Rituximab|rituximab|mesh-list
20157091|NCT00110006|Doxorubicin|doxorubicin|mesh-list
20157092|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20157093|NCT00110006|Vincristine|vincristine|mesh-list
20323886|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323887|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19796925|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323888|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323889|NCT00734669|Glyburide|glyburide|mesh-list
20323890|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20323891|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323892|NCT00734682|Irinotecan|irinotecan|mesh-list
20323893|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20323894|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20323895|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323896|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323897|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323898|NCT00734695|Vitamins|vitamins|mesh-list
20323899|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
20323900|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
20323901|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323902|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
20323903|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323904|NCT00734695|Protective Agents|protective agents|mesh-ancestor
20323905|NCT00734773|Cytarabine|cytarabine|mesh-list
20323906|NCT00734773|Rituximab|rituximab|mesh-list
20323907|NCT00734773|Methotrexate|methotrexate|mesh-list
19796926|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796927|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19796928|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
19796929|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19796930|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20157094|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20157095|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157096|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
20157097|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157098|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157099|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20157100|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
20157101|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157102|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157103|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20157104|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20323908|NCT00734773|Vincristine|vincristine|mesh-list
20157105|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20157106|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20157107|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20323909|NCT00734773|Procarbazine|procarbazine|mesh-list
20323910|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
20323911|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20323912|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323913|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
20323914|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323915|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20323916|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20323917|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
20323918|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20323919|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20323920|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
20323921|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323922|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
20323923|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20323924|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19642483|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19642484|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
19642485|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157108|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157109|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157110|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
20157111|NCT00110006|Hormones|hormones|mesh-ancestor
19642486|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19642487|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19642488|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642489|NCT02386059|Dexamethasone|dexamethasone|mesh-list
19642490|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
19642491|NCT02386059|Ondansetron|ondansetron|mesh-list
19642492|NCT02386059|BB 1101|bb 1101|mesh-list
19642493|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642494|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
19642495|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
20323925|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157112|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796931|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796932|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
19796933|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
19796934|NCT03796195|Bupivacaine|bupivacaine|mesh-list
19796935|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
19796936|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
19796937|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19796938|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796939|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
19796940|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796941|NCT03770689|Capecitabine|capecitabine|mesh-list
19796942|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19796943|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
19796944|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796945|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19796946|NCT03751631|Phenylephrine|phenylephrine|mesh-list
19796947|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
19796948|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19796949|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19796950|NCT03751631|Tropicamide|tropicamide|mesh-list
19796951|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19796952|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
19796953|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
19796954|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796955|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796956|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
19796957|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19796958|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
19796959|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
19796960|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19796961|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19796962|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19796963|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
20323926|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20323927|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
20323928|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323929|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20323930|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
20323931|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
20323932|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323933|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20323934|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
20323935|NCT00734877|Thalidomide|thalidomide|mesh-list
20323936|NCT00734877|Dexamethasone|dexamethasone|mesh-list
19796964|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19796965|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796966|NCT03751631|Protective Agents|protective agents|mesh-ancestor
19796967|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19796968|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19796969|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
19796970|NCT03751098|Phenylephrine|phenylephrine|mesh-list
19796971|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
19796972|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19796973|NCT03751098|Tropicamide|tropicamide|mesh-list
19796974|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19796975|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19796976|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
20157113|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20157114|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20157115|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
20157116|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157117|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157118|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20157119|NCT00110032|Etanidazole|etanidazole|mesh-list
20157120|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157121|NCT00110045|Caspofungin|caspofungin|mesh-list
20157122|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
20157123|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323937|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
20323938|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
20157124|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157125|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157126|NCT00110058|Interferons|interferons|mesh-list
20157127|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
20157128|NCT00110058|Cyclosporine|cyclosporine|mesh-list
20157129|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
20323939|NCT00734877|Melphalan|melphalan|mesh-list
20323940|NCT00734877|Cisplatin|cisplatin|mesh-list
20323941|NCT00734877|Etoposide|etoposide|mesh-list
19642496|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642497|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642498|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642499|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
20323942|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
20323943|NCT00734877|Doxorubicin|doxorubicin|mesh-list
20323944|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20323945|NCT00734877|Bortezomib|bortezomib|mesh-list
20323946|NCT00734877|BB 1101|bb 1101|mesh-list
20323947|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20323948|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
20323949|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323950|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157130|NCT00110058|Fludarabine|fludarabine|mesh-list
20157131|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
20157132|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
20157133|NCT00110058|Cyclosporins|cyclosporins|mesh-list
19796977|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
19796978|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796979|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19796980|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
19796981|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19796982|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
19796983|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
20157134|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157135|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157136|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
20323951|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20323952|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
20323953|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20323954|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323955|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20157137|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157138|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157139|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
20157140|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157141|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
20157142|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157143|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157144|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
20157145|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
20157146|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157147|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20157148|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20157149|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20157150|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
20323956|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642500|NCT02386059|Hormones|hormones|mesh-ancestor
19642501|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642502|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642503|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642504|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
19642505|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19796984|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19796985|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20323957|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
20323958|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
19642506|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642507|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
19642508|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
19642509|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19642510|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
19642511|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642512|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19642513|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19642514|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642515|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19642516|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19796986|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19796987|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
20323959|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19796988|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20157151|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20323960|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19796989|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19796990|NCT03751098|Protective Agents|protective agents|mesh-ancestor
19796991|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19796992|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19796993|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
20157152|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20157153|NCT00110071|Iodine|iodine|mesh-list
20157154|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
20157155|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20157156|NCT00110071|Fludarabine|fludarabine|mesh-list
20157157|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
20157158|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
20157159|NCT00110071|Antibodies|antibodies|mesh-list
20157160|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
20611451|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611452|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611453|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611454|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611455|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
19642517|NCT02386072|Mirabegron|mirabegron|mesh-list
19642518|NCT02386072|Oxybutynin|oxybutynin|mesh-list
19642519|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19796994|NCT03729869|Progesterone|progesterone|mesh-list
19796995|NCT03729869|Progestins|progestins|mesh-ancestor
19796996|NCT03729869|Hormones|hormones|mesh-ancestor
19796997|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19796998|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323961|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
20323962|NCT00734877|Hormones|hormones|mesh-ancestor
20323963|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20323964|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20323965|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
19796999|NCT03677141|Prednisone|prednisone|mesh-list
19797000|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
19797001|NCT03677141|Doxorubicin|doxorubicin|mesh-list
19642520|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19642521|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19642522|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19642523|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19642524|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797002|NCT03677141|Vincristine|vincristine|mesh-list
19797003|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797004|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
19797005|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797006|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797007|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797008|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
19797009|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797010|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797011|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797012|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19797013|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797014|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797015|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797016|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797017|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
19797018|NCT03677141|Hormones|hormones|mesh-ancestor
19642525|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797019|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797020|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797021|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19642526|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642527|NCT02386072|Urological Agents|urological agents|mesh-ancestor
19642528|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19642529|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
19642530|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
19642531|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
19642532|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642533|NCT02385825|Vaccines|vaccines|mesh-list
19642534|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
19797022|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797023|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797024|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
20323966|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611456|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157161|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19797025|NCT03675412|Caffeine|caffeine|mesh-list
19797026|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19797027|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797028|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19797029|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797030|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797031|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20323967|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20323968|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20323969|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20323970|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20323971|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
20323972|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20323973|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20323974|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797032|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19797033|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
19797034|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797035|NCT03636503|Rituximab|rituximab|mesh-list
19797036|NCT03636503|Avelumab|avelumab|mesh-list
20323975|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20323976|NCT00734877|Growth Substances|growth substances|mesh-ancestor
20323977|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
20323978|NCT00734890|Bevacizumab|bevacizumab|mesh-list
20323979|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20323980|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20323981|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20323982|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20323983|NCT00734890|Growth Substances|growth substances|mesh-ancestor
19797037|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797038|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797039|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
19797040|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323984|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323985|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
20323986|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20323987|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20323988|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20323989|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20323990|NCT00735020|Vaccines|vaccines|mesh-list
19642535|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642536|NCT02385656|Modafinil|modafinil|mesh-list
19642537|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19642538|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642539|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19642540|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20323991|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
20323992|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323993|NCT00735124|Gabapentin|gabapentin|mesh-list
20323994|NCT00735124|Analgesics|analgesics|mesh-ancestor
20323995|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
20323996|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642541|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19642542|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642543|NCT02385617|Octreotide|octreotide|mesh-list
19642544|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642545|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642546|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642547|NCT02385734|Mitogens|mitogens|mesh-list
19642548|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19642549|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642550|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19797041|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797042|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
19797043|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797044|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19797045|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19797046|NCT03561584|Analgesics|analgesics|mesh-ancestor
19642551|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
19642552|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642553|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
19642554|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
19797047|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
19642555|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
19642556|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20323997|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20323998|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
20323999|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20324000|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20324001|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324002|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324003|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19797048|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797049|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797050|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797051|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797052|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19797053|NCT03554083|Atezolizumab|atezolizumab|mesh-list
19797054|NCT03554083|Vemurafenib|vemurafenib|mesh-list
19642557|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642558|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
19642559|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642560|NCT02385500|Fesoterodine|fesoterodine|mesh-list
20324004|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20324005|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324006|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797055|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19797056|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797057|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
19797058|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797059|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797060|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157162|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
20157163|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642561|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19642562|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19642563|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
19642564|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642565|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642566|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324007|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
20157164|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157165|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157166|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
19797061|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797062|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19797063|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157167|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157168|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347678|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347679|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20347680|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20157169|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20157170|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157171|NCT00110071|Trace Elements|trace elements|mesh-ancestor
20157172|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
20157173|NCT00110123|Fotemustine|fotemustine|mesh-list
20157174|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157175|NCT00110162|Hormones|hormones|mesh-list
20157176|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
20157177|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642567|NCT02385500|Urological Agents|urological agents|mesh-ancestor
19642568|NCT02385474|Fluorides|fluorides|mesh-list
19642569|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
19642570|NCT02385474|Protective Agents|protective agents|mesh-ancestor
19642571|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642572|NCT02385461|Heparin|heparin|mesh-list
19642573|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19642574|NCT02385461|Tinzaparin|tinzaparin|mesh-list
19642575|NCT02385461|Dalteparin|dalteparin|mesh-list
19642576|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
19642577|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19642578|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19642579|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611457|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
19642580|NCT02385448|Dienogest|dienogest|mesh-list
19642581|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19642582|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19642583|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19642584|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
19642585|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19642586|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642587|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19642588|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19642589|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19642590|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19642591|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
19642592|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642593|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642594|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642595|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19642596|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19642597|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19642598|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19642599|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19642600|NCT02385422|Propranolol|propranolol|mesh-list
20324008|NCT00735228|Pancrelipase|pancrelipase|mesh-list
20324009|NCT00735228|Pancreatin|pancreatin|mesh-list
20324010|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324011|NCT00735241|Leucovorin|leucovorin|mesh-list
20324012|NCT00735241|Folic Acid|folic acid|mesh-list
20324013|NCT00735241|Bevacizumab|bevacizumab|mesh-list
20324014|NCT00735241|Fluorouracil|fluorouracil|mesh-list
20324015|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
20324016|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
20324017|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20324018|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157178|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611458|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157179|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
20157180|NCT00110188|Sirolimus|sirolimus|mesh-list
20157181|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20157182|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157183|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20157184|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157185|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
20157186|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157187|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
20324019|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20324020|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20324021|NCT00735241|Growth Substances|growth substances|mesh-ancestor
20324022|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324023|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
20324024|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
20324025|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642601|NCT02385422|Carvedilol|carvedilol|mesh-list
19797064|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797065|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
19797066|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797067|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797068|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
20157188|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157189|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20157190|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
20157191|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157192|NCT00110240|Vildagliptin|vildagliptin|mesh-list
20157193|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157194|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157195|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20157196|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
20157197|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157198|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157199|NCT00110253|Lidocaine|lidocaine|mesh-list
20324026|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324027|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324028|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
20611459|NCT01062425|Temozolomide|temozolomide|mesh-list
20611460|NCT01062425|Cediranib|cediranib|mesh-list
20324029|NCT00735241|Antidotes|antidotes|mesh-ancestor
20324030|NCT00735241|Protective Agents|protective agents|mesh-ancestor
20324031|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
20324032|NCT00735241|Vitamins|vitamins|mesh-ancestor
20324033|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
19642602|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19642603|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19642604|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
19642605|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642606|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642607|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797069|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
19797070|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797071|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797072|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797073|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
19797074|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
19797075|NCT03344965|Olaparib|olaparib|mesh-list
19797076|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19797077|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797078|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797079|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797080|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19797081|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19797082|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797083|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
19797084|NCT03302234|Ipilimumab|ipilimumab|mesh-list
19797085|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797086|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797087|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19797088|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797089|NCT03284723|Letrozole|letrozole|mesh-list
19797090|NCT03284723|Palbociclib|palbociclib|mesh-list
19797091|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797092|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19797093|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19797094|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797095|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797096|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19797097|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
19797098|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797099|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797100|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797101|NCT03282981|Timolol|timolol|mesh-list
19797102|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19797103|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20157200|NCT00110253|Tetracaine|tetracaine|mesh-list
20157201|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
20157202|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
20157203|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642608|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19642609|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19642610|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
19642611|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
19642612|NCT02385422|Protective Agents|protective agents|mesh-ancestor
19642613|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19642614|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642615|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19642616|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19642617|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19642618|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
19642619|NCT02385435|Bupivacaine|bupivacaine|mesh-list
19642620|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
19642621|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
20157204|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157205|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
20157206|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157207|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20157208|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20157209|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20324034|NCT00735241|Hematinics|hematinics|mesh-ancestor
19642622|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19797104|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
19797105|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797106|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797107|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797108|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19797109|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19797110|NCT03278717|Olaparib|olaparib|mesh-list
19797111|NCT03278717|Cediranib|cediranib|mesh-list
19797112|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19797113|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797114|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797115|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797116|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797117|NCT03165955|Paclitaxel|paclitaxel|mesh-list
19797118|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797119|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324035|NCT00735280|Heparin|heparin|mesh-list
20324036|NCT00735280|Calcium heparin|calcium heparin|mesh-list
20324037|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
19797120|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797121|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797122|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797123|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797124|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
19797125|NCT03133793|Vitamins|vitamins|mesh-ancestor
19797126|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
19642623|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642624|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
19642625|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642626|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19642627|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19642628|NCT02385435|Analgesics|analgesics|mesh-ancestor
19642629|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19642630|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19642631|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19642632|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
19642633|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642634|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642635|NCT02385396|Folic Acid|folic acid|mesh-list
19642636|NCT02385396|Inositol|inositol|mesh-list
19797127|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797128|NCT03130127|Terlipressin|terlipressin|mesh-list
19797129|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19797130|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19797131|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
20324038|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20324039|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20324040|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324041|NCT00735345|Docetaxel|docetaxel|mesh-list
19797132|NCT03127774|Antidotes|antidotes|mesh-ancestor
19797133|NCT03127774|Protective Agents|protective agents|mesh-ancestor
19797134|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642637|NCT02385396|Hematinics|hematinics|mesh-ancestor
19642638|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
19642639|NCT02385396|Vitamins|vitamins|mesh-ancestor
19642640|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
19642641|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642642|NCT02385266|Cycloserine|cycloserine|mesh-list
19642643|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19642644|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797135|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
20324042|NCT00735345|Cetuximab|cetuximab|mesh-list
20324043|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797136|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797137|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
19797138|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19797139|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797140|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
19797141|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
19834210|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834211|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834212|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20324044|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
19834213|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19642645|NCT02385266|Renal Agents|renal agents|mesh-ancestor
20324045|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797142|NCT03127267|Riluzole|riluzole|mesh-list
19797143|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
19797144|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19797145|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19797146|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797147|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642646|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19642647|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
19642648|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642649|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
19642650|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642651|NCT02385305|Anesthetics|anesthetics|mesh-list
19642652|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642653|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642654|NCT02385058|Mebendazole|mebendazole|mesh-list
19642655|NCT02385058|Piperazine|piperazine|mesh-list
19642656|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
19642657|NCT02385058|DMP 777|dmp 777|mesh-list
19642658|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
19797148|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797149|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19797150|NCT03127267|Protective Agents|protective agents|mesh-ancestor
19797151|NCT03108131|Atezolizumab|atezolizumab|mesh-list
20324046|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797152|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20324047|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324048|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797153|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797154|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
19797155|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797156|NCT03063203|Decitabine|decitabine|mesh-list
19797157|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157210|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20157211|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157212|NCT00110344|Sorafenib|sorafenib|mesh-list
20157213|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157214|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20157215|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157216|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157217|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
20157218|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157219|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157220|NCT00110448|Aspirin|aspirin|mesh-list
20157221|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20157222|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157223|NCT00110448|Analgesics|analgesics|mesh-ancestor
20157224|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
20157225|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157226|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157227|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157228|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157229|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20157230|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20157231|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157232|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20157233|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20157234|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157235|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
20157236|NCT00110474|Acetaminophen|acetaminophen|mesh-list
20157237|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157238|NCT00110474|Analgesics|analgesics|mesh-ancestor
20157239|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
20157240|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157241|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157242|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
20157243|NCT00110578|Aldesleukin|aldesleukin|mesh-list
20157244|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157245|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20157246|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20157247|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
20157248|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157249|NCT00110591|Leronlimab|leronlimab|mesh-list
20157250|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20157251|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19797158|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
20324049|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
20324050|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20324051|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324052|NCT00735527|Lorazepam|lorazepam|mesh-list
20324053|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
20324054|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
20324055|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
20324056|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324057|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324058|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324059|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20324060|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324061|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20324062|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20324063|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324064|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
20324065|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
20324066|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324067|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324068|NCT00735748|Tramadol|tramadol|mesh-list
20324069|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20324070|NCT00735748|Narcotics|narcotics|mesh-ancestor
20324071|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324072|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324073|NCT00735748|Analgesics|analgesics|mesh-ancestor
20324074|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
20324075|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324076|NCT00735761|Acyclovir|acyclovir|mesh-list
20157252|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157253|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20157254|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20157255|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
20157256|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157257|NCT00110604|Folic Acid|folic acid|mesh-list
20157258|NCT00110604|Hematinics|hematinics|mesh-ancestor
20157259|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
19797159|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797160|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797161|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797162|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20324077|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
20324078|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
20324079|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324080|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324081|NCT00735813|Heparin|heparin|mesh-list
20324082|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
20324083|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20324084|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19642659|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
19642660|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19642661|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642662|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
19642663|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797163|NCT03057795|Nivolumab|nivolumab|mesh-list
19797164|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19797165|NCT03057795|Antibodies|antibodies|mesh-list
19642664|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
19642665|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642666|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642667|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642668|NCT02385227|Nicotine|nicotine|mesh-list
19642669|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19642670|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
19642671|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642672|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642673|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19642674|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19642675|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
19642676|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642677|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797166|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
19797167|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19797168|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
20157260|NCT00110604|Vitamins|vitamins|mesh-ancestor
20157261|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
20157262|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157263|NCT00110630|Nicotine|nicotine|mesh-list
20324085|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797169|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
19797170|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797171|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797172|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19797173|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797174|NCT02947685|Trastuzumab|trastuzumab|mesh-list
19797175|NCT02947685|Pertuzumab|pertuzumab|mesh-list
19797176|NCT02947685|Letrozole|letrozole|mesh-list
19797177|NCT02947685|Fulvestrant|fulvestrant|mesh-list
19797178|NCT02947685|Palbociclib|palbociclib|mesh-list
20157264|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20157265|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
19797179|NCT02947685|Anastrozole|anastrozole|mesh-list
19797180|NCT02947685|Exemestane|exemestane|mesh-list
19797181|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797182|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797183|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19797184|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19797185|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797186|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797187|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19797188|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
19797189|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797190|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797191|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797192|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19797193|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797194|NCT02845882|Cytarabine|cytarabine|mesh-list
19797195|NCT02845882|Dexamethasone|dexamethasone|mesh-list
19797196|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
19797197|NCT02845882|Prednisone|prednisone|mesh-list
19797198|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
19797199|NCT02845882|Ifosfamide|ifosfamide|mesh-list
19797200|NCT02845882|Doxorubicin|doxorubicin|mesh-list
19797201|NCT02845882|Methotrexate|methotrexate|mesh-list
19797202|NCT02845882|Etoposide|etoposide|mesh-list
19797203|NCT02845882|Vincristine|vincristine|mesh-list
19797204|NCT02845882|Daunorubicin|daunorubicin|mesh-list
19797205|NCT02845882|Asparaginase|asparaginase|mesh-list
19797206|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
19797207|NCT02845882|Vindesine|vindesine|mesh-list
19797208|NCT02845882|Pegaspargase|pegaspargase|mesh-list
19797209|NCT02845882|BB 1101|bb 1101|mesh-list
19797210|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797211|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
19797212|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797213|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797214|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797215|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
19797216|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797217|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797218|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797219|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797220|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
19797221|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
19797222|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797223|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19797224|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
19797225|NCT02845882|Hormones|hormones|mesh-ancestor
19797226|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797227|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797228|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
19797229|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797230|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19797231|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797232|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797233|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19797234|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
19797235|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19797236|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797237|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
20157266|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157267|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157268|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20324086|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19797238|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
19797239|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19834214|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
19797240|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19797241|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797242|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
19797243|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797244|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797245|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797246|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797247|NCT02843451|Silymarin|silymarin|mesh-list
19797248|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
19797249|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797250|NCT02843451|Protective Agents|protective agents|mesh-ancestor
19797251|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797252|NCT02795156|Afatinib|afatinib|mesh-list
19797253|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797254|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797255|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797256|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797257|NCT02782949|Curcumin|curcumin|mesh-list
19797258|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19797259|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19797260|NCT02782949|Analgesics|analgesics|mesh-ancestor
19797261|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
19797262|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797263|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157269|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20157270|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
20157271|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20157272|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157273|NCT00110669|Prednisone|prednisone|mesh-list
20157274|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157275|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
20157276|NCT00110669|Hormones|hormones|mesh-ancestor
19642678|NCT02385188|Acetaminophen|acetaminophen|mesh-list
19642679|NCT02385188|Imiquimod|imiquimod|mesh-list
19642680|NCT02385188|Lidocaine|lidocaine|mesh-list
19642681|NCT02385188|Petrolatum|petrolatum|mesh-list
19642682|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
19642683|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
19642684|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642685|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642686|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
19642687|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642688|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19642689|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19642690|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19642691|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642692|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642693|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157277|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157278|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157279|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642694|NCT02385188|Analgesics|analgesics|mesh-ancestor
19642695|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
19642696|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19642697|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
20157280|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157281|NCT00110682|Imiquimod|imiquimod|mesh-list
20157282|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20157283|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
20157284|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157285|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157286|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
20157287|NCT00110695|Paclitaxel|paclitaxel|mesh-list
20157288|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20157289|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20157290|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157291|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
20157292|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157293|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157294|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157295|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
20157296|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20157297|NCT00110708|Antibodies|antibodies|mesh-list
20157298|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
19642698|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157299|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157300|NCT00110721|Fluorouracil|fluorouracil|mesh-list
20157301|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
20157302|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157303|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157304|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157305|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797264|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797265|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797266|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797267|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797268|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797269|NCT02772003|Interleukin-12|interleukin-12|mesh-list
19797270|NCT02772003|Vaccines|vaccines|mesh-list
19797271|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
19797272|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797273|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19797274|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797275|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19797276|NCT02772003|Growth Substances|growth substances|mesh-ancestor
19797277|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
19797278|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797279|NCT02662634|Paclitaxel|paclitaxel|mesh-list
19797280|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19797281|NCT02662634|Cisplatin|cisplatin|mesh-list
19797282|NCT02662634|Carboplatin|carboplatin|mesh-list
19797283|NCT02662634|Pemetrexed|pemetrexed|mesh-list
19797284|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797285|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324087|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
20324088|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20324089|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
20324090|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19797286|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797287|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797288|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797289|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797290|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797291|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19797292|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19797293|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
19797294|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797295|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797296|NCT02599714|Fulvestrant|fulvestrant|mesh-list
19797297|NCT02599714|Palbociclib|palbociclib|mesh-list
19797298|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797299|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797300|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19797301|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19797302|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
19797303|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797304|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797305|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797306|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797307|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797308|NCT02503722|Osimertinib|osimertinib|mesh-list
19797309|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797310|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797311|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797312|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797313|NCT02491632|Dexamethasone|dexamethasone|mesh-list
19797314|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
19797315|NCT02491632|Ichthammol|ichthammol|mesh-list
19797316|NCT02491632|BB 1101|bb 1101|mesh-list
19797317|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797318|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
19797319|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
19797320|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797321|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157306|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
20157307|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157308|NCT00110734|Lidocaine|lidocaine|mesh-list
20157309|NCT00110734|Tetracaine|tetracaine|mesh-list
20324091|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797322|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19797323|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
20157310|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
20157311|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
20157312|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157313|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797324|NCT02491632|Hormones|hormones|mesh-ancestor
19797325|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797326|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797327|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797328|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
19797329|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797330|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797331|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
19797332|NCT02448420|Trastuzumab|trastuzumab|mesh-list
19797333|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19797334|NCT02448420|Palbociclib|palbociclib|mesh-list
19797335|NCT02448420|Antibodies|antibodies|mesh-list
19797336|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
19642699|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
19642700|NCT02385188|Emollients|emollients|mesh-ancestor
19797337|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
19797338|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797339|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797340|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797341|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797342|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797343|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797344|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797345|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797346|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797347|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
19797348|NCT02432963|Vaccines|vaccines|mesh-list
19797349|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
19797350|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797351|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797352|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797353|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19797354|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19797355|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19797356|NCT02405676|Cytarabine|cytarabine|mesh-list
19797357|NCT02405676|Prednisone|prednisone|mesh-list
19797358|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
19797359|NCT02405676|Ifosfamide|ifosfamide|mesh-list
19797360|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
20324092|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20324093|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642701|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
19797361|NCT02405676|Rituximab|rituximab|mesh-list
19797362|NCT02405676|Methotrexate|methotrexate|mesh-list
19797363|NCT02405676|Etoposide|etoposide|mesh-list
19797364|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
19797365|NCT02405676|Vincristine|vincristine|mesh-list
19797366|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797367|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
19797368|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797369|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797370|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797371|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
19797372|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797373|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157314|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
20157315|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157316|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19797374|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797375|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797376|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797377|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
20347681|NCT00861419|Growth Substances|growth substances|mesh-ancestor
19642702|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19642703|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19642704|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642705|NCT02385136|Temozolomide|temozolomide|mesh-list
19642706|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797378|NCT02405676|Hormones|hormones|mesh-ancestor
20157317|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19642707|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
19797379|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797380|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797381|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19642708|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642709|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642710|NCT02385071|Simeprevir|simeprevir|mesh-list
19642711|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
19797382|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
19797383|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19797384|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797385|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
19797386|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
19797387|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797388|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19797389|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19797390|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797391|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797392|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797393|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
19797394|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797395|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797396|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797397|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797398|NCT02362451|Vaccines|vaccines|mesh-list
19797399|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
19797400|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797401|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
19797402|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797403|NCT02342782|Cytarabine|cytarabine|mesh-list
19797404|NCT02342782|Etoposide|etoposide|mesh-list
19797405|NCT02342782|Melphalan|melphalan|mesh-list
19797406|NCT02342782|Carmustine|carmustine|mesh-list
19797407|NCT02342782|Basiliximab|basiliximab|mesh-list
19797408|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797409|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797410|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797411|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797412|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797413|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797414|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19642712|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642713|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
19642714|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642715|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663611|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663612|NCT03311555|Hormones|hormones|mesh-ancestor
19663613|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663614|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663615|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
19663616|NCT03264404|Azacitidine|azacitidine|mesh-list
19663617|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663618|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663619|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663620|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
19797415|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
19797416|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
19797417|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797418|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797419|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
19797420|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797421|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797422|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
19797423|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797424|NCT02337634|Silymarin|silymarin|mesh-list
20157318|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20157319|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20157320|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663621|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663622|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663623|NCT03246074|Paclitaxel|paclitaxel|mesh-list
19663624|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19663625|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663626|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797425|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
19797426|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642716|NCT02384668|Vitamin D|vitamin d|mesh-list
19642717|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
19642718|NCT02384668|Vitamins|vitamins|mesh-ancestor
19642719|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
19642720|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642721|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19642722|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19642723|NCT02384915|Prilocaine|prilocaine|mesh-list
20157321|NCT00110747|Lidocaine|lidocaine|mesh-list
20157322|NCT00110747|Tetracaine|tetracaine|mesh-list
20157323|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
20157324|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
19797427|NCT02337634|Protective Agents|protective agents|mesh-ancestor
19797428|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797429|NCT02336087|Metformin|metformin|mesh-list
19797430|NCT02336087|Gemcitabine|gemcitabine|mesh-list
19797431|NCT02336087|Paclitaxel|paclitaxel|mesh-list
19797432|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19797433|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797434|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797435|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797436|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797437|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797438|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797439|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797440|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
19797441|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
19797442|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797443|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797444|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797445|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
19797446|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797447|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19797448|NCT02335580|Somatostatin|somatostatin|mesh-list
19797449|NCT02335580|Hormones|hormones|mesh-ancestor
19797450|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797451|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797452|NCT02282020|Olaparib|olaparib|mesh-list
19797453|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19797454|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797455|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797456|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797457|NCT02277782|Fentanyl|fentanyl|mesh-list
19797458|NCT02277782|Hydromorphone|hydromorphone|mesh-list
19797459|NCT02277782|Bupivacaine|bupivacaine|mesh-list
19797460|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
19797461|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
20157325|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157326|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157327|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
20157328|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157329|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20157330|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19797462|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19797463|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642724|NCT02384915|Mepivacaine|mepivacaine|mesh-list
19642725|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
19642726|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642727|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642728|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
19642729|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
19642730|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642731|NCT02384954|Rituximab|rituximab|mesh-list
19642732|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19642733|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642734|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
19642735|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642736|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642737|NCT02384967|Darunavir|darunavir|mesh-list
19642738|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19642739|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19642740|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
19797464|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
19797465|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797466|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19797467|NCT02277782|Narcotics|narcotics|mesh-ancestor
20157331|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19642741|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642742|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642743|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19642744|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19642745|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
19642746|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642747|NCT02384876|Ephedrine|ephedrine|mesh-list
19642748|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
19642749|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19642750|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19642751|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642752|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
19642753|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
19642754|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642755|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19642756|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
19797468|NCT02277782|Analgesics|analgesics|mesh-ancestor
19797469|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19797470|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19797471|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
19797472|NCT02271230|Vitamin D|vitamin d|mesh-list
19797473|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
19642757|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642758|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642759|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19642760|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19642761|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
19642762|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
19642763|NCT02384837|Sirolimus|sirolimus|mesh-list
19642764|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19642765|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642766|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19642767|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642768|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
19642769|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797474|NCT02271230|Vitamins|vitamins|mesh-list
19797475|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
19797476|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797477|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19797478|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19797479|NCT02268448|Clonidine|clonidine|mesh-list
19797480|NCT02268448|Naltrexone|naltrexone|mesh-list
19797481|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19797482|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19797483|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797484|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
20157332|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20157333|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157334|NCT00110760|Lidocaine|lidocaine|mesh-list
20157335|NCT00110760|Tetracaine|tetracaine|mesh-list
20157336|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
20157337|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
20157338|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157339|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157340|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
20157341|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157342|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19797485|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797486|NCT02268448|Analgesics|analgesics|mesh-ancestor
19797487|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19797488|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
19797489|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
19797490|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19797491|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19797492|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19797493|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
19797494|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797495|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797496|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
19797497|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157343|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20157344|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20157345|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20157346|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157347|NCT00110773|Lidocaine|lidocaine|mesh-list
19797498|NCT02048150|Antibodies|antibodies|mesh-list
19797499|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19797500|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
19797501|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797502|NCT02038777|Cytarabine|cytarabine|mesh-list
19797503|NCT02038777|Azacitidine|azacitidine|mesh-list
19797504|NCT02038777|Daunorubicin|daunorubicin|mesh-list
19797505|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797506|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
19797507|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797508|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797509|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
19797510|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797511|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797512|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
19797513|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797514|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797515|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19797516|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797517|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797518|NCT01996449|Amlodipine|amlodipine|mesh-list
19797519|NCT01996449|Eplerenone|eplerenone|mesh-list
19797520|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19797521|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19797522|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19797523|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324094|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324095|NCT00735930|Lenalidomide|lenalidomide|mesh-list
20324096|NCT00735930|Alvocidib|alvocidib|mesh-list
20324097|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
20324098|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324099|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20324100|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20324101|NCT00735930|Growth Substances|growth substances|mesh-ancestor
19797524|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19797525|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797526|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
19797527|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19797528|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
19797529|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797530|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20157348|NCT00110773|Tetracaine|tetracaine|mesh-list
20157349|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
20157350|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
20157351|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642770|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
19642771|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642772|NCT02384889|Eflornithine|eflornithine|mesh-list
19642773|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642774|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19642775|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19642776|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19642777|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157352|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157353|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
20157354|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157355|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20157356|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20157357|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20157358|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20157359|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642778|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19642779|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642780|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642781|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
19642782|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19642783|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642784|NCT02384746|Fulvestrant|fulvestrant|mesh-list
19642785|NCT02384746|Ixazomib|ixazomib|mesh-list
19642786|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20157360|NCT00110851|Metformin|metformin|mesh-list
19642787|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157361|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
20324102|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
20157362|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157363|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157364|NCT00110864|Insulin|insulin|mesh-list
20157365|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157366|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797531|NCT01996449|Diuretics|diuretics|mesh-ancestor
19797532|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
19797533|NCT01958190|Sirolimus|sirolimus|mesh-list
19797534|NCT01958190|Tacrolimus|tacrolimus|mesh-list
19797535|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797536|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
19797537|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797538|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19797539|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797540|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797541|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19797542|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797543|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19797544|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797545|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
19797546|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
19797547|NCT01936831|Pyridoxal|pyridoxal|mesh-list
19797548|NCT01936831|Pyridoxine|pyridoxine|mesh-list
19797549|NCT01936831|Isoniazid|isoniazid|mesh-list
19797550|NCT01936831|Vitamins|vitamins|mesh-ancestor
19797551|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
19797552|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797553|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
19797554|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
19797555|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19797556|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797557|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20324103|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324104|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20324105|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324106|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324107|NCT00736021|Citalopram|citalopram|mesh-list
19642788|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19797558|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19797559|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
19797560|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157367|NCT00110877|Darunavir|darunavir|mesh-list
20157368|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20157369|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20157370|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
20157371|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157372|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157373|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20157374|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20157375|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
20157376|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19642789|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19642790|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
19642791|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642792|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642793|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
19642794|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642795|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642796|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
19797561|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19797562|NCT01927419|Nivolumab|nivolumab|mesh-list
19797563|NCT01927419|Ipilimumab|ipilimumab|mesh-list
19797564|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797565|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797566|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19797567|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797568|NCT01924533|Paclitaxel|paclitaxel|mesh-list
19797569|NCT01924533|Olaparib|olaparib|mesh-list
19797570|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797571|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797572|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797573|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157377|NCT00110903|Etanercept|etanercept|mesh-list
19797574|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157378|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20157379|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157380|NCT00110903|Analgesics|analgesics|mesh-ancestor
20157381|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
20157382|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157383|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797575|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797576|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19797577|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324108|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20324109|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20324110|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19642797|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19642798|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19642799|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642800|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19642801|NCT02384343|Analgesics|analgesics|mesh-ancestor
19642802|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
20324111|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324112|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324113|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
20324114|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324115|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20324116|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
20324117|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324118|NCT00736164|Selenium|selenium|mesh-list
20324119|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
20324120|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324121|NCT00736164|Protective Agents|protective agents|mesh-ancestor
20324122|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324123|NCT00736164|Trace Elements|trace elements|mesh-ancestor
20324124|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
20324125|NCT00736294|Ramipril|ramipril|mesh-list
20324126|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20324127|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
20324128|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324129|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324130|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20324131|NCT00736320|Vincristine|vincristine|mesh-list
20324132|NCT00736320|Doxorubicin|doxorubicin|mesh-list
20324133|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20324134|NCT00736320|Dacarbazine|dacarbazine|mesh-list
20324135|NCT00736320|Bleomycin|bleomycin|mesh-list
19642803|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642804|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19642805|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19642806|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19642807|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
19642808|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642809|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642810|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19642811|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
19642812|NCT02384499|Coagulants|coagulants|mesh-ancestor
19642813|NCT02384512|Rasagiline|rasagiline|mesh-list
19642814|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19642815|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642816|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642817|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19642818|NCT02384512|Protective Agents|protective agents|mesh-ancestor
19642819|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642820|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
19642821|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19642822|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19642823|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797578|NCT01773395|Methotrexate|methotrexate|mesh-list
19642824|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
19642825|NCT02384135|Coagulants|coagulants|mesh-ancestor
19642826|NCT02384122|Octreotide|octreotide|mesh-list
19642827|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157384|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157385|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157386|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157387|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157388|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
20157389|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20157390|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157391|NCT00110929|Cinacalcet|cinacalcet|mesh-list
19797579|NCT01773395|Fludarabine|fludarabine|mesh-list
19797580|NCT01773395|Busulfan|busulfan|mesh-list
19797581|NCT01773395|Tacrolimus|tacrolimus|mesh-list
19797582|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19642828|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642829|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324136|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20324137|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324138|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
20324139|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
20324140|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324141|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324142|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20324143|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20324144|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20324145|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324146|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20324147|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
20324148|NCT00736346|Paroxetine|paroxetine|mesh-list
20324149|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20324150|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20324151|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20324152|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324153|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642830|NCT02383901|Methotrexate|methotrexate|mesh-list
19642831|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19642832|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
19642833|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19642834|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642835|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19642836|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
19642837|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642838|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642839|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
19642840|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642841|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19642842|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642843|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
19642844|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642845|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19642846|NCT02383823|Estradiol|estradiol|mesh-list
19642847|NCT02383823|Estrogens|estrogens|mesh-list
19642848|NCT02383823|Hormones|hormones|mesh-ancestor
19642849|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642850|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642851|NCT02383888|BI 425809|bi 425809|mesh-list
19797583|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
19797584|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19797585|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797586|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797587|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
19797588|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797589|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797590|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
19797591|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797592|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19797593|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797594|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
19797595|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797596|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19797597|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20157392|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20157393|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157394|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20157395|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
20157396|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157397|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
20157398|NCT00110955|Hematinics|hematinics|mesh-ancestor
20157399|NCT00110981|Etanercept|etanercept|mesh-list
20157400|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20157401|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157402|NCT00110981|Analgesics|analgesics|mesh-ancestor
19797598|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
19797599|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797600|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797601|NCT01750073|Paclitaxel|paclitaxel|mesh-list
19797602|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
19797603|NCT01750073|Doxorubicin|doxorubicin|mesh-list
19797604|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19797605|NCT01750073|Trastuzumab|trastuzumab|mesh-list
19797606|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19642852|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
19642853|NCT02383927|Tipifarnib|tipifarnib|mesh-list
19642854|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642855|NCT02384083|Dexamethasone|dexamethasone|mesh-list
19642856|NCT02384083|Pomalidomide|pomalidomide|mesh-list
19642857|NCT02384083|Filanesib|filanesib|mesh-list
19642858|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642859|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
19642860|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
19642861|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324154|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
20324155|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324156|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20324157|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
20324158|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324159|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20324160|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20324161|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324162|NCT00736463|Atorvastatin|atorvastatin|mesh-list
20324163|NCT00736463|Simvastatin|simvastatin|mesh-list
20324164|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20324165|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20324166|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
20324167|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324168|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20324169|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20324170|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324171|NCT00736515|Insulin|insulin|mesh-list
20324172|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20324173|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
19642862|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642863|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19642864|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
19642865|NCT02384083|Hormones|hormones|mesh-ancestor
19642866|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642867|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642868|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642869|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
19642870|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797607|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19797608|NCT01750073|Antibodies|antibodies|mesh-list
19797609|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
19797610|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19797611|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797612|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157403|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
20157404|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157405|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157406|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157407|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157408|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157409|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157410|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
20157411|NCT00111020|Sorafenib|sorafenib|mesh-list
20157412|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157413|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20157414|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157415|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157416|NCT00111046|Ibuprofen|ibuprofen|mesh-list
20157417|NCT00111046|Tramadol|tramadol|mesh-list
20157418|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20157419|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157420|NCT00111046|Analgesics|analgesics|mesh-ancestor
20157421|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
20324174|NCT00736515|Gliclazide|gliclazide|mesh-list
19797613|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
20157422|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157423|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324175|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20324176|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324177|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
20324178|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19797614|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797615|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797616|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797617|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797618|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
19797619|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797620|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797621|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797622|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
20157424|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157425|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157426|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20157427|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157428|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797623|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797624|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20157429|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20157430|NCT00111046|Narcotics|narcotics|mesh-ancestor
20157431|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157432|NCT00111072|Dexamethasone|dexamethasone|mesh-list
20157433|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157434|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
20157435|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
19642871|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19642872|NCT02384083|Growth Substances|growth substances|mesh-ancestor
19642873|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
19642874|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19642875|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19642876|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642877|NCT02384187|Gabapentin|gabapentin|mesh-list
19642878|NCT02384187|Analgesics|analgesics|mesh-ancestor
19642879|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
19797625|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797626|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797627|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324179|NCT00736541|Cystatins|cystatins|mesh-list
20324180|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
19642880|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642881|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642882|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
19797628|NCT01730833|Paclitaxel|paclitaxel|mesh-list
19797629|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19797630|NCT01730833|Trastuzumab|trastuzumab|mesh-list
19797631|NCT01730833|Pertuzumab|pertuzumab|mesh-list
19797632|NCT01730833|Antibodies|antibodies|mesh-list
19642883|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19642884|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19797633|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
19797634|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797635|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797636|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797637|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797638|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797639|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797640|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
19797641|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797642|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797643|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
19797644|NCT01723839|Rituximab|rituximab|mesh-list
19797645|NCT01723839|Fludarabine|fludarabine|mesh-list
19797646|NCT01723839|Lenalidomide|lenalidomide|mesh-list
19797647|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797648|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
19797649|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157436|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157437|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157438|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157439|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
20157440|NCT00111072|Hormones|hormones|mesh-ancestor
20157441|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157442|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642885|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19797650|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797651|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797652|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
19797653|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797654|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642886|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19642887|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19642888|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19642889|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20157443|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157444|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
20157445|NCT00111098|Hematinics|hematinics|mesh-ancestor
19797655|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797656|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797657|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797658|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19797659|NCT01723839|Growth Substances|growth substances|mesh-ancestor
19797660|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
20157446|NCT00111111|Etanercept|etanercept|mesh-list
20157447|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19642890|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642891|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
19642892|NCT02383680|Vaccines|vaccines|mesh-list
19642893|NCT02383680|Immunologic Factors|immunologic factors|mesh-ancestor
19642894|NCT02383680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642895|NCT02383771|Aspirin|aspirin|mesh-list
19642896|NCT02383771|Ticagrelor|ticagrelor|mesh-list
19642897|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19642898|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157448|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19797661|NCT01711879|Aflibercept|aflibercept|mesh-list
19797662|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797663|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19797664|NCT01711879|Growth Substances|growth substances|mesh-ancestor
19797665|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642899|NCT02383771|Analgesics|analgesics|mesh-ancestor
19642900|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
19642901|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642902|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324181|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324182|NCT00736541|Expectorants|expectorants|mesh-ancestor
20324183|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
20324184|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19642903|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642904|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642905|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19642906|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19642907|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642908|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19642909|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19642910|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642911|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
19642912|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19642913|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19642914|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19642915|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
19642916|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642917|NCT02383563|Metformin|metformin|mesh-list
19642918|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19642919|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642920|NCT02383121|Midodrine|midodrine|mesh-list
19642921|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
19642922|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
19642923|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642924|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642925|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20157449|NCT00111111|Analgesics|analgesics|mesh-ancestor
20157450|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
20157451|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157452|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157453|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324185|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
19797666|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
20157454|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20611461|NCT01062425|Maleic acid|maleic acid|mesh-list
20324186|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324187|NCT00736541|Protective Agents|protective agents|mesh-ancestor
20324188|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324189|NCT00736541|Antidotes|antidotes|mesh-ancestor
20324190|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20324191|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
20324192|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324193|NCT00736606|Simvastatin|simvastatin|mesh-list
20324194|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20157455|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157456|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157457|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
20157458|NCT00111124|Etanercept|etanercept|mesh-list
20324195|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20324196|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
20324197|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324198|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19642926|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19642927|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19642928|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19642929|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19642930|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642931|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642932|NCT02383212|Paclitaxel|paclitaxel|mesh-list
19642933|NCT02383212|Docetaxel|docetaxel|mesh-list
19642934|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
19642935|NCT02383212|Carboplatin|carboplatin|mesh-list
19642936|NCT02383212|Pemetrexed|pemetrexed|mesh-list
19642937|NCT02383212|Cemiplimab|cemiplimab|mesh-list
19642938|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19642939|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642940|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
20157459|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20157460|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157461|NCT00111124|Analgesics|analgesics|mesh-ancestor
20157462|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
20157463|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157464|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157465|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642941|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
19642942|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157466|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157467|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157468|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157469|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
20157470|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
20157471|NCT00111137|Hematinics|hematinics|mesh-ancestor
20157472|NCT00111150|Tenofovir|tenofovir|mesh-list
19642943|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157473|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
20157474|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157475|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20157476|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20157477|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157478|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157479|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20174139|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
20324199|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19642944|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19642945|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
19642946|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642947|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642948|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19642949|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
19663627|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
19663628|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
19663629|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663630|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
19663631|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20157480|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20157481|NCT00111163|Artesunate|artesunate|mesh-list
20157482|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
20157483|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
20157484|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20324200|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642950|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19642951|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642952|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19642953|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19642954|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19642955|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
19642956|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19642957|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642958|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19642959|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642960|NCT02383030|Fulvestrant|fulvestrant|mesh-list
19642961|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19642962|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642963|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19642964|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19642965|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
19642966|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19642967|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663632|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19663633|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19663634|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663635|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663636|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
20324201|NCT00736619|Paclitaxel|paclitaxel|mesh-list
20324202|NCT00736619|Cetuximab|cetuximab|mesh-list
20324203|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19663637|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663638|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324204|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20324205|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324206|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
20324207|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
20324208|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324209|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324210|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20324211|NCT00736697|Moxidectin|moxidectin|mesh-list
20324212|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
20324213|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20324214|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324215|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
19663639|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19663640|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663641|NCT03148327|Durvalumab|durvalumab|mesh-list
19797667|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797668|NCT01697267|Rituximab|rituximab|mesh-list
19797669|NCT01697267|Azathioprine|azathioprine|mesh-list
19797670|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797671|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797672|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
19797673|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157485|NCT00111163|Amodiaquine|amodiaquine|mesh-list
20157486|NCT00111163|Dapsone|dapsone|mesh-list
20157487|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
20157488|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
20157489|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20324216|NCT00736801|Fluticasone|fluticasone|mesh-list
20611462|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611463|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
20611464|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797674|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797675|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
19797676|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797677|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797678|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797679|NCT01653223|Simvastatin|simvastatin|mesh-list
19797680|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19797681|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19797682|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
19797683|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797684|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19797685|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19797686|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797687|NCT01527149|Cytarabine|cytarabine|mesh-list
19797688|NCT01527149|Dexamethasone|dexamethasone|mesh-list
19797689|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
19797690|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
19797691|NCT01527149|Doxorubicin|doxorubicin|mesh-list
19797692|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19797693|NCT01527149|Methotrexate|methotrexate|mesh-list
19797694|NCT01527149|Vincristine|vincristine|mesh-list
19797695|NCT01527149|Ofatumumab|ofatumumab|mesh-list
19797696|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19797697|NCT01527149|BB 1101|bb 1101|mesh-list
19797698|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797699|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
20157490|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20157491|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157492|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324217|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20324218|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324219|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20324220|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
20324221|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324222|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324223|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20324224|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
20157493|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
20157494|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
19797700|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797701|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797702|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797703|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
19797704|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797705|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797706|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797707|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797708|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
19797709|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
19797710|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797711|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19797712|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
19797713|NCT01527149|Hormones|hormones|mesh-ancestor
19797714|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797715|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797716|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19797717|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797718|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797719|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797720|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19797721|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
20157495|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20157496|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
20157497|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20157498|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157499|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157500|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20157501|NCT00111163|Renal Agents|renal agents|mesh-ancestor
20157502|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
20157503|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20157504|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20611465|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157505|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20157506|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19797722|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20324225|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
20324226|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20324227|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20324228|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20324229|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20157507|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157508|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157509|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20157510|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20157511|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20157512|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
20157513|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642968|NCT02382757|Insulin|insulin|mesh-list
19642969|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19642970|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19642971|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642972|NCT02382653|Piroxicam|piroxicam|mesh-list
19642973|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19642974|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19642975|NCT02382653|Analgesics|analgesics|mesh-ancestor
19642976|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
19642977|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19642978|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642979|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19642980|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19642981|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19642982|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642983|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642984|NCT02382679|Vitamins|vitamins|mesh-list
19642985|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
19642986|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642987|NCT02382666|Rolapitant|rolapitant|mesh-list
20157514|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157515|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19642988|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19642989|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19642990|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642991|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19642992|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19642993|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
19642994|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
20157516|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20157517|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
20157518|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20157519|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
20157520|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20157521|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20157522|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157523|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
20157524|NCT00111215|Coagulants|coagulants|mesh-ancestor
20157525|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20157526|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
20157527|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157528|NCT00111267|Vitamins|vitamins|mesh-list
20157529|NCT00111267|Folic Acid|folic acid|mesh-list
20324230|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
20324231|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20611466|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157530|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
20157531|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
20157532|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
20157533|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
20157534|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157535|NCT00111267|Hematinics|hematinics|mesh-ancestor
20157536|NCT00111280|Etravirine|etravirine|mesh-list
20157537|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20157538|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20157539|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157540|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157541|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
20157542|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174140|NCT00163605|Coagulants|coagulants|mesh-ancestor
20174141|NCT00163618|Formaldehyde|formaldehyde|mesh-list
20174142|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
20174143|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174144|NCT00163748|Gemcitabine|gemcitabine|mesh-list
20157543|NCT00111306|Epratuzumab|epratuzumab|mesh-list
20157544|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157545|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157546|NCT00111319|Bortezomib|bortezomib|mesh-list
20157547|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157548|NCT00111345|Daunorubicin|daunorubicin|mesh-list
20157549|NCT00111345|Idarubicin|idarubicin|mesh-list
20157550|NCT00111345|Cladribine|cladribine|mesh-list
20157551|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20157552|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157553|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20157554|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20157555|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19642995|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19642996|NCT02382549|Trametinib|trametinib|mesh-list
19642997|NCT02382549|Dabrafenib|dabrafenib|mesh-list
19642998|NCT02382549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19642999|NCT02382549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19643000|NCT02382549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643001|NCT02382549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643002|NCT02382263|Gemcitabine|gemcitabine|mesh-list
19643003|NCT02382263|Paclitaxel|paclitaxel|mesh-list
19643004|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19643005|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19643006|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643007|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
19643008|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
19643009|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
19643010|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643011|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797723|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157556|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324232|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324233|NCT00736814|Gemcitabine|gemcitabine|mesh-list
20324234|NCT00736814|Carboplatin|carboplatin|mesh-list
20324235|NCT00736814|Docetaxel|docetaxel|mesh-list
20324236|NCT00736814|Vinorelbine|vinorelbine|mesh-list
20324237|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324238|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324239|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
20324240|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324241|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
20324242|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324243|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324244|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324245|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
20324246|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157557|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157558|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
20157559|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324247|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
20324248|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
20324249|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324250|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20324251|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
20157560|NCT00111371|Levodopa|levodopa|mesh-list
20157561|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20157562|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20157563|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
20157564|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20157565|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157566|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157567|NCT00111397|Interferons|interferons|mesh-list
20157568|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
20157569|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324252|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20157570|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
20157571|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157572|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19797724|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
19797725|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
19797726|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19797727|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19797728|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
20157573|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324253|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
20324254|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324255|NCT00736866|Expectorants|expectorants|mesh-ancestor
20324256|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
20324257|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20324258|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
19797729|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797730|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797731|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797732|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797733|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797734|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
19797735|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
19797736|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797737|NCT01494662|Capecitabine|capecitabine|mesh-list
19797738|NCT01494662|Trastuzumab|trastuzumab|mesh-list
19797739|NCT01494662|Maytansine|maytansine|mesh-list
19797740|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19797741|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797742|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
19797743|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797744|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797745|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797746|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797747|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797748|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797749|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797750|NCT01476839|Cytarabine|cytarabine|mesh-list
19797751|NCT01476839|Etoposide|etoposide|mesh-list
19797752|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
19797753|NCT01476839|Melphalan|melphalan|mesh-list
19797754|NCT01476839|Carmustine|carmustine|mesh-list
19797755|NCT01476839|Basiliximab|basiliximab|mesh-list
19797756|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797757|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157574|NCT00111436|Etanercept|etanercept|mesh-list
20157575|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19643012|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
19643013|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
19643014|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643015|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324259|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157576|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157577|NCT00111436|Analgesics|analgesics|mesh-ancestor
20157578|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
20157579|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157580|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157581|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157582|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157583|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157584|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157585|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
20157586|NCT00111449|Etanercept|etanercept|mesh-list
20324260|NCT00736866|Protective Agents|protective agents|mesh-ancestor
20324261|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797758|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797759|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797760|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797761|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324262|NCT00736866|Antidotes|antidotes|mesh-ancestor
20324263|NCT00736905|Rilpivirine|rilpivirine|mesh-list
20324264|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20611467|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19643016|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643017|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
19643018|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643019|NCT02382354|Remifentanil|remifentanil|mesh-list
19643020|NCT02382354|Propofol|propofol|mesh-list
19643021|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19643022|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643023|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643024|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19643025|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
19643026|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
19643027|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19797762|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19643028|NCT02382354|Narcotics|narcotics|mesh-ancestor
20174145|NCT00163748|Vinorelbine|vinorelbine|mesh-list
20611468|NCT01042379|Metformin|metformin|mesh-list
20324265|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20324266|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324267|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324268|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
20324269|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324270|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20611469|NCT01042379|Paclitaxel|paclitaxel|mesh-list
19643029|NCT02382354|Analgesics|analgesics|mesh-ancestor
19643030|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
19643031|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643032|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
19643033|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
19643034|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643035|NCT02382328|Protective Agents|protective agents|mesh-ancestor
19643036|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643037|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
19643038|NCT02382328|Vitamins|vitamins|mesh-ancestor
19643039|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
19643040|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
19643041|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19643042|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19643043|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19643044|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
19643045|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643046|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643047|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643048|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19643049|NCT02382523|Hormones|hormones|mesh-ancestor
19643050|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643051|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643052|NCT02382432|Meperidine|meperidine|mesh-list
19643053|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
19643054|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19643055|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643056|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643057|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19643058|NCT02382432|Analgesics|analgesics|mesh-ancestor
19643059|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
19643060|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643061|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19643062|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19643063|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19643064|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
19643065|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643066|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643067|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19643068|NCT02382432|Narcotics|narcotics|mesh-ancestor
19643069|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19643070|NCT02382146|Dexamethasone|dexamethasone|mesh-list
19643071|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
19643072|NCT02382146|Ondansetron|ondansetron|mesh-list
19643073|NCT02382146|BB 1101|bb 1101|mesh-list
19643074|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643075|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
19643076|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
19643077|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643078|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643079|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643080|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
19643081|NCT02382146|Hormones|hormones|mesh-ancestor
19643082|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643083|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19643084|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643085|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
19643086|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643087|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643088|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
19643089|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
19643090|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19797763|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
19643091|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
19643092|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797764|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
19797765|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797766|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797767|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
19797768|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797769|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797770|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
19797771|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797772|NCT01388920|Tesamorelin|tesamorelin|mesh-list
19797773|NCT01388920|Growth Substances|growth substances|mesh-ancestor
19797774|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797775|NCT01164202|Sunitinib|sunitinib|mesh-list
19797776|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797777|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797778|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19797779|NCT01164202|Growth Substances|growth substances|mesh-ancestor
19797780|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797781|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
20157587|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20324271|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20324272|NCT00736931|Levetiracetam|levetiracetam|mesh-list
20324273|NCT00736931|Lorazepam|lorazepam|mesh-list
20324274|NCT00736931|Brivaracetam|brivaracetam|mesh-list
20157588|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157589|NCT00111449|Analgesics|analgesics|mesh-ancestor
20157590|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
20157591|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157592|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157593|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157594|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797782|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797783|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797784|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324275|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
20324276|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
20324277|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
20324278|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
20324279|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324280|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324281|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324282|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20324283|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324284|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20324285|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20324286|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324287|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
20324288|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
20324289|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324290|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324291|NCT00736970|Sirolimus|sirolimus|mesh-list
20324292|NCT00736970|Trastuzumab|trastuzumab|mesh-list
20324293|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20324294|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797785|NCT01163357|Sirolimus|sirolimus|mesh-list
19797786|NCT01163357|Fludarabine|fludarabine|mesh-list
20324295|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19643093|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19643094|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19643095|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643096|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19643097|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19643098|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
19643099|NCT02381964|Vitamins|vitamins|mesh-ancestor
19643100|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
19643101|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643102|NCT02382068|Dexamethasone|dexamethasone|mesh-list
19643103|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643104|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643105|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
19643106|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
19643107|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643108|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643109|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643110|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
19643111|NCT02382068|Hormones|hormones|mesh-ancestor
19643112|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643113|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19797787|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
19797788|NCT01163357|Bortezomib|bortezomib|mesh-list
19797789|NCT01163357|Melphalan|melphalan|mesh-list
19797790|NCT01163357|Tacrolimus|tacrolimus|mesh-list
19797791|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797792|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797793|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
19797794|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797795|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643114|NCT02382094|Bicalutamide|bicalutamide|mesh-list
19643115|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
19643116|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
19643117|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643118|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643119|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643120|NCT02382029|Clonazepam|clonazepam|mesh-list
19643121|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
19643122|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
19643123|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
19643124|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643125|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643126|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643127|NCT02381899|Rituximab|rituximab|mesh-list
19643128|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19643129|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157595|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157596|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157597|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
20157598|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
19797796|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
19797797|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797798|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19797799|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797800|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19797801|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797802|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19797803|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
20157599|NCT00111462|Hematinics|hematinics|mesh-ancestor
20157600|NCT00111540|Exenatide|exenatide|mesh-list
20157601|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157602|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157603|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20157604|NCT00111540|Incretins|incretins|mesh-ancestor
20157605|NCT00111540|Hormones|hormones|mesh-ancestor
20157606|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157607|NCT00111566|Eptifibatide|eptifibatide|mesh-list
20157608|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20157609|NCT00111618|Vadimezan|vadimezan|mesh-list
20157610|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157611|NCT00111631|Metformin|metformin|mesh-list
20157612|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20157613|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157614|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157615|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
20157616|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157617|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797804|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797805|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
19797806|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20157618|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
20157619|NCT00111644|Lactams|lactams|mesh-list
19643130|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643131|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
19643132|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643133|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643134|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19643135|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
19643136|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643137|NCT02381600|Vitamin D|vitamin d|mesh-list
19643138|NCT02381600|Vitamins|vitamins|mesh-ancestor
19643139|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
19643140|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643141|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20157620|NCT00111644|beta-Lactams|beta-lactams|mesh-list
19643142|NCT02381717|Morphine|morphine|mesh-list
20157621|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20157622|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643143|NCT02381717|Bupivacaine|bupivacaine|mesh-list
19643144|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
19643145|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
19643146|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643147|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643148|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
19643149|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157623|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20157624|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
20157625|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157626|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157627|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157628|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157629|NCT00111748|Thalidomide|thalidomide|mesh-list
20157630|NCT00111748|Dexamethasone|dexamethasone|mesh-list
20157631|NCT00111748|Bortezomib|bortezomib|mesh-list
20157632|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157633|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
20157634|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
19643150|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19643151|NCT02381717|Narcotics|narcotics|mesh-ancestor
19643152|NCT02381717|Analgesics|analgesics|mesh-ancestor
19643153|NCT02381730|Aflibercept|aflibercept|mesh-list
19643154|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797807|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
19797808|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797809|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
19797810|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797811|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797812|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797813|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
19797814|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797815|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797816|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797817|NCT00638898|Melphalan|melphalan|mesh-list
19797818|NCT00638898|Busulfan|busulfan|mesh-list
19797819|NCT00638898|Topotecan|topotecan|mesh-list
19797820|NCT00638898|Lenograstim|lenograstim|mesh-list
19797821|NCT00638898|Sargramostim|sargramostim|mesh-list
19797822|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19797823|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
19797824|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157635|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157636|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157637|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643155|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19643156|NCT02381730|Growth Substances|growth substances|mesh-ancestor
19643157|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797825|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797826|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
19797827|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797828|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797829|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797830|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797831|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19797832|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19797833|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797834|NCT00609791|Paclitaxel|paclitaxel|mesh-list
19797835|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19643158|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
19643159|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663642|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663643|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663644|NCT03046862|Gemcitabine|gemcitabine|mesh-list
19663645|NCT03046862|Durvalumab|durvalumab|mesh-list
19663646|NCT03046862|Tremelimumab|tremelimumab|mesh-list
19663647|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663648|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663649|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
19663650|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663651|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
19663652|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157638|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
19663653|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663654|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797836|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797837|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643160|NCT02381548|Belinostat|belinostat|mesh-list
19643161|NCT02381548|Adavosertib|adavosertib|mesh-list
19643162|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643163|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324296|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324297|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20324298|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
20324299|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324300|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
20324301|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324302|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
20324303|NCT00736983|Adalimumab|adalimumab|mesh-list
20324304|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324305|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324306|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19643164|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324307|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324308|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20324309|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20324310|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643165|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19643166|NCT02381249|Octreotide|octreotide|mesh-list
19643167|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643168|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19643169|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643170|NCT02381314|Ipilimumab|ipilimumab|mesh-list
20324311|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324312|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324313|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20324314|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20324315|NCT00737113|Hormones|hormones|mesh-list
20324316|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20324317|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324318|NCT00737126|Folic Acid|folic acid|mesh-list
20324319|NCT00737126|Hematinics|hematinics|mesh-ancestor
20324320|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
20324321|NCT00737126|Vitamins|vitamins|mesh-ancestor
20324322|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
20324323|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324324|NCT00737139|Epinephrine|epinephrine|mesh-list
20324325|NCT00737139|Bupivacaine|bupivacaine|mesh-list
20324326|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20324327|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20324328|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
20324329|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324330|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643171|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19643172|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643173|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19643174|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643175|NCT02381275|Tenofovir|tenofovir|mesh-list
19643176|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
19643177|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643178|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19643179|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19643180|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643181|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643182|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19643183|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19643184|NCT02381184|Clomiphene|clomiphene|mesh-list
19643185|NCT02381184|Enclomiphene|enclomiphene|mesh-list
19643186|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
19643187|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19643188|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
19663655|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
19663656|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663657|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663658|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19663659|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19663660|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19663661|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19663662|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
19663663|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663664|NCT02925234|Bevacizumab|bevacizumab|mesh-list
19663665|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
19797838|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
19643189|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643190|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643191|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19643192|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
19643193|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19643194|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19643195|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19643196|NCT02381470|Amoxicillin|amoxicillin|mesh-list
19643197|NCT02381470|Rifampin|rifampin|mesh-list
19643198|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19797839|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
19797840|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797841|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797842|NCT00577278|Sirolimus|sirolimus|mesh-list
19797843|NCT00577278|Rituximab|rituximab|mesh-list
19797844|NCT00577278|Fludarabine|fludarabine|mesh-list
19797845|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
19797846|NCT00577278|Melphalan|melphalan|mesh-list
19643199|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
19643200|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
19643201|NCT02381470|Cefadroxil|cefadroxil|mesh-list
19643202|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19797847|NCT00577278|Tacrolimus|tacrolimus|mesh-list
19797848|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19797849|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797850|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797851|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
19797852|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797853|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797854|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19797855|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
19797856|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797857|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797858|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19797859|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797860|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19797861|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797862|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19797863|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
19797864|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797865|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
19797866|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797867|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
19797868|NCT00576979|Etoposide|etoposide|mesh-list
19797869|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
19797870|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797871|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
19797872|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797873|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797874|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797875|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
19797876|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797877|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797878|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797879|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797880|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19797881|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19643203|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643204|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19643205|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
19643206|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
19643207|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19643208|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643209|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643210|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19643211|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19643212|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19643213|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19643214|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19643215|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19643216|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19797882|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797883|NCT00554840|Varenicline|varenicline|mesh-list
19797884|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19643217|NCT02381158|Beclomethasone|beclomethasone|mesh-list
19643218|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643219|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
20324331|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324332|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20324333|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19643220|NCT02381158|Hormones|hormones|mesh-ancestor
19643221|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643222|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643223|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19643224|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
19643225|NCT02381028|Emollients|emollients|mesh-list
19797885|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19797886|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
19797887|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797888|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797889|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797890|NCT00538031|Celecoxib|celecoxib|mesh-list
19797891|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
19797892|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19797893|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
20157639|NCT00111748|Hormones|hormones|mesh-ancestor
20157640|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157641|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20157642|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324334|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
19643226|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
19643227|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19643228|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
19643229|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157643|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157644|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
20157645|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
20157646|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20157647|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643230|NCT02381145|Resveratrol|resveratrol|mesh-list
19643231|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
19643232|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643233|NCT02381145|Protective Agents|protective agents|mesh-ancestor
19643234|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643235|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643236|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19643237|NCT02381080|Voriconazole|voriconazole|mesh-list
20157648|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20157649|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20157650|NCT00111748|Growth Substances|growth substances|mesh-ancestor
19643238|NCT02381080|Erythromycin|erythromycin|mesh-list
20157651|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
20157652|NCT00111774|Panitumumab|panitumumab|mesh-list
20157653|NCT00111774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157654|NCT00111774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157655|NCT00111787|Paclitaxel|paclitaxel|mesh-list
20157656|NCT00111787|Lapatinib|lapatinib|mesh-list
20157657|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20157658|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157659|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
20157660|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157661|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157662|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157663|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20157664|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157665|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
20157666|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20157667|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20157668|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157669|NCT00111891|Niacin|niacin|mesh-list
20157670|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20157671|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
20157672|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157673|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19643239|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
20157674|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
20157675|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
20157676|NCT00111891|Vitamins|vitamins|mesh-ancestor
20157677|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
20157678|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157679|NCT00111904|Paclitaxel|paclitaxel|mesh-list
20157680|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20157681|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157682|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797894|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797895|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797896|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19797897|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
19797898|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157683|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157684|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324335|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157685|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157686|NCT00111943|Tenofovir|tenofovir|mesh-list
20157687|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
20157688|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157689|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20157690|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20157691|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157692|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157693|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19797899|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797900|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19797901|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19797902|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19797903|NCT00538031|Analgesics|analgesics|mesh-ancestor
19797904|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
19797905|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797906|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19797907|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19797908|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19797909|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797910|NCT00003656|Interferons|interferons|mesh-list
19797911|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
20157694|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20324336|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20324337|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
20324338|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
20324339|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
20324340|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20324341|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
19643240|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20157695|NCT00111956|Etanercept|etanercept|mesh-list
20157696|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19643241|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
19643242|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
19643243|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643244|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19643245|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19643246|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643247|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643248|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19643249|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
19643250|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19797912|NCT00003656|Tretinoin|tretinoin|mesh-list
19643251|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643252|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19643253|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19643254|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643255|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20157697|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20157698|NCT00111956|Analgesics|analgesics|mesh-ancestor
20324342|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
19797913|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797914|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
19797915|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797916|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
19797917|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797918|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
19797919|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
19797920|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19797921|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
19797922|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797923|NCT00370552|Paclitaxel|paclitaxel|mesh-list
19797924|NCT00370552|Epothilones|epothilones|mesh-list
19797925|NCT00370552|Bevacizumab|bevacizumab|mesh-list
19797926|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19797927|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797928|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
19797929|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
19643256|NCT02380898|Ketorolac|ketorolac|mesh-list
19643257|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19643258|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19643259|NCT02380898|Analgesics|analgesics|mesh-ancestor
19643260|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
19643261|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157699|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
20157700|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157701|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157702|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157703|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157704|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643262|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643263|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643264|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19797930|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
19797931|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797932|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19797933|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19797934|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19797935|NCT00370552|Growth Substances|growth substances|mesh-ancestor
19797936|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797937|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
19797938|NCT00370682|Vaccines|vaccines|mesh-list
19797939|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
19797940|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19797941|NCT00370838|Clonidine|clonidine|mesh-list
19797942|NCT00370838|Levetiracetam|levetiracetam|mesh-list
19797943|NCT00370838|Analgesics|analgesics|mesh-ancestor
19797944|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
19643265|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19643266|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643267|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643268|NCT02380573|Methylene Blue|methylene blue|mesh-list
19643269|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643270|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643271|NCT02380755|Clomiphene|clomiphene|mesh-list
19643272|NCT02380755|Enclomiphene|enclomiphene|mesh-list
19643273|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
19643274|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19643275|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
19643276|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643277|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643278|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19643279|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
19643280|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19797945|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19797946|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643281|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19643282|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19643283|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
19643284|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19643285|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157705|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157706|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
20157707|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
20157708|NCT00111995|Hematinics|hematinics|mesh-ancestor
20157709|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
20157710|NCT00112008|Hematinics|hematinics|mesh-ancestor
20157711|NCT00112021|Pramlintide|pramlintide|mesh-list
20157712|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20157713|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157714|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157715|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
20157716|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20157717|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
20157718|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157719|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
20157720|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20157721|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20157722|NCT00112034|Prednisolone|prednisolone|mesh-list
20157723|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
20157724|NCT00112034|Methotrexate|methotrexate|mesh-list
20324343|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324344|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
19643286|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
19643287|NCT02380625|Azithromycin|azithromycin|mesh-list
19643288|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20157725|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20157726|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
20157727|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20157728|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
20157729|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20157730|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157731|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157732|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
20157733|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157734|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157735|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
20157736|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157737|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19643289|NCT02380625|Sunitinib|sunitinib|mesh-list
19643290|NCT02380625|Irbesartan|irbesartan|mesh-list
19643291|NCT02380625|Atorvastatin|atorvastatin|mesh-list
19643292|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19643293|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19643294|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
20157738|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157739|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
20157740|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157741|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20157742|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157743|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
20157744|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
19643295|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643296|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19643297|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19643298|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643299|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643300|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19643301|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19643302|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643303|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19643304|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19643305|NCT02380625|Growth Substances|growth substances|mesh-ancestor
19643306|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643307|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
19643308|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19643309|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19643310|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19643311|NCT02380521|Exenatide|exenatide|mesh-list
19643312|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19643313|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643314|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19643315|NCT02380521|Incretins|incretins|mesh-ancestor
19643316|NCT02380521|Hormones|hormones|mesh-ancestor
19643317|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157745|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157746|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157747|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
20157748|NCT00112034|Hormones|hormones|mesh-ancestor
20174146|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157749|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157750|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20157751|NCT00112034|Protective Agents|protective agents|mesh-ancestor
20157752|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20157753|NCT00112086|Paclitaxel|paclitaxel|mesh-list
19643318|NCT02380586|Anesthetics|anesthetics|mesh-list
19643319|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643320|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643321|NCT02380508|Vaccines|vaccines|mesh-list
19643322|NCT02380508|Immunologic Factors|immunologic factors|mesh-ancestor
19643323|NCT02380508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643324|NCT02380417|Ropivacaine|ropivacaine|mesh-list
19643325|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
19643326|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
19643327|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643328|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157754|NCT00112086|Carboplatin|carboplatin|mesh-list
20157755|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20157756|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157757|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
20157758|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157759|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157760|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157761|NCT00112138|Gabapentin|gabapentin|mesh-list
19797947|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19797948|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
19797949|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
19797950|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19797951|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19797952|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19797953|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
19797954|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19797955|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797956|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
19797957|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
19797958|NCT00371150|Entecavir|entecavir|mesh-list
19797959|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
19797960|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797961|NCT00371176|Cycloserine|cycloserine|mesh-list
19797962|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19797963|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19797964|NCT00371176|Renal Agents|renal agents|mesh-ancestor
19797965|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19797966|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
19797967|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19797968|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
19797969|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797970|NCT00371254|Dasatinib|dasatinib|mesh-list
19797971|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797972|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797973|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797974|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797975|NCT00371345|Dasatinib|dasatinib|mesh-list
19797976|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797977|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797978|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797979|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797980|NCT00371566|Lapatinib|lapatinib|mesh-list
19797981|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19797982|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19797983|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19797984|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797985|NCT00371683|Enoxaparin|enoxaparin|mesh-list
19797986|NCT00371683|Apixaban|apixaban|mesh-list
19797987|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
19797988|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19797989|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19797990|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19797991|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19797992|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
19797993|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19797994|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
19797995|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643329|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
19643330|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157762|NCT00112138|Analgesics|analgesics|mesh-ancestor
20324345|NCT00737191|Olanzapine|olanzapine|mesh-list
20324346|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
20324347|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
20324348|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643331|NCT02380313|Prednisone|prednisone|mesh-list
19643332|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643333|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
19643334|NCT02380313|Hormones|hormones|mesh-ancestor
19643335|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643336|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643337|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19643338|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643339|NCT02380352|Amoxicillin|amoxicillin|mesh-list
19643340|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19643341|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643342|NCT02380131|Capecitabine|capecitabine|mesh-list
19797996|NCT00371761|Interferons|interferons|mesh-list
19797997|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
19797998|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
19797999|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19798000|NCT00371761|Adefovir|adefovir|mesh-list
20157763|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
20157764|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157765|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157766|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
20157767|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20157768|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19798001|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19643343|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
19643344|NCT02380131|Trastuzumab|trastuzumab|mesh-list
19798002|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643345|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19643346|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
19643347|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643348|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643349|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19643350|NCT02380118|Midazolam|midazolam|mesh-list
19643351|NCT02380118|Haloperidol|haloperidol|mesh-list
19798003|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
19798004|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798005|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
19798006|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798007|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19798008|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19798009|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798010|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798011|NCT00371826|Cyclosporine|cyclosporine|mesh-list
20611470|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19643352|NCT02380118|Olanzapine|olanzapine|mesh-list
19643353|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
19643354|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19798012|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
19798013|NCT00371826|Prednisone|prednisone|mesh-list
19798014|NCT00371826|Everolimus|everolimus|mesh-list
19798015|NCT00371826|Cyclosporins|cyclosporins|mesh-list
19798016|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19798017|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798018|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
19798019|NCT00371826|Hormones|hormones|mesh-ancestor
19798020|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157769|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157770|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20157771|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20157772|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20157773|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20157774|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157775|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
20157776|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20157777|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157778|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20157779|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174147|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
20611471|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19798021|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324349|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643355|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19643356|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643357|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643358|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19643359|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19643360|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19643361|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19643362|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
19643363|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
19643364|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
19798022|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798023|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798024|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643365|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
19643366|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20157780|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157781|NCT00112346|Gemcitabine|gemcitabine|mesh-list
20157782|NCT00112346|Cetuximab|cetuximab|mesh-list
19798025|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798026|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798027|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
19798028|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
19798029|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157783|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157784|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
20157785|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157786|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157787|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
20157788|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157789|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157790|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157791|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
20157792|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157793|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157794|NCT00112372|Sirolimus|sirolimus|mesh-list
20157795|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20157796|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157797|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20157798|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157799|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
20157800|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157801|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
20157802|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157803|NCT00112476|Sirolimus|sirolimus|mesh-list
20157804|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
20157805|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20157806|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324350|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324351|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20324352|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20324353|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157807|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20157808|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157809|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
20324354|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324355|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19643367|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643368|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
20324356|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20324357|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20324358|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324359|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643369|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
19643370|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643371|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643372|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19643373|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19643374|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19643375|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19643376|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
19643377|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20157810|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157811|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
20157812|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643378|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
19643379|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20157813|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19798030|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
19798031|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798032|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798033|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19798034|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
19798035|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798036|NCT00372060|Pioglitazone|pioglitazone|mesh-list
20324360|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
20347682|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347683|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798037|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19798038|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19798039|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798040|NCT00372060|Incretins|incretins|mesh-ancestor
19798041|NCT00372060|Hormones|hormones|mesh-ancestor
19798042|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798043|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19798044|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
19798045|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347684|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20347685|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347686|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347687|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
20347688|NCT00861419|Vitamins|vitamins|mesh-ancestor
20347689|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
20347690|NCT00861445|Lacosamide|lacosamide|mesh-list
19798046|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798047|NCT00372385|Interferons|interferons|mesh-list
19798048|NCT00372385|Ribavirin|ribavirin|mesh-list
20347691|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
20347692|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20347693|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20347694|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347695|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347696|NCT00861510|ON 01910|on 01910|mesh-list
20347697|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347698|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20347699|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347700|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347701|NCT00861523|Thiamine|thiamine|mesh-list
20347702|NCT00861523|Promethazine|promethazine|mesh-list
20347703|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
20347704|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
20347705|NCT00861523|Vitamins|vitamins|mesh-ancestor
20347706|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
19643380|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19643381|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19798049|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
19798050|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
19798051|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20157814|NCT00112515|Modafinil|modafinil|mesh-list
20157815|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20157816|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157817|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19643382|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19643383|NCT02380001|Analgesics|analgesics|mesh-ancestor
19643384|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
19643385|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643386|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643387|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643388|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643389|NCT02379754|Gentamicins|gentamicins|mesh-list
19643390|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798052|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157818|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20157819|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20157820|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347707|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347708|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
20347709|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
19798053|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
19798054|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643391|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643392|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19643393|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643394|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643395|NCT02380053|Celiprolol|celiprolol|mesh-list
19643396|NCT02380053|Bisoprolol|bisoprolol|mesh-list
19643397|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19643398|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
19643399|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
19643400|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643401|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643402|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19643403|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19643404|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19643405|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
19643406|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643407|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643408|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19643409|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
19798055|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
19798056|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798057|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
19798058|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798059|NCT00372424|Docetaxel|docetaxel|mesh-list
19798060|NCT00372424|Trastuzumab|trastuzumab|mesh-list
19798061|NCT00372424|Sunitinib|sunitinib|mesh-list
19798062|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798063|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
20157821|NCT00112528|Gemcitabine|gemcitabine|mesh-list
19643410|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
19643411|NCT02379806|Enoxaparin|enoxaparin|mesh-list
19643412|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
19643413|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19643414|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19643415|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663666|NCT02925234|Nivolumab|nivolumab|mesh-list
19663667|NCT02925234|Trastuzumab|trastuzumab|mesh-list
19663668|NCT02925234|Ipilimumab|ipilimumab|mesh-list
19663669|NCT02925234|Durvalumab|durvalumab|mesh-list
19663670|NCT02925234|Pertuzumab|pertuzumab|mesh-list
19663671|NCT02925234|Panitumumab|panitumumab|mesh-list
19663672|NCT02925234|Sunitinib|sunitinib|mesh-list
19663673|NCT02925234|Atezolizumab|atezolizumab|mesh-list
19663674|NCT02925234|Olaparib|olaparib|mesh-list
19663675|NCT02925234|Lenvatinib|lenvatinib|mesh-list
19663676|NCT02925234|Palbociclib|palbociclib|mesh-list
19663677|NCT02925234|Trametinib|trametinib|mesh-list
19663678|NCT02925234|Axitinib|axitinib|mesh-list
19663679|NCT02925234|Afatinib|afatinib|mesh-list
19663680|NCT02925234|Vemurafenib|vemurafenib|mesh-list
19663681|NCT02925234|Dabrafenib|dabrafenib|mesh-list
19663682|NCT02925234|Crizotinib|crizotinib|mesh-list
19663683|NCT02925234|Talazoparib|talazoparib|mesh-list
19663684|NCT02925234|Rucaparib|rucaparib|mesh-list
19663685|NCT02925234|Entrectinib|entrectinib|mesh-list
19663686|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663687|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663688|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19663689|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19663690|NCT02925234|Growth Substances|growth substances|mesh-ancestor
19663691|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663692|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798064|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157822|NCT00112528|Bevacizumab|bevacizumab|mesh-list
20157823|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
20157824|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157825|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157826|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20157827|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20157828|NCT00112528|Growth Substances|growth substances|mesh-ancestor
20157829|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157830|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
20157831|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157832|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
19663693|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20175183|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663694|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663695|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19663696|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663697|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20157833|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157834|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
20157835|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157836|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643416|NCT02379793|Mineral Oil|mineral oil|mesh-list
19643417|NCT02379793|Emollients|emollients|mesh-ancestor
19643418|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
19643419|NCT02379767|Harmine|harmine|mesh-list
19643420|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
19643421|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643422|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19643423|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19643424|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643425|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643426|NCT02379715|Remifentanil|remifentanil|mesh-list
19643427|NCT02379715|Desflurane|desflurane|mesh-list
19798065|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
19798066|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798067|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19798068|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20157837|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157838|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
20157839|NCT00112554|Cytarabine|cytarabine|mesh-list
20157840|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157841|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
20157842|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157843|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157844|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
20157845|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157846|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157847|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
20157848|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157849|NCT00112567|Fludarabine|fludarabine|mesh-list
20157850|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
20157851|NCT00112567|Thiotepa|thiotepa|mesh-list
20157852|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157853|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798069|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798070|NCT00372424|Growth Substances|growth substances|mesh-ancestor
19798071|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798072|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798073|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798074|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798075|NCT00372528|Pregabalin|pregabalin|mesh-list
19798076|NCT00372528|Analgesics|analgesics|mesh-ancestor
19798077|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
20157854|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
19643428|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19643429|NCT02379715|Narcotics|narcotics|mesh-ancestor
19643430|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643431|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643432|NCT02379715|Analgesics|analgesics|mesh-ancestor
19643433|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
19643434|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643435|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19643436|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
19643437|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
19643438|NCT02379663|Enoxaparin|enoxaparin|mesh-list
19643439|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
19643440|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19643441|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
19643442|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19643443|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
19643444|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643445|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643446|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
19643447|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19643448|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19643449|NCT02379546|Desflurane|desflurane|mesh-list
19643450|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19643451|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
19643452|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
19643453|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20157855|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643454|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157856|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643455|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
19643456|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
19643457|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19643458|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19643459|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643460|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643461|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643462|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643463|NCT02379676|Clopidogrel|clopidogrel|mesh-list
19643464|NCT02379676|Ticagrelor|ticagrelor|mesh-list
19643465|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20324361|NCT00737256|Aripiprazole|aripiprazole|mesh-list
20324362|NCT00737256|Perphenazine|perphenazine|mesh-list
20324363|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
19643466|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19643467|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19643468|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19798078|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798079|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324364|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324365|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20324366|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20324367|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324368|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324369|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
20324370|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
20324371|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324372|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324373|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20324374|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20324375|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
20324376|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20324377|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20324378|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19798080|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
19798081|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20157857|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
19643469|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
19643470|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643471|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643472|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643473|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19643474|NCT02379377|Fluorides|fluorides|mesh-list
19643475|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19643476|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643477|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
19643478|NCT02379377|Protective Agents|protective agents|mesh-ancestor
19643479|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643480|NCT02379299|Hormones|hormones|mesh-list
19643481|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157858|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157859|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20157860|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
20157861|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20157862|NCT00112619|Topotecan|topotecan|mesh-list
20157863|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20157864|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20157865|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643482|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643483|NCT02379000|Triamcinolone|triamcinolone|mesh-list
19643484|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19643485|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19643486|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19643487|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643488|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
20324379|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20324380|NCT00737373|Leucovorin|leucovorin|mesh-list
20324381|NCT00737373|Folic Acid|folic acid|mesh-list
20324382|NCT00737373|Docetaxel|docetaxel|mesh-list
20324383|NCT00737373|Fluorouracil|fluorouracil|mesh-list
20324384|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
19643489|NCT02379000|Hormones|hormones|mesh-ancestor
19643490|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643491|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643492|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643493|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
19643494|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643495|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643496|NCT02379026|Vitamin D|vitamin d|mesh-list
19643497|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
19643498|NCT02379026|Vitamins|vitamins|mesh-ancestor
19643499|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
19643500|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643501|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20324385|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
20324386|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324387|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
20324388|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
20324389|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324390|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324391|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
20324392|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324393|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324394|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
20324395|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324396|NCT00737373|Antidotes|antidotes|mesh-ancestor
20324397|NCT00737373|Protective Agents|protective agents|mesh-ancestor
20324398|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
20324399|NCT00737373|Vitamins|vitamins|mesh-ancestor
20324400|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
20324401|NCT00737373|Hematinics|hematinics|mesh-ancestor
20324402|NCT00737542|Lidocaine|lidocaine|mesh-list
20324403|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20324404|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
20324405|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324406|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324407|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
20324408|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324409|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20324410|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20324411|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20324412|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611472|NCT01042379|Carboplatin|carboplatin|mesh-list
19643502|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19643503|NCT02379156|Midodrine|midodrine|mesh-list
19643504|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
19643505|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
19798082|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19798083|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643506|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643507|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643508|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19643509|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19643510|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19643511|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19643512|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
19643513|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643514|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643515|NCT02378623|Apixaban|apixaban|mesh-list
19643516|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19643517|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
20324413|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643518|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20324414|NCT00737555|Tosedostat|tosedostat|mesh-list
20611473|NCT01042379|Doxorubicin|doxorubicin|mesh-list
19643519|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
19643520|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643521|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643522|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
19643523|NCT02378740|Ketamine|ketamine|mesh-list
19643524|NCT02378740|Analgesics|analgesics|mesh-ancestor
19643525|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
19643526|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643527|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643528|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20324415|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324416|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324417|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
20324418|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20324419|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324420|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19643529|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19643530|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
19643531|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
19643532|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643533|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19643534|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19643535|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643536|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643537|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
19643538|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
19643539|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19643540|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19643541|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643542|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643543|NCT02378649|Urological Agents|urological agents|mesh-ancestor
19643544|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19643545|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643546|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643547|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643548|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19643549|NCT02378415|Ketamine|ketamine|mesh-list
19643550|NCT02378415|Analgesics|analgesics|mesh-ancestor
19643551|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
19643552|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643553|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643554|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19643555|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19643556|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
20324421|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
20324422|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20324423|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643557|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
19643558|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643559|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19643560|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19643561|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643562|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643563|NCT02378441|Metformin|metformin|mesh-list
19643564|NCT02378441|Atorvastatin|atorvastatin|mesh-list
19643565|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19643566|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643567|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20324424|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324425|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324426|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
20324427|NCT00737685|Fludarabine|fludarabine|mesh-list
20324428|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
20324429|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324430|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
19643568|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19643569|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
19643570|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663698|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
19663699|NCT02758431|Anastrozole|anastrozole|mesh-list
19663700|NCT02758431|Testosterone|testosterone|mesh-list
19663701|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
19663702|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
19663703|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19798084|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19798085|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20157866|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157867|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157868|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
20157869|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324431|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324432|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324433|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20324434|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
20324435|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324436|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324437|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20324438|NCT00737724|Efavirenz|efavirenz|mesh-list
20324439|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20324440|NCT00737724|Isoniazid|isoniazid|mesh-list
20324441|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20324442|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19643571|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19643572|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19643573|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643574|NCT02378532|Chloroquine|chloroquine|mesh-list
19643575|NCT02378532|Temozolomide|temozolomide|mesh-list
19643576|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19643577|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
19643578|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324443|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324444|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324445|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
20157870|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20157871|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157872|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157873|NCT00112645|Cyclosporine|cyclosporine|mesh-list
20157874|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
20157875|NCT00112645|Methotrexate|methotrexate|mesh-list
20157876|NCT00112645|Melphalan|melphalan|mesh-list
20157877|NCT00112645|Busulfan|busulfan|mesh-list
20157878|NCT00112645|Cyclosporins|cyclosporins|mesh-list
19798086|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19798087|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19798088|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324446|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324447|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20324448|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20324449|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20324450|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20324451|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19643579|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643580|NCT02378532|Amebicides|amebicides|mesh-ancestor
19643581|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19798089|NCT00372567|Sunitinib|sunitinib|mesh-list
19798090|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
19798091|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798092|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798093|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20157879|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20157880|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20157881|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
20157882|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20157883|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157884|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798094|NCT00372567|Growth Substances|growth substances|mesh-ancestor
19643582|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19643583|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643584|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
19643585|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643586|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
19643587|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19643588|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19643589|NCT02378298|Prednisolone|prednisolone|mesh-list
19643590|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
19643591|NCT02378298|Rituximab|rituximab|mesh-list
19798095|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798096|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
20324452|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20324453|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20324454|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20324455|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
20324456|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20324457|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20324458|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20324459|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
20324460|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20324461|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
20324462|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
19798097|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798098|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798099|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798100|NCT00372593|Cytarabine|cytarabine|mesh-list
19798101|NCT00372593|Etoposide|etoposide|mesh-list
19798102|NCT00372593|Daunorubicin|daunorubicin|mesh-list
19798103|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
19798104|NCT00372593|Asparaginase|asparaginase|mesh-list
19798105|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
19798106|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19798107|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798108|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19798109|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19798110|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798111|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798112|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324463|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20324464|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20324465|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324466|NCT00737789|Mesalamine|mesalamine|mesh-list
20324467|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20324468|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20324469|NCT00737789|Analgesics|analgesics|mesh-ancestor
20324470|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
20324471|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324472|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324473|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324474|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324475|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
20324476|NCT00737815|Cathartics|cathartics|mesh-ancestor
20324477|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324478|NCT00737867|Gemcitabine|gemcitabine|mesh-list
19643592|NCT02378298|Methotrexate|methotrexate|mesh-list
19643593|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19643594|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
19643595|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19643596|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643597|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
19643598|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643599|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643600|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19643601|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
19643602|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19643603|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19643604|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
19643605|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643606|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
19643607|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643608|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19643609|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643610|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19643611|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643612|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
19643613|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
20324479|NCT00737867|Carboplatin|carboplatin|mesh-list
20324480|NCT00737867|Vinorelbine|vinorelbine|mesh-list
20324481|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643614|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324482|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324483|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
19643615|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643616|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
19798113|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
20324484|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324485|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
19643617|NCT02378298|Hormones|hormones|mesh-ancestor
19643618|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643619|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19643620|NCT02378298|Protective Agents|protective agents|mesh-ancestor
19643621|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19643622|NCT02378389|Docetaxel|docetaxel|mesh-list
19643623|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643624|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19643625|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
19643626|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
19643627|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663704|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20157885|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
20157886|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157887|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157888|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
20157889|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157890|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19798114|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
19798115|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798116|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798117|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
19798118|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798119|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798120|NCT00372593|Analgesics|analgesics|mesh-ancestor
19798121|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
19798122|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798123|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19798124|NCT00372619|Cytarabine|cytarabine|mesh-list
19798125|NCT00372619|Methotrexate|methotrexate|mesh-list
20157891|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157892|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
19663705|NCT02758431|Acyline|acyline|mesh-list
19663706|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
19663707|NCT02758431|Hormones|hormones|mesh-ancestor
19663708|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663709|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663710|NCT02758431|Androgens|androgens|mesh-ancestor
19663711|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19663712|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663713|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
19663714|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19663715|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663716|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663717|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19663718|NCT02698293|Vitamin D|vitamin d|mesh-list
19663719|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
19663720|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
19663721|NCT02698293|Vitamins|vitamins|mesh-list
19663722|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
19663723|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663724|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19663725|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19663726|NCT02643056|Panitumumab|panitumumab|mesh-list
19663727|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663728|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663729|NCT02471118|Adalimumab|adalimumab|mesh-list
19663730|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19663731|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663732|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
19663733|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663734|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663735|NCT02398396|Lactitol|lactitol|mesh-list
19663736|NCT02398396|Cathartics|cathartics|mesh-ancestor
19663737|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19663738|NCT02359968|Paclitaxel|paclitaxel|mesh-list
19663739|NCT02359968|Fluorouracil|fluorouracil|mesh-list
19663740|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
19663741|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19663742|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663743|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
19663744|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
19663745|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
19663746|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663747|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
19663748|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324486|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643628|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
19643629|NCT02378129|Methamphetamine|methamphetamine|mesh-list
19643630|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19643631|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643632|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
19643633|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
19643634|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643635|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
19798126|NCT00372619|Clofarabine|clofarabine|mesh-list
19798127|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19798128|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
19798129|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19798130|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798131|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798132|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
19798133|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798134|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798135|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
19798136|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798137|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19798138|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798139|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
20157893|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20157894|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19643636|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643637|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643638|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
19643639|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19643640|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19643641|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19643642|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19643643|NCT02377856|Interferons|interferons|mesh-list
19643644|NCT02377856|Ribavirin|ribavirin|mesh-list
19643645|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
19643646|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
20157895|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
20157896|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157897|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20157898|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20157899|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
20157900|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
19643647|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19643648|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643649|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
19643650|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643651|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
20157901|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157902|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157903|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
20157904|NCT00112645|Hormones|hormones|mesh-ancestor
20157905|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20157906|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20324487|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324488|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324489|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
20324490|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324491|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20324492|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
20324493|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
20324494|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324495|NCT00737880|Pancrelipase|pancrelipase|mesh-list
20324496|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324497|NCT00737971|Triamcinolone|triamcinolone|mesh-list
20324498|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20324499|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20324500|NCT00737971|Bevacizumab|bevacizumab|mesh-list
20157907|NCT00112645|Protective Agents|protective agents|mesh-ancestor
20324501|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19643652|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643653|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
19643654|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643655|NCT02377778|Thiopental|thiopental|mesh-list
19643656|NCT02377778|Propofol|propofol|mesh-list
19643657|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20324502|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19643658|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643659|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643660|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19643661|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
19643662|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
19643663|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
19643664|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
19643665|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
19643666|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643667|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643668|NCT02377609|Tacrolimus|tacrolimus|mesh-list
19643669|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643670|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
19643671|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643672|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19643673|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643674|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798140|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798141|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19798142|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
19798143|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798144|NCT00372697|Octreotide|octreotide|mesh-list
19798145|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19798146|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798147|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798148|NCT00372775|Sunitinib|sunitinib|mesh-list
19798149|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798150|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798151|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798152|NCT00372775|Growth Substances|growth substances|mesh-ancestor
19798153|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798154|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798155|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798156|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798157|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798158|NCT00372905|Rituximab|rituximab|mesh-list
20157908|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20157909|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
20157910|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19643675|NCT02377648|Everolimus|everolimus|mesh-list
19643676|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643677|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643678|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
19643679|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643680|NCT02377635|Selenious Acid|selenious acid|mesh-list
19643681|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
19643682|NCT02377635|Trace Elements|trace elements|mesh-ancestor
19643683|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
19643684|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643685|NCT02377661|Amlodipine|amlodipine|mesh-list
19643686|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19643687|NCT02377661|Olmesartan|olmesartan|mesh-list
19643688|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19643689|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19643690|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19643691|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19643692|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643693|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19643694|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643695|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
19643696|NCT02377661|Diuretics|diuretics|mesh-ancestor
19643697|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
19643698|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19643699|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19643700|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19798159|NCT00372905|Bortezomib|bortezomib|mesh-list
19798160|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19798161|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20157911|NCT00112658|Leucovorin|leucovorin|mesh-list
20157912|NCT00112658|Gemcitabine|gemcitabine|mesh-list
20157913|NCT00112658|Fluorouracil|fluorouracil|mesh-list
19798162|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798163|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
20157914|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
19643701|NCT02377401|Zanamivir|zanamivir|mesh-list
19798164|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157915|NCT00112658|Irinotecan|irinotecan|mesh-list
20157916|NCT00112658|Calcium|calcium|mesh-list
20157917|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
20157918|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157919|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
20157920|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157921|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157922|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
20157923|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157924|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157925|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157926|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
20157927|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643702|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
19643703|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643704|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643705|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643706|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19643707|NCT02377388|Saxagliptin|saxagliptin|mesh-list
19643708|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19643709|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324503|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324504|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20324505|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20324506|NCT00737971|Growth Substances|growth substances|mesh-ancestor
19256649|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19643710|NCT02377388|Incretins|incretins|mesh-ancestor
19643711|NCT02377388|Hormones|hormones|mesh-ancestor
19643712|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643713|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19643714|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
19643715|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643716|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643717|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
19643718|NCT02377193|Tacrolimus|tacrolimus|mesh-list
19643719|NCT02377193|Basiliximab|basiliximab|mesh-list
19643720|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643721|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
20157928|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20157929|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20157930|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20157931|NCT00112658|Antidotes|antidotes|mesh-ancestor
20157932|NCT00112658|Protective Agents|protective agents|mesh-ancestor
20157933|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
20157934|NCT00112658|Vitamins|vitamins|mesh-ancestor
20157935|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
19643722|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643723|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20611474|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
19643724|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643725|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643726|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19643727|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643728|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19643729|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
19643730|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19643731|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643732|NCT02377180|Anesthetics|anesthetics|mesh-list
19643733|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
19643734|NCT02377180|Capsaicin|capsaicin|mesh-list
19643735|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643736|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643737|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
19643738|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643739|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
19643740|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
19643741|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
19643742|NCT02377076|Calcium|calcium|mesh-list
20157936|NCT00112684|Alvocidib|alvocidib|mesh-list
20611475|NCT01042379|Trastuzumab|trastuzumab|mesh-list
20611476|NCT01042379|Irinotecan|irinotecan|mesh-list
20611477|NCT01042379|Durvalumab|durvalumab|mesh-list
20611478|NCT01042379|Letrozole|letrozole|mesh-list
20611479|NCT01042379|Olaparib|olaparib|mesh-list
20611480|NCT01042379|Pertuzumab|pertuzumab|mesh-list
20611481|NCT01042379|Veliparib|veliparib|mesh-list
20611482|NCT01042379|Talazoparib|talazoparib|mesh-list
20611483|NCT01042379|Cemiplimab|cemiplimab|mesh-list
20157937|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798165|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798166|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
20157938|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
20157939|NCT00112684|Growth Substances|growth substances|mesh-ancestor
20157940|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157941|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798167|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19798168|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19798169|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20157942|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324507|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324508|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
20324509|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324510|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
20324511|NCT00737971|Hormones|hormones|mesh-ancestor
20324512|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20324513|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324514|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
20324515|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324516|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324517|NCT00737997|Morphine|morphine|mesh-list
20324518|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20324519|NCT00737997|Narcotics|narcotics|mesh-ancestor
20324520|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324521|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324522|NCT00737997|Analgesics|analgesics|mesh-ancestor
20324523|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
20611484|NCT01042379|Trebananib|trebananib|mesh-list
20611485|NCT01042379|Tucatinib|tucatinib|mesh-list
20324524|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324525|NCT00738088|Gliclazide|gliclazide|mesh-list
20324526|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20324527|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324528|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
20324529|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20324530|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324531|NCT00738192|Fentanyl|fentanyl|mesh-list
20157943|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157944|NCT00112697|Docetaxel|docetaxel|mesh-list
20157945|NCT00112697|Fluorouracil|fluorouracil|mesh-list
20157946|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324532|NCT00738192|Sufentanil|sufentanil|mesh-list
20611486|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611487|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611488|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611489|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
19643743|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20324533|NCT00738192|Dsuvia|dsuvia|mesh-list
19643744|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643745|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19643746|NCT02376972|Rifaximin|rifaximin|mesh-list
19643747|NCT02376972|Metronidazole|metronidazole|mesh-list
19643748|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19643749|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324534|NCT00738192|Butorphanol|butorphanol|mesh-list
20324535|NCT00738192|Citric Acid|citric acid|mesh-list
20324536|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
20324537|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20324538|NCT00738192|Narcotics|narcotics|mesh-ancestor
20324539|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324540|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324541|NCT00738192|Analgesics|analgesics|mesh-ancestor
20324542|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
20324543|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643750|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643751|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19643752|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19643753|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
19643754|NCT02376881|Hematinics|hematinics|mesh-ancestor
19643755|NCT02376985|Everolimus|everolimus|mesh-list
20157947|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
20324544|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20611490|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
19643756|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798170|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20324545|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20324546|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
20324547|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
19643757|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643758|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
19643759|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643760|NCT02376803|Warfarin|warfarin|mesh-list
19643761|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
19643762|NCT02376478|Folic Acid|folic acid|mesh-list
19643763|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
19643764|NCT02376478|Adalimumab|adalimumab|mesh-list
19643765|NCT02376478|Etanercept|etanercept|mesh-list
19643766|NCT02376478|Methotrexate|methotrexate|mesh-list
19643767|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
19643768|NCT02376478|Infliximab|infliximab|mesh-list
20324548|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
20324549|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20324550|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
20324551|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
20324552|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324553|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
20324554|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
19643769|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
19643770|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19643771|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
19643772|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19643773|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643774|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19643775|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
19643776|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643777|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643778|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19643779|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643780|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643781|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
19643782|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643783|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19643784|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643785|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643786|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19643787|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19643788|NCT02376478|Analgesics|analgesics|mesh-ancestor
20157948|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
20157949|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
20157950|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157951|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
20157952|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157953|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157954|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
20157955|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157956|NCT00112710|Gemcitabine|gemcitabine|mesh-list
20157957|NCT00112710|Carboplatin|carboplatin|mesh-list
20157958|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157959|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20157960|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
20157961|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157962|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
20324555|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20324556|NCT00738257|Pamidronate|pamidronate|mesh-list
20324557|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20324558|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324559|NCT00738296|Simvastatin|simvastatin|mesh-list
20324560|NCT00738296|Ezetimibe|ezetimibe|mesh-list
20324561|NCT00738296|Pravastatin|pravastatin|mesh-list
20324562|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20324563|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20324564|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
20324565|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324566|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20324567|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20324568|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157963|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20157964|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157965|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20157966|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
20324569|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20324570|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643789|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
20157967|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643790|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643791|NCT02376478|Hematinics|hematinics|mesh-ancestor
20157968|NCT00112749|Infliximab|infliximab|mesh-list
20157969|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
20157970|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157971|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798171|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798172|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
19798173|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643792|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
20324571|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20324572|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347710|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19643793|NCT02376478|Vitamins|vitamins|mesh-ancestor
19643794|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
19643795|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643796|NCT02376595|Bromides|bromides|mesh-list
19643797|NCT02376595|Rocuronium|rocuronium|mesh-list
19643798|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
19643799|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19643800|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19643801|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19643802|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643803|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643804|NCT02376452|Leucovorin|leucovorin|mesh-list
19643805|NCT02376452|Fluorouracil|fluorouracil|mesh-list
19643806|NCT02376452|Raltitrexed|raltitrexed|mesh-list
19643807|NCT02376452|Irinotecan|irinotecan|mesh-list
19643808|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
19643809|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643810|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19643811|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798174|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798175|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19798176|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798177|NCT00372996|Fulvestrant|fulvestrant|mesh-list
19798178|NCT00372996|Exemestane|exemestane|mesh-list
19798179|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798180|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798181|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19798182|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19798183|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
19643812|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643813|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
19643814|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643815|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19643816|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19643817|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643818|NCT02376452|Antidotes|antidotes|mesh-ancestor
19643819|NCT02376452|Protective Agents|protective agents|mesh-ancestor
19798184|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798185|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643820|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
19643821|NCT02376452|Vitamins|vitamins|mesh-ancestor
19643822|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
19798186|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19798187|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20157972|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
20157973|NCT00112775|Dasatinib|dasatinib|mesh-list
20157974|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20157975|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20157976|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157977|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157978|NCT00112853|Etoposide|etoposide|mesh-list
20157979|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
20157980|NCT00112853|Tipifarnib|tipifarnib|mesh-list
20157981|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20157982|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643823|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19643824|NCT02376413|Trastuzumab|trastuzumab|mesh-list
19643825|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19643826|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663749|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663750|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
19663751|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663752|NCT05098704|Clopidogrel|clopidogrel|mesh-list
19798188|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798189|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798190|NCT00373113|Capecitabine|capecitabine|mesh-list
19798191|NCT00373113|Sunitinib|sunitinib|mesh-list
19798192|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798193|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
19798194|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798195|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798196|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798197|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798198|NCT00373113|Growth Substances|growth substances|mesh-ancestor
19798199|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663753|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19663754|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19663755|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19663756|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19663757|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
19663758|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663759|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663760|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663761|NCT05098574|Drospirenone|drospirenone|mesh-list
19663762|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19663763|NCT05098574|Estradiol|estradiol|mesh-list
19663764|NCT05098574|Estrogens|estrogens|mesh-ancestor
19663765|NCT05098574|Hormones|hormones|mesh-ancestor
19663766|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19663767|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663768|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19663769|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
19663770|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19663771|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19663772|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19663773|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19798200|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798201|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20157983|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20157984|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20157985|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20157986|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157987|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
19798202|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798203|NCT00373256|Paclitaxel|paclitaxel|mesh-list
19798204|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19663774|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19663775|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
19663776|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19663777|NCT05098574|Diuretics|diuretics|mesh-ancestor
19663778|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
19663779|NCT05098366|Furosemide|furosemide|mesh-list
19663780|NCT05098366|Diuretics|diuretics|mesh-ancestor
19663781|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
19663782|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663783|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19663784|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663785|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663786|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19663787|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
19663788|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19663789|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19663790|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19663791|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663792|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798205|NCT00373256|Bevacizumab|bevacizumab|mesh-list
19798206|NCT00373256|Sunitinib|sunitinib|mesh-list
20157988|NCT00112879|Thalidomide|thalidomide|mesh-list
19798207|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19798208|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798209|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19798210|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19798211|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19798212|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798213|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19798214|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798215|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798216|NCT00373256|Growth Substances|growth substances|mesh-ancestor
19798217|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643827|NCT02376309|Nandrolone|nandrolone|mesh-list
19643828|NCT02376309|Androgens|androgens|mesh-ancestor
19643829|NCT02376309|Hormones|hormones|mesh-ancestor
19643830|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643831|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643832|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
19643833|NCT02376088|Methimazole|methimazole|mesh-list
19643834|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
19643835|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
19643836|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643837|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798218|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798219|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798220|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798221|NCT00373295|Baclofen|baclofen|mesh-list
19643838|NCT02376296|Docetaxel|docetaxel|mesh-list
19643839|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643840|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
19643841|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
19643842|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
19643843|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643844|NCT02376374|Vaccines|vaccines|mesh-list
19798222|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19798223|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798224|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19798225|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798226|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19798227|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
19643845|NCT02376374|Immunologic Factors|immunologic factors|mesh-ancestor
19643846|NCT02376374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643847|NCT02376192|Phenylephrine|phenylephrine|mesh-list
19643848|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
19643849|NCT02376192|Ephedrine|ephedrine|mesh-list
19643850|NCT02376192|Bupivacaine|bupivacaine|mesh-list
19643851|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
19643852|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
19643853|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643854|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643855|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
19643856|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643857|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19643858|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
19643859|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
19643860|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
19798228|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
19798229|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798230|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798231|NCT00373334|Nizatidine|nizatidine|mesh-list
20611491|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611492|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20157989|NCT00112879|Dexamethasone|dexamethasone|mesh-list
20157990|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
19798232|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19798233|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19798234|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19798235|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
19798236|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
19798237|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798238|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798239|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157991|NCT00112879|Mitogens|mitogens|mesh-list
20157992|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643861|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19643862|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
19643863|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
19798240|NCT00373360|Treprostinil|treprostinil|mesh-list
19798241|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19798242|NCT00373386|Hormones|hormones|mesh-list
19798243|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798244|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798245|NCT00373399|Dronabinol|dronabinol|mesh-list
19798246|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
19798247|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798248|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19798249|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19798250|NCT00373399|Analgesics|analgesics|mesh-ancestor
19798251|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
19798252|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798253|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19798254|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19798255|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798256|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798257|NCT00373399|Hormones|hormones|mesh-ancestor
19798258|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798259|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19798260|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611493|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611494|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611495|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20611496|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611497|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611498|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20611499|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20611500|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20611501|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19643864|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19643865|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19798261|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798262|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798263|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157993|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
20157994|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
20157995|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20157996|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20157997|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20157998|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
19798264|NCT00373490|Vorinostat|vorinostat|mesh-list
19798265|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798266|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19643866|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19643867|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
19643868|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643869|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643870|NCT02376192|Protective Agents|protective agents|mesh-ancestor
19643871|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19798267|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798268|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20157999|NCT00112879|Hormones|hormones|mesh-ancestor
20158000|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158001|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20158002|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158003|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
19643872|NCT02376049|Betamethasone|betamethasone|mesh-list
20158004|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158005|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158006|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
20158007|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
20175184|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
20175185|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175186|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
20175187|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
20175188|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175189|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20175190|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20175191|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20175192|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
20175193|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158008|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20158009|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158010|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20158011|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20158012|NCT00112879|Growth Substances|growth substances|mesh-ancestor
20158013|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
20158014|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
20158015|NCT00112879|Protective Agents|protective agents|mesh-ancestor
20158016|NCT00112879|Vitamins|vitamins|mesh-ancestor
20158017|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
20158018|NCT00112892|Selenium|selenium|mesh-list
20158019|NCT00112892|Irinotecan|irinotecan|mesh-list
20158020|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20158021|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20158022|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158023|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158024|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158025|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
20158026|NCT00112892|Protective Agents|protective agents|mesh-ancestor
20158027|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158028|NCT00112892|Trace Elements|trace elements|mesh-ancestor
20324573|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324574|NCT00738413|Deferasirox|deferasirox|mesh-list
20324575|NCT00738413|Deferoxamine|deferoxamine|mesh-list
20324576|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20324577|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
20324578|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
20324579|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324580|NCT00738413|Siderophores|siderophores|mesh-ancestor
20324581|NCT00738452|Antibodies|antibodies|mesh-list
20324582|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20324583|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
20324584|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324585|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
19798269|NCT00373529|Clofarabine|clofarabine|mesh-list
20158029|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
20158030|NCT00112931|Rituximab|rituximab|mesh-list
20158031|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158032|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158033|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
20158034|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798270|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798271|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
19798272|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798273|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798274|NCT00373685|Celecoxib|celecoxib|mesh-list
19798275|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19798276|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19798277|NCT00373685|Analgesics|analgesics|mesh-ancestor
19798278|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
19798279|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798280|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158035|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158036|NCT00112983|Eculizumab|eculizumab|mesh-list
20158037|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20158038|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158039|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
20158040|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158041|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
20158042|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
20158043|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158044|NCT00112996|Protective Agents|protective agents|mesh-ancestor
20158045|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158046|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
20158047|NCT00112996|Vitamins|vitamins|mesh-ancestor
20158048|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
20158049|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
20324586|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20324587|NCT00738517|Antibodies|antibodies|mesh-list
19643873|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
19643874|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19643875|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
19643876|NCT02376049|Clobetasol|clobetasol|mesh-list
19643877|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
19643878|NCT02376049|Emollients|emollients|mesh-list
19643879|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19643880|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643881|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
19643882|NCT02376049|Hormones|hormones|mesh-ancestor
20324588|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
20324589|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324590|NCT00738556|Sirolimus|sirolimus|mesh-list
20324591|NCT00738556|Paclitaxel|paclitaxel|mesh-list
20324592|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20324593|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324594|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
20324595|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20324596|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324597|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324598|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20324599|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324600|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20324601|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
20324602|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324603|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
20324604|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324605|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
20324606|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20324607|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19643883|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643884|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643885|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20158050|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158051|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158052|NCT00113074|Nicotine|nicotine|mesh-list
20158053|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20158054|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
20158055|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158056|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158057|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20158058|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20158059|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
20158060|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158061|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158062|NCT00113100|Ethanol|ethanol|mesh-list
20158063|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20158064|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20158065|NCT00113100|Estradiol|estradiol|mesh-list
20158066|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20158067|NCT00113100|Estrogens|estrogens|mesh-ancestor
20158068|NCT00113100|Hormones|hormones|mesh-ancestor
20158069|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158070|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158071|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20158072|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
20158073|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20158074|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20158075|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20158076|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158077|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158078|NCT00113113|Rubitecan|rubitecan|mesh-list
20158079|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158080|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20158081|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20158082|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158083|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158084|NCT00113165|Lamotrigine|lamotrigine|mesh-list
20158085|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
20158086|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20158087|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19643886|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
19643887|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19643888|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19643889|NCT02376049|Analgesics|analgesics|mesh-ancestor
19643890|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
19643891|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643892|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643893|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
20158088|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158089|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20324608|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
20324609|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158090|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158091|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20158092|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20158093|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158094|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158095|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20174148|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174149|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174150|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
20174151|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174152|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174153|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174154|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
20174155|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174156|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20174157|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174158|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174159|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174160|NCT00163761|Gemcitabine|gemcitabine|mesh-list
20174161|NCT00163761|Vinorelbine|vinorelbine|mesh-list
19643894|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643895|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
19643896|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19643897|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643898|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643899|NCT02376205|Bupivacaine|bupivacaine|mesh-list
20174162|NCT00163761|Ifosfamide|ifosfamide|mesh-list
20174163|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20174164|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
20174165|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174166|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174167|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
20174168|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174169|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643900|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19643901|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
19643902|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
19643903|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643904|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174170|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174171|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
20174172|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174173|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20174174|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174175|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174176|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174177|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20174178|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
19643905|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
19643906|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643907|NCT02376075|Linagliptin|linagliptin|mesh-list
20174179|NCT00163969|Ketamine|ketamine|mesh-list
20174180|NCT00163969|Analgesics|analgesics|mesh-ancestor
20174181|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
20174182|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174183|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174184|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20174185|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20174186|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
20174187|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
20174188|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20174189|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20174190|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20174191|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174192|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643908|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20174193|NCT00163982|Norfloxacin|norfloxacin|mesh-list
20174194|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174195|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611502|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20611503|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
20174196|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20174197|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19643909|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158096|NCT00113256|Rubitecan|rubitecan|mesh-list
20158097|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158098|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20158099|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20158100|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158101|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798281|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798282|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158102|NCT00113282|Interleukin-2|interleukin-2|mesh-list
20158103|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158104|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20158105|NCT00113282|Analgesics|analgesics|mesh-ancestor
19643910|NCT02376075|Incretins|incretins|mesh-ancestor
19798283|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19798284|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19798285|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798286|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798287|NCT00373880|Cocaine|cocaine|mesh-list
20158106|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
20158107|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158108|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158109|NCT00113347|Docetaxel|docetaxel|mesh-list
20158110|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20158111|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158112|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158113|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
19643911|NCT02376075|Hormones|hormones|mesh-ancestor
19643912|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643913|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19643914|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
19643915|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643916|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643917|NCT02375828|Glyburide|glyburide|mesh-list
19643918|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20158114|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
20158115|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158116|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20158117|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158118|NCT00113503|Azathioprine|azathioprine|mesh-list
20158119|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
20158120|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158121|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20158122|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158123|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158124|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
20158125|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158126|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158127|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20158128|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
20158129|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
20158130|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158131|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158132|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20158133|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798288|NCT00373880|Aripiprazole|aripiprazole|mesh-list
19798289|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
19798290|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19798291|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19798292|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19798293|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158134|NCT00113542|Growth Substances|growth substances|mesh-ancestor
20158135|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158136|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
20158137|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158138|NCT00113594|Olanzapine|olanzapine|mesh-list
20158139|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
20158140|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
20158141|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158142|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324610|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20324611|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19643919|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158143|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158144|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20324612|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158145|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20158146|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158147|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158148|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20158149|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20158150|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20158151|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158152|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158153|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
20158154|NCT00113685|Dextrans|dextrans|mesh-list
20158155|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20158156|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
20158157|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
20158158|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
20158159|NCT00113698|Enalapril|enalapril|mesh-list
20158160|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20158161|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
20158162|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158163|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158164|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20158165|NCT00113737|Fluoxetine|fluoxetine|mesh-list
20158166|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20158167|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20158168|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20158169|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158170|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158171|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
20158172|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158173|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20158174|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158175|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158176|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20158177|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20158178|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158179|NCT00113776|Panitumumab|panitumumab|mesh-list
20158180|NCT00113776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158181|NCT00113776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158182|NCT00113802|Epratuzumab|epratuzumab|mesh-list
20158183|NCT00113802|Antibodies|antibodies|mesh-list
20158184|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
20158185|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158186|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158187|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158188|NCT00113815|Topiramate|topiramate|mesh-list
20158189|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
20158190|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20158191|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158192|NCT00113828|Cyclosporine|cyclosporine|mesh-list
20158193|NCT00113828|Cyclosporins|cyclosporins|mesh-list
20158194|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158195|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158196|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158197|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
20158198|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158199|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
20158200|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158201|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
20158202|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158203|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20158204|NCT00113854|Mannitol|mannitol|mesh-list
20158205|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20158206|NCT00113854|Diuretics|diuretics|mesh-ancestor
20158207|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
20158208|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158209|NCT00113906|Melatonin|melatonin|mesh-list
20158210|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
20158211|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158212|NCT00113906|Protective Agents|protective agents|mesh-ancestor
20158213|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174198|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347711|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
19643920|NCT02376335|Rituximab|rituximab|mesh-list
19643921|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19643922|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643923|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
20158214|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158215|NCT00113945|Cinacalcet|cinacalcet|mesh-list
19798294|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798295|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
19798296|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
19798297|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798298|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798299|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20158216|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20158217|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158218|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20158219|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
20158220|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158221|NCT00113958|Cinacalcet|cinacalcet|mesh-list
20158222|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20158223|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158224|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20158225|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
20158226|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158227|NCT00113971|Epratuzumab|epratuzumab|mesh-list
20158228|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158229|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158230|NCT00113984|Metronidazole|metronidazole|mesh-list
20158231|NCT00113984|Ipilimumab|ipilimumab|mesh-list
20158232|NCT00113984|Sargramostim|sargramostim|mesh-list
20158233|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
20158234|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158235|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158236|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158237|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20158238|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158239|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158240|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20158241|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20158242|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20158243|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20158244|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20158245|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
20158246|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158247|NCT00114010|Antacids|antacids|mesh-ancestor
20175194|NCT00167648|Leuprolide|leuprolide|mesh-list
19643924|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643925|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19643926|NCT02375880|Gemcitabine|gemcitabine|mesh-list
19643927|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643928|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19643929|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
19643930|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643931|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
19643932|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19643933|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643934|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19643935|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
19643936|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643937|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
19643938|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19643939|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19643940|NCT02375867|Prednisolone|prednisolone|mesh-list
19643941|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
19643942|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19643943|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
19643944|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19643945|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
19643946|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
19643947|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643948|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643949|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643950|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
19643951|NCT02375867|Hormones|hormones|mesh-ancestor
19643952|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19643953|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19643954|NCT02375867|Protective Agents|protective agents|mesh-ancestor
19643955|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20324613|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324614|NCT00738595|Nicotine|nicotine|mesh-list
20324615|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20324616|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
20158248|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158249|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158250|NCT00114023|Imiquimod|imiquimod|mesh-list
20158251|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20158252|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
20158253|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158254|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158255|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
20158256|NCT00114153|Carboplatin|carboplatin|mesh-list
20158257|NCT00114153|Capecitabine|capecitabine|mesh-list
20158258|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158259|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20158260|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
20158261|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158262|NCT00114179|Gemcitabine|gemcitabine|mesh-list
20158263|NCT00114179|Bevacizumab|bevacizumab|mesh-list
20158264|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20158265|NCT00114179|Capecitabine|capecitabine|mesh-list
20611504|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611505|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20611506|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611507|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611508|NCT01042379|Growth Substances|growth substances|mesh-ancestor
20611509|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611510|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611511|NCT01004978|Cisplatin|cisplatin|mesh-list
20611512|NCT01004978|Doxorubicin|doxorubicin|mesh-list
20611513|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20611514|NCT01004978|Sorafenib|sorafenib|mesh-list
20611515|NCT01004978|Mitomycins|mitomycins|mesh-list
20324617|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324618|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324619|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20324620|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20324621|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
20158266|NCT00114179|Antibodies|antibodies|mesh-list
20158267|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
20158268|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20158269|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158270|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20158271|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20158272|NCT00114179|Growth Substances|growth substances|mesh-ancestor
20611516|NCT01004978|Mitomycin|mitomycin|mesh-list
20611517|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611518|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611519|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20611520|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611521|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611522|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611523|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611524|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
20611525|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20611526|NCT00980460|Sirolimus|sirolimus|mesh-list
20611527|NCT00980460|Cisplatin|cisplatin|mesh-list
19643956|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158273|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324622|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324623|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324624|NCT00738621|Dexamethasone|dexamethasone|mesh-list
20324625|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
20324626|NCT00738621|Ondansetron|ondansetron|mesh-list
20324627|NCT00738621|Aprepitant|aprepitant|mesh-list
20324628|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
20324629|NCT00738621|BB 1101|bb 1101|mesh-list
20324630|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324631|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
20324632|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
20324633|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324634|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324635|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158274|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
20324636|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
20611528|NCT00980460|Doxorubicin|doxorubicin|mesh-list
20611529|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20324637|NCT00738621|Hormones|hormones|mesh-ancestor
20324638|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158275|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
20158276|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20158277|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
20158278|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158279|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
20158280|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158281|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158282|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158283|NCT00114192|Thalidomide|thalidomide|mesh-list
20158284|NCT00114192|Docetaxel|docetaxel|mesh-list
20158285|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158286|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158287|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
20158288|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
20158289|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158290|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158291|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
20158292|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158293|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
20158294|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20158295|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158296|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20158297|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20158298|NCT00114192|Growth Substances|growth substances|mesh-ancestor
20158299|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
20158300|NCT00114205|Docetaxel|docetaxel|mesh-list
20158301|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158302|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158303|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
20158304|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
20158305|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158306|NCT00114257|Decitabine|decitabine|mesh-list
20158307|NCT00114257|Romidepsin|romidepsin|mesh-list
20324639|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19643957|NCT02375646|Heparin|heparin|mesh-list
19643958|NCT02375646|Enoxaparin|enoxaparin|mesh-list
19643959|NCT02375646|Warfarin|warfarin|mesh-list
20158308|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20158309|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
20158310|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643960|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
19643961|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19643962|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19643963|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158311|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158312|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158313|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20158314|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
20158315|NCT00114270|Letrozole|letrozole|mesh-list
20158316|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158317|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20158318|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20158319|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643964|NCT02375464|Octreotide|octreotide|mesh-list
19643965|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19643966|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19643967|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19643968|NCT02375503|Vitamin D|vitamin d|mesh-list
19643969|NCT02375503|Calcium|calcium|mesh-list
19643970|NCT02375503|Vitamins|vitamins|mesh-ancestor
20158320|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158321|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20158322|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
20158323|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158324|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158325|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20158326|NCT00114283|Lapatinib|lapatinib|mesh-list
20158327|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158328|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20158329|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158330|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158331|NCT00114361|Ribavirin|ribavirin|mesh-list
20158332|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20158333|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
19798300|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19798301|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
19798302|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19798303|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19798304|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19798305|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19798306|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
19798307|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
19798308|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
19798309|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158334|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158335|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
20158336|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158337|NCT00114374|Citalopram|citalopram|mesh-list
20158338|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20158339|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20158340|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20158341|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158342|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158343|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
20158344|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158345|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20158346|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158347|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158348|NCT00114387|Tocopherols|tocopherols|mesh-list
20158349|NCT00114387|Vitamin E|vitamin e|mesh-list
20158350|NCT00114387|Tocotrienols|tocotrienols|mesh-list
20158351|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
20158352|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
20158353|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158354|NCT00114387|Protective Agents|protective agents|mesh-ancestor
20158355|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158356|NCT00114387|Vitamins|vitamins|mesh-ancestor
20158357|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
20158358|NCT00114400|Vitamins|vitamins|mesh-list
20158359|NCT00114400|Folic Acid|folic acid|mesh-list
20158360|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
20158361|NCT00114400|Hydroxocobalamin|hydroxocobalamin|mesh-list
20158362|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
20158363|NCT00114400|Pyridoxal|pyridoxal|mesh-list
20158364|NCT00114400|Pyridoxine|pyridoxine|mesh-list
20158365|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
20158366|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
20158367|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158368|NCT00114400|Hematinics|hematinics|mesh-ancestor
20158369|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
20158370|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158371|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158372|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158373|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158374|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
20158375|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20158376|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158377|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158378|NCT00114478|Epinephrine|epinephrine|mesh-list
20158379|NCT00114478|Albuterol|albuterol|mesh-list
20158380|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20158381|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20158382|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
20158383|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175195|NCT00167648|Goserelin|goserelin|mesh-list
20324640|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324641|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
20158384|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158385|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158386|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20158387|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20158388|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
20158389|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158390|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20158391|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
20158392|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
20158393|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
20158394|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20324642|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324643|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324644|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
20324645|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
20324646|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20324647|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
20324648|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324649|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20324650|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20324651|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324652|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19643971|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
19643972|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643973|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19643974|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19643975|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
19643976|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19643977|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19643978|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324653|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20324654|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19643979|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19643980|NCT02375243|Analgesics|analgesics|mesh-ancestor
19643981|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
19643982|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19643983|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19643984|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19798310|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20158395|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
20158396|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20158397|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20158398|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20158399|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20158400|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20158401|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
20158402|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158403|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20158404|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20324655|NCT00738660|Telmisartan|telmisartan|mesh-list
19798311|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19798312|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19798313|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19798314|NCT00373958|Vaccines|vaccines|mesh-list
19798315|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19798316|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
19798317|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324656|NCT00738660|Ramipril|ramipril|mesh-list
20324657|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20324658|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20324659|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20324660|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798318|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
19798319|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19798320|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
20158405|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158406|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
20158407|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20158408|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158409|NCT00114569|Lorazepam|lorazepam|mesh-list
20158410|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
20158411|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
20158412|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
20158413|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158414|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158415|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158416|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20158417|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158418|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20158419|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20158420|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158421|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
20158422|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
20158423|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158424|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158425|NCT00114686|Valproic Acid|valproic acid|mesh-list
20158426|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20158427|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158428|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158429|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20158430|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20158431|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158432|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158433|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158434|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158435|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
20158436|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
20158437|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
20158438|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158439|NCT00114764|Lenograstim|lenograstim|mesh-list
20158440|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20158441|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
20158442|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158443|NCT00114803|Calcitonin|calcitonin|mesh-list
20158444|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
20158445|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20158446|NCT00114803|Katacalcin|katacalcin|mesh-list
20158447|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20158448|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158449|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20158450|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
20158451|NCT00114816|Docetaxel|docetaxel|mesh-list
20158452|NCT00114816|Capecitabine|capecitabine|mesh-list
20158453|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324661|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20324662|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
20324663|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324664|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20324665|NCT00738751|Panobinostat|panobinostat|mesh-list
20158454|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158455|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
20158456|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
20158457|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158458|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20158459|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
20158460|NCT00114868|Vitamins|vitamins|mesh-list
20158461|NCT00114868|Vitamin A|vitamin a|mesh-list
20158462|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
20158463|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
20158464|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158465|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
20158466|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158467|NCT00114868|Protective Agents|protective agents|mesh-ancestor
20158468|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20158469|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158470|NCT00114933|Ritonavir|ritonavir|mesh-list
20158471|NCT00114933|Lopinavir|lopinavir|mesh-list
19798321|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158472|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20158473|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20158474|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
20158475|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158476|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798322|NCT00374088|Expectorants|expectorants|mesh-ancestor
19798323|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
19798324|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19798325|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
19798326|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798327|NCT00374088|Protective Agents|protective agents|mesh-ancestor
19798328|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798329|NCT00374088|Antidotes|antidotes|mesh-ancestor
19798330|NCT00374140|Everolimus|everolimus|mesh-list
19798331|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798332|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798333|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
19798334|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798335|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
19798336|NCT00374231|Prednisone|prednisone|mesh-list
19798337|NCT00374231|Tacrolimus|tacrolimus|mesh-list
19798338|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798339|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
19798340|NCT00374231|Hormones|hormones|mesh-ancestor
19798341|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798342|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798343|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798344|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798345|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158477|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20158478|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20158479|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
20158480|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158481|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20158482|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20158483|NCT00114946|Bevacizumab|bevacizumab|mesh-list
20158484|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158485|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158486|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20158487|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20158488|NCT00114946|Growth Substances|growth substances|mesh-ancestor
20158489|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158490|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
20158491|NCT00115011|Citalopram|citalopram|mesh-list
20158492|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20158493|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20158494|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20158495|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324666|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20324667|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324668|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20324669|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324670|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324671|NCT00738777|Tamoxifen|tamoxifen|mesh-list
20324672|NCT00738777|Fulvestrant|fulvestrant|mesh-list
19798346|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
20158496|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158497|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
20158498|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158499|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20158500|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158501|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158502|NCT00115024|Estradiol|estradiol|mesh-list
20158503|NCT00115024|Estrogens|estrogens|mesh-ancestor
20158504|NCT00115024|Hormones|hormones|mesh-ancestor
20324673|NCT00738777|Anastrozole|anastrozole|mesh-list
20158505|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158506|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158507|NCT00115089|Beclomethasone|beclomethasone|mesh-list
20158508|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158509|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
20158510|NCT00115089|Hormones|hormones|mesh-ancestor
20158511|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158512|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643985|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19643986|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
19643987|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643988|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643989|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
19643990|NCT02375217|Neostigmine|neostigmine|mesh-list
19643991|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19643992|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19643993|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19643994|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
19643995|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19643996|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19643997|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19643998|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
20158513|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20158514|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
20158515|NCT00115102|Fentanyl|fentanyl|mesh-list
20158516|NCT00115102|Ketamine|ketamine|mesh-list
20158517|NCT00115102|Esketamine|esketamine|mesh-list
20158518|NCT00115102|Analgesics|analgesics|mesh-ancestor
20158519|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
20158520|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158521|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798347|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19798348|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158522|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20158523|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20158524|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
20158525|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
20158526|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158527|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20158528|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20158529|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158530|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158531|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20158532|NCT00115102|Narcotics|narcotics|mesh-ancestor
20158533|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20158534|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158535|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20174199|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174200|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175196|NCT00167648|Estradiol|estradiol|mesh-list
19643999|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175197|NCT00167648|Estrogens|estrogens|mesh-ancestor
19644000|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19798349|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175198|NCT00167648|Hormones|hormones|mesh-ancestor
20175199|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175200|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175201|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20175202|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20175203|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
20175204|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20175205|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175206|NCT00167674|Zidovudine|zidovudine|mesh-list
20175207|NCT00167674|Nevirapine|nevirapine|mesh-list
20175208|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
20175209|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175210|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20175211|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20175212|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175213|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
20175214|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175215|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20175216|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20158536|NCT00115115|Dopamine|dopamine|mesh-list
20158537|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20324674|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20324675|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
20324676|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20324677|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324678|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20324679|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324680|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20324681|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20158538|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
20158539|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
20158540|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158541|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158542|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
20158543|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158544|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158545|NCT00115115|Protective Agents|protective agents|mesh-ancestor
20158546|NCT00115128|Lenograstim|lenograstim|mesh-list
20158547|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20158548|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
20158549|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324682|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20324683|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20158550|NCT00115154|Imiquimod|imiquimod|mesh-list
20158551|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20324684|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20324685|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20324686|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324687|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324688|NCT00738829|Vidarabine|vidarabine|mesh-list
20324689|NCT00738829|Rituximab|rituximab|mesh-list
20324690|NCT00738829|Fludarabine|fludarabine|mesh-list
20324691|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
20324692|NCT00738829|Lenalidomide|lenalidomide|mesh-list
20324693|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20324694|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324695|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
20324696|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324697|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324698|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324699|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
20324700|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324701|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324702|NCT00738829|Antiviral Agents|antiviral agents|mesh-ancestor
20324703|NCT00738829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324704|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20324705|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20324706|NCT00738829|Growth Substances|growth substances|mesh-ancestor
20324707|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
20324708|NCT00738842|Ticagrelor|ticagrelor|mesh-list
20324709|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20324710|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20324711|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20324712|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20324713|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
20324714|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324715|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644001|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19644002|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20158552|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
20158553|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158554|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158555|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
20158556|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
20158557|NCT00115167|Hematinics|hematinics|mesh-ancestor
20158558|NCT00115219|Etanercept|etanercept|mesh-list
20158559|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20158560|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20158561|NCT00115219|Analgesics|analgesics|mesh-ancestor
20158562|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
20158563|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158564|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158565|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158566|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158567|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19798350|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798351|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19798352|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
19798353|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798354|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798355|NCT00374244|Pimozide|pimozide|mesh-list
19798356|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20324716|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324717|NCT00738868|Cetuximab|cetuximab|mesh-list
20324718|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19798357|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20324719|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324720|NCT00738985|Simvastatin|simvastatin|mesh-list
20324721|NCT00738985|Ezetimibe|ezetimibe|mesh-list
20324722|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20324723|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20324724|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20324725|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
20324726|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324727|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20324728|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20324729|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347712|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
20347713|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347714|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347715|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20347716|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19798358|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19798359|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798360|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19798361|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19798362|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
19798363|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798364|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798365|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19798366|NCT00374322|Lapatinib|lapatinib|mesh-list
19798367|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798368|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20347717|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20347718|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347719|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
20347720|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
20347721|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
20347722|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347723|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
20347724|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
20347725|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20347726|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
20347727|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
20347728|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347729|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158568|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347730|NCT00861627|Paclitaxel|paclitaxel|mesh-list
20158569|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
20324730|NCT00739128|Vaccines|vaccines|mesh-list
20324731|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
19798369|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324732|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324733|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
20324734|NCT00739141|Thiotepa|thiotepa|mesh-list
20324735|NCT00739141|Fludarabine|fludarabine|mesh-list
20324736|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324737|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
20324738|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324739|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324740|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20324741|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
20158570|NCT00115245|Adefovir|adefovir|mesh-list
20158571|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20158572|NCT00115245|Telbivudine|telbivudine|mesh-list
20158573|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
20158574|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158575|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20158576|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20158577|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158578|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158579|NCT00115310|Capsaicin|capsaicin|mesh-list
20158580|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
20324742|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324743|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324744|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20324745|NCT00739193|Amiodarone|amiodarone|mesh-list
20158581|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
20158582|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
20158583|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158584|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158585|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20158586|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19798370|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798371|NCT00374556|Eszopiclone|eszopiclone|mesh-list
20158587|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20158588|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20158589|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158590|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158591|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158592|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20158593|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158594|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158595|NCT00115375|Clopidogrel|clopidogrel|mesh-list
20158596|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20158597|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20158598|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20158599|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20158600|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
20158601|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158602|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158603|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158604|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
20158605|NCT00115414|Docetaxel|docetaxel|mesh-list
20158606|NCT00115414|Doxorubicin|doxorubicin|mesh-list
20158607|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158608|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
20324746|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20324747|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
20324748|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20324749|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20324750|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324751|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20324752|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20324753|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20324754|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798372|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19256650|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20158609|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158610|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158611|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20158612|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
20158613|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158614|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158615|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20158616|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158617|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
20158618|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
20158619|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20158620|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20158621|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20158622|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158623|NCT00115479|Benzocaine|benzocaine|mesh-list
20158624|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158625|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
20158626|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
20158627|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158628|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
20158629|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158630|NCT00115492|Fluticasone|fluticasone|mesh-list
20158631|NCT00115492|Xhance|xhance|mesh-list
20158632|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20158633|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20158634|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158635|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20158636|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
20158637|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158638|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158639|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20158640|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
20158641|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
20158642|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20158643|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20158644|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20158645|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20158646|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
20158647|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158648|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324755|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20324756|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20324757|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20611530|NCT00980460|Fluorouracil|fluorouracil|mesh-list
20611531|NCT00980460|Irinotecan|irinotecan|mesh-list
20611532|NCT00980460|Vincristine|vincristine|mesh-list
20611533|NCT00980460|Camptothecin|camptothecin|mesh-list
20611534|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
20611535|NCT00980460|Razoxane|razoxane|mesh-list
20611536|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
20611537|NCT00980460|Liver Extracts|liver extracts|mesh-list
20611538|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611539|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611540|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20324758|NCT00739388|Azacitidine|azacitidine|mesh-list
20324759|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324760|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
20324761|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324762|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324763|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324764|NCT00739414|Panobinostat|panobinostat|mesh-list
20324765|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324766|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20324767|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324768|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324769|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20324770|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324771|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611541|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611542|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158649|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
20158650|NCT00115492|Hormones|hormones|mesh-ancestor
20174201|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20611543|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611544|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
20611545|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611546|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611547|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
20158651|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158652|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
20158653|NCT00115518|Cetuximab|cetuximab|mesh-list
20158654|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158655|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158656|NCT00115531|Vaccines|vaccines|mesh-list
20158657|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
20158658|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158659|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20324772|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324773|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158660|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158661|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158662|NCT00115570|Insulin|insulin|mesh-list
20158663|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20158664|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
20158665|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
20158666|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
20158667|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
20158668|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
20158669|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
20158670|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20158671|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158672|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20158673|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20158674|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20324774|NCT00739466|Alendronate|alendronate|mesh-list
20324775|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20324776|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324777|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
20324778|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
20324779|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158675|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158676|NCT00115609|Tenofovir|tenofovir|mesh-list
20158677|NCT00115609|Emtricitabine|emtricitabine|mesh-list
20158678|NCT00115609|Efavirenz|efavirenz|mesh-list
20158679|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
20158680|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158681|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20324780|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
20324781|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20324782|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
20324783|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324784|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324785|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20324786|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
20324787|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20324788|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
20324789|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158682|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20158683|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158684|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158685|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20158686|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20158687|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20158688|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20158689|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20158690|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20158691|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20158692|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20158693|NCT00115622|Fluticasone|fluticasone|mesh-list
20158694|NCT00115622|Xhance|xhance|mesh-list
20158695|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158696|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20324790|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644003|NCT02375139|Metformin|metformin|mesh-list
20158697|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
20158698|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324791|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19798373|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644004|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644005|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644006|NCT02375191|Fentanyl|fentanyl|mesh-list
19644007|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
19644008|NCT02375191|Ropivacaine|ropivacaine|mesh-list
20324792|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
20324793|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
20324794|NCT00739531|Protective Agents|protective agents|mesh-ancestor
20324795|NCT00739609|Tryptophan|tryptophan|mesh-list
20324796|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20324797|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
19644009|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19644010|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644011|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644012|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644013|NCT02375191|Analgesics|analgesics|mesh-ancestor
19644014|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
19644015|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644016|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19644017|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19644018|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19644019|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19644020|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644021|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644022|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
19798374|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798375|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
19798376|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798377|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798378|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19798379|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
20158699|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158700|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20158701|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
20158702|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
20158703|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20158704|NCT00115635|Gemcitabine|gemcitabine|mesh-list
20158705|NCT00115635|Docetaxel|docetaxel|mesh-list
20158706|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20158707|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
20158708|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158709|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158710|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
20158711|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158712|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158713|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158714|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
20158715|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158716|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158717|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
20158718|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
20324798|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20324799|NCT00739622|Rilpivirine|rilpivirine|mesh-list
20324800|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20324801|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20324802|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324803|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324804|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
19644023|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
19644024|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19644025|NCT02375191|Narcotics|narcotics|mesh-ancestor
19644026|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19644027|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19644028|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
19644029|NCT02375178|Biguanides|biguanides|mesh-list
19644030|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
19644031|NCT02375178|Polihexanide|polihexanide|mesh-list
19644032|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19644033|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158719|NCT00115648|Zidovudine|zidovudine|mesh-list
20324805|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644034|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
19644035|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644036|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644037|NCT02375100|Acetaminophen|acetaminophen|mesh-list
20158720|NCT00115648|Nevirapine|nevirapine|mesh-list
20158721|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
20158722|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158723|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20158724|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20158725|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158726|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
20158727|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158728|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20158729|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20158730|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20158731|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20158732|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
20158733|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20158734|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158735|NCT00115687|Nicotine|nicotine|mesh-list
20158736|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20158737|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
20158738|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158739|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158740|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20158741|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20158742|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
20158743|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158744|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158745|NCT00115700|Prednisolone|prednisolone|mesh-list
20158746|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
20158747|NCT00115700|Rituximab|rituximab|mesh-list
20158748|NCT00115700|Vincristine|vincristine|mesh-list
20158749|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158750|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
20158751|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158752|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798380|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798381|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798382|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798383|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798384|NCT00374868|Pemetrexed|pemetrexed|mesh-list
19798385|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798386|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798387|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798388|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19798389|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19798390|NCT00374907|Metformin|metformin|mesh-list
19798391|NCT00374907|Saxagliptin|saxagliptin|mesh-list
19798392|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19798393|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798394|NCT00374907|Incretins|incretins|mesh-ancestor
19798395|NCT00374907|Hormones|hormones|mesh-ancestor
19798396|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798397|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19798398|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19798399|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798400|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798401|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
19798402|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19798403|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798404|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19798405|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798406|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798407|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
19798408|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19798409|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798410|NCT00375492|Exenatide|exenatide|mesh-list
19798411|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19798412|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798413|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19798414|NCT00375492|Incretins|incretins|mesh-ancestor
19798415|NCT00375492|Hormones|hormones|mesh-ancestor
19798416|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798417|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
19798418|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19798419|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798420|NCT00375518|Atorvastatin|atorvastatin|mesh-list
20158753|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19798421|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19798422|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19798423|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
19798424|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798425|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19798426|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19798427|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798428|NCT00375609|Enoxaparin|enoxaparin|mesh-list
19798429|NCT00375609|Betrixaban|betrixaban|mesh-list
20324806|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20324807|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20324808|NCT00739830|Sirolimus|sirolimus|mesh-list
20324809|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20324810|NCT00739830|Megestrol|megestrol|mesh-list
20324811|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
20324812|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
20324813|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20324814|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20324815|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20324816|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
20158754|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
20158755|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158756|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158757|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20158758|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158759|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20158760|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158761|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
20158762|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
20158763|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158764|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
20158765|NCT00115700|Hormones|hormones|mesh-ancestor
20158766|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158767|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20158768|NCT00115726|Furosemide|furosemide|mesh-list
20158769|NCT00115726|Diuretics|diuretics|mesh-ancestor
20158770|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
20158771|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158772|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20158773|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20158774|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158775|NCT00115752|Valdecoxib|valdecoxib|mesh-list
20324817|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20324818|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324819|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19798430|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
19798431|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19798432|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19798433|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798434|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19798435|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
19798436|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19798437|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
19798438|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798439|NCT00375674|Sunitinib|sunitinib|mesh-list
20324820|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20324821|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20324822|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798440|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798441|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798442|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798443|NCT00375674|Growth Substances|growth substances|mesh-ancestor
19798444|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798445|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798446|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798447|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798448|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798449|NCT00375713|Cetirizine|cetirizine|mesh-list
19798450|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
19798451|NCT00375713|Levocetirizine|levocetirizine|mesh-list
19798452|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798453|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19798454|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20324823|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644038|NCT02375100|Tramadol|tramadol|mesh-list
19644039|NCT02375100|Analgesics|analgesics|mesh-list
19644040|NCT02375100|Bupivacaine|bupivacaine|mesh-list
19644041|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
20158776|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
19644042|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
19644043|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644044|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644045|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
20158777|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20158778|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158779|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158780|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20158781|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20158782|NCT00115752|Analgesics|analgesics|mesh-ancestor
20158783|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
20158784|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158785|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158786|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158787|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158788|NCT00115817|Atorvastatin|atorvastatin|mesh-list
20158789|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20158790|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20158791|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
20158792|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158793|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19644046|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644047|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644048|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
19644049|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19644050|NCT02375100|Narcotics|narcotics|mesh-ancestor
19644051|NCT02375022|Endostar protein|endostar protein|mesh-list
19644052|NCT02375022|Endostatins|endostatins|mesh-list
19644053|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19644054|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19644055|NCT02375022|Growth Substances|growth substances|mesh-ancestor
19644056|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644057|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
19644058|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663793|NCT05098327|Pioglitazone|pioglitazone|mesh-list
19663794|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19663795|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663796|NCT05098119|Paclitaxel|paclitaxel|mesh-list
19663797|NCT05098119|Carboplatin|carboplatin|mesh-list
19663798|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19663799|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663800|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
19663801|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
19663802|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
19663803|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663804|NCT05098067|Ondansetron|ondansetron|mesh-list
19663805|NCT05098067|Metoclopramide|metoclopramide|mesh-list
19663806|NCT05098067|Capsaicin|capsaicin|mesh-list
19663807|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
19663808|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
19663809|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663810|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663811|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19663812|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
19663813|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
19663814|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19663815|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
19663816|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663817|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663818|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19663819|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19663820|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663821|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19663822|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19663823|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
19663824|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19663825|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19663826|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
19663827|NCT05097950|Acetaminophen|acetaminophen|mesh-list
19663828|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19663829|NCT05097950|Analgesics|analgesics|mesh-ancestor
19644059|NCT02374853|Vancomycin|vancomycin|mesh-list
19644060|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19644061|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644062|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
19644063|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20324824|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
19644064|NCT02374736|Antibodies|antibodies|mesh-list
19644065|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
19644066|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
19644067|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158794|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20158795|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158796|NCT00115830|Atorvastatin|atorvastatin|mesh-list
20158797|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20158798|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20158799|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20158800|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
20158801|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158802|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20158803|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20158804|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158805|NCT00115908|Ribavirin|ribavirin|mesh-list
20158806|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20158807|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
20158808|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158809|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
20158810|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158811|NCT00115921|Antimalarials|antimalarials|mesh-list
20158812|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20158813|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20158814|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158815|NCT00115947|Terlipressin|terlipressin|mesh-list
20158816|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20158817|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20158818|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
20158819|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20158820|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798455|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19798456|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
19798457|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
19798458|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798459|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798460|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798461|NCT00375752|Letrozole|letrozole|mesh-list
19798462|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798463|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19798464|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19798465|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798466|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644068|NCT02374931|Estradiol|estradiol|mesh-list
19798467|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19798468|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
19798469|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798470|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798471|NCT00375830|Diphosphonates|diphosphonates|mesh-list
19798472|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
20158821|NCT00116064|Lorazepam|lorazepam|mesh-list
20158822|NCT00116064|Paraldehyde|paraldehyde|mesh-list
20158823|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
20158824|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
20158825|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
20158826|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798473|NCT00375830|Listerine|listerine|mesh-list
19798474|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
20158827|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324825|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19798475|NCT00375830|Fluorides|fluorides|mesh-list
19798476|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
20158828|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158829|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19644069|NCT02374931|Estrogens|estrogens|mesh-ancestor
19644070|NCT02374931|Hormones|hormones|mesh-ancestor
19644071|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644072|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644073|NCT02374632|Octreotide|octreotide|mesh-list
19644074|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644075|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798477|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19798478|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
19798479|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
19798480|NCT00375830|Protective Agents|protective agents|mesh-ancestor
20324826|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20324827|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324828|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20324829|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
20324830|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324831|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
20324832|NCT00739986|Semapimod|semapimod|mesh-list
20324833|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20324834|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20324835|NCT00739986|Analgesics|analgesics|mesh-ancestor
20324836|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
20324837|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644076|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644077|NCT02374645|Gefitinib|gefitinib|mesh-list
19644078|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644079|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19644080|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798481|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798482|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19798483|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798484|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19798485|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798486|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
20158830|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158831|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20158832|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20158833|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158834|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
19798487|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
19798488|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19798489|NCT00375934|Diclofenac|diclofenac|mesh-list
19798490|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20158835|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
20158836|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158837|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158838|NCT00116103|Tacrolimus|tacrolimus|mesh-list
20158839|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158840|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
20158841|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158842|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20158843|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158844|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158845|NCT00116181|Etanercept|etanercept|mesh-list
20158846|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20158847|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20158848|NCT00116181|Analgesics|analgesics|mesh-ancestor
20158849|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
20158850|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158851|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158852|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158853|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20158854|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158855|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158856|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
20158857|NCT00116259|Aripiprazole|aripiprazole|mesh-list
20158858|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158859|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158860|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20158861|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20158862|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324838|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798491|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20324839|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324840|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324841|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324842|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
19798492|NCT00375934|Analgesics|analgesics|mesh-ancestor
19798493|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
19798494|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798495|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798496|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798497|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798498|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19798499|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798500|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798501|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19798502|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19798503|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19798504|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19798505|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798506|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798507|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798508|NCT00375973|Analgesics|analgesics|mesh-ancestor
19798509|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
19798510|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798511|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
19798512|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19798513|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
19798514|NCT00375999|Docetaxel|docetaxel|mesh-list
19798515|NCT00375999|Epirubicin|epirubicin|mesh-list
19798516|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798517|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
19798518|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
19798519|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
19798520|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798521|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798522|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19798523|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19798524|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798525|NCT00376220|Riluzole|riluzole|mesh-list
19798526|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
19798527|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19798528|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19798529|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798530|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798531|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798532|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19798533|NCT00376220|Protective Agents|protective agents|mesh-ancestor
19798534|NCT00376246|Ezetimibe|ezetimibe|mesh-list
19798535|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19798536|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19798537|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
19798538|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798539|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19798540|NCT00376259|Adefovir|adefovir|mesh-list
19798541|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19798542|NCT00376259|Telbivudine|telbivudine|mesh-list
19798543|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
19798544|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798545|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19798546|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19798547|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798548|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158863|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158864|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
20158865|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
20158866|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158867|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158868|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20158869|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20158870|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
20158871|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20324843|NCT00740064|Lamivudine|lamivudine|mesh-list
20324844|NCT00740064|Abacavir|abacavir|mesh-list
19798549|NCT00376675|Methylphenidate|methylphenidate|mesh-list
19798550|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19798551|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798552|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19798553|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19798554|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19798555|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324845|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
20324846|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20324847|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19798556|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
19798557|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798558|NCT00376688|Sirolimus|sirolimus|mesh-list
19798559|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798560|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798561|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798562|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798563|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
19798564|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798565|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
19798566|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798567|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
19798568|NCT00376805|Fludarabine|fludarabine|mesh-list
19798569|NCT00376805|Interleukin-2|interleukin-2|mesh-list
19798570|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798571|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
19798572|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798573|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798574|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19798575|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
19798576|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798577|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798578|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19798579|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19798580|NCT00376805|Analgesics|analgesics|mesh-ancestor
19798581|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
19798582|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798583|NCT00376948|Gemcitabine|gemcitabine|mesh-list
19798584|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19798585|NCT00376948|Genistein|genistein|mesh-list
19798586|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798587|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
19798588|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798589|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798590|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
19798591|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798592|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798593|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798594|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
19798595|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798596|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19798597|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19798598|NCT00376948|Protective Agents|protective agents|mesh-ancestor
19798599|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
19798600|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19798601|NCT00376948|Estrogens|estrogens|mesh-ancestor
19798602|NCT00376948|Hormones|hormones|mesh-ancestor
19798603|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798604|NCT00376961|Prednisone|prednisone|mesh-list
19798605|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
19798606|NCT00376961|Rituximab|rituximab|mesh-list
19798607|NCT00376961|Doxorubicin|doxorubicin|mesh-list
19798608|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19798609|NCT00376961|Vincristine|vincristine|mesh-list
19798610|NCT00376961|Bortezomib|bortezomib|mesh-list
19798611|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798612|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
19798613|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798614|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798615|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19798616|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
19798617|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324848|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324849|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798618|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798619|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19798620|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19798621|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798622|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19798623|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19798624|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798625|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798626|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
19798627|NCT00376961|Hormones|hormones|mesh-ancestor
19798628|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798629|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798630|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19798631|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
19798632|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
19798633|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
19798634|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
19798635|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
19798636|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19798637|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19798638|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798639|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19798640|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798641|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19798642|NCT00377260|Amoxicillin|amoxicillin|mesh-list
20158872|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20158873|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20158874|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20158875|NCT00116324|Montelukast|montelukast|mesh-list
20158876|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20158877|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
20158878|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20158879|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
20158880|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158881|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324850|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
19644081|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798643|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
19798644|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
19798645|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19798646|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19644082|NCT02374489|Ceritinib|ceritinib|mesh-list
19644083|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644084|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19644085|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644086|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644087|NCT02374320|Bupivacaine|bupivacaine|mesh-list
19644088|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
19644089|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
19644090|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644091|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644092|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
19644093|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644094|NCT02374567|Topiramate|topiramate|mesh-list
19798647|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644095|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
19644096|NCT02374567|Promethazine|promethazine|mesh-list
19644097|NCT02374567|Pregabalin|pregabalin|mesh-list
19644098|NCT02374567|Lamotrigine|lamotrigine|mesh-list
19644099|NCT02374567|Lacosamide|lacosamide|mesh-list
19644100|NCT02374567|Carbamazepine|carbamazepine|mesh-list
19644101|NCT02374567|Phenytoin|phenytoin|mesh-list
19644102|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
19644103|NCT02374567|Nicergoline|nicergoline|mesh-list
19644104|NCT02374567|Midazolam|midazolam|mesh-list
19644105|NCT02374567|Diazepam|diazepam|mesh-list
19644106|NCT02374567|Triazolam|triazolam|mesh-list
19644107|NCT02374567|Acamprosate|acamprosate|mesh-list
19798648|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19798649|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798650|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798651|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19798652|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
19798653|NCT00377312|Hormones|hormones|mesh-list
19644108|NCT02374567|Gabapentin|gabapentin|mesh-list
19798654|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
19644109|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19644110|NCT02374567|Amitriptyline|amitriptyline|mesh-list
19798655|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20158882|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20158883|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20158884|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158885|NCT00116350|Misoprostol|misoprostol|mesh-list
20158886|NCT00116350|Oxytocin|oxytocin|mesh-list
20158887|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
20158888|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20158889|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158890|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20158891|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
20158892|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20158893|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158894|NCT00116389|Gemcitabine|gemcitabine|mesh-list
20158895|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20158896|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
20158897|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158898|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158899|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
20158900|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158901|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158902|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20158903|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
20158904|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158905|NCT00116402|Fluticasone|fluticasone|mesh-list
19798656|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798657|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19798658|NCT00377364|Acetaminophen|acetaminophen|mesh-list
19798659|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19798660|NCT00377364|Analgesics|analgesics|mesh-ancestor
19798661|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
19798662|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798663|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798664|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
19798665|NCT00377403|Acetaminophen|acetaminophen|mesh-list
19798666|NCT00377403|Amoxicillin|amoxicillin|mesh-list
20158906|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20158907|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20158908|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20158909|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
20158910|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158911|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798667|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
20158912|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20324851|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324852|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20324853|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20324854|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20324855|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20324856|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20324857|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20324858|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
20324859|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324860|NCT00740090|Antacids|antacids|mesh-ancestor
20324861|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324862|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19798668|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
19798669|NCT00377403|Ephedrine|ephedrine|mesh-list
19798670|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
19798671|NCT00377403|Guaifenesin|guaifenesin|mesh-list
19798672|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19798673|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19798674|NCT00377403|Analgesics|analgesics|mesh-ancestor
19798675|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
19798676|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798677|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798678|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
19798679|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798680|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798681|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
19798682|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
19798683|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19798684|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19798685|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798686|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798687|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19798688|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
19798689|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19798690|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
19798691|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19798692|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19798693|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
19798694|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
19798695|NCT00377403|Expectorants|expectorants|mesh-ancestor
19798696|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19798697|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19798698|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
19798699|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19798700|NCT00377429|Catumaxomab|catumaxomab|mesh-list
19798701|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19798702|NCT00377520|Pemetrexed|pemetrexed|mesh-list
19798703|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798704|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798705|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798706|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19798707|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19798708|NCT00377572|Omalizumab|omalizumab|mesh-list
19798709|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19798710|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19798711|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19798712|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
19798713|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
19798714|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798715|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
19798716|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
19798717|NCT00377637|Azathioprine|azathioprine|mesh-list
19798718|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798719|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
19798720|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798721|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324863|NCT00740103|Semapimod|semapimod|mesh-list
20324864|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19798722|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20324865|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19798723|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
20324866|NCT00740103|Analgesics|analgesics|mesh-ancestor
19798724|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798725|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798726|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19798727|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798728|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19798729|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
19798730|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798731|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798732|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798733|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
19798734|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798735|NCT00377676|Bromocriptine|bromocriptine|mesh-list
20158913|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
20158914|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
20158915|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20158916|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20158917|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19798736|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19798737|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19798738|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
19798739|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798740|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798741|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
19798742|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
19798743|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19798744|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798745|NCT00377741|Valganciclovir|valganciclovir|mesh-list
19798746|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
19798747|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798748|NCT00377819|Denosumab|denosumab|mesh-list
19798749|NCT00377819|Alendronate|alendronate|mesh-list
19798750|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19798751|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798752|NCT00377832|Acetaminophen|acetaminophen|mesh-list
19798753|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19798754|NCT00377832|Analgesics|analgesics|mesh-ancestor
19798755|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
19798756|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798757|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798758|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
19798759|NCT00377858|Insulin|insulin|mesh-list
19798760|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20324867|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
20324868|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798761|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
19798762|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
19798763|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19798764|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798765|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
19798766|NCT00377962|Everolimus|everolimus|mesh-list
20324869|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324870|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324871|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20324872|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324873|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
20324874|NCT00740142|Lactulose|lactulose|mesh-list
20324875|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
20324876|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324877|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20324878|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20324879|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324880|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324881|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798767|NCT00377962|Azathioprine|azathioprine|mesh-list
19798768|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19798769|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158918|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20158919|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
20158920|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20158921|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158922|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
20158923|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158924|NCT00116467|Vaccines|vaccines|mesh-list
20158925|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
20158926|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158927|NCT00116480|Misoprostol|misoprostol|mesh-list
20158928|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20324882|NCT00740168|Bevacizumab|bevacizumab|mesh-list
20324883|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20324884|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324885|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20324886|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20324887|NCT00740168|Growth Substances|growth substances|mesh-ancestor
20324888|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324889|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
20324890|NCT00740194|Estradiol|estradiol|mesh-list
20324891|NCT00740194|Estrogens|estrogens|mesh-ancestor
20324892|NCT00740194|Hormones|hormones|mesh-ancestor
20158929|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
20158930|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20158931|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158932|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20158933|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20158934|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
20158935|NCT00116493|Folic Acid|folic acid|mesh-list
20158936|NCT00116493|Mebendazole|mebendazole|mesh-list
20158937|NCT00116493|Piperazine|piperazine|mesh-list
20158938|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
20158939|NCT00116493|DMP 777|dmp 777|mesh-list
20158940|NCT00116493|Hematinics|hematinics|mesh-ancestor
20158941|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
20158942|NCT00116493|Vitamins|vitamins|mesh-ancestor
20158943|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
19644111|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
19644112|NCT02374567|Levetiracetam|levetiracetam|mesh-list
19644113|NCT02374567|Valproic Acid|valproic acid|mesh-list
19644114|NCT02374567|Lorazepam|lorazepam|mesh-list
19644115|NCT02374567|Clonazepam|clonazepam|mesh-list
19644116|NCT02374567|Phenobarbital|phenobarbital|mesh-list
19644117|NCT02374567|Clobazam|clobazam|mesh-list
19644118|NCT02374567|Zaleplon|zaleplon|mesh-list
19644119|NCT02374567|Nitrazepam|nitrazepam|mesh-list
19644120|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
19644121|NCT02374567|Memantine|memantine|mesh-list
19644122|NCT02374567|Biperiden|biperiden|mesh-list
19644123|NCT02374567|Haloperidol|haloperidol|mesh-list
19644124|NCT02374567|Pimozide|pimozide|mesh-list
19644125|NCT02374567|Olanzapine|olanzapine|mesh-list
19644126|NCT02374567|Zolpidem|zolpidem|mesh-list
19644127|NCT02374567|Alprazolam|alprazolam|mesh-list
19644128|NCT02374567|Zopiclone|zopiclone|mesh-list
19644129|NCT02374567|S 20098|s 20098|mesh-list
19644130|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
19644131|NCT02374567|Doxepin|doxepin|mesh-list
19644132|NCT02374567|Oxazepam|oxazepam|mesh-list
20158944|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158945|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
20158946|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
20158947|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20158948|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20158949|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
20158950|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
20158951|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
20158952|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158953|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158954|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158955|NCT00116506|Bevacizumab|bevacizumab|mesh-list
20158956|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20158957|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20158958|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644133|NCT02374567|Temazepam|temazepam|mesh-list
19644134|NCT02374567|Brotizolam|brotizolam|mesh-list
20158959|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20158960|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20324893|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611548|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644135|NCT02374567|Lormetazepam|lormetazepam|mesh-list
19644136|NCT02374567|Flurazepam|flurazepam|mesh-list
19644137|NCT02374567|Mirtazapine|mirtazapine|mesh-list
19644138|NCT02374567|Buspirone|buspirone|mesh-list
19644139|NCT02374567|Trazodone|trazodone|mesh-list
19644140|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
19644141|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
19644142|NCT02374567|Bromazepam|bromazepam|mesh-list
19644143|NCT02374567|Risperidone|risperidone|mesh-list
19644144|NCT02374567|Melatonin|melatonin|mesh-list
20158961|NCT00116506|Growth Substances|growth substances|mesh-ancestor
20158962|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798770|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798771|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
19798772|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798773|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798774|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798775|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
19798776|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798777|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798778|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798779|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19798780|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
19798781|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798782|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798783|NCT00378014|Everolimus|everolimus|mesh-list
19798784|NCT00378014|Basiliximab|basiliximab|mesh-list
19798785|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798786|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798787|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
19798788|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798789|NCT00378079|Methadone|methadone|mesh-list
19798790|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19798791|NCT00378079|Narcotics|narcotics|mesh-ancestor
19644145|NCT02374567|Aripiprazole|aripiprazole|mesh-list
19644146|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19798792|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19798793|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798794|NCT00378079|Analgesics|analgesics|mesh-ancestor
19798795|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
19798796|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798797|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
19644147|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19644148|NCT02374567|Ziprasidone|ziprasidone|mesh-list
19644149|NCT02374567|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19644150|NCT02374567|Clozapine|clozapine|mesh-list
19644151|NCT02374567|Amisulpride|amisulpride|mesh-list
19644152|NCT02374567|Flupenthixol|flupenthixol|mesh-list
19644153|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
19644154|NCT02374567|Perphenazine|perphenazine|mesh-list
19644155|NCT02374567|Sertindole|sertindole|mesh-list
19644156|NCT02374567|Fluphenazine|fluphenazine|mesh-list
19644157|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
19644158|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
19644159|NCT02374567|Sulpiride|sulpiride|mesh-list
19644160|NCT02374567|Thioridazine|thioridazine|mesh-list
19644161|NCT02374567|Pipamperone|pipamperone|mesh-list
19644162|NCT02374567|Clopenthixol|clopenthixol|mesh-list
19644163|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
19644164|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
19644165|NCT02374567|Fluspirilene|fluspirilene|mesh-list
19644166|NCT02374567|Benperidol|benperidol|mesh-list
19644167|NCT02374567|Bromperidol|bromperidol|mesh-list
19644168|NCT02374567|Perazine|perazine|mesh-list
19644169|NCT02374567|Rivastigmine|rivastigmine|mesh-list
19644170|NCT02374567|Piracetam|piracetam|mesh-list
19644171|NCT02374567|Donepezil|donepezil|mesh-list
19644172|NCT02374567|Galantamine|galantamine|mesh-list
19644173|NCT02374567|Citalopram|citalopram|mesh-list
19644174|NCT02374567|Bupropion|bupropion|mesh-list
19644175|NCT02374567|Sertraline|sertraline|mesh-list
19644176|NCT02374567|Fluoxetine|fluoxetine|mesh-list
19644177|NCT02374567|Paroxetine|paroxetine|mesh-list
19644178|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19644179|NCT02374567|Nortriptyline|nortriptyline|mesh-list
19644180|NCT02374567|Reboxetine|reboxetine|mesh-list
19798798|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
19798799|NCT00378105|Dexamethasone|dexamethasone|mesh-list
19798800|NCT00378105|Lenalidomide|lenalidomide|mesh-list
19798801|NCT00378105|Bortezomib|bortezomib|mesh-list
19798802|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798803|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
19798804|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
19798805|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798806|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798807|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19798808|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
19798809|NCT00378105|Hormones|hormones|mesh-ancestor
19798810|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798811|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798812|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798813|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
19798814|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798815|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798816|NCT00378105|Growth Substances|growth substances|mesh-ancestor
20158963|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
20158964|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20158965|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158966|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158967|NCT00116532|Citalopram|citalopram|mesh-list
20158968|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20158969|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20158970|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20158971|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158972|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324894|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798817|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798818|NCT00378209|Dexamethasone|dexamethasone|mesh-list
19798819|NCT00378209|Lenalidomide|lenalidomide|mesh-list
19798820|NCT00378209|Bortezomib|bortezomib|mesh-list
19798821|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798822|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
19798823|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
19798824|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798825|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798826|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19798827|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
19798828|NCT00378209|Hormones|hormones|mesh-ancestor
19798829|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798830|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20324895|NCT00740259|Flunarizine|flunarizine|mesh-list
20324896|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
20324897|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20324898|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19798831|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798832|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
19798833|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798834|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798835|NCT00378209|Growth Substances|growth substances|mesh-ancestor
19798836|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798837|NCT00378326|Tacrolimus|tacrolimus|mesh-list
19798838|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798839|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
19798840|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798841|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19798842|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798843|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798844|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
20347731|NCT00861627|Carboplatin|carboplatin|mesh-list
19644181|NCT02374567|Imipramine|imipramine|mesh-list
19644182|NCT02374567|Clomipramine|clomipramine|mesh-list
19644183|NCT02374567|Mianserin|mianserin|mesh-list
19644184|NCT02374567|Moclobemide|moclobemide|mesh-list
19644185|NCT02374567|Opipramol|opipramol|mesh-list
19644186|NCT02374567|Maprotiline|maprotiline|mesh-list
19644187|NCT02374567|Trimipramine|trimipramine|mesh-list
19644188|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
19644189|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19644190|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19644191|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19798845|NCT00378352|Hematinics|hematinics|mesh-ancestor
19798846|NCT00378534|Cyclosporine|cyclosporine|mesh-list
19798847|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
19798848|NCT00378534|Fludarabine|fludarabine|mesh-list
19798849|NCT00378534|Cyclosporins|cyclosporins|mesh-list
19798850|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798851|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
19798852|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798853|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798854|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19798855|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
19798856|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798857|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20158973|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
20158974|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158975|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19798858|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19798859|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798860|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
19798861|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798862|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
19798863|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19798864|NCT00378573|Gemcitabine|gemcitabine|mesh-list
19798865|NCT00378573|Bevacizumab|bevacizumab|mesh-list
19798866|NCT00378573|Docetaxel|docetaxel|mesh-list
19798867|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19798868|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798869|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798870|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798871|NCT00378573|Growth Substances|growth substances|mesh-ancestor
20158976|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
20158977|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20158978|NCT00116545|Troglitazone|troglitazone|mesh-list
20324899|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324900|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20324901|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324902|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20324903|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
20324904|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
20324905|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20324906|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
20324907|NCT00740285|Lidocaine|lidocaine|mesh-list
20324908|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
20324909|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
20324910|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158979|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20158980|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158981|NCT00116597|Vaccines|vaccines|mesh-list
20158982|NCT00116597|Immunologic Factors|immunologic factors|mesh-ancestor
19798872|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798873|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798874|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19644192|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644193|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19644194|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19644195|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19644196|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19644197|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
19644198|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
19644199|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
19644200|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
19644201|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644202|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644203|NCT02374567|Analgesics|analgesics|mesh-ancestor
19644204|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
19644205|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324911|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324912|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
20324913|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324914|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20324915|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20324916|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20324917|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20324918|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324919|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20324920|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19798875|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
19798876|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324921|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324922|NCT00740363|Incretins|incretins|mesh-ancestor
20324923|NCT00740363|Hormones|hormones|mesh-ancestor
19644206|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
19644207|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19644208|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20324924|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20324925|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20324926|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
20324927|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20158983|NCT00116597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20158984|NCT00116623|Indomethacin|indomethacin|mesh-list
20158985|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
20158986|NCT00116623|Analgesics|analgesics|mesh-ancestor
20158987|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
20158988|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20158989|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324928|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324929|NCT00740389|Etravirine|etravirine|mesh-list
20324930|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20324931|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20324932|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324933|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324934|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
20324935|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324936|NCT00740415|Dexamethasone|dexamethasone|mesh-list
20324937|NCT00740415|Rituximab|rituximab|mesh-list
20324938|NCT00740415|Bortezomib|bortezomib|mesh-list
20324939|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20324940|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20324941|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324942|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
20324943|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324944|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644209|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19644210|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19644211|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19644212|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
19644213|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19644214|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
19644215|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19644216|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19644217|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
19644218|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
19644219|NCT02374567|Protective Agents|protective agents|mesh-ancestor
19644220|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19644221|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19644222|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19644223|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
19644224|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19644225|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20324945|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20324946|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
20324947|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
20324948|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20324949|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20324950|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
20324951|NCT00740415|Hormones|hormones|mesh-ancestor
19644226|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
19644227|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
19644228|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19644229|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19644230|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
19644231|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
19644232|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644233|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19644234|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19644235|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19644236|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644237|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
19644238|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19644239|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19644240|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20158990|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
19644241|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19644242|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19644243|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19644244|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
19644245|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644246|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19644247|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19644248|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
19644249|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19644250|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
19644251|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
19644252|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19644253|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
19644254|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
19644255|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20324952|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20324953|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20324954|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20324955|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
20324956|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644256|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
19644257|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19644258|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19644259|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19644260|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19644261|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
19644262|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19644263|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19644264|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644265|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19644266|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19644267|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19644268|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19644269|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19644270|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19644271|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19798877|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
19798878|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798879|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798880|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798881|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
19798882|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
19798883|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
19798884|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
19798885|NCT00378599|Interferons|interferons|mesh-list
19798886|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
19798887|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
19798888|NCT00378599|Ribavirin|ribavirin|mesh-list
19798889|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19798890|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798891|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
19798892|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798893|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
19798894|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798895|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
19798896|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798897|NCT00378703|Sirolimus|sirolimus|mesh-list
19798898|NCT00378703|Bevacizumab|bevacizumab|mesh-list
19798899|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19798900|NCT00378703|Sorafenib|sorafenib|mesh-list
19798901|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
19798902|NCT00378703|Antibodies|antibodies|mesh-list
19798903|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
19798904|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19798905|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
19798906|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798907|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798908|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798909|NCT00378703|Growth Substances|growth substances|mesh-ancestor
19798910|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798911|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798912|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
19798913|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19644272|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
19798914|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324957|NCT00740467|Cyclosporine|cyclosporine|mesh-list
20324958|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
20324959|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
20324960|NCT00740467|Busulfan|busulfan|mesh-list
20324961|NCT00740467|Fludarabine|fludarabine|mesh-list
20324962|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
20324963|NCT00740467|Cyclosporins|cyclosporins|mesh-list
20324964|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20324965|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20324966|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
20324967|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644273|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20158991|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20158992|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20158993|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
20158994|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20158995|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19644274|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19644275|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20158996|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20158997|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20158998|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
20158999|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20159000|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20159001|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20159002|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159003|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159004|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
20159005|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20159006|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159007|NCT00116636|Lopinavir|lopinavir|mesh-list
20324968|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644276|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19644277|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19644278|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19644279|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
19644280|NCT02374242|Nivolumab|nivolumab|mesh-list
19644281|NCT02374242|Ipilimumab|ipilimumab|mesh-list
19644282|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19644283|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644284|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19663830|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
19663831|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663832|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663833|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
19663834|NCT05097911|Bevacizumab|bevacizumab|mesh-list
19663835|NCT05097911|Atezolizumab|atezolizumab|mesh-list
19663836|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19663837|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663838|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19663839|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19663840|NCT05097911|Growth Substances|growth substances|mesh-ancestor
19663841|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663842|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
19663843|NCT05097781|Antibodies|antibodies|mesh-list
19663844|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
19663845|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
19663846|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663847|NCT05097508|Bromides|bromides|mesh-list
19663848|NCT05097508|Rocuronium|rocuronium|mesh-list
19663849|NCT05097508|Atracurium|atracurium|mesh-list
19663850|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
19663851|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19663852|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19663853|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19663854|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663855|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663856|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19663857|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19663858|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19663859|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663860|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663861|NCT05097365|Folic Acid|folic acid|mesh-list
19663862|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
19663863|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
19798915|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798916|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798917|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798918|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798919|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
19798920|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798921|NCT00379145|Trabectedin|trabectedin|mesh-list
19798922|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19798923|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
19798924|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798925|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798926|NCT00379197|Naltrexone|naltrexone|mesh-list
19798927|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19798928|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19798929|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798930|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
19798931|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19798932|NCT00379353|Thalidomide|thalidomide|mesh-list
19798933|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798934|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
19798935|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798936|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
19798937|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19798938|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798939|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798940|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798941|NCT00379353|Growth Substances|growth substances|mesh-ancestor
19798942|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
19798943|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798944|NCT00379574|Prednisolone|prednisolone|mesh-list
19798945|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
19798946|NCT00379574|Doxorubicin|doxorubicin|mesh-list
19798947|NCT00379574|Vincristine|vincristine|mesh-list
19798948|NCT00379574|Bortezomib|bortezomib|mesh-list
19798949|NCT00379574|Lenograstim|lenograstim|mesh-list
19798950|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798951|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
19798952|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798953|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798954|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19798955|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
19798956|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798957|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324969|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20324970|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
20324971|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324972|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20324973|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20324974|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20324975|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
20324976|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20324977|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
20324978|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20324979|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
20324980|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19798958|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19798959|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798960|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19798961|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19798962|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798963|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19798964|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
19798965|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
19798966|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
19798967|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19798968|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
19798969|NCT00379574|Hormones|hormones|mesh-ancestor
19798970|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19798971|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19798972|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19798973|NCT00379587|Rituximab|rituximab|mesh-list
19798974|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19798975|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798976|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
19798977|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798978|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19798979|NCT00379639|Gemcitabine|gemcitabine|mesh-list
20159008|NCT00116636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20159009|NCT00116636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20159010|NCT00116636|Protease Inhibitors|protease inhibitors|mesh-ancestor
20159011|NCT00116636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159012|NCT00116636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798980|NCT00379639|Romidepsin|romidepsin|mesh-list
19798981|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19798982|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
19798983|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19798984|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19798985|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
19798986|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19798987|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19798988|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19798989|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
19798990|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798991|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19798992|NCT00379769|Metformin|metformin|mesh-list
19798993|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
19798994|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19798995|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19798996|NCT00379795|Ranibizumab|ranibizumab|mesh-list
19798997|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19798998|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19798999|NCT00379795|Growth Substances|growth substances|mesh-ancestor
19799000|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324981|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20324982|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20324983|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
20324984|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20324985|NCT00740493|Warfarin|warfarin|mesh-list
19799001|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19799002|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799003|NCT00379808|Montelukast|montelukast|mesh-list
19799004|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19799005|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
19799006|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19799007|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
19799008|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799009|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799010|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19799011|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19799012|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159013|NCT00116636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20159014|NCT00116636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20159015|NCT00116636|Antiviral Agents|antiviral agents|mesh-ancestor
20159016|NCT00116636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159017|NCT00116636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20159018|NCT00116636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20159019|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
19799013|NCT00379821|Azithromycin|azithromycin|mesh-list
19799014|NCT00379821|Artesunate|artesunate|mesh-list
20324986|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
20324987|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
20324988|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20324989|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799015|NCT00379821|Chloroquine|chloroquine|mesh-list
19799016|NCT00379821|Atovaquone|atovaquone|mesh-list
19799017|NCT00379821|Proguanil|proguanil|mesh-list
19799018|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19799019|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19799020|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159020|NCT00116701|Hematinics|hematinics|mesh-ancestor
20174202|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20174203|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
20174204|NCT00164008|Pamidronate|pamidronate|mesh-list
20174205|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20174206|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174207|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
20174208|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20174209|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
20174210|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
20174211|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20324990|NCT00740545|Enoxaparin|enoxaparin|mesh-list
20159021|NCT00116727|Etanercept|etanercept|mesh-list
20159022|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20159023|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20159024|NCT00116727|Analgesics|analgesics|mesh-ancestor
20159025|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
20159026|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159027|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159028|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159029|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159030|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20159031|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159032|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
20159033|NCT00116870|Lovastatin|lovastatin|mesh-list
20159034|NCT00116870|L 647318|l 647318|mesh-list
20159035|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
20159036|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20159037|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20159038|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
20159039|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159040|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20159041|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20159042|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799021|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
19799022|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19644285|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644286|NCT02374047|Atorvastatin|atorvastatin|mesh-list
19644287|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19644288|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19644289|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
19644290|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644291|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19644292|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19644293|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644294|NCT02373943|Carotenoids|carotenoids|mesh-list
19644295|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
19799023|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19799024|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799025|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
19799026|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
19799027|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19799028|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
19799029|NCT00379821|Amebicides|amebicides|mesh-ancestor
19799030|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799031|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799032|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799033|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
19799034|NCT00379834|Timolol|timolol|mesh-list
19799035|NCT00379834|Dorzolamide|dorzolamide|mesh-list
19799036|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19799037|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19799038|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
19799039|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799040|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799041|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799042|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19799043|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19799044|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19799045|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799046|NCT00379899|Vitamin D|vitamin d|mesh-list
19799047|NCT00379899|Cinacalcet|cinacalcet|mesh-list
19799048|NCT00379899|Vitamins|vitamins|mesh-ancestor
19799049|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
19799050|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799051|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19799052|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19799053|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19799054|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
19799055|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799056|NCT00379912|Azacitidine|azacitidine|mesh-list
20159043|NCT00116896|Cisplatin|cisplatin|mesh-list
20159044|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159045|NCT00116922|Metformin|metformin|mesh-list
20159046|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
19799057|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
19799058|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159047|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20324991|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
19644296|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644297|NCT02373943|Protective Agents|protective agents|mesh-ancestor
19644298|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20324992|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20324993|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20324994|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20324995|NCT00740571|Pregabalin|pregabalin|mesh-list
20324996|NCT00740571|Amitriptyline|amitriptyline|mesh-list
20324997|NCT00740571|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20324998|NCT00740571|Analgesics|analgesics|mesh-ancestor
20324999|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
20325000|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325001|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325002|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
19644299|NCT02374008|Dexamethasone|dexamethasone|mesh-list
19644300|NCT02374008|Ketorolac|ketorolac|mesh-list
19644301|NCT02374008|Ropivacaine|ropivacaine|mesh-list
19644302|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644303|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
19644304|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
19644305|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799059|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
19799060|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799061|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799062|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799063|NCT00379912|Hematinics|hematinics|mesh-ancestor
19799064|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19799065|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799066|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19799067|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799068|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799069|NCT00380068|Ambrisentan|ambrisentan|mesh-list
19799070|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19644306|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644307|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644308|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
19799071|NCT00380081|Zolpidem|zolpidem|mesh-list
19799072|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19799073|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19799074|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799075|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799076|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19799077|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
19799078|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
19799079|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799080|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799081|NCT00380250|Lubiprostone|lubiprostone|mesh-list
19799082|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19799083|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19799084|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799085|NCT00380393|Vaccines|vaccines|mesh-list
19644309|NCT02374008|Hormones|hormones|mesh-ancestor
19644310|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644311|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19644312|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644313|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799086|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
19644314|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644315|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
19644316|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
19644317|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644318|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
20159048|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159049|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
20159050|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159051|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20159052|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159053|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159054|NCT00116948|Cimetidine|cimetidine|mesh-list
20159055|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20159056|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20159057|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20159058|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
20159059|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
19799087|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159060|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644319|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644320|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644321|NCT02374008|Analgesics|analgesics|mesh-ancestor
19644322|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644323|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19644324|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
19644325|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
19644326|NCT02374021|Adalimumab|adalimumab|mesh-list
19644327|NCT02374021|Etanercept|etanercept|mesh-list
20159061|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159062|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799088|NCT00380588|Gemcitabine|gemcitabine|mesh-list
19799089|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799090|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159063|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20159064|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20159065|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159066|NCT00116961|Dexamethasone|dexamethasone|mesh-list
20159067|NCT00116961|Bortezomib|bortezomib|mesh-list
20159068|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159069|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
20159070|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
19799091|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
20159071|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159072|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256651|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256652|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256653|NCT04311723|Anesthetics|anesthetics|mesh-list
19256654|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256655|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256656|NCT04300595|Anesthetics|anesthetics|mesh-list
19256657|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256658|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256659|NCT04297293|Ramosetron|ramosetron|mesh-list
19256660|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
19256661|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
19256662|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256663|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256664|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19256665|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19256666|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
19644328|NCT02374021|Methotrexate|methotrexate|mesh-list
19644329|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19644330|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
19799092|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799093|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
19799094|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799095|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799096|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799097|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
19799098|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799099|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19799100|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19799101|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19799102|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19799103|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799104|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
19799105|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799106|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256667|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644331|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19644332|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644333|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19644334|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
19644335|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644336|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644337|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
19799107|NCT00380718|Pemetrexed|pemetrexed|mesh-list
19256668|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644338|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644339|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19644340|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19644341|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
19644342|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644343|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19644344|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799108|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799109|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799110|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799111|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19799112|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799113|NCT00380874|Pregabalin|pregabalin|mesh-list
19799114|NCT00380874|Analgesics|analgesics|mesh-ancestor
19799115|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
19799116|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799117|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799118|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
19799119|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19799120|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19644345|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
19644346|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19644347|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19644348|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644349|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644350|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644351|NCT02374021|Analgesics|analgesics|mesh-ancestor
20159073|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20159074|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
20325003|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20325004|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325005|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325006|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325007|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20325008|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20325009|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325010|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20325011|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20325012|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
20325013|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20325014|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20325015|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20325016|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
20325017|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325018|NCT00740571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20325019|NCT00740883|Warfarin|warfarin|mesh-list
19644352|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
20159075|NCT00116961|Hormones|hormones|mesh-ancestor
20159076|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159077|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20159078|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159079|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
20159080|NCT00117000|Testosterone|testosterone|mesh-list
20159081|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
20159082|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
20159083|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20159084|NCT00117000|Androgens|androgens|mesh-ancestor
20159085|NCT00117000|Hormones|hormones|mesh-ancestor
20159086|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799121|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799122|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19799123|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19799124|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19799125|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799126|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799127|NCT00380978|Narcotics|narcotics|mesh-list
20159087|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159088|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20159089|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159090|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
20159091|NCT00117013|Topotecan|topotecan|mesh-list
20159092|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20159093|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20159094|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325020|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
20325021|NCT00740922|Becaplermin|becaplermin|mesh-list
20325022|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
20325023|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20325024|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325025|NCT00740922|Growth Substances|growth substances|mesh-ancestor
20325026|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325027|NCT00740948|Rituximab|rituximab|mesh-list
20325028|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20325029|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325030|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
20325031|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325032|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20347732|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20347733|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347734|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
20347735|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
20347736|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
20347737|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159095|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159096|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159097|NCT00117026|Benphothiamine|benphothiamine|mesh-list
20159098|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20159099|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
20347738|NCT00861640|Omeprazole|omeprazole|mesh-list
20159100|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159101|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
20159102|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
20159103|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159104|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159105|NCT00117039|Hematinics|hematinics|mesh-ancestor
20159106|NCT00117052|Cinacalcet|cinacalcet|mesh-list
20159107|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20159108|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159109|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20159110|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
20159111|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159112|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
20347739|NCT00861640|Rabeprazole|rabeprazole|mesh-list
20347740|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20347741|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20347742|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20347743|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347744|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348595|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
20348596|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
20348597|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20159113|NCT00117065|Hematinics|hematinics|mesh-ancestor
20159114|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159115|NCT00117078|Hematinics|hematinics|mesh-ancestor
20159116|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20159117|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799128|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799129|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799130|NCT00380978|Analgesics|analgesics|mesh-ancestor
19799131|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
19799132|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799133|NCT00381004|Vidarabine|vidarabine|mesh-list
19799134|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
19799135|NCT00381004|Rituximab|rituximab|mesh-list
19799136|NCT00381004|Fludarabine|fludarabine|mesh-list
19799137|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
19799138|NCT00381004|Sargramostim|sargramostim|mesh-list
20159118|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159119|NCT00117104|Hematinics|hematinics|mesh-ancestor
20159120|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159121|NCT00117117|Hematinics|hematinics|mesh-ancestor
20159122|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159123|NCT00117130|Hematinics|hematinics|mesh-ancestor
20159124|NCT00117182|Budesonide|budesonide|mesh-list
20348598|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
19799139|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799140|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
19799141|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799142|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799143|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19799144|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
19799145|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799146|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799147|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19799148|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19799149|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799150|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
19799151|NCT00381004|Antiviral Agents|antiviral agents|mesh-ancestor
19799152|NCT00381004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799153|NCT00381043|Acamprosate|acamprosate|mesh-list
19799154|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19799155|NCT00381095|Pregabalin|pregabalin|mesh-list
19799156|NCT00381095|Analgesics|analgesics|mesh-ancestor
19799157|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
19799158|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799159|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799160|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
19799161|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19799162|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325033|NCT00741052|Azithromycin|azithromycin|mesh-list
19799163|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799164|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19799165|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19799166|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19799167|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799168|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799169|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
19799170|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19799171|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325034|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
20325035|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20325036|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325037|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20325038|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325039|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325040|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325041|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325042|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20325043|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20325044|NCT00741078|Amlodipine|amlodipine|mesh-list
20325045|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20325046|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20325047|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325048|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325049|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325050|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325051|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
20325052|NCT00741117|Bilirubin|bilirubin|mesh-list
20325053|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
20325054|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325055|NCT00741117|Protective Agents|protective agents|mesh-ancestor
20325056|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799172|NCT00381303|Ritonavir|ritonavir|mesh-list
19644353|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644354|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644355|NCT02373735|Mannitol|mannitol|mesh-list
19644356|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19644357|NCT02373735|Diuretics|diuretics|mesh-ancestor
19644358|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
19644359|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644360|NCT02373449|Ketamine|ketamine|mesh-list
20325057|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20325058|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20325059|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
20325060|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
20347745|NCT00861731|Simvastatin|simvastatin|mesh-list
19644361|NCT02373449|Analgesics|analgesics|mesh-ancestor
19644362|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
19644363|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799173|NCT00381303|Darunavir|darunavir|mesh-list
19799174|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19799175|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19799176|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
19799177|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799178|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799179|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19799180|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19799181|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
19799182|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799183|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19799184|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19799185|NCT00381550|Fludarabine|fludarabine|mesh-list
19799186|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
19799187|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799188|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799189|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
19799190|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799191|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20325061|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325062|NCT00741169|Rifampin|rifampin|mesh-list
20325063|NCT00741169|Simeprevir|simeprevir|mesh-list
19799192|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
19799193|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799194|NCT00381615|Vaccines|vaccines|mesh-list
19799195|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
19799196|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799197|NCT00381680|Leucovorin|leucovorin|mesh-list
19799198|NCT00381680|Cytarabine|cytarabine|mesh-list
19799199|NCT00381680|Dexamethasone|dexamethasone|mesh-list
19799200|NCT00381680|Prednisone|prednisone|mesh-list
19799201|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
19799202|NCT00381680|Doxorubicin|doxorubicin|mesh-list
19799203|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19799204|NCT00381680|Methotrexate|methotrexate|mesh-list
19799205|NCT00381680|Etoposide|etoposide|mesh-list
19799206|NCT00381680|Vincristine|vincristine|mesh-list
19799207|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
20159125|NCT00117182|Mannitol|mannitol|mesh-list
20159126|NCT00117182|Bromides|bromides|mesh-list
20159127|NCT00117182|Albuterol|albuterol|mesh-list
20159128|NCT00117182|Ipratropium|ipratropium|mesh-list
20159129|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159130|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20159131|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
20325064|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20325065|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
20325066|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19644364|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159132|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325067|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325068|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
20325069|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20325070|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325071|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644365|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19644366|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19644367|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
19644368|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
19644369|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644370|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19644371|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19644372|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644373|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644374|NCT02373722|Petrolatum|petrolatum|mesh-list
19644375|NCT02373722|Mineral Oil|mineral oil|mesh-list
19644376|NCT02373722|Emollients|emollients|mesh-ancestor
19644377|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
19644378|NCT02373514|Acetaminophen|acetaminophen|mesh-list
19644379|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19644380|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644381|NCT02373514|Analgesics|analgesics|mesh-ancestor
19799208|NCT00381680|Asparaginase|asparaginase|mesh-list
19799209|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
19799210|NCT00381680|Pegaspargase|pegaspargase|mesh-list
19799211|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
19799212|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159133|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325072|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19799213|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
19799214|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799215|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799216|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20325073|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20325074|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20325075|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20325076|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20325077|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20325078|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
20325079|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
20325080|NCT00741182|Teriparatide|teriparatide|mesh-list
20325081|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325082|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325083|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20325084|NCT00741195|Bevacizumab|bevacizumab|mesh-list
20325085|NCT00741195|Docetaxel|docetaxel|mesh-list
20325086|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20325087|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325088|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20325089|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325090|NCT00741195|Growth Substances|growth substances|mesh-ancestor
20325091|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325092|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
20325093|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
20325094|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
20325095|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
20325096|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325097|NCT00741221|Bevacizumab|bevacizumab|mesh-list
20325098|NCT00741221|Pemetrexed|pemetrexed|mesh-list
20325099|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20325100|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325101|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19644382|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
19644383|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644384|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644385|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
19644386|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644387|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799217|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
19799218|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159134|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20159135|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
20159136|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
20159137|NCT00117182|Hormones|hormones|mesh-ancestor
20159138|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159139|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
20159140|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
20159141|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20159142|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20159143|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20159144|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20159145|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
20159146|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799219|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799220|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19799221|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325102|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325103|NCT00741221|Growth Substances|growth substances|mesh-ancestor
20325104|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644388|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644389|NCT02373384|Allopurinol|allopurinol|mesh-list
19799222|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
19799223|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
19644390|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
19644391|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644392|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
19644393|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644394|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
19644395|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799224|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325105|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
20325106|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325107|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325108|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20325109|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799225|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19799226|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
19799227|NCT00381680|Hormones|hormones|mesh-ancestor
19799228|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799229|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19799230|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19799231|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19799232|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19799233|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799234|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19799235|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
20325110|NCT00741234|Azacitidine|azacitidine|mesh-list
20325111|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20325112|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
20325113|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325114|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325115|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325116|NCT00741325|Plerixafor|plerixafor|mesh-list
20325117|NCT00741325|Sargramostim|sargramostim|mesh-list
20325118|NCT00741325|Lenograstim|lenograstim|mesh-list
20325119|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
20325120|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325121|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20325122|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325123|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19799236|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19799237|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799238|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
19799239|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
19799240|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19799241|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799242|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19799243|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
19799244|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799245|NCT00381680|Antidotes|antidotes|mesh-ancestor
19799246|NCT00381680|Protective Agents|protective agents|mesh-ancestor
19799247|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
19799248|NCT00381680|Vitamins|vitamins|mesh-ancestor
19799249|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
19799250|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
19799251|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
19799252|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
19799253|NCT00381693|Azacitidine|azacitidine|mesh-list
19799254|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799255|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
19799256|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799257|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799258|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799259|NCT00381706|Leucovorin|leucovorin|mesh-list
19799260|NCT00381706|Cisplatin|cisplatin|mesh-list
19799261|NCT00381706|Fluorouracil|fluorouracil|mesh-list
19799262|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
19799263|NCT00381706|Irinotecan|irinotecan|mesh-list
20159147|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159148|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20159149|NCT00117182|Diuretics|diuretics|mesh-ancestor
20159150|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
20159151|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20159152|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
20159153|NCT00117208|Mannitol|mannitol|mesh-list
20159154|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20159155|NCT00117208|Diuretics|diuretics|mesh-ancestor
20159156|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
20159157|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159158|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159159|NCT00117234|Hematinics|hematinics|mesh-ancestor
20159160|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159161|NCT00117247|Hematinics|hematinics|mesh-ancestor
20159162|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
19799264|NCT00381706|Cetuximab|cetuximab|mesh-list
20159163|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20159164|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20159165|NCT00117260|Estradiol|estradiol|mesh-list
20325124|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
19799265|NCT00381706|Epirubicin|epirubicin|mesh-list
19799266|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799267|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
19799268|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799269|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20325125|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325126|NCT00741351|Fentanyl|fentanyl|mesh-list
20325127|NCT00741351|Remifentanil|remifentanil|mesh-list
20325128|NCT00741351|Propofol|propofol|mesh-list
20325129|NCT00741351|Sevoflurane|sevoflurane|mesh-list
20325130|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20325131|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325132|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325133|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20325134|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
20325135|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
20325136|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20325137|NCT00741351|Narcotics|narcotics|mesh-ancestor
20325138|NCT00741351|Analgesics|analgesics|mesh-ancestor
20325139|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
20325140|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325141|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20325142|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20325143|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20325144|NCT00741364|Vitamin D|vitamin d|mesh-list
20325145|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
20325146|NCT00741364|Vitamins|vitamins|mesh-ancestor
20325147|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
20325148|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325149|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20325150|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325151|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
20325152|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20325153|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325154|NCT00741429|Insulin|insulin|mesh-list
20325155|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325156|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325157|NCT00741507|Ethanol|ethanol|mesh-list
19644396|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19799270|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799271|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
19799272|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799273|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20159166|NCT00117260|Estrogens|estrogens|mesh-ancestor
20159167|NCT00117260|Hormones|hormones|mesh-ancestor
20159168|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159169|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159170|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20159171|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
20159172|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20159173|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20159174|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20159175|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20159176|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20159177|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20159178|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
20159179|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20159180|NCT00117273|Estradiol|estradiol|mesh-list
20159181|NCT00117273|Estrogens|estrogens|mesh-ancestor
20159182|NCT00117273|Hormones|hormones|mesh-ancestor
20159183|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159184|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159185|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20325158|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20325159|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644397|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
19644398|NCT02373384|Protective Agents|protective agents|mesh-ancestor
19644399|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644400|NCT02373384|Diuretics|diuretics|mesh-ancestor
19644401|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
19644402|NCT02373384|Expectorants|expectorants|mesh-ancestor
19644403|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
19644404|NCT02373579|Methotrexate|methotrexate|mesh-list
19644405|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19799274|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325160|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799275|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799276|NCT00381706|Antidotes|antidotes|mesh-ancestor
19799277|NCT00381706|Protective Agents|protective agents|mesh-ancestor
19799278|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
19799279|NCT00381706|Vitamins|vitamins|mesh-ancestor
19799280|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
19799281|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19799282|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19644406|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
19644407|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19644408|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644409|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19644410|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
19644411|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644412|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644413|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
19644414|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644415|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19644416|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19644417|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
19644418|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644419|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19644420|NCT02373410|Bupivacaine|bupivacaine|mesh-list
19799283|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19799284|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
19799285|NCT00381797|Bevacizumab|bevacizumab|mesh-list
19799286|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19799287|NCT00381797|Irinotecan|irinotecan|mesh-list
19799288|NCT00381797|Camptothecin|camptothecin|mesh-list
20325161|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325162|NCT00741585|Atenolol|atenolol|mesh-list
20325163|NCT00741585|Amlodipine|amlodipine|mesh-list
20325164|NCT00741585|Valsartan|valsartan|mesh-list
20325165|NCT00741585|Telmisartan|telmisartan|mesh-list
20325166|NCT00741585|Carvedilol|carvedilol|mesh-list
20325167|NCT00741585|Candesartan|candesartan|mesh-list
20325168|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
20325169|NCT00741585|Ramipril|ramipril|mesh-list
20325170|NCT00741585|Olmesartan|olmesartan|mesh-list
20325171|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20325172|NCT00741585|Enalapril|enalapril|mesh-list
20325173|NCT00741585|Enalaprilat|enalaprilat|mesh-list
20325174|NCT00741585|Lisinopril|lisinopril|mesh-list
20325175|NCT00741585|Irbesartan|irbesartan|mesh-list
20325176|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
20325177|NCT00741585|Quinapril|quinapril|mesh-list
20325178|NCT00741585|Lercanidipine|lercanidipine|mesh-list
20325179|NCT00741585|Manidipine|manidipine|mesh-list
20325180|NCT00741585|Doxazosin|doxazosin|mesh-list
20325181|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20325182|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325183|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325184|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325185|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325186|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
20325187|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19644421|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
19799289|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
19799290|NCT00381797|Antibodies|antibodies|mesh-list
19799291|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
19799292|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19799293|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
19799294|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20325188|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20325189|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20325190|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19644422|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
19644423|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644424|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644425|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
19644426|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644427|NCT02373462|Olmesartan|olmesartan|mesh-list
20325191|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
19644428|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
19799295|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325192|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325193|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
20325194|NCT00741585|Protective Agents|protective agents|mesh-ancestor
19799296|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19799297|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325195|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20325196|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20325197|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20325198|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
20325199|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159186|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
20159187|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20159188|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20159189|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20159190|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20159191|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20159192|NCT00117299|Vatalanib|vatalanib|mesh-list
20159193|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20159194|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159195|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159196|NCT00117351|Bortezomib|bortezomib|mesh-list
20159197|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159198|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
20159199|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20159200|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20159201|NCT00117377|Analgesics|analgesics|mesh-ancestor
20159202|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
20159203|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159204|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159205|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159206|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799298|NCT00381797|Growth Substances|growth substances|mesh-ancestor
19799299|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799300|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
19799301|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
19799302|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19799303|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19799304|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799305|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799306|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19799307|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19799308|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
19799309|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
19799310|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799311|NCT00381810|Acetaminophen|acetaminophen|mesh-list
19799312|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
19799313|NCT00381810|Promethazine|promethazine|mesh-list
19799314|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
19799315|NCT00381810|Rituximab|rituximab|mesh-list
19799316|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19799317|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799318|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
19799319|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799320|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799321|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19799322|NCT00381810|Analgesics|analgesics|mesh-ancestor
19799323|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
19799324|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799325|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
19799326|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799327|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
19799328|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
19799329|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19799330|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
19799331|NCT00381810|Hormones|hormones|mesh-ancestor
19799332|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799333|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19799334|NCT00381810|Protective Agents|protective agents|mesh-ancestor
19799335|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19799336|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19799337|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799338|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
19799339|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
19799340|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19799341|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
19799342|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
19799343|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799344|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799345|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20159207|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
20325200|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20325201|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20325202|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
20325203|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
20325204|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799346|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
19799347|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
19799348|NCT00381862|Leucovorin|leucovorin|mesh-list
19799349|NCT00381862|Dexamethasone|dexamethasone|mesh-list
19799350|NCT00381862|Fluorouracil|fluorouracil|mesh-list
19799351|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
19799352|NCT00381862|Irinotecan|irinotecan|mesh-list
19799353|NCT00381862|Camptothecin|camptothecin|mesh-list
19799354|NCT00381862|Aprepitant|aprepitant|mesh-list
19799355|NCT00381862|Palonosetron|palonosetron|mesh-list
19799356|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
20159208|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159209|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
20159210|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20159211|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159212|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159213|NCT00117403|Vitamins|vitamins|mesh-list
20159214|NCT00117403|Vitamin E|vitamin e|mesh-list
20159215|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
20159216|NCT00117403|Ubiquinone|ubiquinone|mesh-list
20159217|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
20159218|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159219|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
20325205|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20325206|NCT00741663|Furosemide|furosemide|mesh-list
20325207|NCT00741663|Spironolactone|spironolactone|mesh-list
20325208|NCT00741663|Diuretics|diuretics|mesh-ancestor
20325209|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
20325210|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325211|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20325212|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325213|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159220|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159221|NCT00117403|Protective Agents|protective agents|mesh-ancestor
20159222|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
20159223|NCT00117442|Paclitaxel|paclitaxel|mesh-list
20159224|NCT00117442|Carboplatin|carboplatin|mesh-list
20325214|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20325215|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
20325216|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325217|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20325218|NCT00741741|Rilpivirine|rilpivirine|mesh-list
20325219|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20325220|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20159225|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20159226|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159227|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
20159228|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
20159229|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
20159230|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159231|NCT00117455|Lenograstim|lenograstim|mesh-list
20159232|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20159233|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
20159234|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159235|NCT00117468|Progesterone|progesterone|mesh-list
20159236|NCT00117468|Progestins|progestins|mesh-ancestor
20159237|NCT00117468|Hormones|hormones|mesh-ancestor
20159238|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159239|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159240|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20159241|NCT00117494|Pravastatin|pravastatin|mesh-list
20159242|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20159243|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20159244|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
20159245|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799357|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799358|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
19799359|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
20159246|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20159247|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20159248|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325221|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325222|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159249|NCT00117520|Caffeine|caffeine|mesh-list
20159250|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19799360|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799361|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799362|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19799363|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
19799364|NCT00381862|Hormones|hormones|mesh-ancestor
19799365|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799366|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19799367|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799368|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
19799369|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799370|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799371|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799372|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
19799373|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19799374|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19799375|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799376|NCT00381862|Antidotes|antidotes|mesh-ancestor
19799377|NCT00381862|Protective Agents|protective agents|mesh-ancestor
19799378|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
19799379|NCT00381862|Vitamins|vitamins|mesh-ancestor
19799380|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
19799381|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19799382|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799383|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19799384|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19799385|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
19799386|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19799387|NCT00381888|PENTA|penta|mesh-list
19799388|NCT00381888|Fondaparinux|fondaparinux|mesh-list
19799389|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19799390|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
19799391|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20325223|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
20325224|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325225|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325226|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325227|NCT00741767|Fluticasone|fluticasone|mesh-list
20325228|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20325229|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20325230|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325231|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20325232|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
20325233|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325234|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325235|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20325236|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
20325237|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
20325238|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19799392|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
19799393|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159251|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159252|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20159253|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159254|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325239|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20325240|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20325241|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20325242|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
20325243|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325244|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325245|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
20325246|NCT00741767|Hormones|hormones|mesh-ancestor
20325247|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325248|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
20325249|NCT00741780|Plerixafor|plerixafor|mesh-list
20325250|NCT00741780|Sargramostim|sargramostim|mesh-list
20325251|NCT00741780|Lenograstim|lenograstim|mesh-list
20325252|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
20159255|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20325253|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325254|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20325255|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325256|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325257|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
20325258|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325259|NCT00741845|Metronidazole|metronidazole|mesh-list
20325260|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325261|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20325262|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20325263|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20325264|NCT00741884|Varenicline|varenicline|mesh-list
20325265|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20325266|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20325267|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
20325268|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325269|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325270|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325271|NCT00741897|Fexofenadine|fexofenadine|mesh-list
20325272|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20325273|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20325274|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20325275|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
20325276|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
20325277|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799394|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799395|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
19799396|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19799397|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19799398|NCT00381940|Bortezomib|bortezomib|mesh-list
19799399|NCT00381940|Vinorelbine|vinorelbine|mesh-list
19799400|NCT00381940|Ifosfamide|ifosfamide|mesh-list
19799401|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799402|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19799403|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
19799404|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
19799405|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
19799406|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799407|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19799408|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
20325278|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325279|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325280|NCT00741910|Semapimod|semapimod|mesh-list
20325281|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20325282|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20325283|NCT00741910|Analgesics|analgesics|mesh-ancestor
20325284|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
20325285|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799409|NCT00382031|Zalutumumab|zalutumumab|mesh-list
19799410|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19799411|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19799412|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799413|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
19799414|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799415|NCT00382070|Letrozole|letrozole|mesh-list
20159256|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20159257|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
20159258|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159259|NCT00117533|Ribavirin|ribavirin|mesh-list
20159260|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
20159261|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
20159262|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159263|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
20159264|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159265|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159266|NCT00117546|Methyldopa|methyldopa|mesh-list
20159267|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20159268|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
20159269|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
20159270|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159271|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159272|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20159273|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20325286|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159274|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20159275|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
20325287|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325288|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20325289|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20325290|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
20325291|NCT00741949|Propofol|propofol|mesh-list
20325292|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20159276|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644429|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19644430|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19644431|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799416|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799417|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19799418|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19799419|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799420|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799421|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19799422|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
19799423|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799424|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799425|NCT00382109|Sirolimus|sirolimus|mesh-list
19799426|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
19799427|NCT00382109|Thiotepa|thiotepa|mesh-list
20159277|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159278|NCT00117611|Omalizumab|omalizumab|mesh-list
20159279|NCT00117611|Antibodies|antibodies|mesh-list
20159280|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
20159281|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159282|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20159283|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20325293|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325294|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325295|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20325296|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
20325297|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
20325298|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
20325299|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
20325300|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20325301|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20325302|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325303|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325304|NCT00742014|Urological Agents|urological agents|mesh-ancestor
20325305|NCT00742040|Captopril|captopril|mesh-list
20325306|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20325307|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
20325308|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325309|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325310|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20325311|NCT00742066|Felodipine|felodipine|mesh-list
20325312|NCT00742066|Irbesartan|irbesartan|mesh-list
20325313|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20325314|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20325315|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20325316|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325317|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20325318|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19663864|NCT05097365|Vitamins|vitamins|mesh-ancestor
19663865|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
19663866|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663867|NCT05097365|Hematinics|hematinics|mesh-ancestor
19663868|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
19666014|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666015|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666016|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19666017|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19666018|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20159284|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
20325319|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159285|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159286|NCT00117624|Hematinics|hematinics|mesh-ancestor
20159287|NCT00117663|Hormones|hormones|mesh-list
20159288|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159289|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159290|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
19799428|NCT00382109|Methotrexate|methotrexate|mesh-list
19799429|NCT00382109|Tacrolimus|tacrolimus|mesh-list
20325320|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325321|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325322|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
19799430|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799431|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
19799432|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799433|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799434|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19799435|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
19799436|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799437|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799438|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19799439|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19799440|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
19799441|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19799442|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799443|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
19799444|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
19799445|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799446|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20159291|NCT00117689|Tacrolimus|tacrolimus|mesh-list
20159292|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
20159293|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20159294|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159295|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
20159296|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159297|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20159298|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325323|NCT00742092|Miglustat|miglustat|mesh-list
20325324|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325325|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159299|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159300|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20159301|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159302|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20159303|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
20159304|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20159305|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159306|NCT00117702|Everolimus|everolimus|mesh-list
20159307|NCT00117702|Tacrolimus|tacrolimus|mesh-list
20159308|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799447|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799448|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19799449|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20159309|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
20159310|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159311|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20159312|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159313|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159314|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159315|NCT00117728|Nevirapine|nevirapine|mesh-list
20159316|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20159317|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20159318|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159319|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799450|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799451|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20325326|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325327|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325328|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
20325329|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325330|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20325331|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325332|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325333|NCT00742144|Ofatumumab|ofatumumab|mesh-list
19799452|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
19799453|NCT00382148|Omalizumab|omalizumab|mesh-list
19799454|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19799455|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19799456|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
19799457|NCT00382265|Tamsulosin|tamsulosin|mesh-list
19799458|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19799459|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19799460|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19799461|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
20325334|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325335|NCT00742157|Hormones|hormones|mesh-list
20325336|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325337|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325338|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
20325339|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20325340|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
20325341|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325342|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325343|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20325344|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
20325345|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20325346|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20325347|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20325348|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
20325349|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325350|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325351|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
20325352|NCT00742287|Procyanidin|procyanidin|mesh-list
20325353|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
20325354|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325355|NCT00742287|Protective Agents|protective agents|mesh-ancestor
20325356|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325357|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20325358|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20325359|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325360|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
19799462|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799463|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799464|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799465|NCT00382265|Urological Agents|urological agents|mesh-ancestor
19799466|NCT00382590|Cytarabine|cytarabine|mesh-list
19799467|NCT00382590|Azacitidine|azacitidine|mesh-list
19799468|NCT00382590|Valproic Acid|valproic acid|mesh-list
19799469|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159320|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
20159321|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159322|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20159323|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20159324|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19799470|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
19799471|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799472|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799473|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
19799474|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799475|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799476|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
19799477|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799478|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799479|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
19799480|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
20325361|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20325362|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
20325363|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325364|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20325365|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19799481|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159325|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20159326|NCT00117754|Terbinafine|terbinafine|mesh-list
20159327|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
20159328|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159329|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159330|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799482|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
19799483|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19799484|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325366|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
20325367|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799485|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799486|NCT00382720|Docetaxel|docetaxel|mesh-list
19799487|NCT00382720|Capecitabine|capecitabine|mesh-list
19799488|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
19799489|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799490|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
20325368|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325369|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20325370|NCT00742339|Octreotide|octreotide|mesh-list
20325371|NCT00742339|Terlipressin|terlipressin|mesh-list
20325372|NCT00742339|Midodrine|midodrine|mesh-list
20325373|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325374|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20325375|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325376|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
20325377|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
20325378|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325379|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325380|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20325381|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20325382|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20325383|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20325384|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
20325385|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325386|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325387|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20325388|NCT00742404|Dexamethasone|dexamethasone|mesh-list
20325389|NCT00742404|Doxorubicin|doxorubicin|mesh-list
20325390|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20325391|NCT00742404|Bortezomib|bortezomib|mesh-list
20325392|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325393|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
19799491|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
19799492|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
19799493|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799494|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799495|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
19799496|NCT00382733|Topotecan|topotecan|mesh-list
19799497|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19799498|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19799499|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799500|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799501|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799502|NCT00382824|Ubiquinone|ubiquinone|mesh-list
19799503|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
19799504|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
19799505|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799506|NCT00382824|Vitamins|vitamins|mesh-ancestor
19834215|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19834216|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19834217|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19834218|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19834219|NCT00592839|Estrogens|estrogens|mesh-list
19834220|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19834221|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
19834222|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
19834223|NCT00592839|Hormones|hormones|mesh-ancestor
19834224|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19834225|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834226|NCT00592852|Fluoxetine|fluoxetine|mesh-list
19834227|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19834228|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19834229|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159331|NCT00117767|Terbinafine|terbinafine|mesh-list
20159332|NCT00117767|Griseofulvin|griseofulvin|mesh-list
20159333|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
20159334|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159335|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159336|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159337|NCT00117780|Insulin|insulin|mesh-list
20159338|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20159339|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
20159340|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
20325394|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
20325395|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799507|NCT00382993|Naproxen|naproxen|mesh-list
20325396|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325397|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325398|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
20325399|NCT00742404|Hormones|hormones|mesh-ancestor
20325400|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325401|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20325402|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325403|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20325404|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20325405|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325406|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325407|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325408|NCT00742638|Valproic Acid|valproic acid|mesh-list
20325409|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20325410|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
20325411|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20325412|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20325413|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20325414|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325415|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325416|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
20159341|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20159342|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159343|NCT00117832|Azelastine|azelastine|mesh-list
20159344|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20159345|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
20159346|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159347|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159348|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20159349|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
20159350|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20159351|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159352|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159353|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20159354|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20159355|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20159356|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
20159357|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
20159358|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159359|NCT00117897|Lenograstim|lenograstim|mesh-list
20159360|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20159361|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
20159362|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799508|NCT00382993|Sumatriptan|sumatriptan|mesh-list
19799509|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19799510|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19799511|NCT00382993|Analgesics|analgesics|mesh-ancestor
19799512|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
19799513|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799514|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799515|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799516|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799517|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
19799518|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19799519|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799520|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799521|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19799522|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19799523|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19799524|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
19799525|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799526|NCT00383019|Latanoprost|latanoprost|mesh-list
19799527|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19799528|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19799529|NCT00383149|Cetuximab|cetuximab|mesh-list
19799530|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19799531|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799532|NCT00383162|Naproxen|naproxen|mesh-list
19799533|NCT00383162|Sumatriptan|sumatriptan|mesh-list
19799534|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20325417|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799535|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19799536|NCT00383162|Analgesics|analgesics|mesh-ancestor
19799537|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
19799538|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799539|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799540|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799541|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799542|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
19799543|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19799544|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799545|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799546|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19799547|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19799548|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19799549|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
19799550|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799551|NCT00383266|Carboplatin|carboplatin|mesh-list
19799552|NCT00383266|Pemetrexed|pemetrexed|mesh-list
19799553|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799554|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799555|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799556|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19799557|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799558|NCT00383331|Gemcitabine|gemcitabine|mesh-list
19799559|NCT00383331|Pemetrexed|pemetrexed|mesh-list
19799560|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799561|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
19799562|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799563|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799564|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
19799565|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799566|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159363|NCT00117936|Mitogens|mitogens|mesh-list
20159364|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
20159365|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159366|NCT00117975|Galiximab|galiximab|mesh-list
20159367|NCT00117975|Rituximab|rituximab|mesh-list
20159368|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20159369|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159370|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
20159371|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159372|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159373|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159374|NCT00118014|Sertraline|sertraline|mesh-list
20159375|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
20159376|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20159377|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20159378|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20159379|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159380|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159381|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159382|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
20159383|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159384|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
20159385|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
20159386|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20159387|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
20159388|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20159389|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20159390|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159391|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19644432|NCT02373215|Nalbuphine|nalbuphine|mesh-list
19644433|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19644434|NCT02373215|Narcotics|narcotics|mesh-ancestor
19644435|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644436|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644437|NCT02373215|Analgesics|analgesics|mesh-ancestor
19644438|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
19644439|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644440|NCT02373254|Acetaminophen|acetaminophen|mesh-list
19644441|NCT02373254|Ibuprofen|ibuprofen|mesh-list
19644442|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19644443|NCT02373254|Hydrocodone|hydrocodone|mesh-list
19644444|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644445|NCT02373254|Analgesics|analgesics|mesh-ancestor
19644446|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
19644447|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644448|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644449|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
19644450|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644451|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644452|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644453|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19799567|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799568|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
19799569|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799570|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19799571|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799572|NCT00383448|Cyclosporine|cyclosporine|mesh-list
19799573|NCT00383448|Melphalan|melphalan|mesh-list
19799574|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
19799575|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
19799576|NCT00383448|Clofarabine|clofarabine|mesh-list
19799577|NCT00383448|Cyclosporins|cyclosporins|mesh-list
19799578|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799579|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325418|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325419|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
20325420|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325421|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
20325422|NCT00742690|Terlipressin|terlipressin|mesh-list
19799580|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799581|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
19799582|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799583|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
19799584|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799585|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19799586|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799587|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19799588|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19799589|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
19799590|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799591|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19799592|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19799593|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
19799594|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799595|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799596|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
19799597|NCT00383565|Romidepsin|romidepsin|mesh-list
19799598|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19799599|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799600|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
20159392|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159393|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159394|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20159395|NCT00118027|Renal Agents|renal agents|mesh-ancestor
20159396|NCT00118066|Calcitriol|calcitriol|mesh-list
19799601|NCT00383643|Zolpidem|zolpidem|mesh-list
19799602|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19799603|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19799604|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799605|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799606|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19799607|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
19799608|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
19799609|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799610|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799611|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19799612|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19799613|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
19799614|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
19799615|NCT00383747|Nicotine|nicotine|mesh-list
19799616|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19799617|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
19799618|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799619|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799620|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19799621|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20159397|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325423|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19644454|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644455|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644456|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19644457|NCT02373254|Narcotics|narcotics|mesh-ancestor
19799622|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
19799623|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799624|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799625|NCT00383786|Vofopitant|vofopitant|mesh-list
19799626|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
19799627|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
19799628|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799629|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799630|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19799631|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19799632|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799633|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799634|NCT00383942|Misoprostol|misoprostol|mesh-list
19799635|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19799636|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
19799637|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19799638|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799639|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19799640|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19799641|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
19799642|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19799643|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19799644|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19799645|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19799646|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19799647|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159398|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159399|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19799648|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799649|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799650|NCT00384033|Analgesics|analgesics|mesh-ancestor
19799651|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
19799652|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799653|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
19799654|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799655|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
20159400|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159401|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325424|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20325425|NCT00742768|Vitamins|vitamins|mesh-list
20325426|NCT00742768|Vitamin K|vitamin k|mesh-list
20325427|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
20325428|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
19256669|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
19644458|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644459|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
19644460|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
19644461|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19644462|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19644463|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644464|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644465|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644466|NCT02373033|Folic Acid|folic acid|mesh-list
19644467|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
19644468|NCT02373033|Hematinics|hematinics|mesh-ancestor
19644469|NCT02373033|Vitamins|vitamins|mesh-ancestor
19644470|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
19644471|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644472|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19644473|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
19644474|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
20159402|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20159403|NCT00118066|Vitamins|vitamins|mesh-ancestor
20159404|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
20159405|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20159406|NCT00118105|Bevacizumab|bevacizumab|mesh-list
20159407|NCT00118105|Capecitabine|capecitabine|mesh-list
20159408|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
19644475|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
19644476|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
19644477|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799656|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19799657|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
20159409|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20159410|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159411|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19799658|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799659|NCT00384085|Insulin|insulin|mesh-list
19799660|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19799661|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
19799662|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
19799663|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19799664|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799665|NCT00384176|Leucovorin|leucovorin|mesh-list
19799666|NCT00384176|Bevacizumab|bevacizumab|mesh-list
19799667|NCT00384176|Fluorouracil|fluorouracil|mesh-list
19799668|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
19799669|NCT00384176|Cediranib|cediranib|mesh-list
19799670|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19799671|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799672|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19799673|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19799674|NCT00384176|Growth Substances|growth substances|mesh-ancestor
19799675|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799676|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
19799677|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
19799678|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799679|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799680|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799681|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
19799682|NCT00384176|Antidotes|antidotes|mesh-ancestor
19799683|NCT00384176|Protective Agents|protective agents|mesh-ancestor
19799684|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
19799685|NCT00384176|Vitamins|vitamins|mesh-ancestor
19799686|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
19799687|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19799688|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799689|NCT00384189|Ciclesonide|ciclesonide|mesh-list
19799690|NCT00384189|Albuterol|albuterol|mesh-list
19799691|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19799692|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
19799693|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799694|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799695|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20325429|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799696|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
19799697|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
19644478|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644479|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644480|NCT02373280|Amoxicillin|amoxicillin|mesh-list
19644481|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
19644482|NCT02373280|Metronidazole|metronidazole|mesh-list
19644483|NCT02373280|Clarithromycin|clarithromycin|mesh-list
19644484|NCT02373280|Esomeprazole|esomeprazole|mesh-list
19644485|NCT02373280|Bismuth|bismuth|mesh-list
19644486|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19644487|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19799698|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19799699|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19799700|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19799701|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19799702|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
20159412|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20159413|NCT00118105|Growth Substances|growth substances|mesh-ancestor
20159414|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159415|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
19799703|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799704|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799705|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
19799706|NCT00384189|Hormones|hormones|mesh-ancestor
19799707|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799708|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19799709|NCT00384332|Olanzapine|olanzapine|mesh-list
20159416|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159417|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
20159418|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159419|NCT00118170|Sorafenib|sorafenib|mesh-list
20159420|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159421|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20159422|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159423|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159424|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20325430|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20325431|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20325432|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325433|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
20159425|NCT00118183|Cetuximab|cetuximab|mesh-list
20159426|NCT00118183|Docetaxel|docetaxel|mesh-list
20159427|NCT00118183|Bortezomib|bortezomib|mesh-list
20159428|NCT00118183|Antibodies|antibodies|mesh-list
19799710|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
20325434|NCT00742768|Coagulants|coagulants|mesh-ancestor
20347746|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20347747|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20347748|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
20347749|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347750|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19644488|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644489|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19644490|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19799711|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
19799712|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799713|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799714|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19799715|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19799716|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19799717|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799718|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799719|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19799720|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19799721|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19799722|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799723|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799724|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
19799725|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19799726|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
19799727|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159429|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
20159430|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20159431|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
20159432|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159433|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159434|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
20159435|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
20159436|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
20159437|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644491|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644492|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644493|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644494|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19644495|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
20159438|NCT00118196|Azacitidine|azacitidine|mesh-list
20348599|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19644496|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19644497|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644498|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20325435|NCT00742807|Alfentanil|alfentanil|mesh-list
20325436|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20325437|NCT00742807|Narcotics|narcotics|mesh-ancestor
20325438|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325439|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325440|NCT00742807|Analgesics|analgesics|mesh-ancestor
20325441|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
20325442|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325443|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20325444|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
20325445|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
20325446|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
20325447|NCT00742820|Calcium|calcium|mesh-list
20325448|NCT00742820|Calcium acetate|calcium acetate|mesh-list
19799728|NCT00384449|Ranibizumab|ranibizumab|mesh-list
19799729|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19799730|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19799731|NCT00384449|Growth Substances|growth substances|mesh-ancestor
19799732|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799733|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
19799734|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799735|NCT00384670|Vaccines|vaccines|mesh-list
19799736|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
19799737|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799738|NCT00384774|Lasmiditan|lasmiditan|mesh-list
19799739|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19799740|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
19799741|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799742|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799743|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159439|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
20159440|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159441|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
20159442|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159443|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159444|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159445|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20159446|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
20159447|NCT00118222|Ether|ether|mesh-list
20159448|NCT00118222|Trioxsalen|trioxsalen|mesh-list
20159449|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644499|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20159450|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
20159451|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20159452|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20159453|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
20159454|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
20159455|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20159456|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159457|NCT00118235|Bevacizumab|bevacizumab|mesh-list
20159458|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20159459|NCT00118235|Irinotecan|irinotecan|mesh-list
20325449|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325450|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325451|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19644500|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19644501|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19644502|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19644503|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19644504|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644505|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19644506|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19644507|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19644508|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19644509|NCT02373280|Antacids|antacids|mesh-ancestor
19256670|NCT04295863|Nivolumab|nivolumab|mesh-list
19799744|NCT00384839|Azacitidine|azacitidine|mesh-list
20159460|NCT00118235|Antibodies|antibodies|mesh-list
20159461|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
20159462|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20159463|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159464|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20159465|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20159466|NCT00118235|Growth Substances|growth substances|mesh-ancestor
20325452|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
20325453|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
20325454|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325455|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20325456|NCT00742846|Triamcinolone|triamcinolone|mesh-list
20325457|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20325458|NCT00742846|Lidocaine|lidocaine|mesh-list
20325459|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20325460|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
20325461|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
20611549|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20611550|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611551|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611552|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611553|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611554|NCT00980460|Hematinics|hematinics|mesh-ancestor
20611555|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611556|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611557|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
20611558|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20611559|NCT00980460|Protective Agents|protective agents|mesh-ancestor
20159467|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159468|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
20159469|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
20159470|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20159471|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20159472|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159473|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159474|NCT00118261|Leucovorin|leucovorin|mesh-list
20159475|NCT00118261|Bevacizumab|bevacizumab|mesh-list
20159476|NCT00118261|Fluorouracil|fluorouracil|mesh-list
20159477|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
20611560|NCT00843882|Lenalidomide|lenalidomide|mesh-list
20611561|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
20611562|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
20159478|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20159479|NCT00118261|Calcium|calcium|mesh-list
20325462|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325463|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325464|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
20325465|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325466|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20325467|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20325468|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20325469|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325470|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325471|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325472|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
20325473|NCT00742846|Hormones|hormones|mesh-ancestor
20325474|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325475|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20325476|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
20159480|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
20159481|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20159482|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159483|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20159484|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20159485|NCT00118261|Growth Substances|growth substances|mesh-ancestor
20159486|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159487|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
20159488|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20159489|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
20159490|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159491|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159492|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159493|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
20159494|NCT00118261|Antidotes|antidotes|mesh-ancestor
20611563|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611564|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611565|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325477|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325478|NCT00742911|Copper|copper|mesh-list
20325479|NCT00742911|Disulfiram|disulfiram|mesh-list
20325480|NCT00742911|Trace Elements|trace elements|mesh-ancestor
20325481|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
20325482|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325483|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20159495|NCT00118261|Protective Agents|protective agents|mesh-ancestor
20159496|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
20159497|NCT00118261|Vitamins|vitamins|mesh-ancestor
20159498|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
20159499|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20159500|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799745|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799746|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
19799747|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799748|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799749|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799750|NCT00384865|Aspirin|aspirin|mesh-list
19799751|NCT00384865|Simvastatin|simvastatin|mesh-list
19799752|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19799753|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19799754|NCT00384865|Analgesics|analgesics|mesh-ancestor
19799755|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
19799756|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159501|NCT00118300|Capecitabine|capecitabine|mesh-list
20159502|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159503|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
20159504|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159505|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159506|NCT00118313|Imiquimod|imiquimod|mesh-list
20159507|NCT00118313|Sargramostim|sargramostim|mesh-list
20159508|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
20159509|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20159510|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
20159511|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159512|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159513|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20159514|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
20159515|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20159516|NCT00118313|Protective Agents|protective agents|mesh-ancestor
20159517|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20159518|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
20159519|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159520|NCT00118326|Lenograstim|lenograstim|mesh-list
20159521|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20159522|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
20159523|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159524|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
20159525|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20325484|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20325485|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325486|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325487|NCT00742937|Vitamin A|vitamin a|mesh-list
20325488|NCT00742937|Vitamins|vitamins|mesh-ancestor
20325489|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
20159526|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19799757|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799758|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799759|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20325490|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325491|NCT00742976|Insulin|insulin|mesh-list
20325492|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20325493|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
20325494|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
20325495|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
19799760|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19799761|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19799762|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799763|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19799764|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19799765|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799766|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
19799767|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20174212|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325496|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
20325497|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19799768|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19799769|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
19799770|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19799771|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19799772|NCT00384930|Tadalafil|tadalafil|mesh-list
19799773|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
19799774|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19799775|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19799776|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799777|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159527|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159528|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20159529|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325498|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325499|NCT00743028|Navitoclax|navitoclax|mesh-list
20325500|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325501|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20325502|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20325503|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325504|NCT00743327|Pioglitazone|pioglitazone|mesh-list
20325505|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325506|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325507|NCT00743470|Ritonavir|ritonavir|mesh-list
20325508|NCT00743470|Lopinavir|lopinavir|mesh-list
20325509|NCT00743470|Rifabutin|rifabutin|mesh-list
20325510|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20325511|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20325512|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
20325513|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325514|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325515|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325516|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325517|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
20159530|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20159531|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159532|NCT00118638|Hematinics|hematinics|mesh-ancestor
20174213|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20174214|NCT00164047|Analgesics|analgesics|mesh-ancestor
20174215|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
20174216|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174217|NCT00164086|Atorvastatin|atorvastatin|mesh-list
20174218|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20325518|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325519|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20325520|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20325521|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20325522|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20325523|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
20325524|NCT00743496|Antibodies|antibodies|mesh-list
20325525|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
20325526|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325527|NCT00743587|Naproxen|naproxen|mesh-list
20325528|NCT00743587|Oxycodone|oxycodone|mesh-list
20325529|NCT00743587|Tramadol|tramadol|mesh-list
20325530|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20325531|NCT00743587|Narcotics|narcotics|mesh-ancestor
20325532|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325533|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325534|NCT00743587|Analgesics|analgesics|mesh-ancestor
20325535|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
20174219|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20174220|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
20174221|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174222|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20174223|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20174224|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174225|NCT00164112|Azithromycin|azithromycin|mesh-list
20174226|NCT00164112|Levofloxacin|levofloxacin|mesh-list
20174227|NCT00164112|Ofloxacin|ofloxacin|mesh-list
20325536|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325537|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20325538|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20325539|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174228|NCT00164112|Telithromycin|telithromycin|mesh-list
20174229|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20325540|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20325541|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
20325542|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20325543|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325544|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159533|NCT00118690|Fluticasone|fluticasone|mesh-list
20159534|NCT00118690|Xhance|xhance|mesh-list
20159535|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20159536|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159537|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20159538|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
20159539|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799778|NCT00384930|Urological Agents|urological agents|mesh-ancestor
19799779|NCT00384956|Azacitidine|azacitidine|mesh-list
19799780|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799781|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
19799782|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799783|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799784|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799785|NCT00385008|Naproxen|naproxen|mesh-list
19799786|NCT00385008|Sumatriptan|sumatriptan|mesh-list
19799787|NCT00385008|Eletriptan|eletriptan|mesh-list
19799788|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19799789|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19799790|NCT00385008|Analgesics|analgesics|mesh-ancestor
19799791|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
19799792|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325545|NCT00743678|Cetuximab|cetuximab|mesh-list
20325546|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20325547|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325548|NCT00743743|Resveratrol|resveratrol|mesh-list
20325549|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
20325550|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799793|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799794|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799795|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799796|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
19799797|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19799798|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799799|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799800|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19799801|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19799802|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19799803|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
19799804|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799805|NCT00385138|Clopidogrel|clopidogrel|mesh-list
19799806|NCT00385138|Cangrelor|cangrelor|mesh-list
19799807|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19799808|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19799809|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19799810|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19799811|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
19799812|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799813|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799814|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799815|NCT00385203|Cediranib|cediranib|mesh-list
19799816|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799817|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19799818|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799819|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799820|NCT00385216|Nicotine|nicotine|mesh-list
19799821|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19799822|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
19799823|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159540|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159541|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20159542|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
20159543|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
20159544|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20159545|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20159546|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20159547|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20159548|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
20159549|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159550|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159551|NCT00118768|Interferons|interferons|mesh-list
20159552|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
19644510|NCT02372942|Progesterone|progesterone|mesh-list
19644511|NCT02372942|Progestins|progestins|mesh-ancestor
19644512|NCT02372942|Hormones|hormones|mesh-ancestor
19644513|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644514|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644515|NCT02373163|Amlodipine|amlodipine|mesh-list
19644516|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19644517|NCT02373163|Telmisartan|telmisartan|mesh-list
19644518|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19644519|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19644520|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19644521|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644522|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19644523|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644524|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
19644525|NCT02373163|Diuretics|diuretics|mesh-ancestor
19644526|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
19644527|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19644528|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19644529|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19644530|NCT02372903|Palmidrol|palmidrol|mesh-list
20159553|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159554|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
19799824|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799825|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19799826|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19799827|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
19799828|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799829|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799830|NCT00385268|Acamprosate|acamprosate|mesh-list
19799831|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19799832|NCT00385541|Morphine|morphine|mesh-list
19799833|NCT00385541|Hydromorphone|hydromorphone|mesh-list
19799834|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19799835|NCT00385541|Narcotics|narcotics|mesh-ancestor
19799836|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799837|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799838|NCT00385541|Analgesics|analgesics|mesh-ancestor
19799839|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
19799840|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799841|NCT00385580|Dasatinib|dasatinib|mesh-list
19799842|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799843|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19799844|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799845|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799846|NCT00385593|Budesonide|budesonide|mesh-list
19799847|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
19799848|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19799849|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799850|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19799851|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
19799852|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799853|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799854|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19799855|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
19799856|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
19799857|NCT00385593|Hormones|hormones|mesh-ancestor
19799858|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19799859|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19799860|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20159555|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325551|NCT00743743|Protective Agents|protective agents|mesh-ancestor
20325552|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325553|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644531|NCT02372903|Analgesics|analgesics|mesh-ancestor
20159556|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
20159557|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159558|NCT00118794|Lumefantrine|lumefantrine|mesh-list
20159559|NCT00118794|Artemether|artemether|mesh-list
20159560|NCT00118794|Dapsone|dapsone|mesh-list
20159561|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
20159562|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20159563|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
20159564|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20159565|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20159566|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159567|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20159568|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159569|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159570|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
20159571|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20159572|NCT00118807|Artesunate|artesunate|mesh-list
20159573|NCT00118807|Chloroquine|chloroquine|mesh-list
20159574|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
20159575|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
20159576|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20159577|NCT00118807|Amodiaquine|amodiaquine|mesh-list
20325554|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20325555|NCT00743782|Hormones|hormones|mesh-list
20325556|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
20325557|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325558|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325559|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325560|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
20325561|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20325562|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20325563|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325564|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159578|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
20159579|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20159580|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20159581|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159582|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159583|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
20159584|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
20159585|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20159586|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
20159587|NCT00118807|Amebicides|amebicides|mesh-ancestor
20159588|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159589|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20159590|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159591|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159592|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20159593|NCT00118807|Renal Agents|renal agents|mesh-ancestor
20159594|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20159595|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159596|NCT00118937|Metformin|metformin|mesh-list
20159597|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20159598|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159599|NCT00118950|Metformin|metformin|mesh-list
20159600|NCT00118950|Repaglinide|repaglinide|mesh-list
20159601|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20159602|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159603|NCT00118963|Metformin|metformin|mesh-list
20159604|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
20159605|NCT00118963|Repaglinide|repaglinide|mesh-list
20325565|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20159606|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20159607|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159608|NCT00118976|Lisinopril|lisinopril|mesh-list
20159609|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20159610|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
20159611|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159612|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159613|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20159614|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20325566|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20159615|NCT00118976|Protective Agents|protective agents|mesh-ancestor
20159616|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159617|NCT00119002|Dexamethasone|dexamethasone|mesh-list
20159618|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159619|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
20159620|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
20159621|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159622|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159623|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20159624|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
20159625|NCT00119002|Hormones|hormones|mesh-ancestor
20159626|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159627|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20159628|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159629|NCT00119119|Tocopherols|tocopherols|mesh-list
19799861|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19799862|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19799863|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799864|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799865|NCT00385671|Pregabalin|pregabalin|mesh-list
19799866|NCT00385671|Gabapentin|gabapentin|mesh-list
19799867|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19799868|NCT00385671|Analgesics|analgesics|mesh-ancestor
19799869|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
19799870|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799871|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799872|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
19799873|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19799874|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159630|NCT00119119|Vitamin E|vitamin e|mesh-list
20159631|NCT00119119|Tocotrienols|tocotrienols|mesh-list
20159632|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
20159633|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
20159634|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159635|NCT00119119|Protective Agents|protective agents|mesh-ancestor
19799875|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799876|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19799877|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19799878|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19799879|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799880|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799881|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19799882|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19799883|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799884|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
19799885|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19799886|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19799887|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
19799888|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
19799889|NCT00385684|Acetaminophen|acetaminophen|mesh-list
20159636|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159637|NCT00119119|Vitamins|vitamins|mesh-ancestor
20159638|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
20159639|NCT00119132|Artesunate|artesunate|mesh-list
20159640|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
20159641|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
20159642|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20159643|NCT00119132|Amodiaquine|amodiaquine|mesh-list
20159644|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
20159645|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20159646|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20159647|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159648|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159649|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
20159650|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
20159651|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20159652|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
20159653|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20159654|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159655|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325567|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20325568|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325569|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325570|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325571|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
20348600|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
20159656|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20159657|NCT00119132|Renal Agents|renal agents|mesh-ancestor
20159658|NCT00119145|Artesunate|artesunate|mesh-list
20159659|NCT00119145|Amodiaquine|amodiaquine|mesh-list
20159660|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20159661|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
20159662|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20159663|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20159664|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159665|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159666|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
19799890|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19799891|NCT00385684|Hydrocodone|hydrocodone|mesh-list
19799892|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19799893|NCT00385684|Narcotics|narcotics|mesh-ancestor
19799894|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799895|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799896|NCT00385684|Analgesics|analgesics|mesh-ancestor
19799897|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
19799898|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799899|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
19799900|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
19799901|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20159667|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
20159668|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20159669|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
19799902|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
19799903|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19799904|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799905|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799906|NCT00385736|Adalimumab|adalimumab|mesh-list
19799907|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799908|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799909|NCT00385762|Paroxetine|paroxetine|mesh-list
19799910|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19799911|NCT00385762|Serotonin|serotonin|mesh-list
19799912|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19799913|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19799914|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799915|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799916|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
19799917|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799918|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19799919|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
19799920|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799921|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19799922|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19799923|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799924|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20159670|NCT00119171|Capecitabine|capecitabine|mesh-list
20159671|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159672|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
20159673|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159674|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159675|NCT00119184|Anesthetics|anesthetics|mesh-list
20159676|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20159677|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159678|NCT00119210|Bupropion|bupropion|mesh-list
20159679|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20159680|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
20159681|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20159682|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20159683|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20159684|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159685|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159686|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
20159687|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159688|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159689|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20159690|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20159691|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159692|NCT00119236|Irinotecan|irinotecan|mesh-list
20159693|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20159694|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20159695|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611566|NCT00843882|Growth Substances|growth substances|mesh-ancestor
20159696|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159697|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159698|NCT00119249|Sorafenib|sorafenib|mesh-list
20159699|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159700|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20159701|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159702|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159703|NCT00119301|Leucovorin|leucovorin|mesh-list
20159704|NCT00119301|Trimetrexate|trimetrexate|mesh-list
20159705|NCT00119301|Methotrexate|methotrexate|mesh-list
20159706|NCT00119301|Calcium|calcium|mesh-list
19799925|NCT00385788|Gemcitabine|gemcitabine|mesh-list
19799926|NCT00385788|Vidarabine|vidarabine|mesh-list
19799927|NCT00385788|Methotrexate|methotrexate|mesh-list
19799928|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
19799929|NCT00385788|Fludarabine|fludarabine|mesh-list
19799930|NCT00385788|Melphalan|melphalan|mesh-list
19799931|NCT00385788|Tacrolimus|tacrolimus|mesh-list
19799932|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
19799933|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20159707|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
20159708|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20159709|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159710|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20159711|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
20325572|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20325573|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
20325574|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20325575|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20325576|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325577|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20325578|NCT00743847|Varenicline|varenicline|mesh-list
20325579|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20325580|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20325581|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
20325582|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325583|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325584|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325585|NCT00743860|Darapladib|darapladib|mesh-list
20325586|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20325587|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325588|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159712|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20159713|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159714|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
20159715|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159716|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159717|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
20159718|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159719|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20159720|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159721|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
20159722|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159723|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20159724|NCT00119301|Antidotes|antidotes|mesh-ancestor
20159725|NCT00119301|Protective Agents|protective agents|mesh-ancestor
20159726|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
20159727|NCT00119301|Vitamins|vitamins|mesh-ancestor
20159728|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
20159729|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
20159730|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325589|NCT00743873|Mitogens|mitogens|mesh-list
20325590|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
20325591|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325592|NCT00743886|Mitogens|mitogens|mesh-list
20325593|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
20325594|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325595|NCT00743912|Rifaximin|rifaximin|mesh-list
20325596|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20159731|NCT00119314|Gemcitabine|gemcitabine|mesh-list
19799934|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19799935|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
20159732|NCT00119314|Capecitabine|capecitabine|mesh-list
20159733|NCT00119314|Docetaxel|docetaxel|mesh-list
20159734|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159735|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
20159736|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159737|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799936|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799937|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799938|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
19799939|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19799940|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799941|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19799942|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
19799943|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799944|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19799945|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
19799946|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19799947|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
19799948|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19799949|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19799950|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19799951|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19799952|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19799953|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
19799954|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19799955|NCT00385801|Risperidone|risperidone|mesh-list
19799956|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19799957|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
19799958|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799959|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799960|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799961|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19799962|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19799963|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19799964|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19799965|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19799966|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
19799967|NCT00385827|Prednisone|prednisone|mesh-list
19799968|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
19799969|NCT00385827|Siltuximab|siltuximab|mesh-list
19799970|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19799971|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
19799972|NCT00385827|Hormones|hormones|mesh-ancestor
19799973|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159738|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
20159739|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159740|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799974|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799975|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19799976|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799977|NCT00385827|Analgesics|analgesics|mesh-ancestor
19799978|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
19799979|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19799980|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19799981|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19799982|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799983|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159741|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159742|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
20159743|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159744|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
20159745|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
20159746|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
20159747|NCT00119340|Cyclosporine|cyclosporine|mesh-list
20159748|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
20159749|NCT00119340|Fludarabine|fludarabine|mesh-list
20159750|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
20159751|NCT00119340|Cyclosporins|cyclosporins|mesh-list
20159752|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159753|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159754|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
20159755|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159756|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159757|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
19799984|NCT00385944|Clopidogrel|clopidogrel|mesh-list
19799985|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19799986|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19799987|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20159758|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159759|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159760|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
20159761|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159762|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
20159763|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159764|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20159765|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20159766|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20159767|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
20159768|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20159769|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
20159770|NCT00119483|Testosterone|testosterone|mesh-list
20159771|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
20159772|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
20159773|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20159774|NCT00119483|Androgens|androgens|mesh-ancestor
20159775|NCT00119483|Hormones|hormones|mesh-ancestor
20159776|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159777|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799988|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19799989|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19799990|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
19799991|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19799992|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799993|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19799994|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19799995|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19799996|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19799997|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19799998|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19799999|NCT00386009|Tadalafil|tadalafil|mesh-list
19800000|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
19800001|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19800002|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19800003|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800004|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800005|NCT00386009|Urological Agents|urological agents|mesh-ancestor
19800006|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19800007|NCT00386022|Estrogens|estrogens|mesh-list
19800008|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
19800009|NCT00386022|Hormones|hormones|mesh-ancestor
19800010|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800011|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800012|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
19800013|NCT00386100|Metformin|metformin|mesh-list
19800014|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19800015|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800016|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
19800017|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
19800018|NCT00386152|Hematinics|hematinics|mesh-ancestor
19800019|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
19800020|NCT00386243|Analgesics|analgesics|mesh-list
19800021|NCT00386243|Narcotics|narcotics|mesh-ancestor
19800022|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800023|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800024|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
19800025|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800026|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
19800027|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20159778|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20159779|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159780|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
20159781|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
20159782|NCT00119496|Beclomethasone|beclomethasone|mesh-list
20159783|NCT00119496|Theophylline|theophylline|mesh-list
20159784|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159785|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159786|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20159787|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159788|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159789|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
20325597|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325598|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325599|NCT00743964|Capecitabine|capecitabine|mesh-list
20325600|NCT00743964|Epirubicin|epirubicin|mesh-list
20325601|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325602|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20325603|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
20159790|NCT00119496|Hormones|hormones|mesh-ancestor
20325604|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325605|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20325606|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20325607|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325608|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325609|NCT00743990|Camphor|camphor|mesh-list
20325610|NCT00743990|Menthol|menthol|mesh-list
20325611|NCT00743990|Petrolatum|petrolatum|mesh-list
20325612|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
20325613|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
20325614|NCT00743990|Emollients|emollients|mesh-ancestor
20325615|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20325616|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325617|NCT00744016|Mesalamine|mesalamine|mesh-list
20325618|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20325619|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20325620|NCT00744016|Analgesics|analgesics|mesh-ancestor
20325621|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
20325622|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325623|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159791|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159792|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19800028|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19800029|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800030|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
19800031|NCT00386308|Coagulants|coagulants|mesh-ancestor
19800032|NCT00386334|Eszopiclone|eszopiclone|mesh-list
19800033|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19800034|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800035|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800036|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
19800037|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19800038|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19800039|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800040|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19800041|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800042|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19800043|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19800044|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800045|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
19800046|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19800047|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800048|NCT00386607|Valsartan|valsartan|mesh-list
19800049|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19800050|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19800051|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19800052|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19800053|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800054|NCT00386607|Diuretics|diuretics|mesh-ancestor
20159793|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
20159794|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20159795|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
19800055|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
19800056|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159796|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159797|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19256671|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20159798|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
20159799|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20159800|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20159801|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
20159802|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325624|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325625|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800057|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19800058|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19800059|NCT00387010|Fentanyl|fentanyl|mesh-list
19800060|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19800061|NCT00387010|Narcotics|narcotics|mesh-ancestor
19800062|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800063|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800064|NCT00387010|Analgesics|analgesics|mesh-ancestor
20159803|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159804|NCT00119587|Hematinics|hematinics|mesh-ancestor
20159805|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
20159806|NCT00119613|Hematinics|hematinics|mesh-ancestor
20159807|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
20159808|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
20159809|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159810|NCT00119626|Protective Agents|protective agents|mesh-ancestor
19800065|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
19800066|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800067|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19800068|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19800069|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
19800070|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
19800071|NCT00387023|Rituximab|rituximab|mesh-list
19800072|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800073|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800074|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
19800075|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800076|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800077|NCT00387036|Fluticasone|fluticasone|mesh-list
19800078|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19800079|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19800080|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
20159811|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159812|NCT00119639|Sorafenib|sorafenib|mesh-list
20159813|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800081|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800082|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800083|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19800084|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
19800085|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
19800086|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19800087|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
19800088|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19800089|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
19800090|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800091|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800092|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19800093|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
19800094|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
19800095|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19800096|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
19800097|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800098|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800099|NCT00387127|Lapatinib|lapatinib|mesh-list
19800100|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800101|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800102|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800103|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800104|NCT00387335|Sunitinib|sunitinib|mesh-list
19800105|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800106|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800107|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800108|NCT00387335|Growth Substances|growth substances|mesh-ancestor
19800109|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800110|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800111|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800112|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800113|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800114|NCT00387348|Dexetimide|dexetimide|mesh-list
19800115|NCT00387348|Citalopram|citalopram|mesh-list
19800116|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20159814|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20159815|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325626|NCT00744081|Topotecan|topotecan|mesh-list
19800117|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19800118|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19800119|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800120|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800121|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
19800122|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800123|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19800124|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
19800125|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800126|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19800127|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19800128|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
19800129|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
19800130|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800131|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19800132|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20325627|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
20325628|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20325629|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325630|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325631|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325632|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325633|NCT00744081|Analgesics|analgesics|mesh-ancestor
20325634|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
20325635|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325636|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325637|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20325638|NCT00744107|Cobalt|cobalt|mesh-list
20325639|NCT00744107|Trace Elements|trace elements|mesh-ancestor
20325640|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
19800133|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
19800134|NCT00387426|Sunitinib|sunitinib|mesh-list
19800135|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159816|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159817|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20159818|NCT00119652|Paroxetine|paroxetine|mesh-list
20159819|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
20159820|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20159821|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20159822|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20159823|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20159824|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159825|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20159826|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20159827|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19800136|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800137|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800138|NCT00387426|Growth Substances|growth substances|mesh-ancestor
19800139|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800140|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800141|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800142|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800143|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800144|NCT00387465|Azacitidine|azacitidine|mesh-list
19800145|NCT00387465|Entinostat|entinostat|mesh-list
19800146|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19800147|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800148|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
19800149|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800150|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800151|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800152|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19800153|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
19800154|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800155|NCT00387647|Azacitidine|azacitidine|mesh-list
19800156|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800157|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
19800158|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800159|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159828|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159829|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159830|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
20325641|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159831|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20159832|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20159833|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20159834|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159835|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20159836|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
20159837|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800160|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800161|NCT00387660|Carboplatin|carboplatin|mesh-list
19800162|NCT00387660|Irinotecan|irinotecan|mesh-list
19800163|NCT00387660|Camptothecin|camptothecin|mesh-list
19800164|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644532|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
19644533|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644534|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644535|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644536|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19800165|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19800166|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19800167|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800168|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800169|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800170|NCT00387751|Bevacizumab|bevacizumab|mesh-list
19800171|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19800172|NCT00387751|Sorafenib|sorafenib|mesh-list
19800173|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
19800174|NCT00387751|Antibodies|antibodies|mesh-list
19800175|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
19800176|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19800177|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
19800178|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800179|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800180|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800181|NCT00387751|Growth Substances|growth substances|mesh-ancestor
19800182|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800183|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800184|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
19800185|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800186|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800187|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644537|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644538|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644539|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
20159838|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
20159839|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20159840|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20159841|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20159842|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159843|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800188|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
19800189|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800190|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19800191|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
20159844|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
20159845|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159846|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159847|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19644540|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644541|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19644542|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19644543|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644544|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644545|NCT02372903|Hormones|hormones|mesh-ancestor
19644546|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644547|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
19644548|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19644549|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800192|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19800193|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19644550|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644551|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644552|NCT02372916|Ranibizumab|ranibizumab|mesh-list
19644553|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19644554|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19644555|NCT02372916|Growth Substances|growth substances|mesh-ancestor
19644556|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644557|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
19644558|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644559|NCT02372526|Orlistat|orlistat|mesh-list
19644560|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644561|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644562|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19644563|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20159848|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159849|NCT00119730|Rituximab|rituximab|mesh-list
20159850|NCT00119730|Fludarabine|fludarabine|mesh-list
20159851|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
20159852|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20159853|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159854|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
20159855|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159856|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159857|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159858|NCT00119730|Analgesics|analgesics|mesh-ancestor
20159859|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
20159860|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159861|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20325642|NCT00744185|Propranolol|propranolol|mesh-list
20611567|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
19644564|NCT02372656|Metformin|metformin|mesh-list
19644565|NCT02372656|Simvastatin|simvastatin|mesh-list
19644566|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644567|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644568|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19644569|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19644570|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
19644571|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644572|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19663869|NCT05097261|Ketamine|ketamine|mesh-list
19663870|NCT05097261|Analgesics|analgesics|mesh-ancestor
19663871|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
19663872|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663873|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663874|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19663875|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19663876|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
19663877|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
19663878|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19663879|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19663880|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19663881|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663882|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663883|NCT05097248|Doxorubicin|doxorubicin|mesh-list
19663884|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19663885|NCT05097248|Losartan|losartan|mesh-list
19663886|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19663887|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663888|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19663889|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19663890|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663891|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663892|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19663893|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19663894|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19663895|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19663896|NCT05097209|Gemcitabine|gemcitabine|mesh-list
19663897|NCT05097209|Cisplatin|cisplatin|mesh-list
19663898|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19663899|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19663900|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
19663901|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663902|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
19663903|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800194|NCT00387829|Estradiol|estradiol|mesh-list
19800195|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19800196|NCT00387829|Estrogens|estrogens|mesh-ancestor
19800197|NCT00387829|Hormones|hormones|mesh-ancestor
19800198|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800199|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800200|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19800201|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
19800202|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19800203|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19800204|NCT00387881|Naproxen|naproxen|mesh-list
19800205|NCT00387881|Sumatriptan|sumatriptan|mesh-list
19800206|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19800207|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19800208|NCT00387881|Analgesics|analgesics|mesh-ancestor
19800209|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
19800210|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800211|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800212|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19800213|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800214|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
19800215|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19800216|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800217|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800218|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19800219|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19800220|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19800221|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
19800222|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800223|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19800224|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800225|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800226|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800227|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800228|NCT00387959|Cyclosporine|cyclosporine|mesh-list
19800229|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
19800230|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
19800231|NCT00387959|Rituximab|rituximab|mesh-list
19800232|NCT00387959|Fludarabine|fludarabine|mesh-list
19800233|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
19800234|NCT00387959|Cyclosporins|cyclosporins|mesh-list
19800235|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800236|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
19800237|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800238|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800239|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19800240|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
19800241|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800242|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800243|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19800244|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20325643|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20325644|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19644573|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19644574|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644575|NCT02372591|Buprenorphine|buprenorphine|mesh-list
19800245|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800246|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
19800247|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644576|NCT02372591|Hydromorphone|hydromorphone|mesh-list
19644577|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19644578|NCT02372591|Narcotics|narcotics|mesh-ancestor
19644579|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644580|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644581|NCT02372591|Analgesics|analgesics|mesh-ancestor
19644582|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
19644583|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644584|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19644585|NCT02372786|Lidocaine|lidocaine|mesh-list
19800248|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
19800249|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800250|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
19644586|NCT02372786|Tetracaine|tetracaine|mesh-list
19644587|NCT02372786|Prilocaine|prilocaine|mesh-list
19800251|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20159862|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20159863|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159864|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20159865|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20159866|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20325645|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
19644588|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
19644589|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
19644590|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644591|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644592|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
19644593|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644594|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19644595|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19644596|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19644597|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19644598|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644599|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
19663904|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663905|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663906|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
19663907|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663908|NCT05090280|Nafamostat|nafamostat|mesh-list
19663909|NCT05090280|Naltrexone|naltrexone|mesh-list
19663910|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19663911|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19663912|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663913|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
19663914|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663915|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19663916|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19663917|NCT05090280|Analgesics|analgesics|mesh-ancestor
19663918|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19663919|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663920|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
19663921|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
19663922|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663923|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663924|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19663925|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19663926|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19663927|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19663928|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
19663929|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
19663930|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
19663931|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19663932|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19663933|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19663934|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663935|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663936|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
19663937|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663938|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663939|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19663940|NCT05089851|Protective Agents|protective agents|mesh-ancestor
19663941|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
19663942|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19663943|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663944|NCT05087940|Diuretics|diuretics|mesh-list
19666019|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800252|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19800253|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20159867|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20159868|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159869|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20159870|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20159871|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20159872|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
20325646|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325647|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325648|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325649|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20325650|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20325651|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
20325652|NCT00744224|Exenatide|exenatide|mesh-list
20325653|NCT00744224|Prednisolone|prednisolone|mesh-list
19800254|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
19800255|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19800256|NCT00388037|Sunitinib|sunitinib|mesh-list
20325654|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20325655|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
20325656|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20325657|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
20325658|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20325659|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
20325660|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325661|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
20325662|NCT00744224|Hormones|hormones|mesh-ancestor
20325663|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325664|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800257|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800258|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800259|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800260|NCT00388037|Growth Substances|growth substances|mesh-ancestor
19800261|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800262|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800263|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800264|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159873|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159874|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325665|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20325666|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325667|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
20611568|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611569|NCT00843882|Hematinics|hematinics|mesh-ancestor
20611570|NCT00652574|Dasatinib|dasatinib|mesh-list
20611571|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611572|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611573|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611574|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611575|NCT00644228|Dexamethasone|dexamethasone|mesh-list
20611576|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
20159875|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20159876|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20159877|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
20159878|NCT00119769|Hormones|hormones|mesh-list
20159879|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20159880|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159881|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
20611577|NCT00644228|Lenalidomide|lenalidomide|mesh-list
20611578|NCT00644228|Bortezomib|bortezomib|mesh-list
20611579|NCT00644228|Ichthammol|ichthammol|mesh-list
20611580|NCT00644228|BB 1101|bb 1101|mesh-list
20611581|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20611582|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
20325668|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
20325669|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325670|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325671|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20325672|NCT00744224|Protective Agents|protective agents|mesh-ancestor
20159882|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20325673|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325674|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20611583|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
20611584|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611585|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800265|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800266|NCT00388154|Gemcitabine|gemcitabine|mesh-list
20159883|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20159884|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159885|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
20159886|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20159887|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159888|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
20159889|NCT00119990|Icodextrin|icodextrin|mesh-list
20159890|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20159891|NCT00120003|Candesartan|candesartan|mesh-list
20325675|NCT00744224|Incretins|incretins|mesh-ancestor
20325676|NCT00744250|Pancrelipase|pancrelipase|mesh-list
20325677|NCT00744250|Pancreatin|pancreatin|mesh-list
20325678|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325679|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
20325680|NCT00744302|Calcium|calcium|mesh-list
20325681|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325682|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325683|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20325684|NCT00744354|Doxorubicin|doxorubicin|mesh-list
20325685|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20325686|NCT00744354|Bortezomib|bortezomib|mesh-list
20325687|NCT00744354|Vorinostat|vorinostat|mesh-list
20325688|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20325689|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325690|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20325691|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325692|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325693|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325694|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20325695|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
20325696|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20325697|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20325698|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
20325699|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
20325700|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325701|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325702|NCT00744406|Sertraline|sertraline|mesh-list
20325703|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20325704|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
20325705|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20325706|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20159892|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
20159893|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20159894|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20159895|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19800267|NCT00388154|Cisplatin|cisplatin|mesh-list
19800268|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800269|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800270|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
19800271|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800272|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
19800273|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800274|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800275|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800276|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
19800277|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800278|NCT00388349|Gemcitabine|gemcitabine|mesh-list
19800279|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
19800280|NCT00388349|Carmustine|carmustine|mesh-list
19800281|NCT00388349|Etoposide|etoposide|mesh-list
19800282|NCT00388349|Vinorelbine|vinorelbine|mesh-list
19800283|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800284|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
19800285|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800286|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800287|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19800288|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
19800289|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800290|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800291|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20325707|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20159896|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325708|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325709|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325710|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325711|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
20325712|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325713|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20325714|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20325715|NCT00744419|Pantoprazole|pantoprazole|mesh-list
20325716|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20325717|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325718|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20325719|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325720|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325721|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
20325722|NCT00744445|Hematinics|hematinics|mesh-ancestor
20325723|NCT00744536|Lenalidomide|lenalidomide|mesh-list
20325724|NCT00744536|Melphalan|melphalan|mesh-list
20325725|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
20325726|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325727|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20325728|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325729|NCT00744536|Growth Substances|growth substances|mesh-ancestor
20325730|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
20325731|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325732|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20325733|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
20325734|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325735|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20325736|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159897|NCT00120055|Atorvastatin|atorvastatin|mesh-list
20159898|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20159899|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20159900|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
20159901|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159902|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20159903|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20159904|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159905|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20159906|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20159907|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
20159908|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159909|NCT00120081|Antacids|antacids|mesh-ancestor
20159910|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159911|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20159912|NCT00120120|Lenalidomide|lenalidomide|mesh-list
19800292|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800293|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
20159913|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
20159914|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159915|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20159916|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325737|NCT00744549|Vitamin D|vitamin d|mesh-list
19800294|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
19800295|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800296|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800297|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800298|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19800299|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19800300|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800301|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800302|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834230|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834231|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834232|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
19834233|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159917|NCT00120120|Growth Substances|growth substances|mesh-ancestor
20159918|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
20159919|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159920|NCT00120133|Atorvastatin|atorvastatin|mesh-list
20159921|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20159922|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20325738|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
20325739|NCT00744549|Vitamins|vitamins|mesh-list
20159923|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
20159924|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800303|NCT00388362|Sirolimus|sirolimus|mesh-list
19800304|NCT00388362|Prednisone|prednisone|mesh-list
19800305|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19800306|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
19800307|NCT00388362|Hormones|hormones|mesh-ancestor
19800308|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800309|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800310|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19800311|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800312|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19800313|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800314|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19800315|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
19800316|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800317|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
19800318|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19800319|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19800320|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19800321|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19800322|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159925|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20159926|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20159927|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159928|NCT00120172|Bevacizumab|bevacizumab|mesh-list
20159929|NCT00120172|Capecitabine|capecitabine|mesh-list
20325740|NCT00744549|Vitamin E|vitamin e|mesh-list
19800323|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800324|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800325|NCT00388414|Analgesics|analgesics|mesh-ancestor
19800326|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
19800327|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800328|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
19800329|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800330|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
19800331|NCT00388505|Tobramycin|tobramycin|mesh-list
19800332|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19800333|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800334|NCT00388583|Vaccines|vaccines|mesh-list
19800335|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
19800336|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800337|NCT00388674|Entecavir|entecavir|mesh-list
19800338|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
19800339|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800340|NCT00388804|Leuprolide|leuprolide|mesh-list
19800341|NCT00388804|Goserelin|goserelin|mesh-list
19800342|NCT00388804|Flutamide|flutamide|mesh-list
19800343|NCT00388804|Bicalutamide|bicalutamide|mesh-list
19800344|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19800345|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
19800346|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19800347|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800348|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19800349|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800350|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
19800351|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
19800352|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800353|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19800354|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
20159930|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
20159931|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20159932|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159933|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20159934|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20159935|NCT00120172|Growth Substances|growth substances|mesh-ancestor
20159936|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159937|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
20159938|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20159939|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
20159940|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159941|NCT00120185|Interleukin-2|interleukin-2|mesh-list
20159942|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159943|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20325741|NCT00744549|Selenium|selenium|mesh-list
20159944|NCT00120185|Analgesics|analgesics|mesh-ancestor
20159945|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
19800355|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19644600|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644601|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
19644602|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19644603|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19644604|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644605|NCT02372487|Urological Agents|urological agents|mesh-ancestor
19644606|NCT02372669|Chitosan|chitosan|mesh-list
19644607|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19644608|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19644609|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
19644610|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644611|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19644612|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
19644613|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
19644614|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
20159946|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159947|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159948|NCT00120198|Rituximab|rituximab|mesh-list
20159949|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20159950|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20159951|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
20159952|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159953|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159954|NCT00120237|Misoprostol|misoprostol|mesh-list
20159955|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20159956|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
20159957|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19800356|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19800357|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800358|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800359|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800360|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19800361|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
19800362|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800363|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19800364|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800365|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800366|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800367|NCT00389168|Atenolol|atenolol|mesh-list
19800368|NCT00389168|Irbesartan|irbesartan|mesh-list
19800369|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19800370|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19800371|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19800372|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800373|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19800374|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
19800375|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
19800376|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800377|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800378|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19800379|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19800380|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19800381|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
19800382|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800383|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19800384|NCT00389207|Nevirapine|nevirapine|mesh-list
20159958|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159959|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20159960|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20159961|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
20159962|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
20159963|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20159964|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20159965|NCT00120302|Analgesics|analgesics|mesh-ancestor
20159966|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
19800385|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19800386|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19800387|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
20325742|NCT00744549|Lycopene|lycopene|mesh-list
19800388|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800389|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800390|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19800391|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325743|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
20325744|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325745|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20325746|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20325747|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
20325748|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325749|NCT00744549|Protective Agents|protective agents|mesh-ancestor
19800392|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
19800393|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800394|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19800395|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19800396|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19800397|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19800398|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
19800399|NCT00389324|Antibodies|antibodies|mesh-list
19800400|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
19800401|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19800402|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19800403|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
20159967|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159968|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20159969|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20159970|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20159971|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
20159972|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20159973|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
20159974|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20159975|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159976|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159977|NCT00120315|Esomeprazole|esomeprazole|mesh-list
19800404|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
19800405|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800406|NCT00389441|Axitinib|axitinib|mesh-list
19800407|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800408|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800409|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800410|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800411|NCT00389493|Risperidone|risperidone|mesh-list
19800412|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19800413|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
19800414|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800415|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800416|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800417|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19800418|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800419|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325750|NCT00744549|Trace Elements|trace elements|mesh-ancestor
20325751|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325752|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20325753|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20325754|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325755|NCT00744640|Gemcitabine|gemcitabine|mesh-list
20325756|NCT00744640|Capecitabine|capecitabine|mesh-list
19800420|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800421|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19800422|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
19800423|NCT00389519|Ramipril|ramipril|mesh-list
20325757|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
20325758|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20325759|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
20325760|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325761|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325762|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
20325763|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325764|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325765|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20325766|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
20325767|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800424|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20159978|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19800425|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
20325768|NCT00744666|Prednisolone|prednisolone|mesh-list
20325769|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20325770|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325771|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
20325772|NCT00744666|Hormones|hormones|mesh-ancestor
20325773|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325774|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325775|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20325776|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800426|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800427|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800428|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19800429|NCT00389532|Vaccines|vaccines|mesh-list
19800430|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
20325777|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20325778|NCT00744679|Natalizumab|natalizumab|mesh-list
20325779|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
20325780|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347751|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20347752|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347753|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
20347754|NCT00861783|Irinotecan|irinotecan|mesh-list
20347755|NCT00861783|Camptothecin|camptothecin|mesh-list
20347756|NCT00861783|ON 01910|on 01910|mesh-list
20347757|NCT00861783|Glycine|glycine|mesh-list
20159979|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20159980|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20159981|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159982|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159983|NCT00120341|Analgesics|analgesics|mesh-list
20159984|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
20159985|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20159986|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174230|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174231|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20174232|NCT00164112|Renal Agents|renal agents|mesh-ancestor
20174233|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19800431|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174234|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20347758|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347759|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20347760|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20347761|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800432|NCT00389805|Pemetrexed|pemetrexed|mesh-list
19800433|NCT00389805|Bortezomib|bortezomib|mesh-list
19800434|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800435|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800436|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800437|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19800438|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19800439|NCT00389818|Prednisone|prednisone|mesh-list
20174235|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174236|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174237|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174238|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20174239|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20174240|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20174241|NCT00164125|Laxatives|laxatives|mesh-ancestor
20174242|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20174243|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20174244|NCT00164164|Laxatives|laxatives|mesh-ancestor
20174245|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20174246|NCT00164216|Artesunate|artesunate|mesh-list
20174247|NCT00164216|Mefloquine|mefloquine|mesh-list
20174248|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
20174249|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20174250|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20347762|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800440|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
19800441|NCT00389818|Rituximab|rituximab|mesh-list
19800442|NCT00389818|Doxorubicin|doxorubicin|mesh-list
19800443|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19800444|NCT00389818|Vincristine|vincristine|mesh-list
20174251|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347763|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800445|NCT00389818|Sargramostim|sargramostim|mesh-list
20159987|NCT00120354|Lamivudine|lamivudine|mesh-list
20159988|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20159989|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20159990|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20159991|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20159992|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
20159993|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20159994|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20159995|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20159996|NCT00120367|Tenofovir|tenofovir|mesh-list
20159997|NCT00120367|Emtricitabine|emtricitabine|mesh-list
20159998|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
20159999|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
19800446|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800447|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
19800448|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160000|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160001|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160002|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160003|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160004|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160005|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160006|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160007|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20160008|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20160009|NCT00120380|Iloprost|iloprost|mesh-list
20160010|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20160011|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
20160012|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
20160013|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20160014|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160015|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20160016|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
20160017|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20160018|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160019|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160020|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160021|NCT00120432|Phenylephrine|phenylephrine|mesh-list
20160022|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
20160023|NCT00120432|Tropicamide|tropicamide|mesh-list
20160024|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20160025|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
20160026|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
20325781|NCT00744718|Bevacizumab|bevacizumab|mesh-list
20325782|NCT00744718|Carboplatin|carboplatin|mesh-list
20325783|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800449|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800450|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19800451|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
20160027|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160028|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160029|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
20160030|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20160031|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
20160032|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
20160033|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20160034|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20160035|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20325784|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325785|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20325786|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325787|NCT00744718|Growth Substances|growth substances|mesh-ancestor
20325788|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325789|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
20325790|NCT00744770|Rilpivirine|rilpivirine|mesh-list
20325791|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20325792|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256672|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160036|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
20160037|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160038|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160039|NCT00120432|Protective Agents|protective agents|mesh-ancestor
20160040|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20160041|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20160042|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
20160043|NCT00120471|Tenofovir|tenofovir|mesh-list
20160044|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
20160045|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160046|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160047|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19800452|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800453|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800454|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19800455|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800456|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19800457|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19800458|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19800459|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800460|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19800461|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
19800462|NCT00389818|Hormones|hormones|mesh-ancestor
19800463|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800464|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19800465|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800466|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800467|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800468|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800469|NCT00389831|Rotigotine|rotigotine|mesh-list
19800470|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
19800471|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
19800472|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800473|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800474|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800475|NCT00389857|Vaccines|vaccines|mesh-list
19800476|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
19800477|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800478|NCT00389974|Sunitinib|sunitinib|mesh-list
19800479|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800480|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800481|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800482|NCT00389974|Growth Substances|growth substances|mesh-ancestor
19800483|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800484|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800485|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800486|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800487|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800488|NCT00390013|Gabapentin|gabapentin|mesh-list
19800489|NCT00390013|Analgesics|analgesics|mesh-ancestor
19800490|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
19800491|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800492|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800493|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
19800494|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19800495|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800496|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800497|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800498|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19800499|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19800500|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800501|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800502|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
20160048|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160049|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160050|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160051|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160052|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
20160053|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
19644615|NCT02372669|Coagulants|coagulants|mesh-ancestor
19644616|NCT02372760|Lidocaine|lidocaine|mesh-list
19644617|NCT02372760|Anesthetics|anesthetics|mesh-list
19644618|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
19644619|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644620|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644621|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
19644622|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644623|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19644624|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19644625|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19644626|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19644627|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644628|NCT02372461|Amoxicillin|amoxicillin|mesh-list
19644629|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19644630|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644631|NCT02372812|Dexamethasone|dexamethasone|mesh-list
19644632|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644633|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
19644634|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
19644635|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644636|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644637|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644638|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
20325793|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325794|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644639|NCT02372812|Hormones|hormones|mesh-ancestor
19644640|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644641|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19644642|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644643|NCT02372604|Cetirizine|cetirizine|mesh-list
19644644|NCT02372604|Levocetirizine|levocetirizine|mesh-list
19644645|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19644646|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19644647|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
19644648|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
20325795|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
20325796|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325797|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325798|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325799|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
20325800|NCT00744809|Efavirenz|efavirenz|mesh-list
20325801|NCT00744809|Rilpivirine|rilpivirine|mesh-list
20325802|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20325803|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325804|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20325805|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325806|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325807|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325808|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325809|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20325810|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20325811|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
20325812|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20325813|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20325814|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20325815|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20325816|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20325817|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20325818|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325819|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325820|NCT00744887|Darunavir|darunavir|mesh-list
20325821|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20325822|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20325823|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
20325824|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325825|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325826|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20325827|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20325828|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
20325829|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20325830|NCT00744900|Pemetrexed|pemetrexed|mesh-list
20325831|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644649|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666020|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19666021|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19666022|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
19666023|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
19666024|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
19666025|NCT02683018|Dronabinol|dronabinol|mesh-list
19666026|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
19666027|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666028|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19666029|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666030|NCT02683018|Analgesics|analgesics|mesh-ancestor
19666031|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
19800503|NCT00390182|Gemcitabine|gemcitabine|mesh-list
19800504|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20325832|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20325833|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325834|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20325835|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20325836|NCT00744913|Nicotine|nicotine|mesh-list
20325837|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20325838|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
20325839|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325840|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325841|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20325842|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20325843|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
20325844|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325845|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325846|NCT00745004|Ondansetron|ondansetron|mesh-list
20160054|NCT00120484|Vitamins|vitamins|mesh-ancestor
20160055|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
20160056|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160057|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
20160058|NCT00120484|Hematinics|hematinics|mesh-ancestor
20325847|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
20325848|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
20325849|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325850|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325851|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325852|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
20325853|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
20325854|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20325855|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
20325856|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325857|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325858|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20325859|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20325860|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325861|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20325862|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20325863|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
20325864|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20325865|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
20325866|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
20325867|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325868|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325869|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20325870|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
20325871|NCT00745069|Tapentadol|tapentadol|mesh-list
20325872|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20325873|NCT00745069|Narcotics|narcotics|mesh-ancestor
20325874|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20325875|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325876|NCT00745069|Analgesics|analgesics|mesh-ancestor
20325877|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
20325878|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325879|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20325880|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19800505|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
19800506|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800507|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800508|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
19800509|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800510|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800511|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800512|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
19800513|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800514|NCT00390221|Daclizumab|daclizumab|mesh-list
20160059|NCT00120497|Hormones|hormones|mesh-list
20160060|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20160061|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160062|NCT00120510|Lamivudine|lamivudine|mesh-list
20160063|NCT00120510|Zidovudine|zidovudine|mesh-list
20160064|NCT00120510|Efavirenz|efavirenz|mesh-list
20325881|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160065|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20160066|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19800515|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800516|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
19800517|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800518|NCT00390234|Aflibercept|aflibercept|mesh-list
19800519|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
19800520|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800521|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800522|NCT00390234|Growth Substances|growth substances|mesh-ancestor
19800523|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160067|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160068|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160069|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800524|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800525|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800526|NCT00390364|Everolimus|everolimus|mesh-list
19800527|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800528|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800529|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
19800530|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800531|NCT00390416|Leucovorin|leucovorin|mesh-list
19800532|NCT00390416|Bevacizumab|bevacizumab|mesh-list
19800533|NCT00390416|Docetaxel|docetaxel|mesh-list
19800534|NCT00390416|Fluorouracil|fluorouracil|mesh-list
19800535|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800536|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800537|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800538|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800539|NCT00390416|Growth Substances|growth substances|mesh-ancestor
20325882|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325883|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
19800540|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800541|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800542|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800543|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800544|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800545|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800546|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
19800547|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800548|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800549|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
19800550|NCT00390416|Antidotes|antidotes|mesh-ancestor
19800551|NCT00390416|Protective Agents|protective agents|mesh-ancestor
19800552|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
19800553|NCT00390416|Vitamins|vitamins|mesh-ancestor
19800554|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
19800555|NCT00390429|Docetaxel|docetaxel|mesh-list
19800556|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19800557|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800558|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
20160070|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
20160071|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160072|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160073|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160074|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
20160075|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20160076|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160077|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20160078|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20160079|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19800559|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800560|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800561|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800562|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800563|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800564|NCT00390455|Fulvestrant|fulvestrant|mesh-list
19800565|NCT00390455|Lapatinib|lapatinib|mesh-list
19800566|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19800567|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800568|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19800569|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19800570|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
19644650|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325884|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20325885|NCT00745147|Laxatives|laxatives|mesh-list
20325886|NCT00745147|Lactulose|lactulose|mesh-list
20325887|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325888|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20325889|NCT00745173|Estrogens|estrogens|mesh-ancestor
20325890|NCT00745173|Hormones|hormones|mesh-ancestor
20325891|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325892|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325893|NCT00745186|Glucagon|glucagon|mesh-list
20325894|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20325895|NCT00745186|Hormones|hormones|mesh-ancestor
20325896|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20160080|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20160081|NCT00120536|Vildagliptin|vildagliptin|mesh-list
20160082|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20160083|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160084|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20160085|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160086|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160087|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160088|NCT00120601|Naltrexone|naltrexone|mesh-list
20160089|NCT00120601|Acamprosate|acamprosate|mesh-list
20160090|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20160091|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20160092|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160093|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
20160094|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160095|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20160096|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20160097|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20160098|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
20160099|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20160100|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160101|NCT00120640|Progestins|progestins|mesh-ancestor
20325897|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325898|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
20325899|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
20325900|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
20325901|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325902|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325903|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20325904|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
20325905|NCT00745225|Pioglitazone|pioglitazone|mesh-list
20325906|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325907|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325908|NCT00745407|Fenofibrate|fenofibrate|mesh-list
20325909|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20325910|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
20325911|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325912|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20325913|NCT00745433|Metformin|metformin|mesh-list
20325914|NCT00745433|Repaglinide|repaglinide|mesh-list
20325915|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325916|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325917|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
20325918|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20325919|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325920|NCT00745511|Bevacizumab|bevacizumab|mesh-list
20325921|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20325922|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644651|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644652|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19644653|NCT02372110|Caffeine|caffeine|mesh-list
19644654|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19644655|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644656|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19644657|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644658|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644659|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19644660|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19644661|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
19800571|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800572|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800573|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800574|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800575|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644662|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644663|NCT02372240|Dexamethasone|dexamethasone|mesh-list
19644664|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644665|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
19644666|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
19644667|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644668|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644669|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644670|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
19644671|NCT02372240|Hormones|hormones|mesh-ancestor
19644672|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644673|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19644674|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644675|NCT02372188|Caffeine|caffeine|mesh-list
19800576|NCT00390546|Propranolol|propranolol|mesh-list
19800577|NCT00390546|Digoxin|digoxin|mesh-list
19800578|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19800579|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19800580|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
19800581|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800582|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800583|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800584|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19800585|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19800586|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
20325923|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20325924|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20325925|NCT00745511|Growth Substances|growth substances|mesh-ancestor
20325926|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325927|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
20325928|NCT00745589|Sevelamer|sevelamer|mesh-list
20325929|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
20325930|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
20325931|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325932|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20325933|NCT00745693|BQ 788|bq 788|mesh-list
20325934|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19800587|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19800588|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800589|NCT00390546|Protective Agents|protective agents|mesh-ancestor
19800590|NCT00390559|Nicotine|nicotine|mesh-list
19800591|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19800592|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
19800593|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800594|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800595|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19800596|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19800597|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
19800598|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800599|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800600|NCT00390611|Paclitaxel|paclitaxel|mesh-list
19800601|NCT00390611|Carboplatin|carboplatin|mesh-list
19800602|NCT00390611|Sorafenib|sorafenib|mesh-list
19800603|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800604|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800605|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800606|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800607|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800608|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800609|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800610|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800611|NCT00390689|Pramipexole|pramipexole|mesh-list
19800612|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
19800613|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800614|NCT00390689|Protective Agents|protective agents|mesh-ancestor
19800615|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800616|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19644676|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19644677|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325935|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20160102|NCT00120640|Hormones|hormones|mesh-ancestor
20160103|NCT00120653|Metoclopramide|metoclopramide|mesh-list
20160104|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
20160105|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
20160106|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160107|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160108|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20160109|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20325936|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325937|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20325938|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
20325939|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
20325940|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325941|NCT00745914|Pioglitazone|pioglitazone|mesh-list
20325942|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325943|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325944|NCT00745953|Valsartan|valsartan|mesh-list
20325945|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20325946|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20325947|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20325948|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20325949|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325950|NCT00745953|Diuretics|diuretics|mesh-ancestor
20325951|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
20325952|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325953|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20160110|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19800617|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19800618|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
19800619|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
19800620|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800621|NCT00390780|Clotrimazole|clotrimazole|mesh-list
19800622|NCT00390780|Miconazole|miconazole|mesh-list
19800623|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19800624|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800625|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
19800626|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20325954|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20325955|NCT00746031|Goserelin|goserelin|mesh-list
20325956|NCT00746031|Cetrorelix|cetrorelix|mesh-list
20325957|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20325958|NCT00746031|Hormones|hormones|mesh-ancestor
20325959|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325960|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325961|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20325962|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20325963|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20325964|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
20325965|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20325966|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
20325967|NCT00746070|Spironolactone|spironolactone|mesh-list
20325968|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20325969|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
20325970|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325971|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325972|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20325973|NCT00746070|Diuretics|diuretics|mesh-ancestor
20325974|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
20325975|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
20325976|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20325977|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325978|NCT00746447|Mesalamine|mesalamine|mesh-list
19644678|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19644679|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644680|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644681|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19644682|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19644683|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
19644684|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644685|NCT02372292|Furosemide|furosemide|mesh-list
20160111|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
20325979|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644686|NCT02372292|Diuretics|diuretics|mesh-ancestor
20325980|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20325981|NCT00746447|Analgesics|analgesics|mesh-ancestor
20325982|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
20325983|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325984|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325985|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325986|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20325987|NCT00746486|Budesonide|budesonide|mesh-list
20325988|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20325989|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20325990|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
20325991|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20325992|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20325993|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20160112|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160113|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160114|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
20160115|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
19800627|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19800628|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800629|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800630|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19800631|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
20160116|NCT00120679|Hematinics|hematinics|mesh-ancestor
20160117|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
20160118|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
19800632|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800633|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800634|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20160119|NCT00120692|Hematinics|hematinics|mesh-ancestor
20160120|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
20160121|NCT00120705|Hematinics|hematinics|mesh-ancestor
20160122|NCT00120718|Fasudil|fasudil|mesh-list
20160123|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20160124|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160125|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20325994|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
20325995|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
20325996|NCT00746486|Hormones|hormones|mesh-ancestor
19800635|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19800636|NCT00390806|Topotecan|topotecan|mesh-list
19800637|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19800638|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20325997|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20325998|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
20325999|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19800639|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800640|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800641|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800642|NCT00390858|Deferasirox|deferasirox|mesh-list
19800643|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19800644|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
19800645|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
19800646|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800647|NCT00390884|Vaccines|vaccines|mesh-list
20160126|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20160127|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160128|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
20160129|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20160130|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800648|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
19800649|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800650|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19800651|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
19800652|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160131|NCT00120731|Acetazolamide|acetazolamide|mesh-list
20160132|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
20160133|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160134|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
20160135|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20160136|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160137|NCT00120731|Diuretics|diuretics|mesh-ancestor
20326000|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20326001|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
20160138|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
20160139|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160140|NCT00120731|Expectorants|expectorants|mesh-ancestor
20160141|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
20160142|NCT00120744|Ondansetron|ondansetron|mesh-list
20160143|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
20160144|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
20160145|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160146|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160147|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20160148|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
20160149|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160150|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20160151|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
20160152|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800653|NCT00391027|Insulin|insulin|mesh-list
19800654|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19800655|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
20160153|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160154|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20160155|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800656|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19800657|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800658|NCT00391053|Vaccines|vaccines|mesh-list
19800659|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
19800660|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800661|NCT00391079|Nabiximols|nabiximols|mesh-list
19800662|NCT00391079|Analgesics|analgesics|mesh-ancestor
19800663|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
19800664|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800665|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800666|NCT00391092|Bevacizumab|bevacizumab|mesh-list
19800667|NCT00391092|Trastuzumab|trastuzumab|mesh-list
19800668|NCT00391092|Docetaxel|docetaxel|mesh-list
19800669|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800670|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800671|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800672|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800673|NCT00391092|Growth Substances|growth substances|mesh-ancestor
19800674|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160156|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160157|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20326002|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326003|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20326004|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20326005|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326006|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347764|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20347765|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
20347766|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347767|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160158|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20160159|NCT00120757|Alendronate|alendronate|mesh-list
20160160|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20160161|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160162|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
20160163|NCT00120783|Ritonavir|ritonavir|mesh-list
20160164|NCT00120783|Indinavir|indinavir|mesh-list
20160165|NCT00120783|Lamivudine|lamivudine|mesh-list
20160166|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20160167|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160168|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160169|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160170|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160171|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20347768|NCT00861861|Atorvastatin|atorvastatin|mesh-list
20160172|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160173|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
20160174|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160175|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20347769|NCT00861861|Pitavastatin|pitavastatin|mesh-list
20160176|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160177|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160178|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160179|NCT00120796|Lamivudine|lamivudine|mesh-list
20160180|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160181|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160182|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800675|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800676|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800677|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800678|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800679|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800680|NCT00391118|Paclitaxel|paclitaxel|mesh-list
19800681|NCT00391118|Carboplatin|carboplatin|mesh-list
19800682|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20160183|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160184|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
20160185|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160186|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160187|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160188|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
20160189|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
20160190|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20160191|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
20160192|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20160193|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20160194|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160195|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20160196|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160197|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160198|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20160199|NCT00120809|Renal Agents|renal agents|mesh-ancestor
19800683|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800684|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800685|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800686|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800687|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800688|NCT00391222|Olanzapine|olanzapine|mesh-list
19800689|NCT00391222|Risperidone|risperidone|mesh-list
19800690|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19800691|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
19800692|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800693|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800694|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800695|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19800696|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800697|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800698|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800699|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19800700|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
19800701|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
19800702|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
19800703|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800704|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20160200|NCT00120822|Folic Acid|folic acid|mesh-list
20160201|NCT00120822|Hematinics|hematinics|mesh-ancestor
20160202|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
20160203|NCT00120822|Vitamins|vitamins|mesh-ancestor
20160204|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
19644687|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
19644688|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644689|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19644690|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19644691|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644692|NCT02372318|Nalmefene|nalmefene|mesh-list
19644693|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19644694|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644695|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
19800705|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19800706|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19800707|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19800708|NCT00391274|Docetaxel|docetaxel|mesh-list
19800709|NCT00391274|Pemetrexed|pemetrexed|mesh-list
19800710|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800711|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800712|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800713|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800714|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800715|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800716|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19800717|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19800718|NCT00391391|Vaccines|vaccines|mesh-list
19800719|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
19800720|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800721|NCT00391443|Bosentan|bosentan|mesh-list
19800722|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19800723|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19800724|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800725|NCT00391586|Gemcitabine|gemcitabine|mesh-list
19800726|NCT00391586|Paclitaxel|paclitaxel|mesh-list
19800727|NCT00391586|Etoposide|etoposide|mesh-list
19800728|NCT00391586|Vinorelbine|vinorelbine|mesh-list
19800729|NCT00391586|Docetaxel|docetaxel|mesh-list
19800730|NCT00391586|Irinotecan|irinotecan|mesh-list
19800731|NCT00391586|Pemetrexed|pemetrexed|mesh-list
19800732|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19800733|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800734|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800735|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800736|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800737|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
20326007|NCT00746655|Cisplatin|cisplatin|mesh-list
20326008|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326009|NCT00746681|Pregabalin|pregabalin|mesh-list
20326010|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20326011|NCT00746681|Analgesics|analgesics|mesh-ancestor
20326012|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
20326013|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326014|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800738|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160205|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160206|NCT00120835|Interferons|interferons|mesh-list
20160207|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160208|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
20160209|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160210|NCT00120861|Interferons|interferons|mesh-list
20160211|NCT00120861|Ribavirin|ribavirin|mesh-list
19800739|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800740|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
19800741|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
19800742|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800743|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800744|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800745|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
19800746|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800747|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19800748|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19800749|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19800750|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19800751|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19800752|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800753|NCT00391716|Gabapentin|gabapentin|mesh-list
19800754|NCT00391716|Analgesics|analgesics|mesh-ancestor
19800755|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
20160212|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160213|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
20160214|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160215|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
20160216|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160217|NCT00120887|Atorvastatin|atorvastatin|mesh-list
20160218|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20326015|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
19800756|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160219|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20160220|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
20326016|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20326017|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20326018|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326019|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20326020|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20326021|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20326022|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326023|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20326024|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20326025|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19800757|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800758|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
19800759|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19800760|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800761|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326026|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
20326027|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326028|NCT00746681|Urological Agents|urological agents|mesh-ancestor
20326029|NCT00746720|Etoricoxib|etoricoxib|mesh-list
20326030|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20326031|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326032|NCT00746720|Analgesics|analgesics|mesh-ancestor
19800762|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800763|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19800764|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19800765|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800766|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800767|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
19800768|NCT00391768|Oseltamivir|oseltamivir|mesh-list
20326033|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
20326034|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326035|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326036|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326037|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160221|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160222|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20160223|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20160224|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160225|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
20326038|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20326039|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20326040|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326041|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326042|NCT00746746|Interferons|interferons|mesh-list
20326043|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
20326044|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
20326045|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20326046|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326047|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
20326048|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326049|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
20326050|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326051|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
20326052|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20326053|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326054|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20326055|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19800769|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
19800770|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800771|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800772|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800773|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19800774|NCT00391807|Norethindrone|norethindrone|mesh-list
19800775|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
19800776|NCT00391807|Estradiol|estradiol|mesh-list
19800777|NCT00391807|Estrogens|estrogens|mesh-ancestor
19800778|NCT00391807|Hormones|hormones|mesh-ancestor
19800779|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800780|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160226|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20160227|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19800781|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19800782|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
19800783|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19800784|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19800785|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19800786|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19800787|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19800788|NCT00391846|Metoprolol|metoprolol|mesh-list
19800789|NCT00391846|Valsartan|valsartan|mesh-list
19800790|NCT00391846|Carvedilol|carvedilol|mesh-list
19800791|NCT00391846|Candesartan|candesartan|mesh-list
19800792|NCT00391846|Ramipril|ramipril|mesh-list
19800793|NCT00391846|Enalapril|enalapril|mesh-list
19800794|NCT00391846|Lisinopril|lisinopril|mesh-list
19800795|NCT00391846|Eplerenone|eplerenone|mesh-list
19800796|NCT00391846|Bisoprolol|bisoprolol|mesh-list
19800797|NCT00391846|Captopril|captopril|mesh-list
19800798|NCT00391846|Trandolapril|trandolapril|mesh-list
19800799|NCT00391846|Spironolactone|spironolactone|mesh-list
19800800|NCT00391846|Diuretics|diuretics|mesh-list
20326056|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
20326057|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326058|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
19644696|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644697|NCT02372357|Posaconazole|posaconazole|mesh-list
19644698|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
19644699|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644700|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19644701|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19644702|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19644703|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19644704|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19644705|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644706|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644707|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19644708|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
19644709|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644710|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644711|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
19644712|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19800801|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19800802|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19800803|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19800804|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800805|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19800806|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
19800807|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
19800808|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800809|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800810|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19800811|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19800812|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19800813|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
19800814|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800815|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19800816|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
19800817|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800818|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19800819|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
19800820|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
19800821|NCT00391846|Protective Agents|protective agents|mesh-ancestor
19800822|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19800823|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19800824|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19800825|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
20160228|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
20160229|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20160230|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160231|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
20160232|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160233|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20160234|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160235|NCT00120952|Cobalt|cobalt|mesh-list
20160236|NCT00120952|Chromium|chromium|mesh-list
20160237|NCT00120952|Trace Elements|trace elements|mesh-ancestor
20160238|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
20160239|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326059|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
20326060|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20326061|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20160240|NCT00120978|Fluticasone|fluticasone|mesh-list
20160241|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20160242|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
20160243|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160244|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160245|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20160246|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
20160247|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20160248|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160249|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20160250|NCT00121017|Ritonavir|ritonavir|mesh-list
20160251|NCT00121017|Lopinavir|lopinavir|mesh-list
20160252|NCT00121017|Tenofovir|tenofovir|mesh-list
20160253|NCT00121017|Emtricitabine|emtricitabine|mesh-list
20160254|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20160255|NCT00121017|Efavirenz|efavirenz|mesh-list
20160256|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20160257|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160258|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160259|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160260|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160261|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160262|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160263|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
20160264|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160265|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20160266|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160267|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20326062|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326063|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326064|NCT00746967|Urological Agents|urological agents|mesh-ancestor
20326065|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
20326066|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20326067|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160268|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160269|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20160270|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20160271|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20160272|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20160273|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20160274|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
19800826|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19800827|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19800828|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20160275|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
20160276|NCT00121030|Hematinics|hematinics|mesh-ancestor
20160277|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20160278|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160279|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20160280|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160281|NCT00121069|Citalopram|citalopram|mesh-list
20160282|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20160283|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20160284|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160285|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160286|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160287|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
20160288|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160289|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20160290|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
20160291|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800829|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
19800830|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800831|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19800832|NCT00391872|Clopidogrel|clopidogrel|mesh-list
19800833|NCT00391872|Ticagrelor|ticagrelor|mesh-list
19800834|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19800835|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19800836|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20160292|NCT00121095|Docetaxel|docetaxel|mesh-list
19800837|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19800838|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
19800839|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800840|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800841|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800842|NCT00391898|Levodopa|levodopa|mesh-list
19800843|NCT00391898|Carbidopa|carbidopa|mesh-list
19800844|NCT00391898|Entacapone|entacapone|mesh-list
19800845|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19800846|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19800847|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
19800848|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800849|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800850|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800851|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19800852|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800853|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19800854|NCT00391976|Tobramycin|tobramycin|mesh-list
19800855|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19800856|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800857|NCT00391989|Dasatinib|dasatinib|mesh-list
19800858|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800859|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800860|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800861|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800862|NCT00392041|Eszopiclone|eszopiclone|mesh-list
19800863|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19800864|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800865|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800866|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19800867|NCT00392171|Temozolomide|temozolomide|mesh-list
19800868|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19800869|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
19800870|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800871|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800872|NCT00392197|Aripiprazole|aripiprazole|mesh-list
19800873|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
19800874|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19800875|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19800876|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19800877|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19800878|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800879|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
19800880|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
20160293|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
20160294|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160295|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20160296|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
20160297|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
20160298|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160299|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20160300|NCT00121095|Analgesics|analgesics|mesh-ancestor
20160301|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
20160302|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160303|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160304|NCT00121147|Travoprost|travoprost|mesh-list
20160305|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20160306|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20160307|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19644713|NCT02372149|Antibodies|antibodies|mesh-list
19644714|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
19644715|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19644716|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
20160308|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20160309|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20160310|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
20160311|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160312|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160313|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160314|NCT00121264|Sorafenib|sorafenib|mesh-list
20160315|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160316|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800881|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19800882|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160317|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160318|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160319|NCT00121277|Capecitabine|capecitabine|mesh-list
20160320|NCT00121277|Vorinostat|vorinostat|mesh-list
20160321|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20160322|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
20160323|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160324|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160325|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20160326|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160327|NCT00121303|Cytarabine|cytarabine|mesh-list
20160328|NCT00121303|Daunorubicin|daunorubicin|mesh-list
20160329|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
20160330|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20160331|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
20160332|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160333|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160334|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
19800883|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19800884|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19800885|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
19800886|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20326068|NCT00747097|Gemcitabine|gemcitabine|mesh-list
20326069|NCT00747097|Cetuximab|cetuximab|mesh-list
20326070|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326071|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
19800887|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19800888|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19800889|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19800890|NCT00392223|Azithromycin|azithromycin|mesh-list
19800891|NCT00392223|Minocycline|minocycline|mesh-list
19800892|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19800893|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19800894|NCT00392288|Ciclesonide|ciclesonide|mesh-list
19800895|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
19800896|NCT00392288|Hormones|hormones|mesh-ancestor
19800897|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19800898|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800899|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19800900|NCT00392379|Nicotine|nicotine|mesh-list
19800901|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19800902|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
20160335|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160336|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160337|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
20160338|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160339|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20160340|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20160341|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20160342|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160343|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20160344|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
20160345|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20160346|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20160347|NCT00121316|Analgesics|analgesics|mesh-ancestor
20160348|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
20160349|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160350|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160351|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20160352|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160353|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160354|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800903|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347770|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20326072|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326073|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326074|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
20326075|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326076|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326077|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326078|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
20326079|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326080|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20326081|NCT00747110|Budesonide|budesonide|mesh-list
20160355|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
20160356|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20160357|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160358|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160359|NCT00121329|Lidocaine|lidocaine|mesh-list
19800904|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800905|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19800906|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19800907|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
19800908|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326082|NCT00747110|Mesalamine|mesalamine|mesh-list
20326083|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326084|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20326085|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
20326086|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326087|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326088|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20326089|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
20326090|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
20326091|NCT00747110|Hormones|hormones|mesh-ancestor
20326092|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20326093|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20611586|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19800909|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800910|NCT00392392|Paclitaxel|paclitaxel|mesh-list
19800911|NCT00392392|Bevacizumab|bevacizumab|mesh-list
19800912|NCT00392392|Trastuzumab|trastuzumab|mesh-list
19800913|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800914|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160360|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
20160361|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
20160362|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160363|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160364|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
20160365|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160366|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20160367|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20160368|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20160369|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160370|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160371|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
20160372|NCT00121381|Tacrolimus|tacrolimus|mesh-list
20160373|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19800915|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800916|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800917|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800918|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800919|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800920|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800921|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800922|NCT00392392|Growth Substances|growth substances|mesh-ancestor
19800923|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800924|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
19644717|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644718|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
19644719|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19644720|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
19644721|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644722|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644723|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19644724|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
19644725|NCT02371993|Choline|choline|mesh-list
20326094|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20160374|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20160375|NCT00121381|Analgesics|analgesics|mesh-ancestor
20160376|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
20160377|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160378|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160379|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20160380|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160381|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160382|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160383|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
20160384|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20160385|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174252|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326095|NCT00747110|Analgesics|analgesics|mesh-ancestor
20326096|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
20326097|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326098|NCT00747279|Insulin|insulin|mesh-list
20326099|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20326100|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326101|NCT00747305|Sunitinib|sunitinib|mesh-list
20326102|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326103|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20326104|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20326105|NCT00747305|Growth Substances|growth substances|mesh-ancestor
20326106|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326107|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
20326108|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326109|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326110|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326111|NCT00747331|Fenoldopam|fenoldopam|mesh-list
20326112|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326113|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
20326114|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
20326115|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
20326116|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326117|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326118|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326119|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20326120|NCT00747383|Glimepiride|glimepiride|mesh-list
20326121|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20326122|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326123|NCT00747383|Incretins|incretins|mesh-ancestor
20326124|NCT00747383|Hormones|hormones|mesh-ancestor
20326125|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20326126|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20326127|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
20326128|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326129|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326130|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20326131|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611587|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
20611588|NCT00644228|Hormones|hormones|mesh-ancestor
20611589|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611590|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20611591|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644726|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
19644727|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19644728|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
19644729|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644730|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644731|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19644732|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
19663945|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19663946|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
19663947|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663948|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663949|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663950|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
19663951|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19663952|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
19663953|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663954|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
19663955|NCT05086939|Protective Agents|protective agents|mesh-ancestor
19663956|NCT05083325|Oseltamivir|oseltamivir|mesh-list
19800925|NCT00392444|Sunitinib|sunitinib|mesh-list
19800926|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800927|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800928|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800929|NCT00392444|Growth Substances|growth substances|mesh-ancestor
19800930|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800931|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800932|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800933|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160386|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160387|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
20160388|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20160389|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160390|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
20160391|NCT00121407|Verteporfin|verteporfin|mesh-list
20160392|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20160393|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160394|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
20160395|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160396|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19800934|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800935|NCT00392496|Sunitinib|sunitinib|mesh-list
20326132|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
20326133|NCT00747409|Insulin|insulin|mesh-list
20326134|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20326135|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
20326136|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
20326137|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
20326138|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20326139|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
19800936|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800937|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800938|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800939|NCT00392496|Growth Substances|growth substances|mesh-ancestor
19800940|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800941|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800942|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800943|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800944|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800945|NCT00392665|Sulindac|sulindac|mesh-list
19800946|NCT00392665|Bevacizumab|bevacizumab|mesh-list
19800947|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19800948|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800949|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800950|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800951|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800952|NCT00392665|Growth Substances|growth substances|mesh-ancestor
19800953|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800954|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
19800955|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19800956|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800957|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800958|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19800959|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19800960|NCT00392665|Analgesics|analgesics|mesh-ancestor
20326140|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
20326141|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
20326142|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20326143|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800961|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
19800962|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800963|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19800964|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800965|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19800966|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19800967|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
19800968|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19800969|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19800970|NCT00392678|Analgesics|analgesics|mesh-ancestor
20160397|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
20326144|NCT00747487|Idebenone|idebenone|mesh-list
20160398|NCT00121446|Enoxaparin|enoxaparin|mesh-list
20160399|NCT00121446|Tenecteplase|tenecteplase|mesh-list
20160400|NCT00121446|Clopidogrel|clopidogrel|mesh-list
20326145|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
20326146|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326147|NCT00747487|Protective Agents|protective agents|mesh-ancestor
20326148|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644733|NCT02371577|Lenalidomide|lenalidomide|mesh-list
19644734|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
19644735|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644736|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19644737|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19644738|NCT02371577|Growth Substances|growth substances|mesh-ancestor
19644739|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
19644740|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644741|NCT02371603|Pioglitazone|pioglitazone|mesh-list
19644742|NCT02371603|Trimethoprim|trimethoprim|mesh-list
19644743|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19644744|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19644745|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19800971|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
19800972|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19800973|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800974|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19800975|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19800976|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19800977|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19800978|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800979|NCT00392704|Paclitaxel|paclitaxel|mesh-list
19800980|NCT00392704|Bevacizumab|bevacizumab|mesh-list
19800981|NCT00392704|Fluorouracil|fluorouracil|mesh-list
19800982|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19800983|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19800984|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19800985|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
19800986|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
19800987|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
19800988|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19800989|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19800990|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19800991|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19800992|NCT00392704|Growth Substances|growth substances|mesh-ancestor
19800993|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19800994|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
20160401|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20160402|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20160403|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20160404|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20160405|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
20160406|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160407|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160408|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326149|NCT00747526|Rabeprazole|rabeprazole|mesh-list
20160409|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
20326150|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20326151|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20326152|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19644746|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
20160410|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20160411|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20160412|NCT00121459|Psyllium|psyllium|mesh-list
20160413|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
20160414|NCT00121459|Cathartics|cathartics|mesh-ancestor
20160415|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19800995|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
19800996|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19800997|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19800998|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
19800999|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19801000|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801001|NCT00392769|Cetuximab|cetuximab|mesh-list
19801002|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801003|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801004|NCT00392782|Fludarabine|fludarabine|mesh-list
19801005|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
19801006|NCT00392782|Thiotepa|thiotepa|mesh-list
19801007|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19801008|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801009|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801010|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
20160416|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
20160417|NCT00121498|Lidocaine|lidocaine|mesh-list
20160418|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
20160419|NCT00121498|Anesthetics|anesthetics|mesh-list
20160420|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160421|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160422|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
20160423|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160424|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20160425|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20160426|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20160427|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160428|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326153|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326154|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326155|NCT00747539|Interferons|interferons|mesh-list
20326156|NCT00747539|Ribavirin|ribavirin|mesh-list
20326157|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
20326158|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326159|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
20326160|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326161|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
20326162|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326163|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
20326164|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326165|NCT00747604|Mecasermin|mecasermin|mesh-list
20326166|NCT00747604|Growth Substances|growth substances|mesh-ancestor
20326167|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326168|NCT00747669|Lidocaine|lidocaine|mesh-list
20326169|NCT00747669|Tetracaine|tetracaine|mesh-list
20326170|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
19644747|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644748|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19644749|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19644750|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644751|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644752|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644753|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19644754|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644755|NCT02371603|Renal Agents|renal agents|mesh-ancestor
19644756|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
19644757|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19644758|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19644759|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19644760|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19644761|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20160429|NCT00121511|Fluorouracil|fluorouracil|mesh-list
20160430|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
20326171|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
20326172|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326173|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326174|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
20326175|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326176|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20326177|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20326178|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20326179|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20326180|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326181|NCT00747695|Rabeprazole|rabeprazole|mesh-list
20326182|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20160431|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160432|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20160433|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644762|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19644763|NCT02371590|Lenalidomide|lenalidomide|mesh-list
19644764|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
19644765|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
19644766|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644767|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19644768|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20160434|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160435|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
20160436|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801011|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801012|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19801013|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
19801014|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801015|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19801016|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
19801017|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19801018|NCT00392834|Leucovorin|leucovorin|mesh-list
19801019|NCT00392834|Cytarabine|cytarabine|mesh-list
20160437|NCT00121524|Atropine|atropine|mesh-list
20160438|NCT00121524|Amiodarone|amiodarone|mesh-list
20160439|NCT00121524|Epinephrine|epinephrine|mesh-list
20160440|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20160441|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19801020|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
20160442|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
19644769|NCT02371590|Growth Substances|growth substances|mesh-ancestor
19644770|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
19644771|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160443|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160444|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160445|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160446|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20160447|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20160448|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
20160449|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160450|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20160451|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
20160452|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
20160453|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
20160454|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20160455|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20160456|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20160457|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
20326183|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644772|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19644773|NCT02371473|Acetazolamide|acetazolamide|mesh-list
19644774|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
20160458|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20160459|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20160460|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
20160461|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
20160462|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20160463|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160464|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20160465|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20160466|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160467|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347771|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19644775|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20160468|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20326184|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19644776|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644777|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644778|NCT02371473|Diuretics|diuretics|mesh-ancestor
20326185|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326186|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160469|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20160470|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20160471|NCT00121550|Clarithromycin|clarithromycin|mesh-list
20326187|NCT00747708|Sargramostim|sargramostim|mesh-list
20326188|NCT00747708|Lenograstim|lenograstim|mesh-list
20326189|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
20326190|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326191|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20326192|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
20326193|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20326194|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19644779|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
20160472|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20160473|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160474|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19644780|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644781|NCT02371421|Allopurinol|allopurinol|mesh-list
19644782|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
19644783|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644784|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644785|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
19644786|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644787|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19644788|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
19644789|NCT02371421|Protective Agents|protective agents|mesh-ancestor
19644790|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644791|NCT02371408|Ribavirin|ribavirin|mesh-list
19644792|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
19644793|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
19644794|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644795|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
19644796|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644797|NCT02371226|Insulin|insulin|mesh-list
19644798|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19644799|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644800|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644801|NCT02371304|Capecitabine|capecitabine|mesh-list
19644802|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19644803|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
19644804|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644805|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644806|NCT02371096|Rituximab|rituximab|mesh-list
19644807|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19644808|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160475|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801021|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19801022|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19801023|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19801024|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
19801025|NCT00392834|Ifosfamide|ifosfamide|mesh-list
19801026|NCT00392834|Rituximab|rituximab|mesh-list
19801027|NCT00392834|Doxorubicin|doxorubicin|mesh-list
20160476|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160477|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20160478|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160479|NCT00121563|Thalidomide|thalidomide|mesh-list
20160480|NCT00121563|Ibuprofen|ibuprofen|mesh-list
20160481|NCT00121563|Diazepam|diazepam|mesh-list
20160482|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20160483|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20160484|NCT00121563|Analgesics|analgesics|mesh-ancestor
20160485|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
20160486|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160487|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160488|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20160489|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644809|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
19644810|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644811|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801028|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19644812|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20160490|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20160491|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160492|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160493|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160494|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
20160495|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
20160496|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20160497|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160498|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20160499|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20160500|NCT00121563|Growth Substances|growth substances|mesh-ancestor
20160501|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
20160502|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160503|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20160504|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
20160505|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
19644813|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
19644814|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644815|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644816|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644817|NCT02371148|Rituximab|rituximab|mesh-list
19644818|NCT02371148|Bortezomib|bortezomib|mesh-list
19644819|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19644820|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20160506|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
20160507|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20160508|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20160509|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160510|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20160511|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20160512|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20160513|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19801029|NCT00392834|Methotrexate|methotrexate|mesh-list
19801030|NCT00392834|Etoposide|etoposide|mesh-list
19801031|NCT00392834|Vincristine|vincristine|mesh-list
19801032|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
19801033|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19801034|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
19801035|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801036|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801037|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19801038|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
19801039|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801040|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801041|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19801042|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801043|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19801044|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19801045|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19801046|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801047|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19801048|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
19801049|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801050|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801051|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
19801052|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
19801053|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19801054|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19801055|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19801056|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
19801057|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160514|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160515|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20160516|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
20160517|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
20160518|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
20160519|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
20160520|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160521|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
20160522|NCT00121602|Hematinics|hematinics|mesh-ancestor
19644821|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801058|NCT00392834|Antidotes|antidotes|mesh-ancestor
20160523|NCT00121615|Etanercept|etanercept|mesh-list
20160524|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20160525|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19801059|NCT00392834|Protective Agents|protective agents|mesh-ancestor
19801060|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
19801061|NCT00392834|Vitamins|vitamins|mesh-ancestor
19801062|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
19801063|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
19801064|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
19801065|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801066|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19801067|NCT00392925|Pramlintide|pramlintide|mesh-list
19801068|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
19801069|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801070|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801071|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
19801072|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19801073|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
20160526|NCT00121615|Analgesics|analgesics|mesh-ancestor
20160527|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
20160528|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160529|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160530|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20160531|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160532|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20160533|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160534|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
20160535|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
20160536|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20160537|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160538|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160539|NCT00121680|Lenvatinib|lenvatinib|mesh-list
20160540|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326195|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326196|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326197|NCT00747721|Analgesics|analgesics|mesh-ancestor
20326198|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
20326199|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326200|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20611592|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
20611593|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611594|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611595|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
19644822|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
19644823|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326201|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20326202|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20326203|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
20326204|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326205|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326206|NCT00747799|Fluorouracil|fluorouracil|mesh-list
20326207|NCT00747799|Sorafenib|sorafenib|mesh-list
20326208|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326209|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
20326210|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326211|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326212|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326213|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
20326214|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611596|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611597|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19644824|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644825|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19644826|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
19644827|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644828|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
19644829|NCT02370862|Neostigmine|neostigmine|mesh-list
19644830|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19644831|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644832|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644833|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
19801074|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801075|NCT00392951|Sirolimus|sirolimus|mesh-list
20611598|NCT00644228|Growth Substances|growth substances|mesh-ancestor
20611599|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
20160541|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20160542|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160543|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160544|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
20160545|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20160546|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160547|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20160548|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
20160549|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20160550|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160551|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160552|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160553|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20160554|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801076|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19801077|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801078|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19801079|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801080|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
19801081|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326215|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326216|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326217|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
19801082|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
19801083|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801084|NCT00392990|Cytarabine|cytarabine|mesh-list
19801085|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
19801086|NCT00392990|Ifosfamide|ifosfamide|mesh-list
19801087|NCT00392990|Rituximab|rituximab|mesh-list
20326218|NCT00747877|Melphalan|melphalan|mesh-list
20326219|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326220|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
20326221|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326222|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326223|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19801088|NCT00392990|Doxorubicin|doxorubicin|mesh-list
19801089|NCT00392990|Methotrexate|methotrexate|mesh-list
19801090|NCT00392990|Etoposide|etoposide|mesh-list
19801091|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
19801092|NCT00392990|Vincristine|vincristine|mesh-list
19801093|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19801094|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
19801095|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19801096|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
20160555|NCT00121875|Hormones|hormones|mesh-list
20160556|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20160557|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160558|NCT00121888|Paroxetine|paroxetine|mesh-list
20160559|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20160560|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20160561|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160562|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326224|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
20326225|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326226|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326227|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20326228|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20326229|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20326230|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160563|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160564|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
19644834|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644835|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644836|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19644837|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
19644838|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644839|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19644840|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19644841|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19644842|NCT02370680|Aspirin|aspirin|mesh-list
19644843|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644844|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644845|NCT02370680|Analgesics|analgesics|mesh-ancestor
19801097|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160565|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160566|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20160567|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
20160568|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160569|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19801098|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801099|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19801100|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
20326231|NCT00747968|Exenatide|exenatide|mesh-list
20326232|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20326233|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326234|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20326235|NCT00747968|Incretins|incretins|mesh-ancestor
19801101|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801102|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801103|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19801104|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20326236|NCT00747968|Hormones|hormones|mesh-ancestor
20326237|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20326238|NCT00748007|Rivastigmine|rivastigmine|mesh-list
20326239|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
20326240|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326241|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326242|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
20326243|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326244|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326245|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20326246|NCT00748007|Protective Agents|protective agents|mesh-ancestor
20326247|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20326248|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326249|NCT00748059|Propranolol|propranolol|mesh-list
20326250|NCT00748059|Atropine|atropine|mesh-list
20326251|NCT00748059|Clonidine|clonidine|mesh-list
20326252|NCT00748059|Nitroprusside|nitroprusside|mesh-list
20326253|NCT00748059|Methyldopa|methyldopa|mesh-list
20326254|NCT00748059|Phenylephrine|phenylephrine|mesh-list
20326255|NCT00748059|Isoproterenol|isoproterenol|mesh-list
20326256|NCT00748059|Metoclopramide|metoclopramide|mesh-list
20326257|NCT00748059|Yohimbine|yohimbine|mesh-list
20326258|NCT00748059|Tyramine|tyramine|mesh-list
20326259|NCT00748059|Edrophonium|edrophonium|mesh-list
20326260|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20326261|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20326262|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
20326263|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326264|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326265|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326266|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20326267|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326268|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
19644846|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
19644847|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801105|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19801106|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19801107|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19801108|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160570|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160571|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160572|NCT00121914|Ethanol|ethanol|mesh-list
20160573|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20160574|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160575|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160576|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174253|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
20174254|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
19644848|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644849|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644850|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644851|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19644852|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19644853|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644854|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20174255|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20326269|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20326270|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
20326271|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
20347772|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
20326272|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326273|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
20326274|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20326275|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
20326276|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
20160577|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
20160578|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20160579|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160580|NCT00121966|Insulin|insulin|mesh-list
20160581|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20160582|NCT00121966|Metformin|metformin|mesh-list
20160583|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
20160584|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
20160585|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
20160586|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
20160587|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
20160588|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20326277|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20326278|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20326279|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20160589|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160590|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20160591|NCT00121979|Racivir|racivir|mesh-list
20160592|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160593|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160594|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160595|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
20160596|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326280|NCT00748059|Protective Agents|protective agents|mesh-ancestor
20326281|NCT00748059|Analgesics|analgesics|mesh-ancestor
20326282|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
20326283|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
20326284|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20326285|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20326286|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20326287|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20326288|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
20326289|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20326290|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20326291|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
20326292|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
20326293|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20326294|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20326295|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20326296|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
20326297|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20326298|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20326299|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20326300|NCT00748059|Urological Agents|urological agents|mesh-ancestor
20326301|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20326302|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20326303|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20326304|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20326305|NCT00748059|Antidotes|antidotes|mesh-ancestor
20326306|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20326307|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326308|NCT00748150|Vaccines|vaccines|mesh-list
20326309|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
20326310|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326311|NCT00748163|Paclitaxel|paclitaxel|mesh-list
20326312|NCT00748163|Sunitinib|sunitinib|mesh-list
20326313|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20326314|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20326315|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326316|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
20326317|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
20160597|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
20160598|NCT00122018|Fenoldopam|fenoldopam|mesh-list
20160599|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20160600|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
20160601|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160602|NCT00122018|Expectorants|expectorants|mesh-ancestor
20160603|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
20326318|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
20160604|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20160605|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
20160606|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611600|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
20326319|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326320|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20326321|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20326322|NCT00748163|Growth Substances|growth substances|mesh-ancestor
20326323|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326324|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
20160607|NCT00122018|Protective Agents|protective agents|mesh-ancestor
20160608|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160609|NCT00122018|Antidotes|antidotes|mesh-ancestor
20160610|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20160611|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
19801109|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19801110|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
19801111|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801112|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801113|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
19801114|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
19801115|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19801116|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19801117|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19801118|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
19801119|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801120|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
19801121|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
19801122|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801123|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
20326325|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326326|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326327|NCT00748176|Anesthetics|anesthetics|mesh-list
20326328|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326329|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326330|NCT00748202|Complement C1s|complement c1s|mesh-list
20326331|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20326332|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20326333|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
20326334|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326335|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20326336|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326337|NCT00748345|Caspofungin|caspofungin|mesh-list
20326338|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
20326339|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326340|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326341|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326342|NCT00748358|Sunitinib|sunitinib|mesh-list
20326343|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326344|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20326345|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20326346|NCT00748358|Growth Substances|growth substances|mesh-ancestor
20326347|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801124|NCT00393029|Aldesleukin|aldesleukin|mesh-list
19801125|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
20160612|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
20326348|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
20326349|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326350|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326351|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326352|NCT00748371|Aspirin|aspirin|mesh-list
20326353|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20326354|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326355|NCT00748371|Analgesics|analgesics|mesh-ancestor
20326356|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
20326357|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160613|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
20160614|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160615|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
20160616|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20160617|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20160618|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20160619|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20160620|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
20160621|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160622|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160623|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160624|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20160625|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160626|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20160627|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
20326358|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326359|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326360|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160628|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160629|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20160630|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20160631|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160632|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160633|NCT00122096|Valdecoxib|valdecoxib|mesh-list
20160634|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20160635|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20160636|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160637|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160638|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20160639|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20160640|NCT00122096|Analgesics|analgesics|mesh-ancestor
20326361|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20326362|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20326363|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326364|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20326365|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20326366|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326367|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
20326368|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
20326369|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20326370|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
20326371|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326372|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326373|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20326374|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
20326375|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20326376|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
20326377|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326378|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644855|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19644856|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644857|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
19644858|NCT02370745|Insulin|insulin|mesh-list
19644859|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19644860|NCT02370745|Incretins|incretins|mesh-list
19644861|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19644862|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644863|NCT02370745|Hormones|hormones|mesh-ancestor
19644864|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644865|NCT02370758|Valganciclovir|valganciclovir|mesh-list
19644866|NCT02370758|Ganciclovir|ganciclovir|mesh-list
19644867|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19644868|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
19644869|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644870|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19644871|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663957|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
19663958|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19663959|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663960|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663961|NCT05060484|Vaccines|vaccines|mesh-list
19663962|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
19663963|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663964|NCT05057572|Carvedilol|carvedilol|mesh-list
19663965|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19663966|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19663967|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
19663968|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19663969|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663970|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663971|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19663972|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
19663973|NCT05057572|Protective Agents|protective agents|mesh-ancestor
19663974|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19663975|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19663976|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19644872|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644873|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
19644874|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644875|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19644876|NCT02370550|Cyclosporine|cyclosporine|mesh-list
19644877|NCT02370550|Prednisone|prednisone|mesh-list
20160641|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
20160642|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160643|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801126|NCT00393029|Fludarabine|fludarabine|mesh-list
19801127|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
19801128|NCT00393029|Interleukin-2|interleukin-2|mesh-list
19801129|NCT00393029|Lenograstim|lenograstim|mesh-list
19801130|NCT00393029|Sargramostim|sargramostim|mesh-list
19801131|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19801132|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
19801133|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801134|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801135|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20160644|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20160645|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20160646|NCT00122226|Ritonavir|ritonavir|mesh-list
19801136|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
20160647|NCT00122226|Lopinavir|lopinavir|mesh-list
20160648|NCT00122226|Lamivudine|lamivudine|mesh-list
20160649|NCT00122226|Zidovudine|zidovudine|mesh-list
20160650|NCT00122226|Nevirapine|nevirapine|mesh-list
19801137|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801138|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801139|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19801140|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801141|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
19801142|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19801143|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19801144|NCT00393029|Analgesics|analgesics|mesh-ancestor
19801145|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
19801146|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160651|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20160652|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160653|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160654|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160655|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644878|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
19644879|NCT02370550|Calcium|calcium|mesh-list
19644880|NCT02370550|Cyclosporins|cyclosporins|mesh-list
19644881|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19644882|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644883|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644884|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
19644885|NCT02370550|Hormones|hormones|mesh-ancestor
19644886|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644887|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19644888|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644889|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644890|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644891|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19644892|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
19644893|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
19644894|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644895|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
19644896|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644897|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19644898|NCT02370550|Antacids|antacids|mesh-ancestor
19644899|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19644900|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
19644901|NCT02370433|Neostigmine|neostigmine|mesh-list
19644902|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19644903|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801147|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19801148|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160656|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19801149|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
19801150|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801151|NCT00393042|Amphetamine|amphetamine|mesh-list
19801152|NCT00393042|Adderall|adderall|mesh-list
19801153|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19801154|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19801155|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801156|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
20326379|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20326380|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
20326381|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
20326382|NCT00748423|Protective Agents|protective agents|mesh-ancestor
20326383|NCT00748436|Betahistine|betahistine|mesh-list
20326384|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
20326385|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
20326386|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
20326387|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326388|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326389|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347773|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347774|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20347775|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20347776|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347777|NCT00861874|Sirolimus|sirolimus|mesh-list
20347778|NCT00861874|Decitabine|decitabine|mesh-list
20347779|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20347780|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
20347781|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347782|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347783|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347784|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347785|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347786|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20160657|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160658|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
20160659|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160660|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20160661|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160662|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160663|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160664|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
20160665|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20160666|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20160667|NCT00122291|Capecitabine|capecitabine|mesh-list
20160668|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20160669|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
20160670|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174256|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
19801157|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
19801158|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801159|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
19801160|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801161|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347787|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
20347788|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347789|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
20347790|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347791|NCT00861887|Vancomycin|vancomycin|mesh-list
20347792|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347793|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347794|NCT00861926|Beclomethasone|beclomethasone|mesh-list
20347795|NCT00861926|Albuterol|albuterol|mesh-list
20347796|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
19644904|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644905|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
19644906|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19644907|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644908|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19644909|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
19644910|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644911|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19644912|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19801162|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347797|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19801163|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19801164|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19801165|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801166|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19801167|NCT00393094|Bevacizumab|bevacizumab|mesh-list
19801168|NCT00393094|Irinotecan|irinotecan|mesh-list
19801169|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801170|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801171|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801172|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801173|NCT00393094|Growth Substances|growth substances|mesh-ancestor
20160671|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160672|NCT00122304|Eculizumab|eculizumab|mesh-list
20160673|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20160674|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160675|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
19801174|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801175|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801176|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19801177|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19801178|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801179|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801180|NCT00393367|Prednisone|prednisone|mesh-list
19801181|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
19801182|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19801183|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19801184|NCT00393367|Prednisolone|prednisolone|mesh-list
19801185|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
20326390|NCT00748527|Carboplatin|carboplatin|mesh-list
20326391|NCT00748527|Decitabine|decitabine|mesh-list
20326392|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326393|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326394|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
20326395|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326396|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326397|NCT00748618|Vitamin D|vitamin d|mesh-list
20326398|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
20326399|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
20326400|NCT00748618|Vitamins|vitamins|mesh-list
20326401|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
20326402|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326403|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20326404|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20326405|NCT00748644|Rituximab|rituximab|mesh-list
20326406|NCT00748644|Azathioprine|azathioprine|mesh-list
20326407|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20326408|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326409|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
20326410|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326411|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326412|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
20326413|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326414|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326415|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326416|NCT00748787|Psyllium|psyllium|mesh-list
20326417|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
19801186|NCT00393367|Budesonide|budesonide|mesh-list
19801187|NCT00393367|Bromides|bromides|mesh-list
20160676|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160677|NCT00122330|Eculizumab|eculizumab|mesh-list
20160678|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20160679|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160680|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
20160681|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160682|NCT00122343|Sirolimus|sirolimus|mesh-list
20326418|NCT00748787|Cathartics|cathartics|mesh-ancestor
20326419|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20326420|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
20160683|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20326421|NCT00748891|Cediranib|cediranib|mesh-list
20160684|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160685|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20160686|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160687|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
20160688|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160689|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
20160690|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160691|NCT00122356|Alendronate|alendronate|mesh-list
20160692|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19801188|NCT00393367|Albuterol|albuterol|mesh-list
19801189|NCT00393367|Ipratropium|ipratropium|mesh-list
19801190|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19801191|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
19801192|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19801193|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
19801194|NCT00393367|Hormones|hormones|mesh-ancestor
19801195|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801196|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801197|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20326422|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326423|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326424|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326425|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801198|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801199|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
19801200|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
19801201|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801202|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19801203|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19801204|NCT00393367|Protective Agents|protective agents|mesh-ancestor
20160693|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160694|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
20160695|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20160696|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
20160697|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160698|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160699|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20160700|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
20326426|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
20326427|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
20326428|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
20326429|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326430|NCT00749021|Ranibizumab|ranibizumab|mesh-list
20326431|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20326432|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20326433|NCT00749021|Growth Substances|growth substances|mesh-ancestor
20326434|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326435|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
20326436|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326437|NCT00749047|Pioglitazone|pioglitazone|mesh-list
20326438|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20326439|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326440|NCT00749099|Pancrelipase|pancrelipase|mesh-list
19801205|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19801206|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19801207|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
19801208|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
19801209|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
19801210|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801211|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19801212|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19801213|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19801214|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
20160701|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
20326441|NCT00749099|Pancreatin|pancreatin|mesh-list
19801215|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801216|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801217|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19801218|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
20326442|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20326443|NCT00749112|Rituximab|rituximab|mesh-list
20326444|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
20326445|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20326446|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326447|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
20326448|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326449|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326450|NCT00749138|Tamoxifen|tamoxifen|mesh-list
20326451|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20326452|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
20326453|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20326454|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326455|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20326456|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326457|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20326458|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20326459|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20326460|NCT00749346|Pemetrexed|pemetrexed|mesh-list
20326461|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326462|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326463|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801219|NCT00393380|Teriparatide|teriparatide|mesh-list
19801220|NCT00393380|Hormones|hormones|mesh-list
19801221|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
19801222|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801223|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801224|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19801225|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19801226|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
19801227|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19801228|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
19801229|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801230|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801231|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19801232|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
19801233|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19801234|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19801235|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19801236|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
19801237|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801238|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801239|NCT00393484|Lamivudine|lamivudine|mesh-list
19801240|NCT00393484|Entecavir|entecavir|mesh-list
19801241|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19801242|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20326464|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20326465|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19801243|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160702|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20160703|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
20160704|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160705|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160706|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
20160707|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160708|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20160709|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160710|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160711|NCT00122486|Tenofovir|tenofovir|mesh-list
20160712|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
20160713|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160714|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160715|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160716|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160717|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160718|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160719|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160720|NCT00122499|Tadalafil|tadalafil|mesh-list
20160721|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
20326466|NCT00749359|Paroxetine|paroxetine|mesh-list
20326467|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20326468|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20326469|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20326470|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347798|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
19801244|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801245|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
19801246|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801247|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160722|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20160723|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20160724|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801248|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19801249|NCT00393705|Insulin|insulin|mesh-list
19801250|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19801251|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
19801252|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801253|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834234|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19834235|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
19834236|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834237|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19834238|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19834239|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834240|NCT00592943|Modafinil|modafinil|mesh-list
19834241|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19834242|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834243|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19834244|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19644913|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19644914|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19644915|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
19644916|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644917|NCT02369978|Benzonidazole|benzonidazole|mesh-list
19644918|NCT02369978|Nifurtimox|nifurtimox|mesh-list
19644919|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19644920|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
19644921|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644922|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19644923|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19644924|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19644925|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644926|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19644927|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
19644928|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19644929|NCT02369965|Ritonavir|ritonavir|mesh-list
19644930|NCT02369965|Lopinavir|lopinavir|mesh-list
19644931|NCT02369965|Tenofovir|tenofovir|mesh-list
19644932|NCT02369965|Lamivudine|lamivudine|mesh-list
19834245|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19834246|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834247|NCT00593112|Methylphenidate|methylphenidate|mesh-list
19834248|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19834249|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834250|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19834251|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19834252|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834253|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644933|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19644934|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19644935|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
19834254|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
19834255|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834256|NCT00593450|Bevacizumab|bevacizumab|mesh-list
19834257|NCT00593450|Ranibizumab|ranibizumab|mesh-list
19834258|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20160725|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160726|NCT00122499|Urological Agents|urological agents|mesh-ancestor
20160727|NCT00122512|Tenofovir|tenofovir|mesh-list
20160728|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
20160729|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801254|NCT00393718|Liraglutide|liraglutide|mesh-list
20160730|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160731|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160732|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160733|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160734|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160735|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160736|NCT00122538|Lamivudine|lamivudine|mesh-list
20160737|NCT00122538|Efavirenz|efavirenz|mesh-list
20160738|NCT00122538|Didanosine|didanosine|mesh-list
20160739|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19644936|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644937|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644938|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19644939|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19644940|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
19644941|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644942|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19644943|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19644944|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160740|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160741|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160742|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160743|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
19801255|NCT00393718|Glyburide|glyburide|mesh-list
19801256|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801257|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801258|NCT00393718|Incretins|incretins|mesh-ancestor
19801259|NCT00393718|Hormones|hormones|mesh-ancestor
19801260|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801261|NCT00393796|Sunitinib|sunitinib|mesh-list
19801262|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801263|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801264|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801265|NCT00393796|Growth Substances|growth substances|mesh-ancestor
19801266|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801267|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801268|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19801269|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801270|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801271|NCT00393848|Ketoconazole|ketoconazole|mesh-list
19801272|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
20160744|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160745|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160746|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20326471|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801273|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801274|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19801275|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19801276|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801277|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801278|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19801279|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
19801280|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801281|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801282|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19801283|NCT00393861|Bevacizumab|bevacizumab|mesh-list
19801284|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
19801285|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20174257|NCT00164242|Galantamine|galantamine|mesh-list
20326472|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
20326473|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326474|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20326475|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
20326476|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20326477|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20326478|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20326479|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326480|NCT00749385|Naproxen|naproxen|mesh-list
20326481|NCT00749385|Esomeprazole|esomeprazole|mesh-list
20326482|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20326483|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20326484|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20160747|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20160748|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19801286|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801287|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801288|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801289|NCT00393861|Growth Substances|growth substances|mesh-ancestor
19801290|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801291|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801292|NCT00393874|Prazosin|prazosin|mesh-list
19801293|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326485|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326486|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326487|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20326488|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326489|NCT00749385|Analgesics|analgesics|mesh-ancestor
20326490|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
20326491|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326492|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326493|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326494|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326495|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
20326496|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19801294|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19801295|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19801296|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19801297|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
19801298|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801299|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801300|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801301|NCT00393939|Docetaxel|docetaxel|mesh-list
19801302|NCT00393939|Sunitinib|sunitinib|mesh-list
19801303|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160749|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20160750|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20160751|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20160752|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20160753|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
20160754|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20160755|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
20160756|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160757|NCT00122577|Ritonavir|ritonavir|mesh-list
19801304|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
19801305|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
19801306|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801307|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160758|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20326497|NCT00749450|Fluorouracil|fluorouracil|mesh-list
20326498|NCT00749450|Capecitabine|capecitabine|mesh-list
19644945|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19644946|NCT02369939|Fluorouracil|fluorouracil|mesh-list
20326499|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
20326500|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
20326501|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326502|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326503|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644947|NCT02369939|Mitomycins|mitomycins|mesh-list
19644948|NCT02369939|Mitomycin|mitomycin|mesh-list
19644949|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
20160759|NCT00122577|Tenofovir|tenofovir|mesh-list
20160760|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20160761|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160762|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160763|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160764|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160765|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160766|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20326504|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19644950|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644951|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19644952|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644953|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19644954|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
19644955|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644956|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20326505|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
20326506|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326507|NCT00749502|Niraparib|niraparib|mesh-list
20326508|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20326509|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801308|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801309|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801310|NCT00393939|Growth Substances|growth substances|mesh-ancestor
19801311|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801312|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801313|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19801314|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801315|NCT00393978|Topiramate|topiramate|mesh-list
19801316|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19801317|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
19801318|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19801319|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19801320|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19801321|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801322|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801323|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
19801324|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801325|NCT00394082|Paclitaxel|paclitaxel|mesh-list
19801326|NCT00394082|Bevacizumab|bevacizumab|mesh-list
19801327|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19801328|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19801329|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160767|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
20160768|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160769|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20160770|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160771|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20160772|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160773|NCT00122590|Ritonavir|ritonavir|mesh-list
20160774|NCT00122590|Lopinavir|lopinavir|mesh-list
20160775|NCT00122590|Nelfinavir|nelfinavir|mesh-list
20160776|NCT00122590|Indinavir|indinavir|mesh-list
20160777|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20160778|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160779|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160780|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160781|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160782|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160783|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160784|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
20160785|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160786|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20160787|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160788|NCT00122603|Saquinavir|saquinavir|mesh-list
20160789|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
20160790|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20160791|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160792|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160793|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160794|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160795|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160796|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160797|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
20160798|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160799|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20160800|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160801|NCT00122616|Ribavirin|ribavirin|mesh-list
20160802|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20160803|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20160804|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
20160805|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160806|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
20160807|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160808|NCT00122629|Interferons|interferons|mesh-list
20160809|NCT00122629|Ribavirin|ribavirin|mesh-list
20160810|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
20160811|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
20160812|NCT00122629|Amantadine|amantadine|mesh-list
20160813|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19801330|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
20160814|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160815|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
20160816|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160817|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
20160818|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160819|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
20160820|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160821|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20160822|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20160823|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
20160824|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160825|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20160826|NCT00122629|Analgesics|analgesics|mesh-ancestor
20160827|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
20160828|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644957|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
19644958|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19644959|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19644960|NCT02369822|Ascorbic Acid|ascorbic acid|mesh-list
19644961|NCT02369822|Vitamins|vitamins|mesh-ancestor
19644962|NCT02369822|Micronutrients|micronutrients|mesh-ancestor
19644963|NCT02369822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644964|NCT02369822|Antioxidants|antioxidants|mesh-ancestor
19644965|NCT02369822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644966|NCT02369822|Protective Agents|protective agents|mesh-ancestor
19663977|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
19663978|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19663979|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19663980|NCT05026801|Azithromycin|azithromycin|mesh-list
19663981|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
19663982|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19663983|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19663984|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
19663985|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19663986|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19663987|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19663988|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19663989|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19663990|NCT05019885|Ketamine|ketamine|mesh-list
19663991|NCT05019885|Analgesics|analgesics|mesh-ancestor
19663992|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
19663993|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19663994|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19663995|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19663996|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19663997|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
19663998|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
19663999|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664000|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19664001|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19664002|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664003|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664004|NCT04999631|Ethanol|ethanol|mesh-list
19664005|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
19664006|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19664007|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664008|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664009|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664010|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19664011|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
19664012|NCT04985955|Tofacitinib|tofacitinib|mesh-list
19664013|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19664014|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664015|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664016|NCT04950660|Caffeine|caffeine|mesh-list
19664017|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19664018|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664019|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19664020|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664021|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664022|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19664023|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19664024|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
19664025|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664026|NCT04912791|Anesthetics|anesthetics|mesh-list
20160829|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20160830|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19801331|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
19801332|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801333|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801334|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801335|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801336|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801337|NCT00394082|Growth Substances|growth substances|mesh-ancestor
19801338|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801339|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801340|NCT00394095|Topiramate|topiramate|mesh-list
19801341|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
19801342|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801343|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801344|NCT00394251|Paclitaxel|paclitaxel|mesh-list
19801345|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
19801346|NCT00394251|Bevacizumab|bevacizumab|mesh-list
19801347|NCT00394251|Doxorubicin|doxorubicin|mesh-list
19801348|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20160831|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
20160832|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160833|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160834|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160835|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
20160836|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160837|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160838|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160839|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160840|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19801349|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19801350|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19801351|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801352|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19801353|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19801354|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801355|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801356|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20160841|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20160842|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
20160843|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20160844|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160845|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326510|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801357|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
19801358|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801359|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801360|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19801361|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
19801362|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19801363|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20326511|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326512|NCT00749567|Bevacizumab|bevacizumab|mesh-list
20326513|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19801364|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801365|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801366|NCT00394251|Growth Substances|growth substances|mesh-ancestor
19801367|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801368|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19801369|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19801370|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20326514|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20326515|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326516|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20326517|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20326518|NCT00749567|Growth Substances|growth substances|mesh-ancestor
20326519|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326520|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
20326521|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326522|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326523|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326524|NCT00749619|Taurolidine|taurolidine|mesh-list
19801371|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326525|NCT00749619|Heparin|heparin|mesh-list
20326526|NCT00749619|Calcium heparin|calcium heparin|mesh-list
20326527|NCT00749619|Citric Acid|citric acid|mesh-list
19801372|NCT00394277|Ribavirin|ribavirin|mesh-list
19801373|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19801374|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
19801375|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
19801376|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801377|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
19801378|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801379|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
19801380|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801381|NCT00394329|Beclomethasone|beclomethasone|mesh-list
19801382|NCT00394329|Albuterol|albuterol|mesh-list
19801383|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19801384|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
19801385|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801386|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801387|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19801388|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
19801389|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
19801390|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801391|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19801392|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19801393|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19801394|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
20160846|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
20160847|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160848|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20160849|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20160850|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20160851|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
20160852|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
20160853|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801395|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801396|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801397|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19801398|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
19801399|NCT00394329|Hormones|hormones|mesh-ancestor
20160854|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
20160855|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160856|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160857|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
20160858|NCT00122720|Hematinics|hematinics|mesh-ancestor
20160859|NCT00122733|Loxapine|loxapine|mesh-list
20160860|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20160861|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20160862|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160863|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801400|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801401|NCT00394433|Bevacizumab|bevacizumab|mesh-list
19801402|NCT00394433|Cisplatin|cisplatin|mesh-list
20160864|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160865|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20160866|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
20160867|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160868|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160869|NCT00122746|Cisplatin|cisplatin|mesh-list
20160870|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160871|NCT00122759|Ketamine|ketamine|mesh-list
20160872|NCT00122759|Analgesics|analgesics|mesh-ancestor
20160873|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
20160874|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160875|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160876|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20160877|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20160878|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
20160879|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
20160880|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20160881|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20160882|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20160883|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160884|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801403|NCT00394433|Docetaxel|docetaxel|mesh-list
19801404|NCT00394433|Irinotecan|irinotecan|mesh-list
20160885|NCT00122772|Cisplatin|cisplatin|mesh-list
20326528|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
19801405|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801406|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801407|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801408|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801409|NCT00394433|Growth Substances|growth substances|mesh-ancestor
19801410|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801411|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801412|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
19801413|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
19801414|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801415|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801416|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19801417|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19801418|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801419|NCT00394472|Lesogaberan|lesogaberan|mesh-list
19801420|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19801421|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19801422|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
19801423|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
19801424|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801425|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801426|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801427|NCT00394524|Insulin|insulin|mesh-list
19801428|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801429|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801430|NCT00394589|Infliximab|infliximab|mesh-list
19801431|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
19801432|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19801433|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801434|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19801435|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19801436|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
19801437|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19801438|NCT00394771|Estradiol|estradiol|mesh-list
19801439|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19801440|NCT00394771|Estrogens|estrogens|mesh-ancestor
19801441|NCT00394771|Hormones|hormones|mesh-ancestor
20160886|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160887|NCT00122785|Dexamethasone|dexamethasone|mesh-list
20160888|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20160889|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
20160890|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
20160891|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160892|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160893|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20160894|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
20160895|NCT00122785|Hormones|hormones|mesh-ancestor
20160896|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20160897|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20160898|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160899|NCT00122811|Perindopril|perindopril|mesh-list
20160900|NCT00122811|Indapamide|indapamide|mesh-list
20160901|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20160902|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
20160903|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160904|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160905|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20160906|NCT00122811|Diuretics|diuretics|mesh-ancestor
20160907|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
20160908|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160909|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20160910|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160911|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20174258|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19644967|NCT02369549|Curcumin|curcumin|mesh-list
19644968|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19644969|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19644970|NCT02369549|Analgesics|analgesics|mesh-ancestor
19644971|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
19644972|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644973|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644974|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19644975|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19644976|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19644977|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834259|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160912|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20160913|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20160914|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160915|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160916|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160917|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160918|NCT00122824|Analgesics|analgesics|mesh-ancestor
20160919|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
20160920|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160921|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
20160922|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160923|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
20160924|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20160925|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20160926|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20160927|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19644978|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644979|NCT02369523|Bupivacaine|bupivacaine|mesh-list
19644980|NCT02369523|Ropivacaine|ropivacaine|mesh-list
19644981|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
19644982|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
19644983|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326529|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20326530|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
20326531|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20160928|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20160929|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160930|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160931|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160932|NCT00122837|Analgesics|analgesics|mesh-ancestor
20160933|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
20160934|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160935|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
20160936|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160937|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
20160938|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20160939|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20160940|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20160941|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20160942|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20160943|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801442|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801443|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801444|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19801445|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
19801446|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801447|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19801448|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20160944|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160945|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160946|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326532|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
20326533|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
20326534|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326535|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20326536|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20326537|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644984|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19644985|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
19644986|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19644987|NCT02369406|Lamivudine|lamivudine|mesh-list
19644988|NCT02369406|Zidovudine|zidovudine|mesh-list
19644989|NCT02369406|Nevirapine|nevirapine|mesh-list
19644990|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19644991|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19644992|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20160947|NCT00122850|Analgesics|analgesics|mesh-ancestor
20326538|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19644993|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19644994|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
19801449|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19801450|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19801451|NCT00394836|Ofatumumab|ofatumumab|mesh-list
19801452|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19801453|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801454|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
19801455|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801456|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
19801457|NCT00394901|Pregabalin|pregabalin|mesh-list
19801458|NCT00394901|Analgesics|analgesics|mesh-ancestor
19801459|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
19801460|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801461|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160948|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
20160949|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160950|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
20160951|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160952|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
20160953|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20160954|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20160955|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20160956|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20160957|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801462|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
20326539|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326540|NCT00749710|Clopidogrel|clopidogrel|mesh-list
20326541|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20326542|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20326543|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20326544|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20326545|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
20326546|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801463|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19801464|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801465|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801466|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19801467|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19801468|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19801469|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801470|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19801471|NCT00394914|Pleconaril|pleconaril|mesh-list
20326547|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326548|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326549|NCT00749723|Carboplatin|carboplatin|mesh-list
20326550|NCT00749723|Etoposide|etoposide|mesh-list
19801472|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
19801473|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801474|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
19801475|NCT00394953|Hematinics|hematinics|mesh-ancestor
20160958|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160959|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20160960|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160961|NCT00122863|Analgesics|analgesics|mesh-ancestor
20160962|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
20160963|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20160964|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
20160965|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20160966|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
20160967|NCT00122876|Talaporfin|talaporfin|mesh-list
20160968|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20160969|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20160970|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
20160971|NCT00122889|Allicin|allicin|mesh-list
20160972|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
20160973|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
20160974|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20160975|NCT00122889|Protective Agents|protective agents|mesh-ancestor
20160976|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160977|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20160978|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326551|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
20160979|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20160980|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801476|NCT00395018|Entecavir|entecavir|mesh-list
19801477|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
19801478|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801479|NCT00395044|Gabapentin|gabapentin|mesh-list
19801480|NCT00395044|Analgesics|analgesics|mesh-ancestor
19801481|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
19801482|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801483|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801484|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
19801485|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20160981|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20160982|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20160983|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
20160984|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20160985|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20160986|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20160987|NCT00122941|Micronutrients|micronutrients|mesh-list
20160988|NCT00122941|Trace Elements|trace elements|mesh-list
20160989|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20160990|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
20160991|NCT00123149|Hematinics|hematinics|mesh-ancestor
20160992|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20160993|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
20160994|NCT00123175|Progestins|progestins|mesh-list
20160995|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20160996|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20160997|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20160998|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
20160999|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20161000|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161001|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20161002|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20161003|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20161004|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20161005|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161006|NCT00123175|Hormones|hormones|mesh-ancestor
20161007|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19644995|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19644996|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19644997|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19644998|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
19644999|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19645000|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19645001|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
19645002|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19645003|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
19645004|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161008|NCT00123201|Dronabinol|dronabinol|mesh-list
20161009|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
20161010|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161011|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161012|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20161013|NCT00123201|Analgesics|analgesics|mesh-ancestor
20161014|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
20161015|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161016|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19645005|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
19645006|NCT02369380|Protective Agents|protective agents|mesh-ancestor
19645007|NCT02369133|Acetaminophen|acetaminophen|mesh-list
19645008|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645009|NCT02369133|Analgesics|analgesics|mesh-ancestor
19645010|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
19645011|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645012|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645013|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
19645014|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19645015|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19645016|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19645017|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
19645018|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645019|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19645020|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19645021|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645022|NCT02369146|UB-421|ub-421|mesh-list
19645023|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20161017|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20161018|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645024|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
20161019|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161020|NCT00123201|Hormones|hormones|mesh-ancestor
20161021|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801486|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19801487|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801488|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19801489|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19801490|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19801491|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801492|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801493|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
19801494|NCT00395057|Ranibizumab|ranibizumab|mesh-list
19801495|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801496|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801497|NCT00395057|Growth Substances|growth substances|mesh-ancestor
19801498|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801499|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801500|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801501|NCT00395161|Selenium|selenium|mesh-list
19801502|NCT00395161|Metoclopramide|metoclopramide|mesh-list
19801503|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
19801504|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161022|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
20161023|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20161024|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161025|NCT00123253|Tesamorelin|tesamorelin|mesh-list
20161026|NCT00123253|Growth Substances|growth substances|mesh-ancestor
20161027|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161028|NCT00123266|Plasminogen|plasminogen|mesh-list
20161029|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20161030|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20161031|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161032|NCT00123279|Plasminogen|plasminogen|mesh-list
20161033|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20326552|NCT00749723|Temozolomide|temozolomide|mesh-list
20161034|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20161035|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161036|NCT00123292|Plasminogen|plasminogen|mesh-list
20161037|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
20326553|NCT00749723|Thiotepa|thiotepa|mesh-list
20326554|NCT00749723|Trofosfamide|trofosfamide|mesh-list
20326555|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
20326556|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326557|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20326558|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20326559|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20326560|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326561|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326562|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20326563|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
19645025|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645026|NCT02369081|Bisoprolol|bisoprolol|mesh-list
20161038|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20161039|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20161040|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161041|NCT00123305|Plasminogen|plasminogen|mesh-list
20161042|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
19645027|NCT02369081|Doxazosin|doxazosin|mesh-list
19645028|NCT02369081|Spironolactone|spironolactone|mesh-list
19645029|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19645030|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
19645031|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645032|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645033|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19645034|NCT02369081|Diuretics|diuretics|mesh-ancestor
19645035|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
19645036|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19645037|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
19645038|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
20326564|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20611601|NCT00602641|Thalidomide|thalidomide|mesh-list
19801505|NCT00395161|Protective Agents|protective agents|mesh-ancestor
19801506|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801507|NCT00395161|Trace Elements|trace elements|mesh-ancestor
19801508|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
19801509|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
19801510|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
19801511|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801512|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19801513|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19801514|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19801515|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
19801516|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801517|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
19801518|NCT00395226|Astringents|astringents|mesh-ancestor
19801519|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801520|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
19801521|NCT00395304|Fluticasone|fluticasone|mesh-list
19801522|NCT00395304|Xhance|xhance|mesh-list
19801523|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19801524|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19801525|NCT00395304|Montelukast|montelukast|mesh-list
19801526|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19801527|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19801528|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
19801529|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801530|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801531|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19801532|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19801533|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
19801534|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20326565|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326566|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
20326567|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326568|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326569|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
20326570|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20326571|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20326572|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326573|NCT00749736|Vitamins|vitamins|mesh-ancestor
20326574|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
20326575|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20326576|NCT00749814|Melatonin|melatonin|mesh-list
20326577|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
20326578|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801535|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19801536|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19801537|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19801538|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
19801539|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801540|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801541|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19801542|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
19801543|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801544|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20161043|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20161044|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20161045|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161046|NCT00123318|Cisplatin|cisplatin|mesh-list
20161047|NCT00123318|Fluorouracil|fluorouracil|mesh-list
20161048|NCT00123318|Epirubicin|epirubicin|mesh-list
20161049|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161050|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
20161051|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161052|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161053|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161054|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
20161055|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161056|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20161057|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20161058|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20161059|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161060|NCT00123331|Cyclosporine|cyclosporine|mesh-list
19801545|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19801546|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
19801547|NCT00395304|Hormones|hormones|mesh-ancestor
19801548|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
19801549|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19801550|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801551|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161061|NCT00123331|Sirolimus|sirolimus|mesh-list
20161062|NCT00123331|Cyclosporins|cyclosporins|mesh-list
20161063|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161064|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161065|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161066|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
20161067|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161068|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
20161069|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161070|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
20161071|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20161072|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20161073|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20161074|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20161075|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161076|NCT00123370|Modafinil|modafinil|mesh-list
20326579|NCT00749814|Protective Agents|protective agents|mesh-ancestor
20326580|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326581|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326582|NCT00749853|Buserelin|buserelin|mesh-list
20161077|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20161078|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161079|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20161080|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20161081|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20161082|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161083|NCT00123383|Modafinil|modafinil|mesh-list
20161084|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20161085|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161086|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20161087|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20161088|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20161089|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161090|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20161091|NCT00123461|Vitamins|vitamins|mesh-ancestor
20161092|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
20161093|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161094|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20174259|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174260|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174261|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
20174262|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174263|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174264|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20174265|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
20174266|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174267|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
19645039|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645040|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19645041|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19645042|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19645043|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645044|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645045|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645046|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19645047|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19645048|NCT02368860|Capecitabine|capecitabine|mesh-list
19645049|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
19645050|NCT02368860|Irinotecan|irinotecan|mesh-list
20174268|NCT00164255|Artesunate|artesunate|mesh-list
20174269|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
20326583|NCT00749853|Hormones|hormones|mesh-list
20326584|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20326585|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20326586|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174270|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
20174271|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
19645051|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801552|NCT00395343|Incretins|incretins|mesh-ancestor
19801553|NCT00395343|Hormones|hormones|mesh-ancestor
19801554|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801555|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19801556|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
19801557|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801558|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801559|NCT00395486|Atorvastatin|atorvastatin|mesh-list
19801560|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19801561|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19801562|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19801563|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
20326587|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20326588|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
20326589|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20326590|NCT00749866|Gentamicins|gentamicins|mesh-list
20326591|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20326592|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326593|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20326594|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326595|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326596|NCT00749918|Vitamin D|vitamin d|mesh-list
20326597|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
20326598|NCT00749918|Vitamins|vitamins|mesh-ancestor
20326599|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
20326600|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326601|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20326602|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20326603|NCT00750048|Acetaminophen|acetaminophen|mesh-list
19801564|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801565|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19801566|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19801567|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801568|NCT00395512|Pioglitazone|pioglitazone|mesh-list
19801569|NCT00395512|Alogliptin|alogliptin|mesh-list
19801570|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801571|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801572|NCT00395512|Incretins|incretins|mesh-ancestor
19801573|NCT00395512|Hormones|hormones|mesh-ancestor
19801574|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801575|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19801576|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
19801577|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801578|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801579|NCT00395629|Deferasirox|deferasirox|mesh-list
19801580|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19801581|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
19801582|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
19801583|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161095|NCT00123539|Estrogens|estrogens|mesh-list
20161096|NCT00123539|Hormones|hormones|mesh-ancestor
20161097|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20161098|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161099|NCT00123552|Artesunate|artesunate|mesh-list
20326604|NCT00750048|Naloxone|naloxone|mesh-list
20161100|NCT00123552|Lumefantrine|lumefantrine|mesh-list
20161101|NCT00123552|Artemether|artemether|mesh-list
20161102|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
20161103|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
20161104|NCT00123552|Amodiaquine|amodiaquine|mesh-list
20161105|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20161106|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
20161107|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20161108|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20161109|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161110|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161111|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
20161112|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
20161113|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20161114|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
20326605|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20161115|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20161116|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174272|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20326606|NCT00750048|Analgesics|analgesics|mesh-ancestor
20326607|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
20326608|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326609|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326610|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
20326611|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20326612|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20161117|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161118|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20161119|NCT00123552|Renal Agents|renal agents|mesh-ancestor
20161120|NCT00123578|Pentobarbital|pentobarbital|mesh-list
20161121|NCT00123578|Lorazepam|lorazepam|mesh-list
20161122|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
20161123|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
20161124|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
20161125|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161126|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161127|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20161128|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20161129|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326613|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20326614|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326615|NCT00750113|Telmisartan|telmisartan|mesh-list
20326616|NCT00750113|Nifedipine|nifedipine|mesh-list
20326617|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326618|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20161130|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20161131|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20161132|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161133|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
20161134|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
20161135|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161136|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161137|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20161138|NCT00123656|Fluticasone|fluticasone|mesh-list
20161139|NCT00123656|Esomeprazole|esomeprazole|mesh-list
20161140|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20161141|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20161142|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
20326619|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20326620|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645052|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
19645053|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645054|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645055|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19645056|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19645057|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645058|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19645059|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
19645060|NCT02368730|Coagulants|coagulants|mesh-ancestor
19645061|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20326621|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20326622|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20326623|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20326624|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161143|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161144|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161145|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20161146|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
20161147|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
20161148|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20161149|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20161150|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20161151|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20161152|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161153|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161154|NCT00123669|Progesterone|progesterone|mesh-list
20161155|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20161156|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20161157|NCT00123669|Progestins|progestins|mesh-ancestor
20161158|NCT00123669|Hormones|hormones|mesh-ancestor
20161159|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20161160|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161161|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20161162|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
20161163|NCT00123825|Gemcitabine|gemcitabine|mesh-list
20161164|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161165|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161166|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
19801584|NCT00395694|Lamotrigine|lamotrigine|mesh-list
19801585|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
19801586|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19801587|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801588|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801589|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19801590|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801591|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19801592|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19801593|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801594|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19801595|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19801596|NCT00395746|Liraglutide|liraglutide|mesh-list
19801597|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801598|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161167|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161168|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
20161169|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161170|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161171|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161172|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
20161173|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161174|NCT00123851|Capecitabine|capecitabine|mesh-list
20161175|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
20161176|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20161177|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161178|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
20161179|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161180|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326625|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
19801599|NCT00395746|Incretins|incretins|mesh-ancestor
19801600|NCT00395746|Hormones|hormones|mesh-ancestor
19801601|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801602|NCT00395850|Disulfiram|disulfiram|mesh-list
19801603|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19801604|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20326626|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
20326627|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20326628|NCT00750126|Fludarabine|fludarabine|mesh-list
20326629|NCT00750126|Busulfan|busulfan|mesh-list
20326630|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
20326631|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326632|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326633|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326634|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
20326635|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326636|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
20326637|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20326638|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20326639|NCT00750178|Vorinostat|vorinostat|mesh-list
19801605|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801606|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801607|NCT00395876|Tenecteplase|tenecteplase|mesh-list
19801608|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19801609|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19801610|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801611|NCT00395967|Plerixafor|plerixafor|mesh-list
19801612|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19801613|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20326640|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645062|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
19645063|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645064|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19645065|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19645066|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
19645067|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19645068|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
19645069|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801614|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
20161181|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326641|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19645070|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645071|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19645072|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19645073|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645074|NCT02368795|Indomethacin|indomethacin|mesh-list
19801615|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801616|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
19801617|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19801618|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801619|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801620|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19801621|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19801622|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19801623|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
19801624|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801625|NCT00396032|Tenecteplase|tenecteplase|mesh-list
19801626|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19801627|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19801628|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801629|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
19801630|NCT00396084|Levofloxacin|levofloxacin|mesh-list
19801631|NCT00396084|Ofloxacin|ofloxacin|mesh-list
19801632|NCT00396084|Isoniazid|isoniazid|mesh-list
19801633|NCT00396084|Linezolid|linezolid|mesh-list
19801634|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
19801635|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19801636|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801637|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20326642|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326643|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326644|NCT00750217|Buprenorphine|buprenorphine|mesh-list
20326645|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19645075|NCT02368795|Isosorbide|isosorbide|mesh-list
19645076|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19645077|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19645078|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19645079|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645080|NCT02368795|Analgesics|analgesics|mesh-ancestor
19645081|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
19645082|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801638|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19801639|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801640|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801641|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801642|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19801643|NCT00396084|Renal Agents|renal agents|mesh-ancestor
20161182|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161183|NCT00123877|Esorubicin|esorubicin|mesh-list
20161184|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20161185|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161186|NCT00123890|Aplaviroc|aplaviroc|mesh-list
20161187|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20161188|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20161189|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161190|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20161191|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20161192|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
20161193|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161194|NCT00123903|Metoprolol|metoprolol|mesh-list
20161195|NCT00123903|Carvedilol|carvedilol|mesh-list
20161196|NCT00123903|Lisinopril|lisinopril|mesh-list
20161197|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20161198|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20161199|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
20161200|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
20161201|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161202|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161203|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20161204|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20161205|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20161206|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
20161207|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161208|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161209|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
20161210|NCT00123903|Protective Agents|protective agents|mesh-ancestor
20161211|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20161212|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161213|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20161214|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
20326646|NCT00750217|Narcotics|narcotics|mesh-ancestor
20326647|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326648|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326649|NCT00750217|Analgesics|analgesics|mesh-ancestor
20326650|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
20326651|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326652|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20326653|NCT00750334|Clofarabine|clofarabine|mesh-list
20326654|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326655|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
20326656|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326657|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161215|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20161216|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20161217|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19801644|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19801645|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19801646|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
19801647|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19801648|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19801649|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
19801650|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19801651|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19801652|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19801653|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19801654|NCT00396201|Plerixafor|plerixafor|mesh-list
19801655|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19801656|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19801657|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
19801658|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801659|NCT00396253|Tenecteplase|tenecteplase|mesh-list
19801660|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19801661|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19801662|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801663|NCT00396266|Plerixafor|plerixafor|mesh-list
19801664|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19801665|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19801666|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
19801667|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801668|NCT00396279|Vitamin D|vitamin d|mesh-list
19801669|NCT00396279|Denosumab|denosumab|mesh-list
19801670|NCT00396279|Calcium|calcium|mesh-list
19801671|NCT00396279|Vitamins|vitamins|mesh-ancestor
19801672|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
19801673|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801674|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19801675|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19801676|NCT00396318|Tenecteplase|tenecteplase|mesh-list
19801677|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19801678|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19801679|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801680|NCT00396331|Plerixafor|plerixafor|mesh-list
20161218|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
20161219|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161220|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20161221|NCT00123916|Benzonidazole|benzonidazole|mesh-list
20161222|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161223|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
20161224|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161225|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20161226|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20161227|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20161228|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161229|NCT00123929|Docetaxel|docetaxel|mesh-list
20161230|NCT00123929|Doxorubicin|doxorubicin|mesh-list
20161231|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161232|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
20161233|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
20326658|NCT00750347|Acetaminophen|acetaminophen|mesh-list
20161234|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801681|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19801682|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20174273|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20161235|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161236|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19801683|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
19801684|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801685|NCT00396383|Plerixafor|plerixafor|mesh-list
19801686|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19801687|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20161237|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20161238|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20161239|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161240|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20161241|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
20161242|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161243|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20161244|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20161245|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161246|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161247|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
20161248|NCT00124098|Hematinics|hematinics|mesh-ancestor
20161249|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
20161250|NCT00124111|Fluorouracil|fluorouracil|mesh-list
20161251|NCT00124111|Methotrexate|methotrexate|mesh-list
20161252|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161253|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
20161254|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161255|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20161256|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20161257|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
20161258|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161259|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161260|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20161261|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
20161262|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161263|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20161264|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
20326659|NCT00750347|Rimonabant|rimonabant|mesh-list
20326660|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326661|NCT00750347|Analgesics|analgesics|mesh-ancestor
20326662|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
20326663|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326664|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326665|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
20326666|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20326667|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20326668|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19645083|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161265|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20161266|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
20161267|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161268|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19645084|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645085|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645086|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
20161269|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20161270|NCT00124137|Diuretics|diuretics|mesh-list
20161271|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
20161272|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161273|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
20161274|NCT00124150|Analgesics|analgesics|mesh-ancestor
19645087|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
19645088|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19645089|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19645090|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645091|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645092|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19645093|NCT02368795|Diuretics|diuretics|mesh-ancestor
19645094|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
19645095|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645096|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19645097|NCT02368717|Mesalamine|mesalamine|mesh-list
19645098|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20161275|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
19645099|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20161276|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326669|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161277|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161278|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
20161279|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161280|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20161281|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
20326670|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326671|NCT00750347|Hormones|hormones|mesh-ancestor
20326672|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20326673|NCT00750386|Paclitaxel|paclitaxel|mesh-list
20326674|NCT00750386|Carboplatin|carboplatin|mesh-list
20326675|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20326676|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326677|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
20326678|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
20326679|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
20326680|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326681|NCT00750399|Ranibizumab|ranibizumab|mesh-list
20326682|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20326683|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20161282|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20161283|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161284|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161285|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20161286|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
20161287|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20326684|NCT00750399|Growth Substances|growth substances|mesh-ancestor
20326685|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326686|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
20326687|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326688|NCT00750425|Cediranib|cediranib|mesh-list
20326689|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326690|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20326691|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326692|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161288|NCT00124241|Lamivudine|lamivudine|mesh-list
20161289|NCT00124241|Telbivudine|telbivudine|mesh-list
20161290|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20161291|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20161292|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161293|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161294|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
20161295|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161296|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20161297|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20161298|NCT00124267|Quinine|quinine|mesh-list
20161299|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
20161300|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19801688|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
20326693|NCT00750451|Heparin|heparin|mesh-list
20326694|NCT00750451|Enoxaparin|enoxaparin|mesh-list
20326695|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19801689|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801690|NCT00396409|Omalizumab|omalizumab|mesh-list
19801691|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19801692|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19801693|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
19801694|NCT00396565|Olanzapine|olanzapine|mesh-list
19801695|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19801696|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
19801697|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
19801698|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801699|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801700|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19801701|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20161301|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20161302|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161303|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20161304|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161305|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20161306|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161307|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20161308|NCT00124267|Analgesics|analgesics|mesh-ancestor
20161309|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
20326696|NCT00750451|Tinzaparin|tinzaparin|mesh-list
20326697|NCT00750451|Dalteparin|dalteparin|mesh-list
19801702|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20326698|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
20326699|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
20326700|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20326701|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20326702|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347799|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347800|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161310|NCT00124280|Everolimus|everolimus|mesh-list
20161311|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801703|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801704|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19801705|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19801706|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161312|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161313|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
20161314|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161315|NCT00124306|Amitriptyline|amitriptyline|mesh-list
20161316|NCT00124306|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20161317|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20161318|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
20161319|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161320|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20161321|NCT00124306|Analgesics|analgesics|mesh-ancestor
20161322|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
20161323|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161324|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161325|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20161326|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161327|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161328|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161329|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
20161330|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161331|NCT00124306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20161332|NCT00124306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20161333|NCT00124306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161334|NCT00124332|Rimonabant|rimonabant|mesh-list
20161335|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20161336|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20347801|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20347802|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
20347803|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20347804|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20347805|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20347806|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347807|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347808|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347809|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
20347810|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20347811|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347812|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
20347813|NCT00861926|Hormones|hormones|mesh-ancestor
20347814|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347815|NCT00861939|Bupropion|bupropion|mesh-list
20347816|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20347817|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
20347818|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20347819|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20347820|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20347821|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347822|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347823|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
20347824|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347825|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347826|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20347827|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20347828|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347829|NCT00861952|Mineral Oil|mineral oil|mesh-list
20347830|NCT00861952|Emollients|emollients|mesh-ancestor
20347831|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
20347832|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
20347833|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326703|NCT00750529|Donepezil|donepezil|mesh-list
20326704|NCT00750529|Galantamine|galantamine|mesh-list
20161337|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20161338|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161339|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161340|NCT00124332|Hormones|hormones|mesh-ancestor
20161341|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20161342|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801707|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801708|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801709|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801710|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
19801711|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19801712|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19801713|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19801714|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19801715|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
19801716|NCT00396591|Aflibercept|aflibercept|mesh-list
20161343|NCT00124358|Buprenorphine|buprenorphine|mesh-list
20161344|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20161345|NCT00124358|Narcotics|narcotics|mesh-ancestor
20161346|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161347|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161348|NCT00124358|Analgesics|analgesics|mesh-ancestor
20161349|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
20161350|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161351|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20161352|NCT00124384|Modafinil|modafinil|mesh-list
20161353|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20161354|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161355|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20161356|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20161357|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20161358|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161359|NCT00124397|Atorvastatin|atorvastatin|mesh-list
19801717|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801718|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801719|NCT00396591|Growth Substances|growth substances|mesh-ancestor
19801720|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801721|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801722|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801723|NCT00396656|Atenolol|atenolol|mesh-list
19801724|NCT00396656|Valsartan|valsartan|mesh-list
19801725|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19801726|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19801727|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20326705|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20326706|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326707|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326708|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
20326709|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326710|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326711|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
20326712|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20326713|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
20326714|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326715|NCT00750581|Indomethacin|indomethacin|mesh-list
20326716|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20326717|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326718|NCT00750581|Analgesics|analgesics|mesh-ancestor
20326719|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
20326720|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326721|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326722|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326723|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20161360|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20161361|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20161362|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
20161363|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161364|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20161365|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20161366|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161367|NCT00124436|Alitretinoin|alitretinoin|mesh-list
19801728|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20326724|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
20326725|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
20326726|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801729|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161368|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161369|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
20161370|NCT00124475|Alitretinoin|alitretinoin|mesh-list
20161371|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161372|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
20161373|NCT00124527|Capecitabine|capecitabine|mesh-list
20161374|NCT00124527|Irofulven|irofulven|mesh-list
20161375|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161376|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
20161377|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161378|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161379|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20161380|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
20161381|NCT00124540|Misoprostol|misoprostol|mesh-list
20161382|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20161383|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
20161384|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20161385|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161386|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20161387|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20161388|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
20161389|NCT00124566|Prednisone|prednisone|mesh-list
20161390|NCT00124566|Capecitabine|capecitabine|mesh-list
20161391|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
20161392|NCT00124566|Irofulven|irofulven|mesh-list
20161393|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20161394|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
20161395|NCT00124566|Hormones|hormones|mesh-ancestor
20161396|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20161397|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161398|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20161399|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161400|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161401|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
20161402|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161403|NCT00124566|Analgesics|analgesics|mesh-ancestor
20326727|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19801730|NCT00396656|Diuretics|diuretics|mesh-ancestor
19801731|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
19801732|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801733|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19801734|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801735|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19645100|NCT02368717|Analgesics|analgesics|mesh-ancestor
19645101|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
19801736|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
19801737|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
19801738|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801739|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19801740|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19645102|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645103|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645104|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645105|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645106|NCT02368743|Mesalamine|mesalamine|mesh-list
19645107|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19645108|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645109|NCT02368743|Analgesics|analgesics|mesh-ancestor
19645110|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
19645111|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645112|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645113|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645114|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645115|NCT02368665|Amlodipine|amlodipine|mesh-list
19645116|NCT02368665|Candesartan|candesartan|mesh-list
19801741|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19645117|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
19801742|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
20161404|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
20161405|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161406|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20161407|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20161408|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161409|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20161410|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
20161411|NCT00124605|Pamidronate|pamidronate|mesh-list
20161412|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
20161413|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161414|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20161415|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161416|NCT00124644|Cytarabine|cytarabine|mesh-list
20161417|NCT00124644|Etoposide|etoposide|mesh-list
20161418|NCT00124644|Daunorubicin|daunorubicin|mesh-list
20161419|NCT00124644|Tipifarnib|tipifarnib|mesh-list
20161420|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20161421|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20161422|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161423|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20161424|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20161425|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161426|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161427|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
20161428|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
20161429|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645118|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19645119|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19645120|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801743|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801744|NCT00396812|Rituximab|rituximab|mesh-list
19801745|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801746|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161430|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161431|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
20161432|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161433|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20161434|NCT00124683|Bupropion|bupropion|mesh-list
20161435|NCT00124683|Nicotine|nicotine|mesh-list
20161436|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20161437|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
20161438|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161439|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161440|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20326728|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326729|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326730|NCT00750620|Mirabegron|mirabegron|mesh-list
20326731|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20326732|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20326733|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20326734|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
20326735|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326736|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326737|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326738|NCT00750620|Urological Agents|urological agents|mesh-ancestor
20326739|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
20326740|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20326741|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
20326742|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326743|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
20326744|NCT00750724|Protective Agents|protective agents|mesh-ancestor
20326745|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
20326746|NCT00750763|Cathartics|cathartics|mesh-ancestor
20326747|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20326748|NCT00750802|Lorazepam|lorazepam|mesh-list
20326749|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
20326750|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
20326751|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
19645121|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645122|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19645123|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645124|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645125|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19645126|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19645127|NCT02368652|Amlodipine|amlodipine|mesh-list
19645128|NCT02368652|Candesartan|candesartan|mesh-list
19645129|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
20161441|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19801747|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
19801748|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801749|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801750|NCT00396877|Clopidogrel|clopidogrel|mesh-list
19801751|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20161442|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
20161443|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161444|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161445|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20161446|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
20161447|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161448|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20161449|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161450|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161451|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
20161452|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20161453|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20161454|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161455|NCT00124696|Cocaethylene|cocaethylene|mesh-list
20161456|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20161457|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161458|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161459|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161460|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
20161461|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161462|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161463|NCT00124722|Bromides|bromides|mesh-list
20161464|NCT00124722|Rocuronium|rocuronium|mesh-list
20161465|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
20161466|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20161467|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20161468|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20326752|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326753|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326754|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20326755|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20326756|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326757|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20326758|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20326759|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20326760|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
20326761|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
20326762|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326763|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326764|NCT00750997|Dextrans|dextrans|mesh-list
20326765|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
20326766|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
20326767|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
20326768|NCT00751049|Timolol|timolol|mesh-list
20326769|NCT00751049|Latanoprost|latanoprost|mesh-list
20326770|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20161469|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161470|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161471|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
20161472|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
20161473|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
20161474|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161475|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161476|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20161477|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20161478|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
20161479|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
20161480|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161481|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161482|NCT00124813|Thalidomide|thalidomide|mesh-list
20161483|NCT00124813|Idarubicin|idarubicin|mesh-list
20161484|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326771|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20326772|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
20326773|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326774|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347834|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
19801752|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19801753|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19801754|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19801755|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
19801756|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801757|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801758|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801759|NCT00397020|Valproic Acid|valproic acid|mesh-list
19801760|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19801761|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
20161485|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
20161486|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161487|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
20161488|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20161489|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161490|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20161491|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20161492|NCT00124813|Growth Substances|growth substances|mesh-ancestor
20161493|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
20161494|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161495|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20161496|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20161497|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20161498|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161499|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161500|NCT00124826|Insulin|insulin|mesh-list
20161501|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20161502|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161503|NCT00124839|Naltrexone|naltrexone|mesh-list
20161504|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20161505|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20161506|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161507|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
20161508|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161509|NCT00124930|Olanzapine|olanzapine|mesh-list
20161510|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
20326775|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326776|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20326777|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326778|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20326779|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20326780|NCT00751062|Timolol|timolol|mesh-list
20326781|NCT00751062|Latanoprost|latanoprost|mesh-list
20326782|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20326783|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20326784|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
20326785|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326786|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326787|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326788|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20326789|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326790|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20326791|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20326792|NCT00751127|Timolol|timolol|mesh-list
20326793|NCT00751127|Latanoprost|latanoprost|mesh-list
20326794|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20326795|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20326796|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
20326797|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326798|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326799|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326800|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20326801|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20161511|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
20161512|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161513|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161514|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20161515|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20161516|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20161517|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161518|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161519|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20161520|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161521|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611602|NCT00602641|Prednisone|prednisone|mesh-list
19801762|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20611603|NCT00602641|Cortisone|cortisone|mesh-list
20326802|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20326803|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20326804|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
20326805|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20326806|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20326807|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19645130|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19645131|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19645132|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19645133|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161522|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161523|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161524|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
20161525|NCT00124956|Doxorubicin|doxorubicin|mesh-list
20161526|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20161527|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161528|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19801763|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19801764|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19801765|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801766|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801767|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
19801768|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801769|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801770|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
19801771|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801772|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
19801773|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19801774|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20161529|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20161530|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161531|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161532|NCT00124969|Amlodipine|amlodipine|mesh-list
20161533|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20161534|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20161535|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161536|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801775|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19801776|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801777|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801778|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19801779|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19801780|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19801781|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
19801782|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801783|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161537|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20161538|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161539|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
20161540|NCT00124995|Terbutaline|terbutaline|mesh-list
20161541|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20161542|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
20161543|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161544|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326808|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
19801784|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19801785|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19801786|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
19801787|NCT00397189|Melatonin|melatonin|mesh-list
19801788|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
19801789|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801790|NCT00397189|Protective Agents|protective agents|mesh-ancestor
19801791|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801792|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645134|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19645135|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801793|NCT00397488|Sunitinib|sunitinib|mesh-list
19801794|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645136|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
19801795|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801796|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801797|NCT00397488|Growth Substances|growth substances|mesh-ancestor
19801798|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161545|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20161546|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
20161547|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
20161548|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
20161549|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19801799|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801800|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19801801|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801802|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801803|NCT00397631|Pioglitazone|pioglitazone|mesh-list
19801804|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19801805|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19801806|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801807|NCT00397631|Incretins|incretins|mesh-ancestor
19801808|NCT00397631|Hormones|hormones|mesh-ancestor
19801809|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801810|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19801811|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
19801812|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801813|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801814|NCT00397813|Cyclosporine|cyclosporine|mesh-list
19801815|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
19801816|NCT00397813|Fludarabine|fludarabine|mesh-list
19801817|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
19801818|NCT00397813|Cyclosporins|cyclosporins|mesh-list
19801819|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801820|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801821|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
19801822|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801823|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19801824|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
19801825|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801826|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801827|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
19801828|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801829|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
19801830|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19801831|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19801832|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19801833|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19801834|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
19801835|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19801836|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
19801837|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19801838|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801839|NCT00397878|Saracatinib|saracatinib|mesh-list
19801840|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801841|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801842|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801843|NCT00397904|Irinotecan|irinotecan|mesh-list
19801844|NCT00397904|Cetuximab|cetuximab|mesh-list
19801845|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801846|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19801847|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19801848|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801849|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801850|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801851|NCT00397943|Vaccines|vaccines|mesh-list
19801852|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
19801853|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801854|NCT00397982|Sirolimus|sirolimus|mesh-list
19801855|NCT00397982|Bevacizumab|bevacizumab|mesh-list
19801856|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19801857|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
19801858|NCT00397982|Antibodies|antibodies|mesh-list
19801859|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
19801860|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19801861|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
19801862|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161550|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20161551|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20161552|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19801863|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801864|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801865|NCT00397982|Growth Substances|growth substances|mesh-ancestor
20161553|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
19801866|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801867|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801868|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
19801869|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19801870|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801871|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19801872|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
19801873|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19801874|NCT00398047|Mitogens|mitogens|mesh-list
19801875|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801876|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801877|NCT00398086|Gemcitabine|gemcitabine|mesh-list
19801878|NCT00398086|Paclitaxel|paclitaxel|mesh-list
19801879|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19801880|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19801881|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801882|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
19801883|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
19801884|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
19801885|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801886|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801887|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
19801888|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
19801889|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801890|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801891|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19801892|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
19801893|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801894|NCT00398112|Sunitinib|sunitinib|mesh-list
19801895|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801896|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801897|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801898|NCT00398112|Growth Substances|growth substances|mesh-ancestor
19801899|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801900|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801901|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19801902|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801903|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801904|NCT00398138|Sargramostim|sargramostim|mesh-list
19801905|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
19801906|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
19801907|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801908|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19834260|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19834261|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19834262|NCT00593450|Growth Substances|growth substances|mesh-ancestor
19834263|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834264|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834265|NCT00593489|Insulin|insulin|mesh-list
19834266|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19834267|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834268|NCT00593554|Fludarabine|fludarabine|mesh-list
19834269|NCT00593554|Thiotepa|thiotepa|mesh-list
19834270|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
19834271|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19834272|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834273|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834274|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834275|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
19834276|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834277|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834278|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
19834279|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834280|NCT00593606|Rotigotine|rotigotine|mesh-list
19834281|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
19834282|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
19834283|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834284|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834285|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834286|NCT00593645|Cytarabine|cytarabine|mesh-list
19834287|NCT00593645|Clofarabine|clofarabine|mesh-list
19834288|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
20326809|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326810|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20326811|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19834289|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20326812|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326813|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801909|NCT00398216|Edoxaban|edoxaban|mesh-list
19801910|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
19801911|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
19801912|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19801913|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
19801914|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801915|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801916|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
19801917|NCT00398320|Bevacizumab|bevacizumab|mesh-list
19801918|NCT00398320|Capecitabine|capecitabine|mesh-list
19801919|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
19801920|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801921|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801922|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19801923|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19801924|NCT00398320|Growth Substances|growth substances|mesh-ancestor
19801925|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801926|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
19801927|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801928|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
19801929|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801930|NCT00398398|Capecitabine|capecitabine|mesh-list
19801931|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
19801932|NCT00398398|Cetuximab|cetuximab|mesh-list
19801933|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19801934|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
19801935|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161554|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161555|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161556|NCT00125008|Vaccines|vaccines|mesh-list
20161557|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
20161558|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161559|NCT00125021|Capecitabine|capecitabine|mesh-list
20161560|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20161561|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161562|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
20161563|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161564|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161565|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20161566|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161567|NCT00125047|Vaccines|vaccines|mesh-list
20161568|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
20161569|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161570|NCT00125060|Simvastatin|simvastatin|mesh-list
19801936|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801937|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801938|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
20161571|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20161572|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20161573|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
20161574|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161575|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20161576|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20161577|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326814|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20326815|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20326816|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
20326817|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
20161578|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
20161579|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
20161580|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20161581|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20161582|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20161583|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161584|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161585|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
20161586|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161587|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161588|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20161589|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326818|NCT00751205|Prednisone|prednisone|mesh-list
20326819|NCT00751205|Prednisolone|prednisolone|mesh-list
20161590|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20161591|NCT00125229|Mannitol|mannitol|mesh-list
20161592|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20161593|NCT00125229|Diuretics|diuretics|mesh-ancestor
20161594|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
20161595|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174274|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174275|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174276|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
20174277|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
20174278|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20174279|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
20174280|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20174281|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174282|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174283|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20174284|NCT00164255|Renal Agents|renal agents|mesh-ancestor
20174285|NCT00164281|Isoniazid|isoniazid|mesh-list
20174286|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
20174287|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174288|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174289|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20174290|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20174291|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
20174292|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174293|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20174294|NCT00164359|Artesunate|artesunate|mesh-list
20174295|NCT00164359|Amodiaquine|amodiaquine|mesh-list
20174296|NCT00164359|Dapsone|dapsone|mesh-list
20174297|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
20174298|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
20174299|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20174300|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20174301|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174302|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174303|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
20174304|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
20174305|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20174306|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
20174307|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20174308|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174309|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174310|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
20174311|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20326820|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20326821|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
20326822|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20326823|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
20326824|NCT00751205|Sagopilone|sagopilone|mesh-list
20326825|NCT00751205|Epothilones|epothilones|mesh-list
20326826|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20326827|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
20326828|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326829|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
20326830|NCT00751205|Hormones|hormones|mesh-ancestor
20326831|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20326832|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326833|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20326834|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326835|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
20326836|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
20174312|NCT00164411|Vaccines|vaccines|mesh-list
20174313|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20174314|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
20174315|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174316|NCT00164424|Acyclovir|acyclovir|mesh-list
20174317|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
20174318|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174319|NCT00164450|Isoniazid|isoniazid|mesh-list
20174320|NCT00164450|Rifapentine|rifapentine|mesh-list
20174321|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
20174322|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174323|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174324|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20174325|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20174326|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
20326837|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326838|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20611604|NCT00602641|Lenalidomide|lenalidomide|mesh-list
20161596|NCT00125255|Lidocaine|lidocaine|mesh-list
19801939|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19801940|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19801941|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19801942|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19801943|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19801944|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801945|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801946|NCT00398476|Fluticasone|fluticasone|mesh-list
19801947|NCT00398476|Xhance|xhance|mesh-list
19801948|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19801949|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19801950|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
19801951|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161597|NCT00125255|Tetracaine|tetracaine|mesh-list
20161598|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
20161599|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
20161600|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161601|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161602|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
20161603|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161604|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20161605|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20161606|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20161607|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161608|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161609|NCT00125294|Methadone|methadone|mesh-list
20161610|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20161611|NCT00125294|Narcotics|narcotics|mesh-ancestor
20161612|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161613|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161614|NCT00125294|Analgesics|analgesics|mesh-ancestor
20326839|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20326840|NCT00751205|Protective Agents|protective agents|mesh-ancestor
20326841|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
20326842|NCT00751205|Vitamins|vitamins|mesh-ancestor
20161615|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
20161616|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161617|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
20161618|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
20161619|NCT00125307|Tacrolimus|tacrolimus|mesh-list
20161620|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161621|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
20161622|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161623|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20161624|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161625|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161626|NCT00125346|Tobramycin|tobramycin|mesh-list
20161627|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20161628|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161629|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20161630|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
20161631|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801952|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801953|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19801954|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
20161632|NCT00125398|Fospropofol|fospropofol|mesh-list
20161633|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20161634|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161635|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161636|NCT00125411|Docetaxel|docetaxel|mesh-list
20161637|NCT00125411|Satraplatin|satraplatin|mesh-list
20161638|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161639|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
20161640|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
20161641|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
20161642|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161643|NCT00125424|Midazolam|midazolam|mesh-list
20161644|NCT00125424|Fospropofol|fospropofol|mesh-list
20161645|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20161646|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20161647|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161648|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161649|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19801955|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
20326843|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
20161650|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20161651|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161652|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20161653|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
20161654|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
20161655|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
20161656|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
20161657|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161658|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161659|NCT00125437|Spironolactone|spironolactone|mesh-list
20161660|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20161661|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
20161662|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20161663|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161664|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20161665|NCT00125437|Diuretics|diuretics|mesh-ancestor
20161666|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
20161667|NCT00125463|Candesartan|candesartan|mesh-list
20161668|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
20161669|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20161670|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20161671|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20161672|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161673|NCT00125489|Chloroquine|chloroquine|mesh-list
20161674|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20161675|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
20161676|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
20161677|NCT00125489|Amebicides|amebicides|mesh-ancestor
20161678|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20161679|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20161680|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161681|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
20161682|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20161683|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20161684|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20161685|NCT00125489|Analgesics|analgesics|mesh-ancestor
20326844|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
19801956|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19801957|NCT00398567|Trastuzumab|trastuzumab|mesh-list
19801958|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19801959|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19801960|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19801961|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19801962|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19801963|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801964|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801965|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19801966|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801967|NCT00398632|Analgesics|analgesics|mesh-ancestor
19801968|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
19801969|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801970|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
19801971|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19801972|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
19801973|NCT00398866|Triamcinolone|triamcinolone|mesh-list
19801974|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19801975|NCT00398866|Bupivacaine|bupivacaine|mesh-list
19801976|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
19801977|NCT00398866|Hylan|hylan|mesh-list
19801978|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
19801979|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
19801980|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19801981|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19801982|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
19801983|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19801984|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19801985|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
19801986|NCT00398866|Hormones|hormones|mesh-ancestor
20326845|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
20326846|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
20326847|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
20326848|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801987|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19801988|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161686|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
19801989|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
19801990|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19801991|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
19801992|NCT00398866|Protective Agents|protective agents|mesh-ancestor
19801993|NCT00398918|Zonisamide|zonisamide|mesh-list
19801994|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
19801995|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20326849|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
20326850|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20326851|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
20326852|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326853|NCT00751257|Expectorants|expectorants|mesh-ancestor
20326854|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
20326855|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20326856|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
20326857|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326858|NCT00751257|Protective Agents|protective agents|mesh-ancestor
20326859|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326860|NCT00751257|Antidotes|antidotes|mesh-ancestor
19801996|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19801997|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19801998|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19645137|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19645138|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19645139|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
19645140|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19645141|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645142|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645143|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326861|NCT00751270|Valacyclovir|valacyclovir|mesh-list
20326862|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
20326863|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326864|NCT00751374|Gentamicins|gentamicins|mesh-list
20326865|NCT00751374|Mupirocin|mupirocin|mesh-list
20326866|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20326867|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326868|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20326869|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326870|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326871|NCT00751478|Naltrexone|naltrexone|mesh-list
19801999|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802000|NCT00398983|Decitabine|decitabine|mesh-list
19802001|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19802002|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
19802003|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802004|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802005|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802006|NCT00399035|Leucovorin|leucovorin|mesh-list
19802007|NCT00399035|Fluorouracil|fluorouracil|mesh-list
19802008|NCT00399035|Capecitabine|capecitabine|mesh-list
19802009|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
19802010|NCT00399035|Cediranib|cediranib|mesh-list
19802011|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
19802012|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
19802013|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802014|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326872|NCT00751478|Morphine|morphine|mesh-list
20326873|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20326874|NCT00751478|Narcotics|narcotics|mesh-ancestor
20326875|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326876|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326877|NCT00751478|Analgesics|analgesics|mesh-ancestor
20326878|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
20326879|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326880|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20326881|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20326882|NCT00751491|Clopidogrel|clopidogrel|mesh-list
20326883|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20326884|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19645144|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19645145|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20326885|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19645146|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802015|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326886|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20326887|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
20611605|NCT00602641|Melphalan|melphalan|mesh-list
19802016|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802017|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
19802018|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802019|NCT00399035|Antidotes|antidotes|mesh-ancestor
19802020|NCT00399035|Protective Agents|protective agents|mesh-ancestor
19802021|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
19802022|NCT00399035|Vitamins|vitamins|mesh-ancestor
19802023|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
19802024|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19802025|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802026|NCT00399360|Metformin|metformin|mesh-list
19802027|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19802028|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802029|NCT00399490|Tanezumab|tanezumab|mesh-list
19802030|NCT00399490|Analgesics|analgesics|mesh-ancestor
19802031|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
19802032|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802033|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802034|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
19802035|NCT00399529|Trastuzumab|trastuzumab|mesh-list
19802036|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802037|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
19802038|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802039|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802040|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19802041|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
19802042|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802043|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802044|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19802045|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802046|NCT00399542|Lubiprostone|lubiprostone|mesh-list
19802047|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20326888|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326889|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326890|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802048|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802049|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802050|NCT00399568|Acetaminophen|acetaminophen|mesh-list
19802051|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19802052|NCT00399568|Analgesics|analgesics|mesh-ancestor
19802053|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
19802054|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802055|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802056|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
19802057|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19802058|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19802059|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802060|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802061|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802062|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
20161687|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161688|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161689|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20161690|NCT00125489|Filaricides|filaricides|mesh-ancestor
20161691|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
19802063|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802064|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802065|NCT00399893|Octreotide|octreotide|mesh-list
19802066|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802067|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19802068|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802069|NCT00400153|Ipratropium|ipratropium|mesh-list
19802070|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19802071|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
19802072|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802073|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802074|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19802075|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
20161692|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
20161693|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20161694|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802076|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19802077|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
20161695|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802078|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802079|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802080|NCT00400179|Cisplatin|cisplatin|mesh-list
19802081|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802082|NCT00400205|Docetaxel|docetaxel|mesh-list
19802083|NCT00400205|Fluorouracil|fluorouracil|mesh-list
19802084|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802085|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
19802086|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
19802087|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
19802088|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802089|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
19802090|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19802091|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802092|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
19802093|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802094|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
19802095|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19802096|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802097|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19802098|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
19802099|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802100|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802101|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802102|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802103|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
19802104|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19802105|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19802106|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
19802107|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802108|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19802109|NCT00400517|Thalidomide|thalidomide|mesh-list
19802110|NCT00400517|Sargramostim|sargramostim|mesh-list
19802111|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802112|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
19802113|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802114|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
19802115|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802116|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802117|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19802118|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802119|NCT00400517|Growth Substances|growth substances|mesh-ancestor
19802120|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802121|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802122|NCT00400569|Sunitinib|sunitinib|mesh-list
19802123|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802124|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19802125|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802126|NCT00400569|Growth Substances|growth substances|mesh-ancestor
19802127|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802128|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802129|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19802130|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802131|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802132|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
19802133|NCT00400686|Hematinics|hematinics|mesh-ancestor
19802134|NCT00400764|Rituximab|rituximab|mesh-list
19802135|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802136|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802137|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
19802138|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161696|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20161697|NCT00125489|Renal Agents|renal agents|mesh-ancestor
20161698|NCT00125554|Metyrapone|metyrapone|mesh-list
20161699|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
20161700|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161701|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161702|NCT00125567|Levodopa|levodopa|mesh-list
20161703|NCT00125567|Carbidopa|carbidopa|mesh-list
20161704|NCT00125567|Entacapone|entacapone|mesh-list
20161705|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20161706|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20161707|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
20161708|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161709|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802139|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326891|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20326892|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
20326893|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20326894|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20326895|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20326896|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20326897|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326898|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
20326899|NCT00751517|Methotrexate|methotrexate|mesh-list
20326900|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20326901|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
20326902|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326903|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326904|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20326905|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
20326906|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326907|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326908|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19802140|NCT00400803|Gemcitabine|gemcitabine|mesh-list
19802141|NCT00400803|Bevacizumab|bevacizumab|mesh-list
19802142|NCT00400803|Carboplatin|carboplatin|mesh-list
19802143|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20161710|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161711|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20161712|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802144|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802145|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19802146|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802147|NCT00400803|Growth Substances|growth substances|mesh-ancestor
19802148|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802149|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802150|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19802151|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
19802152|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802153|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
19802154|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802155|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802156|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802157|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
19802158|NCT00400946|Leucovorin|leucovorin|mesh-list
19802159|NCT00400946|Cytarabine|cytarabine|mesh-list
19802160|NCT00400946|Dexamethasone|dexamethasone|mesh-list
19802161|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
19802162|NCT00400946|Prednisolone|prednisolone|mesh-list
19802163|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
19802164|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19802165|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19802166|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19802167|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
19802168|NCT00400946|Doxorubicin|doxorubicin|mesh-list
19802169|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19802170|NCT00400946|Methotrexate|methotrexate|mesh-list
19802171|NCT00400946|Etoposide|etoposide|mesh-list
20161713|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20161714|NCT00125645|Irbesartan|irbesartan|mesh-list
20161715|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20161716|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20161717|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20161718|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161719|NCT00125671|Warfarin|warfarin|mesh-list
20161720|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
20161721|NCT00125684|Morphine|morphine|mesh-list
20161722|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20161723|NCT00125684|Narcotics|narcotics|mesh-ancestor
20161724|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161725|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161726|NCT00125684|Analgesics|analgesics|mesh-ancestor
20161727|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
20161728|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161729|NCT00125736|Rabeprazole|rabeprazole|mesh-list
20161730|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20161731|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802172|NCT00400946|Vincristine|vincristine|mesh-list
19802173|NCT00400946|Asparaginase|asparaginase|mesh-list
19802174|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
19802175|NCT00400946|Pegaspargase|pegaspargase|mesh-list
19802176|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
19802177|NCT00400946|Razoxane|razoxane|mesh-list
19802178|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
19802179|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802180|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
19802181|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802182|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802183|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19802184|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
19802185|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802186|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802187|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19802188|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802189|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
19802190|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
19802191|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802192|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802193|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
19802194|NCT00400946|Hormones|hormones|mesh-ancestor
19802195|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19802196|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19802197|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19802198|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19802199|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19802200|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802201|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19802202|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
19802203|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19802204|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19802205|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
19802206|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
19802207|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19802208|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19802209|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19802210|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
19802211|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802212|NCT00400946|Antidotes|antidotes|mesh-ancestor
19802213|NCT00400946|Protective Agents|protective agents|mesh-ancestor
19802214|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
19802215|NCT00400946|Vitamins|vitamins|mesh-ancestor
19802216|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
19802217|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
19802218|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
19802219|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
19802220|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20326909|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20326910|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
20326911|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20326912|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20326913|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
20326914|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
20326915|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326916|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20326917|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20326918|NCT00751556|Naproxen|naproxen|mesh-list
20326919|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20326920|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326921|NCT00751556|Analgesics|analgesics|mesh-ancestor
20326922|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
20326923|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326924|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326925|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645147|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
19645148|NCT02368561|Hylan|hylan|mesh-list
19645149|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19645150|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
19645151|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645152|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
19645153|NCT02368561|Protective Agents|protective agents|mesh-ancestor
19645154|NCT02368288|Entecavir|entecavir|mesh-list
19645155|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
19645156|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645157|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
19645158|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
19645159|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19645160|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
19645161|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802221|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19802222|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
19802223|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19802224|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19802225|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802226|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
19802227|NCT00401193|Coagulants|coagulants|mesh-ancestor
19802228|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19802229|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19802230|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802231|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802232|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802233|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802234|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802235|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
19802236|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802237|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19802238|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19802239|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802240|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802241|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802242|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802243|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802244|NCT00401258|Analgesics|analgesics|mesh-ancestor
19802245|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
19802246|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802247|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
19802248|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802249|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
19802250|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
19802251|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19802252|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802253|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
19802254|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802255|NCT00401401|Zalutumumab|zalutumumab|mesh-list
19802256|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326926|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326927|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
20326928|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20326929|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326930|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326931|NCT00751699|Mesalamine|mesalamine|mesh-list
20326932|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20326933|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20326934|NCT00751699|Analgesics|analgesics|mesh-ancestor
20326935|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
20326936|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20326937|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326938|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326939|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20326940|NCT00751738|Azimilide|azimilide|mesh-list
20326941|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19802257|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802258|NCT00401414|Warfarin|warfarin|mesh-list
19802259|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
19802260|NCT00401531|Vaccines|vaccines|mesh-list
19802261|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19802262|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
19802263|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802264|NCT00401544|Dextrans|dextrans|mesh-list
19802265|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
19802266|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
19802267|NCT00401544|Hematinics|hematinics|mesh-ancestor
19802268|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
19802269|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
19802270|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
19802271|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19802272|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19802273|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802274|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802275|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802276|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20326942|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19802277|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802278|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19802279|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
19802280|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802281|NCT00401752|Esomeprazole|esomeprazole|mesh-list
19802282|NCT00401752|Ranitidine|ranitidine|mesh-list
19802283|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19802284|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19802285|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802286|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19802287|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802288|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802289|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19802290|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
19802291|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
20326943|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20326944|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326945|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20326946|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326947|NCT00751751|Losartan|losartan|mesh-list
20326948|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20326949|NCT00751751|Olmesartan|olmesartan|mesh-list
20326950|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20326951|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20326952|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326953|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20326954|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20326955|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326956|NCT00751751|Diuretics|diuretics|mesh-ancestor
20326957|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
20326958|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326959|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20326960|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802292|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802293|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802294|NCT00401778|Everolimus|everolimus|mesh-list
19802295|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802296|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802297|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
20161732|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20161733|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161734|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161735|NCT00125749|Vaccines|vaccines|mesh-list
20161736|NCT00125749|Immunologic Factors|immunologic factors|mesh-ancestor
20161737|NCT00125749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161738|NCT00125801|Hydromorphone|hydromorphone|mesh-list
20161739|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20161740|NCT00125801|Narcotics|narcotics|mesh-ancestor
20161741|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161742|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326961|NCT00751764|Moxidectin|moxidectin|mesh-list
19645162|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645163|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19645164|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
19645165|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19645166|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
19645167|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645168|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645169|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19645170|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645171|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
19645172|NCT02368171|Protective Agents|protective agents|mesh-ancestor
19645173|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
19645174|NCT02368054|Epinephrine|epinephrine|mesh-list
19645175|NCT02368054|Racepinephrine|racepinephrine|mesh-list
19802298|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802299|NCT00401817|Bevacizumab|bevacizumab|mesh-list
19802300|NCT00401817|Rituximab|rituximab|mesh-list
19802301|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802302|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802303|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19802304|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802305|NCT00401817|Growth Substances|growth substances|mesh-ancestor
19802306|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802307|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802308|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
19802309|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802310|NCT00401830|Lacosamide|lacosamide|mesh-list
20161743|NCT00125801|Analgesics|analgesics|mesh-ancestor
20161744|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
19802311|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
19802312|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19802313|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19802314|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802315|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802316|NCT00401843|Dexamethasone|dexamethasone|mesh-list
19802317|NCT00401843|Bortezomib|bortezomib|mesh-list
19802318|NCT00401843|Siltuximab|siltuximab|mesh-list
19802319|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802320|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
19802321|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
19802322|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802323|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802324|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802325|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
19802326|NCT00401843|Hormones|hormones|mesh-ancestor
19802327|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19802328|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19802329|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802330|NCT00401882|Metoprolol|metoprolol|mesh-list
19802331|NCT00401882|Epinephrine|epinephrine|mesh-list
19802332|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19802333|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19802334|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
19802335|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802336|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802337|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802338|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19802339|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19802340|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
19802341|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802342|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19802343|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
19802344|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
19802345|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
19802346|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19802347|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19802348|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19802349|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
19802350|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19802351|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19802352|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19802353|NCT00401960|Daptomycin|daptomycin|mesh-list
19802354|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802355|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802356|NCT00401973|Metformin|metformin|mesh-list
19802357|NCT00401973|Amantadine|amantadine|mesh-list
19802358|NCT00401973|Zonisamide|zonisamide|mesh-list
19802359|NCT00401973|Olanzapine|olanzapine|mesh-list
19802360|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19802361|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802362|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
19802363|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
19802364|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161745|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161746|NCT00125814|Interferons|interferons|mesh-list
20161747|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
20161748|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
20161749|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802365|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802366|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19802367|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19802368|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161750|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
19802369|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802370|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19802371|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802372|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802373|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802374|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802375|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
19802376|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19802377|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19802378|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
19802379|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802380|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
19802381|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19802382|NCT00401973|Analgesics|analgesics|mesh-ancestor
19802383|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
19802384|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
19802385|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19802386|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19802387|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19802388|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802389|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802390|NCT00402051|Carboplatin|carboplatin|mesh-list
19802391|NCT00402051|Pemetrexed|pemetrexed|mesh-list
19802392|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802393|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802394|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802395|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19802396|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19802397|NCT00402103|Amlodipine|amlodipine|mesh-list
19802398|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19802399|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19802400|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19802401|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802402|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802403|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20161751|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645176|NCT02368054|Bupivacaine|bupivacaine|mesh-list
19645177|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
19645178|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
19645179|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
19645180|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645181|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645182|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
20161752|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
20161753|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161754|NCT00125827|Clofarabine|clofarabine|mesh-list
20161755|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161756|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
20161757|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161758|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161759|NCT00125840|Clofarabine|clofarabine|mesh-list
20161760|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161761|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
20161762|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161763|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161764|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20161765|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20326962|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
20326963|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19645183|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645184|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19645185|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19645186|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645187|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645188|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645189|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19645190|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19645191|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
19645192|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19645193|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
20326964|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20326965|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
20326966|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20326967|NCT00751829|Olmesartan|olmesartan|mesh-list
20326968|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20326969|NCT00751829|Nitrendipine|nitrendipine|mesh-list
20326970|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20326971|NCT00751829|Diuretics|diuretics|mesh-ancestor
20326972|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
19802404|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802405|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
19802406|NCT00402103|Diuretics|diuretics|mesh-ancestor
19802407|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
19802408|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19802409|NCT00402116|Temozolomide|temozolomide|mesh-list
19802410|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19802411|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
19802412|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802413|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802414|NCT00402168|Cyclosporine|cyclosporine|mesh-list
20326973|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20326974|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20326975|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20326976|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326977|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20326978|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20326979|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20326980|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20326981|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
20326982|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
20326983|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20326984|NCT00751907|Atorvastatin|atorvastatin|mesh-list
20326985|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20326986|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20326987|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
20326988|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20326989|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20326990|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20326991|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20326992|NCT00751959|Poractant alfa|poractant alfa|mesh-list
20326993|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20326994|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
20326995|NCT00752011|Carboplatin|carboplatin|mesh-list
20326996|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20326997|NCT00752024|Hemostatics|hemostatics|mesh-list
20326998|NCT00752024|Coagulants|coagulants|mesh-ancestor
20326999|NCT00752037|Ritonavir|ritonavir|mesh-list
20327000|NCT00752037|Lopinavir|lopinavir|mesh-list
20327001|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
20327002|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20327003|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19802415|NCT00402168|Abatacept|abatacept|mesh-list
19802416|NCT00402168|Tacrolimus|tacrolimus|mesh-list
19802417|NCT00402168|Cyclosporins|cyclosporins|mesh-list
19802418|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802419|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
19802420|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802421|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19802422|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802423|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802424|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
19802425|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802426|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
19802427|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802428|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19802429|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802430|NCT00402194|Losartan|losartan|mesh-list
19802431|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19802432|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19802433|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19802434|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19802435|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327004|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
20327005|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611606|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
19802436|NCT00402233|Pramipexole|pramipexole|mesh-list
19802437|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
19802438|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802439|NCT00402233|Protective Agents|protective agents|mesh-ancestor
19802440|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327006|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327007|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20327008|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20327009|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
19802441|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19802442|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19802443|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
19802444|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
19802445|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802446|NCT00402285|Lycopene|lycopene|mesh-list
19802447|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802448|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
19802449|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802450|NCT00402285|Protective Agents|protective agents|mesh-ancestor
19802451|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802452|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19802453|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19802454|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802455|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19802456|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
19802457|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802458|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802459|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
19802460|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802461|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802462|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19802463|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802464|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802465|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
19802466|NCT00402324|Valproic Acid|valproic acid|mesh-list
19802467|NCT00402324|Olanzapine|olanzapine|mesh-list
19802468|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
19802469|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
19802470|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802471|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802472|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802473|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19802474|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19802475|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19802476|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802477|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19802478|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802479|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802480|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802481|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802482|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
19802483|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
19802484|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802485|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
19802486|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
20327010|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327011|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19645194|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
19802487|NCT00402337|Linaclotide|linaclotide|mesh-list
19645195|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
19645196|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19645197|NCT02368379|Metyrapone|metyrapone|mesh-list
19645198|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
19645199|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645200|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645201|NCT02368015|Cefazolin|cefazolin|mesh-list
19645202|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19645203|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645204|NCT02368197|Paclitaxel|paclitaxel|mesh-list
19645205|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19645206|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802488|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19802489|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
19802490|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802491|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802492|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
19802493|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19802494|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
19802495|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19802496|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
19802497|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802498|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802499|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
19802500|NCT00402688|Levofloxacin|levofloxacin|mesh-list
19802501|NCT00402688|Ofloxacin|ofloxacin|mesh-list
19802502|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19802503|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802504|NCT00402688|Renal Agents|renal agents|mesh-ancestor
19802505|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802506|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19802507|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19802508|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802509|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802510|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802511|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19802512|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19802513|NCT00402714|Pentostatin|pentostatin|mesh-list
19802514|NCT00402714|Methoxsalen|methoxsalen|mesh-list
19802515|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802516|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19802517|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802518|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802519|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19802520|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
19802521|NCT00402727|Amoxicillin|amoxicillin|mesh-list
19802522|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
19802523|NCT00402727|Tazobactam|tazobactam|mesh-list
19802524|NCT00402727|Piperacillin|piperacillin|mesh-list
19802525|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
19802526|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
19802527|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19802528|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19802529|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802530|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802531|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19802532|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19802533|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802534|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802535|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802536|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19802537|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
19802538|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19802539|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802540|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19802541|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19802542|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19802543|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19802544|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19802545|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802546|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19802547|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802548|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802549|NCT00402896|Mitogens|mitogens|mesh-list
19802550|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
19802551|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
20161766|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161767|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161768|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161769|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161770|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161771|NCT00125892|Analgesics|analgesics|mesh-ancestor
20161772|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
20161773|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161774|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
20161775|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161776|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
20161777|NCT00125905|Bupropion|bupropion|mesh-list
19802552|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645207|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
19645208|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
19645209|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
19645210|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161778|NCT00125905|Nicotine|nicotine|mesh-list
20161779|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19664027|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664028|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664029|NCT04908293|Listerine|listerine|mesh-list
19664030|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
19802553|NCT00402896|Growth Substances|growth substances|mesh-ancestor
19802554|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664031|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
19664032|NCT04908293|Protective Agents|protective agents|mesh-ancestor
19664033|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802555|NCT00402987|Celecoxib|celecoxib|mesh-list
19802556|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19802557|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19802558|NCT00402987|Analgesics|analgesics|mesh-ancestor
19802559|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
19802560|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802561|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802562|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802563|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802564|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19802565|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19802566|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802567|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802568|NCT00403117|Naltrexone|naltrexone|mesh-list
19802569|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20327012|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20327013|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20327014|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20327015|NCT00752063|Capecitabine|capecitabine|mesh-list
19664034|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19802570|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19802571|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802572|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
19802573|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802574|NCT00403130|Gemcitabine|gemcitabine|mesh-list
19802575|NCT00403130|Paclitaxel|paclitaxel|mesh-list
19802576|NCT00403130|Bevacizumab|bevacizumab|mesh-list
19802577|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19802578|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802579|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
19802580|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
19802581|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
19802582|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802583|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802584|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19802585|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802586|NCT00403130|Growth Substances|growth substances|mesh-ancestor
19802587|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802588|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802589|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19802590|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
19802591|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
19802592|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802593|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802594|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802595|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
19802596|NCT00403234|Buprenorphine|buprenorphine|mesh-list
19802597|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19802598|NCT00403234|Narcotics|narcotics|mesh-ancestor
20161780|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
20161781|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161782|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161783|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20161784|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20161785|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
20161786|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161787|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161788|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20161789|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
20327016|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
20327017|NCT00752063|Sorafenib|sorafenib|mesh-list
20327018|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20327019|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
20327020|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327021|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327022|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20327023|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327024|NCT00752115|Paclitaxel|paclitaxel|mesh-list
20327025|NCT00752115|Carboplatin|carboplatin|mesh-list
20327026|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
20327027|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20327028|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327029|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
20327030|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327031|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327032|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327033|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
20327034|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19802599|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19802600|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802601|NCT00403234|Analgesics|analgesics|mesh-ancestor
19802602|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
19802603|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802604|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19802605|NCT00403260|Artesunate|artesunate|mesh-list
19802606|NCT00403260|Mefloquine|mefloquine|mesh-list
19802607|NCT00403260|Pyronaridine|pyronaridine|mesh-list
19802608|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
19802609|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19802610|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19802611|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802612|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802613|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
19802614|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
19802615|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19802616|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
19802617|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
19802618|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19802619|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19802620|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19802621|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802622|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802623|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
19802624|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802625|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802626|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19802627|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802628|NCT00403403|Bevacizumab|bevacizumab|mesh-list
19802629|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802630|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802631|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19802632|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802633|NCT00403403|Growth Substances|growth substances|mesh-ancestor
19802634|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802635|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802636|NCT00403455|Paroxetine|paroxetine|mesh-list
19802637|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19802638|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802639|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802640|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802641|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802642|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
19802643|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802644|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19802645|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
19802646|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802647|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19802648|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19802649|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802650|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20327035|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19802651|NCT00403481|Olmesartan|olmesartan|mesh-list
19802652|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20327036|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802653|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19802654|NCT00403481|Diuretics|diuretics|mesh-ancestor
19802655|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
19802656|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802657|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19802658|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802659|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802660|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19802661|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19802662|NCT00403494|Verapamil|verapamil|mesh-list
19802663|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19802664|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19802665|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802666|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802667|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19802668|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802669|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
19802670|NCT00403546|Ziprasidone|ziprasidone|mesh-list
19802671|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19802672|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
19802673|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802674|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802675|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802676|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19802677|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19802678|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19802679|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802680|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19802681|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
19802682|NCT00403585|Adefovir|adefovir|mesh-list
19802683|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19802684|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
19802685|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802686|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19802687|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19802688|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802689|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802690|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19802691|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19802692|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
19802693|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802694|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802695|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19802696|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
20161790|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20327037|NCT00752115|Urological Agents|urological agents|mesh-ancestor
20327038|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
20327039|NCT00752141|Oxybutynin|oxybutynin|mesh-list
20327040|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
20327041|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
20161791|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20161792|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161793|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161794|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
20161795|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20161796|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20161797|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161798|NCT00125918|Tadalafil|tadalafil|mesh-list
20161799|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645211|NCT02368249|Terlipressin|terlipressin|mesh-list
19645212|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19645213|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19645214|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
19645215|NCT02367937|Midazolam|midazolam|mesh-list
19645216|NCT02367937|Omeprazole|omeprazole|mesh-list
19645217|NCT02367937|Simvastatin|simvastatin|mesh-list
19645218|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19645219|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19645220|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645221|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645222|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19645223|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19645224|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19645225|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20327042|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327043|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327044|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20327045|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20327046|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
20327047|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327048|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327049|NCT00752141|Urological Agents|urological agents|mesh-ancestor
20327050|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20327051|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327052|NCT00752141|Renal Agents|renal agents|mesh-ancestor
20327053|NCT00752154|Curcumin|curcumin|mesh-list
20327054|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20327055|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20327056|NCT00752154|Analgesics|analgesics|mesh-ancestor
20327057|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
20327058|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327059|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327060|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327061|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327062|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327063|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327064|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327065|NCT00752180|Insulin|insulin|mesh-list
20327066|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19802697|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19802698|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19802699|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19802700|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
19802701|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802702|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802703|NCT00403767|Warfarin|warfarin|mesh-list
19802704|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
19802705|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
19802706|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19802707|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
19802708|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19802709|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
19802710|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802711|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802712|NCT00404066|Dexamethasone|dexamethasone|mesh-list
19802713|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
19802714|NCT00404066|Docetaxel|docetaxel|mesh-list
19802715|NCT00404066|Doxorubicin|doxorubicin|mesh-list
19802716|NCT00404066|Trastuzumab|trastuzumab|mesh-list
19802717|NCT00404066|Lapatinib|lapatinib|mesh-list
19802718|NCT00404066|Lenograstim|lenograstim|mesh-list
19802719|NCT00404066|Sargramostim|sargramostim|mesh-list
19802720|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802721|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
19802722|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802723|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802724|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19802725|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
19802726|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802727|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802728|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19802729|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802730|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
19802731|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
19802732|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802733|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19802734|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
19802735|NCT00404066|Hormones|hormones|mesh-ancestor
19802736|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19802737|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19802738|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
19802739|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
19802740|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
19802741|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19802742|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19802743|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19802744|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327067|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19802745|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802746|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19802747|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19802748|NCT00404092|Caspofungin|caspofungin|mesh-list
19802749|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
19802750|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802751|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802752|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834290|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19834291|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
19834292|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834293|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834294|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
19834295|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834296|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834297|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
19834298|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327068|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327069|NCT00752310|Darunavir|darunavir|mesh-list
20327070|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20327071|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20327072|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
20327073|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327074|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327075|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20327076|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20327077|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
20327078|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327079|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20327080|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20327081|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
20327082|NCT00752375|Trimethoprim|trimethoprim|mesh-list
20347835|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19834299|NCT00593827|Epothilones|epothilones|mesh-list
19834300|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
19834301|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
19834302|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834303|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834304|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834305|NCT00593866|Gemcitabine|gemcitabine|mesh-list
19834306|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19834307|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
19834308|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834309|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834310|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
19834311|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834312|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834313|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834314|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
19834315|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834316|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
19834317|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
19834318|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
19834319|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19834320|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19834321|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834322|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834323|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834324|NCT00594165|Rotigotine|rotigotine|mesh-list
19834325|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
19834326|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
19834327|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834328|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834329|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834330|NCT00594204|Varenicline|varenicline|mesh-list
19834331|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19834332|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19834333|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
19834334|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161800|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20161801|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20161802|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161803|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161804|NCT00125918|Urological Agents|urological agents|mesh-ancestor
20161805|NCT00125983|Ritonavir|ritonavir|mesh-list
20161806|NCT00125983|Lopinavir|lopinavir|mesh-list
20161807|NCT00125983|Norinyl|norinyl|mesh-list
20327083|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20327084|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
20327085|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19802753|NCT00404235|Paclitaxel|paclitaxel|mesh-list
19802754|NCT00404235|Carboplatin|carboplatin|mesh-list
19802755|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19802756|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19802757|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802758|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
19802759|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327086|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327087|NCT00752375|Renal Agents|renal agents|mesh-ancestor
20327088|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
20327089|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20327090|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20327091|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20327092|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327093|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327094|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20327095|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20327096|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20327097|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327098|NCT00752401|Vitamin D|vitamin d|mesh-list
20327099|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
19802760|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
19802761|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802762|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
19802763|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19802764|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
19802765|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802766|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802767|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
19802768|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802769|NCT00404495|Irinotecan|irinotecan|mesh-list
19802770|NCT00404495|Temozolomide|temozolomide|mesh-list
19802771|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19802772|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19802773|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802774|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802775|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802776|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19802777|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
19802778|NCT00404547|Ciclesonide|ciclesonide|mesh-list
19802779|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
19802780|NCT00404547|Hormones|hormones|mesh-ancestor
19802781|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19802782|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802783|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19802784|NCT00404651|Vaccines|vaccines|mesh-list
19802785|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
19802786|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802787|NCT00404755|Citalopram|citalopram|mesh-list
19802788|NCT00404755|Bupropion|bupropion|mesh-list
19802789|NCT00404755|Imipramine|imipramine|mesh-list
19802790|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19802791|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19802792|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19802793|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802794|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19802795|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
19802796|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327100|NCT00752401|Vitamins|vitamins|mesh-ancestor
20327101|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
20327102|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327103|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20327104|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20327105|NCT00752414|Levofloxacin|levofloxacin|mesh-list
20327106|NCT00752414|Ofloxacin|ofloxacin|mesh-list
20327107|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19802797|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19802798|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
19802799|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19802800|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19802801|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
20327108|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802802|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19802803|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19802804|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161808|NCT00125983|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20161809|NCT00125983|Ortho Evra|ortho evra|mesh-list
20161810|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20161811|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19802805|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19802806|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19802807|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
19802808|NCT00404820|Vitamin D|vitamin d|mesh-list
20327109|NCT00752414|Renal Agents|renal agents|mesh-ancestor
20327110|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802809|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
19802810|NCT00404820|Alendronate|alendronate|mesh-list
19802811|NCT00404820|Calcium|calcium|mesh-list
19802812|NCT00404820|Vitamins|vitamins|mesh-ancestor
19802813|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
19802814|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802815|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19802816|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19802817|NCT00405067|Ezetimibe|ezetimibe|mesh-list
19802818|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19802819|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19802820|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
19802821|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802822|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19802823|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
19802824|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
19802825|NCT00405275|Etanercept|etanercept|mesh-list
19802826|NCT00405275|Methotrexate|methotrexate|mesh-list
19802827|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19802828|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
19802829|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19802830|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802831|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19802832|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
19802833|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802834|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802835|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
19802836|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802837|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19802838|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802839|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
19802840|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802841|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19802842|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
19802843|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19802844|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19802845|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802846|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19802847|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19802848|NCT00405275|Analgesics|analgesics|mesh-ancestor
20327111|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20327112|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327113|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327114|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327115|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327116|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20327117|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20347836|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20347837|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347838|NCT00862043|Urological Agents|urological agents|mesh-ancestor
20347839|NCT00862095|Topiramate|topiramate|mesh-list
20347840|NCT00862095|Propranolol|propranolol|mesh-list
20161812|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
20161813|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161814|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161815|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20161816|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20161817|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
20161818|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161819|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20347841|NCT00862095|Amitriptyline|amitriptyline|mesh-list
19802849|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
20327118|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19802850|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802851|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802852|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645226|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
19645227|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
19645228|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
19645229|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
19645230|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645231|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645232|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19645233|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19645234|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
19645235|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19645236|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19645237|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645238|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19645239|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645240|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19645241|NCT02367937|Analgesics|analgesics|mesh-ancestor
19645242|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
19645243|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645244|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19645245|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645246|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645247|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645248|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19645249|NCT02367924|Trabectedin|trabectedin|mesh-list
19645250|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19645251|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
19645252|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645253|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645254|NCT02367807|Tenofovir|tenofovir|mesh-list
19645255|NCT02367807|Emtricitabine|emtricitabine|mesh-list
19645256|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
19645257|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645258|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19645259|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19645260|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645261|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645262|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19645263|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19802853|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
19802854|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19802855|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19802856|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19802857|NCT00405288|Pramoxine|pramoxine|mesh-list
19802858|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802859|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
19802860|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
19802861|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19802862|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802863|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
19802864|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802865|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
19802866|NCT00405353|Testosterone|testosterone|mesh-list
19802867|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
19802868|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
19802869|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19802870|NCT00405353|Androgens|androgens|mesh-ancestor
19802871|NCT00405353|Hormones|hormones|mesh-ancestor
19802872|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19802873|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802874|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19802875|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327119|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19645264|NCT02367755|Lorazepam|lorazepam|mesh-list
19645265|NCT02367755|Propofol|propofol|mesh-list
19645266|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19645267|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645268|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645269|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19645270|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
19645271|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
19645272|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
20327120|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20327121|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327122|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802876|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
19802877|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
19802878|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19802879|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802880|NCT00405522|Remifentanil|remifentanil|mesh-list
19802881|NCT00405522|Propofol|propofol|mesh-list
19802882|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19802883|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19802884|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802885|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19802886|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
19802887|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
19802888|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19802889|NCT00405522|Narcotics|narcotics|mesh-ancestor
19802890|NCT00405522|Analgesics|analgesics|mesh-ancestor
19802891|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
19802892|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802893|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19802894|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
19802895|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802896|NCT00405587|Vemurafenib|vemurafenib|mesh-list
19802897|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802898|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19802899|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802900|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802901|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19802902|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
19802903|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802904|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
19802905|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19802906|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802907|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19802908|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
19802909|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802910|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802911|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802912|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802913|NCT00405704|Trimethoprim|trimethoprim|mesh-list
19802914|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19802915|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
19802916|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19802917|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802918|NCT00405704|Renal Agents|renal agents|mesh-ancestor
19802919|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
19802920|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19802921|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19802922|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19802923|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802924|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802925|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19802926|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19802927|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19802928|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19802929|NCT00405756|Aspirin|aspirin|mesh-list
19802930|NCT00405756|Prednisone|prednisone|mesh-list
19802931|NCT00405756|Lenalidomide|lenalidomide|mesh-list
19802932|NCT00405756|Melphalan|melphalan|mesh-list
19802933|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19802934|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
19802935|NCT00405756|Hormones|hormones|mesh-ancestor
19802936|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20161820|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20161821|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20161822|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20161823|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20161824|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
20161825|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20161826|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161827|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20161828|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20161829|NCT00125983|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19802937|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802938|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19802939|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802940|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19802941|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19802942|NCT00405756|Analgesics|analgesics|mesh-ancestor
19802943|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
19802944|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19802945|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19802946|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19802947|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19802948|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802949|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19802950|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19802951|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802952|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
19802953|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
19802954|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327123|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20327124|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20327125|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20327126|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
20327127|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327128|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802955|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802956|NCT00405756|Growth Substances|growth substances|mesh-ancestor
19802957|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802958|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19802959|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
19802960|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19802961|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802962|NCT00405821|Acyclovir|acyclovir|mesh-list
19802963|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
19802964|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19802965|NCT00405938|Bevacizumab|bevacizumab|mesh-list
19802966|NCT00405938|Fulvestrant|fulvestrant|mesh-list
19802967|NCT00405938|Anastrozole|anastrozole|mesh-list
19802968|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19802969|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802970|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19802971|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19802972|NCT00405938|Growth Substances|growth substances|mesh-ancestor
19802973|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802974|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
19802975|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19802976|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19802977|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19802978|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
19802979|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19802980|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19802981|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19802982|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19802983|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327129|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20327130|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20327131|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
20327132|NCT00752466|Topiramate|topiramate|mesh-list
20327133|NCT00752466|Flunarizine|flunarizine|mesh-list
20327134|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
20327135|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20327136|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327137|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20327138|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20327139|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327140|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20327141|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20327142|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
20327143|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
19802984|NCT00406029|Levodopa|levodopa|mesh-list
19802985|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19802986|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19802987|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
19802988|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327144|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327145|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
20327146|NCT00752479|Cyclosporine|cyclosporine|mesh-list
20327147|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
20327148|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
20327149|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19802989|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802990|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19802991|NCT00406276|Docetaxel|docetaxel|mesh-list
20327150|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20327151|NCT00752479|Prednisolone|prednisolone|mesh-list
20327152|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
19645273|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
20161830|NCT00125983|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19802992|NCT00406276|Everolimus|everolimus|mesh-list
19802993|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19802994|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
19802995|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
19802996|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
19802997|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19802998|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19802999|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
19803000|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803001|NCT00406315|Ziprasidone|ziprasidone|mesh-list
19803002|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19803003|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
19803004|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803005|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803006|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803007|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19803008|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19803009|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19803010|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803011|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19803012|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
19803013|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19803014|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19803015|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20161831|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20161832|NCT00125996|Hematinics|hematinics|mesh-ancestor
20161833|NCT00126009|Amisulpride|amisulpride|mesh-list
20161834|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20161835|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20161836|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20161837|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161838|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161839|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20161840|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
20161841|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161842|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161843|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20161844|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
20161845|NCT00126022|Tedisamil|tedisamil|mesh-list
20161846|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20161847|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20161848|NCT00126022|Protective Agents|protective agents|mesh-ancestor
20161849|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161850|NCT00126048|Atorvastatin|atorvastatin|mesh-list
20161851|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20161852|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20161853|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
20161854|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161855|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20161856|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20161857|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161858|NCT00126061|Tedisamil|tedisamil|mesh-list
20161859|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20327153|NCT00752479|Cyclosporins|cyclosporins|mesh-list
20327154|NCT00752479|Basiliximab|basiliximab|mesh-list
19645274|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
19645275|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645276|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645277|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19645278|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19645279|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19645280|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
19645281|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
19803016|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803017|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803018|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
19803019|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803020|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803021|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19803022|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19803023|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803024|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803025|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19803026|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803027|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803028|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
19803029|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803030|NCT00406393|Sirolimus|sirolimus|mesh-list
19803031|NCT00406393|Methotrexate|methotrexate|mesh-list
19803032|NCT00406393|Tacrolimus|tacrolimus|mesh-list
19803033|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19803034|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
19803035|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19803036|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803037|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803038|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
19803039|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803040|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803041|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
19803042|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803043|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19803044|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803045|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
19803046|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803047|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803048|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19803049|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19803050|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803051|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19803052|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
19803053|NCT00406419|Methotrexate|methotrexate|mesh-list
19803054|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
19803055|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19803056|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
19803057|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19803058|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803059|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803060|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
19803061|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803062|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803063|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
19803064|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803065|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19803066|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803067|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
19803068|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803069|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803070|NCT00406640|Citalopram|citalopram|mesh-list
19803071|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19803072|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19803073|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19803074|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803075|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645282|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645283|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645284|NCT02367664|Vaccines|vaccines|mesh-list
19645285|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
19645286|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645287|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
19645288|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19645289|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19645290|NCT02367560|Prednisolone|prednisolone|mesh-list
19645291|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
20161860|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19645292|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19645293|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
20161861|NCT00126061|Protective Agents|protective agents|mesh-ancestor
20161862|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161863|NCT00126074|Tedisamil|tedisamil|mesh-list
20161864|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20161865|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20161866|NCT00126074|Protective Agents|protective agents|mesh-ancestor
20161867|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161868|NCT00126087|Dopamine|dopamine|mesh-list
20161869|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20161870|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
20161871|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
20161872|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20161873|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161874|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
20161875|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161876|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161877|NCT00126087|Protective Agents|protective agents|mesh-ancestor
20161878|NCT00126100|Sargramostim|sargramostim|mesh-list
20161879|NCT00126100|Lenograstim|lenograstim|mesh-list
20161880|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
20161881|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161882|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20327155|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
19803076|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803077|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
19803078|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327156|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20327157|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
20327158|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645294|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645295|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
19645296|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
20327159|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327160|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327161|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
20327162|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327163|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
20327164|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327165|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
20327166|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327167|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20327168|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20327169|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327170|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20327171|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
20327172|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327173|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327174|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
19645297|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327175|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
20327176|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327177|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20327178|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
20327179|NCT00752479|Hormones|hormones|mesh-ancestor
20327180|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327181|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20327182|NCT00752479|Protective Agents|protective agents|mesh-ancestor
20327183|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20327184|NCT00752518|Bortezomib|bortezomib|mesh-list
20327185|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327186|NCT00752544|Simeprevir|simeprevir|mesh-list
20327187|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
20327188|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327189|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
20327190|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645298|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645299|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645300|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
19645301|NCT02367560|Hormones|hormones|mesh-ancestor
19645302|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645303|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19645304|NCT02367560|Protective Agents|protective agents|mesh-ancestor
20161883|NCT00126139|Abciximab|abciximab|mesh-list
20161884|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
20161885|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20327191|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327192|NCT00752596|Azimilide|azimilide|mesh-list
20327193|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20327194|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20327195|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803079|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19803080|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
19803081|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803082|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19803083|NCT00406653|Abatacept|abatacept|mesh-list
19803084|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19803085|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803086|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803087|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327196|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327197|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20327198|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327199|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
20327200|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
20327201|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20327202|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20327203|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20327204|NCT00752635|Norgestimate|norgestimate|mesh-list
20327205|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20327206|NCT00752635|Estradiol|estradiol|mesh-list
20327207|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20327208|NCT00752635|Cyproterone|cyproterone|mesh-list
20327209|NCT00752635|Estrogens|estrogens|mesh-ancestor
19803088|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
19803089|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803090|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803091|NCT00406692|Zonisamide|zonisamide|mesh-list
19803092|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
19803093|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19803094|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803095|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803096|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19803097|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803098|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19803099|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19803100|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19803101|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803102|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803103|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803104|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327210|NCT00752635|Hormones|hormones|mesh-ancestor
20327211|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327212|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327213|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20327214|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
20327215|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20327216|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19803105|NCT00406848|Analgesics|analgesics|mesh-ancestor
19803106|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
19803107|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803108|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
19803109|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803110|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
19803111|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19803112|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19803113|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19803114|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803115|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803116|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19803117|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20327217|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19803118|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803119|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
19803120|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803121|NCT00407355|Ranibizumab|ranibizumab|mesh-list
19803122|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803123|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803124|NCT00407355|Growth Substances|growth substances|mesh-ancestor
19803125|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803126|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803127|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803128|NCT00407381|Ranibizumab|ranibizumab|mesh-list
19803129|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803130|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803131|NCT00407381|Growth Substances|growth substances|mesh-ancestor
19803132|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803133|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803134|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803135|NCT00407485|Aflibercept|aflibercept|mesh-list
19803136|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803137|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20327218|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20327219|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
20327220|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
20327221|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327222|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20327223|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19803138|NCT00407485|Growth Substances|growth substances|mesh-ancestor
19803139|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803140|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803141|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803142|NCT00407511|Pregabalin|pregabalin|mesh-list
19803143|NCT00407511|Analgesics|analgesics|mesh-ancestor
19803144|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
19803145|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803146|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803147|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
19803148|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19803149|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803150|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803151|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19803152|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19803153|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20327224|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327225|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327226|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20327227|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327228|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327229|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327230|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20327231|NCT00752648|Simeprevir|simeprevir|mesh-list
20327232|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
20327233|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327234|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
20327235|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327236|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327237|NCT00752661|Tramadol|tramadol|mesh-list
19645305|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19645306|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645307|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19645308|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19645309|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19645310|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
19645311|NCT02367196|Rituximab|rituximab|mesh-list
19645312|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19645313|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645314|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
19645315|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645316|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645317|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19645318|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19645319|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19645320|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803154|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327238|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20327239|NCT00752661|Narcotics|narcotics|mesh-ancestor
20327240|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327241|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327242|NCT00752661|Analgesics|analgesics|mesh-ancestor
20327243|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
20327244|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327245|NCT00752739|Selenium|selenium|mesh-list
20327246|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
20327247|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327248|NCT00752739|Protective Agents|protective agents|mesh-ancestor
20327249|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327250|NCT00752739|Trace Elements|trace elements|mesh-ancestor
20327251|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
20327252|NCT00752843|Mifepristone|mifepristone|mesh-list
20327253|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20161886|NCT00126204|Doxycycline|doxycycline|mesh-list
20161887|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20161888|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161889|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
20161890|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20161891|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20161892|NCT00126230|Docetaxel|docetaxel|mesh-list
20161893|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327254|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
20327255|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20327256|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327257|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20327258|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20327259|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20327260|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
20327261|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20327262|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20327263|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
20327264|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327265|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
20327266|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20327267|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20327268|NCT00752869|Dutasteride|dutasteride|mesh-list
20327269|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20327270|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20327271|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327272|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327273|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
20327274|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327275|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327276|NCT00752882|Ceftazidime|ceftazidime|mesh-list
20327277|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327278|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327279|NCT00752921|Etoricoxib|etoricoxib|mesh-list
19645321|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645322|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645323|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645324|NCT02367404|Analgesics|analgesics|mesh-ancestor
19645325|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
19645326|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645327|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
19645328|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19645329|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
19645330|NCT02367248|Deferoxamine|deferoxamine|mesh-list
19645331|NCT02367248|Siderophores|siderophores|mesh-ancestor
19645332|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19645333|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
19645334|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
19645335|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645336|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
19645337|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19645338|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
19645339|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19645340|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
19803155|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19645341|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161894|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
20161895|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
19645342|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803156|NCT00407537|Amlodipine|amlodipine|mesh-list
19803157|NCT00407537|Atorvastatin|atorvastatin|mesh-list
19803158|NCT00407537|Calcium|calcium|mesh-list
19803159|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19803160|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803161|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19803162|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19803163|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
19803164|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803165|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19803166|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19803167|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803168|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19803169|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19803170|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803171|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
19803172|NCT00407550|Gemcitabine|gemcitabine|mesh-list
19803173|NCT00407550|Pemetrexed|pemetrexed|mesh-list
19645343|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
19645344|NCT02367053|Glucagon|glucagon|mesh-list
19645345|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645346|NCT02367053|Hormones|hormones|mesh-ancestor
19645347|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645348|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645349|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19645350|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
19645351|NCT02366884|Clotrimazole|clotrimazole|mesh-list
19645352|NCT02366884|Miconazole|miconazole|mesh-list
19645353|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
19645354|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645355|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19645356|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19645357|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19645358|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645359|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645360|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19645361|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
19645362|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19803174|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803175|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
19803176|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803177|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803178|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
19803179|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803180|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327280|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20327281|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20327282|NCT00752921|Analgesics|analgesics|mesh-ancestor
20327283|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
20327284|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327285|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327286|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327287|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327288|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20327289|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20327290|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327291|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327292|NCT00752934|Baclofen|baclofen|mesh-list
20327293|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20327294|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327295|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20327296|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327297|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20327298|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
20327299|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
20327300|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327301|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327302|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
20327303|NCT00752947|Metronidazole|metronidazole|mesh-list
20327304|NCT00752947|Levofloxacin|levofloxacin|mesh-list
20327305|NCT00752947|Ofloxacin|ofloxacin|mesh-list
19803181|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803182|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
19803183|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803184|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19803185|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803186|NCT00407563|Paclitaxel|paclitaxel|mesh-list
20327306|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327307|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327308|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20327309|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327310|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327311|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327312|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327313|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20327314|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20327315|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20327316|NCT00752947|Renal Agents|renal agents|mesh-ancestor
20327317|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20327318|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19803187|NCT00407563|Bevacizumab|bevacizumab|mesh-list
19803188|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19803189|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19803190|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803191|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
19803192|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
19803193|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
19803194|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803195|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803196|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803197|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803198|NCT00407563|Growth Substances|growth substances|mesh-ancestor
19803199|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803200|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803201|NCT00407654|Aflibercept|aflibercept|mesh-list
19803202|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
19803203|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803204|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803205|NCT00407654|Growth Substances|growth substances|mesh-ancestor
19803206|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803207|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803208|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803209|NCT00407745|Pregabalin|pregabalin|mesh-list
19803210|NCT00407745|Analgesics|analgesics|mesh-ancestor
19803211|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
19803212|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803213|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803214|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
19803215|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19803216|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803217|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803218|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19803219|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19803220|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19803221|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19803222|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803223|NCT00407797|Pregabalin|pregabalin|mesh-list
19803224|NCT00407797|Analgesics|analgesics|mesh-ancestor
19803225|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
19803226|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803227|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803228|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
19803229|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19803230|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803231|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803232|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19803233|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19803234|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19803235|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19803236|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803237|NCT00407888|Paclitaxel|paclitaxel|mesh-list
19803238|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19803239|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
19803240|NCT00407888|Doxorubicin|doxorubicin|mesh-list
19803241|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20327319|NCT00753038|Paclitaxel|paclitaxel|mesh-list
20327320|NCT00753038|Carboplatin|carboplatin|mesh-list
20327321|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20327322|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327323|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
19645363|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645364|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19645365|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19645366|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19645367|NCT02366975|Testosterone|testosterone|mesh-list
19645368|NCT02366975|Androgens|androgens|mesh-ancestor
19645369|NCT02366975|Hormones|hormones|mesh-ancestor
19645370|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645371|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803242|NCT00407888|Trastuzumab|trastuzumab|mesh-list
19803243|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19803244|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803245|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
19803246|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
19803247|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
19803248|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803249|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803250|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
19803251|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803252|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803253|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19803254|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
19803255|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19803256|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19803257|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19803258|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19803259|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803260|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803261|NCT00407966|Cytarabine|cytarabine|mesh-list
19803262|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
19803263|NCT00407966|Alvocidib|alvocidib|mesh-list
19803264|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803265|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
19803266|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803267|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803268|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
19803269|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803270|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803271|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
19803272|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803273|NCT00407966|Analgesics|analgesics|mesh-ancestor
19803274|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
19803275|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803276|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19803277|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19803278|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803279|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803280|NCT00407966|Growth Substances|growth substances|mesh-ancestor
19803281|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803282|NCT00408070|Paclitaxel|paclitaxel|mesh-list
19803283|NCT00408070|Bevacizumab|bevacizumab|mesh-list
19803284|NCT00408070|Carboplatin|carboplatin|mesh-list
19803285|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19803286|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803287|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
19803288|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
19803289|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
19645372|NCT02367118|Prednisone|prednisone|mesh-list
19645373|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645374|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
19645375|NCT02367118|Hormones|hormones|mesh-ancestor
19645376|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19803290|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803291|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803292|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20161896|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
20161897|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161898|NCT00126243|Rituximab|rituximab|mesh-list
20161899|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20161900|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161901|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
19803293|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803294|NCT00408070|Growth Substances|growth substances|mesh-ancestor
19803295|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803296|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803297|NCT00408200|Sotalol|sotalol|mesh-list
19803298|NCT00408200|Flecainide|flecainide|mesh-list
19803299|NCT00408200|Propafenone|propafenone|mesh-list
19803300|NCT00408200|Dofetilide|dofetilide|mesh-list
19803301|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19803302|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19803303|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
19803304|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803305|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803306|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803307|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19803308|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
19803309|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
19803310|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803311|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19803312|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19803313|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803314|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19803315|NCT00408317|Pancrelipase|pancrelipase|mesh-list
19803316|NCT00408317|Pancreatin|pancreatin|mesh-list
19803317|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19803318|NCT00408408|Gemcitabine|gemcitabine|mesh-list
19803319|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
19803320|NCT00408408|Bevacizumab|bevacizumab|mesh-list
19803321|NCT00408408|Docetaxel|docetaxel|mesh-list
19803322|NCT00408408|Doxorubicin|doxorubicin|mesh-list
19803323|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19803324|NCT00408408|Capecitabine|capecitabine|mesh-list
19803325|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803326|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
19803327|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803328|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803329|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19803330|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
19803331|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803332|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803333|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19803334|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803335|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803336|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803337|NCT00408408|Growth Substances|growth substances|mesh-ancestor
19803338|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803339|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803340|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
19803341|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
19803342|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803343|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803344|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
19803345|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
19803346|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
19803347|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19803348|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19803349|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19803350|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19803351|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20161902|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161903|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20161904|NCT00126256|Leucovorin|leucovorin|mesh-list
19645377|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645378|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19645379|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645380|NCT02366949|Paclitaxel|paclitaxel|mesh-list
19645381|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19645382|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645383|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19645384|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19645385|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19645386|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645387|NCT02366819|Leucovorin|leucovorin|mesh-list
19645388|NCT02366819|Fluorouracil|fluorouracil|mesh-list
19645389|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
19645390|NCT02366819|Irinotecan|irinotecan|mesh-list
19645391|NCT02366819|Calcium|calcium|mesh-list
19803352|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19803353|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803354|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803355|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803356|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803357|NCT00408421|Analgesics|analgesics|mesh-ancestor
19803358|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
19803359|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803360|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
19803361|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803362|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
19803363|NCT00408434|Efatutazone|efatutazone|mesh-list
19803364|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803365|NCT00408460|Paclitaxel|paclitaxel|mesh-list
19803366|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
19803367|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19803368|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327324|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327325|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327326|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327327|NCT00753051|Haloperidol|haloperidol|mesh-list
20327328|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
20327329|NCT00753051|Clozapine|clozapine|mesh-list
20327330|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
20327331|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
20327332|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327333|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803369|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
19803370|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
19803371|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
19803372|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803373|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803374|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803375|NCT00408499|Cetuximab|cetuximab|mesh-list
19803376|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19803377|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803378|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803379|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803380|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803381|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803382|NCT00408564|Gemcitabine|gemcitabine|mesh-list
19803383|NCT00408564|Capecitabine|capecitabine|mesh-list
19803384|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
19803385|NCT00408564|Cetuximab|cetuximab|mesh-list
19803386|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803387|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
19645392|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
19645393|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19645394|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645395|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
19645396|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645397|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19645398|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645399|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645400|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
19645401|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19645402|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19645403|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645404|NCT02366819|Antidotes|antidotes|mesh-ancestor
19645405|NCT02366819|Protective Agents|protective agents|mesh-ancestor
19645406|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
19645407|NCT02366819|Vitamins|vitamins|mesh-ancestor
19645408|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
20161905|NCT00126256|Fluorouracil|fluorouracil|mesh-list
20161906|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
20161907|NCT00126256|Irinotecan|irinotecan|mesh-list
20161908|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
20161909|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161910|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161911|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161912|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161913|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
20161914|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161915|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20161916|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327334|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20327335|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19645409|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
19645410|NCT02366546|Fludarabine|fludarabine|mesh-list
19645411|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645412|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
19645413|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645414|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645415|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19645416|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
19664035|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664036|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19664037|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19664038|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19664039|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
19664040|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664041|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19664042|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19664043|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664044|NCT04858854|Sulforaphane|sulforaphane|mesh-list
19664045|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19664046|NCT04858854|Protective Agents|protective agents|mesh-ancestor
19664047|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664048|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664049|NCT04853004|Antibodies|antibodies|mesh-list
19664050|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
19664051|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664052|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19664053|NCT04839185|Hematinics|hematinics|mesh-ancestor
19664054|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19664055|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19664056|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19664057|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664058|NCT04814940|Menotropins|menotropins|mesh-list
19664059|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19664060|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
19664061|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19664062|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664063|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
19664064|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19664065|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664066|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
19664067|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
19664068|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664069|NCT04796636|Protective Agents|protective agents|mesh-ancestor
19664070|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664071|NCT04796636|Vitamins|vitamins|mesh-ancestor
19664072|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
19664073|NCT04759274|Diuretics|diuretics|mesh-list
19664074|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
19664075|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664076|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
19664077|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
19664078|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19664079|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
19664080|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19664081|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664082|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19664083|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19664084|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19664085|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19664086|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664087|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19664088|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19664089|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664090|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664091|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664092|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
19664093|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19664094|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664095|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19664096|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664097|NCT04689945|Morphine|morphine|mesh-list
19645417|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645418|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645419|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19645420|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
19645421|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19803388|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803389|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803390|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
19803391|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803392|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803393|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803394|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
19803395|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803396|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803397|NCT00408629|Adalimumab|adalimumab|mesh-list
19803398|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19803399|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803400|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
19803401|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
19803402|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803403|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803404|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803405|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
19803406|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19803407|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19803408|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803409|NCT00408694|Bevacizumab|bevacizumab|mesh-list
19803410|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19803411|NCT00408694|Cisplatin|cisplatin|mesh-list
20327336|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19645422|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
19803412|NCT00408694|Fluorouracil|fluorouracil|mesh-list
19803413|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
19803414|NCT00408694|Antibodies|antibodies|mesh-list
19803415|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
19803416|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19803417|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
19803418|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803419|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803420|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803421|NCT00408694|Growth Substances|growth substances|mesh-ancestor
19803422|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803423|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803424|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
19803425|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
19645423|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645424|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
19645425|NCT02366676|Protective Agents|protective agents|mesh-ancestor
19645426|NCT02366585|Cyclosporine|cyclosporine|mesh-list
19645427|NCT02366585|Cyclosporins|cyclosporins|mesh-list
19645428|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645429|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645430|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645431|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
19645432|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645433|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
19803426|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803427|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803428|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803429|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19803430|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19803431|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19803432|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803433|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803434|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803435|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803436|NCT00408876|Analgesics|analgesics|mesh-ancestor
19803437|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
19803438|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803439|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
19645434|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803440|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803441|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
19803442|NCT00408928|Bortezomib|bortezomib|mesh-list
19803443|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803444|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19803445|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19803446|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19803447|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803448|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803449|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803450|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803451|NCT00408993|Analgesics|analgesics|mesh-ancestor
19803452|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
20327337|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327338|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161917|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161918|NCT00126256|Antidotes|antidotes|mesh-ancestor
20161919|NCT00126256|Protective Agents|protective agents|mesh-ancestor
20161920|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
20161921|NCT00126256|Vitamins|vitamins|mesh-ancestor
20161922|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
19803453|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803454|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
19803455|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803456|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
19803457|NCT00409006|Pemetrexed|pemetrexed|mesh-list
19803458|NCT00409006|Gefitinib|gefitinib|mesh-list
19803459|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803460|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803461|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803462|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19803463|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803464|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803465|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
19803466|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803467|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
19803468|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803469|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803470|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19803471|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
19803472|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803473|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803474|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19803475|NCT00409292|Everolimus|everolimus|mesh-list
19803476|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803477|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803478|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
19803479|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803480|NCT00409565|Bevacizumab|bevacizumab|mesh-list
19803481|NCT00409565|Cetuximab|cetuximab|mesh-list
19803482|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803483|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803484|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803485|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803486|NCT00409565|Growth Substances|growth substances|mesh-ancestor
19803487|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803488|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803489|NCT00409578|Valsartan|valsartan|mesh-list
19803490|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19803491|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19803492|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19803493|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803494|NCT00409617|Adalimumab|adalimumab|mesh-list
19803495|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19803496|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20161923|NCT00126269|Gemcitabine|gemcitabine|mesh-list
20161924|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161925|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20161926|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
20161927|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161928|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
20161929|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161930|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161931|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161932|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
20161933|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327339|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19645435|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
19645436|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645437|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19645438|NCT02366481|Vitamins|vitamins|mesh-list
19645439|NCT02366481|Vitamin K|vitamin k|mesh-list
19645440|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
19803497|NCT00409682|Adalimumab|adalimumab|mesh-list
19803498|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19803499|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803500|NCT00409708|Methylphenidate|methylphenidate|mesh-list
19803501|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19803502|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803503|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19803504|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20327340|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
20327341|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327342|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327343|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19803505|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803506|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803507|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
19803508|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803509|NCT00409747|Minocycline|minocycline|mesh-list
19803510|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19803511|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803512|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19803513|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19803514|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19803515|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
19803516|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19803517|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803518|NCT00409825|Progestins|progestins|mesh-ancestor
19803519|NCT00409825|Hormones|hormones|mesh-ancestor
19803520|NCT00409838|Methotrexate|methotrexate|mesh-list
19803521|NCT00409838|Abatacept|abatacept|mesh-list
19803522|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19803523|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
19803524|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19803525|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803526|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803527|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
19803528|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803529|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803530|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
19803531|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803532|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19803533|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803534|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
19803535|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803536|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803537|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19803538|NCT00410046|Etanercept|etanercept|mesh-list
19803539|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19803540|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19803541|NCT00410046|Analgesics|analgesics|mesh-ancestor
19803542|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
19803543|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803544|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327344|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20327345|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
20327346|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
20327347|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
20327348|NCT00753064|Prazosin|prazosin|mesh-list
20327349|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20327350|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20327351|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20327352|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20327353|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645441|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
19645442|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
19645443|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645444|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19645445|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19645446|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645447|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
19803545|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19803546|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803547|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19803548|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803549|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
19803550|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19803551|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803552|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803553|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803554|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327354|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327355|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327356|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327357|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
20161934|NCT00126282|Cycloserine|cycloserine|mesh-list
20161935|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20161936|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161937|NCT00126282|Renal Agents|renal agents|mesh-ancestor
20161938|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20161939|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
20161940|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20161941|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
20327358|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
20327359|NCT00753103|Prednisolone|prednisolone|mesh-list
20327360|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
20327361|NCT00753103|Azathioprine|azathioprine|mesh-list
20327362|NCT00753103|Infliximab|infliximab|mesh-list
20327363|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327364|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
20327365|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327366|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327367|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20327368|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
20327369|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803555|NCT00410072|Tenofovir|tenofovir|mesh-list
19803556|NCT00410072|Entecavir|entecavir|mesh-list
19803557|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
19803558|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803559|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19803560|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803561|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803562|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327370|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327371|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20327372|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20327373|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20327374|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
20327375|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19803563|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19803564|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19803565|NCT00410124|Everolimus|everolimus|mesh-list
19803566|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803567|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803568|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
19803569|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803570|NCT00410150|Albuterol|albuterol|mesh-list
19803571|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19803572|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
19803573|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803574|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803575|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19803576|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
19803577|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
19803578|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19803579|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19803580|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19803581|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19803582|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
20161942|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327376|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327377|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803583|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803584|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327378|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327379|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
19803585|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
19803586|NCT00410163|Fludarabine|fludarabine|mesh-list
19803587|NCT00410163|Ofatumumab|ofatumumab|mesh-list
19803588|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19803589|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803590|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
19803591|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803592|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803593|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19803594|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
19803595|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803596|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803597|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19803598|NCT00410202|Tenofovir|tenofovir|mesh-list
19803599|NCT00410202|Lamivudine|lamivudine|mesh-list
19803600|NCT00410202|Entecavir|entecavir|mesh-list
19803601|NCT00410202|Adefovir|adefovir|mesh-list
19803602|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
19803603|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803604|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19803605|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803606|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803607|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803608|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19803609|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19803610|NCT00410384|Belimumab|belimumab|mesh-list
19803611|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803612|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
19803613|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803614|NCT00410410|Abatacept|abatacept|mesh-list
19803615|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19803616|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803617|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803618|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803619|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
19803620|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803621|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834335|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834336|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834337|NCT00594230|Panobinostat|panobinostat|mesh-list
19834338|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834339|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19834340|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834341|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834342|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
19834343|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19834344|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19834345|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
19834346|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
19834347|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834348|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834349|NCT00594308|Cyclosporine|cyclosporine|mesh-list
19834350|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
19834351|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
19834352|NCT00594308|Fludarabine|fludarabine|mesh-list
19834353|NCT00594308|Cyclosporins|cyclosporins|mesh-list
19834354|NCT00594308|Basiliximab|basiliximab|mesh-list
19834355|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834356|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
19834357|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834358|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20161943|NCT00126308|Mannitol|mannitol|mesh-list
20161944|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19834359|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834360|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
19834361|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834362|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834363|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834364|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834365|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
19834366|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834367|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
19834368|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19834369|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19834370|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20161945|NCT00126308|Diuretics|diuretics|mesh-ancestor
20327380|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
20327381|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327382|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20327383|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
20161946|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
20161947|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161948|NCT00126321|Cladribine|cladribine|mesh-list
20161949|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20161950|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20161951|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
20161952|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161953|NCT00126347|Folic Acid|folic acid|mesh-list
20161954|NCT00126347|Betaine|betaine|mesh-list
20161955|NCT00126347|Hematinics|hematinics|mesh-ancestor
20161956|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
20161957|NCT00126347|Vitamins|vitamins|mesh-ancestor
20161958|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
20327384|NCT00753103|Hormones|hormones|mesh-ancestor
20327385|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327386|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20327387|NCT00753103|Protective Agents|protective agents|mesh-ancestor
20327388|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20327389|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
20327390|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
20327391|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20327392|NCT00753168|Timolol|timolol|mesh-list
20327393|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20327394|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20327395|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20327396|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20327397|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
20327398|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327399|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327400|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327401|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20327402|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20327403|NCT00753207|Epirubicin|epirubicin|mesh-list
20327404|NCT00753207|Lapatinib|lapatinib|mesh-list
19645448|NCT02366481|Coagulants|coagulants|mesh-ancestor
19645449|NCT02366247|Adefovir|adefovir|mesh-list
19645450|NCT02366247|Thymalfasin|thymalfasin|mesh-list
19645451|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
19645452|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645453|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19645454|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19645455|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645456|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645457|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19645458|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
19664098|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19664099|NCT04689945|Narcotics|narcotics|mesh-ancestor
19664100|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664101|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664102|NCT04689945|Analgesics|analgesics|mesh-ancestor
19664103|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
19664104|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664105|NCT04655755|Decitabine|decitabine|mesh-list
19664106|NCT04655755|Venetoclax|venetoclax|mesh-list
19664107|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19664108|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
19664109|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664110|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664111|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664112|NCT04644796|Bupivacaine|bupivacaine|mesh-list
19664113|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
19664114|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
19664115|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664116|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664117|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
19664118|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664119|NCT04616924|Clarithromycin|clarithromycin|mesh-list
19664120|NCT04616924|Rifabutin|rifabutin|mesh-list
19664121|NCT04616924|Clofazimine|clofazimine|mesh-list
19664122|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19664123|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664124|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19664125|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803622|NCT00410423|Cytarabine|cytarabine|mesh-list
19803623|NCT00410423|Etoposide|etoposide|mesh-list
19803624|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
19803625|NCT00410423|Bortezomib|bortezomib|mesh-list
19803626|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19803627|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803628|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19803629|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19803630|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803631|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803632|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803633|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
19803634|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
19803635|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803636|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803637|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
19803638|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803639|NCT00410423|Analgesics|analgesics|mesh-ancestor
19803640|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
19803641|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803642|NCT00410488|Dexamethasone|dexamethasone|mesh-list
19803643|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
19803644|NCT00410488|Doxorubicin|doxorubicin|mesh-list
19803645|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19803646|NCT00410488|Vincristine|vincristine|mesh-list
19803647|NCT00410488|Ifosfamide|ifosfamide|mesh-list
19803648|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
19803649|NCT00410488|Palonosetron|palonosetron|mesh-list
19645459|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645460|NCT02366377|Metformin|metformin|mesh-list
19645461|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19645462|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645463|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
19645464|NCT02366299|Propofol|propofol|mesh-list
19645465|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19645466|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645467|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645468|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19645469|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
19645470|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
19645471|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645472|NCT02366299|Analgesics|analgesics|mesh-ancestor
19803650|NCT00410488|BB 1101|bb 1101|mesh-list
19803651|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19803652|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
19803653|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
19803654|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803655|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803656|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19803657|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
19803658|NCT00410488|Hormones|hormones|mesh-ancestor
19803659|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19803660|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19803661|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803662|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
19803663|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803664|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803665|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19803666|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19803667|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19803668|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20161959|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161960|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20161961|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
20161962|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20161963|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
20161964|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161965|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20161966|NCT00126360|Anastrozole|anastrozole|mesh-list
20161967|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20161968|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327405|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19645473|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
19645474|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803669|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
19803670|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
19803671|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
19803672|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19803673|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
19803674|NCT00410488|Protective Agents|protective agents|mesh-ancestor
19803675|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19803676|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19803677|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
19803678|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803679|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19803680|NCT00410514|Mirabegron|mirabegron|mesh-list
19803681|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19803682|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19803683|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19803684|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645475|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19645476|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19645477|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19645478|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645479|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645480|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645481|NCT02366065|Acetaminophen|acetaminophen|mesh-list
19645482|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645483|NCT02366065|Analgesics|analgesics|mesh-ancestor
19645484|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
20327406|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327407|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20327408|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327409|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327410|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161969|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20161970|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20327411|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20327412|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
20327413|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327414|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327415|NCT00753311|Rizatriptan|rizatriptan|mesh-list
20327416|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20327417|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
20327418|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327419|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327420|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327421|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20327422|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
20327423|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327424|NCT00753389|Anesthetics|anesthetics|mesh-list
20327425|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327426|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327427|NCT00753402|Epinephrine|epinephrine|mesh-list
20327428|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20327429|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20327430|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645485|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645486|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645487|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
19645488|NCT02366208|Adefovir|adefovir|mesh-list
19645489|NCT02366208|Thymalfasin|thymalfasin|mesh-list
19645490|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
19645491|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645492|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19645493|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19645494|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803685|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161971|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161972|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161973|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20161974|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
20161975|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20161976|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161977|NCT00126373|Bupropion|bupropion|mesh-list
20161978|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20161979|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
20161980|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20161981|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20161982|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19645495|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645496|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19645497|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
19645498|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664126|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664127|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19664128|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19664129|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19664130|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
19664131|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664132|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
19664133|NCT04616274|Venetoclax|venetoclax|mesh-list
19664134|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664135|NCT04613622|Venetoclax|venetoclax|mesh-list
19664136|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664137|NCT04562792|Daunorubicin|daunorubicin|mesh-list
19803686|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803687|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803688|NCT00410514|Urological Agents|urological agents|mesh-ancestor
19803689|NCT00410605|Dexamethasone|dexamethasone|mesh-list
19803690|NCT00410605|Bevacizumab|bevacizumab|mesh-list
19803691|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19803692|NCT00410605|Lenalidomide|lenalidomide|mesh-list
19803693|NCT00410605|Antibodies|antibodies|mesh-list
19803694|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
19803695|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19803696|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803697|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803698|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803699|NCT00410605|Growth Substances|growth substances|mesh-ancestor
19803700|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803701|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
20161983|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20161984|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20161985|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
20161986|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20161987|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161988|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20161989|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20161990|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20161991|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
20161992|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20161993|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20161994|NCT00126399|Doxycycline|doxycycline|mesh-list
20161995|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20161996|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20161997|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
20161998|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20161999|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20162000|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19803702|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
19803703|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19803704|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
19803705|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
19803706|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803707|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19803708|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
19803709|NCT00410605|Hormones|hormones|mesh-ancestor
19803710|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19803711|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19803712|NCT00410813|Dasatinib|dasatinib|mesh-list
19803713|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803714|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803715|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803716|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803717|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19803718|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803719|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803720|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803721|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803722|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
19803723|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20162001|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803724|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803725|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19803726|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19803727|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19803728|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19803729|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803730|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803731|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803732|NCT00410904|Pemetrexed|pemetrexed|mesh-list
19803733|NCT00410904|Cediranib|cediranib|mesh-list
19803734|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803735|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803736|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803737|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19803738|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803739|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19645499|NCT02365909|Bupivacaine|bupivacaine|mesh-list
19645500|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
19645501|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
19645502|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645503|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803740|NCT00411086|Rituximab|rituximab|mesh-list
19803741|NCT00411086|Molgramostim|molgramostim|mesh-list
19803742|NCT00411086|Sargramostim|sargramostim|mesh-list
19803743|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803744|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803745|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
19803746|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803747|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327431|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327432|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327433|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327434|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20327435|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20327436|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
20327437|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327438|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20327439|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
20327440|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
20327441|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
20327442|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20327443|NCT00753467|Interferons|interferons|mesh-list
20327444|NCT00753467|Adefovir|adefovir|mesh-list
20327445|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20327446|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
20327447|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327448|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
20327449|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327450|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20327451|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20327452|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327453|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327454|NCT00753493|Topiramate|topiramate|mesh-list
20327455|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
20327456|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20327457|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327458|NCT00753558|Gentamicins|gentamicins|mesh-list
20327459|NCT00753558|Polymyxins|polymyxins|mesh-list
20327460|NCT00753558|Colistin|colistin|mesh-list
20327461|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327462|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645504|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
19645505|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645506|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
19803748|NCT00411151|Sunitinib|sunitinib|mesh-list
19803749|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803750|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803751|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803752|NCT00411151|Growth Substances|growth substances|mesh-ancestor
19803753|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327463|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19645507|NCT02365857|Bupivacaine|bupivacaine|mesh-list
19803754|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
20327464|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327465|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803755|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20327466|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
19803756|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803757|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803758|NCT00411398|Memantine|memantine|mesh-list
19803759|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19803760|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19803761|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
19803762|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803763|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803764|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803765|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19803766|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20162002|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162003|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162004|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20162005|NCT00126451|Vorinostat|vorinostat|mesh-list
20162006|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162007|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20162008|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162009|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162010|NCT00126464|Tamoxifen|tamoxifen|mesh-list
20162011|NCT00126464|Fulvestrant|fulvestrant|mesh-list
20162012|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20162013|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
20327467|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20327468|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20327469|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327470|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327471|NCT00753571|Protective Agents|protective agents|mesh-ancestor
20327472|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327473|NCT00753597|Rituximab|rituximab|mesh-list
20327474|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327475|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327476|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
20327477|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327478|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327479|NCT00753727|Sunitinib|sunitinib|mesh-list
20327480|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327481|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327482|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20327483|NCT00753727|Growth Substances|growth substances|mesh-ancestor
20327484|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327485|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
20327486|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20327487|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327488|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327489|NCT00753740|Camptothecin|camptothecin|mesh-list
20327490|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19645508|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
19645509|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
19645510|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645511|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645512|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
19645513|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645514|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19645515|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645516|NCT02365857|Analgesics|analgesics|mesh-ancestor
19645517|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19645518|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19645519|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19645520|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645521|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645522|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645523|NCT02365935|Paclitaxel|paclitaxel|mesh-list
19645524|NCT02365935|Cisplatin|cisplatin|mesh-list
19645525|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19645526|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645527|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
19645528|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
19645529|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
19645530|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645531|NCT02365675|Petrolatum|petrolatum|mesh-list
19645532|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19645533|NCT02365675|Laxatives|laxatives|mesh-ancestor
19803767|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19803768|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20327491|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327492|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20327493|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327494|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327495|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327496|NCT00753779|Simvastatin|simvastatin|mesh-list
20327497|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20327498|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20327499|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20327500|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
20327501|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327502|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20327503|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20327504|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327505|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
20327506|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20327507|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20327508|NCT00753792|Prednisolone|prednisolone|mesh-list
20327509|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
20327510|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20327511|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
20327512|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327513|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
20327514|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
20327515|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327516|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327517|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19803769|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803770|NCT00411411|Incretins|incretins|mesh-ancestor
19803771|NCT00411411|Hormones|hormones|mesh-ancestor
19803772|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19803773|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19803774|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
19803775|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803776|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803777|NCT00411450|Panitumumab|panitumumab|mesh-list
19803778|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803779|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803780|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19803781|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
19803782|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803783|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19803784|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19803785|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19803786|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803787|NCT00411554|Inositol|inositol|mesh-list
19803788|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19803789|NCT00411554|Voglibose|voglibose|mesh-list
19803790|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19803791|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327518|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
20327519|NCT00753792|Hormones|hormones|mesh-ancestor
20327520|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327521|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20327522|NCT00753792|Protective Agents|protective agents|mesh-ancestor
20327523|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20327524|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327525|NCT00753883|Simvastatin|simvastatin|mesh-list
20327526|NCT00753883|Ezetimibe|ezetimibe|mesh-list
20327527|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20327528|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20327529|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
20327530|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327531|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20327532|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19803792|NCT00411554|Incretins|incretins|mesh-ancestor
19803793|NCT00411554|Hormones|hormones|mesh-ancestor
19803794|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19803795|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20327533|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803796|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
19803797|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327534|NCT00753909|Paclitaxel|paclitaxel|mesh-list
20327535|NCT00753909|Bevacizumab|bevacizumab|mesh-list
20327536|NCT00753909|Carboplatin|carboplatin|mesh-list
19645534|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645535|NCT02365675|Emollients|emollients|mesh-ancestor
20327537|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20327538|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327539|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19645536|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
19645537|NCT02365571|Itraconazole|itraconazole|mesh-list
19645538|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
19645539|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645540|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19645541|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19645542|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664138|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19664139|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664140|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19664141|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19664142|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664143|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664144|NCT04546620|Prednisolone|prednisolone|mesh-list
19664145|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19664146|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
19664147|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19664148|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
19664149|NCT04546620|Prednisone|prednisone|mesh-list
19664150|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
19664151|NCT04546620|Rituximab|rituximab|mesh-list
19664152|NCT04546620|Doxorubicin|doxorubicin|mesh-list
19664153|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19664154|NCT04546620|Vincristine|vincristine|mesh-list
19664155|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
19664156|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19664157|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
19664158|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664159|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
19664160|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664161|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19664162|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19664163|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
19664164|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664165|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664166|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19664167|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19664168|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19664169|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19664170|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19664171|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664172|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19664173|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
19664174|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
19664175|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
19664176|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664177|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
19664178|NCT04546620|Hormones|hormones|mesh-ancestor
19664179|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664180|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19664181|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
19664182|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
19664183|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664184|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664185|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19664186|NCT04546620|Protective Agents|protective agents|mesh-ancestor
19664187|NCT04523935|Topiramate|topiramate|mesh-list
19664188|NCT04523935|Lamotrigine|lamotrigine|mesh-list
19664189|NCT04523935|Diazepam|diazepam|mesh-list
19664190|NCT04523935|Gabapentin|gabapentin|mesh-list
19664191|NCT04523935|Amitriptyline|amitriptyline|mesh-list
19664192|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
19664193|NCT04523935|Clonazepam|clonazepam|mesh-list
19664194|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
19664195|NCT04523935|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19664196|NCT04523935|Baclofen|baclofen|mesh-list
19664197|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
19803798|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803799|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19803800|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
19645543|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645544|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19645545|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
19645546|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645547|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645548|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19645549|NCT02365740|Insulin|insulin|mesh-list
19645550|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19645551|NCT02365740|Hormones|hormones|mesh-list
19645552|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19645553|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645554|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645555|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
19645556|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803801|NCT00411554|Vitamins|vitamins|mesh-ancestor
19803802|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
19803803|NCT00411619|Everolimus|everolimus|mesh-list
19803804|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803805|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803806|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
19803807|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803808|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20162014|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162015|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162016|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162017|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162018|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20162019|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20327540|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327541|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327542|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327543|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327544|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327545|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20327546|NCT00753909|Growth Substances|growth substances|mesh-ancestor
20327547|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327548|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
20327549|NCT00754039|Fenofibrate|fenofibrate|mesh-list
20327550|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20327551|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19645557|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
19803809|NCT00411632|Bexarotene|bexarotene|mesh-list
19803810|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803811|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803812|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803813|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803814|NCT00411645|Maribavir|maribavir|mesh-list
19803815|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
19803816|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803817|NCT00411671|Sorafenib|sorafenib|mesh-list
19803818|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803819|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803820|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803821|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803822|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
19803823|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19803824|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
19803825|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19803826|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803827|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20162020|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20162021|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20162022|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
20162023|NCT00126516|Giapreza|giapreza|mesh-list
20162024|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20162025|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
20162026|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20162027|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20327552|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
19803828|NCT00411762|Capecitabine|capecitabine|mesh-list
19803829|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803830|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
20162028|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162029|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20162030|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20162031|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
19645558|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645559|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645560|NCT02365727|Clonidine|clonidine|mesh-list
19645561|NCT02365727|Epinephrine|epinephrine|mesh-list
19645562|NCT02365727|Bupivacaine|bupivacaine|mesh-list
19645563|NCT02365727|Ropivacaine|ropivacaine|mesh-list
19645564|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
19645565|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
19645566|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645567|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327553|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327554|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20327555|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20327556|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20327557|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645568|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
19803831|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803832|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803833|NCT00411788|Sirolimus|sirolimus|mesh-list
19803834|NCT00411788|Trastuzumab|trastuzumab|mesh-list
19803835|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19803836|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803837|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19803838|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803839|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19803840|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
19803841|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803842|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
19803843|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803844|NCT00412061|Everolimus|everolimus|mesh-list
19803845|NCT00412061|Octreotide|octreotide|mesh-list
19803846|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803847|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803848|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
19803849|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803850|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19803851|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19803852|NCT00412074|Vitamin D|vitamin d|mesh-list
19803853|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
19803854|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
19803855|NCT00412074|Vitamins|vitamins|mesh-list
19803856|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
19803857|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803858|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19803859|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20162032|NCT00126542|Bevacizumab|bevacizumab|mesh-list
20162033|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20162034|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20162035|NCT00126542|Antibodies|antibodies|mesh-list
20162036|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
20162037|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20162038|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162039|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20162040|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20162041|NCT00126542|Growth Substances|growth substances|mesh-ancestor
20162042|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162043|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803860|NCT00412087|Vitamin D|vitamin d|mesh-list
19803861|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
19803862|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
19803863|NCT00412087|Vitamins|vitamins|mesh-list
19803864|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
19803865|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803866|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19803867|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20162044|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
20162045|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20327558|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803868|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
19803869|NCT00412113|Amlodipine|amlodipine|mesh-list
19803870|NCT00412113|Atorvastatin|atorvastatin|mesh-list
19803871|NCT00412113|Calcium|calcium|mesh-list
19803872|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19803873|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803874|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19803875|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19803876|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19803877|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
19803878|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803879|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19803880|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19803881|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327559|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348601|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803882|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19803883|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19803884|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19803885|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
19803886|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19803887|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803888|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19803889|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803890|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803891|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
19803892|NCT00412243|Clofarabine|clofarabine|mesh-list
19803893|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803894|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
19803895|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803896|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803897|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19803898|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
19803899|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803900|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803901|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19803902|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803903|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
19803904|NCT00412360|Cyclosporine|cyclosporine|mesh-list
19803905|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
19803906|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
19803907|NCT00412360|Fludarabine|fludarabine|mesh-list
19803908|NCT00412360|Cyclosporins|cyclosporins|mesh-list
19803909|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803910|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
19803911|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803912|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19803913|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19803914|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
19803915|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803916|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803917|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19803918|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803919|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
19803920|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803921|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
19803922|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19803923|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19803924|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19803925|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
19803926|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19803927|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19803928|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19803929|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19803930|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19803931|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803932|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19803933|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19803934|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19803935|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
19803936|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803937|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803938|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19803939|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19803940|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
19803941|NCT00412425|Palonosetron|palonosetron|mesh-list
19803942|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
19645569|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803943|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
19803944|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19803945|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803946|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19803947|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19803948|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19803949|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
19803950|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19803951|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803952|NCT00412451|Plasminogen|plasminogen|mesh-list
20327560|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327561|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20327562|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
20327563|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327564|NCT00754260|Caffeine|caffeine|mesh-list
20327565|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20327566|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327567|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20327568|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327569|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327570|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19645570|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20162046|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162047|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162048|NCT00126607|Trastuzumab|trastuzumab|mesh-list
20162049|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162050|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162051|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20162052|NCT00126620|Sorafenib|sorafenib|mesh-list
20327571|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20327572|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
20327573|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327574|NCT00754312|Entinostat|entinostat|mesh-list
20327575|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327576|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20327577|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327578|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327579|NCT00754351|Gemcitabine|gemcitabine|mesh-list
20327580|NCT00754351|Bevacizumab|bevacizumab|mesh-list
20327581|NCT00754351|Docetaxel|docetaxel|mesh-list
20327582|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327583|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327584|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327585|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20327586|NCT00754351|Growth Substances|growth substances|mesh-ancestor
20327587|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327588|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
20327589|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20327590|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
20327591|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327592|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
19645571|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19645572|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645573|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645574|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645575|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19645576|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19645577|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
19645578|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19645579|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
19645580|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
19645581|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
19645582|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20162053|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162054|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20162055|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162056|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162057|NCT00126633|Gemcitabine|gemcitabine|mesh-list
20162058|NCT00126633|Bevacizumab|bevacizumab|mesh-list
20162059|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162060|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162061|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327593|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327594|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803953|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19803954|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19803955|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803956|NCT00412464|PENTA|penta|mesh-list
19803957|NCT00412464|Fondaparinux|fondaparinux|mesh-list
19803958|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20327595|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327596|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
20327597|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
19803959|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
19803960|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19803961|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
19803962|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803963|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803964|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
19803965|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19803966|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19803967|NCT00412529|Entecavir|entecavir|mesh-list
19803968|NCT00412529|Telbivudine|telbivudine|mesh-list
19803969|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
19803970|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803971|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19803972|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803973|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803974|NCT00412542|Thalidomide|thalidomide|mesh-list
19803975|NCT00412542|Irinotecan|irinotecan|mesh-list
19803976|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19803977|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19803978|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803979|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327598|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327599|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327600|NCT00754364|Gemcitabine|gemcitabine|mesh-list
20327601|NCT00754364|Carboplatin|carboplatin|mesh-list
19803980|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162062|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20162063|NCT00126633|Growth Substances|growth substances|mesh-ancestor
20162064|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162065|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
20162066|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162067|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
20162068|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162069|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
20162070|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162071|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162072|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162073|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
20162074|NCT00126646|Antibodies|antibodies|mesh-list
19803981|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19803982|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
19803983|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19803984|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
19803985|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19803986|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19803987|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19803988|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19803989|NCT00412542|Growth Substances|growth substances|mesh-ancestor
19803990|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
19803991|NCT00412737|Oseltamivir|oseltamivir|mesh-list
20162075|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
20162076|NCT00126646|Immunotoxins|immunotoxins|mesh-list
20162077|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
20162078|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162079|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
20162080|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20162081|NCT00126698|Trimethoprim|trimethoprim|mesh-list
20162082|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
20162083|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327602|NCT00754364|Pemetrexed|pemetrexed|mesh-list
20327603|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19803992|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
20162084|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327604|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19803993|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162085|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20327605|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
20327606|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327607|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
20327608|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327609|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645583|NCT02365727|Analgesics|analgesics|mesh-ancestor
19645584|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20327610|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327611|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
20327612|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327613|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20327614|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20327615|NCT00754403|Metformin|metformin|mesh-list
20327616|NCT00754403|Pioglitazone|pioglitazone|mesh-list
20327617|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20327618|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347842|NCT00862095|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20347843|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20347844|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20347845|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347846|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347847|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645585|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
19645586|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19645587|NCT02365805|Paclitaxel|paclitaxel|mesh-list
19645588|NCT02365805|Docetaxel|docetaxel|mesh-list
19645589|NCT02365805|Fluorouracil|fluorouracil|mesh-list
19645590|NCT02365805|Epirubicin|epirubicin|mesh-list
19645591|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
19645592|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19645593|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645594|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
20347848|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347849|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20347850|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20347851|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
20347852|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
20347853|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20347854|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20347855|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
20347856|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20347857|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645595|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
19645596|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
19664198|NCT04523935|Analgesics|analgesics|mesh-ancestor
19664199|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
19664200|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664201|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664202|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19664203|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19664204|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664205|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19664206|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19664207|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19664208|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664209|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664210|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
19664211|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19664212|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19664213|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19664214|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19664215|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19664216|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19664217|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19664218|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19664219|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19664220|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
19664221|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
19664222|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19664223|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
19664224|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19664225|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19664226|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19664227|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
19803994|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19803995|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19803996|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19803997|NCT00412750|Telbivudine|telbivudine|mesh-list
19803998|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
19803999|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804000|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19804001|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804002|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804003|NCT00412841|Atorvastatin|atorvastatin|mesh-list
19804004|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19804005|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19804006|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
19804007|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804008|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19804009|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19804010|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804011|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19804012|NCT00412867|Plasminogen|plasminogen|mesh-list
19804013|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19804014|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19804015|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804016|NCT00412893|Voriconazole|voriconazole|mesh-list
19804017|NCT00412893|Isavuconazole|isavuconazole|mesh-list
19804018|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
19804019|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804020|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19804021|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20327619|NCT00754429|Losartan|losartan|mesh-list
20327620|NCT00754429|Amlodipine|amlodipine|mesh-list
20327621|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20327622|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20327623|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20327624|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327625|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20327626|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327627|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
20327628|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20327629|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20327630|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20327631|NCT00754507|Atorvastatin|atorvastatin|mesh-list
20327632|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20327633|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20327634|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20327635|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
20327636|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327637|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20327638|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20327639|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327640|NCT00754689|Metformin|metformin|mesh-list
20327641|NCT00754689|Rimonabant|rimonabant|mesh-list
20327642|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20327643|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804022|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804023|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804024|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19804025|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
19804026|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804027|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804028|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19804029|NCT00412958|Plasminogen|plasminogen|mesh-list
19804030|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
19804031|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19804032|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19804033|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804034|NCT00412984|Warfarin|warfarin|mesh-list
19804035|NCT00412984|Apixaban|apixaban|mesh-list
19804036|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
19804037|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19804038|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
19804039|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19804040|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
19804041|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804042|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804043|NCT00413010|Pregabalin|pregabalin|mesh-list
19804044|NCT00413010|Analgesics|analgesics|mesh-ancestor
19804045|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
19804046|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804047|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804048|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
19804049|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19804050|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804051|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804052|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804053|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19804054|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19804055|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19804056|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19804057|NCT00413036|Lenalidomide|lenalidomide|mesh-list
19804058|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
19804059|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804060|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19804061|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19804062|NCT00413036|Growth Substances|growth substances|mesh-ancestor
19804063|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
19804064|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804065|NCT00413049|Amlodipine|amlodipine|mesh-list
19804066|NCT00413049|Valsartan|valsartan|mesh-list
19804067|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19804068|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19804069|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804070|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804071|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804072|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804073|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
19804074|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19804075|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19804076|NCT00413153|Ritonavir|ritonavir|mesh-list
19804077|NCT00413153|Lopinavir|lopinavir|mesh-list
19804078|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19804079|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19804080|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19804081|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
19804082|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804083|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804084|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19804085|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19804086|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
19804087|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804088|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19804089|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19804090|NCT00413166|Idarubicin|idarubicin|mesh-list
19804091|NCT00413166|Tretinoin|tretinoin|mesh-list
19804092|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
19804093|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
19804094|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19804095|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804096|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19804097|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19804098|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804099|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804100|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
19804101|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
20327644|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20327645|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20327646|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20327647|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327648|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804102|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804103|NCT00413218|Voriconazole|voriconazole|mesh-list
19804104|NCT00413218|Caspofungin|caspofungin|mesh-list
19804105|NCT00413218|Isavuconazole|isavuconazole|mesh-list
19804106|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
19804107|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804108|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19804109|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19804110|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327649|NCT00754689|Hormones|hormones|mesh-ancestor
20327650|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327651|NCT00754702|Vinorelbine|vinorelbine|mesh-list
20327652|NCT00754702|Lapatinib|lapatinib|mesh-list
20327653|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20327654|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327655|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
20327656|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327657|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327658|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327659|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20327660|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327661|NCT00754780|Pirfenidone|pirfenidone|mesh-list
20327662|NCT00754780|Analgesics|analgesics|mesh-ancestor
20327663|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
20327664|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327665|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327666|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20327667|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20327668|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327669|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327670|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327671|NCT00754819|Colchicine|colchicine|mesh-list
20327672|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
20327673|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327674|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
20327675|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327676|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327677|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327678|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327679|NCT00754858|Belotecan|belotecan|mesh-list
20327680|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327681|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20327682|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327683|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327684|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327685|NCT00754871|Dienogest|dienogest|mesh-list
20327686|NCT00754871|Nandrolone|nandrolone|mesh-list
20327687|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20327688|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
20327689|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20327690|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327691|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20327692|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20327693|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20327694|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20327695|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
19645597|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645598|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
19645599|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19645600|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645601|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
20327696|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327697|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19804111|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327698|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645602|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645603|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19645604|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19645605|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19645606|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645607|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804112|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19804113|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
19804114|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804115|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804116|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19804117|NCT00413244|Testosterone|testosterone|mesh-list
19804118|NCT00413244|Androgens|androgens|mesh-ancestor
19804119|NCT00413244|Hormones|hormones|mesh-ancestor
19804120|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804121|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804122|NCT00413283|Gemcitabine|gemcitabine|mesh-list
19804123|NCT00413283|Carboplatin|carboplatin|mesh-list
19804124|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804125|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804126|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
19804127|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804128|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
19804129|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804130|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804131|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804132|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
19804133|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804134|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
19804135|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19804136|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804137|NCT00413374|Enoxaparin|enoxaparin|mesh-list
19804138|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
19804139|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19804140|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19804141|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804142|NCT00413400|Etanercept|etanercept|mesh-list
19804143|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19804144|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19804145|NCT00413400|Analgesics|analgesics|mesh-ancestor
19804146|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
19804147|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804148|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327699|NCT00754871|Androgens|androgens|mesh-ancestor
20327700|NCT00754871|Hormones|hormones|mesh-ancestor
20327701|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
20327702|NCT00754884|Calcitonin|calcitonin|mesh-list
20327703|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
20327704|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20327705|NCT00754884|Glycerol|glycerol|mesh-list
20327706|NCT00754884|Katacalcin|katacalcin|mesh-list
19804149|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804150|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804151|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19804152|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804153|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
19804154|NCT00413413|Amlodipine|amlodipine|mesh-list
19804155|NCT00413413|Valsartan|valsartan|mesh-list
19804156|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19804157|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19804158|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804159|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804160|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804161|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804162|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
19804163|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19804164|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19804165|NCT00413478|Azacitidine|azacitidine|mesh-list
19804166|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804167|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
19804168|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804169|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804170|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804171|NCT00413634|Anagrelide|anagrelide|mesh-list
19804172|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19804173|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19834371|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
20327707|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19804174|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804175|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19804176|NCT00413660|Tofacitinib|tofacitinib|mesh-list
20327708|NCT00754884|Protective Agents|protective agents|mesh-ancestor
20327709|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327710|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20327711|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20327712|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645608|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19645609|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
19645610|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19645611|NCT02365623|Bedaquiline|bedaquiline|mesh-list
19645612|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
19645613|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
19645614|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19645615|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645616|NCT02365766|Gemcitabine|gemcitabine|mesh-list
19645617|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
20327713|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20327714|NCT00754910|Trioxsalen|trioxsalen|mesh-list
19645618|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645619|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19645620|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
19645621|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162086|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20162087|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162088|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162089|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162090|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20162091|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20162092|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19645622|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
19645623|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645624|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645625|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645626|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
19645627|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645628|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19645629|NCT02365532|Dofetilide|dofetilide|mesh-list
19645630|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19645631|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19645632|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19645633|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645634|NCT02365155|Vitamin D|vitamin d|mesh-list
19645635|NCT02365155|Vitamins|vitamins|mesh-list
19645636|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
19645637|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645638|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19645639|NCT02365272|Amikacin|amikacin|mesh-list
19645640|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19645641|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645642|NCT02365415|Sirolimus|sirolimus|mesh-list
19645643|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19645644|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645645|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19645646|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645647|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
19645648|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645649|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
19645650|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645651|NCT02365493|Cefazolin|cefazolin|mesh-list
19645652|NCT02365493|Lactams|lactams|mesh-list
19804177|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19804178|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804179|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804180|NCT00413777|Tolvaptan|tolvaptan|mesh-list
20162093|NCT00126698|Renal Agents|renal agents|mesh-ancestor
20162094|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
20162095|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20162096|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20327715|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645653|NCT02365493|beta-Lactams|beta-lactams|mesh-list
19645654|NCT02365493|Floxacillin|floxacillin|mesh-list
19645655|NCT02365493|Cloxacillin|cloxacillin|mesh-list
19645656|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327716|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19804181|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19804182|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804183|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
19804184|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804185|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
19804186|NCT00413894|Hematinics|hematinics|mesh-ancestor
19804187|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
19804188|NCT00413920|Prednisone|prednisone|mesh-list
19804189|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804190|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
19804191|NCT00413920|Hormones|hormones|mesh-ancestor
19804192|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645657|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645658|NCT02365402|Entecavir|entecavir|mesh-list
19645659|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
19804193|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804194|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19804195|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804196|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19804197|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19804198|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
19804199|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19804200|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327717|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20327718|NCT00754962|Protriptyline|protriptyline|mesh-list
19804201|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804202|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804203|NCT00413959|Dexamethasone|dexamethasone|mesh-list
19804204|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
19804205|NCT00413959|Rituximab|rituximab|mesh-list
19804206|NCT00413959|Bortezomib|bortezomib|mesh-list
19804207|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804208|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
19804209|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804210|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804211|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19804212|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
19804213|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804214|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804215|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19804216|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804217|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804218|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
20162097|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20162098|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20162099|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20162100|NCT00126763|Fentanyl|fentanyl|mesh-list
20162101|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19645660|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645661|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
19645662|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645663|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19645664|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645665|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645666|NCT02365181|Ropivacaine|ropivacaine|mesh-list
19645667|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
19645668|NCT02365181|Anesthetics|anesthetics|mesh-list
19645669|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20162102|NCT00126763|Narcotics|narcotics|mesh-ancestor
20162103|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20162104|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162105|NCT00126763|Analgesics|analgesics|mesh-ancestor
20162106|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
20162107|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162108|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20162109|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20162110|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
19645670|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645671|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
19804219|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
19804220|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162111|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
19804221|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19804222|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
19804223|NCT00413959|Hormones|hormones|mesh-ancestor
19804224|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804225|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19804226|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
19804227|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
20327719|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20327720|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
20327721|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20327722|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20327723|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20327724|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20327725|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327726|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
20327727|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327728|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804228|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19804229|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804230|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19804231|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19804232|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804233|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327729|NCT00755014|Ethanol|ethanol|mesh-list
20327730|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20327731|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327732|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327733|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327734|NCT00755027|Rasagiline|rasagiline|mesh-list
20327735|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20327736|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327737|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327738|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20327739|NCT00755027|Protective Agents|protective agents|mesh-ancestor
20327740|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327741|NCT00755053|Clotrimazole|clotrimazole|mesh-list
20327742|NCT00755053|Miconazole|miconazole|mesh-list
20327743|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19804234|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804235|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19804236|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19804237|NCT00414050|Vaccines|vaccines|mesh-list
19804238|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
19804239|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804240|NCT00414076|Letrozole|letrozole|mesh-list
19804241|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804242|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19804243|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19804244|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804245|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804246|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19804247|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
19804248|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804249|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804250|NCT00414167|Bupropion|bupropion|mesh-list
20162112|NCT00126789|Fentanyl|fentanyl|mesh-list
20162113|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20162114|NCT00126789|Narcotics|narcotics|mesh-ancestor
20162115|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20162116|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162117|NCT00126789|Analgesics|analgesics|mesh-ancestor
20162118|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
20162119|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804251|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19804252|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
19804253|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19804254|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19804255|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19804256|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804257|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804258|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
20162120|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20162121|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20162122|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
19804259|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804260|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804261|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19804262|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19804263|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804264|NCT00414206|Mecamylamine|mecamylamine|mesh-list
19804265|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19804266|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19804267|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
19804268|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804269|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327744|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327745|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
20327746|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20327747|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20327748|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327749|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327750|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20327751|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
20327752|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327753|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327754|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20327755|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20327756|NCT00755066|Fluticasone|fluticasone|mesh-list
20327757|NCT00755066|Xhance|xhance|mesh-list
20327758|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327759|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20327760|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
20327761|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327762|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327763|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20327764|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
20327765|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
20327766|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20327767|NCT00755118|Leucovorin|leucovorin|mesh-list
19645672|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645673|NCT02364986|Interferons|interferons|mesh-list
19645674|NCT02364986|Interferon-beta|interferon-beta|mesh-list
19645675|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
19645676|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645677|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
19804270|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19804271|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19804272|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
20327768|NCT00755118|Bevacizumab|bevacizumab|mesh-list
19645678|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645679|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
19804273|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804274|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804275|NCT00414271|Docetaxel|docetaxel|mesh-list
19804276|NCT00414271|Capecitabine|capecitabine|mesh-list
19804277|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804278|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
19804279|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
19804280|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
19804281|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804282|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804283|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
19804284|NCT00414310|Decitabine|decitabine|mesh-list
19804285|NCT00414310|Valproic Acid|valproic acid|mesh-list
19804286|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804287|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
19804288|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804289|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804290|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804291|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
19804292|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
19804293|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804294|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804295|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
19804296|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20327769|NCT00755118|Cetuximab|cetuximab|mesh-list
19804297|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645680|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804298|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19804299|NCT00414388|Sorafenib|sorafenib|mesh-list
19804300|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804301|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19804302|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804303|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804304|NCT00414440|Everolimus|everolimus|mesh-list
19804305|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804306|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804307|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
19804308|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804309|NCT00414466|Gabapentin|gabapentin|mesh-list
19804310|NCT00414466|Analgesics|analgesics|mesh-ancestor
19804311|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
19804312|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804313|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804314|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
19804315|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19804316|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19804317|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19804318|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19804319|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19804320|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19804321|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804322|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804323|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
19804324|NCT00414518|Ritonavir|ritonavir|mesh-list
19804325|NCT00414518|Lopinavir|lopinavir|mesh-list
19804326|NCT00414518|Tenofovir|tenofovir|mesh-list
19804327|NCT00414518|Emtricitabine|emtricitabine|mesh-list
19804328|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19804329|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19804330|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
19804331|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804332|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804333|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19804334|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19804335|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
19804336|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804337|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19804338|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19804339|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19804340|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19804341|NCT00414661|Tofacitinib|tofacitinib|mesh-list
19804342|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19804343|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804344|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804345|NCT00414765|Aldesleukin|aldesleukin|mesh-list
19804346|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804347|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19804348|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19804349|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
19804350|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804351|NCT00414908|Pancrelipase|pancrelipase|mesh-list
19804352|NCT00414908|Pancreatin|pancreatin|mesh-list
19804353|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19804354|NCT00414973|Teriparatide|teriparatide|mesh-list
19804355|NCT00414973|Calcitonin|calcitonin|mesh-list
19804356|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
19804357|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19804358|NCT00414973|Katacalcin|katacalcin|mesh-list
19804359|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804360|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804361|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19804362|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
19804363|NCT00415168|Pemetrexed|pemetrexed|mesh-list
19804364|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804365|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804366|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804367|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19804368|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19804369|NCT00415194|Pemetrexed|pemetrexed|mesh-list
19804370|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804371|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804372|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804373|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20162123|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
19804374|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19804375|NCT00415506|Rituximab|rituximab|mesh-list
20327770|NCT00755118|Fluorouracil|fluorouracil|mesh-list
20327771|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
20327772|NCT00755118|Irinotecan|irinotecan|mesh-list
20327773|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327774|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327775|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19804376|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804377|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804378|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
19804379|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804380|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834372|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19834373|NCT00594386|Rotigotine|rotigotine|mesh-list
19834374|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
19834375|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
19834376|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834377|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834378|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834379|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19834380|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19834381|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19834382|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
19834383|NCT00594464|Rotigotine|rotigotine|mesh-list
19834384|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
19834385|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
19834386|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834387|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834388|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834389|NCT00594516|Tapentadol|tapentadol|mesh-list
19834390|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19834391|NCT00594516|Narcotics|narcotics|mesh-ancestor
19834392|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834393|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834394|NCT00594516|Analgesics|analgesics|mesh-ancestor
19834395|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
19834396|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834397|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19834398|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19834399|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834400|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834401|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
19834402|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834403|NCT00594646|Tenofovir|tenofovir|mesh-list
19834404|NCT00594646|Emtricitabine|emtricitabine|mesh-list
19834405|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
19834406|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19834407|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
19834408|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834409|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19834410|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19834411|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834412|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834413|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19834414|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20162124|NCT00126880|Lamivudine|lamivudine|mesh-list
20162125|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20162126|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162127|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162128|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162129|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
20162130|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162131|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20162132|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20162133|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
20162134|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
20162135|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
20162136|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20162137|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20327776|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19804381|NCT00415519|Edaravone|edaravone|mesh-list
19804382|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19804383|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
19804384|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804385|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19804386|NCT00415519|Protective Agents|protective agents|mesh-ancestor
19804387|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804388|NCT00415597|Naltrexone|naltrexone|mesh-list
19804389|NCT00415597|Morphine|morphine|mesh-list
19804390|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19804391|NCT00415597|Narcotics|narcotics|mesh-ancestor
19804392|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19804393|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804394|NCT00415597|Analgesics|analgesics|mesh-ancestor
19804395|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
19804396|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804397|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19804398|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19804399|NCT00415610|Nicardipine|nicardipine|mesh-list
19804400|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19804401|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19804402|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804403|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804404|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804405|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804406|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
20327777|NCT00755118|Growth Substances|growth substances|mesh-ancestor
20327778|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327779|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
20327780|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
20327781|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327782|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20327783|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327784|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
20327785|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20327786|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327787|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327788|NCT00755118|Antidotes|antidotes|mesh-ancestor
19804407|NCT00415636|Pemetrexed|pemetrexed|mesh-list
19804408|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804409|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804410|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804411|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19804412|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19804413|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19804414|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
19804415|NCT00415857|Vaccines|vaccines|mesh-list
19804416|NCT00415857|Sargramostim|sargramostim|mesh-list
19804417|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
19804418|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804419|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804420|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19804421|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804422|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804423|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
19804424|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804425|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
19804426|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804427|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19804428|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804429|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804430|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19804431|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19804432|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804433|NCT00416494|Bevacizumab|bevacizumab|mesh-list
19804434|NCT00416494|Capecitabine|capecitabine|mesh-list
19804435|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
19804436|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804437|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804438|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19804439|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19804440|NCT00416494|Growth Substances|growth substances|mesh-ancestor
20327789|NCT00755118|Protective Agents|protective agents|mesh-ancestor
20327790|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
20327791|NCT00755118|Vitamins|vitamins|mesh-ancestor
19804441|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804442|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
19804443|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804444|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
19804445|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804446|NCT00416520|Sevelamer|sevelamer|mesh-list
19804447|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
19804448|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
19804449|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804450|NCT00416598|Cytarabine|cytarabine|mesh-list
19804451|NCT00416598|Etoposide|etoposide|mesh-list
19804452|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
20327792|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
20327793|NCT00755157|Bevacizumab|bevacizumab|mesh-list
20327794|NCT00755157|Docetaxel|docetaxel|mesh-list
20327795|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327796|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804453|NCT00416598|Daunorubicin|daunorubicin|mesh-list
19804454|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
19804455|NCT00416598|Busulfan|busulfan|mesh-list
19804456|NCT00416598|Decitabine|decitabine|mesh-list
19804457|NCT00416598|Lenograstim|lenograstim|mesh-list
19804458|NCT00416598|Sargramostim|sargramostim|mesh-list
19804459|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19804460|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804461|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19804462|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19804463|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804464|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804465|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804466|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
19804467|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
19804468|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804469|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804470|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
19804471|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804472|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19804473|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
19804474|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19804475|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19804476|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19804477|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
19804478|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
19804479|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
19804480|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
19804481|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
19804482|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
19804483|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
19804484|NCT00416624|Hematinics|hematinics|mesh-ancestor
19804485|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
19804486|NCT00416715|Vitamin D|vitamin d|mesh-list
19804487|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
19804488|NCT00416715|Letrozole|letrozole|mesh-list
19804489|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
19804490|NCT00416715|Citric Acid|citric acid|mesh-list
19804491|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
20162138|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162139|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20162140|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162141|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162142|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20162143|NCT00126906|Renal Agents|renal agents|mesh-ancestor
20174327|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174328|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20174329|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20327797|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327798|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20327799|NCT00755157|Growth Substances|growth substances|mesh-ancestor
20327800|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327801|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
20327802|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
20327803|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174330|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
19804492|NCT00416715|Calcium|calcium|mesh-list
19804493|NCT00416715|Vitamins|vitamins|mesh-ancestor
19804494|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
19804495|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174331|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
20327804|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19804496|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804497|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19804498|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
19804499|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19804500|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
19804501|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
19804502|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645681|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19645682|NCT02364934|Propofol|propofol|mesh-list
19645683|NCT02364934|Sevoflurane|sevoflurane|mesh-list
19645684|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19645685|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645686|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645687|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19645688|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
19645689|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
19645690|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19645691|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19645692|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
19645693|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645694|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19645695|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19645696|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645697|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327805|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327806|NCT00755170|Bevacizumab|bevacizumab|mesh-list
20327807|NCT00755170|Vinorelbine|vinorelbine|mesh-list
20327808|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327809|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645698|NCT02364882|Urological Agents|urological agents|mesh-ancestor
19804503|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804504|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19804505|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19804506|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804507|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19804508|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
19804509|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804510|NCT00416715|Antacids|antacids|mesh-ancestor
19804511|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19804512|NCT00416793|Carboplatin|carboplatin|mesh-list
19804513|NCT00416793|Bortezomib|bortezomib|mesh-list
19804514|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804515|NCT00416884|Fludarabine|fludarabine|mesh-list
19804516|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
19804517|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804518|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804519|NCT00417079|Prednisone|prednisone|mesh-list
19804520|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
19804521|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804522|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
19804523|NCT00417079|Hormones|hormones|mesh-ancestor
19804524|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804525|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804526|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19804527|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804528|NCT00417079|Analgesics|analgesics|mesh-ancestor
19804529|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
19804530|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804531|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19804532|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19804533|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804534|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804535|NCT00417170|Amlodipine|amlodipine|mesh-list
19804536|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19804537|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19804538|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804539|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804540|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804541|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804542|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
19804543|NCT00417274|Quinacrine|quinacrine|mesh-list
19804544|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
19645699|NCT02364804|Aprepitant|aprepitant|mesh-list
19804545|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20347858|NCT00862095|Analgesics|analgesics|mesh-ancestor
19804546|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
19804547|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19804548|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804549|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
19804550|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19804551|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
19804552|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804553|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804554|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804555|NCT00417417|Rilonacept|rilonacept|mesh-list
19804556|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804557|NCT00417482|Risperidone|risperidone|mesh-list
19804558|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19804559|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
19804560|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804561|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804562|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804563|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19804564|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19804565|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19804566|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19804567|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19804568|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
19804569|NCT00417885|Sunitinib|sunitinib|mesh-list
19804570|NCT00417885|Exemestane|exemestane|mesh-list
19804571|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804572|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19804573|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19804574|NCT00417885|Growth Substances|growth substances|mesh-ancestor
19804575|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804576|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
19804577|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19804578|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804579|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804580|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19804581|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19804582|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19804583|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
19804584|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804585|NCT00417976|Gemcitabine|gemcitabine|mesh-list
19804586|NCT00417976|Bevacizumab|bevacizumab|mesh-list
19804587|NCT00417976|Fluorouracil|fluorouracil|mesh-list
19804588|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804589|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804590|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19804591|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19804592|NCT00417976|Growth Substances|growth substances|mesh-ancestor
19804593|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804594|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
19804595|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804596|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
19804597|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804598|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
19804599|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804600|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804601|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804602|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
19804603|NCT00418028|Capecitabine|capecitabine|mesh-list
20327810|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327811|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20327812|NCT00755170|Growth Substances|growth substances|mesh-ancestor
19645700|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
19645701|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
19645702|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645703|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645704|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645705|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19645706|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645707|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645708|NCT02365012|Midodrine|midodrine|mesh-list
20327813|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327814|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
20327815|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19645709|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
20327816|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
19804604|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804605|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
19804606|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804607|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804608|NCT00418093|Gemcitabine|gemcitabine|mesh-list
19804609|NCT00418093|Bevacizumab|bevacizumab|mesh-list
19804610|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
19804611|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804612|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804613|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19804614|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19804615|NCT00418093|Growth Substances|growth substances|mesh-ancestor
19804616|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804617|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
19804618|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804619|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
19804620|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804621|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
19804622|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804623|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804624|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804625|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
19804626|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19804627|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19804628|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19804629|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804630|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804631|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
19804632|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804633|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804634|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
19804635|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804636|NCT00418457|Anesthetics|anesthetics|mesh-list
19804637|NCT00418457|Propofol|propofol|mesh-list
19804638|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19804639|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804640|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19804641|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19804642|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
19804643|NCT00418522|Insulin|insulin|mesh-list
19804644|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19804645|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
19804646|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19804647|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804648|NCT00418574|Abagovomab|abagovomab|mesh-list
19645710|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
19804649|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804650|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804651|NCT00418691|Methylphenidate|methylphenidate|mesh-list
19804652|NCT00418691|Modafinil|modafinil|mesh-list
19804653|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19804654|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804655|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19804656|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19804657|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804658|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804659|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
20162144|NCT00126971|Dapsone|dapsone|mesh-list
19645711|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645712|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645713|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19645714|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19645715|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19645716|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19645717|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645718|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645719|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162145|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
20162146|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162147|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
20162148|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20162149|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20162150|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19804660|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804661|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19804662|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19804663|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19804664|NCT00418717|Etanercept|etanercept|mesh-list
19804665|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19804666|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19804667|NCT00418717|Analgesics|analgesics|mesh-ancestor
19804668|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
19804669|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804670|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804671|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804672|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804673|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19804674|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804675|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
19804676|NCT00418886|Pemetrexed|pemetrexed|mesh-list
19804677|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804678|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804679|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804680|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19804681|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19804682|NCT00418938|Leucovorin|leucovorin|mesh-list
19804683|NCT00418938|Bevacizumab|bevacizumab|mesh-list
19804684|NCT00418938|Panitumumab|panitumumab|mesh-list
20162151|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162152|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162153|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
20162154|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20162155|NCT00127010|Vaccines|vaccines|mesh-list
20162156|NCT00127010|Immunoglobulins|immunoglobulins|mesh-list
20162157|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
20327817|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327818|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
19804685|NCT00418938|Fluorouracil|fluorouracil|mesh-list
19804686|NCT00418938|Irinotecan|irinotecan|mesh-list
19804687|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19804688|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804689|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19804690|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19804691|NCT00418938|Growth Substances|growth substances|mesh-ancestor
19804692|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804693|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
19804694|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
19804695|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804696|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19804697|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804698|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
19804699|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19804700|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19804701|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804702|NCT00418938|Antidotes|antidotes|mesh-ancestor
19804703|NCT00418938|Protective Agents|protective agents|mesh-ancestor
19804704|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
19804705|NCT00418938|Vitamins|vitamins|mesh-ancestor
19804706|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
19804707|NCT00418951|Voriconazole|voriconazole|mesh-list
19804708|NCT00418951|Amphotericin B|amphotericin b|mesh-list
19804709|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20327819|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804710|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
19804711|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804712|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20162158|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327820|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
19804713|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19804714|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804715|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804716|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19804717|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
19804718|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804719|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804720|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19804721|NCT00418951|Amebicides|amebicides|mesh-ancestor
19804722|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19804723|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19804724|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19804725|NCT00419003|Lamotrigine|lamotrigine|mesh-list
19804726|NCT00419003|Ketamine|ketamine|mesh-list
19804727|NCT00419003|Riluzole|riluzole|mesh-list
19804728|NCT00419003|Analgesics|analgesics|mesh-ancestor
19804729|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
19804730|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804731|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804732|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19804733|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20327821|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20327822|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20327823|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327824|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
20327825|NCT00755209|Coagulants|coagulants|mesh-ancestor
20327826|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
20327827|NCT00755313|Carboplatin|carboplatin|mesh-list
20327828|NCT00755313|Docetaxel|docetaxel|mesh-list
20327829|NCT00755313|Doxorubicin|doxorubicin|mesh-list
19804734|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
19804735|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
19804736|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19804737|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19804738|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19804739|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804740|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804741|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
19804742|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19804743|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804744|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804745|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19804746|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19804747|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19804748|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19804749|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19804750|NCT00419003|Protective Agents|protective agents|mesh-ancestor
19804751|NCT00419094|Levetiracetam|levetiracetam|mesh-list
19804752|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
19804753|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
19804754|NCT00419159|Everolimus|everolimus|mesh-list
19804755|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327830|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20327831|NCT00755313|Trastuzumab|trastuzumab|mesh-list
20327832|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20327833|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20327834|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327835|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
20327836|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804756|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804757|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
19804758|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327837|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162159|NCT00127023|Vaccines|vaccines|mesh-list
20162160|NCT00127023|Immunoglobulins|immunoglobulins|mesh-list
20162161|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
20162162|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162163|NCT00127049|Gemcitabine|gemcitabine|mesh-list
20162164|NCT00127049|Ifosfamide|ifosfamide|mesh-list
20162165|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162166|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162167|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
20162168|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162169|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
20162170|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327838|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20162171|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162172|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327839|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
20347859|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
19804759|NCT00419263|Peramivir|peramivir|mesh-list
19804760|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
19804761|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804762|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804763|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804764|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
19804765|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19804766|NCT00419341|Antibodies|antibodies|mesh-list
19804767|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
19804768|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804769|NCT00419393|Levetiracetam|levetiracetam|mesh-list
19804770|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
19804771|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
19804772|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
19804773|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19804774|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19804775|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
19804776|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804777|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804778|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804779|NCT00419562|Insulin|insulin|mesh-list
19804780|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19804781|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804782|NCT00419666|Calcitriol|calcitriol|mesh-list
19804783|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19804784|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804785|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19804786|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804787|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804788|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19804789|NCT00419666|Vitamins|vitamins|mesh-ancestor
19804790|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
20162173|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
20162174|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327840|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645720|NCT02364765|Remifentanil|remifentanil|mesh-list
20327841|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327842|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20327843|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
20327844|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327845|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327846|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19645721|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19645722|NCT02364765|Narcotics|narcotics|mesh-ancestor
19645723|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19645724|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645725|NCT02364765|Analgesics|analgesics|mesh-ancestor
19645726|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
19645727|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645728|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
19645729|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162175|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20162176|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
20162177|NCT00127075|Estradiol|estradiol|mesh-list
20162178|NCT00127075|Estrogens|estrogens|mesh-ancestor
20162179|NCT00127075|Hormones|hormones|mesh-ancestor
20162180|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162181|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162182|NCT00127088|Docetaxel|docetaxel|mesh-list
20162183|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804791|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19645730|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19804792|NCT00419744|Budesonide|budesonide|mesh-list
19804793|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
19804794|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19804795|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804796|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19804797|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
19804798|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804799|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804800|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19804801|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
19804802|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
19804803|NCT00419744|Hormones|hormones|mesh-ancestor
19804804|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804805|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19804806|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19804807|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19804808|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
19804809|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804810|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804811|NCT00419757|Budesonide|budesonide|mesh-list
19804812|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
19804813|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19804814|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804815|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19804816|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
19804817|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804818|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804819|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19804820|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
19804821|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
19804822|NCT00419757|Hormones|hormones|mesh-ancestor
19804823|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804824|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19804825|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19804826|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20327847|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20327848|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327849|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327850|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327851|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20327852|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19645731|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645732|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645733|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
19645734|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645735|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645736|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19645737|NCT02364479|Etanercept|etanercept|mesh-list
19645738|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19804827|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
19804828|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804829|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804830|NCT00419770|Amphotericin B|amphotericin b|mesh-list
19804831|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19804832|NCT00419770|Deferasirox|deferasirox|mesh-list
19804833|NCT00419770|Amebicides|amebicides|mesh-ancestor
19804834|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19804835|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19804836|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804837|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19804838|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
19804839|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19804840|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
19804841|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
19804842|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804843|NCT00419926|Cyclosporine|cyclosporine|mesh-list
19804844|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
19804845|NCT00419926|Prednisone|prednisone|mesh-list
19804846|NCT00419926|Cyclosporins|cyclosporins|mesh-list
19804847|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804848|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
19804849|NCT00419926|Hormones|hormones|mesh-ancestor
19804850|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804851|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804852|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19804853|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645739|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645740|NCT02364479|Analgesics|analgesics|mesh-ancestor
19645741|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
19645742|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804854|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162184|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20327853|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19804855|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804856|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804857|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
19804858|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
19804859|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19804860|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
19804861|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804862|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19804863|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19804864|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20327854|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
20327855|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327856|NCT00755352|Pravastatin|pravastatin|mesh-list
20327857|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20327858|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20327859|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20327860|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
20327861|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327862|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20327863|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20327864|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804865|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
19804866|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19804867|NCT00419952|Budesonide|budesonide|mesh-list
19804868|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
19804869|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19804870|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804871|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19804872|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
19804873|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804874|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804875|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19804876|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
19804877|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
19804878|NCT00419952|Hormones|hormones|mesh-ancestor
19804879|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804880|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19804881|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19804882|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19804883|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
19804884|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19804885|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804886|NCT00420004|Citalopram|citalopram|mesh-list
19804887|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19645743|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645744|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645745|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645746|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645747|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645748|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
19645749|NCT02364752|Diuretics|diuretics|mesh-list
19804888|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19804889|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804890|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804891|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327865|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20327866|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20327867|NCT00755495|Doxepin|doxepin|mesh-list
20327868|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20327869|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20327870|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327871|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327872|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20327873|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
19645750|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19804892|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
19804893|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804894|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19804895|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
20327874|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20327875|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
19645751|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
19804896|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19804897|NCT00420017|Amiodarone|amiodarone|mesh-list
19804898|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19804899|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
19804900|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19804901|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19804902|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804903|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19804904|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19804905|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19804906|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804907|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19804908|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19804909|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19804910|NCT00420056|Palbociclib|palbociclib|mesh-list
19804911|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804912|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19804913|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19804914|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19804915|NCT00420095|Insulin|insulin|mesh-list
19645752|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645753|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19645754|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645755|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
19645756|NCT02364609|Afatinib|afatinib|mesh-list
19645757|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19645758|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804916|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19804917|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
19804918|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19804919|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804920|NCT00420199|Abatacept|abatacept|mesh-list
19804921|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19804922|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162185|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162186|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327876|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
20327877|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327878|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327879|NCT00755508|Gabapentin|gabapentin|mesh-list
20327880|NCT00755508|Analgesics|analgesics|mesh-ancestor
20327881|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
20327882|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327883|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327884|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
20327885|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20327886|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20327887|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20327888|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20327889|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19645759|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19645760|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645761|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645762|NCT02364583|Primaquine|primaquine|mesh-list
19645763|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
19645764|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19645765|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19645766|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645767|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
19645768|NCT02364453|Growth Substances|growth substances|mesh-ancestor
20162187|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162188|NCT00127114|Amantadine|amantadine|mesh-list
20162189|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20162190|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20162191|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
20162192|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162193|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
20162194|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162195|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162196|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162197|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645769|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645770|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645771|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645772|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664228|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19664229|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
19664230|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
19804923|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804924|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804925|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
19804926|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804927|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804928|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19804929|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
19804930|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804931|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
19804932|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804933|NCT00420238|Etanercept|etanercept|mesh-list
19804934|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19804935|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19804936|NCT00420238|Analgesics|analgesics|mesh-ancestor
19804937|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
19804938|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804939|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804940|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804941|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804942|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19804943|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804944|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
19804945|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19804946|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804947|NCT00420303|Etanercept|etanercept|mesh-list
19804948|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19804949|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19804950|NCT00420303|Analgesics|analgesics|mesh-ancestor
19804951|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
19804952|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19804953|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804954|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19804955|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19804956|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19804957|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19804958|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
19804959|NCT00420316|Vaccines|vaccines|mesh-list
19804960|NCT00420316|Immunologic Factors|immunologic factors|mesh-ancestor
19804961|NCT00420316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804962|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19804963|NCT00420342|Drospirenone|drospirenone|mesh-list
19804964|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19804965|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19804966|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
19804967|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19804968|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19804969|NCT00420342|Estradiol|estradiol|mesh-list
19804970|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19804971|NCT00420342|Estrogens|estrogens|mesh-ancestor
19804972|NCT00420342|Hormones|hormones|mesh-ancestor
19804973|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19804974|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804975|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19804976|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
20162198|NCT00127114|Analgesics|analgesics|mesh-ancestor
20162199|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
20162200|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162201|NCT00127140|Vorinostat|vorinostat|mesh-list
20162202|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664231|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664232|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19664233|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19664234|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
19664235|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
19664236|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
19804977|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20162203|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19804978|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19804979|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19804980|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19804981|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19804982|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19804983|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19804984|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19804985|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19804986|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
19804987|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19804988|NCT00420342|Diuretics|diuretics|mesh-ancestor
19804989|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
19804990|NCT00420407|Vasopressins|vasopressins|mesh-list
19804991|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
19804992|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
19804993|NCT00420407|Coagulants|coagulants|mesh-ancestor
19804994|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19804995|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19804996|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
19804997|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19804998|NCT00420459|Aripiprazole|aripiprazole|mesh-list
19804999|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
19805000|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19805001|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19805002|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19805003|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805004|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805005|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
19805006|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
19805007|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805008|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805009|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19805010|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19805011|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
19805012|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19805013|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19805014|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19805015|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19805016|NCT00420511|Metformin|metformin|mesh-list
19805017|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19805018|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19805019|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805020|NCT00420511|Incretins|incretins|mesh-ancestor
19805021|NCT00420511|Hormones|hormones|mesh-ancestor
19805022|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805023|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19805024|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
19805025|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805026|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805027|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19805028|NCT00420628|Tobramycin|tobramycin|mesh-list
19805029|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19805030|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805031|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19805032|NCT00420641|Paroxetine|paroxetine|mesh-list
19805033|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19805034|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19805035|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805036|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805037|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805038|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
19805039|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805040|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19805041|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
20162204|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645773|NCT02364206|Temozolomide|temozolomide|mesh-list
19645774|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19645775|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
19645776|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645777|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645778|NCT02364258|Atorvastatin|atorvastatin|mesh-list
19645779|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19645780|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19645781|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20174332|NCT00164463|Isoniazid|isoniazid|mesh-list
19805042|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19805043|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19805044|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19805045|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805046|NCT00420771|Gabapentin|gabapentin|mesh-list
19805047|NCT00420771|Analgesics|analgesics|mesh-ancestor
19805048|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
19805049|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805050|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805051|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
19805052|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19805053|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19805054|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805055|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19805056|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19805057|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19805058|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805059|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805060|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
19805061|NCT00420784|Interferons|interferons|mesh-list
19805062|NCT00420784|Ribavirin|ribavirin|mesh-list
19805063|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
19805064|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
19805065|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19805066|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805067|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
19805068|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805069|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
19805070|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805071|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
19805072|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805073|NCT00420849|Dexamethasone|dexamethasone|mesh-list
19805074|NCT00420849|Lenalidomide|lenalidomide|mesh-list
19805075|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805076|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
19805077|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
19805078|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805079|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805080|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805081|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
19805082|NCT00420849|Hormones|hormones|mesh-ancestor
19805083|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805084|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19805085|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805086|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
19805087|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20327890|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20327891|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327892|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327893|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
20327894|NCT00755521|Etoricoxib|etoricoxib|mesh-list
20327895|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20327896|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645782|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
19645783|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645784|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19645785|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19645786|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645787|NCT02364362|Docetaxel|docetaxel|mesh-list
19805088|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805089|NCT00420849|Growth Substances|growth substances|mesh-ancestor
19805090|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
19805091|NCT00420927|Adalimumab|adalimumab|mesh-list
19805092|NCT00420927|Methotrexate|methotrexate|mesh-list
19805093|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19805094|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
19805095|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19805096|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805097|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19645788|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645789|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
19645790|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
19645791|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805098|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
19834415|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19805099|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805100|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805101|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805102|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805103|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19805104|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805105|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
19805106|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805107|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19805108|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805109|NCT00420992|Naltrexone|naltrexone|mesh-list
19805110|NCT00420992|Morphine|morphine|mesh-list
19805111|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19805112|NCT00420992|Narcotics|narcotics|mesh-ancestor
19805113|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805114|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805115|NCT00420992|Analgesics|analgesics|mesh-ancestor
19805116|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
19805117|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611607|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20611608|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20611609|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
20611610|NCT00602641|Hormones|hormones|mesh-ancestor
20611611|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611612|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611613|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20611614|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611615|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
19645792|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805118|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19805119|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19805120|NCT00421148|Bromides|bromides|mesh-list
19805121|NCT00421148|Rocuronium|rocuronium|mesh-list
19805122|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
19645793|NCT02364089|Epinephrine|epinephrine|mesh-list
19645794|NCT02364089|Racepinephrine|racepinephrine|mesh-list
19645795|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
19645796|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19645797|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19645798|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
19645799|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805123|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19805124|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19805125|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19805126|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805127|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805128|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
19805129|NCT00421174|Etanercept|etanercept|mesh-list
19805130|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805131|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
19805132|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
19805133|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645800|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645801|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645802|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19645803|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19645804|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
19645805|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645806|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20162205|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162206|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20162207|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
20162208|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162209|NCT00127257|Diazepam|diazepam|mesh-list
20162210|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20162211|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
20162212|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
20162213|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
20162214|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162215|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645807|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
19805134|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805135|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805136|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
20162216|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20327897|NCT00755521|Analgesics|analgesics|mesh-ancestor
20327898|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
20162217|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20162218|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20162219|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20162220|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20162221|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20162222|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20162223|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20162224|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20162225|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
20162226|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
20162227|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
20162228|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
20162229|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20327899|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327900|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327901|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327902|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327903|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20327904|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20327905|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327906|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327907|NCT00755534|Capecitabine|capecitabine|mesh-list
20327908|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
20327909|NCT00755534|Irinotecan|irinotecan|mesh-list
20327910|NCT00755534|Cetuximab|cetuximab|mesh-list
20327911|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20327912|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
20327913|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327914|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327915|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20327916|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20327917|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327918|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20327919|NCT00755560|Albendazole|albendazole|mesh-list
20327920|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
20327921|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20327922|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327923|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
20327924|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20327925|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20327926|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
20327927|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
20327928|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
20327929|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327930|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327931|NCT00755573|Pregabalin|pregabalin|mesh-list
20327932|NCT00755573|Analgesics|analgesics|mesh-ancestor
20327933|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
20327934|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20327935|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327936|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
20327937|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20327938|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805137|NCT00421174|Hormones|hormones|mesh-ancestor
19805138|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805139|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19805140|NCT00421174|Protective Agents|protective agents|mesh-ancestor
19805141|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19805142|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19805143|NCT00421174|Analgesics|analgesics|mesh-ancestor
19805144|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
19805145|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805146|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805147|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
19805148|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
19805149|NCT00421343|Alendronate|alendronate|mesh-list
19805150|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
19805151|NCT00421343|Calcium|calcium|mesh-list
19805152|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19805153|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805154|NCT00421343|Vitamins|vitamins|mesh-ancestor
20162230|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327939|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805155|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
19805156|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19805157|NCT00421343|Antacids|antacids|mesh-ancestor
19805158|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805159|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19834416|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19835486|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835487|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835488|NCT00603239|Exenatide|exenatide|mesh-list
19835489|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19835490|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835491|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19835492|NCT00603239|Incretins|incretins|mesh-ancestor
19835493|NCT00603239|Hormones|hormones|mesh-ancestor
19835494|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835495|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19645808|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
19645809|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
19645810|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19645811|NCT02363985|Vitamin A|vitamin a|mesh-list
19645812|NCT02363985|Vitamins|vitamins|mesh-ancestor
19645813|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
20347860|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835496|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19835497|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835498|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19645814|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645815|NCT02363829|Nelfinavir|nelfinavir|mesh-list
19645816|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19645817|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19645818|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
19645819|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645820|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645821|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19645822|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19645823|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
19645824|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645825|NCT02363699|Lidocaine|lidocaine|mesh-list
19835499|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835500|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835501|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835502|NCT00603265|Analgesics|analgesics|mesh-ancestor
19835503|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
19835504|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835505|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835506|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835507|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
19835508|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
19835509|NCT00603304|Urological Agents|urological agents|mesh-ancestor
19835510|NCT00603408|Cisplatin|cisplatin|mesh-list
19835511|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835512|NCT00603447|Dexamethasone|dexamethasone|mesh-list
19835513|NCT00603447|Lenalidomide|lenalidomide|mesh-list
19835514|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835515|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
19835516|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
19835517|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835518|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835519|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19835520|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
19835521|NCT00603447|Hormones|hormones|mesh-ancestor
19835522|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835523|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19835524|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835525|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
19835526|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20162231|NCT00127270|Darifenacin|darifenacin|mesh-list
19645826|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
20162232|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20162233|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19645827|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
19645828|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20162234|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
20162235|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162236|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805160|NCT00421603|Topiramate|topiramate|mesh-list
19805161|NCT00421603|Adderall|adderall|mesh-list
19805162|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
19805163|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19805164|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805165|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19805166|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
19805167|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19805168|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805169|NCT00421733|Vitamins|vitamins|mesh-ancestor
19805170|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
19805171|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19805172|NCT00421889|Paclitaxel|paclitaxel|mesh-list
19805173|NCT00421889|Carboplatin|carboplatin|mesh-list
19805174|NCT00421889|Belinostat|belinostat|mesh-list
19805175|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19805176|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805177|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
19805178|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
19805179|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805180|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805181|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19805182|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805183|NCT00421928|Oxycodone|oxycodone|mesh-list
19805184|NCT00421928|Tapentadol|tapentadol|mesh-list
19805185|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19805186|NCT00421928|Narcotics|narcotics|mesh-ancestor
19805187|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805188|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805189|NCT00421928|Analgesics|analgesics|mesh-ancestor
19805190|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
19805191|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805192|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19805193|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19805194|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805195|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805196|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
19805197|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805198|NCT00421993|Adapalene|adapalene|mesh-list
19805199|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19805200|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19805201|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805202|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19805203|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20327940|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20327941|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20327942|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20327943|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805204|NCT00421993|Analgesics|analgesics|mesh-ancestor
19805205|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
19805206|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805207|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805208|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805209|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805210|NCT00422032|Clofarabine|clofarabine|mesh-list
19805211|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805212|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
19805213|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805214|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805215|NCT00422058|Liraglutide|liraglutide|mesh-list
19805216|NCT00422058|Orlistat|orlistat|mesh-list
19805217|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19805218|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805219|NCT00422058|Incretins|incretins|mesh-ancestor
19805220|NCT00422058|Hormones|hormones|mesh-ancestor
19805221|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805222|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805223|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327944|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20327945|NCT00755664|Vitamins|vitamins|mesh-list
20327946|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
20327947|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
19805224|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19805225|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19805226|NCT00422084|Artesunate|artesunate|mesh-list
20327948|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805227|NCT00422084|Lumefantrine|lumefantrine|mesh-list
19805228|NCT00422084|Artemether|artemether|mesh-list
19805229|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19805230|NCT00422084|Pyronaridine|pyronaridine|mesh-list
19805231|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
19805232|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19805233|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19805234|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805235|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805236|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
19805237|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
19805238|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19805239|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
19805240|NCT00422097|Epothilones|epothilones|mesh-list
19805241|NCT00422097|Famotidine|famotidine|mesh-list
19805242|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
19805243|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
19805244|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805245|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805246|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805247|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19805248|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805249|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19805250|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
19805251|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
19805252|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805253|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805254|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19805255|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20327949|NCT00755781|Cyclosporine|cyclosporine|mesh-list
20327950|NCT00755781|Cyclosporins|cyclosporins|mesh-list
20327951|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20327952|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327953|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327954|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
20327955|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327956|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
20327957|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327958|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
20327959|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20327960|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20327961|NCT00755820|Cycloserine|cycloserine|mesh-list
20327962|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20327963|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20327964|NCT00755820|Renal Agents|renal agents|mesh-ancestor
20327965|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20327966|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
20327967|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20327968|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
20327969|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327970|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
20327971|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
20327972|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20327973|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327974|NCT00755859|Prednisone|prednisone|mesh-list
20327975|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20327976|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19805256|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19805257|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805258|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327977|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
20327978|NCT00755859|Prednisolone|prednisolone|mesh-list
20327979|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
20327980|NCT00755859|Azathioprine|azathioprine|mesh-list
20327981|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20327982|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
20327983|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
20327984|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20327985|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20327986|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20327987|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20327988|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
20327989|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20327990|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805259|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805260|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805261|NCT00422162|Analgesics|analgesics|mesh-ancestor
19805262|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
19805263|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805264|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
19805265|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19805266|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
19805267|NCT00422201|Mifepristone|mifepristone|mesh-list
19805268|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19805269|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
19805270|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19805271|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805272|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19805273|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19805274|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19805275|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
19805276|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19805277|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19805278|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
19805279|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805280|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
19805281|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19805282|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19805283|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
19805284|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
19805285|NCT00422227|Etanercept|etanercept|mesh-list
19805286|NCT00422227|Methotrexate|methotrexate|mesh-list
19805287|NCT00422227|Leflunomide|leflunomide|mesh-list
20162237|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162238|NCT00127270|Urological Agents|urological agents|mesh-ancestor
20162239|NCT00127335|Atorvastatin|atorvastatin|mesh-list
20162240|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20162241|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20162242|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
20162243|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162244|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20162245|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19805288|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19805289|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
19805290|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19805291|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805292|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805293|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
19805294|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805295|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805296|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805297|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805298|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19805299|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805300|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
19805301|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805302|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19805303|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
19805304|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19805305|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19805306|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805307|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19805308|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19805309|NCT00422227|Analgesics|analgesics|mesh-ancestor
19805310|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
19805311|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805312|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805313|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805314|NCT00422292|Vaccines|vaccines|mesh-list
19805315|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
19805316|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805317|NCT00422383|Rituximab|rituximab|mesh-list
19805318|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805319|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805320|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
19805321|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805322|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805323|NCT00422422|Brivaracetam|brivaracetam|mesh-list
20162246|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645829|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805324|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
19805325|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
19805326|NCT00422513|Hematinics|hematinics|mesh-ancestor
19805327|NCT00422591|Cytarabine|cytarabine|mesh-list
19805328|NCT00422591|Idarubicin|idarubicin|mesh-list
19805329|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805330|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
19805331|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805332|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805333|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
19805334|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645830|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
19645831|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645832|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19645833|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19645834|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19645835|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19645836|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645837|NCT02363751|Bevacizumab|bevacizumab|mesh-list
19664237|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19664238|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20162247|NCT00127387|Etanercept|etanercept|mesh-list
20162248|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20162249|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20162250|NCT00127387|Analgesics|analgesics|mesh-ancestor
20162251|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
20162252|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162253|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162254|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162255|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162256|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20162257|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162258|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
20162259|NCT00127478|Atrasentan|atrasentan|mesh-list
20162260|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162261|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20162262|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20162263|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162264|NCT00127504|Azithromycin|azithromycin|mesh-list
20162265|NCT00127504|Rifampin|rifampin|mesh-list
20162266|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20162267|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162268|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20162269|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
20162270|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
20162271|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162272|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162273|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162274|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20162275|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19664239|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19664240|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19664241|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
19664242|NCT04515186|Miltefosine|miltefosine|mesh-list
19664243|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19664244|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
19664245|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664246|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664247|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19664248|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19664249|NCT04507841|Niraparib|niraparib|mesh-list
19664250|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19664251|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664252|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664253|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664254|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
19664255|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
19664256|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19664257|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19664258|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664259|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664260|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664261|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805335|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805336|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
19805337|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805338|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19805339|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19805340|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19805341|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805342|NCT00422734|Tadalafil|tadalafil|mesh-list
19805343|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
19805344|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19805345|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19805346|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805347|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805348|NCT00422734|Urological Agents|urological agents|mesh-ancestor
19805349|NCT00422799|Rituximab|rituximab|mesh-list
19805350|NCT00422799|Bortezomib|bortezomib|mesh-list
19805351|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805352|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162276|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20162277|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20162278|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20162279|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20162280|NCT00127569|Rituximab|rituximab|mesh-list
20162281|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162282|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162283|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
20162284|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162285|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162286|NCT00127595|Gemcitabine|gemcitabine|mesh-list
20162287|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
20162288|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162289|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
20327991|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20327992|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
20327993|NCT00755859|Hormones|hormones|mesh-ancestor
20327994|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20327995|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162290|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162291|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162292|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
20162293|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162294|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162295|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162296|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
20327996|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20327997|NCT00755859|Protective Agents|protective agents|mesh-ancestor
20327998|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
20327999|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
20328000|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328001|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328002|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
20328003|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
20328004|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20328005|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328006|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328007|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20328008|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328009|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20328010|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
20328011|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328012|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20328013|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328014|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328015|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
20328016|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328017|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328018|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20328019|NCT00755898|Amantadine|amantadine|mesh-list
19805353|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
19805354|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805355|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805356|NCT00422903|Letrozole|letrozole|mesh-list
19805357|NCT00422903|Lapatinib|lapatinib|mesh-list
19805358|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805359|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20162297|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162298|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
20162299|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
20162300|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
20162301|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20162302|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20162303|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328020|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20328021|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19805360|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19805361|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805362|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805363|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19805364|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
19805365|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805366|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805367|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19805368|NCT00423085|Rivastigmine|rivastigmine|mesh-list
19805369|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19805370|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805371|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805372|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
19805373|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805374|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805375|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19805376|NCT00423085|Protective Agents|protective agents|mesh-ancestor
19805377|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
19805378|NCT00423098|Prednisone|prednisone|mesh-list
20328022|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
20328023|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328024|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
20328025|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328026|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328027|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328028|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328029|NCT00755898|Analgesics|analgesics|mesh-ancestor
20328030|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
20328031|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328032|NCT00755924|Acetic Acid|acetic acid|mesh-list
20328033|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328034|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328035|NCT00755950|Silymarin|silymarin|mesh-list
20328036|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
20328037|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328038|NCT00755950|Protective Agents|protective agents|mesh-ancestor
20328039|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805379|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
19805380|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19805381|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19805382|NCT00423098|Prednisolone|prednisolone|mesh-list
19805383|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
19805384|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19805385|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
19805386|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805387|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
19805388|NCT00423098|Hormones|hormones|mesh-ancestor
19805389|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805390|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805391|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19805392|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805393|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19805394|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19805395|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
19805396|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19805397|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805398|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834417|NCT00594815|Leucovorin|leucovorin|mesh-list
20328040|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19834418|NCT00594815|Cytarabine|cytarabine|mesh-list
19805399|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805400|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
19805401|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
19805402|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805403|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805404|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19805405|NCT00423098|Protective Agents|protective agents|mesh-ancestor
19805406|NCT00423150|Temozolomide|temozolomide|mesh-list
19805407|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19805408|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
20328041|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20328042|NCT00755963|Estradiol|estradiol|mesh-list
20328043|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20328044|NCT00755963|Progesterone|progesterone|mesh-list
20328045|NCT00755963|Estrogens|estrogens|mesh-ancestor
20328046|NCT00755963|Hormones|hormones|mesh-ancestor
20328047|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805409|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805410|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805411|NCT00423189|Ranibizumab|ranibizumab|mesh-list
19805412|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805413|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805414|NCT00423189|Growth Substances|growth substances|mesh-ancestor
19805415|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805416|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19805417|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805418|NCT00423267|Fluconazole|fluconazole|mesh-list
19805419|NCT00423267|Posaconazole|posaconazole|mesh-list
19805420|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
19805421|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805422|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19805423|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19805424|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805425|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805426|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19805427|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
19805428|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805429|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805430|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19805431|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19805432|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19805433|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19805434|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19805435|NCT00423293|Fluorouracil|fluorouracil|mesh-list
19805436|NCT00423293|Mitomycins|mitomycins|mesh-list
19805437|NCT00423293|Mitomycin|mitomycin|mesh-list
19805438|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
19805439|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805440|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805441|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805442|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805443|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
19805444|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834419|NCT00594815|Rituximab|rituximab|mesh-list
20162304|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328048|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162305|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162306|NCT00127764|Dexamethasone|dexamethasone|mesh-list
20162307|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162308|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
20162309|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
20162310|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805445|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19645838|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19645839|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805446|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
19805447|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19805448|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805449|NCT00423319|Enoxaparin|enoxaparin|mesh-list
19805450|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
19805451|NCT00423319|Apixaban|apixaban|mesh-list
19805452|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
19805453|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19805454|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19805455|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805456|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19805457|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
19805458|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19805459|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
19805460|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805461|NCT00423332|Cediranib|cediranib|mesh-list
19805462|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805463|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19805464|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805465|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805466|NCT00423358|Vitamin D|vitamin d|mesh-list
19805467|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
19805468|NCT00423358|Vitamins|vitamins|mesh-ancestor
19805469|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
19805470|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805471|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19805472|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19805473|NCT00423449|Gemcitabine|gemcitabine|mesh-list
20328049|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20328050|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
20328051|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20328052|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20328053|NCT00755963|Progestins|progestins|mesh-ancestor
20328054|NCT00755976|Sulindac|sulindac|mesh-list
20328055|NCT00755976|Epirubicin|epirubicin|mesh-list
20328056|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20328057|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328058|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20328059|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20328060|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328061|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328062|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20328063|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328064|NCT00755976|Analgesics|analgesics|mesh-ancestor
20328065|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
20328066|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805474|NCT00423449|Vorinostat|vorinostat|mesh-list
19805475|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805476|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
19805477|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805478|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805479|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
19805480|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328067|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328068|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645840|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19645841|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19645842|NCT02363751|Growth Substances|growth substances|mesh-ancestor
19645843|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645844|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
19645845|NCT02363556|Misoprostol|misoprostol|mesh-list
19645846|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19645847|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
19805481|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328069|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256673|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19805482|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805483|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
19805484|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805485|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19805486|NCT00423592|Ambrisentan|ambrisentan|mesh-list
19805487|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19805488|NCT00423657|Vancomycin|vancomycin|mesh-list
19805489|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19805490|NCT00423657|Aztreonam|aztreonam|mesh-list
19805491|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19805492|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805493|NCT00423670|Ribavirin|ribavirin|mesh-list
19805494|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19805495|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
19805496|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805497|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
19805498|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805499|NCT00423683|PENTA|penta|mesh-list
19805500|NCT00423683|Fondaparinux|fondaparinux|mesh-list
19805501|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19805502|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
19805503|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19805504|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
19805505|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805506|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805507|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
19805508|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19805509|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19805510|NCT00423735|Dasatinib|dasatinib|mesh-list
19805511|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805512|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19805513|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805514|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805515|NCT00423800|Interferons|interferons|mesh-list
19805516|NCT00423800|Ribavirin|ribavirin|mesh-list
19805517|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
19805518|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
19805519|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19805520|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805521|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
19805522|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805523|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
19805524|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805525|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
19805526|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805527|NCT00423852|Paclitaxel|paclitaxel|mesh-list
19805528|NCT00423852|Carboplatin|carboplatin|mesh-list
19805529|NCT00423852|Ifosfamide|ifosfamide|mesh-list
19805530|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19805531|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805532|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
19805533|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
19805534|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805535|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805536|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19805537|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
19805538|NCT00423878|Olanzapine|olanzapine|mesh-list
19805539|NCT00423878|Risperidone|risperidone|mesh-list
19805540|NCT00423878|Aripiprazole|aripiprazole|mesh-list
19805541|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19805542|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19805543|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
19805544|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805545|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805546|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805547|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19805548|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19805549|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805550|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19805551|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19805552|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
19805553|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
19805554|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
19805555|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805556|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805557|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19805558|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328070|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19805559|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805560|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
19805561|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
19805562|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19805563|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19805564|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19805565|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19805566|NCT00423891|Entecavir|entecavir|mesh-list
19805567|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
19805568|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805569|NCT00423917|Bevacizumab|bevacizumab|mesh-list
19805570|NCT00423917|Fulvestrant|fulvestrant|mesh-list
19805571|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805572|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805573|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805574|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805575|NCT00423917|Growth Substances|growth substances|mesh-ancestor
19805576|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805577|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
19805578|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19805579|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19805580|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19805581|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
19805582|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805583|NCT00423930|Bevacizumab|bevacizumab|mesh-list
19805584|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805585|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805586|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805587|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805588|NCT00423930|Growth Substances|growth substances|mesh-ancestor
19805589|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162311|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162312|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20162313|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
20162314|NCT00127764|Hormones|hormones|mesh-ancestor
20162315|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162316|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162317|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162318|NCT00127777|Amantadine|amantadine|mesh-list
20162319|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20162320|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20162321|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
20162322|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162323|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
19645848|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19645849|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645850|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19645851|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645852|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
19645853|NCT02363452|Lamivudine|lamivudine|mesh-list
19645854|NCT02363452|Zidovudine|zidovudine|mesh-list
19645855|NCT02363452|Abacavir|abacavir|mesh-list
19645856|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19645857|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19645858|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645859|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645860|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
19645861|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645862|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19645863|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19645864|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
19645865|NCT02363374|Leucovorin|leucovorin|mesh-list
19645866|NCT02363374|Folic Acid|folic acid|mesh-list
19645867|NCT02363374|Fluorouracil|fluorouracil|mesh-list
19645868|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
19645869|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
19645870|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
19645871|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645872|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19645873|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805590|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
19805591|NCT00423943|Modafinil|modafinil|mesh-list
20162324|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645874|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19645875|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
20328071|NCT00755989|Morphine|morphine|mesh-list
19805592|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19805593|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805594|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19805595|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19805596|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19805597|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805598|NCT00424021|Ambrisentan|ambrisentan|mesh-list
19805599|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19805600|NCT00424047|Dexamethasone|dexamethasone|mesh-list
19805601|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
19805602|NCT00424047|Lenalidomide|lenalidomide|mesh-list
19805603|NCT00424047|BB 1101|bb 1101|mesh-list
20162325|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162326|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162327|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20162328|NCT00127777|Analgesics|analgesics|mesh-ancestor
20162329|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
20162330|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162331|NCT00127829|Gefitinib|gefitinib|mesh-list
20162332|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162333|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20162334|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162335|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162336|NCT00127868|Selenium|selenium|mesh-list
19805604|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805605|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
19805606|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
19805607|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805608|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805609|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805610|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
19805611|NCT00424047|Hormones|hormones|mesh-ancestor
19805612|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805613|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19805614|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805615|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
19805616|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805617|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805618|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
19805619|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805620|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805621|NCT00424047|Growth Substances|growth substances|mesh-ancestor
19805622|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
19805623|NCT00424190|Vancomycin|vancomycin|mesh-list
19805624|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19805625|NCT00424190|Aztreonam|aztreonam|mesh-list
19805626|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19805627|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805628|NCT00424255|Lapatinib|lapatinib|mesh-list
19805629|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805630|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19805631|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805632|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805633|NCT00424294|Celecoxib|celecoxib|mesh-list
19805634|NCT00424294|Methotrexate|methotrexate|mesh-list
19805635|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19805636|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
19805637|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19805638|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805639|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805640|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
19805641|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805642|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805643|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805644|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805645|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19805646|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805647|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
19805648|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805649|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19805650|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19805651|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19805652|NCT00424294|Analgesics|analgesics|mesh-ancestor
19805653|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
19834420|NCT00594815|Methotrexate|methotrexate|mesh-list
19805654|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328072|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20328073|NCT00755989|Narcotics|narcotics|mesh-ancestor
20328074|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328075|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328076|NCT00755989|Analgesics|analgesics|mesh-ancestor
20328077|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
20328078|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328079|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20328080|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
20328081|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328082|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20328083|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20328084|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20328085|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
20328086|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328087|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20328088|NCT00756184|Travoprost|travoprost|mesh-list
20328089|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20328090|NCT00756301|Lidocaine|lidocaine|mesh-list
20328091|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
20328092|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
20328093|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328094|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328095|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
20328096|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328097|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20328098|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20328099|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20328100|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328101|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328102|NCT00756340|Bevacizumab|bevacizumab|mesh-list
20328103|NCT00756340|Everolimus|everolimus|mesh-list
20328104|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20328105|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328106|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805655|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805656|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19805657|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19805658|NCT00424372|Pregabalin|pregabalin|mesh-list
19805659|NCT00424372|Analgesics|analgesics|mesh-ancestor
19805660|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
19805661|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805662|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805663|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
19805664|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19805665|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805666|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805667|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19805668|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19805669|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19805670|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805671|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19805672|NCT00424385|Sorafenib|sorafenib|mesh-list
19805673|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
19805674|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805675|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19805676|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162337|NCT00127868|Ketoconazole|ketoconazole|mesh-list
20162338|NCT00127868|Ciclopirox|ciclopirox|mesh-list
20162339|NCT00127868|Griseofulvin|griseofulvin|mesh-list
20162340|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
20162341|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
20162342|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162343|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20162344|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20162345|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162346|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162347|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20162348|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
20328107|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805677|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328108|NCT00756340|Growth Substances|growth substances|mesh-ancestor
19805678|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
19805679|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19805680|NCT00424463|Edaravone|edaravone|mesh-list
19805681|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19805682|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
19805683|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805684|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19805685|NCT00424463|Protective Agents|protective agents|mesh-ancestor
19805686|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805687|NCT00424476|Belimumab|belimumab|mesh-list
19805688|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805689|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
19805690|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805691|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
19805692|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19805693|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19805694|NCT00424489|Prednisolone|prednisolone|mesh-list
19645876|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645877|NCT02363374|Antidotes|antidotes|mesh-ancestor
19645878|NCT02363374|Protective Agents|protective agents|mesh-ancestor
19645879|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
19645880|NCT02363374|Vitamins|vitamins|mesh-ancestor
19645881|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
19805695|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
19805696|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
19805697|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19805698|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
19805699|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805700|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
19805701|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805702|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805703|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19805704|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
19805705|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805706|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805707|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19805708|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805709|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
19805710|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
19805711|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805712|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805713|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
19645882|NCT02363374|Hematinics|hematinics|mesh-ancestor
19645883|NCT02363400|Cisplatin|cisplatin|mesh-list
19645884|NCT02363400|Epirubicin|epirubicin|mesh-list
19645885|NCT02363400|Mitomycins|mitomycins|mesh-list
19645886|NCT02363400|Mitomycin|mitomycin|mesh-list
19645887|NCT02363400|Tegafur|tegafur|mesh-list
19645888|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645889|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19645890|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19645891|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19645892|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162349|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328109|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328110|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
20328111|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328112|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
19645893|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645894|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
19805714|NCT00424489|Hormones|hormones|mesh-ancestor
19805715|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162350|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162351|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20162352|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
20162353|NCT00127868|Protective Agents|protective agents|mesh-ancestor
20162354|NCT00127868|Trace Elements|trace elements|mesh-ancestor
20162355|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
20162356|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
20162357|NCT00127881|Zanolimumab|zanolimumab|mesh-list
20162358|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162359|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347861|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20162360|NCT00127907|Vasopressins|vasopressins|mesh-list
19645895|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19645896|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19645897|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
19645898|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
19645899|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19805716|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19805717|NCT00424489|Protective Agents|protective agents|mesh-ancestor
19805718|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19805719|NCT00424502|Rituximab|rituximab|mesh-list
19805720|NCT00424502|Methotrexate|methotrexate|mesh-list
19805721|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805722|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805723|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
19805724|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805725|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645900|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19645901|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
19645902|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
19645903|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645904|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
19645905|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645906|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19645907|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645908|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645909|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
19805726|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19805727|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
19805728|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19805729|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805730|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
19805731|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805732|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805733|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805734|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19805735|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328113|NCT00756405|Antioxidants|antioxidants|mesh-list
20328114|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328115|NCT00756405|Protective Agents|protective agents|mesh-ancestor
20328116|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328117|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20328118|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19805736|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19805737|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
19805738|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805739|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19805740|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805741|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805742|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
19805743|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
19805744|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19805745|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
19805746|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805747|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805748|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20328119|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328120|NCT00756847|Paclitaxel|paclitaxel|mesh-list
20328121|NCT00756847|Carboplatin|carboplatin|mesh-list
20328122|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20328123|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328124|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
20328125|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
20328126|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
20328127|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328128|NCT00756860|Sevelamer|sevelamer|mesh-list
19805749|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
19805750|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
19805751|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20328129|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
20328130|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
20328131|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328132|NCT00756873|Etoricoxib|etoricoxib|mesh-list
20328133|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20328134|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328135|NCT00756873|Analgesics|analgesics|mesh-ancestor
19645910|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19645911|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805752|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
20328136|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
20328137|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328138|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328139|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328140|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328141|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20328142|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20328143|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328144|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834421|NCT00594815|Vincristine|vincristine|mesh-list
20162361|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
20162362|NCT00127907|Epinephrine|epinephrine|mesh-list
20162363|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20162364|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20162365|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
20162366|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162367|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162368|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162369|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20328145|NCT00756990|Naltrexone|naltrexone|mesh-list
20328146|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20328147|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20328148|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328149|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
20328150|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328151|NCT00757016|Triamcinolone|triamcinolone|mesh-list
20328152|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20328153|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20328154|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20162370|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20162371|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
20162372|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162373|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20162374|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
20162375|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
20162376|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
20328155|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328156|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
19645912|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19645913|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19645914|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19645915|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645916|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
19645917|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645918|NCT02362906|Azithromycin|azithromycin|mesh-list
19645919|NCT02362906|Erythromycin|erythromycin|mesh-list
19645920|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
19664262|NCT04395222|Fludarabine|fludarabine|mesh-list
19664263|NCT04395222|Melphalan|melphalan|mesh-list
19664264|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
19664265|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19664266|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664267|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664268|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664269|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
19664270|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664271|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19664272|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
19664273|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19664274|NCT04389775|Glucagon|glucagon|mesh-list
19664275|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19664276|NCT04389775|Incretins|incretins|mesh-ancestor
19664277|NCT04389775|Hormones|hormones|mesh-ancestor
19664278|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664279|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664280|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664281|NCT04368455|Vaccines|vaccines|mesh-list
19664282|NCT04368455|Immunologic Factors|immunologic factors|mesh-ancestor
19664283|NCT04368455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664284|NCT04345887|Spironolactone|spironolactone|mesh-list
19664285|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19664286|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
19664287|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664288|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805753|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805754|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805755|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19805756|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19805757|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19805758|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
19805759|NCT00424554|Temozolomide|temozolomide|mesh-list
19805760|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19805761|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
19805762|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805763|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805764|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19805765|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19805766|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19805767|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805768|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805769|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19805770|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805771|NCT00424593|Analgesics|analgesics|mesh-ancestor
19805772|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
19805773|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805774|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
19805775|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19805776|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
19805777|NCT00424619|Vitamin D|vitamin d|mesh-list
20328157|NCT00757016|Hormones|hormones|mesh-ancestor
20328158|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328159|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328160|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328161|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
20328162|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328163|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328164|NCT00757029|Norepinephrine|norepinephrine|mesh-list
20328165|NCT00757029|Methylphenidate|methylphenidate|mesh-list
20328166|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20328167|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328168|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20328169|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328170|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328171|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328172|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
20328173|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328174|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20328175|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19805778|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
19805779|NCT00424619|Vitamins|vitamins|mesh-list
19805780|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
19805781|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805782|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19805783|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19805784|NCT00424749|Prednisone|prednisone|mesh-list
19805785|NCT00424749|Rituximab|rituximab|mesh-list
19805786|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805787|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805788|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
19805789|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805790|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805791|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805792|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
19805793|NCT00424749|Hormones|hormones|mesh-ancestor
20162377|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20162378|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
20162379|NCT00127907|Coagulants|coagulants|mesh-ancestor
20162380|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20162381|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
20162382|NCT00127920|Bevacizumab|bevacizumab|mesh-list
20162383|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162384|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162385|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805794|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805795|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19805796|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
19805797|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19805798|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805799|NCT00424775|Vorinostat|vorinostat|mesh-list
19805800|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805801|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19805802|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805803|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805804|NCT00424827|Gemcitabine|gemcitabine|mesh-list
19805805|NCT00424827|Fluorouracil|fluorouracil|mesh-list
19805806|NCT00424827|Cetuximab|cetuximab|mesh-list
19805807|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19805808|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
19805809|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328176|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
20328177|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
20328178|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
20328179|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328180|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20328181|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
20328182|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20328183|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328184|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
19645921|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19645922|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
19645923|NCT02362906|Cephalosporins|cephalosporins|mesh-list
20328185|NCT00757185|Testosterone|testosterone|mesh-list
20328186|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
20328187|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
20328188|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20328189|NCT00757185|Ganirelix|ganirelix|mesh-list
20328190|NCT00757185|Androgens|androgens|mesh-ancestor
20328191|NCT00757185|Hormones|hormones|mesh-ancestor
20328192|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328193|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328194|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20328195|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328196|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
19645924|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19645925|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805810|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805811|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
19805812|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805813|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805814|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805815|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
19805816|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805817|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805818|NCT00424840|Bevacizumab|bevacizumab|mesh-list
19805819|NCT00424840|Carboplatin|carboplatin|mesh-list
19805820|NCT00424840|Bortezomib|bortezomib|mesh-list
19805821|NCT00424840|Docetaxel|docetaxel|mesh-list
19805822|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805823|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805824|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805825|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805826|NCT00424840|Growth Substances|growth substances|mesh-ancestor
19805827|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805828|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
20328197|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
20328198|NCT00757198|Remifentanil|remifentanil|mesh-list
20328199|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19645926|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19645927|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19645928|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645929|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645930|NCT02362958|Capecitabine|capecitabine|mesh-list
19645931|NCT02362958|Vinorelbine|vinorelbine|mesh-list
19645932|NCT02362958|Lapatinib|lapatinib|mesh-list
19645933|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19645934|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
19645935|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645936|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19645937|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19645938|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
19645939|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
19645940|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805829|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
19805830|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
19805831|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805832|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805833|NCT00425113|Metronidazole|metronidazole|mesh-list
19805834|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805835|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19805836|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19805837|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19805838|NCT00425308|Cyclosporine|cyclosporine|mesh-list
19805839|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
19805840|NCT00425308|Everolimus|everolimus|mesh-list
19805841|NCT00425308|Cyclosporins|cyclosporins|mesh-list
19805842|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805843|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805844|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805845|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
19805846|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805847|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
19805848|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805849|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805850|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805851|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19805852|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805853|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20328200|NCT00757198|Narcotics|narcotics|mesh-ancestor
20328201|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328202|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328203|NCT00757198|Analgesics|analgesics|mesh-ancestor
20328204|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
20328205|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328206|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20328207|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20328208|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
20328209|NCT00757315|Triamcinolone|triamcinolone|mesh-list
20328210|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20328211|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20328212|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20328213|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328214|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
19805854|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19805855|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
19805856|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19805857|NCT00425373|Amlodipine|amlodipine|mesh-list
19805858|NCT00425373|Valsartan|valsartan|mesh-list
19805859|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19805860|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20162386|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611616|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611617|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611618|NCT00602641|Growth Substances|growth substances|mesh-ancestor
20611619|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611620|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20162387|NCT00127920|Growth Substances|growth substances|mesh-ancestor
20162388|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162389|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
20162390|NCT00127959|Tenofovir|tenofovir|mesh-list
20162391|NCT00127959|Zidovudine|zidovudine|mesh-list
20162392|NCT00127959|Emtricitabine|emtricitabine|mesh-list
20162393|NCT00127959|Efavirenz|efavirenz|mesh-list
20162394|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
20162395|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162396|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20162397|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162398|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162399|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328215|NCT00757315|Hormones|hormones|mesh-ancestor
20611621|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
20611622|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162400|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20328216|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19805861|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19805862|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805863|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19805864|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805865|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
19805866|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19805867|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19805868|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19805869|NCT00425386|Sunitinib|sunitinib|mesh-list
19805870|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805871|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20328217|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328218|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328219|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
20328220|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328221|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328222|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
20328223|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20328224|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20328225|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328226|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20328227|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
20328228|NCT00757393|Vitamin D|vitamin d|mesh-list
20162401|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20162402|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
20162403|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20328229|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
20328230|NCT00757393|Vitamins|vitamins|mesh-list
20328231|NCT00757393|Calcium|calcium|mesh-list
20328232|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
20328233|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328234|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20328235|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20328236|NCT00757419|Lesogaberan|lesogaberan|mesh-list
20328237|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328238|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20328239|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
19645941|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19645942|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645943|NCT02363127|Progesterone|progesterone|mesh-list
19645944|NCT02363127|Progestins|progestins|mesh-ancestor
19645945|NCT02363127|Hormones|hormones|mesh-ancestor
19645946|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19645947|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162404|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20328240|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
20328241|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328242|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328243|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328244|NCT00757458|Propofol|propofol|mesh-list
20328245|NCT00757458|Edetic Acid|edetic acid|mesh-list
20328246|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
20328247|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20328248|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328249|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328250|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20328251|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
19645948|NCT02362945|Oxytocin|oxytocin|mesh-list
20162405|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20162406|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20162407|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20162408|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20328252|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
20328253|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
19645949|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
19645950|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19645951|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645952|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
19645953|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19645954|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19645955|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
19645956|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20328254|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19645957|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805872|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805873|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805874|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19805875|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19805876|NCT00425386|Growth Substances|growth substances|mesh-ancestor
19805877|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805878|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
19805879|NCT00425477|Bexarotene|bexarotene|mesh-list
19805880|NCT00425477|Sargramostim|sargramostim|mesh-list
19805881|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
19805882|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805883|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805884|NCT00425503|Bortezomib|bortezomib|mesh-list
19805885|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805886|NCT00425555|Panobinostat|panobinostat|mesh-list
19805887|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805888|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19805889|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805890|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805891|NCT00425607|Lonafarnib|lonafarnib|mesh-list
19805892|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805893|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805894|NCT00425672|Interleukin-2|interleukin-2|mesh-list
19805895|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
19805896|NCT00425672|Immunotoxins|immunotoxins|mesh-list
19805897|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805898|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19805899|NCT00425672|Analgesics|analgesics|mesh-ancestor
19805900|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
19805901|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805902|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805903|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
19805904|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
19805905|NCT00425698|Hematinics|hematinics|mesh-ancestor
19805906|NCT00425750|Docetaxel|docetaxel|mesh-list
19805907|NCT00425750|Bortezomib|bortezomib|mesh-list
19805908|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805909|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
20328255|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
20328256|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
20328257|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328258|NCT00757458|Antidotes|antidotes|mesh-ancestor
20328259|NCT00757458|Protective Agents|protective agents|mesh-ancestor
20328260|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20328261|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19805910|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
19805911|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805912|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805913|NCT00425802|Cyclosporine|cyclosporine|mesh-list
19805914|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
19805915|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
19805916|NCT00425802|Rituximab|rituximab|mesh-list
19805917|NCT00425802|Fludarabine|fludarabine|mesh-list
19805918|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
19805919|NCT00425802|Cyclosporins|cyclosporins|mesh-list
19805920|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19805921|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19805922|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
19805923|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805924|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19805925|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19805926|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
19805927|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162409|NCT00127972|Lamivudine|lamivudine|mesh-list
20162410|NCT00127972|Efavirenz|efavirenz|mesh-list
20162411|NCT00127972|Nevirapine|nevirapine|mesh-list
20162412|NCT00127972|Stavudine|stavudine|mesh-list
20162413|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20162414|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162415|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162416|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328262|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19805928|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805929|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19805930|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19805931|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162417|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
20328263|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328264|NCT00757523|Analgesics|analgesics|mesh-ancestor
20328265|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
20328266|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328267|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328268|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328269|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328270|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
20328271|NCT00757549|Cetuximab|cetuximab|mesh-list
20328272|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20328273|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328274|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20328275|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20328276|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328277|NCT00757679|Milnacipran|milnacipran|mesh-list
20328278|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
20328279|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20328280|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328281|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328282|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328283|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19645958|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19645959|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19645960|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19645961|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19645962|NCT02362711|Estrogens|estrogens|mesh-ancestor
19645963|NCT02362711|Hormones|hormones|mesh-ancestor
19645964|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664289|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19664290|NCT04345887|Diuretics|diuretics|mesh-ancestor
19664291|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
19664292|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
19664293|NCT04316169|Letrozole|letrozole|mesh-list
19664294|NCT04316169|Fulvestrant|fulvestrant|mesh-list
19664295|NCT04316169|Anastrozole|anastrozole|mesh-list
19664296|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664297|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19664298|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19664299|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664300|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664301|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19664302|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
19664303|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664304|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664305|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
19664306|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19664307|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19664308|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664309|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19664310|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19664311|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19664312|NCT04305145|Prednisone|prednisone|mesh-list
19664313|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
19664314|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19664315|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19664316|NCT04305145|Prednisolone|prednisolone|mesh-list
19664317|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
19664318|NCT04305145|Infliximab|infliximab|mesh-list
19664319|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19664320|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
19664321|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664322|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
19664323|NCT04305145|Hormones|hormones|mesh-ancestor
19664324|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664325|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664326|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19664327|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664328|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
19664329|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
19664330|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664331|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664332|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19664333|NCT04305145|Protective Agents|protective agents|mesh-ancestor
20611623|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19645965|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20162418|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162419|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20162420|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20162421|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20162422|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20162423|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20162424|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20162425|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20162426|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20162427|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
20162428|NCT00127985|Prednisolone|prednisolone|mesh-list
20162429|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20162430|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
20162431|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20162432|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
20162433|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20162434|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
20162435|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162436|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
20328284|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328285|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328286|NCT00757679|Analgesics|analgesics|mesh-ancestor
20328287|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
20328288|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328289|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
20328290|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328291|NCT00757692|Bicalutamide|bicalutamide|mesh-list
20328292|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
20328293|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
20328294|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328295|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328296|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328297|NCT00757731|Milnacipran|milnacipran|mesh-list
20328298|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
19645966|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
19645967|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645968|NCT02362516|BI 425809|bi 425809|mesh-list
19645969|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
19645970|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
19645971|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645972|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
19645973|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19645974|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19645975|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645976|NCT02362399|Urological Agents|urological agents|mesh-ancestor
19645977|NCT02362529|Minocycline|minocycline|mesh-list
19645978|NCT02362529|Celecoxib|celecoxib|mesh-list
19664334|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
19664335|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19664336|NCT04188145|Bevacizumab|bevacizumab|mesh-list
19664337|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19664338|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664339|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19664340|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19664341|NCT04188145|Growth Substances|growth substances|mesh-ancestor
19664342|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664343|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
19664344|NCT04181606|Esmolol|esmolol|mesh-list
19664345|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19664346|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19664347|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19664348|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
19664349|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664350|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664351|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664352|NCT04128774|Dexamethasone|dexamethasone|mesh-list
19664353|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
19664354|NCT04128774|BB 1101|bb 1101|mesh-list
19664355|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664356|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
19664357|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
19664358|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805932|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
19805933|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805934|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
19805935|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805936|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805937|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19805938|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19805939|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19805940|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
19805941|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19805942|NCT00425854|Afatinib|afatinib|mesh-list
19805943|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805944|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19805945|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805946|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805947|NCT00425945|Pycnogenols|pycnogenols|mesh-list
19805948|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19805949|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
19805950|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805951|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
19805952|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805953|NCT00425945|Protective Agents|protective agents|mesh-ancestor
19805954|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19805955|NCT00426127|Docetaxel|docetaxel|mesh-list
19805956|NCT00426127|Doxorubicin|doxorubicin|mesh-list
19805957|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19805958|NCT00426127|Enoxaparin|enoxaparin|mesh-list
19805959|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805960|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
20328299|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20328300|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328301|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347862|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19645979|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19805961|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
19805962|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
19805963|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19805964|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19805965|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19805966|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19805967|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805968|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
19805969|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19805970|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19805971|NCT00426153|Octreotide|octreotide|mesh-list
19805972|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19805973|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19805974|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834422|NCT00594815|Procarbazine|procarbazine|mesh-list
19834423|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834424|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834425|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
19834426|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834427|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834428|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19645980|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19645981|NCT02362529|Analgesics|analgesics|mesh-ancestor
19645982|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
19645983|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19645984|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19645985|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645986|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19645987|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19834429|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
19834430|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19834431|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162437|NCT00127985|Hormones|hormones|mesh-ancestor
19834432|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
20162438|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162439|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162440|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162441|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162442|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
20162443|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
19805975|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
19805976|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
19805977|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805978|NCT00426283|Fluticasone|fluticasone|mesh-list
19805979|NCT00426283|Xhance|xhance|mesh-list
19805980|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19805981|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19805982|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
19805983|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19805984|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805985|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20328302|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328303|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328304|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328305|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328306|NCT00757731|Analgesics|analgesics|mesh-ancestor
20328307|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
20328308|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328309|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
20328310|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328311|NCT00757835|Timolol|timolol|mesh-list
20328312|NCT00757835|Latanoprost|latanoprost|mesh-list
20328313|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20328314|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20328315|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
20328316|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328317|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328318|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328319|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20328320|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20328321|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20328322|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20328323|NCT00757874|Clobetasol|clobetasol|mesh-list
20328324|NCT00757874|Tacrolimus|tacrolimus|mesh-list
20328325|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328326|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
20328327|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328328|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20328329|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19805986|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
19805987|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
19805988|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19805989|NCT00426361|Vaccines|vaccines|mesh-list
19805990|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
19805991|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805992|NCT00426517|Sirolimus|sirolimus|mesh-list
20328330|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328331|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328332|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
20328333|NCT00757874|Hormones|hormones|mesh-ancestor
20328334|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328335|NCT00757978|Memantine|memantine|mesh-list
20328336|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20328337|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20328338|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
20328339|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328340|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328341|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328342|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20328343|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20328344|NCT00758004|Atorvastatin|atorvastatin|mesh-list
20328345|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20328346|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20328347|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
20328348|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328349|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20328350|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20328351|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328352|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20328353|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20328354|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20328355|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19805993|NCT00426517|Busulfan|busulfan|mesh-list
19805994|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
19805995|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328356|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328357|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328358|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20328359|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20328360|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
20328361|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328362|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328363|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20328364|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20328365|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
20328366|NCT00758134|Trastuzumab|trastuzumab|mesh-list
20328367|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20328368|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347863|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347864|NCT00862095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20347865|NCT00862095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20347866|NCT00862095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347867|NCT00862108|Methylphenidate|methylphenidate|mesh-list
20347868|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20347869|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347870|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20347871|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20347872|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347873|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347874|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
20347875|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347876|NCT00862264|Beclomethasone|beclomethasone|mesh-list
20347877|NCT00862264|Norflurane|norflurane|mesh-list
20347878|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
20347879|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20347880|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
20347881|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347882|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19805996|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19805997|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19805998|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19805999|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
19806000|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806001|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
19806002|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806003|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
19806004|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806005|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806006|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806007|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806008|NCT00426556|Paclitaxel|paclitaxel|mesh-list
19806009|NCT00426556|Trastuzumab|trastuzumab|mesh-list
19806010|NCT00426556|Everolimus|everolimus|mesh-list
19806011|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20347883|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20347884|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
20347885|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20347886|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20347887|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20347888|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347889|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347890|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347891|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19645988|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19645989|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19645990|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19645991|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19645992|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19645993|NCT02362581|Factor VIII|factor viii|mesh-list
19645994|NCT02362581|Coagulants|coagulants|mesh-ancestor
19645995|NCT02362308|Eplerenone|eplerenone|mesh-list
19645996|NCT02362308|Spironolactone|spironolactone|mesh-list
19645997|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19645998|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
19645999|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
19646000|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806012|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806013|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806014|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806015|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806016|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806017|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806018|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806019|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
19806020|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806021|NCT00426660|Maraviroc|maraviroc|mesh-list
19806022|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19806023|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19806024|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806025|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19806026|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19806027|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
19806028|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806029|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19806030|NCT00426751|Abciximab|abciximab|mesh-list
19806031|NCT00426751|Eptifibatide|eptifibatide|mesh-list
19806032|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
19806033|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19806034|NCT00426764|Romidepsin|romidepsin|mesh-list
19806035|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806036|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806037|NCT00426842|Midodrine|midodrine|mesh-list
19806038|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
19806039|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
19806040|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806041|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806042|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19806043|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19806044|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19806045|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19806046|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
19806047|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806048|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806049|NCT00426855|Bortezomib|bortezomib|mesh-list
19806050|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19806051|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806052|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806053|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
19806054|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806055|NCT00427037|Vitamin D|vitamin d|mesh-list
19806056|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
19806057|NCT00427037|Vitamins|vitamins|mesh-ancestor
19806058|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
19806059|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806060|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19806061|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19806062|NCT00427297|Ritonavir|ritonavir|mesh-list
19806063|NCT00427297|Lopinavir|lopinavir|mesh-list
19806064|NCT00427297|Tenofovir|tenofovir|mesh-list
19806065|NCT00427297|Lamivudine|lamivudine|mesh-list
20328369|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
20328370|NCT00758199|Prednisolone|prednisolone|mesh-list
20328371|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20328372|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
20328373|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20328374|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
20328375|NCT00758199|Bromfenac|bromfenac|mesh-list
20328376|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20328377|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20328378|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
20328379|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328380|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
20328381|NCT00758199|Hormones|hormones|mesh-ancestor
20328382|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328383|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328384|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20328385|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806066|NCT00427297|Zidovudine|zidovudine|mesh-list
19806067|NCT00427297|Nevirapine|nevirapine|mesh-list
19806068|NCT00427297|Abacavir|abacavir|mesh-list
19806069|NCT00427297|Stavudine|stavudine|mesh-list
19806070|NCT00427297|Didanosine|didanosine|mesh-list
19806071|NCT00427297|Efavirenz|efavirenz|mesh-list
19806072|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
20328386|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
19806073|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19806074|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19806075|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
19806076|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806077|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806078|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19806079|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19806080|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
19806081|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806082|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19806083|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19806084|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19806085|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19806086|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
19806087|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19806088|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19806089|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19806090|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19806091|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19806092|NCT00427336|Vidarabine|vidarabine|mesh-list
19806093|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
19806094|NCT00427336|Fludarabine|fludarabine|mesh-list
19806095|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
19806096|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
19806097|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19806098|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806099|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
19806100|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806101|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806102|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806103|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
19806104|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806105|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806106|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806107|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19806108|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
19806109|NCT00427336|Antiviral Agents|antiviral agents|mesh-ancestor
19806110|NCT00427336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806111|NCT00427349|Octreotide|octreotide|mesh-list
19806112|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
19806113|NCT00427349|Imetelstat|imetelstat|mesh-list
19806114|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806115|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806116|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806117|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806118|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806119|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806120|NCT00427557|Vidarabine|vidarabine|mesh-list
19806121|NCT00427557|Rituximab|rituximab|mesh-list
20328387|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
20328388|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328389|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328390|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20328391|NCT00758199|Protective Agents|protective agents|mesh-ancestor
19806122|NCT00427557|Fludarabine|fludarabine|mesh-list
19806123|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
19806124|NCT00427557|Melphalan|melphalan|mesh-list
19806125|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806126|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806127|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
19806128|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806129|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806130|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19806131|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
19806132|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162444|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162445|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20162446|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20162447|NCT00127985|Protective Agents|protective agents|mesh-ancestor
20162448|NCT00127998|Artesunate|artesunate|mesh-list
20162449|NCT00127998|Chloroquine|chloroquine|mesh-list
20162450|NCT00127998|Lumefantrine|lumefantrine|mesh-list
20162451|NCT00127998|Artemether|artemether|mesh-list
19806133|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162452|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
20162453|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
19646001|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646002|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19646003|NCT02362308|Diuretics|diuretics|mesh-ancestor
20162454|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20162455|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20162456|NCT00127998|Amodiaquine|amodiaquine|mesh-list
20162457|NCT00127998|Mefloquine|mefloquine|mesh-list
20162458|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
20162459|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20162460|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20162461|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162462|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162463|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
20162464|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
20162465|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20162466|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
20162467|NCT00127998|Amebicides|amebicides|mesh-ancestor
20162468|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328392|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328393|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328394|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20328395|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20328396|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328397|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328398|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20328399|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
20328400|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20328401|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20328402|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20328403|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20328404|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20328405|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328406|NCT00758199|Analgesics|analgesics|mesh-ancestor
20328407|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
20328408|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328409|NCT00758212|Vaccines|vaccines|mesh-list
20328410|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
19646004|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
19646005|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19646006|NCT02362308|Hormones|hormones|mesh-ancestor
19646007|NCT02362256|Clonidine|clonidine|mesh-list
19646008|NCT02362256|Naltrexone|naltrexone|mesh-list
19646009|NCT02362256|Lorazepam|lorazepam|mesh-list
19646010|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19646011|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19646012|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646013|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
19646014|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646015|NCT02362256|Analgesics|analgesics|mesh-ancestor
19646016|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19646017|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
19646018|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
19646019|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19646020|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19646021|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19646022|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19646023|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646024|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646025|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
19646026|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
19646027|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646028|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19646029|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646030|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19646031|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19646032|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19646033|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
19646034|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
19646035|NCT02362152|Diclofenac|diclofenac|mesh-list
19646036|NCT02362152|Fluorouracil|fluorouracil|mesh-list
20162469|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20328411|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328412|NCT00758225|Idebenone|idebenone|mesh-list
19646037|NCT02362152|Imiquimod|imiquimod|mesh-list
19646038|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
19646039|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646040|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20328413|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
20328414|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328415|NCT00758225|Protective Agents|protective agents|mesh-ancestor
20328416|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328417|NCT00758277|Levetiracetam|levetiracetam|mesh-list
20328418|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
20328419|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
20328420|NCT00758368|Apomorphine|apomorphine|mesh-list
20328421|NCT00758368|Emetics|emetics|mesh-ancestor
20328422|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328423|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
20328424|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328425|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328426|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
20328427|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
20328428|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328429|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646041|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646042|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19646043|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
19646044|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646045|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19806134|NCT00427557|Antiviral Agents|antiviral agents|mesh-ancestor
19806135|NCT00427557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806136|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806137|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
19806138|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806139|NCT00427635|Esomeprazole|esomeprazole|mesh-list
19806140|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19806141|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806142|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19806143|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806144|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806145|NCT00427648|Lidocaine|lidocaine|mesh-list
20162470|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162471|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162472|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20162473|NCT00127998|Renal Agents|renal agents|mesh-ancestor
20162474|NCT00128037|Mitomycins|mitomycins|mesh-list
20162475|NCT00128037|Mitomycin|mitomycin|mesh-list
20162476|NCT00128037|Vindesine|vindesine|mesh-list
20162477|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162478|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20162479|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
20162480|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162481|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162482|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162483|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19646046|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646047|NCT02362152|Analgesics|analgesics|mesh-ancestor
19646048|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
19646049|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646050|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646051|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646052|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19646053|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646054|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19646055|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
19646056|NCT02362165|Dexamethasone|dexamethasone|mesh-list
19806146|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
19806147|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
19806148|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19806149|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806150|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
19806151|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806152|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19806153|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19806154|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19806155|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806156|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162484|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
20328430|NCT00758381|Sorafenib|sorafenib|mesh-list
19646057|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
19646058|NCT02362165|Doxorubicin|doxorubicin|mesh-list
20328431|NCT00758381|Cisplatin|cisplatin|mesh-list
19646059|NCT02362165|Bortezomib|bortezomib|mesh-list
19646060|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19646061|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
19646062|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646063|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646064|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19646065|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
19646066|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646067|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646068|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19646069|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646070|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
19646071|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
19646072|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646073|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646074|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
19646075|NCT02362165|Hormones|hormones|mesh-ancestor
19646076|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19646077|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806157|NCT00427661|Cyclosporine|cyclosporine|mesh-list
19806158|NCT00427661|Fludarabine|fludarabine|mesh-list
19806159|NCT00427661|Busulfan|busulfan|mesh-list
19806160|NCT00427661|Cyclosporins|cyclosporins|mesh-list
19806161|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806162|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806163|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806164|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
20328432|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806165|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806166|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806167|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
19806168|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806169|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
19806170|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806171|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19806172|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
19806173|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806174|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806175|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19806176|NCT00427700|Clomiphene|clomiphene|mesh-list
19806177|NCT00427700|Enclomiphene|enclomiphene|mesh-list
19806178|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
19806179|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19806180|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
19806181|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806182|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806183|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19806184|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
19806185|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19806186|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19806187|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19806188|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19806189|NCT00427765|Melphalan|melphalan|mesh-list
19806190|NCT00427765|Busulfan|busulfan|mesh-list
19806191|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806192|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
19806193|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806194|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806195|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806196|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806197|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
19806198|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806199|NCT00427791|Rituximab|rituximab|mesh-list
19806200|NCT00427791|Etoposide|etoposide|mesh-list
19806201|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806202|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806203|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
19806204|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806205|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806206|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19806207|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19646078|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806208|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19806209|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806210|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806211|NCT00427804|Calcitriol|calcitriol|mesh-list
19806212|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19806213|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806214|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19806215|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806216|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806217|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19806218|NCT00427804|Vitamins|vitamins|mesh-ancestor
19806219|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
19806220|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19806221|NCT00427895|Vaccines|vaccines|mesh-list
19806222|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19806223|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
19806224|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806225|NCT00427921|Adalimumab|adalimumab|mesh-list
19806226|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19806227|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806228|NCT00427934|Maraviroc|maraviroc|mesh-list
19806229|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19806230|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19806231|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806232|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19806233|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19806234|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
19806235|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806236|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19806237|NCT00427960|Atorvastatin|atorvastatin|mesh-list
19806238|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19806239|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19806240|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19806241|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
19806242|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806243|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19806244|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19806245|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806246|NCT00427973|Cediranib|cediranib|mesh-list
19806247|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806248|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806249|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806250|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806251|NCT00427999|Pioglitazone|pioglitazone|mesh-list
19806252|NCT00427999|Dexamethasone|dexamethasone|mesh-list
19806253|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
19806254|NCT00427999|Etoricoxib|etoricoxib|mesh-list
20162485|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162486|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
20162487|NCT00128154|Chromium|chromium|mesh-list
20162488|NCT00128154|Picolinic acid|picolinic acid|mesh-list
20162489|NCT00128154|Trace Elements|trace elements|mesh-ancestor
20162490|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
20162491|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328433|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20328434|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328435|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646079|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20162492|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20162493|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
20162494|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
19646080|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19646081|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646082|NCT02362022|Morphine|morphine|mesh-list
20162495|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162496|NCT00128232|Octreotide|octreotide|mesh-list
19646083|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19646084|NCT02362022|Narcotics|narcotics|mesh-ancestor
19646085|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646086|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646087|NCT02362022|Analgesics|analgesics|mesh-ancestor
19646088|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
19646089|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646090|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
19806255|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
19806256|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328436|NCT00758407|Methylphenidate|methylphenidate|mesh-list
19806257|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
19806258|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
19806259|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806260|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806261|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806262|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
19806263|NCT00427999|Hormones|hormones|mesh-ancestor
19806264|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806265|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806266|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806267|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19806268|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806269|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328437|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20328438|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328439|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20328440|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328441|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806270|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806271|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19806272|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19806273|NCT00427999|Analgesics|analgesics|mesh-ancestor
19806274|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
19806275|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806276|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19806277|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19806278|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
19806279|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19806280|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806281|NCT00428220|Sunitinib|sunitinib|mesh-list
19806282|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806283|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19806284|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19806285|NCT00428220|Growth Substances|growth substances|mesh-ancestor
19806286|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806287|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
19806288|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806289|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806290|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806291|NCT00428298|Valacyclovir|valacyclovir|mesh-list
19806292|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
19806293|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806294|NCT00428389|Rivastigmine|rivastigmine|mesh-list
19806295|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19806296|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806297|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806298|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
19806299|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806300|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806301|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19806302|NCT00428389|Protective Agents|protective agents|mesh-ancestor
19806303|NCT00428441|Warfarin|warfarin|mesh-list
19806304|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
19806305|NCT00428584|Interferons|interferons|mesh-list
19806306|NCT00428584|Interferon-beta|interferon-beta|mesh-list
19806307|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
20162497|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20162498|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162499|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162500|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
20162501|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20162502|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20162503|NCT00128245|Analgesics|analgesics|mesh-ancestor
20162504|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
20162505|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162506|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162507|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162508|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162509|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
20162510|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806308|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806309|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
19806310|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806311|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
19806312|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806313|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19806314|NCT00428597|Sunitinib|sunitinib|mesh-list
20328442|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328443|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
20328444|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328445|NCT00758433|Capsaicin|capsaicin|mesh-list
20328446|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
20328447|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
20328448|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
20328449|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328450|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328451|NCT00758693|Rituximab|rituximab|mesh-list
20328452|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20328453|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20328454|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328455|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
20328456|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328457|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328458|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20328459|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
20328460|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806315|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806316|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19806317|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19806318|NCT00428597|Growth Substances|growth substances|mesh-ancestor
19806319|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806320|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
19806321|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806322|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806323|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162511|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
20162512|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20162513|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162514|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162515|NCT00128271|Bavituximab|bavituximab|mesh-list
20328461|NCT00758732|Carboplatin|carboplatin|mesh-list
20328462|NCT00758732|Docetaxel|docetaxel|mesh-list
20328463|NCT00758732|Doxorubicin|doxorubicin|mesh-list
19646091|NCT02361931|Hematinics|hematinics|mesh-ancestor
19646092|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
19646093|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20162516|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162517|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162518|NCT00128297|Pamidronate|pamidronate|mesh-list
19646094|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
19646095|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19646096|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162519|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20162520|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162521|NCT00128310|Gemcitabine|gemcitabine|mesh-list
20162522|NCT00128310|Vinorelbine|vinorelbine|mesh-list
20162523|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162524|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
20162525|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162526|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162527|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
20162528|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162529|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162530|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162531|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
20162532|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328464|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20328465|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646097|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20328466|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
19646098|NCT02361567|Acetaminophen|acetaminophen|mesh-list
19646099|NCT02361567|Oxycodone|oxycodone|mesh-list
19806324|NCT00428792|Methylphenidate|methylphenidate|mesh-list
19806325|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19806326|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806327|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19806328|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19806329|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806330|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806331|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
19806332|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806333|NCT00428844|Vancomycin|vancomycin|mesh-list
19806334|NCT00428844|Daptomycin|daptomycin|mesh-list
19806335|NCT00428844|Teicoplanin|teicoplanin|mesh-list
19806336|NCT00428844|Floxacillin|floxacillin|mesh-list
19806337|NCT00428844|Oxacillin|oxacillin|mesh-list
19806338|NCT00428844|Nafcillin|nafcillin|mesh-list
19806339|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806340|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806341|NCT00428922|Bevacizumab|bevacizumab|mesh-list
19806342|NCT00428922|Trastuzumab|trastuzumab|mesh-list
19806343|NCT00428922|Docetaxel|docetaxel|mesh-list
19806344|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806345|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806346|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19806347|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19806348|NCT00428922|Growth Substances|growth substances|mesh-ancestor
19806349|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646100|NCT02361567|Tramadol|tramadol|mesh-list
19646101|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19646102|NCT02361567|Narcotics|narcotics|mesh-ancestor
19646103|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646104|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646105|NCT02361567|Analgesics|analgesics|mesh-ancestor
19646106|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
19646107|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806350|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
19806351|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806352|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806353|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806354|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806355|NCT00428948|Tolvaptan|tolvaptan|mesh-list
19806356|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19806357|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806358|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
19806359|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806360|NCT00429104|Trastuzumab|trastuzumab|mesh-list
19806361|NCT00429104|Sargramostim|sargramostim|mesh-list
19806362|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806363|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806364|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
19806365|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806366|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
19806367|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
19806368|NCT00429143|Tacrolimus|tacrolimus|mesh-list
19806369|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806370|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
19806371|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806372|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162533|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20162534|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20162535|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162536|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20162537|NCT00128323|Nystatin|nystatin|mesh-list
20162538|NCT00128323|Gentian Violet|gentian violet|mesh-list
19646108|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646109|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
20162539|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19646110|NCT02361879|Leuprolide|leuprolide|mesh-list
19806373|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20162540|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20162541|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806374|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
19806375|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806376|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806377|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806378|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19806379|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806380|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806381|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19806382|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
19806383|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806384|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806385|NCT00429169|Bupropion|bupropion|mesh-list
19806386|NCT00429169|Paroxetine|paroxetine|mesh-list
19806387|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19806388|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
19806389|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19806390|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19806391|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19806392|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806393|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806394|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
19806395|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328467|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
20328468|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
20328469|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806396|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806397|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19806398|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20162542|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
19646111|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
19646112|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20162543|NCT00128323|Ionophores|ionophores|mesh-ancestor
20162544|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20162545|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162546|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20162547|NCT00128414|Colchicine|colchicine|mesh-list
20162548|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
20162549|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162550|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
20162551|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162552|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
20162553|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162554|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162555|NCT00128427|Colchicine|colchicine|mesh-list
20162556|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
20162557|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162558|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
20162559|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
20328470|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19646113|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
19646114|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19646115|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646116|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19646117|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646118|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19646119|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
19646120|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19646121|NCT02361645|Ketorolac|ketorolac|mesh-list
19646122|NCT02361645|Indomethacin|indomethacin|mesh-list
19646123|NCT02361645|Nepafenac|nepafenac|mesh-list
19646124|NCT02361645|Bromfenac|bromfenac|mesh-list
19646125|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19646126|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19646127|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646128|NCT02361645|Analgesics|analgesics|mesh-ancestor
19646129|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
19646130|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646131|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646132|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646133|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646134|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19646135|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646136|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328471|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20328472|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20328473|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328474|NCT00758914|Vitamin E|vitamin e|mesh-list
20328475|NCT00758914|Vitamins|vitamins|mesh-ancestor
19806399|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806400|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19806401|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
19806402|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
19806403|NCT00429182|Thiotepa|thiotepa|mesh-list
19806404|NCT00429182|Carboplatin|carboplatin|mesh-list
19806405|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806406|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
19806407|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806408|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806409|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806410|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
19646137|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
19646138|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
19646139|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19806411|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806412|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806413|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806414|NCT00429273|Guanfacine|guanfacine|mesh-list
19806415|NCT00429273|Methylphenidate|methylphenidate|mesh-list
19806416|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19806417|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19806418|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806419|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19806420|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19806421|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806422|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806423|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
19806424|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806425|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19806426|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19806427|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19806428|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19806429|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
19806430|NCT00429299|Paclitaxel|paclitaxel|mesh-list
19806431|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
20328476|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
20328477|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328478|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
20328479|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328480|NCT00758914|Protective Agents|protective agents|mesh-ancestor
20328481|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
20328482|NCT00759005|Propranolol|propranolol|mesh-list
20328483|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19806432|NCT00429299|Fluorouracil|fluorouracil|mesh-list
20162560|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
20162561|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162562|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162563|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
20162564|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20162565|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
20162566|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162567|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162568|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20162569|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
20162570|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
20162571|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20162572|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
20328484|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20328485|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
20328486|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646140|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19646141|NCT02361502|Mirabegron|mirabegron|mesh-list
19646142|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19646143|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19646144|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19646145|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
19646146|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646147|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646148|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328487|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328488|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328489|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20328490|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20328491|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
20328492|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328493|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
19806433|NCT00429299|Trastuzumab|trastuzumab|mesh-list
19806434|NCT00429299|Lapatinib|lapatinib|mesh-list
19806435|NCT00429299|Epirubicin|epirubicin|mesh-list
19806436|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19806437|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806438|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806439|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806440|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806441|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806442|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806443|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
19806444|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806445|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806446|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806447|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
19806448|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806449|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
19806450|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19806451|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806452|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806453|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806454|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806455|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19806456|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19806457|NCT00429364|Losartan|losartan|mesh-list
19806458|NCT00429364|Atenolol|atenolol|mesh-list
19806459|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19806460|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19806461|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20328494|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328495|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
20328496|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328497|NCT00759070|Ritonavir|ritonavir|mesh-list
20328498|NCT00759070|Lopinavir|lopinavir|mesh-list
20328499|NCT00759070|Tenofovir|tenofovir|mesh-list
20328500|NCT00759070|Emtricitabine|emtricitabine|mesh-list
20328501|NCT00759070|Efavirenz|efavirenz|mesh-list
20328502|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20328503|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20328504|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
19806462|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20162573|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162574|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162575|NCT00128453|Colchicine|colchicine|mesh-list
20162576|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
20162577|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162578|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
20162579|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162580|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
20162581|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162582|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162583|NCT00128466|Gentamicins|gentamicins|mesh-list
20162584|NCT00128466|Streptomycin|streptomycin|mesh-list
20162585|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20162586|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162587|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20162588|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806463|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806464|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
19806465|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
19806466|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806467|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806468|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19806469|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20174333|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328505|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328506|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328507|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19806470|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19806471|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
19806472|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806473|NCT00429403|Goserelin|goserelin|mesh-list
19806474|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806475|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806476|NCT00429416|Cytarabine|cytarabine|mesh-list
19806477|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
19806478|NCT00429416|Fludarabine|fludarabine|mesh-list
19806479|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
19806480|NCT00429416|Molgramostim|molgramostim|mesh-list
19806481|NCT00429416|Tacrolimus|tacrolimus|mesh-list
19806482|NCT00429416|Sargramostim|sargramostim|mesh-list
19806483|NCT00429416|Mesna|mesna|mesh-list
19806484|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806485|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
19806486|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806487|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806488|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806489|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
19806490|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806491|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806492|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806493|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19806494|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
19806495|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
19806496|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806497|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19806498|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806499|NCT00429416|Protective Agents|protective agents|mesh-ancestor
19806500|NCT00429494|Leuprolide|leuprolide|mesh-list
19806501|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19806502|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
20162589|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162590|NCT00128479|Mifepristone|mifepristone|mesh-list
20162591|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20162592|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
20162593|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20162594|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162595|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20162596|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20162597|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20162598|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
20162599|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20162600|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20162601|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
20162602|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162603|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
20162604|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20162605|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20162606|NCT00128505|Mifepristone|mifepristone|mesh-list
20162607|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20162608|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
20162609|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20162610|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162611|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20162612|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20162613|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20162614|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
20162615|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20162616|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20162617|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
20328508|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19806503|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19806504|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806505|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806506|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806507|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
19806508|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19806509|NCT00429507|Analgesics|analgesics|mesh-ancestor
19806510|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
19806511|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806512|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806513|NCT00429572|Fludarabine|fludarabine|mesh-list
19806514|NCT00429572|Melphalan|melphalan|mesh-list
20328509|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
20328510|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328511|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20328512|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20328513|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20328514|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20328515|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20328516|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20328517|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20328518|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20328519|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20328520|NCT00759083|Bivalirudin|bivalirudin|mesh-list
20328521|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
20328522|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20328523|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
20328524|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328525|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328526|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
20328527|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20328528|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20328529|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328530|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328531|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328532|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328533|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328534|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20328535|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
20328536|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19806515|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806516|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806517|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806518|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
19806519|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162618|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162619|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
20162620|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20162621|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20162622|NCT00128518|Perindopril|perindopril|mesh-list
20162623|NCT00128518|Indapamide|indapamide|mesh-list
20162624|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20162625|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
20162626|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162627|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162628|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20162629|NCT00128518|Diuretics|diuretics|mesh-ancestor
20328537|NCT00759200|Interferons|interferons|mesh-list
20328538|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
20328539|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
20328540|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328541|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
20328542|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328543|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
19646149|NCT02361502|Urological Agents|urological agents|mesh-ancestor
19646150|NCT02361905|Leuprolide|leuprolide|mesh-list
20162630|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
20162631|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162632|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20162633|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20162634|NCT00128531|Leuprolide|leuprolide|mesh-list
20162635|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19646151|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
19646152|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19646153|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
19646154|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19646155|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646156|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19646157|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646158|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19646159|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
19646160|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19646161|NCT02361775|Ropivacaine|ropivacaine|mesh-list
20328544|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328545|NCT00759226|Leucovorin|leucovorin|mesh-list
20328546|NCT00759226|Folic Acid|folic acid|mesh-list
20328547|NCT00759226|Gemcitabine|gemcitabine|mesh-list
20328548|NCT00759226|Cisplatin|cisplatin|mesh-list
20328549|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
19806520|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806521|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
19806522|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806523|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
19806524|NCT00429702|Promethazine|promethazine|mesh-list
19806525|NCT00429702|Dexamethasone|dexamethasone|mesh-list
19806526|NCT00429702|Lorazepam|lorazepam|mesh-list
19806527|NCT00429702|Ondansetron|ondansetron|mesh-list
19806528|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162636|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
20162637|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20162638|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162639|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162640|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162641|NCT00128544|Telbivudine|telbivudine|mesh-list
20162642|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
20162643|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162644|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162645|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162646|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162647|NCT00128557|Vitamin A|vitamin a|mesh-list
20162648|NCT00128557|Vitamins|vitamins|mesh-ancestor
20162649|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
20162650|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162651|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
20162652|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806529|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
19806530|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
20162653|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
20162654|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162655|NCT00128635|Antibodies|antibodies|mesh-list
20162656|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20162657|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
20162658|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162659|NCT00128700|Temozolomide|temozolomide|mesh-list
20162660|NCT00128700|Vatalanib|vatalanib|mesh-list
20162661|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20162662|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
20162663|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162664|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328550|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328551|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20328552|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
19806531|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806532|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806533|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806534|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
19806535|NCT00429702|Hormones|hormones|mesh-ancestor
19806536|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806537|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806538|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806539|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806540|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
19806541|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
19806542|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20162665|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20328553|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806543|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
19806544|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806545|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19806546|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19806547|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328554|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
20328555|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328556|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328557|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328558|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
19806548|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19806549|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19806550|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19806551|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19806552|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
20162666|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162667|NCT00128739|Budesonide|budesonide|mesh-list
20162668|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162669|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20162670|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
20162671|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162672|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162673|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20162674|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
20162675|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
20162676|NCT00128739|Hormones|hormones|mesh-ancestor
20162677|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162678|NCT00128752|Beta Carotene|beta carotene|mesh-list
20162679|NCT00128752|Carotenoids|carotenoids|mesh-list
20162680|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
20162681|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162682|NCT00128752|Protective Agents|protective agents|mesh-ancestor
20162683|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162684|NCT00128752|Provitamins|provitamins|mesh-ancestor
20162685|NCT00128752|Vitamins|vitamins|mesh-ancestor
20162686|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
20162687|NCT00128778|Doxorubicin|doxorubicin|mesh-list
20162688|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20162689|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20162690|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162691|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20162692|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20162693|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162694|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162695|NCT00128791|Nitroprusside|nitroprusside|mesh-list
20162696|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20162697|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
20162698|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20162699|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174334|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174335|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20174336|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20174337|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174338|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174339|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328559|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328560|NCT00759226|Antidotes|antidotes|mesh-ancestor
20328561|NCT00759226|Protective Agents|protective agents|mesh-ancestor
20328562|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
19646162|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
19646163|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
20174340|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
20174341|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20174342|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19646164|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646165|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646166|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
19646167|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646168|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
19646169|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19646170|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806553|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
20174343|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
20328563|NCT00759226|Vitamins|vitamins|mesh-ancestor
20328564|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
19646171|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646172|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
19806554|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
19806555|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20162700|NCT00128804|Beta Carotene|beta carotene|mesh-list
20328565|NCT00759226|Hematinics|hematinics|mesh-ancestor
20328566|NCT00759239|Timolol|timolol|mesh-list
20328567|NCT00759239|Travoprost|travoprost|mesh-list
20328568|NCT00759239|Maleic acid|maleic acid|mesh-list
20328569|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20328570|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20328571|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
20328572|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328573|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328574|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328575|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20328576|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20328577|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646173|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162701|NCT00128804|Carotenoids|carotenoids|mesh-list
20162702|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
20162703|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162704|NCT00128804|Protective Agents|protective agents|mesh-ancestor
20162705|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162706|NCT00128804|Provitamins|provitamins|mesh-ancestor
20162707|NCT00128804|Vitamins|vitamins|mesh-ancestor
20162708|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
20162709|NCT00128843|Anastrozole|anastrozole|mesh-list
20162710|NCT00128843|Exemestane|exemestane|mesh-list
20162711|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162712|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162713|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20162714|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20162715|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162716|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162717|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20162718|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
20162719|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162720|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162721|NCT00128856|Gemcitabine|gemcitabine|mesh-list
20162722|NCT00128856|Paclitaxel|paclitaxel|mesh-list
20162723|NCT00128856|Doxorubicin|doxorubicin|mesh-list
20162724|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20162725|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162726|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
20162727|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162728|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
20162729|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162730|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162731|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
20162732|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
20162733|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162734|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162735|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162736|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
20162737|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162738|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20162739|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20162740|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20162741|NCT00128895|Azathioprine|azathioprine|mesh-list
20162742|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
20162743|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162744|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162745|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646174|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646175|NCT02361619|Clarithromycin|clarithromycin|mesh-list
19646176|NCT02361619|Diclofenac|diclofenac|mesh-list
19646177|NCT02361619|Metoprolol|metoprolol|mesh-list
19646178|NCT02361619|Midazolam|midazolam|mesh-list
19646179|NCT02361619|Caffeine|caffeine|mesh-list
20162746|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19646180|NCT02361619|Esomeprazole|esomeprazole|mesh-list
20162747|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
20328578|NCT00759291|Acipimox|acipimox|mesh-list
19646181|NCT02361619|Dabigatran|dabigatran|mesh-list
20162748|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162749|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162750|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20162751|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
20162752|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162753|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
20162754|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20162755|NCT00128934|Estradiol|estradiol|mesh-list
20162756|NCT00128934|Estrogens|estrogens|mesh-ancestor
20162757|NCT00128934|Hormones|hormones|mesh-ancestor
20162758|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162759|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162760|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20162761|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
20162762|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19806556|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
19806557|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
19806558|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19806559|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
19806560|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
19806561|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
19806562|NCT00429793|Sirolimus|sirolimus|mesh-list
19806563|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806564|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806565|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806566|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806567|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
19806568|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806569|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
19806570|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806571|NCT00429949|Dasatinib|dasatinib|mesh-list
19646182|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19646183|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19646184|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19806572|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806573|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806574|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806575|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806576|NCT00430183|Docetaxel|docetaxel|mesh-list
19806577|NCT00430183|Leuprolide|leuprolide|mesh-list
19806578|NCT00430183|Goserelin|goserelin|mesh-list
19806579|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806580|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806581|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806582|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806583|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806584|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19806585|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
19806586|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19806587|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806588|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806589|NCT00430248|Allopurinol|allopurinol|mesh-list
19806590|NCT00430248|Febuxostat|febuxostat|mesh-list
19806591|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
19806592|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806593|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806594|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
19806595|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806596|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19806597|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
19806598|NCT00430248|Protective Agents|protective agents|mesh-ancestor
19806599|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806600|NCT00430352|Rituximab|rituximab|mesh-list
19806601|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806602|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806603|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
20162763|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20162764|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20328579|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19646185|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646186|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19646187|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19646188|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19646189|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19646190|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
19646191|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
19646192|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
19646193|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
19806604|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806605|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806606|NCT00430521|Vaccines|vaccines|mesh-list
19806607|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
19806608|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806609|NCT00430573|Cycloserine|cycloserine|mesh-list
19806610|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19806611|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806612|NCT00430573|Renal Agents|renal agents|mesh-ancestor
19806613|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19806614|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
19806615|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806616|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
19806617|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162765|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20162766|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20162767|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
20162768|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20162769|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162770|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20162771|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
20162772|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20162773|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328580|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
19646194|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162774|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162775|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162776|NCT00129038|Aspirin|aspirin|mesh-list
20162777|NCT00129038|Dipyridamole|dipyridamole|mesh-list
20162778|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20162779|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20162780|NCT00129038|Analgesics|analgesics|mesh-ancestor
20162781|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
20162782|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162783|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162784|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162785|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162786|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20162787|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20162788|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162789|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20162790|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20162791|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162792|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
20162793|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20162794|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
20162795|NCT00129090|Rituximab|rituximab|mesh-list
20162796|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162797|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646195|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646196|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20162798|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
20162799|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162800|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162801|NCT00129142|Toremifene|toremifene|mesh-list
20162802|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20162803|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162804|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20162805|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20162806|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
19646197|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646198|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19646199|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646200|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19646201|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646202|NCT02361619|Analgesics|analgesics|mesh-ancestor
19646203|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
19646204|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646205|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646206|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646207|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19646208|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19806618|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20347892|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
20328581|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328582|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20328583|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20328584|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20328585|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328586|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328587|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328588|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328589|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806619|NCT00430638|Olmesartan|olmesartan|mesh-list
19806620|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19806621|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19806622|NCT00430638|Diuretics|diuretics|mesh-ancestor
19806623|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
19806624|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806625|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19806626|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806627|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806628|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19806629|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19806630|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
19806631|NCT00430677|Prednisone|prednisone|mesh-list
19806632|NCT00430677|Prednisolone|prednisolone|mesh-list
19806633|NCT00430677|Abatacept|abatacept|mesh-list
19806634|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19806635|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
19806636|NCT00430677|Hormones|hormones|mesh-ancestor
19806637|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806638|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806639|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19806640|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806641|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806642|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19806643|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
20328590|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20328591|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
20328592|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328593|NCT00759421|Olanzapine|olanzapine|mesh-list
20328594|NCT00759421|Sertindole|sertindole|mesh-list
20328595|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
20328596|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
20328597|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328598|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328599|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806644|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806645|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806646|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162807|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162808|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162809|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20162810|NCT00129155|Treosulfan|treosulfan|mesh-list
20328600|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20328601|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20328602|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328603|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328604|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20328605|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328606|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328607|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328608|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328609|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
20328610|NCT00759460|Olanzapine|olanzapine|mesh-list
20328611|NCT00759460|Sertindole|sertindole|mesh-list
20162811|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20162812|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
20162813|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162814|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162815|NCT00129168|Cytarabine|cytarabine|mesh-list
20162816|NCT00129168|Daunorubicin|daunorubicin|mesh-list
20162817|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20162818|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
20162819|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328612|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
20328613|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
20328614|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328615|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328616|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328617|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20328618|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20328619|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328620|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19806647|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806648|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19806649|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806650|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
19806651|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806652|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
19806653|NCT00430716|Citric Acid|citric acid|mesh-list
19806654|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
19806655|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
19806656|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19806657|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
19806658|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
19806659|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806660|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
19806661|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19806662|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19806663|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806664|NCT00430716|Urological Agents|urological agents|mesh-ancestor
19806665|NCT00430781|Lapatinib|lapatinib|mesh-list
19806666|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806667|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806668|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806669|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806670|NCT00430937|Vancomycin|vancomycin|mesh-list
19806671|NCT00430937|Daptomycin|daptomycin|mesh-list
19806672|NCT00430937|Teicoplanin|teicoplanin|mesh-list
19806673|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806674|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328621|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20328622|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20162820|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162821|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
20162822|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162823|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162824|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
20162825|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162826|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20162827|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20162828|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20162829|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162830|NCT00129181|Levodopa|levodopa|mesh-list
20162831|NCT00129181|Carbidopa|carbidopa|mesh-list
20162832|NCT00129181|Cabergoline|cabergoline|mesh-list
20162833|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20162834|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20162835|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20162836|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
20162837|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162838|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162839|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162840|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20162841|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162842|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
20162843|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20162844|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
20328623|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328624|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328625|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328626|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
19806675|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
19806676|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19806677|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
19806678|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
19806679|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20162845|NCT00129207|Bortezomib|bortezomib|mesh-list
19806680|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162846|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806681|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19806682|NCT00430989|Analgesics|analgesics|mesh-ancestor
19806683|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
19806684|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806685|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
19806686|NCT00431041|Oxybutynin|oxybutynin|mesh-list
19806687|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19806688|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19806689|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
19806690|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806691|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806692|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806693|NCT00431041|Urological Agents|urological agents|mesh-ancestor
19806694|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
19806695|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
19806696|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806697|NCT00431067|Afatinib|afatinib|mesh-list
19806698|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806699|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19806700|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806701|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806702|NCT00431132|Estradiol|estradiol|mesh-list
19806703|NCT00431132|Estrogens|estrogens|mesh-ancestor
19806704|NCT00431132|Hormones|hormones|mesh-ancestor
19806705|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806706|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162847|NCT00129233|Amlodipine|amlodipine|mesh-list
20162848|NCT00129233|Valsartan|valsartan|mesh-list
20162849|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20162850|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20162851|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20162852|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162853|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20162854|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162855|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
20162856|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20162857|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20162858|NCT00129298|Tiagabine|tiagabine|mesh-list
20162859|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
20162860|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20162861|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20162862|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20162863|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162864|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
20162865|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162866|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162867|NCT00129337|Bavituximab|bavituximab|mesh-list
20162868|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162869|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162870|NCT00129363|Carvedilol|carvedilol|mesh-list
20162871|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20162872|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20162873|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
20162874|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162875|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162876|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162877|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20162878|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
20162879|NCT00129363|Protective Agents|protective agents|mesh-ancestor
20162880|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20162881|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20162882|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20162883|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
20162884|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20162885|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20162886|NCT00129506|Methotrexate|methotrexate|mesh-list
20162887|NCT00129506|Misoprostol|misoprostol|mesh-list
20162888|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20162889|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
20162890|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20162891|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162892|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19806707|NCT00431184|Pentazocine|pentazocine|mesh-list
19806708|NCT00431184|Lorazepam|lorazepam|mesh-list
19806709|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
19806710|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
19806711|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
19806712|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806713|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806714|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806715|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19806716|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19806717|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19806718|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19806719|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19806720|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
19806721|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
19806722|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806723|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806724|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19806725|NCT00431184|Narcotics|narcotics|mesh-ancestor
19806726|NCT00431184|Analgesics|analgesics|mesh-ancestor
19806727|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
20162893|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
20162894|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162895|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162896|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
20162897|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162898|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20162899|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20162900|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
20162901|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162902|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162903|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20162904|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20162905|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
20162906|NCT00129519|Imiquimod|imiquimod|mesh-list
20162907|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20162908|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
20162909|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162910|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162911|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
20162912|NCT00129597|Ketamine|ketamine|mesh-list
20162913|NCT00129597|Analgesics|analgesics|mesh-ancestor
20162914|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
20162915|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162916|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162917|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20162918|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20162919|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
20162920|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
20162921|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20162922|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20162923|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20162924|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162925|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162926|NCT00129688|Amikacin|amikacin|mesh-list
20162927|NCT00129688|Cloxacillin|cloxacillin|mesh-list
20162928|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20162929|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162930|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
20162931|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162932|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162933|NCT00129805|Aspirin|aspirin|mesh-list
20162934|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
20162935|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20162936|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20162937|NCT00129805|Analgesics|analgesics|mesh-ancestor
20162938|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
20162939|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162940|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20162941|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20162942|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20162943|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20162944|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19806728|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20162945|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162946|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19806729|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20162947|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19806730|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
19806731|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19806732|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19806733|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806734|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19806735|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
19806736|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20162948|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162949|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
20162950|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20162951|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
20162952|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162953|NCT00129818|Famciclovir|famciclovir|mesh-list
20162954|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
20162955|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20162956|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20162957|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162958|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162959|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
20162960|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162961|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20162962|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
20162963|NCT00129857|HU 211|hu 211|mesh-list
20162964|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20162965|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
20162966|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
20328627|NCT00759551|Olmesartan|olmesartan|mesh-list
20328628|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20328629|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20328630|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20328631|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20162967|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20162968|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646209|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19646210|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20162969|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20162970|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20162971|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20162972|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20162973|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162974|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20162975|NCT00129857|Protective Agents|protective agents|mesh-ancestor
20162976|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
20162977|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162978|NCT00129896|Docetaxel|docetaxel|mesh-list
20162979|NCT00129896|Doxorubicin|doxorubicin|mesh-list
20162980|NCT00129896|Trastuzumab|trastuzumab|mesh-list
20162981|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162982|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
20162983|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162984|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
20162985|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20162986|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20162987|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20162988|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20162989|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20162990|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20162991|NCT00129922|Paclitaxel|paclitaxel|mesh-list
20162992|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
20162993|NCT00129922|Fluorouracil|fluorouracil|mesh-list
20162994|NCT00129922|Epirubicin|epirubicin|mesh-list
20162995|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20162996|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20162997|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
20162998|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
20162999|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
19646211|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19646212|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
19646213|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646214|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646215|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19646216|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20163000|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163001|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163002|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
20163003|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328632|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328633|NCT00759720|Glyburide|glyburide|mesh-list
20328634|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20328635|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163004|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163005|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20163006|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
20163007|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20163008|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
20163009|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20163010|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20163011|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20163012|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163013|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163014|NCT00129948|Troxacitabine|troxacitabine|mesh-list
20163015|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163016|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20163017|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20163018|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
20163019|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163020|NCT00130000|Eculizumab|eculizumab|mesh-list
20163021|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20163022|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163023|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
20163024|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163025|NCT00130013|Amoxicillin|amoxicillin|mesh-list
20163026|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163027|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163028|NCT00130026|Caffeine|caffeine|mesh-list
20163029|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20163030|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163031|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20163032|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163033|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163034|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20163035|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20163036|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
20163037|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163038|NCT00130065|Folic Acid|folic acid|mesh-list
20163039|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
20163040|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
20163041|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20163042|NCT00130065|Hematinics|hematinics|mesh-ancestor
20163043|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
20163044|NCT00130065|Vitamins|vitamins|mesh-ancestor
20163045|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
20163046|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163047|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
20163048|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20163049|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163050|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163051|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163052|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163053|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163054|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20328636|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20328637|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
19646217|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19646218|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
19646219|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19646220|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
19646221|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
19646222|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19646223|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19646224|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
19646225|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
19646226|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19646227|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19646228|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19806737|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19806738|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20163055|NCT00130065|Renal Agents|renal agents|mesh-ancestor
20163056|NCT00130091|Clonidine|clonidine|mesh-list
20163057|NCT00130091|Analgesics|analgesics|mesh-ancestor
20347893|NCT00862264|Hormones|hormones|mesh-ancestor
20163058|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
20163059|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163060|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163061|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20163062|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
20163063|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
20163064|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20163065|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19646229|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
19646230|NCT02361528|Sargramostim|sargramostim|mesh-list
19646231|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
20163066|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20163067|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
20163068|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163069|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611624|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611625|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
20611626|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611627|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646232|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163070|NCT00130143|Amifostine|amifostine|mesh-list
20163071|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20163072|NCT00130143|Protective Agents|protective agents|mesh-ancestor
20163073|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163074|NCT00130156|Doxazosin|doxazosin|mesh-list
20163075|NCT00130156|Bunazosin|bunazosin|mesh-list
20163076|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20163077|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20163078|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20163079|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20163080|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
20163081|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163082|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163083|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163084|NCT00130195|Cytarabine|cytarabine|mesh-list
20163085|NCT00130195|Dexamethasone|dexamethasone|mesh-list
20163086|NCT00130195|Prednisolone|prednisolone|mesh-list
20163087|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
20163088|NCT00130195|Methotrexate|methotrexate|mesh-list
20163089|NCT00130195|Vincristine|vincristine|mesh-list
20163090|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
20163091|NCT00130195|Daunorubicin|daunorubicin|mesh-list
20163092|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163093|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
20163094|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163095|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163096|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20163097|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
20163098|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163099|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163100|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20163101|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163102|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
20163103|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
20163104|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163105|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20163106|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
20163107|NCT00130195|Hormones|hormones|mesh-ancestor
20163108|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163109|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163110|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20163111|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
20163112|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20163113|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20163114|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
19646233|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
19646234|NCT02361190|Testosterone|testosterone|mesh-list
19646235|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
19646236|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
19646237|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19646238|NCT02361190|Androgens|androgens|mesh-ancestor
20163115|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611628|NCT00559936|Bevacizumab|bevacizumab|mesh-list
19646239|NCT02361190|Hormones|hormones|mesh-ancestor
19806739|NCT00431496|Cinacalcet|cinacalcet|mesh-list
20163116|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611629|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20163117|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163118|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20163119|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
20163120|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163121|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20163122|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163123|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163124|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163125|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20163126|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20163127|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20163128|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163129|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
20163130|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20163131|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20163132|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163133|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
20163134|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
20163135|NCT00130234|Omalizumab|omalizumab|mesh-list
20163136|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20163137|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20163138|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
20163139|NCT00130325|Isoniazid|isoniazid|mesh-list
20163140|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
20163141|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163142|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646240|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19646241|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646242|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163143|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20163144|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20163145|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
20163146|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163147|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20163148|NCT00130338|Rivastigmine|rivastigmine|mesh-list
20163149|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20163150|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163151|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163152|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
20163153|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163154|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163155|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20163156|NCT00130338|Protective Agents|protective agents|mesh-ancestor
20163157|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
20163158|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20163159|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
20163160|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163161|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611630|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611631|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611632|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611633|NCT00559936|Growth Substances|growth substances|mesh-ancestor
20611634|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611635|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611636|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20611637|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
20611638|NCT00504582|Coagulants|coagulants|mesh-ancestor
20611639|NCT00494182|Paclitaxel|paclitaxel|mesh-list
20163162|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20163163|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
20163164|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20163165|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20163166|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19646243|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646244|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
19646245|NCT02361112|Capecitabine|capecitabine|mesh-list
19646246|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19646247|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
19646248|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646249|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646250|NCT02361177|Oxytocin|oxytocin|mesh-list
19646251|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
20163167|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
20163168|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20611640|NCT00494182|Carboplatin|carboplatin|mesh-list
19806740|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19806741|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806742|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19806743|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
20163169|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163170|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
20163171|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20163172|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20163173|NCT00130364|Analgesics|analgesics|mesh-ancestor
20163174|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
20163175|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163176|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163177|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163178|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163179|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
20163180|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163181|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
20163182|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20163183|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163184|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163185|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
20163186|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163187|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163188|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
20163189|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20163190|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20163191|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163192|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20163193|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163194|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20163195|NCT00130455|Citalopram|citalopram|mesh-list
20163196|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20163197|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20163198|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20163199|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163200|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163201|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
20163202|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163203|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20611641|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20611642|NCT00494182|Sorafenib|sorafenib|mesh-list
20611643|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611644|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611645|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611646|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611647|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611648|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163204|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
20163205|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20163206|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
20163207|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20163208|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
20163209|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163210|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
20163211|NCT00130468|Protective Agents|protective agents|mesh-ancestor
20163212|NCT00130481|Atorvastatin|atorvastatin|mesh-list
20163213|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20163214|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20163215|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
20163216|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163217|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20163218|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20163219|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163220|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
20163221|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20163222|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163223|NCT00130507|Capecitabine|capecitabine|mesh-list
20163224|NCT00130507|Trastuzumab|trastuzumab|mesh-list
20328638|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328639|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
20328640|NCT00759824|Doxorubicin|doxorubicin|mesh-list
20328641|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20328642|NCT00759824|Vindesine|vindesine|mesh-list
20328643|NCT00759824|Valproic Acid|valproic acid|mesh-list
20328644|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163225|NCT00130507|Vinorelbine|vinorelbine|mesh-list
20163226|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20163227|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
20163228|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163229|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163230|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20163231|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20163232|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163233|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163234|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163235|NCT00130546|Sirolimus|sirolimus|mesh-list
20163236|NCT00130546|Paclitaxel|paclitaxel|mesh-list
20163237|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20163238|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163239|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163240|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163241|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163242|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163243|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163244|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163245|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20163246|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
20163247|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163248|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
20163249|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163250|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
20163251|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20163252|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20163253|NCT00130572|Analgesics|analgesics|mesh-ancestor
20163254|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
20163255|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163256|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163257|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163258|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163259|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19646252|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19646253|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664359|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163260|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163261|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
20163262|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20163263|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163264|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163265|NCT00130585|Folic Acid|folic acid|mesh-list
20163266|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
20163267|NCT00130585|Hematinics|hematinics|mesh-ancestor
20163268|NCT00130585|Vitamins|vitamins|mesh-ancestor
20163269|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
20163270|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174344|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20174345|NCT00164710|Artesunate|artesunate|mesh-list
20174346|NCT00164710|Lumefantrine|lumefantrine|mesh-list
20174347|NCT00164710|Artemether|artemether|mesh-list
20174348|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
20174349|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
20174350|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20174351|NCT00164710|Amodiaquine|amodiaquine|mesh-list
20174352|NCT00164710|Dapsone|dapsone|mesh-list
19664360|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664361|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
19664362|NCT04128774|Hormones|hormones|mesh-ancestor
19664363|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664364|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19664365|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664366|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
20174353|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
20174354|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
20174355|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20174356|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20328645|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
20163271|NCT00130676|Mifepristone|mifepristone|mesh-list
20163272|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20163273|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
20163274|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20163275|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163276|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20163277|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20163278|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20163279|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
20163280|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20163281|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20163282|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
20163283|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163284|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
20163285|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20163286|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20163287|NCT00130702|Gefitinib|gefitinib|mesh-list
20163288|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163289|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20163290|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163291|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163292|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
20163293|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
20163294|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163295|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163296|NCT00130767|Finasteride|finasteride|mesh-list
20163297|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20163298|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20163299|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163300|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163301|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
20163302|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163303|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163304|NCT00130767|Urological Agents|urological agents|mesh-ancestor
20163305|NCT00130819|Buprenorphine|buprenorphine|mesh-list
20163306|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20163307|NCT00130819|Narcotics|narcotics|mesh-ancestor
20163308|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20163309|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163310|NCT00130819|Analgesics|analgesics|mesh-ancestor
20163311|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
20163312|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163313|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20163314|NCT00130845|Octreotide|octreotide|mesh-list
20163315|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20163316|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163317|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163318|NCT00130858|Carboplatin|carboplatin|mesh-list
20163319|NCT00130858|Topotecan|topotecan|mesh-list
20163320|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163321|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20163322|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163323|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163324|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163325|NCT00130871|Simendan|simendan|mesh-list
19646254|NCT02360956|Olmesartan|olmesartan|mesh-list
19646255|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19646256|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
19646257|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19646258|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19646259|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646260|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19646261|NCT02360800|Hemostatics|hemostatics|mesh-list
19646262|NCT02360800|Coagulants|coagulants|mesh-ancestor
19646263|NCT02360826|Simvastatin|simvastatin|mesh-list
19646264|NCT02360826|Pravastatin|pravastatin|mesh-list
19646265|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19646266|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19646267|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
19646268|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646269|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20163326|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19664367|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328646|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328647|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328648|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20328649|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
19646270|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19646271|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163327|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
20163328|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20163329|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20163330|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163331|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163332|NCT00130871|Protective Agents|protective agents|mesh-ancestor
20328650|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328651|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328652|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20328653|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20328654|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20163333|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163334|NCT00130884|Simendan|simendan|mesh-list
20163335|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20163336|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
20163337|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20163338|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20163339|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163340|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163341|NCT00130884|Protective Agents|protective agents|mesh-ancestor
20163342|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163343|NCT00130897|Sunitinib|sunitinib|mesh-list
20163344|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163345|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20163346|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20163347|NCT00130897|Growth Substances|growth substances|mesh-ancestor
20163348|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163349|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
20163350|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20163351|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163352|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163353|NCT00130910|Albendazole|albendazole|mesh-list
20163354|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
20163355|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163356|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163357|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
20163358|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20163359|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20163360|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163361|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163362|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163363|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163364|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163365|NCT00130936|Carboplatin|carboplatin|mesh-list
20163366|NCT00130936|Capecitabine|capecitabine|mesh-list
20163367|NCT00130936|Epirubicin|epirubicin|mesh-list
20163368|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163369|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20163370|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
20163371|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163372|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20163373|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20163374|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163375|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163376|NCT00130975|Candesartan|candesartan|mesh-list
20163377|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20163378|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20163379|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20163380|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163381|NCT00131027|Cytarabine|cytarabine|mesh-list
20163382|NCT00131027|Dexamethasone|dexamethasone|mesh-list
20163383|NCT00131027|Prednisolone|prednisolone|mesh-list
20163384|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
20163385|NCT00131027|Doxorubicin|doxorubicin|mesh-list
20328655|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163386|NCT00131027|Methotrexate|methotrexate|mesh-list
20163387|NCT00131027|Etoposide|etoposide|mesh-list
20163388|NCT00131027|Vincristine|vincristine|mesh-list
20163389|NCT00131027|Daunorubicin|daunorubicin|mesh-list
19806744|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806745|NCT00431626|Dutasteride|dutasteride|mesh-list
19806746|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19806747|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19806748|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163390|NCT00131027|Asparaginase|asparaginase|mesh-list
20163391|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
20163392|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163393|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
20163394|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163395|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163396|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20163397|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
20163398|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163399|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163400|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20163401|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163402|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
20163403|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
20163404|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163405|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20163406|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
20163407|NCT00131027|Hormones|hormones|mesh-ancestor
20163408|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163409|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163410|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20163411|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20163412|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163413|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163414|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20163415|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
20163416|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20163417|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20163418|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
20163419|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
20163420|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163421|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20163422|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20163423|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
20163424|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163425|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163426|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163427|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163428|NCT00131040|Aprotinin|aprotinin|mesh-list
20163429|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
20163430|NCT00131040|Coagulants|coagulants|mesh-ancestor
20163431|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20163432|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20163433|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
20163434|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163435|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163436|NCT00131053|Cytarabine|cytarabine|mesh-list
20163437|NCT00131053|Dexamethasone|dexamethasone|mesh-list
20163438|NCT00131053|Prednisolone|prednisolone|mesh-list
20163439|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
20163440|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
20163441|NCT00131053|Methotrexate|methotrexate|mesh-list
20163442|NCT00131053|Vincristine|vincristine|mesh-list
20163443|NCT00131053|Asparaginase|asparaginase|mesh-list
20163444|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
20163445|NCT00131053|Pirarubicin|pirarubicin|mesh-list
20163446|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163447|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
20163448|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163449|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163450|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20163451|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
20163452|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163453|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163454|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20163455|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163456|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
19806749|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163457|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
20163458|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163459|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806750|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
19806751|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806752|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806753|NCT00431847|Anesthetics|anesthetics|mesh-list
19806754|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19806755|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806756|NCT00431964|Azithromycin|azithromycin|mesh-list
19806757|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806758|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806759|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
19806760|NCT00432172|Carboplatin|carboplatin|mesh-list
19806761|NCT00432172|Docetaxel|docetaxel|mesh-list
19806762|NCT00432172|Epirubicin|epirubicin|mesh-list
19806763|NCT00432172|Exemestane|exemestane|mesh-list
19806764|NCT00432172|Goserelin|goserelin|mesh-list
20328656|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328657|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
20328658|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
20328659|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328660|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
20328661|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20328662|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328663|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328664|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20328665|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
20328666|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
20328667|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
20328668|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20328669|NCT00759928|Sorafenib|sorafenib|mesh-list
20328670|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328671|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20328672|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328673|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328674|NCT00759993|Chromium|chromium|mesh-list
19806765|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806766|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
19806767|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806768|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806769|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806770|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
19806771|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328675|NCT00759993|Trace Elements|trace elements|mesh-ancestor
20328676|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
20328677|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806772|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806773|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806774|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806775|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806776|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806777|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806778|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19806779|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19806780|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806781|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19806782|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19806783|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19806784|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
19806785|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163460|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
20163461|NCT00131053|Hormones|hormones|mesh-ancestor
20163462|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163463|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163464|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20163465|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
20163466|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20163467|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20163468|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
20163469|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
20163470|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163471|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163472|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20328678|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
19806786|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20328679|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328680|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328681|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20328682|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19806787|NCT00432276|Metformin|metformin|mesh-list
19806788|NCT00432276|Pioglitazone|pioglitazone|mesh-list
19806789|NCT00432276|Alogliptin|alogliptin|mesh-list
19806790|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19806791|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806792|NCT00432276|Incretins|incretins|mesh-ancestor
19806793|NCT00432276|Hormones|hormones|mesh-ancestor
19806794|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806795|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19806796|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
19806797|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806798|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806799|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
19806800|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19806801|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19806802|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19806803|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806804|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806805|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
19806806|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806807|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806808|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19806809|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834433|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834434|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19834435|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834436|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19834437|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834438|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19834439|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
19834440|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834441|NCT00594815|Antidotes|antidotes|mesh-ancestor
19834442|NCT00594815|Protective Agents|protective agents|mesh-ancestor
19834443|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
19834444|NCT00594815|Vitamins|vitamins|mesh-ancestor
19834445|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
19834446|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19834447|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
19834448|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
19834449|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834450|NCT00594854|Diclofenac|diclofenac|mesh-list
19834451|NCT00594854|Arthrotec|arthrotec|mesh-list
19834452|NCT00594854|Misoprostol|misoprostol|mesh-list
19834453|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19834454|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
19834455|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19834456|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834457|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19834458|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19834459|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
19834460|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19834461|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19834462|NCT00594854|Analgesics|analgesics|mesh-ancestor
19834463|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
19834464|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834465|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834466|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834467|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19834468|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834469|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834470|NCT00594880|Interferons|interferons|mesh-list
19834471|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
19834472|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
20328683|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328684|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328685|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328686|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19834473|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19834474|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834475|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
19834476|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834477|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
20328687|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20328688|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20328689|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
20328690|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20328691|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20328692|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
20328693|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806810|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
19806811|NCT00432458|Thalidomide|thalidomide|mesh-list
19806812|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806813|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
19806814|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806815|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
19806816|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19806817|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19806818|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19806819|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19806820|NCT00432458|Growth Substances|growth substances|mesh-ancestor
19806821|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
19806822|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806823|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19806824|NCT00432562|Vinorelbine|vinorelbine|mesh-list
19806825|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19806826|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806827|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806828|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806829|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806830|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806831|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19806832|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19806833|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806834|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806835|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19806836|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806837|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806838|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
19806839|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328694|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
20328695|NCT00760045|Protective Agents|protective agents|mesh-ancestor
20328696|NCT00760149|Rifampin|rifampin|mesh-list
20328697|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19806840|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
19806841|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19806842|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806843|NCT00432991|Ephedrine|ephedrine|mesh-list
19806844|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19806845|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806846|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
19806847|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
19806848|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806849|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19806850|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
19806851|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806852|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328698|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
20328699|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328700|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328701|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
20328702|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20328703|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328704|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328705|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20328706|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20328707|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20328708|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20328709|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19806853|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
19806854|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19806855|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
19806856|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19806857|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806858|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20328710|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20163473|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
20163474|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163475|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19806859|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19806860|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19806861|NCT00433017|Ranibizumab|ranibizumab|mesh-list
19806862|NCT00433017|Verteporfin|verteporfin|mesh-list
19806863|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19806864|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19806865|NCT00433017|Growth Substances|growth substances|mesh-ancestor
19806866|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806867|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
19806868|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806869|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19806870|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
19806871|NCT00433160|Teriparatide|teriparatide|mesh-list
19806872|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19806873|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806874|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19806875|NCT00433199|Testosterone|testosterone|mesh-list
19806876|NCT00433199|Androgens|androgens|mesh-ancestor
19806877|NCT00433199|Hormones|hormones|mesh-ancestor
19806878|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806879|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806880|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19806881|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19806882|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20328711|NCT00760175|Vaccines|vaccines|mesh-list
20328712|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
20328713|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328714|NCT00760279|Azithromycin|azithromycin|mesh-list
20328715|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328716|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328717|NCT00760318|Levetiracetam|levetiracetam|mesh-list
20328718|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
19806883|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19806884|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806885|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19806886|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806887|NCT00433290|Analgesics|analgesics|mesh-ancestor
19806888|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
19806889|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19806890|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
19806891|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19806892|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
19806893|NCT00433329|Bosentan|bosentan|mesh-list
19806894|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
20163476|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163477|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163478|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163479|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
20328719|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
20347894|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347895|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
20347896|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347897|NCT00862329|Caseins|caseins|mesh-list
19646272|NCT02361060|Atropine|atropine|mesh-list
19646273|NCT02361060|Neostigmine|neostigmine|mesh-list
19646274|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19646275|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19646276|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19646277|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
19646278|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646279|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646280|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19646281|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
19646282|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
19646283|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
19806895|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
20163480|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20163481|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163482|NCT00131144|Octreotide|octreotide|mesh-list
20163483|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20163484|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163485|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347898|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
20328720|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
19806896|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19806897|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19806898|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806899|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806900|NCT00433329|Urological Agents|urological agents|mesh-ancestor
19806901|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19806902|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19806903|NCT00433381|Bevacizumab|bevacizumab|mesh-list
19806904|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19806905|NCT00433381|Irinotecan|irinotecan|mesh-list
19806906|NCT00433381|Temozolomide|temozolomide|mesh-list
19806907|NCT00433381|Camptothecin|camptothecin|mesh-list
19806908|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
19806909|NCT00433381|Antibodies|antibodies|mesh-list
19806910|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
19806911|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19806912|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
19806913|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806914|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19806915|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19806916|NCT00433381|Growth Substances|growth substances|mesh-ancestor
19646284|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19646285|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19646286|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
19806917|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806918|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
19806919|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
19806920|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19806921|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19806922|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806923|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806924|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806925|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
19806926|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19806927|NCT00433446|Siltuximab|siltuximab|mesh-list
19806928|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806929|NCT00433537|Dexamethasone|dexamethasone|mesh-list
19806930|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
19806931|NCT00433537|Rituximab|rituximab|mesh-list
19806932|NCT00433537|Doxorubicin|doxorubicin|mesh-list
19806933|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19806934|NCT00433537|Vincristine|vincristine|mesh-list
19806935|NCT00433537|Bortezomib|bortezomib|mesh-list
19806936|NCT00433537|Lenograstim|lenograstim|mesh-list
19806937|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19806938|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
19806939|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806940|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19806941|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19806942|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
19806943|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806944|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806945|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19806946|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19806947|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19806948|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
19806949|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
19806950|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646287|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646288|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646289|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19646290|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163486|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
20163487|NCT00131183|Androgens|androgens|mesh-ancestor
20163488|NCT00131183|Hormones|hormones|mesh-ancestor
19806951|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19806952|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
19806953|NCT00433537|Hormones|hormones|mesh-ancestor
19806954|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19806955|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163489|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163490|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163491|NCT00131235|Azithromycin|azithromycin|mesh-list
19806956|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19806957|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19806958|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19806959|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806960|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19806961|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19806962|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806963|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806964|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806965|NCT00433550|Capecitabine|capecitabine|mesh-list
19806966|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
19806967|NCT00433550|Irinotecan|irinotecan|mesh-list
19806968|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19806969|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
19806970|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806971|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806972|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19806973|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19806974|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806975|NCT00433745|Vaccines|vaccines|mesh-list
19806976|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
19806977|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806978|NCT00433836|Valsartan|valsartan|mesh-list
19806979|NCT00433836|Enalapril|enalapril|mesh-list
19806980|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19806981|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19806982|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19806983|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19806984|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19806985|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
19806986|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19806987|NCT00433914|Vaccines|vaccines|mesh-list
19806988|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
19806989|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19806990|NCT00433966|Paclitaxel|paclitaxel|mesh-list
19806991|NCT00433966|Heparin|heparin|mesh-list
19806992|NCT00433966|Calcium heparin|calcium heparin|mesh-list
19806993|NCT00433966|Bivalirudin|bivalirudin|mesh-list
19806994|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19806995|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19806996|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
19806997|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
19806998|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
19806999|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328721|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20328722|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328723|NCT00760448|Insulin|insulin|mesh-list
20328724|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20328725|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
20328726|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
19807000|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
19807001|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19807002|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19807003|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
19807004|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19807005|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
19807006|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807007|NCT00434109|Sunitinib|sunitinib|mesh-list
19807008|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807009|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807010|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807011|NCT00434109|Growth Substances|growth substances|mesh-ancestor
19807012|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807013|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807014|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807015|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807016|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807017|NCT00434148|Pasireotide|pasireotide|mesh-list
19807018|NCT00434148|Hormones|hormones|mesh-ancestor
19807019|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807020|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807021|NCT00434213|Methylphenidate|methylphenidate|mesh-list
19807022|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19807023|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807024|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19807025|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19807026|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807027|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807028|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
19807029|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807030|NCT00434252|Paclitaxel|paclitaxel|mesh-list
19807031|NCT00434252|Bevacizumab|bevacizumab|mesh-list
19807032|NCT00434252|Carboplatin|carboplatin|mesh-list
19807033|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19807034|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807035|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
19807036|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
19807037|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
20328727|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
20328728|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
20328729|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20328730|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328731|NCT00760695|Dronabinol|dronabinol|mesh-list
20328732|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
20328733|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328734|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328735|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328736|NCT00760695|Analgesics|analgesics|mesh-ancestor
20328737|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
20328738|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328739|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20328740|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20328741|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328742|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328743|NCT00760695|Hormones|hormones|mesh-ancestor
20328744|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328745|NCT00760864|Methotrexate|methotrexate|mesh-list
20328746|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20328747|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
20328748|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20328749|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328750|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20328751|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
20328752|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328753|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328754|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807038|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807039|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807040|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807041|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807042|NCT00434252|Growth Substances|growth substances|mesh-ancestor
19807043|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807044|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807045|NCT00434304|Ropinirole|ropinirole|mesh-list
19807046|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19807047|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19807048|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
19807049|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
19807050|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807051|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807052|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807053|NCT00434356|Paclitaxel|paclitaxel|mesh-list
19807054|NCT00434356|Bevacizumab|bevacizumab|mesh-list
19807055|NCT00434356|Sunitinib|sunitinib|mesh-list
19807056|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19807057|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807058|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
19807059|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
19807060|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
19807061|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807062|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807063|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807064|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807065|NCT00434356|Growth Substances|growth substances|mesh-ancestor
19807066|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807067|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
20328755|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807068|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807069|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807070|NCT00434434|Omalizumab|omalizumab|mesh-list
19807071|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19807072|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19807073|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19807074|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
19807075|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
19807076|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807077|NCT00434577|Vaccines|vaccines|mesh-list
19807078|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
19807079|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807080|NCT00434642|Gemcitabine|gemcitabine|mesh-list
19807081|NCT00434642|Bevacizumab|bevacizumab|mesh-list
19807082|NCT00434642|Carboplatin|carboplatin|mesh-list
19807083|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807084|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807085|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807086|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807087|NCT00434642|Growth Substances|growth substances|mesh-ancestor
19807088|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807089|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807090|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807091|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
19807092|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807093|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
20328756|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20328757|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328758|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
20328759|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328760|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20328761|NCT00760916|Treprostinil|treprostinil|mesh-list
20328762|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19807094|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807095|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807096|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807097|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
19807098|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19807099|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
20328763|NCT00760968|Methotrexate|methotrexate|mesh-list
20328764|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20328765|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
20328766|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20328767|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328768|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20328769|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
20328770|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328771|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163492|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
20163493|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
20163494|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20163495|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163496|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163497|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
20163498|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20163499|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163500|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163501|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163502|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163503|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20328772|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
20328773|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328774|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20328775|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328776|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
20328777|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328778|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19807100|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807101|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19807102|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19807103|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19807104|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807105|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
20328779|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
19807106|NCT00434954|Exenatide|exenatide|mesh-list
19807107|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20328780|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328781|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20328782|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328783|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328784|NCT00761020|Mefloquine|mefloquine|mesh-list
20328785|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
20328786|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20328787|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20328788|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328789|NCT00761228|Apomorphine|apomorphine|mesh-list
20328790|NCT00761228|Emetics|emetics|mesh-ancestor
20328791|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328792|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
20328793|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807108|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807109|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19807110|NCT00434954|Incretins|incretins|mesh-ancestor
19807111|NCT00434954|Hormones|hormones|mesh-ancestor
19807112|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807113|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19807114|NCT00434967|Candesartan|candesartan|mesh-list
19807115|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
19807116|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19807117|NCT00434967|Diuretics|diuretics|mesh-ancestor
20328794|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328795|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
20328796|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
20328797|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328798|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328799|NCT00761241|Gemcitabine|gemcitabine|mesh-list
20328800|NCT00761241|Interferons|interferons|mesh-list
20328801|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
20328802|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20328803|NCT00761241|Docetaxel|docetaxel|mesh-list
20328804|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
20328805|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20328806|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
20328807|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807118|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
19807119|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807120|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19807121|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807122|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807123|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19807124|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19807125|NCT00434993|Albuterol|albuterol|mesh-list
19807126|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19807127|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
19807128|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807129|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807130|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19807131|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
19807132|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
19807133|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19807134|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19807135|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19807136|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19807137|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
19807138|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807139|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807140|NCT00435019|Insulin|insulin|mesh-list
19807141|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19807142|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
19807143|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
19807144|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
19807145|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
19807146|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
19807147|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19807148|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807149|NCT00435045|Atorvastatin|atorvastatin|mesh-list
19807150|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19807151|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19807152|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
19807153|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328808|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328809|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
19807154|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19807155|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19807156|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807157|NCT00435162|Valsartan|valsartan|mesh-list
19807158|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19807159|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19807160|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19807161|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807162|NCT00435370|Tropisetron|tropisetron|mesh-list
19807163|NCT00435370|Risperidone|risperidone|mesh-list
19807164|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19807165|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
19807166|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807167|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807168|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807169|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19807170|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19807171|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19807172|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807173|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19807174|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
19807175|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
19807176|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
19807177|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807178|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19807179|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19807180|NCT00435409|Capecitabine|capecitabine|mesh-list
20163504|NCT00131235|Renal Agents|renal agents|mesh-ancestor
20163505|NCT00131261|Dexamethasone|dexamethasone|mesh-list
20163506|NCT00131261|Belinostat|belinostat|mesh-list
20163507|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163508|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
20163509|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
19646291|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19646292|NCT02360982|Fentanyl|fentanyl|mesh-list
19646293|NCT02360982|Propofol|propofol|mesh-list
19646294|NCT02360982|Bupivacaine|bupivacaine|mesh-list
19646295|NCT02360982|Rocuronium|rocuronium|mesh-list
19646296|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19807181|NCT00435409|Sunitinib|sunitinib|mesh-list
19807182|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807183|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
19807184|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807185|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807186|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807187|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807188|NCT00435409|Growth Substances|growth substances|mesh-ancestor
19807189|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807190|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807191|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807192|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807193|NCT00435461|Fluticasone|fluticasone|mesh-list
19807194|NCT00435461|Xhance|xhance|mesh-list
19807195|NCT00435461|Fexofenadine|fexofenadine|mesh-list
19807196|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19807197|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19807198|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
19807199|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807200|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807201|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19807202|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
19807203|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807204|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19807205|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19807206|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20163510|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163511|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646297|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646298|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646299|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19646300|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
20163512|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20163513|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
20163514|NCT00131261|Hormones|hormones|mesh-ancestor
19807207|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
19807208|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
19807209|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807210|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807211|NCT00435487|Heparin|heparin|mesh-list
19807212|NCT00435487|Calcium heparin|calcium heparin|mesh-list
19807213|NCT00435487|Dalteparin|dalteparin|mesh-list
19807214|NCT00435487|Tinzaparin|tinzaparin|mesh-list
19807215|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19807216|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
19807217|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19807218|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19807219|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807220|NCT00435539|Plasminogen|plasminogen|mesh-list
19807221|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
19807222|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19807223|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19807224|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807225|NCT00435591|Conivaptan|conivaptan|mesh-list
19807226|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19807227|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807228|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
19807229|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807230|NCT00435812|Vaccines|vaccines|mesh-list
20328810|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328811|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328812|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328813|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
20328814|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328815|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
20328816|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
20328817|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
20328818|NCT00761254|Domperidone|domperidone|mesh-list
20328819|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
20328820|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
20328821|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328822|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807231|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
19807232|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163515|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163516|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163517|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163518|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20163519|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163520|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163521|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
20163522|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163523|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20163524|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163525|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807233|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19807234|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
19807235|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807236|NCT00435929|Ritonavir|ritonavir|mesh-list
19807237|NCT00435929|Saquinavir|saquinavir|mesh-list
19807238|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19807239|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19807240|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
19807241|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807242|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807243|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19807244|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19807245|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
19807246|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807247|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19807248|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19807249|NCT00435994|Epinephrine|epinephrine|mesh-list
19807250|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19807251|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20328823|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19807252|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
19807253|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834478|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807254|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807255|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807256|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19807257|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19807258|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
19807259|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807260|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19807261|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
19807262|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
19807263|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
19807264|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19807265|NCT00436007|Vaccines|vaccines|mesh-list
19807266|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
19807267|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807268|NCT00436046|Interferons|interferons|mesh-list
19807269|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807270|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
19807271|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807272|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19807273|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
19807274|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807275|NCT00436215|Bevacizumab|bevacizumab|mesh-list
19807276|NCT00436215|Sorafenib|sorafenib|mesh-list
19807277|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807278|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807279|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807280|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807281|NCT00436215|Growth Substances|growth substances|mesh-ancestor
19807282|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807283|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807284|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807285|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807286|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807287|NCT00436280|Gemcitabine|gemcitabine|mesh-list
19807288|NCT00436280|Rituximab|rituximab|mesh-list
19807289|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
19807290|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807291|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807292|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
19807293|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807294|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807295|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807296|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
19807297|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807298|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
19807299|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807300|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807301|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807302|NCT00436332|Bevacizumab|bevacizumab|mesh-list
19807303|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19807304|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807305|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807306|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807307|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807308|NCT00436332|Growth Substances|growth substances|mesh-ancestor
19646301|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
19646302|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19646303|NCT02360982|Narcotics|narcotics|mesh-ancestor
19646304|NCT02360982|Analgesics|analgesics|mesh-ancestor
19646305|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
19646306|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646307|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19646308|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19646309|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19646310|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19646311|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19646312|NCT02360709|Sirolimus|sirolimus|mesh-list
19646313|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646314|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646315|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19646316|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646317|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
19646318|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834479|NCT00594906|Teriparatide|teriparatide|mesh-list
19646319|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
19646320|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807309|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807310|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807311|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807312|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807313|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807314|NCT00436345|Remifentanil|remifentanil|mesh-list
19807315|NCT00436345|Propofol|propofol|mesh-list
19807316|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19807317|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19807318|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807319|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19807320|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
19807321|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
19807322|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19807323|NCT00436345|Narcotics|narcotics|mesh-ancestor
19807324|NCT00436345|Analgesics|analgesics|mesh-ancestor
19807325|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
19807326|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807327|NCT00436436|Temozolomide|temozolomide|mesh-list
19807328|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19807329|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19807330|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
19807331|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807332|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807333|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807334|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
19807335|NCT00436475|Vitamin D|vitamin d|mesh-list
19807336|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
19807337|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
19807338|NCT00436475|Vitamins|vitamins|mesh-list
19807339|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
19807340|NCT00436475|Calcium|calcium|mesh-list
19807341|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
19807342|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328824|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20328825|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
20328826|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328827|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328828|NCT00761332|Teriparatide|teriparatide|mesh-list
20328829|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20328830|NCT00761332|Diphosphonates|diphosphonates|mesh-list
20328831|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20328832|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328833|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20328834|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20328835|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
20328836|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807343|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19807344|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19807345|NCT00436475|Antacids|antacids|mesh-ancestor
19807346|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807347|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19807348|NCT00436501|Docetaxel|docetaxel|mesh-list
19807349|NCT00436501|Aflibercept|aflibercept|mesh-list
19807350|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
19807351|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807352|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
19807353|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
19807354|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
19807355|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807356|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807357|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807358|NCT00436501|Growth Substances|growth substances|mesh-ancestor
19807359|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807360|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807361|NCT00436553|Ranibizumab|ranibizumab|mesh-list
19807362|NCT00436553|Verteporfin|verteporfin|mesh-list
19807363|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807364|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807365|NCT00436553|Growth Substances|growth substances|mesh-ancestor
19807366|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163526|NCT00131300|Hylan|hylan|mesh-list
20163527|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
20163528|NCT00131300|Protective Agents|protective agents|mesh-ancestor
19807367|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
20163529|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163530|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
20163531|NCT00131313|Rituximab|rituximab|mesh-list
20163532|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163533|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
20163534|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163535|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646321|NCT02360644|Vitamin D|vitamin d|mesh-list
19646322|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
19646323|NCT02360644|Vitamins|vitamins|mesh-ancestor
19646324|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
19646325|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646326|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20328837|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20328838|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20328839|NCT00761358|Z 338|z 338|mesh-list
20328840|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20328841|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328842|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646327|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20163536|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20163537|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
20174357|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328843|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
20328844|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646328|NCT02360501|Docetaxel|docetaxel|mesh-list
19646329|NCT02360501|Capecitabine|capecitabine|mesh-list
19646330|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646331|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
19646332|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
19646333|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
19646334|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646335|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19646336|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
19646337|NCT02360618|Metformin|metformin|mesh-list
19646338|NCT02360618|Simvastatin|simvastatin|mesh-list
19646339|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19646340|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646341|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19646342|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19646343|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
19646344|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646345|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19646346|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19646347|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646348|NCT02360423|Sirolimus|sirolimus|mesh-list
19646349|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646350|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646351|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19646352|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646353|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
19646354|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19646355|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
19646356|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646357|NCT02360592|Interferons|interferons|mesh-list
19646358|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
19646359|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
19646360|NCT02360592|Entecavir|entecavir|mesh-list
19646361|NCT02360592|Interleukin-2|interleukin-2|mesh-list
19646362|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646363|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
19646364|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646365|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
19646366|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646367|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646368|NCT02360592|Analgesics|analgesics|mesh-ancestor
19646369|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
19646370|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646371|NCT02360384|Linaclotide|linaclotide|mesh-list
19646372|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19646373|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
19807368|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646374|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807369|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19807370|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807371|NCT00436566|Paclitaxel|paclitaxel|mesh-list
19807372|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
19807373|NCT00436566|Doxorubicin|doxorubicin|mesh-list
19807374|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19807375|NCT00436566|Trastuzumab|trastuzumab|mesh-list
19807376|NCT00436566|Lapatinib|lapatinib|mesh-list
19807377|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19807378|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807379|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
19807380|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
19807381|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
19807382|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807383|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807384|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
19807385|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807386|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807387|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19807388|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
19807389|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19807390|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19807391|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19807392|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19807393|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807394|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807395|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807396|NCT00436605|Dasatinib|dasatinib|mesh-list
19807397|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807398|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807399|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807400|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807401|NCT00436618|Everolimus|everolimus|mesh-list
20328845|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807402|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807403|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807404|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
19807405|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807406|NCT00436644|Topotecan|topotecan|mesh-list
19807407|NCT00436644|Lapatinib|lapatinib|mesh-list
19807408|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19807409|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19807410|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807411|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807412|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807413|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807414|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
19807415|NCT00436748|Hematinics|hematinics|mesh-ancestor
19807416|NCT00436904|Rituximab|rituximab|mesh-list
19807417|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
19807418|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807419|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807420|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
19807421|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807422|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807423|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
19807424|NCT00436917|Letrozole|letrozole|mesh-list
19807425|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807426|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19807427|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19807428|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807429|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163538|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163539|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163540|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20163541|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20163542|NCT00131326|Hylan|hylan|mesh-list
20163543|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
20163544|NCT00131326|Protective Agents|protective agents|mesh-ancestor
20163545|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163546|NCT00131339|Cycloserine|cycloserine|mesh-list
20163547|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19807430|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19807431|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
19807432|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807433|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328846|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20328847|NCT00761449|Lenalidomide|lenalidomide|mesh-list
20328848|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
20328849|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328850|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20328851|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20328852|NCT00761449|Growth Substances|growth substances|mesh-ancestor
20328853|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
20328854|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328855|NCT00761501|Naproxen|naproxen|mesh-list
20328856|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20328857|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20328858|NCT00761501|Analgesics|analgesics|mesh-ancestor
20328859|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
20328860|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163548|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163549|NCT00131339|Renal Agents|renal agents|mesh-ancestor
20163550|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20163551|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
20163552|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19807434|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19807435|NCT00436956|Prednisone|prednisone|mesh-list
19807436|NCT00436956|Cediranib|cediranib|mesh-list
19807437|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19807438|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
20163553|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
20163554|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163555|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20163556|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20163557|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20163558|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163559|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163560|NCT00131391|Hormones|hormones|mesh-ancestor
20163561|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163562|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174358|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328861|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328862|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20328863|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20328864|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
19807439|NCT00436956|Hormones|hormones|mesh-ancestor
19807440|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807441|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807442|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19807443|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807444|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807445|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807446|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807447|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
19807448|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19807449|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
19807450|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807451|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
19807452|NCT00436969|Protective Agents|protective agents|mesh-ancestor
19807453|NCT00437034|Aflibercept|aflibercept|mesh-list
19807454|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
19807455|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807456|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807457|NCT00437034|Growth Substances|growth substances|mesh-ancestor
19807458|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807459|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807460|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328865|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20328866|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328867|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328868|NCT00761540|Liraglutide|liraglutide|mesh-list
20328869|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20328870|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328871|NCT00761540|Incretins|incretins|mesh-ancestor
20328872|NCT00761540|Hormones|hormones|mesh-ancestor
19807461|NCT00437073|Capecitabine|capecitabine|mesh-list
19807462|NCT00437073|Topotecan|topotecan|mesh-list
19807463|NCT00437073|Lapatinib|lapatinib|mesh-list
20328873|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20328874|NCT00761644|Sirolimus|sirolimus|mesh-list
20328875|NCT00761644|Bevacizumab|bevacizumab|mesh-list
20328876|NCT00761644|Doxorubicin|doxorubicin|mesh-list
20328877|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20328878|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20328879|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328880|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20328881|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20328882|NCT00761644|Growth Substances|growth substances|mesh-ancestor
20328883|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328884|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
20328885|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20328886|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20328887|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20328888|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328889|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328890|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20328891|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328892|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
20328893|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328894|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
19807464|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807465|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
19807466|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807467|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807468|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19807469|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19807470|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807471|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807472|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19807473|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19807474|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19807475|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807476|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807477|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807478|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328895|NCT00761670|Risperidone|risperidone|mesh-list
20328896|NCT00761670|Amisulpride|amisulpride|mesh-list
20328897|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20328898|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
20328899|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20328900|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328901|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328902|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20328903|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20328904|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328905|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19646375|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646376|NCT02360202|Clobetasol|clobetasol|mesh-list
19646377|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646378|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
19646379|NCT02360202|Hormones|hormones|mesh-ancestor
19646380|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19646381|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646382|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
19646383|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646384|NCT02360254|Insulin|insulin|mesh-list
19646385|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19646386|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646387|NCT02360007|Buprenorphine|buprenorphine|mesh-list
19646388|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19646389|NCT02360007|Narcotics|narcotics|mesh-ancestor
19646390|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646391|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646392|NCT02360007|Analgesics|analgesics|mesh-ancestor
19646393|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
19646394|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646395|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19646396|NCT02359942|Citric Acid|citric acid|mesh-list
19646397|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
19646398|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
19646399|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19807479|NCT00437125|Analgesics|analgesics|mesh-ancestor
19807480|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
20163563|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20163564|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20163565|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20163566|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163567|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807481|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807482|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
19807483|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807484|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
19807485|NCT00437203|Gemcitabine|gemcitabine|mesh-list
19807486|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807487|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
19807488|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807489|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807490|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
19807491|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807492|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807493|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807494|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
19807495|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807496|NCT00437268|Irinotecan|irinotecan|mesh-list
19807497|NCT00437268|Cetuximab|cetuximab|mesh-list
19807498|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19807499|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19807500|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807501|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807502|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807503|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807504|NCT00437281|Pregabalin|pregabalin|mesh-list
19807505|NCT00437281|Analgesics|analgesics|mesh-ancestor
19807506|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
19807507|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807508|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807509|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
19807510|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19807511|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807512|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807513|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19807514|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19807515|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19807516|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19807517|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807518|NCT00437294|Capecitabine|capecitabine|mesh-list
19807519|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807520|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
19807521|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807522|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807523|NCT00437489|Insulin|insulin|mesh-list
19807524|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19807525|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19807526|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807527|NCT00437645|Amlodipine|amlodipine|mesh-list
19807528|NCT00437645|Valsartan|valsartan|mesh-list
19807529|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19807530|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19807531|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807532|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807533|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19807534|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807535|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
19807536|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19807537|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19807538|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19807539|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
19807540|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20163568|NCT00131404|Hormones|hormones|mesh-ancestor
20163569|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163570|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174359|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
20328906|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20328907|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
19646400|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
19646401|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
19646402|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646403|NCT02359604|Esomeprazole|esomeprazole|mesh-list
19646404|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19646405|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19807541|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19807542|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19807543|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
19807544|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19807545|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807546|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19807547|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19807548|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20328908|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20328909|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
20328910|NCT00761722|Azacitidine|azacitidine|mesh-list
20328911|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20328912|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
20328913|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807549|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19807550|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328914|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328915|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328916|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
20328917|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328918|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328919|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20328920|NCT00761904|Simvastatin|simvastatin|mesh-list
20328921|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19807551|NCT00438100|Capecitabine|capecitabine|mesh-list
19807552|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807553|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
19807554|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807555|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834480|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19834481|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834482|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19834483|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
19834484|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19834485|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834486|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19834487|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
20328922|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20328923|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
20328924|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328925|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20328926|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20328927|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328928|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20328929|NCT00761904|Diuretics|diuretics|mesh-ancestor
20328930|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
20328931|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328932|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20328933|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328934|NCT00762060|Anesthetics|anesthetics|mesh-list
19646406|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19646407|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646408|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646409|NCT02359695|Hormones|hormones|mesh-list
19646410|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19646411|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646412|NCT02359643|Aspirin|aspirin|mesh-list
20328935|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
20328936|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328937|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328938|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
19646413|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19834488|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19834489|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807556|NCT00438204|Gemcitabine|gemcitabine|mesh-list
19807557|NCT00438204|Bevacizumab|bevacizumab|mesh-list
19807558|NCT00438204|Pemetrexed|pemetrexed|mesh-list
19807559|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807560|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807561|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807562|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807563|NCT00438204|Growth Substances|growth substances|mesh-ancestor
19807564|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807565|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807566|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807567|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
19807568|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807569|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
19807570|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328939|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328940|NCT00762099|Pregabalin|pregabalin|mesh-list
20328941|NCT00762099|Analgesics|analgesics|mesh-ancestor
20328942|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
20328943|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807571|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807572|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807573|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
19807574|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19646414|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646415|NCT02359643|Analgesics|analgesics|mesh-ancestor
19646416|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
19646417|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646418|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807575|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19807576|NCT00438256|Capecitabine|capecitabine|mesh-list
19807577|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807578|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
19807579|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807580|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807581|NCT00438360|Cyclosporine|cyclosporine|mesh-list
19807582|NCT00438360|Cyclosporins|cyclosporins|mesh-list
20328944|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328945|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
20328946|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20328947|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20328948|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807583|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807584|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807585|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807586|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
19807587|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807588|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
20328949|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20328950|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20328951|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20328952|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20328953|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20328954|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20328955|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20328956|NCT00762190|Insulin|insulin|mesh-list
20328957|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20328958|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20328959|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328960|NCT00762255|Bevacizumab|bevacizumab|mesh-list
20328961|NCT00762255|Irinotecan|irinotecan|mesh-list
19807589|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807590|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807591|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807592|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19646419|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646420|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646421|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19646422|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19807593|NCT00438451|Lamotrigine|lamotrigine|mesh-list
20328962|NCT00762255|Vorinostat|vorinostat|mesh-list
19807594|NCT00438451|Carbamazepine|carbamazepine|mesh-list
20328963|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807595|NCT00438451|Levetiracetam|levetiracetam|mesh-list
19807596|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
19807597|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
19807598|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19807599|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807600|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807601|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19807602|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807603|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19807604|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19807605|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19807606|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807607|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19807608|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
19807609|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19807610|NCT00438451|Analgesics|analgesics|mesh-ancestor
19807611|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
19807612|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807613|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19807614|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19807615|NCT00438464|Finasteride|finasteride|mesh-list
19807616|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19807617|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19807618|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807619|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807620|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
19807621|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807622|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807623|NCT00438464|Urological Agents|urological agents|mesh-ancestor
19807624|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
19807625|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646423|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646424|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19646425|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19646426|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646427|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
19646428|NCT02359721|Clarithromycin|clarithromycin|mesh-list
19646429|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646430|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646431|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19646432|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646433|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807626|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807627|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19807628|NCT00438672|Dexamethasone|dexamethasone|mesh-list
19807629|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19807630|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
19807631|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
19807632|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807633|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646434|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19646435|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19807634|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19807635|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
19807636|NCT00438672|Hormones|hormones|mesh-ancestor
19807637|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163571|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20163572|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20163573|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20163574|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163575|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163576|NCT00131430|Hormones|hormones|mesh-ancestor
20163577|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163578|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163579|NCT00131443|Topiramate|topiramate|mesh-list
20163580|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
20163581|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20163582|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163583|NCT00131482|Thrombin|thrombin|mesh-list
19834490|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807638|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19807639|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807640|NCT00438802|Alefacept|alefacept|mesh-list
19807641|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807642|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
19807643|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807644|NCT00438815|Complement C1s|complement c1s|mesh-list
19807645|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19807646|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19807647|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
19807648|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807649|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19807650|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807651|NCT00438854|Dasatinib|dasatinib|mesh-list
19807652|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807653|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807654|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807655|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807656|NCT00438880|Rituximab|rituximab|mesh-list
19807657|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19807658|NCT00438880|Antibodies|antibodies|mesh-list
19807659|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
19807660|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19807661|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
19807662|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807663|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807664|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807665|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19807666|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19807667|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19807668|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807669|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807670|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807671|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807672|NCT00438971|Analgesics|analgesics|mesh-ancestor
19807673|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
19807674|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807675|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
19807676|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807677|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
19807678|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
19807679|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19807680|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19807681|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20163584|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
19646436|NCT02359617|Insulin|insulin|mesh-list
19646437|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19646438|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646439|NCT02359292|Charcoal|charcoal|mesh-list
19646440|NCT02359292|Antidotes|antidotes|mesh-ancestor
19646441|NCT02359292|Protective Agents|protective agents|mesh-ancestor
19646442|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646443|NCT02359214|Vitamin D|vitamin d|mesh-list
19646444|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
19646445|NCT02359214|Vitamins|vitamins|mesh-ancestor
19646446|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
19646447|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646448|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19646449|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646450|NCT02359370|Lidocaine|lidocaine|mesh-list
19646451|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
19646452|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
19646453|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
19646454|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646455|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646456|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
19646457|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646458|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19646459|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20163585|NCT00131482|Coagulants|coagulants|mesh-ancestor
19646460|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19646461|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19646462|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646463|NCT02359370|Analgesics|analgesics|mesh-ancestor
19807682|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807683|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807684|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
19807685|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807686|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807687|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19807688|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807689|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19807690|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807691|NCT00439231|Lenalidomide|lenalidomide|mesh-list
19807692|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
19807693|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807694|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19807695|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807696|NCT00439231|Growth Substances|growth substances|mesh-ancestor
19807697|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
19807698|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807699|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
19807700|NCT00439244|Teriparatide|teriparatide|mesh-list
19807701|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19807702|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807703|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19807704|NCT00439270|Docetaxel|docetaxel|mesh-list
19807705|NCT00439270|Dasatinib|dasatinib|mesh-list
19807706|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807707|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
19807708|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
19807709|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
19807710|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807711|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19807712|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807713|NCT00439296|Cytarabine|cytarabine|mesh-list
19807714|NCT00439296|Dexamethasone|dexamethasone|mesh-list
19807715|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
19807716|NCT00439296|Doxorubicin|doxorubicin|mesh-list
19807717|NCT00439296|Methotrexate|methotrexate|mesh-list
19807718|NCT00439296|Asparaginase|asparaginase|mesh-list
19807719|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
19807720|NCT00439296|Thioguanine|thioguanine|mesh-list
19807721|NCT00439296|Pegaspargase|pegaspargase|mesh-list
19807722|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807723|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
19807724|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807725|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807726|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19807727|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
19807728|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807729|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807730|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19807731|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19807732|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
19807733|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
19807734|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807735|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19807736|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
19807737|NCT00439296|Hormones|hormones|mesh-ancestor
19807738|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19646464|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
19646465|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19646466|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646467|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
19646468|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19646469|NCT02359448|Melatonin|melatonin|mesh-list
19646470|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
19646471|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646472|NCT02359448|Protective Agents|protective agents|mesh-ancestor
19646473|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646474|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19807739|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19807740|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19807741|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19646475|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20163586|NCT00131495|Testosterone|testosterone|mesh-list
20163587|NCT00131495|Androgens|androgens|mesh-ancestor
20163588|NCT00131495|Hormones|hormones|mesh-ancestor
20163589|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163590|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163591|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
20163592|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
20163593|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163594|NCT00131521|Expectorants|expectorants|mesh-ancestor
20163595|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
20163596|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20163597|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
20163598|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163599|NCT00131521|Protective Agents|protective agents|mesh-ancestor
20328964|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328965|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20328966|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20328967|NCT00762255|Growth Substances|growth substances|mesh-ancestor
20328968|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328969|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
20328970|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20328971|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20328972|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20328973|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328974|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20174360|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
20328975|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
20328976|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20328977|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328978|NCT00762567|Phenylephrine|phenylephrine|mesh-list
20328979|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
20328980|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
19646476|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646477|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
19646478|NCT02359526|Hormones|hormones|mesh-ancestor
19646479|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19646480|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646481|NCT02359331|Amoxicillin|amoxicillin|mesh-list
19646482|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
19646483|NCT02359331|Metronidazole|metronidazole|mesh-list
19646484|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19646485|NCT02359331|Tetracycline|tetracycline|mesh-list
19646486|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
19646487|NCT02359331|Bismuth|bismuth|mesh-list
19646488|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19646489|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19646490|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19646491|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666032|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666033|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19666034|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19666035|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666036|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666037|NCT02683018|Hormones|hormones|mesh-ancestor
19666038|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666039|NCT02675842|Dronabinol|dronabinol|mesh-list
19666040|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
19666041|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666042|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19666043|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666044|NCT02675842|Analgesics|analgesics|mesh-ancestor
19666045|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
19666046|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666047|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19666048|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19666049|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666050|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666051|NCT02675842|Hormones|hormones|mesh-ancestor
19666052|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666053|NCT02615119|Isoproterenol|isoproterenol|mesh-list
19666054|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20328981|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20328982|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
20328983|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
20328984|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20328985|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328986|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
19807742|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19807743|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807744|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19807745|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
19807746|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19807747|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807748|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
19807749|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807750|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19807751|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19807752|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
19807753|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807754|NCT00439309|Thrombin|thrombin|mesh-list
19807755|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19807756|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
19807757|NCT00439309|Coagulants|coagulants|mesh-ancestor
19807758|NCT00439335|Vaccines|vaccines|mesh-list
19807759|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
19807760|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807761|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19807762|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19807763|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19807764|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
19807765|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807766|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807767|NCT00439374|Progestins|progestins|mesh-ancestor
19807768|NCT00439374|Hormones|hormones|mesh-ancestor
19807769|NCT00439413|Selegiline|selegiline|mesh-list
19807770|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
19807771|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807772|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19807773|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19807774|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19807775|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807776|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807777|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19807778|NCT00439413|Protective Agents|protective agents|mesh-ancestor
19807779|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807780|NCT00439517|Cetuximab|cetuximab|mesh-list
19807781|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807782|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807783|NCT00439556|Cytarabine|cytarabine|mesh-list
19807784|NCT00439556|Rituximab|rituximab|mesh-list
19807785|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19807786|NCT00439556|Methotrexate|methotrexate|mesh-list
19807787|NCT00439556|Etoposide|etoposide|mesh-list
19807788|NCT00439556|Bortezomib|bortezomib|mesh-list
19807789|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
19807790|NCT00439556|Melphalan|melphalan|mesh-list
19807791|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
19807792|NCT00439556|Carmustine|carmustine|mesh-list
20163600|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20328987|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20328988|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
20328989|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20328990|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20328991|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20163601|NCT00131703|Chloroquine|chloroquine|mesh-list
20163602|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
20163603|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
20163604|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20163605|NCT00131703|Amodiaquine|amodiaquine|mesh-list
20163606|NCT00131703|Amebicides|amebicides|mesh-ancestor
20163607|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20328992|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
19807793|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
19807794|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19807795|NCT00439556|Antibodies|antibodies|mesh-list
20328993|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807796|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
19807797|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19807798|NCT00439556|Lenograstim|lenograstim|mesh-list
19807799|NCT00439556|Tacrolimus|tacrolimus|mesh-list
19807800|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
19807801|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19807802|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
19807803|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807804|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807805|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807806|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19807807|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
19807808|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19807809|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807810|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
19807811|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807812|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807813|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807814|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19807815|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328994|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20328995|NCT00762567|Protective Agents|protective agents|mesh-ancestor
20328996|NCT00762632|Everolimus|everolimus|mesh-list
20328997|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20328998|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20328999|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
20329000|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807816|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19807817|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19807818|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19807819|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19807820|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
19807821|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807822|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19807823|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19807824|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19807825|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
19807826|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19807827|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
19807828|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19807829|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19807830|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19807831|NCT00439608|Paclitaxel|paclitaxel|mesh-list
19807832|NCT00439608|Carboplatin|carboplatin|mesh-list
19807833|NCT00439608|Cetuximab|cetuximab|mesh-list
19807834|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20329001|NCT00762658|Betamethasone|betamethasone|mesh-list
20329002|NCT00762658|Tacrolimus|tacrolimus|mesh-list
20329003|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20329004|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807835|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807836|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
19807837|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
19807838|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
19807839|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807840|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807841|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
19807842|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19807843|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807844|NCT00439673|Azacitidine|azacitidine|mesh-list
19807845|NCT00439673|Valproic Acid|valproic acid|mesh-list
19807846|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807847|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
20329005|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
20329006|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329007|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20329008|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807848|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807849|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807850|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807851|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
19807852|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
19807853|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807854|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807855|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
19807856|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19807857|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329009|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329010|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19807858|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807859|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
20329011|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
20329012|NCT00762658|Hormones|hormones|mesh-ancestor
20329013|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329014|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20329015|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
20329016|NCT00762671|Ebselen|ebselen|mesh-list
20329017|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20329018|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20329019|NCT00762671|Analgesics|analgesics|mesh-ancestor
20329020|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
20329021|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646492|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646493|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646494|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19646495|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19646496|NCT02359331|Antacids|antacids|mesh-ancestor
19646497|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646498|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19646499|NCT02359266|Vitamin D|vitamin d|mesh-list
19646500|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
19646501|NCT02359266|Vitamins|vitamins|mesh-ancestor
19646502|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
19666055|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19666056|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
19666057|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666058|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666059|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666060|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19666061|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
19666062|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666063|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19666064|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
19666065|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19666066|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
19666067|NCT02615119|Protective Agents|protective agents|mesh-ancestor
19666068|NCT02605486|Palbociclib|palbociclib|mesh-list
19666069|NCT02605486|Bicalutamide|bicalutamide|mesh-list
19666070|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666071|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19666072|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666073|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666074|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
19666075|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
19666076|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666077|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666078|NCT02598349|Capecitabine|capecitabine|mesh-list
19666079|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19666080|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
19666081|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666082|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666083|NCT02574728|Sirolimus|sirolimus|mesh-list
19666084|NCT02574728|Celecoxib|celecoxib|mesh-list
19666085|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
19666086|NCT02574728|Etoposide|etoposide|mesh-list
19666087|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19666088|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
19666089|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666090|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666091|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19666092|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
19666093|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666094|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666095|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19666096|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19666097|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19666098|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19666099|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666100|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666101|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666102|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19666103|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
19666104|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20329022|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329023|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329024|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329025|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20329026|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329027|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
20329028|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329029|NCT00762671|Protective Agents|protective agents|mesh-ancestor
20329030|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20329031|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329032|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20329033|NCT00762736|Pioglitazone|pioglitazone|mesh-list
20329034|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20329035|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329036|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329037|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19646503|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646504|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19646505|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646506|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
20329038|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20329039|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329040|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
20329041|NCT00762749|Promethazine|promethazine|mesh-list
20329042|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20329043|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20329044|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329045|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329046|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
20329047|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
20329048|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
20329049|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329050|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
20329051|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
20329052|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329053|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20329054|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
20329055|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
20329056|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329057|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329058|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20329059|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
20329060|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
20329061|NCT00762775|Vitamin D|vitamin d|mesh-list
20329062|NCT00762775|Calcium|calcium|mesh-list
20329063|NCT00762775|Vitamins|vitamins|mesh-ancestor
20329064|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
20329065|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329066|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646507|NCT02359149|Growth Substances|growth substances|mesh-ancestor
19646508|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646509|NCT02359500|Octreotide|octreotide|mesh-list
19646510|NCT02359500|Edotreotide|edotreotide|mesh-list
19646511|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646512|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19646513|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646514|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19666105|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666106|NCT02574728|Analgesics|analgesics|mesh-ancestor
19666107|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
19666108|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666109|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666110|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19666111|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19666112|NCT02555293|Rifaximin|rifaximin|mesh-list
19666113|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666114|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666115|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666116|NCT02494921|Prednisone|prednisone|mesh-list
19666117|NCT02494921|Docetaxel|docetaxel|mesh-list
19666118|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666119|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
19666120|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
19666121|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
19666122|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807860|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19807861|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
19807862|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19807863|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
19807864|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807865|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807866|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
19807867|NCT00439777|Enoxaparin|enoxaparin|mesh-list
19807868|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
19807869|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19807870|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
19807871|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19807872|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
19807873|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807874|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807875|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
19807876|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19807877|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19807878|NCT00439946|Treprostinil|treprostinil|mesh-list
19807879|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19807880|NCT00440011|Bimatoprost|bimatoprost|mesh-list
19807881|NCT00440011|Travoprost|travoprost|mesh-list
19807882|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19807883|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19807884|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19807885|NCT00440115|Bupropion|bupropion|mesh-list
19807886|NCT00440115|Nicotine|nicotine|mesh-list
19807887|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19807888|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
19807889|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807890|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807891|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20163608|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163609|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329067|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20347899|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
20347900|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807892|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20347901|NCT00862342|Bevacizumab|bevacizumab|mesh-list
20347902|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19807893|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
19807894|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807895|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807896|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19807897|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
19807898|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19807899|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19807900|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20347903|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347904|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20347905|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19807901|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807902|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
19807903|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19807904|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19807905|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163610|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
20163611|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163612|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163613|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163614|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163615|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20163616|NCT00131703|Renal Agents|renal agents|mesh-ancestor
20163617|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
20163618|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
20163619|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20163620|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
20163621|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20163622|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163623|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163624|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163625|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329068|NCT00762918|Vitamin D|vitamin d|mesh-list
20329069|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
20329070|NCT00762918|Vitamins|vitamins|mesh-ancestor
20329071|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
20329072|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329073|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20329074|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20329075|NCT00762944|Cimetidine|cimetidine|mesh-list
20329076|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20329077|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329078|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20329079|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
20329080|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
20329081|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329082|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329083|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329084|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20329085|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20329086|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329087|NCT00762957|Metformin|metformin|mesh-list
20329088|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329089|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329090|NCT00762983|Loratadine|loratadine|mesh-list
20329091|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
20329092|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
20329093|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20329094|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20329095|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19646515|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646516|NCT02359474|Trabectedin|trabectedin|mesh-list
19646517|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19646518|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
19646519|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646520|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664368|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664369|NCT04088123|Ticagrelor|ticagrelor|mesh-list
19664370|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19664371|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19664372|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19664373|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19664374|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
19664375|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664376|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664377|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664378|NCT03945721|Niraparib|niraparib|mesh-list
19664379|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19664380|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664381|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664382|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664383|NCT03891706|Interleukin-2|interleukin-2|mesh-list
19664384|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664385|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19664386|NCT03891706|Analgesics|analgesics|mesh-ancestor
19664387|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
19664388|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664389|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664390|NCT03847181|Vitamin K|vitamin k|mesh-list
19664391|NCT03847181|Warfarin|warfarin|mesh-list
19664392|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
19664393|NCT03847181|Apixaban|apixaban|mesh-list
19664394|NCT03847181|Anticoagulants|anticoagulants|mesh-list
19664395|NCT03847181|Vitamins|vitamins|mesh-ancestor
19664396|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
19664397|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664398|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19664399|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
19664400|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19664401|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
19664402|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664403|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664404|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19664405|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19664406|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
19664407|NCT03847181|Coagulants|coagulants|mesh-ancestor
19807906|NCT00440180|Anastrozole|anastrozole|mesh-list
19807907|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19807908|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807909|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19807910|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19807911|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807912|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807913|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19807914|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
19807915|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807916|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807917|NCT00440193|Enoxaparin|enoxaparin|mesh-list
19807918|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
19807919|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19807920|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
19807921|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19807922|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
19807923|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19807924|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807925|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
19807926|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19807927|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19807928|NCT00440232|Frovatriptan|frovatriptan|mesh-list
19807929|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19807930|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
19807931|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807932|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807933|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807934|NCT00440310|Talaporfin|talaporfin|mesh-list
19807935|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807936|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19807937|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807938|NCT00440401|Thrombin|thrombin|mesh-list
19807939|NCT00440401|Hemostatics|hemostatics|mesh-list
19807940|NCT00440401|Coagulants|coagulants|mesh-ancestor
19807941|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
19807942|NCT00440466|Hematinics|hematinics|mesh-ancestor
19807943|NCT00440505|Nicotine|nicotine|mesh-list
19807944|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19807945|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
19807946|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807947|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807948|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19807949|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19807950|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
19807951|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19807952|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807953|NCT00440518|Lacosamide|lacosamide|mesh-list
19807954|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
19807955|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19807956|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19807957|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19807958|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19807959|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
19807960|NCT00440557|Hematinics|hematinics|mesh-ancestor
19807961|NCT00440726|Cytarabine|cytarabine|mesh-list
19807962|NCT00440726|Dexamethasone|dexamethasone|mesh-list
20163626|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163627|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20163628|NCT00131716|Renal Agents|renal agents|mesh-ancestor
20163629|NCT00131742|Lamivudine|lamivudine|mesh-list
20163630|NCT00131742|Telbivudine|telbivudine|mesh-list
20163631|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20163632|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20163633|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163634|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163635|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
20163636|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163637|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20163638|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19807963|NCT00440726|Doxorubicin|doxorubicin|mesh-list
19807964|NCT00440726|Methotrexate|methotrexate|mesh-list
19807965|NCT00440726|Vincristine|vincristine|mesh-list
19807966|NCT00440726|Bortezomib|bortezomib|mesh-list
19807967|NCT00440726|Asparaginase|asparaginase|mesh-list
19807968|NCT00440726|Pegaspargase|pegaspargase|mesh-list
20163639|NCT00131755|Diazoxide|diazoxide|mesh-list
19646521|NCT02358824|Amlodipine|amlodipine|mesh-list
19646522|NCT02358824|Telmisartan|telmisartan|mesh-list
19807969|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19807970|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
19807971|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
19807972|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19807973|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807974|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19807975|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
19807976|NCT00440726|Hormones|hormones|mesh-ancestor
19807977|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19807978|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19807979|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807980|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19807981|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19807982|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19807983|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611649|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611650|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611651|NCT00454753|Dasatinib|dasatinib|mesh-list
20611652|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611653|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611654|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611655|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611656|NCT00436254|Molgramostim|molgramostim|mesh-list
20611657|NCT00436254|Sargramostim|sargramostim|mesh-list
20611658|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
20611659|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807984|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163640|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20329096|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
20329097|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
20329098|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329099|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329100|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329101|NCT00763165|Triclosan|triclosan|mesh-list
20329102|NCT00763165|Fluorides|fluorides|mesh-list
19646523|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19646524|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19646525|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19646526|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646527|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646528|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646529|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
19646530|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19646531|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19646532|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
19646533|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
19646534|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
19646535|NCT02358993|Methenamine|methenamine|mesh-list
19646536|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646537|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646538|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19646539|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19646540|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646541|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646542|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19807985|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20163641|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
20163642|NCT00131768|Hylan|hylan|mesh-list
20163643|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
20163644|NCT00131768|Protective Agents|protective agents|mesh-ancestor
20163645|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163646|NCT00131846|Diuretics|diuretics|mesh-list
20163647|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20163648|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
20163649|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163650|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20163651|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163652|NCT00131963|Paclitaxel|paclitaxel|mesh-list
20163653|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
20329103|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
20329104|NCT00763165|Protective Agents|protective agents|mesh-ancestor
20329105|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19807986|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
19807987|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19807988|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19807989|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
19807990|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
19807991|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19807992|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19807993|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
19807994|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19807995|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19807996|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
19807997|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19807998|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19807999|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
19808000|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808001|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
19808002|NCT00440830|Nicotine|nicotine|mesh-list
19808003|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19808004|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
19808005|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808006|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808007|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19808008|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19808009|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
19808010|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808011|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329106|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20329107|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329108|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20329109|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20329110|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
20329111|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329112|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20329113|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20329114|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20329115|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20329116|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329117|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329118|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329119|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329120|NCT00763178|Analgesics|analgesics|mesh-ancestor
20329121|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
19808012|NCT00440947|Ritonavir|ritonavir|mesh-list
19808013|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19808014|NCT00440947|Lamivudine|lamivudine|mesh-list
19808015|NCT00440947|Abacavir|abacavir|mesh-list
19808016|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
19808017|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19808018|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19808019|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
19808020|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808021|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808022|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19808023|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19808024|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
19808025|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808026|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20163654|NCT00131963|Doxorubicin|doxorubicin|mesh-list
20163655|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20163656|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163657|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163658|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163659|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163660|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163661|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163662|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
20163663|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163664|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163665|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19808027|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19808028|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20329122|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329123|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
20329124|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20329125|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
20329126|NCT00763204|Betamethasone|betamethasone|mesh-list
20329127|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20329128|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329129|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
20329130|NCT00763204|Hormones|hormones|mesh-ancestor
20329131|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329132|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329133|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20329134|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
20329135|NCT00763347|Alogliptin|alogliptin|mesh-list
20329136|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329137|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329138|NCT00763347|Incretins|incretins|mesh-ancestor
20329139|NCT00763347|Hormones|hormones|mesh-ancestor
20329140|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329141|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20329142|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
19808029|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19808030|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
19808031|NCT00440999|Artesunate|artesunate|mesh-list
19808032|NCT00440999|Chloroquine|chloroquine|mesh-list
19808033|NCT00440999|Pyronaridine|pyronaridine|mesh-list
19808034|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
19808035|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19808036|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19808037|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808038|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808039|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
19808040|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
20163666|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
20163667|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20163668|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19808041|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19808042|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
19808043|NCT00440999|Amebicides|amebicides|mesh-ancestor
19808044|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808045|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
19808046|NCT00441103|Interferon-beta|interferon-beta|mesh-list
19808047|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19808048|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
19808049|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808050|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808051|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
19808052|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329143|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329144|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329145|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20329146|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20329147|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329148|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
20329149|NCT00763438|Sertindole|sertindole|mesh-list
20329150|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20329151|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20329152|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329153|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808053|NCT00441116|Dutasteride|dutasteride|mesh-list
19808054|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19808055|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20163669|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20163670|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163671|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163672|NCT00131989|Sorafenib|sorafenib|mesh-list
20163673|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163674|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20329154|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20329155|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19808056|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808057|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808058|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
20329156|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
19808059|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808060|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808061|NCT00441129|Insulin|insulin|mesh-list
19808062|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19808063|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329157|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
19808064|NCT00441142|Temozolomide|temozolomide|mesh-list
19808065|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19808066|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
20329158|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329159|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20329160|NCT00763633|Vitamins|vitamins|mesh-list
20329161|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
20329162|NCT00763633|Pyridoxal|pyridoxal|mesh-list
20329163|NCT00763633|Pyridoxine|pyridoxine|mesh-list
20329164|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
20329165|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
20329166|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329167|NCT00763646|Docetaxel|docetaxel|mesh-list
20329168|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329169|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329170|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
20329171|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329172|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329173|NCT00763685|Etoricoxib|etoricoxib|mesh-list
20329174|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20329175|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20329176|NCT00763685|Analgesics|analgesics|mesh-ancestor
19808067|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808068|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808069|NCT00441168|Dexamethasone|dexamethasone|mesh-list
19808070|NCT00441168|Vincristine|vincristine|mesh-list
19808071|NCT00441168|Doxorubicin|doxorubicin|mesh-list
19808072|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19808073|NCT00441168|Bortezomib|bortezomib|mesh-list
19808074|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808075|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
19808076|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
19808077|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808078|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808079|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808080|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
19808081|NCT00441168|Hormones|hormones|mesh-ancestor
19808082|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808083|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19808084|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808085|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19808086|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
19808087|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808088|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
19808089|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808090|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19808091|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19808092|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19808093|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808094|NCT00441285|Albendazole|albendazole|mesh-list
19808095|NCT00441285|Praziquantel|praziquantel|mesh-list
19808096|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
19808097|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19808098|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329177|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
19808099|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
19808100|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19808101|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19808102|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329178|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329179|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808103|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808104|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
19808105|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808106|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808107|NCT00441337|Nivolumab|nivolumab|mesh-list
20329180|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329181|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329182|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20329183|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20329184|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329185|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329186|NCT00763763|Interferons|interferons|mesh-list
20329187|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20329188|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
20329189|NCT00763763|Dexamethasone|dexamethasone|mesh-list
20329190|NCT00763763|Vincristine|vincristine|mesh-list
20329191|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
20329192|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329193|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
19808108|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808109|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808110|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19808111|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808112|NCT00441363|Bromocriptine|bromocriptine|mesh-list
19808113|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19808114|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19808115|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
19808116|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808117|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808118|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
19808119|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
19808120|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808121|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808122|NCT00441441|Fluticasone|fluticasone|mesh-list
19808123|NCT00441441|Xhance|xhance|mesh-list
19808124|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19808125|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808126|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19808127|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
19808128|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808129|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808130|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19808131|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
19808132|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
19808133|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19808134|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19808135|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19808136|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19808137|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
19808138|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808139|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808140|NCT00441545|Sevelamer|sevelamer|mesh-list
19808141|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
19808142|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
19808143|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808144|NCT00441584|Ribavirin|ribavirin|mesh-list
19808145|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19808146|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
19808147|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
19808148|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808149|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
19808150|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808151|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
19808152|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808153|NCT00441727|Esomeprazole|esomeprazole|mesh-list
19808154|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19808155|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808156|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19808157|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808158|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808159|NCT00441792|Midazolam|midazolam|mesh-list
20329194|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
20329195|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329196|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808160|NCT00441792|Etomidate|etomidate|mesh-list
19808161|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19808162|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19808163|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19808164|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808165|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19808166|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19808167|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19808168|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19808169|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
19808170|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
19808171|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
19808172|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
19808173|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808174|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808175|NCT00441883|Latanoprost|latanoprost|mesh-list
19808176|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19808177|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20329197|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329198|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
20329199|NCT00763763|Hormones|hormones|mesh-ancestor
20329200|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329201|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20329202|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329203|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
20329204|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329205|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20329206|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329207|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808178|NCT00441974|Adefovir|adefovir|mesh-list
19808179|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19808180|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
19808181|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808182|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19808183|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19808184|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329208|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329209|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329210|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20329211|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329212|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
20329213|NCT00763789|Remifentanil|remifentanil|mesh-list
20329214|NCT00763789|Anesthetics|anesthetics|mesh-list
20329215|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329216|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329217|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20329218|NCT00763789|Narcotics|narcotics|mesh-ancestor
19808185|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808186|NCT00442013|Lansoprazole|lansoprazole|mesh-list
19808187|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
19808188|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19808189|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808190|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19808191|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808192|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808193|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19808194|NCT00442364|Polidocanol|polidocanol|mesh-list
19808195|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19808196|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19808197|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
19808198|NCT00442416|Hematinics|hematinics|mesh-ancestor
19808199|NCT00442507|Bevacizumab|bevacizumab|mesh-list
19808200|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19808201|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808202|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808203|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20329219|NCT00763789|Analgesics|analgesics|mesh-ancestor
20329220|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
19808204|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808205|NCT00442507|Growth Substances|growth substances|mesh-ancestor
19808206|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808207|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808208|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20329221|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808209|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808210|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329222|NCT00763880|Lidocaine|lidocaine|mesh-list
19808211|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19808212|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
20329223|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
20329224|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
20329225|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329226|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329227|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
20329228|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329229|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20329230|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20329231|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20329232|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329233|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329234|NCT00763893|Losartan|losartan|mesh-list
20329235|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20329236|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20329237|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19808213|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808214|NCT00442611|Abatacept|abatacept|mesh-list
19808215|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19808216|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808217|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808218|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808219|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
19808220|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808221|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808222|NCT00442689|Flutamide|flutamide|mesh-list
20163675|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163676|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163677|NCT00132054|Irinotecan|irinotecan|mesh-list
20163678|NCT00132054|Amrubicin|amrubicin|mesh-list
20329238|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20329239|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329240|NCT00763906|Norepinephrine|norepinephrine|mesh-list
20329241|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20329242|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20329243|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
20329244|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329245|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329246|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329247|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
20329248|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
20329249|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329250|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20329251|NCT00763997|Acetaminophen|acetaminophen|mesh-list
20329252|NCT00763997|Dipyrone|dipyrone|mesh-list
20329253|NCT00763997|Ibuprofen|ibuprofen|mesh-list
19808223|NCT00442689|Drospirenone|drospirenone|mesh-list
19808224|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19808225|NCT00442689|Estradiol|estradiol|mesh-list
19808226|NCT00442689|Estrogens|estrogens|mesh-ancestor
19808227|NCT00442689|Hormones|hormones|mesh-ancestor
19808228|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808229|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808230|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19808231|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
19808232|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19808233|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19808234|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20163679|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20163680|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20163681|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163682|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163683|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163684|NCT00132067|Vorinostat|vorinostat|mesh-list
20163685|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163686|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20163687|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163688|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329254|NCT00763997|Parecoxib|parecoxib|mesh-list
20329255|NCT00763997|Valdecoxib|valdecoxib|mesh-list
20329256|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19808235|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19808236|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20329257|NCT00763997|Analgesics|analgesics|mesh-ancestor
20329258|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
20329259|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329260|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329261|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
20329262|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20329263|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329264|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329265|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20329266|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329267|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329268|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20329269|NCT00764036|Artesunate|artesunate|mesh-list
20329270|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
20329271|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20329272|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20329273|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329274|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329275|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
20329276|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
20329277|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20329278|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
20329279|NCT00764062|Amoxicillin|amoxicillin|mesh-list
20329280|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20329281|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329282|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20329283|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329284|NCT00764140|Mitogens|mitogens|mesh-list
20329285|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329286|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329287|NCT00764166|Docetaxel|docetaxel|mesh-list
20329288|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20329289|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329290|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329291|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
20329292|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329293|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329294|NCT00764166|Hormones|hormones|mesh-ancestor
20329295|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329296|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329297|NCT00764244|Triamcinolone|triamcinolone|mesh-list
20329298|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20329299|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20329300|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20329301|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329302|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
20329303|NCT00764244|Hormones|hormones|mesh-ancestor
20329304|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329305|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347906|NCT00862342|Growth Substances|growth substances|mesh-ancestor
19646543|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19646544|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19646545|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19646546|NCT02358993|Renal Agents|renal agents|mesh-ancestor
19646547|NCT02358850|Acetaminophen|acetaminophen|mesh-list
19646548|NCT02358850|Oxycodone|oxycodone|mesh-list
19646549|NCT02358850|Hydromorphone|hydromorphone|mesh-list
19646550|NCT02358850|Hydrocodone|hydrocodone|mesh-list
19646551|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646552|NCT02358850|Analgesics|analgesics|mesh-ancestor
19646553|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
19664408|NCT03825796|Cytarabine|cytarabine|mesh-list
19664409|NCT03825796|Daunorubicin|daunorubicin|mesh-list
19664410|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19664411|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
19664412|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664413|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664414|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
19664415|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664416|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664417|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
19664418|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664419|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19664420|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19664421|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19664422|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808237|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
19808238|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19808239|NCT00442689|Diuretics|diuretics|mesh-ancestor
19808240|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
19808241|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
19808242|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19808243|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808244|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
19808245|NCT00442702|Hematinics|hematinics|mesh-ancestor
19808246|NCT00442767|Insulin|insulin|mesh-list
19808247|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19808248|NCT00442767|Pramlintide|pramlintide|mesh-list
19808249|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
19808250|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19808251|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808252|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
19808253|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19808254|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
19808255|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808256|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
19808257|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
19808258|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19808259|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19808260|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
19808261|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808262|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808263|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808264|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808265|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19808266|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808267|NCT00442962|Tenofovir|tenofovir|mesh-list
19808268|NCT00442962|Emtricitabine|emtricitabine|mesh-list
19808269|NCT00442962|Efavirenz|efavirenz|mesh-list
19808270|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19808271|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
19808272|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808273|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19808274|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19808275|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808276|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808277|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19808278|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19808279|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19808280|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19808281|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19808282|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19808283|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19808284|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19808285|NCT00443053|PENTA|penta|mesh-list
19808286|NCT00443053|Fondaparinux|fondaparinux|mesh-list
19808287|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19808288|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
19808289|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19808290|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
19808291|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808292|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808293|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
19808294|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19808295|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19834491|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834492|NCT00594945|Clonazepam|clonazepam|mesh-list
19834493|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
19834494|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
19834495|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
19834496|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834497|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834498|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163689|NCT00132093|Eplerenone|eplerenone|mesh-list
20163690|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20163691|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
20163692|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163693|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163694|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19834499|NCT00594958|Vaccines|vaccines|mesh-list
19808296|NCT00443209|Rizatriptan|rizatriptan|mesh-list
19808297|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19808298|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
19808299|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808300|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808301|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834500|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
19834501|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834502|NCT00595101|Latanoprost|latanoprost|mesh-list
19834503|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19834504|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19834505|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
19834506|NCT00595127|Fludarabine|fludarabine|mesh-list
19834507|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834508|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
19834509|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834510|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834511|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834512|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
19834513|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834514|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834515|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834516|NCT00595153|Budesonide|budesonide|mesh-list
19834517|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834518|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19834519|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
19834520|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834521|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834522|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19834523|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
19834524|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
19834525|NCT00595153|Hormones|hormones|mesh-ancestor
19834526|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19834527|NCT00595231|Rufinamide|rufinamide|mesh-list
19834528|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
19834529|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19834530|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19834531|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834532|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834533|NCT00595270|Vaccines|vaccines|mesh-list
19834534|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
19834535|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834536|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
19834537|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19834538|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19834539|NCT00595335|Prednisolone|prednisolone|mesh-list
19834540|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
19834541|NCT00595335|Rituximab|rituximab|mesh-list
19834542|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19834543|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
19834544|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834545|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834546|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
19834547|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834548|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834549|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834550|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
19834551|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
19834552|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834553|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19834554|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
19834555|NCT00595335|Hormones|hormones|mesh-ancestor
19834556|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19834557|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19834558|NCT00595335|Protective Agents|protective agents|mesh-ancestor
19834559|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19834560|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19834561|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19834562|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
19834563|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834564|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834565|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19834566|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
19834567|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19834568|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19808302|NCT00443261|Azacitidine|azacitidine|mesh-list
19808303|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808304|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19808305|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
19808306|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808307|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163695|NCT00132093|Diuretics|diuretics|mesh-ancestor
20163696|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
20163697|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19808308|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19808309|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19808310|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19808311|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19808312|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808313|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808314|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808315|NCT00443352|Analgesics|analgesics|mesh-ancestor
19808316|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
19808317|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808318|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
19808319|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19808320|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
19808321|NCT00443430|Prednisone|prednisone|mesh-list
19808322|NCT00443430|Prednisolone|prednisolone|mesh-list
19808323|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19808324|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
19808325|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19808326|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
19808327|NCT00443430|Etanercept|etanercept|mesh-list
19808328|NCT00443430|Methotrexate|methotrexate|mesh-list
19808329|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19808330|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
19808331|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808332|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
19808333|NCT00443430|Hormones|hormones|mesh-ancestor
19808334|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163698|NCT00132106|Phentolamine|phentolamine|mesh-list
20163699|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20329306|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20329307|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
20329308|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329309|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329310|NCT00764374|Z 338|z 338|mesh-list
20329311|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19646554|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163700|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20163701|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
20163702|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329312|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646555|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646556|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
19646557|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19646558|NCT02358850|Narcotics|narcotics|mesh-ancestor
19646559|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646560|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
19646561|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
19646562|NCT02359136|Epinephrine|epinephrine|mesh-list
19646563|NCT02359136|Analgesics|analgesics|mesh-list
19646564|NCT02359136|Anesthetics|anesthetics|mesh-list
19646565|NCT02359136|Ropivacaine|ropivacaine|mesh-list
19646566|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646567|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646568|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
19646569|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
19646570|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646571|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19646572|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19646573|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
19646574|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646575|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646576|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19646577|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19808335|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163703|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808336|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19808337|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808338|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19808339|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
19808340|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19808341|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19808342|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
19808343|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808344|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
19808345|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808346|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19808347|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808348|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
19808349|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808350|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19808351|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
19808352|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
19808353|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808354|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808355|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19808356|NCT00443430|Protective Agents|protective agents|mesh-ancestor
19808357|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19808358|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19808359|NCT00443430|Analgesics|analgesics|mesh-ancestor
20329313|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329314|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
20329315|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329316|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329317|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329318|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
20329319|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19808360|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
19808361|NCT00443456|Amlodipine|amlodipine|mesh-list
19808362|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19808363|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19808364|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19808365|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808366|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19808367|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808368|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
19808369|NCT00443534|Sunitinib|sunitinib|mesh-list
19808370|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808371|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808372|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808373|NCT00443534|Growth Substances|growth substances|mesh-ancestor
19808374|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808375|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808376|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19808377|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808378|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808379|NCT00443560|Fentanyl|fentanyl|mesh-list
19808380|NCT00443560|Bupivacaine|bupivacaine|mesh-list
19808381|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
19808382|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
19808383|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19808384|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808385|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
19808386|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808387|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19808388|NCT00443560|Narcotics|narcotics|mesh-ancestor
19808389|NCT00443560|Analgesics|analgesics|mesh-ancestor
20163704|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163705|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20163706|NCT00132119|Nalmefene|nalmefene|mesh-list
20163707|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20163708|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163709|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
20163710|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163711|NCT00132158|Irinotecan|irinotecan|mesh-list
20163712|NCT00132158|Gefitinib|gefitinib|mesh-list
20163713|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20163714|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19808390|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19808391|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19808392|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
19808393|NCT00443599|Insulin|insulin|mesh-list
19808394|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19808395|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19808396|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808397|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19808398|NCT00443651|Rituximab|rituximab|mesh-list
19808399|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808400|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808401|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
19808402|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808403|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646578|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
19646579|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19646580|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
19646581|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
19646582|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
20163715|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163716|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163717|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163718|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20163719|NCT00132184|Vitamin D|vitamin d|mesh-list
20163720|NCT00132184|Vitamins|vitamins|mesh-ancestor
20163721|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
20163722|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329320|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19808404|NCT00443703|Ritonavir|ritonavir|mesh-list
19808405|NCT00443703|Lopinavir|lopinavir|mesh-list
19808406|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
19808407|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19808408|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19646583|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19646584|NCT02358967|Vitamin E|vitamin e|mesh-list
19646585|NCT02358967|Tocopherols|tocopherols|mesh-list
19646586|NCT02358967|Tocotrienols|tocotrienols|mesh-list
19808409|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
19808410|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808411|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808412|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19808413|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19808414|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
19808415|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808416|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19808417|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20329321|NCT00764413|Prednisolone|prednisolone|mesh-list
20329322|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
20329323|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20329324|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
20329325|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329326|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
20329327|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
20329328|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329329|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329330|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329331|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
20329332|NCT00764413|Hormones|hormones|mesh-ancestor
20329333|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329334|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20329335|NCT00764413|Protective Agents|protective agents|mesh-ancestor
20329336|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20329337|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329338|NCT00764426|Ethanol|ethanol|mesh-list
20329339|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20329340|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329341|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329342|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646587|NCT02358967|Vitamins|vitamins|mesh-ancestor
19646588|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
19646589|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646590|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
19646591|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808418|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20329343|NCT00764439|Nicotine|nicotine|mesh-list
19646592|NCT02358967|Protective Agents|protective agents|mesh-ancestor
19646593|NCT02359162|Gemcitabine|gemcitabine|mesh-list
19808419|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19646594|NCT02359162|Prednisone|prednisone|mesh-list
19808420|NCT00443729|Ritonavir|ritonavir|mesh-list
19808421|NCT00443729|Lopinavir|lopinavir|mesh-list
19808422|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
19808423|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19808424|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19808425|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
19808426|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808427|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808428|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19808429|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19808430|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
19808431|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808432|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19808433|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19808434|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19808435|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19808436|NCT00443755|Metformin|metformin|mesh-list
19808437|NCT00443755|Pioglitazone|pioglitazone|mesh-list
19808438|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19808439|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808440|NCT00443781|Anesthetics|anesthetics|mesh-list
19808441|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19808442|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808443|NCT00443820|Terbinafine|terbinafine|mesh-list
19808444|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
19808445|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808446|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808447|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808448|NCT00443872|Selegiline|selegiline|mesh-list
19808449|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
19808450|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19808451|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19808452|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19808453|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19808454|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808455|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808456|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19808457|NCT00443872|Protective Agents|protective agents|mesh-ancestor
19808458|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808459|NCT00443898|Terbinafine|terbinafine|mesh-list
19808460|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
19808461|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808462|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808463|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808464|NCT00444028|Loxapine|loxapine|mesh-list
19808465|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19808466|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19808467|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19808468|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808469|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19808470|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19808471|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
19808472|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808473|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808474|NCT00444106|Artesunate|artesunate|mesh-list
19808475|NCT00444106|Lumefantrine|lumefantrine|mesh-list
19808476|NCT00444106|Artemether|artemether|mesh-list
19808477|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19808478|NCT00444106|Mefloquine|mefloquine|mesh-list
19808479|NCT00444106|Atovaquone|atovaquone|mesh-list
19808480|NCT00444106|Proguanil|proguanil|mesh-list
19808481|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19646595|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
19646596|NCT02359162|Doxorubicin|doxorubicin|mesh-list
19646597|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
19646598|NCT02359162|Etoposide|etoposide|mesh-list
19646599|NCT02359162|Vincristine|vincristine|mesh-list
19646600|NCT02359162|Pegaspargase|pegaspargase|mesh-list
19646601|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19646602|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
19646603|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808482|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
19646604|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808483|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19646605|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19646606|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
19808484|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19808485|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808486|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808487|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
19808488|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
19808489|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19808490|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
19808491|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808492|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808493|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
19808494|NCT00444145|Lansoprazole|lansoprazole|mesh-list
19808495|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19808496|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808497|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19808498|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808499|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808500|NCT00444275|Esomeprazole|esomeprazole|mesh-list
19808501|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19808502|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808503|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19808504|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664423|NCT03753204|Furosemide|furosemide|mesh-list
19808505|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808506|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19808507|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
19808508|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808509|NCT00444535|Bevacizumab|bevacizumab|mesh-list
19808510|NCT00444535|Lapatinib|lapatinib|mesh-list
19808511|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808512|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808513|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808514|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808515|NCT00444535|Growth Substances|growth substances|mesh-ancestor
19808516|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808517|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808518|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19808519|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808520|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808521|NCT00444587|Trastuzumab|trastuzumab|mesh-list
19808522|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808523|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808524|NCT00444600|Triamcinolone|triamcinolone|mesh-list
19808525|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19808526|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19808527|NCT00444600|Bevacizumab|bevacizumab|mesh-list
19808528|NCT00444600|Ranibizumab|ranibizumab|mesh-list
19808529|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19808530|NCT00444600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808531|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808532|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808533|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808534|NCT00444600|Growth Substances|growth substances|mesh-ancestor
19808535|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808536|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808537|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808538|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
19808539|NCT00444600|Hormones|hormones|mesh-ancestor
19808540|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808541|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808542|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
20163723|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20163724|NCT00132210|Interferons|interferons|mesh-list
20163725|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163726|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
19664424|NCT03753204|Diuretics|diuretics|mesh-ancestor
19664425|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
19664426|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664427|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19664428|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19664429|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664430|NCT03679611|Neostigmine|neostigmine|mesh-list
19664431|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19664432|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664433|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664434|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
20329344|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20329345|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
20329346|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329347|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329348|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20329349|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20329350|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
20329351|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329352|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329353|NCT00764556|Insulin|insulin|mesh-list
19808543|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808544|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808545|NCT00444626|Lidocaine|lidocaine|mesh-list
19808546|NCT00444626|Prilocaine|prilocaine|mesh-list
19808547|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19808548|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
19808549|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
19808550|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
19808551|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19808552|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808553|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
19808554|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808555|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19808556|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19808557|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19808558|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19808559|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808560|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19808561|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
19808562|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
19808563|NCT00444626|Protective Agents|protective agents|mesh-ancestor
19808564|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19808565|NCT00444678|Capecitabine|capecitabine|mesh-list
19808566|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
19808567|NCT00444678|Cetuximab|cetuximab|mesh-list
19808568|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19808569|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
19808570|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808571|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808572|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808573|NCT00444795|Sunitinib|sunitinib|mesh-list
19808574|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808575|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808576|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808577|NCT00444795|Growth Substances|growth substances|mesh-ancestor
19808578|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808579|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808580|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19808581|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808582|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808583|NCT00444912|Plerixafor|plerixafor|mesh-list
19808584|NCT00444912|Rituximab|rituximab|mesh-list
19808585|NCT00444912|Lenograstim|lenograstim|mesh-list
19808586|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808587|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808588|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
19808589|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808590|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808591|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19808592|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19808593|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19808594|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
19808595|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808596|NCT00444925|Fesoterodine|fesoterodine|mesh-list
19808597|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19808598|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19808599|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19808600|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
19808601|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808602|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808603|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808604|NCT00444925|Urological Agents|urological agents|mesh-ancestor
19808605|NCT00444951|Vaccines|vaccines|mesh-list
19808606|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
20329354|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329355|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329356|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
19808607|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808608|NCT00444964|Hormones|hormones|mesh-list
19808609|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808610|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329357|NCT00764582|Levofloxacin|levofloxacin|mesh-list
20329358|NCT00764582|Ofloxacin|ofloxacin|mesh-list
20329359|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19808611|NCT00445003|Triamcinolone|triamcinolone|mesh-list
19808612|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19808613|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19808614|NCT00445003|Ranibizumab|ranibizumab|mesh-list
19808615|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19808616|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808617|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808618|NCT00445003|Growth Substances|growth substances|mesh-ancestor
19808619|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646607|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646608|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646609|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19646610|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19646611|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
19646612|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
19646613|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808620|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808621|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808622|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808623|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
19808624|NCT00445003|Hormones|hormones|mesh-ancestor
19808625|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808626|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808627|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
19808628|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808629|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808630|NCT00445068|Panobinostat|panobinostat|mesh-list
19808631|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808632|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19808633|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808634|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808635|NCT00445146|Elvitegravir|elvitegravir|mesh-list
19808636|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20329360|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20329361|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646614|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808637|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19808638|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
19808639|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808640|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19808641|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808642|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808643|NCT00445211|Heparin|heparin|mesh-list
19808644|NCT00445211|Calcium heparin|calcium heparin|mesh-list
19808645|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
19808646|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19808647|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19808648|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808649|NCT00445263|Tirofiban|tirofiban|mesh-list
19808650|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19808651|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19808652|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808653|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20163727|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163728|NCT00132236|Nicotine|nicotine|mesh-list
20163729|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20163730|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
20163731|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163732|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163733|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20163734|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20163735|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
19808654|NCT00445302|Plerixafor|plerixafor|mesh-list
20163736|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329362|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329363|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19808655|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19808656|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19808657|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
19808658|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808659|NCT00445328|Heparin|heparin|mesh-list
19808660|NCT00445328|Calcium heparin|calcium heparin|mesh-list
19808661|NCT00445328|Dalteparin|dalteparin|mesh-list
19808662|NCT00445328|Tinzaparin|tinzaparin|mesh-list
19808663|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19808664|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
19808665|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19808666|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19808667|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808668|NCT00445341|Alvocidib|alvocidib|mesh-list
19808669|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808670|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808671|NCT00445341|Growth Substances|growth substances|mesh-ancestor
19808672|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808673|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19808674|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808675|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808676|NCT00445432|Adalimumab|adalimumab|mesh-list
19808677|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808678|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808679|NCT00445458|Paclitaxel|paclitaxel|mesh-list
19808680|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19808681|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808682|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
19808683|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808684|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
19808685|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808686|NCT00445484|Lenalidomide|lenalidomide|mesh-list
19808687|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19808688|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
19808689|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808690|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808691|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808692|NCT00445484|Growth Substances|growth substances|mesh-ancestor
19808693|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808694|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808695|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19808696|NCT00445588|Sorafenib|sorafenib|mesh-list
19808697|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808698|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19808699|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808700|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808701|NCT00445601|Gemcitabine|gemcitabine|mesh-list
19808702|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19808703|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
19808704|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808705|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329364|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20329365|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329366|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329367|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329368|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20329369|NCT00764582|Renal Agents|renal agents|mesh-ancestor
20329370|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20329371|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20329372|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
20329373|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329374|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20329375|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329376|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329377|NCT00764712|Insulin|insulin|mesh-list
20329378|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329379|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347907|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808706|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
19808707|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808708|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808709|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808710|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
19808711|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808712|NCT00445679|Paroxetine|paroxetine|mesh-list
19808713|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19808714|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19808715|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19808716|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808717|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19808718|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
19808719|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808720|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19808721|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
19808722|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19808723|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19808724|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19808725|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808726|NCT00445692|Clarithromycin|clarithromycin|mesh-list
19646615|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19646616|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19646617|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19646618|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646619|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
19646620|NCT02359162|Hormones|hormones|mesh-ancestor
19646621|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19646622|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19646623|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19646624|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
19808727|NCT00445692|Dexamethasone|dexamethasone|mesh-list
19808728|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
19808729|NCT00445692|Lenalidomide|lenalidomide|mesh-list
19808730|NCT00445692|Ichthammol|ichthammol|mesh-list
19808731|NCT00445692|BB 1101|bb 1101|mesh-list
19808732|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808733|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
19808734|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
19646625|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808735|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808736|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808737|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808738|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
19808739|NCT00445692|Hormones|hormones|mesh-ancestor
19808740|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808741|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19808742|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808743|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
19808744|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808745|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808746|NCT00445692|Growth Substances|growth substances|mesh-ancestor
19808747|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808748|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19808749|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808750|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19808751|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808752|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808753|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19808754|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19808755|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19808756|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
20163737|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174361|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20174362|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
19646626|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
19646627|NCT02358707|Ibuprofen|ibuprofen|mesh-list
19646628|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19646629|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646630|NCT02358707|Analgesics|analgesics|mesh-ancestor
19646631|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
19646632|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808757|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
20174363|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20174364|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174365|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174366|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20174367|NCT00164710|Renal Agents|renal agents|mesh-ancestor
20174368|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
20174369|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646633|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646634|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646635|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646636|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19646637|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646638|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646639|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
19646640|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19646641|NCT02358694|Antibodies|antibodies|mesh-list
19646642|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
19646643|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646644|NCT02358642|Lisinopril|lisinopril|mesh-list
19646645|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19808758|NCT00445744|Busulfan|busulfan|mesh-list
19808759|NCT00445744|Methotrexate|methotrexate|mesh-list
19808760|NCT00445744|Tacrolimus|tacrolimus|mesh-list
19808761|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808762|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
19808763|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808764|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808765|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19646646|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19646647|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
19646648|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646649|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19646650|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19808766|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
19808767|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808768|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808769|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19808770|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19808771|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
19808772|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19808773|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19808774|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
19646651|NCT02358642|Protective Agents|protective agents|mesh-ancestor
19646652|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646653|NCT02358499|Posaconazole|posaconazole|mesh-list
19646654|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
19646655|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646656|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19808775|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
19808776|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808777|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19808778|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19808779|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19808780|NCT00445770|Etanercept|etanercept|mesh-list
19808781|NCT00445770|Methotrexate|methotrexate|mesh-list
19808782|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19808783|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
19808784|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19808785|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808786|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19808787|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
19808788|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808789|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808790|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
19808791|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808792|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19808793|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808794|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
20163738|NCT00132275|Amoxicillin|amoxicillin|mesh-list
20163739|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
20163740|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
20163741|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163742|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163743|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20163744|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163745|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163746|NCT00132379|Docetaxel|docetaxel|mesh-list
20163747|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163748|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
19808795|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163749|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
19646657|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19808796|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19808797|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19808798|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19808799|NCT00445770|Analgesics|analgesics|mesh-ancestor
19808800|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
19808801|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808802|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808803|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19808804|NCT00445848|Bevacizumab|bevacizumab|mesh-list
20329380|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
20329381|NCT00764725|Methotrexate|methotrexate|mesh-list
20329382|NCT00764725|Infliximab|infliximab|mesh-list
20329383|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20329384|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
20329385|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20329386|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329387|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20329388|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
20329389|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329390|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329391|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
20329392|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329393|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20329394|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20329395|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
20329396|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329397|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20163750|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163751|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163752|NCT00132418|Etanercept|etanercept|mesh-list
20163753|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20163754|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20163755|NCT00132418|Analgesics|analgesics|mesh-ancestor
20163756|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
20329398|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329399|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329400|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20329401|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20329402|NCT00764725|Analgesics|analgesics|mesh-ancestor
20329403|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
20329404|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329405|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329406|NCT00764816|Caseins|caseins|mesh-list
20329407|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
20329408|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
20329409|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329410|NCT00764855|Propofol|propofol|mesh-list
20329411|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20347908|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
19646658|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19808805|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19808806|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808807|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808808|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808809|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808810|NCT00445848|Growth Substances|growth substances|mesh-ancestor
19808811|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808812|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
19646659|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19808813|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19808814|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808815|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808816|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
19646660|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19646661|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646662|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646663|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19646664|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
19646665|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808817|NCT00445887|Norgestrel|norgestrel|mesh-list
19808818|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19808819|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
20163757|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808820|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19808821|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808822|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19808823|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19808824|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19808825|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19808826|NCT00445939|Adalimumab|adalimumab|mesh-list
19808827|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808828|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808829|NCT00445978|Verapamil|verapamil|mesh-list
19808830|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19808831|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20329412|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329413|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329414|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20329415|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
20329416|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
20329417|NCT00764907|Leucovorin|leucovorin|mesh-list
20329418|NCT00764907|Cytarabine|cytarabine|mesh-list
20329419|NCT00764907|Dexamethasone|dexamethasone|mesh-list
20329420|NCT00764907|Prednisone|prednisone|mesh-list
20329421|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
20329422|NCT00764907|Ifosfamide|ifosfamide|mesh-list
20329423|NCT00764907|Doxorubicin|doxorubicin|mesh-list
20329424|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20329425|NCT00764907|Methotrexate|methotrexate|mesh-list
20329426|NCT00764907|Etoposide|etoposide|mesh-list
20329427|NCT00764907|Vincristine|vincristine|mesh-list
20329428|NCT00764907|Daunorubicin|daunorubicin|mesh-list
20329429|NCT00764907|Asparaginase|asparaginase|mesh-list
19808832|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19808833|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808834|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19808835|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808836|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
19808837|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
19808838|NCT00446030|Bevacizumab|bevacizumab|mesh-list
19808839|NCT00446030|Carboplatin|carboplatin|mesh-list
19808840|NCT00446030|Docetaxel|docetaxel|mesh-list
19808841|NCT00446030|Doxorubicin|doxorubicin|mesh-list
19808842|NCT00446030|Trastuzumab|trastuzumab|mesh-list
19808843|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808844|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
19808845|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808846|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808847|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19808848|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
19808849|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808850|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808851|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19808852|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808853|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19808854|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19808855|NCT00446030|Growth Substances|growth substances|mesh-ancestor
19808856|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
19808857|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
19808858|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808859|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
19808860|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19808861|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19808862|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19808863|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808864|NCT00446134|Ribavirin|ribavirin|mesh-list
19808865|NCT00446134|Taribavirin|taribavirin|mesh-list
19808866|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
19808867|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808868|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
19808869|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808870|NCT00446147|Pyridoxine|pyridoxine|mesh-list
19808871|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
19808872|NCT00446147|Vitamins|vitamins|mesh-ancestor
19808873|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
19808874|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808875|NCT00446199|Drospirenone|drospirenone|mesh-list
19808876|NCT00446199|Estradiol|estradiol|mesh-list
19808877|NCT00446199|Estrogens|estrogens|mesh-ancestor
20329430|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
20329431|NCT00764907|Thioguanine|thioguanine|mesh-list
20329432|NCT00764907|Vindesine|vindesine|mesh-list
20329433|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
20329434|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808878|NCT00446199|Hormones|hormones|mesh-ancestor
20329435|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
20329436|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329437|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329438|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20329439|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
20329440|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329441|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329442|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20329443|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329444|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
20329445|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
20329446|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329447|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329448|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
19808879|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19808880|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808881|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19808882|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
19808883|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19808884|NCT00446199|Diuretics|diuretics|mesh-ancestor
19808885|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
19808886|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
19808887|NCT00446251|Rituximab|rituximab|mesh-list
19808888|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808889|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808890|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
20329449|NCT00764907|Hormones|hormones|mesh-ancestor
20329450|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329451|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20329452|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20329453|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20329454|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20329455|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808891|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808892|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808893|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19808894|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19808895|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
20329456|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20329457|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
19808896|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19808897|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808898|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808899|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808900|NCT00446264|Sirolimus|sirolimus|mesh-list
19808901|NCT00446264|Tacrolimus|tacrolimus|mesh-list
19808902|NCT00446264|Daclizumab|daclizumab|mesh-list
19808903|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19808904|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
19808905|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808906|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20329458|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20329459|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19646666|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646667|NCT02358356|Capecitabine|capecitabine|mesh-list
19646668|NCT02358356|Temozolomide|temozolomide|mesh-list
19646669|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19646670|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
19646671|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646672|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646673|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19646674|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
19646675|NCT02358304|Calcitonin|calcitonin|mesh-list
19646676|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
19646677|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19646678|NCT02358304|Katacalcin|katacalcin|mesh-list
19646679|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646680|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808907|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808908|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808909|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19834569|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20329460|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
20329461|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
20329462|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20329463|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20329464|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20329465|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
20329466|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808910|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808911|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19808912|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808913|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
20329467|NCT00764907|Antidotes|antidotes|mesh-ancestor
20329468|NCT00764907|Protective Agents|protective agents|mesh-ancestor
20329469|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
20329470|NCT00764907|Vitamins|vitamins|mesh-ancestor
20329471|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
20329472|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329473|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
20329474|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329475|NCT00764972|Sorafenib|sorafenib|mesh-list
20329476|NCT00764972|Vinorelbine|vinorelbine|mesh-list
20329477|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329478|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19808914|NCT00446290|Docetaxel|docetaxel|mesh-list
19808915|NCT00446290|Capecitabine|capecitabine|mesh-list
19808916|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
19808917|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808918|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
19808919|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808920|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
19808921|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808922|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19808923|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
19808924|NCT00446446|Panitumumab|panitumumab|mesh-list
19808925|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19808926|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808927|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
19808928|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19808929|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808930|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19808931|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
19808932|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19808933|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19808934|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808935|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808936|NCT00446511|Valsartan|valsartan|mesh-list
19808937|NCT00446511|Enalapril|enalapril|mesh-list
19808938|NCT00446511|Enalaprilat|enalaprilat|mesh-list
19808939|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19808940|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19808941|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19808942|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808943|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19808944|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
19808945|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808946|NCT00446563|Losartan|losartan|mesh-list
19808947|NCT00446563|Amlodipine|amlodipine|mesh-list
19808948|NCT00446563|Valsartan|valsartan|mesh-list
19808949|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19808950|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19808951|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19808952|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19808953|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808954|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19808955|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808956|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
19808957|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19808958|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19808959|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19808960|NCT00446563|Diuretics|diuretics|mesh-ancestor
20329479|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329480|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808961|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
20329481|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20329482|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329483|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
19808962|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19808963|NCT00446641|Cilostazol|cilostazol|mesh-list
19808964|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19808965|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
19808966|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808967|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808968|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19808969|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
19808970|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19808971|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19808972|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808973|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19808974|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
19808975|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20329484|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329485|NCT00765011|Cetuximab|cetuximab|mesh-list
20329486|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20329487|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19808976|NCT00446641|Protective Agents|protective agents|mesh-ancestor
19808977|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19808978|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19808979|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808980|NCT00446797|Celecoxib|celecoxib|mesh-list
19808981|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19808982|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19808983|NCT00446797|Analgesics|analgesics|mesh-ancestor
19808984|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
19808985|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808986|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19808987|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19808988|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19808989|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19808990|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19808991|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19808992|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329488|NCT00765024|Ivermectin|ivermectin|mesh-list
20329489|NCT00765024|Albendazole|albendazole|mesh-list
20329490|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20329491|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329492|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
20329493|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
20329494|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20329495|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20329496|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329497|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
20329498|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329499|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19808993|NCT00446849|Mesalamine|mesalamine|mesh-list
19808994|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19808995|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19808996|NCT00446849|Analgesics|analgesics|mesh-ancestor
19808997|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
19808998|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19808999|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809000|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646681|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19646682|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
19646683|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
19809001|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646684|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
19646685|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
19646686|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646687|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19646688|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
19809002|NCT00446992|Olanzapine|olanzapine|mesh-list
20329500|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646689|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
19809003|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
19809004|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
19809005|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809006|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809007|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19809008|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19809009|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19809010|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19809011|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19809012|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19809013|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19809014|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809015|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809016|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809017|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
19809018|NCT00447005|Axitinib|axitinib|mesh-list
19809019|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809020|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809021|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809022|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809023|NCT00447057|Pemetrexed|pemetrexed|mesh-list
19809024|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19809025|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809026|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809027|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809028|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19809029|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19809030|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809031|NCT00447226|Lapatinib|lapatinib|mesh-list
19809032|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809033|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809034|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809035|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809036|NCT00447265|Etanercept|etanercept|mesh-list
19809037|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19809038|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19809039|NCT00447265|Analgesics|analgesics|mesh-ancestor
19809040|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
19809041|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809042|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809043|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329501|NCT00765154|Ritonavir|ritonavir|mesh-list
20329502|NCT00765154|Darunavir|darunavir|mesh-list
20329503|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20329504|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20329505|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
19809044|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809045|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329506|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329507|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329508|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20329509|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20329510|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
20329511|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646690|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329512|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19646691|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646692|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646693|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19646694|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
19646695|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19646696|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
19646697|NCT02358057|Alfentanil|alfentanil|mesh-list
20329513|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20329514|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
20329515|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20329516|NCT00765167|Triclosan|triclosan|mesh-list
20329517|NCT00765167|Fluorides|fluorides|mesh-list
20329518|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
20329519|NCT00765167|Protective Agents|protective agents|mesh-ancestor
20329520|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329521|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20329522|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329523|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
20329524|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
20329525|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20329526|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20329527|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
20329528|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809046|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809047|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
19809048|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20329529|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20329530|NCT00765271|Ritonavir|ritonavir|mesh-list
20329531|NCT00765271|Darunavir|darunavir|mesh-list
19809049|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19809050|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19809051|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809052|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809053|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809054|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809055|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809056|NCT00447330|Bevacizumab|bevacizumab|mesh-list
19809057|NCT00447330|Capecitabine|capecitabine|mesh-list
19809058|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
19809059|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809060|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329532|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
20329533|NCT00765271|Abacavir|abacavir|mesh-list
20329534|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20329535|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20329536|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
20329537|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329538|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646698|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19646699|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19809061|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809062|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809063|NCT00447330|Growth Substances|growth substances|mesh-ancestor
19809064|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809065|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809066|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809067|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
20163758|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163759|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163760|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163761|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20163762|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163763|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
20163764|NCT00132431|Cinacalcet|cinacalcet|mesh-list
20163765|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20163766|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163767|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20163768|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
20329539|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19646700|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646701|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646702|NCT02358057|Analgesics|analgesics|mesh-ancestor
19646703|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
19646704|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646705|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19646706|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19646707|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19646708|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
19646709|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646710|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646711|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19809068|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329540|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20329541|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
20329542|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329543|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20329544|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20611660|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611661|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
20611662|NCT00408005|Leucovorin|leucovorin|mesh-list
20329545|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20329546|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20329547|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20329548|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20329549|NCT00765427|Retinol acetate|retinol acetate|mesh-list
20163769|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163770|NCT00132444|UC-781|uc-781|mesh-list
20163771|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20163772|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
20163773|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163774|NCT00132535|Chloroquine|chloroquine|mesh-list
20163775|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
20163776|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
20163777|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20163778|NCT00132535|Amebicides|amebicides|mesh-ancestor
20163779|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20163780|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163781|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163782|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
20163783|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163784|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163785|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163786|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329550|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20329551|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
19809069|NCT00447382|Insulin|insulin|mesh-list
19809070|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19809071|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
19809072|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
19809073|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19809074|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163787|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20329552|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329553|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20329554|NCT00765427|Protective Agents|protective agents|mesh-ancestor
20329555|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329556|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20329557|NCT00765557|Laxatives|laxatives|mesh-ancestor
20611663|NCT00408005|Folic Acid|folic acid|mesh-list
19646712|NCT02358057|Narcotics|narcotics|mesh-ancestor
19646713|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19646714|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
19646715|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
19646716|NCT02358083|Vaccines|vaccines|mesh-list
19646717|NCT02358083|Immunologic Factors|immunologic factors|mesh-ancestor
19646718|NCT02358083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646719|NCT02358161|Gemcitabine|gemcitabine|mesh-list
19646720|NCT02358161|Paclitaxel|paclitaxel|mesh-list
19646721|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19646722|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646723|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
19646724|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
19646725|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
19646726|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646727|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19646728|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
19646729|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
19646730|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646731|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646732|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19646733|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
19646734|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646735|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19646736|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163788|NCT00132535|Renal Agents|renal agents|mesh-ancestor
19646737|NCT02358187|Poly ICLC|poly iclc|mesh-list
20163789|NCT00132548|Artesunate|artesunate|mesh-list
20163790|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
20611664|NCT00408005|Cytarabine|cytarabine|mesh-list
19809075|NCT00447499|Lanreotide|lanreotide|mesh-list
20163791|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
20163792|NCT00132548|Amodiaquine|amodiaquine|mesh-list
20163793|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20163794|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
20163795|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20163796|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163797|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163798|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163799|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
20163800|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
20163801|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20163802|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
20163803|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163804|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163805|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163806|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20163807|NCT00132548|Renal Agents|renal agents|mesh-ancestor
20163808|NCT00132561|Artesunate|artesunate|mesh-list
20163809|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
20163810|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
20163811|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
20163812|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20163813|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20163814|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163815|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163816|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
20163817|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
20163818|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20329558|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329559|NCT00765921|Ranibizumab|ranibizumab|mesh-list
19809076|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809077|NCT00447694|Deferasirox|deferasirox|mesh-list
19809078|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19809079|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
19646738|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
19646739|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
19646740|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646741|NCT02358200|Paclitaxel|paclitaxel|mesh-list
19646742|NCT02358200|Carboplatin|carboplatin|mesh-list
19646743|NCT02358200|Talazoparib|talazoparib|mesh-list
19646744|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19809080|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
19809081|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809082|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
19809083|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19809084|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19809085|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19809086|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329560|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20329561|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20329562|NCT00765921|Growth Substances|growth substances|mesh-ancestor
19809087|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809088|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
19809089|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809090|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809091|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19809092|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809093|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
19809094|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19809095|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19809096|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19809097|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809098|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809099|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
19809100|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809101|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809102|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19809103|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809104|NCT00447902|Ritonavir|ritonavir|mesh-list
20163819|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
19809105|NCT00447902|Tipranavir|tipranavir|mesh-list
20163820|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19646745|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163821|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163822|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646746|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
19809106|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19809107|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19809108|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
19809109|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809110|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809111|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19809112|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19809113|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
19809114|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809115|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19809116|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19809117|NCT00448019|Vidarabine|vidarabine|mesh-list
19809118|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
19809119|NCT00448019|Bevacizumab|bevacizumab|mesh-list
19809120|NCT00448019|Rituximab|rituximab|mesh-list
19809121|NCT00448019|Fludarabine|fludarabine|mesh-list
19809122|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
19809123|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809124|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
19809125|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809126|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809127|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809128|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
19809129|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809130|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809131|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19809132|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809133|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809134|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809135|NCT00448019|Growth Substances|growth substances|mesh-ancestor
19809136|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
20329563|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329564|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
20329565|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329566|NCT00765934|Lidocaine|lidocaine|mesh-list
20329567|NCT00765934|Tetracaine|tetracaine|mesh-list
20329568|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
20329569|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
20329570|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329571|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329572|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
20329573|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329574|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20329575|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20329576|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20329577|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329578|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329579|NCT00765973|Topotecan|topotecan|mesh-list
20329580|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20329581|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20329582|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329583|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329584|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329585|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20329586|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20329587|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19809137|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809138|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
19809139|NCT00448019|Antiviral Agents|antiviral agents|mesh-ancestor
19809140|NCT00448019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809141|NCT00448123|Tamsulosin|tamsulosin|mesh-list
19809142|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19809143|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19809144|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19809145|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809146|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809147|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809148|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809149|NCT00448123|Urological Agents|urological agents|mesh-ancestor
19809150|NCT00448136|Bevacizumab|bevacizumab|mesh-list
19809151|NCT00448136|Streptozocin|streptozocin|mesh-list
19809152|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809153|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809154|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20329588|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329589|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20329590|NCT00766025|Calcium|calcium|mesh-list
20329591|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20329592|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329593|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20329594|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20329595|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
20329596|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329597|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20329598|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20329599|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329600|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20329601|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20329602|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20329603|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329604|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329605|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20329606|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20329607|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19809155|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809156|NCT00448136|Growth Substances|growth substances|mesh-ancestor
19809157|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809158|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809159|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19809160|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19809161|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19809162|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19809163|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
19809164|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809165|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809166|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809167|NCT00448175|Urological Agents|urological agents|mesh-ancestor
19809168|NCT00448201|Methotrexate|methotrexate|mesh-list
19809169|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
19809170|NCT00448201|Fludarabine|fludarabine|mesh-list
20329608|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
20329609|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329610|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329611|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20329612|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20329613|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
20329614|NCT00766155|Capecitabine|capecitabine|mesh-list
20329615|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
19809171|NCT00448201|Busulfan|busulfan|mesh-list
19809172|NCT00448201|Tacrolimus|tacrolimus|mesh-list
19809173|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19809174|NCT00448201|Sargramostim|sargramostim|mesh-list
20329616|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20329617|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
20329618|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329619|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329620|NCT00766181|Lidocaine|lidocaine|mesh-list
20329621|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
20329622|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
20347909|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
19646747|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
19646748|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
19646749|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646750|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19646751|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646752|NCT02358018|Edotreotide|edotreotide|mesh-list
19646753|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19646754|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646755|NCT02357797|Vortioxetine|vortioxetine|mesh-list
19646756|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
19646757|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19646758|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19646759|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19646760|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646761|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646762|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19646763|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19646764|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809175|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19809176|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
19809177|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19809178|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809179|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809180|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
19809181|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809182|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809183|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809184|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809185|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19809186|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809187|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
19809188|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809189|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19809190|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19809191|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
19809192|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809193|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20329623|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329624|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329625|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
20329626|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329627|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20329628|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20329629|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20329630|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329631|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329632|NCT00766220|Irinotecan|irinotecan|mesh-list
20329633|NCT00766220|Cetuximab|cetuximab|mesh-list
20329634|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20329635|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20329636|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809194|NCT00448227|Famciclovir|famciclovir|mesh-list
19809195|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
19809196|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809197|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19809198|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809199|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834570|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
20329637|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329638|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329639|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20329640|NCT00766246|Bevacizumab|bevacizumab|mesh-list
20329641|NCT00766246|Carboplatin|carboplatin|mesh-list
20329642|NCT00766246|Docetaxel|docetaxel|mesh-list
20329643|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20329644|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329645|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20329646|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20329647|NCT00766246|Growth Substances|growth substances|mesh-ancestor
20329648|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329649|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834571|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834572|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834573|NCT00595413|Adalimumab|adalimumab|mesh-list
19834574|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834575|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329650|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
20329651|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
20329652|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
20329653|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646765|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646766|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646767|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
19646768|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19646769|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19646770|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19646771|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19646772|NCT02357849|Aripiprazole|aripiprazole|mesh-list
19646773|NCT02357849|Fluoxetine|fluoxetine|mesh-list
19646774|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
20329654|NCT00766285|Vaccines|vaccines|mesh-list
20329655|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
20329656|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809200|NCT00448279|Trastuzumab|trastuzumab|mesh-list
19809201|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809202|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809203|NCT00448357|Methotrexate|methotrexate|mesh-list
19809204|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
19809205|NCT00448357|Fludarabine|fludarabine|mesh-list
19809206|NCT00448357|Busulfan|busulfan|mesh-list
19809207|NCT00448357|Tacrolimus|tacrolimus|mesh-list
19809208|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19809209|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
19809210|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19809211|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
19809212|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19809213|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809214|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809215|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
19809216|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809217|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809218|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809219|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809220|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19809221|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809222|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
19809223|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809224|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20329657|NCT00766337|Sirolimus|sirolimus|mesh-list
20329658|NCT00766337|Ranibizumab|ranibizumab|mesh-list
20329659|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20329660|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329661|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20329662|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329663|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
20329664|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20329665|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
20329666|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329667|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20329668|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20329669|NCT00766337|Growth Substances|growth substances|mesh-ancestor
20329670|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
20329671|NCT00766350|Amitriptyline|amitriptyline|mesh-list
20329672|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20329673|NCT00766350|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20329674|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
20329675|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20329676|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19809225|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19809226|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
19809227|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809228|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19809229|NCT00448435|Fluticasone|fluticasone|mesh-list
19809230|NCT00448435|Xhance|xhance|mesh-list
19809231|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19809232|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19809233|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809234|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19809235|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
19809236|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809237|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809238|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19809239|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
19809240|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809241|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19809242|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19809243|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19809244|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19809245|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809246|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809247|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809248|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
19809249|NCT00448435|Hormones|hormones|mesh-ancestor
19809250|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329677|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20329678|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19809251|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
19809252|NCT00448539|Rufinamide|rufinamide|mesh-list
19809253|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
19809254|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19809255|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19809256|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809257|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809258|NCT00448591|Bevacizumab|bevacizumab|mesh-list
19809259|NCT00448591|Taxane|taxane|mesh-list
20329679|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329680|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20329681|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20329682|NCT00766350|Analgesics|analgesics|mesh-ancestor
20329683|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
20329684|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329685|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20329686|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20329687|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329688|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329689|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
20329690|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329691|NCT00766402|Acetaminophen|acetaminophen|mesh-list
20329692|NCT00766402|Diclofenac|diclofenac|mesh-list
20329693|NCT00766402|Tramadol|tramadol|mesh-list
20329694|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20329695|NCT00766402|Analgesics|analgesics|mesh-ancestor
20329696|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
20329697|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809260|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809261|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809262|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809263|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809264|NCT00448591|Growth Substances|growth substances|mesh-ancestor
19809265|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809266|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809267|NCT00448669|Tenofovir|tenofovir|mesh-list
19809268|NCT00448669|Emtricitabine|emtricitabine|mesh-list
19809269|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
19809270|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809271|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19809272|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19809273|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809274|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809275|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19809276|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19809277|NCT00448708|Paclitaxel|paclitaxel|mesh-list
19809278|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19809279|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19809280|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809281|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19809282|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19809283|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834576|NCT00595517|Esomeprazole|esomeprazole|mesh-list
20163823|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20163824|NCT00132561|Renal Agents|renal agents|mesh-ancestor
20163825|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20329698|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329699|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
20329700|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20329701|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329702|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329703|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20163826|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
20329704|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329705|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329706|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20329707|NCT00766402|Narcotics|narcotics|mesh-ancestor
20329708|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329709|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20163827|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20163828|NCT00132587|Protective Agents|protective agents|mesh-ancestor
20163829|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163830|NCT00132600|Bacitracin|bacitracin|mesh-list
20163831|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20163832|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809284|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809285|NCT00448760|Leucovorin|leucovorin|mesh-list
19809286|NCT00448760|Docetaxel|docetaxel|mesh-list
19809287|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
19809288|NCT00448760|Floxuridine|floxuridine|mesh-list
19809289|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809290|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
19809291|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
19809292|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
19809293|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809294|NCT00448760|Antidotes|antidotes|mesh-ancestor
19809295|NCT00448760|Protective Agents|protective agents|mesh-ancestor
19809296|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809297|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
19809298|NCT00448760|Vitamins|vitamins|mesh-ancestor
19809299|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
19809300|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809301|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
19809302|NCT00448864|Ecallantide|ecallantide|mesh-list
19809303|NCT00448864|Analgesics|analgesics|mesh-ancestor
19809304|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
19809305|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809306|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809307|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19809308|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19809309|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809310|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809311|NCT00448916|Pregabalin|pregabalin|mesh-list
19809312|NCT00448916|Analgesics|analgesics|mesh-ancestor
19809313|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
19809314|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809315|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809316|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
19809317|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19809318|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809319|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809320|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19809321|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19809322|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19809323|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20329710|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329711|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329712|NCT00766441|Incretins|incretins|mesh-ancestor
20329713|NCT00766441|Hormones|hormones|mesh-ancestor
20329714|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329715|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20329716|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
20329717|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809324|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19809325|NCT00449007|Bupropion|bupropion|mesh-list
19809326|NCT00449007|Fluoxetine|fluoxetine|mesh-list
19809327|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19809328|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
19809329|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19809330|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19809331|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19809332|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809333|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163833|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163834|NCT00132613|Bleomycin|bleomycin|mesh-list
20163835|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20163836|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163837|NCT00132639|Docetaxel|docetaxel|mesh-list
20163838|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163839|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163840|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163841|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163842|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163843|NCT00132652|Lamivudine|lamivudine|mesh-list
20163844|NCT00132652|Telbivudine|telbivudine|mesh-list
19809334|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
19809335|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163845|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20174370|NCT00164736|Ritonavir|ritonavir|mesh-list
19809336|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809337|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19809338|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19809339|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809340|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19809341|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
19809342|NCT00449033|Gemcitabine|gemcitabine|mesh-list
19809343|NCT00449033|Sorafenib|sorafenib|mesh-list
19809344|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809345|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809346|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
19809347|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809348|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
19809349|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809350|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809351|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809352|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
19809353|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646775|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19646776|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19646777|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19646778|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646779|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646780|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
19646781|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
19809354|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809355|NCT00449046|Fluticasone|fluticasone|mesh-list
19809356|NCT00449046|Xhance|xhance|mesh-list
20163846|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20163847|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163848|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163849|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
19809357|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19809358|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163850|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163851|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20163852|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20163853|NCT00132743|Cilostazol|cilostazol|mesh-list
20163854|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20163855|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
20163856|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163857|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163858|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20163859|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
20329718|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329719|NCT00766480|Fluorouracil|fluorouracil|mesh-list
19809359|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19809360|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
19809361|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809362|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809363|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19809364|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
19809365|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809366|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19809367|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19809368|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19809369|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19809370|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809371|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809372|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809373|NCT00449072|Loratadine|loratadine|mesh-list
19809374|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
19809375|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809376|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19809377|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19809378|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19809379|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
19809380|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
19809381|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809382|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646782|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809383|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163860|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19646783|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163861|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19809384|NCT00449150|Cetrorelix|cetrorelix|mesh-list
19809385|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19809386|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
19809387|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19809388|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809389|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
19809390|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809391|NCT00449163|Leucovorin|leucovorin|mesh-list
19809392|NCT00449163|Bevacizumab|bevacizumab|mesh-list
19809393|NCT00449163|Irinotecan|irinotecan|mesh-list
19809394|NCT00449163|Floxuridine|floxuridine|mesh-list
19809395|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
19809396|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809397|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809398|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809399|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809400|NCT00449163|Growth Substances|growth substances|mesh-ancestor
19809401|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809402|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809403|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19809404|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19809405|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809406|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809407|NCT00449163|Antidotes|antidotes|mesh-ancestor
19809408|NCT00449163|Protective Agents|protective agents|mesh-ancestor
19809409|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
19809410|NCT00449163|Vitamins|vitamins|mesh-ancestor
19809411|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
19809412|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809413|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
19809414|NCT00449176|Oxycodone|oxycodone|mesh-list
19809415|NCT00449176|Tapentadol|tapentadol|mesh-list
19809416|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19646784|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19646785|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19646786|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
19646787|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19646788|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19646789|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19646790|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19646791|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19809417|NCT00449176|Narcotics|narcotics|mesh-ancestor
19809418|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19809419|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163862|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163863|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20163864|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
20163865|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20163866|NCT00132743|Protective Agents|protective agents|mesh-ancestor
20163867|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20163868|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20163869|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329720|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329721|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
20329722|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329723|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20329724|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20329725|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
20329726|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163870|NCT00132756|Estramustine|estramustine|mesh-list
20163871|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20329727|NCT00766545|Cilostazol|cilostazol|mesh-list
20329728|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19646792|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19646793|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19646794|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19646795|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19646796|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19646797|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646798|NCT02357693|Aprepitant|aprepitant|mesh-list
19809420|NCT00449176|Analgesics|analgesics|mesh-ancestor
19809421|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
19809422|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809423|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20329729|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
20329730|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809424|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19809425|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809426|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809427|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809428|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809429|NCT00449644|Bedaquiline|bedaquiline|mesh-list
19809430|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
19809431|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19809432|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809433|NCT00449670|Vaccines|vaccines|mesh-list
19809434|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
19809435|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809436|NCT00449748|Everolimus|everolimus|mesh-list
19809437|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809438|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809439|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
19809440|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809441|NCT00449761|Panobinostat|panobinostat|mesh-list
19809442|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809443|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19809444|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809445|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809446|NCT00449787|Naproxen|naproxen|mesh-list
19809447|NCT00449787|Sumatriptan|sumatriptan|mesh-list
19809448|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19809449|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19809450|NCT00449787|Analgesics|analgesics|mesh-ancestor
19809451|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
19809452|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809453|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809454|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809455|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809456|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
19809457|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19809458|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809459|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809460|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19809461|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19809462|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20163872|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
20163873|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163874|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163875|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163876|NCT00132821|Bupropion|bupropion|mesh-list
19809463|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
19809464|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163877|NCT00132821|Nicotine|nicotine|mesh-list
20163878|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20163879|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
20163880|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20163881|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163882|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20163883|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20163884|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
20163885|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163886|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163887|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20163888|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
20163889|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20163890|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20163891|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20163892|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20163893|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
20163894|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20163895|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20163896|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329731|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809465|NCT00449930|Metformin|metformin|mesh-list
19809466|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19809467|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19809468|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809469|NCT00449930|Incretins|incretins|mesh-ancestor
19809470|NCT00449930|Hormones|hormones|mesh-ancestor
19809471|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809472|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19809473|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
20329732|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20329733|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
20329734|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20329735|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20329736|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329737|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20329738|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
20329739|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20329740|NCT00766545|Protective Agents|protective agents|mesh-ancestor
20329741|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20329742|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20329743|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329744|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
20329745|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
20329746|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20329747|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
19809474|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809475|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809476|NCT00449956|Timolol|timolol|mesh-list
19809477|NCT00449956|Dorzolamide|dorzolamide|mesh-list
19809478|NCT00449956|Maleic acid|maleic acid|mesh-list
19809479|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19809480|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19809481|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809482|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809483|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809484|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809485|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19809486|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19809487|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809488|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19809489|NCT00450073|Vitamin D|vitamin d|mesh-list
19809490|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
19809491|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
19809492|NCT00450073|Vitamins|vitamins|mesh-list
19809493|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
19809494|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809495|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19809496|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19809497|NCT00450216|Ibuprofen|ibuprofen|mesh-list
19809498|NCT00450216|Famotidine|famotidine|mesh-list
19809499|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19809500|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19809501|NCT00450216|Analgesics|analgesics|mesh-ancestor
19809502|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
19809503|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809504|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809505|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809506|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809507|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19809508|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809509|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809510|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19809511|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19809512|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19809513|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
19809514|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
19809515|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809516|NCT00450242|Lidocaine|lidocaine|mesh-list
19809517|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
19809518|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
20329748|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19646799|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
19646800|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
19646801|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646802|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646803|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646804|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19646805|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646806|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329749|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20329750|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329751|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20329752|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329753|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329754|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20329755|NCT00766662|Renal Agents|renal agents|mesh-ancestor
20329756|NCT00766805|Propranolol|propranolol|mesh-list
20163897|NCT00132860|Azithromycin|azithromycin|mesh-list
20163898|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163899|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163900|NCT00132886|Tolvaptan|tolvaptan|mesh-list
20163901|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20163902|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163903|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
20163904|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163905|NCT00132899|Methotrexate|methotrexate|mesh-list
20163906|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20163907|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
20163908|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20163909|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163910|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20163911|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
20163912|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163913|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163914|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
20163915|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163916|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20163917|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163918|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
20163919|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20163920|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20163921|NCT00132912|Vorapaxar|vorapaxar|mesh-list
20163922|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20163923|NCT00132925|Triamcinolone|triamcinolone|mesh-list
20329757|NCT00766805|Isosorbide|isosorbide|mesh-list
19809519|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19809520|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809521|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
19809522|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809523|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19809524|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20329758|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20329759|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20329760|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20329761|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20329762|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
20329763|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329764|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329765|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329766|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20329767|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20329768|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
20329769|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20329770|NCT00766805|Diuretics|diuretics|mesh-ancestor
20329771|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
20329772|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20347910|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347911|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
20347912|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20347913|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
20347914|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347915|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347916|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20347917|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
20347918|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20347919|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20347920|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20347921|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347922|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809525|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20163924|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347923|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809526|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809527|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809528|NCT00450255|Aflibercept|aflibercept|mesh-list
19809529|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
19809530|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809531|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809532|NCT00450255|Growth Substances|growth substances|mesh-ancestor
19809533|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809534|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809535|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809536|NCT00450385|Prednisone|prednisone|mesh-list
19809537|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
19809538|NCT00450385|Rituximab|rituximab|mesh-list
19809539|NCT00450385|Doxorubicin|doxorubicin|mesh-list
19809540|NCT00450385|Vincristine|vincristine|mesh-list
19646807|NCT02357732|Nivolumab|nivolumab|mesh-list
19646808|NCT02357732|Trametinib|trametinib|mesh-list
19646809|NCT02357732|Dabrafenib|dabrafenib|mesh-list
19646810|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19646811|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809541|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809542|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
19809543|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809544|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809545|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809546|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
19809547|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809548|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809549|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19809550|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809551|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19809552|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19809553|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19809554|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809555|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809556|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
19809557|NCT00450385|Hormones|hormones|mesh-ancestor
19809558|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809559|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19809560|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19809561|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
19809562|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
19809563|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
19809564|NCT00450463|Metronidazole|metronidazole|mesh-list
19809565|NCT00450463|Molgramostim|molgramostim|mesh-list
19809566|NCT00450463|Flutamide|flutamide|mesh-list
19809567|NCT00450463|Sargramostim|sargramostim|mesh-list
19809568|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
19809569|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809570|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809571|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329773|NCT00766818|Lopinavir|lopinavir|mesh-list
20329774|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20329775|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20329776|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19646812|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19646813|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646814|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19646815|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646816|NCT02357524|Oritavancin|oritavancin|mesh-list
19646817|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646818|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646819|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19646820|NCT02357563|Leuprolide|leuprolide|mesh-list
19646821|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
19646822|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19646823|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
19646824|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19646825|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646826|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19646827|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646828|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20329777|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646829|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
19809572|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19809573|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19809574|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19809575|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
19809576|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
19809577|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809578|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19809579|NCT00450580|Ritonavir|ritonavir|mesh-list
19809580|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
19809581|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19809582|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20163925|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
20163926|NCT00132925|Hormones|hormones|mesh-ancestor
20329778|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809583|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
20163927|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163928|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163929|NCT00132938|Telithromycin|telithromycin|mesh-list
20163930|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163931|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163932|NCT00132951|Azithromycin|azithromycin|mesh-list
20163933|NCT00132951|Telithromycin|telithromycin|mesh-list
20163934|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163935|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163936|NCT00133003|Abciximab|abciximab|mesh-list
20163937|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
20163938|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20163939|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20163940|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163941|NCT00133042|Omalizumab|omalizumab|mesh-list
20163942|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20163943|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20329779|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20329780|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20329781|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
20329782|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646830|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19646831|NCT02357615|Nifedipine|nifedipine|mesh-list
19646832|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19646833|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19646834|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646835|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646836|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646837|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
19646838|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
19646839|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19646840|NCT02357602|Tenofovir|tenofovir|mesh-list
19646841|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
19646842|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646843|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19646844|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19646845|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646846|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646847|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19646848|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19646849|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19646850|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19646851|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
19646852|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664435|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664436|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664437|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19664438|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
19664439|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664440|NCT03608436|Bromides|bromides|mesh-list
19664441|NCT03608436|Rocuronium|rocuronium|mesh-list
19664442|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
19664443|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19664444|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19664445|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19664446|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664447|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664448|NCT03556904|Docetaxel|docetaxel|mesh-list
19664449|NCT03556904|Hormones|hormones|mesh-list
19809584|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20163944|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
20163945|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
19809585|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809586|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19809587|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19809588|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
19809589|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809590|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19809591|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19809592|NCT00450619|Metronidazole|metronidazole|mesh-list
19809593|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
19809594|NCT00450619|Vaccines|vaccines|mesh-list
19809595|NCT00450619|Sargramostim|sargramostim|mesh-list
19809596|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
19809597|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809598|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809599|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19809600|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19809601|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19809602|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19809603|NCT00450619|Analgesics|analgesics|mesh-ancestor
19809604|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
19809605|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809606|NCT00450658|Ibuprofen|ibuprofen|mesh-list
19809607|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19809608|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19809609|NCT00450658|Analgesics|analgesics|mesh-ancestor
19809610|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
19809611|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809612|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809613|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329783|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20329784|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20329785|NCT00766857|Insulin|insulin|mesh-list
20329786|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20329787|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
20329788|NCT00766857|Exenatide|exenatide|mesh-list
20329789|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329790|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329791|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20329792|NCT00766857|Incretins|incretins|mesh-ancestor
19809614|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809615|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19809616|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809617|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809618|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19809619|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20329793|NCT00766857|Hormones|hormones|mesh-ancestor
19646853|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
19646854|NCT02357303|Simethicone|simethicone|mesh-list
19646855|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19646856|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
19646857|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646858|NCT02357303|Expectorants|expectorants|mesh-ancestor
19646859|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
19646860|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19646861|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
19646862|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646863|NCT02357303|Protective Agents|protective agents|mesh-ancestor
19646864|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646865|NCT02357303|Antidotes|antidotes|mesh-ancestor
19646866|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
19646867|NCT02357303|Emollients|emollients|mesh-ancestor
19646868|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
19646869|NCT02357277|Budesonide|budesonide|mesh-list
19646870|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646871|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19646872|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
19646873|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646874|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646875|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19646876|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
19646877|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
19646878|NCT02357277|Hormones|hormones|mesh-ancestor
19646879|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809620|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347924|NCT00862420|Ticlopidine|ticlopidine|mesh-list
19646880|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
20329794|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329795|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20347925|NCT00862420|Clopidogrel|clopidogrel|mesh-list
19646881|NCT02357407|Ofloxacin|ofloxacin|mesh-list
19646882|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19646883|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19646884|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19646885|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19646886|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646887|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646888|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646889|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19646890|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19646891|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19646892|NCT02357407|Renal Agents|renal agents|mesh-ancestor
19646893|NCT02357225|Bromides|bromides|mesh-list
19646894|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19646895|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
19646896|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19646897|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646898|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163946|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
20163947|NCT00133172|Prednisone|prednisone|mesh-list
20163948|NCT00133172|Tacrolimus|tacrolimus|mesh-list
20163949|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646899|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
19646900|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646901|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646902|NCT02357212|Adenosine|adenosine|mesh-list
19646903|NCT02357212|Analgesics|analgesics|mesh-ancestor
19646904|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
19646905|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646906|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163950|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
19809621|NCT00450749|Lycopene|lycopene|mesh-list
19809622|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809623|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
19809624|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809625|NCT00450749|Protective Agents|protective agents|mesh-ancestor
19809626|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809627|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19809628|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19809629|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809630|NCT00450801|Leucovorin|leucovorin|mesh-list
19809631|NCT00450801|Cytarabine|cytarabine|mesh-list
19809632|NCT00450801|Thalidomide|thalidomide|mesh-list
19809633|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
19809634|NCT00450801|Ifosfamide|ifosfamide|mesh-list
19809635|NCT00450801|Rituximab|rituximab|mesh-list
19809636|NCT00450801|Doxorubicin|doxorubicin|mesh-list
19809637|NCT00450801|Methotrexate|methotrexate|mesh-list
19809638|NCT00450801|Etoposide|etoposide|mesh-list
19809639|NCT00450801|Vincristine|vincristine|mesh-list
19809640|NCT00450801|Granisetron|granisetron|mesh-list
20163951|NCT00133172|Hormones|hormones|mesh-ancestor
20163952|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20163953|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163954|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20163955|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163956|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20163957|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
20163958|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20163959|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809641|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809642|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
19809643|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809644|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809645|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809646|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
19809647|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809648|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809649|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19809650|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20163960|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809651|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20174371|NCT00164736|Lopinavir|lopinavir|mesh-list
20329796|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20329797|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20329798|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329799|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329800|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329801|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329802|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20329803|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
20329804|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20329805|NCT00766896|Aspirin|aspirin|mesh-list
20329806|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19809652|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19809653|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19809654|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809655|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19809656|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
19809657|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19809658|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809659|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
19809660|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809661|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19809662|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19809663|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19809664|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
19809665|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809666|NCT00450801|Antidotes|antidotes|mesh-ancestor
19809667|NCT00450801|Protective Agents|protective agents|mesh-ancestor
19809668|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
19809669|NCT00450801|Vitamins|vitamins|mesh-ancestor
19809670|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
19809671|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
19809672|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
19809673|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611665|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
20611666|NCT00408005|Dexamethasone|dexamethasone|mesh-list
19809674|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
19809675|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
19809676|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809677|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19809678|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
19809679|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19809680|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809681|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809682|NCT00450801|Growth Substances|growth substances|mesh-ancestor
19809683|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809684|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19809685|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
19809686|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809687|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
19809688|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809689|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
19809690|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809691|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809692|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809693|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
19809694|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809695|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809696|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19809697|NCT00450866|Epothilones|epothilones|mesh-list
19809698|NCT00450866|Epothilone B|epothilone b|mesh-list
19809699|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163961|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20163962|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20163963|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
20163964|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20163965|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20163966|NCT00133185|Losartan|losartan|mesh-list
20163967|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20163968|NCT00133185|Telmisartan|telmisartan|mesh-list
20163969|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20163970|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19809700|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
19809701|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834577|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20174372|NCT00164736|Lamivudine|lamivudine|mesh-list
20329807|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20329808|NCT00766896|Analgesics|analgesics|mesh-ancestor
20329809|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
20329810|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329811|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329812|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329813|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329814|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20329815|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20329816|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329817|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20329818|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20611667|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
20611668|NCT00408005|Prednisone|prednisone|mesh-list
20163971|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20163972|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20163973|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163974|NCT00133185|Diuretics|diuretics|mesh-ancestor
20163975|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
20163976|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163977|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20163978|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20163979|NCT00133198|Pramipexole|pramipexole|mesh-list
20163980|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
20163981|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163982|NCT00133198|Protective Agents|protective agents|mesh-ancestor
20163983|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20163984|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20163985|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20163986|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
20163987|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
20163988|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20163989|NCT00133224|Prednisone|prednisone|mesh-list
20163990|NCT00133224|Docetaxel|docetaxel|mesh-list
20163991|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20163992|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
20163993|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
20163994|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
20163995|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20163996|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20163997|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
20163998|NCT00133224|Hormones|hormones|mesh-ancestor
20163999|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164000|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164001|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164002|NCT00133237|Sirolimus|sirolimus|mesh-list
20164003|NCT00133237|Paclitaxel|paclitaxel|mesh-list
20164004|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164005|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164006|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
20164007|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
20329819|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329820|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
19809702|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809703|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809704|NCT00450983|Methotrexate|methotrexate|mesh-list
19809705|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
19809706|NCT00450983|Fludarabine|fludarabine|mesh-list
19809707|NCT00450983|Thiotepa|thiotepa|mesh-list
19809708|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
19809709|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19809710|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
19809711|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19809712|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809713|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809714|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
19809715|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809716|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809717|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809718|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809719|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19809720|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164008|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
20164009|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809721|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
19809722|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809723|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19809724|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809725|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
19809726|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19809727|NCT00451035|Panobinostat|panobinostat|mesh-list
19809728|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809729|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19809730|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809731|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164010|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611669|NCT00408005|Cortisone|cortisone|mesh-list
20611670|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
20611671|NCT00408005|Doxorubicin|doxorubicin|mesh-list
20164011|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164012|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20164013|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
20164014|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164015|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
20164016|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164017|NCT00133250|Heparin|heparin|mesh-list
20164018|NCT00133250|Calcium heparin|calcium heparin|mesh-list
20164019|NCT00133250|Abciximab|abciximab|mesh-list
20329821|NCT00766909|Cyclosporine|cyclosporine|mesh-list
19646907|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19646908|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
20611672|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20611673|NCT00408005|Methotrexate|methotrexate|mesh-list
20329822|NCT00766909|Tacrolimus|tacrolimus|mesh-list
20329823|NCT00766909|Cyclosporins|cyclosporins|mesh-list
20329824|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20329825|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
20329826|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329827|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20329828|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329829|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329830|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
20329831|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329832|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
20329833|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329834|NCT00767091|Rivastigmine|rivastigmine|mesh-list
20329835|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
20329836|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329837|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329838|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
20329839|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329840|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329841|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20329842|NCT00767091|Protective Agents|protective agents|mesh-ancestor
20329843|NCT00767117|Ritonavir|ritonavir|mesh-list
20329844|NCT00767117|Lopinavir|lopinavir|mesh-list
20329845|NCT00767117|Etravirine|etravirine|mesh-list
20329846|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20329847|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20329848|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
20329849|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329850|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329851|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19646909|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19646910|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
19646911|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
19646912|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646913|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646914|NCT02357004|Carvedilol|carvedilol|mesh-list
19646915|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
19646916|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19646917|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19646918|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
19646919|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646920|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329852|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20329853|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
19809732|NCT00451048|Sunitinib|sunitinib|mesh-list
20329854|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20329855|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20611674|NCT00408005|Vincristine|vincristine|mesh-list
20329856|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20329857|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20329858|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19809733|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809734|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809735|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809736|NCT00451048|Growth Substances|growth substances|mesh-ancestor
19809737|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809738|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809739|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809740|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809741|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809742|NCT00451178|Prednisone|prednisone|mesh-list
19809743|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
20329859|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
20329860|NCT00767169|Pamidronate|pamidronate|mesh-list
20329861|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20329862|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329863|NCT00767221|Budesonide|budesonide|mesh-list
20329864|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20329865|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20329866|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
20329867|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329868|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809744|NCT00451178|Rituximab|rituximab|mesh-list
19809745|NCT00451178|Doxorubicin|doxorubicin|mesh-list
19809746|NCT00451178|Vincristine|vincristine|mesh-list
19809747|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809748|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
19809749|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809750|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809751|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19809752|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
19809753|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809754|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809755|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19809756|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809757|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19809758|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20329869|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20329870|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
20329871|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
20329872|NCT00767221|Hormones|hormones|mesh-ancestor
20329873|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329874|NCT00767260|Insulin|insulin|mesh-list
20329875|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20329876|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329877|NCT00767286|Cobalt|cobalt|mesh-list
20329878|NCT00767286|Goserelin|goserelin|mesh-list
20329879|NCT00767286|Flutamide|flutamide|mesh-list
20329880|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20329881|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329882|NCT00767286|Trace Elements|trace elements|mesh-ancestor
20329883|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
20329884|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329885|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
19646921|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646922|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19646923|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
19646924|NCT02357004|Protective Agents|protective agents|mesh-ancestor
19646925|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19646926|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19646927|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19646928|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
19646929|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19646930|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19646931|NCT02357004|Diuretics|diuretics|mesh-ancestor
19646932|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
19809759|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19809760|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809761|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329886|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
20329887|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20329888|NCT00767468|Sorafenib|sorafenib|mesh-list
19809762|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
19809763|NCT00451178|Hormones|hormones|mesh-ancestor
19809764|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809765|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19809766|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19809767|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
19809768|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
19809769|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
19809770|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
19809771|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19809772|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19809773|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19809774|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809775|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809776|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
19809777|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809778|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809779|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19809780|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809781|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
19809782|NCT00451204|Estrogens|estrogens|mesh-list
19809783|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
19809784|NCT00451204|Hormones|hormones|mesh-ancestor
19809785|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809786|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809787|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19809788|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
19809789|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809790|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809791|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
19809792|NCT00451217|Neostigmine|neostigmine|mesh-list
19809793|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19809794|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809795|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809796|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
19809797|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809798|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809799|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19809800|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
19809801|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809802|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19809803|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19809804|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20164020|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
20164021|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20164022|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20164023|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164024|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20164025|NCT00133276|Citalopram|citalopram|mesh-list
20164026|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20164027|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19646933|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19646934|NCT02357069|Etanercept|etanercept|mesh-list
20329889|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329890|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20329891|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329892|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329893|NCT00767481|Travoprost|travoprost|mesh-list
20329894|NCT00767481|Brinzolamide|brinzolamide|mesh-list
20164028|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174373|NCT00164736|Zidovudine|zidovudine|mesh-list
20329895|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19646935|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19646936|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19646937|NCT02357069|Analgesics|analgesics|mesh-ancestor
20329896|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19646938|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
19646939|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646940|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646941|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19646942|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19646943|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19646944|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19646945|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
19646946|NCT02356913|Nicotine|nicotine|mesh-list
19646947|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19646948|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
19646949|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646950|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646951|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19646952|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19646953|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
19646954|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664450|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20329897|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329898|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329899|NCT00767494|Travoprost|travoprost|mesh-list
20329900|NCT00767494|Brinzolamide|brinzolamide|mesh-list
20329901|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20329902|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20329903|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329904|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329905|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
20329906|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20329907|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329908|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329909|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
20329910|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329911|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329912|NCT00767559|PENTA|penta|mesh-list
20329913|NCT00767559|Warfarin|warfarin|mesh-list
20329914|NCT00767559|Fondaparinux|fondaparinux|mesh-list
20329915|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
20329916|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20329917|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
20329918|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20329919|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
20329920|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329921|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329922|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20329923|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20329924|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
20329925|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20329926|NCT00767598|Udenafil|udenafil|mesh-list
20329927|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
20329928|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
20329929|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20329930|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329931|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329932|NCT00767598|Urological Agents|urological agents|mesh-ancestor
20329933|NCT00767663|Dipyridamole|dipyridamole|mesh-list
20329934|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20329935|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20329936|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329937|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20329938|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
20329939|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
20329940|NCT00767689|Pyridoxal|pyridoxal|mesh-list
20329941|NCT00767689|Pyridoxine|pyridoxine|mesh-list
20329942|NCT00767689|Vitamins|vitamins|mesh-ancestor
20329943|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
20329944|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329945|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
20329946|NCT00767715|Haloperidol|haloperidol|mesh-list
20329947|NCT00767715|Olanzapine|olanzapine|mesh-list
20329948|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
20329949|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
20329950|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
20329951|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329952|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329953|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20329954|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20329955|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20329956|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664451|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
19664452|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
19664453|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
19664454|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664455|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664456|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664457|NCT03477851|Tramadol|tramadol|mesh-list
20329957|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20329958|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20329959|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20329960|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329961|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329962|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329963|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
19809805|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
19809806|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19809807|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
19809808|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809809|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809810|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
19809811|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809812|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19809813|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809814|NCT00451555|Fulvestrant|fulvestrant|mesh-list
19809815|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19809816|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809817|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19809818|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19809819|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
19809820|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809821|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809822|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
19809823|NCT00451698|Hematinics|hematinics|mesh-ancestor
19809824|NCT00451906|Bevacizumab|bevacizumab|mesh-list
19809825|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809826|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809827|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19809828|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19809829|NCT00451906|Growth Substances|growth substances|mesh-ancestor
19809830|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809831|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
19809832|NCT00451958|Leuprolide|leuprolide|mesh-list
19809833|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19809834|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
19809835|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19809836|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329964|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20329965|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
20329966|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20329967|NCT00767728|Mesalamine|mesalamine|mesh-list
19809837|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19809838|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809839|NCT00452335|Lubiprostone|lubiprostone|mesh-list
19809840|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19809841|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809842|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809843|NCT00452348|Fluticasone|fluticasone|mesh-list
19809844|NCT00452348|Xhance|xhance|mesh-list
19809845|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19809846|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19809847|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809848|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19809849|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
19809850|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809851|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809852|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19809853|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
19809854|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809855|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20329968|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20329969|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20329970|NCT00767728|Analgesics|analgesics|mesh-ancestor
20329971|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
19646955|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646956|NCT02356965|Ketamine|ketamine|mesh-list
19646957|NCT02356965|Analgesics|analgesics|mesh-ancestor
19646958|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
19646959|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646960|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646961|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19646962|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20611675|NCT00408005|Daunorubicin|daunorubicin|mesh-list
20329972|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20329973|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329974|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20329975|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20329976|NCT00767754|Paroxetine|paroxetine|mesh-list
20329977|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20329978|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20329979|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329980|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329981|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329982|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
20329983|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329984|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20329985|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
20329986|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20329987|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20329988|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20329989|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809856|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19809857|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19809858|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19809859|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809860|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809861|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809862|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
19809863|NCT00452348|Hormones|hormones|mesh-ancestor
19809864|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809865|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
19809866|NCT00452374|Vidarabine|vidarabine|mesh-list
19809867|NCT00452374|Cytarabine|cytarabine|mesh-list
19809868|NCT00452374|Rituximab|rituximab|mesh-list
19809869|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
19809870|NCT00452374|Fludarabine|fludarabine|mesh-list
19809871|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
19809872|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19809873|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809874|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
20329990|NCT00767871|Citalopram|citalopram|mesh-list
20329991|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20329992|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20329993|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20329994|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20329995|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20329996|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
20329997|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20329998|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20329999|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
19646963|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
19646964|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
19646965|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19646966|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19646967|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19646968|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646969|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646970|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
19646971|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19646972|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
19646973|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19646974|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646975|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19646976|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
19646977|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19646978|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
19646979|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646980|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19646981|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19646982|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
19809875|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809876|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19809877|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809878|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
19809879|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809880|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19809881|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
19809882|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809883|NCT00452387|Prednisone|prednisone|mesh-list
19809884|NCT00452387|Sorafenib|sorafenib|mesh-list
19809885|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
19809886|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809887|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
19809888|NCT00452387|Hormones|hormones|mesh-ancestor
19809889|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19809890|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809891|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19809892|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809893|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809894|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809895|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809896|NCT00452387|Analgesics|analgesics|mesh-ancestor
19809897|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
19809898|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809899|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19809900|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19809901|NCT00452400|Olodaterol|olodaterol|mesh-list
19809902|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19809903|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
19809904|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809905|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809906|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19809907|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
19809908|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19809909|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809910|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809911|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809912|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809913|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
19809914|NCT00452426|Narcotics|narcotics|mesh-ancestor
19809915|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19809916|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809917|NCT00452426|Analgesics|analgesics|mesh-ancestor
19809918|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
19809919|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809920|NCT00452439|Vitamin D|vitamin d|mesh-list
19809921|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
19809922|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
19809923|NCT00452439|Calcium|calcium|mesh-list
19809924|NCT00452439|Vitamins|vitamins|mesh-ancestor
19809925|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
19809926|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330000|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20330001|NCT00767975|Rifampin|rifampin|mesh-list
20330002|NCT00767975|Isoniazid|isoniazid|mesh-list
20330003|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20330004|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
20330005|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330006|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19809927|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19809928|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19809929|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19809930|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809931|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809932|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20330007|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
20330008|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20330009|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330010|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330011|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20330012|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20330013|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19809933|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
19809934|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809935|NCT00452530|Enoxaparin|enoxaparin|mesh-list
20330014|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19646983|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
19646984|NCT02356835|Protective Agents|protective agents|mesh-ancestor
19646985|NCT02356445|Methotrexate|methotrexate|mesh-list
19646986|NCT02356445|Azathioprine|azathioprine|mesh-list
19646987|NCT02356445|Infliximab|infliximab|mesh-list
19646988|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19646989|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
19809936|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
19809937|NCT00452530|Apixaban|apixaban|mesh-list
19809938|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
19646990|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19809939|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19809940|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19809941|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809942|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19809943|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
19809944|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19809945|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
19809946|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809947|NCT00452543|Acamprosate|acamprosate|mesh-list
19809948|NCT00452543|Dexetimide|dexetimide|mesh-list
19809949|NCT00452543|Citalopram|citalopram|mesh-list
19809950|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19809951|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19809952|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19809953|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809954|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809955|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
19809956|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809957|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19809958|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
19809959|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19809960|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19809961|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19809962|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
19809963|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
19809964|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809965|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19809966|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20164029|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164030|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164031|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
20164032|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164033|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19809967|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
19809968|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19809969|NCT00452673|Capecitabine|capecitabine|mesh-list
19809970|NCT00452673|Dasatinib|dasatinib|mesh-list
19809971|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19809972|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
19809973|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809974|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19809975|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19809976|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19809977|NCT00452699|Fluticasone|fluticasone|mesh-list
19809978|NCT00452699|Xhance|xhance|mesh-list
19809979|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19809980|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19809981|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19809982|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
19809983|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19809984|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809985|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19809986|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
19809987|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809988|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19809989|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20164034|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
20164035|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20164036|NCT00133315|Adalimumab|adalimumab|mesh-list
19646991|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19646992|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19646993|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
19646994|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19646995|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19646996|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
19809990|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19809991|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19809992|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
19809993|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19809994|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19809995|NCT00452790|Vaccines|vaccines|mesh-list
19809996|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19809997|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
19809998|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19809999|NCT00452868|Donepezil|donepezil|mesh-list
19810000|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19810001|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810002|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810003|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
20330015|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20330016|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20330017|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20330018|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330019|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
20330020|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20330021|NCT00768131|Paclitaxel|paclitaxel|mesh-list
19810004|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810005|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810006|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
19810007|NCT00453102|Rituximab|rituximab|mesh-list
19810008|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19810009|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810010|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
19810011|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810012|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810013|NCT00453154|Cisplatin|cisplatin|mesh-list
19810014|NCT00453154|Carboplatin|carboplatin|mesh-list
19810015|NCT00453154|Etoposide|etoposide|mesh-list
19810016|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
19810017|NCT00453154|Sunitinib|sunitinib|mesh-list
19810018|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
19810019|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810020|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19810021|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19810022|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19810023|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810024|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810025|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810026|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810027|NCT00453154|Growth Substances|growth substances|mesh-ancestor
19810028|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810029|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810030|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810031|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
19810032|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
20330022|NCT00768131|Carboplatin|carboplatin|mesh-list
20330023|NCT00768131|Cetuximab|cetuximab|mesh-list
20330024|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20330025|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330026|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
20330027|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
20330028|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
20330029|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330030|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20330031|NCT00768157|Lamivudine|lamivudine|mesh-list
20330032|NCT00768157|Entecavir|entecavir|mesh-list
20330033|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
20330034|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20330035|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20330036|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330037|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330038|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330039|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20330040|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20330041|NCT00768183|Ethanol|ethanol|mesh-list
20330042|NCT00768183|Morphine|morphine|mesh-list
20330043|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19810033|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810034|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810035|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810036|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
20330044|NCT00768183|Narcotics|narcotics|mesh-ancestor
19810037|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19810038|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
19810039|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810040|NCT00453180|Expectorants|expectorants|mesh-ancestor
19810041|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
19810042|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19810043|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
19810044|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810045|NCT00453180|Protective Agents|protective agents|mesh-ancestor
19810046|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810047|NCT00453180|Antidotes|antidotes|mesh-ancestor
19810048|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
19810049|NCT00453193|Pentostatin|pentostatin|mesh-list
19810050|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19810051|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810052|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19810053|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810054|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810055|NCT00453310|Sunitinib|sunitinib|mesh-list
19810056|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810057|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810058|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810059|NCT00453310|Growth Substances|growth substances|mesh-ancestor
19810060|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810061|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810062|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810063|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810064|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810065|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19810066|NCT00453336|Trioxsalen|trioxsalen|mesh-list
19810067|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810068|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
19810069|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19810070|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
19810071|NCT00453349|Metronidazole|metronidazole|mesh-list
19810072|NCT00453349|Levofloxacin|levofloxacin|mesh-list
19810073|NCT00453349|Ofloxacin|ofloxacin|mesh-list
19810074|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19810075|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19810076|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810077|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19810078|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19810079|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810080|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810081|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810082|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19810083|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
19810084|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19810085|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810086|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19810087|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19810088|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19810089|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19810090|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19810091|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19810092|NCT00453349|Renal Agents|renal agents|mesh-ancestor
19810093|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19810094|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19810095|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19810096|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810097|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810098|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810099|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810100|NCT00453388|Cyclosporine|cyclosporine|mesh-list
19810101|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
19810102|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
19810103|NCT00453388|Fludarabine|fludarabine|mesh-list
19810104|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
19810105|NCT00453388|Cyclosporins|cyclosporins|mesh-list
19810106|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810107|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
19810108|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164037|NCT00133315|Etanercept|etanercept|mesh-list
19810109|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164038|NCT00133315|Infliximab|infliximab|mesh-list
20164039|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810110|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19810111|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
19810112|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810113|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810114|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19810115|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19810116|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
19810117|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810118|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
19810119|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810120|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
19810121|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19810122|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19810123|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19810124|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
19810125|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19810126|NCT00453895|Sunitinib|sunitinib|mesh-list
19810127|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810128|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810129|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810130|NCT00453895|Growth Substances|growth substances|mesh-ancestor
19810131|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330045|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330046|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330047|NCT00768183|Analgesics|analgesics|mesh-ancestor
20330048|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
20330049|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330050|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20330051|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330052|NCT00768209|Topiramate|topiramate|mesh-list
20330053|NCT00768209|Phentermine|phentermine|mesh-list
19646997|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19646998|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19646999|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647000|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
19647001|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19647002|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19647003|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647004|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
19647005|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
20330054|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
20330055|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19647006|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
19647007|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647008|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647009|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
19810132|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
20330056|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330057|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19647010|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647011|NCT02356679|Ethanol|ethanol|mesh-list
20164040|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164041|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164042|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164043|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20164044|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20164045|NCT00133315|Analgesics|analgesics|mesh-ancestor
20164046|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
20164047|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647012|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20164048|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164049|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164050|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
20164051|NCT00133328|Valsartan|valsartan|mesh-list
20164052|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20174374|NCT00164736|Nevirapine|nevirapine|mesh-list
19647013|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647014|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647015|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647016|NCT02356146|Tacrolimus|tacrolimus|mesh-list
19647017|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647018|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
19647019|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647020|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19647021|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664458|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19664459|NCT03477851|Narcotics|narcotics|mesh-ancestor
19664460|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664461|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664462|NCT03477851|Analgesics|analgesics|mesh-ancestor
19664463|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
19664464|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664465|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19664466|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
19664467|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664468|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
19664469|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664470|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664471|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
19664472|NCT03412188|Hormones|hormones|mesh-ancestor
19664473|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664474|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19664475|NCT03412188|Protective Agents|protective agents|mesh-ancestor
19664476|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19664477|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19664478|NCT03298945|Laxatives|laxatives|mesh-ancestor
19664479|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664480|NCT03250975|Azithromycin|azithromycin|mesh-list
19664481|NCT03250975|Budesonide|budesonide|mesh-list
19664482|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664483|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19664484|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
19664485|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664486|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664487|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19664488|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
19664489|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
19664490|NCT03250975|Hormones|hormones|mesh-ancestor
19664491|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664492|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19664493|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664494|NCT03218137|Adenosine|adenosine|mesh-list
19664495|NCT03218137|Verapamil|verapamil|mesh-list
19664496|NCT03218137|Analgesics|analgesics|mesh-ancestor
19664497|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
19664498|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664499|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664500|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19664501|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
19664502|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19664503|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
19664504|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
19664505|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664506|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664507|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20164053|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20164054|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20164055|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164056|NCT00133341|Parthenolide|parthenolide|mesh-list
20164057|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20164058|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20164059|NCT00133341|Analgesics|analgesics|mesh-ancestor
20164060|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
20164061|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810133|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810134|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810135|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810136|NCT00453921|Methylphenidate|methylphenidate|mesh-list
19810137|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19810138|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330058|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
20330059|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20330060|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
19810139|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19810140|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19810141|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810142|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810143|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
19810144|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810145|NCT00453999|Oseltamivir|oseltamivir|mesh-list
19810146|NCT00453999|Peramivir|peramivir|mesh-list
19810147|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
19810148|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810149|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810150|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810151|NCT00454051|Omalizumab|omalizumab|mesh-list
19810152|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19810153|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19810154|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
20330061|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
20330062|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330063|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330064|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330065|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330066|NCT00768391|Olaratumab|olaratumab|mesh-list
20330067|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330068|NCT00768404|Phentermine|phentermine|mesh-list
20330069|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19834578|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19834579|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19834580|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834581|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834582|NCT00595530|Ketamine|ketamine|mesh-list
19834583|NCT00595530|Analgesics|analgesics|mesh-ancestor
19834584|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
19834585|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834586|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164062|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164063|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164064|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164065|NCT00133354|Anastrozole|anastrozole|mesh-list
20164066|NCT00133354|Hormones|hormones|mesh-list
20164067|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164068|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330070|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330071|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
20164069|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164070|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164071|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19810155|NCT00454181|Interferons|interferons|mesh-list
19810156|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
19810157|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810158|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
19810159|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810160|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
19810161|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810162|NCT00454194|Pemetrexed|pemetrexed|mesh-list
19810163|NCT00454194|Sorafenib|sorafenib|mesh-list
19810164|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810165|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810166|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810167|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19810168|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19810169|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810170|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
19810171|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810172|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
19810173|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19810174|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19810175|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810176|NCT00454207|Urological Agents|urological agents|mesh-ancestor
19810177|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
19810178|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
19810179|NCT00454246|Hematinics|hematinics|mesh-ancestor
19810180|NCT00454324|Paclitaxel|paclitaxel|mesh-list
19810181|NCT00454324|Carboplatin|carboplatin|mesh-list
19810182|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19810183|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19810184|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810185|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810186|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810187|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810188|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810189|NCT00454584|Etanercept|etanercept|mesh-list
19810190|NCT00454584|Ustekinumab|ustekinumab|mesh-list
19810191|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19810192|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19810193|NCT00454584|Analgesics|analgesics|mesh-ancestor
19810194|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
19810195|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810196|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810197|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810198|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810199|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810200|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810201|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
19810202|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
19810203|NCT00454636|Cisplatin|cisplatin|mesh-list
19810204|NCT00454636|Docetaxel|docetaxel|mesh-list
19810205|NCT00454636|Capecitabine|capecitabine|mesh-list
19810206|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
19810207|NCT00454636|Epirubicin|epirubicin|mesh-list
19810208|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810209|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810210|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810211|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810212|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810213|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19810214|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
19810215|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19810216|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19810217|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19810218|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810219|NCT00454649|Gemcitabine|gemcitabine|mesh-list
19810220|NCT00454649|Paclitaxel|paclitaxel|mesh-list
19810221|NCT00454649|Docetaxel|docetaxel|mesh-list
19810222|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19810223|NCT00454649|Cisplatin|cisplatin|mesh-list
19810224|NCT00454649|Carboplatin|carboplatin|mesh-list
19810225|NCT00454649|Capecitabine|capecitabine|mesh-list
19810226|NCT00454649|Pemetrexed|pemetrexed|mesh-list
19810227|NCT00454649|Axitinib|axitinib|mesh-list
19810228|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19810229|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810230|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810231|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810232|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810233|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810234|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19810235|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
19810236|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
19810237|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810238|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810239|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810240|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
19810241|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810242|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19810243|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19810244|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810245|NCT00454779|Cisplatin|cisplatin|mesh-list
19810246|NCT00454779|Docetaxel|docetaxel|mesh-list
19810247|NCT00454779|Panitumumab|panitumumab|mesh-list
19810248|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810249|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810250|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810251|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810252|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810253|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19810254|NCT00454805|Fulvestrant|fulvestrant|mesh-list
19810255|NCT00454805|Cediranib|cediranib|mesh-list
19810256|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19810257|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810258|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19810259|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20330072|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20330073|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
20330074|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
20330075|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330076|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330077|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330078|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330079|NCT00768456|Ropivacaine|ropivacaine|mesh-list
20330080|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
20330081|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
20330082|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330083|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330084|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
20330085|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330086|NCT00768508|Naltrexone|naltrexone|mesh-list
20330087|NCT00768508|Ondansetron|ondansetron|mesh-list
20330088|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20330089|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20330090|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330091|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
20330092|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330093|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
20330094|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
20330095|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810260|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
19810261|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164072|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20164073|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164074|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164075|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20164076|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
20164077|NCT00133367|Sirolimus|sirolimus|mesh-list
20164078|NCT00133367|Fludarabine|fludarabine|mesh-list
20164079|NCT00133367|Melphalan|melphalan|mesh-list
20164080|NCT00133367|Tacrolimus|tacrolimus|mesh-list
20164081|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
20164082|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20164083|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164084|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164085|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164086|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
20164087|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164088|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20164089|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164090|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20164091|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330096|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
19647022|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647023|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19647024|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19647025|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
19647026|NCT02356419|Hematinics|hematinics|mesh-ancestor
19647027|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19647028|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19647029|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
19647030|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
19647031|NCT02355938|Vancomycin|vancomycin|mesh-list
19647032|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
19647033|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19647034|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647035|NCT02355704|Atorvastatin|atorvastatin|mesh-list
19647036|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19647037|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19647038|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
19647039|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647040|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19647041|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20330097|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
19810262|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810263|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810264|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810265|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810266|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
19810267|NCT00455013|Sirolimus|sirolimus|mesh-list
19810268|NCT00455013|Abatacept|abatacept|mesh-list
19810269|NCT00455013|Tacrolimus|tacrolimus|mesh-list
19810270|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
19810271|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810272|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
19810273|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810274|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19810275|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810276|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810277|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19810278|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810279|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19810280|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
19810281|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19810282|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810283|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
19810284|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19810285|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810286|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
19810287|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
20330098|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20330099|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
20330100|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330101|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330102|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20330103|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19810288|NCT00455312|Fludarabine|fludarabine|mesh-list
19810289|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
19810290|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
19810291|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19810292|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810293|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
19810294|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810295|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810296|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19810297|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
20330104|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330105|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19647042|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810298|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810299|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810300|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19810301|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810302|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
20164092|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20164093|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
20164094|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19810303|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
19810304|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810305|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810306|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
19810307|NCT00455312|Hormones|hormones|mesh-ancestor
19810308|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810309|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19810310|NCT00455312|Protective Agents|protective agents|mesh-ancestor
19810311|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19810312|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19810313|NCT00455520|Tapentadol|tapentadol|mesh-list
19810314|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19810315|NCT00455520|Narcotics|narcotics|mesh-ancestor
20164095|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
20164096|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20164097|NCT00133380|Atorvastatin|atorvastatin|mesh-list
20164098|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20164099|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330106|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19810316|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19810317|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810318|NCT00455520|Analgesics|analgesics|mesh-ancestor
19810319|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
19810320|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810321|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19810322|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19810323|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810324|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810325|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
19810326|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810327|NCT00455533|Paclitaxel|paclitaxel|mesh-list
19810328|NCT00455533|Epothilones|epothilones|mesh-list
19810329|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
19810330|NCT00455533|Doxorubicin|doxorubicin|mesh-list
19810331|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19810332|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810333|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810334|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810335|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810336|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810337|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164100|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
20330107|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
20330108|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
20330109|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20330110|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19647043|NCT02355678|Acetaminophen|acetaminophen|mesh-list
19647044|NCT02355678|Dexamethasone|dexamethasone|mesh-list
19647045|NCT02355678|Propacetamol|propacetamol|mesh-list
19647046|NCT02355678|Tramadol|tramadol|mesh-list
19647047|NCT02355678|Anesthetics|anesthetics|mesh-list
19647048|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
19647049|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647050|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
19647051|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
19647052|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647053|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647054|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647055|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
19647056|NCT02355678|Hormones|hormones|mesh-ancestor
19647057|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647058|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19647059|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647060|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647061|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19647062|NCT02355678|Analgesics|analgesics|mesh-ancestor
19647063|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
19647064|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
19647065|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19810338|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
20330111|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330112|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330113|NCT00768573|Urological Agents|urological agents|mesh-ancestor
20330114|NCT00768612|Risperidone|risperidone|mesh-list
20330115|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20330116|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
20330117|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330118|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330119|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330120|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20330121|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20330122|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330123|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20330124|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20330125|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
20330126|NCT00768638|Atorvastatin|atorvastatin|mesh-list
20330127|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20330128|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330129|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
20611676|NCT00408005|Asparaginase|asparaginase|mesh-list
19647066|NCT02355678|Narcotics|narcotics|mesh-ancestor
19647067|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19647068|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19664508|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19664509|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19666123|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666124|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
19666125|NCT02494921|Hormones|hormones|mesh-ancestor
19666126|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666127|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666128|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666129|NCT05104255|Anesthetics|anesthetics|mesh-list
19666130|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666131|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666132|NCT05104229|Aspirin|aspirin|mesh-list
19666133|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19666134|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666135|NCT05104229|Analgesics|analgesics|mesh-ancestor
19666136|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
19666137|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666138|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666139|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666140|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666141|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19666142|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19666143|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666144|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19666145|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19666146|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666147|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
19666148|NCT05104138|Eplerenone|eplerenone|mesh-list
19666149|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19666150|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
19666151|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666152|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666153|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19666154|NCT05104138|Diuretics|diuretics|mesh-ancestor
19666155|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
19666156|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19666249|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666250|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
19666251|NCT05092555|Coagulants|coagulants|mesh-ancestor
19666252|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
19666253|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19666254|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19666255|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666256|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
19666257|NCT05087199|Coagulants|coagulants|mesh-ancestor
19666258|NCT05060666|Ivermectin|ivermectin|mesh-list
19666259|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19666260|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666261|NCT05048134|Trametinib|trametinib|mesh-list
20330130|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330131|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20330132|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19647069|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19647070|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647071|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19647072|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647073|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647074|NCT02355522|Lidocaine|lidocaine|mesh-list
19647075|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
19647076|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
19647077|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647078|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647079|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
19647080|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664510|NCT03079999|Aspirin|aspirin|mesh-list
19664511|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19664512|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19664513|NCT03079999|Analgesics|analgesics|mesh-ancestor
19664514|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
19664515|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664516|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664517|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664518|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19664519|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19664520|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19664521|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664522|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19664523|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19664524|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664525|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
19664526|NCT02958709|Rifampin|rifampin|mesh-list
19664527|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19664528|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
19664529|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19664530|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664531|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
19664532|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19664533|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664534|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664535|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19664536|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19664537|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19664538|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19664539|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19664540|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19664541|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
19664542|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19664543|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
19664544|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19664545|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664546|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19664547|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19664548|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19664549|NCT02947581|Albendazole|albendazole|mesh-list
19664550|NCT02947581|Praziquantel|praziquantel|mesh-list
19664551|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
19664552|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19664553|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664554|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
19664555|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19664556|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19664557|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
19664558|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
19664559|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
19664560|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664561|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664562|NCT02861898|Cetuximab|cetuximab|mesh-list
19664563|NCT02861898|Mannitol|mannitol|mesh-list
19664564|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19664565|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810339|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810340|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810341|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19810342|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
19810343|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19810344|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19810345|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19810346|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19810347|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810348|NCT00455650|Mecamylamine|mecamylamine|mesh-list
19810349|NCT00455650|Varenicline|varenicline|mesh-list
19810350|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19810351|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19810352|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
19810353|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810354|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810355|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810356|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19810357|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20330133|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330134|NCT00768677|Topiramate|topiramate|mesh-list
20330135|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
19810358|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
19810359|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810360|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19810361|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19810362|NCT00455689|Leuprolide|leuprolide|mesh-list
19810363|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19810364|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
19810365|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19810366|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810367|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19810368|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810369|NCT00455702|Cycloserine|cycloserine|mesh-list
20330136|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330137|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347926|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20347927|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20347928|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20347929|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20347930|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
20347931|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347932|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810370|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19810371|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810372|NCT00455702|Renal Agents|renal agents|mesh-ancestor
19810373|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19810374|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
20347933|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347934|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20347935|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20347936|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20347937|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20347938|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347939|NCT00862472|Timolol|timolol|mesh-list
20347940|NCT00862472|Cloprostenol|cloprostenol|mesh-list
20347941|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
20347942|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20347943|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
20347944|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20347945|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810375|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19810376|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
19810377|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810378|NCT00455741|Estradiol|estradiol|mesh-list
19810379|NCT00455741|Progesterone|progesterone|mesh-list
19810380|NCT00455741|Estrogens|estrogens|mesh-ancestor
19810381|NCT00455741|Hormones|hormones|mesh-ancestor
19810382|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810383|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810384|NCT00455741|Progestins|progestins|mesh-ancestor
19810385|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
19810386|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19810387|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810388|NCT00455923|Fluticasone|fluticasone|mesh-list
20330138|NCT00768690|Ketoconazole|ketoconazole|mesh-list
20330139|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
20330140|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330141|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20330142|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20330143|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330144|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330145|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20330146|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
20330147|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330148|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611677|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
19647081|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19810389|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19810390|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19810391|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
19810392|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810393|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810394|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19810395|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19810396|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
19810397|NCT00455923|Hormones|hormones|mesh-ancestor
19810398|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810399|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
19810400|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810401|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
19810402|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19810403|NCT00455962|Estradiol|estradiol|mesh-list
19810404|NCT00455962|Progesterone|progesterone|mesh-list
19810405|NCT00455962|Estrogens|estrogens|mesh-ancestor
19810406|NCT00455962|Hormones|hormones|mesh-ancestor
20164101|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164102|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20164103|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20164104|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164105|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
20164106|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20164107|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164108|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164109|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20164110|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20164111|NCT00133393|Protective Agents|protective agents|mesh-ancestor
20164112|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164113|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
20164114|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20164115|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
20164116|NCT00133406|Vitamin A|vitamin a|mesh-list
20164117|NCT00133406|Glycine|glycine|mesh-list
20164118|NCT00133406|Vitamins|vitamins|mesh-ancestor
20164119|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
20164120|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174375|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19647082|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19647083|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19647084|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647085|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647086|NCT02355639|Betamethasone|betamethasone|mesh-list
19647087|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
19647088|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19647089|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
19647090|NCT02355639|Clobetasol|clobetasol|mesh-list
19647091|NCT02355639|Petrolatum|petrolatum|mesh-list
19647092|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19647093|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647094|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
19647095|NCT02355639|Hormones|hormones|mesh-ancestor
19647096|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647097|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647098|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19647099|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
19647100|NCT02355639|Emollients|emollients|mesh-ancestor
19647101|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
19647102|NCT02355509|Acarbose|acarbose|mesh-list
19810407|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810408|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810409|NCT00455962|Progestins|progestins|mesh-ancestor
19810410|NCT00455975|Bevacizumab|bevacizumab|mesh-list
19810411|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19810412|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810413|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810414|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810415|NCT00455975|Growth Substances|growth substances|mesh-ancestor
19810416|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810417|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810418|NCT00456014|Citalopram|citalopram|mesh-list
19810419|NCT00456014|Desipramine|desipramine|mesh-list
19810420|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19810421|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19810422|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810423|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810424|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647103|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19647104|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647105|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647106|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19647107|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647108|NCT02355184|Leronlimab|leronlimab|mesh-list
19647109|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19810425|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
19810426|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810427|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19810428|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
19810429|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19810430|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19810431|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810432|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19810433|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330149|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20330150|NCT00768729|Sirolimus|sirolimus|mesh-list
19647110|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19647111|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810434|NCT00456092|Apremilast|apremilast|mesh-list
19810435|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19810436|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19810437|NCT00456092|Analgesics|analgesics|mesh-ancestor
19810438|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
19810439|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810440|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810441|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810442|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810443|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19810444|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19810445|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810446|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810447|NCT00456300|Exenatide|exenatide|mesh-list
19810448|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19810449|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810450|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19810451|NCT00456300|Incretins|incretins|mesh-ancestor
19810452|NCT00456300|Hormones|hormones|mesh-ancestor
19810453|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810454|NCT00456365|Pravastatin|pravastatin|mesh-list
19810455|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19810456|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19810457|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
19810458|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810459|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19810460|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19810461|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810462|NCT00456495|Ranibizumab|ranibizumab|mesh-list
19810463|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20164121|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164122|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
19647112|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19647113|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19810464|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810465|NCT00456495|Growth Substances|growth substances|mesh-ancestor
19810466|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810467|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810468|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810469|NCT00456508|Ecallantide|ecallantide|mesh-list
19810470|NCT00456508|Analgesics|analgesics|mesh-ancestor
19810471|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
19810472|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810473|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810474|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19810475|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19810476|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810477|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810478|NCT00456521|Naltrexone|naltrexone|mesh-list
19810479|NCT00456521|Bupropion|bupropion|mesh-list
19810480|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19810481|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19810482|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810483|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
19810484|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810485|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19810486|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
19810487|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19810488|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19810489|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19810490|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810491|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810492|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
19810493|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810494|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19810495|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19810496|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810497|NCT00456599|Gemcitabine|gemcitabine|mesh-list
19810498|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
19810499|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19810500|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
19810501|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810502|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810503|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
19810504|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810505|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810506|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810507|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
19810508|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810509|NCT00456625|Vaccines|vaccines|mesh-list
19810510|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
19810511|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810512|NCT00456807|Vaccines|vaccines|mesh-list
19810513|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
19810514|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810515|NCT00456846|Paclitaxel|paclitaxel|mesh-list
19810516|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19647114|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
19647115|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647116|NCT02355236|Celecoxib|celecoxib|mesh-list
19647117|NCT02355236|Naproxen|naproxen|mesh-list
19647118|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19647119|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20164123|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164124|NCT00133419|Vitamins|vitamins|mesh-list
20164125|NCT00133419|Vitamin A|vitamin a|mesh-list
20164126|NCT00133419|Zinc|zinc|mesh-list
20164127|NCT00133419|Trace Elements|trace elements|mesh-list
20164128|NCT00133419|Micronutrients|micronutrients|mesh-list
20164129|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
20164130|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647120|NCT02355236|Analgesics|analgesics|mesh-ancestor
19647121|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
19647122|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647123|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647124|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810517|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164131|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
20164132|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647125|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810518|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810519|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810520|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810521|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810522|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810523|NCT00456885|Exenatide|exenatide|mesh-list
19810524|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19810525|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810526|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19810527|NCT00456885|Incretins|incretins|mesh-ancestor
19810528|NCT00456885|Hormones|hormones|mesh-ancestor
19810529|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810530|NCT00457002|Enoxaparin|enoxaparin|mesh-list
19810531|NCT00457002|Apixaban|apixaban|mesh-list
19810532|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
19810533|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19810534|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19810535|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810536|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19810537|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
19810538|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19810539|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
19810540|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810541|NCT00457015|Ecallantide|ecallantide|mesh-list
19810542|NCT00457015|Analgesics|analgesics|mesh-ancestor
19810543|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
19810544|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810545|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810546|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19810547|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19810548|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810549|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810550|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19810551|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
19810552|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19810553|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19810554|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19810555|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19810556|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810557|NCT00457366|Lorazepam|lorazepam|mesh-list
19810558|NCT00457366|Haloperidol|haloperidol|mesh-list
20330151|NCT00768729|Azathioprine|azathioprine|mesh-list
20330152|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330153|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330154|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20330155|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330156|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
20330157|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330158|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
20330159|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330160|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
20330161|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330162|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20330163|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20330164|NCT00768768|Terbinafine|terbinafine|mesh-list
20330165|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
19647126|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19647127|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19647128|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647129|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647130|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
19647131|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
19647132|NCT02355197|Vitamins|vitamins|mesh-ancestor
19647133|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
19647134|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647135|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
19647136|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647137|NCT02355197|Protective Agents|protective agents|mesh-ancestor
19647138|NCT02355119|Gemcitabine|gemcitabine|mesh-list
19647139|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19647140|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
19647141|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647142|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810559|NCT00457366|Benztropine|benztropine|mesh-list
19810560|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19810561|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
19810562|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
19810563|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19810564|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19810565|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19810566|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19810567|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810568|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
20330166|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330167|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330168|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330169|NCT00768859|Paclitaxel|paclitaxel|mesh-list
20330170|NCT00768859|Carboplatin|carboplatin|mesh-list
20330171|NCT00768859|Trastuzumab|trastuzumab|mesh-list
20330172|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20330173|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330174|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
20330175|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
20330176|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
20330177|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330178|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20330179|NCT00768911|Temozolomide|temozolomide|mesh-list
20330180|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20330181|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
20330182|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330183|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647143|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
19647144|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647145|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647146|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647147|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
19810569|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
19810570|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810571|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810572|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19810573|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
19810574|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810575|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810576|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19810577|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
19810578|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19810579|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19810580|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
19810581|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
19810582|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19810583|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
19810584|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19810585|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19810586|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
19810587|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19810588|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19810589|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810590|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19810591|NCT00457392|Sunitinib|sunitinib|mesh-list
19810592|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810593|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810594|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810595|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810596|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810597|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810598|NCT00457392|Growth Substances|growth substances|mesh-ancestor
19810599|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810600|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810601|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19810602|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
19810603|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810604|NCT00457626|Valsartan|valsartan|mesh-list
19810605|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19647148|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647149|NCT02355093|Ropivacaine|ropivacaine|mesh-list
19647150|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
19647151|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
19647152|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611678|NCT00408005|Pegaspargase|pegaspargase|mesh-list
19647153|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810606|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19810607|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19810608|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810609|NCT00457639|Cholic Acids|cholic acids|mesh-list
19810610|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810611|NCT00457665|Efavirenz|efavirenz|mesh-list
19810612|NCT00457665|Nelfinavir|nelfinavir|mesh-list
19810613|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19810614|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19810615|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810616|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810617|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
19810618|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810619|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19810620|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19810621|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19810622|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19810623|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19810624|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19810625|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19810626|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19810627|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
19810628|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19810629|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19810630|NCT00457691|Leucovorin|leucovorin|mesh-list
19810631|NCT00457691|Fluorouracil|fluorouracil|mesh-list
19810632|NCT00457691|Irinotecan|irinotecan|mesh-list
19810633|NCT00457691|Sunitinib|sunitinib|mesh-list
19647154|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
19647155|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647156|NCT02355054|Choline|choline|mesh-list
19647157|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
20330184|NCT00768937|Sorafenib|sorafenib|mesh-list
20330185|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330186|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20330187|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330188|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330189|NCT00768963|Ranibizumab|ranibizumab|mesh-list
20330190|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20330191|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19647158|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19647159|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
19810634|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
19810635|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
19810636|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810637|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19810638|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810639|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810640|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
19810641|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810642|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19810643|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19810644|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810645|NCT00457691|Antidotes|antidotes|mesh-ancestor
19810646|NCT00457691|Protective Agents|protective agents|mesh-ancestor
19810647|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
19810648|NCT00457691|Vitamins|vitamins|mesh-ancestor
19810649|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
19810650|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20330192|NCT00768963|Growth Substances|growth substances|mesh-ancestor
20330193|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647160|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647161|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647162|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19647163|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
19647164|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
19647165|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19647166|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19647167|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647168|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
19647169|NCT02354885|Coagulants|coagulants|mesh-ancestor
19647170|NCT02354768|Lanreotide|lanreotide|mesh-list
19647171|NCT02354768|Loperamide|loperamide|mesh-list
19647172|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
19810651|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810652|NCT00457691|Growth Substances|growth substances|mesh-ancestor
19647173|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810653|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810654|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810655|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19810656|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19810657|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19810658|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810659|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810660|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810661|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810662|NCT00457730|Analgesics|analgesics|mesh-ancestor
19810663|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
19810664|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810665|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
19810666|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19810667|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
19810668|NCT00457743|Sunitinib|sunitinib|mesh-list
19810669|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810670|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810671|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810672|NCT00457743|Growth Substances|growth substances|mesh-ancestor
19810673|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810674|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810675|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810676|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810677|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810678|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19810679|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19810680|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19810681|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19810682|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19810683|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
19810684|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810685|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810686|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810687|NCT00457821|Ivacaftor|ivacaftor|mesh-list
19810688|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19810689|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810690|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810691|NCT00457977|Vaccines|vaccines|mesh-list
19810692|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19810693|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
19810694|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810695|NCT00458211|Ziprasidone|ziprasidone|mesh-list
19810696|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19810697|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
19810698|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810699|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810700|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810701|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19810702|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19810703|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19810704|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19810705|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19810706|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
19810707|NCT00458237|Trastuzumab|trastuzumab|mesh-list
19810708|NCT00458237|Everolimus|everolimus|mesh-list
19810709|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19810710|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810711|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810712|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
19810713|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810714|NCT00458302|Darunavir|darunavir|mesh-list
19810715|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19810716|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19810717|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
19810718|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810719|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810720|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19810721|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19810722|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
19810723|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164133|NCT00133419|Protective Agents|protective agents|mesh-ancestor
20164134|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20330194|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
20330195|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330196|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
20330197|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330198|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330199|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20330200|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20330201|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330202|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330203|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330204|NCT00769054|Ropivacaine|ropivacaine|mesh-list
20330205|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
20330206|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
19810724|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19810725|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19810726|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19810727|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810728|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810729|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
19810730|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810731|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19810732|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19810733|NCT00458705|Thalidomide|thalidomide|mesh-list
19810734|NCT00458705|Dexamethasone|dexamethasone|mesh-list
19810735|NCT00458705|Doxorubicin|doxorubicin|mesh-list
19810736|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19810737|NCT00458705|Bortezomib|bortezomib|mesh-list
19810738|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810739|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
19810740|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
19810741|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810742|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810743|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810744|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
19810745|NCT00458705|Hormones|hormones|mesh-ancestor
19810746|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810747|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19810748|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259282|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19810749|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19810750|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19810751|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19810752|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810753|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810754|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810755|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
19810756|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
19810757|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19810758|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810759|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810760|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20330207|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330208|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330209|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
19810761|NCT00458705|Growth Substances|growth substances|mesh-ancestor
19810762|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810763|NCT00458822|Dexamethasone|dexamethasone|mesh-list
19810764|NCT00458822|Bortezomib|bortezomib|mesh-list
19810765|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810766|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
19810767|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
19810768|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810769|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810770|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810771|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
19810772|NCT00458822|Hormones|hormones|mesh-ancestor
19810773|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810774|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19810775|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810776|NCT00458848|Prednisone|prednisone|mesh-list
19810777|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
19810778|NCT00458848|Methotrexate|methotrexate|mesh-list
19810779|NCT00458848|Etoposide|etoposide|mesh-list
19810780|NCT00458848|Vincristine|vincristine|mesh-list
19810781|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
19810782|NCT00458848|Daunorubicin|daunorubicin|mesh-list
19810783|NCT00458848|Asparaginase|asparaginase|mesh-list
19810784|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
19810785|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
19810786|NCT00458848|Idarubicin|idarubicin|mesh-list
19810787|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810788|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
19810789|NCT00458848|Hormones|hormones|mesh-ancestor
19810790|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810791|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810792|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19810793|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810794|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19810795|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
19810796|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19810797|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19810798|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
19810799|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810800|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
19810801|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810802|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19810803|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810804|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
19810805|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810806|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19810807|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19810808|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19810809|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19810810|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810811|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810812|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810813|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
19810814|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
19810815|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810816|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810817|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19810818|NCT00458848|Protective Agents|protective agents|mesh-ancestor
19810819|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810820|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19810821|NCT00458848|Analgesics|analgesics|mesh-ancestor
19810822|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
19810823|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19810824|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810825|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810826|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810827|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19810828|NCT00459043|Docetaxel|docetaxel|mesh-list
19810829|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810830|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810831|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810832|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
20330210|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330211|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19810833|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810834|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19810835|NCT00459056|Carvedilol|carvedilol|mesh-list
19810836|NCT00459056|Lisinopril|lisinopril|mesh-list
19810837|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19810838|NCT00459056|Diuretics|diuretics|mesh-ancestor
19810839|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
19810840|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810841|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19810842|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19810843|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330212|NCT00769093|Hematinics|hematinics|mesh-ancestor
20330213|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20330214|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20330215|NCT00769145|Ranibizumab|ranibizumab|mesh-list
20330216|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20330217|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20330218|NCT00769145|Growth Substances|growth substances|mesh-ancestor
20330219|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330220|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
20330221|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330222|NCT00769158|Topiramate|topiramate|mesh-list
20330223|NCT00769158|Naltrexone|naltrexone|mesh-list
20330224|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20330225|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20330226|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330227|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
20330228|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330229|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
20330230|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330231|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
20330232|NCT00769171|Metronidazole|metronidazole|mesh-list
20330233|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
20330234|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20330235|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330236|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330237|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20330238|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20330239|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330240|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330241|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330242|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19810844|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19810845|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19810846|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
19810847|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810848|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
19810849|NCT00459056|Protective Agents|protective agents|mesh-ancestor
19810850|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19810851|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19810852|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
19810853|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19810854|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19810855|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19810856|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
19810857|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810858|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19810859|NCT00459108|Dasatinib|dasatinib|mesh-list
19810860|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810861|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810862|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810863|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810864|NCT00459186|Prednisone|prednisone|mesh-list
19810865|NCT00459186|Docetaxel|docetaxel|mesh-list
19810866|NCT00459186|Everolimus|everolimus|mesh-list
19810867|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810868|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810869|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810870|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810871|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810872|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810873|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
19810874|NCT00459186|Hormones|hormones|mesh-ancestor
19810875|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810876|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810877|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20330243|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
20611679|NCT00408005|Thioguanine|thioguanine|mesh-list
19810878|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810879|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
19810880|NCT00459290|Mifepristone|mifepristone|mesh-list
19810881|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19810882|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
19810883|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19810884|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810885|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19810886|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19810887|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19810888|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
19810889|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20330244|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20330245|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330246|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20330247|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20330248|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20330249|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20330250|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20330251|NCT00769210|Simvastatin|simvastatin|mesh-list
20330252|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20330253|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330254|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
20330255|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330256|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20330257|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19810890|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19810891|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
19810892|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810893|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
20330258|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330259|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
20330260|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
20330261|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
20330262|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330263|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
19810894|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19810895|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19810896|NCT00459342|Dasatinib|dasatinib|mesh-list
19810897|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810898|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810899|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810900|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810901|NCT00459537|Terbinafine|terbinafine|mesh-list
19810902|NCT00459537|Amorolfine|amorolfine|mesh-list
19810903|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
20330264|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330265|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
20330266|NCT00769288|Growth Substances|growth substances|mesh-ancestor
20330267|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330268|NCT00769405|Leucovorin|leucovorin|mesh-list
19647174|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647175|NCT02354807|Mirabegron|mirabegron|mesh-list
19647176|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19647177|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19647178|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19647179|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
19647180|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647181|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647182|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647183|NCT02354807|Urological Agents|urological agents|mesh-ancestor
19647184|NCT02354937|Cabotegravir|cabotegravir|mesh-list
19647185|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19647186|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19259283|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19810904|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810905|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810906|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810907|NCT00459667|Interferons|interferons|mesh-list
19810908|NCT00459667|Interferon-beta|interferon-beta|mesh-list
19810909|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
19810910|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810911|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
19810912|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164135|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164136|NCT00133445|Vaccines|vaccines|mesh-list
20164137|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
20164138|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810913|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
19810914|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810915|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19810916|NCT00459706|Etanercept|etanercept|mesh-list
19810917|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19810918|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19810919|NCT00459706|Analgesics|analgesics|mesh-ancestor
19810920|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
19810921|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810922|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810923|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810924|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19810925|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19810926|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19810927|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
19810928|NCT00459732|Zinc|zinc|mesh-list
19810929|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
19810930|NCT00459732|Trace Elements|trace elements|mesh-ancestor
19810931|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
19810932|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810933|NCT00459732|Astringents|astringents|mesh-ancestor
19810934|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
19810935|NCT00459810|Paclitaxel|paclitaxel|mesh-list
19810936|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19810937|NCT00459810|Estradiol|estradiol|mesh-list
19810938|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19810939|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810940|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
19810941|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
19810942|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
19810943|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810944|NCT00459810|Estrogens|estrogens|mesh-ancestor
19810945|NCT00459810|Hormones|hormones|mesh-ancestor
19810946|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19810947|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810948|NCT00459875|Sunitinib|sunitinib|mesh-list
19810949|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810950|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810951|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810952|NCT00459875|Growth Substances|growth substances|mesh-ancestor
19810953|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810954|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810955|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810956|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810957|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810958|NCT00459953|Nicotine|nicotine|mesh-list
19810959|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19810960|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
19810961|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19810962|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810963|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19810964|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19810965|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19810966|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19810967|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810968|NCT00459979|Sunitinib|sunitinib|mesh-list
19810969|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810970|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810971|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20164139|NCT00133458|Albendazole|albendazole|mesh-list
20164140|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
20164141|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19810972|NCT00459979|Growth Substances|growth substances|mesh-ancestor
19810973|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810974|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810975|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19810976|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810977|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810978|NCT00460031|Ketoconazole|ketoconazole|mesh-list
19810979|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
19810980|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19810981|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19810982|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19810983|NCT00460031|Lenalidomide|lenalidomide|mesh-list
19810984|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
19810985|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19810986|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19810987|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19810988|NCT00460031|Growth Substances|growth substances|mesh-ancestor
19810989|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
19810990|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19810991|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19810992|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
19810993|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19810994|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19810995|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19810996|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19810997|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19810998|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20330269|NCT00769405|Fluorouracil|fluorouracil|mesh-list
20330270|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
20330271|NCT00769405|Calcium|calcium|mesh-list
20330272|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
20330273|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20330274|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330275|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
20330276|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330277|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20330278|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330279|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330280|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
20330281|NCT00769405|Antidotes|antidotes|mesh-ancestor
20330282|NCT00769405|Protective Agents|protective agents|mesh-ancestor
20330283|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
20330284|NCT00769405|Vitamins|vitamins|mesh-ancestor
20330285|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
20330286|NCT00769470|Carboplatin|carboplatin|mesh-list
20330287|NCT00769470|Docetaxel|docetaxel|mesh-list
20330288|NCT00769470|Trastuzumab|trastuzumab|mesh-list
20330289|NCT00769470|Lapatinib|lapatinib|mesh-list
20330290|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330291|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20330292|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20330293|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20330294|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330295|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20330296|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20330297|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330298|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
20330299|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20330300|NCT00769522|Rituximab|rituximab|mesh-list
20330301|NCT00769522|Fludarabine|fludarabine|mesh-list
20330302|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330303|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
20330304|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330305|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20330306|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20330307|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
19810999|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
19811000|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811001|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19811002|NCT00460109|Rituximab|rituximab|mesh-list
19811003|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
20330308|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330309|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330310|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20330311|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811004|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811005|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811006|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
19811007|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811008|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834587|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19834588|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19834589|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
19834590|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
19834591|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834592|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19834593|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19834594|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834595|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834596|NCT00595556|Zonisamide|zonisamide|mesh-list
20330312|NCT00769548|Goserelin|goserelin|mesh-list
20330313|NCT00769548|Flutamide|flutamide|mesh-list
20330314|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20330315|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330316|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
20330317|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
20330318|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330319|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330320|NCT00769587|Thalidomide|thalidomide|mesh-list
20330321|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330322|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
20330323|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330324|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
20330325|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330326|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330327|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19647187|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647188|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647189|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19647190|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19834597|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
19834598|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19834599|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834600|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834601|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19834602|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834603|NCT00595790|Vaccines|vaccines|mesh-list
19834604|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
19834605|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834606|NCT00595868|Varenicline|varenicline|mesh-list
19834607|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19834608|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19834609|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
19834610|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834611|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834612|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834613|NCT00595946|Lubiprostone|lubiprostone|mesh-list
19834614|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19834615|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647191|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
19647192|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647193|NCT02354950|Cabotegravir|cabotegravir|mesh-list
19647194|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19647195|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19647196|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647197|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647198|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19647199|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19647200|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
19647201|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647202|NCT02354872|Nicotine|nicotine|mesh-list
19647203|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19647204|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
19647205|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647206|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835527|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20330328|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20330329|NCT00769587|Growth Substances|growth substances|mesh-ancestor
20330330|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
20330331|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330332|NCT00769873|Heparin|heparin|mesh-list
19811009|NCT00460239|Morphine|morphine|mesh-list
19811010|NCT00460239|Buprenorphine|buprenorphine|mesh-list
19811011|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19811012|NCT00460239|Narcotics|narcotics|mesh-ancestor
19811013|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811014|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811015|NCT00460239|Analgesics|analgesics|mesh-ancestor
19811016|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
19811017|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811018|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19811019|NCT00460551|Zalutumumab|zalutumumab|mesh-list
19811020|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811021|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811022|NCT00460577|Bromides|bromides|mesh-list
19811023|NCT00460577|Fenoterol|fenoterol|mesh-list
19811024|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
19811025|NCT00460577|Ipratropium|ipratropium|mesh-list
19811026|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19811027|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
19811028|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811029|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811030|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19811031|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
19811032|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19811033|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19811034|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19811035|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
19811036|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811037|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811038|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
19811039|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19811040|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
19811041|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
19811042|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
19811043|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19811044|NCT00460603|Bevacizumab|bevacizumab|mesh-list
19811045|NCT00460603|Axitinib|axitinib|mesh-list
19811046|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811047|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811048|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811049|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811050|NCT00460603|Growth Substances|growth substances|mesh-ancestor
19811051|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811052|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
20330333|NCT00769873|Enoxaparin|enoxaparin|mesh-list
20330334|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20330335|NCT00769873|Tinzaparin|tinzaparin|mesh-list
20330336|NCT00769873|Dalteparin|dalteparin|mesh-list
20330337|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
20330338|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19647207|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19647208|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19647209|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
19647210|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647211|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647212|NCT02354638|Nicotine|nicotine|mesh-list
19647213|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19647214|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
19647215|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647216|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647217|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19647218|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19647219|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
19647220|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647221|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647222|NCT02354612|Bevacizumab|bevacizumab|mesh-list
19647223|NCT02354612|Capecitabine|capecitabine|mesh-list
19647224|NCT02354612|Axitinib|axitinib|mesh-list
19647225|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19647226|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811053|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811054|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330339|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20611680|NCT00408005|BB 1101|bb 1101|mesh-list
20347946|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19811055|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811056|NCT00460746|Ritonavir|ritonavir|mesh-list
19811057|NCT00460746|Darunavir|darunavir|mesh-list
19811058|NCT00460746|Etravirine|etravirine|mesh-list
19811059|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19811060|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19811061|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
19811062|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811063|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811064|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19811065|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19811066|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
19811067|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811068|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19811069|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19811070|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19811071|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19811072|NCT00460798|Sunitinib|sunitinib|mesh-list
19811073|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811074|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811075|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811076|NCT00460798|Growth Substances|growth substances|mesh-ancestor
19811077|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811078|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811079|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811080|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811081|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811082|NCT00460811|Linaclotide|linaclotide|mesh-list
19811083|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19811084|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
19811085|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811086|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19811087|NCT00460993|Eszopiclone|eszopiclone|mesh-list
19811088|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19811089|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811090|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811091|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19811092|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
19811093|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19811094|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19811095|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811096|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164142|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164143|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
20164144|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20164145|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20164146|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
20164147|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
20164148|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
20164149|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164150|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164151|NCT00133523|Vaccines|vaccines|mesh-list
20164152|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
20164153|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811097|NCT00461123|Urological Agents|urological agents|mesh-ancestor
19811098|NCT00461253|Copper|copper|mesh-list
19811099|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
19811100|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19811101|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
19811102|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19811103|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647227|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19647228|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19647229|NCT02354612|Growth Substances|growth substances|mesh-ancestor
19647230|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647231|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
19647232|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19647233|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
19647234|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647235|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19647236|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647237|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
19647238|NCT02354547|Topotecan|topotecan|mesh-list
19647239|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647240|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
19647241|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811104|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19811105|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19811106|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19811107|NCT00461253|Trace Elements|trace elements|mesh-ancestor
19811108|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
19811109|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
19811110|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19811111|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19811112|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19811113|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19811114|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811115|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
19811116|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811117|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811118|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19811119|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811120|NCT00461305|Drospirenone|drospirenone|mesh-list
19811121|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19811122|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
19811123|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811124|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811125|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19811126|NCT00461305|Diuretics|diuretics|mesh-ancestor
19811127|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
19811128|NCT00461331|Insulin|insulin|mesh-list
19811129|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19811130|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
19811131|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
19811132|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19811133|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
19811134|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19811135|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811136|NCT00461500|Fluticasone|fluticasone|mesh-list
19811137|NCT00461500|Xhance|xhance|mesh-list
19811138|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19811139|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811140|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20164154|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19811141|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
19835528|NCT00603447|Growth Substances|growth substances|mesh-ancestor
20164155|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
20164156|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164157|NCT00133562|Glycine|glycine|mesh-list
20164158|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
20164159|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164160|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811142|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811143|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811144|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19811145|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
19811146|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
19811147|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19811148|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19811149|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19811150|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19811151|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
19811152|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811153|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811154|NCT00461591|Apaziquone|apaziquone|mesh-list
19811155|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811156|NCT00461630|Niacin|niacin|mesh-list
19811157|NCT00461630|Simvastatin|simvastatin|mesh-list
19811158|NCT00461630|Ezetimibe|ezetimibe|mesh-list
19811159|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19811160|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19811161|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19811162|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
19811163|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811164|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19811165|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19811166|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811167|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
19811168|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
19811169|NCT00461630|Vitamins|vitamins|mesh-ancestor
19811170|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
19811171|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811172|NCT00461708|Gemcitabine|gemcitabine|mesh-list
19811173|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19811174|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811175|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
19811176|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811177|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811178|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
19811179|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811180|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811181|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811182|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
19811183|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811184|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811185|NCT00461773|Bevacizumab|bevacizumab|mesh-list
19811186|NCT00461773|Letrozole|letrozole|mesh-list
19811187|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811188|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811189|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811190|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811191|NCT00461773|Growth Substances|growth substances|mesh-ancestor
19811192|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811193|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811194|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19811195|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19811196|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811197|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811198|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19811199|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
19811200|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811201|NCT00461786|Pemetrexed|pemetrexed|mesh-list
19811202|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811203|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811204|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811205|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19811206|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19811207|NCT00461851|Gemcitabine|gemcitabine|mesh-list
19811208|NCT00461851|Carboplatin|carboplatin|mesh-list
19811209|NCT00461851|Sorafenib|sorafenib|mesh-list
20164161|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164162|NCT00133627|Ketotifen|ketotifen|mesh-list
20164163|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
20164164|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164165|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20164166|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
19811210|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647242|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19647243|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19647244|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
19647245|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647246|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647247|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19647248|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19647249|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19647250|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647251|NCT02354313|Lenalidomide|lenalidomide|mesh-list
19811211|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811212|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
19811213|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811214|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
19811215|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811216|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811217|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811218|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
19811219|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811220|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811221|NCT00461981|Vaccines|vaccines|mesh-list
19811222|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
19811223|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811224|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19811225|NCT00462020|Metronidazole|metronidazole|mesh-list
19811226|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
19811227|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
19811228|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
19811229|NCT00462020|Ampicillin|ampicillin|mesh-list
19811230|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19811231|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811232|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
19811233|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19811234|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19811235|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164167|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
20164168|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811236|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811237|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19811238|NCT00462072|Infliximab|infliximab|mesh-list
19811239|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
19811240|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19811241|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19811242|NCT00462228|Memantine|memantine|mesh-list
19811243|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19811244|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19811245|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
19811246|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811247|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811248|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811249|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19811250|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19811251|NCT00462280|Lovastatin|lovastatin|mesh-list
19811252|NCT00462280|L 647318|l 647318|mesh-list
19811253|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
19811254|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19811255|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19811256|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
19811257|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811258|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19811259|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19811260|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811261|NCT00462332|Vidarabine|vidarabine|mesh-list
19811262|NCT00462332|Fludarabine|fludarabine|mesh-list
19811263|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
19811264|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
19811265|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811266|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811267|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
20164169|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164170|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164171|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20164172|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
20164173|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20164174|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164175|NCT00133640|Vitamins|vitamins|mesh-ancestor
19811268|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811269|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811270|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
19811271|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811272|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
19811273|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164176|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
20164177|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20164178|NCT00133692|Atenolol|atenolol|mesh-list
20330340|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811274|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811275|NCT00462345|Rituximab|rituximab|mesh-list
19811276|NCT00462345|Methotrexate|methotrexate|mesh-list
19811277|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811278|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811279|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
19811280|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811281|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20330341|NCT00769990|Genistein|genistein|mesh-list
20330342|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20330343|NCT00769990|Protective Agents|protective agents|mesh-ancestor
20330344|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330345|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330346|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20330347|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811282|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19811283|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
19811284|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19811285|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811286|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
19811287|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811288|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
19811289|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811290|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19811291|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811292|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19811293|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
19811294|NCT00462384|Hematinics|hematinics|mesh-ancestor
19811295|NCT00462423|Bevacizumab|bevacizumab|mesh-list
19811296|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19811297|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811298|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330348|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330349|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
20330350|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20330351|NCT00769990|Estrogens|estrogens|mesh-ancestor
20330352|NCT00769990|Hormones|hormones|mesh-ancestor
20330353|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330354|NCT00770042|Ritonavir|ritonavir|mesh-list
20330355|NCT00770042|Ketoconazole|ketoconazole|mesh-list
20330356|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20330357|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20330358|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19811299|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811300|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811301|NCT00462423|Growth Substances|growth substances|mesh-ancestor
19811302|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811303|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811304|NCT00462462|Ethanol|ethanol|mesh-list
19811305|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19811306|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811307|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811308|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811309|NCT00462501|Leucovorin|leucovorin|mesh-list
19811310|NCT00462501|Bevacizumab|bevacizumab|mesh-list
19811311|NCT00462501|Fluorouracil|fluorouracil|mesh-list
20164179|NCT00133692|Verapamil|verapamil|mesh-list
20164180|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20164181|NCT00133692|Trandolapril|trandolapril|mesh-list
20164182|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20164183|NCT00133692|Diuretics|diuretics|mesh-ancestor
20164184|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
20611681|NCT00408005|Calcium|calcium|mesh-list
20164185|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811312|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
19811313|NCT00462501|Calcium|calcium|mesh-list
19811314|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
19811315|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811316|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811317|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811318|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811319|NCT00462501|Growth Substances|growth substances|mesh-ancestor
19811320|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811321|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811322|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19811323|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
19811324|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811325|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811326|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811327|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
19811328|NCT00462501|Antidotes|antidotes|mesh-ancestor
19811329|NCT00462501|Protective Agents|protective agents|mesh-ancestor
19811330|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
19811331|NCT00462501|Vitamins|vitamins|mesh-ancestor
19811332|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
19811333|NCT00462605|Entinostat|entinostat|mesh-list
19811334|NCT00462605|Sargramostim|sargramostim|mesh-list
19811335|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19811336|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
19811337|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811338|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811339|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811340|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811341|NCT00462644|Fentanyl|fentanyl|mesh-list
19811342|NCT00462644|Midazolam|midazolam|mesh-list
19811343|NCT00462644|Etomidate|etomidate|mesh-list
19811344|NCT00462644|Succinylcholine|succinylcholine|mesh-list
19811345|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19811346|NCT00462644|Narcotics|narcotics|mesh-ancestor
19811347|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811348|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811349|NCT00462644|Analgesics|analgesics|mesh-ancestor
19811350|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
19811351|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811352|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19811353|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19811354|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
19811355|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
19811356|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19811357|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19811358|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19811359|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19811360|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
19811361|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
19811362|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811363|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811364|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19811365|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19811366|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19811367|NCT00462670|Tolvaptan|tolvaptan|mesh-list
19811368|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19811369|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811370|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
19811371|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811372|NCT00462709|Complement C1s|complement c1s|mesh-list
19811373|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19811374|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19811375|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
19811376|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811377|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19811378|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811379|NCT00462722|Ibuprofen|ibuprofen|mesh-list
19811380|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19811381|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19811382|NCT00462722|Analgesics|analgesics|mesh-ancestor
19811383|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
19811384|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811385|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811386|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811387|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19811388|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19811389|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811390|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811391|NCT00462735|Fluorouracil|fluorouracil|mesh-list
19811392|NCT00462735|Cetuximab|cetuximab|mesh-list
20330359|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330360|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330361|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20330362|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20330363|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
20330364|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330365|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20330366|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20330367|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
20330368|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20330369|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20330370|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
20330371|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330372|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330373|NCT00770107|Thiamine|thiamine|mesh-list
20330374|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
20330375|NCT00770107|Vitamins|vitamins|mesh-ancestor
20330376|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
20330377|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330378|NCT00770172|Lenograstim|lenograstim|mesh-list
20330379|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20330380|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
20330381|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330382|NCT00770263|Sirolimus|sirolimus|mesh-list
20330383|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20330384|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330385|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20330386|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330387|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647252|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
19647253|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647254|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19647255|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19647256|NCT02354313|Growth Substances|growth substances|mesh-ancestor
19647257|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
20164186|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20164187|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647258|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647259|NCT02354560|Erythromycin|erythromycin|mesh-list
19647260|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
19647261|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19647262|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
19811393|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
19811394|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
19811395|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811396|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811397|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811398|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811399|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
19811400|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811401|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811402|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
19811403|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164188|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164189|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20164190|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
20164191|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
20164192|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164193|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20164194|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20164195|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19647263|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20164196|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
20164197|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164198|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20164199|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20164200|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
20330388|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19811404|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19811405|NCT00462826|Aflibercept|aflibercept|mesh-list
19811406|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
19811407|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811408|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811409|NCT00462826|Growth Substances|growth substances|mesh-ancestor
19811410|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811411|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811412|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811413|NCT00462865|Gemcitabine|gemcitabine|mesh-list
19811414|NCT00462865|Bevacizumab|bevacizumab|mesh-list
19811415|NCT00462865|Capecitabine|capecitabine|mesh-list
19811416|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811417|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811418|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811419|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811420|NCT00462865|Growth Substances|growth substances|mesh-ancestor
19811421|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811422|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811423|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811424|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
19811425|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811426|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
19811427|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811428|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811429|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811430|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
19811431|NCT00462982|Sunitinib|sunitinib|mesh-list
19811432|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811433|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811434|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811435|NCT00462982|Growth Substances|growth substances|mesh-ancestor
19811436|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811437|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811438|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811439|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811440|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811441|NCT00463047|Fentanyl|fentanyl|mesh-list
19811442|NCT00463047|Oxycodone|oxycodone|mesh-list
19811443|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19811444|NCT00463047|Narcotics|narcotics|mesh-ancestor
19811445|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811446|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811447|NCT00463047|Analgesics|analgesics|mesh-ancestor
19811448|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
19811449|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811450|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19811451|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19811452|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
19811453|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
19811454|NCT00463060|Sunitinib|sunitinib|mesh-list
19811455|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811456|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811457|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811458|NCT00463060|Growth Substances|growth substances|mesh-ancestor
19811459|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811460|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811461|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811462|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811463|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811464|NCT00463151|Rebamipide|rebamipide|mesh-list
19811465|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19811466|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19811467|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
19811468|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811469|NCT00463151|Protective Agents|protective agents|mesh-ancestor
19811470|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811471|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811472|NCT00463346|Acamprosate|acamprosate|mesh-list
19811473|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19811474|NCT00463385|Thalidomide|thalidomide|mesh-list
19811475|NCT00463385|Prednisone|prednisone|mesh-list
19811476|NCT00463385|Pomalidomide|pomalidomide|mesh-list
19811477|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811478|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
19811479|NCT00463385|Hormones|hormones|mesh-ancestor
19835529|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811480|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811481|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811482|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19811483|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164201|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20164202|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19811484|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
19811485|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811486|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811487|NCT00463385|Growth Substances|growth substances|mesh-ancestor
19811488|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
20164203|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164204|NCT00133731|Heparin|heparin|mesh-list
20164205|NCT00133731|Calcium heparin|calcium heparin|mesh-list
20164206|NCT00133731|Otamixaban|otamixaban|mesh-list
20164207|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
20164208|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20164209|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20164210|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164211|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20164212|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
20164213|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20164214|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
20164215|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164216|NCT00133744|Folic Acid|folic acid|mesh-list
20164217|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
20164218|NCT00133744|Vitamins|vitamins|mesh-ancestor
20164219|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
20164220|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330389|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330390|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20330391|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
20330392|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330393|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
20330394|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330395|NCT00770302|Saxagliptin|saxagliptin|mesh-list
20330396|NCT00770302|Incretins|incretins|mesh-ancestor
20330397|NCT00770302|Hormones|hormones|mesh-ancestor
20330398|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330399|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811489|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811490|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
19811491|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19811492|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811493|NCT00463437|Vaccines|vaccines|mesh-list
19811494|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19811495|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
19811496|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811497|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
19811498|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
19811499|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19811500|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
19811501|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811502|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811503|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19811504|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
19811505|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19811506|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19811507|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19811508|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
19811509|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811510|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811511|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
19811512|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19811513|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
19811514|NCT00463580|Infliximab|infliximab|mesh-list
19811515|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
19811516|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19811517|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19811518|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
19811519|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19811520|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
19811521|NCT00463606|Calcium|calcium|mesh-list
19835530|NCT00603473|Gabapentin|gabapentin|mesh-list
20164221|NCT00133744|Hematinics|hematinics|mesh-ancestor
20164222|NCT00133757|Bupropion|bupropion|mesh-list
20330400|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19811522|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19811523|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811524|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19811525|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19811526|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19811527|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
19811528|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811529|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19811530|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19811531|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811532|NCT00463684|Vaccines|vaccines|mesh-list
19811533|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
19811534|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811535|NCT00463788|Cisplatin|cisplatin|mesh-list
19811536|NCT00463788|Cetuximab|cetuximab|mesh-list
19811537|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811538|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811539|NCT00463801|Daptomycin|daptomycin|mesh-list
19811540|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19811541|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811542|NCT00463840|Fluorouracil|fluorouracil|mesh-list
19811543|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
19811544|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
19811545|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811546|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19811547|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811548|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19811549|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
19811550|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811551|NCT00463866|Budesonide|budesonide|mesh-list
19811552|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
19811553|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811554|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19811555|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
19811556|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811557|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811558|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19811559|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
19811560|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
19811561|NCT00463866|Hormones|hormones|mesh-ancestor
19811562|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811563|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19811564|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19811565|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19811566|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
19811567|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811568|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811569|NCT00464087|Heparin|heparin|mesh-list
19811570|NCT00464087|Calcium heparin|calcium heparin|mesh-list
19811571|NCT00464087|PENTA|penta|mesh-list
19811572|NCT00464087|Bivalirudin|bivalirudin|mesh-list
19811573|NCT00464087|Fondaparinux|fondaparinux|mesh-list
19811574|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
19811575|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19811576|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19811577|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811578|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
19811579|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19811580|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
19811581|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811582|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19811583|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19811584|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
20164223|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20164224|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
20164225|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20164226|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20164227|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20164228|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164229|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164230|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
20164231|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811585|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
20330401|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
19811586|NCT00464269|Brivaracetam|brivaracetam|mesh-list
19647264|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647265|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647266|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19647267|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647268|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647269|NCT02354261|Itraconazole|itraconazole|mesh-list
19647270|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
20330402|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330403|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330404|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330405|NCT00770354|Letrozole|letrozole|mesh-list
20330406|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330407|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20330408|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20330409|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330410|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330411|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20330412|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
20330413|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330414|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330415|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
20330416|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20330417|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20330418|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20330419|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647271|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647272|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19647273|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19647274|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647275|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647276|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19647277|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
19664566|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19664567|NCT02861898|Diuretics|diuretics|mesh-ancestor
19664568|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
19664569|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664570|NCT02806687|Gemcitabine|gemcitabine|mesh-list
19664571|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19664572|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
19664573|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664574|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664575|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
19664576|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664577|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664578|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664579|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
19664580|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664581|NCT02632396|Rituximab|rituximab|mesh-list
19664582|NCT02632396|Ixazomib|ixazomib|mesh-list
19664583|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19664584|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664585|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
19664586|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664587|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19664588|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664589|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
19664590|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664591|NCT02595060|Molgramostim|molgramostim|mesh-list
19664592|NCT02595060|Sargramostim|sargramostim|mesh-list
19664593|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664594|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
19664595|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664596|NCT02404155|Clozapine|clozapine|mesh-list
19664597|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19664598|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
19664599|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664600|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664601|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664602|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19664603|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19664604|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664605|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20330420|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330421|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
20330422|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647278|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647279|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647280|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19647281|NCT02354170|Mifepristone|mifepristone|mesh-list
19647282|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19647283|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
19647284|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19647285|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647286|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19647287|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19647288|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19647289|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
19647290|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19647291|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19647292|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
19647293|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647294|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
19647295|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19647296|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20330423|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330424|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20330425|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330426|NCT00770445|Insulin|insulin|mesh-list
20330427|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20330428|NCT00770445|Metformin|metformin|mesh-list
20330429|NCT00770445|Pioglitazone|pioglitazone|mesh-list
20330430|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330431|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330432|NCT00770471|Temozolomide|temozolomide|mesh-list
20330433|NCT00770471|Veliparib|veliparib|mesh-list
20330434|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20330435|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
20330436|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647297|NCT02353949|Flutemetamol|flutemetamol|mesh-list
19647298|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19647299|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647300|NCT02354027|Metformin|metformin|mesh-list
19647301|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19647302|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647303|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19647304|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19647305|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
19647306|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330437|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330438|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20330439|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330440|NCT00770497|Pioglitazone|pioglitazone|mesh-list
20330441|NCT00770497|Ramipril|ramipril|mesh-list
20330442|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330443|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611682|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
19647307|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664606|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
19664607|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
19664608|NCT05101005|Sirolimus|sirolimus|mesh-list
19664609|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19664610|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664611|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19664612|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664613|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
19664614|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664615|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
19664616|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664617|NCT05100719|Mebeverine|mebeverine|mesh-list
19664618|NCT05100719|Simethicone|simethicone|mesh-list
19664619|NCT05100719|Citric Acid|citric acid|mesh-list
19664620|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
19664621|NCT05100719|Alverine|alverine|mesh-list
19664622|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
19664623|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19664624|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
19664625|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
19647308|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19647309|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19647310|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19811587|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
19811588|NCT00464308|Esomeprazole|esomeprazole|mesh-list
19811589|NCT00464308|Rabeprazole|rabeprazole|mesh-list
19811590|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19811591|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19811592|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19811593|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811594|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811595|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
19811596|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
19811597|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19811598|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19811599|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811600|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19811601|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19811602|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811603|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811604|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811605|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19811606|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
19811607|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19811608|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811609|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811610|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19811611|NCT00464490|Analgesics|analgesics|mesh-ancestor
19811612|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
19811613|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811614|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19811615|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19811616|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19811617|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19811618|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811619|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811620|NCT00464542|Metronidazole|metronidazole|mesh-list
19811621|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811622|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19811623|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19811624|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19811625|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
19811626|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19811627|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19811628|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811629|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811630|NCT00464620|Dasatinib|dasatinib|mesh-list
19811631|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811632|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811633|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811634|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811635|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
19811636|NCT00464646|Bevacizumab|bevacizumab|mesh-list
19811637|NCT00464646|Docetaxel|docetaxel|mesh-list
19811638|NCT00464646|Trastuzumab|trastuzumab|mesh-list
19647311|NCT02354053|Triumeq|triumeq|mesh-list
19647312|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19647313|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19811639|NCT00464646|Epirubicin|epirubicin|mesh-list
20164232|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164233|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20164234|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20164235|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164236|NCT00133770|Pantoprazole|pantoprazole|mesh-list
19647314|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
19647315|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647316|NCT02353936|Afatinib|afatinib|mesh-list
19647317|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647318|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19647319|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647320|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811640|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164237|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20330444|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20330445|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
20330446|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330447|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811641|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
19811642|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811643|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19811644|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19811645|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
20330448|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20330449|NCT00770536|Doxorubicin|doxorubicin|mesh-list
20330450|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20330451|NCT00770536|Topotecan|topotecan|mesh-list
20330452|NCT00770536|Trebananib|trebananib|mesh-list
20330453|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20330454|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330455|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20330456|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20330457|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330458|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330459|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20330460|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20330461|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20330462|NCT00770536|Growth Substances|growth substances|mesh-ancestor
20330463|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330464|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
20330465|NCT00770575|Pioglitazone|pioglitazone|mesh-list
20330466|NCT00770575|Atorvastatin|atorvastatin|mesh-list
20330467|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20330468|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330469|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
20330470|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330471|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20330472|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20330473|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330474|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330475|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347947|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20347948|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20347949|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
20347950|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347951|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347952|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20347953|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20347954|NCT00862628|Rebamipide|rebamipide|mesh-list
20347955|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20347956|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20347957|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
20347958|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347959|NCT00862628|Protective Agents|protective agents|mesh-ancestor
20347960|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347961|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347962|NCT00862693|Calcitriol|calcitriol|mesh-list
20347963|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20347964|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347965|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20347966|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347967|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347968|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20347969|NCT00862693|Vitamins|vitamins|mesh-ancestor
20347970|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
20347971|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20347972|NCT00862706|Telbivudine|telbivudine|mesh-list
20347973|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
20347974|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347975|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20347976|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347977|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347978|NCT00862875|Insulin|insulin|mesh-list
20347979|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20347980|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
19835531|NCT00603473|Analgesics|analgesics|mesh-ancestor
20347981|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
19811646|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811647|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811648|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19811649|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811650|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811651|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811652|NCT00464646|Growth Substances|growth substances|mesh-ancestor
19811653|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811654|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
19811655|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
19811656|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
20330476|NCT00770640|Insulin|insulin|mesh-list
20330477|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20330478|NCT00770640|Pioglitazone|pioglitazone|mesh-list
20330479|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330480|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330481|NCT00770666|Bupropion|bupropion|mesh-list
20330482|NCT00770666|Nicotine|nicotine|mesh-list
20330483|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20330484|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
20330485|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811657|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19811658|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19811659|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19811660|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811661|NCT00464672|Vaccines|vaccines|mesh-list
19811662|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
19811663|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811664|NCT00464685|Dexamethasone|dexamethasone|mesh-list
19811665|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811666|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
19811667|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
19811668|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811669|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811670|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19811671|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
19811672|NCT00464685|Hormones|hormones|mesh-ancestor
19811673|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811674|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19811675|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811676|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19811677|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19811678|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20164238|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164239|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20164240|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164241|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174376|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20174377|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
20174378|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174379|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174380|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20174381|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20174382|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
20174383|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174384|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20174385|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20174386|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20174387|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20174388|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
20174389|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20174390|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20175217|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20175218|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20175219|NCT00167687|Prazosin|prazosin|mesh-list
20175220|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20175221|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20175222|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20175223|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20175224|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
20175225|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330486|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330487|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19811679|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19811680|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811681|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811682|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647321|NCT02353858|Fluorouracil|fluorouracil|mesh-list
19647322|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
19647323|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647324|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19647325|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647326|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647327|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
19811683|NCT00464698|Analgesics|analgesics|mesh-ancestor
19811684|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
19811685|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811686|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
19811687|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19811688|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
20164242|NCT00133796|Trastuzumab|trastuzumab|mesh-list
20164243|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20164244|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164245|NCT00133822|Risperidone|risperidone|mesh-list
20164246|NCT00133822|Sertraline|sertraline|mesh-list
20164247|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20164248|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
20164249|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330488|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20330489|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
20330490|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330491|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330492|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20330493|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
19811689|NCT00464711|Citalopram|citalopram|mesh-list
19811690|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19811691|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20330494|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20330495|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20330496|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20330497|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20330498|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
20330499|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20330500|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20330501|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330502|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
20330503|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20330504|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20330505|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330506|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330507|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330508|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330509|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20330510|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
19647328|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811692|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19811693|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811694|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811695|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
19811696|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811697|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19811698|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
19811699|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19811700|NCT00464737|Rotigotine|rotigotine|mesh-list
19811701|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
19811702|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
19811703|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811704|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811705|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835532|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
20164250|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647329|NCT02353988|Bicalutamide|bicalutamide|mesh-list
19647330|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
20164251|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647331|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
20164252|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20164253|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20164254|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20164255|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20164256|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20164257|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
20164258|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
20164259|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20164260|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20164261|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164262|NCT00133848|Retapamulin|retapamulin|mesh-list
20164263|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20164264|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164265|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
20164266|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20164267|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164268|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330511|NCT00770718|Thrombin|thrombin|mesh-list
20330512|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
20330513|NCT00770718|Coagulants|coagulants|mesh-ancestor
20330514|NCT00770731|Sirolimus|sirolimus|mesh-list
20330515|NCT00770731|Bortezomib|bortezomib|mesh-list
20330516|NCT00770731|Topotecan|topotecan|mesh-list
20330517|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330518|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20330519|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20330520|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330521|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330522|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330523|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330524|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20330525|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
20330526|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330527|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
20330528|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330529|NCT00770744|Olanzapine|olanzapine|mesh-list
20330530|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
19647332|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647333|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647334|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647335|NCT02353702|Ropivacaine|ropivacaine|mesh-list
19647336|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
19647337|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
19647338|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647339|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647340|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
19647341|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664626|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664627|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
19664628|NCT05100719|Emollients|emollients|mesh-ancestor
19664629|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19664630|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
19664631|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
19664632|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664633|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664634|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
19664635|NCT05100563|Naltrexone|naltrexone|mesh-list
19664636|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19664637|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19664638|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664639|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
19664640|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664641|NCT05100446|Amoxicillin|amoxicillin|mesh-list
19664642|NCT05100446|Esomeprazole|esomeprazole|mesh-list
19664643|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19664644|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664645|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19664646|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664647|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19664648|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664649|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664650|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
19664651|NCT05100329|Analgesics|analgesics|mesh-ancestor
19664652|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
19664653|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811706|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19811707|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
19811708|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811709|NCT00465088|Niacin|niacin|mesh-list
19811710|NCT00465088|Niacinamide|niacinamide|mesh-list
19811711|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
19811712|NCT00465088|Atorvastatin|atorvastatin|mesh-list
19811713|NCT00465088|Simvastatin|simvastatin|mesh-list
19811714|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19811715|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19811716|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
19811717|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811718|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19811719|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19811720|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811721|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
19811722|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
19811723|NCT00465088|Vitamins|vitamins|mesh-ancestor
19811724|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
19811725|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811726|NCT00465179|Sunitinib|sunitinib|mesh-list
19811727|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811728|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811729|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811730|NCT00465179|Growth Substances|growth substances|mesh-ancestor
19811731|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811732|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811733|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811734|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811735|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834616|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834617|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19834618|NCT00596167|Vancomycin|vancomycin|mesh-list
19834619|NCT00596167|Levofloxacin|levofloxacin|mesh-list
19834620|NCT00596167|Gentamicins|gentamicins|mesh-list
19834621|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834622|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19834623|NCT00596167|Renal Agents|renal agents|mesh-ancestor
19834624|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19834625|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19834626|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834627|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834628|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834629|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19834630|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19834631|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19834632|NCT00596271|Vaccines|vaccines|mesh-list
19834633|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
19834634|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834635|NCT00596362|Bevacizumab|bevacizumab|mesh-list
19834636|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834637|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834638|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19834639|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19834640|NCT00596362|Growth Substances|growth substances|mesh-ancestor
19834641|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834642|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834643|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19834644|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19834645|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19834646|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
19834647|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834648|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19834649|NCT00596440|Nicotine|nicotine|mesh-list
19834650|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19834651|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
19834652|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834653|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834654|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19834655|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20164269|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
19834656|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
19834657|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834658|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834659|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
19811736|NCT00465530|Gentamicins|gentamicins|mesh-list
19811737|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19811738|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811739|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19811740|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811741|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811742|NCT00465595|Psilocybin|psilocybin|mesh-list
19811743|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
20330531|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
20330532|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330533|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330534|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20330535|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20330536|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20330537|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330538|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20330539|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20330540|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20330541|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20330542|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330543|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330544|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
20330545|NCT00770796|Atorvastatin|atorvastatin|mesh-list
20330546|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20330547|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330548|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
20330549|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330550|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20330551|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20330552|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330553|NCT00770835|Metformin|metformin|mesh-list
20330554|NCT00770835|Pioglitazone|pioglitazone|mesh-list
20330555|NCT00770835|Glyburide|glyburide|mesh-list
20330556|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330557|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330558|NCT00770900|Montelukast|montelukast|mesh-list
20330559|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20330560|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
20330561|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20330562|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
20330563|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330564|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811744|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
19811745|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811746|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19811747|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19811748|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
19811749|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811750|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811751|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19811752|NCT00465647|Hydromorphone|hydromorphone|mesh-list
19811753|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19811754|NCT00465647|Narcotics|narcotics|mesh-ancestor
19811755|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811756|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811757|NCT00465647|Analgesics|analgesics|mesh-ancestor
19811758|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
19811759|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811760|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
19811761|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19811762|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19811763|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20164270|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164271|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164272|NCT00133874|Retapamulin|retapamulin|mesh-list
20164273|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20164274|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164275|NCT00133887|Sirolimus|sirolimus|mesh-list
20164276|NCT00133887|Cyclosporine|cyclosporine|mesh-list
20164277|NCT00133887|Tacrolimus|tacrolimus|mesh-list
20164278|NCT00133887|Cyclosporins|cyclosporins|mesh-list
19811764|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19811765|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164279|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164280|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
20330565|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20330566|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20330567|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330568|NCT00770952|Pioglitazone|pioglitazone|mesh-list
19811766|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811767|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
19811768|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811769|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811770|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19811771|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811772|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19811773|NCT00465894|Estradiol|estradiol|mesh-list
19811774|NCT00465894|Estrogens|estrogens|mesh-ancestor
19811775|NCT00465894|Hormones|hormones|mesh-ancestor
19811776|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811777|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811778|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19811779|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19811780|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
19811781|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811782|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811783|NCT00465894|Urological Agents|urological agents|mesh-ancestor
19811784|NCT00465972|Doxepin|doxepin|mesh-list
19811785|NCT00465972|Temazepam|temazepam|mesh-list
19811786|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19811787|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19811788|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811789|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330569|NCT00770952|Glimepiride|glimepiride|mesh-list
20330570|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330571|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330572|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20330573|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330574|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
20330575|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
20330576|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20330577|NCT00770978|Cephalosporins|cephalosporins|mesh-list
20330578|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330579|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330580|NCT00771004|Pioglitazone|pioglitazone|mesh-list
20330581|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330582|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330583|NCT00771017|Leuprolide|leuprolide|mesh-list
20330584|NCT00771017|Goserelin|goserelin|mesh-list
20330585|NCT00771017|Bicalutamide|bicalutamide|mesh-list
20330586|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19811790|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19811791|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
19811792|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19811793|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
19811794|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
19811795|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811796|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330587|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
20330588|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19647342|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19647343|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19647344|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647345|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
19647346|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647347|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19647348|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647349|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647350|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
19647351|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647352|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647353|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19647354|NCT02353676|Bupivacaine|bupivacaine|mesh-list
19647355|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
20330589|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330590|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20330591|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647356|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
20330592|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
19811797|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19811798|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19811799|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
19811800|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
19811801|NCT00466167|Pramipexole|pramipexole|mesh-list
19811802|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
20330593|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
20330594|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330595|NCT00771043|Natalizumab|natalizumab|mesh-list
19811803|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811804|NCT00466167|Protective Agents|protective agents|mesh-ancestor
20330596|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
20330597|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330598|NCT00771147|Sorafenib|sorafenib|mesh-list
20330599|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330600|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20330601|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330602|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330603|NCT00771199|Fentanyl|fentanyl|mesh-list
20330604|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20330605|NCT00771199|Narcotics|narcotics|mesh-ancestor
20330606|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330607|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330608|NCT00771199|Analgesics|analgesics|mesh-ancestor
20330609|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
19811805|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811806|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19811807|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19811808|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
19811809|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
19811810|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811811|NCT00466193|Zolpidem|zolpidem|mesh-list
20330610|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330611|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20330612|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20330613|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
20330614|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
20330615|NCT00771251|Golimumab|golimumab|mesh-list
19811812|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19811813|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19811814|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811815|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811816|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19811817|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
19811818|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
19811819|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811820|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811821|NCT00466310|Risperidone|risperidone|mesh-list
19811822|NCT00466310|Aripiprazole|aripiprazole|mesh-list
19811823|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19811824|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
19811825|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811826|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811827|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811828|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19811829|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19811830|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19811831|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19811832|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19811833|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
19811834|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
19811835|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
19811836|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19811837|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19811838|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19811839|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19811840|NCT00466440|Prednisone|prednisone|mesh-list
19811841|NCT00466440|Docetaxel|docetaxel|mesh-list
19811842|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811843|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
20330616|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20330617|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811844|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
19811845|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
19811846|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811847|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811848|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
19811849|NCT00466440|Hormones|hormones|mesh-ancestor
19811850|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811851|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811852|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19811853|NCT00466505|Celecoxib|celecoxib|mesh-list
19811854|NCT00466505|Cetuximab|cetuximab|mesh-list
19811855|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811856|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811857|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19811858|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19811859|NCT00466505|Analgesics|analgesics|mesh-ancestor
19811860|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
19811861|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811862|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811863|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811864|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19811865|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19811866|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19811867|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330618|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20330619|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
20330620|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330621|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
20330622|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20330623|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19811868|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811869|NCT00466661|Acamprosate|acamprosate|mesh-list
19811870|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19811871|NCT00466687|Bevacizumab|bevacizumab|mesh-list
19811872|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19811873|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19811874|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811875|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811876|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811877|NCT00466687|Growth Substances|growth substances|mesh-ancestor
19811878|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811879|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811880|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811881|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811882|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811883|NCT00466726|Sargramostim|sargramostim|mesh-list
19811884|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
20330624|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330625|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
20330626|NCT00771303|Coagulants|coagulants|mesh-ancestor
20330627|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
20330628|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20330629|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
20330630|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330631|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330632|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20330633|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
20330634|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20330635|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
19647357|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647358|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647359|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
19647360|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647361|NCT02353494|Piperaquine|piperaquine|mesh-list
19647362|NCT02353494|Artenimol|artenimol|mesh-list
19647363|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
19647364|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19647365|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19647366|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647367|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19647368|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
19647369|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647370|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
20347982|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19647371|NCT02353325|Fesoterodine|fesoterodine|mesh-list
19647372|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
19811885|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811886|NCT00466752|Sorafenib|sorafenib|mesh-list
19811887|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811888|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811889|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811890|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811891|NCT00466817|Valganciclovir|valganciclovir|mesh-list
19811892|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
19811893|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811894|NCT00466921|Lenalidomide|lenalidomide|mesh-list
19811895|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
19811896|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811897|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19811898|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19811899|NCT00466921|Growth Substances|growth substances|mesh-ancestor
19811900|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
19811901|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811902|NCT00466947|Vaccines|vaccines|mesh-list
19811903|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19811904|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
19811905|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811906|NCT00466960|Paclitaxel|paclitaxel|mesh-list
19811907|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19811908|NCT00466960|Sargramostim|sargramostim|mesh-list
19811909|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19811910|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811911|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
19811912|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
19811913|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
19811914|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811915|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
19811916|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811917|NCT00467051|Paclitaxel|paclitaxel|mesh-list
19811918|NCT00467051|Carboplatin|carboplatin|mesh-list
19811919|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19811920|NCT00467051|Ifosfamide|ifosfamide|mesh-list
19811921|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
19811922|NCT00467051|Lenograstim|lenograstim|mesh-list
19811923|NCT00467051|Sargramostim|sargramostim|mesh-list
19811924|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19811925|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811926|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
19811927|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
19811928|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
19811929|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811930|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19811931|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
20164281|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164282|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20164283|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330636|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647373|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647374|NCT02353325|Protective Agents|protective agents|mesh-ancestor
19647375|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647376|NCT02353325|Vitamins|vitamins|mesh-ancestor
19647377|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
19647378|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19647379|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19647380|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
19647381|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647382|NCT02353325|Urological Agents|urological agents|mesh-ancestor
19647383|NCT02353260|Docetaxel|docetaxel|mesh-list
20164284|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164285|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20164286|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164287|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20164288|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164289|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
20164290|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
19647384|NCT02353260|Fluorouracil|fluorouracil|mesh-list
19647385|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811932|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811933|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19811934|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
19811935|NCT00467077|Interferons|interferons|mesh-list
19811936|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
19811937|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
19811938|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19811939|NCT00467077|Gefitinib|gefitinib|mesh-list
19811940|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19811941|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
19811942|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811943|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
19811944|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811945|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19811946|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811947|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811948|NCT00467259|Testosterone|testosterone|mesh-list
19811949|NCT00467259|Androgens|androgens|mesh-ancestor
19811950|NCT00467259|Hormones|hormones|mesh-ancestor
19811951|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19811952|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811953|NCT00467272|Daptomycin|daptomycin|mesh-list
19811954|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19811955|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19811956|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19811957|NCT00467350|Laxatives|laxatives|mesh-ancestor
19811958|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19811959|NCT00467363|Aspirin|aspirin|mesh-list
19811960|NCT00467363|Folic Acid|folic acid|mesh-list
19811961|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19811962|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19811963|NCT00467363|Analgesics|analgesics|mesh-ancestor
19811964|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
19811965|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811966|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330637|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330638|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20330639|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
19811967|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19811968|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19811969|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19811970|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19811971|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811972|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20330640|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
20330641|NCT00771342|Protective Agents|protective agents|mesh-ancestor
20330642|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
20330643|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19647386|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
19647387|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
19811973|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19811974|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19811975|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
19811976|NCT00467363|Hematinics|hematinics|mesh-ancestor
19811977|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
19811978|NCT00467363|Vitamins|vitamins|mesh-ancestor
20164291|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164292|NCT00134030|Interferons|interferons|mesh-list
20164293|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
20164294|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
20164295|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20164296|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20164297|NCT00134030|Cisplatin|cisplatin|mesh-list
20164298|NCT00134030|Doxorubicin|doxorubicin|mesh-list
20164299|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20164300|NCT00134030|Methotrexate|methotrexate|mesh-list
19647388|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
19647389|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647390|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
19647391|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19647392|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647393|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
19647394|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647395|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
19811979|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
19811980|NCT00467389|Donepezil|donepezil|mesh-list
20164301|NCT00134030|Etoposide|etoposide|mesh-list
20164302|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
19811981|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19811982|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164303|NCT00134030|Ifosfamide|ifosfamide|mesh-list
20164304|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
20164305|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
20330644|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
19647396|NCT02353182|Remifentanil|remifentanil|mesh-list
19647397|NCT02353182|Bupivacaine|bupivacaine|mesh-list
19811983|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19811984|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
19811985|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19811986|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811987|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
19811988|NCT00467558|Naltrexone|naltrexone|mesh-list
19811989|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19811990|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19811991|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19811992|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
19811993|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19811994|NCT00467584|Aspirin|aspirin|mesh-list
19811995|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19811996|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19811997|NCT00467584|Analgesics|analgesics|mesh-ancestor
19811998|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
19811999|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812000|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812001|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19812002|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812003|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19812004|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20330645|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330646|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330647|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20330648|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
20330649|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20330650|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
20330651|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330652|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330653|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20330654|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
20330655|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
19812005|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812006|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19812007|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19812008|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812009|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
19812010|NCT00467597|Levodopa|levodopa|mesh-list
19812011|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20164306|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330656|NCT00771368|Protective Agents|protective agents|mesh-ancestor
20330657|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20330658|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20330659|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647398|NCT02353182|Ropivacaine|ropivacaine|mesh-list
19647399|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
19647400|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
19647401|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647402|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647403|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
19647404|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647405|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19647406|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19647407|NCT02353182|Analgesics|analgesics|mesh-ancestor
19812012|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20164307|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20164308|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20164309|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20164310|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164311|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164312|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20164313|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
20164314|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20164315|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164316|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20164317|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
20164318|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164319|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20164320|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647408|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19812013|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
19812014|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812015|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812016|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812017|NCT00467649|Insulin|insulin|mesh-list
19812018|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19812019|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
19812020|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
19812021|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
19812022|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
19812023|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
19812024|NCT00467649|Pramlintide|pramlintide|mesh-list
19812025|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
19812026|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19812027|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812028|NCT00467740|Olodaterol|olodaterol|mesh-list
19812029|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19812030|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
19812031|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812032|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812033|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19812034|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
19812035|NCT00467779|Midazolam|midazolam|mesh-list
19812036|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
19812037|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19812038|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19812039|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812040|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812041|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20330660|NCT00771394|Tamsulosin|tamsulosin|mesh-list
20330661|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
20330662|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20330663|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20330664|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20330665|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330666|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330667|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330668|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330669|NCT00771394|Urological Agents|urological agents|mesh-ancestor
20330670|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20330671|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20330672|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
20330673|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
20330674|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20330675|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20330676|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
20330677|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330678|NCT00771433|Lenograstim|lenograstim|mesh-list
20330679|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20330680|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
20330681|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330682|NCT00771459|Ropivacaine|ropivacaine|mesh-list
20330683|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
20330684|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
20330685|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330686|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812042|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19812043|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19812044|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19812045|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
19812046|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
19812047|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
19812048|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
19812049|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812050|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812051|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
19812052|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
19812053|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19812054|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19812055|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
20330687|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
19812056|NCT00467831|Erythromycin|erythromycin|mesh-list
20330688|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330689|NCT00771498|Lopinavir|lopinavir|mesh-list
19812057|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
19812058|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19812059|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
19812060|NCT00467831|Zileuton|zileuton|mesh-list
20330690|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20330691|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19647409|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19647410|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19647411|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
19647412|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812061|NCT00467831|Losartan|losartan|mesh-list
19812062|NCT00467831|Pravastatin|pravastatin|mesh-list
19812063|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19812064|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19812065|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19812066|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19812067|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19812068|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812069|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
19812070|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812071|NCT00467831|Expectorants|expectorants|mesh-ancestor
19812072|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
19812073|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19812074|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
19812075|NCT00467831|Protective Agents|protective agents|mesh-ancestor
19812076|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812077|NCT00467831|Antidotes|antidotes|mesh-ancestor
19812078|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19812079|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19812080|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
19812081|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19812082|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19812083|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812084|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19812085|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19812086|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19812087|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19812088|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19647413|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647414|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19647415|NCT02353182|Narcotics|narcotics|mesh-ancestor
19647416|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19647417|NCT02353507|Laxatives|laxatives|mesh-ancestor
19647418|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647419|NCT02353429|Toremifene|toremifene|mesh-list
19647420|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19647421|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647422|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19647423|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19647424|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
19647425|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647426|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647427|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19647428|NCT02353130|Memantine|memantine|mesh-list
20164321|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
19647429|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19647430|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19647431|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
19647432|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647433|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647434|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647435|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19647436|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19647437|NCT02353078|Sucralfate|sucralfate|mesh-list
19647438|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19647439|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19812089|NCT00467831|Analgesics|analgesics|mesh-ancestor
19812090|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
20164322|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164323|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20164324|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164325|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
20164326|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164327|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20164328|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
20164329|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
20164330|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
19812091|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812092|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20330692|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
20330693|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330694|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330695|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20330696|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20330697|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
20330698|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330699|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20330700|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20330701|NCT00771511|Capsaicin|capsaicin|mesh-list
19812093|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812094|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19812095|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19812096|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
19812097|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812098|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
19812099|NCT00467870|Testosterone|testosterone|mesh-list
19812100|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
20164331|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
20164332|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
20164333|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20164334|NCT00134069|Cetuximab|cetuximab|mesh-list
20164335|NCT00134069|Irinotecan|irinotecan|mesh-list
20164336|NCT00134069|Sorafenib|sorafenib|mesh-list
20164337|NCT00134069|Antibodies|antibodies|mesh-list
20164338|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
20164339|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20164340|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
20330702|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
20164341|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164342|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812101|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
19812102|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19812103|NCT00467870|Androgens|androgens|mesh-ancestor
19812104|NCT00467870|Hormones|hormones|mesh-ancestor
19812105|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812106|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812107|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19812108|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812109|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
19812110|NCT00467896|Iloprost|iloprost|mesh-list
19812111|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19812112|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
19812113|NCT00468052|Fentanyl|fentanyl|mesh-list
19812114|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
19812115|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19812116|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812117|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812118|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19812119|NCT00468052|Analgesics|analgesics|mesh-ancestor
19812120|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
19812121|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164343|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19812122|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20330703|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
19812123|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19812124|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19812125|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
19812126|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812127|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812128|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19812129|NCT00468052|Narcotics|narcotics|mesh-ancestor
19812130|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19647440|NCT02353026|Artesunate|artesunate|mesh-list
19647441|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
20330704|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
20330705|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812131|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19812132|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
20164344|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20164345|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164346|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812133|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
19812134|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19812135|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19812136|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19812137|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812138|NCT00468143|Adderall|adderall|mesh-list
19812139|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19812140|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812141|NCT00468169|Cetuximab|cetuximab|mesh-list
19812142|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
19812143|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812144|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812145|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
19812146|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812147|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812148|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19812149|NCT00468208|Abatacept|abatacept|mesh-list
19812150|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19812151|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812152|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812153|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812154|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
19812155|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812156|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812157|NCT00468299|Misoprostol|misoprostol|mesh-list
19812158|NCT00468299|Mifepristone|mifepristone|mesh-list
19812159|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19812160|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
19812161|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19812162|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812163|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19812164|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19812165|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
19812166|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19812167|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19812168|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20164347|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20164348|NCT00134095|Irinotecan|irinotecan|mesh-list
20164349|NCT00134095|Tegafur|tegafur|mesh-list
20164350|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20164351|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20164352|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164353|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164354|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164355|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20330706|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647442|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19647443|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19647444|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647445|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647446|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
19647447|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
19647448|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19647449|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
19647450|NCT02352883|Hormones|hormones|mesh-list
19647451|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812169|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20164356|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
19812170|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
19812171|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19812172|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19812173|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
19812174|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812175|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
19812176|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19812177|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19812178|NCT00468481|Drospirenone|drospirenone|mesh-list
19812179|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19812180|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19812181|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19812182|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19812183|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19812184|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
19812185|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19812186|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812187|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20330707|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
19812188|NCT00468481|Estrogens|estrogens|mesh-ancestor
19812189|NCT00468481|Hormones|hormones|mesh-ancestor
19812190|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812191|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19812192|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
19812193|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19812194|NCT00468481|Diuretics|diuretics|mesh-ancestor
19812195|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
19812196|NCT00468546|Methotrexate|methotrexate|mesh-list
19812197|NCT00468546|Rituximab|rituximab|mesh-list
19812198|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20164357|NCT00134147|Insulin|insulin|mesh-list
20164358|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19812199|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
19812200|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19812201|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812202|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812203|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
19812204|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812205|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812206|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
19812207|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812208|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19812209|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812210|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
19812211|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812212|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19812213|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812214|NCT00468559|Esomeprazole|esomeprazole|mesh-list
19812215|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19812216|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19812217|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19812218|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812219|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812220|NCT00468585|Bevacizumab|bevacizumab|mesh-list
19812221|NCT00468585|Capecitabine|capecitabine|mesh-list
19812222|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812223|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812224|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19812225|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19812226|NCT00468585|Growth Substances|growth substances|mesh-ancestor
19812227|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164359|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164360|NCT00134160|Amlodipine|amlodipine|mesh-list
20164361|NCT00134160|Olmesartan|olmesartan|mesh-list
20164362|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20164363|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
20164364|NCT00134160|Calcium|calcium|mesh-list
20164365|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20164366|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164367|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20164368|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19812228|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
20174391|NCT00164749|Curcumin|curcumin|mesh-list
19812229|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812230|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
19812231|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812232|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
19812233|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812234|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
19812235|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19812236|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19812237|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812238|NCT00468650|Urological Agents|urological agents|mesh-ancestor
19812239|NCT00468728|Vancomycin|vancomycin|mesh-list
19812240|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19812241|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812242|NCT00468845|Pregabalin|pregabalin|mesh-list
19812243|NCT00468845|Analgesics|analgesics|mesh-ancestor
19812244|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
19812245|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812246|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812247|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
19812248|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19812249|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19812250|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812251|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19812252|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19812253|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19812254|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812255|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19812256|NCT00468910|Aspirin|aspirin|mesh-list
19812257|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19812258|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19812259|NCT00468910|Analgesics|analgesics|mesh-ancestor
19812260|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
19812261|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812262|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812263|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19812264|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812265|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20330708|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20330709|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330710|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330711|NCT00771563|Cisplatin|cisplatin|mesh-list
20330712|NCT00771563|Docetaxel|docetaxel|mesh-list
20330713|NCT00771563|Enoxaparin|enoxaparin|mesh-list
20330714|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330715|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
20330716|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
20330717|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
20330718|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330719|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
20330720|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20330721|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20330722|NCT00771641|Cobalt|cobalt|mesh-list
20330723|NCT00771641|Trace Elements|trace elements|mesh-ancestor
20330724|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
20330725|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330726|NCT00771680|Insulin|insulin|mesh-list
20330727|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20330728|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
19812266|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19812267|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330729|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
20330730|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20330731|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
20330732|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
20330733|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19812268|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19812269|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19812270|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812271|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
19812272|NCT00469014|Vidarabine|vidarabine|mesh-list
19812273|NCT00469014|Fludarabine|fludarabine|mesh-list
19812274|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
19812275|NCT00469014|Busulfan|busulfan|mesh-list
19812276|NCT00469014|Clofarabine|clofarabine|mesh-list
19812277|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
19812278|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19812279|NCT00469014|Lenograstim|lenograstim|mesh-list
19812280|NCT00469014|Sargramostim|sargramostim|mesh-list
19812281|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812282|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812283|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
19812284|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812285|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812286|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
19812287|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812288|NCT00469014|Antiviral Agents|antiviral agents|mesh-ancestor
19812289|NCT00469014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812290|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19812291|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
19812292|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19812293|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19812294|NCT00469079|Nicotine|nicotine|mesh-list
19812295|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19812296|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
19812297|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812298|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812299|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19812300|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19812301|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
19812302|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812303|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812304|NCT00469092|Insulin|insulin|mesh-list
19812305|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19812306|NCT00469092|Metformin|metformin|mesh-list
19812307|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
19812308|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
19812309|NCT00469092|Glimepiride|glimepiride|mesh-list
19812310|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
19812311|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19812312|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812313|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19812314|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812315|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
19812316|NCT00469144|Fludarabine|fludarabine|mesh-list
19812317|NCT00469144|Busulfan|busulfan|mesh-list
19812318|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330734|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330735|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330736|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20330737|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330738|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330739|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
20330740|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20330741|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20330742|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330743|NCT00771823|Maraviroc|maraviroc|mesh-list
20330744|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20330745|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20330746|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330747|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20330748|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20330749|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
20330750|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812319|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812320|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812321|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
19812322|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812323|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
19812324|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19812325|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19812326|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
19812327|NCT00469209|Bortezomib|bortezomib|mesh-list
20330751|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20330752|NCT00771888|Lanreotide|lanreotide|mesh-list
20330753|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330754|NCT00771979|Saracatinib|saracatinib|mesh-list
20330755|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330756|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330757|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812328|NCT00469209|Melphalan|melphalan|mesh-list
19812329|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
19812330|NCT00469209|Vitamins|vitamins|mesh-ancestor
19812331|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
19812332|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812333|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812334|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19812335|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
19812336|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812337|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20330758|NCT00772057|Propranolol|propranolol|mesh-list
20330759|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20330760|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20330761|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330762|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330763|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812338|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812339|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
19812340|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
19812341|NCT00469209|Protective Agents|protective agents|mesh-ancestor
19812342|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19812343|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19812344|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812345|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
20330764|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330765|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20330766|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20330767|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
20330768|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
20330769|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330770|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
19812346|NCT00469456|Memantine|memantine|mesh-list
19812347|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19812348|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19812349|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
19812350|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812351|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164369|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164370|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
20330771|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20330772|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20164371|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20164372|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20164373|NCT00134173|Atorvastatin|atorvastatin|mesh-list
20330773|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330774|NCT00772135|Urological Agents|urological agents|mesh-ancestor
20330775|NCT00772161|Methylphenidate|methylphenidate|mesh-list
20164374|NCT00134173|Torcetrapib|torcetrapib|mesh-list
20164375|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20164376|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20164377|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
20164378|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164379|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20164380|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20164381|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164382|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
20164383|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164384|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20164385|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164386|NCT00134199|Sibutramine|sibutramine|mesh-list
20164387|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
20330776|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20330777|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812352|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812353|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19812354|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19812355|NCT00469508|Modafinil|modafinil|mesh-list
19812356|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19812357|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812358|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19812359|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19812360|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19812361|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812362|NCT00469833|Insulin|insulin|mesh-list
19812363|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19812364|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
20330778|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20330779|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20330780|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20330781|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330782|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
20330783|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330784|NCT00772174|Metformin|metformin|mesh-list
20330785|NCT00772174|Pioglitazone|pioglitazone|mesh-list
20330786|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330787|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330788|NCT00772187|Fentanyl|fentanyl|mesh-list
20330789|NCT00772187|Morphine|morphine|mesh-list
20330790|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
20330791|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330792|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330793|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20330794|NCT00772187|Narcotics|narcotics|mesh-ancestor
20330795|NCT00772187|Analgesics|analgesics|mesh-ancestor
20330796|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
19812365|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
19812366|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19812367|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812368|NCT00469859|Cytarabine|cytarabine|mesh-list
19812369|NCT00469859|Idarubicin|idarubicin|mesh-list
19812370|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812371|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
19812372|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812373|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812374|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
19812375|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812376|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164388|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20164389|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
20164390|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20164391|NCT00134212|Epinephrine|epinephrine|mesh-list
20164392|NCT00134212|Norepinephrine|norepinephrine|mesh-list
20164393|NCT00134212|Dopexamine|dopexamine|mesh-list
20164394|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20164395|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20164396|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
20164397|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164398|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164399|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164400|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20164401|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19647452|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647453|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
19647454|NCT02352987|Salicylates|salicylates|mesh-list
19647455|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647456|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
19647457|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
19647458|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
19647459|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19647460|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19647461|NCT02352987|Analgesics|analgesics|mesh-ancestor
19647462|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
19647463|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647464|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647465|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647466|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19647467|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19647468|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164402|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
20164403|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330797|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330798|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19647469|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647470|NCT02352714|Lidocaine|lidocaine|mesh-list
19647471|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
19647472|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
19812377|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
19812378|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812379|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19812380|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19812381|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19812382|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812383|NCT00469898|Carboplatin|carboplatin|mesh-list
19812384|NCT00469898|Irinotecan|irinotecan|mesh-list
19812385|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812386|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19812387|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20330799|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20330800|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
19647473|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647474|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647475|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
19647476|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647477|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19647478|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20330801|NCT00772265|Insulin|insulin|mesh-list
20330802|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
20330803|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330804|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330805|NCT00772291|Pregabalin|pregabalin|mesh-list
20330806|NCT00772291|Analgesics|analgesics|mesh-ancestor
20330807|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
20330808|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330809|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647479|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19812388|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812389|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812390|NCT00470054|Dasatinib|dasatinib|mesh-list
19812391|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812392|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812393|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812394|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812395|NCT00470093|Interferons|interferons|mesh-list
19812396|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812397|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
19812398|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812399|NCT00470158|Iron|iron|mesh-list
19812400|NCT00470158|Zinc|zinc|mesh-list
19812401|NCT00470158|Trace Elements|trace elements|mesh-ancestor
19812402|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
20164404|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20164405|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
20164406|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
20164407|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
20164408|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20164409|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
20164410|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
19647480|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19812403|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164411|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
20164412|NCT00134290|Metformin|metformin|mesh-list
20164413|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20164414|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164415|NCT00134303|Metformin|metformin|mesh-list
20164416|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20164417|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164418|NCT00134355|Vatalanib|vatalanib|mesh-list
20164419|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20164420|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164421|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164422|NCT00134368|Etanercept|etanercept|mesh-list
20164423|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19812404|NCT00470184|Capecitabine|capecitabine|mesh-list
20164424|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20330810|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
19812405|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
20164425|NCT00134368|Analgesics|analgesics|mesh-ancestor
20164426|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
19812406|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812407|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
19812408|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812409|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812410|NCT00470262|Pioglitazone|pioglitazone|mesh-list
19812411|NCT00470262|Fenofibrate|fenofibrate|mesh-list
19812412|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19812413|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812414|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19812415|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
19812416|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812417|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19812418|NCT00470275|Cytarabine|cytarabine|mesh-list
19812419|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812420|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
19812421|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812422|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812423|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
19812424|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812425|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812426|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
19812427|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812428|NCT00470301|Paclitaxel|paclitaxel|mesh-list
19812429|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
20330811|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20330812|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20330813|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330814|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20330815|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20330816|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20330817|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330818|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19812430|NCT00470301|Doxorubicin|doxorubicin|mesh-list
19812431|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19812432|NCT00470301|Tipifarnib|tipifarnib|mesh-list
19812433|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19812434|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812435|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
19812436|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
19812437|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
19812438|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812439|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812440|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
19812441|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812442|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812443|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19812444|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
19812445|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19812446|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19812447|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19812448|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19812449|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812450|NCT00470366|Paclitaxel|paclitaxel|mesh-list
19812451|NCT00470366|Ifosfamide|ifosfamide|mesh-list
19812452|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19812453|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812454|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
19812455|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
19812456|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
19812457|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812458|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19812459|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
19812460|NCT00470392|Clobetasol|clobetasol|mesh-list
19812461|NCT00470392|Imiquimod|imiquimod|mesh-list
19812462|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19812463|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
19812464|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812465|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812466|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
19812467|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19812468|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
19812469|NCT00470392|Hormones|hormones|mesh-ancestor
19812470|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812471|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
20330819|NCT00772356|Insulin|insulin|mesh-list
19812472|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812473|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812474|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812475|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812476|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19812477|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812478|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812479|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812480|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812481|NCT00470548|Paclitaxel|paclitaxel|mesh-list
19812482|NCT00470548|Pemetrexed|pemetrexed|mesh-list
19812483|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19812484|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19812485|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812486|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
19812487|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
19812488|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
19812489|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812490|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812491|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19812492|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19812493|NCT00470600|Ibuprofen|ibuprofen|mesh-list
19812494|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19647481|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647482|NCT02352545|Montelukast|montelukast|mesh-list
19647483|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19647484|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
19647485|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19647486|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
19647487|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647488|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647489|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19812495|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19812496|NCT00470600|Analgesics|analgesics|mesh-ancestor
19812497|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
19812498|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330820|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20330821|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20330822|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330823|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
20330824|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20330825|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20330826|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330827|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20330828|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330829|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20330830|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
20330831|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20330832|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
20330833|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330834|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330835|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330836|NCT00772499|Atenolol|atenolol|mesh-list
20330837|NCT00772499|Amlodipine|amlodipine|mesh-list
20330838|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20330839|NCT00772499|Olmesartan|olmesartan|mesh-list
20330840|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20330841|NCT00772499|Hydralazine|hydralazine|mesh-list
20330842|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20330843|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20330844|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20330845|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330846|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20330847|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330848|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
20330849|NCT00772499|Diuretics|diuretics|mesh-ancestor
20330850|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
20330851|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19647490|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20330852|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20330853|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20330854|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20330855|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
20330856|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
19812499|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812500|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20330857|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330858|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20330859|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20330860|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20330861|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330862|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330863|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
20330864|NCT00772551|Ezetimibe|ezetimibe|mesh-list
20330865|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20330866|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330867|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
20330868|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330869|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20330870|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20330871|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20330872|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
20330873|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330874|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20330875|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20330876|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330877|NCT00772564|Atorvastatin|atorvastatin|mesh-list
20330878|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20330879|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20330880|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
20330881|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330882|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20330883|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19812501|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812502|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19812503|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812504|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812505|NCT00470834|Bicalutamide|bicalutamide|mesh-list
19812506|NCT00470834|Dutasteride|dutasteride|mesh-list
19812507|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
19812508|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
19812509|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812510|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812511|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812512|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19812513|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19812514|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812515|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812516|NCT00470847|Trastuzumab|trastuzumab|mesh-list
19812517|NCT00470847|Lapatinib|lapatinib|mesh-list
19812518|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812519|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812520|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812521|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812522|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834660|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19834661|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834662|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19834663|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19834664|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834665|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834666|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834667|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19834668|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19834669|NCT00596466|Pregabalin|pregabalin|mesh-list
19834670|NCT00596466|Analgesics|analgesics|mesh-ancestor
19834671|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
19834672|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834673|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834674|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
19834675|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19834676|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834677|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330884|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812523|NCT00471068|Timolol|timolol|mesh-list
19812524|NCT00471068|Travoprost|travoprost|mesh-list
19812525|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19812526|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19812527|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
19812528|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812529|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812530|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812531|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19812532|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19647491|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647492|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20330885|NCT00772616|Sufentanil|sufentanil|mesh-list
20330886|NCT00772616|Remifentanil|remifentanil|mesh-list
20330887|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20330888|NCT00772616|Narcotics|narcotics|mesh-ancestor
20330889|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20330890|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647493|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19647494|NCT02352597|Clomiphene|clomiphene|mesh-list
19647495|NCT02352597|Enclomiphene|enclomiphene|mesh-list
19647496|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
19647497|NCT02352597|Estradiol|estradiol|mesh-list
19647498|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19647499|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
19647500|NCT02352597|Estrogens|estrogens|mesh-ancestor
19647501|NCT02352597|Hormones|hormones|mesh-ancestor
19647502|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647503|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647504|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19812533|NCT00471146|Gemcitabine|gemcitabine|mesh-list
19812534|NCT00471146|Axitinib|axitinib|mesh-list
19812535|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812536|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
19812537|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812538|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812539|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
19812540|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812541|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812542|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812543|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
19812544|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812545|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812546|NCT00471237|Alendronate|alendronate|mesh-list
19812547|NCT00471237|Teriparatide|teriparatide|mesh-list
19812548|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19812549|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812550|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19812551|NCT00471276|Sunitinib|sunitinib|mesh-list
20330891|NCT00772616|Analgesics|analgesics|mesh-ancestor
20330892|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
20330893|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20330894|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20330895|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20330896|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
19812552|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812553|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19812554|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20330897|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
19647505|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
20330898|NCT00772655|Rituximab|rituximab|mesh-list
19812555|NCT00471276|Growth Substances|growth substances|mesh-ancestor
19812556|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812557|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
19812558|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812559|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812560|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812561|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19812562|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19812563|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19812564|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19812565|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812566|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812567|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812568|NCT00471315|Analgesics|analgesics|mesh-ancestor
20330899|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20330900|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330901|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
20330902|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330903|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20347983|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347984|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
20347985|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
20347986|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20347987|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19812569|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
19812570|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164427|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164428|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164429|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164430|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164431|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164432|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164433|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
20164434|NCT00134394|Etanercept|etanercept|mesh-list
20164435|NCT00134394|Tacrolimus|tacrolimus|mesh-list
20164436|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164437|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
20164438|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164439|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20164440|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347988|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347989|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347990|NCT00862888|Urological Agents|urological agents|mesh-ancestor
20347991|NCT00862966|Heparin|heparin|mesh-list
19647506|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19647507|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19647508|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19647509|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
19647510|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19812571|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
19812572|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19812573|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
19812574|NCT00471328|Sunitinib|sunitinib|mesh-list
19647511|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
19647512|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19647513|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19647514|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19647515|NCT02352519|Anesthetics|anesthetics|mesh-list
19647516|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
19647517|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647518|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647519|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
19647520|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647521|NCT02352701|Amoxicillin|amoxicillin|mesh-list
19647522|NCT02352701|Levofloxacin|levofloxacin|mesh-list
19647523|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19647524|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647525|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19647526|NCT02352701|Renal Agents|renal agents|mesh-ancestor
19812575|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
19812576|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812577|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19812578|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20347992|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
19812579|NCT00471328|Growth Substances|growth substances|mesh-ancestor
19812580|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812581|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
19812582|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812583|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812584|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330904|NCT00772681|Docetaxel|docetaxel|mesh-list
20330905|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330906|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
20330907|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
19647527|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19647528|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19647529|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647530|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647531|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812585|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19812586|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19812587|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19812588|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19812589|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812590|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
19812591|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812592|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812593|NCT00471380|Timolol|timolol|mesh-list
19812594|NCT00471380|Travoprost|travoprost|mesh-list
19812595|NCT00471380|Dorzolamide|dorzolamide|mesh-list
19812596|NCT00471380|Brinzolamide|brinzolamide|mesh-list
19812597|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19812598|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19812599|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
19812600|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812601|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812602|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812603|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19647532|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19647533|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19812604|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19812605|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19812606|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812607|NCT00471445|Ketamine|ketamine|mesh-list
20164441|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647534|NCT02352402|Ticagrelor|ticagrelor|mesh-list
20164442|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20164443|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20164444|NCT00134394|Analgesics|analgesics|mesh-ancestor
20164445|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
20164446|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164447|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164448|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164449|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164450|NCT00134420|Clonidine|clonidine|mesh-list
20164451|NCT00134420|Mitogens|mitogens|mesh-list
20164452|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164453|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
20164454|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164455|NCT00134420|Analgesics|analgesics|mesh-ancestor
20164456|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
20164457|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164458|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20164459|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
20164460|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
20164461|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20164462|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20164463|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20164464|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
20164465|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164466|NCT00134485|Atorvastatin|atorvastatin|mesh-list
20164467|NCT00134485|Torcetrapib|torcetrapib|mesh-list
20164468|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20164469|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20164470|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
20164471|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330908|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
19812608|NCT00471445|Amitriptyline|amitriptyline|mesh-list
19812609|NCT00471445|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19812610|NCT00471445|Analgesics|analgesics|mesh-ancestor
19812611|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
19812612|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812613|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812614|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19812615|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19812616|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
19812617|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
19812618|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812619|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19812620|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19812621|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812622|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812623|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19812624|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
19812625|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19812626|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19812627|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19812628|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19812629|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19812630|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
19812631|NCT00471445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19812632|NCT00471445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19812633|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
19812634|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812635|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812636|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812637|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812638|NCT00471705|Miltefosine|miltefosine|mesh-list
19812639|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19812640|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
19812641|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812642|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812643|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19812644|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19812645|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
19812646|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19812647|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
19812648|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812649|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812650|NCT00471887|Tremelimumab|tremelimumab|mesh-list
19812651|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812652|NCT00472030|Omalizumab|omalizumab|mesh-list
19812653|NCT00472030|Prednisone|prednisone|mesh-list
19812654|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19812655|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
19812656|NCT00472030|Hormones|hormones|mesh-ancestor
19812657|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812658|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812659|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19812660|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812661|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19812662|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19812663|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
19812664|NCT00472056|Cytarabine|cytarabine|mesh-list
19812665|NCT00472056|Rituximab|rituximab|mesh-list
19812666|NCT00472056|Etoposide|etoposide|mesh-list
19812667|NCT00472056|Melphalan|melphalan|mesh-list
19812668|NCT00472056|Carmustine|carmustine|mesh-list
19812669|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812670|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812671|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
19812672|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812673|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812674|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19812675|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19812676|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19812677|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812678|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812679|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812680|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
19812681|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
19812682|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812683|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812684|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19812685|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
19812686|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19812687|NCT00472199|Pramipexole|pramipexole|mesh-list
19812688|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
19812689|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812690|NCT00472199|Protective Agents|protective agents|mesh-ancestor
19812691|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812692|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19812693|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19812694|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
19812695|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
19812696|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812697|NCT00472303|Morphine|morphine|mesh-list
19812698|NCT00472303|Tapentadol|tapentadol|mesh-list
19812699|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19812700|NCT00472303|Narcotics|narcotics|mesh-ancestor
19812701|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812702|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812703|NCT00472303|Analgesics|analgesics|mesh-ancestor
19812704|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
19812705|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812706|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19812707|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19812708|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19812709|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812710|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
19812711|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812712|NCT00472420|Rituximab|rituximab|mesh-list
19812713|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812714|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812715|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
20330909|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330910|NCT00772694|Sorafenib|sorafenib|mesh-list
20330911|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330912|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19812716|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812717|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812718|NCT00472641|Ziprasidone|ziprasidone|mesh-list
19812719|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19812720|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
19812721|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812722|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812723|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812724|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19812725|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19812726|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812727|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19812728|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19812729|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
19812730|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
19812731|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19812732|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
19812733|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812734|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812735|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
19812736|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812737|NCT00472849|Cytarabine|cytarabine|mesh-list
20330913|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330914|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330915|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
20330916|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20330917|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20330918|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
20330919|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330920|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20330921|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20330922|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330923|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330924|NCT00772759|AZD-3199|azd-3199|mesh-list
20330925|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20330926|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19812738|NCT00472849|Rituximab|rituximab|mesh-list
19812739|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
19812740|NCT00472849|Fludarabine|fludarabine|mesh-list
20330927|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19812741|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812742|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164472|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19812743|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
19812744|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812745|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812746|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19812747|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
19812748|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812749|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812750|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
19812751|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812752|NCT00473083|Minocycline|minocycline|mesh-list
19812753|NCT00473083|Clindamycin|clindamycin|mesh-list
19647535|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19647536|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19647537|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19647538|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19647539|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
19647540|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647541|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647542|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812754|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
19812755|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
19812756|NCT00473083|Triamcinolone|triamcinolone|mesh-list
19812757|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19812758|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19812759|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
19812760|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19812761|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812762|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812763|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19812764|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
19812765|NCT00473083|Hormones|hormones|mesh-ancestor
19812766|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812767|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812768|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19812769|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
19812770|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19812771|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812772|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19812773|NCT00473265|Teriparatide|teriparatide|mesh-list
19812774|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19812775|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812776|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19812777|NCT00473330|Ranibizumab|ranibizumab|mesh-list
19812778|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19812779|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19812780|NCT00473330|Growth Substances|growth substances|mesh-ancestor
19812781|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812782|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
19812783|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164473|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20164474|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164475|NCT00134498|Atorvastatin|atorvastatin|mesh-list
20164476|NCT00134498|Torcetrapib|torcetrapib|mesh-list
20164477|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20164478|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20164479|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
20164480|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164481|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20164482|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20164483|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164484|NCT00134511|Atorvastatin|atorvastatin|mesh-list
19647543|NCT02352285|Tolvaptan|tolvaptan|mesh-list
19647544|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19647545|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647546|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
19647547|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812784|NCT00473382|Ranibizumab|ranibizumab|mesh-list
19812785|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19812786|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19812787|NCT00473382|Growth Substances|growth substances|mesh-ancestor
19812788|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812789|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
19812790|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812791|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19812792|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19812793|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19812794|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812795|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812796|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19812797|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19812798|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19812799|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
19812800|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812801|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812802|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19812803|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19812804|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
19812805|NCT00473512|Dexamethasone|dexamethasone|mesh-list
19812806|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
19812807|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19812808|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
19812809|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
19812810|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812811|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812812|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19812813|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
19812814|NCT00473512|Hormones|hormones|mesh-ancestor
19812815|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812816|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19812817|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812818|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19812819|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812820|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812821|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
19812822|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19812823|NCT00473590|Bevacizumab|bevacizumab|mesh-list
19812824|NCT00473590|Bortezomib|bortezomib|mesh-list
19812825|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19812826|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812827|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19812828|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19812829|NCT00473590|Growth Substances|growth substances|mesh-ancestor
19812830|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812831|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
19812832|NCT00473642|Ranibizumab|ranibizumab|mesh-list
19812833|NCT00473642|Verteporfin|verteporfin|mesh-list
19812834|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20330928|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
20330929|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20330930|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330931|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330932|NCT00772798|Paclitaxel|paclitaxel|mesh-list
20330933|NCT00772798|Carboplatin|carboplatin|mesh-list
20330934|NCT00772798|Vorinostat|vorinostat|mesh-list
19812835|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19812836|NCT00473642|Growth Substances|growth substances|mesh-ancestor
19812837|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812838|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
19812839|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812840|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19812841|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
19812842|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19812843|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19812844|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19812845|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
20330935|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20330936|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330937|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
19812846|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330938|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
19812847|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19812848|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19812849|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812850|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
19812851|NCT00473694|Rocuronium|rocuronium|mesh-list
20330939|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
20330940|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330941|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20330942|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330943|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20330944|NCT00772837|Amoxicillin|amoxicillin|mesh-list
19812852|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
19812853|NCT00473694|Neostigmine|neostigmine|mesh-list
19812854|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19812855|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19812856|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19812857|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812858|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812859|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19812860|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812861|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812862|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
19812863|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812864|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19812865|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
19812866|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19812867|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19812868|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19812869|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19812870|NCT00473746|Dexamethasone|dexamethasone|mesh-list
19812871|NCT00473746|Prednisone|prednisone|mesh-list
19812872|NCT00473746|Prednisolone|prednisolone|mesh-list
19812873|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
19812874|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19812875|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
19812876|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
19812877|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812878|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812879|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19812880|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
19812881|NCT00473746|Hormones|hormones|mesh-ancestor
20330945|NCT00772837|Clarithromycin|clarithromycin|mesh-list
20330946|NCT00772837|Omeprazole|omeprazole|mesh-list
20330947|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647548|NCT02352168|Budesonide|budesonide|mesh-list
19812882|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812883|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19812884|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812885|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19812886|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812887|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812888|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
19812889|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19812890|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
19812891|NCT00473824|Antibodies|antibodies|mesh-list
19812892|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
19647549|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647550|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19647551|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
19647552|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647553|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647554|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19647555|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
19812893|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20330948|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20330949|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20330950|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20330951|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330952|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330953|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20330954|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20330955|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20330956|NCT00772863|Docetaxel|docetaxel|mesh-list
20330957|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20330958|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
20330959|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
20330960|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
19812894|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19812895|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
19812896|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812897|NCT00473837|Chloroquine|chloroquine|mesh-list
19812898|NCT00473837|Amebicides|amebicides|mesh-ancestor
19812899|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19812900|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19812901|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812902|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
19812903|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19812904|NCT00473876|Metformin|metformin|mesh-list
19812905|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19812906|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812907|NCT00473889|Paclitaxel|paclitaxel|mesh-list
19812908|NCT00473889|Carboplatin|carboplatin|mesh-list
19812909|NCT00473889|Vorinostat|vorinostat|mesh-list
19812910|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19812911|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812912|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
19812913|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
19812914|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
19812915|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812916|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19812917|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812918|NCT00474045|Insulin|insulin|mesh-list
19812919|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19812920|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
19812921|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
19812922|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
19812923|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
19812924|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
19812925|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19812926|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812927|NCT00474058|Rotigotine|rotigotine|mesh-list
19812928|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
19812929|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
19812930|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19812931|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812932|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812933|NCT00474123|Simvastatin|simvastatin|mesh-list
19812934|NCT00474123|Ezetimibe|ezetimibe|mesh-list
19812935|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19812936|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19812937|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
19812938|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812939|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19812940|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19812941|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20330961|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330962|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20330963|NCT00772902|Lopinavir|lopinavir|mesh-list
20330964|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20330965|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20330966|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812942|NCT00474175|Benzocaine|benzocaine|mesh-list
19812943|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
19812944|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
19812945|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19812946|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812947|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
19812948|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812949|NCT00474201|Ritonavir|ritonavir|mesh-list
19812950|NCT00474201|Lopinavir|lopinavir|mesh-list
19812951|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
19812952|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19812953|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19812954|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
19812955|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812956|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812957|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19812958|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19812959|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
19812960|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19812961|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19812962|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19812963|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19812964|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
19812965|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19812966|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19812967|NCT00474240|Atorvastatin|atorvastatin|mesh-list
19812968|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19812969|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19812970|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
19812971|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812972|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19812973|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19812974|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812975|NCT00474253|Rocuronium|rocuronium|mesh-list
19812976|NCT00474253|Succinylcholine|succinylcholine|mesh-list
19812977|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19812978|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19812979|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19812980|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19812981|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812982|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19812983|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
19812984|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
19812985|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19812986|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19812987|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812988|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19812989|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
19812990|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19812991|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812992|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20330967|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330968|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
20330969|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20330970|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20330971|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20330972|NCT00772902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20330973|NCT00772902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20330974|NCT00772902|Protease Inhibitors|protease inhibitors|mesh-ancestor
20330975|NCT00772902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20330976|NCT00772902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20330977|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
20330978|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
20330979|NCT00773058|Hormones|hormones|mesh-ancestor
20330980|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330981|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330982|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20330983|NCT00773084|Lisinopril|lisinopril|mesh-list
20330984|NCT00773084|Spironolactone|spironolactone|mesh-list
20330985|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20330986|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
20330987|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20330988|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20330989|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20330990|NCT00773084|Diuretics|diuretics|mesh-ancestor
20330991|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
20330992|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20330993|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
20330994|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19812993|NCT00474383|Hormones|hormones|mesh-ancestor
19812994|NCT00474487|Vaccines|vaccines|mesh-list
19812995|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
19812996|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19812997|NCT00474526|Vaccines|vaccines|mesh-list
19812998|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19812999|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
19813000|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813001|NCT00474539|Vaccines|vaccines|mesh-list
19813002|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19813003|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
19813004|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813005|NCT00474630|Naltrexone|naltrexone|mesh-list
19813006|NCT00474630|Bupropion|bupropion|mesh-list
19813007|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19813008|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19813009|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813010|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
19813011|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813012|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19813013|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
19813014|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813015|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19813016|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19813017|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813018|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813019|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
19813020|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813021|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19813022|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19813023|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813024|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19813025|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19813026|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19813027|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813028|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813029|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813030|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813031|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19813032|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
19813033|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813034|NCT00474786|Sirolimus|sirolimus|mesh-list
19813035|NCT00474786|Sorafenib|sorafenib|mesh-list
19813036|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813037|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813038|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813039|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813040|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19813041|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813042|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19813043|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
19813044|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813045|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
19813046|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813047|NCT00474812|Dasatinib|dasatinib|mesh-list
19813048|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813049|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813050|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813051|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813052|NCT00474851|Norethindrone|norethindrone|mesh-list
19813053|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
19813054|NCT00474851|Estrogens|estrogens|mesh-list
19813055|NCT00474851|Hormones|hormones|mesh-ancestor
19813056|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813057|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813058|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19813059|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19813060|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19813061|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
19813062|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19813063|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19813064|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19813065|NCT00474903|Aspirin|aspirin|mesh-list
19813066|NCT00474903|Esomeprazole|esomeprazole|mesh-list
19813067|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19813068|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813069|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19813070|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813071|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813072|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20330995|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20330996|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20330997|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20330998|NCT00773084|Protective Agents|protective agents|mesh-ancestor
20330999|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
20331000|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331001|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331002|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20331003|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
20331004|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20331005|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20331006|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20331007|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20331008|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331009|NCT00773188|Bevacizumab|bevacizumab|mesh-list
20331010|NCT00773188|Vinorelbine|vinorelbine|mesh-list
20331011|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331012|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331013|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20331014|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20331015|NCT00773188|Growth Substances|growth substances|mesh-ancestor
20331016|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331017|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
20331018|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20331019|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
20331020|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
20331021|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
20331022|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813073|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813074|NCT00474903|Analgesics|analgesics|mesh-ancestor
20331023|NCT00773201|Sotalol|sotalol|mesh-list
20331024|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20331025|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20331026|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
20331027|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331028|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331029|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331030|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19813075|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
19813076|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813077|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813078|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813079|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813080|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19813081|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19813082|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19813083|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19813084|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
19813085|NCT00474929|Everolimus|everolimus|mesh-list
19813086|NCT00474929|Sorafenib|sorafenib|mesh-list
19813087|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813088|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813089|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
19813090|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813091|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813092|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813093|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813094|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19813095|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
19813096|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813097|NCT00474994|Sunitinib|sunitinib|mesh-list
19813098|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813099|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19813100|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19813101|NCT00474994|Growth Substances|growth substances|mesh-ancestor
19813102|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813103|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
19813104|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813105|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813106|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813107|NCT00475020|Vidarabine|vidarabine|mesh-list
19813108|NCT00475020|Fludarabine|fludarabine|mesh-list
19813109|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
20331031|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
20331032|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
20331033|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331034|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
19813110|NCT00475020|Busulfan|busulfan|mesh-list
19813111|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
19813112|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19813113|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813114|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813115|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
19813116|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813117|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813118|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
19813119|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813120|NCT00475020|Antiviral Agents|antiviral agents|mesh-ancestor
19813121|NCT00475020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813122|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
19813123|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19813124|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19813125|NCT00475033|Vaccines|vaccines|mesh-list
19813126|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19813127|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
19813128|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813129|NCT00475085|Dexamethasone|dexamethasone|mesh-list
19813130|NCT00475085|Aprepitant|aprepitant|mesh-list
19813131|NCT00475085|Palonosetron|palonosetron|mesh-list
19813132|NCT00475085|Granisetron|granisetron|mesh-list
19813133|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
19813134|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813135|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
19813136|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
19813137|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813138|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813139|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813140|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
19813141|NCT00475085|Hormones|hormones|mesh-ancestor
19813142|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813143|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813144|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813145|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19813146|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331035|NCT00773331|Hematinics|hematinics|mesh-ancestor
20331036|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
20331037|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20331038|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20331039|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331040|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331041|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331042|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331043|NCT00773552|Urological Agents|urological agents|mesh-ancestor
20331044|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
19647556|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
19647557|NCT02352168|Hormones|hormones|mesh-ancestor
19647558|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647559|NCT02352051|Methylphenidate|methylphenidate|mesh-list
19647560|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19647561|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19647562|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647563|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20331045|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20331046|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
19647564|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19647565|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647566|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813147|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813148|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19813149|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20331047|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164485|NCT00134511|Torcetrapib|torcetrapib|mesh-list
20164486|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20164487|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20164488|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
20164489|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164490|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20164491|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20164492|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164493|NCT00134550|Atorvastatin|atorvastatin|mesh-list
20164494|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20331048|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813150|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
19813151|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19813152|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19813153|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813154|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813155|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19813156|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
19813157|NCT00475150|Cediranib|cediranib|mesh-list
19813158|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813159|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813160|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813161|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813162|NCT00475176|Ribavirin|ribavirin|mesh-list
19813163|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19813164|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
19813165|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813166|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
19813167|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813168|NCT00475215|Rocuronium|rocuronium|mesh-list
19813169|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19813170|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19813171|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19813172|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813173|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813174|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
19813175|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19813176|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
19813177|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19813178|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813179|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19813180|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19813181|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19813182|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
19813183|NCT00475306|Promethazine|promethazine|mesh-list
19813184|NCT00475306|Metoclopramide|metoclopramide|mesh-list
19813185|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19813186|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19813187|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813188|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813189|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
19813190|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
19813191|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
19813192|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813193|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
19813194|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
19813195|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813196|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19813197|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
19813198|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
19813199|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813200|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813201|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19813202|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
19813203|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
19813204|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20164495|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20164496|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
20164497|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813205|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19813206|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
19813207|NCT00475319|Rebamipide|rebamipide|mesh-list
19813208|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20611683|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
19813209|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813210|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
19813211|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813212|NCT00475319|Protective Agents|protective agents|mesh-ancestor
19813213|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813214|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813215|NCT00475423|Rituximab|rituximab|mesh-list
19813216|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19813217|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813218|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
19813219|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813220|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813221|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
19813222|NCT00475501|Finasteride|finasteride|mesh-list
19813223|NCT00475501|Testosterone|testosterone|mesh-list
19813224|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
19813225|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
19813226|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19813227|NCT00475501|Androgens|androgens|mesh-ancestor
19813228|NCT00475501|Hormones|hormones|mesh-ancestor
19813229|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813230|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813231|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813232|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813233|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
19813234|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19813235|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19813236|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813237|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813238|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
19813239|NCT00475501|Urological Agents|urological agents|mesh-ancestor
19813240|NCT00475670|Paclitaxel|paclitaxel|mesh-list
19813241|NCT00475670|Docetaxel|docetaxel|mesh-list
19813242|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19813243|NCT00475670|Trastuzumab|trastuzumab|mesh-list
19813244|NCT00475670|Taxane|taxane|mesh-list
19813245|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19813246|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813247|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
20331049|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20331050|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
20331051|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20331052|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
20331053|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331054|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331055|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20331056|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
19647567|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
19647568|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647569|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19647570|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
19647571|NCT02351973|Amiloride|amiloride|mesh-list
19647572|NCT02351973|Diuretics|diuretics|mesh-ancestor
19647573|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
19647574|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647575|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19647576|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19647577|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647578|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647579|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19647580|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19647581|NCT02352155|Epinephrine|epinephrine|mesh-list
19647582|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19647583|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19647584|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
19647585|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647586|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331057|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
20331058|NCT00773578|Protective Agents|protective agents|mesh-ancestor
20331059|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19813248|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
19813249|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
19813250|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331060|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
20331061|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19813251|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19813252|NCT00475735|Methylphenidate|methylphenidate|mesh-list
19813253|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19813254|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813255|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19813256|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20331062|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20331063|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331064|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331065|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20331066|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813257|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813258|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813259|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
19813260|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813261|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19813262|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
19813263|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813264|NCT00475865|Teriflunomide|teriflunomide|mesh-list
19813265|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
19813266|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
19813267|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19813268|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
19813269|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813270|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813271|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813272|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19813273|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813274|NCT00475865|Analgesics|analgesics|mesh-ancestor
19813275|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
19813276|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813277|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813278|NCT00475878|Citalopram|citalopram|mesh-list
19813279|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19813280|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19813281|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813282|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813283|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813284|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
19813285|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813286|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19813287|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
19813288|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20331067|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331068|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331069|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331070|NCT00773630|Cilostazol|cilostazol|mesh-list
20331071|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20331072|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
20331073|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331074|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813289|NCT00475904|Gabapentin|gabapentin|mesh-list
19813290|NCT00475904|Analgesics|analgesics|mesh-ancestor
19813291|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
19813292|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813293|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813294|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
19813295|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19813296|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19813297|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813298|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813299|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19813300|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19813301|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813302|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813303|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
19813304|NCT00476008|Memantine|memantine|mesh-list
19813305|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19813306|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19813307|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
19813308|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331075|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20331076|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
20331077|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20331078|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20331079|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331080|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20331081|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
20331082|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20331083|NCT00773630|Protective Agents|protective agents|mesh-ancestor
20331084|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20331085|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20331086|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331087|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
20331088|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20331089|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20331090|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
19813309|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813310|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813311|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19813312|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19813313|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
19813314|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19813315|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
19813316|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19813317|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813318|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19813319|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19813320|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19813321|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
19813322|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813323|NCT00476086|Gemcitabine|gemcitabine|mesh-list
19813324|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
19813325|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813326|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
19813327|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813328|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813329|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
19813330|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813331|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813332|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813333|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
19813334|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813335|NCT00476151|Ketamine|ketamine|mesh-list
19813336|NCT00476151|Amitriptyline|amitriptyline|mesh-list
19813337|NCT00476151|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19813338|NCT00476151|Analgesics|analgesics|mesh-ancestor
20331091|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331092|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20331093|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20331094|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331095|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331096|NCT00773812|Mecamylamine|mecamylamine|mesh-list
19813339|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
19813340|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813341|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813342|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19813343|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19813344|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
19813345|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
19813346|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813347|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19813348|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19813349|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813350|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813351|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19813352|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
19813353|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813354|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813355|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19813356|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20331097|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20164498|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20164499|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20164500|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164501|NCT00134641|Gemcitabine|gemcitabine|mesh-list
20164502|NCT00134641|Vinorelbine|vinorelbine|mesh-list
20164503|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20164504|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
20164505|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164506|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331098|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20331099|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
20331100|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331101|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331102|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20331103|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20164507|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
20164508|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331104|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331105|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331106|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331107|NCT00773916|Methylphenidate|methylphenidate|mesh-list
20331108|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20331109|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331110|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20331111|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20331112|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331113|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331114|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
20331115|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331116|NCT00774007|Mesalamine|mesalamine|mesh-list
20331117|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20331118|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331119|NCT00774007|Analgesics|analgesics|mesh-ancestor
20331120|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
20331121|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331122|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331123|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331124|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331125|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
20331126|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19647587|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647588|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19647589|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19647590|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
19647591|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647592|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19647593|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
19647594|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
19647595|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
19647596|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19664654|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664655|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664656|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19664657|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19664658|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664659|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664660|NCT05100303|Cytarabine|cytarabine|mesh-list
19664661|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
19664662|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19664663|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
19664664|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664665|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664666|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
19664667|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664668|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664669|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
19664670|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664671|NCT05100303|Analgesics|analgesics|mesh-ancestor
19664672|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
19664673|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664674|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19664675|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19813357|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813358|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
19813359|NCT00476151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19813360|NCT00476151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19813361|NCT00476229|Rituximab|rituximab|mesh-list
19813362|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
19813363|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19813364|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331127|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331128|NCT00774072|Tobramycin|tobramycin|mesh-list
20331129|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331130|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331131|NCT00774111|Dolutegravir|dolutegravir|mesh-list
20331132|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20331133|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19813365|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813366|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
19813367|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813368|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813369|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834678|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19834679|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19834680|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19834681|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834682|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834683|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
19834684|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
19834685|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834686|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834687|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834688|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
19834689|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19834690|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834691|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834692|NCT00596687|Insulin|insulin|mesh-list
19834693|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19834694|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
19834695|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
19834696|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19834697|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834698|NCT00596752|Alprostadil|alprostadil|mesh-list
19834699|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19834700|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
19834701|NCT00596752|Urological Agents|urological agents|mesh-ancestor
19834702|NCT00596817|Vortioxetine|vortioxetine|mesh-list
20331134|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331135|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834703|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
19834704|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834705|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19834706|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19834707|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834708|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834709|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19834710|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19834711|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834712|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834713|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834714|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
19834715|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19834716|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19834717|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19834718|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19834719|NCT00596830|Paclitaxel|paclitaxel|mesh-list
19834720|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19834721|NCT00596830|Carboplatin|carboplatin|mesh-list
19834722|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19834723|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834724|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
19834725|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
19834726|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834727|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331136|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20331137|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20331138|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
20164509|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164510|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164511|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
20164512|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164513|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164514|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
20164515|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
20164516|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
20164517|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20164518|NCT00134654|Estrogens|estrogens|mesh-ancestor
20164519|NCT00134654|Hormones|hormones|mesh-ancestor
20164520|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164521|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164522|NCT00134667|Verteporfin|verteporfin|mesh-list
20164523|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20164524|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164525|NCT00134680|Trastuzumab|trastuzumab|mesh-list
20164526|NCT00134680|Letrozole|letrozole|mesh-list
20164527|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20164528|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164529|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20164530|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20164531|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164532|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164533|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20164534|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
20164535|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164536|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164537|NCT00134693|Prednisolone|prednisolone|mesh-list
20164538|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20164539|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
20164540|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19813370|NCT00476242|Naltrexone|naltrexone|mesh-list
19813371|NCT00476242|Memantine|memantine|mesh-list
20164541|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
20164542|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20164543|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
19813372|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19813373|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19813374|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
19813375|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164544|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164545|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
20164546|NCT00134693|Hormones|hormones|mesh-ancestor
20164547|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164548|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647597|NCT02351895|Copper|copper|mesh-list
19647598|NCT02351895|Trace Elements|trace elements|mesh-ancestor
20164549|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164550|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164551|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
20164552|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
20164553|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164554|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164555|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20164556|NCT00134693|Protective Agents|protective agents|mesh-ancestor
20164557|NCT00134706|Carboplatin|carboplatin|mesh-list
20164558|NCT00134706|Docetaxel|docetaxel|mesh-list
20164559|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164560|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
19647599|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
19813376|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813377|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647600|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647601|NCT02351882|Nabilone|nabilone|mesh-list
19647602|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
19647603|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
19647604|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647605|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647606|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647607|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19813378|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20164561|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
20164562|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
19813379|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19647608|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19813380|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19813381|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19813382|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
19813383|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813384|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19813385|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813386|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813387|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813388|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813389|NCT00476593|Dexamethasone|dexamethasone|mesh-list
19813390|NCT00476593|Diclofenac|diclofenac|mesh-list
19813391|NCT00476593|Lactitol|lactitol|mesh-list
19813392|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19813393|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813394|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
19813395|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
19813396|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813397|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813398|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813399|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
19813400|NCT00476593|Hormones|hormones|mesh-ancestor
19813401|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813402|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813403|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813404|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19813405|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19813406|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813407|NCT00476593|Analgesics|analgesics|mesh-ancestor
19813408|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
19813409|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813410|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19813411|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813412|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813413|NCT00476593|Cathartics|cathartics|mesh-ancestor
19813414|NCT00476645|Fulvestrant|fulvestrant|mesh-list
19813415|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813416|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813417|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19813418|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19813419|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
19813420|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813421|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813422|NCT00476788|Insulin|insulin|mesh-list
19813423|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19813424|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19813425|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813426|NCT00476957|Sirolimus|sirolimus|mesh-list
19813427|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19813428|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813429|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19813430|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813431|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
19813432|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813433|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
19813434|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813435|NCT00476996|Methotrexate|methotrexate|mesh-list
19813436|NCT00476996|Leflunomide|leflunomide|mesh-list
19813437|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
20164563|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164564|NCT00134745|Estradiol|estradiol|mesh-list
20164565|NCT00134745|Estrogens|estrogens|mesh-ancestor
20164566|NCT00134745|Hormones|hormones|mesh-ancestor
20164567|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164568|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164569|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20164570|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20164571|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164572|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
20164573|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20164574|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20164575|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20164576|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164577|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813438|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20331139|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331140|NCT00774189|Clarithromycin|clarithromycin|mesh-list
19813439|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
19813440|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19813441|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813442|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813443|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
19813444|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813445|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813446|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
20331141|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331142|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647609|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647610|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19647611|NCT02352311|Tadalafil|tadalafil|mesh-list
19813447|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813448|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19813449|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813450|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
19813451|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813452|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19813453|NCT00477087|Molgramostim|molgramostim|mesh-list
19813454|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
19813455|NCT00477087|Sargramostim|sargramostim|mesh-list
19813456|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
19813457|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813458|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813459|NCT00477087|Analgesics|analgesics|mesh-ancestor
19813460|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
19813461|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813462|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19813463|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19813464|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164578|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
20164579|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647612|NCT02352311|Dutasteride|dutasteride|mesh-list
19647613|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
19647614|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19647615|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19647616|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647617|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647618|NCT02352311|Urological Agents|urological agents|mesh-ancestor
19647619|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19647620|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19647621|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
19647622|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164580|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164581|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20164582|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164583|NCT00134875|Buprenorphine|buprenorphine|mesh-list
20164584|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20164585|NCT00134875|Naloxone|naloxone|mesh-list
19647623|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647624|NCT02352025|Equol|equol|mesh-list
19647625|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
20164586|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20164587|NCT00134875|Narcotics|narcotics|mesh-ancestor
20164588|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20164589|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164590|NCT00134875|Analgesics|analgesics|mesh-ancestor
20164591|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
20164592|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164593|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20164594|NCT00134888|Buprenorphine|buprenorphine|mesh-list
20164595|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20164596|NCT00134888|Naloxone|naloxone|mesh-list
20164597|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20164598|NCT00134888|Narcotics|narcotics|mesh-ancestor
20164599|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20164600|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164601|NCT00134888|Analgesics|analgesics|mesh-ancestor
20164602|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
20331143|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19647626|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20164603|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813465|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813466|NCT00477165|Citalopram|citalopram|mesh-list
19813467|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19813468|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19813469|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813470|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813471|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813472|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
19813473|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813474|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19813475|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
19813476|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20331144|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331145|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331146|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20331147|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20331148|NCT00774241|Bevacizumab|bevacizumab|mesh-list
20331149|NCT00774241|Docetaxel|docetaxel|mesh-list
20331150|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331151|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331152|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20331153|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20331154|NCT00774241|Growth Substances|growth substances|mesh-ancestor
20331155|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331156|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
20331157|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
20331158|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
20331159|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
19813477|NCT00477191|Etanercept|etanercept|mesh-list
19813478|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19813479|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813480|NCT00477191|Analgesics|analgesics|mesh-ancestor
19813481|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
19813482|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813483|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813484|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813485|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813486|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813487|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813488|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
19813489|NCT00477204|Simvastatin|simvastatin|mesh-list
19813490|NCT00477204|Ezetimibe|ezetimibe|mesh-list
19813491|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19813492|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19813493|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19813494|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
19813495|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813496|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19813497|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19813498|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813499|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
19813500|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813501|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813502|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813503|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813504|NCT00477295|Carbamazepine|carbamazepine|mesh-list
19813505|NCT00477295|Zonisamide|zonisamide|mesh-list
19813506|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
19813507|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
19813508|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19813509|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813510|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813511|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813512|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813513|NCT00477295|Analgesics|analgesics|mesh-ancestor
19813514|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
20164604|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20164605|NCT00134914|Buprenorphine|buprenorphine|mesh-list
20164606|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20164607|NCT00134914|Narcotics|narcotics|mesh-ancestor
20164608|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20164609|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164610|NCT00134914|Analgesics|analgesics|mesh-ancestor
20164611|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
19813515|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813516|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19813517|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813518|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813519|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19813520|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19813521|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19813522|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19813523|NCT00477334|Famciclovir|famciclovir|mesh-list
19813524|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
19813525|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813526|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19813527|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813528|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813529|NCT00477386|Decitabine|decitabine|mesh-list
19813530|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813531|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
19813532|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813533|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813534|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813535|NCT00477451|Alprazolam|alprazolam|mesh-list
19813536|NCT00477451|Doxapram|doxapram|mesh-list
19813537|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19813538|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813539|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813540|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19813541|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20331160|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331161|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
20331162|NCT00774280|Busulfan|busulfan|mesh-list
19813542|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813543|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
19813544|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
19813545|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813546|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813547|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19813548|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
19813549|NCT00477464|Capecitabine|capecitabine|mesh-list
19813550|NCT00477464|Lapatinib|lapatinib|mesh-list
19813551|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813552|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
19813553|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813554|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813555|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20331163|NCT00774280|Fludarabine|fludarabine|mesh-list
20331164|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20331165|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
20331166|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813556|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813557|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19813558|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
19813559|NCT00477490|Coagulants|coagulants|mesh-ancestor
19813560|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20331167|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19647627|NCT02352025|Estrogens|estrogens|mesh-ancestor
19647628|NCT02352025|Hormones|hormones|mesh-ancestor
19647629|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647630|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647631|NCT02351908|Tenofovir|tenofovir|mesh-list
19647632|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
19647633|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19647634|NCT02351908|Dolutegravir|dolutegravir|mesh-list
19647635|NCT02351908|Cobicistat|cobicistat|mesh-list
19647636|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19647637|NCT02351908|Elvitegravir|elvitegravir|mesh-list
19647638|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
19647639|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647640|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19647641|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19647642|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647643|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647644|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19813561|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
19813562|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813563|NCT00477594|Mipomersen|mipomersen|mesh-list
19813564|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19813565|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19813566|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
19813567|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813568|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19813569|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
19813570|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
19813571|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813572|NCT00477607|Protective Agents|protective agents|mesh-ancestor
19813573|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813574|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
19813575|NCT00477607|Vitamins|vitamins|mesh-ancestor
19813576|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
19813577|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19813578|NCT00477633|Norethindrone|norethindrone|mesh-list
19813579|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
19813580|NCT00477633|Estradiol|estradiol|mesh-list
19813581|NCT00477633|Estrogens|estrogens|mesh-ancestor
19813582|NCT00477633|Hormones|hormones|mesh-ancestor
19813583|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813584|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813585|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19813586|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
19813587|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19813588|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19813589|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19813590|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19813591|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19813592|NCT00477659|Donepezil|donepezil|mesh-list
19813593|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19813594|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813595|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813596|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
19813597|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813598|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813599|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
19813600|NCT00477672|Pimavanserin|pimavanserin|mesh-list
19813601|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19813602|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19813603|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19813604|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19813605|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813606|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813607|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19813608|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19813609|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19813610|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
19813611|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813612|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813613|NCT00477750|Prednisone|prednisone|mesh-list
19813614|NCT00477750|Lenalidomide|lenalidomide|mesh-list
19813615|NCT00477750|Melphalan|melphalan|mesh-list
19813616|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813617|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
19813618|NCT00477750|Hormones|hormones|mesh-ancestor
19813619|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813620|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813621|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813622|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813623|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
19813624|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19813625|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19813626|NCT00477750|Growth Substances|growth substances|mesh-ancestor
19813627|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
19813628|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19813629|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
19813630|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164612|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164613|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20164614|NCT00134953|Rivastigmine|rivastigmine|mesh-list
20164615|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20164616|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331168|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19813631|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19813632|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813633|NCT00477971|Dexamethasone|dexamethasone|mesh-list
19813634|NCT00477971|Melphalan|melphalan|mesh-list
19813635|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813636|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
19813637|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
19813638|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813639|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813640|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813641|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
19813642|NCT00477971|Hormones|hormones|mesh-ancestor
19813643|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813644|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813645|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813646|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
19813647|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19813648|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
19813649|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813650|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19813651|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813652|NCT00478023|Morphine|morphine|mesh-list
19813653|NCT00478023|Tapentadol|tapentadol|mesh-list
19813654|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19813655|NCT00478023|Narcotics|narcotics|mesh-ancestor
19813656|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19813657|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331169|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
20331170|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331171|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331172|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20331173|NCT00774319|Cisplatin|cisplatin|mesh-list
20331174|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331175|NCT00774358|Aldesleukin|aldesleukin|mesh-list
20331176|NCT00774358|Interleukin-2|interleukin-2|mesh-list
20331177|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331178|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331179|NCT00774358|Analgesics|analgesics|mesh-ancestor
20331180|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
20331181|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331182|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331183|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20331184|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20331185|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
20331186|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331187|NCT00774423|Riluzole|riluzole|mesh-list
20331188|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
20331189|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20331190|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20331191|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813658|NCT00478023|Analgesics|analgesics|mesh-ancestor
19813659|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
19813660|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813661|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19813662|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19813663|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813664|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813665|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
19813666|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813667|NCT00478036|Prednisolone|prednisolone|mesh-list
19813668|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
19813669|NCT00478036|Ketorolac|ketorolac|mesh-list
19813670|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19813671|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19813672|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813673|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
19813674|NCT00478036|Hormones|hormones|mesh-ancestor
19813675|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813676|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813677|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813678|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813679|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331192|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331193|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331194|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19813680|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813681|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19813682|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813683|NCT00478036|Analgesics|analgesics|mesh-ancestor
19813684|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
19813685|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813686|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19813687|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813688|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813689|NCT00478036|Laxatives|laxatives|mesh-ancestor
19813690|NCT00478140|Trastuzumab|trastuzumab|mesh-list
19813691|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19813692|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813693|NCT00478192|Conivaptan|conivaptan|mesh-list
19813694|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19813695|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813696|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
20331195|NCT00774423|Protective Agents|protective agents|mesh-ancestor
20331196|NCT00774462|Rituximab|rituximab|mesh-list
20331197|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19813697|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813698|NCT00478205|Donepezil|donepezil|mesh-list
19813699|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20331198|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813700|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813701|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813702|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
19813703|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813704|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813705|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
19813706|NCT00478218|Dexamethasone|dexamethasone|mesh-list
19813707|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
19813708|NCT00478218|Lenalidomide|lenalidomide|mesh-list
19813709|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813710|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
19813711|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813712|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813713|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19813714|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
19813715|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813716|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813717|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19813718|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813719|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
19813720|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
19813721|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813722|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813723|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
19813724|NCT00478218|Hormones|hormones|mesh-ancestor
19813725|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164617|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164618|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
20164619|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164620|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164621|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20164622|NCT00134953|Protective Agents|protective agents|mesh-ancestor
20164623|NCT00134966|Levodopa|levodopa|mesh-list
19813726|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813727|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19813728|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19813729|NCT00478218|Growth Substances|growth substances|mesh-ancestor
19813730|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
19813731|NCT00478231|Maraviroc|maraviroc|mesh-list
20164624|NCT00134966|Carbidopa|carbidopa|mesh-list
20164625|NCT00134966|Entacapone|entacapone|mesh-list
20164626|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20164627|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20164628|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
20164629|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164630|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164631|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331199|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
20331200|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813732|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19813733|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19813734|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813735|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19813736|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19813737|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
19813738|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813739|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19813740|NCT00478244|Vidarabine|vidarabine|mesh-list
19813741|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
19813742|NCT00478244|Busulfan|busulfan|mesh-list
19813743|NCT00478244|Fludarabine|fludarabine|mesh-list
19813744|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
19813745|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813746|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
19813747|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813748|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813749|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19813750|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
19813751|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813752|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813753|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19813754|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20331201|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331202|NCT00774475|Clopidogrel|clopidogrel|mesh-list
20331203|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20331204|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20331205|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20331206|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20331207|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
20331208|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331209|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331210|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331211|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20331212|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20331213|NCT00774488|Incretins|incretins|mesh-ancestor
20331214|NCT00774488|Hormones|hormones|mesh-ancestor
20331215|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331216|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331217|NCT00774501|Anesthetics|anesthetics|mesh-list
19813755|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
19813756|NCT00478244|Antiviral Agents|antiviral agents|mesh-ancestor
19813757|NCT00478244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813758|NCT00478335|Calcitonin|calcitonin|mesh-list
19813759|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
19813760|NCT00478335|Indomethacin|indomethacin|mesh-list
19813761|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19813762|NCT00478335|Amiloride|amiloride|mesh-list
19813763|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
19813764|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19813765|NCT00478335|Katacalcin|katacalcin|mesh-list
20164632|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20164633|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164634|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20164635|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
20164636|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20164637|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
20164638|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164639|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164640|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20164641|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
20164642|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20164643|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20164644|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20164645|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
20164646|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164647|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813766|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
19813767|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19813768|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19813769|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813770|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813771|NCT00478335|Urological Agents|urological agents|mesh-ancestor
19813772|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19813773|NCT00478335|Diuretics|diuretics|mesh-ancestor
19813774|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
19813775|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813776|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19813777|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813778|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19813779|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19813780|NCT00478335|Analgesics|analgesics|mesh-ancestor
19813781|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
19813782|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813783|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331218|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20331219|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331220|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
20331221|NCT00774527|Fludarabine|fludarabine|mesh-list
20331222|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20331223|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20331224|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
20331225|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331226|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331227|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20331228|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
20331229|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331230|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813784|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19813785|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
19813786|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
19813787|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19813788|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19813789|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19813790|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19813791|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19813792|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19813793|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19813794|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19813795|NCT00478361|Gemcitabine|gemcitabine|mesh-list
19813796|NCT00478361|Paclitaxel|paclitaxel|mesh-list
19813797|NCT00478361|Doxorubicin|doxorubicin|mesh-list
19813798|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19813799|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19813800|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813801|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
19813802|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
19813803|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
19813804|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813805|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813806|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
19813807|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
19813808|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813809|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813810|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813811|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
19813812|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813813|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19813814|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19813815|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19813816|NCT00478426|Sunitinib|sunitinib|mesh-list
19813817|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813818|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19813819|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19813820|NCT00478426|Growth Substances|growth substances|mesh-ancestor
19813821|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813822|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
19813823|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813824|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813825|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813826|NCT00478569|Hormones|hormones|mesh-list
19813827|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
19834728|NCT00597038|Dasatinib|dasatinib|mesh-list
19813828|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813829|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813830|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19813831|NCT00478608|Sirolimus|sirolimus|mesh-list
19813832|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19813833|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813834|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19813835|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813836|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
19813837|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19813838|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
19813839|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813840|NCT00478777|Dexamethasone|dexamethasone|mesh-list
19813841|NCT00478777|Lenalidomide|lenalidomide|mesh-list
19813842|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813843|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
19813844|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
19813845|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813846|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647645|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19647646|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19647647|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19647648|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19647649|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19813847|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813848|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
19813849|NCT00478777|Hormones|hormones|mesh-ancestor
19813850|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813851|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19813852|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813853|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
19813854|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19813855|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19813856|NCT00478777|Growth Substances|growth substances|mesh-ancestor
19813857|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
19813858|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19813859|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
19813860|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19813861|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19813862|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813863|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813864|NCT00478881|Urological Agents|urological agents|mesh-ancestor
19813865|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
19813866|NCT00479037|Hormones|hormones|mesh-list
19813867|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
19813868|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19813869|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813870|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19813871|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19813872|NCT00479089|Dexamethasone|dexamethasone|mesh-list
19813873|NCT00479089|Docetaxel|docetaxel|mesh-list
20331231|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20347993|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347994|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20347995|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20347996|NCT00863096|Vaccines|vaccines|mesh-list
19813874|NCT00479089|Gefitinib|gefitinib|mesh-list
19813875|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19813876|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
19813877|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
19813878|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813879|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813880|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19813881|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
19647650|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19647651|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19813882|NCT00479089|Hormones|hormones|mesh-ancestor
19813883|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19834729|NCT00597038|Dacarbazine|dacarbazine|mesh-list
20347997|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
20347998|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813884|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20331232|NCT00774540|Ketorolac|ketorolac|mesh-list
20331233|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20331234|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20331235|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331236|NCT00774540|Analgesics|analgesics|mesh-ancestor
19813885|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813886|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
19813887|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
19813888|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
19813889|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813890|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813891|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813892|NCT00479115|Plerixafor|plerixafor|mesh-list
19813893|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19813894|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19813895|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
19813896|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19813897|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
19813898|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19813899|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19813900|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19813901|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19813902|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813903|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
19813904|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813905|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813906|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19813907|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19813908|NCT00479232|Decitabine|decitabine|mesh-list
19813909|NCT00479232|Vorinostat|vorinostat|mesh-list
19813910|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813911|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
19813912|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813913|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813914|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813915|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19813916|NCT00479336|Tolvaptan|tolvaptan|mesh-list
19813917|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19813918|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813919|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
19813920|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813921|NCT00479388|Niacin|niacin|mesh-list
19813922|NCT00479388|Atorvastatin|atorvastatin|mesh-list
19813923|NCT00479388|Simvastatin|simvastatin|mesh-list
19813924|NCT00479388|Calcium|calcium|mesh-list
19813925|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19813926|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813927|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19813928|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19813929|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
19813930|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813931|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19813932|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19813933|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813934|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
19813935|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
19813936|NCT00479388|Vitamins|vitamins|mesh-ancestor
19813937|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
19813938|NCT00479401|Pramipexole|pramipexole|mesh-list
19813939|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
19813940|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813941|NCT00479401|Protective Agents|protective agents|mesh-ancestor
19813942|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164648|NCT00134992|Prednisolone|prednisolone|mesh-list
20164649|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20164650|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
20164651|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20164652|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
20164653|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20164654|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
20164655|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164656|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
20164657|NCT00134992|Hormones|hormones|mesh-ancestor
20331237|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
20347999|NCT00863148|Busulfan|busulfan|mesh-list
19813943|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19813944|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19813945|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
19813946|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
19813947|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19813948|NCT00479466|Metformin|metformin|mesh-list
19813949|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19813950|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813951|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
19813952|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19813953|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
19813954|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813955|NCT00479674|Paclitaxel|paclitaxel|mesh-list
19813956|NCT00479674|Bevacizumab|bevacizumab|mesh-list
19813957|NCT00479674|Carboplatin|carboplatin|mesh-list
19813958|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19813959|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19813960|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813961|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
19813962|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19813963|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19813964|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813965|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19813966|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19813967|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19813968|NCT00479674|Growth Substances|growth substances|mesh-ancestor
19813969|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813970|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
19813971|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
19813972|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19813973|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
19813974|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813975|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
19813976|NCT00479687|Protective Agents|protective agents|mesh-ancestor
19813977|NCT00479856|Paclitaxel|paclitaxel|mesh-list
19813978|NCT00479856|Docetaxel|docetaxel|mesh-list
19813979|NCT00479856|Capecitabine|capecitabine|mesh-list
19813980|NCT00479856|Lapatinib|lapatinib|mesh-list
19813981|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19813982|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19813983|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
19813984|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
19813985|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
19813986|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813987|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19813988|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
20331238|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331239|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19813989|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19813990|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813991|NCT00479882|Simvastatin|simvastatin|mesh-list
20164658|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164659|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164660|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164661|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164662|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
20164663|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
20164664|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164665|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164666|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20164667|NCT00134992|Protective Agents|protective agents|mesh-ancestor
20164668|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
19647652|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647653|NCT02351869|Midazolam|midazolam|mesh-list
19647654|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
19647655|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19647656|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19647657|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647658|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647659|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19647660|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19647661|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19647662|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19647663|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
19647664|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
19813992|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20164669|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164670|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20164671|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164672|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164673|NCT00135018|Celecoxib|celecoxib|mesh-list
20164674|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20164675|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20164676|NCT00135018|Analgesics|analgesics|mesh-ancestor
20164677|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
19813993|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19813994|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
19813995|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19813996|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19813997|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19813998|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19813999|NCT00480441|Dronabinol|dronabinol|mesh-list
19814000|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
19814001|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814002|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19814003|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19814004|NCT00480441|Analgesics|analgesics|mesh-ancestor
19814005|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
19814006|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814007|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19814008|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19814009|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814010|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814011|NCT00480441|Hormones|hormones|mesh-ancestor
19814012|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814013|NCT00480532|Doxycycline|doxycycline|mesh-list
20331240|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331241|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331242|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20331243|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814014|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
19814015|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19814016|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19814017|NCT00480532|Estradiol|estradiol|mesh-list
19814018|NCT00480532|Estrogens|estrogens|mesh-ancestor
19814019|NCT00480532|Hormones|hormones|mesh-ancestor
19814020|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814021|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814022|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19814023|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
19814024|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19814025|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19814026|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19814027|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814028|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
19814029|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19814030|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19814031|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19814032|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19814033|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19814034|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19814035|NCT00480636|Dalteparin|dalteparin|mesh-list
19814036|NCT00480636|Tinzaparin|tinzaparin|mesh-list
19814037|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19814038|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
19814039|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19814040|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19814041|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814042|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
19814043|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19814044|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814045|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164678|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814046|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331244|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814047|NCT00480740|Analgesics|analgesics|mesh-ancestor
19814048|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
19814049|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814050|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19814051|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20331245|NCT00774605|Varenicline|varenicline|mesh-list
20331246|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20331247|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19814052|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19814053|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19814054|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814055|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814056|NCT00480857|Docetaxel|docetaxel|mesh-list
19814057|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814058|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814059|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814060|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814061|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814062|NCT00480987|Vidarabine|vidarabine|mesh-list
19814063|NCT00480987|Cytarabine|cytarabine|mesh-list
19814064|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
19814065|NCT00480987|Fludarabine|fludarabine|mesh-list
19814066|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
19814067|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814068|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19814069|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
19814070|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814071|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814072|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
19814073|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814074|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
19814075|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814076|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
19814077|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19814078|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
19814079|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331248|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331249|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331250|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331251|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331252|NCT00774644|Clarithromycin|clarithromycin|mesh-list
20331253|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331254|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331255|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20331256|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331257|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331258|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20331259|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20331260|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
20331261|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20331262|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20331263|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
20331264|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331265|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20331266|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20331267|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331268|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647665|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
19647666|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
19647667|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647668|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647669|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19647670|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19647671|NCT02351869|Analgesics|analgesics|mesh-ancestor
19647672|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
19647673|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647674|NCT02351765|Cisplatin|cisplatin|mesh-list
19647675|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647676|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
19647677|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
19647678|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19647679|NCT02351687|Albendazole|albendazole|mesh-list
19647680|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
19647681|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19814080|NCT00481078|Paclitaxel|paclitaxel|mesh-list
19814081|NCT00481078|Carboplatin|carboplatin|mesh-list
19814082|NCT00481078|Vorinostat|vorinostat|mesh-list
19647682|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19647683|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647684|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19647685|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647686|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647687|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19647688|NCT02351687|Renal Agents|renal agents|mesh-ancestor
19647689|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
19647690|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
19647691|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19647692|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
19647693|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
19647694|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
19647695|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647696|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
19647697|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
19647698|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19647699|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19647700|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647701|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814083|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814084|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331269|NCT00774696|Clarithromycin|clarithromycin|mesh-list
20331270|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19814085|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814086|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814087|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814088|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814089|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19814090|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814091|NCT00481195|Modafinil|modafinil|mesh-list
19814092|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19814093|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814094|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19814095|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19814096|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19814097|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814098|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
19814099|NCT00481247|Dasatinib|dasatinib|mesh-list
19814100|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814101|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814102|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814103|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814104|NCT00481351|Simvastatin|simvastatin|mesh-list
19814105|NCT00481351|Ezetimibe|ezetimibe|mesh-list
19814106|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19814107|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19814108|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
19814109|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814110|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19814111|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19814112|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814113|NCT00481676|Omalizumab|omalizumab|mesh-list
19814114|NCT00481676|Loratadine|loratadine|mesh-list
19814115|NCT00481676|Clemastine|clemastine|mesh-list
19814116|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19814117|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19814118|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19814119|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
20331271|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331272|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20331273|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331274|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331275|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20331276|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19647702|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647703|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814120|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
19814121|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647704|NCT02351622|Dexamethasone|dexamethasone|mesh-list
19647705|NCT02351622|Caffeic acid|caffeic acid|mesh-list
19647706|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647707|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
19647708|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
19647709|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647710|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647711|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647712|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
19647713|NCT02351622|Hormones|hormones|mesh-ancestor
19664676|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664677|NCT05100186|Dexamethasone|dexamethasone|mesh-list
19664678|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19664679|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
19664680|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
19664681|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664682|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664683|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664684|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
19664685|NCT05100186|Hormones|hormones|mesh-ancestor
19664686|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664687|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19664688|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664689|NCT05100017|Methocarbamol|methocarbamol|mesh-list
19664690|NCT05100017|Oxybutynin|oxybutynin|mesh-list
19664691|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
19664692|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
19664693|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664694|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664695|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19664696|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19664697|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
19664698|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664699|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664700|NCT05100017|Urological Agents|urological agents|mesh-ancestor
19664701|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19664702|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19664703|NCT05099848|Leucovorin|leucovorin|mesh-list
19664704|NCT05099848|Fluorouracil|fluorouracil|mesh-list
19664705|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
19664706|NCT05099848|Apatinib|apatinib|mesh-list
19664707|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
19664708|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664709|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19664710|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664711|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664712|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
19664713|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664714|NCT05099848|Antidotes|antidotes|mesh-ancestor
19664715|NCT05099848|Protective Agents|protective agents|mesh-ancestor
19664716|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
19664717|NCT05099848|Vitamins|vitamins|mesh-ancestor
19664718|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
19664719|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19664720|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664721|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
19664722|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19664723|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
19664724|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664725|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
19664726|NCT05099718|Protective Agents|protective agents|mesh-ancestor
19664727|NCT05099614|Naloxone|naloxone|mesh-list
19664728|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19664729|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664730|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
19664731|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664732|NCT05099601|Silymarin|silymarin|mesh-list
19664733|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
19664734|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664735|NCT05099601|Protective Agents|protective agents|mesh-ancestor
19664736|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664737|NCT05099575|Oxytocin|oxytocin|mesh-list
19664738|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
19664739|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19664740|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664741|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19664742|NCT05099198|Glimepiride|glimepiride|mesh-list
19814122|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
19814123|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
19814124|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19814125|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19814126|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
19814127|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
19814128|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814129|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814130|NCT00481767|Vaccines|vaccines|mesh-list
19814131|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
19814132|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814133|NCT00481832|Cyclosporine|cyclosporine|mesh-list
19814134|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
19814135|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
19814136|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19814137|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19814138|NCT00481832|Prednisolone|prednisolone|mesh-list
19814139|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
19814140|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
19814141|NCT00481832|Carmustine|carmustine|mesh-list
19814142|NCT00481832|Rituximab|rituximab|mesh-list
19814143|NCT00481832|Etoposide|etoposide|mesh-list
19814144|NCT00481832|Cyclosporins|cyclosporins|mesh-list
19814145|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19814146|NCT00481832|Lenograstim|lenograstim|mesh-list
19814147|NCT00481832|Sargramostim|sargramostim|mesh-list
19814148|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19814149|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
19814150|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814151|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
19814152|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814153|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814154|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19814155|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
19814156|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814157|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814158|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19814159|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19814160|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814161|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19814162|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19814163|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814164|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19814165|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
19814166|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814167|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
19814168|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19814169|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19814170|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19814171|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
19814172|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19814173|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814174|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
19814175|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
19814176|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814177|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19814178|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
19814179|NCT00481832|Hormones|hormones|mesh-ancestor
19814180|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814181|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20331277|NCT00774722|Metronidazole|metronidazole|mesh-list
19647714|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647715|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19647716|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647717|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
19647718|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647719|NCT02351622|Protective Agents|protective agents|mesh-ancestor
19647720|NCT02351804|Dexamethasone|dexamethasone|mesh-list
19647721|NCT02351804|Ropivacaine|ropivacaine|mesh-list
19647722|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647723|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
19814182|NCT00481832|Protective Agents|protective agents|mesh-ancestor
19814183|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20331278|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814184|NCT00481845|Anastrozole|anastrozole|mesh-list
19814185|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19814186|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814187|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19814188|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19814189|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814190|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814191|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19814192|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
19814193|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814194|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814195|NCT00481871|Vitamins|vitamins|mesh-list
19814196|NCT00481871|Folic Acid|folic acid|mesh-list
19814197|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
19814198|NCT00481871|Hydroxocobalamin|hydroxocobalamin|mesh-list
19814199|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
19814200|NCT00481871|Gemcitabine|gemcitabine|mesh-list
19814201|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19814202|NCT00481871|Aminopterin|aminopterin|mesh-list
19814203|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
19814204|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814205|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20331279|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19647724|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
19647725|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647726|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647727|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647728|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
19647729|NCT02351804|Hormones|hormones|mesh-ancestor
19647730|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647731|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19647732|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164679|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164680|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164681|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164682|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20164683|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20164684|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164685|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331280|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20331281|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19814206|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
19814207|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814208|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814209|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
19814210|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814211|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814212|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647733|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
20331282|NCT00774735|Dolutegravir|dolutegravir|mesh-list
19814213|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
19814214|NCT00481871|Hematinics|hematinics|mesh-ancestor
19814215|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19814216|NCT00482001|Donepezil|donepezil|mesh-list
19814217|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19814218|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814219|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814220|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
19814221|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814222|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814223|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
19814224|NCT00482014|Carboplatin|carboplatin|mesh-list
19814225|NCT00482014|Pemetrexed|pemetrexed|mesh-list
19814226|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814227|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814228|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814229|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19814230|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19814231|NCT00482053|Acetaminophen|acetaminophen|mesh-list
19814232|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
19814233|NCT00482053|Promethazine|promethazine|mesh-list
19814234|NCT00482053|Cyclosporine|cyclosporine|mesh-list
19814235|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
19814236|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
19814237|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19814238|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
20164686|NCT00135057|Insulin|insulin|mesh-list
20164687|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20164688|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
19814239|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
19814240|NCT00482053|Carmustine|carmustine|mesh-list
19814241|NCT00482053|Rituximab|rituximab|mesh-list
19814242|NCT00482053|Etoposide|etoposide|mesh-list
19814243|NCT00482053|Cyclosporins|cyclosporins|mesh-list
19814244|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19814245|NCT00482053|Lenograstim|lenograstim|mesh-list
19814246|NCT00482053|Sargramostim|sargramostim|mesh-list
19814247|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814248|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
19814249|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814250|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814251|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19814252|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
19814253|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814254|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814255|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19814256|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19814257|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814258|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19814259|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19814260|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814261|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19814262|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
19814263|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814264|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
19814265|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19814266|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19814267|NCT00482053|Analgesics|analgesics|mesh-ancestor
19814268|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
19814269|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814270|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
19814271|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19814272|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19814273|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
19814274|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19814275|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814276|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
19814277|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
19814278|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19814279|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
19814280|NCT00482053|Hormones|hormones|mesh-ancestor
19814281|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814282|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19814283|NCT00482053|Protective Agents|protective agents|mesh-ancestor
19814284|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19814285|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19814286|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19814287|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814288|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
19814289|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
19814290|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19814291|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
19814292|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
19814293|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814294|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19814295|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
19814296|NCT00482170|Etanercept|etanercept|mesh-list
20331283|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20331284|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20331285|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331286|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331287|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20331288|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20331289|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
20331290|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331291|NCT00774813|Citalopram|citalopram|mesh-list
20331292|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20331293|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19814297|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19814298|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19814299|NCT00482170|Analgesics|analgesics|mesh-ancestor
19814300|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
19814301|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331294|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814302|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814303|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814304|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814305|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19814306|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814307|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
19814308|NCT00482274|Docetaxel|docetaxel|mesh-list
19814309|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814310|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814311|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814312|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814313|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814314|NCT00482391|Paclitaxel|paclitaxel|mesh-list
19814315|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
19814316|NCT00482391|Doxorubicin|doxorubicin|mesh-list
19814317|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19814318|NCT00482391|Trastuzumab|trastuzumab|mesh-list
20331295|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331296|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331297|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
20331298|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331299|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20331300|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
19814319|NCT00482391|Lapatinib|lapatinib|mesh-list
19814320|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814321|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814322|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814323|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814324|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814325|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814326|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814327|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
19814328|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814329|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814330|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19814331|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
19814332|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19814333|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19814334|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19814335|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19814336|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814337|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19814338|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814339|NCT00482612|Mirtazapine|mirtazapine|mesh-list
19814340|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
20331301|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20331302|NCT00774878|Fulvestrant|fulvestrant|mesh-list
20331303|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20331304|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331305|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20331306|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20331307|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
20331308|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331309|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331310|NCT00774904|Losartan|losartan|mesh-list
20331311|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20331312|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331313|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20348000|NCT00863148|Clofarabine|clofarabine|mesh-list
19814341|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19814342|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19814343|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
19814344|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
19814345|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814346|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814347|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814348|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19814349|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19814350|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814351|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19814352|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19814353|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19814354|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
19814355|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19814356|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19814357|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
19814358|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19814359|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19814360|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814361|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814362|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814363|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814364|NCT00482677|Temozolomide|temozolomide|mesh-list
19814365|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19814366|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
19814367|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814368|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814369|NCT00482703|Dasatinib|dasatinib|mesh-list
19814370|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814371|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814372|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814373|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814374|NCT00482729|Metformin|metformin|mesh-list
19814375|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19814376|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19814377|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814378|NCT00482729|Incretins|incretins|mesh-ancestor
19814379|NCT00482729|Hormones|hormones|mesh-ancestor
19814380|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814381|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19814382|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
19814383|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814384|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814385|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
19814386|NCT00482911|Lenalidomide|lenalidomide|mesh-list
19814387|NCT00482911|Sunitinib|sunitinib|mesh-list
19814388|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814389|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
19814390|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814391|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814392|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19814393|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
19814394|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814395|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814396|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19814397|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19814398|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19814399|NCT00482911|Growth Substances|growth substances|mesh-ancestor
19814400|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
19814401|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814402|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814403|NCT00483002|Varenicline|varenicline|mesh-list
19814404|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19814405|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19814406|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
19814407|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814408|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814409|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834730|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834731|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19834732|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164689|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
20164690|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20164691|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834733|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834734|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834735|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
19834736|NCT00597116|Vinorelbine|vinorelbine|mesh-list
20164692|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
20331314|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20331315|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331316|NCT00774969|Metronidazole|metronidazole|mesh-list
20331317|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331318|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331319|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20331320|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20331321|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
19647734|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
19647735|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19647736|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
19647737|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
19647738|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19647739|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19647740|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19647741|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647742|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647743|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331322|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
20331323|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331324|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20331325|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331326|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20331327|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
20331328|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331329|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19814410|NCT00483223|Carboplatin|carboplatin|mesh-list
19814411|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814412|NCT00483262|Bortezomib|bortezomib|mesh-list
19814413|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814414|NCT00483327|Megestrol|megestrol|mesh-list
19814415|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
19814416|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19814417|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19814418|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19814419|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
19814420|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19814421|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814422|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19814423|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19814424|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19814425|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814426|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
19814427|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19814428|NCT00483405|Capecitabine|capecitabine|mesh-list
19814429|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
19814430|NCT00483405|Cetuximab|cetuximab|mesh-list
19814431|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19814432|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
19814433|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814434|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814435|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19814436|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
19814437|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
19814438|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19814439|NCT00483496|Protective Agents|protective agents|mesh-ancestor
19814440|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814441|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
19814442|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19814443|NCT00483509|Doxorubicin|doxorubicin|mesh-list
19814444|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19814445|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814446|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19814447|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19814448|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814449|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814450|NCT00483548|Ziprasidone|ziprasidone|mesh-list
19814451|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19814452|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
19647744|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814453|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814454|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814455|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814456|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19814457|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19814458|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814459|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19814460|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19814461|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
19814462|NCT00483561|Etoposide|etoposide|mesh-list
19814463|NCT00483561|Gefitinib|gefitinib|mesh-list
19814464|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814465|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814466|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19814467|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19814468|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814469|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814470|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814471|NCT00483574|Vaccines|vaccines|mesh-list
19814472|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
19814473|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814474|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
19814475|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19814476|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814477|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814478|NCT00483717|Ketorolac|ketorolac|mesh-list
19814479|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19814480|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19814481|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19814482|NCT00483717|Analgesics|analgesics|mesh-ancestor
19814483|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
19814484|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814485|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814486|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814487|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814488|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19814489|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814490|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814491|NCT00483756|Cyclosporine|cyclosporine|mesh-list
19814492|NCT00483756|Cyclosporins|cyclosporins|mesh-list
19814493|NCT00483756|Tofacitinib|tofacitinib|mesh-list
19814494|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331330|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331331|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20331332|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
20331333|NCT00775034|Coagulants|coagulants|mesh-ancestor
20331334|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20331335|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
19814495|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814496|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814497|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
19814498|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814499|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
19814500|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814501|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
19814502|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814503|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19814504|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814505|NCT00483938|Interferons|interferons|mesh-list
19814506|NCT00483938|Ribavirin|ribavirin|mesh-list
19814507|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
19814508|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
19814509|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19814510|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164693|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20164694|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164695|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
20164696|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20164697|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164698|NCT00135096|Insulin|insulin|mesh-list
20164699|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20164700|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
20164701|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
20164702|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20164703|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164704|NCT00135122|Prednisolone|prednisolone|mesh-list
20164705|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20164706|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
20331336|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19647745|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647746|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20331337|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
20331338|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20331339|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331340|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20331341|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20331342|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20331343|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331344|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19814511|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
19814512|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814513|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
19814514|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814515|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
19814516|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814517|NCT00484094|Sirolimus|sirolimus|mesh-list
19814518|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19814519|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814520|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19814521|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814522|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
19814523|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814524|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
19814525|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814526|NCT00484159|Lidocaine|lidocaine|mesh-list
19814527|NCT00484159|Bupivacaine|bupivacaine|mesh-list
19814528|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
19814529|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
19814530|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814531|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164707|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20164708|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
20164709|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20164710|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
20164711|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164712|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
20164713|NCT00135122|Hormones|hormones|mesh-ancestor
20164714|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331345|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20331346|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20331347|NCT00775073|Bevacizumab|bevacizumab|mesh-list
20331348|NCT00775073|Everolimus|everolimus|mesh-list
20331349|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331350|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647747|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647748|NCT02351297|Caseins|caseins|mesh-list
19647749|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
19647750|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
19647751|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647752|NCT02351232|Liraglutide|liraglutide|mesh-list
19647753|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19647754|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647755|NCT02351232|Incretins|incretins|mesh-ancestor
19647756|NCT02351232|Hormones|hormones|mesh-ancestor
19647757|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647758|NCT02351427|Bortezomib|bortezomib|mesh-list
19647759|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647760|NCT02351310|Betamethasone|betamethasone|mesh-list
19647761|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647762|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
19814532|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
19814533|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814534|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19814535|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19814536|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19814537|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814538|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814539|NCT00484198|Pioglitazone|pioglitazone|mesh-list
19814540|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19814541|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814542|NCT00484289|Abatacept|abatacept|mesh-list
19814543|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19814544|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814545|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814546|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814547|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
19814548|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814549|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814550|NCT00484315|Paclitaxel|paclitaxel|mesh-list
19814551|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19814552|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814553|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814554|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814555|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814556|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814557|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814558|NCT00484393|Tetracaine|tetracaine|mesh-list
19814559|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
19814560|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
19814561|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814562|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814563|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
19814564|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814565|NCT00484679|Triamcinolone|triamcinolone|mesh-list
19814566|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19814567|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19814568|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19814569|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814570|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
19814571|NCT00484679|Hormones|hormones|mesh-ancestor
19814572|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814573|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814574|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814575|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
19814576|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814577|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814578|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
19814579|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814580|NCT00484939|Bevacizumab|bevacizumab|mesh-list
19814581|NCT00484939|Capecitabine|capecitabine|mesh-list
19814582|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19814583|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814584|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19814585|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19814586|NCT00484939|Growth Substances|growth substances|mesh-ancestor
19814587|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814588|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
19814589|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19814590|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
19814591|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814592|NCT00485069|Levodopa|levodopa|mesh-list
19814593|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19814594|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20164715|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164716|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164717|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164718|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
20164719|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
20164720|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164721|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164722|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20164723|NCT00135122|Protective Agents|protective agents|mesh-ancestor
20331351|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19814595|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
20164724|NCT00135135|Carboplatin|carboplatin|mesh-list
19814596|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814597|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814598|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814599|NCT00485134|Vaccines|vaccines|mesh-list
19814600|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
19814601|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814602|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
19814603|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19814604|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19814605|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
19814606|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814607|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19814608|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19814609|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814610|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814611|NCT00485303|Prednisone|prednisone|mesh-list
20331352|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20331353|NCT00775073|Growth Substances|growth substances|mesh-ancestor
20331354|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331355|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
20331356|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20331357|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
20331358|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20331359|NCT00775086|Norelgestromin|norelgestromin|mesh-list
20331360|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
20331361|NCT00775086|Estradiol|estradiol|mesh-list
20331362|NCT00775086|Estrogens|estrogens|mesh-ancestor
20331363|NCT00775086|Hormones|hormones|mesh-ancestor
19814612|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
19814613|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814614|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
19814615|NCT00485303|Hormones|hormones|mesh-ancestor
19814616|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814617|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814618|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19814619|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814620|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19814621|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814622|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814623|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
19814624|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19814625|NCT00485433|Epinephrine|epinephrine|mesh-list
19814626|NCT00485433|Bupivacaine|bupivacaine|mesh-list
19814627|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
19814628|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
19814629|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814630|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814631|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
19814632|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814633|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19814634|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19814635|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19814636|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814637|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814638|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19814639|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20331364|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331365|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331366|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20331367|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20331368|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20331369|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20331370|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20331371|NCT00775125|Ritonavir|ritonavir|mesh-list
20331372|NCT00775125|Darunavir|darunavir|mesh-list
20331373|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
19814640|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
19814641|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19814642|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
20331374|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19814643|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
19814644|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
19814645|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20331375|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20331376|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
19814646|NCT00485472|Lacosamide|lacosamide|mesh-list
19814647|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
19814648|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19814649|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19814650|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814651|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814652|NCT00485485|Docetaxel|docetaxel|mesh-list
19814653|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
19814654|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814655|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814656|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814657|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814658|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814659|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814660|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814661|NCT00485589|Methotrexate|methotrexate|mesh-list
19814662|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
19814663|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19814664|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
19814665|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19814666|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814667|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19814668|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
19814669|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814670|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814671|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
19814672|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814673|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19814674|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814675|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
19814676|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814677|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20331377|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331378|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331379|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20331380|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20331381|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
20331382|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331383|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19814678|NCT00485732|Vaccines|vaccines|mesh-list
19814679|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
19814680|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814681|NCT00485758|Niacin|niacin|mesh-list
19814682|NCT00485758|Niacinamide|niacinamide|mesh-list
19814683|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
19814684|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19814685|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
19814686|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814687|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19814688|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
19814689|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
19814690|NCT00485758|Vitamins|vitamins|mesh-ancestor
19814691|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
19814692|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814693|NCT00485836|Ranibizumab|ranibizumab|mesh-list
19814694|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19814695|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19814696|NCT00485836|Growth Substances|growth substances|mesh-ancestor
19814697|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814698|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
19814699|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814700|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
19814701|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19814702|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814703|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814704|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19814705|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814706|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19814707|NCT00486018|Ranibizumab|ranibizumab|mesh-list
19814708|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19814709|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19814710|NCT00486018|Growth Substances|growth substances|mesh-ancestor
20331384|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19814711|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814712|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
19814713|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814714|NCT00486031|Balsalazide|balsalazide|mesh-list
19814715|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19814716|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19814717|NCT00486031|Analgesics|analgesics|mesh-ancestor
19814718|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
19814719|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814720|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814721|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814722|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814723|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19814724|NCT00486044|Simvastatin|simvastatin|mesh-list
19814725|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19814726|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19814727|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
19814728|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814729|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19814730|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19814731|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814732|NCT00486330|Ritonavir|ritonavir|mesh-list
19814733|NCT00486330|Tipranavir|tipranavir|mesh-list
19814734|NCT00486330|Buprenorphine|buprenorphine|mesh-list
19814735|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19814736|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19814737|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
19814738|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814739|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814740|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19814741|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19814742|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
19814743|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814744|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19814745|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19814746|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19814747|NCT00486330|Narcotics|narcotics|mesh-ancestor
19814748|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814749|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814750|NCT00486330|Analgesics|analgesics|mesh-ancestor
19814751|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
19814752|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814753|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19814754|NCT00486434|Calcitonin|calcitonin|mesh-list
19814755|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
19814756|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19814757|NCT00486434|Katacalcin|katacalcin|mesh-list
19814758|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19814759|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814760|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19814761|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
19814762|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
19814763|NCT00486603|Temozolomide|temozolomide|mesh-list
19814764|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19814765|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
19814766|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814767|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814768|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
19814769|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19814770|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19814771|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814772|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814773|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814774|NCT00486642|Bicalutamide|bicalutamide|mesh-list
20164725|NCT00135135|Doxorubicin|doxorubicin|mesh-list
20164726|NCT00135135|Irinotecan|irinotecan|mesh-list
20164727|NCT00135135|Etoposide|etoposide|mesh-list
20164728|NCT00135135|Melphalan|melphalan|mesh-list
20164729|NCT00135135|Topotecan|topotecan|mesh-list
20164730|NCT00135135|Gefitinib|gefitinib|mesh-list
20164731|NCT00135135|Tretinoin|tretinoin|mesh-list
20164732|NCT00135135|Isotretinoin|isotretinoin|mesh-list
20164733|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814775|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
19814776|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
19834737|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164734|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20164735|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20164736|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20331385|NCT00775151|Amlodipine|amlodipine|mesh-list
20331386|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331387|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20331388|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331389|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331390|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20331391|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331392|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
20331393|NCT00775164|Metformin|metformin|mesh-list
20331394|NCT00775164|Pioglitazone|pioglitazone|mesh-list
20331395|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20331396|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331397|NCT00775177|Doxycycline|doxycycline|mesh-list
20331398|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331399|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331400|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
20331401|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20331402|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19814777|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19814778|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814779|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814780|NCT00486720|Vorinostat|vorinostat|mesh-list
19814781|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331403|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20331404|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20331405|NCT00775242|Estradiol|estradiol|mesh-list
20331406|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20331407|NCT00775242|Estrogens|estrogens|mesh-list
20331408|NCT00775242|Progesterone|progesterone|mesh-list
20331409|NCT00775242|Progestins|progestins|mesh-list
20331410|NCT00775242|Hormones|hormones|mesh-ancestor
20331411|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331412|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331413|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20331414|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
20331415|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19814782|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20331416|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19814783|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814784|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814785|NCT00486759|Bevacizumab|bevacizumab|mesh-list
19814786|NCT00486759|Rituximab|rituximab|mesh-list
19814787|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19814788|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814789|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19814790|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19814791|NCT00486759|Growth Substances|growth substances|mesh-ancestor
19814792|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814793|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
19814794|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
19814795|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814796|NCT00486811|Oxycodone|oxycodone|mesh-list
19814797|NCT00486811|Tapentadol|tapentadol|mesh-list
19814798|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19814799|NCT00486811|Narcotics|narcotics|mesh-ancestor
19814800|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814801|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814802|NCT00486811|Analgesics|analgesics|mesh-ancestor
20164737|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164738|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164739|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20164740|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164741|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20164742|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
20164743|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20164744|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164745|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
20164746|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164747|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20164748|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
20164749|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164750|NCT00135187|Dexamethasone|dexamethasone|mesh-list
20164751|NCT00135187|Bortezomib|bortezomib|mesh-list
20164752|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164753|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
19814803|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
19814804|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331417|NCT00775255|Clarithromycin|clarithromycin|mesh-list
20331418|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331419|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331420|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20331421|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331422|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814805|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19814806|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19814807|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331423|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20331424|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20331425|NCT00775294|Maraviroc|maraviroc|mesh-list
20331426|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20331427|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19814808|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814809|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
19814810|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814811|NCT00486824|Indomethacin|indomethacin|mesh-list
19814812|NCT00486824|Nifedipine|nifedipine|mesh-list
19814813|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19814814|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814815|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814816|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19814817|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814818|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
19814819|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
20164754|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
20164755|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164756|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164757|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164758|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
20164759|NCT00135187|Hormones|hormones|mesh-ancestor
20164760|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164761|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164762|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164763|NCT00135304|Vitamin D|vitamin d|mesh-list
20331428|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814820|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19814821|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19814822|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19814823|NCT00486824|Analgesics|analgesics|mesh-ancestor
19814824|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
19814825|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814826|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814827|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814828|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
19814829|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19814830|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814831|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
19814832|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19814833|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814834|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814835|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19814836|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19814837|NCT00486863|Praziquantel|praziquantel|mesh-list
19814838|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
19814839|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19814840|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814841|NCT00486902|Ketamine|ketamine|mesh-list
19814842|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
19814843|NCT00486902|Analgesics|analgesics|mesh-ancestor
19814844|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
19814845|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814846|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814847|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19814848|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19814849|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
19814850|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
19814851|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814852|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19814853|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19814854|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814855|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814856|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19814857|NCT00486954|Paclitaxel|paclitaxel|mesh-list
19814858|NCT00486954|Lapatinib|lapatinib|mesh-list
19814859|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814860|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814861|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814862|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814863|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814864|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814865|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19814866|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814867|NCT00487084|Lidocaine|lidocaine|mesh-list
19814868|NCT00487084|Morphine|morphine|mesh-list
19814869|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
19814870|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
19814871|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814872|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814873|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
19814874|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814875|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19814876|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19814877|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19814878|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814879|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814880|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19814881|NCT00487084|Narcotics|narcotics|mesh-ancestor
19814882|NCT00487084|Analgesics|analgesics|mesh-ancestor
19814883|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19814884|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
19814885|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
20331429|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20331430|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20331431|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
20331432|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331433|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20331434|NCT00775359|Fenofibrate|fenofibrate|mesh-list
20331435|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20331436|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
20331437|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331438|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20331439|NCT00775372|Clarithromycin|clarithromycin|mesh-list
20331440|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331441|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331442|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20331443|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331444|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331445|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20331446|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20331447|NCT00775489|Beclomethasone|beclomethasone|mesh-list
20331448|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331449|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
20331450|NCT00775489|Hormones|hormones|mesh-ancestor
20331451|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331452|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331453|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20331454|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
19814886|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814887|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19814888|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19814889|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814890|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19814891|NCT00487240|Insulin|insulin|mesh-list
19814892|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19814893|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
19814894|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
19814895|NCT00487240|Protamines|protamines|mesh-list
19814896|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19814897|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814898|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
19814899|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814900|NCT00487240|Coagulants|coagulants|mesh-ancestor
19814901|NCT00487435|Tapentadol|tapentadol|mesh-list
20331455|NCT00775541|Ascorbic Acid|ascorbic acid|mesh-list
20331456|NCT00775541|Vitamins|vitamins|mesh-ancestor
19814902|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19814903|NCT00487435|Narcotics|narcotics|mesh-ancestor
19814904|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814905|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814906|NCT00487435|Analgesics|analgesics|mesh-ancestor
19814907|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
19814908|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814909|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19814910|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19814911|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19814912|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814913|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
19814914|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814915|NCT00487539|Golimumab|golimumab|mesh-list
19814916|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19814917|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19814918|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19814919|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814920|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
19814921|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814922|NCT00487669|Paclitaxel|paclitaxel|mesh-list
19814923|NCT00487669|Pemetrexed|pemetrexed|mesh-list
20331457|NCT00775541|Micronutrients|micronutrients|mesh-ancestor
20331458|NCT00775541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331459|NCT00775541|Antioxidants|antioxidants|mesh-ancestor
20331460|NCT00775541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331461|NCT00775541|Protective Agents|protective agents|mesh-ancestor
20331462|NCT00775580|Atenolol|atenolol|mesh-list
19814924|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19814925|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19814926|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814927|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
19814928|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19814929|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19814930|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814931|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814932|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19814933|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19814934|NCT00487721|Silymarin|silymarin|mesh-list
19814935|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
19814936|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814937|NCT00487721|Protective Agents|protective agents|mesh-ancestor
19814938|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814939|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19814940|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
19647763|NCT02351310|Hormones|hormones|mesh-ancestor
19647764|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647765|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647766|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19647767|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
19647768|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19647769|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19647770|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19647771|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647772|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647773|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647774|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647775|NCT02351440|Analgesics|analgesics|mesh-ancestor
19647776|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
19647777|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647778|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
19647779|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19647780|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
19647781|NCT02351128|Lanreotide|lanreotide|mesh-list
19814941|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814942|NCT00487825|Methotrexate|methotrexate|mesh-list
19814943|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20331463|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19814944|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
19814945|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19814946|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814947|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19814948|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
19814949|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814950|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19814951|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
19814952|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814953|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19814954|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19814955|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
19814956|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19814957|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19814958|NCT00487942|Modafinil|modafinil|mesh-list
19814959|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19814960|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814961|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20331464|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331465|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
20331466|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
20331467|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19814962|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19814963|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19814964|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814965|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
19814966|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
19814967|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
19814968|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19814969|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19814970|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814971|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19814972|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19814973|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
19814974|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814975|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814976|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19814977|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19814978|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19814979|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19814980|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19814981|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19814982|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19814983|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19814984|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
19814985|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19814986|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814987|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19814988|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19814989|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
19814990|NCT00488345|Tigecycline|tigecycline|mesh-list
19814991|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19814992|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19814993|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19814994|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19814995|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19814996|NCT00488475|Etanercept|etanercept|mesh-list
19814997|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19814998|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19814999|NCT00488475|Analgesics|analgesics|mesh-ancestor
19815000|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
19815001|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815002|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815003|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815004|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815005|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19815006|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815007|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
19815008|NCT00488488|Tigecycline|tigecycline|mesh-list
19815009|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815010|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815011|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19815012|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815013|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815014|NCT00488514|Naproxen|naproxen|mesh-list
19815015|NCT00488514|Sumatriptan|sumatriptan|mesh-list
19815016|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19815017|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815018|NCT00488514|Analgesics|analgesics|mesh-ancestor
19815019|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
19815020|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815021|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815022|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815023|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815024|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
19815025|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19815026|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815027|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815028|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19815029|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19815030|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19815031|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
19815032|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815033|NCT00488592|Molgramostim|molgramostim|mesh-list
19815034|NCT00488592|Sargramostim|sargramostim|mesh-list
19815035|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
19815036|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815037|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815038|NCT00488618|Cariprazine|cariprazine|mesh-list
19815039|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19815040|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19815041|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815042|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815043|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19815044|NCT00488631|Golimumab|golimumab|mesh-list
19815045|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19815046|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19815047|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815048|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815049|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
19815050|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815051|NCT00488683|Vaccines|vaccines|mesh-list
19815052|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
19815053|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815054|NCT00488774|Golimumab|golimumab|mesh-list
19815055|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19815056|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19815057|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815058|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815059|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
19815060|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815061|NCT00488826|Vaccines|vaccines|mesh-list
19815062|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19815063|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
19815064|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815065|NCT00488982|Docetaxel|docetaxel|mesh-list
19815066|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815067|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19815068|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
19815069|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
19815070|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815071|NCT00489086|Tazarotene|tazarotene|mesh-list
19815072|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
19815073|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
19815074|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
19815075|NCT00489281|Sirolimus|sirolimus|mesh-list
19815076|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
19815077|NCT00489281|Fludarabine|fludarabine|mesh-list
19815078|NCT00489281|Levetiracetam|levetiracetam|mesh-list
19815079|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
19815080|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19815081|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815082|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
19815083|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815084|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815085|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19815086|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
19815087|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348001|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
19815088|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331468|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331469|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20331470|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20331471|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20331472|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
20331473|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331474|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331475|NCT00775619|Carvedilol|carvedilol|mesh-list
20331476|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20331477|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19815089|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19815090|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19815091|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20331478|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
20331479|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331480|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331481|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331482|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331483|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
20331484|NCT00775619|Protective Agents|protective agents|mesh-ancestor
20331485|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20331486|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331487|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20331488|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
19815092|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
19815093|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815094|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815095|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815096|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
19815097|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
19815098|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
19815099|NCT00489359|Carboplatin|carboplatin|mesh-list
19647782|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647783|NCT02351102|Valacyclovir|valacyclovir|mesh-list
19647784|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
19647785|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647786|NCT02350751|MEDI8852|medi8852|mesh-list
19815100|NCT00489359|Pemetrexed|pemetrexed|mesh-list
19815101|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815102|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815103|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815104|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19815105|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19815106|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19815107|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19815108|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19815109|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19815110|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815111|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815112|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815113|NCT00489411|Analgesics|analgesics|mesh-ancestor
19815114|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
19815115|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815116|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
19815117|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19815118|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
19834738|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834739|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
19834740|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
19834741|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
19834742|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834743|NCT00597402|Bevacizumab|bevacizumab|mesh-list
19834744|NCT00597402|Irinotecan|irinotecan|mesh-list
19834745|NCT00597402|Temozolomide|temozolomide|mesh-list
19834746|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834747|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331489|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19647787|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
19647788|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19647789|NCT02351024|Naproxen|naproxen|mesh-list
19647790|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19647791|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19647792|NCT02351024|Analgesics|analgesics|mesh-ancestor
19815119|NCT00489424|Acetaminophen|acetaminophen|mesh-list
19815120|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815121|NCT00489424|Analgesics|analgesics|mesh-ancestor
19815122|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
19815123|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815124|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815125|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
19815126|NCT00489476|Loxapine|loxapine|mesh-list
19815127|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19815128|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19815129|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815130|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815131|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19815132|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19815133|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
19815134|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815135|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815136|NCT00489489|Interferons|interferons|mesh-list
19815137|NCT00489489|Interferon-beta|interferon-beta|mesh-list
19815138|NCT00489489|Teriflunomide|teriflunomide|mesh-list
19815139|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
19815140|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815141|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
19815142|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815143|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19815144|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
19815145|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815146|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19815147|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815148|NCT00489489|Analgesics|analgesics|mesh-ancestor
19815149|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
19815150|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815151|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815152|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815153|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815154|NCT00489541|Paclitaxel|paclitaxel|mesh-list
19815155|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20331490|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20331491|NCT00775632|Cyclosporine|cyclosporine|mesh-list
20331492|NCT00775632|Methotrexate|methotrexate|mesh-list
20331493|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
20331494|NCT00775632|Cyclosporins|cyclosporins|mesh-list
19664743|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19664744|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664745|NCT05099198|Incretins|incretins|mesh-ancestor
19664746|NCT05099198|Hormones|hormones|mesh-ancestor
19664747|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664748|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19664749|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
19664750|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664751|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664752|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19664753|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664754|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
19664755|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
19664756|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19664757|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19664758|NCT05092165|Methylene Blue|methylene blue|mesh-list
19664759|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664760|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664761|NCT05092152|Propofol|propofol|mesh-list
19664762|NCT05092152|Esketamine|esketamine|mesh-list
19664763|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19664764|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664765|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664766|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19664767|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
19664768|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
19664769|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
19664770|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19664771|NCT05088356|Plerixafor|plerixafor|mesh-list
19664772|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
19664773|NCT05088356|Melphalan|melphalan|mesh-list
19664774|NCT05088356|Fludarabine|fludarabine|mesh-list
19664775|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
19664776|NCT05088356|Tacrolimus|tacrolimus|mesh-list
19664777|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
20164764|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20164765|NCT00135304|Cinacalcet|cinacalcet|mesh-list
20164766|NCT00135304|Vitamins|vitamins|mesh-ancestor
20164767|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
20164768|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164769|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19815156|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815157|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
19815158|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
19815159|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
19815160|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815161|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19815162|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
19815163|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815164|NCT00489736|Amiodarone|amiodarone|mesh-list
20164770|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20164771|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20164772|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
20164773|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164774|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
20164775|NCT00135317|Hematinics|hematinics|mesh-ancestor
19815165|NCT00489736|Dronedarone|dronedarone|mesh-list
19815166|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19815167|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
19815168|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19815169|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19815170|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815171|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19815172|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19815173|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19815174|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815175|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19815176|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19815177|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19815178|NCT00489853|Budesonide|budesonide|mesh-list
19815179|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
19815180|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815181|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19815182|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
19815183|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815184|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815185|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19815186|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
19815187|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
19815188|NCT00489853|Hormones|hormones|mesh-ancestor
19815189|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815190|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19815191|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19815192|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19815193|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
19815194|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815195|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815196|NCT00489866|Aripiprazole|aripiprazole|mesh-list
20164776|NCT00135408|Budesonide|budesonide|mesh-list
20164777|NCT00135408|Ipilimumab|ipilimumab|mesh-list
19647793|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
19647794|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647795|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647796|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647797|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19647798|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
19647799|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19647800|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647801|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647802|NCT02350725|Furosemide|furosemide|mesh-list
19647803|NCT02350725|Diuretics|diuretics|mesh-ancestor
19647804|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
19815197|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
19815198|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19815199|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19815200|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20331495|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20331496|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
20331497|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20331498|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331499|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20331500|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
20331501|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331502|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331503|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
20331504|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331505|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20331506|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20331507|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
20331508|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331509|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20331510|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
20331511|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331512|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19815201|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815202|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815203|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
19815204|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
19815205|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815206|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815207|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19647805|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647806|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19647807|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647808|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647809|NCT02350959|Atorvastatin|atorvastatin|mesh-list
19647810|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19647811|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19647812|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
19647813|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647814|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19647815|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19647816|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647817|NCT02350985|Propranolol|propranolol|mesh-list
19647818|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19647819|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19647820|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19647821|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
19647822|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647823|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647824|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647825|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19647826|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19647827|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
19647828|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19647829|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19647830|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19647831|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19647832|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
19647833|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19647834|NCT02350946|Oxytocin|oxytocin|mesh-list
19647835|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
19647836|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19647837|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647838|NCT02350712|Carboplatin|carboplatin|mesh-list
19647839|NCT02350712|Cetuximab|cetuximab|mesh-list
19647840|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647841|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19647842|NCT02350439|Adenosine|adenosine|mesh-list
19647843|NCT02350439|Analgesics|analgesics|mesh-ancestor
19647844|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
19815208|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19815209|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
19815210|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19815211|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19815212|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19815213|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19815214|NCT00489918|Teriparatide|teriparatide|mesh-list
19815215|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19815216|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815217|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19815218|NCT00490009|Acetaminophen|acetaminophen|mesh-list
19815219|NCT00490009|Iodine|iodine|mesh-list
19815220|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
19815221|NCT00490009|Promethazine|promethazine|mesh-list
19815222|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
19815223|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
19815224|NCT00490009|Lugol's solution|lugol's solution|mesh-list
19815225|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19815226|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815227|NCT00490009|Analgesics|analgesics|mesh-ancestor
19815228|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
19815229|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815230|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815231|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
19815232|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19815233|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815234|NCT00490009|Trace Elements|trace elements|mesh-ancestor
19815235|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
19815236|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19815237|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19815238|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815239|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
19815240|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
19815241|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
19815242|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
19815243|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19815244|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19815245|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
19815246|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
19815247|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815248|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815249|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19815250|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
19815251|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
19815252|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815253|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
19815254|NCT00490009|Coagulants|coagulants|mesh-ancestor
19815255|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
19815256|NCT00490022|Androgens|androgens|mesh-ancestor
19815257|NCT00490022|Hormones|hormones|mesh-ancestor
19815258|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815259|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815260|NCT00490035|Brivaracetam|brivaracetam|mesh-list
19815261|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
19815262|NCT00490061|Lapatinib|lapatinib|mesh-list
19815263|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815264|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19815265|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815266|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815267|NCT00490100|Mecasermin|mecasermin|mesh-list
19815268|NCT00490100|Growth Substances|growth substances|mesh-ancestor
19815269|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815270|NCT00490139|Trastuzumab|trastuzumab|mesh-list
19815271|NCT00490139|Lapatinib|lapatinib|mesh-list
19815272|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19815273|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815274|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19815275|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815276|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815277|NCT00490269|Dronabinol|dronabinol|mesh-list
19815278|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
19815279|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815280|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19815281|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815282|NCT00490269|Analgesics|analgesics|mesh-ancestor
19815283|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
19815284|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815285|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20331513|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331514|NCT00775697|Montelukast|montelukast|mesh-list
20331515|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
20331516|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20331517|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
20331518|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
20331519|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331520|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815286|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19815287|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815288|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815289|NCT00490269|Hormones|hormones|mesh-ancestor
19815290|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815291|NCT00490477|Polymyxins|polymyxins|mesh-list
19815292|NCT00490477|Polymyxin B|polymyxin b|mesh-list
19815293|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815294|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815295|NCT00490490|Iodine|iodine|mesh-list
19815296|NCT00490490|Lugol's solution|lugol's solution|mesh-list
19815297|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19815298|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19815299|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815300|NCT00490490|Trace Elements|trace elements|mesh-ancestor
19815301|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
19815302|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815303|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
19815304|NCT00490490|Coagulants|coagulants|mesh-ancestor
19815305|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
19815306|NCT00490529|Rituximab|rituximab|mesh-list
19815307|NCT00490529|Vaccines|vaccines|mesh-list
19815308|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
19815309|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815310|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815311|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815312|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19815313|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
19815314|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815315|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815316|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19815317|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19815318|NCT00490542|Ziprasidone|ziprasidone|mesh-list
19815319|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19815320|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
19815321|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815322|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331521|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20331522|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20331523|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331524|NCT00775736|Insulin|insulin|mesh-list
20331525|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20331526|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
20331527|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
20331528|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20331529|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
20331530|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20331531|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19815323|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815324|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19815325|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19815326|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20164778|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20164779|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164780|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20164781|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164782|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164783|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20164784|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
20164785|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164786|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164787|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19815327|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19815328|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20331532|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331533|NCT00775749|Nicotine|nicotine|mesh-list
20331534|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20331535|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
20331536|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331537|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331538|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20331539|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20331540|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331541|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331542|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331543|NCT00775762|Aspirin|aspirin|mesh-list
20331544|NCT00775762|Clopidogrel|clopidogrel|mesh-list
20331545|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20331546|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331547|NCT00775762|Analgesics|analgesics|mesh-ancestor
20331548|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
20331549|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331550|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331551|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331552|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19647845|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647846|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647847|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19647848|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
19647849|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19647850|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
19647851|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
19647852|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647853|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647854|NCT02350686|Capecitabine|capecitabine|mesh-list
19647855|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
19647856|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19647857|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
19647858|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647859|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647860|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
19647861|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19647862|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19647863|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
19647864|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664778|NCT05088356|Lenograstim|lenograstim|mesh-list
19664779|NCT05088356|Sargramostim|sargramostim|mesh-list
19664780|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19664781|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
19664782|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664783|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19664784|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19664785|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664786|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664787|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19664788|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19664789|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
19664790|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
19664791|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664792|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19664793|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19664794|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664795|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19664796|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19666157|NCT05103813|Beraprost|beraprost|mesh-list
19666158|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19666159|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
19666160|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
19666161|NCT05103501|Fluorouracil|fluorouracil|mesh-list
19666162|NCT05103501|Cisplatin|cisplatin|mesh-list
19666163|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19666164|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666165|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666166|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
19666167|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666168|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19666169|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19666170|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
19815329|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
19815330|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
19815331|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19815332|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
19815333|NCT00490555|Testosterone|testosterone|mesh-list
19815334|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
19815335|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
19815336|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19815337|NCT00490555|Dutasteride|dutasteride|mesh-list
19815338|NCT00490555|Androgens|androgens|mesh-ancestor
19815339|NCT00490555|Hormones|hormones|mesh-ancestor
19815340|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815341|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815342|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19815343|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815344|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
19815345|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19815346|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19815347|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815348|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815349|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
19815350|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19815351|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19815352|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19815353|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
19815354|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19815355|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19815356|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19815357|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19815358|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
19815359|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19815360|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815361|NCT00490646|Docetaxel|docetaxel|mesh-list
19815362|NCT00490646|Trastuzumab|trastuzumab|mesh-list
19815363|NCT00490646|Epothilones|epothilones|mesh-list
19815364|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815365|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
19815366|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
19815367|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
19815368|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815369|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331553|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20331554|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20331555|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331556|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19647865|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647866|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647867|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
19647868|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
19647869|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647870|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
19647871|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19647872|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
19647873|NCT02350673|Atezolizumab|atezolizumab|mesh-list
19815370|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
19815371|NCT00490698|Atorvastatin|atorvastatin|mesh-list
19815372|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19815373|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19815374|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
19815375|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815376|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19815377|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19815378|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815379|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19815380|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815381|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19815382|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
20331557|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20331558|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331559|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
19815383|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815384|NCT00490802|Oxytocin|oxytocin|mesh-list
19815385|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
19815386|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19815387|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815388|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19815389|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815390|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
19815391|NCT00490815|Hormones|hormones|mesh-ancestor
19815392|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815393|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815394|NCT00490919|Buprenorphine|buprenorphine|mesh-list
19815395|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19815396|NCT00490919|Narcotics|narcotics|mesh-ancestor
19815397|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815398|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815399|NCT00490919|Analgesics|analgesics|mesh-ancestor
20331560|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20331561|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20331562|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20331563|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
20331564|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331565|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20331566|NCT00775814|Candesartan|candesartan|mesh-list
20331567|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19647874|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647875|NCT02350361|Endostatins|endostatins|mesh-list
19815400|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
19815401|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815402|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19815403|NCT00490971|Olanzapine|olanzapine|mesh-list
19815404|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19815405|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
19815406|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
19815407|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815408|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815409|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19647876|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19647877|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19647878|NCT02350361|Growth Substances|growth substances|mesh-ancestor
19647879|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647880|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
19647881|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647882|NCT02350335|Nicotine|nicotine|mesh-list
19647883|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19647884|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
19647885|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647886|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647887|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19647888|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19647889|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
19647890|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815410|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19815411|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19647891|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331568|NCT00775814|Diuretics|diuretics|mesh-ancestor
19647892|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19815412|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815413|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19815414|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19815415|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19815416|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19815417|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815418|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815419|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
19815420|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19815421|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19815422|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19815423|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19815424|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
19815425|NCT00491075|Gemcitabine|gemcitabine|mesh-list
19815426|NCT00491075|Pemetrexed|pemetrexed|mesh-list
19815427|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19815428|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
19815429|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815430|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815431|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
19815432|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815433|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815434|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815435|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
19815436|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815437|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19815438|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19815439|NCT00491179|Interferons|interferons|mesh-list
19815440|NCT00491179|Ribavirin|ribavirin|mesh-list
19815441|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
19815442|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
19815443|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19815444|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815445|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
19815446|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815447|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
19815448|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815449|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
19815450|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815451|NCT00491244|Interferons|interferons|mesh-list
19815452|NCT00491244|Ribavirin|ribavirin|mesh-list
19815453|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
19815454|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
20331569|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
20331570|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331571|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20331572|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331573|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331574|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20331575|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20331576|NCT00775827|Fenofibrate|fenofibrate|mesh-list
19647893|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19647894|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647895|NCT02350530|Bevacizumab|bevacizumab|mesh-list
19647896|NCT02350530|Fluorouracil|fluorouracil|mesh-list
19647897|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
19647898|NCT02350530|Irinotecan|irinotecan|mesh-list
19647899|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19647900|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647901|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19647902|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19647903|NCT02350530|Growth Substances|growth substances|mesh-ancestor
19647904|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815455|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19815456|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815457|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
19815458|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331577|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19815459|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
19815460|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815461|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
19815462|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815463|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
19815464|NCT00491322|Vitamin D|vitamin d|mesh-list
19815465|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19815466|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815467|NCT00491322|Vitamins|vitamins|mesh-ancestor
19815468|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
19815469|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19815470|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
20331578|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
20331579|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331580|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20331581|NCT00775840|Candesartan|candesartan|mesh-list
20331582|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331583|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20331584|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20331585|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331586|NCT00775879|Sevoflurane|sevoflurane|mesh-list
20331587|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19815471|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815472|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
19815473|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19815474|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
19815475|NCT00491530|Atorvastatin|atorvastatin|mesh-list
19815476|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19815477|NCT00491530|Simvastatin|simvastatin|mesh-list
19815478|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
19815479|NCT00491530|Calcium|calcium|mesh-list
19815480|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19815481|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815482|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19815483|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19815484|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19815485|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
19815486|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815487|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19815488|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19815489|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815490|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19815491|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
19815492|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815493|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
19815494|NCT00491751|Atorvastatin|atorvastatin|mesh-list
19815495|NCT00491751|Vitamins|vitamins|mesh-ancestor
19815496|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
19815497|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815498|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19815499|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19815500|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
19815501|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815502|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19815503|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19815504|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164788|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
20164789|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
20164790|NCT00135408|Hormones|hormones|mesh-ancestor
19815505|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
19815506|NCT00491751|Protective Agents|protective agents|mesh-ancestor
19815507|NCT00491764|Posaconazole|posaconazole|mesh-list
19815508|NCT00491764|Terbinafine|terbinafine|mesh-list
19815509|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
19815510|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164791|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164792|NCT00135434|Ritonavir|ritonavir|mesh-list
20164793|NCT00135434|Lopinavir|lopinavir|mesh-list
20164794|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20164795|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20164796|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20164797|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
20164798|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164799|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164800|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20164801|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19815511|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19815512|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19815513|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19815514|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19815515|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19815516|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815517|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815518|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20164802|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
20164803|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815519|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
19815520|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815521|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815522|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
19815523|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19815524|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19815525|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19815526|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
19815527|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815528|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815529|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815530|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
19815531|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19815532|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815533|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815534|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19815535|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19815536|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815537|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815538|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815539|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19815540|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
19815541|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19815542|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815543|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19815544|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19815545|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19815546|NCT00492063|Vaccines|vaccines|mesh-list
19815547|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
19815548|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815549|NCT00492089|Bevacizumab|bevacizumab|mesh-list
19815550|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19815551|NCT00492089|Antibodies|antibodies|mesh-list
19815552|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
19815553|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19815554|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164804|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20164805|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20174392|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20174393|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20174394|NCT00164749|Analgesics|analgesics|mesh-ancestor
20174395|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
20174396|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174397|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174398|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174399|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174400|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174401|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174402|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174403|NCT00164775|Imipramine|imipramine|mesh-list
20174404|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20174405|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
20174406|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20174407|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20174408|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20174409|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174410|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174411|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
20174412|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174413|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174414|NCT00164788|Esomeprazole|esomeprazole|mesh-list
20174415|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19815555|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19815556|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19815557|NCT00492089|Growth Substances|growth substances|mesh-ancestor
19815558|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815559|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
19815560|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
19815561|NCT00492206|Cetuximab|cetuximab|mesh-list
19815562|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19815563|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815564|NCT00492232|Zolpidem|zolpidem|mesh-list
19815565|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19815566|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19815567|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815568|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815569|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19815570|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
20331588|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20331589|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
20331590|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
20331591|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20331592|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331593|NCT00775905|Amlodipine|amlodipine|mesh-list
20331594|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331595|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20331596|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331597|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331598|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20331599|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331600|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
20331601|NCT00775918|Doxycycline|doxycycline|mesh-list
20331602|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331603|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331604|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
20331605|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20331606|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20331607|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
20331608|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
20331609|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19647905|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
19647906|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
19647907|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647908|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19647909|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19647910|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
19647911|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19647912|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19647913|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647914|NCT02350543|Aspirin|aspirin|mesh-list
19647915|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19647916|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19647917|NCT02350543|Analgesics|analgesics|mesh-ancestor
19647918|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
19647919|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647920|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647921|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647922|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19647923|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19647924|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19647925|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647926|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19647927|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19647928|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647929|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
19647930|NCT02350517|Paclitaxel|paclitaxel|mesh-list
19647931|NCT02350517|Endostar protein|endostar protein|mesh-list
19647932|NCT02350517|Endostatins|endostatins|mesh-list
19647933|NCT02350517|Nedaplatin|nedaplatin|mesh-list
19647934|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19647935|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647936|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
19815571|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
19815572|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815573|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331610|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19815574|NCT00492284|Dexamethasone|dexamethasone|mesh-list
19815575|NCT00492284|Ranibizumab|ranibizumab|mesh-list
19815576|NCT00492284|Verteporfin|verteporfin|mesh-list
19815577|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815578|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
19815579|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
19815580|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815581|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815582|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19815583|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
19815584|NCT00492284|Hormones|hormones|mesh-ancestor
19815585|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815586|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19815587|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815588|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19815589|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19815590|NCT00492284|Growth Substances|growth substances|mesh-ancestor
19815591|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
19815592|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19815593|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
19815594|NCT00492297|Sorafenib|sorafenib|mesh-list
19815595|NCT00492297|Dacarbazine|dacarbazine|mesh-list
19815596|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815597|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19815598|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815599|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815600|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19815601|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
19815602|NCT00492336|Rasagiline|rasagiline|mesh-list
19815603|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19815604|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815605|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815606|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19815607|NCT00492336|Protective Agents|protective agents|mesh-ancestor
19815608|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815609|NCT00492401|Decitabine|decitabine|mesh-list
19815610|NCT00492401|Azacitidine|azacitidine|mesh-list
19815611|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19815612|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
19815613|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815614|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815615|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815616|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
20331611|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20331612|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331613|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20331614|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
20331615|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
20331616|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331617|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331618|NCT00776022|Cetirizine|cetirizine|mesh-list
20331619|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20331620|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19815617|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19815618|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
19815619|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19815620|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815621|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815622|NCT00492531|Urological Agents|urological agents|mesh-ancestor
19815623|NCT00492544|Vaccines|vaccines|mesh-list
19815624|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
19815625|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815626|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19815627|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
19815628|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815629|NCT00492622|Omeprazole|omeprazole|mesh-list
19815630|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19815631|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19815632|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19815633|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815634|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815635|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
19815636|NCT00492726|Ertapenem|ertapenem|mesh-list
20331621|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19815637|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20164806|NCT00135473|Insulin|insulin|mesh-list
20164807|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20164808|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19647937|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
19647938|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
19647939|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647940|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19647941|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19647942|NCT02350517|Growth Substances|growth substances|mesh-ancestor
19647943|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647944|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
19664797|NCT05087615|Ondansetron|ondansetron|mesh-list
19664798|NCT05087615|Metoclopramide|metoclopramide|mesh-list
19664799|NCT05087615|Granisetron|granisetron|mesh-list
19664800|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
19664801|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
19664802|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664803|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664804|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664805|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
19664806|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
19664807|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19664808|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
19664809|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664810|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664811|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19664812|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19664813|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664814|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19664815|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19664816|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19664817|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19664818|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
19664819|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
19664820|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
19664821|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664822|NCT05033041|Metoclopramide|metoclopramide|mesh-list
19664823|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
19664824|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
19664825|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664826|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664827|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664828|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19664829|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19664830|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
19664831|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664832|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664833|NCT05024214|Sunitinib|sunitinib|mesh-list
19664834|NCT05024214|Lenvatinib|lenvatinib|mesh-list
19664835|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664836|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19664837|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19664838|NCT05024214|Growth Substances|growth substances|mesh-ancestor
19664839|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664840|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
19664841|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19664842|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664843|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664844|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
19664845|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19664846|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664847|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19664848|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664849|NCT04911660|Empagliflozin|empagliflozin|mesh-list
19664850|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19664851|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664852|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19664853|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664854|NCT04877093|Clonidine|clonidine|mesh-list
19664855|NCT04877093|Analgesics|analgesics|mesh-ancestor
19664856|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
19664857|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664858|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815638|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815639|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815640|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19815641|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19815642|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815643|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815644|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331622|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
20331623|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
20331624|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331625|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331626|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331627|NCT00776074|Leuprolide|leuprolide|mesh-list
20331628|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20331629|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
20331630|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20331631|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331632|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20331633|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331634|NCT00776113|Carvedilol|carvedilol|mesh-list
20331635|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20331636|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20331637|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19815645|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19815646|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
19815647|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19815648|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815649|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19815650|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19815651|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19815652|NCT00492752|Sorafenib|sorafenib|mesh-list
19815653|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815654|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19815655|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815656|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815657|NCT00492856|Methotrexate|methotrexate|mesh-list
19815658|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
19815659|NCT00492856|Tretinoin|tretinoin|mesh-list
19815660|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19815661|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
19815662|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19815663|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815664|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19815665|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
19815666|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815667|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815668|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
19815669|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815670|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19815671|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815672|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
19815673|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815674|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19815675|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
19815676|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
19815677|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815678|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
19815679|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815680|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815681|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19815682|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
19815683|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815684|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815685|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19815686|NCT00492973|Cefuroxime|cefuroxime|mesh-list
19815687|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
19815688|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19815689|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19815690|NCT00492973|Prednisolone|prednisolone|mesh-list
19815691|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
19815692|NCT00492973|Clonidine|clonidine|mesh-list
19815693|NCT00492973|Epinephrine|epinephrine|mesh-list
20331638|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815694|NCT00492973|Morphine|morphine|mesh-list
19815695|NCT00492973|Bupivacaine|bupivacaine|mesh-list
19815696|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19815697|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
19815698|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
19815699|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
19815700|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19815701|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815702|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
19815703|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815704|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19815705|NCT00492973|Narcotics|narcotics|mesh-ancestor
19815706|NCT00492973|Analgesics|analgesics|mesh-ancestor
19815707|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815708|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
19815709|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
19815710|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19815711|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
19815712|NCT00492973|Hormones|hormones|mesh-ancestor
19815713|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815714|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19815715|NCT00492973|Protective Agents|protective agents|mesh-ancestor
19815716|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19815717|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815718|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19815719|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19815720|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
19815721|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815722|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815723|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19815724|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19815725|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19815726|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
19815727|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
19815728|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
19815729|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19815730|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19815731|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
19815732|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19815733|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815734|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815735|NCT00493012|Vitamin D|vitamin d|mesh-list
19815736|NCT00493012|Vitamins|vitamins|mesh-ancestor
19815737|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
19815738|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815739|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19815740|NCT00493038|Amoxicillin|amoxicillin|mesh-list
19815741|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
19815742|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
19815743|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
19815744|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19815745|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20331639|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331640|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815746|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815747|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815748|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19815749|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19815750|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815751|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815752|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815753|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19815754|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
19815755|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19815756|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815757|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19815758|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19815759|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19815760|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19815761|NCT00493064|Niacin|niacin|mesh-list
19815762|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
19815763|NCT00493064|Niacinamide|niacinamide|mesh-list
19815764|NCT00493064|Prednisolone|prednisolone|mesh-list
19815765|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19815766|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
19815767|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19815768|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
19815769|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19815770|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
19815771|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815772|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
19815773|NCT00493064|Hormones|hormones|mesh-ancestor
19815774|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331641|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331642|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
20331643|NCT00776113|Protective Agents|protective agents|mesh-ancestor
20331644|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20331645|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331646|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20331647|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
20331648|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20331649|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20331650|NCT00776139|Cetirizine|cetirizine|mesh-list
20331651|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20331652|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20331653|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20331654|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
20331655|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
20331656|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331657|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331658|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331659|NCT00776217|Loratadine|loratadine|mesh-list
20331660|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
20331661|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
19815775|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815776|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19815777|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815778|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
19815779|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
19815780|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815781|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19815782|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19815783|NCT00493064|Protective Agents|protective agents|mesh-ancestor
19815784|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19815785|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
19815786|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815787|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19815788|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
19815789|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
19815790|NCT00493064|Vitamins|vitamins|mesh-ancestor
19815791|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
19815792|NCT00493181|Oprelvekin|oprelvekin|mesh-list
19815793|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815794|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
19815795|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815796|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815797|NCT00493246|Acetaminophen|acetaminophen|mesh-list
19815798|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815799|NCT00493246|Analgesics|analgesics|mesh-ancestor
19815800|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
19815801|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815802|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815803|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
19815804|NCT00493311|Acetaminophen|acetaminophen|mesh-list
19815805|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815806|NCT00493311|Analgesics|analgesics|mesh-ancestor
19815807|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
19815808|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815809|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815810|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
19815811|NCT00493454|Rituximab|rituximab|mesh-list
19815812|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19815813|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19815814|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815815|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
19815816|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815817|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815818|NCT00493467|Rituximab|rituximab|mesh-list
19815819|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19815820|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815821|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
19815822|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331662|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19815823|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815824|NCT00493636|Gemcitabine|gemcitabine|mesh-list
19815825|NCT00493636|Capecitabine|capecitabine|mesh-list
19815826|NCT00493636|Sorafenib|sorafenib|mesh-list
19815827|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19815828|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
20331663|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20331664|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19815829|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815830|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815831|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
19815832|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815833|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815834|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815835|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
19815836|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815837|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19815838|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
19815839|NCT00493649|Docetaxel|docetaxel|mesh-list
19815840|NCT00493649|Trastuzumab|trastuzumab|mesh-list
19815841|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815842|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
19815843|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815844|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815845|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19815846|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
19815847|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815848|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331665|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
20331666|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
20331667|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331668|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331669|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331670|NCT00776282|Loratadine|loratadine|mesh-list
20331671|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
20331672|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
20331673|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20164809|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20164810|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164811|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
20164812|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
20164813|NCT00135499|Prednisone|prednisone|mesh-list
20331674|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20331675|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20331676|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
20331677|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
20331678|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331679|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331680|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331681|NCT00776334|Fosinopril|fosinopril|mesh-list
20331682|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19815849|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19815850|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
19815851|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
19815852|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
19815853|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19815854|NCT00493805|Interferons|interferons|mesh-list
19815855|NCT00493805|Ribavirin|ribavirin|mesh-list
19815856|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
19815857|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
19815858|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20164814|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
20164815|NCT00135499|Rituximab|rituximab|mesh-list
20164816|NCT00135499|Doxorubicin|doxorubicin|mesh-list
20164817|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20164818|NCT00135499|Vincristine|vincristine|mesh-list
20164819|NCT00135499|Bleomycin|bleomycin|mesh-list
20164820|NCT00135499|Vindesine|vindesine|mesh-list
20164821|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164822|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
20164823|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164824|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815859|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164825|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19815860|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
20164826|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
20164827|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331683|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
19815861|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815862|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
19815863|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815864|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
19815865|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815866|NCT00493974|Zileuton|zileuton|mesh-list
19815867|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19815868|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815869|NCT00493974|Analgesics|analgesics|mesh-ancestor
19815870|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
19815871|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815872|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815873|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815874|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815875|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19815876|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815877|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815878|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19815879|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
19815880|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815881|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
19815882|NCT00494013|Protamines|protamines|mesh-list
19815883|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19815884|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815885|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
19815886|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815887|NCT00494013|Coagulants|coagulants|mesh-ancestor
19815888|NCT00494026|Carboplatin|carboplatin|mesh-list
19815889|NCT00494026|Pemetrexed|pemetrexed|mesh-list
19815890|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815891|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815892|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331684|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331685|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331686|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348002|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348003|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20348004|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
19815893|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19815894|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19815895|NCT00494091|Sirolimus|sirolimus|mesh-list
19815896|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19815897|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19815898|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20348005|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348006|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20348007|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348008|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20348009|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20348010|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
20348011|NCT00863161|Lesogaberan|lesogaberan|mesh-list
20348012|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20348013|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20348014|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
20348015|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
20348016|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348017|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815899|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815900|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
19815901|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815902|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
19815903|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815904|NCT00494221|Leucovorin|leucovorin|mesh-list
19815905|NCT00494221|Fluorouracil|fluorouracil|mesh-list
19815906|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
19815907|NCT00494221|Cediranib|cediranib|mesh-list
20348018|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348019|NCT00863187|Rituximab|rituximab|mesh-list
20348020|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19815908|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
20348021|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815909|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
19815910|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815911|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19815912|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815913|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815914|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
19815915|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815916|NCT00494221|Antidotes|antidotes|mesh-ancestor
19815917|NCT00494221|Protective Agents|protective agents|mesh-ancestor
19815918|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
19815919|NCT00494221|Vitamins|vitamins|mesh-ancestor
19815920|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
19815921|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19815922|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815923|NCT00494299|Sorafenib|sorafenib|mesh-list
19815924|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815925|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19815926|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815927|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815928|NCT00494442|Olaparib|olaparib|mesh-list
19815929|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19815930|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815931|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815932|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815933|NCT00494481|Docetaxel|docetaxel|mesh-list
19815934|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19815935|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
19815936|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
19815937|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
19815938|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815939|NCT00494494|Nepafenac|nepafenac|mesh-list
19815940|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19815941|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19815942|NCT00494494|Analgesics|analgesics|mesh-ancestor
19815943|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
19815944|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815945|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815946|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815947|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815948|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
19815949|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19815950|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815951|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815952|NCT00494676|Methamphetamine|methamphetamine|mesh-list
19815953|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19815954|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815955|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
19815956|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
19815957|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19815958|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
19815959|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19815960|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815961|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
19815962|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19815963|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19815964|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19815965|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19815966|NCT00494780|Prednisone|prednisone|mesh-list
19815967|NCT00494780|Prednisolone|prednisolone|mesh-list
19815968|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
19815969|NCT00494780|Doxorubicin|doxorubicin|mesh-list
19815970|NCT00494780|Vincristine|vincristine|mesh-list
19815971|NCT00494780|Ofatumumab|ofatumumab|mesh-list
19815972|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19815973|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
20331687|NCT00776347|Donepezil|donepezil|mesh-list
19647945|NCT02350400|Irinotecan|irinotecan|mesh-list
19647946|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19647947|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19647948|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19647949|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647950|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19647951|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
19647952|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19647953|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19647954|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19647955|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
19647956|NCT02350179|Coagulants|coagulants|mesh-ancestor
19647957|NCT02350231|Progesterone|progesterone|mesh-list
20331688|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20331689|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331690|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331691|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331692|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331693|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331694|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
20331695|NCT00776360|Oxytocin|oxytocin|mesh-list
20331696|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
20331697|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19815974|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19815975|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19815976|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19815977|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
19815978|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19815979|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331698|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331699|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
20331700|NCT00776425|Hematinics|hematinics|mesh-ancestor
20331701|NCT00776438|Vaccines|vaccines|mesh-list
20331702|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
20331703|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331704|NCT00776477|Aspirin|aspirin|mesh-list
20331705|NCT00776477|Clopidogrel|clopidogrel|mesh-list
20331706|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20331707|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331708|NCT00776477|Analgesics|analgesics|mesh-ancestor
20331709|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
20331710|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331711|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331712|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815980|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19815981|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19815982|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19815983|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19815984|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19815985|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19815986|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
19815987|NCT00494780|Hormones|hormones|mesh-ancestor
19815988|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19815989|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19815990|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19815991|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
19815992|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
19815993|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20331713|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331714|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20331715|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20331716|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331717|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20331718|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20331719|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331720|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
20331721|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20331722|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20331723|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20331724|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
20331725|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331726|NCT00776490|Glimepiride|glimepiride|mesh-list
19647958|NCT02350231|Progestins|progestins|mesh-ancestor
19647959|NCT02350231|Hormones|hormones|mesh-ancestor
19647960|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647961|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647962|NCT02350218|Alprostadil|alprostadil|mesh-list
19647963|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19647964|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
19647965|NCT02350218|Urological Agents|urological agents|mesh-ancestor
19647966|NCT02349919|Procaterol|procaterol|mesh-list
19647967|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19647968|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
19647969|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19647970|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647971|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19647972|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
19815994|NCT00494871|Warfarin|warfarin|mesh-list
19815995|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
19815996|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
19815997|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19815998|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
19815999|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19816000|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
19816001|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816002|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834748|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19834749|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19834750|NCT00597402|Growth Substances|growth substances|mesh-ancestor
19834751|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834752|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834753|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19834754|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19834755|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834756|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834757|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834758|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
19647973|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
19647974|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19647975|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20331727|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20331728|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19647976|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19647977|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
19647978|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19647979|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834759|NCT00597428|Lubiprostone|lubiprostone|mesh-list
19834760|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19834761|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834762|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834763|NCT00597493|Temozolomide|temozolomide|mesh-list
19834764|NCT00597493|Sorafenib|sorafenib|mesh-list
19834765|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834766|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
19834767|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834768|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834769|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19834770|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834771|NCT00597506|Bevacizumab|bevacizumab|mesh-list
19834772|NCT00597506|Everolimus|everolimus|mesh-list
19834773|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834774|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834775|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19834776|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19834777|NCT00597506|Growth Substances|growth substances|mesh-ancestor
19834778|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834779|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834780|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834781|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
19834782|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
19834783|NCT00597519|Fludarabine|fludarabine|mesh-list
19647980|NCT02350023|Betamethasone|betamethasone|mesh-list
19647981|NCT02350023|Latanoprost|latanoprost|mesh-list
19647982|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19647983|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19647984|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19647985|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
19647986|NCT02350023|Hormones|hormones|mesh-ancestor
19647987|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19647988|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647989|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19647990|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
19647991|NCT02349802|Exenatide|exenatide|mesh-list
19647992|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19647993|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19647994|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19647995|NCT02349802|Incretins|incretins|mesh-ancestor
19647996|NCT02349802|Hormones|hormones|mesh-ancestor
19647997|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19834784|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834785|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
20331729|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816003|NCT00495079|Vincristine|vincristine|mesh-list
19816004|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816005|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816006|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816007|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816008|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816009|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816010|NCT00495170|Paclitaxel|paclitaxel|mesh-list
19816011|NCT00495170|Carboplatin|carboplatin|mesh-list
19816012|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816013|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816014|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816015|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816016|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816017|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816018|NCT00495391|Ribavirin|ribavirin|mesh-list
19816019|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20331730|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20331731|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
19816020|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
19816021|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
19816022|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816023|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
19816024|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816025|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19816026|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19816027|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
19816028|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19816029|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816030|NCT00495586|Amoxicillin|amoxicillin|mesh-list
19816031|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
19816032|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
19816033|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19816034|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816035|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816036|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816037|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19816038|NCT00495612|Omalizumab|omalizumab|mesh-list
19816039|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19816040|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20331732|NCT00776503|Vorinostat|vorinostat|mesh-list
20331733|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331734|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20331735|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331736|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331737|NCT00776516|Rifampin|rifampin|mesh-list
20331738|NCT00776516|Mirabegron|mirabegron|mesh-list
20331739|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20331740|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
20331741|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331742|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331743|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
20331744|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20331745|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331746|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331747|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20331748|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20331749|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20331750|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20331751|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20331752|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20331753|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20331754|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19647998|NCT02349958|Doxorubicin|doxorubicin|mesh-list
19647999|NCT02349958|Cisplatin|cisplatin|mesh-list
19648000|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19648001|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648002|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19648003|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19648004|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648005|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648006|NCT02349763|Dexamethasone|dexamethasone|mesh-list
19816041|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
19816042|NCT00495625|Sunitinib|sunitinib|mesh-list
19816043|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816044|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19816045|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816046|NCT00495625|Growth Substances|growth substances|mesh-ancestor
19816047|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816048|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
19816049|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19816050|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816051|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816052|NCT00495677|PF 232798|pf 232798|mesh-list
19816053|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19816054|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816055|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19816056|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19816057|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
19816058|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816059|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
19816060|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816061|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816062|NCT00495820|Methylphenidate|methylphenidate|mesh-list
19816063|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19816064|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816065|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19816066|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19816067|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816068|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816069|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
19816070|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816071|NCT00496015|Acetaminophen|acetaminophen|mesh-list
19816072|NCT00496015|Vaccines|vaccines|mesh-list
19816073|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19816074|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
19816075|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816076|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19816077|NCT00496015|Analgesics|analgesics|mesh-ancestor
19816078|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
19816079|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816080|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
19816081|NCT00496054|Vaccines|vaccines|mesh-list
19816082|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
19816083|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816084|NCT00496197|Fluconazole|fluconazole|mesh-list
19816085|NCT00496197|Voriconazole|voriconazole|mesh-list
19816086|NCT00496197|Anidulafungin|anidulafungin|mesh-list
19816087|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
19816088|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816089|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19816090|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19816091|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816092|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816093|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19816094|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
19816095|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19816096|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816097|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19816098|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19816099|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19816100|NCT00496340|Rituximab|rituximab|mesh-list
19816101|NCT00496340|Busulfan|busulfan|mesh-list
19816102|NCT00496340|Pentostatin|pentostatin|mesh-list
19816103|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816104|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816105|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
19816106|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816107|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816108|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
19816109|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816110|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816111|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816112|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816113|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19816114|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331755|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20331756|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
20331757|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331758|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331759|NCT00776516|Urological Agents|urological agents|mesh-ancestor
19816115|NCT00496366|Capecitabine|capecitabine|mesh-list
19816116|NCT00496366|Lapatinib|lapatinib|mesh-list
19816117|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816118|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
19816119|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816120|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816121|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19816122|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816123|NCT00496379|Epothilones|epothilones|mesh-list
20331760|NCT00776542|Minocycline|minocycline|mesh-list
20331761|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331762|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331763|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
20331764|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20331765|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19816124|NCT00496379|Sagopilone|sagopilone|mesh-list
19816125|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816126|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816127|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
20164828|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164829|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20331766|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331767|NCT00776620|Glimepiride|glimepiride|mesh-list
20331768|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20331769|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20331770|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331771|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20331772|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
20331773|NCT00776633|Aspirin|aspirin|mesh-list
20331774|NCT00776633|Clopidogrel|clopidogrel|mesh-list
20331775|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20331776|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331777|NCT00776633|Analgesics|analgesics|mesh-ancestor
20331778|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
20331779|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331780|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331781|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331782|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331783|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20331784|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20331785|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331786|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19816128|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816129|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816130|NCT00496470|Budesonide|budesonide|mesh-list
19816131|NCT00496470|Bromides|bromides|mesh-list
19816132|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
19816133|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
19816134|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19816135|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19816136|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19816137|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
19816138|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164830|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20164831|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20164832|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20164833|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20164834|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164835|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331787|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19816139|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816140|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19816141|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
19816142|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
19816143|NCT00496470|Hormones|hormones|mesh-ancestor
19816144|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19816145|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19816146|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20164836|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
20164837|NCT00135499|Hormones|hormones|mesh-ancestor
19816147|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20611684|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611685|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
20331788|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331789|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
20164838|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164839|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164840|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164841|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
20164842|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
20164843|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
20164844|NCT00135525|Paroxetine|paroxetine|mesh-list
20164845|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20164846|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20164847|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164848|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164849|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164850|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
20331790|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20331791|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20331792|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20331793|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
20331794|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331795|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20331796|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331797|NCT00776646|Diuretics|diuretics|mesh-ancestor
20331798|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
20331799|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331800|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20331801|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648007|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
20611686|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611687|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20611688|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611689|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
19648008|NCT02349763|BB 1101|bb 1101|mesh-list
19648009|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648010|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
19648011|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
19648012|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648013|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648014|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648015|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
19648016|NCT02349763|Hormones|hormones|mesh-ancestor
19648017|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648018|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648019|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648020|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
19648021|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648022|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648023|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19648024|NCT02349945|Hormones|hormones|mesh-ancestor
19648025|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648026|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648027|NCT02349841|Amoxicillin|amoxicillin|mesh-list
19648028|NCT02349841|Meropenem|meropenem|mesh-list
20348022|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
20348023|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348024|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348025|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20348026|NCT00863239|Interferons|interferons|mesh-list
20348027|NCT00863239|Ribavirin|ribavirin|mesh-list
20348028|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
20348029|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
20611690|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611691|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611692|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20611693|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20611694|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
20611695|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
20611696|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611697|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20611698|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
20611699|NCT00408005|Hormones|hormones|mesh-ancestor
20611700|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611701|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20611702|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
20611703|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611704|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611705|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20611706|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611707|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20611708|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20611709|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20611710|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
19816148|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
19816149|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816150|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816151|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
19816152|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19816153|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
19816154|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
19816155|NCT00496483|Tacrolimus|tacrolimus|mesh-list
19816156|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816157|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
19816158|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816159|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19816160|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816161|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816162|NCT00496587|Gemcitabine|gemcitabine|mesh-list
19816163|NCT00496587|Bevacizumab|bevacizumab|mesh-list
19816164|NCT00496587|Capecitabine|capecitabine|mesh-list
19816165|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816166|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816167|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19816168|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816169|NCT00496587|Growth Substances|growth substances|mesh-ancestor
19816170|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816171|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
19816172|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816173|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
19816174|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816175|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
19816176|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816177|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816178|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816179|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
19816180|NCT00496769|Aspirin|aspirin|mesh-list
19816181|NCT00496769|Apixaban|apixaban|mesh-list
19648029|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
19648030|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
19648031|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648032|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648033|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648034|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648035|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19648036|NCT02349828|Acyclovir|acyclovir|mesh-list
19648037|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
19648038|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648039|NCT02349490|Hemostatics|hemostatics|mesh-list
19648040|NCT02349490|Coagulants|coagulants|mesh-ancestor
19648041|NCT02349516|Squalamine|squalamine|mesh-list
19648042|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19648043|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19816182|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19648044|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648045|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816183|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19816184|NCT00496769|Analgesics|analgesics|mesh-ancestor
19816185|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
19816186|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816187|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816188|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19816189|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816190|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19816191|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19816192|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816193|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19816194|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19816195|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164851|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164852|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20164853|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
20611711|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20611712|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611713|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
20611714|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164854|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20164855|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20164856|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20164857|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164858|NCT00135551|Benidipine|benidipine|mesh-list
20164859|NCT00135551|Diuretics|diuretics|mesh-list
20164860|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20164861|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20164862|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20164863|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
20164864|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164865|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164866|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164867|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20164868|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
20164869|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164870|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20331802|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331803|NCT00776672|Fosinopril|fosinopril|mesh-list
20331804|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20331805|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
19816196|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
19816197|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19816198|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
19816199|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19816200|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
19816201|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
19816202|NCT00496808|Trastuzumab|trastuzumab|mesh-list
19816203|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816204|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816205|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
19816206|NCT00496873|Rituximab|rituximab|mesh-list
19816207|NCT00496873|Pentostatin|pentostatin|mesh-list
19816208|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816209|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
19816210|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816211|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816212|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816213|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
19816214|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816215|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816216|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816217|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816218|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20331806|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331807|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331808|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331809|NCT00776698|Bevacizumab|bevacizumab|mesh-list
20331810|NCT00776698|Etoposide|etoposide|mesh-list
20331811|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331812|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816219|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816220|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
19816221|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19816222|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19816223|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19816224|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816225|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331813|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20331814|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20331815|NCT00776698|Growth Substances|growth substances|mesh-ancestor
19816226|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331816|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331817|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
20331818|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20331819|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20331820|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20331821|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331822|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331823|NCT00776724|Docetaxel|docetaxel|mesh-list
20331824|NCT00776724|Epirubicin|epirubicin|mesh-list
20331825|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331826|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
20331827|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
20331828|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
20331829|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331830|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20331831|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20331832|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20331833|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331834|NCT00776763|Bevacizumab|bevacizumab|mesh-list
19816227|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816228|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816229|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19816230|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816231|NCT00497055|Aripiprazole|aripiprazole|mesh-list
19816232|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
19816233|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19816234|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19816235|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19816236|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648046|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19648047|NCT02349516|Protective Agents|protective agents|mesh-ancestor
19816237|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816238|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
20331835|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20331836|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331837|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19648048|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648049|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648050|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19648051|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20331838|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20331839|NCT00776763|Growth Substances|growth substances|mesh-ancestor
20331840|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331841|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
20331842|NCT00776802|Dexamethasone|dexamethasone|mesh-list
20331843|NCT00776802|Etoposide|etoposide|mesh-list
20331844|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648052|NCT02349516|Growth Substances|growth substances|mesh-ancestor
19816239|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
19816240|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331845|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
19648053|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
19648054|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19816241|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816242|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19816243|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19816244|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
20331846|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
20331847|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331848|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816245|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19816246|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19816247|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19816248|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19816249|NCT00497081|Mirtazapine|mirtazapine|mesh-list
19816250|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
19816251|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19816252|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19816253|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
19816254|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
19816255|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816256|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816257|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816258|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19816259|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19816260|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19816261|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19816262|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19816263|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19816264|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
19816265|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19816266|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19816267|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
19816268|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19816269|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
19816270|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19816271|NCT00497770|Pemetrexed|pemetrexed|mesh-list
19816272|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816273|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816274|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816275|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19816276|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19816277|NCT00497796|Ganciclovir|ganciclovir|mesh-list
19816278|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19816279|NCT00497796|Maribavir|maribavir|mesh-list
19816280|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
19816281|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816282|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19816283|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816284|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816285|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19816286|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19816287|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19816288|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816289|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816290|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19816291|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816292|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816293|NCT00498186|Rotigotine|rotigotine|mesh-list
20331849|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19816294|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
19816295|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
19816296|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816297|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816298|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816299|NCT00498355|Ranibizumab|ranibizumab|mesh-list
19816300|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19816301|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816302|NCT00498355|Growth Substances|growth substances|mesh-ancestor
19816303|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331850|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
20331851|NCT00776802|Hormones|hormones|mesh-ancestor
20331852|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20331853|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20331854|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816304|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
19816305|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816306|NCT00498368|Rituximab|rituximab|mesh-list
19816307|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
19816308|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816309|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816310|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
19816311|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816312|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816313|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19816314|NCT00498433|Amlodipine|amlodipine|mesh-list
19816315|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19816316|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19816317|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816318|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816319|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19816320|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816321|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
19816322|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
19816323|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19816324|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19816325|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
19816326|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
19816327|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19816328|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816329|NCT00498550|Clozapine|clozapine|mesh-list
19816330|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19816331|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
19816332|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816333|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816334|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816335|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19816336|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19816337|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19816338|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19816339|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
19816340|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
19816341|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
19816342|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19816343|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
19816344|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816345|NCT00498615|Fasudil|fasudil|mesh-list
19816346|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19816347|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816348|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816349|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19816350|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816351|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
19816352|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19816353|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816354|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19816355|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
19816356|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19816357|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20348030|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19816358|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19816359|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19816360|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816361|NCT00498797|Prednisolone|prednisolone|mesh-list
19816362|NCT00498797|Docetaxel|docetaxel|mesh-list
19816363|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816364|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816365|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816366|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816367|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816368|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19816369|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
19816370|NCT00498797|Hormones|hormones|mesh-ancestor
19816371|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19816372|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816373|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19816374|NCT00498927|Temozolomide|temozolomide|mesh-list
19816375|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816376|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
19816377|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816378|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816379|NCT00499031|Cetuximab|cetuximab|mesh-list
19816380|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816381|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816382|NCT00499083|Tamoxifen|tamoxifen|mesh-list
20164871|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20164872|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
20164873|NCT00135577|Alvimopan|alvimopan|mesh-list
20164874|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164875|NCT00135603|Amoxicillin|amoxicillin|mesh-list
19648055|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19648056|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20164876|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
20164877|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
20164878|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20164879|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20164880|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20164881|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20164882|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164883|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611715|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19648057|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19648058|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
19648059|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19648060|NCT02349399|Cyproterone|cyproterone|mesh-list
19648061|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
19648062|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19648063|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19648064|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19648065|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
19648066|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648067|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648068|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19648069|NCT02349399|Estrogens|estrogens|mesh-ancestor
19648070|NCT02349399|Hormones|hormones|mesh-ancestor
19648071|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648072|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
19648073|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648074|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648075|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19648076|NCT02349581|Bupivacaine|bupivacaine|mesh-list
19648077|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
19648078|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
19648079|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648080|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648081|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
19648082|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648083|NCT02349607|Ibuprofen|ibuprofen|mesh-list
19648084|NCT02349607|Pregabalin|pregabalin|mesh-list
20164884|NCT00135668|Nitroprusside|nitroprusside|mesh-list
20611716|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19816383|NCT00499083|Paclitaxel|paclitaxel|mesh-list
19816384|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
19816385|NCT00499083|Doxorubicin|doxorubicin|mesh-list
19816386|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19816387|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19816388|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816389|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816390|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816391|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816392|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816393|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816394|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816395|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
19816396|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816397|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816398|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816399|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
19816400|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816401|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19816402|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19816403|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19816404|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816405|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19816406|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
19816407|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19816408|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19816409|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19816410|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19816411|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19816412|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19816413|NCT00499109|Gemcitabine|gemcitabine|mesh-list
19816414|NCT00499109|Carboplatin|carboplatin|mesh-list
19816415|NCT00499109|Docetaxel|docetaxel|mesh-list
19816416|NCT00499109|Vinorelbine|vinorelbine|mesh-list
19816417|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
19816418|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816419|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
19816420|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816421|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
19816422|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816423|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816424|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816425|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
19816426|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816427|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816428|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816429|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816430|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816431|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
19816432|NCT00499122|Docetaxel|docetaxel|mesh-list
19816433|NCT00499122|Doxorubicin|doxorubicin|mesh-list
19816434|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816435|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
19816436|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816437|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816438|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816439|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
19816440|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816441|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816442|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816443|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816444|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816445|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816446|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19816447|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19816448|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19816449|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816450|NCT00499252|Paclitaxel|paclitaxel|mesh-list
19816451|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19816452|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816453|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816454|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816455|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816456|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816457|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816458|NCT00499343|Rituximab|rituximab|mesh-list
19816459|NCT00499343|Etoposide|etoposide|mesh-list
19816460|NCT00499343|Ifosfamide|ifosfamide|mesh-list
19816461|NCT00499343|Sargramostim|sargramostim|mesh-list
19816462|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816463|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816464|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
19648085|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19648086|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19648087|NCT02349607|Analgesics|analgesics|mesh-ancestor
19816465|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816466|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816467|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816468|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19816469|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19816470|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816471|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816472|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19648088|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
19648089|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816473|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
19648090|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648091|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648092|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648093|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19816474|NCT00499369|Leucovorin|leucovorin|mesh-list
19816475|NCT00499369|Bevacizumab|bevacizumab|mesh-list
19816476|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19816477|NCT00499369|Cetuximab|cetuximab|mesh-list
19816478|NCT00499369|Fluorouracil|fluorouracil|mesh-list
19816479|NCT00499369|Irinotecan|irinotecan|mesh-list
19816480|NCT00499369|Antibodies|antibodies|mesh-list
19816481|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
19816482|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19816483|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
19816484|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816485|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19816486|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816487|NCT00499369|Growth Substances|growth substances|mesh-ancestor
19816488|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816489|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
19816490|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
19816491|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
19816492|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816493|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816494|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816495|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19816496|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19816497|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816498|NCT00499369|Antidotes|antidotes|mesh-ancestor
19816499|NCT00499369|Protective Agents|protective agents|mesh-ancestor
19816500|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
19816501|NCT00499369|Vitamins|vitamins|mesh-ancestor
19816502|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
19816503|NCT00499408|Vitamin D|vitamin d|mesh-list
19816504|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
19816505|NCT00499408|Vitamins|vitamins|mesh-ancestor
19816506|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
19816507|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816508|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19648094|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648095|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648096|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
19816509|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19816510|NCT00499460|Oxycodone|oxycodone|mesh-list
19816511|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19816512|NCT00499460|Narcotics|narcotics|mesh-ancestor
19816513|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19816514|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816515|NCT00499460|Analgesics|analgesics|mesh-ancestor
19816516|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
19648097|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19648098|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648099|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19648100|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19648101|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19648102|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648103|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19648104|NCT02349282|Vitamin D|vitamin d|mesh-list
19648105|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
19648106|NCT02349282|Calcifediol|calcifediol|mesh-list
19648107|NCT02349282|Vitamins|vitamins|mesh-ancestor
19648108|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
19648109|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648110|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19648111|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19816517|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816518|NCT00499473|Sunitinib|sunitinib|mesh-list
19816519|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816520|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19648112|NCT02349243|Entacapone|entacapone|mesh-list
19816521|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816522|NCT00499473|Growth Substances|growth substances|mesh-ancestor
19816523|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816524|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611717|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
20611718|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611719|NCT00408005|Antidotes|antidotes|mesh-ancestor
19816525|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19816526|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816527|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816528|NCT00499486|Sirolimus|sirolimus|mesh-list
19648113|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19648114|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19648115|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19648116|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648117|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816529|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19816530|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816531|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19816532|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816533|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
19816534|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816535|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
19816536|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816537|NCT00499603|Paclitaxel|paclitaxel|mesh-list
19816538|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
19816539|NCT00499603|Fluorouracil|fluorouracil|mesh-list
19816540|NCT00499603|Epirubicin|epirubicin|mesh-list
19816541|NCT00499603|Everolimus|everolimus|mesh-list
19816542|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20331855|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20331856|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20331857|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20331858|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331859|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331860|NCT00776828|Cilostazol|cilostazol|mesh-list
20331861|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19648118|NCT02349204|Zaleplon|zaleplon|mesh-list
19648119|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
19648120|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19648121|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648122|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611720|NCT00408005|Protective Agents|protective agents|mesh-ancestor
20611721|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
20611722|NCT00408005|Vitamins|vitamins|mesh-ancestor
20611723|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
19648123|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
19648124|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
19648125|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648126|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648127|NCT02349165|Riboflavin|riboflavin|mesh-list
20331862|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
20331863|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331864|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331865|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20331866|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
20331867|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20331868|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20331869|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331870|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20611724|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20164885|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20164886|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
20611725|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611726|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611727|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816543|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164887|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20164888|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164889|NCT00135681|Nedocromil|nedocromil|mesh-list
20164890|NCT00135681|Budesonide|budesonide|mesh-list
20164891|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164892|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20164893|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
20611728|NCT00408005|Hematinics|hematinics|mesh-ancestor
20611729|NCT00358163|Paclitaxel|paclitaxel|mesh-list
20331871|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
20331872|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20331873|NCT00776828|Protective Agents|protective agents|mesh-ancestor
20331874|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20331875|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20331876|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816544|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816545|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816546|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816547|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816548|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816549|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
19816550|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816551|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816552|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816553|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
19816554|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816555|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
20331877|NCT00776841|Cholic Acids|cholic acids|mesh-list
20331878|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
20331879|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20331880|NCT00777114|Bortezomib|bortezomib|mesh-list
20331881|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331882|NCT00777140|Deferoxamine|deferoxamine|mesh-list
20331883|NCT00777140|Siderophores|siderophores|mesh-ancestor
20331884|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20331885|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
20331886|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
19648128|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
20331887|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331888|NCT00777166|Oxytocin|oxytocin|mesh-list
20331889|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
20331890|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20331891|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331892|NCT00777218|Topiramate|topiramate|mesh-list
20331893|NCT00777218|Propranolol|propranolol|mesh-list
20331894|NCT00777218|Zonisamide|zonisamide|mesh-list
20331895|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20331896|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20331897|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
20331898|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331899|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331900|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331901|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19648129|NCT02349165|Vitamins|vitamins|mesh-ancestor
20331902|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331903|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
20331904|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
20331905|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20331906|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20331907|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20331908|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20331909|NCT00777244|Mitotane|mitotane|mesh-list
20331910|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20331911|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331912|NCT00777322|Riboflavin|riboflavin|mesh-list
19648130|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
19648131|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648132|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19648133|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
19648134|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19648135|NCT02348905|Hormones|hormones|mesh-ancestor
19648136|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648137|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648138|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19648139|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19648140|NCT02349113|Estrogens|estrogens|mesh-list
19648141|NCT02349113|Estradiol|estradiol|mesh-list
19648142|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19648143|NCT02349113|Hormones|hormones|mesh-ancestor
19648144|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648145|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648146|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20331913|NCT00777322|Dextrans|dextrans|mesh-list
20331914|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
20331915|NCT00777322|Vitamins|vitamins|mesh-ancestor
20331916|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
19816556|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816557|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19816558|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19816559|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19816560|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816561|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
19816562|NCT00499616|Carboplatin|carboplatin|mesh-list
19816563|NCT00499616|Doxorubicin|doxorubicin|mesh-list
19816564|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19816565|NCT00499616|Etoposide|etoposide|mesh-list
19816566|NCT00499616|Topotecan|topotecan|mesh-list
20164894|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164895|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164896|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20164897|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
20164898|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
20164899|NCT00135681|Hormones|hormones|mesh-ancestor
20164900|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20164901|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
20164902|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
20164903|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20164904|NCT00135720|Etanercept|etanercept|mesh-list
20164905|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20164906|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20164907|NCT00135720|Analgesics|analgesics|mesh-ancestor
20164908|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
20164909|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164910|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164911|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164912|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164913|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164914|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164915|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
20164916|NCT00135733|Alefacept|alefacept|mesh-list
20164917|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164918|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
20331917|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331918|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20331919|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
20331920|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
20331921|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
20331922|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
20331923|NCT00777413|Minocycline|minocycline|mesh-list
20331924|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20331925|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20331926|NCT00777439|Domperidone|domperidone|mesh-list
20331927|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331928|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
20331929|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
20331930|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331931|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331932|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20331933|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19648147|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
19648148|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648149|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19648150|NCT02348788|Chloroquine|chloroquine|mesh-list
19648151|NCT02348788|Lumefantrine|lumefantrine|mesh-list
19648152|NCT02348788|Artemether|artemether|mesh-list
19648153|NCT02348788|Primaquine|primaquine|mesh-list
19648154|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19648155|NCT02348788|Amebicides|amebicides|mesh-ancestor
19648156|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19648157|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20164919|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164920|NCT00135746|Nicotine|nicotine|mesh-list
20164921|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20164922|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
20164923|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164924|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164925|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20164926|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20164927|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
20164928|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164929|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164930|NCT00135759|Naltrexone|naltrexone|mesh-list
20164931|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20164932|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19816567|NCT00499616|Isotretinoin|isotretinoin|mesh-list
19816568|NCT00499616|Lenograstim|lenograstim|mesh-list
19816569|NCT00499616|Sargramostim|sargramostim|mesh-list
19816570|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816571|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
19816572|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816573|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816574|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816575|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
19816576|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816577|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816578|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816579|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19816580|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19816581|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20164933|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164934|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
20164935|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164936|NCT00135785|Bupropion|bupropion|mesh-list
20164937|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19816582|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816583|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816584|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19816585|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19816586|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
19816587|NCT00499655|Celecoxib|celecoxib|mesh-list
19816588|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19816589|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816590|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19816591|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816592|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816593|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19816594|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19816595|NCT00499655|Analgesics|analgesics|mesh-ancestor
19816596|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
19816597|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816598|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816599|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19816600|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816601|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20331934|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
19816602|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19816603|NCT00499681|Letrozole|letrozole|mesh-list
19816604|NCT00499681|Lapatinib|lapatinib|mesh-list
19816605|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816606|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19816607|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19816608|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816609|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816610|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19816611|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
19816612|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19816613|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816614|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20331935|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331936|NCT00777478|Sunitinib|sunitinib|mesh-list
20331937|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331938|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20331939|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20331940|NCT00777478|Growth Substances|growth substances|mesh-ancestor
20164938|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
20164939|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20164940|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20164941|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20164942|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20164943|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164944|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
20164945|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20164946|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331941|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331942|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
20331943|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20331944|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331945|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331946|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19816615|NCT00499694|Bevacizumab|bevacizumab|mesh-list
19816616|NCT00499694|Satraplatin|satraplatin|mesh-list
19816617|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816618|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816619|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19816620|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816621|NCT00499694|Growth Substances|growth substances|mesh-ancestor
19816622|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816623|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
19816624|NCT00499746|Tramadol|tramadol|mesh-list
19816625|NCT00499746|Hydromorphone|hydromorphone|mesh-list
19816626|NCT00499746|Methylphenidate|methylphenidate|mesh-list
19816627|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19816628|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816629|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19816630|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19816631|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816632|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816633|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
19816634|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816635|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19816636|NCT00499746|Narcotics|narcotics|mesh-ancestor
19816637|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20331947|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816638|NCT00499746|Analgesics|analgesics|mesh-ancestor
19816639|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
20331948|NCT00777504|Growth Substances|growth substances|mesh-ancestor
20331949|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331950|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
20331951|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331952|NCT00777517|Atorvastatin|atorvastatin|mesh-list
20331953|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20331954|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20331955|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
20331956|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331957|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20331958|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20331959|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20331960|NCT00777543|Ferulic acid|ferulic acid|mesh-list
20331961|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20331962|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20331963|NCT00777543|Analgesics|analgesics|mesh-ancestor
20331964|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
20331965|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331966|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331967|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20331968|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331969|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
20331970|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20331971|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20331972|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20331973|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20331974|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
20331975|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331976|NCT00777543|Protective Agents|protective agents|mesh-ancestor
20331977|NCT00777569|Nicotine|nicotine|mesh-list
20331978|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20331979|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
20331980|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20331981|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20331982|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20331983|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20331984|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
20331985|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20331986|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331987|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
20331988|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19816640|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816641|NCT00499863|Methylphenidate|methylphenidate|mesh-list
19816642|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19816643|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816644|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19816645|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19816646|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816647|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816648|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
19816649|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816650|NCT00499889|Vidarabine|vidarabine|mesh-list
19816651|NCT00499889|Methotrexate|methotrexate|mesh-list
19816652|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
19816653|NCT00499889|Fludarabine|fludarabine|mesh-list
19816654|NCT00499889|Busulfan|busulfan|mesh-list
19816655|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
19816656|NCT00499889|Tacrolimus|tacrolimus|mesh-list
19816657|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
19816658|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19816659|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19816660|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
20331989|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816661|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19816662|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816663|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816664|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
19816665|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816666|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816667|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
19816668|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816669|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19816670|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816671|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
19816672|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816673|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19816674|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
19816675|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816676|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19816677|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
19816678|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816679|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816680|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19816681|NCT00500110|Docetaxel|docetaxel|mesh-list
19816682|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
19816683|NCT00500110|Leuprolide|leuprolide|mesh-list
19816684|NCT00500110|Goserelin|goserelin|mesh-list
19816685|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816686|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816687|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816688|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816689|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816690|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19816691|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816692|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19816693|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
19816694|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19816695|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816696|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19816697|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19816698|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19816699|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816700|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19816701|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19816702|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816703|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816704|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
19816705|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816706|NCT00500240|Insulin|insulin|mesh-list
19816707|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19816708|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
19816709|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
19816710|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19816711|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816712|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19816713|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
19816714|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816715|NCT00500292|Leucovorin|leucovorin|mesh-list
19816716|NCT00500292|Folic Acid|folic acid|mesh-list
19816717|NCT00500292|Fluorouracil|fluorouracil|mesh-list
19816718|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
19816719|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
19816720|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
19816721|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816722|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816723|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816724|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816725|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
19816726|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816727|NCT00500292|Antidotes|antidotes|mesh-ancestor
19816728|NCT00500292|Protective Agents|protective agents|mesh-ancestor
19816729|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
19816730|NCT00500292|Vitamins|vitamins|mesh-ancestor
19816731|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
20611730|NCT00358163|Vatalanib|vatalanib|mesh-list
19816732|NCT00500292|Hematinics|hematinics|mesh-ancestor
19816733|NCT00500318|Bromides|bromides|mesh-list
19816734|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
19816735|NCT00500331|Pioglitazone|pioglitazone|mesh-list
19816736|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19816737|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816738|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19816739|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
19816740|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816741|NCT00500370|Exenatide|exenatide|mesh-list
19816742|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19816743|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816744|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19816745|NCT00500370|Incretins|incretins|mesh-ancestor
19816746|NCT00500370|Hormones|hormones|mesh-ancestor
20331990|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20331991|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20331992|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816747|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19816748|NCT00500539|Omalizumab|omalizumab|mesh-list
19816749|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19816750|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19816751|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
19816752|NCT00500578|Ribavirin|ribavirin|mesh-list
19816753|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
19816754|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816755|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
19816756|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816757|NCT00500656|Icatibant|icatibant|mesh-list
19816758|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
19816759|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19816760|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19816761|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816762|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
19816763|NCT00500656|Coagulants|coagulants|mesh-ancestor
19816764|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19816765|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19816766|NCT00500656|Analgesics|analgesics|mesh-ancestor
19816767|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
19816768|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816769|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816770|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19816771|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20331993|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20331994|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20331995|NCT00777673|Paclitaxel|paclitaxel|mesh-list
19816772|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19816773|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19816774|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19816775|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816776|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
20331996|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
20331997|NCT00777673|Bevacizumab|bevacizumab|mesh-list
20331998|NCT00777673|Carboplatin|carboplatin|mesh-list
20331999|NCT00777673|Doxorubicin|doxorubicin|mesh-list
20332000|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20332001|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20332002|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332003|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
20332004|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
20332005|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
20332006|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332007|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332008|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
20332009|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332010|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332011|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19648158|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648159|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
19648160|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648161|NCT02348528|Dexamethasone|dexamethasone|mesh-list
19648162|NCT02348528|Lenalidomide|lenalidomide|mesh-list
19648163|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648164|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
19648165|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
19648166|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816777|NCT00500760|Panitumumab|panitumumab|mesh-list
19816778|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332012|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
20332013|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19648167|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816779|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816780|NCT00501059|Aspirin|aspirin|mesh-list
19816781|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19816782|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19816783|NCT00501059|Analgesics|analgesics|mesh-ancestor
19816784|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
19816785|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816786|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816787|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19816788|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332014|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20332015|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20332016|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20332017|NCT00777673|Growth Substances|growth substances|mesh-ancestor
20332018|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19816789|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19816790|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19816791|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816792|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19816793|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19816794|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816795|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
19816796|NCT00501293|Methylphenidate|methylphenidate|mesh-list
19816797|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19816798|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816799|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19816800|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19816801|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19816802|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816803|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
19816804|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816805|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
19816806|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
19816807|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19816808|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816809|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816810|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
19816811|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19816812|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19816813|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834786|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834787|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834788|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834789|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
19834790|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834791|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834792|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834793|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
19834794|NCT00597584|Hematinics|hematinics|mesh-ancestor
19834795|NCT00597701|Lorazepam|lorazepam|mesh-list
20332019|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20332020|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20332021|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20332022|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332023|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20332024|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332025|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20332026|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834796|NCT00597701|Baclofen|baclofen|mesh-list
19834797|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19834798|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834799|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19834800|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834801|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19834802|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
19834803|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
19834804|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834805|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834806|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
19834807|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
19834808|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
19834809|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20332027|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816814|NCT00501631|Naltrexone|naltrexone|mesh-list
19816815|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19816816|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19816817|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816818|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
19816819|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816820|NCT00501644|Interferons|interferons|mesh-list
19816821|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
19816822|NCT00501644|Carboplatin|carboplatin|mesh-list
19816823|NCT00501644|Molgramostim|molgramostim|mesh-list
19816824|NCT00501644|Sargramostim|sargramostim|mesh-list
19816825|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816826|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
19816827|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816828|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
19816829|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816830|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
19816831|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
19816832|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19816833|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
19816834|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816835|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816836|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19816837|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
19816838|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
19816839|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19816840|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
19816841|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816842|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816843|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19816844|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19816845|NCT00501891|Bevacizumab|bevacizumab|mesh-list
19816846|NCT00501891|Temozolomide|temozolomide|mesh-list
19816847|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816848|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816849|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19816850|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19816851|NCT00501891|Growth Substances|growth substances|mesh-ancestor
19816852|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816853|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
19816854|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816855|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
19816856|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816857|NCT00501943|Interferons|interferons|mesh-list
19816858|NCT00501943|Interferon-beta|interferon-beta|mesh-list
19816859|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
19816860|NCT00501943|Riluzole|riluzole|mesh-list
19816861|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816862|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
19816863|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816864|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
19816865|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816866|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19816867|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
19816868|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19816869|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19648168|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648169|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
19648170|NCT02348528|Hormones|hormones|mesh-ancestor
19648171|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648172|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648173|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648174|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
19648175|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19648176|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19648177|NCT02348528|Growth Substances|growth substances|mesh-ancestor
19648178|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
19648179|NCT02348463|Clindamycin|clindamycin|mesh-list
19816870|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816871|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816872|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19816873|NCT00501943|Protective Agents|protective agents|mesh-ancestor
19816874|NCT00501969|Rotigotine|rotigotine|mesh-list
19816875|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
19816876|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
19816877|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816878|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816879|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816880|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
19816881|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816882|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
19816883|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816884|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816885|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19816886|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
19816887|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816888|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816889|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816890|NCT00502203|Paclitaxel|paclitaxel|mesh-list
19816891|NCT00502203|Carboplatin|carboplatin|mesh-list
19816892|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19816893|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816894|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
19816895|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
19816896|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
19816897|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816898|NCT00502216|Naltrexone|naltrexone|mesh-list
19816899|NCT00502216|Varenicline|varenicline|mesh-list
19816900|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19816901|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19816902|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816903|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
19816904|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19816905|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19816906|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19816907|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
19816908|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816909|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816910|NCT00502242|Ramipril|ramipril|mesh-list
19816911|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19816912|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
19816913|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816914|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816915|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19816916|NCT00502671|Capecitabine|capecitabine|mesh-list
19816917|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816918|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
19816919|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816920|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816921|NCT00502775|Fluticasone|fluticasone|mesh-list
19816922|NCT00502775|Xhance|xhance|mesh-list
19816923|NCT00502775|Fexofenadine|fexofenadine|mesh-list
19816924|NCT00502775|Terfenadine|terfenadine|mesh-list
19816925|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19816926|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20332028|NCT00777738|Bortezomib|bortezomib|mesh-list
20332029|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332030|NCT00777933|Cyclosporine|cyclosporine|mesh-list
20332031|NCT00777933|Tacrolimus|tacrolimus|mesh-list
20332032|NCT00777933|Cyclosporins|cyclosporins|mesh-list
20332033|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332034|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
20332035|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332036|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20332037|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332038|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332039|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
20332040|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332041|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
20332042|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332043|NCT00777959|Sirolimus|sirolimus|mesh-list
20332044|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332045|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332046|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20332047|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816927|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
19816928|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332048|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
20332049|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816929|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816930|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19816931|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
19816932|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
19816933|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19816934|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20164947|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20164948|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20164949|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164950|NCT00135811|Cyclosporine|cyclosporine|mesh-list
20164951|NCT00135811|Dexamethasone|dexamethasone|mesh-list
20164952|NCT00135811|Cyclosporins|cyclosporins|mesh-list
20164953|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20164954|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
20164955|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
20164956|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20164957|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164958|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20164959|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
19816935|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19816936|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
20332050|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
20332051|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332052|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20332053|NCT00777972|Fosinopril|fosinopril|mesh-list
20332054|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20332055|NCT00777972|Diuretics|diuretics|mesh-ancestor
20332056|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
20332057|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332058|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20332059|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332060|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332061|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20332062|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
20332063|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332064|NCT00777985|Bosentan|bosentan|mesh-list
20332065|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20332066|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20332067|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816937|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
19816938|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19816939|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816940|NCT00502801|Doripenem|doripenem|mesh-list
19816941|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19816942|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816943|NCT00502840|Rituximab|rituximab|mesh-list
19816944|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816945|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816946|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
19816947|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816948|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816949|NCT00502853|Rituximab|rituximab|mesh-list
19816950|NCT00502853|Methotrexate|methotrexate|mesh-list
20332068|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
20332069|NCT00777998|Thalidomide|thalidomide|mesh-list
20332070|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816951|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816952|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816953|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
19816954|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816955|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816956|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19816957|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
20332071|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
20332072|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164960|NCT00135811|Hormones|hormones|mesh-ancestor
20164961|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332073|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
20332074|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332075|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332076|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19816958|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19816959|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816960|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
19816961|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816962|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
19816963|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19816964|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19816965|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332077|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20332078|NCT00777998|Growth Substances|growth substances|mesh-ancestor
20332079|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
19648180|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
19648181|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
19648182|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648183|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648184|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19648185|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648186|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648187|NCT02348255|Bevacizumab|bevacizumab|mesh-list
19648188|NCT02348255|Carmustine|carmustine|mesh-list
19648189|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19648190|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648191|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19648192|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19648193|NCT02348255|Growth Substances|growth substances|mesh-ancestor
19648194|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648195|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
19648196|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19648197|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
19648198|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664859|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19664860|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
19664861|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
19664862|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19664863|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19664864|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19664865|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
19664866|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664867|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664868|NCT04856566|Ethanol|ethanol|mesh-list
19816966|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19816967|NCT00502905|Vidarabine|vidarabine|mesh-list
19648199|NCT02348268|Analgesics|analgesics|mesh-list
19648200|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
19648201|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648202|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648203|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
19648204|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
19648205|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19816968|NCT00502905|Fludarabine|fludarabine|mesh-list
19816969|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
19816970|NCT00502905|Busulfan|busulfan|mesh-list
19816971|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816972|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816973|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
19816974|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816975|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19816976|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
19816977|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816978|NCT00502905|Antiviral Agents|antiviral agents|mesh-ancestor
19816979|NCT00502905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19816980|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
19816981|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19648206|NCT02348346|Protective Agents|protective agents|mesh-ancestor
19648207|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648208|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
19648209|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20332080|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332081|NCT00777998|Trace Elements|trace elements|mesh-ancestor
20332082|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
20332083|NCT00778011|Ondansetron|ondansetron|mesh-list
19816982|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19816983|NCT00502996|Rituximab|rituximab|mesh-list
19816984|NCT00502996|Methotrexate|methotrexate|mesh-list
19816985|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19816986|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816987|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
19816988|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19816989|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19816990|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19816991|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
19816992|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19816993|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19816994|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
19816995|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19816996|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164962|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20164963|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20164964|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20164965|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332084|NCT00778011|Metoclopramide|metoclopramide|mesh-list
20332085|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
20332086|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
19648210|NCT02348333|Dotinurad|dotinurad|mesh-list
19648211|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
19648212|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
19648213|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648214|NCT02348333|Renal Agents|renal agents|mesh-ancestor
19648215|NCT02348307|Dotinurad|dotinurad|mesh-list
19648216|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
19648217|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
19648218|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648219|NCT02348307|Renal Agents|renal agents|mesh-ancestor
20164966|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20164967|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
20164968|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
19648220|NCT02348424|Solithromycin|solithromycin|mesh-list
19648221|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648222|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648223|NCT02348450|Irinotecan|irinotecan|mesh-list
19648224|NCT02348450|Etoposide|etoposide|mesh-list
19648225|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19816997|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648226|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19816998|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20164969|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648227|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19816999|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332087|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817000|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817001|NCT00503113|Alendronate|alendronate|mesh-list
19817002|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
19817003|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19817004|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817005|NCT00503139|Etanercept|etanercept|mesh-list
19648228|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648229|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648230|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19648231|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19648232|NCT02348372|Glycine|glycine|mesh-list
19648233|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
19648234|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648235|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648236|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648237|NCT02348281|Bicalutamide|bicalutamide|mesh-list
19648238|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
19648239|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648240|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648241|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648242|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648243|NCT02348398|Topotecan|topotecan|mesh-list
19648244|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19648245|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19648246|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648247|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648248|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648249|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
19648250|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20332088|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817006|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19817007|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19817008|NCT00503139|Analgesics|analgesics|mesh-ancestor
20164970|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164971|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20164972|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20164973|NCT00135824|Povidone|povidone|mesh-list
20164974|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20164975|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20164976|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
20164977|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
20164978|NCT00135837|Verteporfin|verteporfin|mesh-list
20164979|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20164980|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
20164981|NCT00135863|Tinzaparin|tinzaparin|mesh-list
20164982|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20164983|NCT00135863|Dalteparin|dalteparin|mesh-list
20164984|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
20164985|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20164986|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20164987|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332089|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20332090|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
19817009|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
19817010|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817011|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817012|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817013|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817014|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19817015|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332091|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
20332092|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20332093|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
20332094|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332095|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648251|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19648252|NCT02348190|Heparin|heparin|mesh-list
19648253|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
19817016|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
19817017|NCT00503399|Teriparatide|teriparatide|mesh-list
19817018|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
20164988|NCT00135876|Dalteparin|dalteparin|mesh-list
20164989|NCT00135876|Tinzaparin|tinzaparin|mesh-list
20164990|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20164991|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
20164992|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20332096|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20332097|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20332098|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332099|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332100|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20332101|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20332102|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20332103|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
20332104|NCT00778024|Fluoxetine|fluoxetine|mesh-list
20332105|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20332106|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20332107|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332108|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332109|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648254|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19648255|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19648256|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648257|NCT02348177|Ritonavir|ritonavir|mesh-list
19648258|NCT02348177|Lopinavir|lopinavir|mesh-list
19817019|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19817020|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20164993|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20164994|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20164995|NCT00135902|Progesterone|progesterone|mesh-list
20164996|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20164997|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20164998|NCT00135902|Progestins|progestins|mesh-ancestor
20164999|NCT00135902|Hormones|hormones|mesh-ancestor
20165000|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165001|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332110|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
19648259|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19648260|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19648261|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
19648262|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648263|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648264|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19648265|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20332111|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817021|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19817022|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19817023|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19817024|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817025|NCT00503425|Rituximab|rituximab|mesh-list
19817026|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817027|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817028|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
19817029|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817030|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817031|NCT00503685|Cetuximab|cetuximab|mesh-list
19817032|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20332112|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20332113|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
20611731|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817033|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817034|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19817035|NCT00503750|Vinorelbine|vinorelbine|mesh-list
19817036|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817037|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817038|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817039|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817040|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817041|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817042|NCT00503776|Amifostine|amifostine|mesh-list
19817043|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19817044|NCT00503776|Protective Agents|protective agents|mesh-ancestor
19648266|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
20165002|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19817045|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817046|NCT00503906|Gemcitabine|gemcitabine|mesh-list
19817047|NCT00503906|Paclitaxel|paclitaxel|mesh-list
19817048|NCT00503906|Bevacizumab|bevacizumab|mesh-list
19817049|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19817050|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817051|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817052|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817053|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817054|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
19648267|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648268|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19648269|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19817055|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817056|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817057|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20332114|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332115|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20332116|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20332117|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332118|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
20332119|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20332120|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
20332121|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332122|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20332123|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332124|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20332125|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332126|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20332127|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332128|NCT00778050|Amoxicillin|amoxicillin|mesh-list
20332129|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332130|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332131|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
19817058|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19817059|NCT00503906|Growth Substances|growth substances|mesh-ancestor
19817060|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817061|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
19817062|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817063|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
19817064|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
19817065|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817066|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817067|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817068|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
19817069|NCT00503984|Prednisone|prednisone|mesh-list
19817070|NCT00503984|Docetaxel|docetaxel|mesh-list
19817071|NCT00503984|Azacitidine|azacitidine|mesh-list
19817072|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817073|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817074|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817075|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817076|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817077|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817078|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
19817079|NCT00503984|Hormones|hormones|mesh-ancestor
19817080|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817081|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817082|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19817083|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817084|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
19817085|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817086|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
20332132|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19648270|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
19648271|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648272|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
19648273|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
19648274|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817087|NCT00503997|Pemetrexed|pemetrexed|mesh-list
19817088|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817089|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817090|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817091|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19817092|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817093|NCT00504023|Imiquimod|imiquimod|mesh-list
19817094|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19817095|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
20332133|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332134|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332135|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20332136|NCT00778063|Analgesics|analgesics|mesh-ancestor
20332137|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
20332138|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332139|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20332140|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20332141|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20332142|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
20332143|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332144|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332145|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
20332146|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20332147|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
20332148|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332149|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
20332150|NCT00778076|Protective Agents|protective agents|mesh-ancestor
20332151|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20332152|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
20332153|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20332154|NCT00778089|Protective Agents|protective agents|mesh-ancestor
20332155|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332156|NCT00778115|Simethicone|simethicone|mesh-list
20332157|NCT00778115|Loperamide|loperamide|mesh-list
20332158|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
20332159|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20332160|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
20332161|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332162|NCT00778115|Emollients|emollients|mesh-ancestor
20332163|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
20332164|NCT00778128|Gemcitabine|gemcitabine|mesh-list
20332165|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20332166|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
19817096|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817097|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817098|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
19817099|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
19817100|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19817101|NCT00504075|Antibodies|antibodies|mesh-list
19817102|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
19817103|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19817104|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
19817105|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817106|NCT00504153|Dasatinib|dasatinib|mesh-list
19817107|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817108|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817109|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817110|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817111|NCT00504166|Alendronate|alendronate|mesh-list
19817112|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19817113|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817114|NCT00504257|Bevacizumab|bevacizumab|mesh-list
19817115|NCT00504257|Docetaxel|docetaxel|mesh-list
19817116|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817117|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817118|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19817119|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19817120|NCT00504257|Growth Substances|growth substances|mesh-ancestor
19817121|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817122|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
19817123|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817124|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817125|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817126|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817127|NCT00504348|Tacrolimus|tacrolimus|mesh-list
19817128|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817129|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
19817130|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817131|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20332167|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332168|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332169|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
20332170|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817132|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817133|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817134|NCT00504504|Rituximab|rituximab|mesh-list
19817135|NCT00504504|Doxorubicin|doxorubicin|mesh-list
19817136|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19817137|NCT00504504|Dacarbazine|dacarbazine|mesh-list
19817138|NCT00504504|Bleomycin|bleomycin|mesh-list
19817139|NCT00504504|Vinblastine|vinblastine|mesh-list
19817140|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817141|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817142|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
19817143|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817144|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817145|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19817146|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19817147|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19648275|NCT02348125|Protective Agents|protective agents|mesh-ancestor
19648276|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332171|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332172|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332173|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
20332174|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332175|NCT00778141|Metformin|metformin|mesh-list
20332176|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20332177|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332178|NCT00778180|Furosemide|furosemide|mesh-list
20332179|NCT00778180|Diuretics|diuretics|mesh-ancestor
20332180|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
20332181|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332182|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20332183|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332184|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348031|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348032|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
20348033|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648277|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
19648278|NCT02348125|Vitamins|vitamins|mesh-ancestor
19648279|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
20348034|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
20348035|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348036|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
20348037|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348038|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
20348039|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20348040|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348041|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20348042|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
20348043|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20348044|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348045|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348046|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348047|NCT00863291|Buprenorphine|buprenorphine|mesh-list
20348048|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19648280|NCT02347878|Aprepitant|aprepitant|mesh-list
19648281|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
19648282|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
19648283|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648284|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648285|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648286|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19648287|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648288|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648289|NCT02347891|Belimumab|belimumab|mesh-list
19648290|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19648291|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
19648292|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648293|NCT02347865|Denosumab|denosumab|mesh-list
19648294|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19817148|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817149|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348049|NCT00863291|Narcotics|narcotics|mesh-ancestor
19648295|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817150|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817151|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
19817152|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20332185|NCT00778193|Aspirin|aspirin|mesh-list
20332186|NCT00778193|Celecoxib|celecoxib|mesh-list
20332187|NCT00778193|Naproxen|naproxen|mesh-list
20332188|NCT00778193|Clopidogrel|clopidogrel|mesh-list
20332189|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20332190|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20332191|NCT00778193|Analgesics|analgesics|mesh-ancestor
20332192|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
20332193|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332194|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332195|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648296|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19817153|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817154|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817155|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817156|NCT00504556|Warfarin|warfarin|mesh-list
19817157|NCT00504556|Edoxaban|edoxaban|mesh-list
19817158|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
19817159|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19817160|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
19817161|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19817162|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
19817163|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817164|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817165|NCT00504660|Celecoxib|celecoxib|mesh-list
19817166|NCT00504660|Capecitabine|capecitabine|mesh-list
19817167|NCT00504660|Thioguanine|thioguanine|mesh-list
19817168|NCT00504660|Temozolomide|temozolomide|mesh-list
19817169|NCT00504660|Lomustine|lomustine|mesh-list
19817170|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817171|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
19817172|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817173|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817174|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817175|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
19817176|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19817177|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19817178|NCT00504660|Analgesics|analgesics|mesh-ancestor
19817179|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
19817180|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817181|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817182|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817183|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817184|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19648297|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19648298|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648299|NCT02347501|Incretins|incretins|mesh-ancestor
19648300|NCT02347501|Hormones|hormones|mesh-ancestor
19648301|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648302|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19648303|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
19648304|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648305|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648306|NCT02347839|Gefitinib|gefitinib|mesh-list
19648307|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648308|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19648309|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648310|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648311|NCT02347319|Silymarin|silymarin|mesh-list
19648312|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
19648313|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817185|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19817186|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817187|NCT00504725|Ketamine|ketamine|mesh-list
19817188|NCT00504725|Analgesics|analgesics|mesh-ancestor
19817189|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
19817190|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817191|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817192|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20332196|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332197|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20332198|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20332199|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332200|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20332201|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20332202|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332203|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
20332204|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19817193|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19817194|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
19817195|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
19817196|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19817197|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19817198|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19817199|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648314|NCT02347319|Protective Agents|protective agents|mesh-ancestor
19648315|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648316|NCT02347423|Vaccines|vaccines|mesh-list
19648317|NCT02347423|Immunologic Factors|immunologic factors|mesh-ancestor
19648318|NCT02347423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648319|NCT02347358|Plasminogen|plasminogen|mesh-list
19648320|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19817200|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817201|NCT00504751|Dexamethasone|dexamethasone|mesh-list
19817202|NCT00504751|Rituximab|rituximab|mesh-list
20332205|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20332206|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19817203|NCT00504751|Etoposide|etoposide|mesh-list
19817204|NCT00504751|Bortezomib|bortezomib|mesh-list
19817205|NCT00504751|Ifosfamide|ifosfamide|mesh-list
19817206|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817207|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817208|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
19817209|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817210|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817211|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817212|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
19817213|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
19817214|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817215|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19817216|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
19817217|NCT00504751|Hormones|hormones|mesh-ancestor
19817218|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817219|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19817220|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817221|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19817222|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19817223|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817224|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817225|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817226|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
19817227|NCT00504777|Rituximab|rituximab|mesh-list
19817228|NCT00504777|Methotrexate|methotrexate|mesh-list
19817229|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19648321|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19648322|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19648323|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648324|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
19648325|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19648326|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648327|NCT02347046|Dotinurad|dotinurad|mesh-list
19648328|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
19648329|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
19648330|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648331|NCT02347046|Renal Agents|renal agents|mesh-ancestor
19817230|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817231|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
20332207|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
20332208|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332209|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20332210|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
20332211|NCT00778232|Gabapentin|gabapentin|mesh-list
20332212|NCT00778232|Analgesics|analgesics|mesh-ancestor
20332213|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
20332214|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332215|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332216|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
20332217|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19817232|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817233|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817234|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19817235|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
19817236|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19817237|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817238|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
20332218|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20332219|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332220|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332221|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20332222|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20332223|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332224|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332225|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
20332226|NCT00778245|Cefprozil|cefprozil|mesh-list
20332227|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332228|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332229|NCT00778271|Gabapentin|gabapentin|mesh-list
20332230|NCT00778271|Analgesics|analgesics|mesh-ancestor
20332231|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
19817239|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817240|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
19817241|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817242|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19817243|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817244|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817245|NCT00504829|Atorvastatin|atorvastatin|mesh-list
19817246|NCT00504829|Fenofibrate|fenofibrate|mesh-list
19817247|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19817248|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20165003|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
20165004|NCT00135928|Sargramostim|sargramostim|mesh-list
20165005|NCT00135928|Lenograstim|lenograstim|mesh-list
20165006|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
20165007|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165008|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20165009|NCT00135941|Insulin|insulin|mesh-list
20165010|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20165011|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
20165012|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
20165013|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165014|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165015|NCT00135954|Prednisolone|prednisolone|mesh-list
20165016|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
20332232|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165017|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165018|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
19817249|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
19817250|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817251|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19817252|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19817253|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817254|NCT00504881|Brivaracetam|brivaracetam|mesh-list
19817255|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
19648332|NCT02347059|Dopamine|dopamine|mesh-list
20332233|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332234|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
20332235|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20332236|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20332237|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332238|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332239|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19648333|NCT02347059|Levodopa|levodopa|mesh-list
19648334|NCT02347059|Pramipexole|pramipexole|mesh-list
19648335|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
19648336|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19648337|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19648338|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
19648339|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648340|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648341|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648342|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
19648343|NCT02347059|Protective Agents|protective agents|mesh-ancestor
19648344|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19648345|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
19648346|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
19648347|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648348|NCT02347033|Sertraline|sertraline|mesh-list
19648349|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
19648350|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19648351|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19648352|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19648353|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648354|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648355|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648356|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
19648357|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648358|NCT02346890|Sevelamer|sevelamer|mesh-list
19648359|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
19648360|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
19648361|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648362|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
19648363|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19648364|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664869|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19664870|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664871|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664872|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664873|NCT04825704|Bupivacaine|bupivacaine|mesh-list
19664874|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
19664875|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
19664876|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664877|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664878|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
19664879|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664880|NCT04733040|Felzartamab|felzartamab|mesh-list
19664881|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664882|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
19664883|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664884|NCT04730232|Paclitaxel|paclitaxel|mesh-list
19664885|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19664886|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664887|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
19664888|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
19664889|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
19664890|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664891|NCT04721353|Prazosin|prazosin|mesh-list
19817256|NCT00504894|Thiopental|thiopental|mesh-list
19817257|NCT00504894|Propofol|propofol|mesh-list
19664892|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19664893|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19817258|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20332240|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20332241|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332242|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332243|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
20332244|NCT00778284|Amoxicillin|amoxicillin|mesh-list
20332245|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332246|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332247|NCT00778297|Vaccines|vaccines|mesh-list
20332248|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
20332249|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332250|NCT00778349|Metformin|metformin|mesh-list
20332251|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19817259|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19817260|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817261|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19817262|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
19817263|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
19817264|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
19817265|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
19817266|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
19817267|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817268|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817269|NCT00505375|Abatacept|abatacept|mesh-list
19817270|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19817271|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817272|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817273|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817274|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
19817275|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817276|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817277|NCT00505414|Morphine|morphine|mesh-list
19817278|NCT00505414|Tapentadol|tapentadol|mesh-list
19817279|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19817280|NCT00505414|Narcotics|narcotics|mesh-ancestor
19817281|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19817282|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817283|NCT00505414|Analgesics|analgesics|mesh-ancestor
19817284|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
19817285|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817286|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19817287|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19817288|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19817289|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817290|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
20165019|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165020|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165021|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20165022|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
20165023|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165024|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165025|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20165026|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165027|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
20165028|NCT00135954|Hormones|hormones|mesh-ancestor
20165029|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165030|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20165031|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
20165032|NCT00135967|Prednisone|prednisone|mesh-list
20165033|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
20165034|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20165035|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20165036|NCT00135967|Prednisolone|prednisolone|mesh-list
20165037|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
20165038|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20165039|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
20165040|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165041|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
20165042|NCT00135967|Hormones|hormones|mesh-ancestor
20165043|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165044|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165045|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20165046|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332252|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332253|NCT00778401|Gabapentin|gabapentin|mesh-list
20332254|NCT00778401|Analgesics|analgesics|mesh-ancestor
20332255|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
20332256|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332257|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332258|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
19817291|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817292|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
19817293|NCT00505635|Interferons|interferons|mesh-list
19817294|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
19817295|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
19817296|NCT00505635|Thalidomide|thalidomide|mesh-list
20332259|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20332260|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20332261|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332262|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332263|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20332264|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20332265|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332266|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332267|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
20332268|NCT00778414|Amoxicillin|amoxicillin|mesh-list
20332269|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
20332270|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
20332271|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20332272|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332273|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332274|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332275|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332276|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20332277|NCT00778427|Metformin|metformin|mesh-list
20332278|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20332279|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332280|NCT00778466|Metformin|metformin|mesh-list
20332281|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20332282|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332283|NCT00778505|Remifentanil|remifentanil|mesh-list
20332284|NCT00778505|Propofol|propofol|mesh-list
20332285|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20332286|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332287|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332288|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19817297|NCT00505635|Cisplatin|cisplatin|mesh-list
19817298|NCT00505635|Temozolomide|temozolomide|mesh-list
19817299|NCT00505635|Interleukin-2|interleukin-2|mesh-list
19817300|NCT00505635|Vinblastine|vinblastine|mesh-list
19817301|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817302|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
19817303|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817304|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817305|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
19817306|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817307|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
19817308|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817309|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19817310|NCT00505635|Analgesics|analgesics|mesh-ancestor
19817311|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
19817312|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817313|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817314|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
19817315|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19817316|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19817317|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19817318|NCT00505635|Growth Substances|growth substances|mesh-ancestor
19817319|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
19817320|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817321|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817322|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817323|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817324|NCT00505661|Letrozole|letrozole|mesh-list
19817325|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817326|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19817327|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19817328|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817329|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332289|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
19817330|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20332290|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
19817331|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
19817332|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817333|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817334|NCT00505687|Rotigotine|rotigotine|mesh-list
19817335|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
19817336|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
19817337|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817338|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817339|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817340|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19817341|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19817342|NCT00505752|Hormones|hormones|mesh-ancestor
19817343|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817344|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817345|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19817346|NCT00505778|Mesalamine|mesalamine|mesh-list
19817347|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19817348|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19817349|NCT00505778|Analgesics|analgesics|mesh-ancestor
19817350|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
19817351|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332291|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20332292|NCT00778505|Narcotics|narcotics|mesh-ancestor
19817352|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817353|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817354|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817355|NCT00505895|Vidarabine|vidarabine|mesh-list
19817356|NCT00505895|Rituximab|rituximab|mesh-list
19817357|NCT00505895|Fludarabine|fludarabine|mesh-list
19817358|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
19817359|NCT00505895|Melphalan|melphalan|mesh-list
20332293|NCT00778505|Analgesics|analgesics|mesh-ancestor
20332294|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
20332295|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332296|NCT00778544|Amoxicillin|amoxicillin|mesh-list
20332297|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
19648365|NCT02346682|Clonazepam|clonazepam|mesh-list
19817360|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817361|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817362|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
19817363|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817364|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817365|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817366|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
19817367|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817368|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817369|NCT00505895|Antiviral Agents|antiviral agents|mesh-ancestor
19817370|NCT00505895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817371|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817372|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
19817373|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817374|NCT00505921|Cytarabine|cytarabine|mesh-list
19817375|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
19817376|NCT00505921|Melphalan|melphalan|mesh-list
20332298|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
20332299|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19648366|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19648367|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19648368|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19648369|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648370|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648371|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648372|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648373|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19648374|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
19648375|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19648376|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
19648377|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
19648378|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
19648379|NCT02346539|Nicotine|nicotine|mesh-list
19648380|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19648381|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
19817377|NCT00505921|Carmustine|carmustine|mesh-list
19817378|NCT00505921|Fludarabine|fludarabine|mesh-list
20332300|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19817379|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
19817380|NCT00505921|Etoposide|etoposide|mesh-list
19817381|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
19817382|NCT00505921|Molgramostim|molgramostim|mesh-list
19817383|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
19817384|NCT00505921|Sargramostim|sargramostim|mesh-list
19817385|NCT00505921|Lenograstim|lenograstim|mesh-list
19817386|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817387|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
19817388|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817389|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817390|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817391|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
19817392|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817393|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817394|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817395|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817396|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
19817397|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
19817398|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817399|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817400|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19817401|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19817402|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817403|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19817404|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817405|NCT00505934|Levetiracetam|levetiracetam|mesh-list
19817406|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
19817407|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
19817408|NCT00506129|Vidarabine|vidarabine|mesh-list
19817409|NCT00506129|Fludarabine|fludarabine|mesh-list
19817410|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
19817411|NCT00506129|Melphalan|melphalan|mesh-list
19817412|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
19817413|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19817414|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817415|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817416|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
19817417|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817418|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817419|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
19817420|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817421|NCT00506129|Antiviral Agents|antiviral agents|mesh-ancestor
19817422|NCT00506129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817423|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817424|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
19817425|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817426|NCT00506142|Vincristine|vincristine|mesh-list
19817427|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817428|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817429|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817430|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817431|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817432|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817433|NCT00506155|Bevacizumab|bevacizumab|mesh-list
19817434|NCT00506155|Cisplatin|cisplatin|mesh-list
19817435|NCT00506155|Doxorubicin|doxorubicin|mesh-list
19817436|NCT00506155|Methotrexate|methotrexate|mesh-list
19817437|NCT00506155|Vinblastine|vinblastine|mesh-list
19817438|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817439|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817440|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19817441|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19817442|NCT00506155|Growth Substances|growth substances|mesh-ancestor
19817443|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817444|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
19817445|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19817446|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19817447|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19817448|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817449|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817450|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19817451|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
19817452|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19817453|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817454|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
19817455|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
19817456|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19817457|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817458|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
19817459|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817460|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817461|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817462|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817463|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817464|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817465|NCT00506285|Methylphenidate|methylphenidate|mesh-list
19817466|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19817467|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817468|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19817469|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19817470|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648382|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648383|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648384|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19648385|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19648386|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
19648387|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648388|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648389|NCT02346578|Flutamide|flutamide|mesh-list
19648390|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
19648391|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648392|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648393|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648394|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19817471|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817472|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
19817473|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817474|NCT00506350|Vaccines|vaccines|mesh-list
19817475|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
19817476|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817477|NCT00506389|Mirtazapine|mirtazapine|mesh-list
19817478|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
19817479|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19817480|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19817481|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
19817482|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
20165047|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20165048|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20165049|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
20165050|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165051|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817483|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817484|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817485|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817486|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19817487|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19817488|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19817489|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19817490|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19817491|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19817492|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
19817493|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19817494|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19817495|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
19817496|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19817497|NCT00506415|Rivastigmine|rivastigmine|mesh-list
19817498|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19817499|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817500|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817501|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
19817502|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817503|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817504|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19817505|NCT00506415|Protective Agents|protective agents|mesh-ancestor
19817506|NCT00506519|Antithrombins|antithrombins|mesh-list
19817507|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
19817508|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19817509|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
19817510|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817511|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817512|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
19817513|NCT00506597|Asparaginase|asparaginase|mesh-list
19817514|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817515|NCT00506662|Insulin|insulin|mesh-list
19817516|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19817517|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
19817518|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
19817519|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
19817520|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
19817521|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19817522|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817523|NCT00506675|Atropine|atropine|mesh-list
19817524|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19817525|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19817526|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19817527|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
19817528|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817529|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817530|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19817531|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
19817532|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
19817533|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
19817534|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19817535|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19817536|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
19817537|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332301|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332302|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256674|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256675|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
20332303|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332304|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20332305|NCT00778557|Cefprozil|cefprozil|mesh-list
20332306|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332307|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332308|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
20332309|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19256676|NCT04249297|Progestins|progestins|mesh-ancestor
19256677|NCT04249297|Hormones|hormones|mesh-ancestor
19834810|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20332310|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817538|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817539|NCT00506779|Paclitaxel|paclitaxel|mesh-list
19817540|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
19817541|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817542|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817543|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
20332311|NCT00778583|Renal Agents|renal agents|mesh-ancestor
20332312|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332313|NCT00778596|Prednisolone|prednisolone|mesh-list
20332314|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332315|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
20332316|NCT00778596|Hormones|hormones|mesh-ancestor
20332317|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332318|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332319|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20332320|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332321|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20332322|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20332323|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20332324|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
20332325|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20332326|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332327|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19817544|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817545|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817546|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817547|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817548|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817549|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
19817550|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817551|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817552|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817553|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817554|NCT00506857|Vidarabine|vidarabine|mesh-list
19817555|NCT00506857|Fludarabine|fludarabine|mesh-list
19817556|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
19817557|NCT00506857|Busulfan|busulfan|mesh-list
19817558|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817559|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817560|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
19817561|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817562|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817563|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
20332328|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20332329|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20332330|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20332331|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19817564|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817565|NCT00506857|Antiviral Agents|antiviral agents|mesh-ancestor
19817566|NCT00506857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817567|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
19817568|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817569|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817570|NCT00506883|Colchicine|colchicine|mesh-list
19817571|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
19817572|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332332|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20332333|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20332334|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20332335|NCT00778661|Amoxicillin|amoxicillin|mesh-list
20332336|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332337|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332338|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20332339|NCT00778674|Benazepril|benazepril|mesh-list
19648395|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648396|NCT02346201|Methylphenidate|methylphenidate|mesh-list
19648397|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19648398|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648399|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19648400|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19648401|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332340|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20332341|NCT00778674|Diuretics|diuretics|mesh-ancestor
20332342|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
20332343|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648402|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648403|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
19648404|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648405|NCT02346357|Ropivacaine|ropivacaine|mesh-list
19648406|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
19648407|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
19817573|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817574|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817575|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817576|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817577|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332344|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20332345|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332346|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332347|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20332348|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
20332349|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332350|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20332351|NCT00778713|Fosinopril|fosinopril|mesh-list
20332352|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20332353|NCT00778713|Diuretics|diuretics|mesh-ancestor
20332354|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
20332355|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332356|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20332357|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332358|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332359|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20332360|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
20332361|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332362|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20332363|NCT00778726|Benazepril|benazepril|mesh-list
20332364|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20332365|NCT00778726|Diuretics|diuretics|mesh-ancestor
20332366|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
20332367|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332368|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20332369|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332370|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332371|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20332372|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165052|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165053|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165054|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
20165055|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
19817578|NCT00506922|Methotrexate|methotrexate|mesh-list
19817579|NCT00506922|Pentostatin|pentostatin|mesh-list
19817580|NCT00506922|Tacrolimus|tacrolimus|mesh-list
19817581|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19817582|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
19817583|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19817584|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817585|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817586|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
20165056|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648408|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165057|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20165058|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20165059|NCT00135967|Protective Agents|protective agents|mesh-ancestor
20165060|NCT00135993|Rotigotine|rotigotine|mesh-list
20165061|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
20165062|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
20165063|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165064|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165065|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165066|NCT00136045|Rotigotine|rotigotine|mesh-list
20332373|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332374|NCT00778739|Cefprozil|cefprozil|mesh-list
19648409|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648410|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
19648411|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648412|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19648413|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648414|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
19817587|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817588|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165067|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
20165068|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
20165069|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165070|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165071|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817589|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
19817590|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817591|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19817592|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817593|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
19817594|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817595|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817596|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19817597|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20165072|NCT00136058|Alendronate|alendronate|mesh-list
20165073|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
20165074|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20165075|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165076|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20165077|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332375|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19817598|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
19817599|NCT00506948|Sirolimus|sirolimus|mesh-list
19817600|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
19817601|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19817602|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19817603|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817604|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19817605|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
19817606|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19817607|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817608|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817609|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817610|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
19817611|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817612|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
19817613|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817614|NCT00507026|Diclofenac|diclofenac|mesh-list
19817615|NCT00507026|Ketorolac|ketorolac|mesh-list
19817616|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19817617|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19817618|NCT00507026|Analgesics|analgesics|mesh-ancestor
19817619|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
19817620|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817621|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817622|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817623|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817624|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19817625|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817626|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817627|NCT00507416|Thalidomide|thalidomide|mesh-list
19817628|NCT00507416|Dexamethasone|dexamethasone|mesh-list
19817629|NCT00507416|Prednisone|prednisone|mesh-list
20165078|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165079|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20165080|NCT00136110|Valproic Acid|valproic acid|mesh-list
20165081|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
20165082|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165083|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648415|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
19648416|NCT02346188|Trace Elements|trace elements|mesh-ancestor
19648417|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
19648418|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648419|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
19648420|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
19817630|NCT00507416|Bortezomib|bortezomib|mesh-list
19817631|NCT00507416|Melphalan|melphalan|mesh-list
20165084|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
19817632|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165085|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648421|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19648422|NCT02346188|Protective Agents|protective agents|mesh-ancestor
19648423|NCT02346253|Leuprolide|leuprolide|mesh-list
19648424|NCT02346253|Goserelin|goserelin|mesh-list
19648425|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19648426|NCT02346253|Bicalutamide|bicalutamide|mesh-list
19648427|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19648428|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
19648429|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648430|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817633|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
19817634|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
19817635|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648431|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648432|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648433|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
19648434|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648435|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648436|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
19648437|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19648438|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
19648439|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19648440|NCT02346110|Dexamethasone|dexamethasone|mesh-list
19648441|NCT02346110|Epinephrine|epinephrine|mesh-list
19817636|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817637|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648442|NCT02346110|Racepinephrine|racepinephrine|mesh-list
19648443|NCT02346110|Bupivacaine|bupivacaine|mesh-list
19817638|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
19817639|NCT00507416|Hormones|hormones|mesh-ancestor
19817640|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817641|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19817642|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817643|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817644|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
19817645|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817646|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817647|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817648|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
19817649|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
19817650|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19817651|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817652|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19817653|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19817654|NCT00507416|Growth Substances|growth substances|mesh-ancestor
19817655|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
19817656|NCT00507429|Paclitaxel|paclitaxel|mesh-list
19817657|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
19817658|NCT00507429|Combretastatin|combretastatin|mesh-list
19817659|NCT00507429|Carboplatin|carboplatin|mesh-list
19817660|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19817661|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817662|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817663|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165086|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332376|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332377|NCT00778752|Lenalidomide|lenalidomide|mesh-list
20332378|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
20165087|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
20165088|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20165089|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165090|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165091|NCT00136175|Gemcitabine|gemcitabine|mesh-list
20165092|NCT00136175|Paclitaxel|paclitaxel|mesh-list
20165093|NCT00136175|Carboplatin|carboplatin|mesh-list
20165094|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20165095|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165096|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
19648444|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
20332379|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648445|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648446|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
19648447|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
19817664|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817665|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834811|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834812|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19834813|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19834814|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19834815|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
19834816|NCT00597727|Glycerol|glycerol|mesh-list
19834817|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19834818|NCT00597727|Protective Agents|protective agents|mesh-ancestor
19834819|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834820|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
19834821|NCT00597753|Hematinics|hematinics|mesh-ancestor
19834822|NCT00597766|Triamcinolone|triamcinolone|mesh-list
19834823|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19834824|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19834825|NCT00597766|Lidocaine|lidocaine|mesh-list
19834826|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19834827|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
19834828|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
19834829|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834830|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834831|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
19834832|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834833|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19834834|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19834835|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19834836|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834837|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834838|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834839|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
19834840|NCT00597766|Hormones|hormones|mesh-ancestor
19834841|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19834842|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834843|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
19834844|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834845|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19834846|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19834847|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19834848|NCT00597818|Analgesics|analgesics|mesh-ancestor
19834849|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
20165097|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165098|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
20165099|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165100|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165101|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
20165102|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
20165103|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165104|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165105|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332380|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20332381|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20332382|NCT00778752|Growth Substances|growth substances|mesh-ancestor
20332383|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
20332384|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332385|NCT00778765|Gabapentin|gabapentin|mesh-list
20332386|NCT00778765|Analgesics|analgesics|mesh-ancestor
20332387|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
20332388|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332389|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332390|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
20332391|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20332392|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20332393|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332394|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332395|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20332396|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20332397|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332398|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332399|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
20332400|NCT00778778|Cefprozil|cefprozil|mesh-list
20332401|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332402|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332403|NCT00778791|Metformin|metformin|mesh-list
20332404|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20332405|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332406|NCT00778908|Cisplatin|cisplatin|mesh-list
20332407|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332408|NCT00778973|Sertraline|sertraline|mesh-list
19817666|NCT00507442|Dexamethasone|dexamethasone|mesh-list
20165106|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
20165107|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165108|NCT00136188|Folic Acid|folic acid|mesh-list
20165109|NCT00136188|Hematinics|hematinics|mesh-ancestor
20165110|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
20165111|NCT00136188|Vitamins|vitamins|mesh-ancestor
20165112|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
20165113|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332409|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
19817667|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
19817668|NCT00507442|Lenalidomide|lenalidomide|mesh-list
19817669|NCT00507442|Bortezomib|bortezomib|mesh-list
19817670|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817671|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
19817672|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817673|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817674|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817675|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
19817676|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817677|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817678|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817679|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817680|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
19817681|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
19817682|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817683|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19817684|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
19817685|NCT00507442|Hormones|hormones|mesh-ancestor
19817686|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817687|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19817688|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19817689|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19817690|NCT00507442|Growth Substances|growth substances|mesh-ancestor
19817691|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
19817692|NCT00507455|Tamsulosin|tamsulosin|mesh-list
19817693|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
19817694|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20332410|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19817695|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19817696|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20332411|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20332412|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19648448|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648449|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648450|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648451|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
19648452|NCT02346110|Hormones|hormones|mesh-ancestor
19648453|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648454|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648455|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648456|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
19648457|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
19648458|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648459|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
19648460|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19648461|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19648462|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
19817697|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
19817698|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332413|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332414|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332415|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817699|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817700|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817701|NCT00507455|Urological Agents|urological agents|mesh-ancestor
19817702|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19817703|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19817704|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
19817705|NCT00507507|Tenofovir|tenofovir|mesh-list
19817706|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
19817707|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817708|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19817709|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817710|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817711|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817712|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19817713|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19817714|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
19817715|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19817716|NCT00507689|Antibodies|antibodies|mesh-list
19817717|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
19817718|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817719|NCT00507728|Bupropion|bupropion|mesh-list
19817720|NCT00507728|Varenicline|varenicline|mesh-list
19817721|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19817722|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
19817723|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19817724|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19648463|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648464|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648465|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19648466|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19648467|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19648468|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19817725|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20332416|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
20332417|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817726|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19817727|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648469|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
19648470|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
19817728|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
19817729|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817730|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165114|NCT00136201|Tigecycline|tigecycline|mesh-list
20165115|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165116|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165117|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20165118|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165119|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165120|NCT00136266|Vitamin D|vitamin d|mesh-list
20165121|NCT00136266|Vitamins|vitamins|mesh-list
20165122|NCT00136266|Vitamin A|vitamin a|mesh-list
20165123|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
20165124|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
20165125|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817731|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19817732|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19817733|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817734|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19817735|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19817736|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
19817737|NCT00507767|Dasatinib|dasatinib|mesh-list
20332418|NCT00779012|Infliximab|infliximab|mesh-list
20332419|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
20332420|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20332421|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332422|NCT00779051|Zolpidem|zolpidem|mesh-list
20332423|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20332424|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20332425|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332426|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332427|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20332428|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
20332429|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
20332430|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332431|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332432|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
20332433|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20332434|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
20332435|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20332436|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
20332437|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332438|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332439|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
20332440|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
20332441|NCT00779129|Doxorubicin|doxorubicin|mesh-list
20332442|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332443|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
20332444|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332445|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332446|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817738|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817739|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817740|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817741|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817742|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
19817743|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
19817744|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19817745|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19817746|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817747|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817748|NCT00507819|Urological Agents|urological agents|mesh-ancestor
19817749|NCT00508027|Simvastatin|simvastatin|mesh-list
19817750|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19817751|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19817752|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
20332447|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
20332448|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648471|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19648472|NCT02346084|Maraviroc|maraviroc|mesh-list
19648473|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20332449|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332450|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20332451|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20332452|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20332453|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20332454|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332455|NCT00779194|Sirolimus|sirolimus|mesh-list
19648474|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19648475|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648476|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19648477|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19648478|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
19648479|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648480|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19648481|NCT02345902|Haloperidol|haloperidol|mesh-list
19817753|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817754|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20332456|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332457|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648482|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
19648483|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
19648484|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
19648485|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817755|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19817756|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817757|NCT00508118|Nicardipine|nicardipine|mesh-list
19817758|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19817759|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19817760|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19817761|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817762|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19817763|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648486|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648487|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648488|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19648489|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19648490|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648491|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19648492|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19648493|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
19648494|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648495|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648496|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19648497|NCT02345837|Clomiphene|clomiphene|mesh-list
19648498|NCT02345837|Enclomiphene|enclomiphene|mesh-list
19648499|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
19648500|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19648501|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648502|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648503|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648504|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19648505|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
19648506|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648507|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19817764|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
19817765|NCT00508144|Pemetrexed|pemetrexed|mesh-list
19817766|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817767|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817768|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817769|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19817770|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817771|NCT00508157|Olanzapine|olanzapine|mesh-list
20165126|NCT00136266|Trace Elements|trace elements|mesh-ancestor
20165127|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20165128|NCT00136292|Daptomycin|daptomycin|mesh-list
20165129|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165130|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165131|NCT00136344|Levofloxacin|levofloxacin|mesh-list
20165132|NCT00136344|Ofloxacin|ofloxacin|mesh-list
20165133|NCT00136344|Cefuroxime|cefuroxime|mesh-list
20165134|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
20165135|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20165136|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165137|NCT00136344|Renal Agents|renal agents|mesh-ancestor
19817772|NCT00508157|Risperidone|risperidone|mesh-list
19817773|NCT00508157|Aripiprazole|aripiprazole|mesh-list
20165138|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165139|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165140|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19817774|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19817775|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
19817776|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19817777|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
19817778|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817779|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817780|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332458|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20332459|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332460|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
20332461|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332462|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
19817781|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19817782|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19817783|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19648508|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19817784|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19817785|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
19817786|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
19817787|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
19817788|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817789|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19817790|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20332463|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332464|NCT00779220|Methotrexate|methotrexate|mesh-list
20332465|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
20332466|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20332467|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
20332468|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648509|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19817791|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19817792|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19817793|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
19817794|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
19817795|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19817796|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20165141|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165142|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165143|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165144|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20165145|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20165146|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
20165147|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20165148|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165149|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
20165150|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19648510|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
19648511|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19648512|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
19648513|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648514|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648515|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19648516|NCT02345993|Beclomethasone|beclomethasone|mesh-list
19648517|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
19648518|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19648519|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
19648520|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648521|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648522|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19648523|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
19648524|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19648525|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19648526|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19648527|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
19648528|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332469|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332470|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20332471|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
20332472|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332473|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332474|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
20332475|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332476|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20332477|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332478|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
20332479|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332480|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20332481|NCT00779233|Zidovudine|zidovudine|mesh-list
20332482|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
20332483|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817797|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19817798|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19817799|NCT00508274|Capecitabine|capecitabine|mesh-list
19817800|NCT00508274|Lapatinib|lapatinib|mesh-list
19817801|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817802|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
19817803|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817804|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817805|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817806|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817807|NCT00508404|Panitumumab|panitumumab|mesh-list
19817808|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817809|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817810|NCT00508469|Timolol|timolol|mesh-list
19817811|NCT00508469|Travoprost|travoprost|mesh-list
19817812|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19817813|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19817814|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19817815|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19817816|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
19817817|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817818|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817819|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817820|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19817821|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20332484|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20332485|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20332486|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332487|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
20332488|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817822|NCT00508482|Lactulose|lactulose|mesh-list
19817823|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19817824|NCT00508742|Vaccines|vaccines|mesh-list
19817825|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19817826|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
19817827|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817828|NCT00508924|Heparin|heparin|mesh-list
19817829|NCT00508924|Argatroban|argatroban|mesh-list
19817830|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
19817831|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19817832|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19817833|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817834|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
19817835|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19817836|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
20332489|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20332490|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20332491|NCT00779350|Sertraline|sertraline|mesh-list
20332492|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
20332493|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332494|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20332495|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20332496|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19817837|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332497|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332498|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817838|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19817839|NCT00509002|Gefitinib|gefitinib|mesh-list
19817840|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817841|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817842|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817843|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817844|NCT00509028|Budesonide|budesonide|mesh-list
19817845|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19817846|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19817847|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
19817848|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817849|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817850|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19817851|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
19817852|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
19817853|NCT00509028|Hormones|hormones|mesh-ancestor
19817854|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817855|NCT00509041|Dasatinib|dasatinib|mesh-list
19817856|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817857|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817858|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817859|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817860|NCT00509067|Olanzapine|olanzapine|mesh-list
20332499|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
20332500|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332501|NCT00779376|Zidovudine|zidovudine|mesh-list
20332502|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
20332503|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332504|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20332505|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20332506|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332507|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
20332508|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332509|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20332510|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20332511|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20332512|NCT00779389|Dasatinib|dasatinib|mesh-list
20332513|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332514|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20332515|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817861|NCT00509067|Risperidone|risperidone|mesh-list
19817862|NCT00509067|Aripiprazole|aripiprazole|mesh-list
19817863|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19817864|NCT00509067|Ziprasidone|ziprasidone|mesh-list
19817865|NCT00509067|Choline|choline|mesh-list
19817866|NCT00509067|Galantamine|galantamine|mesh-list
19817867|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19817868|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19817869|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
19817870|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19817871|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817872|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817873|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19817874|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19817875|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19817876|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19817877|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19817878|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
19817879|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
20165151|NCT00136383|Paroxetine|paroxetine|mesh-list
20165152|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20165153|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20165154|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20165155|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165156|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165157|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165158|NCT00136383|Analgesics|analgesics|mesh-ancestor
20165159|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
20165160|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165161|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
20332516|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332517|NCT00779441|Zolpidem|zolpidem|mesh-list
20332518|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20332519|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19817880|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
19817881|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332520|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332521|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332522|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20332523|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
20332524|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
20332525|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332526|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332527|NCT00779454|Gemcitabine|gemcitabine|mesh-list
19817882|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19817883|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19817884|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19817885|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19817886|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
19817887|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
19648529|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648530|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648531|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
19817888|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19817889|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19817890|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19817891|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19817892|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
19817893|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19817894|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
19817895|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19817896|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
19817897|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19817898|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817899|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
19648532|NCT02345993|Hormones|hormones|mesh-ancestor
19648533|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648534|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
19648535|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
19648536|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19648537|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19648538|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648539|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648540|NCT02345980|Urological Agents|urological agents|mesh-ancestor
19648541|NCT02345746|Leucovorin|leucovorin|mesh-list
19648542|NCT02345746|Folic Acid|folic acid|mesh-list
19648543|NCT02345746|Fluorouracil|fluorouracil|mesh-list
19648544|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
19648545|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
19648546|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
19648547|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817900|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19817901|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
19648548|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19648549|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648550|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19648551|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
19648552|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648553|NCT02345746|Antidotes|antidotes|mesh-ancestor
19648554|NCT02345746|Protective Agents|protective agents|mesh-ancestor
19648555|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
19648556|NCT02345746|Vitamins|vitamins|mesh-ancestor
19648557|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
19648558|NCT02345746|Hematinics|hematinics|mesh-ancestor
19648559|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19648560|NCT02345733|Amoxicillin|amoxicillin|mesh-list
19648561|NCT02345733|Metronidazole|metronidazole|mesh-list
19817902|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817903|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19817904|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817905|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817906|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
19817907|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19817908|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19817909|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817910|NCT00509197|Fluticasone|fluticasone|mesh-list
19817911|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648562|NCT02345733|Doxycycline|doxycycline|mesh-list
19817912|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19648563|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648564|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20332528|NCT00779454|Capecitabine|capecitabine|mesh-list
20332529|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
20332530|NCT00779454|Panitumumab|panitumumab|mesh-list
20332531|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20332532|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
20332533|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332534|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332535|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
20332536|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332537|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332538|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332539|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
20332540|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332541|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19817913|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
19817914|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19817915|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817916|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19817917|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
19817918|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
19817919|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19817920|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19817921|NCT00509236|Glipizide|glipizide|mesh-list
19817922|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19817923|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817924|NCT00509236|Incretins|incretins|mesh-ancestor
19817925|NCT00509236|Hormones|hormones|mesh-ancestor
19817926|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817927|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19817928|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
19817929|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817930|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817931|NCT00509249|Aflibercept|aflibercept|mesh-list
19817932|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
19817933|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19817934|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19817935|NCT00509249|Growth Substances|growth substances|mesh-ancestor
19817936|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817937|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
19817938|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817939|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19817940|NCT00509262|Glipizide|glipizide|mesh-list
19817941|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19817942|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817943|NCT00509262|Incretins|incretins|mesh-ancestor
19817944|NCT00509262|Hormones|hormones|mesh-ancestor
19817945|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19817946|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19817947|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
19817948|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165162|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165163|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
20165164|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20165165|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
20165166|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20165167|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20165168|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20165169|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165170|NCT00136396|Rituximab|rituximab|mesh-list
20165171|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20165172|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165173|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
20165174|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165175|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165176|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
20165177|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817949|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817950|NCT00509288|Aldesleukin|aldesleukin|mesh-list
19817951|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
19817952|NCT00509288|Fludarabine|fludarabine|mesh-list
19817953|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817954|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
19817955|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817956|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817957|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817958|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
19817959|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817960|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817961|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817962|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19817963|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19817964|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
19817965|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817966|NCT00509366|Gemcitabine|gemcitabine|mesh-list
19817967|NCT00509366|Cisplatin|cisplatin|mesh-list
19817968|NCT00509366|Docetaxel|docetaxel|mesh-list
19817969|NCT00509366|Pemetrexed|pemetrexed|mesh-list
19817970|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817971|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817972|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
19817973|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817974|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
20332542|NCT00779493|Curcumin|curcumin|mesh-list
20332543|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332544|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20332545|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20332546|NCT00779493|Analgesics|analgesics|mesh-ancestor
20332547|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
19817975|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19817976|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817977|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19817978|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
19817979|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817980|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
19817981|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
19817982|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
19817983|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19817984|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19817985|NCT00509496|Aldesleukin|aldesleukin|mesh-list
19817986|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
19817987|NCT00509496|Fludarabine|fludarabine|mesh-list
19817988|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
19817989|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332548|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332549|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332550|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332551|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332552|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19817990|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
19817991|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19817992|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19817993|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19817994|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
19817995|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19817996|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19817997|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19817998|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19817999|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
20165178|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20165179|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165180|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165181|NCT00136435|Leucovorin|leucovorin|mesh-list
20165182|NCT00136435|Cytarabine|cytarabine|mesh-list
20165183|NCT00136435|Dexamethasone|dexamethasone|mesh-list
20165184|NCT00136435|Prednisone|prednisone|mesh-list
20165185|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
20165186|NCT00136435|Doxorubicin|doxorubicin|mesh-list
20165187|NCT00136435|Methotrexate|methotrexate|mesh-list
19818000|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19818001|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19818002|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
19818003|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818004|NCT00509665|Gemcitabine|gemcitabine|mesh-list
19818005|NCT00509665|Doxorubicin|doxorubicin|mesh-list
19818006|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19818007|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818008|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
19818009|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818010|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818011|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
19818012|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818013|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818014|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818015|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
19818016|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818017|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19818018|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19818019|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818020|NCT00509769|Trastuzumab|trastuzumab|mesh-list
19818021|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19818022|NCT00509769|Maytansine|maytansine|mesh-list
19818023|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818024|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818025|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818026|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818027|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818028|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818029|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818030|NCT00509795|Ranibizumab|ranibizumab|mesh-list
19818031|NCT00509795|Aflibercept|aflibercept|mesh-list
19818032|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818033|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818034|NCT00509795|Growth Substances|growth substances|mesh-ancestor
19818035|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818036|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818037|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818038|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
19818039|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19818040|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19818041|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19818042|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818043|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19818044|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818045|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818046|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818047|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818048|NCT00509925|Insulin|insulin|mesh-list
19818049|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19818050|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
19818051|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
19818052|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
19818053|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
19818054|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
20165188|NCT00136435|Vincristine|vincristine|mesh-list
19259284|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19818055|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165189|NCT00136435|Asparaginase|asparaginase|mesh-list
20165190|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
19818056|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818057|NCT00510068|Everolimus|everolimus|mesh-list
19818058|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818059|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19648565|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19648566|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
19648567|NCT02345707|Cabotegravir|cabotegravir|mesh-list
19648568|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19648569|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19648570|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648571|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648572|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19648573|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19648574|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
19648575|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648576|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
19648577|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19648578|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
19648579|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648580|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818060|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
19818061|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818062|NCT00510146|Olanzapine|olanzapine|mesh-list
19818063|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
19818064|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
19818065|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818066|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818067|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818068|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19818069|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19648581|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19648582|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
19648583|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19648584|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
19648585|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818070|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818071|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19818072|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19818073|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19818074|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818075|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818076|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818077|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
19818078|NCT00510224|Octreotide|octreotide|mesh-list
19818079|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818080|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19818081|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818082|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19818083|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19818084|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19818085|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332553|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648586|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648587|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19648588|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
19648589|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
19648590|NCT02345616|Protective Agents|protective agents|mesh-ancestor
19648591|NCT02345681|Furosemide|furosemide|mesh-list
19648592|NCT02345681|Diuretics|diuretics|mesh-ancestor
19648593|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
19648594|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648595|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19648596|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648597|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648598|NCT02345304|Digoxin|digoxin|mesh-list
19648599|NCT02345304|Midazolam|midazolam|mesh-list
19648600|NCT02345304|Omeprazole|omeprazole|mesh-list
19648601|NCT02345304|Warfarin|warfarin|mesh-list
19648602|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19648603|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19648604|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648605|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818086|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648606|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20332554|NCT00779649|Bisacodyl|bisacodyl|mesh-list
20332555|NCT00779649|Cathartics|cathartics|mesh-ancestor
20332556|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648607|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19648608|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19648609|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19648610|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
19648611|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
19648612|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
19648613|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
19648614|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648615|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165191|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165192|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
20165193|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
20332557|NCT00779649|Laxatives|laxatives|mesh-ancestor
20332558|NCT00779714|Cytarabine|cytarabine|mesh-list
20332559|NCT00779714|Paclitaxel|paclitaxel|mesh-list
20332560|NCT00779714|Cisplatin|cisplatin|mesh-list
20332561|NCT00779714|Dacarbazine|dacarbazine|mesh-list
20332562|NCT00779714|Treosulfan|treosulfan|mesh-list
20332563|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19648616|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
19648617|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19818087|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
20332564|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818088|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818089|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818090|NCT00510289|Sorafenib|sorafenib|mesh-list
19818091|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818092|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818093|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818094|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818095|NCT00510484|Pancrelipase|pancrelipase|mesh-list
19818096|NCT00510484|Pancreatin|pancreatin|mesh-list
19818097|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818098|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
19818099|NCT00510510|Bromides|bromides|mesh-list
19818100|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
19818101|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19818102|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19818103|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19818104|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
19818105|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818106|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818107|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818108|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
19818109|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818110|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818111|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818112|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165194|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165195|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165196|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20165197|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
20165198|NCT00136435|Hormones|hormones|mesh-ancestor
20165199|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165200|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20332565|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
20332566|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
20332567|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
20332568|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332569|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20332570|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
20332571|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
20332572|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332573|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818113|NCT00510783|Phenytoin|phenytoin|mesh-list
19818114|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
19818115|NCT00510783|Levetiracetam|levetiracetam|mesh-list
19818116|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
19818117|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
20165201|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332574|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
20332575|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332576|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19648618|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20332577|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
19818118|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19818119|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19818120|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332578|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
20332579|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20332580|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20332581|NCT00779792|Triamcinolone|triamcinolone|mesh-list
20332582|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20332583|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20332584|NCT00779792|Clobetasol|clobetasol|mesh-list
19648619|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19648620|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818121|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818122|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19818123|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19818124|NCT00510809|Ethanol|ethanol|mesh-list
19818125|NCT00510809|Policosanol|policosanol|mesh-list
19818126|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19818127|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19818128|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818129|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818130|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818131|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19818132|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19818133|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
20165202|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19648621|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19648622|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20165203|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165204|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165205|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165206|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165207|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20165208|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
20165209|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20165210|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165211|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
20165212|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
20165213|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20165214|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165215|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
20165216|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165217|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20165218|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
20165219|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165220|NCT00136435|Antidotes|antidotes|mesh-ancestor
20165221|NCT00136435|Protective Agents|protective agents|mesh-ancestor
20332585|NCT00779792|Mineral Oil|mineral oil|mesh-list
19648623|NCT02345304|Protective Agents|protective agents|mesh-ancestor
19648624|NCT02345343|Apixaban|apixaban|mesh-list
19648625|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19648626|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
19648627|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19818134|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818135|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818136|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19818137|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19818138|NCT00510887|Dexamethasone|dexamethasone|mesh-list
19818139|NCT00510887|Rituximab|rituximab|mesh-list
19818140|NCT00510887|Fludarabine|fludarabine|mesh-list
19818141|NCT00510887|Bortezomib|bortezomib|mesh-list
19818142|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
19818143|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818144|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818145|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
19818146|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332586|NCT00779792|Tacrolimus|tacrolimus|mesh-list
20332587|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20332588|NCT00779792|Glycerol|glycerol|mesh-list
19818147|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818148|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19818149|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
19818150|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
19818151|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818152|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818153|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
19818154|NCT00510887|Hormones|hormones|mesh-ancestor
19818155|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818156|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19818157|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818158|NCT00510887|Analgesics|analgesics|mesh-ancestor
19818159|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
19818160|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19818161|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818162|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818163|NCT00510952|Insulin|insulin|mesh-list
19818164|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19818165|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
19818166|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
19818167|NCT00510952|Protamines|protamines|mesh-list
19818168|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19818169|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818170|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
19818171|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818172|NCT00510952|Coagulants|coagulants|mesh-ancestor
19818173|NCT00511004|Albendazole|albendazole|mesh-list
19818174|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
19818175|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
19818176|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19818177|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818178|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
19818179|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19818180|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19818181|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818182|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818183|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818184|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818185|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818186|NCT00511004|Filaricides|filaricides|mesh-ancestor
19818187|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
19818188|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19818189|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818190|NCT00511108|Pioglitazone|pioglitazone|mesh-list
19818191|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20165222|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
20165223|NCT00136435|Vitamins|vitamins|mesh-ancestor
20165224|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
20165225|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20165226|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
20165227|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165228|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
20165229|NCT00136448|Cytarabine|cytarabine|mesh-list
20165230|NCT00136448|Interleukin-2|interleukin-2|mesh-list
20165231|NCT00136448|Daunorubicin|daunorubicin|mesh-list
20165232|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165233|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
20165234|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818192|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19818193|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165235|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165236|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
19818194|NCT00511108|Incretins|incretins|mesh-ancestor
19818195|NCT00511108|Hormones|hormones|mesh-ancestor
19818196|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818197|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19818198|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
19818199|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818200|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818201|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
19818202|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19818203|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
19818204|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19818205|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
19818206|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818207|NCT00511173|Warfarin|warfarin|mesh-list
19818208|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
19818209|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
19818210|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19648628|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
19648629|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648630|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648631|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
19818211|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818212|NCT00511706|Dexamethasone|dexamethasone|mesh-list
19818213|NCT00511706|Ranibizumab|ranibizumab|mesh-list
19818214|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19818215|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
19818216|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
19818217|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818218|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818219|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818220|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
19818221|NCT00511706|Hormones|hormones|mesh-ancestor
19818222|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818223|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19818224|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818225|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818226|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818227|NCT00511706|Growth Substances|growth substances|mesh-ancestor
19818228|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818229|NCT00511836|Naltrexone|naltrexone|mesh-list
19818230|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19818231|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19818232|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332589|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332590|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
20332591|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332592|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20332593|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332594|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332595|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332596|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
20332597|NCT00779792|Hormones|hormones|mesh-ancestor
20332598|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332599|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20332600|NCT00779792|Protective Agents|protective agents|mesh-ancestor
20332601|NCT00779792|Emollients|emollients|mesh-ancestor
20332602|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
19648632|NCT02345590|Eplerenone|eplerenone|mesh-list
19648633|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19648634|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648635|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648636|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648637|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19648638|NCT02345590|Diuretics|diuretics|mesh-ancestor
19648639|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
19648640|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19648641|NCT02345239|Pantoprazole|pantoprazole|mesh-list
19648642|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19648643|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818233|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
19818234|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818235|NCT00511875|Doxycycline|doxycycline|mesh-list
19818236|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19818237|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818238|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
19818239|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19818240|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19818241|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
19818242|NCT00511901|Hematinics|hematinics|mesh-ancestor
19818243|NCT00511992|Paclitaxel|paclitaxel|mesh-list
19818244|NCT00511992|Bevacizumab|bevacizumab|mesh-list
19818245|NCT00511992|Cisplatin|cisplatin|mesh-list
19818246|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818247|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818248|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818249|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818250|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818251|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818252|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818253|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818254|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818255|NCT00511992|Growth Substances|growth substances|mesh-ancestor
19818256|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818257|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818258|NCT00512096|Paclitaxel|paclitaxel|mesh-list
19818259|NCT00512096|Cisplatin|cisplatin|mesh-list
19818260|NCT00512096|Ifosfamide|ifosfamide|mesh-list
19818261|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818262|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818263|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818264|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
20332603|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
20332604|NCT00779805|Ephedrine|ephedrine|mesh-list
20332605|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20332606|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
20332607|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818265|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818266|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332608|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332609|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20332610|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
20332611|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
20332612|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20332613|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20332614|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
19818267|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19818268|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
19818269|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
19818270|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19818271|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19818272|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19818273|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19818274|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818275|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818276|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
19818277|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818278|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818279|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19818280|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818281|NCT00512252|Cytarabine|cytarabine|mesh-list
19818282|NCT00512252|Plerixafor|plerixafor|mesh-list
19818283|NCT00512252|Etoposide|etoposide|mesh-list
19818284|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
19818285|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818286|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818287|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19818288|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818289|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818290|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165237|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165238|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165239|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
20165240|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165241|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20332615|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
20332616|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332617|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332618|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
20332619|NCT00779831|Ephedrine|ephedrine|mesh-list
20332620|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20332621|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
19648644|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19648645|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648646|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648647|NCT02345148|Esketamine|esketamine|mesh-list
19648648|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
19648649|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19648650|NCT02345044|Eplerenone|eplerenone|mesh-list
19648651|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19648652|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648653|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648654|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648655|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19648656|NCT02345044|Diuretics|diuretics|mesh-ancestor
19648657|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
19818291|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165242|NCT00136448|Analgesics|analgesics|mesh-ancestor
20165243|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
20165244|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165245|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20165246|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165247|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165248|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165249|NCT00136461|Tretinoin|tretinoin|mesh-list
20165250|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
20165251|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165252|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
20165253|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
20165254|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20165255|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
20165256|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165257|NCT00136474|Amifostine|amifostine|mesh-list
20332622|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332623|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332624|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20332625|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
20332626|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
20332627|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20332628|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20332629|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
19818292|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
19818293|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
19818294|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818295|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818296|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
19818297|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818298|NCT00512252|Analgesics|analgesics|mesh-ancestor
19818299|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
19818300|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818301|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19818302|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19818303|NCT00512278|Infliximab|infliximab|mesh-list
19818304|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
19818305|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818306|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818307|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
19818308|NCT00512707|Testosterone|testosterone|mesh-list
19818309|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332630|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
20332631|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332632|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332633|NCT00779896|Tazarotene|tazarotene|mesh-list
20332634|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
20332635|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
20332636|NCT00779922|Lenalidomide|lenalidomide|mesh-list
20332637|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
20332638|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332639|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20332640|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20332641|NCT00779922|Growth Substances|growth substances|mesh-ancestor
20332642|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
20332643|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818310|NCT00512707|Androgens|androgens|mesh-ancestor
19818311|NCT00512707|Hormones|hormones|mesh-ancestor
19818312|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818313|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818314|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
19818315|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19818316|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19818317|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818318|NCT00512707|Urological Agents|urological agents|mesh-ancestor
19818319|NCT00512798|Bortezomib|bortezomib|mesh-list
19818320|NCT00512798|Temozolomide|temozolomide|mesh-list
19818321|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818322|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19818323|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
19818324|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834850|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834851|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834852|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834853|NCT00597896|Pramipexole|pramipexole|mesh-list
19834854|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
19834855|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834856|NCT00597896|Protective Agents|protective agents|mesh-ancestor
19834857|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834858|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19834859|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19834860|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
19834861|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
19834862|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818325|NCT00512876|Bevacizumab|bevacizumab|mesh-list
19818326|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818327|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818328|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818329|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818330|NCT00512876|Growth Substances|growth substances|mesh-ancestor
19818331|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818332|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818333|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
19818334|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818335|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818336|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818337|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818338|NCT00513019|Lamotrigine|lamotrigine|mesh-list
19818339|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
19818340|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19818341|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332644|NCT00779935|Infliximab|infliximab|mesh-list
20332645|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
20332646|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20332647|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332648|NCT00780013|Metformin|metformin|mesh-list
20332649|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20332650|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332651|NCT00780039|Carboplatin|carboplatin|mesh-list
20332652|NCT00780039|Doxorubicin|doxorubicin|mesh-list
20332653|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20332654|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332655|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19818342|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818343|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19818344|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818345|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19818346|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19818347|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648658|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19648659|NCT02345213|Donepezil|donepezil|mesh-list
19648660|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19648661|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648662|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648663|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
19648664|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648665|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648666|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
19818348|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19818349|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19818350|NCT00513071|Saracatinib|saracatinib|mesh-list
19818351|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818352|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818353|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818354|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
19818355|NCT00513240|Hematinics|hematinics|mesh-ancestor
19818356|NCT00513292|Paclitaxel|paclitaxel|mesh-list
19818357|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
20165258|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19818358|NCT00513292|Trastuzumab|trastuzumab|mesh-list
20165259|NCT00136474|Protective Agents|protective agents|mesh-ancestor
20165260|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165261|NCT00136487|Celecoxib|celecoxib|mesh-list
20165262|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20165263|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20165264|NCT00136487|Analgesics|analgesics|mesh-ancestor
20165265|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
20165266|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165267|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165268|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332656|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20332657|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818359|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19818360|NCT00513292|Epirubicin|epirubicin|mesh-list
20332658|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332659|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332660|NCT00780104|Cytarabine|cytarabine|mesh-list
20332661|NCT00780104|Sirolimus|sirolimus|mesh-list
20332662|NCT00780104|Etoposide|etoposide|mesh-list
20332663|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
20332664|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20332665|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332666|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20332667|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20332668|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332669|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332670|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20332671|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
20332672|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
20332673|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332674|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332675|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
20332676|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332677|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332678|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19648667|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
19648668|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19648669|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648670|NCT02345187|Micronutrients|micronutrients|mesh-list
19648671|NCT02345187|Trace Elements|trace elements|mesh-list
19648672|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648673|NCT02344940|Tamoxifen|tamoxifen|mesh-list
19648674|NCT02344940|Toremifene|toremifene|mesh-list
19648675|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19648676|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648677|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648678|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648679|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648680|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648681|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19818361|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19648682|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19648683|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19818362|NCT00513292|Antibodies|antibodies|mesh-list
19818363|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
19818364|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19818365|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818366|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818367|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818368|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818369|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818370|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818371|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818372|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
19818373|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818374|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818375|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19818376|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
19818377|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19818378|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19818379|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19818380|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818381|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818382|NCT00513305|Cytarabine|cytarabine|mesh-list
19818383|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
19818384|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818385|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
19818386|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818387|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818388|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
19818389|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818390|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818391|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
19818392|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818393|NCT00513357|Melatonin|melatonin|mesh-list
19818394|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
19818395|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818396|NCT00513357|Protective Agents|protective agents|mesh-ancestor
19818397|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818398|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818399|NCT00513370|Adalimumab|adalimumab|mesh-list
19818400|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648684|NCT02344888|Folic Acid|folic acid|mesh-list
19648685|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
19648686|NCT02344888|Prednisolone|prednisolone|mesh-list
19648687|NCT02344888|Citric Acid|citric acid|mesh-list
19648688|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
19648689|NCT02344888|Clomiphene|clomiphene|mesh-list
19818401|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818402|NCT00513435|Saracatinib|saracatinib|mesh-list
19818403|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332679|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
20332680|NCT00780104|Analgesics|analgesics|mesh-ancestor
20332681|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
20332682|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348050|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348051|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348052|NCT00863291|Analgesics|analgesics|mesh-ancestor
20348053|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
20348054|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818404|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818405|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818406|NCT00513474|Cyclosporine|cyclosporine|mesh-list
19818407|NCT00513474|Sirolimus|sirolimus|mesh-list
19818408|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
19818409|NCT00513474|Busulfan|busulfan|mesh-list
19818410|NCT00513474|Methotrexate|methotrexate|mesh-list
19648690|NCT02344888|Enclomiphene|enclomiphene|mesh-list
19818411|NCT00513474|Fludarabine|fludarabine|mesh-list
19818412|NCT00513474|Etoposide|etoposide|mesh-list
19648691|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
19818413|NCT00513474|Allopurinol|allopurinol|mesh-list
19648692|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
19818414|NCT00513474|Rasburicase|rasburicase|mesh-list
19818415|NCT00513474|Tacrolimus|tacrolimus|mesh-list
20332683|NCT00780169|Sorafenib|sorafenib|mesh-list
20332684|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332685|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818416|NCT00513474|Cyclosporins|cyclosporins|mesh-list
19818417|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818418|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
19818419|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818420|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818421|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19818422|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
19818423|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611732|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611733|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611734|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611735|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611736|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611737|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20611738|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611739|NCT00268385|Temozolomide|temozolomide|mesh-list
20611740|NCT00268385|Vorinostat|vorinostat|mesh-list
20611741|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611742|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
20611743|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611744|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332686|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332687|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332688|NCT00780182|Brincidofovir|brincidofovir|mesh-list
20332689|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
20332690|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165269|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165270|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20165271|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20165272|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165273|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165274|NCT00136526|Docetaxel|docetaxel|mesh-list
20165275|NCT00136526|Fosfestrol|fosfestrol|mesh-list
20165276|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
20165277|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165278|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
20165279|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165280|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
20165281|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332691|NCT00780325|Celecoxib|celecoxib|mesh-list
20332692|NCT00780325|Naproxen|naproxen|mesh-list
20611745|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20611746|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611747|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
20611748|NCT00217737|Leucovorin|leucovorin|mesh-list
20611749|NCT00217737|Folic Acid|folic acid|mesh-list
20611750|NCT00217737|Bevacizumab|bevacizumab|mesh-list
20611751|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20611752|NCT00217737|Fluorouracil|fluorouracil|mesh-list
20332693|NCT00780325|Acetazolamide|acetazolamide|mesh-list
20332694|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20332695|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20332696|NCT00780325|Analgesics|analgesics|mesh-ancestor
20332697|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
20332698|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611753|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
19818424|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818425|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19818426|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19818427|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
19818428|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19818429|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818430|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
19818431|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
19818432|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818433|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19818434|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19818435|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20332699|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818436|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165282|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20165283|NCT00136526|Estrogens|estrogens|mesh-ancestor
20611754|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
19818437|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818438|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19818439|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
19818440|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818441|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19818442|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19818443|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
19818444|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19818445|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
19818446|NCT00513474|Protective Agents|protective agents|mesh-ancestor
19818447|NCT00513500|Amoxicillin|amoxicillin|mesh-list
19818448|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19818449|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19818450|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818451|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
19818452|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19818453|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19818454|NCT00513526|Vaccines|vaccines|mesh-list
19818455|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
19818456|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818457|NCT00513604|Aldesleukin|aldesleukin|mesh-list
19818458|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
19818459|NCT00513604|Fludarabine|fludarabine|mesh-list
19818460|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
19818461|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818462|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
19818463|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818464|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818465|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19818466|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
19818467|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818468|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818469|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19818470|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818471|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
19818472|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19818473|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19818474|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
19818475|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818476|NCT00513682|Pancrelipase|pancrelipase|mesh-list
19818477|NCT00513682|Pancreatin|pancreatin|mesh-list
19818478|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818479|NCT00513695|Paclitaxel|paclitaxel|mesh-list
19818480|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
19818481|NCT00513695|Doxorubicin|doxorubicin|mesh-list
19818482|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19818483|NCT00513695|Sunitinib|sunitinib|mesh-list
19818484|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818485|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818486|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818487|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818488|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818489|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818490|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165284|NCT00136526|Hormones|hormones|mesh-ancestor
20165285|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818491|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
19818492|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818493|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818494|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19818495|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
19818496|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20165286|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165287|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20165288|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
20165289|NCT00136539|Doxorubicin|doxorubicin|mesh-list
20165290|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20165291|NCT00136539|Trastuzumab|trastuzumab|mesh-list
20332700|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332701|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332702|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20332703|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20332704|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332705|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332706|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
20332707|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
20332708|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20332709|NCT00780325|Diuretics|diuretics|mesh-ancestor
20332710|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
20332711|NCT00780377|Bradykinin|bradykinin|mesh-list
20332712|NCT00780377|Kininogens|kininogens|mesh-list
20332713|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
20332714|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20332715|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
19648693|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19648694|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
20165292|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165293|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
20332716|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348055|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19648695|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
19648696|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648697|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648698|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
19648699|NCT02344888|Hormones|hormones|mesh-ancestor
19648700|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648701|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648702|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648703|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648704|NCT02344888|Hematinics|hematinics|mesh-ancestor
19648705|NCT02344888|Vitamins|vitamins|mesh-ancestor
19648706|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
19648707|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19648708|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648709|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19648710|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
19648711|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648712|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19648713|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19664894|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19664895|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19664896|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
19664897|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664898|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664899|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664900|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
19664901|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19664902|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664903|NCT04658277|Clarithromycin|clarithromycin|mesh-list
19664904|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19664905|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19664906|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19664907|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664908|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664909|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19664910|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19664911|NCT04602117|Paclitaxel|paclitaxel|mesh-list
19664912|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19664913|NCT04602117|Trastuzumab|trastuzumab|mesh-list
19664914|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19664915|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664916|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
19664917|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
19664918|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
19664919|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664920|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818497|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19818498|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19818499|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818500|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818501|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818502|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818503|NCT00513695|Growth Substances|growth substances|mesh-ancestor
19818504|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818505|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818506|NCT00513747|Rituximab|rituximab|mesh-list
19818507|NCT00513747|Fludarabine|fludarabine|mesh-list
19818508|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
19818509|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818510|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818511|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
19818512|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818513|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818514|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818515|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
19818516|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818517|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818518|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
19818519|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19818520|NCT00513799|Mupirocin|mupirocin|mesh-list
19818521|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19818522|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818523|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
19818524|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
19818525|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19818526|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19648714|NCT02344862|Dotinurad|dotinurad|mesh-list
19648715|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
19648716|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
19648717|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648718|NCT02344862|Renal Agents|renal agents|mesh-ancestor
19648719|NCT02344875|Dotinurad|dotinurad|mesh-list
19648720|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
19648721|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
19648722|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648723|NCT02344875|Renal Agents|renal agents|mesh-ancestor
19648724|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19648725|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
19648726|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19818527|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818528|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818529|NCT00514020|Leucovorin|leucovorin|mesh-list
19818530|NCT00514020|Fluorouracil|fluorouracil|mesh-list
19818531|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
19818532|NCT00514020|Calcium|calcium|mesh-list
19818533|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
19818534|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19818535|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165294|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165295|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165296|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20165297|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
20165298|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165299|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165300|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20165301|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20165302|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165303|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165304|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165305|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20165306|NCT00136552|Rituximab|rituximab|mesh-list
20165307|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20165308|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165309|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
20165310|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165311|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165312|NCT00136565|Prednisone|prednisone|mesh-list
20165313|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
20165314|NCT00136565|Doxorubicin|doxorubicin|mesh-list
20611755|NCT00217737|Antibodies|antibodies|mesh-list
20165315|NCT00136565|Bortezomib|bortezomib|mesh-list
19648727|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19648728|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818536|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
19818537|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818538|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818539|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818540|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818541|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
19818542|NCT00514020|Antidotes|antidotes|mesh-ancestor
19818543|NCT00514020|Protective Agents|protective agents|mesh-ancestor
19818544|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
19818545|NCT00514020|Vitamins|vitamins|mesh-ancestor
19818546|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
19818547|NCT00514137|Sunitinib|sunitinib|mesh-list
19818548|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818549|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818550|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818551|NCT00514137|Growth Substances|growth substances|mesh-ancestor
19818552|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818553|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818554|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818555|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332717|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332718|NCT00780598|Tosedostat|tosedostat|mesh-list
20332719|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332720|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332721|NCT00780637|Bradykinin|bradykinin|mesh-list
20332722|NCT00780637|Kininogens|kininogens|mesh-list
20332723|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
20332724|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19818556|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818557|NCT00514215|Molgramostim|molgramostim|mesh-list
19818558|NCT00514215|Sargramostim|sargramostim|mesh-list
19818559|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
19818560|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818561|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818562|NCT00514449|Valacyclovir|valacyclovir|mesh-list
19818563|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
19818564|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818565|NCT00514514|Cyclosporine|cyclosporine|mesh-list
19818566|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
19818567|NCT00514514|Everolimus|everolimus|mesh-list
19818568|NCT00514514|Cyclosporins|cyclosporins|mesh-list
19818569|NCT00514514|Basiliximab|basiliximab|mesh-list
19818570|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818571|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818572|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818573|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
19818574|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818575|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
19818576|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818577|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
19818578|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818579|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19818580|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818581|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19818582|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19818583|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
19818584|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332725|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
20332726|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648729|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648730|NCT02344823|Urological Agents|urological agents|mesh-ancestor
19648731|NCT02344810|Leucovorin|leucovorin|mesh-list
19818585|NCT00514540|Carboplatin|carboplatin|mesh-list
19648732|NCT02344810|Fluorouracil|fluorouracil|mesh-list
19648733|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
19648734|NCT02344810|Calcium|calcium|mesh-list
19648735|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
19648736|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19648737|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648738|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
19648739|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648740|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818586|NCT00514540|Docetaxel|docetaxel|mesh-list
19818587|NCT00514540|Etoposide|etoposide|mesh-list
19818588|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818589|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818590|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
20348056|NCT00863395|Lidocaine|lidocaine|mesh-list
19818591|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818592|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648741|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648742|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19648743|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
19648744|NCT02344810|Antidotes|antidotes|mesh-ancestor
19648745|NCT02344810|Protective Agents|protective agents|mesh-ancestor
19648746|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
19648747|NCT02344810|Vitamins|vitamins|mesh-ancestor
19648748|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
19648749|NCT02344511|Vancomycin|vancomycin|mesh-list
19648750|NCT02344511|Cefazolin|cefazolin|mesh-list
19648751|NCT02344511|Dalbavancin|dalbavancin|mesh-list
19648752|NCT02344511|Oxacillin|oxacillin|mesh-list
19648753|NCT02344511|Nafcillin|nafcillin|mesh-list
19648754|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332727|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332728|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20332729|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20332730|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20332731|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332732|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332733|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19818593|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818594|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19818595|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818596|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818597|NCT00514683|Nintedanib|nintedanib|mesh-list
19648755|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648756|NCT02344550|Everolimus|everolimus|mesh-list
19648757|NCT02344550|Letrozole|letrozole|mesh-list
19648758|NCT02344550|Leuprolide|leuprolide|mesh-list
19648759|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648760|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19648761|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
19818598|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818599|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818600|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818601|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818602|NCT00514709|Vaccines|vaccines|mesh-list
19818603|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
19818604|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818605|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19818606|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19818607|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
19818608|NCT00514852|Glycerol|glycerol|mesh-list
19818609|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19818610|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19818611|NCT00514852|Laxatives|laxatives|mesh-ancestor
19818612|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818613|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19818614|NCT00514852|Protective Agents|protective agents|mesh-ancestor
19818615|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818616|NCT00514904|Vaccines|vaccines|mesh-list
19818617|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
19818618|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818619|NCT00514917|Docetaxel|docetaxel|mesh-list
19818620|NCT00514917|Leuprolide|leuprolide|mesh-list
19818621|NCT00514917|Bicalutamide|bicalutamide|mesh-list
19818622|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818623|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818624|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818625|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818626|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818627|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19818628|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
19818629|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19818630|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818631|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19818632|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
19818633|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648762|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332734|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648763|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19648764|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19648765|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818634|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818635|NCT00514943|Cetuximab|cetuximab|mesh-list
19818636|NCT00514943|Afatinib|afatinib|mesh-list
19818637|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818638|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818639|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19818640|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332735|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332736|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
20332737|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
20332738|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20332739|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20332740|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818641|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818642|NCT00515021|Eplerenone|eplerenone|mesh-list
20332741|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332742|NCT00780728|Urological Agents|urological agents|mesh-ancestor
20332743|NCT00780754|Dutasteride|dutasteride|mesh-list
20332744|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19818643|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19818644|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
19818645|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818646|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818647|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19818648|NCT00515021|Diuretics|diuretics|mesh-ancestor
19818649|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
19818650|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19818651|NCT00515034|Imipenem|imipenem|mesh-list
19818652|NCT00515034|Doripenem|doripenem|mesh-list
19818653|NCT00515034|Cilastatin|cilastatin|mesh-list
19818654|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19818655|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818656|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
19818657|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818658|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818659|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
19818660|NCT00515073|Promethazine|promethazine|mesh-list
19818661|NCT00515073|Dexamethasone|dexamethasone|mesh-list
19818662|NCT00515073|Paclitaxel|paclitaxel|mesh-list
19818663|NCT00515073|Cimetidine|cimetidine|mesh-list
19818664|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818665|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818666|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
20332745|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20332746|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332747|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332748|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
20332749|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332750|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332751|NCT00780780|Triamcinolone|triamcinolone|mesh-list
20332752|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20332753|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20332754|NCT00780780|Nepafenac|nepafenac|mesh-list
19818667|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818668|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818669|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818670|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19818671|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
19818672|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
19818673|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818674|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818675|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818676|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
19818677|NCT00515073|Hormones|hormones|mesh-ancestor
19818678|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818679|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19818680|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19818681|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19818682|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818683|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
19818684|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
19818685|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
19818686|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19818687|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
19818688|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
19818689|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818690|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20165316|NCT00136565|Bleomycin|bleomycin|mesh-list
20165317|NCT00136565|Vindesine|vindesine|mesh-list
20165318|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165319|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
20165320|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165321|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165322|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20165323|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
20165324|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165325|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818691|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
19818692|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
19818693|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19818694|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19818695|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19818696|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19818697|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818698|NCT00515086|Everolimus|everolimus|mesh-list
19818699|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818700|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818701|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
19818702|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818703|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
19818704|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19818705|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
19818706|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818707|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818708|NCT00515177|Eszopiclone|eszopiclone|mesh-list
20332755|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20332756|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332757|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
20332758|NCT00780780|Hormones|hormones|mesh-ancestor
20332759|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332760|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332761|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332762|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
20332763|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332764|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332765|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20332766|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20332767|NCT00780780|Analgesics|analgesics|mesh-ancestor
20332768|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
20332769|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332770|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20332771|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
20332772|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332773|NCT00780832|Caffeine|caffeine|mesh-list
20332774|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20332775|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19818709|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19818710|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818711|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818712|NCT00515216|Leucovorin|leucovorin|mesh-list
19818713|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
19818714|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19818715|NCT00515216|Fluorouracil|fluorouracil|mesh-list
19818716|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
19818717|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
19818718|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
19818719|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818720|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165326|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20165327|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20332776|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664921|NCT04540848|Bupivacaine|bupivacaine|mesh-list
19664922|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
19664923|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
19664924|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664925|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664926|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
19664927|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19664928|NCT04531592|Valproic Acid|valproic acid|mesh-list
19664929|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
19664930|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664931|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834863|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
20332777|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20332778|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332779|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332780|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20332781|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19648766|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648767|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19648768|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648769|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648770|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19648771|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
19648772|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648773|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648774|NCT02344784|Methylphenidate|methylphenidate|mesh-list
19648775|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19648776|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648777|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19648778|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19648779|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19664932|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
19664933|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664934|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664935|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
19664936|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19664937|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664938|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19664939|NCT04531579|Valproic Acid|valproic acid|mesh-list
19664940|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19664941|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
19664942|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664943|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664944|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
19664945|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19664946|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664947|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
19664948|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19664949|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19664950|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19664951|NCT04517357|Apatinib|apatinib|mesh-list
19664952|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664953|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19664954|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664955|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664956|NCT04510584|Bevacizumab|bevacizumab|mesh-list
19664957|NCT04510584|Atezolizumab|atezolizumab|mesh-list
19664958|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19664959|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664960|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19664961|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19664962|NCT04510584|Growth Substances|growth substances|mesh-ancestor
19664963|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664964|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
19664965|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
19664966|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19664967|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
19664968|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19664969|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
19664970|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664971|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664972|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
19664973|NCT04469764|Letrozole|letrozole|mesh-list
19664974|NCT04469764|Anastrozole|anastrozole|mesh-list
19664975|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19664976|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19664977|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19664978|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19664979|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19664980|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19664981|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
19664982|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818721|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818722|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818723|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
19818724|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818725|NCT00515216|Antidotes|antidotes|mesh-ancestor
19818726|NCT00515216|Protective Agents|protective agents|mesh-ancestor
19818727|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
19818728|NCT00515216|Vitamins|vitamins|mesh-ancestor
19818729|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
19818730|NCT00515294|Caffeine|caffeine|mesh-list
19818731|NCT00515294|Methamphetamine|methamphetamine|mesh-list
19818732|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19818733|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818734|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19818735|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818736|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818737|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19818738|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19818739|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
19818740|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818741|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
19818742|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
19818743|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818744|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
19818745|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
19818746|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19818747|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19818748|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818749|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19818750|NCT00515411|Leucovorin|leucovorin|mesh-list
19818751|NCT00515411|Cisplatin|cisplatin|mesh-list
19818752|NCT00515411|Docetaxel|docetaxel|mesh-list
19818753|NCT00515411|Fluorouracil|fluorouracil|mesh-list
19818754|NCT00515411|Trastuzumab|trastuzumab|mesh-list
19818755|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818756|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818757|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818758|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818759|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818760|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
19818761|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818762|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818763|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
19818764|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818765|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818766|NCT00515411|Antidotes|antidotes|mesh-ancestor
19818767|NCT00515411|Protective Agents|protective agents|mesh-ancestor
19818768|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
19818769|NCT00515411|Vitamins|vitamins|mesh-ancestor
19818770|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
19818771|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19818772|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
19818773|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19818774|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19818775|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19818776|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818777|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818778|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
19818779|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818780|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648780|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648781|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
19648782|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19648783|NCT02344602|Febuxostat|febuxostat|mesh-list
19648784|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
19648785|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648786|NCT02344589|Lidocaine|lidocaine|mesh-list
19648787|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
19648788|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
19648789|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818781|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19818782|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818783|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19648790|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818784|NCT00515463|Denosumab|denosumab|mesh-list
19818785|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19818786|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818787|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
19818788|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19818789|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
19818790|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818791|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818792|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19818793|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
19818794|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
19818795|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19818796|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
19818797|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818798|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818799|NCT00515619|Lacosamide|lacosamide|mesh-list
19818800|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
19818801|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19818802|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19818803|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818804|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818805|NCT00515697|Ramucirumab|ramucirumab|mesh-list
19818806|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818807|NCT00515723|Olanzapine|olanzapine|mesh-list
19818808|NCT00515723|Risperidone|risperidone|mesh-list
19818809|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19818810|NCT00515723|Ziprasidone|ziprasidone|mesh-list
19818811|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19818812|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
19818813|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818814|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818815|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818816|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19818817|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19818818|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818819|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19818820|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19818821|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
19818822|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
19818823|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
19818824|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818825|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19818826|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19818827|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19818828|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818829|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
19818830|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
19818831|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19818832|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19818833|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
19818834|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818835|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19818836|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19818837|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818838|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818839|NCT00515879|Cycloserine|cycloserine|mesh-list
19818840|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19818841|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818842|NCT00515879|Renal Agents|renal agents|mesh-ancestor
19818843|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19818844|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
19818845|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19818846|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
19818847|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165328|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165329|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165330|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165331|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165332|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
20165333|NCT00136565|Hormones|hormones|mesh-ancestor
20165334|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165335|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20332782|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
20332783|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165336|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818848|NCT00516048|Exenatide|exenatide|mesh-list
19818849|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19818850|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818851|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19818852|NCT00516048|Incretins|incretins|mesh-ancestor
19818853|NCT00516048|Hormones|hormones|mesh-ancestor
19818854|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818855|NCT00516074|Exenatide|exenatide|mesh-list
19818856|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19818857|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818858|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19818859|NCT00516074|Incretins|incretins|mesh-ancestor
19818860|NCT00516074|Hormones|hormones|mesh-ancestor
19818861|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19818862|NCT00516139|Lamotrigine|lamotrigine|mesh-list
19818863|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
19818864|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19818865|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818866|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818867|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19818868|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818869|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19818870|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19818871|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818872|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19818873|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19818874|NCT00516165|Everolimus|everolimus|mesh-list
19818875|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818876|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818877|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
19818878|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818879|NCT00516217|Galiximab|galiximab|mesh-list
19818880|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19818881|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818882|NCT00516269|Methylphenidate|methylphenidate|mesh-list
19818883|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19818884|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818885|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19818886|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19818887|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818888|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818889|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
19818890|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818891|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
19818892|NCT00516295|Bevacizumab|bevacizumab|mesh-list
19818893|NCT00516295|Vincristine|vincristine|mesh-list
19818894|NCT00516295|Topotecan|topotecan|mesh-list
19818895|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20332784|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
20332785|NCT00780858|Ganirelix|ganirelix|mesh-list
20332786|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
20165337|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
20165338|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165339|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
20165340|NCT00136578|Carboplatin|carboplatin|mesh-list
20165341|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165342|NCT00136591|Bortezomib|bortezomib|mesh-list
20165343|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165344|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
19818896|NCT00516295|Antibodies|antibodies|mesh-list
19818897|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
20165345|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20165346|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20348057|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
19818898|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19818899|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19818900|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
19818901|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818902|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818903|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19818904|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
19818905|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818906|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818907|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19818908|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818909|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818910|NCT00516295|Growth Substances|growth substances|mesh-ancestor
19818911|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818912|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19818913|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
19818914|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
19818915|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
19818916|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19818917|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19818918|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818919|NCT00516386|Mecasermin|mecasermin|mesh-list
19818920|NCT00516386|Growth Substances|growth substances|mesh-ancestor
19818921|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818922|NCT00516503|Ketamine|ketamine|mesh-list
19818923|NCT00516503|Amitriptyline|amitriptyline|mesh-list
20165347|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165348|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165349|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20165350|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19818924|NCT00516503|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19818925|NCT00516503|Baclofen|baclofen|mesh-list
19818926|NCT00516503|Analgesics|analgesics|mesh-ancestor
19818927|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
19818928|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19818929|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818930|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19818931|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19818932|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
19818933|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
19818934|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19818935|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19818936|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19818937|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19818938|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818939|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19818940|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19818941|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19818942|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
19818943|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
19818944|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19818945|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
19818946|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19818947|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19818948|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19818949|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19818950|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19818951|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19818952|NCT00516503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19818953|NCT00516503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19818954|NCT00516893|Natalizumab|natalizumab|mesh-list
19818955|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
19818956|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818957|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
19818958|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20165351|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165352|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
20165353|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
20165354|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165355|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818959|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19818960|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19818961|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
19818962|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19818963|NCT00516919|Orlistat|orlistat|mesh-list
19818964|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19818965|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19818966|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19818967|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19818968|NCT00517010|Ranibizumab|ranibizumab|mesh-list
19818969|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818970|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818971|NCT00517010|Growth Substances|growth substances|mesh-ancestor
19818972|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332787|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332788|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332789|NCT00781105|Telbivudine|telbivudine|mesh-list
20332790|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
20332791|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332792|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20332793|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332794|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332795|NCT00781131|Pregabalin|pregabalin|mesh-list
20332796|NCT00781131|Analgesics|analgesics|mesh-ancestor
20332797|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
20332798|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332799|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332800|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
20332801|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20332802|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20332803|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332804|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20332805|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19648791|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
19818973|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818974|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818975|NCT00517296|Adalimumab|adalimumab|mesh-list
19818976|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19818977|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19818978|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
19818979|NCT00517413|Hematinics|hematinics|mesh-ancestor
19818980|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
19818981|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818982|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818983|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
19818984|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
19818985|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19818986|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19818987|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19818988|NCT00517595|Gemcitabine|gemcitabine|mesh-list
19818989|NCT00517595|Bevacizumab|bevacizumab|mesh-list
19818990|NCT00517595|Pemetrexed|pemetrexed|mesh-list
19818991|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19818992|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19818993|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19818994|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19818995|NCT00517595|Growth Substances|growth substances|mesh-ancestor
19818996|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648792|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648793|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19648794|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19648795|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19648796|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648797|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648798|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
19648799|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19648800|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
19648801|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648802|NCT02344641|Exenatide|exenatide|mesh-list
19648803|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19648804|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648805|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19818997|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
19818998|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19818999|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
19819000|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819001|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
19819002|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332806|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20332807|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332808|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332809|NCT00781157|Phenylephrine|phenylephrine|mesh-list
20332810|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
20332811|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20332812|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
20332813|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
20332814|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819003|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819004|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819005|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
20332815|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332816|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
20332817|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20332818|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
20332819|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
20332820|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19648806|NCT02344641|Incretins|incretins|mesh-ancestor
19648807|NCT02344641|Hormones|hormones|mesh-ancestor
19648808|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648809|NCT02344732|Polymyxins|polymyxins|mesh-list
19648810|NCT02344732|Neomycin|neomycin|mesh-list
19648811|NCT02344732|Polymyxin B|polymyxin b|mesh-list
19648812|NCT02344732|Dexamethasone|dexamethasone|mesh-list
19648813|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19648814|NCT02344732|Homatropine|homatropine|mesh-list
19648815|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648816|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
19648817|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
19819006|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19819007|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19819008|NCT00517829|Docetaxel|docetaxel|mesh-list
19819009|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
19819010|NCT00517829|Cetuximab|cetuximab|mesh-list
19819011|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648818|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648819|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648820|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648821|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
19648822|NCT02344732|Hormones|hormones|mesh-ancestor
19648823|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648824|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648825|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648826|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19648827|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648828|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648829|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19648830|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648831|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648832|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
19648833|NCT02344472|Paclitaxel|paclitaxel|mesh-list
19648834|NCT02344472|Vinorelbine|vinorelbine|mesh-list
19648835|NCT02344472|Docetaxel|docetaxel|mesh-list
19819012|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20332821|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20332822|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20332823|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
20332824|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332825|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332826|NCT00781157|Protective Agents|protective agents|mesh-ancestor
20332827|NCT00781196|Folic Acid|folic acid|mesh-list
20332828|NCT00781196|Hematinics|hematinics|mesh-ancestor
20332829|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
20332830|NCT00781196|Vitamins|vitamins|mesh-ancestor
20332831|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
19648836|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19648837|NCT02344472|Capecitabine|capecitabine|mesh-list
19648838|NCT02344472|Trastuzumab|trastuzumab|mesh-list
19819013|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
19648839|NCT02344472|Letrozole|letrozole|mesh-list
19648840|NCT02344472|Fulvestrant|fulvestrant|mesh-list
19819014|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20332832|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332833|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
20348058|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
19819015|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819016|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819017|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
19819018|NCT00517881|Hematinics|hematinics|mesh-ancestor
19819019|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
19819020|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819021|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
19819022|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19819023|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19819024|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819025|NCT00517933|Urological Agents|urological agents|mesh-ancestor
20332834|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20332835|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332836|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
20332837|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20332838|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20332839|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
20332840|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332841|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20332842|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20332843|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332844|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332845|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19648841|NCT02344472|Anastrozole|anastrozole|mesh-list
19819026|NCT00518011|Gemcitabine|gemcitabine|mesh-list
19819027|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19819028|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19819029|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
19819030|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819031|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819032|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
19819033|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819034|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819035|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165356|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20332846|NCT00781300|Dexamethasone|dexamethasone|mesh-list
20332847|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20332848|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
20332849|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
20332850|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332851|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332852|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20332853|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
20332854|NCT00781300|Hormones|hormones|mesh-ancestor
20332855|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332856|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648842|NCT02344472|Exemestane|exemestane|mesh-list
19648843|NCT02344472|Pertuzumab|pertuzumab|mesh-list
19648844|NCT02344472|Goserelin|goserelin|mesh-list
19648845|NCT02344472|Leuprolide|leuprolide|mesh-list
19648846|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19648847|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648848|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19648849|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19648850|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
19648851|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648852|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165357|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19819036|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
19819037|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165358|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165359|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
20165360|NCT00136734|Methylphenidate|methylphenidate|mesh-list
20165361|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20165362|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165363|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19819038|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819039|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
19819040|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19819041|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19819042|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19819043|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332857|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332858|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20332859|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
20332860|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20332861|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
20332862|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
20332863|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19819044|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19819045|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19819046|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819047|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819048|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819049|NCT00518115|Exenatide|exenatide|mesh-list
19819050|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
19819051|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19819052|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819053|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19819054|NCT00518115|Incretins|incretins|mesh-ancestor
20332864|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332865|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20332866|NCT00781352|Analgesics|analgesics|mesh-ancestor
20332867|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
20332868|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332869|NCT00781378|Plasminogen|plasminogen|mesh-list
20332870|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20332871|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20332872|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20332873|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332874|NCT00781404|Adenosine|adenosine|mesh-list
20332875|NCT00781404|Analgesics|analgesics|mesh-ancestor
19819055|NCT00518115|Hormones|hormones|mesh-ancestor
19819056|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819057|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19819058|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19819059|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819060|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819061|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
19819062|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819063|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819064|NCT00518180|Lactitol|lactitol|mesh-list
19819065|NCT00518180|Vaccines|vaccines|mesh-list
19819066|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
19819067|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819068|NCT00518180|Cathartics|cathartics|mesh-ancestor
19819069|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19819070|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
20332876|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
20332877|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332878|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332879|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20332880|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
20332881|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20332882|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
19648853|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
19648854|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19648855|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19648856|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19648857|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648858|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19648859|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
19648860|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648861|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648862|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648863|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19648864|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19648865|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
19819071|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819072|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
19819073|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332883|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
19819074|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819075|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19819076|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
19819077|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819078|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819079|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19819080|NCT00518284|Paclitaxel|paclitaxel|mesh-list
19819081|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19819082|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19819083|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819084|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819085|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819086|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819087|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332884|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332885|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332886|NCT00781417|Vitamin D|vitamin d|mesh-list
20332887|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
20332888|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
20332889|NCT00781417|Vitamins|vitamins|mesh-list
20332890|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
20332891|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332892|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20332893|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20332894|NCT00781482|Zolpidem|zolpidem|mesh-list
20332895|NCT00781482|Eszopiclone|eszopiclone|mesh-list
20332896|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19819088|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19819089|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19819090|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19819091|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19819092|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819093|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819094|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19819095|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19819096|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
19819097|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819098|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819099|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19819100|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19819101|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
19819102|NCT00518531|Denosumab|denosumab|mesh-list
19819103|NCT00518531|Alendronate|alendronate|mesh-list
19819104|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19819105|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819106|NCT00518687|Vaccines|vaccines|mesh-list
19819107|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
19819108|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819109|NCT00518713|Clobazam|clobazam|mesh-list
19819110|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
19819111|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19819112|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19819113|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19819114|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819115|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20332897|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20332898|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20332899|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332900|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20332901|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
20332902|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
20332903|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332904|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332905|NCT00781521|Ofloxacin|ofloxacin|mesh-list
20332906|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20332907|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332908|NCT00781521|Renal Agents|renal agents|mesh-ancestor
20332909|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332910|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20332911|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20332912|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332913|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819116|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19819117|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
19819118|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
19819119|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819120|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819121|NCT00518882|Liraglutide|liraglutide|mesh-list
19819122|NCT00518882|Exenatide|exenatide|mesh-list
19819123|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19819124|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819125|NCT00518882|Incretins|incretins|mesh-ancestor
19819126|NCT00518882|Hormones|hormones|mesh-ancestor
19819127|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819128|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19819129|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19819130|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
19819131|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819132|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19819133|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19819134|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19819135|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819136|NCT00518986|Modafinil|modafinil|mesh-list
19819137|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19819138|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819139|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19819140|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19819141|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19819142|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834864|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19834865|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19834866|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
19834867|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
19834868|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834869|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834870|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
19834871|NCT00598273|Hematinics|hematinics|mesh-ancestor
19834872|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
19834873|NCT00598442|Hematinics|hematinics|mesh-ancestor
19834874|NCT00598481|Busulfan|busulfan|mesh-list
19834875|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
19834876|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834877|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19834878|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
19834879|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834880|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19834881|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834882|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19834883|NCT00598507|Sagopilone|sagopilone|mesh-list
19834884|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165364|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20165365|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20165366|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834885|NCT00598559|Acetaminophen|acetaminophen|mesh-list
19834886|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19834887|NCT00598559|Analgesics|analgesics|mesh-ancestor
20165367|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
20165368|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165369|NCT00136747|Memantine|memantine|mesh-list
20165370|NCT00136747|Bupropion|bupropion|mesh-list
19648866|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19648867|NCT02344264|Ropivacaine|ropivacaine|mesh-list
19648868|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
19648869|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
19648870|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648871|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648872|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
19648873|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648874|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
19648875|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648876|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648877|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19648878|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19648879|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834888|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
19834889|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611756|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
19648880|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819143|NCT00519077|Gefitinib|gefitinib|mesh-list
19819144|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819145|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819146|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819147|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819148|NCT00519285|Prednisone|prednisone|mesh-list
19819149|NCT00519285|Prednisolone|prednisolone|mesh-list
19819150|NCT00519285|Docetaxel|docetaxel|mesh-list
19819151|NCT00519285|Aflibercept|aflibercept|mesh-list
19819152|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819153|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819154|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819155|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
20332914|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332915|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19819156|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332916|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20332917|NCT00781547|Hormones|hormones|mesh-list
20332918|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20332919|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332920|NCT00781573|Clopidogrel|clopidogrel|mesh-list
20332921|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20332922|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20332923|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20332924|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20332925|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
20332926|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332927|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332928|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332929|NCT00781586|Caffeine|caffeine|mesh-list
20332930|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332931|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20332932|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20332933|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20332934|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819157|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819158|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
19819159|NCT00519285|Hormones|hormones|mesh-ancestor
19819160|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819161|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819162|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19819163|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819164|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819165|NCT00519285|Growth Substances|growth substances|mesh-ancestor
19819166|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819167|NCT00519428|Dexetimide|dexetimide|mesh-list
19819168|NCT00519428|Citalopram|citalopram|mesh-list
19819169|NCT00519428|Bupropion|bupropion|mesh-list
19819170|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19819171|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19819172|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819173|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819174|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819175|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
19819176|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819177|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19819178|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
19819179|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819180|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19819181|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19819182|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
19819183|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
20332935|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20332936|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19819184|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819185|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19819186|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19819187|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
19819188|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19819189|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
19819190|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19819191|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19819192|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819193|NCT00519532|Rotigotine|rotigotine|mesh-list
19819194|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
20332937|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
20332938|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332939|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
20332940|NCT00781625|Methenamine|methenamine|mesh-list
20332941|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
19819195|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
19819196|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819197|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819198|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819199|NCT00519584|Bupivacaine|bupivacaine|mesh-list
19819200|NCT00519584|Ropivacaine|ropivacaine|mesh-list
19819201|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
19819202|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
19819203|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165371|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19648881|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648882|NCT02344186|Liraglutide|liraglutide|mesh-list
19648883|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19648884|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648885|NCT02344186|Incretins|incretins|mesh-ancestor
19648886|NCT02344186|Hormones|hormones|mesh-ancestor
19648887|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648888|NCT02344095|Paclitaxel|paclitaxel|mesh-list
19648889|NCT02344095|Cisplatin|cisplatin|mesh-list
19648890|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19648891|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648892|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
19648893|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
19648894|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
19648895|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648896|NCT02343926|Metformin|metformin|mesh-list
19648897|NCT02343926|Vildagliptin|vildagliptin|mesh-list
20165372|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
20165373|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165374|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20165375|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20165376|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20165377|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165378|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
20165379|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165380|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165381|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20165382|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20165383|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165384|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20165385|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20165386|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20165387|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20165388|NCT00136773|Amlodipine|amlodipine|mesh-list
20165389|NCT00136773|Benazepril|benazepril|mesh-list
20165390|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20165391|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20165392|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20165393|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165394|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20165395|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165396|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
20332942|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20332943|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332944|NCT00781625|Renal Agents|renal agents|mesh-ancestor
20332945|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648898|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19648899|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819204|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165397|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20165398|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165399|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165400|NCT00136786|Memantine|memantine|mesh-list
20165401|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19819205|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
19819206|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819207|NCT00519623|Insulin|insulin|mesh-list
19819208|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19819209|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819210|NCT00519636|Fluticasone|fluticasone|mesh-list
19819211|NCT00519636|Xhance|xhance|mesh-list
19819212|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819213|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19819214|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
19819215|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819216|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819217|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19819218|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
19819219|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
19819220|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19819221|NCT00519831|Cetuximab|cetuximab|mesh-list
19819222|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819223|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819224|NCT00519896|Sunitinib|sunitinib|mesh-list
19819225|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819226|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819227|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819228|NCT00519896|Growth Substances|growth substances|mesh-ancestor
19819229|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332946|NCT00781755|Varenicline|varenicline|mesh-list
20332947|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19819230|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819231|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819232|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819233|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819234|NCT00520013|Paclitaxel|paclitaxel|mesh-list
19819235|NCT00520013|Bevacizumab|bevacizumab|mesh-list
19819236|NCT00520013|Carboplatin|carboplatin|mesh-list
19819237|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19819238|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19819239|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819240|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819241|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819242|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819243|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819244|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819245|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819246|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819247|NCT00520013|Growth Substances|growth substances|mesh-ancestor
19819248|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819249|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819250|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819251|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819252|NCT00520130|Cytarabine|cytarabine|mesh-list
19819253|NCT00520130|Cyclosporine|cyclosporine|mesh-list
19819254|NCT00520130|Rituximab|rituximab|mesh-list
19819255|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
19819256|NCT00520130|Fludarabine|fludarabine|mesh-list
19819257|NCT00520130|Cyclosporins|cyclosporins|mesh-list
19819258|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20165402|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20165403|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
20165404|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165405|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165406|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165407|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20165408|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20165409|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
20165410|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20165411|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
20165412|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332948|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19819259|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819260|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
19819261|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332949|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
19819262|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819263|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19819264|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
19819265|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819266|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819267|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
19819268|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819269|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819270|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
19819271|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
19819272|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19819273|NCT00520234|Caspofungin|caspofungin|mesh-list
19819274|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
19819275|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819276|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819277|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819278|NCT00520286|Modafinil|modafinil|mesh-list
19819279|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19819280|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819281|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19819282|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19819283|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19819284|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819285|NCT00520403|Interferons|interferons|mesh-list
19819286|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
19819287|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
19819288|NCT00520403|Bevacizumab|bevacizumab|mesh-list
19819289|NCT00520403|Vinblastine|vinblastine|mesh-list
19819290|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819291|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819292|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819293|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819294|NCT00520403|Growth Substances|growth substances|mesh-ancestor
19819295|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819296|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819297|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
20332950|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20332951|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332952|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332953|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
20332954|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819298|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819299|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
20332955|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332956|NCT00781820|Bifonazole|bifonazole|mesh-list
20332957|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
20332958|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332959|NCT00781846|Sirolimus|sirolimus|mesh-list
20332960|NCT00781846|Bevacizumab|bevacizumab|mesh-list
20332961|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20332962|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332963|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20332964|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20332965|NCT00781846|Growth Substances|growth substances|mesh-ancestor
20332966|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332967|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
20332968|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20332969|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20332970|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20332971|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
20332972|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332973|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
19648900|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19648901|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
19648902|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648903|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648904|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
19648905|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
19648906|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
19648907|NCT02344017|Prednisone|prednisone|mesh-list
20348059|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348060|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819300|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20348061|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
20165413|NCT00136825|Expectorants|expectorants|mesh-ancestor
20165414|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
20165415|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20165416|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
20165417|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165418|NCT00136825|Protective Agents|protective agents|mesh-ancestor
20165419|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165420|NCT00136825|Antidotes|antidotes|mesh-ancestor
20165421|NCT00136851|Amlodipine|amlodipine|mesh-list
20165422|NCT00136851|Benazepril|benazepril|mesh-list
20165423|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20165424|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20165425|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19648908|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648909|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
19648910|NCT02344017|Hormones|hormones|mesh-ancestor
20174416|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19664983|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174417|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20174418|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174419|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174420|NCT00164801|Diltiazem|diltiazem|mesh-list
20174421|NCT00164801|Baclofen|baclofen|mesh-list
20174422|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20174423|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174424|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20174425|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174426|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20174427|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
20174428|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
20174429|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174430|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174431|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20174432|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20174433|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174434|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20174435|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
20174436|NCT00164840|Esomeprazole|esomeprazole|mesh-list
20174437|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20174438|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20174439|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20174440|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174441|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174442|NCT00164866|Omeprazole|omeprazole|mesh-list
20174443|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20174444|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20174445|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20174446|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174447|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174448|NCT00164892|Rofecoxib|rofecoxib|mesh-list
20174449|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20174450|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20174451|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174452|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174453|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20174454|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20174455|NCT00164892|Analgesics|analgesics|mesh-ancestor
20174456|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
20174457|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174458|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174459|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174460|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174461|NCT00164931|Omeprazole|omeprazole|mesh-list
20174462|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20174463|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20174464|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20174465|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174466|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174467|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
20174468|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
20174469|NCT00164970|Vitamins|vitamins|mesh-ancestor
20174470|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
20174471|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332974|NCT00782041|Leucovorin|leucovorin|mesh-list
20332975|NCT00782041|Folic Acid|folic acid|mesh-list
20332976|NCT00782041|Fluorouracil|fluorouracil|mesh-list
20332977|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
20332978|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
20332979|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
20332980|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20332981|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20332982|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648911|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648912|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648913|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648914|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648915|NCT02343861|Emollients|emollients|mesh-list
19648916|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
19648917|NCT02343718|Sirolimus|sirolimus|mesh-list
19648918|NCT02343718|Vinblastine|vinblastine|mesh-list
19648919|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19648920|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648921|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19648922|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648923|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
19648924|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19648925|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
19648926|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648927|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19819301|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819302|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819303|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819304|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819305|NCT00520468|Cyclosporine|cyclosporine|mesh-list
19819306|NCT00520468|Prednisone|prednisone|mesh-list
19819307|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
19819308|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
19819309|NCT00520468|Cyclosporins|cyclosporins|mesh-list
19819310|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819311|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
19819312|NCT00520468|Hormones|hormones|mesh-ancestor
19819313|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819314|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819315|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19819316|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819317|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819318|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819319|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819320|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
19819321|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
19819322|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819323|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
19819324|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819325|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19819326|NCT00520468|Hematinics|hematinics|mesh-ancestor
19819327|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19819328|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
19819329|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819330|NCT00520533|Sunitinib|sunitinib|mesh-list
19819331|NCT00520533|Antibodies|antibodies|mesh-list
19819332|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19819333|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
19819334|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819335|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819336|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819337|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819338|NCT00520533|Growth Substances|growth substances|mesh-ancestor
19819339|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819340|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819341|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819342|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819343|NCT00520572|Etanercept|etanercept|mesh-list
19819344|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19819345|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19819346|NCT00520572|Analgesics|analgesics|mesh-ancestor
19819347|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
19819348|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20332983|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20332984|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
20611757|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20332985|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332986|NCT00782041|Antidotes|antidotes|mesh-ancestor
20332987|NCT00782041|Protective Agents|protective agents|mesh-ancestor
20332988|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
20332989|NCT00782041|Vitamins|vitamins|mesh-ancestor
20332990|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
20332991|NCT00782041|Hematinics|hematinics|mesh-ancestor
20332992|NCT00782093|Volociximab|volociximab|mesh-list
20332993|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20332994|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20332995|NCT00782093|Growth Substances|growth substances|mesh-ancestor
20332996|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20332997|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
20332998|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20332999|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
20333000|NCT00782106|Antibodies|antibodies|mesh-list
20333001|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
20333002|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20333003|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20333004|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
20333005|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
20333006|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333007|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
20333008|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20333009|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
20333010|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819349|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819350|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819351|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819352|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19819353|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819354|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
19819355|NCT00520676|Carboplatin|carboplatin|mesh-list
19819356|NCT00520676|Docetaxel|docetaxel|mesh-list
19819357|NCT00520676|Pemetrexed|pemetrexed|mesh-list
19819358|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819359|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819360|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819361|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819362|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819363|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819364|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20333011|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
20333012|NCT00782197|Protective Agents|protective agents|mesh-ancestor
20333013|NCT00782301|Maraviroc|maraviroc|mesh-list
20333014|NCT00782301|Etravirine|etravirine|mesh-list
20333015|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20333016|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20333017|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333018|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20333019|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20333020|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
20165426|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165427|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20165428|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165429|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
20333021|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819365|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19819366|NCT00520741|Lacosamide|lacosamide|mesh-list
19819367|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
19819368|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19819369|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19819370|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819371|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819372|NCT00520845|Celecoxib|celecoxib|mesh-list
19819373|NCT00520845|Docetaxel|docetaxel|mesh-list
19819374|NCT00520845|Pemetrexed|pemetrexed|mesh-list
19819375|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165430|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20165431|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165432|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165433|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
20333022|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19819376|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819377|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
20333023|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19819378|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819379|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819380|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819381|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19819382|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19819383|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19819384|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19819385|NCT00520845|Analgesics|analgesics|mesh-ancestor
19819386|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
19819387|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819388|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819389|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819390|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819391|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19819392|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19819393|NCT00520936|Pemetrexed|pemetrexed|mesh-list
19819394|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819395|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819396|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819397|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19819398|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19819399|NCT00520975|Paclitaxel|paclitaxel|mesh-list
19819400|NCT00520975|Bevacizumab|bevacizumab|mesh-list
19819401|NCT00520975|Carboplatin|carboplatin|mesh-list
19819402|NCT00520975|Trastuzumab|trastuzumab|mesh-list
19819403|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19819404|NCT00520975|Antibodies|antibodies|mesh-list
19819405|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
19819406|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19819407|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20333024|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20333025|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333026|NCT00782327|Losartan|losartan|mesh-list
20333027|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20333028|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20333029|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20333030|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20333031|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333032|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20333033|NCT00782405|Mirtazapine|mirtazapine|mesh-list
20333034|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
20333035|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333036|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20333037|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20333038|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333039|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333040|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20333041|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
20333042|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
20333043|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333044|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333045|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20333046|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20333047|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20333048|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20333049|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
20333050|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20333051|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19819408|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819409|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819410|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819411|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819412|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819413|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819414|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819415|NCT00520975|Growth Substances|growth substances|mesh-ancestor
19819416|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819417|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819418|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
19819419|NCT00521001|Everolimus|everolimus|mesh-list
19819420|NCT00521001|Temozolomide|temozolomide|mesh-list
19819421|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819422|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333052|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
19648928|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
19648929|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
19648930|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
19648931|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648932|NCT02343692|Pancrelipase|pancrelipase|mesh-list
19648933|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19648934|NCT02343666|Plerixafor|plerixafor|mesh-list
19648935|NCT02343666|Carmustine|carmustine|mesh-list
19819423|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
19819424|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819425|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19819426|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
19819427|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819428|NCT00521014|Cytarabine|cytarabine|mesh-list
19819429|NCT00521014|Rituximab|rituximab|mesh-list
19819430|NCT00521014|Etoposide|etoposide|mesh-list
19819431|NCT00521014|Melphalan|melphalan|mesh-list
19819432|NCT00521014|Carmustine|carmustine|mesh-list
19819433|NCT00521014|Sargramostim|sargramostim|mesh-list
19819434|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819435|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333053|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20333054|NCT00782470|Factor VIII|factor viii|mesh-list
20333055|NCT00782470|Coagulants|coagulants|mesh-ancestor
20333056|NCT00782548|Morphine|morphine|mesh-list
20333057|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19819436|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
19819437|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819438|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819439|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19819440|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19819441|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19819442|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819443|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819444|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19819445|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
19819446|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
19819447|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819448|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819449|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19819450|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
19819451|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19819452|NCT00521144|Topotecan|topotecan|mesh-list
19819453|NCT00521144|Obatoclax|obatoclax|mesh-list
19819454|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19819455|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19819456|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819457|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819458|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819459|NCT00521339|Apremilast|apremilast|mesh-list
19819460|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19819461|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19819462|NCT00521339|Analgesics|analgesics|mesh-ancestor
19819463|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
19819464|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819465|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819466|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819467|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819468|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19819469|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19819470|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819471|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819472|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19819473|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
19819474|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819475|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19819476|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19819477|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19819478|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819479|NCT00521404|Gemcitabine|gemcitabine|mesh-list
19819480|NCT00521404|Antibodies|antibodies|mesh-list
19819481|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
19819482|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819483|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20333058|NCT00782548|Narcotics|narcotics|mesh-ancestor
19648936|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20611758|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
20333059|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611759|NCT00217737|Calcium|calcium|mesh-list
20611760|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
20611761|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611762|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611763|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611764|NCT00217737|Growth Substances|growth substances|mesh-ancestor
20611765|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648937|NCT02343666|Lenograstim|lenograstim|mesh-list
19648938|NCT02343666|Sargramostim|sargramostim|mesh-list
19819484|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
19819485|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819486|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819487|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
19648939|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19648940|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
19648941|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648942|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19648943|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
19648944|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819488|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819489|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819490|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819491|NCT00521456|Ketorolac|ketorolac|mesh-list
19819492|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19819493|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19819494|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19819495|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19819496|NCT00521456|Analgesics|analgesics|mesh-ancestor
19819497|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
19819498|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819499|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819500|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819501|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819502|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19819503|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819504|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819505|NCT00521586|Vaccines|vaccines|mesh-list
19819506|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19819507|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
19819508|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819509|NCT00521989|Prednisolone|prednisolone|mesh-list
19819510|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19819511|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
19819512|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19819513|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
20165434|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20165435|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648945|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648946|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19648947|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19648948|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
19648949|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648950|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19648951|NCT02343679|Ceritinib|ceritinib|mesh-list
20165436|NCT00136942|Atorvastatin|atorvastatin|mesh-list
20165437|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20165438|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20165439|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
20165440|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165441|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20165442|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20165443|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165444|NCT00136968|Voriconazole|voriconazole|mesh-list
20165445|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
20165446|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165447|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20165448|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20165449|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165450|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165451|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20165452|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
20611766|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
19648952|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819514|NCT00521989|Dipyridamole|dipyridamole|mesh-list
19819515|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19819516|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
19819517|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819518|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
19819519|NCT00521989|Hormones|hormones|mesh-ancestor
19819520|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819521|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819522|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19819523|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819524|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
19819525|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
19819526|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819527|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19819528|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19819529|NCT00521989|Protective Agents|protective agents|mesh-ancestor
19819530|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19819531|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819532|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819533|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19819534|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
19819535|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
19819536|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
19819537|NCT00522275|Lacosamide|lacosamide|mesh-list
19819538|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
19819539|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19819540|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19819541|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819542|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819543|NCT00522379|Rotigotine|rotigotine|mesh-list
19819544|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
19819545|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
19819546|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819547|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819548|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819549|NCT00522392|Dexamethasone|dexamethasone|mesh-list
19819550|NCT00522392|Lenalidomide|lenalidomide|mesh-list
19819551|NCT00522392|Bortezomib|bortezomib|mesh-list
19819552|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819553|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
20333060|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333061|NCT00782548|Analgesics|analgesics|mesh-ancestor
20333062|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
20333063|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819554|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
19819555|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819556|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819557|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19819558|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
19819559|NCT00522392|Hormones|hormones|mesh-ancestor
20333064|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
20333065|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20333066|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
20333067|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333068|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333069|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20333070|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
20333071|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20333072|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
20333073|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333074|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333075|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20333076|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
20333077|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
20333078|NCT00782652|Protective Agents|protective agents|mesh-ancestor
20333079|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
20333080|NCT00782847|Cyproterone|cyproterone|mesh-list
20333081|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
20333082|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333083|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333084|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333085|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819560|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819561|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20333086|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19648953|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819562|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819563|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
19819564|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819565|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819566|NCT00522392|Growth Substances|growth substances|mesh-ancestor
19819567|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819568|NCT00522431|Testosterone|testosterone|mesh-list
19819569|NCT00522431|Androgens|androgens|mesh-ancestor
19819570|NCT00522431|Hormones|hormones|mesh-ancestor
19819571|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819572|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819573|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
19819574|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19819575|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648954|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165453|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165454|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165455|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19648955|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648956|NCT02343432|Triamcinolone|triamcinolone|mesh-list
19648957|NCT02343432|Bupivacaine|bupivacaine|mesh-list
19648958|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
19648959|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
19648960|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648961|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648962|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
19648963|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19648964|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648965|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
19648966|NCT02343432|Hormones|hormones|mesh-ancestor
19819576|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19819577|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
19819578|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19819579|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819580|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819581|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819582|NCT00522795|Paclitaxel|paclitaxel|mesh-list
19819583|NCT00522795|Cisplatin|cisplatin|mesh-list
19819584|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19819585|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19819586|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174472|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
20174473|NCT00164970|Hematinics|hematinics|mesh-ancestor
20174474|NCT00164996|Anesthetics|anesthetics|mesh-list
20174475|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20174476|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174477|NCT00165035|Paclitaxel|paclitaxel|mesh-list
20174478|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20174479|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20174480|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174481|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174482|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174483|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174484|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174485|NCT00165048|Rofecoxib|rofecoxib|mesh-list
20174486|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20174487|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20174488|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174489|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174490|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20174491|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20174492|NCT00165048|Analgesics|analgesics|mesh-ancestor
20174493|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
20174494|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174495|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333087|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
20333088|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20333089|NCT00782951|Morphine|morphine|mesh-list
20333090|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20333091|NCT00782951|Narcotics|narcotics|mesh-ancestor
20333092|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165456|NCT00136981|Atorvastatin|atorvastatin|mesh-list
20165457|NCT00136981|Torcetrapib|torcetrapib|mesh-list
20333093|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819587|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819588|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819589|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819590|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819591|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
19819592|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19819593|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19819594|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
19819595|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819596|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19819597|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19819598|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819599|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819600|NCT00523341|Denosumab|denosumab|mesh-list
19819601|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19819602|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819603|NCT00523419|Pemetrexed|pemetrexed|mesh-list
19819604|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819605|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819606|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819607|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19819608|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19819609|NCT00523549|Amlodipine|amlodipine|mesh-list
19819610|NCT00523549|Valsartan|valsartan|mesh-list
19819611|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19819612|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19819613|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819614|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819615|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19819616|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819617|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
19819618|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19819619|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19819620|NCT00523640|Gemcitabine|gemcitabine|mesh-list
19819621|NCT00523640|Bevacizumab|bevacizumab|mesh-list
19819622|NCT00523640|Capecitabine|capecitabine|mesh-list
19819623|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819624|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819625|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819626|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819627|NCT00523640|Growth Substances|growth substances|mesh-ancestor
19819628|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819629|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819630|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19819631|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
19819632|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819633|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
19819634|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819635|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819636|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819637|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
19819638|NCT00523705|Citalopram|citalopram|mesh-list
19819639|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19819640|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20165458|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20165459|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20165460|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
20165461|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165462|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20165463|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20165464|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165465|NCT00136994|Ziprasidone|ziprasidone|mesh-list
20165466|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20165467|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
20333094|NCT00782951|Analgesics|analgesics|mesh-ancestor
20333095|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
20333096|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333097|NCT00783016|Morphine|morphine|mesh-list
20333098|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20333099|NCT00783016|Narcotics|narcotics|mesh-ancestor
20333100|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333101|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333102|NCT00783016|Analgesics|analgesics|mesh-ancestor
20333103|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
20333104|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819641|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819642|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819643|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819644|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
19819645|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819646|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19819647|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
19819648|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819649|NCT00523718|Riluzole|riluzole|mesh-list
19819650|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
19819651|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19819652|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19819653|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819654|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819655|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819656|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19819657|NCT00523718|Protective Agents|protective agents|mesh-ancestor
19819658|NCT00523744|Amlodipine|amlodipine|mesh-list
19819659|NCT00523744|Valsartan|valsartan|mesh-list
19819660|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19819661|NCT00523744|Olmesartan|olmesartan|mesh-list
19819662|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19819663|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19819664|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19819665|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819666|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819667|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19819668|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819669|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
19819670|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19819671|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19819672|NCT00523744|Diuretics|diuretics|mesh-ancestor
19819673|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
19819674|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19819675|NCT00523848|Thalidomide|thalidomide|mesh-list
19819676|NCT00523848|Doxorubicin|doxorubicin|mesh-list
19819677|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19819678|NCT00523848|Bortezomib|bortezomib|mesh-list
19819679|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20165468|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165469|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165470|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819680|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819681|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19819682|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165471|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20165472|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20165473|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165474|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165475|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20165476|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
20165477|NCT00137007|Azithromycin|azithromycin|mesh-list
20165478|NCT00137007|Ampicillin|ampicillin|mesh-list
20165479|NCT00137007|Sulbactam|sulbactam|mesh-list
20165480|NCT00137007|Sultamicillin|sultamicillin|mesh-list
20165481|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165482|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165483|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20165484|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165485|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165486|NCT00137020|Ziprasidone|ziprasidone|mesh-list
20165487|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20165488|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
20333105|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19819683|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819684|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819685|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819686|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
19819687|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819688|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
19819689|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19819690|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819691|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819692|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819693|NCT00523848|Growth Substances|growth substances|mesh-ancestor
19819694|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819695|NCT00523978|Sotalol|sotalol|mesh-list
19819696|NCT00523978|Flecainide|flecainide|mesh-list
19819697|NCT00523978|Propafenone|propafenone|mesh-list
19819698|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19819699|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20333106|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20333107|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20333108|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
20333109|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333110|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20333111|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20333112|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333113|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
20333114|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20333115|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20333116|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
20333117|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333118|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333119|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333120|NCT00783081|Cilostazol|cilostazol|mesh-list
20333121|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20333122|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
20333123|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333124|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819700|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
19819701|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819702|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819703|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819704|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19819705|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
19819706|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
19819707|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819708|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19819709|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19819710|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819711|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
19819712|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19819713|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
19819714|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819715|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819716|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19819717|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
19819718|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
19819719|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19819720|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
20165489|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165490|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165491|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165492|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20165493|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20165494|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165495|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165496|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20165497|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
20165498|NCT00137033|Celecoxib|celecoxib|mesh-list
20165499|NCT00137033|Naproxen|naproxen|mesh-list
20165500|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20165501|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20165502|NCT00137033|Analgesics|analgesics|mesh-ancestor
20165503|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
19819721|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333125|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19819722|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819723|NCT00524017|Cetuximab|cetuximab|mesh-list
19819724|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819725|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819726|NCT00524030|Pregabalin|pregabalin|mesh-list
20165504|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165505|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165506|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165507|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165508|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20165509|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20165510|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165511|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165512|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
20165513|NCT00137059|Acetaminophen|acetaminophen|mesh-list
20165514|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20165515|NCT00137059|Analgesics|analgesics|mesh-ancestor
20165516|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
20165517|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819727|NCT00524030|Analgesics|analgesics|mesh-ancestor
19819728|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
19819729|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333126|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
20333127|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20333128|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20333129|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333130|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20333131|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
20333132|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19819730|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819731|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
20165518|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165519|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
20165520|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
20165521|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333133|NCT00783081|Protective Agents|protective agents|mesh-ancestor
20333134|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19819732|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19819733|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819734|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819735|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19819736|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19819737|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19819738|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19819739|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819740|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19819741|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19819742|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19819743|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333135|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20333136|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333137|NCT00783107|Cyclosporine|cyclosporine|mesh-list
20333138|NCT00783107|Cyclosporins|cyclosporins|mesh-list
20333139|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333140|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648967|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648968|NCT02343484|Ethanol|ethanol|mesh-list
19648969|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19648970|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19648971|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19648972|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648973|NCT02343536|Prednisone|prednisone|mesh-list
19648974|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
19648975|NCT02343536|Rituximab|rituximab|mesh-list
19648976|NCT02343536|Vincristine|vincristine|mesh-list
19648977|NCT02343536|Azacitidine|azacitidine|mesh-list
19648978|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19648979|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
19648980|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19648981|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19648982|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20333141|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819744|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333142|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
20333143|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333144|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
20333145|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333146|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
20333147|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333148|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20333149|NCT00783172|Gemcitabine|gemcitabine|mesh-list
20333150|NCT00783172|Mitogens|mitogens|mesh-list
20333151|NCT00783172|Enkephalin, Methionine|enkephalin, methionine|mesh-list
20333152|NCT00783172|Enkephalins|enkephalins|mesh-list
19819745|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819746|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19819747|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19819748|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
19819749|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819750|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819751|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19819752|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19819753|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
20333153|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20333154|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
20333155|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333156|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333157|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
20333158|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333159|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333160|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333161|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
20333162|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333163|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
20333164|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333165|NCT00783250|Albuterol|albuterol|mesh-list
20333166|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
20333167|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20333168|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
20333169|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333170|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333171|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20333172|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
20333173|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
20333174|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20333175|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
20333176|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333177|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333178|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
19819754|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19819755|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819756|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819757|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819758|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819759|NCT00524173|Tenofovir|tenofovir|mesh-list
19819760|NCT00524173|Emtricitabine|emtricitabine|mesh-list
19819761|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
19819762|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819763|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19819764|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19819765|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819766|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819767|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19819768|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19819769|NCT00524225|Oprelvekin|oprelvekin|mesh-list
19819770|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819771|NCT00524264|Ketorolac|ketorolac|mesh-list
19819772|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19819773|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19819774|NCT00524264|Analgesics|analgesics|mesh-ancestor
19819775|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
19819776|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333179|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19819777|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333180|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19819778|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819779|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333181|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20333182|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19819780|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19819781|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819782|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819783|NCT00524303|Paclitaxel|paclitaxel|mesh-list
19819784|NCT00524303|Trastuzumab|trastuzumab|mesh-list
19819785|NCT00524303|Lapatinib|lapatinib|mesh-list
19819786|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19819787|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819788|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
19819789|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
19819790|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819791|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819792|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819793|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819794|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819795|NCT00524316|Doxorubicin|doxorubicin|mesh-list
19819796|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19819797|NCT00524316|Sunitinib|sunitinib|mesh-list
19819798|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19819799|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819800|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19819801|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19819802|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819803|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819804|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819805|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819806|NCT00524316|Growth Substances|growth substances|mesh-ancestor
19819807|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819808|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819809|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819810|NCT00524342|Oprelvekin|oprelvekin|mesh-list
19819811|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819812|NCT00524368|Ritonavir|ritonavir|mesh-list
19819813|NCT00524368|Darunavir|darunavir|mesh-list
19819814|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19819815|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19819816|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
19819817|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819818|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819819|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19819820|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19819821|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
19819822|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819823|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19819824|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19819825|NCT00524472|Insulin|insulin|mesh-list
19819826|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19819827|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19819828|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819829|NCT00524576|Vaccines|vaccines|mesh-list
19819830|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
19819831|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819832|NCT00524589|Calcitriol|calcitriol|mesh-list
19819833|NCT00524589|Dexamethasone|dexamethasone|mesh-list
19819834|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819835|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
19819836|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
19819837|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819838|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819839|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19819840|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
19819841|NCT00524589|Hormones|hormones|mesh-ancestor
19819842|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165522|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
19648983|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
19648984|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19648985|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19648986|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19648987|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19648988|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19648989|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
19648990|NCT02343536|Hormones|hormones|mesh-ancestor
20165523|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20333183|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
20333184|NCT00783380|Vaccines|vaccines|mesh-list
20333185|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
20333186|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333187|NCT00783393|Temozolomide|temozolomide|mesh-list
20333188|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20333189|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
20333190|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333191|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333192|NCT00783471|Docetaxel|docetaxel|mesh-list
20333193|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20333194|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333195|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
20333196|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
20333197|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
19819843|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19819844|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819845|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19819846|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19819847|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19819848|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819849|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19819850|NCT00524589|Vitamins|vitamins|mesh-ancestor
19819851|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
19819852|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19819853|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
19819854|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19819855|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819856|NCT00524680|Vitamins|vitamins|mesh-ancestor
19819857|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
19819858|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19819859|NCT00525031|Interferons|interferons|mesh-list
19819860|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
19819861|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
19819862|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19819863|NCT00525031|Temozolomide|temozolomide|mesh-list
19819864|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819865|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
19819866|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819867|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19819868|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
19819869|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819870|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
19819871|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819872|NCT00525044|Ambroxol|ambroxol|mesh-list
19819873|NCT00525044|Expectorants|expectorants|mesh-ancestor
19819874|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
19819875|NCT00525057|Dalteparin|dalteparin|mesh-list
19819876|NCT00525057|Tinzaparin|tinzaparin|mesh-list
19819877|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19819878|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
19819879|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19819880|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19819881|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819882|NCT00525135|Valproic Acid|valproic acid|mesh-list
19819883|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
19819884|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819885|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819886|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
20165524|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20165525|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165526|NCT00137072|Urological Agents|urological agents|mesh-ancestor
20165527|NCT00137085|Ketamine|ketamine|mesh-list
20165528|NCT00137085|Analgesics|analgesics|mesh-ancestor
20165529|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
20165530|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165531|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165532|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20165533|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20165534|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
20165535|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
20165536|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333198|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819887|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819888|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819889|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
19819890|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19819891|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19819892|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19819893|NCT00525148|Afatinib|afatinib|mesh-list
19819894|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819895|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819896|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819897|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819898|NCT00525161|Sorafenib|sorafenib|mesh-list
19819899|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819900|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819901|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819902|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834890|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834891|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
19834892|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
19834893|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
19834894|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19834895|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19834896|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834897|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834898|NCT00598585|Urological Agents|urological agents|mesh-ancestor
20333199|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333200|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333201|NCT00783484|Maraviroc|maraviroc|mesh-list
20333202|NCT00783484|Darunavir|darunavir|mesh-list
20333203|NCT00783484|Midazolam|midazolam|mesh-list
20333204|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20333205|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20333206|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333207|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333208|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20333209|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20333210|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333211|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20333212|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
19648991|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19648992|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19648993|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19648994|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
19648995|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
19648996|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
19648997|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19648998|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
19648999|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834899|NCT00598650|Donepezil|donepezil|mesh-list
19834900|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19834901|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834902|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834903|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
19834904|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165537|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20165538|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20165539|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165540|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165541|NCT00137098|Caffeine|caffeine|mesh-list
20165542|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20165543|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165544|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20165545|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333213|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
19649000|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
19649001|NCT02343419|Miotics|miotics|mesh-ancestor
19649002|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
19649003|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649004|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649005|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19649006|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19649007|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
19649008|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19834905|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333214|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
19819903|NCT00525265|Tolvaptan|tolvaptan|mesh-list
19819904|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19819905|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819906|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
19819907|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819908|NCT00525421|Curcumin|curcumin|mesh-list
19819909|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19819910|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19819911|NCT00525421|Analgesics|analgesics|mesh-ancestor
19819912|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
19819913|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819914|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819915|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19819916|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819917|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819918|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819919|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819920|NCT00525499|Androgens|androgens|mesh-list
19819921|NCT00525499|Hormones|hormones|mesh-ancestor
19819922|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19819923|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819924|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
19819925|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19819926|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
19819927|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819928|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819929|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19819930|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
20333215|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
20333216|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333217|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649009|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19649010|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
19649011|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649012|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649013|NCT02343614|Celecoxib|celecoxib|mesh-list
19649014|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19649015|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19649016|NCT02343614|Analgesics|analgesics|mesh-ancestor
19819931|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
19819932|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19819933|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
19819934|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19819935|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819936|NCT00525525|Bevacizumab|bevacizumab|mesh-list
19819937|NCT00525525|Temozolomide|temozolomide|mesh-list
20165546|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333218|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20333219|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20333220|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20333221|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20333222|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
20333223|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333224|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20333225|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20333226|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20333227|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
20333228|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333229|NCT00783510|Adalimumab|adalimumab|mesh-list
20333230|NCT00783510|Methotrexate|methotrexate|mesh-list
20333231|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20165547|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20165548|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20165549|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
20165550|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165551|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
20165552|NCT00137202|Promethazine|promethazine|mesh-list
20165553|NCT00137202|Ondansetron|ondansetron|mesh-list
20165554|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
20165555|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
20333232|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
19649017|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
20165556|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649018|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19819938|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19819939|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819940|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819941|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19819942|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19819943|NCT00525525|Growth Substances|growth substances|mesh-ancestor
19819944|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819945|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
19819946|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19819947|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
19819948|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819949|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19819950|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819951|NCT00525590|Carmustine|carmustine|mesh-list
19819952|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19819953|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
19819954|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819955|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819956|NCT00525603|Vidarabine|vidarabine|mesh-list
19819957|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
19819958|NCT00525603|Rituximab|rituximab|mesh-list
19819959|NCT00525603|Fludarabine|fludarabine|mesh-list
19819960|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
19819961|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
19819962|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19819963|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
19819964|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19819965|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19819966|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19819967|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
19819968|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819969|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19819970|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19819971|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19819972|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19819973|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
19819974|NCT00525603|Antiviral Agents|antiviral agents|mesh-ancestor
19819975|NCT00525603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819976|NCT00525733|Ritonavir|ritonavir|mesh-list
19819977|NCT00525733|Darunavir|darunavir|mesh-list
19819978|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
19819979|NCT00525733|Maraviroc|maraviroc|mesh-list
19819980|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19819981|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19819982|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
19819983|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19819984|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19819985|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19819986|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19819987|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
19819988|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19819989|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19819990|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19819991|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19819992|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19819993|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19819994|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19819995|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19819996|NCT00525785|Leucovorin|leucovorin|mesh-list
19819997|NCT00525785|Folic Acid|folic acid|mesh-list
19819998|NCT00525785|Fluorouracil|fluorouracil|mesh-list
19819999|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
20333233|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20333234|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333235|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820000|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
19820001|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
19820002|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820003|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820004|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820005|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820006|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
19820007|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820008|NCT00525785|Antidotes|antidotes|mesh-ancestor
19820009|NCT00525785|Protective Agents|protective agents|mesh-ancestor
19820010|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
19820011|NCT00525785|Vitamins|vitamins|mesh-ancestor
19820012|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
19820013|NCT00525785|Hematinics|hematinics|mesh-ancestor
19820014|NCT00525798|Calcitonin|calcitonin|mesh-list
19820015|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
19820016|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19820017|NCT00525798|Katacalcin|katacalcin|mesh-list
19820018|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19820019|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820020|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19820021|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
19820022|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19820023|NCT00525824|Simvastatin|simvastatin|mesh-list
19820024|NCT00525824|Ezetimibe|ezetimibe|mesh-list
19820025|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19820026|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19820027|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
19820028|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820029|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19820030|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19820031|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820032|NCT00525837|Varenicline|varenicline|mesh-list
19820033|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19820034|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19820035|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
19820036|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820037|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820038|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820039|NCT00525876|Vidarabine|vidarabine|mesh-list
19820040|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
19820041|NCT00525876|Rituximab|rituximab|mesh-list
19820042|NCT00525876|Fludarabine|fludarabine|mesh-list
19820043|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
19820044|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
19820045|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820046|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
20333236|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
20333237|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333238|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333239|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
20333240|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333241|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20333242|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333243|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
20333244|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333245|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20333246|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20333247|NCT00783523|Doxycycline|doxycycline|mesh-list
20333248|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20333249|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333250|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
20333251|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20333252|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20333253|NCT00783601|Montelukast|montelukast|mesh-list
20333254|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20333255|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
20333256|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20333257|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333258|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333259|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333260|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20333261|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19649019|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649020|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19649021|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649022|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19649023|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19649024|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649025|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649026|NCT02343393|Hydralazine|hydralazine|mesh-list
19649027|NCT02343393|Isosorbide|isosorbide|mesh-list
19649028|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19649029|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19649030|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19649031|NCT02343393|Diuretics|diuretics|mesh-ancestor
19649032|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
20333262|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333263|NCT00783653|Sunitinib|sunitinib|mesh-list
20333264|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649033|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649034|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
19649035|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19649036|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649037|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19664984|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19664985|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
19664986|NCT04379024|Estrogens|estrogens|mesh-list
19664987|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19664988|NCT04379024|Hormones|hormones|mesh-ancestor
19664989|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19664990|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19664991|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19664992|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19664993|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
19664994|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19664995|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19664996|NCT04272008|Estradiol|estradiol|mesh-list
19664997|NCT04272008|Estrogens|estrogens|mesh-ancestor
19664998|NCT04272008|Hormones|hormones|mesh-ancestor
19664999|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19665000|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665001|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19665002|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
19665003|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665004|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19665005|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19665006|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19665007|NCT04176718|Dexamethasone|dexamethasone|mesh-list
19665008|NCT04176718|Daratumumab|daratumumab|mesh-list
19665009|NCT04176718|Pomalidomide|pomalidomide|mesh-list
19665010|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19665011|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
19665012|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
19665013|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665014|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665015|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19665016|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
19665017|NCT04176718|Hormones|hormones|mesh-ancestor
19665018|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19665019|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19665020|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665021|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
19665022|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19665023|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19665024|NCT04176718|Growth Substances|growth substances|mesh-ancestor
19665025|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
19665026|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
19665027|NCT04163406|Trace Elements|trace elements|mesh-ancestor
19665028|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
19665029|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666171|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666172|NCT05103410|Aripiprazole|aripiprazole|mesh-list
19666173|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
19666174|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19666175|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19666176|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19666177|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666178|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666179|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
19666180|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
19666181|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666182|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666183|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19666184|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19666185|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
19666186|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19820047|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820048|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820049|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19820050|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
19820051|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820052|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820053|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19820054|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19820055|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820056|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
19820057|NCT00525876|Antiviral Agents|antiviral agents|mesh-ancestor
19820058|NCT00525876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820059|NCT00525902|Adalimumab|adalimumab|mesh-list
19820060|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820061|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820062|NCT00525915|Fluorouracil|fluorouracil|mesh-list
19820063|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
19820064|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
19820065|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820066|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820067|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820068|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820069|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
19820070|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820071|NCT00526058|Clotrimazole|clotrimazole|mesh-list
19820072|NCT00526058|Miconazole|miconazole|mesh-list
19820073|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19820074|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820075|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
19820076|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19820077|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19820078|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820079|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820080|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19820081|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
19820082|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820083|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820084|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19820085|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19820086|NCT00526097|Bisacodyl|bisacodyl|mesh-list
19820087|NCT00526097|Cathartics|cathartics|mesh-ancestor
19820088|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820089|NCT00526097|Laxatives|laxatives|mesh-ancestor
19820090|NCT00526110|Docetaxel|docetaxel|mesh-list
19820091|NCT00526110|Fluorouracil|fluorouracil|mesh-list
19820092|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
19820093|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820094|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
19820095|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19820096|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19649038|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
19649039|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19649040|NCT02343211|Antibodies|antibodies|mesh-list
19649041|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
19649042|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649043|NCT02343289|Clarithromycin|clarithromycin|mesh-list
19649044|NCT02343289|Esketamine|esketamine|mesh-list
19649045|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19649046|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649047|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19649048|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649049|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649050|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19649051|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19649052|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
19649053|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19649054|NCT02342977|Lacosamide|lacosamide|mesh-list
19820097|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649055|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
19649056|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19649057|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19649058|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820098|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
19820099|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820100|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820101|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
19820102|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820103|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
19649059|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649060|NCT02343250|Valsartan|valsartan|mesh-list
19649061|NCT02343250|Cilnidipine|cilnidipine|mesh-list
19649062|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19649063|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19649064|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19649065|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649066|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19649067|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19649068|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19649069|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649070|NCT02342925|Metformin|metformin|mesh-list
19649071|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19649072|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649073|NCT02342769|Abacavir|abacavir|mesh-list
19649074|NCT02342769|Dolutegravir|dolutegravir|mesh-list
19649075|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20333265|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20333266|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20333267|NCT00783653|Growth Substances|growth substances|mesh-ancestor
20333268|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333269|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
20333270|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333271|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333272|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333273|NCT00783731|Midazolam|midazolam|mesh-list
20333274|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20333275|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20333276|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333277|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333278|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20333279|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20333280|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333281|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20333282|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
19649076|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19649077|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820104|NCT00526292|Fludarabine|fludarabine|mesh-list
19820105|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333283|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
19256678|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256679|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256680|NCT04245514|Durvalumab|durvalumab|mesh-list
19256681|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256682|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256683|NCT04233216|Islatravir|islatravir|mesh-list
19256684|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
19256685|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256686|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256687|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256688|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19820106|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
19820107|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820108|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820109|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19820110|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
19820111|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820112|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820113|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19820114|NCT00526474|Vorapaxar|vorapaxar|mesh-list
19820115|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19820116|NCT00526591|Everolimus|everolimus|mesh-list
19820117|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820118|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820119|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
19820120|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820121|NCT00526630|Methylphenidate|methylphenidate|mesh-list
19820122|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19820123|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820124|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19820125|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19820126|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820127|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820128|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
19820129|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820130|NCT00526656|Sunitinib|sunitinib|mesh-list
19820131|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820132|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19820133|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19820134|NCT00526656|Growth Substances|growth substances|mesh-ancestor
19820135|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820136|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
19820137|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19820138|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820139|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820140|NCT00526669|Capecitabine|capecitabine|mesh-list
19820141|NCT00526669|Lapatinib|lapatinib|mesh-list
19820142|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649078|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649079|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
19820143|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
19820144|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820145|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820146|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19820147|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820148|NCT00526799|Sorafenib|sorafenib|mesh-list
19820149|NCT00526799|Topotecan|topotecan|mesh-list
19820150|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333284|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
20333285|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
20333286|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649080|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649081|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19649082|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19649083|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19649084|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19649085|NCT02342717|Itraconazole|itraconazole|mesh-list
19649086|NCT02342717|BI 425809|bi 425809|mesh-list
19649087|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
19649088|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649089|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19649090|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19649091|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649092|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649093|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19649094|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649095|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649096|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165557|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165558|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20165559|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
20165560|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
20165561|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20165562|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
19820151|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333287|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333288|NCT00783744|Insulin|insulin|mesh-list
20333289|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20333290|NCT00783744|Metformin|metformin|mesh-list
20333291|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
20333292|NCT00783744|Glimepiride|glimepiride|mesh-list
20333293|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
20333294|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
20333295|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
20333296|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20333297|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333298|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20333299|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649097|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19649098|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
19649099|NCT02342600|Trametinib|trametinib|mesh-list
19649100|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649101|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19649102|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820152|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820153|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820154|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19649103|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649104|NCT02342587|Lapatinib|lapatinib|mesh-list
19820155|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19820156|NCT00526890|Selenium|selenium|mesh-list
19820157|NCT00526890|Paclitaxel|paclitaxel|mesh-list
19820158|NCT00526890|Carboplatin|carboplatin|mesh-list
19820159|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19820160|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820161|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
19820162|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165563|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165564|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820163|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
19820164|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820165|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
19820166|NCT00526890|Protective Agents|protective agents|mesh-ancestor
19820167|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820168|NCT00526890|Trace Elements|trace elements|mesh-ancestor
19820169|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
19820170|NCT00527072|Infliximab|infliximab|mesh-list
19820171|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
19820172|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820173|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820174|NCT00527111|Fluorouracil|fluorouracil|mesh-list
19820175|NCT00527111|Cetuximab|cetuximab|mesh-list
19820176|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
19820177|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820178|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820179|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820180|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820181|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
19820182|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165565|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20165566|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20165567|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165568|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165569|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20165570|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20165571|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20165572|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
20165573|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
20165574|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
20165575|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20165576|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
20165577|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
20165578|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20165579|NCT00137254|Insulin|insulin|mesh-list
20165580|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165581|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165582|NCT00137345|Sirolimus|sirolimus|mesh-list
20165583|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20333300|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
19820183|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19820184|NCT00527124|Prednisone|prednisone|mesh-list
19820185|NCT00527124|Docetaxel|docetaxel|mesh-list
19820186|NCT00527124|Cediranib|cediranib|mesh-list
19820187|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820188|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
19820189|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
19820190|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
19820191|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611767|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
20611768|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20611769|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20611770|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
20611771|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820192|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820193|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
19820194|NCT00527124|Hormones|hormones|mesh-ancestor
19820195|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820196|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820197|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20333301|NCT00783900|Metoprolol|metoprolol|mesh-list
20333302|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20333303|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20333304|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
20333305|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
20333306|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333307|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333308|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20333309|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20333310|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20333311|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
19820198|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820199|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19820200|NCT00527332|Fentanyl|fentanyl|mesh-list
19820201|NCT00527332|Morphine|morphine|mesh-list
19820202|NCT00527332|Bupivacaine|bupivacaine|mesh-list
19820203|NCT00527332|Propofol|propofol|mesh-list
19820204|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
19820205|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
19820206|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19820207|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165584|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165585|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20165586|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165587|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
20165588|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165589|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
20165590|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165591|NCT00137358|Amifostine|amifostine|mesh-list
20165592|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20333312|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333313|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348062|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348063|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20348064|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20348065|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20348066|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19649105|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649106|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19649107|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649108|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649109|NCT02342509|Sevoflurane|sevoflurane|mesh-list
19649110|NCT02342509|Desflurane|desflurane|mesh-list
19649111|NCT02342509|Isoflurane|isoflurane|mesh-list
19649112|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19649113|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19649114|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
19649115|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
19649116|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649117|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649118|NCT02342574|Olorofim|olorofim|mesh-list
19820208|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
19820209|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820210|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19820211|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20165593|NCT00137358|Protective Agents|protective agents|mesh-ancestor
20165594|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165595|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20165596|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20165597|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19820212|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
19820213|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19820214|NCT00527332|Narcotics|narcotics|mesh-ancestor
19820215|NCT00527332|Analgesics|analgesics|mesh-ancestor
19820216|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19820217|NCT00527397|Insulin|insulin|mesh-list
19820218|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19820219|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820220|NCT00527423|Aflibercept|aflibercept|mesh-list
19820221|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19820222|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19820223|NCT00527423|Growth Substances|growth substances|mesh-ancestor
19820224|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820225|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
19820226|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820227|NCT00527475|Ranibizumab|ranibizumab|mesh-list
19820228|NCT00527475|Verteporfin|verteporfin|mesh-list
19820229|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19820230|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19820231|NCT00527475|Growth Substances|growth substances|mesh-ancestor
19820232|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820233|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
19820234|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820235|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19820236|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19820237|NCT00527514|Amlodipine|amlodipine|mesh-list
19820238|NCT00527514|Olmesartan|olmesartan|mesh-list
19820239|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19820240|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19820241|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19820242|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820243|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820244|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19820245|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820246|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
20333314|NCT00783926|Vaccines|vaccines|mesh-list
20333315|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
19820247|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19820248|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19820249|NCT00527592|Travoprost|travoprost|mesh-list
19820250|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19820251|NCT00527592|Latanoprost|latanoprost|mesh-list
19820252|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19820253|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19820254|NCT00527605|Dutasteride|dutasteride|mesh-list
19820255|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19820256|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20165598|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
20165599|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165600|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165601|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333316|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
20333317|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333318|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
20333319|NCT00784017|Asparaginase|asparaginase|mesh-list
20333320|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165602|NCT00137397|Urological Agents|urological agents|mesh-ancestor
20165603|NCT00137410|Celecoxib|celecoxib|mesh-list
20165604|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20165605|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20165606|NCT00137410|Analgesics|analgesics|mesh-ancestor
20165607|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
20165608|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165609|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165610|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165611|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333321|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
19820257|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820258|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820259|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333322|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333323|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
19820260|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820261|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820262|NCT00527618|Valacyclovir|valacyclovir|mesh-list
19820263|NCT00527618|Acyclovir|acyclovir|mesh-list
19820264|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
19820265|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820266|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19820267|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19820268|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
19820269|NCT00527644|Hormones|hormones|mesh-ancestor
19820270|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820271|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820272|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820273|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820274|NCT00527735|Paclitaxel|paclitaxel|mesh-list
19820275|NCT00527735|Carboplatin|carboplatin|mesh-list
19820276|NCT00527735|Ipilimumab|ipilimumab|mesh-list
19820277|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19820278|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820279|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
19820280|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
19820281|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
19820282|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820283|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19820284|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19820285|NCT00527787|Naproxen|naproxen|mesh-list
19820286|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19820287|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19820288|NCT00527787|Analgesics|analgesics|mesh-ancestor
19820289|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
19820290|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820291|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820292|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820293|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820294|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
20333324|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333325|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333326|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20333327|NCT00784186|Misoprostol|misoprostol|mesh-list
20333328|NCT00784186|Mifepristone|mifepristone|mesh-list
20333329|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20333330|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
20333331|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20333332|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333333|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20333334|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20333335|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
19820295|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19820296|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820297|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820298|NCT00527826|Fluticasone|fluticasone|mesh-list
19820299|NCT00527826|Xhance|xhance|mesh-list
19820300|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19820301|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820302|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19820303|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
19820304|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820305|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820306|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19820307|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
19820308|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
19820309|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19820310|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19820311|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19820312|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19820313|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
19820314|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820315|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820316|NCT00527878|Ranitidine|ranitidine|mesh-list
19820317|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19820318|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19820319|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20333336|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19820320|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19820321|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
19820322|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
19820323|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820324|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820325|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820326|NCT00527904|Naproxen|naproxen|mesh-list
19820327|NCT00527904|Esomeprazole|esomeprazole|mesh-list
19820328|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19820329|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820330|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19820331|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820332|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820333|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19820334|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19820335|NCT00527904|Analgesics|analgesics|mesh-ancestor
19820336|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
19820337|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820338|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820339|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820340|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820341|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
19820342|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19820343|NCT00527943|Vorapaxar|vorapaxar|mesh-list
19820344|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19820345|NCT00528190|Itraconazole|itraconazole|mesh-list
19820346|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
19820347|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820348|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19820349|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19820350|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820351|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820352|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19820353|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
19820354|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820355|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820356|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20333337|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20333338|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20333339|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20333340|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
20333341|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20333342|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20333343|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333344|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333345|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
19820357|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19820358|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820359|NCT00528372|Metformin|metformin|mesh-list
19820360|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
19820361|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19820362|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820363|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19820364|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820365|NCT00528398|Cytarabine|cytarabine|mesh-list
19820366|NCT00528398|Idarubicin|idarubicin|mesh-list
19820367|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820368|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
19820369|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820370|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820371|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
19820372|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165612|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20165613|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20165614|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165615|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165616|NCT00137462|Atorvastatin|atorvastatin|mesh-list
20165617|NCT00137462|Torcetrapib|torcetrapib|mesh-list
20165618|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20165619|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20165620|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
19820373|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820374|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
19820375|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820376|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19820377|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19820378|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19820379|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820380|NCT00528411|Aspirin|aspirin|mesh-list
19820381|NCT00528411|Clopidogrel|clopidogrel|mesh-list
19820382|NCT00528411|Ticagrelor|ticagrelor|mesh-list
19820383|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19820384|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19820385|NCT00528411|Analgesics|analgesics|mesh-ancestor
19820386|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
19820387|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820388|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820389|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820390|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820391|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19820392|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19820393|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820394|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19820395|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19820396|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820397|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
19820398|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19820399|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19820400|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19820401|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
19820402|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165621|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165622|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20165623|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19820403|NCT00528450|Idarubicin|idarubicin|mesh-list
19820404|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
19820405|NCT00528450|Tretinoin|tretinoin|mesh-list
19820406|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19820407|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820408|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19820409|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19820410|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820411|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820412|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
19820413|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
19820414|NCT00528528|Ribavirin|ribavirin|mesh-list
19820415|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
19820416|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
19820417|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19820418|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19820419|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19820420|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
19820421|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820422|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
19820423|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820424|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
19820425|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820426|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820427|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
19820428|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19820429|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19820430|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19820431|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820432|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820433|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
19820434|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820435|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820436|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19820437|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165624|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165625|NCT00137501|Nifedipine|nifedipine|mesh-list
20165626|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19820438|NCT00528567|Bevacizumab|bevacizumab|mesh-list
19820439|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19820440|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820441|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19820442|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19820443|NCT00528567|Growth Substances|growth substances|mesh-ancestor
19820444|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820445|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
19820446|NCT00528580|Simvastatin|simvastatin|mesh-list
20333346|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20333347|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20333348|NCT00784290|Orantinib|orantinib|mesh-list
20333349|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19649119|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
19649120|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649121|NCT02342392|Ranibizumab|ranibizumab|mesh-list
19820447|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19820448|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19820449|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
19820450|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820451|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19820452|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19820453|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820454|NCT00528645|Saracatinib|saracatinib|mesh-list
19820455|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820456|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820457|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820458|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
19820459|NCT00528788|Vitamins|vitamins|mesh-ancestor
19820460|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
19820461|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820462|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19820463|NCT00528866|Docetaxel|docetaxel|mesh-list
19820464|NCT00528866|Bicalutamide|bicalutamide|mesh-list
19820465|NCT00528866|Flutamide|flutamide|mesh-list
19820466|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820467|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
19820468|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
19820469|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
19820470|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820471|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
19820472|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
19820473|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820474|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820475|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19820476|NCT00528879|Metformin|metformin|mesh-list
19820477|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
19820478|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19820479|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820480|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19820481|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820482|NCT00528957|Tenofovir|tenofovir|mesh-list
19820483|NCT00528957|Zidovudine|zidovudine|mesh-list
19820484|NCT00528957|Stavudine|stavudine|mesh-list
19820485|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
19820486|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820487|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19820488|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19820489|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820490|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820491|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19649122|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19649123|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19649124|NCT02342392|Growth Substances|growth substances|mesh-ancestor
19649125|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649126|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
19649127|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649128|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19649129|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649130|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19649131|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649132|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649133|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
20333350|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611772|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649134|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19649135|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20333351|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333352|NCT00784316|Metoprolol|metoprolol|mesh-list
20333353|NCT00784316|Amiodarone|amiodarone|mesh-list
20333354|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19820492|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19820493|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
19820494|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
19820495|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19820496|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820497|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
19820498|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820499|NCT00528996|Bromides|bromides|mesh-list
19820500|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
19820501|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19820502|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
19820503|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820504|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820505|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19820506|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
19820507|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
19820508|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19820509|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
19820510|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820511|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820512|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
19820513|NCT00529035|Interleukin-2|interleukin-2|mesh-list
19820514|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820515|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19820516|NCT00529035|Analgesics|analgesics|mesh-ancestor
19820517|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
19820518|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333355|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20333356|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
20333357|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
20333358|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333359|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333360|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20333361|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20333362|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20333363|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
20333364|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333365|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333366|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
20333367|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20333368|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20333369|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20333370|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20333371|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20333372|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333373|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20333374|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19820519|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820520|NCT00529087|Bromides|bromides|mesh-list
19820521|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
19820522|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
19820523|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19820524|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820525|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
19820526|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820527|NCT00529100|Cisplatin|cisplatin|mesh-list
19820528|NCT00529100|Pemetrexed|pemetrexed|mesh-list
19820529|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820530|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820531|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820532|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20333375|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19820533|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19820534|NCT00529126|Epinephrine|epinephrine|mesh-list
19820535|NCT00529126|Bupivacaine|bupivacaine|mesh-list
19820536|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
20611773|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820537|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
19820538|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19820539|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820540|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
19820541|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820542|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19820543|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19820544|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
19820545|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820546|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820547|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19820548|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19820549|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
19820550|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19820551|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
19820552|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
19820553|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
19820554|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19820555|NCT00529191|Atorvastatin|atorvastatin|mesh-list
19820556|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19820557|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19820558|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
19820559|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820560|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19820561|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19820562|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820563|NCT00529204|Exenatide|exenatide|mesh-list
19820564|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19820565|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820566|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19820567|NCT00529204|Incretins|incretins|mesh-ancestor
19820568|NCT00529204|Hormones|hormones|mesh-ancestor
19820569|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820570|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
19820571|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19820572|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19820573|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
19820574|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820575|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19820576|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19820577|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820578|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820579|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
19820580|NCT00529373|Vitamin D|vitamin d|mesh-list
19820581|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
19820582|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
19820583|NCT00529373|Calcium|calcium|mesh-list
19820584|NCT00529373|Vitamins|vitamins|mesh-ancestor
19820585|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
19820586|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820587|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19820588|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19820589|NCT00529373|Antacids|antacids|mesh-ancestor
19820590|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820591|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820592|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19820593|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
19820594|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19820595|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
19820596|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820597|NCT00529399|Antacids|antacids|mesh-ancestor
19820598|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820599|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820600|NCT00529451|Ramipril|ramipril|mesh-list
19820601|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19820602|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
19820603|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820604|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820605|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19820606|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19820607|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19820608|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
19820609|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820610|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820611|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19820612|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
19820613|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19820614|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20333376|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20333377|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20333378|NCT00784394|Protective Agents|protective agents|mesh-ancestor
20333379|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333380|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333381|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
20333382|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20333383|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20333384|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
20333385|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333386|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20333387|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20333388|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333389|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333390|NCT00784446|Bevacizumab|bevacizumab|mesh-list
20333391|NCT00784446|Capecitabine|capecitabine|mesh-list
20333392|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
20333393|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
20333394|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20333395|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333396|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20333397|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20333398|NCT00784446|Growth Substances|growth substances|mesh-ancestor
20333399|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333400|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
20333401|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20333402|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
20333403|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333404|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333405|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333406|NCT00784472|Morphine|morphine|mesh-list
20333407|NCT00784472|Oxycodone|oxycodone|mesh-list
19649136|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
19649137|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
19649138|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649139|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649140|NCT02342275|Propranolol|propranolol|mesh-list
19649141|NCT02342275|Atenolol|atenolol|mesh-list
19649142|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19649143|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19649144|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
19649145|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649146|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649147|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649148|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19649149|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19649150|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
19649151|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
19649152|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
19649153|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649154|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19649155|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19649156|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
19649157|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649158|NCT02342145|Cyclosporine|cyclosporine|mesh-list
19649159|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
19649160|NCT02342145|Methotrexate|methotrexate|mesh-list
19649161|NCT02342145|Cyclosporins|cyclosporins|mesh-list
19649162|NCT02342145|Basiliximab|basiliximab|mesh-list
19649163|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19649164|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
19649165|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649166|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649167|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649168|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
19665030|NCT03965845|Palbociclib|palbociclib|mesh-list
19665031|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665032|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665033|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665034|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665035|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
19665036|NCT03825289|Trametinib|trametinib|mesh-list
19665037|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
19665038|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19665039|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20333408|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20333409|NCT00784472|Narcotics|narcotics|mesh-ancestor
20333410|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19820615|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19820616|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
19820617|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820618|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165627|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20165628|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165629|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20165630|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165631|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
20165632|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
19820619|NCT00529542|Atorvastatin|atorvastatin|mesh-list
19820620|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19820621|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19820622|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
19820623|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820624|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19820625|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19820626|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820627|NCT00529555|Minocycline|minocycline|mesh-list
19820628|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19820629|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820630|NCT00529633|Thalidomide|thalidomide|mesh-list
19820631|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820632|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
19820633|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820634|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
19820635|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19820636|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820637|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19820638|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19820639|NCT00529633|Growth Substances|growth substances|mesh-ancestor
19820640|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
19820641|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834906|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
19834907|NCT00598663|Insulin|insulin|mesh-list
19834908|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19834909|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19834910|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834911|NCT00598702|Acetaminophen|acetaminophen|mesh-list
19834912|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19834913|NCT00598702|Analgesics|analgesics|mesh-ancestor
19834914|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
19834915|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834916|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834917|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
19834918|NCT00598806|Apaziquone|apaziquone|mesh-list
19834919|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834920|NCT00598832|Adapalene|adapalene|mesh-list
19834921|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20333411|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333412|NCT00784472|Analgesics|analgesics|mesh-ancestor
19834922|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19834923|NCT00598832|Analgesics|analgesics|mesh-ancestor
19834924|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
19834925|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834926|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834927|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834928|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165633|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20165634|NCT00137514|Chloroquine|chloroquine|mesh-list
20165635|NCT00137514|Amodiaquine|amodiaquine|mesh-list
20165636|NCT00137514|Amebicides|amebicides|mesh-ancestor
20165637|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20165638|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20165639|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165640|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
20165641|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165642|NCT00137527|Anesthetics|anesthetics|mesh-list
20165643|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165644|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834929|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
19834930|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20165645|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19820642|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19820643|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19820644|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19820645|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820646|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820647|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820648|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820649|NCT00529789|Analgesics|analgesics|mesh-ancestor
19820650|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
19820651|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820652|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
19820653|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19820654|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
19820655|NCT00529802|Everolimus|everolimus|mesh-list
19820656|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820657|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820658|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
19820659|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820660|NCT00530023|Insulin|insulin|mesh-list
19820661|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19820662|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820663|NCT00530075|Gusperimus|gusperimus|mesh-list
19820664|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19820665|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820666|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19820667|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820668|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820669|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
19820670|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19820671|NCT00530075|Protective Agents|protective agents|mesh-ancestor
19820672|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19820673|NCT00530088|Trioxsalen|trioxsalen|mesh-list
19820674|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820675|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
19820676|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19820677|NCT00530218|Ganciclovir|ganciclovir|mesh-list
19820678|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19820679|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
19820680|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820681|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20333413|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
19649169|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649170|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649171|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
19649172|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649173|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19649174|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649175|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
19649176|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649177|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19649178|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
19649179|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649180|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19649181|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19649182|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19649183|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
19649184|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19820682|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820683|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820684|NCT00530257|Methylphenidate|methylphenidate|mesh-list
19820685|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19820686|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820687|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19820688|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19820689|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820690|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820691|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
19820692|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820693|NCT00530270|Dexamethasone|dexamethasone|mesh-list
19820694|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820695|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
19820696|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
19820697|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333414|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649185|NCT02342093|Drospirenone|drospirenone|mesh-list
20333415|NCT00784485|Omalizumab|omalizumab|mesh-list
20333416|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20333417|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20333418|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
20333419|NCT00784498|Midazolam|midazolam|mesh-list
20333420|NCT00784498|Ketamine|ketamine|mesh-list
20333421|NCT00784498|Propofol|propofol|mesh-list
20333422|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20333423|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333424|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333425|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19820698|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820699|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820700|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
19820701|NCT00530270|Hormones|hormones|mesh-ancestor
19820702|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820703|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19820704|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820705|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19820706|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19820707|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19820708|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820709|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820710|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
19820711|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820712|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820713|NCT00530348|Interferons|interferons|mesh-list
19820714|NCT00530348|Interferon-beta|interferon-beta|mesh-list
19820715|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
19820716|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
19820717|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820718|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
19820719|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820720|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19820721|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
19820722|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820723|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19820724|NCT00530621|Pemetrexed|pemetrexed|mesh-list
19820725|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820726|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820727|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820728|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19820729|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19820730|NCT00530634|Gemcitabine|gemcitabine|mesh-list
19820731|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820732|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19820733|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
19820734|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333426|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
20333427|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
20333428|NCT00784498|Analgesics|analgesics|mesh-ancestor
20333429|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
20333430|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333431|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20333432|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20333433|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20333434|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333435|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333436|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20333437|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20333438|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19820735|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
19649186|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19649187|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649188|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649189|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649190|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19649191|NCT02342093|Diuretics|diuretics|mesh-ancestor
19649192|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
19649193|NCT02342067|Pioglitazone|pioglitazone|mesh-list
19649194|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
19649195|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20333439|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19820736|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820737|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820738|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820739|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
19820740|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820741|NCT00530764|Nabiximols|nabiximols|mesh-list
19820742|NCT00530764|Dronabinol|dronabinol|mesh-list
19820743|NCT00530764|Cannabidiol|cannabidiol|mesh-list
19820744|NCT00530764|Analgesics|analgesics|mesh-ancestor
19820745|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
19820746|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820747|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820748|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
19820749|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
20165646|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
20165647|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
20165648|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20165649|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
20165650|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20165651|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19820750|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19820751|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19820752|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19820753|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19820754|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820755|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820756|NCT00530764|Hormones|hormones|mesh-ancestor
19820757|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820758|NCT00530777|Valacyclovir|valacyclovir|mesh-list
19820759|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
19820760|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820761|NCT00530790|Ropinirole|ropinirole|mesh-list
19820762|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19820763|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19820764|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
19820765|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
19820766|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820767|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820768|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820769|NCT00530803|Lidocaine|lidocaine|mesh-list
19820770|NCT00530803|Tetracaine|tetracaine|mesh-list
19820771|NCT00530803|Prilocaine|prilocaine|mesh-list
19820772|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19820773|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
19820774|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
19820775|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19820776|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820777|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
19820778|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820779|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19820780|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19820781|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19820782|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820783|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820784|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19820785|NCT00530842|Fluticasone|fluticasone|mesh-list
19820786|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
19820787|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19820788|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19820789|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820790|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19820791|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
19820792|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820793|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820794|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19820795|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
19820796|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
19820797|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20165652|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165653|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20165654|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165655|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165656|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20165657|NCT00137553|Renal Agents|renal agents|mesh-ancestor
19820798|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
20165658|NCT00137566|Acetaminophen|acetaminophen|mesh-list
19820799|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19820800|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
19820801|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820802|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820803|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19820804|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19820805|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19820806|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
19820807|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
19820808|NCT00530842|Hormones|hormones|mesh-ancestor
20165659|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20165660|NCT00137566|Analgesics|analgesics|mesh-ancestor
20165661|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
20165662|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165663|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165664|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
20165665|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20165666|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
20165667|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165668|NCT00137657|Trimethoprim|trimethoprim|mesh-list
20165669|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20165670|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
20165671|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20165672|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165673|NCT00137657|Renal Agents|renal agents|mesh-ancestor
20165674|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
19820809|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820810|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
19820811|NCT00530855|Lacosamide|lacosamide|mesh-list
19820812|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
19820813|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19820814|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19820815|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820816|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820817|NCT00530920|Ritonavir|ritonavir|mesh-list
19820818|NCT00530920|Tipranavir|tipranavir|mesh-list
19820819|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19820820|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19820821|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
19820822|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820823|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820824|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19820825|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19820826|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
19820827|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820828|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19820829|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19820830|NCT00530946|Amlodipine|amlodipine|mesh-list
19820831|NCT00530946|Atorvastatin|atorvastatin|mesh-list
19820832|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19820833|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19820834|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
19820835|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820836|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19820837|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19820838|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820839|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19820840|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19820841|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19820842|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19820843|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820844|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
19820845|NCT00531011|Paclitaxel|paclitaxel|mesh-list
19820846|NCT00531011|Everolimus|everolimus|mesh-list
19820847|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19820848|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820849|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
19820850|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
19820851|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
19820852|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820853|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165675|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19820854|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
20165676|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20333440|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
20333441|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
20333442|NCT00784511|Vitamin D|vitamin d|mesh-list
20333443|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
20333444|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
20333445|NCT00784511|Vitamins|vitamins|mesh-list
20333446|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
20333447|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333448|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20333449|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20333450|NCT00784589|Rituximab|rituximab|mesh-list
20333451|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20333452|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333453|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
20333454|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333455|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333456|NCT00784667|Cetuximab|cetuximab|mesh-list
20333457|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20333458|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20333459|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333460|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333461|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333462|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333463|NCT00784680|Tamoxifen|tamoxifen|mesh-list
20333464|NCT00784680|Anastrozole|anastrozole|mesh-list
20333465|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20333466|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333467|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333468|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333469|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20333470|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333471|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20333472|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20333473|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20333474|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20333475|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20333476|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333477|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333478|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
20333479|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20333480|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
20333481|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20333482|NCT00784745|Dexamethasone|dexamethasone|mesh-list
20333483|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20333484|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
20333485|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
20333486|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333487|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333488|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20333489|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
20333490|NCT00784745|Hormones|hormones|mesh-ancestor
20333491|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333492|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19649196|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649197|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19649198|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649199|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19649200|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19649201|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
19649202|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649203|NCT02341872|Calcium|calcium|mesh-list
19649204|NCT02341872|Fluorides|fluorides|mesh-list
19649205|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19649206|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649207|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
19649208|NCT02341872|Protective Agents|protective agents|mesh-ancestor
19649209|NCT02342002|Misoprostol|misoprostol|mesh-list
19649210|NCT02342002|Mifepristone|mifepristone|mesh-list
19649211|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19649212|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
19649213|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649214|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333493|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333494|NCT00784797|Oxytocin|oxytocin|mesh-list
20333495|NCT00784797|Mifepristone|mifepristone|mesh-list
20333496|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
20333497|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20333498|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333499|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20333500|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
20333501|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20333502|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20333503|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20333504|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
20333505|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20333506|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20333507|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333508|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333509|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
20333510|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20333511|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20333512|NCT00784823|Bortezomib|bortezomib|mesh-list
20333513|NCT00784823|Melphalan|melphalan|mesh-list
20333514|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333515|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19820855|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820856|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19820857|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19820858|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
19820859|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820860|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820861|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19820862|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
19820863|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19820864|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19820865|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19820866|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
19820867|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820868|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820869|NCT00531206|Ritonavir|ritonavir|mesh-list
19820870|NCT00531206|Tipranavir|tipranavir|mesh-list
20333516|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
20333517|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333518|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20333519|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333520|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
20333521|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333522|NCT00784862|Tamoxifen|tamoxifen|mesh-list
20333523|NCT00784862|Anastrozole|anastrozole|mesh-list
20333524|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20333525|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333526|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333527|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333528|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20333529|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333530|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20333531|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20333532|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20333533|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19649215|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19649216|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19649217|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
19649218|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19649219|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19649220|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19649221|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19649222|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
19649223|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19649224|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19649225|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649226|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649227|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
19649228|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19649229|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19820871|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19820872|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19820873|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
19820874|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820875|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820876|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19820877|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19820878|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
19820879|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820880|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19820881|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19820882|NCT00531284|Dexamethasone|dexamethasone|mesh-list
19820883|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820884|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
19820885|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
19820886|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820887|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820888|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820889|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
19820890|NCT00531284|Hormones|hormones|mesh-ancestor
19820891|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820892|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19820893|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820894|NCT00531427|Buprenorphine|buprenorphine|mesh-list
19820895|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19820896|NCT00531427|Narcotics|narcotics|mesh-ancestor
19820897|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19820898|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820899|NCT00531427|Analgesics|analgesics|mesh-ancestor
19820900|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
19820901|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820902|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19820903|NCT00531453|Thalidomide|thalidomide|mesh-list
19820904|NCT00531453|Dexamethasone|dexamethasone|mesh-list
19820905|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
19820906|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
19820907|NCT00531453|Bortezomib|bortezomib|mesh-list
19820908|NCT00531453|BB 1101|bb 1101|mesh-list
19820909|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19820910|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
19820911|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820912|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19820913|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19820914|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
19820915|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820916|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19820917|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19820918|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19820919|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
19820920|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
19820921|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19820922|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19820923|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
19820924|NCT00531453|Hormones|hormones|mesh-ancestor
19820925|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820926|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19820927|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
19820928|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820929|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
19820930|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19820931|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820932|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19820933|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19820934|NCT00531453|Growth Substances|growth substances|mesh-ancestor
19820935|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
19820936|NCT00531479|Voriconazole|voriconazole|mesh-list
19820937|NCT00531479|Anidulafungin|anidulafungin|mesh-list
19820938|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
19820939|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19820940|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19820941|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19820942|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820943|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820944|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19820945|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
19820946|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19820947|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820948|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19820949|NCT00531518|Lamotrigine|lamotrigine|mesh-list
19820950|NCT00531518|Aripiprazole|aripiprazole|mesh-list
19820951|NCT00531518|Bupropion|bupropion|mesh-list
19820952|NCT00531518|Fluoxetine|fluoxetine|mesh-list
19820953|NCT00531518|Sertraline|sertraline|mesh-list
19820954|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19820955|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
19820956|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19820957|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19820958|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19820959|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20333534|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20333535|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333536|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333537|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19820960|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820961|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
19820962|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19820963|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19820964|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19820965|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19820966|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820967|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19820968|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19820969|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19820970|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
19820971|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19820972|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19820973|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
19820974|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19820975|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19820976|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19820977|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19820978|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19820979|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
19820980|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19820981|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19820982|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19820983|NCT00531843|PENTA|penta|mesh-list
19820984|NCT00531843|Fondaparinux|fondaparinux|mesh-list
19820985|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19820986|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
19820987|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19820988|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
19820989|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19820990|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19820991|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
19820992|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19820993|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20333538|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20333539|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333540|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333541|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20333542|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333543|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333544|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333545|NCT00784914|Sirolimus|sirolimus|mesh-list
19649230|NCT02341833|Sevoflurane|sevoflurane|mesh-list
19649231|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19649232|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19649233|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
19649234|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
20333546|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20333547|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649235|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649236|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649237|NCT02341963|Ketamine|ketamine|mesh-list
19649238|NCT02341963|Analgesics|analgesics|mesh-ancestor
19820994|NCT00531882|Pioglitazone|pioglitazone|mesh-list
19649239|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
19820995|NCT00531882|Ibuprofen|ibuprofen|mesh-list
19820996|NCT00531882|Simvastatin|simvastatin|mesh-list
19820997|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19820998|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19820999|NCT00531882|Analgesics|analgesics|mesh-ancestor
19821000|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
19821001|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821002|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649240|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333548|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20333549|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649241|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649242|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19821003|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821004|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821005|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19821006|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821007|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821008|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19821009|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19821010|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
19821011|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19821012|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19821013|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19821014|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19821015|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821016|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19821017|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821018|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821019|NCT00531947|Selegiline|selegiline|mesh-list
19821020|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821021|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821022|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19821023|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19821024|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19821025|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821026|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821027|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19821028|NCT00531947|Protective Agents|protective agents|mesh-ancestor
19821029|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821030|NCT00531960|Bevacizumab|bevacizumab|mesh-list
19821031|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19821032|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821033|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821034|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821035|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19649243|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19649244|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
19649245|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
19649246|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649247|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19649248|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19649249|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649250|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649251|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19649252|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19649253|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19649254|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
19649255|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649256|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20333550|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
20333551|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333552|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
20333553|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333554|NCT00784940|Tamoxifen|tamoxifen|mesh-list
19821036|NCT00531960|Growth Substances|growth substances|mesh-ancestor
19821037|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821038|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821039|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19821040|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821041|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821042|NCT00532129|Rituximab|rituximab|mesh-list
19821043|NCT00532129|Chlorambucil|chlorambucil|mesh-list
19821044|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821045|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821046|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
19821047|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821048|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821049|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19821050|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
19821051|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821052|NCT00532155|Dexamethasone|dexamethasone|mesh-list
19821053|NCT00532155|Docetaxel|docetaxel|mesh-list
19821054|NCT00532155|Aflibercept|aflibercept|mesh-list
19821055|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821056|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
19821057|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
19821058|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821059|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821060|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19821061|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
19821062|NCT00532155|Hormones|hormones|mesh-ancestor
19821063|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821064|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19821065|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821066|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
20333555|NCT00784940|Anastrozole|anastrozole|mesh-list
20333556|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20333557|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
20333558|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333559|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333560|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20333561|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333562|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20333563|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20333564|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20333565|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20333566|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20333567|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333568|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333569|NCT00784966|Etanercept|etanercept|mesh-list
20333570|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20333571|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20333572|NCT00784966|Analgesics|analgesics|mesh-ancestor
20333573|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
20333574|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333575|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333576|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20333577|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333578|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20333579|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333580|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
20333581|NCT00785018|Complement C1s|complement c1s|mesh-list
19649257|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19649258|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649259|NCT02341729|Ticagrelor|ticagrelor|mesh-list
19649260|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19649261|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19649262|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19649263|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19649264|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
19649265|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649266|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821067|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
19821068|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
19821069|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821070|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821071|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821072|NCT00532155|Growth Substances|growth substances|mesh-ancestor
19821073|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821074|NCT00532259|Pidilizumab|pidilizumab|mesh-list
19821075|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821076|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821077|NCT00532298|Vaccines|vaccines|mesh-list
19821078|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
19821079|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821080|NCT00532441|Docetaxel|docetaxel|mesh-list
19821081|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19821082|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821083|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
19821084|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19821085|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
19821086|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821087|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19821088|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821089|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19821090|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19821091|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19821092|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821093|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821094|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821095|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821096|NCT00532480|Analgesics|analgesics|mesh-ancestor
19821097|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
19821098|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821099|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821100|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333582|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20333583|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20333584|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
20333585|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333586|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20333587|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333588|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20333589|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19649267|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649268|NCT02341703|Metformin|metformin|mesh-list
19649269|NCT02341703|Pioglitazone|pioglitazone|mesh-list
19649270|NCT02341703|Letrozole|letrozole|mesh-list
19649271|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19649272|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821101|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
19821102|NCT00532493|Prazosin|prazosin|mesh-list
19821103|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19821104|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19821105|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19821106|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19821107|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
19821108|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821109|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821110|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821111|NCT00532779|Naltrexone|naltrexone|mesh-list
19821112|NCT00532779|Bupropion|bupropion|mesh-list
19821113|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19821114|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19821115|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821116|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
19649273|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649274|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19649275|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19649276|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649277|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649278|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19649279|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649280|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821117|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649281|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
19821118|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19821119|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821120|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821121|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19821122|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19821123|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821124|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821125|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
19821126|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821127|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19821128|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19821129|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821130|NCT00532844|Vitamins|vitamins|mesh-list
19821131|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
19821132|NCT00532844|Verapamil|verapamil|mesh-list
19821133|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
19821134|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821135|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
19821136|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821137|NCT00532844|Protective Agents|protective agents|mesh-ancestor
19821138|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19821139|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19821140|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821141|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19821142|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
19821143|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
19821144|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821145|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
19821146|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821147|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821148|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19821149|NCT00532935|Metformin|metformin|mesh-list
19821150|NCT00532935|Pioglitazone|pioglitazone|mesh-list
19821151|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19821152|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19821153|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821154|NCT00532935|Incretins|incretins|mesh-ancestor
19821155|NCT00532935|Hormones|hormones|mesh-ancestor
19821156|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821157|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19821158|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
19821159|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821160|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821161|NCT00532948|Capecitabine|capecitabine|mesh-list
19821162|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821163|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
19821164|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821165|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821166|NCT00533117|Fluoxetine|fluoxetine|mesh-list
19821167|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19821168|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19821169|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821170|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821171|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821172|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
19821173|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821174|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19821175|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821176|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821177|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19821178|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19821179|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821180|NCT00533429|Bevacizumab|bevacizumab|mesh-list
19821181|NCT00533429|Carboplatin|carboplatin|mesh-list
19821182|NCT00533429|Pemetrexed|pemetrexed|mesh-list
19821183|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821184|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821185|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821186|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821187|NCT00533429|Growth Substances|growth substances|mesh-ancestor
19821188|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821189|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821190|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821191|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821192|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19821193|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19821194|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
19821195|NCT00533442|Sirolimus|sirolimus|mesh-list
19821196|NCT00533442|Tacrolimus|tacrolimus|mesh-list
19821197|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821198|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
19821199|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821200|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19821201|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821202|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821203|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19821204|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821205|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19821206|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
19821207|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19821208|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821209|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
19821210|NCT00533507|Vaccines|vaccines|mesh-list
19821211|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19821212|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
19821213|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821214|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19821215|NCT00533546|Protein C|protein c|mesh-list
19821216|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
19821217|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19821218|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19821219|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821220|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821221|NCT00533702|Dacarbazine|dacarbazine|mesh-list
19821222|NCT00533702|Ramucirumab|ramucirumab|mesh-list
19821223|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19821224|NCT00533702|Imidazole|imidazole|mesh-list
19821225|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19821226|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
19821227|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821228|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821229|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
19821230|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821231|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821232|NCT00533845|Bupivacaine|bupivacaine|mesh-list
19821233|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
19821234|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
19821235|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821236|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821237|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
19821238|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821239|NCT00533897|Abatacept|abatacept|mesh-list
19821240|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19821241|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821242|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333590|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333591|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333592|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
20333593|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333594|NCT00785109|Vitamin K|vitamin k|mesh-list
20333595|NCT00785109|Vitamins|vitamins|mesh-ancestor
20333596|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
20333597|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333598|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19821243|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821244|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
19821245|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821246|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821247|NCT00533910|Rifaximin|rifaximin|mesh-list
19821248|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19821249|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821250|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19821251|NCT00533949|Paclitaxel|paclitaxel|mesh-list
20333599|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20333600|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821252|NCT00533949|Carboplatin|carboplatin|mesh-list
19821253|NCT00533949|Cetuximab|cetuximab|mesh-list
19821254|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19821255|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821256|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19821257|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19821258|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19821259|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821260|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821261|NCT00534001|Bupropion|bupropion|mesh-list
19821262|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19821263|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821264|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821265|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19821266|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19821267|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821268|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821269|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
19821270|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821271|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821272|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19821273|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19821274|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821275|NCT00534313|Abatacept|abatacept|mesh-list
19821276|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19821277|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821278|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821279|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821280|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
19821281|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821282|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821283|NCT00534352|Ritonavir|ritonavir|mesh-list
19821284|NCT00534352|Darunavir|darunavir|mesh-list
19821285|NCT00534352|Etravirine|etravirine|mesh-list
19821286|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19821287|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19821288|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
19821289|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821290|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821291|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19821292|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19821293|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
19821294|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821295|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19821296|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19821297|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19821298|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19821299|NCT00534404|Nicotine|nicotine|mesh-list
19821300|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19821301|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
19821302|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821303|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821304|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19821305|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19821306|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
20333601|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
20333602|NCT00785109|Coagulants|coagulants|mesh-ancestor
20333603|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
20333604|NCT00785122|Molgramostim|molgramostim|mesh-list
20333605|NCT00785122|Imiquimod|imiquimod|mesh-list
20333606|NCT00785122|Sargramostim|sargramostim|mesh-list
20333607|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333608|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
20333609|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333610|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333611|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20333612|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
20333613|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333614|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333615|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20333616|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20333617|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
20333618|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
20333619|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20333620|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333621|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
19821307|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821308|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821309|NCT00534417|Capecitabine|capecitabine|mesh-list
19821310|NCT00534417|Fulvestrant|fulvestrant|mesh-list
19821311|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821312|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
19821313|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821314|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821315|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19821316|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19821317|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19821318|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
19821319|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821320|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821321|NCT00534495|Rilonacept|rilonacept|mesh-list
19821322|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821323|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19821324|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821325|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165677|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20165678|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165679|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165680|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19649282|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
19821326|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19821327|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19821328|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821329|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649283|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649284|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649285|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649286|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
19649287|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19649288|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
19649289|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649290|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649291|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649292|NCT02341586|Iron|iron|mesh-list
19649293|NCT02341586|Trace Elements|trace elements|mesh-ancestor
19649294|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
19649295|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649296|NCT02341638|Aspirin|aspirin|mesh-list
19649297|NCT02341638|Itraconazole|itraconazole|mesh-list
19649298|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19649299|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19649300|NCT02341638|Analgesics|analgesics|mesh-ancestor
19649301|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
19649302|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649303|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649304|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19649305|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821330|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19821331|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19821332|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19821333|NCT00534794|Analgesics|analgesics|mesh-ancestor
20333622|NCT00785330|Rituximab|rituximab|mesh-list
20333623|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19649306|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20165681|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20165682|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20165683|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165684|NCT00137696|Vaccines|vaccines|mesh-list
20165685|NCT00137696|Immunologic Factors|immunologic factors|mesh-ancestor
20333624|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649307|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19649308|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649309|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19649310|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19649311|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649312|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
19649313|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
19821334|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
20165686|NCT00137696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165687|NCT00137709|Lamotrigine|lamotrigine|mesh-list
20165688|NCT00137709|Valproic Acid|valproic acid|mesh-list
20165689|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
20165690|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20165691|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20165692|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165693|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20165694|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165695|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20165696|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20165697|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165698|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333625|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
19649314|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649315|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19649316|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19649317|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19649318|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649319|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649320|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19665040|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665041|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665042|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665043|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665044|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665045|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665046|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
19665047|NCT03809533|Velpatasvir|velpatasvir|mesh-list
19665048|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
19665049|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665050|NCT03759366|Eculizumab|eculizumab|mesh-list
19665051|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19665052|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665053|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
19665054|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665055|NCT03649321|Gemcitabine|gemcitabine|mesh-list
19665056|NCT03649321|Paclitaxel|paclitaxel|mesh-list
19665057|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19665058|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19665059|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665060|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
19665061|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
19665062|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665063|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665064|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665065|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
19665066|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
19665067|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665068|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665069|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665070|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
19665071|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665072|NCT03572530|Azacitidine|azacitidine|mesh-list
19665073|NCT03572530|Decitabine|decitabine|mesh-list
19665074|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665075|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
19665076|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665077|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665078|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665079|NCT03481842|Axitinib|axitinib|mesh-list
19665080|NCT03481842|Afatinib|afatinib|mesh-list
19665081|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665082|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665083|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665084|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665085|NCT03466346|Fluoxetine|fluoxetine|mesh-list
19665086|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19665087|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19665088|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19665089|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665090|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821335|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821336|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821337|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821338|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821339|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19821340|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19821341|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19821342|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
19821343|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
19821344|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165699|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20165700|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165701|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
20165702|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165703|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
20165704|NCT00137735|Gabapentin|gabapentin|mesh-list
20165705|NCT00137735|Analgesics|analgesics|mesh-ancestor
20165706|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
19821345|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821346|NCT00534833|Vaccines|vaccines|mesh-list
19821347|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
19821348|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821349|NCT00535002|Yohimbine|yohimbine|mesh-list
19821350|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
19821351|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
19821352|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821353|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821354|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19821355|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19821356|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19821357|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
19821358|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821359|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821360|NCT00535002|Urological Agents|urological agents|mesh-ancestor
19821361|NCT00535132|Risperidone|risperidone|mesh-list
19821362|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19821363|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19821364|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
19821365|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821366|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821367|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821368|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19821369|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19821370|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821371|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821372|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19821373|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
19821374|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19821375|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19821376|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19821377|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19821378|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19821379|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821380|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821381|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821382|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19821383|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19821384|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
19821385|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821386|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821387|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19821388|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19821389|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
19821390|NCT00535288|Mirtazapine|mirtazapine|mesh-list
19821391|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821392|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821393|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821394|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19821395|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
19821396|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
19821397|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821398|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165707|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165708|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821399|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19821400|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19821401|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821402|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19821403|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19821404|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19821405|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
19821406|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19821407|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19821408|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
19821409|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20165709|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
20165710|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20165711|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20165712|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165713|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20165714|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19821410|NCT00535392|Levetiracetam|levetiracetam|mesh-list
19821411|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
19821412|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
19821413|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19821414|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19821415|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821416|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821417|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
19821418|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821419|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821420|NCT00535613|Propofol|propofol|mesh-list
19821421|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19821422|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821423|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821424|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19821425|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
19821426|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
19821427|NCT00535652|Ertapenem|ertapenem|mesh-list
19821428|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19821429|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821430|NCT00535730|Vaccines|vaccines|mesh-list
19821431|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19821432|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
19821433|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821434|NCT00535743|Bromides|bromides|mesh-list
19821435|NCT00535743|Rocuronium|rocuronium|mesh-list
19821436|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
19821437|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19821438|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19821439|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19821440|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649321|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
19649322|NCT02341547|Hematinics|hematinics|mesh-ancestor
19649323|NCT02341352|Fluorides|fluorides|mesh-list
19649324|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
19649325|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
19649326|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19649327|NCT02341352|Antibodies|antibodies|mesh-list
19649328|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
19649329|NCT02341352|Protective Agents|protective agents|mesh-ancestor
19649330|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821441|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834931|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19834932|NCT00598975|Irinotecan|irinotecan|mesh-list
19834933|NCT00598975|Cetuximab|cetuximab|mesh-list
19834934|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
19834935|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19834936|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19834937|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834938|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649331|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
19834939|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834940|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19834941|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19834942|NCT00599053|Azithromycin|azithromycin|mesh-list
20165715|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19834943|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19649332|NCT02341365|Vitamin D|vitamin d|mesh-list
19649333|NCT02341365|Vitamins|vitamins|mesh-ancestor
19821442|NCT00535782|Methotrexate|methotrexate|mesh-list
19821443|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19821444|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
19821445|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19821446|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821447|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821448|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
19821449|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821450|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821451|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
19821452|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821453|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19821454|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821455|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
19821456|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821457|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20333626|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333627|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333628|NCT00785382|Pregabalin|pregabalin|mesh-list
20333629|NCT00785382|Analgesics|analgesics|mesh-ancestor
19821458|NCT00535847|Interferons|interferons|mesh-list
19821459|NCT00535847|Ribavirin|ribavirin|mesh-list
19821460|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
19821461|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
19821462|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19821463|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821464|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
19821465|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821466|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
19821467|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333630|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
20333631|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333632|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333633|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
20333634|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19649334|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
19649335|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649336|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19649337|NCT02341209|Doxycycline|doxycycline|mesh-list
19649338|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19649339|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649340|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
19649341|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19821468|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
19821469|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821470|NCT00535873|Lenalidomide|lenalidomide|mesh-list
20333635|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20333636|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333637|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20333638|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20333639|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20333640|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333641|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333642|NCT00785395|Oxytocin|oxytocin|mesh-list
20333643|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
20333644|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20333645|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333646|NCT00785421|Leucovorin|leucovorin|mesh-list
20333647|NCT00785421|Folic Acid|folic acid|mesh-list
20333648|NCT00785421|Gemcitabine|gemcitabine|mesh-list
20333649|NCT00785421|Cisplatin|cisplatin|mesh-list
19821471|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
19821472|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821473|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821474|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821475|NCT00535873|Growth Substances|growth substances|mesh-ancestor
19821476|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821477|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821478|NCT00535925|Aspirin|aspirin|mesh-list
19821479|NCT00535925|Atenolol|atenolol|mesh-list
19821480|NCT00535925|Amlodipine|amlodipine|mesh-list
19821481|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19649342|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20333650|NCT00785421|Enoxaparin|enoxaparin|mesh-list
19821482|NCT00535925|Clonidine|clonidine|mesh-list
19821483|NCT00535925|Ramipril|ramipril|mesh-list
20333651|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
19821484|NCT00535925|Irbesartan|irbesartan|mesh-list
19821485|NCT00535925|Doxazosin|doxazosin|mesh-list
19821486|NCT00535925|Furosemide|furosemide|mesh-list
19821487|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
19821488|NCT00535925|Simvastatin|simvastatin|mesh-list
19821489|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821490|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19821491|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19821492|NCT00535925|Analgesics|analgesics|mesh-ancestor
19821493|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
19821494|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821495|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821496|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821497|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19821498|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19821499|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821500|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19821501|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19821502|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821503|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
19821504|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19821505|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19821506|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821507|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19821508|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
19821509|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19821510|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19821511|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
19821512|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19821513|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19821514|NCT00535925|Diuretics|diuretics|mesh-ancestor
19821515|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
20333652|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
20333653|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333654|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20333655|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
19821516|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19821517|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19821518|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
19821519|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
19821520|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19821521|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19821522|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19821523|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
19821524|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821525|NCT00535925|Hematinics|hematinics|mesh-ancestor
19821526|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19821527|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
19821528|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19821529|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19821530|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19821531|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19821532|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19821533|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19821534|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19821535|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19821536|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
19821537|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19821538|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19821539|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19821540|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821541|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821542|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
19821543|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821544|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821545|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19821546|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821547|NCT00536107|Docetaxel|docetaxel|mesh-list
19821548|NCT00536107|Gefitinib|gefitinib|mesh-list
19821549|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821550|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19821551|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19821552|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
20333656|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333657|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
20333658|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821553|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821554|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19821555|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821556|NCT00536120|Natalizumab|natalizumab|mesh-list
19821557|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19821558|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
19821559|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821560|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19821561|NCT00536172|Citalopram|citalopram|mesh-list
19821562|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19821563|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19821564|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821565|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821566|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821567|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
19821568|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821569|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19821570|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821571|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821572|NCT00536198|Sertraline|sertraline|mesh-list
19821573|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821574|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821575|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19821576|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19821577|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821578|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821579|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821580|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
19821581|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821582|NCT00536263|Interferons|interferons|mesh-list
19821583|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
19821584|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
19821585|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19821586|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821587|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
19821588|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821589|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
19821590|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821591|NCT00536341|Rituximab|rituximab|mesh-list
19821592|NCT00536341|Fludarabine|fludarabine|mesh-list
19821593|NCT00536341|Lenalidomide|lenalidomide|mesh-list
19821594|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821595|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821596|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
19821597|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821598|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821599|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821600|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821601|NCT00536341|Growth Substances|growth substances|mesh-ancestor
19821602|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821603|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19821604|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19821605|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19821606|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821607|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821608|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821609|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821610|NCT00536471|Analgesics|analgesics|mesh-ancestor
19821611|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
20165716|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165717|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165718|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
20165719|NCT00137761|Docetaxel|docetaxel|mesh-list
20165720|NCT00137761|Gefitinib|gefitinib|mesh-list
20165721|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165722|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
20165723|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
20333659|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821612|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821613|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
20165724|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
20333660|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165725|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165726|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20165727|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165728|NCT00137774|Bevacizumab|bevacizumab|mesh-list
20165729|NCT00137774|Temozolomide|temozolomide|mesh-list
20165730|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20165731|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165732|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20165733|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20333661|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
20333662|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333663|NCT00785421|Antidotes|antidotes|mesh-ancestor
20333664|NCT00785421|Protective Agents|protective agents|mesh-ancestor
20333665|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
20333666|NCT00785421|Vitamins|vitamins|mesh-ancestor
20333667|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
20333668|NCT00785421|Hematinics|hematinics|mesh-ancestor
19649343|NCT02341300|Iron|iron|mesh-list
19649344|NCT02341300|Trace Elements|trace elements|mesh-ancestor
19649345|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
19649346|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649347|NCT02341274|Tacrolimus|tacrolimus|mesh-list
19649348|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649349|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
19649350|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649351|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19649352|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649353|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649354|NCT02341105|Amiodarone|amiodarone|mesh-list
19649355|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19649356|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
19649357|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19649358|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19649359|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649360|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19649361|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19649362|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19649363|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665091|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
19665092|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665093|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19665094|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
19665095|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19665096|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19665097|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19665098|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665099|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19665100|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
19665101|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665102|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
19665103|NCT03237819|Analgesics|analgesics|mesh-ancestor
19665104|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
19665105|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665106|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665107|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
19665108|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665109|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19665110|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
19665111|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19665112|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19665113|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665114|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19665115|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
19665116|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665117|NCT03205956|Levodopa|levodopa|mesh-list
19665118|NCT03205956|Carbidopa|carbidopa|mesh-list
19665119|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19665120|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19665121|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
19665122|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665123|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665124|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665125|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19821614|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821615|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
19821616|NCT00536484|Fesoterodine|fesoterodine|mesh-list
19821617|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19821618|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19821619|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
19821620|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821621|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821622|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821623|NCT00536484|Urological Agents|urological agents|mesh-ancestor
19821624|NCT00536510|Niacin|niacin|mesh-list
19821625|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19821626|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
19821627|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821628|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19821629|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
19821630|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
19821631|NCT00536510|Vitamins|vitamins|mesh-ancestor
19821632|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
19821633|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821634|NCT00536575|Bortezomib|bortezomib|mesh-list
19821635|NCT00536575|Sorafenib|sorafenib|mesh-list
19821636|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821637|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19821638|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821639|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821640|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
19821641|NCT00536601|Melphalan|melphalan|mesh-list
19821642|NCT00536601|Busulfan|busulfan|mesh-list
19821643|NCT00536601|Thiotepa|thiotepa|mesh-list
19821644|NCT00536601|Carmustine|carmustine|mesh-list
19821645|NCT00536601|Carboplatin|carboplatin|mesh-list
19821646|NCT00536601|Etoposide|etoposide|mesh-list
19821647|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
19821648|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821649|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
19821650|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821651|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821652|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19821653|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
19821654|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821655|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821656|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19821657|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19821658|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19821659|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19821660|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821661|NCT00536731|Budesonide|budesonide|mesh-list
19821662|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19821663|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19821664|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
19821665|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821666|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19821667|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
19821668|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821669|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821670|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
19821671|NCT00536731|Hormones|hormones|mesh-ancestor
19821672|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821673|NCT00536809|Capecitabine|capecitabine|mesh-list
19821674|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
19821675|NCT00536809|Lapatinib|lapatinib|mesh-list
19821676|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821677|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
19821678|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821679|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821680|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19821681|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821682|NCT00536874|Gemcitabine|gemcitabine|mesh-list
19821683|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
19821684|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821685|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
19821686|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821687|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821688|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
19821689|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821690|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821691|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821692|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
19821693|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821694|NCT00536913|Budesonide|budesonide|mesh-list
19821695|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
19821696|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19821697|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821698|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19821699|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
19821700|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821701|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821702|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19821703|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
19821704|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
19821705|NCT00536913|Hormones|hormones|mesh-ancestor
19649364|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19649365|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19649366|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19649367|NCT02341079|Bupivacaine|bupivacaine|mesh-list
19649368|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
19649369|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
19649370|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649371|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649372|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
19649373|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649374|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
19821706|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821707|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19821708|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19821709|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19821710|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
19821711|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19821712|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821713|NCT00536939|Paclitaxel|paclitaxel|mesh-list
19821714|NCT00536939|Bevacizumab|bevacizumab|mesh-list
19821715|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19821716|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821717|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
19821718|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
19821719|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
19821720|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821721|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821722|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821723|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821724|NCT00536939|Growth Substances|growth substances|mesh-ancestor
19821725|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821726|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821727|NCT00536991|Calcitriol|calcitriol|mesh-list
19821728|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19821729|NCT00536991|Ketoconazole|ketoconazole|mesh-list
19821730|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
19821731|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19821732|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20165734|NCT00137774|Growth Substances|growth substances|mesh-ancestor
20165735|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165736|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
20165737|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20165738|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
20165739|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165740|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
20165741|NCT00137787|Cefepime|cefepime|mesh-list
20165742|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165743|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165744|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165745|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165746|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165747|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165748|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165749|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20165750|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19821733|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19821734|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821735|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
19821736|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821737|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19821738|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19821739|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821740|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821741|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19821742|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
19821743|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821744|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821745|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19821746|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19821747|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19821748|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821749|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19821750|NCT00536991|Vitamins|vitamins|mesh-ancestor
19821751|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
19821752|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19821753|NCT00537017|Levodopa|levodopa|mesh-list
19821754|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19821755|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19821756|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
19821757|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333669|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
20333670|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20333671|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20333672|NCT00785434|Citalopram|citalopram|mesh-list
20333673|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20333674|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20333675|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20333676|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834944|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165751|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20165752|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165753|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20165754|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165755|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165756|NCT00137813|Bevacizumab|bevacizumab|mesh-list
20165757|NCT00137813|Docetaxel|docetaxel|mesh-list
20165758|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20333677|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333678|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
20333679|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333680|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20333681|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
20333682|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333683|NCT00785460|Benphothiamine|benphothiamine|mesh-list
20333684|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20333685|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
20333686|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165759|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165760|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20333687|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
20333688|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
20333689|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333690|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
20333691|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
20333692|NCT00785473|Calcium|calcium|mesh-list
20333693|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20333694|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333695|NCT00785473|Vitamins|vitamins|mesh-ancestor
20333696|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
19665126|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665127|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
19665128|NCT03149029|Trametinib|trametinib|mesh-list
19665129|NCT03149029|Dabrafenib|dabrafenib|mesh-list
19665130|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665131|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665132|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665133|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665134|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665135|NCT03139916|Temozolomide|temozolomide|mesh-list
19665136|NCT03139916|Bavituximab|bavituximab|mesh-list
19665137|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19821758|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821759|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821760|NCT00537030|Asparaginase|asparaginase|mesh-list
19821761|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821762|NCT00537056|Sunitinib|sunitinib|mesh-list
19821763|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19821764|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821765|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821766|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821767|NCT00537056|Growth Substances|growth substances|mesh-ancestor
19821768|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821769|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821770|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19821771|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821772|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821773|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19821774|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19821775|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19821776|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821777|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821778|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
19821779|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821780|NCT00537238|Pregabalin|pregabalin|mesh-list
19821781|NCT00537238|Levetiracetam|levetiracetam|mesh-list
20165761|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20165762|NCT00137813|Growth Substances|growth substances|mesh-ancestor
20165763|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821782|NCT00537238|Analgesics|analgesics|mesh-ancestor
19821783|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
19821784|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821785|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821786|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
19821787|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19821788|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821789|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821790|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19821791|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19821792|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19821793|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821794|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821795|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
19821796|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
19821797|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
19821798|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19821799|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19821800|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821801|NCT00537290|Rituximab|rituximab|mesh-list
19821802|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821803|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821804|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
19821805|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821806|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821807|NCT00537303|Insulin|insulin|mesh-list
19821808|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19821809|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
19821810|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
19821811|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19821812|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
19821813|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19821814|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821815|NCT00537316|Azathioprine|azathioprine|mesh-list
19821816|NCT00537316|Infliximab|infliximab|mesh-list
19821817|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
19821818|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19821819|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19821820|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
19821821|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821822|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821823|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821824|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821825|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
19821826|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821827|NCT00537329|Anidulafungin|anidulafungin|mesh-list
20165764|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
20333697|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20333698|NCT00785473|Antacids|antacids|mesh-ancestor
20333699|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333700|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19821828|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
19821829|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821830|NCT00537381|Prednisone|prednisone|mesh-list
19821831|NCT00537381|Docetaxel|docetaxel|mesh-list
19821832|NCT00537381|Intetumumab|intetumumab|mesh-list
19821833|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821834|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
19821835|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
20333701|NCT00785551|Quinine|quinine|mesh-list
20333702|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
20333703|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19821836|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
19821837|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821838|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19821839|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
19821840|NCT00537381|Hormones|hormones|mesh-ancestor
19821841|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821842|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821843|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19821844|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821845|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
19821846|NCT00537394|Maraviroc|maraviroc|mesh-list
19821847|NCT00537394|Darunavir|darunavir|mesh-list
19821848|NCT00537394|Tipranavir|tipranavir|mesh-list
19821849|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
19821850|NCT00537394|Etravirine|etravirine|mesh-list
19821851|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19821852|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19821853|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
19821854|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821855|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19821856|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19821857|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821858|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821859|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19821860|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19821861|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19821862|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19821863|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19821864|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
19821865|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19821866|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19821867|NCT00537407|Ribavirin|ribavirin|mesh-list
19821868|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19821869|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
19821870|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821871|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
19821872|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19821873|NCT00537511|Etoposide|etoposide|mesh-list
19821874|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
19821875|NCT00537511|Pomalidomide|pomalidomide|mesh-list
19834945|NCT00599196|Rotigotine|rotigotine|mesh-list
20333704|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20333705|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333706|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19665138|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
19665139|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665140|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665141|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665142|NCT03019003|Durvalumab|durvalumab|mesh-list
19665143|NCT03019003|Decitabine|decitabine|mesh-list
19665144|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665145|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665146|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665147|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
19665148|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665149|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821876|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821877|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19821878|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19821879|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19821880|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821881|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821882|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
19821883|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821884|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821885|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821886|NCT00537511|Growth Substances|growth substances|mesh-ancestor
19821887|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821888|NCT00537680|Ubiquinone|ubiquinone|mesh-list
19821889|NCT00537680|Idebenone|idebenone|mesh-list
19821890|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
19821891|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821892|NCT00537680|Protective Agents|protective agents|mesh-ancestor
19821893|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821894|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
20333707|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333708|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20333709|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333710|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20333711|NCT00785551|Analgesics|analgesics|mesh-ancestor
20333712|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
20333713|NCT00785603|Tramadol|tramadol|mesh-list
20333714|NCT00785603|Paroxetine|paroxetine|mesh-list
20333715|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20333716|NCT00785603|Narcotics|narcotics|mesh-ancestor
20333717|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333718|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333719|NCT00785603|Analgesics|analgesics|mesh-ancestor
20333720|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
20333721|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333722|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20333723|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20333724|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20333725|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333726|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333727|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
20333728|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20333729|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
20333730|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333731|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20333732|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20333733|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348067|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348068|NCT00863460|Cytarabine|cytarabine|mesh-list
20348069|NCT00863460|Prednisone|prednisone|mesh-list
20348070|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
20348071|NCT00863460|Busulfan|busulfan|mesh-list
20348072|NCT00863460|Thiotepa|thiotepa|mesh-list
20348073|NCT00863460|Carmustine|carmustine|mesh-list
20348074|NCT00863460|Methotrexate|methotrexate|mesh-list
20348075|NCT00863460|Etoposide|etoposide|mesh-list
20348076|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20348077|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
20348078|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348079|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348080|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20348081|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
19821895|NCT00537745|Naltrexone|naltrexone|mesh-list
19821896|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19821897|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19821898|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821899|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
19821900|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821901|NCT00537771|Tamoxifen|tamoxifen|mesh-list
19821902|NCT00537771|Anastrozole|anastrozole|mesh-list
19821903|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19821904|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
20348082|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348083|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348084|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20348085|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834946|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
20333734|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
20333735|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20333736|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20333737|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333738|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333739|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333740|NCT00785863|Ketorolac|ketorolac|mesh-list
19821905|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19821906|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821907|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19821908|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821909|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19821910|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20333741|NCT00785863|Parecoxib|parecoxib|mesh-list
20333742|NCT00785863|Remifentanil|remifentanil|mesh-list
20333743|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19649375|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19649376|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19649377|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
19821911|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19821912|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19821913|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19821914|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821915|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821916|NCT00537810|Sibutramine|sibutramine|mesh-list
19821917|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
19821918|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821919|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
19821920|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19821921|NCT00537823|Leucovorin|leucovorin|mesh-list
19821922|NCT00537823|Bevacizumab|bevacizumab|mesh-list
19821923|NCT00537823|Cetuximab|cetuximab|mesh-list
19821924|NCT00537823|Fluorouracil|fluorouracil|mesh-list
19821925|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
19821926|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821927|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821928|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19821929|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19821930|NCT00537823|Growth Substances|growth substances|mesh-ancestor
19821931|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821932|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
19821933|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
19821934|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821935|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821936|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19821937|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
19821938|NCT00537823|Antidotes|antidotes|mesh-ancestor
19821939|NCT00537823|Protective Agents|protective agents|mesh-ancestor
19821940|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
19821941|NCT00537823|Vitamins|vitamins|mesh-ancestor
19821942|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
19821943|NCT00537940|Pregabalin|pregabalin|mesh-list
19821944|NCT00537940|Gabapentin|gabapentin|mesh-list
19821945|NCT00537940|Analgesics|analgesics|mesh-ancestor
19821946|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
19821947|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19821948|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821949|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
19821950|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19821951|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19821952|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821953|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19821954|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19821955|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19821956|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649378|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649379|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649380|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649381|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
19649382|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
19821957|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19821958|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19821959|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19821960|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333744|NCT00785863|Narcotics|narcotics|mesh-ancestor
19821961|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
19821962|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
19821963|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19821964|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821965|NCT00537979|Vitamins|vitamins|mesh-ancestor
19821966|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
19821967|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19821968|NCT00538291|Capecitabine|capecitabine|mesh-list
19821969|NCT00538291|Cetuximab|cetuximab|mesh-list
19821970|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19821971|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
19821972|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821973|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821974|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19821975|NCT00538304|Bimatoprost|bimatoprost|mesh-list
19821976|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19821977|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19821978|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19821979|NCT00538434|Reslizumab|reslizumab|mesh-list
19821980|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19821981|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
19821982|NCT00538590|Mitomycins|mitomycins|mesh-list
19821983|NCT00538590|Mitomycin|mitomycin|mesh-list
19821984|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19821985|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19821986|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
19821987|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19821988|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19821989|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19821990|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
19821991|NCT00538616|Propofol|propofol|mesh-list
19821992|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19821993|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19821994|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19821995|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19821996|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
19821997|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
19821998|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19821999|NCT00538616|Analgesics|analgesics|mesh-ancestor
19822000|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
19822001|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822002|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19822003|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19822004|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19822005|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
19822006|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822007|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822008|NCT00538642|Ziprasidone|ziprasidone|mesh-list
19822009|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20333745|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333746|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333747|NCT00785863|Analgesics|analgesics|mesh-ancestor
20333748|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
20333749|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333750|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19822010|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
19822011|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822012|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822013|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822014|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19822015|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19822016|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20165765|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
20165766|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165767|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
20165768|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165769|NCT00137826|Bevacizumab|bevacizumab|mesh-list
20165770|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20165771|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20165772|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822017|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19822018|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19822019|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
20165773|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822020|NCT00538681|Pemetrexed|pemetrexed|mesh-list
19822021|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822022|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822023|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822024|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19822025|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19822026|NCT00538733|Clarithromycin|clarithromycin|mesh-list
19822027|NCT00538733|Thalidomide|thalidomide|mesh-list
19822028|NCT00538733|Dexamethasone|dexamethasone|mesh-list
19822029|NCT00538733|Lenalidomide|lenalidomide|mesh-list
19822030|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822031|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
19822032|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
19822033|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822034|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822035|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822036|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
19822037|NCT00538733|Hormones|hormones|mesh-ancestor
19822038|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822039|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19822040|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822041|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
19822042|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822043|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822044|NCT00538733|Growth Substances|growth substances|mesh-ancestor
19822045|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822046|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822047|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822048|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19822049|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822050|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822051|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19822052|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19822053|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822054|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
19822055|NCT00538785|Palivizumab|palivizumab|mesh-list
19822056|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
19822057|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333751|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20333752|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20333753|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333754|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20333755|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333756|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333757|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20333758|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20333759|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
20333760|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333761|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20333762|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
19822058|NCT00538824|Thalidomide|thalidomide|mesh-list
19822059|NCT00538824|Dexamethasone|dexamethasone|mesh-list
19822060|NCT00538824|Lenalidomide|lenalidomide|mesh-list
19822061|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822062|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
19822063|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
19822064|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822065|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822066|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822067|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
19822068|NCT00538824|Hormones|hormones|mesh-ancestor
19822069|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822070|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19822071|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822072|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
19822073|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822074|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822075|NCT00538824|Growth Substances|growth substances|mesh-ancestor
19822076|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822077|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822078|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
19822079|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822080|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822081|NCT00538850|Fentanyl|fentanyl|mesh-list
19822082|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19822083|NCT00538850|Narcotics|narcotics|mesh-ancestor
19822084|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19822085|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822086|NCT00538850|Analgesics|analgesics|mesh-ancestor
19822087|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
19822088|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822089|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19822090|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19822091|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
19822092|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
19822093|NCT00538863|Fentanyl|fentanyl|mesh-list
19822094|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19822095|NCT00538863|Narcotics|narcotics|mesh-ancestor
19822096|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19822097|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822098|NCT00538863|Analgesics|analgesics|mesh-ancestor
19822099|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
19822100|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822101|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19822102|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19822103|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
19822104|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
19822105|NCT00538902|Adalimumab|adalimumab|mesh-list
19822106|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822107|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19822108|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
19822109|NCT00538915|Antibodies|antibodies|mesh-list
19822110|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
19822111|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19822112|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19822113|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
20333763|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333764|NCT00786058|Fluorouracil|fluorouracil|mesh-list
20333765|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
20333766|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333767|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20333768|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165774|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20165775|NCT00137826|Growth Substances|growth substances|mesh-ancestor
20165776|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165777|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
20165778|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20165779|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165780|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165781|NCT00137852|Celecoxib|celecoxib|mesh-list
20165782|NCT00137852|Irinotecan|irinotecan|mesh-list
20165783|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165784|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20165785|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165786|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165787|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165788|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20165789|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20333769|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333770|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
19822114|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822115|NCT00539006|Fluticasone|fluticasone|mesh-list
19822116|NCT00539006|Xhance|xhance|mesh-list
19822117|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822118|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20333771|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333772|NCT00786110|Paclitaxel|paclitaxel|mesh-list
20333773|NCT00786110|Sorafenib|sorafenib|mesh-list
20333774|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20333775|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333776|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
20333777|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19649383|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649384|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
19649385|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19649386|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
19649387|NCT02340936|Lenalidomide|lenalidomide|mesh-list
19649388|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
19649389|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649390|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822119|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
19822120|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834947|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
19822121|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822122|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19822123|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
19822124|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
19822125|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19822126|NCT00539032|Vaccines|vaccines|mesh-list
19822127|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
19822128|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822129|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
19822130|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19822131|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
19822132|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822133|NCT00539188|Expectorants|expectorants|mesh-ancestor
19822134|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
19822135|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19822136|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
19822137|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822138|NCT00539188|Protective Agents|protective agents|mesh-ancestor
19822139|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822140|NCT00539188|Antidotes|antidotes|mesh-ancestor
19822141|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
19822142|NCT00539240|Nortriptyline|nortriptyline|mesh-list
19822143|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
19822144|NCT00539240|Rabeprazole|rabeprazole|mesh-list
19822145|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19822146|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822147|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19822148|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333778|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
20333779|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333780|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333781|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165790|NCT00137852|Analgesics|analgesics|mesh-ancestor
20165791|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
19822149|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822150|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19822151|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19822152|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19822153|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19822154|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19822155|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822156|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333782|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20333783|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20333784|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20333785|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
20333786|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333787|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20333788|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20333789|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822157|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
19822158|NCT00539305|Testosterone|testosterone|mesh-list
19822159|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
19822160|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
19822161|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20165792|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165793|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165794|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20165795|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20165796|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20165797|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20165798|NCT00137995|Cytarabine|cytarabine|mesh-list
20165799|NCT00137995|Dexamethasone|dexamethasone|mesh-list
20165800|NCT00137995|Rituximab|rituximab|mesh-list
20333790|NCT00786149|Varenicline|varenicline|mesh-list
20333791|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20333792|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20333793|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
20333794|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333795|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333796|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165801|NCT00137995|Etoposide|etoposide|mesh-list
20165802|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
19822162|NCT00539305|Androgens|androgens|mesh-ancestor
19822163|NCT00539305|Hormones|hormones|mesh-ancestor
20165803|NCT00137995|Melphalan|melphalan|mesh-list
20165804|NCT00137995|Ifosfamide|ifosfamide|mesh-list
19822164|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822165|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822166|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19822167|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822168|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
19822169|NCT00539500|Carboplatin|carboplatin|mesh-list
19822170|NCT00539500|Etoposide|etoposide|mesh-list
19822171|NCT00539500|Melphalan|melphalan|mesh-list
19649391|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19649392|NCT02340936|Growth Substances|growth substances|mesh-ancestor
20333797|NCT00786240|Fesoterodine|fesoterodine|mesh-list
20333798|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19822172|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822173|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822174|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19822175|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19822176|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822177|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822178|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19822179|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
19822180|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19822181|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822182|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
19822183|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822184|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
19822185|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19822186|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
19822187|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822188|NCT00539513|Expectorants|expectorants|mesh-ancestor
19822189|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
19822190|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19822191|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
19822192|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822193|NCT00539513|Protective Agents|protective agents|mesh-ancestor
19822194|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822195|NCT00539513|Antidotes|antidotes|mesh-ancestor
19822196|NCT00539526|Bimatoprost|bimatoprost|mesh-list
19822197|NCT00539526|Travoprost|travoprost|mesh-list
19822198|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20165805|NCT00137995|Carboplatin|carboplatin|mesh-list
20165806|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19649393|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
19649394|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649395|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
19649396|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
19649397|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649398|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649399|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19649400|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19649401|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19649402|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19649403|NCT02340988|Oritavancin|oritavancin|mesh-list
19649404|NCT02340988|Warfarin|warfarin|mesh-list
19649405|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
19649406|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19649407|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649408|NCT02340455|Pregabalin|pregabalin|mesh-list
19649409|NCT02340455|Analgesics|analgesics|mesh-ancestor
19649410|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
19649411|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165807|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165808|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
20165809|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165810|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19822199|NCT00539526|Latanoprost|latanoprost|mesh-list
19822200|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19822201|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19822202|NCT00539695|Aldesleukin|aldesleukin|mesh-list
19822203|NCT00539695|Interleukin-2|interleukin-2|mesh-list
19822204|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822205|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19822206|NCT00539695|Analgesics|analgesics|mesh-ancestor
19822207|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
19822208|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822209|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822210|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19822211|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19822212|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
19822213|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822214|NCT00539734|Ranibizumab|ranibizumab|mesh-list
19822215|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822216|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822217|NCT00539734|Growth Substances|growth substances|mesh-ancestor
19822218|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822219|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822220|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822221|NCT00539864|Vaccines|vaccines|mesh-list
19822222|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
19822223|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
19822224|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822225|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
19822226|NCT00539942|PENTA|penta|mesh-list
19822227|NCT00539942|Fondaparinux|fondaparinux|mesh-list
19822228|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19822229|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
19822230|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19822231|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
19822232|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822233|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822234|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
19822235|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19822236|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19822237|NCT00539994|Retapamulin|retapamulin|mesh-list
19822238|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822239|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822240|NCT00540007|Lenalidomide|lenalidomide|mesh-list
19822241|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
19822242|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822243|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822244|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822245|NCT00540007|Growth Substances|growth substances|mesh-ancestor
19822246|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822247|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822248|NCT00540046|Copper|copper|mesh-list
19822249|NCT00540046|Trace Elements|trace elements|mesh-ancestor
19822250|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
19822251|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822252|NCT00540124|Tadalafil|tadalafil|mesh-list
20348086|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
19822253|NCT00540124|Tamsulosin|tamsulosin|mesh-list
19822254|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
19822255|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19822256|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20165811|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822257|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822258|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822259|NCT00540124|Urological Agents|urological agents|mesh-ancestor
20165812|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
20333799|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20333800|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
20333801|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333802|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333803|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333804|NCT00786240|Urological Agents|urological agents|mesh-ancestor
20333805|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20333806|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
20333807|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20333808|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20333809|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333810|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333811|NCT00786253|Urological Agents|urological agents|mesh-ancestor
19822260|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19822261|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19822262|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19822263|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
19822264|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822265|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822266|NCT00540293|Atorvastatin|atorvastatin|mesh-list
19822267|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19822268|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19822269|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
19822270|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822271|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19822272|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19822273|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822274|NCT00540436|Ambrisentan|ambrisentan|mesh-list
19822275|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19822276|NCT00540449|Efavirenz|efavirenz|mesh-list
19822277|NCT00540449|Rilpivirine|rilpivirine|mesh-list
19822278|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19822279|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19822280|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822281|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822282|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
19822283|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822284|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19822285|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19822286|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20333812|NCT00786279|Ethanol|ethanol|mesh-list
20333813|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20333814|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333815|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333816|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333817|NCT00786305|Amikacin|amikacin|mesh-list
20333818|NCT00786305|Ceftazidime|ceftazidime|mesh-list
20333819|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20333820|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333821|NCT00786318|Ziprasidone|ziprasidone|mesh-list
20333822|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20333823|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
20333824|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333825|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333826|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333827|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20333828|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20333829|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333830|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333831|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20333832|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
20333833|NCT00786331|Carboplatin|carboplatin|mesh-list
20333834|NCT00786331|Pemetrexed|pemetrexed|mesh-list
20333835|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649412|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649413|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
19649414|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19649415|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19649416|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649417|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19649418|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19649419|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19822287|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19649420|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649421|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19649422|NCT02340481|Simethicone|simethicone|mesh-list
19649423|NCT02340481|Loperamide|loperamide|mesh-list
20333836|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333837|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333838|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20333839|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20333840|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
20333841|NCT00786370|Propofol|propofol|mesh-list
20333842|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20333843|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20333844|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822288|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19822289|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19822290|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19822291|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19822292|NCT00540514|Paclitaxel|paclitaxel|mesh-list
19822293|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19822294|NCT00540514|Carboplatin|carboplatin|mesh-list
19822295|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822296|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822297|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
19822298|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822299|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822300|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822301|NCT00540579|Gemcitabine|gemcitabine|mesh-list
19822302|NCT00540579|Pomalidomide|pomalidomide|mesh-list
19822303|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19822304|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
19822305|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822306|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822307|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
19822308|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822309|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822310|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822311|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
19822312|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822313|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822314|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822315|NCT00540579|Growth Substances|growth substances|mesh-ancestor
19649424|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
19649425|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822316|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822317|NCT00540644|Prednisone|prednisone|mesh-list
20333845|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20333846|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
20333847|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
20333848|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20333849|NCT00786370|Analgesics|analgesics|mesh-ancestor
20333850|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
20333851|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20333852|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20333853|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20333854|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20333855|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
20333856|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333857|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333858|NCT00786383|Ramucirumab|ramucirumab|mesh-list
20333859|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333860|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20333861|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
20333862|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649426|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
19649427|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649428|NCT02340481|Emollients|emollients|mesh-ancestor
19649429|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
19649430|NCT02340611|Olaparib|olaparib|mesh-list
19649431|NCT02340611|Cediranib|cediranib|mesh-list
19649432|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19649433|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649434|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822318|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
19822319|NCT00540644|Lenalidomide|lenalidomide|mesh-list
20333863|NCT00786448|Darifenacin|darifenacin|mesh-list
19822320|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822321|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
19822322|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822323|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19822324|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19822325|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
19822326|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822327|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822328|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19822329|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822330|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
20165813|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
20165814|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20165815|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20165816|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
20165817|NCT00137995|Hormones|hormones|mesh-ancestor
19822331|NCT00540644|Hormones|hormones|mesh-ancestor
19822332|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822333|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19822334|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822335|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822336|NCT00540644|Growth Substances|growth substances|mesh-ancestor
19822337|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822338|NCT00540722|Acetic Acid|acetic acid|mesh-list
19822339|NCT00540722|Retinol acetate|retinol acetate|mesh-list
19822340|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
19822341|NCT00540722|Gossypol|gossypol|mesh-list
19822342|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822343|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822344|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19822345|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
19822346|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822347|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19822348|NCT00540722|Protective Agents|protective agents|mesh-ancestor
19822349|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822350|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19822351|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
19822352|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19822353|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822354|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19822355|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19822356|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19822357|NCT00540982|Vinorelbine|vinorelbine|mesh-list
19822358|NCT00540982|Lidocaine|lidocaine|mesh-list
19822359|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19822360|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
20165818|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20165819|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20165820|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20165821|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165822|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165823|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165824|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333864|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20333865|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20333866|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
20333867|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822361|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19822362|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333868|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333869|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649435|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649436|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19649437|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
19649438|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19649439|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19649440|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649441|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649442|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649443|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
19649444|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19649445|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19822363|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
20333870|NCT00786448|Urological Agents|urological agents|mesh-ancestor
20333871|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
20333872|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20333873|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333874|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
20333875|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20333876|NCT00786552|Paclitaxel|paclitaxel|mesh-list
20333877|NCT00786552|Pemetrexed|pemetrexed|mesh-list
20333878|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20333879|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333880|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
20333881|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
20333882|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
20333883|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333884|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333885|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20333886|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20333887|NCT00786669|Cefixime|cefixime|mesh-list
20333888|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
20333889|NCT00786669|Bevacizumab|bevacizumab|mesh-list
20333890|NCT00786669|Irinotecan|irinotecan|mesh-list
20333891|NCT00786669|Vincristine|vincristine|mesh-list
20333892|NCT00786669|Temozolomide|temozolomide|mesh-list
20333893|NCT00786669|Camptothecin|camptothecin|mesh-list
20333894|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20333895|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333896|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20333897|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20333898|NCT00786669|Growth Substances|growth substances|mesh-ancestor
20333899|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333900|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
20333901|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20333902|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20333903|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333904|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333905|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822364|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822365|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19822366|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19822367|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19822368|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19822369|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822370|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822371|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822372|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19822373|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822374|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822375|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
19649446|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
19649447|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822376|NCT00541034|Rituximab|rituximab|mesh-list
19822377|NCT00541034|Pentostatin|pentostatin|mesh-list
19822378|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822379|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
19822380|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822381|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19822382|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19822383|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
19822384|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822385|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822386|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19822387|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19649448|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649449|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649450|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
19649451|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
19649452|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649453|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
19649454|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19649455|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
20333906|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
20333907|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
20333908|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
20333909|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20333910|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
20333911|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20333912|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333913|NCT00786695|Esomeprazole|esomeprazole|mesh-list
20333914|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20333915|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20333916|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20333917|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333918|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822388|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19822389|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333919|NCT00786734|Pitavastatin|pitavastatin|mesh-list
20333920|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20333921|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20333922|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19834948|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19834949|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834950|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834951|NCT00599313|Sunitinib|sunitinib|mesh-list
19834952|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19834953|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19834954|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19834955|NCT00599313|Growth Substances|growth substances|mesh-ancestor
19834956|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834957|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
19834958|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19834959|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834960|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834961|NCT00599326|Deferasirox|deferasirox|mesh-list
19834962|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19834963|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
19834964|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
20165825|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165826|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
20165827|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
20165828|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165829|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165830|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20165831|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
20165832|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20165833|NCT00138060|Fluorouracil|fluorouracil|mesh-list
20165834|NCT00138060|Irinotecan|irinotecan|mesh-list
20165835|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
20165836|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165837|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165838|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165839|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165840|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
20165841|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165842|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20165843|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165844|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165845|NCT00138099|Dalteparin|dalteparin|mesh-list
20165846|NCT00138099|Tinzaparin|tinzaparin|mesh-list
20165847|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20165848|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
20165849|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20165850|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20165851|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165852|NCT00138112|Vancomycin|vancomycin|mesh-list
20165853|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20333923|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
19649456|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19649457|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19649458|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19649459|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19649460|NCT02340247|Cathartics|cathartics|mesh-ancestor
19649461|NCT02340117|Gemcitabine|gemcitabine|mesh-list
19649462|NCT02340117|Paclitaxel|paclitaxel|mesh-list
19649463|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19649464|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19649465|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822390|NCT00541099|Bevacizumab|bevacizumab|mesh-list
19822391|NCT00541099|Docetaxel|docetaxel|mesh-list
19822392|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19822393|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822394|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822395|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822396|NCT00541099|Growth Substances|growth substances|mesh-ancestor
19822397|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822398|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822399|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
19822400|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822401|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822402|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822403|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19822404|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19822405|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822406|NCT00541229|Incretins|incretins|mesh-ancestor
19822407|NCT00541229|Hormones|hormones|mesh-ancestor
19822408|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822409|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19822410|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
19822411|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822412|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822413|NCT00541242|Bimatoprost|bimatoprost|mesh-list
19822414|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19822415|NCT00541242|Latanoprost|latanoprost|mesh-list
19822416|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19822417|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19822418|NCT00541307|Heparin|heparin|mesh-list
19822419|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
19822420|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19822421|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19822422|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822423|NCT00541346|Methylphenidate|methylphenidate|mesh-list
19822424|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19822425|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822426|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19822427|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19822428|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19822429|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822430|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
19822431|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822432|NCT00541385|Artesunate|artesunate|mesh-list
19822433|NCT00541385|Lumefantrine|lumefantrine|mesh-list
19822434|NCT00541385|Pyronaridine|pyronaridine|mesh-list
19822435|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
20333924|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333925|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333926|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20333927|NCT00786851|Lenalidomide|lenalidomide|mesh-list
20333928|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
20333929|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333930|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20333931|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20333932|NCT00786851|Growth Substances|growth substances|mesh-ancestor
20333933|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
20333934|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333935|NCT00787007|Equol|equol|mesh-list
20333936|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
20333937|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20333938|NCT00787007|Estrogens|estrogens|mesh-ancestor
19649466|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
19649467|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
19649468|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
19649469|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649470|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649471|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
19649472|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
19649473|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649474|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649475|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822436|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20333939|NCT00787007|Hormones|hormones|mesh-ancestor
19649476|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
19822437|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20348087|NCT00863460|Hormones|hormones|mesh-ancestor
19822438|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822439|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822440|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
19822441|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
19822442|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19822443|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
19822444|NCT00541450|Metformin|metformin|mesh-list
19822445|NCT00541450|Pioglitazone|pioglitazone|mesh-list
19822446|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19822447|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19822448|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822449|NCT00541450|Incretins|incretins|mesh-ancestor
19822450|NCT00541450|Hormones|hormones|mesh-ancestor
19822451|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822452|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19822453|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
19822454|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822455|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822456|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
19822457|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
19822458|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19822459|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19822460|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822461|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19822462|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822463|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19822464|NCT00541671|Promethazine|promethazine|mesh-list
19822465|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
19822466|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
19822467|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19822468|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
19822469|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
19822470|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822471|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822472|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333940|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20333941|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333942|NCT00787111|Fluoxetine|fluoxetine|mesh-list
20333943|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20333944|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20333945|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20333946|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333947|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333948|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
20333949|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333950|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20333951|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
20333952|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20333953|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20333954|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20333955|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333956|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20333957|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
20333958|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
20333959|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333960|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
19649477|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649478|NCT02340182|Metronidazole|metronidazole|mesh-list
19649479|NCT02340182|Vancomycin|vancomycin|mesh-list
19649480|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
19649481|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649482|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19649483|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19649484|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19649485|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19649486|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19649487|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649488|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649489|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649490|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19649491|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19822473|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19822474|NCT00541775|Metformin|metformin|mesh-list
19822475|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19822476|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
19822477|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19822478|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822479|NCT00541775|Incretins|incretins|mesh-ancestor
19822480|NCT00541775|Hormones|hormones|mesh-ancestor
19822481|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822482|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19822483|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
19822484|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822485|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822486|NCT00541866|Cytarabine|cytarabine|mesh-list
19822487|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19822488|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
19822489|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822490|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822491|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
19822492|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822493|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822494|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
19822495|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822496|NCT00541970|Vaccines|vaccines|mesh-list
19822497|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
19822498|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822499|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19822500|NCT00542178|Simvastatin|simvastatin|mesh-list
19822501|NCT00542178|Fenofibrate|fenofibrate|mesh-list
19822502|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20333961|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333962|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
20333963|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333964|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333965|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333966|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333967|NCT00787410|Gefitinib|gefitinib|mesh-list
20333968|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20333969|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20333970|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20333971|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333972|NCT00787436|Thalidomide|thalidomide|mesh-list
20333973|NCT00787436|Timolol|timolol|mesh-list
19822503|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19822504|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
19822505|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822506|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19822507|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19822508|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822509|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822510|NCT00542191|Paclitaxel|paclitaxel|mesh-list
19822511|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
19822512|NCT00542191|Carboplatin|carboplatin|mesh-list
19822513|NCT00542191|Doxorubicin|doxorubicin|mesh-list
19822514|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822515|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822516|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
19822517|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822518|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822519|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333974|NCT00787436|Propranolol|propranolol|mesh-list
20333975|NCT00787436|Nadolol|nadolol|mesh-list
19822520|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822521|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
20333976|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20333977|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
20333978|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333979|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
20333980|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20333981|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20333982|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20333983|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20333984|NCT00787436|Growth Substances|growth substances|mesh-ancestor
19822522|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333985|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822523|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20333986|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822524|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19822525|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
19822526|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19822527|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19822528|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19822529|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19822530|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822531|NCT00542269|Amlodipine|amlodipine|mesh-list
19822532|NCT00542269|Ramipril|ramipril|mesh-list
19822533|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19649492|NCT02340169|Desoximetasone|desoximetasone|mesh-list
19649493|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19649494|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
19649495|NCT02340169|Hormones|hormones|mesh-ancestor
19649496|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649497|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649498|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19649499|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
19649500|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19649501|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19649502|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19649503|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
19649504|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649505|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649506|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19649507|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19649508|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19649509|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19822534|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19822535|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19822536|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822537|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19822538|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822539|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
19822540|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19822541|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
19822542|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822543|NCT00542308|Zalutumumab|zalutumumab|mesh-list
19822544|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19822545|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822546|NCT00542425|Teriparatide|teriparatide|mesh-list
19822547|NCT00542425|Abaloparatide|abaloparatide|mesh-list
19822548|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
20333987|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20333988|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20333989|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
20333990|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20333991|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20333992|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20333993|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20333994|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
20333995|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
20333996|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
19822549|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19822550|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822551|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19822552|NCT00542620|Insulin|insulin|mesh-list
19822553|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19822554|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
19822555|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
19822556|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19822557|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
19822558|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19822559|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822560|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
19822561|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19822562|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
19822563|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822564|NCT00542750|Expectorants|expectorants|mesh-ancestor
19822565|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
19822566|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20333997|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822567|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
20333998|NCT00787462|Pregabalin|pregabalin|mesh-list
19822568|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822569|NCT00542750|Protective Agents|protective agents|mesh-ancestor
19822570|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822571|NCT00542750|Antidotes|antidotes|mesh-ancestor
19822572|NCT00542789|Esomeprazole|esomeprazole|mesh-list
19822573|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19822574|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822575|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19822576|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822577|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822578|NCT00542815|Sevelamer|sevelamer|mesh-list
19822579|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
19822580|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
19822581|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822582|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
19822583|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
19822584|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19822585|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
19822586|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20333999|NCT00787462|Analgesics|analgesics|mesh-ancestor
20334000|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
20334001|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334002|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334003|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
20334004|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20334005|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334006|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334007|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20334008|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20334009|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334010|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334011|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334012|NCT00787501|Citalopram|citalopram|mesh-list
20334013|NCT00787501|Fluoxetine|fluoxetine|mesh-list
20334014|NCT00787501|Sertraline|sertraline|mesh-list
20334015|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20334016|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19822587|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822588|NCT00542880|Fluticasone|fluticasone|mesh-list
19822589|NCT00542880|Budesonide|budesonide|mesh-list
20334017|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334018|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649510|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649511|NCT02339714|Loratadine|loratadine|mesh-list
19822590|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
19822591|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19822592|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19822593|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19822594|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822595|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19822596|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
19822597|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822598|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822599|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19822600|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
19822601|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
19822602|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19822603|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
19822604|NCT00542880|Hormones|hormones|mesh-ancestor
19649512|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
19649513|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
19649514|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19649515|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19649516|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19649517|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
19649518|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
19649519|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649520|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649521|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649522|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19649523|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19649524|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822605|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822606|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19822607|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19822608|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19822609|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19822610|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822611|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822612|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
19822613|NCT00542971|Cytarabine|cytarabine|mesh-list
19822614|NCT00542971|Sorafenib|sorafenib|mesh-list
19822615|NCT00542971|Idarubicin|idarubicin|mesh-list
19822616|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19822617|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
19822618|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822619|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822620|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
19822621|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822622|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822623|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
19822624|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822625|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19822626|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822627|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19822628|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19822629|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19822630|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
19822631|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19822632|NCT00542997|Antibodies|antibodies|mesh-list
19822633|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
19822634|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334019|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334020|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
20334021|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334022|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20334023|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
20334024|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19822635|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
19822636|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
19822637|NCT00543062|Loxapine|loxapine|mesh-list
19822638|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822639|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822640|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19822641|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19822642|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822643|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822644|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822645|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822646|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
19822647|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
19822648|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822649|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822650|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19822651|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19822652|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19822653|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19822654|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19822655|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
19822656|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822657|NCT00543101|Darunavir|darunavir|mesh-list
19822658|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19822659|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19822660|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
19822661|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822662|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822663|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19822664|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19822665|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
19822666|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822667|NCT00543127|Fulvestrant|fulvestrant|mesh-list
19822668|NCT00543127|Anastrozole|anastrozole|mesh-list
19822669|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19822670|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822671|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19822672|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19822673|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
19835533|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822674|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822675|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822676|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19822677|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19822678|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822679|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822680|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19822681|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822682|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
19822683|NCT00543296|Hormones|hormones|mesh-ancestor
19822684|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822685|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822686|NCT00543309|Milrinone|milrinone|mesh-list
19822687|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19822688|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
19822689|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822690|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19822691|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19822692|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
19822693|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19822694|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19822695|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822696|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822697|NCT00543309|Protective Agents|protective agents|mesh-ancestor
19822698|NCT00543387|Docetaxel|docetaxel|mesh-list
19822699|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822700|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
19822701|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822702|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822703|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649525|NCT02339753|Carboplatin|carboplatin|mesh-list
19649526|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822704|NCT00543400|Heparin|heparin|mesh-list
19822705|NCT00543400|Calcium heparin|calcium heparin|mesh-list
19822706|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
19822707|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19822708|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19822709|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822710|NCT00543439|Factor VIII|factor viii|mesh-list
19822711|NCT00543439|Coagulants|coagulants|mesh-ancestor
19822712|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
19822713|NCT00543569|Alefacept|alefacept|mesh-list
19649527|NCT02339662|Gabapentin|gabapentin|mesh-list
19649528|NCT02339662|Amitriptyline|amitriptyline|mesh-list
19649529|NCT02339662|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19649530|NCT02339662|Analgesics|analgesics|mesh-ancestor
19649531|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
19649532|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649533|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649534|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
19649535|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19649536|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19822714|NCT00543569|Tacrolimus|tacrolimus|mesh-list
19822715|NCT00543569|Basiliximab|basiliximab|mesh-list
19822716|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822717|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
19822718|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822719|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19822720|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822721|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822722|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19822723|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822724|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19822725|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
19822726|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165854|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165855|NCT00138138|Methylphenidate|methylphenidate|mesh-list
20165856|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20165857|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165858|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20165859|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20165860|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19649537|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649538|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19822727|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822728|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
20165861|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165862|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
19822729|NCT00543725|Efavirenz|efavirenz|mesh-list
19822730|NCT00543725|Rilpivirine|rilpivirine|mesh-list
19822731|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19822732|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19822733|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822734|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822735|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
19822736|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822737|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19822738|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19822739|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19822740|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19822741|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19822742|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19822743|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19822744|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19822745|NCT00543855|Donepezil|donepezil|mesh-list
19822746|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19822747|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822748|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822749|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
19822750|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822751|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822752|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
19822753|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
19822754|NCT00544076|Alprostadil|alprostadil|mesh-list
19822755|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822756|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
19822757|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19822758|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19822759|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822760|NCT00544076|Urological Agents|urological agents|mesh-ancestor
19822761|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19822762|NCT00544167|Paclitaxel|paclitaxel|mesh-list
19822763|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
19822764|NCT00544167|Doxorubicin|doxorubicin|mesh-list
19822765|NCT00544167|Sorafenib|sorafenib|mesh-list
19822766|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822767|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822768|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
19822769|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822770|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822771|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822772|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822773|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
19822774|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822775|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19822776|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19822777|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
19822778|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19822779|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19822780|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19822781|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19822782|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822783|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19822784|NCT00544440|Prednisone|prednisone|mesh-list
19822785|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
19822786|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822787|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
19822788|NCT00544440|Hormones|hormones|mesh-ancestor
19822789|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822790|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822791|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19822792|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822793|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19822794|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822795|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165863|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20165864|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
19822796|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
19822797|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19822798|NCT00544544|Riluzole|riluzole|mesh-list
19822799|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
19822800|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19822801|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19822802|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822803|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822804|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822805|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19822806|NCT00544544|Protective Agents|protective agents|mesh-ancestor
19822807|NCT00544557|Etanercept|etanercept|mesh-list
19822808|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19822809|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19822810|NCT00544557|Analgesics|analgesics|mesh-ancestor
19822811|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
19822812|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822813|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822814|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822815|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19822816|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822817|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822818|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
19822819|NCT00544648|Paclitaxel|paclitaxel|mesh-list
19822820|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19822821|NCT00544648|Carboplatin|carboplatin|mesh-list
19822822|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19822823|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822824|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
19822825|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822826|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822827|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822828|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19822829|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
19822830|NCT00544713|Glycerol|glycerol|mesh-list
19822831|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19822832|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19822833|NCT00544713|Laxatives|laxatives|mesh-ancestor
19822834|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19822835|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19822836|NCT00544713|Protective Agents|protective agents|mesh-ancestor
19822837|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822838|NCT00544778|Doxorubicin|doxorubicin|mesh-list
19822839|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19822840|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
20165865|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165866|NCT00138177|Leucovorin|leucovorin|mesh-list
20165867|NCT00138177|Fluorouracil|fluorouracil|mesh-list
20165868|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
20165869|NCT00138177|Vorinostat|vorinostat|mesh-list
20165870|NCT00138177|Calcium|calcium|mesh-list
20165871|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
20165872|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20165873|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165874|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
20165875|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165876|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165877|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165878|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165879|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
20165880|NCT00138177|Antidotes|antidotes|mesh-ancestor
20165881|NCT00138177|Protective Agents|protective agents|mesh-ancestor
20165882|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
20165883|NCT00138177|Vitamins|vitamins|mesh-ancestor
20165884|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
20165885|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20165886|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165887|NCT00138216|Irinotecan|irinotecan|mesh-list
20165888|NCT00138216|Vincristine|vincristine|mesh-list
19822841|NCT00544778|Irinotecan|irinotecan|mesh-list
19822842|NCT00544778|Ifosfamide|ifosfamide|mesh-list
19822843|NCT00544778|Razoxane|razoxane|mesh-list
19822844|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19822845|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165889|NCT00138216|Temozolomide|temozolomide|mesh-list
19822846|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165890|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19822847|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165891|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19822848|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822849|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822850|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20334025|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20334026|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20334027|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334028|NCT00787553|Cefazolin|cefazolin|mesh-list
20334029|NCT00787553|Tinidazole|tinidazole|mesh-list
20334030|NCT00787553|Imidazole|imidazole|mesh-list
20334031|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822851|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822852|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19822853|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
19822854|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19822855|NCT00544778|Protective Agents|protective agents|mesh-ancestor
19822856|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
19822857|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
19822858|NCT00544817|Temozolomide|temozolomide|mesh-list
19822859|NCT00544817|Sorafenib|sorafenib|mesh-list
19822860|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19822861|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
19822862|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334032|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334033|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334034|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334035|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
19822863|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334036|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20334037|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20334038|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20334039|NCT00787657|Interferons|interferons|mesh-list
20334040|NCT00787657|Interferon-beta|interferon-beta|mesh-list
20334041|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
20334042|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334043|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
20334044|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334045|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
19822864|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19822865|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822866|NCT00544869|Tolvaptan|tolvaptan|mesh-list
19822867|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19822868|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822869|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
19822870|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822871|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19822872|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19822873|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19822874|NCT00544882|Desogestrel|desogestrel|mesh-list
19822875|NCT00544882|Oviol|oviol|mesh-list
19822876|NCT00544882|Estradiol|estradiol|mesh-list
19822877|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19822878|NCT00544882|Estrogens|estrogens|mesh-ancestor
19822879|NCT00544882|Hormones|hormones|mesh-ancestor
19822880|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822881|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822882|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19822883|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
19822884|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19822885|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19822886|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19822887|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19822888|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19822889|NCT00544882|Progestins|progestins|mesh-ancestor
19822890|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19822891|NCT00544908|Dasatinib|dasatinib|mesh-list
20334046|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334047|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19822892|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822893|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19822894|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822895|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822896|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
19822897|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19822898|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822899|NCT00545064|Timolol|timolol|mesh-list
20334048|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
20334049|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20334050|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20334051|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
20334052|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822900|NCT00545064|Dorzolamide|dorzolamide|mesh-list
19822901|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19822902|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19822903|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
19822904|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822905|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649539|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19649540|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19649541|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649542|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649543|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
19822906|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822907|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19822908|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19822909|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822910|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20334053|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20334054|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20334055|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334056|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334057|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
20334058|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20334059|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
20334060|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334061|NCT00787813|Expectorants|expectorants|mesh-ancestor
20334062|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
20334063|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20334064|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
20334065|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334066|NCT00787813|Protective Agents|protective agents|mesh-ancestor
19822911|NCT00545077|Bevacizumab|bevacizumab|mesh-list
19822912|NCT00545077|Letrozole|letrozole|mesh-list
19822913|NCT00545077|Fulvestrant|fulvestrant|mesh-list
19822914|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334067|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334068|NCT00787813|Antidotes|antidotes|mesh-ancestor
20334069|NCT00787826|Vaccines|vaccines|mesh-list
20334070|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
20334071|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649544|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19649545|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
19822915|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822916|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19822917|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19822918|NCT00545077|Growth Substances|growth substances|mesh-ancestor
19822919|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822920|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
19822921|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19822922|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19822923|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822924|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822925|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20334072|NCT00787969|Sirolimus|sirolimus|mesh-list
20334073|NCT00787969|Rituximab|rituximab|mesh-list
19649546|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19649547|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20334074|NCT00787969|Cladribine|cladribine|mesh-list
20165892|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822926|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
19822927|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19822928|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20334075|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334076|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334077|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
20334078|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334079|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334080|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822929|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19822930|NCT00545103|Mesalamine|mesalamine|mesh-list
19822931|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19822932|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19822933|NCT00545103|Analgesics|analgesics|mesh-ancestor
19822934|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
19822935|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822936|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822937|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19822938|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19822939|NCT00545168|Permethrin|permethrin|mesh-list
19822940|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822941|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822942|NCT00545181|Metronidazole|metronidazole|mesh-list
19822943|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822944|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19822945|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19822946|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19822947|NCT00545233|Pioglitazone|pioglitazone|mesh-list
19822948|NCT00545233|Ribavirin|ribavirin|mesh-list
19822949|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19822950|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
19822951|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822952|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
19822953|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19822954|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19822955|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822956|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
19822957|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19822958|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
19822959|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822960|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822961|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19822962|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
19822963|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19822964|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19822965|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19822966|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
19822967|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822968|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822969|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
19822970|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19822971|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
19822972|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19822973|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822974|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19822975|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
19822976|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19822977|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
19822978|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822979|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822980|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20165893|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165894|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165895|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20165896|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
20165897|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165898|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
20165899|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20165900|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
20165901|NCT00138229|Aldesleukin|aldesleukin|mesh-list
20165902|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
20165903|NCT00138229|Fludarabine|fludarabine|mesh-list
19822981|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
19822982|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
19822983|NCT00545298|Protective Agents|protective agents|mesh-ancestor
19822984|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
19822985|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19822986|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822987|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
19822988|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20334081|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334082|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20334083|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
20334084|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334085|NCT00788034|Vortioxetine|vortioxetine|mesh-list
20334086|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
20334087|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334088|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20334089|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334090|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334091|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334092|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20334093|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20334094|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334095|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334096|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19822989|NCT00545402|Tacrolimus|tacrolimus|mesh-list
19822990|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19822991|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
19822992|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19822993|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19822994|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19822995|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19822996|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19822997|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19822998|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19822999|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
19823000|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19823001|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823002|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20334097|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
20334098|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20334099|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20334100|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20334101|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334102|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
20334103|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
20334104|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
20334105|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20334106|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20334107|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334108|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334109|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334110|NCT00788060|Everolimus|everolimus|mesh-list
20334111|NCT00788060|Sunitinib|sunitinib|mesh-list
20334112|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334113|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334114|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
20334115|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334116|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20334117|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20334118|NCT00788060|Growth Substances|growth substances|mesh-ancestor
20334119|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
20334120|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334121|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334122|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334123|NCT00788099|Gemcitabine|gemcitabine|mesh-list
20334124|NCT00788099|Sorafenib|sorafenib|mesh-list
20334125|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20334126|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
20334127|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823003|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
19823004|NCT00545402|Hormones|hormones|mesh-ancestor
19823005|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19823006|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19823007|NCT00545402|Protective Agents|protective agents|mesh-ancestor
19823008|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19823009|NCT00545532|Oseltamivir|oseltamivir|mesh-list
19823010|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
19823011|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823012|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823013|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823014|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
19823015|NCT00545571|Hematinics|hematinics|mesh-ancestor
19823016|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19823017|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19823018|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823019|NCT00545584|Incretins|incretins|mesh-ancestor
19823020|NCT00545584|Hormones|hormones|mesh-ancestor
19823021|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19823022|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19823023|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
19823024|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823025|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823026|NCT00545662|Choline|choline|mesh-list
19823027|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19823028|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
19823029|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19823030|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
19823031|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823032|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19823033|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19823034|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
19823035|NCT00545688|Docetaxel|docetaxel|mesh-list
19823036|NCT00545688|Trastuzumab|trastuzumab|mesh-list
19823037|NCT00545688|Pertuzumab|pertuzumab|mesh-list
19823038|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823039|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
19823040|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
19823041|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
19823042|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823043|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823044|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
19823045|NCT00545714|Rituximab|rituximab|mesh-list
19649548|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19649549|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19649550|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
19649551|NCT02339662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19649552|NCT02339844|Aripiprazole|aripiprazole|mesh-list
19649553|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
19649554|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823046|NCT00545714|Fludarabine|fludarabine|mesh-list
19823047|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823048|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
19823049|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823050|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823051|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19823052|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
19823053|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823054|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823055|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19823056|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823057|NCT00545740|Mesalamine|mesalamine|mesh-list
19823058|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19823059|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19823060|NCT00545740|Analgesics|analgesics|mesh-ancestor
19823061|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
19823062|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649555|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19649556|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19649557|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649558|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649559|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
19823063|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823064|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20334128|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334129|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
20334130|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334131|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334132|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334133|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
19649560|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
19823065|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823066|NCT00545753|Permethrin|permethrin|mesh-list
19823067|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823068|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823069|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
19823070|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19823071|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823072|NCT00545792|Bevacizumab|bevacizumab|mesh-list
19823073|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823074|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823075|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19823076|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19823077|NCT00545792|Growth Substances|growth substances|mesh-ancestor
19823078|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823079|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
19823080|NCT00545948|Cisplatin|cisplatin|mesh-list
19823081|NCT00545948|Pemetrexed|pemetrexed|mesh-list
19823082|NCT00545948|Vinorelbine|vinorelbine|mesh-list
19823083|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823084|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823085|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823086|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19823087|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19823088|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19823089|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
19823090|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
19823091|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
19823092|NCT00545974|Memantine|memantine|mesh-list
19823093|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19823094|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19823095|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
19823096|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823097|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823098|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823099|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19823100|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19823101|NCT00546000|Fluticasone|fluticasone|mesh-list
19823102|NCT00546000|Xhance|xhance|mesh-list
19823103|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823104|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19823105|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
19823106|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823107|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823108|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19823109|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
19823110|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
19823111|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19649561|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19649562|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649563|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19649564|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19649565|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
19649566|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19649567|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19649568|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19649569|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19823112|NCT00546078|Vaccines|vaccines|mesh-list
19823113|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
20334134|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334135|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334136|NCT00788112|Vorinostat|vorinostat|mesh-list
20334137|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334138|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20334139|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334140|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334141|NCT00788138|Vitamin D|vitamin d|mesh-list
20334142|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
20334143|NCT00788138|Vitamins|vitamins|mesh-ancestor
20334144|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
20334145|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334146|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20334147|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19823114|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823115|NCT00546104|Dasatinib|dasatinib|mesh-list
19823116|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823117|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823118|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823119|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334148|NCT00788164|Imiquimod|imiquimod|mesh-list
20334149|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20334150|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
20334151|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334152|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334153|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
20334154|NCT00788242|Insulin|insulin|mesh-list
20334155|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19823120|NCT00546117|Lansoprazole|lansoprazole|mesh-list
19823121|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
19823122|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19823123|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19823124|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19823125|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823126|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823127|NCT00546156|Paclitaxel|paclitaxel|mesh-list
19823128|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
19823129|NCT00546156|Bevacizumab|bevacizumab|mesh-list
19823130|NCT00546156|Doxorubicin|doxorubicin|mesh-list
19823131|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19823132|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823133|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
20334156|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334157|NCT00788294|Tanezumab|tanezumab|mesh-list
20334158|NCT00788294|Analgesics|analgesics|mesh-ancestor
20334159|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
20334160|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334161|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334162|NCT00788320|Vitamin D|vitamin d|mesh-list
19823134|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
19823135|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
19823136|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823137|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823138|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
19823139|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823140|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823141|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19823142|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
19823143|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19823144|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823145|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19823146|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19823147|NCT00546156|Growth Substances|growth substances|mesh-ancestor
19823148|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
19823149|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19823150|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19823151|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19823152|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334163|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
20334164|NCT00788320|Vitamins|vitamins|mesh-ancestor
20334165|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
20334166|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823153|NCT00546351|Lacosamide|lacosamide|mesh-list
19823154|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
19823155|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20334167|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20334168|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19823156|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19823157|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823158|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823159|NCT00546364|Docetaxel|docetaxel|mesh-list
19823160|NCT00546364|Capecitabine|capecitabine|mesh-list
19823161|NCT00546364|Epothilones|epothilones|mesh-list
19823162|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823163|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
19823164|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
19823165|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
19823166|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823167|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19823168|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
19823169|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
19823170|NCT00546377|Rituximab|rituximab|mesh-list
19823171|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
19823172|NCT00546377|Pentostatin|pentostatin|mesh-list
19823173|NCT00546377|Sargramostim|sargramostim|mesh-list
19823174|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823175|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
19823176|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823177|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823178|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19823179|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
19823180|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823181|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823182|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19823183|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823184|NCT00546377|Analgesics|analgesics|mesh-ancestor
19823185|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
19823186|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823187|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19823188|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19823189|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823190|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19834965|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834966|NCT00599521|Adapalene|adapalene|mesh-list
19834967|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19834968|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19834969|NCT00599521|Analgesics|analgesics|mesh-ancestor
19834970|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
19834971|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834972|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834973|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19834974|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19834975|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
19834976|NCT00599638|Pregabalin|pregabalin|mesh-list
19834977|NCT00599638|Analgesics|analgesics|mesh-ancestor
19834978|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
19834979|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19834980|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19834981|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
19834982|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19834983|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834984|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834985|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19834986|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19834987|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19834988|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19834989|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835534|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835535|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
19835536|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19835537|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835538|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835539|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835540|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20165904|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
20165905|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20165906|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
20165907|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165908|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835541|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20165909|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19823191|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
19823192|NCT00546481|Hematinics|hematinics|mesh-ancestor
19823193|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19823194|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
19823195|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823196|NCT00546637|Fesoterodine|fesoterodine|mesh-list
19823197|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19823198|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19823199|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
19823200|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823201|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823202|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823203|NCT00546637|Urological Agents|urological agents|mesh-ancestor
19823204|NCT00546728|Metformin|metformin|mesh-list
19823205|NCT00546728|Exenatide|exenatide|mesh-list
19823206|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19823207|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823208|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19823209|NCT00546728|Incretins|incretins|mesh-ancestor
19823210|NCT00546728|Hormones|hormones|mesh-ancestor
19823211|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19823212|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
19823213|NCT00546871|Antibodies|antibodies|mesh-list
20334169|NCT00788333|Trastuzumab|trastuzumab|mesh-list
20334170|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334171|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334172|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19823214|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
19823215|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19823216|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19823217|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
20334173|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20334174|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20334175|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
20334176|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334177|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823218|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823219|NCT00546897|Lenalidomide|lenalidomide|mesh-list
19823220|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
19823221|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334178|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20334179|NCT00788424|Protective Agents|protective agents|mesh-ancestor
20334180|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20334181|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20334182|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334183|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334184|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
20334185|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334186|NCT00788463|Beclomethasone|beclomethasone|mesh-list
20334187|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823222|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19823223|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19823224|NCT00546897|Growth Substances|growth substances|mesh-ancestor
19823225|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
19823226|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823227|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19823228|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19649570|NCT02339350|Methotrexate|methotrexate|mesh-list
19649571|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19649572|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
19649573|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649574|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649575|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649576|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
19649577|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649578|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649579|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
19823229|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19823230|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823231|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823232|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
19823233|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823234|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823235|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19823236|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823237|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823238|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823239|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823240|NCT00547118|Rimonabant|rimonabant|mesh-list
19823241|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19823242|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19823243|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19823244|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823245|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823246|NCT00547118|Hormones|hormones|mesh-ancestor
19823247|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19823248|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823249|NCT00547157|Cisplatin|cisplatin|mesh-list
19823250|NCT00547157|Panitumumab|panitumumab|mesh-list
19823251|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823252|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823253|NCT00547248|Vaccines|vaccines|mesh-list
19823254|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19823255|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
19823256|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334188|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
20334189|NCT00788463|Hormones|hormones|mesh-ancestor
20334190|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20334191|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334192|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20334193|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20334194|NCT00788515|Lormetazepam|lormetazepam|mesh-list
19823257|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
19823258|NCT00547365|Antibodies|antibodies|mesh-list
19823259|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
19823260|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19823261|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19823262|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
19823263|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823264|NCT00547521|Methotrexate|methotrexate|mesh-list
19823265|NCT00547521|Abatacept|abatacept|mesh-list
19823266|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19823267|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
19823268|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19823269|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823270|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19823271|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
19823272|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823273|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823274|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
19823275|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823276|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19823277|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823278|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
19823279|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334195|NCT00788515|Volinanserin|volinanserin|mesh-list
20334196|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20334197|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334198|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649580|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649581|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19649582|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649583|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
19649584|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649585|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19649586|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
19649587|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
19649588|NCT02339441|Methotrexate|methotrexate|mesh-list
19649589|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649590|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
19823280|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19823281|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19823282|NCT00547534|Rituximab|rituximab|mesh-list
19823283|NCT00547534|Bortezomib|bortezomib|mesh-list
19823284|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19823285|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823286|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823287|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
19823288|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823289|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649591|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649592|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649593|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19649594|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
19649595|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649596|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649597|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19649598|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19649599|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
19649600|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649601|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649602|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
19649603|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
19649604|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649605|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19649606|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19823290|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19823291|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
19823292|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823293|NCT00547586|Bromides|bromides|mesh-list
19823294|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
19823295|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
19823296|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19823297|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823298|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
19823299|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823300|NCT00547703|Nortriptyline|nortriptyline|mesh-list
20165910|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
20165911|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823301|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19823302|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
19823303|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823304|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19823305|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20165912|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165913|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20165914|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20165915|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
20165916|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20165917|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20165918|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
20165919|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165920|NCT00138242|Carboplatin|carboplatin|mesh-list
20165921|NCT00138242|Docetaxel|docetaxel|mesh-list
20165922|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165923|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
20165924|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
20165925|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
20334199|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334200|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
20334201|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334202|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334203|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
20334204|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20334205|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334206|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19823306|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823307|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823308|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
19823309|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823310|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165926|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165927|NCT00138359|Niclosamide|niclosamide|mesh-list
19823311|NCT00547911|Carbidopa|carbidopa|mesh-list
19823312|NCT00547911|Entacapone|entacapone|mesh-list
19823313|NCT00547911|Droxidopa|droxidopa|mesh-list
19823314|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19823315|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19823316|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
19823317|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823318|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823319|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823320|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19823321|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823322|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19823323|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
19823324|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19823325|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823326|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
19823327|NCT00548145|Ezetimibe|ezetimibe|mesh-list
19823328|NCT00548145|Pitavastatin|pitavastatin|mesh-list
19823329|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19823330|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19823331|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
19823332|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823333|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19823334|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19823335|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823336|NCT00548184|Trastuzumab|trastuzumab|mesh-list
19823337|NCT00548184|Lapatinib|lapatinib|mesh-list
19823338|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823339|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334207|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
20334208|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20334209|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334210|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334211|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334212|NCT00788580|Sirolimus|sirolimus|mesh-list
20334213|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20334214|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334215|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19823340|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823341|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823342|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823343|NCT00548197|Bevacizumab|bevacizumab|mesh-list
19823344|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823345|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823346|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19823347|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19823348|NCT00548197|Growth Substances|growth substances|mesh-ancestor
19823349|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823350|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
19823351|NCT00548249|Iron|iron|mesh-list
19823352|NCT00548249|Trace Elements|trace elements|mesh-ancestor
19823353|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
19823354|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823355|NCT00548262|Voriconazole|voriconazole|mesh-list
19823356|NCT00548262|Anidulafungin|anidulafungin|mesh-list
19823357|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
19823358|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823359|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19834990|NCT00599755|Gemcitabine|gemcitabine|mesh-list
20165928|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
20165929|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20165930|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
20165931|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20165932|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165933|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
20165934|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
20165935|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20165936|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20165937|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20165938|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20165939|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165940|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165941|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20165942|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20334216|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334217|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
19823360|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19823361|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823362|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823363|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19823364|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
19823365|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19823366|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823367|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19823368|NCT00548405|Interferons|interferons|mesh-list
19823369|NCT00548405|Interferon-beta|interferon-beta|mesh-list
19823370|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
19823371|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
19823372|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823373|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
19823374|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823375|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823376|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
19823377|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823378|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19823379|NCT00548418|Bevacizumab|bevacizumab|mesh-list
19823380|NCT00548418|Topotecan|topotecan|mesh-list
19823381|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823382|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823383|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19823384|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19823385|NCT00548418|Growth Substances|growth substances|mesh-ancestor
19823386|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823387|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
19823388|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19823389|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19823390|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823391|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823392|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
19823393|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
19823394|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823395|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19823396|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823397|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823398|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
19823399|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823400|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19823401|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823402|NCT00548470|Varenicline|varenicline|mesh-list
19823403|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19823404|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19823405|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
19823406|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823407|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823408|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823409|NCT00548548|Bevacizumab|bevacizumab|mesh-list
19823410|NCT00548548|Fluorouracil|fluorouracil|mesh-list
19823411|NCT00548548|Capecitabine|capecitabine|mesh-list
19823412|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823413|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823414|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19823415|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19823416|NCT00548548|Growth Substances|growth substances|mesh-ancestor
19823417|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823418|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
19823419|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
20165943|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20165944|NCT00138515|Vildagliptin|vildagliptin|mesh-list
20165945|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165946|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165947|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20165948|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165949|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165950|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174496|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174497|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174498|NCT00165074|Calfactant|calfactant|mesh-list
20174499|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20174500|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
19823420|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823421|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19823422|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823423|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
19823424|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
19823425|NCT00548717|Sirolimus|sirolimus|mesh-list
19823426|NCT00548717|Bortezomib|bortezomib|mesh-list
19823427|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19823428|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823429|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19823430|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
19823431|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19823432|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823433|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823434|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823435|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
19823436|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823437|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
19823438|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823439|NCT00548808|Insulin|insulin|mesh-list
19823440|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19823441|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
19823442|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
19823443|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20334218|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334219|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
20334220|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334221|NCT00788606|Bevacizumab|bevacizumab|mesh-list
20334222|NCT00788606|Rituximab|rituximab|mesh-list
20334223|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334224|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334225|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20334226|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20334227|NCT00788606|Growth Substances|growth substances|mesh-ancestor
20334228|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334229|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
20334230|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
20334231|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334232|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
20334233|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20334234|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
19823444|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823445|NCT00548847|Interferons|interferons|mesh-list
19823446|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
19823447|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
20334235|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20334236|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334237|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20334238|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20334239|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20334240|NCT00788749|Fluticasone|fluticasone|mesh-list
20334241|NCT00788749|Xhance|xhance|mesh-list
20334242|NCT00788749|Prednisolone|prednisolone|mesh-list
20334243|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20334244|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20334245|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
20334246|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334247|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334248|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20334249|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
20334250|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19823448|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19823449|NCT00548847|Molgramostim|molgramostim|mesh-list
20334251|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20334252|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
20334253|NCT00788749|Hormones|hormones|mesh-ancestor
20334254|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20334255|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20334256|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334257|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
20334258|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
20334259|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
19823450|NCT00548847|Sargramostim|sargramostim|mesh-list
19823451|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823452|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
19823453|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334260|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20611774|NCT00217737|Antidotes|antidotes|mesh-ancestor
19823454|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
20165951|NCT00138541|Vildagliptin|vildagliptin|mesh-list
20165952|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165953|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165954|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20165955|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165956|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165957|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165958|NCT00138554|Pioglitazone|pioglitazone|mesh-list
20165959|NCT00138554|Vildagliptin|vildagliptin|mesh-list
20165960|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165961|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165962|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20165963|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165964|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165965|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165966|NCT00138567|Vildagliptin|vildagliptin|mesh-list
20165967|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165968|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165969|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20165970|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165971|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649607|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19649608|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20174501|NCT00165087|Doxorubicin|doxorubicin|mesh-list
19649609|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
19649610|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19649611|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649612|NCT02339324|Interferons|interferons|mesh-list
19649613|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
19649614|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
19649615|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
19649616|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19649617|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649618|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
19649619|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649620|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
19665173|NCT02951130|Milrinone|milrinone|mesh-list
19665174|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19665175|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19665176|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
19665177|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19665178|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19665179|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665180|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665181|NCT02951130|Protective Agents|protective agents|mesh-ancestor
19823455|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823456|NCT00549042|Hydromorphone|hydromorphone|mesh-list
19823457|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19823458|NCT00549042|Narcotics|narcotics|mesh-ancestor
19823459|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823460|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334261|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334262|NCT00788918|Interferons|interferons|mesh-list
20334263|NCT00788918|Ribavirin|ribavirin|mesh-list
20334264|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334265|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
20334266|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334267|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
20334268|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334269|NCT00788931|Paclitaxel|paclitaxel|mesh-list
20334270|NCT00788931|Trastuzumab|trastuzumab|mesh-list
20334271|NCT00788931|Panobinostat|panobinostat|mesh-list
20334272|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20334273|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334274|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
20334275|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
20334276|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
20334277|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334278|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334279|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20334280|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334281|NCT00789061|Lansoprazole|lansoprazole|mesh-list
20334282|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19823461|NCT00549042|Analgesics|analgesics|mesh-ancestor
19823462|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
19823463|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823464|NCT00549198|Tenofovir|tenofovir|mesh-list
19823465|NCT00549198|Lamivudine|lamivudine|mesh-list
19823466|NCT00549198|Emtricitabine|emtricitabine|mesh-list
19823467|NCT00549198|Efavirenz|efavirenz|mesh-list
19823468|NCT00549198|Abacavir|abacavir|mesh-list
19823469|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
19823470|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823471|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19823472|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19823473|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823474|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823475|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19823476|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19823477|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19823478|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19823479|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19823480|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19823481|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19823482|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19823483|NCT00549302|Tadalafil|tadalafil|mesh-list
19823484|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
19823485|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19823486|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19823487|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823488|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823489|NCT00549302|Urological Agents|urological agents|mesh-ancestor
19823490|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
19823491|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19823492|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19823493|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823494|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
20334283|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19649621|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649622|NCT02339428|Diclofenac|diclofenac|mesh-list
19649623|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19649624|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19649625|NCT02339428|Analgesics|analgesics|mesh-ancestor
19649626|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
19649627|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649628|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649629|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19649630|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649631|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20334284|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19823495|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
19823496|NCT00549445|Azithromycin|azithromycin|mesh-list
19823497|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19823498|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823499|NCT00549549|Celecoxib|celecoxib|mesh-list
19823500|NCT00549549|Indomethacin|indomethacin|mesh-list
19823501|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19823502|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19823503|NCT00549549|Analgesics|analgesics|mesh-ancestor
19823504|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
19823505|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823506|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823507|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823508|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823509|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19823510|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19823511|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823512|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823513|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
19823514|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
19823515|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19823516|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19823517|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19823518|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19823519|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823520|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823521|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823522|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19823523|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19823524|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
19823525|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823526|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823527|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19823528|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19823529|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
19823530|NCT00549601|Rivastigmine|rivastigmine|mesh-list
19823531|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19823532|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823533|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823534|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
19823535|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823536|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823537|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19823538|NCT00549601|Protective Agents|protective agents|mesh-ancestor
19823539|NCT00549640|Methylphenidate|methylphenidate|mesh-list
19823540|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19823541|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823542|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19823543|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19823544|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823545|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823546|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
19823547|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823548|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19823549|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19823550|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19823551|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823552|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823553|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823554|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19823555|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19823556|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19823557|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
19823558|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823559|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823560|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19823561|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19823562|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
19823563|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19823564|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19823565|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
20334285|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334286|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823566|NCT00549770|Valsartan|valsartan|mesh-list
19823567|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19823568|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19823569|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19823570|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19823571|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334287|NCT00789165|Quinidine|quinidine|mesh-list
20334288|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20334289|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20334290|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
20334291|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334292|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334293|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165972|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165973|NCT00138580|Vildagliptin|vildagliptin|mesh-list
20165974|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165975|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165976|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20165977|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165978|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165979|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334294|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20334295|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
20334296|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20334297|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20334298|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334299|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334300|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20334301|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20334302|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
20334303|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20334304|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20334305|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334306|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20334307|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20334308|NCT00789308|Cyclosporine|cyclosporine|mesh-list
20334309|NCT00789308|Sirolimus|sirolimus|mesh-list
20334310|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
20334311|NCT00789308|Etanercept|etanercept|mesh-list
19823572|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
19823573|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19823574|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19823575|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19823576|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823577|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823578|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
19823579|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823580|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823581|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19823582|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823583|NCT00549822|Letrozole|letrozole|mesh-list
19823584|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823585|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19823586|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19823587|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823588|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823589|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19823590|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
19823591|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19823592|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823593|NCT00549900|Vaccines|vaccines|mesh-list
19823594|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
19823595|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823596|NCT00549939|Alfuzosin|alfuzosin|mesh-list
19823597|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19823598|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20334312|NCT00789308|Heparin|heparin|mesh-list
20334313|NCT00789308|Dextrans|dextrans|mesh-list
20334314|NCT00789308|Tacrolimus|tacrolimus|mesh-list
20334315|NCT00789308|Cyclosporins|cyclosporins|mesh-list
20334316|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
20334317|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19823599|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19823600|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
19823601|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823602|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823603|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823604|NCT00549939|Urological Agents|urological agents|mesh-ancestor
19823605|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19823606|NCT00550147|Methylphenidate|methylphenidate|mesh-list
19823607|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19649632|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649633|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649634|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
20165980|NCT00138593|Vildagliptin|vildagliptin|mesh-list
20165981|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165982|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165983|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20165984|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165985|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165986|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165987|NCT00138606|Vildagliptin|vildagliptin|mesh-list
20165988|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165989|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165990|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19649635|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
19649636|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649637|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
19649638|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19649639|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19649640|NCT02339142|Prednisolone|prednisolone|mesh-list
19649641|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
19649642|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19649643|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
19649644|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19649645|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
19649646|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
19649647|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823608|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823609|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19823610|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19823611|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823612|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165991|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165992|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20165993|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20165994|NCT00138619|Vildagliptin|vildagliptin|mesh-list
20165995|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20165996|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20165997|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20165998|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
20165999|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334318|NCT00789308|Basiliximab|basiliximab|mesh-list
20334319|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334320|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
20334321|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823613|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
19823614|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823615|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
20334322|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20334323|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823616|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823617|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19823618|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19823619|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823620|NCT00550173|Pemetrexed|pemetrexed|mesh-list
19823621|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19823622|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823623|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823624|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823625|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19823626|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19823627|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823628|NCT00550238|Pimavanserin|pimavanserin|mesh-list
20334324|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334325|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
20334326|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334327|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
20334328|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334329|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20334330|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334331|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20334332|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
20334333|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20334334|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
20334335|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20334336|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20334337|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20334338|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20334339|NCT00789308|Analgesics|analgesics|mesh-ancestor
20334340|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
20334341|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334342|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20334343|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19823629|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19823630|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19823631|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19823632|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19823633|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823634|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823635|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823636|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19823637|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19823638|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
19823639|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823640|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823641|NCT00550277|Panobinostat|panobinostat|mesh-list
19823642|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823643|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19823644|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823645|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823646|NCT00550290|Cefazolin|cefazolin|mesh-list
19823647|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20334344|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
20334345|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
20334346|NCT00789386|Midazolam|midazolam|mesh-list
19823648|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823649|NCT00550394|Topiramate|topiramate|mesh-list
19823650|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19823651|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
19823652|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823653|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19823654|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19823655|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823656|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823657|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
19823658|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19823659|NCT00550407|Lamotrigine|lamotrigine|mesh-list
19823660|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
19823661|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19823662|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19834991|NCT00599755|Carboplatin|carboplatin|mesh-list
20334347|NCT00789386|Remifentanil|remifentanil|mesh-list
20334348|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20334349|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20334350|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823663|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823664|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19823665|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823666|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19823667|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19823668|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823669|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823670|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19823671|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
19823672|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19823673|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823674|NCT00550446|Adalimumab|adalimumab|mesh-list
19823675|NCT00550446|Tofacitinib|tofacitinib|mesh-list
19823676|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823677|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823678|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823679|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823680|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823681|NCT00550459|Tolvaptan|tolvaptan|mesh-list
19823682|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19823683|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823684|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
20166000|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166001|NCT00138632|Vatalanib|vatalanib|mesh-list
20166002|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20166003|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166004|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166005|NCT00138710|Letrozole|letrozole|mesh-list
20166006|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823685|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823686|NCT00550537|Paclitaxel|paclitaxel|mesh-list
19823687|NCT00550537|Bevacizumab|bevacizumab|mesh-list
19823688|NCT00550537|Carboplatin|carboplatin|mesh-list
19823689|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19823690|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19823691|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823692|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19823693|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19823694|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19823695|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823696|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823697|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19823698|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19823699|NCT00550537|Growth Substances|growth substances|mesh-ancestor
19823700|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823701|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
19823702|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823703|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823704|NCT00550550|Fluticasone|fluticasone|mesh-list
19823705|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
19823706|NCT00550550|Loratadine|loratadine|mesh-list
19823707|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19823708|NCT00550550|Prednisone|prednisone|mesh-list
19823709|NCT00550550|Albuterol|albuterol|mesh-list
19823710|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823711|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
19823712|NCT00550550|Hormones|hormones|mesh-ancestor
19823713|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649648|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649649|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19649650|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
19649651|NCT02339142|Hormones|hormones|mesh-ancestor
19649652|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649653|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19649654|NCT02339142|Protective Agents|protective agents|mesh-ancestor
19649655|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20166007|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20166008|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20166009|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166010|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166011|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20166012|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
20174502|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
19823714|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823715|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19823716|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823717|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19823718|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
19823719|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334351|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334352|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20334353|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334354|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334355|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20334356|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
20334357|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
20334358|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
20334359|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
20334360|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823720|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19823721|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
19823722|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
20334361|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334362|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20334363|NCT00789386|Narcotics|narcotics|mesh-ancestor
20334364|NCT00789386|Analgesics|analgesics|mesh-ancestor
20334365|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
19823723|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19823724|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
19823725|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19823726|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19823727|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19823728|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19823729|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
19823730|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823731|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823732|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
19823733|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19823734|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19823735|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
19823736|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
19823737|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19823738|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19823739|NCT00550550|Analgesics|analgesics|mesh-ancestor
19823740|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
19823741|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823742|NCT00550589|Cidofovir|cidofovir|mesh-list
19823743|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
19823744|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823745|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823746|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823747|NCT00550615|Dasatinib|dasatinib|mesh-list
19823748|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823749|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823750|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823751|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823752|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
19823753|NCT00550680|Hematinics|hematinics|mesh-ancestor
19823754|NCT00550732|Posaconazole|posaconazole|mesh-list
19823755|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
19823756|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823757|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19823758|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19823759|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19823760|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19823761|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19823762|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823763|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823764|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19823765|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
19823766|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174503|NCT00165087|Asparaginase|asparaginase|mesh-list
20174504|NCT00165087|Razoxane|razoxane|mesh-list
20174505|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20174506|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174507|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20174508|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20174509|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174510|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823767|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823768|NCT00550771|Paclitaxel|paclitaxel|mesh-list
19823769|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19823770|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
19823771|NCT00550771|Doxorubicin|doxorubicin|mesh-list
19823772|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19823773|NCT00550771|Trastuzumab|trastuzumab|mesh-list
19823774|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19823775|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823776|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
19823777|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
19823778|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
19823779|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823780|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823781|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
19823782|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823783|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823784|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19823785|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
19823786|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19823787|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19823788|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19823789|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19823790|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823791|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823792|NCT00550836|Gemcitabine|gemcitabine|mesh-list
19823793|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19823794|NCT00550836|Panitumumab|panitumumab|mesh-list
19823795|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19823796|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
19823797|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823798|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823799|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
19823800|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19823801|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823802|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823803|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
19823804|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823805|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19823806|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823807|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19823808|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19823809|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19823810|NCT00550953|Amlodipine|amlodipine|mesh-list
19823811|NCT00550953|Telmisartan|telmisartan|mesh-list
19823812|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19823813|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19823814|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19823815|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823816|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823817|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19823818|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823819|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
19823820|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19823821|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19823822|NCT00551031|Vaccines|vaccines|mesh-list
19823823|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
20166013|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166014|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166015|NCT00138736|Lectins|lectins|mesh-list
20166016|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
20166017|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
20166018|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166019|NCT00138736|Coagulants|coagulants|mesh-ancestor
20166020|NCT00138801|Doxycycline|doxycycline|mesh-list
20166021|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
20166022|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19823824|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823825|NCT00551135|Pregabalin|pregabalin|mesh-list
19823826|NCT00551135|Analgesics|analgesics|mesh-ancestor
19823827|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
19823828|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823829|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823830|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
20334366|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334367|NCT00789399|PENTA|penta|mesh-list
20334368|NCT00789399|Fondaparinux|fondaparinux|mesh-list
20334369|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20334370|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
20334371|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20334372|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
20334373|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334374|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334375|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
20334376|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20334377|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20334378|NCT00789464|Trimethoprim|trimethoprim|mesh-list
19823831|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19823832|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19823833|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823834|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19823835|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19823836|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19823837|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19823838|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823839|NCT00551161|Memantine|memantine|mesh-list
19823840|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19823841|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19823842|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
19823843|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823844|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823845|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823846|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19823847|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19823848|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
19823849|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19823850|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649656|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649657|NCT02339090|Hormones|hormones|mesh-list
19649658|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649659|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823851|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19823852|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334379|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
20334380|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20334381|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649660|NCT02339116|Bevacizumab|bevacizumab|mesh-list
19649661|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
19649662|NCT02339116|Irinotecan|irinotecan|mesh-list
20334382|NCT00789464|Renal Agents|renal agents|mesh-ancestor
20334383|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
20334384|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20334385|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20334386|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20334387|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334388|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334389|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20334390|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20334391|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20334392|NCT00789503|Vitamin D|vitamin d|mesh-list
20334393|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
20334394|NCT00789503|Calcium|calcium|mesh-list
20334395|NCT00789503|Vitamins|vitamins|mesh-ancestor
20334396|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
20334397|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334398|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19649663|NCT02339116|Fluorouracil|fluorouracil|mesh-list
19649664|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19649665|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649666|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19649667|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19649668|NCT02339116|Growth Substances|growth substances|mesh-ancestor
19649669|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649670|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
19649671|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20334399|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20348088|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649672|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19823853|NCT00551213|Capecitabine|capecitabine|mesh-list
19823854|NCT00551213|Irinotecan|irinotecan|mesh-list
19823855|NCT00551213|Cetuximab|cetuximab|mesh-list
19823856|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19823857|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
19823858|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823859|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823860|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19823861|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19823862|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823863|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334400|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
20334401|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20334402|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20334403|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334404|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20334405|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20334406|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823864|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
19823865|NCT00551291|Prednisone|prednisone|mesh-list
20334407|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334408|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334409|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20334410|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
20334411|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20334412|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334413|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20334414|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20334415|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20334416|NCT00789620|Lidocaine|lidocaine|mesh-list
20334417|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
20334418|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
20334419|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334420|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334421|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
20334422|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334423|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20334424|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20334425|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20334426|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334427|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334428|NCT00789646|Lidocaine|lidocaine|mesh-list
20334429|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
20334430|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
20334431|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334432|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334433|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
20334434|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334435|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19649673|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649674|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649675|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
19649676|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649677|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649678|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
19649679|NCT02338934|Vitamin D|vitamin d|mesh-list
19649680|NCT02338934|Cinacalcet|cinacalcet|mesh-list
19649681|NCT02338934|Vitamins|vitamins|mesh-ancestor
19649682|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
19649683|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649684|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19649685|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19649686|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19823866|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
19649687|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649688|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649689|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
19649690|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649691|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20166023|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166024|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
20166025|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20166026|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20611775|NCT00217737|Protective Agents|protective agents|mesh-ancestor
20611776|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
20611777|NCT00217737|Vitamins|vitamins|mesh-ancestor
20611778|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
20611779|NCT00217737|Hematinics|hematinics|mesh-ancestor
20611780|NCT00026312|Vitamin A|vitamin a|mesh-list
20166027|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
20166028|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20166029|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166030|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166031|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20166032|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166033|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20166034|NCT00138944|Eplerenone|eplerenone|mesh-list
20166035|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20334436|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20334437|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20334438|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334439|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334440|NCT00789711|Insulin|insulin|mesh-list
20334441|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20334442|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
20334443|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
20334444|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
20334445|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20334446|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20334447|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334448|NCT00789763|Gemcitabine|gemcitabine|mesh-list
20334449|NCT00789763|Sorafenib|sorafenib|mesh-list
20334450|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20334451|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
20334452|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334453|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334454|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
20334455|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334456|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334457|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334458|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
20334459|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334460|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334461|NCT00789945|Insulin|insulin|mesh-list
20334462|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20334463|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20334464|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334465|NCT00789971|Triamcinolone|triamcinolone|mesh-list
19823867|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823868|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
20334466|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20334467|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20334468|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20334469|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20334470|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
19649692|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19649693|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334471|NCT00789971|Hormones|hormones|mesh-ancestor
20611781|NCT00026312|Aldesleukin|aldesleukin|mesh-list
19823869|NCT00551291|Hormones|hormones|mesh-ancestor
19823870|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20334472|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20334473|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334474|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334475|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
20334476|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334477|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334478|NCT00790075|Risperidone|risperidone|mesh-list
20334479|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334480|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
20334481|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334482|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334483|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334484|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334485|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334486|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334487|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334488|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334489|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
20334490|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
20334491|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20334492|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20334493|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334494|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334495|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20334496|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334497|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20334498|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20334499|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
20334500|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20334501|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20334502|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20334503|NCT00790114|Midazolam|midazolam|mesh-list
20334504|NCT00790114|Caffeine|caffeine|mesh-list
20334505|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20334506|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20334507|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334508|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334509|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20334510|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334511|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19823871|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823872|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19823873|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823874|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19823875|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19823876|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
19823877|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19823878|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649694|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649695|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
19649696|NCT02338830|Progesterone|progesterone|mesh-list
19649697|NCT02338830|Progestins|progestins|mesh-ancestor
19649698|NCT02338830|Hormones|hormones|mesh-ancestor
19649699|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649700|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649701|NCT02338687|Calcium|calcium|mesh-list
19649702|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19649703|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649704|NCT02338674|Tenofovir|tenofovir|mesh-list
19649705|NCT02338674|Telbivudine|telbivudine|mesh-list
19649706|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
19649707|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649708|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19649709|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19649710|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166036|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
20166037|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166038|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166039|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20166040|NCT00138944|Diuretics|diuretics|mesh-ancestor
20166041|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
20166042|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20166043|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
20166044|NCT00138970|Cyclosporine|cyclosporine|mesh-list
20166045|NCT00138970|Prednisolone|prednisolone|mesh-list
20166046|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20166047|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
20166048|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20166049|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
20166050|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20166051|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
20166052|NCT00138970|Daclizumab|daclizumab|mesh-list
20166053|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166054|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
19649711|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649712|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19649713|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19649714|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
19649715|NCT02338518|Etoposide|etoposide|mesh-list
19649716|NCT02338518|Epirubicin|epirubicin|mesh-list
19649717|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649718|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19649719|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19649720|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19649721|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649722|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649723|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19649724|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19649725|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19649726|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19649727|NCT02338544|Adapalene|adapalene|mesh-list
19649728|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20166055|NCT00138970|Hormones|hormones|mesh-ancestor
20174511|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20174512|NCT00165087|Protective Agents|protective agents|mesh-ancestor
20174513|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174514|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174515|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174516|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
20174517|NCT00165139|Melphalan|melphalan|mesh-list
20174518|NCT00165139|Ifosfamide|ifosfamide|mesh-list
20174519|NCT00165139|Carboplatin|carboplatin|mesh-list
20174520|NCT00165139|Etoposide|etoposide|mesh-list
20174521|NCT00165139|Vincristine|vincristine|mesh-list
20174522|NCT00165139|Doxorubicin|doxorubicin|mesh-list
20174523|NCT00165139|Sargramostim|sargramostim|mesh-list
20174524|NCT00165139|Lenograstim|lenograstim|mesh-list
20174525|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174526|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
20174527|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174528|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174529|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20174530|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
20174531|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174532|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174533|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20174534|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20174535|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20174536|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20174537|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174538|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174539|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174540|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174541|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20174542|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20174543|NCT00165178|Leucovorin|leucovorin|mesh-list
20174544|NCT00165178|Cytarabine|cytarabine|mesh-list
20174545|NCT00165178|Dexamethasone|dexamethasone|mesh-list
20174546|NCT00165178|Prednisone|prednisone|mesh-list
20174547|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
20174548|NCT00165178|Doxorubicin|doxorubicin|mesh-list
20174549|NCT00165178|Methotrexate|methotrexate|mesh-list
20174550|NCT00165178|Vincristine|vincristine|mesh-list
20174551|NCT00165178|Asparaginase|asparaginase|mesh-list
19649729|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
19649730|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19649731|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19649732|NCT02338544|Analgesics|analgesics|mesh-ancestor
19649733|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
19649734|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649735|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649736|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19649737|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823879|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334512|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20334513|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
20334514|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
20334515|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
20334516|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
20334517|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334518|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334519|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20334520|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20334521|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334522|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20334523|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19823880|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823881|NCT00551291|Hematinics|hematinics|mesh-ancestor
19823882|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19649738|NCT02338570|Everolimus|everolimus|mesh-list
19823883|NCT00551421|Cetuximab|cetuximab|mesh-list
19823884|NCT00551421|Pertuzumab|pertuzumab|mesh-list
19823885|NCT00551421|Irinotecan|irinotecan|mesh-list
19823886|NCT00551421|Antibodies|antibodies|mesh-list
19823887|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
19823888|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19823889|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
19823890|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823891|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823892|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19823893|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19823894|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823895|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823896|NCT00551460|Methotrexate|methotrexate|mesh-list
19823897|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
19823898|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
19823899|NCT00551460|Tretinoin|tretinoin|mesh-list
19823900|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
19823901|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19823902|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
19823903|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19823904|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823905|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19823906|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
19823907|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166056|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166057|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166058|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20166059|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166060|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
20166061|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
20166062|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166063|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20166064|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20166065|NCT00138970|Protective Agents|protective agents|mesh-ancestor
20166066|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20166067|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20166068|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
20166069|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19823908|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823909|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19823910|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823911|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19823912|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823913|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
19823914|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823915|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19823916|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
19823917|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20166070|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166071|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166072|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166073|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
20166074|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
20166075|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166076|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
20334524|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
19649739|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649740|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334525|NCT00790153|Insulin|insulin|mesh-list
20334526|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20334527|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823918|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
19823919|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19823920|NCT00551525|Analgesics|analgesics|mesh-ancestor
19823921|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
19823922|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823923|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334528|NCT00790179|Ropivacaine|ropivacaine|mesh-list
20334529|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
20334530|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
20334531|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334532|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334533|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
20334534|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334535|NCT00790244|Doxorubicin|doxorubicin|mesh-list
20334536|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20334537|NCT00790244|Ifosfamide|ifosfamide|mesh-list
20334538|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
20334539|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19823924|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
19823925|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19823926|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
19823927|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823928|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823929|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19823930|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
19823931|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19823932|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
19823933|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823934|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823935|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19823936|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
19823937|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
19649741|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
19649742|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649743|NCT02338622|Olaparib|olaparib|mesh-list
19649744|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19649745|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649746|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649747|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649748|NCT02338466|Tenecteplase|tenecteplase|mesh-list
19649749|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19649750|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19649751|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649752|NCT02338323|Febuxostat|febuxostat|mesh-list
19823938|NCT00551642|Protective Agents|protective agents|mesh-ancestor
19834992|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649753|NCT02338323|Benzbromarone|benzbromarone|mesh-list
19649754|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
20334540|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823939|NCT00551707|Prednisolone|prednisolone|mesh-list
19823940|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19823941|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
19823942|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19823943|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
19823944|NCT00551707|Dipyridamole|dipyridamole|mesh-list
19823945|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19823946|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
19823947|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823948|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
19823949|NCT00551707|Hormones|hormones|mesh-ancestor
19823950|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19823951|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823952|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20166077|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166078|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20166079|NCT00138983|Vitamin D|vitamin d|mesh-list
19823953|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823954|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
19823955|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
19823956|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19823957|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19823958|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19823959|NCT00551707|Protective Agents|protective agents|mesh-ancestor
19823960|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19823961|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19823962|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19823963|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19823964|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
19823965|NCT00551759|Docetaxel|docetaxel|mesh-list
19823966|NCT00551759|Fluorouracil|fluorouracil|mesh-list
19823967|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
19823968|NCT00551759|Cetuximab|cetuximab|mesh-list
19823969|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166080|NCT00138983|Alendronate|alendronate|mesh-list
20334541|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20334542|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20334543|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334544|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334545|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20334546|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
20334547|NCT00790387|Heparin|heparin|mesh-list
20334548|NCT00790387|Enoxaparin|enoxaparin|mesh-list
20334549|NCT00790387|Calcium heparin|calcium heparin|mesh-list
20334550|NCT00790387|Tirofiban|tirofiban|mesh-list
20334551|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
20334552|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19823970|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
19823971|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
20166081|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
20166082|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20166083|NCT00138983|Vitamins|vitamins|mesh-ancestor
20166084|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
20166085|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823972|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
20166086|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20334553|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19823973|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611782|NCT00026312|Interleukin-2|interleukin-2|mesh-list
20611783|NCT00026312|Tretinoin|tretinoin|mesh-list
20611784|NCT00026312|Dinutuximab|dinutuximab|mesh-list
20611785|NCT00026312|Isotretinoin|isotretinoin|mesh-list
20611786|NCT00026312|Sargramostim|sargramostim|mesh-list
19823974|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
19823975|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649755|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649756|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
19649757|NCT02338323|Renal Agents|renal agents|mesh-ancestor
19649758|NCT02338310|Letrozole|letrozole|mesh-list
19649759|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19649760|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823976|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823977|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
19823978|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823979|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19823980|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
19823981|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19823982|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
19823983|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19823984|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19823985|NCT00552071|Octreotide|octreotide|mesh-list
19823986|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19823987|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19823988|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19823989|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
19823990|NCT00552110|Phenylephrine|phenylephrine|mesh-list
19823991|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
19823992|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19823993|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
20334554|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334555|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19649761|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19823994|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19823995|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19823996|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19823997|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
19823998|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19823999|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824000|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824001|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
19824002|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
19824003|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824004|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
19649762|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824005|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19824006|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824007|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19824008|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
19824009|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19824010|NCT00552110|Protective Agents|protective agents|mesh-ancestor
19824011|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19824012|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19824013|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19824014|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824015|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824016|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824017|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824018|NCT00552175|Analgesics|analgesics|mesh-ancestor
19824019|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
19824020|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824021|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
20166087|NCT00139009|Cyclosporine|cyclosporine|mesh-list
20166088|NCT00139009|Cyclosporins|cyclosporins|mesh-list
20166089|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166090|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166091|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166092|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
20166093|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166094|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
20166095|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649763|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649764|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19649765|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
19649766|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824022|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20166096|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20334556|NCT00790413|Rituximab|rituximab|mesh-list
20334557|NCT00790413|Fludarabine|fludarabine|mesh-list
19649767|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649768|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19649769|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
19649770|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649771|NCT02338089|Oxytocin|oxytocin|mesh-list
19824023|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
19824024|NCT00552188|Atreleuton|atreleuton|mesh-list
20166097|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166098|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20166099|NCT00139035|Cyclosporine|cyclosporine|mesh-list
20166100|NCT00139035|Cyclosporins|cyclosporins|mesh-list
19649772|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
19824025|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19824026|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824027|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824028|NCT00552240|Ritonavir|ritonavir|mesh-list
19824029|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19824030|NCT00552240|Tenofovir|tenofovir|mesh-list
19824031|NCT00552240|Emtricitabine|emtricitabine|mesh-list
19824032|NCT00552240|Nevirapine|nevirapine|mesh-list
19649773|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649774|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649775|NCT02338232|Telmisartan|telmisartan|mesh-list
19649776|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19649777|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19649778|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19649779|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649780|NCT02338245|Capecitabine|capecitabine|mesh-list
19649781|NCT02338245|Lapatinib|lapatinib|mesh-list
19649782|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19649783|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
19649784|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649785|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649786|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19649787|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649788|NCT02338206|Hormones|hormones|mesh-list
19649789|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649790|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649791|NCT02338011|Gefitinib|gefitinib|mesh-list
19649792|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649793|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19649794|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649795|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649796|NCT02338115|Paclitaxel|paclitaxel|mesh-list
19649797|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19824033|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19824034|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19824035|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
19824036|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824037|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824038|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19824039|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19824040|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
19824041|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824042|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19824043|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19824044|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19824045|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19824046|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19824047|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19824048|NCT00552279|Vaccines|vaccines|mesh-list
19824049|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
19824050|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824051|NCT00552305|Lacosamide|lacosamide|mesh-list
19824052|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
19824053|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20166101|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166102|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166103|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166104|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
20166105|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334558|NCT00790413|Thiotepa|thiotepa|mesh-list
19824054|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20334559|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20611787|NCT00026312|Vitamins|vitamins|mesh-ancestor
19824055|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824056|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824057|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
19824058|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824059|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
19824060|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824061|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824062|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
19824063|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19824064|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824065|NCT00552409|Vitamins|vitamins|mesh-ancestor
19824066|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
19824067|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19824068|NCT00552422|Domperidone|domperidone|mesh-list
19824069|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
19824070|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
19824071|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824072|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824073|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19824074|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19824075|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
19824076|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824077|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824078|NCT00552578|Buprenorphine|buprenorphine|mesh-list
19824079|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19824080|NCT00552578|Naloxone|naloxone|mesh-list
19824081|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19824082|NCT00552578|Narcotics|narcotics|mesh-ancestor
19824083|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824084|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824085|NCT00552578|Analgesics|analgesics|mesh-ancestor
20334560|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334561|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334562|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
19824086|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
19824087|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824088|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19824089|NCT00552617|Rocuronium|rocuronium|mesh-list
19824090|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
19824091|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19824092|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19824093|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19824094|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824095|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824096|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19824097|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19824098|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
19824099|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824100|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824101|NCT00552669|Sirolimus|sirolimus|mesh-list
19824102|NCT00552669|Paclitaxel|paclitaxel|mesh-list
19824103|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19824104|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824105|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
19824106|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19824107|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19824108|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824109|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19824110|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824111|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19824112|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
19824113|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824114|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
19824115|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824116|NCT00552695|Lidocaine|lidocaine|mesh-list
19824117|NCT00552695|Tetracaine|tetracaine|mesh-list
19824118|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
19824119|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
19824120|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824121|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824122|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
19824123|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334563|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824124|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20166106|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
19824125|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19824126|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19824127|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824128|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824129|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
20334564|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334565|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334566|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334567|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20334568|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
20334569|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20334570|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824130|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19824131|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
19824132|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824133|NCT00552786|Expectorants|expectorants|mesh-ancestor
19824134|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824135|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19824136|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
19824137|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824138|NCT00552786|Protective Agents|protective agents|mesh-ancestor
19824139|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824140|NCT00552786|Antidotes|antidotes|mesh-ancestor
19824141|NCT00553059|Dexamethasone|dexamethasone|mesh-list
19824142|NCT00553059|Dronabinol|dronabinol|mesh-list
19824143|NCT00553059|Palonosetron|palonosetron|mesh-list
19824144|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824145|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
19824146|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
19824147|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824148|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824149|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19824150|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
19824151|NCT00553059|Hormones|hormones|mesh-ancestor
19824152|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824153|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19824154|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824155|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19824156|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19824157|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
19824158|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824159|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824160|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
19824161|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19824162|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19824163|NCT00553059|Analgesics|analgesics|mesh-ancestor
19824164|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
19824165|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19824166|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19824167|NCT00553098|Cyclosporine|cyclosporine|mesh-list
19824168|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
19824169|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19824170|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
19824171|NCT00553098|Fludarabine|fludarabine|mesh-list
19824172|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
19824173|NCT00553098|Antibodies|antibodies|mesh-list
20334571|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20334572|NCT00790439|Cyclosporine|cyclosporine|mesh-list
20334573|NCT00790439|Sirolimus|sirolimus|mesh-list
19649798|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649799|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
19649800|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
19649801|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
19649802|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649803|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
19649804|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649805|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19649806|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19649807|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
19649808|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649809|NCT02337855|Antacids|antacids|mesh-ancestor
19649810|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824174|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
19824175|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20334574|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
19649811|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20334575|NCT00790439|Heparin|heparin|mesh-list
20334576|NCT00790439|Calcium heparin|calcium heparin|mesh-list
20334577|NCT00790439|Dextrans|dextrans|mesh-list
20334578|NCT00790439|Tacrolimus|tacrolimus|mesh-list
20334579|NCT00790439|Cyclosporins|cyclosporins|mesh-list
20334580|NCT00790439|Basiliximab|basiliximab|mesh-list
20334581|NCT00790439|Daclizumab|daclizumab|mesh-list
20334582|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334583|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
20334584|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334585|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20334586|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824176|NCT00553098|Cyclosporins|cyclosporins|mesh-list
19824177|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
19824178|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824179|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824180|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19824181|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
19824182|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824183|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824184|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824185|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
19824186|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824187|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824188|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824189|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19824190|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19824191|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19824192|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
19824193|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19824194|NCT00553150|Everolimus|everolimus|mesh-list
19824195|NCT00553150|Temozolomide|temozolomide|mesh-list
19824196|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334587|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334588|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
20334589|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334590|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20334591|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334592|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20334593|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334594|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20334595|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
20334596|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20334597|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
20334598|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20334599|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20334600|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
20334601|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
20334602|NCT00790595|Sunitinib|sunitinib|mesh-list
20334603|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334604|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20334605|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20334606|NCT00790595|Growth Substances|growth substances|mesh-ancestor
20334607|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334608|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
20334609|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334610|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334611|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334612|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
20334613|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20334614|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
20334615|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334616|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334617|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20334618|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
20334619|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20334620|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
20334621|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334622|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334623|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19824197|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334624|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
19824198|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
19824199|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824200|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19824201|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
19824202|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824203|NCT00553202|Cyclosporine|cyclosporine|mesh-list
19824204|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
19824205|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19824206|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19824207|NCT00553202|Prednisolone|prednisolone|mesh-list
19824208|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
19824209|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
19824210|NCT00553202|Busulfan|busulfan|mesh-list
19824211|NCT00553202|Methotrexate|methotrexate|mesh-list
19824212|NCT00553202|Tacrolimus|tacrolimus|mesh-list
19824213|NCT00553202|Cyclosporins|cyclosporins|mesh-list
19824214|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
19824215|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19824216|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19824217|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
19824218|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824219|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
19824220|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824221|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824222|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19824223|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
19824224|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824225|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824226|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19824227|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19824228|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
19824229|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19824230|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20166107|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166108|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
20166109|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166110|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19824231|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
19824232|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824233|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824234|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19824235|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19824236|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19824237|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
19824238|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824239|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824240|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
19824241|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
19824242|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824243|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19824244|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
19824245|NCT00553202|Hormones|hormones|mesh-ancestor
19824246|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824247|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19824248|NCT00553202|Protective Agents|protective agents|mesh-ancestor
19824249|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19824250|NCT00553267|Amlodipine|amlodipine|mesh-list
19824251|NCT00553267|Telmisartan|telmisartan|mesh-list
19824252|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19824253|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19824254|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19824255|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824256|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824257|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19824258|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824259|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
19824260|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19824261|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19824262|NCT00553280|Pregabalin|pregabalin|mesh-list
19824263|NCT00553280|Analgesics|analgesics|mesh-ancestor
19824264|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
19824265|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824266|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824267|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
19824268|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19824269|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824270|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824271|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19824272|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19824273|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19824274|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824275|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19824276|NCT00553319|Amphetamine|amphetamine|mesh-list
19824277|NCT00553319|Adderall|adderall|mesh-list
19824278|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19824279|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824280|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
19824281|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
19824282|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824283|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
19824284|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824285|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824286|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
19824287|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19649812|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
19649813|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
19649814|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19649815|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19824288|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19824289|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824290|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19824291|NCT00553358|Paclitaxel|paclitaxel|mesh-list
19824292|NCT00553358|Trastuzumab|trastuzumab|mesh-list
19824293|NCT00553358|Lapatinib|lapatinib|mesh-list
19824294|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19824295|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824296|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19824297|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19824298|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19824299|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824300|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19824301|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824302|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824303|NCT00553410|Letrozole|letrozole|mesh-list
19824304|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824305|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19824306|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19824307|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824308|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824309|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19824310|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
19824311|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824312|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824313|NCT00553462|Paclitaxel|paclitaxel|mesh-list
19824314|NCT00553462|Carboplatin|carboplatin|mesh-list
19824315|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19824316|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19824317|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19824318|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334625|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
20334626|NCT00790608|Protective Agents|protective agents|mesh-ancestor
20334627|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20334628|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334629|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334630|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334631|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334632|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19649816|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649817|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649818|NCT02337881|Urological Agents|urological agents|mesh-ancestor
19665182|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665183|NCT02905110|Methotrexate|methotrexate|mesh-list
19665184|NCT02905110|Etoposide|etoposide|mesh-list
19665185|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19665186|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
19665187|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665188|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824319|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
19824320|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
19824321|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
19824322|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824323|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824324|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824325|NCT00553475|Pregabalin|pregabalin|mesh-list
19824326|NCT00553475|Analgesics|analgesics|mesh-ancestor
19824327|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
19824328|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824329|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824330|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
19824331|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19824332|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824333|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824334|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19824335|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19824336|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19824337|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824338|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19824339|NCT00553501|Rituximab|rituximab|mesh-list
19824340|NCT00553501|Epratuzumab|epratuzumab|mesh-list
19824341|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19824342|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824343|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
19824344|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824345|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824346|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19824347|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19824348|NCT00553514|Hormones|hormones|mesh-ancestor
19824349|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824350|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824351|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19824352|NCT00553605|Ketoprofen|ketoprofen|mesh-list
19824353|NCT00553605|Parecoxib|parecoxib|mesh-list
19824354|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19824355|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19824356|NCT00553605|Analgesics|analgesics|mesh-ancestor
19824357|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
19824358|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824359|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824360|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824361|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824362|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20334633|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334634|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334635|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
20334636|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334637|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824363|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824364|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824365|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19824366|NCT00553644|Lenalidomide|lenalidomide|mesh-list
19824367|NCT00553644|Bortezomib|bortezomib|mesh-list
19824368|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
19824369|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824370|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19824371|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19824372|NCT00553644|Growth Substances|growth substances|mesh-ancestor
19824373|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
19824374|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824375|NCT00553696|Sunitinib|sunitinib|mesh-list
19824376|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824377|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19824378|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19824379|NCT00553696|Growth Substances|growth substances|mesh-ancestor
19824380|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334638|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334639|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334640|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
20334641|NCT00790816|Lapatinib|lapatinib|mesh-list
20334642|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
20334643|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334644|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824381|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
20334645|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334646|NCT00790881|Lumefantrine|lumefantrine|mesh-list
20334647|NCT00790881|Artemether|artemether|mesh-list
19824382|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824383|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824384|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824385|NCT00553735|Cyclosporine|cyclosporine|mesh-list
19824386|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
19824387|NCT00553735|Cyclosporins|cyclosporins|mesh-list
19824388|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824389|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824390|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824391|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
19824392|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824393|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
19824394|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824395|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824396|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824397|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19824398|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19824399|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19824400|NCT00553839|Ketamine|ketamine|mesh-list
19824401|NCT00553839|Analgesics|analgesics|mesh-ancestor
19824402|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
19824403|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824404|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824405|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19824406|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19824407|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
19824408|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
19824409|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824410|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19824411|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19824412|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824413|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824414|NCT00553969|Carvedilol|carvedilol|mesh-list
19824415|NCT00553969|Lisinopril|lisinopril|mesh-list
19824416|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19824417|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19824418|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
19824419|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824420|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824421|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824422|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19824423|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
20166111|NCT00139061|Atorvastatin|atorvastatin|mesh-list
20166112|NCT00139061|Torcetrapib|torcetrapib|mesh-list
20166113|NCT00139061|Fenofibrate|fenofibrate|mesh-list
19824424|NCT00553969|Protective Agents|protective agents|mesh-ancestor
19824425|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19824426|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824427|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19824428|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
19824429|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19824430|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19824431|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19824432|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
19824433|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824434|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19824435|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19824436|NCT00554099|Mesalamine|mesalamine|mesh-list
19824437|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824438|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19824439|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19824440|NCT00554099|Analgesics|analgesics|mesh-ancestor
19824441|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
19824442|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166114|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20166115|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20166116|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
20166117|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166118|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20166119|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20334648|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19824443|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824444|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824445|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824446|NCT00554216|Topiramate|topiramate|mesh-list
19824447|NCT00554216|Phentermine|phentermine|mesh-list
19824448|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
19824449|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19824450|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824451|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19824452|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
19824453|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19824454|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
19824455|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
19824456|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824457|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
19824458|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824459|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824460|NCT00554463|Etoposide|etoposide|mesh-list
19824461|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824462|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19824463|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19824464|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19824465|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824466|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824467|NCT00554515|Aldesleukin|aldesleukin|mesh-list
19824468|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824469|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19824470|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19824471|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
19824472|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824473|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
19824474|NCT00554788|Thiotepa|thiotepa|mesh-list
19824475|NCT00554788|Cisplatin|cisplatin|mesh-list
19824476|NCT00554788|Carboplatin|carboplatin|mesh-list
19824477|NCT00554788|Etoposide|etoposide|mesh-list
19824478|NCT00554788|Vincristine|vincristine|mesh-list
19824479|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
19824480|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
19824481|NCT00554788|Lenograstim|lenograstim|mesh-list
19824482|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824483|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
19824484|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824485|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824486|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19824487|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
19824488|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824489|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824490|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20334649|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
20334650|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20334651|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20334652|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334653|NCT00790894|Epothilones|epothilones|mesh-list
20334654|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
20334655|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
20334656|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
19824491|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19824492|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19824493|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19824494|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824495|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19824496|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
19824497|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
19824498|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
19824499|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
19824500|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824501|NCT00554853|Pioglitazone|pioglitazone|mesh-list
19824502|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
19824503|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20334657|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824504|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824505|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
19824506|NCT00554970|Budesonide|budesonide|mesh-list
19824507|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824508|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19824509|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
19824510|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334658|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334659|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
20334660|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20334661|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20334662|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334663|NCT00790946|Valsartan|valsartan|mesh-list
20334664|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19824511|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824512|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19824513|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824514|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
19824515|NCT00554970|Hormones|hormones|mesh-ancestor
19824516|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824517|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
19824518|NCT00555048|Busulfan|busulfan|mesh-list
19824519|NCT00555048|Methotrexate|methotrexate|mesh-list
19824520|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
19824521|NCT00555048|Tacrolimus|tacrolimus|mesh-list
19824522|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824523|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
19649819|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
19649820|NCT02337972|Povidone|povidone|mesh-list
19649821|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
19649822|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
19649823|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19649824|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649825|NCT02337712|Etoposide|etoposide|mesh-list
19824524|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824525|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824526|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19824527|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
19824528|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824529|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824530|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19824531|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19824532|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
19824533|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20166120|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166121|NCT00139074|Valproic Acid|valproic acid|mesh-list
20166122|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20166123|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
20166124|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20166125|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20166126|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20166127|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166128|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166129|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
20166130|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166131|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166132|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
20166133|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166134|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
20166135|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
20166136|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20166137|NCT00139152|Omalizumab|omalizumab|mesh-list
20166138|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19649826|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649827|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19649828|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19649829|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19649830|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649831|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649832|NCT02337426|Temozolomide|temozolomide|mesh-list
19649833|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19649834|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19649835|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
19649836|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649837|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649838|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824534|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19824535|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
19824536|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824537|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824538|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19824539|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19824540|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19824541|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19824542|NCT00555061|Retapamulin|retapamulin|mesh-list
19824543|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19824544|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824545|NCT00555152|Lapatinib|lapatinib|mesh-list
19824546|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824547|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824548|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824549|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824550|NCT00555217|Losartan|losartan|mesh-list
19824551|NCT00555217|Lisinopril|lisinopril|mesh-list
19824552|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19824553|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19824554|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19824555|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19824556|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824557|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19824558|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
19824559|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824560|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19824561|NCT00555217|Protective Agents|protective agents|mesh-ancestor
19824562|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824563|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
19824564|NCT00555321|Abatacept|abatacept|mesh-list
19824565|NCT00555321|Tacrolimus|tacrolimus|mesh-list
19824566|NCT00555321|Basiliximab|basiliximab|mesh-list
19824567|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824568|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
19824569|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824570|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19824571|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824572|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824573|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19824574|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824575|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19824576|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
19824577|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19824578|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824579|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19824580|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824581|NCT00555425|Buprenorphine|buprenorphine|mesh-list
19824582|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19824583|NCT00555425|Naloxone|naloxone|mesh-list
20334665|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20334666|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20334667|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334668|NCT00790985|Naproxen|naproxen|mesh-list
20334669|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20334670|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20334671|NCT00790985|Analgesics|analgesics|mesh-ancestor
20334672|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
20334673|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334674|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334675|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20334676|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334677|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
19824584|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19824585|NCT00555425|Narcotics|narcotics|mesh-ancestor
19824586|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824587|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824588|NCT00555425|Analgesics|analgesics|mesh-ancestor
19824589|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
19824590|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824591|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19824592|NCT00555438|PENTA|penta|mesh-list
20334678|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20334679|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334680|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334681|NCT00790998|Ivermectin|ivermectin|mesh-list
20334682|NCT00790998|Moxidectin|moxidectin|mesh-list
20334683|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20334684|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334685|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
20334686|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
20334687|NCT00791011|Bortezomib|bortezomib|mesh-list
20334688|NCT00791011|Vorinostat|vorinostat|mesh-list
20334689|NCT00791011|Conatumumab|conatumumab|mesh-list
20334690|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334691|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20334692|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334693|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334694|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334695|NCT00791024|Lidocaine|lidocaine|mesh-list
20334696|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
20334697|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
20334698|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334699|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334700|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
20334701|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334702|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20334703|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20334704|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20334705|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334706|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334707|NCT00791141|Cetuximab|cetuximab|mesh-list
20334708|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20334709|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334710|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20334711|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334712|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334713|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824593|NCT00555438|Fondaparinux|fondaparinux|mesh-list
19824594|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19824595|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
19824596|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19824597|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
19824598|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824599|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824600|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
19824601|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19824602|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19824603|NCT00555464|Prednisone|prednisone|mesh-list
19824604|NCT00555464|Prednisolone|prednisolone|mesh-list
19824605|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19824606|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
19824607|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19824608|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
19824609|NCT00555464|Vincristine|vincristine|mesh-list
19824610|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19824611|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
19824612|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824613|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
19824614|NCT00555464|Hormones|hormones|mesh-ancestor
19824615|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824616|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334714|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334715|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334716|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334717|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334718|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
20334719|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824617|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19824618|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824619|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19824620|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
19824621|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
19824622|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
19824623|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824624|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
19824625|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
19824626|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824627|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19824628|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19824629|NCT00555464|Protective Agents|protective agents|mesh-ancestor
19824630|NCT00555477|Anastrozole|anastrozole|mesh-list
19824631|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19824632|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824633|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19824634|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19824635|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824636|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824637|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19824638|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
19824639|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824640|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824641|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
19824642|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824643|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824644|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824645|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824646|NCT00555620|Capecitabine|capecitabine|mesh-list
19824647|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
19824648|NCT00555620|Sunitinib|sunitinib|mesh-list
19824649|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824650|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19824651|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
19824652|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824653|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19824654|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19824655|NCT00555620|Growth Substances|growth substances|mesh-ancestor
19824656|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824657|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
19824658|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824659|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824660|NCT00555672|Fluorouracil|fluorouracil|mesh-list
19824661|NCT00555672|Sunitinib|sunitinib|mesh-list
19824662|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824663|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
19824664|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166139|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20166140|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
20166141|NCT00139165|Budesonide|budesonide|mesh-list
20166142|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166143|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20166144|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
20166145|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166146|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166147|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20166148|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
20166149|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
20166150|NCT00139165|Hormones|hormones|mesh-ancestor
20166151|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166152|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
20166153|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20166154|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166155|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
20166156|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20334720|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334721|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334722|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334723|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
20334724|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20334725|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334726|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334727|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611788|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
20166157|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
19824665|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19824666|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824667|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
19824668|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824669|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19824670|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19824671|NCT00555672|Growth Substances|growth substances|mesh-ancestor
19824672|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
19824673|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824674|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824675|NCT00555750|Eszopiclone|eszopiclone|mesh-list
19824676|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19824677|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824678|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166158|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166159|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824679|NCT00555880|Midodrine|midodrine|mesh-list
19824680|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
19824681|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
19824682|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824683|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824684|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19824685|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19824686|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19824687|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19824688|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19824689|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824690|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824691|NCT00555893|Oseltamivir|oseltamivir|mesh-list
19824692|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
20334728|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334729|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334730|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334731|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334732|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
20334733|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334734|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334735|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334736|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334737|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
20334738|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20334739|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334740|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334741|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334742|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334743|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334744|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334745|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334746|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
20334747|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334748|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824693|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824694|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824695|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824696|NCT00555906|Dexamethasone|dexamethasone|mesh-list
19824697|NCT00555906|Bortezomib|bortezomib|mesh-list
19824698|NCT00555906|Palbociclib|palbociclib|mesh-list
19824699|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824700|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
20166160|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20166161|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
20166162|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20166163|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
20166164|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166165|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166166|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20166167|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
20166168|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
20166169|NCT00139217|Protective Agents|protective agents|mesh-ancestor
20166170|NCT00139230|Leucovorin|leucovorin|mesh-list
20166171|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
19824701|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
19824702|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334749|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334750|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334751|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
20334752|NCT00791271|Interferons|interferons|mesh-list
20334753|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
20334754|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
20334755|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19824703|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824704|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19824705|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
19824706|NCT00555906|Hormones|hormones|mesh-ancestor
19824707|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824708|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19824709|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824710|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824711|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824712|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824713|NCT00555971|Omalizumab|omalizumab|mesh-list
19824714|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19824715|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19824716|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824717|NCT00555997|Ziprasidone|ziprasidone|mesh-list
19824718|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19824719|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
19824720|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824721|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824722|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824723|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19824724|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19824725|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824726|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19824727|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19824728|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
20334756|NCT00791271|Decitabine|decitabine|mesh-list
20334757|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334758|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
20334759|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334760|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
20334761|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334762|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20334763|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
20334764|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334765|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334766|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20334767|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334768|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334769|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334770|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334771|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19824729|NCT00556049|Gemcitabine|gemcitabine|mesh-list
19824730|NCT00556049|Sunitinib|sunitinib|mesh-list
19824731|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19824732|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
19824733|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824734|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824735|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
19824736|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824737|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824738|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824739|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
20166172|NCT00139230|Fluorouracil|fluorouracil|mesh-list
20166173|NCT00139230|Docetaxel|docetaxel|mesh-list
20166174|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166175|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
20166176|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166177|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20166178|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166179|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
20166180|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166181|NCT00139230|Antidotes|antidotes|mesh-ancestor
20166182|NCT00139230|Protective Agents|protective agents|mesh-ancestor
20166183|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
20166184|NCT00139230|Vitamins|vitamins|mesh-ancestor
20166185|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
20166186|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
20166187|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
20334772|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334773|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19824740|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824741|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19824742|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19824743|NCT00556049|Growth Substances|growth substances|mesh-ancestor
19824744|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
19824745|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824746|NCT00556140|Aripiprazole|aripiprazole|mesh-list
19824747|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
19824748|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19824749|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19824750|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19824751|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824752|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824753|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
19824754|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
19824755|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334774|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
20334775|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824756|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824757|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19824758|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19824759|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
19824760|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19824761|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19824762|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19824763|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19824764|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19824765|NCT00556322|Docetaxel|docetaxel|mesh-list
19824766|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824767|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334776|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334777|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334778|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334779|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
20334780|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
20334781|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20334782|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
20334783|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20334784|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334785|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19649839|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824768|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824769|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824770|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
19824771|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
19824772|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
19824773|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
19824774|NCT00556374|Denosumab|denosumab|mesh-list
19824775|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19824776|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19824777|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824778|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19824779|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824780|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824781|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19649840|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
19649841|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649842|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19649843|NCT02337413|Laxatives|laxatives|mesh-ancestor
19649844|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19649845|NCT02337283|BI 425809|bi 425809|mesh-list
19649846|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
19649847|NCT02337257|Vitamin D|vitamin d|mesh-list
19649848|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
19649849|NCT02337257|Vitamins|vitamins|mesh-ancestor
19649850|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
19649851|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649852|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19649853|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20334786|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19649854|NCT02337231|Borage oil|borage oil|mesh-list
19649855|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649856|NCT02337322|Ritonavir|ritonavir|mesh-list
19824782|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
19824783|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824784|NCT00556439|Abatacept|abatacept|mesh-list
19824785|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19824786|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824787|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824788|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824789|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
19824790|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824791|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19824792|NCT00556452|Busulfan|busulfan|mesh-list
19824793|NCT00556452|Clofarabine|clofarabine|mesh-list
19649857|NCT02337322|Darunavir|darunavir|mesh-list
20334787|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334788|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334789|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334790|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334791|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19649858|NCT02337322|Dolutegravir|dolutegravir|mesh-list
19649859|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19649860|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19649861|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
19649862|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824794|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
19824795|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824796|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824797|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
19824798|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824799|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19824800|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824801|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19824802|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19824803|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
20334792|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334793|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334794|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
20334795|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334796|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824804|NCT00556478|Lidocaine|lidocaine|mesh-list
19824805|NCT00556478|Prilocaine|prilocaine|mesh-list
19824806|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19824807|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
19824808|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
19824809|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19824810|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824811|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
19824812|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824813|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19824814|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19824815|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19824816|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824817|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824818|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19824819|NCT00556491|Minocycline|minocycline|mesh-list
19824820|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19824821|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824822|NCT00556504|Ribavirin|ribavirin|mesh-list
19824823|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19824824|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19824825|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
19824826|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824827|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
19824828|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649863|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649864|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19649865|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19649866|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
19649867|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649868|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19649869|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19649870|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19649871|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19649872|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
19824829|NCT00556673|Fluticasone|fluticasone|mesh-list
19824830|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
19824831|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19824832|NCT00556673|Maleic acid|maleic acid|mesh-list
19824833|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824834|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19824835|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
19824836|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824837|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824838|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19824839|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824840|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824841|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19824842|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19824843|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19824844|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19824845|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
19824846|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824847|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824848|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824849|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19824850|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824851|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19824852|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824853|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834993|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19834994|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
19834995|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19834996|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
19834997|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19834998|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19834999|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835000|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
19835001|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835002|NCT00599924|Leucovorin|leucovorin|mesh-list
19835003|NCT00599924|Sunitinib|sunitinib|mesh-list
19835004|NCT00599924|Fluorouracil|fluorouracil|mesh-list
19835005|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
19835006|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835007|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835008|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835009|NCT00599924|Growth Substances|growth substances|mesh-ancestor
19835010|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835011|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835012|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835013|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835014|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835015|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
19835016|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19835017|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835018|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
20334797|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334798|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334799|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
20334800|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19835019|NCT00599924|Antidotes|antidotes|mesh-ancestor
19835020|NCT00599924|Protective Agents|protective agents|mesh-ancestor
19835021|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
19835022|NCT00599924|Vitamins|vitamins|mesh-ancestor
19835023|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
19835024|NCT00600028|Thalidomide|thalidomide|mesh-list
19835025|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835026|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
19835027|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835028|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
19835029|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19835030|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835031|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835032|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835033|NCT00600028|Growth Substances|growth substances|mesh-ancestor
19835034|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835035|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835036|NCT00600067|Topiramate|topiramate|mesh-list
20334801|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19824854|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
19824855|NCT00556933|Sirolimus|sirolimus|mesh-list
19824856|NCT00556933|Tacrolimus|tacrolimus|mesh-list
19824857|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
19824858|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19824859|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824860|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
19824861|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824862|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19824863|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824864|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824865|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19824866|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824867|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19824868|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
19824869|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19824870|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824871|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
19824872|NCT00556998|Voriconazole|voriconazole|mesh-list
19824873|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
19824874|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824875|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19824876|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19824877|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824878|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824879|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19824880|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
19824881|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824882|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824883|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19824884|NCT00557245|Tenofovir|tenofovir|mesh-list
19824885|NCT00557245|Emtricitabine|emtricitabine|mesh-list
19824886|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19824887|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
19824888|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824889|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19824890|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19824891|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824892|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824893|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19824894|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19824895|NCT00557284|Montelukast|montelukast|mesh-list
19824896|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19824897|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824898|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19824899|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
19824900|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824901|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824902|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19824903|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19824904|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824905|NCT00557310|Teriparatide|teriparatide|mesh-list
19824906|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19824907|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166188|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
20166189|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166190|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166191|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20166192|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20334802|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334803|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334804|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334805|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334806|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334807|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334808|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
20334809|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166193|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166194|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20166195|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20166196|NCT00139243|Leucovorin|leucovorin|mesh-list
20334810|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334811|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334812|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334813|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
20334814|NCT00791427|Ranibizumab|ranibizumab|mesh-list
20334815|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20334816|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20334817|NCT00791427|Growth Substances|growth substances|mesh-ancestor
20334818|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334819|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
20334820|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334821|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
20334822|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20334823|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
19824908|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19824909|NCT00557349|Omeprazole|omeprazole|mesh-list
19824910|NCT00557349|Famotidine|famotidine|mesh-list
19824911|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19824912|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19824913|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19824914|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824915|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824916|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19824917|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
19824918|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
19824919|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824920|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824921|NCT00557362|Voriconazole|voriconazole|mesh-list
19824922|NCT00557362|Natamycin|natamycin|mesh-list
19824923|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
19824924|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824925|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19824926|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19824927|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824928|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824929|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19824930|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
19824931|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824932|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824933|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19824934|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19824935|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19824936|NCT00557440|Fluticasone|fluticasone|mesh-list
19824937|NCT00557440|Xhance|xhance|mesh-list
19824938|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
19824939|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19824940|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19824941|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19824942|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19824943|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
19824944|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824945|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824946|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19824947|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
20334824|NCT00791505|Trimethoprim|trimethoprim|mesh-list
19824948|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
19824949|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19824950|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19824951|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19824952|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19824953|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
19824954|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824955|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824956|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
19824957|NCT00557440|Hormones|hormones|mesh-ancestor
19824958|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19824959|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
19824960|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
19824961|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19824962|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
19824963|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19824964|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824965|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20334825|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
20334826|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20334827|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20334828|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20334829|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20334830|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334831|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334832|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334833|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20334834|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19824966|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824967|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19824968|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19824969|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19824970|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
19824971|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824972|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824973|NCT00557492|Gemcitabine|gemcitabine|mesh-list
19824974|NCT00557492|Bevacizumab|bevacizumab|mesh-list
19824975|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19824976|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19824977|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19824978|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19824979|NCT00557492|Growth Substances|growth substances|mesh-ancestor
19824980|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824981|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
19824982|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19824983|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
19824984|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824985|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
19824986|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19824987|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19824988|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19824989|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
19824990|NCT00557622|Paroxetine|paroxetine|mesh-list
19824991|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19824992|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19824993|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19824994|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19824995|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19824996|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
19824997|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19824998|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20334835|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20334836|NCT00791505|Renal Agents|renal agents|mesh-ancestor
20334837|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
20334838|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20334839|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20334840|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20334841|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20334842|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19649873|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19649874|NCT02337192|Curcumin|curcumin|mesh-list
19649875|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19649876|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19649877|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649878|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
19649879|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
19649880|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19649881|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19649882|NCT02337192|Analgesics|analgesics|mesh-ancestor
19649883|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
19649884|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649885|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649886|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19649887|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649888|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649889|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649890|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649891|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
19824999|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
19825000|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825001|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19825002|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19825003|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825004|NCT00557830|Sorafenib|sorafenib|mesh-list
19825005|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825006|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19825007|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334843|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20334844|NCT00791531|Methotrexate|methotrexate|mesh-list
20334845|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20334846|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
20334847|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20334848|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825008|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825009|NCT00558012|Vitamin D|vitamin d|mesh-list
19825010|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
19825011|NCT00558012|Calcium|calcium|mesh-list
20334849|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20334850|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
20334851|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825012|NCT00558012|Vitamins|vitamins|mesh-ancestor
19825013|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
19825014|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825015|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19825016|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19825017|NCT00558025|Pramipexole|pramipexole|mesh-list
19825018|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
19825019|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825020|NCT00558025|Protective Agents|protective agents|mesh-ancestor
19825021|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825022|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19825023|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19825024|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
19825025|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
19825026|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825027|NCT00558064|Amlodipine|amlodipine|mesh-list
19825028|NCT00558064|Telmisartan|telmisartan|mesh-list
19825029|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19825030|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19825031|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20334852|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334853|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
20334854|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334855|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20334856|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334857|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
20334858|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20334859|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20334860|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20334861|NCT00791544|Sorafenib|sorafenib|mesh-list
20334862|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334863|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334864|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334865|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334866|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20334867|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334868|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334869|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334870|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334871|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334872|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334873|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334874|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
20334875|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334876|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334877|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19825032|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825033|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825034|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19825035|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825036|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
19825037|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19825038|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19825039|NCT00558103|Lapatinib|lapatinib|mesh-list
19825040|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825041|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19825042|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825043|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825044|NCT00558259|Dabigatran|dabigatran|mesh-list
19825045|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
19825046|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19825047|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
19825048|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825049|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334878|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334879|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
20334880|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20334881|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20334882|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334883|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334884|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334885|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334886|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20334887|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20334888|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
20334889|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334890|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334891|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20334892|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20334893|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
20334894|NCT00791739|Pregabalin|pregabalin|mesh-list
20334895|NCT00791739|Trazodone|trazodone|mesh-list
20334896|NCT00791739|Analgesics|analgesics|mesh-ancestor
20334897|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
20334898|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334899|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334900|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
19825050|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
19825051|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
19825052|NCT00558272|Saracatinib|saracatinib|mesh-list
19825053|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19825054|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825055|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825056|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825057|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825058|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
19825059|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19825060|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19825061|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19825062|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
19825063|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825064|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825065|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825066|NCT00558363|Dutasteride|dutasteride|mesh-list
19825067|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19825068|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19825069|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825070|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825071|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
19825072|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19825073|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825074|NCT00558428|Amlodipine|amlodipine|mesh-list
19825075|NCT00558428|Telmisartan|telmisartan|mesh-list
19825076|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19825077|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19825078|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19825079|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825080|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825081|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19825082|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825083|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
19825084|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20334901|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19825085|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19825086|NCT00558467|Pramipexole|pramipexole|mesh-list
19825087|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
19825088|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825089|NCT00558467|Protective Agents|protective agents|mesh-ancestor
19825090|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825091|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19825092|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19825093|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
19825094|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
19825095|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825096|NCT00558519|Cytarabine|cytarabine|mesh-list
19649892|NCT02337127|Lamivudine|lamivudine|mesh-list
19649893|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19649894|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19649895|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649896|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649897|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
19649898|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649899|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20334902|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334903|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334904|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20334905|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20334906|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334907|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334908|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334909|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20334910|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20334911|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334912|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
19825097|NCT00558519|Dexamethasone|dexamethasone|mesh-list
19825098|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
19825099|NCT00558519|Doxorubicin|doxorubicin|mesh-list
19825100|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19825101|NCT00558519|Methotrexate|methotrexate|mesh-list
19825102|NCT00558519|Vincristine|vincristine|mesh-list
19825103|NCT00558519|Daunorubicin|daunorubicin|mesh-list
19825104|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
19825105|NCT00558519|Pegaspargase|pegaspargase|mesh-list
19825106|NCT00558519|Thioguanine|thioguanine|mesh-list
19825107|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20334913|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20334914|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348089|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20348090|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20348091|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
20348092|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20348093|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20348094|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
20348095|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
20348096|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348097|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20348098|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20348099|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20348100|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20348101|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20348102|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
20348103|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348104|NCT00863499|Methylphenidate|methylphenidate|mesh-list
20348105|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20348106|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348107|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20348108|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348109|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825108|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
19825109|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825110|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825111|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19825112|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
19825113|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649900|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19825114|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825115|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19825116|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825117|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
19825118|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
20334915|NCT00791804|Fentanyl|fentanyl|mesh-list
20334916|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20334917|NCT00791804|Narcotics|narcotics|mesh-ancestor
19825119|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825120|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20334918|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334919|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334920|NCT00791804|Analgesics|analgesics|mesh-ancestor
20334921|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
20334922|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334923|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20334924|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20334925|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
20334926|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
20334927|NCT00791830|Irbesartan|irbesartan|mesh-list
20334928|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20334929|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20334930|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20334931|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334932|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
20334933|NCT00791856|Testosterone|testosterone|mesh-list
20334934|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
20334935|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
20334936|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19825121|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
19825122|NCT00558519|Hormones|hormones|mesh-ancestor
19825123|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19825124|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825125|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19825126|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19825127|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825128|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825129|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19825130|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
19825131|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19825132|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19825133|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
19825134|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
19825135|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19825136|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19825137|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
19825138|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825139|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19825140|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
19825141|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
19825142|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
19825143|NCT00558571|Empagliflozin|empagliflozin|mesh-list
19825144|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19825145|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825146|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19825147|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825148|NCT00558636|Paclitaxel|paclitaxel|mesh-list
19825149|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20334937|NCT00791856|Androgens|androgens|mesh-ancestor
20334938|NCT00791856|Hormones|hormones|mesh-ancestor
20334939|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20334940|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334941|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20334942|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334943|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
20334944|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
20334945|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
20334946|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20334947|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20334948|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334949|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
19825150|NCT00558636|Carboplatin|carboplatin|mesh-list
19825151|NCT00558636|Sorafenib|sorafenib|mesh-list
19825152|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19825153|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825154|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
19825155|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
19825156|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
19825157|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825158|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19825159|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825160|NCT00558753|Pregabalin|pregabalin|mesh-list
19825161|NCT00558753|Analgesics|analgesics|mesh-ancestor
19825162|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
19825163|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825164|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825165|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
19825166|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19825167|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825168|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825169|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19649901|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
19649902|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19649903|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
19649904|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649905|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
19649906|NCT02337166|Protective Agents|protective agents|mesh-ancestor
19649907|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
19825170|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19825171|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19825172|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19825173|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825174|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19825175|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
19825176|NCT00558896|Dexamethasone|dexamethasone|mesh-list
19825177|NCT00558896|Pomalidomide|pomalidomide|mesh-list
19825178|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825179|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
19825180|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
19825181|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825182|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825183|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825184|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
19825185|NCT00558896|Hormones|hormones|mesh-ancestor
19825186|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20334950|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
20334951|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
20334952|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20334953|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334954|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20334955|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20334956|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
20334957|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
20334958|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334959|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334960|NCT00792012|Temozolomide|temozolomide|mesh-list
20334961|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20334962|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
20334963|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334964|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20334965|NCT00792025|Sunitinib|sunitinib|mesh-list
20334966|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649908|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649909|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334967|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20334968|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20334969|NCT00792025|Growth Substances|growth substances|mesh-ancestor
20334970|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334971|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
20334972|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20334973|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20334974|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334975|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20334976|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20334977|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20334978|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20334979|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334980|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334981|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334982|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19649910|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
19825187|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825188|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825189|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
19825190|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19825191|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19825192|NCT00558896|Growth Substances|growth substances|mesh-ancestor
19825193|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
19825194|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
19825195|NCT00559104|Carmustine|carmustine|mesh-list
19825196|NCT00559104|Etoposide|etoposide|mesh-list
19825197|NCT00559104|Sargramostim|sargramostim|mesh-list
19825198|NCT00559104|Lenograstim|lenograstim|mesh-list
19825199|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825200|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
19825201|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825202|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825203|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19825204|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
19825205|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825206|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825207|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19825208|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19825209|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19825210|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825211|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825212|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19825213|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
19825214|NCT00559273|Hematinics|hematinics|mesh-ancestor
19825215|NCT00559364|Omeprazole|omeprazole|mesh-list
19825216|NCT00559364|Pancrelipase|pancrelipase|mesh-list
19825217|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19825218|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19825219|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825220|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825221|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825222|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19825223|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19825224|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825225|NCT00559468|Bromides|bromides|mesh-list
19825226|NCT00559468|Propofol|propofol|mesh-list
19825227|NCT00559468|Sevoflurane|sevoflurane|mesh-list
19825228|NCT00559468|Rocuronium|rocuronium|mesh-list
19825229|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19825230|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649911|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19649912|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649913|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19649914|NCT02337036|Tacrolimus|tacrolimus|mesh-list
19649915|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649916|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
19649917|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649918|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19649919|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825231|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825232|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19825233|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
20334983|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
19649920|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825234|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
19825235|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19825236|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19825237|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
19825238|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19825239|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19825240|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19825241|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825242|NCT00559507|Saracatinib|saracatinib|mesh-list
20334984|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334985|NCT00792181|Midazolam|midazolam|mesh-list
20334986|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19825243|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825244|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825245|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825246|NCT00559585|Abatacept|abatacept|mesh-list
19825247|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19825248|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825249|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825250|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825251|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
19825252|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825253|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825254|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
19825255|NCT00559637|Hematinics|hematinics|mesh-ancestor
19825256|NCT00559754|Bevacizumab|bevacizumab|mesh-list
19825257|NCT00559754|Docetaxel|docetaxel|mesh-list
19825258|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19825259|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825260|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19825261|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19825262|NCT00559754|Growth Substances|growth substances|mesh-ancestor
19825263|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825264|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
19825265|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
19825266|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
19825267|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
19825268|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825269|NCT00559845|Paclitaxel|paclitaxel|mesh-list
19825270|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
19825271|NCT00559845|Bevacizumab|bevacizumab|mesh-list
19825272|NCT00559845|Fluorouracil|fluorouracil|mesh-list
19825273|NCT00559845|Epirubicin|epirubicin|mesh-list
19825274|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19825275|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825276|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19825277|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
19825278|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
19825279|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20334987|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19649921|NCT02336984|Trastuzumab|trastuzumab|mesh-list
19649922|NCT02336984|Pertuzumab|pertuzumab|mesh-list
19649923|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19649924|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649925|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19649926|NCT02336906|Laxatives|laxatives|mesh-ancestor
19649927|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19649928|NCT02336854|Tacrolimus|tacrolimus|mesh-list
19649929|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649930|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
19649931|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649932|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19649933|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649934|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825280|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825281|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
19825282|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825283|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825284|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19825285|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
19825286|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19825287|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19825288|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19825289|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19825290|NCT00559845|Growth Substances|growth substances|mesh-ancestor
19825291|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
19825292|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
19825293|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19825294|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19825295|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19825296|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825297|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825298|NCT00559962|Atorvastatin|atorvastatin|mesh-list
19825299|NCT00559962|Ezetimibe|ezetimibe|mesh-list
19825300|NCT00559962|Fenofibrate|fenofibrate|mesh-list
19825301|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19825302|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19825303|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
19825304|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825305|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19825306|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19825307|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825308|NCT00560066|Vaccines|vaccines|mesh-list
19825309|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
19825310|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825311|NCT00560352|Dexamethasone|dexamethasone|mesh-list
19825312|NCT00560352|Bortezomib|bortezomib|mesh-list
19825313|NCT00560352|Dasatinib|dasatinib|mesh-list
19825314|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825315|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
19825316|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
19825317|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825318|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825319|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825320|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
19825321|NCT00560352|Hormones|hormones|mesh-ancestor
19825322|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19825323|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825324|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825325|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19825326|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825327|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825328|NCT00560391|Dexamethasone|dexamethasone|mesh-list
19825329|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
19825330|NCT00560391|Lenalidomide|lenalidomide|mesh-list
19825331|NCT00560391|Dasatinib|dasatinib|mesh-list
19825332|NCT00560391|BB 1101|bb 1101|mesh-list
19825333|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825334|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
19825335|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
19825336|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825337|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825338|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825339|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
19825340|NCT00560391|Hormones|hormones|mesh-ancestor
19825341|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19825342|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825343|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825344|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
19825345|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825346|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825347|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
19825348|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19825349|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19825350|NCT00560391|Growth Substances|growth substances|mesh-ancestor
19825351|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
19825352|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19825353|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
19825354|NCT00560404|Hematinics|hematinics|mesh-ancestor
19825355|NCT00560417|Insulin|insulin|mesh-list
19825356|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19825357|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
20334988|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20334989|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20334990|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20334991|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20334992|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20334993|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20334994|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
20334995|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
20334996|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
20334997|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
20334998|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20334999|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825358|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
19825359|NCT00560417|Protamines|protamines|mesh-list
19825360|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19825361|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825362|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
19825363|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825364|NCT00560417|Coagulants|coagulants|mesh-ancestor
19825365|NCT00560508|Pramipexole|pramipexole|mesh-list
19825366|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
19825367|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825368|NCT00560508|Protective Agents|protective agents|mesh-ancestor
19825369|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825370|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19825371|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19825372|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
19825373|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
19825374|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825375|NCT00560573|Gemcitabine|gemcitabine|mesh-list
19825376|NCT00560573|Pemetrexed|pemetrexed|mesh-list
19825377|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825378|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19825379|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
19825380|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825381|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
19825382|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825383|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825384|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825385|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
19825386|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825387|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19825388|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19825389|NCT00560612|Paroxetine|paroxetine|mesh-list
19825390|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20335000|NCT00792246|Voriconazole|voriconazole|mesh-list
20335001|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
20335002|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335003|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20335004|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20335005|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335006|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335007|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20335008|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
20335009|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335010|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335011|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20335012|NCT00792324|Efavirenz|efavirenz|mesh-list
20335013|NCT00792324|Etravirine|etravirine|mesh-list
20166197|NCT00139243|Fluorouracil|fluorouracil|mesh-list
20166198|NCT00139243|Docetaxel|docetaxel|mesh-list
20166199|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166200|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
20166201|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166202|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20166203|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166204|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
20166205|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825391|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20166206|NCT00139243|Antidotes|antidotes|mesh-ancestor
20335014|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20335015|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20335016|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335017|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335018|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
20335019|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335020|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20335021|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20335022|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20335023|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20335024|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20335025|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20335026|NCT00792337|Simvastatin|simvastatin|mesh-list
20335027|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19825392|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825393|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825394|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825395|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
19825396|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825397|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19825398|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
19825399|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825400|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19825401|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19825402|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825403|NCT00560703|Doxycycline|doxycycline|mesh-list
19825404|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19825405|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825406|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
19825407|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19825408|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19825409|NCT00560794|Blinatumomab|blinatumomab|mesh-list
19825410|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19825411|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825412|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
19825413|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825414|NCT00560833|Mirtazapine|mirtazapine|mesh-list
19825415|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825416|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
19825417|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825418|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19825419|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
19825420|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
19825421|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825422|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335028|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20335029|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
20335030|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335031|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20335032|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20335033|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335034|NCT00792350|Sorafenib|sorafenib|mesh-list
20335035|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335036|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20335037|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335038|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335039|NCT00792363|Irinotecan|irinotecan|mesh-list
20335040|NCT00792363|Panitumumab|panitumumab|mesh-list
20335041|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20335042|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20335043|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335044|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335045|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335046|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335047|NCT00792376|Diclofenac|diclofenac|mesh-list
20335048|NCT00792376|Etoricoxib|etoricoxib|mesh-list
20335049|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20335050|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20335051|NCT00792376|Analgesics|analgesics|mesh-ancestor
19825423|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19825424|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19825425|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19825426|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19825427|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19825428|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19825429|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825430|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19825431|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19825432|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
19825433|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19825434|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19825435|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
19825436|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825437|NCT00561002|Vaccines|vaccines|mesh-list
19825438|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
19825439|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825440|NCT00561015|Ribavirin|ribavirin|mesh-list
19825441|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
19825442|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19825443|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
19825444|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825445|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
19825446|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825447|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825448|NCT00561080|Vaccines|vaccines|mesh-list
19825449|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
19825450|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825451|NCT00561353|Ribavirin|ribavirin|mesh-list
19825452|NCT00561353|Simeprevir|simeprevir|mesh-list
19825453|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
19825454|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825455|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
19825456|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825457|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
19825458|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825459|NCT00561392|Rivastigmine|rivastigmine|mesh-list
19825460|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20335052|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
20335053|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335054|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335055|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335056|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335057|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20335058|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335059|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335060|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20335061|NCT00792584|Efavirenz|efavirenz|mesh-list
20335062|NCT00792584|Etravirine|etravirine|mesh-list
20335063|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20335064|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20335065|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335066|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335067|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
20335068|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825461|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825462|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825463|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
19825464|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825465|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825466|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19825467|NCT00561392|Protective Agents|protective agents|mesh-ancestor
19825468|NCT00561418|Vorinostat|vorinostat|mesh-list
20335069|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20335070|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20335071|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20335072|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20335073|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20335074|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20335075|NCT00792662|Methylphenidate|methylphenidate|mesh-list
20335076|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20335077|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335078|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20335079|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20335080|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825469|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825470|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19825471|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825472|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825473|NCT00561470|Leucovorin|leucovorin|mesh-list
19825474|NCT00561470|Fluorouracil|fluorouracil|mesh-list
19825475|NCT00561470|Irinotecan|irinotecan|mesh-list
19825476|NCT00561470|Aflibercept|aflibercept|mesh-list
19825477|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
19825478|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
19825479|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825480|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19825481|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825482|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825483|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
19825484|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825485|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19825486|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825487|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825488|NCT00561470|Antidotes|antidotes|mesh-ancestor
19825489|NCT00561470|Protective Agents|protective agents|mesh-ancestor
19825490|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
19825491|NCT00561470|Vitamins|vitamins|mesh-ancestor
19825492|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
20335081|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335082|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
20335083|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335084|NCT00792714|Mannitol|mannitol|mesh-list
20335085|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20335086|NCT00792714|Diuretics|diuretics|mesh-ancestor
19649935|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19649936|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19649937|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649938|NCT02336659|Incretins|incretins|mesh-ancestor
19649939|NCT02336659|Hormones|hormones|mesh-ancestor
19649940|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19649941|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19649942|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
19825493|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19825494|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20335087|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
20335088|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335089|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
20335090|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20335091|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335092|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335093|NCT00792766|Everolimus|everolimus|mesh-list
20335094|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335095|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335096|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
20335097|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335098|NCT00792779|Propofol|propofol|mesh-list
20335099|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20335100|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335101|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335102|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20335103|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
20335104|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
19825495|NCT00561470|Growth Substances|growth substances|mesh-ancestor
19825496|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
19825497|NCT00561574|Mirtazapine|mirtazapine|mesh-list
19825498|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
19825499|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825500|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19825501|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
19825502|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
19825503|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825504|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825505|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825506|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20335105|NCT00792818|Ibuprofen|ibuprofen|mesh-list
20335106|NCT00792818|Curcumin|curcumin|mesh-list
19649943|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825507|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19825508|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335107|NCT00792818|Turmeric extract|turmeric extract|mesh-list
19825509|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19825510|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19825511|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19825512|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825513|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19825514|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19825515|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
19825516|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19825517|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
19825518|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19825519|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19825520|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825521|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19825522|NCT00561678|Analgesics|analgesics|mesh-ancestor
19825523|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
19825524|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825525|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19825526|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19825527|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19825528|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825529|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825530|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825531|NCT00561730|Pantoprazole|pantoprazole|mesh-list
19825532|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19825533|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825534|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19825535|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825536|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825537|NCT00561821|Mirtazapine|mirtazapine|mesh-list
19825538|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
19825539|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825540|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19825541|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
19825542|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
19825543|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825544|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825545|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825546|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19825547|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19825548|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19825549|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19825550|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19825551|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19825552|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825553|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19825554|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19825555|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
19825556|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19825557|NCT00561834|Ranibizumab|ranibizumab|mesh-list
19825558|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19825559|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19825560|NCT00561834|Growth Substances|growth substances|mesh-ancestor
19825561|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825562|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
19825563|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825564|NCT00561925|Nevirapine|nevirapine|mesh-list
19825565|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19825566|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19825567|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825568|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825569|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
19825570|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825571|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19825572|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19825573|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19825574|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19825575|NCT00561951|Fesoterodine|fesoterodine|mesh-list
19825576|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19825577|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19825578|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166207|NCT00139243|Protective Agents|protective agents|mesh-ancestor
20166208|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
20166209|NCT00139243|Vitamins|vitamins|mesh-ancestor
20335108|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20335109|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20335110|NCT00792818|Analgesics|analgesics|mesh-ancestor
20335111|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
20335112|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825579|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825580|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825581|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825582|NCT00561951|Urological Agents|urological agents|mesh-ancestor
19825583|NCT00562094|Pantoprazole|pantoprazole|mesh-list
19825584|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19825585|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825586|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19825587|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825588|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825589|NCT00562120|Fexofenadine|fexofenadine|mesh-list
19825590|NCT00562120|Terfenadine|terfenadine|mesh-list
19825591|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19825592|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19825593|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19825594|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
19825595|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
19825596|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825597|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825598|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825599|NCT00562159|Fluticasone|fluticasone|mesh-list
19825600|NCT00562159|Xhance|xhance|mesh-list
19825601|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
19825602|NCT00562159|Loratadine|loratadine|mesh-list
19825603|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19825604|NCT00562159|Prednisone|prednisone|mesh-list
19825605|NCT00562159|Albuterol|albuterol|mesh-list
19825606|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825607|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
19825608|NCT00562159|Hormones|hormones|mesh-ancestor
19825609|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19825610|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825611|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825612|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825613|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19825614|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
19825615|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825616|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19825617|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
19825618|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
19825619|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19825620|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
19825621|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19825622|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19825623|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19825624|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19825625|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825626|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825627|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825628|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
20335113|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335114|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335115|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335116|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20335117|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335118|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335119|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649944|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335120|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
19649945|NCT02336633|Resveratrol|resveratrol|mesh-list
19649946|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
19649947|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649948|NCT02336633|Protective Agents|protective agents|mesh-ancestor
19649949|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649950|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19649951|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19649952|NCT02336477|Mexiletine|mexiletine|mesh-list
19649953|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19649954|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19649955|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19649956|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19649957|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649958|NCT02336568|Oxytocin|oxytocin|mesh-list
19649959|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
19649960|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19649961|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825629|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19825630|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19825631|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
19825632|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
19825633|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19825634|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19825635|NCT00562159|Analgesics|analgesics|mesh-ancestor
19825636|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
19825637|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835037|NCT00600067|Phentermine|phentermine|mesh-list
19835038|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
19835039|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20335121|NCT00792818|Protective Agents|protective agents|mesh-ancestor
20335122|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20335123|NCT00792857|Vitamins|vitamins|mesh-ancestor
20335124|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
20335125|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335126|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20335127|NCT00793052|Dexamethasone|dexamethasone|mesh-list
20335128|NCT00793052|Etoricoxib|etoricoxib|mesh-list
20335129|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335130|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
20335131|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
20335132|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335133|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335134|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335135|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
20335136|NCT00793052|Hormones|hormones|mesh-ancestor
20335137|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335138|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20335139|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335140|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20335141|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20335142|NCT00793052|Analgesics|analgesics|mesh-ancestor
20335143|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
20335144|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335145|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20335146|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20335147|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335148|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335149|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20335150|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20335151|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20335152|NCT00793195|SMOFlipid|smoflipid|mesh-list
20335153|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20335154|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20335155|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20335156|NCT00793221|Sirolimus|sirolimus|mesh-list
20335157|NCT00793221|Everolimus|everolimus|mesh-list
20335158|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835040|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835041|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19835042|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
19835043|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19835044|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
19835045|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
19835046|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835047|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
19835048|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835049|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335159|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335160|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
20335161|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335162|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20335163|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335164|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20335165|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
19649962|NCT02336529|Bupivacaine|bupivacaine|mesh-list
19835050|NCT00600119|Naloxegol|naloxegol|mesh-list
19825638|NCT00562328|Rituximab|rituximab|mesh-list
19825639|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
19825640|NCT00562328|Sargramostim|sargramostim|mesh-list
19825641|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19825642|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825643|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
19825644|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825645|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825646|NCT00562588|Dipyridamole|dipyridamole|mesh-list
19825647|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
19825648|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19825649|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825650|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825651|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19825652|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
19825653|NCT00562627|Ketorolac|ketorolac|mesh-list
19825654|NCT00562627|Epinephrine|epinephrine|mesh-list
19825655|NCT00562627|Racepinephrine|racepinephrine|mesh-list
19825656|NCT00562627|Fentanyl|fentanyl|mesh-list
19825657|NCT00562627|Morphine|morphine|mesh-list
19825658|NCT00562627|Bupivacaine|bupivacaine|mesh-list
19825659|NCT00562627|Ropivacaine|ropivacaine|mesh-list
19825660|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
19825661|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
19825662|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
19825663|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19825664|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825665|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
19825666|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825667|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20335166|NCT00793234|Enoxaparin|enoxaparin|mesh-list
20335167|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
20335168|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20335169|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20335170|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335171|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
20335172|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20335173|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335174|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
20335175|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
20335176|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20335177|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20335178|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825668|NCT00562627|Narcotics|narcotics|mesh-ancestor
19825669|NCT00562627|Analgesics|analgesics|mesh-ancestor
19825670|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19825671|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19825672|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
19825673|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19825674|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19825675|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825676|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825677|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825678|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19825679|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19825680|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
19825681|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19825682|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
19825683|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
19825684|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
19825685|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19825686|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19825687|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19825688|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825689|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825690|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19825691|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825692|NCT00562718|Capecitabine|capecitabine|mesh-list
19825693|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19825694|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
19825695|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825696|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335179|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825697|NCT00562861|Lamotrigine|lamotrigine|mesh-list
19825698|NCT00562861|Carbamazepine|carbamazepine|mesh-list
19825699|NCT00562861|Valproic Acid|valproic acid|mesh-list
19825700|NCT00562861|Citalopram|citalopram|mesh-list
19825701|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
19825702|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19649963|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
19649964|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
19825703|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825704|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825705|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19825706|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825707|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19825708|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19825709|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19825710|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825711|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19825712|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19825713|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19825714|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825715|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
19825716|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19825717|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
19825718|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825719|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166210|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
20335180|NCT00793338|Urological Agents|urological agents|mesh-ancestor
19649965|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166211|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19649966|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649967|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
19649968|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649969|NCT02336516|Azithromycin|azithromycin|mesh-list
19649970|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19649971|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19649972|NCT02336308|Ketamine|ketamine|mesh-list
19649973|NCT02336308|Analgesics|analgesics|mesh-ancestor
19649974|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
19649975|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19649976|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166212|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
20166213|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
20166214|NCT00139256|Betamethasone|betamethasone|mesh-list
20166215|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166216|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
20166217|NCT00139256|Hormones|hormones|mesh-ancestor
20166218|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166219|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166220|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20166221|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
20166222|NCT00139269|Docetaxel|docetaxel|mesh-list
20166223|NCT00139269|Fluorouracil|fluorouracil|mesh-list
20166224|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166225|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
20166226|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
20166227|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
19825720|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
19649977|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20174552|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
20174553|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174554|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
20174555|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
20174556|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174557|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174558|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20174559|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
20174560|NCT00165178|Hormones|hormones|mesh-ancestor
20174561|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174562|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20174563|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174564|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20174565|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20174566|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20174567|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174568|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174569|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20174570|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
20335181|NCT00793377|Tamoxifen|tamoxifen|mesh-list
20335182|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
20335183|NCT00793377|Docetaxel|docetaxel|mesh-list
19825721|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
19825722|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19825723|NCT00562861|Analgesics|analgesics|mesh-ancestor
19825724|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
19825725|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19825726|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19825727|NCT00562965|Dexamethasone|dexamethasone|mesh-list
19825728|NCT00562965|Prednisone|prednisone|mesh-list
20335184|NCT00793377|Doxorubicin|doxorubicin|mesh-list
20335185|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20335186|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335187|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
20335188|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335189|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166228|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166229|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
20335190|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20335191|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
20335192|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335193|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825729|NCT00562965|Prednisolone|prednisolone|mesh-list
19825730|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
19825731|NCT00562965|Rituximab|rituximab|mesh-list
19825732|NCT00562965|Fludarabine|fludarabine|mesh-list
19825733|NCT00562965|Vincristine|vincristine|mesh-list
19825734|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
19825735|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19825736|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825737|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
19825738|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825739|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825740|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19825741|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
19825742|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335194|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20335195|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
20335196|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
20335197|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
20335198|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20335199|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20335200|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20335201|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335202|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20335203|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
20335204|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335205|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20335206|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20335207|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20335208|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20335209|NCT00793429|Prucalopride|prucalopride|mesh-list
19825743|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825744|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19825745|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20166230|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20166231|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166232|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
20166233|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166234|NCT00139282|Squalamine|squalamine|mesh-list
20166235|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166236|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166237|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20166238|NCT00139282|Protective Agents|protective agents|mesh-ancestor
20166239|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166240|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166241|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20166242|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20166243|NCT00139282|Growth Substances|growth substances|mesh-ancestor
20166244|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
20335210|NCT00793429|Laxatives|laxatives|mesh-ancestor
19825746|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825747|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
20166245|NCT00139360|Bevacizumab|bevacizumab|mesh-list
19825748|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
19825749|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825750|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825751|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
19825752|NCT00562965|Hormones|hormones|mesh-ancestor
19825753|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19825754|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825755|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19825756|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
19825757|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
19825758|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
19825759|NCT00562965|Analgesics|analgesics|mesh-ancestor
19825760|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
19825761|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19825762|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825763|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825764|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19825765|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
19825766|NCT00562978|Etoposide|etoposide|mesh-list
19825767|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825768|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
19825769|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825770|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825771|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19825772|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
19825773|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825774|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825775|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19825776|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19825777|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19825778|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825779|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825780|NCT00563290|Dasatinib|dasatinib|mesh-list
19825781|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825782|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19825783|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825784|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825785|NCT00563316|Irinotecan|irinotecan|mesh-list
20166246|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20166247|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166248|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20166249|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20166250|NCT00139360|Growth Substances|growth substances|mesh-ancestor
20166251|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166252|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
20166253|NCT00139373|Donepezil|donepezil|mesh-list
20166254|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20335211|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335212|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20335213|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20335214|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
20335215|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335216|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335217|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335218|NCT00793468|Nicotine|nicotine|mesh-list
20335219|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20335220|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
19649978|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19649979|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
19649980|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
19649981|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19649982|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19649983|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19649984|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825786|NCT00563316|Panitumumab|panitumumab|mesh-list
19825787|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20166255|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166256|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166257|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166258|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166259|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166260|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
19649985|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19649986|NCT02336386|Dexamethasone|dexamethasone|mesh-list
19825788|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825789|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825790|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825791|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825792|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335221|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335222|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335223|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20335224|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20335225|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
20335226|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335227|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335228|NCT00793559|Terlipressin|terlipressin|mesh-list
20335229|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20335230|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20335231|NCT00793663|Dexamethasone|dexamethasone|mesh-list
20335232|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
20335233|NCT00793663|Ondansetron|ondansetron|mesh-list
20335234|NCT00793663|Sevoflurane|sevoflurane|mesh-list
19825793|NCT00563368|Topiramate|topiramate|mesh-list
19825794|NCT00563368|Phentermine|phentermine|mesh-list
19825795|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
19825796|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19825797|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335235|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335236|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
20335237|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
19825798|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19825799|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
19825800|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19825801|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
19825802|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
19825803|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825804|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825805|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825806|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825807|NCT00563381|Bromides|bromides|mesh-list
19825808|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
19825809|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19649987|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
19649988|NCT02336386|Doxorubicin|doxorubicin|mesh-list
19649989|NCT02336386|Bortezomib|bortezomib|mesh-list
19649990|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19649991|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
19649992|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19649993|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19649994|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19649995|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
19825810|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19825811|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
19825812|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825813|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825814|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19825815|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
19825816|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
19825817|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19825818|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
20335238|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335239|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335240|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335241|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
20335242|NCT00793663|Hormones|hormones|mesh-ancestor
19649996|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166261|NCT00139386|Candesartan|candesartan|mesh-list
20166262|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20166263|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20166264|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20166265|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166266|NCT00139516|Nicotine|nicotine|mesh-list
20166267|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20166268|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
19825819|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166269|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335243|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835051|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20166270|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166271|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20166272|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20166273|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166274|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166275|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166276|NCT00139555|Amlodipine|amlodipine|mesh-list
20335244|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20335245|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825820|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825821|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19825822|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19825823|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19825824|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
19825825|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
19825826|NCT00563706|Risperidone|risperidone|mesh-list
19825827|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19825828|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
19825829|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825830|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825831|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825832|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19825833|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19825834|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19825835|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19825836|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19825837|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
19825838|NCT00563784|Paclitaxel|paclitaxel|mesh-list
19825839|NCT00563784|Carboplatin|carboplatin|mesh-list
19825840|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19825841|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20335246|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20335247|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20335248|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
20335249|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
20335250|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335251|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
20335252|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335253|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335254|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
20335255|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335256|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335257|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335258|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335259|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335260|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20348110|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348111|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
20348112|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348602|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348603|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20348604|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20348605|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20348606|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
20348607|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
20348608|NCT00864812|Hormones|hormones|mesh-ancestor
20348609|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348610|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
19825842|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825843|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
19825844|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
19825845|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
19825846|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825847|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19825848|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825849|NCT00563797|Mecamylamine|mecamylamine|mesh-list
19825850|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20166277|NCT00139555|Benazepril|benazepril|mesh-list
20166278|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20166279|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20166280|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166281|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166282|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19825851|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19825852|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
19825853|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825854|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825855|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19825856|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19825857|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
19825858|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825859|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825860|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
19825861|NCT00564018|Protamines|protamines|mesh-list
19825862|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19825863|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825864|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
19825865|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335261|NCT00793741|Somatostatin|somatostatin|mesh-list
20335262|NCT00793741|Hormones|hormones|mesh-ancestor
20335263|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335264|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335265|NCT00793754|Aspirin|aspirin|mesh-list
20335266|NCT00793754|Atorvastatin|atorvastatin|mesh-list
20335267|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20335268|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20335269|NCT00793754|Analgesics|analgesics|mesh-ancestor
20335270|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
20335271|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335272|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335273|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335274|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335275|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20335276|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20335277|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335278|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20335279|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20335280|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335281|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
19825866|NCT00564018|Coagulants|coagulants|mesh-ancestor
19825867|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
19825868|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335282|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20335283|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20335284|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
20335285|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20335286|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20335287|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
20335288|NCT00793767|Hematinics|hematinics|mesh-ancestor
20335289|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
20335290|NCT00793845|Melphalan|melphalan|mesh-list
20335291|NCT00793845|Thiotepa|thiotepa|mesh-list
20335292|NCT00793845|Carboplatin|carboplatin|mesh-list
20335293|NCT00793845|Etoposide|etoposide|mesh-list
20335294|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335295|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
20335296|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335297|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335298|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20335299|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
20335300|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335301|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335302|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20335303|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20335304|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20335305|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20335306|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335307|NCT00793858|Ciclesonide|ciclesonide|mesh-list
19649997|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19649998|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19649999|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650000|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
19650001|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
19650002|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650003|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825869|NCT00564395|Insulin|insulin|mesh-list
20335308|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
20335309|NCT00793858|Hormones|hormones|mesh-ancestor
19650004|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
19650005|NCT02336386|Hormones|hormones|mesh-ancestor
19825870|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19825871|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
19825872|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19825873|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825874|NCT00564447|Azithromycin|azithromycin|mesh-list
19825875|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
19650006|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650007|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650008|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650009|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19650010|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19650011|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19650012|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
19825876|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19825877|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19825878|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19825879|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19825880|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825881|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825882|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825883|NCT00564486|Acetaminophen|acetaminophen|mesh-list
19825884|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19825885|NCT00564486|Analgesics|analgesics|mesh-ancestor
19825886|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
19825887|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825888|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825889|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
19825890|NCT00564629|Acetaminophen|acetaminophen|mesh-list
19825891|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19825892|NCT00564629|Analgesics|analgesics|mesh-ancestor
19825893|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
19825894|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825895|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825896|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
19825897|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
19825898|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19825899|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19825900|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19825901|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825902|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825903|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
19825904|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825905|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825906|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19825907|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825908|NCT00564733|Gemcitabine|gemcitabine|mesh-list
19825909|NCT00564733|Paclitaxel|paclitaxel|mesh-list
20335310|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335311|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335312|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20335313|NCT00793897|Paclitaxel|paclitaxel|mesh-list
20335314|NCT00793897|Carboplatin|carboplatin|mesh-list
20335315|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20335316|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335317|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
20335318|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
20335319|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
20335320|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825910|NCT00564733|Docetaxel|docetaxel|mesh-list
19825911|NCT00564733|Carboplatin|carboplatin|mesh-list
19825912|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19825913|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19825914|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825915|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
19825916|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
19825917|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
20335321|NCT00793923|Dexamethasone|dexamethasone|mesh-list
20335322|NCT00793923|Ranibizumab|ranibizumab|mesh-list
20335323|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335324|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
19825918|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825919|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19825920|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
19825921|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
19825922|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335325|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
19825923|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825924|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825925|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
19825926|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825927|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19825928|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19825929|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
19825930|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19825931|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
19825932|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19825933|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335326|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335327|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335328|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335329|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
20335330|NCT00793923|Hormones|hormones|mesh-ancestor
20335331|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335332|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825934|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19825935|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825936|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825937|NCT00564889|Dexamethasone|dexamethasone|mesh-list
19825938|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
19825939|NCT00564889|Lenalidomide|lenalidomide|mesh-list
19825940|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19825941|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
19825942|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825943|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825944|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19825945|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
19825946|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825947|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19825948|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19825949|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825950|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
19825951|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
19825952|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825953|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19825954|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
19825955|NCT00564889|Hormones|hormones|mesh-ancestor
19825956|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19825957|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19825958|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19825959|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19825960|NCT00564889|Growth Substances|growth substances|mesh-ancestor
19825961|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19825962|NCT00564954|Methylphenidate|methylphenidate|mesh-list
19825963|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19825964|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19825965|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825966|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19825967|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19825968|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19825969|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825970|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
19825971|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825972|NCT00565084|Ibuprofen|ibuprofen|mesh-list
19825973|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19825974|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20335333|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335334|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20335335|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20335336|NCT00793923|Growth Substances|growth substances|mesh-ancestor
20335337|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
20335338|NCT00793975|Ramucirumab|ramucirumab|mesh-list
20335339|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335340|NCT00793988|Anesthetics|anesthetics|mesh-list
20335341|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335342|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825975|NCT00565084|Analgesics|analgesics|mesh-ancestor
19825976|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
19825977|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335343|NCT00794209|Fentanyl|fentanyl|mesh-list
20335344|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20335345|NCT00794209|Narcotics|narcotics|mesh-ancestor
20335346|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335347|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335348|NCT00794209|Analgesics|analgesics|mesh-ancestor
20335349|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
20335350|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335351|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20335352|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20335353|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
20335354|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
20335355|NCT00794235|Sorafenib|sorafenib|mesh-list
20335356|NCT00794235|Dacarbazine|dacarbazine|mesh-list
20335357|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335358|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20335359|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335360|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335361|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20335362|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
20335363|NCT00794261|Lenograstim|lenograstim|mesh-list
20335364|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20335365|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
20335366|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825978|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825979|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19825980|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19825981|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19825982|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19825983|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825984|NCT00565266|Beclomethasone|beclomethasone|mesh-list
19825985|NCT00565266|Bromides|bromides|mesh-list
19825986|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
19825987|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19825988|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19825989|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
19825990|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19825991|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19825992|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19825993|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
19825994|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
19825995|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19825996|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
19825997|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19825998|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19825999|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19826000|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19826001|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19826002|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826003|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
19826004|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826005|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
19826006|NCT00565266|Hormones|hormones|mesh-ancestor
19826007|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826008|NCT00565370|Capecitabine|capecitabine|mesh-list
19826009|NCT00565370|Sorafenib|sorafenib|mesh-list
19826010|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826011|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19826012|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
19826013|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826014|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19826015|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826016|NCT00565409|Etanercept|etanercept|mesh-list
19826017|NCT00565409|Methotrexate|methotrexate|mesh-list
19826018|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20335367|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
20335368|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20335369|NCT00794443|Diphosphonates|diphosphonates|mesh-list
20335370|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20335371|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335372|NCT00794625|Valproic Acid|valproic acid|mesh-list
19826019|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
19826020|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19826021|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826022|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19826023|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
20335373|NCT00794625|Risperidone|risperidone|mesh-list
20335374|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
20335375|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335376|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
20335377|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335378|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335379|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335380|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19826024|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826025|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826026|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826027|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826028|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19826029|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826030|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
19826031|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826032|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19826033|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19826034|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826035|NCT00565409|Analgesics|analgesics|mesh-ancestor
19826036|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
19826037|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826038|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826039|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826040|NCT00565448|Docetaxel|docetaxel|mesh-list
19826041|NCT00565448|Fluorouracil|fluorouracil|mesh-list
19826042|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826043|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
19826044|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
19826045|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
19826046|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826047|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
19826048|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19826049|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826050|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
19826051|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826052|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19826053|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
19826054|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19826055|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
19826056|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826057|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
19826058|NCT00565643|Protective Agents|protective agents|mesh-ancestor
19826059|NCT00565643|Laxatives|laxatives|mesh-ancestor
19826060|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826061|NCT00565669|Cyclosporine|cyclosporine|mesh-list
19826062|NCT00565669|Cyclosporins|cyclosporins|mesh-list
19826063|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826064|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826065|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826066|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
19826067|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826068|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
19826069|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826070|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826071|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826072|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19826073|NCT00565773|Sirolimus|sirolimus|mesh-list
20166283|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166284|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
20166285|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20166286|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
20166287|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166288|NCT00139568|Tegaserod|tegaserod|mesh-list
20166289|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20166290|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
20166291|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166292|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166293|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166294|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
20166295|NCT00139581|Tacrolimus|tacrolimus|mesh-list
20166296|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20166297|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20166298|NCT00139581|Analgesics|analgesics|mesh-ancestor
19826074|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
20166299|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
19826075|NCT00565773|Abatacept|abatacept|mesh-list
19826076|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19826077|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826078|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19826079|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826080|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
19826081|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826082|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
19826083|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826084|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826085|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19826086|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826087|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826088|NCT00565916|Estradiol|estradiol|mesh-list
19826089|NCT00565916|Estrogens|estrogens|mesh-list
20335381|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335382|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335383|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335384|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335385|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
20335386|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
20335387|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335388|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
20335389|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
20335390|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20335391|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20335392|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20335393|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20335394|NCT00794638|Rituximab|rituximab|mesh-list
20335395|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19826090|NCT00565916|Progesterone|progesterone|mesh-list
19826091|NCT00565916|Hormones|hormones|mesh-ancestor
19826092|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826093|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826094|NCT00565916|Progestins|progestins|mesh-ancestor
19826095|NCT00566020|Lamotrigine|lamotrigine|mesh-list
19826096|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
19826097|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19826098|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826099|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826100|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19826101|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826102|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19826103|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19826104|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826105|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19826106|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19826107|NCT00566098|Melphalan|melphalan|mesh-list
19826108|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19826109|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
19826110|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826111|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826112|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19826113|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826114|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
19826115|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826116|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
19826117|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19826118|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826119|NCT00566150|Levetiracetam|levetiracetam|mesh-list
20335396|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335397|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335398|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
20335399|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335400|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335401|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20335402|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
20335403|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826120|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
19826121|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
19826122|NCT00566254|Zonisamide|zonisamide|mesh-list
19826123|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
20335404|NCT00794703|Itraconazole|itraconazole|mesh-list
19826124|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19826125|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826126|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826127|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19826128|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826129|NCT00566501|Donepezil|donepezil|mesh-list
19826130|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19826131|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826132|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826133|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826134|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826135|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826136|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
19826137|NCT00566540|Paclitaxel|paclitaxel|mesh-list
19826138|NCT00566540|Cisplatin|cisplatin|mesh-list
19826139|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19826140|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826141|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
19826142|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
19826143|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
19826144|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826145|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19826146|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19826147|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335405|NCT00794703|Micafungin|micafungin|mesh-list
20335406|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
20335407|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335408|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20335409|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20335410|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826148|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826149|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166300|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166301|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166302|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166303|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166304|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
20166305|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166306|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
20166307|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20166308|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166309|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166310|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20166311|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166312|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20166313|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166314|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166315|NCT00139633|Carboplatin|carboplatin|mesh-list
20166316|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166317|NCT00139646|Diclofenac|diclofenac|mesh-list
19826150|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19826151|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19826152|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19826153|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
19826154|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826155|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826156|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19826157|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19826158|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
19826159|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
19826160|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
19826161|NCT00566696|Melphalan|melphalan|mesh-list
19826162|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
19826163|NCT00566696|Thiotepa|thiotepa|mesh-list
19826164|NCT00566696|Rituximab|rituximab|mesh-list
19826165|NCT00566696|Fludarabine|fludarabine|mesh-list
19826166|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
19826167|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
19826168|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19826169|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
19826170|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826171|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
19826172|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166318|NCT00139646|Parecoxib|parecoxib|mesh-list
20166319|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20166320|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826173|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166321|NCT00139646|Analgesics|analgesics|mesh-ancestor
19826174|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19650013|NCT02336048|Chlorambucil|chlorambucil|mesh-list
19650014|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19650015|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650016|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19650017|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
19650018|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826175|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
19826176|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335411|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335412|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20335413|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
20335414|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335415|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335416|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20335417|NCT00794755|Vitamin K|vitamin k|mesh-list
19826177|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826178|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19826179|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826180|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19826181|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19826182|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
19826183|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19826184|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826185|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826186|NCT00566722|Adalimumab|adalimumab|mesh-list
19826187|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335418|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
20335419|NCT00794755|Vitamins|vitamins|mesh-ancestor
20335420|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
20335421|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335422|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20335423|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20335424|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826188|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826189|NCT00566735|Galantamine|galantamine|mesh-list
19826190|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19826191|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826192|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826193|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826194|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826195|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826196|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20335425|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
20335426|NCT00794755|Coagulants|coagulants|mesh-ancestor
20335427|NCT00794807|Alefacept|alefacept|mesh-list
20335428|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335429|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
20335430|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335431|NCT00794859|Sorafenib|sorafenib|mesh-list
20335432|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335433|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20335434|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335435|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335436|NCT00794885|Folic Acid|folic acid|mesh-list
20335437|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
19650019|NCT02336152|Anesthetics|anesthetics|mesh-list
19650020|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650021|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650022|NCT02336347|Quinidine|quinidine|mesh-list
19650023|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
19650024|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
19650025|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
19650026|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19650027|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19650028|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650029|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826197|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
19826198|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335438|NCT00794885|Enalapril|enalapril|mesh-list
20335439|NCT00794885|Enalaprilat|enalaprilat|mesh-list
20611789|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335440|NCT00794885|Maleic acid|maleic acid|mesh-list
19826199|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
19826200|NCT00566813|Exenatide|exenatide|mesh-list
19826201|NCT00566813|Etanercept|etanercept|mesh-list
19826202|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19826203|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826204|NCT00566813|Analgesics|analgesics|mesh-ancestor
19826205|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
20335441|NCT00794885|Hematinics|hematinics|mesh-ancestor
20335442|NCT00794885|Vitamins|vitamins|mesh-ancestor
20335443|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
20335444|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335445|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335446|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335447|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20335448|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
20335449|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20335450|NCT00794898|Infliximab|infliximab|mesh-list
20335451|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335452|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335453|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335454|NCT00794976|Dexamethasone|dexamethasone|mesh-list
19826206|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826207|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826208|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826209|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826210|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826211|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826212|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
19826213|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19826214|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19826215|NCT00566813|Incretins|incretins|mesh-ancestor
19826216|NCT00566813|Hormones|hormones|mesh-ancestor
19826217|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826218|NCT00566852|Memantine|memantine|mesh-list
19826219|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19826220|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19826221|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
19826222|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335455|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
20335456|NCT00794976|BB 1101|bb 1101|mesh-list
20335457|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335458|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
20335459|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
20335460|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335461|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335462|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826223|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826224|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826225|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19826226|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19826227|NCT00566969|Carvedilol|carvedilol|mesh-list
19826228|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19826229|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19826230|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826231|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826232|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826233|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826234|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20335463|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
20335464|NCT00794976|Hormones|hormones|mesh-ancestor
19650030|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650031|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19650032|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19650033|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
19650034|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19650035|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
19650036|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19650037|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19650038|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650039|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650040|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19650041|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19650042|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826235|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
19826236|NCT00566969|Protective Agents|protective agents|mesh-ancestor
19650043|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20348113|NCT00863577|Bemiparin|bemiparin|mesh-list
20335465|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335466|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20335467|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335468|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
20335469|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335470|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335471|NCT00795015|Insulin|insulin|mesh-list
20335472|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20335473|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20335474|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335475|NCT00795106|Capsaicin|capsaicin|mesh-list
20335476|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
20335477|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335478|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
20335479|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335480|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335481|NCT00795171|Docetaxel|docetaxel|mesh-list
20335482|NCT00795171|Sunitinib|sunitinib|mesh-list
19826237|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19826238|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826239|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19826240|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
19826241|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19826242|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19826243|NCT00567008|Varenicline|varenicline|mesh-list
19826244|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20335483|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335484|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
20335485|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
20335486|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
19650044|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19650045|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650046|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19650047|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19665189|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665190|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
19665191|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335487|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335488|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20335489|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20335490|NCT00795171|Growth Substances|growth substances|mesh-ancestor
20335491|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335492|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
20335493|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20335494|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335495|NCT00795223|Morphine|morphine|mesh-list
20335496|NCT00795223|Bupivacaine|bupivacaine|mesh-list
20335497|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
20335498|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
20335499|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335500|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335501|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
20335502|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335503|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20335504|NCT00795223|Narcotics|narcotics|mesh-ancestor
20335505|NCT00795223|Analgesics|analgesics|mesh-ancestor
20335506|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
19826245|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19826246|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826247|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826248|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826249|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826250|NCT00567164|Drospirenone|drospirenone|mesh-list
19826251|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19826252|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
19826253|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826254|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335507|NCT00795262|Quinapril|quinapril|mesh-list
20335508|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
19665192|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665193|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665194|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665195|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19665196|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826255|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19826256|NCT00567164|Diuretics|diuretics|mesh-ancestor
19826257|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
19826258|NCT00567190|Docetaxel|docetaxel|mesh-list
19826259|NCT00567190|Trastuzumab|trastuzumab|mesh-list
19826260|NCT00567190|Pertuzumab|pertuzumab|mesh-list
19826261|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826262|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
19826263|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
19826264|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
19826265|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826266|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826267|NCT00567229|Rituximab|rituximab|mesh-list
19826268|NCT00567229|Lenalidomide|lenalidomide|mesh-list
20335509|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335510|NCT00795262|Protective Agents|protective agents|mesh-ancestor
20335511|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335512|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
20335513|NCT00795262|Vitamins|vitamins|mesh-ancestor
20335514|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
20335515|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20335516|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
20335517|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826269|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826270|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826271|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
19826272|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826273|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826274|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19826275|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19826276|NCT00567229|Growth Substances|growth substances|mesh-ancestor
19826277|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
19826278|NCT00567255|Naltrexone|naltrexone|mesh-list
19826279|NCT00567255|Bupropion|bupropion|mesh-list
19826280|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19826281|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19826282|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826283|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
19826284|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826285|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19826286|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
19826287|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19826288|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19826289|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19826290|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826291|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826292|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
19826293|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826294|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19826295|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19826296|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826297|NCT00567268|Gabapentin|gabapentin|mesh-list
19826298|NCT00567268|Analgesics|analgesics|mesh-ancestor
19826299|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
20335518|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20335519|NCT00795301|Capecitabine|capecitabine|mesh-list
20335520|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
20335521|NCT00795301|Cetuximab|cetuximab|mesh-list
20335522|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20335523|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
20335524|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335525|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335526|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335527|NCT00795314|Fentanyl|fentanyl|mesh-list
20335528|NCT00795314|Butorphanol|butorphanol|mesh-list
20335529|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20335530|NCT00795314|Narcotics|narcotics|mesh-ancestor
20335531|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335532|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335533|NCT00795314|Analgesics|analgesics|mesh-ancestor
20335534|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
20335535|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826300|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348114|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
19826301|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611790|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335536|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20335537|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20335538|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
20335539|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
20335540|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
20335541|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
20335542|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20335543|NCT00795353|Alefacept|alefacept|mesh-list
20335544|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335545|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
20335546|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335547|NCT00795444|Maraviroc|maraviroc|mesh-list
20335548|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20335549|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20335550|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335551|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20335552|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20335553|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
20335554|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335555|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20335556|NCT00795457|Poly I-C|poly i-c|mesh-list
20335557|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20335558|NCT00795457|Vaccines|vaccines|mesh-list
20335559|NCT00795457|Poly ICLC|poly iclc|mesh-list
20335560|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
20335561|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335562|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
20335563|NCT00795457|Laxatives|laxatives|mesh-ancestor
19826302|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
19826303|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19826304|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19826305|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826306|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19826307|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19826308|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19826309|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826310|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826311|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
19826312|NCT00567320|Varenicline|varenicline|mesh-list
19826313|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19826314|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19826315|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166322|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
20166323|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166324|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166325|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166326|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166327|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20166328|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166329|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826316|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826317|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826318|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826319|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19826320|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826321|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19826322|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826323|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826324|NCT00567398|Icodextrin|icodextrin|mesh-list
19826325|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
19826326|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19826327|NCT00567476|Omalizumab|omalizumab|mesh-list
19826328|NCT00567476|Terbutaline|terbutaline|mesh-list
19826329|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
19826330|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
19826331|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19826332|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
19826333|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826334|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826335|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19826336|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
20335564|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335565|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
19826337|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
20335566|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335567|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
20166330|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20166331|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19826338|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20166332|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
20166333|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
20166334|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20166335|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166336|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20166337|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20166338|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20166339|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20166340|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166341|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20166342|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20166343|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20166344|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20166345|NCT00139698|Olmesartan|olmesartan|mesh-list
20166346|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20166347|NCT00139698|Diuretics|diuretics|mesh-ancestor
19650048|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
19650049|NCT02336139|Velpatasvir|velpatasvir|mesh-list
19650050|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
19650051|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650052|NCT02335736|Cetrorelix|cetrorelix|mesh-list
19650053|NCT02335736|Hormones|hormones|mesh-list
19650054|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
19650055|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650056|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650057|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19650058|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
19665197|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
19665198|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665199|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19665200|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19665201|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19665202|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19665203|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
19665204|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19665205|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665206|NCT02813655|Cosyntropin|cosyntropin|mesh-list
19665207|NCT02813655|Hormones|hormones|mesh-ancestor
19665208|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19665209|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665210|NCT02747407|Vaccines|vaccines|mesh-list
19665211|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
19665212|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665213|NCT02718833|Dexamethasone|dexamethasone|mesh-list
19665214|NCT02718833|Bortezomib|bortezomib|mesh-list
19665215|NCT02718833|Pomalidomide|pomalidomide|mesh-list
19665216|NCT02718833|Elotuzumab|elotuzumab|mesh-list
19665217|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19665218|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
19665219|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
19665220|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665221|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665222|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19665223|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
19665224|NCT02718833|Hormones|hormones|mesh-ancestor
19665225|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19665226|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19665227|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665228|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
19665229|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19665230|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19665231|NCT02718833|Growth Substances|growth substances|mesh-ancestor
19665232|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
19665233|NCT02700841|Melphalan|melphalan|mesh-list
19665234|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
19826339|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19826340|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19826341|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335568|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20335569|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
19826342|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826343|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19826344|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
19826345|NCT00567489|Icodextrin|icodextrin|mesh-list
19826346|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
19826347|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20335570|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20335571|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335572|NCT00795496|Histamine|histamine|mesh-list
20335573|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
20335574|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
20335575|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335576|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335577|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335578|NCT00795548|Azacitidine|azacitidine|mesh-list
20335579|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20335580|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
20335581|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335582|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335583|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335584|NCT00795574|Infliximab|infliximab|mesh-list
20335585|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335586|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335587|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335588|NCT00795587|Mannitol|mannitol|mesh-list
20335589|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20335590|NCT00795587|Diuretics|diuretics|mesh-ancestor
20335591|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
20335592|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335593|NCT00795613|Doxorubicin|doxorubicin|mesh-list
19256689|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256690|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19826348|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
20335594|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20335595|NCT00795613|Vincristine|vincristine|mesh-list
20335596|NCT00795613|Procarbazine|procarbazine|mesh-list
20335597|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20335598|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335599|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20335600|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20335601|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335602|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335603|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20335604|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
20335605|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
19826349|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19826350|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826351|NCT00567879|Trastuzumab|trastuzumab|mesh-list
19826352|NCT00567879|Panobinostat|panobinostat|mesh-list
19826353|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826354|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826355|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20335606|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
20335607|NCT00795678|Gemcitabine|gemcitabine|mesh-list
20335608|NCT00795678|Paclitaxel|paclitaxel|mesh-list
20335609|NCT00795678|Vinorelbine|vinorelbine|mesh-list
20335610|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20335611|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
20335612|NCT00795678|Doxorubicin|doxorubicin|mesh-list
20335613|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19826356|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335614|NCT00795678|Capecitabine|capecitabine|mesh-list
19256691|NCT04226248|Rivastigmine|rivastigmine|mesh-list
20335615|NCT00795678|Trastuzumab|trastuzumab|mesh-list
20335616|NCT00795678|Lapatinib|lapatinib|mesh-list
20335617|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20348115|NCT00863629|Insulin|insulin|mesh-list
19826357|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826358|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19826359|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19826360|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
19826361|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826362|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826363|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19826364|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
19826365|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19826366|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19826367|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19826368|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826369|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826370|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826371|NCT00568022|Capecitabine|capecitabine|mesh-list
19826372|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19826373|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
19826374|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335618|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335619|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
20335620|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
20335621|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
20335622|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335623|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335624|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
19826375|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826376|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
19826377|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19826378|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
19826379|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826380|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826381|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19826382|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
19826383|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19826384|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
19826385|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826386|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826387|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19826388|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
19826389|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
20166348|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
20166349|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166350|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20166351|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166352|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166353|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19826390|NCT00568061|Protective Agents|protective agents|mesh-ancestor
19826391|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
19826392|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19826393|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
19826394|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826395|NCT00568087|Expectorants|expectorants|mesh-ancestor
19826396|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
19826397|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19826398|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
19826399|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826400|NCT00568087|Protective Agents|protective agents|mesh-ancestor
19826401|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826402|NCT00568087|Antidotes|antidotes|mesh-ancestor
19826403|NCT00568321|Tanezumab|tanezumab|mesh-list
19826404|NCT00568321|Analgesics|analgesics|mesh-ancestor
19826405|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
19826406|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826407|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826408|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19826409|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
19826410|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20166354|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20166355|NCT00139711|Docetaxel|docetaxel|mesh-list
20166356|NCT00139711|Irinotecan|irinotecan|mesh-list
20166357|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335625|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826411|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
19826412|NCT00568399|Antidotes|antidotes|mesh-ancestor
19826413|NCT00568399|Protective Agents|protective agents|mesh-ancestor
19826414|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826415|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
19826416|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826417|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
19826418|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166358|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
20166359|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
20166360|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
20166361|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166362|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20166363|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20166364|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166365|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20335626|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335627|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20335628|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
20335629|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20335630|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20335631|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
20335632|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
20335633|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826419|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826420|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
19826421|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
19826422|NCT00568451|Paclitaxel|paclitaxel|mesh-list
19826423|NCT00568451|Carboplatin|carboplatin|mesh-list
19826424|NCT00568451|Temozolomide|temozolomide|mesh-list
19826425|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19826426|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826427|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
19826428|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
19826429|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
19826430|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826431|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19826432|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
19835052|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835053|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
19835054|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835055|NCT00600340|Paclitaxel|paclitaxel|mesh-list
20335634|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335635|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20335636|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20335637|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20335638|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335639|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20335640|NCT00795756|Cytarabine|cytarabine|mesh-list
20335641|NCT00795756|Methotrexate|methotrexate|mesh-list
19835056|NCT00600340|Bevacizumab|bevacizumab|mesh-list
19835057|NCT00600340|Capecitabine|capecitabine|mesh-list
19835058|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19835059|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835060|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
19835061|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
19835062|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
19835063|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835064|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835065|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835066|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835067|NCT00600340|Growth Substances|growth substances|mesh-ancestor
19835068|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835069|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835070|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19835071|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
19835072|NCT00600353|Dexamethasone|dexamethasone|mesh-list
19835073|NCT00600353|Aprepitant|aprepitant|mesh-list
19835074|NCT00600353|Palonosetron|palonosetron|mesh-list
19835075|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835076|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
19835077|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
19835078|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835079|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335642|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20335643|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
19835080|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20166366|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20166367|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20166368|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166369|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166370|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166371|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166372|NCT00139724|Urological Agents|urological agents|mesh-ancestor
20166373|NCT00139750|Varenicline|varenicline|mesh-list
20166374|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20166375|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20166376|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166377|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166378|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166379|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166380|NCT00139815|Enoxaparin|enoxaparin|mesh-list
20166381|NCT00139815|PENTA|penta|mesh-list
20166382|NCT00139815|Fondaparinux|fondaparinux|mesh-list
20166383|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
20166384|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20166385|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20166386|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166387|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20166388|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
20166389|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20335644|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20335645|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826433|NCT00568555|Naltrexone|naltrexone|mesh-list
19826434|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19826435|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20335646|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20335647|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
20335648|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335649|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335650|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611791|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20611792|NCT00026312|Analgesics|analgesics|mesh-ancestor
19826436|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826437|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
19826438|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826439|NCT00568633|Cyclosporine|cyclosporine|mesh-list
19826440|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
19826441|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
19826442|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19826443|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19826444|NCT00568633|Prednisolone|prednisolone|mesh-list
19826445|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
19826446|NCT00568633|Cyclosporins|cyclosporins|mesh-list
19826447|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
19826448|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19826449|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19826450|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
19826451|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826452|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826453|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826454|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
19826455|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826456|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
19826457|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826458|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826459|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826460|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19826461|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19826462|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826463|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19826464|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
19826465|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19826466|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826467|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
19826468|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
20166390|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
20166391|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826469|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826470|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826471|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
20166392|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20166393|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19826472|NCT00568633|Hormones|hormones|mesh-ancestor
20166394|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
20166395|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166396|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166397|NCT00139854|Alprazolam|alprazolam|mesh-list
20166398|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20166399|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166400|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166401|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20335651|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335652|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20335653|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826473|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826474|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19826475|NCT00568633|Protective Agents|protective agents|mesh-ancestor
19826476|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19826477|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19826478|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19826479|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19826480|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826481|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826482|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826483|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826484|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826485|NCT00568776|Inositol|inositol|mesh-list
19826486|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
19826487|NCT00568776|Vitamins|vitamins|mesh-ancestor
19826488|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
19826489|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826490|NCT05363449|Naftifine|naftifine|mesh-list
19826491|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
19826492|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826493|NCT05363436|Oxycodone|oxycodone|mesh-list
19826494|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19826495|NCT05363436|Narcotics|narcotics|mesh-ancestor
19826496|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826497|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826498|NCT05363436|Analgesics|analgesics|mesh-ancestor
19826499|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
19826500|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826501|NCT05363267|Curcumin|curcumin|mesh-list
19826502|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19826503|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826504|NCT05363267|Analgesics|analgesics|mesh-ancestor
19826505|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
19826506|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826507|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826508|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826509|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826510|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826511|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826512|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826513|NCT05363202|Fluticasone|fluticasone|mesh-list
19826514|NCT05363202|Xhance|xhance|mesh-list
19826515|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826516|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19826517|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
19826518|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826519|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826520|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19826521|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
19826522|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826523|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19826524|NCT05363111|Daratumumab|daratumumab|mesh-list
19826525|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19826526|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19826527|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335654|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
20335655|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335656|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20166402|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20166403|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335657|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
19826528|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
19826529|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335658|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335659|NCT00795808|Metformin|metformin|mesh-list
20335660|NCT00795808|Clomiphene|clomiphene|mesh-list
19826530|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
19826531|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
19826532|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826533|NCT05362955|Fluorouracil|fluorouracil|mesh-list
19826534|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
19826535|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826536|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19826537|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826538|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826539|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
19826540|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826541|NCT05362942|Cytarabine|cytarabine|mesh-list
19826542|NCT05362942|Azacitidine|azacitidine|mesh-list
19826543|NCT05362942|Decitabine|decitabine|mesh-list
19826544|NCT05362942|Venetoclax|venetoclax|mesh-list
19826545|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19826546|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
19826547|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826548|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826549|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
19826550|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826551|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826552|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
19826553|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826554|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826555|NCT05362916|Letermovir|letermovir|mesh-list
20335661|NCT00795808|Enclomiphene|enclomiphene|mesh-list
20335662|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
20335663|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20335664|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335665|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20335666|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
20335667|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335668|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20335669|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
20335670|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20335671|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20335672|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20348116|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348117|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348118|NCT00863668|Tenofovir|tenofovir|mesh-list
20348119|NCT00863668|Emtricitabine|emtricitabine|mesh-list
20348120|NCT00863668|Efavirenz|efavirenz|mesh-list
20348121|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
20348122|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20348123|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19826556|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19826557|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826558|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826559|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826560|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
19826561|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826562|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
19826563|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826564|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
19826565|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
19826566|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826567|NCT05362851|Celecoxib|celecoxib|mesh-list
19826568|NCT05362851|Tramadol|tramadol|mesh-list
19826569|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19826570|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826571|NCT05362851|Analgesics|analgesics|mesh-ancestor
19826572|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
19826573|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826574|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826575|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826576|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826577|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19826578|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19826579|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348124|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
20348125|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
20348126|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335673|NCT00795847|Losartan|losartan|mesh-list
20335674|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20335675|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20335676|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20335677|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19650059|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19650060|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
19650061|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
19650062|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19650063|NCT02335593|Hematinics|hematinics|mesh-ancestor
19650064|NCT02335593|Astringents|astringents|mesh-ancestor
19650065|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650066|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
19650067|NCT02335684|Methamphetamine|methamphetamine|mesh-list
19826580|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826581|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19826582|NCT05362851|Narcotics|narcotics|mesh-ancestor
19826583|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826584|NCT05362799|Metformin|metformin|mesh-list
19826585|NCT05362799|Letrozole|letrozole|mesh-list
19826586|NCT05362799|Lactitol|lactitol|mesh-list
19826587|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19826588|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826589|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826590|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19826591|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19826592|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826593|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826594|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19826595|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
19826596|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826597|NCT05362799|Cathartics|cathartics|mesh-ancestor
19826598|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826599|NCT05362760|Fulvestrant|fulvestrant|mesh-list
19826600|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19826601|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19826602|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650068|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19650069|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650070|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
19650071|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
19650072|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650073|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
19826603|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19826604|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19826605|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
19826606|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826607|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826608|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19826609|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166404|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
20166405|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
20166406|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166407|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166408|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20166409|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20166410|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
20166411|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166412|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20348611|NCT00864825|Allopurinol|allopurinol|mesh-list
19650074|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650075|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650076|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
19650077|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19650078|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19650079|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650080|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19650081|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
19650082|NCT02335411|Capecitabine|capecitabine|mesh-list
19650083|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650084|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19650085|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19650086|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
19835081|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
19826610|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826611|NCT05362513|Ivermectin|ivermectin|mesh-list
19826612|NCT05362513|Permethrin|permethrin|mesh-list
19826613|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19826614|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826615|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826616|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826617|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
19826618|NCT05362500|Glycolic acid|glycolic acid|mesh-list
19826619|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
19826620|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19826621|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19826622|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826623|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
19826624|NCT05362500|Coagulants|coagulants|mesh-ancestor
19826625|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
20611793|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
20611794|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826626|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826627|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
19826628|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19826629|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19826630|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826631|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19826632|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19826633|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826634|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826635|NCT05362474|Montelukast|montelukast|mesh-list
19826636|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19826637|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
19826638|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19826639|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
19826640|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826641|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826642|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19826643|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20335678|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20335679|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335680|NCT00795847|Diuretics|diuretics|mesh-ancestor
20335681|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
20335682|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335683|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20335684|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20335685|NCT00795899|Paclitaxel|paclitaxel|mesh-list
20335686|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
20335687|NCT00795899|Trastuzumab|trastuzumab|mesh-list
20335688|NCT00795899|Epirubicin|epirubicin|mesh-list
19650087|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650088|NCT02335372|Acetic Acid|acetic acid|mesh-list
19650089|NCT02335372|Proflavine|proflavine|mesh-list
19650090|NCT02335372|Retinol acetate|retinol acetate|mesh-list
19650091|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650092|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650093|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19650094|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
19650095|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650096|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19650097|NCT02335372|Protective Agents|protective agents|mesh-ancestor
19650098|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650099|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19650100|NCT02335255|Naftifine|naftifine|mesh-list
20348612|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
20348613|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348614|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348615|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
20348616|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348617|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20348618|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
20348619|NCT00864825|Protective Agents|protective agents|mesh-ancestor
20348620|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348621|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20348622|NCT00864838|Acetazolamide|acetazolamide|mesh-list
20348623|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348624|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20348625|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19826644|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826645|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19826646|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19826647|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826648|NCT05362318|Nicotine|nicotine|mesh-list
19826649|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19826650|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
19826651|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826652|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826653|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19826654|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19826655|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826656|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826657|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826658|NCT05362292|Mirabegron|mirabegron|mesh-list
19826659|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19826660|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19826661|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19826662|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19826663|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826664|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826665|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826666|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826667|NCT05362292|Urological Agents|urological agents|mesh-ancestor
19826668|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19826669|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19826670|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826671|NCT05362188|Niacinamide|niacinamide|mesh-list
19826672|NCT05362188|Niacin|niacin|mesh-list
19826673|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
19826674|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
19826675|NCT05362188|Vitamins|vitamins|mesh-ancestor
19826676|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
19826677|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826678|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19826679|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
19826680|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826681|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19826682|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
19826683|NCT05362019|Norethindrone|norethindrone|mesh-list
19826684|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
19826685|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
19826686|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19826687|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19826688|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19826689|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
19826690|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20335689|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20335690|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335691|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
19650101|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
19826691|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826692|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19826693|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19826694|NCT05361993|Aripiprazole|aripiprazole|mesh-list
19826695|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
19826696|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19826697|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19826698|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19826699|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826700|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826701|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
19826702|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
20335692|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
19650102|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650103|NCT02335151|Desflurane|desflurane|mesh-list
19650104|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19650105|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
19650106|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
19650107|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650108|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650109|NCT02335281|Mesalamine|mesalamine|mesh-list
19650110|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19826703|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826704|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335693|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
20335694|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335695|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335696|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
20335697|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335698|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335699|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20335700|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
20335701|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20335702|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335703|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20335704|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20335705|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20335706|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335707|NCT00795912|Atorvastatin|atorvastatin|mesh-list
20335708|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20335709|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20335710|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
20335711|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335712|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20335713|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20335714|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335715|NCT00795925|Propiverine|propiverine|mesh-list
20335716|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
20335717|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
20335718|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335719|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335720|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20335721|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19826705|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19826706|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19826707|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
19826708|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19826709|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19826710|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19826711|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19826712|NCT05361915|Abivertinib|abivertinib|mesh-list
19826713|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19826714|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826715|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826716|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
19826717|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19826718|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826719|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826720|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826721|NCT05361837|Analgesics|analgesics|mesh-ancestor
19826722|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
19826723|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826724|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19826725|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19826726|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19826727|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826728|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335722|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
20335723|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335724|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335725|NCT00795925|Urological Agents|urological agents|mesh-ancestor
20335726|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
20335727|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
20335728|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20335729|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19650111|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19650112|NCT02335281|Analgesics|analgesics|mesh-ancestor
19650113|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
19650114|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650115|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650116|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650117|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650118|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
19826729|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650119|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19826730|NCT05361824|Acetaminophen|acetaminophen|mesh-list
19826731|NCT05361824|Ketorolac|ketorolac|mesh-list
19826732|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826733|NCT05361824|Analgesics|analgesics|mesh-ancestor
19650120|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19650121|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650122|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
19650123|NCT02335359|Coagulants|coagulants|mesh-ancestor
19650124|NCT02335398|Methadone|methadone|mesh-list
19650125|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19650126|NCT02335398|Narcotics|narcotics|mesh-ancestor
19650127|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826734|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
19826735|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826736|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826737|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
19826738|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19826739|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826740|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826741|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19826742|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826743|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826744|NCT05361772|Colchicine|colchicine|mesh-list
19826745|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
19826746|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826747|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
19826748|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
19826749|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
19826750|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650128|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826751|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826752|NCT05361720|Nivolumab|nivolumab|mesh-list
19826753|NCT05361720|Ipilimumab|ipilimumab|mesh-list
19826754|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826755|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826756|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19826757|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826758|NCT05361655|Palbociclib|palbociclib|mesh-list
19826759|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19826760|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826761|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19826762|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826763|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826764|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19826765|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19826766|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
19826767|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826768|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826769|NCT05361642|Lidocaine|lidocaine|mesh-list
19826770|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
19826771|NCT05361642|Bupivacaine|bupivacaine|mesh-list
19826772|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
19826773|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
19826774|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826775|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826776|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
19826777|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826778|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20166413|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20166414|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
20166415|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
20166416|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166417|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166418|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20166419|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20166420|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
20166421|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166422|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20166423|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20166424|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
20166425|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
20166426|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166427|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166428|NCT00139893|Metoclopramide|metoclopramide|mesh-list
19835082|NCT00600353|Hormones|hormones|mesh-ancestor
19826779|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19826780|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19826781|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826782|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826783|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19826784|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19826785|NCT05361642|Analgesics|analgesics|mesh-ancestor
19826786|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19826787|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19826788|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19826789|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826790|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835083|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835084|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19835085|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835086|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19835087|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835088|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835089|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19835090|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19835091|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
19835092|NCT00600756|Risperidone|risperidone|mesh-list
19835093|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19835094|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19835095|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
19835096|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835097|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835098|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835099|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19835100|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835101|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835102|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835103|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335730|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335731|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335732|NCT00795938|Urological Agents|urological agents|mesh-ancestor
20335733|NCT00795977|Picibanil|picibanil|mesh-list
20335734|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335735|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20335736|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335737|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335738|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335739|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335740|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335741|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335742|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335743|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
20335744|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335745|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650129|NCT02335398|Analgesics|analgesics|mesh-ancestor
19650130|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
19835104|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
19835105|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835106|NCT00600821|Paclitaxel|paclitaxel|mesh-list
19835107|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19835108|NCT00600821|Bevacizumab|bevacizumab|mesh-list
19835109|NCT00600821|Carboplatin|carboplatin|mesh-list
19835110|NCT00600821|Axitinib|axitinib|mesh-list
19835111|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19835112|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835113|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
19835114|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
19835115|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
19835116|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650131|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650132|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
19650133|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
19650134|NCT02335190|Lidocaine|lidocaine|mesh-list
19650135|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
19650136|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
19835117|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835118|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20335746|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19650137|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650138|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650139|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
19650140|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650141|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19650142|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19650143|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19650144|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826791|NCT05361291|Dexamethasone|dexamethasone|mesh-list
19826792|NCT05361291|Lidocaine|lidocaine|mesh-list
20611795|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
20611796|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20611797|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19650145|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650146|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
19650147|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
19650148|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
19650149|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650150|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19650151|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
19650152|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19650153|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19650154|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19650155|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
19650156|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19650157|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650158|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19650159|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19826793|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19826794|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
19826795|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
20611798|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
20611799|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611800|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
20611801|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826796|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826797|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826798|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826799|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
19826800|NCT05361291|Hormones|hormones|mesh-ancestor
19826801|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826802|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19826803|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826804|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826805|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
19826806|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
19826807|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19826808|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
19826809|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19826810|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19826811|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19826812|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19826813|NCT05360368|Cetuximab|cetuximab|mesh-list
19826814|NCT05360368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826815|NCT05360368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826816|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
19826817|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826818|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826819|NCT05356104|Exenatide|exenatide|mesh-list
19826820|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19826821|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826822|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19826823|NCT05356104|Incretins|incretins|mesh-ancestor
19826824|NCT05356104|Hormones|hormones|mesh-ancestor
19826825|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826826|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
19826827|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19826828|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826829|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
19826830|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
19826831|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
19826832|NCT05355311|Vitamins|vitamins|mesh-ancestor
19826833|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
20611802|NCT02248571|Bevacizumab|bevacizumab|mesh-list
20611803|NCT02248571|Capecitabine|capecitabine|mesh-list
19826834|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826835|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
19826836|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
19826837|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826838|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826839|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
19826840|NCT05353374|Petrolatum|petrolatum|mesh-list
19826841|NCT05353374|Emollients|emollients|mesh-ancestor
19826842|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826843|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19826844|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826845|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19826846|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826847|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826848|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
19826849|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19826850|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
19826851|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826852|NCT05340504|Expectorants|expectorants|mesh-ancestor
19826853|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
19826854|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19826855|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
19826856|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826857|NCT05340504|Protective Agents|protective agents|mesh-ancestor
19826858|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826859|NCT05340504|Antidotes|antidotes|mesh-ancestor
19826860|NCT05324449|Cannabidiol|cannabidiol|mesh-list
19826861|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
19826862|NCT05323552|Curare|curare|mesh-list
19826863|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19826864|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19826865|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19826866|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826867|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826868|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19826869|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19826870|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826871|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826872|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826873|NCT05320380|Cytarabine|cytarabine|mesh-list
19826874|NCT05320380|Prednisolone|prednisolone|mesh-list
19826875|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20335747|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335748|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
20335749|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20335750|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335751|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335752|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335753|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335754|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335755|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335756|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335757|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
20335758|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826876|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
19826877|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19826878|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
19826879|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
19826880|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19826881|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19826882|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19826883|NCT05320380|Cortisone|cortisone|mesh-list
19826884|NCT05320380|Methotrexate|methotrexate|mesh-list
20335759|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335760|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20335761|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335762|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
20335763|NCT00796159|Olmesartan|olmesartan|mesh-list
20335764|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20335765|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20335766|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20335767|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19826885|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
19826886|NCT05320380|Fludarabine|fludarabine|mesh-list
19826887|NCT05320380|Daunorubicin|daunorubicin|mesh-list
19826888|NCT05320380|Immunoconjugates|immunoconjugates|mesh-list
19826889|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19826890|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
20166429|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
20166430|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
20166431|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335768|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335769|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19826891|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19826892|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
19826893|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19826894|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826895|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19826896|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
19826897|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826898|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826899|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826900|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19826901|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19826902|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19826903|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
19826904|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19826905|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19826906|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
19826907|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19826908|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335770|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335771|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335772|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166432|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166433|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20166434|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19826909|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
19826910|NCT05320380|Hormones|hormones|mesh-ancestor
19826911|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19826912|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19826913|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
19826914|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
19826915|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826916|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826917|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19826918|NCT05320380|Protective Agents|protective agents|mesh-ancestor
19826919|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19826920|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19826921|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19826922|NCT05305313|Propofol|propofol|mesh-list
19826923|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19826924|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166435|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20166436|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
20335773|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335774|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335775|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335776|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335777|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
20335778|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335779|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335780|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20335781|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335782|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
20335783|NCT00796198|Latanoprost|latanoprost|mesh-list
20335784|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19650160|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19650161|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650162|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650163|NCT02335099|Ticagrelor|ticagrelor|mesh-list
19650164|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19650165|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19650166|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19650167|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19650168|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
19650169|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650170|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166437|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335785|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20335786|NCT00796211|Nortriptyline|nortriptyline|mesh-list
20335787|NCT00796211|Calcipotriene|calcipotriene|mesh-list
20335788|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335789|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20335790|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
20335791|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335792|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20335793|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20335794|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20335795|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335796|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
20335797|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335798|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335799|NCT00796250|Prednisolone|prednisolone|mesh-list
20335800|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19826925|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826926|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19826927|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
19826928|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
19826929|NCT05291156|Cetuximab|cetuximab|mesh-list
19826930|NCT05291156|Avelumab|avelumab|mesh-list
19826931|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826932|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826933|NCT05290740|Norepinephrine|norepinephrine|mesh-list
19826934|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19826935|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19826936|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19826937|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826938|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826939|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826940|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
19826941|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
19826942|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826943|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19826944|NCT05270733|Ustekinumab|ustekinumab|mesh-list
19826945|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335801|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
20335802|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20335803|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
20335804|NCT00796250|Azathioprine|azathioprine|mesh-list
20335805|NCT00796250|Infliximab|infliximab|mesh-list
20335806|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20335807|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
20335808|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335809|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
20335810|NCT00796250|Hormones|hormones|mesh-ancestor
20335811|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335812|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335813|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20335814|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335815|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
20335816|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
19826946|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
19826947|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
19826948|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826949|NCT05259800|Peppermint oil|peppermint oil|mesh-list
19826950|NCT05259800|Mineral Oil|mineral oil|mesh-list
19826951|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
19826952|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
19826953|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826954|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826955|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826956|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
19826957|NCT05259800|Emollients|emollients|mesh-ancestor
19826958|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826959|NCT05238363|Cetuximab|cetuximab|mesh-list
19826960|NCT05238363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826961|NCT05238363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826962|NCT05236894|Nicotine|nicotine|mesh-list
19826963|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19826964|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
19826965|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826966|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826967|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20335817|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19826968|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19826969|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
19826970|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19826971|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335818|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335819|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19650171|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826972|NCT05221658|Cisplatin|cisplatin|mesh-list
19826973|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826974|NCT05214339|Bevacizumab|bevacizumab|mesh-list
19826975|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19826976|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826977|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19826978|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19826979|NCT05214339|Growth Substances|growth substances|mesh-ancestor
19826980|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826981|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
19826982|NCT05203510|Treprostinil|treprostinil|mesh-list
19826983|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19650172|NCT02334904|Risperidone|risperidone|mesh-list
19650173|NCT02334904|Aripiprazole|aripiprazole|mesh-list
19650174|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19650175|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
19650176|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835119|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835120|NCT00600821|Growth Substances|growth substances|mesh-ancestor
19835121|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835122|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835123|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835124|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835125|NCT00600886|Octreotide|octreotide|mesh-list
19835126|NCT00600886|Pasireotide|pasireotide|mesh-list
19835127|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19835128|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19835129|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835130|NCT00600886|Hormones|hormones|mesh-ancestor
19835131|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835132|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835133|NCT00600925|Gentamicins|gentamicins|mesh-list
19835134|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19835135|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835136|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19835137|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835138|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650177|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650178|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650179|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19650180|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19650181|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650182|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19650183|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19650184|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
19650185|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
19650186|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
19835139|NCT00600938|Deferasirox|deferasirox|mesh-list
19835140|NCT00600938|Deferoxamine|deferoxamine|mesh-list
19835141|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19835142|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
19835143|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
19835144|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835145|NCT00600938|Siderophores|siderophores|mesh-ancestor
19835146|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
19835147|NCT00601107|Vitamins|vitamins|mesh-ancestor
19835148|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
19835149|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166438|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166439|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
20166440|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20166441|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
20166442|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166443|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166444|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20166445|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
20166446|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20166447|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19835150|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20335820|NCT00796250|Protective Agents|protective agents|mesh-ancestor
20335821|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19826984|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
19826985|NCT05198232|TEMPO|tempo|mesh-list
19826986|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
19826987|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19826988|NCT05198232|Protective Agents|protective agents|mesh-ancestor
19826989|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826990|NCT05198232|Antacids|antacids|mesh-ancestor
19826991|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19826992|NCT05183854|Vaccines|vaccines|mesh-list
19826993|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20335822|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335823|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
20335824|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335825|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20335826|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335827|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
20335828|NCT00796263|Dolutegravir|dolutegravir|mesh-list
20335829|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20335830|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20335831|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335832|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335833|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20335834|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20335835|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
20335836|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335837|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20335838|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335839|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335840|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335841|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335842|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335843|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335844|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19826994|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
19826995|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826996|NCT05183828|Letrozole|letrozole|mesh-list
19826997|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19826998|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19650187|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19650188|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19650189|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19650190|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19650191|NCT02334735|Vaccines|vaccines|mesh-list
19650192|NCT02334735|Poly ICLC|poly iclc|mesh-list
19650193|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
19650194|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19826999|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19827000|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827001|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827002|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19827003|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
19827004|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827005|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827006|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19827007|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827008|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
19827009|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19827010|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827011|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20335845|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
20335846|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335847|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335848|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20335849|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335850|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
20335851|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20335852|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335853|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335854|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827012|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827013|NCT05167487|Cisplatin|cisplatin|mesh-list
19827014|NCT05167487|Carboplatin|carboplatin|mesh-list
19827015|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827016|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
19827017|NCT05163223|Capecitabine|capecitabine|mesh-list
19827018|NCT05163223|Sargramostim|sargramostim|mesh-list
19827019|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827020|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827021|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827022|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
19827023|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827024|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
19827025|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827026|NCT05142241|Temozolomide|temozolomide|mesh-list
19827027|NCT05142241|Talazoparib|talazoparib|mesh-list
19827028|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19827029|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
19827030|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827031|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827032|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19827033|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827034|NCT05117554|Midazolam|midazolam|mesh-list
19827035|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19827036|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19827037|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827038|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827039|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19827040|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19827041|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19827042|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19827043|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
19827044|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
19827045|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
19827046|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
19827047|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827048|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827049|NCT05099185|Trace Elements|trace elements|mesh-list
20166448|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20335855|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335856|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335857|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335858|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335859|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
20335860|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335861|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335862|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19650195|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
19650196|NCT02334501|Lansoprazole|lansoprazole|mesh-list
19650197|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
19650198|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19650199|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650200|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19650201|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650202|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650203|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
19650204|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19650205|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19650206|NCT02334475|Prednisolone|prednisolone|mesh-list
20166449|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
20166450|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166451|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174571|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20174572|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20174573|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
20174574|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
20174575|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20174576|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174577|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
20174578|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174579|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20335863|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19827050|NCT05099185|Micronutrients|micronutrients|mesh-list
19827051|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650207|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
20335864|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
20335865|NCT00796458|Docetaxel|docetaxel|mesh-list
20335866|NCT00796458|Hormones|hormones|mesh-list
20335867|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335868|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
20335869|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
20335870|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
20335871|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335872|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20335873|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335874|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20335875|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335876|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19827052|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
19827053|NCT05096195|Vitamin D|vitamin d|mesh-list
19827054|NCT05096195|Denosumab|denosumab|mesh-list
19827055|NCT05096195|Calcium|calcium|mesh-list
19827056|NCT05096195|Vitamins|vitamins|mesh-ancestor
19827057|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
19827058|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827059|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20335877|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335878|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335879|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335880|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335881|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335882|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
20335883|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335884|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650208|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19650209|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
19650210|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827060|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19827061|NCT05092412|Carboplatin|carboplatin|mesh-list
19827062|NCT05092412|Etoposide|etoposide|mesh-list
19827063|NCT05092412|Durvalumab|durvalumab|mesh-list
19827064|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827065|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19827066|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19827067|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19827068|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827069|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827070|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827071|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
19827072|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335885|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20335886|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335887|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
20335888|NCT00796497|Ondansetron|ondansetron|mesh-list
20335889|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
20335890|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
20335891|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335892|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335893|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335894|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
20335895|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335896|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335897|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
20335898|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335899|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335900|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335901|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335902|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335903|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335904|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19650211|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
19650212|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
19650213|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650214|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650215|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650216|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
19827073|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827074|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
19650217|NCT02334475|Hormones|hormones|mesh-ancestor
19827075|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827076|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827077|NCT05076292|Glucagon|glucagon|mesh-list
19827078|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20335905|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20335906|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335907|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335908|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335909|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335910|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335911|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335912|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20335913|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
20335914|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20335915|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335916|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20335917|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335918|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
20335919|NCT00796692|Heparin|heparin|mesh-list
19827079|NCT05076292|Hormones|hormones|mesh-ancestor
19827080|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827081|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827082|NCT05068609|Nivolumab|nivolumab|mesh-list
19827083|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827084|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827085|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827086|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827087|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19827088|NCT05065671|Tolcapone|tolcapone|mesh-list
19827089|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19827090|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19827091|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19827092|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827093|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827094|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827095|NCT05065671|Analgesics|analgesics|mesh-ancestor
19827096|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
19827097|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650218|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650219|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19650220|NCT02334475|Protective Agents|protective agents|mesh-ancestor
19827098|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
19827099|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19827100|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
19827101|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20335920|NCT00796692|Calcium heparin|calcium heparin|mesh-list
20335921|NCT00796692|Nadroparin|nadroparin|mesh-list
20335922|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
20335923|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20335924|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20335925|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335926|NCT00796796|Sirolimus|sirolimus|mesh-list
19827102|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19827103|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19827104|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827105|NCT05042102|Donepezil|donepezil|mesh-list
19827106|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19827107|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827108|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827109|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
20335927|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650221|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19827110|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827111|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827112|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
19827113|NCT05039281|Atezolizumab|atezolizumab|mesh-list
19827114|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19827115|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827116|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
19650222|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650223|NCT02334605|Capsaicin|capsaicin|mesh-list
19650224|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
19650225|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
19835151|NCT00601172|Dexamethasone|dexamethasone|mesh-list
19650226|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
19827117|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827118|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19827119|NCT05039073|Nivolumab|nivolumab|mesh-list
19827120|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19827121|NCT05039073|Antibodies|antibodies|mesh-list
19827122|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
19827123|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19827124|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
19827125|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
19827126|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827127|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335928|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335929|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20335930|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20335931|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
19827128|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827129|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827130|NCT05038462|Lactoferrin|lactoferrin|mesh-list
19827131|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827132|NCT05017194|Emodepside|emodepside|mesh-list
19827133|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19827134|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827135|NCT04994717|Blinatumomab|blinatumomab|mesh-list
19827136|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827137|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
20335932|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335933|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
20335934|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335935|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20335936|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20335937|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20335938|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827138|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827139|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827140|NCT04927312|Metronidazole|metronidazole|mesh-list
19827141|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827142|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650227|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650228|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650229|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
19650230|NCT02334488|Everolimus|everolimus|mesh-list
19650231|NCT02334488|Tacrolimus|tacrolimus|mesh-list
19650232|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650233|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
19650234|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827143|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19827144|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19827145|NCT04925648|Dasatinib|dasatinib|mesh-list
19827146|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827147|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827148|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827149|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827150|NCT04891484|Ondansetron|ondansetron|mesh-list
19827151|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
19827152|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
19827153|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827154|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827155|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827156|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
19827157|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
19827158|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19827159|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
19827160|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827161|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827162|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19827163|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19827164|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827165|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19827166|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19827167|NCT04866602|Atovaquone|atovaquone|mesh-list
19827168|NCT04866602|Proguanil|proguanil|mesh-list
19827169|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19827170|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827171|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
19650235|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19827172|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19827173|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19827174|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827175|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827176|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
19835152|NCT00601172|Ondansetron|ondansetron|mesh-list
19835153|NCT00601172|Casopitant|casopitant|mesh-list
19835154|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835155|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
19835156|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
19835157|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835158|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835159|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19835160|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
19835161|NCT00601172|Hormones|hormones|mesh-ancestor
19835162|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835163|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19835164|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835165|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
19835166|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
19835167|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19835168|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
19835169|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835170|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835171|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19835172|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835173|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835174|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835175|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19835176|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19835177|NCT00601250|Linagliptin|linagliptin|mesh-list
19835178|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19835179|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835180|NCT00601250|Incretins|incretins|mesh-ancestor
19835181|NCT00601250|Hormones|hormones|mesh-ancestor
19835182|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166452|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
20166453|NCT00140010|Hematinics|hematinics|mesh-ancestor
20166454|NCT00140023|Azithromycin|azithromycin|mesh-list
20166455|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166456|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166457|NCT00140062|Latanoprost|latanoprost|mesh-list
20166458|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20166459|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20166460|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
20166461|NCT00140075|Epirubicin|epirubicin|mesh-list
20166462|NCT00140075|Taxane|taxane|mesh-list
20166463|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835183|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19835184|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
19835185|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835186|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835187|NCT00601354|Orlistat|orlistat|mesh-list
19835188|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835189|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835190|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19835191|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19835192|NCT00601458|Naproxen|naproxen|mesh-list
19835193|NCT00601458|Pregabalin|pregabalin|mesh-list
19835194|NCT00601458|Analgesics|analgesics|mesh-ancestor
19835195|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
19835196|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835197|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835198|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
20166464|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
19835199|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19835200|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166465|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166466|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174580|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
20174581|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174582|NCT00165178|Antidotes|antidotes|mesh-ancestor
20174583|NCT00165178|Protective Agents|protective agents|mesh-ancestor
20174584|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
20174585|NCT00165178|Vitamins|vitamins|mesh-ancestor
20174586|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
20174587|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20174588|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174589|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827177|NCT04839042|Cloricromen|cloricromen|mesh-list
19827178|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19827179|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
19827180|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827181|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827182|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827183|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827184|NCT04794569|Tinzaparin|tinzaparin|mesh-list
19827185|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19827186|NCT04794569|Dalteparin|dalteparin|mesh-list
20335939|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335940|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20335941|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20335942|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19650236|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650237|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650238|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650239|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19650240|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19650241|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
19650242|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650243|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650244|NCT02334670|Fluconazole|fluconazole|mesh-list
19650245|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
19650246|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650247|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19827187|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
19827188|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19827189|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
19827190|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19827191|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
19827192|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827193|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827194|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
19827195|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19827196|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19827197|NCT04789330|Phenylephrine|phenylephrine|mesh-list
19827198|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
19827199|NCT04789330|Norepinephrine|norepinephrine|mesh-list
19827200|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19827201|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
19827202|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
19827203|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827204|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827205|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
19827206|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19827207|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
19827208|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
19827209|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19827210|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19827211|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19827212|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
19827213|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827214|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827215|NCT04789330|Protective Agents|protective agents|mesh-ancestor
19827216|NCT04774094|Ceftazidime|ceftazidime|mesh-list
19827217|NCT04774094|Avibactam|avibactam|mesh-list
19827218|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19827219|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19827220|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827221|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19827222|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827223|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827224|NCT04762758|Naltrexone|naltrexone|mesh-list
19827225|NCT04762758|Baclofen|baclofen|mesh-list
19827226|NCT04762758|Sorbitol|sorbitol|mesh-list
20166467|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20166468|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
20166469|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166470|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166471|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20166472|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20166473|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20166474|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20166475|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166476|NCT00140101|Paclitaxel|paclitaxel|mesh-list
20166477|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20166478|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166479|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
20166480|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
20166481|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
20166482|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166483|NCT00140114|Misoprostol|misoprostol|mesh-list
20166484|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20166485|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
20166486|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20166487|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166488|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20166489|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20166490|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
20166491|NCT00140153|Testosterone|testosterone|mesh-list
20166492|NCT00140153|Androgens|androgens|mesh-ancestor
20166493|NCT00140153|Hormones|hormones|mesh-ancestor
20166494|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166495|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166496|NCT00140166|Pyridoxine|pyridoxine|mesh-list
20166497|NCT00140166|Niacinamide|niacinamide|mesh-list
20166498|NCT00140166|Niacin|niacin|mesh-list
20166499|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
20166500|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
20166501|NCT00140166|Vitamins|vitamins|mesh-ancestor
19827227|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19827228|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19827229|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827230|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
19827231|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827232|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19827233|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19827234|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19827235|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
19827236|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
19827237|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827238|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827239|NCT04762758|Cathartics|cathartics|mesh-ancestor
20166502|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
20166503|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166504|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20166505|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
20166506|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827240|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827241|NCT04720781|Esomeprazole|esomeprazole|mesh-list
19827242|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19827243|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827244|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20166507|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20166508|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
19827245|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827246|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827247|NCT04704505|Androgens|androgens|mesh-list
19827248|NCT04704505|Hormones|hormones|mesh-ancestor
19827249|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827250|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827251|NCT04698187|Nivolumab|nivolumab|mesh-list
19827252|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827253|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827254|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827255|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827256|NCT04685135|Docetaxel|docetaxel|mesh-list
19827257|NCT04685135|Adagrasib|adagrasib|mesh-list
19827258|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827259|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827260|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827261|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
20166509|NCT00140218|Pramipexole|pramipexole|mesh-list
20166510|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
20166511|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827262|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827263|NCT04684368|Carboplatin|carboplatin|mesh-list
19827264|NCT04684368|Etoposide|etoposide|mesh-list
19827265|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
20166512|NCT00140218|Protective Agents|protective agents|mesh-ancestor
20166513|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827266|NCT04684368|Ifosfamide|ifosfamide|mesh-list
19827267|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
19827268|NCT04684368|Thiotepa|thiotepa|mesh-list
19827269|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
19827270|NCT04684368|Lenograstim|lenograstim|mesh-list
19827271|NCT04684368|Mesna|mesna|mesh-list
19827272|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827273|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19827274|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19827275|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19827276|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827277|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827278|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19827279|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
19827280|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166514|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20166515|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20335943|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
19650248|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19650249|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650250|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650251|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19650252|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
19650253|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650254|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650255|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19650256|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19650257|NCT02334631|Simethicone|simethicone|mesh-list
19650258|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
19650259|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650260|NCT02334631|Emollients|emollients|mesh-ancestor
19650261|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
19650262|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19650263|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19650264|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
19650265|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650266|NCT02334462|Antacids|antacids|mesh-ancestor
19650267|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650268|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650269|NCT02334254|Warfarin|warfarin|mesh-list
19650270|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
19650271|NCT02334254|Clopidogrel|clopidogrel|mesh-list
19650272|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19650273|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19650274|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19650275|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19650276|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
19650277|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650278|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650279|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650280|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
19650281|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19650282|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
19650283|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19650284|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
19650285|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650286|NCT02334163|Metronidazole|metronidazole|mesh-list
19650287|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
19650288|NCT02334163|Lactulose|lactulose|mesh-list
19650289|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650290|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650291|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19650292|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20166516|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
20166517|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
20166518|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166519|NCT00140257|Citalopram|citalopram|mesh-list
20166520|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20335944|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348127|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19650293|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650294|NCT02334176|Lidocaine|lidocaine|mesh-list
19827281|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20166521|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19827282|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
19827283|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827284|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19827285|NCT04684368|Protective Agents|protective agents|mesh-ancestor
19827286|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
19827287|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19827288|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827289|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827290|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827291|NCT04643002|Dexamethasone|dexamethasone|mesh-list
19827292|NCT04643002|Pomalidomide|pomalidomide|mesh-list
19827293|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827294|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
20335945|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335946|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20335947|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20335948|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
20335949|NCT00796887|Niacin|niacin|mesh-list
20335950|NCT00796887|Niacinamide|niacinamide|mesh-list
20335951|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
20335952|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20335953|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
20335954|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335955|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20335956|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
20335957|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
20335958|NCT00796887|Vitamins|vitamins|mesh-ancestor
20335959|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
20335960|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335961|NCT00796900|Dantrolene|dantrolene|mesh-list
20335962|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20335963|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335964|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20335965|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335966|NCT00797017|Fentanyl|fentanyl|mesh-list
20335967|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20611804|NCT02248571|Everolimus|everolimus|mesh-list
19650295|NCT02334176|Epinephrine|epinephrine|mesh-list
19650296|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
19650297|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
19650298|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650299|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650300|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
19650301|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650302|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19650303|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19827295|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
19827296|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827297|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827298|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827299|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
19827300|NCT04643002|Hormones|hormones|mesh-ancestor
19827301|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827302|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19827303|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827304|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
19827305|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19827306|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19827307|NCT04643002|Growth Substances|growth substances|mesh-ancestor
19827308|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
19827309|NCT04606576|Insulin|insulin|mesh-list
20166522|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166523|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166524|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166525|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
20166526|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166527|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20166528|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
20166529|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20166530|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
20166531|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20166532|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166533|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
20166534|NCT00140309|Rifampin|rifampin|mesh-list
20166535|NCT00140309|Isoniazid|isoniazid|mesh-list
19827310|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20335968|NCT00797017|Narcotics|narcotics|mesh-ancestor
20335969|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20335970|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335971|NCT00797017|Analgesics|analgesics|mesh-ancestor
20335972|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
20335973|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335974|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20335975|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20335976|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
20335977|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
20335978|NCT00797030|Cyclosporine|cyclosporine|mesh-list
20335979|NCT00797030|Cyclosporins|cyclosporins|mesh-list
20335980|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20335981|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20335982|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20335983|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
20335984|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827311|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19827312|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827313|NCT04560179|Tobramycin|tobramycin|mesh-list
19827314|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19827315|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19827316|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827317|NCT04550546|Nystatin|nystatin|mesh-list
19827318|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19827319|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827320|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
19827321|NCT04550546|Ionophores|ionophores|mesh-ancestor
19827322|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19827323|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827324|NCT04544111|Trametinib|trametinib|mesh-list
19827325|NCT04544111|Dabrafenib|dabrafenib|mesh-list
20335985|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
20335986|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20335987|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
20335988|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20335989|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19827326|NCT04544111|Spartalizumab|spartalizumab|mesh-list
19827327|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827328|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827329|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827330|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827331|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827332|NCT04509622|Cytarabine|cytarabine|mesh-list
20335990|NCT00797056|Aspirin|aspirin|mesh-list
20335991|NCT00797056|Clopidogrel|clopidogrel|mesh-list
20335992|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19827333|NCT04509622|Venetoclax|venetoclax|mesh-list
19827334|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827335|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
19827336|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827337|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827338|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
19827339|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827340|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827341|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
19827342|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827343|NCT04501380|Rifamycins|rifamycins|mesh-list
19827344|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
19827345|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19827346|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827347|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19827348|NCT04480372|Gemcitabine|gemcitabine|mesh-list
19827349|NCT04480372|Atezolizumab|atezolizumab|mesh-list
19827350|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827351|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
19827352|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827353|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827354|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
20335993|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20335994|NCT00797056|Analgesics|analgesics|mesh-ancestor
19827355|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827356|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827357|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827358|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
19827359|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827360|NCT04465734|Sorafenib|sorafenib|mesh-list
19827361|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348128|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827362|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827363|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827364|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827365|NCT04450316|Naltrexone|naltrexone|mesh-list
19827366|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19827367|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19827368|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827369|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
19827370|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827371|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
19827372|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827373|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827374|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
19827375|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20335995|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
20335996|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20335997|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20335998|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20335999|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336000|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20336001|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20336002|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336003|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20336004|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20336005|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336006|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
20336007|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20336008|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19827376|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827377|NCT04416633|Durvalumab|durvalumab|mesh-list
19827378|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827379|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827380|NCT04415905|Propofol|propofol|mesh-list
19827381|NCT04415905|Sevoflurane|sevoflurane|mesh-list
19827382|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19827383|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827384|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827385|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19827386|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
19827387|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
19827388|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19827389|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19827390|NCT04402073|Vincristine|vincristine|mesh-list
19827391|NCT04402073|Lomustine|lomustine|mesh-list
19827392|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827393|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19827394|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827395|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827396|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827397|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827398|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19827399|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
19827400|NCT04396860|Nivolumab|nivolumab|mesh-list
19827401|NCT04396860|Ipilimumab|ipilimumab|mesh-list
19827402|NCT04396860|Temozolomide|temozolomide|mesh-list
19827403|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827404|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827405|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827406|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827407|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19827408|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
19827409|NCT04395508|Trastuzumab|trastuzumab|mesh-list
19827410|NCT04395508|Pertuzumab|pertuzumab|mesh-list
19827411|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827412|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827413|NCT04384367|Naproxen|naproxen|mesh-list
19827414|NCT04384367|Rizatriptan|rizatriptan|mesh-list
19827415|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19827416|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19827417|NCT04384367|Analgesics|analgesics|mesh-ancestor
19827418|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
19827419|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827420|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827421|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336009|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20336010|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
20336011|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336012|NCT00797160|Propofol|propofol|mesh-list
20336013|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20336014|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336015|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827422|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336016|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20336017|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
20336018|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
20336019|NCT00797264|Ketamine|ketamine|mesh-list
20336020|NCT00797264|Morphine|morphine|mesh-list
20336021|NCT00797264|Analgesics|analgesics|mesh-ancestor
20336022|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
20336023|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336024|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336025|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20336026|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20336027|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
20336028|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
20336029|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336030|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20336031|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20336032|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336033|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336034|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20336035|NCT00797264|Narcotics|narcotics|mesh-ancestor
20336036|NCT00797303|Bevacizumab|bevacizumab|mesh-list
20336037|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336038|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336039|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20336040|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20336041|NCT00797303|Growth Substances|growth substances|mesh-ancestor
20336042|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336043|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
20336044|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
20336045|NCT00797394|Urological Agents|urological agents|mesh-ancestor
20336046|NCT00797420|Fluconazole|fluconazole|mesh-list
19827423|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
19827424|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19827425|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827426|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827427|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19827428|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
19827429|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827430|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
19827431|NCT04348747|Vaccines|vaccines|mesh-list
19827432|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
19827433|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827434|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827435|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827436|NCT04341311|Panobinostat|panobinostat|mesh-list
19827437|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827438|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19827439|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827440|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835201|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336047|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
20336048|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336049|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20336050|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20336051|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336052|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348626|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20336053|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20336054|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
20336055|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336056|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336057|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20336058|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20336059|NCT00797472|Bleomycin|bleomycin|mesh-list
20336060|NCT00797472|Dacarbazine|dacarbazine|mesh-list
19827441|NCT04324840|Temozolomide|temozolomide|mesh-list
19827442|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19827443|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
19827444|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827445|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827446|NCT04317430|Niclosamide|niclosamide|mesh-list
19827447|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
19827448|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19827449|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
19827450|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19827451|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827452|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
19827453|NCT04315233|Belinostat|belinostat|mesh-list
19827454|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827455|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19827456|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827457|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827458|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
19827459|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
19827460|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827461|NCT04286178|Vitamins|vitamins|mesh-ancestor
19827462|NCT04268199|Bortezomib|bortezomib|mesh-list
19827463|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827464|NCT04259398|Propofol|propofol|mesh-list
19827465|NCT04259398|Sevoflurane|sevoflurane|mesh-list
19827466|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20166536|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
20166537|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166538|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166539|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20166540|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20166541|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166542|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166543|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166544|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20166545|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
20166546|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
20166547|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20166548|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20166549|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20166550|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20166551|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20336061|NCT00797472|Vinblastine|vinblastine|mesh-list
20336062|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336063|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336064|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336065|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336066|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
20336067|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336068|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336069|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336070|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336071|NCT00797485|Leucovorin|leucovorin|mesh-list
20336072|NCT00797485|Bevacizumab|bevacizumab|mesh-list
20336073|NCT00797485|Fluorouracil|fluorouracil|mesh-list
20336074|NCT00797485|Capecitabine|capecitabine|mesh-list
20336075|NCT00797485|Irinotecan|irinotecan|mesh-list
19827467|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827468|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827469|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19827470|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
19827471|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
20336076|NCT00797485|Calcium|calcium|mesh-list
20336077|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
20336078|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827472|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19827473|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19827474|NCT04257188|Anesthetics|anesthetics|mesh-list
20336079|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336080|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20336081|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20336082|NCT00797485|Growth Substances|growth substances|mesh-ancestor
20336083|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336084|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
20336085|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20336086|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
20336087|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336088|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20336089|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336090|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
20336091|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20336092|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20336093|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336094|NCT00797485|Antidotes|antidotes|mesh-ancestor
20336095|NCT00797485|Protective Agents|protective agents|mesh-ancestor
20336096|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
20336097|NCT00797485|Vitamins|vitamins|mesh-ancestor
20336098|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
20336099|NCT00797693|Misoprostol|misoprostol|mesh-list
20336100|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20336101|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
20336102|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20336103|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336104|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20336105|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20336106|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
20348129|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348130|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20348131|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20348132|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20348133|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348134|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20348135|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20348136|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20348137|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20348138|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20348139|NCT00863733|Acetic Acid|acetic acid|mesh-list
20348140|NCT00863733|Vadimezan|vadimezan|mesh-list
20348141|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20348142|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827475|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827476|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827477|NCT04224428|Fexofenadine|fexofenadine|mesh-list
19827478|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19827479|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19827480|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19827481|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
19827482|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
19827483|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827484|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827485|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827486|NCT04224194|Adalimumab|adalimumab|mesh-list
19827487|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827488|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19827489|NCT04200833|Golimumab|golimumab|mesh-list
19827490|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19827491|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827492|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827493|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
20174590|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174591|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20174592|NCT00165191|Doxorubicin|doxorubicin|mesh-list
20174593|NCT00165191|Fluorouracil|fluorouracil|mesh-list
20174594|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174595|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20174596|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20174597|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20174598|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174599|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174600|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
20174601|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20166552|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20166553|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20166554|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19827494|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827495|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
19827496|NCT04195568|Antacids|antacids|mesh-ancestor
19827497|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827498|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827499|NCT04191889|Apatinib|apatinib|mesh-list
19827500|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827501|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827502|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827503|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827504|NCT04186871|Abatacept|abatacept|mesh-list
19827505|NCT04186871|Branebrutinib|branebrutinib|mesh-list
19827506|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827507|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827508|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827509|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827510|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
19827511|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827512|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19827513|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827514|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827515|NCT04185883|Bevacizumab|bevacizumab|mesh-list
19827516|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
19827517|NCT04185883|Panitumumab|panitumumab|mesh-list
19827518|NCT04185883|Carboplatin|carboplatin|mesh-list
19827519|NCT04185883|Docetaxel|docetaxel|mesh-list
19827520|NCT04185883|Pemetrexed|pemetrexed|mesh-list
19827521|NCT04185883|Everolimus|everolimus|mesh-list
19827522|NCT04185883|Atezolizumab|atezolizumab|mesh-list
19827523|NCT04185883|Palbociclib|palbociclib|mesh-list
19827524|NCT04185883|Trametinib|trametinib|mesh-list
19827525|NCT04185883|Afatinib|afatinib|mesh-list
19827526|NCT04185883|Loperamide|loperamide|mesh-list
19827527|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827528|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827529|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19827530|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19827531|NCT04185883|Growth Substances|growth substances|mesh-ancestor
19827532|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827533|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
19827534|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827535|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827536|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827537|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827538|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827539|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19827540|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19827541|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827542|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
19827543|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827544|NCT04185883|Antidiarrheals|antidiarrheals|mesh-ancestor
19827545|NCT04185883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827546|NCT04181333|Trastuzumab|trastuzumab|mesh-list
19827547|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827548|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827549|NCT04173507|Avelumab|avelumab|mesh-list
19827550|NCT04173507|Talazoparib|talazoparib|mesh-list
20166555|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20166556|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
20166557|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20166558|NCT00140361|Artesunate|artesunate|mesh-list
20166559|NCT00140361|Lumefantrine|lumefantrine|mesh-list
20166560|NCT00140361|Artemether|artemether|mesh-list
20166561|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
20166562|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
20166563|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20166564|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
20166565|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19827551|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19827552|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827553|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827554|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19827555|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827556|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166566|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19827557|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
19827558|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827559|NCT04165135|Factor VIII|factor viii|mesh-list
19827560|NCT04165135|Coagulants|coagulants|mesh-ancestor
19827561|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
19827562|NCT04150640|Nivolumab|nivolumab|mesh-list
19827563|NCT04150640|Trastuzumab|trastuzumab|mesh-list
19827564|NCT04150640|Fluorouracil|fluorouracil|mesh-list
19827565|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
19827566|NCT04150640|Irinotecan|irinotecan|mesh-list
19827567|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827568|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827569|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
19827570|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827571|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827572|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827573|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
19827574|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827575|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827576|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19827577|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19827578|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827579|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
19827580|NCT04140526|Osimertinib|osimertinib|mesh-list
19827581|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827582|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827583|NCT04140526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827584|NCT04140526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827585|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827586|NCT04111458|Trametinib|trametinib|mesh-list
19827587|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827588|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827589|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827590|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827591|NCT04110314|Vaccines|vaccines|mesh-list
19827592|NCT04110314|Immunologic Factors|immunologic factors|mesh-ancestor
19827593|NCT04110314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827594|NCT04092452|PF-06700841|pf-06700841|mesh-list
19827595|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827596|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827597|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827598|NCT04091750|Nivolumab|nivolumab|mesh-list
19827599|NCT04091750|Ipilimumab|ipilimumab|mesh-list
19827600|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827601|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827602|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827603|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827604|NCT04068753|Niraparib|niraparib|mesh-list
19827605|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19827606|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827607|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827608|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827609|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
19827610|NCT04066114|Prednisone|prednisone|mesh-list
19827611|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
19827612|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19827613|NCT04066114|Everolimus|everolimus|mesh-list
19827614|NCT04066114|Abatacept|abatacept|mesh-list
19827615|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
19827616|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19827617|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827618|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
19827619|NCT04066114|Hormones|hormones|mesh-ancestor
19827620|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166567|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166568|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166569|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
19650304|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19650305|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650306|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650307|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19650308|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19650309|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19650310|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650311|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20166570|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
20336107|NCT00797745|Ritonavir|ritonavir|mesh-list
20336108|NCT00797745|Ribavirin|ribavirin|mesh-list
20336109|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20336110|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20166571|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20166572|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
20166573|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20166574|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166575|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166576|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20166577|NCT00140361|Renal Agents|renal agents|mesh-ancestor
20166578|NCT00140452|Thalidomide|thalidomide|mesh-list
20166579|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166580|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
20166581|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166582|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
20166583|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166584|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166585|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20166586|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20166587|NCT00140452|Growth Substances|growth substances|mesh-ancestor
20166588|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
20166589|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166590|NCT00140465|Clopidogrel|clopidogrel|mesh-list
20166591|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20166592|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20166593|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20166594|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20166595|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
19650312|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19650313|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
19650314|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19650315|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19650316|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
19650317|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
20166596|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166597|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166598|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336111|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19650318|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19650319|NCT02334150|Sufentanil|sufentanil|mesh-list
19650320|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19650321|NCT02334150|Narcotics|narcotics|mesh-ancestor
19650322|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650323|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650324|NCT02334150|Analgesics|analgesics|mesh-ancestor
19650325|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
19650326|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650327|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19650328|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19650329|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
19650330|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
19665235|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665236|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
19665237|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665238|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665239|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19665240|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665241|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
19665242|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665243|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
19665244|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19665245|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
19665246|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665247|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665248|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19665249|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
19665250|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
19665251|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19665252|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
19827621|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336112|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
20336113|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336114|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336115|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20336116|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20336117|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
20336118|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336119|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20336120|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20336121|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
20336122|NCT00797771|Insulin|insulin|mesh-list
20336123|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20336124|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336125|NCT00797784|Etanercept|etanercept|mesh-list
20336126|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20336127|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336128|NCT00797784|Analgesics|analgesics|mesh-ancestor
20336129|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
20336130|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336131|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336132|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336133|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336134|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20336135|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336136|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
20336137|NCT00797810|Cytarabine|cytarabine|mesh-list
20336138|NCT00797810|Dexamethasone|dexamethasone|mesh-list
20336139|NCT00797810|Prednisone|prednisone|mesh-list
20336140|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
20336141|NCT00797810|Ifosfamide|ifosfamide|mesh-list
20336142|NCT00797810|Rituximab|rituximab|mesh-list
20336143|NCT00797810|Vincristine|vincristine|mesh-list
20336144|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827622|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19827623|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827624|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827625|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
19827626|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19827627|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19827628|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
19827629|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19827630|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827631|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827632|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827633|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
19827634|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
19827635|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827636|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827637|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19827638|NCT04066114|Protective Agents|protective agents|mesh-ancestor
19827639|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827640|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19827641|NCT04064294|Levodopa|levodopa|mesh-list
19827642|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19827643|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19827644|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
19827645|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827646|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827647|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827648|NCT04004442|Avelumab|avelumab|mesh-list
19827649|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827650|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827651|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
19827652|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
19827653|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827654|NCT03971071|Erenumab|erenumab|mesh-list
19827655|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19827656|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19827657|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827658|NCT03971071|Analgesics|analgesics|mesh-ancestor
19827659|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
19827660|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336145|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
20336146|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336147|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19827661|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827662|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
19827663|NCT03952403|Bevacizumab|bevacizumab|mesh-list
19827664|NCT03952403|Carboplatin|carboplatin|mesh-list
19827665|NCT03952403|Pemetrexed|pemetrexed|mesh-list
19827666|NCT03952403|Antibodies|antibodies|mesh-list
19827667|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827668|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827669|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19827670|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19827671|NCT03952403|Growth Substances|growth substances|mesh-ancestor
19827672|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827673|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
19827674|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
19827675|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827676|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827677|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19650331|NCT02334046|Remifentanil|remifentanil|mesh-list
19650332|NCT02334046|Sevoflurane|sevoflurane|mesh-list
19650333|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19827678|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19827679|NCT03944902|Niraparib|niraparib|mesh-list
19827680|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19827681|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827682|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827683|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835202|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19835203|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19835204|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835205|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835206|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835207|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19835208|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19835209|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835210|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835211|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
19835212|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19835213|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835214|NCT00601484|Tanezumab|tanezumab|mesh-list
19835215|NCT00601484|Analgesics|analgesics|mesh-ancestor
19835216|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
19835217|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835218|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835219|NCT00601523|Pramipexole|pramipexole|mesh-list
19835220|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
19835221|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835222|NCT00601523|Protective Agents|protective agents|mesh-ancestor
19835223|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835224|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19835225|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19835226|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
19835227|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
19835228|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835229|NCT00601627|Gemcitabine|gemcitabine|mesh-list
19835230|NCT00601627|Fluorouracil|fluorouracil|mesh-list
19835231|NCT00601627|Capecitabine|capecitabine|mesh-list
19835232|NCT00601627|Panitumumab|panitumumab|mesh-list
19835233|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19835234|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
19835235|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166599|NCT00140478|Mifepristone|mifepristone|mesh-list
20166600|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19650334|NCT02334046|Narcotics|narcotics|mesh-ancestor
19650335|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650336|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650337|NCT02334046|Analgesics|analgesics|mesh-ancestor
19650338|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
19650339|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650340|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19650341|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19650342|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
19650343|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
19650344|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
19650345|NCT02334124|Floxacillin|floxacillin|mesh-list
19650346|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650347|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827684|NCT03916094|Trastuzumab|trastuzumab|mesh-list
19827685|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827686|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827687|NCT03914742|Temozolomide|temozolomide|mesh-list
19827688|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19827689|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19827690|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
19827691|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827692|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827693|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827694|NCT03901339|Gemcitabine|gemcitabine|mesh-list
19650348|NCT02333890|Chloroquine|chloroquine|mesh-list
19650349|NCT02333890|Amebicides|amebicides|mesh-ancestor
19650350|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19650351|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19650352|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650353|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
19650354|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650355|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
19827695|NCT03901339|Capecitabine|capecitabine|mesh-list
19827696|NCT03901339|Vinorelbine|vinorelbine|mesh-list
19827697|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827698|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
19827699|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827700|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827701|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
19827702|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827703|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827704|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827705|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
19827706|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827707|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19827708|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827709|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827710|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827711|NCT03895840|Triamcinolone|triamcinolone|mesh-list
19650356|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19827712|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19827713|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19827714|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19827715|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827716|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
19827717|NCT03895840|Hormones|hormones|mesh-ancestor
19827718|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827719|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827720|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827721|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
19650357|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
19650358|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19650359|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
19650360|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650361|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650362|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
19650363|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
20166601|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
19650364|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19650365|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650366|NCT02333838|Vidarabine|vidarabine|mesh-list
19827722|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166602|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20166603|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166604|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20166605|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20166606|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20166607|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
20166608|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19650367|NCT02333838|Fludarabine|fludarabine|mesh-list
19835236|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336148|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336149|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
20336150|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336151|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336152|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20336153|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336154|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336155|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
20336156|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
20336157|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336158|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20336159|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
20336160|NCT00797810|Hormones|hormones|mesh-ancestor
20336161|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166609|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20336162|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20336163|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20336164|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
20336165|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
20336166|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336167|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336168|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336169|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336170|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336171|NCT00797836|Interferons|interferons|mesh-list
20336172|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336173|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
20336174|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336175|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20336176|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
20336177|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
20336178|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20336179|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20336180|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336181|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336182|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
20336183|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
20336184|NCT00798070|Fluorouracil|fluorouracil|mesh-list
20336185|NCT00798070|Docetaxel|docetaxel|mesh-list
20336186|NCT00798070|Epirubicin|epirubicin|mesh-list
20336187|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336188|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
20336189|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336190|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336191|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336192|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
20336193|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336194|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650368|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
19650369|NCT02333838|Busulfan|busulfan|mesh-list
19650370|NCT02333838|Thiotepa|thiotepa|mesh-list
19650371|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650372|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19650373|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
19650374|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650375|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650376|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
19650377|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650378|NCT02333838|Antiviral Agents|antiviral agents|mesh-ancestor
20166610|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
20166611|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166612|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
20166613|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20166614|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20166615|NCT00140517|Chloroquine|chloroquine|mesh-list
20166616|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
20166617|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
20166618|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20166619|NCT00140517|Amebicides|amebicides|mesh-ancestor
20336195|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19650379|NCT02333838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650380|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
19650381|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336196|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
20166620|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19827723|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827724|NCT03895762|Fentanyl|fentanyl|mesh-list
19827725|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19827726|NCT03895762|Narcotics|narcotics|mesh-ancestor
19827727|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827728|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827729|NCT03895762|Analgesics|analgesics|mesh-ancestor
19827730|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
19827731|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827732|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19827733|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19827734|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
19827735|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
19827736|NCT03874338|Colchicine|colchicine|mesh-list
19827737|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
19827738|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19827739|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827740|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827741|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827742|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827743|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827744|NCT03869034|Leucovorin|leucovorin|mesh-list
19827745|NCT03869034|Fluorouracil|fluorouracil|mesh-list
19827746|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
19827747|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
19827748|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827749|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827750|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827751|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827752|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
19827753|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827754|NCT03869034|Antidotes|antidotes|mesh-ancestor
19827755|NCT03869034|Protective Agents|protective agents|mesh-ancestor
20336197|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20336198|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336199|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336200|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336201|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336202|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20336203|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20336204|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336205|NCT00798083|Lidocaine|lidocaine|mesh-list
20336206|NCT00798083|Ketamine|ketamine|mesh-list
20336207|NCT00798083|Amitriptyline|amitriptyline|mesh-list
20336208|NCT00798083|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20336209|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
20336210|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
20336211|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827756|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
19827757|NCT03869034|Vitamins|vitamins|mesh-ancestor
19827758|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
19827759|NCT03856632|Liraglutide|liraglutide|mesh-list
19827760|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19827761|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19827762|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827763|NCT03856632|Incretins|incretins|mesh-ancestor
20336212|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336213|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
20336214|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827764|NCT03856632|Hormones|hormones|mesh-ancestor
19827765|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827766|NCT03840421|Gemcitabine|gemcitabine|mesh-list
19827767|NCT03840421|Cisplatin|cisplatin|mesh-list
19827768|NCT03840421|Fluorouracil|fluorouracil|mesh-list
19827769|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336215|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20336216|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19827770|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827771|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
19827772|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827773|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
19827774|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827775|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827776|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827777|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
19827778|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827779|NCT03838159|Paclitaxel|paclitaxel|mesh-list
19827780|NCT03838159|Carboplatin|carboplatin|mesh-list
19827781|NCT03838159|Nivolumab|nivolumab|mesh-list
19827782|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19827783|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827784|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
20166621|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20166622|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166623|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
20166624|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166625|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20166626|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166627|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166628|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20166629|NCT00140517|Renal Agents|renal agents|mesh-ancestor
20166630|NCT00140530|Sirolimus|sirolimus|mesh-list
20336217|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20336218|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20336219|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336220|NCT00798083|Analgesics|analgesics|mesh-ancestor
20336221|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20336222|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20336223|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
20336224|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20336225|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20336226|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336227|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20336228|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
20336229|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20336230|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336231|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20336232|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20336233|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
20336234|NCT00798083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20336235|NCT00798083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20336236|NCT00798148|Carboplatin|carboplatin|mesh-list
20336237|NCT00798148|Etoposide|etoposide|mesh-list
20336238|NCT00798148|Melphalan|melphalan|mesh-list
20336239|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336240|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336241|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20336242|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20336243|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336244|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336245|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336246|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
20336247|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20336248|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336249|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
20336250|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336251|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
20336252|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336253|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336254|NCT00798252|Paclitaxel|paclitaxel|mesh-list
20336255|NCT00798252|Docetaxel|docetaxel|mesh-list
19650382|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19650383|NCT02334007|Dalteparin|dalteparin|mesh-list
19650384|NCT02334007|Tinzaparin|tinzaparin|mesh-list
19650385|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19650386|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
19650387|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19650388|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19650389|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650390|NCT02333799|Linezolid|linezolid|mesh-list
19650391|NCT02333799|Bedaquiline|bedaquiline|mesh-list
19650392|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650393|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650394|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19827785|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
19650395|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827786|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827787|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827788|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827789|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19827790|NCT03828201|Levofloxacin|levofloxacin|mesh-list
19827791|NCT03828201|Ofloxacin|ofloxacin|mesh-list
19827792|NCT03828201|Linezolid|linezolid|mesh-list
19827793|NCT03828201|Bedaquiline|bedaquiline|mesh-list
20166631|NCT00140530|Paclitaxel|paclitaxel|mesh-list
20166632|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20166633|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827794|NCT03828201|Clofazimine|clofazimine|mesh-list
19827795|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19827796|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827797|NCT03828201|Renal Agents|renal agents|mesh-ancestor
19827798|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19827799|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19827800|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19827801|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827802|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827803|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827804|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19827805|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19827806|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19827807|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
19827808|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827809|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
19827810|NCT03819465|Gemcitabine|gemcitabine|mesh-list
19827811|NCT03819465|Paclitaxel|paclitaxel|mesh-list
19827812|NCT03819465|Carboplatin|carboplatin|mesh-list
19827813|NCT03819465|Pemetrexed|pemetrexed|mesh-list
19827814|NCT03819465|Durvalumab|durvalumab|mesh-list
19827815|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19827816|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827817|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827818|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827819|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827820|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650396|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650397|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
19650398|NCT02333682|Vitamin D|vitamin d|mesh-list
20336256|NCT00798252|Doxorubicin|doxorubicin|mesh-list
20336257|NCT00798252|Capecitabine|capecitabine|mesh-list
20336258|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336259|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336260|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
19650399|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
19650400|NCT02333682|Calcifediol|calcifediol|mesh-list
19650401|NCT02333682|Vitamins|vitamins|mesh-ancestor
19650402|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
20336261|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336262|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336263|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650403|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650404|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19650405|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19650406|NCT02333565|Everolimus|everolimus|mesh-list
19650407|NCT02333565|Octreotide|octreotide|mesh-list
19650408|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650409|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650410|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
19827821|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827822|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
19827823|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
19827824|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19827825|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827826|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827827|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
19827828|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166634|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
20166635|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
20166636|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
20166637|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166638|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166639|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336264|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336265|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20336266|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20336267|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336268|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19827829|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19827830|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19827831|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827832|NCT03818399|Buprenorphine|buprenorphine|mesh-list
19827833|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19827834|NCT03818399|Narcotics|narcotics|mesh-ancestor
19827835|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19827836|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827837|NCT03818399|Analgesics|analgesics|mesh-ancestor
19827838|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
19827839|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827840|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19827841|NCT03810287|Domperidone|domperidone|mesh-list
19827842|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
19827843|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
19827844|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827845|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827846|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827847|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19827848|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
19827849|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336269|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
20336270|NCT00798343|Vaccines|vaccines|mesh-list
20336271|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
20336272|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336273|NCT00798395|Zopiclone|zopiclone|mesh-list
20336274|NCT00798395|Mirtazapine|mirtazapine|mesh-list
20336275|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20336276|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336277|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336278|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
20336279|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20336280|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20336281|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
20336282|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
20336283|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336284|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336285|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20336286|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20336287|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20336288|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20336289|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19827850|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827851|NCT03805477|Nintedanib|nintedanib|mesh-list
19827852|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827853|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827854|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827855|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827856|NCT03794999|Benralizumab|benralizumab|mesh-list
19827857|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19827858|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
19827859|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19827860|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
19827861|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827862|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19827863|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19827864|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
19827865|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827866|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827867|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19827868|NCT03742193|Apatinib|apatinib|mesh-list
19827869|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827870|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19827871|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827872|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827873|NCT03737643|Paclitaxel|paclitaxel|mesh-list
20336290|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
19827874|NCT03737643|Bevacizumab|bevacizumab|mesh-list
19827875|NCT03737643|Carboplatin|carboplatin|mesh-list
20336291|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19827876|NCT03737643|Durvalumab|durvalumab|mesh-list
20336292|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20336293|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
20336294|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20336295|NCT00798460|Lamivudine|lamivudine|mesh-list
20336296|NCT00798460|Adefovir|adefovir|mesh-list
20336297|NCT00798460|Clevudine|clevudine|mesh-list
20336298|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20336299|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20336300|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336301|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336302|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
20336303|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336304|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20336305|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20336306|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
20336307|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20336308|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336309|NCT00798525|Lepirudin|lepirudin|mesh-list
20336310|NCT00798525|Argatroban|argatroban|mesh-list
20336311|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
20336312|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20336313|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
20336314|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827877|NCT03737643|Olaparib|olaparib|mesh-list
19827878|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19827879|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19827880|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827881|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
19827882|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
19827883|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
19827884|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827885|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827886|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19827887|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20336315|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336316|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
20336317|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20336318|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20336319|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20336320|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
20336321|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20336322|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20336323|NCT00798616|Prednisolone|prednisolone|mesh-list
20336324|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
20336325|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19650411|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166640|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20166641|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
20166642|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166643|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
20166644|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166645|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
20166646|NCT00140543|Sirolimus|sirolimus|mesh-list
20166647|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20166648|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166649|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20166650|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
20336326|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
19650412|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650413|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650414|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
19650415|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19650416|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650417|NCT02333513|Vincristine|vincristine|mesh-list
19650418|NCT02333513|Lomustine|lomustine|mesh-list
19650419|NCT02333513|Procarbazine|procarbazine|mesh-list
19650420|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19650421|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650422|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
19650423|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
19650424|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
19650425|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827888|NCT03737643|Growth Substances|growth substances|mesh-ancestor
19835237|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
20336327|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827889|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827890|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
19827891|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
19827892|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19827893|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827894|NCT03728881|Vaccines|vaccines|mesh-list
19827895|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
19827896|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827897|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
19827898|NCT03725384|Iron|iron|mesh-list
19827899|NCT03725384|Vitamins|vitamins|mesh-ancestor
19827900|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
19827901|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827902|NCT03725384|Trace Elements|trace elements|mesh-ancestor
19827903|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
19827904|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827905|NCT03725384|Protective Agents|protective agents|mesh-ancestor
19827906|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19827907|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
19827908|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650426|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19650427|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
19650428|NCT02333253|Cetrorelix|cetrorelix|mesh-list
19650429|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19650430|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
19650431|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19650432|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650433|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
19827909|NCT03674827|Vaccines|vaccines|mesh-list
19827910|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
19827911|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827912|NCT03642366|Tadalafil|tadalafil|mesh-list
19827913|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
19827914|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19827915|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19827916|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827917|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827918|NCT03642366|Urological Agents|urological agents|mesh-ancestor
19827919|NCT03641846|Tadalafil|tadalafil|mesh-list
19827920|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
19827921|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19827922|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19827923|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827924|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827925|NCT03641846|Urological Agents|urological agents|mesh-ancestor
19827926|NCT03627741|Triamcinolone|triamcinolone|mesh-list
19827927|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19827928|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20336328|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
20336329|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
20336330|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336331|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336332|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20336333|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
20336334|NCT00798616|Hormones|hormones|mesh-ancestor
20336335|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336336|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20336337|NCT00798616|Protective Agents|protective agents|mesh-ancestor
19827929|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19827930|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827931|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
19827932|NCT03627741|Hormones|hormones|mesh-ancestor
19827933|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827934|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827935|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19827936|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
19827937|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827938|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827939|NCT03603496|Nicotine|nicotine|mesh-list
19827940|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19827941|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
19827942|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827943|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336338|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19827944|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20336339|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336340|NCT00798772|Micronutrients|micronutrients|mesh-list
20336341|NCT00798772|Trace Elements|trace elements|mesh-list
20336342|NCT00798772|Antioxidants|antioxidants|mesh-list
20336343|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336344|NCT00798772|Protective Agents|protective agents|mesh-ancestor
20336345|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336346|NCT00798785|Rituximab|rituximab|mesh-list
20336347|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336348|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336349|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
20336350|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336351|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336352|NCT00798876|Vitamin E|vitamin e|mesh-list
19827945|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19827946|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
19827947|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827948|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336353|NCT00798876|Vitamins|vitamins|mesh-ancestor
20336354|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
20336355|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336356|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
20336357|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336358|NCT00798876|Protective Agents|protective agents|mesh-ancestor
20336359|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20336360|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20336361|NCT00798915|Incretins|incretins|mesh-ancestor
20336362|NCT00798915|Hormones|hormones|mesh-ancestor
20336363|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336364|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336365|NCT00798954|Sirolimus|sirolimus|mesh-list
20336366|NCT00798954|Paclitaxel|paclitaxel|mesh-list
19827949|NCT03591861|Carmustine|carmustine|mesh-list
19827950|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19827951|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
19827952|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827953|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827954|NCT03582033|Dexamethasone|dexamethasone|mesh-list
19827955|NCT03582033|Pomalidomide|pomalidomide|mesh-list
19827956|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19827957|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
19827958|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
20336367|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336368|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336369|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336370|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336371|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336372|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827959|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827960|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827961|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19827962|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
19827963|NCT03582033|Hormones|hormones|mesh-ancestor
19827964|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19827965|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19827966|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827967|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
19827968|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19827969|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20336373|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20336374|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336375|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336376|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
20611805|NCT02248571|Exemestane|exemestane|mesh-list
20611806|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20611807|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611808|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20611809|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611810|NCT02248571|Growth Substances|growth substances|mesh-ancestor
20611811|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611812|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
20336377|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336378|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
20336379|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336380|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
20336381|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20336382|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
20336383|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20336384|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336385|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19827970|NCT03582033|Growth Substances|growth substances|mesh-ancestor
19827971|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835238|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835239|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835240|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835241|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
19835242|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835243|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835244|NCT00601640|Eflornithine|eflornithine|mesh-list
19835245|NCT00601640|Diclofenac|diclofenac|mesh-list
19835246|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19835247|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19835248|NCT00601640|Analgesics|analgesics|mesh-ancestor
19835249|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
19835250|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835251|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835252|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835253|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835254|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19835255|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835256|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835257|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835258|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19835259|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19835260|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19835261|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835262|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19835263|NCT00601705|Fluorouracil|fluorouracil|mesh-list
19835264|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
19835265|NCT00601705|Epirubicin|epirubicin|mesh-list
19835266|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835267|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
19835268|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835269|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19835270|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835271|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
19835272|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835273|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19835274|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19835275|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19835276|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835277|NCT00601718|Rituximab|rituximab|mesh-list
19835278|NCT00601718|Carboplatin|carboplatin|mesh-list
19835279|NCT00601718|Etoposide|etoposide|mesh-list
19835280|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
19835281|NCT00601718|Ifosfamide|ifosfamide|mesh-list
19835282|NCT00601718|Vorinostat|vorinostat|mesh-list
19835283|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19650434|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650435|NCT02333292|Ritonavir|ritonavir|mesh-list
19650436|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
19650437|NCT02333292|Grazoprevir|grazoprevir|mesh-list
19650438|NCT02333292|Ledipasvir|ledipasvir|mesh-list
19650439|NCT02333292|Velpatasvir|velpatasvir|mesh-list
19650440|NCT02333292|Simeprevir|simeprevir|mesh-list
19650441|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19650442|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19650443|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
19650444|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650445|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835284|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835285|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
19835286|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835287|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650446|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19835288|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336386|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20336387|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20336388|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
20336389|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20336390|NCT00798993|Calcifediol|calcifediol|mesh-list
20336391|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20336392|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336393|NCT00798993|Vitamins|vitamins|mesh-ancestor
20336394|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
20336395|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20336396|NCT00799045|Clopidogrel|clopidogrel|mesh-list
20336397|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20336398|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19827972|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19827973|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
19827974|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827975|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19827976|NCT03548454|Desipramine|desipramine|mesh-list
19827977|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19827978|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19827979|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19827980|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19827981|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19827982|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19827983|NCT03548454|Analgesics|analgesics|mesh-ancestor
19827984|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
19827985|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19827986|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
19827987|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19827988|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
19827989|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19827990|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19827991|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19827992|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19827993|NCT03526900|Atezolizumab|atezolizumab|mesh-list
19827994|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827995|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
19827996|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19827997|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19827998|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
19827999|NCT03517137|Dacarbazine|dacarbazine|mesh-list
19828000|NCT03517137|Etoposide|etoposide|mesh-list
19828001|NCT03517137|Doxorubicin|doxorubicin|mesh-list
19828002|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19828003|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19828004|NCT03517137|Vinblastine|vinblastine|mesh-list
19828005|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828006|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
19828007|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828008|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828009|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828010|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
19828011|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828012|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828013|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19828014|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19828015|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19828016|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19828017|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828018|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19828019|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828020|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
19828021|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19828022|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
20348627|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
19828023|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
20166651|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166652|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336399|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19650447|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19650448|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
19650449|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650450|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19650451|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19650452|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
19650453|NCT02333305|Vitamins|vitamins|mesh-ancestor
20336400|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19828024|NCT03516981|Lenvatinib|lenvatinib|mesh-list
19828025|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828026|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828027|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828028|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828029|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828030|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
19828031|NCT03513211|Itraconazole|itraconazole|mesh-list
19828032|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
19828033|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19828034|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19828035|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828036|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828037|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828038|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828039|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
19828040|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20166653|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166654|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166655|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
20166656|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166657|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
20166658|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166659|NCT00140569|Interferons|interferons|mesh-list
20166660|NCT00140569|Fludarabine|fludarabine|mesh-list
20166661|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166662|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
20166663|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166664|NCT00140582|Rituximab|rituximab|mesh-list
20166665|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20166666|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166667|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
20166668|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166669|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166670|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
20166671|NCT00140595|Rituximab|rituximab|mesh-list
20166672|NCT00140595|Doxorubicin|doxorubicin|mesh-list
20166673|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166674|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
20166675|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166676|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166677|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20166678|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
20166679|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166680|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166681|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20166682|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828041|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19828042|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19828043|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
19828044|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166683|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20166684|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20166685|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20166686|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166687|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
20166688|NCT00140647|Ramipril|ramipril|mesh-list
20166689|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20166690|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166691|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19650454|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
19828045|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828046|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19828047|NCT03481972|Doxycycline|doxycycline|mesh-list
19828048|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19828049|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19828050|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828051|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
19828052|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19828053|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19828054|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
19828055|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19828056|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19828057|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19828058|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
19828059|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828060|NCT03474458|Doxycycline|doxycycline|mesh-list
19828061|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19828062|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828063|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
19828064|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19828065|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19828066|NCT03472521|Gabapentin|gabapentin|mesh-list
19828067|NCT03472521|Analgesics|analgesics|mesh-ancestor
19828068|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
19828069|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828070|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828071|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
19828072|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19828073|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19828074|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19828075|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19828076|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19828077|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19828078|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828079|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828080|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
20336401|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
20336402|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336403|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336404|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336405|NCT00799071|Posaconazole|posaconazole|mesh-list
20336406|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
20336407|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336408|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20336409|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20336410|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20336411|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20336412|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20336413|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828081|NCT03439280|Dexamethasone|dexamethasone|mesh-list
19828082|NCT03439280|Pomalidomide|pomalidomide|mesh-list
19828083|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19828084|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
19828085|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
19828086|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828087|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828088|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19828089|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
19828090|NCT03439280|Hormones|hormones|mesh-ancestor
19828091|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828092|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19828093|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828094|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
19828095|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19828096|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19828097|NCT03439280|Growth Substances|growth substances|mesh-ancestor
19828098|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
19828099|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20348143|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828100|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828101|NCT03383458|Nivolumab|nivolumab|mesh-list
19828102|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828103|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828104|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19828105|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828106|NCT03363217|Trametinib|trametinib|mesh-list
19828107|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828108|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828109|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828110|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828111|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
19828112|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19828113|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
19828114|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19828115|NCT03357159|Antibodies|antibodies|mesh-list
19828116|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828117|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
19828118|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828119|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828120|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828121|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
19828122|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828123|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828124|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19828125|NCT03337919|Nivolumab|nivolumab|mesh-list
19828126|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828127|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828128|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20166692|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
20166693|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166694|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166695|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20166696|NCT00140660|Rituximab|rituximab|mesh-list
20166697|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20166698|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166699|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
20166700|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166701|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166702|NCT00140712|Ropinirole|ropinirole|mesh-list
20166703|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20166704|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20166705|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
20166706|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
20166707|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174602|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174603|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
20174604|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174605|NCT00165204|Tibolone|tibolone|mesh-list
20174606|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
20174607|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
20174608|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174609|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174610|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20174611|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20174612|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174613|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20174614|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
20174615|NCT00165204|Hormones|hormones|mesh-ancestor
20174616|NCT00165217|Thalidomide|thalidomide|mesh-list
20174617|NCT00165217|Capecitabine|capecitabine|mesh-list
20174618|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20174619|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
20174620|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174621|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174622|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174623|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
20336414|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336415|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20166708|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166709|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166710|NCT00140725|Interferons|interferons|mesh-list
20166711|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
20166712|NCT00140725|Lamivudine|lamivudine|mesh-list
20336416|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
20336417|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336418|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336419|NCT00799136|Prednisone|prednisone|mesh-list
20336420|NCT00799136|Vincristine|vincristine|mesh-list
19828129|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828130|NCT03334253|Atropine|atropine|mesh-list
19828131|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19828132|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19828133|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19828134|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19828135|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
19828136|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828137|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828138|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19650455|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650456|NCT02333188|Leucovorin|leucovorin|mesh-list
19650457|NCT02333188|Paclitaxel|paclitaxel|mesh-list
19650458|NCT02333188|Fluorouracil|fluorouracil|mesh-list
19650459|NCT02333188|Irinotecan|irinotecan|mesh-list
19650460|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20336421|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336422|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
20336423|NCT00799136|Hormones|hormones|mesh-ancestor
20336424|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336425|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336426|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20336427|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336428|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20166713|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
20166714|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166715|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
20166716|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166717|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
20166718|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166719|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20166720|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20166721|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166722|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166723|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19650461|NCT02333188|Calcium|calcium|mesh-list
19650462|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
20166724|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20336429|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336430|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336431|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336432|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336433|NCT00799149|Etoricoxib|etoricoxib|mesh-list
20336434|NCT00799149|Gabapentin|gabapentin|mesh-list
20336435|NCT00799149|Analgesics|analgesics|mesh-ancestor
20336436|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
19650463|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20166725|NCT00140751|Ritonavir|ritonavir|mesh-list
20166726|NCT00140751|Lopinavir|lopinavir|mesh-list
20336437|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828139|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
19828140|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
19828141|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
19828142|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19828143|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19828144|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
19828145|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828146|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828147|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19828148|NCT03316859|Naloxegol|naloxegol|mesh-list
19828149|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19828150|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828151|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
19828152|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828153|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
19828154|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19828155|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828156|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
19828157|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
19828158|NCT03303950|Busulfan|busulfan|mesh-list
19828159|NCT03303950|Fludarabine|fludarabine|mesh-list
19828160|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828161|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
19828162|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828163|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828164|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828165|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
19828166|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828167|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828168|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19828169|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
19828170|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828171|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828172|NCT03258320|Docetaxel|docetaxel|mesh-list
19828173|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
19828174|NCT03258320|Satraplatin|satraplatin|mesh-list
19828175|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828176|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
19828177|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
19828178|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
19828179|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828180|NCT03258320|Analgesics|analgesics|mesh-ancestor
19828181|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
19828182|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828183|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828184|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19828185|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19828186|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828187|NCT03215927|Abatacept|abatacept|mesh-list
19828188|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19828189|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828190|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828191|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828192|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
19828193|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828194|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828195|NCT03169101|Nicotine|nicotine|mesh-list
19828196|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19828197|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
19828198|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828199|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828200|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19828201|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19828202|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166727|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20166728|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20166729|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
20166730|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166731|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166732|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20166733|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20166734|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
19828203|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166735|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166736|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20348144|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
19828204|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828205|NCT03094286|Durvalumab|durvalumab|mesh-list
19828206|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828207|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828208|NCT03072771|Cytarabine|cytarabine|mesh-list
19828209|NCT03072771|Etoposide|etoposide|mesh-list
19828210|NCT03072771|Melphalan|melphalan|mesh-list
19828211|NCT03072771|Carmustine|carmustine|mesh-list
19828212|NCT03072771|Blinatumomab|blinatumomab|mesh-list
19828213|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19828214|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828215|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20166737|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20166738|NCT00140764|Metronidazole|metronidazole|mesh-list
20166739|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166740|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20166741|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20166742|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20166743|NCT00140790|Valsartan|valsartan|mesh-list
20166744|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20166745|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20166746|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20166747|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166748|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20166749|NCT00140803|Verteporfin|verteporfin|mesh-list
20166750|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19828216|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19828217|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828218|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828219|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828220|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
19828221|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
19828222|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828223|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828224|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
19828225|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828226|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828227|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
19828228|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19828229|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
19828230|NCT03071666|Vitamins|vitamins|mesh-ancestor
19828231|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
19828232|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828233|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
19828234|NCT03069924|Nicotine|nicotine|mesh-list
19828235|NCT03069924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19828236|NCT03069924|Autonomic Agents|autonomic agents|mesh-ancestor
19828237|NCT03069924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166751|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
19828238|NCT03069924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828239|NCT03069924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19828240|NCT03069924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19828241|NCT03069924|Cholinergic Agents|cholinergic agents|mesh-ancestor
19828242|NCT03069924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828243|NCT03069924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166752|NCT00140803|Hormones|hormones|mesh-ancestor
19828244|NCT03031210|Amoxicillin|amoxicillin|mesh-list
19828245|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174624|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828246|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174625|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
20174626|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174627|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174628|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20174629|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20174630|NCT00165217|Growth Substances|growth substances|mesh-ancestor
20174631|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
20174632|NCT00165230|Thalidomide|thalidomide|mesh-list
20174633|NCT00165230|Temozolomide|temozolomide|mesh-list
20174634|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174635|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
20174636|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174637|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
20336438|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336439|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
20336440|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20336441|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19828247|NCT03026790|Buprenorphine|buprenorphine|mesh-list
19828248|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19828249|NCT03026790|Naloxone|naloxone|mesh-list
19828250|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19828251|NCT03026790|Narcotics|narcotics|mesh-ancestor
19828252|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19828253|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828254|NCT03026790|Analgesics|analgesics|mesh-ancestor
19828255|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
19828256|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828257|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19828258|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20336442|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336443|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20336444|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20336445|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20336446|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336447|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336448|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
20336449|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20336450|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336451|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336452|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336453|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20336454|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20336455|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336456|NCT00799175|Ketorolac|ketorolac|mesh-list
20336457|NCT00799175|Epinephrine|epinephrine|mesh-list
20336458|NCT00799175|Ropivacaine|ropivacaine|mesh-list
20336459|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
19828259|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19828260|NCT03018366|Estradiol|estradiol|mesh-list
19828261|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19828262|NCT03018366|Progesterone|progesterone|mesh-list
19828263|NCT03018366|Estrogens|estrogens|mesh-ancestor
19828264|NCT03018366|Hormones|hormones|mesh-ancestor
19828265|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828266|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828267|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19828268|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
19828269|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20336460|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
20336461|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336462|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336463|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
20336464|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336465|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20336466|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20336467|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
20336468|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336469|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336470|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20336471|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20336472|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
20336473|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20336474|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
20336475|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
20336476|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
20336477|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20336478|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20336479|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336480|NCT00799175|Analgesics|analgesics|mesh-ancestor
20336481|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336482|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336483|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20336484|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336485|NCT00799188|Everolimus|everolimus|mesh-list
19828270|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20336486|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336487|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336488|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
20336489|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336490|NCT00799201|Naloxone|naloxone|mesh-list
20336491|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20336492|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336493|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
20166753|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166754|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166755|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20166756|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
20166757|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20166758|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
20166759|NCT00140868|Phenobarbital|phenobarbital|mesh-list
20166760|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
20166761|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20166762|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166763|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166764|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20166765|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20166766|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166767|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166768|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
20166769|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
20166770|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20166771|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20336494|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336495|NCT00799214|Metronidazole|metronidazole|mesh-list
20336496|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828271|NCT03018366|Progestins|progestins|mesh-ancestor
19828272|NCT03001882|Nivolumab|nivolumab|mesh-list
19828273|NCT03001882|Ipilimumab|ipilimumab|mesh-list
19828274|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828275|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828276|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19828277|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336497|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20336498|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19828278|NCT02958514|Tobramycin|tobramycin|mesh-list
19828279|NCT02958514|Dexamethasone|dexamethasone|mesh-list
19828280|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19828281|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
19828282|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
19828283|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828284|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828285|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19828286|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
19828287|NCT02958514|Hormones|hormones|mesh-ancestor
20336499|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20336500|NCT00799240|Cisplatin|cisplatin|mesh-list
20336501|NCT00799240|Pemetrexed|pemetrexed|mesh-list
20336502|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20336503|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336504|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336505|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336506|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20336507|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20336508|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
19828288|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828289|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19828290|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828291|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19828292|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828293|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
19828294|NCT02897700|Doxorubicin|doxorubicin|mesh-list
19828295|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19828296|NCT02897700|Fluorouracil|fluorouracil|mesh-list
19828297|NCT02897700|Methotrexate|methotrexate|mesh-list
19828298|NCT02897700|Epirubicin|epirubicin|mesh-list
20336509|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828299|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336510|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
20336511|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19828300|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
19828301|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828302|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828303|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828304|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
19828305|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828306|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828307|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19828308|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19828309|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19828310|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19828311|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828312|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
19828313|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828314|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19828315|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
19828316|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19828317|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
19828318|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19828319|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19828320|NCT02889666|Gemcitabine|gemcitabine|mesh-list
19828321|NCT02889666|Cisplatin|cisplatin|mesh-list
19828322|NCT02889666|Carboplatin|carboplatin|mesh-list
19828323|NCT02889666|Docetaxel|docetaxel|mesh-list
19828324|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
19828325|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828326|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828327|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
19828328|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828329|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
19828330|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828331|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828332|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828333|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
19828334|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828335|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
19828336|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
19828337|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
19828338|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
19828339|NCT02870829|Vitamin K|vitamin k|mesh-list
19828340|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
19828341|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19828342|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19828343|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828344|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
19828345|NCT02870829|Coagulants|coagulants|mesh-ancestor
19828346|NCT02870829|Vitamins|vitamins|mesh-ancestor
19828347|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
19828348|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828349|NCT02864251|Carboplatin|carboplatin|mesh-list
19828350|NCT02864251|Nivolumab|nivolumab|mesh-list
19828351|NCT02864251|Pemetrexed|pemetrexed|mesh-list
19828352|NCT02864251|Ipilimumab|ipilimumab|mesh-list
19828353|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336512|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336513|NCT00799448|Insulin|insulin|mesh-list
20336514|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19650464|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650465|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
19650466|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
19650467|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
19650468|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650469|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19650470|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650471|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
19650472|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19650473|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650474|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
19650475|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19828354|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828355|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19828356|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828357|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336515|NCT00799448|Repaglinide|repaglinide|mesh-list
19828358|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19828359|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20166772|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20166773|NCT00140894|Rofecoxib|rofecoxib|mesh-list
20166774|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166775|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166776|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828360|NCT02862132|Vedolizumab|vedolizumab|mesh-list
19828361|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19828362|NCT02798471|Heparin|heparin|mesh-list
19828363|NCT02798471|Enoxaparin|enoxaparin|mesh-list
19828364|NCT02798471|Warfarin|warfarin|mesh-list
19828365|NCT02798471|Edoxaban|edoxaban|mesh-list
19828366|NCT02798471|Fondaparinux|fondaparinux|mesh-list
19828367|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
19828368|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19828369|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19828370|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828371|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19828372|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
19828373|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19828374|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
19828375|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828376|NCT02794571|Paclitaxel|paclitaxel|mesh-list
19828377|NCT02794571|Etoposide|etoposide|mesh-list
19828378|NCT02794571|Bevacizumab|bevacizumab|mesh-list
19828379|NCT02794571|Carboplatin|carboplatin|mesh-list
19828380|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
19828381|NCT02794571|Capecitabine|capecitabine|mesh-list
19828382|NCT02794571|Pemetrexed|pemetrexed|mesh-list
19828383|NCT02794571|Atezolizumab|atezolizumab|mesh-list
19828384|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19828385|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828386|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
19828387|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
19828388|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
19828389|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828390|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828391|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19828392|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19828393|NCT02794571|Growth Substances|growth substances|mesh-ancestor
19828394|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828395|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
19828396|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828397|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
19828398|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19828399|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19828400|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828401|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19828402|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19835289|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19835290|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19835291|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650476|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19650477|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650478|NCT02333188|Antidotes|antidotes|mesh-ancestor
19650479|NCT02333188|Protective Agents|protective agents|mesh-ancestor
19650480|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
19650481|NCT02333188|Vitamins|vitamins|mesh-ancestor
19650482|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
19650483|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
19650484|NCT02332941|Rituximab|rituximab|mesh-list
20166777|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20166778|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20166779|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336516|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
20336517|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
20336518|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
20336519|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20336520|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166780|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20166781|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336521|NCT00799513|Lenalidomide|lenalidomide|mesh-list
19650485|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20166782|NCT00140894|Analgesics|analgesics|mesh-ancestor
19650486|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835292|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336522|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
19828403|NCT02738229|Valacyclovir|valacyclovir|mesh-list
19828404|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
19828405|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828406|NCT02664441|Exenatide|exenatide|mesh-list
19828407|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19828408|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828409|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19828410|NCT02664441|Incretins|incretins|mesh-ancestor
19828411|NCT02664441|Hormones|hormones|mesh-ancestor
19828412|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828413|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
19828414|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828415|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828416|NCT02476409|Tolvaptan|tolvaptan|mesh-list
19828417|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19828418|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828419|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
19828420|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828421|NCT02471391|Venetoclax|venetoclax|mesh-list
19828422|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828423|NCT02460887|Gemcitabine|gemcitabine|mesh-list
19828424|NCT02460887|Cisplatin|cisplatin|mesh-list
19828425|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828426|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828427|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
19828428|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828429|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
20336523|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336524|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20336525|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20336526|NCT00799513|Growth Substances|growth substances|mesh-ancestor
20336527|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
20336528|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336529|NCT00799539|Prednisone|prednisone|mesh-list
19650487|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
19650488|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650489|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650490|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
19650491|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650492|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650493|NCT02333123|Aspirin|aspirin|mesh-list
19650494|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19650495|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19650496|NCT02333123|Analgesics|analgesics|mesh-ancestor
19650497|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
19650498|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650499|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166783|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
20166784|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166785|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166786|NCT00140920|Diclofenac|diclofenac|mesh-list
20166787|NCT00140920|Rofecoxib|rofecoxib|mesh-list
20166788|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20166789|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20166790|NCT00140920|Analgesics|analgesics|mesh-ancestor
20166791|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
19650500|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650501|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650502|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19650503|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19650504|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828430|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166792|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336530|NCT00799539|Bortezomib|bortezomib|mesh-list
19828431|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828432|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828433|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
19828434|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828435|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
19828436|NCT02454322|Analgesics|analgesics|mesh-ancestor
19828437|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
19828438|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828439|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828440|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
19828441|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19828442|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19828443|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
19828444|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19828445|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20336531|NCT00799539|Melphalan|melphalan|mesh-list
20336532|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336533|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
20336534|NCT00799539|Hormones|hormones|mesh-ancestor
20336535|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336536|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336537|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20336538|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336539|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336540|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
19828446|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828447|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19828448|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
19828449|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19828450|NCT02446236|Rituximab|rituximab|mesh-list
19828451|NCT02446236|Lenalidomide|lenalidomide|mesh-list
19828452|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828453|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828454|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
19828455|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828456|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828457|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19828458|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19828459|NCT02446236|Growth Substances|growth substances|mesh-ancestor
19828460|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
19828461|NCT02431845|Fluoxetine|fluoxetine|mesh-list
20336541|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336542|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19828462|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19828463|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19828464|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19828465|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828466|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828467|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
19828468|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828469|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19828470|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
19828471|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19828472|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19828473|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19828474|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828475|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
19828476|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19828477|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19828478|NCT02429570|Analgesics|analgesics|mesh-ancestor
20336543|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336544|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
20348145|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20348146|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
20348147|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348148|NCT00863785|Expectorants|expectorants|mesh-ancestor
19828479|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
19828480|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828481|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828482|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19828483|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828484|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19828485|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828486|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828487|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19828488|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19828489|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
19828490|NCT02184416|Everolimus|everolimus|mesh-list
19828491|NCT02184416|Sorafenib|sorafenib|mesh-list
19828492|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828493|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828494|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
19828495|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828496|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828497|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828498|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828499|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
19828500|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19828501|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19828502|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828503|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
19828504|NCT01980355|Coagulants|coagulants|mesh-ancestor
19828505|NCT01941641|Capecitabine|capecitabine|mesh-list
19828506|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828507|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
19828508|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828509|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828510|NCT01711242|Capecitabine|capecitabine|mesh-list
19828511|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
19828512|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828513|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
19828514|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828515|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828516|NCT01559935|Clarithromycin|clarithromycin|mesh-list
19828517|NCT01559935|Dexamethasone|dexamethasone|mesh-list
19828518|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
19828519|NCT01559935|Lenalidomide|lenalidomide|mesh-list
19828520|NCT01559935|BB 1101|bb 1101|mesh-list
20336545|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
20336546|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
20336547|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336548|NCT00799682|Travoprost|travoprost|mesh-list
20336549|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20336550|NCT00799682|Latanoprost|latanoprost|mesh-list
20336551|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20336552|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20336553|NCT00799760|Oseltamivir|oseltamivir|mesh-list
20336554|NCT00799760|Zanamivir|zanamivir|mesh-list
19828521|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19828522|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
19828523|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
20336555|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
20336556|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336557|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336558|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828524|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828525|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828526|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19828527|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
20166793|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166794|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166795|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166796|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20166797|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166798|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166799|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20166800|NCT00140933|Diclofenac|diclofenac|mesh-list
20166801|NCT00140933|Rofecoxib|rofecoxib|mesh-list
20166802|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20336559|NCT00799838|Amoxicillin|amoxicillin|mesh-list
19828528|NCT01559935|Hormones|hormones|mesh-ancestor
19828529|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828530|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19828531|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828532|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
19828533|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828534|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828535|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
19828536|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19828537|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19828538|NCT01559935|Growth Substances|growth substances|mesh-ancestor
19828539|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
19828540|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19828541|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828542|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19828543|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19828544|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19828545|NCT01067144|Gabapentin|gabapentin|mesh-list
19828546|NCT01067144|Lorazepam|lorazepam|mesh-list
19828547|NCT01067144|Analgesics|analgesics|mesh-ancestor
19828548|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
19828549|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828550|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828551|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
19828552|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19828553|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19828554|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19828555|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19828556|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19828557|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19828558|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828559|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828560|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
19828561|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
19828562|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
19828563|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19828564|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19828565|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
19828566|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
19828567|NCT00777036|Dasatinib|dasatinib|mesh-list
19828568|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828569|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828570|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828571|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828572|NCT00600483|Gentamicins|gentamicins|mesh-list
19828573|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19828574|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828575|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19828576|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828577|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828578|NCT00280761|Fluorouracil|fluorouracil|mesh-list
19828579|NCT00280761|Capecitabine|capecitabine|mesh-list
19828580|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
19828581|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828582|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828583|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828584|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828585|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
19828586|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828587|NCT00006256|Paclitaxel|paclitaxel|mesh-list
19828588|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19828589|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20166803|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20166804|NCT00140933|Analgesics|analgesics|mesh-ancestor
20166805|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
20166806|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166807|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166808|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166809|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166810|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20166811|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828590|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19828591|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19828592|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19828593|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828594|NCT00568958|Naltrexone|naltrexone|mesh-list
19650505|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19650506|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19650507|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650508|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
19650509|NCT02333058|Treosulfan|treosulfan|mesh-list
19650510|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19650511|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
19650512|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828595|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19828596|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19828597|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828598|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
19828599|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828600|NCT00569010|Cytarabine|cytarabine|mesh-list
19828601|NCT00569010|Azacitidine|azacitidine|mesh-list
19828602|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828603|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
19828604|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828605|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828606|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
19828607|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828608|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828609|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
19828610|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828611|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828612|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19828613|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
19828614|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828615|NCT00569374|Modafinil|modafinil|mesh-list
19828616|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19828617|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828618|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19828619|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19828620|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19828621|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828622|NCT00569530|Calfactant|calfactant|mesh-list
19828623|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19828624|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
19828625|NCT00569582|Mifepristone|mifepristone|mesh-list
19828626|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19828627|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
19828628|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19828629|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828630|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19828631|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19828632|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19828633|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
19828634|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19828635|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19828636|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
19828637|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828638|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
19828639|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19828640|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19828641|NCT00569660|Azacitidine|azacitidine|mesh-list
19828642|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828643|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
19650513|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650514|NCT02332954|Vortioxetine|vortioxetine|mesh-list
19650515|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
19650516|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19650517|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19650518|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19650519|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650520|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650521|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19650522|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19650523|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650524|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650525|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828644|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336560|NCT00799838|Ketoprofen|ketoprofen|mesh-list
20336561|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20336562|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336563|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20336564|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336565|NCT00799838|Analgesics|analgesics|mesh-ancestor
20336566|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
20336567|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336568|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336569|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336570|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336571|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20336572|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336573|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336574|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20336575|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
20336576|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336577|NCT00799890|Protective Agents|protective agents|mesh-ancestor
20336578|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336579|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20336580|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20336581|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336582|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20336583|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
20336584|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20336585|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828645|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828646|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828647|NCT00569673|Docetaxel|docetaxel|mesh-list
19828648|NCT00569673|Trabectedin|trabectedin|mesh-list
19828649|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828650|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
19828651|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
19828652|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
19828653|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828654|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828655|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
19828656|NCT00569777|Ketotifen|ketotifen|mesh-list
19828657|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
19828658|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
19828659|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19828660|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
19828661|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
19828662|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828663|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828664|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828665|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19828666|NCT00569803|Abatacept|abatacept|mesh-list
19828667|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19828668|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828669|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828670|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828671|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
19828672|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828673|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828674|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
20166812|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166813|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20166814|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20166815|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20166816|NCT00140998|Estradiol|estradiol|mesh-list
20166817|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20166818|NCT00140998|Estrogens|estrogens|mesh-ancestor
20166819|NCT00140998|Hormones|hormones|mesh-ancestor
20166820|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20166821|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166822|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20166823|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
19828675|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19828676|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19828677|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
19828678|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828679|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828680|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828681|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19828682|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
19828683|NCT00569946|Axitinib|axitinib|mesh-list
19828684|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828685|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828686|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828687|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828688|NCT00570089|Ranolazine|ranolazine|mesh-list
19828689|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19828690|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19828691|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828692|NCT00570128|Donepezil|donepezil|mesh-list
20336586|NCT00800137|Heparin|heparin|mesh-list
20336587|NCT00800137|Calcium heparin|calcium heparin|mesh-list
20336588|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20336589|NCT00800137|Tinzaparin|tinzaparin|mesh-list
20336590|NCT00800137|Dalteparin|dalteparin|mesh-list
20336591|NCT00800137|Warfarin|warfarin|mesh-list
19828693|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19828694|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828695|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828696|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
19828697|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828698|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828699|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
19828700|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19828701|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828702|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828703|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828704|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835293|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19835294|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
19835295|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19835296|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
19835297|NCT00601796|Tretinoin|tretinoin|mesh-list
19835298|NCT00601796|Vaccines|vaccines|mesh-list
19835299|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
19835300|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835301|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835302|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835303|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19835304|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
19835305|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835306|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835307|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19835308|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
20336592|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
20336593|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20336594|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20336595|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336596|NCT00800150|Fludarabine|fludarabine|mesh-list
20336597|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
20336598|NCT00800150|Melphalan|melphalan|mesh-list
20336599|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336600|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20336601|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
20336602|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336603|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336604|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
20336605|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650526|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
19650527|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19650528|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19650529|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19650530|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19650531|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
19650532|NCT02332980|Idelalisib|idelalisib|mesh-list
19650533|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19650534|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650535|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650536|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835309|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
20336606|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828705|NCT00570310|Pregabalin|pregabalin|mesh-list
19828706|NCT00570310|Analgesics|analgesics|mesh-ancestor
19828707|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
19828708|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828709|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828710|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
19828711|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19828712|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19828713|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828714|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19828715|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19828716|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19828717|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336607|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
20336608|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20336609|NCT00800215|Lacosamide|lacosamide|mesh-list
20336610|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
20336611|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20336612|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20336613|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20336614|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336615|NCT00800267|Timolol|timolol|mesh-list
20336616|NCT00800267|Latanoprost|latanoprost|mesh-list
20336617|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20336618|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20336619|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
19828718|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19828719|NCT00570323|Fulvestrant|fulvestrant|mesh-list
19828720|NCT00570323|Anastrozole|anastrozole|mesh-list
19828721|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19828722|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828723|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19828724|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19828725|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
19828726|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828727|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828728|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19828729|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19828730|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828731|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828732|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
19828733|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19828734|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
19828735|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828736|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828737|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19828738|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
19828739|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19828740|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
19828741|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828742|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828743|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19828744|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
19828745|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
19828746|NCT00570349|Protective Agents|protective agents|mesh-ancestor
20336620|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336621|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336622|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336623|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20336624|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20336625|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20336626|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20336627|NCT00800280|Cimetidine|cimetidine|mesh-list
20336628|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20336629|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20336630|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20336631|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
20336632|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
20336633|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336634|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336635|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336636|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19828747|NCT00570401|Dasatinib|dasatinib|mesh-list
19828748|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828749|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828750|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828751|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828752|NCT00570492|Fluticasone|fluticasone|mesh-list
19828753|NCT00570492|Xhance|xhance|mesh-list
19828754|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19828755|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19828756|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
19828757|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828758|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828759|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19828760|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
19828761|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
19828762|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19828763|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19828764|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19828765|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828766|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828767|NCT00570674|Paclitaxel|paclitaxel|mesh-list
19828768|NCT00570674|Carboplatin|carboplatin|mesh-list
19828769|NCT00570674|Cetuximab|cetuximab|mesh-list
19650537|NCT02332811|Sevelamer|sevelamer|mesh-list
19650538|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
19650539|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
19650540|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650541|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19650542|NCT02332473|Molgramostim|molgramostim|mesh-list
19650543|NCT02332473|Sargramostim|sargramostim|mesh-list
19650544|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
19650545|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650546|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
19650547|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650548|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650549|NCT02332512|Apatinib|apatinib|mesh-list
19650550|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650551|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19650552|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650553|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650554|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
19650555|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19650556|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19650557|NCT02332603|Prednisolone|prednisolone|mesh-list
19828770|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19828771|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19828772|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828773|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
19828774|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19828775|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19828776|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828777|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19828778|NCT00570687|Insulin|insulin|mesh-list
19828779|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19828780|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828781|NCT00570700|Dasatinib|dasatinib|mesh-list
19828782|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828783|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828784|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828785|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828786|NCT00570713|Gemcitabine|gemcitabine|mesh-list
19828787|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828788|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
19828789|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828790|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828791|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
19828792|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828793|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828794|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650558|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
19650559|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19828795|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
19828796|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828797|NCT00570739|Metformin|metformin|mesh-list
19828798|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19828799|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19828800|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828801|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20336637|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20336638|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336639|NCT00800293|Betamethasone|betamethasone|mesh-list
20336640|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
20336641|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20336642|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
20336643|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20336644|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336645|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
20336646|NCT00800293|Hormones|hormones|mesh-ancestor
20336647|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336648|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336649|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20336650|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
20336651|NCT00800306|Simendan|simendan|mesh-list
20336652|NCT00800306|Dobutamine|dobutamine|mesh-list
20336653|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20336654|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
20336655|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20336656|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20336657|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336658|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336659|NCT00800306|Protective Agents|protective agents|mesh-ancestor
20336660|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336661|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
20336662|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
20336663|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336664|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20336665|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20336666|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20336667|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
20336668|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336669|NCT00800319|ALKS-33|alks-33|mesh-list
20336670|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20336671|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336672|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
20336673|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336674|NCT00800358|Calcitriol|calcitriol|mesh-list
20336675|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20336676|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336677|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20336678|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20336679|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336680|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20336681|NCT00800358|Vitamins|vitamins|mesh-ancestor
20336682|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
20336683|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20336684|NCT00800423|Timolol|timolol|mesh-list
20336685|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20336686|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20336687|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20336688|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
20336689|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336690|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650560|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
19650561|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650562|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
19650563|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
19650564|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650565|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650566|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650567|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
19650568|NCT02332603|Hormones|hormones|mesh-ancestor
19650569|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650570|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19650571|NCT02332603|Protective Agents|protective agents|mesh-ancestor
19828802|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19828803|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
19828804|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828805|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19828806|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19828807|NCT00570765|Cathartics|cathartics|mesh-ancestor
19828808|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19828809|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
19828810|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19828811|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19828812|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19828813|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
19828814|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828815|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828816|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828817|NCT00570908|Capecitabine|capecitabine|mesh-list
19828818|NCT00570908|Sunitinib|sunitinib|mesh-list
19828819|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828820|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
19828821|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828822|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828823|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19828824|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19828825|NCT00570908|Growth Substances|growth substances|mesh-ancestor
19828826|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828827|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
19828828|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19828829|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828830|NCT00570921|Everolimus|everolimus|mesh-list
19828831|NCT00570921|Fulvestrant|fulvestrant|mesh-list
19828832|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828833|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828834|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
19828835|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828836|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19828837|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19828838|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19828839|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
19828840|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19828841|NCT00570960|Dextrans|dextrans|mesh-list
19828842|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
19828843|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
19828844|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
19828845|NCT00571064|Donepezil|donepezil|mesh-list
19828846|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19828847|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828848|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828849|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
19828850|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828851|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828852|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
19828853|NCT00571103|Acamprosate|acamprosate|mesh-list
19828854|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19828855|NCT00571259|Gentamicins|gentamicins|mesh-list
19828856|NCT00571259|Heparin|heparin|mesh-list
19828857|NCT00571259|Citric Acid|citric acid|mesh-list
19828858|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
19828859|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
19828860|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19828861|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
19828862|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
19828863|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166824|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20166825|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20166826|NCT00141011|Ancrod|ancrod|mesh-list
20166827|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
20166828|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20166829|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20166830|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828864|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19828865|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19828866|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19828867|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828868|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20166831|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19828869|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828870|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19828871|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
19828872|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19828873|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
19828874|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828875|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828876|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19828877|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
19828878|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19828879|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19828880|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19828881|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
19828882|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828883|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828884|NCT00571493|Cytarabine|cytarabine|mesh-list
19828885|NCT00571493|Etoposide|etoposide|mesh-list
19828886|NCT00571493|Bortezomib|bortezomib|mesh-list
19828887|NCT00571493|Melphalan|melphalan|mesh-list
19828888|NCT00571493|Carmustine|carmustine|mesh-list
19828889|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19828890|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828891|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19828892|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19828893|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828894|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828895|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19828896|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
19828897|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
19828898|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828899|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828900|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
19828901|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828902|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19828903|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
19828904|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19828905|NCT00571519|Metformin|metformin|mesh-list
19828906|NCT00571519|Pioglitazone|pioglitazone|mesh-list
19828907|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19828908|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828909|NCT00571649|Enoxaparin|enoxaparin|mesh-list
19828910|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
19828911|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
19828912|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19828913|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
19828914|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19828915|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
20336691|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336692|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20336693|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20336694|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20336695|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20336696|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20336697|NCT00800462|Bromides|bromides|mesh-list
20336698|NCT00800462|Oxybutynin|oxybutynin|mesh-list
20336699|NCT00800462|Darifenacin|darifenacin|mesh-list
19650572|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650573|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665253|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665254|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665255|NCT02369458|Mitomycins|mitomycins|mesh-list
19665256|NCT02369458|Mitomycin|mitomycin|mesh-list
19665257|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19665258|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665259|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
19665260|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665261|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19665262|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665263|NCT05102448|Methotrexate|methotrexate|mesh-list
19665264|NCT05102448|Tofacitinib|tofacitinib|mesh-list
19665265|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19665266|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
19665267|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665268|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665269|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665270|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
19828916|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666187|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20336700|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
20336701|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
20336702|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
20336703|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336704|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336705|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20336706|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20336707|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
20336708|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336709|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336710|NCT00800462|Urological Agents|urological agents|mesh-ancestor
19650574|NCT02332447|Naloxone|naloxone|mesh-list
19828917|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828918|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
19828919|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19828920|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20336711|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
19650575|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19650576|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650577|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
19650578|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650579|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
19650580|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19650581|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19650582|NCT02332629|Prednisolone|prednisolone|mesh-list
19650583|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
19650584|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19650585|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
19650586|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650587|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
19650588|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
19650589|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650590|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650591|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650592|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
19650593|NCT02332629|Hormones|hormones|mesh-ancestor
19650594|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650595|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19650596|NCT02332629|Protective Agents|protective agents|mesh-ancestor
19650597|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19828921|NCT00571662|Cyclosporine|cyclosporine|mesh-list
19828922|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
19828923|NCT00571662|Pentostatin|pentostatin|mesh-list
19828924|NCT00571662|Cyclosporins|cyclosporins|mesh-list
19828925|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828926|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828927|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19828928|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
19828929|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828930|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
19828931|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828932|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
19828933|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828934|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19828935|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19828936|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828937|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19828938|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
19828939|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19828940|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19828941|NCT00571688|Risperidone|risperidone|mesh-list
20166832|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20166833|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166834|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20166835|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20166836|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166837|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166838|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
20166839|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166840|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
20166841|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20336712|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19650598|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19828942|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19828943|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
19828944|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19828945|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828946|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828947|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19828948|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19828949|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19828950|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19828951|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19828952|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
19828953|NCT00571701|Celecoxib|celecoxib|mesh-list
19828954|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19828955|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20166842|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166843|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20166844|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20166845|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166846|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166847|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
19828956|NCT00571701|Analgesics|analgesics|mesh-ancestor
19828957|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
19828958|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828959|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828960|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19828961|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19828962|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19828963|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19828964|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828965|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828966|NCT00571961|Ritonavir|ritonavir|mesh-list
19828967|NCT00571961|Lopinavir|lopinavir|mesh-list
19828968|NCT00571961|Buprenorphine|buprenorphine|mesh-list
19828969|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19828970|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19828971|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
19828972|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19828973|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19828974|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19828975|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19828976|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
19828977|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19828978|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19828979|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19828980|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19828981|NCT00571961|Narcotics|narcotics|mesh-ancestor
19828982|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19828983|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828984|NCT00571961|Analgesics|analgesics|mesh-ancestor
19828985|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
19828986|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19828987|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19828988|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19828989|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19828990|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
19828991|NCT00572117|Topiramate|topiramate|mesh-list
19828992|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
19828993|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19828994|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19828995|NCT00572156|Mecasermin|mecasermin|mesh-list
19828996|NCT00572156|Growth Substances|growth substances|mesh-ancestor
19828997|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336713|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
20336714|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336715|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20336716|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20336717|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20336718|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336719|NCT00800527|Diclofenac|diclofenac|mesh-list
19828998|NCT00572234|Bupropion|bupropion|mesh-list
19828999|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20166848|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166849|NCT00141089|Tegaserod|tegaserod|mesh-list
20166850|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20166851|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
20166852|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336720|NCT00800527|Gabapentin|gabapentin|mesh-list
20336721|NCT00800527|Analgesics|analgesics|mesh-ancestor
20336722|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
20336723|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829000|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
19829001|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19829002|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19829003|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19829004|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829005|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829006|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
19829007|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829008|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829009|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19829010|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19829011|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829012|NCT00572455|Latanoprost|latanoprost|mesh-list
19829013|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19829014|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19829015|NCT00572468|Simvastatin|simvastatin|mesh-list
19829016|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19829017|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19829018|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
19829019|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829020|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19829021|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19829022|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829023|NCT00572572|Aprepitant|aprepitant|mesh-list
19829024|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
19829025|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
19829026|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829027|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829028|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19829029|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19829030|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829031|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829032|NCT00572728|Alovudine|alovudine|mesh-list
19829033|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
19829034|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
19829035|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829036|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
19829037|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829038|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19829039|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19829040|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829041|NCT00572832|Vaccines|vaccines|mesh-list
19829042|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
19829043|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829044|NCT00572897|Fludarabine|fludarabine|mesh-list
19829045|NCT00572897|Melphalan|melphalan|mesh-list
19829046|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829047|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829048|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829049|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
19829050|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829051|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829052|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
19829053|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19829054|NCT00572936|Timolol|timolol|mesh-list
19829055|NCT00572936|Dorzolamide|dorzolamide|mesh-list
20166853|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166854|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166855|NCT00141141|Atorvastatin|atorvastatin|mesh-list
20166856|NCT00141141|Simvastatin|simvastatin|mesh-list
20166857|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20166858|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20166859|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
20166860|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166861|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20166862|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20166863|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336724|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336725|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
19829056|NCT00572936|Latanoprost|latanoprost|mesh-list
19829057|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19829058|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19829059|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829060|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829061|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829062|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829063|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19829064|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19829065|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19829066|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19829067|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19829068|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829069|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
20336726|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20336727|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20336728|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336729|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20336730|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20336731|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20336732|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336733|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336734|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
20336735|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20336736|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336737|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336738|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336739|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20336740|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336741|NCT00800553|Donepezil|donepezil|mesh-list
20336742|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20336743|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336744|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336745|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
20336746|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336747|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336748|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
20336749|NCT00800566|Clofarabine|clofarabine|mesh-list
20336750|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829070|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20611813|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611814|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
20611815|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611816|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611817|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
20611818|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20611819|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20611820|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611821|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20611822|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
20611823|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829071|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829072|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166864|NCT00141154|Celecoxib|celecoxib|mesh-list
20166865|NCT00141154|Loxoprofen|loxoprofen|mesh-list
20336751|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
20336752|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336753|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336754|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
20336755|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
20336756|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20336757|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20336758|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336759|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166866|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20166867|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20166868|NCT00141154|Analgesics|analgesics|mesh-ancestor
20166869|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
20166870|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166871|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166872|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336760|NCT00800592|Urological Agents|urological agents|mesh-ancestor
20336761|NCT00800709|Memantine|memantine|mesh-list
20611824|NCT02248584|Ascorbic Acid|ascorbic acid|mesh-list
20336762|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20336763|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20336764|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
20336765|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336766|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336767|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336768|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20336769|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20336770|NCT00800722|Sirolimus|sirolimus|mesh-list
19829073|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19829074|NCT00573066|Analgesics|analgesics|mesh-ancestor
19829075|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
20336771|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20336772|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336773|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336774|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336775|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
20336776|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336777|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
20336778|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829076|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829077|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19829078|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19829079|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19829080|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829081|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829082|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829083|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19829084|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
19829085|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829086|NCT00573248|Nicotine|nicotine|mesh-list
19829087|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19829088|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
19829089|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829090|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829091|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19829092|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19829093|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
19829094|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829095|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829096|NCT00573261|Pregabalin|pregabalin|mesh-list
19829097|NCT00573261|Analgesics|analgesics|mesh-ancestor
19829098|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
19829099|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829100|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829101|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
19829102|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19829103|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829104|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829105|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19829106|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19829107|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19829108|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829109|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19829110|NCT00573287|Risperidone|risperidone|mesh-list
19829111|NCT00573287|Clozapine|clozapine|mesh-list
19829112|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19829113|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
19829114|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829115|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829116|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829117|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19829118|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19829119|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829120|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19829121|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19829122|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
20336779|NCT00800748|Ribavirin|ribavirin|mesh-list
20336780|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20336781|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
20336782|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336783|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
19829123|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
20336784|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336785|NCT00800761|Deferiprone|deferiprone|mesh-list
19829124|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
19829125|NCT00573430|Candesartan|candesartan|mesh-list
19829126|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
19829127|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19829128|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19829129|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19829130|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829131|NCT00573443|Quinidine|quinidine|mesh-list
19829132|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
19829133|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
19829134|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
19829135|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
19829136|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19829137|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19829138|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829139|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829140|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829141|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19829142|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19829143|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829144|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19829145|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
19829146|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19829147|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19829148|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829149|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829150|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19829151|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19829152|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
19829153|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19829154|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19829155|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829156|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19829157|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19829158|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
20166873|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166874|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20166875|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20166876|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166877|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166878|NCT00141167|Varenicline|varenicline|mesh-list
20166879|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20166880|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20166881|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166882|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166883|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166884|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166885|NCT00141193|Celecoxib|celecoxib|mesh-list
20166886|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20166887|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20166888|NCT00141193|Analgesics|analgesics|mesh-ancestor
20166889|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
20166890|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166891|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166892|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20166893|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20166894|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20166895|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20166896|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166897|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166898|NCT00141206|Varenicline|varenicline|mesh-list
20166899|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20336786|NCT00800761|Deferoxamine|deferoxamine|mesh-list
19650599|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
19650600|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19650601|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19650602|NCT02332616|Prednisolone|prednisolone|mesh-list
19650603|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
19650604|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19650605|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
19650606|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829159|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19829160|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19829161|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19829162|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829163|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829164|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829165|NCT00573508|Urological Agents|urological agents|mesh-ancestor
19829166|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19829167|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19829168|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829169|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19829170|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19829171|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829172|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829173|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
19829174|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829175|NCT00573755|Sorafenib|sorafenib|mesh-list
19829176|NCT00573755|Letrozole|letrozole|mesh-list
19829177|NCT00573755|Anastrozole|anastrozole|mesh-list
19829178|NCT00573755|Exemestane|exemestane|mesh-list
19829179|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829180|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829181|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829182|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829183|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19829184|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19829185|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19829186|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
19650607|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
19650608|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
19650609|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650610|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166900|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20166901|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
20166902|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20166903|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166904|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166905|NCT00141232|Atorvastatin|atorvastatin|mesh-list
20166906|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20336787|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19650611|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650612|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
19650613|NCT02332616|Hormones|hormones|mesh-ancestor
19650614|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650615|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19650616|NCT02332616|Protective Agents|protective agents|mesh-ancestor
19650617|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650618|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336788|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
20336789|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
20336790|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650619|NCT02332174|Rufinamide|rufinamide|mesh-list
20166907|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20166908|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
20166909|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166910|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20166911|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20166912|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166913|NCT00141245|Pregabalin|pregabalin|mesh-list
20166914|NCT00141245|Analgesics|analgesics|mesh-ancestor
20166915|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
20166916|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166917|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166918|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
20166919|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20166920|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166921|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166922|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19650620|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
19829187|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829188|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829189|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19829190|NCT00573768|Diclofenac|diclofenac|mesh-list
19829191|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19829192|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19829193|NCT00573768|Analgesics|analgesics|mesh-ancestor
19829194|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
19829195|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829196|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829197|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829198|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829199|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19829200|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829201|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829202|NCT00573794|Adalimumab|adalimumab|mesh-list
19829203|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829204|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829205|NCT00573859|Methylphenidate|methylphenidate|mesh-list
19829206|NCT00573859|Amphetamine|amphetamine|mesh-list
19829207|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19829208|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
19829209|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19829210|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19829211|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829212|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19829213|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19829214|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829215|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829216|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
19829217|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829218|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19829219|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829220|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
19829221|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
19829222|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829223|NCT00573989|Pemetrexed|pemetrexed|mesh-list
19829224|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19829225|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829226|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829227|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829228|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19829229|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19829230|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829231|NCT00574067|Buprenorphine|buprenorphine|mesh-list
19829232|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19829233|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19829234|NCT00574067|Narcotics|narcotics|mesh-ancestor
19829235|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829236|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829237|NCT00574067|Analgesics|analgesics|mesh-ancestor
19829238|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
19829239|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829240|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19829241|NCT00574119|Spironolactone|spironolactone|mesh-list
19829242|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19829243|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
19829244|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829245|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829246|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20611825|NCT02248584|Vitamins|vitamins|mesh-ancestor
19650621|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19650622|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19650623|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650624|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650625|NCT02332135|Vitamin D|vitamin d|mesh-list
19650626|NCT02332135|Vitamins|vitamins|mesh-ancestor
19650627|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
19650628|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650629|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19650630|NCT02332356|Adalimumab|adalimumab|mesh-list
19650631|NCT02332356|Azathioprine|azathioprine|mesh-list
19829247|NCT00574119|Diuretics|diuretics|mesh-ancestor
19829248|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
19829249|NCT00574171|Capecitabine|capecitabine|mesh-list
19829250|NCT00574171|Lapatinib|lapatinib|mesh-list
19650632|NCT02332356|Infliximab|infliximab|mesh-list
19650633|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650634|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829251|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829252|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
19829253|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829254|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829255|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829256|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829257|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
19829258|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19650635|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
19650636|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650637|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
19650638|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650639|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19650640|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650641|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829259|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829260|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19829261|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
19829262|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19829263|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829264|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829265|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650642|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
19650643|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829266|NCT00574236|Doxorubicin|doxorubicin|mesh-list
19829267|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19829268|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829269|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19829270|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829271|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829272|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829273|NCT00574249|Adalimumab|adalimumab|mesh-list
19829274|NCT00574249|Betamethasone|betamethasone|mesh-list
19829275|NCT00574249|Calcipotriene|calcipotriene|mesh-list
19829276|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650644|NCT02332057|Diclofenac|diclofenac|mesh-list
19829277|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829278|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
19829279|NCT00574249|Hormones|hormones|mesh-ancestor
19829280|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829281|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829282|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19829283|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
19829284|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
19829285|NCT00574275|Gemcitabine|gemcitabine|mesh-list
19829286|NCT00574275|Aflibercept|aflibercept|mesh-list
19829287|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829288|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
19829289|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829290|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829291|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
20166923|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20166924|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20166925|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166926|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20166927|NCT00141258|Pregabalin|pregabalin|mesh-list
20166928|NCT00141258|Analgesics|analgesics|mesh-ancestor
20166929|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
20166930|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166931|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166932|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
20166933|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20166934|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166935|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166936|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20166937|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19650645|NCT02332057|Lidocaine|lidocaine|mesh-list
19835310|NCT00601835|Vaccines|vaccines|mesh-list
19829292|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829293|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829294|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829295|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
19829296|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829297|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19829298|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19829299|NCT00574275|Growth Substances|growth substances|mesh-ancestor
19829300|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
19829301|NCT00574288|Dexamethasone|dexamethasone|mesh-list
19829302|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
19829303|NCT00574288|Daratumumab|daratumumab|mesh-list
19829304|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19829305|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336791|NCT00800761|Siderophores|siderophores|mesh-ancestor
20336792|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
19829306|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
19829307|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
19829308|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829309|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829310|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19829311|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
19829312|NCT00574288|Hormones|hormones|mesh-ancestor
19829313|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829314|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19829315|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829316|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19829317|NCT00574288|Protective Agents|protective agents|mesh-ancestor
19829318|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
19829319|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19829320|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829321|NCT00574405|Insulin|insulin|mesh-list
19829322|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19829323|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
19829324|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
19829325|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
19829326|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
19829327|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
19829328|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19829329|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829330|NCT00574548|Vaccines|vaccines|mesh-list
19829331|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19829332|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
19829333|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829334|NCT00574587|Paclitaxel|paclitaxel|mesh-list
19829335|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
19829336|NCT00574587|Doxorubicin|doxorubicin|mesh-list
19829337|NCT00574587|Trastuzumab|trastuzumab|mesh-list
19829338|NCT00574587|Vorinostat|vorinostat|mesh-list
19829339|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19829340|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829341|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
19829342|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19829343|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
19829344|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829345|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829346|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
19829347|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829348|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829349|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829350|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
19829351|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19829352|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19829353|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19829354|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829355|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829356|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829357|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19829358|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19829359|NCT00574834|Ramipril|ramipril|mesh-list
19829360|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19829361|NCT00574834|Diuretics|diuretics|mesh-ancestor
19829362|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
19829363|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829364|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19829365|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20336793|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
19829366|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829367|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19829368|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
19829369|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829370|NCT00574847|Citalopram|citalopram|mesh-list
19829371|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19829372|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19829373|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829374|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829375|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829376|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
19829377|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829378|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19829379|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
19829380|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19829381|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
19829382|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829383|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829384|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829385|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829386|NCT00574912|Insulin|insulin|mesh-list
19829387|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19829388|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
19829389|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19829390|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829391|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
19650646|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
19650647|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
19650648|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611826|NCT02248584|Micronutrients|micronutrients|mesh-ancestor
20611827|NCT02248584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611828|NCT02248584|Antioxidants|antioxidants|mesh-ancestor
20611829|NCT02248584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611830|NCT02248584|Protective Agents|protective agents|mesh-ancestor
20611831|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
20611832|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
20611833|NCT02248597|Busulfan|busulfan|mesh-list
20611834|NCT02248597|Fludarabine|fludarabine|mesh-list
20611835|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
20611836|NCT02248597|Tacrolimus|tacrolimus|mesh-list
20611837|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611838|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
20611839|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650649|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650650|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
19650651|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650652|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19650653|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19650654|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19650655|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650656|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829392|NCT00574951|Imetelstat|imetelstat|mesh-list
19829393|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829394|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829395|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829396|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
19829397|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19829398|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19829399|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19829400|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829401|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611840|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650657|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19650658|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19650659|NCT02332057|Analgesics|analgesics|mesh-ancestor
19650660|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650661|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650662|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19650663|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650664|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
19650665|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19650666|NCT02332031|Sorafenib|sorafenib|mesh-list
19829402|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
19829403|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829404|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829405|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19829406|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829407|NCT00575029|Megestrol|megestrol|mesh-list
19829408|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
19829409|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20336794|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336795|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20336796|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20336797|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20336798|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
20336799|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336800|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20336801|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20336802|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336803|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
20336804|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20336805|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336806|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336807|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20336808|NCT00800826|Analgesics|analgesics|mesh-ancestor
20336809|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
20336810|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336811|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20336812|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20336813|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20336814|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
20336815|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20336816|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829410|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19829411|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19829412|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
19829413|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19829414|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829415|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19829416|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19829417|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19829418|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829419|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
19829420|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19829421|NCT00575042|Fenofibrate|fenofibrate|mesh-list
19829422|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19829423|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
19829424|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829425|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19829426|NCT00575094|Tigecycline|tigecycline|mesh-list
19829427|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19829428|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829429|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19829430|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829431|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829432|NCT00575367|Azithromycin|azithromycin|mesh-list
19829433|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
19829434|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19829435|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19829436|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19829437|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19829438|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829439|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19829440|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829441|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829442|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829443|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829444|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20336817|NCT00800917|Sirolimus|sirolimus|mesh-list
20611841|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20611842|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
20611843|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611844|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336818|NCT00800917|Bevacizumab|bevacizumab|mesh-list
20611845|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19650667|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650668|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19650669|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650670|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166938|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20166939|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829445|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
19829446|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19829447|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829448|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19829449|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19829450|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19829451|NCT00575380|Azithromycin|azithromycin|mesh-list
19829452|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
19829453|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19829454|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19829455|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19829456|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19829457|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829458|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19829459|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829460|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829461|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829462|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829463|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19829464|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
19829465|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19829466|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829467|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19829468|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19829469|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19835311|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
19835312|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835313|NCT00601926|Bevacizumab|bevacizumab|mesh-list
19835314|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835315|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835316|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835317|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835318|NCT00601926|Growth Substances|growth substances|mesh-ancestor
20166940|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20166941|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
20166942|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166943|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
20166944|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19835319|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835320|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835321|NCT00601965|Citalopram|citalopram|mesh-list
19835322|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19835323|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835324|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835325|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835326|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835327|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
19835328|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835329|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19835330|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835331|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835332|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20166945|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20166946|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20166947|NCT00141310|Urological Agents|urological agents|mesh-ancestor
20166948|NCT00141336|Pregabalin|pregabalin|mesh-list
20166949|NCT00141336|Analgesics|analgesics|mesh-ancestor
20166950|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
20166951|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166952|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166953|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
20166954|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20166955|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166956|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611846|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20336819|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336820|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336821|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20336822|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20336823|NCT00800917|Growth Substances|growth substances|mesh-ancestor
20336824|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829470|NCT00575588|Metformin|metformin|mesh-list
19829471|NCT00575588|Saxagliptin|saxagliptin|mesh-list
19829472|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19829473|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166957|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20166958|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20166959|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20166960|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829474|NCT00575588|Incretins|incretins|mesh-ancestor
19829475|NCT00575588|Hormones|hormones|mesh-ancestor
19829476|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829477|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19829478|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
19829479|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829480|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829481|NCT00575666|Insulin|insulin|mesh-list
19829482|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19829483|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829484|NCT00575887|Temozolomide|temozolomide|mesh-list
19829485|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829486|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
19829487|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829488|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829489|NCT00575965|Simvastatin|simvastatin|mesh-list
19829490|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19829491|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19829492|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
19829493|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829494|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19829495|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19829496|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829497|NCT00576056|Sorafenib|sorafenib|mesh-list
19829498|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829499|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829500|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829501|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829502|NCT00576199|Bevacizumab|bevacizumab|mesh-list
19829503|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829504|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829505|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19829506|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19829507|NCT00576199|Growth Substances|growth substances|mesh-ancestor
19829508|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829509|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
19829510|NCT00576251|Tobramycin|tobramycin|mesh-list
19829511|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19829512|NCT00576251|Dexamethasone|dexamethasone|mesh-list
19829513|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829514|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
19829515|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
19829516|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829517|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829518|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19829519|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
19829520|NCT00576251|Hormones|hormones|mesh-ancestor
19829521|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829522|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19829523|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829524|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19829525|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20166961|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20166962|NCT00141362|Pregabalin|pregabalin|mesh-list
20166963|NCT00141362|Analgesics|analgesics|mesh-ancestor
20166964|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
20166965|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336825|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
20611847|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
20611848|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19829526|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19829527|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19829528|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
19829529|NCT00576303|Hematinics|hematinics|mesh-ancestor
20336826|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20336827|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336828|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336829|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
20336830|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336831|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
20336832|NCT00800930|Butyric Acid|butyric acid|mesh-list
20336833|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
19829530|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19829531|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19829532|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
19829533|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
19829534|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19829535|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829536|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829537|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19829538|NCT00576381|Analgesics|analgesics|mesh-ancestor
19829539|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
19829540|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829541|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19829542|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19829543|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19829544|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829545|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829546|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829547|NCT00576472|Methylphenidate|methylphenidate|mesh-list
19829548|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19829549|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166966|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166967|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
19829550|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19829551|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19829552|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829553|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829554|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
19829555|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829556|NCT00576576|Atorvastatin|atorvastatin|mesh-list
19829557|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19829558|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19829559|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
19829560|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829561|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19829562|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20336834|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
20336835|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20611849|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829563|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829564|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
19829565|NCT00576628|Hematinics|hematinics|mesh-ancestor
19829566|NCT00576680|Temozolomide|temozolomide|mesh-list
19829567|NCT00576680|Everolimus|everolimus|mesh-list
19829568|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829569|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
19829570|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829571|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829572|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829573|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
19829574|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829575|NCT00576732|Risperidone|risperidone|mesh-list
20166968|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20166969|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166970|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166971|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20166972|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20166973|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20166974|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166975|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20336836|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166976|NCT00141375|Pregabalin|pregabalin|mesh-list
20166977|NCT00141375|Analgesics|analgesics|mesh-ancestor
19829576|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19829577|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
19829578|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829579|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829580|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829581|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19829582|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19829583|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829584|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19829585|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19829586|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
19829587|NCT00576758|Rituximab|rituximab|mesh-list
19829588|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
19829589|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829590|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829591|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
19829592|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829593|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829594|NCT00576823|Alfuzosin|alfuzosin|mesh-list
19829595|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19829596|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19829597|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19829598|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829599|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829600|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829601|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829602|NCT00576823|Urological Agents|urological agents|mesh-ancestor
19829603|NCT00576901|Bevacizumab|bevacizumab|mesh-list
19829604|NCT00576901|Docetaxel|docetaxel|mesh-list
19829605|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829606|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829607|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19829608|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20611850|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20611851|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20611852|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
20611853|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611854|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611855|NCT02248753|Metoprolol|metoprolol|mesh-list
20611856|NCT02248753|Digoxin|digoxin|mesh-list
20611857|NCT02248753|Amiodarone|amiodarone|mesh-list
20611858|NCT02248753|Verapamil|verapamil|mesh-list
20611859|NCT02248753|Flecainide|flecainide|mesh-list
20166978|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
20166979|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166980|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650671|NCT02331771|Donepezil|donepezil|mesh-list
20611860|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20611861|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20611862|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
20611863|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
20611864|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611865|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611866|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20611867|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19829609|NCT00576901|Growth Substances|growth substances|mesh-ancestor
19829610|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829611|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
19829612|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
19829613|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
19829614|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
19829615|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166981|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
20166982|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19650672|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19650673|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650674|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650675|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
19650676|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650677|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650678|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
19650679|NCT02331745|Sargramostim|sargramostim|mesh-list
19650680|NCT02331745|Lenograstim|lenograstim|mesh-list
19650681|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
19829616|NCT00577005|Levetiracetam|levetiracetam|mesh-list
19829617|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
19829618|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
19829619|NCT00577031|Bevacizumab|bevacizumab|mesh-list
19829620|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
19829621|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829622|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829623|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19829624|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19829625|NCT00577031|Growth Substances|growth substances|mesh-ancestor
19829626|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829627|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
19829628|NCT00577096|Thalidomide|thalidomide|mesh-list
19829629|NCT00577096|Dexamethasone|dexamethasone|mesh-list
20166983|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166984|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166985|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20166986|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20166987|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20166988|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20166989|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20166990|NCT00141388|Pregabalin|pregabalin|mesh-list
20166991|NCT00141388|Analgesics|analgesics|mesh-ancestor
20166992|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
20166993|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20166994|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20166995|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
20166996|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20166997|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20166998|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20166999|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167000|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167001|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167002|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167003|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167004|NCT00141401|Pregabalin|pregabalin|mesh-list
20167005|NCT00141401|Analgesics|analgesics|mesh-ancestor
20167006|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
20167007|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167008|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167009|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
20336837|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336838|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
20336839|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336840|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336841|NCT00801034|Calcium|calcium|mesh-list
20336842|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20336843|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336844|NCT00801047|Remifentanil|remifentanil|mesh-list
20336845|NCT00801047|Bupivacaine|bupivacaine|mesh-list
20336846|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
20336847|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
19829630|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
19829631|NCT00577096|Melphalan|melphalan|mesh-list
19829632|NCT00577096|Cisplatin|cisplatin|mesh-list
19829633|NCT00577096|Doxorubicin|doxorubicin|mesh-list
19829634|NCT00577096|Etoposide|etoposide|mesh-list
19829635|NCT00577096|Vincristine|vincristine|mesh-list
19829636|NCT00577096|Heparin|heparin|mesh-list
19829637|NCT00577096|Calcium heparin|calcium heparin|mesh-list
19829638|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19829639|NCT00577096|Tinzaparin|tinzaparin|mesh-list
19829640|NCT00577096|Dalteparin|dalteparin|mesh-list
19829641|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
19829642|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829643|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
19829644|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829645|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829646|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829647|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
19829648|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829649|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336848|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336849|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829650|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19829651|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829652|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
19829653|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
19829654|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829655|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19829656|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
19829657|NCT00577096|Hormones|hormones|mesh-ancestor
19829658|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829659|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19829660|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829661|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19829662|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19829663|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829664|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19829665|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
19829666|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
19829667|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
19829668|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
19829669|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19829670|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19650682|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650683|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19650684|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
19829671|NCT00577096|Hematinics|hematinics|mesh-ancestor
19829672|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
19829673|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19829674|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829675|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19829676|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19829677|NCT00577096|Growth Substances|growth substances|mesh-ancestor
19829678|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
19829679|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
19829680|NCT00577122|Methotrexate|methotrexate|mesh-list
19829681|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19829682|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
19829683|NCT00577122|Progesterone|progesterone|mesh-list
19829684|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829685|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
19829686|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336850|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
20336851|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20336852|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20336853|NCT00801047|Narcotics|narcotics|mesh-ancestor
20336854|NCT00801047|Analgesics|analgesics|mesh-ancestor
20336855|NCT00801086|Ethanol|ethanol|mesh-list
20336856|NCT00801086|Tempol|tempol|mesh-list
20336857|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20336858|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336859|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20336860|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336861|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
20336862|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829687|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829688|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829689|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
19829690|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829691|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829692|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20336863|NCT00801086|Protective Agents|protective agents|mesh-ancestor
20336864|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20336865|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650685|NCT02331823|Isoniazid|isoniazid|mesh-list
19650686|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
19650687|NCT02331823|Ethambutol|ethambutol|mesh-list
19650688|NCT02331823|Rifabutin|rifabutin|mesh-list
19650689|NCT02331823|Streptomycin|streptomycin|mesh-list
19650690|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19650691|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829693|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20336866|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20336867|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19650692|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19650693|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829694|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
20336868|NCT00801125|Natalizumab|natalizumab|mesh-list
20336869|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
20336870|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336871|NCT00801151|Vinorelbine|vinorelbine|mesh-list
20336872|NCT00801151|Vorinostat|vorinostat|mesh-list
20336873|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336874|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336875|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336876|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336877|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336878|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336879|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20336880|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336881|NCT00801177|Necitumumab|necitumumab|mesh-list
20336882|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20336883|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336884|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336885|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
20336886|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336887|NCT00801255|Lactams|lactams|mesh-list
20336888|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20336889|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336890|NCT00801268|Emodin|emodin|mesh-list
20336891|NCT00801268|Cathartics|cathartics|mesh-ancestor
20336892|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20336893|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20336894|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336895|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336896|NCT00801281|Prednisone|prednisone|mesh-list
20336897|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
20336898|NCT00801281|Rituximab|rituximab|mesh-list
20336899|NCT00801281|Doxorubicin|doxorubicin|mesh-list
20336900|NCT00801281|Vincristine|vincristine|mesh-list
20336901|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336902|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
20336903|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336904|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336905|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336906|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
20336907|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336908|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336909|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20336910|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336911|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336912|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20336913|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20336914|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336915|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336916|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
20336917|NCT00801281|Hormones|hormones|mesh-ancestor
19829695|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20336918|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336919|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20336920|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20336921|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336922|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336923|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
20348149|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
20348150|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20348151|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
20348152|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348153|NCT00863785|Protective Agents|protective agents|mesh-ancestor
20348154|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348155|NCT00863785|Antidotes|antidotes|mesh-ancestor
20348156|NCT00863837|Terlipressin|terlipressin|mesh-list
20348157|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20348158|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20348159|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348160|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348161|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611868|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19650694|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650695|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650696|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650697|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19650698|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
19650699|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19650700|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19650701|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
19650702|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19650703|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19650704|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
19650705|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19650706|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19650707|NCT02331862|Prednisolone|prednisolone|mesh-list
19650708|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
19650709|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19650710|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
19650711|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829696|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829697|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
19829698|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
19829699|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829700|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19829701|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19829702|NCT00577122|Progestins|progestins|mesh-ancestor
19829703|NCT00577122|Hormones|hormones|mesh-ancestor
19829704|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829705|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19829706|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19829707|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19829708|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
19829709|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19829710|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19829711|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19829712|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19829713|NCT00577135|Furosemide|furosemide|mesh-list
20167010|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167011|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167012|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829714|NCT00577135|Diuretics|diuretics|mesh-list
19829715|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19829716|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
19829717|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829718|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829719|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829720|NCT00577382|Sunitinib|sunitinib|mesh-list
19829721|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829722|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19829723|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19829724|NCT00577382|Growth Substances|growth substances|mesh-ancestor
19829725|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829726|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
19829727|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829728|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829729|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829730|NCT00577408|Naltrexone|naltrexone|mesh-list
20167013|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167014|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167015|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167016|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167017|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167018|NCT00141414|Pregabalin|pregabalin|mesh-list
20167019|NCT00141414|Analgesics|analgesics|mesh-ancestor
20167020|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
20167021|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167022|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167023|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
20167024|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167025|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167026|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167027|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167028|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167029|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167030|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167031|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19650712|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
19650713|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
20336924|NCT00801294|Nintedanib|nintedanib|mesh-list
20336925|NCT00801294|Afatinib|afatinib|mesh-list
20336926|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336927|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20336928|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336929|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336930|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20336931|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20336932|NCT00801385|Sorafenib|sorafenib|mesh-list
20336933|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336934|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20336935|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336936|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336937|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
20336938|NCT00801411|Docetaxel|docetaxel|mesh-list
20336939|NCT00801411|Doxorubicin|doxorubicin|mesh-list
20336940|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20336941|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336942|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
20336943|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336944|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20336945|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20336946|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
19829731|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19829732|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19829733|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829734|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
19829735|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829736|NCT00577460|Pramipexole|pramipexole|mesh-list
19829737|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
19829738|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829739|NCT00577460|Protective Agents|protective agents|mesh-ancestor
19829740|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829741|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19829742|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19829743|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
19829744|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
20336947|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336948|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336949|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20336950|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
20336951|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
20336952|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
20336953|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20167032|NCT00141427|Pregabalin|pregabalin|mesh-list
20167033|NCT00141427|Analgesics|analgesics|mesh-ancestor
20167034|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
20167035|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167036|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167037|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
20167038|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167039|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20336954|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20336955|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20336956|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336957|NCT00801450|Triamcinolone|triamcinolone|mesh-list
20611869|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829745|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829746|NCT00577473|Mesalamine|mesalamine|mesh-list
19829747|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19829748|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19829749|NCT00577473|Analgesics|analgesics|mesh-ancestor
19829750|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
20611870|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650714|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650715|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650716|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650717|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
19650718|NCT02331862|Hormones|hormones|mesh-ancestor
19650719|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650720|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19650721|NCT02331862|Protective Agents|protective agents|mesh-ancestor
19829751|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167040|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336958|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19829752|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829753|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829754|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829755|NCT00577590|Metformin|metformin|mesh-list
19829756|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
19829757|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19829758|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829759|NCT00577629|Cytarabine|cytarabine|mesh-list
19829760|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
19829761|NCT00577629|Rituximab|rituximab|mesh-list
19829762|NCT00577629|Doxorubicin|doxorubicin|mesh-list
19829763|NCT00577629|Etoposide|etoposide|mesh-list
19829764|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829765|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
19829766|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829767|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829768|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829769|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
19829770|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829771|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829772|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19829773|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829774|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19829775|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19829776|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829777|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829778|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19829779|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829780|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
19829781|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
19829782|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829783|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
19829784|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19829785|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829786|NCT00577655|Albuterol|albuterol|mesh-list
19829787|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19829788|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
19829789|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829790|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829791|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19829792|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
19829793|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
19829794|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19829795|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19829796|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19829797|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19829798|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
19829799|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829800|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829801|NCT00577707|Pemetrexed|pemetrexed|mesh-list
19829802|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19829803|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829804|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829805|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829806|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20167041|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167042|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167043|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167044|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167045|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167046|NCT00141492|Testosterone|testosterone|mesh-list
19829807|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19829808|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19829809|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
19829810|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
19829811|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19829812|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19829813|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829814|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19829815|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829816|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19829817|NCT00577824|Exenatide|exenatide|mesh-list
19829818|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19829819|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336959|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19650722|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650723|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650724|NCT02331927|Aflibercept|aflibercept|mesh-list
19650725|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19650726|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19650727|NCT02331927|Growth Substances|growth substances|mesh-ancestor
19650728|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650729|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
19829820|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19829821|NCT00577824|Incretins|incretins|mesh-ancestor
19829822|NCT00577824|Hormones|hormones|mesh-ancestor
19829823|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829824|NCT00577863|Teriparatide|teriparatide|mesh-list
19829825|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19829826|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829827|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19829828|NCT00577889|Gemcitabine|gemcitabine|mesh-list
19829829|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829830|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
19829831|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829832|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829833|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
19829834|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829835|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829836|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829837|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
19829838|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829839|NCT00577993|Interferons|interferons|mesh-list
19829840|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
19829841|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
19829842|NCT00577993|Dexamethasone|dexamethasone|mesh-list
19829843|NCT00577993|Prednisone|prednisone|mesh-list
19829844|NCT00577993|Prednisolone|prednisolone|mesh-list
19829845|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19829846|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
19829847|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19829848|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
19829849|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
19829850|NCT00577993|Rituximab|rituximab|mesh-list
19829851|NCT00577993|Doxorubicin|doxorubicin|mesh-list
19829852|NCT00577993|Fludarabine|fludarabine|mesh-list
19829853|NCT00577993|Etoposide|etoposide|mesh-list
19829854|NCT00577993|Vincristine|vincristine|mesh-list
19829855|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
19829856|NCT00577993|Bleomycin|bleomycin|mesh-list
19829857|NCT00577993|Procarbazine|procarbazine|mesh-list
19650730|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650731|NCT02332005|Choline|choline|mesh-list
19650732|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
19829858|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19829859|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
19829860|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829861|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
19829862|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829863|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829864|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829865|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
19829866|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650733|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19650734|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
19650735|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650736|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19829867|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829868|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20167047|NCT00141492|Androgens|androgens|mesh-ancestor
20167048|NCT00141492|Hormones|hormones|mesh-ancestor
20167049|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20167050|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167051|NCT00141531|Apaziquone|apaziquone|mesh-list
20167052|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167053|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
20167054|NCT00141544|Estrogens|estrogens|mesh-list
20167055|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
20167056|NCT00141544|Estrone|estrone|mesh-list
19829869|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829870|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20167057|NCT00141544|Testosterone|testosterone|mesh-list
19829871|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
19829872|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
19829873|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829874|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19829875|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
19829876|NCT00577993|Hormones|hormones|mesh-ancestor
19829877|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829878|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19829879|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829880|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19829881|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19829882|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19829883|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19829884|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
19829885|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19829886|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19829887|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
19829888|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19829889|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19829890|NCT00577993|Protective Agents|protective agents|mesh-ancestor
19829891|NCT00577993|Analgesics|analgesics|mesh-ancestor
19829892|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
19829893|NCT00578071|Capecitabine|capecitabine|mesh-list
19829894|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
19829895|NCT00578071|Panitumumab|panitumumab|mesh-list
19829896|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829897|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
19829898|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829899|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829900|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829901|NCT00578136|Bupivacaine|bupivacaine|mesh-list
19829902|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
19829903|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
20336960|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20336961|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20336962|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
20336963|NCT00801450|Hormones|hormones|mesh-ancestor
20336964|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20336965|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336966|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336967|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
20336968|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336969|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336970|NCT00801489|Cytarabine|cytarabine|mesh-list
19829904|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829905|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829906|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
19829907|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829908|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19829909|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
19829910|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829911|NCT00578214|Midazolam|midazolam|mesh-list
19829912|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
19829913|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19829914|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829915|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19829916|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19829917|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19829918|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19829919|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19829920|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19829921|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
19829922|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
19829923|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
19829924|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829925|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829926|NCT00578227|Vaccines|vaccines|mesh-list
19829927|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
19829928|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829929|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
19829930|NCT00578292|Busulfan|busulfan|mesh-list
19829931|NCT00578292|Fludarabine|fludarabine|mesh-list
19829932|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
20336971|NCT00801489|Fludarabine|fludarabine|mesh-list
20336972|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
20336973|NCT00801489|Decitabine|decitabine|mesh-list
19829933|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167058|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
20167059|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
20167060|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20167061|NCT00141544|Hormones|hormones|mesh-ancestor
20167062|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20167063|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167064|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20336974|NCT00801489|Idarubicin|idarubicin|mesh-list
20336975|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
20336976|NCT00801489|Calicheamicins|calicheamicins|mesh-list
20336977|NCT00801489|Lenograstim|lenograstim|mesh-list
20336978|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20336979|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20336980|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
20336981|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336982|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20336983|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
20336984|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20336985|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
20336986|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20336987|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19829934|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
19829935|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829936|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829937|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19829938|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
19829939|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829940|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829941|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19829942|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829943|NCT00578305|Folic Acid|folic acid|mesh-list
19829944|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
19829945|NCT00578305|Rituximab|rituximab|mesh-list
19829946|NCT00578305|Methotrexate|methotrexate|mesh-list
19829947|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19829948|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19829949|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
19829950|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829951|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829952|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19829953|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
19829954|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19829955|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19829956|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
19829957|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336988|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20336989|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20336990|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20336991|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20336992|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20336993|NCT00801515|Maraviroc|maraviroc|mesh-list
20336994|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20336995|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20336996|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20336997|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20336998|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20336999|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
20337000|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337001|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20337002|NCT00801528|Diclofenac|diclofenac|mesh-list
19829958|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
19829959|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19829960|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19829961|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829962|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19829963|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829964|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
19829965|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
19829966|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829967|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19829968|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
19829969|NCT00578305|Hormones|hormones|mesh-ancestor
20337003|NCT00801528|Ropivacaine|ropivacaine|mesh-list
19835333|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20337004|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
19829970|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19829971|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19829972|NCT00578305|Protective Agents|protective agents|mesh-ancestor
19829973|NCT00578305|Hematinics|hematinics|mesh-ancestor
19829974|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
19829975|NCT00578305|Vitamins|vitamins|mesh-ancestor
19829976|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
19829977|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19829978|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19829979|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19829980|NCT00578331|Analgesics|analgesics|mesh-ancestor
19829981|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
19829982|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19829983|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19829984|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19829985|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19829986|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19829987|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19829988|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19829989|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
19829990|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
19829991|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19829992|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19829993|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
19829994|NCT00578344|Busulfan|busulfan|mesh-list
19829995|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
19829996|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19829997|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
19829998|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167065|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167066|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
20167067|NCT00141544|Androgens|androgens|mesh-ancestor
19829999|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830000|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830001|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
19830002|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830003|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830004|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830005|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830006|NCT00578448|Abatacept|abatacept|mesh-list
19830007|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19830008|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830009|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830010|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830011|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
19830012|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830013|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830014|NCT00578461|Cytarabine|cytarabine|mesh-list
19830015|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
19830016|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830017|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
19830018|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830019|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830020|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830021|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
19830022|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830023|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830024|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830025|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830026|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
19830027|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
19830028|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830029|NCT00578539|Cytarabine|cytarabine|mesh-list
19830030|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
20167068|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
20167069|NCT00141557|Estrogens|estrogens|mesh-list
20167070|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
20167071|NCT00141557|Estrone|estrone|mesh-list
20167072|NCT00141557|Testosterone|testosterone|mesh-list
19830031|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
19830032|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830033|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
19830034|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830035|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167073|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
20167074|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
20337005|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
20337006|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337007|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337008|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
20337009|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337010|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337011|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337012|NCT00801528|Analgesics|analgesics|mesh-ancestor
20337013|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337014|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337015|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20337016|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650737|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19650738|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
19650739|NCT02331706|Interferons|interferons|mesh-list
19650740|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
19650741|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
19650742|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650743|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
19650744|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650745|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
19650746|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650747|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
19650748|NCT02331602|Dabigatran|dabigatran|mesh-list
19650749|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19650750|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
19650751|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19650752|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
19650753|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650754|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650755|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
19830036|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830037|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
19830038|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830039|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830040|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830041|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830042|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
19830043|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
19650756|NCT02331576|Fentanyl|fentanyl|mesh-list
19650757|NCT02331576|Ropivacaine|ropivacaine|mesh-list
19650758|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
19650759|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
19650760|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650761|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650762|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
19650763|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650764|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19650765|NCT02331576|Narcotics|narcotics|mesh-ancestor
19830044|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830045|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830046|NCT00578552|Gabapentin|gabapentin|mesh-list
19830047|NCT00578552|Analgesics|analgesics|mesh-ancestor
19830048|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
19830049|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830050|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830051|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
19830052|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19830053|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19830054|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830055|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19830056|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19830057|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19830058|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830059|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830060|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
19830061|NCT00578565|Rituximab|rituximab|mesh-list
19830062|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830063|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830064|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
20337017|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337018|NCT00801580|Doxorubicin|doxorubicin|mesh-list
19650766|NCT02331576|Analgesics|analgesics|mesh-ancestor
19830065|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650767|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19650768|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19830066|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830067|NCT00578617|Amiodarone|amiodarone|mesh-list
19830068|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830069|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19830070|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
19830071|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19830072|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167075|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20167076|NCT00141557|Hormones|hormones|mesh-ancestor
20167077|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20167078|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167079|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20167080|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167081|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
20167082|NCT00141557|Androgens|androgens|mesh-ancestor
19830073|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19830074|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19830075|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19830076|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830077|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19830078|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19830079|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19830080|NCT00578643|Cyclosporine|cyclosporine|mesh-list
19830081|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
19830082|NCT00578643|Busulfan|busulfan|mesh-list
19830083|NCT00578643|Fludarabine|fludarabine|mesh-list
19830084|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
19830085|NCT00578643|Cyclosporins|cyclosporins|mesh-list
19830086|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830087|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
19830088|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830089|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830090|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830091|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
19830092|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830093|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830094|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830095|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830096|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
19830097|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830098|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
19830099|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19830100|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830101|NCT00578669|Fluoxetine|fluoxetine|mesh-list
19830102|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19830103|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19830104|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19830105|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830106|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830107|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
19830108|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337019|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20337020|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20337021|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337022|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20337023|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20337024|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337025|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830109|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19830110|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
19830111|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19830112|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19830113|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20167083|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
20167084|NCT00141570|Estrogens|estrogens|mesh-list
20167085|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
20167086|NCT00141570|Testosterone|testosterone|mesh-list
20167087|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
20167088|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
20167089|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19830114|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830115|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20167090|NCT00141570|Hormones|hormones|mesh-ancestor
20337026|NCT00801606|Zinc|zinc|mesh-list
20337027|NCT00801606|Trace Elements|trace elements|mesh-list
20337028|NCT00801606|Micronutrients|micronutrients|mesh-list
20337029|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337030|NCT00801697|Vaccines|vaccines|mesh-list
20337031|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
19830116|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
19830117|NCT00578786|Ambrisentan|ambrisentan|mesh-list
19830118|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19830119|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
19830120|NCT00578864|Doxorubicin|doxorubicin|mesh-list
20337032|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337033|NCT00801736|Paclitaxel|paclitaxel|mesh-list
20337034|NCT00801736|Cisplatin|cisplatin|mesh-list
20337035|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20337036|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830121|NCT00578864|Etoposide|etoposide|mesh-list
19830122|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
19830123|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830124|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
19830125|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830126|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830127|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830128|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
19830129|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830130|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830131|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830132|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20337037|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
20337038|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
20337039|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
20337040|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337041|NCT00801788|Oxycodone|oxycodone|mesh-list
20337042|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20337043|NCT00801788|Narcotics|narcotics|mesh-ancestor
19830133|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19830134|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19830135|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830136|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830137|NCT00578877|Nonoxynol|nonoxynol|mesh-list
19830138|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19830139|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19830140|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830141|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19830142|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
19830143|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19830144|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19830145|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
19830146|NCT00578903|Methotrexate|methotrexate|mesh-list
19830147|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
19830148|NCT00578903|Tacrolimus|tacrolimus|mesh-list
19830149|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830150|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
19830151|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830152|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830153|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830154|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
19830155|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830156|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830157|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830158|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19830159|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
19830160|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19830161|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830162|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
19830163|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
19830164|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830165|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19830166|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19830167|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19830168|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830169|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19830170|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337044|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337045|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337046|NCT00801788|Analgesics|analgesics|mesh-ancestor
20337047|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
19830171|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830172|NCT00578929|Analgesics|analgesics|mesh-ancestor
19830173|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
19830174|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337048|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337049|NCT00801853|Interleukin-4|interleukin-4|mesh-list
20337050|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20337051|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
20337052|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337053|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337054|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337055|NCT00801866|Bevacizumab|bevacizumab|mesh-list
20337056|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337057|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611871|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611872|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19650769|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
19830175|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830176|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830177|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830178|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19830179|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19830180|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19830181|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
19830182|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
19830183|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830184|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830185|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
19830186|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830187|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830188|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
19830189|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19830190|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
19830191|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830192|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830193|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19830194|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
19830195|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
19830196|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19830197|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
19830198|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830199|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830200|NCT00579098|Atorvastatin|atorvastatin|mesh-list
19830201|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19830202|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19830203|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
19830204|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830205|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19830206|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19830207|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830208|NCT00579111|Fludarabine|fludarabine|mesh-list
19830209|NCT00579111|Busulfan|busulfan|mesh-list
19830210|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
19830211|NCT00579111|Tacrolimus|tacrolimus|mesh-list
19830212|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830213|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830214|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830215|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
19830216|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830217|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19830218|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830219|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
19830220|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830221|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830222|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830223|NCT00579137|Fludarabine|fludarabine|mesh-list
19650770|NCT02331511|Aspirin|aspirin|mesh-list
19650771|NCT02331511|Clopidogrel|clopidogrel|mesh-list
19650772|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19650773|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19650774|NCT02331511|Analgesics|analgesics|mesh-ancestor
19650775|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
19650776|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650777|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830224|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
19830225|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830226|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830227|NCT00579280|Valproic Acid|valproic acid|mesh-list
19830228|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19830229|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
19830230|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19830231|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19830232|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19830233|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830234|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830235|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
19830236|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167091|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20167092|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167093|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20167094|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167095|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
20167096|NCT00141570|Androgens|androgens|mesh-ancestor
20167097|NCT00141583|Candesartan|candesartan|mesh-list
20167098|NCT00141583|Enalapril|enalapril|mesh-list
20167099|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20167100|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20167101|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20167102|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337058|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337059|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337060|NCT00801866|Growth Substances|growth substances|mesh-ancestor
20337061|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337062|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337063|NCT00801879|Mupirocin|mupirocin|mesh-list
20337064|NCT00801879|Calcium|calcium|mesh-list
20337065|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20337066|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337067|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20337068|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830237|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830238|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
19830239|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830240|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
19830241|NCT00579345|Vaccines|vaccines|mesh-list
19830242|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
19830243|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337069|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20337070|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337071|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337072|NCT00801905|Nepafenac|nepafenac|mesh-list
20337073|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337074|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337075|NCT00801905|Analgesics|analgesics|mesh-ancestor
19830244|NCT00579501|Dexamethasone|dexamethasone|mesh-list
19830245|NCT00579501|Trabectedin|trabectedin|mesh-list
19830246|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830247|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
19830248|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
19830249|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830250|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830251|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830252|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
19830253|NCT00579501|Hormones|hormones|mesh-ancestor
19830254|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19830255|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19830256|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830257|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830258|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
19830259|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830260|NCT00579553|Progesterone|progesterone|mesh-list
19830261|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20337076|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
20337077|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337078|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337079|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337080|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337081|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
19830262|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19830263|NCT00579553|Progestins|progestins|mesh-ancestor
19830264|NCT00579553|Hormones|hormones|mesh-ancestor
19830265|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19830266|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830267|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20167103|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20167104|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
20167105|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830268|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
19830269|NCT00579670|Ziprasidone|ziprasidone|mesh-list
20337082|NCT00801918|Ifosfamide|ifosfamide|mesh-list
20337083|NCT00801918|Etoposide|etoposide|mesh-list
20337084|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
20337085|NCT00801918|Interleukin-2|interleukin-2|mesh-list
20337086|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337087|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
20337088|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337089|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830270|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19830271|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
19830272|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830273|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830274|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830275|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19830276|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19830277|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830278|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19830279|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19830280|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
19830281|NCT00579813|Pioglitazone|pioglitazone|mesh-list
19830282|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19830283|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830284|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
19830285|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
20337090|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20337091|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
19650778|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650779|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650780|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19650781|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19650782|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650783|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19650784|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19650785|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650786|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
19650787|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19650788|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19650789|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19650790|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
19650791|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167106|NCT00141596|Amiloride|amiloride|mesh-list
20167107|NCT00141596|Furosemide|furosemide|mesh-list
20167108|NCT00141596|Diuretics|diuretics|mesh-ancestor
20167109|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
20167110|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167111|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20167112|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167113|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167114|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20167115|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20167116|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20167117|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19650792|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
19650793|NCT02331563|Bupivacaine|bupivacaine|mesh-list
19830286|NCT00579878|Methotrexate|methotrexate|mesh-list
19830287|NCT00579878|Leflunomide|leflunomide|mesh-list
20348162|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19830288|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19830289|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
19830290|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19830291|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830292|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830293|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
19830294|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830295|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830296|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
19830297|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830298|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19830299|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830300|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
20337092|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337093|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337094|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20337095|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20337096|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20337097|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20337098|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337099|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337100|NCT00801918|Analgesics|analgesics|mesh-ancestor
19830301|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830302|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19830303|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
19830304|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19830305|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19830306|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830307|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337101|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
20337102|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337103|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
20337104|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20337105|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20337106|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
20337107|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337108|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337109|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337110|NCT00801944|Urological Agents|urological agents|mesh-ancestor
20337111|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
19830308|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830309|NCT00579878|Analgesics|analgesics|mesh-ancestor
19830310|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
19830311|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830312|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830313|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830314|NCT00579982|Lamotrigine|lamotrigine|mesh-list
19830315|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
19830316|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19830317|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19830318|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830319|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19830320|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830321|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19830322|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19830323|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830324|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19830325|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19830326|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
19830327|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830328|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830329|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
19830330|NCT00580047|Vitamin D|vitamin d|mesh-list
19830331|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
19830332|NCT00580047|Alendronate|alendronate|mesh-list
19830333|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
19830334|NCT00580047|Calcium|calcium|mesh-list
19830335|NCT00580047|Vitamins|vitamins|mesh-ancestor
19830336|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
19830337|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830338|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19830339|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19830340|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830341|NCT00580047|Antacids|antacids|mesh-ancestor
19830342|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830343|NCT00580073|Leucovorin|leucovorin|mesh-list
19830344|NCT00580073|Fluorouracil|fluorouracil|mesh-list
20337112|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20337113|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20337114|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20337115|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
20337116|NCT00801957|Tacrolimus|tacrolimus|mesh-list
20337117|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337118|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
20337119|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337120|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19830345|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
19830346|NCT00580073|Cetuximab|cetuximab|mesh-list
19830347|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
19830348|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830349|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830350|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337121|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611873|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650794|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
19650795|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
19830351|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830352|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
19830353|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830354|NCT00580073|Antidotes|antidotes|mesh-ancestor
19830355|NCT00580073|Protective Agents|protective agents|mesh-ancestor
19830356|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
19830357|NCT00580073|Vitamins|vitamins|mesh-ancestor
19830358|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
19830359|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830360|NCT00580151|Clonidine|clonidine|mesh-list
19830361|NCT00580151|Analgesics|analgesics|mesh-ancestor
19830362|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
19830363|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830364|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830365|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19830366|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
19830367|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
19830368|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19830369|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19830370|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20167118|NCT00141648|Prednisolone|prednisolone|mesh-list
19650796|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650797|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650798|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
19650799|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650800|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19650801|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19650802|NCT02331563|Analgesics|analgesics|mesh-ancestor
19650803|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19650804|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19650805|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19650806|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
19650807|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650808|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650809|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19650810|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650811|NCT02330952|Prednisone|prednisone|mesh-list
19830371|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
20167119|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
20167120|NCT00141648|Doxorubicin|doxorubicin|mesh-list
20167121|NCT00141648|Vincristine|vincristine|mesh-list
20167122|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167123|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
20167124|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167125|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167126|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20167127|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
20167128|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167129|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650812|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830372|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167130|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20167131|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20348163|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830373|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830374|NCT00580229|Prednisone|prednisone|mesh-list
19830375|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830376|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
19830377|NCT00580229|Hormones|hormones|mesh-ancestor
19830378|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19830379|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830380|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19830381|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830382|NCT00580294|Oxymorphone|oxymorphone|mesh-list
19830383|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19830384|NCT00580294|Narcotics|narcotics|mesh-ancestor
19830385|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830386|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830387|NCT00580294|Analgesics|analgesics|mesh-ancestor
19830388|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
19830389|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830390|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19830391|NCT00580333|Paclitaxel|paclitaxel|mesh-list
19830392|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
19830393|NCT00580333|Bevacizumab|bevacizumab|mesh-list
19830394|NCT00580333|Doxorubicin|doxorubicin|mesh-list
20337122|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337123|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337124|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
20337125|NCT00802009|Dexamethasone|dexamethasone|mesh-list
20337126|NCT00802009|Mepivacaine|mepivacaine|mesh-list
20337127|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337128|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
20337129|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
20337130|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337131|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337132|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337133|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
20337134|NCT00802009|Hormones|hormones|mesh-ancestor
20337135|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337136|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20337137|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337138|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
20337139|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
19650813|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
19650814|NCT02330952|Hormones|hormones|mesh-ancestor
19650815|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650816|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650817|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650818|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650819|NCT02330991|Temozolomide|temozolomide|mesh-list
19650820|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19650821|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
19650822|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650823|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650824|NCT02331173|Dorzolamide|dorzolamide|mesh-list
19650825|NCT02331173|Brinzolamide|brinzolamide|mesh-list
19650826|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19650827|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650828|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650829|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19650830|NCT02331030|Ropivacaine|ropivacaine|mesh-list
19650831|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
19650832|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
19650833|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19650834|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650835|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
19650836|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650837|NCT02331251|Gemcitabine|gemcitabine|mesh-list
19650838|NCT02331251|Paclitaxel|paclitaxel|mesh-list
19650839|NCT02331251|Vinorelbine|vinorelbine|mesh-list
19650840|NCT02331251|Docetaxel|docetaxel|mesh-list
19650841|NCT02331251|Doxorubicin|doxorubicin|mesh-list
19830395|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830396|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337140|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830397|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830398|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830399|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
19830400|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830401|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830402|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
19830403|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830404|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830405|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830406|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
19830407|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830408|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830409|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19830410|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19830411|NCT00580333|Growth Substances|growth substances|mesh-ancestor
19830412|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
19830413|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19830414|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20167132|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19650842|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19650843|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
19650844|NCT02331251|Irinotecan|irinotecan|mesh-list
19650845|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19650846|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650847|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19650848|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19650849|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19650850|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167133|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20167134|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167135|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20167136|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
20167137|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
20167138|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
20167139|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20167140|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
20167141|NCT00141648|Hormones|hormones|mesh-ancestor
20167142|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20167143|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20174638|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174639|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174640|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19650851|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20174641|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20174642|NCT00165230|Growth Substances|growth substances|mesh-ancestor
20174643|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
20174644|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174645|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20174646|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
20174647|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174648|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
20174649|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174650|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
20174651|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20174652|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20174653|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174654|NCT00165295|Urological Agents|urological agents|mesh-ancestor
20174655|NCT00165308|Tamoxifen|tamoxifen|mesh-list
20174656|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20174657|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
20174658|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174659|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830415|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19830416|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830417|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
19830418|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830419|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
19830420|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830421|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830422|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830423|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
19830424|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830425|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830426|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830427|NCT00580398|Varenicline|varenicline|mesh-list
19830428|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19830429|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19830430|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
19830431|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830432|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830433|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830434|NCT00580606|Glycerol|glycerol|mesh-list
19830435|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19830436|NCT00580606|Protective Agents|protective agents|mesh-ancestor
19830437|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830438|NCT00580645|Varenicline|varenicline|mesh-list
19830439|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19830440|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19830441|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
19650852|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
19650853|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
19650854|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650855|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650856|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650857|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
19650858|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650859|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19830442|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830443|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167144|NCT00141700|Rituximab|rituximab|mesh-list
20167145|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19650860|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20167146|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167147|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
20167148|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167149|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167150|NCT00141713|Etanercept|etanercept|mesh-list
20174660|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20174661|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174662|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20174663|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20174664|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20174665|NCT00165334|Cetuximab|cetuximab|mesh-list
20174666|NCT00165334|Vinorelbine|vinorelbine|mesh-list
20174667|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20174668|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174669|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20174670|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174671|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174672|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174673|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174674|NCT00165347|Vatalanib|vatalanib|mesh-list
20174675|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20174676|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174677|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174678|NCT00165360|Temozolomide|temozolomide|mesh-list
20174679|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20174680|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
20174681|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174682|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174683|NCT00165373|Endostatins|endostatins|mesh-list
20174684|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174685|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20174686|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20174687|NCT00165373|Growth Substances|growth substances|mesh-ancestor
20337141|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
20337142|NCT00802035|Baclofen|baclofen|mesh-list
20337143|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20337144|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337145|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20337146|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830444|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835334|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835335|NCT00602225|Cytarabine|cytarabine|mesh-list
19835336|NCT00602225|Clofarabine|clofarabine|mesh-list
19835337|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19650861|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19650862|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19650863|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19835338|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
19835339|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835340|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835341|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
19835342|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835343|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835344|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
19835345|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835346|NCT00602290|Methylphenidate|methylphenidate|mesh-list
19835347|NCT00602290|Citalopram|citalopram|mesh-list
19835348|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19835349|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835350|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19835351|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835352|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835353|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835354|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
19835355|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835356|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19835357|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
19835358|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19835359|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835360|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835361|NCT00602355|Sertraline|sertraline|mesh-list
19835362|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835363|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835364|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19835365|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835366|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835367|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337147|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20337148|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
20337149|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
20337150|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337151|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337152|NCT00802048|Ropivacaine|ropivacaine|mesh-list
20337153|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
20337154|NCT00802048|Anesthetics|anesthetics|mesh-list
20337155|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337156|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337157|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
20337158|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337159|NCT00802087|Acetaminophen|acetaminophen|mesh-list
20337160|NCT00802087|Hydrocodone|hydrocodone|mesh-list
20337161|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337162|NCT00802087|Analgesics|analgesics|mesh-ancestor
20337163|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
19665271|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665272|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665273|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665274|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665275|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19665276|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665277|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
19665278|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665279|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20337164|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337165|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337166|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
20337167|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20337168|NCT00802087|Narcotics|narcotics|mesh-ancestor
20337169|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337170|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
20337171|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
20337172|NCT00802139|Iron|iron|mesh-list
20337173|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19830445|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
19830446|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
19830447|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167151|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20167152|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20167153|NCT00141713|Analgesics|analgesics|mesh-ancestor
19830448|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19830449|NCT00580801|Interferons|interferons|mesh-list
19830450|NCT00580801|Ribavirin|ribavirin|mesh-list
19830451|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
19830452|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
19830453|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19830454|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830455|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
19830456|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830457|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
19830458|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830459|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
19830460|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830461|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
19830462|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167154|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
20167155|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167156|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167157|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20167158|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167159|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20167160|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167161|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
20167162|NCT00141791|Etanercept|etanercept|mesh-list
20167163|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20167164|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20167165|NCT00141791|Analgesics|analgesics|mesh-ancestor
20167166|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
20167167|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337174|NCT00802139|Trace Elements|trace elements|mesh-ancestor
20337175|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
19650864|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19650865|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19650866|NCT02330757|Clomiphene|clomiphene|mesh-list
19650867|NCT02330757|Enclomiphene|enclomiphene|mesh-list
19650868|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
19650869|NCT02330757|Estradiol|estradiol|mesh-list
19650870|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19650871|NCT02330757|Estrogens|estrogens|mesh-ancestor
19650872|NCT02330757|Hormones|hormones|mesh-ancestor
19650873|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650874|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650875|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19650876|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
19650877|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19650878|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19650879|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19650880|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
19650881|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19650882|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
19650883|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19650884|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19650885|NCT02330796|Bucillamine|bucillamine|mesh-list
19650886|NCT02330796|Colchicine|colchicine|mesh-list
20337176|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337177|NCT00802139|Hematinics|hematinics|mesh-ancestor
20337178|NCT00802217|Capsaicin|capsaicin|mesh-list
19650887|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
19650888|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830463|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
20337179|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
20337180|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
20337181|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
19650889|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
19650890|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
19650891|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
19650892|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650893|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830464|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830465|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830466|NCT00580853|Bupropion|bupropion|mesh-list
19830467|NCT00580853|Varenicline|varenicline|mesh-list
19830468|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19830469|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
19830470|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19830471|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19830472|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19830473|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19830474|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337182|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337183|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337184|NCT00802230|Terbutaline|terbutaline|mesh-list
20337185|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20337186|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
19830475|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
19830476|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830477|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830478|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19830479|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19830480|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830481|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19830482|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19830483|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
19830484|NCT00580957|Trimethaphan|trimethaphan|mesh-list
19830485|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19830486|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19830487|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19830488|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
19830489|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830490|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830491|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20167168|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167169|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20167170|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167171|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20167172|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167173|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
20337187|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337188|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337189|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20337190|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
20337191|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
20337192|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
19650894|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19650895|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19650896|NCT02330796|Analgesics|analgesics|mesh-ancestor
19650897|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
19650898|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650899|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650900|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650901|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
19650902|NCT02330796|Protective Agents|protective agents|mesh-ancestor
19650903|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19650904|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19650905|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650906|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19650907|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19650908|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
20167174|NCT00141804|Sirolimus|sirolimus|mesh-list
20167175|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20167176|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167177|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19830492|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19830493|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
20337193|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20167178|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167179|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
20167180|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167181|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
20167182|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167183|NCT00141830|Methotrexate|methotrexate|mesh-list
19650909|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19650910|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
19650911|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19650912|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650913|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19650914|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19650915|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830494|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830495|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830496|NCT00580970|Lovastatin|lovastatin|mesh-list
19830497|NCT00580970|L 647318|l 647318|mesh-list
19830498|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
19830499|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19830500|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19830501|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
19830502|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830503|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19830504|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19830505|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830506|NCT00580983|Paclitaxel|paclitaxel|mesh-list
19830507|NCT00580983|Carboplatin|carboplatin|mesh-list
19830508|NCT00580983|Fluorouracil|fluorouracil|mesh-list
19830509|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830510|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830511|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830512|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830513|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
20167184|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20167185|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
20167186|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19830514|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830515|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
19830516|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830517|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650916|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
19650917|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19650918|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19650919|NCT02330640|Clopidogrel|clopidogrel|mesh-list
19650920|NCT02330640|Ticagrelor|ticagrelor|mesh-list
19830518|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
20337194|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19830519|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830520|NCT00581048|Vitamin E|vitamin e|mesh-list
19830521|NCT00581048|Tocopherols|tocopherols|mesh-list
19830522|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
19830523|NCT00581048|Vitamins|vitamins|mesh-ancestor
19830524|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
19830525|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830526|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
19830527|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830528|NCT00581048|Protective Agents|protective agents|mesh-ancestor
19830529|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
19830530|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19830531|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19830532|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
19830533|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830534|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830535|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830536|NCT00581061|Urological Agents|urological agents|mesh-ancestor
19830537|NCT00581100|Etanercept|etanercept|mesh-list
19830538|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19830539|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830540|NCT00581100|Analgesics|analgesics|mesh-ancestor
19830541|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
19830542|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830543|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830544|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830545|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830546|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830547|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830548|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
19830549|NCT00581360|Doxorubicin|doxorubicin|mesh-list
19830550|NCT00581360|Bortezomib|bortezomib|mesh-list
19830551|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19830552|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830553|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19830554|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19830555|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830556|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830557|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
19830558|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19830559|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830560|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19830561|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19830562|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830563|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830564|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830565|NCT00581555|Etanercept|etanercept|mesh-list
19830566|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19830567|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830568|NCT00581555|Analgesics|analgesics|mesh-ancestor
19830569|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
20167187|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167188|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20167189|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
20167190|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167191|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167192|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
20167193|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167194|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20167195|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167196|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
20167197|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650921|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19650922|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19650923|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19650924|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19650925|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
19650926|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650927|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650928|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650929|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
19830570|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337195|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20337196|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20337197|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
20337198|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337199|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337200|NCT00802243|Leflunomide|leflunomide|mesh-list
20337201|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337202|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337203|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337204|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
20337205|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337206|NCT00802282|Psilocybin|psilocybin|mesh-list
20337207|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
20337208|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337209|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20337210|NCT00802308|Morphine|morphine|mesh-list
20337211|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20337212|NCT00802308|Narcotics|narcotics|mesh-ancestor
20337213|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337214|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337215|NCT00802308|Analgesics|analgesics|mesh-ancestor
20337216|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
20337217|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337218|NCT00802321|Dutasteride|dutasteride|mesh-list
20337219|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20337220|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20337221|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337222|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337223|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
20337224|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337225|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337226|NCT00802334|Ritonavir|ritonavir|mesh-list
20337227|NCT00802334|Lopinavir|lopinavir|mesh-list
20337228|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20337229|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20337230|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
20337231|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337232|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337233|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20337234|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20337235|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
20337236|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337237|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19830571|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830572|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830573|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830574|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830575|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830576|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
19830577|NCT00581776|Dexamethasone|dexamethasone|mesh-list
19830578|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
19830579|NCT00581776|Rituximab|rituximab|mesh-list
19830580|NCT00581776|Doxorubicin|doxorubicin|mesh-list
19830581|NCT00581776|Vincristine|vincristine|mesh-list
19830582|NCT00581776|Bortezomib|bortezomib|mesh-list
19830583|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830584|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
19830585|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830586|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830587|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830588|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
19830589|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830590|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830591|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830592|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830593|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830594|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
19830595|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
19830596|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830597|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830598|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
19830599|NCT00581776|Hormones|hormones|mesh-ancestor
19830600|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337238|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19830601|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19830602|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19830603|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19830604|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19830605|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830606|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830607|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830608|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830609|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
19830610|NCT00581828|Vitamin D|vitamin d|mesh-list
19830611|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
19830612|NCT00581828|Vitamins|vitamins|mesh-list
19830613|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
19830614|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830615|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19830616|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19830617|NCT00581867|Insulin|insulin|mesh-list
19830618|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19830619|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
19830620|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19830621|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830622|NCT00581893|Phenytoin|phenytoin|mesh-list
19830623|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
19830624|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19830625|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19830626|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19830627|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830628|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19830629|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19830630|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
19830631|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830632|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
19830633|NCT00581919|Vitamins|vitamins|mesh-ancestor
19830634|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
19830635|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
19830636|NCT00581971|Celecoxib|celecoxib|mesh-list
19830637|NCT00581971|Paclitaxel|paclitaxel|mesh-list
20337239|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
20337240|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20337241|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20337242|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20337243|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
20337244|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337245|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337246|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337247|NCT00802373|Urological Agents|urological agents|mesh-ancestor
20337248|NCT00802451|Mesalamine|mesalamine|mesh-list
20337249|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337250|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337251|NCT00802451|Analgesics|analgesics|mesh-ancestor
20337252|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
20337253|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337254|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337255|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830638|NCT00581971|Carboplatin|carboplatin|mesh-list
19830639|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830640|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830641|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830642|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830643|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
19830644|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830645|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19830646|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830647|NCT00581971|Analgesics|analgesics|mesh-ancestor
19830648|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
19830649|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830650|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830651|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830652|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830653|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19830654|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20337256|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337257|NCT00802568|Fludarabine|fludarabine|mesh-list
20337258|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
19830655|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830656|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
20337259|NCT00802568|Busulfan|busulfan|mesh-list
19830657|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19830658|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
19830659|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830660|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830661|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19830662|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
19830663|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19830664|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
19830665|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830666|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830667|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19830668|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
19830669|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
19830670|NCT00582010|Protective Agents|protective agents|mesh-ancestor
19830671|NCT00582075|Temozolomide|temozolomide|mesh-list
19830672|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830673|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
19830674|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830675|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830676|NCT00582114|Atenolol|atenolol|mesh-list
19830677|NCT00582114|Lisinopril|lisinopril|mesh-list
19830678|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19830679|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
20337260|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20337261|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337262|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20337263|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
20337264|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337265|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337266|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
20337267|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337268|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
20337269|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20337270|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830680|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830681|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830682|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19830683|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19830684|NCT00582114|Protective Agents|protective agents|mesh-ancestor
19830685|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830686|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19830687|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
19830688|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
19830689|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830690|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19830691|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19830692|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19830693|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
19830694|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830695|NCT00582166|Rituximab|rituximab|mesh-list
19830696|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19830697|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830698|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830699|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
19830700|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830701|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830702|NCT00582205|Paclitaxel|paclitaxel|mesh-list
19830703|NCT00582205|Cisplatin|cisplatin|mesh-list
19830704|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830705|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830706|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830707|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830708|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
19830709|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337271|NCT00802581|Anesthetics|anesthetics|mesh-list
20337272|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
20337273|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337274|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337275|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
20337276|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337277|NCT00802594|Pafuramidine|pafuramidine|mesh-list
20611874|NCT02248753|Protective Agents|protective agents|mesh-ancestor
20611875|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
19830710|NCT00582309|Insulin|insulin|mesh-list
19650930|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19650931|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
19650932|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650933|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
19650934|NCT02330822|Protective Agents|protective agents|mesh-ancestor
19650935|NCT02330783|Bevacizumab|bevacizumab|mesh-list
20337278|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20337279|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20337280|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20337281|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337282|NCT00802646|Epinephrine|epinephrine|mesh-list
20611876|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20611877|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20611878|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19650936|NCT02330783|Sorafenib|sorafenib|mesh-list
19830711|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19830712|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19830713|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830714|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
19830715|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830716|NCT00582426|Octreotide|octreotide|mesh-list
19830717|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830718|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20167198|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167199|NCT00141843|Factor VIII|factor viii|mesh-list
20167200|NCT00141843|Coagulants|coagulants|mesh-ancestor
20167201|NCT00141882|Memantine|memantine|mesh-list
20167202|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20167203|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20167204|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
20167205|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167206|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167207|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167208|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20167209|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20167210|NCT00141895|Misoprostol|misoprostol|mesh-list
20167211|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20167212|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
20167213|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20167214|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167215|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20167216|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20167217|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
20167218|NCT00141908|Castor Oil|castor oil|mesh-list
20167219|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20167220|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20167221|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20167222|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
20337283|NCT00802646|Fentanyl|fentanyl|mesh-list
19650937|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830719|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830720|NCT00582491|Modafinil|modafinil|mesh-list
19830721|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19830722|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830723|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19830724|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19830725|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19830726|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830727|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
19830728|NCT00582556|Leuprolide|leuprolide|mesh-list
19830729|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19830730|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830731|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19650938|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650939|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19650940|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19650941|NCT02330783|Growth Substances|growth substances|mesh-ancestor
19650942|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167223|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337284|NCT00802646|Bupivacaine|bupivacaine|mesh-list
20337285|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
20611879|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20611880|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20611881|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19830732|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
19830733|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19830734|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19830735|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830736|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
19830737|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19830738|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830739|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830740|NCT00582660|Celecoxib|celecoxib|mesh-list
19830741|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19830742|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830743|NCT00582660|Analgesics|analgesics|mesh-ancestor
19830744|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
19830745|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830746|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830747|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830748|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830749|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19830750|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19830751|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830752|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830753|NCT00582738|Everolimus|everolimus|mesh-list
19830754|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830755|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830756|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
19256692|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19256693|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256694|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256695|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
19256696|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256697|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256698|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19256699|NCT04226248|Protective Agents|protective agents|mesh-ancestor
19256700|NCT04191928|Apixaban|apixaban|mesh-list
19830757|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830758|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
19830759|NCT00582790|Interleukin-2|interleukin-2|mesh-list
19830760|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830761|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830762|NCT00582790|Analgesics|analgesics|mesh-ancestor
19830763|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
19830764|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830765|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830766|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19256701|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19256702|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
19256703|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19256704|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
19256705|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256706|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830767|NCT00582894|Fludarabine|fludarabine|mesh-list
19830768|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
19830769|NCT00582894|Busulfan|busulfan|mesh-list
19830770|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830771|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830772|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830773|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
19830774|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167224|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167225|NCT00141908|Progestins|progestins|mesh-ancestor
20167226|NCT00141908|Hormones|hormones|mesh-ancestor
20167227|NCT00141908|Cathartics|cathartics|mesh-ancestor
20167228|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20167229|NCT00141947|Bexarotene|bexarotene|mesh-list
20167230|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167231|NCT00141960|Famotidine|famotidine|mesh-list
20167232|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19256707|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
19256708|NCT04170348|Vitamin D|vitamin d|mesh-list
19256709|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
19256710|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
20167233|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20167234|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19830775|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830776|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
20337286|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
20337287|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337288|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337289|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
20337290|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337291|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20337292|NCT00802646|Narcotics|narcotics|mesh-ancestor
20337293|NCT00802646|Analgesics|analgesics|mesh-ancestor
20337294|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20337295|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20337296|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
20337297|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20337298|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20337299|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
20337300|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337301|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337302|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20337303|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20337304|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
20337305|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20337306|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
20337307|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
20337308|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
20337309|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20337310|NCT00802802|Efavirenz|efavirenz|mesh-list
20337311|NCT00802802|Rifampin|rifampin|mesh-list
20337312|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20337313|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20337314|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337315|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337316|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
20337317|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337318|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20337319|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20337320|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20337321|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19830777|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830778|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830779|NCT00582907|Rilonacept|rilonacept|mesh-list
19830780|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337322|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20337323|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20337324|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20337325|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
20337326|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20337327|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
20337328|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20337329|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20337330|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20337331|NCT00802815|Etanercept|etanercept|mesh-list
19650943|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
19830781|NCT00582933|Vidarabine|vidarabine|mesh-list
19830782|NCT00582933|Fludarabine|fludarabine|mesh-list
19830783|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
19830784|NCT00582933|Melphalan|melphalan|mesh-list
19830785|NCT00582933|Busulfan|busulfan|mesh-list
19830786|NCT00582933|Lenograstim|lenograstim|mesh-list
19830787|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830788|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19650944|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19650945|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650946|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650947|NCT02330367|Abivertinib|abivertinib|mesh-list
19650948|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19650949|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650950|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650951|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19830789|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
19830790|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830791|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830792|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
19830793|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830794|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
19830795|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830796|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830797|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
19830798|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830799|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19830800|NCT00582972|Omeprazole|omeprazole|mesh-list
19830801|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19830802|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19830803|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20167235|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
20167236|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
20167237|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167238|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167239|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167240|NCT00141986|Vitamin D|vitamin d|mesh-list
19830804|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830805|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830806|NCT00583011|Anesthetics|anesthetics|mesh-list
19830807|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830808|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830809|NCT00583102|Cytarabine|cytarabine|mesh-list
19830810|NCT00583102|Lovastatin|lovastatin|mesh-list
19830811|NCT00583102|L 647318|l 647318|mesh-list
19830812|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
19830813|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830814|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
19830815|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830816|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830817|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
19830818|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830819|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830820|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
19830821|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830822|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19830823|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19830824|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19830825|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19830826|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830827|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19830828|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20337332|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337333|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337334|NCT00802815|Analgesics|analgesics|mesh-ancestor
20337335|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
20337336|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830829|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19830830|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19830831|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19830832|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830833|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
19830834|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830835|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830836|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20167241|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
20167242|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
20167243|NCT00141986|Vitamins|vitamins|mesh-list
20167244|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
20348164|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
19830837|NCT00583219|Protective Agents|protective agents|mesh-ancestor
20167245|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830838|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19830839|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
19830840|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19830841|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830842|NCT00583362|Belimumab|belimumab|mesh-list
19830843|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830844|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
19830845|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830846|NCT00583453|Celecoxib|celecoxib|mesh-list
19830847|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19830848|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830849|NCT00583453|Analgesics|analgesics|mesh-ancestor
19830850|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
19830851|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830852|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830853|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830854|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830855|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19830856|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19830857|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830858|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830859|NCT00583557|Belimumab|belimumab|mesh-list
19830860|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830861|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
19830862|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830863|NCT00583622|Gemcitabine|gemcitabine|mesh-list
19830864|NCT00583622|Bevacizumab|bevacizumab|mesh-list
19830865|NCT00583622|Carboplatin|carboplatin|mesh-list
19830866|NCT00583622|Docetaxel|docetaxel|mesh-list
19830867|NCT00583622|Melphalan|melphalan|mesh-list
20167246|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20167247|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167248|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
20167249|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
20167250|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19650952|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19650953|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19650954|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650955|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650956|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19650957|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650958|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
19830868|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19830869|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830870|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19830871|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19830872|NCT00583622|Growth Substances|growth substances|mesh-ancestor
19830873|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830874|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
19830875|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19830876|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
19830877|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830878|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
19650959|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167251|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19650960|NCT02330380|Adalimumab|adalimumab|mesh-list
19650961|NCT02330380|Etanercept|etanercept|mesh-list
19650962|NCT02330380|Methotrexate|methotrexate|mesh-list
19650963|NCT02330380|Ustekinumab|ustekinumab|mesh-list
19650964|NCT02330380|Acitretin|acitretin|mesh-list
19650965|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19650966|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
19650967|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19830879|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19830880|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650968|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650969|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19650970|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
19650971|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650972|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19650973|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
19650974|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650975|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19650976|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19650977|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
19650978|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19650979|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19650980|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19650981|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19830881|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19830882|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
19830883|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830884|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830885|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
19830886|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19830887|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
19830888|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19830889|NCT00583700|Vitamin E|vitamin e|mesh-list
19830890|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
19830891|NCT00583700|Vitamins|vitamins|mesh-ancestor
19830892|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
19830893|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830894|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
19830895|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830896|NCT00583700|Protective Agents|protective agents|mesh-ancestor
19830897|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19830898|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830899|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19830900|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19830901|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
19830902|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19830903|NCT00583947|Albuterol|albuterol|mesh-list
19830904|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
19830905|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19830906|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
19830907|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830908|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830909|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19830910|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
19830911|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
19830912|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19830913|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19830914|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19830915|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19830916|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
19830917|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830918|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830919|NCT00584701|Risperidone|risperidone|mesh-list
19830920|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19830921|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
19830922|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167252|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19650982|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20611882|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20611883|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19256711|NCT04170348|Vitamins|vitamins|mesh-list
20611884|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20611885|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20611886|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20611887|NCT02248792|Methotrexate|methotrexate|mesh-list
20611888|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20611889|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
20611890|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20611891|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611892|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20611893|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
20612248|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20167253|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167254|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20167255|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20167256|NCT00142038|Docetaxel|docetaxel|mesh-list
20167257|NCT00142038|Capecitabine|capecitabine|mesh-list
20167258|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167259|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
20167260|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
20167261|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
20167262|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167263|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20167264|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
20167265|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
19650983|NCT02330380|Analgesics|analgesics|mesh-ancestor
19650984|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
19650985|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19650986|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19650987|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
19650988|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19650989|NCT02330406|Anagliptin|anagliptin|mesh-list
19650990|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19650991|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19650992|NCT02330406|Incretins|incretins|mesh-ancestor
19650993|NCT02330406|Hormones|hormones|mesh-ancestor
19650994|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19650995|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19650996|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
19650997|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19650998|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19650999|NCT02330302|Ropivacaine|ropivacaine|mesh-list
19651000|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
19651001|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
19651002|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651003|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651004|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
19651005|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651006|NCT02330419|Naltrexone|naltrexone|mesh-list
19651007|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19651008|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19651009|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651010|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
19651011|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651012|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
19651013|NCT02330120|Propofol|propofol|mesh-list
19651014|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19651015|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651016|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651017|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19651018|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
19651019|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
19651020|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651021|NCT02330120|Analgesics|analgesics|mesh-ancestor
19651022|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
19651023|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651024|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19651025|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19651026|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19651027|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
19651028|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651029|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651030|NCT02330029|Pinaverium|pinaverium|mesh-list
19651031|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19830923|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830924|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830925|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19830926|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19830927|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19830928|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19830929|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19830930|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
19830931|NCT00584857|Paclitaxel|paclitaxel|mesh-list
19830932|NCT00584857|Carboplatin|carboplatin|mesh-list
19830933|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830934|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830935|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830936|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830937|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19830938|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830939|NCT00584870|Naproxen|naproxen|mesh-list
19830940|NCT00584870|Tanezumab|tanezumab|mesh-list
19830941|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19830942|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19830943|NCT00584870|Analgesics|analgesics|mesh-ancestor
19830944|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
19830945|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830946|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830947|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830948|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19830949|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
19830950|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19830951|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19830952|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830953|NCT00584909|Paclitaxel|paclitaxel|mesh-list
19830954|NCT00584909|Carboplatin|carboplatin|mesh-list
19830955|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19830956|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19830957|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19830958|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
19830959|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
19830960|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830961|NCT00584948|Memantine|memantine|mesh-list
19830962|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19830963|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19830964|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
19830965|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830966|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830967|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830968|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19830969|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19830970|NCT00584987|Fluticasone|fluticasone|mesh-list
19830971|NCT00584987|Xhance|xhance|mesh-list
19830972|NCT00584987|Phenylephrine|phenylephrine|mesh-list
19830973|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
19830974|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19830975|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19830976|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
19830977|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830978|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830979|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19830980|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
19830981|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
19830982|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19651032|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167266|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20167267|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
20167268|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167269|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19830983|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19830984|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19830985|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
19830986|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19830987|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19830988|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
19830989|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
19830990|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19830991|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19830992|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
19830993|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19830994|NCT00584987|Protective Agents|protective agents|mesh-ancestor
19830995|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
19830996|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19830997|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
19830998|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19830999|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831000|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19831001|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
19831002|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19831003|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
19831004|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831005|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831006|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19831007|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
19831008|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
19831009|NCT00585013|Protective Agents|protective agents|mesh-ancestor
20167270|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20167271|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
20167272|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20167273|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
20167274|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167275|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612249|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19651033|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651034|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19651035|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651036|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
19651037|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
19651038|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651039|NCT02330068|Citalopram|citalopram|mesh-list
19651040|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19651041|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19651042|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651043|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651044|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651045|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
19651046|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651047|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19651048|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
19651049|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19651050|NCT02329860|Apatinib|apatinib|mesh-list
19651051|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651052|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19651053|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831010|NCT00585039|Albuterol|albuterol|mesh-list
19831011|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19831012|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
19831013|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831014|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831015|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19831016|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
19831017|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
19831018|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19831019|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20337337|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651054|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651055|NCT02329795|Temozolomide|temozolomide|mesh-list
19651056|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19651057|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
19651058|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651059|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651060|NCT02329561|Tramadol|tramadol|mesh-list
19651061|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19651062|NCT02329561|Narcotics|narcotics|mesh-ancestor
19831020|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19831021|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19651063|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651064|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651065|NCT02329561|Analgesics|analgesics|mesh-ancestor
19651066|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
19651067|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651068|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19651069|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19651070|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651071|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
19651072|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19831022|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
19831023|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337338|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337339|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20612250|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
20612251|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651073|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20612252|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612253|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20612254|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
20612255|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
20612256|NCT02250833|Amlodipine|amlodipine|mesh-list
20612257|NCT02250833|Telmisartan|telmisartan|mesh-list
20612258|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20612259|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20612260|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20612261|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612262|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19831024|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831025|NCT00585052|Paclitaxel|paclitaxel|mesh-list
19831026|NCT00585052|Lovastatin|lovastatin|mesh-list
19831027|NCT00585052|L 647318|l 647318|mesh-list
19831028|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
19831029|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19831030|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831031|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
19831032|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
19831033|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
19831034|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831035|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19831036|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19831037|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
19831038|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19831039|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19831040|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831041|NCT00585078|Capecitabine|capecitabine|mesh-list
19831042|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
19831043|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831044|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
19831045|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831046|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831047|NCT00585104|Simendan|simendan|mesh-list
19831048|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19831049|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
19831050|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19831051|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19831052|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831053|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831054|NCT00585104|Protective Agents|protective agents|mesh-ancestor
19831055|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831056|NCT00585169|Memantine|memantine|mesh-list
19831057|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19831058|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19831059|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
19831060|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831061|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831062|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831063|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19831064|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19831065|NCT00585182|Enoxaparin|enoxaparin|mesh-list
19831066|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
19831067|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19831068|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19831069|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835368|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835369|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
19835370|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835371|NCT00602420|Naproxen|naproxen|mesh-list
19835372|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19835373|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19835374|NCT00602420|Analgesics|analgesics|mesh-ancestor
19835375|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
19835376|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835377|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835378|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835379|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835380|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
19835381|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19835382|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835383|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835384|NCT00602446|Deferasirox|deferasirox|mesh-list
19835385|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19835386|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
19835387|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
19835388|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835389|NCT00602472|Linagliptin|linagliptin|mesh-list
19835390|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19835391|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835392|NCT00602472|Incretins|incretins|mesh-ancestor
19835393|NCT00602472|Hormones|hormones|mesh-ancestor
19835394|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835395|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19831070|NCT00585247|Imiquimod|imiquimod|mesh-list
19831071|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19831072|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
19831073|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831074|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831075|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
20337340|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337341|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337342|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
20337343|NCT00802828|Famotidine|famotidine|mesh-list
20337344|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20337345|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337346|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20337347|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
20337348|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
20337349|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337350|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337351|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337352|NCT00802906|Bevacizumab|bevacizumab|mesh-list
20337353|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337354|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337355|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337356|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337357|NCT00802906|Growth Substances|growth substances|mesh-ancestor
20337358|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337359|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337360|NCT00802958|Clobetasol|clobetasol|mesh-list
20337361|NCT00802958|Halobetasol|halobetasol|mesh-list
20337362|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20337363|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337364|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
20337365|NCT00802958|Hormones|hormones|mesh-ancestor
20337366|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337367|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337368|NCT00803166|Clobetasol|clobetasol|mesh-list
20337369|NCT00803166|Halobetasol|halobetasol|mesh-list
20337370|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20337371|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337372|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
20337373|NCT00803166|Hormones|hormones|mesh-ancestor
20337374|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337375|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348165|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348166|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348167|NCT00863863|Griseofulvin|griseofulvin|mesh-list
20348168|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
20348169|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348170|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20348171|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
20348172|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20348173|NCT00863889|Prednisolone|prednisolone|mesh-list
20348174|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
20348175|NCT00863889|Lidocaine|lidocaine|mesh-list
19651074|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651075|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
19651076|NCT02329756|Coagulants|coagulants|mesh-ancestor
19651077|NCT02329535|Progesterone|progesterone|mesh-list
19651078|NCT02329535|Progestins|progestins|mesh-ancestor
19651079|NCT02329535|Hormones|hormones|mesh-ancestor
19651080|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651081|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651082|NCT02329405|Rifampin|rifampin|mesh-list
19831076|NCT00585312|Celecoxib|celecoxib|mesh-list
19831077|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20348176|NCT00863889|Bupivacaine|bupivacaine|mesh-list
19651083|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19831078|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20348177|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20348178|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
20337376|NCT00803192|Famotidine|famotidine|mesh-list
20337377|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20337378|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337379|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20337380|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
20337381|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
20337382|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337383|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337384|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337385|NCT00803218|Fluticasone|fluticasone|mesh-list
20337386|NCT00803218|Xhance|xhance|mesh-list
20337387|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337388|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20337389|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
20337390|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337391|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337392|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20337393|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
20337394|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
20337395|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20337396|NCT00803309|Interferons|interferons|mesh-list
20337397|NCT00803309|Ribavirin|ribavirin|mesh-list
20337398|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
19651084|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
19651085|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651086|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651087|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
19651088|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651089|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651090|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651091|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19651092|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19651093|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19651094|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19651095|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19651096|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19651097|NCT02329288|Triamcinolone|triamcinolone|mesh-list
19651098|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19651099|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19831079|NCT00585312|Analgesics|analgesics|mesh-ancestor
20337399|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
20337400|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20337401|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337402|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
20337403|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337404|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
20337405|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337406|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
20337407|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337408|NCT00803335|Estrogens|estrogens|mesh-list
20337409|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20337410|NCT00803335|Hormones|hormones|mesh-ancestor
20337411|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337412|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337413|NCT00803374|Ipilimumab|ipilimumab|mesh-list
20337414|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20337415|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337416|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651100|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20337417|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20348179|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
20337418|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337419|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
20337420|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337421|NCT00803387|Travoprost|travoprost|mesh-list
20337422|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20337423|NCT00803439|Clobetasol|clobetasol|mesh-list
20167276|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20167277|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
20167278|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
20167279|NCT00142051|Protective Agents|protective agents|mesh-ancestor
20167280|NCT00142129|Bortezomib|bortezomib|mesh-list
19831080|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
19831081|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831082|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831083|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831084|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831085|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19831086|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19831087|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831088|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831089|NCT00585325|Lidocaine|lidocaine|mesh-list
19831090|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
19831091|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
19831092|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19831093|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831094|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
19831095|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831096|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19831097|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19831098|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19831099|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167281|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337424|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337425|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
20337426|NCT00803439|Hormones|hormones|mesh-ancestor
20337427|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831100|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831101|NCT00585351|Ranitidine|ranitidine|mesh-list
19831102|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19831103|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19831104|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20167282|NCT00142155|Rituximab|rituximab|mesh-list
20167283|NCT00142155|Antibodies|antibodies|mesh-list
20167284|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20167285|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
20167286|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167287|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167288|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167289|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337428|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337429|NCT00803465|Fluticasone|fluticasone|mesh-list
20167290|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
20167291|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167292|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167293|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
20337430|NCT00803465|Xhance|xhance|mesh-list
19831105|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19831106|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
19831107|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
19831108|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831109|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831110|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831111|NCT00585377|Bevacizumab|bevacizumab|mesh-list
19831112|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19831113|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831114|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831115|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19831116|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19831117|NCT00585377|Growth Substances|growth substances|mesh-ancestor
19831118|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831119|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
19831120|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19831121|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831122|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831123|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
19831124|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19831125|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831126|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19831127|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
19831128|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19831129|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831130|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831131|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831132|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19831133|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337431|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337432|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20337433|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
20337434|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337435|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337436|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20337437|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
20337438|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
20337439|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20337440|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
20337441|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
20337442|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337443|NCT00803530|Protective Agents|protective agents|mesh-ancestor
20337444|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337445|NCT00803530|Vitamins|vitamins|mesh-ancestor
20337446|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
20337447|NCT00803556|Paclitaxel|paclitaxel|mesh-list
20337448|NCT00803556|Trastuzumab|trastuzumab|mesh-list
20337449|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20337450|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337451|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19831134|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19831135|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831136|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831137|NCT00585546|Clenbuterol|clenbuterol|mesh-list
19831138|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19831139|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19831140|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
19831141|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831142|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831143|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831144|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19831145|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
19831146|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831147|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19831148|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
19831149|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
19831150|NCT00585637|Vitamin D|vitamin d|mesh-list
19831151|NCT00585637|Vitamins|vitamins|mesh-ancestor
19831152|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
19831153|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831154|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19831155|NCT00585650|Etanercept|etanercept|mesh-list
19831156|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19831157|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19831158|NCT00585650|Analgesics|analgesics|mesh-ancestor
19831159|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
19831160|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831161|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831162|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831163|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831164|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19831165|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831166|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
19831167|NCT00585689|Gemcitabine|gemcitabine|mesh-list
19831168|NCT00585689|Carboplatin|carboplatin|mesh-list
19831169|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19831170|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831171|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831172|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
19831173|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831174|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
19831175|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831176|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831177|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831178|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
19831179|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831180|NCT00585780|Prazosin|prazosin|mesh-list
19831181|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19831182|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19831183|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19831184|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19831185|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
19831186|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831187|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831188|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831189|NCT00585910|Methylphenidate|methylphenidate|mesh-list
19831190|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19831191|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19831192|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831193|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19831194|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19831195|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19831196|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831197|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
19831198|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337452|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20337453|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19831199|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19831200|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
19831201|NCT00585975|Bromfenac|bromfenac|mesh-list
19831202|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20337454|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337455|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337456|NCT00803699|Selenium|selenium|mesh-list
20337457|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
20337458|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337459|NCT00803699|Protective Agents|protective agents|mesh-ancestor
20337460|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337461|NCT00803699|Trace Elements|trace elements|mesh-ancestor
20337462|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
20337463|NCT00803725|Fentanyl|fentanyl|mesh-list
20337464|NCT00803725|Mepivacaine|mepivacaine|mesh-list
20337465|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20337466|NCT00803725|Narcotics|narcotics|mesh-ancestor
20337467|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337468|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337469|NCT00803725|Analgesics|analgesics|mesh-ancestor
19256712|NCT04170348|Trientine|trientine|mesh-list
19256713|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
19256714|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256715|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19256716|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19651101|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651102|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
19651103|NCT02329288|Hormones|hormones|mesh-ancestor
19651104|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651105|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256717|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
19256718|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
19256719|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256720|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
19256721|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19256722|NCT04167761|Glipizide|glipizide|mesh-list
19256723|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256724|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256725|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256726|NCT04160052|Azacitidine|azacitidine|mesh-list
19256727|NCT04160052|Venetoclax|venetoclax|mesh-list
19256728|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19651106|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651107|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
19651108|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651109|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651110|NCT02329054|Favipiravir|favipiravir|mesh-list
19651111|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
20337470|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
20337471|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337472|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20337473|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20337474|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
20337475|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
20337476|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
20337477|NCT00803764|Naproxen|naproxen|mesh-list
20337478|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337479|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337480|NCT00803764|Analgesics|analgesics|mesh-ancestor
20337481|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
19256729|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
19651112|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665280|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665281|NCT05102422|Propofol|propofol|mesh-list
19665282|NCT05102422|Sevoflurane|sevoflurane|mesh-list
19665283|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19665284|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665285|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665286|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19665287|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
19665288|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
19665289|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19665290|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19665291|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
19665292|NCT05102396|Oxybutynin|oxybutynin|mesh-list
19665293|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
19665294|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
19665295|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831203|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19831204|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19831205|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19831206|NCT00585975|Analgesics|analgesics|mesh-ancestor
19831207|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
19831208|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831209|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831210|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831211|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831212|NCT00586066|Memantine|memantine|mesh-list
19831213|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19831214|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19831215|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
19831216|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831217|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167294|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
20167295|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20337482|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337483|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337484|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337485|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337486|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
20337487|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19651113|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19651114|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19651115|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651116|NCT02329080|Cytarabine|cytarabine|mesh-list
19651117|NCT02329080|Rituximab|rituximab|mesh-list
20167296|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
20167297|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20167298|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20167299|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167300|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20167301|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167302|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167303|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20167304|NCT00142207|Renal Agents|renal agents|mesh-ancestor
20167305|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
20167306|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20167307|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20167308|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337488|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337489|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337490|NCT00803803|Pilocarpine|pilocarpine|mesh-list
20337491|NCT00803803|Miotics|miotics|mesh-ancestor
20167309|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167310|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167311|NCT00142246|Amodiaquine|amodiaquine|mesh-list
20167312|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
20167313|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20167314|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19651118|NCT02329080|Methotrexate|methotrexate|mesh-list
19651119|NCT02329080|Etoposide|etoposide|mesh-list
19651120|NCT02329080|Ifosfamide|ifosfamide|mesh-list
19651121|NCT02329080|Thiotepa|thiotepa|mesh-list
19831218|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651122|NCT02329080|Carmustine|carmustine|mesh-list
19831219|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20167315|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167316|NCT00142324|Donepezil|donepezil|mesh-list
19831220|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19831221|NCT00586105|Sorafenib|sorafenib|mesh-list
19831222|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831223|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19831224|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831225|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831226|NCT00586157|Methylphenidate|methylphenidate|mesh-list
19831227|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19831228|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831229|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19831230|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19831231|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19831232|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831233|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
19831234|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831235|NCT00586196|Donepezil|donepezil|mesh-list
19831236|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19831237|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831238|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831239|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
19831240|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831241|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831242|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
19831243|NCT00586261|Pioglitazone|pioglitazone|mesh-list
19831244|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
19831245|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19831246|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831247|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
19831248|NCT00586482|Nicotine|nicotine|mesh-list
19831249|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19831250|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
19831251|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831252|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831253|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19831254|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19831255|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167317|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19651123|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19651124|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651125|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
19651126|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651127|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651128|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19651129|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
19651130|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19651131|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19651132|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
19651133|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651134|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
19651135|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651136|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19651137|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651138|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651139|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19651140|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19651141|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19651142|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
19651143|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651144|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20337492|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
20167318|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167319|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167320|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167321|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167322|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167323|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
20167324|NCT00142337|Zidovudine|zidovudine|mesh-list
20167325|NCT00142337|Didanosine|didanosine|mesh-list
20167326|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
19651145|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
19651146|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19651147|NCT02329171|Imiquimod|imiquimod|mesh-list
19651148|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19651149|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
19651150|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651151|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651152|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
19651153|NCT02329132|Ranibizumab|ranibizumab|mesh-list
19651154|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19651155|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19651156|NCT02329132|Growth Substances|growth substances|mesh-ancestor
19651157|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651158|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
19651159|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651160|NCT02328950|Cytarabine|cytarabine|mesh-list
19651161|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
19651162|NCT02328950|Busulfan|busulfan|mesh-list
19651163|NCT02328950|Fludarabine|fludarabine|mesh-list
19651164|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831256|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831257|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831258|NCT00586495|Sorafenib|sorafenib|mesh-list
19831259|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831260|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19831261|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831262|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831263|NCT00586508|Bevacizumab|bevacizumab|mesh-list
19831264|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
19831265|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831266|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831267|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19831268|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19831269|NCT00586508|Growth Substances|growth substances|mesh-ancestor
19831270|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831271|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
19831272|NCT00586521|Factor VIII|factor viii|mesh-list
19831273|NCT00586521|Coagulants|coagulants|mesh-ancestor
19831274|NCT00586573|Memantine|memantine|mesh-list
19831275|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19831276|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19831277|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
19831278|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831279|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831280|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831281|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19831282|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19831283|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19831284|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
19831285|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831286|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
19831287|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19831288|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
19831289|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19831290|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19831291|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19651165|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
19651166|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651167|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651168|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19651169|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
19651170|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651171|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651172|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19831292|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20348180|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
20612263|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612264|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
20612265|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19651173|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19651174|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
19651175|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
19831293|NCT00586690|Antibodies|antibodies|mesh-list
19831294|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
19831295|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19831296|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
19831297|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831298|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831299|NCT00586729|Mafenide|mafenide|mesh-list
19831300|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19831301|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831302|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19831303|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19831304|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831305|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831306|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
19831307|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19831308|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19831309|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831310|NCT00586846|Doxorubicin|doxorubicin|mesh-list
19831311|NCT00586846|Methotrexate|methotrexate|mesh-list
19831312|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831313|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19831314|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19831315|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19831316|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831317|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831318|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19831319|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
19831320|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19831321|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831322|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831323|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
19831324|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
19831325|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19831326|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831327|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
19831328|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831329|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19831330|NCT00586898|Ketoconazole|ketoconazole|mesh-list
19831331|NCT00586898|Bicalutamide|bicalutamide|mesh-list
19831332|NCT00586898|Testosterone|testosterone|mesh-list
19831333|NCT00586898|Estrogens|estrogens|mesh-list
19831334|NCT00586898|Androgens|androgens|mesh-ancestor
19831335|NCT00586898|Hormones|hormones|mesh-ancestor
19831336|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831337|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831338|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831339|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
19651176|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651177|NCT02328729|Epinephrine|epinephrine|mesh-list
19651178|NCT02328729|Racepinephrine|racepinephrine|mesh-list
19651179|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
19651180|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19651181|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19651182|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
19651183|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651184|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651185|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167327|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167328|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20167329|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167330|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167331|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
20167332|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167333|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20167334|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20167335|NCT00142350|Fluorouracil|fluorouracil|mesh-list
20167336|NCT00142350|Irinotecan|irinotecan|mesh-list
19651186|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19831340|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651187|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19651188|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
19831341|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19831342|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19831343|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831344|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831345|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19831346|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
19831347|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19831348|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
19831349|NCT00587067|Floxuridine|floxuridine|mesh-list
19831350|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831351|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
19831352|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831353|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831354|NCT00587132|Secretin|secretin|mesh-list
19831355|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19831356|NCT00587132|Hormones|hormones|mesh-ancestor
19831357|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831358|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831359|NCT00587288|Reslizumab|reslizumab|mesh-list
20167337|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651189|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651190|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19651191|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
19651192|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
19651193|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
19651194|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19651195|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
20167338|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
19651196|NCT02328963|Everolimus|everolimus|mesh-list
19651197|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651198|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651199|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
19651200|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651201|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19651202|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19831360|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19831361|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
19831362|NCT00587431|Docetaxel|docetaxel|mesh-list
19831363|NCT00587431|Leuprolide|leuprolide|mesh-list
19831364|NCT00587431|Testosterone|testosterone|mesh-list
19831365|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337493|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337494|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337495|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20337496|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20337497|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
19831366|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
19831367|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
19831368|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
19831369|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831370|NCT00587431|Androgens|androgens|mesh-ancestor
20167339|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337498|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337499|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337500|NCT00803816|Everolimus|everolimus|mesh-list
20337501|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337502|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337503|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
20337504|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337505|NCT00803829|Sulfalene|sulfalene|mesh-list
20167340|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20167341|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167342|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
20167343|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167344|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20167345|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20167346|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167347|NCT00142402|Modafinil|modafinil|mesh-list
20167348|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20167349|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337506|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337507|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20337508|NCT00803829|Renal Agents|renal agents|mesh-ancestor
20611894|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651203|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
19651204|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651205|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167350|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20167351|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20167352|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20167353|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167354|NCT00142428|Cetuximab|cetuximab|mesh-list
19651206|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651207|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651208|NCT02328794|Varenicline|varenicline|mesh-list
19651209|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19651210|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19651211|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
19651212|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651213|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651214|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651215|NCT02328716|Cisplatin|cisplatin|mesh-list
20167355|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167356|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167357|NCT00142467|Gemcitabine|gemcitabine|mesh-list
20167358|NCT00142467|Bevacizumab|bevacizumab|mesh-list
19651216|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651217|NCT02328651|Ribavirin|ribavirin|mesh-list
19651218|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
19651219|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651220|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
19651221|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651222|NCT02328521|Nicorandil|nicorandil|mesh-list
19651223|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19831371|NCT00587431|Hormones|hormones|mesh-ancestor
19831372|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337509|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
19831373|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831374|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19831375|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19831376|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
19831377|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19831378|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
19831379|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831380|NCT00587483|Lidocaine|lidocaine|mesh-list
19831381|NCT00587483|Amiodarone|amiodarone|mesh-list
20167359|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
20167360|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167361|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167362|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20167363|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20167364|NCT00142467|Growth Substances|growth substances|mesh-ancestor
20167365|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167366|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
20167367|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20167368|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
20167369|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167370|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
20337510|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20337511|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20337512|NCT00803842|Doxycycline|doxycycline|mesh-list
20337513|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20337514|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337515|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
20337516|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20337517|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20337518|NCT00803868|Varenicline|varenicline|mesh-list
20337519|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20337520|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20337521|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
20337522|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337523|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337524|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337525|NCT00803907|Imiquimod|imiquimod|mesh-list
20337526|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
20337527|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19651224|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19651225|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
19651226|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
20337528|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337529|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651227|NCT02328521|Vitamins|vitamins|mesh-ancestor
20167371|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167372|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167373|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167374|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
20167375|NCT00142480|Bevacizumab|bevacizumab|mesh-list
20167376|NCT00142480|Capecitabine|capecitabine|mesh-list
20167377|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
20167378|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167379|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167380|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337530|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
20337531|NCT00803933|Pentamidine|pentamidine|mesh-list
20337532|NCT00803933|Pafuramidine|pafuramidine|mesh-list
20337533|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
19651228|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
19651229|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651230|NCT02328469|Doxycycline|doxycycline|mesh-list
19651231|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
19651232|NCT02328469|Acyclovir|acyclovir|mesh-list
19651233|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651234|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651235|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
19651236|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19651237|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19831382|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
19831383|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
19651238|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
19651239|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19651240|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19831384|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337534|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831385|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831386|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
19831387|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831388|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19831389|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19831390|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20167381|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20167382|NCT00142480|Growth Substances|growth substances|mesh-ancestor
20167383|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167384|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
20167385|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20167386|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
20167387|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167388|NCT00142493|Midazolam|midazolam|mesh-list
20167389|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
20167390|NCT00142493|Thiopental|thiopental|mesh-list
20167391|NCT00142493|Propofol|propofol|mesh-list
20167392|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19651241|NCT02328495|Misoprostol|misoprostol|mesh-list
19651242|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19651243|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
19651244|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19651245|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651246|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19651247|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337535|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20337536|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19651248|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
19651249|NCT02328183|Polymyxins|polymyxins|mesh-list
19651250|NCT02328183|Polymyxin B|polymyxin b|mesh-list
19651251|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20167393|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167394|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167395|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20167396|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
20167397|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
20167398|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20167399|NCT00142493|Analgesics|analgesics|mesh-ancestor
20167400|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
20167401|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167402|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20167403|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20167404|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20167405|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
20167406|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167407|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167408|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20167409|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167410|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167411|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167412|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
20167413|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
20167414|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
20167415|NCT00142545|Apomorphine|apomorphine|mesh-list
20337537|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19651252|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651253|NCT02328053|Voriconazole|voriconazole|mesh-list
19651254|NCT02328053|Natamycin|natamycin|mesh-list
20167416|NCT00142545|Emetics|emetics|mesh-ancestor
19831391|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19831392|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831393|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
20337538|NCT00803946|Ibuprofen|ibuprofen|mesh-list
20337539|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337540|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337541|NCT00803946|Analgesics|analgesics|mesh-ancestor
19651255|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
19651256|NCT02328053|Clotrimazole|clotrimazole|mesh-list
19651257|NCT02328053|Miconazole|miconazole|mesh-list
19651258|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651259|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19651260|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19651261|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651262|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651263|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19651264|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
19651265|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651266|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651267|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19651268|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19651269|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651270|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19651271|NCT02328079|Acyclovir|acyclovir|mesh-list
19651272|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
19651273|NCT02328079|Prednisolone|prednisolone|mesh-list
19651274|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19651275|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
19651276|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19651277|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
19651278|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19651279|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
19651280|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651281|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
19651282|NCT02328079|Hormones|hormones|mesh-ancestor
19651283|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651284|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651285|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20337542|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
20337543|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337544|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337545|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337546|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337547|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20337548|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337549|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337550|NCT00803972|Insulin|insulin|mesh-list
19651286|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651287|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
19651288|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
19651289|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651290|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19651291|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19651292|NCT02328079|Protective Agents|protective agents|mesh-ancestor
19651293|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651294|NCT02328209|Ranibizumab|ranibizumab|mesh-list
19831394|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19831395|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19831396|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19831397|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651295|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19651296|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19651297|NCT02328209|Growth Substances|growth substances|mesh-ancestor
19651298|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831398|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19831399|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19651299|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
19651300|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651301|NCT02328118|Triamcinolone|triamcinolone|mesh-list
19651302|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19651303|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19651304|NCT02328118|Ranibizumab|ranibizumab|mesh-list
19651305|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19651306|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19651307|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20167417|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337551|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20337552|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
20337553|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20337554|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337555|NCT00804050|Vitamins|vitamins|mesh-list
20337556|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
20337557|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337558|NCT00804115|Timolol|timolol|mesh-list
20337559|NCT00804115|Latanoprost|latanoprost|mesh-list
20337560|NCT00804115|Pilocarpine|pilocarpine|mesh-list
20337561|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20337562|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20337563|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
20337564|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337565|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337566|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167418|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
20167419|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651308|NCT02328118|Growth Substances|growth substances|mesh-ancestor
19651309|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651310|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
19651311|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651312|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651313|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
19651314|NCT02328118|Hormones|hormones|mesh-ancestor
19651315|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651316|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651317|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
19651318|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651319|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651320|NCT02328443|Itraconazole|itraconazole|mesh-list
19831400|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20167420|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20167421|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
20167422|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
20167423|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167424|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167425|NCT00142571|Gemcitabine|gemcitabine|mesh-list
20167426|NCT00142571|Docetaxel|docetaxel|mesh-list
20167427|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20167428|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
20337567|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19651321|NCT02328443|Rifampin|rifampin|mesh-list
19831401|NCT00587678|Simvastatin|simvastatin|mesh-list
19831402|NCT00587678|Ezetimibe|ezetimibe|mesh-list
20337568|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20337569|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19651322|NCT02328443|Midazolam|midazolam|mesh-list
19651323|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19651324|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19651325|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167429|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651326|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651327|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19651328|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19651329|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19651330|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19651331|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
19651332|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
19651333|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
19651334|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
19651335|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651336|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651337|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
19651338|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651339|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19651340|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19651341|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651342|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19651343|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
19651344|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651345|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19651346|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19651347|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
19651348|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651349|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
19651350|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651351|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19651352|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19651353|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19651354|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19651355|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19651356|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19651357|NCT02328144|Metronidazole|metronidazole|mesh-list
19651358|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651359|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651360|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19651361|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19651362|NCT02327663|Emtricitabine|emtricitabine|mesh-list
19651363|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
19651364|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167430|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167431|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
20167432|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167433|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167434|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167435|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
20167436|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651365|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19651366|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19831403|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19831404|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19831405|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
19831406|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831407|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19831408|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19831409|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831410|NCT00587769|Bupropion|bupropion|mesh-list
19831411|NCT00587769|Varenicline|varenicline|mesh-list
19831412|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19831413|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
19831414|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19831415|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20167437|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
20337570|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20337571|NCT00804115|Miotics|miotics|mesh-ancestor
20337572|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
20337573|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337574|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20337575|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20337576|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167438|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
19651367|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651368|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651369|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19651370|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19651371|NCT02327676|Emtricitabine|emtricitabine|mesh-list
19651372|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
19651373|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651374|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19831416|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19831417|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167439|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
20167440|NCT00142610|Vitamins|vitamins|mesh-list
20167441|NCT00142610|Vitamin E|vitamin e|mesh-list
20167442|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
20167443|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167444|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
20167445|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167446|NCT00142610|Protective Agents|protective agents|mesh-ancestor
20167447|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
20167448|NCT00142727|Methadone|methadone|mesh-list
20167449|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
20167450|NCT00142727|Narcotics|narcotics|mesh-ancestor
20167451|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167452|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167453|NCT00142727|Analgesics|analgesics|mesh-ancestor
20167454|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
20167455|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167456|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
20167457|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
20337577|NCT00804206|Bevacizumab|bevacizumab|mesh-list
20337578|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337579|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337580|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337581|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337582|NCT00804206|Growth Substances|growth substances|mesh-ancestor
20337583|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337584|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337585|NCT00804219|Vaccines|vaccines|mesh-list
20337586|NCT00804219|Immunologic Factors|immunologic factors|mesh-ancestor
20337587|NCT00804219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337588|NCT00804245|Choline|choline|mesh-list
20337589|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
20337590|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19651375|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651376|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651377|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651378|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19651379|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19651380|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
19651381|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19651382|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19651383|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19651384|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651385|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651386|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
19651387|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337591|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
20337592|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337593|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337594|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20337595|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
19651388|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831418|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167458|NCT00142779|Fluoxetine|fluoxetine|mesh-list
20167459|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20167460|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20167461|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20337596|NCT00804271|Memantine|memantine|mesh-list
20337597|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20337598|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20337599|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
20337600|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337601|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337602|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337603|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20167462|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167463|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337604|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20337605|NCT00804297|Octreotide|octreotide|mesh-list
20337606|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19831419|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
20167464|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
20167465|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167466|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20167467|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
20337607|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19831420|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831421|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831422|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19831423|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19831424|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831425|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19831426|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19831427|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
19831428|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
19831429|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831430|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831431|NCT05247424|Heparin|heparin|mesh-list
19831432|NCT05247424|Calcium heparin|calcium heparin|mesh-list
20337608|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337609|NCT00804310|Lapatinib|lapatinib|mesh-list
20337610|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337611|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20337612|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651389|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19651390|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651391|NCT02327624|Clopidogrel|clopidogrel|mesh-list
19651392|NCT02327624|Ticagrelor|ticagrelor|mesh-list
19651393|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19651394|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19651395|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19651396|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19651397|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
19651398|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651399|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651400|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651401|NCT02327936|Fesoterodine|fesoterodine|mesh-list
19651402|NCT02327936|Oxybutynin|oxybutynin|mesh-list
19651403|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19651404|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19651405|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
19651406|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651407|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651408|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337613|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337614|NCT00804336|Everolimus|everolimus|mesh-list
20337615|NCT00804336|Pasireotide|pasireotide|mesh-list
20337616|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337617|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337618|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
20337619|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337620|NCT00804336|Hormones|hormones|mesh-ancestor
20337621|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337622|NCT00804388|Vitamin E|vitamin e|mesh-list
20337623|NCT00804388|Vitamins|vitamins|mesh-ancestor
19831433|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
19831434|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20337624|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
20337625|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831435|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20337626|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
20167468|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167469|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20167470|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20167471|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167472|NCT00142844|Naltrexone|naltrexone|mesh-list
20167473|NCT00142844|Disulfiram|disulfiram|mesh-list
19651409|NCT02327936|Urological Agents|urological agents|mesh-ancestor
19651410|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
19651411|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
19651412|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651413|NCT02327793|Labetalol|labetalol|mesh-list
19651414|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
19651415|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
19651416|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19651417|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19651418|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
19651419|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651420|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651421|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651422|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19651423|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
19651424|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
19651425|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651426|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19651427|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19651428|NCT02327754|FYX-051|fyx-051|mesh-list
19651429|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651430|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651431|NCT02327689|Emtricitabine|emtricitabine|mesh-list
19651432|NCT02327689|Adefovir|adefovir|mesh-list
19651433|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19651434|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
19651435|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651436|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19651437|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651438|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651439|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651440|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19651441|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19665296|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665297|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20167474|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20167475|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20167476|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167477|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
20167478|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167479|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20167480|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665298|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19665299|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
19665300|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665301|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665302|NCT05102396|Urological Agents|urological agents|mesh-ancestor
19665303|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19665304|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665305|NCT05102396|Renal Agents|renal agents|mesh-ancestor
19665306|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
19665307|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19665308|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665309|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665310|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19665311|NCT05102058|Analgesics|analgesics|mesh-ancestor
19665312|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
20337627|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337628|NCT00804388|Protective Agents|protective agents|mesh-ancestor
20337629|NCT00804401|Naproxen|naproxen|mesh-list
20337630|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337631|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337632|NCT00804401|Analgesics|analgesics|mesh-ancestor
20337633|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
20337634|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337635|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651442|NCT02327923|Ketorolac|ketorolac|mesh-list
19651443|NCT02327923|Lidocaine|lidocaine|mesh-list
19651444|NCT02327923|Atropine|atropine|mesh-list
19651445|NCT02327923|Ephedrine|ephedrine|mesh-list
19651446|NCT02327923|Fentanyl|fentanyl|mesh-list
19256730|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256731|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651447|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
19651448|NCT02327923|Morphine|morphine|mesh-list
20167481|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167482|NCT00142870|Bupropion|bupropion|mesh-list
20167483|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20167484|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
20167485|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19651449|NCT02327923|Tramadol|tramadol|mesh-list
19651450|NCT02327923|Ondansetron|ondansetron|mesh-list
19651451|NCT02327923|Bupivacaine|bupivacaine|mesh-list
19651452|NCT02327923|Propofol|propofol|mesh-list
19651453|NCT02327923|Neostigmine|neostigmine|mesh-list
19651454|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
20167486|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20167487|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19651455|NCT02327923|Esmolol|esmolol|mesh-list
19651456|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
19651457|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
19651458|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651459|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167488|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167489|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167490|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
20167491|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167492|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167493|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20337636|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651460|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
19651461|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651462|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20337637|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337638|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
20337639|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20337640|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337641|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337642|NCT00804440|Ibuprofen|ibuprofen|mesh-list
20337643|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337644|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337645|NCT00804440|Analgesics|analgesics|mesh-ancestor
20337646|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
20337647|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337648|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337649|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337650|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337651|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20337652|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337653|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337654|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20337655|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
20167494|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20167495|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337656|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20337657|NCT00804531|Prednisolone|prednisolone|mesh-list
20337658|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
20337659|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20337660|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
20337661|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337662|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
20337663|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
20337664|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337665|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337666|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337667|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
20337668|NCT00804531|Hormones|hormones|mesh-ancestor
20337669|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337670|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20337671|NCT00804531|Protective Agents|protective agents|mesh-ancestor
20337672|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20337673|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337674|NCT00804622|Tenofovir|tenofovir|mesh-list
20337675|NCT00804622|Telbivudine|telbivudine|mesh-list
20337676|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
20337677|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167496|NCT00142883|Pregabalin|pregabalin|mesh-list
20167497|NCT00142883|Analgesics|analgesics|mesh-ancestor
20167498|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
20167499|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167500|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167501|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
20167502|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167503|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167504|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167505|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20337678|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20337679|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651463|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19651464|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19651465|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651466|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651467|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19651468|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19651469|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
19651470|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19651471|NCT02327923|Narcotics|narcotics|mesh-ancestor
19651472|NCT02327923|Analgesics|analgesics|mesh-ancestor
19651473|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19651474|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651475|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
19651476|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
19651477|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19651478|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
19651479|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
19651480|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20337680|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337681|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337682|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20337683|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19651481|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
19651482|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651483|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19651484|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19651485|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19651486|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19651487|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19651488|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651489|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651490|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20167506|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167507|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167508|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167509|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167510|NCT00142896|Morphine|morphine|mesh-list
20167511|NCT00142896|Tramadol|tramadol|mesh-list
20167512|NCT00142896|Naloxone|naloxone|mesh-list
20167513|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20167514|NCT00142896|Narcotics|narcotics|mesh-ancestor
20167515|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167516|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167517|NCT00142896|Analgesics|analgesics|mesh-ancestor
20167518|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
20167519|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167520|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20167521|NCT00142948|Naltrexone|naltrexone|mesh-list
20167522|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20167523|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20167524|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167525|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
20167526|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167527|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20167528|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20167529|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20337684|NCT00804674|Bupivacaine|bupivacaine|mesh-list
20337685|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
19651491|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651492|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19651493|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19651494|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19651495|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
19651496|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
19651497|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19651498|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19651499|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
19651500|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19651501|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19651502|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19651503|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19651504|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19651505|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
19651506|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19651507|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
19831436|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167530|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167531|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167532|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
20167533|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167534|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167535|NCT00142974|Tegaserod|tegaserod|mesh-list
20167536|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20167537|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
20167538|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167539|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167540|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337686|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
20337687|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337688|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337689|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
20337690|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337691|NCT00804752|Vitamin D|vitamin d|mesh-list
20337692|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
20337693|NCT00804752|Vitamins|vitamins|mesh-list
20337694|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
20337695|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337696|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20337697|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20337698|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20337699|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
20337700|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20337701|NCT00804830|Bevacizumab|bevacizumab|mesh-list
20337702|NCT00804830|Doxorubicin|doxorubicin|mesh-list
20337703|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167541|NCT00142987|Tegaserod|tegaserod|mesh-list
20167542|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20167543|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
20167544|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167545|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167546|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167547|NCT00143000|Ribavirin|ribavirin|mesh-list
20167548|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20167549|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
20167550|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167551|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
20337704|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651508|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20337705|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19651509|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19651510|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19651511|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19651512|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19651513|NCT02327715|Emtricitabine|emtricitabine|mesh-list
19651514|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
19651515|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651516|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19651517|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651518|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651519|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651520|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19651521|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19651522|NCT02327702|Emtricitabine|emtricitabine|mesh-list
19651523|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
19651524|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651525|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19651526|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651527|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651528|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651529|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19651530|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19651531|NCT02327338|Ibuprofen|ibuprofen|mesh-list
19651532|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19651533|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651534|NCT02327338|Analgesics|analgesics|mesh-ancestor
19651535|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
19651536|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651537|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651538|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651539|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651540|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20167552|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167553|NCT00143026|Levodopa|levodopa|mesh-list
20167554|NCT00143026|Carbidopa|carbidopa|mesh-list
20167555|NCT00143026|Entacapone|entacapone|mesh-list
20167556|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20167557|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20167558|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
20167559|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167560|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167561|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167562|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20167563|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167564|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20167565|NCT00143065|Rituximab|rituximab|mesh-list
20167566|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
20167567|NCT00143065|Fludarabine|fludarabine|mesh-list
20167568|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167569|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167570|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
20167571|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167572|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167573|NCT00143091|Sertraline|sertraline|mesh-list
20167574|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
20167575|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167576|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20167577|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20167578|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167579|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167580|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167581|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
20167582|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167583|NCT00143104|Insulin|insulin|mesh-list
20167584|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20167585|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167586|NCT00143130|Pregabalin|pregabalin|mesh-list
20167587|NCT00143130|Analgesics|analgesics|mesh-ancestor
20167588|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
20167589|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167590|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167591|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
20337706|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337707|NCT00804830|Growth Substances|growth substances|mesh-ancestor
20337708|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337709|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337710|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20337711|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20337712|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20337713|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337714|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651541|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651542|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651543|NCT02327299|Fesoterodine|fesoterodine|mesh-list
19651544|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19651545|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19651546|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
19651547|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651548|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651549|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651550|NCT02327299|Urological Agents|urological agents|mesh-ancestor
19651551|NCT02327416|Entecavir|entecavir|mesh-list
19651552|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19651553|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
19651554|NCT02327416|Adefovir|adefovir|mesh-list
20167592|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167593|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167594|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167595|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167596|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20337715|NCT00804856|Cytarabine|cytarabine|mesh-list
20337716|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20337717|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
20337718|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337719|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337720|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
20337721|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337722|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337723|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
20337724|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337725|NCT00804895|Cortivazol|cortivazol|mesh-list
20337726|NCT00804895|Verapamil|verapamil|mesh-list
20337727|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20337728|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20337729|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20337730|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337731|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20337732|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337733|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
20337734|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337735|NCT00804921|Bevacizumab|bevacizumab|mesh-list
20337736|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20337737|NCT00804921|Acetazolamide|acetazolamide|mesh-list
20167597|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167598|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167599|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167600|NCT00143143|Pregabalin|pregabalin|mesh-list
20167601|NCT00143143|Analgesics|analgesics|mesh-ancestor
20167602|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
20167603|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167604|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167605|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
20167606|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167607|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167608|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167609|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167610|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167611|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167612|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167613|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167614|NCT00143156|Pregabalin|pregabalin|mesh-list
20167615|NCT00143156|Analgesics|analgesics|mesh-ancestor
20167616|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
20167617|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167618|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651555|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19651556|NCT02327416|Molgramostim|molgramostim|mesh-list
19651557|NCT02327416|Sargramostim|sargramostim|mesh-list
19651558|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
20337738|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337739|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337740|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337741|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337742|NCT00804921|Growth Substances|growth substances|mesh-ancestor
20337743|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337744|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337745|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20337746|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19651559|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651560|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
19651561|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651562|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19651563|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19651564|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651565|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651566|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651567|NCT02327234|Ibuprofen|ibuprofen|mesh-list
19651568|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19651569|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651570|NCT02327234|Analgesics|analgesics|mesh-ancestor
19651571|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
19651572|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651573|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831437|NCT05247385|Ticagrelor|ticagrelor|mesh-list
20167619|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
20167620|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167621|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167622|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167623|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167624|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20167625|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167626|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167627|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167628|NCT00143169|Parecoxib|parecoxib|mesh-list
20167629|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20167630|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20167631|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167632|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167633|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20167634|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20167635|NCT00143169|Analgesics|analgesics|mesh-ancestor
20167636|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
20167637|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167638|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167639|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20167640|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167641|NCT00143195|Amlodipine|amlodipine|mesh-list
20167642|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20167643|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167644|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167645|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167646|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167647|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167648|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
20167649|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
20167650|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
20167651|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19651574|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651575|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167652|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19651576|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19651577|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651578|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651579|NCT02327247|Felodipine|felodipine|mesh-list
20167653|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167654|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167655|NCT00143221|Urological Agents|urological agents|mesh-ancestor
20167656|NCT00143234|Amlodipine|amlodipine|mesh-list
20167657|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
20167658|NCT00143234|Atorvastatin|atorvastatin|mesh-list
20167659|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20167660|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20167661|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
20167662|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167663|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20167664|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20167665|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167666|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20167667|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167668|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167669|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167670|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167671|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
20167672|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
20167673|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167674|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
20167675|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20167676|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20167677|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651580|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19651581|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19651582|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20167678|NCT00143260|Urological Agents|urological agents|mesh-ancestor
20167679|NCT00143286|Varenicline|varenicline|mesh-list
20167680|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20167681|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20167682|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167683|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167684|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167685|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167686|NCT00143299|Varenicline|varenicline|mesh-list
20167687|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20167688|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20167689|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167690|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167691|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167692|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174688|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174689|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
20174690|NCT00165399|Docetaxel|docetaxel|mesh-list
20174691|NCT00165399|Goserelin|goserelin|mesh-list
20174692|NCT00165399|Bicalutamide|bicalutamide|mesh-list
20174693|NCT00165399|Estramustine|estramustine|mesh-list
20174694|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174695|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174696|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174697|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174698|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174699|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20174700|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
20174701|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
20174702|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20174703|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174704|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20174705|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
20174706|NCT00165451|Thalidomide|thalidomide|mesh-list
20174707|NCT00165451|Celecoxib|celecoxib|mesh-list
20337747|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19651583|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651584|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651585|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19651586|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651587|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
19651588|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
19651589|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19651590|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651591|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651592|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651593|NCT02327156|Analgesics|analgesics|mesh-ancestor
19651594|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
19651595|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651596|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19651597|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20167693|NCT00143325|Varenicline|varenicline|mesh-list
20167694|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20167695|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20167696|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167697|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167698|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167699|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167700|NCT00143338|Insulin|insulin|mesh-list
20167701|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20167702|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167703|NCT00143351|Ziprasidone|ziprasidone|mesh-list
20167704|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20167705|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
20167706|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167707|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167708|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167709|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20167710|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20167711|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167712|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167713|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20167714|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
20167715|NCT00143364|Varenicline|varenicline|mesh-list
20167716|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20167717|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20167718|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167719|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167720|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167721|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167722|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20167723|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20167724|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20167725|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167726|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167727|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167728|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167729|NCT00143377|Urological Agents|urological agents|mesh-ancestor
20167730|NCT00143429|Latanoprost|latanoprost|mesh-list
20167731|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20167732|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20337748|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20337749|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
20337750|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167733|NCT00143442|Reboxetine|reboxetine|mesh-list
20167734|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
20167735|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20167736|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20167737|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20167738|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651598|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20167739|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167740|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
20167741|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167742|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167743|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20167744|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20167745|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20167746|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167747|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167748|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167749|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167750|NCT00143481|Urological Agents|urological agents|mesh-ancestor
20167751|NCT00143520|Pioglitazone|pioglitazone|mesh-list
20167752|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20167753|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167754|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
20167755|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
20167756|NCT00143533|Irinotecan|irinotecan|mesh-list
20167757|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20167758|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20167759|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167760|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167761|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167762|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20167763|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167764|NCT00143546|Defibrotide|defibrotide|mesh-list
20167765|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20167766|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20167767|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167768|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20167769|NCT00143559|Antibodies|antibodies|mesh-list
20167770|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
20167771|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167772|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
20167773|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167774|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
20167775|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167776|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167777|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167778|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
20167779|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20167780|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167781|NCT00143676|Atorvastatin|atorvastatin|mesh-list
20167782|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20167783|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20167784|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
20167785|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167786|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20167787|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20167788|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167789|NCT00143689|Ritonavir|ritonavir|mesh-list
20167790|NCT00143689|Lopinavir|lopinavir|mesh-list
20167791|NCT00143689|Lamivudine|lamivudine|mesh-list
20167792|NCT00143689|Zidovudine|zidovudine|mesh-list
20167793|NCT00143689|Nevirapine|nevirapine|mesh-list
20167794|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20167795|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20167796|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
20167797|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167798|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167799|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20167800|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20167801|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
20337751|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651599|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
20167802|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167803|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19651600|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651601|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651602|NCT02327000|Pregabalin|pregabalin|mesh-list
19651603|NCT02327000|Analgesics|analgesics|mesh-ancestor
19651604|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
19651605|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651606|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651607|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
19651608|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19651609|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651610|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651611|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19651612|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19651613|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19651614|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651615|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19651616|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
19651617|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19651618|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19651619|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651620|NCT02327091|Vitamins|vitamins|mesh-ancestor
19651621|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
19651622|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
19651623|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19651624|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
19831438|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20337752|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
20337753|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20337754|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337755|NCT00804921|Diuretics|diuretics|mesh-ancestor
19831439|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19831440|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19831441|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20167804|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20167805|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20167806|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167807|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
20167808|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20167809|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20167810|NCT00143702|Riboflavin|riboflavin|mesh-list
20167811|NCT00143702|Thiamine|thiamine|mesh-list
20167812|NCT00143702|Abacavir|abacavir|mesh-list
20167813|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20167814|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167815|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167816|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167817|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
20167818|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167819|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20167820|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20167821|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
20167822|NCT00143702|Vitamins|vitamins|mesh-ancestor
20167823|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
20167824|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167825|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20167826|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
20167827|NCT00143715|Vitamin K|vitamin k|mesh-list
20167828|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
20167829|NCT00143715|Vitamins|vitamins|mesh-ancestor
20167830|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
20167831|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831442|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19831443|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
19831444|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651625|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19651626|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167832|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20167833|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19835396|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
20167834|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167835|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
20167836|NCT00143715|Coagulants|coagulants|mesh-ancestor
20167837|NCT00143728|Lamivudine|lamivudine|mesh-list
20167838|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20167839|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167840|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167841|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167842|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
20167843|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167844|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20167845|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20167846|NCT00143741|Atorvastatin|atorvastatin|mesh-list
20167847|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20167848|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20167849|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
20167850|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167851|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20167852|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20167853|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167854|NCT00143780|Vaccines|vaccines|mesh-list
20167855|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
20167856|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167857|NCT00143806|Cyclosporine|cyclosporine|mesh-list
20167858|NCT00143806|Alefacept|alefacept|mesh-list
20167859|NCT00143806|Cyclosporins|cyclosporins|mesh-list
20167860|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167861|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167862|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167863|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
20167864|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167865|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
20167866|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167867|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
20167868|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167869|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20167870|NCT00143871|Rituximab|rituximab|mesh-list
20167871|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167872|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167873|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
20167874|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167875|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20167876|NCT00143949|Losartan|losartan|mesh-list
20167877|NCT00143949|Enalapril|enalapril|mesh-list
20167878|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20167879|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20167880|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20167881|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20167882|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167883|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20167884|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
20167885|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167886|NCT00143975|Cytarabine|cytarabine|mesh-list
20167887|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
20167888|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
20167889|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20167890|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
20167891|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167892|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167893|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
20167894|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167895|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20167896|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
20167897|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167898|NCT00143975|Analgesics|analgesics|mesh-ancestor
20167899|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
20174708|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
20174709|NCT00165451|Etoposide|etoposide|mesh-list
20174710|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174711|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
20174712|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337756|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
20337757|NCT00804934|Ranibizumab|ranibizumab|mesh-list
20337758|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337759|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337760|NCT00804934|Growth Substances|growth substances|mesh-ancestor
20337761|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337762|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337763|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348181|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167900|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167901|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20167902|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20167903|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167904|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20167905|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20167906|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20167907|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167908|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
20167909|NCT00144053|Paclitaxel|paclitaxel|mesh-list
20167910|NCT00144053|Vindesine|vindesine|mesh-list
20167911|NCT00144053|Carboplatin|carboplatin|mesh-list
20167912|NCT00144053|Irinotecan|irinotecan|mesh-list
20348182|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348183|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
20348184|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348185|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20348186|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20348187|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20348188|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348189|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348190|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348191|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
20348192|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
20348193|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20348194|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
20348195|NCT00863889|Hormones|hormones|mesh-ancestor
19256732|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831445|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831446|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831447|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
19831448|NCT05247177|Ketamine|ketamine|mesh-list
19831449|NCT05247177|Anesthetics|anesthetics|mesh-list
19831450|NCT05247177|Sevoflurane|sevoflurane|mesh-list
19831451|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19831452|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831453|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19831454|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19831455|NCT05247177|Analgesics|analgesics|mesh-ancestor
19831456|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
19831457|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831458|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19831459|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19831460|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19831461|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
19831462|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831463|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831464|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19831465|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19831466|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
19831467|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19831468|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19831469|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19831470|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19831471|NCT05247151|Oxytocin|oxytocin|mesh-list
19831472|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
19831473|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20167913|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20167914|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167915|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
20337764|NCT00804947|Melphalan|melphalan|mesh-list
20337765|NCT00804947|Busulfan|busulfan|mesh-list
20337766|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20337767|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
20337768|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167916|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
20167917|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
20167918|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167919|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20167920|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20167921|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167922|NCT00144066|Gefitinib|gefitinib|mesh-list
20167923|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20167924|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20167925|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167926|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167927|NCT00144118|Sevoflurane|sevoflurane|mesh-list
20167928|NCT00144118|Isoflurane|isoflurane|mesh-list
20167929|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20167930|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20167931|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
20167932|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
20167933|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20167934|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167935|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
20167936|NCT00144131|Hematinics|hematinics|mesh-ancestor
20167937|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
20167938|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
20167939|NCT00144144|Giapreza|giapreza|mesh-list
20167940|NCT00144144|Calcium|calcium|mesh-list
20167941|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
20167942|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20167943|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20167944|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167945|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20167946|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20167947|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
20167948|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167949|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167950|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20167951|NCT00144157|Zidovudine|zidovudine|mesh-list
20167952|NCT00144157|Nevirapine|nevirapine|mesh-list
20167953|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
20167954|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167955|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20167956|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167957|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167958|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
20167959|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167960|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20167961|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20337769|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651627|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19651628|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19651629|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19651630|NCT02326987|Pregabalin|pregabalin|mesh-list
19651631|NCT02326987|Analgesics|analgesics|mesh-ancestor
19651632|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
19651633|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651634|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651635|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
19651636|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19651637|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651638|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665313|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665314|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19665315|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20167962|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20167963|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20167964|NCT00144183|Zidovudine|zidovudine|mesh-list
20167965|NCT00144183|Nevirapine|nevirapine|mesh-list
20167966|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
20167967|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167968|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20167969|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20167970|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20167971|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
20167972|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20167973|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20167974|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20167975|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20167976|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20167977|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
20167978|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20167979|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
20167980|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20167981|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167982|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20167983|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
20167984|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
20167985|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20167986|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
20167987|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167988|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167989|NCT00144209|Levodopa|levodopa|mesh-list
20167990|NCT00144209|Pramipexole|pramipexole|mesh-list
20167991|NCT00144209|Benserazide|benserazide|mesh-list
20167992|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20167993|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20167994|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
20167995|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20167996|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20167997|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20167998|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
19651639|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19651640|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19651641|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19651642|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651643|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19651644|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
19651645|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19665316|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20167999|NCT00144209|Protective Agents|protective agents|mesh-ancestor
20168000|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
20168001|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168002|NCT00144222|Telmisartan|telmisartan|mesh-list
20168003|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168004|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20168005|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20168006|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665317|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
19665318|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665319|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665320|NCT05102045|Memantine|memantine|mesh-list
19665321|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
19665322|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19665323|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19665324|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
19665325|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665326|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665327|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665328|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20337770|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20337771|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20337772|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
20337773|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337774|NCT00804960|Letrozole|letrozole|mesh-list
20168007|NCT00144248|Nevirapine|nevirapine|mesh-list
20168008|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20168009|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20168010|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168011|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168012|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
20168013|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168014|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20168015|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20168016|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20168017|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20168018|NCT00144261|Nevirapine|nevirapine|mesh-list
20168019|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20168020|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20168021|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168022|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168023|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
20168024|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168025|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20168026|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20168027|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20168028|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20168029|NCT00144274|Ambroxol|ambroxol|mesh-list
20168030|NCT00144274|Expectorants|expectorants|mesh-ancestor
20168031|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
20168032|NCT00144287|Ritonavir|ritonavir|mesh-list
20168033|NCT00144287|Tipranavir|tipranavir|mesh-list
20168034|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20168035|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20168036|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
20168037|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168038|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168039|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20168040|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20168041|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
20168042|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168043|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20168044|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20168045|NCT00144326|Bromides|bromides|mesh-list
20168046|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
20168047|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20168048|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
20168049|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168050|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168051|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20168052|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
20168053|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
20168054|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20168055|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
20168056|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168057|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168058|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
20168059|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
20168060|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
20168061|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20168062|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
20168063|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20168064|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19665329|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20168065|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168066|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20168067|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168068|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651646|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651647|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19651648|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651649|NCT02327078|Nivolumab|nivolumab|mesh-list
19651650|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831474|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168069|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20168070|NCT00144352|Renal Agents|renal agents|mesh-ancestor
19651651|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651652|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20168071|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20168072|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
20168073|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168074|NCT00144378|Irinotecan|irinotecan|mesh-list
20168075|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20168076|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168077|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168078|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168079|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168080|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
20168081|NCT00144417|Rifampin|rifampin|mesh-list
20168082|NCT00144417|Isoniazid|isoniazid|mesh-list
20168083|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
20168084|NCT00144417|Ethambutol|ethambutol|mesh-list
20168085|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168086|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168087|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20168088|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168089|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168090|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168091|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168092|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20168093|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
20168094|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
20168095|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20168096|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20168097|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20168098|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20168099|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20168100|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20168101|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20168102|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20168103|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20168104|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
20337775|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651653|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831475|NCT05247125|Melatonin|melatonin|mesh-list
19831476|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831477|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
19831478|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831479|NCT05247125|Protective Agents|protective agents|mesh-ancestor
19835397|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651654|NCT02326779|Aspirin|aspirin|mesh-list
20168105|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20168106|NCT00144430|Pentostatin|pentostatin|mesh-list
20337776|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20337777|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20337778|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337779|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337780|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20337781|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
20168107|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168108|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20168109|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168110|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168111|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
20168112|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20168113|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
20168114|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20168115|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168116|NCT00144456|Vitamins|vitamins|mesh-ancestor
20168117|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
20168118|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20168119|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
20168120|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168121|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
20168122|NCT00144482|Hematinics|hematinics|mesh-ancestor
20168123|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
20168124|NCT00144495|Hematinics|hematinics|mesh-ancestor
20168125|NCT00144677|Sirolimus|sirolimus|mesh-list
20168126|NCT00144677|Tacrolimus|tacrolimus|mesh-list
20168127|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168128|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
20168129|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168130|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20168131|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168132|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168133|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168134|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168135|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168136|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168137|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
20168138|NCT00144703|Sirolimus|sirolimus|mesh-list
20168139|NCT00144703|Tacrolimus|tacrolimus|mesh-list
20168140|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168141|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
20168142|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168143|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20168144|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168145|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168146|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168147|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168148|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168149|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168150|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
20168151|NCT00144716|Insect Repellents|insect repellents|mesh-list
20168152|NCT00144716|Protective Agents|protective agents|mesh-ancestor
20168153|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168154|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
20168155|NCT00144755|Hematinics|hematinics|mesh-ancestor
20168156|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
20168157|NCT00144807|Rituximab|rituximab|mesh-list
20168158|NCT00144807|Doxorubicin|doxorubicin|mesh-list
20168159|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168160|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
20168161|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168162|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337782|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168163|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20168164|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
20168165|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168166|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168167|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20168168|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20168169|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168170|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20168171|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168172|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168173|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
20168174|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20168175|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
20168176|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168177|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
20168178|NCT00144820|Protective Agents|protective agents|mesh-ancestor
20168179|NCT00144833|Ritonavir|ritonavir|mesh-list
20168180|NCT00144833|Lopinavir|lopinavir|mesh-list
20168181|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
20168182|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20168183|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20168184|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
20168185|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168186|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168187|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20168188|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20168189|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
20168190|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168191|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20168192|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20168193|NCT00144846|Albuterol|albuterol|mesh-list
20168194|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20168195|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
20168196|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168197|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168198|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20168199|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
20168200|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
20168201|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20168202|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20168203|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20168204|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20168205|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
20168206|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168207|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174713|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174714|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20174715|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
20174716|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174717|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174718|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20174719|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20174720|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20174721|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20174722|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174723|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20174724|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20174725|NCT00165451|Analgesics|analgesics|mesh-ancestor
20174726|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
20174727|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174728|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174729|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20174730|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20174731|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
20174732|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174733|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174734|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20174735|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20174736|NCT00165451|Growth Substances|growth substances|mesh-ancestor
20174737|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
20174738|NCT00165464|Irinotecan|irinotecan|mesh-list
20174739|NCT00165464|Docetaxel|docetaxel|mesh-list
20174740|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174741|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20174742|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20337783|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337784|NCT00805012|Docetaxel|docetaxel|mesh-list
20337785|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337786|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
20337787|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
20337788|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
20337789|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337790|NCT00805064|Triamcinolone|triamcinolone|mesh-list
20337791|NCT00805064|Bevacizumab|bevacizumab|mesh-list
20337792|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337793|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651655|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19651656|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651657|NCT02326779|Analgesics|analgesics|mesh-ancestor
19651658|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
19651659|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651660|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168208|NCT00144872|Lamotrigine|lamotrigine|mesh-list
20168209|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
20168210|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20168211|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20168212|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168213|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20168214|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168215|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20168216|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19651661|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651662|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651663|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19651664|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20168217|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168218|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20168219|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20168220|NCT00144911|Fluticasone|fluticasone|mesh-list
20168221|NCT00144911|Xhance|xhance|mesh-list
20168222|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20168223|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20168224|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20337794|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20168225|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
19651665|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168226|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168227|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168228|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20337795|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19651666|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19651667|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19651668|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651669|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
19651670|NCT02326727|Fentanyl|fentanyl|mesh-list
19651671|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
19651672|NCT02326727|Propofol|propofol|mesh-list
19651673|NCT02326727|Ropivacaine|ropivacaine|mesh-list
19651674|NCT02326727|Isoflurane|isoflurane|mesh-list
19651675|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19665330|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665331|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
19665332|NCT05101954|Mitogens|mitogens|mesh-list
19665333|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
19665334|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665335|NCT05101928|Prednisone|prednisone|mesh-list
19665336|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19665337|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
19665338|NCT05101928|Hormones|hormones|mesh-ancestor
19665339|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168229|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
20168230|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
20168231|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20168232|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20168233|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20168234|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20168235|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
20337796|NCT00805064|Growth Substances|growth substances|mesh-ancestor
20337797|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337798|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337799|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337800|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
20337801|NCT00805064|Hormones|hormones|mesh-ancestor
20337802|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337803|NCT00805090|Itraconazole|itraconazole|mesh-list
20337804|NCT00805090|Diclofenac|diclofenac|mesh-list
20337805|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337806|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337807|NCT00805090|Analgesics|analgesics|mesh-ancestor
20337808|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
20337809|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337810|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337811|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651676|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651677|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651678|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19651679|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
19651680|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
19651681|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
19651682|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
19651683|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651684|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19651685|NCT02326727|Narcotics|narcotics|mesh-ancestor
19651686|NCT02326727|Analgesics|analgesics|mesh-ancestor
19651687|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19651688|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20168236|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337812|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337813|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20337814|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337815|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337816|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
20168237|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168238|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20168239|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168240|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20168241|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168242|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168243|NCT00144989|Cisplatin|cisplatin|mesh-list
20168244|NCT00144989|Irinotecan|irinotecan|mesh-list
20168245|NCT00144989|Etoposide|etoposide|mesh-list
20168246|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651689|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651690|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19651691|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19651692|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20337817|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337818|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20337819|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20337820|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20337821|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
20337822|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337823|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20337824|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
20337825|NCT00805116|Vitamins|vitamins|mesh-ancestor
19651693|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337826|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
20337827|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337828|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
20337829|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337830|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
20337831|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20337832|NCT00805233|Bromfenac|bromfenac|mesh-list
19651694|NCT02326441|KX2-361|kx2-361|mesh-list
20337833|NCT00805233|Ranibizumab|ranibizumab|mesh-list
20337834|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337835|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337836|NCT00805233|Growth Substances|growth substances|mesh-ancestor
20337837|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337838|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337839|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168247|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20168248|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168249|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256733|NCT04156334|Anesthetics|anesthetics|mesh-list
19256734|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256735|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256736|NCT04147546|Artenimol|artenimol|mesh-list
19256737|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
19256738|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19256739|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19256740|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256741|NCT04139304|Prednisone|prednisone|mesh-list
19256742|NCT04139304|Cortisone|cortisone|mesh-list
19256743|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
19256744|NCT04139304|Doxorubicin|doxorubicin|mesh-list
19256745|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19651695|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19651696|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651697|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651698|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256746|NCT04139304|Etoposide|etoposide|mesh-list
19256747|NCT04139304|Vincristine|vincristine|mesh-list
19256748|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
19831480|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19831481|NCT05246865|Androgens|androgens|mesh-list
19831482|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19831483|NCT05246865|Hormones|hormones|mesh-ancestor
19831484|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256749|NCT04139304|Daunorubicin|daunorubicin|mesh-list
19651699|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19651700|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
19651701|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651702|NCT02326584|Cytarabine|cytarabine|mesh-list
19651703|NCT02326584|Daunorubicin|daunorubicin|mesh-list
19651704|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19651705|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
19651706|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651707|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651708|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
19651709|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651710|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651711|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
19651712|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168250|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168251|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20168252|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20168253|NCT00145002|Lenograstim|lenograstim|mesh-list
20168254|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20168255|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
20168256|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337840|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337841|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19256750|NCT04139304|Daratumumab|daratumumab|mesh-list
19256751|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
19256752|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651713|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19651714|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19831485|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831486|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19831487|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
19831488|NCT05246644|Acetaminophen|acetaminophen|mesh-list
19831489|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19831490|NCT05246644|Analgesics|analgesics|mesh-ancestor
19831491|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
19831492|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831493|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831494|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
19831495|NCT05246631|Dexamethasone|dexamethasone|mesh-list
19831496|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
20337842|NCT00805233|Analgesics|analgesics|mesh-ancestor
20337843|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
20337844|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337845|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651715|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19651716|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651717|NCT02326623|Anesthetics|anesthetics|mesh-list
19651718|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
19651719|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651720|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651721|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
19651722|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651723|NCT02326610|Hormones|hormones|mesh-list
19651724|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651725|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651726|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19651727|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651728|NCT02326350|Aspirin|aspirin|mesh-list
19831497|NCT05246631|Haloperidol|haloperidol|mesh-list
20168257|NCT00145028|Carboplatin|carboplatin|mesh-list
20168258|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168259|NCT00145093|Chromium|chromium|mesh-list
20168260|NCT00145093|Trace Elements|trace elements|mesh-ancestor
20168261|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
20168262|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168263|NCT00145106|Minocycline|minocycline|mesh-list
20168264|NCT00145106|Tazarotene|tazarotene|mesh-list
20168265|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168266|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337846|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831498|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
19831499|NCT05246631|BB 1101|bb 1101|mesh-list
20168267|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
20168268|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
19651729|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19651730|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19651731|NCT02326350|Analgesics|analgesics|mesh-ancestor
19651732|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
19651733|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651734|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651735|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651736|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651737|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19651738|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19651739|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651740|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19651741|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19651742|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651743|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
19651744|NCT02326285|Docetaxel|docetaxel|mesh-list
19651745|NCT02326285|Gefitinib|gefitinib|mesh-list
19651746|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651747|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
19651748|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
19651749|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
19651750|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651751|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19651752|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651753|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19651754|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19651755|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
19651756|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651757|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651758|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19651759|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19651760|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651761|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651762|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651763|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19651764|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19651765|NCT02326194|Vaccines|vaccines|mesh-list
19651766|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
19651767|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651768|NCT02325986|Fluorouracil|fluorouracil|mesh-list
19651769|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651770|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
19651771|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651772|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19651773|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651774|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
19651775|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651776|NCT02326038|Methylphenidate|methylphenidate|mesh-list
19651777|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19651778|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651779|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20337847|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
20337848|NCT00805298|Epinephrine|epinephrine|mesh-list
20337849|NCT00805298|Racepinephrine|racepinephrine|mesh-list
20337850|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
20337851|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337852|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
20337853|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
20337854|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337855|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337856|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337857|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
20337858|NCT00805298|Hormones|hormones|mesh-ancestor
20337859|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337860|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20337861|NCT00805298|Protective Agents|protective agents|mesh-ancestor
20337862|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20337863|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20337864|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
20337865|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337866|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337867|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20337868|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20337869|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20337870|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
20337871|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
20337872|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
20337873|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20337874|NCT00805311|Aspirin|aspirin|mesh-list
20337875|NCT00805311|Losartan|losartan|mesh-list
20337876|NCT00805311|Amlodipine|amlodipine|mesh-list
20337877|NCT00805311|Atorvastatin|atorvastatin|mesh-list
20337878|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337879|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337880|NCT00805311|Analgesics|analgesics|mesh-ancestor
20337881|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
20337882|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337883|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337884|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337885|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337886|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20337887|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20337888|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651780|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19651781|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19651782|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651783|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
20337889|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20337890|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20337891|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337892|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
19651784|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651785|NCT02326051|Enoxaparin|enoxaparin|mesh-list
19651786|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
19651787|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
19651788|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19651789|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19651790|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651791|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
19651792|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19651793|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
19651794|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651795|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19651796|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20337893|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20337894|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19651797|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665340|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665341|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19665342|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666188|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19666189|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19666190|NCT05103397|Prednisolone|prednisolone|mesh-list
19666191|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19666192|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
19666193|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19666194|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
19666195|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19666196|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
19666197|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666198|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
19666199|NCT05103397|Hormones|hormones|mesh-ancestor
19666200|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666201|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666202|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666203|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666204|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
19666205|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
19666206|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666207|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666208|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19666209|NCT05103397|Protective Agents|protective agents|mesh-ancestor
19666210|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19666211|NCT05103254|Ezetimibe|ezetimibe|mesh-list
19666212|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19666213|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19666214|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
19666215|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168269|NCT00145171|Apomorphine|apomorphine|mesh-list
20168270|NCT00145171|Emetics|emetics|mesh-ancestor
20168271|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168272|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
20168273|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168274|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20168275|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
19831500|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831501|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
19831502|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
19831503|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831504|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831505|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19831506|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
19831507|NCT05246631|Hormones|hormones|mesh-ancestor
19831508|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651798|NCT05076955|Vancomycin|vancomycin|mesh-list
19651799|NCT05076955|Tobramycin|tobramycin|mesh-list
19651800|NCT05076955|Itraconazole|itraconazole|mesh-list
19651801|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651802|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651803|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
19651804|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19651805|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19651806|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651807|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651808|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19651809|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
19651810|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651811|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651812|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19651813|NCT05076942|Cisplatin|cisplatin|mesh-list
19651814|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651815|NCT05076799|Lactulose|lactulose|mesh-list
19651816|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19651817|NCT05076773|Morphine|morphine|mesh-list
19651818|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20168276|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
19651819|NCT05076773|Narcotics|narcotics|mesh-ancestor
19651820|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651821|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651822|NCT05076773|Analgesics|analgesics|mesh-ancestor
19651823|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
19651824|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651825|NCT05076695|Trastuzumab|trastuzumab|mesh-list
19651826|NCT05076695|Fulvestrant|fulvestrant|mesh-list
19651827|NCT05076695|Palbociclib|palbociclib|mesh-list
19651828|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19651829|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651830|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19651831|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19651832|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19651833|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
19651834|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651835|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651836|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19651837|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651838|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651839|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
19651840|NCT05076682|Choline|choline|mesh-list
19651841|NCT05076682|Antibodies|antibodies|mesh-list
19651842|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
19651843|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651844|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
19651845|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19651846|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
19651847|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651848|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19651849|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19651850|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
19651851|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19651852|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19651853|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19651854|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
19651855|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
19651856|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19651857|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
19651858|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19651859|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
19651860|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651861|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
19651862|NCT05076526|Protective Agents|protective agents|mesh-ancestor
19651863|NCT05076474|Orlistat|orlistat|mesh-list
19651864|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651865|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651866|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19651867|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19651868|NCT05076461|Ondansetron|ondansetron|mesh-list
19651869|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
19651870|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
19651871|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651872|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651873|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19651874|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
19651875|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665343|NCT05101811|Vitamin D|vitamin d|mesh-list
19665344|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
19665345|NCT05101811|Vitamins|vitamins|mesh-list
19665346|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
19665347|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651876|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19651877|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
19651878|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651879|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651880|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20337895|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
20337896|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20337897|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20337898|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20337899|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20337900|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20337901|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20337902|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
20337903|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20337904|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20337905|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20337906|NCT00805519|Chloroquine|chloroquine|mesh-list
20337907|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20337908|NCT00805519|Prednisolone|prednisolone|mesh-list
20337909|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20337910|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
20337911|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20337912|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
20337913|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20337914|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
20337915|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337916|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
20337917|NCT00805519|Hormones|hormones|mesh-ancestor
20337918|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337919|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337920|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20337921|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337922|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
19651881|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20168277|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168278|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168279|NCT00145184|Vitamins|vitamins|mesh-list
20168280|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
19651882|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651883|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19651884|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19651885|NCT05076227|Vaccines|vaccines|mesh-list
19651886|NCT05076227|Immunologic Factors|immunologic factors|mesh-ancestor
19651887|NCT05076227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168281|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
20168282|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168283|NCT00145210|Atenolol|atenolol|mesh-list
20168284|NCT00145210|Nebivolol|nebivolol|mesh-list
20168285|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20168286|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168287|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
20168288|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
20168289|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168290|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168291|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20168292|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20168293|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20337923|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
19256753|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
19651894|NCT05076019|Atorvastatin|atorvastatin|mesh-list
19651895|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19651896|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19651897|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
19651898|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651899|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19651900|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19651901|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651902|NCT05069857|Apatinib|apatinib|mesh-list
20168294|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
20168295|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168296|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168297|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
19651903|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19651904|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651905|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19651906|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651907|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651908|NCT05063136|Capecitabine|capecitabine|mesh-list
19651909|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19651910|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
19651911|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651912|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651913|NCT05034809|Melatonin|melatonin|mesh-list
19651914|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
19651915|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651916|NCT05034809|Protective Agents|protective agents|mesh-ancestor
19651917|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651918|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651919|NCT04998032|Metformin|metformin|mesh-list
19651920|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19651921|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651922|NCT04993924|Cetrorelix|cetrorelix|mesh-list
19651923|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19651924|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
19651925|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19651926|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651927|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
19651928|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19651929|NCT04956042|Cytarabine|cytarabine|mesh-list
19651930|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19651931|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
19651932|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651933|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651934|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
19651935|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651936|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651937|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
20168298|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20168299|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20168300|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20168301|NCT00145236|Nebivolol|nebivolol|mesh-list
20168302|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20337924|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337925|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19651938|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651939|NCT04893785|Temozolomide|temozolomide|mesh-list
19651940|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19651941|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
19651942|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651943|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651944|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
19651945|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19651946|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19651947|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19651948|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19651949|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19651950|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651951|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651952|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
19651953|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19651954|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19651955|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651956|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
19651957|NCT04803591|Coagulants|coagulants|mesh-ancestor
19651958|NCT04696822|Epinephrine|epinephrine|mesh-list
19651959|NCT04696822|Racepinephrine|racepinephrine|mesh-list
19651960|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
19651961|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19651962|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19651963|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
19651964|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651965|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651966|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651967|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19651968|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19651969|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
19651970|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19651971|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19651972|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
19651973|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
19651974|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
19651975|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19651976|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
19651977|NCT04608487|Fludarabine|fludarabine|mesh-list
19651978|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19651979|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
19651980|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651981|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19651982|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19651983|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
19651984|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651985|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19651986|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19651987|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19651988|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19651989|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831509|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19651990|NCT04501861|Vasopressins|vasopressins|mesh-list
19831510|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831511|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
19831512|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831513|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831514|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19651991|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
19651992|NCT04501861|Norepinephrine|norepinephrine|mesh-list
19651993|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19651994|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19651995|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
19651996|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19651997|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19651998|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19651999|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
19652000|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
19652001|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611895|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652002|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19652003|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
19652004|NCT04501861|Coagulants|coagulants|mesh-ancestor
19652005|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19652006|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
19652007|NCT04498741|Midazolam|midazolam|mesh-list
19652008|NCT04498741|Dabigatran|dabigatran|mesh-list
19652009|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19652010|NCT04498741|Tacrolimus|tacrolimus|mesh-list
19652011|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19652012|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
19652013|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652014|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19652015|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652016|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652017|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19652018|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19652019|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652020|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19652021|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652022|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652023|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19652024|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
20337926|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20337927|NCT00805519|Protective Agents|protective agents|mesh-ancestor
20337928|NCT00805519|Amebicides|amebicides|mesh-ancestor
20337929|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20337930|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20337931|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337932|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
20337933|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20337934|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20337935|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337936|NCT00805519|Analgesics|analgesics|mesh-ancestor
20337937|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
20337938|NCT00805519|Filaricides|filaricides|mesh-ancestor
20337939|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
20337940|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
20337941|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
20337942|NCT00805558|Metronidazole|metronidazole|mesh-list
20337943|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
20337944|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20337945|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20337946|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20337947|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20337948|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20337949|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337950|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337951|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337952|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19652025|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
19652026|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
20337953|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
20611896|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
20611897|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611898|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20611899|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20611900|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
19652027|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
19652028|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652029|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19652030|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19652031|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
19652032|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19652033|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19652034|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
19652035|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19652036|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
19652037|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
19665348|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19665349|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19665350|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19665351|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19665352|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
19665353|NCT05101785|Lidocaine|lidocaine|mesh-list
19665354|NCT05101785|Epinephrine|epinephrine|mesh-list
19665355|NCT05101785|Racepinephrine|racepinephrine|mesh-list
19665356|NCT05101785|Carticaine|carticaine|mesh-list
19665357|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
19665358|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
19665359|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
19665360|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665361|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665362|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
19665363|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256754|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256755|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665364|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19665365|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19665366|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19665367|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19665368|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665369|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19665370|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20168303|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
20168304|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20168305|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19665371|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
19665372|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665373|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19665374|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19665375|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
19665376|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19665377|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
19665378|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
19665379|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
20337954|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20611901|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665380|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19665381|NCT05101551|Gemcitabine|gemcitabine|mesh-list
19665382|NCT05101551|Topotecan|topotecan|mesh-list
19665383|NCT05101551|Talazoparib|talazoparib|mesh-list
19665384|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19665385|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
19665386|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665387|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665388|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
19665389|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665390|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665391|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665392|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
19665393|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337955|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337956|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20337957|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20337958|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20168306|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20168307|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
20168308|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168309|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168310|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168311|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
19652044|NCT04407988|Letrozole|letrozole|mesh-list
19652045|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652046|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19652047|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19652048|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652049|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652050|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19652051|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
19652052|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19652053|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337959|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20337960|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20337961|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20337962|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20337963|NCT00805649|Dexamethasone|dexamethasone|mesh-list
20337964|NCT00805649|Bevacizumab|bevacizumab|mesh-list
20337965|NCT00805649|Temazepam|temazepam|mesh-list
20337966|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20337967|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20337968|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20337969|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20337970|NCT00805649|Growth Substances|growth substances|mesh-ancestor
20337971|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337972|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
20337973|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20337974|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
20337975|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
20337976|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20337977|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20337978|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
20337979|NCT00805649|Hormones|hormones|mesh-ancestor
20168312|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20168313|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168314|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
20168315|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20168316|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20168317|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168318|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168319|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20168320|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20337980|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20337981|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20168321|NCT00145301|Analgesics|analgesics|mesh-ancestor
20168322|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
20168323|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652054|NCT04342078|Vitamin D|vitamin d|mesh-list
19652055|NCT04342078|Vitamins|vitamins|mesh-ancestor
19652056|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
19652057|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652058|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19652059|NCT04218266|Apixaban|apixaban|mesh-list
19652060|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19652061|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
19652062|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19652063|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
19652064|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652065|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652066|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
19652067|NCT04102241|Hemay005|hemay005|mesh-list
19652068|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
19652069|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19652070|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19652071|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652072|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652073|NCT04083014|Bortezomib|bortezomib|mesh-list
19652074|NCT04083014|Antibodies|antibodies|mesh-list
19652075|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
19652076|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652077|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652078|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19652079|NCT04039750|Clindamycin|clindamycin|mesh-list
19652080|NCT04039750|Gentamicins|gentamicins|mesh-list
19652081|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652082|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19652083|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652084|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652085|NCT04026945|Lidocaine|lidocaine|mesh-list
19652086|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
19652087|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
19652088|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652089|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652090|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
19652091|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652092|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19652093|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19652094|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19831515|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652095|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19652096|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652097|NCT03990467|Tazobactam|tazobactam|mesh-list
19652098|NCT03990467|Piperacillin|piperacillin|mesh-list
20337982|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20337983|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20337984|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20337985|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20337986|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20337987|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
20337988|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
20337989|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20337990|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20337991|NCT00805662|Oxytocin|oxytocin|mesh-list
20337992|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
20337993|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20337994|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20337995|NCT00805701|Dutasteride|dutasteride|mesh-list
20337996|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20337997|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20337998|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20337999|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338000|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
20338001|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338002|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338003|NCT00805857|Tipranavir|tipranavir|mesh-list
20338004|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20338005|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20338006|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
20338007|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338008|NCT00806169|Triamcinolone|triamcinolone|mesh-list
20338009|NCT00806169|Bevacizumab|bevacizumab|mesh-list
20338010|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20338011|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338012|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20338013|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20338014|NCT00806169|Growth Substances|growth substances|mesh-ancestor
20338015|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338016|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
20338017|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338018|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
20338019|NCT00806169|Hormones|hormones|mesh-ancestor
20338020|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338021|NCT00806247|Tapentadol|tapentadol|mesh-list
20338022|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20338023|NCT00806247|Narcotics|narcotics|mesh-ancestor
19652099|NCT03990467|Amikacin|amikacin|mesh-list
19652100|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19652101|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338024|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338025|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338026|NCT00806247|Analgesics|analgesics|mesh-ancestor
20338027|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
20338028|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338029|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20338030|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20338031|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20338032|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338033|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
20338034|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338035|NCT00806299|Loperamide|loperamide|mesh-list
20338036|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
20338037|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19652102|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19652103|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338038|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19652104|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652105|NCT03980561|Varenicline|varenicline|mesh-list
19652106|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19652107|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19652108|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
20338039|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
19652109|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652110|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652111|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652112|NCT03978767|Acetaminophen|acetaminophen|mesh-list
19652113|NCT03978767|Ibuprofen|ibuprofen|mesh-list
20611902|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20611903|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
20338040|NCT00806468|Coagulants|coagulants|mesh-ancestor
20338041|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20611904|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20611905|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20611906|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20611907|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19652114|NCT03978767|Ketorolac|ketorolac|mesh-list
19652115|NCT03978767|Oxycodone|oxycodone|mesh-list
19652116|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652117|NCT03978767|Analgesics|analgesics|mesh-ancestor
19652118|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
19652119|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652120|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652121|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
19652122|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19652123|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652124|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19652125|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19652126|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652127|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652128|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20168324|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168325|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20168326|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168327|NCT00145314|Leucovorin|leucovorin|mesh-list
20168328|NCT00145314|Folic Acid|folic acid|mesh-list
20168329|NCT00145314|Fluorouracil|fluorouracil|mesh-list
20168330|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
20168331|NCT00145314|Cetuximab|cetuximab|mesh-list
20611908|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168332|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
20168333|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
20338042|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
20611909|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
20611910|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20611911|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611912|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20611913|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611914|NCT02248870|Dexamethasone|dexamethasone|mesh-list
20611915|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652129|NCT03978767|Narcotics|narcotics|mesh-ancestor
19652130|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652131|NCT03971669|Vaccines|vaccines|mesh-list
19652132|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
20338043|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338044|NCT00806481|Sevelamer|sevelamer|mesh-list
19652133|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652134|NCT03970993|Vaccines|vaccines|mesh-list
19652135|NCT03970993|Immunologic Factors|immunologic factors|mesh-ancestor
19652136|NCT03970993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652137|NCT03838692|Ponatinib|ponatinib|mesh-list
19652138|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652139|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19652140|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652141|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652142|NCT03774186|Pancrelipase|pancrelipase|mesh-list
19652143|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19652144|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19652145|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19652146|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652147|NCT03739268|Sevelamer|sevelamer|mesh-list
19652148|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
19652149|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
20168334|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168335|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20168336|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338045|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
20338046|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
20338047|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338048|NCT00806611|Ethanol|ethanol|mesh-list
20338049|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20338050|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338051|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338052|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338053|NCT00806663|Sunitinib|sunitinib|mesh-list
20168337|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168338|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
20168339|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168340|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20168341|NCT00145314|Antidotes|antidotes|mesh-ancestor
20168342|NCT00145314|Protective Agents|protective agents|mesh-ancestor
20168343|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
20168344|NCT00145314|Vitamins|vitamins|mesh-ancestor
20168345|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
20168346|NCT00145314|Hematinics|hematinics|mesh-ancestor
20168347|NCT00145340|Pioglitazone|pioglitazone|mesh-list
20168348|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20168349|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168350|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
20168351|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20168352|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168353|NCT00145379|Metformin|metformin|mesh-list
20168354|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20168355|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168356|NCT00145405|Octreotide|octreotide|mesh-list
20168357|NCT00145405|Lanreotide|lanreotide|mesh-list
20168358|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338054|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168359|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338055|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19652150|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652151|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19652152|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652153|NCT03671525|Nimodipine|nimodipine|mesh-list
20168360|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168361|NCT00145444|Olanzapine|olanzapine|mesh-list
20168362|NCT00145444|Ziprasidone|ziprasidone|mesh-list
20168363|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
19652154|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19652155|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19652156|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19652157|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652158|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20338056|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20338057|NCT00806663|Growth Substances|growth substances|mesh-ancestor
20338058|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338059|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
20338060|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20338061|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338062|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338063|NCT00806741|Phenylephrine|phenylephrine|mesh-list
20338064|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
19652159|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652160|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
19652161|NCT03660553|Insulin|insulin|mesh-list
19652162|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19652163|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
19652164|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
19652165|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
19652166|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19652167|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652168|NCT03576443|Idelalisib|idelalisib|mesh-list
19652169|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652170|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652171|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652172|NCT03505944|Venetoclax|venetoclax|mesh-list
19652173|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652174|NCT03466294|Azacitidine|azacitidine|mesh-list
19652175|NCT03466294|Venetoclax|venetoclax|mesh-list
19652176|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338065|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19652177|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
19652178|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652179|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652180|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652181|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
19652182|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19652183|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19652184|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652185|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
19652186|NCT03353259|Coagulants|coagulants|mesh-ancestor
19652187|NCT03174184|Amoxicillin|amoxicillin|mesh-list
19652188|NCT03174184|Rifampin|rifampin|mesh-list
19652189|NCT03174184|Meropenem|meropenem|mesh-list
19652190|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
19652191|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
19652192|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19652193|NCT03174184|Rifamycins|rifamycins|mesh-list
20168364|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
20168365|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168366|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168367|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20168368|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20168369|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20168370|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168371|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20168372|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20168373|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20168374|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20338066|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20338067|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
20338068|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
20338069|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338070|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338071|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
20338072|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20338073|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
20338074|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
20338075|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19652194|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19652195|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652196|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19652197|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
19652198|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
19652199|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19652200|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652201|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652202|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19652203|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19652204|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19652205|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20338076|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20338077|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20338078|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
20338079|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338080|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338081|NCT00806741|Protective Agents|protective agents|mesh-ancestor
20338082|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338083|NCT00806754|Ciclesonide|ciclesonide|mesh-list
20338084|NCT00806754|Azelastine|azelastine|mesh-list
20338085|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
20338086|NCT00806754|Hormones|hormones|mesh-ancestor
20338087|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338088|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168375|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168376|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168377|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
20168378|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20168379|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20168380|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
20168381|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
20338089|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20338090|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20338091|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
19652206|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19652207|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19652208|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19652209|NCT03128905|Prednisone|prednisone|mesh-list
19652210|NCT03128905|Colchicine|colchicine|mesh-list
20338092|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652211|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652212|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
19652213|NCT03128905|Hormones|hormones|mesh-ancestor
19652214|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168382|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
20611916|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
20611917|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
20338093|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20338094|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
20338095|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20338096|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338097|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338098|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20168383|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20168384|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20168385|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168386|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168387|NCT00145483|Urological Agents|urological agents|mesh-ancestor
20168388|NCT00145522|Tibolone|tibolone|mesh-list
20168389|NCT00145522|Estradiol|estradiol|mesh-list
20168390|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
20168391|NCT00145522|Estrogens|estrogens|mesh-ancestor
20168392|NCT00145522|Hormones|hormones|mesh-ancestor
20168393|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168394|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168395|NCT00145522|Progestins|progestins|mesh-ancestor
20168396|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
20168397|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
20168398|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168399|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20168400|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168401|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20168402|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
20168403|NCT00145561|Ritonavir|ritonavir|mesh-list
20168404|NCT00145561|Saquinavir|saquinavir|mesh-list
20168405|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20168406|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20168407|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
20168408|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338099|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20338100|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
20338101|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
20338102|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338103|NCT00806767|Fludarabine|fludarabine|mesh-list
20338104|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
20338105|NCT00806767|Busulfan|busulfan|mesh-list
20338106|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
19831516|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19831517|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19831518|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19652215|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652216|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338107|NCT00806767|Antibodies|antibodies|mesh-list
19831519|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
19831520|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831521|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19831522|NCT05246514|Trastuzumab|trastuzumab|mesh-list
19831523|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831524|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835398|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835399|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
20168409|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338108|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
20338109|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20338110|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19652217|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652218|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
19652219|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19652220|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
19652221|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
19652222|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
19652223|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652224|NCT03121586|Pimavanserin|pimavanserin|mesh-list
19652225|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19652226|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19652227|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19652228|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652229|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652230|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652231|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652232|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19652233|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19652234|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
19652235|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652236|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652237|NCT03110926|Leucovorin|leucovorin|mesh-list
19652238|NCT03110926|Paclitaxel|paclitaxel|mesh-list
19652239|NCT03110926|Carboplatin|carboplatin|mesh-list
19652240|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
19652241|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19831525|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
20338111|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338112|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338113|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
20338114|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338115|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338116|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
20338117|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338118|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
20338119|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20338120|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19652242|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652243|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
19652244|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
19652245|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
20338121|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
20338122|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20338123|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20338124|NCT00806871|Prednisolone|prednisolone|mesh-list
20338125|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
20338126|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20338127|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
20338128|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338129|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
20338130|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
20338131|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338132|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338133|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338134|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
20338135|NCT00806871|Hormones|hormones|mesh-ancestor
20338136|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338137|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20338138|NCT00806871|Protective Agents|protective agents|mesh-ancestor
20338139|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338140|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338141|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
20338142|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20338143|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338144|NCT00806910|Conivaptan|conivaptan|mesh-list
20338145|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20338146|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338147|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
20338148|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338149|NCT00806923|Gemcitabine|gemcitabine|mesh-list
20338150|NCT00806923|Bevacizumab|bevacizumab|mesh-list
19652246|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652247|NCT03110926|Antidotes|antidotes|mesh-ancestor
20611918|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611919|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611920|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20611921|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
20611922|NCT02248870|Hormones|hormones|mesh-ancestor
20611923|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20611924|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20611925|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611926|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
20611927|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20611928|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20611929|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20611930|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20611931|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611932|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652248|NCT03110926|Protective Agents|protective agents|mesh-ancestor
19652249|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652250|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
19652251|NCT03110926|Vitamins|vitamins|mesh-ancestor
19652252|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
19652253|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19652254|NCT02997761|Blinatumomab|blinatumomab|mesh-list
19652255|NCT02997761|Antibodies|antibodies|mesh-list
19652256|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
19652257|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19652258|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
19652259|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19652260|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
19652261|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652262|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652263|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19652264|NCT02913495|Progesterone|progesterone|mesh-list
19652265|NCT02913495|Progestins|progestins|mesh-ancestor
19652266|NCT02913495|Hormones|hormones|mesh-ancestor
19652267|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19652268|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652269|NCT02823990|Nivolumab|nivolumab|mesh-list
19652270|NCT02823990|Interleukin-2|interleukin-2|mesh-list
19652271|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652272|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19652273|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652274|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19652275|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652276|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652277|NCT02823990|Analgesics|analgesics|mesh-ancestor
19652278|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
19652279|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652280|NCT02633098|Artesunate|artesunate|mesh-list
19652281|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
19652282|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19652283|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19652284|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338151|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20338152|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611933|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611934|NCT02248896|Telmisartan|telmisartan|mesh-list
19652285|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652286|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
19831526|NCT05246371|Propofol|propofol|mesh-list
19652287|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
20611935|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
20611936|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20611937|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20611938|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20611939|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20612266|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19652288|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19652289|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
19652290|NCT02624128|Cetuximab|cetuximab|mesh-list
20338153|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20338154|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20338155|NCT00806923|Growth Substances|growth substances|mesh-ancestor
20338156|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338157|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
20338158|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338159|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
20338160|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338161|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
20338162|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338163|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338164|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338165|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
20338166|NCT00806936|Insulin|insulin|mesh-list
20338167|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20338168|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20338169|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338170|NCT00806962|Vaccines|vaccines|mesh-list
20338171|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
20338172|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338173|NCT00807053|Ciclesonide|ciclesonide|mesh-list
20338174|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
20338175|NCT00807053|Hormones|hormones|mesh-ancestor
20338176|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338177|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338178|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20348196|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348197|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20348198|NCT00863889|Protective Agents|protective agents|mesh-ancestor
20348199|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20348200|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348201|NCT00863902|Cetirizine|cetirizine|mesh-list
20348202|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20348203|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20348204|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20348205|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
20348206|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
20348207|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348208|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348209|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348210|NCT00863915|Ramipril|ramipril|mesh-list
20348211|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20348212|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
20348213|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831527|NCT05246371|Desflurane|desflurane|mesh-list
20612267|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20612268|NCT02250859|Minocycline|minocycline|mesh-list
20612269|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652291|NCT02624128|Valproic Acid|valproic acid|mesh-list
19831528|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
20612270|NCT02250872|Cisplatin|cisplatin|mesh-list
20612271|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612272|NCT02250924|Caffeine|caffeine|mesh-list
20612273|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20612274|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612275|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20612276|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612277|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168410|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20168411|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20168412|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
20168413|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168414|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20168415|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20168416|NCT00145613|Antibodies|antibodies|mesh-list
20168417|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
20168418|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168419|NCT00145639|Carboplatin|carboplatin|mesh-list
20168420|NCT00145639|Doxorubicin|doxorubicin|mesh-list
20168421|NCT00145639|Ifosfamide|ifosfamide|mesh-list
20168422|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168423|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168424|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20168425|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168426|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168427|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168428|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20168429|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
20168430|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20338179|NCT00807066|Gefitinib|gefitinib|mesh-list
20338180|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338181|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20338182|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168431|NCT00145652|Hematinics|hematinics|mesh-ancestor
20338183|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652292|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652293|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19652294|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
20338184|NCT00807079|Carboplatin|carboplatin|mesh-list
20338185|NCT00807079|Topotecan|topotecan|mesh-list
20338186|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338187|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20338188|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20338189|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338190|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338191|NCT00807118|Fesoterodine|fesoterodine|mesh-list
20338192|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20338193|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20338194|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
20338195|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338196|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338197|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652295|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652296|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652297|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
19652298|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652299|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168432|NCT00145665|Telbivudine|telbivudine|mesh-list
20168433|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
20168434|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168435|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20338198|NCT00807118|Urological Agents|urological agents|mesh-ancestor
20338199|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
20338200|NCT00807196|Rituximab|rituximab|mesh-list
20338201|NCT00807196|Fludarabine|fludarabine|mesh-list
20338202|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338203|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
19652300|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
19652301|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652302|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652303|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19665394|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19665395|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19665396|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19665397|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
19665398|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19665399|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665400|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20168436|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168437|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168438|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
20168439|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
20168440|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20168441|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20168442|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20168443|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338204|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665401|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
19665402|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19652304|NCT02578069|Sirolimus|sirolimus|mesh-list
19652305|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19652306|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652307|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19652308|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652309|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
19652310|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19652311|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
19652312|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652313|NCT02514031|Gemcitabine|gemcitabine|mesh-list
19652314|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
19652315|NCT02514031|Paclitaxel|paclitaxel|mesh-list
19652316|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19652317|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652318|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
19652319|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
19831529|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19831530|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831531|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19831532|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19831533|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
19831534|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19831535|NCT05246371|Analgesics|analgesics|mesh-ancestor
19831536|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
19652320|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
19652321|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652322|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19652323|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
19652324|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
19652325|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256756|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19652326|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652327|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831537|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831538|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20338205|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338206|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20338207|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
20338208|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338209|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338210|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20338211|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20338212|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20338213|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20338214|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338215|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20338216|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19652328|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
19652329|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652330|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19652331|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19652332|NCT02427126|Aspirin|aspirin|mesh-list
19652333|NCT02427126|Apixaban|apixaban|mesh-list
19652334|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19652335|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652336|NCT02427126|Analgesics|analgesics|mesh-ancestor
19652337|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
19652338|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652339|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652340|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652341|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19652342|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19652343|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19652344|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652345|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19652346|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19652347|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652348|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
19652349|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19652350|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
19652351|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19652352|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
19652353|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
19652354|NCT05080569|Progesterone|progesterone|mesh-list
20611940|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611941|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
20611942|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
20611943|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20611944|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611945|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611946|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652355|NCT05080569|Progestins|progestins|mesh-ancestor
19652356|NCT05080569|Hormones|hormones|mesh-ancestor
19652357|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19652358|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652359|NCT05080556|Carboplatin|carboplatin|mesh-list
20174743|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174744|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174745|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
20174746|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
20174747|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
20174748|NCT00165477|Lenalidomide|lenalidomide|mesh-list
20174749|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
20174750|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174751|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20174752|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20174753|NCT00165477|Growth Substances|growth substances|mesh-ancestor
20174754|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
20174755|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174756|NCT00165490|Irinotecan|irinotecan|mesh-list
20174757|NCT00165490|Cetuximab|cetuximab|mesh-list
20174758|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174759|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20174760|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20174761|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652360|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168444|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20168445|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20168446|NCT00145730|Ibuprofen|ibuprofen|mesh-list
20338217|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19652361|NCT05080543|Terlipressin|terlipressin|mesh-list
19652362|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19652363|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19652364|NCT05080530|Vitamin D|vitamin d|mesh-list
19652365|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
19652366|NCT05080530|Vitamins|vitamins|mesh-ancestor
19652367|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
19652368|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652369|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19652370|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19652371|NCT05080478|Clopidogrel|clopidogrel|mesh-list
19652372|NCT05080478|Ticagrelor|ticagrelor|mesh-list
19652373|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19652374|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19652375|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19652376|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19652377|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
19652378|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652379|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652380|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652381|NCT05080348|Ropivacaine|ropivacaine|mesh-list
19652382|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
19652383|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
19652384|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652385|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652386|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
19652387|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652388|NCT05080192|Fenofibrate|fenofibrate|mesh-list
20168447|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20168448|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20168449|NCT00145730|Analgesics|analgesics|mesh-ancestor
20168450|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
20168451|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168452|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168453|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20168454|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168455|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20168456|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168457|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168458|NCT00145847|Naltrexone|naltrexone|mesh-list
20168459|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20168460|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20611947|NCT02249013|Paclitaxel|paclitaxel|mesh-list
20611948|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20611949|NCT02249013|Carboplatin|carboplatin|mesh-list
20611950|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20611951|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611952|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
20611953|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
20611954|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
20611955|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338218|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338219|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
20338220|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338221|NCT00807261|Gemcitabine|gemcitabine|mesh-list
20338222|NCT00807261|Docetaxel|docetaxel|mesh-list
20338223|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338224|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
20338225|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338226|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338227|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
20338228|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338229|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338230|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338231|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
20338232|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338233|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
20338234|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
20338235|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
20338236|NCT00807326|Simethicone|simethicone|mesh-list
20338237|NCT00807326|Loperamide|loperamide|mesh-list
20338238|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
20338239|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338240|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
20338241|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652389|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19652390|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
19652391|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652392|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19652393|NCT05080140|Ezetimibe|ezetimibe|mesh-list
19652394|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19652395|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19652396|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
19652397|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652398|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19652399|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
19652400|NCT05080049|Hematinics|hematinics|mesh-ancestor
19652401|NCT05080010|Carboplatin|carboplatin|mesh-list
19652402|NCT05080010|Etoposide|etoposide|mesh-list
19652403|NCT05080010|Vincristine|vincristine|mesh-list
19652404|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652405|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19652406|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19652407|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19652408|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652409|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338242|NCT00807326|Emollients|emollients|mesh-ancestor
20338243|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
20338244|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
20338245|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20338246|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20338247|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
20338248|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338249|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20338250|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20338251|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338252|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338253|NCT00807521|Dexamethasone|dexamethasone|mesh-list
20338254|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338255|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
20338256|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
20338257|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338258|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338259|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338260|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
19652410|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
20338261|NCT00807521|Hormones|hormones|mesh-ancestor
19652411|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
20338262|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338263|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338264|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338265|NCT00807534|Bromides|bromides|mesh-list
20338266|NCT00807534|Ipratropium|ipratropium|mesh-list
20338267|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
20338268|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20338269|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
20338270|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338271|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338272|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20338273|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
20338274|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20338275|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
20338276|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338277|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338278|NCT00807547|Vaccines|vaccines|mesh-list
20338279|NCT00807547|Immunologic Factors|immunologic factors|mesh-ancestor
20338280|NCT00807547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338281|NCT00807625|Copper|copper|mesh-list
20338282|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20338283|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
20338284|NCT00807625|Trace Elements|trace elements|mesh-ancestor
20338285|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
20338286|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338287|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20338288|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
20338289|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20338290|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20338291|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20338292|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338293|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338294|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20338295|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20338296|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20338297|NCT00807690|Tacrolimus|tacrolimus|mesh-list
20338298|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338299|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
20338300|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338301|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20338302|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338303|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338304|NCT00807755|Carboplatin|carboplatin|mesh-list
20338305|NCT00807755|Etoposide|etoposide|mesh-list
20338306|NCT00807755|Everolimus|everolimus|mesh-list
20338307|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338308|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20338309|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20338310|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20338311|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338312|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338313|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338314|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
20338315|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338316|NCT00807807|Folic Acid|folic acid|mesh-list
20338317|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
20338318|NCT00807807|Hematinics|hematinics|mesh-ancestor
20338319|NCT00807807|Vitamins|vitamins|mesh-ancestor
20338320|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
20338321|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338322|NCT00807859|Paclitaxel|paclitaxel|mesh-list
20338323|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20338324|NCT00807859|Capecitabine|capecitabine|mesh-list
20338325|NCT00807859|Trastuzumab|trastuzumab|mesh-list
20338326|NCT00807859|Lapatinib|lapatinib|mesh-list
20338327|NCT00807859|Trebananib|trebananib|mesh-list
20338328|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20338329|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652412|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
19652413|NCT05079880|Caffeine|caffeine|mesh-list
20168461|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168462|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
20168463|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652414|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
19652415|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652416|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19652417|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652418|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19652419|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652420|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19652421|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19652422|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
19652423|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652424|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19652425|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19652426|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652427|NCT05079789|Amiloride|amiloride|mesh-list
19652428|NCT05079789|Furosemide|furosemide|mesh-list
19652429|NCT05079789|Diuretics|diuretics|mesh-ancestor
19652430|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
19652431|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652432|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19652433|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19652434|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652435|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19652436|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19652437|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19652438|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19652439|NCT05079763|Monolaurin|monolaurin|mesh-list
19652440|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
19652441|NCT05079763|Protective Agents|protective agents|mesh-ancestor
19652442|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652443|NCT05079087|Midazolam|midazolam|mesh-list
19652444|NCT05079087|Ketamine|ketamine|mesh-list
19652445|NCT05079087|Analgesics|analgesics|mesh-ancestor
19652446|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
19652447|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652448|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168464|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20168465|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
20168466|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256757|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
20168467|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
20168468|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338330|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
20338331|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
20338332|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
20338333|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338334|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338335|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
20338336|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20338337|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20338338|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652449|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19652450|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20338339|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20338340|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20338341|NCT00807859|Growth Substances|growth substances|mesh-ancestor
20338342|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338343|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
20338344|NCT00807872|Antibodies|antibodies|mesh-list
20338345|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20338346|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
20338347|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338348|NCT00807950|Simvastatin|simvastatin|mesh-list
20338349|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20338350|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20338351|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
20338352|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338353|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20338354|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20338355|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338356|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
19652451|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
19652452|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
19652453|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652454|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19652455|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19652456|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652457|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652458|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19652459|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19652460|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19652461|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652462|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652463|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
20168469|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20168470|NCT00145925|Gliclazide|gliclazide|mesh-list
20168471|NCT00145925|Perindopril|perindopril|mesh-list
20168472|NCT00145925|Indapamide|indapamide|mesh-list
20168473|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
20168474|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20168475|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
20168476|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168477|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168478|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168479|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20168480|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652464|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
19652465|NCT05079022|Aflutinib|aflutinib|mesh-list
19652466|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19652467|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652468|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168481|NCT00145925|Diuretics|diuretics|mesh-ancestor
20168482|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
20168483|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20168484|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19652469|NCT05078944|Donepezil|donepezil|mesh-list
19652470|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19652471|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652472|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652473|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
19652474|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652475|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652476|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
19652477|NCT05078788|Triamcinolone|triamcinolone|mesh-list
19652478|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652479|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
19652480|NCT05078788|Hormones|hormones|mesh-ancestor
19652481|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19652482|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831539|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19831540|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19831541|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
19831542|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831543|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831544|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19831545|NCT05246111|Topotecan|topotecan|mesh-list
19831546|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19831547|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19652483|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19652484|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
19652485|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652486|NCT05078372|Midazolam|midazolam|mesh-list
19652487|NCT05078372|Ropivacaine|ropivacaine|mesh-list
19652488|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
19652489|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
20168485|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
19652490|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168486|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
20168487|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20168488|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20168489|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652491|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652492|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
19652493|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652494|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19652495|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19652496|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20168490|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168491|NCT00145938|Urological Agents|urological agents|mesh-ancestor
20168492|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
20168493|NCT00145990|Miotics|miotics|mesh-ancestor
20168494|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
20168495|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168496|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168497|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20168498|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20168499|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
20168500|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20168501|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20168502|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
19652497|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652498|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652499|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19652500|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
19652501|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
19652502|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
19652503|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652504|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652505|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
19652506|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338357|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20338358|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652507|NCT05078255|Incretins|incretins|mesh-ancestor
19652508|NCT05078255|Hormones|hormones|mesh-ancestor
19652509|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19652510|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652511|NCT05078177|Rituximab|rituximab|mesh-list
19652512|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20338359|NCT00808002|Tenofovir|tenofovir|mesh-list
19652513|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652514|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
19652515|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652516|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19652517|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
19652518|NCT05078138|Hematinics|hematinics|mesh-ancestor
19652519|NCT05077813|Vitamin D|vitamin d|mesh-list
19652520|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
19652521|NCT05077813|Vitamins|vitamins|mesh-list
19652522|NCT05077813|Minocycline|minocycline|mesh-list
19652523|NCT05077813|Tretinoin|tretinoin|mesh-list
19652524|NCT05077813|Alitretinoin|alitretinoin|mesh-list
19652525|NCT05077813|Isotretinoin|isotretinoin|mesh-list
19652526|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
19652527|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652528|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19652529|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19652530|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19652531|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652532|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338360|NCT00808002|Emtricitabine|emtricitabine|mesh-list
20338361|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
20338362|NCT00808002|Maraviroc|maraviroc|mesh-list
20338363|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
20338364|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338365|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20338366|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20338367|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338368|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338369|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20338370|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20338371|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20338372|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20338373|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20338374|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20338375|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20338376|NCT00808054|Lidocaine|lidocaine|mesh-list
20338377|NCT00808054|Prilocaine|prilocaine|mesh-list
20338378|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
20338379|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
19652533|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
19652534|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
20338380|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665403|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665404|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831548|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338381|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338382|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
20338383|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338384|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19652535|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
19652536|NCT05077592|Povidone|povidone|mesh-list
19652537|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
19652538|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
19652539|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19652540|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652541|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
19652542|NCT05077527|Fludarabine|fludarabine|mesh-list
19652543|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19652544|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
19652545|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652546|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19652547|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19652548|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
19652549|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652550|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652551|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19652552|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
19652553|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
19652554|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
19652555|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652556|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652557|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
19652558|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
19652559|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
19652560|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652561|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652562|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
19652563|NCT05077215|Lenvatinib|lenvatinib|mesh-list
19652564|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19652565|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652566|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19652567|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652568|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652569|NCT05077137|Vaccines|vaccines|mesh-list
19652570|NCT05077137|Immunologic Factors|immunologic factors|mesh-ancestor
19652571|NCT05077137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652572|NCT05077111|Anesthetics|anesthetics|mesh-list
19652573|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652574|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652575|NCT05075863|Letrozole|letrozole|mesh-list
19652576|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652577|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19652578|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19652579|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652580|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652581|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19652582|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
20338385|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20338386|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20338387|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20338388|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338389|NCT00808145|Gemcitabine|gemcitabine|mesh-list
20338390|NCT00808145|Cisplatin|cisplatin|mesh-list
20338391|NCT00808145|Sorafenib|sorafenib|mesh-list
20338392|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338393|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338394|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
20338395|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338396|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
20338397|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338398|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338399|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338400|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
20338401|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338402|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20338403|NCT00808171|Lidocaine|lidocaine|mesh-list
20338404|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
19652583|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338405|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
20338406|NCT00808171|Prilocaine|prilocaine|mesh-list
20338407|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20338408|NCT00808171|Anesthetics|anesthetics|mesh-list
20338409|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338410|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338411|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
20338412|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338413|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20338414|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20338415|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19652584|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652585|NCT05068141|Paclitaxel|paclitaxel|mesh-list
19652586|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19652587|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652588|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
19652589|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
19652590|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
20338416|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20338417|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338418|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20338419|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
20338420|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20338421|NCT00808171|Analgesics|analgesics|mesh-ancestor
20338422|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20338423|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
20338424|NCT00808184|Midazolam|midazolam|mesh-list
20338425|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20338426|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20338427|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338428|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338429|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20338430|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20338431|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20338432|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19652591|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652592|NCT05068037|Antiemetics|antiemetics|mesh-list
19652593|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
19652594|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652595|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652596|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19652597|NCT05053425|Cytarabine|cytarabine|mesh-list
19652598|NCT05053425|Azacitidine|azacitidine|mesh-list
19652599|NCT05053425|Venetoclax|venetoclax|mesh-list
19652600|NCT05053425|Idarubicin|idarubicin|mesh-list
19652601|NCT05053425|Cladribine|cladribine|mesh-list
20338433|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
20338434|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
20338435|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
20338436|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
20338437|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338438|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338439|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20338440|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20338441|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
19652602|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19652603|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
19652604|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652605|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652606|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
19652607|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652608|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19652609|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
19652610|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652611|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652612|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20338442|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338443|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19652613|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20338444|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20338445|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652614|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19652615|NCT05044871|Paclitaxel|paclitaxel|mesh-list
19652616|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19652617|NCT05044871|Bevacizumab|bevacizumab|mesh-list
19652618|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19652619|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652620|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
19652621|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19652622|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19652623|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652624|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19652625|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19652626|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19652627|NCT05044871|Growth Substances|growth substances|mesh-ancestor
19652628|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652629|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
19652630|NCT05021562|Niraparib|niraparib|mesh-list
19652631|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19652632|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652633|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652634|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652635|NCT05015686|Vaccines|vaccines|mesh-list
19652636|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
19652637|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168503|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168504|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338446|NCT00808223|Alefacept|alefacept|mesh-list
20338447|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
20338448|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
20338449|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338450|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
20338451|NCT00808275|Calcium|calcium|mesh-list
20338452|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20338453|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338454|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20168505|NCT00146016|Amantadine|amantadine|mesh-list
20168506|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20168507|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20168508|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
20168509|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168510|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
20168511|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168512|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168513|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168514|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20168515|NCT00146016|Analgesics|analgesics|mesh-ancestor
20168516|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
20168517|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168518|NCT00146042|Erythromycin|erythromycin|mesh-list
20168519|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
20338455|NCT00808314|Dipyridamole|dipyridamole|mesh-list
20338456|NCT00808314|Regadenoson|regadenoson|mesh-list
19652638|NCT05005260|Bupivacaine|bupivacaine|mesh-list
19652639|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
19652640|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
19652641|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652642|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652643|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
19652644|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652645|NCT04996199|Zileuton|zileuton|mesh-list
19652646|NCT04996199|Carbamazepine|carbamazepine|mesh-list
19652647|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
19652648|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
19652649|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
19652650|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652651|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652652|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652653|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652654|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652655|NCT04996199|Analgesics|analgesics|mesh-ancestor
19652656|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
19652657|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652658|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19652659|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19652660|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652661|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19652662|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19652663|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19652664|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19652665|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652666|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19652667|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19652668|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652669|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19652670|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
19652671|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19652672|NCT04990284|Levodopa|levodopa|mesh-list
19652673|NCT04990284|Opicapone|opicapone|mesh-list
19652674|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19652675|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19652676|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
19652677|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652678|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652679|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652680|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19652681|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652682|NCT04988971|Corticosterone|corticosterone|mesh-list
19652683|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
19652684|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652685|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19652686|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
19652687|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
19652688|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652689|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652690|NCT04984733|Nivolumab|nivolumab|mesh-list
19652691|NCT04984733|Temozolomide|temozolomide|mesh-list
19652692|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19652693|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168520|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19652694|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19652695|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338457|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20338458|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338459|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338460|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20338461|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
20338462|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20338463|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20338464|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
20168521|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
20168522|NCT00146042|Docetaxel|docetaxel|mesh-list
20168523|NCT00146042|Trastuzumab|trastuzumab|mesh-list
20168524|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168525|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
20168526|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
20168527|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
20168528|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168529|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20168530|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168531|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168532|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20168533|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20168534|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168535|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
20168536|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20168537|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
20168538|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168539|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168540|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
20168541|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338465|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
20338466|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338467|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338468|NCT00808327|Fentanyl|fentanyl|mesh-list
20338469|NCT00808327|Bupivacaine|bupivacaine|mesh-list
20338470|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
20338471|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
20338472|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338473|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338474|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
20338475|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338476|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20338477|NCT00808327|Narcotics|narcotics|mesh-ancestor
20338478|NCT00808327|Analgesics|analgesics|mesh-ancestor
20338479|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20338480|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20338481|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
20338482|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
20338483|NCT00808366|Clotrimazole|clotrimazole|mesh-list
20338484|NCT00808366|Miconazole|miconazole|mesh-list
19652696|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19831549|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831550|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831551|NCT05246072|Ivermectin|ivermectin|mesh-list
19831552|NCT05246072|Colchicine|colchicine|mesh-list
20338485|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
19652697|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
19652698|NCT04973826|Aztreonam|aztreonam|mesh-list
19652699|NCT04973826|Avibactam|avibactam|mesh-list
19652700|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19652701|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652702|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19652703|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652704|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652705|NCT04940637|Niraparib|niraparib|mesh-list
19652706|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19831553|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
20168542|NCT00146120|Etoposide|etoposide|mesh-list
20168543|NCT00146120|Idarubicin|idarubicin|mesh-list
20338486|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338487|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19831554|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831555|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
19831556|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
19831557|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
20338488|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20338489|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20338490|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338491|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338492|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20338493|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
20338494|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338495|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338496|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20338497|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20338498|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
20338499|NCT00808392|Vaccines|vaccines|mesh-list
20338500|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
20338501|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338502|NCT00808418|Docetaxel|docetaxel|mesh-list
20338503|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338504|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
20338505|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
20338506|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
20338507|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338508|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20338509|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20338510|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20338511|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
20338512|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338513|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20338514|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20338515|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338516|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
20338517|NCT00808704|Hematinics|hematinics|mesh-ancestor
20338518|NCT00808717|Atorvastatin|atorvastatin|mesh-list
20338519|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20338520|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20338521|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
20338522|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338523|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20338524|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20338525|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338526|NCT00808743|Celecoxib|celecoxib|mesh-list
20338527|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20338528|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20338529|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20338530|NCT00808743|Analgesics|analgesics|mesh-ancestor
20338531|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
20338532|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338533|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652707|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338534|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338535|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338536|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20338537|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20338538|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338539|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338540|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20338541|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338542|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
20338543|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20338544|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
20338545|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338546|NCT00808795|Expectorants|expectorants|mesh-ancestor
20338547|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
20338548|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20338549|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
20338550|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338551|NCT00808795|Protective Agents|protective agents|mesh-ancestor
20338552|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338553|NCT00808795|Antidotes|antidotes|mesh-ancestor
20338554|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
20338555|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
20338556|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20338557|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20338558|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338559|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338560|NCT00808912|Urological Agents|urological agents|mesh-ancestor
20348214|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348215|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348216|NCT00863941|Bupropion|bupropion|mesh-list
20348217|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20348218|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
20168544|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20168545|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168546|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20168547|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168548|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168549|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831558|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831559|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168550|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168551|NCT00146146|Letrozole|letrozole|mesh-list
20168552|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
20168553|NCT00146146|Dutasteride|dutasteride|mesh-list
20168554|NCT00146146|Testosterone|testosterone|mesh-list
20168555|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
20348219|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348220|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19831560|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19831561|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831562|NCT05245994|Carboplatin|carboplatin|mesh-list
19831563|NCT05245994|Etoposide|etoposide|mesh-list
19831564|NCT05245994|Durvalumab|durvalumab|mesh-list
19831565|NCT05245994|Olaparib|olaparib|mesh-list
20168556|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
19652708|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652709|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652710|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
19652711|NCT04926454|Bupivacaine|bupivacaine|mesh-list
19652712|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
19652713|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
19652714|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652715|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652716|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
20338561|NCT00808951|Artesunate|artesunate|mesh-list
20338562|NCT00808951|Lumefantrine|lumefantrine|mesh-list
20338563|NCT00808951|Artemether|artemether|mesh-list
20338564|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20338565|NCT00808951|Amodiaquine|amodiaquine|mesh-list
20338566|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
20338567|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20338568|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19256758|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256759|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256760|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19256761|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19256762|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19256763|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19256764|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256765|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19256766|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
19256767|NCT04139304|Hormones|hormones|mesh-ancestor
19256768|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256769|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19256770|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256771|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256772|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256773|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
19256774|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
19256775|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
20168557|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20168558|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168559|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20168560|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20168561|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168562|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256782|NCT04060758|Latanoprost|latanoprost|mesh-list
19256783|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19256784|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19256785|NCT04058990|Paclitaxel|paclitaxel|mesh-list
19652717|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652718|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19652719|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652720|NCT04926454|Analgesics|analgesics|mesh-ancestor
19652721|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19652722|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19652723|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19652724|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19652725|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652726|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652727|NCT04925427|Naloxone|naloxone|mesh-list
19652728|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19256786|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19256787|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256788|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256789|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
19652729|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652730|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
19652731|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652732|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
19652733|NCT04913025|Nivolumab|nivolumab|mesh-list
19652734|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20168563|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19256790|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256791|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
19256792|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652735|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168564|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
19652736|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19652737|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652738|NCT04905654|Cromakalim|cromakalim|mesh-list
19652739|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19652740|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19652741|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
19652742|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652743|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652744|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19831566|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831567|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19831568|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19831569|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19831570|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831571|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831572|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831573|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19831574|NCT05245968|Sunitinib|sunitinib|mesh-list
19831575|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
19831576|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831577|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19831578|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19831579|NCT05245968|Growth Substances|growth substances|mesh-ancestor
19831580|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831581|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
19831582|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19831583|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831584|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831585|NCT05245916|Rituximab|rituximab|mesh-list
20168565|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168566|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168567|NCT00146146|Androgens|androgens|mesh-ancestor
20168568|NCT00146146|Hormones|hormones|mesh-ancestor
20168569|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20168570|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
20168571|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20168572|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
20168573|NCT00146159|Analgesics|analgesics|mesh-ancestor
20168574|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
20168575|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168576|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168577|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168578|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20168579|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168580|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168581|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168582|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19652745|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
19652746|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
19652747|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
19665405|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665406|NCT05101291|Bupivacaine|bupivacaine|mesh-list
19665407|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
19665408|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
20338569|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338570|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338571|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
20338572|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
20338573|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20338574|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
20338575|NCT00808977|Mesalamine|mesalamine|mesh-list
20338576|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20338577|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20338578|NCT00808977|Analgesics|analgesics|mesh-ancestor
20338579|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
20338580|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338581|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338582|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338583|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338584|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20338585|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20338586|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168583|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20168584|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20168585|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
20168586|NCT00146224|Hematinics|hematinics|mesh-ancestor
20168587|NCT00146237|Phenytoin|phenytoin|mesh-list
20168588|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
20168589|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20168590|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20168591|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20168592|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168593|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20338587|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20168594|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19652748|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19652749|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19652750|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19652751|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
19652752|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652753|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19652754|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19652755|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652756|NCT04824131|Tenofovir|tenofovir|mesh-list
19652757|NCT04824131|Emtricitabine|emtricitabine|mesh-list
19652758|NCT04824131|Cabotegravir|cabotegravir|mesh-list
19652759|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
19652760|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652761|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19652762|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20338588|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338589|NCT00809029|Incretins|incretins|mesh-ancestor
20338590|NCT00809029|Hormones|hormones|mesh-ancestor
20338591|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338592|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338593|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
20338594|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338595|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
20338596|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338597|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338598|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20338599|NCT00809068|Tibolone|tibolone|mesh-list
20338600|NCT00809068|Fenofibrate|fenofibrate|mesh-list
20338601|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19652763|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338602|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
20338603|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338604|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20338605|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
20338606|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
20338607|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338608|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338609|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20338610|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338611|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338612|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20338613|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
20338614|NCT00809068|Hormones|hormones|mesh-ancestor
19652764|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652765|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19652766|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19652767|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19652768|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19652769|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19652770|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19652771|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19652772|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652773|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652774|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19652775|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20168595|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
20168596|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20168597|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
20168598|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
20168599|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168600|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168601|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20168602|NCT00146250|Analgesics|analgesics|mesh-ancestor
20168603|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
20168604|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168605|NCT00146276|Gemcitabine|gemcitabine|mesh-list
20338615|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20338616|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20168606|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338617|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338618|NCT00809172|Cyclosporine|cyclosporine|mesh-list
20338619|NCT00809172|Methotrexate|methotrexate|mesh-list
20338620|NCT00809172|Cyclosporins|cyclosporins|mesh-list
20338621|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20338622|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
20338623|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20338624|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338625|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20338626|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
20338627|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338628|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338629|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
20338630|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338631|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19652776|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338632|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19652777|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
19652778|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652779|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
19652780|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19652781|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652782|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652783|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652784|NCT04798482|Analgesics|analgesics|mesh-ancestor
19652785|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
19652786|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652787|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19652788|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19652789|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19652790|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
19652791|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652792|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652793|NCT04797312|Sufentanil|sufentanil|mesh-list
20338633|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
19652794|NCT04797312|Remifentanil|remifentanil|mesh-list
19652795|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
19652796|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
19652797|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652798|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652799|NCT04797312|Narcotics|narcotics|mesh-ancestor
19652800|NCT04797312|Analgesics|analgesics|mesh-ancestor
19652801|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
19652802|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652803|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19652804|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19652805|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
19652806|NCT04771156|Ketorolac|ketorolac|mesh-list
19652807|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19652808|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20338634|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338635|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20338636|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
20338637|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338638|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20338639|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20338640|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
20338641|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20338642|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
20338643|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338644|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
19652809|NCT04771156|Analgesics|analgesics|mesh-ancestor
19652810|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
19652811|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652812|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652813|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652814|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338645|NCT00809198|Protective Agents|protective agents|mesh-ancestor
20338646|NCT00809198|Laxatives|laxatives|mesh-ancestor
20338647|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338648|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
20338649|NCT00809237|Gefitinib|gefitinib|mesh-list
20338650|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
20338651|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20338652|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20338653|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338654|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338655|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338656|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338657|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338658|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20338659|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
20338660|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20338661|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338662|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20338663|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20338664|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338665|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652815|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19652816|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652817|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338666|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338667|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
19652818|NCT04735263|Atorvastatin|atorvastatin|mesh-list
19652819|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19652820|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19652821|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
20611956|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20338668|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19665409|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611957|NCT02249026|Buprenorphine|buprenorphine|mesh-list
20611958|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
20611959|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20611960|NCT02249026|Narcotics|narcotics|mesh-ancestor
20611961|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20611962|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611963|NCT02249026|Analgesics|analgesics|mesh-ancestor
20611964|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
20611965|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611966|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20611967|NCT02249039|Clonidine|clonidine|mesh-list
20611968|NCT02249039|Analgesics|analgesics|mesh-ancestor
20611969|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
20611970|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20611971|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20611972|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168607|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
20168608|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168609|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20611973|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
20611974|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
20168610|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
20338669|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20168611|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338670|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338671|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
20338672|NCT00809393|Coagulants|coagulants|mesh-ancestor
20338673|NCT00809536|Metformin|metformin|mesh-list
20338674|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20338675|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338676|NCT00809549|Lenograstim|lenograstim|mesh-list
20338677|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20338678|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
20338679|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338680|NCT00809627|Caffeine|caffeine|mesh-list
20611975|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20611976|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20611977|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20611978|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
20611979|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20611980|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611981|NCT02249078|Quetmolimab|quetmolimab|mesh-list
20611982|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20612278|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20612279|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20612280|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
20612281|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612282|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
20612283|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612284|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
20612285|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
20612286|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612287|NCT02251041|Tocopherols|tocopherols|mesh-list
20612288|NCT02251041|Vitamin E|vitamin e|mesh-list
20612289|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
20612290|NCT02251041|Infliximab|infliximab|mesh-list
20612291|NCT02251041|Epoprostenol|epoprostenol|mesh-list
20612292|NCT02251041|Tezosentan|tezosentan|mesh-list
20612293|NCT02251041|Melatonin|melatonin|mesh-list
20612294|NCT02251041|Antithrombins|antithrombins|mesh-list
20612295|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
20612296|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
20612297|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612298|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612299|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168612|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168613|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168614|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
20168615|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831586|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831587|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831588|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
19831589|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831590|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338681|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20338682|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338683|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20338684|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338685|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338686|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20338687|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20338688|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
20338689|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338690|NCT00809692|Histamine|histamine|mesh-list
20338691|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
20338692|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
20338693|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
20338694|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338695|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338696|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338697|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20338698|NCT00809705|Incretins|incretins|mesh-ancestor
20338699|NCT00809705|Hormones|hormones|mesh-ancestor
19831591|NCT05245877|Enoxaparin|enoxaparin|mesh-list
20338700|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338701|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338702|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
20338703|NCT00809718|Rifapentine|rifapentine|mesh-list
19831592|NCT05245877|Dalteparin|dalteparin|mesh-list
20611983|NCT02249130|Ritonavir|ritonavir|mesh-list
20611984|NCT02249130|Lamivudine|lamivudine|mesh-list
20611985|NCT02249130|Zidovudine|zidovudine|mesh-list
20611986|NCT02249130|Stavudine|stavudine|mesh-list
20611987|NCT02249130|Tipranavir|tipranavir|mesh-list
20611988|NCT02249130|Delavirdine|delavirdine|mesh-list
19831593|NCT05245877|Tinzaparin|tinzaparin|mesh-list
20611989|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20611990|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20611991|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
20611992|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20611993|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20611994|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20611995|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20611996|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
20611997|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612300|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
20611998|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20611999|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20338704|NCT00809718|Rifampin|rifampin|mesh-list
20338705|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20338706|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20338707|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
20338708|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338709|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20338710|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20338711|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338712|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338713|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20338714|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
20338715|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20338716|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
20338717|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20338718|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20338719|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20338720|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20338721|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20338722|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20338723|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20338724|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
20338725|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20338726|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338727|NCT00809744|Vitamins|vitamins|mesh-ancestor
20338728|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
20338729|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20338730|NCT00809796|Pentamidine|pentamidine|mesh-list
20338731|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
20338732|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338733|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20338734|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20338735|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20612000|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20338736|NCT00809874|Caseins|caseins|mesh-list
20338737|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
20338738|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
20338739|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612001|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20612002|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
20612003|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20612004|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20612005|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612006|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612007|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20612008|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20612009|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612010|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
20338740|NCT00809887|Micafungin|micafungin|mesh-list
20338741|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
20338742|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338743|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
20338744|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20338745|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338746|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20612011|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612012|NCT02249299|Nabiximols|nabiximols|mesh-list
20612013|NCT02249299|Analgesics|analgesics|mesh-ancestor
20612014|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
20612015|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652822|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652823|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19652824|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20338747|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20338748|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612016|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612017|NCT02249364|Propofol|propofol|mesh-list
20612018|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20612019|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612020|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612021|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20338749|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338750|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338751|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20338752|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20338753|NCT00809939|Progesterone|progesterone|mesh-list
20338754|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20338755|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20338756|NCT00809939|Progestins|progestins|mesh-ancestor
20338757|NCT00809939|Hormones|hormones|mesh-ancestor
20338758|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338759|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338760|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20338761|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
20338762|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20338763|NCT00810030|Hematinics|hematinics|mesh-ancestor
20338764|NCT00810121|Ketoprofen|ketoprofen|mesh-list
20338765|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20338766|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20338767|NCT00810121|Analgesics|analgesics|mesh-ancestor
20338768|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
20338769|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338770|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338771|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338772|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338773|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20338774|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338775|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338776|NCT00810316|Clonazepam|clonazepam|mesh-list
20338777|NCT00810316|Alprazolam|alprazolam|mesh-list
20338778|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20338779|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338780|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338781|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20338782|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20338783|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20338784|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
20338785|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
20338786|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338787|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338788|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
20338789|NCT00810381|Nitroprusside|nitroprusside|mesh-list
20338790|NCT00810381|Isosorbide|isosorbide|mesh-list
20338791|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20338792|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20338793|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
20338794|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
20338795|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20338796|NCT00810381|Diuretics|diuretics|mesh-ancestor
19652825|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652826|NCT04734886|Vitamin D|vitamin d|mesh-list
19652827|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
20338797|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
20338798|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338799|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20338800|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338801|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20338802|NCT00810446|Rifabutin|rifabutin|mesh-list
20338803|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20338804|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338805|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20338806|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
20338807|NCT00810524|Lamivudine|lamivudine|mesh-list
20338808|NCT00810524|Adefovir|adefovir|mesh-list
19256796|NCT04035837|Interferons|interferons|mesh-list
19256797|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
19256798|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256799|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
19256800|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256801|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
19256802|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256803|NCT04019327|Temozolomide|temozolomide|mesh-list
19256804|NCT04019327|Talazoparib|talazoparib|mesh-list
19256805|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19256806|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
19256807|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256808|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256809|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19256810|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338809|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20338810|NCT00810524|Telbivudine|telbivudine|mesh-list
20338811|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20338812|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20338813|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338814|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338815|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
19652828|NCT04734886|Vitamins|vitamins|mesh-list
19652829|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
19652830|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652831|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19652832|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19652833|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
19652834|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19652835|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20338816|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338817|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20338818|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20338819|NCT00810563|Bupivacaine|bupivacaine|mesh-list
20338820|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
20338821|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
20338822|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338823|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338824|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
20338825|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338826|NCT00810589|Insulin|insulin|mesh-list
20338827|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20338828|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
19256811|NCT04019288|Durvalumab|durvalumab|mesh-list
19256812|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
19652836|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20338829|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
20338830|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20338831|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338832|NCT00810680|Valproic Acid|valproic acid|mesh-list
20338833|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
20338834|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338835|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338836|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
20338837|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20338838|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338839|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
20338840|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20338841|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338842|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20168616|NCT00146289|Telmisartan|telmisartan|mesh-list
20168617|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19652837|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20168618|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20168619|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20168620|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168621|NCT00146341|Telmisartan|telmisartan|mesh-list
20168622|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168623|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20168624|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20168625|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168626|NCT00146380|Lamivudine|lamivudine|mesh-list
20168627|NCT00146380|Zidovudine|zidovudine|mesh-list
20168628|NCT00146380|Nevirapine|nevirapine|mesh-list
20168629|NCT00146380|Nelfinavir|nelfinavir|mesh-list
20338843|NCT00810706|Exemestane|exemestane|mesh-list
20338844|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338845|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19652838|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652839|NCT04664959|Denosumab|denosumab|mesh-list
19652840|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19652841|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652842|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
19652843|NCT04662723|Empagliflozin|empagliflozin|mesh-list
19652844|NCT04662723|Canagliflozin|canagliflozin|mesh-list
19652845|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20338846|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20338847|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612022|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
19652846|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
19652847|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19652848|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19652849|NCT04662723|Prednisolone|prednisolone|mesh-list
19652850|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
19652851|NCT04662723|Losartan|losartan|mesh-list
20338848|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338849|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20338850|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
20338851|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338852|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338853|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20338854|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
20338855|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338856|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
20338857|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338858|NCT00810849|Prednisolone|prednisolone|mesh-list
20338859|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338860|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
20338861|NCT00810849|Hormones|hormones|mesh-ancestor
20338862|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338863|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338864|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338865|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338866|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
20338867|NCT00810862|Lactitol|lactitol|mesh-list
19652852|NCT04662723|Ramipril|ramipril|mesh-list
19652853|NCT04662723|Lisinopril|lisinopril|mesh-list
19831594|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20338868|NCT00810862|Cathartics|cathartics|mesh-ancestor
20338869|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338870|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20338871|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20338872|NCT00810862|Analgesics|analgesics|mesh-ancestor
20338873|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
20338874|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338875|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338876|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338877|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19652854|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19831595|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
19652855|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
19652856|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19652857|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
19652858|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
19652859|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652860|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652861|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19652862|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
19652863|NCT04662723|Hormones|hormones|mesh-ancestor
19652864|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19652865|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19652866|NCT04662723|Protective Agents|protective agents|mesh-ancestor
19652867|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19652868|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168630|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20168631|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20168632|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168633|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168634|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
20168635|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168636|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19652869|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652870|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19652871|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19652872|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19652873|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19652874|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19652875|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19652876|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
19652877|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652878|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19652879|NCT04654429|Ondansetron|ondansetron|mesh-list
19256813|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19652880|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
20168637|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20338878|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
20168638|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
20168639|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20168640|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20168641|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20168642|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20168643|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
20168644|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20168645|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20168646|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174762|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174763|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20174764|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
20174765|NCT00165516|Antidotes|antidotes|mesh-ancestor
20174766|NCT00165516|Protective Agents|protective agents|mesh-ancestor
20174767|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174768|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
20174769|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174770|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
20174771|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174772|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174773|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
20174774|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
20174775|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
20174776|NCT00165555|Antidotes|antidotes|mesh-ancestor
20174777|NCT00165555|Protective Agents|protective agents|mesh-ancestor
20174778|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174779|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
20174780|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174781|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
20174782|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174783|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174784|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
20174785|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
20174786|NCT00165568|Bevacizumab|bevacizumab|mesh-list
20174787|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20174788|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174789|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20174790|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20174791|NCT00165568|Growth Substances|growth substances|mesh-ancestor
20174792|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174793|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
20174794|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20174795|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174796|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20174797|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174798|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174799|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
20174800|NCT00165633|Menatetrenone|menatetrenone|mesh-list
20174801|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
20174802|NCT00165633|Coagulants|coagulants|mesh-ancestor
20174803|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20174804|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20174805|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174806|NCT00165633|Vitamins|vitamins|mesh-ancestor
20174807|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
20174808|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174809|NCT00165659|Donepezil|donepezil|mesh-list
20174810|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20174811|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174812|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174813|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
20174814|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174815|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174816|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
20174817|NCT00165685|Sibutramine|sibutramine|mesh-list
20174818|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
20174819|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20174820|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
20174821|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20174822|NCT00165737|Donepezil|donepezil|mesh-list
20174823|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20174824|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256814|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
19256815|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256816|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256817|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
19256818|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256819|NCT03991403|Paclitaxel|paclitaxel|mesh-list
19256820|NCT03991403|Bevacizumab|bevacizumab|mesh-list
19256821|NCT03991403|Carboplatin|carboplatin|mesh-list
19256822|NCT03991403|Pemetrexed|pemetrexed|mesh-list
19256823|NCT03991403|Atezolizumab|atezolizumab|mesh-list
19256824|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256825|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256826|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256827|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256828|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
19831596|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19831597|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20338879|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338880|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
20338881|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20338882|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338883|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338884|NCT00810914|Bupivacaine|bupivacaine|mesh-list
19831598|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831599|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
19831600|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20338885|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
20338886|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
20338887|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20338888|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338889|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
19831601|NCT05245734|Antibodies|antibodies|mesh-list
19831602|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
19831603|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19831604|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
19831605|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338890|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20338891|NCT00810940|Mannitol|mannitol|mesh-list
19256829|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256830|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256831|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19256832|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19256833|NCT03991403|Growth Substances|growth substances|mesh-ancestor
19256834|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256835|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
19256836|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256837|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19256838|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256839|NCT03978091|Ceftazidime|ceftazidime|mesh-list
19256840|NCT03978091|Avibactam|avibactam|mesh-list
19256841|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
20338892|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20338893|NCT00810940|Diuretics|diuretics|mesh-ancestor
20338894|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
20338895|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338896|NCT00810953|Pentamidine|pentamidine|mesh-list
20338897|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
20338898|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338899|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19256842|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19256843|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256844|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19256845|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256846|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259135|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259136|NCT00364637|Anesthetics|anesthetics|mesh-list
19259137|NCT00364637|Sevoflurane|sevoflurane|mesh-list
19259138|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652881|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
19831606|NCT05245721|Nalbuphine|nalbuphine|mesh-list
20338900|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20338901|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20338902|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
20338903|NCT00811005|Methoxsalen|methoxsalen|mesh-list
20338904|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20338905|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
20338906|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338907|NCT00811031|Prednisone|prednisone|mesh-list
20338908|NCT00811031|Docetaxel|docetaxel|mesh-list
20338909|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338910|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20338911|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20338912|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20338913|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20338914|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338915|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
20338916|NCT00811031|Hormones|hormones|mesh-ancestor
20338917|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338918|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338919|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20338920|NCT00811083|Succimer|succimer|mesh-list
20338921|NCT00811083|Antidotes|antidotes|mesh-ancestor
20338922|NCT00811083|Protective Agents|protective agents|mesh-ancestor
20338923|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338924|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
20338925|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
20338926|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348221|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348222|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348223|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348224|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
20168647|NCT00146471|Levetiracetam|levetiracetam|mesh-list
20168648|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
20168649|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
20168650|NCT00146484|Insulin|insulin|mesh-list
20168651|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20168652|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168653|NCT00146497|Budesonide|budesonide|mesh-list
20168654|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20168655|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20168656|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20168657|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
20168658|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168659|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168660|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20168661|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
20168662|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
20168663|NCT00146497|Hormones|hormones|mesh-ancestor
20168664|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168665|NCT00146523|Mifepristone|mifepristone|mesh-list
20168666|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20168667|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
20168668|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20338927|NCT00811096|Chloroquine|chloroquine|mesh-list
20338928|NCT00811096|Tinidazole|tinidazole|mesh-list
20338929|NCT00811096|Amebicides|amebicides|mesh-ancestor
20168669|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338930|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20338931|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20338932|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20338933|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
20338934|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20338935|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
20338936|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168670|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20168671|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20168672|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20168673|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
20168674|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20168675|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20168676|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
20338937|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20338938|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20338939|NCT00811122|Corticosterone|corticosterone|mesh-list
20338940|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338941|NCT00811200|Triamcinolone|triamcinolone|mesh-list
20338942|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20338943|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20338944|NCT00811200|Ranibizumab|ranibizumab|mesh-list
20338945|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20338946|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20338947|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20338948|NCT00811200|Growth Substances|growth substances|mesh-ancestor
20338949|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338950|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
20338951|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20338952|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20338953|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
20338954|NCT00811200|Hormones|hormones|mesh-ancestor
20338955|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20338956|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20338957|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
20338958|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831607|NCT05245721|Bupivacaine|bupivacaine|mesh-list
19831608|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
19831609|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
20338959|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652882|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652883|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652884|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20338960|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20338961|NCT00811226|Olmesartan|olmesartan|mesh-list
20338962|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20338963|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20338964|NCT00811226|Diuretics|diuretics|mesh-ancestor
20338965|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
20338966|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338967|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20338968|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20338969|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652885|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
19652886|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
19652887|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19652888|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
19652889|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612023|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
19652890|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652891|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19652892|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19652893|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19652894|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652895|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19652896|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
19652897|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19652898|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19652899|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652900|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
19652901|NCT04650698|Coagulants|coagulants|mesh-ancestor
19652902|NCT04593563|Psilocybin|psilocybin|mesh-list
20168677|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168678|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
19652903|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
20168679|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19652904|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831610|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168680|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20168681|NCT00146549|Paclitaxel|paclitaxel|mesh-list
20168682|NCT00146549|Vinorelbine|vinorelbine|mesh-list
20168683|NCT00146549|Docetaxel|docetaxel|mesh-list
20168684|NCT00146549|Trastuzumab|trastuzumab|mesh-list
20168685|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20168686|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168687|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
20168688|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
19831611|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831612|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
19831613|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831614|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19831615|NCT05245721|Narcotics|narcotics|mesh-ancestor
19831616|NCT05245721|Analgesics|analgesics|mesh-ancestor
20168689|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
20168690|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168691|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20168692|NCT00146562|Paclitaxel|paclitaxel|mesh-list
20168693|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
19652905|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19652906|NCT04554836|Cetuximab|cetuximab|mesh-list
19652907|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19652908|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652909|NCT04551911|Calcifediol|calcifediol|mesh-list
19652910|NCT04551911|Vitamins|vitamins|mesh-ancestor
19652911|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
19831617|NCT05245708|Oxytocin|oxytocin|mesh-list
19256847|NCT03945357|Gemcitabine|gemcitabine|mesh-list
20168694|NCT00146562|Doxorubicin|doxorubicin|mesh-list
20168695|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
20168696|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20168697|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168698|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
20168699|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
20338970|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20338971|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20338972|NCT00811239|Antivenins|antivenins|mesh-list
20338973|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
20338974|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338975|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
20338976|NCT00811291|Folic Acid|folic acid|mesh-list
20338977|NCT00811291|Calcium|calcium|mesh-list
20338978|NCT00811291|Vitamins|vitamins|mesh-ancestor
19831618|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
20168700|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
19652912|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831619|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19831620|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338979|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
20168701|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168702|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168703|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
20168704|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168705|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168706|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20168707|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
20168708|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20168709|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168710|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20338980|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20338981|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20338982|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20338983|NCT00811291|Hematinics|hematinics|mesh-ancestor
20338984|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
20338985|NCT00811330|Atorvastatin|atorvastatin|mesh-list
20338986|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20338987|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20338988|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
20338989|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831621|NCT05245604|Cyclosporine|cyclosporine|mesh-list
20168711|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20168712|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168713|NCT00146562|Hematinics|hematinics|mesh-ancestor
20168714|NCT00146575|Sirolimus|sirolimus|mesh-list
20168715|NCT00146575|Paclitaxel|paclitaxel|mesh-list
20168716|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20168717|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168718|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
20168719|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
20338990|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20338991|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20338992|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20338993|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
20338994|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20338995|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20338996|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20338997|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
19652913|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19652914|NCT04536272|Heparin|heparin|mesh-list
19652915|NCT04536272|Calcium heparin|calcium heparin|mesh-list
19652916|NCT04536272|Enoxaparin|enoxaparin|mesh-list
19652917|NCT04536272|Nadroparin|nadroparin|mesh-list
19652918|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
19652919|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19652920|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19652921|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652922|NCT04533880|Calcium|calcium|mesh-list
19652923|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19652924|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652925|NCT04529460|Antibodies|antibodies|mesh-list
19652926|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
19652927|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665410|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665411|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
20338998|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168720|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
20168721|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168722|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168723|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168724|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168725|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
20168726|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168727|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
20168728|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168729|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
20338999|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20339000|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20339001|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339002|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339003|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339004|NCT00811369|Fulvestrant|fulvestrant|mesh-list
20339005|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339006|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339007|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20339008|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20339009|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
20339010|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339011|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339012|NCT00811408|Cidofovir|cidofovir|mesh-list
20339013|NCT00811408|Carboplatin|carboplatin|mesh-list
20339014|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339015|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
20339016|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168730|NCT00146588|Capecitabine|capecitabine|mesh-list
20339017|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339018|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339019|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
20339020|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
20339021|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20339022|NCT00811421|Mefloquine|mefloquine|mesh-list
20339023|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
20339024|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20168731|NCT00146588|Epirubicin|epirubicin|mesh-list
20168732|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168733|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
20168734|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168735|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168736|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20168737|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
20168738|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168739|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339025|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20339026|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339027|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20339028|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339029|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339030|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20339031|NCT00811421|Renal Agents|renal agents|mesh-ancestor
20339032|NCT00811447|Docetaxel|docetaxel|mesh-list
20339033|NCT00811447|Fluorouracil|fluorouracil|mesh-list
20339034|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339035|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
20339036|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
20339037|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
20339038|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339039|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
20339040|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339041|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339042|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
20339043|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168740|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20168741|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20168742|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
20168743|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168744|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20168745|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20339044|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20339045|NCT00811460|Incretins|incretins|mesh-ancestor
20339046|NCT00811460|Hormones|hormones|mesh-ancestor
20348225|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168746|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652928|NCT04478721|Meropenem|meropenem|mesh-list
19652929|NCT04478721|Temocillin|temocillin|mesh-list
19652930|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19652931|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652932|NCT04428203|Cannabidiol|cannabidiol|mesh-list
19652933|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
19652934|NCT04427956|Riboflavin|riboflavin|mesh-list
19652935|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
19652936|NCT04427956|Vitamins|vitamins|mesh-ancestor
19652937|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
19652938|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652939|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19652940|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
19652941|NCT04417062|Olaparib|olaparib|mesh-list
19652942|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19652943|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19652944|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652945|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652946|NCT04397107|Aldesleukin|aldesleukin|mesh-list
19652947|NCT04397107|Interleukin-2|interleukin-2|mesh-list
19652948|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652949|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652950|NCT04397107|Analgesics|analgesics|mesh-ancestor
19652951|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
19652952|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652953|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652954|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19652955|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19652956|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
19652957|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339047|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339048|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339049|NCT00811486|Spironolactone|spironolactone|mesh-list
20339050|NCT00811486|Conivaptan|conivaptan|mesh-list
20339051|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20339052|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
20348226|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652958|NCT04387942|Aldesleukin|aldesleukin|mesh-list
19652959|NCT04387942|Interleukin-2|interleukin-2|mesh-list
19652960|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19652961|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19652962|NCT04387942|Analgesics|analgesics|mesh-ancestor
19652963|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
20168747|NCT00146601|Fulvestrant|fulvestrant|mesh-list
20168748|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19831622|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19831623|NCT05245604|Cyclosporins|cyclosporins|mesh-list
20168749|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339053|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339054|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339055|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20339056|NCT00811486|Diuretics|diuretics|mesh-ancestor
20339057|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
20339058|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20339059|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339060|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20339061|NCT00811603|Cefazolin|cefazolin|mesh-list
20339062|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339063|NCT00811681|Pioglitazone|pioglitazone|mesh-list
20339064|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339065|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339066|NCT00811746|Eszopiclone|eszopiclone|mesh-list
19831624|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168750|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20168751|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20168752|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
20168753|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168754|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168755|NCT00146614|Sirolimus|sirolimus|mesh-list
20168756|NCT00146614|Methotrexate|methotrexate|mesh-list
20168757|NCT00146614|Tacrolimus|tacrolimus|mesh-list
19831625|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339067|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20168758|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20168759|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
20168760|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20168761|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168762|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256848|NCT03945357|Clindamycin|clindamycin|mesh-list
19256849|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
19256850|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
19256851|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256852|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
19256853|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256854|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256855|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
19256856|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256857|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256858|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256859|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
19256860|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256861|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19256862|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19256863|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20339068|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339069|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339070|NCT00811759|Temozolomide|temozolomide|mesh-list
20339071|NCT00811759|Sorafenib|sorafenib|mesh-list
20339072|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20339073|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
19256864|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20168763|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
20168764|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168765|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168766|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
20168767|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168768|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20168769|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339074|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256865|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256866|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256867|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
19256868|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256869|NCT03934814|Rituximab|rituximab|mesh-list
19256870|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
19256871|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256872|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256873|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
20339075|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339076|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20339077|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339078|NCT00811785|Copper|copper|mesh-list
20339079|NCT00811785|Trace Elements|trace elements|mesh-ancestor
20339080|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
20339081|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256874|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256875|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256876|NCT03930771|Capecitabine|capecitabine|mesh-list
19256877|NCT03930771|Temozolomide|temozolomide|mesh-list
19256878|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256879|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
19256880|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256881|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256882|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19256883|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
19256884|NCT03926624|Cytarabine|cytarabine|mesh-list
19256885|NCT03926624|Fludarabine|fludarabine|mesh-list
19256886|NCT03926624|Etoposide|etoposide|mesh-list
20339082|NCT00811837|Midazolam|midazolam|mesh-list
19256887|NCT03926624|Azacitidine|azacitidine|mesh-list
19256888|NCT03926624|Decitabine|decitabine|mesh-list
19256889|NCT03926624|Venetoclax|venetoclax|mesh-list
19256890|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
19652964|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19652965|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652966|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19652967|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19652968|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
19652969|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19652970|NCT04386317|Terazosin|terazosin|mesh-list
19652971|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19652972|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19652973|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19652974|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
19652975|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652976|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652977|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652978|NCT04386317|Urological Agents|urological agents|mesh-ancestor
19652979|NCT04380142|Levodopa|levodopa|mesh-list
19652980|NCT04380142|Carbidopa|carbidopa|mesh-list
19652981|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19652982|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19652983|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
19652984|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19652985|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19652986|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652987|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20168770|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
20168771|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168772|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20168773|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20168774|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168775|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168776|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20168777|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
20339083|NCT00811837|Remifentanil|remifentanil|mesh-list
20339084|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20339085|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20339086|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339087|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339088|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20339089|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20339090|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20339091|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20339092|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
20339093|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
20339094|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
20339095|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
20339096|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339097|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339098|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20339099|NCT00811837|Narcotics|narcotics|mesh-ancestor
20339100|NCT00811837|Analgesics|analgesics|mesh-ancestor
20339101|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
20339102|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339103|NCT00811876|Leuprolide|leuprolide|mesh-list
20339104|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20339105|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
20339106|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20339107|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339108|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339109|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339110|NCT00811915|Sirolimus|sirolimus|mesh-list
20339111|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339112|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339113|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20339114|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339115|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
20339116|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339117|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
20339118|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339119|NCT00811967|Ribavirin|ribavirin|mesh-list
20339120|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20339121|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
20339122|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
20339123|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339124|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
20339125|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339126|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
20339127|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339128|NCT00811980|Vancomycin|vancomycin|mesh-list
20339129|NCT00811980|Linezolid|linezolid|mesh-list
20339130|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339131|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339132|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20339133|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339134|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339135|NCT00811993|Gemcitabine|gemcitabine|mesh-list
20339136|NCT00811993|Etoposide|etoposide|mesh-list
20339137|NCT00811993|Docetaxel|docetaxel|mesh-list
20339138|NCT00811993|Bevacizumab|bevacizumab|mesh-list
20339139|NCT00811993|Carboplatin|carboplatin|mesh-list
20339140|NCT00811993|Capecitabine|capecitabine|mesh-list
20339141|NCT00811993|Trastuzumab|trastuzumab|mesh-list
20339142|NCT00811993|Irinotecan|irinotecan|mesh-list
20339143|NCT00811993|Cetuximab|cetuximab|mesh-list
20339144|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20339145|NCT00811993|Temozolomide|temozolomide|mesh-list
20339146|NCT00811993|Sorafenib|sorafenib|mesh-list
20339147|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20339148|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339149|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256891|NCT03926624|Idarubicin|idarubicin|mesh-list
20339150|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
20339151|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
20339152|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339153|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20339154|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20339155|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339156|NCT00811993|Growth Substances|growth substances|mesh-ancestor
20339157|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339158|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
20339159|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339160|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
20339161|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
20339162|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339163|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339164|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339165|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
20339166|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20339167|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19652988|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339168|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20339169|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20339170|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20339171|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
20339172|NCT00812019|Vaccines|vaccines|mesh-list
20339173|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20339174|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
20339175|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652989|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19652990|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
19652991|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652992|NCT04278573|Vitamin D|vitamin d|mesh-list
19652993|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
20168778|NCT00146627|Eflornithine|eflornithine|mesh-list
20168779|NCT00146627|Nifurtimox|nifurtimox|mesh-list
20168780|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168781|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20168782|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20168783|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20168784|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168785|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20168786|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168787|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168788|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
20168789|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
19652994|NCT04278573|Vitamins|vitamins|mesh-ancestor
19652995|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
19652996|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19652997|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19652998|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20339176|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20168790|NCT00146718|Amodiaquine|amodiaquine|mesh-list
20168791|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
20168792|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20168793|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20168794|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168795|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20168796|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168797|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168798|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20168799|NCT00146718|Renal Agents|renal agents|mesh-ancestor
20168800|NCT00146731|Artesunate|artesunate|mesh-list
20168801|NCT00146731|Amodiaquine|amodiaquine|mesh-list
20168802|NCT00146731|Dapsone|dapsone|mesh-list
20168803|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
20168804|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
20339177|NCT00812123|Cyclosporine|cyclosporine|mesh-list
20168805|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20168806|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20168807|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168808|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168809|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
20168810|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
20168811|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20168812|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
20168813|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20168814|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168815|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339178|NCT00812123|Sirolimus|sirolimus|mesh-list
20339179|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
20339180|NCT00812123|Prednisone|prednisone|mesh-list
20339181|NCT00812123|Cyclosporins|cyclosporins|mesh-list
20339182|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339183|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
20339184|NCT00812123|Hormones|hormones|mesh-ancestor
20339185|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339186|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339187|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339188|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339189|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339190|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339191|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339192|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
20339193|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
20339194|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339195|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
20339196|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339197|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20339198|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20339199|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20339200|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
20339201|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339202|NCT00812175|Sorafenib|sorafenib|mesh-list
19831626|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831627|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
20168816|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
20339203|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168817|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168818|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
20168819|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
20168820|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20168821|NCT00146783|Amodiaquine|amodiaquine|mesh-list
20168822|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
20168823|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20168824|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20168825|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168826|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20168827|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339204|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20339205|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653020|NCT04259944|Capecitabine|capecitabine|mesh-list
20339206|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339207|NCT00812214|Eszopiclone|eszopiclone|mesh-list
20339208|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20339209|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339210|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339211|NCT00812266|Carboplatin|carboplatin|mesh-list
20339212|NCT00812266|Etoposide|etoposide|mesh-list
20339213|NCT00812266|Topotecan|topotecan|mesh-list
20339214|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339215|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20339216|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20339217|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20339218|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339219|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339220|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19653021|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19653022|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
19653023|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339221|NCT00812292|Rilpivirine|rilpivirine|mesh-list
20339222|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20339223|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20339224|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339225|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339226|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
20339227|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339228|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20339229|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20339230|NCT00812318|Cabotegravir|cabotegravir|mesh-list
20339231|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20339232|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20339233|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339234|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339235|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20339236|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20339237|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
20339238|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339239|NCT00812344|Ketoconazole|ketoconazole|mesh-list
20339240|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
20339241|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339242|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20339243|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20339244|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339245|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339246|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20339247|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
20339248|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339249|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339250|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20339251|NCT00812370|Bivalirudin|bivalirudin|mesh-list
20339252|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
20339253|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20339254|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
20339255|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339256|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339257|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
20339258|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
20339259|NCT00812396|Testosterone|testosterone|mesh-list
20339260|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
20339261|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
20339262|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20339263|NCT00812396|Androgens|androgens|mesh-ancestor
20339264|NCT00812396|Hormones|hormones|mesh-ancestor
20339265|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339266|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653024|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339267|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339268|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339269|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
20339270|NCT00812422|Ibuprofen|ibuprofen|mesh-list
20339271|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20339272|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20339273|NCT00812422|Analgesics|analgesics|mesh-ancestor
20339274|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
20339275|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339276|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339277|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339278|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339279|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20339280|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339281|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339282|NCT00812435|Eptifibatide|eptifibatide|mesh-list
20339283|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20339284|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20339285|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
20339286|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339287|NCT00812448|Protective Agents|protective agents|mesh-ancestor
20339288|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339289|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20339290|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20339291|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339292|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20339293|NCT00812513|Becaplermin|becaplermin|mesh-list
20339294|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
20339295|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20339296|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339297|NCT00812513|Growth Substances|growth substances|mesh-ancestor
20339298|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831628|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831629|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
19831630|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831631|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
19831632|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831633|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20168828|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168829|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20168830|NCT00146783|Renal Agents|renal agents|mesh-ancestor
20168831|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20168832|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
19653025|NCT04217278|Cytarabine|cytarabine|mesh-list
19653026|NCT04217278|Fludarabine|fludarabine|mesh-list
19653027|NCT04217278|Busulfan|busulfan|mesh-list
19653028|NCT04217278|Thiotepa|thiotepa|mesh-list
19653029|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653030|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339299|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
20168833|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339300|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20339301|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339302|NCT00812578|Vitamins|vitamins|mesh-ancestor
20339303|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
20339304|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20339305|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
20339306|NCT00812669|Rituximab|rituximab|mesh-list
20339307|NCT00812669|Fludarabine|fludarabine|mesh-list
20339308|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
20339309|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339310|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
20339311|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339312|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168834|NCT00146900|Citalopram|citalopram|mesh-list
20168835|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20168836|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20168837|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20168838|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168839|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168840|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
20339313|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19653031|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
19653032|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653033|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653034|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
19653035|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653036|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
19653037|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653038|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
19653039|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20339314|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
20339315|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339316|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339317|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20339318|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20339319|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339320|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
20339321|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20339322|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19653040|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19653041|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19653042|NCT04205266|Hematinics|hematinics|mesh-ancestor
19653043|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19653044|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19653045|NCT04202263|Minocycline|minocycline|mesh-list
19653046|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19653047|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653048|NCT04192955|Salicylates|salicylates|mesh-list
19653049|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19653050|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653051|NCT04192955|Analgesics|analgesics|mesh-ancestor
19653052|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
19653053|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653054|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653055|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653056|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653057|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19653058|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653059|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653060|NCT04170517|Progesterone|progesterone|mesh-list
19653061|NCT04170517|Progestins|progestins|mesh-ancestor
19653062|NCT04170517|Hormones|hormones|mesh-ancestor
19653063|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653064|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653065|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
19653066|NCT04162756|Fludarabine|fludarabine|mesh-list
19653067|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653068|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
19653069|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168841|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653070|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339323|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
20339324|NCT00812760|Levodopa|levodopa|mesh-list
20339325|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20339326|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20339327|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
20339328|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339329|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339330|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339331|NCT00812786|Cyclosporine|cyclosporine|mesh-list
19831634|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19831635|NCT05245552|Vaccines|vaccines|mesh-list
20339332|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
19831636|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
19831637|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256892|NCT03926624|Cladribine|cladribine|mesh-list
19256893|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256894|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256895|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
19259139|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653071|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19653072|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
19653073|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653074|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653075|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19653076|NCT04156581|Dexamethasone|dexamethasone|mesh-list
19653077|NCT04156581|Bupivacaine|bupivacaine|mesh-list
19653078|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653079|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
20168842|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20168843|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
20168844|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20168845|NCT00146913|Interferons|interferons|mesh-list
20168846|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
20168847|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168848|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
20168849|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168850|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20168851|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168852|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168853|NCT00146926|Lidocaine|lidocaine|mesh-list
20168854|NCT00146926|Ephedrine|ephedrine|mesh-list
20168855|NCT00146926|Ketamine|ketamine|mesh-list
20168856|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
20168857|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
20168858|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168859|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168860|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
20168861|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168862|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20168863|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19653080|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
19653081|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653082|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653083|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19653084|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
19653085|NCT04156581|Hormones|hormones|mesh-ancestor
19653086|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653087|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19653088|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653089|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
19653090|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
19653091|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653092|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
19653093|NCT04153136|Valsartan|valsartan|mesh-list
19653094|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19653095|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19831638|NCT05245448|Tetrandrine|tetrandrine|mesh-list
20168864|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20168865|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339333|NCT00812786|Everolimus|everolimus|mesh-list
20339334|NCT00812786|Tacrolimus|tacrolimus|mesh-list
20339335|NCT00812786|Cyclosporins|cyclosporins|mesh-list
20339336|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20339337|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
20339338|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168866|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168867|NCT00146926|Analgesics|analgesics|mesh-ancestor
20168868|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20168869|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20168870|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
20168871|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20168872|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20168873|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168874|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20168875|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
20339339|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20339340|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168876|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
20339341|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339342|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
20339343|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339344|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
20339345|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339346|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339347|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20339348|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20339349|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
20339350|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339351|NCT00812825|Prednisolone|prednisolone|mesh-list
20339352|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339353|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
20168877|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20168878|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
20168879|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
20168880|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20168881|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20168882|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20168883|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20168884|NCT00147121|Rituximab|rituximab|mesh-list
20168885|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20168886|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168887|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
20339354|NCT00812825|Hormones|hormones|mesh-ancestor
20339355|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339356|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339357|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339358|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339359|NCT00812851|Dronabinol|dronabinol|mesh-list
20339360|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
20339361|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339362|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20339363|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20339364|NCT00812851|Analgesics|analgesics|mesh-ancestor
20339365|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
20339366|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339367|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20339368|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20339369|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653096|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19653097|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19653098|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653099|NCT04149990|Valsartan|valsartan|mesh-list
20168888|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168889|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339370|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339371|NCT00812851|Hormones|hormones|mesh-ancestor
20339372|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339373|NCT00812864|Capecitabine|capecitabine|mesh-list
20339374|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339375|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
20339376|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339377|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339378|NCT00812994|Citalopram|citalopram|mesh-list
20339379|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20339380|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20339381|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339382|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339383|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339384|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
20339385|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339386|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20339387|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
20339388|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348227|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20348228|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348229|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348230|NCT00863980|Telmisartan|telmisartan|mesh-list
20348231|NCT00863980|Candesartan|candesartan|mesh-list
20348232|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
20348233|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19653100|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168890|NCT00147160|Temozolomide|temozolomide|mesh-list
20168891|NCT00147160|Cisplatin|cisplatin|mesh-list
20168892|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20168893|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
20168894|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168895|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168896|NCT00147186|Hylan|hylan|mesh-list
20168897|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
20168898|NCT00147186|Protective Agents|protective agents|mesh-ancestor
20168899|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168900|NCT00147264|Telmisartan|telmisartan|mesh-list
20168901|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168902|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20168903|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19653101|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19653102|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19653103|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653104|NCT04149964|Acetaminophen|acetaminophen|mesh-list
19653105|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19653106|NCT04149964|Oxycodone|oxycodone|mesh-list
19653107|NCT04149964|Hydrocodone|hydrocodone|mesh-list
19653108|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653109|NCT04149964|Analgesics|analgesics|mesh-ancestor
19653110|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
19653111|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653112|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339389|NCT00813059|Bevacizumab|bevacizumab|mesh-list
20339390|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20339391|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339392|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20339393|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339394|NCT00813059|Growth Substances|growth substances|mesh-ancestor
20168904|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168905|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
20168906|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20168907|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20168908|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168909|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20168910|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20168911|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
20168912|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259140|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20168913|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612024|NCT02249416|Ritonavir|ritonavir|mesh-list
19653113|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
19653114|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19653115|NCT04149964|Narcotics|narcotics|mesh-ancestor
19653116|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653117|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
20168914|NCT00147355|Acetaminophen|acetaminophen|mesh-list
20168915|NCT00147355|Ibuprofen|ibuprofen|mesh-list
20168916|NCT00147355|Codeine|codeine|mesh-list
20168917|NCT00147355|Ondansetron|ondansetron|mesh-list
20168918|NCT00147355|Metoclopramide|metoclopramide|mesh-list
19653118|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
19653119|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19653120|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653121|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653122|NCT04123379|Nivolumab|nivolumab|mesh-list
19653123|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653124|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653125|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19653126|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665412|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665413|NCT05101187|Amphotericin B|amphotericin b|mesh-list
20168919|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20168920|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20168921|NCT00147355|Analgesics|analgesics|mesh-ancestor
20168922|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
20339395|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339396|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
20339397|NCT00813072|Docetaxel|docetaxel|mesh-list
20339398|NCT00813072|Irinotecan|irinotecan|mesh-list
20168923|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20168924|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168925|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20168926|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20168927|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20168928|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168929|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168930|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
20168931|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
20168932|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
20168933|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20168934|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
20168935|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
20168936|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20168937|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
20339399|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339400|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
20339401|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
19665414|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19665415|NCT05101187|Olorofim|olorofim|mesh-list
19665416|NCT05101187|Amebicides|amebicides|mesh-ancestor
19665417|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19665418|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19665419|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665420|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19665421|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
19665422|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19665423|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19665424|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19665425|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339402|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
20339403|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339404|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20339405|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20339406|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339407|NCT00813137|Endostar protein|endostar protein|mesh-list
20339408|NCT00813137|Endostatins|endostatins|mesh-list
20339409|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20339410|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339411|NCT00813137|Growth Substances|growth substances|mesh-ancestor
20339412|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339413|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
20168938|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168939|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20168940|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20168941|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168942|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20168943|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20168944|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20168945|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20168946|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
20168947|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20168948|NCT00147355|Narcotics|narcotics|mesh-ancestor
20168949|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
19831639|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
19831640|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19831641|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19831642|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168950|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
20168951|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
20168952|NCT00147381|Tacrolimus|tacrolimus|mesh-list
20168953|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20168954|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
20339414|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339415|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20339416|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
20339417|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831643|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19831644|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831645|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
19831646|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19831647|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19831648|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831649|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19831650|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339418|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20339419|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339420|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339421|NCT00813228|Incretins|incretins|mesh-ancestor
19256896|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256897|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256898|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
19256899|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256900|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256901|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19256902|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19256903|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256904|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
20168955|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168956|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20168957|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168958|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168959|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20168960|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20168961|NCT00147394|Risperidone|risperidone|mesh-list
20168962|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20168963|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
20168964|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20168965|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168966|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168967|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20168968|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20168969|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20168970|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20168971|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20168972|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
20168973|NCT00147511|Linezolid|linezolid|mesh-list
20168974|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20168975|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20168976|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20168977|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168978|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168979|NCT00147524|Quinapril|quinapril|mesh-list
20168980|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20168981|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
20168982|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20168983|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20168984|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168985|NCT00147563|Eplerenone|eplerenone|mesh-list
20168986|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20168987|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
20168988|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168989|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831651|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339422|NCT00813228|Hormones|hormones|mesh-ancestor
20339423|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339424|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20339425|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
20339426|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339427|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339428|NCT00813241|Celecoxib|celecoxib|mesh-list
20339429|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20339430|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20339431|NCT00813241|Analgesics|analgesics|mesh-ancestor
20339432|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
20339433|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339434|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339435|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339436|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339437|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20339438|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20168990|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20168991|NCT00147563|Diuretics|diuretics|mesh-ancestor
20339439|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339440|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339441|NCT00813332|Docetaxel|docetaxel|mesh-list
20339442|NCT00813332|Endostar protein|endostar protein|mesh-list
20339443|NCT00813332|Endostatins|endostatins|mesh-list
20339444|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339445|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
20339446|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
20339447|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
20339448|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339449|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20339450|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339451|NCT00813332|Growth Substances|growth substances|mesh-ancestor
20339452|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339453|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
20339454|NCT00813410|Insulin|insulin|mesh-list
20339455|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339456|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339457|NCT00813436|Oxytocin|oxytocin|mesh-list
20339458|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
20339459|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20339460|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339461|NCT00813449|Dacarbazine|dacarbazine|mesh-list
20339462|NCT00813449|Endostar protein|endostar protein|mesh-list
20339463|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20339464|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
20339465|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339466|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339467|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20339468|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339469|NCT00813449|Growth Substances|growth substances|mesh-ancestor
20168992|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
20168993|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20168994|NCT00147589|Eplerenone|eplerenone|mesh-list
20168995|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20168996|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
20168997|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20168998|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20168999|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20169000|NCT00147589|Diuretics|diuretics|mesh-ancestor
20169001|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
20169002|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20169003|NCT00147602|Atorvastatin|atorvastatin|mesh-list
20169004|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20169005|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20169006|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
20169007|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169008|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20169009|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20169010|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169011|NCT00147615|Eplerenone|eplerenone|mesh-list
20169012|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20169013|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
20169014|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169015|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169016|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20169017|NCT00147615|Diuretics|diuretics|mesh-ancestor
20169018|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
20169019|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20169020|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
20169021|NCT00147628|Citric Acid|citric acid|mesh-list
20169022|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
20169023|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
20169024|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20169025|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
20169026|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
20169027|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169028|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
20169029|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20169030|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19653127|NCT04066491|Gemcitabine|gemcitabine|mesh-list
19653128|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653129|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19653130|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
19653131|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653132|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
19653133|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653134|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653135|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653136|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
19653137|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653138|NCT04037605|Ketoconazole|ketoconazole|mesh-list
19653139|NCT04037605|Dexamethasone|dexamethasone|mesh-list
19653140|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
19653141|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
19653142|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19653143|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19653144|NCT04037605|Hormones|hormones|mesh-list
19653145|NCT04037605|Cosyntropin|cosyntropin|mesh-list
19653146|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19653147|NCT04037605|BB 1101|bb 1101|mesh-list
20339470|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339471|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
20339472|NCT00813475|Insulin|insulin|mesh-list
20339473|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20339474|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339475|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339476|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20339477|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
20339478|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339479|NCT00813527|Fenofibrate|fenofibrate|mesh-list
20339480|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20339481|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
20339482|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339483|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20339484|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20339485|NCT00813631|Laxatives|laxatives|mesh-ancestor
20339486|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20339487|NCT00813696|Gemcitabine|gemcitabine|mesh-list
20339488|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339489|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339490|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
20339491|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339492|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
20339493|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339494|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339495|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339496|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
20339497|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339498|NCT00813722|Losartan|losartan|mesh-list
19653148|NCT04037605|Ganirelix|ganirelix|mesh-list
19653149|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169031|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169032|NCT00147628|Urological Agents|urological agents|mesh-ancestor
20169033|NCT00147654|Tamsulosin|tamsulosin|mesh-list
20169034|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20169035|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20169036|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20169037|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20169038|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
19653150|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
19653151|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
19653152|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653153|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169039|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339499|NCT00813722|Atenolol|atenolol|mesh-list
19653154|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19653155|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
20339500|NCT00813722|Amlodipine|amlodipine|mesh-list
20169040|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653156|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653157|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339501|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20339502|NCT00813722|Calcium|calcium|mesh-list
20339503|NCT00813722|Diuretics|diuretics|mesh-list
19653158|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653159|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
20339504|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20339505|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20339506|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339507|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20339508|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20339509|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339510|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339511|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
20339512|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20339513|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20339514|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20339515|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
20339516|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20339517|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20339518|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
20339519|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339520|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
20339521|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
20339522|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339523|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20339524|NCT00813735|Dexetimide|dexetimide|mesh-list
20339525|NCT00813735|Eszopiclone|eszopiclone|mesh-list
20339526|NCT00813735|Citalopram|citalopram|mesh-list
20339527|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20339528|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20339529|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339530|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339531|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339532|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
20339533|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339534|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20339535|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
20339536|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653160|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339537|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20339538|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20339539|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
20339540|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
20339541|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339542|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20339543|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20339544|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
20339545|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20339546|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653161|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653162|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
19831652|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
19831653|NCT05220917|Insulin|insulin|mesh-list
20169041|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339547|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
20339548|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339549|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
20339550|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339551|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169042|NCT00147654|Urological Agents|urological agents|mesh-ancestor
20169043|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20169044|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20169045|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
20169046|NCT00147667|Erythromycin|erythromycin|mesh-list
20169047|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
20169048|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20169049|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
20169050|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169051|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169052|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169053|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20169054|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169055|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339552|NCT00813891|Ranibizumab|ranibizumab|mesh-list
20339553|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19653163|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653164|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19653165|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20339554|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339555|NCT00813891|Growth Substances|growth substances|mesh-ancestor
20339556|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339557|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
20339558|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339559|NCT00814008|Insulin|insulin|mesh-list
19653166|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19653167|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
19653168|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19653169|NCT04022967|Ritonavir|ritonavir|mesh-list
19653170|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19653171|NCT04022967|Tenofovir|tenofovir|mesh-list
19653172|NCT04022967|Lamivudine|lamivudine|mesh-list
19653173|NCT04022967|Dolutegravir|dolutegravir|mesh-list
19653174|NCT04022967|Efavirenz|efavirenz|mesh-list
20339560|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339561|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339562|NCT00814021|Sunitinib|sunitinib|mesh-list
20339563|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339564|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20339565|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339566|NCT00814021|Growth Substances|growth substances|mesh-ancestor
20339567|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339568|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
20339569|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19653175|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20169056|NCT00147680|Paclitaxel|paclitaxel|mesh-list
20339570|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612025|NCT02249416|Zidovudine|zidovudine|mesh-list
20169057|NCT00147680|Carboplatin|carboplatin|mesh-list
20169058|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20169059|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169060|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169061|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169062|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169063|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169064|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20169065|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20169066|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20169067|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
20169068|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169069|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20169070|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20169071|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20169072|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20169073|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
20169074|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169075|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20169076|NCT00147771|Imiquimod|imiquimod|mesh-list
20169077|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20169078|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
20169079|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169080|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653176|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19653177|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
19653178|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169081|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
20169082|NCT00147784|Interferons|interferons|mesh-list
20169083|NCT00147784|Ribavirin|ribavirin|mesh-list
20339571|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653179|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169084|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339572|NCT00814047|Yohimbine|yohimbine|mesh-list
20169085|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
20339573|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
20339574|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
20339575|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339576|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339577|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20339578|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20339579|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20339580|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
20339581|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339582|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169086|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169087|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
20169088|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169089|NCT00147836|Insulin|insulin|mesh-list
20169090|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20169091|NCT00147836|Metformin|metformin|mesh-list
20169092|NCT00147836|Gliclazide|gliclazide|mesh-list
20169093|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
20169094|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
20169095|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
20339583|NCT00814047|Urological Agents|urological agents|mesh-ancestor
20339584|NCT00814086|Paclitaxel|paclitaxel|mesh-list
20339585|NCT00814086|Cisplatin|cisplatin|mesh-list
20339586|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20339587|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339588|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
20339589|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
20339590|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169096|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20169097|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169098|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
20169099|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20169100|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20169101|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169102|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
20169103|NCT00147862|Coagulants|coagulants|mesh-ancestor
20169104|NCT00147875|Gemcitabine|gemcitabine|mesh-list
20169105|NCT00147875|Prednisone|prednisone|mesh-list
20169106|NCT00147875|Doxorubicin|doxorubicin|mesh-list
20169107|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20169108|NCT00147875|Vinblastine|vinblastine|mesh-list
20339591|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169109|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20169110|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
20169111|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169112|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169113|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
20169114|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169115|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169116|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169117|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
20169118|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339592|NCT00814125|Tamoxifen|tamoxifen|mesh-list
20339593|NCT00814125|Anastrozole|anastrozole|mesh-list
20339594|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20339595|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
20339596|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339597|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339598|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339599|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339600|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20339601|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20339602|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20339603|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20339604|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20339605|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653180|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19653181|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20169119|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169120|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20339606|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339607|NCT00814216|Fluticasone|fluticasone|mesh-list
20339608|NCT00814216|Xhance|xhance|mesh-list
20339609|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339610|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20339611|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
20169121|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20169122|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169123|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
20169124|NCT00147875|Hormones|hormones|mesh-ancestor
20169125|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169126|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19653182|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
19653183|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653184|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19653185|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19653186|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19653187|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20339612|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339613|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339614|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20339615|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
20339616|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
20339617|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20339618|NCT00814229|Vaccines|vaccines|mesh-list
20339619|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
20339620|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
20339621|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339622|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20339623|NCT00814268|Aspirin|aspirin|mesh-list
20339624|NCT00814268|Clopidogrel|clopidogrel|mesh-list
20339625|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20339626|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20339627|NCT00814268|Analgesics|analgesics|mesh-ancestor
20339628|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
20339629|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339630|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339631|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339632|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339633|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20339634|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20339635|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339636|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20339637|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19653188|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19256905|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256906|NCT03926624|Analgesics|analgesics|mesh-ancestor
19256907|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
19256908|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256909|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19256910|NCT03905902|Vaccines|vaccines|mesh-list
19256911|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
19256912|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339638|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339639|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
20339640|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20339641|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20339642|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20339643|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
20339644|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339645|NCT00814281|Montelukast|montelukast|mesh-list
20339646|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20339647|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
19256913|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
19256914|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256915|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256916|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
19256917|NCT03858049|Progestins|progestins|mesh-ancestor
19256918|NCT03858049|Hormones|hormones|mesh-ancestor
19256919|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256920|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256921|NCT03852888|Methotrexate|methotrexate|mesh-list
19256922|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
19256923|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19256924|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
19256925|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19256926|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256927|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256928|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
19256929|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256930|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256931|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
19653189|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20339648|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20339649|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
20339650|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653190|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19653191|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19653192|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19653193|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19653194|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19653195|NCT03995004|Dexamethasone|dexamethasone|mesh-list
19653196|NCT03995004|Melatonin|melatonin|mesh-list
19653197|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
19653198|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653199|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
19653200|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
19653201|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169127|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20169128|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
19653202|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169129|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169130|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169131|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
20169132|NCT00147901|Fludarabine|fludarabine|mesh-list
20169133|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
20169134|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169135|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
20169136|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169137|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169138|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20169139|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
20169140|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653203|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169141|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169142|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20169143|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20169144|NCT00147914|Amoxicillin|amoxicillin|mesh-list
20169145|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
20169146|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
20169147|NCT00147914|Cefdinir|cefdinir|mesh-list
20169148|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20169149|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339651|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339652|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20339653|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20339654|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339655|NCT00814359|Benzydamine|benzydamine|mesh-list
20169150|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339656|NCT00814359|Sucralfate|sucralfate|mesh-list
19831654|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20169151|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19831655|NCT05220917|Metformin|metformin|mesh-list
20169152|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339657|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339658|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20339659|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20339660|NCT00814515|Cyclosporine|cyclosporine|mesh-list
20339661|NCT00814515|Cyclosporins|cyclosporins|mesh-list
20339662|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339663|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339664|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339665|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
20169153|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169154|NCT00147953|Rituximab|rituximab|mesh-list
20169155|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20169156|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169157|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
20169158|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169159|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169160|NCT00147979|Heparin|heparin|mesh-list
20339666|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339667|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
20339668|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339669|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
20339670|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169161|NCT00147979|Calcium heparin|calcium heparin|mesh-list
20169162|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
20169163|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20169164|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20169165|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169166|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20169167|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
20169168|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169169|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339671|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20169170|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169171|NCT00148018|Dexamethasone|dexamethasone|mesh-list
20169172|NCT00148018|Bortezomib|bortezomib|mesh-list
20169173|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169174|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
20169175|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
20169176|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169177|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169178|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169179|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
20169180|NCT00148018|Hormones|hormones|mesh-ancestor
20169181|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169182|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20169183|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169184|NCT00148031|Interferons|interferons|mesh-list
20169185|NCT00148031|Ribavirin|ribavirin|mesh-list
20169186|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339672|NCT00814528|Imiquimod|imiquimod|mesh-list
20339673|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20339674|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
20339675|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339676|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339677|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
20339678|NCT00814541|Dexamethasone|dexamethasone|mesh-list
20339679|NCT00814541|Doxorubicin|doxorubicin|mesh-list
20339680|NCT00814541|Bortezomib|bortezomib|mesh-list
20339681|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339682|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
20339683|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
20339684|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339685|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339686|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20339687|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
20339688|NCT00814541|Hormones|hormones|mesh-ancestor
20339689|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339690|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339691|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339692|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20339693|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20339694|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20339695|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339696|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256932|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169187|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
20339697|NCT00814593|Carmustine|carmustine|mesh-list
20339698|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20339699|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
20339700|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339701|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169188|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169189|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
20169190|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169191|NCT00148070|Erythromycin|erythromycin|mesh-list
20169192|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
20169193|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20169194|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
20339702|NCT00814606|Ribavirin|ribavirin|mesh-list
20339703|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20339704|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
19256933|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19256934|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256935|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
19653204|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
19653205|NCT03995004|Hormones|hormones|mesh-ancestor
19653206|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653207|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19653208|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256936|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256937|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256938|NCT03850418|Azacitidine|azacitidine|mesh-list
19256939|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256940|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
19256941|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256942|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256943|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256944|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
19256945|NCT03850379|Levofloxacin|levofloxacin|mesh-list
19256946|NCT03850379|Ofloxacin|ofloxacin|mesh-list
19256947|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19256948|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256949|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19256950|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19256951|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256952|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256953|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256954|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19256955|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19256956|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19256957|NCT03850379|Renal Agents|renal agents|mesh-ancestor
19256958|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
19256959|NCT03850366|Bortezomib|bortezomib|mesh-list
19256960|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256961|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
19256962|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256963|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256964|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19256965|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
19256966|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256967|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256968|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19653209|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
19653210|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653211|NCT03995004|Protective Agents|protective agents|mesh-ancestor
20169195|NCT00148070|Docetaxel|docetaxel|mesh-list
20169196|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612026|NCT02249416|Tipranavir|tipranavir|mesh-list
20339705|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339706|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
20339707|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339708|NCT00814619|Capecitabine|capecitabine|mesh-list
20339709|NCT00814619|Panitumumab|panitumumab|mesh-list
20339710|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339711|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
20339712|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169197|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169198|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169199|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169200|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169201|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169202|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169203|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169204|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20169205|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169206|NCT00148083|Risperidone|risperidone|mesh-list
20169207|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20169208|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
20169209|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169210|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169211|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169212|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20169213|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169214|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169215|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169216|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20169217|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
19653212|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653213|NCT03995004|Cathartics|cathartics|mesh-ancestor
19653214|NCT03971474|Gemcitabine|gemcitabine|mesh-list
19653215|NCT03971474|Docetaxel|docetaxel|mesh-list
20339713|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653216|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
19653217|NCT03971474|Pemetrexed|pemetrexed|mesh-list
20169218|NCT00148135|Gemcitabine|gemcitabine|mesh-list
20169219|NCT00148135|Carboplatin|carboplatin|mesh-list
20339714|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20339715|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20339716|NCT00814723|Ezetimibe|ezetimibe|mesh-list
20339717|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20339718|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20339719|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
20339720|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339721|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20339722|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
20339723|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
19653218|NCT03971474|Ramucirumab|ramucirumab|mesh-list
19653219|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19653220|NCT03971474|Antibodies|antibodies|mesh-list
19653221|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
19653222|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19653223|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
19653224|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339724|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20339725|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20339726|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339727|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339728|NCT00814736|Urological Agents|urological agents|mesh-ancestor
20339729|NCT00814762|Vaccines|vaccines|mesh-list
20339730|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
20339731|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339732|NCT00814866|Adalimumab|adalimumab|mesh-list
20339733|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339734|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339735|NCT00814905|Clindamycin|clindamycin|mesh-list
20339736|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
20339737|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
20339738|NCT00814905|Gentamicins|gentamicins|mesh-list
20339739|NCT00814905|Ampicillin|ampicillin|mesh-list
20339740|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339741|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339742|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20339743|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339744|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339745|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20339746|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20339747|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
20339748|NCT00814944|Sirolimus|sirolimus|mesh-list
20339749|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339750|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339751|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20339752|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339753|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
20339754|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339755|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
20339756|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339757|NCT00815022|Fentanyl|fentanyl|mesh-list
20339758|NCT00815022|Morphine|morphine|mesh-list
20339759|NCT00815022|Bupivacaine|bupivacaine|mesh-list
20339760|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
20339761|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
20339762|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339763|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339764|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
20339765|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339766|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19831656|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
20339767|NCT00815022|Narcotics|narcotics|mesh-ancestor
20339768|NCT00815022|Analgesics|analgesics|mesh-ancestor
20339769|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20339770|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20339771|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
20339772|NCT00815048|Atropine|atropine|mesh-list
20339773|NCT00815048|Fentanyl|fentanyl|mesh-list
20339774|NCT00815048|Remifentanil|remifentanil|mesh-list
20339775|NCT00815048|Succinylcholine|succinylcholine|mesh-list
20339776|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20339777|NCT00815048|Narcotics|narcotics|mesh-ancestor
20339778|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339779|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339780|NCT00815048|Analgesics|analgesics|mesh-ancestor
20339781|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
20339782|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339783|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20339784|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20169220|NCT00148135|Capecitabine|capecitabine|mesh-list
20169221|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169222|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20169223|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
19653225|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19653226|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
19831657|NCT05220917|Pioglitazone|pioglitazone|mesh-list
20169224|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339785|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
20339786|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
20339787|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20339788|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20339789|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
20339790|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20339791|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
20339792|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
20339793|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
20339794|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20339795|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20339796|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
20339797|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339798|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339799|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20339800|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20339801|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20348234|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20348235|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20348236|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348237|NCT00864006|Valproic Acid|valproic acid|mesh-list
20348238|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
20348239|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348240|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348241|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
20348242|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348243|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348244|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
20169225|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
20169226|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169227|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348245|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169228|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169229|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
20169230|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169231|NCT00148148|Amphotericin B|amphotericin b|mesh-list
19653227|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653228|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653229|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
19653230|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653231|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653232|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653233|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169232|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19653234|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
19653235|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
19653236|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19653237|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19653238|NCT03970655|Dexamethasone|dexamethasone|mesh-list
19653239|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
19653240|NCT03970655|Epinephrine|epinephrine|mesh-list
19653241|NCT03970655|Racepinephrine|racepinephrine|mesh-list
19653242|NCT03970655|Bupivacaine|bupivacaine|mesh-list
19831658|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19831659|NCT05220917|Liraglutide|liraglutide|mesh-list
19653243|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
19653244|NCT03970655|BB 1101|bb 1101|mesh-list
19653245|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653246|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
19653247|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
19831660|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
19831661|NCT05220917|Empagliflozin|empagliflozin|mesh-list
19831662|NCT05220917|Exenatide|exenatide|mesh-list
19831663|NCT05220917|Glimepiride|glimepiride|mesh-list
19831664|NCT05220917|Linagliptin|linagliptin|mesh-list
19831665|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
19653248|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653249|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831666|NCT05220917|Saxagliptin|saxagliptin|mesh-list
19831667|NCT05220917|Canagliflozin|canagliflozin|mesh-list
19831668|NCT05220917|Alogliptin|alogliptin|mesh-list
19831669|NCT05220917|Glyburide|glyburide|mesh-list
19831670|NCT05220917|Dulaglutide|dulaglutide|mesh-list
20169233|NCT00148148|Caspofungin|caspofungin|mesh-list
19653250|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19653251|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
20169234|NCT00148148|Amebicides|amebicides|mesh-ancestor
20169235|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20169236|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20169237|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169238|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169239|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
20169240|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169241|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174825|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174826|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
20174827|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653252|NCT03970655|Hormones|hormones|mesh-ancestor
20174828|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174829|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
20174830|NCT00165750|Donepezil|donepezil|mesh-list
20174831|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20174832|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174833|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174834|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
20174835|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174836|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174837|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
19831671|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
20169242|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
20169243|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169244|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169245|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19653253|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653254|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19653255|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653256|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
19653257|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653258|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653259|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
19653260|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
19653261|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653262|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
19653263|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19653264|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19653265|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
19653266|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653267|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19831672|NCT05220917|Lixisenatide|lixisenatide|mesh-list
19831673|NCT05220917|Glipizide|glipizide|mesh-list
19831674|NCT05220917|Xultophy|xultophy|mesh-list
19831675|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19831676|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19831677|NCT05220917|Simvastatin|simvastatin|mesh-list
19831678|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
20169246|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169247|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169248|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169249|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831679|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19831680|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174838|NCT00165763|Donepezil|donepezil|mesh-list
20169250|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169251|NCT00148265|Triamcinolone|triamcinolone|mesh-list
20169252|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169253|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
20169254|NCT00148265|Hormones|hormones|mesh-ancestor
20169255|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169256|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169257|NCT00148278|Dobutamine|dobutamine|mesh-list
20169258|NCT00148278|Epinephrine|epinephrine|mesh-list
20169259|NCT00148278|Norepinephrine|norepinephrine|mesh-list
20169260|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20169261|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19653268|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19653269|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19653270|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
19653271|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
19653272|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
19653273|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19653274|NCT03968562|Doxycycline|doxycycline|mesh-list
19653275|NCT03968562|Petrolatum|petrolatum|mesh-list
19256972|NCT03840148|Meropenem|meropenem|mesh-list
19256973|NCT03840148|Cefepime|cefepime|mesh-list
19256974|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19653276|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169262|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
20169263|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169264|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169265|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169266|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20169267|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20169268|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
20169269|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169270|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20169271|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
19653277|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339802|NCT00815204|Dexamethasone|dexamethasone|mesh-list
20339803|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20339804|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
20339805|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
20339806|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339807|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339808|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20339809|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
20339810|NCT00815204|Hormones|hormones|mesh-ancestor
20339811|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20339812|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20339813|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339814|NCT00815256|Riboflavin|riboflavin|mesh-list
20339815|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
20339816|NCT00815256|Vitamins|vitamins|mesh-ancestor
20339817|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
20339818|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339819|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20339820|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
20339821|NCT00815269|Sevoflurane|sevoflurane|mesh-list
19653278|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
20339822|NCT00815269|Desflurane|desflurane|mesh-list
20339823|NCT00815269|Isoflurane|isoflurane|mesh-list
20339824|NCT00815269|Halothane|halothane|mesh-list
20339825|NCT00815269|Enflurane|enflurane|mesh-list
20339826|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20339827|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20339828|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
20339829|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
20339830|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339831|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339832|NCT00815282|Vaccines|vaccines|mesh-list
20339833|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
20169272|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
20169273|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
20169274|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20169275|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20169276|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20169277|NCT00148278|Protective Agents|protective agents|mesh-ancestor
20169278|NCT00148291|Docetaxel|docetaxel|mesh-list
20169279|NCT00148291|Vinorelbine|vinorelbine|mesh-list
20169280|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653279|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19653280|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19653281|NCT03968562|Emollients|emollients|mesh-ancestor
19653282|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
19653283|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
19653284|NCT03939026|Fludarabine|fludarabine|mesh-list
19653285|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653286|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
20339834|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653287|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169281|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169282|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169283|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169284|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169285|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20169286|NCT00148330|Triamcinolone|triamcinolone|mesh-list
20169287|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169288|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
20169289|NCT00148330|Hormones|hormones|mesh-ancestor
20169290|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169291|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169292|NCT00148356|Paclitaxel|paclitaxel|mesh-list
20169293|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20169294|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169295|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169296|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
19653288|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20339835|NCT00815373|Timolol|timolol|mesh-list
20339836|NCT00815373|Dorzolamide|dorzolamide|mesh-list
19653289|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19653290|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
19653291|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653292|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653293|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19653294|NCT03915613|Insulin|insulin|mesh-list
19653295|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20339837|NCT00815373|Latanoprost|latanoprost|mesh-list
20339838|NCT00815373|Maleic acid|maleic acid|mesh-list
20339839|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20339840|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19653296|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339841|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
19653297|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339842|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339843|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653298|NCT03868150|Amiodarone|amiodarone|mesh-list
20169297|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
20339844|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653299|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19653300|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
19653301|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20339845|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20339846|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20339847|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339848|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20339849|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19831681|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19831682|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19831683|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
19831684|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831685|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19831686|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19831687|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831688|NCT05220917|Incretins|incretins|mesh-ancestor
19831689|NCT05220917|Hormones|hormones|mesh-ancestor
19831690|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831691|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
19831692|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19831693|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20339850|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19256975|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256976|NCT03832127|Fludarabine|fludarabine|mesh-list
19256977|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256978|NCT03824522|BAX 855|bax 855|mesh-list
19256979|NCT03824522|Coagulants|coagulants|mesh-ancestor
19256980|NCT03823365|Blinatumomab|blinatumomab|mesh-list
19256981|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256982|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
19256983|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19256984|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
19256985|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19256986|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256987|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19256988|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19256989|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19256990|NCT03808077|Rocuronium|rocuronium|mesh-list
19256991|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19256992|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19256993|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19256994|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256995|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256996|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19256997|NCT03804268|Pilocarpine|pilocarpine|mesh-list
19256998|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19256999|NCT03804268|Miotics|miotics|mesh-ancestor
19257000|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
19257001|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257002|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257003|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19257004|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19257005|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
19257006|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257007|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257008|NCT05239390|Dronabinol|dronabinol|mesh-list
19257009|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
19257010|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257011|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19257012|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257013|NCT05239390|Analgesics|analgesics|mesh-ancestor
19257014|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
19257015|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257016|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20339851|NCT00815399|Metformin|metformin|mesh-list
19257017|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19257018|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257019|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257020|NCT05239390|Hormones|hormones|mesh-ancestor
19257021|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257022|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
19257023|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19257024|NCT05239286|Anesthetics|anesthetics|mesh-list
19257025|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257026|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257027|NCT05239078|Anesthetics|anesthetics|mesh-list
19257028|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
19257029|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257030|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257031|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
19257032|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257033|NCT05238948|Midazolam|midazolam|mesh-list
19653302|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339852|NCT00815399|Pioglitazone|pioglitazone|mesh-list
20339853|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339854|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339855|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
20339856|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339857|NCT00815503|Ropivacaine|ropivacaine|mesh-list
19257034|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20339858|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
20339859|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
20339860|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339861|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653303|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653304|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19653305|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19653306|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19653307|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653308|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20169298|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339862|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
20339863|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339864|NCT00815542|Dinoprostone|dinoprostone|mesh-list
20339865|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
20169299|NCT00148382|Cetilistat|cetilistat|mesh-list
20169300|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169301|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169302|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20169303|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20169304|NCT00148395|Gemcitabine|gemcitabine|mesh-list
20169305|NCT00148395|Carboplatin|carboplatin|mesh-list
20169306|NCT00148395|Ifosfamide|ifosfamide|mesh-list
20169307|NCT00148395|Mitomycins|mitomycins|mesh-list
20169308|NCT00148395|Mitomycin|mitomycin|mesh-list
20169309|NCT00148395|Vinorelbine|vinorelbine|mesh-list
20169310|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831694|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831695|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
20339866|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20339867|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339868|NCT00815568|Vidarabine|vidarabine|mesh-list
20339869|NCT00815568|Fludarabine|fludarabine|mesh-list
20339870|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
20339871|NCT00815568|Busulfan|busulfan|mesh-list
20339872|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339873|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339874|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
20339875|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339876|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339877|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
20339878|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339879|NCT00815568|Antiviral Agents|antiviral agents|mesh-ancestor
20339880|NCT00815568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653309|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19653310|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19653311|NCT03864276|Propofol|propofol|mesh-list
19653312|NCT03864276|Desflurane|desflurane|mesh-list
19653313|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
19653314|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653315|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653316|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19653317|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19653318|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
19653319|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19653320|NCT03856788|Bupivacaine|bupivacaine|mesh-list
19831696|NCT05220046|Psilocybin|psilocybin|mesh-list
20339881|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
20339882|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20339883|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20339884|NCT00815594|Bevacizumab|bevacizumab|mesh-list
20339885|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20339886|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339887|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19831697|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
20169311|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20169312|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
20169313|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169314|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
20169315|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169316|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169317|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169318|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
20169319|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169320|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20169321|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
20169322|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169323|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20169324|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20169325|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169326|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169327|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169328|NCT00148408|Montelukast|montelukast|mesh-list
20169329|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20169330|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
20169331|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20169332|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
20339888|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20339889|NCT00815594|Growth Substances|growth substances|mesh-ancestor
20339890|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339891|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
20339892|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
20339893|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
19653321|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
19653322|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
19653323|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169333|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169334|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169335|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20169336|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20169337|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169338|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
20169339|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
20169340|NCT00148421|Hematinics|hematinics|mesh-ancestor
20169341|NCT00148447|Citalopram|citalopram|mesh-list
20169342|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20169343|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20169344|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339894|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20339895|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19257035|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19257036|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257037|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257038|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19257039|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19257040|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19257041|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19257042|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
19257043|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
19257044|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
19257045|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
19257046|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257047|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257048|NCT05238727|Mepivacaine|mepivacaine|mesh-list
19257049|NCT05238727|Carticaine|carticaine|mesh-list
19257050|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
19257051|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
19257052|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257053|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257054|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
19257055|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257056|NCT05238467|Antibodies|antibodies|mesh-list
19257057|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
19257058|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257059|NCT05238220|Valganciclovir|valganciclovir|mesh-list
19257060|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
19257061|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257062|NCT05238207|Psyllium|psyllium|mesh-list
19257063|NCT05238207|Cathartics|cathartics|mesh-ancestor
19257064|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19257065|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
19257066|NCT05238064|Doxorubicin|doxorubicin|mesh-list
19257067|NCT05238064|Vincristine|vincristine|mesh-list
19257068|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257069|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
19257070|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339896|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339897|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339898|NCT00815646|Urological Agents|urological agents|mesh-ancestor
19257071|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257072|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19257073|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
19257074|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257075|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257076|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19257077|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19257078|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19257079|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19257080|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257081|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19257082|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257083|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
19257084|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
19259141|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19259142|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
19653324|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653325|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
19259143|NCT00248287|Carboplatin|carboplatin|mesh-list
19259144|NCT00248287|Irinotecan|irinotecan|mesh-list
20339899|NCT00815841|Methylphenidate|methylphenidate|mesh-list
20339900|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20339901|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339902|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20339903|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19831698|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257085|NCT05238012|Atorvastatin|atorvastatin|mesh-list
20339904|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339905|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339906|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
20339907|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339908|NCT00815854|Folic Acid|folic acid|mesh-list
20339909|NCT00815854|Hematinics|hematinics|mesh-ancestor
20339910|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
19653326|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653327|NCT03840902|Paclitaxel|paclitaxel|mesh-list
19653328|NCT03840902|Etoposide|etoposide|mesh-list
19653329|NCT03840902|Carboplatin|carboplatin|mesh-list
19653330|NCT03840902|Pemetrexed|pemetrexed|mesh-list
19653331|NCT03840902|Durvalumab|durvalumab|mesh-list
19653332|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19653333|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653334|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
19653335|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
19653336|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
19653337|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653338|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19653339|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19653340|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653341|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20339911|NCT00815854|Vitamins|vitamins|mesh-ancestor
20339912|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
19653342|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19257086|NCT05238012|Calcium|calcium|mesh-list
20339913|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339914|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
20339915|NCT00815867|Hematinics|hematinics|mesh-ancestor
20339916|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
20339917|NCT00815893|Propofol|propofol|mesh-list
20339918|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20339919|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20339920|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339921|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20339922|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
20339923|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
20339924|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20339925|NCT00815893|Analgesics|analgesics|mesh-ancestor
20339926|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
20339927|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20339928|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20339929|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20339930|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20339931|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
20339932|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20339933|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339934|NCT00815945|Carboplatin|carboplatin|mesh-list
20339935|NCT00815945|Doxorubicin|doxorubicin|mesh-list
20339936|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339937|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20339938|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20339939|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20339940|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339941|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339942|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
20339943|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
20339944|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339945|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20339946|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339947|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20339948|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
20339949|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339950|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20339951|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339952|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20339953|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
20339954|NCT00816127|Coagulants|coagulants|mesh-ancestor
20339955|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20339956|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
20339957|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339958|NCT00816140|Clarithromycin|clarithromycin|mesh-list
20339959|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20339960|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20339961|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20339962|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339963|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339964|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20339965|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20339966|NCT00816205|Nifedipine|nifedipine|mesh-list
20339967|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20339968|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20339969|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339970|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20339971|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339972|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
20339973|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
20339974|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20339975|NCT00816218|Pioglitazone|pioglitazone|mesh-list
20339976|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20339977|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20339978|NCT00816244|Atorvastatin|atorvastatin|mesh-list
20339979|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20339980|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20339981|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
20339982|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339983|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20339984|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20339985|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339986|NCT00816283|Dasatinib|dasatinib|mesh-list
20339987|NCT00816283|Vorinostat|vorinostat|mesh-list
20339988|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20339989|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20339990|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20339991|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339992|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20339993|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20339994|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20339995|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20339996|NCT00816413|Cyclosporine|cyclosporine|mesh-list
20339997|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
20339998|NCT00816413|Pentostatin|pentostatin|mesh-list
20339999|NCT00816413|Cyclosporins|cyclosporins|mesh-list
20340000|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340001|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257087|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19257088|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257089|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19257090|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19257091|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
19257092|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257093|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19257094|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19257095|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257096|NCT05237960|Metformin|metformin|mesh-list
19257097|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19257098|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257099|NCT05237843|Aspirin|aspirin|mesh-list
19257100|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
19257101|NCT05237843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19257102|NCT05237843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257103|NCT05237843|Analgesics|analgesics|mesh-ancestor
19257104|NCT05237843|Sensory System Agents|sensory system agents|mesh-ancestor
19257105|NCT05237843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257106|NCT05237843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257107|NCT05237843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20340002|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340003|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
20340004|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340005|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
20340006|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340007|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
20340008|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340009|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20340010|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340011|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340012|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20340013|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
20340014|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340015|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20340016|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
20169345|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169346|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169347|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
20169348|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169349|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20169350|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
20169351|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169352|NCT00148460|Tenecteplase|tenecteplase|mesh-list
20169353|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20169354|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20169355|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169356|NCT00148473|Misoprostol|misoprostol|mesh-list
20169357|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20169358|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
20169359|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20169360|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169361|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20340017|NCT00816426|Rifampin|rifampin|mesh-list
20340018|NCT00816426|Isoniazid|isoniazid|mesh-list
20340019|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
20340020|NCT00816426|Kanamycin|kanamycin|mesh-list
20169362|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169363|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
20169364|NCT00148499|Benzocaine|benzocaine|mesh-list
20169365|NCT00148499|Ambroxol|ambroxol|mesh-list
20169366|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
20169367|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
20169368|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169369|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169370|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
20169371|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169372|NCT00148499|Expectorants|expectorants|mesh-ancestor
20340021|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169373|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
20169374|NCT00148551|Triamcinolone|triamcinolone|mesh-list
20169375|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20169376|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19831699|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19831700|NCT05219877|Levofloxacin|levofloxacin|mesh-list
19831701|NCT05219877|Ofloxacin|ofloxacin|mesh-list
19653343|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653344|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
19653345|NCT03821610|Melphalan|melphalan|mesh-list
19653346|NCT03821610|Fludarabine|fludarabine|mesh-list
19653347|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
19653348|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653349|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
19653350|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169377|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20169378|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169379|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
20169380|NCT00148551|Hormones|hormones|mesh-ancestor
20174839|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19653351|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174840|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340022|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340023|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20340024|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20340025|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340026|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340027|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340028|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20340029|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
20340030|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
20340031|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19257108|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257109|NCT05237843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19257110|NCT05237843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19257111|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257112|NCT05237843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19257113|NCT05237843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257114|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340032|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20340033|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20340034|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20340035|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20340036|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20340037|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20340038|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20340039|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20340040|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
20340041|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20340042|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20340043|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
20340044|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20340045|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20340046|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20340047|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340048|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340049|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
20340050|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340051|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340052|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20340053|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340054|NCT00816543|Docetaxel|docetaxel|mesh-list
20340055|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
20340056|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340057|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340058|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340059|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340060|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340061|NCT00816634|Paclitaxel|paclitaxel|mesh-list
20340062|NCT00816634|Capecitabine|capecitabine|mesh-list
20340063|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19257115|NCT05237843|Antipyretics|antipyretics|mesh-ancestor
19257116|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
19257117|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19257118|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19257119|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257120|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
19257121|NCT05237791|Analgesics|analgesics|mesh-ancestor
19257122|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
19257123|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257124|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257125|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
19257126|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257127|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19257128|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
20340064|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257129|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19257130|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19257131|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257132|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19257133|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
19257134|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19257135|NCT05237492|Tramadol|tramadol|mesh-list
19257136|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19257137|NCT05237492|Narcotics|narcotics|mesh-ancestor
19257138|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257139|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257140|NCT05237492|Analgesics|analgesics|mesh-ancestor
19257141|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
19257142|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340065|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340066|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340067|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340068|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340069|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19653352|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20340070|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
19653353|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
20340071|NCT00816660|Factor VIII|factor viii|mesh-list
20340072|NCT00816660|Coagulants|coagulants|mesh-ancestor
20340073|NCT00816673|Melatonin|melatonin|mesh-list
20340074|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
20340075|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340076|NCT00816673|Protective Agents|protective agents|mesh-ancestor
20340077|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340078|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340079|NCT00816699|Anesthetics|anesthetics|mesh-list
20340080|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340081|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340082|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
19653354|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653355|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340083|NCT00816712|Testosterone|testosterone|mesh-list
20340084|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
20340085|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
20340086|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20340087|NCT00816712|Androgens|androgens|mesh-ancestor
20340088|NCT00816712|Hormones|hormones|mesh-ancestor
20340089|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20340090|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340091|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20340092|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340093|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
20348246|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348247|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348248|NCT00864019|Sertraline|sertraline|mesh-list
20348249|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348250|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348251|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20348252|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348253|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348254|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653356|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19653357|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653358|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19653359|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19653360|NCT03815929|Estradiol|estradiol|mesh-list
19653361|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19653362|NCT03815929|Estrogens|estrogens|mesh-ancestor
19653363|NCT03815929|Hormones|hormones|mesh-ancestor
19653364|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653365|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653366|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19653367|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
19831702|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19831703|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169381|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169382|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169383|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169384|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
19831704|NCT05219877|Renal Agents|renal agents|mesh-ancestor
19831705|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19831706|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19831707|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19653368|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19831708|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831709|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831710|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831711|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19831712|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19831713|NCT05216432|Fulvestrant|fulvestrant|mesh-list
20169385|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169386|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169387|NCT00148564|Olanzapine|olanzapine|mesh-list
20169388|NCT00148564|Ziprasidone|ziprasidone|mesh-list
19257143|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
20169389|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
20169390|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
20340094|NCT00816790|Tazobactam|tazobactam|mesh-list
20340095|NCT00816790|Piperacillin|piperacillin|mesh-list
20340096|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20340097|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169391|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169392|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169393|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169394|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20169395|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169396|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169397|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169398|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20169399|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20340098|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340099|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20340100|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340101|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340102|NCT00816816|Docetaxel|docetaxel|mesh-list
20340103|NCT00816816|Fluorouracil|fluorouracil|mesh-list
20340104|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340105|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340106|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340107|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340108|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340109|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
20340110|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831714|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19831715|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169400|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19653369|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19653370|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
19653371|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653372|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653373|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
19653374|NCT03811756|Vitamins|vitamins|mesh-ancestor
19653375|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
19653376|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653377|NCT03792516|Artesunate|artesunate|mesh-list
19653378|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
20169401|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169402|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169403|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
20169404|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20169405|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20169406|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
19653379|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20169407|NCT00148590|Memantine|memantine|mesh-list
19653380|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20169408|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20340111|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340112|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
20340113|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340114|NCT00816855|Docetaxel|docetaxel|mesh-list
20340115|NCT00816855|Fluorouracil|fluorouracil|mesh-list
20340116|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340117|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340118|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340119|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340120|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340121|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
20340122|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20340123|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340124|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
20340125|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340126|NCT00816868|Capecitabine|capecitabine|mesh-list
20340127|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20340128|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20340129|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
20340130|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340131|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340132|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20340133|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340134|NCT00816894|Olanzapine|olanzapine|mesh-list
20340135|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
20340136|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
20340137|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340138|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340139|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340140|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20340141|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340142|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340143|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340144|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19257144|NCT05237323|Azathioprine|azathioprine|mesh-list
20340145|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20340146|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340147|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340148|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340149|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
20340150|NCT00816959|Bleomycin|bleomycin|mesh-list
20340151|NCT00816959|Dacarbazine|dacarbazine|mesh-list
20340152|NCT00816959|Vinblastine|vinblastine|mesh-list
20340153|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340154|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340155|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340156|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20340157|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
20340158|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20340159|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340160|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340161|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340162|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20340163|NCT00817011|Mirtazapine|mirtazapine|mesh-list
20340164|NCT00817011|Trazodone|trazodone|mesh-list
20340165|NCT00817011|Bupropion|bupropion|mesh-list
20340166|NCT00817011|Fluoxetine|fluoxetine|mesh-list
20340167|NCT00817011|Paroxetine|paroxetine|mesh-list
20340168|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20340169|NCT00817011|Citalopram|citalopram|mesh-list
20340170|NCT00817011|Sertraline|sertraline|mesh-list
20340171|NCT00817011|Nortriptyline|nortriptyline|mesh-list
20340172|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19257145|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19257146|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257147|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19257148|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
19257149|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257150|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257151|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257152|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257153|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
19257154|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19257155|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257156|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
19831716|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19831717|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19831718|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
19831719|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831720|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831721|NCT05213481|Tepotinib|tepotinib|mesh-list
19831722|NCT05213481|Carbamazepine|carbamazepine|mesh-list
19831723|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
19831724|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
19831725|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19831726|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169409|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19257157|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257158|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257159|NCT05237297|Celecoxib|celecoxib|mesh-list
19257160|NCT05237297|Naproxen|naproxen|mesh-list
19257161|NCT05237297|Aceclofenac|aceclofenac|mesh-list
19257162|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19257163|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257164|NCT05237297|Analgesics|analgesics|mesh-ancestor
19257165|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
19257166|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257167|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257168|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257169|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257170|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19257171|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257172|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257173|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257174|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
19257175|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19257176|NCT05216328|Antacids|antacids|mesh-ancestor
19257177|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257178|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19257179|NCT05215990|Metformin|metformin|mesh-list
19257180|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19257181|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257182|NCT05215834|Remifentanil|remifentanil|mesh-list
19257183|NCT05215834|Propofol|propofol|mesh-list
19257184|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19257185|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257186|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257187|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19257188|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
19257189|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
19257190|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19257191|NCT05215834|Narcotics|narcotics|mesh-ancestor
19257192|NCT05215834|Analgesics|analgesics|mesh-ancestor
19257193|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
19257194|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257195|NCT05214183|Rituximab|rituximab|mesh-list
19257196|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
19257197|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257198|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257199|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
19257200|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257201|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169410|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
19257202|NCT05189509|Plasminogen|plasminogen|mesh-list
19257203|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19831727|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257204|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19831728|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653381|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653382|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653383|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
19653384|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
19653385|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19653386|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
19653387|NCT03768414|Gemcitabine|gemcitabine|mesh-list
20340173|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
20340174|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340175|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20340176|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20340177|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340178|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653388|NCT03768414|Paclitaxel|paclitaxel|mesh-list
19653389|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19653390|NCT03768414|Cisplatin|cisplatin|mesh-list
19653391|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19653392|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653393|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
19653394|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
19653395|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
19653396|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653397|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19653398|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
19653399|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
19653400|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653401|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340179|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
19653402|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653403|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
20340180|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340181|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340182|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20340183|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20340184|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340185|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20340186|NCT00817011|Analgesics|analgesics|mesh-ancestor
20340187|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
20340188|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340189|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20340190|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
20340191|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20340192|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
20340193|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
20340194|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20340195|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340196|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340197|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20340198|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20340199|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20340200|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
20340201|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20340202|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20340203|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20340204|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20340205|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20340206|NCT00817037|Nifedipine|nifedipine|mesh-list
20340207|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
20340208|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20340209|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340210|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340211|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20340212|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340213|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
20340214|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
20340215|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20340216|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20340217|NCT00817245|Amoxicillin|amoxicillin|mesh-list
20340218|NCT00817245|Metronidazole|metronidazole|mesh-list
20340219|NCT00817245|Omeprazole|omeprazole|mesh-list
20340220|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340221|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340222|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20340223|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20340224|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20340225|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340226|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20340227|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340228|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340229|NCT00817258|Cisplatin|cisplatin|mesh-list
20340230|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340231|NCT00817271|Glucagon|glucagon|mesh-list
20340232|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340233|NCT00817271|Hormones|hormones|mesh-ancestor
20340234|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20340235|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612027|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20612028|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20612029|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612030|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612031|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612032|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20612033|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19259145|NCT00248287|Cetuximab|cetuximab|mesh-list
20169411|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169412|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169413|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169414|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19831729|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19831730|NCT05213481|Analgesics|analgesics|mesh-ancestor
19831731|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
19831732|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831733|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19831734|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19831735|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831736|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19831737|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19831738|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831739|NCT05208710|Vaccines|vaccines|mesh-list
19831740|NCT05208710|Immunologic Factors|immunologic factors|mesh-ancestor
19831741|NCT05208710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831742|NCT05204563|Imipenem|imipenem|mesh-list
19831743|NCT05204563|Relebactam|relebactam|mesh-list
20612034|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
20340236|NCT00817284|Bevacizumab|bevacizumab|mesh-list
20340237|NCT00817284|Irinotecan|irinotecan|mesh-list
20340238|NCT00817284|Temozolomide|temozolomide|mesh-list
20340239|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20340240|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340241|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20340242|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20340243|NCT00817284|Growth Substances|growth substances|mesh-ancestor
20340244|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340245|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
20340246|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20340247|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20340248|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340249|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340250|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20340251|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
20340252|NCT00817375|Milnacipran|milnacipran|mesh-list
20340253|NCT00817375|Mirtazapine|mirtazapine|mesh-list
20340254|NCT00817375|Sertraline|sertraline|mesh-list
20340255|NCT00817375|Fluoxetine|fluoxetine|mesh-list
20340256|NCT00817375|Paroxetine|paroxetine|mesh-list
20340257|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20340258|NCT00817375|Nortriptyline|nortriptyline|mesh-list
20340259|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
20340260|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19831744|NCT05204563|Cilastatin|cilastatin|mesh-list
19831745|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340261|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20612035|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257205|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19257206|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257207|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
19257208|NCT05181527|Serotonin|serotonin|mesh-list
19257209|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19257210|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
19257211|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257212|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19257213|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19257214|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257215|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257216|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257217|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19257218|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
19257219|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19257220|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19257221|NCT05131204|Eculizumab|eculizumab|mesh-list
19257222|NCT05131204|Ravulizumab|ravulizumab|mesh-list
19257223|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19257224|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257225|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
19257226|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257227|NCT05097768|Dexamethasone|dexamethasone|mesh-list
19257228|NCT05097768|Ibuprofen|ibuprofen|mesh-list
19257229|NCT05097768|Ketorolac|ketorolac|mesh-list
19257230|NCT05097768|Meloxicam|meloxicam|mesh-list
19257231|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257232|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
19257233|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
19257234|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257235|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257236|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19257237|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
19257238|NCT05097768|Hormones|hormones|mesh-ancestor
19257239|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257240|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19257241|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257242|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20169415|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20169416|NCT00148603|Montelukast|montelukast|mesh-list
20169417|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20169418|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
20169419|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20169420|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
20169421|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169422|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169423|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19257243|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257244|NCT05097768|Analgesics|analgesics|mesh-ancestor
19257245|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
19257246|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257247|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257248|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653404|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169424|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19653405|NCT03764137|Panitumumab|panitumumab|mesh-list
20169425|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169426|NCT00148616|Memantine|memantine|mesh-list
20169427|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20169428|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20340262|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20340263|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340264|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340265|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340266|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
20340267|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340268|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20340269|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20169429|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
20169430|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169431|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169432|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169433|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20169434|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20169435|NCT00148681|Paclitaxel|paclitaxel|mesh-list
20169436|NCT00148681|Vinorelbine|vinorelbine|mesh-list
20169437|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
20169438|NCT00148681|Doxorubicin|doxorubicin|mesh-list
20169439|NCT00148681|Trastuzumab|trastuzumab|mesh-list
20169440|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20169441|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169442|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169443|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169444|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169445|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340270|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20340271|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169446|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340272|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20340273|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20340274|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
19653406|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653407|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653408|NCT03757130|Liraglutide|liraglutide|mesh-list
19653409|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19653410|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653411|NCT03757130|Incretins|incretins|mesh-ancestor
19653412|NCT03757130|Hormones|hormones|mesh-ancestor
19653413|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653414|NCT03733418|Vitamin D|vitamin d|mesh-list
19653415|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
19653416|NCT03733418|Vitamins|vitamins|mesh-ancestor
19653417|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
19653418|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653419|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20169447|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
20169448|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169449|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169450|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20169451|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
20169452|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20169453|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340275|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
19653420|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19653421|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
19653422|NCT03732664|Nivolumab|nivolumab|mesh-list
20169454|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20169455|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20169456|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169457|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20169458|NCT00148694|Cisplatin|cisplatin|mesh-list
20169459|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169460|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20169461|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169462|NCT00148720|Capecitabine|capecitabine|mesh-list
20169463|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20169464|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
20340276|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20340277|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340278|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340279|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20340280|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20340281|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20340282|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
20340283|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20340284|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20340285|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20340286|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20340287|NCT00817375|Analgesics|analgesics|mesh-ancestor
20340288|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
20340289|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340290|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20340291|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20340292|NCT00817466|Epinephrine|epinephrine|mesh-list
20340293|NCT00817466|Racepinephrine|racepinephrine|mesh-list
20169465|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169466|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340294|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
20340295|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20340296|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20340297|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
20340298|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169467|NCT00148746|Cyclosporine|cyclosporine|mesh-list
20169468|NCT00148746|Prednisolone|prednisolone|mesh-list
20169469|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
20169470|NCT00148746|Prednicarbate|prednicarbate|mesh-list
20169471|NCT00148746|Tacrolimus|tacrolimus|mesh-list
20169472|NCT00148746|Cyclosporins|cyclosporins|mesh-list
20169473|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169474|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
20169475|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169476|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20169477|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169478|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169479|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
20169480|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169481|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
20169482|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348255|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340299|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340300|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340301|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20340302|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20340303|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
20340304|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340305|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20340306|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
20340307|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
20340308|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
20340309|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20340310|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20340311|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19831746|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169483|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20340312|NCT00817583|Docetaxel|docetaxel|mesh-list
20340313|NCT00817583|Fluorouracil|fluorouracil|mesh-list
20340314|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340315|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340316|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340317|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340318|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340319|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
20340320|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831747|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
19831748|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169484|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
20169485|NCT00148746|Hormones|hormones|mesh-ancestor
20169486|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169487|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20169488|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169489|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169490|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19831749|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831750|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19831751|NCT05204368|Meropenem|meropenem|mesh-list
19831752|NCT05204368|Imipenem|imipenem|mesh-list
19831753|NCT05204368|Cilastatin|cilastatin|mesh-list
19831754|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19831755|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831756|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
19831757|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835400|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20340321|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340322|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
20340323|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653423|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653424|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653425|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19653426|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653427|NCT03675256|Vaccines|vaccines|mesh-list
19653428|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
19653429|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653430|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
19653431|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653432|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831758|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831759|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
19831760|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19831761|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19831762|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19831763|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19831764|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831765|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
19831766|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831767|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831768|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19653433|NCT03620201|Atezolizumab|atezolizumab|mesh-list
19653434|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653435|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19653436|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19653437|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19653438|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19653439|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653440|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653441|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653442|NCT03618225|Analgesics|analgesics|mesh-ancestor
19653443|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
19653444|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653445|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
19653446|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653447|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
19653448|NCT03566199|Panobinostat|panobinostat|mesh-list
19653449|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257249|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257250|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19257251|NCT05093582|Cromakalim|cromakalim|mesh-list
19257252|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20340324|NCT00817622|Vitamin E|vitamin e|mesh-list
20340325|NCT00817622|Vitamins|vitamins|mesh-ancestor
20340326|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
20340327|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340328|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
20340329|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340330|NCT00817622|Protective Agents|protective agents|mesh-ancestor
19257253|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19257254|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
19257255|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340331|NCT00817648|Risperidone|risperidone|mesh-list
20340332|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20340333|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19257256|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257257|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19257258|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257259|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
19257260|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
19257261|NCT05069350|Bupivacaine|bupivacaine|mesh-list
19257262|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
19257263|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
20340334|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
20340335|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340336|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340337|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340338|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20340339|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169491|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20169492|NCT00148746|Analgesics|analgesics|mesh-ancestor
20169493|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
20169494|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20169495|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169496|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20169497|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169498|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169499|NCT00148785|Ritonavir|ritonavir|mesh-list
20169500|NCT00148785|Indinavir|indinavir|mesh-list
20169501|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
20169502|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19257264|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257265|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257266|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
19257267|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257268|NCT05040282|Etonogestrel|etonogestrel|mesh-list
19257269|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19257270|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
19257271|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19257272|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257273|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19257274|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
19257275|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19257276|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
19257277|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257278|NCT04982172|Infliximab|infliximab|mesh-list
19257279|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
19257280|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19257281|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257282|NCT04978272|Piperaquine|piperaquine|mesh-list
19257283|NCT04978272|Artenimol|artenimol|mesh-list
19257284|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
19257285|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19257286|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19257287|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257288|NCT04934800|Cladribine|cladribine|mesh-list
19257289|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257290|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257291|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
19257292|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257293|NCT04915144|Edotreotide|edotreotide|mesh-list
19257294|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20340340|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169503|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20169504|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
20169505|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169506|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169507|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20169508|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20169509|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
20169510|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169511|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20169512|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20169513|NCT00148824|Vaccines|vaccines|mesh-list
20169514|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20169515|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
20169516|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169517|NCT00148837|Interferons|interferons|mesh-list
20169518|NCT00148837|Ribavirin|ribavirin|mesh-list
20169519|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
20169520|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
20169521|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20169522|NCT00148837|Prazosin|prazosin|mesh-list
20169523|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169524|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
20169525|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169526|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
20169527|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169528|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
20169529|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169530|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20169531|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20169532|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20169533|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20169534|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
20169535|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169536|NCT00148850|Pioglitazone|pioglitazone|mesh-list
20169537|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20169538|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169539|NCT00148863|Interferons|interferons|mesh-list
20169540|NCT00148863|Ribavirin|ribavirin|mesh-list
20169541|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
20169542|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
20169543|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
20169544|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20169545|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169546|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
20169547|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169548|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
20169549|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169550|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
20169551|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169552|NCT00148876|Capecitabine|capecitabine|mesh-list
20169553|NCT00148876|Trastuzumab|trastuzumab|mesh-list
20169554|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20340341|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340342|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20340343|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
20340344|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
20340345|NCT00817661|Vitamin A|vitamin a|mesh-list
20340346|NCT00817661|Vitamins|vitamins|mesh-ancestor
20340347|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
20340348|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340349|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
20340350|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340351|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340352|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20340353|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
20340354|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340355|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340356|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340357|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340358|NCT00817713|Ivermectin|ivermectin|mesh-list
20340359|NCT00817713|Albendazole|albendazole|mesh-list
20340360|NCT00817713|Praziquantel|praziquantel|mesh-list
20169555|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
20169556|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169557|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169558|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20169559|NCT00148902|Docetaxel|docetaxel|mesh-list
20169560|NCT00148902|Lapatinib|lapatinib|mesh-list
20169561|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169562|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
20169563|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169564|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
20169565|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169566|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20169567|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340361|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20340362|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340363|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
20340364|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
20340365|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20340366|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20340367|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340368|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340369|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340370|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340371|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653450|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19653451|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653452|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653453|NCT03561831|Propofol|propofol|mesh-list
19653454|NCT03561831|Sevoflurane|sevoflurane|mesh-list
19653455|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19653456|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340372|NCT00817739|Leuprolide|leuprolide|mesh-list
20340373|NCT00817739|Flutamide|flutamide|mesh-list
20340374|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20340375|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
20340376|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20340377|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340378|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19653457|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653458|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20169568|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
20169569|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20169570|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169571|NCT00149019|Antibodies|antibodies|mesh-list
20169572|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20169573|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
20169574|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169575|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
20169576|NCT00149058|Hematinics|hematinics|mesh-ancestor
20169577|NCT00149084|Amoxicillin|amoxicillin|mesh-list
20169578|NCT00149084|Clarithromycin|clarithromycin|mesh-list
20340379|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169579|NCT00149084|Lansoprazole|lansoprazole|mesh-list
20340380|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
20340381|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
20340382|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20340383|NCT00817765|Ritonavir|ritonavir|mesh-list
20340384|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
20340385|NCT00817765|Posaconazole|posaconazole|mesh-list
20340386|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20340387|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20340388|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
20340389|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340390|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340391|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20340392|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20340393|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
20340394|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340395|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20340396|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20340397|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
20340398|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20340399|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20340400|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20340401|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20340402|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20340403|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
20340404|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20340405|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340406|NCT00817895|Cisplatin|cisplatin|mesh-list
20340407|NCT00817895|Fluorouracil|fluorouracil|mesh-list
20340408|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340409|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
20340410|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340411|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20340412|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340413|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
20340414|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340415|NCT00817934|Bisacodyl|bisacodyl|mesh-list
20340416|NCT00817934|Cathartics|cathartics|mesh-ancestor
20340417|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340418|NCT00817934|Laxatives|laxatives|mesh-ancestor
20340419|NCT00817960|Methylphenidate|methylphenidate|mesh-list
20340420|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20340421|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612036|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20340422|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20340423|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20340424|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340425|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340426|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
20340427|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340428|NCT00817973|Caseins|caseins|mesh-list
20340429|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
20340430|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
20340431|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340432|NCT00818038|Natalizumab|natalizumab|mesh-list
20169580|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
20169581|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169582|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169583|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20169584|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169585|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169586|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20340433|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
20340434|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653459|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
19653460|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
19653461|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19653462|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19665426|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612037|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612038|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
19665427|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
19665428|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340435|NCT00818090|Paclitaxel|paclitaxel|mesh-list
20340436|NCT00818090|Cisplatin|cisplatin|mesh-list
20340437|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20340438|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340439|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340440|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340441|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340442|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340443|NCT00818103|Interferons|interferons|mesh-list
20340444|NCT00818103|Atorvastatin|atorvastatin|mesh-list
20340445|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340446|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
20340447|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340448|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20340449|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20340450|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
20340451|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340452|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20340453|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20340454|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340455|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20340456|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20340457|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20340458|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340459|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340460|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340461|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340462|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
20612039|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20340463|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340464|NCT00818194|Cyclosporine|cyclosporine|mesh-list
20340465|NCT00818194|Tacrolimus|tacrolimus|mesh-list
20340466|NCT00818194|Cyclosporins|cyclosporins|mesh-list
20340467|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340468|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
20340469|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340470|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20340471|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340472|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340473|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
20340474|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340475|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
20340476|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340477|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
20340478|NCT00818298|Ziprasidone|ziprasidone|mesh-list
20340479|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20340480|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
20340481|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340482|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340483|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340484|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20340485|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340486|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340487|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340488|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20340489|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
20340490|NCT00818350|Sunitinib|sunitinib|mesh-list
20340491|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340492|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20340493|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20340494|NCT00818350|Growth Substances|growth substances|mesh-ancestor
20340495|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340496|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
20340497|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20340498|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340499|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340500|NCT00818415|Naproxen|naproxen|mesh-list
20340501|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20340502|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20340503|NCT00818415|Analgesics|analgesics|mesh-ancestor
20340504|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
20340505|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653463|NCT03551626|Trametinib|trametinib|mesh-list
19653464|NCT03551626|Dabrafenib|dabrafenib|mesh-list
20340506|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653465|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653466|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19653467|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653468|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653469|NCT03544736|Paclitaxel|paclitaxel|mesh-list
19257295|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257296|NCT04874480|Decitabine|decitabine|mesh-list
19257297|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20340507|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20340508|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340509|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
20340510|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20340511|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340512|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348256|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
20348257|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348258|NCT00864045|Olanzapine|olanzapine|mesh-list
20348259|NCT00864045|Sertindole|sertindole|mesh-list
20348260|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
20348261|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
19257298|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
19257299|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653470|NCT03544736|Carboplatin|carboplatin|mesh-list
19257300|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257301|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257302|NCT04861584|Gemcitabine|gemcitabine|mesh-list
19653471|NCT03544736|Nivolumab|nivolumab|mesh-list
20340513|NCT00818584|Micafungin|micafungin|mesh-list
20340514|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
20340515|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340516|NCT00818610|Amoxicillin|amoxicillin|mesh-list
20340517|NCT00818610|Clarithromycin|clarithromycin|mesh-list
20340518|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20340519|NCT00818610|Cefuroxime|cefuroxime|mesh-list
20340520|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
20340521|NCT00818610|Lactams|lactams|mesh-list
20340522|NCT00818610|beta-Lactams|beta-lactams|mesh-list
20340523|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340524|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340525|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20340526|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340527|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340528|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20340529|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20340530|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20340531|NCT00818675|Sirolimus|sirolimus|mesh-list
20340532|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340533|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340534|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340535|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340536|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
20340537|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340538|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
20340539|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340540|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20340541|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
20340542|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
20340543|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20340544|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20340545|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340546|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340547|NCT00818701|Urological Agents|urological agents|mesh-ancestor
20340548|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
20340549|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340550|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20340551|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20340552|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20169587|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20169588|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20169589|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169590|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20169591|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20169592|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20169593|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20169594|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20169595|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169596|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169597|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169598|NCT00149110|Analgesics|analgesics|mesh-ancestor
20340553|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340554|NCT00818870|Omeprazole|omeprazole|mesh-list
20340555|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20340556|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340557|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20340558|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340559|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340560|NCT00819000|Interferon-beta|interferon-beta|mesh-list
20340561|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
20340562|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
20340563|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
20340564|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20340565|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
20340566|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340567|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653472|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19653473|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653474|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
19653475|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
19653476|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
19653477|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653478|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653479|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20340568|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340569|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340570|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
20340571|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340572|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
20340573|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20340574|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20340575|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20340576|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340577|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340578|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
20340579|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653480|NCT03508232|Doxycycline|doxycycline|mesh-list
20340580|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340581|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20340582|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653481|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19653482|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653483|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
20340583|NCT00819078|Bupropion|bupropion|mesh-list
20340584|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20340585|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
20340586|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340587|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20340588|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20340589|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340590|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340591|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
20340592|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340593|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340594|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20340595|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20340596|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340597|NCT00819104|Metoprolol|metoprolol|mesh-list
20340598|NCT00819104|Amlodipine|amlodipine|mesh-list
20340599|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20340600|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20340601|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340602|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340603|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20340604|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340605|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
20340606|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20340607|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
20340608|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
20340609|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340610|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19653484|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19653485|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19653486|NCT03501979|Capecitabine|capecitabine|mesh-list
19653487|NCT03501979|Trastuzumab|trastuzumab|mesh-list
19653488|NCT03501979|Tucatinib|tucatinib|mesh-list
19653489|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19653490|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
19653491|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653492|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653493|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653494|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19653495|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340611|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20340612|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19653496|NCT03473574|Gemcitabine|gemcitabine|mesh-list
19653497|NCT03473574|Durvalumab|durvalumab|mesh-list
19653498|NCT03473574|Tremelimumab|tremelimumab|mesh-list
19653499|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653500|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19653501|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
19653502|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653503|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
19653504|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653505|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653506|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653507|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
19653508|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653509|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20340613|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
20340614|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340615|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
20340616|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
20340617|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19831769|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831770|NCT05183984|Bevacizumab|bevacizumab|mesh-list
19831771|NCT05183984|Niraparib|niraparib|mesh-list
19831772|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831773|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831774|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19831775|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19831776|NCT05183984|Growth Substances|growth substances|mesh-ancestor
20340618|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
20340619|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653510|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
19653511|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19653512|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19653513|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19653514|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19653515|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653516|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
19653517|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653518|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653519|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19653520|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831777|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257303|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257304|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19257305|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
19257306|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257307|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
19257308|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257309|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257310|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257311|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
19257312|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257313|NCT04848584|Vaccines|vaccines|mesh-list
19257314|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
19257315|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259146|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259147|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19259148|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19259149|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259150|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259151|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19259152|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
19259153|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19259154|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
19259155|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259156|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
19259157|NCT00225095|Protective Agents|protective agents|mesh-ancestor
19259158|NCT00038727|Metformin|metformin|mesh-list
19259159|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19259160|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259161|NCT05174312|Diuretics|diuretics|mesh-list
19259162|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
19259163|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259164|NCT05174195|Desogestrel|desogestrel|mesh-list
19259165|NCT05174195|Etonogestrel|etonogestrel|mesh-list
19259166|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19259167|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19259168|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19259169|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
19259170|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19259171|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169599|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
20169600|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169601|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
20169602|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169603|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
20169604|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
20169605|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169606|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
20169607|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340620|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340621|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340622|NCT00819325|Pioglitazone|pioglitazone|mesh-list
20340623|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20340624|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340625|NCT00819351|Asparaginase|asparaginase|mesh-list
20340626|NCT00819351|Pegaspargase|pegaspargase|mesh-list
20340627|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340628|NCT00819377|Milrinone|milrinone|mesh-list
20340629|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20340630|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19653521|NCT03370263|Belimumab|belimumab|mesh-list
19653522|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653523|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
19653524|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340631|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
20340632|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20340633|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20340634|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340635|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340636|NCT00819377|Protective Agents|protective agents|mesh-ancestor
20340637|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653525|NCT03351439|Celecoxib|celecoxib|mesh-list
19653526|NCT03351439|Naproxen|naproxen|mesh-list
20169608|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20340638|NCT00819468|Teduglutide|teduglutide|mesh-list
20340639|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340640|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20340641|NCT00819468|Protective Agents|protective agents|mesh-ancestor
20340642|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340643|NCT00819520|Ivermectin|ivermectin|mesh-list
20340644|NCT00819520|Malathion|malathion|mesh-list
20340645|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20169609|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169610|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169611|NCT00149149|Polaprezinc|polaprezinc|mesh-list
20169612|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20169613|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169614|NCT00149162|Aldesleukin|aldesleukin|mesh-list
20169615|NCT00149162|Interleukin-2|interleukin-2|mesh-list
20169616|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169617|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20169618|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20169619|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
20169620|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169621|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653527|NCT03351439|Gabapentin|gabapentin|mesh-list
19653528|NCT03351439|Zopiclone|zopiclone|mesh-list
20169622|NCT00149162|Analgesics|analgesics|mesh-ancestor
20169623|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
20340646|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340647|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20340648|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340649|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340650|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
20340651|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340652|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340653|NCT00819572|Antibodies|antibodies|mesh-list
20340654|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
20340655|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
20340656|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340657|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
20340658|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20340659|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
20340660|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340661|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340662|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20340663|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
20340664|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20340665|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
19653529|NCT03351439|Analgesics|analgesics|mesh-ancestor
19653530|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
19653531|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653532|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653533|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
20169624|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653534|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19653535|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169625|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169626|NCT00149188|Lanreotide|lanreotide|mesh-list
20169627|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169628|NCT00149201|Fluorouracil|fluorouracil|mesh-list
20169629|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
20169630|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169631|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20169632|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169633|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340666|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340667|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340668|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20340669|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
20340670|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
20340671|NCT00819676|Protective Agents|protective agents|mesh-ancestor
20340672|NCT00819728|Docetaxel|docetaxel|mesh-list
20169634|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
20169635|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169636|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
20169637|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20169638|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20169639|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19653536|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340673|NCT00819728|Irinotecan|irinotecan|mesh-list
20340674|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653537|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653538|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19653539|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19653540|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653541|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653542|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
19653543|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19653544|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19831778|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
20169640|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20169641|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169642|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
20340675|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340676|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
19257316|NCT04817410|Naltrexone|naltrexone|mesh-list
20340677|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340678|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340679|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20340680|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20340681|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340682|NCT00819754|Bevacizumab|bevacizumab|mesh-list
20340683|NCT00819754|Capecitabine|capecitabine|mesh-list
20340684|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
20340685|NCT00819754|Irinotecan|irinotecan|mesh-list
20340686|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20340687|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340688|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20340689|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20340690|NCT00819754|Growth Substances|growth substances|mesh-ancestor
20340691|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340692|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
20340693|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20340694|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
20340695|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340696|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20340697|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20340698|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340699|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
20340700|NCT00819806|Vaccines|vaccines|mesh-list
20340701|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
20340702|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653545|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169643|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169644|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169645|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20169646|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169647|NCT00149253|Etoricoxib|etoricoxib|mesh-list
19653546|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653547|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19653548|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19653549|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653550|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
19653551|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19653552|NCT03316274|Nivolumab|nivolumab|mesh-list
19257317|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20169648|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169649|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20169650|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20169651|NCT00149253|Analgesics|analgesics|mesh-ancestor
20169652|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
20340703|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340704|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340705|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20340706|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
20340707|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340708|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340709|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20340710|NCT00819845|Carvedilol|carvedilol|mesh-list
20340711|NCT00819845|Ramipril|ramipril|mesh-list
20340712|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20340713|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20340714|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20340715|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
20340716|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340717|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340718|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340719|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20340720|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
20340721|NCT00819845|Protective Agents|protective agents|mesh-ancestor
20340722|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20340723|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340724|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20340725|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
20340726|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20340727|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20340728|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
20340729|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340730|NCT00819962|Bupivacaine|bupivacaine|mesh-list
20340731|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
20340732|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
20340733|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340734|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340735|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
20340736|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340737|NCT00819975|Caseins|caseins|mesh-list
20340738|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
20340739|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
20169653|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169654|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169655|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169656|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19653553|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653554|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653555|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19653556|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653557|NCT03252626|Alprostadil|alprostadil|mesh-list
19653558|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19653559|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
19653560|NCT03252626|Urological Agents|urological agents|mesh-ancestor
20169657|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20340740|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340741|NCT00819988|Pregabalin|pregabalin|mesh-list
20169658|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169659|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169660|NCT00149292|Olanzapine|olanzapine|mesh-list
20169661|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
20169662|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
20169663|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169664|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169665|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169666|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20169667|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169668|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169669|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169670|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20169671|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20169672|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20169673|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169674|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169675|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
19257318|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19257319|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257320|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
19257321|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257322|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
19257323|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
19257324|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19257325|NCT04808414|Polymyxins|polymyxins|mesh-list
19257326|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257327|NCT04770012|Aspirin|aspirin|mesh-list
19257328|NCT04770012|Clopidogrel|clopidogrel|mesh-list
19257329|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19257330|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257331|NCT04770012|Analgesics|analgesics|mesh-ancestor
19257332|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
19257333|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257334|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257335|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257336|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257337|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19257338|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19257339|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257340|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19257341|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257342|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257343|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
19257344|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19257345|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19257346|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19257347|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
19257348|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257349|NCT04760626|Insulin|insulin|mesh-list
20340742|NCT00819988|Analgesics|analgesics|mesh-ancestor
20340743|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
20340744|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340745|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340746|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
20340747|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20340748|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20340749|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340750|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20340751|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20340752|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340753|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653561|NCT03245008|Fasinumab|fasinumab|mesh-list
19653562|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653563|NCT03245008|Analgesics|analgesics|mesh-ancestor
20340754|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340755|NCT00820053|Epirubicin|epirubicin|mesh-list
20340756|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
20340757|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340758|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340759|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20340760|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20340761|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340762|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340763|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20340764|NCT00820092|Hormones|hormones|mesh-ancestor
20340765|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20340766|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653564|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
19653565|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653566|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653567|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
19653568|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19653569|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
20340767|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20340768|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20340769|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20340770|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20340771|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340772|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340773|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
20340774|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340775|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20340776|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20340777|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20340778|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20340779|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
20340780|NCT00820326|Dolasetron|dolasetron|mesh-list
20340781|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
20340782|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
20340783|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20340784|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340785|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340786|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20340787|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
20340788|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340789|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340790|NCT00820352|Bosentan|bosentan|mesh-list
20340791|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20340792|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20340793|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340794|NCT00820404|BLI-489|bli-489|mesh-list
20340795|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20340796|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340797|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340798|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340799|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653570|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653571|NCT03238300|Expectorants|expectorants|mesh-ancestor
19653572|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
19653573|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19653574|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
19653575|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653576|NCT03238300|Protective Agents|protective agents|mesh-ancestor
19653577|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653578|NCT03238300|Antidotes|antidotes|mesh-ancestor
19653579|NCT03237377|Durvalumab|durvalumab|mesh-list
19653580|NCT03237377|Tremelimumab|tremelimumab|mesh-list
19653581|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653582|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653583|NCT03236545|Estradiol|estradiol|mesh-list
19653584|NCT03236545|Estrogens|estrogens|mesh-list
19653585|NCT03236545|Hormones|hormones|mesh-ancestor
19653586|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20340800|NCT00820417|Cetuximab|cetuximab|mesh-list
20340801|NCT00820417|Gefitinib|gefitinib|mesh-list
20340802|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20340803|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340804|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20340805|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340806|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348262|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653587|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653588|NCT03199755|Lumefantrine|lumefantrine|mesh-list
19653589|NCT03199755|Artemether|artemether|mesh-list
19653590|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19653591|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
19653592|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19653593|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19653594|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653595|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
19653596|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20169676|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
20169677|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20169678|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169679|NCT00149539|Buprenorphine|buprenorphine|mesh-list
20169680|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20169681|NCT00149539|Naloxone|naloxone|mesh-list
20169682|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20169683|NCT00149539|Narcotics|narcotics|mesh-ancestor
20169684|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169685|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653597|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169686|NCT00149539|Analgesics|analgesics|mesh-ancestor
19653598|NCT03181126|Venetoclax|venetoclax|mesh-list
20340807|NCT00820469|Rituximab|rituximab|mesh-list
20340808|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20340809|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340810|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
20340811|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340812|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340813|NCT00820482|Menotropins|menotropins|mesh-list
20340814|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20340815|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
20340816|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20340817|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340818|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
20340819|NCT00820547|Bevacizumab|bevacizumab|mesh-list
20340820|NCT00820547|Docetaxel|docetaxel|mesh-list
20340821|NCT00820547|Fluorouracil|fluorouracil|mesh-list
20340822|NCT00820547|Epirubicin|epirubicin|mesh-list
19653599|NCT03181126|Navitoclax|navitoclax|mesh-list
19653600|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653601|NCT03174405|Avelumab|avelumab|mesh-list
19653602|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653603|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653604|NCT03139747|Everolimus|everolimus|mesh-list
19653605|NCT03139747|Lenvatinib|lenvatinib|mesh-list
20340823|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257350|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19653606|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653607|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340824|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
19653608|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
19653609|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653610|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19653611|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653612|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653613|NCT03059498|Bupivacaine|bupivacaine|mesh-list
19653614|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
20169687|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
20169688|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169689|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20169690|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
20169691|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169692|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
20169693|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169694|NCT00149578|Leucovorin|leucovorin|mesh-list
20169695|NCT00149578|Gemcitabine|gemcitabine|mesh-list
20169696|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
20169697|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20169698|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
20169699|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169700|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169701|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
20169702|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169703|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169704|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169705|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
20169706|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169707|NCT00149578|Antidotes|antidotes|mesh-ancestor
20169708|NCT00149578|Protective Agents|protective agents|mesh-ancestor
20169709|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
20169710|NCT00149578|Vitamins|vitamins|mesh-ancestor
20169711|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
19257351|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
20169712|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19653615|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
20169713|NCT00149604|Estrogens|estrogens|mesh-list
20169714|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20169715|NCT00149604|Hormones|hormones|mesh-ancestor
20169716|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169717|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169718|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20169719|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
20169720|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20169721|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20169722|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20169723|NCT00149617|Buspirone|buspirone|mesh-list
20169724|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20169725|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169726|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169727|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169728|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653616|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653617|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653618|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
19653619|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257352|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19257353|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257354|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
19257355|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19257356|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
19257357|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257358|NCT04755972|Expectorants|expectorants|mesh-ancestor
19257359|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257360|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19257361|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
19257362|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257363|NCT04755972|Protective Agents|protective agents|mesh-ancestor
19257364|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257365|NCT04755972|Antidotes|antidotes|mesh-ancestor
19257366|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19257367|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19257368|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257369|NCT04709250|Bupivacaine|bupivacaine|mesh-list
19257370|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
19257371|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
19257372|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257373|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257374|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
19257375|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257376|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19257377|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19257378|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257379|NCT04652245|Fluticasone|fluticasone|mesh-list
19257380|NCT04652245|Xhance|xhance|mesh-list
19257381|NCT04652245|Azelastine|azelastine|mesh-list
19257382|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257383|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19257384|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
19257385|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257386|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653620|NCT02943590|Atorvastatin|atorvastatin|mesh-list
19653621|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20340825|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340826|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340827|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20340828|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
20340829|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340830|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340831|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20340832|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20340833|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20340834|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20340835|NCT00820547|Growth Substances|growth substances|mesh-ancestor
20340836|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
20340837|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340838|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340839|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340840|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
20340841|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20340842|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340843|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20340844|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20340845|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340846|NCT00820690|Paclitaxel|paclitaxel|mesh-list
20340847|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
20340848|NCT00820690|Doxorubicin|doxorubicin|mesh-list
20340849|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20340850|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340851|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340852|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340853|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340854|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340855|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340856|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
20340857|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340858|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340859|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20340860|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
20340861|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20340862|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340863|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20340864|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20340865|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340866|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20340867|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340868|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
20340869|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
20340870|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340871|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340872|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340873|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
20340874|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340875|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340876|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340877|NCT00820885|Teduglutide|teduglutide|mesh-list
20340878|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20340879|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20340880|NCT00820885|Protective Agents|protective agents|mesh-ancestor
20340881|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340882|NCT00820911|Cyclosporine|cyclosporine|mesh-list
20340883|NCT00820911|Everolimus|everolimus|mesh-list
20340884|NCT00820911|Cyclosporins|cyclosporins|mesh-list
20340885|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340886|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340887|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340888|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
20340889|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340890|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
20340891|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340892|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
20340893|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340894|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20340895|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169729|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20169730|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
20169731|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169732|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169733|NCT00149656|Selenium|selenium|mesh-list
20169734|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
20169735|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169736|NCT00149656|Protective Agents|protective agents|mesh-ancestor
20169737|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169738|NCT00149656|Trace Elements|trace elements|mesh-ancestor
20169739|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
20174841|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174842|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
20174843|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174844|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174845|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
20174846|NCT00165815|Donepezil|donepezil|mesh-list
20174847|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20174848|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174849|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174850|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
20174851|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174852|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174853|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
20174854|NCT00165828|Zonisamide|zonisamide|mesh-list
20340896|NCT00820963|Temozolomide|temozolomide|mesh-list
20340897|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20340898|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
19653622|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20169740|NCT00149708|Hormones|hormones|mesh-list
20169741|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169742|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169743|NCT00149851|Tegaserod|tegaserod|mesh-list
20169744|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20169745|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
20169746|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174855|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
19257387|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19257388|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257389|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
19257390|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19257391|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19257392|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257393|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174856|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19257394|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20174857|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174858|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174859|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20174860|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340899|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340900|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340901|NCT00821028|Paclitaxel|paclitaxel|mesh-list
20340902|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20340903|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340904|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
20340905|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20340906|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340907|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340908|NCT00821054|Lapatinib|lapatinib|mesh-list
20340909|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340910|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20340911|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20340912|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340913|NCT00821080|Sirolimus|sirolimus|mesh-list
20340914|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20340915|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340916|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20340917|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340918|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
20340919|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20340920|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
20340921|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340922|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20340923|NCT00821158|Antioxidants|antioxidants|mesh-list
20340924|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340925|NCT00821158|Protective Agents|protective agents|mesh-ancestor
20340926|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340927|NCT00821262|Propofol|propofol|mesh-list
20340928|NCT00821262|Sevoflurane|sevoflurane|mesh-list
20340929|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20340930|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340931|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653623|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
19653624|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653625|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19653626|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20340932|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20340933|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
20340934|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
20340935|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20340936|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20340937|NCT00821301|Fluphenazine|fluphenazine|mesh-list
20340938|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
19653627|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653628|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
19653629|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
19653630|NCT02918292|Fludarabine|fludarabine|mesh-list
19653631|NCT02918292|Tacrolimus|tacrolimus|mesh-list
19653632|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
19653633|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19653634|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653635|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
19653636|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653637|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653638|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19653639|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
20340939|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
20340940|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20340941|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340942|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340943|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340944|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340945|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20340946|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
19653640|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653641|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340947|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340948|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340949|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20340950|NCT00821392|Febuxostat|febuxostat|mesh-list
20340951|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
20340952|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20340953|NCT00821444|Ziprasidone|ziprasidone|mesh-list
20340954|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20340955|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
20340956|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340957|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340958|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340959|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20340960|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20340961|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20340962|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20340963|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20340964|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
20340965|NCT00821457|Mitogens|mitogens|mesh-list
20340966|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
20340967|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340968|NCT00821483|Frovatriptan|frovatriptan|mesh-list
20340969|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20340970|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
20340971|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20340972|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340973|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340974|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20340975|NCT00821496|Norethindrone|norethindrone|mesh-list
20340976|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
20340977|NCT00821496|Norinyl|norinyl|mesh-list
20340978|NCT00821496|Estradiol|estradiol|mesh-list
20340979|NCT00821496|Estrogens|estrogens|mesh-ancestor
20340980|NCT00821496|Hormones|hormones|mesh-ancestor
20340981|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20340982|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20340983|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20340984|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
20169747|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169748|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169749|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
20169750|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169751|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169752|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169753|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169754|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169755|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169756|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169757|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169758|NCT00149877|Tegaserod|tegaserod|mesh-list
20169759|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20340985|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20340986|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20340987|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19257395|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19257396|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
19257397|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
19257398|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257399|NCT04647643|Paclitaxel|paclitaxel|mesh-list
19257400|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19653642|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19653643|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19653644|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653645|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19653646|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19653647|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
19653648|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19653649|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653650|NCT02902120|Grazoprevir|grazoprevir|mesh-list
19653651|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
19653652|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653653|NCT02896712|Modafinil|modafinil|mesh-list
19653654|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19653655|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653656|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19257401|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20340988|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19257402|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
19653657|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19653658|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19653659|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653660|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
19653661|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653662|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653663|NCT02654080|Vaccines|vaccines|mesh-list
20340989|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20340990|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20340991|NCT00821535|Maraviroc|maraviroc|mesh-list
20340992|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20340993|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20340994|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20340995|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20340996|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20340997|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
20340998|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20340999|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20341000|NCT00821574|Valsartan|valsartan|mesh-list
20169760|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
20169761|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169762|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169763|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169764|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
20169765|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169766|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169767|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169768|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169769|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20341001|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20341002|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20341003|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20341004|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20341005|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341006|NCT00821574|Diuretics|diuretics|mesh-ancestor
19653664|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
19653665|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653666|NCT02639026|Durvalumab|durvalumab|mesh-list
19653667|NCT02639026|Tremelimumab|tremelimumab|mesh-list
19653668|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653669|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341007|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
20341008|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341009|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20341010|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341011|NCT00821600|Risperidone|risperidone|mesh-list
20341012|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20341013|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
20341014|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341015|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341016|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341017|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20341018|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341019|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341020|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653670|NCT02618148|Estrogens|estrogens|mesh-list
20341021|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20169770|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169771|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169772|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169773|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
20169774|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169775|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169776|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169777|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169778|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169779|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169780|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169781|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169782|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
20169783|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169784|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169785|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169786|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169787|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20341022|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
20341023|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
20341024|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20169788|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169789|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169790|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169791|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
20341025|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
19257403|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
19257404|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
19257405|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257406|NCT04631536|Folic Acid|folic acid|mesh-list
19257407|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
19257408|NCT04631536|Nicorandil|nicorandil|mesh-list
19257409|NCT04631536|Nebivolol|nebivolol|mesh-list
19257410|NCT04631536|Atorvastatin|atorvastatin|mesh-list
19257411|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19257412|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19257413|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
19257414|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257415|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19257416|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19257417|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257418|NCT04631536|Hematinics|hematinics|mesh-ancestor
19257419|NCT04631536|Vitamins|vitamins|mesh-ancestor
19257420|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
19257421|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257422|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19257423|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
19257424|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19257425|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19257426|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19257427|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
19257428|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257429|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19257430|NCT04567992|Bupivacaine|bupivacaine|mesh-list
19257431|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
19257432|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
19257433|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257434|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257435|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
19257436|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257437|NCT04565600|Etoricoxib|etoricoxib|mesh-list
19257438|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19257439|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257440|NCT04565600|Analgesics|analgesics|mesh-ancestor
20341026|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341027|NCT00821782|Azithromycin|azithromycin|mesh-list
20341028|NCT00821782|Levofloxacin|levofloxacin|mesh-list
20341029|NCT00821782|Ofloxacin|ofloxacin|mesh-list
20341030|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20341031|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341032|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20341033|NCT00821782|Renal Agents|renal agents|mesh-ancestor
20341034|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20341035|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20341036|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653671|NCT02618148|Hormones|hormones|mesh-ancestor
19653672|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653673|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341037|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653674|NCT02553447|Vitamin D|vitamin d|mesh-list
20341038|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341039|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20341040|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19653675|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
20341041|NCT00821834|Ticlopidine|ticlopidine|mesh-list
19653676|NCT02553447|Vitamins|vitamins|mesh-ancestor
19653677|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
19653678|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653679|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19653680|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19653681|NCT02486666|Enoxaparin|enoxaparin|mesh-list
19653682|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
19653683|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
19653684|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19653685|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19653686|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653687|NCT02431767|Interleukin-12|interleukin-12|mesh-list
19653688|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19653689|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
19653690|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653691|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19653692|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19653693|NCT02431767|Growth Substances|growth substances|mesh-ancestor
19653694|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
20341042|NCT00821834|Clopidogrel|clopidogrel|mesh-list
19653695|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653696|NCT02390284|Timolol|timolol|mesh-list
20341043|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19653697|NCT02390284|Bimatoprost|bimatoprost|mesh-list
19653698|NCT02390284|Travoprost|travoprost|mesh-list
19653699|NCT02390284|Dorzolamide|dorzolamide|mesh-list
19653700|NCT02390284|Acetazolamide|acetazolamide|mesh-list
19653701|NCT02390284|Methazolamide|methazolamide|mesh-list
19653702|NCT02390284|Latanoprost|latanoprost|mesh-list
19653703|NCT02390284|Brinzolamide|brinzolamide|mesh-list
19653704|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19653705|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20169792|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19653706|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
19653707|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653708|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169793|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169794|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169795|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
20341044|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20341045|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20341046|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20341047|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
20341048|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341049|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341050|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257441|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
19257442|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257443|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257444|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257445|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257446|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19257447|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257448|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257449|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257450|NCT04501211|Granisetron|granisetron|mesh-list
19257451|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
19257452|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
19257453|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257454|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257455|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19257456|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19257457|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
19257458|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257459|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257460|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
19257461|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
19257462|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19257463|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19257464|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257465|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257466|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257467|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257468|NCT04409262|Remdesivir|remdesivir|mesh-list
19257469|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
19257470|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257471|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
19257472|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257473|NCT04408508|Amoxicillin|amoxicillin|mesh-list
19257474|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257475|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257476|NCT04352439|Aspirin|aspirin|mesh-list
19257477|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19257478|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20341051|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20341052|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20341053|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20341054|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20341055|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341056|NCT00821912|Docetaxel|docetaxel|mesh-list
20341057|NCT00821912|Capecitabine|capecitabine|mesh-list
20341058|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341059|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
20341060|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
20169796|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169797|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169798|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169799|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169800|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
20169801|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169802|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169803|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169804|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169805|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169806|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169807|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169808|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169809|NCT00149981|Everolimus|everolimus|mesh-list
20341061|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
20341062|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341063|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20341064|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
20341065|NCT00822029|Alendronate|alendronate|mesh-list
20341066|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20341067|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341068|NCT00822055|Timolol|timolol|mesh-list
20341069|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20341070|NCT00822055|Dorzolamide|dorzolamide|mesh-list
20341071|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
20341072|NCT00822055|Maleic acid|maleic acid|mesh-list
20341073|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20341074|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20341075|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20341076|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341077|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341078|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341079|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341080|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20341081|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341082|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20341083|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20341084|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20341085|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20341086|NCT00822081|Timolol|timolol|mesh-list
20341087|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20341088|NCT00822081|Dorzolamide|dorzolamide|mesh-list
20341089|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
20341090|NCT00822081|Maleic acid|maleic acid|mesh-list
20341091|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20341092|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20341093|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
20341094|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341095|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341096|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341097|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341098|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20341099|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341100|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20341101|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20341102|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20341103|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20341104|NCT00822133|Lidocaine|lidocaine|mesh-list
20341105|NCT00822133|Ketamine|ketamine|mesh-list
20341106|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
20341107|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
20341108|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341109|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341110|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
20341111|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341112|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341113|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20341114|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20341115|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341116|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341117|NCT00822133|Analgesics|analgesics|mesh-ancestor
20341118|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20341119|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20341120|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
20341121|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20341122|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20341123|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341124|NCT00822211|Vildagliptin|vildagliptin|mesh-list
20341125|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20341126|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341127|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20341128|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
20341129|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341130|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341131|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
20341132|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19653709|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653710|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19653711|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20169810|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341133|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
20341134|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341135|NCT00822263|Expectorants|expectorants|mesh-ancestor
20341136|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
20341137|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20341138|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
20341139|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341140|NCT00822263|Protective Agents|protective agents|mesh-ancestor
20341141|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653712|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19653713|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20169811|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169812|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
20169813|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169814|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
20169815|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169816|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169817|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169818|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169819|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169820|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169821|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169822|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169823|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
19257479|NCT04352439|Analgesics|analgesics|mesh-ancestor
19257480|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
19257481|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257482|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257483|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257484|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257485|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19257486|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19257487|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257488|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19257489|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257490|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257491|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
19257492|NCT04330430|Nivolumab|nivolumab|mesh-list
19257493|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257494|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257495|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19257496|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257497|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19257498|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257499|NCT04219540|Buprenorphine|buprenorphine|mesh-list
19257500|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19257501|NCT04219540|Narcotics|narcotics|mesh-ancestor
19257502|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257503|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257504|NCT04219540|Analgesics|analgesics|mesh-ancestor
19257505|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
19653714|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
20169824|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20169825|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341142|NCT00822263|Antidotes|antidotes|mesh-ancestor
20348263|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348264|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20348265|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20348266|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348267|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348268|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348269|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20348270|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348271|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348272|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169826|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20169827|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
20169828|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169829|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169830|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169831|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169832|NCT00150046|Everolimus|everolimus|mesh-list
20169833|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169834|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20169835|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
20169836|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169837|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
20169838|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20348273|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341143|NCT00822315|Efavirenz|efavirenz|mesh-list
20341144|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
20341145|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20341146|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20341147|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341148|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341149|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
20341150|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341151|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20341152|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20341153|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20341154|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20341155|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20341156|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20341157|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20341158|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20341159|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20341160|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20341161|NCT00822380|Iron|iron|mesh-list
20341162|NCT00822380|Trace Elements|trace elements|mesh-list
20341163|NCT00822380|Folic Acid|folic acid|mesh-list
20341164|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
20341165|NCT00822380|Micronutrients|micronutrients|mesh-list
20341166|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169839|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20169840|NCT00150059|Analgesics|analgesics|mesh-ancestor
20169841|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
20169842|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169843|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169844|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169845|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169846|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
20169847|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20341167|NCT00822380|Hematinics|hematinics|mesh-ancestor
20341168|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
20341169|NCT00822380|Vitamins|vitamins|mesh-ancestor
20341170|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
20341171|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341172|NCT00822380|Protective Agents|protective agents|mesh-ancestor
19653715|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19653716|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653717|NCT02390284|Diuretics|diuretics|mesh-ancestor
19653718|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
19653719|NCT02389517|Dexamethasone|dexamethasone|mesh-list
19653720|NCT02389517|Lenalidomide|lenalidomide|mesh-list
19653721|NCT02389517|Ixazomib|ixazomib|mesh-list
19653722|NCT02389517|Glycine|glycine|mesh-list
19653723|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19653724|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831779|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19831780|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831781|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653725|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
19653726|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
20341173|NCT00822393|Busulfan|busulfan|mesh-list
20341174|NCT00822393|Treosulfan|treosulfan|mesh-list
20341175|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
20341176|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341177|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20341178|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
20341179|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341180|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20341181|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341182|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20341183|NCT00822419|Lidocaine|lidocaine|mesh-list
19257506|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257507|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19257508|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
19257509|NCT04146298|Fludarabine|fludarabine|mesh-list
19257510|NCT04146298|Antibodies|antibodies|mesh-list
19257511|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19257512|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257513|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
19257514|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257515|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257516|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19257517|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
19257518|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257519|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257520|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19653727|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653728|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653729|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19653730|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
19653731|NCT02389517|Hormones|hormones|mesh-ancestor
19653732|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653733|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259172|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19259173|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19259174|NCT05174195|Progestins|progestins|mesh-ancestor
19259175|NCT05174195|Hormones|hormones|mesh-ancestor
19259176|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259177|NCT05174156|Paclitaxel|paclitaxel|mesh-list
19259178|NCT05174156|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19259179|NCT05174156|Cisplatin|cisplatin|mesh-list
19259180|NCT05174156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19259181|NCT05174156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259182|NCT05174156|Tubulin Modulators|tubulin modulators|mesh-ancestor
19259183|NCT05174156|Antimitotic Agents|antimitotic agents|mesh-ancestor
19259184|NCT05174156|Mitosis Modulators|mitosis modulators|mesh-ancestor
19259185|NCT05174156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831782|NCT05175768|Niacinamide|niacinamide|mesh-list
19831783|NCT05175768|Niacin|niacin|mesh-list
19831784|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
19831785|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
19831786|NCT05175768|Vitamins|vitamins|mesh-ancestor
19259191|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
19259192|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19259193|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19259194|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259195|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
19259196|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
19259197|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259198|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19259199|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
19259200|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259201|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19259202|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
19259203|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259204|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259205|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19259206|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19259207|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19259208|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
19259209|NCT05173584|Albuterol|albuterol|mesh-list
19259210|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19259211|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
19259212|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259213|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259214|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19259215|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
19259216|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
19259217|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19259218|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19259219|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19831787|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
19831788|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169848|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
20169849|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20341184|NCT00822419|Ketamine|ketamine|mesh-list
20341185|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
20341186|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
20341187|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341188|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341189|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
20341190|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341191|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341192|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20341193|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20341194|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341195|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341196|NCT00822419|Analgesics|analgesics|mesh-ancestor
20341197|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20341198|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20341199|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
20341200|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20341201|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20341202|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341203|NCT00822536|Aspirin|aspirin|mesh-list
20169850|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169851|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169852|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
20169853|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169854|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20169855|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169856|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169857|NCT00150085|Cyclosporine|cyclosporine|mesh-list
20169858|NCT00150085|Cyclosporins|cyclosporins|mesh-list
20169859|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169860|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169861|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20341204|NCT00822536|Clopidogrel|clopidogrel|mesh-list
20348274|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
20341205|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20341206|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20341207|NCT00822536|Analgesics|analgesics|mesh-ancestor
20341208|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
20341209|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341210|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341211|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20341212|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20341213|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20341214|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20341215|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341216|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20341217|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20341218|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341219|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
20341220|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20341221|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20341222|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20341223|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
20341224|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341225|NCT00822549|Morphine|morphine|mesh-list
20341226|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20341227|NCT00822549|Narcotics|narcotics|mesh-ancestor
20341228|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341229|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341230|NCT00822549|Analgesics|analgesics|mesh-ancestor
20341231|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
20341232|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341233|NCT00822614|Fentanyl|fentanyl|mesh-list
20341234|NCT00822614|Morphine|morphine|mesh-list
20341235|NCT00822614|Oxycodone|oxycodone|mesh-list
20341236|NCT00822614|Hydromorphone|hydromorphone|mesh-list
20341237|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20341238|NCT00822614|Narcotics|narcotics|mesh-ancestor
20341239|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341240|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257521|NCT03994146|Remifentanil|remifentanil|mesh-list
20169862|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
20169863|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169864|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
20169865|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169866|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
20169867|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169868|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20169869|NCT00150111|Rituximab|rituximab|mesh-list
20341241|NCT00822614|Analgesics|analgesics|mesh-ancestor
20341242|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
20341243|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341244|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20341245|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20341246|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
20341247|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
20341248|NCT00822627|Vaccines|vaccines|mesh-list
20341249|NCT00822627|Immunologic Factors|immunologic factors|mesh-ancestor
20341250|NCT00822627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341251|NCT00822666|Clopidogrel|clopidogrel|mesh-list
20341252|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20341253|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20341254|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20341255|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20341256|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
20341257|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341258|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341259|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341260|NCT00822744|Citalopram|citalopram|mesh-list
20341261|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20341262|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20341263|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341264|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341265|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341266|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
20341267|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341268|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20341269|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
20341270|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341271|NCT00822783|Omalizumab|omalizumab|mesh-list
20341272|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20341273|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20341274|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
20341275|NCT00822809|Prednisolone|prednisolone|mesh-list
20341276|NCT00822809|Catumaxomab|catumaxomab|mesh-list
20341277|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20341278|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
20341279|NCT00822809|Hormones|hormones|mesh-ancestor
20341280|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653734|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341281|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169870|NCT00150111|Vaccines|vaccines|mesh-list
20341282|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20341283|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169871|NCT00150111|Methimazole|methimazole|mesh-list
20169872|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20169873|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20169874|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
20169875|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169876|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20169877|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
20169878|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
20169879|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169880|NCT00150124|Methimazole|methimazole|mesh-list
20169881|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
20169882|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
20169883|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169884|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169885|NCT00150137|Methimazole|methimazole|mesh-list
20169886|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
20169887|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
20169888|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20169889|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169890|NCT00150215|Olanzapine|olanzapine|mesh-list
20169891|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
20169892|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
20169893|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169894|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169895|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20169896|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20169897|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169898|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20169899|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169900|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20341284|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20341285|NCT00822848|Sorafenib|sorafenib|mesh-list
20341286|NCT00822848|Epirubicin|epirubicin|mesh-list
20341287|NCT00822848|Ifosfamide|ifosfamide|mesh-list
20341288|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341289|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20341290|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341291|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341292|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19257522|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19257523|NCT03994146|Narcotics|narcotics|mesh-ancestor
19257524|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257525|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257526|NCT03994146|Analgesics|analgesics|mesh-ancestor
19257527|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
19257528|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257529|NCT03987919|Tirzepatide|tirzepatide|mesh-list
19257530|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19257531|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257532|NCT03987919|Incretins|incretins|mesh-ancestor
19257533|NCT03987919|Hormones|hormones|mesh-ancestor
19257534|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257535|NCT03987711|Warfarin|warfarin|mesh-list
19257536|NCT03987711|Apixaban|apixaban|mesh-list
19257537|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
19257538|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19257539|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
19257540|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19257541|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
19257542|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257543|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257544|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
19257545|NCT03873818|Ipilimumab|ipilimumab|mesh-list
19257546|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257547|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257548|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19257549|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257550|NCT03861039|Tirzepatide|tirzepatide|mesh-list
19257551|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19257552|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257553|NCT03861039|Incretins|incretins|mesh-ancestor
19257554|NCT03861039|Hormones|hormones|mesh-ancestor
19257555|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257556|NCT03759587|Niraparib|niraparib|mesh-list
19257557|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19257558|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259220|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20169901|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19653735|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
19653736|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19653737|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20341293|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20341294|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20341295|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20341296|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
20341297|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19653738|NCT02389517|Growth Substances|growth substances|mesh-ancestor
19653739|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
20341298|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20341299|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20341300|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341301|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341302|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20341303|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341304|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341305|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
20341306|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341307|NCT00823004|Letrozole|letrozole|mesh-list
20341308|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
20341309|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
20341310|NCT00823004|Buserelin|buserelin|mesh-list
20341311|NCT00823004|Ganirelix|ganirelix|mesh-list
20341312|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341313|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20341314|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20341315|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341316|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341317|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20341318|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
20341319|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653740|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612040|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20612041|NCT02249442|Ritonavir|ritonavir|mesh-list
20612042|NCT02249442|Tipranavir|tipranavir|mesh-list
20612043|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20612044|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20612045|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612046|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612047|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653741|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
19653742|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653743|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
19653744|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665429|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665430|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
19665431|NCT05092074|Velpatasvir|velpatasvir|mesh-list
19665432|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
19665433|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665434|NCT05091372|Lenalidomide|lenalidomide|mesh-list
19665435|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
19665436|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665437|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19665438|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19665439|NCT05091372|Growth Substances|growth substances|mesh-ancestor
19665440|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
19665441|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665442|NCT05083949|Metformin|metformin|mesh-list
19831789|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19831790|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
19831791|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831792|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19831793|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
19831794|NCT05166616|Osimertinib|osimertinib|mesh-list
19831795|NCT05166616|Triptolide|triptolide|mesh-list
19831796|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665443|NCT05083949|Empagliflozin|empagliflozin|mesh-list
19665444|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19665445|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665446|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19665447|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665448|NCT05058417|Empagliflozin|empagliflozin|mesh-list
19831797|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19831798|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831799|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831800|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19831801|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
19831802|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19831803|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169902|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20612048|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19665449|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19665450|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831804|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19665451|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19831805|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
19831806|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20169903|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653745|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
19653746|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19653747|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19653748|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653749|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
19653750|NCT05082142|Coagulants|coagulants|mesh-ancestor
19653751|NCT05081986|Cycloserine|cycloserine|mesh-list
19653752|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19653753|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653754|NCT05081986|Renal Agents|renal agents|mesh-ancestor
19653755|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19653756|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
19653757|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19653758|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
19653759|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653760|NCT05081765|Olaparib|olaparib|mesh-list
19653761|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19653762|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653763|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653764|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653765|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
19653766|NCT05081687|Irinotecan|irinotecan|mesh-list
19653767|NCT05081687|Folfirinox|folfirinox|mesh-list
19653768|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653769|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19653770|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19653771|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653772|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653773|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
19653774|NCT05081674|Nivolumab|nivolumab|mesh-list
19653775|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19653776|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653777|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653778|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19831807|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831808|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
19831809|NCT05145010|Infigratinib|infigratinib|mesh-list
20169904|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169905|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
20169906|NCT00150228|Varenicline|varenicline|mesh-list
19653779|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653780|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19831810|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831811|NCT05139043|Dexamethasone|dexamethasone|mesh-list
19831812|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
19653781|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831813|NCT05139043|Ichthammol|ichthammol|mesh-list
20169907|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19831814|NCT05139043|BB 1101|bb 1101|mesh-list
20169908|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20169909|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
20169910|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169911|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169912|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169913|NCT00150241|Varenicline|varenicline|mesh-list
20169914|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20169915|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20169916|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
20169917|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341320|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341321|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20341322|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20341323|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20341324|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
20341325|NCT00823030|Lidocaine|lidocaine|mesh-list
20341326|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
19653782|NCT05081466|Vitamin D|vitamin d|mesh-list
19653783|NCT05081466|Calcium|calcium|mesh-list
19653784|NCT05081466|Vitamins|vitamins|mesh-ancestor
20169918|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259221|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
20341327|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
20341328|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653785|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
20341329|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341330|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
20341331|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341332|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341333|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20341334|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20341335|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341336|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341337|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20341338|NCT00823121|Buserelin|buserelin|mesh-list
20341339|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20341340|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341341|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20341342|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
20341343|NCT00823186|Paclitaxel|paclitaxel|mesh-list
20341344|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20341345|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341346|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257559|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257560|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257561|NCT03733314|Quetmolimab|quetmolimab|mesh-list
19257562|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257563|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
19257564|NCT03730662|Tirzepatide|tirzepatide|mesh-list
19257565|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19257566|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257567|NCT03730662|Incretins|incretins|mesh-ancestor
19257568|NCT03730662|Hormones|hormones|mesh-ancestor
19257569|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257570|NCT03717623|Posaconazole|posaconazole|mesh-list
19257571|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
19257572|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257573|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19257574|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19257575|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19257576|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19257577|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19257578|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257579|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341347|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
20341348|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
20341349|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341350|NCT00823238|Tobramycin|tobramycin|mesh-list
20341351|NCT00823238|Ceftazidime|ceftazidime|mesh-list
20341352|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20341353|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341354|NCT00823290|Sorafenib|sorafenib|mesh-list
20341355|NCT00823290|Panobinostat|panobinostat|mesh-list
20341356|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341357|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20341358|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341359|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341360|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20341361|NCT00823342|Tenofovir|tenofovir|mesh-list
20341362|NCT00823342|Clevudine|clevudine|mesh-list
19257580|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19257581|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
19257582|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257583|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257584|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20341363|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
20341364|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341365|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20169919|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169920|NCT00150254|Varenicline|varenicline|mesh-list
20169921|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19831815|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831816|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
19831817|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
19831818|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831819|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831820|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19831821|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
19831822|NCT05139043|Hormones|hormones|mesh-ancestor
19831823|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831824|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19831825|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831826|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
19831827|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831828|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831829|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
19831830|NCT05139004|Fludarabine|fludarabine|mesh-list
20169922|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20169923|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
20341366|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20341367|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653786|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653787|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19653788|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20341368|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341369|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20341370|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20341371|NCT00823381|Resveratrol|resveratrol|mesh-list
20341372|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
20341373|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341374|NCT00823381|Protective Agents|protective agents|mesh-ancestor
20341375|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341376|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341377|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19653789|NCT05081102|Ibuprofen|ibuprofen|mesh-list
19653790|NCT05081102|Oxycodone|oxycodone|mesh-list
20169924|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169925|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169926|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169927|NCT00150280|Ibuprofen|ibuprofen|mesh-list
20169928|NCT00150280|Celecoxib|celecoxib|mesh-list
20169929|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20341378|NCT00823433|Penicillins|penicillins|mesh-list
20341379|NCT00823433|Penicillin V|penicillin v|mesh-list
20341380|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20341381|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341382|NCT00823550|Lamivudine|lamivudine|mesh-list
20341383|NCT00823550|Entecavir|entecavir|mesh-list
20341384|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19653791|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19653792|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653793|NCT05081102|Analgesics|analgesics|mesh-ancestor
19653794|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
19653795|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653796|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653797|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831831|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
20341385|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19831832|NCT05139004|Melphalan|melphalan|mesh-list
19831833|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
19653798|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653799|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19653800|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653801|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653802|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19653803|NCT05081102|Narcotics|narcotics|mesh-ancestor
19653804|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653805|NCT05080985|Bupivacaine|bupivacaine|mesh-list
19653806|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
19653807|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
19653808|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653809|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653810|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
19653811|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653812|NCT05080803|Bevacizumab|bevacizumab|mesh-list
19653813|NCT05080803|Ranibizumab|ranibizumab|mesh-list
19653814|NCT05080803|Aflibercept|aflibercept|mesh-list
19653815|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19653816|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653817|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19653818|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19653819|NCT05080803|Growth Substances|growth substances|mesh-ancestor
19653820|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653821|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
20341386|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341387|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341388|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
20341389|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341390|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20341391|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20341392|NCT00823563|Adenosine|adenosine|mesh-list
20341393|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
20341394|NCT00823563|Analgesics|analgesics|mesh-ancestor
19653822|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
19653823|NCT05062278|Vinblastine|vinblastine|mesh-list
19653824|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653825|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
19653826|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653827|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653828|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19653829|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19653830|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
19653831|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
19653832|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
19653833|NCT05059873|Prednisone|prednisone|mesh-list
19653834|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653835|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
19653836|NCT05059873|Hormones|hormones|mesh-ancestor
19653837|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653838|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653839|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19653840|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653841|NCT05055830|Acetaminophen|acetaminophen|mesh-list
19653842|NCT05055830|Methadone|methadone|mesh-list
19653843|NCT05055830|Caffeine|caffeine|mesh-list
19653844|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653845|NCT05055830|Analgesics|analgesics|mesh-ancestor
19653846|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
19653847|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653848|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653849|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
19653850|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20341395|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
19831834|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20341396|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653851|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19653852|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653853|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653854|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19653855|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19653856|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
19653857|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653858|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20341397|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341398|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341399|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
20341400|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20341401|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
20341402|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
19653859|NCT05055830|Narcotics|narcotics|mesh-ancestor
19653860|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653861|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
19653862|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
19653863|NCT05010629|Carboplatin|carboplatin|mesh-list
19653864|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653865|NCT04997239|Vaccines|vaccines|mesh-list
19653866|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
19653867|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653868|NCT04997174|Celecoxib|celecoxib|mesh-list
19653869|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19653870|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653871|NCT04997174|Analgesics|analgesics|mesh-ancestor
19653872|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
19653873|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653874|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653875|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653876|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653877|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19653878|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19653879|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653880|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653881|NCT04976387|Acetaminophen|acetaminophen|mesh-list
19653882|NCT04976387|Ibuprofen|ibuprofen|mesh-list
19653883|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20341403|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653884|NCT04976387|Hydrocodone|hydrocodone|mesh-list
19653885|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19653886|NCT04976387|Analgesics|analgesics|mesh-ancestor
19653887|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
19653888|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341404|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341405|NCT00823576|Ropivacaine|ropivacaine|mesh-list
20341406|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
20341407|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
20341408|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341409|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341410|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
19653889|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653890|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
19653891|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20341411|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341412|NCT00823602|Buserelin|buserelin|mesh-list
20341413|NCT00823602|Ganirelix|ganirelix|mesh-list
20341414|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
20341415|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653892|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19653893|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653894|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19653895|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653896|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653897|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19653898|NCT04976387|Narcotics|narcotics|mesh-ancestor
19653899|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653900|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
19653901|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
19653902|NCT04895488|Vortioxetine|vortioxetine|mesh-list
19653903|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
19653904|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
19653905|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653906|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19653907|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341416|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653908|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653909|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341417|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20341418|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
20341419|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20341420|NCT00823641|Infliximab|infliximab|mesh-list
20341421|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
20341422|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20341423|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20341424|NCT00823849|Cilostazol|cilostazol|mesh-list
20341425|NCT00823849|Probucol|probucol|mesh-list
20341426|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20341427|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
20341428|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19653910|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19653911|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19653912|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19653913|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653914|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653915|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
20341429|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653916|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19653917|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19653918|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19653919|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19653920|NCT04830735|Dasatinib|dasatinib|mesh-list
19653921|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653922|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19653923|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653924|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665452|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665453|NCT05037617|Oxytocin|oxytocin|mesh-list
19665454|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
19665455|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665456|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665457|NCT05036473|Levodopa|levodopa|mesh-list
19665458|NCT05036473|Carbidopa|carbidopa|mesh-list
19665459|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19665460|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19665461|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19665462|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
19665463|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665464|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665465|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665466|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20341430|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20341431|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
20341432|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20341433|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20341434|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341435|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20341436|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
20341437|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19653925|NCT04800692|Verapamil|verapamil|mesh-list
19653926|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19653927|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19653928|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19653929|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653930|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19653931|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653932|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
19831835|NCT05139004|Basiliximab|basiliximab|mesh-list
19831836|NCT05139004|Mitogens|mitogens|mesh-list
19831837|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19831838|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831839|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831840|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
19831841|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831842|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831843|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
19831844|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831845|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19831846|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
19831847|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19831848|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
20341438|NCT00823849|Protective Agents|protective agents|mesh-ancestor
20341439|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20341440|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20341441|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341442|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20341443|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20341444|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
19653933|NCT04700527|Butyric Acid|butyric acid|mesh-list
19831849|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
20341445|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20341446|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
19653934|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
19653935|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
19653936|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653937|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653938|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653939|NCT04585724|Palbociclib|palbociclib|mesh-list
19653940|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653941|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19653942|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653943|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653944|NCT04571697|Methotrexate|methotrexate|mesh-list
19653945|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19653946|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
19831850|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
19831851|NCT05132153|Milrinone|milrinone|mesh-list
20341447|NCT00823862|Ribavirin|ribavirin|mesh-list
20341448|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
20341449|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341450|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
20341451|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169930|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20169931|NCT00150280|Analgesics|analgesics|mesh-ancestor
20169932|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
20169933|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169934|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169935|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20169936|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20341452|NCT00823875|Cilostazol|cilostazol|mesh-list
20341453|NCT00823875|Probucol|probucol|mesh-list
20341454|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20341455|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
20341456|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341457|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341458|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20341459|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
20341460|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20341461|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20341462|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341463|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20341464|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
20341465|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20341466|NCT00823875|Protective Agents|protective agents|mesh-ancestor
20341467|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20341468|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20341469|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341470|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20341471|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20341472|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
20341473|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20341474|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
20341475|NCT00823940|Glucagon|glucagon|mesh-list
20341476|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19653947|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19653948|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653949|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20341477|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20341478|NCT00823940|Hormones|hormones|mesh-ancestor
20341479|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20341480|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341481|NCT00823940|Incretins|incretins|mesh-ancestor
20341482|NCT00824057|Midazolam|midazolam|mesh-list
20341483|NCT00824057|Caffeine|caffeine|mesh-list
20341484|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20341485|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20169937|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20169938|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169939|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169940|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20169941|NCT00150293|Pregabalin|pregabalin|mesh-list
20341486|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341487|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341488|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19653950|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
19653951|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653952|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19653953|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
19653954|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653955|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19653956|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19653957|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
19653958|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19653959|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19653960|NCT04531982|Pimavanserin|pimavanserin|mesh-list
19653961|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19653962|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19653963|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19653964|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19653965|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19653966|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653967|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19653968|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19653969|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19653970|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
19653971|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19653972|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653973|NCT04455100|Itraconazole|itraconazole|mesh-list
19653974|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
19653975|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653976|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19653977|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19653978|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653979|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653980|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19653981|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
19653982|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19653983|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19653984|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19653985|NCT04439578|Rifampin|rifampin|mesh-list
19653986|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19653987|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
19653988|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19653989|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19653990|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
19653991|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19653992|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19653993|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19653994|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19653995|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19653996|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19653997|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19653998|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19653999|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19654000|NCT04423601|Itraconazole|itraconazole|mesh-list
19654001|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
19654002|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654003|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19654004|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654005|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654006|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654007|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19654008|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
19665467|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341489|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341490|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341491|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20341492|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
20341493|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
20341494|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
20341495|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
20341496|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341497|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341498|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19654009|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654010|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654011|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19831852|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19831853|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19831854|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
19831855|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19831856|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19831857|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831858|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831859|NCT05132153|Protective Agents|protective agents|mesh-ancestor
19831860|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835401|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835402|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835403|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835404|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835405|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
19835406|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835407|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835408|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835409|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19835410|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835411|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835412|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835413|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19835414|NCT00602771|Etoposide|etoposide|mesh-list
19835415|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
19835416|NCT00602771|Tipifarnib|tipifarnib|mesh-list
19835417|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20169942|NCT00150293|Analgesics|analgesics|mesh-ancestor
19654012|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19654013|NCT04387071|Antibodies|antibodies|mesh-list
19654014|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
19654015|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19654016|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
19257585|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19654017|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654018|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654019|NCT04355858|Paclitaxel|paclitaxel|mesh-list
19654020|NCT04355858|Capecitabine|capecitabine|mesh-list
19654021|NCT04355858|Everolimus|everolimus|mesh-list
20341499|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20341500|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341501|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20341502|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20341503|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
20348275|NCT00864058|Gabapentin|gabapentin|mesh-list
20348276|NCT00864058|Analgesics|analgesics|mesh-ancestor
20348277|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
20348278|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348279|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348280|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
20348281|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20348282|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348283|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348284|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348285|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20348286|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20348287|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348288|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348289|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
20348290|NCT00864071|Griseofulvin|griseofulvin|mesh-list
20348291|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
20348292|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348293|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
20348294|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20348295|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20348296|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348297|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
20348298|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
20348299|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348300|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
20348301|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19654022|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19654023|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654024|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
19654025|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
19654026|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
19654027|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348302|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
19654028|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654029|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
19654030|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654031|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
19654032|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654033|NCT04315701|Cemiplimab|cemiplimab|mesh-list
19654034|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654035|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654036|NCT04249076|Clobetasol|clobetasol|mesh-list
19654037|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19654038|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
19654039|NCT04249076|Hormones|hormones|mesh-ancestor
19654040|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654041|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654042|NCT04246801|Clobetasol|clobetasol|mesh-list
19654043|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19654044|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
19654045|NCT04246801|Hormones|hormones|mesh-ancestor
19654046|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654047|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654048|NCT04173533|Azacitidine|azacitidine|mesh-list
19654049|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654050|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
19654051|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654052|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341504|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
20341505|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20341506|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
20341507|NCT00824135|Rituximab|rituximab|mesh-list
20341508|NCT00824135|Melphalan|melphalan|mesh-list
20341509|NCT00824135|Thiotepa|thiotepa|mesh-list
20341510|NCT00824135|Clofarabine|clofarabine|mesh-list
20341511|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
20341512|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20341513|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341514|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
20341515|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341516|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20341517|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20341518|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20341519|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
20341520|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257586|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257587|NCT03613506|Captopril|captopril|mesh-list
19257588|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19257589|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
19257590|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257591|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257592|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19257593|NCT03571633|Paclitaxel|paclitaxel|mesh-list
19257594|NCT03571633|Trastuzumab|trastuzumab|mesh-list
19257595|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19257596|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257597|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257598|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
19257599|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
19257600|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257601|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257602|NCT03537833|Pemetrexed|pemetrexed|mesh-list
19257603|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257604|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257605|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257606|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19257607|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19257608|NCT03521570|Nivolumab|nivolumab|mesh-list
19257609|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257610|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257611|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19257612|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257613|NCT03446040|Nivolumab|nivolumab|mesh-list
19654053|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341521|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341522|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831861|NCT05121350|Epirubicin|epirubicin|mesh-list
19831862|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19654054|NCT04167033|Hormones|hormones|mesh-list
19654055|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654056|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654057|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19654058|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654059|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19654060|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19654061|NCT03971929|Diuretics|diuretics|mesh-ancestor
19654062|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
19654063|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654064|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19654065|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654066|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654067|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
19654068|NCT03971084|Caseins|caseins|mesh-list
19654069|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19654070|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
19654071|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654072|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654073|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654074|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
19654075|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
20341523|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341524|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20341525|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
20341526|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20341527|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20341528|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20341529|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
19654076|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19654077|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20169943|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
20169944|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20169945|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169946|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
20169947|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20169948|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20169949|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169950|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20169951|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20169952|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20169953|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19831863|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831864|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19831865|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19831866|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831867|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831868|NCT05098457|Lidocaine|lidocaine|mesh-list
19831869|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
19831870|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
19831871|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19831872|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831873|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
19831874|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831875|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19831876|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19831877|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19831878|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654078|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654079|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654080|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
19654081|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654082|NCT03916263|Metformin|metformin|mesh-list
19654083|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654084|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654085|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
19654086|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654087|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654088|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
19654089|NCT03832647|Salicylates|salicylates|mesh-list
20341530|NCT00824200|Tamsulosin|tamsulosin|mesh-list
20341531|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
19654090|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654091|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
19654092|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
19831879|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831880|NCT05097846|Amoxicillin|amoxicillin|mesh-list
19831881|NCT05097846|Doxycycline|doxycycline|mesh-list
19831882|NCT05097846|Furazolidone|furazolidone|mesh-list
19831883|NCT05097846|Esomeprazole|esomeprazole|mesh-list
19831884|NCT05097846|Bismuth|bismuth|mesh-list
19831885|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19831886|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831887|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19654093|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
19654094|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19654095|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19654096|NCT03832647|Analgesics|analgesics|mesh-ancestor
19654097|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
19654098|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831888|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19831889|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19831890|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341532|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19654099|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654100|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19654101|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19654102|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19654103|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654104|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654105|NCT03778671|Fentanyl|fentanyl|mesh-list
19654106|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
19654107|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
19654108|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19654109|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654110|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654111|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19654112|NCT03778671|Analgesics|analgesics|mesh-ancestor
19654113|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
19654114|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654115|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19654116|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19654117|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19654118|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
19654119|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831891|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831892|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
19831893|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19831894|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19831895|NCT05097846|Antacids|antacids|mesh-ancestor
19831896|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19831897|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19831898|NCT05097846|Renal Agents|renal agents|mesh-ancestor
19831899|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19831900|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19831901|NCT05085496|Atezolizumab|atezolizumab|mesh-list
19831902|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19831903|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831904|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
19831905|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831906|NCT05084222|Budesonide|budesonide|mesh-list
19831907|NCT05084222|Albuterol|albuterol|mesh-list
19831908|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
19831909|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831910|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19831911|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
19831912|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831913|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654120|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654121|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19654122|NCT03778671|Narcotics|narcotics|mesh-ancestor
19831914|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19654123|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19654124|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19831915|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
19831916|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
20341533|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
20341534|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20341535|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341536|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341537|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341538|NCT00824200|Urological Agents|urological agents|mesh-ancestor
20341539|NCT00824239|Fentanyl|fentanyl|mesh-list
20341540|NCT00824239|Midazolam|midazolam|mesh-list
20341541|NCT00824239|Propofol|propofol|mesh-list
20341542|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20341543|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341544|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341545|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20341546|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
20341547|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
20341548|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19654125|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
19654126|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
19654127|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
19654128|NCT03698162|Bevacizumab|bevacizumab|mesh-list
19654129|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654130|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654131|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19831917|NCT05084222|Hormones|hormones|mesh-ancestor
20341549|NCT00824239|Narcotics|narcotics|mesh-ancestor
20341550|NCT00824239|Analgesics|analgesics|mesh-ancestor
20341551|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
19654132|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19654133|NCT03698162|Growth Substances|growth substances|mesh-ancestor
19654134|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654135|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
19654136|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
19654137|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19654138|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341552|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341553|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19831918|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831919|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19831920|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19831921|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19831922|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
19831923|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19831924|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831925|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
19831926|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20169954|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169955|NCT00150306|Sertraline|sertraline|mesh-list
19654139|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19654140|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19654141|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654142|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654143|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654144|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19654145|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654146|NCT03644186|Paclitaxel|paclitaxel|mesh-list
20169956|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
20169957|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20169958|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20169959|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20169960|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341554|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20341555|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341556|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341557|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
20341558|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
20341559|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341560|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341561|NCT00824317|Methylphenidate|methylphenidate|mesh-list
20341562|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20341563|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341564|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20341565|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20341566|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341567|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341568|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
20341569|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341570|NCT00824668|Insulin|insulin|mesh-list
20341571|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20341572|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
20341573|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
20341574|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
20341575|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20341576|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
20341577|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20341578|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341579|NCT00824707|Entecavir|entecavir|mesh-list
20341580|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
20341581|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341582|NCT00824785|Capecitabine|capecitabine|mesh-list
20341583|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
20341584|NCT00824785|Epirubicin|epirubicin|mesh-list
20341585|NCT00824785|Panitumumab|panitumumab|mesh-list
20341586|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20341587|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
20341588|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341589|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341590|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20341591|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20341592|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20341593|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341594|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20341595|NCT00824811|Fluorometholone|fluorometholone|mesh-list
19831927|NCT05069051|Belimumab|belimumab|mesh-list
19831928|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831929|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
19831930|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831931|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
20169961|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169962|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20169963|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
20169964|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20169965|NCT00150332|Linezolid|linezolid|mesh-list
20169966|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20169967|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20169968|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20169969|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169970|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341596|NCT00824811|Cyclosporine|cyclosporine|mesh-list
19831932|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19831933|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341597|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19257614|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257615|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257616|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20169971|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
20169972|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169973|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
20169974|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20169975|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19257617|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257618|NCT03439085|Durvalumab|durvalumab|mesh-list
19257619|NCT03439085|Interleukin-12|interleukin-12|mesh-list
19257620|NCT03439085|Vaccines|vaccines|mesh-list
19257621|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
19257622|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19257623|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
19257624|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
19257625|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257626|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257627|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257628|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19257629|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19257630|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19257631|NCT03439085|Growth Substances|growth substances|mesh-ancestor
19257632|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
19257633|NCT03433183|Sirolimus|sirolimus|mesh-list
19257634|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257635|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257636|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19257637|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257638|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
19257639|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257640|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
19257641|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257642|NCT03427736|Ketorolac|ketorolac|mesh-list
19257643|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19257644|NCT03427736|Ketamine|ketamine|mesh-list
19654147|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19654148|NCT03644186|Trastuzumab|trastuzumab|mesh-list
19654149|NCT03644186|Letrozole|letrozole|mesh-list
19654150|NCT03644186|Palbociclib|palbociclib|mesh-list
19654151|NCT03644186|Pertuzumab|pertuzumab|mesh-list
19654152|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19654153|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341598|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
20341599|NCT00824811|Cyclosporins|cyclosporins|mesh-list
20341600|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341601|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341602|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20341603|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
20341604|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341605|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
20341606|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341607|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
20341608|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257645|NCT03427736|Morphine|morphine|mesh-list
19654154|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257646|NCT03427736|Oxycodone|oxycodone|mesh-list
19654155|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
19257647|NCT03427736|Hydromorphone|hydromorphone|mesh-list
19257648|NCT03427736|Analgesics|analgesics|mesh-ancestor
19654156|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
19654157|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654158|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654159|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19654160|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19654161|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341609|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20341610|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20341611|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20341612|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
20341613|NCT00824811|Hormones|hormones|mesh-ancestor
20169976|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169977|NCT00150358|Urological Agents|urological agents|mesh-ancestor
20169978|NCT00150371|Atorvastatin|atorvastatin|mesh-list
19654162|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19654163|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
19654164|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654165|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654166|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665468|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19665469|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
20169979|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20169980|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20169981|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
20169982|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169983|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20169984|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20169985|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169986|NCT00150384|Amlodipine|amlodipine|mesh-list
20169987|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
20169988|NCT00150384|Atorvastatin|atorvastatin|mesh-list
20169989|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20169990|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20169991|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
20169992|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20169993|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20169994|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20169995|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20169996|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20169997|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20169998|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20169999|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170000|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170001|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
20170002|NCT00150410|Insulin|insulin|mesh-list
20170003|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20170004|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170005|NCT00150423|Pregabalin|pregabalin|mesh-list
20341614|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654167|NCT03563066|Benralizumab|benralizumab|mesh-list
19654168|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19831934|NCT05032183|Leucovorin|leucovorin|mesh-list
19831935|NCT05032183|Cytarabine|cytarabine|mesh-list
19831936|NCT05032183|Dexamethasone|dexamethasone|mesh-list
19831937|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
19831938|NCT05032183|Prednisone|prednisone|mesh-list
19831939|NCT05032183|Cortisone|cortisone|mesh-list
19831940|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
19831941|NCT05032183|Rituximab|rituximab|mesh-list
19831942|NCT05032183|Methotrexate|methotrexate|mesh-list
19831943|NCT05032183|Vincristine|vincristine|mesh-list
20170006|NCT00150423|Analgesics|analgesics|mesh-ancestor
20341615|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20341616|NCT00824863|Ketoconazole|ketoconazole|mesh-list
20341617|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
20341618|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341619|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20341620|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20341621|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341622|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654169|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
19654170|NCT03558789|Lactoferrin|lactoferrin|mesh-list
19654171|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654172|NCT03495921|Irinotecan|irinotecan|mesh-list
19654173|NCT03495921|Camptothecin|camptothecin|mesh-list
19654174|NCT03495921|Temozolomide|temozolomide|mesh-list
19654175|NCT03495921|Immunologic Factors|immunologic factors|mesh-list
19654176|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19654177|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19654178|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654179|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654180|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654181|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19654182|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
19654183|NCT03495921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654184|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19654185|NCT03330821|Cytarabine|cytarabine|mesh-list
20170007|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
20170008|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170009|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170010|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
20170011|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20170012|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170013|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170014|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170015|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20170016|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20170017|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170018|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170019|NCT00150436|Pregabalin|pregabalin|mesh-list
19654186|NCT03330821|Idarubicin|idarubicin|mesh-list
19654187|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19654188|NCT03330821|Pevonedistat|pevonedistat|mesh-list
19831944|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
19831945|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19831946|NCT05032183|Antibodies|antibodies|mesh-list
20341623|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20341624|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
20341625|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20341626|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341627|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20341628|NCT00825019|Paroxetine|paroxetine|mesh-list
20341629|NCT00825019|Amibegron|amibegron|mesh-list
20341630|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20341631|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20341632|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341633|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341634|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654189|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654190|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
19654191|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654192|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654193|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
19654194|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654195|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654196|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
19665470|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
19665471|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
19665472|NCT05020444|Fludarabine|fludarabine|mesh-list
19665473|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19665474|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
19665475|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665476|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20341635|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
20341636|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341637|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20341638|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
20341639|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341640|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20341641|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20341642|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341643|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20341644|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20341645|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19654197|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654198|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19831947|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
20341646|NCT00825045|Risperidone|risperidone|mesh-list
20341647|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20341648|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
20341649|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341650|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341651|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341652|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20341653|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341654|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341655|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341656|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20341657|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
20341658|NCT00825058|Paroxetine|paroxetine|mesh-list
20341659|NCT00825058|Amibegron|amibegron|mesh-list
20341660|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20341661|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20341662|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341663|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341664|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341665|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
20341666|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341667|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20341668|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
20341669|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341670|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20341671|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20341672|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341673|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20341674|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20341675|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
20341676|NCT00825071|Dexamethasone|dexamethasone|mesh-list
20341677|NCT00825071|Ondansetron|ondansetron|mesh-list
20341678|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831948|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19831949|NCT05032183|Lenograstim|lenograstim|mesh-list
19831950|NCT05032183|BB 1101|bb 1101|mesh-list
19831951|NCT05032183|Mesna|mesna|mesh-list
19831952|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19831953|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
19831954|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831955|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19831956|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19654199|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19654200|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19654201|NCT03317223|Amoxicillin|amoxicillin|mesh-list
19654202|NCT03317223|Clarithromycin|clarithromycin|mesh-list
19654203|NCT03317223|Lansoprazole|lansoprazole|mesh-list
19654204|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19654205|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654206|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19654207|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654208|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654209|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19654210|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19831957|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
19831958|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831959|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19831960|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19831961|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19831962|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
19831963|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
19831964|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19831965|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19831966|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
19831967|NCT05032183|Hormones|hormones|mesh-ancestor
19831968|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19831969|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19831970|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
20341679|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
20341680|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
19831971|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19831972|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20341681|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341682|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341683|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20341684|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
20341685|NCT00825071|Hormones|hormones|mesh-ancestor
20341686|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20341687|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20341688|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341689|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
19831973|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
19831974|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19831975|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19831976|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
19831977|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
19831978|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20170020|NCT00150436|Analgesics|analgesics|mesh-ancestor
20170021|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
20170022|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170023|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170024|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
20170025|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20170026|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19831979|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19831980|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
20341690|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
20341691|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20341692|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
20341693|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341694|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341695|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20341696|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341697|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341698|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341699|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20341700|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
20341701|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20341702|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341703|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19831981|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19831982|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19831983|NCT05032183|Antidotes|antidotes|mesh-ancestor
19831984|NCT05032183|Protective Agents|protective agents|mesh-ancestor
19831985|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
20341704|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
20341705|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341706|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654211|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19654212|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654213|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19654214|NCT03304821|Sargramostim|sargramostim|mesh-list
19654215|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
19654216|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654217|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
19654218|NCT03154749|Carboplatin|carboplatin|mesh-list
19654219|NCT03154749|Docetaxel|docetaxel|mesh-list
19654220|NCT03154749|Epirubicin|epirubicin|mesh-list
19654221|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654222|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
19654223|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654224|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19654225|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19654226|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
19654227|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654228|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654229|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19654230|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
19654231|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
19654232|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
19654233|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19654234|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19831986|NCT05032183|Vitamins|vitamins|mesh-ancestor
19831987|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
19654235|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19831988|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19831989|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
20341707|NCT00825123|Metoprolol|metoprolol|mesh-list
19654236|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654237|NCT03136731|Antibodies|antibodies|mesh-list
19654238|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
19654239|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654240|NCT02983006|Nivolumab|nivolumab|mesh-list
19654241|NCT02983006|DS-8273a|ds-8273a|mesh-list
20341708|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341709|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20341710|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
19654242|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654243|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654244|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19654245|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654246|NCT02936687|Ambrisentan|ambrisentan|mesh-list
19654247|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19654248|NCT02787590|Simvastatin|simvastatin|mesh-list
19654249|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19654250|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19654251|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
19654252|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654253|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19654254|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19831990|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
19831991|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
19831992|NCT05023993|Niacinamide|niacinamide|mesh-list
19831993|NCT05023993|Niacin|niacin|mesh-list
19831994|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
20341711|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
20341712|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341713|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341714|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20341715|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20341716|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20341717|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
20341718|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341719|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341720|NCT00825149|Prednisone|prednisone|mesh-list
20341721|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
20341722|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19831995|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
19831996|NCT05023993|Vitamins|vitamins|mesh-ancestor
19831997|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
19831998|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19831999|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19832000|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
20170027|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170028|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170029|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19654255|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170030|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20170031|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170032|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170033|NCT00150449|Pregabalin|pregabalin|mesh-list
20170034|NCT00150449|Analgesics|analgesics|mesh-ancestor
20170035|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
20170036|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170037|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170038|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
20170039|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20341723|NCT00825149|Doxorubicin|doxorubicin|mesh-list
19654256|NCT02734004|Bevacizumab|bevacizumab|mesh-list
19832001|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170040|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341724|NCT00825149|Fludarabine|fludarabine|mesh-list
19654257|NCT02734004|Durvalumab|durvalumab|mesh-list
19654258|NCT02734004|Olaparib|olaparib|mesh-list
19654259|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654260|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654261|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19257649|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
19257650|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257651|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257652|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19257653|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19257654|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
19257655|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
19257656|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19257657|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19257658|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19257659|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257660|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257661|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19257662|NCT03427736|Narcotics|narcotics|mesh-ancestor
19257663|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19257664|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257665|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19654262|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19654263|NCT02734004|Growth Substances|growth substances|mesh-ancestor
19832002|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19257666|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257667|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257668|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257669|NCT03421639|Leuprolide|leuprolide|mesh-list
19257670|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19257671|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19257672|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19257673|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
19257674|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19257675|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341725|NCT00825149|Vincristine|vincristine|mesh-list
20341726|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
20341727|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20341728|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
20341729|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341730|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20341731|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20341732|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
19257676|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19832003|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
19832004|NCT05012371|Everolimus|everolimus|mesh-list
19832005|NCT05012371|Lenvatinib|lenvatinib|mesh-list
19832006|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832007|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832008|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
19832009|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832010|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19257677|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257678|NCT03421639|Hormones|hormones|mesh-ancestor
19257679|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257680|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19257681|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257682|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257683|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19654264|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654265|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
19654266|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19654267|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654268|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654269|NCT02659813|Copper|copper|mesh-list
19654270|NCT02659813|Nickel|nickel|mesh-list
19654271|NCT02659813|Trace Elements|trace elements|mesh-ancestor
19654272|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
19832011|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341733|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341734|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341735|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20341736|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20341737|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20341738|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20341739|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341740|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20341741|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
20341742|NCT00825149|Hormones|hormones|mesh-ancestor
20341743|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654273|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654274|NCT02658890|Nivolumab|nivolumab|mesh-list
19654275|NCT02658890|Ipilimumab|ipilimumab|mesh-list
19654276|NCT02658890|Linrodostat|linrodostat|mesh-list
19654277|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654278|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341744|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20341745|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20341746|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
20341747|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
20341748|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
20341749|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654279|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19654280|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341750|NCT00825188|Amlodipine|amlodipine|mesh-list
20341751|NCT00825188|Eplerenone|eplerenone|mesh-list
20341752|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19654281|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654282|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
19654283|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19654284|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654285|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654286|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19654287|NCT02566863|Analgesics|analgesics|mesh-ancestor
19654288|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
19654289|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654290|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19654291|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19654292|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20341753|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20341754|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341755|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654293|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
19832012|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832013|NCT04941144|Vaccines|vaccines|mesh-list
19832014|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
19832015|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832016|NCT04929392|Paclitaxel|paclitaxel|mesh-list
19832017|NCT04929392|Carboplatin|carboplatin|mesh-list
19832018|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
19832019|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19832020|NCT04929392|Lenvatinib|lenvatinib|mesh-list
19832021|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19654294|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654295|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654296|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19654297|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654298|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19654299|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654300|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654301|NCT05084456|Docetaxel|docetaxel|mesh-list
19654302|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654303|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
19654304|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
19654305|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
19654306|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832022|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832023|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
19832024|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
19832025|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
19832026|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341756|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20341757|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341758|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
19832027|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19832028|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19832029|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832030|NCT04906213|Dapagliflozin|dapagliflozin|mesh-list
19832031|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19832032|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832033|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19832034|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832035|NCT04892888|Vaccines|vaccines|mesh-list
20170041|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170042|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170043|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20170044|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19654307|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19654308|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
19654309|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
19654310|NCT05084378|Povidone|povidone|mesh-list
19654311|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19654312|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654313|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20170045|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654314|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
20170046|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170047|NCT00150527|Dexamethasone|dexamethasone|mesh-list
20170048|NCT00150527|Citalopram|citalopram|mesh-list
20341759|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20341760|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
20341761|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20341762|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20341763|NCT00825188|Diuretics|diuretics|mesh-ancestor
20341764|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
20341765|NCT00825201|Paclitaxel|paclitaxel|mesh-list
20341766|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20341767|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20341768|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341769|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
20341770|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
20341771|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
19257684|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
19654315|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
19654316|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
19654317|NCT05084365|Sulforaphane|sulforaphane|mesh-list
19654318|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19654319|NCT05084365|Protective Agents|protective agents|mesh-ancestor
20170049|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20170050|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
20170051|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
20170052|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170053|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170054|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20170055|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
20170056|NCT00150527|Hormones|hormones|mesh-ancestor
20170057|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170058|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20170059|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170060|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20170061|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170062|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170063|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170064|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170065|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
20170066|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19832036|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
19832037|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832038|NCT04856228|Lidocaine|lidocaine|mesh-list
19832039|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
19832040|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
19654320|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654321|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654322|NCT05084235|Empagliflozin|empagliflozin|mesh-list
19654323|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19654324|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654325|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654326|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654327|NCT05084196|Melatonin|melatonin|mesh-list
19832041|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832042|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832043|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
19832044|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832045|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19832046|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19832047|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19832048|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832049|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170067|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
20170068|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170069|NCT00150553|Carbamazepine|carbamazepine|mesh-list
20170070|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
20170071|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
19654328|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
20170072|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19654329|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654330|NCT05084196|Protective Agents|protective agents|mesh-ancestor
19654331|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654332|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654333|NCT05084079|Insulin|insulin|mesh-list
19654334|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19654335|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654336|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654337|NCT05084001|Listerine|listerine|mesh-list
19654338|NCT05084001|Fluorides|fluorides|mesh-list
19654339|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
20341772|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341773|NCT00825253|Insulin|insulin|mesh-list
20341774|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20341775|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
19832050|NCT04842604|Azacitidine|azacitidine|mesh-list
19832051|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832052|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
19832053|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832054|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832055|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832056|NCT04820023|Cetuximab|cetuximab|mesh-list
19832057|NCT04820023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19832058|NCT04820023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832059|NCT04810546|Lactoferrin|lactoferrin|mesh-list
19832060|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832061|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
19832062|NCT04784052|Rituximab|rituximab|mesh-list
19832063|NCT04784052|Fludarabine|fludarabine|mesh-list
19832064|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
19832065|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19832066|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832067|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
19832068|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832069|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832070|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19832071|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
19832072|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832073|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654340|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
19832074|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19832075|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654341|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
19654342|NCT05084001|Protective Agents|protective agents|mesh-ancestor
19654343|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832076|NCT04771871|Paclitaxel|paclitaxel|mesh-list
19832077|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
19832078|NCT04771871|Carboplatin|carboplatin|mesh-list
20170073|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654344|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19654345|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341776|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
20341777|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20341778|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20341779|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341780|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20341781|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19654346|NCT05083793|Pregabalin|pregabalin|mesh-list
19654347|NCT05083793|Analgesics|analgesics|mesh-ancestor
19654348|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
20341782|NCT00825422|Ropivacaine|ropivacaine|mesh-list
20341783|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
20341784|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
19654349|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654350|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654351|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
20170074|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170075|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170076|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20170077|NCT00150553|Analgesics|analgesics|mesh-ancestor
20170078|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
20170079|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170080|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19832079|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19832080|NCT04771871|Epirubicin|epirubicin|mesh-list
19654352|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19654353|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654354|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654355|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19654356|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19654357|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19654358|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654359|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19654360|NCT05083689|Bevacizumab|bevacizumab|mesh-list
19654361|NCT05083689|Timolol|timolol|mesh-list
20170081|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654362|NCT05083689|Dorzolamide|dorzolamide|mesh-list
20170082|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170083|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20170084|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20170085|NCT00150579|Amphetamine|amphetamine|mesh-list
20170086|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
20170087|NCT00150579|Adderall|adderall|mesh-list
20170088|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20170089|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170090|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
19832081|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19832082|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832083|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
20170091|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
19654363|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
19654364|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654365|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654366|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19654367|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19654368|NCT05083689|Growth Substances|growth substances|mesh-ancestor
19654369|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654370|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
19654371|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19654372|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19654373|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
19832084|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19832085|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19832086|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170092|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170093|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
20170094|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170095|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170096|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
20170097|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20170098|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170099|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170100|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20170101|NCT00150605|Carbamazepine|carbamazepine|mesh-list
20170102|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
20170103|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
20170104|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20170105|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170106|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170107|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19257685|NCT03367156|Dexamethasone|dexamethasone|mesh-list
19257686|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
19257687|NCT03367156|Ichthammol|ichthammol|mesh-list
19257688|NCT03367156|BB 1101|bb 1101|mesh-list
19257689|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257690|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
19257691|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
19257692|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257693|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257694|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19257695|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
19257696|NCT03367156|Hormones|hormones|mesh-ancestor
19257697|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170108|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20170109|NCT00150605|Analgesics|analgesics|mesh-ancestor
20170110|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
20170111|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170112|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20170113|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170114|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170115|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20170116|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20170117|NCT00150631|Candesartan|candesartan|mesh-list
20170118|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170119|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20170120|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20170121|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170122|NCT00150657|Gemcitabine|gemcitabine|mesh-list
20170123|NCT00150657|Bevacizumab|bevacizumab|mesh-list
20170124|NCT00150657|Carboplatin|carboplatin|mesh-list
20170125|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20170126|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170127|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20170128|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20170129|NCT00150657|Growth Substances|growth substances|mesh-ancestor
20170130|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170131|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
20170132|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170133|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
20170134|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170135|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
20170136|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170137|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170138|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170139|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
20170140|NCT00150670|Cisplatin|cisplatin|mesh-list
20170141|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170142|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
20170143|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20170144|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170145|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170146|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170147|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170148|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20170149|NCT00150709|Levetiracetam|levetiracetam|mesh-list
20170150|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
20170151|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
19257698|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19654374|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170152|NCT00150722|Atorvastatin|atorvastatin|mesh-list
20341785|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341786|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341787|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
20341788|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341789|NCT00825552|Risperidone|risperidone|mesh-list
20341790|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20341791|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
20341792|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341793|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341794|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341795|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20341796|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341797|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341798|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341799|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20341800|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
20341801|NCT00825591|Melatonin|melatonin|mesh-list
19654375|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654376|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19654377|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19654378|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19654379|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19654380|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19654381|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654382|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19654383|NCT05083455|Enoxaparin|enoxaparin|mesh-list
19654384|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
19654385|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19654386|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
19654387|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19654388|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
19654389|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170153|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20170154|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19832087|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654390|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832088|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
19832089|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654391|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
19654392|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19654393|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19654394|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
19654395|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19654396|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19832090|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19654397|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
19832091|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19257699|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832092|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
19832093|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19832094|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19832095|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19832096|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19832097|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832098|NCT04756232|Mecamylamine|mecamylamine|mesh-list
20341802|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
20341803|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341804|NCT00825591|Protective Agents|protective agents|mesh-ancestor
20341805|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341806|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654398|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654399|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654400|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19654401|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
19654402|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
19654403|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19654404|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
19654405|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654406|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832099|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19832100|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19832101|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
19654407|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19654408|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19654409|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19654410|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
19654411|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
19654412|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19832102|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832103|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654413|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19832104|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19832105|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19832106|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
19832107|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832108|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832109|NCT04692077|Tenofovir|tenofovir|mesh-list
19832110|NCT04692077|Emtricitabine|emtricitabine|mesh-list
19832111|NCT04692077|Cabotegravir|cabotegravir|mesh-list
19832112|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
19832113|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832114|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19832115|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19832116|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832117|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832118|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20341807|NCT00825617|Hormones|hormones|mesh-list
20341808|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20341809|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341810|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
20341811|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20341812|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341813|NCT00825656|Capsaicin|capsaicin|mesh-list
20341814|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
20341815|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
20341816|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
20341817|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341818|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341819|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19832119|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19832120|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19832121|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19832122|NCT04603391|Cannabidiol|cannabidiol|mesh-list
19832123|NCT04603391|Methylphenidate|methylphenidate|mesh-list
19832124|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19832125|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832126|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19832127|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19832128|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832129|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654414|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654415|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19832130|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
19832131|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654416|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19654417|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
19654418|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654419|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654420|NCT05083247|Gemcitabine|gemcitabine|mesh-list
19654421|NCT05083247|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19654422|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654423|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
19832132|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
19654424|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654425|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654426|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
19654427|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654428|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654429|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654430|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
19654431|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654432|NCT05083026|Antibodies|antibodies|mesh-list
19654433|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
19654434|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
19654435|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654436|NCT05082974|Varenicline|varenicline|mesh-list
19654437|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19654438|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20341820|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20341821|NCT00825851|Nicotine|nicotine|mesh-list
20341822|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20341823|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
20341824|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341825|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654439|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
19654440|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341826|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19654441|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654442|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341827|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20341828|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
20341829|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341830|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341831|NCT00825864|Dexamethasone|dexamethasone|mesh-list
20341832|NCT00825864|Diclofenac|diclofenac|mesh-list
20341833|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
20341834|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20341835|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20341836|NCT00825864|BB 1101|bb 1101|mesh-list
20341837|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20341838|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
20341839|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
20341840|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341841|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341842|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20341843|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
20341844|NCT00825864|Hormones|hormones|mesh-ancestor
19832133|NCT04599790|Lenvatinib|lenvatinib|mesh-list
19832134|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170155|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
20170156|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170157|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20170158|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20170159|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170160|NCT00150735|Levetiracetam|levetiracetam|mesh-list
20170161|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
20341845|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20341846|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20170162|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
20170163|NCT00150748|Levetiracetam|levetiracetam|mesh-list
20170164|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
20170165|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
20170166|NCT00150761|Levocetirizine|levocetirizine|mesh-list
20170167|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20170168|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20170169|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
20170170|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
20170171|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170172|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170173|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170174|NCT00150774|Levetiracetam|levetiracetam|mesh-list
20170175|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
20170176|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
20170177|NCT00150787|Levetiracetam|levetiracetam|mesh-list
20170178|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
20170179|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
19257700|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
19257701|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257702|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257703|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
19257704|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
19257705|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257706|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
19832135|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20170180|NCT00150826|Quinapril|quinapril|mesh-list
20170181|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20170182|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
20170183|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170184|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170185|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170186|NCT00150839|Mirtazapine|mirtazapine|mesh-list
20170187|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20341847|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341848|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19654443|NCT05082896|Anesthetics|anesthetics|mesh-list
19654444|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654445|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654446|NCT05082753|Ivermectin|ivermectin|mesh-list
19654447|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19654448|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19665477|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19665478|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
19665479|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665480|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665481|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19665482|NCT04971746|Pirfenidone|pirfenidone|mesh-list
19665483|NCT04971746|Nintedanib|nintedanib|mesh-list
19665484|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665485|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19665486|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665487|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665488|NCT04971746|Analgesics|analgesics|mesh-ancestor
19665489|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
19665490|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665491|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665492|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19665493|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19665494|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19665495|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665496|NCT04964466|Becaplermin|becaplermin|mesh-list
19665497|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
19665498|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
19665499|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19665500|NCT04964466|Growth Substances|growth substances|mesh-ancestor
19665501|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665502|NCT04945616|Aspirin|aspirin|mesh-list
20170188|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20170189|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20341849|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20341850|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20341851|NCT00825864|Analgesics|analgesics|mesh-ancestor
20341852|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
20341853|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20341854|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20341855|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341856|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341857|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
20341858|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20341859|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20348303|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20348304|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348305|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20348306|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20348307|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20348308|NCT00864149|Carvedilol|carvedilol|mesh-list
20348309|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20348310|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20348311|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
19654449|NCT05082662|Diclofenac|diclofenac|mesh-list
19654450|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19654451|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19654452|NCT05082662|Analgesics|analgesics|mesh-ancestor
19654453|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
19654454|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654455|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654456|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19654457|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19654458|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19654459|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654460|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654461|NCT05082441|Bupivacaine|bupivacaine|mesh-list
19654462|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
20348312|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348313|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348314|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348315|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348316|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
20348317|NCT00864149|Protective Agents|protective agents|mesh-ancestor
20170190|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170191|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170192|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170193|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170194|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20170195|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
20170196|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170197|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20170198|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
20170199|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
20170200|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20170201|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20170202|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170203|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20170204|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20348318|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19654463|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
19654464|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654465|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654466|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
19654467|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654468|NCT05075941|Vaccines|vaccines|mesh-list
19654469|NCT05075941|Immunologic Factors|immunologic factors|mesh-ancestor
19654470|NCT05075941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654471|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19654472|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19654473|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654474|NCT05072054|Atorvastatin|atorvastatin|mesh-list
19654475|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19654476|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19654477|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19654478|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
20612049|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612050|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
20612051|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654479|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654480|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19654481|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19654482|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654483|NCT05049902|Amoxicillin|amoxicillin|mesh-list
19654484|NCT05049902|Metronidazole|metronidazole|mesh-list
19654485|NCT05049902|Clarithromycin|clarithromycin|mesh-list
19654486|NCT05049902|Tetracycline|tetracycline|mesh-list
20170205|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20170206|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
20170207|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20170208|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20170209|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
20170210|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19654487|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
20612052|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19654488|NCT05049902|Bismuth|bismuth|mesh-list
19654489|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654490|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19654491|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654492|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19654493|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19654494|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20341860|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
20341861|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20341862|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
20341863|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20341864|NCT00826163|Budesonide|budesonide|mesh-list
20341865|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20341866|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20341867|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
20341868|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341869|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341870|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20341871|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
20341872|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
19654495|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654496|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19654497|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654498|NCT05049902|Antacids|antacids|mesh-ancestor
19654499|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654500|NCT05049902|Diuretics|diuretics|mesh-ancestor
19654501|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
19654502|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654503|NCT05049902|Expectorants|expectorants|mesh-ancestor
19654504|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
19654505|NCT05048069|Rebamipide|rebamipide|mesh-list
19654506|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19654507|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20341873|NCT00826163|Hormones|hormones|mesh-ancestor
19654508|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
19654509|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654510|NCT05048069|Protective Agents|protective agents|mesh-ancestor
19654511|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654512|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341874|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20341875|NCT00826254|Vitamins|vitamins|mesh-list
20341876|NCT00826254|Vitamin K|vitamin k|mesh-list
20341877|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
20341878|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341879|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19654513|NCT05036577|Dexamethasone|dexamethasone|mesh-list
19654514|NCT05036577|Rituximab|rituximab|mesh-list
19654515|NCT05036577|Methotrexate|methotrexate|mesh-list
19654516|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654517|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654518|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
19654519|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654520|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19654521|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19654522|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
19654523|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
19654524|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341880|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20341881|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654525|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654526|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
19654527|NCT05036577|Hormones|hormones|mesh-ancestor
19654528|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654529|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20341882|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
20341883|NCT00826254|Coagulants|coagulants|mesh-ancestor
20341884|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
20341885|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20341886|NCT00826306|Protective Agents|protective agents|mesh-ancestor
20341887|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341888|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
19654530|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20341889|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20341890|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20341891|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20341892|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
19654531|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
20170211|NCT00150852|Vancomycin|vancomycin|mesh-list
20170212|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20170213|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170214|NCT00150865|Ropivacaine|ropivacaine|mesh-list
20170215|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
20170216|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
20170217|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170218|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341893|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341894|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20341895|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20341896|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341897|NCT00826371|Ranibizumab|ranibizumab|mesh-list
20341898|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20341899|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20341900|NCT00826371|Growth Substances|growth substances|mesh-ancestor
20341901|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341902|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
20341903|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341904|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
20341905|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20341906|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20341907|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
20341908|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341909|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341910|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341911|NCT00826527|Urological Agents|urological agents|mesh-ancestor
20341912|NCT00826553|Midazolam|midazolam|mesh-list
20341913|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
20341914|NCT00826553|Lorazepam|lorazepam|mesh-list
20341915|NCT00826553|Propofol|propofol|mesh-list
20341916|NCT00826553|GABA Agonists|gaba agonists|mesh-list
20341917|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20341918|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20341919|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341920|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20341921|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
20341922|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
20341923|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20341924|NCT00826553|Analgesics|analgesics|mesh-ancestor
20341925|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
20341926|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20341927|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20341928|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20341929|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20341930|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
20341931|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341932|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341933|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20341934|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20341935|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20341936|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20341937|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
20341938|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
20341939|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
19654532|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19654533|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654534|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
19654535|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654536|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
19654537|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654538|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19654539|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654540|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19654541|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
19654542|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19654543|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654544|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654545|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654546|NCT04962230|Ritonavir|ritonavir|mesh-list
19654547|NCT04962230|Carbamazepine|carbamazepine|mesh-list
19654548|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20170219|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
19257707|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19257708|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
19257709|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257710|NCT03252925|Expectorants|expectorants|mesh-ancestor
19257711|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257712|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19257713|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
19257714|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257715|NCT03252925|Protective Agents|protective agents|mesh-ancestor
19257716|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257717|NCT03252925|Antidotes|antidotes|mesh-ancestor
19257718|NCT03217565|Tedizolid|tedizolid|mesh-list
19257719|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
19257720|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
19257721|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257722|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257723|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19257724|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257725|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257726|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
19257727|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
19257728|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257729|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
19257730|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257731|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257732|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19257733|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
19257734|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257735|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257736|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19257737|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257738|NCT02976337|Naloxone|naloxone|mesh-list
19257739|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19257740|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257741|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
20170220|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170221|NCT00150891|Cyclosporine|cyclosporine|mesh-list
20170222|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
19257742|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257743|NCT02963714|Vaccines|vaccines|mesh-list
19257744|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
19257745|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257746|NCT02959918|Sirolimus|sirolimus|mesh-list
20170223|NCT00150891|Azathioprine|azathioprine|mesh-list
20170224|NCT00150891|Tacrolimus|tacrolimus|mesh-list
20170225|NCT00150891|Cyclosporins|cyclosporins|mesh-list
20341940|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
20341941|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
19257747|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257748|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170226|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20341942|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19665503|NCT04945616|Clopidogrel|clopidogrel|mesh-list
20341943|NCT00826566|Caffeine|caffeine|mesh-list
20341944|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20341945|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341946|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20341947|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341948|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665504|NCT04945616|Ticagrelor|ticagrelor|mesh-list
20341949|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20341950|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20341951|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
20341952|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20341953|NCT00826644|Etoposide|etoposide|mesh-list
20341954|NCT00826644|Belotecan|belotecan|mesh-list
20341955|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341956|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20341957|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20341958|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20341959|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341960|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341961|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20341962|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
20341963|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
20341964|NCT00826657|Vitamins|vitamins|mesh-ancestor
20341965|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
20341966|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341967|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
20341968|NCT00826657|Hematinics|hematinics|mesh-ancestor
20341969|NCT00826722|Levetiracetam|levetiracetam|mesh-list
20341970|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
20341971|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
20341972|NCT00826787|Levetiracetam|levetiracetam|mesh-list
20341973|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
20341974|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
20341975|NCT00826826|Amiodarone|amiodarone|mesh-list
20341976|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20341977|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
20341978|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20341979|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20341980|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20341981|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20341982|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20341983|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19257749|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19257750|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170227|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
20170228|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170229|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20170230|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170231|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170232|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
20170233|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170234|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
20170235|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170236|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20170237|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170238|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20170239|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
20170240|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257751|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
19257752|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257753|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
19257754|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257755|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
19257756|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
19257757|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257758|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
19257759|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257760|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259222|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259223|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259224|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
19259225|NCT05173545|Analgesics|analgesics|mesh-ancestor
19259226|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
19259227|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259228|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259229|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259230|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19259231|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19259232|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259233|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259234|NCT05173337|Nefopam|nefopam|mesh-list
19259235|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19259236|NCT05173337|Analgesics|analgesics|mesh-ancestor
19259237|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
19259238|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654549|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20341984|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20341985|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20341986|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20341987|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20341988|NCT00826839|Leuprolide|leuprolide|mesh-list
20341989|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
20341990|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
20341991|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20341992|NCT00826839|Ganirelix|ganirelix|mesh-list
20341993|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20341994|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20341995|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20341996|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
20341997|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20341998|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20341999|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20342000|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
20342001|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342002|NCT00826852|Carboplatin|carboplatin|mesh-list
20342003|NCT00826852|Docetaxel|docetaxel|mesh-list
20342004|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342005|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
20342006|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
20342007|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
20342008|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342009|NCT00826865|Levetiracetam|levetiracetam|mesh-list
20342010|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
20342011|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
20342012|NCT00826891|Topotecan|topotecan|mesh-list
20342013|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342014|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20342015|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20342016|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342017|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342018|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
20342019|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
20342020|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342021|NCT00826930|Protective Agents|protective agents|mesh-ancestor
20342022|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342023|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20342024|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342025|NCT00826969|Ciclesonide|ciclesonide|mesh-list
20342026|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
20342027|NCT00826969|Hormones|hormones|mesh-ancestor
20342028|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342029|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342030|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20342031|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
20342032|NCT00827021|Hematinics|hematinics|mesh-list
20342033|NCT00827034|Warfarin|warfarin|mesh-list
20342034|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
20342035|NCT00827138|Rebastinib|rebastinib|mesh-list
20342036|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342037|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20170241|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
20170242|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170243|NCT00150982|Alefacept|alefacept|mesh-list
20170244|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
20170245|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
20170246|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170247|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20170248|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
20170249|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
20170250|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170251|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170252|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20342038|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342039|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342040|NCT00827151|Estrogens|estrogens|mesh-list
20342041|NCT00827151|Hormones|hormones|mesh-ancestor
20342042|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342043|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342044|NCT00827177|Sorafenib|sorafenib|mesh-list
20342045|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342046|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20342047|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342048|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342049|NCT00827216|Erythromycin|erythromycin|mesh-list
20342050|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
20342051|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20342052|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
20342053|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342054|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342055|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20342056|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20342057|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342058|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342059|NCT00827281|Cycloserine|cycloserine|mesh-list
20342060|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20342061|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342062|NCT00827281|Renal Agents|renal agents|mesh-ancestor
20342063|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20342064|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
20342065|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20170253|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20170254|NCT00150995|Growth Substances|growth substances|mesh-ancestor
20170255|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170256|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
20170257|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170258|NCT00151008|Bexarotene|bexarotene|mesh-list
20170259|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170260|NCT00151034|Gemcitabine|gemcitabine|mesh-list
20170261|NCT00151034|Paclitaxel|paclitaxel|mesh-list
20170262|NCT00151034|Carboplatin|carboplatin|mesh-list
20170263|NCT00151034|Trastuzumab|trastuzumab|mesh-list
20342066|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
20342067|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342068|NCT00827307|Tamoxifen|tamoxifen|mesh-list
20342069|NCT00827307|Goserelin|goserelin|mesh-list
20342070|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20342071|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
20348319|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654550|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
19654551|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654552|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170264|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20170265|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170266|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
20342072|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342073|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342074|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20342075|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342076|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20342077|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20342078|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20342079|NCT00827320|Levetiracetam|levetiracetam|mesh-list
20342080|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
20342081|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
20342082|NCT00827346|Clopidogrel|clopidogrel|mesh-list
20342083|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20342084|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20342085|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20342086|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20342087|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
20342088|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342089|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342090|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342091|NCT00827411|Aspirin|aspirin|mesh-list
20342092|NCT00827411|Clopidogrel|clopidogrel|mesh-list
20342093|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20342094|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20342095|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20342096|NCT00827411|Analgesics|analgesics|mesh-ancestor
20342097|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
20342098|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342099|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342100|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342101|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342102|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20342103|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20342104|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342105|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20170267|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
20170268|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
20170269|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170270|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19257761|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
19257762|NCT02817789|Clopidogrel|clopidogrel|mesh-list
20342106|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20342107|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342108|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
20342109|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20342110|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20342111|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20342112|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
20342113|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342114|NCT00827450|Caffeine|caffeine|mesh-list
20342115|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20170271|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
20170272|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
20170273|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170274|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170275|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170276|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
20170277|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170278|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20170279|NCT00151047|Docetaxel|docetaxel|mesh-list
20342116|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342117|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20342118|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832136|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832137|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832138|NCT04575857|Atorvastatin|atorvastatin|mesh-list
19832139|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19832140|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19832141|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
19832142|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832143|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19832144|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19832145|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832146|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19832147|NCT04561206|Nivolumab|nivolumab|mesh-list
19832148|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20170280|NCT00151047|Capecitabine|capecitabine|mesh-list
20342119|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342120|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20342121|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20342122|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
20342123|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342124|NCT00827554|Nadroparin|nadroparin|mesh-list
20342125|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
20342126|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20342127|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20342128|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342129|NCT00827580|Eniluracil|eniluracil|mesh-list
20342130|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342131|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342132|NCT00827671|Cetuximab|cetuximab|mesh-list
20342133|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20342134|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342135|NCT00827684|Sirolimus|sirolimus|mesh-list
20342136|NCT00827684|Irinotecan|irinotecan|mesh-list
20342137|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20170281|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342138|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20342139|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342140|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342141|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342142|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342143|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342144|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20342145|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
20342146|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342147|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
20342148|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348320|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20348321|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
20170282|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
20170283|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
19654553|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19654554|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19654555|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
19654556|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654557|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19654558|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654559|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
19654560|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
19654561|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20170284|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
20170285|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170286|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170287|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
20170288|NCT00151060|Paclitaxel|paclitaxel|mesh-list
20170289|NCT00151060|Etoposide|etoposide|mesh-list
20170290|NCT00151060|Estramustine|estramustine|mesh-list
20170291|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20170292|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170293|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
20170294|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
20170295|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
19654562|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654563|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654564|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19654565|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19654566|NCT04962230|Analgesics|analgesics|mesh-ancestor
19654567|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
19654568|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654569|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19832149|NCT04561206|Antibodies|antibodies|mesh-list
19832150|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
19832151|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19832152|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
20170296|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170297|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20170298|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20170299|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170300|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20170301|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
19832153|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
20170302|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19832154|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170303|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
20170304|NCT00151073|Docetaxel|docetaxel|mesh-list
20342149|NCT00827814|Dutasteride|dutasteride|mesh-list
20342150|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20342151|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20342152|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342153|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654570|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654571|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20342154|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
20342155|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342156|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342157|NCT00827840|Risperidone|risperidone|mesh-list
20342158|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20342159|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20342160|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
20342161|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342162|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342163|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342164|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20342165|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20342166|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342167|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20342168|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20342169|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
20342170|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20342171|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20342172|NCT00827892|Pioglitazone|pioglitazone|mesh-list
20342173|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20342174|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342175|NCT00827996|Adalimumab|adalimumab|mesh-list
20170305|NCT00151073|Estramustine|estramustine|mesh-list
20170306|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170307|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
20170308|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
20170309|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
20170310|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170311|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20612053|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612054|NCT02249481|Bupivacaine|bupivacaine|mesh-list
20612055|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
20342176|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257763|NCT02817789|Ticagrelor|ticagrelor|mesh-list
20342177|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342178|NCT00828087|Cobalt|cobalt|mesh-list
20342179|NCT00828087|Chromium|chromium|mesh-list
20342180|NCT00828087|Everolimus|everolimus|mesh-list
20342181|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342182|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342183|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
20342184|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342185|NCT00828087|Trace Elements|trace elements|mesh-ancestor
20342186|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
20342187|NCT00828230|Budesonide|budesonide|mesh-list
20342188|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342189|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20342190|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
20342191|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342192|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342193|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20342194|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
20342195|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
20342196|NCT00828230|Hormones|hormones|mesh-ancestor
20342197|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342198|NCT00828282|Simvastatin|simvastatin|mesh-list
20342199|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20342200|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20342201|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
20342202|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342203|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20342204|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20342205|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342206|NCT00828373|Lidocaine|lidocaine|mesh-list
20612056|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
20612057|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612058|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170312|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170313|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20170314|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
20170315|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20342207|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
19654572|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19654573|NCT04943341|Triamcinolone|triamcinolone|mesh-list
19654574|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19654575|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19654576|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19654577|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342208|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
20342209|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342210|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342211|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
20342212|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342213|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19257764|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19257765|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19257766|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19257767|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19257768|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
19257769|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170316|NCT00151086|Vinorelbine|vinorelbine|mesh-list
20170317|NCT00151086|Estramustine|estramustine|mesh-list
20170318|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20170319|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170320|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
20170321|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
20170322|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
20170323|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170324|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20170325|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
20170326|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20170327|NCT00151112|Anesthetics|anesthetics|mesh-list
20170328|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170329|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170330|NCT00151125|Oprelvekin|oprelvekin|mesh-list
20170331|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170332|NCT00151138|Atenolol|atenolol|mesh-list
20170333|NCT00151138|Lisinopril|lisinopril|mesh-list
20170334|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20170335|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
20170336|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348628|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342214|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20342215|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20342216|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20342217|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342218|NCT00828477|Nepafenac|nepafenac|mesh-list
20342219|NCT00828477|Bromfenac|bromfenac|mesh-list
20342220|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20342221|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20342222|NCT00828477|Analgesics|analgesics|mesh-ancestor
20342223|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
20342224|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342225|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342226|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342227|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342228|NCT00828503|Valganciclovir|valganciclovir|mesh-list
20342229|NCT00828503|Everolimus|everolimus|mesh-list
19654578|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
19654579|NCT04943341|Hormones|hormones|mesh-ancestor
19654580|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654581|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654582|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654583|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
19654584|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654585|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654586|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
20342230|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342231|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342232|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
19654587|NCT04941040|Anesthetics|anesthetics|mesh-list
20342233|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342234|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
20342235|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342236|NCT00828529|Bedaquiline|bedaquiline|mesh-list
20342237|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
20342238|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342239|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342240|NCT00828555|Vaccines|vaccines|mesh-list
20342241|NCT00828555|Immunologic Factors|immunologic factors|mesh-ancestor
20342242|NCT00828555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342243|NCT00828594|Sorafenib|sorafenib|mesh-list
20342244|NCT00828594|Everolimus|everolimus|mesh-list
20342245|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342246|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20342247|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342248|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342249|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342250|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
20342251|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342252|NCT00828763|Dolutegravir|dolutegravir|mesh-list
20342253|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20342254|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20342255|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342256|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342257|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20342258|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20342259|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
20342260|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342261|NCT00828776|Heparin|heparin|mesh-list
20342262|NCT00828776|Calcium heparin|calcium heparin|mesh-list
20342263|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
20342264|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20342265|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20342266|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342267|NCT00828789|Tenofovir|tenofovir|mesh-list
20342268|NCT00828789|Efavirenz|efavirenz|mesh-list
20342269|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
20342270|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342271|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20342272|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20342273|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342274|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342275|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20342276|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20342277|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20342278|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20342279|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20342280|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20342281|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20342282|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20342283|NCT00828802|Lenalidomide|lenalidomide|mesh-list
20342284|NCT00828802|Decitabine|decitabine|mesh-list
20342285|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
20342286|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342287|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20342288|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20342289|NCT00828802|Growth Substances|growth substances|mesh-ancestor
20342290|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832155|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832156|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19832157|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835418|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835419|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20342291|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342292|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20342293|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
20342294|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342295|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342296|NCT00828815|Etravirine|etravirine|mesh-list
20342297|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20342298|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20342299|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342300|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342301|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
20342302|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342303|NCT00828828|Vaccines|vaccines|mesh-list
20342304|NCT00828828|Immunologic Factors|immunologic factors|mesh-ancestor
20342305|NCT00828828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342306|NCT00828854|Entinostat|entinostat|mesh-list
20342307|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342308|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19257770|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257771|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257772|NCT02817789|Analgesics|analgesics|mesh-ancestor
19257773|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
19257774|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342309|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342310|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342311|NCT00828919|Axitinib|axitinib|mesh-list
20342312|NCT00828919|Crizotinib|crizotinib|mesh-list
20342313|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342314|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20342315|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342316|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342317|NCT00828958|Risperidone|risperidone|mesh-list
20342318|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20342319|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
20342320|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342321|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342322|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342323|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20342324|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20342325|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342326|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20342327|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20342328|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
20342329|NCT00828971|Amoxicillin|amoxicillin|mesh-list
20342330|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
20342331|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20342332|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342333|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654588|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654589|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654590|NCT04941040|Narcotics|narcotics|mesh-ancestor
19654591|NCT04941040|Analgesics|analgesics|mesh-ancestor
19654592|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
20342334|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20342335|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20342336|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342337|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342338|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342339|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20342340|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
20342341|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20342342|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342343|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20342344|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20342345|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20342346|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20342347|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
19832158|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
20342348|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342349|NCT00829023|Ethanol|ethanol|mesh-list
20342350|NCT00829023|Chlorhexidine|chlorhexidine|mesh-list
20342351|NCT00829023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20342352|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
20342353|NCT00829023|Povidone|povidone|mesh-list
20342354|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20342355|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342356|NCT00829023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342357|NCT00829023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342358|NCT00829023|Disinfectants|disinfectants|mesh-ancestor
20342359|NCT00829023|Dermatologic Agents|dermatologic agents|mesh-ancestor
20342360|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
20342361|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
20342362|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20342363|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20342364|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20342365|NCT00829114|Estradiol|estradiol|mesh-list
20342366|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20342367|NCT00829114|Estrogens|estrogens|mesh-ancestor
20342368|NCT00829114|Hormones|hormones|mesh-ancestor
20342369|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342370|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342371|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20342372|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
20342373|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20342374|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20342375|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20342376|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20342377|NCT00829192|Afamelanotide|afamelanotide|mesh-list
20342378|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
20342379|NCT00829205|Rituximab|rituximab|mesh-list
20342380|NCT00829205|Carboplatin|carboplatin|mesh-list
20342381|NCT00829205|Etoposide|etoposide|mesh-list
20342382|NCT00829205|Ifosfamide|ifosfamide|mesh-list
20342383|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
20342384|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20342385|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342386|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
20342387|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342388|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342389|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19654593|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654594|NCT04934410|Midazolam|midazolam|mesh-list
19654595|NCT04934410|Etomidate|etomidate|mesh-list
19654596|NCT04934410|Sevoflurane|sevoflurane|mesh-list
20342390|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20342391|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20342392|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342393|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342394|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20342395|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
20342396|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20342397|NCT00829205|Protective Agents|protective agents|mesh-ancestor
20342398|NCT00829231|Sorafenib|sorafenib|mesh-list
20342399|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342400|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20342401|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342402|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342403|NCT00829257|Fluticasone|fluticasone|mesh-list
20342404|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20342405|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342406|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20342407|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
20342408|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342409|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342410|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20342411|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
20342412|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
20342413|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20342414|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
20342415|NCT00829257|Hormones|hormones|mesh-ancestor
20342416|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342417|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
20342418|NCT00829322|Modafinil|modafinil|mesh-list
20342419|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20342420|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342421|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20342422|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20342423|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20342424|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342425|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20342426|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
20342427|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170337|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170338|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170339|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20170340|NCT00151138|Protective Agents|protective agents|mesh-ancestor
20170341|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170342|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20170343|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
20170344|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
20170345|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170346|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20342428|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19654597|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19654598|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19654599|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654600|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654601|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19654602|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19654603|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19654604|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19654605|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
19654606|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
19654607|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
19654608|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
19654609|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342429|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20342430|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20342431|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20342432|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20342433|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
20612059|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
19654610|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257775|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19257776|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19257777|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257778|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257779|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257780|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257781|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
19257782|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19257783|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19257784|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
19257785|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257786|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257787|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19257788|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257789|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
19257790|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19257791|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
19654611|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19654612|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19654613|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
20170347|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20170348|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19257792|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257793|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257794|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
19654614|NCT04918927|Favipiravir|favipiravir|mesh-list
19654615|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19654616|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170349|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
19257795|NCT02813200|Hormones|hormones|mesh-ancestor
19257796|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257797|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
19257798|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
19257799|NCT02744742|Busulfan|busulfan|mesh-list
19257800|NCT02744742|Decitabine|decitabine|mesh-list
19257801|NCT02744742|Sargramostim|sargramostim|mesh-list
19257802|NCT02744742|Lenograstim|lenograstim|mesh-list
19257803|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257804|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
19257805|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257806|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257807|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19257808|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
19654617|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
20170350|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174861|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20174862|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257809|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342434|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342435|NCT00829608|Vaccines|vaccines|mesh-list
20342436|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
20342437|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348322|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20348323|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20348324|NCT00864162|Ramipril|ramipril|mesh-list
20348325|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20348326|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
20348327|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348328|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348329|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348330|NCT00864188|Beta Carotene|beta carotene|mesh-list
20348331|NCT00864188|Carotenoids|carotenoids|mesh-list
20348332|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
20348333|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348334|NCT00864188|Protective Agents|protective agents|mesh-ancestor
20348335|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348336|NCT00864188|Provitamins|provitamins|mesh-ancestor
20348337|NCT00864188|Vitamins|vitamins|mesh-ancestor
20348338|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
20348339|NCT00864201|Bosentan|bosentan|mesh-list
20348340|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348341|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20342438|NCT00829634|Methamphetamine|methamphetamine|mesh-list
20342439|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20342440|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342441|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
20342442|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
20342443|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342444|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
20342445|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342446|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342447|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
20342448|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20342449|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20342450|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20342451|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20342452|NCT00829647|Lenalidomide|lenalidomide|mesh-list
19654618|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20342453|NCT00829647|Dasatinib|dasatinib|mesh-list
20342454|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
20342455|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342456|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20342457|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20342458|NCT00829647|Growth Substances|growth substances|mesh-ancestor
20342459|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
20342460|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342461|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20342462|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342463|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342464|NCT00829660|Acarbose|acarbose|mesh-list
20342465|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20342466|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342467|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342468|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20342469|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654619|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19654620|NCT04873297|Metoclopramide|metoclopramide|mesh-list
19654621|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
19654622|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
19654623|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654624|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654625|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654626|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19654627|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19654628|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
19654629|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654630|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654631|NCT04858711|Lidocaine|lidocaine|mesh-list
19654632|NCT04858711|Fentanyl|fentanyl|mesh-list
19654633|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
19654634|NCT04858711|Ketamine|ketamine|mesh-list
19654635|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
19654636|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
19654637|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654638|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654639|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
19654640|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654641|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19654642|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19654643|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19654644|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654645|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654646|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19654647|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19654648|NCT04858711|Analgesics|analgesics|mesh-ancestor
19654649|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19654650|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19654651|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19654652|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
19654653|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654654|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19654655|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19654656|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
19654657|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19654658|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20170351|NCT00151203|Clarithromycin|clarithromycin|mesh-list
20170352|NCT00151203|Dexamethasone|dexamethasone|mesh-list
20170353|NCT00151203|Lenalidomide|lenalidomide|mesh-list
20170354|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20170355|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
20170356|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
20170357|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170358|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170359|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20170360|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
20170361|NCT00151203|Hormones|hormones|mesh-ancestor
20170362|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170363|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20342470|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20342471|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20342472|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20342473|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20342474|NCT00829777|Naloxone|naloxone|mesh-list
20342475|NCT00829777|Lactulose|lactulose|mesh-list
20342476|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20342477|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654659|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19654660|NCT04858711|Narcotics|narcotics|mesh-ancestor
19654661|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19654662|NCT04852224|Leuprolide|leuprolide|mesh-list
19654663|NCT04852224|Goserelin|goserelin|mesh-list
19654664|NCT04852224|Androgens|androgens|mesh-list
19654665|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19654666|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
19654667|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19654668|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654669|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19654670|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654671|NCT04852224|Hormones|hormones|mesh-ancestor
20170364|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654672|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170365|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
19257810|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257811|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19654673|NCT04826484|Bupivacaine|bupivacaine|mesh-list
20342478|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
20342479|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342480|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20342481|NCT00829881|Betahistine|betahistine|mesh-list
20342482|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
20342483|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
20342484|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
20342485|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342486|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654674|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
20342487|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342488|NCT00829894|Risperidone|risperidone|mesh-list
20342489|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20342490|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
20342491|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342492|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342493|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342494|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20342495|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20342496|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342497|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20342498|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20342499|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
20342500|NCT00830050|Naproxen|naproxen|mesh-list
20342501|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20342502|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20342503|NCT00830050|Analgesics|analgesics|mesh-ancestor
20342504|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
20342505|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342506|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342507|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342508|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342509|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
20342510|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20342511|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654675|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
19654676|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654677|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654678|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
19654679|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654680|NCT04810793|Amoxicillin|amoxicillin|mesh-list
20342512|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257812|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654681|NCT04810793|Levofloxacin|levofloxacin|mesh-list
19654682|NCT04810793|Ofloxacin|ofloxacin|mesh-list
19654683|NCT04810793|Tetracycline|tetracycline|mesh-list
19654684|NCT04810793|Furazolidone|furazolidone|mesh-list
20342513|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
19654685|NCT04810793|Esomeprazole|esomeprazole|mesh-list
19654686|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342514|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
20342515|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
20342516|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342517|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342518|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
20342519|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342520|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
20342521|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20342522|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
20342523|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342524|NCT00830193|Expectorants|expectorants|mesh-ancestor
20170366|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20170367|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20170368|NCT00151203|Growth Substances|growth substances|mesh-ancestor
20170369|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
20170370|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20170371|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170372|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20170373|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170374|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612060|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257813|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
19257814|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832159|NCT04545008|Famotidine|famotidine|mesh-list
19832160|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19832161|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
19832162|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832163|NCT04545008|Expectorants|expectorants|mesh-ancestor
19832164|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
19832165|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19832166|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
19832167|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832168|NCT04545008|Protective Agents|protective agents|mesh-ancestor
19832169|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832170|NCT04545008|Antidotes|antidotes|mesh-ancestor
19832171|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19832172|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20342525|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
20342526|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20342527|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
20342528|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342529|NCT00830193|Protective Agents|protective agents|mesh-ancestor
20342530|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342531|NCT00830193|Antidotes|antidotes|mesh-ancestor
20342532|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20342533|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342534|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20342535|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612061|NCT02249546|Amoxicillin|amoxicillin|mesh-list
19654687|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654688|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19654689|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654690|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19654691|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654692|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832173|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19832174|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
20342536|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342537|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
20342538|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
20342539|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
20342540|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
20342541|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20342542|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342543|NCT00830323|Oseltamivir|oseltamivir|mesh-list
20342544|NCT00830323|Amantadine|amantadine|mesh-list
20342545|NCT00830323|Zanamivir|zanamivir|mesh-list
20342546|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
20342547|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342548|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342549|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342550|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20342551|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20342552|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
20342553|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342554|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342555|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20342556|NCT00830323|Analgesics|analgesics|mesh-ancestor
20342557|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
20342558|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342559|NCT00830349|Risperidone|risperidone|mesh-list
20342560|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20342561|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
20342562|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342563|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342564|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342565|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20342566|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20342567|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342568|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20342569|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20342570|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
20342571|NCT00830401|Doxycycline|doxycycline|mesh-list
20342572|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342573|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342574|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
20342575|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19654693|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19654694|NCT04810793|Renal Agents|renal agents|mesh-ancestor
19654695|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19654696|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19654697|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654698|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19654699|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654700|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20170375|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20170376|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20170377|NCT00151242|Cytarabine|cytarabine|mesh-list
19654701|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19654702|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20170378|NCT00151242|Etoposide|etoposide|mesh-list
20170379|NCT00151242|Idarubicin|idarubicin|mesh-list
20342576|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20342577|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20170380|NCT00151242|Tretinoin|tretinoin|mesh-list
20170381|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20170382|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170383|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20170384|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20170385|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170386|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170387|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170388|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
20170389|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
20170390|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342578|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
20170391|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342579|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20342580|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20342581|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20342582|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
20342583|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20342584|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342585|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20342586|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20342587|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20342588|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20342589|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832175|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
20342590|NCT00830466|Sirolimus|sirolimus|mesh-list
20342591|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342592|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342593|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20342594|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342595|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
20342596|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342597|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
20342598|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342599|NCT00830492|Clomiphene|clomiphene|mesh-list
20342600|NCT00830492|Enclomiphene|enclomiphene|mesh-list
20342601|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
20342602|NCT00830492|Buserelin|buserelin|mesh-list
19832176|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832177|NCT04527770|Dexamethasone|dexamethasone|mesh-list
19832178|NCT04527770|Midazolam|midazolam|mesh-list
19832179|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832180|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
19832181|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
19832182|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654703|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19654704|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19654705|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19654706|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19654707|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
19654708|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654709|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
19654710|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654711|NCT04728633|Carmustine|carmustine|mesh-list
19654712|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
19654713|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19832183|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342603|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19654714|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
20342604|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
20612062|NCT02249546|Clarithromycin|clarithromycin|mesh-list
19654715|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654716|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19665505|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19665506|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19665507|NCT04945616|Analgesics|analgesics|mesh-ancestor
19665508|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
19665509|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19665510|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665511|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19665512|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19665513|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19665514|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19665515|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19665516|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19665517|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19665518|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19665519|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
20170392|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
20170393|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170394|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20342605|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342606|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170395|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
20170396|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
20170397|NCT00151255|Cytarabine|cytarabine|mesh-list
20170398|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
20170399|NCT00151255|Idarubicin|idarubicin|mesh-list
20170400|NCT00151255|Tretinoin|tretinoin|mesh-list
20170401|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20342607|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20342608|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
20342609|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20342610|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20342611|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20342612|NCT00830505|Fluticasone|fluticasone|mesh-list
20342613|NCT00830505|Xhance|xhance|mesh-list
20342614|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20342615|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20342616|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342617|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20170402|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
20170403|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342618|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
20170404|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170405|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
20170406|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342619|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342620|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342621|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20342622|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
20170407|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170408|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
20170409|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170410|NCT00151255|Analgesics|analgesics|mesh-ancestor
20170411|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
20170412|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342623|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
19654717|NCT05393817|Caffeine|caffeine|mesh-list
19654718|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
19654719|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654720|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19654721|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654722|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19654723|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654724|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19654725|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19654726|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
19654727|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654728|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
19654729|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654730|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19654731|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654732|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654733|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
19654734|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170413|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20342624|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20342625|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20342626|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20342627|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20342628|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
20342629|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342630|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342631|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
20342632|NCT00830505|Hormones|hormones|mesh-ancestor
20342633|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342634|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
20342635|NCT00830531|Bumetanide|bumetanide|mesh-list
20342636|NCT00830531|Diuretics|diuretics|mesh-ancestor
20342637|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
20342638|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342639|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20342640|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20342641|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342642|NCT00830570|Warfarin|warfarin|mesh-list
20342643|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
20342644|NCT00830609|Ribavirin|ribavirin|mesh-list
20342645|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20342646|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
20342647|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
20342648|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342649|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
20342650|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342651|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
20342652|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342653|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
20342654|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20342655|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
20342656|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342657|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
20342658|NCT00830830|Protective Agents|protective agents|mesh-ancestor
20342659|NCT00830843|Propofol|propofol|mesh-list
19832184|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20170414|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20170415|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170416|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20170417|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
20170418|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
20342660|NCT00830843|Isoflurane|isoflurane|mesh-list
20342661|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20342662|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342663|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342664|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19654735|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654736|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654737|NCT05393713|Antibodies|antibodies|mesh-list
19654738|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19654739|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
19654740|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654741|NCT05393674|Nivolumab|nivolumab|mesh-list
20170419|NCT00151294|Dexetimide|dexetimide|mesh-list
20170420|NCT00151294|Citalopram|citalopram|mesh-list
20170421|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
20342665|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
20342666|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
20342667|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20342668|NCT00830856|Lamivudine|lamivudine|mesh-list
20170422|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20170423|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170424|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170425|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170426|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170427|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
20342669|NCT00830856|Nevirapine|nevirapine|mesh-list
20342670|NCT00830856|Stavudine|stavudine|mesh-list
19654742|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654743|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654744|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19654745|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654746|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19832185|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
19832186|NCT04527770|Hormones|hormones|mesh-ancestor
20342671|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
20342672|NCT00830856|Fluconazole|fluconazole|mesh-list
20342673|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20342674|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20342675|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342676|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342677|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
20342678|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342679|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20342680|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20342681|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
20342682|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20342683|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20342684|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20342685|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
20170428|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170429|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20170430|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170431|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20170432|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20170433|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
20170434|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
20170435|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170436|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20170437|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20170438|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
20170439|NCT00151346|Fentanyl|fentanyl|mesh-list
20170440|NCT00151346|Bupivacaine|bupivacaine|mesh-list
20170441|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
20170442|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
20170443|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170444|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170445|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
20170446|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170447|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20170448|NCT00151346|Narcotics|narcotics|mesh-ancestor
20170449|NCT00151346|Analgesics|analgesics|mesh-ancestor
20170450|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20170451|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20170452|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
20342686|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19257815|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19257816|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
19257817|NCT02687386|Analgesics|analgesics|mesh-ancestor
19257818|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
19257819|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257820|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257821|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257822|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19257823|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19257824|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257825|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257826|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
19257827|NCT02678143|Sirolimus|sirolimus|mesh-list
19257828|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
19257829|NCT02678143|Fludarabine|fludarabine|mesh-list
19257830|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
19257831|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19257832|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
19257833|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257834|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170453|NCT00151450|Pregabalin|pregabalin|mesh-list
20342687|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342688|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20342689|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20342690|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20342691|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20342692|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
20342693|NCT00830882|Albuterol|albuterol|mesh-list
20342694|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20342695|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
20342696|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342697|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342698|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20342699|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
20342700|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
20342701|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20342702|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20342703|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20342704|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20342705|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
20342706|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342707|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342708|NCT00830895|Everolimus|everolimus|mesh-list
20342709|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342710|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342711|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
20170454|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20170455|NCT00151450|Analgesics|analgesics|mesh-ancestor
20170456|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
20170457|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170458|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170459|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
20170460|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20170461|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170462|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170463|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170464|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20170465|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20170466|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170467|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20342712|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342713|NCT00831103|Valacyclovir|valacyclovir|mesh-list
20342714|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
20342715|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342716|NCT00831155|Nicotine|nicotine|mesh-list
20342717|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20342718|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
20342719|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342720|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342721|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20342722|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20342723|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
20342724|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342725|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342726|NCT00831350|Ranibizumab|ranibizumab|mesh-list
20342727|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19654747|NCT05393505|Amoxicillin|amoxicillin|mesh-list
20342728|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20342729|NCT00831350|Growth Substances|growth substances|mesh-ancestor
20342730|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654748|NCT05393505|Levofloxacin|levofloxacin|mesh-list
20342731|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
20342732|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342733|NCT00831376|Albuterol|albuterol|mesh-list
20342734|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19654749|NCT05393505|Ofloxacin|ofloxacin|mesh-list
19654750|NCT05393505|Meropenem|meropenem|mesh-list
19654751|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
20342735|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
20342736|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342737|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342738|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20342739|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
20342740|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
20342741|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20342742|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19654752|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
19665520|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19654753|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20170468|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20170469|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170470|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170471|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20170472|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
20170473|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
20170474|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654754|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170475|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
20170476|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20170477|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20170478|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170479|NCT00151463|Urological Agents|urological agents|mesh-ancestor
20170480|NCT00151489|Pregabalin|pregabalin|mesh-list
20170481|NCT00151489|Analgesics|analgesics|mesh-ancestor
20170482|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
19654755|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19654756|NCT05393505|Renal Agents|renal agents|mesh-ancestor
19654757|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19654758|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19654759|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654760|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654761|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654762|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19654763|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654764|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19654765|NCT05393414|Acetaminophen|acetaminophen|mesh-list
19654766|NCT05393414|Ketorolac|ketorolac|mesh-list
19654767|NCT05393414|Morphine|morphine|mesh-list
19654768|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
19654769|NCT05393414|Narcotics|narcotics|mesh-ancestor
19654770|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654771|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654772|NCT05393414|Analgesics|analgesics|mesh-ancestor
19654773|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
19654774|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654775|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19654776|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
20170483|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170484|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170485|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
20170486|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20170487|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170488|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170489|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170490|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20170491|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19654777|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20342743|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20342744|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19257835|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19257836|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
20342745|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
20342746|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257837|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257838|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257839|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19257840|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19257841|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19257842|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
19257843|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19257844|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19257845|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257846|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
19257847|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257848|NCT02628405|Rituximab|rituximab|mesh-list
19257849|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19257850|NCT02628405|Carboplatin|carboplatin|mesh-list
19257851|NCT02628405|Etoposide|etoposide|mesh-list
19257852|NCT02628405|Lenalidomide|lenalidomide|mesh-list
19257853|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
19257854|NCT02628405|Ifosfamide|ifosfamide|mesh-list
19257855|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
19257856|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
19257857|NCT02628405|Antibodies|antibodies|mesh-list
19257858|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
19257859|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19257860|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
19257861|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257862|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342747|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342748|NCT00831506|Digoxin|digoxin|mesh-list
20342749|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20342750|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20342751|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342752|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257863|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19257864|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19257865|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19257866|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20170492|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170493|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170494|NCT00151502|Atorvastatin|atorvastatin|mesh-list
20170495|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20170496|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20170497|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
20170498|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170499|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20170500|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20342753|NCT00831506|Protective Agents|protective agents|mesh-ancestor
20342754|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342755|NCT00831545|Temozolomide|temozolomide|mesh-list
20342756|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20342757|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
20342758|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342759|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342760|NCT00831597|Rituximab|rituximab|mesh-list
20342761|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20342762|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20342763|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342764|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
20170501|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170502|NCT00151515|Minoxidil|minoxidil|mesh-list
20170503|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170504|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
20170505|NCT00151528|Pregabalin|pregabalin|mesh-list
20170506|NCT00151528|Analgesics|analgesics|mesh-ancestor
20170507|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
20170508|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170509|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170510|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
20170511|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20170512|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170513|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170514|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170515|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20170516|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20170517|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342765|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342766|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342767|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20342768|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
20342769|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342770|NCT00831636|Cytarabine|cytarabine|mesh-list
20342771|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654778|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19654779|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19654780|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19654781|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654782|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654783|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
19654784|NCT05393245|Olodaterol|olodaterol|mesh-list
19654785|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
19654786|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19654787|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20342772|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
20342773|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342774|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342775|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
20342776|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342777|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342778|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
20342779|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342780|NCT00831649|Natalizumab|natalizumab|mesh-list
20342781|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
20342782|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342783|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
19654788|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
19654789|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654790|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654791|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19654792|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
20342784|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19654793|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
20170518|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20342785|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
19654794|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19654795|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654796|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654797|NCT05393050|Methotrexate|methotrexate|mesh-list
19654798|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20170519|NCT00151541|Dapsone|dapsone|mesh-list
20170520|NCT00151541|Adapalene|adapalene|mesh-list
20170521|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20170522|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
20170523|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19654799|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
19654800|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19654801|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342786|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20342787|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
20342788|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342789|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342790|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
20170524|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20170525|NCT00151541|Analgesics|analgesics|mesh-ancestor
20170526|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
20170527|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170528|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170529|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20170530|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170531|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170532|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
20170533|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20170534|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20170535|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20612063|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
20342791|NCT00831857|Bevacizumab|bevacizumab|mesh-list
20342792|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20342793|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20170536|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170537|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170538|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
20170539|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19654802|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19654803|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
19654804|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170540|NCT00151567|Tamsulosin|tamsulosin|mesh-list
20170541|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20170542|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20170543|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20342794|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342795|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20342796|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20342797|NCT00831857|Growth Substances|growth substances|mesh-ancestor
20342798|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257867|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257868|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257869|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20170544|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
20170545|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170546|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170547|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170548|NCT00151567|Urological Agents|urological agents|mesh-ancestor
20170549|NCT00151580|Ribavirin|ribavirin|mesh-list
20170550|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
20170551|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170552|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
20170553|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170554|NCT00151619|Amlodipine|amlodipine|mesh-list
20170555|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170556|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20170557|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170558|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342799|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
19257870|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19257871|NCT02628405|Growth Substances|growth substances|mesh-ancestor
19257872|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
20170559|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20170560|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170561|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
20170562|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
20170563|NCT00151632|Tacrolimus|tacrolimus|mesh-list
20170564|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170565|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
20342800|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20342801|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342802|NCT00832013|Propofol|propofol|mesh-list
20342803|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20342804|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342805|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342806|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20342807|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
20342808|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
20342809|NCT00832039|Selenious Acid|selenious acid|mesh-list
20342810|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
20342811|NCT00832039|Trace Elements|trace elements|mesh-ancestor
20342812|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
20170566|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170567|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20170568|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170569|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170570|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20342813|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342814|NCT00832182|Insulin|insulin|mesh-list
20342815|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20342816|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
20342817|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
20342818|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
20342819|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
20342820|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19832187|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19832188|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19832189|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832190|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20342821|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342822|NCT00832208|Amphotericin B|amphotericin b|mesh-list
20342823|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20342824|NCT00832208|Amebicides|amebicides|mesh-ancestor
20342825|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20342826|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20342827|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342828|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342829|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
20342830|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20342831|NCT00832221|Raclopride|raclopride|mesh-list
20342832|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
20342833|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19832191|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19832192|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832193|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19832194|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19832195|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19832196|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19832197|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
19832198|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
19832199|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
19832200|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
19832201|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170571|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170572|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19832202|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832203|NCT04514211|Propofol|propofol|mesh-list
19832204|NCT04514211|Sevoflurane|sevoflurane|mesh-list
19832205|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20170573|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
19654805|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654806|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
19654807|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170574|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20170575|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170576|NCT00151684|Diazoxide|diazoxide|mesh-list
20170577|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170578|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
20170579|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
20170580|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20342834|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20342835|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20342836|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654808|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19654809|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19654810|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
19654811|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19654812|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19654813|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19654814|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
19832206|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832207|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832208|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19832209|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
19832210|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
20170581|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20170582|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170583|NCT00151710|Pioglitazone|pioglitazone|mesh-list
20170584|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20170585|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170586|NCT00151736|Etodolac|etodolac|mesh-list
19654815|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654816|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20170587|NCT00151736|Chlorambucil|chlorambucil|mesh-list
20342837|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342838|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20342839|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
20342840|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342841|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342842|NCT00832234|Dexamethasone|dexamethasone|mesh-list
20342843|NCT00832234|Rituximab|rituximab|mesh-list
20342844|NCT00832234|Bortezomib|bortezomib|mesh-list
20342845|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20342846|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257873|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19257874|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
19257875|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
19257876|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
19257877|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257878|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
20342847|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
20342848|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342849|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342850|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257879|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
19257880|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
19257881|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257882|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257883|NCT02523040|Lenalidomide|lenalidomide|mesh-list
19257884|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
19257885|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257886|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19257887|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19257888|NCT02523040|Growth Substances|growth substances|mesh-ancestor
19257889|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
19257890|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257891|NCT02520778|Osimertinib|osimertinib|mesh-list
19257892|NCT02520778|Navitoclax|navitoclax|mesh-list
19257893|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257894|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19257895|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257896|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170588|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20170589|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
20170590|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170591|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170592|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20170593|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20170594|NCT00151736|Analgesics|analgesics|mesh-ancestor
20170595|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
20170596|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170597|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170598|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20170599|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170600|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20170601|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19257911|NCT02479646|Lenograstim|lenograstim|mesh-list
19257912|NCT02479646|Sargramostim|sargramostim|mesh-list
19257913|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20342851|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
20342852|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
20342853|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342854|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20170602|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170603|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20170604|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20170605|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20170606|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
20170607|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170608|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20170609|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20170610|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20342855|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
20342856|NCT00832234|Hormones|hormones|mesh-ancestor
20342857|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20342858|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20170611|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20170612|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
20170613|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170614|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20170615|NCT00151801|Interferons|interferons|mesh-list
20170616|NCT00151801|Interferon-beta|interferon-beta|mesh-list
20170617|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
20170618|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170619|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
20170620|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170621|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
20170622|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170623|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20170624|NCT00151827|Losartan|losartan|mesh-list
20170625|NCT00151827|Olmesartan|olmesartan|mesh-list
20170626|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20170627|NCT00151827|Furosemide|furosemide|mesh-list
20170628|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20170629|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170630|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20170631|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20170632|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170633|NCT00151827|Diuretics|diuretics|mesh-ancestor
20170634|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
20342859|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
20342860|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342861|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342862|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20342863|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20342864|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342865|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342866|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654817|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19654818|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654819|NCT05392972|Anesthetics|anesthetics|mesh-list
19654820|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654821|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654822|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
19654823|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20170635|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170636|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20170637|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170638|NCT00151944|Mesalamine|mesalamine|mesh-list
20170639|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20170640|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20170641|NCT00151944|Analgesics|analgesics|mesh-ancestor
20170642|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
20170643|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654824|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342867|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20342868|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20342869|NCT00832364|Etanercept|etanercept|mesh-list
20342870|NCT00832364|Acitretin|acitretin|mesh-list
20342871|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20342872|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20342873|NCT00832364|Analgesics|analgesics|mesh-ancestor
20342874|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
20342875|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342876|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342877|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342878|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342879|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20342880|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342881|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
20342882|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
20342883|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
20342884|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20342885|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20342886|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342887|NCT00832442|Metoprolol|metoprolol|mesh-list
20342888|NCT00832442|Carvedilol|carvedilol|mesh-list
20170644|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170645|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20170646|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170647|NCT00151957|Methylphenidate|methylphenidate|mesh-list
20170648|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20170649|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170650|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20170651|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170652|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174863|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20174864|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257914|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
20174865|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174866|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20174867|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174868|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20174869|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174870|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174871|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
20174872|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174873|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20174874|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174875|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174876|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20174877|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
20174878|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174879|NCT00166127|Simendan|simendan|mesh-list
20174880|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20174881|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
20174882|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20174883|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20174884|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257915|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257916|NCT02472964|Paclitaxel|paclitaxel|mesh-list
19257917|NCT02472964|Docetaxel|docetaxel|mesh-list
19257918|NCT02472964|Trastuzumab|trastuzumab|mesh-list
19257919|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19257920|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257921|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257922|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
19257923|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
19257924|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257925|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257926|NCT02467868|Lenograstim|lenograstim|mesh-list
19257927|NCT02467868|Sargramostim|sargramostim|mesh-list
19257928|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19257929|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
19257930|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257931|NCT02421263|Psilocybin|psilocybin|mesh-list
19257932|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
19257933|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257934|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19257935|NCT02402920|Cisplatin|cisplatin|mesh-list
19257936|NCT02402920|Carboplatin|carboplatin|mesh-list
19257937|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
19257938|NCT02402920|Etoposide|etoposide|mesh-list
19257939|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
19257940|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
19257941|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257942|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19257943|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19257944|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19257945|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19257946|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257947|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257948|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
19257949|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
19257950|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257951|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
19257952|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
19257953|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
19257954|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20170653|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170654|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
20170655|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170656|NCT00151970|Methylphenidate|methylphenidate|mesh-list
20170657|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20170658|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170659|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20170660|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170661|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20342889|NCT00832442|Nebivolol|nebivolol|mesh-list
19257955|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257956|NCT01889303|Docetaxel|docetaxel|mesh-list
19257957|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257958|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
19257959|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
20342890|NCT00832442|Bisoprolol|bisoprolol|mesh-list
20342891|NCT00832442|Bucindolol|bucindolol|mesh-list
19654825|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654826|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654827|NCT05392946|Dexamethasone|dexamethasone|mesh-list
20170662|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170663|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
20170664|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170665|NCT00151983|Methylphenidate|methylphenidate|mesh-list
20170666|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20170667|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170668|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20170669|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170670|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170671|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170672|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
20342892|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20170673|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170674|NCT00152022|Amphetamine|amphetamine|mesh-list
20170675|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
20170676|NCT00152022|Adderall|adderall|mesh-list
20170677|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20170678|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170679|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
20170680|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
20170681|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170682|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
20170683|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342893|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20342894|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20342895|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
20342896|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
20342897|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342898|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342899|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20342900|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20170684|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170685|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
20170686|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20170687|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170688|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20170689|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20170690|NCT00152035|Amphetamine|amphetamine|mesh-list
20170691|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
20170692|NCT00152035|Adderall|adderall|mesh-list
20170693|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20170694|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170695|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
20342901|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
20342902|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342903|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342904|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
20342905|NCT00832442|Protective Agents|protective agents|mesh-ancestor
20342906|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20342907|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20342908|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20342909|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
20342910|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20342911|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20342912|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20342913|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20342914|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20342915|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
20342916|NCT00832481|Metformin|metformin|mesh-list
20342917|NCT00832481|Repaglinide|repaglinide|mesh-list
20342918|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20342919|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342920|NCT00832494|Paclitaxel|paclitaxel|mesh-list
20342921|NCT00832494|Carboplatin|carboplatin|mesh-list
20342922|NCT00832494|Vadimezan|vadimezan|mesh-list
19257960|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
20170696|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
20170697|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654828|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
19654829|NCT05392946|Bortezomib|bortezomib|mesh-list
20170698|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
20170699|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170700|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170701|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
20170702|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20170703|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20170704|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654830|NCT05392946|Daratumumab|daratumumab|mesh-list
20170705|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20170706|NCT00152048|Eflornithine|eflornithine|mesh-list
20170707|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170708|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19654831|NCT05392946|Ichthammol|ichthammol|mesh-list
19654832|NCT05392946|BB 1101|bb 1101|mesh-list
19654833|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342923|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20342924|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342925|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
20342926|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
20342927|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
20342928|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342929|NCT00832689|Gemcitabine|gemcitabine|mesh-list
20342930|NCT00832689|Irinotecan|irinotecan|mesh-list
20342931|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20342932|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
20342933|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342934|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20342935|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
20342936|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20342937|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342938|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342939|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
20342940|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170709|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20170710|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20170711|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170712|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20170713|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170714|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170715|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
19257961|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257962|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19257963|NCT01787500|Cetuximab|cetuximab|mesh-list
19257964|NCT01787500|Irinotecan|irinotecan|mesh-list
19257965|NCT01787500|Camptothecin|camptothecin|mesh-list
19257966|NCT01787500|Vemurafenib|vemurafenib|mesh-list
19257967|NCT01787500|Antibodies|antibodies|mesh-list
19257968|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
19257969|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19257970|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
19257971|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257972|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19257973|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19257974|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19257975|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19257976|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257977|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19257978|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19257979|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
19257980|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
19257981|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19257982|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
19257983|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19257984|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19257985|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19257986|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
19257987|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19257988|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19257989|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19257990|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
19257991|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19257992|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19257993|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19257994|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
19257995|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19257996|NCT01104922|Cetuximab|cetuximab|mesh-list
19257997|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20170716|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20170717|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170718|NCT00152126|Melphalan|melphalan|mesh-list
19257998|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612064|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20170719|NCT00152126|Busulfan|busulfan|mesh-list
20170720|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20170721|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
20342941|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20342942|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20342943|NCT00832806|Varenicline|varenicline|mesh-list
20342944|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20342945|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20342946|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
20342947|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170722|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170723|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170724|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20170725|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170726|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
20170727|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170728|NCT00152139|Antibodies|antibodies|mesh-list
20170729|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
20612065|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20342948|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342949|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342950|NCT00832884|Lacosamide|lacosamide|mesh-list
20342951|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
20342952|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20342953|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20342954|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20342955|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342956|NCT00833079|Tacrolimus|tacrolimus|mesh-list
20342957|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20342958|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
20342959|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342960|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19654834|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
19654835|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
19654836|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654837|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654838|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654839|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
19654840|NCT05392946|Hormones|hormones|mesh-ancestor
20342961|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20342962|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342963|NCT00833157|Ibuprofen|ibuprofen|mesh-list
20342964|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20342965|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20170730|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170731|NCT00152178|Tamoxifen|tamoxifen|mesh-list
20170732|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
20170733|NCT00152178|Fluorouracil|fluorouracil|mesh-list
19257999|NCT00862251|Atorvastatin|atorvastatin|mesh-list
19258000|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19258001|NCT00862251|Simvastatin|simvastatin|mesh-list
19258002|NCT00862251|Ezetimibe|ezetimibe|mesh-list
19258003|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258004|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20170734|NCT00152178|Methotrexate|methotrexate|mesh-list
20170735|NCT00152178|Tegafur|tegafur|mesh-list
20170736|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170737|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
20170738|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170739|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170740|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20170741|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
19258005|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
19258006|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258007|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258008|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258009|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258010|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19258011|NCT00783263|Ezetimibe|ezetimibe|mesh-list
19258012|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258013|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258014|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
19258015|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258016|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258017|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258018|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258019|NCT00782184|Atorvastatin|atorvastatin|mesh-list
20170742|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342966|NCT00833157|Analgesics|analgesics|mesh-ancestor
19258020|NCT00782184|Simvastatin|simvastatin|mesh-list
20342967|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
20342968|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832211|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19832212|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19832213|NCT04507503|Futibatinib|futibatinib|mesh-list
19832214|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832215|NCT04507204|Methylphenidate|methylphenidate|mesh-list
19832216|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20342969|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342970|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20342971|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20342972|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20342973|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654841|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654842|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19654843|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654844|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
19654845|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654846|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654847|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
19654848|NCT05392933|Lidocaine|lidocaine|mesh-list
19654849|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
19654850|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
19654851|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654852|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654853|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
19654854|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654855|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19654856|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19654857|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19832217|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342974|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342975|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
20342976|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20342977|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20342978|NCT00833300|Haloperidol|haloperidol|mesh-list
20342979|NCT00833300|Olanzapine|olanzapine|mesh-list
20342980|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
20342981|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
20342982|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
20342983|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20342984|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20342985|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654858|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19654859|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654860|NCT05392790|Calcium|calcium|mesh-list
19654861|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19654862|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654863|NCT05392764|Empagliflozin|empagliflozin|mesh-list
19654864|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19258021|NCT00782184|Ezetimibe|ezetimibe|mesh-list
20342986|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20342987|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20342988|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20342989|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20342990|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20342991|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20342992|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20342993|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20342994|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20342995|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
20342996|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20342997|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
20342998|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20342999|NCT00833326|Docetaxel|docetaxel|mesh-list
20343000|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
20343001|NCT00833326|Mitogens|mitogens|mesh-list
20343002|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343003|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20343004|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20343005|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343006|NCT00833339|Mifepristone|mifepristone|mesh-list
20343007|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20343008|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
20343009|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20343010|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343011|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20343012|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20343013|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20343014|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
20343015|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20343016|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20343017|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
19654865|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654866|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654867|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612066|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343018|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20343019|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
20343020|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20343021|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20343022|NCT00833378|Ritonavir|ritonavir|mesh-list
20343023|NCT00833378|Lopinavir|lopinavir|mesh-list
20343024|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19654868|NCT05392699|Interleukin-12|interleukin-12|mesh-list
19654869|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20343025|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20343026|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
20343027|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654870|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
19654871|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343028|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343029|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20343030|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20343031|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
20343032|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343033|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20343034|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19654872|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19654873|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19654874|NCT05392699|Growth Substances|growth substances|mesh-ancestor
19654875|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
20343035|NCT00833404|Nicotine|nicotine|mesh-list
20343036|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20343037|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
20343038|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343039|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343040|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20343041|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20343042|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
19654876|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343043|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343044|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343045|NCT00833534|Rituximab|rituximab|mesh-list
20343046|NCT00833534|Lenalidomide|lenalidomide|mesh-list
20343047|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20343048|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343049|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
20343050|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343051|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20343052|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20343053|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20343054|NCT00833534|Growth Substances|growth substances|mesh-ancestor
20343055|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
20343056|NCT00833729|Etanercept|etanercept|mesh-list
20343057|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20343058|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20343059|NCT00833729|Analgesics|analgesics|mesh-ancestor
20343060|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
20343061|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343062|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343063|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20343064|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20343065|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20343066|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343067|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
20348342|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348343|NCT00864214|Hormones|hormones|mesh-list
20348344|NCT00864214|Estradiol|estradiol|mesh-list
20348345|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348346|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348347|NCT00864214|Estrogens|estrogens|mesh-ancestor
20348348|NCT00864240|Clobetasol|clobetasol|mesh-list
20348349|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348350|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
20348351|NCT00864240|Hormones|hormones|mesh-ancestor
20348352|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348353|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348354|NCT00864279|Cetirizine|cetirizine|mesh-list
20348355|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20348356|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20348357|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20348358|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
20348359|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
20348360|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348361|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348362|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348363|NCT00864305|Gabapentin|gabapentin|mesh-list
20348364|NCT00864305|Analgesics|analgesics|mesh-ancestor
20348365|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
20348366|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348367|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348368|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
20348369|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20348370|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348371|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348372|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348373|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20348374|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20348375|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348376|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348377|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
20348378|NCT00864318|Paclitaxel|paclitaxel|mesh-list
20348379|NCT00864318|Etoposide|etoposide|mesh-list
20348380|NCT00864318|Ifosfamide|ifosfamide|mesh-list
20348381|NCT00864318|Carboplatin|carboplatin|mesh-list
20348382|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20348383|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170743|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170744|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20343068|NCT00833768|Sevelamer|sevelamer|mesh-list
20343069|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
20343070|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
20343071|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343072|NCT00833807|Paclitaxel|paclitaxel|mesh-list
20170745|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
20170746|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170747|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20170748|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
20170749|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20170750|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
20170751|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170752|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20170753|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20170754|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20170755|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
20343073|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20343074|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20170756|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170757|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20170758|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20170759|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20170760|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20343075|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343076|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
20343077|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
20343078|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
20343079|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343080|NCT00833963|Trastuzumab|trastuzumab|mesh-list
20343081|NCT00833963|Pertuzumab|pertuzumab|mesh-list
20343082|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20170761|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
20170762|NCT00152191|Fluorouracil|fluorouracil|mesh-list
20170763|NCT00152191|Methotrexate|methotrexate|mesh-list
20170764|NCT00152191|Tegafur|tegafur|mesh-list
20170765|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170766|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
20170767|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170768|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170769|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20343083|NCT00833963|Maytansine|maytansine|mesh-list
20343084|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20343085|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343086|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20343087|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
20170770|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
20343088|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
20343089|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
20343090|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343091|NCT00834184|Nikkomycin|nikkomycin|mesh-list
20343092|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
20343093|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343094|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343095|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258022|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20170771|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170772|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258023|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258024|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258025|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
19832218|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19832219|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19832220|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343096|NCT00834262|Insulin|insulin|mesh-list
19654877|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19654878|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20343097|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20343098|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
20343099|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
20343100|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20343101|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
20343102|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20343103|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20343104|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343105|NCT00834379|Pravastatin|pravastatin|mesh-list
20343106|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20343107|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20343108|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
20343109|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343110|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19654879|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654880|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343111|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20343112|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343113|NCT00834457|Ritonavir|ritonavir|mesh-list
20343114|NCT00834457|Lopinavir|lopinavir|mesh-list
20343115|NCT00834457|Zidovudine|zidovudine|mesh-list
20343116|NCT00834457|Lamivudine|lamivudine|mesh-list
20343117|NCT00834457|Abacavir|abacavir|mesh-list
20343118|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
20343119|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20343120|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20343121|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
20343122|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343123|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654881|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654882|NCT05392673|Bilirubin|bilirubin|mesh-list
19654883|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
19654884|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654885|NCT05392673|Protective Agents|protective agents|mesh-ancestor
20343124|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20343125|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20343126|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
20343127|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343128|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20343129|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20343130|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
20343131|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20343132|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20343133|NCT00834470|Atropine|atropine|mesh-list
20343134|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20343135|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20343136|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20343137|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
20343138|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343139|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343140|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20343141|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
20343142|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
20343143|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
20343144|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19832221|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832222|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
19832223|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832224|NCT04505566|Ketorolac|ketorolac|mesh-list
20343145|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20343146|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
20343147|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343148|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343149|NCT00834600|Amlodipine|amlodipine|mesh-list
20343150|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20343151|NCT00834600|Olmesartan|olmesartan|mesh-list
20343152|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20343153|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20343154|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20343155|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343156|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343157|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20343158|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343159|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
20343160|NCT00834600|Diuretics|diuretics|mesh-ancestor
20343161|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
20343162|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20343163|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20343164|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20343165|NCT00834665|Molgramostim|molgramostim|mesh-list
20343166|NCT00834665|Sargramostim|sargramostim|mesh-list
20343167|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
20343168|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343169|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343170|NCT00834730|Ketamine|ketamine|mesh-list
20343171|NCT00834730|Analgesics|analgesics|mesh-ancestor
20343172|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
20343173|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343174|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343175|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20343176|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20612067|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20612068|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612069|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612070|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20612071|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612072|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
20343177|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
20343178|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
20343179|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343180|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20343181|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20343182|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654886|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832225|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20170773|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20170774|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
20170775|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170776|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20170777|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
20170778|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20170779|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
20170780|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170781|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20170782|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20170783|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
20170784|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
20343183|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343184|NCT00834847|Pravastatin|pravastatin|mesh-list
20343185|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20343186|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20343187|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
20343188|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343189|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20343190|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20170785|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20170786|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
20170787|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20170788|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20170789|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170790|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20170791|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170792|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170793|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20170794|NCT00152204|Renal Agents|renal agents|mesh-ancestor
20170795|NCT00152230|Tegafur|tegafur|mesh-list
20170796|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170797|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
20170798|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170799|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170800|NCT00152243|Tegafur|tegafur|mesh-list
20343191|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654897|NCT05392608|Fulvestrant|fulvestrant|mesh-list
19654898|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19654899|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654900|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20343192|NCT00834860|Ribavirin|ribavirin|mesh-list
20343193|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20343194|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
20343195|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343196|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
20343197|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343198|NCT00834925|Diltiazem|diltiazem|mesh-list
19654901|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20343199|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20343200|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20343201|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343202|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343203|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20343204|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343205|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
20343206|NCT00835029|Clotrimazole|clotrimazole|mesh-list
20343207|NCT00835029|Miconazole|miconazole|mesh-list
20343208|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20343209|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343210|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
20343211|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20343212|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20343213|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343214|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343215|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20343216|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
20343217|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20343218|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343219|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20343220|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20612073|NCT02249546|Expectorants|expectorants|mesh-ancestor
20612074|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
20170801|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20170802|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
20170803|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170804|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170805|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20170806|NCT00152282|Estrogens|estrogens|mesh-ancestor
20170807|NCT00152282|Hormones|hormones|mesh-ancestor
20170808|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170809|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170810|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20170811|NCT00152295|Estrogens|estrogens|mesh-ancestor
20170812|NCT00152295|Hormones|hormones|mesh-ancestor
20343221|NCT00835107|Ziprasidone|ziprasidone|mesh-list
20343222|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20343223|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
20343224|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343225|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343226|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343227|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20343228|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20343229|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343230|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20170813|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170814|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170815|NCT00152308|Sirolimus|sirolimus|mesh-list
20170816|NCT00152308|Ethanol|ethanol|mesh-list
20170817|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20170818|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170819|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20170820|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170821|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
20170822|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343231|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20343232|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
20343233|NCT00835393|Pantoprazole|pantoprazole|mesh-list
20343234|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20343235|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20343236|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20343237|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343238|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343239|NCT00835471|Docetaxel|docetaxel|mesh-list
20343240|NCT00835471|Pemetrexed|pemetrexed|mesh-list
20343241|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20343242|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343243|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
20343244|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
20343245|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
20343246|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343247|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343248|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20343249|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20343250|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20343251|NCT00835627|Sertraline|sertraline|mesh-list
19258026|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258027|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258028|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258029|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258030|NCT00664937|Montelukast|montelukast|mesh-list
19258031|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258032|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258033|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258034|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258035|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258036|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258037|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258038|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258039|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258040|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
19258041|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
19258042|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19258043|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
19258044|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258045|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258046|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19654902|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
19654903|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19654904|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654905|NCT05392530|Macitentan|macitentan|mesh-list
20343252|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
20343253|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343254|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20343255|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20343256|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343257|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343258|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654906|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19654907|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19654908|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654909|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19654910|NCT05392452|Insulin|insulin|mesh-list
19654911|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654912|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654913|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
19654914|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19654915|NCT05392374|TIC10 compound|tic10 compound|mesh-list
19654916|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654917|NCT05392361|Gabapentin|gabapentin|mesh-list
19654918|NCT05392361|Baclofen|baclofen|mesh-list
19654919|NCT05392361|Analgesics|analgesics|mesh-ancestor
20170823|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
20170824|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170825|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20170826|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20170827|NCT00152360|Orlistat|orlistat|mesh-list
20170828|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170829|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170830|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20170831|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20170832|NCT00152373|Levetiracetam|levetiracetam|mesh-list
20170833|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
20170834|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
20170835|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
20170836|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170837|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
20170838|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170839|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170840|NCT00152399|Somatostatin|somatostatin|mesh-list
20170841|NCT00152399|Hormones|hormones|mesh-ancestor
20170842|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170843|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170844|NCT00152412|Levocetirizine|levocetirizine|mesh-list
20170845|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20170846|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20170847|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
20170848|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
20343259|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
20343260|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343261|NCT00835744|Clomiphene|clomiphene|mesh-list
20343262|NCT00835744|Enclomiphene|enclomiphene|mesh-list
20343263|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
20343264|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20343265|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
20343266|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20343267|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343268|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20343269|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
20343270|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20343271|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20343272|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20343273|NCT00835848|Exenatide|exenatide|mesh-list
20343274|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20343275|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343276|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19654920|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
19654921|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654922|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654923|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
19654924|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19654925|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19654926|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654927|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19654928|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19654929|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19654930|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654931|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654932|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
19654933|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19654934|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19654935|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19654936|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
19654937|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
19654938|NCT05392257|Rituximab|rituximab|mesh-list
19654939|NCT05392257|Lenalidomide|lenalidomide|mesh-list
19654940|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
19654941|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654942|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19654943|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
20170849|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170850|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170851|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170852|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
20170853|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170854|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
20170855|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170856|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170857|NCT00152438|Progesterone|progesterone|mesh-list
20170858|NCT00152438|Progestins|progestins|mesh-ancestor
20170859|NCT00152438|Hormones|hormones|mesh-ancestor
20170860|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170861|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170862|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
20170863|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20170864|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
20170865|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170866|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170867|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
20170868|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20170869|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
20170870|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343277|NCT00835848|Incretins|incretins|mesh-ancestor
20343278|NCT00835848|Hormones|hormones|mesh-ancestor
20170871|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170872|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20170873|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
20170874|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20170875|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
19258047|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258048|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19258049|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19258050|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19258051|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
19258052|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258053|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258054|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19258055|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
19258056|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19258057|NCT00586391|Ipilimumab|ipilimumab|mesh-list
19258058|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258059|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258060|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19258061|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258062|NCT00545324|Fluticasone|fluticasone|mesh-list
19258063|NCT00545324|Montelukast|montelukast|mesh-list
19258064|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19258065|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19258066|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
19258067|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654944|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170876|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343279|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20343280|NCT00835939|Lidocaine|lidocaine|mesh-list
20343281|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
20343282|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
20343283|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343284|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343285|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
20343286|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343287|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20343288|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20343289|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20343290|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343291|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343292|NCT00835965|Dexamethasone|dexamethasone|mesh-list
20343293|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
20343294|NCT00835965|Aprepitant|aprepitant|mesh-list
20343295|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
20343296|NCT00835965|BB 1101|bb 1101|mesh-list
20343297|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20343298|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
20343299|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
20343300|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343301|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343302|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20343303|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
20343304|NCT00835965|Hormones|hormones|mesh-ancestor
20343305|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20343306|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20343307|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343308|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
20343309|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343310|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343311|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20343312|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343313|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
20343314|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19654945|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832226|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
20343315|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343316|NCT00836134|Bupivacaine|bupivacaine|mesh-list
20343317|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
20343318|NCT00836134|Anesthetics|anesthetics|mesh-list
20343319|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343320|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343321|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
19654946|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19654947|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19654948|NCT05392257|Growth Substances|growth substances|mesh-ancestor
19654949|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
19654950|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19654951|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654952|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170877|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170878|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20170879|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
19654956|NCT05392166|Calcium|calcium|mesh-list
19654957|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19654958|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654959|NCT05392127|Vitamin K|vitamin k|mesh-list
19654960|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
19654961|NCT05392127|Repaglinide|repaglinide|mesh-list
19654962|NCT05392127|Midazolam|midazolam|mesh-list
19654963|NCT05392127|Omeprazole|omeprazole|mesh-list
19654964|NCT05392127|Warfarin|warfarin|mesh-list
20170880|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
20343322|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19654965|NCT05392127|Vitamins|vitamins|mesh-ancestor
20343323|NCT00836199|Vaccines|vaccines|mesh-list
20343324|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
20343325|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343326|NCT00836212|Efavirenz|efavirenz|mesh-list
20343327|NCT00836212|Lopinavir|lopinavir|mesh-list
20343328|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20343329|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20343330|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343331|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258068|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258069|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258070|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258071|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
19258072|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19258073|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258074|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258075|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258076|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258077|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258078|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258079|NCT00540839|Fluticasone|fluticasone|mesh-list
19258080|NCT00540839|Xhance|xhance|mesh-list
19258081|NCT00540839|Montelukast|montelukast|mesh-list
19258082|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19258083|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19258084|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
19258085|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258086|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258087|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258088|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258089|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
19258090|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19258091|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258092|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
19654966|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
19259239|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343332|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
20343333|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343334|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20343335|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20170881|NCT00152542|Protective Agents|protective agents|mesh-ancestor
20170882|NCT00152581|Interferons|interferons|mesh-list
20343336|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20343337|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20343338|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20343339|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20343340|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20170883|NCT00152581|Ribavirin|ribavirin|mesh-list
20170884|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
20170885|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
20170886|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19832227|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20343341|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19832228|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19832229|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19832230|NCT04505566|Analgesics|analgesics|mesh-ancestor
19832231|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
19832232|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343342|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
20343343|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20343344|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19259240|NCT05173246|Paclitaxel|paclitaxel|mesh-list
20170887|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170888|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
20170889|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170890|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
20170891|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170892|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
20170893|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170894|NCT00152594|Voriconazole|voriconazole|mesh-list
20170895|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
20170896|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20170897|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20170898|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20170899|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170900|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170901|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20170902|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
20170903|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170904|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170905|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20170906|NCT00152620|Dexamethasone|dexamethasone|mesh-list
20170907|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
20343345|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20343346|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
20343347|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
20170908|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20170909|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20170910|NCT00152620|Prednisolone|prednisolone|mesh-list
20170911|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
20343348|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
20343349|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343350|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343351|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
20343352|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343353|NCT00836368|Vitamin E|vitamin e|mesh-list
20343354|NCT00836368|Tocopherols|tocopherols|mesh-list
20343355|NCT00836368|Tocotrienols|tocotrienols|mesh-list
20343356|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
20343357|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
20343358|NCT00836368|Vitamins|vitamins|mesh-ancestor
20343359|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
20343360|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343361|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
20343362|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343363|NCT00836368|Protective Agents|protective agents|mesh-ancestor
20343364|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20343365|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20343366|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20343367|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
20343368|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343369|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832233|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832234|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832235|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832236|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19832237|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343370|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343371|NCT00836381|Urological Agents|urological agents|mesh-ancestor
20343372|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20343373|NCT00836485|Ketotifen|ketotifen|mesh-list
20343374|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
20343375|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20343376|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20343377|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20343378|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20343379|NCT00836485|Analgesics|analgesics|mesh-ancestor
20343380|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
20343381|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343382|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343383|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20343384|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20343385|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20343386|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20343387|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20343388|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
20343389|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
20343390|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343391|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343392|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
20343393|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
20348384|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
20348385|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
20348386|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
20348387|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348388|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20343394|NCT00836537|Benazepril|benazepril|mesh-list
20343395|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20343396|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
20343397|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343398|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343399|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20343400|NCT00836576|Benazepril|benazepril|mesh-list
20343401|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20343402|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
20343403|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343404|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343405|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20343406|NCT00836628|Busulfan|busulfan|mesh-list
20343407|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
20343408|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343409|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343410|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
20343411|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343412|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20343413|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343414|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20343415|NCT00836654|Catumaxomab|catumaxomab|mesh-list
20343416|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20343417|NCT00836667|Sertraline|sertraline|mesh-list
20343418|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
20170912|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20170913|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
20170914|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20170915|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
20170916|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
20170917|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170918|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170919|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20170920|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
20170921|NCT00152620|Hormones|hormones|mesh-ancestor
20170922|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20170923|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20170924|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20170925|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20170926|NCT00152620|Protective Agents|protective agents|mesh-ancestor
20170927|NCT00152633|Losartan|losartan|mesh-list
20170928|NCT00152633|Metoprolol|metoprolol|mesh-list
20170929|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20343419|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19832238|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343420|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20343421|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20343422|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343423|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343424|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343425|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
20343426|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343427|NCT00836823|Alfuzosin|alfuzosin|mesh-list
20343428|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20343429|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20343430|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20343431|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
20343432|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343433|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343434|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832239|NCT04504331|Tamoxifen|tamoxifen|mesh-list
19832240|NCT04504331|Infigratinib|infigratinib|mesh-list
19832241|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19832242|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
19832243|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19832244|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832245|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19832246|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343435|NCT00836823|Urological Agents|urological agents|mesh-ancestor
20343436|NCT00836849|Sertraline|sertraline|mesh-list
20343437|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
20343438|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343439|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20343440|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20343441|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343442|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343443|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343444|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
20343445|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343446|NCT00836914|Idelalisib|idelalisib|mesh-list
20343447|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343448|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343449|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343450|NCT00837044|Naproxen|naproxen|mesh-list
20343451|NCT00837044|Sumatriptan|sumatriptan|mesh-list
20343452|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20343453|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20343454|NCT00837044|Analgesics|analgesics|mesh-ancestor
20343455|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
19258093|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258094|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258095|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258096|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258097|NCT00535405|Atorvastatin|atorvastatin|mesh-list
19258098|NCT00535405|Simvastatin|simvastatin|mesh-list
19258099|NCT00535405|Ezetimibe|ezetimibe|mesh-list
19258100|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258101|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258102|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
19258103|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343456|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343457|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612075|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20343458|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20343459|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20343460|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
20343461|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20343462|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343463|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343464|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20343465|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20343466|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20343467|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
20343468|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343469|NCT00837135|Vaccines|vaccines|mesh-list
20343470|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
20343471|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343472|NCT00837174|Bortezomib|bortezomib|mesh-list
20343473|NCT00837174|Vorinostat|vorinostat|mesh-list
20343474|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343475|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20343476|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348389|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20343477|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343478|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
20343479|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20343480|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343481|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343482|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20343483|NCT00837187|Analgesics|analgesics|mesh-ancestor
20343484|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
20343485|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343486|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20343487|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20170930|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170931|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20170932|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20170933|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170934|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
20170935|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
20170936|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170937|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170938|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20170939|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20170940|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20170941|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
20343488|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20343489|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
20343490|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170942|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170943|NCT00152646|Clopidogrel|clopidogrel|mesh-list
20170944|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20343491|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343492|NCT00837239|Gemcitabine|gemcitabine|mesh-list
20343493|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20343494|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
20343495|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343496|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343497|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
20343498|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343499|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343500|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343501|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
20343502|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343503|NCT00837317|Phenol|phenol|mesh-list
19832247|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19832248|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19832249|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19832250|NCT04497298|Vaccines|vaccines|mesh-list
19832251|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
19832252|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832253|NCT04483102|Liver Extracts|liver extracts|mesh-list
19832254|NCT04483102|Hematinics|hematinics|mesh-ancestor
19832255|NCT04482244|Cannabidiol|cannabidiol|mesh-list
19832256|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
19832257|NCT04459715|Cisplatin|cisplatin|mesh-list
19832258|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832259|NCT04459117|Acetaminophen|acetaminophen|mesh-list
19832260|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19832261|NCT04459117|Analgesics|analgesics|mesh-ancestor
19832262|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
20170945|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20170946|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20170947|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20170948|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
20170949|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170950|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170951|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170952|NCT00152698|Irbesartan|irbesartan|mesh-list
20170953|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170954|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20343504|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20343505|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832263|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832264|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170955|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20170956|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174885|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174886|NCT00166127|Protective Agents|protective agents|mesh-ancestor
20174887|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174888|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
20174889|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20174890|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174891|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20174892|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
20174893|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174894|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174895|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174896|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174897|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
19654967|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654968|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19654969|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19654970|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19654971|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19654972|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19654973|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20174898|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20174899|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174900|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20174901|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
20174902|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174903|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612076|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
19654974|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19654975|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
20170957|NCT00152724|Aspirin|aspirin|mesh-list
20170958|NCT00152724|Celecoxib|celecoxib|mesh-list
20170959|NCT00152724|Indomethacin|indomethacin|mesh-list
20170960|NCT00152724|Nitroprusside|nitroprusside|mesh-list
20170961|NCT00152724|Acetylcholine|acetylcholine|mesh-list
20170962|NCT00152724|Capsaicin|capsaicin|mesh-list
20170963|NCT00152724|Clopidogrel|clopidogrel|mesh-list
20170964|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20170965|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20170966|NCT00152724|Analgesics|analgesics|mesh-ancestor
20170967|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
20170968|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170969|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20170970|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20170971|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20170972|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19654976|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
19654977|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
19654978|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
20170973|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20343506|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
20343507|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20343508|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20343509|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20343510|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
20170974|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20170975|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20170976|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20170977|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20170978|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
20343511|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343512|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20343513|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20343514|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343515|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343516|NCT00837369|Regadenoson|regadenoson|mesh-list
20343517|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20343518|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20343519|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
20343520|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
20343521|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343522|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343523|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343524|NCT00837564|Citalopram|citalopram|mesh-list
20343525|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20343526|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20343527|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19258104|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258105|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258106|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258107|NCT00496730|Atorvastatin|atorvastatin|mesh-list
19258108|NCT00496730|Simvastatin|simvastatin|mesh-list
19258109|NCT00496730|Ezetimibe|ezetimibe|mesh-list
19258110|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258111|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258112|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
19258113|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258114|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258115|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258116|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258117|NCT00462748|Atorvastatin|atorvastatin|mesh-list
19258118|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19258119|NCT00462748|Simvastatin|simvastatin|mesh-list
20170979|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20170980|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20170981|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20170982|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
20170983|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20170984|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20170985|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
20170986|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
20170987|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
20170988|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
20170989|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20170990|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20170991|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
20170992|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20170993|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19258120|NCT00462748|Ezetimibe|ezetimibe|mesh-list
20348390|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832265|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
19832266|NCT04457557|Ropivacaine|ropivacaine|mesh-list
20170994|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
20170995|NCT00152750|Clonidine|clonidine|mesh-list
20343528|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343529|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343530|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
20170996|NCT00152750|Analgesics|analgesics|mesh-ancestor
20170997|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
20170998|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20170999|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171000|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171001|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
20171002|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
20171003|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20343531|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343532|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20343533|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
19832267|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
19832268|NCT04457557|Anesthetics|anesthetics|mesh-list
20171004|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19654979|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19654980|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654981|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
19654982|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19654983|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19654984|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19654985|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19654986|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19654987|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19654988|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
20343534|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343535|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
20343536|NCT00837655|Calcium|calcium|mesh-list
19832269|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343537|NCT00837655|Sevelamer|sevelamer|mesh-list
20343538|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20343539|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343540|NCT00837655|Antacids|antacids|mesh-ancestor
20343541|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343542|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20343543|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
20343544|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
20343545|NCT00837707|Aripiprazole|aripiprazole|mesh-list
20343546|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
20343547|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343548|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20343549|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20343550|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343551|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171005|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20171006|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
20171007|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171008|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171009|NCT00152802|Vaccines|vaccines|mesh-list
20343552|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
20343553|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
20343554|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343555|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258121|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258122|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20171010|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
20171011|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171012|NCT00152815|Vitamin E|vitamin e|mesh-list
20171013|NCT00152815|Antioxidants|antioxidants|mesh-list
20171014|NCT00152815|Vitamins|vitamins|mesh-ancestor
20171015|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
20171016|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171017|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171018|NCT00152815|Protective Agents|protective agents|mesh-ancestor
20171019|NCT00152828|Celecoxib|celecoxib|mesh-list
20171020|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20171021|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171022|NCT00152828|Analgesics|analgesics|mesh-ancestor
20343556|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20343557|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20343558|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
20343559|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20343560|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20343561|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20343562|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20343563|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
20343564|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20343565|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343566|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348391|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19654989|NCT05392127|Coagulants|coagulants|mesh-ancestor
19654990|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19654991|NCT05392101|Deferasirox|deferasirox|mesh-list
19654992|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19654993|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
19654994|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
19654995|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19654996|NCT05392075|Vaccines|vaccines|mesh-list
19654997|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
19654998|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19654999|NCT05391971|Bupivacaine|bupivacaine|mesh-list
19655000|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
19655001|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
19655002|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655003|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655004|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
19655005|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655006|NCT05391958|Anesthetics|anesthetics|mesh-list
19655007|NCT05391958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655008|NCT05391958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655009|NCT05391893|Diltiazem|diltiazem|mesh-list
19655010|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19655011|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19655012|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19665521|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20343567|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19655013|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655014|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19655015|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655016|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
19655017|NCT05391867|Sorafenib|sorafenib|mesh-list
19655018|NCT05391867|Lenvatinib|lenvatinib|mesh-list
19655019|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655020|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20348392|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
20343568|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343569|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20343570|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20343571|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
20343572|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343573|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
20343574|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343575|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
20343576|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
20343577|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
19655021|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655022|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655023|NCT05391828|Cimetidine|cimetidine|mesh-list
19655024|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19655025|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19655026|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19655027|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
19655028|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
19655029|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343578|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19832270|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832271|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
20171023|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
20343579|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
20343580|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
20343581|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343582|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343583|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343584|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19655030|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655031|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655032|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19655033|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19655034|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655035|NCT05391789|Urinastatin|urinastatin|mesh-list
20171024|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171025|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171026|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171027|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171028|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20171029|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171030|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171031|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171032|NCT00152841|Vitamin E|vitamin e|mesh-list
20171033|NCT00152841|Vitamins|vitamins|mesh-ancestor
20171034|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
20171035|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171036|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
20171037|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171038|NCT00152841|Protective Agents|protective agents|mesh-ancestor
20171039|NCT00152854|Acetaminophen|acetaminophen|mesh-list
20171040|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171041|NCT00152854|Analgesics|analgesics|mesh-ancestor
20171042|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
19655036|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20343585|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20171043|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171044|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171045|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
20171046|NCT00152867|Dexamethasone|dexamethasone|mesh-list
20171047|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171048|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
20171049|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
20171050|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171051|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343586|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
20343587|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20343588|NCT00837850|Protective Agents|protective agents|mesh-ancestor
20343589|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343590|NCT00837889|Diuretics|diuretics|mesh-list
20343591|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
20343592|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343593|NCT00837915|Loratadine|loratadine|mesh-list
20343594|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
20343595|NCT00837915|Ephedrine|ephedrine|mesh-list
20343596|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
20343597|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
20171052|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171053|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
20171054|NCT00152867|Hormones|hormones|mesh-ancestor
20171055|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20171056|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20171057|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343598|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20343599|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20343600|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20343601|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
20343602|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
20343603|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343604|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343605|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343606|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20343607|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
20343608|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343609|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20343610|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
20343611|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
20343612|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20343613|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20343614|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
20343615|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
20343616|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20343617|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20343618|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
20343619|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343620|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343621|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
20343622|NCT00837941|Promethazine|promethazine|mesh-list
20343623|NCT00837941|Pregabalin|pregabalin|mesh-list
19258123|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
19258124|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258125|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258126|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258127|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258128|NCT00446186|Montelukast|montelukast|mesh-list
19258129|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258130|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258131|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258132|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258133|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258134|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258135|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258136|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258137|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258138|NCT00445107|Montelukast|montelukast|mesh-list
19258139|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258140|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258141|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258142|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258143|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258144|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343624|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20343625|NCT00837941|Analgesics|analgesics|mesh-ancestor
20343626|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
20171058|NCT00152893|Chromium|chromium|mesh-list
20171059|NCT00152893|Niacin|niacin|mesh-list
20171060|NCT00152893|Trace Elements|trace elements|mesh-ancestor
20171061|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
20171062|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171063|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20171064|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
20171065|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171066|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20171067|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
20171068|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
20171069|NCT00152893|Vitamins|vitamins|mesh-ancestor
20171070|NCT00152919|Meloxicam|meloxicam|mesh-list
20343627|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258145|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258146|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20171071|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20171072|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20343628|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343629|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
20343630|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20343631|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343632|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343633|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20343634|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20343635|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20343636|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343637|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343638|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20343639|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20343640|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343641|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
20343642|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
20343643|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20343644|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20343645|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
20343646|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
20343647|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
20343648|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
20343649|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171073|NCT00152919|Analgesics|analgesics|mesh-ancestor
20343650|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20343651|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
20343652|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
20343653|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20343654|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
20343655|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
20343656|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
20343657|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
20343658|NCT00837954|Coagulants|coagulants|mesh-ancestor
20343659|NCT00838032|Haloperidol|haloperidol|mesh-list
20343660|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20343661|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
20343662|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
20343663|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343664|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20343665|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20343666|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343667|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343668|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
20343669|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
20343670|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343671|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20343672|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20343673|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
20343674|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343675|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343676|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20343677|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
20343678|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20343679|NCT00838071|Antibodies|antibodies|mesh-list
20343680|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
20343681|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343682|NCT00838214|Prednisone|prednisone|mesh-list
20343683|NCT00838214|Budesonide|budesonide|mesh-list
20343684|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20343685|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
19655037|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20343686|NCT00838214|Hormones|hormones|mesh-ancestor
20343687|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20343688|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343689|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20343690|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343691|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20343692|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
20343693|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343694|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20343695|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
20343696|NCT00838227|Modafinil|modafinil|mesh-list
20343697|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20343698|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343699|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20343700|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20343701|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20343702|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343703|NCT00838240|Cytarabine|cytarabine|mesh-list
20343704|NCT00838240|Clofarabine|clofarabine|mesh-list
20343705|NCT00838240|Idarubicin|idarubicin|mesh-list
20343706|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20343707|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
20343708|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343709|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343710|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
20343711|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343712|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343713|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
20343714|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343715|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20343716|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20343717|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20343718|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343719|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
20343720|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20343721|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343722|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
20343723|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343724|NCT00838266|Protective Agents|protective agents|mesh-ancestor
20343725|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343726|NCT00838305|Citalopram|citalopram|mesh-list
20343727|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20343728|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20343729|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343730|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655038|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
19655039|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655040|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343731|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343732|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
20343733|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343734|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20343735|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
20343736|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343737|NCT00838357|Plerixafor|plerixafor|mesh-list
20343738|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20343739|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19655041|NCT05391750|Venetoclax|venetoclax|mesh-list
19655042|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
19655043|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
20343740|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
20343741|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171074|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
20171075|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171076|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171077|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171078|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171079|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20171080|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171081|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171082|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171083|NCT00152932|Dorzolamide|dorzolamide|mesh-list
20171084|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171085|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20171086|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171087|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171088|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20171089|NCT00152945|Glycerol|glycerol|mesh-list
19832272|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832273|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19832274|NCT04417569|Estradiol|estradiol|mesh-list
19832275|NCT04417569|Progesterone|progesterone|mesh-list
19832276|NCT04417569|Hormones|hormones|mesh-ancestor
19832277|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19832278|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832279|NCT04417569|Estrogens|estrogens|mesh-ancestor
19832280|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19832281|NCT04417569|Progestins|progestins|mesh-ancestor
19832282|NCT04411680|Sargramostim|sargramostim|mesh-list
19832283|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
19832284|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832285|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19832286|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
19832287|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
19655044|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
19655045|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655046|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655047|NCT05391724|Brincidofovir|brincidofovir|mesh-list
19655048|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
19655049|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19655050|NCT05391555|Remifentanil|remifentanil|mesh-list
19655051|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19655052|NCT05391555|Narcotics|narcotics|mesh-ancestor
19655053|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655054|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655055|NCT05391555|Analgesics|analgesics|mesh-ancestor
19655056|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
19655057|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655058|NCT05391451|Anesthetics|anesthetics|mesh-list
20343742|NCT00838370|Fluorouracil|fluorouracil|mesh-list
20343743|NCT00838370|Capecitabine|capecitabine|mesh-list
20343744|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
20343745|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832288|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19832289|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
19832290|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832291|NCT04405908|Antacids|antacids|mesh-ancestor
19655059|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655060|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171090|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20171091|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20171092|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20171093|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20171094|NCT00152945|Protective Agents|protective agents|mesh-ancestor
19832292|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832293|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20343746|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832294|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20171095|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171096|NCT00152958|Pramipexole|pramipexole|mesh-list
20343747|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258147|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258148|NCT00418834|Atorvastatin|atorvastatin|mesh-list
19258149|NCT00418834|Ezetimibe|ezetimibe|mesh-list
19258150|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258151|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258152|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
19258153|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258154|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258155|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258156|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258157|NCT00409773|Atorvastatin|atorvastatin|mesh-list
19258158|NCT00409773|Simvastatin|simvastatin|mesh-list
19258159|NCT00409773|Ezetimibe|ezetimibe|mesh-list
19258160|NCT00409773|Calcium|calcium|mesh-list
19258161|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19258162|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258163|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258164|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258165|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
19258166|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258167|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258168|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258169|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258170|NCT00398151|Montelukast|montelukast|mesh-list
19258171|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258172|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258173|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258174|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258175|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258176|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258177|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258178|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258179|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258180|NCT00394160|Montelukast|montelukast|mesh-list
19258181|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258182|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258183|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258184|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258185|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258186|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258187|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258188|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258189|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258190|NCT00380705|Montelukast|montelukast|mesh-list
19258191|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20343748|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343749|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
20343750|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343751|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
20343752|NCT00838396|Baclofen|baclofen|mesh-list
20343753|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19258192|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258193|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258194|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
20171097|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
20343754|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343755|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20343756|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171098|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171099|NCT00152958|Protective Agents|protective agents|mesh-ancestor
20171100|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171101|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20171102|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20171103|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
20171104|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
20171105|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171106|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
20171107|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20171108|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
20171109|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343757|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20343758|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
20343759|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
20343760|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343761|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348393|NCT00864344|Sertraline|sertraline|mesh-list
20348394|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348395|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348396|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20348397|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348398|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348399|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348400|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348401|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
20348402|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348403|NCT00864357|Ibuprofen|ibuprofen|mesh-list
20348404|NCT00864357|Oxycodone|oxycodone|mesh-list
20348405|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20348406|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20348407|NCT00864357|Analgesics|analgesics|mesh-ancestor
20348408|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
20348409|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348410|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348411|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348412|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348413|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20348414|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348415|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348416|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20348417|NCT00864357|Narcotics|narcotics|mesh-ancestor
20171110|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259241|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20171111|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20171112|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
20171113|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
19832295|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19832296|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19832297|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171114|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20171115|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
20171116|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171117|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171118|NCT00152997|Pramipexole|pramipexole|mesh-list
19832298|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
19832299|NCT04363437|Colchicine|colchicine|mesh-list
19832300|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
19832301|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832302|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
19832303|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
19832304|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
19832305|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832306|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832307|NCT04362839|Nivolumab|nivolumab|mesh-list
19832308|NCT04362839|Ipilimumab|ipilimumab|mesh-list
19832309|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20171119|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
20171120|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171121|NCT00152997|Protective Agents|protective agents|mesh-ancestor
20171122|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171123|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20171124|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20171125|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
20171126|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
20171127|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171128|NCT00153023|Valsartan|valsartan|mesh-list
20343762|NCT00838656|Gemcitabine|gemcitabine|mesh-list
20343763|NCT00838656|Paclitaxel|paclitaxel|mesh-list
20343764|NCT00838656|Carboplatin|carboplatin|mesh-list
20343765|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20343766|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258195|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258196|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258197|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258198|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258199|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258200|NCT00276484|Atorvastatin|atorvastatin|mesh-list
19258201|NCT00276484|Ezetimibe|ezetimibe|mesh-list
19258202|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258203|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258204|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
19258205|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171129|NCT00153023|Telmisartan|telmisartan|mesh-list
20171130|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19258206|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258207|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258208|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258209|NCT00276458|Atorvastatin|atorvastatin|mesh-list
19258210|NCT00276458|Ezetimibe|ezetimibe|mesh-list
19258211|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20171131|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171132|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19258212|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20171133|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171134|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20171135|NCT00153049|Telmisartan|telmisartan|mesh-list
20343767|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
20343768|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
20343769|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
20343770|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343771|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20343772|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
20343773|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
20343774|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343775|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343776|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343777|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
20343778|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343779|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20343780|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20343781|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20343782|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343783|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343784|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343785|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20343786|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20343787|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
20343788|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343789|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343790|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20343791|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20343792|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
20343793|NCT00838760|Darunavir|darunavir|mesh-list
20343794|NCT00838760|TMC-310911|tmc-310911|mesh-list
20343795|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20343796|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20343797|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
20171136|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20171137|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171138|NCT00153049|Diuretics|diuretics|mesh-ancestor
20171139|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
20171140|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171141|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20171142|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20171143|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174904|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174905|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832310|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171144|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171145|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20171146|NCT00153075|Fenoterol|fenoterol|mesh-list
20171147|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20171148|NCT00153075|Ipratropium|ipratropium|mesh-list
20171149|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20171150|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
20171151|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343798|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343799|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343800|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20343801|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20343802|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
20343803|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343804|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
20343805|NCT00838838|Testosterone|testosterone|mesh-list
20343806|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
20171152|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171153|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20171154|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
20171155|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
20171156|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
20171157|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20171158|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20171159|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20171160|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20171161|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
20171162|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171163|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171164|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20171165|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
20171166|NCT00153088|Telmisartan|telmisartan|mesh-list
20171167|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171168|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171169|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20171170|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171171|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20171172|NCT00153114|Laxatives|laxatives|mesh-ancestor
20171173|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171174|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20171175|NCT00153127|Laxatives|laxatives|mesh-ancestor
20343807|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
20171176|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612077|NCT02249546|Protective Agents|protective agents|mesh-ancestor
20343808|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20343809|NCT00838838|Androgens|androgens|mesh-ancestor
20343810|NCT00838838|Hormones|hormones|mesh-ancestor
20343811|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20343812|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343813|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20343814|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343815|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
20343816|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
20343817|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20343818|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171177|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20171178|NCT00153140|Laxatives|laxatives|mesh-ancestor
20171179|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171180|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20171181|NCT00153153|Laxatives|laxatives|mesh-ancestor
20171182|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171183|NCT00153192|Dronabinol|dronabinol|mesh-list
20171184|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
20171185|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171186|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20171187|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171188|NCT00153192|Analgesics|analgesics|mesh-ancestor
20171189|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
20171190|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171191|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20171192|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20343819|NCT00838955|Sirolimus|sirolimus|mesh-list
20343820|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20343821|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343822|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20343823|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343824|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
20343825|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20343826|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
20343827|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343828|NCT00838968|Interferons|interferons|mesh-list
20343829|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
20343830|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343831|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
20343832|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343833|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
20343834|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343835|NCT00839059|Lenalidomide|lenalidomide|mesh-list
20343836|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
20343837|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343838|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20343839|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20343840|NCT00839059|Growth Substances|growth substances|mesh-ancestor
20343841|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
20343842|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343843|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
19258213|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
20343844|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
20343845|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
20343846|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343847|NCT00839085|Protective Agents|protective agents|mesh-ancestor
20343848|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171193|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171194|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171195|NCT00153192|Hormones|hormones|mesh-ancestor
20171196|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20171197|NCT00153244|Lamotrigine|lamotrigine|mesh-list
20171198|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
20171199|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20171200|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20174906|NCT00166400|Metoprolol|metoprolol|mesh-list
20174907|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20174908|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20174909|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
20174910|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
19655095|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19655096|NCT05387811|Diuretics|diuretics|mesh-list
19655097|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
19655098|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655099|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
19655100|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19655101|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19655102|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655103|NCT05386784|Vitamins|vitamins|mesh-ancestor
19655104|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
19655105|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19655106|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19655107|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
19665522|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19665523|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
19665524|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19665525|NCT04940013|Misoprostol|misoprostol|mesh-list
19665526|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19665527|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
19665528|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19665529|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19665530|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19665531|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19258214|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258215|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258216|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258217|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258218|NCT00271817|Niacin|niacin|mesh-list
19258219|NCT00271817|Niacinamide|niacinamide|mesh-list
19258220|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
19258221|NCT00271817|Simvastatin|simvastatin|mesh-list
20343849|NCT00839085|Vitamins|vitamins|mesh-ancestor
20343850|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
20343851|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20343852|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343853|NCT00839111|Irinotecan|irinotecan|mesh-list
20343854|NCT00839111|Sorafenib|sorafenib|mesh-list
20343855|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20343856|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20343857|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343858|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343859|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20343860|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20343861|NCT00839163|Vitamin K|vitamin k|mesh-list
20343862|NCT00839163|Enoxaparin|enoxaparin|mesh-list
19258222|NCT00271817|Ezetimibe|ezetimibe|mesh-list
19258223|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19258224|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258225|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258226|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
19258227|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258228|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258229|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19258230|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258231|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
19258232|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
19258233|NCT00271817|Vitamins|vitamins|mesh-ancestor
19258234|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
19258235|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258236|NCT00157937|Theophylline|theophylline|mesh-list
19258237|NCT00157937|Montelukast|montelukast|mesh-list
20343863|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
20343864|NCT00839163|Vitamins|vitamins|mesh-ancestor
20343865|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
20343866|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258238|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343867|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19832311|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20343868|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
20343869|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20343870|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
20343871|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343872|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343873|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
20171201|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171202|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20171203|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171204|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20171205|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20171206|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20171207|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20171208|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20171209|NCT00153270|Valproic Acid|valproic acid|mesh-list
20343874|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20343875|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20343876|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20171210|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
20343877|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
20171211|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171212|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171213|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
20171214|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171215|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171216|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
20171217|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20171218|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343878|NCT00839163|Coagulants|coagulants|mesh-ancestor
20343879|NCT00839228|Perhexiline|perhexiline|mesh-list
20343880|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20343881|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343882|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343883|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20343884|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343885|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
20343886|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
20343887|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
20343888|NCT00839280|Vitamins|vitamins|mesh-ancestor
20343889|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
20171219|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20171220|NCT00153283|Gabapentin|gabapentin|mesh-list
20171221|NCT00153283|Analgesics|analgesics|mesh-ancestor
20171222|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
20171223|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171224|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171225|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
20343890|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343891|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
19655108|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655109|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19655110|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20171226|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20171227|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20171228|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343892|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19259242|NCT05173246|Cisplatin|cisplatin|mesh-list
20343893|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20343894|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
20343895|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343896|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20343897|NCT00839345|Clopidogrel|clopidogrel|mesh-list
20343898|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20343899|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20171229|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20171230|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20171231|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19655111|NCT05386524|Bevacizumab|bevacizumab|mesh-list
19655112|NCT05386524|Doxorubicin|doxorubicin|mesh-list
19655113|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19655114|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19655115|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655116|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20171232|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343900|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20343901|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20343902|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
20343903|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343904|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343905|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343906|NCT00839358|Midodrine|midodrine|mesh-list
20343907|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
20343908|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
20343909|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343910|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343911|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20343912|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20343913|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20343914|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20343915|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
20343916|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343917|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343918|NCT00839371|Midazolam|midazolam|mesh-list
20343919|NCT00839371|Propofol|propofol|mesh-list
20343920|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20343921|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343922|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343923|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20343924|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
20343925|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
20343926|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20343927|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20343928|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20343929|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343930|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
20343931|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
20343932|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343933|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171233|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171234|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
20171235|NCT00153296|Carbamazepine|carbamazepine|mesh-list
20171236|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
20171237|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
20171238|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20171239|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20171240|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343934|NCT00839397|Paroxetine|paroxetine|mesh-list
20343935|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20171241|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19655117|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20171242|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20343936|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20171243|NCT00153296|Analgesics|analgesics|mesh-ancestor
20171244|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
20171245|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171246|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20171247|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20171248|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171249|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20171250|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20171251|NCT00153491|Lumefantrine|lumefantrine|mesh-list
20343937|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20343938|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343939|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343940|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
20343941|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343942|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20343943|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
20343944|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20343945|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20343946|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20343947|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343948|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20343949|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20343950|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20343951|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
20343952|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
20343953|NCT00839462|Vitamins|vitamins|mesh-ancestor
20343954|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
20343955|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343956|NCT00839488|Pantoprazole|pantoprazole|mesh-list
20343957|NCT00839488|Famotidine|famotidine|mesh-list
20343958|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20343959|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171252|NCT00153491|Artemether|artemether|mesh-list
20343960|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20343961|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343962|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343963|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20171253|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20171254|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
19655118|NCT05386524|Growth Substances|growth substances|mesh-ancestor
19655119|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655120|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
19655121|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19655122|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19655123|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19655124|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20343964|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
20343965|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
20343966|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343967|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343968|NCT00839501|Acetazolamide|acetazolamide|mesh-list
20343969|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
20343970|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20343971|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259243|NCT05173246|Carboplatin|carboplatin|mesh-list
20343972|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343973|NCT00839501|Diuretics|diuretics|mesh-ancestor
20343974|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
20343975|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343976|NCT00839553|Minocycline|minocycline|mesh-list
20343977|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20343978|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20343979|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
20343980|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20343981|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20343982|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20343983|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20343984|NCT00839605|Analgesics|analgesics|mesh-ancestor
20343985|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
20343986|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20343987|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20343988|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20343989|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20343990|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
20343991|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20343992|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20343993|NCT00839657|Warfarin|warfarin|mesh-list
20343994|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
20343995|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
20171255|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20171256|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20171257|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171258|NCT00153517|Metronidazole|metronidazole|mesh-list
20171259|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171260|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20171261|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20171262|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20171263|NCT00153530|Methotrexate|methotrexate|mesh-list
20171264|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20171265|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
20171266|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20171267|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171268|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171269|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
20171270|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171271|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171272|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
20171273|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171274|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20171275|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171276|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
20171277|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20343996|NCT00839683|Valsartan|valsartan|mesh-list
20343997|NCT00839683|Simvastatin|simvastatin|mesh-list
19258239|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258240|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258241|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
19258242|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258243|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258244|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258245|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258246|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258247|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258248|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20171278|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20171279|NCT00153543|Vaccines|vaccines|mesh-list
20171280|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20171281|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
20171282|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171283|NCT00153556|Vaccines|vaccines|mesh-list
20171284|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
20171285|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171286|NCT00153634|Azithromycin|azithromycin|mesh-list
20171287|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
19258249|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258250|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19655125|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655126|NCT05385562|Triamcinolone|triamcinolone|mesh-list
20171288|NCT00153634|Meropenem|meropenem|mesh-list
19258251|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20171289|NCT00153634|Tazobactam|tazobactam|mesh-list
20343998|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20343999|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20344000|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
20344001|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344002|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20344003|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20344004|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344005|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20344006|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20344007|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20344008|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20344009|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20171290|NCT00153634|Piperacillin|piperacillin|mesh-list
19258252|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258253|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
19258254|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20171291|NCT00153634|Tobramycin|tobramycin|mesh-list
20171292|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
20171293|NCT00153634|Amikacin|amikacin|mesh-list
20344010|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344011|NCT00839761|Iron|iron|mesh-list
20344012|NCT00839761|Trace Elements|trace elements|mesh-ancestor
20344013|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
20344014|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344015|NCT00839787|Morphine|morphine|mesh-list
20344016|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20344017|NCT00839787|Narcotics|narcotics|mesh-ancestor
20612078|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612079|NCT02249546|Antidotes|antidotes|mesh-ancestor
20612080|NCT02249663|Fluticasone|fluticasone|mesh-list
20344018|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612081|NCT02249663|Xhance|xhance|mesh-list
20612082|NCT02249663|Azelastine|azelastine|mesh-list
19655127|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19655128|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19655129|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
19655130|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19655131|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19655132|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
19655133|NCT05385562|Hormones|hormones|mesh-ancestor
19655134|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655135|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612083|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612084|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20612085|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
20612086|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655136|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19655137|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
19655138|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655139|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655140|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19655141|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
19655142|NCT05385562|Protective Agents|protective agents|mesh-ancestor
19655143|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
19655144|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655145|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20171294|NCT00153634|Ceftazidime|ceftazidime|mesh-list
20171295|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20171296|NCT00153634|Ticarcillin|ticarcillin|mesh-list
20171297|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
20171298|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20171299|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171300|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20171301|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20171302|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171303|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171304|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171305|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20171306|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20171307|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20171308|NCT00153660|Celecoxib|celecoxib|mesh-list
20171309|NCT00153660|Naproxen|naproxen|mesh-list
20171310|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20171311|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19655146|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171312|NCT00153660|Analgesics|analgesics|mesh-ancestor
20171313|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
20344019|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344020|NCT00839787|Analgesics|analgesics|mesh-ancestor
20344021|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
20344022|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344023|NCT00839826|Enoxaparin|enoxaparin|mesh-list
20344024|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
20344025|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20344026|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
20344027|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20344028|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
20344029|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344030|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344031|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
20344032|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20612087|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258255|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19258256|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
19258257|NCT00127647|Montelukast|montelukast|mesh-list
19258258|NCT00127647|Pranlukast|pranlukast|mesh-list
19258259|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258260|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258261|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258262|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258263|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258264|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258265|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258266|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258267|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258268|NCT00092989|Montelukast|montelukast|mesh-list
19258269|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258270|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258271|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258272|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258273|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258274|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258275|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258276|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258277|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258278|NCT00092144|Montelukast|montelukast|mesh-list
19258279|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258280|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258281|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258282|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258283|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19258284|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
20344033|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20344034|NCT00840112|Vitamin E|vitamin e|mesh-list
20344035|NCT00840112|Tocopherols|tocopherols|mesh-list
20344036|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
20344037|NCT00840112|Vitamins|vitamins|mesh-ancestor
19258285|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258286|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19258287|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19258288|NCT03754153|Atropine|atropine|mesh-list
19258289|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19258290|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19258291|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19258292|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
19258293|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258294|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258295|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258296|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
19258297|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
19655147|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655148|NCT05385263|Nivolumab|nivolumab|mesh-list
19665532|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
20344038|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
20344039|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655149|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19655150|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655151|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19655152|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655153|NCT05384665|Sufentanil|sufentanil|mesh-list
19655154|NCT05384665|Remifentanil|remifentanil|mesh-list
19655155|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19655156|NCT05384665|Narcotics|narcotics|mesh-ancestor
19655157|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655158|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655159|NCT05384665|Analgesics|analgesics|mesh-ancestor
19655160|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
20171314|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171315|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171316|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171317|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171318|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20171319|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171320|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171321|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171322|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
20171323|NCT00153673|Celecoxib|celecoxib|mesh-list
20171324|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20344040|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
20344041|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344042|NCT00840112|Protective Agents|protective agents|mesh-ancestor
20344043|NCT00840125|Docetaxel|docetaxel|mesh-list
20344044|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20344045|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655161|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655162|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19655163|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19655164|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
19655165|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
19655166|NCT05383482|Paclitaxel|paclitaxel|mesh-list
20344046|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19655167|NCT05383482|Docetaxel|docetaxel|mesh-list
19655168|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19655169|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171325|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171326|NCT00153673|Analgesics|analgesics|mesh-ancestor
20171327|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
20171328|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655170|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
19655171|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171329|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171330|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19655172|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
19655173|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171331|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171332|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20171333|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171334|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171335|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344047|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
20344048|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
20344049|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344050|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20344051|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344052|NCT00840229|Triamcinolone|triamcinolone|mesh-list
20344053|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20344054|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20344055|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20171336|NCT00153699|Topiramate|topiramate|mesh-list
20171337|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
20171338|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20171339|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171340|NCT00153725|Aspirin|aspirin|mesh-list
20171341|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20171342|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171343|NCT00153725|Analgesics|analgesics|mesh-ancestor
20171344|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
20171345|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344056|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344057|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
20344058|NCT00840229|Hormones|hormones|mesh-ancestor
20344059|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344060|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344061|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344062|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
20344063|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344064|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344065|NCT00840242|Nicotine|nicotine|mesh-list
20344066|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20344067|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
20344068|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258298|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
19258299|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19258300|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19258301|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
19258302|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258303|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258304|NCT03753074|Tenofovir|tenofovir|mesh-list
19258305|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
20171346|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171347|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171348|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171349|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20171350|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20171351|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171352|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20344069|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344070|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20344071|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20344072|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
20344073|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344074|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344075|NCT00840333|Levofloxacin|levofloxacin|mesh-list
20344076|NCT00840333|Ofloxacin|ofloxacin|mesh-list
20344077|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20344078|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344079|NCT00840333|Renal Agents|renal agents|mesh-ancestor
20344080|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20344081|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20344082|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20344083|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344084|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344085|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344086|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20344087|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20344088|NCT00840346|Panobinostat|panobinostat|mesh-list
20344089|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344090|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20344091|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344092|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344093|NCT00840385|Vidarabine|vidarabine|mesh-list
20344094|NCT00840385|Fludarabine|fludarabine|mesh-list
20344095|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
20344096|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344097|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171353|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171354|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171355|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
20171356|NCT00153764|Vitamins|vitamins|mesh-list
20171357|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
20171358|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171359|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
20171360|NCT00153868|Hematinics|hematinics|mesh-ancestor
20171361|NCT00153881|Carboplatin|carboplatin|mesh-list
20171362|NCT00153881|Docetaxel|docetaxel|mesh-list
20171363|NCT00153881|Capecitabine|capecitabine|mesh-list
20171364|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171365|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171366|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171367|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
20344098|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
20344099|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344100|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344101|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
20344102|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344103|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
20344104|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344105|NCT00840398|Buspirone|buspirone|mesh-list
20344106|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20344107|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20612088|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20171368|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344108|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20344109|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344110|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20344111|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20344112|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
20344113|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344114|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348418|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348419|NCT00864396|Lansoprazole|lansoprazole|mesh-list
19655174|NCT05372588|Vaccines|vaccines|mesh-list
19655175|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
19655176|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171369|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171370|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
20171371|NCT00153907|Capecitabine|capecitabine|mesh-list
20171372|NCT00153907|Vinorelbine|vinorelbine|mesh-list
20171373|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171374|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
20171375|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171376|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171377|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19655186|NCT05367401|Azacitidine|azacitidine|mesh-list
19655187|NCT05367401|Magrolimab|magrolimab|mesh-list
19655188|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19655189|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
19655190|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655191|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655192|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655193|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19655194|NCT05366166|Cisplatin|cisplatin|mesh-list
19655195|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
19655196|NCT05366166|Olaparib|olaparib|mesh-list
20171378|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
20344115|NCT00840489|Ribavirin|ribavirin|mesh-list
20344116|NCT00840489|Colchicine|colchicine|mesh-list
20344117|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
20344118|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344119|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
20344120|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344121|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
20344122|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344123|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
20344124|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171379|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171380|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171381|NCT00153933|Lenalidomide|lenalidomide|mesh-list
19655197|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655198|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19655199|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19655200|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655201|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655202|NCT05362058|Insulin|insulin|mesh-list
19655203|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19655204|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344125|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
20344126|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344127|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
20344128|NCT00840580|Levofloxacin|levofloxacin|mesh-list
20344129|NCT00840580|Ofloxacin|ofloxacin|mesh-list
20344130|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20344131|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20344132|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20344133|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20344134|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344135|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20344136|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20344137|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171382|NCT00153933|Bortezomib|bortezomib|mesh-list
20171383|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
20171384|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171385|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20171386|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20171387|NCT00153933|Growth Substances|growth substances|mesh-ancestor
20171388|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
20171389|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171390|NCT00153946|Edaravone|edaravone|mesh-list
20171391|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20171392|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
20171393|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171394|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20171395|NCT00153946|Protective Agents|protective agents|mesh-ancestor
20344138|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171396|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171397|NCT00153972|Levodopa|levodopa|mesh-list
20171398|NCT00153972|Cabergoline|cabergoline|mesh-list
20171399|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20344139|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344140|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20344141|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
20344142|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344143|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344144|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20344145|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19258306|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258307|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20171400|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20171401|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
20171402|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171403|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171404|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171405|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
20171406|NCT00153998|Leucovorin|leucovorin|mesh-list
20171407|NCT00153998|Folic Acid|folic acid|mesh-list
20171408|NCT00153998|Fluorouracil|fluorouracil|mesh-list
20171409|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
20171410|NCT00153998|Irinotecan|irinotecan|mesh-list
20171411|NCT00153998|Cetuximab|cetuximab|mesh-list
20171412|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
20344146|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19258308|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19258309|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258310|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258311|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19258312|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19258313|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
19258314|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19258315|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
19258316|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19258317|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
19258318|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258319|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258320|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
19258321|NCT03731923|Liver Extracts|liver extracts|mesh-list
19258322|NCT03731923|Hematinics|hematinics|mesh-ancestor
19258323|NCT03727633|Idarubicin|idarubicin|mesh-list
19258324|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
19258325|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19258326|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258327|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19258328|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19258329|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171413|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
20171414|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344147|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20344148|NCT00840580|Renal Agents|renal agents|mesh-ancestor
20344149|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20344150|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20344151|NCT00840606|Buspirone|buspirone|mesh-list
20344152|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20344153|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20344154|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20344155|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344156|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20344157|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20344158|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
20344159|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344160|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344161|NCT00840645|Mirabegron|mirabegron|mesh-list
20344162|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20344163|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20344164|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20344165|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
20344166|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344167|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171415|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171416|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171417|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171418|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
20171419|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171420|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20171421|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20171422|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171423|NCT00153998|Antidotes|antidotes|mesh-ancestor
20171424|NCT00153998|Protective Agents|protective agents|mesh-ancestor
20171425|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
20344168|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171426|NCT00153998|Vitamins|vitamins|mesh-ancestor
20344169|NCT00840645|Urological Agents|urological agents|mesh-ancestor
20344170|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
20344171|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20344172|NCT00840671|Protective Agents|protective agents|mesh-ancestor
20344173|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344174|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
20344175|NCT00840684|Cytarabine|cytarabine|mesh-list
20344176|NCT00840684|Melphalan|melphalan|mesh-list
20344177|NCT00840684|Busulfan|busulfan|mesh-list
20344178|NCT00840684|Daunorubicin|daunorubicin|mesh-list
20344179|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
20171427|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
20171428|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20171429|NCT00153998|Hematinics|hematinics|mesh-ancestor
19655225|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19655226|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19655227|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171430|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
20171431|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20171432|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171433|NCT00154024|Irbesartan|irbesartan|mesh-list
20171434|NCT00154024|Atorvastatin|atorvastatin|mesh-list
20171435|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20344180|NCT00840684|Amsacrine|amsacrine|mesh-list
20171436|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20344181|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171437|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
20344182|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
20348420|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20171438|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171439|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20171440|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20171441|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171442|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171443|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171444|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20171445|NCT00154037|Pioglitazone|pioglitazone|mesh-list
20171446|NCT00154037|Candesartan|candesartan|mesh-list
20171447|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344183|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344184|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344185|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
20344186|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344187|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344188|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
19655246|NCT05349448|Triamcinolone|triamcinolone|mesh-list
19655247|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20171448|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171449|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171450|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171451|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20171452|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171453|NCT00154050|Candesartan|candesartan|mesh-list
20171454|NCT00154050|Quinapril|quinapril|mesh-list
20171455|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171456|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171457|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19655248|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19655249|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
20344189|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344190|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20344191|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
20344192|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20344193|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20344194|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20344195|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20344196|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344197|NCT00840684|Analgesics|analgesics|mesh-ancestor
20344198|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
20344199|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344200|NCT00840801|Vaccines|vaccines|mesh-list
19258330|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258331|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
19258332|NCT03713593|Lenvatinib|lenvatinib|mesh-list
19258333|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258334|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258335|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19258336|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258337|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258338|NCT03713086|Vaccines|vaccines|mesh-list
19258339|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
19258340|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258341|NCT03699540|Ethanol|ethanol|mesh-list
19258342|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19655250|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19655251|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19258343|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258344|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19258345|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258346|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
19258347|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19258348|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
19258349|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258350|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
19258351|NCT03697876|Protective Agents|protective agents|mesh-ancestor
19258352|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
19258353|NCT03690765|Progestins|progestins|mesh-ancestor
19258354|NCT03690765|Hormones|hormones|mesh-ancestor
19258355|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258356|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258357|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
19258358|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258359|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
19258360|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19258361|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19258362|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258363|NCT03686813|Urological Agents|urological agents|mesh-ancestor
19258364|NCT03679624|Daratumumab|daratumumab|mesh-list
19258365|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258366|NCT03658304|Mitomycins|mitomycins|mesh-list
19258367|NCT03658304|Mitomycin|mitomycin|mesh-list
19258368|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19258369|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258370|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
19258371|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258372|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19258373|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258374|NCT03642028|Suvorexant|suvorexant|mesh-list
19258375|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19258376|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19258377|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19258378|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258379|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19258380|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655252|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655253|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655254|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19655255|NCT05349448|Analgesics|analgesics|mesh-ancestor
19655256|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
19655257|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655258|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20171458|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344201|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
20344202|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344203|NCT00840853|Acetaminophen|acetaminophen|mesh-list
20344204|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
20344205|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20344206|NCT00840853|Analgesics|analgesics|mesh-ancestor
20344207|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
20344208|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344209|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344210|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
20344211|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19655259|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20171459|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20171460|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
20171461|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171462|NCT00154076|Topiramate|topiramate|mesh-list
20171463|NCT00154076|Zonisamide|zonisamide|mesh-list
20171464|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
20171465|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20171466|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171467|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20171468|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20344212|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20344213|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20344214|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
20344215|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
20344216|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
20171469|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171470|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20171471|NCT00154089|Masoprocol|masoprocol|mesh-list
20171472|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
20171473|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171474|NCT00154089|Protective Agents|protective agents|mesh-ancestor
20171475|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171476|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20171477|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171478|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171479|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20171480|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171481|NCT00154089|Analgesics|analgesics|mesh-ancestor
19655260|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19655261|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
19655262|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171482|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
20344217|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
19832312|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832313|NCT04333459|Vaccines|vaccines|mesh-list
19832314|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
19832315|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832316|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19832317|NCT04304274|Morphine|morphine|mesh-list
19832318|NCT04304274|Ropivacaine|ropivacaine|mesh-list
19832319|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19832320|NCT04304274|Narcotics|narcotics|mesh-ancestor
19832321|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832322|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832323|NCT04304274|Analgesics|analgesics|mesh-ancestor
19832324|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
19832325|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832326|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
19832327|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
19832328|NCT04298853|Morphine|morphine|mesh-list
19832329|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19655263|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655264|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19655265|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
19655266|NCT05349448|Hormones|hormones|mesh-ancestor
19655267|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655268|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19655269|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
19655270|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655271|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
19655272|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655273|NCT05339386|Xenon|xenon|mesh-list
19655274|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19655275|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
19655276|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
19655277|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20171483|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171484|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344218|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19258381|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259244|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19655278|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655279|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
19655280|NCT05338931|Gossypol|gossypol|mesh-list
19655281|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20171485|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171486|NCT00154115|Simendan|simendan|mesh-list
20171487|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20171488|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
20171489|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20171490|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19655282|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259245|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171491|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171492|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171493|NCT00154115|Protective Agents|protective agents|mesh-ancestor
20171494|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171495|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
20171496|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171497|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
20171498|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
20171499|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
20171500|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20171501|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
20171502|NCT00154141|Coagulants|coagulants|mesh-ancestor
20171503|NCT00154167|Phentolamine|phentolamine|mesh-list
20171504|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20171505|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20171506|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
20171507|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171508|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171509|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171510|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171511|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20171512|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20171513|NCT00154180|Estradiol|estradiol|mesh-list
20171514|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20171515|NCT00154180|Estrogens|estrogens|mesh-list
20171516|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20171517|NCT00154180|Progesterone|progesterone|mesh-list
20171518|NCT00154180|Hormones|hormones|mesh-ancestor
19655283|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19655284|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
19655285|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19655286|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655287|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19655288|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19655289|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20171519|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20171520|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171521|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20171522|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
20171523|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19655295|NCT05327595|Midazolam|midazolam|mesh-list
19655296|NCT05327595|Atorvastatin|atorvastatin|mesh-list
19655297|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19655298|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19655299|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
19655300|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344219|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20171524|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20171525|NCT00154180|Progestins|progestins|mesh-ancestor
20174911|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174912|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174913|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20174914|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20174915|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20344220|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
20344221|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
20344222|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344223|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344224|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20174916|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
20174917|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174918|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174919|NCT00166413|Thalidomide|thalidomide|mesh-list
20174920|NCT00166413|Lenalidomide|lenalidomide|mesh-list
20174921|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174922|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
20174923|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174924|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
20174925|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20174926|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20174927|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20174928|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20174929|NCT00166413|Growth Substances|growth substances|mesh-ancestor
20174930|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832330|NCT04298853|Narcotics|narcotics|mesh-ancestor
19832331|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832332|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832333|NCT04298853|Analgesics|analgesics|mesh-ancestor
19832334|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
19832335|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832336|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19832337|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
19832338|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344225|NCT00840918|Lidocaine|lidocaine|mesh-list
20344226|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
20171526|NCT00154193|Cyclosporine|cyclosporine|mesh-list
20171527|NCT00154193|Cyclosporins|cyclosporins|mesh-list
20171528|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171529|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171530|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171531|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
20171532|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344227|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
20344228|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20344229|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344230|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
19258382|NCT03636451|Lidocaine|lidocaine|mesh-list
19258383|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
19258384|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
20171533|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
20171534|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171535|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
19258385|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19258386|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258387|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
19258388|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655301|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19655302|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19655303|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655304|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20171536|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171537|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20171538|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
20171539|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20171540|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171541|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20344231|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171542|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
20171543|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20171544|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171545|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171546|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171547|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
20171548|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19655305|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20344232|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20344233|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20344234|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20344235|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20344236|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655306|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655307|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655308|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19655309|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19655310|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19655311|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19655312|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
19655313|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
19655314|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
19655315|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
19655316|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171549|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171550|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171551|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171552|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20171553|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171554|NCT00154219|Analgesics|analgesics|mesh-ancestor
20171555|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
20171556|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171557|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171558|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171559|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171560|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
20171561|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20171562|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171563|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20171564|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
20344237|NCT00840931|Lenalidomide|lenalidomide|mesh-list
20171565|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20171566|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171567|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171568|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171569|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
20171570|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20171571|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171572|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20171573|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
20344238|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
20344239|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344240|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20344241|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20344242|NCT00840931|Growth Substances|growth substances|mesh-ancestor
20344243|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
19258389|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19259246|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171574|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20171575|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171576|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171577|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171578|NCT00154258|Clozapine|clozapine|mesh-list
20171579|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20171580|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
20171581|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171582|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171583|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171584|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20171585|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19832339|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
19832340|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832341|NCT04233567|Infigratinib|infigratinib|mesh-list
19832342|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171586|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20171587|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20171588|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
20171589|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
20171590|NCT00154271|Valsartan|valsartan|mesh-list
20171591|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19655338|NCT05325502|Mannitol|mannitol|mesh-list
20344244|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344245|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20344246|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344247|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
20344248|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20344249|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
20344250|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344251|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20344252|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20344253|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344254|NCT00840957|Infliximab|infliximab|mesh-list
20344255|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
20344256|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20344257|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344258|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
20344259|NCT00841061|Trace Elements|trace elements|mesh-ancestor
19655339|NCT05325502|Caffeine|caffeine|mesh-list
19832343|NCT04224740|Cisplatin|cisplatin|mesh-list
20344260|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
19832344|NCT04224740|Carboplatin|carboplatin|mesh-list
19832345|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
19655340|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19655341|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655342|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19655343|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655344|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655345|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19655346|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19655347|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
20344261|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344262|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
20344263|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20344264|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20344265|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344266|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
19259247|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
19832346|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344267|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
20171592|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171593|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20171594|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171595|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
20171596|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
20171597|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20171598|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20344268|NCT00841113|Goserelin|goserelin|mesh-list
20344269|NCT00841113|Bicalutamide|bicalutamide|mesh-list
20344270|NCT00841113|Abarelix|abarelix|mesh-list
20344271|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20344272|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344273|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
20344274|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
20344275|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344276|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344277|NCT00841126|Iron|iron|mesh-list
20344278|NCT00841126|Trace Elements|trace elements|mesh-ancestor
20344279|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
20344280|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344281|NCT00841139|Perhexiline|perhexiline|mesh-list
20344282|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20344283|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20344284|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344285|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20344286|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344287|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
20344288|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20344289|NCT00841191|Siltuximab|siltuximab|mesh-list
20344290|NCT00841191|Antibodies|antibodies|mesh-list
20344291|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
20344292|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20344293|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
20344294|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344295|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344296|NCT00841256|Glycerol|glycerol|mesh-list
20344297|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20344298|NCT00841256|Protective Agents|protective agents|mesh-ancestor
20344299|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344300|NCT00841373|Ranibizumab|ranibizumab|mesh-list
20344301|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20344302|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20344303|NCT00841373|Growth Substances|growth substances|mesh-ancestor
20344304|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344305|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
20344306|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344307|NCT00841386|Riboflavin|riboflavin|mesh-list
20344308|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
20344309|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
20344310|NCT00841386|Vitamins|vitamins|mesh-ancestor
20344311|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
20344312|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344313|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20344314|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
20344315|NCT00841438|Abciximab|abciximab|mesh-list
20344316|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
20344317|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20344318|NCT00841477|Vaccines|vaccines|mesh-list
20344319|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
19832347|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20344320|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344321|NCT00841581|Ranibizumab|ranibizumab|mesh-list
20344322|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20344323|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20344324|NCT00841581|Growth Substances|growth substances|mesh-ancestor
20344325|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655348|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655349|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19655350|NCT05325502|Diuretics|diuretics|mesh-ancestor
19655351|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
20344326|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
20344327|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344328|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
20344329|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
19832348|NCT04220684|Cytarabine|cytarabine|mesh-list
20344330|NCT00841633|Norepinephrine|norepinephrine|mesh-list
20344331|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20344332|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20344333|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
20344334|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344335|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832349|NCT04220684|Fludarabine|fludarabine|mesh-list
19832350|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832351|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832352|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
20344336|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344337|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
20344338|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
20344339|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344340|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20344341|NCT00841724|Fludarabine|fludarabine|mesh-list
19655352|NCT05318157|Emedastine|emedastine|mesh-list
19655353|NCT05318157|Budesonide|budesonide|mesh-list
20344342|NCT00841724|Busulfan|busulfan|mesh-list
20344343|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
20344344|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344345|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344346|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344347|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
20344348|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344349|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
20344350|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20344351|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20344352|NCT00841789|Etanercept|etanercept|mesh-list
20344353|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20344354|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20344355|NCT00841789|Analgesics|analgesics|mesh-ancestor
20344356|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
20344357|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344358|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344359|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344360|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344361|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20344362|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344363|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
20344364|NCT00841802|Prednisone|prednisone|mesh-list
19655354|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19655355|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19655356|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19655357|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19655358|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
19655359|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655360|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655361|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19655362|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
20344365|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
20344366|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832353|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832354|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19832355|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
19832356|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832357|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
19832358|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832359|NCT04159974|Durvalumab|durvalumab|mesh-list
19832360|NCT04159974|Tremelimumab|tremelimumab|mesh-list
19832361|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19832362|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832363|NCT04157725|Clomiphene|clomiphene|mesh-list
19832364|NCT04157725|Enclomiphene|enclomiphene|mesh-list
19832365|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
19832366|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19832367|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
19832368|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19832369|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832370|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19832371|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
20344367|NCT00841802|Hormones|hormones|mesh-ancestor
20344368|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344369|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344370|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20344371|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344372|NCT00841841|Acetaminophen|acetaminophen|mesh-list
20344373|NCT00841841|Dipyrone|dipyrone|mesh-list
20344374|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20344375|NCT00841841|Analgesics|analgesics|mesh-ancestor
20344376|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
19832372|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19832373|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19832374|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20171599|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19655363|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
19655364|NCT05318157|Hormones|hormones|mesh-ancestor
19655365|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655366|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19655367|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
19655368|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
19655369|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344377|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258390|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19258391|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19258392|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19258393|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258394|NCT03629340|Metformin|metformin|mesh-list
19258395|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19258396|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171600|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655370|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344378|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344379|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
20344380|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20344381|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344382|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344383|NCT00841854|Metronidazole|metronidazole|mesh-list
20344384|NCT00841854|Tetracycline|tetracycline|mesh-list
20344385|NCT00841854|Pantoprazole|pantoprazole|mesh-list
20344386|NCT00841854|Bismuth|bismuth|mesh-list
20344387|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344388|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20344389|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20344390|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20344391|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20344392|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20344393|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20344394|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344395|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344396|NCT00841854|Antacids|antacids|mesh-ancestor
20344397|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20344398|NCT00841880|Felodipine|felodipine|mesh-list
20344399|NCT00841880|Ramipril|ramipril|mesh-list
20344400|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20344401|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
20344402|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344403|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344404|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20344405|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20344406|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20344407|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20344408|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20344409|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344410|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
20344411|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
20344412|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
20344413|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344414|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20344415|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344416|NCT00841919|Insulin|insulin|mesh-list
20344417|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20344418|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
20344419|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
20344420|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
20344421|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
19832375|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
19832376|NCT04142502|Propofol|propofol|mesh-list
19832377|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20344422|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
20344423|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344424|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344425|NCT00841945|Prednisone|prednisone|mesh-list
20344426|NCT00841945|Rituximab|rituximab|mesh-list
20344427|NCT00841945|Doxorubicin|doxorubicin|mesh-list
20344428|NCT00841945|Vincristine|vincristine|mesh-list
20344429|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20344430|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344431|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
20344432|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344433|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344434|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20344435|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20344436|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20344437|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344438|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344439|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344440|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
20344441|NCT00841945|Hormones|hormones|mesh-ancestor
20344442|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344443|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20344444|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20344445|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
20344446|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
20344447|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
20344448|NCT00842114|Interferons|interferons|mesh-list
20344449|NCT00842114|Prednisone|prednisone|mesh-list
20344450|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
20344451|NCT00842114|Vincristine|vincristine|mesh-list
20344452|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344453|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
20344454|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344455|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344456|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20344457|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
20344458|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344459|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344460|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20344461|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344462|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
20344463|NCT00842114|Hormones|hormones|mesh-ancestor
20344464|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344465|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20344466|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
20344467|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344468|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20344469|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
20344470|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
20344471|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
20344472|NCT00842127|Methylphenidate|methylphenidate|mesh-list
20344473|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20344474|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344475|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20344476|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20171601|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20171602|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20171603|NCT00154336|Methotrexate|methotrexate|mesh-list
20171604|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
20171605|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20171606|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
20171607|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20171608|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171609|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171610|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
20171611|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171612|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171613|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
20171614|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171615|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20171616|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259248|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
20344477|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20344478|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344479|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
20344480|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344481|NCT00842140|Metformin|metformin|mesh-list
20344482|NCT00842140|Spironolactone|spironolactone|mesh-list
20344483|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
20344484|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
20344485|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344486|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344487|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344488|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20344489|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
20344490|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344491|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20344492|NCT00842140|Diuretics|diuretics|mesh-ancestor
20344493|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
20171617|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
20171618|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171619|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20171620|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20171621|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
20171622|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171623|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20171624|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344494|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20171625|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344495|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
20344496|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344497|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344498|NCT00842205|Interferons|interferons|mesh-list
20344499|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344500|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
20344501|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348421|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20348422|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20348423|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348424|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348425|NCT00864409|Ropivacaine|ropivacaine|mesh-list
20348426|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
20348427|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
20348428|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348429|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348430|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
20348431|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348432|NCT00864435|Carvedilol|carvedilol|mesh-list
20348433|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20348434|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20348435|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
20348436|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348437|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348438|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348439|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348440|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
20348441|NCT00864435|Protective Agents|protective agents|mesh-ancestor
20348442|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20348443|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348444|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20348445|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
20348446|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20348447|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20344502|NCT00842400|Metformin|metformin|mesh-list
20344503|NCT00842400|Probenecid|probenecid|mesh-list
20344504|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344505|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344506|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
19655371|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19655372|NCT05314998|Leucovorin|leucovorin|mesh-list
19655373|NCT05314998|Folic Acid|folic acid|mesh-list
19655374|NCT05314998|Gemcitabine|gemcitabine|mesh-list
19655375|NCT05314998|Fluorouracil|fluorouracil|mesh-list
20344507|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
20344508|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344509|NCT00842400|Renal Agents|renal agents|mesh-ancestor
20344510|NCT00842452|Topotecan|topotecan|mesh-list
20344511|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20344512|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19655376|NCT05314998|Capecitabine|capecitabine|mesh-list
19655377|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
19655378|NCT05314998|Irinotecan|irinotecan|mesh-list
19655379|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
19655380|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20344513|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344514|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344515|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344516|NCT00842491|Cisplatin|cisplatin|mesh-list
20344517|NCT00842491|Capecitabine|capecitabine|mesh-list
20344518|NCT00842491|Endostar protein|endostar protein|mesh-list
20344519|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344520|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20344521|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
20344522|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655381|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
19655382|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655383|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655384|NCT05314998|Antiviral Agents|antiviral agents|mesh-ancestor
19655385|NCT05314998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19655386|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655387|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171626|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
20171627|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
20171628|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20171629|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20171630|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20171631|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171632|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20171633|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20171634|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
20171635|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171636|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20171637|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171638|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171639|NCT00154401|Liraglutide|liraglutide|mesh-list
20171640|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20171641|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171642|NCT00154401|Incretins|incretins|mesh-ancestor
20171643|NCT00154401|Hormones|hormones|mesh-ancestor
20171644|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655388|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
19655389|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655390|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20171645|NCT00154414|Liraglutide|liraglutide|mesh-list
20344523|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20344524|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20344525|NCT00842491|Growth Substances|growth substances|mesh-ancestor
20344526|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344527|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832378|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832379|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832380|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19832381|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
19832382|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
19832383|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171646|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344528|NCT00842504|Micafungin|micafungin|mesh-list
20344529|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
20171647|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171648|NCT00154414|Incretins|incretins|mesh-ancestor
20171649|NCT00154414|Hormones|hormones|mesh-ancestor
20171650|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20171651|NCT00154440|Amoxicillin|amoxicillin|mesh-list
20171652|NCT00154440|Metronidazole|metronidazole|mesh-list
20171653|NCT00154440|Clarithromycin|clarithromycin|mesh-list
20171654|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20171655|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19258413|NCT03622775|Daratumumab|daratumumab|mesh-list
19258414|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258415|NCT03618134|Durvalumab|durvalumab|mesh-list
19258416|NCT03618134|Ipilimumab|ipilimumab|mesh-list
19258417|NCT03618134|Tremelimumab|tremelimumab|mesh-list
19258418|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
19258419|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19258420|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
19258421|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258422|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258423|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
19258424|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258425|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19258426|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258427|NCT03603509|Vaccines|vaccines|mesh-list
19258428|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
19258429|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258430|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
19258431|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
19258432|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
19258433|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
19258434|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19258435|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258436|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20171656|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171657|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20171658|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20171659|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19655391|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19655392|NCT05314998|Antidotes|antidotes|mesh-ancestor
19258437|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19258438|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258439|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258440|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19258441|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19258442|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258443|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
19258444|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258445|NCT03570619|Nivolumab|nivolumab|mesh-list
19258446|NCT03570619|Ipilimumab|ipilimumab|mesh-list
19258447|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258448|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258449|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19258450|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258451|NCT03565783|Cemiplimab|cemiplimab|mesh-list
19258452|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258453|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258454|NCT03493126|Estradiol|estradiol|mesh-list
19258455|NCT03493126|Estrogens|estrogens|mesh-ancestor
19258456|NCT03493126|Hormones|hormones|mesh-ancestor
19258457|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258458|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655393|NCT05314998|Protective Agents|protective agents|mesh-ancestor
19258459|NCT03483012|Atezolizumab|atezolizumab|mesh-list
19258460|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258461|NCT03474029|Rifampin|rifampin|mesh-list
20171660|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344530|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171661|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171662|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20171663|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19655394|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
20344531|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20344532|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
20344533|NCT00842556|Glimepiride|glimepiride|mesh-list
19655395|NCT05314998|Vitamins|vitamins|mesh-ancestor
19655396|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
19655397|NCT05314998|Hematinics|hematinics|mesh-ancestor
19655398|NCT05291325|Linaclotide|linaclotide|mesh-list
19655399|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19655400|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
19655401|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655402|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171664|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
20171665|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20171666|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171667|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171668|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20171669|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20171670|NCT00154661|Protective Agents|protective agents|mesh-ancestor
20171671|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171672|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
20171673|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20171674|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
20171675|NCT00154687|Paclitaxel|paclitaxel|mesh-list
20344534|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344535|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344536|NCT00842556|Incretins|incretins|mesh-ancestor
20344537|NCT00842556|Hormones|hormones|mesh-ancestor
20344538|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344539|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20344540|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
20344541|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344542|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344543|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20344544|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20171676|NCT00154687|Fluorouracil|fluorouracil|mesh-list
20171677|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20171678|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171679|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171680|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171681|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171682|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171683|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
20171684|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171685|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171686|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
20171687|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171688|NCT00154700|Folic Acid|folic acid|mesh-list
20171689|NCT00154700|Paclitaxel|paclitaxel|mesh-list
20171690|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20344545|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171691|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171692|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171693|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171694|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171695|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171696|NCT00154700|Hematinics|hematinics|mesh-ancestor
20171697|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
20171698|NCT00154700|Vitamins|vitamins|mesh-ancestor
20171699|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
20171700|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171701|NCT00154726|Paclitaxel|paclitaxel|mesh-list
20171702|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20171703|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171704|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171705|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171706|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171707|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171708|NCT00154739|Gemcitabine|gemcitabine|mesh-list
20171709|NCT00154739|Epirubicin|epirubicin|mesh-list
20171710|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171711|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171712|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
20171713|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655441|NCT05275205|Aflibercept|aflibercept|mesh-list
19655442|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19655443|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20171714|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
20171715|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171716|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171717|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171718|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
19655444|NCT05275205|Growth Substances|growth substances|mesh-ancestor
19655445|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655446|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
19655447|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171719|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171720|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20171721|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20171722|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20171723|NCT00154778|Leucovorin|leucovorin|mesh-list
19655448|NCT05272384|Nivolumab|nivolumab|mesh-list
19655449|NCT05272384|Decitabine|decitabine|mesh-list
20171724|NCT00154778|Antidotes|antidotes|mesh-ancestor
20171725|NCT00154778|Protective Agents|protective agents|mesh-ancestor
19655450|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19655451|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655452|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19655453|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832384|NCT04142502|Analgesics|analgesics|mesh-ancestor
19832385|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
20171726|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655454|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19655455|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
19655456|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655457|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
19655458|NCT05268497|Esketamine|esketamine|mesh-list
19655459|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19832386|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171727|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
20171728|NCT00154778|Vitamins|vitamins|mesh-ancestor
20171729|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
20171730|NCT00154791|Gemcitabine|gemcitabine|mesh-list
20171731|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
20171732|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171733|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
20171734|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171735|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171736|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
20171737|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171738|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171739|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171740|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
20171741|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171742|NCT00154804|Paclitaxel|paclitaxel|mesh-list
20344546|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
20344547|NCT00842582|Azacitidine|azacitidine|mesh-list
20344548|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20344549|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
20344550|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344551|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344552|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344553|NCT00842595|Prednisone|prednisone|mesh-list
20344554|NCT00842595|Rituximab|rituximab|mesh-list
20344555|NCT00842595|Vinorelbine|vinorelbine|mesh-list
20344556|NCT00842595|Ifosfamide|ifosfamide|mesh-list
20344557|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
20344558|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20344559|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344560|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
20344561|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344562|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344563|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344564|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
20344565|NCT00842595|Hormones|hormones|mesh-ancestor
20344566|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344567|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20348448|NCT00864448|Ramipril|ramipril|mesh-list
20344568|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20344569|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
20344570|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
20344571|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
20344572|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344573|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20344574|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
20344575|NCT00842595|Analgesics|analgesics|mesh-ancestor
20344576|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
20344577|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344578|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20344579|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19655460|NCT05254639|Donepezil|donepezil|mesh-list
19655461|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19655462|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655463|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344580|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344581|NCT00842660|Gemcitabine|gemcitabine|mesh-list
20344582|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20344583|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
20344584|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344585|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344586|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
20344587|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344588|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344589|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344590|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
20344591|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344592|NCT00842686|Bevacizumab|bevacizumab|mesh-list
20344593|NCT00842686|Capecitabine|capecitabine|mesh-list
20344594|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20344595|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344596|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20344597|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20344598|NCT00842686|Growth Substances|growth substances|mesh-ancestor
20344599|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344600|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
20344601|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20344602|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
20344603|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344604|NCT00842894|Insulin|insulin|mesh-list
20344605|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20344606|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
20344607|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
20344608|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
20344609|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20344610|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344611|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344612|NCT00842907|Tretinoin|tretinoin|mesh-list
20344613|NCT00842907|Isotretinoin|isotretinoin|mesh-list
20344614|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344615|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
20344616|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
20344617|NCT00842920|Simvastatin|simvastatin|mesh-list
20344618|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20344619|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20344620|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
20344621|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344622|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20344623|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20344624|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344625|NCT00842933|Prednisone|prednisone|mesh-list
20344626|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
20344627|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
20344628|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20344629|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20344630|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20344631|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344632|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
20344633|NCT00842933|Hormones|hormones|mesh-ancestor
20344634|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20171743|NCT00154804|Cisplatin|cisplatin|mesh-list
20171744|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20171745|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171746|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171747|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171748|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171749|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171750|NCT00154843|Lycopene|lycopene|mesh-list
20171751|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171752|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
20171753|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171754|NCT00154843|Protective Agents|protective agents|mesh-ancestor
20171755|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171756|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20171757|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20171758|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171759|NCT00154869|Ribavirin|ribavirin|mesh-list
20171760|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20171761|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
20171762|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171763|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
20344635|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344636|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20344637|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344638|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
20344639|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
20344640|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344641|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20344642|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20344643|NCT00842933|Protective Agents|protective agents|mesh-ancestor
20344644|NCT00842998|Trastuzumab|trastuzumab|mesh-list
20344645|NCT00842998|Lapatinib|lapatinib|mesh-list
20344646|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20344647|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344648|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20344649|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258462|NCT03474029|Rifapentine|rifapentine|mesh-list
19258463|NCT03474029|Isoniazid|isoniazid|mesh-list
19258464|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19258465|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
19258466|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19258467|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258468|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
19258469|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19258470|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258471|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258472|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19258473|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20344650|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344651|NCT00843063|Pantoprazole|pantoprazole|mesh-list
20344652|NCT00843063|Famotidine|famotidine|mesh-list
20344653|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20344654|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20344655|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20344656|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344657|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258474|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19655464|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
20171764|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832387|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19832388|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19832389|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20344658|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20344659|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
20344660|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
20344661|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344662|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344663|NCT00843154|Candesartan|candesartan|mesh-list
20344664|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20344665|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20344666|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20344667|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344668|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20344669|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20344670|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
20344671|NCT00843362|Dinoprostone|dinoprostone|mesh-list
20344672|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
20344673|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344674|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344675|NCT00843440|Bevacizumab|bevacizumab|mesh-list
20344676|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20344677|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832390|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
20344678|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20344679|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20344680|NCT00843440|Growth Substances|growth substances|mesh-ancestor
19832391|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832392|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832393|NCT04118166|Nivolumab|nivolumab|mesh-list
19832394|NCT04118166|Ipilimumab|ipilimumab|mesh-list
19832395|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19832396|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171765|NCT00154882|Paclitaxel|paclitaxel|mesh-list
20171766|NCT00154882|Cisplatin|cisplatin|mesh-list
20171767|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20171768|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832397|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19258475|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19258476|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19258477|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19258478|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19258479|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19258480|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
19258481|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19258482|NCT03467789|Vitamin D|vitamin d|mesh-list
19258483|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
19258484|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
19258485|NCT03467789|Vitamins|vitamins|mesh-list
19258486|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
19258487|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258488|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19258489|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19258490|NCT03460015|Propofol|propofol|mesh-list
19258491|NCT03460015|Sevoflurane|sevoflurane|mesh-list
19258492|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19258493|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19258494|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832398|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832399|NCT04117581|Vitamin D|vitamin d|mesh-list
19832400|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
19832401|NCT04117581|Vitamins|vitamins|mesh-ancestor
19832402|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
19832403|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832404|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19832405|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19832406|NCT04066725|Aspirin|aspirin|mesh-list
19832407|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19832408|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171769|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171770|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171771|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171772|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258495|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19258496|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
19258497|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
19258498|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20171773|NCT00154895|Minocycline|minocycline|mesh-list
20171774|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20171775|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19655465|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655466|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655467|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
20344681|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344682|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
20344683|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
20344684|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
20344685|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
20344686|NCT00843453|Vitamins|vitamins|mesh-ancestor
20344687|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
20344688|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344689|NCT00843453|Hematinics|hematinics|mesh-ancestor
19655468|NCT05252533|Ustekinumab|ustekinumab|mesh-list
19655469|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
19655470|NCT05243563|Clobetasol|clobetasol|mesh-list
19655471|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19655472|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
19655473|NCT05243563|Hormones|hormones|mesh-ancestor
19655474|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655475|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655476|NCT05231122|Bevacizumab|bevacizumab|mesh-list
19655477|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19655478|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
19655479|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
19655480|NCT05231122|Antibodies|antibodies|mesh-list
19655481|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
19655482|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19655483|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
20171776|NCT00155064|Losartan|losartan|mesh-list
20171777|NCT00155064|Captopril|captopril|mesh-list
20171778|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20171779|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171780|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20171781|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20171782|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171783|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20171784|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
20171785|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171786|NCT00155233|Morphine|morphine|mesh-list
20171787|NCT00155233|Nalbuphine|nalbuphine|mesh-list
19655484|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655485|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20171788|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20344690|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20344691|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20344692|NCT00843570|Nafarelin|nafarelin|mesh-list
20344693|NCT00843570|Estradiol|estradiol|mesh-list
20344694|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20344695|NCT00843570|Progesterone|progesterone|mesh-list
20344696|NCT00843570|Estrogens|estrogens|mesh-ancestor
20344697|NCT00843570|Hormones|hormones|mesh-ancestor
19655486|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19655487|NCT05231122|Growth Substances|growth substances|mesh-ancestor
19655488|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655489|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
19655490|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
19832409|NCT04066725|Analgesics|analgesics|mesh-ancestor
19832410|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
19832411|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171789|NCT00155233|Narcotics|narcotics|mesh-ancestor
20344698|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655491|NCT05223829|Brexanolone|brexanolone|mesh-list
19655492|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
20344699|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655493|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655494|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344700|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20344701|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
20344702|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344703|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20344704|NCT00843570|Progestins|progestins|mesh-ancestor
20344705|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20344706|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
20344707|NCT00843661|Ezetimibe|ezetimibe|mesh-list
20344708|NCT00843661|Pravastatin|pravastatin|mesh-list
20344709|NCT00843661|Fenofibrate|fenofibrate|mesh-list
20344710|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20344711|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20344712|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
20344713|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344714|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20344715|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20344716|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344717|NCT00843791|Pioglitazone|pioglitazone|mesh-list
20344718|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19655495|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655496|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
19655497|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
19655498|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
19655499|NCT05217446|Cetuximab|cetuximab|mesh-list
19655500|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19655501|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171790|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20171791|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171792|NCT00155233|Analgesics|analgesics|mesh-ancestor
20171793|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
20171794|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171795|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
20171796|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20171797|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171798|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171799|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20171800|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20171801|NCT00155246|Protective Agents|protective agents|mesh-ancestor
20171802|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171803|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
20171804|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20171805|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
20171806|NCT00155259|Docetaxel|docetaxel|mesh-list
20171807|NCT00155259|Capecitabine|capecitabine|mesh-list
20171808|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171809|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171810|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171811|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171812|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171813|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171814|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
20171815|NCT00155272|Thalidomide|thalidomide|mesh-list
20171816|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171817|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
20171818|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171819|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
20171820|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20171821|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171822|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20171823|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20171824|NCT00155272|Growth Substances|growth substances|mesh-ancestor
20171825|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
20171826|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171827|NCT00155350|Pioglitazone|pioglitazone|mesh-list
20171828|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20171829|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171830|NCT00155376|Morphine|morphine|mesh-list
20171831|NCT00155376|Glucagon|glucagon|mesh-list
20171832|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20171833|NCT00155376|Narcotics|narcotics|mesh-ancestor
20344719|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20344720|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344721|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20344722|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
20344723|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344724|NCT00843908|Imidacloprid|imidacloprid|mesh-list
20344725|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
20344726|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344727|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344728|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344729|NCT00843934|Epirubicin|epirubicin|mesh-list
20344730|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344731|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20171834|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20171835|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171836|NCT00155376|Analgesics|analgesics|mesh-ancestor
20171837|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
20171838|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171839|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171840|NCT00155376|Hormones|hormones|mesh-ancestor
20171841|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344732|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19258499|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19258500|NCT03459859|Cytarabine|cytarabine|mesh-list
19258501|NCT03459859|Pevonedistat|pevonedistat|mesh-list
19258502|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19258503|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
19258504|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258505|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258506|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
20344733|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20344734|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344735|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344736|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20344737|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20344738|NCT00844012|Estradiol|estradiol|mesh-list
20344739|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20344740|NCT00844012|Estrogens|estrogens|mesh-ancestor
20344741|NCT00844012|Hormones|hormones|mesh-ancestor
20344742|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344743|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344744|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20344745|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
20344746|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344747|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20344748|NCT00844064|Trabedersen|trabedersen|mesh-list
20344749|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258507|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258508|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19258509|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
19258510|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258511|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258512|NCT03452865|Esomeprazole|esomeprazole|mesh-list
19258513|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19258514|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19258515|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19258516|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258517|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258518|NCT03452839|Meropenem|meropenem|mesh-list
19258519|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19258520|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258521|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
19258522|NCT03401710|Hematinics|hematinics|mesh-ancestor
19258523|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19258524|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19258525|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258526|NCT03358563|Docetaxel|docetaxel|mesh-list
19258527|NCT03358563|Bicalutamide|bicalutamide|mesh-list
19258528|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19258529|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258530|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
20344750|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
20344751|NCT00844142|Etanercept|etanercept|mesh-list
20344752|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20344753|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20344754|NCT00844142|Analgesics|analgesics|mesh-ancestor
20344755|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
20344756|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344757|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344758|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344759|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344760|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20344761|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344762|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
20344763|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344764|NCT00844155|Oseltamivir|oseltamivir|mesh-list
20344765|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
20344766|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344767|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344768|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344769|NCT00844168|Sorafenib|sorafenib|mesh-list
20344770|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344771|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20344772|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344773|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348449|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20171842|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20171843|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
20171844|NCT00155402|Coagulants|coagulants|mesh-ancestor
20171845|NCT00155558|Leucovorin|leucovorin|mesh-list
20171846|NCT00155558|Fluorouracil|fluorouracil|mesh-list
20171847|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
20171848|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171849|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171850|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171851|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171852|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
20171853|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171854|NCT00155558|Antidotes|antidotes|mesh-ancestor
20171855|NCT00155558|Protective Agents|protective agents|mesh-ancestor
20171856|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
20171857|NCT00155558|Vitamins|vitamins|mesh-ancestor
20171858|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
20174931|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174932|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
20174933|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174934|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20174935|NCT00166426|Protective Agents|protective agents|mesh-ancestor
20174936|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174937|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20174938|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174939|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171859|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
20171860|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
20171861|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
19655522|NCT05208983|Vaccines|vaccines|mesh-list
20171862|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20171863|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171864|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171865|NCT00155714|Urological Agents|urological agents|mesh-ancestor
20171866|NCT00155883|Leucovorin|leucovorin|mesh-list
20171867|NCT00155883|Fluorouracil|fluorouracil|mesh-list
20171868|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
20171869|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171870|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171871|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171872|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171873|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
20171874|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171875|NCT00155883|Antidotes|antidotes|mesh-ancestor
19655523|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
19655524|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655525|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
19655526|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19655527|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655528|NCT05199753|Antibodies|antibodies|mesh-list
20344774|NCT00844207|Azithromycin|azithromycin|mesh-list
20344775|NCT00844207|Chloroquine|chloroquine|mesh-list
20344776|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20344777|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20344778|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344779|NCT00844207|Amebicides|amebicides|mesh-ancestor
20344780|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20344781|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20344782|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
20344783|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344784|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20344785|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19655529|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
19655530|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655531|NCT05199597|Atropine|atropine|mesh-list
19655532|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19655533|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20344786|NCT00844207|Analgesics|analgesics|mesh-ancestor
20344787|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
20344788|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344789|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344790|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344791|NCT00844207|Filaricides|filaricides|mesh-ancestor
20344792|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
20344793|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
20344794|NCT00844233|Irinotecan|irinotecan|mesh-list
20344795|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20344796|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20344797|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344798|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344799|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344800|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
19258531|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
20344801|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344802|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
20344803|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344804|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344805|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20344806|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344807|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655534|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19655535|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
19655536|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655537|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655538|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19655539|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
19655540|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
19655541|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
19655542|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19655543|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20344808|NCT00844324|Candesartan|candesartan|mesh-list
20344809|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
20344810|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20344811|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20344812|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20344813|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344814|NCT00844337|Amoxicillin|amoxicillin|mesh-list
20344815|NCT00844337|Gentamicins|gentamicins|mesh-list
19258532|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
19258533|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258534|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
19258535|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
19258536|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258537|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258538|NCT03358563|Hematinics|hematinics|mesh-ancestor
19258539|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19258540|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19258541|NCT03354728|Vaccines|vaccines|mesh-list
19258542|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
19258543|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258544|NCT03346135|Melphalan|melphalan|mesh-list
19258545|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
19258546|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19258547|NCT03346135|Daratumumab|daratumumab|mesh-list
19258548|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19258549|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
19258550|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655544|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
19655545|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655546|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655547|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19655548|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
19655549|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344816|NCT00844337|Penicillins|penicillins|mesh-list
19258551|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258552|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19258553|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19258554|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
19258555|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258556|NCT03339284|Dexamethasone|dexamethasone|mesh-list
20344817|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20344818|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344819|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20344820|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258557|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
19258558|NCT03339284|Ropivacaine|ropivacaine|mesh-list
19258559|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19258560|NCT03339284|BB 1101|bb 1101|mesh-list
19258561|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19258562|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
19258563|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
19258564|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258565|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258566|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19258567|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
19258568|NCT03339284|Hormones|hormones|mesh-ancestor
19832412|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832413|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832414|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832415|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20344821|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344822|NCT00844350|Letrozole|letrozole|mesh-list
20171876|NCT00155883|Protective Agents|protective agents|mesh-ancestor
20171877|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
20171878|NCT00155883|Vitamins|vitamins|mesh-ancestor
20171879|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
20171880|NCT00156078|Pregabalin|pregabalin|mesh-list
20171881|NCT00156078|Analgesics|analgesics|mesh-ancestor
20171882|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
20171883|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20171884|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171885|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
20171886|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20171887|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20171888|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655557|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
19655558|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19655559|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655560|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19655561|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344823|NCT00844350|Oxytocin|oxytocin|mesh-list
19258569|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258570|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19258571|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258572|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
19258573|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
19258574|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832416|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19832417|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832418|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19832419|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20171889|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20171890|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20171891|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20171892|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20171893|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20171894|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
20171895|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655565|NCT05155579|Vaccines|vaccines|mesh-list
19655566|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
20344824|NCT00844350|Clomiphene|clomiphene|mesh-list
20344825|NCT00844350|Enclomiphene|enclomiphene|mesh-list
20344826|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
20344827|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344828|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
20344829|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20344830|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344831|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344832|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20344833|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20344834|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655567|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171896|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20171897|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171898|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171899|NCT00156299|Dexamethasone|dexamethasone|mesh-list
20171900|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
20171901|NCT00156299|Choline|choline|mesh-list
20171902|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20171903|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
20171904|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
20171905|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20344835|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20344836|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
20344837|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344838|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20344839|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
20344840|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20344841|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20344842|NCT00844402|Atorvastatin|atorvastatin|mesh-list
20344843|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20344844|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20344845|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
20344846|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344847|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20344848|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20344849|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344850|NCT00844454|Ethanol|ethanol|mesh-list
20344851|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20171906|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171907|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20171908|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
20171909|NCT00156299|Hormones|hormones|mesh-ancestor
20171910|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20171911|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20171912|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171913|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
20171914|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20171915|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
20171916|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171917|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20171918|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
20171919|NCT00156299|Analgesics|analgesics|mesh-ancestor
20171920|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
20171921|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20171922|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20171923|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20171924|NCT00156312|Docetaxel|docetaxel|mesh-list
20171925|NCT00156312|Capecitabine|capecitabine|mesh-list
20171926|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171927|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
20171928|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
20171929|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
20171930|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171931|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20171932|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
20171933|NCT00156325|Citalopram|citalopram|mesh-list
19258575|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
19258576|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
19258577|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258578|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258579|NCT03316586|Nivolumab|nivolumab|mesh-list
19258580|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258581|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258582|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19258583|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258584|NCT03301857|Denosumab|denosumab|mesh-list
19258585|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
19258586|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
19258587|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
19258588|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258589|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19258590|NCT03277066|Diclofenac|diclofenac|mesh-list
19258591|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19258592|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19258593|NCT03277066|Analgesics|analgesics|mesh-ancestor
19258594|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
19258595|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258596|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258597|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19258598|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19258599|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19258600|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258601|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258602|NCT03268811|Teduglutide|teduglutide|mesh-list
19258603|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19258604|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19258605|NCT03268811|Protective Agents|protective agents|mesh-ancestor
19258606|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258607|NCT03267433|Rituximab|rituximab|mesh-list
19258608|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20171934|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20171935|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20171936|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20171937|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171938|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20171939|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
20171940|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171941|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20171942|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
20171943|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20171944|NCT00156377|Mupirocin|mupirocin|mesh-list
20171945|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20344852|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171946|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171947|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20171948|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20171949|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171950|NCT00156403|Amlodipine|amlodipine|mesh-list
20171951|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20171952|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20171953|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20171954|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171955|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20171956|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171957|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
20171958|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
20171959|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20171960|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20171961|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171962|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
20171963|NCT00156520|Coagulants|coagulants|mesh-ancestor
20171964|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20171965|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20171966|NCT00156611|Abciximab|abciximab|mesh-list
20171967|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
20171968|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20171969|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20171970|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
20171971|NCT00156650|Testosterone|testosterone|mesh-list
20171972|NCT00156650|Acyline|acyline|mesh-list
20171973|NCT00156650|Androgens|androgens|mesh-ancestor
20171974|NCT00156650|Hormones|hormones|mesh-ancestor
20171975|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20171976|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171977|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20171978|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655582|NCT05138575|Empagliflozin|empagliflozin|mesh-list
19655583|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19655584|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655585|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20171979|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20171980|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20171981|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20171982|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
20171983|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20171984|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20171985|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20171986|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20171987|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
20171988|NCT00156689|Levetiracetam|levetiracetam|mesh-list
20171989|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
19655586|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655587|NCT05135650|Myeloma Proteins|myeloma proteins|mesh-list
19655588|NCT05135650|Paraproteins|paraproteins|mesh-list
20344853|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20344854|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344855|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
20344856|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20344857|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344858|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
20344859|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344860|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
20344861|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344862|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344863|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20344864|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
20344865|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344866|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344867|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20344868|NCT00844662|Sevelamer|sevelamer|mesh-list
20344869|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
20344870|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
19832420|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832421|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
20344871|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344872|NCT00844675|Rabeprazole|rabeprazole|mesh-list
20344873|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20344874|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20344875|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20344876|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344877|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344878|NCT00844688|Gemcitabine|gemcitabine|mesh-list
20344879|NCT00844688|Sorafenib|sorafenib|mesh-list
19655589|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
19655590|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171990|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
20171991|NCT00156858|Busulfan|busulfan|mesh-list
20171992|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
20171993|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20171994|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20171995|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
20171996|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20171997|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20171998|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20171999|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20344880|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20344881|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
20344882|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344883|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344884|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
20344885|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172000|NCT00156884|Cisplatin|cisplatin|mesh-list
19655597|NCT05106153|Zolpidem|zolpidem|mesh-list
20172001|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172002|NCT00156897|Orlistat|orlistat|mesh-list
19655598|NCT05106153|Suvorexant|suvorexant|mesh-list
19655599|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19655600|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19655601|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655602|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655603|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19655604|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
19655605|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
20172003|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172004|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172005|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20172006|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20172007|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
20172008|NCT00156949|Hematinics|hematinics|mesh-ancestor
20172009|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
20172010|NCT00156962|Hematinics|hematinics|mesh-ancestor
20172011|NCT00156975|Capecitabine|capecitabine|mesh-list
20172012|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
20172013|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20172014|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
20172015|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172016|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172017|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
20172018|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20172019|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
20172020|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20172021|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172022|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20172023|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20172024|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
20172025|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20172026|NCT00157040|Factor VIII|factor viii|mesh-list
20172027|NCT00157040|Coagulants|coagulants|mesh-ancestor
20172028|NCT00157053|Factor VIII|factor viii|mesh-list
20172029|NCT00157053|Coagulants|coagulants|mesh-ancestor
20172030|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
20172031|NCT00157066|Vitamin D|vitamin d|mesh-list
20172032|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20172033|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172034|NCT00157066|Vitamins|vitamins|mesh-ancestor
20172035|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
20172036|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20172037|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
20172038|NCT00157079|Antibodies|antibodies|mesh-list
20172039|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
20172040|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20172041|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20172042|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
20172043|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172044|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20172045|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
20172046|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20172047|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20172048|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
20172049|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172050|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174940|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20174941|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20174942|NCT00166426|Analgesics|analgesics|mesh-ancestor
20174943|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
19655606|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655607|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655608|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20174944|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174945|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174946|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174947|NCT00166465|Leucovorin|leucovorin|mesh-list
19655613|NCT05097326|Misoprostol|misoprostol|mesh-list
19655614|NCT05097326|Mifepristone|mifepristone|mesh-list
19655615|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19655616|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
19655617|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19655618|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655619|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20174948|NCT00166465|Fluorouracil|fluorouracil|mesh-list
20174949|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
20344886|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344887|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344888|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
20344889|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344890|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20344891|NCT00844727|Rofecoxib|rofecoxib|mesh-list
20344892|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20344893|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20344894|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344895|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344896|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20344897|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20344898|NCT00844727|Analgesics|analgesics|mesh-ancestor
20344899|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
19258609|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258610|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
19258611|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258612|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19258613|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
19258614|NCT03231085|Trace Elements|trace elements|mesh-ancestor
19258615|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
19258616|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258617|NCT03207347|Niraparib|niraparib|mesh-list
19258618|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19258619|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258620|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258621|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258622|NCT03193333|Timolol|timolol|mesh-list
19258623|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19258624|NCT03193333|Dorzolamide|dorzolamide|mesh-list
19258625|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19258626|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19258627|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19258628|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19258629|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
19258630|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258631|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258632|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258633|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19258634|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19258635|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19258636|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19258637|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19258638|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19258639|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258661|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
19258662|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258663|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258664|NCT03110744|Palbociclib|palbociclib|mesh-list
19258665|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258666|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19258667|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258668|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258669|NCT03093246|Aspirin|aspirin|mesh-list
19258670|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19258671|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19258672|NCT03093246|Analgesics|analgesics|mesh-ancestor
19258673|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
19258674|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258675|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258676|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344900|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655620|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19655621|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
19655622|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19655623|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19655624|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20344901|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832422|NCT04062032|Aspirin|aspirin|mesh-list
19832423|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19832424|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19832425|NCT04062032|Analgesics|analgesics|mesh-ancestor
19832426|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
19832427|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832428|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344902|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344903|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344904|NCT00844740|Cinacalcet|cinacalcet|mesh-list
19832429|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832430|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19832431|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19832432|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20172051|NCT00157105|Factor VIII|factor viii|mesh-list
19258677|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19655625|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19655626|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
20172052|NCT00157105|Coagulants|coagulants|mesh-ancestor
20172053|NCT00157118|Protein C|protein c|mesh-list
20172054|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
20172055|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20172056|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20172057|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172058|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20172059|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
20172060|NCT00157131|Coagulants|coagulants|mesh-ancestor
20172061|NCT00157235|Bromides|bromides|mesh-list
20344905|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20344906|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344907|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20344908|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
20344909|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20344910|NCT00844792|Vitamin D|vitamin d|mesh-list
20344911|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
20344912|NCT00844792|Vitamins|vitamins|mesh-list
20344913|NCT00844792|Vitamin E|vitamin e|mesh-list
20344914|NCT00844792|Selenium|selenium|mesh-list
20344915|NCT00844792|Lycopene|lycopene|mesh-list
20344916|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
19655627|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19655628|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19655629|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
19655630|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655631|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
19655632|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19655633|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19655634|NCT05092269|Ustekinumab|ustekinumab|mesh-list
19655635|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
19655636|NCT05083182|Ustekinumab|ustekinumab|mesh-list
19655637|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
20172062|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
20172063|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20172064|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
20172065|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172066|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655643|NCT05076838|Diazepam|diazepam|mesh-list
19655644|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20172067|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20172068|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
20172069|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
20172070|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20172071|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
20172072|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172073|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172074|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
20172075|NCT00157261|Tenecteplase|tenecteplase|mesh-list
20172076|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20172077|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20172078|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172079|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
20172080|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20172081|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172082|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
20172083|NCT00157300|Hematinics|hematinics|mesh-ancestor
20172084|NCT00157326|Tadalafil|tadalafil|mesh-list
20172085|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172086|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20172087|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20172088|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172089|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172090|NCT00157326|Urological Agents|urological agents|mesh-ancestor
20172091|NCT00157378|Haloperidol|haloperidol|mesh-list
20172092|NCT00157378|Risperidone|risperidone|mesh-list
20172093|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
20172094|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20172095|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
20172096|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172097|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344917|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655645|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
19655646|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
19655647|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
19655648|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655649|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655650|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19655651|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20172098|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172099|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20172100|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172101|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172102|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172103|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20172104|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
20172105|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
20172106|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
20172107|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172108|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20172109|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20172110|NCT00157482|Simvastatin|simvastatin|mesh-list
20172111|NCT00157482|Ezetimibe|ezetimibe|mesh-list
20172112|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20172113|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20172114|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
20174950|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
20174951|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174952|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20174953|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174954|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174955|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
20174956|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174957|NCT00166465|Antidotes|antidotes|mesh-ancestor
20174958|NCT00166465|Protective Agents|protective agents|mesh-ancestor
20174959|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
20174960|NCT00166465|Vitamins|vitamins|mesh-ancestor
20174961|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
20344918|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20344919|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20344920|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
20344921|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344922|NCT00844792|Protective Agents|protective agents|mesh-ancestor
20344923|NCT00844792|Trace Elements|trace elements|mesh-ancestor
20344924|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20344925|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20344926|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20344927|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344928|NCT00845104|Bevacizumab|bevacizumab|mesh-list
20344929|NCT00845104|Rituximab|rituximab|mesh-list
20344930|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20344931|NCT00845104|Fludarabine|fludarabine|mesh-list
20344932|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
20344933|NCT00845104|Antibodies|antibodies|mesh-list
20344934|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
20344935|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20344936|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344937|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20344938|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20344939|NCT00845104|Growth Substances|growth substances|mesh-ancestor
20344940|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344941|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
20344942|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
20344943|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20344944|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20344945|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
20344946|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344947|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20344948|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
20344949|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
20344950|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344951|NCT00845156|Protective Agents|protective agents|mesh-ancestor
20344952|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344953|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
19258678|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19258679|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19258680|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258681|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19258682|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19258683|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258684|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
19258685|NCT03090997|Vitamins|vitamins|mesh-list
19258686|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
20344954|NCT00845156|Vitamins|vitamins|mesh-ancestor
20344955|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
20344956|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
20344957|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344958|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19258687|NCT03090997|Resveratrol|resveratrol|mesh-list
20344959|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20344960|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344961|NCT00845338|Darifenacin|darifenacin|mesh-list
20344962|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20344963|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20344964|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
20344965|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344966|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344967|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344968|NCT00845338|Urological Agents|urological agents|mesh-ancestor
19655652|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655653|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19655654|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19655655|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19655656|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20344969|NCT00845351|Bexarotene|bexarotene|mesh-list
20344970|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20344971|NCT00845364|Perhexiline|perhexiline|mesh-list
20344972|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20344973|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20344974|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344975|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20344976|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344977|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
20344978|NCT00845533|Piperaquine|piperaquine|mesh-list
20344979|NCT00845533|Artenimol|artenimol|mesh-list
20344980|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
20344981|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20344982|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20344983|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20344984|NCT00845546|Loratadine|loratadine|mesh-list
20344985|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
20344986|NCT00845546|Ephedrine|ephedrine|mesh-list
20344987|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
20344988|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
20344989|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20344990|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20344991|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20344992|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
20344993|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
20344994|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20344995|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20344996|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20344997|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20344998|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
20344999|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345000|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20345001|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
20345002|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
20345003|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20345004|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20345005|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
20345006|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
20345007|NCT00845559|Exenatide|exenatide|mesh-list
20345008|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19655657|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19655658|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19655659|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
19655660|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
19655661|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
19655662|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
20345009|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345010|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20345011|NCT00845559|Incretins|incretins|mesh-ancestor
20345012|NCT00845559|Hormones|hormones|mesh-ancestor
20345013|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345014|NCT00845572|Risperidone|risperidone|mesh-list
19655663|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655664|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172115|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172116|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20172117|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20172118|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172119|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
20172120|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20172121|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20172122|NCT00157508|Analgesics|analgesics|mesh-ancestor
20172123|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
20172124|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172125|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172126|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20172127|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20172128|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20172129|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20172130|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345015|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20345016|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
20345017|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345018|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345019|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345020|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20345021|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20345022|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345023|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20345024|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20345025|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
20345026|NCT00845598|Fluticasone|fluticasone|mesh-list
20345027|NCT00845598|Xhance|xhance|mesh-list
20345028|NCT00845598|Azelastine|azelastine|mesh-list
20345029|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345030|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20345031|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
20345032|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345033|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345034|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20345035|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
20345036|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
20345037|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20172131|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20172132|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20172133|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
20172134|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172135|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
20172136|NCT00157547|Citalopram|citalopram|mesh-list
20172137|NCT00157547|Fluoxetine|fluoxetine|mesh-list
20172138|NCT00157547|Paroxetine|paroxetine|mesh-list
20172139|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20172140|NCT00157547|Sertraline|sertraline|mesh-list
20172141|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20345038|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20172142|NCT00157547|Serotonin|serotonin|mesh-list
20172143|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20172144|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172145|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172146|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172147|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
20172148|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172149|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20345039|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345040|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345041|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20345042|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20345043|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
20345044|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
20345045|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345046|NCT00845689|Adenosine|adenosine|mesh-list
20345047|NCT00845689|Analgesics|analgesics|mesh-ancestor
20345048|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
20345049|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345050|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172150|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
20345051|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20172151|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172152|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20172153|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20172154|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172155|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20172156|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20172157|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20172158|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172159|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172160|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20172161|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20172162|NCT00157586|Manidipine|manidipine|mesh-list
20172163|NCT00157586|Delapril|delapril|mesh-list
20172164|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20172165|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20174962|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
20174963|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174964|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20174965|NCT00166478|Protective Agents|protective agents|mesh-ancestor
20174966|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174967|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20174968|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174969|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174970|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20174971|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20174972|NCT00166478|Analgesics|analgesics|mesh-ancestor
20174973|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
20174974|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20174975|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20174976|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20174977|NCT00166491|Insulin|insulin|mesh-list
20174978|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20174979|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174980|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
20174981|NCT00166556|Tacrolimus|tacrolimus|mesh-list
20174982|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20174983|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
20174984|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174985|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20174986|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20174987|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20174988|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20172166|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345052|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172167|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172168|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20172169|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172170|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20172171|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
20172172|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172173|NCT00157651|Warfarin|warfarin|mesh-list
20172174|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
20172175|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
20172176|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20345053|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20345054|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
20345055|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
20345056|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345057|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345058|NCT00845754|Ketorolac|ketorolac|mesh-list
20345059|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20345060|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20345061|NCT00845754|Analgesics|analgesics|mesh-ancestor
20345062|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
20345063|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345064|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345065|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345066|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345067|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20345068|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345069|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345070|NCT00845780|Amiodarone|amiodarone|mesh-list
20172177|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19655668|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19655669|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19655670|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
19655671|NCT05057494|Venetoclax|venetoclax|mesh-list
20345071|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20345072|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
20345073|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20345074|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345075|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345076|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20345077|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20345078|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20345079|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345080|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20345081|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20345082|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20345083|NCT00845819|Iodine|iodine|mesh-list
20345084|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
20345085|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20345086|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
20345087|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
20345088|NCT00845819|Nystatin|nystatin|mesh-list
20345089|NCT00845819|Povidone|povidone|mesh-list
20345090|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20345091|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345092|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
20345093|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
20345094|NCT00845819|Trace Elements|trace elements|mesh-ancestor
19655672|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
20172178|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172179|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
20172180|NCT00157677|Coagulants|coagulants|mesh-ancestor
20172181|NCT00157690|Alendronate|alendronate|mesh-list
20172182|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20172183|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172184|NCT00157716|Pyridoxal|pyridoxal|mesh-list
20172185|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
20172186|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
20172187|NCT00157716|Vitamins|vitamins|mesh-ancestor
20172188|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
20345095|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
20345096|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345097|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
20345098|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
20345099|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20345100|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
20345101|NCT00845819|Ionophores|ionophores|mesh-ancestor
20345102|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345103|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172189|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172190|NCT00157729|Pyridoxal|pyridoxal|mesh-list
20172191|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
20172192|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20172193|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
20172194|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172195|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345104|NCT00845884|Bevacizumab|bevacizumab|mesh-list
20345105|NCT00845884|Cisplatin|cisplatin|mesh-list
20345106|NCT00845884|Docetaxel|docetaxel|mesh-list
20345107|NCT00845884|Capecitabine|capecitabine|mesh-list
20345108|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258688|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
19258689|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258690|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
19258691|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258692|NCT03090997|Protective Agents|protective agents|mesh-ancestor
19258693|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258694|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19258695|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
19258696|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20345109|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345110|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345111|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20345112|NCT00845884|Growth Substances|growth substances|mesh-ancestor
20345113|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345114|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345115|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
20345116|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
20345117|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
20345118|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345119|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20345120|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
20345121|NCT00845910|Bevacizumab|bevacizumab|mesh-list
20345122|NCT00845910|Docetaxel|docetaxel|mesh-list
20345123|NCT00845910|Capecitabine|capecitabine|mesh-list
20172196|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
20172197|NCT00157729|Vitamins|vitamins|mesh-ancestor
20345124|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20345125|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345126|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345127|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20172198|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
20172199|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172200|NCT00157859|Chloroquine|chloroquine|mesh-list
20172201|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
20172202|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
20172203|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20172204|NCT00157859|Amebicides|amebicides|mesh-ancestor
20172205|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20172206|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20172207|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172208|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
20172209|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20172210|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20172211|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655673|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
20345128|NCT00845910|Growth Substances|growth substances|mesh-ancestor
20345129|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345130|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345131|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
20345132|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
20345133|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
20345134|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345135|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20345136|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
20345137|NCT00845936|Metformin|metformin|mesh-list
20345138|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20345139|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345140|NCT00845962|Bupivacaine|bupivacaine|mesh-list
20345141|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
20345142|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
20345143|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
20345144|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345145|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345146|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
20345147|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345148|NCT00845988|Aripiprazole|aripiprazole|mesh-list
20345149|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
20345150|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20345151|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20345152|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20345153|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345154|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345155|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
20345156|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
20345157|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348450|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
20345158|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345159|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20345160|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20345161|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
20345162|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20345163|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20348451|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345164|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20345165|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20345166|NCT00846079|Regadenoson|regadenoson|mesh-list
20345167|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20345168|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20345169|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
20345170|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
20345171|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345172|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345173|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345174|NCT00846118|Pitavastatin|pitavastatin|mesh-list
20345175|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20345176|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20345177|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20345178|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
20345179|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345180|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345181|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20345182|NCT00846131|Sorafenib|sorafenib|mesh-list
20345183|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345184|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20345185|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345186|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348452|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348453|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348454|NCT00864474|Maraviroc|maraviroc|mesh-list
20348455|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20348456|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20348457|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348458|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20348459|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20348460|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
20348461|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348462|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20348463|NCT00864500|Clobetasol|clobetasol|mesh-list
20348464|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348465|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
20348466|NCT00864500|Hormones|hormones|mesh-ancestor
20345187|NCT00846144|Copper|copper|mesh-list
20345188|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
20345189|NCT00846144|Trace Elements|trace elements|mesh-ancestor
20345190|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
20345191|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345192|NCT00846144|Antidotes|antidotes|mesh-ancestor
20345193|NCT00846144|Protective Agents|protective agents|mesh-ancestor
20345194|NCT00846144|Emetics|emetics|mesh-ancestor
20345195|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
20345196|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345197|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20345198|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
20345199|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
20345200|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20345201|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345202|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345203|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20345204|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345205|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20345206|NCT00846235|Glycerol|glycerol|mesh-list
20345207|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20345208|NCT00846235|Protective Agents|protective agents|mesh-ancestor
20345209|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345210|NCT00846248|Chromium|chromium|mesh-list
20345211|NCT00846248|Trace Elements|trace elements|mesh-ancestor
20345212|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
20345213|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345214|NCT00846274|Antithrombins|antithrombins|mesh-list
20345215|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
20172212|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172213|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20172214|NCT00157859|Renal Agents|renal agents|mesh-ancestor
19258697|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258698|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20172215|NCT00157872|Naproxen|naproxen|mesh-list
20172216|NCT00157872|Rofecoxib|rofecoxib|mesh-list
20172217|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20172218|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20172219|NCT00157872|Analgesics|analgesics|mesh-ancestor
20172220|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
20172221|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172222|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172223|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20172224|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20172225|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
20345216|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20345217|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
20345218|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345219|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345220|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
20345221|NCT00846326|Fluticasone|fluticasone|mesh-list
20345222|NCT00846326|Xhance|xhance|mesh-list
20345223|NCT00846326|Phenylephrine|phenylephrine|mesh-list
20345224|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
20345225|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345226|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20345227|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
20345228|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345229|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345230|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20345231|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
20345232|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
20345233|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20345234|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20345235|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20345236|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
20345237|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345238|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345239|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
20345240|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
20345241|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20345242|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20345243|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
20345244|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20345245|NCT00846326|Protective Agents|protective agents|mesh-ancestor
20345246|NCT00846339|Bupropion|bupropion|mesh-list
20345247|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20345248|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
20345249|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20345250|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20345251|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20345252|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345253|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345254|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
20345255|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345256|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345257|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20345258|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20345259|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345260|NCT00846430|Interferons|interferons|mesh-list
20345261|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
20345262|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
20345263|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20345264|NCT00846430|Celecoxib|celecoxib|mesh-list
20345265|NCT00846430|Vincristine|vincristine|mesh-list
20345266|NCT00846430|Temozolomide|temozolomide|mesh-list
20345267|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345268|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
20345269|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345270|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20345271|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
20345272|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
20345273|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
20345274|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345275|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20345276|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
20345277|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
20345278|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345279|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20345280|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20345281|NCT00846430|Analgesics|analgesics|mesh-ancestor
20345282|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
20345283|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345284|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345285|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19655674|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345286|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20345287|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20345288|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345289|NCT00846443|Cisplatin|cisplatin|mesh-list
20345290|NCT00846443|Pemetrexed|pemetrexed|mesh-list
20345291|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345292|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345293|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172226|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20172227|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172228|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172229|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20172230|NCT00157885|Artesunate|artesunate|mesh-list
20345294|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20345295|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20345296|NCT00846508|Cisplatin|cisplatin|mesh-list
20172231|NCT00157885|Amodiaquine|amodiaquine|mesh-list
20345297|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345298|NCT00846612|Bevacizumab|bevacizumab|mesh-list
20345299|NCT00846612|Doxorubicin|doxorubicin|mesh-list
20345300|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20345301|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345302|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345303|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20345304|NCT00846612|Growth Substances|growth substances|mesh-ancestor
20345305|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345306|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345307|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20345308|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20345309|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20345310|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345311|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345312|NCT00846625|Triamcinolone|triamcinolone|mesh-list
20345313|NCT00846625|Ranibizumab|ranibizumab|mesh-list
20345314|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345315|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20172232|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
20172233|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20172234|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20172235|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172236|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172237|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
20345316|NCT00846625|Growth Substances|growth substances|mesh-ancestor
20345317|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172238|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
20345318|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345319|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345320|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345321|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
20345322|NCT00846625|Hormones|hormones|mesh-ancestor
20345323|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345324|NCT00846677|Vitamin D|vitamin d|mesh-list
20345325|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
20345326|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
20345327|NCT00846677|Vitamins|vitamins|mesh-list
20345328|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
20345329|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345330|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20345331|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20345332|NCT00846690|Lidocaine|lidocaine|mesh-list
20345333|NCT00846690|Phenylephrine|phenylephrine|mesh-list
20345334|NCT00846690|Benzocaine|benzocaine|mesh-list
20345335|NCT00846690|Tetracaine|tetracaine|mesh-list
20345336|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
20345337|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
20345338|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345339|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345340|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
20345341|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345342|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20172239|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20172240|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
20172241|NCT00157898|Metronidazole|metronidazole|mesh-list
20172242|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
20172243|NCT00157898|Ertapenem|ertapenem|mesh-list
20172244|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172245|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20172246|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20172247|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20172248|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
20172249|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20345343|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20345344|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20345345|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345346|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345347|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20345348|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
20345349|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
20345350|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
20345351|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20345352|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
20172250|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
20172251|NCT00158002|Topiramate|topiramate|mesh-list
20172252|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
20172253|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20172254|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345353|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
20345354|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20345355|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20345356|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20345357|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
20345358|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345359|NCT00846690|Protective Agents|protective agents|mesh-ancestor
20345360|NCT00846703|Dexamethasone|dexamethasone|mesh-list
20172255|NCT00158028|Risperidone|risperidone|mesh-list
20172256|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20172257|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
20345361|NCT00846703|Methotrexate|methotrexate|mesh-list
20345362|NCT00846703|Vincristine|vincristine|mesh-list
20345363|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
20345364|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345365|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
20345366|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
20345367|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345368|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345369|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20345370|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
20345371|NCT00846703|Hormones|hormones|mesh-ancestor
20345372|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345373|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20345374|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345375|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20345376|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
20345377|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20345378|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20345379|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
20345380|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345381|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
20345382|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345383|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20345384|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345385|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
20345386|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345387|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20345388|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20345389|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
20345390|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
20345391|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
20345392|NCT00846716|Pioglitazone|pioglitazone|mesh-list
20345393|NCT00846716|Biguanides|biguanides|mesh-list
20345394|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20345395|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345396|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
20345397|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
20345398|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345399|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
20345400|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
20345401|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655675|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20172258|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172259|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172260|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172261|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20172262|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19655681|NCT05046184|Midazolam|midazolam|mesh-list
19832433|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655682|NCT05046184|Ketamine|ketamine|mesh-list
19655683|NCT05046184|Analgesics|analgesics|mesh-ancestor
19655684|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
19655685|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655686|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832434|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20172263|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172264|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172265|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20172266|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
20172267|NCT00158041|Amifostine|amifostine|mesh-list
20172268|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20172269|NCT00158041|Protective Agents|protective agents|mesh-ancestor
20172270|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172271|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
20172272|NCT00158093|Atenolol|atenolol|mesh-list
20172273|NCT00158093|Nebivolol|nebivolol|mesh-list
20172274|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20172275|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172276|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20172277|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20172278|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172279|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655687|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19655688|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19655689|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
19655690|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
19655691|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655692|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19655693|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19655694|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655695|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655696|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19655697|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19655698|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19655699|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19655700|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19655701|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
20172280|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172281|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172282|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20172283|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20172284|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
20172285|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
20172286|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172287|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20172288|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20172289|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20172290|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
20172291|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172292|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172293|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20172294|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20172295|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20172296|NCT00158132|Amantadine|amantadine|mesh-list
20172297|NCT00158132|Propranolol|propranolol|mesh-list
20172298|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20172299|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20172300|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
19258699|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259249|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259285|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19259286|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259287|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259288|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
19259289|NCT05172531|Cisatracurium|cisatracurium|mesh-list
19259290|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19259291|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19259292|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259293|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259294|NCT05172518|Capecitabine|capecitabine|mesh-list
19259295|NCT05172518|Taxane|taxane|mesh-list
19259296|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259297|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
19259298|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259299|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259300|NCT05172440|Axitinib|axitinib|mesh-list
19259301|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259302|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19259303|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259304|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259305|NCT05172401|Triamcinolone|triamcinolone|mesh-list
19259306|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19259307|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19259308|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19259309|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259310|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
19259311|NCT05172401|Hormones|hormones|mesh-ancestor
19259312|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259313|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259314|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259315|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
19259316|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259317|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259318|NCT05172310|FAPI-46|fapi-46|mesh-list
19259319|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19259320|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259321|NCT05172115|Heparin|heparin|mesh-list
19259322|NCT05172115|Enoxaparin|enoxaparin|mesh-list
19259323|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19259324|NCT05172115|Tinzaparin|tinzaparin|mesh-list
19259325|NCT05172115|Dalteparin|dalteparin|mesh-list
19259326|NCT05172115|Plasminogen|plasminogen|mesh-list
19259327|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19259328|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
19259329|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19259330|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19259331|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259332|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
19259333|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19259334|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259335|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259336|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19259337|NCT05171985|Analgesics|analgesics|mesh-ancestor
19259338|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
19259339|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259340|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19259341|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19259342|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19259343|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
19259344|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259345|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259346|NCT05171946|Vaccines|vaccines|mesh-list
19259347|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
19259348|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259349|NCT05171751|Octreotide|octreotide|mesh-list
19259350|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19259351|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259352|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259353|NCT05171660|Capecitabine|capecitabine|mesh-list
19259354|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
19259355|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655702|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
20612089|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612090|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612091|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20612092|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20612093|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612094|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612095|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20612096|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20612097|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
20612098|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
20612099|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612100|NCT02249702|Gemcitabine|gemcitabine|mesh-list
20612101|NCT02249702|Docetaxel|docetaxel|mesh-list
20612102|NCT02249702|Trabectedin|trabectedin|mesh-list
20612103|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20612104|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
20612105|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612106|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612107|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
20612108|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612109|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345402|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345403|NCT00846859|Varenicline|varenicline|mesh-list
20345404|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20345405|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20345406|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
20345407|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345408|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345409|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345410|NCT00846872|Mannitol|mannitol|mesh-list
20345411|NCT00846872|Hormones|hormones|mesh-list
20345412|NCT00846872|Secretagogues|secretagogues|mesh-list
20345413|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345414|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345415|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20345416|NCT00846872|Diuretics|diuretics|mesh-ancestor
20345417|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
20345418|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
20345419|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20345420|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20345421|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345422|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20345423|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20345424|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345425|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345426|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345427|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20345428|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
20345429|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20345430|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345431|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20612110|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345432|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20345433|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20345434|NCT00846950|Lorazepam|lorazepam|mesh-list
20345435|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20345436|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
20345437|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
20345438|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
20345439|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345440|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345441|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20345442|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20345443|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345444|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20345445|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20345446|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20345447|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
20345448|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
20345449|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345450|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345451|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20345452|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
20345453|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
20345454|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20345455|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20345456|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20345457|NCT00846976|Bicalutamide|bicalutamide|mesh-list
20345458|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
20345459|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
20345460|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345461|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345462|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345463|NCT00847054|Antibodies|antibodies|mesh-list
20345464|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20345465|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
20345466|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345467|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20345468|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20345469|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345470|NCT00847080|Incretins|incretins|mesh-ancestor
20345471|NCT00847080|Hormones|hormones|mesh-ancestor
20345472|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345473|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20345474|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
20345475|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345476|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345477|NCT00847093|Lidocaine|lidocaine|mesh-list
20345478|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
20345479|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
20345480|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345481|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345482|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
20345483|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345484|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20172301|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172302|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172303|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172304|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20172305|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20172306|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172307|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20172308|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20172309|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
20172310|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345485|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20345486|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20345487|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345488|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345489|NCT00847106|Daclizumab|daclizumab|mesh-list
20345490|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345491|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
20345492|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345493|NCT00847119|Bevacizumab|bevacizumab|mesh-list
20345494|NCT00847119|Capecitabine|capecitabine|mesh-list
20345495|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20345496|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345497|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345498|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20345499|NCT00847119|Growth Substances|growth substances|mesh-ancestor
20345500|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345501|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
20172311|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
20172312|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20172313|NCT00158132|Analgesics|analgesics|mesh-ancestor
20172314|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
20172315|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172316|NCT00158158|Nicotine|nicotine|mesh-list
20172317|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20172318|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
20172319|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172320|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172321|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20172322|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20345502|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20172323|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
20172324|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172325|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172326|NCT00158171|Folic Acid|folic acid|mesh-list
20172327|NCT00158171|Nicotine|nicotine|mesh-list
20172328|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20172329|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
20345503|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
19258700|NCT02991599|Vaccines|vaccines|mesh-list
20172330|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172331|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172332|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20172333|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20172334|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
20172335|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172336|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172337|NCT00158171|Hematinics|hematinics|mesh-ancestor
20172338|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
20172339|NCT00158171|Vitamins|vitamins|mesh-ancestor
20172340|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
20172341|NCT00158210|Rivastigmine|rivastigmine|mesh-list
20172342|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20172343|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172344|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172345|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
19655719|NCT05032794|Bisacodyl|bisacodyl|mesh-list
19832435|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19832436|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832437|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
19832438|NCT04055844|Decitabine|decitabine|mesh-list
19832439|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19832440|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
19832441|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832442|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832443|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19832444|NCT04052698|Factor VIII|factor viii|mesh-list
19832445|NCT04052698|Coagulants|coagulants|mesh-ancestor
19832446|NCT04033991|Sunitinib|sunitinib|mesh-list
19832447|NCT04033991|Axitinib|axitinib|mesh-list
19832448|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832449|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19832450|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19832451|NCT04033991|Growth Substances|growth substances|mesh-ancestor
19832452|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832453|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
19832454|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19258701|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
19655720|NCT05032794|Cathartics|cathartics|mesh-ancestor
19832455|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172346|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345504|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345505|NCT00847223|Tipifarnib|tipifarnib|mesh-list
20345506|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345507|NCT00847262|Amlodipine|amlodipine|mesh-list
20345508|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20345509|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20345510|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345511|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345512|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20345513|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345514|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
20345515|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
20345516|NCT00847314|Testosterone|testosterone|mesh-list
20345517|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
20345518|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
20345519|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20345520|NCT00847314|Androgens|androgens|mesh-ancestor
20345521|NCT00847314|Hormones|hormones|mesh-ancestor
20345522|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345523|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345524|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20345525|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345526|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
20345527|NCT00847418|Esketamine|esketamine|mesh-list
20345528|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
20345529|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20345530|NCT00847483|Bimatoprost|bimatoprost|mesh-list
20345531|NCT00847483|Travoprost|travoprost|mesh-list
20345532|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20345533|NCT00847483|Latanoprost|latanoprost|mesh-list
20345534|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20345535|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20345536|NCT00847639|Lenalidomide|lenalidomide|mesh-list
20345537|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
20345538|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345539|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345540|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20345541|NCT00847639|Growth Substances|growth substances|mesh-ancestor
20345542|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345543|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345544|NCT00847678|Amphotericin B|amphotericin b|mesh-list
20345545|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20345546|NCT00847678|Flucytosine|flucytosine|mesh-list
20345547|NCT00847678|Efungumab|efungumab|mesh-list
20345548|NCT00847678|Amebicides|amebicides|mesh-ancestor
20345549|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20345550|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20345551|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345552|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20345553|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
20345554|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
20345555|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345556|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20345557|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
20345558|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20345559|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
20345560|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345561|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345562|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20345563|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20345564|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20345565|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20345566|NCT00847834|Irbesartan|irbesartan|mesh-list
20345567|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20345568|NCT00847834|Diuretics|diuretics|mesh-ancestor
20345569|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
20345570|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345571|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20345572|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345573|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345574|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20345575|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20345576|NCT00847860|Aspirin|aspirin|mesh-list
20345577|NCT00847860|Cilostazol|cilostazol|mesh-list
20345578|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20345579|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20345580|NCT00847860|Analgesics|analgesics|mesh-ancestor
20345581|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
20345582|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345583|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345584|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345585|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345586|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20345587|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20345588|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345589|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20345590|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20345591|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345592|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
20345593|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20612111|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
19655721|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20345594|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
19258702|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258703|NCT02970500|Methylphenidate|methylphenidate|mesh-list
19258704|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19258705|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258706|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19258707|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19258708|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19258709|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258710|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
19258711|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258712|NCT02969928|Amoxicillin|amoxicillin|mesh-list
19258713|NCT02969928|Metronidazole|metronidazole|mesh-list
19258714|NCT02969928|Clarithromycin|clarithromycin|mesh-list
19258715|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19258716|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258717|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19258718|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19258719|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19258720|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258721|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258722|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19258723|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19258724|NCT02968446|Vitamin D|vitamin d|mesh-list
19258725|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
19258726|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
19258727|NCT02968446|Vitamins|vitamins|mesh-ancestor
19258728|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
19258729|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258730|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19258731|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19258732|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
19258733|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258734|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19258735|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258736|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
19258737|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258738|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258739|NCT02939183|Dexamethasone|dexamethasone|mesh-list
19258740|NCT02939183|Pomalidomide|pomalidomide|mesh-list
20345595|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20345596|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
20345597|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
20345598|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20345599|NCT00847860|Protective Agents|protective agents|mesh-ancestor
20345600|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20345601|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20345602|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
20345603|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19258741|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345604|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345605|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348467|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348468|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348469|NCT00864526|Ibuprofen|ibuprofen|mesh-list
20348470|NCT00864526|Oxycodone|oxycodone|mesh-list
20348471|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20348472|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20348473|NCT00864526|Analgesics|analgesics|mesh-ancestor
20348474|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
20348475|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348476|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348477|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348478|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348479|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20348480|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348481|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348482|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20348483|NCT00864526|Narcotics|narcotics|mesh-ancestor
20348484|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655722|NCT05032794|Laxatives|laxatives|mesh-ancestor
19655723|NCT05029921|Ustekinumab|ustekinumab|mesh-list
19655724|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
19655725|NCT05029401|Ibogaine|ibogaine|mesh-list
19655726|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
19655727|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348485|NCT00864552|Factor VIII|factor viii|mesh-list
20348486|NCT00864552|Coagulants|coagulants|mesh-ancestor
20348487|NCT00864565|Fentanyl|fentanyl|mesh-list
20348488|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20348489|NCT00864565|Narcotics|narcotics|mesh-ancestor
19655728|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348490|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655729|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20345606|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20345607|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
20345608|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20345609|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
19655730|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19655731|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655732|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172347|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172348|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20172349|NCT00158210|Protective Agents|protective agents|mesh-ancestor
20172350|NCT00158236|Buprenorphine|buprenorphine|mesh-list
20172351|NCT00158236|Hydromorphone|hydromorphone|mesh-list
20172352|NCT00158236|Naloxone|naloxone|mesh-list
20172353|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20172354|NCT00158236|Narcotics|narcotics|mesh-ancestor
20172355|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172356|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172357|NCT00158236|Analgesics|analgesics|mesh-ancestor
20172358|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
19832456|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172359|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172360|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20172361|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
19258742|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
20172362|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172363|NCT00158301|Fluoxetine|fluoxetine|mesh-list
20172364|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20172365|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20172366|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172367|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172368|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172369|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
20172370|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172371|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20172372|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
20172373|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172374|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20172375|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20172376|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345610|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20345611|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
20345612|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345613|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345614|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20345615|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
20345616|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20345617|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
20345618|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345619|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345620|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20345621|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
20345622|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
20345623|NCT00848302|Protective Agents|protective agents|mesh-ancestor
20345624|NCT00848432|Risperidone|risperidone|mesh-list
20345625|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20172377|NCT00158405|Ritonavir|ritonavir|mesh-list
20345626|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
20172378|NCT00158405|Indinavir|indinavir|mesh-list
20172379|NCT00158405|Lamivudine|lamivudine|mesh-list
20172380|NCT00158405|Zidovudine|zidovudine|mesh-list
20172381|NCT00158405|Efavirenz|efavirenz|mesh-list
20172382|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20172383|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20172384|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
20172385|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172386|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172387|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20172388|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20172389|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
20172390|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345627|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345628|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345629|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345630|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20345631|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20345632|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345633|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20345634|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20345635|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
20345636|NCT00848458|Azelaic acid|azelaic acid|mesh-list
20345637|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345638|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
20345639|NCT00848523|Panobinostat|panobinostat|mesh-list
20345640|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345641|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20345642|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345643|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345644|NCT00848562|Nicorandil|nicorandil|mesh-list
20345645|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20345646|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20345647|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
20345648|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
20345649|NCT00848562|Vitamins|vitamins|mesh-ancestor
20345650|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
20345651|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345652|NCT00848640|Sorafenib|sorafenib|mesh-list
20345653|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345654|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20345655|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345656|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345657|NCT00848679|Lidocaine|lidocaine|mesh-list
20345658|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
20345659|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
20172391|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20172392|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20172393|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20172394|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20172395|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
20345660|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345661|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345662|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
20345663|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345664|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20345665|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20345666|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20345667|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20345668|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345669|NCT00848692|Rituximab|rituximab|mesh-list
20345670|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20345671|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345672|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
20345673|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345674|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345675|NCT00848770|Norepinephrine|norepinephrine|mesh-list
20345676|NCT00848770|Esmolol|esmolol|mesh-list
20345677|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20345678|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20345679|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
20345680|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345681|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345682|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345683|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
20345684|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
20345685|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345686|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20345687|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20345688|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20345689|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20345690|NCT00848796|Heparin|heparin|mesh-list
20345691|NCT00848796|Calcium heparin|calcium heparin|mesh-list
20345692|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
20345693|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20345694|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20345695|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345696|NCT00848809|Vancomycin|vancomycin|mesh-list
20345697|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20345698|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345699|NCT00848848|Vaccines|vaccines|mesh-list
20345700|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
20345701|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345702|NCT00848861|Midazolam|midazolam|mesh-list
20345703|NCT00848861|Meperidine|meperidine|mesh-list
20345704|NCT00848861|Propofol|propofol|mesh-list
20345705|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20345706|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345707|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345708|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20345709|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
20345710|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
20345711|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20345712|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20345713|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20345714|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20345715|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
20345716|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
20345717|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345718|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258743|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
19258744|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258745|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258746|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19258747|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
19258748|NCT02939183|Hormones|hormones|mesh-ancestor
19258749|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258750|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19258751|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258752|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
19258753|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19258754|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19258755|NCT02939183|Growth Substances|growth substances|mesh-ancestor
19258756|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
20172396|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20172397|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20345719|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19832457|NCT04027361|Amphetamine|amphetamine|mesh-list
20345720|NCT00848861|Narcotics|narcotics|mesh-ancestor
20345721|NCT00848861|Analgesics|analgesics|mesh-ancestor
20345722|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
20345723|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345724|NCT00848939|Treprostinil|treprostinil|mesh-list
20345725|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20345726|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
20345727|NCT00848991|Propofol|propofol|mesh-list
20345728|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20345729|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345730|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345731|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20345732|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
19258765|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
20345733|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
20345734|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20345735|NCT00848991|Analgesics|analgesics|mesh-ancestor
20345736|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
20345737|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345738|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20345739|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20345740|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20345741|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
20345742|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345743|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345744|NCT00849030|Tamoxifen|tamoxifen|mesh-list
20345745|NCT00849030|Anastrozole|anastrozole|mesh-list
20345746|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20345747|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
20345748|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345749|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345750|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20345751|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345752|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20345753|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20345754|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20345755|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20345756|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20345757|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345758|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345759|NCT00849082|Goserelin|goserelin|mesh-list
20345760|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
20345761|NCT00849082|Cyproterone|cyproterone|mesh-list
20345762|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20345763|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345764|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
20345765|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
20345766|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345767|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345768|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20345769|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
20345770|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20345771|NCT00849095|Budesonide|budesonide|mesh-list
20345772|NCT00849095|Terbutaline|terbutaline|mesh-list
20345773|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
20345774|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20345775|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345776|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20345777|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
20345778|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345779|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345780|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20345781|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
20345782|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
20345783|NCT00849095|Hormones|hormones|mesh-ancestor
20345784|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20172398|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20172399|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20172400|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20172401|NCT00158457|Tenofovir|tenofovir|mesh-list
20172402|NCT00158457|Emtricitabine|emtricitabine|mesh-list
20172403|NCT00158457|Efavirenz|efavirenz|mesh-list
20172404|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
20172405|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172406|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20172407|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20172408|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172409|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172410|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20172411|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20172412|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20172413|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20345785|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20172414|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20172415|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20172416|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20172417|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20172418|NCT00158470|Lamivudine|lamivudine|mesh-list
20172419|NCT00158470|Efavirenz|efavirenz|mesh-list
20172420|NCT00158470|Didanosine|didanosine|mesh-list
20172421|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20172422|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20172423|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172424|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172425|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
20172426|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172427|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20172428|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20172429|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20172430|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20345786|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19832458|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19832459|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832460|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
19832461|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
19832462|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832463|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
20345787|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20345788|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
20345789|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20345790|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345791|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
20345792|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
20345793|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20345794|NCT00849160|Darunavir|darunavir|mesh-list
20345795|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20345796|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20345797|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
20345798|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345799|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345800|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20345801|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20345802|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
20345803|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345804|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
20345805|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20172431|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20172432|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20172433|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20172434|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20172435|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
20172436|NCT00158483|Acyclovir|acyclovir|mesh-list
20172437|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
20172438|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172439|NCT00158496|Interferons|interferons|mesh-list
20172440|NCT00158496|Ribavirin|ribavirin|mesh-list
20172441|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
20172442|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
20172443|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20172444|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172445|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
20172446|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172447|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
20345806|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172448|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172449|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
20172450|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172451|NCT00158509|Valacyclovir|valacyclovir|mesh-list
20172452|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
20172453|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172454|NCT00158522|Interferons|interferons|mesh-list
20172455|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
20172456|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
20345807|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20345808|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
20345809|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20345810|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345811|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345812|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172457|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20172458|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172459|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
20172460|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172461|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
20172462|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172463|NCT00158548|Artesunate|artesunate|mesh-list
20345813|NCT00849264|Fluorouracil|fluorouracil|mesh-list
20345814|NCT00849264|Endostar protein|endostar protein|mesh-list
20172464|NCT00158548|Chloroquine|chloroquine|mesh-list
19655765|NCT05022563|Warfarin|warfarin|mesh-list
19655766|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
19655767|NCT05022563|Dabigatran|dabigatran|mesh-list
19655768|NCT05022563|Apixaban|apixaban|mesh-list
19655769|NCT05022563|Edoxaban|edoxaban|mesh-list
19655770|NCT05022563|Anticoagulants|anticoagulants|mesh-list
19655771|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19832464|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832465|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832466|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
19655772|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
19655773|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19655774|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
19655775|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655776|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655777|NCT05020522|Phenobarbital|phenobarbital|mesh-list
19655778|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
19655779|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19832467|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19832468|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19832469|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832470|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19832471|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
20172465|NCT00158548|Primaquine|primaquine|mesh-list
20172466|NCT00158548|Amodiaquine|amodiaquine|mesh-list
20172467|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
20172468|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19655780|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345815|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
20345816|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345817|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20172469|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20172470|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172471|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172472|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
20172473|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
20172474|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20172475|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
20345818|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345819|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345820|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
20345821|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345822|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345823|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20345824|NCT00849264|Growth Substances|growth substances|mesh-ancestor
20345825|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345826|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
20345827|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20345828|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655781|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655782|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19655783|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19655784|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172476|NCT00158548|Amebicides|amebicides|mesh-ancestor
20172477|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345829|NCT00849329|Lapatinib|lapatinib|mesh-list
20345830|NCT00849329|Esomeprazole|esomeprazole|mesh-list
20345831|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20345832|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20345833|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19258766|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
19258767|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258768|NCT02857426|Nivolumab|nivolumab|mesh-list
19258769|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258770|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258771|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19258772|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258773|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
19258774|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258775|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
19258776|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
19258777|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
19258778|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
19258779|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258780|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258781|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
19258782|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19258783|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19258784|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
19258785|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258786|NCT02710331|Ethanol|ethanol|mesh-list
19258787|NCT02710331|Dronabinol|dronabinol|mesh-list
19258788|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19258789|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258790|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655785|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655786|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
19655787|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
19655788|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19655789|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19655790|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19655791|NCT05020236|Dexamethasone|dexamethasone|mesh-list
19655792|NCT05020236|Daratumumab|daratumumab|mesh-list
19655793|NCT05020236|Pomalidomide|pomalidomide|mesh-list
19655794|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19258791|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258792|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
19655795|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
19655796|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
20345834|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172478|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
20172479|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
20172480|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20345835|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345836|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345837|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20345838|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
20345839|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20345840|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345841|NCT00849355|Rituximab|rituximab|mesh-list
20345842|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20345843|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345844|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
20345845|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345846|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345847|NCT00849368|Azathioprine|azathioprine|mesh-list
20345848|NCT00849368|Allopurinol|allopurinol|mesh-list
20345849|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
20345850|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345851|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345852|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
20345853|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20172481|NCT00158561|Dapsone|dapsone|mesh-list
20345854|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20345855|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
20345856|NCT00849368|Protective Agents|protective agents|mesh-ancestor
20345857|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345858|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20345859|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345860|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345861|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
20345862|NCT00849459|Interleukin-12|interleukin-12|mesh-list
20345863|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20345864|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
20345865|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345866|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345867|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20345868|NCT00849459|Growth Substances|growth substances|mesh-ancestor
20345869|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345870|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345871|NCT00849511|Melatonin|melatonin|mesh-list
20345872|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
20345873|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345874|NCT00849511|Protective Agents|protective agents|mesh-ancestor
20345875|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172482|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
20172483|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
20172484|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20172485|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20172486|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172487|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20172488|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172489|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345876|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345877|NCT00849537|Triamcinolone|triamcinolone|mesh-list
20345878|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345879|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
20345880|NCT00849537|Hormones|hormones|mesh-ancestor
20345881|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345882|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345883|NCT00849550|Bevacizumab|bevacizumab|mesh-list
20345884|NCT00849550|Capecitabine|capecitabine|mesh-list
20345885|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
20345886|NCT00849550|Everolimus|everolimus|mesh-list
20345887|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20345888|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345889|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20345890|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20345891|NCT00849550|Growth Substances|growth substances|mesh-ancestor
20345892|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345893|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
20345894|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20345895|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
19655797|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19655798|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655799|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19655800|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
19655801|NCT05020236|Hormones|hormones|mesh-ancestor
20345896|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345897|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345898|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
20345899|NCT00849602|Chloroquine|chloroquine|mesh-list
20345900|NCT00849602|Amebicides|amebicides|mesh-ancestor
20345901|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20345902|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20345903|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345904|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
20345905|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345906|NCT00849615|Leucovorin|leucovorin|mesh-list
20345907|NCT00849615|Folic Acid|folic acid|mesh-list
20345908|NCT00849615|Docetaxel|docetaxel|mesh-list
20345909|NCT00849615|Fluorouracil|fluorouracil|mesh-list
20345910|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
20345911|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
20345912|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345913|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
20345914|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19655802|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20345915|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
20345916|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345917|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
20345918|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20345919|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345920|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
20345921|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345922|NCT00849615|Antidotes|antidotes|mesh-ancestor
20345923|NCT00849615|Protective Agents|protective agents|mesh-ancestor
20345924|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
20345925|NCT00849615|Vitamins|vitamins|mesh-ancestor
20345926|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
20345927|NCT00849615|Hematinics|hematinics|mesh-ancestor
20345928|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
20345929|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20345930|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345931|NCT00849966|Celecoxib|celecoxib|mesh-list
20345932|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20345933|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20345934|NCT00849966|Analgesics|analgesics|mesh-ancestor
20345935|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
20345936|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20345937|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345938|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20345939|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20345940|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20345941|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20345942|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345943|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345944|NCT00849992|Imiquimod|imiquimod|mesh-list
20345945|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20345946|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
20345947|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345948|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345949|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
20345950|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
20345951|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20345952|NCT00850005|Antibodies|antibodies|mesh-list
20345953|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
20345954|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20345955|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
20345956|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345957|NCT00850044|Ritonavir|ritonavir|mesh-list
20345958|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20345959|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20345960|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
20345961|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345962|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345963|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20345964|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20345965|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
20345966|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345967|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20345968|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348491|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348492|NCT00864565|Analgesics|analgesics|mesh-ancestor
20348493|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
19832472|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
19832473|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
19832474|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20345969|NCT00850122|Cefazolin|cefazolin|mesh-list
20345970|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20345971|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345972|NCT00850161|Insulin|insulin|mesh-list
20345973|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20345974|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
20345975|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20345976|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345977|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
20345978|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345979|NCT00850382|Cytarabine|cytarabine|mesh-list
20345980|NCT00850382|Daunorubicin|daunorubicin|mesh-list
20345981|NCT00850382|Dasatinib|dasatinib|mesh-list
20345982|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20345983|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
20345984|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20345985|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20345986|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
20345987|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345988|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20345989|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
20345990|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20345991|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20612112|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612113|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612114|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
20345992|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20345993|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20345994|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20345995|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20345996|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
20345997|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
20345998|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20345999|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
20346000|NCT00850746|Z 338|z 338|mesh-list
20346001|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346002|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346003|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20346004|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20346005|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346006|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346007|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346008|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346009|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20346010|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
20346011|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346012|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346013|NCT00850850|Physostigmine|physostigmine|mesh-list
20346014|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20346015|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346016|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346017|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
20346018|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346019|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172490|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20172491|NCT00158561|Renal Agents|renal agents|mesh-ancestor
19655803|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19655804|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655805|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
19655806|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19655807|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20346020|NCT00850850|Miotics|miotics|mesh-ancestor
20346021|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
20346022|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346023|NCT00851136|Bevacizumab|bevacizumab|mesh-list
20346024|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20346025|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346026|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20346027|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19655808|NCT05020236|Growth Substances|growth substances|mesh-ancestor
19655809|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
20172492|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
20172493|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20172494|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
20172495|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
20172496|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20172497|NCT00158574|Dapsone|dapsone|mesh-list
20172498|NCT00158574|Mefloquine|mefloquine|mesh-list
20172499|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
20172500|NCT00158574|Proguanil|proguanil|mesh-list
20172501|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
19665533|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20172502|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20172503|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19258793|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19258794|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19258795|NCT02710331|Analgesics|analgesics|mesh-ancestor
19258796|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
19258797|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258798|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19258799|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19258800|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258801|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258802|NCT02710331|Hormones|hormones|mesh-ancestor
20172504|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19655821|NCT05005728|Carboplatin|carboplatin|mesh-list
19655822|NCT05005728|Olaparib|olaparib|mesh-list
19655823|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655824|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19655825|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655826|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172505|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20172506|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172507|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172508|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20172509|NCT00158574|Renal Agents|renal agents|mesh-ancestor
20172510|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
20346028|NCT00851136|Growth Substances|growth substances|mesh-ancestor
20346029|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346030|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
20346031|NCT00851175|Caffeine|caffeine|mesh-list
20346032|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20346033|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19258803|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258804|NCT02705300|Leucovorin|leucovorin|mesh-list
20346034|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20172511|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20172512|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
20346035|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
20346036|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346037|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20346038|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20346039|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346040|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20346041|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346042|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20346043|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20346044|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20346045|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
20346046|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346047|NCT00851227|Conivaptan|conivaptan|mesh-list
20346048|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20346049|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258805|NCT02705300|Tocotrienols|tocotrienols|mesh-list
19258806|NCT02705300|Vitamin E|vitamin e|mesh-list
19258807|NCT02705300|Tocopherols|tocopherols|mesh-list
20172513|NCT00158587|Primaquine|primaquine|mesh-list
20172514|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
20172515|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19655838|NCT04985266|Tamoxifen|tamoxifen|mesh-list
19655839|NCT04985266|Letrozole|letrozole|mesh-list
19655840|NCT04985266|Fulvestrant|fulvestrant|mesh-list
19655841|NCT04985266|Palbociclib|palbociclib|mesh-list
19655842|NCT04985266|Anastrozole|anastrozole|mesh-list
19655843|NCT04985266|Exemestane|exemestane|mesh-list
19655844|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655845|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19655846|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19655847|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655848|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258808|NCT02705300|Fluorouracil|fluorouracil|mesh-list
19655849|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19655850|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
19665534|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20172516|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20346050|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
20346051|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346052|NCT00851344|Cetirizine|cetirizine|mesh-list
20346053|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20346054|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20346055|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20346056|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
20346057|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
20346058|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346059|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346060|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346061|NCT00851370|Omalizumab|omalizumab|mesh-list
20346062|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20346063|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20346064|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
20346065|NCT00851461|Goserelin|goserelin|mesh-list
20346066|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20346067|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655851|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655852|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655853|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19655854|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19655855|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19655856|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19655857|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20172517|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172518|NCT00158652|Carboplatin|carboplatin|mesh-list
20172519|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172520|NCT00158678|Cisplatin|cisplatin|mesh-list
20172521|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172522|NCT00158691|Amifostine|amifostine|mesh-list
20172523|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20172524|NCT00158691|Protective Agents|protective agents|mesh-ancestor
20172525|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172526|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20172527|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
20172528|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172529|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20172530|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20172531|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172532|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172533|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20172534|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
20346068|NCT00851487|Amoxicillin|amoxicillin|mesh-list
20346069|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346070|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346071|NCT00851513|Lidocaine|lidocaine|mesh-list
20346072|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
20346073|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
20346074|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346075|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346076|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
20346077|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346078|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20346079|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20346080|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20346081|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346082|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346083|NCT00851565|Infliximab|infliximab|mesh-list
20346084|NCT00851565|Antibodies|antibodies|mesh-list
20346085|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
20346086|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346087|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
20346088|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346089|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346090|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
20346091|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20346092|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
20346093|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346094|NCT00851708|Expectorants|expectorants|mesh-ancestor
20346095|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
20346096|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20346097|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
20346098|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346099|NCT00851708|Protective Agents|protective agents|mesh-ancestor
20346100|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346101|NCT00851708|Antidotes|antidotes|mesh-ancestor
20346102|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20172535|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346103|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20346104|NCT00851864|Tinzaparin|tinzaparin|mesh-list
20346105|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20346106|NCT00851864|Dalteparin|dalteparin|mesh-list
20172536|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20346107|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
20346108|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20346109|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20346110|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348494|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348495|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20348496|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20348497|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
20348498|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
20348499|NCT00864591|Adenosine|adenosine|mesh-list
20348500|NCT00864591|Analgesics|analgesics|mesh-ancestor
20348501|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
20348502|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348503|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348504|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20348505|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
20348506|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20348507|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
20348508|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
20348509|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348510|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348511|NCT00864604|Nabumetone|nabumetone|mesh-list
20348512|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20348513|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20348514|NCT00864604|Analgesics|analgesics|mesh-ancestor
20348515|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
20348516|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348517|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348518|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348519|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348520|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20348521|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20348522|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348523|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348524|NCT00864617|Nifedipine|nifedipine|mesh-list
20348525|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20348526|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348527|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348528|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20348529|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348530|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
20348531|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
20348532|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20348533|NCT00864643|Atorvastatin|atorvastatin|mesh-list
20348534|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20348535|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20348536|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
20348537|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348538|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20348539|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20348540|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348541|NCT00864669|Metformin|metformin|mesh-list
20348542|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348543|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258809|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
20346111|NCT00851929|Ambrisentan|ambrisentan|mesh-list
20346112|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19258810|NCT02705300|Irinotecan|irinotecan|mesh-list
19258811|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
19258812|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346113|NCT00851942|Cosyntropin|cosyntropin|mesh-list
20346114|NCT00851942|Hormones|hormones|mesh-ancestor
20346115|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346116|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346117|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
20346118|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20346119|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19258813|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
19258814|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258815|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19258816|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346120|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346121|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20172537|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20172538|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172539|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172540|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20172541|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
20172542|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172543|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20172544|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20172545|NCT00158782|Lapatinib|lapatinib|mesh-list
20172546|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172547|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20172548|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172549|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172550|NCT00158821|Tenofovir|tenofovir|mesh-list
20172551|NCT00158821|Lamivudine|lamivudine|mesh-list
20172552|NCT00158821|Efavirenz|efavirenz|mesh-list
20172553|NCT00158821|Stavudine|stavudine|mesh-list
20172554|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
20172555|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172556|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19258817|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19258818|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
19258819|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19258820|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19258821|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258822|NCT02705300|Antidotes|antidotes|mesh-ancestor
19258823|NCT02705300|Protective Agents|protective agents|mesh-ancestor
19258824|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
19258825|NCT02705300|Vitamins|vitamins|mesh-ancestor
19258826|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
19258827|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
19258828|NCT02678533|Plerixafor|plerixafor|mesh-list
19258829|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19258830|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19258831|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
19258832|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258833|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
19258834|NCT02593123|Molgramostim|molgramostim|mesh-list
19258835|NCT02593123|Lenograstim|lenograstim|mesh-list
20346122|NCT00852046|Analgesics|analgesics|mesh-ancestor
20346123|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
20346124|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258836|NCT02593123|Sargramostim|sargramostim|mesh-list
19258837|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19258838|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
19258839|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346125|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20346126|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20346127|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20346128|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
20346129|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346130|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346131|NCT00852059|Methylphenidate|methylphenidate|mesh-list
20172557|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20172558|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172559|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172560|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20172561|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20172562|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20346132|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20346133|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346134|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20172563|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20172564|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20172565|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20172566|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20172567|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20172568|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
20172569|NCT00158834|Fluticasone|fluticasone|mesh-list
20172570|NCT00158834|Xhance|xhance|mesh-list
20172571|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20172572|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20172573|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20172574|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
20346135|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20346136|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346137|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346138|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
20346139|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346140|NCT00852163|Busulfan|busulfan|mesh-list
20346141|NCT00852163|Clofarabine|clofarabine|mesh-list
20346142|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
20346143|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346144|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346145|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
20346146|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346147|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20346148|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346149|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20346150|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20346151|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
20346152|NCT00852189|Folic Acid|folic acid|mesh-list
20346153|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
20346154|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
20346155|NCT00852189|Hematinics|hematinics|mesh-ancestor
20346156|NCT00852189|Vitamins|vitamins|mesh-ancestor
20346157|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
20346158|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346159|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346160|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
20346161|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
20346162|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
20346163|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346164|NCT00852228|Cetuximab|cetuximab|mesh-list
20346165|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
20346166|NCT00852228|Irinotecan|irinotecan|mesh-list
20346167|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20346168|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346169|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20346170|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20346171|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346172|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346173|NCT00852332|Curcumin|curcumin|mesh-list
20346174|NCT00852332|Docetaxel|docetaxel|mesh-list
20346175|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346176|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
19655858|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19655859|NCT04983095|Hormones|hormones|mesh-list
20172575|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172576|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172577|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20172578|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
20172579|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20172580|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20172581|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20346177|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
20346178|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
20346179|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346180|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19655860|NCT04983095|Androgens|androgens|mesh-list
20346181|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20346182|NCT00852332|Analgesics|analgesics|mesh-ancestor
20346183|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
20346184|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346185|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346186|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20346187|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346188|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346189|NCT00852345|Clofazimine|clofazimine|mesh-list
20346190|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20346191|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
20346192|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346193|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346194|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
20346195|NCT00852371|Piperaquine|piperaquine|mesh-list
20346196|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
20346197|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20346198|NCT00852371|Amodiaquine|amodiaquine|mesh-list
20172582|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20172583|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20172584|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
20172585|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172586|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172587|NCT00158847|Fluticasone|fluticasone|mesh-list
20172588|NCT00158847|Xhance|xhance|mesh-list
20172589|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20172590|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20172591|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20172592|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
20172593|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172594|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172595|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20172596|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
20346199|NCT00852371|Artenimol|artenimol|mesh-list
19258840|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19258841|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258842|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19258843|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
19258844|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19258845|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258846|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258847|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258848|NCT02591147|Fluorides|fluorides|mesh-list
19258849|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
19258850|NCT02591147|Protective Agents|protective agents|mesh-ancestor
19258851|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258852|NCT02574455|Gemcitabine|gemcitabine|mesh-list
19258853|NCT02574455|Capecitabine|capecitabine|mesh-list
19258854|NCT02574455|Vinorelbine|vinorelbine|mesh-list
19258855|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19258856|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
19258857|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258858|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258859|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
19258860|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258861|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258862|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19258863|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
19258864|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258865|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19258866|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
20172597|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
20172598|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20172599|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20172600|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20172601|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20172602|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
20172603|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172604|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346200|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
20346201|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20346202|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20346203|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346204|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20346205|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346206|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346207|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20346208|NCT00852371|Renal Agents|renal agents|mesh-ancestor
20346209|NCT00852410|Lidocaine|lidocaine|mesh-list
20346210|NCT00852410|Epinephrine|epinephrine|mesh-list
20346211|NCT00852410|Racepinephrine|racepinephrine|mesh-list
20346212|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
20346213|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
20346214|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
20346215|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346216|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346217|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
20346218|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346219|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20346220|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20346221|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20346222|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346223|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346224|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20346225|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20346226|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
20346227|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346228|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20346229|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20346230|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
20346231|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20346232|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612115|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
20612116|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20612117|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
20612118|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
20174989|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20174990|NCT00166595|Risperidone|risperidone|mesh-list
20174991|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20174992|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
20174993|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20174994|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346233|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
20346234|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
20346235|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20346236|NCT00852423|Artesunate|artesunate|mesh-list
20346237|NCT00852423|Lumefantrine|lumefantrine|mesh-list
20346238|NCT00852423|Artemether|artemether|mesh-list
20174995|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20174996|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20174997|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20174998|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20174999|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175000|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20175001|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
20175002|NCT00166621|Buspirone|buspirone|mesh-list
20175003|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20175004|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175005|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175006|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175007|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175008|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20175009|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
20175010|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175011|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346239|NCT00852423|Piperaquine|piperaquine|mesh-list
20346240|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20346241|NCT00852423|Amodiaquine|amodiaquine|mesh-list
20612119|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19655861|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
19655862|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655863|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655864|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19655865|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
19655866|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832475|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832476|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
19832477|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19832478|NCT03991091|Oxytocin|oxytocin|mesh-list
19832479|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
19832480|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19832481|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832482|NCT03973229|Estradiol|estradiol|mesh-list
19832483|NCT03973229|Estrogens|estrogens|mesh-ancestor
19832484|NCT03973229|Hormones|hormones|mesh-ancestor
19832485|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20172605|NCT00158873|Fentanyl|fentanyl|mesh-list
20172606|NCT00158873|Midazolam|midazolam|mesh-list
20172607|NCT00158873|Morphine|morphine|mesh-list
20172608|NCT00158873|Remifentanil|remifentanil|mesh-list
20172609|NCT00158873|Lorazepam|lorazepam|mesh-list
20172610|NCT00158873|Propofol|propofol|mesh-list
20172611|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20172612|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172613|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172614|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20172615|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
20172616|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
20172617|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19655867|NCT04963725|Ustekinumab|ustekinumab|mesh-list
20172618|NCT00158873|Narcotics|narcotics|mesh-ancestor
20172619|NCT00158873|Analgesics|analgesics|mesh-ancestor
20175012|NCT00166686|Clonidine|clonidine|mesh-list
20175013|NCT00166686|Analgesics|analgesics|mesh-ancestor
20175014|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
20175015|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175016|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175017|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20175018|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
20175019|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
20175020|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20175021|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20175022|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20175023|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
20175024|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175025|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175026|NCT00166725|Octreotide|octreotide|mesh-list
20175027|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20175028|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20175029|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175030|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
20175031|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20175032|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175033|NCT00166816|Cyclosporine|cyclosporine|mesh-list
20175034|NCT00166816|Sirolimus|sirolimus|mesh-list
20175035|NCT00166816|Tacrolimus|tacrolimus|mesh-list
20175036|NCT00166816|Cyclosporins|cyclosporins|mesh-list
20175037|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20175038|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
20175039|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175040|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20175041|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175042|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175043|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
20175044|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175045|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
20346242|NCT00852423|Artenimol|artenimol|mesh-list
20346243|NCT00852423|Mefloquine|mefloquine|mesh-list
20346244|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
20346245|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20346246|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20346247|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346248|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346249|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
20346250|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
20346251|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20346252|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
20346253|NCT00852436|Pregabalin|pregabalin|mesh-list
20346254|NCT00852436|Analgesics|analgesics|mesh-ancestor
20346255|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
20346256|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346257|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655868|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
19655869|NCT04959266|Itraconazole|itraconazole|mesh-list
19655870|NCT04959266|Rifampin|rifampin|mesh-list
20346258|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
20346259|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20346260|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346261|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346262|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20346263|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20346264|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19655871|NCT04959266|Omeprazole|omeprazole|mesh-list
19655872|NCT04959266|Adavosertib|adavosertib|mesh-list
19655873|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19655874|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19655875|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20172620|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
20172621|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172622|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20172623|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20172624|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172625|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172626|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
20172627|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
20172628|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172629|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172630|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
19258867|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
20346265|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655876|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346266|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19665535|NCT04923867|Estradiol|estradiol|mesh-list
20172631|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
20346267|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
20172632|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
20172633|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20172634|NCT00158886|Topotecan|topotecan|mesh-list
20172635|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20172636|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20172637|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172638|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346268|NCT00852566|Dasatinib|dasatinib|mesh-list
20346269|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346270|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20172639|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172640|NCT00158990|Sertraline|sertraline|mesh-list
19258868|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
19258869|NCT02527798|Furosemide|furosemide|mesh-list
19258870|NCT02527798|Diuretics|diuretics|mesh-ancestor
19258871|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
19258872|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258873|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19258874|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19258875|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258876|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
19258877|NCT02457598|Idelalisib|idelalisib|mesh-list
19258878|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258879|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258880|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258881|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258882|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19258883|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19258884|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258885|NCT02346630|Levodopa|levodopa|mesh-list
19258886|NCT02346630|Carbidopa|carbidopa|mesh-list
19258887|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19258888|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19258889|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
19258890|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259250|NCT05173090|Ropivacaine|ropivacaine|mesh-list
20346271|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346272|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346273|NCT00852579|Azithromycin|azithromycin|mesh-list
20346274|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346275|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346276|NCT00852670|Ponesimod|ponesimod|mesh-list
20346277|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20346278|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346279|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346280|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
20346281|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346282|NCT00852683|Pregabalin|pregabalin|mesh-list
20346283|NCT00852683|Analgesics|analgesics|mesh-ancestor
20346284|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
20346285|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346286|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346287|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
20346288|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20346289|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346290|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346291|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20346292|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20346293|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20346294|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346295|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20346296|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
20346297|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20346298|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20346299|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20172641|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
20172642|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172643|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20172644|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20172645|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172646|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172647|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172648|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
20172649|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655877|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655878|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
19655879|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19655880|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19655881|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20172650|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
20172651|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346300|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
19655882|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19655883|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
19655884|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19655885|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655886|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19655887|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19655888|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
19655889|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19655890|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
19655891|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19655892|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19655893|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19655894|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19655895|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19655896|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20346301|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655897|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20172652|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20172653|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172654|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172655|NCT00159081|Haloperidol|haloperidol|mesh-list
20172656|NCT00159081|Risperidone|risperidone|mesh-list
20172657|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
20172658|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20172659|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
20172660|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172661|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172662|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172663|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20172664|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172665|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172666|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172667|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20172668|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
20172669|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
20172670|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
20175046|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19655918|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
19655919|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19655920|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655921|NCT04957758|Varenicline|varenicline|mesh-list
20175047|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175048|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20175049|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175050|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
20175051|NCT00166829|Sirolimus|sirolimus|mesh-list
20175052|NCT00166829|Tacrolimus|tacrolimus|mesh-list
20175053|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20175054|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
20175055|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175056|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20175057|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175058|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175059|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20175060|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175061|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20346302|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346303|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346304|NCT00852696|Urological Agents|urological agents|mesh-ancestor
20346305|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
20346306|NCT00852709|Clofarabine|clofarabine|mesh-list
20346307|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346308|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
20346309|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346310|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346311|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20346312|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
20346313|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346314|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346315|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20346316|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20346317|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
20346318|NCT00852787|Digoxin|digoxin|mesh-list
20346319|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20346320|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20346321|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346322|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346323|NCT00852787|Protective Agents|protective agents|mesh-ancestor
20346324|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346325|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20346326|NCT00852956|Betahistine|betahistine|mesh-list
20346327|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
20346328|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
20346329|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
20346330|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346331|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346332|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346333|NCT00853008|Cytarabine|cytarabine|mesh-list
20346334|NCT00853008|Dexamethasone|dexamethasone|mesh-list
19655922|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20346335|NCT00853008|Prednisone|prednisone|mesh-list
20346336|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
20346337|NCT00853008|Methotrexate|methotrexate|mesh-list
20346338|NCT00853008|Vincristine|vincristine|mesh-list
20346339|NCT00853008|Daunorubicin|daunorubicin|mesh-list
20346340|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
20346341|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
20346342|NCT00853008|Teniposide|teniposide|mesh-list
20346343|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20346344|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
20346345|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
20346346|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172671|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172672|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20172673|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20172674|NCT00159094|Vinorelbine|vinorelbine|mesh-list
20172675|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20172676|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172677|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
20172678|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
20172679|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
20172680|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655923|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20172681|NCT00159107|Acamprosate|acamprosate|mesh-list
20172682|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20172683|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
20172684|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172685|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172686|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172687|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172688|NCT00159133|Lorazepam|lorazepam|mesh-list
20172689|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
20172690|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
20172691|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
20172692|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
20172693|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172694|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172695|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346347|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172696|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20346348|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346349|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
20346350|NCT00853008|Hormones|hormones|mesh-ancestor
20346351|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346352|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20346353|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346354|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20346355|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
20346356|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20346357|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20346358|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
20346359|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346360|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
20346361|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346362|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20346363|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346364|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
20346365|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346366|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20346367|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
20346368|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346369|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20346370|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20346371|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20346372|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20346373|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20346374|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20346375|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20346376|NCT00853008|Analgesics|analgesics|mesh-ancestor
20346377|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
20346378|NCT00853177|Lidocaine|lidocaine|mesh-list
20346379|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
19655924|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
19655925|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655926|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655927|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655928|NCT04950621|Propofol|propofol|mesh-list
19655929|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19655930|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655931|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655932|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19655933|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
20346380|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346381|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346382|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
20346383|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
20346384|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346385|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20346386|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20346387|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20346388|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346389|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346390|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
20346391|NCT00853190|Hydrocodone|hydrocodone|mesh-list
19655934|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
19655935|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
20346392|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346393|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346394|NCT00853190|Narcotics|narcotics|mesh-ancestor
20346395|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346396|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346397|NCT00853190|Analgesics|analgesics|mesh-ancestor
20346398|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
20346399|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346400|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
20346401|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
19655936|NCT04947501|Ifosfamide|ifosfamide|mesh-list
20346402|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
19259251|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
20346403|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
20346404|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20346405|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
20346406|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
19655937|NCT04947501|Carboplatin|carboplatin|mesh-list
19655938|NCT04947501|Doxorubicin|doxorubicin|mesh-list
19655939|NCT04947501|Etoposide|etoposide|mesh-list
19655940|NCT04947501|Vincristine|vincristine|mesh-list
19655941|NCT04947501|Topotecan|topotecan|mesh-list
19655942|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19655943|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
19655944|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655945|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19655946|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19655947|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
19655948|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655949|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655950|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20346407|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346408|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20346409|NCT00853216|Oxycodone|oxycodone|mesh-list
20346410|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346411|NCT00853216|Narcotics|narcotics|mesh-ancestor
20346412|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346413|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346414|NCT00853216|Analgesics|analgesics|mesh-ancestor
20346415|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
20346416|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172697|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172698|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20172699|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172700|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172701|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
20172702|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
20172703|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346417|NCT00853268|Oxycodone|oxycodone|mesh-list
20346418|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346419|NCT00853268|Narcotics|narcotics|mesh-ancestor
20346420|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655951|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20172704|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172705|NCT00159146|Pindolol|pindolol|mesh-list
20346421|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346422|NCT00853268|Analgesics|analgesics|mesh-ancestor
20346423|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
20346424|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346425|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
20346426|NCT00853294|Hydrocodone|hydrocodone|mesh-list
20346427|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346428|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346429|NCT00853294|Narcotics|narcotics|mesh-ancestor
20346430|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346431|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346432|NCT00853294|Analgesics|analgesics|mesh-ancestor
20346433|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
20346434|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346435|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
20346436|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
20346437|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
20346438|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
20346439|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20346440|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
20346441|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
20346442|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346443|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20346444|NCT00853320|Oxycodone|oxycodone|mesh-list
20346445|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346446|NCT00853320|Narcotics|narcotics|mesh-ancestor
20346447|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346448|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346449|NCT00853320|Analgesics|analgesics|mesh-ancestor
20346450|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
20346451|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346452|NCT00853411|Prednisone|prednisone|mesh-list
20346453|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20346454|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
20346455|NCT00853411|Hormones|hormones|mesh-ancestor
20346456|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346457|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346458|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20346459|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346460|NCT00853450|Clopidogrel|clopidogrel|mesh-list
20346461|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20346462|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20346463|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20346464|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20346465|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
20346466|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172706|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20172707|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20172708|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
20172709|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172710|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172711|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172712|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20172713|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20172714|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
20172715|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172716|NCT00159159|Cyclosporine|cyclosporine|mesh-list
20172717|NCT00159159|Cyclosporins|cyclosporins|mesh-list
20172718|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172719|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346467|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346468|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346469|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
19655952|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19655953|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20346470|NCT00853502|Testosterone|testosterone|mesh-list
20346471|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
20346472|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
20346473|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20346474|NCT00853502|Androgens|androgens|mesh-ancestor
20346475|NCT00853502|Hormones|hormones|mesh-ancestor
20346476|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346477|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346478|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20346479|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346480|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
20346481|NCT00853554|Hydromorphone|hydromorphone|mesh-list
20346482|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346483|NCT00853554|Narcotics|narcotics|mesh-ancestor
20346484|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346485|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346486|NCT00853554|Analgesics|analgesics|mesh-ancestor
20346487|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
20346488|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346489|NCT00853684|Capecitabine|capecitabine|mesh-list
20346490|NCT00853684|Endostar protein|endostar protein|mesh-list
20346491|NCT00853684|Endostatins|endostatins|mesh-list
20346492|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20346493|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
20346494|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346495|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346496|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20346497|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20172720|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19655954|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19655955|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20346498|NCT00853684|Growth Substances|growth substances|mesh-ancestor
20346499|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346500|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
20346501|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
20346502|NCT00853697|Testosterone|testosterone|mesh-list
20346503|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
20346504|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
20346505|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20346506|NCT00853697|Dutasteride|dutasteride|mesh-list
19655956|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
19655957|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
19655958|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
19655959|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20346507|NCT00853697|Androgens|androgens|mesh-ancestor
20346508|NCT00853697|Hormones|hormones|mesh-ancestor
20346509|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346510|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172721|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
20172722|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172723|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
20172724|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172725|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
20346511|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20346512|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346513|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
20172726|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20172727|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19655960|NCT04940065|Ofatumumab|ofatumumab|mesh-list
20172728|NCT00159211|Pioglitazone|pioglitazone|mesh-list
20172729|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20172730|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172731|NCT00159224|Ritonavir|ritonavir|mesh-list
20172732|NCT00159224|Lopinavir|lopinavir|mesh-list
20172733|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19655961|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19655962|NCT04940039|Risperidone|risperidone|mesh-list
19655963|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19655964|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19655965|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
19655966|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19655967|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19655968|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655969|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19655970|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19832486|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832487|NCT03934840|Prednisone|prednisone|mesh-list
19832488|NCT03934840|Carboplatin|carboplatin|mesh-list
20346514|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20346515|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20346516|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346517|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346518|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
20346519|NCT00853736|Oxycodone|oxycodone|mesh-list
20346520|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346521|NCT00853736|Narcotics|narcotics|mesh-ancestor
20346522|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346523|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346524|NCT00853736|Analgesics|analgesics|mesh-ancestor
20346525|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
20346526|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348544|NCT00864734|Metformin|metformin|mesh-list
20348545|NCT00864734|Glyburide|glyburide|mesh-list
20348546|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348547|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348548|NCT00864747|Propranolol|propranolol|mesh-list
20348549|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20348550|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20348551|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
20348552|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348553|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348554|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832489|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832490|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832491|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
19832492|NCT03934840|Hormones|hormones|mesh-ancestor
20172734|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20172735|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
20172736|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172737|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172738|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20172739|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20172740|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
20172741|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19832493|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612120|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348555|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20612121|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
20612122|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19832494|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655971|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19655972|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19655973|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19655974|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
20346527|NCT00853866|Reboxetine|reboxetine|mesh-list
20346528|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
20346529|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20346530|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20346531|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20346532|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346533|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346534|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
20346535|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346536|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346537|NCT00853879|Vitamins|vitamins|mesh-list
20346538|NCT00853879|Folic Acid|folic acid|mesh-list
20346539|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
20346540|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
20346541|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
20346542|NCT00853879|Pyridoxal|pyridoxal|mesh-list
20346543|NCT00853879|Pyridoxine|pyridoxine|mesh-list
20346544|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
20346545|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
20346546|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346547|NCT00853879|Hematinics|hematinics|mesh-ancestor
20346548|NCT00853892|Oxycodone|oxycodone|mesh-list
20346549|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20346550|NCT00853892|Narcotics|narcotics|mesh-ancestor
20346551|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19832495|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20346552|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346553|NCT00853892|Analgesics|analgesics|mesh-ancestor
20346554|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
20346555|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346556|NCT00853931|Panitumumab|panitumumab|mesh-list
20346557|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20346558|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346559|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20346560|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20346561|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20346562|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346563|NCT00853944|Incretins|incretins|mesh-ancestor
20346564|NCT00853944|Hormones|hormones|mesh-ancestor
20346565|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346566|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20346567|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346568|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346569|NCT00853983|Saracatinib|saracatinib|mesh-list
20346570|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346571|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346572|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346573|NCT00854009|BLI-489|bli-489|mesh-list
20346574|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20346575|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346576|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346577|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346578|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346579|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20346580|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20346581|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346582|NCT00854035|Incretins|incretins|mesh-ancestor
20346583|NCT00854035|Hormones|hormones|mesh-ancestor
20346584|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346585|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20346586|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
20346587|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346588|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346589|NCT00854139|Cyclosporine|cyclosporine|mesh-list
20346590|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
20346591|NCT00854139|Cyclosporins|cyclosporins|mesh-list
20346592|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20346593|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346594|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
19259252|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
20346595|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346596|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346597|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20346598|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
20346599|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346600|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346601|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20346602|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346603|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
20346604|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346605|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612123|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612124|NCT02249871|Omeprazole|omeprazole|mesh-list
20172742|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20172743|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20172744|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
20172745|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20172746|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
20346606|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20346607|NCT00854178|Anesthetics|anesthetics|mesh-list
20346608|NCT00854178|Isoflurane|isoflurane|mesh-list
20346609|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346610|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346611|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
20346612|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20346613|NCT00854204|Darunavir|darunavir|mesh-list
20346614|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20346615|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20346616|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
20346617|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346618|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346619|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20346620|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20346621|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
20346622|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346623|NCT00854230|Naltrexone|naltrexone|mesh-list
20346624|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20346625|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20346626|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19655975|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19655976|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19655977|NCT04938830|Palivizumab|palivizumab|mesh-list
19655978|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
20172747|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172748|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172749|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20172750|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
20346627|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
19832496|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
20346628|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346629|NCT00854256|Mitomycins|mitomycins|mesh-list
20346630|NCT00854256|Mitomycin|mitomycin|mesh-list
20346631|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20346632|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346633|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
20346634|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346635|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20346636|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346637|NCT00854321|Rituximab|rituximab|mesh-list
20346638|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20346639|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346640|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
20346641|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346642|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346643|NCT00854425|Asparaginase|asparaginase|mesh-list
20346644|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346645|NCT00854451|Amoxicillin|amoxicillin|mesh-list
20346646|NCT00854451|Omeprazole|omeprazole|mesh-list
20346647|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346648|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346649|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19655979|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172751|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20172752|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
20172753|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172754|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172755|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20172756|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172757|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
20172758|NCT00159302|Protective Agents|protective agents|mesh-ancestor
20172759|NCT00159380|Pimagedine|pimagedine|mesh-list
20172760|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172761|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172762|NCT00159445|Gemcitabine|gemcitabine|mesh-list
20172763|NCT00159445|Capecitabine|capecitabine|mesh-list
20172764|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20172765|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
20172766|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346650|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346651|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20346652|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346653|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346654|NCT00854477|Capecitabine|capecitabine|mesh-list
20346655|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20346656|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
20346657|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346658|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346659|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20346660|NCT00854503|Simvastatin|simvastatin|mesh-list
20346661|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20172767|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172768|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
20346662|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20346663|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
20346664|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346665|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20346666|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20346667|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346668|NCT00854529|Bevacizumab|bevacizumab|mesh-list
20346669|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20346670|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346671|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20346672|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20346673|NCT00854529|Growth Substances|growth substances|mesh-ancestor
20346674|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346675|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
20346676|NCT00854633|Lactoferrin|lactoferrin|mesh-list
20172769|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172770|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172771|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20172772|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
20172773|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172774|NCT00159458|Gemcitabine|gemcitabine|mesh-list
20172775|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
20172776|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20172777|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
20172778|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172779|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258891|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346677|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
20346678|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346679|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258892|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258893|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19258894|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172780|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
20172781|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172782|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172783|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20172784|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
20172785|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172786|NCT00159471|Gemcitabine|gemcitabine|mesh-list
20172787|NCT00159471|Capecitabine|capecitabine|mesh-list
20172788|NCT00159471|Docetaxel|docetaxel|mesh-list
20172789|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20172790|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
19258906|NCT02067975|Tryptophan|tryptophan|mesh-list
19258907|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19258908|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
19258909|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19258910|NCT02035137|Irinotecan|irinotecan|mesh-list
19258911|NCT02035137|Vincristine|vincristine|mesh-list
19258912|NCT02035137|Vorinostat|vorinostat|mesh-list
19258913|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19258914|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19258915|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19258916|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19258917|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258918|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258919|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19258920|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
19258921|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19258922|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19258923|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19258924|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19258925|NCT01964807|Nicotine|nicotine|mesh-list
19258926|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19258927|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
19258928|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19258929|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258930|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19258931|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19258932|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
19258933|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258934|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258935|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
19258936|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19258937|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19258938|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19258939|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19258940|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346680|NCT00854646|ON 01910|on 01910|mesh-list
20346681|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346682|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20346683|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346684|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346685|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
20346686|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20346687|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
20172791|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172792|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19832497|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20172793|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
20172794|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612125|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20172795|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172796|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20172797|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
20172798|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172799|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
20172800|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
20172801|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
20172802|NCT00159484|Celecoxib|celecoxib|mesh-list
20172803|NCT00159484|Epothilone B|epothilone b|mesh-list
20172804|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20172805|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20172806|NCT00159484|Analgesics|analgesics|mesh-ancestor
20346688|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346689|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346690|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20346691|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
20346692|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20346693|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
20346694|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346695|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346696|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20346697|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
20346698|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
20346699|NCT00854711|Protective Agents|protective agents|mesh-ancestor
20346700|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20346701|NCT00854750|Hormones|hormones|mesh-ancestor
20346702|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346703|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346704|NCT00854763|Olmesartan|olmesartan|mesh-list
19832498|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19832499|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832500|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832501|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19832502|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
19832503|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19832504|NCT03879629|Carvedilol|carvedilol|mesh-list
19832505|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19832506|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20346705|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20346706|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20346707|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20346708|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346709|NCT00854776|Lansoprazole|lansoprazole|mesh-list
20346710|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
20172807|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
19832507|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
20172808|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172809|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346711|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20346712|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20172810|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20172811|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20172812|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20346713|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346714|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20346715|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346716|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346717|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20346718|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
20172813|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20346719|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172814|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346720|NCT00854776|Antacids|antacids|mesh-ancestor
20346721|NCT00854802|Ribavirin|ribavirin|mesh-list
20346722|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20346723|NCT00854802|Cyclosporine|cyclosporine|mesh-list
20346724|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
20346725|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346726|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
20346727|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346728|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
20346729|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
20346730|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346731|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346732|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
20346733|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346734|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346735|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20346736|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
20346737|NCT00854841|Dasatinib|dasatinib|mesh-list
20346738|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346739|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20346740|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346741|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346742|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
20346743|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20346744|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346745|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346746|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20346747|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20346748|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20172815|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172816|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20172817|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
20172818|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
20172819|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
20172820|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
20172821|NCT00159510|Methylene Blue|methylene blue|mesh-list
20172822|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20172823|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
20172824|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172825|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172826|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20172827|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
20172828|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20172829|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
20172830|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172831|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346749|NCT00855049|Acetaminophen|acetaminophen|mesh-list
20346750|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19665536|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19665537|NCT04923867|Estrogens|estrogens|mesh-ancestor
20172832|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20172833|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172834|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
20172835|NCT00159510|Protective Agents|protective agents|mesh-ancestor
20172836|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172837|NCT00159536|Metformin|metformin|mesh-list
20172838|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20172839|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172840|NCT00159575|Metformin|metformin|mesh-list
20172841|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20172842|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172843|NCT00159614|Rolofylline|rolofylline|mesh-list
20172844|NCT00159614|Diuretics|diuretics|mesh-ancestor
20172845|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
20172846|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172847|NCT00159627|Rolofylline|rolofylline|mesh-list
20172848|NCT00159627|Diuretics|diuretics|mesh-ancestor
20172849|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
20172850|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172851|NCT00159653|Timolol|timolol|mesh-list
20172852|NCT00159653|Latanoprost|latanoprost|mesh-list
20172853|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20172854|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20172855|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
20172856|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172857|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172858|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172859|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20172860|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20172861|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20172862|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20172863|NCT00159666|Pregabalin|pregabalin|mesh-list
20172864|NCT00159666|Analgesics|analgesics|mesh-ancestor
20172865|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
20172866|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346751|NCT00855049|Analgesics|analgesics|mesh-ancestor
20346752|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
20346753|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346754|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346755|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
20172867|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172868|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
20172869|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20346756|NCT00855088|Ritonavir|ritonavir|mesh-list
20346757|NCT00855088|Darunavir|darunavir|mesh-list
20346758|NCT00855088|Etravirine|etravirine|mesh-list
20346759|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20346760|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20346761|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
20346762|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346763|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346764|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20346765|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20346766|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
20346767|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346768|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20346769|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20346770|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20346771|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20346772|NCT00855101|Voriconazole|voriconazole|mesh-list
20346773|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
20346774|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346775|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20346776|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20346777|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346778|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346779|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20346780|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
20172870|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172871|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172872|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20172873|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20172874|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172875|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172876|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172877|NCT00159679|Pregabalin|pregabalin|mesh-list
20172878|NCT00159679|Analgesics|analgesics|mesh-ancestor
20346781|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346782|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346783|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20346784|NCT00855114|Everolimus|everolimus|mesh-list
20346785|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346786|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346787|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
20172879|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
20172880|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172881|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172882|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
20172883|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20172884|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172885|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172886|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20172887|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20172888|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172889|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172890|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172891|NCT00159692|Amlodipine|amlodipine|mesh-list
20172892|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20172893|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20346788|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346789|NCT00855153|Cycloserine|cycloserine|mesh-list
20346790|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20346791|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346792|NCT00855153|Renal Agents|renal agents|mesh-ancestor
20346793|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20346794|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
20346795|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346796|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
20346797|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346798|NCT00855205|Rituximab|rituximab|mesh-list
20346799|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20346800|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346801|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
20346802|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346803|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346804|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
20346805|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20346806|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
20346807|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20346808|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20346809|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20346810|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
20346811|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348556|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20346812|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346813|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346814|NCT00855361|Rabeprazole|rabeprazole|mesh-list
20346815|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20346816|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346817|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20346818|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346819|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255312|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
19255313|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255314|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255315|NCT02979977|Cetuximab|cetuximab|mesh-list
19255316|NCT02979977|Afatinib|afatinib|mesh-list
19255317|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255318|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255319|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19255320|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255321|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255322|NCT02975492|Vitamin D|vitamin d|mesh-list
19255323|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
19255324|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
19255325|NCT02975492|Vitamins|vitamins|mesh-list
19255326|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
19255327|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346820|NCT00855387|Pancrelipase|pancrelipase|mesh-list
19255328|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19255329|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20346821|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20346822|NCT00855517|Latanoprost|latanoprost|mesh-list
20346823|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20346824|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20346825|NCT00855530|Amibegron|amibegron|mesh-list
19255330|NCT02866682|Tacrolimus|tacrolimus|mesh-list
19255331|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255332|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
19255333|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255334|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19255335|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255336|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255337|NCT02855229|Methylphenidate|methylphenidate|mesh-list
19255338|NCT02855229|Modafinil|modafinil|mesh-list
19255339|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19255340|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255341|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19255342|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19255343|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19255344|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255345|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
19255346|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255347|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19255348|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19255349|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19255350|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19255351|NCT02827526|Ketamine|ketamine|mesh-list
19255352|NCT02827526|Analgesics|analgesics|mesh-ancestor
19255353|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
19255354|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19255355|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255356|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19255357|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19255358|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
19255359|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
19255360|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19255361|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19255362|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19255363|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255364|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255365|NCT02743923|Paclitaxel|paclitaxel|mesh-list
19255366|NCT02743923|Bevacizumab|bevacizumab|mesh-list
19255367|NCT02743923|Carboplatin|carboplatin|mesh-list
19255368|NCT02743923|Pemetrexed|pemetrexed|mesh-list
19255369|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20346826|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20346827|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20346828|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
20346829|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346830|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346831|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255370|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255371|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
19255372|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
19255373|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
19255374|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255375|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255376|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19255377|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19255378|NCT02743923|Growth Substances|growth substances|mesh-ancestor
19255379|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255380|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
19255381|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255382|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19255383|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19255384|NCT02735707|Aspirin|aspirin|mesh-list
19255385|NCT02735707|Vitamins|vitamins|mesh-list
19255386|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
19255387|NCT02735707|Interferons|interferons|mesh-list
19255388|NCT02735707|Ritonavir|ritonavir|mesh-list
19255389|NCT02735707|Lopinavir|lopinavir|mesh-list
19255390|NCT02735707|Interferon-beta|interferon-beta|mesh-list
19255391|NCT02735707|Oseltamivir|oseltamivir|mesh-list
19255392|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
19255393|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
19255394|NCT02735707|Amoxicillin|amoxicillin|mesh-list
19255395|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
19255396|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
19255397|NCT02735707|Levofloxacin|levofloxacin|mesh-list
19255398|NCT02735707|Ivermectin|ivermectin|mesh-list
19255399|NCT02735707|Tazobactam|tazobactam|mesh-list
19255400|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
19255401|NCT02735707|Piperacillin|piperacillin|mesh-list
19255402|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
19255403|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19255404|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19255405|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19255406|NCT02735707|Apremilast|apremilast|mesh-list
19255407|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
19255408|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19255409|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20172894|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172895|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172896|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19656022|NCT04929223|Bevacizumab|bevacizumab|mesh-list
19656023|NCT04929223|Cetuximab|cetuximab|mesh-list
19656024|NCT04929223|Atezolizumab|atezolizumab|mesh-list
19656025|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656026|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656027|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20346832|NCT00855608|Adalimumab|adalimumab|mesh-list
19255410|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19255411|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19255412|NCT02735707|Losartan|losartan|mesh-list
20346833|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20346834|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346835|NCT00855660|Riociguat|riociguat|mesh-list
20346836|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
20348557|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
19255413|NCT02735707|Valsartan|valsartan|mesh-list
19255414|NCT02735707|Telmisartan|telmisartan|mesh-list
19255415|NCT02735707|Candesartan|candesartan|mesh-list
19255416|NCT02735707|Ramipril|ramipril|mesh-list
19255417|NCT02735707|Olmesartan|olmesartan|mesh-list
19255418|NCT02735707|Enalapril|enalapril|mesh-list
19255419|NCT02735707|Lisinopril|lisinopril|mesh-list
19255420|NCT02735707|Irbesartan|irbesartan|mesh-list
19255421|NCT02735707|Perindopril|perindopril|mesh-list
19255422|NCT02735707|Captopril|captopril|mesh-list
19255423|NCT02735707|Trandolapril|trandolapril|mesh-list
19255424|NCT02735707|Clopidogrel|clopidogrel|mesh-list
19255425|NCT02735707|Ticagrelor|ticagrelor|mesh-list
19255426|NCT02735707|Simvastatin|simvastatin|mesh-list
19255427|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19255428|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
19255429|NCT02735707|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19255430|NCT02735707|Antibodies|antibodies|mesh-list
19255431|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19255432|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19255433|NCT02735707|Cysteamine|cysteamine|mesh-list
19255434|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
19255435|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255436|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255437|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255438|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19255439|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19255440|NCT02735707|Analgesics|analgesics|mesh-ancestor
19255441|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
19255442|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19255443|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19255444|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255445|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19255446|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19255447|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255448|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19255449|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19255450|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
19255451|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20172897|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172898|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172899|NCT00159705|Pregabalin|pregabalin|mesh-list
20172900|NCT00159705|Analgesics|analgesics|mesh-ancestor
20172901|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
20172902|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172903|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172904|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
20172905|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19255452|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19255453|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
19255454|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19255455|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19255456|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19255457|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19255458|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19255459|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19255460|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19255461|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
19255462|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255463|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19255464|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19255465|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19255466|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
19255467|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19255468|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19255469|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19255470|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19255471|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
19255472|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19656028|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19656029|NCT04929223|Growth Substances|growth substances|mesh-ancestor
19255473|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19255474|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
19255475|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19255476|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19255477|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19255478|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
19255479|NCT02735707|Protective Agents|protective agents|mesh-ancestor
19255480|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19255481|NCT02735707|Renal Agents|renal agents|mesh-ancestor
19255482|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19255483|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19255484|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19255485|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19255486|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19255487|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19255488|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19255489|NCT02431247|Tenofovir|tenofovir|mesh-list
19255490|NCT02431247|Emtricitabine|emtricitabine|mesh-list
19255491|NCT02431247|Darunavir|darunavir|mesh-list
19255492|NCT02431247|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19255493|NCT02431247|Cobicistat|cobicistat|mesh-list
19255494|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19255495|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
19255496|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255497|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19255498|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19255499|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255500|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255501|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19255502|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19255503|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19255504|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19255505|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
19255506|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19255507|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19255508|NCT02397226|Anesthetics|anesthetics|mesh-list
19255509|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19255510|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255511|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
19255512|NCT02345850|Methotrexate|methotrexate|mesh-list
19255513|NCT02345850|Tacrolimus|tacrolimus|mesh-list
19255514|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255515|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
19255516|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255517|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656030|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172906|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172907|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172908|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20172909|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19255518|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19255519|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
19255520|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255521|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255522|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19255523|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19255524|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
19255525|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19255526|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19656031|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
20172910|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172911|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19255527|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
19255528|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
19255529|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255530|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19255531|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19255532|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19255533|NCT02281084|Azacitidine|azacitidine|mesh-list
19255534|NCT02281084|Durvalumab|durvalumab|mesh-list
19255535|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20346837|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346838|NCT00855686|Memantine|memantine|mesh-list
20172912|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172913|NCT00159718|Amlodipine|amlodipine|mesh-list
20172914|NCT00159718|Atorvastatin|atorvastatin|mesh-list
20172915|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19255536|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
19255537|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255538|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255539|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255540|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255541|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
19255542|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
19255543|NCT02220985|Thiotepa|thiotepa|mesh-list
19255544|NCT02220985|Methotrexate|methotrexate|mesh-list
19255545|NCT02220985|Fludarabine|fludarabine|mesh-list
19255546|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
19255547|NCT02220985|Tacrolimus|tacrolimus|mesh-list
19255548|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255549|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
19255550|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255551|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255552|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19255553|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
19255554|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255555|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255556|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19255557|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19255558|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
20172916|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20172917|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
20172918|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172919|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19656038|NCT04927975|Upadacitinib|upadacitinib|mesh-list
20346839|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20172920|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20172921|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172922|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20172923|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20172924|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172925|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20172926|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172927|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172928|NCT00159731|Pregabalin|pregabalin|mesh-list
20172929|NCT00159731|Analgesics|analgesics|mesh-ancestor
20346840|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20346841|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
19255559|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19255560|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19255561|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
19255562|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
19255563|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172930|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
20346842|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255564|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19255565|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19255566|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19255567|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19255568|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19255569|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
19255570|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19255571|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255572|NCT02109081|Dexamethasone|dexamethasone|mesh-list
19255573|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19255574|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
19255575|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
19255576|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19255577|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255578|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19255579|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
19255580|NCT02109081|Hormones|hormones|mesh-ancestor
19255581|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19255582|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19255583|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258941|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258942|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259253|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259254|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259255|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
19259256|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259257|NCT05172934|Tenecteplase|tenecteplase|mesh-list
20172931|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172932|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172933|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
20172934|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20172935|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20172936|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172937|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20172938|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20172939|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172940|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172941|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172942|NCT00159757|Ziprasidone|ziprasidone|mesh-list
20172943|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20172944|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
20172945|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172946|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172947|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172948|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20172949|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172950|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172951|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19259258|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19259259|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19259260|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259261|NCT05172817|Adalimumab|adalimumab|mesh-list
19259262|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259263|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259264|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19259265|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259266|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
19259267|NCT05172739|Anesthetics|anesthetics|mesh-list
19259268|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259269|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259270|NCT05172739|Narcotics|narcotics|mesh-ancestor
20172952|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20172953|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
19259271|NCT05172739|Analgesics|analgesics|mesh-ancestor
19259272|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
19259273|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259274|NCT05172570|Gabapentin|gabapentin|mesh-list
19259275|NCT05172570|Analgesics|analgesics|mesh-ancestor
19259276|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
19259277|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259278|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259279|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
20172954|NCT00159770|Olanzapine|olanzapine|mesh-list
19259280|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19255584|NCT01962792|Dexamethasone|dexamethasone|mesh-list
19255585|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20172955|NCT00159770|Risperidone|risperidone|mesh-list
20172956|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20172957|NCT00159770|Ziprasidone|ziprasidone|mesh-list
20172958|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20172959|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
20172960|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20172961|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172962|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20172963|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20172964|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20172965|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20172966|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20172967|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20172968|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
20172969|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
20172970|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
20172971|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20172972|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20172973|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20172974|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20172975|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346843|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346844|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346845|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20346846|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20346847|NCT00855699|Acamprosate|acamprosate|mesh-list
20346848|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20346849|NCT00855777|Ibuprofen|ibuprofen|mesh-list
20346850|NCT00855777|Etoricoxib|etoricoxib|mesh-list
20346851|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20346852|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20346853|NCT00855777|Analgesics|analgesics|mesh-ancestor
20346854|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
20346855|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346856|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346857|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20346858|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20346859|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20346860|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346861|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346862|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20346863|NCT00855881|Tegafur|tegafur|mesh-list
20346864|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20346865|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
20346866|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346867|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346868|NCT00855972|Naltrexone|naltrexone|mesh-list
20346869|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20346870|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20346871|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346872|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
20346873|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346874|NCT00856037|Doxorubicin|doxorubicin|mesh-list
20346875|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20346876|NCT00856037|Topotecan|topotecan|mesh-list
20346877|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20172976|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
19255586|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
19255587|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
19255588|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19255589|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255590|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19255591|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
19255592|NCT01962792|Hormones|hormones|mesh-ancestor
19255593|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19255594|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19255595|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255596|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
19255597|NCT01850108|Sirolimus|sirolimus|mesh-list
20172977|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
20172978|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346878|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255598|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
19255599|NCT01850108|Fludarabine|fludarabine|mesh-list
19255600|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
19255601|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255602|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
19255603|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255604|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255605|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20346879|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20346880|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20346881|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346882|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346883|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20346884|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20346885|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20346886|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20346887|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20346888|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346889|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
20346890|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346891|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346892|NCT00856089|Retapamulin|retapamulin|mesh-list
20346893|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346894|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346895|NCT00856271|Losartan|losartan|mesh-list
20346896|NCT00856271|Olmesartan|olmesartan|mesh-list
20346897|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20346898|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20346899|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20346900|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20346901|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20346902|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346903|NCT00856310|Fasinumab|fasinumab|mesh-list
20346904|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20346905|NCT00856310|Analgesics|analgesics|mesh-ancestor
20346906|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
20346907|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20346908|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346909|NCT00856362|Moxidectin|moxidectin|mesh-list
20346910|NCT00856362|Midazolam|midazolam|mesh-list
20346911|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20346912|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20346913|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20346914|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346915|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20346916|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20346917|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20346918|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20346919|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
19255606|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
19255607|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255608|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346920|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
20346921|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
20346922|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
20346923|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346924|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255609|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19255610|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19255611|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19255612|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
19255613|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19255614|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255615|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255616|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
19255617|NCT01546948|Methadone|methadone|mesh-list
19255618|NCT01546948|Hydromorphone|hydromorphone|mesh-list
19255619|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19255620|NCT01546948|Narcotics|narcotics|mesh-ancestor
19255621|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19255622|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255623|NCT01546948|Analgesics|analgesics|mesh-ancestor
19255624|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
20346925|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
19255625|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19255626|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
20346926|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20346927|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346928|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
20346929|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
20346930|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346931|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20346932|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
20346933|NCT00856505|Everolimus|everolimus|mesh-list
20346934|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20346935|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255627|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
19255628|NCT01495676|Gemcitabine|gemcitabine|mesh-list
19255629|NCT01495676|Cisplatin|cisplatin|mesh-list
19255630|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255631|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19255632|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
19255633|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255634|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
19255635|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255636|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255637|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255638|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
19255639|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255640|NCT01464164|Prednisone|prednisone|mesh-list
19255641|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19255642|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
19255643|NCT01464164|Hormones|hormones|mesh-ancestor
19255644|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19255645|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255646|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19255647|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255648|NCT01318317|Plerixafor|plerixafor|mesh-list
19255649|NCT01318317|Rituximab|rituximab|mesh-list
19255650|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19255651|NCT01318317|Antibodies|antibodies|mesh-list
19255652|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
19255653|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19255654|NCT01318317|Lenograstim|lenograstim|mesh-list
19255655|NCT01318317|Sargramostim|sargramostim|mesh-list
19255656|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
19255657|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255658|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255659|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255660|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19255661|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20346936|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
20346937|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346938|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20346939|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20346940|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
20346941|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19255662|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19255663|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
19255664|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255665|NCT01111565|Aripiprazole|aripiprazole|mesh-list
19255666|NCT01111565|Citalopram|citalopram|mesh-list
19255667|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19255668|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19255669|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19255670|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255671|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255672|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
19255673|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255674|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19255675|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
19255676|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19255677|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19255678|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19255679|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19255680|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
19255681|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
19255682|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19255683|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19832508|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255684|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19255685|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20346942|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346943|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20346944|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346945|NCT00856570|Warfarin|warfarin|mesh-list
20172979|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172980|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20172981|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20172982|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172983|NCT00159809|Urological Agents|urological agents|mesh-ancestor
20172984|NCT00159835|Atorvastatin|atorvastatin|mesh-list
20172985|NCT00159835|Simvastatin|simvastatin|mesh-list
20172986|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20172987|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20172988|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
20172989|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172990|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20172991|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20172992|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172993|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
20172994|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20172995|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
20172996|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20172997|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20172998|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20172999|NCT00159887|Urological Agents|urological agents|mesh-ancestor
20173000|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
20346946|NCT00856570|Mirabegron|mirabegron|mesh-list
19255686|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19255687|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19255688|NCT00950989|Folic Acid|folic acid|mesh-list
19255689|NCT00950989|Methotrexate|methotrexate|mesh-list
19255690|NCT00950989|Brodalumab|brodalumab|mesh-list
19255691|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19255692|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
19255693|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19255694|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255695|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19255696|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
19255697|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255698|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255699|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
19255700|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255701|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19255702|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255703|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
19255704|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255705|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19255706|NCT00950989|Hematinics|hematinics|mesh-ancestor
19255707|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
19255708|NCT00950989|Vitamins|vitamins|mesh-ancestor
19255709|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
19255710|NCT00904046|Pioglitazone|pioglitazone|mesh-list
19255711|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19255712|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19255713|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255714|NCT00489307|Dexamethasone|dexamethasone|mesh-list
19255715|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19255716|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
19255717|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
19255718|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19255719|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255720|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19255721|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
19255722|NCT00489307|Hormones|hormones|mesh-ancestor
19255723|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19255724|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19255725|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255726|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19255727|NCT00072410|Antibodies|antibodies|mesh-list
19255728|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
19255729|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19255730|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
19255731|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255732|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255733|NCT05171400|Insulin|insulin|mesh-list
19255734|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19258943|NCT01921335|Trastuzumab|trastuzumab|mesh-list
20346947|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
20346948|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20346949|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19255735|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255736|NCT05171374|Trametinib|trametinib|mesh-list
19255737|NCT05171374|Dabrafenib|dabrafenib|mesh-list
19255738|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255739|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19255740|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255741|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255742|NCT05171335|Lenvatinib|lenvatinib|mesh-list
19255743|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255744|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19255745|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255746|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255747|NCT05171309|Apatinib|apatinib|mesh-list
19255748|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255749|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19255750|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255751|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255752|NCT05171179|Lidocaine|lidocaine|mesh-list
19255753|NCT05171179|Bupivacaine|bupivacaine|mesh-list
19255754|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
19255755|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
19656039|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19656040|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19255756|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19255757|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255758|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
19255759|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656041|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19656042|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19656043|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656044|NCT04919629|Bevacizumab|bevacizumab|mesh-list
19656045|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19656046|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
19656047|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
19656048|NCT04919629|Antibodies|antibodies|mesh-list
19255760|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19255761|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19255762|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19255763|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19255764|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255765|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
19255766|NCT05170828|Sirolimus|sirolimus|mesh-list
19255767|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
19255768|NCT05170828|Busulfan|busulfan|mesh-list
19255769|NCT05170828|Fludarabine|fludarabine|mesh-list
19255770|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19255771|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
19255772|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255773|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255774|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19255775|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
19255776|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255777|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255778|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19255779|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19255780|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19255781|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
19255782|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19255783|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255784|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255785|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
19255786|NCT05170607|Antibodies|antibodies|mesh-list
19255787|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
19255788|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346950|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20346951|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
20346952|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346953|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346954|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346955|NCT00856570|Urological Agents|urological agents|mesh-ancestor
19255789|NCT05170594|Bevacizumab|bevacizumab|mesh-list
19255790|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
20346956|NCT00856596|Sertaconazole|sertaconazole|mesh-list
20346957|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
20346958|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255791|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255792|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255793|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19255794|NCT05170594|Growth Substances|growth substances|mesh-ancestor
19255795|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255796|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
19255797|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19255798|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255799|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255800|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19255801|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
19255802|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19255803|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255804|NCT05170256|Trastuzumab|trastuzumab|mesh-list
19255805|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255806|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255807|NCT05170217|Cannabidiol|cannabidiol|mesh-list
19255808|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
19255809|NCT05170113|Caffeine|caffeine|mesh-list
19255810|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19255811|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255812|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19255813|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255814|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255815|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19255816|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19255817|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
19255818|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255819|NCT05170061|Valsartan|valsartan|mesh-list
19255820|NCT05170061|Nebivolol|nebivolol|mesh-list
19255821|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19255822|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19255823|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19255824|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255825|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
19255826|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19255827|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19255828|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19255829|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
19255830|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19255831|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255832|NCT05169801|Paclitaxel|paclitaxel|mesh-list
19255833|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19255834|NCT05169801|Carboplatin|carboplatin|mesh-list
19255835|NCT05169801|Bevacizumab|bevacizumab|mesh-list
19255836|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19255837|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255838|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
19255839|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
19255840|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
19255841|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255842|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255843|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19255844|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19255845|NCT05169801|Growth Substances|growth substances|mesh-ancestor
19255846|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255847|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
20346959|NCT00856622|Timolol|timolol|mesh-list
20346960|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20346961|NCT00856622|Latanoprost|latanoprost|mesh-list
20346962|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20346963|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20346964|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20346965|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
20346966|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20346967|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346968|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255848|NCT05169593|Adalimumab|adalimumab|mesh-list
19255849|NCT05169593|Infliximab|infliximab|mesh-list
19255850|NCT05169593|Ustekinumab|ustekinumab|mesh-list
19255851|NCT05169593|Vedolizumab|vedolizumab|mesh-list
20346969|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19255852|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19255853|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255854|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
19255855|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19255856|NCT05169554|Amoxicillin|amoxicillin|mesh-list
19255857|NCT05169554|Clarithromycin|clarithromycin|mesh-list
19255858|NCT05169554|Rifampin|rifampin|mesh-list
19255859|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
19255860|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
19255861|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19255862|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19255863|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255864|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19255865|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255866|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255867|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19255868|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19255869|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19255870|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
19255871|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
19255872|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19255873|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19255874|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19255875|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19255876|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19255877|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19255878|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19255879|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19258944|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19258945|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258946|NCT01907360|Methylphenidate|methylphenidate|mesh-list
19258947|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19258948|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346970|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20346971|NCT00856687|Montelukast|montelukast|mesh-list
20346972|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19258949|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19258950|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19258951|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19258952|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258953|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
19258954|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19258955|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19258956|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
19258957|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
19258958|NCT01873170|Etonogestrel|etonogestrel|mesh-list
19258959|NCT01873170|Desogestrel|desogestrel|mesh-list
20346973|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
20346974|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20346975|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
20346976|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346977|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346978|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20346979|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20346980|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346981|NCT00856700|Incretins|incretins|mesh-list
20346982|NCT00856700|Hormones|hormones|mesh-ancestor
20346983|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20346984|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346985|NCT00856804|Ribavirin|ribavirin|mesh-list
20346986|NCT00856804|Thalidomide|thalidomide|mesh-list
19258960|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
19258961|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19258962|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19258963|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258964|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19258965|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19258966|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19258967|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19258968|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259281|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20346987|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
19255880|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19255881|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255882|NCT05169229|Vancomycin|vancomycin|mesh-list
19255883|NCT05169229|Tobramycin|tobramycin|mesh-list
19255884|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19255885|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255886|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
19255887|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19255888|NCT05169112|Leuprolide|leuprolide|mesh-list
20346988|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20346989|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
20346990|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20346991|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20346992|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
20346993|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20346994|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
20346995|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20346996|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20346997|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20346998|NCT00856804|Growth Substances|growth substances|mesh-ancestor
20346999|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
20347000|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347001|NCT00856882|Caseins|caseins|mesh-list
20347002|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
20347003|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
20347004|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173001|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173002|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
20173003|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20612126|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612127|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20612128|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255889|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19255890|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
19255891|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19255892|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255893|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19255894|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255895|NCT05169021|Folic Acid|folic acid|mesh-list
19255896|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
19255897|NCT05169021|Amlodipine|amlodipine|mesh-list
19255898|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
19255899|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19255900|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19255901|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255902|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19255903|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255904|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
19255905|NCT05169021|Hematinics|hematinics|mesh-ancestor
19255906|NCT05169021|Vitamins|vitamins|mesh-ancestor
19255907|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
19255908|NCT05168787|Valsartan|valsartan|mesh-list
19255909|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19255910|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19255911|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19255912|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255913|NCT05168475|Rituximab|rituximab|mesh-list
19255914|NCT05168475|Infliximab|infliximab|mesh-list
19255915|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19255916|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255917|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
19255918|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173004|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20173005|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173006|NCT00159900|Urological Agents|urological agents|mesh-ancestor
20173007|NCT00159952|Insulin|insulin|mesh-list
20173008|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20173009|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173010|NCT00159978|Alovudine|alovudine|mesh-list
20173011|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
20612129|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255919|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255920|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19255921|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19255922|NCT05168176|Dolutegravir|dolutegravir|mesh-list
19656049|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
19255923|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19255924|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19255925|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255926|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255927|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19255928|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19255929|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
19255930|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255931|NCT05168137|Colchicine|colchicine|mesh-list
19255932|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
19255933|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19255934|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
19255935|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19255936|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19255937|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255938|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173012|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173013|NCT00160030|Cisplatin|cisplatin|mesh-list
20173014|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173015|NCT00160043|Vatalanib|vatalanib|mesh-list
20173016|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20173017|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612130|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
19255939|NCT05168059|Clevidipine|clevidipine|mesh-list
19255940|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19255941|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19255942|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255943|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19255944|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255945|NCT05168007|Cariprazine|cariprazine|mesh-list
20612131|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20612132|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19255946|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20173018|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173019|NCT00160069|Sagopilone|sagopilone|mesh-list
20347005|NCT00856960|Losartan|losartan|mesh-list
20347006|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20347007|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20347008|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20347009|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20347010|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347011|NCT00857038|Doxycycline|doxycycline|mesh-list
20347012|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20347013|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347014|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
20347015|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20347016|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20347017|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
20347018|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
20347019|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20347020|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
19255947|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19255948|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19255949|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347021|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19255950|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19255951|NCT05167851|Lazertinib|lazertinib|mesh-list
19255952|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19255953|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255954|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255955|NCT05167760|Apraclonidine|apraclonidine|mesh-list
19255956|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19255957|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19255958|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19255959|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
19255960|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19656050|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20173020|NCT00160069|Epothilones|epothilones|mesh-list
20173021|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173022|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
20173023|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
20173024|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
20173025|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173026|NCT00160160|Eprosartan|eprosartan|mesh-list
20347022|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20612133|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
20347023|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347024|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20347025|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347026|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347027|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19255961|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255962|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255963|NCT05167175|Prednisone|prednisone|mesh-list
19656051|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
19656052|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19656053|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19656054|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20347028|NCT00857077|Renal Agents|renal agents|mesh-ancestor
20347029|NCT00857116|Albendazole|albendazole|mesh-list
20347030|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
20347031|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20347032|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20347033|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
20347034|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20347035|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19255964|NCT05167175|Olaparib|olaparib|mesh-list
19255965|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
19255966|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19255967|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
19255968|NCT05167175|Hormones|hormones|mesh-ancestor
19656055|NCT04919629|Growth Substances|growth substances|mesh-ancestor
19656056|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656057|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
19255969|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19255970|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255971|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19255972|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255973|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20347036|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
19656058|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
20173027|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20173028|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
20173029|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20173030|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173031|NCT00160173|Estradiol|estradiol|mesh-list
20173032|NCT00160173|Estrogens|estrogens|mesh-ancestor
19255974|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19255975|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255976|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19255977|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
19255978|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19255979|NCT05167123|Calcium|calcium|mesh-list
19255980|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19255981|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255982|NCT05166668|Letrozole|letrozole|mesh-list
19255983|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19255984|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20347037|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
20347038|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
20347039|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347040|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347041|NCT00857142|Oxymorphone|oxymorphone|mesh-list
20347042|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20347043|NCT00857142|Narcotics|narcotics|mesh-ancestor
19255985|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19255986|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173033|NCT00160173|Hormones|hormones|mesh-ancestor
20173034|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173035|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347044|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19665538|NCT04923867|Hormones|hormones|mesh-ancestor
20347045|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347046|NCT00857142|Analgesics|analgesics|mesh-ancestor
20347047|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
20347048|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347049|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20347050|NCT00857155|Clopidogrel|clopidogrel|mesh-list
20347051|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20347052|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20173036|NCT00160186|Pancreatin|pancreatin|mesh-list
20173037|NCT00160186|Pancrelipase|pancrelipase|mesh-list
19255987|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19255988|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19255989|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
19255990|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19255991|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19255992|NCT05166538|Clopidogrel|clopidogrel|mesh-list
19255993|NCT05166538|Ticagrelor|ticagrelor|mesh-list
19255994|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19255995|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19255996|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19255997|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19255998|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
19255999|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256000|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256001|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256002|NCT05161429|Insulin|insulin|mesh-list
19256003|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256004|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256005|NCT05159453|Insulin|insulin|mesh-list
19256006|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19256007|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256008|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258969|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258970|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19258971|NCT01873170|Progestins|progestins|mesh-ancestor
19258972|NCT01873170|Hormones|hormones|mesh-ancestor
19258973|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19258974|NCT01835041|Leucovorin|leucovorin|mesh-list
19258975|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
19258976|NCT01835041|Fluorouracil|fluorouracil|mesh-list
19258977|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
19258978|NCT01835041|Irinotecan|irinotecan|mesh-list
19258979|NCT01835041|Calcium|calcium|mesh-list
19258980|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
19258981|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19258982|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19258983|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
19258984|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19258985|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19258986|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19258987|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19258988|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
19258989|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19258990|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19258991|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347053|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20347054|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20347055|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
20347056|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347057|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347058|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347059|NCT00857168|Testosterone|testosterone|mesh-list
20347060|NCT00857168|Androgens|androgens|mesh-ancestor
19258992|NCT01835041|Antidotes|antidotes|mesh-ancestor
19258993|NCT01835041|Protective Agents|protective agents|mesh-ancestor
19258994|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
19258995|NCT01835041|Vitamins|vitamins|mesh-ancestor
19258996|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
19258997|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
19258998|NCT01808820|Imiquimod|imiquimod|mesh-list
19258999|NCT01808820|Vaccines|vaccines|mesh-list
19259000|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
19259001|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173038|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20173039|NCT00160238|Betahistine|betahistine|mesh-list
20173040|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
20173041|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
20173042|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
20173043|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173044|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173045|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173046|NCT00160264|Vitamin D|vitamin d|mesh-list
20173047|NCT00160264|Lactulose|lactulose|mesh-list
20173048|NCT00160264|Calcium|calcium|mesh-list
19259002|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19256009|NCT05148949|Vaccines|vaccines|mesh-list
19256010|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
19256011|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256012|NCT05148377|Heparin|heparin|mesh-list
19256013|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
19256014|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19256015|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19256016|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256017|NCT05144698|Sirolimus|sirolimus|mesh-list
19256018|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19256019|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256020|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19256021|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256022|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
19256023|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256024|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
19256025|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256026|NCT05141721|Bevacizumab|bevacizumab|mesh-list
19256027|NCT05141721|Ipilimumab|ipilimumab|mesh-list
19256028|NCT05141721|Oxaliplatin|oxaliplatin|mesh-list
19256029|NCT05141721|Atezolizumab|atezolizumab|mesh-list
19256030|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256031|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256032|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19256033|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19256034|NCT05141721|Growth Substances|growth substances|mesh-ancestor
20173049|NCT00160264|Vitamins|vitamins|mesh-ancestor
20173050|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
20173051|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173052|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20173053|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20173054|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20173055|NCT00160277|Moxonidine|moxonidine|mesh-list
19256035|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256036|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
19256037|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19256038|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256039|NCT05116059|Amphotericin B|amphotericin b|mesh-list
19256040|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19256041|NCT05116059|Amebicides|amebicides|mesh-ancestor
19256042|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19256043|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19256044|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256045|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19256046|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
19256047|NCT05111912|Liraglutide|liraglutide|mesh-list
19256048|NCT05111912|Glucagon|glucagon|mesh-list
19256049|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19256050|NCT05111912|Incretins|incretins|mesh-ancestor
19256051|NCT05111912|Hormones|hormones|mesh-ancestor
19256052|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256053|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256054|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19256055|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256056|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
19256057|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19256058|NCT05105672|Cisplatin|cisplatin|mesh-list
19256059|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256060|NCT05093517|Volagidemab|volagidemab|mesh-list
19256061|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256062|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256063|NCT05075161|Pirfenidone|pirfenidone|mesh-list
19256064|NCT05075161|Analgesics|analgesics|mesh-ancestor
19256065|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
19256066|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256067|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256068|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20173056|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20173057|NCT00160290|Lactulose|lactulose|mesh-list
20173058|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20173059|NCT00160316|Estradiol|estradiol|mesh-list
20173060|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
20173061|NCT00160316|Estrogens|estrogens|mesh-ancestor
19256069|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20173062|NCT00160316|Hormones|hormones|mesh-ancestor
20173063|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256070|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19256071|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256072|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256073|NCT05070156|Vaccines|vaccines|mesh-list
19256074|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
19256075|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256076|NCT05067920|Antibodies|antibodies|mesh-list
19256077|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
19256078|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256079|NCT05053828|Clopidogrel|clopidogrel|mesh-list
19256080|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19256081|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19256082|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19256083|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19256084|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
19256085|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256086|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256087|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256088|NCT05051189|Fentanyl|fentanyl|mesh-list
19256089|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19256090|NCT05051189|Narcotics|narcotics|mesh-ancestor
19256091|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256092|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256093|NCT05051189|Analgesics|analgesics|mesh-ancestor
19256094|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
19256095|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256096|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19256097|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19256098|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
19256099|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
19256100|NCT05031078|Lidocaine|lidocaine|mesh-list
20347061|NCT00857168|Hormones|hormones|mesh-ancestor
20347062|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347063|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347064|NCT00857324|Vorinostat|vorinostat|mesh-list
20347065|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347066|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20347067|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347068|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347069|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
20347070|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
20347071|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347072|NCT00857376|Protective Agents|protective agents|mesh-ancestor
20347073|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347074|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
20347075|NCT00857376|Vitamins|vitamins|mesh-ancestor
20347076|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
20347077|NCT00857428|Oxymorphone|oxymorphone|mesh-list
20347078|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20347079|NCT00857428|Narcotics|narcotics|mesh-ancestor
20347080|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347081|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347082|NCT00857428|Analgesics|analgesics|mesh-ancestor
20347083|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
20347084|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347085|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19256101|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256102|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
19256103|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
19256104|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256105|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
19256106|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256107|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19256108|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19256109|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19256110|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19256111|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256112|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19256113|NCT05024188|Metronidazole|metronidazole|mesh-list
19256114|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
19256115|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256116|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19256117|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20347086|NCT00857519|Carboplatin|carboplatin|mesh-list
19256118|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19256119|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19835420|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20347087|NCT00857519|Melphalan|melphalan|mesh-list
20347088|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20347089|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20347090|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
20347091|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347092|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20347093|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20347094|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
20347095|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347096|NCT00857558|Saxagliptin|saxagliptin|mesh-list
20347097|NCT00857558|Incretins|incretins|mesh-ancestor
20347098|NCT00857558|Hormones|hormones|mesh-ancestor
20347099|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347100|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256120|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256121|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256122|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256123|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19256124|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19256125|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19256126|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19256127|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20173064|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173065|NCT00160316|Progestins|progestins|mesh-ancestor
20173066|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20173067|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20173068|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20173069|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
20173070|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173071|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256128|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19256129|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
19256130|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256131|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19256132|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19256133|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256134|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19256135|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19256136|NCT04982367|Sirolimus|sirolimus|mesh-list
19256137|NCT04982367|Paclitaxel|paclitaxel|mesh-list
19256138|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19256139|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256140|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256141|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256142|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256143|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
19256144|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173072|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20347101|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20347102|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
20347103|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256145|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20173073|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19666216|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20173074|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
20173075|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173076|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
20173077|NCT00160342|Estrogens|estrogens|mesh-list
20173078|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
20173079|NCT00160342|Estrone|estrone|mesh-list
20173080|NCT00160342|Testosterone|testosterone|mesh-list
20173081|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
20173082|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
20173083|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20173084|NCT00160342|Hormones|hormones|mesh-ancestor
20173085|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173086|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173087|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20173088|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173089|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
20173090|NCT00160342|Androgens|androgens|mesh-ancestor
20173091|NCT00160355|Fludarabine|fludarabine|mesh-list
20173092|NCT00160355|Melphalan|melphalan|mesh-list
20173093|NCT00160355|Thiotepa|thiotepa|mesh-list
19256146|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256147|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19256148|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
19256149|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256150|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
19256151|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259003|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259004|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
19259005|NCT01481272|Leucovorin|leucovorin|mesh-list
19259006|NCT01481272|Cytarabine|cytarabine|mesh-list
19259007|NCT01481272|Methotrexate|methotrexate|mesh-list
19259008|NCT01481272|Etoposide|etoposide|mesh-list
19259009|NCT01481272|Ofatumumab|ofatumumab|mesh-list
19259010|NCT01481272|Sargramostim|sargramostim|mesh-list
19259011|NCT01481272|Lenograstim|lenograstim|mesh-list
19259012|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19259013|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
19259014|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19259015|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259016|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259017|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
19259018|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259019|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259020|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
19259021|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259022|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19259023|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259024|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
19259025|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259026|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19259027|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19259028|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19259029|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19259030|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
19259031|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259032|NCT01481272|Antidotes|antidotes|mesh-ancestor
19259033|NCT01481272|Protective Agents|protective agents|mesh-ancestor
19259034|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
19259035|NCT01481272|Vitamins|vitamins|mesh-ancestor
19259036|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
19259037|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19259038|NCT01434316|Veliparib|veliparib|mesh-list
19259039|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19259040|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259041|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259042|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259043|NCT01380028|Prednisone|prednisone|mesh-list
19259044|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259045|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
19259046|NCT01380028|Hormones|hormones|mesh-ancestor
19259047|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259048|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259049|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259050|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259051|NCT01305460|Azacitidine|azacitidine|mesh-list
19259052|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259053|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
20173094|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173095|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173096|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173097|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
20173098|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173099|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20173100|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
20173101|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20175062|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
20175063|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175064|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175065|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
20175066|NCT00166842|Cyclosporine|cyclosporine|mesh-list
20175067|NCT00166842|Sirolimus|sirolimus|mesh-list
20175068|NCT00166842|Tacrolimus|tacrolimus|mesh-list
19259054|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259055|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175069|NCT00166842|Cyclosporins|cyclosporins|mesh-list
19259056|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175070|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256152|NCT04965506|Dulaglutide|dulaglutide|mesh-list
19256153|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256154|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256155|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19256156|NCT04960930|Minocycline|minocycline|mesh-list
19256157|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19256158|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256159|NCT04957368|Midazolam|midazolam|mesh-list
19256160|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
19256161|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20173102|NCT00160394|Adapalene|adapalene|mesh-list
20173103|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20173104|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20173105|NCT00160394|Analgesics|analgesics|mesh-ancestor
20173106|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
20347104|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347105|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20347106|NCT00857597|Esomeprazole|esomeprazole|mesh-list
19256162|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19256163|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256164|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256165|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19256166|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19256167|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19256168|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19256169|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
19256170|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
20347107|NCT00857597|Omeprazole|omeprazole|mesh-list
20347108|NCT00857597|Rabeprazole|rabeprazole|mesh-list
20347109|NCT00857597|Pantoprazole|pantoprazole|mesh-list
20347110|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20347111|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19256171|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
19256172|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
19256173|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256174|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256175|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19256176|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19256177|NCT04957368|Analgesics|analgesics|mesh-ancestor
19256178|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
19256179|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256180|NCT04933682|Rifampin|rifampin|mesh-list
19256181|NCT04933682|Fluconazole|fluconazole|mesh-list
19256182|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19256183|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
19256184|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19256185|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256186|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
19256187|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256188|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256189|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256190|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19256191|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19256192|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19256193|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19256194|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19256195|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19256196|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
19256197|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19256198|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19256199|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19256200|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
19256201|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256202|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19656084|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
20173107|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20173108|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173109|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20173110|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173111|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
20173112|NCT00160407|Orlistat|orlistat|mesh-list
20173113|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173114|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173115|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20173116|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19256203|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19256204|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19256205|NCT04929600|Amlodipine|amlodipine|mesh-list
19256206|NCT04929600|Valsartan|valsartan|mesh-list
19256207|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19256208|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19256209|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19256210|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256211|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19256212|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256213|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
19256214|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19256215|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19256216|NCT04928521|Bupivacaine|bupivacaine|mesh-list
19256217|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
19256218|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
19256219|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256220|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256221|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
19256222|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19656085|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656086|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173117|NCT00160485|Glyburide|glyburide|mesh-list
20173118|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20173119|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173120|NCT00160498|Lercanidipine|lercanidipine|mesh-list
20173121|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20173122|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20173123|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173124|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173125|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20173126|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173127|NCT00160511|Levetiracetam|levetiracetam|mesh-list
20173128|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
20173129|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
20173130|NCT00160537|Levocetirizine|levocetirizine|mesh-list
20173131|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20173132|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20173133|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
20173134|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
20173135|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256223|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
20175071|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
20175072|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175073|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20175074|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175075|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175076|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
20175077|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175078|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
20175079|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175080|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175081|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20175082|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175083|NCT00166868|Neomycin|neomycin|mesh-list
20175084|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175085|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175086|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20175087|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175088|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175089|NCT00166881|Docetaxel|docetaxel|mesh-list
20175090|NCT00166881|Irinotecan|irinotecan|mesh-list
20175091|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175092|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
20175093|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
20175094|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175095|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175096|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20175097|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20175098|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175099|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
20175100|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
20175101|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19256224|NCT04889118|Lenvatinib|lenvatinib|mesh-list
19256225|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256226|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256227|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19256228|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256229|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347112|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20347113|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347114|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256261|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19256262|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
19256263|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
20347115|NCT00857753|Fentanyl|fentanyl|mesh-list
20347116|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20347117|NCT00857753|Narcotics|narcotics|mesh-ancestor
20347118|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20347119|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347120|NCT00857753|Analgesics|analgesics|mesh-ancestor
20347121|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
20347122|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347123|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20347124|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20347125|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
20347126|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
20347127|NCT00857831|Vitamin D|vitamin d|mesh-list
20347128|NCT00857831|Calcium|calcium|mesh-list
20347129|NCT00857831|Vitamins|vitamins|mesh-ancestor
20347130|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
19256264|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256265|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19256266|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
19256267|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256268|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256269|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19256270|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19256271|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19256272|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
19256273|NCT04817241|Cytarabine|cytarabine|mesh-list
19256274|NCT04817241|Decitabine|decitabine|mesh-list
19256275|NCT04817241|Daunorubicin|daunorubicin|mesh-list
19256276|NCT04817241|Venetoclax|venetoclax|mesh-list
19256277|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256278|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
19259057|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
20347131|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256279|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256280|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256281|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
19256282|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256283|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256284|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
19256285|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256286|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256287|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19256288|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19256289|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19256290|NCT04812002|Bevacizumab|bevacizumab|mesh-list
19256291|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19256292|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256293|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256294|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19256295|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19256296|NCT04812002|Growth Substances|growth substances|mesh-ancestor
19256297|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256298|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
19256299|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256300|NCT04809311|Insulin|insulin|mesh-list
19256301|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19256302|NCT04809311|Glucagon|glucagon|mesh-list
19256303|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19256304|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256305|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256306|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19256307|NCT04809311|Hormones|hormones|mesh-ancestor
19256308|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256309|NCT04809311|Incretins|incretins|mesh-ancestor
19256310|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19256311|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19256312|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256313|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19256314|NCT04784208|Hormones|hormones|mesh-list
19256315|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256316|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256317|NCT04780321|Antibodies|antibodies|mesh-list
19256318|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19256319|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
19256320|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256321|NCT04780204|Tenofovir|tenofovir|mesh-list
19256322|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
19256323|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256324|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19256325|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256326|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256327|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256328|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19256329|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19256330|NCT04772547|Vigabatrin|vigabatrin|mesh-list
19256331|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
19256332|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256333|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256334|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
19256335|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256336|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256337|NCT04769206|Galantamine|galantamine|mesh-list
19256338|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19256339|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173136|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173137|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173138|NCT00160550|Levetiracetam|levetiracetam|mesh-list
20173139|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
20173140|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
20173141|NCT00160576|Levetiracetam|levetiracetam|mesh-list
20173142|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
20173143|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
20173144|NCT00160589|Levocetirizine|levocetirizine|mesh-list
20173145|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20173146|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20173147|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
20173148|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
20173149|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256340|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256341|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
19256342|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256343|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256344|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19256345|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
19256346|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256347|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
19256348|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19256349|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20173150|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173151|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173152|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
19656097|NCT04889066|Durvalumab|durvalumab|mesh-list
19656098|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19656099|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173153|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173154|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
20173155|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173156|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20173157|NCT00160628|Levetiracetam|levetiracetam|mesh-list
20173158|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
19656106|NCT04882072|Ustekinumab|ustekinumab|mesh-list
19656107|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
20173159|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
20173160|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20173161|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20173162|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20173163|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
20173164|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173165|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20173166|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20173167|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173168|NCT00160849|Lopinavir|lopinavir|mesh-list
20173169|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20173170|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20173171|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
20173172|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173173|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173174|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20173175|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20173176|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
20173177|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173178|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20173179|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20173180|NCT00160875|Irinotecan|irinotecan|mesh-list
20173181|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173182|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19256350|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256351|NCT04757090|Trastuzumab|trastuzumab|mesh-list
20173183|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20173184|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173185|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173186|NCT00160888|Nitroprusside|nitroprusside|mesh-list
20173187|NCT00160888|Acetylcholine|acetylcholine|mesh-list
20173188|NCT00160888|Bradykinin|bradykinin|mesh-list
19256352|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256353|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256354|NCT04727307|Bevacizumab|bevacizumab|mesh-list
19256355|NCT04727307|Atezolizumab|atezolizumab|mesh-list
19256356|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19256357|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256358|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256359|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19256360|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19256361|NCT04727307|Growth Substances|growth substances|mesh-ancestor
19256362|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256363|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
19256364|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
19256365|NCT04726969|Ivermectin|ivermectin|mesh-list
19256366|NCT04726969|Albendazole|albendazole|mesh-list
19256367|NCT04726969|Moxidectin|moxidectin|mesh-list
20173189|NCT00160888|Kininogens|kininogens|mesh-list
19256368|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20173190|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20173191|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
20347132|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20347133|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20348558|NCT00864760|Gabapentin|gabapentin|mesh-list
20348559|NCT00864760|Analgesics|analgesics|mesh-ancestor
20348560|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
20348561|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348562|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348563|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
20348564|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20173192|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20173193|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173194|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20173195|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
20173196|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173197|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173198|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20173199|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
20173200|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173201|NCT00160927|Nitroprusside|nitroprusside|mesh-list
19256369|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256370|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
19256371|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
19256372|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19256373|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19256374|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256375|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256376|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
19256377|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256378|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256379|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
19256380|NCT04691960|Metformin|metformin|mesh-list
19256381|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19256382|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256383|NCT04679012|Prednisone|prednisone|mesh-list
19256384|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
19256385|NCT04679012|Rituximab|rituximab|mesh-list
19256386|NCT04679012|Doxorubicin|doxorubicin|mesh-list
19256387|NCT04679012|Etoposide|etoposide|mesh-list
19256388|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20173202|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20173203|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
20173204|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19256389|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256390|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
19256391|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256392|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256393|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20173205|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173206|NCT00160966|Cyclosporine|cyclosporine|mesh-list
20173207|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
20173208|NCT00160966|Everolimus|everolimus|mesh-list
20173209|NCT00160966|Tacrolimus|tacrolimus|mesh-list
20173210|NCT00160966|Cyclosporins|cyclosporins|mesh-list
20173211|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20173212|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
20173213|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173214|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20173215|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173216|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173217|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
20348565|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348566|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348567|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348568|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19256394|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
19256395|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256396|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256397|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19256398|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256399|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19256400|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20348569|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20348570|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348571|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256401|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19256402|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347134|NCT00857870|Metformin|metformin|mesh-list
20347135|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
20347136|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20347137|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347138|NCT00857909|Amiloride|amiloride|mesh-list
20347139|NCT00857909|Spironolactone|spironolactone|mesh-list
20347140|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19256403|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19256404|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
19256405|NCT04679012|Hormones|hormones|mesh-ancestor
19256406|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19256407|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19256408|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256409|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
19256410|NCT04673617|Rituximab|rituximab|mesh-list
19256411|NCT04673617|Fludarabine|fludarabine|mesh-list
19256412|NCT04673617|Interleukin-2|interleukin-2|mesh-list
19256413|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256414|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
19256415|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256416|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256417|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19256418|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
19256419|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256420|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256421|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19256422|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256423|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20173218|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173219|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
20173220|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19656143|NCT04829318|Esketamine|esketamine|mesh-list
19656144|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
19656145|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20347141|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
20347142|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20347143|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347144|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20347145|NCT00857909|Diuretics|diuretics|mesh-ancestor
20347146|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
20347147|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20347148|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20347149|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20347150|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347151|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20347152|NCT00857935|Permethrin|permethrin|mesh-list
20347153|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20347154|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347155|NCT00857987|Expectorants|expectorants|mesh-list
20347156|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
20347157|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20347158|NCT00858195|Indomethacin|indomethacin|mesh-list
20347159|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20347160|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20347161|NCT00858195|Analgesics|analgesics|mesh-ancestor
20173221|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256424|NCT04673617|Analgesics|analgesics|mesh-ancestor
19256425|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
19256426|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256427|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19256428|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
19256429|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256430|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19256431|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20173222|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19256432|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
20173223|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20173224|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
20173225|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20173226|NCT00161018|Risperidone|risperidone|mesh-list
20173227|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20173228|NCT00161018|Fluphenazine|fluphenazine|mesh-list
20173229|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
20173230|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
19256433|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256434|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256435|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19259058|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19259059|NCT01300143|Estrogens|estrogens|mesh-ancestor
19259060|NCT01300143|Hormones|hormones|mesh-ancestor
19259061|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259062|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259063|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259064|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259065|NCT01199302|Brodalumab|brodalumab|mesh-list
19259066|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
19259067|NCT01164995|Carboplatin|carboplatin|mesh-list
19259068|NCT01164995|Adavosertib|adavosertib|mesh-list
19259069|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259070|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259071|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259072|NCT01123707|Aripiprazole|aripiprazole|mesh-list
19259073|NCT01123707|Citalopram|citalopram|mesh-list
19832509|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19832510|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19832511|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19832512|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
19832513|NCT03879629|Protective Agents|protective agents|mesh-ancestor
19832514|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19832515|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19832516|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20173231|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20173232|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
19259074|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19259075|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20347162|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
20347163|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347164|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347165|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20347166|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20347167|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
19259076|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19259077|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259078|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259079|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
19259080|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259081|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19259082|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
19259083|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19259084|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19259085|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19259086|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259087|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
19259088|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
19259089|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19259090|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19259091|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19259092|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19259093|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19259094|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19259095|NCT00999401|Roscovitine|roscovitine|mesh-list
19259096|NCT00999401|Sapacitabine|sapacitabine|mesh-list
19259097|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259098|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
19832517|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
20173233|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173234|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173235|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173236|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20173237|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20173238|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20173239|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20173240|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20173241|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
20173242|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
20347168|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
19259099|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20173243|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20173244|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20173245|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20173246|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20173247|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173248|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
20173249|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20347169|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20347170|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20347171|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256436|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19256437|NCT04648930|Omalizumab|omalizumab|mesh-list
19256438|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19256439|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19256440|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
19256441|NCT04648033|Atovaquone|atovaquone|mesh-list
19256442|NCT04648033|Cisplatin|cisplatin|mesh-list
19256443|NCT04648033|Vinorelbine|vinorelbine|mesh-list
19256444|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256445|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256446|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256447|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256448|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19256449|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256450|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256451|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
19256452|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19256453|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19256454|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256455|NCT04645212|Aflibercept|aflibercept|mesh-list
19256456|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19256457|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19256458|NCT04645212|Growth Substances|growth substances|mesh-ancestor
19256459|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256460|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
19256461|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256462|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
19256463|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
19256464|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256465|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
20173250|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347172|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20347173|NCT00858273|Insulin|insulin|mesh-list
20347174|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20347175|NCT00858273|Antioxidants|antioxidants|mesh-list
20173251|NCT00161070|Aspirin|aspirin|mesh-list
20173252|NCT00161070|Dipyridamole|dipyridamole|mesh-list
20173253|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19256466|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19256467|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256468|NCT04632706|Ivermectin|ivermectin|mesh-list
19256469|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19256470|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256471|NCT04629781|Docetaxel|docetaxel|mesh-list
19256472|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256473|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256474|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256475|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
19256476|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256477|NCT04620187|Cisplatin|cisplatin|mesh-list
19256478|NCT04620187|Carboplatin|carboplatin|mesh-list
19256479|NCT04620187|Trastuzumab|trastuzumab|mesh-list
19256480|NCT04620187|Maytansine|maytansine|mesh-list
19256481|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256482|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19256483|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19256484|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
19256485|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
19256486|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
19256487|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256488|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20347176|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348572|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
19256489|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256490|NCT04588818|Adalimumab|adalimumab|mesh-list
19256491|NCT04588818|Methotrexate|methotrexate|mesh-list
19256492|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19256493|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
19256494|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19256495|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256496|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19256497|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
19256498|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256499|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19256500|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
19256501|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256502|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19256503|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19256504|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
19256505|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19256506|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256507|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20173254|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20173255|NCT00161070|Analgesics|analgesics|mesh-ancestor
20173256|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
20173257|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20347177|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20347178|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256508|NCT04579510|Vaccines|vaccines|mesh-list
19256509|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
19256510|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256511|NCT04540835|Calcium|calcium|mesh-list
19256512|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19256513|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259100|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19259101|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259102|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259103|NCT00885963|Sapacitabine|sapacitabine|mesh-list
19259104|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259105|NCT00725127|Aspirin|aspirin|mesh-list
19259106|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19259107|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19259108|NCT00725127|Analgesics|analgesics|mesh-ancestor
19259109|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
19259110|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259111|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259112|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259113|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259114|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19259115|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19259116|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173258|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173259|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19656152|NCT04812912|Hormones|hormones|mesh-list
19656153|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20173260|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259117|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19259118|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19259119|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259120|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
19259121|NCT00476554|Sapacitabine|sapacitabine|mesh-list
19259122|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259123|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
19259124|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19259125|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259126|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19259127|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259128|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259129|NCT00372073|Roscovitine|roscovitine|mesh-list
20173261|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20173262|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20173263|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173264|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20173265|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20173266|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173267|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
20173268|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19259130|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20173269|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
20173270|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20173271|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20173272|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20173273|NCT00161096|Pantoprazole|pantoprazole|mesh-list
20173274|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20173275|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20173276|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20173277|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173278|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173279|NCT00161122|Vaccines|vaccines|mesh-list
20173280|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20173281|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
20173282|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173283|NCT00161200|Pantoprazole|pantoprazole|mesh-list
20173284|NCT00161200|Ranitidine|ranitidine|mesh-list
20173285|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20173286|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20173287|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20173288|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20173289|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20173290|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20173291|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20173292|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
20173293|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
20173294|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20173295|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173296|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
20173297|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20173298|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
20173299|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20173300|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173301|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20173302|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20173303|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20173304|NCT00161239|Prednisone|prednisone|mesh-list
20173305|NCT00161239|Methotrexate|methotrexate|mesh-list
19656154|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20173306|NCT00161239|Asparaginase|asparaginase|mesh-list
19256514|NCT04539730|Bupivacaine|bupivacaine|mesh-list
19256515|NCT04539730|Ropivacaine|ropivacaine|mesh-list
19256516|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
19256517|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
19256518|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19256519|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256520|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
19256521|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19256522|NCT04535791|Vitamin D|vitamin d|mesh-list
19256523|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
19256524|NCT04535791|Vitamins|vitamins|mesh-ancestor
19256525|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
19256526|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256527|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19256528|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19256529|NCT04523246|Vaccines|vaccines|mesh-list
19256530|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
19256531|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19256532|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
19256533|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19256534|NCT04500847|Emtricitabine|emtricitabine|mesh-list
19256535|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
19256536|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19256537|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19256538|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19256539|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256540|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19256541|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19256542|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19256543|NCT04484675|Milrinone|milrinone|mesh-list
19256544|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19256545|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19256546|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
19256547|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20173307|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19256548|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19256549|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19256550|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666217|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348629|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348630|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348631|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
20348632|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20348633|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259356|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259357|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
19259358|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259359|NCT05171530|Lenvatinib|lenvatinib|mesh-list
19259360|NCT05171530|Taxane|taxane|mesh-list
19259361|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259362|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19259363|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259364|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259365|NCT05164653|Valsartan|valsartan|mesh-list
19259366|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
19259367|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19259368|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19259369|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19259370|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19259371|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19259372|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259373|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19259374|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
19259375|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259376|NCT05155293|Aflibercept|aflibercept|mesh-list
19259377|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19259378|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19259379|NCT05155293|Growth Substances|growth substances|mesh-ancestor
19259380|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259381|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
19259382|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259383|NCT05151588|Docetaxel|docetaxel|mesh-list
19259384|NCT05151588|Fluorouracil|fluorouracil|mesh-list
19259385|NCT05151588|Cisplatin|cisplatin|mesh-list
19259386|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259387|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
19259388|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
19259389|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
19259390|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259391|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
19259392|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259393|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259394|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
19259395|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392424|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392425|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392426|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19392427|NCT03694873|Narcotics|narcotics|mesh-ancestor
19392428|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392429|NCT03694587|Ibuprofen|ibuprofen|mesh-list
19392430|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392431|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392432|NCT03694587|Analgesics|analgesics|mesh-ancestor
19392433|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
19392434|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392435|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392436|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392437|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392438|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19392439|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392440|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392441|NCT03694535|Mitomycins|mitomycins|mesh-list
19392442|NCT03694535|Mitomycin|mitomycin|mesh-list
19392443|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19392444|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392445|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
19392446|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392447|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19392448|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392449|NCT03694236|Durvalumab|durvalumab|mesh-list
19392450|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392451|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259396|NCT05145348|Vaccines|vaccines|mesh-list
19259397|NCT05145348|Immunologic Factors|immunologic factors|mesh-ancestor
19259398|NCT05145348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259399|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
19259400|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19259401|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259402|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
19259403|NCT05137938|Ketamine|ketamine|mesh-list
19259404|NCT05137938|Analgesics|analgesics|mesh-ancestor
19259405|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
19259406|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259407|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259408|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19259409|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19259410|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
19259411|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
19259412|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259413|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19259414|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19259415|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259416|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259417|NCT05117307|Bupivacaine|bupivacaine|mesh-list
19259418|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
19259419|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
19259420|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259421|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259422|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
19259423|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259424|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19259425|NCT05105633|Tenecteplase|tenecteplase|mesh-list
19259426|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19259427|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19259428|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259429|NCT05077332|Celecoxib|celecoxib|mesh-list
19259430|NCT05077332|Famotidine|famotidine|mesh-list
19259431|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19259432|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19259433|NCT05077332|Analgesics|analgesics|mesh-ancestor
19259434|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
19259435|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259436|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259437|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259438|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259439|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19259440|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19259441|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259442|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259443|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19259444|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19259445|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19259446|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
19259447|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
19259448|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259449|NCT05054374|Fulvestrant|fulvestrant|mesh-list
20175226|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175227|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175228|NCT00167713|Ibuprofen|ibuprofen|mesh-list
20175229|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20175230|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20175231|NCT00167713|Analgesics|analgesics|mesh-ancestor
20175232|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
20175233|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175234|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175235|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20175236|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175237|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20175238|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175239|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175240|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
20175241|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
20175242|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20175243|NCT00167739|Quinine|quinine|mesh-list
20175244|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
20175245|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19259450|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259451|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666262|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666263|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19666264|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666265|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666266|NCT05019846|Bicalutamide|bicalutamide|mesh-list
20348634|NCT00864838|Diuretics|diuretics|mesh-ancestor
19259452|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19259453|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19259454|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
19259455|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259456|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348635|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
20348636|NCT00864864|Sunitinib|sunitinib|mesh-list
20348637|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348638|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20348639|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19259457|NCT05030272|Nicotine|nicotine|mesh-list
19259458|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19259459|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
19259460|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259461|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259462|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19259463|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19259464|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
19259465|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259466|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259467|NCT05027425|Durvalumab|durvalumab|mesh-list
19259468|NCT05027425|Tremelimumab|tremelimumab|mesh-list
19259469|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19259470|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259471|NCT05024513|Fluorouracil|fluorouracil|mesh-list
19259472|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
19259473|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
19259474|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259475|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259476|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259477|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259478|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
19259479|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259480|NCT04995003|Cyclophosphamide|cyclophosphamide|mesh-list
19259481|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
19259482|NCT04995003|Nivolumab|nivolumab|mesh-list
19259483|NCT04995003|Fludarabine|fludarabine|mesh-list
19259484|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19259485|NCT04995003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259486|NCT04995003|Immunologic Factors|immunologic factors|mesh-ancestor
19259487|NCT04995003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259488|NCT04995003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259489|NCT04995003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20175246|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19259490|NCT04995003|Alkylating Agents|alkylating agents|mesh-ancestor
19259491|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259492|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259493|NCT04995003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20175247|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175248|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19259494|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19259495|NCT04994561|Niacinamide|niacinamide|mesh-list
20175249|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175250|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175251|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20175252|NCT00167739|Renal Agents|renal agents|mesh-ancestor
20175253|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20175254|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175255|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20175256|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175257|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20175258|NCT00167739|Analgesics|analgesics|mesh-ancestor
20175259|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
20175260|NCT00167765|Abciximab|abciximab|mesh-list
19259496|NCT04994561|Metformin|metformin|mesh-list
19666267|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20348640|NCT00864864|Growth Substances|growth substances|mesh-ancestor
20175261|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
20175262|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20175263|NCT00167791|Rituximab|rituximab|mesh-list
20175264|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175265|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175266|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
20175267|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835543|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835544|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
19835545|NCT00603512|Tofacitinib|tofacitinib|mesh-list
20175268|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259497|NCT04994561|Dasatinib|dasatinib|mesh-list
19259498|NCT04994561|Resveratrol|resveratrol|mesh-list
19259499|NCT04994561|Quercetin|quercetin|mesh-list
19259500|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19259501|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259502|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259503|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19259504|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259505|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259506|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
19259507|NCT04994561|Protective Agents|protective agents|mesh-ancestor
19259508|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19259509|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
19259510|NCT04994561|Vitamins|vitamins|mesh-ancestor
19259511|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
19259512|NCT04991662|Phenylephrine|phenylephrine|mesh-list
19259513|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
19259514|NCT04991662|Norepinephrine|norepinephrine|mesh-list
19259515|NCT04991662|Metaraminol|metaraminol|mesh-list
19259516|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19259517|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
19259518|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
19259519|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259520|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259521|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
19259522|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19259523|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
19259524|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
19259525|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19259526|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19259527|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19259528|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
19259529|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259530|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259531|NCT04991662|Protective Agents|protective agents|mesh-ancestor
19259532|NCT04947072|Anesthetics|anesthetics|mesh-list
19259533|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259534|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259535|NCT04942158|Eugenol|eugenol|mesh-list
19259536|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
19259537|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
19259538|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
19259539|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19259540|NCT04942158|Protective Agents|protective agents|mesh-ancestor
19259541|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259542|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259543|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
19259544|NCT04941703|Cathartics|cathartics|mesh-ancestor
19259545|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19259546|NCT04911166|Atezolizumab|atezolizumab|mesh-list
19259547|NCT04911166|Interleukin-12|interleukin-12|mesh-list
19259548|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259549|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19259550|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
19259551|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259552|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19259553|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19259554|NCT04911166|Growth Substances|growth substances|mesh-ancestor
19259555|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835546|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835547|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175269|NCT00167817|Aripiprazole|aripiprazole|mesh-list
19259556|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
19259557|NCT04827836|Povidone|povidone|mesh-list
19259558|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19259559|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19259560|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
20175270|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
19259561|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
19259562|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19259563|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259564|NCT04810208|Docetaxel|docetaxel|mesh-list
19259565|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259566|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
19259567|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
19259568|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
19259569|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259570|NCT04802161|Cytarabine|cytarabine|mesh-list
19259571|NCT04802161|Daunorubicin|daunorubicin|mesh-list
19259572|NCT04802161|Pomalidomide|pomalidomide|mesh-list
19259573|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259574|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
19259575|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259576|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259577|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
19259578|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259579|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259580|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
19259581|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259582|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19259583|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19259584|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19259585|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259586|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19259587|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19259588|NCT04802161|Growth Substances|growth substances|mesh-ancestor
19259589|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
19259590|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19259591|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
19259592|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259593|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
19259594|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19259595|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392452|NCT03694119|Phenelzine|phenelzine|mesh-list
19392453|NCT03694119|Ozanimod|ozanimod|mesh-list
19392454|NCT03694119|Tyramine|tyramine|mesh-list
19392455|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19392456|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392457|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392458|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
19392459|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392460|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
19392461|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19392462|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19392463|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392464|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
19392465|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
19392466|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392467|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19392468|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19392469|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19392470|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
19666268|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
19666269|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
19666270|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175271|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175272|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20175273|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175274|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175275|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175276|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
20175277|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
20175278|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218092|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19392471|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392472|NCT03694080|Calcium|calcium|mesh-list
19666271|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175279|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175280|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20175281|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20175282|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
20175283|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20175284|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20175285|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20175286|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20175287|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
20175288|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
20175289|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20175290|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
20175291|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20175292|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20175293|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175294|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20175295|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175296|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259618|NCT04703621|Daratumumab|daratumumab|mesh-list
19259619|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259620|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
19259621|NCT04671030|Neostigmine|neostigmine|mesh-list
19259622|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19259623|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259624|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259625|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
19259626|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259627|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259628|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19259629|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
19259630|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835548|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835549|NCT00603525|Ofatumumab|ofatumumab|mesh-list
19835550|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835551|NCT00603538|Paclitaxel|paclitaxel|mesh-list
19835552|NCT00603538|Carboplatin|carboplatin|mesh-list
19835553|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19835554|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835555|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
19835556|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
20348641|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348642|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
20348643|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20348644|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348645|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348646|NCT00864890|Dexetimide|dexetimide|mesh-list
20348647|NCT00864890|Citalopram|citalopram|mesh-list
20175297|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20175298|NCT00167843|Renal Agents|renal agents|mesh-ancestor
20348648|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20348649|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348650|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348651|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348652|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348653|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
20348654|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348655|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20348656|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348657|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348658|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20348659|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20348660|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
20348661|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
20348662|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835557|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175299|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20175300|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20175301|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20175302|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175303|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348663|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19259631|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19259632|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19259633|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19259634|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
19259635|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19259636|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19259637|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259638|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19259639|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19259640|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259641|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259642|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259643|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19259644|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
19259645|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19259646|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259647|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19259648|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19259649|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19259650|NCT04652206|Gemcitabine|gemcitabine|mesh-list
19259651|NCT04652206|Paclitaxel|paclitaxel|mesh-list
19259652|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19259653|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259654|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19259655|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
19259656|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
19259657|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259658|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259659|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
19259660|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
19259661|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259662|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259663|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259664|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
19259665|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259666|NCT04647903|Amphetamine|amphetamine|mesh-list
19835558|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835559|NCT00603720|Phenylephrine|phenylephrine|mesh-list
19835560|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
19835561|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
19835562|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20175304|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175305|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259667|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
19259668|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19259669|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259670|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
19259671|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
19259672|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259673|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
19259674|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259675|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259676|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
19259677|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19259678|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19259679|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19259680|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19259681|NCT04632264|Oxytocin|oxytocin|mesh-list
19259682|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
19259683|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19259684|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259685|NCT04616248|Poly I-C|poly i-c|mesh-list
19259686|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19259687|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19259688|NCT04616248|Antibodies|antibodies|mesh-list
19259689|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
19259690|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19259691|NCT04616248|Poly ICLC|poly iclc|mesh-list
19259692|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
19259693|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
19259694|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259695|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175306|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19259696|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
19259697|NCT04616248|Laxatives|laxatives|mesh-ancestor
19259698|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19835563|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
19259699|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
19259700|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259701|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19259702|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19259703|NCT04616248|Protective Agents|protective agents|mesh-ancestor
19259704|NCT04607928|Pirfenidone|pirfenidone|mesh-list
19259705|NCT04607928|Analgesics|analgesics|mesh-ancestor
19259706|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
19259707|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259708|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348664|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20348665|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
20348666|NCT00864942|Lenalidomide|lenalidomide|mesh-list
20348667|NCT00864942|Rituximab|rituximab|mesh-list
19259709|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19259710|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19259711|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259712|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259713|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259714|NCT04552223|Nivolumab|nivolumab|mesh-list
20175307|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
20175308|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175309|NCT00167882|Mesalamine|mesalamine|mesh-list
20175310|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20175311|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20175312|NCT00167882|Analgesics|analgesics|mesh-ancestor
19259715|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19259716|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259717|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19259718|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259719|NCT04537026|Dexamethasone|dexamethasone|mesh-list
19259720|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
19259721|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19259722|NCT04537026|BB 1101|bb 1101|mesh-list
19259723|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259724|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
19259725|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
19259726|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259727|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259728|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19259729|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
19259730|NCT04537026|Hormones|hormones|mesh-ancestor
19259731|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259732|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259733|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259734|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
19259735|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259736|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259737|NCT04526730|Nivolumab|nivolumab|mesh-list
19259738|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19259739|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259740|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19259741|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259742|NCT04506086|Blinatumomab|blinatumomab|mesh-list
19259743|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259744|NCT04498780|Valsartan|valsartan|mesh-list
19259745|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19259746|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19259747|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19259748|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19259749|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259750|NCT04448717|Antibodies|antibodies|mesh-list
19259751|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
19259752|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259753|NCT04436965|Cisplatin|cisplatin|mesh-list
19259754|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259755|NCT04420741|Iloprost|iloprost|mesh-list
19259756|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19259757|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
19259758|NCT04409041|Naltrexone|naltrexone|mesh-list
19259759|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19259760|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20175313|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
20175314|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348668|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19259761|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259762|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
19259763|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259764|NCT04407286|Vitamin D|vitamin d|mesh-list
19259765|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
19259766|NCT04407286|Vitamins|vitamins|mesh-ancestor
19259767|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
20348669|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
20348670|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348671|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20348672|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20348673|NCT00864942|Growth Substances|growth substances|mesh-ancestor
20348674|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
20348675|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348676|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20348677|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348678|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20348679|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
20348680|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348681|NCT00864968|Nabumetone|nabumetone|mesh-list
20348682|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19259768|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259769|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19259770|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19259771|NCT04373369|Atezolizumab|atezolizumab|mesh-list
19259772|NCT04373369|Vorolanib|vorolanib|mesh-list
19259773|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259774|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19259775|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259776|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259777|NCT04317404|Triamcinolone|triamcinolone|mesh-list
19259778|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19259779|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19259780|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19259781|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259782|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
20175315|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175316|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20175317|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20217063|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348683|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20348684|NCT00864968|Analgesics|analgesics|mesh-ancestor
20348685|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
20348686|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259783|NCT04317404|Hormones|hormones|mesh-ancestor
19259784|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259785|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259786|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259787|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
19259788|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259789|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259790|NCT04282239|Lidocaine|lidocaine|mesh-list
19259791|NCT04282239|Epinephrine|epinephrine|mesh-list
19259792|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
19259793|NCT04282239|Ropivacaine|ropivacaine|mesh-list
19259794|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
19259795|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
19259796|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259797|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259798|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
19259799|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259800|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19259801|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19259802|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19259803|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19259804|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217064|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217065|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20217066|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20217067|NCT00308438|Teduglutide|teduglutide|mesh-list
20217068|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19259805|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19259806|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20348687|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348688|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259807|NCT04282239|Analgesics|analgesics|mesh-ancestor
19259808|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19259809|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19259810|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19259811|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
19259812|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259813|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19259814|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19259815|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
19259816|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19259817|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
19259818|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
19259819|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
19259820|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20175318|NCT00167908|Amifostine|amifostine|mesh-list
20175319|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20175320|NCT00167908|Protective Agents|protective agents|mesh-ancestor
20175321|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175322|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20175323|NCT00167921|Estrogens|estrogens|mesh-ancestor
20175324|NCT00167921|Hormones|hormones|mesh-ancestor
20175325|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175326|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175327|NCT00167947|Cyclosporine|cyclosporine|mesh-list
20175328|NCT00167947|Sirolimus|sirolimus|mesh-list
20348689|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348690|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19259821|NCT04232072|Ibuprofen|ibuprofen|mesh-list
19259822|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19259823|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19259824|NCT04232072|Analgesics|analgesics|mesh-ancestor
19259825|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
19259826|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259827|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259828|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259829|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19259830|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19259831|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612308|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20612309|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
19259832|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259833|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
19259834|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19259835|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259836|NCT04182633|Vancomycin|vancomycin|mesh-list
19259837|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19259838|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19259839|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259840|NCT04182633|Laxatives|laxatives|mesh-ancestor
19259841|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19259842|NCT04143477|Peficitinib|peficitinib|mesh-list
19666272|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666273|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
19666274|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19666275|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
19666276|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19666277|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19666278|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666279|NCT04985851|Durvalumab|durvalumab|mesh-list
19666280|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19666281|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666282|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666283|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
19666284|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175329|NCT00167947|Cyclosporins|cyclosporins|mesh-list
20348691|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20348692|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348693|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348694|NCT00864981|Bupropion|bupropion|mesh-list
20348695|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19259843|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259844|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175330|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348696|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348697|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348698|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20348699|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348700|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348701|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348702|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
20348703|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348704|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348705|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20348706|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348707|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348708|NCT00865007|Ritonavir|ritonavir|mesh-list
20348709|NCT00865007|Lopinavir|lopinavir|mesh-list
20348710|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20348711|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20348712|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
20348713|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348714|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348715|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20348716|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20348717|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
20348718|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348719|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19666285|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
19666286|NCT04976374|Gabapentin|gabapentin|mesh-list
19666287|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19666288|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666289|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666290|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666291|NCT04976374|Analgesics|analgesics|mesh-ancestor
19666292|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
19259845|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19259846|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
19259847|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259848|NCT04132427|Vancomycin|vancomycin|mesh-list
19259849|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
19259850|NCT04132427|Citric Acid|citric acid|mesh-list
19259851|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
19666293|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666294|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19666295|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19666296|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19666297|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
19259852|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
19259853|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19259854|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
19259855|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
19259856|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259857|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19259858|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259859|NCT04132427|Cathartics|cathartics|mesh-ancestor
19259860|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20348720|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348721|NCT00865033|Metformin|metformin|mesh-list
20348722|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348723|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348724|NCT00865059|Gabapentin|gabapentin|mesh-list
20348725|NCT00865059|Analgesics|analgesics|mesh-ancestor
20348726|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
19259861|NCT04122755|Buprenorphine|buprenorphine|mesh-list
19259862|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19259863|NCT04122755|Narcotics|narcotics|mesh-ancestor
19259864|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259865|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259866|NCT04122755|Analgesics|analgesics|mesh-ancestor
19259867|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
19259868|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666298|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666299|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666300|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
20348727|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348728|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348729|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
19259869|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19259870|NCT04097470|Decitabine|decitabine|mesh-list
19259871|NCT04097470|Midostaurin|midostaurin|mesh-list
19259872|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259873|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
19259874|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259875|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259876|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259877|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19259878|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
19259879|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
19259880|NCT04054999|Methylene Blue|methylene blue|mesh-list
19259881|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348730|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20348731|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348732|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348733|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348734|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20348735|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20348736|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348737|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348738|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
19259882|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175331|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175332|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20175333|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
20175334|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175335|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
20175336|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175337|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
20175338|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175339|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20175340|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175341|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20348739|NCT00865072|Metformin|metformin|mesh-list
19666301|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19666302|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348740|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19259883|NCT04054999|Hematinics|hematinics|mesh-ancestor
19259884|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
19259885|NCT04054999|Vitamins|vitamins|mesh-ancestor
19259886|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
19259887|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392473|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392474|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392475|NCT03693976|Xylometazoline|xylometazoline|mesh-list
19392476|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
19392477|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19392478|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
19392479|NCT03693885|Oxytocin|oxytocin|mesh-list
19392480|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
19392481|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19392482|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392483|NCT03693872|Dopamine|dopamine|mesh-list
19392484|NCT03693872|Apomorphine|apomorphine|mesh-list
19392485|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
19392486|NCT03693872|Emetics|emetics|mesh-ancestor
19392487|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392488|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
19392489|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392490|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19392491|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
19392492|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392493|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392494|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19392495|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
19392496|NCT03693872|Protective Agents|protective agents|mesh-ancestor
19392497|NCT03693833|Cannabidiol|cannabidiol|mesh-list
19392498|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
19392499|NCT03693638|Fentanyl|fentanyl|mesh-list
19392500|NCT03693638|Bupivacaine|bupivacaine|mesh-list
19392501|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
19392502|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
19392503|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392504|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666303|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19666304|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19392505|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
19392506|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259888|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19259889|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259890|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19259891|NCT03857542|Pilocarpine|pilocarpine|mesh-list
19259892|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19259893|NCT03857542|Miotics|miotics|mesh-ancestor
19259894|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
19259895|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259896|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259897|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19259898|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19259899|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
19259900|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259901|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259902|NCT03848832|Cannabidiol|cannabidiol|mesh-list
19259903|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
19259904|NCT03835013|Exenatide|exenatide|mesh-list
19259905|NCT03835013|Glucagon|glucagon|mesh-list
19259906|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19259907|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19259908|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259909|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19259910|NCT03835013|Incretins|incretins|mesh-ancestor
19259911|NCT03835013|Hormones|hormones|mesh-ancestor
19259912|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259913|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19259914|NCT03810807|Osimertinib|osimertinib|mesh-list
19259915|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259916|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19259917|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259918|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259919|NCT03794388|Pregabalin|pregabalin|mesh-list
19259920|NCT03794388|Capsaicin|capsaicin|mesh-list
19259921|NCT03794388|Analgesics|analgesics|mesh-ancestor
19259922|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
19259923|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259924|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259925|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
19259926|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19259927|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19259928|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259929|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19259930|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19259931|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19259932|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259933|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19259934|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
19259935|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
19259936|NCT03712943|Nivolumab|nivolumab|mesh-list
19259937|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19259938|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259939|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19259940|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259941|NCT03700541|Morphine|morphine|mesh-list
19259942|NCT03700541|Pirinitramide|pirinitramide|mesh-list
19259943|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19259944|NCT03700541|Narcotics|narcotics|mesh-ancestor
19259945|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259946|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175342|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175343|NCT00167960|Tazobactam|tazobactam|mesh-list
20175344|NCT00167960|Piperacillin|piperacillin|mesh-list
20175345|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20175346|NCT00167960|Lactams|lactams|mesh-list
20175347|NCT00167960|beta-Lactams|beta-lactams|mesh-list
20175348|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175349|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175350|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20175351|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175352|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175353|NCT00167986|Vancomycin|vancomycin|mesh-list
20175354|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19259947|NCT03700541|Analgesics|analgesics|mesh-ancestor
19259948|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
19259949|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428565|NCT01292356|Cetuximab|cetuximab|mesh-list
20175355|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259950|NCT03700411|Morphine|morphine|mesh-list
19259951|NCT03700411|Pirinitramide|pirinitramide|mesh-list
19259952|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19259953|NCT03700411|Narcotics|narcotics|mesh-ancestor
19259954|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19259955|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259956|NCT03700411|Analgesics|analgesics|mesh-ancestor
19259957|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
20348741|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348742|NCT00865085|Dexetimide|dexetimide|mesh-list
20348743|NCT00865085|Citalopram|citalopram|mesh-list
20348744|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20348745|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19259958|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19259959|NCT03691051|Capecitabine|capecitabine|mesh-list
19259960|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19259961|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
19259962|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259963|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19259964|NCT03688802|Varenicline|varenicline|mesh-list
19259965|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19259966|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19259967|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
19259968|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19259969|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259970|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259971|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
19259972|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19259973|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19259974|NCT03630666|Hormones|hormones|mesh-list
19259975|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19259976|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259977|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259978|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
19259979|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19259980|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19259981|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19259982|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19259983|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19259984|NCT03625648|Protective Agents|protective agents|mesh-ancestor
19259985|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259986|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
19259987|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19259988|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
19259989|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
19259990|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19259991|NCT03595917|Prednisone|prednisone|mesh-list
19259992|NCT03595917|Dasatinib|dasatinib|mesh-list
19259993|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19259994|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
19259995|NCT03595917|Hormones|hormones|mesh-ancestor
19259996|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19259997|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19259998|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19259999|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260000|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19260001|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260002|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260003|NCT03562195|Albuterol|albuterol|mesh-list
19260004|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19260005|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
19260006|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260007|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260008|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19260009|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
19260010|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
19260011|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19260012|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19260013|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19260014|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19260015|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260016|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348746|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19260017|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260018|NCT03541083|Blinatumomab|blinatumomab|mesh-list
19260019|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260020|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
19260021|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19260022|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19260023|NCT03465111|Hormones|hormones|mesh-list
19260024|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19260025|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19260026|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
19260027|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260028|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260029|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348747|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260030|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260031|NCT03446612|Nitroprusside|nitroprusside|mesh-list
19260032|NCT03446612|Acetylcholine|acetylcholine|mesh-list
19260033|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
20348748|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348749|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
20348750|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260034|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19260035|NCT03446612|Hematinics|hematinics|mesh-ancestor
19260036|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19260037|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
19260038|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20348751|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20348752|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348753|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348754|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20348755|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19260039|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260040|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19260041|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
19260042|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260043|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260044|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260045|NCT03436433|Lacosamide|lacosamide|mesh-list
19260046|NCT03436433|Levetiracetam|levetiracetam|mesh-list
19260047|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
19260048|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
19260049|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19260050|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19260051|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19260052|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260053|NCT03408886|Vancomycin|vancomycin|mesh-list
19260054|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260055|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260056|NCT03387774|Urinastatin|urinastatin|mesh-list
19260057|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19260058|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19260059|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
19260060|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612310|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612311|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
20612312|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20612313|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20612314|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
20612315|NCT02251119|Ritonavir|ritonavir|mesh-list
20612316|NCT02251119|Tipranavir|tipranavir|mesh-list
19260061|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260062|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19260063|NCT03387579|SMOFlipid|smoflipid|mesh-list
19260064|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19835564|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
20175356|NCT00167999|Tazobactam|tazobactam|mesh-list
20175357|NCT00167999|Piperacillin|piperacillin|mesh-list
20175358|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20175359|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175360|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175361|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20175362|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175363|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175364|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
20612317|NCT02251119|Loperamide|loperamide|mesh-list
19392507|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20612318|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
20348756|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
20348757|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
20348758|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835565|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835566|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175365|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20175366|NCT00168012|Antibodies|antibodies|mesh-list
20175367|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
20175368|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835567|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
19835568|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19835569|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
19835570|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
19835571|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19835572|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20175369|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
20175370|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20175371|NCT00168025|Antibodies|antibodies|mesh-list
20348759|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20348760|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19260065|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20348761|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
20348762|NCT00865111|Bupropion|bupropion|mesh-list
20348763|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19260066|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19260067|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
19260068|NCT03290079|Lenvatinib|lenvatinib|mesh-list
19260069|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260070|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260071|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19260072|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260073|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260074|NCT03255512|Isosorbide|isosorbide|mesh-list
19260075|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19260076|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19260077|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19260078|NCT03255512|Diuretics|diuretics|mesh-ancestor
19260079|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
19260080|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260081|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
19260082|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19260083|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260084|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
19260085|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19260086|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260087|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260088|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260089|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260090|NCT03230266|Insulin|insulin|mesh-list
19260091|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19260092|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392508|NCT03693638|Narcotics|narcotics|mesh-ancestor
19392509|NCT03693638|Analgesics|analgesics|mesh-ancestor
19392510|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19392511|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19392512|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
19392513|NCT03693612|Paclitaxel|paclitaxel|mesh-list
19392514|NCT03693612|Docetaxel|docetaxel|mesh-list
19392515|NCT03693612|Cetuximab|cetuximab|mesh-list
19392516|NCT03693612|Tremelimumab|tremelimumab|mesh-list
19392517|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19392518|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392519|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19392520|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
19392521|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392522|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392523|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392524|NCT03693599|Carbetocin|carbetocin|mesh-list
19392525|NCT03693599|Syntometrine|syntometrine|mesh-list
19392526|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
19392527|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19392528|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175372|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
20175373|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392529|NCT03693573|Bevacizumab|bevacizumab|mesh-list
19392530|NCT03693573|Atezolizumab|atezolizumab|mesh-list
19392531|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20348764|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348765|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348766|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20348767|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348768|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348769|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348770|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
20348771|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348772|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348773|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20348774|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348775|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348776|NCT00865137|Tacrolimus|tacrolimus|mesh-list
20348777|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20348778|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
20348779|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348780|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20348781|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348782|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348783|NCT00865176|Eplerenone|eplerenone|mesh-list
20348784|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20348785|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
20348786|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612319|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19260093|NCT03112590|Interferons|interferons|mesh-list
19260094|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
19260095|NCT03112590|Paclitaxel|paclitaxel|mesh-list
19260096|NCT03112590|Trastuzumab|trastuzumab|mesh-list
19260097|NCT03112590|Pertuzumab|pertuzumab|mesh-list
19260098|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19260099|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260100|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
19260101|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
19260102|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
19260103|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260104|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260105|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
19260106|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260107|NCT03111212|Iloprost|iloprost|mesh-list
19260108|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19260109|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
19260110|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
19260111|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19260112|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260113|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260114|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
19260115|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19260116|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
19260117|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260118|NCT03063021|Expectorants|expectorants|mesh-ancestor
19260119|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
19260120|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19260121|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
19260122|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260123|NCT03063021|Protective Agents|protective agents|mesh-ancestor
19260124|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260125|NCT03063021|Antidotes|antidotes|mesh-ancestor
19260126|NCT02997358|Doxorubicin|doxorubicin|mesh-list
19260127|NCT02997358|Trabectedin|trabectedin|mesh-list
19260128|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19260129|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260130|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19260131|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19260132|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260133|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260134|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19260135|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
19260136|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
19260137|NCT02963610|Lenalidomide|lenalidomide|mesh-list
19260138|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260139|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260140|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
19666305|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19666306|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
19260141|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260142|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19260143|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19260144|NCT02963610|Growth Substances|growth substances|mesh-ancestor
19260145|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
19260146|NCT02945800|Gemcitabine|gemcitabine|mesh-list
19260147|NCT02945800|Paclitaxel|paclitaxel|mesh-list
19260148|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19260149|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260150|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
19260151|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
19260152|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
19260153|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260154|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19260155|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
19260156|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
19260157|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260158|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260159|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260160|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
19260161|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260162|NCT02903160|Prednisone|prednisone|mesh-list
19260163|NCT02903160|Carboplatin|carboplatin|mesh-list
19260164|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
19260165|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19260166|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260167|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19260168|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
19260169|NCT02903160|Hormones|hormones|mesh-ancestor
19260170|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260171|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260172|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19260173|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19260174|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260175|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260176|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
19835573|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20175374|NCT00168051|Factor VIII|factor viii|mesh-list
20175375|NCT00168051|Coagulants|coagulants|mesh-ancestor
20175376|NCT00168077|Thrombin|thrombin|mesh-list
20175377|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
20175378|NCT00168077|Coagulants|coagulants|mesh-ancestor
20175379|NCT00168090|Factor VIII|factor viii|mesh-list
20175380|NCT00168090|Coagulants|coagulants|mesh-ancestor
20175381|NCT00168168|Lenograstim|lenograstim|mesh-list
20175382|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20175383|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
20175384|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175385|NCT00168181|Pilocarpine|pilocarpine|mesh-list
20175386|NCT00168181|Miotics|miotics|mesh-ancestor
20175387|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
20175388|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175389|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175390|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20175391|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20175392|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
20175393|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175394|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175395|NCT00168350|Memantine|memantine|mesh-list
20175396|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20175397|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20175398|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
20175399|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175400|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175401|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175402|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20175403|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20175404|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20175405|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20175406|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20175407|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20175408|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20175409|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
20175410|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260177|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20218093|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
19260178|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
19260179|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19260180|NCT02836925|Ledipasvir|ledipasvir|mesh-list
19260181|NCT02836925|Velpatasvir|velpatasvir|mesh-list
19260182|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
19260183|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260184|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
19260185|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
19260186|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260187|NCT02814695|Protective Agents|protective agents|mesh-ancestor
19260188|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260189|NCT02814695|Vitamins|vitamins|mesh-ancestor
19260190|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
19260191|NCT02798536|Paclitaxel|paclitaxel|mesh-list
19260192|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19260193|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260194|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
19260195|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
19260196|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
19260197|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260198|NCT02766335|Docetaxel|docetaxel|mesh-list
19260199|NCT02766335|Durvalumab|durvalumab|mesh-list
19260200|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
19260201|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19260202|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
19260203|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260204|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
19260205|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
19260206|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
19260207|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260208|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260209|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
19260210|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260211|NCT02736422|Xenon|xenon|mesh-list
19260212|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20348787|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348788|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20348789|NCT00865176|Diuretics|diuretics|mesh-ancestor
20348790|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
19260213|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
19260214|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
19260215|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260216|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260217|NCT02710643|Ofatumumab|ofatumumab|mesh-list
19260218|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260219|NCT02675439|Ipilimumab|ipilimumab|mesh-list
19260220|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260221|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260222|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19260223|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260224|NCT02651740|Rifaximin|rifaximin|mesh-list
19260225|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260226|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260227|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19260228|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
19260229|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
19666307|NCT04949412|Vitamin D|vitamin d|mesh-list
20175411|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175412|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175413|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
20348791|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348792|NCT00865215|Propranolol|propranolol|mesh-list
20175414|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20175415|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20175416|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20175417|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175418|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175419|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
20175420|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348793|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19260230|NCT02606136|Mitogens|mitogens|mesh-list
20175421|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348794|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20348795|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260231|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
19260232|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666308|NCT04949412|Vitamins|vitamins|mesh-ancestor
19260233|NCT02493426|Oxytocin|oxytocin|mesh-list
19260234|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
19260235|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19260236|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260237|NCT02432378|Celecoxib|celecoxib|mesh-list
19260238|NCT02432378|Cisplatin|cisplatin|mesh-list
19260239|NCT02432378|Vaccines|vaccines|mesh-list
19260240|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
19260241|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260242|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260243|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19260244|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19260245|NCT02432378|Analgesics|analgesics|mesh-ancestor
19260246|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
19260247|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260248|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19260249|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19260250|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19260251|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19260252|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260253|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835574|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
19835575|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835576|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835577|NCT00603720|Protective Agents|protective agents|mesh-ancestor
19835578|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835579|NCT00603733|Mesalamine|mesalamine|mesh-list
19835580|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19835581|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19835582|NCT00603733|Analgesics|analgesics|mesh-ancestor
19835583|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
19260254|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19260255|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19260256|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260257|NCT02090998|Lidocaine|lidocaine|mesh-list
19260258|NCT02090998|Amitriptyline|amitriptyline|mesh-list
19260259|NCT02090998|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19260260|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
19260261|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
19260262|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260263|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260264|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
19260265|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260266|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19260267|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19260268|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19260269|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19260270|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260271|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19260272|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
19260273|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19260274|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19260275|NCT02090998|Analgesics|analgesics|mesh-ancestor
19260276|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19260277|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19260278|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260279|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260280|NCT02090998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19260281|NCT02090998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19260282|NCT02063685|Prednisone|prednisone|mesh-list
19260283|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
19835584|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175422|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20175423|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175424|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
20175425|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20175426|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20175427|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20175428|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175429|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175430|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
20175431|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175432|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175433|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19260284|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19260285|NCT02063685|Rituximab|rituximab|mesh-list
19260286|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19260287|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260288|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
19260289|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260290|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348796|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348797|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348798|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348799|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20348800|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348801|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
20424769|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424770|NCT01271153|Protective Agents|protective agents|mesh-ancestor
20424771|NCT01271166|Leucovorin|leucovorin|mesh-list
20424772|NCT01271166|Bevacizumab|bevacizumab|mesh-list
20424773|NCT01271166|Fluorouracil|fluorouracil|mesh-list
20424774|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
20424775|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
20424776|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20424777|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424778|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19260291|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19260292|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
19260293|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260294|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260295|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19260296|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260297|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19260298|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
19260299|NCT02063685|Hormones|hormones|mesh-ancestor
19260300|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260301|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19260302|NCT02051309|Guanfacine|guanfacine|mesh-list
19260303|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19260304|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19260305|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19260306|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19260307|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260308|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260309|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260310|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260311|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
19260312|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260313|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260314|NCT01900002|Sorafenib|sorafenib|mesh-list
19260315|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260316|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19260317|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260318|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260319|NCT01595061|Gemcitabine|gemcitabine|mesh-list
19260320|NCT01595061|Cisplatin|cisplatin|mesh-list
19260321|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260322|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19260323|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
19260324|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260325|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
19260326|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260327|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260328|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260329|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
19260330|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260331|NCT01587352|Vorinostat|vorinostat|mesh-list
20424779|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20424780|NCT01271166|Growth Substances|growth substances|mesh-ancestor
20424781|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424782|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
20424783|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
20424784|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424785|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19260332|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260333|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19260334|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260335|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260336|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
19260337|NCT00902044|Fludarabine|fludarabine|mesh-list
19260338|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260339|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
19260340|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260341|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19260342|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19260343|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
19260344|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260345|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260346|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19260347|NCT00165724|Donepezil|donepezil|mesh-list
19260348|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19260349|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260350|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260351|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
19260352|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260353|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260354|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
19260355|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
19260356|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19260357|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
19260358|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19260359|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19260360|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260361|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260362|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
19260363|NCT04527133|Aprotinin|aprotinin|mesh-list
19260364|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
19260365|NCT04527133|Coagulants|coagulants|mesh-ancestor
19260366|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19260367|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19260368|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
19260369|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260370|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260371|NCT04527055|Metronidazole|metronidazole|mesh-list
19260372|NCT04527055|Tetracycline|tetracycline|mesh-list
19260373|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19260374|NCT04527055|Esomeprazole|esomeprazole|mesh-list
19260375|NCT04527055|Bismuth|bismuth|mesh-list
20175434|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175435|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
19260376|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260377|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260378|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19260379|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19260380|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19260381|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19260382|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19260383|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260384|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260385|NCT04527055|Antacids|antacids|mesh-ancestor
19260386|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19260387|NCT04526951|Aspirin|aspirin|mesh-list
19260388|NCT04526951|Tenecteplase|tenecteplase|mesh-list
19260389|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19260390|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19260391|NCT04526951|Analgesics|analgesics|mesh-ancestor
19260392|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
19260393|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260394|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260395|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19260396|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19260397|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19260398|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19260399|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260400|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19260401|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19260402|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260403|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
20175436|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19260404|NCT04527068|Bevacizumab|bevacizumab|mesh-list
19260405|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260406|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260407|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19260408|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19260409|NCT04527068|Growth Substances|growth substances|mesh-ancestor
19260410|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260411|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
19260412|NCT04526470|Paclitaxel|paclitaxel|mesh-list
19260413|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19260414|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260415|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
19260416|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
19260417|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
19260418|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392532|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392533|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19392534|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19392535|NCT03693573|Growth Substances|growth substances|mesh-ancestor
19392536|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392537|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19392538|NCT03693560|Metformin|metformin|mesh-list
19392539|NCT03693560|Glimepiride|glimepiride|mesh-list
19392540|NCT03693560|Vildagliptin|vildagliptin|mesh-list
19392541|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19392542|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392543|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19392544|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392545|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
19392546|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19392547|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
19392548|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392549|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392550|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19392551|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19392552|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19392553|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
19392554|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392555|NCT03693404|Ketorolac|ketorolac|mesh-list
19392556|NCT03693404|Morphine|morphine|mesh-list
19392557|NCT03693404|Bupivacaine|bupivacaine|mesh-list
20175437|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20175438|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20175439|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348802|NCT00865241|Metformin|metformin|mesh-list
20348803|NCT00865241|Glyburide|glyburide|mesh-list
20348804|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348805|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348806|NCT00865267|Halobetasol|halobetasol|mesh-list
20348807|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20348808|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
20348809|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20348810|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20348811|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348812|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
19392558|NCT03693404|Anesthetics|anesthetics|mesh-list
19392559|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
19392560|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
19392561|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392562|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392563|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
19392564|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392565|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392566|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20175440|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175441|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
20175442|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175443|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175444|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20175445|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175446|NCT00168467|Ramipril|ramipril|mesh-list
20175447|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20348813|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
20348814|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392567|NCT03693404|Analgesics|analgesics|mesh-ancestor
20348815|NCT00865371|Bupropion|bupropion|mesh-list
20348816|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19666309|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
19260419|NCT04526353|Oxybutynin|oxybutynin|mesh-list
19260420|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
19260421|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
19260422|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260423|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260424|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19260425|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19260426|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
19260427|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260428|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260429|NCT04526353|Urological Agents|urological agents|mesh-ancestor
19260430|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19260431|NCT04526210|Choline|choline|mesh-list
19260432|NCT04526210|Bupropion|bupropion|mesh-list
20175448|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
20175449|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175450|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175451|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20175452|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
20175453|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20175454|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20175455|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19260433|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19260434|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
19260435|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19260436|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19260437|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19260438|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19260439|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260440|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
19260441|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260442|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260443|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19260444|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19260445|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260446|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
19260447|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19260448|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
19260449|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19260450|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19260451|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
19260452|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
19260453|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
19260454|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19260455|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19260456|NCT04526210|Growth Substances|growth substances|mesh-ancestor
19260457|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835585|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835586|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835587|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835588|NCT00603798|Imiquimod|imiquimod|mesh-list
19835589|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19835590|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
19835591|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175456|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175457|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835592|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835593|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
19835594|NCT00603915|Gemcitabine|gemcitabine|mesh-list
19835595|NCT00603915|Carboplatin|carboplatin|mesh-list
19835596|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19835597|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835598|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19835599|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
19835600|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835601|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
19835602|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835603|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835604|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835605|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
19835606|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835607|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19260458|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260459|NCT04526028|Fulvestrant|fulvestrant|mesh-list
19260460|NCT04526028|Palbociclib|palbociclib|mesh-list
19260461|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19260462|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260463|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19260464|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19260465|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
19260466|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260467|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260468|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835608|NCT00603941|Paclitaxel|paclitaxel|mesh-list
19835609|NCT00603941|Efatutazone|efatutazone|mesh-list
20175458|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
19260469|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260470|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260471|NCT04526119|Z 338|z 338|mesh-list
19260472|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19260473|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260474|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260475|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
19260476|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260477|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260478|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19260479|NCT04526236|Methadone|methadone|mesh-list
19260480|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19260481|NCT04526236|Narcotics|narcotics|mesh-ancestor
19260482|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260483|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260484|NCT04526236|Analgesics|analgesics|mesh-ancestor
19260485|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
19260486|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260487|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
19260488|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
19260489|NCT04525820|Vitamin D|vitamin d|mesh-list
19260490|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
19260491|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
19260492|NCT04525820|Vitamins|vitamins|mesh-list
19260493|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19260494|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
19260495|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260496|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19260497|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19260498|NCT04525664|Amoxicillin|amoxicillin|mesh-list
19260499|NCT04525664|Clarithromycin|clarithromycin|mesh-list
19260500|NCT04525664|Omeprazole|omeprazole|mesh-list
19260501|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260502|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260503|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20175459|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175460|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175461|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19260504|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19835610|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19835611|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835612|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
19835613|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
19835614|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
19835615|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835616|NCT00603980|Alprazolam|alprazolam|mesh-list
19835617|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19835618|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835619|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260505|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19260506|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260507|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260508|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19260509|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19260510|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19260511|NCT04525729|Rituximab|rituximab|mesh-list
19260512|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260513|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260514|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
19260515|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175462|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260516|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19260517|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
19260518|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19260519|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666310|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175463|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
20175464|NCT00168493|Serotonin|serotonin|mesh-list
20175465|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20175466|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175467|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19260520|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
19666311|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19666312|NCT04947020|Metformin|metformin|mesh-list
19666313|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19666314|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666315|NCT04904614|Letermovir|letermovir|mesh-list
19260521|NCT04525495|Dopamine|dopamine|mesh-list
19260522|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19260523|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
19260524|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
19260525|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260526|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260527|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
19260528|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260529|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260530|NCT04525495|Protective Agents|protective agents|mesh-ancestor
19260531|NCT04525638|Nivolumab|nivolumab|mesh-list
19260532|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19260533|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260534|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260535|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19260536|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260537|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19260538|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
19260539|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19260540|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
19260541|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260542|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
19260543|NCT04525066|Protective Agents|protective agents|mesh-ancestor
19260544|NCT04525235|Tolbutamide|tolbutamide|mesh-list
19260545|NCT04525235|Rifampin|rifampin|mesh-list
19260546|NCT04525235|Digoxin|digoxin|mesh-list
19260547|NCT04525235|Midazolam|midazolam|mesh-list
19260548|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
19260549|NCT04525235|Caffeine|caffeine|mesh-list
19260550|NCT04525235|Omeprazole|omeprazole|mesh-list
19260551|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19260552|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19260553|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260554|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260555|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19666316|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19666317|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666318|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260556|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19260557|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19260558|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19260559|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
19260560|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
19260561|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
19260562|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
19260563|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260564|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260565|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19260566|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19260567|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19260568|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260569|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19260570|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19260571|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19260572|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19260573|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
19666319|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175468|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
19260574|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19260575|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
20175469|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260576|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260577|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260578|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
19260579|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19260580|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19260581|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19260582|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19260583|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19260584|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19260585|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19260586|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19260587|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19260588|NCT04525235|Protective Agents|protective agents|mesh-ancestor
19260589|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
19260590|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
19260591|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19260592|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19260593|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19260594|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
19260595|NCT04525274|Ketamine|ketamine|mesh-list
19260596|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19260597|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260598|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260599|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19260600|NCT04525274|Analgesics|analgesics|mesh-ancestor
19260601|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
19260602|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260603|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19260604|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19260605|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19260606|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260607|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260608|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260609|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19260610|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19260611|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
19260612|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
19260613|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19260614|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19260615|NCT04525326|Bevacizumab|bevacizumab|mesh-list
19260616|NCT04525326|Cetuximab|cetuximab|mesh-list
19260617|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260618|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260619|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19260620|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19260621|NCT04525326|Growth Substances|growth substances|mesh-ancestor
19260622|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348817|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348818|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348819|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20348820|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348821|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348822|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348823|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
20348824|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348825|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348826|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20348827|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348828|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348829|NCT00865384|Mirtazapine|mirtazapine|mesh-list
20348830|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348831|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348832|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20348833|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
20348834|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
20348835|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348836|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348837|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348838|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20348839|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19260623|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
20348840|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348841|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20348842|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20348843|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20348844|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260624|NCT04525300|Liraglutide|liraglutide|mesh-list
19260625|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19260626|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260627|NCT04525300|Incretins|incretins|mesh-ancestor
19260628|NCT04525300|Hormones|hormones|mesh-ancestor
19260629|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260630|NCT04524728|Letrozole|letrozole|mesh-list
19260631|NCT04524728|Fulvestrant|fulvestrant|mesh-list
19260632|NCT04524728|Palbociclib|palbociclib|mesh-list
19260633|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260634|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19260635|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19260636|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260637|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260638|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19260639|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
19260640|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260641|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260642|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19260643|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19260644|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19260645|NCT04524897|Triamcinolone|triamcinolone|mesh-list
19260646|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19260647|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19260648|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19260649|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19260650|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
19260651|NCT04524897|Hormones|hormones|mesh-ancestor
19260652|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260653|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260654|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260655|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
19260656|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260657|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175470|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260658|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19260659|NCT04524169|Thymalfasin|thymalfasin|mesh-list
19260660|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19260661|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
19260662|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666320|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
19666321|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666322|NCT04874935|Lansoprazole|lansoprazole|mesh-list
19666323|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
19666324|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19666325|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666326|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19666327|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175471|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175472|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20175473|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175474|NCT00168519|Nitroprusside|nitroprusside|mesh-list
20175475|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19666328|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175476|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
20175477|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20175478|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175479|NCT00168532|Trimethoprim|trimethoprim|mesh-list
20175480|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20175481|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
20175482|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20175483|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175484|NCT00168532|Renal Agents|renal agents|mesh-ancestor
20175485|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
20175486|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20175487|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20175488|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20175489|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348845|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20348846|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20348847|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
20348848|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20348849|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
19260663|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
20175490|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175491|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20175492|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20175493|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20175494|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175495|NCT00168584|Vitamin A|vitamin a|mesh-list
20175496|NCT00168584|Vitamins|vitamins|mesh-ancestor
20175497|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
20175498|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175499|NCT00168597|Vitamin A|vitamin a|mesh-list
20175500|NCT00168597|Vitamins|vitamins|mesh-ancestor
20175501|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
20175502|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260664|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260665|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260666|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19260667|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19260668|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260669|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260670|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260671|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19260672|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19260673|NCT04524026|Letrozole|letrozole|mesh-list
19260674|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19260675|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260676|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19260677|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260678|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260679|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19260680|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
19260681|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19260682|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260683|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19260684|NCT04523844|Brinzolamide|brinzolamide|mesh-list
19260685|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19260686|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19260687|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19260688|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19260689|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260690|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260691|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260692|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260693|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19260694|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260695|NCT04523818|Fluorouracil|fluorouracil|mesh-list
19260696|NCT04523818|Capecitabine|capecitabine|mesh-list
19260697|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
19260698|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260699|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19260700|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175503|NCT00168610|Vitamin A|vitamin a|mesh-list
20175504|NCT00168610|Vitamins|vitamins|mesh-ancestor
20175505|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
20175506|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175507|NCT00168623|Vitamin A|vitamin a|mesh-list
20175508|NCT00168623|Vitamins|vitamins|mesh-ancestor
20175509|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
20175510|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175511|NCT00168636|Vitamin A|vitamin a|mesh-list
20175512|NCT00168636|Vitamins|vitamins|mesh-ancestor
20175513|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
20175514|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175515|NCT00168649|Vitamin A|vitamin a|mesh-list
20175516|NCT00168649|Vitamins|vitamins|mesh-ancestor
20175517|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
20175518|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175519|NCT00168688|Micronutrients|micronutrients|mesh-list
20175520|NCT00168688|Trace Elements|trace elements|mesh-list
20175521|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175522|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19260701|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260702|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
19260703|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260704|NCT04523792|Buprenorphine|buprenorphine|mesh-list
19260705|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19260706|NCT04523792|Narcotics|narcotics|mesh-ancestor
19260707|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260708|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260709|NCT04523792|Analgesics|analgesics|mesh-ancestor
19260710|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
19260711|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260712|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19260713|NCT04523740|Acetaminophen|acetaminophen|mesh-list
19260714|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19260715|NCT04523740|Analgesics|analgesics|mesh-ancestor
19260716|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
19260717|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260718|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260719|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
19260720|NCT04523623|Ibuprofen|ibuprofen|mesh-list
19260721|NCT04523623|Oxycodone|oxycodone|mesh-list
19260722|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19260723|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19260724|NCT04523623|Analgesics|analgesics|mesh-ancestor
19260725|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
19260726|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260727|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260728|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19260729|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19260730|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19260731|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260732|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260733|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19260734|NCT04523623|Narcotics|narcotics|mesh-ancestor
20348850|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348851|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348852|NCT00865410|Bupropion|bupropion|mesh-list
20348853|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20348854|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348855|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348856|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20348857|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348858|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348859|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348860|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
20348861|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348862|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348863|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20348864|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19260735|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260736|NCT04523662|Apatinib|apatinib|mesh-list
19260737|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260738|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19260739|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260740|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260741|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
19260742|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19260743|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
20348865|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348866|NCT00865423|Gabapentin|gabapentin|mesh-list
20348867|NCT00865423|Analgesics|analgesics|mesh-ancestor
20348868|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
20348869|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348870|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348871|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
19666329|NCT04834063|Selenium|selenium|mesh-list
20175523|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20175524|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20175525|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
20175526|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175527|NCT00168714|Interferons|interferons|mesh-list
20175528|NCT00168714|Interferon-beta|interferon-beta|mesh-list
20175529|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
20175530|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666330|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
20175531|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
20348872|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20348873|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348874|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348875|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348876|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20348877|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20348878|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348879|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348880|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
20348881|NCT00865436|Metformin|metformin|mesh-list
20348882|NCT00865436|Glyburide|glyburide|mesh-list
20348883|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20348884|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348885|NCT00865449|Spironolactone|spironolactone|mesh-list
20348886|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20348887|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
20348888|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348889|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348890|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20348891|NCT00865449|Diuretics|diuretics|mesh-ancestor
20348892|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
20348893|NCT00865462|Bupropion|bupropion|mesh-list
20348894|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20348895|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
20348896|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348897|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20348898|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20348899|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20348900|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348901|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
20348902|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348903|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348904|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20348905|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348906|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348907|NCT00865475|Lopinavir|lopinavir|mesh-list
20348908|NCT00865475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20348909|NCT00865475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20348910|NCT00865475|Protease Inhibitors|protease inhibitors|mesh-ancestor
20348911|NCT00865475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348912|NCT00865475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348913|NCT00865475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20348914|NCT00865475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20348915|NCT00865475|Antiviral Agents|antiviral agents|mesh-ancestor
20348916|NCT00865475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20348917|NCT00865475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20348918|NCT00865475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348919|NCT00865501|Spironolactone|spironolactone|mesh-list
20348920|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20348921|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
19260744|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260745|NCT04523675|Expectorants|expectorants|mesh-ancestor
19260746|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
19260747|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19260748|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
19260749|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260750|NCT04523675|Protective Agents|protective agents|mesh-ancestor
19260751|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260752|NCT04523675|Antidotes|antidotes|mesh-ancestor
19260753|NCT04523701|SMOFlipid|smoflipid|mesh-list
20175532|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175533|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
20175534|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175535|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20175536|NCT00168740|Rituximab|rituximab|mesh-list
20175537|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175538|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175539|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
20175540|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175541|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19260754|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20175542|NCT00168753|Alefacept|alefacept|mesh-list
20175543|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
20175544|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
19260755|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19260756|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19260757|NCT04523688|Temozolomide|temozolomide|mesh-list
19260758|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19260759|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
19260760|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260761|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260762|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19260763|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
19260764|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19260765|NCT04523467|Growth Substances|growth substances|mesh-ancestor
19260766|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260767|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
19260768|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260769|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19260770|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
19260771|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20348922|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348923|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348924|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20348925|NCT00865501|Diuretics|diuretics|mesh-ancestor
20348926|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
20348927|NCT00865540|Prednisolone|prednisolone|mesh-list
20348928|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20348929|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
20348930|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20348931|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
20348932|NCT00865540|Ketorolac|ketorolac|mesh-list
19260772|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19260773|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260774|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
19260775|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260776|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260777|NCT04523233|Vitamins|vitamins|mesh-list
19260778|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
19260779|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260780|NCT04523272|Sunitinib|sunitinib|mesh-list
19260781|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260782|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19260783|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19260784|NCT04523272|Growth Substances|growth substances|mesh-ancestor
19260785|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260786|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
19260787|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19260788|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260789|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260790|NCT04523077|Antibodies|antibodies|mesh-list
19260791|NCT04523077|Hormones|hormones|mesh-list
19260792|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
19260793|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260794|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175545|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175546|NCT00168766|Interferons|interferons|mesh-list
20175547|NCT00168766|Interferon-beta|interferon-beta|mesh-list
20175548|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
20175549|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
20175550|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175551|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
20175552|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175553|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20175554|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
20175555|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
20175556|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175557|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175558|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20175559|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
20175560|NCT00168766|Hormones|hormones|mesh-ancestor
20175561|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175562|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20175563|NCT00168766|Protective Agents|protective agents|mesh-ancestor
20175564|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
20175565|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20348933|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20348934|NCT00865540|Nepafenac|nepafenac|mesh-list
19260795|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19260796|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19260797|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
19260798|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19260799|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260800|NCT04522882|Insulin|insulin|mesh-list
19260801|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19260802|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260803|NCT04523064|Empagliflozin|empagliflozin|mesh-list
19260804|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19260805|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260806|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19260807|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260808|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19260809|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260810|NCT04522622|Teriparatide|teriparatide|mesh-list
19260811|NCT04522622|Listerine|listerine|mesh-list
19260812|NCT04522622|Fluorides|fluorides|mesh-list
19260813|NCT04522622|Sodium Fluoride|sodium fluoride|mesh-list
19260814|NCT04522622|Cariostatic Agents|cariostatic agents|mesh-ancestor
19260815|NCT04522622|Protective Agents|protective agents|mesh-ancestor
19260816|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260817|NCT04522622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19260818|NCT04522622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260819|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19260820|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19260821|NCT04522336|Docetaxel|docetaxel|mesh-list
19260822|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
19260823|NCT04522336|Fluorouracil|fluorouracil|mesh-list
19260824|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
19260825|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260826|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
19260827|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
19666331|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666332|NCT04834063|Protective Agents|protective agents|mesh-ancestor
19666333|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666334|NCT04834063|Trace Elements|trace elements|mesh-ancestor
19666335|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
19666336|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19666337|NCT04794205|Caryophyllene|caryophyllene|mesh-list
20175566|NCT00168779|Valsartan|valsartan|mesh-list
19260828|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
19260829|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260830|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19260831|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
19260832|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19260833|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260834|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
19260835|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260836|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
19260837|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
19666338|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20175567|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20175568|NCT00168779|Telmisartan|telmisartan|mesh-list
20175569|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20175570|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20175571|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20175572|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175573|NCT00168779|Diuretics|diuretics|mesh-ancestor
20175574|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
20175575|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175576|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20175577|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175578|NCT00168792|Tenecteplase|tenecteplase|mesh-list
20175579|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20175580|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20175581|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175582|NCT00168857|Losartan|losartan|mesh-list
20175583|NCT00168857|Telmisartan|telmisartan|mesh-list
20175584|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20175585|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19260838|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19260839|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19260840|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175586|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19260841|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260842|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260843|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19260844|NCT04522297|Octreotide|octreotide|mesh-list
19260845|NCT04522297|Epinephrine|epinephrine|mesh-list
19260846|NCT04522297|Midodrine|midodrine|mesh-list
19260847|NCT04522297|Norepinephrine|norepinephrine|mesh-list
19260848|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19260849|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20175587|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20175588|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175589|NCT00168870|Gemcitabine|gemcitabine|mesh-list
20175590|NCT00168870|Treosulfan|treosulfan|mesh-list
20175591|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20175592|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
20175593|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175594|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175595|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
20175596|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175597|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175598|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20175599|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
20348935|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20348936|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
20348937|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348938|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
20348939|NCT00865540|Hormones|hormones|mesh-ancestor
20348940|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348941|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260850|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
19260851|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260852|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260853|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260854|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19260855|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19260856|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
19260857|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260858|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19260859|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
19260860|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
19260861|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
19260862|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19260863|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19260864|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19260865|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260866|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19260867|NCT04522206|Oxycodone|oxycodone|mesh-list
19260868|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19260869|NCT04522206|Narcotics|narcotics|mesh-ancestor
19260870|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260871|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260872|NCT04522206|Analgesics|analgesics|mesh-ancestor
19260873|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
19260874|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260875|NCT04521868|Sulforaphane|sulforaphane|mesh-list
20175600|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175601|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19260876|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19260877|NCT04521868|Protective Agents|protective agents|mesh-ancestor
19260878|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260879|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835620|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19835621|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835622|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175602|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
19260880|NCT04522050|Gemcitabine|gemcitabine|mesh-list
20175603|NCT00168883|Paclitaxel|paclitaxel|mesh-list
20175604|NCT00168883|Vinorelbine|vinorelbine|mesh-list
20175605|NCT00168883|Carboplatin|carboplatin|mesh-list
20175606|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20175607|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175608|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
20348942|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20175609|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
19260881|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835623|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
19260882|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19260883|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
19260884|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260885|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
19260886|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260887|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260888|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260889|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
19260890|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260891|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
19260892|NCT04521946|Fludarabine|fludarabine|mesh-list
19260893|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
19260894|NCT04521946|Etoposide|etoposide|mesh-list
19260895|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
19260896|NCT04521946|Melphalan|melphalan|mesh-list
19260897|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
19260898|NCT04521946|Thiotepa|thiotepa|mesh-list
19260899|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
19260900|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19260901|NCT04521946|Tacrolimus|tacrolimus|mesh-list
19260902|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
20175610|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175611|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175612|NCT00168896|Carboplatin|carboplatin|mesh-list
20175613|NCT00168896|Irinotecan|irinotecan|mesh-list
20175614|NCT00168896|Etoposide|etoposide|mesh-list
20175615|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175616|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20175617|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20175618|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175619|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175620|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20175621|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20175622|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
20175623|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19260903|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19260904|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
19260905|NCT04521946|Antibodies|antibodies|mesh-list
20175624|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20175625|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175626|NCT00168909|Vitamins|vitamins|mesh-ancestor
20175627|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
20175628|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20175629|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20175630|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
20175631|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175632|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175633|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
20175634|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
20175635|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20175636|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20175637|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175638|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20175639|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260906|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
19260907|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19260908|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19260909|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175640|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175641|NCT00169000|Docetaxel|docetaxel|mesh-list
20175642|NCT00169000|Capecitabine|capecitabine|mesh-list
20175643|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260910|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19260911|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
19260912|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260913|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19260914|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
19260915|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260916|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19260917|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19260918|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19260919|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260920|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19260921|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19666339|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666340|NCT04794205|Analgesics|analgesics|mesh-ancestor
19835624|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
20348943|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348944|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
20175644|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
20175645|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
20175646|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175647|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348945|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
20348946|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348947|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20348948|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20175648|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20175649|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
20175650|NCT00169013|Gabapentin|gabapentin|mesh-list
20348949|NCT00865540|Protective Agents|protective agents|mesh-ancestor
20348950|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20348951|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20348952|NCT00865540|Analgesics|analgesics|mesh-ancestor
20348953|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
20348954|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20348955|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20348956|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20348957|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348958|NCT00865605|Clobetasol|clobetasol|mesh-list
20348959|NCT00865605|Halobetasol|halobetasol|mesh-list
20348960|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20175651|NCT00169013|Analgesics|analgesics|mesh-ancestor
20175652|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
20348961|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20348962|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
20348963|NCT00865605|Hormones|hormones|mesh-ancestor
20348964|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348965|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260922|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19260923|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
19260924|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19260925|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260926|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20612320|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20612321|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612322|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260927|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
19260928|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20348966|NCT00865618|Eplerenone|eplerenone|mesh-list
20348967|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20348968|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
20348969|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20348970|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348971|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20348972|NCT00865618|Diuretics|diuretics|mesh-ancestor
20348973|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
20175653|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175654|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175655|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
20175656|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20175657|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175658|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175659|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175660|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20175661|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20175662|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175663|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175664|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
20175665|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
20348974|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20348975|NCT00865631|Gabapentin|gabapentin|mesh-list
19260929|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
19260930|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
19260931|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
19260932|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
19260933|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392568|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392569|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175666|NCT00169026|Clozapine|clozapine|mesh-list
20348976|NCT00865631|Analgesics|analgesics|mesh-ancestor
20612323|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260934|NCT04522037|Morphine|morphine|mesh-list
19260935|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19260936|NCT04522037|Narcotics|narcotics|mesh-ancestor
19260937|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260938|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260939|NCT04522037|Analgesics|analgesics|mesh-ancestor
19260940|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
19260941|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19260942|NCT04521400|Interferons|interferons|mesh-list
19260943|NCT04521400|Ritonavir|ritonavir|mesh-list
19260944|NCT04521400|Lopinavir|lopinavir|mesh-list
19260945|NCT04521400|Interferon-beta|interferon-beta|mesh-list
19260946|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
19260947|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19260948|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
19260949|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19260950|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19260951|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19260952|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612324|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20612325|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612326|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
20612327|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612328|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20612329|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20348977|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
20348978|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20348979|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348980|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
20348981|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20348982|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20348983|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20348984|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20348985|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20348986|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20348987|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20348988|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348989|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
20612330|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612331|NCT02251132|Ritonavir|ritonavir|mesh-list
20612332|NCT02251132|Erythromycin|erythromycin|mesh-list
20612333|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
20612334|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20612335|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
20612336|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20612337|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20612338|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612339|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612340|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260953|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260954|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20348990|NCT00865644|Imiquimod|imiquimod|mesh-list
20348991|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20348992|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
20348993|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20348994|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20348995|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
20348996|NCT00865657|Alprazolam|alprazolam|mesh-list
20348997|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20348998|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260955|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20175667|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175668|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175669|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175670|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175671|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20175672|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
20175673|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175674|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175675|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
20175676|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
20175677|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
20175678|NCT00169039|Clozapine|clozapine|mesh-list
20348999|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175679|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20612341|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19260956|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19260957|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19260958|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19260959|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
19260960|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260961|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19260962|NCT04521569|Regadenoson|regadenoson|mesh-list
19260963|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19260964|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19260965|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
19260966|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
19260967|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19260968|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260969|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260970|NCT04521556|Morphine|morphine|mesh-list
19260971|NCT04521556|Tramadol|tramadol|mesh-list
19260972|NCT04521556|Anesthetics|anesthetics|mesh-list
19260973|NCT04521556|Ropivacaine|ropivacaine|mesh-list
19260974|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19260975|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260976|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19260977|NCT04521556|Narcotics|narcotics|mesh-ancestor
19260978|NCT04521556|Analgesics|analgesics|mesh-ancestor
19260979|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
19260980|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349000|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20349001|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20349002|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20349003|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
19260981|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
19260982|NCT04521582|Amlodipine|amlodipine|mesh-list
19260983|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19260984|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19260985|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19260986|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260987|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19260988|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260989|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
19260990|NCT04521751|Acarbose|acarbose|mesh-list
19260991|NCT04521751|Orlistat|orlistat|mesh-list
19260992|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19260993|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19260994|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19260995|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19260996|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19260997|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19260998|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19260999|NCT04521517|Imidacloprid|imidacloprid|mesh-list
19261000|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
19261001|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261002|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261003|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261004|NCT04521491|Leucovorin|leucovorin|mesh-list
19261005|NCT04521491|Fluorouracil|fluorouracil|mesh-list
19835625|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835626|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835627|NCT00603993|Adalimumab|adalimumab|mesh-list
19835628|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835629|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349004|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
19261006|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
19261007|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
19835630|NCT00604019|Dopamine|dopamine|mesh-list
19835631|NCT00604019|Norepinephrine|norepinephrine|mesh-list
19835632|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19835633|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19835634|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19835635|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835636|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835637|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835638|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
19835639|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
19835640|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835641|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20349005|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261008|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261009|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19261010|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261011|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261012|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
19261013|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261014|NCT04521491|Antidotes|antidotes|mesh-ancestor
19261015|NCT04521491|Protective Agents|protective agents|mesh-ancestor
19261016|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
19261017|NCT04521491|Vitamins|vitamins|mesh-ancestor
19261018|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
19261019|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
19261020|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19261021|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
19261022|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261023|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
19261024|NCT04521387|Protective Agents|protective agents|mesh-ancestor
19261025|NCT04521075|Nivolumab|nivolumab|mesh-list
19261026|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261027|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261028|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19261029|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261030|NCT04521140|Dexamethasone|dexamethasone|mesh-list
19261031|NCT04521140|Prednisolone|prednisolone|mesh-list
19261032|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19261033|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
19261034|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19261035|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
19261036|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19261037|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
19261038|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261039|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
19261040|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
19261041|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261042|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261043|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261044|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
19261045|NCT04521140|Hormones|hormones|mesh-ancestor
19261046|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261047|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19261048|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261049|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19261050|NCT04521140|Protective Agents|protective agents|mesh-ancestor
19261051|NCT04521348|Antibodies|antibodies|mesh-list
19261052|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
19261053|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
19261054|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261055|NCT04521309|Antibodies|antibodies|mesh-list
19261056|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
19261057|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261058|NCT04521153|Apatinib|apatinib|mesh-list
20175680|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
20175681|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175682|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175683|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175684|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20175685|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175686|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175687|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175688|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
20175689|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
20175690|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
20175691|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
20175692|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175693|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20175694|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20175695|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
20175696|NCT00169065|Olanzapine|olanzapine|mesh-list
20175697|NCT00169065|Clozapine|clozapine|mesh-list
20175698|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
20175699|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
20175700|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175701|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261059|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261060|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20175702|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20175703|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20175704|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19261061|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261062|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261063|NCT04521049|Saxagliptin|saxagliptin|mesh-list
19835642|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19835643|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
19835644|NCT00604019|Protective Agents|protective agents|mesh-ancestor
19835645|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19835646|NCT00604188|Buprenorphine|buprenorphine|mesh-list
19835647|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19835648|NCT00604188|Narcotics|narcotics|mesh-ancestor
19835649|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835650|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835651|NCT00604188|Analgesics|analgesics|mesh-ancestor
19835652|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
19835653|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835654|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19835655|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19261064|NCT04521049|Incretins|incretins|mesh-ancestor
20175705|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175706|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175707|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20175708|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20175709|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175710|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175711|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175712|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
20175713|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20175714|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
20175715|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
20175716|NCT00169078|Chloroquine|chloroquine|mesh-list
19261065|NCT04521049|Hormones|hormones|mesh-ancestor
19261066|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835656|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349006|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835657|NCT00604279|Risperidone|risperidone|mesh-list
20175717|NCT00169078|Amebicides|amebicides|mesh-ancestor
20175718|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20175719|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20175720|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175721|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
20175722|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175723|NCT00169091|Haloperidol|haloperidol|mesh-list
20175724|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
20175725|NCT00169091|Clozapine|clozapine|mesh-list
20175726|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
20175727|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
20175728|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175729|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835658|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19835659|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19835660|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
19835661|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835662|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835663|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835664|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19835665|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835666|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175730|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20175731|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20175732|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175733|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175734|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175735|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20175736|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
19835667|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835668|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19835669|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
20175737|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175738|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175739|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20349007|NCT00865670|Azithromycin|azithromycin|mesh-list
20349008|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19835670|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20175740|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20175741|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
20175742|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
19261067|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261068|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19261069|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
19261070|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261071|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261072|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19261073|NCT04520646|Empagliflozin|empagliflozin|mesh-list
19261074|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19261075|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261076|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19261077|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261078|NCT04520620|Enoxaparin|enoxaparin|mesh-list
19261079|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
19261080|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19261081|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19261082|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261083|NCT04520880|Antibodies|antibodies|mesh-list
19261084|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
19261085|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
19261086|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
19261087|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261088|NCT04520919|Anesthetics|anesthetics|mesh-list
19261089|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261090|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261091|NCT04520503|Propofol|propofol|mesh-list
19261092|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20175743|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
20175744|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
20175745|NCT00169130|Doxorubicin|doxorubicin|mesh-list
20175746|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20175747|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
20175748|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175749|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175750|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20175751|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
20175752|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175753|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175754|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20175755|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20175756|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20349009|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349010|NCT00865696|Mirtazapine|mirtazapine|mesh-list
20349011|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
20175757|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20175758|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175759|NCT00169143|Rituximab|rituximab|mesh-list
20175760|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175761|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175762|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
20175763|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175764|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175765|NCT00169156|Prednisone|prednisone|mesh-list
20175766|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
20175767|NCT00169156|Rituximab|rituximab|mesh-list
20175768|NCT00169156|Doxorubicin|doxorubicin|mesh-list
20175769|NCT00169156|Vincristine|vincristine|mesh-list
20175770|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349012|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20349013|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20349014|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
20349015|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
20349016|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349017|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349018|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349019|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20349020|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20349021|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20349022|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20349023|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20349024|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19261093|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261094|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175771|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
20175772|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666341|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
19666342|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349025|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
20349026|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20349027|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20349028|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
20349029|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20349030|NCT00865748|Metformin|metformin|mesh-list
20349031|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20349032|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349033|NCT00865761|Alprazolam|alprazolam|mesh-list
20349034|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19261095|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19261096|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
20175773|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175774|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20175775|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
20175776|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175777|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175778|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20175779|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175780|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20175781|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20175782|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20349035|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20349036|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349037|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20349038|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19261097|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
19261098|NCT04520230|Budesonide|budesonide|mesh-list
19261099|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
19261100|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
20612342|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612343|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
20612344|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612345|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20612346|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20175783|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175784|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20175785|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
20175786|NCT00169156|Hormones|hormones|mesh-ancestor
20175787|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175788|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20175789|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20175790|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
20175791|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
20175792|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175793|NCT00169169|Rituximab|rituximab|mesh-list
20175794|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175795|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175796|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
19392570|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19666343|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666344|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666345|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666346|NCT04725032|Propofol|propofol|mesh-list
19666347|NCT04725032|Sevoflurane|sevoflurane|mesh-list
19666348|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19666349|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666350|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666351|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19666352|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
19666353|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
19666354|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19666355|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19835671|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19835672|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
19835673|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835674|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835675|NCT00604461|Bevacizumab|bevacizumab|mesh-list
19835676|NCT00604461|Carboplatin|carboplatin|mesh-list
19835677|NCT00604461|Pemetrexed|pemetrexed|mesh-list
19835678|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835679|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666356|NCT04716114|Cytarabine|cytarabine|mesh-list
19261101|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19261102|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261103|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19261104|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
19261105|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261106|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261107|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19261108|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
19261109|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
19261110|NCT04520230|Hormones|hormones|mesh-ancestor
19261111|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261112|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19261113|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19261114|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19261115|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
19261116|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261117|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261118|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
19261119|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19261120|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
19261121|NCT04520490|Exenatide|exenatide|mesh-list
19261122|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19261123|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261124|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19261125|NCT04520490|Incretins|incretins|mesh-ancestor
19261126|NCT04520490|Hormones|hormones|mesh-ancestor
19261127|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261128|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
19261129|NCT04520074|Carboplatin|carboplatin|mesh-list
19261130|NCT04520074|Etoposide|etoposide|mesh-list
19261131|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261132|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
19261133|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261134|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19261135|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19261136|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
19261137|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261138|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261139|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20175797|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175798|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175799|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
20175800|NCT00169182|Niacin|niacin|mesh-list
20175801|NCT00169182|Docetaxel|docetaxel|mesh-list
20175802|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175803|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
20175804|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
20175805|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175806|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175807|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
20175808|NCT00169182|Vitamins|vitamins|mesh-ancestor
20175809|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
20175810|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175811|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20175812|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
20175813|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20175814|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
20175815|NCT00169195|Gemcitabine|gemcitabine|mesh-list
19835680|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835681|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835682|NCT00604461|Growth Substances|growth substances|mesh-ancestor
19835683|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835684|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835685|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835686|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175816|NCT00169195|Rituximab|rituximab|mesh-list
20175817|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
20175818|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175819|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175820|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
20175821|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175822|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349039|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19261140|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20175823|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349040|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
20349041|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
20349042|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349043|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349044|NCT00865839|Metformin|metformin|mesh-list
20349045|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20349046|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349047|NCT00865852|Metformin|metformin|mesh-list
20349048|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20349049|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349050|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20349051|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20349052|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
20349053|NCT00865891|Nifedipine|nifedipine|mesh-list
19261141|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19261142|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19261143|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261144|NCT04520178|Carbidopa|carbidopa|mesh-list
19261145|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
19261146|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19261147|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19261148|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
19261149|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261150|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261151|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261152|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19261153|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261154|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19261155|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
19261156|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19261157|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
19261158|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261159|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
20175824|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
20175825|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175826|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
20175827|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175828|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175829|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20175830|NCT00169208|Rituximab|rituximab|mesh-list
20175831|NCT00169208|Fludarabine|fludarabine|mesh-list
20175832|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
20175833|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175834|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175835|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
20175836|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175837|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175838|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175839|NCT00169208|Analgesics|analgesics|mesh-ancestor
20175840|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
20175841|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175842|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20175843|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20175844|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175845|NCT00169221|Gefitinib|gefitinib|mesh-list
20175846|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175847|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20175848|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175849|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175850|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20175851|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
20175852|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175853|NCT00169247|Cetuximab|cetuximab|mesh-list
20175854|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175855|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175856|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20175857|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
20175858|NCT00169299|Estrogens|estrogens|mesh-list
20175859|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20349054|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19261160|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261161|NCT04520126|Protective Agents|protective agents|mesh-ancestor
20349055|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175860|NCT00169299|Hormones|hormones|mesh-ancestor
20349056|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261162|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261163|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19261164|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
19261165|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19261166|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
19261167|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261168|NCT04520139|Expectorants|expectorants|mesh-ancestor
19261169|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
19261170|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19261171|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
19261172|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261173|NCT04520139|Protective Agents|protective agents|mesh-ancestor
19261174|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261175|NCT04520139|Antidotes|antidotes|mesh-ancestor
19261176|NCT04519983|Osimertinib|osimertinib|mesh-list
19261177|NCT04519983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261178|NCT04519983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19261179|NCT04519983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261180|NCT04519983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261181|NCT04520035|Paclitaxel|paclitaxel|mesh-list
19261182|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19261183|NCT04520035|Cisplatin|cisplatin|mesh-list
19261184|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19261185|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349057|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20349058|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349059|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
20349060|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
20349061|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20349062|NCT00865917|Metoprolol|metoprolol|mesh-list
20175861|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175862|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175863|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20175864|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20175865|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20175866|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
20175867|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20175868|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20175869|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20175870|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20349063|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19835687|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19835688|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19835689|NCT00604695|Tenecteplase|tenecteplase|mesh-list
19835690|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19666357|NCT04716114|Fludarabine|fludarabine|mesh-list
19666358|NCT04716114|Azacitidine|azacitidine|mesh-list
19666359|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
19666360|NCT04716114|Aclarubicin|aclarubicin|mesh-list
19666361|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666362|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19666363|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
19666364|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835691|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19835692|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349064|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19261186|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
19261187|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
19261188|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
19261189|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392571|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392572|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392573|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19392574|NCT03693404|Narcotics|narcotics|mesh-ancestor
19392575|NCT03693391|Fluorides|fluorides|mesh-list
19392576|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
19392577|NCT03693391|Protective Agents|protective agents|mesh-ancestor
19666365|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19835693|NCT00604708|Vaccines|vaccines|mesh-list
19835694|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
20349065|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19392578|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392579|NCT03693326|Spartalizumab|spartalizumab|mesh-list
19666366|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
19261190|NCT04519463|Lidocaine|lidocaine|mesh-list
19261191|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
19261192|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
19261193|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261194|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261195|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
19261196|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261197|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19261198|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19261199|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19261200|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261201|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261202|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20349066|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
20349067|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
20349068|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349069|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349070|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20349071|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20349072|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
20349073|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349074|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349075|NCT00865943|Dexetimide|dexetimide|mesh-list
20349076|NCT00865943|Citalopram|citalopram|mesh-list
20349077|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20349078|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20349079|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20349080|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349081|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175871|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20175872|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217069|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20217070|NCT00308438|Protective Agents|protective agents|mesh-ancestor
20217071|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217072|NCT00308451|Chromium|chromium|mesh-list
20217073|NCT00308451|Biotin|biotin|mesh-list
20217074|NCT00308451|Picolinic acid|picolinic acid|mesh-list
20217075|NCT00308451|Trace Elements|trace elements|mesh-ancestor
20217076|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
20217077|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217078|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
20217079|NCT00308451|Vitamins|vitamins|mesh-ancestor
20217080|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20217081|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
20217082|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
20217083|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217084|NCT00308477|Dexamethasone|dexamethasone|mesh-list
20217085|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217086|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
20217087|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
20217088|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217089|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217090|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217091|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
20217092|NCT00308477|Hormones|hormones|mesh-ancestor
20217093|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217094|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217095|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217096|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20217097|NCT00308490|Hematinics|hematinics|mesh-ancestor
20217098|NCT00308503|SR 46349B|sr 46349b|mesh-list
20217099|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20217100|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19261203|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261204|NCT04519710|Rituximab|rituximab|mesh-list
20349082|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
19261205|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
19261206|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261207|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261208|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
19261209|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261210|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349083|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217101|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349084|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20349085|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
20349086|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20349087|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19261211|NCT04519125|Tenofovir|tenofovir|mesh-list
19261212|NCT04519125|Emtricitabine|emtricitabine|mesh-list
19261213|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
19261214|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261215|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19261216|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19261217|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261218|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261219|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19261220|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19261221|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
19261222|NCT04519151|Lenvatinib|lenvatinib|mesh-list
19261223|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261224|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261225|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19261226|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261227|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261228|NCT04519281|Ascorbic Acid|ascorbic acid|mesh-list
19261229|NCT04519281|Vitamins|vitamins|mesh-ancestor
19666367|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175873|NCT00169416|Valacyclovir|valacyclovir|mesh-list
20175874|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
20175875|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175876|NCT00169468|Rituximab|rituximab|mesh-list
20175877|NCT00169468|Bortezomib|bortezomib|mesh-list
20175878|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20175879|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175880|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
20175881|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175882|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20175883|NCT00169520|Docetaxel|docetaxel|mesh-list
20175884|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175885|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
20175886|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
20175887|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
20175888|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175889|NCT00169533|Lapatinib|lapatinib|mesh-list
20175890|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175891|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20175892|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175893|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175894|NCT00169546|Fluticasone|fluticasone|mesh-list
20175895|NCT00169546|Xhance|xhance|mesh-list
20175896|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20175897|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20175898|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20175899|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
20175900|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175901|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175902|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20175903|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
20175904|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
20175905|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20175906|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20175907|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20175908|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20175909|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
20175910|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175911|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175912|NCT00169559|Fenofibrate|fenofibrate|mesh-list
20175913|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20175914|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
20175915|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349088|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20349089|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
20349090|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
20349091|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261230|NCT04519281|Micronutrients|micronutrients|mesh-ancestor
20175916|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20175917|NCT00169572|Dexamethasone|dexamethasone|mesh-list
19261231|NCT04519281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261232|NCT04519281|Antioxidants|antioxidants|mesh-ancestor
20349092|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20349093|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20349094|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
20349095|NCT00865982|Docetaxel|docetaxel|mesh-list
20349096|NCT00865982|Capecitabine|capecitabine|mesh-list
19392580|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20175918|NCT00169572|Ondansetron|ondansetron|mesh-list
20175919|NCT00169572|Aprepitant|aprepitant|mesh-list
20175920|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
20175921|NCT00169572|Casopitant|casopitant|mesh-list
20175922|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20175923|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
20175924|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
20175925|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20175926|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175927|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20175928|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
20175929|NCT00169572|Hormones|hormones|mesh-ancestor
20175930|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20175931|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20175932|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175933|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
20175934|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
20175935|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20175936|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
20175937|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175938|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175939|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20175940|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20175941|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20175942|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175943|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20175944|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20175945|NCT00169585|Levofloxacin|levofloxacin|mesh-list
20175946|NCT00169585|Ofloxacin|ofloxacin|mesh-list
20175947|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20175948|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175949|NCT00169585|Renal Agents|renal agents|mesh-ancestor
20175950|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20175951|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20175952|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20175953|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20175954|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175955|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175956|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20175957|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20175958|NCT00169611|Methylphenidate|methylphenidate|mesh-list
20175959|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20175960|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175961|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20175962|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20175963|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20175964|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20175965|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
20175966|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20175967|NCT00169624|Metformin|metformin|mesh-list
20175968|NCT00169624|Gliclazide|gliclazide|mesh-list
20175969|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20175970|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175971|NCT00169728|Vaccines|vaccines|mesh-list
20175972|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20175973|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
20175974|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175975|NCT00169819|Abciximab|abciximab|mesh-list
20175976|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
20175977|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20175978|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
20175979|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20175980|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175981|NCT00169845|Tocopherols|tocopherols|mesh-list
20175982|NCT00169845|Vitamin E|vitamin e|mesh-list
20175983|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
20175984|NCT00169845|Beta Carotene|beta carotene|mesh-list
20349097|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20175985|NCT00169845|Carotenoids|carotenoids|mesh-list
20175986|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
20175987|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261233|NCT04519281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261234|NCT04519281|Protective Agents|protective agents|mesh-ancestor
19261235|NCT04519385|Dexamethasone|dexamethasone|mesh-list
19261236|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261237|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
19666368|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
20349098|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
20349099|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
20349100|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349101|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349102|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349103|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
20349104|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20349105|NCT00866008|Ganirelix|ganirelix|mesh-list
20349106|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
20349107|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20349108|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
20349109|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19666369|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20175988|NCT00169845|Protective Agents|protective agents|mesh-ancestor
20175989|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175990|NCT00169845|Vitamins|vitamins|mesh-ancestor
20175991|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
20175992|NCT00169845|Provitamins|provitamins|mesh-ancestor
20175993|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
20175994|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20175995|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20175996|NCT00169949|Aripiprazole|aripiprazole|mesh-list
20175997|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
20175998|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20175999|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20176000|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20176001|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666370|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666371|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19666372|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19666373|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19666374|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19666375|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19666376|NCT04667780|Colchicine|colchicine|mesh-list
19666377|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
20176002|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176003|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
20349110|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349111|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20349112|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20349113|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176004|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
20176005|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176006|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176007|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20176008|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20176009|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
20176010|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20176011|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20176012|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20176013|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20176014|NCT00169988|Risperidone|risperidone|mesh-list
20176015|NCT00169988|Sertraline|sertraline|mesh-list
20176016|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20176017|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
20176018|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176019|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176020|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176021|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20176022|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20176023|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20176024|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20176025|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20176026|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
20349114|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
20349115|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176027|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
20176028|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20176029|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20349116|NCT00866021|Ritonavir|ritonavir|mesh-list
20349117|NCT00866021|Lopinavir|lopinavir|mesh-list
20349118|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20349119|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20349120|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
20349121|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349122|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261238|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
19261239|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261240|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261241|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261242|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
19261243|NCT04519385|Hormones|hormones|mesh-ancestor
19261244|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261245|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666378|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176030|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176031|NCT00170001|Esomeprazole|esomeprazole|mesh-list
20176032|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20176033|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176034|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20176035|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176036|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176037|NCT00170053|Sirolimus|sirolimus|mesh-list
20176038|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176039|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261246|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261247|NCT04518852|Sorafenib|sorafenib|mesh-list
19261248|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261249|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19261250|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261251|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261252|NCT04518735|Anticoagulants|anticoagulants|mesh-list
20349123|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20349124|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20349125|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
19666379|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
19666380|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
19666381|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349126|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349127|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20349128|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20349129|NCT00866060|Memantine|memantine|mesh-list
20349130|NCT00866060|Donepezil|donepezil|mesh-list
20349131|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20349132|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349133|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349134|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
20349135|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349136|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349137|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
20349138|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20349139|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20349140|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
20349141|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20612347|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666382|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666383|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666384|NCT04655222|Interferons|interferons|mesh-list
19666385|NCT04655222|Interferon-beta|interferon-beta|mesh-list
19666386|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666387|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
20612348|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612349|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20612350|NCT02251145|Ritonavir|ritonavir|mesh-list
20612351|NCT02251145|Tenofovir|tenofovir|mesh-list
20612352|NCT02251145|Tipranavir|tipranavir|mesh-list
20612353|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20176040|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20176041|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176042|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
20176043|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261253|NCT04518618|Fentanyl|fentanyl|mesh-list
19261254|NCT04518618|Naloxone|naloxone|mesh-list
19261255|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20176044|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
19666388|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261256|NCT04518618|Narcotics|narcotics|mesh-ancestor
19261257|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261258|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261259|NCT04518618|Analgesics|analgesics|mesh-ancestor
19261260|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
19261261|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261262|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19261263|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19261264|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
19261265|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
19261266|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19261267|NCT04518982|Lenalidomide|lenalidomide|mesh-list
19261268|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
19261269|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261270|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19261271|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19261272|NCT04518982|Growth Substances|growth substances|mesh-ancestor
19261273|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
19261274|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261275|NCT04518280|Capecitabine|capecitabine|mesh-list
19261276|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
19261277|NCT04518280|Antibodies|antibodies|mesh-list
19261278|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
19261279|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261280|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349142|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20349143|NCT00866073|Decitabine|decitabine|mesh-list
20349144|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349145|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
20349146|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349147|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349148|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349149|NCT00866216|Azithromycin|azithromycin|mesh-list
20349150|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20349151|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349152|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20349153|NCT00866229|Simvastatin|simvastatin|mesh-list
20349154|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20349155|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20349156|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
20349157|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349158|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20349159|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19261281|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
19261282|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261283|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261284|NCT04518319|Olanzapine|olanzapine|mesh-list
19261285|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
19261286|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
19261287|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261288|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261289|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261290|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19261291|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19261292|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261293|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19261294|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19261295|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19261296|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261297|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261298|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261299|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
19261300|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
19261301|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261302|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
19261303|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
19261304|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261305|NCT04518540|Protective Agents|protective agents|mesh-ancestor
19261306|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261307|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
20349160|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261308|NCT04518540|Vitamins|vitamins|mesh-ancestor
19261309|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
19261310|NCT04518475|Rituximab|rituximab|mesh-list
19261311|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349161|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20176045|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176046|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20176047|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
19261312|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261313|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
19261314|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261315|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19261316|NCT04518462|Bupivacaine|bupivacaine|mesh-list
19261317|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
19261318|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
19261319|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261320|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261321|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
19261322|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261323|NCT04518202|Lidocaine|lidocaine|mesh-list
19261324|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
19261325|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
19261326|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261327|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261328|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
19261329|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261330|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19261331|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19261332|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19261333|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261334|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261335|NCT04518189|Lidocaine|lidocaine|mesh-list
19261336|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
19261337|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
19261338|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261339|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261340|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
19261341|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176048|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176049|NCT00170196|Prednisone|prednisone|mesh-list
20176050|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261342|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19261343|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19261344|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19261345|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261346|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261347|NCT04517890|Lidocaine|lidocaine|mesh-list
19261348|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
19261349|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
19261350|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261351|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261352|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
19261353|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261354|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19261355|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19261356|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19261357|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261358|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261359|NCT04518176|Oxytocin|oxytocin|mesh-list
19261360|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
19261361|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19261362|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261363|NCT04517851|Elotuzumab|elotuzumab|mesh-list
20176051|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
20176052|NCT00170196|Hormones|hormones|mesh-ancestor
20176053|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176054|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176055|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20176056|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176057|NCT00170209|Rifampin|rifampin|mesh-list
20176058|NCT00170209|Isoniazid|isoniazid|mesh-list
20176059|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20176060|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
20176061|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176062|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176063|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
20176064|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20612354|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20176065|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176066|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176067|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20176068|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20176069|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20176070|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19261364|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261365|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
19261366|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19261367|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19261368|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261369|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
19261370|NCT04518163|Coagulants|coagulants|mesh-ancestor
19261371|NCT04517526|Bevacizumab|bevacizumab|mesh-list
19261372|NCT04517526|Durvalumab|durvalumab|mesh-list
19261373|NCT04517526|Carboplatin|carboplatin|mesh-list
20612355|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
19261374|NCT04517526|Pemetrexed|pemetrexed|mesh-list
20349162|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20349163|NCT00866437|Estropipate|estropipate|mesh-list
20349164|NCT00866437|Estradiol|estradiol|mesh-list
20349165|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20349166|NCT00866437|Estrone|estrone|mesh-list
20349167|NCT00866437|Progesterone|progesterone|mesh-list
20349168|NCT00866437|Estrogens|estrogens|mesh-ancestor
20349169|NCT00866437|Hormones|hormones|mesh-ancestor
20349170|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349171|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349172|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20349173|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
20349174|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20349175|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20349176|NCT00866437|Progestins|progestins|mesh-ancestor
20349177|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
20349178|NCT00866450|Calcium|calcium|mesh-list
20349179|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20349180|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349181|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20349182|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
20349183|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
20349184|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20349185|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20349186|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349187|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349188|NCT00866463|Urological Agents|urological agents|mesh-ancestor
20349189|NCT00866515|Ketoconazole|ketoconazole|mesh-list
20349190|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
20349191|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349192|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20349193|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20349194|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349195|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349196|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20349197|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
20349198|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349199|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349200|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20349201|NCT00866528|Paclitaxel|paclitaxel|mesh-list
20349202|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20349203|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349204|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
19261375|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261376|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261377|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20176071|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20176072|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20176073|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20176074|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20176075|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
20176076|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20176077|NCT00170222|Doxycycline|doxycycline|mesh-list
20176078|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176079|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349205|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
19666389|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
20176080|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
20176081|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20176082|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20176083|NCT00170378|Enoxaparin|enoxaparin|mesh-list
20176084|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
20176085|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20176086|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20349206|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349207|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349208|NCT00866554|Tamoxifen|tamoxifen|mesh-list
20349209|NCT00866554|Bicalutamide|bicalutamide|mesh-list
20349210|NCT00866554|Dutasteride|dutasteride|mesh-list
20349211|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19261378|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19261379|NCT04517526|Growth Substances|growth substances|mesh-ancestor
19261380|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261381|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
19261382|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261383|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261384|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19261385|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19392581|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392582|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403978|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19403979|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403980|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403981|NCT03598374|Folic Acid|folic acid|mesh-list
19403982|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
19403983|NCT03598374|Inositol|inositol|mesh-list
20349212|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
20349213|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349214|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349215|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19403984|NCT03598374|Hematinics|hematinics|mesh-ancestor
19403985|NCT03598374|Vitamins|vitamins|mesh-ancestor
19403986|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
19403987|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403988|NCT03598348|Capecitabine|capecitabine|mesh-list
19403989|NCT03598348|Apatinib|apatinib|mesh-list
19403990|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19403991|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
19403992|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403993|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403994|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403995|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403996|NCT03598192|Sufentanil|sufentanil|mesh-list
19403997|NCT03598192|Dsuvia|dsuvia|mesh-list
19403998|NCT03598192|Ropivacaine|ropivacaine|mesh-list
19403999|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
19404000|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
19404001|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404002|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404003|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
19404004|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404005|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404006|NCT03598192|Narcotics|narcotics|mesh-ancestor
19404007|NCT03598192|Analgesics|analgesics|mesh-ancestor
20349216|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349217|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20349218|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20349219|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19404008|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19404009|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19666390|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176087|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176088|NCT00170404|Vitamins|vitamins|mesh-list
20176089|NCT00170404|Folic Acid|folic acid|mesh-list
20176090|NCT00170404|Vitamin A|vitamin a|mesh-list
20176091|NCT00170404|Thiamine|thiamine|mesh-list
20176092|NCT00170404|Selenium|selenium|mesh-list
19404010|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
19404011|NCT03598075|Pramlintide|pramlintide|mesh-list
19404012|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404013|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176093|NCT00170404|Micronutrients|micronutrients|mesh-list
20176094|NCT00170404|Trace Elements|trace elements|mesh-list
19261386|NCT04517292|Gemcitabine|gemcitabine|mesh-list
19261387|NCT04517292|Cisplatin|cisplatin|mesh-list
19261388|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261389|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19261390|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
19261391|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261392|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
19261393|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261394|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261395|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261396|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
19261397|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261398|NCT04517227|Durvalumab|durvalumab|mesh-list
19261399|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261400|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261401|NCT04517214|Gemcitabine|gemcitabine|mesh-list
19261402|NCT04517214|Capecitabine|capecitabine|mesh-list
19261403|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261404|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19261405|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
20176095|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176096|NCT00170404|Hematinics|hematinics|mesh-ancestor
20176097|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
20176098|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
20176099|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176100|NCT00170404|Protective Agents|protective agents|mesh-ancestor
20176101|NCT00170430|Fluconazole|fluconazole|mesh-list
20176102|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
20176103|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176104|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20176105|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20176106|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176107|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176108|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20176109|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
20176110|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176111|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176112|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19261406|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261407|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
19261408|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261409|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261410|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261411|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
19261412|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261413|NCT04517201|Insulin|insulin|mesh-list
19261414|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20349220|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
20349221|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20349222|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20349223|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349224|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349225|NCT00866593|Dexetimide|dexetimide|mesh-list
20349226|NCT00866593|Citalopram|citalopram|mesh-list
20349227|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20349228|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20349229|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20349230|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349231|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349232|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
20349233|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349234|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20349235|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
19261415|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19261416|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261417|NCT04517110|Pregabalin|pregabalin|mesh-list
19261418|NCT04517110|Analgesics|analgesics|mesh-ancestor
19261419|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
20176113|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20176114|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20176115|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20176116|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
19261420|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349236|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20349237|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20349238|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20349239|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
20349240|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
20349241|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349242|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19261421|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261422|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
19261423|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19261424|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261425|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261426|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20612356|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349243|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20349244|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
20349245|NCT00866645|Haloperidol|haloperidol|mesh-list
20349246|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
20349247|NCT00866645|Sulpiride|sulpiride|mesh-list
20349248|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20349249|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
20349250|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
20349251|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349252|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612357|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612358|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19261427|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19261428|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19261429|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261430|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19261431|NCT04517188|Iodine|iodine|mesh-list
20349253|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20349254|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20349255|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20349256|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20349257|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20349258|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19261432|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
19261433|NCT04517188|Povidone|povidone|mesh-list
19261434|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19261435|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261436|NCT04517188|Trace Elements|trace elements|mesh-ancestor
19261437|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
19261438|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261439|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
19261440|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
19261441|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19261442|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19261443|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
19261444|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176117|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176118|NCT00170456|Antacids|antacids|mesh-ancestor
20176119|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176120|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176121|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20176122|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20176123|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
20612359|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612360|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
20349259|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
20176124|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176125|NCT00170469|Antacids|antacids|mesh-ancestor
20176126|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176127|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176128|NCT00170547|Vaccines|vaccines|mesh-list
20176129|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
20176130|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176131|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20176132|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20176133|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176134|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20176135|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
20176136|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349260|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612361|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261445|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19261446|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
19261447|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261448|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261449|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19261450|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19261451|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261452|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
19261453|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19261454|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19261455|NCT04516941|Colchicine|colchicine|mesh-list
19261456|NCT04516941|Edoxaban|edoxaban|mesh-list
19261457|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
19261458|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19261459|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
19261460|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
20349261|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349262|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20349263|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20349264|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
20349265|NCT00866684|Cyclosporine|cyclosporine|mesh-list
20349266|NCT00866684|Sirolimus|sirolimus|mesh-list
20349267|NCT00866684|Azathioprine|azathioprine|mesh-list
20349268|NCT00866684|Tacrolimus|tacrolimus|mesh-list
20349269|NCT00866684|Cyclosporins|cyclosporins|mesh-list
19261461|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
19261462|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261463|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261464|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19261465|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
19261466|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19261467|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
19261468|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261469|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
19261470|NCT04516915|Oseltamivir|oseltamivir|mesh-list
19261471|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
19261472|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261473|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261474|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261475|NCT04517162|Povidone|povidone|mesh-list
19261476|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
19261477|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
19261478|NCT04516616|Paclitaxel|paclitaxel|mesh-list
19261479|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19261480|NCT04516616|Cisplatin|cisplatin|mesh-list
19261481|NCT04516616|Antibodies|antibodies|mesh-list
19261482|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19261483|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19261484|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261485|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19261486|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19261487|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19261488|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261489|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
19261490|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261491|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
19261492|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261493|NCT04516681|Vitamins|vitamins|mesh-ancestor
19261494|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
19261495|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
19261496|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261497|NCT04516681|Protective Agents|protective agents|mesh-ancestor
19261498|NCT04516655|Rituximab|rituximab|mesh-list
19261499|NCT04516655|Methotrexate|methotrexate|mesh-list
19261500|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261501|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261502|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
19261503|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261504|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19261505|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19261506|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
19261507|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19261508|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349270|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261509|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
19261510|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261511|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
19261512|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261513|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19261514|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261515|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19261516|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
19261517|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19261518|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261519|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261520|NCT04516304|Equol|equol|mesh-list
19261521|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
19261522|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19261523|NCT04516304|Estrogens|estrogens|mesh-ancestor
19261524|NCT04516304|Hormones|hormones|mesh-ancestor
19261525|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261526|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261527|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
19261528|NCT04516174|Ropivacaine|ropivacaine|mesh-list
19261529|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19261530|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261531|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261532|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19261533|NCT04516174|Analgesics|analgesics|mesh-ancestor
19261534|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
19261535|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261536|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19261537|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19261538|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19261539|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
19261540|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261541|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261542|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
19835695|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835696|NCT00604786|Omalizumab|omalizumab|mesh-list
19835697|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19835698|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20176137|NCT00170664|Paclitaxel|paclitaxel|mesh-list
19261543|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
19261544|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19261545|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19261546|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261547|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
19261548|NCT04516148|Clindamycin|clindamycin|mesh-list
19261549|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
19261550|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
19261551|NCT04516148|Cefazolin|cefazolin|mesh-list
19261552|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19261553|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261554|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19261555|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261556|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261557|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
19261558|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19261559|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19261560|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261561|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
19261562|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
19261563|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
19261564|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19261565|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19261566|NCT04515966|Prednisolone|prednisolone|mesh-list
19261567|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
19261568|NCT04515966|Lidocaine|lidocaine|mesh-list
19261569|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19261570|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
19261571|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
19261572|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
19261573|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261574|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261575|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
19261576|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261577|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20176138|NCT00170664|Carboplatin|carboplatin|mesh-list
20176139|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20176140|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176141|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
20176142|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
19261578|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19261579|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19261580|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261581|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261582|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261583|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
19261584|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
19261585|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261586|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
19261587|NCT04515966|Hormones|hormones|mesh-ancestor
19261588|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261589|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19261590|NCT04515966|Protective Agents|protective agents|mesh-ancestor
19261591|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19261592|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261593|NCT04515719|Belimumab|belimumab|mesh-list
19261594|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261595|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
19261596|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261597|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
19261598|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261599|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176143|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
19666391|NCT04620746|Penicillins|penicillins|mesh-list
19666392|NCT04620746|Penicillin G|penicillin g|mesh-list
19261600|NCT04515836|Olaparib|olaparib|mesh-list
19261601|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19261602|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261603|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261604|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261605|NCT04515368|Vaccines|vaccines|mesh-list
20176144|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176145|NCT00170677|Topotecan|topotecan|mesh-list
20176146|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20176147|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20176148|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176149|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261606|NCT04515368|Immunologic Factors|immunologic factors|mesh-ancestor
19261607|NCT04515368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261608|NCT04515732|Apremilast|apremilast|mesh-list
19261609|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19261610|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19261611|NCT04515732|Analgesics|analgesics|mesh-ancestor
19261612|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
19261613|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261614|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261615|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261616|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19261617|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19261618|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19261619|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261620|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261621|NCT04515420|Norepinephrine|norepinephrine|mesh-list
19261622|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19261623|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19261624|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
19261625|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261626|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261627|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261628|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
19261629|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
19261630|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261631|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19261632|NCT04515641|Islatravir|islatravir|mesh-list
19261633|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
19666393|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176150|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176151|NCT00170690|Treosulfan|treosulfan|mesh-list
20176152|NCT00170690|Busulfan|busulfan|mesh-list
20349271|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
19261634|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261635|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392583|NCT03693248|Paclitaxel|paclitaxel|mesh-list
19666394|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666395|NCT04552327|Diclofenac|diclofenac|mesh-list
20349272|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349273|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20349274|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349275|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349276|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
20349277|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261636|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261637|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19261638|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19261639|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19261640|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
19261641|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392584|NCT03693248|Carboplatin|carboplatin|mesh-list
19392585|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19392586|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392587|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19392588|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19392589|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392590|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392591|NCT03693222|Morphine|morphine|mesh-list
19392592|NCT03693222|Tramadol|tramadol|mesh-list
19392593|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19392594|NCT03693222|Narcotics|narcotics|mesh-ancestor
20349278|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
20349279|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392595|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392596|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392597|NCT03693222|Analgesics|analgesics|mesh-ancestor
19392598|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
19392599|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392600|NCT03693183|Ketorolac|ketorolac|mesh-list
19392601|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19392602|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392603|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392604|NCT03693183|Analgesics|analgesics|mesh-ancestor
19392605|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
20612362|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20612363|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612364|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20612365|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20612366|NCT02251158|Ritonavir|ritonavir|mesh-list
20612367|NCT02251158|Tipranavir|tipranavir|mesh-list
19666396|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176153|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20612368|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19392606|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392607|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392608|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392609|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392610|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19392611|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392612|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392613|NCT03693170|Cetuximab|cetuximab|mesh-list
19392614|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392615|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392616|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19392617|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19392618|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19392619|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
19392620|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19392621|NCT03693066|Disinfectants|disinfectants|mesh-list
19666397|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176154|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
20176155|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176156|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176157|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176158|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
20176159|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176160|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20176161|NCT00170729|Prednisolone|prednisolone|mesh-list
20176162|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20176163|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
20349280|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19261642|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19261643|NCT04515238|Venetoclax|venetoclax|mesh-list
19261644|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
19261645|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
19261646|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19261647|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
19261648|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261649|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261650|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261651|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19261652|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261653|NCT04514835|Capecitabine|capecitabine|mesh-list
19261654|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261655|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19261656|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
19261657|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261658|NCT04514770|Misoprostol|misoprostol|mesh-list
19261659|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19261660|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
19261661|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19261662|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261663|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19261664|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261665|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
19261666|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
19261667|NCT04514731|Analgesics|analgesics|mesh-ancestor
19261668|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
19261669|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261670|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261671|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
19261672|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261673|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19261674|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
19261675|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19261676|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261677|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261678|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19261679|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
19261680|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19261681|NCT04514796|Adalimumab|adalimumab|mesh-list
19261682|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261683|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19261684|NCT04514419|Docetaxel|docetaxel|mesh-list
19261685|NCT04514419|Trastuzumab|trastuzumab|mesh-list
19261686|NCT04514419|Pertuzumab|pertuzumab|mesh-list
19261687|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261688|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
19261689|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
19261690|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
19261691|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261692|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261693|NCT04514588|Caffeine|caffeine|mesh-list
19261694|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19261695|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261696|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19261697|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261698|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261699|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19261700|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19261701|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
19261702|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261703|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19261704|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19261705|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261706|NCT04514094|Fluorides|fluorides|mesh-list
19261707|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
19261708|NCT04514094|Protective Agents|protective agents|mesh-ancestor
19261709|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261710|NCT04514029|Dexamethasone|dexamethasone|mesh-list
19261711|NCT04514029|Simvastatin|simvastatin|mesh-list
19261712|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261713|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
20176164|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20176165|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
20176166|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19261714|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
19261715|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261716|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261717|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261718|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
19261719|NCT04514029|Hormones|hormones|mesh-ancestor
19261720|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349281|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349282|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20349283|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
20349284|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349285|NCT00866736|Dasatinib|dasatinib|mesh-list
20349286|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349287|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20349288|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349289|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349290|NCT00866762|Vorinostat|vorinostat|mesh-list
20349291|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20349292|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349293|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349294|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349295|NCT00866840|Riluzole|riluzole|mesh-list
20349296|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
19261721|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19261722|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261723|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19261724|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19261725|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
19261726|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261727|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19261728|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19261729|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261730|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19261731|NCT04514081|Decitabine|decitabine|mesh-list
19261732|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19261733|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
19261734|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261735|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261736|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261737|NCT04513821|Ethanol|ethanol|mesh-list
19261738|NCT04513821|Minocycline|minocycline|mesh-list
19261739|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19261740|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261741|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261742|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261743|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19261744|NCT04513808|Anesthetics|anesthetics|mesh-list
19261745|NCT04513808|Propofol|propofol|mesh-list
19261746|NCT04513808|Sevoflurane|sevoflurane|mesh-list
19261747|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261748|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261749|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20349297|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20349298|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20349299|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349300|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261750|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19261751|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
19261752|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19261753|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19261754|NCT04513639|Dexamethasone|dexamethasone|mesh-list
19261755|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
19261756|NCT04513639|Daratumumab|daratumumab|mesh-list
19261757|NCT04513639|BB 1101|bb 1101|mesh-list
19261758|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19261759|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261760|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
19261761|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
19261762|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261763|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261764|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261765|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
19261766|NCT04513639|Hormones|hormones|mesh-ancestor
19261767|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261768|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19261769|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261770|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
19261771|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176167|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
20176168|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176169|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
20176170|NCT00170729|Hormones|hormones|mesh-ancestor
20176171|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176172|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176173|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19261772|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261773|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
19261774|NCT04513509|Propranolol|propranolol|mesh-list
19261775|NCT04513509|Metoprolol|metoprolol|mesh-list
19261776|NCT04513509|Digoxin|digoxin|mesh-list
19261777|NCT04513509|Atenolol|atenolol|mesh-list
19261778|NCT04513509|Verapamil|verapamil|mesh-list
19261779|NCT04513509|Nebivolol|nebivolol|mesh-list
19261780|NCT04513509|Diltiazem|diltiazem|mesh-list
19261781|NCT04513509|Bisoprolol|bisoprolol|mesh-list
19261782|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19261783|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19261784|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
19261785|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261786|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261787|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261788|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19261789|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19261790|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
19261791|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
19261792|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
19261793|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261794|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19261795|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19261796|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261797|NCT04513509|Protective Agents|protective agents|mesh-ancestor
19261798|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19261799|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19261800|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19261801|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19261802|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19261803|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19261804|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
19261805|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19261806|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19261807|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
19261808|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261809|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19261810|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19261811|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261812|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261813|NCT04513457|Liver Extracts|liver extracts|mesh-list
19261814|NCT04513457|Hematinics|hematinics|mesh-ancestor
19261815|NCT04513340|Levodopa|levodopa|mesh-list
19261816|NCT04513340|Carbidopa|carbidopa|mesh-list
19261817|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19261818|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19261819|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
19261820|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261821|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261822|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261823|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19261824|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261825|NCT04513379|Efavirenz|efavirenz|mesh-list
20176174|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176175|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
20176176|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
20176177|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176178|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176179|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20176180|NCT00170729|Protective Agents|protective agents|mesh-ancestor
20176181|NCT00170742|Octreotide|octreotide|mesh-list
19261826|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19261827|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20176182|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261828|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261829|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261830|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
19261831|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261832|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19261833|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19261834|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19261835|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19261836|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19261837|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19261838|NCT04513015|Antioxidants|antioxidants|mesh-list
19261839|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261840|NCT04513015|Protective Agents|protective agents|mesh-ancestor
20349301|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349302|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20349303|NCT00866840|Protective Agents|protective agents|mesh-ancestor
20349304|NCT00866853|Simeprevir|simeprevir|mesh-list
20349305|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
19261841|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261842|NCT04513184|Dexamethasone|dexamethasone|mesh-list
19261843|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
19261844|NCT04513184|BB 1101|bb 1101|mesh-list
19261845|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261846|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
19261847|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
19261848|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666398|NCT04552327|Analgesics|analgesics|mesh-ancestor
19666399|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
19666400|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349306|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349307|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
20349308|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349309|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349310|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
20349311|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20349312|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
20349313|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349314|NCT00866866|Expectorants|expectorants|mesh-ancestor
19261849|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261850|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19261851|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
19261852|NCT04513184|Hormones|hormones|mesh-ancestor
19261853|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261854|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19261855|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261856|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
19261857|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261858|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261859|NCT04512872|Denosumab|denosumab|mesh-list
19261860|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19666401|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349315|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
20349316|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20349317|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
20349318|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349319|NCT00866866|Protective Agents|protective agents|mesh-ancestor
20349320|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349321|NCT00866866|Antidotes|antidotes|mesh-ancestor
20349322|NCT00866944|Leucovorin|leucovorin|mesh-list
20349323|NCT00866944|Fluorouracil|fluorouracil|mesh-list
20349324|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
20349325|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20349326|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
20349327|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349328|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349329|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349330|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349331|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
20349332|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349333|NCT00866944|Antidotes|antidotes|mesh-ancestor
20349334|NCT00866944|Protective Agents|protective agents|mesh-ancestor
20349335|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
20349336|NCT00866944|Vitamins|vitamins|mesh-ancestor
20349337|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
20612369|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19261861|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261862|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19261863|NCT04512638|Amoxicillin|amoxicillin|mesh-list
19261864|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
19261865|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19261866|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261867|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19261868|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
19261869|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
19392622|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19392623|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392624|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
19392625|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19392626|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
19392627|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392628|NCT03692819|Amoxicillin|amoxicillin|mesh-list
19392629|NCT03692819|Metronidazole|metronidazole|mesh-list
19392630|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19392631|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392632|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19392633|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19392634|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
19392635|NCT03692754|Dexamethasone|dexamethasone|mesh-list
19392636|NCT03692754|Atorvastatin|atorvastatin|mesh-list
19392637|NCT03692754|Calcium|calcium|mesh-list
19392638|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392639|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
19392640|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
20349338|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
20349339|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
20349340|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20349341|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20349342|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349343|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349344|NCT00866983|Urological Agents|urological agents|mesh-ancestor
20349345|NCT00866996|Methylphenidate|methylphenidate|mesh-list
19392641|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392642|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392643|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19392644|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
19392645|NCT03692754|Hormones|hormones|mesh-ancestor
19392646|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19392647|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19392648|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392649|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392650|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19392651|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20349346|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20349347|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20349348|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392652|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19392653|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
19392654|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392655|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19392656|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19392657|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392658|NCT03692546|Bupivacaine|bupivacaine|mesh-list
19392659|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
19392660|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
19392661|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392662|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392663|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
19392664|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392665|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19392666|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20349349|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20349350|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20349351|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19392667|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392668|NCT03692416|Prednisone|prednisone|mesh-list
19392669|NCT03692416|Ibuprofen|ibuprofen|mesh-list
20424786|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392670|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19392671|NCT03692416|Methotrexate|methotrexate|mesh-list
19392672|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349352|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349353|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
20349354|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349355|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20349356|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20349357|NCT00867061|ON 01910|on 01910|mesh-list
20349358|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349359|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20349360|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349361|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349362|NCT00867126|Pioglitazone|pioglitazone|mesh-list
20349363|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20349364|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349365|NCT00867152|Ritonavir|ritonavir|mesh-list
20349366|NCT00867152|Lopinavir|lopinavir|mesh-list
20349367|NCT00867152|Darunavir|darunavir|mesh-list
20349368|NCT00867152|Dolutegravir|dolutegravir|mesh-list
20349369|NCT00867152|Etravirine|etravirine|mesh-list
20349370|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20349371|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20349372|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
20349373|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349374|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349375|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20349376|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20349377|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
20349378|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349379|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20349380|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20349381|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20349382|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20349383|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20349384|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20349385|NCT00867295|Cefazolin|cefazolin|mesh-list
20349386|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20349387|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19261870|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19261871|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19261872|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19261873|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
19261874|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261875|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261876|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19261877|NCT04512313|Rocuronium|rocuronium|mesh-list
19261878|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19261879|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19261880|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19261881|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261882|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261883|NCT04512105|Venetoclax|venetoclax|mesh-list
19261884|NCT04512105|Pitavastatin|pitavastatin|mesh-list
19261885|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261886|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19261887|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19261888|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19261889|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
19261890|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349388|NCT00867672|Decitabine|decitabine|mesh-list
20349389|NCT00867672|Tretinoin|tretinoin|mesh-list
20349390|NCT00867672|Valproic Acid|valproic acid|mesh-list
20349391|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349392|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
19261891|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261892|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19261893|NCT04512365|Dronabinol|dronabinol|mesh-list
19261894|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
19261895|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261896|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19261897|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19261898|NCT04512365|Analgesics|analgesics|mesh-ancestor
19261899|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
19261900|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261901|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19261902|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20349393|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666402|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666403|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666404|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20349394|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349395|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261903|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261904|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261905|NCT04512365|Hormones|hormones|mesh-ancestor
19261906|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19261907|NCT04511975|Azacitidine|azacitidine|mesh-list
19261908|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19261909|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
19261910|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349396|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
20349397|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
20349398|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
20349399|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
20349400|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349401|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349402|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
20349403|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20349404|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20349405|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20349406|NCT00867737|Fluticasone|fluticasone|mesh-list
20349407|NCT00867737|Budesonide|budesonide|mesh-list
20349408|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
20349409|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20349410|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20349411|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20349412|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349413|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20349414|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
20349415|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349416|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349417|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20349418|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
20349419|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
20349420|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20349421|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
20349422|NCT00867737|Hormones|hormones|mesh-ancestor
20349423|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349424|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20349425|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20349426|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20349427|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
20349428|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349429|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349430|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
20349431|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
20349432|NCT00867867|Trace Elements|trace elements|mesh-ancestor
20349433|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
20349434|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349435|NCT00868010|Donepezil|donepezil|mesh-list
20349436|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20349437|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349438|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261911|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176183|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20176184|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176185|NCT00170755|Darifenacin|darifenacin|mesh-list
20176186|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20176187|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20176188|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
20176189|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176190|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176191|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176192|NCT00170755|Urological Agents|urological agents|mesh-ancestor
20176193|NCT00170768|Oxybutynin|oxybutynin|mesh-list
20176194|NCT00170768|Darifenacin|darifenacin|mesh-list
20176195|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
20176196|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
20176197|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349439|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
20349440|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19261912|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261913|NCT04511832|Diclofenac|diclofenac|mesh-list
20176198|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176199|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20176200|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19261914|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19261915|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19261916|NCT04511832|Analgesics|analgesics|mesh-ancestor
19261917|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
19261918|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261919|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261920|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19261921|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19261922|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19261923|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261924|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261925|NCT04511715|Bevacizumab|bevacizumab|mesh-list
19261926|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19261927|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19261928|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19261929|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19261930|NCT04511715|Growth Substances|growth substances|mesh-ancestor
19261931|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261932|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
19261933|NCT04511897|Expectorants|expectorants|mesh-list
19261934|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
19261935|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20176201|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
20176202|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176203|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176204|NCT00170768|Urological Agents|urological agents|mesh-ancestor
20176205|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
20176206|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20176207|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19261943|NCT04511923|Heparin|heparin|mesh-list
19261944|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
19261945|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19261946|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19261947|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261948|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
19261949|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19261950|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
19261951|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19261952|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
19261953|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261954|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261955|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
19261956|NCT04511468|Ascorbic Acid|ascorbic acid|mesh-list
19261957|NCT04511468|Copper|copper|mesh-list
19261958|NCT04511468|Chromium|chromium|mesh-list
19261959|NCT04511468|Vitamins|vitamins|mesh-ancestor
19261960|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
19261961|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261962|NCT04511468|Antioxidants|antioxidants|mesh-ancestor
19261963|NCT04511468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261964|NCT04511468|Protective Agents|protective agents|mesh-ancestor
19261965|NCT04511468|Trace Elements|trace elements|mesh-ancestor
19261966|NCT04511416|Metformin|metformin|mesh-list
19261967|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19261968|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176208|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176209|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176210|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176211|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176212|NCT00170781|Analgesics|analgesics|mesh-ancestor
20176213|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
20176214|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176215|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176216|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176217|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176218|NCT00170794|Everolimus|everolimus|mesh-list
20176219|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176220|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19261969|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
19261970|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19261971|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
19261972|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19261973|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
19261974|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261975|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261976|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
19261977|NCT04511299|SMOFlipid|smoflipid|mesh-list
19261978|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19261979|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19261980|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19261981|NCT04511000|Atorvastatin|atorvastatin|mesh-list
19261982|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19261983|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19261984|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
19261985|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19261986|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19261987|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19261988|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19261989|NCT04510935|Anesthetics|anesthetics|mesh-list
19261990|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19261991|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261992|NCT04511195|Diclofenac|diclofenac|mesh-list
19261993|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19261994|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19261995|NCT04511195|Analgesics|analgesics|mesh-ancestor
19261996|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
19261997|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19261998|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19261999|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262000|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19262001|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19262002|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262003|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262004|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
19262005|NCT04510870|Hematinics|hematinics|mesh-ancestor
19262006|NCT04510922|Droxidopa|droxidopa|mesh-list
19262007|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19262008|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19262009|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19262010|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
19262011|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262012|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262013|NCT04510649|Rifampin|rifampin|mesh-list
19262014|NCT04510649|Rabeprazole|rabeprazole|mesh-list
19262015|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19262016|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262017|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19262018|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262019|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262020|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19262021|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
19262022|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262023|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262024|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
19262025|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262026|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19262027|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19262028|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19262029|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19262030|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19262031|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19262032|NCT04510818|Capecitabine|capecitabine|mesh-list
19262033|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262034|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
19262035|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262036|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262037|NCT04510610|Decitabine|decitabine|mesh-list
19262038|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262039|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
19262040|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262041|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262042|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392673|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
19666405|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262043|NCT04510662|Telmisartan|telmisartan|mesh-list
19262044|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19262045|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19262046|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19262047|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262048|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
19262049|NCT04510285|Trastuzumab|trastuzumab|mesh-list
19262050|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262051|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262052|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
19262053|NCT04510428|Antibodies|antibodies|mesh-list
19262054|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
19262055|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19262056|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19262057|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
19262058|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262059|NCT04510220|Ofatumumab|ofatumumab|mesh-list
19262060|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262061|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
19262062|NCT04510337|Rocuronium|rocuronium|mesh-list
19262063|NCT04510337|Analgesics|analgesics|mesh-ancestor
19262064|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
19262065|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262066|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262067|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
19262068|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262069|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19262070|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
19262071|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19262072|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19262073|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262074|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19262075|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
19262076|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262077|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19262078|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19262079|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19262080|NCT04510233|Ivermectin|ivermectin|mesh-list
19262081|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19262082|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262083|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
19262084|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19262085|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262086|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
19262087|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
19262088|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262089|NCT04509999|Bicalutamide|bicalutamide|mesh-list
19262090|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
19262091|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
19262092|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262093|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262094|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262095|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
19262096|NCT04509466|Pegaspargase|pegaspargase|mesh-list
19262097|NCT04509466|Asparaginase|asparaginase|mesh-list
19262098|NCT04509466|Analgesics|analgesics|mesh-ancestor
19262099|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
19262100|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262101|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262102|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262103|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19262104|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19262105|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262106|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262107|NCT04509583|Vitamin E|vitamin e|mesh-list
19262108|NCT04509583|Vitamins|vitamins|mesh-ancestor
19262109|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
19262110|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262111|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
19262112|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262113|NCT04509583|Protective Agents|protective agents|mesh-ancestor
19262114|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
20349441|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349442|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
20349443|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
19262115|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
20349444|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20349445|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
20349446|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349447|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349448|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20349449|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
20349450|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20349451|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19262116|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262117|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262118|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19262119|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
19262120|NCT04509596|Capecitabine|capecitabine|mesh-list
19262121|NCT04509596|Trastuzumab|trastuzumab|mesh-list
19262122|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262123|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
19262124|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262125|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262126|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666406|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666407|NCT04519905|Paclitaxel|paclitaxel|mesh-list
19666408|NCT04519905|Carboplatin|carboplatin|mesh-list
19666409|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19666410|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349452|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20349453|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
19666411|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
19666412|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
19666413|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
19666414|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666415|NCT04482686|Vitamin D|vitamin d|mesh-list
19666416|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
19666417|NCT04482686|Vitamins|vitamins|mesh-list
19666418|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
19666419|NCT04482686|Zinc|zinc|mesh-list
19666420|NCT04482686|Doxycycline|doxycycline|mesh-list
19666421|NCT04482686|Ivermectin|ivermectin|mesh-list
19666422|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
19666423|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
19666424|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666425|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19666426|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19666427|NCT04482686|Trace Elements|trace elements|mesh-ancestor
19666428|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
19666429|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666430|NCT04482686|Protective Agents|protective agents|mesh-ancestor
19666431|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666432|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666433|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
19666434|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19666435|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19666436|NCT04482686|Astringents|astringents|mesh-ancestor
19666437|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
19666438|NCT04450407|Insulin|insulin|mesh-list
20349454|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262127|NCT04509635|Cetuximab|cetuximab|mesh-list
19262128|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262129|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262130|NCT04509440|Triamcinolone|triamcinolone|mesh-list
19262131|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19262132|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19262133|NCT04509440|Anesthetics|anesthetics|mesh-list
19262134|NCT04509440|Mepivacaine|mepivacaine|mesh-list
19262135|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
19262136|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19262137|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262138|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349455|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262139|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262140|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
19666439|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19666440|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666441|NCT04423341|Cannabidiol|cannabidiol|mesh-list
19666442|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
20349456|NCT00868062|Polygeline|polygeline|mesh-list
19262141|NCT04509440|Hormones|hormones|mesh-ancestor
19666443|NCT04323462|Insulin|insulin|mesh-list
19666444|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19262142|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666445|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
19262143|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19262144|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
19262145|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262146|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262147|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
19262148|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262149|NCT04509102|Adderall|adderall|mesh-list
19262150|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19262151|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262152|NCT04509323|Huperzine A|huperzine a|mesh-list
19262153|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19262154|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262155|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262156|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
19262157|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262158|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262159|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19262160|NCT04509323|Protective Agents|protective agents|mesh-ancestor
19262161|NCT04508946|Ascorbic Acid|ascorbic acid|mesh-list
19262162|NCT04508946|Thiamine|thiamine|mesh-list
19262163|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
19262164|NCT04508946|Vitamins|vitamins|mesh-ancestor
19262165|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
19262166|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262167|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262168|NCT04508946|Antioxidants|antioxidants|mesh-ancestor
19262169|NCT04508946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262170|NCT04508946|Protective Agents|protective agents|mesh-ancestor
19262171|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
19262172|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
19262173|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19262174|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19262175|NCT04509219|Prednisolone|prednisolone|mesh-list
19262176|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
19262177|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19262178|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
19262179|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262180|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
19262181|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
19262182|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262183|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262184|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262185|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
19262186|NCT04509219|Hormones|hormones|mesh-ancestor
19262187|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176221|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
20176222|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176223|NCT00170820|Everolimus|everolimus|mesh-list
20176224|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176225|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176226|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
20176227|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176228|NCT00170833|Everolimus|everolimus|mesh-list
20176229|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176230|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176231|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
20176232|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176233|NCT00170859|Everolimus|everolimus|mesh-list
20176234|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176235|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176236|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
20176237|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217102|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20217103|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20217104|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
20217105|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217106|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217107|NCT00308529|Bevacizumab|bevacizumab|mesh-list
20217108|NCT00308529|Carboplatin|carboplatin|mesh-list
20217109|NCT00308529|Irinotecan|irinotecan|mesh-list
20217110|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349457|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
19262188|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19666446|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20349458|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
20349459|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
20349460|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20349461|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
20349462|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20349463|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349464|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20349465|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20349466|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20349467|NCT00868179|Dabigatran|dabigatran|mesh-list
20349468|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
20349469|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20349470|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
20349471|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349472|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349473|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
20349474|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
20349475|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20349476|NCT00868283|Protective Agents|protective agents|mesh-ancestor
20349477|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349478|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
20349479|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
20349480|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20349481|NCT00868413|Rituximab|rituximab|mesh-list
20349482|NCT00868413|Fludarabine|fludarabine|mesh-list
20349483|NCT00868413|Navitoclax|navitoclax|mesh-list
20349484|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349485|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
19666447|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666448|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
19666449|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
19666450|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666451|NCT04279535|Protective Agents|protective agents|mesh-ancestor
19666452|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262189|NCT04509219|Protective Agents|protective agents|mesh-ancestor
19262190|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19262191|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176238|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
20176239|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20176240|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20176241|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176242|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176243|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176244|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176245|NCT00170872|Analgesics|analgesics|mesh-ancestor
20176246|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
20176247|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176248|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176249|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176250|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176251|NCT00170885|Everolimus|everolimus|mesh-list
20176252|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176253|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176254|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
20176255|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176256|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
20176257|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20349486|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349487|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349488|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19262192|NCT04509232|Fluorides|fluorides|mesh-list
19262193|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
19262194|NCT04509232|Protective Agents|protective agents|mesh-ancestor
19262195|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262196|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
19262197|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
19262198|NCT04509258|Ondansetron|ondansetron|mesh-list
19262199|NCT04509258|Mineral Oil|mineral oil|mesh-list
19262200|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19262201|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
19666453|NCT04279535|Vitamins|vitamins|mesh-ancestor
19666454|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
19262202|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
19666455|NCT04166669|Itraconazole|itraconazole|mesh-list
19666456|NCT04166669|Rifampin|rifampin|mesh-list
20176258|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20349489|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
20349490|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262203|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262204|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262205|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262206|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
19262207|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
19262208|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19262209|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
19262210|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262211|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262212|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19262213|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19262214|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262215|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19262216|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19262217|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
19262218|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262219|NCT04509258|Expectorants|expectorants|mesh-ancestor
19262220|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
19262221|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19262222|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
19262223|NCT04509258|Protective Agents|protective agents|mesh-ancestor
19262224|NCT04509258|Antidotes|antidotes|mesh-ancestor
19262225|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
19262226|NCT04509258|Vitamins|vitamins|mesh-ancestor
19262227|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
19262228|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
19262229|NCT04509258|Emollients|emollients|mesh-ancestor
19262230|NCT04509193|Warfarin|warfarin|mesh-list
19262231|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
19262232|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
19262233|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19262234|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
19262235|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19262236|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
19262237|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262238|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262239|NCT04508803|Trastuzumab|trastuzumab|mesh-list
19262240|NCT04508803|Niraparib|niraparib|mesh-list
19262241|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262242|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262243|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19262244|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262245|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262246|NCT04508829|Cetuximab|cetuximab|mesh-list
19262247|NCT04508829|Antibodies|antibodies|mesh-list
19262248|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19262249|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
19262250|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262251|NCT04508829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262252|NCT04508829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262253|NCT04508816|Cetuximab|cetuximab|mesh-list
19262254|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
19262255|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262256|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262257|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
19262258|NCT04508894|Ketamine|ketamine|mesh-list
19262259|NCT04508894|Bupivacaine|bupivacaine|mesh-list
19262260|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
19262261|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
19262262|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262263|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262264|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
19262265|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262266|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19262267|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19262268|NCT04508894|Analgesics|analgesics|mesh-ancestor
19262269|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19262270|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20176259|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262271|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19262272|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
19262273|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262274|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262275|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19262276|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20217111|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262277|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
19392674|NCT03692416|Hormones|hormones|mesh-ancestor
20176260|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176261|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176262|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19262278|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19262279|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19262280|NCT04508686|Capecitabine|capecitabine|mesh-list
19262281|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262282|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
19262283|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262284|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392675|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19392676|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392677|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19392678|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392679|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19392680|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
19392681|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19392682|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19392683|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
19392684|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392685|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
19392686|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392687|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19392688|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392689|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
19392690|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392691|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19392692|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392693|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392694|NCT03692416|Analgesics|analgesics|mesh-ancestor
19392695|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
19392696|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392697|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19392698|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19392699|NCT03692416|Protective Agents|protective agents|mesh-ancestor
19392700|NCT03692299|Metronidazole|metronidazole|mesh-list
19392701|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392702|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19392703|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19392704|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19392705|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
19392706|NCT03692286|Calcium|calcium|mesh-list
19392707|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392708|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392709|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19392710|NCT03692143|Alendronate|alendronate|mesh-list
19392711|NCT03692143|Teriparatide|teriparatide|mesh-list
19392712|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19392713|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392714|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392715|NCT03692065|Apixaban|apixaban|mesh-list
19392716|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19392717|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
19392718|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19392719|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
19392720|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392721|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392722|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
19392723|NCT03692026|Melatonin|melatonin|mesh-list
19392724|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
19392725|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
19392726|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392727|NCT03692026|Protective Agents|protective agents|mesh-ancestor
19392728|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392729|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392730|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19392731|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
19392732|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
19392733|NCT03692013|Losartan|losartan|mesh-list
19392734|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19392735|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19392736|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176263|NCT00170898|Analgesics|analgesics|mesh-ancestor
20349491|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349492|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20349493|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349494|NCT00868426|Budesonide|budesonide|mesh-list
20349495|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
20349496|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20349497|NCT00868426|Charcoal|charcoal|mesh-list
20349498|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349499|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20349500|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
20349501|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262285|NCT04508439|Heparin|heparin|mesh-list
19262286|NCT04508439|Enoxaparin|enoxaparin|mesh-list
19262287|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19262288|NCT04508439|Tinzaparin|tinzaparin|mesh-list
19262289|NCT04508439|Dalteparin|dalteparin|mesh-list
19262290|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
19262291|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19262292|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19262293|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262294|NCT04508400|Dexamethasone|dexamethasone|mesh-list
19262295|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
19262296|NCT04508400|Ondansetron|ondansetron|mesh-list
19262297|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
19262298|NCT04508400|Aprepitant|aprepitant|mesh-list
19262299|NCT04508400|BB 1101|bb 1101|mesh-list
19262300|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262301|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
19262302|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
19262303|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262304|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262305|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262306|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
19262307|NCT04508400|Hormones|hormones|mesh-ancestor
19262308|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262309|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19262310|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262311|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
19262312|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262313|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262314|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
19262315|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
19262316|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19262317|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
19262318|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262319|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19262320|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19262321|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262322|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19262323|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19262324|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19262325|NCT04508452|Bevacizumab|bevacizumab|mesh-list
19262326|NCT04508452|Capecitabine|capecitabine|mesh-list
19262327|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
19262328|NCT04508452|Irinotecan|irinotecan|mesh-list
19262329|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262330|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262331|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19262332|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19262333|NCT04508452|Growth Substances|growth substances|mesh-ancestor
19262334|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262335|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
19262336|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262337|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
19262338|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262339|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20349502|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349503|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20349504|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
20349505|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
19262340|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19262341|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262342|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
19262343|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
19262344|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19262345|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20349506|NCT00868426|Hormones|hormones|mesh-ancestor
20424787|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
19262346|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262347|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19262348|NCT04508166|Analgesics|analgesics|mesh-ancestor
19262349|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
19262350|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262351|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19262352|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19262353|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19262354|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19262355|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262356|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262357|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19262358|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19262359|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
19262360|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
19262361|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
19262362|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262363|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262364|NCT04508244|Propranolol|propranolol|mesh-list
19262365|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19262366|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19262367|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
19262368|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262369|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262370|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666457|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
19666458|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666459|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19666460|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19666461|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666462|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666463|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19666464|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
19262371|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19262372|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19262373|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
19262374|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
19262375|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19666465|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666466|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666467|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19666468|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19666469|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
19666470|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666471|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
19666472|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19666473|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19666474|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19666475|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19666476|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19666477|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20176264|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
20176265|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176266|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176267|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176268|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176269|NCT00170924|Valsartan|valsartan|mesh-list
20176270|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176271|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176272|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176273|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176274|NCT00170937|Valsartan|valsartan|mesh-list
20176275|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20176276|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176277|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176278|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176279|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176280|NCT00170937|Diuretics|diuretics|mesh-ancestor
20176281|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
19262376|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19666478|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19666479|NCT04150770|Infliximab|infliximab|mesh-list
19666480|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
20349507|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349508|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20349509|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19262377|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262378|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
19262379|NCT04508036|Coagulants|coagulants|mesh-ancestor
19262380|NCT04507906|Nivolumab|nivolumab|mesh-list
19262381|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262382|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262383|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19262384|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262385|NCT04508231|Hormones|hormones|mesh-list
19262386|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262387|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262388|NCT04507919|Dabrafenib|dabrafenib|mesh-list
19262389|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262390|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19262391|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262392|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262393|NCT04507607|Tenofovir|tenofovir|mesh-list
20349510|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20349511|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
20349512|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349513|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349514|NCT00868426|Antidotes|antidotes|mesh-ancestor
20349515|NCT00868426|Protective Agents|protective agents|mesh-ancestor
20349516|NCT00868465|Lumefantrine|lumefantrine|mesh-list
20349517|NCT00868465|Artemether|artemether|mesh-list
20349518|NCT00868465|Piperaquine|piperaquine|mesh-list
20349519|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20349520|NCT00868465|Artenimol|artenimol|mesh-list
20349521|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
19262394|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
19262395|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262396|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19262397|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262398|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262399|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262400|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19262401|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19262402|NCT04507477|Rituximab|rituximab|mesh-list
19262403|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262404|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262405|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
19262406|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262407|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19262408|NCT04507750|Apatinib|apatinib|mesh-list
19262409|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262410|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19262411|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262412|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262413|NCT04507412|Dexamethasone|dexamethasone|mesh-list
19262414|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262415|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
19262416|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
19262417|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262418|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262419|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262420|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
19262421|NCT04507412|Hormones|hormones|mesh-ancestor
19262422|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262423|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19262424|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262425|NCT04507217|Carboplatin|carboplatin|mesh-list
19262426|NCT04507217|Pemetrexed|pemetrexed|mesh-list
19262427|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262428|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404014|NCT03597997|Propofol|propofol|mesh-list
19404015|NCT03597997|Sevoflurane|sevoflurane|mesh-list
19404016|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19404017|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404018|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262429|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262430|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19262431|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262432|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
19262433|NCT04507165|Anesthetics|anesthetics|mesh-list
19262434|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262435|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262436|NCT04507165|Narcotics|narcotics|mesh-ancestor
19262437|NCT04507165|Analgesics|analgesics|mesh-ancestor
19262438|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
19262439|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262440|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
19262441|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19262442|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
19262443|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262444|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
19262445|NCT04506827|Protective Agents|protective agents|mesh-ancestor
19262446|NCT04506554|Nivolumab|nivolumab|mesh-list
19262447|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262448|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262449|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19262450|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262451|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19262452|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19262453|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262454|NCT04506450|Anesthetics|anesthetics|mesh-list
19262455|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262456|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392737|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19392738|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392739|NCT03691935|Ropivacaine|ropivacaine|mesh-list
19392740|NCT03691935|Anesthetics|anesthetics|mesh-list
19392741|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
19392742|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392743|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392744|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
19392745|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392746|NCT03691922|Epinephrine|epinephrine|mesh-list
19392747|NCT03691922|Racepinephrine|racepinephrine|mesh-list
19392748|NCT03691922|Bupivacaine|bupivacaine|mesh-list
19392749|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
19392750|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
19392751|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
19392752|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392753|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392754|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
19392755|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392756|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19392757|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19392758|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392759|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392760|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392761|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19392762|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19392763|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
19392764|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19392765|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
19392766|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
19392767|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
19392768|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19392769|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
19392770|NCT03691896|Vitamin D|vitamin d|mesh-list
19392771|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392772|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392773|NCT03691896|Vitamins|vitamins|mesh-ancestor
19392774|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
19392775|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19392776|NCT03691818|Ibuprofen|ibuprofen|mesh-list
20176282|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392777|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176283|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20176284|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176285|NCT00170963|Amlodipine|amlodipine|mesh-list
20176286|NCT00170963|Valsartan|valsartan|mesh-list
19262457|NCT04506034|Lidocaine|lidocaine|mesh-list
19262458|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
19262459|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
19262460|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262461|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262462|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
19262463|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262464|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19262465|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19262466|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19262467|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19262468|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262469|NCT04506242|Apatinib|apatinib|mesh-list
19262470|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262471|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19262472|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262473|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262474|NCT04505930|Vaccines|vaccines|mesh-list
19262475|NCT04505930|Immunologic Factors|immunologic factors|mesh-ancestor
19262476|NCT04505930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262477|NCT04505904|Oxytocin|oxytocin|mesh-list
19262478|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
19262479|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262480|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262481|NCT04505943|Isoniazid|isoniazid|mesh-list
19262482|NCT04505943|Misoprostol|misoprostol|mesh-list
19262483|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19262484|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
20349522|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20349523|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20349524|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262485|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262486|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262487|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20349525|NCT00868491|Cisplatin|cisplatin|mesh-list
20349526|NCT00868491|Docetaxel|docetaxel|mesh-list
20349527|NCT00868491|Fluorouracil|fluorouracil|mesh-list
20349528|NCT00868491|Cetuximab|cetuximab|mesh-list
20349529|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349530|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
20349531|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
19262488|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262489|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
19262490|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
19262491|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262492|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262493|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19262494|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19262495|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
19262496|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262497|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19262498|NCT04505995|Azacitidine|azacitidine|mesh-list
19262499|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
19262500|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262501|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
19262502|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262503|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262504|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262505|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19262506|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19262507|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19262508|NCT04505514|Hematinics|hematinics|mesh-ancestor
19262509|NCT04505644|Lidocaine|lidocaine|mesh-list
19262510|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
19262511|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
19262512|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262513|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262514|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
19262515|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262516|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19262517|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19262518|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19262519|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20349532|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349533|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349534|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
20176287|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176288|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20176289|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176290|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176291|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176292|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176293|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176294|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176295|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176296|NCT00170976|Amlodipine|amlodipine|mesh-list
20176297|NCT00170976|Valsartan|valsartan|mesh-list
19835699|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
19835700|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19262520|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262521|NCT04505475|Hemostatics|hemostatics|mesh-list
19262522|NCT04505475|Coagulants|coagulants|mesh-ancestor
19262523|NCT04505800|Tryptophan|tryptophan|mesh-list
19262524|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19262525|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
19262526|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19262527|NCT04505917|Misoprostol|misoprostol|mesh-list
19262528|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19262529|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
19262530|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262531|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262532|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19262533|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262534|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
19262535|NCT04505592|Tenecteplase|tenecteplase|mesh-list
19262536|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19262537|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19262538|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262539|NCT04505683|Ertapenem|ertapenem|mesh-list
19262540|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262541|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262542|NCT04505657|Celecoxib|celecoxib|mesh-list
19262543|NCT04505657|Lidocaine|lidocaine|mesh-list
19262544|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
19262545|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
19262546|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835701|NCT00604825|Estrogens|estrogens|mesh-ancestor
20176298|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176299|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20176300|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19262547|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262548|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
19262549|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176301|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176302|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176303|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176304|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176305|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176306|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176307|NCT00170989|Valsartan|valsartan|mesh-list
20176308|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20176309|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176310|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176311|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176312|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612370|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19262550|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19262551|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20612371|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612372|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612373|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612374|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20612375|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19262552|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19262553|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835702|NCT00604825|Hormones|hormones|mesh-ancestor
19835703|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262554|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262555|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19262556|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19262557|NCT04505657|Analgesics|analgesics|mesh-ancestor
19262558|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262559|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19262560|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19262561|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19262562|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262563|NCT04505189|Psilocybin|psilocybin|mesh-list
19262564|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
19262565|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262566|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19262567|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
19262568|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19262569|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19262570|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262571|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
19262572|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19262573|NCT04505228|Atropine|atropine|mesh-list
19262574|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19262575|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20349535|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349536|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349537|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
20349538|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349539|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349540|NCT00868569|Leucovorin|leucovorin|mesh-list
20349541|NCT00868569|Fluorouracil|fluorouracil|mesh-list
20349542|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
20349543|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
20349544|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349545|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349546|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349547|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349548|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
20349549|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349550|NCT00868569|Antidotes|antidotes|mesh-ancestor
20349551|NCT00868569|Protective Agents|protective agents|mesh-ancestor
20349552|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
20349553|NCT00868569|Vitamins|vitamins|mesh-ancestor
20349554|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
20349555|NCT00868634|Bevacizumab|bevacizumab|mesh-list
20349556|NCT00868634|Capecitabine|capecitabine|mesh-list
20349557|NCT00868634|Vinorelbine|vinorelbine|mesh-list
19262576|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19262577|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
19262578|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262579|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262580|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19262581|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
19262582|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
19262583|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
19262584|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19262585|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19262586|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
20349558|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349559|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349560|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20349561|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20349562|NCT00868634|Growth Substances|growth substances|mesh-ancestor
20349563|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349564|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
20349565|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349566|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
20349567|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349568|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20349569|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
20349570|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20349571|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349572|NCT00868738|Vitamin D|vitamin d|mesh-list
19262587|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262588|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349573|NCT00868738|Vitamins|vitamins|mesh-ancestor
20349574|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
20349575|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262589|NCT04504877|Cannabidiol|cannabidiol|mesh-list
19262590|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
19262591|NCT04504851|Rifampin|rifampin|mesh-list
19262592|NCT04504851|Isoniazid|isoniazid|mesh-list
19262593|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
19262594|NCT04504851|Ethambutol|ethambutol|mesh-list
19262595|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19262596|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19262597|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19262598|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
19262599|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262600|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19262601|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19262602|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262603|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19262604|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
19262605|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262606|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262607|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
20349576|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20349577|NCT00868764|Granisetron|granisetron|mesh-list
20349578|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
20349579|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
20349580|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349581|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349582|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262608|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262609|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19262610|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19262611|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19262612|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19262613|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19262614|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19262615|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19262616|NCT04504552|Avelumab|avelumab|mesh-list
19262617|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262618|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262619|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19262620|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19262621|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262622|NCT04504045|Metformin|metformin|mesh-list
19262623|NCT04504045|Efavirenz|efavirenz|mesh-list
19262624|NCT04504045|Losartan|losartan|mesh-list
19262625|NCT04504045|Metoprolol|metoprolol|mesh-list
19262626|NCT04504045|Midazolam|midazolam|mesh-list
19262627|NCT04504045|Caffeine|caffeine|mesh-list
20349583|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20349584|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
20349585|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349586|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349587|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
20349588|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349589|NCT00868829|Chromium|chromium|mesh-list
20349590|NCT00868829|Sirolimus|sirolimus|mesh-list
19262628|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19262629|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262630|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19262631|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19262632|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262633|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19262634|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19262635|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19262636|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20176313|NCT00170989|Diuretics|diuretics|mesh-ancestor
20176314|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
20176315|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176316|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20176317|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176318|NCT00171002|Amlodipine|amlodipine|mesh-list
20176319|NCT00171002|Valsartan|valsartan|mesh-list
20176320|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176321|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20176322|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20349591|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262637|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
19262638|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
19262639|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
19262640|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
20176323|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176324|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176325|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176326|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176327|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176328|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176329|NCT00171015|Valsartan|valsartan|mesh-list
20176330|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19262641|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262642|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262643|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19262644|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19262645|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176331|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176332|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176333|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176334|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176335|NCT00171015|Diuretics|diuretics|mesh-ancestor
20176336|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
20349592|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349593|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20349594|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349595|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
20349596|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349597|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
20349598|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349599|NCT00868829|Trace Elements|trace elements|mesh-ancestor
20349600|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
20349601|NCT00868855|Bradykinin|bradykinin|mesh-list
20349602|NCT00868855|Kininogens|kininogens|mesh-list
19262646|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19262647|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19262648|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19262649|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262650|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19262651|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19262652|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
19262653|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19262654|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262655|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
19262656|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262657|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20349603|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
20349604|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20349605|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
19262658|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19262659|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19262660|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19262661|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19262662|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19262663|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
19262664|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
19262665|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262666|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19262667|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19262668|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19262669|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
19262670|NCT04503915|Estrogens|estrogens|mesh-list
19262671|NCT04503915|Hormones|hormones|mesh-ancestor
19262672|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262673|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262674|NCT04503967|Nivolumab|nivolumab|mesh-list
19262675|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262676|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262677|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19392778|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20349606|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349607|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349608|NCT00868894|Latanoprost|latanoprost|mesh-list
20349609|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20349610|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19262678|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392779|NCT03691818|Analgesics|analgesics|mesh-ancestor
19392780|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
19392781|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392782|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392783|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392784|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392785|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19392786|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392787|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392788|NCT03691688|Aspirin|aspirin|mesh-list
19392789|NCT03691688|Clopidogrel|clopidogrel|mesh-list
19392790|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392791|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392792|NCT03691688|Analgesics|analgesics|mesh-ancestor
19392793|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
19392794|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392795|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392796|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392797|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392798|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19392799|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19392800|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392801|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19392802|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19392803|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392804|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
19392805|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19392806|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19392807|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19392808|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
19392809|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392810|NCT03691662|Timolol|timolol|mesh-list
19392811|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19392812|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19392813|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19392814|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19392815|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392816|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392817|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392818|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392819|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19392820|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19404019|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404020|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
19404021|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
19404022|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19404023|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19404024|NCT03597945|Lidocaine|lidocaine|mesh-list
19404025|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
19404026|NCT03597945|Epinephrine|epinephrine|mesh-list
19404027|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
19404028|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
19404029|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404030|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404031|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
19404032|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666481|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666482|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666483|NCT04125771|Diclofenac|diclofenac|mesh-list
20176337|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176338|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20176339|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176340|NCT00171028|Valsartan|valsartan|mesh-list
20176341|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176342|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176343|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176344|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404033|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19666484|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19666485|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666486|NCT04125771|Analgesics|analgesics|mesh-ancestor
19666487|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
19262679|NCT04503850|Mirabegron|mirabegron|mesh-list
19262680|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19262681|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19262682|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19262683|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19262684|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
19262685|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262686|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262687|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262688|NCT04503850|Urological Agents|urological agents|mesh-ancestor
19262689|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19262690|NCT04503694|Nivolumab|nivolumab|mesh-list
19262691|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19262692|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262693|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19262694|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262695|NCT04503629|Rabeprazole|rabeprazole|mesh-list
19262696|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19262697|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262698|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19262699|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262700|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262701|NCT04503460|Fluticasone|fluticasone|mesh-list
19262702|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19262703|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19262704|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262705|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19262706|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
19262707|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262708|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262709|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19262710|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
19262711|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19262712|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19262713|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19262714|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19262715|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19262716|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
19262717|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262718|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262719|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
19262720|NCT04503460|Hormones|hormones|mesh-ancestor
19262721|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262722|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
19262723|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19262724|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19262725|NCT04503161|Estradiol|estradiol|mesh-list
19262726|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19262727|NCT04503161|Estrogens|estrogens|mesh-ancestor
19262728|NCT04503161|Hormones|hormones|mesh-ancestor
19262729|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262730|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262731|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19262732|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
19262733|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262734|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19262735|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
19262736|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19262737|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262738|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
19262739|NCT04502771|Clotrimazole|clotrimazole|mesh-list
19262740|NCT04502771|Miconazole|miconazole|mesh-list
19262741|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262742|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19262743|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19262744|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19262745|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262746|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262747|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19262748|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
19392821|NCT03691649|Timolol|timolol|mesh-list
19835704|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848149|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262749|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262750|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262751|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19262752|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19262753|NCT04502849|Vitamin E|vitamin e|mesh-list
19262754|NCT04502849|Tocopherols|tocopherols|mesh-list
19262755|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
19262756|NCT04502849|Vitamins|vitamins|mesh-ancestor
19262757|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
19262758|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262759|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
19262760|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262761|NCT04502849|Protective Agents|protective agents|mesh-ancestor
19262762|NCT04502641|Docetaxel|docetaxel|mesh-list
19262763|NCT04502641|Fluorouracil|fluorouracil|mesh-list
19262764|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262765|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
19262766|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
19262767|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
19262768|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262769|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
19262770|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262771|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19262772|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
19262773|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262774|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
19262775|NCT04502537|Hematinics|hematinics|mesh-ancestor
19262776|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
19262777|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19262778|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19262779|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19262780|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20349611|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
20349612|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
20349613|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20349614|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19262781|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262782|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
19262783|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262784|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262785|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19262786|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262787|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19262788|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19262789|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262790|NCT04502277|Fluconazole|fluconazole|mesh-list
19262791|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
19262792|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262793|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19262794|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19262795|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262796|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262797|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19262798|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
19262799|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262800|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262801|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19666488|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666489|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666490|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666491|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666492|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19666493|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666494|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666495|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
19666496|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
19666497|NCT04026438|Protective Agents|protective agents|mesh-ancestor
19666498|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666499|NCT03983993|Panitumumab|panitumumab|mesh-list
19666500|NCT03983993|Niraparib|niraparib|mesh-list
19666501|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349615|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262802|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19262803|NCT04502251|Naltrexone|naltrexone|mesh-list
19262804|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19262805|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19262806|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262807|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
19262808|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262809|NCT04502017|Clopidogrel|clopidogrel|mesh-list
19262810|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19262811|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19262812|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20349616|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20349617|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349618|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20424788|NCT01271166|Antidotes|antidotes|mesh-ancestor
20424789|NCT01271166|Protective Agents|protective agents|mesh-ancestor
20424790|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
20424791|NCT01271166|Vitamins|vitamins|mesh-ancestor
19262813|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19262814|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
19262815|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262816|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262817|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262818|NCT04501965|Azithromycin|azithromycin|mesh-list
19262819|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
19262820|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262821|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262822|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
19262823|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19262824|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19262825|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262826|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424792|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
20424793|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20424794|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424795|NCT01271179|Insulin|insulin|mesh-list
20424796|NCT01271179|Allopurinol|allopurinol|mesh-list
20424797|NCT01271179|Adenosine|adenosine|mesh-list
20612376|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
20612377|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612378|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20612379|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612380|NCT02251171|Ritonavir|ritonavir|mesh-list
20612381|NCT02251171|Tipranavir|tipranavir|mesh-list
19262827|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19262828|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19262829|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666502|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666503|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19262830|NCT04501900|Clopidogrel|clopidogrel|mesh-list
19262831|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19262832|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19262833|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19262834|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19262835|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
19262836|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19262837|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262838|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262839|NCT04501809|Misoprostol|misoprostol|mesh-list
19262840|NCT04501809|Oxytocin|oxytocin|mesh-list
19262841|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
19262842|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262843|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262844|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19262845|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
19262846|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19262847|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262848|NCT04501783|Favipiravir|favipiravir|mesh-list
19262849|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
19262850|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262851|NCT04501523|Capecitabine|capecitabine|mesh-list
19262852|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20424798|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20612382|NCT02251171|Rifabutin|rifabutin|mesh-list
20424799|NCT01271179|Analgesics|analgesics|mesh-ancestor
20612383|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19262853|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
19262854|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262855|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392822|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19392823|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19392824|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19392825|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19392826|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392827|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392828|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392829|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392830|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19392831|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19392832|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19392833|NCT03691636|Lifitegrast|lifitegrast|mesh-list
19392834|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19392835|NCT03691493|Tamoxifen|tamoxifen|mesh-list
19392836|NCT03691493|Letrozole|letrozole|mesh-list
19392837|NCT03691493|Fulvestrant|fulvestrant|mesh-list
19392838|NCT03691493|Palbociclib|palbociclib|mesh-list
19392839|NCT03691493|Anastrozole|anastrozole|mesh-list
19392840|NCT03691493|Exemestane|exemestane|mesh-list
19392841|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392842|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19392843|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19392844|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392845|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392846|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19392847|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
19392848|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19392849|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392850|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19392851|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19392852|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19392853|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19392854|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19392855|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19392856|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
19392857|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19392858|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
20612384|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20612385|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612386|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612387|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612388|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20612389|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612390|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
20612391|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612392|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20612393|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19392859|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392860|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
19392861|NCT03691467|Protective Agents|protective agents|mesh-ancestor
19392862|NCT03691454|Docetaxel|docetaxel|mesh-list
19392863|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
19392864|NCT03691454|Trastuzumab|trastuzumab|mesh-list
19392865|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392866|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
19392867|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
19392868|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392869|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392870|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392871|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
19392872|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19392873|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19392874|NCT03691376|Aldesleukin|aldesleukin|mesh-list
19392875|NCT03691376|Melphalan|melphalan|mesh-list
19392876|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
19392877|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19392878|NCT03691376|Interleukin-2|interleukin-2|mesh-list
19392879|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19392880|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
19392881|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392882|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392883|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19262856|NCT04501224|Tenofovir|tenofovir|mesh-list
19262857|NCT04501224|Entecavir|entecavir|mesh-list
19262858|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
19262859|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262860|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19262861|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262862|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262863|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262864|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19262865|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19262866|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
19262867|NCT04501289|Analgesics|analgesics|mesh-ancestor
19262868|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
19262869|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262870|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262871|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
19262872|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19262873|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19262874|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
19262875|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19262876|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19262877|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262878|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19262879|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
19262880|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262881|NCT04501367|Dexamethasone|dexamethasone|mesh-list
19262882|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
19262883|NCT04501367|Prednisone|prednisone|mesh-list
19262884|NCT04501367|BB 1101|bb 1101|mesh-list
19262885|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19262886|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
19262887|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
19262888|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19262889|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262890|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19262891|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
19262892|NCT04501367|Hormones|hormones|mesh-ancestor
19262893|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262894|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19262895|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262896|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
19262897|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262898|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349619|NCT00868946|Ribavirin|ribavirin|mesh-list
19262899|NCT04501107|Insulin|insulin|mesh-list
19262900|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19262901|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
19262902|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19262903|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262904|NCT04501250|Insulin|insulin|mesh-list
19262905|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19262906|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19262907|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262908|NCT04500860|Tadalafil|tadalafil|mesh-list
19262909|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
19262910|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19262911|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19262912|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262913|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262914|NCT04500860|Urological Agents|urological agents|mesh-ancestor
19262915|NCT04501406|Pioglitazone|pioglitazone|mesh-list
19262916|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19262917|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262918|NCT04500808|Macitentan|macitentan|mesh-list
19262919|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19262920|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19262921|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262922|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19262923|NCT04500717|Carboplatin|carboplatin|mesh-list
19262924|NCT04500717|Pemetrexed|pemetrexed|mesh-list
19262925|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666504|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349620|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
19262926|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262927|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262928|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19262929|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262930|NCT04500496|Isoniazid|isoniazid|mesh-list
19262931|NCT04500496|Dinoprostone|dinoprostone|mesh-list
19262932|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
19262933|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262934|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262935|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
19262936|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262937|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666505|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666511|NCT03765359|Metformin|metformin|mesh-list
20349621|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349622|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
20349623|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349624|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20349625|NCT00868985|Laxatives|laxatives|mesh-ancestor
20349626|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666512|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19666513|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666514|NCT03759041|Vancomycin|vancomycin|mesh-list
19666515|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666516|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666517|NCT03711604|Tenalisib|tenalisib|mesh-list
19666518|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
19666519|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666520|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262938|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19262939|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19262940|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
19262941|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262942|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19262943|NCT04500704|Carboplatin|carboplatin|mesh-list
19262944|NCT04500704|Pemetrexed|pemetrexed|mesh-list
19262945|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262946|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262947|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262948|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19262949|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19262950|NCT04500743|Leuprolide|leuprolide|mesh-list
19262951|NCT04500743|Dienogest|dienogest|mesh-list
19262952|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19262953|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
19262954|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19262955|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262956|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19262957|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262958|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19262959|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
19262960|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19262961|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19262962|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19262963|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19262964|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
19262965|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19262966|NCT04500522|Isoniazid|isoniazid|mesh-list
19262967|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
19262968|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262969|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262970|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19262971|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19262972|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
19262973|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262974|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19262975|NCT04500561|Gemcitabine|gemcitabine|mesh-list
19262976|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
19666521|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
19835705|NCT00604968|Doxorubicin|doxorubicin|mesh-list
19262977|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19262978|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
20349627|NCT00869063|Diclofenac|diclofenac|mesh-list
20349628|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20349629|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20349630|NCT00869063|Analgesics|analgesics|mesh-ancestor
20349631|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
20349632|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349633|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349634|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349635|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349636|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20349637|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349638|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349639|NCT00869180|Diclofenac|diclofenac|mesh-list
20349640|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20349641|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20349642|NCT00869180|Analgesics|analgesics|mesh-ancestor
20349643|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
20349644|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349645|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262979|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262980|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19262981|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
19262982|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262983|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19262984|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19262985|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
19262986|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19262987|NCT04500275|Vancomycin|vancomycin|mesh-list
19262988|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262989|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262990|NCT04499989|Isoniazid|isoniazid|mesh-list
19262991|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
19262992|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19262993|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19262994|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19262995|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19262996|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
19262997|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19262998|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19262999|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
19263000|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
19263001|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263002|NCT04500613|Dexamethasone|dexamethasone|mesh-list
19263003|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
19263004|NCT04500613|Bupivacaine|bupivacaine|mesh-list
19263005|NCT04500613|BB 1101|bb 1101|mesh-list
19263006|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263007|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
19263008|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
19263009|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263010|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263011|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263012|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
19263013|NCT04500613|Hormones|hormones|mesh-ancestor
19263014|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263015|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263016|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263017|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
19263018|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263019|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263020|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
19263021|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
19263022|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263023|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
19263024|NCT04500678|Metformin|metformin|mesh-list
19835706|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19263025|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19263026|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263027|NCT04500002|Isoniazid|isoniazid|mesh-list
19263028|NCT04500002|Misoprostol|misoprostol|mesh-list
19263029|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19263030|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
19263031|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263032|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263033|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20349646|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263034|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263035|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
19263036|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
19263037|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20349647|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349648|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20349649|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349650|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349651|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
20349652|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263038|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263039|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19263040|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19263041|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
19263042|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263043|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19263044|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19263045|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19263046|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263047|NCT04499898|Carvedilol|carvedilol|mesh-list
19263048|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19263049|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19263050|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
19263051|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263052|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263053|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263054|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20349653|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349654|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
20349655|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349656|NCT00869193|Protective Agents|protective agents|mesh-ancestor
20349657|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349658|NCT00869219|Nepafenac|nepafenac|mesh-list
20349659|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20349660|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20349661|NCT00869219|Analgesics|analgesics|mesh-ancestor
20349662|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
20349663|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349664|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349665|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349666|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349667|NCT00869232|Thalidomide|thalidomide|mesh-list
20349668|NCT00869232|Dexamethasone|dexamethasone|mesh-list
20349669|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
20349670|NCT00869232|Melphalan|melphalan|mesh-list
20349671|NCT00869232|Doxorubicin|doxorubicin|mesh-list
20349672|NCT00869232|Etoposide|etoposide|mesh-list
20349673|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20349674|NCT00869232|Bortezomib|bortezomib|mesh-list
20349675|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349676|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
20349677|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349678|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20349679|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20349680|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
20349681|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349682|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349683|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20349684|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263055|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
19263056|NCT04499898|Protective Agents|protective agents|mesh-ancestor
19263057|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19263058|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263059|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19263060|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
19263061|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19263062|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19263063|NCT04499885|Mineral Oil|mineral oil|mesh-list
19263064|NCT04499885|Emollients|emollients|mesh-ancestor
19263065|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
19263066|NCT04499586|Irinotecan|irinotecan|mesh-list
19263067|NCT04499586|Raltitrexed|raltitrexed|mesh-list
19263068|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19263069|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20349685|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
20349686|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
20349687|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349688|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20349689|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
20349690|NCT00869232|Hormones|hormones|mesh-ancestor
20349691|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349692|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20349693|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20349694|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20349695|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263070|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263071|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263072|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263073|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19263074|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
19263075|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19263076|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19263077|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19263078|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19263079|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
19263080|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263081|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19263082|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19263083|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263084|NCT04499573|Cytarabine|cytarabine|mesh-list
19263085|NCT04499573|Dexamethasone|dexamethasone|mesh-list
19263086|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
19263087|NCT04499573|Fludarabine|fludarabine|mesh-list
19263088|NCT04499573|Etoposide|etoposide|mesh-list
19263089|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19263090|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
19263091|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263092|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263093|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19263094|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
19263095|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263096|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263097|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19263098|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263099|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
19263100|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
19263101|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263102|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20349696|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349697|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20349698|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
20349699|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20349700|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349701|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20349702|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20349703|NCT00869232|Growth Substances|growth substances|mesh-ancestor
20349704|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
20349705|NCT00869271|Leucovorin|leucovorin|mesh-list
19263103|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
19263104|NCT04499573|Hormones|hormones|mesh-ancestor
19263105|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263106|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263107|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263108|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19263109|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
20176345|NCT00171041|Valsartan|valsartan|mesh-list
20349706|NCT00869271|Fluorouracil|fluorouracil|mesh-list
20349707|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
20349708|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
20349709|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349710|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20176346|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176347|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176348|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176349|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176350|NCT00171067|Valsartan|valsartan|mesh-list
20176351|NCT00171067|Lisinopril|lisinopril|mesh-list
20176352|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217112|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19263110|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263111|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19263112|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263113|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
19263114|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263115|NCT04499976|Misoprostol|misoprostol|mesh-list
19263116|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19263117|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
19263118|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263119|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263120|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19263121|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263122|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
19263123|NCT04499053|Durvalumab|durvalumab|mesh-list
19263124|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349711|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349712|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349713|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
20349714|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349715|NCT00869271|Antidotes|antidotes|mesh-ancestor
20349716|NCT00869271|Protective Agents|protective agents|mesh-ancestor
19263125|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392884|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392885|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
19392886|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392887|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392888|NCT03691376|Analgesics|analgesics|mesh-ancestor
19392889|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
19392890|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392891|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19392892|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19392893|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
19392894|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392895|NCT03691350|Nicotine|nicotine|mesh-list
19392896|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19392897|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
19392898|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349717|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
20349718|NCT00869271|Vitamins|vitamins|mesh-ancestor
20349719|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
20349720|NCT00869310|Dexamethasone|dexamethasone|mesh-list
20612394|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19392899|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392900|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19392901|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19392902|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
19392903|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392904|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392905|NCT03691337|Bupivacaine|bupivacaine|mesh-list
19392906|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19392907|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
19392908|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
19392909|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392910|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392911|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
19392912|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835707|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19835708|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835709|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19835710|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19835711|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176353|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176354|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176355|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176356|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20176357|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
20176358|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176359|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20176360|NCT00171067|Protective Agents|protective agents|mesh-ancestor
20176361|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176362|NCT00171080|Valsartan|valsartan|mesh-list
20349721|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
20349722|NCT00869310|Aprepitant|aprepitant|mesh-list
19392913|NCT03691090|Paclitaxel|paclitaxel|mesh-list
19392914|NCT03691090|Cisplatin|cisplatin|mesh-list
20349723|NCT00869310|Metoclopramide|metoclopramide|mesh-list
19263126|NCT04499118|Paclitaxel|paclitaxel|mesh-list
19263127|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19263128|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263129|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263130|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19263131|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19263132|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19263133|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263134|NCT04499313|Dexamethasone|dexamethasone|mesh-list
19263135|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
19263136|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19263137|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19263138|NCT04499313|Prednisolone|prednisolone|mesh-list
19263139|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
19263140|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19263141|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
19263142|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263143|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
19263144|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
19263145|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263146|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263147|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263148|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
19263149|NCT04499313|Hormones|hormones|mesh-ancestor
19263150|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263151|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263152|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263153|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19263154|NCT04499313|Protective Agents|protective agents|mesh-ancestor
19263155|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
19263156|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263157|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
19263158|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19263159|NCT04499209|Naproxen|naproxen|mesh-list
19263160|NCT04499209|Pregabalin|pregabalin|mesh-list
19263161|NCT04499209|Analgesics|analgesics|mesh-ancestor
19263162|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
19263163|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263164|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263165|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
19263166|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19263167|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263168|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263169|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19263170|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19263171|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19263172|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263173|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19263174|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19263175|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19263176|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263177|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263178|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
19263179|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19263180|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263181|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
19835712|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835713|NCT00605033|Buprenorphine|buprenorphine|mesh-list
19835714|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19835715|NCT00605033|Naloxone|naloxone|mesh-list
19835716|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19835717|NCT00605033|Narcotics|narcotics|mesh-ancestor
20612395|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20612396|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
20612397|NCT02251184|Aspirin|aspirin|mesh-list
20612398|NCT02251184|Dipyridamole|dipyridamole|mesh-list
20612399|NCT02251184|Lansoprazole|lansoprazole|mesh-list
19263182|NCT04498936|Ledipasvir|ledipasvir|mesh-list
19263183|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20176363|NCT00171080|Irbesartan|irbesartan|mesh-list
20176364|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176365|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20612400|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
19263184|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
19263185|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
19263186|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612401|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
19263187|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19263188|NCT04498897|Acamprosate|acamprosate|mesh-list
19263189|NCT04498897|Vortioxetine|vortioxetine|mesh-list
19263190|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
19263191|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19263192|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19263193|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19263194|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263195|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263196|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19263197|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19263198|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263199|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263200|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263201|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
19263202|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19263203|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19263204|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19263205|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19263206|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19263207|NCT04498689|Gemcitabine|gemcitabine|mesh-list
19263208|NCT04498689|Paclitaxel|paclitaxel|mesh-list
19263209|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263210|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263211|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
19263212|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
20612402|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20612403|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612404|NCT02251184|Analgesics|analgesics|mesh-ancestor
20612405|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
19263213|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
19263214|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263215|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19263216|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
19263217|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
19263218|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263219|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263220|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19263221|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
19263222|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263223|NCT04498793|Paclitaxel|paclitaxel|mesh-list
19263224|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
19263225|NCT04498793|Doxorubicin|doxorubicin|mesh-list
19263226|NCT04498793|Epirubicin|epirubicin|mesh-list
19263227|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263228|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263229|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
19263230|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
19263231|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
19263232|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263233|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19263234|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
19263235|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263236|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263237|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19263238|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
19263239|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19263240|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19263241|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19263242|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263243|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263244|NCT04498884|Insulin|insulin|mesh-list
19263245|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19263246|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20176366|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176367|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176368|NCT00171093|Valsartan|valsartan|mesh-list
20176369|NCT00171093|Simvastatin|simvastatin|mesh-list
20176370|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20176371|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20176372|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
20176373|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263247|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263248|NCT04498325|Antibodies|antibodies|mesh-list
19263249|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
19263250|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263251|NCT04498286|Antibodies|antibodies|mesh-list
19263252|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
19263253|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263254|NCT04498520|Fulvestrant|fulvestrant|mesh-list
19263255|NCT04498520|Palbociclib|palbociclib|mesh-list
20612406|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612407|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612408|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612409|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176374|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19263256|NCT04498520|Abexinostat|abexinostat|mesh-list
19263257|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263258|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263259|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19263260|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19263261|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
19263262|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263263|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263264|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19263265|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263266|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263267|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19263268|NCT04498234|Bupivacaine|bupivacaine|mesh-list
19263269|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
19263270|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
19263271|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263272|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263273|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
19263274|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263275|NCT04498260|Triamcinolone|triamcinolone|mesh-list
19263276|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19263277|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19263278|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19263279|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263280|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
19263281|NCT04498260|Hormones|hormones|mesh-ancestor
19263282|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263283|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263284|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176375|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20176376|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176377|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176378|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176379|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176380|NCT00171106|Valsartan|valsartan|mesh-list
20176381|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19263285|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
19263286|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263287|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263288|NCT04497831|Morphine|morphine|mesh-list
19263289|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19263290|NCT04497831|Narcotics|narcotics|mesh-ancestor
20349724|NCT00869310|BB 1101|bb 1101|mesh-list
20349725|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349726|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
19263291|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263292|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263293|NCT04497831|Analgesics|analgesics|mesh-ancestor
19263294|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
19263295|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263296|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
19263297|NCT04497766|Analgesics|analgesics|mesh-ancestor
19263298|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
19263299|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263300|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263301|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
20349727|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
20349728|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349729|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349730|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20349731|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
20349732|NCT00869310|Hormones|hormones|mesh-ancestor
20424800|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
19263302|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263303|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19263304|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
19263305|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19263306|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263307|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263308|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19263309|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
19263310|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263311|NCT04497792|Metformin|metformin|mesh-list
19263312|NCT04497792|Empagliflozin|empagliflozin|mesh-list
19263313|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19263314|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263315|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19263316|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263317|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
19263318|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
19263319|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263320|NCT04497012|Iron|iron|mesh-list
19263321|NCT04497012|Trace Elements|trace elements|mesh-ancestor
19263322|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
19263323|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263324|NCT04497142|Levetiracetam|levetiracetam|mesh-list
19263325|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
19263326|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
19392915|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19392916|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392917|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
19392918|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
19392919|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392920|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392921|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
19392922|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
19392923|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392924|NCT03691038|Pregabalin|pregabalin|mesh-list
19392925|NCT03691038|Analgesics|analgesics|mesh-ancestor
19392926|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
19392927|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392928|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392929|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
19392930|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19392931|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19392932|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392933|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392934|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20176382|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176383|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176384|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176385|NCT00171119|Valsartan|valsartan|mesh-list
20176386|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176387|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176388|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176389|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176390|NCT00171132|Atenolol|atenolol|mesh-list
20176391|NCT00171132|Valsartan|valsartan|mesh-list
20176392|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20424801|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392935|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19392936|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392937|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19392938|NCT03690947|Ranibizumab|ranibizumab|mesh-list
19392939|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19392940|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19392941|NCT03690947|Growth Substances|growth substances|mesh-ancestor
19392942|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392943|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
19392944|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392945|NCT03690778|Metformin|metformin|mesh-list
19392946|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19392947|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19392948|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392949|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19392950|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19392951|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
20349733|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349734|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20349735|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349736|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
20349737|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349738|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349739|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20349740|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349741|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20349742|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20349743|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
20349744|NCT00869427|Ascorbic Acid|ascorbic acid|mesh-list
20349745|NCT00869427|Vitamins|vitamins|mesh-ancestor
20349746|NCT00869427|Micronutrients|micronutrients|mesh-ancestor
20349747|NCT00869427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349748|NCT00869427|Antioxidants|antioxidants|mesh-ancestor
20349749|NCT00869427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349750|NCT00869427|Protective Agents|protective agents|mesh-ancestor
20349751|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20349752|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
20349753|NCT00869570|Capecitabine|capecitabine|mesh-list
20349754|NCT00869570|Sorafenib|sorafenib|mesh-list
20349755|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349756|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
19263327|NCT04496921|Vitamins|vitamins|mesh-list
19263328|NCT04496921|Vitamin K|vitamin k|mesh-list
19263329|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
19263330|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263331|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20349757|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349758|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349759|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20349760|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263332|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19263333|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263334|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
19263335|NCT04496921|Coagulants|coagulants|mesh-ancestor
19263336|NCT04496882|Tenofovir|tenofovir|mesh-list
19263337|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
19263338|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263339|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19263340|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19263341|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263342|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263343|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19263344|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19263345|NCT04496401|Tacrolimus|tacrolimus|mesh-list
19263346|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19263347|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
19263348|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263349|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20349761|NCT00869596|Fluticasone|fluticasone|mesh-list
20349762|NCT00869596|Xhance|xhance|mesh-list
20349763|NCT00869596|Albuterol|albuterol|mesh-list
20349764|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349765|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20349766|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
20349767|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349768|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349769|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20349770|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
20349771|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
19263350|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263351|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263352|NCT04496492|Tocotrienols|tocotrienols|mesh-list
19263353|NCT04496492|Vitamin E|vitamin e|mesh-list
19263354|NCT04496492|Tocopherols|tocopherols|mesh-list
19263355|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
19263356|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263357|NCT04496492|Protective Agents|protective agents|mesh-ancestor
19263358|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263359|NCT04496492|Vitamins|vitamins|mesh-ancestor
19263360|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
19263361|NCT04496141|Antibodies|antibodies|mesh-list
19263362|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
19263363|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263364|NCT04496037|Rituximab|rituximab|mesh-list
19263365|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19263366|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263367|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
19263368|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263369|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263370|NCT04496050|Alprostadil|alprostadil|mesh-list
19263371|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19263372|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
19263373|NCT04496050|Urological Agents|urological agents|mesh-ancestor
19263374|NCT04495894|Ketorolac|ketorolac|mesh-list
19263375|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19263376|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19263377|NCT04495894|Analgesics|analgesics|mesh-ancestor
19263378|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
19263379|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349772|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20349773|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
20349774|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20349775|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20349776|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20349777|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20349778|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
20349779|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349780|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349781|NCT00869700|Lumefantrine|lumefantrine|mesh-list
20349782|NCT00869700|Artemether|artemether|mesh-list
20349783|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20349784|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
20349785|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20349786|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20349787|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349788|NCT00869752|Etoposide|etoposide|mesh-list
20349789|NCT00869752|Antibodies|antibodies|mesh-list
19263380|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263381|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263382|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263383|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19263384|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263385|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263386|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20349790|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20349791|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
20349792|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349793|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349794|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20349795|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19263387|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19263388|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263389|NCT04495881|Incretins|incretins|mesh-ancestor
19263390|NCT04495881|Hormones|hormones|mesh-ancestor
19263391|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263392|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19263393|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
19263394|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263395|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263396|NCT04495933|Vaccines|vaccines|mesh-list
19263397|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
19263398|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
19263399|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263400|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19263401|NCT04495608|Fluconazole|fluconazole|mesh-list
19263402|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
19263403|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263404|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19263405|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19263406|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263407|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263408|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19263409|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
19666522|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20349796|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20349797|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349798|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349799|NCT00869765|Cycloserine|cycloserine|mesh-list
19263410|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263411|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263412|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19263413|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19263414|NCT04496024|Ofloxacin|ofloxacin|mesh-list
19263415|NCT04496024|Levofloxacin|levofloxacin|mesh-list
19263416|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19263417|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263418|NCT04496024|Renal Agents|renal agents|mesh-ancestor
20612410|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20612411|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20612412|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349800|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19263419|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19263420|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19263421|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263422|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263423|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263424|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263425|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19263426|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19263427|NCT04495569|Antibodies|antibodies|mesh-list
19263428|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19263429|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
19263430|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263431|NCT04495478|Ramucirumab|ramucirumab|mesh-list
19263432|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19263433|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263434|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
19263435|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263436|NCT04495504|Ropivacaine|ropivacaine|mesh-list
19263437|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
19263438|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
19263439|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263440|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349801|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349802|NCT00869765|Renal Agents|renal agents|mesh-ancestor
20349803|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20349804|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
20349805|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20349806|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
20349807|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349808|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
20349809|NCT00869856|Hematinics|hematinics|mesh-ancestor
20349810|NCT00869869|Melatonin|melatonin|mesh-list
20349811|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
20349812|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349813|NCT00869869|Protective Agents|protective agents|mesh-ancestor
20349814|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263441|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
19263442|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263443|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
19263444|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19263445|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263446|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263447|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19263448|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19263449|NCT04494958|Palbociclib|palbociclib|mesh-list
19263450|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263451|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19263452|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263453|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263454|NCT04495010|Nivolumab|nivolumab|mesh-list
19263455|NCT04495010|Ipilimumab|ipilimumab|mesh-list
19263456|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19263457|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263458|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19263459|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263460|NCT04494659|Rifampin|rifampin|mesh-list
19263461|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20349815|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20349816|NCT00869908|Insulin|insulin|mesh-list
20349817|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20349818|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
19263462|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
20349819|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
20349820|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20349821|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
20349822|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
20349823|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20349824|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349825|NCT00869973|Dexamethasone|dexamethasone|mesh-list
20349826|NCT00869973|Aprepitant|aprepitant|mesh-list
20349827|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20349828|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
20612413|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19263463|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19263464|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263465|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
19263466|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19263467|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263468|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263469|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19263470|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19263471|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19263472|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19263473|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19263474|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19263475|NCT04494763|Propranolol|propranolol|mesh-list
19263476|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19263477|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19263478|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
19263479|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263480|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263481|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263482|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19263483|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19263484|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
19263485|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
19263486|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19263487|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666523|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666524|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666525|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666526|NCT03645603|Analgesics|analgesics|mesh-ancestor
19666527|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
19666528|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666529|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19666530|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19835718|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263488|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263489|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19263490|NCT04494828|Analgesics|analgesics|mesh-ancestor
19263491|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
19263492|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263493|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19263494|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19263495|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19263496|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
19263497|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612414|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20612415|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612416|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
20176393|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176394|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176395|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176396|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176397|NCT00171132|Diuretics|diuretics|mesh-ancestor
20176398|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
20176399|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176400|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20176401|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20349829|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
20612417|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20612418|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612419|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19263498|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392952|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392953|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19392954|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19392955|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392956|NCT03690739|Gemcitabine|gemcitabine|mesh-list
19392957|NCT03690739|Paclitaxel|paclitaxel|mesh-list
19392958|NCT03690739|Bevacizumab|bevacizumab|mesh-list
20349830|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20349831|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349832|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19392959|NCT03690739|Carboplatin|carboplatin|mesh-list
19392960|NCT03690739|Trabectedin|trabectedin|mesh-list
19392961|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19392962|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392963|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
20349833|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
20349834|NCT00869973|Hormones|hormones|mesh-ancestor
20349835|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349836|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20349837|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349838|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20349839|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20349840|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349841|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20349842|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20349843|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349844|NCT00870038|Paclitaxel|paclitaxel|mesh-list
20349845|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20349846|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349847|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
20349848|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
20349849|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349850|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349851|NCT00870142|Amlodipine|amlodipine|mesh-list
20349852|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20349853|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20349854|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20349855|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349856|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392964|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
19392965|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392966|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392967|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392968|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19392969|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19392970|NCT03690739|Growth Substances|growth substances|mesh-ancestor
19392971|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392972|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
19392973|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19392974|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
19392975|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
19392976|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392977|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392978|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392979|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
19392980|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19392981|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
19392982|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
19392983|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19392984|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392985|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392986|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392987|NCT03690622|Analgesics|analgesics|mesh-ancestor
19392988|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
19392989|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392990|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19392991|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19392992|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19392993|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392994|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666531|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20349857|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349858|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
20349859|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20349860|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20349861|NCT00870220|Estradiol|estradiol|mesh-list
20349862|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20349863|NCT00870220|Estrogens|estrogens|mesh-ancestor
20349864|NCT00870220|Hormones|hormones|mesh-ancestor
20349865|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349866|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349867|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20349868|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
20349869|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263499|NCT04494529|Betamethasone|betamethasone|mesh-list
19263500|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
19263501|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19263502|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
19263503|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19263504|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263505|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
19263506|NCT04494529|Hormones|hormones|mesh-ancestor
19263507|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263508|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263509|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20349870|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20349871|NCT00870272|Misoprostol|misoprostol|mesh-list
20349872|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20349873|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
20349874|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20349875|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349876|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20349877|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20349878|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
20349879|NCT00870298|Trimethoprim|trimethoprim|mesh-list
20349880|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
20349881|NCT00870298|Warfarin|warfarin|mesh-list
20349882|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
20349883|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20349884|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349885|NCT00870298|Renal Agents|renal agents|mesh-ancestor
19263510|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
19263511|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
19263512|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263513|NCT04494503|Rituximab|rituximab|mesh-list
19263514|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19263515|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263516|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
19263517|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263518|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263519|NCT04494321|Budesonide|budesonide|mesh-list
19263520|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
19263521|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263522|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19263523|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
19263524|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263525|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263526|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19263527|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
19263528|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
19263529|NCT04494321|Hormones|hormones|mesh-ancestor
19263530|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176402|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20176403|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
20176404|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
20176405|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176406|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20176407|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20176408|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20176409|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
20176410|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176411|NCT00171145|Darifenacin|darifenacin|mesh-list
20176412|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19263531|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19263532|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20349886|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
20349887|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19263533|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19263534|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
19263535|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263536|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263537|NCT04494100|Lidocaine|lidocaine|mesh-list
19263538|NCT04494100|Epinephrine|epinephrine|mesh-list
19263539|NCT04494100|Ropivacaine|ropivacaine|mesh-list
20349888|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20349889|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20349890|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349891|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349892|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20349893|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20349894|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20349895|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
20349896|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
20349897|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19263540|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
19263541|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
19263542|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263543|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263544|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
19263545|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263546|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19263547|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19263548|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19263549|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263550|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263551|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19263552|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19263553|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
19263554|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263555|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20349898|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349899|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349900|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
20349901|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20349902|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20349903|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349904|NCT00870337|Everolimus|everolimus|mesh-list
20349905|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349906|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20349907|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
20349908|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349909|NCT00870402|Spironolactone|spironolactone|mesh-list
20349910|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20349911|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
20349912|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263556|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19263557|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
19263558|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19263559|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
19263560|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
19263561|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
19263562|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19263563|NCT04494438|Rituximab|rituximab|mesh-list
19263564|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19263565|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263566|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
20349913|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349914|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20349915|NCT00870402|Diuretics|diuretics|mesh-ancestor
20349916|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
20349917|NCT00870441|Valacyclovir|valacyclovir|mesh-list
20349918|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
20349919|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349920|NCT00870480|Finasteride|finasteride|mesh-list
20349921|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20349922|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20349923|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349924|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263567|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349925|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
19263568|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263569|NCT04494243|Rabeprazole|rabeprazole|mesh-list
19263570|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19263571|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263572|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19263573|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263574|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263575|NCT04494399|Interferons|interferons|mesh-list
19263576|NCT04494399|Ribavirin|ribavirin|mesh-list
19666532|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
19666533|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666534|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666535|NCT03615742|Budesonide|budesonide|mesh-list
19666536|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666537|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19666538|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
19666539|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666540|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666541|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19666542|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
19666543|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
19666544|NCT03615742|Hormones|hormones|mesh-ancestor
19263577|NCT04494399|Interferon-beta|interferon-beta|mesh-list
19263578|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
19263579|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263580|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
19263581|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263582|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
19263583|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263584|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
19263585|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263586|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19263587|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
19263588|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19263589|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19263590|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263591|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
19263592|NCT04494126|Coagulants|coagulants|mesh-ancestor
19263593|NCT04493554|Vasopressins|vasopressins|mesh-list
19263594|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
19263595|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
19263596|NCT04493554|Coagulants|coagulants|mesh-ancestor
19263597|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19263598|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19263599|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
19263600|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263601|NCT04493515|Oxytocin|oxytocin|mesh-list
19263602|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
19263603|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263604|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263605|NCT04493489|Propranolol|propranolol|mesh-list
19263606|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19263607|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19263608|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
19263609|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263610|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263611|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263612|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19263613|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19263614|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
19263615|NCT04493528|Lidocaine|lidocaine|mesh-list
19263616|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
20176413|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20176414|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
20176415|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176416|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176417|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176418|NCT00171145|Urological Agents|urological agents|mesh-ancestor
20176419|NCT00171171|Deferasirox|deferasirox|mesh-list
20176420|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20176421|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
20176422|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
20176423|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263617|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
19666545|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263618|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20176424|NCT00171184|Darifenacin|darifenacin|mesh-list
20349926|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349927|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263619|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263620|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
19263621|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263622|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19263623|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19263624|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19263625|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263626|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263627|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
19263628|NCT04493333|Psyllium|psyllium|mesh-list
19263629|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19263630|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19263631|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
19263632|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263633|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
19263634|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263635|NCT04493333|Cathartics|cathartics|mesh-ancestor
19263636|NCT04493229|Oxytocin|oxytocin|mesh-list
19263637|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
19263638|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263639|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263640|NCT04493125|Mosapride|mosapride|mesh-list
19263641|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263642|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263643|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19263644|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
19263645|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263646|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263647|NCT04493398|Erythritol|erythritol|mesh-list
19263648|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
19263649|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
19263650|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19263651|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19263652|NCT04493463|Prednisolone|prednisolone|mesh-list
19263653|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
19263654|NCT04493463|Ropivacaine|ropivacaine|mesh-list
19263655|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19263656|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
19263657|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
19263658|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
19666546|NCT03587584|Bupivacaine|bupivacaine|mesh-list
19666547|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
19666548|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
19666549|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666550|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666551|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
19666552|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666553|NCT03581487|Durvalumab|durvalumab|mesh-list
19263659|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263660|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263661|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
19263662|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263663|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263664|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
19263665|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
19263666|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263667|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
19263668|NCT04493463|Hormones|hormones|mesh-ancestor
19263669|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263670|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19263671|NCT04493463|Protective Agents|protective agents|mesh-ancestor
19263672|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263673|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263674|NCT04493281|Edaravone|edaravone|mesh-list
19263675|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19263676|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
19263677|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263678|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19263679|NCT04493281|Protective Agents|protective agents|mesh-ancestor
19263680|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263681|NCT04493099|Decitabine|decitabine|mesh-list
19263682|NCT04493099|Venetoclax|venetoclax|mesh-list
19263683|NCT04493099|Alvocidib|alvocidib|mesh-list
19666554|NCT03581487|Ipilimumab|ipilimumab|mesh-list
19263684|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20349928|NCT00870480|Urological Agents|urological agents|mesh-ancestor
20349929|NCT00870532|Sorafenib|sorafenib|mesh-list
20349930|NCT00870532|Vinorelbine|vinorelbine|mesh-list
20349931|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349932|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20349933|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349934|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349935|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20349936|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
20349937|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
19263685|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
19263686|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263687|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263688|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263689|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
19263690|NCT04493099|Growth Substances|growth substances|mesh-ancestor
19263691|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263692|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19263693|NCT04493164|Cytarabine|cytarabine|mesh-list
19263694|NCT04493164|Daunorubicin|daunorubicin|mesh-list
19263695|NCT04493164|Ivosidenib|ivosidenib|mesh-list
19263696|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19263697|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
19263698|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263699|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263700|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
19263701|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263702|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19263703|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
19263704|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263705|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19263706|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19263707|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263708|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263709|NCT04493073|Mitomycins|mitomycins|mesh-list
19263710|NCT04493073|Mitomycin|mitomycin|mesh-list
19263711|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19263712|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263713|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
19263714|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263715|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19263716|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263717|NCT04493060|Niraparib|niraparib|mesh-list
19263718|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
19263719|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
19263720|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
19263721|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263722|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19263723|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263724|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263725|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263726|NCT04492774|Dexamethasone|dexamethasone|mesh-list
19263727|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263728|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
19263729|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
19263730|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263731|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263732|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263733|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
19263734|NCT04492774|Hormones|hormones|mesh-ancestor
19263735|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263736|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263737|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263738|NCT04492813|Remifentanil|remifentanil|mesh-list
19263739|NCT04492813|Propofol|propofol|mesh-list
19263740|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19263741|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263742|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263743|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19263744|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
19263745|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
20349938|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349939|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
19263746|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20349940|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263747|NCT04492813|Narcotics|narcotics|mesh-ancestor
19263748|NCT04492813|Analgesics|analgesics|mesh-ancestor
20349941|NCT00870571|Amlodipine|amlodipine|mesh-list
19263749|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
19263750|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392995|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392996|NCT03690583|Zinc|zinc|mesh-list
19392997|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
19392998|NCT03690583|Trace Elements|trace elements|mesh-ancestor
19392999|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
19393000|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393001|NCT03690583|Astringents|astringents|mesh-ancestor
19393002|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
19393003|NCT03690414|Atropine|atropine|mesh-list
19393004|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19393005|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19393006|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19393007|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19393008|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19393009|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
19393010|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393011|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393012|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19393013|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
19393014|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
19393015|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
19393016|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19393017|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19393018|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
19393019|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393020|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393021|NCT03690323|Gemcitabine|gemcitabine|mesh-list
19393022|NCT03690323|Paclitaxel|paclitaxel|mesh-list
19393023|NCT03690323|Folfirinox|folfirinox|mesh-list
19393024|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19393025|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393026|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
19393027|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
19393028|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
19393029|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393030|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19393031|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
19393032|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
20176425|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20176426|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20176427|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
20176428|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393033|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393034|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393035|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19393036|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
19393037|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393038|NCT03690167|Mitogens|mitogens|mesh-list
19393039|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
19393040|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393041|NCT03690115|Ponatinib|ponatinib|mesh-list
19393042|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393043|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20176429|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176430|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176431|NCT00171184|Urological Agents|urological agents|mesh-ancestor
20176432|NCT00171288|Ezetimibe|ezetimibe|mesh-list
20176433|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20176434|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20176435|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
20176436|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176437|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20176438|NCT00171327|Valsartan|valsartan|mesh-list
20176439|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176440|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19393044|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393045|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393046|NCT03689998|Melatonin|melatonin|mesh-list
19393047|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
19393048|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176441|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19263751|NCT04492709|Midazolam|midazolam|mesh-list
19263752|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19263753|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19263754|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263755|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263756|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19263757|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19263758|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19263759|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19263760|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
19263761|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
19263762|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
19263763|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
19263764|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263765|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263766|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
19263767|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263768|NCT04492319|Neostigmine|neostigmine|mesh-list
19263769|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19263770|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263771|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263772|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
19263773|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263774|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263775|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19263776|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
19263777|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263778|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
19263779|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
19263780|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263781|NCT04492566|Pancrelipase|pancrelipase|mesh-list
19263782|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263783|NCT04492358|Prednisone|prednisone|mesh-list
19263784|NCT04492358|Colchicine|colchicine|mesh-list
19263785|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263786|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
19263787|NCT04492358|Hormones|hormones|mesh-ancestor
19263788|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19263789|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263790|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263791|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263792|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
19263793|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263794|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19263795|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19263796|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19263797|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263798|NCT04492501|Remdesivir|remdesivir|mesh-list
19263799|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
19263800|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263801|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
19263802|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263803|NCT04492072|Misoprostol|misoprostol|mesh-list
19263804|NCT04492072|Oxytocin|oxytocin|mesh-list
19263805|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
19263806|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263807|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263808|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19263809|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
19263810|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19263811|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19263812|NCT04492033|Paclitaxel|paclitaxel|mesh-list
19263813|NCT04492033|Irinotecan|irinotecan|mesh-list
19263814|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263815|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263816|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
19263817|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
19263818|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19263819|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263820|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19263821|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263822|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263823|NCT04491773|Tadalafil|tadalafil|mesh-list
19263824|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
19263825|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19263826|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19263827|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263828|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263829|NCT04491773|Urological Agents|urological agents|mesh-ancestor
19263830|NCT04491786|Gabapentin|gabapentin|mesh-list
19263831|NCT04491786|Nefopam|nefopam|mesh-list
19263832|NCT04491786|Analgesics|analgesics|mesh-ancestor
19263833|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
19263834|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263835|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263836|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
19263837|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19263838|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19263839|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263840|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19263841|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20176442|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176443|NCT00171353|Valsartan|valsartan|mesh-list
20176444|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176445|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176446|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176447|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176448|NCT00171366|Amlodipine|amlodipine|mesh-list
20176449|NCT00171366|Benazepril|benazepril|mesh-list
20176450|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176451|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19263842|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19263843|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19263844|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263845|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
19263846|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19263847|NCT04491695|Tirofiban|tirofiban|mesh-list
19263848|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19263849|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19263850|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263851|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19263852|NCT04491682|Megestrol|megestrol|mesh-list
19263853|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
19263854|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19263855|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19263856|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19263857|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
19263858|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263859|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19263860|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19263861|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263862|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19263863|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19263864|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19263865|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
19263866|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263867|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263868|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19263869|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19263870|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263871|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263872|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
19263873|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19263874|NCT04491474|Lidocaine|lidocaine|mesh-list
19263875|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
19263876|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
19263877|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263878|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263879|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
19263880|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263881|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19263882|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19263883|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19263884|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263885|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263886|NCT04491643|Megestrol|megestrol|mesh-list
19263887|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
19263888|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19263889|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19263890|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19263891|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
19263892|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263893|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19263894|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19263895|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263896|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19263897|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19263898|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20612420|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20612421|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
20612422|NCT02251223|Ritonavir|ritonavir|mesh-list
20349942|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20349943|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20349944|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19263899|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
19263900|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19263901|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263902|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19263903|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19263904|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19263905|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263906|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
20349945|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349946|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20349947|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349948|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
20349949|NCT00870636|Bevacizumab|bevacizumab|mesh-list
19263907|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19263908|NCT04491084|Antibodies|antibodies|mesh-list
19263909|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
19263910|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
19263911|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349950|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20349951|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349952|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20349953|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20349954|NCT00870636|Growth Substances|growth substances|mesh-ancestor
20349955|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349956|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
20349957|NCT00870714|Ketoconazole|ketoconazole|mesh-list
19263912|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19263913|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19263914|NCT04491084|Protective Agents|protective agents|mesh-ancestor
19263915|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
19263916|NCT04491357|Calcium|calcium|mesh-list
19263917|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19263918|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263919|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19263920|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
19263921|NCT04490967|Salicylates|salicylates|mesh-list
19263922|NCT04490967|Silybin|silybin|mesh-list
19263923|NCT04490967|Silymarin|silymarin|mesh-list
19263924|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
19263925|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263926|NCT04490967|Protective Agents|protective agents|mesh-ancestor
19263927|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263928|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263929|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
19263930|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
19263931|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
19263932|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19263933|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19263934|NCT04490967|Analgesics|analgesics|mesh-ancestor
19263935|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
19263936|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263937|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263938|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263939|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19263940|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263941|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263942|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349958|NCT00870714|Docetaxel|docetaxel|mesh-list
20612423|NCT02251223|Tipranavir|tipranavir|mesh-list
19263943|NCT04490837|Antibodies|antibodies|mesh-list
20349959|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349960|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
20349961|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
20349962|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
20349963|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349964|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
20349965|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349966|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20349967|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20349968|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349969|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20349970|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
20349971|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20349972|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349973|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20349974|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20349975|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20349976|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
20424802|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263944|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
19263945|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263946|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
19263947|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19263948|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263949|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19263950|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263951|NCT04490980|Butorphanol|butorphanol|mesh-list
19263952|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19263953|NCT04490980|Narcotics|narcotics|mesh-ancestor
19263954|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19263955|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263956|NCT04490980|Analgesics|analgesics|mesh-ancestor
19263957|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
19263958|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263959|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
19263960|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
19263961|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19393049|NCT03689998|Protective Agents|protective agents|mesh-ancestor
19393050|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393051|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393052|NCT03689972|Natalizumab|natalizumab|mesh-list
19393053|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
19393054|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393055|NCT03689894|Rituximab|rituximab|mesh-list
19393056|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19393057|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393058|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
19393059|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393060|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404034|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19404035|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19404036|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19404037|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404038|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19404039|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19666555|NCT03581487|Tremelimumab|tremelimumab|mesh-list
19404040|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
19404041|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404042|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19404043|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404044|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
19404045|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19404046|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404047|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
19404048|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
19404049|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19404050|NCT03597945|Analgesics|analgesics|mesh-ancestor
19404051|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
19404052|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19404053|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19404054|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
19666556|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
19666557|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19666558|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
19263962|NCT04490694|Lenvatinib|lenvatinib|mesh-list
19263963|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20349977|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
20349978|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20349979|NCT00870883|Deferoxamine|deferoxamine|mesh-list
20349980|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
20349981|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20349982|NCT00870883|Expectorants|expectorants|mesh-ancestor
20349983|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
20349984|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20349985|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
20349986|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20349987|NCT00870883|Protective Agents|protective agents|mesh-ancestor
20176452|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176453|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176454|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176455|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176456|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176457|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20176458|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
20176459|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20349988|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349989|NCT00870883|Antidotes|antidotes|mesh-ancestor
20349990|NCT00870883|Siderophores|siderophores|mesh-ancestor
20349991|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19263964|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19263965|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263966|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263967|NCT04490590|Etoposide|etoposide|mesh-list
19263968|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263969|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263970|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19263971|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263972|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263973|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263974|NCT04490434|Celecoxib|celecoxib|mesh-list
20176460|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
20176461|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20176462|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176463|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20176464|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
20176465|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176466|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176467|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176468|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176469|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
20349992|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
20349993|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
19263975|NCT04490434|Naproxen|naproxen|mesh-list
19263976|NCT04490434|Meloxicam|meloxicam|mesh-list
19263977|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19263978|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20349994|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
20349995|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20349996|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20349997|NCT00870961|Vitamins|vitamins|mesh-ancestor
19263979|NCT04490434|Analgesics|analgesics|mesh-ancestor
19263980|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
19263981|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19263982|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19263983|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19263984|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19263985|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19263986|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19263987|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263988|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19263989|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
19263990|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19263991|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19263992|NCT04490421|Etoposide|etoposide|mesh-list
19263993|NCT04490421|Apatinib|apatinib|mesh-list
19263994|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19263995|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19263996|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20349998|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
19263997|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19263998|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19263999|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264000|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19264001|NCT04490031|Ketamine|ketamine|mesh-list
19264002|NCT04490031|Analgesics|analgesics|mesh-ancestor
19264003|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
19264004|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264005|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264006|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19264007|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19264008|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
19264009|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
19264010|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264011|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19264012|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19264013|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264014|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264015|NCT04490057|Bupropion|bupropion|mesh-list
19264016|NCT04490057|Nicotine|nicotine|mesh-list
19264017|NCT04490057|Varenicline|varenicline|mesh-list
19264018|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19264019|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
19264020|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264021|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264022|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19264023|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19264024|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
19264025|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264026|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264027|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19264028|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
19264029|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19264030|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19264031|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19264032|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19264033|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
19264034|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19264035|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19264036|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264037|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19264038|NCT04490213|Laxatives|laxatives|mesh-ancestor
19264039|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264040|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
19264041|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264042|NCT04489589|Midodrine|midodrine|mesh-list
19264043|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
19264044|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
19666559|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666560|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666561|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
19666562|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176470|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19666563|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19666564|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666565|NCT03542695|Alendronate|alendronate|mesh-list
19666566|NCT03542695|Copper|copper|mesh-list
19666567|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19666568|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666569|NCT03542695|Trace Elements|trace elements|mesh-ancestor
19666570|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
19264045|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264046|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264047|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19264048|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19264049|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19264050|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19264051|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
19666571|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
19666572|NCT03414502|Minocycline|minocycline|mesh-list
19666573|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
19666574|NCT03414502|Adalimumab|adalimumab|mesh-list
20176471|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176472|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19666575|NCT03414502|Etanercept|etanercept|mesh-list
20176473|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
20176474|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176475|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176476|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835719|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835720|NCT00605033|Analgesics|analgesics|mesh-ancestor
19835721|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
19264052|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264053|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264054|NCT04489745|Androgens|androgens|mesh-list
19264055|NCT04489745|Hormones|hormones|mesh-ancestor
19264056|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264057|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264058|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
19264059|NCT04489797|Rabeprazole|rabeprazole|mesh-list
19264060|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19264061|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264062|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19264063|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176477|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176478|NCT00171418|Tegaserod|tegaserod|mesh-list
20176479|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20176480|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
20176481|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264064|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264065|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264066|NCT04489849|Apixaban|apixaban|mesh-list
19264067|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19264068|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
19264069|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19264070|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
19264071|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264072|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264073|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
19264074|NCT04489459|Meropenem|meropenem|mesh-list
19264075|NCT04489459|Colistin|colistin|mesh-list
19264076|NCT04489459|Tigecycline|tigecycline|mesh-list
19264077|NCT04489459|Polymyxins|polymyxins|mesh-list
19264078|NCT04489459|Polymyxin B|polymyxin b|mesh-list
19264079|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666576|NCT03414502|Golimumab|golimumab|mesh-list
19666577|NCT03414502|Rituximab|rituximab|mesh-list
19666578|NCT03414502|Methotrexate|methotrexate|mesh-list
19666579|NCT03414502|Abatacept|abatacept|mesh-list
19666580|NCT03414502|Azathioprine|azathioprine|mesh-list
20349999|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20350000|NCT00870987|Vaccines|vaccines|mesh-list
20350001|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
20350002|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350003|NCT00871039|Midazolam|midazolam|mesh-list
19666581|NCT03414502|Infliximab|infliximab|mesh-list
19666582|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
19666583|NCT03414502|Leflunomide|leflunomide|mesh-list
20176482|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176483|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350004|NCT00871039|Propofol|propofol|mesh-list
20350005|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20350006|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350007|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350008|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19264080|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264081|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19264082|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264083|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264084|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
19264085|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
19264086|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19835722|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835723|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19835724|NCT00605072|Metoprolol|metoprolol|mesh-list
19835725|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20350009|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
19264087|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19264088|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393061|NCT03689465|Cyclosporine|cyclosporine|mesh-list
19666584|NCT03414502|Tofacitinib|tofacitinib|mesh-list
19666585|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835726|NCT00605072|Candesartan|candesartan|mesh-list
19835727|NCT00605072|Lisinopril|lisinopril|mesh-list
20350010|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
20350011|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20350012|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20350013|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20350014|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350015|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
20350016|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
20350017|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350018|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350019|NCT00871052|Vitamin D|vitamin d|mesh-list
20350020|NCT00871052|Calcipotriene|calcipotriene|mesh-list
20176484|NCT00171431|Tegaserod|tegaserod|mesh-list
20176485|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20176486|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
20176487|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176488|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176489|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176490|NCT00171457|Tegaserod|tegaserod|mesh-list
20176491|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20176492|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
20176493|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176494|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176495|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176496|NCT00171470|Tegaserod|tegaserod|mesh-list
20176497|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20176498|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
20176499|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176500|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264089|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264090|NCT04489446|Urological Agents|urological agents|mesh-ancestor
20176501|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176502|NCT00171483|Tegaserod|tegaserod|mesh-list
20176503|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20176504|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
19666586|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666587|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
19666588|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666589|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666590|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19666591|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
19666592|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19264091|NCT04489147|Metformin|metformin|mesh-list
19264092|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19666593|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19666594|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
19666595|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666596|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
19666597|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264093|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264094|NCT04489121|Omalizumab|omalizumab|mesh-list
19264095|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19264096|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19264097|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
19264098|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
19666598|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19666599|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264099|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19264100|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264101|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19264102|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19264103|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264104|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
19264105|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264106|NCT04488978|Amlodipine|amlodipine|mesh-list
19264107|NCT04488978|Irbesartan|irbesartan|mesh-list
19264108|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19666600|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19666601|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666602|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
19666603|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19666604|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20176505|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350021|NCT00871052|Vitamins|vitamins|mesh-ancestor
20350022|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
19264109|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20350023|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264110|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19264111|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264112|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19264113|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264114|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
19264115|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19264116|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19264117|NCT04488705|Albuterol|albuterol|mesh-list
19264118|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19264119|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
19264120|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264121|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264122|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19264123|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
19264124|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
19264125|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19264126|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19264127|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19264128|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19264129|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
19264130|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176506|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176507|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176508|NCT00171496|Cyclosporine|cyclosporine|mesh-list
20176509|NCT00171496|Tacrolimus|tacrolimus|mesh-list
20176510|NCT00171496|Cyclosporins|cyclosporins|mesh-list
20176511|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176512|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
20176513|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176514|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20176515|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264131|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264132|NCT04488744|Nicotine|nicotine|mesh-list
19264133|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19264134|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
19264135|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264136|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350024|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20350025|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
20350026|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
20350027|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350028|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
20350029|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20350030|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20350031|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350032|NCT00871065|Urological Agents|urological agents|mesh-ancestor
20350033|NCT00871104|Vancomycin|vancomycin|mesh-list
20350034|NCT00871104|Imipenem|imipenem|mesh-list
20350035|NCT00871104|Fosfomycin|fosfomycin|mesh-list
20350036|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19264137|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19666605|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666606|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176516|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176517|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
20176518|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176519|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
20176520|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176521|NCT00171509|Cyclosporine|cyclosporine|mesh-list
20176522|NCT00171509|Cyclosporins|cyclosporins|mesh-list
20176523|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176524|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176525|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176526|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
20350037|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666607|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19666608|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666609|NCT03414502|Analgesics|analgesics|mesh-ancestor
19666610|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
19666611|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176527|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176528|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
20176529|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264138|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19264139|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
19264140|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264141|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264142|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
19264143|NCT04488614|Estrogens|estrogens|mesh-list
19264144|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19264145|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264146|NCT04488614|Hormones|hormones|mesh-ancestor
19264147|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393062|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
19393063|NCT03689465|Methotrexate|methotrexate|mesh-list
19393064|NCT03689465|Cyclosporins|cyclosporins|mesh-list
19393065|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19393066|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
19393067|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393068|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393069|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19393070|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
19393071|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393072|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393073|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
19393074|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393075|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19393076|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19393077|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
19393078|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393079|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19393080|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
19393081|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350038|NCT00871156|Chloroquine|chloroquine|mesh-list
20350039|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20350040|NCT00871156|Tafenoquine|tafenoquine|mesh-list
20350041|NCT00871156|Amebicides|amebicides|mesh-ancestor
20350042|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19393082|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19393083|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19393084|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19393085|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
19393086|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393087|NCT03689114|Topiramate|topiramate|mesh-list
19393088|NCT03689114|Lamotrigine|lamotrigine|mesh-list
19393089|NCT03689114|Zonisamide|zonisamide|mesh-list
19393090|NCT03689114|Carbamazepine|carbamazepine|mesh-list
19393091|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
19393092|NCT03689114|Gabapentin|gabapentin|mesh-list
19393093|NCT03689114|Levetiracetam|levetiracetam|mesh-list
19393094|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
19393095|NCT03689114|Valproic Acid|valproic acid|mesh-list
19393096|NCT03689114|Analgesics|analgesics|mesh-ancestor
19393097|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
19393098|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393099|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393100|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19393101|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19393102|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393103|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19393104|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19393105|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19393106|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393107|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393108|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
19393109|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19393110|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
19393111|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19393112|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19393113|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19393114|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19393115|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19393116|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393117|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
19393118|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19393119|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19393120|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19393121|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20350043|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19264148|NCT04488926|Palmidrol|palmidrol|mesh-list
19264149|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19264150|NCT04488926|Analgesics|analgesics|mesh-ancestor
19264151|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
19264152|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264153|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264154|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19264155|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264156|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264157|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
19264158|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264159|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19264160|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19264161|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264162|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264163|NCT04488926|Hormones|hormones|mesh-ancestor
19264164|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264165|NCT04488874|Mannitol|mannitol|mesh-list
19264166|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19264167|NCT04488874|Diuretics|diuretics|mesh-ancestor
19264168|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
19264169|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264170|NCT04488601|Sirolimus|sirolimus|mesh-list
19264171|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19264172|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264173|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19264174|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264175|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
19264176|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350044|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350045|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
20350046|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20350047|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20350048|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20350049|NCT00871156|Analgesics|analgesics|mesh-ancestor
20350050|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
19264177|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
19264178|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264179|NCT04488315|Dexamethasone|dexamethasone|mesh-list
19264180|NCT04488315|Dexamethasone acetate|dexamethasone acetate|mesh-list
19264181|NCT04488315|Ropivacaine|ropivacaine|mesh-list
19264182|NCT04488315|BB 1101|bb 1101|mesh-list
19264183|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264184|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
19264185|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
19264186|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264187|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264188|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264189|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
19264190|NCT04488315|Hormones|hormones|mesh-ancestor
19264191|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264192|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19264193|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264194|NCT04488315|Protease Inhibitors|protease inhibitors|mesh-ancestor
19264195|NCT04488315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264196|NCT04488315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264197|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
19264198|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
19264199|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264200|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
19264201|NCT04488107|Letrozole|letrozole|mesh-list
19264202|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264203|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19264204|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19264205|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264206|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264207|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19264208|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
19264209|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264210|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264211|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
19264212|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19264213|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20350051|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264214|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350052|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350053|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264215|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
19264216|NCT04488367|Coagulants|coagulants|mesh-ancestor
19264217|NCT04488081|Cyclosporine|cyclosporine|mesh-list
19264218|NCT04488081|Remdesivir|remdesivir|mesh-list
19264219|NCT04488081|Celecoxib|celecoxib|mesh-list
19264220|NCT04488081|Famotidine|famotidine|mesh-list
19264221|NCT04488081|Cyclosporins|cyclosporins|mesh-list
19264222|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264223|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264224|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264225|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
19264226|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264227|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
19264228|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264229|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264230|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666612|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666613|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19666614|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19666615|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19666616|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
19264231|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19264232|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19264233|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19264234|NCT04488081|Analgesics|analgesics|mesh-ancestor
19264235|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
19264236|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264237|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264238|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19264239|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19264240|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19264241|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264242|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19264243|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
19264244|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
19264245|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264246|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
19264247|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
19264248|NCT04488172|Vitamins|vitamins|mesh-list
19264249|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
19264250|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264251|NCT04487990|Heparin|heparin|mesh-list
19264252|NCT04487990|Calcium heparin|calcium heparin|mesh-list
19264253|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
19264254|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19264255|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19264256|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264257|NCT04487951|Vitamin D|vitamin d|mesh-list
19264258|NCT04487951|Vitamins|vitamins|mesh-ancestor
19264259|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
19264260|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264261|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19264262|NCT04487743|Liraglutide|liraglutide|mesh-list
19264263|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19264264|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264265|NCT04487743|Incretins|incretins|mesh-ancestor
19264266|NCT04487743|Hormones|hormones|mesh-ancestor
19264267|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264268|NCT04487834|Simethicone|simethicone|mesh-list
19264269|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
19264270|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264271|NCT04487834|Emollients|emollients|mesh-ancestor
19264272|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264273|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
19264274|NCT04487652|Vitamins|vitamins|mesh-ancestor
19264275|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
19264276|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264277|NCT04487756|Carboplatin|carboplatin|mesh-list
19264278|NCT04487756|Atezolizumab|atezolizumab|mesh-list
19264279|NCT04487756|Vaccines|vaccines|mesh-list
19264280|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
19264281|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264282|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350054|NCT00871156|Filaricides|filaricides|mesh-ancestor
19264283|NCT04487587|Olaparib|olaparib|mesh-list
19264284|NCT04487587|Cediranib|cediranib|mesh-list
19393122|NCT03689075|Tacrolimus|tacrolimus|mesh-list
19264285|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19264286|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264287|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264288|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264289|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19264290|NCT04487236|Capecitabine|capecitabine|mesh-list
19264291|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19264292|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
19264293|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264294|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264295|NCT04487444|Thymalfasin|thymalfasin|mesh-list
19264296|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19264297|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
19264298|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264299|NCT04487392|Estrogens|estrogens|mesh-list
20350055|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
20350056|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
20350057|NCT00871208|Retapamulin|retapamulin|mesh-list
20350058|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
20350059|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20350060|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20350061|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20350062|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
20350063|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
20350064|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20350065|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20350066|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350067|NCT00871247|Finasteride|finasteride|mesh-list
20350068|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20350069|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20350070|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350071|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350072|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
20350073|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350074|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350075|NCT00871247|Urological Agents|urological agents|mesh-ancestor
20350076|NCT00871273|Capecitabine|capecitabine|mesh-list
20350077|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350078|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
20350079|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350080|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350081|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20350082|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20350083|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20350084|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350085|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350086|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350087|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350088|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20350089|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
20350090|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350091|NCT00871442|Fentanyl|fentanyl|mesh-list
20350092|NCT00871442|Bupivacaine|bupivacaine|mesh-list
20350093|NCT00871442|Anesthetics|anesthetics|mesh-list
20350094|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
20350095|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350096|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350097|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
19264300|NCT04487392|Hormones|hormones|mesh-ancestor
19264301|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264302|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264303|NCT04487106|Azacitidine|azacitidine|mesh-list
19264304|NCT04487106|Venetoclax|venetoclax|mesh-list
19264305|NCT04487106|Trametinib|trametinib|mesh-list
19264306|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19264307|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
19264308|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264309|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264310|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666617|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
20350098|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264311|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19264312|NCT04487093|Vaccines|vaccines|mesh-list
19264313|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
19264314|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264315|NCT04486690|Ketamine|ketamine|mesh-list
19264316|NCT04486690|Propofol|propofol|mesh-list
19264317|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19264318|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264319|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264320|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19264321|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
19264322|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
20350099|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20350100|NCT00871442|Narcotics|narcotics|mesh-ancestor
20350101|NCT00871442|Analgesics|analgesics|mesh-ancestor
20350102|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20350103|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20350104|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
20350105|NCT00871455|Baclofen|baclofen|mesh-list
20350106|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20350107|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350108|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20350109|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350110|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19264323|NCT04486690|Analgesics|analgesics|mesh-ancestor
19264324|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
19264325|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264326|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19264327|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19264328|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19264329|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264330|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264331|NCT04486651|Irinotecan|irinotecan|mesh-list
19264332|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19264333|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19264334|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264335|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264336|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264337|NCT04486508|Heparin|heparin|mesh-list
19264338|NCT04486508|Calcium heparin|calcium heparin|mesh-list
19264339|NCT04486508|Enoxaparin|enoxaparin|mesh-list
19264340|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
19264341|NCT04486508|Atorvastatin|atorvastatin|mesh-list
19264342|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19264343|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19264344|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19264345|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
19264346|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264347|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19264348|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264349|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
19264350|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19264351|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19264352|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
19264353|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19264354|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264355|NCT04486612|Anesthetics|anesthetics|mesh-list
19264356|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264357|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393123|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19393124|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
19393125|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393126|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19393127|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393128|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393129|NCT03689010|Azelaic acid|azelaic acid|mesh-list
19393130|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393131|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
19393132|NCT03688971|Ketoconazole|ketoconazole|mesh-list
19393133|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
19393134|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393135|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19393136|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19393137|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393138|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393139|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19393140|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
19264358|NCT04486430|Salicylates|salicylates|mesh-list
19264359|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19264360|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19264361|NCT04486430|Analgesics|analgesics|mesh-ancestor
19264362|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
19264363|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264364|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264365|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264366|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264367|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19264368|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264369|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264370|NCT04486521|Siltuximab|siltuximab|mesh-list
19264371|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666618|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19666619|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19666620|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666621|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666622|NCT03199612|Urological Agents|urological agents|mesh-ancestor
19666623|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
19666624|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19666625|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19666626|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666627|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
19666628|NCT03182751|Coagulants|coagulants|mesh-ancestor
19666629|NCT03113643|Azacitidine|azacitidine|mesh-list
19666630|NCT03113643|Venetoclax|venetoclax|mesh-list
19666631|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19666632|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
20176530|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264372|NCT04486092|Valproic Acid|valproic acid|mesh-list
19264373|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
19264374|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264375|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264376|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
19264377|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264378|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264379|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
19264380|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19264381|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264382|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19264383|NCT04485845|Metformin|metformin|mesh-list
19264384|NCT04485845|Vildagliptin|vildagliptin|mesh-list
19264385|NCT04485845|Captopril|captopril|mesh-list
19264386|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19264387|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264388|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19264389|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
19264390|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264391|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264392|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19264393|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19264394|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19264395|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19264396|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
19264397|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264398|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264399|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264400|NCT04485949|Temozolomide|temozolomide|mesh-list
19264401|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19666633|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666634|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666635|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666636|NCT03054519|Metformin|metformin|mesh-list
19666637|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20176531|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176532|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20176533|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20176534|NCT00171522|Tegaserod|tegaserod|mesh-list
20176535|NCT00171522|Laxatives|laxatives|mesh-ancestor
19666638|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693086|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264402|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
20176536|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176537|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19264403|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264404|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264405|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
19264406|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19264407|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19666639|NCT02943733|Temozolomide|temozolomide|mesh-list
19666640|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19666641|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
19666642|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666643|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666644|NCT02850263|Bevacizumab|bevacizumab|mesh-list
19666645|NCT02850263|Aflibercept|aflibercept|mesh-list
19666646|NCT02850263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666647|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666648|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19264408|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19264409|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19264410|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264411|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
19264412|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264413|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264414|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19264415|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264416|NCT04485702|Midazolam|midazolam|mesh-list
19264417|NCT04485702|Ketamine|ketamine|mesh-list
19264418|NCT04485702|Analgesics|analgesics|mesh-ancestor
19264419|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
19264420|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264421|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350111|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
20350112|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
20350113|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350114|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264422|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19264423|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19264424|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
19264425|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
19264426|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264427|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19264428|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19264429|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264430|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264431|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19264432|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19264433|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19666649|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19666650|NCT02850263|Growth Substances|growth substances|mesh-ancestor
19666651|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666652|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
19666653|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19666654|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666655|NCT02427451|Venetoclax|venetoclax|mesh-list
19666656|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
20176538|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
20176539|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176540|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176541|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176542|NCT00171535|Amlodipine|amlodipine|mesh-list
20176543|NCT00171535|Valsartan|valsartan|mesh-list
20176544|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19666657|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666658|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666659|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19666660|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666661|NCT02398240|Rituximab|rituximab|mesh-list
19666662|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19666663|NCT02398240|Doxorubicin|doxorubicin|mesh-list
19666664|NCT02398240|Vincristine|vincristine|mesh-list
19666665|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666666|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176545|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20176546|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176547|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217113|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19666667|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
19666668|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666669|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666670|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19666671|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19666672|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19666673|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666674|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666675|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19666676|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
19666677|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
20350115|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20350116|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20350117|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350118|NCT00871507|Incretins|incretins|mesh-ancestor
20350119|NCT00871507|Hormones|hormones|mesh-ancestor
20350120|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350121|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20350122|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
20350123|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350124|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350125|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
20350126|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
20350127|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19666678|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
19666679|NCT02330562|Bevacizumab|bevacizumab|mesh-list
19666680|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666681|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666682|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19666683|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19264434|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19264435|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19264436|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
19264437|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
19264438|NCT04485585|Tamsulosin|tamsulosin|mesh-list
19264439|NCT04485585|Mirabegron|mirabegron|mesh-list
19264440|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19264441|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19264442|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19264443|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
19264444|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264445|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264446|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264447|NCT04485585|Urological Agents|urological agents|mesh-ancestor
19264448|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19264449|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20350128|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20350129|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
19264450|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19264451|NCT04485689|Capsaicin|capsaicin|mesh-list
19264452|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
19264453|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264454|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
19264455|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264456|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264457|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
19666684|NCT02330562|Growth Substances|growth substances|mesh-ancestor
19666685|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176548|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176549|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176550|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176551|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176552|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176553|NCT00171561|Valsartan|valsartan|mesh-list
20176554|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20176555|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176556|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176557|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176558|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176559|NCT00171561|Diuretics|diuretics|mesh-ancestor
20176560|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
20350130|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264458|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19264459|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264460|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
19264461|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
19264462|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19264463|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19264464|NCT04485429|Prednisolone|prednisolone|mesh-list
19264465|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
19264466|NCT04485429|Heparin|heparin|mesh-list
19264467|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19264468|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
19264469|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264470|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
19264471|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
20350131|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
20350132|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350133|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350134|NCT00871546|Bortezomib|bortezomib|mesh-list
20350135|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
20350136|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350137|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350138|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20350139|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
20350140|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350141|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
20350142|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20350143|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350144|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20350145|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20350146|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
20350147|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350148|NCT00871910|Dexamethasone|dexamethasone|mesh-list
20350149|NCT00871910|Ondansetron|ondansetron|mesh-list
20350150|NCT00871910|Aprepitant|aprepitant|mesh-list
20350151|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20350152|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
20350153|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
20350154|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264472|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264473|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264474|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264475|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
19264476|NCT04485429|Hormones|hormones|mesh-ancestor
19264477|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264478|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19264479|NCT04485429|Protective Agents|protective agents|mesh-ancestor
19264480|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19264481|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264482|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
19264483|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19264484|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19264485|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264486|NCT04485273|Anesthetics|anesthetics|mesh-list
19264487|NCT04485273|Sevoflurane|sevoflurane|mesh-list
20350155|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350156|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20350157|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
20350158|NCT00871910|Hormones|hormones|mesh-ancestor
19264488|NCT04485273|Bupivacaine|bupivacaine|mesh-list
19264489|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
19264490|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19264491|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264492|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264493|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19264494|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19264495|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
19264496|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
19264497|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264498|NCT04485299|Listerine|listerine|mesh-list
19264499|NCT04485299|Fluorides|fluorides|mesh-list
19264500|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
19264501|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
19264502|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
19264503|NCT04485299|Protective Agents|protective agents|mesh-ancestor
20424803|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19264504|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264505|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20350159|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350160|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20350161|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350162|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
20350163|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
20350164|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20350165|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
20350166|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350167|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350168|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20350169|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20350170|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350171|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350172|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20350173|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20350174|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
20350175|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350176|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20350177|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350178|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350179|NCT00872131|Sertraline|sertraline|mesh-list
20176561|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176562|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20176563|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176564|NCT00171574|Valsartan|valsartan|mesh-list
20176565|NCT00171574|Lisinopril|lisinopril|mesh-list
20176566|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20350180|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
20350181|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350182|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20350183|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19264506|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264507|NCT04485403|Ibuprofen|ibuprofen|mesh-list
19264508|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19264509|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19264510|NCT04485403|Analgesics|analgesics|mesh-ancestor
19264511|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
19264512|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264513|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264514|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264515|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264516|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19264517|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264518|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264519|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
19264520|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19264521|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264522|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
19264523|NCT04485195|Procainamide|procainamide|mesh-list
19264524|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19264525|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19264526|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20350184|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350185|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350186|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350187|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
20350188|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350189|NCT00872144|Nabiximols|nabiximols|mesh-list
20350190|NCT00872144|Analgesics|analgesics|mesh-ancestor
20350191|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
20350192|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350193|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350194|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
20350195|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20350196|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350197|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20176567|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176568|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176569|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176570|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20176571|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
19666686|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
19264527|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19264528|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264529|NCT04485117|Anesthetics|anesthetics|mesh-list
19264530|NCT04485117|Propofol|propofol|mesh-list
19264531|NCT04485117|Sevoflurane|sevoflurane|mesh-list
19264532|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264533|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264534|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19264535|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19264536|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
19264537|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19264538|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19264539|NCT04485156|Rifampin|rifampin|mesh-list
19264540|NCT04485156|Isoniazid|isoniazid|mesh-list
19666687|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
19666688|NCT05106517|Denosumab|denosumab|mesh-list
19666689|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19666690|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666691|NCT05106400|Lidocaine|lidocaine|mesh-list
19666692|NCT05106400|Menthol|menthol|mesh-list
19666693|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
20176572|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176573|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20176574|NCT00171574|Protective Agents|protective agents|mesh-ancestor
20176575|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176576|NCT00171587|Vatalanib|vatalanib|mesh-list
20176577|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20176578|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176579|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176580|NCT00171600|Valsartan|valsartan|mesh-list
20176581|NCT00171600|Lisinopril|lisinopril|mesh-list
20176582|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176583|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176584|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20350198|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20350199|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350200|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350201|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350202|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20350203|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20350204|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19264541|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
19264542|NCT04485156|Ethambutol|ethambutol|mesh-list
19264543|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19264544|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
19264545|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19264546|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264547|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
19264548|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19264549|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264550|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264551|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19264552|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19264553|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20350205|NCT00872235|Quinapril|quinapril|mesh-list
20350206|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19264554|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19264555|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19264556|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19264557|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19264558|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19264559|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
19264560|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19264561|NCT04485065|Azacitidine|azacitidine|mesh-list
19264562|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19264563|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
19264564|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264565|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264566|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264567|NCT04485052|Azacitidine|azacitidine|mesh-list
19264568|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19666694|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
20176585|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217114|NCT00308529|Growth Substances|growth substances|mesh-ancestor
20350207|NCT00872235|Diuretics|diuretics|mesh-ancestor
20350208|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
20350209|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350210|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20350211|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350212|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350213|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20350214|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
20350215|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350216|NCT00872248|Anesthetics|anesthetics|mesh-list
20350217|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350218|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350219|NCT00872274|Sumatriptan|sumatriptan|mesh-list
19264569|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
19264570|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264571|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264572|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264573|NCT04484688|Bisoprolol|bisoprolol|mesh-list
19264574|NCT04484688|Perindopril|perindopril|mesh-list
19264575|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19264576|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
19264577|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
19264578|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264579|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264580|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19264581|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19264582|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19264583|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19264584|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264585|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264586|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19264587|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
19264588|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264589|NCT04484779|Insulin|insulin|mesh-list
19264590|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
19264591|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
19264592|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19264593|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264594|NCT04484844|Listerine|listerine|mesh-list
19264595|NCT04484844|Fluorides|fluorides|mesh-list
19264596|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
19264597|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
19264598|NCT04484844|Protective Agents|protective agents|mesh-ancestor
19264599|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264600|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19264601|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264602|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
19264603|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264604|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264605|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19264606|NCT04484506|Prednisone|prednisone|mesh-list
19264607|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
19264608|NCT04484506|Etoposide|etoposide|mesh-list
19264609|NCT04484506|Vincristine|vincristine|mesh-list
19264610|NCT04484506|Pegaspargase|pegaspargase|mesh-list
19264611|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264612|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
19264613|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264614|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264615|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19264616|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
19264617|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264618|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264619|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19264620|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264621|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
19264622|NCT04484506|Hormones|hormones|mesh-ancestor
19264623|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264624|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19264625|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19264626|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19264627|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19264628|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264629|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
19264630|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
19264631|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
19264632|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
19264633|NCT04484610|Narcotics|narcotics|mesh-ancestor
19264634|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264635|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264636|NCT04484610|Analgesics|analgesics|mesh-ancestor
19264637|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
19264638|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264639|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19264640|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19264641|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19264642|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264643|NCT04484467|Menthol|menthol|mesh-list
19264644|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
19264645|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264646|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
19264647|NCT04484272|Narcotics|narcotics|mesh-ancestor
19264648|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264649|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264650|NCT04484272|Analgesics|analgesics|mesh-ancestor
19264651|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
19264652|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264653|NCT04484259|Aspirin|aspirin|mesh-list
19264654|NCT04484259|Clopidogrel|clopidogrel|mesh-list
19264655|NCT04484259|Ticagrelor|ticagrelor|mesh-list
19264656|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19264657|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19264658|NCT04484259|Analgesics|analgesics|mesh-ancestor
19264659|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
19264660|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264661|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264662|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264663|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264664|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19264665|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19264666|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264667|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19264668|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19264669|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264670|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
19264671|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19264672|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19264673|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19264674|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
19264675|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350220|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20350221|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20350222|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20350223|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
20350224|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350225|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350226|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350227|NCT00872365|Micronutrients|micronutrients|mesh-list
20350228|NCT00872365|Trace Elements|trace elements|mesh-list
20350229|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350230|NCT00872378|Exenatide|exenatide|mesh-list
20350231|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20350232|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350233|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20350234|NCT00872378|Incretins|incretins|mesh-ancestor
20350235|NCT00872378|Hormones|hormones|mesh-ancestor
19264676|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19264677|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
19264678|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19264679|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
19264680|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264681|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19264682|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19264683|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19264684|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19264685|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264686|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
19264687|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350236|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264688|NCT04483765|Anesthetics|anesthetics|mesh-list
19835728|NCT00605072|Nifedipine|nifedipine|mesh-list
20350237|NCT00872417|Lamivudine|lamivudine|mesh-list
20350238|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20350239|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20350240|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350241|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350242|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
20350243|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350244|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20350245|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20350246|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
20350247|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20350248|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20350249|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350250|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
20350251|NCT00872469|Coagulants|coagulants|mesh-ancestor
20350252|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
20350253|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350254|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264689|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264690|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264691|NCT04483596|Melatonin|melatonin|mesh-list
19264692|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
19264693|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264694|NCT04483596|Protective Agents|protective agents|mesh-ancestor
19264695|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264696|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264697|NCT04483427|Ketorolac|ketorolac|mesh-list
19264698|NCT04483427|Nalbuphine|nalbuphine|mesh-list
19264699|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19264700|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19264701|NCT04483427|Analgesics|analgesics|mesh-ancestor
19264702|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
19264703|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264704|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264705|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264706|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264707|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19264708|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264709|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264710|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19264711|NCT04483427|Narcotics|narcotics|mesh-ancestor
19264712|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264713|NCT04483635|Vitamin D|vitamin d|mesh-list
19264714|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
19264715|NCT04483635|Vitamins|vitamins|mesh-ancestor
19264716|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
19264717|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264718|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19264719|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19264720|NCT04483466|Methotrexate|methotrexate|mesh-list
19264721|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19264722|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
19264723|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19264724|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264725|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19264726|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
19264727|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264728|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350255|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20176586|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19264729|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264730|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264731|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19264732|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264733|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
20176587|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
20176588|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176589|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20176590|NCT00171600|Protective Agents|protective agents|mesh-ancestor
20176591|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176592|NCT00171613|Octreotide|octreotide|mesh-list
20176593|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176594|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20176595|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264734|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264735|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19264736|NCT04483739|Dexamethasone|dexamethasone|mesh-list
19264737|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
19264738|NCT04483739|Lenalidomide|lenalidomide|mesh-list
19264739|NCT04483739|BB 1101|bb 1101|mesh-list
19264740|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264741|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
19264742|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
19264743|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264744|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264745|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264746|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
19264747|NCT04483739|Hormones|hormones|mesh-ancestor
19264748|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264749|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19264750|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264751|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
19264752|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264753|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264754|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
19264755|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19264756|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19264757|NCT04483739|Growth Substances|growth substances|mesh-ancestor
19264758|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
19264759|NCT04483674|Tenofovir|tenofovir|mesh-list
19264760|NCT04483674|Emtricitabine|emtricitabine|mesh-list
19264761|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
19264762|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264763|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19264764|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19264765|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176596|NCT00171626|Diclofenac|diclofenac|mesh-list
20176597|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176598|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176599|NCT00171626|Analgesics|analgesics|mesh-ancestor
20176600|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
20176601|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176602|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176603|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176604|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20350256|NCT00872586|Olmesartan|olmesartan|mesh-list
20350257|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20350258|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20350259|NCT00872586|Diuretics|diuretics|mesh-ancestor
20350260|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
20350261|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350262|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20350263|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350264|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350265|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20350266|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20350267|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
20350268|NCT00872625|Docetaxel|docetaxel|mesh-list
20350269|NCT00872625|Fluorouracil|fluorouracil|mesh-list
20350270|NCT00872625|Epirubicin|epirubicin|mesh-list
20350271|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350272|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
19264766|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264767|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19264768|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19666695|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350273|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350274|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20350275|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19264769|NCT04483492|Caffeine|caffeine|mesh-list
19264770|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
20350276|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
20350277|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350278|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350279|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20350280|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
19264771|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666696|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350281|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
19264772|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19264773|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264774|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19264775|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264776|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19264777|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19264778|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
19264779|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264780|NCT04483258|Sevoflurane|sevoflurane|mesh-list
19264781|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19264782|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19264783|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
19835729|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19835730|NCT00605072|Diuretics|diuretics|mesh-ancestor
19835731|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
19835732|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835733|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19835734|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835735|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835736|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19835737|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
20350282|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
19264784|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
19264785|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264786|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264787|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
19264788|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19264789|NCT04483284|Estrogens|estrogens|mesh-ancestor
19264790|NCT04483284|Hormones|hormones|mesh-ancestor
19264791|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264792|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264793|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19264794|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350283|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
20350284|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350285|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20350286|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20350287|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19264795|NCT04483219|Antibodies|antibodies|mesh-list
19264796|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
19264797|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264798|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
20350288|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264799|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19264800|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19264801|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264802|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
19264803|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264804|NCT04482907|Hormones|hormones|mesh-list
19264805|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264806|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264807|NCT04482842|Warfarin|warfarin|mesh-list
19264808|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
19264809|NCT04482881|Isosorbide|isosorbide|mesh-list
19264810|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19264811|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19264812|NCT04482881|Misoprostol|misoprostol|mesh-list
19264813|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19264814|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
19264815|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19264816|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264817|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19264818|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264819|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
19264820|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19264821|NCT04482881|Diuretics|diuretics|mesh-ancestor
19264822|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
19264823|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
19264824|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19264825|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264826|NCT04482985|Meclizine|meclizine|mesh-list
19264827|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
19264828|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
19264829|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350289|NCT00872651|Timolol|timolol|mesh-list
20350290|NCT00872651|Travoprost|travoprost|mesh-list
19264830|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350291|NCT00872651|Latanoprost|latanoprost|mesh-list
19264831|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264832|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19264833|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
19264834|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
19264835|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264836|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264837|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19264838|NCT04482504|Vitamin D|vitamin d|mesh-list
19264839|NCT04482504|Vitamins|vitamins|mesh-ancestor
19264840|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
19264841|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264842|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19264843|NCT04482712|Sirolimus|sirolimus|mesh-list
19264844|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19264845|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264846|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19264847|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264848|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
19264849|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264850|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
19264851|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264852|NCT04482764|Valproic Acid|valproic acid|mesh-list
19264853|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
19264854|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264855|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264856|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
19264857|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264858|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264859|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
19264860|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19264861|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19264862|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19264863|NCT04482543|Methotrexate|methotrexate|mesh-list
19264864|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19264865|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
19264866|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19264867|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264868|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19264869|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
19264870|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264871|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264872|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264873|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264874|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19264875|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264876|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
19264877|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264878|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19264879|NCT04482413|Donepezil|donepezil|mesh-list
19264880|NCT04482413|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19264881|NCT04482413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264882|NCT04482413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264883|NCT04482413|Cholinergic Agents|cholinergic agents|mesh-ancestor
19264884|NCT04482413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19264885|NCT04482413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264886|NCT04482413|Nootropic Agents|nootropic agents|mesh-ancestor
19393141|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393142|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393143|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19393144|NCT03688958|Iodine|iodine|mesh-list
19393145|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
19393146|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19393147|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393148|NCT03688958|Trace Elements|trace elements|mesh-ancestor
19393149|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
19393150|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393151|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
19393152|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393153|NCT03688659|Vancomycin|vancomycin|mesh-list
19393154|NCT03688659|Gentamicins|gentamicins|mesh-list
19393155|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393156|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393157|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20176605|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20176606|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176607|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264887|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
19264888|NCT04482296|Astringents|astringents|mesh-ancestor
19264889|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264890|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264891|NCT04482257|Irinotecan|irinotecan|mesh-list
19264892|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19264893|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19264894|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264895|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264896|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264897|NCT04481802|Acemannan|acemannan|mesh-list
19264898|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19264899|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
19264900|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264901|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264902|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
19264903|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264904|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19264905|NCT04481815|Rituximab|rituximab|mesh-list
19264906|NCT04481815|Methotrexate|methotrexate|mesh-list
19264907|NCT04481815|Lenalidomide|lenalidomide|mesh-list
19264908|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19264909|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264910|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
19264911|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264912|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264913|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19264914|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
19264915|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19264916|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19264917|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
19264918|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264919|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264920|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264921|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19264922|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19264923|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19264924|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19264925|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19264926|NCT04481815|Growth Substances|growth substances|mesh-ancestor
19264927|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
19264928|NCT04481841|Vitamins|vitamins|mesh-list
19264929|NCT04481841|Vitamin E|vitamin e|mesh-list
19264930|NCT04481841|Riboflavin|riboflavin|mesh-list
19264931|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
19264932|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264933|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
19264934|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
19264935|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264936|NCT04481841|Protective Agents|protective agents|mesh-ancestor
19264937|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19264938|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264939|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
19264940|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19264941|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19264942|NCT04481724|Analgesics|analgesics|mesh-ancestor
19264943|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
19264944|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264945|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264946|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264947|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19264948|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19264949|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
19264950|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264951|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19666697|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
20176608|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
20176609|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19666698|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835738|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
20424804|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
19264952|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
19264953|NCT04481971|Prednisolone|prednisolone|mesh-list
19264954|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19264955|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
19264956|NCT04481971|Hormones|hormones|mesh-ancestor
19264957|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19264958|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264959|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19264960|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19264961|NCT04481555|Azithromycin|azithromycin|mesh-list
19264962|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19264963|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19264964|NCT04481750|Edaravone|edaravone|mesh-list
19264965|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19264966|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
19264967|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264968|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20350292|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20350293|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20350294|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
20350295|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350296|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350297|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350298|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20350299|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20350300|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20350301|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20350302|NCT00872664|Carotenoids|carotenoids|mesh-list
20350303|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
20350304|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350305|NCT00872664|Protective Agents|protective agents|mesh-ancestor
20350306|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350307|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20350308|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
20350309|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350310|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19264969|NCT04481750|Protective Agents|protective agents|mesh-ancestor
19264970|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264971|NCT04481789|Furosemide|furosemide|mesh-list
19264972|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
19264973|NCT04481789|Edaravone|edaravone|mesh-list
19264974|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19264975|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19264976|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19264977|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
19264978|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19264979|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19264980|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19264981|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19264982|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
19264983|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19264984|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19264985|NCT04481789|Urological Agents|urological agents|mesh-ancestor
19264986|NCT04481789|Diuretics|diuretics|mesh-ancestor
19264987|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
19264988|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19264989|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19264990|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19264991|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19264992|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
19264993|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19264994|NCT04481789|Protective Agents|protective agents|mesh-ancestor
20176610|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350311|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20612424|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20176611|NCT00171652|Diclofenac|diclofenac|mesh-list
20176612|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176613|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176614|NCT00171652|Analgesics|analgesics|mesh-ancestor
20176615|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
20176616|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19264995|NCT04481932|Trastuzumab|trastuzumab|mesh-list
20176617|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176618|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176619|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176620|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20350312|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350313|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350314|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20350315|NCT00872781|Quinapril|quinapril|mesh-list
20350316|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20350317|NCT00872781|Diuretics|diuretics|mesh-ancestor
20350318|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
20350319|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350320|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20350321|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350322|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350323|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20350324|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
20350325|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424805|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20424806|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
20424807|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
20424808|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424809|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424810|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
20424811|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424812|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
20424813|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424814|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20424815|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
19264996|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19264997|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835739|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835740|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19835741|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19265001|NCT04481282|Terbutaline|terbutaline|mesh-list
19265002|NCT04481282|Danazol|danazol|mesh-list
19265003|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19265004|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
19265005|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265006|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265007|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19265008|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
19265009|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
19265010|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
19265011|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19265012|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19265013|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19265014|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20176621|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265015|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
19265016|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265017|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265018|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19265019|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
19265020|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265021|NCT04481204|Leucovorin|leucovorin|mesh-list
19265022|NCT04481204|Gemcitabine|gemcitabine|mesh-list
20176622|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176623|NCT00171665|Diclofenac|diclofenac|mesh-list
20176624|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176625|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176626|NCT00171665|Analgesics|analgesics|mesh-ancestor
20176627|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
20176628|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176629|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176630|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176631|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176632|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20176633|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176634|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176635|NCT00171678|Diclofenac|diclofenac|mesh-list
20176636|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176637|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176638|NCT00171678|Analgesics|analgesics|mesh-ancestor
20176639|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
20424816|NCT01271179|Protective Agents|protective agents|mesh-ancestor
20424817|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19265023|NCT04481204|Paclitaxel|paclitaxel|mesh-list
19265024|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20350326|NCT00872924|Sumatriptan|sumatriptan|mesh-list
20350327|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20350328|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20350329|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20350330|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
20350331|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350332|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350333|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350334|NCT00872963|Vaccines|vaccines|mesh-list
20350335|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
20350336|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350337|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19265025|NCT04481204|Cisplatin|cisplatin|mesh-list
19265026|NCT04481204|Fluorouracil|fluorouracil|mesh-list
19265027|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
20350338|NCT00872976|Dasatinib|dasatinib|mesh-list
20350339|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20350340|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
19265028|NCT04481204|Irinotecan|irinotecan|mesh-list
19265029|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19265030|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265031|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
19265032|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
19265033|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
19265034|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265035|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19265036|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
19265037|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
19265038|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265039|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350341|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350342|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350343|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350344|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350345|NCT00873002|Sorafenib|sorafenib|mesh-list
20350346|NCT00873002|Panobinostat|panobinostat|mesh-list
20350347|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350348|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350349|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350350|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350351|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20350352|NCT00873197|Granisetron|granisetron|mesh-list
20350353|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
20350354|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
20350355|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350356|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350357|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20350358|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20350359|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
20350360|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350361|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350362|NCT00873210|Sunitinib|sunitinib|mesh-list
20350363|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265040|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265041|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
19265042|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265043|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19265044|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19265045|NCT04481204|Antidotes|antidotes|mesh-ancestor
19265046|NCT04481204|Protective Agents|protective agents|mesh-ancestor
19265047|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
19265048|NCT04481204|Vitamins|vitamins|mesh-ancestor
19265049|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
19265050|NCT04481451|Ropivacaine|ropivacaine|mesh-list
19265051|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265052|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
19265053|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350364|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20350365|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350366|NCT00873210|Growth Substances|growth substances|mesh-ancestor
20350367|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265054|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265055|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
19265056|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265057|NCT04481256|Paclitaxel|paclitaxel|mesh-list
20350368|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350369|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350370|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350371|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350372|NCT00873223|Liraglutide|liraglutide|mesh-list
20350373|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
19265058|NCT04481256|Carboplatin|carboplatin|mesh-list
19265059|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19265060|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265061|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19265062|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19265063|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19265064|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265065|NCT04481100|Itraconazole|itraconazole|mesh-list
19265066|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
19265067|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265068|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19265069|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19265070|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265071|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265072|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19265073|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
19265074|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265075|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265076|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19265077|NCT04480827|Cholic Acids|cholic acids|mesh-list
19265078|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19265079|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
19265080|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19265081|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19265082|NCT04480775|Prednisolone|prednisolone|mesh-list
19265083|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
19265084|NCT04480775|Triamcinolone|triamcinolone|mesh-list
19265085|NCT04480775|Bupivacaine|bupivacaine|mesh-list
19265086|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19265087|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
19265088|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265089|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
19265090|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265091|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265092|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
19265093|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265094|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265095|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
19265096|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
19265097|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19265098|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
19265099|NCT04480775|Hormones|hormones|mesh-ancestor
19265100|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265101|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19265102|NCT04480775|Protective Agents|protective agents|mesh-ancestor
19265103|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19265104|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265105|NCT04480593|Propolis|propolis|mesh-list
19666699|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19666700|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19666701|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19265106|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265107|NCT04480450|Rituximab|rituximab|mesh-list
19265108|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19265109|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265110|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
19265111|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265112|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265113|NCT04480086|Navitoclax|navitoclax|mesh-list
19265114|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265115|NCT04480281|Lidocaine|lidocaine|mesh-list
19265116|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265117|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
19265118|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265119|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265120|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
19666702|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265121|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265122|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19265123|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19265124|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19265125|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265126|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265127|NCT04480268|Gemcitabine|gemcitabine|mesh-list
19265128|NCT04480268|Paclitaxel|paclitaxel|mesh-list
20350374|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20350375|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350376|NCT00873223|Incretins|incretins|mesh-ancestor
20350377|NCT00873223|Hormones|hormones|mesh-ancestor
20350378|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350379|NCT00873236|Interferons|interferons|mesh-list
20350380|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
20350381|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
20350382|NCT00873236|Bevacizumab|bevacizumab|mesh-list
20350383|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350384|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265129|NCT04480268|Capecitabine|capecitabine|mesh-list
19265130|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19265131|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265132|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
19265133|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
19265134|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
19265135|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265136|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19265137|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
19265138|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
19666703|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666704|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
19666705|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
19666706|NCT05106179|Propranolol|propranolol|mesh-list
19666707|NCT05106179|Atenolol|atenolol|mesh-list
19666708|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19666709|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20350385|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20350386|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19265139|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265140|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265141|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265142|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
19265143|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265144|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
19265145|NCT04480333|Remdesivir|remdesivir|mesh-list
19265146|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
19265147|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265148|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
19265149|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265150|NCT04480333|Protective Agents|protective agents|mesh-ancestor
19265151|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265152|NCT04480138|Interferons|interferons|mesh-list
19265153|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265154|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
19265155|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265156|NCT04480359|Meloxicam|meloxicam|mesh-list
19265157|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20350387|NCT00873236|Growth Substances|growth substances|mesh-ancestor
20350388|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350389|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350390|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
20350391|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350392|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
20350393|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20350394|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20350395|NCT00873262|Estropipate|estropipate|mesh-list
19265158|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19265159|NCT04480359|Analgesics|analgesics|mesh-ancestor
19265160|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
19265161|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265162|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666710|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
19666711|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666712|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350396|NCT00873262|Estradiol|estradiol|mesh-list
20350397|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20350398|NCT00873262|Estrone|estrone|mesh-list
19265163|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265164|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265165|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19265166|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19265167|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265168|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393158|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393159|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393160|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
19393161|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393162|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19393163|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393164|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393165|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
19393166|NCT03688464|Promethazine|promethazine|mesh-list
19393167|NCT03688464|Melatonin|melatonin|mesh-list
19393168|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
19393169|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393170|NCT03688464|Protective Agents|protective agents|mesh-ancestor
19393171|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393172|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393173|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19393174|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19393175|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
19393176|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
19393177|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
19393178|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393179|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
19393180|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
19393181|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393182|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19393183|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
19393184|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
19393185|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393186|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19393187|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
19393188|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
19393189|NCT03688451|Rituximab|rituximab|mesh-list
19393190|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19393191|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393192|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
19393193|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393194|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393195|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19393196|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19393197|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393198|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
19393199|NCT03688269|Dexamethasone|dexamethasone|mesh-list
19393200|NCT03688269|Ropivacaine|ropivacaine|mesh-list
19393201|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393202|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
19393203|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
19393204|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393205|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393206|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393207|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
19393208|NCT03688269|Hormones|hormones|mesh-ancestor
19393209|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176640|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393210|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393211|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393212|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
19393213|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
19393214|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393215|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
19393216|NCT03688230|Cetuximab|cetuximab|mesh-list
19393217|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19393218|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393219|NCT03688191|Sirolimus|sirolimus|mesh-list
19393220|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393221|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176641|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393222|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19393223|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393224|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
19265169|NCT04479748|Dexamethasone|dexamethasone|mesh-list
19265170|NCT04479748|Prednisolone|prednisolone|mesh-list
19265171|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19265172|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
19265173|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19265174|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
19265175|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19265176|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
19265177|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265178|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
19265179|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
19265180|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265181|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265182|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19265183|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
19265184|NCT04479748|Hormones|hormones|mesh-ancestor
19265185|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265186|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666713|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666714|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19666715|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19666716|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
19666717|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
20350399|NCT00873262|Progesterone|progesterone|mesh-list
19265187|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265188|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19265189|NCT04479748|Protective Agents|protective agents|mesh-ancestor
19265190|NCT04479657|Cefuroxime|cefuroxime|mesh-list
19265191|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
19265192|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265193|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265194|NCT04479865|Donepezil|donepezil|mesh-list
19265195|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19265196|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265197|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265198|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
19265199|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265200|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265201|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
19265202|NCT04479891|Itraconazole|itraconazole|mesh-list
19265203|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
19265204|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265205|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19265206|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19265207|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265208|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265209|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19265210|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
19265211|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265212|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265213|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19265214|NCT04479813|Moxonidine|moxonidine|mesh-list
19265215|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19265216|NCT04479527|Apatinib|apatinib|mesh-list
19265217|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265218|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19265219|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265220|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265221|NCT04479202|Bentonite|bentonite|mesh-list
19265222|NCT04479202|Antidotes|antidotes|mesh-ancestor
19265223|NCT04479202|Protective Agents|protective agents|mesh-ancestor
19265224|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265225|NCT04479371|Bupivacaine|bupivacaine|mesh-list
19265226|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265227|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
19265228|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265229|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265230|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
19265231|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265232|NCT04479449|Otaplimastat|otaplimastat|mesh-list
19265233|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19265234|NCT04479449|Protective Agents|protective agents|mesh-ancestor
19265235|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666718|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
20350400|NCT00873262|Estrogens|estrogens|mesh-ancestor
20350401|NCT00873262|Hormones|hormones|mesh-ancestor
19265236|NCT04478617|Metronidazole|metronidazole|mesh-list
19265237|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265238|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265239|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19265240|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19265241|NCT04478448|Favipiravir|favipiravir|mesh-list
19265242|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
20176642|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176643|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176644|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19265243|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265244|NCT04478461|Antibodies|antibodies|mesh-list
19265245|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19265246|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
19265247|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265248|NCT04478526|Norepinephrine|norepinephrine|mesh-list
19265249|NCT04478526|Serotonin|serotonin|mesh-list
19265250|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19265251|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
19265252|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19265253|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19265254|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19265255|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265256|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265257|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265258|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
19265259|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
19265260|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265261|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19265262|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19265263|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
19265264|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19265265|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265266|NCT04478357|Fesoterodine|fesoterodine|mesh-list
20424818|NCT01271231|Azithromycin|azithromycin|mesh-list
19265267|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19265268|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19265269|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
19265270|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265271|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265272|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265273|NCT04478357|Urological Agents|urological agents|mesh-ancestor
19265274|NCT04478474|Ganciclovir|ganciclovir|mesh-list
19265275|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19265276|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
20176645|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176646|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176647|NCT00171691|Diclofenac|diclofenac|mesh-list
20176648|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176649|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176650|NCT00171691|Analgesics|analgesics|mesh-ancestor
20176651|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
20176652|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176653|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176654|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176655|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176656|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20176657|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176658|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176659|NCT00171717|Cyclosporine|cyclosporine|mesh-list
20176660|NCT00171717|Cyclosporins|cyclosporins|mesh-list
20176661|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176662|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176663|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176664|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
20176665|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176666|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
20176667|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176668|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
20176669|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176670|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20176671|NCT00171743|Cyclosporine|cyclosporine|mesh-list
20176672|NCT00171743|Cyclosporins|cyclosporins|mesh-list
19265277|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176673|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265278|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19265279|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265280|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265281|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
19265282|NCT04478292|Cisplatin|cisplatin|mesh-list
19265283|NCT04478292|Carboplatin|carboplatin|mesh-list
19265284|NCT04478292|Doxorubicin|doxorubicin|mesh-list
19265285|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19265286|NCT04478292|Fluorouracil|fluorouracil|mesh-list
19265287|NCT04478292|Irinotecan|irinotecan|mesh-list
19265288|NCT04478292|Vincristine|vincristine|mesh-list
19265289|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265290|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19265291|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19265292|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19265293|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265294|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265295|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
19265296|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19265297|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265298|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
19265299|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265300|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19265301|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19265302|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
19265303|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
20350402|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350403|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350404|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20350405|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
20350406|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19265304|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
20176674|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176675|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176676|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
20176677|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176678|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
19265305|NCT04478292|Antidotes|antidotes|mesh-ancestor
19265306|NCT04478292|Protective Agents|protective agents|mesh-ancestor
19265307|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
19265308|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
19265309|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265310|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265311|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
19265312|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
19265313|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
19265314|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19265315|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19265316|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265317|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265318|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19265319|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19265320|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19265321|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265322|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265323|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265324|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
19265325|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19265326|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
19265327|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19265328|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19265329|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265330|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19265331|NCT04478500|Minocycline|minocycline|mesh-list
19265332|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265333|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265334|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
20176679|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176680|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
20176681|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176682|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19265335|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20176683|NCT00171756|Atenolol|atenolol|mesh-list
19265336|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265337|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265338|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
19265339|NCT04477629|Abatacept|abatacept|mesh-list
20350407|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20350408|NCT00873262|Progestins|progestins|mesh-ancestor
20350409|NCT00873275|Leucovorin|leucovorin|mesh-list
20350410|NCT00873275|Bevacizumab|bevacizumab|mesh-list
20350411|NCT00873275|Fluorouracil|fluorouracil|mesh-list
20350412|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
20350413|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20350414|NCT00873275|Calcium|calcium|mesh-list
20350415|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
20350416|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19265340|NCT04477629|Tacrolimus|tacrolimus|mesh-list
19265341|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265342|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
19265343|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265344|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20350417|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350418|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20350419|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350420|NCT00873275|Growth Substances|growth substances|mesh-ancestor
20350421|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350422|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350423|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20350424|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
19265345|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265346|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265347|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19265348|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265349|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19265350|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
19265351|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265352|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265353|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19265354|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265355|NCT04477642|Abatacept|abatacept|mesh-list
19265356|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19265357|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265358|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265359|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265360|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
19265361|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265362|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265363|NCT04477811|Vitamins|vitamins|mesh-list
19265364|NCT04477811|Vitamin K|vitamin k|mesh-list
19265365|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
19265366|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
19265367|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
19265368|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265369|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19265370|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19265371|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265372|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
19265373|NCT04477811|Coagulants|coagulants|mesh-ancestor
19265374|NCT04477590|Metformin|metformin|mesh-list
19265375|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19265376|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393225|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19393226|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
19393227|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176684|NCT00171756|Valsartan|valsartan|mesh-list
20176685|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176686|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176687|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176688|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176689|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20176690|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
20176691|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
20176692|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176693|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176694|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20176695|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20176696|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20176697|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
20176698|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265377|NCT04477525|Bupivacaine|bupivacaine|mesh-list
19265378|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265379|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
20350425|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350426|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350427|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350428|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
20350429|NCT00873275|Antidotes|antidotes|mesh-ancestor
20350430|NCT00873275|Protective Agents|protective agents|mesh-ancestor
20350431|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
20350432|NCT00873275|Vitamins|vitamins|mesh-ancestor
20350433|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
20350434|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20350435|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20350436|NCT00873340|Interferons|interferons|mesh-list
20350437|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
20350438|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350439|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
20350440|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350441|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20350442|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
20350443|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350444|NCT00873353|Capecitabine|capecitabine|mesh-list
20350445|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20350446|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350447|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
20350448|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350449|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350450|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350451|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350452|NCT00873366|Tamoxifen|tamoxifen|mesh-list
20350453|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
19265380|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265381|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265382|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
19265383|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265384|NCT04477317|Epinephrine|epinephrine|mesh-list
19265385|NCT04477317|Racepinephrine|racepinephrine|mesh-list
19265386|NCT04477317|Nordefrin|nordefrin|mesh-list
19265387|NCT04477317|Mepivacaine|mepivacaine|mesh-list
19265388|NCT04477317|Carticaine|carticaine|mesh-list
19265389|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
19265390|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19265391|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19265392|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
19265393|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265394|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265395|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176699|NCT00171769|Certoparin|certoparin|mesh-list
20176700|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
20176701|NCT00171782|Valsartan|valsartan|mesh-list
20176702|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20176703|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176704|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20176705|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20176706|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176707|NCT00171782|Diuretics|diuretics|mesh-ancestor
20176708|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
20176709|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176710|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20176711|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176712|NCT00171795|Rivastigmine|rivastigmine|mesh-list
20176713|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20176714|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176715|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176716|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
20176717|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176718|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176719|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20176720|NCT00171795|Protective Agents|protective agents|mesh-ancestor
20176721|NCT00171808|Letrozole|letrozole|mesh-list
20176722|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176723|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19265396|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20176724|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20350454|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350455|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20350456|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
20350457|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350458|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350459|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20350460|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350461|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20350462|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20350463|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20350464|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
20350465|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
20350466|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20350467|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19265397|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19265398|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
19265399|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265400|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19265401|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
19265402|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
20350468|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350469|NCT00873379|Melatonin|melatonin|mesh-list
20350470|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
20350471|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350472|NCT00873379|Protective Agents|protective agents|mesh-ancestor
20350473|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350474|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350475|NCT00873392|Nicotine|nicotine|mesh-list
20350476|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20350477|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
20350478|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350479|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350480|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20350481|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20350482|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
20350483|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350484|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350485|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20350486|NCT00873483|Gestodene|gestodene|mesh-list
20350487|NCT00873483|Femovan|femovan|mesh-list
20350488|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19265403|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
19265404|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19265405|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265406|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
19265407|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350489|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20350490|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20350491|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
20350492|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20350493|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350494|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20350495|NCT00873483|Estrogens|estrogens|mesh-ancestor
20350496|NCT00873483|Hormones|hormones|mesh-ancestor
20350497|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350498|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20350499|NCT00873483|Progestins|progestins|mesh-ancestor
20350500|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20350501|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
20350502|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
20350503|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20350504|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20350505|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350506|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350507|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350508|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20350509|NCT00873509|Buspirone|buspirone|mesh-list
19265408|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
19265409|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
19265410|NCT04477304|Narcotics|narcotics|mesh-ancestor
19265411|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265412|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350510|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19265413|NCT04477304|Analgesics|analgesics|mesh-ancestor
19265414|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
20350511|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20176725|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176726|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176727|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19265415|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265416|NCT04477096|Emtricitabine|emtricitabine|mesh-list
19265417|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
19265418|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265419|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19265420|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19265421|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265422|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265423|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19265424|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19265425|NCT04476979|Dexamethasone|dexamethasone|mesh-list
19265426|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265427|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
19265428|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
19265429|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265430|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265431|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19265432|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
19265433|NCT04476979|Hormones|hormones|mesh-ancestor
19265434|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265435|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19265436|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265437|NCT04476966|Mirabegron|mirabegron|mesh-list
19265438|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19265439|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19265440|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19265441|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
19265442|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265443|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265444|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265445|NCT04476966|Urological Agents|urological agents|mesh-ancestor
19265446|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
19265447|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
19265448|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19265449|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19265450|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265451|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265452|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265453|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265454|NCT04477018|Ascorbic Acid|ascorbic acid|mesh-list
19265455|NCT04477018|Iron|iron|mesh-list
19265456|NCT04477018|Chelating Agents|chelating agents|mesh-list
19265457|NCT04477018|Vitamins|vitamins|mesh-ancestor
19265458|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
19265459|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265460|NCT04477018|Trace Elements|trace elements|mesh-ancestor
19265461|NCT04477018|Antioxidants|antioxidants|mesh-ancestor
19265462|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265463|NCT04477018|Protective Agents|protective agents|mesh-ancestor
19265464|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
19265465|NCT04476628|Budesonide|budesonide|mesh-list
19265466|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265467|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19265468|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
19265469|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265470|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265471|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19265472|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
19265473|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
19265474|NCT04476628|Hormones|hormones|mesh-ancestor
19265475|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265476|NCT04476680|Vitamin D|vitamin d|mesh-list
19265477|NCT04476680|Vitamins|vitamins|mesh-ancestor
19265478|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
19265479|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265480|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19265481|NCT04476459|Apatinib|apatinib|mesh-list
19265482|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265483|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19265484|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265485|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265486|NCT04476121|Aspirin|aspirin|mesh-list
19265487|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19265488|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19265489|NCT04476121|Analgesics|analgesics|mesh-ancestor
19265490|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
19265491|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265492|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265493|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265494|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265495|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19265496|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19265497|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265498|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19265499|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19265500|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265501|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
19265502|NCT04476173|Morphine|morphine|mesh-list
19265503|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
19265504|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19265505|NCT04476173|Narcotics|narcotics|mesh-ancestor
19265506|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265507|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265508|NCT04476173|Analgesics|analgesics|mesh-ancestor
19265509|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
19265510|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265511|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19265512|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
19265513|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
19265514|NCT04476186|Acyclovir|acyclovir|mesh-list
19265515|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
19265516|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265517|NCT04476069|Ibuprofen|ibuprofen|mesh-list
19265518|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19265519|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19265520|NCT04476069|Analgesics|analgesics|mesh-ancestor
19265521|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
19265522|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265523|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265524|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265525|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265526|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19265527|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265528|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265529|NCT04476199|Decitabine|decitabine|mesh-list
19265530|NCT04476199|Venetoclax|venetoclax|mesh-list
19265531|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19265532|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
19265533|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265534|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265535|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265536|NCT04475887|Iron|iron|mesh-list
19265537|NCT04475887|Trace Elements|trace elements|mesh-ancestor
19265538|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
19265539|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265540|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
19265541|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
19265542|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265543|NCT04475276|Protective Agents|protective agents|mesh-ancestor
19265544|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265545|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
19265546|NCT04475276|Vitamins|vitamins|mesh-ancestor
19265547|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
19265548|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
19265549|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19265550|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
19265551|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176728|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
20176729|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176730|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404055|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404056|NCT03597919|Vaccines|vaccines|mesh-list
19404057|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
19404058|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404059|NCT03597893|Oxytocin|oxytocin|mesh-list
19404060|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
19404061|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404062|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404063|NCT03597867|Diclofenac|diclofenac|mesh-list
19265552|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
19265553|NCT04475614|Vitamins|vitamins|mesh-ancestor
19265554|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
19265555|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265556|NCT04475224|Mitogens|mitogens|mesh-list
19265557|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
19265558|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265559|NCT04475016|Paclitaxel|paclitaxel|mesh-list
19265560|NCT04475016|Ifosfamide|ifosfamide|mesh-list
19265561|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20350512|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350513|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350514|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350515|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20350516|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
20350517|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350518|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350519|NCT00873535|Varenicline|varenicline|mesh-list
20350520|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20350521|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20350522|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
20350523|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265562|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
19265563|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19265564|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265565|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
19265566|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
19265567|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
19265568|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265569|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19265570|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
19265571|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19265572|NCT04475107|Artesunate|artesunate|mesh-list
19265573|NCT04475107|Pyronaridine|pyronaridine|mesh-list
19265574|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
19265575|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19265576|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19265577|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265578|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265579|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
19265580|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
19265581|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19265582|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
19265583|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
19265584|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19265585|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265586|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19265587|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265588|NCT04475120|Lactoferrin|lactoferrin|mesh-list
19265589|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265590|NCT04474899|Amlodipine|amlodipine|mesh-list
19265591|NCT04474899|Moxonidine|moxonidine|mesh-list
19265592|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19265593|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19265594|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350524|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350525|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350526|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
20350527|NCT00873626|Levofloxacin|levofloxacin|mesh-list
20350528|NCT00873626|Ofloxacin|ofloxacin|mesh-list
20350529|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
20350530|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20350531|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350532|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20350533|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20350534|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350535|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350536|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350537|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20350538|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20350539|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20350540|NCT00873626|Renal Agents|renal agents|mesh-ancestor
20350541|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19265595|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265596|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19265597|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265598|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
19265599|NCT04475029|Morphine|morphine|mesh-list
19265600|NCT04475029|Methadone|methadone|mesh-list
19265601|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19265602|NCT04475029|Narcotics|narcotics|mesh-ancestor
19265603|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265604|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265605|NCT04475029|Analgesics|analgesics|mesh-ancestor
19265606|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
19265607|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265608|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
19265609|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
19265610|NCT04474600|Propofol|propofol|mesh-list
19265611|NCT04474600|Desflurane|desflurane|mesh-list
19265612|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20176731|NCT00171821|Deferasirox|deferasirox|mesh-list
19835742|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19835743|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19835744|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835745|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19265613|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265614|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265615|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19265616|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
19265617|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
19265618|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19265619|NCT04474457|Favipiravir|favipiravir|mesh-list
19265620|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
19265621|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265622|NCT04474327|Montelukast|montelukast|mesh-list
19265623|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19265624|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
19265625|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19265626|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
19265627|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265628|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265629|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19265630|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19265631|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265632|NCT04474262|Midodrine|midodrine|mesh-list
19265633|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
19265634|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
19265635|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265636|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265637|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19265638|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19265639|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19265640|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19265641|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
19265642|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265643|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265644|NCT04474288|Antibodies|antibodies|mesh-list
19265645|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
19265646|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265647|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
19265648|NCT04474093|Methamphetamine|methamphetamine|mesh-list
19265649|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19265650|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265651|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
19265652|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
19265653|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265654|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
19265655|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265656|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265657|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
19265658|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19265659|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835746|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19835747|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19835748|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19835749|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176732|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20176733|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
19265660|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265661|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19265662|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
19265663|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19265664|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265665|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
19265666|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19265667|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265668|NCT04473989|Teriparatide|teriparatide|mesh-list
19265669|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19265670|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265671|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19265672|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
19265673|NCT04473911|Sirolimus|sirolimus|mesh-list
19265674|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
19265675|NCT04473911|Melphalan|melphalan|mesh-list
19265676|NCT04473911|Fludarabine|fludarabine|mesh-list
19265677|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265678|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
19265679|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265680|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265681|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19265682|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
19265683|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265684|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265685|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19265686|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19265687|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19265688|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
19265689|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265690|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666719|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666720|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19666721|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
19666722|NCT05106127|Lenvatinib|lenvatinib|mesh-list
19666723|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19666724|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666725|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19265691|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265692|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
19265693|NCT04473950|Naloxone|naloxone|mesh-list
19265694|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19265695|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265696|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
19265697|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265698|NCT04473820|Lidocaine|lidocaine|mesh-list
19265699|NCT04473820|Prilocaine|prilocaine|mesh-list
19265700|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19265701|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265702|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
19265703|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265704|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265705|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
19265706|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265707|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19265708|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19265709|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19265710|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265711|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265712|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19265713|NCT04473846|Anesthetics|anesthetics|mesh-list
19265714|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265715|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265716|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
19265717|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19265718|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265719|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19265720|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265721|NCT04473274|Pioglitazone|pioglitazone|mesh-list
19265722|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19265723|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393233|NCT03687931|Dexamethasone|dexamethasone|mesh-list
19393234|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666726|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265724|NCT04473261|Iodine|iodine|mesh-list
19265725|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
19265726|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19265727|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265728|NCT04473261|Trace Elements|trace elements|mesh-ancestor
19265729|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
20350542|NCT00873639|Insulin|insulin|mesh-list
20350543|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20350544|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
20350545|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
20350546|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20350547|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350548|NCT00873652|Vaccines|vaccines|mesh-list
20350549|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
20350550|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350551|NCT00873756|Bevacizumab|bevacizumab|mesh-list
20350552|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350553|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350554|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20350555|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350556|NCT00873756|Growth Substances|growth substances|mesh-ancestor
20350557|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350558|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350559|NCT00873769|Loxapine|loxapine|mesh-list
20350560|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20350561|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20350562|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350563|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350564|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19265730|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265731|NCT04473053|Nafamostat|nafamostat|mesh-list
19265732|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19265733|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19265734|NCT04473053|Analgesics|analgesics|mesh-ancestor
19265735|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
19265736|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265737|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265738|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19265739|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265740|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
20350565|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20350566|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
20350567|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350568|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350569|NCT00873795|Aripiprazole|aripiprazole|mesh-list
20350570|NCT00873795|Sertraline|sertraline|mesh-list
20350571|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
20350572|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350573|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20350574|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20350575|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350576|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265741|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
19265742|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265743|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265744|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19265745|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19265746|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19265747|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265748|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
19265749|NCT04473144|Urinastatin|urinastatin|mesh-list
19265750|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19265751|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19265752|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
19265753|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265754|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265755|NCT04472910|Folfirinox|folfirinox|mesh-list
19265756|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176734|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
20176735|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176736|NCT00171847|Trastuzumab|trastuzumab|mesh-list
20176737|NCT00171847|Letrozole|letrozole|mesh-list
20176738|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20176739|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176740|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20176741|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20176742|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265757|NCT04472949|Carboplatin|carboplatin|mesh-list
19265758|NCT04472949|Etoposide|etoposide|mesh-list
19265759|NCT04472949|Durvalumab|durvalumab|mesh-list
19265760|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265761|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19265762|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19265763|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19265764|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265765|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265766|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19265767|NCT04472585|Ivermectin|ivermectin|mesh-list
19265768|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20350577|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
20350578|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
20350579|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350580|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350581|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19265769|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265770|NCT04472806|Endostar protein|endostar protein|mesh-list
19265771|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19265772|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835750|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
19835751|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19835752|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19835753|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
19835754|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835755|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19835756|NCT00605072|Protective Agents|protective agents|mesh-ancestor
19835757|NCT00605176|Imiquimod|imiquimod|mesh-list
19835758|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19835759|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
19835760|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835761|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835762|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
19835763|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19835764|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20350582|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20350583|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
20350584|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20350585|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20350586|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20350587|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20350588|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20350589|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20350590|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350591|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
20350592|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
20350593|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
20350594|NCT00873808|Tetracycline|tetracycline|mesh-list
20350595|NCT00873808|Demeclocycline|demeclocycline|mesh-list
20350596|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20350597|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350598|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265773|NCT04472806|Growth Substances|growth substances|mesh-ancestor
19265774|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835765|NCT00605202|Diuretics|diuretics|mesh-ancestor
19835766|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
19835767|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350599|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265775|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
19265776|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265777|NCT04472689|Lidocaine|lidocaine|mesh-list
19265778|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
19265779|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
19265780|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265781|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265782|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
19265783|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265784|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19265785|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19265786|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19265787|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265788|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350600|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19265789|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
19265790|NCT04472481|Vitamin D|vitamin d|mesh-list
19265791|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19265792|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666727|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666728|NCT05106023|Temozolomide|temozolomide|mesh-list
19265793|NCT04472481|Vitamins|vitamins|mesh-ancestor
19265794|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
19265795|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19265796|NCT04471922|Rabeprazole|rabeprazole|mesh-list
19265797|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19265798|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19265799|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19265800|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265801|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265802|NCT04472000|Ascorbic Acid|ascorbic acid|mesh-list
20350601|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265803|NCT04472000|Vitamins|vitamins|mesh-ancestor
19265804|NCT04472000|Micronutrients|micronutrients|mesh-ancestor
19265805|NCT04472000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265806|NCT04472000|Antioxidants|antioxidants|mesh-ancestor
19265807|NCT04472000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265808|NCT04472000|Protective Agents|protective agents|mesh-ancestor
19265809|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19265810|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265811|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265812|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
19265813|NCT04471441|Everolimus|everolimus|mesh-list
19265814|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265815|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265816|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
19265817|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265818|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19265819|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19265820|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
19265821|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265822|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265823|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265824|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265825|NCT04471415|Atezolizumab|atezolizumab|mesh-list
19265826|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265827|NCT04470908|Rifabutin|rifabutin|mesh-list
19265828|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
19265829|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265830|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19265831|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265832|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265833|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265834|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265835|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19265836|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
19265837|NCT04470843|Acetazolamide|acetazolamide|mesh-list
19265838|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
19265839|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19265840|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265841|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265842|NCT04470843|Diuretics|diuretics|mesh-ancestor
19265843|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
19265844|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265845|NCT04470479|Pilocarpine|pilocarpine|mesh-list
19265846|NCT04470479|Miotics|miotics|mesh-ancestor
19265847|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
19265848|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265849|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265850|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19265851|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19265852|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
19265853|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265854|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393235|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
19393236|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
19393237|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393238|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424819|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19404064|NCT03597867|Indomethacin|indomethacin|mesh-list
19404065|NCT03597867|Nepafenac|nepafenac|mesh-list
19404066|NCT03597867|Bromfenac|bromfenac|mesh-list
19265855|NCT04470752|Capsaicin|capsaicin|mesh-list
19265856|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19265857|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
19265858|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
19265859|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
19265860|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265861|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265862|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19265863|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19265864|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265865|NCT04470531|Renal Agents|renal agents|mesh-ancestor
19265866|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265867|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
19265868|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19265869|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19265870|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
19265871|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19265872|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19265873|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265874|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
19265875|NCT04470557|Coagulants|coagulants|mesh-ancestor
19265876|NCT04470414|Antibodies|antibodies|mesh-list
19265877|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
19265878|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
19265879|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265880|NCT04470544|Camostat|camostat|mesh-list
19265881|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
19265882|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265883|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265884|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19265885|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19265886|NCT04470791|Antivenins|antivenins|mesh-list
19265887|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
19265888|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265889|NCT04470804|Cyclosporine|cyclosporine|mesh-list
19265890|NCT04470804|Sirolimus|sirolimus|mesh-list
19265891|NCT04470804|Cyclosporins|cyclosporins|mesh-list
19265892|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265893|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265894|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265895|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
19265896|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265897|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
19265898|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265899|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
19265900|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19265901|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19265902|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19265903|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19265904|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265905|NCT04470609|Vaccines|vaccines|mesh-list
19265906|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
19265907|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265908|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19265909|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19265910|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19265911|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19265912|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265913|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
19265914|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265915|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265916|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19265917|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265918|NCT04470076|Gemcitabine|gemcitabine|mesh-list
19265919|NCT04470076|Carboplatin|carboplatin|mesh-list
19265920|NCT04470076|Pemetrexed|pemetrexed|mesh-list
19265921|NCT04470076|Afatinib|afatinib|mesh-list
19265922|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265923|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19265924|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
19265925|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265926|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
19265927|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19265928|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265929|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265930|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
19265931|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265932|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19265933|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19265934|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19265935|NCT04470310|Pioglitazone|pioglitazone|mesh-list
19265936|NCT04470310|Glimepiride|glimepiride|mesh-list
19265937|NCT04470310|Alogliptin|alogliptin|mesh-list
19265938|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19265939|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265940|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19265941|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19265942|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
19265943|NCT04470310|Incretins|incretins|mesh-ancestor
19265944|NCT04470310|Hormones|hormones|mesh-ancestor
19265945|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19265946|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19265947|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
19265948|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265949|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350602|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350603|NCT00873834|Fluoxetine|fluoxetine|mesh-list
20350604|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20350605|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20350606|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20350607|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350608|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350609|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
20350610|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265950|NCT04470115|Anesthetics|anesthetics|mesh-list
20350611|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20350612|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
20350613|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350614|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20350615|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20350616|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350617|NCT00873886|Oseltamivir|oseltamivir|mesh-list
20350618|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
20350619|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350620|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350621|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350622|NCT00873925|Vitamin D|vitamin d|mesh-list
20350623|NCT00873925|Vitamins|vitamins|mesh-ancestor
20350624|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
20350625|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350626|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20350627|NCT00873951|Caseins|caseins|mesh-list
20350628|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
20350629|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
20350630|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350631|NCT00874003|Mirtazapine|mirtazapine|mesh-list
20350632|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
20350633|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20350634|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20350635|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
20350636|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
20350637|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350638|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350639|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350640|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20350641|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20350642|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350643|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20350644|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20350645|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20350646|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
20350647|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20350648|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20350649|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
20350650|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20350651|NCT00874042|Gemcitabine|gemcitabine|mesh-list
20350652|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19265951|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265952|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350653|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
20350654|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350655|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350656|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
19265953|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
19265954|NCT04469868|Narcotics|narcotics|mesh-ancestor
19265955|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265956|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265957|NCT04469868|Analgesics|analgesics|mesh-ancestor
19265958|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
19265959|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265960|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
19265961|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19265962|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19265963|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265964|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19265965|NCT04470050|Analgesics|analgesics|mesh-ancestor
19265966|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
19265967|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19265968|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19265969|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19265970|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19265971|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
19265972|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19265973|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835768|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19835769|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835770|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835771|NCT00605267|Tamoxifen|tamoxifen|mesh-list
19835772|NCT00605267|Goserelin|goserelin|mesh-list
19835773|NCT00605267|Anastrozole|anastrozole|mesh-list
19835774|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19835775|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
19835776|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835777|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835778|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19265986|NCT04469829|Methotrexate|methotrexate|mesh-list
19265987|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19265988|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
19265989|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19265990|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19265991|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19265992|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
19265993|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19265994|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19265995|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
19265996|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19265997|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19265998|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19666729|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19666730|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
19666731|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666732|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666733|NCT05105997|Dexamethasone|dexamethasone|mesh-list
19666734|NCT05105997|Bupivacaine|bupivacaine|mesh-list
19265999|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
19266000|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19266001|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19266002|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
19266003|NCT04469777|Hematinics|hematinics|mesh-ancestor
19266004|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
19266005|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19266006|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19266007|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19266008|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266009|NCT04469413|Acetaminophen|acetaminophen|mesh-list
19266010|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19266011|NCT04469413|Analgesics|analgesics|mesh-ancestor
19266012|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
19266013|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666735|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666736|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
19266014|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266015|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
19266016|NCT04469283|Caffeine|caffeine|mesh-list
19266017|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19266018|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266019|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19266020|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266021|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266022|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20350657|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350658|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350659|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19266023|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19266024|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
19266025|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266026|NCT04469010|Ascorbic Acid|ascorbic acid|mesh-list
19266027|NCT04469010|Iron|iron|mesh-list
19266028|NCT04469010|Chelating Agents|chelating agents|mesh-list
19266029|NCT04469010|Vitamins|vitamins|mesh-ancestor
19266030|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
19266031|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266032|NCT04469010|Trace Elements|trace elements|mesh-ancestor
19266033|NCT04469010|Antioxidants|antioxidants|mesh-ancestor
19266034|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266035|NCT04469010|Protective Agents|protective agents|mesh-ancestor
19266036|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
20176743|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176744|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20176745|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
20176746|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20176747|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176748|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
20176749|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266037|NCT04469114|Tofacitinib|tofacitinib|mesh-list
19266038|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19266039|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666737|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
20176750|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350660|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
19266040|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266041|NCT04469062|Mirikizumab|mirikizumab|mesh-list
19266042|NCT04469062|Vedolizumab|vedolizumab|mesh-list
19266043|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20350661|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350662|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
20350663|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350664|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350665|NCT00874107|Paclitaxel|paclitaxel|mesh-list
20350666|NCT00874107|Bevacizumab|bevacizumab|mesh-list
20350667|NCT00874107|Carboplatin|carboplatin|mesh-list
20350668|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20350669|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350670|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
20350671|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
20350672|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
20350673|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266044|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19266045|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19266046|NCT04469062|Analgesics|analgesics|mesh-ancestor
19266047|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
19266048|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266049|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266050|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266051|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19266052|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19266053|NCT04468568|Terbutaline|terbutaline|mesh-list
19266054|NCT04468568|Atosiban|atosiban|mesh-list
19266055|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19266056|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
19266057|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266058|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266059|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19266060|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
19266061|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
19266062|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
20176751|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266063|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404067|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19266064|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19266065|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19266066|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19266067|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
19266068|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266069|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266070|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
19266071|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266072|NCT04468711|Vitamin D|vitamin d|mesh-list
19266073|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
20350674|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350675|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20350676|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350677|NCT00874107|Growth Substances|growth substances|mesh-ancestor
20350678|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350679|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350680|NCT00874133|Domperidone|domperidone|mesh-list
20350681|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
20350682|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
20350683|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350684|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266074|NCT04468711|Vitamins|vitamins|mesh-ancestor
19266075|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
19266076|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266077|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19266078|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266079|NCT04468685|Ondansetron|ondansetron|mesh-list
19266080|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
19266081|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
19266082|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266083|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266084|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266085|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
19266086|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
19266087|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19266088|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
19266089|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266090|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266091|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19266092|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20350685|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20350686|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20350687|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
20350688|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350689|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350690|NCT00874172|Analgesics|analgesics|mesh-list
20350691|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
20350692|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350693|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350694|NCT00874315|Cyclosporine|cyclosporine|mesh-list
19266093|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266094|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20612425|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20350695|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
20350696|NCT00874315|Fludarabine|fludarabine|mesh-list
20350697|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
20350698|NCT00874315|Busulfan|busulfan|mesh-list
20350699|NCT00874315|Tacrolimus|tacrolimus|mesh-list
20350700|NCT00874315|Cyclosporins|cyclosporins|mesh-list
20350701|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
20350702|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20350703|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350704|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350705|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
20350706|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350707|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350708|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
20350709|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350710|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20350711|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612426|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
19266095|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19266096|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
19266097|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350712|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
20350713|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266098|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
19266099|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
19266100|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
19266101|NCT04468139|Ascorbic Acid|ascorbic acid|mesh-list
19266102|NCT04468139|Quercetin|quercetin|mesh-list
19266103|NCT04468139|Vitamins|vitamins|mesh-ancestor
19266104|NCT04468139|Micronutrients|micronutrients|mesh-ancestor
19266105|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266106|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
19266107|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266108|NCT04468139|Protective Agents|protective agents|mesh-ancestor
19266109|NCT04468542|Triamcinolone|triamcinolone|mesh-list
19266110|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20350714|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
20350715|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20350716|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20350717|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20350718|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
20350719|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20350720|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
20350721|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20350722|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20350723|NCT00874328|Irinotecan|irinotecan|mesh-list
20350724|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350725|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19266111|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19266112|NCT04468542|Bupivacaine|bupivacaine|mesh-list
19266113|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19266114|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
19266115|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
19266116|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350726|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20350727|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350728|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350729|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
20350730|NCT00874393|Dopamine|dopamine|mesh-list
20350731|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20350732|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20350733|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
20350734|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
20350735|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266117|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266118|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
19835779|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835780|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19835781|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19835782|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19835783|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19835784|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19835785|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835786|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350736|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266119|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266120|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266121|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
19266122|NCT04468542|Hormones|hormones|mesh-ancestor
19266123|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266124|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19266125|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
19266126|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266127|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393239|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393240|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
19393241|NCT03687931|Hormones|hormones|mesh-ancestor
19393242|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393243|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393244|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393245|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
19393246|NCT03687905|Chloroquine|chloroquine|mesh-list
19393247|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
19393248|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19393249|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19393250|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393251|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350737|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
20350738|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266128|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19266129|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
19266130|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19266131|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
19266132|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266133|NCT04468438|Estrogens|estrogens|mesh-list
19266134|NCT04468438|Hormones|hormones|mesh-ancestor
19266135|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266136|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266137|NCT04468282|Vigabatrin|vigabatrin|mesh-list
19266138|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
19266139|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266140|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266141|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
19266142|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266143|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266144|NCT04467957|Xenon|xenon|mesh-list
19266145|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19266146|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
19266147|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
19266148|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266149|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266150|NCT04467918|Cannabidiol|cannabidiol|mesh-list
19266151|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
19266152|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
19266153|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20350739|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350740|NCT00874393|Protective Agents|protective agents|mesh-ancestor
19266154|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19266155|NCT04467892|Prednisolone|prednisolone|mesh-list
19266156|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
19266157|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19266158|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
19266159|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266160|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
19266161|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
19266162|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266163|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266164|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266165|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
19266166|NCT04467892|Hormones|hormones|mesh-ancestor
19266167|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266168|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19266169|NCT04467892|Protective Agents|protective agents|mesh-ancestor
20350741|NCT00874406|Leucovorin|leucovorin|mesh-list
20350742|NCT00874406|Fluorouracil|fluorouracil|mesh-list
20350743|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
20350744|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
20350745|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266170|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19266171|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266172|NCT04467931|Losartan|losartan|mesh-list
19266173|NCT04467931|Timolol|timolol|mesh-list
19266174|NCT04467931|Propranolol|propranolol|mesh-list
19266175|NCT04467931|Metoprolol|metoprolol|mesh-list
19266176|NCT04467931|Atenolol|atenolol|mesh-list
19266177|NCT04467931|Verapamil|verapamil|mesh-list
19266178|NCT04467931|Felodipine|felodipine|mesh-list
19266179|NCT04467931|Nadolol|nadolol|mesh-list
19266180|NCT04467931|Acebutolol|acebutolol|mesh-list
19266181|NCT04467931|Amlodipine|amlodipine|mesh-list
19266182|NCT04467931|Valsartan|valsartan|mesh-list
19266183|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19266184|NCT04467931|Telmisartan|telmisartan|mesh-list
19266185|NCT04467931|Clonidine|clonidine|mesh-list
19266186|NCT04467931|Carvedilol|carvedilol|mesh-list
19266187|NCT04467931|Candesartan|candesartan|mesh-list
19266188|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
19266189|NCT04467931|Ramipril|ramipril|mesh-list
19266190|NCT04467931|Olmesartan|olmesartan|mesh-list
19266191|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19266192|NCT04467931|Enalapril|enalapril|mesh-list
19266193|NCT04467931|Enalaprilat|enalaprilat|mesh-list
19266194|NCT04467931|Lisinopril|lisinopril|mesh-list
19266195|NCT04467931|Irbesartan|irbesartan|mesh-list
19266196|NCT04467931|Eplerenone|eplerenone|mesh-list
19266197|NCT04467931|Nebivolol|nebivolol|mesh-list
19266198|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
19266199|NCT04467931|Diltiazem|diltiazem|mesh-list
19266200|NCT04467931|Bisoprolol|bisoprolol|mesh-list
19266201|NCT04467931|Perindopril|perindopril|mesh-list
19266202|NCT04467931|Guanfacine|guanfacine|mesh-list
19266203|NCT04467931|Minoxidil|minoxidil|mesh-list
19266204|NCT04467931|Prazosin|prazosin|mesh-list
19266205|NCT04467931|Doxazosin|doxazosin|mesh-list
20350746|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350747|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350748|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350749|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
20350750|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350751|NCT00874406|Antidotes|antidotes|mesh-ancestor
20350752|NCT00874406|Protective Agents|protective agents|mesh-ancestor
20350753|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
20350754|NCT00874406|Vitamins|vitamins|mesh-ancestor
20350755|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
20424820|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424821|NCT01271257|Misoprostol|misoprostol|mesh-list
20424822|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19266206|NCT04467931|Benazepril|benazepril|mesh-list
19266207|NCT04467931|Labetalol|labetalol|mesh-list
19266208|NCT04467931|Hydralazine|hydralazine|mesh-list
19266209|NCT04467931|Captopril|captopril|mesh-list
19266210|NCT04467931|Indapamide|indapamide|mesh-list
19266211|NCT04467931|Nicardipine|nicardipine|mesh-list
19266212|NCT04467931|Quinapril|quinapril|mesh-list
19266213|NCT04467931|Trandolapril|trandolapril|mesh-list
19266214|NCT04467931|Torsemide|torsemide|mesh-list
19266215|NCT04467931|Metolazone|metolazone|mesh-list
19266216|NCT04467931|Fosinopril|fosinopril|mesh-list
19266217|NCT04467931|Methyldopa|methyldopa|mesh-list
19266218|NCT04467931|Isradipine|isradipine|mesh-list
19266219|NCT04467931|Eprosartan|eprosartan|mesh-list
19266220|NCT04467931|Pindolol|pindolol|mesh-list
19266221|NCT04467931|Betaxolol|betaxolol|mesh-list
19266222|NCT04467931|Moexipril|moexipril|mesh-list
19266223|NCT04467931|Reserpine|reserpine|mesh-list
19266224|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
19266225|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
19266226|NCT04467931|Guanabenz|guanabenz|mesh-list
19266227|NCT04467931|Nisoldipine|nisoldipine|mesh-list
19266228|NCT04467931|Penbutolol|penbutolol|mesh-list
19266229|NCT04467931|Nifedipine|nifedipine|mesh-list
20424823|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
20424824|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20424825|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424826|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20424827|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424828|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
20424829|NCT01271283|Lenalidomide|lenalidomide|mesh-list
20424830|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
20424831|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266230|NCT04467931|Amiloride|amiloride|mesh-list
19266231|NCT04467931|Triamterene|triamterene|mesh-list
19266232|NCT04467931|Furosemide|furosemide|mesh-list
19266233|NCT04467931|Spironolactone|spironolactone|mesh-list
19266234|NCT04467931|Bumetanide|bumetanide|mesh-list
19266235|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
19266236|NCT04467931|Terazosin|terazosin|mesh-list
19266237|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19266238|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19266239|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19266240|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19266241|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266242|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266243|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19266244|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266245|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
19266246|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19266247|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19266248|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19266249|NCT04467931|Diuretics|diuretics|mesh-ancestor
19266250|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
19266251|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19266252|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19266253|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19266254|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
19266255|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266256|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
19835787|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
20424832|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19266257|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
19266258|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266259|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19266260|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19266261|NCT04467931|Analgesics|analgesics|mesh-ancestor
19266262|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
20424833|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20424834|NCT01271283|Growth Substances|growth substances|mesh-ancestor
19266263|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19266264|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19266265|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19266266|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19266267|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
19266268|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266269|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19266270|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
19266271|NCT04467931|Protective Agents|protective agents|mesh-ancestor
19266272|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19266273|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19266274|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
19266275|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266276|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
19266277|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19266278|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19266279|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19266280|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19266281|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19266282|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19266283|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19266284|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
19266285|NCT04467931|Urological Agents|urological agents|mesh-ancestor
19266286|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
19266287|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19266288|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
19266289|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19266290|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19266291|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266292|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19266293|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19266294|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19266295|NCT04467983|Denosumab|denosumab|mesh-list
19266296|NCT04467983|Abaloparatide|abaloparatide|mesh-list
19266297|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19266298|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266299|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
19266300|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
19266301|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
19266302|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266303|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266304|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
19266305|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266306|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19266307|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
19266308|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19266309|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19266310|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19266311|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266312|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266313|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
19266314|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266315|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266316|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19266317|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266318|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266319|NCT04467281|Daratumumab|daratumumab|mesh-list
19266320|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266321|NCT04467346|Temozolomide|temozolomide|mesh-list
19266322|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19266323|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
19266324|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266325|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266326|NCT04467125|Lidocaine|lidocaine|mesh-list
20176752|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176753|NCT00171886|Octreotide|octreotide|mesh-list
20176754|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20176755|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20176756|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176757|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
20176758|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176759|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20176760|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266327|NCT04467125|Prilocaine|prilocaine|mesh-list
19266328|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19266329|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
19266330|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
19266331|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266332|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266333|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
19266334|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266335|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19266336|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19266337|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19266338|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266339|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266340|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19266341|NCT04467086|Propranolol|propranolol|mesh-list
19266342|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19266343|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19266344|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
19266345|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266346|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266347|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266348|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19266349|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19266350|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
19266351|NCT04466904|Dulaglutide|dulaglutide|mesh-list
19266352|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19266353|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266354|NCT04466917|Paclitaxel|paclitaxel|mesh-list
19266355|NCT04466917|Bevacizumab|bevacizumab|mesh-list
19266356|NCT04466917|Carboplatin|carboplatin|mesh-list
19266357|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19266358|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266359|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
19266360|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
19266361|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
19266362|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266363|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266364|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19266365|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19266366|NCT04466917|Growth Substances|growth substances|mesh-ancestor
19266367|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266368|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
19266369|NCT04466943|Rocuronium|rocuronium|mesh-list
19266370|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266371|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19266372|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19266373|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19666738|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666739|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666740|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666741|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
20350756|NCT00874419|Gemcitabine|gemcitabine|mesh-list
19266374|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266375|NCT04466670|Aspirin|aspirin|mesh-list
19266376|NCT04466670|Heparin|heparin|mesh-list
19266377|NCT04466670|Calcium heparin|calcium heparin|mesh-list
19266378|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19266379|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19266380|NCT04466670|Analgesics|analgesics|mesh-ancestor
19266381|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
19266382|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266383|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266384|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266385|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19266386|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19266387|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19266388|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266389|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19266390|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19266391|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666742|NCT05105997|Hormones|hormones|mesh-ancestor
19835788|NCT00605293|Hematinics|hematinics|mesh-ancestor
20350757|NCT00874419|Carboplatin|carboplatin|mesh-list
20350758|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20350759|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350760|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350761|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
20350762|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350763|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
19266392|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
19266393|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
19266394|NCT04466436|Tryptophan|tryptophan|mesh-list
19266395|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19266396|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
19266397|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19266398|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
19266399|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393252|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393253|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393254|NCT03687905|Amebicides|amebicides|mesh-ancestor
19393255|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19393256|NCT03687606|Menotropins|menotropins|mesh-list
19393257|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393258|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393259|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19393260|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
19393261|NCT03687515|Prednisone|prednisone|mesh-list
19393262|NCT03687515|Budesonide|budesonide|mesh-list
19393263|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393264|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
19393265|NCT03687515|Hormones|hormones|mesh-ancestor
19393266|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393267|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393268|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393269|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393270|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19393271|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
19393272|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393273|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20350764|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350765|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350766|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350767|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
20350768|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350769|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350770|NCT00874484|Enoxaparin|enoxaparin|mesh-list
20350771|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
20350772|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20350773|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20350774|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350775|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
20350776|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20350777|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20350778|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20350779|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
20350780|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350781|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20350782|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20350783|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350784|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350785|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20350786|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20350787|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
20350788|NCT00874562|Sirolimus|sirolimus|mesh-list
20350789|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393274|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
19393275|NCT03687463|Decitabine|decitabine|mesh-list
19666743|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666744|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666745|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666746|NCT05105997|Anesthetics, Local|anesthetics, local|mesh-ancestor
19666747|NCT05105997|Anesthetics|anesthetics|mesh-ancestor
19666748|NCT05105997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666749|NCT05105997|Sensory System Agents|sensory system agents|mesh-ancestor
19393276|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19393277|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
19393278|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666750|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
19666751|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19266400|NCT04466046|Midazolam|midazolam|mesh-list
19266401|NCT04466046|Palonosetron|palonosetron|mesh-list
19266402|NCT04466046|Ramosetron|ramosetron|mesh-list
19266403|NCT04466046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19266404|NCT04466046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19266405|NCT04466046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266406|NCT04466046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266407|NCT04466046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19266408|NCT04466046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19266409|NCT04466046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19266410|NCT04466046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19266411|NCT04466046|Anesthetics, General|anesthetics, general|mesh-ancestor
19266412|NCT04466046|Anesthetics|anesthetics|mesh-ancestor
19266413|NCT04466046|GABA Modulators|gaba modulators|mesh-ancestor
19266414|NCT04466046|GABA Agents|gaba agents|mesh-ancestor
19266415|NCT04466046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266416|NCT04466046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266417|NCT04466046|Antiemetics|antiemetics|mesh-ancestor
19266418|NCT04466046|Autonomic Agents|autonomic agents|mesh-ancestor
19266419|NCT04466046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266420|NCT04466046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266421|NCT04466046|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19266422|NCT04466046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19266423|NCT04466046|Serotonin Agents|serotonin agents|mesh-ancestor
19266424|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
19266425|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
19266426|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19266427|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19266428|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266429|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266430|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266431|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19266432|NCT04466254|Cetuximab|cetuximab|mesh-list
20350790|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350791|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20350792|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350793|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
20350794|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350795|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
20350796|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350797|NCT00874575|Vitamin D|vitamin d|mesh-list
19266433|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266434|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266435|NCT04466176|Fluticasone|fluticasone|mesh-list
19266436|NCT04466176|Xhance|xhance|mesh-list
19266437|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19266438|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19266439|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266440|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19266441|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
19266442|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266443|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266444|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19266445|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19266446|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
19266447|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19666752|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19666753|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666754|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19666755|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350798|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
20350799|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
20350800|NCT00874575|Vitamins|vitamins|mesh-list
20350801|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
20350802|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350803|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20350804|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20350805|NCT00874601|Valsartan|valsartan|mesh-list
20350806|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20350807|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20350808|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20350809|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266448|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19266449|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19266450|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19666756|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
20350810|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
19666757|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350811|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20350812|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
20350813|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19266451|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19266452|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266453|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266454|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
19266455|NCT04466176|Hormones|hormones|mesh-ancestor
19266456|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266457|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
19266458|NCT04466241|Ritonavir|ritonavir|mesh-list
19266459|NCT04466241|Lopinavir|lopinavir|mesh-list
19266460|NCT04466241|Telmisartan|telmisartan|mesh-list
19266461|NCT04466241|Atorvastatin|atorvastatin|mesh-list
19266462|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19266463|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19266464|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
19266465|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266466|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19266467|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19266468|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266469|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20350814|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350815|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20350816|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20350817|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20350818|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19266470|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19266471|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
19266472|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19266473|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19266474|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
20350819|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
20350820|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20350821|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20350822|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350823|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350824|NCT00874679|Urological Agents|urological agents|mesh-ancestor
20350825|NCT00874744|Triamcinolone|triamcinolone|mesh-list
20350826|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20350827|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20350828|NCT00874744|Bevacizumab|bevacizumab|mesh-list
20350829|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20350830|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350831|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350832|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20350833|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350834|NCT00874744|Growth Substances|growth substances|mesh-ancestor
19266475|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266476|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19266477|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20350835|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350836|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350837|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20350838|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
20350839|NCT00874744|Hormones|hormones|mesh-ancestor
20424835|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19266478|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19666758|NCT05105412|Gemcitabine|gemcitabine|mesh-list
19666759|NCT05105412|Lenalidomide|lenalidomide|mesh-list
19666760|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19666761|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
19666762|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666763|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666764|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
19666765|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666766|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666767|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19666768|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
19666769|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266479|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19266480|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19666770|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19666771|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350840|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350841|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20350842|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
20350843|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266481|NCT04465968|Durvalumab|durvalumab|mesh-list
19266482|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19266483|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266484|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266485|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
19266486|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266487|NCT04466085|Vaccines|vaccines|mesh-list
19266488|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
19266489|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266490|NCT04465916|Tenofovir|tenofovir|mesh-list
19266491|NCT04465916|Entecavir|entecavir|mesh-list
19266492|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
19266493|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266494|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19266495|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19266496|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266497|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266498|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19266499|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19266500|NCT04465942|Paclitaxel|paclitaxel|mesh-list
19266501|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
19266502|NCT04465942|Nivolumab|nivolumab|mesh-list
19266503|NCT04465942|Pemetrexed|pemetrexed|mesh-list
19266504|NCT04465942|Atezolizumab|atezolizumab|mesh-list
19266505|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19266506|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350844|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350845|NCT00874809|Insulin|insulin|mesh-list
20350846|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
19266507|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
19266508|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
19266509|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
19266510|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266511|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266512|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19266513|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266514|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19266515|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19266516|NCT04465864|Dexamethasone|dexamethasone|mesh-list
19266517|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266518|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
19266519|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
19266520|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266521|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266522|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266523|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
19266524|NCT04465864|Hormones|hormones|mesh-ancestor
19266525|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266526|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19266527|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266528|NCT04465773|Remifentanil|remifentanil|mesh-list
19266529|NCT04465773|Propofol|propofol|mesh-list
19266530|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
19266531|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266532|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266533|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19266534|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19266535|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
19266536|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19266537|NCT04465773|Narcotics|narcotics|mesh-ancestor
19266538|NCT04465773|Analgesics|analgesics|mesh-ancestor
19266539|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
19266540|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266541|NCT04465643|Nivolumab|nivolumab|mesh-list
19266542|NCT04465643|Ipilimumab|ipilimumab|mesh-list
19266543|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266544|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266545|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19266546|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350847|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19266547|NCT04465500|Androgens|androgens|mesh-list
19266548|NCT04465500|Hormones|hormones|mesh-ancestor
19266549|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266550|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266551|NCT04465695|Interferons|interferons|mesh-list
19266552|NCT04465695|Interferon-beta|interferon-beta|mesh-list
19266553|NCT04465695|Clofazimine|clofazimine|mesh-list
19266554|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
19266555|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266556|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
19266557|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266558|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
19266559|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266560|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19266561|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266562|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
19266563|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19266564|NCT04465851|Curcumin|curcumin|mesh-list
19266565|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19266566|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19266567|NCT04465851|Analgesics|analgesics|mesh-ancestor
19266568|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
19266569|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266570|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266571|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266572|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19266573|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266574|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266575|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266576|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
19266577|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19266578|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266579|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
19266580|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
19266581|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19266582|NCT04465123|Spironolactone|spironolactone|mesh-list
19266583|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19266584|NCT04465123|Diuretics|diuretics|mesh-ancestor
19266585|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
19266586|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266587|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19266588|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266589|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266590|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19266591|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
19266592|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266593|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19266594|NCT04465357|Erenumab|erenumab|mesh-list
19266595|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19266596|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266597|NCT04465357|Analgesics|analgesics|mesh-ancestor
19266598|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
19266599|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266600|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266601|NCT04465318|Nicotine|nicotine|mesh-list
19266602|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19266603|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
19666772|NCT05105412|Growth Substances|growth substances|mesh-ancestor
19666773|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
19666774|NCT05105347|Prednisone|prednisone|mesh-list
19266604|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266605|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266606|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19266607|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19266608|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
19266609|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266610|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266611|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
19266612|NCT04465175|Analgesics|analgesics|mesh-ancestor
19266613|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
19666775|NCT05105347|Adalimumab|adalimumab|mesh-list
19666776|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666777|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
19666778|NCT05105347|Hormones|hormones|mesh-ancestor
20612427|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666779|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266614|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176761|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176762|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
20176763|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176764|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20176765|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176766|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350848|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350849|NCT00874861|Poly ICLC|poly iclc|mesh-list
20350850|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
20350851|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
20350852|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350853|NCT00874874|Sorafenib|sorafenib|mesh-list
20350854|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266615|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266616|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
19266617|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266618|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19266619|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
19266620|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19266621|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266622|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266623|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19266624|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
19266625|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19266626|NCT04465396|Teduglutide|teduglutide|mesh-list
19266627|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266628|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19266629|NCT04465396|Protective Agents|protective agents|mesh-ancestor
19266630|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266631|NCT04465383|Propofol|propofol|mesh-list
19266632|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19266633|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266634|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266635|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19266636|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
19266637|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
19266638|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19266639|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
19266640|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19266641|NCT04464967|Trastuzumab|trastuzumab|mesh-list
19266642|NCT04464967|Cetuximab|cetuximab|mesh-list
19266643|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266644|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266645|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
19266646|NCT04464759|Nivolumab|nivolumab|mesh-list
19266647|NCT04464759|Ipilimumab|ipilimumab|mesh-list
19266648|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266649|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266650|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19266651|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266652|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
19266653|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19266654|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19266655|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266656|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266657|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19266658|NCT04464694|Ranibizumab|ranibizumab|mesh-list
19266659|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19266660|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19266661|NCT04464694|Growth Substances|growth substances|mesh-ancestor
19266662|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266663|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
19266664|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266665|NCT04464811|Furosemide|furosemide|mesh-list
19266666|NCT04464811|Diuretics|diuretics|mesh-ancestor
20176767|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
20176768|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176769|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350855|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350856|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266667|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
19835789|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
20424836|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266668|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835790|NCT00605306|Maleic acid|maleic acid|mesh-list
19266669|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19266670|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266671|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666780|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666781|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666782|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266672|NCT04465097|Exemestane|exemestane|mesh-list
19266673|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266674|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19266675|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19266676|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266677|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266678|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19266679|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
19266680|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266681|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266682|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
19266683|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19266684|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266685|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
19266686|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266687|NCT04465110|Protective Agents|protective agents|mesh-ancestor
19266688|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266689|NCT04464850|Iron|iron|mesh-list
19266690|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
19266691|NCT04464850|Folic Acid|folic acid|mesh-list
19266692|NCT04464850|Trace Elements|trace elements|mesh-ancestor
20350857|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350858|NCT00874926|Factor VIII|factor viii|mesh-list
20350859|NCT00874926|Coagulants|coagulants|mesh-ancestor
20350860|NCT00874978|Lenalidomide|lenalidomide|mesh-list
20350861|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
20350862|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350863|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19266693|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
19266694|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266695|NCT04464850|Hematinics|hematinics|mesh-ancestor
19266696|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
19266697|NCT04464850|Vitamins|vitamins|mesh-ancestor
19266698|NCT04464863|Metronidazole|metronidazole|mesh-list
19266699|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266700|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176770|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176771|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176772|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
20176773|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20176774|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176775|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
19266701|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19266702|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19266703|NCT04464629|Prednisolone|prednisolone|mesh-list
19266704|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19266705|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
19266706|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19266707|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
19266708|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19266709|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
19266710|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266711|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
19266712|NCT04464629|Hormones|hormones|mesh-ancestor
19266713|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266714|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266715|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19266716|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266717|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
19266718|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
19266719|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266720|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266721|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20176776|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176777|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20176778|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424837|NCT01271348|Etoricoxib|etoricoxib|mesh-list
19266722|NCT04464629|Protective Agents|protective agents|mesh-ancestor
19266723|NCT04464512|Sufentanil|sufentanil|mesh-list
19266724|NCT04464512|Buprenorphine|buprenorphine|mesh-list
20350864|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350865|NCT00874978|Growth Substances|growth substances|mesh-ancestor
20350866|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
19266725|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19266726|NCT04464512|Narcotics|narcotics|mesh-ancestor
19266727|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266728|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266729|NCT04464512|Analgesics|analgesics|mesh-ancestor
19266730|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
19266731|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266732|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19266733|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20350867|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350868|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
20350869|NCT00875004|Hematinics|hematinics|mesh-ancestor
20350870|NCT00875030|Artesunate|artesunate|mesh-list
20350871|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
20350872|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20350873|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20350874|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350875|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350876|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
20350877|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
20350878|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19266734|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20176779|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176780|NCT00171990|Famciclovir|famciclovir|mesh-list
19266735|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
19266736|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
19266737|NCT04464642|Methotrexate|methotrexate|mesh-list
19266738|NCT04464642|Tofacitinib|tofacitinib|mesh-list
19835791|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835792|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835793|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19835794|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
19835795|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19266739|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19266740|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
19266741|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19266742|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266743|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19266744|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
19266745|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266746|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266747|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
19266748|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266749|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19266750|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19266751|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
20350879|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
20350880|NCT00875069|Ethanol|ethanol|mesh-list
19266752|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835796|NCT00605319|Fesoterodine|fesoterodine|mesh-list
20176781|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
20176782|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176783|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20176784|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176785|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176786|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
20176787|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20176788|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350881|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20350882|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350883|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20350884|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835797|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19835798|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19835799|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
19835800|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835801|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835802|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835803|NCT00605319|Urological Agents|urological agents|mesh-ancestor
19835804|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
19835805|NCT00605345|Hematinics|hematinics|mesh-ancestor
20350885|NCT00875082|Montelukast|montelukast|mesh-list
20176789|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
20176790|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20176791|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176792|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
20176793|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20176794|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176795|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
20176796|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20176797|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266753|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20176798|NCT00172068|Vitamin D|vitamin d|mesh-list
20176799|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
20176800|NCT00172068|Calcium|calcium|mesh-list
19666783|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666784|NCT05105256|Prednisolone|prednisolone|mesh-list
19666785|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176801|NCT00172068|Vitamins|vitamins|mesh-ancestor
20176802|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
19266754|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20350886|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20350887|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
20350888|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20350889|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
20350890|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20350891|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350892|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20350893|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20350894|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350895|NCT00875147|Bevacizumab|bevacizumab|mesh-list
20350896|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350897|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350898|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19266755|NCT04464616|Anesthetics|anesthetics|mesh-list
19266756|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266757|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350899|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350900|NCT00875147|Growth Substances|growth substances|mesh-ancestor
20350901|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266758|NCT04464135|Acetic Acid|acetic acid|mesh-list
19266759|NCT04464135|Retinol acetate|retinol acetate|mesh-list
19266760|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19266761|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266762|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19266763|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
19266764|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266765|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19266766|NCT04464135|Protective Agents|protective agents|mesh-ancestor
19266767|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393279|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393280|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393281|NCT03687268|Naloxone|naloxone|mesh-list
19393282|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19393283|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393284|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
19393285|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393286|NCT03687255|Tazobactam|tazobactam|mesh-list
19393287|NCT03687255|Piperacillin|piperacillin|mesh-list
19393288|NCT03687255|Cefepime|cefepime|mesh-list
19393289|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19393290|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
19393291|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393292|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393293|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19393294|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393295|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393296|NCT03687229|Insulin|insulin|mesh-list
19393297|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19393298|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393299|NCT03687073|Silybin|silybin|mesh-list
19393300|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
20176803|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393301|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19393302|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393303|NCT03687073|Protective Agents|protective agents|mesh-ancestor
19666786|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
19266768|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
19266769|NCT04464005|Analgesics|analgesics|mesh-ancestor
19266770|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
19266771|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266772|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266773|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
19666787|NCT05105256|Hormones|hormones|mesh-ancestor
19666788|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666789|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666790|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666791|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666792|NCT05105035|Meropenem|meropenem|mesh-list
19666793|NCT05105035|Ceftazidime|ceftazidime|mesh-list
19666794|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666795|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666796|NCT05105022|Propofol|propofol|mesh-list
19666797|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19666798|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666799|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666800|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19666801|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
19666802|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
19666803|NCT05105009|Furosemide|furosemide|mesh-list
19666804|NCT05105009|Diuretics|diuretics|mesh-ancestor
19666805|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
19666806|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666807|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19666808|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19666809|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176804|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176805|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19266774|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266775|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19266776|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
20350902|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350903|NCT00875173|Selenium|selenium|mesh-list
20350904|NCT00875173|Antioxidants|antioxidants|mesh-list
20350905|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350906|NCT00875173|Protective Agents|protective agents|mesh-ancestor
20350907|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350908|NCT00875173|Trace Elements|trace elements|mesh-ancestor
20350909|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
20350910|NCT00875238|Doxorubicin|doxorubicin|mesh-list
20350911|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20350912|NCT00875238|Trastuzumab|trastuzumab|mesh-list
20350913|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20350914|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350915|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20350916|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19266777|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19266778|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266779|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266780|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19266781|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
19266782|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19266783|NCT04464122|Somatostatin|somatostatin|mesh-list
19266784|NCT04464122|Hormones|hormones|mesh-ancestor
19266785|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266786|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266787|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
19266788|NCT04463875|Riboflavin|riboflavin|mesh-list
19266789|NCT04463875|Ubiquinone|ubiquinone|mesh-list
19266790|NCT04463875|Andrographolide|andrographolide|mesh-list
19266791|NCT04463875|Vitamins|vitamins|mesh-ancestor
19266792|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
19266793|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176806|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
20176807|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176808|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176809|NCT00172172|Calcium|calcium|mesh-list
20176810|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
20217115|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350917|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266794|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
20350918|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350919|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350920|NCT00875355|Temozolomide|temozolomide|mesh-list
20350921|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20350922|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
20350923|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350924|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350925|NCT00875368|Maraviroc|maraviroc|mesh-list
19666810|NCT05104931|Piroxicam|piroxicam|mesh-list
19666811|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19666812|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666813|NCT05104931|Analgesics|analgesics|mesh-ancestor
20350926|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20350927|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20350928|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350929|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20350930|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20350931|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
20350932|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350933|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19266795|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19266796|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
19266797|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266798|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20350934|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
20350935|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20350936|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
20350937|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350938|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266799|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19266800|NCT04463875|Analgesics|analgesics|mesh-ancestor
19266801|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
19266802|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266803|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19266804|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19266805|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19266806|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266807|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
20350939|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350940|NCT00875537|Capsaicin|capsaicin|mesh-list
20350941|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
20350942|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
20350943|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
20350944|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20350945|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350946|NCT00875745|Sorafenib|sorafenib|mesh-list
20350947|NCT00875745|Vorinostat|vorinostat|mesh-list
20350948|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350949|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19266808|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19266809|NCT04463784|Efavirenz|efavirenz|mesh-list
19266810|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19266811|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19266812|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266813|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266814|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
19266815|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266816|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19266817|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19266818|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19266819|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19266820|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19266821|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19266822|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
19266823|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19266824|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19266825|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266826|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
19266827|NCT04463966|Coagulants|coagulants|mesh-ancestor
19266828|NCT04463953|Dexamethasone|dexamethasone|mesh-list
19266829|NCT04463953|Ixazomib|ixazomib|mesh-list
19266830|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
19266831|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266832|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
19266833|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
19266834|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266835|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266836|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266837|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
19266838|NCT04463953|Hormones|hormones|mesh-ancestor
19266839|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266840|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19266841|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266842|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
19266843|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266844|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266845|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19266846|NCT04463901|Mitomycins|mitomycins|mesh-list
19266847|NCT04463901|Mitomycin|mitomycin|mesh-list
19266848|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19266849|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266850|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
19266851|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266852|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19266853|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266854|NCT04463615|Leflunomide|leflunomide|mesh-list
19266855|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266856|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266857|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19266858|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
19266859|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266860|NCT04463459|Vitamins|vitamins|mesh-list
19266861|NCT04463459|Ascorbic Acid|ascorbic acid|mesh-list
19266862|NCT04463459|Vitamin E|vitamin e|mesh-list
19266863|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
20176811|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176812|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176813|NCT00172302|Ascorbic Acid|ascorbic acid|mesh-list
20176814|NCT00172302|Vitamins|vitamins|mesh-ancestor
19266864|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266865|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
19266866|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266867|NCT04463459|Protective Agents|protective agents|mesh-ancestor
19266868|NCT04463342|Methamphetamine|methamphetamine|mesh-list
19266869|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19266870|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266871|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
19266872|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
19266873|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266874|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
19266875|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266876|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266877|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
19266878|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19266879|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19266880|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19266881|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19266882|NCT04463030|Vitamins|vitamins|mesh-list
19266883|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
19266884|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
19266885|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266886|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
19266887|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266888|NCT04463030|Protective Agents|protective agents|mesh-ancestor
19266889|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
19266890|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19266891|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266892|NCT04463056|Eculizumab|eculizumab|mesh-list
19266893|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19266894|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19266895|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
19266896|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266897|NCT04462939|Micronutrients|micronutrients|mesh-list
19266898|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666814|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
19666815|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666816|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176815|NCT00172302|Micronutrients|micronutrients|mesh-ancestor
20176816|NCT00172302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666817|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666818|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666819|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19666820|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266899|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19266900|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176817|NCT00172302|Antioxidants|antioxidants|mesh-ancestor
20176818|NCT00172302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176819|NCT00172302|Protective Agents|protective agents|mesh-ancestor
20176820|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
20176821|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176822|NCT00172367|Lycopene|lycopene|mesh-list
20176823|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266901|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
19266902|NCT04462796|Cathartics|cathartics|mesh-ancestor
19266903|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19266904|NCT04462588|Metronidazole|metronidazole|mesh-list
19266905|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19266906|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19266907|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19266908|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19266909|NCT04462614|Heparin|heparin|mesh-list
19266910|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
19266911|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19266912|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19266913|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266914|NCT04462822|Fluticasone|fluticasone|mesh-list
19266915|NCT04462822|Xhance|xhance|mesh-list
19266916|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19266917|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19266918|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266919|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19266920|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
19266921|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266922|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266923|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19266924|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
19266925|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
19266926|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19266927|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19266928|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19266929|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19266930|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
19266931|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19266932|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266933|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
19266934|NCT04462822|Hormones|hormones|mesh-ancestor
19266935|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266936|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
19266937|NCT04462809|Talazoparib|talazoparib|mesh-list
19266938|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19266939|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266940|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266941|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266942|NCT04462666|Etoricoxib|etoricoxib|mesh-list
19266943|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19266944|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19266945|NCT04462666|Analgesics|analgesics|mesh-ancestor
19266946|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
19266947|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266948|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266949|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176824|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
20176825|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176826|NCT00172367|Protective Agents|protective agents|mesh-ancestor
20176827|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176828|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20176829|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20176830|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176831|NCT00172380|Docetaxel|docetaxel|mesh-list
20176832|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176833|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
19666821|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176834|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
20176835|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
19266950|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666822|NCT05104788|Carboplatin|carboplatin|mesh-list
19666823|NCT05104788|Pemetrexed|pemetrexed|mesh-list
19266951|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19266952|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19266953|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19266954|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266955|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
19266956|NCT04462250|Narcotics|narcotics|mesh-ancestor
19266957|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266958|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266959|NCT04462250|Analgesics|analgesics|mesh-ancestor
19266960|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
19266961|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266962|NCT04462627|Antibodies|antibodies|mesh-list
19266963|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
19266964|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266965|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
19266966|NCT04462406|Nivolumab|nivolumab|mesh-list
19266967|NCT04462406|Ipilimumab|ipilimumab|mesh-list
19266968|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19266969|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266970|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19266971|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19266972|NCT04462315|Cobalt|cobalt|mesh-list
19266973|NCT04462315|Chromium|chromium|mesh-list
19266974|NCT04462315|Everolimus|everolimus|mesh-list
19266975|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266976|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19266977|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
19266978|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266979|NCT04462315|Trace Elements|trace elements|mesh-ancestor
19266980|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
19266981|NCT04462276|Atezolizumab|atezolizumab|mesh-list
19266982|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19266983|NCT04462523|Prednisolone|prednisolone|mesh-list
19266984|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19266985|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
19266986|NCT04462523|Hormones|hormones|mesh-ancestor
19266987|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19266988|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266989|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19266990|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393304|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393305|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19393306|NCT03687034|Temozolomide|temozolomide|mesh-list
19393307|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19393308|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
19393309|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393310|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393311|NCT03687021|Progesterone|progesterone|mesh-list
19666824|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176836|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217116|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
20217117|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20217118|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217119|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217120|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217121|NCT00308542|Dexamethasone|dexamethasone|mesh-list
20217122|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217123|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
20217124|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
19666825|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217125|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217126|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217127|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217128|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
20217129|NCT00308542|Hormones|hormones|mesh-ancestor
20350950|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350951|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393312|NCT03687021|Progestins|progestins|mesh-ancestor
19393313|NCT03687021|Hormones|hormones|mesh-ancestor
19404068|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19404069|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19404070|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19404071|NCT03597867|Analgesics|analgesics|mesh-ancestor
20176837|NCT00172419|Atorvastatin|atorvastatin|mesh-list
20176838|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20176839|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20176840|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
19266991|NCT04462094|Ketamine|ketamine|mesh-list
19266992|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
19266993|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19266994|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19266995|NCT04462094|Analgesics|analgesics|mesh-ancestor
19266996|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
19266997|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19266998|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19266999|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19267000|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
20176841|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176842|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20176843|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20176844|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176845|NCT00172809|Interferons|interferons|mesh-list
20176846|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
20176847|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
20176848|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20176849|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176850|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
20176851|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267001|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19267002|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19267003|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176852|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
20176853|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176854|NCT00173667|Nifedipine|nifedipine|mesh-list
19267004|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267005|NCT04462003|Enoxaparin|enoxaparin|mesh-list
19267006|NCT04462003|Apixaban|apixaban|mesh-list
19267007|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
19267008|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267009|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267010|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267011|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19267012|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
20350952|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20350953|NCT00875771|Bevacizumab|bevacizumab|mesh-list
20350954|NCT00875771|Capecitabine|capecitabine|mesh-list
20350955|NCT00875771|Irinotecan|irinotecan|mesh-list
20350956|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19267013|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20176855|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19267014|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
19267015|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267016|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19267017|NCT04461925|Azithromycin|azithromycin|mesh-list
20350957|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350958|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19267018|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
19267019|NCT04461925|Dexamethasone|dexamethasone|mesh-list
19267020|NCT04461925|Enoxaparin|enoxaparin|mesh-list
19267021|NCT04461925|Anticoagulants|anticoagulants|mesh-list
19267022|NCT04461925|Hormones|hormones|mesh-list
19267023|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267024|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
19267025|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
19267026|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267027|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267028|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19267029|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
19267030|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267031|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19267032|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267033|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267034|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267035|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267036|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267037|NCT04461665|Vitamin D|vitamin d|mesh-list
19267038|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
20350959|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835806|NCT00605384|Tenofovir|tenofovir|mesh-list
19267039|NCT04461665|Vitamins|vitamins|mesh-list
20176856|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19267040|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
19267041|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267042|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19267043|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19267044|NCT04461535|Hormones|hormones|mesh-list
19267045|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19267046|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19267047|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
19267048|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267049|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267050|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267051|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267052|NCT04461249|Travoprost|travoprost|mesh-list
19267053|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19267054|NCT04461249|Latanoprost|latanoprost|mesh-list
19267055|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19267056|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19267057|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
19267058|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
19267059|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19267060|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19267061|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267062|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267063|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267064|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267065|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
19267066|NCT04461418|Hormones|hormones|mesh-ancestor
19267067|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267068|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267069|NCT04461379|Vaccines|vaccines|mesh-list
19267070|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
19267071|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
19267072|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267073|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19267074|NCT04461288|Nicotine|nicotine|mesh-list
19267075|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19267076|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
19267077|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267078|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267079|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19267080|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19267081|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
19267082|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267083|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267084|NCT04461340|Sirolimus|sirolimus|mesh-list
19267085|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20350960|NCT00875771|Growth Substances|growth substances|mesh-ancestor
20350961|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350962|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350963|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20350964|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
20350965|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350966|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20350967|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20350968|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20350969|NCT00875784|Sumatriptan|sumatriptan|mesh-list
20350970|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20350971|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20350972|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20350973|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
20350974|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20350975|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20350976|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350977|NCT00875849|Cetuximab|cetuximab|mesh-list
20350978|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20350979|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20350980|NCT00875875|Rifaximin|rifaximin|mesh-list
20350981|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20350982|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350983|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20350984|NCT00875927|Zinc|zinc|mesh-list
20350985|NCT00875927|Propolis|propolis|mesh-list
19267086|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350986|NCT00875927|Trace Elements|trace elements|mesh-ancestor
19267087|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19267088|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666826|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666827|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19666828|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19666829|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
19666830|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19666831|NCT05104762|Antibodies|antibodies|mesh-list
19666832|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
19267089|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
19267090|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19267091|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
19267092|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267093|NCT04461041|Empagliflozin|empagliflozin|mesh-list
19267094|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19267095|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267096|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19267097|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267098|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
19267099|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19267100|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19267101|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
19267102|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267103|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267104|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19267105|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
19267106|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19267107|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
19267108|NCT04460963|Protective Agents|protective agents|mesh-ancestor
19267109|NCT04460820|Doxorubicin|doxorubicin|mesh-list
19267110|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19267111|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19267112|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267113|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19267114|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19267115|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267116|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267117|NCT04460807|Exemestane|exemestane|mesh-list
19267118|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267119|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19267120|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20176857|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176858|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176859|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176860|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176861|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
20176862|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20217130|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217131|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217132|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267121|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267122|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267123|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19267124|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
19267125|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267126|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267127|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19267128|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19267129|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19267130|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
19267131|NCT04460872|Testosterone|testosterone|mesh-list
19267132|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
19267133|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
19267134|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19267135|NCT04460872|Androgens|androgens|mesh-ancestor
19267136|NCT04460872|Hormones|hormones|mesh-ancestor
19267137|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267138|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267139|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19267140|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267141|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
19267142|NCT04460547|Interferons|interferons|mesh-list
19666833|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19267143|NCT04460547|Interferon-beta|interferon-beta|mesh-list
19267144|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
19267145|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
19267146|NCT04460547|Ivermectin|ivermectin|mesh-list
19267147|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267148|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
19267149|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267150|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
20176863|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
20176864|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20176865|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20176866|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20176867|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176868|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176869|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
19267151|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19267152|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19267153|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267154|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267155|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267156|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
19267157|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267158|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19267159|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
19267160|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
19267161|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267162|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
19267163|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19267164|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
19267165|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267166|NCT04460521|Expectorants|expectorants|mesh-ancestor
19267167|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
19267168|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19267169|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
19267170|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267171|NCT04460521|Protective Agents|protective agents|mesh-ancestor
19267172|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267173|NCT04460521|Antidotes|antidotes|mesh-ancestor
19393314|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393315|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393316|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19393317|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393318|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19393319|NCT03686878|Lifitegrast|lifitegrast|mesh-list
19393320|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19393321|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19393322|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
19393323|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20176870|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176871|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350987|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
19835807|NCT00605384|Lamivudine|lamivudine|mesh-list
19835808|NCT00605384|Entecavir|entecavir|mesh-list
19835809|NCT00605384|Adefovir|adefovir|mesh-list
19835810|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
19835811|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835812|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19835813|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19835814|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835815|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835816|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19835817|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19835818|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19835819|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176872|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20176873|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176874|NCT00173862|Gemcitabine|gemcitabine|mesh-list
20176875|NCT00173862|Ifosfamide|ifosfamide|mesh-list
20176876|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20176877|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
20176878|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176879|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176880|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
19393324|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19393325|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393326|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
20350988|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350989|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350990|NCT00875966|Azithromycin|azithromycin|mesh-list
20350991|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20350992|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20350993|NCT00876044|Aflibercept|aflibercept|mesh-list
20350994|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20350995|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20350996|NCT00876044|Growth Substances|growth substances|mesh-ancestor
20350997|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20350998|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
20350999|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351000|NCT00876135|Albuterol|albuterol|mesh-list
20351001|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20351002|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
20351003|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351004|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267174|NCT04460001|Triamcinolone|triamcinolone|mesh-list
19666834|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
19666835|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666836|NCT05104437|Vaccines|vaccines|mesh-list
19666837|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
19666838|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666839|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
20351005|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19267175|NCT04460001|Ranibizumab|ranibizumab|mesh-list
19267176|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19267177|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19267178|NCT04460001|Growth Substances|growth substances|mesh-ancestor
19267179|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267180|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
19267181|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267182|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267183|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
19267184|NCT04460001|Hormones|hormones|mesh-ancestor
19267185|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267186|NCT04460092|Insulin|insulin|mesh-list
19267187|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19267188|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19267189|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267190|NCT04460079|Lenograstim|lenograstim|mesh-list
19267191|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19267192|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
19267193|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267194|NCT04459598|Efavirenz|efavirenz|mesh-list
19267195|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19267196|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19267197|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267198|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267199|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
19267200|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267201|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19267202|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19267203|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19267204|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19267205|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19267206|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19267207|NCT04459663|Axitinib|axitinib|mesh-list
19267208|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267209|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19267210|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267211|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267212|NCT04459702|Ritonavir|ritonavir|mesh-list
19267213|NCT04459702|Lopinavir|lopinavir|mesh-list
19267214|NCT04459702|Azithromycin|azithromycin|mesh-list
19267215|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
19267216|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19267217|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19267218|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
19267219|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267220|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267221|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20351006|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
19267222|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19267223|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
19666840|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19666841|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666842|NCT05104333|Vaccines|vaccines|mesh-list
19666843|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
19666844|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666845|NCT05104281|Osimertinib|osimertinib|mesh-list
19666846|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176881|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176882|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176883|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176884|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
20176885|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176886|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19267224|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267225|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20351007|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
20351008|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20351009|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20351010|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20351011|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20351012|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351013|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351014|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351015|NCT00876226|Citalopram|citalopram|mesh-list
20351016|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20351017|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19267226|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19267227|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19267228|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
19267229|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19267230|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19267231|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267232|NCT04459676|Mitogens|mitogens|mesh-list
19267233|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
19267234|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267235|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
19267236|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
19267237|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267238|NCT04459312|Antibodies|antibodies|mesh-list
19267239|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
19267240|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267241|NCT04459078|Apatinib|apatinib|mesh-list
19267242|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19267243|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267244|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19267245|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267246|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267247|NCT04458948|Azithromycin|azithromycin|mesh-list
19267248|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
19267249|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19267250|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267251|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
19267252|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19267253|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19267254|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267255|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267256|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267257|NCT04459377|Ketamine|ketamine|mesh-list
20351018|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20351019|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351020|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666847|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19666848|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176887|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
20351021|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
19267258|NCT04459377|Esketamine|esketamine|mesh-list
19267259|NCT04459377|Analgesics|analgesics|mesh-ancestor
20176888|NCT00173875|Gefitinib|gefitinib|mesh-list
20176889|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176890|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20176891|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176892|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176893|NCT00173888|Gemcitabine|gemcitabine|mesh-list
20351022|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267260|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
19666849|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666850|NCT05087732|Lidocaine|lidocaine|mesh-list
19666851|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
20351023|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19267261|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267262|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267263|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19267264|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19267265|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
19267266|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
19267267|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20176894|NCT00173888|Cisplatin|cisplatin|mesh-list
20176895|NCT00173888|Docetaxel|docetaxel|mesh-list
20176896|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176897|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20176898|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
20176899|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176900|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
20176901|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176902|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176903|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20176904|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
20176905|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176906|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
20176907|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
20176908|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
20176909|NCT00173901|Ceftazidime|ceftazidime|mesh-list
20176910|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20176911|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20176912|NCT00174174|Modafinil|modafinil|mesh-list
20176913|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19267268|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19267269|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19267270|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267271|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267272|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
19267273|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19267274|NCT04459273|FAPI-46|fapi-46|mesh-list
19267275|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19267276|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666852|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
19666853|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666854|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267280|NCT04459026|Ropivacaine|ropivacaine|mesh-list
19267281|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
19267282|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
19267283|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267284|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267285|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
19267286|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267287|NCT04458454|Methocarbamol|methocarbamol|mesh-list
19267288|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19267289|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267290|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19267291|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267292|NCT04458558|Mifepristone|mifepristone|mesh-list
19267293|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19267294|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
19267295|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19267296|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267297|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19267298|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19267299|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19267300|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
19267301|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19267302|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19267303|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
19267304|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267305|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
19393327|NCT03686787|Coagulants|coagulants|mesh-ancestor
20176914|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176915|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20176916|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20176917|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20176918|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351024|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
20351025|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424838|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20424839|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20424840|NCT01271348|Analgesics|analgesics|mesh-ancestor
20424841|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
20424842|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424843|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424844|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424845|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424846|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20424847|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20424848|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424849|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424850|NCT01271361|Sirolimus|sirolimus|mesh-list
20612428|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424851|NCT01271361|Umirolimus|umirolimus|mesh-list
20424852|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267306|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20424853|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20424854|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
20424855|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424856|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20424857|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424858|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20424859|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424860|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
20424861|NCT01271374|Losartan|losartan|mesh-list
20424862|NCT01271374|Amlodipine|amlodipine|mesh-list
20424863|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20424864|NCT01271374|Olmesartan|olmesartan|mesh-list
20424865|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
20424866|NCT01271374|Spironolactone|spironolactone|mesh-list
20424867|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20424868|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20424869|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424870|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424871|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20424872|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424873|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
20424874|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20424875|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20424876|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20424877|NCT01271374|Diuretics|diuretics|mesh-ancestor
20424878|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
20424879|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20424880|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20424881|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
19267307|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19267308|NCT04458610|Rituximab|rituximab|mesh-list
19267309|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19267310|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
19267311|NCT04458610|Antibodies|antibodies|mesh-list
19267312|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
19267313|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19267314|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
19267315|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267316|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267317|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267318|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19267319|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267320|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176919|NCT00174200|Risperidone|risperidone|mesh-list
20176920|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20176921|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
20176922|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176923|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176924|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176925|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20176926|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20176927|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267321|NCT04458545|Heroin|heroin|mesh-list
20176928|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20176929|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20176930|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
20176931|NCT00174226|Buspirone|buspirone|mesh-list
20176932|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20176933|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20176934|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20176935|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176936|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176937|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
20176938|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176939|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176940|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19267322|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19267323|NCT04458545|Narcotics|narcotics|mesh-ancestor
19267324|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267325|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267326|NCT04458545|Analgesics|analgesics|mesh-ancestor
19267327|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
19267328|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267329|NCT04458636|Prednisolone|prednisolone|mesh-list
19267330|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267331|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
19267332|NCT04458636|Hormones|hormones|mesh-ancestor
19267333|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267334|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267335|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19267336|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267337|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
19267338|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
19267339|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267340|NCT04458324|Buspirone|buspirone|mesh-list
19267341|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19267342|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19267343|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267344|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267345|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19267346|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19267347|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
19267348|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267349|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267350|NCT04458285|Valsartan|valsartan|mesh-list
19267351|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20351026|NCT00876317|Etoricoxib|etoricoxib|mesh-list
20351027|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20351028|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20351029|NCT00876317|Analgesics|analgesics|mesh-ancestor
20351030|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
20351031|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351032|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351033|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20351034|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351035|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20351036|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20351037|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351038|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351039|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
20351040|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20351041|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20351042|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20351043|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
20351044|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351045|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351046|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351047|NCT00876421|Urological Agents|urological agents|mesh-ancestor
20351048|NCT00876434|Sirolimus|sirolimus|mesh-list
20351049|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351050|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351051|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19267352|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19267353|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19267354|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19393328|NCT03686774|Memantine|memantine|mesh-list
19267355|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267356|NCT04458116|Curcumin|curcumin|mesh-list
19267357|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19267358|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19267359|NCT04458116|Analgesics|analgesics|mesh-ancestor
19267360|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
19267361|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267362|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267363|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666855|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
19666856|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666857|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19666858|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19666859|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19666860|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19666861|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666862|NCT05076786|Carboplatin|carboplatin|mesh-list
19666863|NCT05076786|Etoposide|etoposide|mesh-list
19666864|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666865|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19666866|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19666867|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19666868|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267364|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267365|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267366|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267367|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393329|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19393330|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19393331|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
19393332|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393333|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393334|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393335|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19393336|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19666869|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666870|NCT05068752|Sorafenib|sorafenib|mesh-list
19666871|NCT05068752|Vemurafenib|vemurafenib|mesh-list
19666872|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351052|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351053|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
20351054|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20351055|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
20351056|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351057|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
20351058|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20351059|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351060|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351061|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20351062|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351063|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351064|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351065|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351066|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20351067|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
20351068|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20351069|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351070|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20351071|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20351072|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20351073|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
20351074|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
20351075|NCT00876616|Tacrolimus|tacrolimus|mesh-list
20351076|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20351077|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
20351078|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351079|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351080|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20351081|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
20351082|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351083|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351084|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20351085|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20351086|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351087|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20351088|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20351089|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
20351090|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351091|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351092|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
20351093|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19267368|NCT04457609|Azithromycin|azithromycin|mesh-list
19267369|NCT04457609|Oseltamivir|oseltamivir|mesh-list
19267370|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19267371|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267372|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
19267373|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267374|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267375|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19267376|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19267377|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
19267378|NCT04457765|Povidone|povidone|mesh-list
19267379|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
19267380|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
19267381|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19267382|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267383|NCT04457258|FAPI-46|fapi-46|mesh-list
19267384|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19267385|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267386|NCT04457050|Ribavirin|ribavirin|mesh-list
19267387|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
19267388|NCT04457050|Ledipasvir|ledipasvir|mesh-list
19267389|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
19267390|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267391|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
19267392|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267393|NCT04457180|Repaglinide|repaglinide|mesh-list
19267394|NCT04457180|Apatinib|apatinib|mesh-list
19267395|NCT04457180|Bupropion|bupropion|mesh-list
19267396|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267397|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19267398|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267399|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267400|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19267401|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
19267402|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19267403|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19267404|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19267405|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19267406|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
19267407|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267408|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267409|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19267410|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19267411|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19267412|NCT04457232|FAPI-46|fapi-46|mesh-list
19267413|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19267414|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267415|NCT04456985|Folic Acid|folic acid|mesh-list
19267416|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
19267417|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
19267418|NCT04456985|Vitamins|vitamins|mesh-ancestor
19267419|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
19267420|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267421|NCT04456985|Hematinics|hematinics|mesh-ancestor
19267422|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
19267423|NCT04456803|Sevelamer|sevelamer|mesh-list
19267424|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
19267425|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
19393337|NCT03686722|Metformin|metformin|mesh-list
19835820|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
20176941|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20176942|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20176943|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20176944|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20176945|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
20176946|NCT00174239|Levodopa|levodopa|mesh-list
20176947|NCT00174239|Carbidopa|carbidopa|mesh-list
20176948|NCT00174239|Cabergoline|cabergoline|mesh-list
20176949|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20351094|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351095|NCT00876772|Olanzapine|olanzapine|mesh-list
20351096|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
20351097|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
20351098|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351099|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351100|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20351101|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20351102|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20351103|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351104|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351105|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20351106|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20351107|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20351108|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351109|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351110|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
20351111|NCT00876824|Amphotericin B|amphotericin b|mesh-list
20351112|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20351113|NCT00876824|Amebicides|amebicides|mesh-ancestor
20351114|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20351115|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20351116|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351117|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351118|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
20351119|NCT00876850|Linezolid|linezolid|mesh-list
20351120|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351121|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351122|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20351123|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351124|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351125|NCT00876889|Riluzole|riluzole|mesh-list
20351126|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
20351127|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20351128|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20351129|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351130|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351131|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351132|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20351133|NCT00876889|Protective Agents|protective agents|mesh-ancestor
20351134|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
20351135|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20351136|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
20351137|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351138|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19267426|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267427|NCT04456829|Resveratrol|resveratrol|mesh-list
19267428|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
19267429|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267430|NCT04456829|Protective Agents|protective agents|mesh-ancestor
19267431|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267432|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267433|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19267434|NCT04456777|Vortioxetine|vortioxetine|mesh-list
19267435|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
20176950|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20176951|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
20176952|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20176953|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176954|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176955|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20176956|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20176957|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
20176958|NCT00174304|Amlodipine|amlodipine|mesh-list
20176959|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
20176960|NCT00174304|Atorvastatin|atorvastatin|mesh-list
20176961|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20176962|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20176963|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
20176964|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176965|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20176966|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20176967|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351139|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267436|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19267437|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19267438|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19267439|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267440|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267441|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19267442|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19267443|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19267444|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267445|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267446|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
19267447|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19267448|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19267449|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19267450|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19267451|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
19267452|NCT04456712|Levofloxacin|levofloxacin|mesh-list
19267453|NCT04456712|Ofloxacin|ofloxacin|mesh-list
19267454|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351140|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
20351141|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351142|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
20351143|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20351144|NCT00876902|Protective Agents|protective agents|mesh-ancestor
20351145|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
20351146|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
20351147|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
20351148|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
20351149|NCT00877097|Trisequens|trisequens|mesh-list
19267455|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267456|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19267457|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19666873|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19666874|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666875|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666876|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19267458|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267459|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351150|NCT00877097|Norethindrone|norethindrone|mesh-list
20351151|NCT00877097|Estradiol|estradiol|mesh-list
20351152|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20351153|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351154|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19666877|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19666878|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666879|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
20351155|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20351156|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20351157|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
20351158|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20351159|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20351160|NCT00877097|Estrogens|estrogens|mesh-ancestor
20351161|NCT00877097|Hormones|hormones|mesh-ancestor
20351162|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20351163|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20351164|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
20351165|NCT00877110|Vincristine|vincristine|mesh-list
20351166|NCT00877110|Topotecan|topotecan|mesh-list
20351167|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19666880|NCT05012735|Provitamins|provitamins|mesh-list
19666881|NCT05012735|Vitamins|vitamins|mesh-ancestor
19666882|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
19666883|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666884|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
19666885|NCT04999215|Choline|choline|mesh-list
19267460|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267461|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19267462|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19267463|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19267464|NCT04456712|Renal Agents|renal agents|mesh-ancestor
19267465|NCT04456608|Aspirin|aspirin|mesh-list
19666886|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
19666887|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19666888|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
19835821|NCT00605423|Hormones|hormones|mesh-ancestor
20351168|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
20612429|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19267466|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19267467|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19267468|NCT04456608|Analgesics|analgesics|mesh-ancestor
19267469|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
19267470|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267471|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835822|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19835823|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835824|NCT00605475|Metformin|metformin|mesh-list
19835825|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19835826|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835827|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
19267472|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267473|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267474|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267475|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267476|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267477|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19267478|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19267479|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267480|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
19267481|NCT04456387|Factor VIII|factor viii|mesh-list
19267482|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19267483|NCT04456387|Coagulants|coagulants|mesh-ancestor
19267484|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
19267485|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267486|NCT04455932|Liver Extracts|liver extracts|mesh-list
19835828|NCT00605566|Sorafenib|sorafenib|mesh-list
19267487|NCT04455932|Hematinics|hematinics|mesh-ancestor
19267488|NCT04455802|Morphine|morphine|mesh-list
19267489|NCT04455802|Buprenorphine|buprenorphine|mesh-list
19267490|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19267491|NCT04455802|Narcotics|narcotics|mesh-ancestor
19267492|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267493|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267494|NCT04455802|Analgesics|analgesics|mesh-ancestor
19267495|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
19267496|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267497|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19267498|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
19267499|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19267500|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
19267501|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835829|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19267502|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267503|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19267504|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
19267505|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19267506|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
19666889|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666890|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666891|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19666892|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
19666893|NCT04941443|Ibuprofen|ibuprofen|mesh-list
19666894|NCT04941443|Methadone|methadone|mesh-list
19666895|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19835830|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
19835831|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835832|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176968|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176969|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20176970|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20176971|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20176972|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176973|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
20176974|NCT00174317|Celecoxib|celecoxib|mesh-list
20176975|NCT00174317|Diclofenac|diclofenac|mesh-list
20176976|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20176977|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20176978|NCT00174317|Analgesics|analgesics|mesh-ancestor
20176979|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
20351169|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351170|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393338|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19666896|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20351171|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19267507|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267508|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267509|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20351172|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
20351173|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351174|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351175|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20351176|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20351177|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
20351178|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
20351179|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19267510|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
19267511|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
19267512|NCT04456088|Protective Agents|protective agents|mesh-ancestor
19393339|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393340|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19393341|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19393342|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19393343|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19393344|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
19393345|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393346|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351180|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20351181|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351182|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351183|NCT00877123|Vitamin D|vitamin d|mesh-list
19393347|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393348|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
19393349|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393350|NCT03686657|Metformin|metformin|mesh-list
19393351|NCT03686657|Celecoxib|celecoxib|mesh-list
19393352|NCT03686657|Valsartan|valsartan|mesh-list
19393353|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19393354|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393355|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19393356|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19393357|NCT03686657|Analgesics|analgesics|mesh-ancestor
19393358|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
19393359|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393360|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393361|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393362|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19666897|NCT04941443|Analgesics|analgesics|mesh-ancestor
19666898|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
19666899|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666900|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666901|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393363|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19393364|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393365|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393366|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19393367|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19393368|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19393369|NCT03686618|Secretin|secretin|mesh-list
19393370|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393371|NCT03686618|Hormones|hormones|mesh-ancestor
19393372|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393373|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393374|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
19393375|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
19393376|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19393377|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393378|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393379|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
19393380|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19393381|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393382|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393383|NCT03686254|Bevacizumab|bevacizumab|mesh-list
19393384|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19393385|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393386|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20351184|NCT00877123|Vitamins|vitamins|mesh-ancestor
19267513|NCT04455711|Lidocaine|lidocaine|mesh-list
19267514|NCT04455711|Remifentanil|remifentanil|mesh-list
19267515|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
19267516|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
19267517|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351185|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
20351186|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351187|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20351188|NCT00877149|Telbivudine|telbivudine|mesh-list
20351189|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
20351190|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351191|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20351192|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351193|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351194|NCT00877175|Phenylephrine|phenylephrine|mesh-list
20351195|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
20351196|NCT00877175|Tropicamide|tropicamide|mesh-list
20351197|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20351198|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
20351199|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
20351200|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351201|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351202|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
20351203|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20351204|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
20351205|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
20351206|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20351207|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20351208|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20351209|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351210|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267518|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267519|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
19267520|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267521|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19267522|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19267523|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19267524|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19267525|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267526|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20176980|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20176981|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20176982|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20176983|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20176984|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20176985|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20176986|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267527|NCT04455711|Narcotics|narcotics|mesh-ancestor
19267528|NCT04455711|Analgesics|analgesics|mesh-ancestor
19267529|NCT04455555|Rotigotine|rotigotine|mesh-list
19267530|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
19267531|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
19267532|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267533|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267534|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267535|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19267536|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
19267537|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267538|NCT04455594|Carboplatin|carboplatin|mesh-list
19267539|NCT04455594|Pemetrexed|pemetrexed|mesh-list
19267540|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19267541|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20176987|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176988|NCT00174330|Amlodipine|amlodipine|mesh-list
20176989|NCT00174330|Atorvastatin|atorvastatin|mesh-list
20176990|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20176991|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20176992|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
20176993|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176994|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20176995|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20176996|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351211|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351212|NCT00877175|Protective Agents|protective agents|mesh-ancestor
19267542|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267543|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267544|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19267545|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19267546|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19267547|NCT04455958|Ritonavir|ritonavir|mesh-list
19267548|NCT04455958|Lopinavir|lopinavir|mesh-list
19267549|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19267550|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19267551|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
19267552|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267553|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267554|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19267555|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19267556|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
19267557|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351213|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20351214|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20351215|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
20351216|NCT00877227|Leucovorin|leucovorin|mesh-list
20351217|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19267558|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19267559|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19267560|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19267561|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19267562|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
19267563|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19267564|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
19267565|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267566|NCT04455243|Expectorants|expectorants|mesh-ancestor
19267567|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
19267568|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19267569|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
19267570|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267571|NCT04455243|Protective Agents|protective agents|mesh-ancestor
19267572|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267573|NCT04455243|Antidotes|antidotes|mesh-ancestor
19267574|NCT04454775|Protein C|protein c|mesh-list
19267575|NCT04454775|Antithrombins|antithrombins|mesh-list
19267576|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
19267577|NCT04454775|Protein S|protein s|mesh-list
19267578|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19267579|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
19267580|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267581|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267582|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
19267583|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267584|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267585|NCT04454840|Riluzole|riluzole|mesh-list
19267586|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
19267587|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19267588|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19267589|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267590|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267591|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267592|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19267593|NCT04454840|Protective Agents|protective agents|mesh-ancestor
19267594|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19267595|NCT04454788|Tenecteplase|tenecteplase|mesh-list
19267596|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267597|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267598|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267599|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19267600|NCT04454580|Azacitidine|azacitidine|mesh-list
19267601|NCT04454580|Decitabine|decitabine|mesh-list
19267602|NCT04454580|Venetoclax|venetoclax|mesh-list
19267603|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19267604|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
19267605|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267606|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267607|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267608|NCT04454307|Tramadol|tramadol|mesh-list
19267609|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19267610|NCT04454307|Narcotics|narcotics|mesh-ancestor
19267611|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267612|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351218|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
19267613|NCT04454307|Analgesics|analgesics|mesh-ancestor
20351219|NCT00877227|Antidotes|antidotes|mesh-ancestor
20351220|NCT00877227|Protective Agents|protective agents|mesh-ancestor
20351221|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351222|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
20351223|NCT00877227|Vitamins|vitamins|mesh-ancestor
20351224|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
20351225|NCT00877253|Carboplatin|carboplatin|mesh-list
20351226|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351227|NCT00877266|Mepivacaine|mepivacaine|mesh-list
19267614|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
19267615|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267616|NCT04454151|Azithromycin|azithromycin|mesh-list
19267617|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19267618|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267619|NCT04454281|Naloxone|naloxone|mesh-list
19267620|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19267621|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267622|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
19267623|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267624|NCT04453930|Irinotecan|irinotecan|mesh-list
19267625|NCT04453930|Apatinib|apatinib|mesh-list
19267626|NCT04453930|Antibodies|antibodies|mesh-list
19267627|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
19267628|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267629|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19267630|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19267631|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267632|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267633|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267634|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19267635|NCT04453735|Atorvastatin|atorvastatin|mesh-list
19267636|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19267637|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19267638|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
19267639|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267640|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19267641|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19267642|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267643|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
19267644|NCT04453761|Vitamins|vitamins|mesh-ancestor
19267645|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
19267646|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393387|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19393388|NCT03686254|Growth Substances|growth substances|mesh-ancestor
19393389|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393390|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
19393391|NCT03686163|Mitogens|mitogens|mesh-list
19393392|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19393393|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20176997|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20176998|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20176999|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20177000|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20177001|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177002|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177003|NCT00174343|Exemestane|exemestane|mesh-list
20177004|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177005|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20177006|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20177007|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177008|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351228|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
20177009|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20177010|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
20177011|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177012|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177013|NCT00174356|Paclitaxel|paclitaxel|mesh-list
20177014|NCT00174356|Carboplatin|carboplatin|mesh-list
20177015|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20177016|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351229|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
19404072|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
19404073|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351230|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267647|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
19267648|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19267649|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267650|NCT04453280|Antibodies|antibodies|mesh-list
19267651|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
19267652|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267653|NCT04453423|Carboplatin|carboplatin|mesh-list
19267654|NCT04453423|Pemetrexed|pemetrexed|mesh-list
19267655|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267656|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267657|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267658|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19267659|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19267660|NCT04453306|Topiramate|topiramate|mesh-list
19267661|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
19267662|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19267663|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267664|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19267665|NCT04453371|Plasminogen|plasminogen|mesh-list
19267666|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267667|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267668|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267669|NCT04453345|Thalidomide|thalidomide|mesh-list
19267670|NCT04453345|Prednisone|prednisone|mesh-list
19267671|NCT04453345|Methotrexate|methotrexate|mesh-list
19267672|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267673|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
19267674|NCT04453345|Hormones|hormones|mesh-ancestor
19267675|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267676|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267677|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19267678|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267679|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20177017|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177018|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
20177019|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177020|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177021|NCT00174395|Eletriptan|eletriptan|mesh-list
20177022|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20177023|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
20177024|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177025|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177026|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177027|NCT00174434|Paclitaxel|paclitaxel|mesh-list
20177028|NCT00174434|Sunitinib|sunitinib|mesh-list
20177029|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20177030|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177031|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177032|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
20177033|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177034|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177035|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20177036|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20177037|NCT00174434|Growth Substances|growth substances|mesh-ancestor
20177038|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177039|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
20177040|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20177041|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177042|NCT00174473|Voriconazole|voriconazole|mesh-list
20177043|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
20177044|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177045|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20177046|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20177047|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177048|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177049|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20177050|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
20177051|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177052|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177053|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20177054|NCT00174486|Tadalafil|tadalafil|mesh-list
20177055|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
20217133|NCT00308594|Dexamethasone|dexamethasone|mesh-list
20351231|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351232|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
20351233|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351234|NCT00877396|Vaccines|vaccines|mesh-list
19267680|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
19267681|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19267682|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19267683|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
19267684|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267685|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
19267686|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267687|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19267688|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19267689|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
19267690|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267691|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19267692|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
19267693|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19267694|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267695|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19267696|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19267697|NCT04453345|Growth Substances|growth substances|mesh-ancestor
19267698|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
19267699|NCT04453436|Tenofovir|tenofovir|mesh-list
19267700|NCT04453436|Lamivudine|lamivudine|mesh-list
19267701|NCT04453436|Dolutegravir|dolutegravir|mesh-list
19267702|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
19267703|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267704|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19267705|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19267706|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267707|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267708|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19267709|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19267710|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19267711|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19267712|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19267713|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19267714|NCT04453332|Hormones|hormones|mesh-list
20351235|NCT00877396|Immunologic Factors|immunologic factors|mesh-ancestor
20351236|NCT00877396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351237|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20351238|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
20351239|NCT00877422|Vitamin D|vitamin d|mesh-list
19267715|NCT04453332|Estradiol|estradiol|mesh-list
19267716|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19267717|NCT04453332|Progesterone|progesterone|mesh-list
19267718|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267719|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267720|NCT04453332|Estrogens|estrogens|mesh-ancestor
19267721|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19267722|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
19267723|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19267724|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19267725|NCT04453332|Progestins|progestins|mesh-ancestor
19267726|NCT04453189|Lansoprazole|lansoprazole|mesh-list
19267727|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
19267728|NCT04453189|Famotidine|famotidine|mesh-list
19267729|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19267730|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19267731|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19267732|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267733|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267734|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19267735|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
19267736|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
19267737|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267738|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267739|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19267740|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267741|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
19267742|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19267743|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
20351240|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
19267744|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351241|NCT00877422|Vitamins|vitamins|mesh-ancestor
20351242|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
19666902|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666903|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19666904|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666905|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666906|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19666907|NCT04941443|Narcotics|narcotics|mesh-ancestor
20351243|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351244|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19267745|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
19267746|NCT04453111|Protective Agents|protective agents|mesh-ancestor
19267747|NCT04452838|Fesoterodine|fesoterodine|mesh-list
19267748|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19267749|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19267750|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
19267751|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19666908|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666909|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
19666910|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
19666911|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
19267752|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267753|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267754|NCT04452838|Urological Agents|urological agents|mesh-ancestor
19267755|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
19267756|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19267757|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267758|NCT04452929|Calcitonin|calcitonin|mesh-list
19267759|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
19267760|NCT04452929|Cilostazol|cilostazol|mesh-list
19267761|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19267762|NCT04452929|Erenumab|erenumab|mesh-list
19267763|NCT04452929|Katacalcin|katacalcin|mesh-list
19267764|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19267765|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
19267766|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267767|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267768|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19267769|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
19267770|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267771|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267772|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267773|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19267774|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
19267775|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19267776|NCT04452929|Protective Agents|protective agents|mesh-ancestor
19267777|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19267778|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19267779|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267780|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19267781|NCT04452929|Analgesics|analgesics|mesh-ancestor
19267782|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
19267783|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19267784|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19267785|NCT04452669|Epoprostenol|epoprostenol|mesh-list
19267786|NCT04452669|Tezosentan|tezosentan|mesh-list
19267787|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19267788|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19267789|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
19267790|NCT04452370|Etoposide|etoposide|mesh-list
19267791|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19267792|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267793|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19267794|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19267795|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666912|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20177056|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20177057|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20177058|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177059|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177060|NCT00174486|Urological Agents|urological agents|mesh-ancestor
20177061|NCT00174499|Nicotine|nicotine|mesh-list
20177062|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20177063|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
20177064|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177065|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267796|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267797|NCT04452461|Leucovorin|leucovorin|mesh-list
19267798|NCT04452461|Gemcitabine|gemcitabine|mesh-list
19267799|NCT04452461|Paclitaxel|paclitaxel|mesh-list
19267800|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
20351245|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20351246|NCT00877539|Fluticasone|fluticasone|mesh-list
20351247|NCT00877539|Xhance|xhance|mesh-list
20351248|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267801|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19267802|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267803|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
19267804|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
19267805|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
19267806|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267807|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19267808|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
19267809|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
19267810|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267811|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267812|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19267813|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
19267814|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267815|NCT04452461|Antidotes|antidotes|mesh-ancestor
19267816|NCT04452461|Protective Agents|protective agents|mesh-ancestor
19267817|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
19267818|NCT04452461|Vitamins|vitamins|mesh-ancestor
19267819|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
19267820|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
19267821|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19267822|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267823|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
19267824|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
19267825|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19267826|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19267827|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267828|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19267829|NCT04451655|Insulin|insulin|mesh-list
19267830|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19267831|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267832|NCT04451395|Micronutrients|micronutrients|mesh-list
19267833|NCT04451395|Trace Elements|trace elements|mesh-list
19267834|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177066|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20177067|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19393396|NCT03686085|Dinoprostone|dinoprostone|mesh-list
19393397|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
19393398|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393399|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393400|NCT03685630|Brivaracetam|brivaracetam|mesh-list
19393401|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
19393402|NCT03685500|Emtricitabine|emtricitabine|mesh-list
19393403|NCT03685500|Darunavir|darunavir|mesh-list
19393404|NCT03685500|Cobicistat|cobicistat|mesh-list
19393405|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
19393406|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393407|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19393408|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19393409|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393410|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393411|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20177068|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
20177069|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177070|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177071|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
20177072|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20177073|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177074|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20177075|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20177076|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217134|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393412|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19393413|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20351249|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20351250|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
19393414|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19393415|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
19393416|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20351251|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351252|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351253|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20351254|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
20351255|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
20177077|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177078|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267835|NCT04451447|SMOFlipid|smoflipid|mesh-list
19267836|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19267837|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19267838|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19267839|NCT04451200|Busulfan|busulfan|mesh-list
19267840|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
19267841|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267842|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19267843|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
19267844|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267845|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19267846|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177079|NCT00174538|Codeine|codeine|mesh-list
20177080|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20351256|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20351257|NCT00877591|Ritonavir|ritonavir|mesh-list
20351258|NCT00877591|Darunavir|darunavir|mesh-list
20351259|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
20351260|NCT00877591|Rifampin|rifampin|mesh-list
20351261|NCT00877591|Rifabutin|rifabutin|mesh-list
19267847|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19267848|NCT04451239|Cyclosporine|cyclosporine|mesh-list
19267849|NCT04451239|Cyclosporins|cyclosporins|mesh-list
19267850|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267851|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267852|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19267853|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
19267854|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267855|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
19267856|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267857|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
19267858|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267859|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19267860|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19267861|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19267862|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19267863|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351262|NCT00877591|Buprenorphine|buprenorphine|mesh-list
20351263|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20351264|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20351265|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
20351266|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351267|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351268|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20351269|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20351270|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
19666913|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19666914|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
20177081|NCT00174538|Narcotics|narcotics|mesh-ancestor
20351271|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351272|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20351273|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20351274|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20351275|NCT00877591|Narcotics|narcotics|mesh-ancestor
20351276|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351277|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267864|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177082|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177083|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177084|NCT00174538|Analgesics|analgesics|mesh-ancestor
20177085|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
20177086|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177087|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
20177088|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177089|NCT00174551|Prazosin|prazosin|mesh-list
20177090|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20177091|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20177092|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20351278|NCT00877591|Analgesics|analgesics|mesh-ancestor
19267865|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19267866|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19267867|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267868|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
19267869|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267870|NCT04451174|Prednisone|prednisone|mesh-list
19267871|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267872|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
19267873|NCT04451174|Hormones|hormones|mesh-ancestor
19267874|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19267875|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267876|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19267877|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267878|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
19267879|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19267880|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267881|NCT04451083|Camostat|camostat|mesh-list
19666915|NCT04893148|Dulaglutide|dulaglutide|mesh-list
19666916|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177093|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20177094|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
20177095|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177096|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177097|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267882|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
19666917|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267883|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267884|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267885|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19267886|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19267887|NCT04450836|Trifluridine|trifluridine|mesh-list
19267888|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
19267889|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267890|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
19267891|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267892|NCT04450680|Lactams|lactams|mesh-list
19267893|NCT04450680|beta-Lactams|beta-lactams|mesh-list
19267894|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19267895|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267896|NCT04450446|Heparin|heparin|mesh-list
19267897|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19267898|NCT04450446|Tinzaparin|tinzaparin|mesh-list
19267899|NCT04450446|Dalteparin|dalteparin|mesh-list
20177098|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
20177099|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177100|NCT00174577|Risperidone|risperidone|mesh-list
20177101|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20177102|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
20177103|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177104|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177105|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177106|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20177107|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19267900|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
19267901|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19267902|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267903|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267904|NCT04450160|Temozolomide|temozolomide|mesh-list
19267905|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19267906|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
19267907|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267908|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267909|NCT04450134|Fexofenadine|fexofenadine|mesh-list
19267910|NCT04450134|Famotidine|famotidine|mesh-list
20177108|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177109|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177110|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19267911|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19267912|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666918|NCT04777422|Defibrotide|defibrotide|mesh-list
19666919|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19666920|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19666921|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267913|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19666922|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19267914|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
19267915|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
19267916|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19267917|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267918|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267919|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19267920|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19267921|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19267922|NCT04450212|Vitamin K|vitamin k|mesh-list
19267923|NCT04450212|Vitamins|vitamins|mesh-ancestor
19267924|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
19267925|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267926|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20351279|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
20351280|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351281|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20351282|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20351283|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
20351284|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351285|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
20351286|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19267927|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19267928|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267929|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
19267930|NCT04450212|Coagulants|coagulants|mesh-ancestor
19267931|NCT04450095|Ambrisentan|ambrisentan|mesh-list
19267932|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19267933|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
19267934|NCT04449965|Povidone|povidone|mesh-list
19267935|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
19267936|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
20351287|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20351288|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20351289|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19267937|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19267938|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267939|NCT04449952|Listerine|listerine|mesh-list
19267940|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
19267941|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
19267942|NCT04449952|Protective Agents|protective agents|mesh-ancestor
19267943|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267944|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19267945|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19267946|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19267947|NCT04449718|Vitamin D|vitamin d|mesh-list
19267948|NCT04449718|Vitamins|vitamins|mesh-ancestor
19267949|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
19267950|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267951|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19267952|NCT04450199|Vitamin D|vitamin d|mesh-list
19267953|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
19267954|NCT04450199|Vitamins|vitamins|mesh-list
19267955|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
19267956|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267957|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19267958|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19267959|NCT04449198|Resveratrol|resveratrol|mesh-list
19267960|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
19267961|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267962|NCT04449198|Protective Agents|protective agents|mesh-ancestor
19267963|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267964|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19267965|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19267966|NCT04449224|Etanercept|etanercept|mesh-list
19267967|NCT04449224|Abatacept|abatacept|mesh-list
19267968|NCT04449224|Tofacitinib|tofacitinib|mesh-list
19267969|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19267970|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19267971|NCT04449224|Analgesics|analgesics|mesh-ancestor
19267972|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
19267973|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267974|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267975|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19267976|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19267977|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19267978|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20351290|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20351291|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20351292|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20351293|NCT00877656|Zanolimumab|zanolimumab|mesh-list
20351294|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20351295|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351296|NCT00877734|Baclofen|baclofen|mesh-list
20351297|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20351298|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351299|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20351300|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351301|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20351302|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
20351303|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
20351304|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351305|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351306|NCT00877760|Interferons|interferons|mesh-list
20351307|NCT00877760|Entecavir|entecavir|mesh-list
19267979|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
19267980|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19267981|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267982|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19267983|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19267984|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393417|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19393418|NCT03685409|Metformin|metformin|mesh-list
19393419|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19393420|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393421|NCT03685331|Olaparib|olaparib|mesh-list
19393422|NCT03685331|Fulvestrant|fulvestrant|mesh-list
19393423|NCT03685331|Palbociclib|palbociclib|mesh-list
20351308|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351309|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
20351310|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351311|NCT00877812|Glycine|glycine|mesh-list
20351312|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
20351313|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351314|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351315|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351316|NCT00877955|Alprazolam|alprazolam|mesh-list
20351317|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20351318|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351319|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351320|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20351321|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19393424|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19393425|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393426|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393427|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393428|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393429|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19393430|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19393431|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
19393432|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393433|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393434|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19393435|NCT03685149|Flecainide|flecainide|mesh-list
19393436|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19393437|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19666923|NCT04681105|Acetaminophen|acetaminophen|mesh-list
19666924|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
19666925|NCT04681105|Promethazine|promethazine|mesh-list
19666926|NCT04681105|Dexamethasone|dexamethasone|mesh-list
19666927|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
20351322|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351323|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
20351324|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
20351325|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351326|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351327|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
19666928|NCT04681105|Ibuprofen|ibuprofen|mesh-list
19666929|NCT04681105|Ranitidine|ranitidine|mesh-list
19666930|NCT04681105|Antibodies|antibodies|mesh-list
19666931|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
20351328|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19666932|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19267985|NCT04449289|Lidocaine|lidocaine|mesh-list
19267986|NCT04449289|Ropivacaine|ropivacaine|mesh-list
19267987|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
19267988|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
19267989|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19267990|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19267991|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
19267992|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19267993|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19267994|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19267995|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19267996|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19267997|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19267998|NCT04449471|Naproxen|naproxen|mesh-list
19267999|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19268000|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19268001|NCT04449471|Analgesics|analgesics|mesh-ancestor
19268002|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
19666933|NCT04681105|BB 1101|bb 1101|mesh-list
19666934|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
19666935|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666936|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19666937|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
19666938|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
19666939|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19666940|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19666941|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
19666942|NCT04681105|Hormones|hormones|mesh-ancestor
19666943|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19666944|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19666945|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19666946|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
19666947|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666948|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666949|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19666950|NCT04681105|Analgesics|analgesics|mesh-ancestor
19666951|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
19666952|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
19666953|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19666954|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19666955|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19666956|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19666957|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19666958|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666959|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
19666960|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
19666961|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19666962|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
20177111|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
20177112|NCT00174590|Risperidone|risperidone|mesh-list
20177113|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20177114|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
20177115|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177116|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177117|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177118|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20177119|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177120|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177121|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177122|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20177123|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
20177124|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20177125|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
20177126|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177127|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20177128|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177129|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177130|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177131|NCT00174616|Capecitabine|capecitabine|mesh-list
20177132|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
20177133|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177134|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
19666963|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
20217135|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
19268003|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268004|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268005|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19268006|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19268007|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
19268008|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19268009|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268010|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268011|NCT04449185|Amoxicillin|amoxicillin|mesh-list
19268012|NCT04449185|Clarithromycin|clarithromycin|mesh-list
19268013|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19268014|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268015|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19268016|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268017|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268018|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19268019|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19268020|NCT04449380|Interferons|interferons|mesh-list
19268021|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268022|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
19268023|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268024|NCT04448873|Sirolimus|sirolimus|mesh-list
19268025|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19268026|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268027|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19268028|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268029|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
19268030|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19268031|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
19268032|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268033|NCT04448821|Metformin|metformin|mesh-list
19268034|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19268035|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268036|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
19268037|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
19268038|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268039|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19268040|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19268041|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268042|NCT04448587|Incretins|incretins|mesh-ancestor
19268043|NCT04448587|Hormones|hormones|mesh-ancestor
19268044|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268045|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19268046|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
20177135|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177136|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177137|NCT00174629|Gemcitabine|gemcitabine|mesh-list
20177138|NCT00174629|Docetaxel|docetaxel|mesh-list
20177139|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177140|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
19268047|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268048|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268049|NCT04448496|Dexamethasone|dexamethasone|mesh-list
19268050|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19268051|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
19666964|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177141|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177142|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177143|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
20177144|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177145|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177146|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177147|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
20177148|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177149|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177150|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
20177151|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177152|NCT00174642|Insulin|insulin|mesh-list
20177153|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20177154|NCT00174642|Metformin|metformin|mesh-list
20177155|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
20177156|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
20177157|NCT00174642|Secretagogues|secretagogues|mesh-list
19666965|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20177158|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20217136|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
19268052|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
19268053|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268054|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268055|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19268056|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
19268057|NCT04448496|Hormones|hormones|mesh-ancestor
19268058|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268059|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19268060|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177159|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177160|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
20177161|NCT00174655|Docetaxel|docetaxel|mesh-list
20177162|NCT00174655|Doxorubicin|doxorubicin|mesh-list
20177163|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19268061|NCT04448457|Sufentanil|sufentanil|mesh-list
19268062|NCT04448457|Oxycodone|oxycodone|mesh-list
19268063|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268064|NCT04448457|Narcotics|narcotics|mesh-ancestor
19268065|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268066|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268067|NCT04448457|Analgesics|analgesics|mesh-ancestor
19268068|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
19268069|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268070|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19268071|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19268072|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
19268073|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
19268074|NCT04448379|Osimertinib|osimertinib|mesh-list
19268075|NCT04448379|Afatinib|afatinib|mesh-list
19268076|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268077|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19268078|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268079|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268080|NCT04448392|Valacyclovir|valacyclovir|mesh-list
19268081|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
19268082|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351329|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424882|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424883|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20424884|NCT01271439|Cetuximab|cetuximab|mesh-list
20424885|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20424886|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424887|NCT01271478|Telmisartan|telmisartan|mesh-list
20424888|NCT01271478|Captopril|captopril|mesh-list
19268083|NCT04448223|Latanoprost|latanoprost|mesh-list
19268084|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19268085|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19268086|NCT04448119|Favipiravir|favipiravir|mesh-list
19268087|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
19268088|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268089|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
19268090|NCT04448015|Narcotics|narcotics|mesh-ancestor
19268091|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268092|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268093|NCT04448015|Analgesics|analgesics|mesh-ancestor
19268094|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
19268095|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177164|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177165|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
20177166|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177167|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20177168|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20177169|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
20177170|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177171|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177172|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20177173|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177174|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
20177175|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177176|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19268096|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
20177177|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19268097|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
19268098|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20177178|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20177179|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177180|NCT00174668|Insulin|insulin|mesh-list
20351330|NCT00878124|Ubiquinone|ubiquinone|mesh-list
19268099|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19268100|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268101|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268102|NCT04447989|Urological Agents|urological agents|mesh-ancestor
19268103|NCT04447781|Citric Acid|citric acid|mesh-list
19268104|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
19268105|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
20351331|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
20351332|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
20351333|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351334|NCT00878124|Vitamins|vitamins|mesh-ancestor
20351335|NCT00878254|Leucovorin|leucovorin|mesh-list
20351336|NCT00878254|Cytarabine|cytarabine|mesh-list
20351337|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
20351338|NCT00878254|Ifosfamide|ifosfamide|mesh-list
20351339|NCT00878254|Rituximab|rituximab|mesh-list
20177181|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20177182|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
20177183|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
19666966|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
19666967|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
19666968|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19666969|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19666970|NCT04642950|Sargramostim|sargramostim|mesh-list
19666971|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
19666972|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666973|NCT04593914|Protective Agents|protective agents|mesh-list
19666974|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835833|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19268106|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19268107|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
19268108|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
19268109|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268110|NCT04448028|Esomeprazole|esomeprazole|mesh-list
19268111|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19268112|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19268113|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19268114|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268115|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268116|NCT04447612|Gemcitabine|gemcitabine|mesh-list
19268117|NCT04447612|Durvalumab|durvalumab|mesh-list
20177184|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177185|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177186|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
20177187|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177188|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177189|NCT00174694|Telithromycin|telithromycin|mesh-list
20177190|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20177191|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268118|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268119|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19268120|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
19268121|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268122|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
19268123|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351340|NCT00878254|Doxorubicin|doxorubicin|mesh-list
20351341|NCT00878254|Methotrexate|methotrexate|mesh-list
19268124|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268125|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19268126|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
19268127|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268128|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19268129|NCT04447352|Leucovorin|leucovorin|mesh-list
19268130|NCT04447352|Docetaxel|docetaxel|mesh-list
19268131|NCT04447352|Fluorouracil|fluorouracil|mesh-list
19268132|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
19268133|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268134|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
19268135|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
19268136|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177192|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
20351342|NCT00878254|Etoposide|etoposide|mesh-list
20351343|NCT00878254|Vincristine|vincristine|mesh-list
19268137|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268138|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
19666975|NCT04578015|Metronidazole|metronidazole|mesh-list
19835834|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
20177193|NCT00174707|Docetaxel|docetaxel|mesh-list
20351344|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20351345|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
19268139|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19268140|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19268141|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
19268142|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268143|NCT04447352|Antidotes|antidotes|mesh-ancestor
19268144|NCT04447352|Protective Agents|protective agents|mesh-ancestor
19268145|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
19268146|NCT04447352|Vitamins|vitamins|mesh-ancestor
20351346|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351347|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351348|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19268147|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
19268148|NCT04447326|Endostar protein|endostar protein|mesh-list
19268149|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19268150|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19268151|NCT04447326|Growth Substances|growth substances|mesh-ancestor
19268152|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268153|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
19268154|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268155|NCT04447274|Apatinib|apatinib|mesh-list
19268156|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268157|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835835|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835836|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835837|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19835838|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835839|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177194|NCT00174707|Methotrexate|methotrexate|mesh-list
19268158|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268159|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268160|NCT04447443|Loperamide|loperamide|mesh-list
19268161|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
19268162|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19268163|NCT04447235|Ivermectin|ivermectin|mesh-list
19268164|NCT04447235|Losartan|losartan|mesh-list
19268165|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19268166|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19268167|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19268168|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20351349|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
20351350|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351351|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268169|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268170|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268171|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268172|NCT04447560|Bupivacaine|bupivacaine|mesh-list
19268173|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
19268174|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
19268175|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268176|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268177|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
20351352|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20351353|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20351354|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20351355|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20351356|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19268178|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268179|NCT04447092|Leucovorin|leucovorin|mesh-list
19268180|NCT04447092|Gemcitabine|gemcitabine|mesh-list
19268181|NCT04447092|Paclitaxel|paclitaxel|mesh-list
19268182|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
19268183|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
20177195|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177196|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
20177197|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177198|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20177199|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20177200|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
20177201|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177202|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177203|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20177204|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177205|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
19268184|NCT04447092|Irinotecan|irinotecan|mesh-list
19268185|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20351357|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268186|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268187|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
19268188|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19268189|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19268190|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268191|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19268192|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
19268193|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
19268194|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268195|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177206|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177207|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19666976|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177208|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
20177209|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20177210|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177211|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
20177212|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
20177213|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177214|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20177215|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20177216|NCT00174720|Ciclesonide|ciclesonide|mesh-list
20177217|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
20177218|NCT00174720|Hormones|hormones|mesh-ancestor
20177219|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177220|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177221|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19268196|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19268197|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
19268198|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268199|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19268200|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19268201|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19268202|NCT04447092|Antidotes|antidotes|mesh-ancestor
19268203|NCT04447092|Protective Agents|protective agents|mesh-ancestor
19268204|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
19268205|NCT04447092|Vitamins|vitamins|mesh-ancestor
19268206|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
19268207|NCT04447378|PENTA|penta|mesh-list
19268208|NCT04447378|Fondaparinux|fondaparinux|mesh-list
19268209|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19268210|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
19268211|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19268212|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
19268213|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268214|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268215|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
19268216|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20177222|NCT00174733|Ciclesonide|ciclesonide|mesh-list
20177223|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
20177224|NCT00174733|Hormones|hormones|mesh-ancestor
19268217|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19393438|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19393439|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19393440|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393441|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19393442|NCT03685084|Piperacillin|piperacillin|mesh-list
19393443|NCT03685084|Cefepime|cefepime|mesh-list
19393444|NCT03685084|Lactams|lactams|mesh-list
19393445|NCT03685084|beta-Lactams|beta-lactams|mesh-list
19393446|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
19393447|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19393448|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393449|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
19393450|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19393451|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393452|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393453|NCT03685032|Dexamethasone|dexamethasone|mesh-list
19393454|NCT03685032|Ondansetron|ondansetron|mesh-list
19393455|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393456|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
20177225|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393457|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
19393458|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393459|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268218|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19268219|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19268220|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268221|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
19268222|NCT04447105|Anesthetics|anesthetics|mesh-list
19268223|NCT04447105|Propofol|propofol|mesh-list
20351358|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20351359|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
20351360|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19268224|NCT04447105|Desflurane|desflurane|mesh-list
19268225|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268226|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268227|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19268228|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19268229|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
19268230|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19268231|NCT04446923|Propranolol|propranolol|mesh-list
19268232|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19268233|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19268234|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
19268235|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19268236|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268237|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268238|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19268239|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19268240|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
19268241|NCT04446871|Methylene Blue|methylene blue|mesh-list
19268242|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268243|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268244|NCT04446663|Paclitaxel|paclitaxel|mesh-list
19268245|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19268246|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19268247|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268248|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
19268249|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
19268250|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177226|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177227|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20177228|NCT00174759|Clopidogrel|clopidogrel|mesh-list
20177229|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20177230|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20177231|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20177232|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20177233|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
20177234|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177235|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177236|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351361|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19268251|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268252|NCT04446715|Sufentanil|sufentanil|mesh-list
19268253|NCT04446715|Meperidine|meperidine|mesh-list
19268254|NCT04446715|Bupivacaine|bupivacaine|mesh-list
19268255|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
19268256|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
19268257|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177237|NCT00174772|Cisplatin|cisplatin|mesh-list
20177238|NCT00174772|Docetaxel|docetaxel|mesh-list
20351362|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
20351363|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
20351364|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20351365|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20351366|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20351367|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
20351368|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351369|NCT00878254|Antidotes|antidotes|mesh-ancestor
20351370|NCT00878254|Protective Agents|protective agents|mesh-ancestor
20351371|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
20351372|NCT00878254|Vitamins|vitamins|mesh-ancestor
20351373|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
20351374|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
20351375|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
20351376|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
20351377|NCT00878306|Ritonavir|ritonavir|mesh-list
20351378|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20351379|NCT00878306|Efavirenz|efavirenz|mesh-list
19268258|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268259|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
19666977|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666978|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19666979|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19666980|NCT04573504|Clindamycin|clindamycin|mesh-list
19666981|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
19666982|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
19666983|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19666984|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19666985|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19666986|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19666987|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666988|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666989|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19666990|NCT04546230|Anesthetics|anesthetics|mesh-list
19268260|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268261|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268262|NCT04446715|Narcotics|narcotics|mesh-ancestor
19268263|NCT04446715|Analgesics|analgesics|mesh-ancestor
19268264|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19268265|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19268266|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
19268267|NCT04446598|Tadalafil|tadalafil|mesh-list
19268268|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19268269|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19268270|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19268271|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268272|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268273|NCT04446598|Urological Agents|urological agents|mesh-ancestor
19268274|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
19268275|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19268276|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19268277|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
19268278|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19268279|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268280|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
19268281|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
19268282|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19268283|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
19268284|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268285|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
19268286|NCT04446533|Protective Agents|protective agents|mesh-ancestor
19268287|NCT04446637|Albuterol|albuterol|mesh-list
19268288|NCT04446637|Ipratropium|ipratropium|mesh-list
19268289|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19268290|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
19268291|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268292|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177239|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177240|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177241|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
20351380|NCT00878306|Disulfiram|disulfiram|mesh-list
20351381|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20351382|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20351383|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
19268293|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20177242|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177243|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177244|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20177245|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20177246|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19666991|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19666992|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19666993|NCT04528667|Abivertinib|abivertinib|mesh-list
19666994|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19666995|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666996|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20177247|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
20177248|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177249|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177250|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177251|NCT00174798|Urological Agents|urological agents|mesh-ancestor
19268294|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177252|NCT00174811|Telithromycin|telithromycin|mesh-list
20177253|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19268295|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
20177254|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177255|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
20351384|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351385|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351386|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20351387|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20351388|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
20351389|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351390|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20351391|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20351392|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20351393|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20351394|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20351395|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20351396|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20351397|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20351398|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20351399|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20351400|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20351401|NCT00878345|Pentobarbital|pentobarbital|mesh-list
20351402|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
20351403|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20351404|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351405|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351406|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177256|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177257|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177258|NCT00174863|SR 31747|sr 31747|mesh-list
20177259|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177260|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177261|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177262|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
20177263|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177264|NCT00174876|Aripiprazole|aripiprazole|mesh-list
20177265|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
20177266|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19268296|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19268297|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19268298|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19268299|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19268300|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
19268301|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351407|NCT00878345|Analgesics|analgesics|mesh-ancestor
20351408|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
20351409|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351410|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20351411|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20351412|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20351413|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351414|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351415|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351416|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20351417|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
20177267|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20177268|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19268302|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268303|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19268304|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
19268305|NCT04446416|Bevacizumab|bevacizumab|mesh-list
19268306|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19268307|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177269|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268308|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19666997|NCT04495257|Nivolumab|nivolumab|mesh-list
19666998|NCT04495257|Ipilimumab|ipilimumab|mesh-list
20177270|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177271|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
20177272|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
20177273|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177274|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19666999|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20177275|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20351418|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
20351419|NCT00878371|Morphine|morphine|mesh-list
20351420|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20351421|NCT00878371|Narcotics|narcotics|mesh-ancestor
20351422|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351423|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351424|NCT00878371|Analgesics|analgesics|mesh-ancestor
20351425|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
20351426|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268309|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20351427|NCT00878449|Etoposide|etoposide|mesh-list
20351428|NCT00878449|Navitoclax|navitoclax|mesh-list
20351429|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351430|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20351431|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20351432|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351433|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351434|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351435|NCT00878514|Alprazolam|alprazolam|mesh-list
20177276|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20177277|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
20177278|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20177279|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20177280|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20177281|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20177282|NCT00174902|Aspirin|aspirin|mesh-list
19268310|NCT04446416|Growth Substances|growth substances|mesh-ancestor
19268311|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268312|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
19268313|NCT04446403|Anesthetics|anesthetics|mesh-list
19268314|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268315|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268316|NCT04446338|Antibodies|antibodies|mesh-list
19268317|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
19268318|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268319|NCT04446364|Disinfectants|disinfectants|mesh-list
19268320|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268321|NCT04445922|Anastrozole|anastrozole|mesh-list
19268322|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19268323|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268324|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19268325|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19835840|NCT00605657|Valproic Acid|valproic acid|mesh-list
19835841|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
19835842|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835843|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835844|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
19835845|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835846|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835847|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
20177283|NCT00174902|Propranolol|propranolol|mesh-list
20177284|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20177285|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177286|NCT00174902|Analgesics|analgesics|mesh-ancestor
20177287|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
20351436|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20351437|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351438|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351439|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20351440|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20351441|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19268326|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177288|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177289|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177290|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177291|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351442|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
20351443|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
19268327|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268328|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19268329|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
19268330|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268331|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268332|NCT04446234|Risperidone|risperidone|mesh-list
19268333|NCT04446234|Aripiprazole|aripiprazole|mesh-list
19268334|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19268335|NCT04446234|Ziprasidone|ziprasidone|mesh-list
20351444|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351445|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351446|NCT00878540|Mirtazapine|mirtazapine|mesh-list
20351447|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
20351448|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351449|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20351450|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
19667000|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667001|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19667002|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268336|NCT04446234|Amisulpride|amisulpride|mesh-list
20351451|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
19268337|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19268338|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
19268339|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19268340|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268341|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268342|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19268343|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19268344|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268345|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19268346|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19268347|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
19268348|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
19268349|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
19268350|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19268351|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19268352|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19268353|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19268354|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19268355|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19268356|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
19268357|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268358|NCT04446065|Protective Agents|protective agents|mesh-ancestor
19268359|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268360|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19268361|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19268362|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268363|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19268364|NCT04445948|Amoxicillin|amoxicillin|mesh-list
19268365|NCT04445948|Metronidazole|metronidazole|mesh-list
19268366|NCT04445948|Clarithromycin|clarithromycin|mesh-list
19268367|NCT04445948|Lactoferrin|lactoferrin|mesh-list
19268368|NCT04445948|Esomeprazole|esomeprazole|mesh-list
19268369|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19268370|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268371|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19268372|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268373|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19268374|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19268375|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19268376|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268377|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268378|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19268379|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19268380|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19268381|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19268382|NCT04446039|Vortioxetine|vortioxetine|mesh-list
19268383|NCT04446039|Mirtazapine|mirtazapine|mesh-list
19268384|NCT04446039|Citalopram|citalopram|mesh-list
19691846|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691847|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
19691848|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691849|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691850|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691851|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
20177292|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20177293|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20177294|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177295|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20177296|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20177297|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177298|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
20177299|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20177300|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20177301|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
20177302|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177303|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20177304|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20177305|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177306|NCT00174928|Lansoprazole|lansoprazole|mesh-list
20177307|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
20351452|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351453|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351454|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177308|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20177309|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20177310|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20177311|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177312|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177313|NCT00174993|Pioglitazone|pioglitazone|mesh-list
20177314|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177315|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351455|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19268385|NCT04446039|Bupropion|bupropion|mesh-list
19268386|NCT04446039|Fluoxetine|fluoxetine|mesh-list
19268387|NCT04446039|Paroxetine|paroxetine|mesh-list
19268388|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19667003|NCT04468776|Zolpidem|zolpidem|mesh-list
19667004|NCT04468776|Trazodone|trazodone|mesh-list
19667005|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19268389|NCT04446039|Sertraline|sertraline|mesh-list
19268390|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19268391|NCT04446039|Tianeptine|tianeptine|mesh-list
19268392|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19268393|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19268394|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19268395|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268396|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19268397|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
19268398|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268399|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19268400|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
19268401|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19268402|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268403|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19268404|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
19268405|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19268406|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19268407|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268408|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19268409|NCT04446039|Analgesics|analgesics|mesh-ancestor
19268410|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
19268411|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19268412|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19268413|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268414|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19268415|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19268416|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19268417|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19268418|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19268419|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
19268420|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
19268421|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19268422|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19268423|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19268424|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351456|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20351457|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268425|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19268426|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19268427|NCT04446091|Irinotecan|irinotecan|mesh-list
19268428|NCT04446091|Apatinib|apatinib|mesh-list
19667006|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19667007|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177316|NCT00175032|Aspirin|aspirin|mesh-list
20177317|NCT00175032|Celecoxib|celecoxib|mesh-list
20177318|NCT00175032|Naproxen|naproxen|mesh-list
20177319|NCT00175032|Lansoprazole|lansoprazole|mesh-list
19268429|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19268430|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19268431|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19268432|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268433|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268434|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268435|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19268436|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20351458|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20351459|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20351460|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20351461|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351462|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20351463|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20351464|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
20351465|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20351466|NCT00878631|Dextrans|dextrans|mesh-list
20351467|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
20351468|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
20351469|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
20351470|NCT00878657|Gemcitabine|gemcitabine|mesh-list
19268437|NCT04446091|Growth Substances|growth substances|mesh-ancestor
19268438|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268439|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
19268440|NCT04446104|Ascorbic Acid|ascorbic acid|mesh-list
19268441|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
19268442|NCT04446104|Ivermectin|ivermectin|mesh-list
19268443|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
19268444|NCT04446104|Povidone|povidone|mesh-list
19268445|NCT04446104|Vitamins|vitamins|mesh-ancestor
19268446|NCT04446104|Micronutrients|micronutrients|mesh-ancestor
19268447|NCT04446104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268448|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
19268449|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19268450|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268451|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351471|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20351472|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
20351473|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268452|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268453|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268454|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351474|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351475|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
20351476|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351477|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351478|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20351479|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
20351480|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351481|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
20351482|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20351483|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20351484|NCT00878670|Analgesics|analgesics|mesh-ancestor
20351485|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
20351486|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351487|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268455|NCT04446104|Antioxidants|antioxidants|mesh-ancestor
19268456|NCT04446104|Protective Agents|protective agents|mesh-ancestor
19268457|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
19268458|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
19268459|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19268460|NCT04445935|Bivalirudin|bivalirudin|mesh-list
19268461|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
20351488|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20351489|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351490|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20351491|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
20351492|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351493|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20351494|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
20351495|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20351496|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20351497|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19268462|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19268463|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
19268464|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268465|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268466|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
19268467|NCT04446130|Decitabine|decitabine|mesh-list
19268468|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19268469|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
19268470|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268471|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268472|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268473|NCT04445857|Calcitonin|calcitonin|mesh-list
19268474|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
19268475|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19268476|NCT04445857|Katacalcin|katacalcin|mesh-list
19268477|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19268478|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268479|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19268480|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
19268481|NCT04445727|Ascorbic Acid|ascorbic acid|mesh-list
19268482|NCT04445727|Vitamins|vitamins|mesh-ancestor
19268483|NCT04445727|Micronutrients|micronutrients|mesh-ancestor
19268484|NCT04445727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268485|NCT04445727|Antioxidants|antioxidants|mesh-ancestor
19268486|NCT04445727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268487|NCT04445727|Protective Agents|protective agents|mesh-ancestor
19268488|NCT04445779|Ubiquinone|ubiquinone|mesh-list
19268489|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
19268490|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
19268491|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268492|NCT04445779|Vitamins|vitamins|mesh-ancestor
19268493|NCT04445467|Favipiravir|favipiravir|mesh-list
19268494|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
19268495|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667008|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667009|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19667010|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
19667011|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
19667012|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667013|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667014|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19667015|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177320|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
20177321|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20177322|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177323|NCT00175032|Analgesics|analgesics|mesh-ancestor
20177324|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
20177325|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177326|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177327|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177328|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667016|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19667017|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19667018|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19667019|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19667020|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
19667021|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19667022|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
19667023|NCT04440007|Abivertinib|abivertinib|mesh-list
20177329|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20177330|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20177331|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177332|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20177333|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20177334|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177335|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
20177336|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20177337|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
20177338|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20177339|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20177340|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20177341|NCT00175045|Lansoprazole|lansoprazole|mesh-list
20177342|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
20177343|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20177344|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20177345|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20177346|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177347|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177348|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20177349|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20177350|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20177351|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177352|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268496|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19268497|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
19268498|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
19268499|NCT04445636|Morphine|morphine|mesh-list
19268500|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19268501|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268502|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268503|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19268504|NCT04445636|Analgesics|analgesics|mesh-ancestor
19268505|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
19268506|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268507|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19268508|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20177353|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20177354|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20177355|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177356|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
20177357|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177358|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20177359|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177360|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19268509|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20177361|NCT00175162|Protective Agents|protective agents|mesh-ancestor
20177362|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217137|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217138|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217139|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217140|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
20217141|NCT00308594|Hormones|hormones|mesh-ancestor
20217142|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217143|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217144|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217145|NCT00308607|Interferons|interferons|mesh-list
20217146|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
20217147|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
20217148|NCT00308607|Bevacizumab|bevacizumab|mesh-list
20217149|NCT00308607|Dacarbazine|dacarbazine|mesh-list
20217150|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20217151|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217152|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20217153|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20217154|NCT00308607|Growth Substances|growth substances|mesh-ancestor
20217155|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217156|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
20217157|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
20217158|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217159|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
20217160|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20217161|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
20217162|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217163|NCT00308763|Bupropion|bupropion|mesh-list
20217164|NCT00308763|Nicotine|nicotine|mesh-list
20217165|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20217166|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
20217167|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217168|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217169|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20217170|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20217171|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
20217172|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217173|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217174|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20217175|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
20217176|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20217177|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20217178|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19268510|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
20177363|NCT00175227|Furosemide|furosemide|mesh-list
20177364|NCT00175227|Mannitol|mannitol|mesh-list
20177365|NCT00175227|Diuretics|diuretics|mesh-ancestor
20177366|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
20177367|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177368|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20177369|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20177370|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268511|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19268512|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268513|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268514|NCT04445636|Narcotics|narcotics|mesh-ancestor
19268515|NCT04445506|Dexamethasone|dexamethasone|mesh-list
19268516|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20351498|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20351499|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351500|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351501|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351502|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20351503|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
20351504|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351505|NCT00878865|Alprazolam|alprazolam|mesh-list
20351506|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20351507|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268517|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
19268518|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
19268519|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268520|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268521|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19268522|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
19268523|NCT04445506|Hormones|hormones|mesh-ancestor
19268524|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268525|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19268526|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268527|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19268528|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19268529|NCT04445311|Ivermectin|ivermectin|mesh-list
19268530|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268531|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393460|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393461|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
19393462|NCT03685032|Hormones|hormones|mesh-ancestor
19393463|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393464|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393465|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393466|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
20351508|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351509|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20351510|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19393467|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
19393468|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19393469|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
19393470|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393471|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393472|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19393473|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19393474|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393475|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19393476|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19393477|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
19393478|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19393479|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19393480|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393481|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
19393482|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
19393483|NCT03684876|Diuretics|diuretics|mesh-list
19393484|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
19393485|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393486|NCT03684863|Capecitabine|capecitabine|mesh-list
19393487|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19667024|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667025|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177371|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19393488|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
20351511|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351512|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
20351513|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
20351514|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351515|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351516|NCT00878904|Epirubicin|epirubicin|mesh-list
19268532|NCT04445194|Vaccines|vaccines|mesh-list
19268533|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
19268534|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268535|NCT04445025|Leuprolide|leuprolide|mesh-list
19268536|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19268537|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
19268538|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19268539|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268540|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19268541|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268542|NCT04444986|Favipiravir|favipiravir|mesh-list
19268543|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
19268544|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177372|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
20177373|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20177374|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177375|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
20177376|NCT00175266|Infliximab|infliximab|mesh-list
20177377|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
20177378|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20177379|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20177380|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19268554|NCT04444635|Fentanyl|fentanyl|mesh-list
19268555|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268556|NCT04444635|Narcotics|narcotics|mesh-ancestor
19268557|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268558|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268559|NCT04444635|Analgesics|analgesics|mesh-ancestor
19268560|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
19268561|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268562|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19268563|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19268564|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
19268565|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
19268566|NCT04444726|Betamethasone|betamethasone|mesh-list
19268567|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
19268568|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19268569|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
19268570|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19268571|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19268572|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
19268573|NCT04444726|Hormones|hormones|mesh-ancestor
19268574|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268575|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268576|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19268577|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
19268578|NCT04444830|Ketorolac|ketorolac|mesh-list
19268579|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19268580|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19268581|NCT04444830|Analgesics|analgesics|mesh-ancestor
19667026|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667027|NCT04434001|Thrombin|thrombin|mesh-list
19667028|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
19667029|NCT04434001|Coagulants|coagulants|mesh-ancestor
19667030|NCT04426591|Biotin|biotin|mesh-list
19667031|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
19667032|NCT04426591|Vitamins|vitamins|mesh-ancestor
19268582|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
19268583|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268584|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268585|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19268586|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19268587|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19268588|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268589|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351517|NCT00878904|Panobinostat|panobinostat|mesh-list
19268590|NCT04444817|Tacrolimus|tacrolimus|mesh-list
19667033|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
19268591|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667034|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667035|NCT04374240|Tretazicar|tretazicar|mesh-list
20177381|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351518|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19268592|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
19268593|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268594|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19268595|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268596|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177382|NCT00175305|Octreotide|octreotide|mesh-list
20177383|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20177384|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20177385|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177386|NCT00175357|Methadone|methadone|mesh-list
19268597|NCT04444167|Lenvatinib|lenvatinib|mesh-list
19268598|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268599|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19268600|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268601|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268602|NCT04444349|Ubiquinone|ubiquinone|mesh-list
19268603|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
19268604|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
19268605|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268606|NCT04444349|Vitamins|vitamins|mesh-ancestor
19268607|NCT04444284|Vaccines|vaccines|mesh-list
19268608|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
19268609|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268610|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
19268611|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351519|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351520|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20351521|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351522|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351523|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268612|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268613|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19268614|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19268615|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177387|NCT00175357|Heroin|heroin|mesh-list
20351524|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20351525|NCT00878917|Dorzolamide|dorzolamide|mesh-list
20351526|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20351527|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20351528|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20351529|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20351530|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351531|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351532|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
20424889|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19268616|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177388|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20177389|NCT00175357|Narcotics|narcotics|mesh-ancestor
20177390|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177391|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177392|NCT00175357|Analgesics|analgesics|mesh-ancestor
20177393|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
20177394|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177395|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
20177396|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177397|NCT00175370|Vancomycin|vancomycin|mesh-list
20177398|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20177399|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177400|NCT00175383|Hormones|hormones|mesh-list
20177401|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20177402|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177403|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177404|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
20177405|NCT00175396|Leuprolide|leuprolide|mesh-list
20177406|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
20177407|NCT00175396|Flutamide|flutamide|mesh-list
20177408|NCT00175396|Bicalutamide|bicalutamide|mesh-list
20177409|NCT00175396|Nilutamide|nilutamide|mesh-list
20177410|NCT00175396|Buserelin|buserelin|mesh-list
20177411|NCT00175396|Androgens|androgens|mesh-list
20177412|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20177413|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20177414|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
19268617|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177415|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20177416|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177417|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19268618|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19268619|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19268620|NCT04444193|Durvalumab|durvalumab|mesh-list
19268621|NCT04444193|Lenvatinib|lenvatinib|mesh-list
19268622|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19268623|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19268624|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268625|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
19268626|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268627|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19268628|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268629|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268630|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
19268631|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19268632|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19268633|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351533|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351534|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
20351535|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20351536|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20351537|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351538|NCT00878943|Urological Agents|urological agents|mesh-ancestor
20351539|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
20351540|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20351541|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351542|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351543|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20351544|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351545|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351546|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351547|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351548|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20351549|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
20351550|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20351551|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351552|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20351553|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20351554|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20351555|NCT00879021|Pregabalin|pregabalin|mesh-list
20351556|NCT00879021|Analgesics|analgesics|mesh-ancestor
20351557|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
20351558|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351559|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351560|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
20351561|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20351562|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19268634|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
19268635|NCT04443920|Coagulants|coagulants|mesh-ancestor
19268636|NCT04443946|Sufentanil|sufentanil|mesh-list
19268637|NCT04443946|Propofol|propofol|mesh-list
20177418|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177419|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
19268638|NCT04443946|Sevoflurane|sevoflurane|mesh-list
19268639|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19268640|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268641|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177420|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
20177421|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177422|NCT00175396|Hormones|hormones|mesh-ancestor
20177423|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
20177424|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177425|NCT00175396|Protective Agents|protective agents|mesh-ancestor
20177426|NCT00175396|Vitamins|vitamins|mesh-ancestor
20177427|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
20177428|NCT00175396|Estrogens|estrogens|mesh-ancestor
20177429|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
20177430|NCT00175435|Vaccines|vaccines|mesh-list
20177431|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
20177432|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177433|NCT00175513|Valacyclovir|valacyclovir|mesh-list
20177434|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
20177435|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268642|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20177436|NCT00175565|Fluticasone|fluticasone|mesh-list
20351563|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351564|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20351565|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20351566|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20351567|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268643|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
20177437|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177438|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20177439|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
20177440|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268644|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
19268645|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19268646|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19268647|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268648|NCT04443946|Narcotics|narcotics|mesh-ancestor
19268649|NCT04443946|Analgesics|analgesics|mesh-ancestor
19268650|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
20351568|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351569|NCT00879047|Ethanol|ethanol|mesh-list
20351570|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20351571|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351572|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351573|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268651|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268652|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19268653|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
19268654|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
19268655|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
19268656|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19268657|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268658|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268659|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268660|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268661|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19268662|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
19268663|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
19268664|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19268665|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
19268666|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268667|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268668|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19268669|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
19268670|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19268671|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
19268672|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268673|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19268674|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19268675|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
19268676|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
19268677|NCT04443868|Protective Agents|protective agents|mesh-ancestor
19268678|NCT04443556|Tramadol|tramadol|mesh-list
19268679|NCT04443556|Anesthetics|anesthetics|mesh-list
19268680|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
19268681|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268682|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268683|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268684|NCT04443556|Narcotics|narcotics|mesh-ancestor
19835848|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177441|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177442|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20177443|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177444|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
20177445|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20177446|NCT00175591|Bupivacaine|bupivacaine|mesh-list
20177447|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
20177448|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
20177449|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177450|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177451|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
20177452|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268685|NCT04443556|Analgesics|analgesics|mesh-ancestor
19268686|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
19268687|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268688|NCT04443634|Bupivacaine|bupivacaine|mesh-list
19268689|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
20177453|NCT00175617|Minoxidil|minoxidil|mesh-list
20177454|NCT00175617|Spironolactone|spironolactone|mesh-list
20177455|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20177456|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
20177457|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177458|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177459|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20177460|NCT00175617|Diuretics|diuretics|mesh-ancestor
19667036|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667037|NCT04230746|Trimethoprim|trimethoprim|mesh-list
19667038|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19667039|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
19667040|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19667041|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667042|NCT04230746|Renal Agents|renal agents|mesh-ancestor
19667043|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
19667044|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19667045|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19667046|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19667047|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667048|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667049|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19667050|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19667051|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667052|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19667053|NCT04201834|Risperidone|risperidone|mesh-list
19268690|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
19268691|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268692|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351574|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19268693|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
19268694|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268695|NCT04443673|Glycine|glycine|mesh-list
19268696|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
19268697|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19268698|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268699|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268700|NCT04443517|Propofol|propofol|mesh-list
19268701|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
19268702|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268703|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268704|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19268705|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19268706|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
19268707|NCT04444011|Amoxicillin|amoxicillin|mesh-list
19268708|NCT04444011|Clarithromycin|clarithromycin|mesh-list
19835849|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835850|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835851|NCT00605696|Insulin|insulin|mesh-list
19835852|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19835853|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835854|NCT00605722|Bevacizumab|bevacizumab|mesh-list
19835855|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19835856|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835857|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177461|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
19268709|NCT04444011|Bismuth|bismuth|mesh-list
19268710|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19667054|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19667055|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
19667056|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667057|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667058|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667059|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19835858|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20177462|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20177463|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177464|NCT00175630|Bupivacaine|bupivacaine|mesh-list
20177465|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
20177466|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
20177467|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177468|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268711|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268712|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19268713|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667060|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19667061|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19667062|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19667063|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19667064|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
19667065|NCT04194775|Lenvatinib|lenvatinib|mesh-list
19667066|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667067|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667068|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351575|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19268714|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177469|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
20177470|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177471|NCT00175643|Imiquimod|imiquimod|mesh-list
20177472|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20177473|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
20177474|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268715|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19268716|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19268717|NCT04444011|Antacids|antacids|mesh-ancestor
19268718|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19268719|NCT04443647|Oxytocin|oxytocin|mesh-list
19268720|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
19268721|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19268722|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268723|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19268724|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19268725|NCT04443387|Vitamin D|vitamin d|mesh-list
19268726|NCT04443387|Vitamins|vitamins|mesh-ancestor
19268727|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
19268728|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268729|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19268730|NCT04443543|Fluorouracil|fluorouracil|mesh-list
19268731|NCT04443543|Capecitabine|capecitabine|mesh-list
19268732|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
19268733|NCT04443543|Irinotecan|irinotecan|mesh-list
19268734|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
19268735|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268736|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19268737|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268738|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19268739|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
19268740|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268741|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19268742|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19268743|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268744|NCT04443270|Chloroquine|chloroquine|mesh-list
19268745|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19268746|NCT04443270|Amebicides|amebicides|mesh-ancestor
19268747|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19268748|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268749|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268750|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
19268751|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19268752|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19268753|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19268754|NCT04443270|Analgesics|analgesics|mesh-ancestor
19268755|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
19268756|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268757|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268758|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19268759|NCT04443270|Filaricides|filaricides|mesh-ancestor
19268760|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
19268761|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
19268762|NCT04443322|Durvalumab|durvalumab|mesh-list
19268763|NCT04443322|Lenvatinib|lenvatinib|mesh-list
19268764|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19268765|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19268766|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268767|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
19667069|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177475|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268768|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177476|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
20177477|NCT00175682|Prazosin|prazosin|mesh-list
19268769|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667070|NCT04115384|Insulin|insulin|mesh-list
19268770|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268771|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268772|NCT04443036|Paclitaxel|paclitaxel|mesh-list
19268773|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19268774|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19268775|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268776|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
19268777|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
19268778|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
19268779|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268780|NCT04443049|Mebendazole|mebendazole|mesh-list
19268781|NCT04443049|Piperazine|piperazine|mesh-list
19268782|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
19268783|NCT04443049|Lenvatinib|lenvatinib|mesh-list
19268784|NCT04443049|DMP 777|dmp 777|mesh-list
19268785|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268786|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19268787|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268788|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268789|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
19268790|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
19268791|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268792|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268793|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
19268794|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
19268795|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
19268796|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
20177478|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20177479|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20177480|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20177481|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20177482|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
19268797|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19268798|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
19268799|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268800|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
19268801|NCT04443166|Protective Agents|protective agents|mesh-ancestor
19268802|NCT04442919|Morphine|morphine|mesh-list
19268803|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
20351576|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
20351577|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351578|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351579|NCT00879099|Timolol|timolol|mesh-list
20351580|NCT00879099|Paroxetine|paroxetine|mesh-list
20351581|NCT00879099|Maleic acid|maleic acid|mesh-list
20351582|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20351583|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20351584|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351585|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351586|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351587|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351588|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20351589|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20351590|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351591|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20351592|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20351593|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20351594|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
20351595|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20351596|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
20351597|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351598|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20351599|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20351600|NCT00879164|Bupivacaine|bupivacaine|mesh-list
19268804|NCT04442919|Ticagrelor|ticagrelor|mesh-list
19268805|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268806|NCT04442919|Narcotics|narcotics|mesh-ancestor
19268807|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177483|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177484|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177485|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177486|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20177487|NCT00175695|Protein C|protein c|mesh-list
20177488|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
19268808|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268809|NCT04442919|Analgesics|analgesics|mesh-ancestor
19268810|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
19268811|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268812|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19268813|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19268814|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19268815|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19268816|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
19268817|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19268818|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268819|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19268820|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
19268821|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
19268822|NCT04442750|Bupivacaine|bupivacaine|mesh-list
19268823|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
19268824|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
19268825|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268826|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268827|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
19268828|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393489|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393490|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351601|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
20351602|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
20351603|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351604|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393491|NCT03684837|Vitamin D|vitamin d|mesh-list
19393492|NCT03684837|Vitamins|vitamins|mesh-ancestor
19393493|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
19393494|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393495|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19393496|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19393497|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
19393498|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19393499|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
19393500|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393501|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393502|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19393503|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393504|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393505|NCT03684772|Digoxin|digoxin|mesh-list
19393506|NCT03684772|Furosemide|furosemide|mesh-list
19393507|NCT03684772|Diuretics|diuretics|mesh-ancestor
19393508|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
19393509|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393510|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19393511|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19393512|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393513|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19393514|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19393515|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393516|NCT03684772|Protective Agents|protective agents|mesh-ancestor
19393517|NCT03684707|Metformin|metformin|mesh-list
19393518|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19393519|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393520|NCT03684564|Warfarin|warfarin|mesh-list
19667071|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19667072|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19667073|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351605|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
20351606|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351607|NCT00879177|Varenicline|varenicline|mesh-list
20351608|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20351609|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20351610|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
20351611|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351612|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351613|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351614|NCT00879242|Deferasirox|deferasirox|mesh-list
20351615|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20351616|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
19667074|NCT03991741|Interleukin-2|interleukin-2|mesh-list
19667075|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667076|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19667077|NCT03991741|Analgesics|analgesics|mesh-ancestor
20351617|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
20351618|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351619|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20351620|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20351621|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
20351622|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351623|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20351624|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20351625|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351626|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351627|NCT00879372|Tianeptine|tianeptine|mesh-list
20351628|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20351629|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
20351630|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351631|NCT00879385|Decitabine|decitabine|mesh-list
20351632|NCT00879385|Panitumumab|panitumumab|mesh-list
20351633|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20351634|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
20351635|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351636|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351637|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667078|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
19667079|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667080|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177489|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20177490|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20177491|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177492|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177493|NCT00175747|Budesonide|budesonide|mesh-list
19268829|NCT04442984|Leucovorin|leucovorin|mesh-list
19268830|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
19268831|NCT04442984|Irinotecan|irinotecan|mesh-list
19268832|NCT04442984|Fluorouracil|fluorouracil|mesh-list
19268833|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268834|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19268835|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351638|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20351639|NCT00879424|Vitamin D|vitamin d|mesh-list
20351640|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
20351641|NCT00879424|Vitamins|vitamins|mesh-ancestor
20351642|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
19268836|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268837|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268838|NCT04442984|Antidotes|antidotes|mesh-ancestor
19268839|NCT04442984|Protective Agents|protective agents|mesh-ancestor
19268840|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268841|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
19268842|NCT04442984|Vitamins|vitamins|mesh-ancestor
19268843|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
20177494|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177495|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20177496|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
20177497|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268844|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
19268845|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19268846|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19268847|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
19268848|NCT04442906|Fentanyl|fentanyl|mesh-list
19268849|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
20351643|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351644|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19268850|NCT04442906|Bupivacaine|bupivacaine|mesh-list
19268851|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
19268852|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
19268853|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19268854|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268855|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
19268856|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268857|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19268858|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19268859|NCT04442906|Analgesics|analgesics|mesh-ancestor
19268860|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19268861|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19268862|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19268863|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
19268864|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393521|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
20177498|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268865|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268866|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19268867|NCT04442906|Narcotics|narcotics|mesh-ancestor
19268868|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19667081|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19667082|NCT03903692|Laxatives|laxatives|mesh-ancestor
19667083|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667084|NCT03777982|Prednisone|prednisone|mesh-list
19667085|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
19268869|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19268870|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
19268871|NCT04443309|Lenvatinib|lenvatinib|mesh-list
19268872|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268873|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19268874|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268875|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268876|NCT04442412|Vitamin D|vitamin d|mesh-list
19268877|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
19268878|NCT04442412|Vitamins|vitamins|mesh-ancestor
19268879|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
19268880|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268881|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19268882|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19268883|NCT04442633|Miconazole|miconazole|mesh-list
19268884|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
19268885|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268886|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19268887|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612430|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612431|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
19268888|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268889|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835859|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835860|NCT00605722|Growth Substances|growth substances|mesh-ancestor
19835861|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835862|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835863|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835864|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835865|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268890|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19268891|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
19268892|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268893|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268894|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19268895|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19268896|NCT04441918|Antibodies|antibodies|mesh-list
19268897|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19268898|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
19268899|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268900|NCT04441385|Maraviroc|maraviroc|mesh-list
19268901|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19268902|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19268903|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268904|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19268905|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19268906|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
20612432|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177499|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20177500|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177501|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
20177502|NCT00175747|Hormones|hormones|mesh-ancestor
19268907|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268908|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19667086|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19667087|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
19667088|NCT03777982|Hormones|hormones|mesh-ancestor
19667089|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667090|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667091|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19835866|NCT00605813|Sertraline|sertraline|mesh-list
20177503|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177504|NCT00175812|Tretinoin|tretinoin|mesh-list
20177505|NCT00175812|Theophylline|theophylline|mesh-list
20177506|NCT00175812|Valproic Acid|valproic acid|mesh-list
19268909|NCT04441424|Azithromycin|azithromycin|mesh-list
19268910|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
19268911|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19268912|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268913|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
19268914|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19268915|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268916|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268917|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268918|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19268919|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
19268920|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268921|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268922|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
19268923|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19268924|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
19268925|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667092|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667093|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19667094|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667095|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667096|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
19667097|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667098|NCT03769688|Metronidazole|metronidazole|mesh-list
19667099|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667100|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19667101|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19667102|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19268926|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
19268927|NCT04441528|Protective Agents|protective agents|mesh-ancestor
19268928|NCT04441112|Triamcinolone|triamcinolone|mesh-list
19268929|NCT04441112|Ketorolac|ketorolac|mesh-list
19268930|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19268931|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
19268932|NCT04441112|Hormones|hormones|mesh-ancestor
19268933|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268934|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268935|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268936|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268937|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19268938|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19268939|NCT04441112|Analgesics|analgesics|mesh-ancestor
19667103|NCT03748953|Ixazomib|ixazomib|mesh-list
19667104|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667105|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
19667106|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667107|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667108|NCT03748810|Metformin|metformin|mesh-list
19835867|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835868|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835869|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19835870|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835871|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835872|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835873|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835874|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
19835875|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835876|NCT00605865|Sertraline|sertraline|mesh-list
19835877|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835878|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835879|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19835880|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835881|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835882|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835883|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835884|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
20351645|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20351646|NCT00879476|Ramipril|ramipril|mesh-list
20351647|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20351648|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
20351649|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268940|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
19268941|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19268942|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667109|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
19667110|NCT03748810|Empagliflozin|empagliflozin|mesh-list
19667111|NCT03748810|Glimepiride|glimepiride|mesh-list
19667112|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19268943|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19268944|NCT04440917|Apatinib|apatinib|mesh-list
20177507|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177508|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
20177509|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
19835885|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268945|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19268946|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268947|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19268948|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268949|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268950|NCT04441138|Durvalumab|durvalumab|mesh-list
19268951|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19268952|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19268953|NCT04441021|Penicillins|penicillins|mesh-list
19268954|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19268955|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393522|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
20351650|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351651|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20351652|NCT00879489|Vaccines|vaccines|mesh-list
20351653|NCT00879489|Immunologic Factors|immunologic factors|mesh-ancestor
20351654|NCT00879489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351655|NCT00879541|Factor VIII|factor viii|mesh-list
20351656|NCT00879541|Coagulants|coagulants|mesh-ancestor
20351657|NCT00879723|Vitamins|vitamins|mesh-list
20351658|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
20351659|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351660|NCT00879788|Ramipril|ramipril|mesh-list
20351661|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19393523|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19393524|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
19393525|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19393526|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
19393527|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393528|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393529|NCT03684538|Zinc|zinc|mesh-list
19393530|NCT03684538|Trace Elements|trace elements|mesh-ancestor
19393531|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
19393532|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393533|NCT03684447|Propofol|propofol|mesh-list
19393534|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19393535|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393536|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393537|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20177510|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
20177511|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177512|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177513|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
20177514|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177515|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177516|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
20177517|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177518|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177519|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177520|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19393538|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
20177521|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
20351662|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
20351663|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351664|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351665|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20351666|NCT00879827|PENTA|penta|mesh-list
19667113|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19667114|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667115|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19667116|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667117|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19667118|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667119|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
19667120|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
19393539|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
19393540|NCT03684395|Warfarin|warfarin|mesh-list
19268956|NCT04440371|Betamethasone|betamethasone|mesh-list
19268957|NCT04440371|Calcipotriene|calcipotriene|mesh-list
19268958|NCT04440371|Tacrolimus|tacrolimus|mesh-list
19268959|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19268960|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
19268961|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268962|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19268963|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268964|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268965|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19268966|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
19268967|NCT04440371|Hormones|hormones|mesh-ancestor
19268968|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19268969|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19268970|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
19268971|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
19268972|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
19268973|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19268974|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19268975|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268976|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19268977|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19268978|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
20177522|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177523|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20177524|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177525|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20177526|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177527|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20177528|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20351667|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
20351668|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20351669|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20351670|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424890|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20424891|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20424892|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424893|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20424894|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
20424895|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424896|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
20424897|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
19268979|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
19268980|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
19268981|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268982|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
19268983|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19268984|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19268985|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19268986|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
19268987|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19268988|NCT04440280|Expectorants|expectorants|mesh-ancestor
19268989|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
19268990|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19268991|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
19268992|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19268993|NCT04440280|Protective Agents|protective agents|mesh-ancestor
19268994|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19268995|NCT04440280|Antidotes|antidotes|mesh-ancestor
19268996|NCT04440267|Dexamethasone|dexamethasone|mesh-list
19268997|NCT04440267|Prednisone|prednisone|mesh-list
19268998|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
19268999|NCT04440267|Methotrexate|methotrexate|mesh-list
19269000|NCT04440267|Vincristine|vincristine|mesh-list
19269001|NCT04440267|Daunorubicin|daunorubicin|mesh-list
19269002|NCT04440267|Asparaginase|asparaginase|mesh-list
19269003|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
19269004|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19269005|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
19269006|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269007|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269008|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19269009|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
19269010|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393541|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
19269011|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269012|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19269013|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269014|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
19269015|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
19269016|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269017|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19269018|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
19269019|NCT04440267|Hormones|hormones|mesh-ancestor
19269020|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269021|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20351671|NCT00879892|Xenon|xenon|mesh-list
20351672|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20351673|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
20351674|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
20351675|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351676|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351677|NCT00879918|Nicotine|nicotine|mesh-list
20351678|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19269022|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19269023|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
19269024|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19269025|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19269026|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
19269027|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
19269028|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269029|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19269030|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19269031|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19269032|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667121|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667122|NCT03691311|Denosumab|denosumab|mesh-list
19269033|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
19269034|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
19269035|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19269036|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19269037|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19269038|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
19269039|NCT04440436|Fludarabine|fludarabine|mesh-list
19269040|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19269041|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
19269042|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269043|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269044|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19269045|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
19269046|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269047|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393542|NCT03684395|Dabigatran|dabigatran|mesh-list
19667123|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19667124|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667125|NCT03690453|Ivermectin|ivermectin|mesh-list
19667126|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19667127|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667128|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
19667129|NCT03650764|Ramucirumab|ramucirumab|mesh-list
19667130|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667131|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667132|NCT03620643|Fulvestrant|fulvestrant|mesh-list
19667133|NCT03620643|Crizotinib|crizotinib|mesh-list
19667134|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667135|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667136|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19667137|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19667138|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
19667139|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667140|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351679|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
20351680|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351681|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351682|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20351683|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20351684|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
20351685|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351686|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667141|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667142|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177529|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
20177530|NCT00175838|Aspirin|aspirin|mesh-list
20177531|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
20177532|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19269048|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19269049|NCT04440085|Midodrine|midodrine|mesh-list
19667143|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667144|NCT03572413|Bromides|bromides|mesh-list
19667145|NCT03572413|Rocuronium|rocuronium|mesh-list
19667146|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
19667147|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19667148|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19667149|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19667150|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667151|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667152|NCT03533946|Rucaparib|rucaparib|mesh-list
19269050|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
19269051|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
19269052|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269053|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269054|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19269055|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19269056|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19269057|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19269058|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
19269059|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19269060|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269061|NCT04439929|Adalimumab|adalimumab|mesh-list
19269062|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269063|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269064|NCT04439890|Carboplatin|carboplatin|mesh-list
19269065|NCT04439890|Pemetrexed|pemetrexed|mesh-list
19269066|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269067|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269068|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269069|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19269070|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19269071|NCT04439786|Lidocaine|lidocaine|mesh-list
19269072|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
19269073|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
19667153|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19667154|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667155|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667156|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667157|NCT03500484|Liraglutide|liraglutide|mesh-list
19269074|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269075|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269076|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
19269077|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269078|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19269079|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19269080|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19269081|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269082|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269083|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
19269084|NCT04439799|Testosterone|testosterone|mesh-list
19269085|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
19269086|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
19269087|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19269088|NCT04439799|Androgens|androgens|mesh-ancestor
19269089|NCT04439799|Hormones|hormones|mesh-ancestor
19269090|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269091|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269092|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19269093|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269094|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
19269095|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
19269096|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19269097|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269098|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667158|NCT03500484|Glucagon|glucagon|mesh-list
20177533|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177534|NCT00175838|Analgesics|analgesics|mesh-ancestor
19667159|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19667160|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19667161|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269099|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
19269100|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19269101|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269102|NCT04439773|Lidocaine|lidocaine|mesh-list
19269103|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
19269104|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
19667162|NCT03500484|Incretins|incretins|mesh-ancestor
19667163|NCT03500484|Hormones|hormones|mesh-ancestor
19667164|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667165|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667166|NCT03496662|Gemcitabine|gemcitabine|mesh-list
19667167|NCT03496662|Paclitaxel|paclitaxel|mesh-list
19667168|NCT03496662|Nivolumab|nivolumab|mesh-list
19667169|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19269105|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269106|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269107|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
19269108|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269109|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19269110|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19269111|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19269112|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269113|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269114|NCT04439474|Vitamin D|vitamin d|mesh-list
19269115|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
19269116|NCT04439474|Vitamins|vitamins|mesh-ancestor
19269117|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
19269118|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269119|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19269120|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19269121|NCT04439305|Dasatinib|dasatinib|mesh-list
19269122|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269123|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19269124|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269125|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269126|NCT04439487|Anesthetics|anesthetics|mesh-list
19269127|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269128|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269129|NCT04439396|Ketorolac|ketorolac|mesh-list
19269130|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19269131|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19269132|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19269133|NCT04439396|Analgesics|analgesics|mesh-ancestor
19269134|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
19269135|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269136|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269137|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269138|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269139|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19269140|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269141|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269142|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
19269143|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19269144|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19269145|NCT04438980|Prednisolone|prednisolone|mesh-list
19269146|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
19269147|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19269148|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
19269149|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269150|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
19269151|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
19269152|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269153|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269154|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19269155|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
19269156|NCT04438980|Hormones|hormones|mesh-ancestor
19269157|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269158|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19269159|NCT04438980|Protective Agents|protective agents|mesh-ancestor
19269160|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667170|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269161|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269162|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19269163|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269164|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
19269165|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
19269166|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19269167|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20351687|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
20351688|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20351689|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20351690|NCT00879931|Prednisolone|prednisolone|mesh-list
20351691|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
20351692|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20351693|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
20351694|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269168|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269169|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351695|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
20351696|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
20351697|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351698|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351699|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20351700|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
20351701|NCT00879931|Hormones|hormones|mesh-ancestor
19269170|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269171|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269172|NCT04438902|Osimertinib|osimertinib|mesh-list
19269173|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269174|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19269175|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269176|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351702|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20351703|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20351704|NCT00879931|Protective Agents|protective agents|mesh-ancestor
20351705|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20351706|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351707|NCT00879957|Heparin|heparin|mesh-list
20351708|NCT00879957|Calcium heparin|calcium heparin|mesh-list
20351709|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
20351710|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20351711|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20351712|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269177|NCT04438733|Anastrozole|anastrozole|mesh-list
19269178|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19269179|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269180|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19269181|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19269182|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269183|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269184|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19269185|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
19269186|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269187|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269188|NCT04438811|Anesthetics|anesthetics|mesh-list
19269189|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269190|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269191|NCT04438850|Ivermectin|ivermectin|mesh-list
19269192|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19269193|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269194|NCT04438928|Micronutrients|micronutrients|mesh-list
19269195|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269196|NCT04438720|Nifedipine|nifedipine|mesh-list
19269197|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19269198|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269199|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269200|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20177535|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
20177536|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177537|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177538|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177539|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20177540|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20177541|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20351713|NCT00879983|Azithromycin|azithromycin|mesh-list
19269201|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269202|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
19269203|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
19269204|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19269205|NCT04438772|Anesthetics|anesthetics|mesh-list
19269206|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269207|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393543|NCT03684395|Apixaban|apixaban|mesh-list
20177542|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177543|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20177544|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20177545|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177546|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
20177547|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177548|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
19393544|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
19393545|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19393546|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
19393547|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19393548|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
19393549|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393550|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351714|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351715|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351716|NCT00880178|Niacin|niacin|mesh-list
20351717|NCT00880178|Niacinamide|niacinamide|mesh-list
20351718|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
19393551|NCT03684330|Vitamin D|vitamin d|mesh-list
19393552|NCT03684330|Vitamins|vitamins|mesh-ancestor
19393553|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
19393554|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393555|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19404074|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404075|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404076|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404077|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19404078|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404079|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404080|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
19404081|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
19404082|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404083|NCT03597815|Aflibercept|aflibercept|mesh-list
19404084|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404085|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19404086|NCT03597815|Growth Substances|growth substances|mesh-ancestor
19404087|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404088|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
19404089|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404090|NCT03597594|Fludarabine|fludarabine|mesh-list
19404091|NCT03597594|Busulfan|busulfan|mesh-list
19404092|NCT03597594|Thiotepa|thiotepa|mesh-list
19404093|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
19404094|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19404095|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404096|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404097|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19404098|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
19404099|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404100|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
19404101|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19404102|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19404103|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
19404104|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19404105|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404106|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
19404107|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
19404108|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404109|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177549|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20177550|NCT00175890|Levetiracetam|levetiracetam|mesh-list
20177551|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
20177552|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
20177553|NCT00175903|Carbamazepine|carbamazepine|mesh-list
19404110|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
20177554|NCT00175903|Levetiracetam|levetiracetam|mesh-list
20351719|NCT00880178|Simvastatin|simvastatin|mesh-list
20351720|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20351721|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20351722|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
20351723|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351724|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20351725|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20351726|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351727|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
20351728|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
20351729|NCT00880178|Vitamins|vitamins|mesh-ancestor
20351730|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
20424898|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
19269208|NCT05389046|Dexetimide|dexetimide|mesh-list
19269209|NCT05389046|Aripiprazole|aripiprazole|mesh-list
19269210|NCT05389046|Citalopram|citalopram|mesh-list
19269211|NCT05389046|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19269212|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19269213|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269214|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269215|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19269216|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
19269217|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269218|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19269219|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
19269220|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19269221|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19269222|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19269223|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
19269224|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
19269225|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269226|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19269227|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19269228|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
19269229|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19269230|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19269231|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269232|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
19269233|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
19269234|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19269235|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19269236|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19269237|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19269238|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19269239|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19269240|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
19269241|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19269242|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
19269243|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
19269244|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269245|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269246|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19269247|NCT05388942|Analgesics|analgesics|mesh-ancestor
19269248|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
19269249|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667171|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177555|NCT00175903|Valproic Acid|valproic acid|mesh-list
20177556|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
20177557|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
20177558|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177559|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177560|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
20177561|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177562|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177563|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
20177564|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177565|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177566|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177567|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177568|NCT00175903|Analgesics|analgesics|mesh-ancestor
20177569|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
20177570|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177571|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20177572|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20177573|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20177574|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20177575|NCT00175929|Brivaracetam|brivaracetam|mesh-list
20177576|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
20177577|NCT00175955|Levetiracetam|levetiracetam|mesh-list
20351731|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351732|NCT00880243|Cytarabine|cytarabine|mesh-list
20351733|NCT00880243|Etoposide|etoposide|mesh-list
20351734|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
20351735|NCT00880243|Daunorubicin|daunorubicin|mesh-list
20351736|NCT00880243|Molgramostim|molgramostim|mesh-list
20351737|NCT00880243|Sargramostim|sargramostim|mesh-list
20351738|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20351739|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351740|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20351741|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351742|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177578|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
19269260|NCT05388877|Dabrafenib|dabrafenib|mesh-list
19269261|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269262|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19269263|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269264|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269265|NCT05388773|Carboplatin|carboplatin|mesh-list
19269266|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269267|NCT05388747|Cefuroxime|cefuroxime|mesh-list
19269268|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
19269269|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19269270|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269271|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
20351743|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351744|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20351745|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
20351746|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
20351747|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351748|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20351749|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
20351750|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351751|NCT00880243|Analgesics|analgesics|mesh-ancestor
20351752|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
20351753|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351754|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20351755|NCT00880282|Sirolimus|sirolimus|mesh-list
20351756|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20351757|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351758|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351759|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20351760|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351761|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
20351762|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19269272|NCT05388669|Lazertinib|lazertinib|mesh-list
19269273|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19269274|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19269275|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269276|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269277|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269278|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269279|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
19269280|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269281|NCT05388656|Estradiol|estradiol|mesh-list
19269282|NCT05388656|Progesterone|progesterone|mesh-list
19269283|NCT05388656|Estrogens|estrogens|mesh-ancestor
19269284|NCT05388656|Hormones|hormones|mesh-ancestor
19269285|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269286|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269287|NCT05388656|Progestins|progestins|mesh-ancestor
20177579|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
20177580|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
20177581|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
20351763|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
20351764|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351765|NCT00880321|Dabrafenib|dabrafenib|mesh-list
20177582|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177583|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20177584|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20177585|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177586|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177587|NCT00175981|Urological Agents|urological agents|mesh-ancestor
20177588|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19269297|NCT05388474|Ibalizumab|ibalizumab|mesh-list
19269298|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19269299|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19269300|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19269301|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
19269302|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269303|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
19269304|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269305|NCT05388448|Amoxicillin|amoxicillin|mesh-list
19269306|NCT05388448|Rifampin|rifampin|mesh-list
19269307|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
19269308|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
19269309|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19269310|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269311|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19269312|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
19269313|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
19269314|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19269315|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269316|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269317|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19269318|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19269319|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19269320|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19269321|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19269322|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19269323|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19269324|NCT05388188|Sufentanil|sufentanil|mesh-list
19269325|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19269326|NCT05388188|Narcotics|narcotics|mesh-ancestor
19269327|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269328|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269329|NCT05388188|Analgesics|analgesics|mesh-ancestor
19269330|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
19269331|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269332|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19269333|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19269334|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
19269335|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
19269336|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19269337|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
19269338|NCT05388123|Rituximab|rituximab|mesh-list
19269339|NCT05388123|Vemurafenib|vemurafenib|mesh-list
19269340|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269341|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269342|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
19269343|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269344|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269345|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19269346|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269347|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269348|NCT05388058|Cannabidiol|cannabidiol|mesh-list
19269349|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
19269350|NCT05388006|Durvalumab|durvalumab|mesh-list
19269351|NCT05388006|Venetoclax|venetoclax|mesh-list
19269352|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
20177589|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177590|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177591|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177592|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177593|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20177594|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20177595|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20177596|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177597|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
20177598|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20177599|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
20177600|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19269353|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
19269354|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19269355|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
19269356|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269357|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269358|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
19269359|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269360|NCT05387967|Valsartan|valsartan|mesh-list
19269361|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19269362|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19269363|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19269364|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269365|NCT05387954|Anticoagulants|anticoagulants|mesh-list
19269366|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
19269367|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
19269368|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19269369|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
19269370|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269371|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269372|NCT05387941|Dexamethasone|dexamethasone|mesh-list
19269373|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269374|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
19269375|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
20177601|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20177602|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20177603|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
20177604|NCT00176020|Niacin|niacin|mesh-list
20177605|NCT00176020|Niacinamide|niacinamide|mesh-list
19269376|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269377|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269378|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19269379|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
19269380|NCT05387941|Hormones|hormones|mesh-ancestor
19269381|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269382|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19269383|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269384|NCT05387876|Vitamin D|vitamin d|mesh-list
19269385|NCT05387876|Vitamins|vitamins|mesh-ancestor
19269386|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
19269387|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269388|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20177606|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
20177607|NCT00176020|Vitamins|vitamins|mesh-ancestor
20177608|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
20177609|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177610|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20177611|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
20177612|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177613|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20177614|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177615|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
20177616|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177617|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20177618|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20177619|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
20177620|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177621|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
20177622|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19269406|NCT05387681|Endostatins|endostatins|mesh-list
19269407|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269408|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19667172|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
19667173|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
19269409|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19269410|NCT05387681|Growth Substances|growth substances|mesh-ancestor
19269411|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269412|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19269413|NCT05387642|Pramoxine|pramoxine|mesh-list
19269414|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
19269415|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
19667174|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269416|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269417|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667175|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19667176|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
19667177|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
19269418|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
19269419|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269420|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
19269421|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269422|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269423|NCT05387603|Capecitabine|capecitabine|mesh-list
19269424|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19269425|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
19667178|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351766|NCT00880321|Midazolam|midazolam|mesh-list
19269426|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269427|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269428|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19269429|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19269430|NCT05387577|Estradiol|estradiol|mesh-list
19269431|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20351767|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20351768|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20351769|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351770|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351771|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20351772|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20351773|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351774|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20351775|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
20351776|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
19269432|NCT05387577|Estrogens|estrogens|mesh-ancestor
19269433|NCT05387577|Hormones|hormones|mesh-ancestor
19269434|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269435|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269436|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19269437|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
19269438|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19269439|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19269440|NCT05387525|Diclofenac|diclofenac|mesh-list
19269441|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
19269442|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20351777|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
20351778|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
20351779|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351780|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351781|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351782|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20351783|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351784|NCT00880373|Ibuprofen|ibuprofen|mesh-list
20351785|NCT00880373|Morphine|morphine|mesh-list
20351786|NCT00880373|Heroin|heroin|mesh-list
20351787|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20351788|NCT00880373|Narcotics|narcotics|mesh-ancestor
20351789|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351790|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351791|NCT00880373|Analgesics|analgesics|mesh-ancestor
20351792|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
20351793|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351794|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20351795|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20351796|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20351797|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351798|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20351799|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351800|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351801|NCT00880386|Losartan|losartan|mesh-list
20351802|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19269443|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19269444|NCT05387525|Analgesics|analgesics|mesh-ancestor
20351803|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20351804|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20351805|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20351806|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269445|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
19667179|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351807|NCT00880412|Etazolate|etazolate|mesh-list
20351808|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19667180|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667181|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
19269446|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269447|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269448|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269449|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269450|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19269451|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269452|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269460|NCT05387343|Vaccines|vaccines|mesh-list
19269461|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
19269462|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269466|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
19269467|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19269468|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269469|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269470|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19269471|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19269472|NCT05387187|Protective Agents|protective agents|mesh-ancestor
19269473|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269474|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
19269475|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19269476|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
19269477|NCT05387148|Cannabidiol|cannabidiol|mesh-list
19269478|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
19269479|NCT05387031|Ustekinumab|ustekinumab|mesh-list
19269480|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
19269481|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
19269482|NCT05386979|Anesthetics|anesthetics|mesh-list
19269483|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269484|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269485|NCT05386979|Narcotics|narcotics|mesh-ancestor
19269486|NCT05386979|Analgesics|analgesics|mesh-ancestor
19269487|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
19269488|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177623|NCT00176059|Antibodies|antibodies|mesh-list
19269490|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
19269491|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19269492|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19269493|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19269494|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269495|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269496|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
19269497|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19269498|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269499|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19269500|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269501|NCT05379855|Atropine|atropine|mesh-list
19269502|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19269503|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19269504|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19269505|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19269506|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19269507|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
19269508|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269509|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269510|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19269511|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
19269512|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
19269513|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
19667182|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177624|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
20177625|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20177626|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
20177627|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177628|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20177629|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269514|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19667183|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667184|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19667185|NCT03386578|Tenofovir|tenofovir|mesh-list
19667186|NCT03386578|Emtricitabine|emtricitabine|mesh-list
19667187|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19667188|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
19667189|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351809|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351810|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351811|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19269515|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19269516|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
19269517|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19269518|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269519|NCT05378464|Trastuzumab|trastuzumab|mesh-list
19269520|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269521|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177630|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177631|NCT00176241|Gemcitabine|gemcitabine|mesh-list
19269522|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19269523|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19269524|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19667190|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19269525|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19269526|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269527|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269528|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
19269529|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269530|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19269531|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19269532|NCT05378100|Midazolam|midazolam|mesh-list
19269533|NCT05378100|Ketamine|ketamine|mesh-list
19269534|NCT05378100|Analgesics|analgesics|mesh-ancestor
19269535|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
19269536|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269537|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269538|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19269539|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19269540|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
19269541|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
19269542|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269543|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19269544|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19269545|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19269546|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269547|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19269548|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19269549|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19269550|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19269551|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19269552|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
19269553|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
19269554|NCT05376046|Thrombin|thrombin|mesh-list
19269555|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
19269556|NCT05376046|Coagulants|coagulants|mesh-ancestor
19269557|NCT05375084|Nivolumab|nivolumab|mesh-list
19269558|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269559|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269560|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19269561|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269562|NCT05374057|Ibuprofen|ibuprofen|mesh-list
20177632|NCT00176241|Paclitaxel|paclitaxel|mesh-list
20177633|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20177634|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177635|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177636|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
20177637|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
20177638|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177639|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177640|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
20177641|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
20177642|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269563|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19269564|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19269565|NCT05374057|Analgesics|analgesics|mesh-ancestor
19269566|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
19269567|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269568|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269569|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269570|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269571|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19269572|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269573|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269574|NCT05373446|Ritonavir|ritonavir|mesh-list
19269575|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19269576|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19269577|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
19269578|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269579|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269580|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19269581|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19269582|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
19269583|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269584|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19269585|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19269586|NCT05373433|Ritonavir|ritonavir|mesh-list
19269587|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19269588|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19269589|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
19269590|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269591|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269592|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19269593|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19269594|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
19269595|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667191|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19667192|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667193|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269596|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19269597|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19269598|NCT05372393|Anesthetics|anesthetics|mesh-list
19269599|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269600|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667194|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19667195|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19667196|NCT03349281|Cytarabine|cytarabine|mesh-list
19667197|NCT03349281|Dexamethasone|dexamethasone|mesh-list
19667198|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
19667199|NCT03349281|Doxorubicin|doxorubicin|mesh-list
19667200|NCT03349281|Methotrexate|methotrexate|mesh-list
19667201|NCT03349281|Vincristine|vincristine|mesh-list
19667202|NCT03349281|Asparaginase|asparaginase|mesh-list
19269610|NCT05367869|Methylene Blue|methylene blue|mesh-list
19269611|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269612|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269613|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19269614|NCT05363462|Vancomycin|vancomycin|mesh-list
19269615|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269616|NCT05361395|Carboplatin|carboplatin|mesh-list
19269617|NCT05361395|Etoposide|etoposide|mesh-list
19269618|NCT05361395|Atezolizumab|atezolizumab|mesh-list
19269619|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667203|NCT03349281|Pegaspargase|pegaspargase|mesh-list
20177643|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177644|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177645|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
20177646|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177647|NCT00176267|Paclitaxel|paclitaxel|mesh-list
20177648|NCT00176267|Carboplatin|carboplatin|mesh-list
20177649|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20177650|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177651|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177652|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
19269620|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19269621|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19393556|NCT03683914|Dinoprostone|dinoprostone|mesh-list
19667204|NCT03349281|Pevonedistat|pevonedistat|mesh-list
19667205|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177653|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667206|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
19667207|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
19667208|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667209|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177654|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177655|NCT00176280|Dexamethasone|dexamethasone|mesh-list
20177656|NCT00176280|Sargramostim|sargramostim|mesh-list
20177657|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177658|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
20177659|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
19269622|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19269623|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269624|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667210|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667211|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
19667212|NCT03349281|Hormones|hormones|mesh-ancestor
19667213|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667214|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667215|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667216|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19667217|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19667218|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19667219|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667220|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667221|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19667222|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
19667223|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19667224|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19667225|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
19667226|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
19667227|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19667228|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667229|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
19667230|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667231|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19667232|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
19667233|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667234|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19667235|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667236|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
19667237|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667238|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
19667239|NCT03299088|Trametinib|trametinib|mesh-list
19667240|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667241|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667242|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667243|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667244|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667245|NCT03292666|Warfarin|warfarin|mesh-list
19667246|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
19667247|NCT03292666|Dabigatran|dabigatran|mesh-list
19667248|NCT03292666|Apixaban|apixaban|mesh-list
19667249|NCT03292666|Edoxaban|edoxaban|mesh-list
20177660|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177661|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177662|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667250|NCT03292666|Anticoagulants|anticoagulants|mesh-list
19667251|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19667252|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
19667253|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19667254|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
19667255|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667256|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667257|NCT03286842|Olaparib|olaparib|mesh-list
19667258|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19667259|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667260|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667261|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667262|NCT03262779|Nivolumab|nivolumab|mesh-list
20177663|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
20177664|NCT00176280|Hormones|hormones|mesh-ancestor
20177665|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667263|NCT03262779|Ipilimumab|ipilimumab|mesh-list
19667264|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19835886|NCT00605904|Acamprosate|acamprosate|mesh-list
19667265|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667266|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19667267|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667268|NCT03236428|Daratumumab|daratumumab|mesh-list
19667269|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667270|NCT03219775|Nivolumab|nivolumab|mesh-list
19667271|NCT03219775|Ipilimumab|ipilimumab|mesh-list
19667272|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667273|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667274|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19667275|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667276|NCT03164564|Tenofovir|tenofovir|mesh-list
19667277|NCT03164564|Emtricitabine|emtricitabine|mesh-list
19667278|NCT03164564|Cabotegravir|cabotegravir|mesh-list
19667279|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
19667280|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667281|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20177666|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20177667|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177668|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
20177669|NCT00176293|Dexamethasone|dexamethasone|mesh-list
20177670|NCT00176293|Doxorubicin|doxorubicin|mesh-list
20177671|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177672|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
20177673|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
20177674|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177675|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177676|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20177677|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
20177678|NCT00176293|Hormones|hormones|mesh-ancestor
20177679|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177680|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20177681|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177682|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20177683|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20177684|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19667282|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19667283|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667284|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667285|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19667286|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19667287|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19667288|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19667289|NCT03143270|Nivolumab|nivolumab|mesh-list
19667290|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667291|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667292|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19667293|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667294|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
19667295|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
20177685|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177686|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177687|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20177688|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20177689|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20177690|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
20177691|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177692|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20177693|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20177694|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177695|NCT00176449|Bupropion|bupropion|mesh-list
20177696|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20177697|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
20177698|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177699|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20177700|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20177701|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20177702|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177703|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
20177704|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177705|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393557|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
19667296|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19667297|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19667298|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177706|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20177707|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667299|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667300|NCT03142568|Urological Agents|urological agents|mesh-ancestor
19667301|NCT03100045|Artesunate|artesunate|mesh-list
19269663|NCT05349188|Melatonin|melatonin|mesh-list
20351812|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20351813|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351814|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351815|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351816|NCT00880477|Edetic Acid|edetic acid|mesh-list
20351817|NCT00880477|Vaccines|vaccines|mesh-list
20351818|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
19269664|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
19269665|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269666|NCT05349188|Protective Agents|protective agents|mesh-ancestor
19269667|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269668|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269669|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
19269670|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269671|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667302|NCT03100045|Artemisinins|artemisinins|mesh-list
19667303|NCT03100045|Artemisinin|artemisinin|mesh-list
19667304|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
19667305|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19667306|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19269677|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20351819|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
20351820|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351821|NCT00880477|Antidotes|antidotes|mesh-ancestor
20351822|NCT00880477|Protective Agents|protective agents|mesh-ancestor
20351823|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
20351824|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
20351825|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351826|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19269678|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
19269679|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667307|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667308|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667309|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
19667310|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
19667311|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19667312|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
19691852|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19691853|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19691854|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19691855|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
19691856|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19691857|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
19691858|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691859|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177708|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177709|NCT00176475|Rituximab|rituximab|mesh-list
20177710|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20177711|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177712|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
20177713|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177714|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20177715|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
20177716|NCT00176527|Interferons|interferons|mesh-list
20177717|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
20177718|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
20177719|NCT00176527|Docetaxel|docetaxel|mesh-list
20177720|NCT00176527|Estramustine|estramustine|mesh-list
20177721|NCT00176527|Isotretinoin|isotretinoin|mesh-list
20177722|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177723|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
20177724|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
20177725|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
20351827|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
19691860|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20177726|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177727|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
19667313|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
19667314|NCT02660281|Melphalan|melphalan|mesh-list
19667315|NCT02660281|Busulfan|busulfan|mesh-list
19667316|NCT02660281|Thiotepa|thiotepa|mesh-list
19667317|NCT02660281|Fludarabine|fludarabine|mesh-list
19667318|NCT02660281|Mesna|mesna|mesh-list
19667319|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667320|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
19667321|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667322|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667323|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19667324|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
19667325|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351828|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20351829|NCT00880529|Morphine|morphine|mesh-list
20351830|NCT00880529|Bupivacaine|bupivacaine|mesh-list
20351831|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
20351832|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
20351833|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351834|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351835|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
19667326|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667327|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19667328|NCT02660281|Protective Agents|protective agents|mesh-ancestor
20351836|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351837|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20351838|NCT00880529|Narcotics|narcotics|mesh-ancestor
20351839|NCT00880529|Analgesics|analgesics|mesh-ancestor
20351840|NCT00880594|Desipramine|desipramine|mesh-list
20351841|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20351842|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
20351843|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20351844|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351845|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351846|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20351847|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20351848|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20351849|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351850|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667329|NCT02571530|Trastuzumab|trastuzumab|mesh-list
19667330|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667331|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667332|NCT02438995|Cetuximab|cetuximab|mesh-list
19269701|NCT05320406|Leuprolide|leuprolide|mesh-list
19269702|NCT05320406|Relugolix|relugolix|mesh-list
19667333|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20177728|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177729|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
20177730|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177731|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
20177732|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20177733|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
20177734|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20177735|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
20177736|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
20177737|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177738|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20177739|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20177740|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177741|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177742|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177743|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
20177744|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
20177745|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
20177746|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20177747|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20177748|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177749|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177750|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177751|NCT00176618|Curcumin|curcumin|mesh-list
20177752|NCT00176618|Sulindac|sulindac|mesh-list
20217179|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269703|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19667334|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667335|NCT05108389|Hemostatics|hemostatics|mesh-list
19269704|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
19269705|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19269706|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269707|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19269708|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269709|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
19269710|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
19269711|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269712|NCT05313997|Diclofenac|diclofenac|mesh-list
19269713|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19269714|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19269715|NCT05313997|Analgesics|analgesics|mesh-ancestor
19269716|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
19269717|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269718|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269719|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269720|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19269721|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19269722|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269723|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269724|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
19269725|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19269726|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269727|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667336|NCT05108389|Coagulants|coagulants|mesh-ancestor
20351851|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351852|NCT00880672|Dutasteride|dutasteride|mesh-list
19667337|NCT05108350|Metformin|metformin|mesh-list
19667338|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19667339|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667340|NCT05108220|Cannabidiol|cannabidiol|mesh-list
19667341|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
19667342|NCT05108051|Oseltamivir|oseltamivir|mesh-list
19667343|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
19667344|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667345|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667346|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667347|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
20351853|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20351854|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20351855|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351856|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351857|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
20351858|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20351859|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351860|NCT00880815|Rituximab|rituximab|mesh-list
20351861|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19667348|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19667349|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19269728|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
19269729|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19269730|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269731|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19269732|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19269733|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269734|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269735|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269736|NCT05301634|Bupivacaine|bupivacaine|mesh-list
20351862|NCT00880815|Methotrexate|methotrexate|mesh-list
20351863|NCT00880815|Fludarabine|fludarabine|mesh-list
20351864|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20351865|NCT00880815|Antibodies|antibodies|mesh-list
20351866|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
20351867|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20351868|NCT00880815|Lenograstim|lenograstim|mesh-list
20351869|NCT00880815|Tacrolimus|tacrolimus|mesh-list
20351870|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
20351871|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20351872|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
20351873|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351874|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667350|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667351|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351875|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351876|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19269737|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
19269738|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
19269739|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269740|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269741|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
19269742|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269743|NCT05297864|Niraparib|niraparib|mesh-list
19269744|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19269745|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269746|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269747|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269748|NCT05288166|Prednisone|prednisone|mesh-list
19269749|NCT05288166|Prednisolone|prednisolone|mesh-list
19269750|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269751|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
19269752|NCT05288166|Hormones|hormones|mesh-ancestor
19269753|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269754|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269755|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19269756|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667352|NCT05107921|Bromfenac|bromfenac|mesh-list
19667353|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19667354|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19667355|NCT05107921|Analgesics|analgesics|mesh-ancestor
19667356|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
20177753|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20177754|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177755|NCT00176618|Analgesics|analgesics|mesh-ancestor
20177756|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
20177757|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177758|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177759|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177760|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20177761|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177762|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177763|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177764|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20177765|NCT00176670|Midazolam|midazolam|mesh-list
20177766|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20177767|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20177768|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177769|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177770|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20177771|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177772|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177773|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20177774|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
20177775|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
20177776|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
20177777|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
20177778|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177779|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177780|NCT00176696|Anesthetics|anesthetics|mesh-list
20177781|NCT00176696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177782|NCT00176696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177783|NCT00176735|Capecitabine|capecitabine|mesh-list
20177784|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177785|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
20177786|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177787|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217180|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
20217181|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20217182|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20217183|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217184|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
20217185|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20217186|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217187|NCT00308841|Lidocaine|lidocaine|mesh-list
20217188|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
20217189|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
20217190|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217191|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217192|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
19667357|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667358|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667359|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19667360|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667361|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19667362|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19667363|NCT05107375|Vaccines|vaccines|mesh-list
19667364|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
19667365|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667366|NCT05107063|Pravastatin|pravastatin|mesh-list
19667367|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19667368|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19667369|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
19667370|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667371|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19667372|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19667373|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667374|NCT05106803|Amoxicillin|amoxicillin|mesh-list
19667375|NCT05106803|Vancomycin|vancomycin|mesh-list
20351877|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
20351878|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20351879|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19667376|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
19667377|NCT05106803|Clindamycin|clindamycin|mesh-list
19667378|NCT05106803|Gentamicins|gentamicins|mesh-list
19667379|NCT05106803|Tetracycline|tetracycline|mesh-list
19667380|NCT05106803|Penicillins|penicillins|mesh-list
19667381|NCT05106803|Erythromycin|erythromycin|mesh-list
19667382|NCT05106803|Ampicillin|ampicillin|mesh-list
19667383|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
19667384|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
19667385|NCT05106803|Cefepime|cefepime|mesh-list
19667386|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19667387|NCT05106803|Norfloxacin|norfloxacin|mesh-list
20351880|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
20351881|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351882|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
20351883|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351884|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20351885|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20351886|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20351887|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20351888|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20351889|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19667388|NCT05106803|Oxacillin|oxacillin|mesh-list
19667389|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
19269795|NCT05258110|Midazolam|midazolam|mesh-list
19269796|NCT05258110|BI 425809|bi 425809|mesh-list
19269797|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19269798|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19269799|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269800|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269801|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19269802|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19269803|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19269804|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19269805|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
19269806|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
19269807|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
19269808|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
19269809|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19269810|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269811|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
19269812|NCT05255159|Furosemide|furosemide|mesh-list
19269813|NCT05255159|Diuretics|diuretics|mesh-ancestor
19269814|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
19269815|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269816|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19269817|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19269818|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269819|NCT05252390|Olaparib|olaparib|mesh-list
19269820|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19269821|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667390|NCT05106803|Trimethoprim|trimethoprim|mesh-list
19269822|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269823|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667391|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
19835887|NCT00605904|Yohimbine|yohimbine|mesh-list
19835888|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19269824|NCT05236543|Itraconazole|itraconazole|mesh-list
19269825|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
19269826|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20351890|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
20351891|NCT00880828|Acetaminophen|acetaminophen|mesh-list
20351892|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20351893|NCT00880828|Analgesics|analgesics|mesh-ancestor
20351894|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
20351895|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351896|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351897|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
20351898|NCT00880841|Buprenorphine|buprenorphine|mesh-list
20351899|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20351900|NCT00880841|Naloxone|naloxone|mesh-list
20351901|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20351902|NCT00880841|Narcotics|narcotics|mesh-ancestor
20351903|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20351904|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351905|NCT00880841|Analgesics|analgesics|mesh-ancestor
20351906|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
20351907|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351908|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20351909|NCT00880854|Tremelimumab|tremelimumab|mesh-list
20351910|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351911|NCT00880867|Poly ICLC|poly iclc|mesh-list
20351912|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
20351913|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
20351914|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351915|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
20351916|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351917|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20351918|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351919|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351920|NCT00881088|PENTA|penta|mesh-list
20351921|NCT00881088|Nadroparin|nadroparin|mesh-list
20351922|NCT00881088|Fondaparinux|fondaparinux|mesh-list
19269827|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19269828|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19269829|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269830|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269831|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19269832|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
19269833|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269834|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269835|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19835889|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
19269836|NCT05231382|Leucovorin|leucovorin|mesh-list
19269837|NCT05231382|Fluorouracil|fluorouracil|mesh-list
19269838|NCT05231382|Raltitrexed|raltitrexed|mesh-list
19269839|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
19269840|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
19269841|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269842|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19269843|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269844|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19269845|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
19269846|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269847|NCT05231382|Antidotes|antidotes|mesh-ancestor
19269848|NCT05231382|Protective Agents|protective agents|mesh-ancestor
19269849|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
19269850|NCT05231382|Vitamins|vitamins|mesh-ancestor
19269851|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
19835890|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
19835891|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835892|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835893|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19835894|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19835895|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19835896|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19835897|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835898|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351923|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20351924|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
20351925|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20351926|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
19269852|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19667392|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19667393|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667394|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19667395|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19667396|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667397|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269853|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269854|NCT05219929|Tetracycline|tetracycline|mesh-list
19269855|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20177788|NCT00176761|Interleukin-2|interleukin-2|mesh-list
20177789|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177790|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177791|NCT00176761|Analgesics|analgesics|mesh-ancestor
20177792|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
20177793|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177794|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177795|NCT00176774|Leucovorin|leucovorin|mesh-list
20177796|NCT00176774|Fluorouracil|fluorouracil|mesh-list
20177797|NCT00176774|Irinotecan|irinotecan|mesh-list
20177798|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19269856|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269857|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19269858|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269859|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177799|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
20177800|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177801|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177802|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177803|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177804|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
20177805|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177806|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20177807|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20177808|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177809|NCT00176774|Antidotes|antidotes|mesh-ancestor
19269871|NCT05214599|Budesonide|budesonide|mesh-list
19269872|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19269873|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19269874|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
19269875|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19269876|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269877|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19269878|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
19269879|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
19269880|NCT05214599|Hormones|hormones|mesh-ancestor
19269881|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667398|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667399|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19667400|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667401|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19667402|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19667403|NCT05106803|Renal Agents|renal agents|mesh-ancestor
19667404|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
19667405|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19667406|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19667407|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19667408|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19667409|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19667410|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667411|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19667412|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
19667413|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19667414|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
19667415|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667416|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
19667417|NCT05106751|Protective Agents|protective agents|mesh-ancestor
19269902|NCT05199714|Pramlintide|pramlintide|mesh-list
19269903|NCT05199714|Pancrelipase|pancrelipase|mesh-list
19269904|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667418|NCT05106712|Vitamin D|vitamin d|mesh-list
19667419|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
19667420|NCT05106712|Letrozole|letrozole|mesh-list
19667421|NCT05106712|Clomiphene|clomiphene|mesh-list
19269905|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177810|NCT00176774|Protective Agents|protective agents|mesh-ancestor
20177811|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
19269906|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269907|NCT05191875|Doxycycline|doxycycline|mesh-list
19269908|NCT05191875|Furazolidone|furazolidone|mesh-list
19269909|NCT05191875|Bismuth|bismuth|mesh-list
19269910|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19269911|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269912|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
19269913|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19269914|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19269915|NCT05191875|Antacids|antacids|mesh-ancestor
19269916|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269917|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19269918|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19269919|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19269920|NCT05191875|Renal Agents|renal agents|mesh-ancestor
19269921|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19269922|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19269923|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269924|NCT05186974|Carboplatin|carboplatin|mesh-list
19269925|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
19269926|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269927|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667422|NCT05106712|Enclomiphene|enclomiphene|mesh-list
19667423|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
19667424|NCT05106712|Vitamins|vitamins|mesh-ancestor
19667425|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
19667426|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667427|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19667428|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269935|NCT05184712|Carboplatin|carboplatin|mesh-list
19269936|NCT05184712|Pemetrexed|pemetrexed|mesh-list
19269937|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269938|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269939|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667429|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19667430|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667431|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20177812|NCT00176774|Vitamins|vitamins|mesh-ancestor
20177813|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
20177814|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
20177815|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
20177816|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20177817|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20177818|NCT00176774|Growth Substances|growth substances|mesh-ancestor
20177819|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
20177820|NCT00176787|Capecitabine|capecitabine|mesh-list
20177821|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177822|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
20177823|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177824|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177825|NCT00176813|Gemcitabine|gemcitabine|mesh-list
20177826|NCT00176813|Celecoxib|celecoxib|mesh-list
20177827|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177828|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20177829|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
20177830|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177831|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
20177832|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177833|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177834|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177835|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
20177836|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177837|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20177838|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20177839|NCT00176813|Analgesics|analgesics|mesh-ancestor
20177840|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
20177841|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177842|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20177843|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20177844|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20177845|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20177846|NCT00176943|Imiquimod|imiquimod|mesh-list
19269940|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19269941|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19835899|NCT00605904|Urological Agents|urological agents|mesh-ancestor
20177847|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19269942|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
19269943|NCT05170711|Anesthetics|anesthetics|mesh-list
19269944|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19269945|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667432|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19667433|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177848|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
20177849|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177850|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177851|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
19667434|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19667435|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
19667436|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667437|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19667438|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
19667439|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19667440|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19667441|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19667442|NCT05093621|Torsemide|torsemide|mesh-list
19667443|NCT05093621|Furosemide|furosemide|mesh-list
20177852|NCT00176969|Capsaicin|capsaicin|mesh-list
20177853|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
20177854|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
19667444|NCT05093621|Diuretics|diuretics|mesh-ancestor
19667445|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
19667446|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269949|NCT05169567|Fulvestrant|fulvestrant|mesh-list
19269950|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19269951|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269952|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19269953|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19269954|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
19269955|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19269956|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269957|NCT05166577|Valganciclovir|valganciclovir|mesh-list
19269958|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
19269959|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19269960|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269961|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
19269962|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19269963|NCT05156905|Docetaxel|docetaxel|mesh-list
19269964|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269965|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
19269966|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
19269967|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
19269968|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269969|NCT05155709|Azacitidine|azacitidine|mesh-list
19269970|NCT05155709|Venetoclax|venetoclax|mesh-list
19269971|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19269972|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
19269973|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19269974|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269975|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667447|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19667448|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19667449|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667450|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19667451|NCT05083000|Topotecan|topotecan|mesh-list
19667452|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19667453|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20177855|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
20351927|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351928|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351929|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
20351930|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20351931|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20351932|NCT00881101|Paclitaxel|paclitaxel|mesh-list
20351933|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19667454|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177856|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177857|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177858|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
19691861|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
20351934|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177859|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
20177860|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20177861|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20351935|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
20351936|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
20351937|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
20351938|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351939|NCT00881114|Cetuximab|cetuximab|mesh-list
20351940|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351941|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20351942|NCT00881127|Cetirizine|cetirizine|mesh-list
20351943|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
20351944|NCT00881127|Ephedrine|ephedrine|mesh-list
20351945|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20351946|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20351947|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20351948|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
20351949|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
20351950|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20351951|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351952|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177862|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177863|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177864|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177865|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20351953|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19667455|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667456|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667457|NCT05010421|Clobetasol|clobetasol|mesh-list
19667458|NCT05010421|Emollients|emollients|mesh-list
19667459|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19667460|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
19667461|NCT05010421|Hormones|hormones|mesh-ancestor
19667462|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667463|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667464|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
19667465|NCT05004077|Amiodarone|amiodarone|mesh-list
19667466|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20351954|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
20351955|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20351956|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20351957|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
20351958|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
20351959|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20351960|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20351961|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
20351962|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
20351963|NCT00881140|Mifepristone|mifepristone|mesh-list
20351964|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20351965|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
19667467|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
19667468|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19667469|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19667470|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667471|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19667472|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19667473|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667474|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691862|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
20177866|NCT00176995|Eflornithine|eflornithine|mesh-list
20177867|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177868|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20177869|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20177870|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20177871|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177872|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20177873|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177874|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177875|NCT00177008|Aripiprazole|aripiprazole|mesh-list
20177876|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
20177877|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177878|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20177879|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20177880|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19667475|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19667476|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19667477|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19667478|NCT04977024|Vaccines|vaccines|mesh-list
19667479|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
20177881|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667480|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19269994|NCT05103605|Osimertinib|osimertinib|mesh-list
19269995|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19269996|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835900|NCT00605917|Sertraline|sertraline|mesh-list
19835901|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835902|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835903|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19835904|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835905|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19835906|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835907|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835908|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
19269997|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19269998|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691863|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19691864|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
19691865|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691866|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691867|NCT04999540|Fulvestrant|fulvestrant|mesh-list
19270004|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
19270005|NCT05073627|Dabigatran|dabigatran|mesh-list
19270006|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
19270007|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19270008|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
19270009|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270010|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270011|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
19270012|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19270013|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270014|NCT05069298|Silybin|silybin|mesh-list
19270015|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19270016|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270017|NCT05069298|Protective Agents|protective agents|mesh-ancestor
19270018|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691868|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691869|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691870|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19270022|NCT05053659|Venetoclax|venetoclax|mesh-list
19270023|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19270024|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270025|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691871|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19835909|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835910|NCT00606008|Sunitinib|sunitinib|mesh-list
19835911|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835912|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835913|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835914|NCT00606008|Growth Substances|growth substances|mesh-ancestor
19835915|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835916|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835917|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19835918|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835919|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835920|NCT00606021|Pemetrexed|pemetrexed|mesh-list
19835921|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835922|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19835923|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835924|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19835925|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19835926|NCT00606034|Insulin|insulin|mesh-list
20177882|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
20177883|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
20177884|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177885|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691872|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
19691873|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667481|NCT04962126|Atezolizumab|atezolizumab|mesh-list
19270031|NCT05048719|Dulaglutide|dulaglutide|mesh-list
19270032|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19270033|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270034|NCT05038735|Fulvestrant|fulvestrant|mesh-list
19270035|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19270036|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270037|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19270038|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19270039|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
19270040|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270041|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667482|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
19667483|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19667484|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667485|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667486|NCT04903093|Famotidine|famotidine|mesh-list
19667487|NCT04903093|Abrocitinib|abrocitinib|mesh-list
19667488|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19667489|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667490|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19667491|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
19667492|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
19667493|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667494|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667495|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835927|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20351966|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20351967|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20351968|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20351969|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20351970|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19667496|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667497|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270058|NCT05029960|Brivaracetam|brivaracetam|mesh-list
19270059|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
19835928|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835929|NCT00606086|Interferons|interferons|mesh-list
19835930|NCT00606086|Ribavirin|ribavirin|mesh-list
19835931|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19835932|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
19835933|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835934|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
19835935|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19835936|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
19835937|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835938|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
19667498|NCT04833413|Insulin|insulin|mesh-list
19667499|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19667500|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19667501|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667502|NCT04771689|Buprenorphine|buprenorphine|mesh-list
19667503|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19667504|NCT04771689|Naloxone|naloxone|mesh-list
19667505|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19667506|NCT04771689|Narcotics|narcotics|mesh-ancestor
19667507|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19667508|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667509|NCT04771689|Analgesics|analgesics|mesh-ancestor
19667510|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
19667511|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667512|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19667513|NCT04751877|Dexamethasone|dexamethasone|mesh-list
20177886|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20177887|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20177888|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
20177889|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20177890|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20177891|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20177892|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20177893|NCT00177021|Imiquimod|imiquimod|mesh-list
19667514|NCT04751877|Lenalidomide|lenalidomide|mesh-list
19667515|NCT04751877|Bortezomib|bortezomib|mesh-list
19667516|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19667517|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
19667518|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
19835939|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667519|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667520|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667521|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667522|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
19667523|NCT04751877|Hormones|hormones|mesh-ancestor
19667524|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667525|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667526|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667527|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
19667528|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19270100|NCT05016076|Dexamethasone|dexamethasone|mesh-list
20351971|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
20351972|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20351973|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20351974|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
20351975|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20351976|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
20351977|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20351978|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20351979|NCT00881153|Cefprozil|cefprozil|mesh-list
20351980|NCT00881153|Cephalosporins|cephalosporins|mesh-list
19270101|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19270102|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
19270103|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
19270104|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270105|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270106|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19270107|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
19270108|NCT05016076|Hormones|hormones|mesh-ancestor
19270109|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270110|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667529|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19667530|NCT04751877|Growth Substances|growth substances|mesh-ancestor
19667531|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
20351981|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20351982|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270111|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270112|NCT05014919|Vortioxetine|vortioxetine|mesh-list
19270113|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
19270114|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19270115|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19270116|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19270117|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270118|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270119|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19270120|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19270121|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270122|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351983|NCT00881166|Paclitaxel|paclitaxel|mesh-list
20351984|NCT00881166|Etoposide|etoposide|mesh-list
20351985|NCT00881166|Docetaxel|docetaxel|mesh-list
20351986|NCT00881166|Carboplatin|carboplatin|mesh-list
20351987|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20351988|NCT00881166|Topotecan|topotecan|mesh-list
20351989|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20351990|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20351991|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
20351992|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
20351993|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
20351994|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20351995|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20351996|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20351997|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20351998|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20351999|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20352000|NCT00881179|Clarithromycin|clarithromycin|mesh-list
20352001|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352002|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352003|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19270123|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270124|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
19270125|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19270126|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20352004|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352005|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352006|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20352007|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667532|NCT04722978|Gemcitabine|gemcitabine|mesh-list
19667533|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
19270127|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19270128|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19667534|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19667535|NCT04722978|Carboplatin|carboplatin|mesh-list
19667536|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19667537|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667538|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19667539|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
19667540|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667541|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
19667542|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667543|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667544|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667545|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
19667546|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667547|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19270143|NCT05002569|Nivolumab|nivolumab|mesh-list
19270144|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19270145|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270146|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19270147|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270148|NCT05000294|Atezolizumab|atezolizumab|mesh-list
19270149|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270150|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
19270151|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19270152|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270153|NCT04975308|Fulvestrant|fulvestrant|mesh-list
19270154|NCT04975308|Exemestane|exemestane|mesh-list
19270155|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667548|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19667549|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20352008|NCT00881218|Regadenoson|regadenoson|mesh-list
20352009|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20352010|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20352011|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
19270156|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270157|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19270158|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19270159|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
19270160|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270161|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270162|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19270163|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19270164|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270165|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270166|NCT04973150|Anesthetics|anesthetics|mesh-list
19270167|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270168|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667550|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
19667551|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19667552|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19667553|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19667554|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19667555|NCT04695106|Aspirin|aspirin|mesh-list
19667556|NCT04695106|Dabigatran|dabigatran|mesh-list
19667557|NCT04695106|Clopidogrel|clopidogrel|mesh-list
19667558|NCT04695106|Ticagrelor|ticagrelor|mesh-list
19667559|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19667560|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19667561|NCT04695106|Analgesics|analgesics|mesh-ancestor
19667562|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
19667563|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667564|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667565|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19667566|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667567|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19667568|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19691874|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667569|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667570|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19270189|NCT04955470|Midazolam|midazolam|mesh-list
19270190|NCT04955470|Ketamine|ketamine|mesh-list
19270191|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19270192|NCT04955470|Analgesics|analgesics|mesh-ancestor
19270193|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
19270194|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270195|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270196|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19270197|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19270198|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
19270199|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
19270200|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270201|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19270202|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19270203|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270204|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270205|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19270206|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19270207|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19270208|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19270209|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19270210|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
19270211|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
19270212|NCT04950608|Psilocybin|psilocybin|mesh-list
19270213|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
19270214|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270215|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19270216|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
19270217|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19270218|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19270219|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19270220|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270221|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270222|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19270223|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270224|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270225|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19270226|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270227|NCT04941716|Venetoclax|venetoclax|mesh-list
19270228|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
19270229|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270230|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
19270231|NCT04939623|Probenecid|probenecid|mesh-list
19270232|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
19270233|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
19270234|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19270235|NCT04939623|Renal Agents|renal agents|mesh-ancestor
19270236|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
19270237|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270238|NCT04936685|Vaccines|vaccines|mesh-list
19270239|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
19270240|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667571|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19667572|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667573|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
19667574|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19667575|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19667576|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19667577|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
19667578|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667579|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
19667580|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19667581|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
19667582|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
19667583|NCT04658147|Nivolumab|nivolumab|mesh-list
19667584|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667585|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667586|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19667587|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667588|NCT04614974|Famotidine|famotidine|mesh-list
19667589|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20177894|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20177895|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
20177896|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667590|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667591|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19667592|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
19667593|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
19667594|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667595|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667596|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667597|NCT04576767|Anesthetics|anesthetics|mesh-list
19667598|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19667599|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667600|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
19667601|NCT04537286|Paclitaxel|paclitaxel|mesh-list
19667602|NCT04537286|Cisplatin|cisplatin|mesh-list
19667603|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19667604|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667605|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667606|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
19667607|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667608|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667609|NCT04527887|Dexamethasone|dexamethasone|mesh-list
19667610|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19667611|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
19667612|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
19667613|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667614|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667615|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667616|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
19667617|NCT04527887|Hormones|hormones|mesh-ancestor
19667618|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667619|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667620|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667621|NCT04486625|Aztreonam|aztreonam|mesh-list
19667622|NCT04486625|Avibactam|avibactam|mesh-list
19667623|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19667624|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667625|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19667626|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352012|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
20352013|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352014|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352015|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352016|NCT00881231|Cilostazol|cilostazol|mesh-list
20352017|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20352018|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
20352019|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667627|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667628|NCT04316364|Paclitaxel|paclitaxel|mesh-list
19667629|NCT04316364|Carboplatin|carboplatin|mesh-list
19667630|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19270289|NCT04925479|Niacinamide|niacinamide|mesh-list
19270290|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
20352020|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352021|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20352022|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
19270291|NCT04925479|Vitamins|vitamins|mesh-ancestor
19270292|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
19270293|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270294|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
19270295|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19270296|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270297|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270298|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19270299|NCT04923737|Analgesics|analgesics|mesh-ancestor
19270300|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
19270301|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270302|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19270303|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19270304|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19270305|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
19270306|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270307|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667631|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667632|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
19835940|NCT00606138|Ranibizumab|ranibizumab|mesh-list
19667633|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
20352023|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20352024|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20177897|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177898|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
20177899|NCT00177060|Hydromorphone|hydromorphone|mesh-list
20177900|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20177901|NCT00177060|Narcotics|narcotics|mesh-ancestor
20177902|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20177903|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177904|NCT00177060|Analgesics|analgesics|mesh-ancestor
20177905|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
20177906|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20177907|NCT00177086|Alfuzosin|alfuzosin|mesh-list
20177908|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20352025|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352026|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20352027|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
20352028|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20352029|NCT00881231|Protective Agents|protective agents|mesh-ancestor
20352030|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20352031|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20352032|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352033|NCT00881296|Gemcitabine|gemcitabine|mesh-list
20352034|NCT00881296|Carboplatin|carboplatin|mesh-list
20352035|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667634|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667635|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667636|NCT04235686|Amphetamine|amphetamine|mesh-list
19667637|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
19667638|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19667639|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270316|NCT04906382|Paclitaxel|paclitaxel|mesh-list
19270317|NCT04906382|Carboplatin|carboplatin|mesh-list
19270318|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19270319|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19270320|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270321|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
19270322|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
19270323|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
19270324|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270325|NCT04903314|Cenobamate|cenobamate|mesh-list
19270326|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
19667640|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
19667641|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
19667642|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667643|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
19667644|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667645|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667646|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
19667647|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19667648|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19667649|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19667650|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19667651|NCT04210141|Antivenins|antivenins|mesh-list
19667652|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
20177909|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20177910|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20177911|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
20177912|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177913|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177914|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177915|NCT00177086|Urological Agents|urological agents|mesh-ancestor
20177916|NCT00177099|Tacrolimus|tacrolimus|mesh-list
20177917|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177918|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
20177919|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177920|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20177921|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177922|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177923|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
20177924|NCT00177138|Tacrolimus|tacrolimus|mesh-list
20177925|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20177926|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
20177927|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667653|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352036|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20352037|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
20352038|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352039|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
20352040|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352041|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352042|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352043|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
20352044|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352045|NCT00881387|Gemcitabine|gemcitabine|mesh-list
20352046|NCT00881387|Rituximab|rituximab|mesh-list
20352047|NCT00881387|Vinorelbine|vinorelbine|mesh-list
20352048|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352049|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352050|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
20352051|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352052|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20352053|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20352054|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
20352055|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352056|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
20352057|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352058|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352059|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352060|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20352061|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667654|NCT04199767|Insulin|insulin|mesh-list
19667655|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19667656|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
19667657|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19270344|NCT04892940|Analgesics|analgesics|mesh-list
19270345|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
19270346|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270347|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667658|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667659|NCT04018872|Itraconazole|itraconazole|mesh-list
19667660|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
19667661|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667662|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19667663|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667664|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667665|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667666|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19667667|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
19270358|NCT04886232|Lidocaine|lidocaine|mesh-list
19270359|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
19270360|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
19270361|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270362|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270363|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
19270364|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270365|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19270366|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19270367|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19270368|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270369|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270370|NCT04884360|Olaparib|olaparib|mesh-list
19270371|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19270372|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270373|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352062|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
20352063|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
20352064|NCT00881400|Cefprozil|cefprozil|mesh-list
20352065|NCT00881400|Cephalosporins|cephalosporins|mesh-list
20352066|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352067|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352068|NCT00881413|Esomeprazole|esomeprazole|mesh-list
20352069|NCT00881413|Pantoprazole|pantoprazole|mesh-list
20352070|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20352071|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20352072|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19270374|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667668|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667669|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667670|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19667671|NCT04001777|Osimertinib|osimertinib|mesh-list
19667672|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667673|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667674|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270381|NCT04879550|Antithrombins|antithrombins|mesh-list
19270382|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
19270383|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19270384|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
19270385|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270386|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270387|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
19270388|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19270389|NCT04876131|Gentamicins|gentamicins|mesh-list
19270390|NCT04876131|Cephalexin|cephalexin|mesh-list
19270391|NCT04876131|Penicillin G|penicillin g|mesh-list
19270392|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19270393|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
19270394|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270395|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19270396|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270397|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177928|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20177929|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352073|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352074|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352075|NCT00881426|Cefprozil|cefprozil|mesh-list
20352076|NCT00881426|Cephalosporins|cephalosporins|mesh-list
20352077|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352078|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352079|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20352080|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20352081|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352082|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
20352083|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
20352084|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
20352085|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352086|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20352087|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20352088|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20352089|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352090|NCT00881543|Incretins|incretins|mesh-ancestor
20352091|NCT00881543|Hormones|hormones|mesh-ancestor
20424899|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177930|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177931|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20177932|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177933|NCT00177242|Gefitinib|gefitinib|mesh-list
20177934|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177935|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20177936|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177937|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270408|NCT04850846|Metformin|metformin|mesh-list
19270409|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19270410|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270411|NCT04847557|Tirzepatide|tirzepatide|mesh-list
19270412|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19270413|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270414|NCT04847557|Incretins|incretins|mesh-ancestor
19270415|NCT04847557|Hormones|hormones|mesh-ancestor
19270416|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667675|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667676|NCT03982576|Nicotine|nicotine|mesh-list
19667677|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19667678|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
19667679|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667680|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667681|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19667682|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19667683|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
19667684|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667685|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667686|NCT03969641|Vaccines|vaccines|mesh-list
19667687|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
19691875|NCT04999293|Clopidogrel|clopidogrel|mesh-list
20352092|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20352093|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
20352094|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352095|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352096|NCT00881556|Fludarabine|fludarabine|mesh-list
19667688|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667689|NCT03965923|Tenofovir|tenofovir|mesh-list
19667690|NCT03965923|Emtricitabine|emtricitabine|mesh-list
19667691|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19667692|NCT03965923|Dapivirine|dapivirine|mesh-list
19667693|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
19667694|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667695|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19667696|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19667697|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667698|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667699|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20352097|NCT00881556|Busulfan|busulfan|mesh-list
20352098|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
20352099|NCT00881556|Lorazepam|lorazepam|mesh-list
20352100|NCT00881556|Tacrolimus|tacrolimus|mesh-list
20352101|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352102|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667700|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19667701|NCT03942328|Vaccines|vaccines|mesh-list
20352103|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667702|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
19667703|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667704|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19667705|NCT03933813|Hematinics|hematinics|mesh-ancestor
19667706|NCT03875144|Cisplatin|cisplatin|mesh-list
19667707|NCT03875144|Doxorubicin|doxorubicin|mesh-list
19667708|NCT03875144|Pemetrexed|pemetrexed|mesh-list
19667709|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667710|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19667711|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19270447|NCT04843462|Esketamine|esketamine|mesh-list
19270448|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
19270449|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19667712|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19667713|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667714|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667715|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19667716|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19270455|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19270456|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
19270457|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19270458|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
19270459|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270460|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270461|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270462|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19270463|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270464|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
19691876|NCT04999293|Ticagrelor|ticagrelor|mesh-list
19691877|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19691878|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19691879|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19691880|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19691881|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
19691882|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691883|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691884|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177938|NCT00177281|Belotecan|belotecan|mesh-list
20177939|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20177940|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20177941|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20177942|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177943|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20177944|NCT00177333|Doxycycline|doxycycline|mesh-list
20177945|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20177946|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20177947|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
20177948|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19270465|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270466|NCT04831398|Melatonin|melatonin|mesh-list
19270467|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
19270468|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270469|NCT04831398|Protective Agents|protective agents|mesh-ancestor
19270470|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270471|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270472|NCT04821856|Cannabidiol|cannabidiol|mesh-list
19270473|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
19667717|NCT03814005|Paclitaxel|paclitaxel|mesh-list
19667718|NCT03814005|Docetaxel|docetaxel|mesh-list
19667719|NCT03814005|Carboplatin|carboplatin|mesh-list
19667720|NCT03814005|Azacitidine|azacitidine|mesh-list
19667721|NCT03814005|Pevonedistat|pevonedistat|mesh-list
19667722|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19667723|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270480|NCT04809285|Insulin|insulin|mesh-list
19270481|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19270482|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667724|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667725|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
19667726|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667727|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667728|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19667729|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
19667730|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667731|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19667732|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19667733|NCT03740204|Estradiol|estradiol|mesh-list
19667734|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19667735|NCT03740204|Progesterone|progesterone|mesh-list
19667736|NCT03740204|Estrogens|estrogens|mesh-ancestor
19667737|NCT03740204|Hormones|hormones|mesh-ancestor
19667738|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667739|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667740|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19667741|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
19270494|NCT04796467|Edetic Acid|edetic acid|mesh-list
19270495|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19270496|NCT04796467|Anticoagulants|anticoagulants|mesh-ancestor
19270497|NCT04796467|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19270498|NCT04796467|Chelating Agents|chelating agents|mesh-ancestor
19270499|NCT04796467|Sequestering Agents|sequestering agents|mesh-ancestor
19270500|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270501|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19270502|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
19667742|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20177949|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19270503|NCT04789096|Trastuzumab|trastuzumab|mesh-list
19270504|NCT04789096|Capecitabine|capecitabine|mesh-list
19270505|NCT04789096|Tucatinib|tucatinib|mesh-list
19270506|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19270507|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270508|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19270509|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
19270510|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270511|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19270512|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270513|NCT04751383|Dinutuximab|dinutuximab|mesh-list
19270514|NCT04751383|Magrolimab|magrolimab|mesh-list
19270515|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270516|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20177950|NCT00177372|Misoprostol|misoprostol|mesh-list
20177951|NCT00177372|Mifepristone|mifepristone|mesh-list
20177952|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19667743|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19667744|NCT03740204|Progestins|progestins|mesh-ancestor
20177953|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
20177954|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20177955|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177956|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20177957|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20177958|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
19667745|NCT03726671|Choline|choline|mesh-list
19667746|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
19667747|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19667748|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
20177959|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19667749|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667750|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667751|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19667752|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
19667753|NCT03701711|Lenalidomide|lenalidomide|mesh-list
19667754|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
19667755|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667756|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19667757|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19667758|NCT03701711|Growth Substances|growth substances|mesh-ancestor
19667759|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
19667760|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667761|NCT03685773|Niacin|niacin|mesh-list
19667762|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
19667763|NCT03685773|Niacinamide|niacinamide|mesh-list
19667764|NCT03685773|Diazoxide|diazoxide|mesh-list
19667765|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19667766|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
19667767|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667768|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19667769|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
19667770|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
19667771|NCT03685773|Vitamins|vitamins|mesh-ancestor
19667772|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
19667773|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667774|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19667775|NCT03596073|Calcipotriene|calcipotriene|mesh-list
19667776|NCT03596073|Petrolatum|petrolatum|mesh-list
20177960|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20177961|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20177962|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20177963|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
19667777|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
19667778|NCT03596073|Emollients|emollients|mesh-ancestor
19667779|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19270534|NCT04729387|Paclitaxel|paclitaxel|mesh-list
19270535|NCT04729387|Doxorubicin|doxorubicin|mesh-list
19270536|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19270537|NCT04729387|Olaparib|olaparib|mesh-list
19270538|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19270539|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270540|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667780|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19667781|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667782|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667783|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
19667784|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667785|NCT03579914|Metoprolol|metoprolol|mesh-list
19835941|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19835942|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19835943|NCT00606138|Growth Substances|growth substances|mesh-ancestor
19667786|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19835944|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835945|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
19835946|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19835947|NCT00606177|Aripiprazole|aripiprazole|mesh-list
19835948|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835949|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177964|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20177965|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20177966|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
20217193|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19835950|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19835951|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835952|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835953|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835954|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
19835955|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
19835956|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835957|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835958|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19270541|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
19270542|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667787|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19835959|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19835960|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
19667788|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
19270543|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270544|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19270545|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19270546|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19270547|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270548|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19667789|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
19667790|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667791|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667792|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19667793|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19270554|NCT04699591|Domperidone|domperidone|mesh-list
19270555|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
19270556|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
19270557|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270558|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270559|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19270560|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19270561|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
19270562|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270563|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177967|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177968|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
20177969|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20177970|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19667794|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19667795|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
20177971|NCT00177398|Insulin|insulin|mesh-list
20177972|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20177973|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
20177974|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20177975|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177976|NCT00177411|Hormones|hormones|mesh-list
20177977|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
20177978|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
20177979|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177980|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177981|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20177982|NCT00177424|Sertraline|sertraline|mesh-list
20177983|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
20177984|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20177985|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20177986|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20177987|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20177988|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177989|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20177990|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
20177991|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177992|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20177993|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20177994|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19270589|NCT04650074|Lidocaine|lidocaine|mesh-list
19270590|NCT04650074|Ketamine|ketamine|mesh-list
19270591|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
19270592|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
19270593|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270594|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270595|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
19270596|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270597|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19270598|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19270599|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19270600|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270601|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270602|NCT04650074|Analgesics|analgesics|mesh-ancestor
19270603|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19270604|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19270605|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
19270606|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19270607|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19270608|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352104|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
19270609|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
19270610|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270611|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19270612|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
19270613|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
19270614|NCT04647721|Protective Agents|protective agents|mesh-ancestor
19667796|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667797|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667798|NCT03560258|Vaccines|vaccines|mesh-list
19667799|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
19667800|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667801|NCT03535363|Osimertinib|osimertinib|mesh-list
19667802|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667803|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19667804|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667805|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667806|NCT03384784|Galantamine|galantamine|mesh-list
19667807|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19667808|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667809|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667810|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
19667811|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667812|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667813|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19667814|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
19667815|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667816|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
19667817|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
19667818|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667819|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667820|NCT03293017|Diazepam|diazepam|mesh-list
19667821|NCT03293017|Baclofen|baclofen|mesh-list
19270640|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
19270641|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19270642|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19270643|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19270644|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19270645|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270646|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270647|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
19270648|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270649|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270650|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19270651|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270652|NCT04604366|Alprostadil|alprostadil|mesh-list
19270653|NCT04604366|Misoprostol|misoprostol|mesh-list
19270654|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19270655|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
19270656|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19270657|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270658|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19270659|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19270660|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
19270661|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19270662|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
19270663|NCT04604366|Urological Agents|urological agents|mesh-ancestor
19667822|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19667823|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667824|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19667825|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270669|NCT04594239|Lidocaine|lidocaine|mesh-list
19270670|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
19270671|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
19270672|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
19270673|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270674|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270675|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
19270676|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270677|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19270678|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19270679|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19270680|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270681|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270682|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19270683|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
20352105|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352106|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20352107|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352108|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
20352109|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20352110|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19270684|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
19270685|NCT04594239|Protective Agents|protective agents|mesh-ancestor
19270686|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
19270687|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19270688|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19270689|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19270690|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19270691|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270692|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270693|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
19270694|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270695|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270696|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19270697|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270698|NCT04585711|Etanercept|etanercept|mesh-list
19270699|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19270700|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19667826|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19667827|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
19667828|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
19667829|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667830|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667831|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19270701|NCT04585711|Analgesics|analgesics|mesh-ancestor
19270702|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
19270703|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270704|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270705|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19270706|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19270707|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19270708|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19270709|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
19270710|NCT04579380|Trastuzumab|trastuzumab|mesh-list
19270711|NCT04579380|Fulvestrant|fulvestrant|mesh-list
19667832|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
19667833|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
20177995|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270712|NCT04579380|Tucatinib|tucatinib|mesh-list
19270713|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19270714|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270715|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19270716|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19270717|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19270718|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
19270719|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20177996|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20177997|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270720|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270721|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20177998|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20177999|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20178000|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178001|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178002|NCT00177567|Lamotrigine|lamotrigine|mesh-list
20178003|NCT00177567|Valproic Acid|valproic acid|mesh-list
20178004|NCT00177567|Olanzapine|olanzapine|mesh-list
20178005|NCT00177567|Risperidone|risperidone|mesh-list
20178006|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
20178007|NCT00177567|Mirtazapine|mirtazapine|mesh-list
20178008|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
20178009|NCT00177567|Bupropion|bupropion|mesh-list
20178010|NCT00177567|Paroxetine|paroxetine|mesh-list
20178011|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19270722|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667834|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
20178012|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20178013|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
19270723|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270724|NCT04569084|Edaravone|edaravone|mesh-list
19270725|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19270726|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
19270727|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270728|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19270729|NCT04569084|Protective Agents|protective agents|mesh-ancestor
19270730|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667835|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667836|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19667837|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19667838|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19667839|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19667840|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19667841|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19667842|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
19667843|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
19667844|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
19667845|NCT03198559|Vorinostat|vorinostat|mesh-list
19270742|NCT04564755|Abrocitinib|abrocitinib|mesh-list
19270743|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19270744|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270745|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270746|NCT04552782|Ethanol|ethanol|mesh-list
19270747|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19270748|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178014|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178015|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178016|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178017|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20178018|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178019|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178020|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178021|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20178022|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
20352111|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352112|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
20352113|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
20352114|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
20352115|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352116|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20352117|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20352118|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270749|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19270750|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270751|NCT04551131|Dexamethasone|dexamethasone|mesh-list
19270752|NCT04551131|Etoposide|etoposide|mesh-list
19270753|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
19270754|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19270755|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
19270756|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
19270757|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270758|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270759|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19270760|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
19270761|NCT04551131|Hormones|hormones|mesh-ancestor
19270762|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270763|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19270764|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270765|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19270766|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19270767|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19270768|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667846|NCT03198559|Disulfiram|disulfiram|mesh-list
19667847|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667848|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19667849|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667850|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667851|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19667852|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19667853|NCT03179943|Atezolizumab|atezolizumab|mesh-list
19667854|NCT03179943|Guadecitabine|guadecitabine|mesh-list
20178023|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
20178024|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
20352119|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20352120|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352121|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352122|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
20352123|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
20352124|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352125|NCT00881582|Interferons|interferons|mesh-list
20352126|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
20352127|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
20352128|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20352129|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352130|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
20352131|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352132|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
19270769|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667855|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667856|NCT03136263|Oxytocin|oxytocin|mesh-list
19667857|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
19667858|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19667859|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667860|NCT03129113|Metformin|metformin|mesh-list
19667861|NCT03129113|Maraviroc|maraviroc|mesh-list
19667862|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19667863|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667864|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19667865|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19667866|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667867|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19667868|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19667869|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
19667870|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667871|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19667872|NCT03102125|Regadenoson|regadenoson|mesh-list
19667873|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19667874|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19667875|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
19667876|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
19270780|NCT04537715|Itraconazole|itraconazole|mesh-list
19270781|NCT04537715|Rifampin|rifampin|mesh-list
19270782|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
19270783|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270784|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19270785|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19270786|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270787|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270788|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19270789|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
19270790|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270791|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270792|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19270793|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19270794|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
19270795|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19270796|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
19270797|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19270798|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19270799|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19667877|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178025|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178026|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20178027|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178028|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178029|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178030|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20178031|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178032|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20178033|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20178034|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178035|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178036|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
20178037|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20178038|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
20178039|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20178040|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19270800|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19270801|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19270802|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19270803|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19270804|NCT04529538|Vaccines|vaccines|mesh-list
19270805|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
19270806|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270807|NCT04523493|Lenvatinib|lenvatinib|mesh-list
19270808|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270809|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19270810|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270811|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178041|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20178042|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19667878|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667879|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667880|NCT02982668|Metoclopramide|metoclopramide|mesh-list
19667881|NCT02982668|Mosapride|mosapride|mesh-list
19270818|NCT04495855|Dienogest|dienogest|mesh-list
19270819|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19270820|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
19835961|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19835962|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19835963|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19835964|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19835965|NCT00606229|Aripiprazole|aripiprazole|mesh-list
19270821|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19270822|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270823|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19270824|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19270825|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19270826|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19270827|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
19270828|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20352133|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352134|NCT00881595|Temozolomide|temozolomide|mesh-list
20352135|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20352136|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
20352137|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178043|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
20178044|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
20178045|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20178046|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20178047|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20178048|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20178049|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
20178050|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19270829|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19270830|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270831|NCT04478734|Thiamine|thiamine|mesh-list
19270832|NCT04478734|Biotin|biotin|mesh-list
19270833|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
19270834|NCT04478734|Vitamins|vitamins|mesh-ancestor
19270835|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
19270836|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667882|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
19667883|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
19667884|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667885|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667886|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19270842|NCT04469075|Clindamycin|clindamycin|mesh-list
19270843|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
19270844|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
19270845|NCT04469075|Triamcinolone|triamcinolone|mesh-list
19270846|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19270847|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19270848|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19835966|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
19835967|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835968|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20178051|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20178052|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
19270849|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19270850|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
19270851|NCT04469075|Hormones|hormones|mesh-ancestor
20352138|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352139|NCT00881634|Cetirizine|cetirizine|mesh-list
19270852|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270853|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270854|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19270855|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
19270856|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270857|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270858|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19270859|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270860|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19270861|NCT04460781|Vaccines|vaccines|mesh-list
19270862|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
19270863|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270864|NCT04456517|Ranolazine|ranolazine|mesh-list
19270865|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19270866|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19270867|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667887|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19667888|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19667889|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
19667890|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667891|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667892|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19667893|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
19270875|NCT04447755|Lenvatinib|lenvatinib|mesh-list
19270876|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270877|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19270878|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270879|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667894|NCT02917096|Vidarabine|vidarabine|mesh-list
19667895|NCT02917096|Sirolimus|sirolimus|mesh-list
19667896|NCT02917096|Fludarabine|fludarabine|mesh-list
19667897|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
19667898|NCT02917096|Melphalan|melphalan|mesh-list
19667899|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
19667900|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19667901|NCT02917096|Tacrolimus|tacrolimus|mesh-list
19667902|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667903|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19835969|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19835970|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835971|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178053|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20178054|NCT00177580|Pravastatin|pravastatin|mesh-list
20178055|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20178056|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20178057|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
20178058|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178059|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20178060|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20178061|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178062|NCT00177619|Alendronate|alendronate|mesh-list
20178063|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20178064|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178065|NCT00177684|Amphotericin B|amphotericin b|mesh-list
20178066|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20178067|NCT00177684|Amebicides|amebicides|mesh-ancestor
20178068|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20178069|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20178070|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178071|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20178072|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
20178073|NCT00177710|Amphotericin B|amphotericin b|mesh-list
20178074|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20352140|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
19667904|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
19667905|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667906|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19667907|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
19667908|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667909|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
19667910|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667911|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19667912|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667913|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19667914|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19667915|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
19667916|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19667917|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
19667918|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19667919|NCT02917083|Cyclophosphamide|cyclophosphamide|mesh-list
19667920|NCT02917083|Fludarabine|fludarabine|mesh-list
19667921|NCT02917083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19270906|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
19270907|NCT04445714|Saxagliptin|saxagliptin|mesh-list
19270908|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19270909|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19270910|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19270911|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270912|NCT04445714|Incretins|incretins|mesh-ancestor
19270913|NCT04445714|Hormones|hormones|mesh-ancestor
19270914|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19270915|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20178075|NCT00177710|Amebicides|amebicides|mesh-ancestor
19270916|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
19270917|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19270918|NCT04445519|Latanoprost|latanoprost|mesh-list
19270919|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19270920|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19270921|NCT04427241|Amantadine|amantadine|mesh-list
19270922|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
19667922|NCT02917083|Immunologic Factors|immunologic factors|mesh-ancestor
19667923|NCT02917083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667924|NCT02917083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667925|NCT02917083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19667926|NCT02917083|Alkylating Agents|alkylating agents|mesh-ancestor
19270923|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19270924|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19270925|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
19270926|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270927|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
19270928|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19270929|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667927|NCT02917083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667928|NCT02917083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667929|NCT02917083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19667930|NCT02913274|Paclitaxel|paclitaxel|mesh-list
19667931|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19667932|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667933|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667934|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
19667935|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667936|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667937|NCT02906007|Bedaquiline|bedaquiline|mesh-list
19667938|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
19667939|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19667940|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667941|NCT02757859|Pancrelipase|pancrelipase|mesh-list
19667942|NCT02757859|Pancreatin|pancreatin|mesh-list
19667943|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19667944|NCT02749513|Itraconazole|itraconazole|mesh-list
19667945|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
19270930|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270931|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19270932|NCT04427241|Analgesics|analgesics|mesh-ancestor
19270933|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
19270934|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19270935|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19270936|NCT04427241|Protective Agents|protective agents|mesh-ancestor
19667946|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19667947|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19667948|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19667949|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19667950|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667951|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20178076|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19270937|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
19270938|NCT04424511|Azithromycin|azithromycin|mesh-list
19667952|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
20178077|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19270939|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19270940|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19270941|NCT04416568|Nivolumab|nivolumab|mesh-list
19270942|NCT04416568|Ipilimumab|ipilimumab|mesh-list
19270943|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19270944|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19270945|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19270946|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667953|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19667954|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667955|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19270950|NCT04394546|Anticoagulants|anticoagulants|mesh-list
19667956|NCT02684227|Paclitaxel|paclitaxel|mesh-list
19667957|NCT02684227|Carboplatin|carboplatin|mesh-list
19667958|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19667959|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19667960|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667961|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19667962|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19667963|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19667964|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667965|NCT02682641|Rituximab|rituximab|mesh-list
19667966|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19667967|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667968|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
19667969|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19270965|NCT04369469|Ravulizumab|ravulizumab|mesh-list
19270966|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19270967|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19270968|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
19270969|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19835972|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
19835973|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
19835974|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19835975|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835976|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19835977|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19835978|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
19835979|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19835980|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19835981|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19835982|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19835983|NCT00606281|Aripiprazole|aripiprazole|mesh-list
19835984|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
19667970|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19667971|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
19667972|NCT05110339|Ropivacaine|ropivacaine|mesh-list
19667973|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19667974|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19667975|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19667976|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19667977|NCT05110339|Analgesics|analgesics|mesh-ancestor
19667978|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
19667979|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19667980|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19667981|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19667982|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19667983|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
19667984|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667985|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667986|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
19667987|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
19667988|NCT05110170|Goserelin|goserelin|mesh-list
19667989|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19667990|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19667991|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19667992|NCT05110144|Amitriptyline|amitriptyline|mesh-list
19667993|NCT05110144|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19667994|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19667995|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19835985|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19835986|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19835987|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178078|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178079|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20178080|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
20178081|NCT00177749|Posaconazole|posaconazole|mesh-list
20352141|NCT00881634|Ephedrine|ephedrine|mesh-list
20352142|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20352143|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20352144|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20352145|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
20352146|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
20352147|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352148|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352149|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352150|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19667996|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178082|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
20178083|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178084|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19667997|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19667998|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19667999|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668000|NCT05110144|Analgesics|analgesics|mesh-ancestor
19668001|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
19668002|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668003|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
19668004|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19668005|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
19668006|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19668007|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19668008|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19668009|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
19668010|NCT05110144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19668011|NCT05110144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19668012|NCT05110144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668013|NCT05110118|Bevacizumab|bevacizumab|mesh-list
19668014|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
19668015|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668016|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668017|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19668018|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19668019|NCT05110118|Growth Substances|growth substances|mesh-ancestor
19668020|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668021|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178085|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19668022|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19668023|NCT05109650|Antibodies|antibodies|mesh-list
19668024|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
19668025|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
19668026|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668027|NCT05109585|Antibodies|antibodies|mesh-list
19668028|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
20178086|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20178087|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20178088|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178089|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178090|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178091|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20178092|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
20178093|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20178094|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178095|NCT00177853|Celecoxib|celecoxib|mesh-list
20178096|NCT00177853|Irinotecan|irinotecan|mesh-list
20352151|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
19668029|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
19668030|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
20178097|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20178098|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178099|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178100|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178101|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178102|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20178103|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20178104|NCT00177853|Analgesics|analgesics|mesh-ancestor
20178105|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
20178106|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178107|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178108|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178109|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178110|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20178111|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20178112|NCT00177996|Sertraline|sertraline|mesh-list
20178113|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178114|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178115|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19668031|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178116|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178117|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178118|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178119|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178120|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
20178121|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178122|NCT00178035|Paroxetine|paroxetine|mesh-list
20178123|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178124|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178125|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19271041|NCT04280406|Azithromycin|azithromycin|mesh-list
19271042|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19271043|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271044|NCT04278053|Inositol|inositol|mesh-list
19271045|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
19271046|NCT04278053|Vitamins|vitamins|mesh-ancestor
19271047|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
19271048|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178126|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178127|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691900|NCT04999449|Scopolamine|scopolamine|mesh-list
19691901|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19691902|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19691903|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
19691904|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
19691905|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691906|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691907|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691908|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
19691909|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19691910|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
19691911|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691912|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691913|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19691914|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
19691915|NCT04999176|Enoxaparin|enoxaparin|mesh-list
19691916|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
19691917|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19271069|NCT04217694|Memantine|memantine|mesh-list
20178128|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
20178129|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178130|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20178131|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178132|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178133|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20178134|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178135|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178136|NCT00178048|Paroxetine|paroxetine|mesh-list
20178137|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178138|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178139|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19271070|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19271071|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19691918|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
20178140|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178141|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178142|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
20178143|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271072|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
19271073|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19271074|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271075|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271076|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19271077|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19668032|NCT05109390|Cyclosporine|cyclosporine|mesh-list
19668033|NCT05109390|Simethicone|simethicone|mesh-list
19668034|NCT05109390|Omeprazole|omeprazole|mesh-list
19668035|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
19668036|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
19668037|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19668038|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
20178144|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20178145|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178146|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178147|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20178148|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178149|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178150|NCT00178100|Paroxetine|paroxetine|mesh-list
20178151|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178152|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178153|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178154|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178155|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178156|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
20178157|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178158|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19668039|NCT05109390|Antacids|antacids|mesh-list
19668040|NCT05109390|Tacrolimus|tacrolimus|mesh-list
19668041|NCT05109390|Cyclosporins|cyclosporins|mesh-list
19668042|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668043|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668044|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
19668045|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19668046|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668047|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668048|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
19668049|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668050|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
19668051|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19668052|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20178159|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178160|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19668053|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19668054|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
19668055|NCT05109390|Emollients|emollients|mesh-ancestor
19668056|NCT05109377|Tadalafil|tadalafil|mesh-list
19668057|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
19668058|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19668059|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19668060|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668061|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835988|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19835989|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668062|NCT05109377|Urological Agents|urological agents|mesh-ancestor
19668063|NCT05109312|Acetaminophen|acetaminophen|mesh-list
19668064|NCT05109312|Ibuprofen|ibuprofen|mesh-list
19668065|NCT05109312|Bupivacaine|bupivacaine|mesh-list
19668066|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
19668067|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
19668068|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178161|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20178162|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178163|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178164|NCT00178113|Lycopene|lycopene|mesh-list
20178165|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178166|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
19668069|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668070|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
19835990|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
20352152|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352153|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20352154|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
20352155|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
20352156|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20352157|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20352158|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
19668071|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668072|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19668073|NCT05109312|Analgesics|analgesics|mesh-ancestor
19668074|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
19668075|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19668076|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668077|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19835991|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
20178167|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668078|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19668079|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668080|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668081|NCT05109299|Fluorides|fluorides|mesh-list
19668082|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
19668083|NCT05109299|Protective Agents|protective agents|mesh-ancestor
19668084|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668085|NCT05108714|Lidocaine|lidocaine|mesh-list
19668086|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
19271101|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
19271102|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19271103|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352159|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
20352160|NCT00881673|Dexamethasone|dexamethasone|mesh-list
20352161|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20352162|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19271104|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271105|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668087|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
19668088|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668089|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668090|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
19668091|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271111|NCT04154787|Rituximab|rituximab|mesh-list
19271112|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271113|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271114|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
19271115|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271116|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19668092|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19668093|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19668094|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19668095|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19668096|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668097|NCT05108597|Misoprostol|misoprostol|mesh-list
19668098|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20178168|NCT00178113|Protective Agents|protective agents|mesh-ancestor
20178169|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178170|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19668099|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
19668100|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668101|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668102|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19668103|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19668104|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
19668105|NCT05108545|Amphotericin B|amphotericin b|mesh-list
19668106|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19668107|NCT05108545|Amebicides|amebicides|mesh-ancestor
19668108|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20178171|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20178172|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178173|NCT00178269|Docetaxel|docetaxel|mesh-list
20178174|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178175|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
20178176|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
19835992|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178177|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
20352163|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668109|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19668110|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668111|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19668112|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
19668113|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
19668114|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19271139|NCT04132661|Bisacodyl|bisacodyl|mesh-list
19271140|NCT04132661|Cathartics|cathartics|mesh-ancestor
19271141|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19271142|NCT04132661|Laxatives|laxatives|mesh-ancestor
19271143|NCT04129788|Bisacodyl|bisacodyl|mesh-list
19271144|NCT04129788|Cathartics|cathartics|mesh-ancestor
19271145|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19271146|NCT04129788|Laxatives|laxatives|mesh-ancestor
19271147|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
19271148|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271149|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271150|NCT04125927|Cysteamine|cysteamine|mesh-list
19271151|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19271152|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271153|NCT04119180|Midazolam|midazolam|mesh-list
19271154|NCT04119180|Ketamine|ketamine|mesh-list
19271155|NCT04119180|Analgesics|analgesics|mesh-ancestor
19271156|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
19271157|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271158|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271159|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19271160|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19271161|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
19271162|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
19271163|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271164|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19271165|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19271166|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19271167|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271168|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19271169|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19271170|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19271171|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19271172|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19271173|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
19271174|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
19271175|NCT04109066|Paclitaxel|paclitaxel|mesh-list
19271176|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
20352164|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
20352165|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
20352166|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352167|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352168|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20352169|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
20178178|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178179|NCT00178373|Modafinil|modafinil|mesh-list
20178180|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20178181|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178182|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20178183|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20178184|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20178185|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217194|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19271177|NCT04109066|Nivolumab|nivolumab|mesh-list
19271178|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19271179|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217195|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20217196|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20352170|NCT00881673|Hormones|hormones|mesh-ancestor
19271180|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
19271181|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
19271182|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
19271183|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271184|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19271185|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
19271186|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271187|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19271188|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19271189|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
19271190|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19271191|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271192|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19668115|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19668116|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668117|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
19668118|NCT05102695|Coagulants|coagulants|mesh-ancestor
19668119|NCT05098847|Lenvatinib|lenvatinib|mesh-list
19668120|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668121|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19668122|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668123|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835993|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19835994|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19835995|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19835996|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
19835997|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19835998|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19835999|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19836000|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19836001|NCT00606294|Misonidazole|misonidazole|mesh-list
20352171|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20352172|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19668124|NCT05097118|Ketamine|ketamine|mesh-list
19668125|NCT05097118|Bupivacaine|bupivacaine|mesh-list
19668126|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
19668127|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
19668128|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668129|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836002|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352173|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352174|NCT00881686|Adenosine|adenosine|mesh-list
20352175|NCT00881686|Analgesics|analgesics|mesh-ancestor
20352176|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
20352177|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352178|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352179|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20352180|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
20352181|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20352182|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
20352183|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
20352184|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352185|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352186|NCT00881725|Metformin|metformin|mesh-list
20352187|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20352188|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352189|NCT00881738|Clarithromycin|clarithromycin|mesh-list
20352190|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352191|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352192|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20352193|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352194|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352195|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20352196|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20352197|NCT00881764|Anesthetics|anesthetics|mesh-list
20352198|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352199|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352200|NCT00881790|Fluorides|fluorides|mesh-list
20352201|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
20352202|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
20352203|NCT00881790|Protective Agents|protective agents|mesh-ancestor
20352204|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352205|NCT00881816|Paclitaxel|paclitaxel|mesh-list
20352206|NCT00881816|Capecitabine|capecitabine|mesh-list
20352207|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20352208|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352209|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
20352210|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
20352211|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
20352212|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352213|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19668130|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
19271209|NCT04093323|Interferons|interferons|mesh-list
20352214|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
19271210|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
20352215|NCT00881855|Cefprozil|cefprozil|mesh-list
20352216|NCT00881855|Cephalosporins|cephalosporins|mesh-list
20352217|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352218|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271211|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
19271212|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19271213|NCT04093323|Celecoxib|celecoxib|mesh-list
19271214|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19271215|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
19271216|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271217|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
19271218|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271219|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
19271220|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271221|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19271222|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19271223|NCT04093323|Analgesics|analgesics|mesh-ancestor
19271224|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
19271225|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271226|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19271227|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19271228|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19271229|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19271230|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271231|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271232|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19668131|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668132|NCT05097118|Analgesics|analgesics|mesh-ancestor
19668133|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19668134|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19668135|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
19668136|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19668137|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19668138|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668139|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668140|NCT05093920|Doxorubicin|doxorubicin|mesh-list
19668141|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19668142|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19668143|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668144|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19668145|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19668146|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668147|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668148|NCT05053737|Atezolizumab|atezolizumab|mesh-list
19668149|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668150|NCT05007769|Atezolizumab|atezolizumab|mesh-list
19668151|NCT05007769|Ramucirumab|ramucirumab|mesh-list
19668152|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668153|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
20178186|NCT00178451|Abciximab|abciximab|mesh-list
20178187|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
20178188|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20178189|NCT00178620|Reteplase|reteplase|mesh-list
20178190|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19668154|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668155|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691919|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19691920|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
19691921|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178191|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20178192|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178193|NCT00178698|Gemcitabine|gemcitabine|mesh-list
20178194|NCT00178698|Interferons|interferons|mesh-list
20178195|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178196|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178197|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
20178198|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178199|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
20178200|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178201|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178202|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352219|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19691922|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691923|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
19691924|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19668156|NCT04772300|Sirolimus|sirolimus|mesh-list
20352220|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20352221|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352222|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
20352223|NCT00882024|Tranilast|tranilast|mesh-list
20352224|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20352225|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20352226|NCT00882024|Analgesics|analgesics|mesh-ancestor
19668157|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19668158|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271266|NCT04065399|Cobicistat|cobicistat|mesh-list
19271267|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19271268|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19271269|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
19271270|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271271|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19271272|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19271273|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178203|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
20178204|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178205|NCT00178763|Gemcitabine|gemcitabine|mesh-list
20178206|NCT00178763|Interferons|interferons|mesh-list
20178207|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
20178208|NCT00178763|Cisplatin|cisplatin|mesh-list
20178209|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352227|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
20352228|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352229|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352230|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352231|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20352232|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20352233|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20352234|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352235|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20352236|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19668159|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19668160|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668161|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
19668162|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668163|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
19668164|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668165|NCT04707222|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19668166|NCT04707222|Metronidazole|metronidazole|mesh-list
19668167|NCT04707222|Ciprofloxacin|ciprofloxacin|mesh-list
19668168|NCT04707222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668169|NCT04707222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19668170|NCT04707222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19668171|NCT04707222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20352237|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
20352238|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
20352239|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352240|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20352241|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20352242|NCT00882076|Etoposide|etoposide|mesh-list
19668172|NCT04707222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19668173|NCT04707222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668174|NCT04707222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668175|NCT04707222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668176|NCT04707222|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20178210|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178211|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
20178212|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178213|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
20178214|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178215|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178216|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178217|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
20178218|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178219|NCT00178802|Interferons|interferons|mesh-list
20178220|NCT00178802|Doxorubicin|doxorubicin|mesh-list
19271274|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668177|NCT04707222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19668178|NCT04701060|Apatinib|apatinib|mesh-list
20178221|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20178222|NCT00178802|Fluorouracil|fluorouracil|mesh-list
20178223|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20178224|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178225|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20178226|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178227|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178228|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178229|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
20178230|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178231|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178232|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
20178233|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178234|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
19668179|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668180|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19668181|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178235|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178236|NCT00178828|Bupropion|bupropion|mesh-list
20178237|NCT00178828|Sertraline|sertraline|mesh-list
20178238|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20178239|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178240|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178241|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20178242|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178243|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178244|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178245|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
20178246|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668182|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668183|NCT04676477|Osimertinib|osimertinib|mesh-list
19668184|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
19668185|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19668186|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668187|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19668188|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668189|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668190|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271288|NCT04029688|Cytarabine|cytarabine|mesh-list
19271289|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
19271290|NCT04029688|Fludarabine|fludarabine|mesh-list
19271291|NCT04029688|Topotecan|topotecan|mesh-list
19271292|NCT04029688|Venetoclax|venetoclax|mesh-list
19271293|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19271294|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
19271295|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271296|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19271297|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19271298|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
19271299|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271300|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271301|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19271302|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19668191|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
19668192|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668193|NCT04674462|Vaccines|vaccines|mesh-list
19668194|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
19668195|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271303|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
19271304|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
19271305|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271306|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19271307|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19271308|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668196|NCT04626141|Abaloparatide|abaloparatide|mesh-list
19668197|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19668198|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271312|NCT04026412|Nivolumab|nivolumab|mesh-list
19271313|NCT04026412|Ipilimumab|ipilimumab|mesh-list
19271314|NCT04026412|Durvalumab|durvalumab|mesh-list
19271315|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271316|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271317|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20178247|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271318|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668199|NCT04595864|Leucovorin|leucovorin|mesh-list
19668200|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
19668201|NCT04595864|Calcium|calcium|mesh-list
20178248|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20178249|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178250|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178251|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178252|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
20178253|NCT00178854|Risperidone|risperidone|mesh-list
20178254|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20178255|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
20178256|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178257|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178258|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178259|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20178260|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178261|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178262|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178263|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20178264|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
20178265|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
20178266|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20178267|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20178268|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19668202|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
19271321|NCT04022057|Ropivacaine|ropivacaine|mesh-list
19271322|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
19271323|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
19271324|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271325|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271326|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
19271327|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271328|NCT04020601|Ropivacaine|ropivacaine|mesh-list
19271329|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
19271330|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
19271331|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271332|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668203|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19668204|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668205|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668206|NCT04595864|Antidotes|antidotes|mesh-ancestor
20178269|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178270|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178271|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
20178272|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352243|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
20352244|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
20352245|NCT00882076|Clofarabine|clofarabine|mesh-list
20352246|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20352247|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352248|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20352249|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20352250|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668207|NCT04595864|Protective Agents|protective agents|mesh-ancestor
19271333|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
19271334|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271335|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
19271336|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19271337|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352251|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668208|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
19668209|NCT04595864|Vitamins|vitamins|mesh-ancestor
19668210|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
19668211|NCT04583462|Metformin|metformin|mesh-list
19668212|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19668213|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668214|NCT04569383|Vaccines|vaccines|mesh-list
19668215|NCT04569383|Immunologic Factors|immunologic factors|mesh-ancestor
19668216|NCT04569383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668217|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
19668218|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19668219|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19668220|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668221|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
19668222|NCT04555343|Coagulants|coagulants|mesh-ancestor
19668223|NCT04495088|Leucovorin|leucovorin|mesh-list
19668224|NCT04495088|Folic Acid|folic acid|mesh-list
19668225|NCT04495088|Capecitabine|capecitabine|mesh-list
19668226|NCT04495088|Fluorouracil|fluorouracil|mesh-list
20352252|NCT00882076|Analgesics|analgesics|mesh-ancestor
20352253|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
20352254|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352255|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352256|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20352257|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
20352258|NCT00882154|Cefdinir|cefdinir|mesh-list
20352259|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352260|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352261|NCT00882193|Ribavirin|ribavirin|mesh-list
20352262|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20352263|NCT00882193|Betaine|betaine|mesh-list
20352264|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
20352265|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352266|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
20352267|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352268|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19271338|NCT04020341|Renal Agents|renal agents|mesh-ancestor
19271339|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19271340|NCT04019093|Ethanol|ethanol|mesh-list
19271341|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19271342|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668227|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
19271343|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271344|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271345|NCT04006210|Levodopa|levodopa|mesh-list
19271346|NCT04006210|Carbidopa|carbidopa|mesh-list
19271347|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19271348|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19271349|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
19271350|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19271351|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271352|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271353|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19271354|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271355|NCT04003805|Nicotine|nicotine|mesh-list
19271356|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19271357|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
19271358|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271359|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271360|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19271361|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19271362|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
19271363|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19271364|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668228|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
19668229|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19668230|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
19668231|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668232|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668233|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668234|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
19271372|NCT03994601|Nivolumab|nivolumab|mesh-list
19271373|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271374|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271375|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19271376|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668235|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668236|NCT04495088|Antidotes|antidotes|mesh-ancestor
19668237|NCT04495088|Protective Agents|protective agents|mesh-ancestor
19668238|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
19668239|NCT04495088|Vitamins|vitamins|mesh-ancestor
19668240|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
19668241|NCT04495088|Hematinics|hematinics|mesh-ancestor
19668242|NCT04472494|Abatacept|abatacept|mesh-list
19668243|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19668244|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668245|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668246|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668247|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
19668248|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668249|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19668250|NCT04464408|Favipiravir|favipiravir|mesh-list
19668251|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
19668252|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668253|NCT04456322|Cisplatin|cisplatin|mesh-list
20352269|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
19668254|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
19668255|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668256|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352270|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20352271|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20352272|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
20352273|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20352274|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
20352275|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352276|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
19668257|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
19668258|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19668259|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
19668260|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668261|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668262|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19668263|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
19668264|NCT04405167|Dexamethasone|dexamethasone|mesh-list
19668265|NCT04405167|Lenalidomide|lenalidomide|mesh-list
19668266|NCT04405167|Ixazomib|ixazomib|mesh-list
19668267|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668268|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
19668269|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
20352277|NCT00882232|Protective Agents|protective agents|mesh-ancestor
20352278|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
20352279|NCT00882323|Fludarabine|fludarabine|mesh-list
20352280|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
20352281|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352282|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
20352283|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352284|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20352285|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19668270|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668271|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668272|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19668273|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
19271405|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19271406|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271407|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
19271408|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271409|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271410|NCT03965962|Vaccines|vaccines|mesh-list
19668274|NCT04405167|Hormones|hormones|mesh-ancestor
19668275|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19668276|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19668277|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668278|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
19668279|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668280|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668281|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
20352286|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
19271411|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
19271412|NCT03965962|Antibodies|antibodies|mesh-list
19271413|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
19271414|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19271415|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19668282|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19668283|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19668284|NCT04405167|Growth Substances|growth substances|mesh-ancestor
19668285|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
19668286|NCT04383119|Gemcitabine|gemcitabine|mesh-list
19668287|NCT04383119|Trabectedin|trabectedin|mesh-list
19668288|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19668289|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
19668290|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352287|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352288|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352289|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20352290|NCT00882375|Nicotine|nicotine|mesh-list
20352291|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19271416|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
19271417|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668291|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668292|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
19668293|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668294|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352292|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
19668295|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668296|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
19668297|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668298|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19668299|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
19668300|NCT04339218|Carboplatin|carboplatin|mesh-list
19668301|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
19668302|NCT04339218|Pemetrexed|pemetrexed|mesh-list
19668303|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668304|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668305|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668306|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668307|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19668308|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19668309|NCT04309877|Theophylline|theophylline|mesh-list
19668310|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19668311|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
19668312|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271439|NCT03962062|Moxidectin|moxidectin|mesh-list
19271440|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
19271441|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19271442|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271443|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
19668313|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668314|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19668315|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
19668316|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19668317|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668318|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668319|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
19668320|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19668321|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19668322|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
19668323|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668324|NCT04305548|Trabectedin|trabectedin|mesh-list
19668325|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19668326|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
19668327|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668328|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668329|NCT04281420|Niacin|niacin|mesh-list
19668330|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19668331|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
19668332|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668333|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19668334|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
19668335|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
19668336|NCT04281420|Vitamins|vitamins|mesh-ancestor
19668337|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
19271469|NCT03941860|Lenalidomide|lenalidomide|mesh-list
19271470|NCT03941860|Ixazomib|ixazomib|mesh-list
19271471|NCT03941860|Glycine|glycine|mesh-list
19271472|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
19271473|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271474|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19668338|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668339|NCT04244552|Doxorubicin|doxorubicin|mesh-list
19668340|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19668341|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
19668342|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19668343|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668344|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19668345|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19668346|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668347|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668348|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668349|NCT04239339|Citalopram|citalopram|mesh-list
19668350|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178273|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178274|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19271475|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178275|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178276|NCT00178971|Buspirone|buspirone|mesh-list
20178277|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19271476|NCT03941860|Growth Substances|growth substances|mesh-ancestor
19271477|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
19271478|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352293|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352294|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352295|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19271479|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271480|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
19271481|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271482|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
19271483|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668351|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19668352|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19668353|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668354|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668355|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
20352296|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20352297|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
20352298|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352299|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668356|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668357|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19668358|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
19668359|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19668360|NCT04200443|Temozolomide|temozolomide|mesh-list
19668361|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19668362|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
19668363|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668364|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668365|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
19668366|NCT04195256|Ketamine|ketamine|mesh-list
19668367|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19668368|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668369|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668370|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19668371|NCT04195256|Analgesics|analgesics|mesh-ancestor
19668372|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
19668373|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668374|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19668375|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19668376|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19668377|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19668378|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668379|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668380|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19668381|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19668382|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
19668383|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
19668384|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19668385|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19668386|NCT04122443|Acetaminophen|acetaminophen|mesh-list
19668387|NCT04122443|Oxycodone|oxycodone|mesh-list
19668388|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19668389|NCT04122443|Analgesics|analgesics|mesh-ancestor
19668390|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
19668391|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668392|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668393|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
19668394|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19668395|NCT04122443|Narcotics|narcotics|mesh-ancestor
19668396|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668397|NCT04121299|Amlodipine|amlodipine|mesh-list
20178278|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178279|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178280|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178281|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178282|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20178283|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
20178284|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178285|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178286|NCT00179023|Trimethaphan|trimethaphan|mesh-list
20178287|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
20178288|NCT00179023|Ephedrine|ephedrine|mesh-list
20178289|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
20178290|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20178291|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
20352300|NCT00882388|Aspirin|aspirin|mesh-list
20178292|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178293|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178294|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20178295|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
20178296|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
20178297|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20178298|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20178299|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
20178300|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
20178301|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178302|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178303|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20178304|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20178305|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20178306|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20178307|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20178308|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
19836003|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19836004|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19836005|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836006|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19836007|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19836008|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836009|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836010|NCT00606320|Aripiprazole|aripiprazole|mesh-list
19836011|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
19836012|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836013|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19836014|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836015|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836016|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836017|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
19836018|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
19836019|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836020|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178309|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
20178310|NCT00179062|Olanzapine|olanzapine|mesh-list
20178311|NCT00179062|Risperidone|risperidone|mesh-list
20178312|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20178313|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
20178314|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178315|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178316|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178317|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20178318|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178319|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178320|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178321|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20178322|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
20178323|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
20178324|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
20178325|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178326|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836021|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19836022|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19836023|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
19836024|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19836025|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19836026|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19836027|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19836028|NCT00606489|Ibuprofen|ibuprofen|mesh-list
19836029|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19836030|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19836031|NCT00606489|Analgesics|analgesics|mesh-ancestor
19836032|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
19836033|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836034|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836035|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836036|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836037|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20178327|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178328|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20352301|NCT00882388|Celecoxib|celecoxib|mesh-list
20352302|NCT00882388|Clopidogrel|clopidogrel|mesh-list
20178329|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178330|NCT00179114|Baclofen|baclofen|mesh-list
20178331|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
20178332|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20178333|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20178334|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20178335|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178336|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178337|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
20178338|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178339|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178340|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20178341|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178342|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20178343|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20178344|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
19271546|NCT03905265|Moxidectin|moxidectin|mesh-list
19271547|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
19271548|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19271549|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271550|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
19271551|NCT03900949|Cytarabine|cytarabine|mesh-list
19271552|NCT03900949|Daunorubicin|daunorubicin|mesh-list
19271553|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
19271554|NCT03900949|Midostaurin|midostaurin|mesh-list
19271555|NCT03900949|Calicheamicins|calicheamicins|mesh-list
20178345|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
20352303|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20352304|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20352305|NCT00882388|Analgesics|analgesics|mesh-ancestor
20352306|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
20352307|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352308|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352309|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352310|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20352311|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19271556|NCT03900949|Staurosporine|staurosporine|mesh-list
20178346|NCT00179231|Olanzapine|olanzapine|mesh-list
20178347|NCT00179231|Clozapine|clozapine|mesh-list
20178348|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
20178349|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
20178350|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352312|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19668398|NCT04121299|Carvedilol|carvedilol|mesh-list
19668399|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19668400|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19668401|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19668402|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668403|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19668404|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668405|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
19271557|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19271558|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
19271559|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271560|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271561|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
19271562|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271563|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19271564|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
19271565|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271566|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19271567|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19271568|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19271569|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271570|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271571|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19271572|NCT03895099|Desogestrel|desogestrel|mesh-list
19271573|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19271574|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19271575|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19271576|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
19271577|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19271578|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271579|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19836038|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352313|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271580|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19271581|NCT03895099|Progestins|progestins|mesh-ancestor
19271582|NCT03895099|Hormones|hormones|mesh-ancestor
19271583|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19271584|NCT03878199|Cytarabine|cytarabine|mesh-list
19271585|NCT03878199|Daunorubicin|daunorubicin|mesh-list
19271586|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19271587|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19271588|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
19271589|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271590|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271591|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
19836039|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836040|NCT00606502|Vitamins|vitamins|mesh-list
19836041|NCT00606502|Folic Acid|folic acid|mesh-list
19836042|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
19836043|NCT00606502|Hydroxocobalamin|hydroxocobalamin|mesh-list
19836044|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
19836045|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19836046|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19836047|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
19836048|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836049|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836050|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19836051|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836052|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836053|NCT00606502|Hematinics|hematinics|mesh-ancestor
19836054|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19836055|NCT00606580|Paromomycin|paromomycin|mesh-list
19836056|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20178351|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178352|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19271592|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178353|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20178354|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178355|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178356|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178357|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178358|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178359|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178360|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178361|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19271593|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19271594|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
19271595|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271596|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19271597|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19271598|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20352314|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20352315|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20352316|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352317|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
20352318|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20352319|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19271599|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271600|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19668406|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19668407|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20352320|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20352321|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
20352322|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352323|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20352324|NCT00882401|Vitamin D|vitamin d|mesh-list
20352325|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
20352326|NCT00882401|Vitamins|vitamins|mesh-ancestor
20352327|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
20352328|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352329|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20352330|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20352331|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
19668408|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
19668409|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668410|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
19668411|NCT04121299|Protective Agents|protective agents|mesh-ancestor
19668412|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19668413|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20352332|NCT00882414|Hematinics|hematinics|mesh-ancestor
20352333|NCT00882453|Interferons|interferons|mesh-list
20352334|NCT00882453|Interferon-beta|interferon-beta|mesh-list
20352335|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
20352336|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352337|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
20352338|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668414|NCT04097912|Aspirin|aspirin|mesh-list
19668415|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19668416|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19668417|NCT04097912|Analgesics|analgesics|mesh-ancestor
19668418|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
19668419|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668420|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668421|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668422|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19668423|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19668424|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19668425|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668426|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19668427|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19668428|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668429|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
19668430|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
19668431|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19668432|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
19668433|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668434|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668435|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19668436|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19836057|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836058|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19836059|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19836060|NCT00606801|Galantamine|galantamine|mesh-list
19836061|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19836062|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836063|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271630|NCT03851159|Mannitol|mannitol|mesh-list
19271631|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19271632|NCT03851159|Diuretics|diuretics|mesh-ancestor
19271633|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
19271634|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271635|NCT03842228|Durvalumab|durvalumab|mesh-list
19271636|NCT03842228|Olaparib|olaparib|mesh-list
19271637|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19271638|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
20178362|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
20178363|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20178364|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
20178365|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
20178366|NCT00179244|Bupropion|bupropion|mesh-list
19836064|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
19836065|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836066|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836067|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19836068|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
19836069|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836070|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
19836071|NCT00606892|Nicotine|nicotine|mesh-list
19836072|NCT00606892|Varenicline|varenicline|mesh-list
20178367|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20178368|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
19271639|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19271640|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
19271641|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271642|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271643|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
19271644|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271645|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271646|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178369|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836073|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19836074|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
19836075|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178370|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20352339|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
20352340|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352341|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19668437|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19668438|NCT04040738|Anesthetics|anesthetics|mesh-list
19271650|NCT03840967|Niraparib|niraparib|mesh-list
19271651|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19271652|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271653|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271654|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271655|NCT03820466|Aspirin|aspirin|mesh-list
19271656|NCT03820466|Atorvastatin|atorvastatin|mesh-list
19668439|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668440|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668441|NCT04007224|Oxytocin|oxytocin|mesh-list
19668442|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
19668443|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668444|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668445|NCT04005339|Leucovorin|leucovorin|mesh-list
19668446|NCT04005339|Fluorouracil|fluorouracil|mesh-list
19668447|NCT04005339|Irinotecan|irinotecan|mesh-list
20178371|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19271657|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19271658|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19271659|NCT03820466|Analgesics|analgesics|mesh-ancestor
19271660|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
19271661|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271662|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271663|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19271664|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19271665|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19271666|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19271667|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836076|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836077|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19836078|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19836079|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
20178372|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178373|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271668|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19271669|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19271670|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271671|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
19271672|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19271673|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19271674|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
19271675|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20178374|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
20178375|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178376|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271676|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19668448|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
19668449|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668450|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19668451|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668452|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668453|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
19668454|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271684|NCT03797924|Ropivacaine|ropivacaine|mesh-list
20178377|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20178378|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178379|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178380|NCT00179257|Sertraline|sertraline|mesh-list
20178381|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178382|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178383|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178384|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178385|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178386|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668455|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19668456|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19271685|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
19668457|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836080|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352342|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
20352343|NCT00882466|Hematinics|hematinics|mesh-ancestor
20352344|NCT00882531|Isotretinoin|isotretinoin|mesh-list
20352345|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
20352346|NCT00882570|Cefdinir|cefdinir|mesh-list
20352347|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352348|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352349|NCT00882609|Fluorides|fluorides|mesh-list
20352350|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
20352351|NCT00882609|Protective Agents|protective agents|mesh-ancestor
20352352|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352353|NCT00882635|Heparin|heparin|mesh-list
20352354|NCT00882635|Enoxaparin|enoxaparin|mesh-list
20352355|NCT00882635|Calcium heparin|calcium heparin|mesh-list
20352356|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
20352357|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19271686|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
19271687|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271688|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271689|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
19271690|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668458|NCT04005339|Antidotes|antidotes|mesh-ancestor
19668459|NCT04005339|Protective Agents|protective agents|mesh-ancestor
19668460|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
19668461|NCT04005339|Vitamins|vitamins|mesh-ancestor
19668462|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
19668463|NCT04003649|Nivolumab|nivolumab|mesh-list
19668464|NCT04003649|Ipilimumab|ipilimumab|mesh-list
19668465|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668466|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668467|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19668468|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668469|NCT03943342|Venetoclax|venetoclax|mesh-list
19271703|NCT03787628|Cannabidiol|cannabidiol|mesh-list
19271704|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
19271705|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
19271706|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19668470|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691925|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19691926|NCT04999137|Vitamins|vitamins|mesh-list
19691927|NCT04999137|Ascorbic Acid|ascorbic acid|mesh-list
19691928|NCT04999137|Thiamine|thiamine|mesh-list
19691929|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
19691930|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691931|NCT04999137|Antioxidants|antioxidants|mesh-ancestor
19691932|NCT04999137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691933|NCT04999137|Protective Agents|protective agents|mesh-ancestor
19691934|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
19691935|NCT04998838|Tenofovir|tenofovir|mesh-list
19691936|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
19691937|NCT04998838|Antibodies|antibodies|mesh-list
19271721|NCT03772574|Nicotine|nicotine|mesh-list
20178387|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178388|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
19836081|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836082|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
19836083|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
19836084|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19271722|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19271723|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
19271724|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271725|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271726|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20178389|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178390|NCT00179283|Sertraline|sertraline|mesh-list
20178391|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20178392|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178393|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178394|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20178395|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178396|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178397|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178398|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352358|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19271727|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19691938|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
19691939|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19691940|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20352359|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271728|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
19271729|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19271730|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178399|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
20178400|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178401|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20178402|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20178403|NCT00179465|Tiagabine|tiagabine|mesh-list
20178404|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
19836085|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19836086|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
19836087|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836088|NCT00607048|Paclitaxel|paclitaxel|mesh-list
20178405|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19668471|NCT03783351|Clopidogrel|clopidogrel|mesh-list
19668472|NCT03783351|Ticagrelor|ticagrelor|mesh-list
19668473|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19668474|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19668475|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20178406|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178407|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178408|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178409|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
20178410|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20178411|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178412|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178413|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178414|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
20178415|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178416|NCT00179608|Lenalidomide|lenalidomide|mesh-list
20178417|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
20178418|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352360|NCT00882700|Cefdinir|cefdinir|mesh-list
20352361|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352362|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352363|NCT00882739|Clopidogrel|clopidogrel|mesh-list
20352364|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20352365|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20352366|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20352367|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20352368|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
20352369|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352370|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668476|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19668477|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
19668478|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668479|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668480|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668481|NCT03682224|Epinephrine|epinephrine|mesh-list
19668482|NCT03682224|Bupivacaine|bupivacaine|mesh-list
19668483|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
19668484|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
19668485|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668486|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668487|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
19668488|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668489|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19668490|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19668491|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
19836089|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19836090|NCT00607048|Carboplatin|carboplatin|mesh-list
19836091|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19836092|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19668492|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668493|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668494|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19668495|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19668496|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
19668497|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19668498|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
19668499|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
19668500|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
19668501|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19668502|NCT03621748|Anesthetics|anesthetics|mesh-list
19271759|NCT03725202|Upadacitinib|upadacitinib|mesh-list
19271760|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19271761|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352371|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352372|NCT00882765|Genistein|genistein|mesh-list
20352373|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20352374|NCT00882765|Protective Agents|protective agents|mesh-ancestor
20352375|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271762|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271763|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271764|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178419|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178420|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178421|NCT00179608|Growth Substances|growth substances|mesh-ancestor
20178422|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178423|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836093|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836094|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
19836095|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
19836096|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
20178424|NCT00179686|Lenalidomide|lenalidomide|mesh-list
19668503|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668504|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668505|NCT03579693|Niacinamide|niacinamide|mesh-list
19668506|NCT03579693|Niacin|niacin|mesh-list
19668507|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
19668508|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
19668509|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
19668510|NCT03579693|Vitamins|vitamins|mesh-ancestor
19668511|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
19668512|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668513|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19668514|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
19668515|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668516|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20178425|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
19668517|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19668518|NCT03540901|Acetazolamide|acetazolamide|mesh-list
19271768|NCT03694808|Vaccines|vaccines|mesh-list
19271769|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
19271770|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271771|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
19271772|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271773|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271774|NCT03690921|Cisplatin|cisplatin|mesh-list
19271775|NCT03690921|Fluorouracil|fluorouracil|mesh-list
19271776|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271777|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
19271778|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271779|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20352376|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271780|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19271781|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
19271782|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271783|NCT03675893|Letrozole|letrozole|mesh-list
19271784|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271785|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19271786|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19668519|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
19668520|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19668521|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178426|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178427|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178428|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178429|NCT00179686|Growth Substances|growth substances|mesh-ancestor
20178430|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178431|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178432|NCT00179699|Pemetrexed|pemetrexed|mesh-list
20178433|NCT00179699|Lenalidomide|lenalidomide|mesh-list
20178434|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178435|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352377|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352378|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271787|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668522|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848289|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19271788|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271789|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19271790|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
19271791|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19271792|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271793|NCT03651128|Dexamethasone|dexamethasone|mesh-list
19271794|NCT03651128|Lenalidomide|lenalidomide|mesh-list
20352379|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352380|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
20352381|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19271795|NCT03651128|Bortezomib|bortezomib|mesh-list
19271796|NCT03651128|Daratumumab|daratumumab|mesh-list
19271797|NCT03651128|Pomalidomide|pomalidomide|mesh-list
19271798|NCT03651128|Ixazomib|ixazomib|mesh-list
19271799|NCT03651128|Elotuzumab|elotuzumab|mesh-list
19271800|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19271801|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
19271802|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
19271803|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271804|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271805|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19271806|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
19271807|NCT03651128|Hormones|hormones|mesh-ancestor
19271808|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19271809|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19271810|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271811|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
19271812|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19271813|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20352382|NCT00882765|Estrogens|estrogens|mesh-ancestor
20352383|NCT00882765|Hormones|hormones|mesh-ancestor
20352384|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20352385|NCT00882856|Bisoprolol|bisoprolol|mesh-list
20352386|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20352387|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
20352388|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
20352389|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352390|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352391|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20352392|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20352393|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20352394|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
20352395|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352396|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352397|NCT00882869|Sorafenib|sorafenib|mesh-list
20352398|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352399|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352400|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352401|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352402|NCT00882882|Metformin|metformin|mesh-list
20352403|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20352404|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271814|NCT03651128|Growth Substances|growth substances|mesh-ancestor
19271815|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
19271816|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
20352405|NCT00882947|Iloprost|iloprost|mesh-list
20352406|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20352407|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
20352408|NCT00882960|Fentanyl|fentanyl|mesh-list
20352409|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20352410|NCT00882960|Narcotics|narcotics|mesh-ancestor
19271817|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271818|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668523|NCT03540901|Diuretics|diuretics|mesh-ancestor
19668524|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
19668525|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668526|NCT03540875|Remifentanil|remifentanil|mesh-list
19668527|NCT03540875|Propofol|propofol|mesh-list
19668528|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
19668529|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668530|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668531|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20352411|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352412|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352413|NCT00882960|Analgesics|analgesics|mesh-ancestor
19668532|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19668533|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
19668534|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19668535|NCT03540875|Narcotics|narcotics|mesh-ancestor
19668536|NCT03540875|Analgesics|analgesics|mesh-ancestor
19668537|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
19668538|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836097|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836098|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
19836099|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836100|NCT00607087|Insulin|insulin|mesh-list
19836101|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19836102|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
19836103|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
19836104|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
19836105|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19836106|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836107|NCT00607113|Bevacizumab|bevacizumab|mesh-list
19836108|NCT00607113|Everolimus|everolimus|mesh-list
19836109|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20178436|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836110|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836111|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19836112|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19836113|NCT00607113|Growth Substances|growth substances|mesh-ancestor
19836114|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836115|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
19836116|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836117|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
19836118|NCT00607373|Mipomersen|mipomersen|mesh-list
19836119|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19836120|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19836121|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
19836122|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836123|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19836124|NCT00607594|Saracatinib|saracatinib|mesh-list
19836125|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836126|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836127|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836128|NCT00607672|Candesartan|candesartan|mesh-list
19836129|NCT00607672|Ramipril|ramipril|mesh-list
19836130|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19836131|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19836132|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19836133|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836134|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19836135|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
19836136|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836137|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19836138|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19836139|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19836140|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836141|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836142|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836143|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668539|NCT03536507|Acetazolamide|acetazolamide|mesh-list
19668540|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
19668541|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19668542|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668543|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668544|NCT03536507|Diuretics|diuretics|mesh-ancestor
19668545|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
19668546|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668547|NCT03522246|Nivolumab|nivolumab|mesh-list
19668548|NCT03522246|Rucaparib|rucaparib|mesh-list
19836144|NCT00607789|Analgesics|analgesics|mesh-ancestor
20178437|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20178438|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20178439|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
19668549|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668550|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668551|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19668552|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691941|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
19668553|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19668554|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668555|NCT03517735|Remifentanil|remifentanil|mesh-list
19668556|NCT03517735|Propofol|propofol|mesh-list
19668557|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19271831|NCT03646123|Doxorubicin|doxorubicin|mesh-list
19271832|NCT03646123|Nivolumab|nivolumab|mesh-list
19271833|NCT03646123|Dacarbazine|dacarbazine|mesh-list
19271834|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19271835|NCT03646123|Vinblastine|vinblastine|mesh-list
19668558|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668559|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668560|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19668561|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
19668562|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
19668563|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19668564|NCT03517735|Narcotics|narcotics|mesh-ancestor
19668565|NCT03517735|Analgesics|analgesics|mesh-ancestor
19668566|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
19668567|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668568|NCT03507491|Gemcitabine|gemcitabine|mesh-list
19668569|NCT03507491|Paclitaxel|paclitaxel|mesh-list
19668570|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19668571|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668572|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
19668573|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
19271836|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19668574|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
19668575|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836145|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
19836146|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836147|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
19836148|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19271837|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271838|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19271839|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19271840|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836149|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
19836150|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19836151|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19836152|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19836153|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836154|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836155|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
20178440|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178441|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178442|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178443|NCT00179699|Growth Substances|growth substances|mesh-ancestor
19271841|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271842|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271843|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19271844|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19271845|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
19271846|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19271847|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
19271848|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
19271849|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
20178444|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178445|NCT00179712|Topotecan|topotecan|mesh-list
20178446|NCT00179712|Lenalidomide|lenalidomide|mesh-list
20178447|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20178448|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178449|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178450|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271850|NCT03643367|Propofol|propofol|mesh-list
19271851|NCT03643367|Sevoflurane|sevoflurane|mesh-list
19271852|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19271853|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271854|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271855|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19271856|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
19271857|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
19271858|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19668576|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19668577|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
20178451|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178452|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
20178453|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178454|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178455|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178456|NCT00179712|Growth Substances|growth substances|mesh-ancestor
20352414|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
20352415|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271859|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19271860|NCT03632044|Ropivacaine|ropivacaine|mesh-list
19271861|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
19271862|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
19271863|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271864|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271865|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
19271866|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668578|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
19668579|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178457|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178458|NCT00179725|Doxorubicin|doxorubicin|mesh-list
20178459|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20178460|NCT00179725|Lenalidomide|lenalidomide|mesh-list
19668580|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668581|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668582|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
19668583|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668584|NCT03400501|Insulin|insulin|mesh-list
19668585|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19668586|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
19668587|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19668588|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271878|NCT03598426|Dexamethasone|dexamethasone|mesh-list
19271879|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19271880|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
19668589|NCT03395314|Midazolam|midazolam|mesh-list
19668590|NCT03395314|Ketamine|ketamine|mesh-list
19668591|NCT03395314|Analgesics|analgesics|mesh-ancestor
19271881|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
19271882|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19271883|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19271884|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19271885|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
19271886|NCT03598426|Hormones|hormones|mesh-ancestor
19271887|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19271888|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19271889|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668592|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
19668593|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668594|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668595|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19668596|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19668597|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
19668598|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
19668599|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668600|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19271899|NCT03533452|Ropivacaine|ropivacaine|mesh-list
19271900|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
19271901|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
19271902|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19271903|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668601|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19668602|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178461|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20178462|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271904|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
19271905|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668603|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668604|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19668605|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19668606|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19668607|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19668608|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19668609|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
19668610|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
19668611|NCT03347838|Nivolumab|nivolumab|mesh-list
19668612|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352416|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20352417|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20352418|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
19668613|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668614|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19668615|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668616|NCT02991807|Everolimus|everolimus|mesh-list
19668617|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668618|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668619|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
19668620|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668621|NCT02944799|Vitamin D|vitamin d|mesh-list
19668622|NCT02944799|Alendronate|alendronate|mesh-list
19668623|NCT02944799|Calcium|calcium|mesh-list
19668624|NCT02944799|Vitamins|vitamins|mesh-ancestor
19668625|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
19668626|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668627|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19668628|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19668629|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
19668630|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19668631|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19668632|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19668633|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19668634|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668635|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
19668636|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836156|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836157|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836158|NCT00608062|Estradiol|estradiol|mesh-list
19836159|NCT00608062|Ganirelix|ganirelix|mesh-list
19836160|NCT00608062|Estrogens|estrogens|mesh-ancestor
19836161|NCT00608062|Hormones|hormones|mesh-ancestor
19836162|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836163|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836164|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
19836165|NCT00608205|Fluorouracil|fluorouracil|mesh-list
19668637|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668638|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19668639|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668640|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
19668641|NCT02722668|Sirolimus|sirolimus|mesh-list
19836166|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836167|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
19836168|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836169|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19836170|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836171|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
19836172|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836173|NCT00608244|Tacrolimus|tacrolimus|mesh-list
19836174|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668642|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
19271919|NCT03513952|Atezolizumab|atezolizumab|mesh-list
19271920|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19271921|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271922|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
19271923|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668643|NCT02722668|Fludarabine|fludarabine|mesh-list
19668644|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19668645|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19668646|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
19668647|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668648|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19668649|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19668650|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
19668651|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668652|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668653|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19668654|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19668655|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19668656|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
19668657|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19668658|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836175|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
19668659|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668660|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
19668661|NCT02633293|Treprostinil|treprostinil|mesh-list
19668662|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19668663|NCT02599363|Paclitaxel|paclitaxel|mesh-list
19668664|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19668665|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668666|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
19668667|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
19668668|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
19668669|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668670|NCT02570672|Metformin|metformin|mesh-list
19668671|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19668672|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178463|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20178464|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178465|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178466|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178467|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
20178468|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178469|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178470|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178471|NCT00179725|Growth Substances|growth substances|mesh-ancestor
20178472|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178473|NCT00179738|Lenalidomide|lenalidomide|mesh-list
20178474|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
20178475|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178476|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178477|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178478|NCT00179738|Growth Substances|growth substances|mesh-ancestor
20178479|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178480|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178481|NCT00179751|Gemcitabine|gemcitabine|mesh-list
20178482|NCT00179751|Lenalidomide|lenalidomide|mesh-list
20178483|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178484|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
19668673|NCT02521311|Clemastine|clemastine|mesh-list
19668674|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
19668675|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
19668676|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19668677|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
19668678|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
19668679|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668680|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668681|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668682|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19668683|NCT05112471|Erythritol|erythritol|mesh-list
19668684|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
20352419|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
20352420|NCT00883064|Lisinopril|lisinopril|mesh-list
20352421|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20352422|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
19668685|NCT05111860|Bevacizumab|bevacizumab|mesh-list
19668686|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668687|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668688|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19668689|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19668690|NCT05111860|Growth Substances|growth substances|mesh-ancestor
19668691|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668692|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
19668693|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19668694|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
19668695|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668696|NCT05111444|Paclitaxel|paclitaxel|mesh-list
20178485|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178486|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178487|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
20178488|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668697|NCT05111444|Capecitabine|capecitabine|mesh-list
20178489|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352423|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668698|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
19668699|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19668700|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668701|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
19668702|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
19668703|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
20178490|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19271941|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19271942|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
19271943|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19271944|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271945|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19271946|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668704|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668705|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19668706|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
19691942|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691943|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19691944|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19271947|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
19271948|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19271949|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691945|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691946|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691947|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19691948|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19691949|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
19691950|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691951|NCT04998071|Bupivacaine|bupivacaine|mesh-list
19691952|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
19691953|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
19836176|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836177|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19836178|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352424|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352425|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20352426|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20352427|NCT00883064|Protective Agents|protective agents|mesh-ancestor
20352428|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352429|NCT00883155|Bupropion|bupropion|mesh-list
20352430|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20352431|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
20352432|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352433|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20352434|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20352435|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20352436|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352437|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
20352438|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836179|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836180|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
19836181|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19836182|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
19836183|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836184|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836185|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19836186|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
19836187|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19836188|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
19836189|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836190|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836191|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19836192|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
19836193|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
19836194|NCT00608322|Protective Agents|protective agents|mesh-ancestor
19836195|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
20352439|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836196|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
19836197|NCT00608517|Fludarabine|fludarabine|mesh-list
19836198|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
19836199|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19836200|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836201|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
19836202|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691954|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691955|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836203|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836204|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19836205|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
19836206|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836207|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836208|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19836209|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19836210|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
20178491|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
20178492|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178493|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178494|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178495|NCT00179751|Growth Substances|growth substances|mesh-ancestor
20178496|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178497|NCT00179764|Busulfan|busulfan|mesh-list
20352440|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20352441|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20352442|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178498|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
20178499|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178500|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178501|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
20178502|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178503|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20178504|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178505|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19668707|NCT05110911|Vaccines|vaccines|mesh-list
19668708|NCT05110911|Immunologic Factors|immunologic factors|mesh-ancestor
19668709|NCT05110911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668710|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
19668711|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
19668712|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19668713|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19668714|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668715|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668716|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668717|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19668718|NCT05110482|Oxytocin|oxytocin|mesh-list
20178506|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
20178507|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178508|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
20178509|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352443|NCT00883194|Ropivacaine|ropivacaine|mesh-list
20352444|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
20352445|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
19668719|NCT05110482|Carbetocin|carbetocin|mesh-list
19668720|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
19668721|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668722|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668723|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
19668724|NCT05110469|Meperidine|meperidine|mesh-list
19271970|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19271971|NCT03474276|Azithromycin|azithromycin|mesh-list
19271972|NCT03474276|Albendazole|albendazole|mesh-list
19271973|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
19271974|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19271975|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
19271976|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
19271977|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19271978|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19271979|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
19271980|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
19271981|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
19271982|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271983|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271984|NCT03474107|Paclitaxel|paclitaxel|mesh-list
19271985|NCT03474107|Docetaxel|docetaxel|mesh-list
19271986|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19668725|NCT05110469|Analgesics|analgesics|mesh-ancestor
19668726|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
19668727|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668728|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668729|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
19668730|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668731|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19836211|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19271987|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19271988|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19271989|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19271990|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19271991|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19271992|NCT03467113|Cannabidiol|cannabidiol|mesh-list
19271993|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
19271994|NCT03453684|Vancomycin|vancomycin|mesh-list
19271995|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19271996|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668732|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
19668733|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19668734|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19668735|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668736|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20178510|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178511|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19668737|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
19668738|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668739|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19668740|NCT05110469|Narcotics|narcotics|mesh-ancestor
19836212|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
19836213|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
19836214|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836215|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836216|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
19836217|NCT00608517|Hormones|hormones|mesh-ancestor
19836218|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836219|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19668741|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19668742|NCT05110417|Bromides|bromides|mesh-list
19668743|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20352446|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352447|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352448|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
20352449|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352450|NCT00883259|Metformin|metformin|mesh-list
20178512|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
20178513|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178514|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178515|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20178516|NCT00179881|Thalidomide|thalidomide|mesh-list
19668744|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
19668745|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19668746|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668747|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668748|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
19668749|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668750|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668751|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19668752|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668753|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836220|NCT00608517|Protective Agents|protective agents|mesh-ancestor
20178517|NCT00179881|Carboplatin|carboplatin|mesh-list
20178518|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178519|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178520|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
20178521|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178522|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
20352451|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20352452|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668754|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
19668755|NCT05103735|Remifentanil|remifentanil|mesh-list
19272018|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19272019|NCT03434041|Citalopram|citalopram|mesh-list
19668756|NCT05103735|Propofol|propofol|mesh-list
19668757|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19668758|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668759|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668760|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19668761|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
19668762|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
19668763|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19668764|NCT05103735|Analgesics|analgesics|mesh-ancestor
19668765|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
19668766|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668767|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19272020|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19272021|NCT03434041|Sertraline|sertraline|mesh-list
19272022|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
19272023|NCT03434041|Esketamine|esketamine|mesh-list
19272024|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19272025|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19272026|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19272027|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272028|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19272029|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
20352453|NCT00883298|Bevacizumab|bevacizumab|mesh-list
20352454|NCT00883298|Temozolomide|temozolomide|mesh-list
20352455|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352456|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352457|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20352458|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178523|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20178524|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178525|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20178526|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178527|NCT00179881|Growth Substances|growth substances|mesh-ancestor
20178528|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178529|NCT00179920|Carboplatin|carboplatin|mesh-list
20178530|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178531|NCT00180011|Omalizumab|omalizumab|mesh-list
20178532|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20178533|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20178534|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
20178535|NCT00180024|Irbesartan|irbesartan|mesh-list
20178536|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20178537|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20178538|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20178539|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178540|NCT00180037|Ubiquinone|ubiquinone|mesh-list
20178541|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
20352459|NCT00883298|Growth Substances|growth substances|mesh-ancestor
19272030|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836221|NCT00608543|Aripiprazole|aripiprazole|mesh-list
19836222|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
19836223|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836224|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19836225|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836226|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352460|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352461|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
20352462|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20352463|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
20352464|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352465|NCT00883480|Gemcitabine|gemcitabine|mesh-list
20352466|NCT00883480|Cisplatin|cisplatin|mesh-list
20352467|NCT00883480|Docetaxel|docetaxel|mesh-list
20352468|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20352469|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352470|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20352471|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
20352472|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352473|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
20352474|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352475|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352476|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352477|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
20352478|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352479|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
20352480|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
20352481|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
20352482|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352483|NCT00883506|Lisinopril|lisinopril|mesh-list
20352484|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20352485|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
20352486|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352487|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836227|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178542|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
20352488|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20352489|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20352490|NCT00883506|Protective Agents|protective agents|mesh-ancestor
20352491|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352492|NCT00883532|Budesonide|budesonide|mesh-list
20352493|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20352494|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352495|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20352496|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
20352497|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352498|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352499|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20352500|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
20352501|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
20352502|NCT00883532|Hormones|hormones|mesh-ancestor
20352503|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20352504|NCT00883623|Lenalidomide|lenalidomide|mesh-list
20352505|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
20352506|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352507|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20352508|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178543|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178544|NCT00180037|Vitamins|vitamins|mesh-ancestor
20178545|NCT00180050|Budesonide|budesonide|mesh-list
20178546|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178547|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20178548|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
20178549|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836228|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
19836229|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
19836230|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836231|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836232|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19836233|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19836234|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
20178550|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178551|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20352509|NCT00883623|Growth Substances|growth substances|mesh-ancestor
20352510|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
20352511|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424900|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424901|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20424902|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
20424903|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
20424904|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424905|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424906|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20424907|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
20424908|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20424909|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20424910|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20424911|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
20424912|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424913|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424914|NCT01271569|Fospropofol|fospropofol|mesh-list
20178552|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
20178553|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
20424915|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20424916|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424917|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424918|NCT01271582|Leucovorin|leucovorin|mesh-list
20424919|NCT01271582|Irinotecan|irinotecan|mesh-list
20424920|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20424921|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20424922|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424923|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178554|NCT00180050|Hormones|hormones|mesh-ancestor
20178555|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20178556|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20178557|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178558|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217197|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217198|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217199|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
20217200|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20178559|NCT00180076|Budesonide|budesonide|mesh-list
20178560|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178561|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20178562|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
20178563|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178564|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178565|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20178566|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
20178567|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
20178568|NCT00180076|Hormones|hormones|mesh-ancestor
20178569|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20178570|NCT00180089|Budesonide|budesonide|mesh-list
20178571|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19272031|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19272032|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19272033|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272034|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19272035|NCT03434041|Analgesics|analgesics|mesh-ancestor
19272036|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
19272037|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
19668768|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19668769|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19668770|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
19668771|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668772|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668773|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19668774|NCT05103735|Narcotics|narcotics|mesh-ancestor
19668775|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
19668776|NCT05101356|Vaccines|vaccines|mesh-list
19668777|NCT05101356|Sargramostim|sargramostim|mesh-list
19668778|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
19668779|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668780|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19668781|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
19668782|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668783|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
19668784|NCT05099250|Bupivacaine|bupivacaine|mesh-list
19668785|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
19272056|NCT03390504|Docetaxel|docetaxel|mesh-list
19272057|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
19272058|NCT03390504|Mitogens|mitogens|mesh-list
19272059|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272060|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
19272061|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
19272062|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
19272063|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272064|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668786|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
19668787|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668788|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668789|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
19668790|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668791|NCT05099250|Analgesics|analgesics|mesh-ancestor
19272071|NCT03378466|Heparin|heparin|mesh-list
19272072|NCT03378466|Calcium heparin|calcium heparin|mesh-list
19272073|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
19272074|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19272075|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19272076|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668792|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19668793|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
19668794|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19668795|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19668796|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668797|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19668798|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
19668799|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668800|NCT05094323|Bupivacaine|bupivacaine|mesh-list
19668801|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
19668802|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
19668803|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668804|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668805|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
20178572|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20178573|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
20352512|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
19668806|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668807|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19668808|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19668809|NCT05079802|Chitosan|chitosan|mesh-list
19668810|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668811|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
19668812|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19668813|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19668814|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
19668815|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668816|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19668817|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
19668818|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
19668819|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
19272092|NCT03328884|Irinotecan|irinotecan|mesh-list
19272093|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19272094|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19272095|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272096|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272097|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668820|NCT05079802|Coagulants|coagulants|mesh-ancestor
19668821|NCT05006599|Insulin|insulin|mesh-list
19668822|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19668823|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19668824|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668825|NCT04974879|Osimertinib|osimertinib|mesh-list
19836235|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19836236|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19836237|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19836238|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19836239|NCT00608569|Ritonavir|ritonavir|mesh-list
19836240|NCT00608569|Lopinavir|lopinavir|mesh-list
19836241|NCT00608569|Tenofovir|tenofovir|mesh-list
19836242|NCT00608569|Zidovudine|zidovudine|mesh-list
19836243|NCT00608569|Emtricitabine|emtricitabine|mesh-list
19836244|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19836245|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19836246|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19836247|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
19836248|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836249|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836250|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19836251|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19836252|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
19836253|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836254|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19836255|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19836256|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19836257|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19836258|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
19836259|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
19836260|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836261|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836262|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836263|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
19836264|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19836265|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836266|NCT00608868|Gefitinib|gefitinib|mesh-list
19836267|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836268|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19836269|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668826|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668827|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19668828|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668829|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668830|NCT04910230|Niacinamide|niacinamide|mesh-list
19668831|NCT04910230|Niacin|niacin|mesh-list
19836270|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836271|NCT00608881|Ubiquinone|ubiquinone|mesh-list
19836272|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
19836273|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
20178574|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668832|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
19668833|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
19668834|NCT04910230|Vitamins|vitamins|mesh-ancestor
19668835|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
19272112|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
19272113|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272114|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272115|NCT03301896|Spartalizumab|spartalizumab|mesh-list
19272116|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19272117|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272118|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668836|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668837|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19668838|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
19668839|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668840|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19668841|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
19668842|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
19668843|NCT04887870|Nivolumab|nivolumab|mesh-list
19668844|NCT04887870|Ipilimumab|ipilimumab|mesh-list
19668845|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668846|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668847|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19668848|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668849|NCT04783857|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19668850|NCT04783857|Medroxyprogesterone|medroxyprogesterone|mesh-list
19668851|NCT04783857|Progesterone|progesterone|mesh-list
19668852|NCT04783857|Progestins|progestins|mesh-ancestor
19668853|NCT04783857|Hormones|hormones|mesh-ancestor
19668854|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19668855|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668856|NCT04783857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19668857|NCT04783857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19668858|NCT04783857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19836274|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836275|NCT00608881|Vitamins|vitamins|mesh-ancestor
19836276|NCT00608894|Prednisone|prednisone|mesh-list
19836277|NCT00608894|Azathioprine|azathioprine|mesh-list
19836278|NCT00608894|Tacrolimus|tacrolimus|mesh-list
19836279|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836280|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
19836281|NCT00608894|Hormones|hormones|mesh-ancestor
19836282|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836283|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836284|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19668859|NCT04783857|Contraceptive Agents|contraceptive agents|mesh-ancestor
19668860|NCT04783857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19668861|NCT04783857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19668862|NCT04783857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19668863|NCT04783857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19668864|NCT04783857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19668865|NCT04783857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668866|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
19668867|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19668868|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668869|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
19668870|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19668871|NCT04774237|Carbachol|carbachol|mesh-list
19668872|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19668873|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19836285|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836286|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836287|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
19668874|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19668875|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19668876|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
19668877|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668878|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668879|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668880|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19668881|NCT04774237|Miotics|miotics|mesh-ancestor
19836288|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19836289|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836290|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836291|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
19836292|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19836293|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836294|NCT00608907|Rifampin|rifampin|mesh-list
19836295|NCT00608907|Dexamethasone|dexamethasone|mesh-list
19668882|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
19668883|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668884|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19668885|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
19668886|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19668887|NCT04774237|Analgesics|analgesics|mesh-ancestor
19668888|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
19668889|NCT04774237|Protective Agents|protective agents|mesh-ancestor
19668890|NCT04764942|Dexamethasone|dexamethasone|mesh-list
19668891|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
19668892|NCT04764942|Pomalidomide|pomalidomide|mesh-list
20178575|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178576|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20178577|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
19668893|NCT04764942|Ichthammol|ichthammol|mesh-list
19668894|NCT04764942|BB 1101|bb 1101|mesh-list
19668895|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668896|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
19668897|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
19668898|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668899|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668900|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19668901|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
19668902|NCT04764942|Hormones|hormones|mesh-ancestor
19668903|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19668904|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19668905|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668906|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
19668907|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668908|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668909|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
19668910|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19272158|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19272159|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19272160|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19272161|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
19272162|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272163|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19272164|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19272165|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668911|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19668912|NCT04764942|Growth Substances|growth substances|mesh-ancestor
19668913|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
19668914|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
19691956|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
19691957|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691958|NCT04998344|Vaccines|vaccines|mesh-list
19691959|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
19691960|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691961|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19691962|NCT04998253|Propofol|propofol|mesh-list
19691963|NCT04998253|Sevoflurane|sevoflurane|mesh-list
19691964|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19691965|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691966|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691967|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19691968|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
19272183|NCT03215706|Paclitaxel|paclitaxel|mesh-list
19691969|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
19691970|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19691971|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19691972|NCT04998500|Hormones|hormones|mesh-list
19691973|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691974|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691975|NCT04998214|Thrombin|thrombin|mesh-list
19691976|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
19691977|NCT04998214|Coagulants|coagulants|mesh-ancestor
19693087|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693088|NCT04983121|Antibodies|antibodies|mesh-list
19693089|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
19693090|NCT04983121|Mitogens|mitogens|mesh-list
19693091|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
20178578|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
20178579|NCT00180089|Hormones|hormones|mesh-ancestor
19693092|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693093|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
19272184|NCT03215706|Carboplatin|carboplatin|mesh-list
19272185|NCT03215706|Nivolumab|nivolumab|mesh-list
19272186|NCT03215706|Pemetrexed|pemetrexed|mesh-list
19272187|NCT03215706|Ipilimumab|ipilimumab|mesh-list
19272188|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20178580|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20178581|NCT00180102|Cytarabine|cytarabine|mesh-list
20178582|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
20178583|NCT00180102|Amsacrine|amsacrine|mesh-list
20178584|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178585|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
20178586|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178587|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178588|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
20178589|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19272189|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272190|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
19272191|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
19272192|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
19272193|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272194|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272195|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19272196|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272197|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19272198|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19668915|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
19668916|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19836296|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
19836297|NCT00608907|Bortezomib|bortezomib|mesh-list
19836298|NCT00608907|BB 1101|bb 1101|mesh-list
20178590|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178591|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
20178592|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178593|NCT00180102|Analgesics|analgesics|mesh-ancestor
20178594|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
20178595|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178596|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20178597|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178598|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178599|NCT00180115|Cytarabine|cytarabine|mesh-list
20178600|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178601|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
20178602|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178603|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178604|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
20178605|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178606|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178607|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
20178608|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178609|NCT00180128|Cytarabine|cytarabine|mesh-list
20178610|NCT00180128|Daunorubicin|daunorubicin|mesh-list
20178611|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
20178612|NCT00180128|Idarubicin|idarubicin|mesh-list
20178613|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178614|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
20178615|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178616|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178617|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
20178618|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20178619|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178620|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
20178621|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178622|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20178623|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19668917|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19668918|NCT04685772|Prednisolone|prednisolone|mesh-list
19668919|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
19668920|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19668921|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
19668922|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668923|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
19668924|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
19668925|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668926|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668927|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19668928|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
19836299|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352513|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20352514|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
20352515|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20352516|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352517|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20352518|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20352519|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20352520|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
20352521|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20352522|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20352523|NCT00883818|Azithromycin|azithromycin|mesh-list
20352524|NCT00883818|Doxycycline|doxycycline|mesh-list
20352525|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352526|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352527|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
20352528|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20352529|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20352530|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
20352531|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20352532|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20352533|NCT00883883|Cefdinir|cefdinir|mesh-list
20352534|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352535|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352536|NCT00883909|Dutasteride|dutasteride|mesh-list
20352537|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20352538|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20352539|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352540|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352541|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
20352542|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20178624|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178625|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668929|NCT04685772|Hormones|hormones|mesh-ancestor
19668930|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19668931|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19668932|NCT04685772|Protective Agents|protective agents|mesh-ancestor
19668933|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19668934|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668935|NCT04674345|Sorafenib|sorafenib|mesh-list
19668936|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668937|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19668938|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668939|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668940|NCT04615936|Methylene Blue|methylene blue|mesh-list
19668941|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668942|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668943|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
19668944|NCT04550832|Bedaquiline|bedaquiline|mesh-list
19668945|NCT04550832|Delpazolid|delpazolid|mesh-list
19668946|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19668947|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19668948|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19668949|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19668950|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668951|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668952|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178626|NCT00180128|Analgesics|analgesics|mesh-ancestor
20178627|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
20178628|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178629|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
20178630|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20178631|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20178632|NCT00180141|Analgesics|analgesics|mesh-ancestor
20178633|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
20178634|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178635|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178636|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178637|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178638|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
20178639|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178640|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
20178641|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20352543|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668953|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
20178642|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178643|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178644|NCT00180310|Paclitaxel|paclitaxel|mesh-list
19668954|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19668955|NCT04461028|Dexamethasone|dexamethasone|mesh-list
19668956|NCT04461028|Bupivacaine|bupivacaine|mesh-list
19668957|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352544|NCT00883935|Ritonavir|ritonavir|mesh-list
20352545|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20352546|NCT00883935|Dolutegravir|dolutegravir|mesh-list
20352547|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20352548|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20352549|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
20352550|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19668958|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
19668959|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
19668960|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668961|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668962|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19668963|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
19668964|NCT04461028|Hormones|hormones|mesh-ancestor
19668965|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19668966|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19668967|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668968|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
19668969|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
19668970|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19668971|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
19668972|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
19668973|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19668974|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
19668975|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668976|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668977|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19668978|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
19668979|NCT04367909|Carboplatin|carboplatin|mesh-list
19668980|NCT04367909|Docetaxel|docetaxel|mesh-list
19668981|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
20352551|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352552|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20352553|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20352554|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
20352555|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352556|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20352557|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20352558|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20352559|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20352560|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
20352561|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20352562|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20352563|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
19668982|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19668983|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19668984|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
20178645|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20178646|NCT00180310|Everolimus|everolimus|mesh-list
20178647|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20178648|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178649|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20178650|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
20178651|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20178652|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668985|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
19668986|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668987|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19668988|NCT04342039|Budesonide|budesonide|mesh-list
19836300|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
19836301|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
19836302|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836303|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836304|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20352564|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19668989|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19668990|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20352565|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19668991|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
19836305|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
20178653|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178654|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
20178655|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668992|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19668993|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19668994|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19668995|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
19668996|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
19668997|NCT04342039|Hormones|hormones|mesh-ancestor
19668998|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19668999|NCT04335058|Iron|iron|mesh-list
19669000|NCT04335058|Lactoferrin|lactoferrin|mesh-list
19669001|NCT04335058|Trace Elements|trace elements|mesh-ancestor
19669002|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
19669003|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178656|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
20178657|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
20178658|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20178659|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
20352566|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352567|NCT00884104|Urological Agents|urological agents|mesh-ancestor
20352568|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
20352569|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20352570|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
20352571|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20352572|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352573|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20352574|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20352575|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20352576|NCT00884299|Antioxidants|antioxidants|mesh-list
20352577|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352578|NCT00884299|Protective Agents|protective agents|mesh-ancestor
20352579|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352580|NCT00884416|Sorafenib|sorafenib|mesh-list
19669004|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669005|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19669006|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
19669007|NCT04329975|Coagulants|coagulants|mesh-ancestor
19669008|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19669009|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
19669010|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669011|NCT04315311|Pancrelipase|pancrelipase|mesh-list
19669012|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669013|NCT04285255|Lidocaine|lidocaine|mesh-list
20178660|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272269|NCT03151057|Idelalisib|idelalisib|mesh-list
19272270|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272271|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272272|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272273|NCT03143153|Fluorouracil|fluorouracil|mesh-list
19272274|NCT03143153|Nivolumab|nivolumab|mesh-list
19272275|NCT03143153|Ipilimumab|ipilimumab|mesh-list
19272276|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272277|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
19272278|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272279|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19272280|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19272281|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
19272282|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272283|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272284|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19272285|NCT03123211|Veliparib|veliparib|mesh-list
19272286|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19272287|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272288|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272289|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669014|NCT04285255|Fentanyl|fentanyl|mesh-list
19669015|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
19669016|NCT04285255|Ketamine|ketamine|mesh-list
19669017|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
19669018|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
19669019|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669020|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669021|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
19669022|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352581|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352582|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352583|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352584|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352585|NCT00884442|Nifedipine|nifedipine|mesh-list
19669023|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20178661|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178662|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20178663|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
20178664|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20178665|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
20178666|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178667|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178668|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20178669|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
20178670|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
20178671|NCT00180622|Protective Agents|protective agents|mesh-ancestor
20178672|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
19669024|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19669025|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19669026|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19669027|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669028|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19669029|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669030|NCT04285255|Analgesics|analgesics|mesh-ancestor
19669031|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19669032|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19669033|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19669034|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669035|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669036|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20178673|NCT00180635|Pimagedine|pimagedine|mesh-list
20178674|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178675|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178676|NCT00180791|Carboplatin|carboplatin|mesh-list
20178677|NCT00180791|Etoposide|etoposide|mesh-list
20178678|NCT00180791|Melphalan|melphalan|mesh-list
20178679|NCT00180791|Thiotepa|thiotepa|mesh-list
20178680|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178681|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20178682|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20178683|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178684|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669037|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19669038|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
19669039|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19669040|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19669041|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19669042|NCT04285255|Narcotics|narcotics|mesh-ancestor
19669043|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19669044|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
19669045|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
19669046|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19669047|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669048|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669049|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
20178685|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178686|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20178687|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
20178688|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20178689|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178690|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
20178691|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178692|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
19669050|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19669051|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669052|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669053|NCT04196075|Andrographolide|andrographolide|mesh-list
19669054|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669055|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19669056|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669057|NCT04196075|Analgesics|analgesics|mesh-ancestor
20178693|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178694|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19669058|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
19669059|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669060|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669061|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178695|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178696|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178697|NCT00180843|Bromides|bromides|mesh-list
20352586|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20352587|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20352588|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352589|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20352590|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352591|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
19669062|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19669063|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19669064|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669065|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
19669066|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19669067|NCT04169828|Leucovorin|leucovorin|mesh-list
19669068|NCT04169828|Folic Acid|folic acid|mesh-list
19669069|NCT04169828|Methotrexate|methotrexate|mesh-list
19669070|NCT04169828|Ondansetron|ondansetron|mesh-list
19669071|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
19669072|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19669073|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
19669074|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19669075|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669076|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19669077|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
19669078|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669079|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669080|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
19669081|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669082|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19669083|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19669084|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
19669085|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669086|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19669087|NCT04169828|Antidotes|antidotes|mesh-ancestor
19669088|NCT04169828|Protective Agents|protective agents|mesh-ancestor
19669089|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
19669090|NCT04169828|Vitamins|vitamins|mesh-ancestor
19669091|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
19669092|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
19669093|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
19669094|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669095|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669096|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
19669097|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19669098|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
20178698|NCT00180843|Albuterol|albuterol|mesh-list
20178699|NCT00180843|Ipratropium|ipratropium|mesh-list
20178700|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
20178701|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20178702|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
20178703|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669099|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669100|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19669101|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19669102|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669103|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178704|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178705|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20178706|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
20178707|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
20178708|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20178709|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20178710|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20178711|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20178712|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669104|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19272372|NCT03060434|Acetaminophen|acetaminophen|mesh-list
19669105|NCT04169828|Hematinics|hematinics|mesh-ancestor
19272373|NCT03060434|Ibuprofen|ibuprofen|mesh-list
19272374|NCT03060434|Pregabalin|pregabalin|mesh-list
19669106|NCT04165824|Edaravone|edaravone|mesh-list
19669107|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19669108|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
19272375|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
19272376|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19272377|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19272378|NCT03060434|Analgesics|analgesics|mesh-ancestor
19272379|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
19272380|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272381|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272382|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19272383|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19272384|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19272385|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272386|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272387|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
19272388|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19272389|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19272390|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19272391|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19272392|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19272393|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19272394|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352592|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
20352593|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20352594|NCT00884481|Natalizumab|natalizumab|mesh-list
20352595|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
20352596|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352597|NCT00884494|Insulin|insulin|mesh-list
20352598|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20352599|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352600|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
19272395|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
19272396|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19669109|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669110|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20178713|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178714|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178715|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20178716|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
20178717|NCT00180882|Rituximab|rituximab|mesh-list
20178718|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669111|NCT04165824|Protective Agents|protective agents|mesh-ancestor
20352601|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20352602|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352603|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20352604|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20352605|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352606|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352607|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352608|NCT00884546|Dexamethasone|dexamethasone|mesh-list
20352609|NCT00884546|Lenalidomide|lenalidomide|mesh-list
20352610|NCT00884546|Bortezomib|bortezomib|mesh-list
19669112|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669113|NCT04161898|Prednisolone|prednisolone|mesh-list
19669114|NCT04161898|Upadacitinib|upadacitinib|mesh-list
20178719|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178720|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
20178721|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178722|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178723|NCT00180895|Rituximab|rituximab|mesh-list
20178724|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20178725|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178726|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
20178727|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178728|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178729|NCT00180908|Doxorubicin|doxorubicin|mesh-list
20178730|NCT00180908|Etoposide|etoposide|mesh-list
19669115|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669116|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
19669117|NCT04161898|Hormones|hormones|mesh-ancestor
19669118|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669119|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178731|NCT00180908|Methotrexate|methotrexate|mesh-list
20178732|NCT00180908|Ifosfamide|ifosfamide|mesh-list
20178733|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20178734|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352611|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836306|NCT00608907|Hormones|hormones|mesh-ancestor
19836307|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836308|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19836309|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836310|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19836311|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836312|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836313|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19836314|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
19836315|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19836316|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836317|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
19836318|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19836319|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20178735|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20178736|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178737|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272397|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19272398|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19272399|NCT03060434|Protective Agents|protective agents|mesh-ancestor
19272400|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
19272401|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19272402|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
19669120|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19669121|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669122|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19669123|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19669124|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669125|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669126|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669127|NCT04053322|Durvalumab|durvalumab|mesh-list
19669128|NCT04053322|Olaparib|olaparib|mesh-list
19669129|NCT04053322|Fulvestrant|fulvestrant|mesh-list
19669130|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669131|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669132|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19669133|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669134|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669135|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19669136|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19669137|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19669138|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
19669139|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669140|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669141|NCT04030182|Vitamin D|vitamin d|mesh-list
19669142|NCT04030182|Vitamins|vitamins|mesh-ancestor
19272421|NCT03022097|Bromides|bromides|mesh-list
19272422|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
19272423|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19272424|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
19272425|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272426|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272427|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19272428|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
19272429|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19272430|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19272431|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19272432|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
20178738|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272433|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19272434|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272435|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
19669143|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
19669144|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669145|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19669146|NCT04000555|Vancomycin|vancomycin|mesh-list
19669147|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19669148|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669149|NCT03988933|Rifampin|rifampin|mesh-list
19669150|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19669151|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
19669152|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19272443|NCT03006705|Capecitabine|capecitabine|mesh-list
20352612|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
20352613|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
20352614|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352615|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352616|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20352617|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
20352618|NCT00884546|Hormones|hormones|mesh-ancestor
20352619|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20352620|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20352621|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352622|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
20352623|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20352624|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20352625|NCT00884546|Growth Substances|growth substances|mesh-ancestor
20352626|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
20352627|NCT00884663|Propranolol|propranolol|mesh-list
20352628|NCT00884663|Candesartan|candesartan|mesh-list
20352629|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20352630|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20352631|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
20352632|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352633|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352634|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352635|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20352636|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20352637|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
20352638|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20352639|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20178739|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19836320|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19836321|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19836322|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19836323|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19836324|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19836325|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
19836326|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20178740|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
20178741|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20178742|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178743|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19272444|NCT03006705|Tegafur|tegafur|mesh-list
19272445|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
19272446|NCT03006705|Nivolumab|nivolumab|mesh-list
19272447|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19272448|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
19272449|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272450|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272451|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272452|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20178744|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
20178745|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
20178746|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20352640|NCT00884676|Sunitinib|sunitinib|mesh-list
20352641|NCT00884676|Epothilone B|epothilone b|mesh-list
20352642|NCT00884676|Epothilones|epothilones|mesh-list
20352643|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178747|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178748|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
20352644|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20352645|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20352646|NCT00884676|Growth Substances|growth substances|mesh-ancestor
20352647|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272453|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
19691978|NCT04997967|Ketamine|ketamine|mesh-list
19691979|NCT04997967|Propofol|propofol|mesh-list
19691980|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19691981|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691982|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691983|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19691984|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
19691985|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
19691986|NCT04997967|Analgesics|analgesics|mesh-ancestor
19691987|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
19691988|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272454|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19272455|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
19272456|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272457|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19272458|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19272459|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
19272460|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272461|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272462|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19272463|NCT02998645|Cyclosporine|cyclosporine|mesh-list
19272464|NCT02998645|Cyclosporins|cyclosporins|mesh-list
20178749|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178750|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20178751|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20178752|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20178753|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
20178754|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
20178755|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178756|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20178757|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352648|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
19272465|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272466|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272467|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836327|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836328|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
19836329|NCT00608985|Zolpidem|zolpidem|mesh-list
19836330|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19836331|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19836332|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836333|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836334|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19836335|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
20352649|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19272468|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
19272469|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272470|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
19272471|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19272472|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
20352650|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352651|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352652|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
20352653|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
19272473|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19272474|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19836336|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
19836337|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836338|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836339|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19836340|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19836341|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19836342|NCT00609128|Analgesics|analgesics|mesh-ancestor
19836343|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
19836344|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836345|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836346|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836347|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836348|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19836349|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19836350|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19836351|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
19669153|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669154|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
19669155|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19669156|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669157|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669158|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19669159|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19669160|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19836352|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
19836353|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217201|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19836354|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669161|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19669162|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19669163|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19669164|NCT03978520|Upadacitinib|upadacitinib|mesh-list
19669165|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19836355|NCT00609167|Dexamethasone|dexamethasone|mesh-list
19836356|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
19836357|NCT00609167|Bortezomib|bortezomib|mesh-list
19836358|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19669166|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19669167|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669168|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669169|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669170|NCT03863483|Docetaxel|docetaxel|mesh-list
19669171|NCT03863483|Pemetrexed|pemetrexed|mesh-list
20352654|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
20352655|NCT00884767|Leucovorin|leucovorin|mesh-list
20352656|NCT00884767|Fluorouracil|fluorouracil|mesh-list
20352657|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
19669172|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669173|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
19669174|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
19669175|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
19669176|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669177|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352658|NCT00884767|Calcium|calcium|mesh-list
20352659|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
20352660|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20352661|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352662|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
20352663|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352664|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20352665|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352666|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352667|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
20352668|NCT00884767|Antidotes|antidotes|mesh-ancestor
20352669|NCT00884767|Protective Agents|protective agents|mesh-ancestor
20352670|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
20352671|NCT00884767|Vitamins|vitamins|mesh-ancestor
20352672|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
19272504|NCT02960763|Aripiprazole|aripiprazole|mesh-list
19272505|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
19272506|NCT02960763|Bupropion|bupropion|mesh-list
19272507|NCT02960763|Nortriptyline|nortriptyline|mesh-list
19272508|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19272509|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
19272510|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19669178|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19836359|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
19272511|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19836360|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836361|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836362|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19836363|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
19836364|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272512|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19272513|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836365|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836366|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19836367|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836368|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
20178758|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178759|NCT00180947|Vinorelbine|vinorelbine|mesh-list
20178760|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20178761|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178762|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
20178763|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
20178764|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
20178765|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178766|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
20178767|NCT00180960|Irinotecan|irinotecan|mesh-list
20178768|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352673|NCT00884819|Fenofibrate|fenofibrate|mesh-list
20352674|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20352675|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
20178769|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20178770|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20178771|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178772|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178773|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
20178774|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178775|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
20178776|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178777|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669179|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19691989|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19691990|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19691991|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19691992|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691993|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691994|NCT04997980|Amiodarone|amiodarone|mesh-list
19691995|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19691996|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
19691997|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19691998|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19691999|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692000|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19692001|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19692002|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19692003|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692004|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20178778|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19692005|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19692006|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19692007|NCT04997837|Capecitabine|capecitabine|mesh-list
19692008|NCT04997837|Tegafur|tegafur|mesh-list
20178779|NCT00181012|Lidocaine|lidocaine|mesh-list
20178780|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
20178781|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
20178782|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178783|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272514|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272515|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
19272516|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19272517|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272518|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19272519|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19272520|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272521|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19272522|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19272523|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692009|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
19692010|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19692011|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19692012|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
19692013|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692014|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692015|NCT04997707|Propofol|propofol|mesh-list
19692016|NCT04997707|Sevoflurane|sevoflurane|mesh-list
19692017|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19692018|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692019|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692020|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19692021|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
19692022|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
19692023|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19692024|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19692025|NCT04997798|Trastuzumab|trastuzumab|mesh-list
19692026|NCT04997798|Letrozole|letrozole|mesh-list
19692027|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19692028|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692029|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19692030|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19692031|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692032|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692033|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19272524|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
19272525|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19272526|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19272527|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
19272528|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19272529|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20178784|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
20178785|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178786|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20178787|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20178788|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19272530|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19272531|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19272532|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
19272533|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19272534|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19272535|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669180|NCT03830411|Docetaxel|docetaxel|mesh-list
19669181|NCT03830411|Pemetrexed|pemetrexed|mesh-list
19669182|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669183|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
19669184|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
19669185|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
19669186|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669187|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669188|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19669189|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19669190|NCT03802305|Anesthetics|anesthetics|mesh-list
19669191|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19272548|NCT02923947|Osimertinib|osimertinib|mesh-list
19272549|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272550|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19272551|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272552|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272553|NCT02918084|Letrozole|letrozole|mesh-list
19272554|NCT02918084|Anastrozole|anastrozole|mesh-list
19272555|NCT02918084|Exemestane|exemestane|mesh-list
19836369|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
19836370|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836371|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19272556|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272557|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20178789|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20352676|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352677|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19272558|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19272559|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272560|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272561|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19669192|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669193|NCT03661632|Nivolumab|nivolumab|mesh-list
19669194|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669195|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669196|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19669197|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669198|NCT03512262|Abaloparatide|abaloparatide|mesh-list
19669199|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
19669200|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19669201|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669202|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19669203|NCT03456882|RNS60|rns60|mesh-list
20178790|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178791|NCT00181025|Melphalan|melphalan|mesh-list
20178792|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20178793|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
20178794|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178795|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178796|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20178797|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178798|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
20352678|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19272562|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
20352679|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352680|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352681|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352682|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352683|NCT00884858|Maraviroc|maraviroc|mesh-list
19272563|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836372|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
19836373|NCT00609167|Hormones|hormones|mesh-ancestor
19272564|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272565|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19669204|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19669205|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669206|NCT03456882|Analgesics|analgesics|mesh-ancestor
19669207|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
19669208|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669209|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669210|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669211|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669212|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19669213|NCT03374956|Liraglutide|liraglutide|mesh-list
19669214|NCT03374956|Topiramate|topiramate|mesh-list
19669215|NCT03374956|Phentermine|phentermine|mesh-list
19669216|NCT03374956|Naltrexone|naltrexone|mesh-list
19669217|NCT03374956|Bupropion|bupropion|mesh-list
19669218|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19669219|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19669220|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669221|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
19669222|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669223|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19669224|NCT03374956|Incretins|incretins|mesh-ancestor
19669225|NCT03374956|Hormones|hormones|mesh-ancestor
19669226|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836374|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836375|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19836376|NCT00609245|Valproic Acid|valproic acid|mesh-list
19836377|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
19836378|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836379|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836380|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
19836381|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836382|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836383|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
19836384|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836385|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836386|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836387|NCT00609336|Gemcitabine|gemcitabine|mesh-list
19836388|NCT00609336|Capecitabine|capecitabine|mesh-list
19836389|NCT00609336|Docetaxel|docetaxel|mesh-list
19836390|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
19669227|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19669228|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
19669229|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19669230|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19669231|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19669232|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19669233|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669234|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
19669235|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669236|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19272599|NCT02884245|Estrogens|estrogens|mesh-list
19272600|NCT02884245|Hormones|hormones|mesh-ancestor
19272601|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19272602|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178799|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178800|NCT00181116|Levetiracetam|levetiracetam|mesh-list
20178801|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
20178802|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
20178803|NCT00181142|Daclizumab|daclizumab|mesh-list
20178804|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178805|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
20178806|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178807|NCT00181181|Atorvastatin|atorvastatin|mesh-list
19836391|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20178808|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19272603|NCT02871297|Vortioxetine|vortioxetine|mesh-list
19272604|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
19272605|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19272606|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19272607|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19272608|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19272609|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272610|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19272611|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19272612|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19272613|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272614|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19272615|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
19272616|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19272617|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19272618|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19272619|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19669237|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19669238|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669239|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
19669240|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19669241|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
19669242|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19669243|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
19669244|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
19669245|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669246|NCT03300479|Urapidil|urapidil|mesh-list
19669247|NCT03300479|Clevidipine|clevidipine|mesh-list
19669248|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19836392|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
19836393|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836394|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352684|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20352685|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20352686|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669249|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19669250|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669251|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19669252|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669253|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19669254|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
19669255|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19669256|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
19669257|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669258|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19669259|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19669260|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19669261|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669262|NCT03272464|Trametinib|trametinib|mesh-list
19669263|NCT03272464|Dabrafenib|dabrafenib|mesh-list
19669264|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669265|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19836395|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
19836396|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836397|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836398|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836399|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
19836400|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178809|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20178810|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
20178811|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178812|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20178813|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20178814|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178815|NCT00181220|Valproic Acid|valproic acid|mesh-list
20178816|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
20178817|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178818|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178819|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
20178820|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178821|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178822|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
20178823|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836401|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
19836402|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
19836403|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
19848150|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848151|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848152|NCT00691093|Urological Agents|urological agents|mesh-ancestor
19848153|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
19848154|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848155|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848156|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19848157|NCT00691132|Protective Agents|protective agents|mesh-ancestor
19848158|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848159|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848160|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19848161|NCT00691197|Glycerol|glycerol|mesh-list
19848162|NCT00691197|Laxatives|laxatives|mesh-ancestor
19848163|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848164|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19848165|NCT00691197|Protective Agents|protective agents|mesh-ancestor
19848166|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848167|NCT00691210|Niacinamide|niacinamide|mesh-list
20178824|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178825|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178826|NCT00181246|Fentanyl|fentanyl|mesh-list
20178827|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20178828|NCT00181246|Narcotics|narcotics|mesh-ancestor
20178829|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178830|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178831|NCT00181246|Analgesics|analgesics|mesh-ancestor
20352687|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20352688|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20352689|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
20352690|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352691|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20352692|NCT00884884|Topiramate|topiramate|mesh-list
20352693|NCT00884884|Aripiprazole|aripiprazole|mesh-list
20352694|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
20352695|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352696|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20352697|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352698|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352699|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352700|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
20178832|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
20178833|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178834|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20178835|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20178836|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
20178837|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
19669266|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669267|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669268|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20178838|NCT00181272|Azithromycin|azithromycin|mesh-list
19669269|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19669270|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669271|NCT03070184|Metoprolol|metoprolol|mesh-list
19669272|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19669273|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19669274|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
20178839|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20178840|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669275|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
19669276|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669277|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669278|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19669279|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19848168|NCT00691210|Niacin|niacin|mesh-list
20178841|NCT00181298|Memantine|memantine|mesh-list
20178842|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20178843|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20178844|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
20352701|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
20352702|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352703|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848169|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
20178845|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669280|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19669281|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669282|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669283|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669284|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
19669285|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669286|NCT02781090|Nicotine|nicotine|mesh-list
19669287|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19669288|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
19669289|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669290|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669291|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19669292|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19669293|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
20178846|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178847|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178848|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20178849|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20178850|NCT00181532|Celecoxib|celecoxib|mesh-list
20178851|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20178852|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20178853|NCT00181532|Analgesics|analgesics|mesh-ancestor
20178854|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
20178855|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178856|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178857|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178858|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178859|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20178860|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20178861|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178862|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178863|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
20178864|NCT00181558|Atrasentan|atrasentan|mesh-list
20178865|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20178866|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178867|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178868|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19669294|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669295|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669296|NCT02758847|Paclitaxel|paclitaxel|mesh-list
19669297|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19669298|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19669299|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669300|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
19669301|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
19669302|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
19669303|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669304|NCT02718066|Nivolumab|nivolumab|mesh-list
19669305|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20178869|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20178870|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178871|NCT00181571|Methylphenidate|methylphenidate|mesh-list
20178872|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19669306|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669307|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19669308|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669309|NCT02390531|Bevacizumab|bevacizumab|mesh-list
19669310|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669311|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669312|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19669313|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20352704|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20352705|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20352706|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
20352707|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20352708|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19669314|NCT02390531|Growth Substances|growth substances|mesh-ancestor
19669315|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669316|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
20178873|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272636|NCT02835222|Cytarabine|cytarabine|mesh-list
19272637|NCT02835222|Daunorubicin|daunorubicin|mesh-list
19669317|NCT05116254|AZD7648|azd7648|mesh-list
19669318|NCT05116254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19669319|NCT05116254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669320|NCT05116254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669321|NCT05116228|Rituximab|rituximab|mesh-list
19669322|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669323|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352709|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20352710|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20352711|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
19669324|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
19669325|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669326|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669327|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
19669328|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19669329|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178874|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20178875|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178876|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178877|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178878|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
20178879|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178880|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
20178881|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20178882|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178883|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
20352712|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20352713|NCT00885066|Gemcitabine|gemcitabine|mesh-list
20352714|NCT00885066|Capecitabine|capecitabine|mesh-list
20178884|NCT00181597|Trilostane|trilostane|mesh-list
19272638|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19272639|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
19272640|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272641|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272642|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
19272643|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19272644|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19272645|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
19272646|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272647|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19272648|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19272649|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19272650|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669330|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
19669331|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669332|NCT05116150|Protective Agents|protective agents|mesh-ancestor
19669333|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669334|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19669335|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
19669336|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669337|NCT05116098|Protective Agents|protective agents|mesh-ancestor
19669338|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669339|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19669340|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19669341|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669342|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19669343|NCT05116007|Carboplatin|carboplatin|mesh-list
19669344|NCT05116007|Etoposide|etoposide|mesh-list
19669345|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669346|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19669347|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19669348|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19669349|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669350|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669351|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
20352715|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20352716|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20352717|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
20352718|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352719|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352720|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
20352721|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352722|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352723|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352724|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
20352725|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352726|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352727|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
20352728|NCT00885274|Citric Acid|citric acid|mesh-list
20352729|NCT00885274|Antacids|antacids|mesh-ancestor
19669352|NCT05115903|Adalimumab|adalimumab|mesh-list
19669353|NCT05115903|Etanercept|etanercept|mesh-list
19669354|NCT05115903|Golimumab|golimumab|mesh-list
19669355|NCT05115903|Infliximab|infliximab|mesh-list
20352730|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352731|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20352732|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
19669356|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
20178885|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178886|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20178887|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
20178888|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20178889|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178890|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178891|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352733|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20352734|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
20352735|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
20352736|NCT00885287|Lumefantrine|lumefantrine|mesh-list
20352737|NCT00885287|Artemether|artemether|mesh-list
20352738|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20352739|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
20352740|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20352741|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20352742|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352743|NCT00885300|Cloxacillin|cloxacillin|mesh-list
20352744|NCT00885300|Heparin|heparin|mesh-list
20352745|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
20178892|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836404|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
20178893|NCT00181636|Galantamine|galantamine|mesh-list
20178894|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20178895|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178896|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178897|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
20352746|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20352747|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20352748|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836405|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19836406|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836407|NCT00609466|Morphine|morphine|mesh-list
19836408|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19836409|NCT00609466|Narcotics|narcotics|mesh-ancestor
19836410|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836411|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836412|NCT00609466|Analgesics|analgesics|mesh-ancestor
19836413|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
19836414|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836415|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20352749|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19669357|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19669358|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669359|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669360|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
19669361|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669362|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19669363|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669364|NCT05115903|Analgesics|analgesics|mesh-ancestor
19669365|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
19669366|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272689|NCT02819479|Bevacizumab|bevacizumab|mesh-list
19272690|NCT02819479|Mannitol|mannitol|mesh-list
19272691|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272692|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272693|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19272694|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19669367|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836416|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
20352750|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352751|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
19669368|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352752|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
20352753|NCT00885326|Bevacizumab|bevacizumab|mesh-list
20352754|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352755|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
20352756|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352757|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20352758|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20352759|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
20352760|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352761|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352762|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20352763|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352764|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19272695|NCT02819479|Growth Substances|growth substances|mesh-ancestor
19272696|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272697|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
19272698|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19272699|NCT02819479|Diuretics|diuretics|mesh-ancestor
19272700|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
19272701|NCT02816424|TEMPO|tempo|mesh-list
19272702|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
19272703|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272704|NCT02816424|Protective Agents|protective agents|mesh-ancestor
19272705|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669369|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
19669370|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20178898|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178899|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669371|NCT05115578|Midazolam|midazolam|mesh-list
19669372|NCT05115578|Remifentanil|remifentanil|mesh-list
19669373|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19669374|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19669375|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669376|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669377|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19669378|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19669379|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19669380|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19669381|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
19669382|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
19669383|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
19669384|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
19669385|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669386|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669387|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19669388|NCT05115578|Narcotics|narcotics|mesh-ancestor
19669389|NCT05115578|Analgesics|analgesics|mesh-ancestor
20178900|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20178901|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
20178902|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178903|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
20178904|NCT00181662|Curcumin|curcumin|mesh-list
19669390|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
19836417|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836418|NCT00609518|Folic Acid|folic acid|mesh-list
19836419|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
19836420|NCT00609518|Hydroxocobalamin|hydroxocobalamin|mesh-list
19836421|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
19836422|NCT00609518|Dexamethasone|dexamethasone|mesh-list
19836423|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
19836424|NCT00609518|Pemetrexed|pemetrexed|mesh-list
19836425|NCT00609518|BB 1101|bb 1101|mesh-list
19836426|NCT00609518|Vitamins|vitamins|mesh-ancestor
19836427|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
19836428|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836429|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669391|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692034|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
19692035|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692036|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692037|NCT04997564|Tenofovir|tenofovir|mesh-list
19692038|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
19692039|NCT04997564|Velpatasvir|velpatasvir|mesh-list
19692040|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
19836430|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
20178905|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19836431|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
20178906|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19836432|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836433|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836434|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
19836435|NCT00609518|Hormones|hormones|mesh-ancestor
19669392|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
19669393|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
19272727|NCT02794896|Fentanyl|fentanyl|mesh-list
19272728|NCT02794896|Propofol|propofol|mesh-list
19836436|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836437|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19836438|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836439|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
19836440|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836441|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836442|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19836443|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19836444|NCT00609518|Hematinics|hematinics|mesh-ancestor
19836445|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
19836446|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19836447|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19669394|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669395|NCT05115149|Protective Agents|protective agents|mesh-ancestor
19669396|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352765|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178907|NCT00181662|Analgesics|analgesics|mesh-ancestor
19272729|NCT02794896|Sevoflurane|sevoflurane|mesh-list
19272730|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19272731|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19272732|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272733|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19272734|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
19272735|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
19272736|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19272737|NCT02794896|Narcotics|narcotics|mesh-ancestor
19272738|NCT02794896|Analgesics|analgesics|mesh-ancestor
19272739|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
19272740|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272741|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19272742|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20178908|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
20178909|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178910|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178911|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178912|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20178913|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178914|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178915|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178916|NCT00181675|Galantamine|galantamine|mesh-list
20178917|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20178918|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178919|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178920|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
20178921|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178922|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272743|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19669397|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19669398|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669399|NCT05114499|Donepezil|donepezil|mesh-list
19669400|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19669401|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669402|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178923|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20352766|NCT00885326|Growth Substances|growth substances|mesh-ancestor
20352767|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
20352768|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19669403|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
19669404|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669405|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669406|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
19669407|NCT05114239|Timolol|timolol|mesh-list
19669408|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19669409|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19669410|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19669411|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20178924|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
20178925|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20178926|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
20178927|NCT00181688|Anastrozole|anastrozole|mesh-list
20178928|NCT00181688|Gefitinib|gefitinib|mesh-list
19669412|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669413|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669414|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669415|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836448|NCT00609609|Prednisolone|prednisolone|mesh-list
19836449|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
19836450|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19836451|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
19836452|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836453|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
19836454|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
19836455|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836456|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178929|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20178930|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20178931|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20178932|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20178933|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178934|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178935|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19669416|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19669417|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19669418|NCT05114096|Betamethasone|betamethasone|mesh-list
19669419|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
19669420|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19669421|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
19669422|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19669423|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669424|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
19669425|NCT05114096|Hormones|hormones|mesh-ancestor
19669426|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19272765|NCT02783404|Amoxicillin|amoxicillin|mesh-list
19272766|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
19272767|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
19272768|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19272769|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19272770|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19272771|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272772|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669427|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669428|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19836457|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836458|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
19836459|NCT00609609|Hormones|hormones|mesh-ancestor
19836460|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836461|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19836462|NCT00609609|Protective Agents|protective agents|mesh-ancestor
19836463|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19836464|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836465|NCT00609622|Bevacizumab|bevacizumab|mesh-list
19836466|NCT00609622|Sunitinib|sunitinib|mesh-list
19836467|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19836468|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836469|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19836470|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20178936|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
19669429|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
19669430|NCT05113628|Methylene Blue|methylene blue|mesh-list
20178937|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20178938|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178939|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19669431|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669432|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669433|NCT05113511|Bevacizumab|bevacizumab|mesh-list
19669434|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669435|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669436|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19836471|NCT00609622|Growth Substances|growth substances|mesh-ancestor
19836472|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178940|NCT00181727|Valproic Acid|valproic acid|mesh-list
20178941|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
19836473|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
19836474|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352769|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20352770|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
20352771|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20352772|NCT00885443|Propofol|propofol|mesh-list
20352773|NCT00885443|Sevoflurane|sevoflurane|mesh-list
20352774|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20352775|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352776|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352777|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19836475|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836476|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836477|NCT00609674|Fluticasone|fluticasone|mesh-list
19836478|NCT00609674|Xhance|xhance|mesh-list
19836479|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20178942|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669437|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19669438|NCT05113511|Growth Substances|growth substances|mesh-ancestor
19669439|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669440|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
19669441|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19669442|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20352778|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
20352779|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
20352780|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20352781|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20352782|NCT00885508|Lenalidomide|lenalidomide|mesh-list
20352783|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
20352784|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352785|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20352786|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20352787|NCT00885508|Growth Substances|growth substances|mesh-ancestor
19272783|NCT02728531|Cytarabine|cytarabine|mesh-list
19272784|NCT02728531|Rituximab|rituximab|mesh-list
19272785|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19272786|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272787|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272788|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
19272789|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272790|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19272791|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19272792|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
19272793|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272794|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
19272795|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19272796|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19272797|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19272798|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
19669443|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19669444|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19669445|NCT05112692|Cetrorelix|cetrorelix|mesh-list
19669446|NCT05112692|Menotropins|menotropins|mesh-list
19272803|NCT02693184|Vitamin D|vitamin d|mesh-list
19272804|NCT02693184|Calcium|calcium|mesh-list
19272805|NCT02693184|Vitamins|vitamins|mesh-ancestor
19272806|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
19272807|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352788|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
19272808|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19272809|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19272810|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
19836480|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20178943|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178944|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
20178945|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178946|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836481|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
20178947|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
19272811|NCT02677181|Methotrexate|methotrexate|mesh-list
19272812|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
19272813|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19669447|NCT05112692|Estradiol|estradiol|mesh-list
20178948|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178949|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178950|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836482|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836483|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836484|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19836485|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
19836486|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
19836487|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19836488|NCT00609739|Cytarabine|cytarabine|mesh-list
19836489|NCT00609739|Cyclosporine|cyclosporine|mesh-list
19836490|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
19836491|NCT00609739|Methotrexate|methotrexate|mesh-list
19836492|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
19272814|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
19272815|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20612433|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19836493|NCT00609739|Tretinoin|tretinoin|mesh-list
20352789|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424924|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424925|NCT01271582|Antidotes|antidotes|mesh-ancestor
20424926|NCT01271582|Protective Agents|protective agents|mesh-ancestor
20424927|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424928|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
20424929|NCT01271582|Vitamins|vitamins|mesh-ancestor
20424930|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
20424931|NCT01271660|Pregabalin|pregabalin|mesh-list
20424932|NCT01271660|Analgesics|analgesics|mesh-ancestor
20424933|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
20424934|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424935|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424936|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
20424937|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20424938|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424939|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424940|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20424941|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20424942|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20424943|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424944|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424945|NCT01271881|Heparin|heparin|mesh-list
20424946|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
20424947|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20424948|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20424949|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424950|NCT01271894|Efavirenz|efavirenz|mesh-list
20424951|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20424952|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20424953|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424954|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424955|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
20424956|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424957|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20424958|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20424959|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20424960|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20424961|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20424962|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19272816|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836494|NCT00609739|Isotretinoin|isotretinoin|mesh-list
19836495|NCT00609739|Cyclosporins|cyclosporins|mesh-list
19836496|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19836497|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
19836498|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19272817|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19272818|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
19272819|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272820|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272821|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
19272822|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272823|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19272824|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19272825|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
19272826|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836499|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836500|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20424963|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
19272827|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19272828|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19272829|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19272830|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
19272831|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19272832|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836501|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
19836502|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836503|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669448|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19669449|NCT05112692|Progesterone|progesterone|mesh-list
19669450|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
19669451|NCT05112692|Estrogens|estrogens|mesh-ancestor
19669452|NCT05112692|Hormones|hormones|mesh-ancestor
19669453|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669454|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669455|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19669456|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
19669457|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19669458|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19669459|NCT05112692|Progestins|progestins|mesh-ancestor
19669460|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
19669461|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19669462|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669463|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19669464|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
19669465|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
19669466|NCT05105919|Aspirin|aspirin|mesh-list
19669467|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19669468|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20352790|NCT00885586|Gabapentin|gabapentin|mesh-list
20352791|NCT00885586|Analgesics|analgesics|mesh-ancestor
20352792|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
20352793|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352794|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352795|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
20352796|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20352797|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352798|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352799|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352800|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20352801|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19669469|NCT05105919|Analgesics|analgesics|mesh-ancestor
19669470|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
19669471|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669472|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669473|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669474|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669475|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19669476|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19669477|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669478|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19272848|NCT02640664|Ranibizumab|ranibizumab|mesh-list
19272849|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19272850|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19272851|NCT02640664|Growth Substances|growth substances|mesh-ancestor
19272852|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272853|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
19272854|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669479|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19669480|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669481|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
19669482|NCT05105685|Hormones|hormones|mesh-list
19669483|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19272860|NCT02621944|Melatonin|melatonin|mesh-list
19272861|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
19669484|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692041|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352802|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352803|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692042|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20352804|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
19272862|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272863|NCT02621944|Protective Agents|protective agents|mesh-ancestor
20178951|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20178952|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20178953|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178954|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19669485|NCT05103306|Empagliflozin|empagliflozin|mesh-list
19669486|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19669487|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669488|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19669489|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669490|NCT05102669|Antibodies|antibodies|mesh-list
19669491|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
19669492|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669493|NCT05100472|Androgens|androgens|mesh-list
19669494|NCT05100472|Hormones|hormones|mesh-ancestor
19272864|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272865|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669495|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669496|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669497|NCT05096962|Antibodies|antibodies|mesh-list
19836504|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
19836505|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836506|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19836507|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836508|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
19836509|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836510|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19836511|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
19836512|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836513|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
19836514|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19836515|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836516|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
20178955|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178956|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
20178957|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178958|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178959|NCT00181779|Aripiprazole|aripiprazole|mesh-list
19836517|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
19836518|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669498|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
19669499|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669500|NCT05091242|Clonidine|clonidine|mesh-list
20352805|NCT00885599|Listerine|listerine|mesh-list
20352806|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20352807|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352808|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20352809|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
20352810|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669501|NCT05091242|Analgesics|analgesics|mesh-ancestor
19669502|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
19669503|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669504|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669505|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19669506|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
19669507|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
19669508|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19669509|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19669510|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19669511|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669512|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669513|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178960|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
20178961|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178962|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20178963|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20178964|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178965|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178966|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
20178967|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
20612434|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19669514|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
19836519|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836520|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
20352811|NCT00885664|Ritonavir|ritonavir|mesh-list
19272884|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
19272885|NCT02601313|Fludarabine|fludarabine|mesh-list
19836521|NCT00609739|Hormones|hormones|mesh-ancestor
19836522|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836523|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19836524|NCT00609739|Protective Agents|protective agents|mesh-ancestor
19836525|NCT00609739|Analgesics|analgesics|mesh-ancestor
19836526|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
19836527|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19836528|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19836529|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
19836530|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19836531|NCT00609804|Sorafenib|sorafenib|mesh-list
19836532|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352812|NCT00885664|Lopinavir|lopinavir|mesh-list
20352813|NCT00885664|Tenofovir|tenofovir|mesh-list
20352814|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20352815|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20352816|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20352817|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
20352818|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352819|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352820|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20612435|NCT02251249|Acetaminophen|acetaminophen|mesh-list
19272886|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836533|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19836534|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836535|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836536|NCT00609869|Rituximab|rituximab|mesh-list
19836537|NCT00609869|Lenalidomide|lenalidomide|mesh-list
19836538|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19836539|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836540|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
19836541|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836542|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836543|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19836544|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19836545|NCT00609869|Growth Substances|growth substances|mesh-ancestor
19836546|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
19836547|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
19836548|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19836549|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836550|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19836551|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19836552|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836553|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836554|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836555|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19272887|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
19272888|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272889|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19272890|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19272891|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
19272892|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272893|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272894|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19272895|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
19272896|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272897|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669515|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19669516|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669517|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19836556|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19836557|NCT00609986|Insulin|insulin|mesh-list
19836558|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19836559|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
19836560|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
19669518|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19669519|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669520|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669521|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669522|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
19669523|NCT05073822|Tacrolimus|tacrolimus|mesh-list
19669524|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19669525|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
20352821|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20352822|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
20352823|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20352824|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19836561|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
19836562|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
19836563|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19836564|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836565|NCT00610155|Pregabalin|pregabalin|mesh-list
19836566|NCT00610155|Tramadol|tramadol|mesh-list
19836567|NCT00610155|Analgesics|analgesics|mesh-ancestor
19669526|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669527|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19669528|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669529|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669530|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19669531|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669532|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19669533|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
19836568|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
19836569|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836570|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836571|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
19836572|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19836573|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836574|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836575|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19836576|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19836577|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836578|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836579|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836580|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19836581|NCT00610155|Narcotics|narcotics|mesh-ancestor
19836582|NCT00610168|Vaccines|vaccines|mesh-list
19836583|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
19836584|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836585|NCT00610311|Aldesleukin|aldesleukin|mesh-list
19836586|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
19836587|NCT00610311|Fludarabine|fludarabine|mesh-list
19836588|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
19836589|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20178968|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178969|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178970|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20352825|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20352826|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20352827|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20352828|NCT00885690|Olanzapine|olanzapine|mesh-list
20352829|NCT00885690|Sertindole|sertindole|mesh-list
20352830|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
20352831|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
20352832|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352833|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352834|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20352835|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20352836|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352837|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669534|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19669535|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669536|NCT05068336|Anesthetics|anesthetics|mesh-list
19669537|NCT05068336|Sevoflurane|sevoflurane|mesh-list
19669538|NCT05068336|Desflurane|desflurane|mesh-list
20178971|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20178972|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
20178973|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20178974|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20178975|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20178976|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19669539|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669540|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836590|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
20217202|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352838|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836591|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272915|NCT02542293|Gemcitabine|gemcitabine|mesh-list
19272916|NCT02542293|Paclitaxel|paclitaxel|mesh-list
19272917|NCT02542293|Cisplatin|cisplatin|mesh-list
19272918|NCT02542293|Carboplatin|carboplatin|mesh-list
19272919|NCT02542293|Pemetrexed|pemetrexed|mesh-list
19272920|NCT02542293|Durvalumab|durvalumab|mesh-list
19272921|NCT02542293|Tremelimumab|tremelimumab|mesh-list
19272922|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19272923|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272924|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
19272925|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
19272926|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
19272927|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272928|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19272929|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
19669541|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19669542|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19669543|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
19669544|NCT05062785|Insulin|insulin|mesh-list
19669545|NCT05062785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19669546|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19669547|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669548|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
19669549|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669550|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669551|NCT05040126|Linezolid|linezolid|mesh-list
19669552|NCT05040126|Bedaquiline|bedaquiline|mesh-list
19669553|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19669554|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669555|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19669556|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272930|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
19272931|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19272932|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272933|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352839|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20352840|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20352841|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19272934|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
19272935|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272936|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19272937|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19272938|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19272939|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19272940|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
19272941|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19272942|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19669557|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669558|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
19669559|NCT05036109|Aspirin|aspirin|mesh-list
19669560|NCT05036109|Vitamin D|vitamin d|mesh-list
19669561|NCT05036109|Vitamins|vitamins|mesh-ancestor
19669562|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
19669563|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669564|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19669565|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19669566|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669567|NCT05036109|Analgesics|analgesics|mesh-ancestor
19669568|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
19669569|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669570|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669571|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669572|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19669573|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19669574|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669575|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19669576|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19669577|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669578|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
19669579|NCT05024747|Nicotine|nicotine|mesh-list
19669580|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19836592|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19272943|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
19272944|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669581|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
19669582|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669583|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352842|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352843|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352844|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
20352845|NCT00885781|SMOFlipid|smoflipid|mesh-list
20352846|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20352847|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20352848|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19669584|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19669585|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19669586|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
19669587|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669588|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669589|NCT05015335|Adalimumab|adalimumab|mesh-list
19669590|NCT05015335|Methotrexate|methotrexate|mesh-list
19669591|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19669592|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
19669593|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19669594|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669595|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19669596|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
19272945|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19272946|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19272947|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669597|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669598|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836593|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19836594|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
19836595|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836596|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836597|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19836598|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19836599|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
19836600|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19836601|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20352849|NCT00885794|Ranibizumab|ranibizumab|mesh-list
20352850|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20352851|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20352852|NCT00885794|Growth Substances|growth substances|mesh-ancestor
20352853|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352854|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
20352855|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836602|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
19836603|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836604|NCT00610363|Rilonacept|rilonacept|mesh-list
19836605|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19836606|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
19836607|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
19836608|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
20352856|NCT00885820|Prednisone|prednisone|mesh-list
19669599|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
19669600|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669601|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19669602|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352857|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
20352858|NCT00885820|Tacrolimus|tacrolimus|mesh-list
20352859|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352860|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
20352861|NCT00885820|Hormones|hormones|mesh-ancestor
20352862|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20352863|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352864|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20352865|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352866|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352867|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
20352868|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20352869|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352870|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352871|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
20352872|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
20352873|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352874|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669603|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
19669604|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836609|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352875|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20178977|NCT00181818|Bupropion|bupropion|mesh-list
20178978|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20352876|NCT00885820|Protective Agents|protective agents|mesh-ancestor
20352877|NCT00885833|Fludarabine|fludarabine|mesh-list
20352878|NCT00885833|Busulfan|busulfan|mesh-list
20352879|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
20352880|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352881|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352882|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20352883|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
20352884|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352885|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
20352886|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20352887|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20352888|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20352889|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20352890|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20352891|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
20352892|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352893|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20352894|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20352895|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352896|NCT00885885|Panitumumab|panitumumab|mesh-list
20352897|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20352898|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352899|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20352900|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
20178979|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
19669605|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19669606|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669607|NCT04982796|Psilocybin|psilocybin|mesh-list
19669608|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
19669609|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669610|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178980|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178981|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20178982|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20178983|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20178984|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20178985|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
20178986|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20178987|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20178988|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20178989|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20178990|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20178991|NCT00181870|Carbamazepine|carbamazepine|mesh-list
20178992|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
20178993|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
20178994|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352901|NCT00885924|Coagulants|coagulants|mesh-ancestor
20352902|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20178995|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20178996|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352903|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
20352904|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352905|NCT00886002|Fentanyl|fentanyl|mesh-list
20352906|NCT00886002|Buprenorphine|buprenorphine|mesh-list
20352907|NCT00886002|Naloxone|naloxone|mesh-list
20178997|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20178998|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20178999|NCT00181870|Analgesics|analgesics|mesh-ancestor
20179000|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
19272961|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19272962|NCT02438722|Cetuximab|cetuximab|mesh-list
19272963|NCT02438722|Afatinib|afatinib|mesh-list
19272964|NCT02438722|Antibodies|antibodies|mesh-list
19272965|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
19272966|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19272967|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
19272968|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272969|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19272970|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20179001|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352908|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20352909|NCT00886002|Narcotics|narcotics|mesh-ancestor
20352910|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352911|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352912|NCT00886002|Analgesics|analgesics|mesh-ancestor
20352913|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
20352914|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19272971|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19272972|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669627|NCT04964622|Ibuprofen|ibuprofen|mesh-list
19669628|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19669629|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669630|NCT04964622|Analgesics|analgesics|mesh-ancestor
19669631|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
19669632|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669633|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669634|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352915|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19669635|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669636|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19669637|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669638|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669639|NCT04954339|Bevacizumab|bevacizumab|mesh-list
19669640|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669641|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669642|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19669643|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19669644|NCT04954339|Growth Substances|growth substances|mesh-ancestor
19836610|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272992|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
19272993|NCT02425306|Poly ICLC|poly iclc|mesh-list
19272994|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
19272995|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19272996|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19272997|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19272998|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19272999|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
19836611|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836612|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20179002|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20179003|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179004|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179005|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20179006|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20179007|NCT00181896|Bupropion|bupropion|mesh-list
20179008|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20179009|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
20179010|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179011|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20179012|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19836613|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836614|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836615|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836616|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19836617|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
19836618|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836619|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836620|NCT00610675|Mirtazapine|mirtazapine|mesh-list
19836621|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
19836622|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836623|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19836624|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
19836625|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
20352916|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19273000|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836626|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836627|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836628|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836629|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19836630|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836631|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836632|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19836633|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19836634|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19836635|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
19836636|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19836637|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19836638|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
19836639|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19836640|NCT00610688|Vitamin D|vitamin d|mesh-list
19836641|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
19273001|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273002|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19273003|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
19273004|NCT02419560|Venetoclax|venetoclax|mesh-list
19273005|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352917|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
20352918|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
20179013|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19273006|NCT02405520|Vaccines|vaccines|mesh-list
19273007|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
19273008|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669645|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669646|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
19669647|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
19669648|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669649|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19273014|NCT02382445|Anesthetics|anesthetics|mesh-list
19273015|NCT02382445|Propofol|propofol|mesh-list
19273016|NCT02382445|Sevoflurane|sevoflurane|mesh-list
19273017|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836642|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
19836643|NCT00610688|Vitamins|vitamins|mesh-list
19836644|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
20179014|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179015|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
20179016|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179017|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179018|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20179019|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20179020|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179021|NCT00181922|Ziprasidone|ziprasidone|mesh-list
20179022|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20179023|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
20179024|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179025|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179026|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179027|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20352919|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20352920|NCT00886028|Doxorubicin|doxorubicin|mesh-list
20352921|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19836645|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836646|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19836647|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19836648|NCT00610714|Paclitaxel|paclitaxel|mesh-list
19836649|NCT00610714|Carboplatin|carboplatin|mesh-list
20179028|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836650|NCT00610714|Saracatinib|saracatinib|mesh-list
19836651|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19836652|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836653|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
19836654|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
20179029|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179030|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179031|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20179032|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
20179033|NCT00181935|Olanzapine|olanzapine|mesh-list
20179034|NCT00181935|Risperidone|risperidone|mesh-list
20179035|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20179036|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
20179037|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179038|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179039|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179040|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20352922|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273018|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669650|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669651|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669652|NCT04951804|Bupivacaine|bupivacaine|mesh-list
19669653|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
19669654|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
19836655|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
19836656|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612436|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612437|NCT02251249|Analgesics|analgesics|mesh-ancestor
20612438|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
20612439|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612440|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612441|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
20612442|NCT02251288|Vaccines|vaccines|mesh-list
20612443|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
19273019|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19273020|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19273021|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
19273022|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19273023|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19669655|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669656|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669657|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
19669658|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669659|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
19669660|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19669661|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19273031|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19273032|NCT02378805|Ramipril|ramipril|mesh-list
19273033|NCT02378805|Spironolactone|spironolactone|mesh-list
19273034|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19273035|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19273036|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
19273037|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19273038|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273039|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19273040|NCT02378805|Diuretics|diuretics|mesh-ancestor
19273041|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
19273042|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
19273043|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273044|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273045|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19273046|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19669662|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669663|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
19669664|NCT04947514|Coagulants|coagulants|mesh-ancestor
19669665|NCT04939753|Sevoflurane|sevoflurane|mesh-list
19669666|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19669667|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19669668|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
19669669|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
19669670|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669671|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669672|NCT04937413|Evolocumab|evolocumab|mesh-list
19669673|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19669674|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19669675|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
20179041|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19669676|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669677|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19273063|NCT02278120|Tamoxifen|tamoxifen|mesh-list
19273064|NCT02278120|Letrozole|letrozole|mesh-list
19273065|NCT02278120|Anastrozole|anastrozole|mesh-list
19273066|NCT02278120|Goserelin|goserelin|mesh-list
19273067|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273068|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19273069|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19273070|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273071|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273072|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19273073|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
19692043|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19836657|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836658|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
19836659|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
19836660|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
20179042|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612444|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836661|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179043|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836662|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836663|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836664|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19836665|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836666|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836667|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836668|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19836669|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
19836670|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836671|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836672|NCT00610740|Gemcitabine|gemcitabine|mesh-list
19836673|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179044|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20179045|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
20179046|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
20179047|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
20179048|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669678|NCT04871529|Gemcitabine|gemcitabine|mesh-list
19669679|NCT04871529|Carboplatin|carboplatin|mesh-list
19669680|NCT04871529|Avelumab|avelumab|mesh-list
19669681|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
19669682|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
19669683|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19669684|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669685|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179049|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19836674|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
19836675|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352923|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20352924|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20352925|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20352926|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20352927|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179050|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20179051|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179052|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179053|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20179054|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20179055|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179056|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179057|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179058|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
20179059|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179060|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179061|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20179062|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
20179063|NCT00181974|Coagulants|coagulants|mesh-ancestor
20179064|NCT00181987|Methylphenidate|methylphenidate|mesh-list
20179065|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20179066|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273074|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19273075|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273076|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19273077|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19273078|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19273079|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19273080|NCT02258451|Everolimus|everolimus|mesh-list
19273081|NCT02258451|Exemestane|exemestane|mesh-list
19273082|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19273083|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273084|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19273085|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
19273086|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273087|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19273088|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19273089|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273090|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273091|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19273092|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
19273093|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669686|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
19669687|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669688|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
19669689|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669690|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669691|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19669692|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
19669693|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669694|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669695|NCT04862468|Dexamethasone|dexamethasone|mesh-list
19669696|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20352928|NCT00886106|Midazolam|midazolam|mesh-list
19669697|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
19669698|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
19836676|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352929|NCT00886106|Remifentanil|remifentanil|mesh-list
20352930|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19669699|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836677|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
19836678|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836679|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836680|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836681|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
19836682|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836683|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19836684|NCT00610857|Antibodies|antibodies|mesh-list
19836685|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
19836686|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19836687|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
19836688|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836689|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836690|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
19836691|NCT00610883|Methotrexate|methotrexate|mesh-list
19669700|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669701|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669702|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
19669703|NCT04862468|Hormones|hormones|mesh-ancestor
19669704|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669705|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19669706|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669707|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
19669708|NCT04828486|Futibatinib|futibatinib|mesh-list
19669709|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669710|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669711|NCT04819568|Terlipressin|terlipressin|mesh-list
19669712|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19669713|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19669714|NCT04818489|Colchicine|colchicine|mesh-list
19836692|NCT00610883|Asparaginase|asparaginase|mesh-list
19669715|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
19669716|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669717|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19669718|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19669719|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19669720|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669721|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669722|NCT04802408|Listerine|listerine|mesh-list
19669723|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
19669724|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20179067|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20179068|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179069|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179070|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179071|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
20179072|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179073|NCT00182013|Olanzapine|olanzapine|mesh-list
20179074|NCT00182013|Risperidone|risperidone|mesh-list
20179075|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20179076|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20179077|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
20179078|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179079|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352931|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20352932|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669725|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836693|NCT00610883|Daunorubicin|daunorubicin|mesh-list
19836694|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836695|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
19669726|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
19836696|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836697|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836698|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19836699|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
19836700|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179080|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179081|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20179082|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19669727|NCT04802408|Protective Agents|protective agents|mesh-ancestor
19669728|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669729|NCT04765787|Acetaminophen|acetaminophen|mesh-list
19669730|NCT04765787|Orphenadrine|orphenadrine|mesh-list
19669731|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669732|NCT04765787|Analgesics|analgesics|mesh-ancestor
19836701|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836702|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20352933|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352934|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20352935|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352936|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352937|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19669733|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
19669734|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669735|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669736|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
19669737|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19669738|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20352938|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
20352939|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
19836703|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19669739|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19669740|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19669741|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
19669742|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
19669743|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19669744|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19669745|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
19669746|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669747|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179083|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179084|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19669748|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
19669749|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19669750|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669751|NCT04756791|Anesthetics|anesthetics|mesh-list
19669752|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669753|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669754|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
19669755|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19669756|NCT04748250|Estrogens|estrogens|mesh-ancestor
19669757|NCT04748250|Hormones|hormones|mesh-ancestor
19669758|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669759|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669760|NCT04726878|Acetaminophen|acetaminophen|mesh-list
19669761|NCT04726878|Oxycodone|oxycodone|mesh-list
19669762|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669763|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669764|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20179085|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20179086|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
20352940|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
20352941|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
20352942|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352943|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352944|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20179087|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
20179088|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
20179089|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179090|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669765|NCT04726878|Analgesics|analgesics|mesh-ancestor
19669766|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
19692044|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179091|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20352945|NCT00886106|Narcotics|narcotics|mesh-ancestor
20352946|NCT00886106|Analgesics|analgesics|mesh-ancestor
20352947|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
20352948|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352949|NCT00886132|Sunitinib|sunitinib|mesh-list
20352950|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20352951|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19669767|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669768|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
19669769|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19669770|NCT04726878|Narcotics|narcotics|mesh-ancestor
19669771|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
19669772|NCT04714372|Fludarabine|fludarabine|mesh-list
19669773|NCT04714372|Daratumumab|daratumumab|mesh-list
19669774|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19669775|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
19669776|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669777|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669778|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19669779|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
19669780|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669781|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669782|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19669783|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19669784|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
19669785|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19669786|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
19669787|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19669788|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669789|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19669790|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19669791|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19273174|NCT02133872|Minocycline|minocycline|mesh-list
19273175|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19273176|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669792|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669793|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19669794|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19669795|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19669796|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19669797|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669798|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19669799|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19669800|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
19669801|NCT04605614|Copper|copper|mesh-list
19836704|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
19836705|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19836706|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19836707|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
19836708|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
19836709|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836710|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19836711|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19836712|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19836713|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19836714|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19836715|NCT00610935|Peramivir|peramivir|mesh-list
19836716|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
19836717|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836718|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836719|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836720|NCT00610987|Cefazolin|cefazolin|mesh-list
20179092|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179093|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179094|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
20179095|NCT00182039|Metoprolol|metoprolol|mesh-list
20179096|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20179097|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179098|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
20179099|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
20179100|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179101|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179102|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20179103|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20179104|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20179105|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
20352952|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19669802|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
19669803|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669804|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669805|NCT04605614|Trace Elements|trace elements|mesh-ancestor
19669806|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
19669807|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669808|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
19669809|NCT04585295|Betaine|betaine|mesh-list
19669810|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669811|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
19669812|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19669813|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
19669814|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669815|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19669816|NCT04583488|Docetaxel|docetaxel|mesh-list
19669817|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669818|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
19669819|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
19669820|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
19669821|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669822|NCT04568616|Letrozole|letrozole|mesh-list
19669823|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669824|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19273193|NCT02120352|Rilpivirine|rilpivirine|mesh-list
20352953|NCT00886132|Growth Substances|growth substances|mesh-ancestor
20352954|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352955|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
20352956|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20352957|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273194|NCT02120352|Cabotegravir|cabotegravir|mesh-list
19273195|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19273196|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19836721|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19836722|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836723|NCT00611026|Fesoterodine|fesoterodine|mesh-list
19836724|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19836725|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19836726|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19836727|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
19836728|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836729|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836730|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179106|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19273197|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273198|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273199|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
19273200|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19273201|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19273202|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19273203|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19273204|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19669825|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19669826|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669827|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669828|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19669829|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
19669830|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19669831|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669832|NCT04560868|Nicotine|nicotine|mesh-list
19669833|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19669834|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
19669835|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669836|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669837|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20179107|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179108|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
20179109|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179110|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179111|NCT00182104|Warfarin|warfarin|mesh-list
20179112|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
20179113|NCT00182143|Heparin|heparin|mesh-list
20179114|NCT00182143|Calcium heparin|calcium heparin|mesh-list
20179115|NCT00182143|Dalteparin|dalteparin|mesh-list
20179116|NCT00182143|Tinzaparin|tinzaparin|mesh-list
20179117|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20612445|NCT02251431|Exenatide|exenatide|mesh-list
19669838|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19669839|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
19669840|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669841|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669842|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
20352958|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352959|NCT00886275|Midazolam|midazolam|mesh-list
20352960|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
20352961|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20352962|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352963|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352964|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19836731|NCT00611026|Urological Agents|urological agents|mesh-ancestor
20352965|NCT00886275|Analgesics|analgesics|mesh-ancestor
20352966|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
20352967|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20352968|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20352969|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20352970|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20352971|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669843|NCT04557215|Rifaximin|rifaximin|mesh-list
19669844|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19669845|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
19669846|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669847|NCT04557215|Expectorants|expectorants|mesh-ancestor
19669848|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
19669849|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19669850|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
19669851|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669852|NCT04557215|Protective Agents|protective agents|mesh-ancestor
19669853|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669854|NCT04557215|Antidotes|antidotes|mesh-ancestor
19669855|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19669856|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692045|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692046|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19692047|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19692048|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19692049|NCT04997525|Estradiol|estradiol|mesh-list
19273232|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
19273233|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19273234|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
19273235|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
19273236|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
19692050|NCT04997525|Progesterone|progesterone|mesh-list
19692051|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19692052|NCT04997525|Estrogens|estrogens|mesh-ancestor
19692053|NCT04997525|Hormones|hormones|mesh-ancestor
19692054|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692055|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692056|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19692057|NCT04997525|Progestins|progestins|mesh-ancestor
19692058|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19692059|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
19692060|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
19692061|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692062|NCT04996979|Ropivacaine|ropivacaine|mesh-list
19692063|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
20352972|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352973|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20352974|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20352975|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20352976|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352977|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352978|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20352979|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
20352980|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
20352981|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
20352982|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
20352983|NCT00886314|Midazolam|midazolam|mesh-list
20352984|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20352985|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19692064|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
19692065|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692066|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352986|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20352987|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20352988|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20352989|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20352990|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20352991|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20352992|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
20352993|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
20352994|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
20352995|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
20352996|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20352997|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669857|NCT04526197|Celecoxib|celecoxib|mesh-list
19669858|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19669859|NCT04526197|Choline|choline|mesh-list
19669860|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19669861|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669862|NCT04526197|Analgesics|analgesics|mesh-ancestor
20352998|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
20352999|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
20353000|NCT00886457|Interferons|interferons|mesh-list
19669863|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
19669864|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836732|NCT00611130|Vigabatrin|vigabatrin|mesh-list
19836733|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
19669865|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669866|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669867|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669868|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19669869|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19669870|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669871|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669872|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
19669873|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19669874|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
19669875|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669876|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19669877|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
20179118|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
20179119|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20179120|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20179121|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669878|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
19669879|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
19669880|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19669881|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19669882|NCT04526197|Growth Substances|growth substances|mesh-ancestor
19669883|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
19669884|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669885|NCT04511013|Nivolumab|nivolumab|mesh-list
19669886|NCT04511013|Ipilimumab|ipilimumab|mesh-list
19669887|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669888|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669889|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19669890|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669891|NCT04468230|Nicotine|nicotine|mesh-list
19669892|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19669893|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
19669894|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669895|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669896|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20179122|NCT00182169|Hormones|hormones|mesh-list
20179123|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179124|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179125|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
20179126|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20179127|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19669897|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19669898|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
19669899|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179128|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179129|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
20353001|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
19669900|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353002|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
19669901|NCT04438382|Prednisone|prednisone|mesh-list
19669902|NCT04438382|Cortisone|cortisone|mesh-list
19836734|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19669903|NCT04438382|Infliximab|infliximab|mesh-list
19669904|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
20179130|NCT00182221|Coagulants|coagulants|mesh-ancestor
20179131|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20179132|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353003|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19669905|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19669906|NCT04438382|Antibodies|antibodies|mesh-list
19669907|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
19669908|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19669909|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
19669910|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19669911|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
19669912|NCT04438382|Hormones|hormones|mesh-ancestor
19669913|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179133|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179134|NCT00182312|Caffeine|caffeine|mesh-list
20179135|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
19669914|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669915|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19669916|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179136|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179137|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19669917|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
19669918|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
19669919|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19669920|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669921|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
20179138|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179139|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20179140|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179141|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20179142|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20179143|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
19669922|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19669923|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669924|NCT04424225|Niacin|niacin|mesh-list
19669925|NCT04424225|Psilocybin|psilocybin|mesh-list
19669926|NCT04424225|Vitamins|vitamins|mesh-ancestor
19669927|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
19669928|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669929|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
19669930|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19669931|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
19669932|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669933|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20179144|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179145|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
20179146|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20179147|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20179148|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179149|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
20179150|NCT00182351|Coagulants|coagulants|mesh-ancestor
20179151|NCT00182364|Heparin|heparin|mesh-list
20179152|NCT00182364|Calcium heparin|calcium heparin|mesh-list
20179153|NCT00182364|Dalteparin|dalteparin|mesh-list
19669934|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
19669935|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
19669936|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19669937|NCT04418895|Leucovorin|leucovorin|mesh-list
19669938|NCT04418895|Fluorouracil|fluorouracil|mesh-list
20179154|NCT00182364|Tinzaparin|tinzaparin|mesh-list
20179155|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20179156|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
20179157|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20179158|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20179159|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179160|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20179161|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
20179162|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
20179163|NCT00182429|Metronidazole|metronidazole|mesh-list
20179164|NCT00182429|Rifampin|rifampin|mesh-list
20179165|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19669939|NCT04418895|Capecitabine|capecitabine|mesh-list
19669940|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
19669941|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
19669942|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179166|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20179167|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19669943|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
19669944|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669945|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19669946|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669947|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836735|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836736|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
19836737|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353004|NCT00886457|Decitabine|decitabine|mesh-list
20353005|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353006|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
20353007|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353008|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
19836738|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836739|NCT00611247|Temozolomide|temozolomide|mesh-list
19836740|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19836741|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
19836742|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836743|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669948|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
19669949|NCT04418895|Antidotes|antidotes|mesh-ancestor
19669950|NCT04418895|Protective Agents|protective agents|mesh-ancestor
19669951|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
19669952|NCT04418895|Vitamins|vitamins|mesh-ancestor
20179168|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20179169|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20179170|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
20179171|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
20179172|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20179173|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179174|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179175|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20179176|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20179177|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20179178|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19836744|NCT00611325|Bevacizumab|bevacizumab|mesh-list
19836745|NCT00611325|Bortezomib|bortezomib|mesh-list
19836746|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19836747|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179179|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20179180|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20179181|NCT00182442|Olanzapine|olanzapine|mesh-list
20179182|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20179183|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
20179184|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
20179185|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179186|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179187|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179188|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20179189|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20179190|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179191|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179192|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20179193|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179194|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179195|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179196|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179197|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
20179198|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
20179199|NCT00182455|Topiramate|topiramate|mesh-list
20179200|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
20179201|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179202|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179203|NCT00182494|Metformin|metformin|mesh-list
20179204|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20217203|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
20353009|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353010|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19669953|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
19669954|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19669955|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19669956|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19669957|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
19836748|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20353011|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
20353012|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353013|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353014|NCT00886496|Lectins|lectins|mesh-list
20353015|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
20353016|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
20353017|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353018|NCT00886496|Coagulants|coagulants|mesh-ancestor
20353019|NCT00886509|Lenograstim|lenograstim|mesh-list
20353020|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19836749|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19836750|NCT00611325|Growth Substances|growth substances|mesh-ancestor
19836751|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836752|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
19836753|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
19836754|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
19836755|NCT00611351|Busulfan|busulfan|mesh-list
19836756|NCT00611351|Tacrolimus|tacrolimus|mesh-list
19836757|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19836758|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836759|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
19836760|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836761|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836762|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19836763|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
19836764|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836765|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836766|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19836767|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19836768|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836769|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19669958|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669959|NCT04396535|Docetaxel|docetaxel|mesh-list
19669960|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836770|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20353021|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
20353022|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353023|NCT00886574|Aspirin|aspirin|mesh-list
20353024|NCT00886574|Cilostazol|cilostazol|mesh-list
20353025|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20353026|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20353027|NCT00886574|Analgesics|analgesics|mesh-ancestor
20353028|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
20353029|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836771|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
19836772|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19836773|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836774|NCT00611403|Cyclosporine|cyclosporine|mesh-list
19836775|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
19836776|NCT00611403|Cyclosporins|cyclosporins|mesh-list
19836777|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836778|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836779|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836780|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
19669961|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
19669962|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
19669963|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
19669964|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836781|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836782|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
19836783|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836784|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
19836785|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836786|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19836787|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19836788|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20353030|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669965|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19669966|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
19692067|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
19692068|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692069|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
19836789|NCT00611442|Lubiprostone|lubiprostone|mesh-list
20353031|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692070|NCT04997291|Razoxane|razoxane|mesh-list
20353032|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19669967|NCT04378426|Midazolam|midazolam|mesh-list
19669968|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
19669969|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19669970|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19669971|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19669972|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353033|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20353034|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20353035|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353036|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20353037|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20353038|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353039|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
20353040|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20353041|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
20353042|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20353043|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
20353044|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
20353045|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19669973|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19669974|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19669975|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19669976|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19669977|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
19669978|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
19669979|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
19669980|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
19669981|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353046|NCT00886574|Protective Agents|protective agents|mesh-ancestor
20353047|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20353048|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20353049|NCT00886678|Carboplatin|carboplatin|mesh-list
20353050|NCT00886678|Pemetrexed|pemetrexed|mesh-list
20353051|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19669982|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669983|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19669984|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19669985|NCT04378426|Analgesics|analgesics|mesh-ancestor
19273315|NCT01886872|Rituximab|rituximab|mesh-list
19273316|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19273317|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19273318|NCT01886872|Antibodies|antibodies|mesh-list
19273319|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
20353052|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353053|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353054|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19273320|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19273321|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
19273322|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273323|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273324|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19273325|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19273326|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
19669986|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
19669987|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669988|NCT04376281|Norepinephrine|norepinephrine|mesh-list
19669989|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20179205|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669990|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20179206|NCT00182507|Olanzapine|olanzapine|mesh-list
20179207|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
20179208|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
20179209|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179210|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179211|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179212|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20179213|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20179214|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179215|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179216|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20217204|NCT00308880|Coagulants|coagulants|mesh-ancestor
20353055|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20353056|NCT00886717|Paclitaxel|paclitaxel|mesh-list
19273327|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669991|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
19669992|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19669993|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19669994|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19669995|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
19669996|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
19669997|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19669998|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19669999|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
19670000|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19670001|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
20179217|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179218|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179219|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179220|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670002|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670003|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
19670004|NCT04332445|Protective Agents|protective agents|mesh-ancestor
19670005|NCT04316910|Anesthetics|anesthetics|mesh-list
19670006|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
19670007|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670008|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670009|NCT04315272|Azithromycin|azithromycin|mesh-list
19670010|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19670011|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670012|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
19670013|NCT04314050|Tramadol|tramadol|mesh-list
19670014|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19670015|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670016|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670017|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19836790|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19670018|NCT04314050|Analgesics|analgesics|mesh-ancestor
19670019|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
19670020|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670021|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19670022|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19670023|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19670024|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670025|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670026|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670027|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19670028|NCT04314050|Narcotics|narcotics|mesh-ancestor
19670029|NCT04299490|Analgesics|analgesics|mesh-list
19670030|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670031|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
19670032|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670033|NCT04299373|Ethanol|ethanol|mesh-list
19670034|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19670035|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670036|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670037|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670038|NCT04282109|Paclitaxel|paclitaxel|mesh-list
19670039|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19670040|NCT04282109|Nivolumab|nivolumab|mesh-list
19670041|NCT04282109|Cetuximab|cetuximab|mesh-list
19670042|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670043|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670044|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670045|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670046|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670047|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836791|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836792|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670048|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670049|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19670050|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
19670051|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19670052|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670053|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
19670054|NCT04205968|Leucovorin|leucovorin|mesh-list
19670055|NCT04205968|Folic Acid|folic acid|mesh-list
19670056|NCT04205968|Paclitaxel|paclitaxel|mesh-list
19670057|NCT04205968|Camptothecin|camptothecin|mesh-list
19670058|NCT04205968|Fluorouracil|fluorouracil|mesh-list
19670059|NCT04205968|Irinotecan|irinotecan|mesh-list
19670060|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19670061|NCT04205968|Ramucirumab|ramucirumab|mesh-list
19670062|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19670063|NCT04205968|Antibodies|antibodies|mesh-list
19670064|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
19670065|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19670066|NCT04205968|Calcium|calcium|mesh-list
19670067|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
19670068|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670069|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670070|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670071|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670072|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670073|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670074|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
19670075|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670076|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19670077|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19670078|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
19670079|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670080|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670081|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19670082|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19670083|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670084|NCT04205968|Antidotes|antidotes|mesh-ancestor
19670085|NCT04205968|Protective Agents|protective agents|mesh-ancestor
19670086|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
19670087|NCT04205968|Vitamins|vitamins|mesh-ancestor
19670088|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
19670089|NCT04205968|Hematinics|hematinics|mesh-ancestor
19670090|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
19670091|NCT04198961|Narcotics|narcotics|mesh-ancestor
19670092|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670093|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670094|NCT04198961|Analgesics|analgesics|mesh-ancestor
19670095|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
19670096|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670097|NCT04198623|Montelukast|montelukast|mesh-list
19670098|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19670099|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
19670100|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19670101|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
19836793|NCT00611455|Ofatumumab|ofatumumab|mesh-list
19836794|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836795|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19836796|NCT00611468|Topotecan|topotecan|mesh-list
19836797|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836798|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19836799|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836800|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836801|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19836802|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19836803|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19836804|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19836805|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19836806|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836807|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836808|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19836809|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670102|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670103|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670104|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19670105|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19836810|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836811|NCT00611559|PENTA|penta|mesh-list
20179221|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
20179222|NCT00182520|Topiramate|topiramate|mesh-list
20179223|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
20179224|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179225|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179226|NCT00182533|Sertraline|sertraline|mesh-list
20179227|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
20179228|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179229|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20179230|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179231|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836812|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
19836813|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19836814|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19836815|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836816|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19836817|NCT00611715|Letrozole|letrozole|mesh-list
19836818|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836819|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19836820|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836821|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179232|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179233|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179234|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
20179235|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179236|NCT00182559|Cyclosporine|cyclosporine|mesh-list
20179237|NCT00182559|Tacrolimus|tacrolimus|mesh-list
20179238|NCT00182559|Cyclosporins|cyclosporins|mesh-list
20179239|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179240|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
19836822|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19836823|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19836824|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19836825|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
19836826|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836827|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836828|NCT00611767|Thiopental|thiopental|mesh-list
20353057|NCT00886717|Carboplatin|carboplatin|mesh-list
20353058|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20353059|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353060|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
20353061|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
20353062|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
19836829|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
19836830|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19836831|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836832|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836833|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19836834|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
19670106|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670107|NCT04189510|Pancrelipase|pancrelipase|mesh-list
19670108|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179241|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179242|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20179243|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670109|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
19670110|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
19670111|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670112|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670113|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670114|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
19670115|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
19670116|NCT04134845|Dantrolene|dantrolene|mesh-list
19670117|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20179244|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179245|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
20179246|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20179247|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
20179248|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20179249|NCT00182572|Naltrexone|naltrexone|mesh-list
20179250|NCT00182572|Buprenorphine|buprenorphine|mesh-list
20179251|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20179252|NCT00182572|Narcotics|narcotics|mesh-ancestor
20217205|NCT00308945|Travoprost|travoprost|mesh-list
19670118|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670119|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19670120|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670121|NCT04071457|Lenalidomide|lenalidomide|mesh-list
19670122|NCT04071457|Daratumumab|daratumumab|mesh-list
19670123|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
19670124|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670125|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19670126|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19670127|NCT04071457|Growth Substances|growth substances|mesh-ancestor
19670128|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
19670129|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836835|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
19836836|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
19836837|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
19836838|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836839|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836840|NCT00611806|Folic Acid|folic acid|mesh-list
19836841|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
19836842|NCT00611806|Hematinics|hematinics|mesh-ancestor
19836843|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
19836844|NCT00611806|Vitamins|vitamins|mesh-ancestor
19836845|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
19836846|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836847|NCT00611858|Fluorouracil|fluorouracil|mesh-list
19836848|NCT00611858|Cetuximab|cetuximab|mesh-list
20353063|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353064|NCT00886860|Misoprostol|misoprostol|mesh-list
20353065|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20353066|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
20353067|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20353068|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353069|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20353070|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353071|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
20353072|NCT00886873|Mifepristone|mifepristone|mesh-list
20353073|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20353074|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
20353075|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20353076|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353077|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20353078|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20353079|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20353080|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
20353081|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20353082|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20353083|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
20353084|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353085|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
20353086|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20353087|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20353088|NCT00886886|Reboxetine|reboxetine|mesh-list
20353089|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
20353090|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20353091|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19670130|NCT04050462|Nivolumab|nivolumab|mesh-list
19670131|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670132|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670133|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20353092|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20353093|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424964|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19670134|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273380|NCT01835145|Temozolomide|temozolomide|mesh-list
19273381|NCT01835145|Dacarbazine|dacarbazine|mesh-list
19273382|NCT01835145|Imidazole|imidazole|mesh-list
19273383|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19273384|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
19273385|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273386|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273387|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273388|NCT01802632|Osimertinib|osimertinib|mesh-list
19670135|NCT04038346|Acetaminophen|acetaminophen|mesh-list
19670136|NCT04038346|Naproxen|naproxen|mesh-list
19670137|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19670138|NCT04038346|Analgesics|analgesics|mesh-ancestor
19670139|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
19670140|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670141|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670142|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
19670143|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19670144|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670145|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19670146|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
19670147|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19670148|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670149|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836849|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
19836850|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836851|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19836852|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836853|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836854|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
19836855|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836856|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19273389|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273390|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19273391|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273392|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670150|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19670151|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692071|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836857|NCT00611884|Insulin|insulin|mesh-list
19836858|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19836859|NCT00611884|Metformin|metformin|mesh-list
19836860|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
19836861|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
19836862|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19692072|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19692073|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19692074|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19692075|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836863|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692076|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692077|NCT04997291|Protective Agents|protective agents|mesh-ancestor
19692078|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692079|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
19836864|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
19836865|NCT00611897|Ketamine|ketamine|mesh-list
19836866|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19836867|NCT00611897|Analgesics|analgesics|mesh-ancestor
19836868|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
19836869|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836870|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836871|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19836872|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19836873|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
19836874|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
19692080|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
19692081|NCT04997304|Albuterol|albuterol|mesh-list
20353094|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353095|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20353096|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353097|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836875|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836876|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19836877|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19836878|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836879|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692082|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19692083|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
19692084|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692085|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692086|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19692087|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19836880|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
19836881|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836882|NCT00611897|Expectorants|expectorants|mesh-ancestor
20353098|NCT00886990|Ritonavir|ritonavir|mesh-list
20353099|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20353100|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20353101|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
20353102|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353103|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692088|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19692089|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19692090|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19692091|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692092|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692093|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836883|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
19836884|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19836885|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
19670152|NCT03943901|Prednisone|prednisone|mesh-list
19670153|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
19670154|NCT03943901|Rituximab|rituximab|mesh-list
20353104|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20353105|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20353106|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
20353107|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353108|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20353109|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20353110|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
20353111|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20353112|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20353113|NCT00887003|Prednisolone|prednisolone|mesh-list
20353114|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
20353115|NCT00887003|Bupivacaine|bupivacaine|mesh-list
20353116|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20353117|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
20353118|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
20353119|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
20353120|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353121|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353122|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
20353123|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353124|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353125|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
20353126|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
20353127|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353128|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
20353129|NCT00887003|Hormones|hormones|mesh-ancestor
20353130|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353131|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20353132|NCT00887003|Protective Agents|protective agents|mesh-ancestor
20353133|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20353134|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353135|NCT00887029|Timolol|timolol|mesh-list
20353136|NCT00887029|Travoprost|travoprost|mesh-list
20353137|NCT00887029|Latanoprost|latanoprost|mesh-list
20353138|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20353139|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20353140|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20353141|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
20353142|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353143|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353144|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353145|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20353146|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20353147|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20353148|NCT00887042|Fludarabine|fludarabine|mesh-list
20353149|NCT00887042|Busulfan|busulfan|mesh-list
20353150|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
20353151|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353152|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353153|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353154|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
20353155|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670155|NCT03943901|Doxorubicin|doxorubicin|mesh-list
20353156|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
20353157|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19670156|NCT03943901|Vincristine|vincristine|mesh-list
19670157|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670158|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
19273416|NCT01668719|Dexamethasone|dexamethasone|mesh-list
19273417|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
19273418|NCT01668719|Lenalidomide|lenalidomide|mesh-list
19273419|NCT01668719|Bortezomib|bortezomib|mesh-list
19273420|NCT01668719|Elotuzumab|elotuzumab|mesh-list
19273421|NCT01668719|Ichthammol|ichthammol|mesh-list
19273422|NCT01668719|BB 1101|bb 1101|mesh-list
19273423|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19273424|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
20353158|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20353159|NCT00887081|Ribavirin|ribavirin|mesh-list
19273425|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
19670159|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670160|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836886|NCT00611897|Protective Agents|protective agents|mesh-ancestor
20353160|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
19273426|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19273427|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273428|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19273429|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
19273430|NCT01668719|Hormones|hormones|mesh-ancestor
19836887|NCT00611897|Antidotes|antidotes|mesh-ancestor
20353161|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
20353162|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20353163|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20353164|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20353165|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
20353166|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353167|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
20353168|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353169|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
20353170|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353171|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353172|NCT00887107|Sorafenib|sorafenib|mesh-list
19836888|NCT00611923|Flutamide|flutamide|mesh-list
19836889|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
19836890|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
19836891|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19836892|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836893|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19836894|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836895|NCT00611975|Bupropion|bupropion|mesh-list
19836896|NCT00611975|Fluoxetine|fluoxetine|mesh-list
19836897|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19273431|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19273432|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19836898|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
19836899|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836900|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19836901|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19836902|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836903|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179253|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179254|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179255|NCT00182572|Analgesics|analgesics|mesh-ancestor
20179256|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
20179257|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179258|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19836904|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
19273433|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273434|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
19273435|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19273436|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19836905|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836906|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179259|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20179260|NCT00182611|Tegafur|tegafur|mesh-list
20179261|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179262|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179263|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
20179264|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179265|NCT00182650|Aldesleukin|aldesleukin|mesh-list
20179266|NCT00182650|Rituximab|rituximab|mesh-list
20179267|NCT00182650|Fludarabine|fludarabine|mesh-list
20179268|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
20179269|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20179270|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179271|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
20179272|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179273|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20179274|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179275|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
20179276|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179277|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179278|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20179279|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20179280|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
20353173|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353174|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19836907|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19836908|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19836909|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836910|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20353175|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353176|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353177|NCT00887120|Ritonavir|ritonavir|mesh-list
20353178|NCT00887120|Lopinavir|lopinavir|mesh-list
20353179|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20353180|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20353181|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
19836911|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
19836912|NCT00612040|Insulin|insulin|mesh-list
19836913|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19836914|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
19836915|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
19836916|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
19836917|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19836918|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836919|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
19836920|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19836921|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836922|NCT00612105|Ezogabine|ezogabine|mesh-list
19836923|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
19836924|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836925|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836926|NCT00612222|Aldesleukin|aldesleukin|mesh-list
19836927|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
19836928|NCT00612222|Fludarabine|fludarabine|mesh-list
19836929|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
19836930|NCT00612222|Interleukin-2|interleukin-2|mesh-list
19836931|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19836932|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
19836933|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836934|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19836935|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19836936|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
19836937|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836938|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836939|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19836940|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19836941|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
19836942|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20353182|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353183|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353184|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20353185|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19836943|NCT00612222|Analgesics|analgesics|mesh-ancestor
19836944|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
19836945|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19836946|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19836947|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19836948|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
19836949|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19836950|NCT00612235|Lamotrigine|lamotrigine|mesh-list
19836951|NCT00612235|Carbamazepine|carbamazepine|mesh-list
19836952|NCT00612235|Levetiracetam|levetiracetam|mesh-list
19836953|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
19836954|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
19836955|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19836956|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836957|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836958|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19836959|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836960|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19836961|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19836962|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19836963|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836964|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19836965|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
20353186|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
19273437|NCT01668719|Growth Substances|growth substances|mesh-ancestor
19836966|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19836967|NCT00612235|Analgesics|analgesics|mesh-ancestor
19836968|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
19836969|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353187|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20179281|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19273438|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
19273439|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
19273440|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273441|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273442|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19670161|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19670162|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
19670163|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670164|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670165|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19670166|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670167|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19670168|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19670169|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19670170|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670171|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670172|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
19670173|NCT03943901|Hormones|hormones|mesh-ancestor
19670174|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670175|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19670176|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670177|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670178|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
20179282|NCT00182663|Thalidomide|thalidomide|mesh-list
20179283|NCT00182663|Clarithromycin|clarithromycin|mesh-list
20179284|NCT00182663|Dexamethasone|dexamethasone|mesh-list
20179285|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20179286|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
20179287|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
20179288|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179289|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179290|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179291|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
20179292|NCT00182663|Hormones|hormones|mesh-ancestor
20179293|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670179|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670180|NCT03932136|Sulforaphane|sulforaphane|mesh-list
19670181|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19670182|NCT03932136|Protective Agents|protective agents|mesh-ancestor
19670183|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670184|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670185|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19670186|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670187|NCT03891849|Octreotide|octreotide|mesh-list
19670188|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670189|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19670190|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670191|NCT03890133|Pregabalin|pregabalin|mesh-list
19670192|NCT03890133|Analgesics|analgesics|mesh-ancestor
19670193|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
20179294|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20179295|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179296|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179297|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
20179298|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
20179299|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20179300|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20179301|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20179302|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19670194|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670195|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670196|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
19692094|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
20179303|NCT00182663|Growth Substances|growth substances|mesh-ancestor
20179304|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
20179305|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20179306|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179307|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179308|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20179309|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20179310|NCT00182702|Epothilones|epothilones|mesh-list
20179311|NCT00182702|Epothilone B|epothilone b|mesh-list
20179312|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
19836970|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19836971|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19670197|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20353188|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20353189|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20353190|NCT00887211|Sirolimus|sirolimus|mesh-list
20353191|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353192|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353193|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20353194|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353195|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
20353196|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353197|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
20353198|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353199|NCT00887263|Budesonide|budesonide|mesh-list
20353200|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353201|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20353202|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
20353203|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353204|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353205|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20353206|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
20353207|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
20353208|NCT00887263|Hormones|hormones|mesh-ancestor
20353209|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353210|NCT00887276|Amoxicillin|amoxicillin|mesh-list
19670198|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19670199|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273463|NCT01625286|Paclitaxel|paclitaxel|mesh-list
19273464|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19273465|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19273466|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273467|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
20353211|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
20353212|NCT00887276|Ampicillin|ampicillin|mesh-list
20353213|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353214|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353215|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20353216|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20353217|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353218|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353219|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353220|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20353221|NCT00887328|Plasminogen|plasminogen|mesh-list
20353222|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20353223|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20353224|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353225|NCT00887367|Ethanol|ethanol|mesh-list
20353226|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20353227|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353228|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353229|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353230|NCT00887380|Anastrozole|anastrozole|mesh-list
20353231|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19273468|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
19273469|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
19273470|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670200|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19670201|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19670202|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19670203|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670204|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19670205|NCT03875638|Levetiracetam|levetiracetam|mesh-list
20353232|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353233|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20353234|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20353235|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353236|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353237|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19670206|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
19670207|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
19670208|NCT03874234|GSK3186899|gsk3186899|mesh-list
19836972|NCT00612313|Fluoxetine|fluoxetine|mesh-list
20353238|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
19670209|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19670210|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670211|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670212|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19670213|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19670214|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670215|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670216|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670217|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273490|NCT01515748|Docetaxel|docetaxel|mesh-list
19273491|NCT01515748|Fluorouracil|fluorouracil|mesh-list
19273492|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
19273493|NCT01515748|Tegafur|tegafur|mesh-list
19273494|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353239|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353240|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424965|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424966|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20424967|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19670218|NCT03727139|Rasagiline|rasagiline|mesh-list
19670219|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19670220|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670221|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424968|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20424969|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20424970|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20424971|NCT01272089|Analgesics|analgesics|mesh-ancestor
19273495|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
19273496|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
19273497|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
19273498|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273499|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
19273500|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19273501|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19273502|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
19273503|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273504|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
20179313|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
20179314|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
20179315|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273505|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
19273506|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273507|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19273508|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273509|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670222|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19670223|NCT03727139|Protective Agents|protective agents|mesh-ancestor
19670224|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836973|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20179316|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179317|NCT00182715|Leucovorin|leucovorin|mesh-list
20179318|NCT00182715|Fluorouracil|fluorouracil|mesh-list
20179319|NCT00182715|Capecitabine|capecitabine|mesh-list
20179320|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
20179321|NCT00182715|Cetuximab|cetuximab|mesh-list
20179322|NCT00182715|Calcium|calcium|mesh-list
20179323|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
20179324|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20179325|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179326|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
20179327|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179328|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179329|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424972|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
20424973|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19273510|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
19273511|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670225|NCT03723772|Insulin|insulin|mesh-list
19670226|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19670227|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19670228|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670229|NCT03713580|Venetoclax|venetoclax|mesh-list
19670230|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670231|NCT03678025|Prednisone|prednisone|mesh-list
19670232|NCT03678025|Cortisone|cortisone|mesh-list
20353241|NCT00887601|Donepezil|donepezil|mesh-list
20353242|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20353243|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353244|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353245|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
20353246|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353247|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353248|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
20353249|NCT00887627|Conivaptan|conivaptan|mesh-list
20353250|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20353251|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353252|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
20353253|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353254|NCT00887757|Gemcitabine|gemcitabine|mesh-list
20353255|NCT00887757|Navitoclax|navitoclax|mesh-list
20353256|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20353257|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
20353258|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353259|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273512|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19273513|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670233|NCT03678025|Docetaxel|docetaxel|mesh-list
19670234|NCT03678025|Leuprolide|leuprolide|mesh-list
19670235|NCT03678025|Goserelin|goserelin|mesh-list
19670236|NCT03678025|Bicalutamide|bicalutamide|mesh-list
20179330|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179331|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
20179332|NCT00182715|Antidotes|antidotes|mesh-ancestor
20179333|NCT00182715|Protective Agents|protective agents|mesh-ancestor
20179334|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
20179335|NCT00182715|Vitamins|vitamins|mesh-ancestor
19670237|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19670238|NCT03678025|Flutamide|flutamide|mesh-list
19836974|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19836975|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19836976|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836977|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19836978|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
19836979|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19836980|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19836981|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
19836982|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19836983|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19836984|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19836985|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19836986|NCT00612339|Bevacizumab|bevacizumab|mesh-list
19836987|NCT00612339|Temozolomide|temozolomide|mesh-list
19836988|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19836989|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19836990|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19836991|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19836992|NCT00612339|Growth Substances|growth substances|mesh-ancestor
19836993|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179336|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
20179337|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20179338|NCT00182741|Calcitriol|calcitriol|mesh-list
20179339|NCT00182741|Prednisone|prednisone|mesh-list
20179340|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
20179341|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20179342|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
20179343|NCT00182741|Hormones|hormones|mesh-ancestor
20179344|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179345|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179346|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20179347|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179348|NCT00182741|Analgesics|analgesics|mesh-ancestor
20179349|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
20353260|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
20353261|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670239|NCT03678025|Nilutamide|nilutamide|mesh-list
19670240|NCT03678025|Tryptophan|tryptophan|mesh-list
19670241|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670242|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670243|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670244|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670245|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836994|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
19836995|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19670246|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670247|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
19670248|NCT03678025|Hormones|hormones|mesh-ancestor
19836996|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
19836997|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19836998|NCT00612352|Ethanol|ethanol|mesh-list
19836999|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19837000|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837001|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837002|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837003|NCT00612430|Bevacizumab|bevacizumab|mesh-list
19837004|NCT00612430|Etoposide|etoposide|mesh-list
19837005|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
19837006|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837007|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837008|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19837009|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19837010|NCT00612430|Growth Substances|growth substances|mesh-ancestor
20179350|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837011|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837012|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837013|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19837014|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19837015|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19837016|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837017|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837018|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19837019|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19837020|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19837021|NCT00612508|Etonogestrel|etonogestrel|mesh-list
19837022|NCT00612508|Desogestrel|desogestrel|mesh-list
19837023|NCT00612508|NuvaRing|nuvaring|mesh-list
19837024|NCT00612508|Estradiol|estradiol|mesh-list
19837025|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19837026|NCT00612508|Estrogens|estrogens|mesh-ancestor
19837027|NCT00612508|Hormones|hormones|mesh-ancestor
19837028|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19837029|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837030|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19837031|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
19837032|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19837033|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19837034|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19837035|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19837036|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19837037|NCT00612508|Progestins|progestins|mesh-ancestor
19837038|NCT00612534|Sufentanil|sufentanil|mesh-list
19837039|NCT00612534|Dsuvia|dsuvia|mesh-list
19837040|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19670249|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179351|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20179352|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179353|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179354|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179355|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20179356|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20179357|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179358|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20179359|NCT00182741|Vitamins|vitamins|mesh-ancestor
20179360|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
20179361|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20179362|NCT00182806|Gemcitabine|gemcitabine|mesh-list
20179363|NCT00182806|Irinotecan|irinotecan|mesh-list
20179364|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179365|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
19670250|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670251|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19670252|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19670253|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
19670254|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19670255|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
19670256|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
19670257|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
19837041|NCT00612534|Narcotics|narcotics|mesh-ancestor
19837042|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837043|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837044|NCT00612534|Analgesics|analgesics|mesh-ancestor
19837045|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
19837046|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837047|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19837048|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19837049|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
19837050|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
19837051|NCT00612560|Anastrozole|anastrozole|mesh-list
19837052|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19837053|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837054|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19837055|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19837056|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837057|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837058|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19837059|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
20353262|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353263|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353264|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
19670258|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19670259|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
19670260|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19670261|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19837060|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19837061|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837062|NCT00612573|Doxycycline|doxycycline|mesh-list
19837063|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19837064|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837065|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
19837066|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19837067|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19837068|NCT00612586|Leucovorin|leucovorin|mesh-list
19837069|NCT00612586|Bevacizumab|bevacizumab|mesh-list
19837070|NCT00612586|Fluorouracil|fluorouracil|mesh-list
19837071|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837072|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837073|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19837074|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19837075|NCT00612586|Growth Substances|growth substances|mesh-ancestor
19837076|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837077|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837078|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
19837079|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837080|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19837081|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837082|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
19837083|NCT00612586|Antidotes|antidotes|mesh-ancestor
19837084|NCT00612586|Protective Agents|protective agents|mesh-ancestor
19837085|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
19837086|NCT00612586|Vitamins|vitamins|mesh-ancestor
19837087|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
19837088|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
19837089|NCT00612716|Busulfan|busulfan|mesh-list
20179366|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179367|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179368|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
20179369|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20179370|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179371|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179372|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
20179373|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179374|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20179375|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179376|NCT00182819|Temozolomide|temozolomide|mesh-list
20179377|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20179378|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
20217206|NCT00308945|Latanoprost|latanoprost|mesh-list
20353265|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670262|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
19670263|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19670264|NCT03631784|Paclitaxel|paclitaxel|mesh-list
19670265|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19670266|NCT03631784|Carboplatin|carboplatin|mesh-list
19837090|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837091|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
19837092|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837093|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837094|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19837095|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
19837096|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837097|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837098|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19837099|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
19837100|NCT00612807|Bupropion|bupropion|mesh-list
19837101|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19837102|NCT00612807|Sertraline|sertraline|mesh-list
19837103|NCT00612807|Nortriptyline|nortriptyline|mesh-list
19837104|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19837105|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
19837106|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837107|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19837108|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19837109|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837110|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837111|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
19837112|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837113|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670267|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
19670268|NCT03631784|Pemetrexed|pemetrexed|mesh-list
19670269|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670270|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670271|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670272|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670273|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670274|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670275|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670276|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670277|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19670278|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19670279|NCT03625986|Nicotine|nicotine|mesh-list
19670280|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19670281|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
19670282|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670283|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670284|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19670285|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19670286|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
19670287|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670288|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670289|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
19670290|NCT03610490|Fludarabine|fludarabine|mesh-list
19670291|NCT03610490|Interleukin-2|interleukin-2|mesh-list
19670292|NCT03610490|Mitogens|mitogens|mesh-list
19670293|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670294|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
19273555|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19273556|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
19273557|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273558|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19273559|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
19273560|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19273561|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353266|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
20353267|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
20353268|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353269|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353270|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20353271|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20353272|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273562|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19273563|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19273564|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19273565|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670295|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670296|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848170|NCT00691210|Etoposide|etoposide|mesh-list
19670297|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19670298|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
19670299|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670300|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670301|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19670302|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19670303|NCT03610490|Analgesics|analgesics|mesh-ancestor
19670304|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
19670305|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670306|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670307|NCT03567642|Etoposide|etoposide|mesh-list
20353273|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353274|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353275|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20353276|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20353277|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20353278|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
20353279|NCT00888043|Bevacizumab|bevacizumab|mesh-list
20353280|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20353281|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353282|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20612446|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19670308|NCT03567642|Osimertinib|osimertinib|mesh-list
19670309|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670310|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670311|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19670312|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19670313|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670314|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670315|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19670316|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
19670317|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670318|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670319|NCT03504410|Cytarabine|cytarabine|mesh-list
19670320|NCT03504410|Fludarabine|fludarabine|mesh-list
19670321|NCT03504410|Etoposide|etoposide|mesh-list
19670322|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
19670323|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670324|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670325|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
19670326|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670327|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670328|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
19670329|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670330|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670331|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19670332|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19670333|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670334|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
19670335|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670336|NCT03504410|Analgesics|analgesics|mesh-ancestor
19670337|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
19670338|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837114|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19837115|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19837116|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670339|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19670340|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19670341|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670342|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
19670343|NCT03418961|Carvedilol|carvedilol|mesh-list
19670344|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19670345|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19670346|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670347|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670348|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670349|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670350|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19670351|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
19670352|NCT03418961|Protective Agents|protective agents|mesh-ancestor
19670353|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19837117|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19670354|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19670355|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19670356|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
19670357|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19670358|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19670359|NCT03416855|Insulin|insulin|mesh-list
19670360|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
19670361|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19670362|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670363|NCT03409718|Cimetidine|cimetidine|mesh-list
19670364|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19670365|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670366|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19670367|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
19670368|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
19670369|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670370|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670371|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670372|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19670373|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19670374|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670375|NCT03404778|Cimetidine|cimetidine|mesh-list
19837118|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
19670376|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19670377|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670378|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19670379|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
19670380|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
19273631|NCT01261247|Panobinostat|panobinostat|mesh-list
19273632|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19273633|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273634|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273635|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670381|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670382|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670383|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670384|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19670385|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19670386|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837119|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19837120|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837121|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19837122|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19837123|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20179379|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179380|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179381|NCT00182845|Donepezil|donepezil|mesh-list
20179382|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19670387|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
19670388|NCT03404180|Propofol|propofol|mesh-list
19670389|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19670390|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670391|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670392|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19670393|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
19670394|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
19670395|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19670396|NCT03404180|Analgesics|analgesics|mesh-ancestor
19670397|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
19670398|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670399|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19670400|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19670401|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19670402|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670403|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670404|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670405|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
19670406|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19670407|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670408|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670409|NCT03347617|Hematinics|hematinics|mesh-ancestor
19670410|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19670411|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19670412|NCT03342417|Nivolumab|nivolumab|mesh-list
19670413|NCT03342417|Ipilimumab|ipilimumab|mesh-list
20179383|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179384|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179385|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
20179386|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837124|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837125|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19837126|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19837127|NCT00613015|Guanfacine|guanfacine|mesh-list
19837128|NCT00613015|Modafinil|modafinil|mesh-list
19670414|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670415|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670416|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19670417|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670418|NCT03293784|Nivolumab|nivolumab|mesh-list
19670419|NCT03293784|Ipilimumab|ipilimumab|mesh-list
19670420|NCT03293784|Infliximab|infliximab|mesh-list
19273669|NCT01169259|Vitamin D|vitamin d|mesh-list
19273670|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
19273671|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
19273672|NCT01169259|Vitamins|vitamins|mesh-list
19273673|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
19273674|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273675|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19273676|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19670421|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
19670422|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670423|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837129|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19837130|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837131|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19837132|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19837133|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19837134|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837135|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19837136|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19837137|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19837138|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19837139|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837140|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837141|NCT00613028|Bevacizumab|bevacizumab|mesh-list
19837142|NCT00613028|Etoposide|etoposide|mesh-list
19837143|NCT00613028|Temozolomide|temozolomide|mesh-list
19837144|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837145|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837146|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19670424|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19670425|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670426|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
19670427|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670428|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19670429|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670430|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
19670431|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670432|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19273689|NCT01117441|Cytarabine|cytarabine|mesh-list
19273690|NCT01117441|Dexamethasone|dexamethasone|mesh-list
19273691|NCT01117441|Prednisone|prednisone|mesh-list
19273692|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
19273693|NCT01117441|Ifosfamide|ifosfamide|mesh-list
19273694|NCT01117441|Doxorubicin|doxorubicin|mesh-list
19273695|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19273696|NCT01117441|Methotrexate|methotrexate|mesh-list
19273697|NCT01117441|Fludarabine|fludarabine|mesh-list
19273698|NCT01117441|Etoposide|etoposide|mesh-list
19273699|NCT01117441|Vincristine|vincristine|mesh-list
19273700|NCT01117441|Daunorubicin|daunorubicin|mesh-list
19273701|NCT01117441|Asparaginase|asparaginase|mesh-list
19273702|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
19273703|NCT01117441|Thioguanine|thioguanine|mesh-list
19273704|NCT01117441|Pegaspargase|pegaspargase|mesh-list
19273705|NCT01117441|Vindesine|vindesine|mesh-list
19273706|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19273707|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
19273708|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837147|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19273709|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19273710|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19273711|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
19670433|NCT03234309|Hematinics|hematinics|mesh-ancestor
19273712|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273713|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19273714|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19273715|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19273716|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
19273717|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
19273718|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19273719|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19273720|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
19273721|NCT01117441|Hormones|hormones|mesh-ancestor
19273722|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19273723|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19273724|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19273725|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19273726|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19273727|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19273728|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19273729|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
19273730|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19273731|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19273732|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
19273733|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
19273734|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19273735|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19273736|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19273737|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
19273738|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19273739|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
19273740|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19273741|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
19273742|NCT01101451|Cisplatin|cisplatin|mesh-list
19273743|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670434|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19670435|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19692095|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19692096|NCT04996550|Metoprolol|metoprolol|mesh-list
19692097|NCT04996550|Carvedilol|carvedilol|mesh-list
19692098|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19692099|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19692100|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
19692101|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
19692102|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692103|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692104|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19692105|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19692106|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19692107|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692108|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692109|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692110|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
19692111|NCT04996550|Protective Agents|protective agents|mesh-ancestor
19692112|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19692113|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19692114|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19692115|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
19692116|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19692117|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19692118|NCT04996485|Ustekinumab|ustekinumab|mesh-list
19692119|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
19692120|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
19692121|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19692122|NCT04996290|Ropivacaine|ropivacaine|mesh-list
19692123|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19692124|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
19837148|NCT00613028|Growth Substances|growth substances|mesh-ancestor
19837149|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837150|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837151|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19837152|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19837153|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19837154|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837155|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837156|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19837157|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
19670436|NCT03222609|Navitoclax|navitoclax|mesh-list
19670437|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670438|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19670439|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19670440|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670441|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19670442|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670443|NCT03096041|Analgesics|analgesics|mesh-list
19670444|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
19670445|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670446|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670447|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
20353283|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20353284|NCT00888043|Growth Substances|growth substances|mesh-ancestor
19670448|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19837158|NCT00613080|Leucovorin|leucovorin|mesh-list
19837159|NCT00613080|Fluorouracil|fluorouracil|mesh-list
19837160|NCT00613080|Capecitabine|capecitabine|mesh-list
19837161|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
20179387|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179388|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
20179389|NCT00182871|Testosterone|testosterone|mesh-list
20179390|NCT00182871|Androgens|androgens|mesh-ancestor
20179391|NCT00182871|Hormones|hormones|mesh-ancestor
20179392|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179393|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670449|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
19670450|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670451|NCT03069300|Expectorants|expectorants|mesh-ancestor
19670452|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
19670453|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19670454|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
19837162|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
19837163|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179394|NCT00182884|Donepezil|donepezil|mesh-list
20179395|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20179396|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179397|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179398|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
19670455|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670456|NCT03069300|Protective Agents|protective agents|mesh-ancestor
19670457|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670458|NCT03069300|Antidotes|antidotes|mesh-ancestor
19670459|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
19670460|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19670461|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273794|NCT00790933|Vedolizumab|vedolizumab|mesh-list
19273795|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670462|NCT03063450|Nivolumab|nivolumab|mesh-list
19670463|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19273798|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
19273799|NCT00602459|Rituximab|rituximab|mesh-list
19273800|NCT00602459|Fludarabine|fludarabine|mesh-list
19273801|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
19273802|NCT00602459|Lenalidomide|lenalidomide|mesh-list
19273803|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19273804|NCT00602459|Antibodies|antibodies|mesh-list
19273805|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
19273806|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19273807|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19273808|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
19273809|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273810|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19273811|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19273812|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
19670464|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670465|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19670466|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670467|NCT02936388|Cisplatin|cisplatin|mesh-list
19670468|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837164|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179399|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217207|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19273813|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273814|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179400|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179401|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
20179402|NCT00183001|Vitamin K|vitamin k|mesh-list
20179403|NCT00183001|Vitamins|vitamins|mesh-ancestor
20179404|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
20179405|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179406|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20179407|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20179408|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179409|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
20179410|NCT00183001|Coagulants|coagulants|mesh-ancestor
19670469|NCT02893241|Cafedrine|cafedrine|mesh-list
19670470|NCT02893241|Theodrenaline|theodrenaline|mesh-list
19670471|NCT02893241|Ephedrine|ephedrine|mesh-list
19670472|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19670473|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670474|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
19670475|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
19670476|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670477|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19670478|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
20179411|NCT00183040|Hormones|hormones|mesh-list
20179412|NCT00183040|Testosterone|testosterone|mesh-list
20179413|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179414|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179415|NCT00183040|Androgens|androgens|mesh-ancestor
20179416|NCT00183222|Naltrexone|naltrexone|mesh-list
20179417|NCT00183222|Ondansetron|ondansetron|mesh-list
20179418|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20179419|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20179420|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179421|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
20179422|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179423|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
19837165|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837166|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837167|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
20353285|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353286|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
20353287|NCT00888082|Goserelin|goserelin|mesh-list
19837168|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837169|NCT00613080|Antidotes|antidotes|mesh-ancestor
19273815|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19273816|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19273817|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
19273818|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19273819|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20179424|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
19273820|NCT00602459|Growth Substances|growth substances|mesh-ancestor
20612447|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612448|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19273821|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837170|NCT00613080|Protective Agents|protective agents|mesh-ancestor
19837171|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
19837172|NCT00613080|Vitamins|vitamins|mesh-ancestor
19837173|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
20179425|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670479|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670480|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670481|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19670482|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
19670483|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
19670484|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19670485|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
19670486|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670487|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19670488|NCT02839265|Protective Agents|protective agents|mesh-ancestor
20179426|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
20179427|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
20179428|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20179429|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
20353288|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20179430|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179431|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179432|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20179433|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20179434|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670489|NCT02807779|Dexamethasone|dexamethasone|mesh-list
19670490|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670491|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
19670492|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
19670493|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670494|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670495|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670496|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
19273839|NCT00127673|Sertraline|sertraline|mesh-list
19273840|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
19273841|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19273842|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19273843|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19273844|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19273845|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19273846|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19273847|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
19273848|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670497|NCT02807779|Hormones|hormones|mesh-ancestor
19670498|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670499|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20179435|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19670500|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670501|NCT02688309|Dexamethasone|dexamethasone|mesh-list
19670502|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670503|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
19670504|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
19670505|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670506|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670507|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670508|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
19670509|NCT02688309|Hormones|hormones|mesh-ancestor
19670510|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670511|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19670512|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670513|NCT02684578|Metformin|metformin|mesh-list
19670514|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837174|NCT00613106|Ibuprofen|ibuprofen|mesh-list
19837175|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19837176|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19837177|NCT00613106|Analgesics|analgesics|mesh-ancestor
19837178|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
19837179|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837180|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837181|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837182|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837183|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19837184|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837185|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670515|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670516|NCT02680561|Fluticasone|fluticasone|mesh-list
19670517|NCT02680561|Xhance|xhance|mesh-list
19670518|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19670519|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19670520|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670521|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19670522|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
19670523|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670524|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670525|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19670526|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
19670527|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
19670528|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19670529|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19670530|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19670531|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19670532|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670533|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837186|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
20179436|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20179437|NCT00183235|Aripiprazole|aripiprazole|mesh-list
20179438|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
20179439|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19670534|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670535|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
20353289|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353290|NCT00888108|Docetaxel|docetaxel|mesh-list
20353291|NCT00888108|Navitoclax|navitoclax|mesh-list
20353292|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353293|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670536|NCT02680561|Hormones|hormones|mesh-ancestor
19670537|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670538|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
19670539|NCT02664935|Docetaxel|docetaxel|mesh-list
19670540|NCT02664935|Durvalumab|durvalumab|mesh-list
19670541|NCT02664935|Palbociclib|palbociclib|mesh-list
19670542|NCT02664935|Osimertinib|osimertinib|mesh-list
19670543|NCT02664935|Crizotinib|crizotinib|mesh-list
19670544|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670545|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670546|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670547|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670548|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670549|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670550|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19670551|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837187|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837188|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19837189|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837190|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837191|NCT00613327|Oxybutynin|oxybutynin|mesh-list
19837192|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
19837193|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
19837194|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837195|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837196|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19670552|NCT02636036|Nivolumab|nivolumab|mesh-list
19670553|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20353294|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
20353295|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
20353296|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353297|NCT00888186|Levodopa|levodopa|mesh-list
20353298|NCT00888186|Carbidopa|carbidopa|mesh-list
20353299|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20353300|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20353301|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
20353302|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353303|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670554|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670555|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19670556|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837197|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19837198|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
19837199|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837200|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837201|NCT00613327|Urological Agents|urological agents|mesh-ancestor
19837202|NCT00613366|Misoprostol|misoprostol|mesh-list
19670557|NCT02592031|Goserelin|goserelin|mesh-list
19670558|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19670559|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670560|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
19670561|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19670562|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19670563|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670564|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
19670565|NCT02568124|Coagulants|coagulants|mesh-ancestor
19670566|NCT02437604|Fluticasone|fluticasone|mesh-list
19670567|NCT02437604|Xhance|xhance|mesh-list
19670568|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19670569|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19670570|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670571|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19670572|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
19670573|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670574|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670575|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19670576|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
19670577|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
20353304|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670578|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19837203|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
20353305|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20353306|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353307|NCT00888303|Dexamethasone|dexamethasone|mesh-list
20353308|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353309|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
20353310|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
19670579|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19670580|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19670581|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19670582|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670583|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670584|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670585|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
19670586|NCT02437604|Hormones|hormones|mesh-ancestor
19670587|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670588|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
19837204|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19837205|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
19837206|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19837207|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837208|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19837209|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837210|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
19837211|NCT00613366|Antacids|antacids|mesh-ancestor
19837212|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837213|NCT00613379|Leronlimab|leronlimab|mesh-list
19837214|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
19837215|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19837216|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19837217|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837218|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19837219|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19837220|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
19837221|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837222|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
19837223|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837224|NCT00613509|Interferons|interferons|mesh-list
19837225|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
19837226|NCT00613509|Vaccines|vaccines|mesh-list
19837227|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837228|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
19837229|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353311|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353312|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353313|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353314|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
20353315|NCT00888303|Hormones|hormones|mesh-ancestor
20353316|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670589|NCT02384577|Budesonide|budesonide|mesh-list
19670590|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
19670591|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353317|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20353318|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353319|NCT00888342|Ethanol|ethanol|mesh-list
20353320|NCT00888342|Zopiclone|zopiclone|mesh-list
20353321|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20353322|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353323|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353324|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353325|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20353326|NCT00888394|Imidacloprid|imidacloprid|mesh-list
20353327|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
20353328|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670592|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19670593|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
19670594|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670595|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670596|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19670597|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
19670598|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
19670599|NCT02384577|Hormones|hormones|mesh-ancestor
19670600|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19837230|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
19837231|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837232|NCT00613574|Bromides|bromides|mesh-list
20353329|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353330|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353331|NCT00888602|Psyllium|psyllium|mesh-list
20353332|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
20353333|NCT00888602|Cathartics|cathartics|mesh-ancestor
20353334|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353335|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
20353336|NCT00888732|Insulin|insulin|mesh-list
20353337|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20353338|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
20353339|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
20353340|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20353341|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20353342|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353343|NCT00888758|Sirolimus|sirolimus|mesh-list
20353344|NCT00888758|Umirolimus|umirolimus|mesh-list
20353345|NCT00888758|Everolimus|everolimus|mesh-list
20353346|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353347|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353348|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
20353349|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353350|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353351|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353352|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353353|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20353354|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
20353355|NCT00888784|Propranolol|propranolol|mesh-list
20353356|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20353357|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20353358|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
20353359|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353360|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353361|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837233|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
19670601|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19670602|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19670603|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20353362|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20353363|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20353364|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
20353365|NCT00888797|Etodolac|etodolac|mesh-list
20353366|NCT00888797|Propranolol|propranolol|mesh-list
20353367|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20353368|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20353369|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670604|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670605|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837234|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19837235|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
19837236|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837237|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837238|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19837239|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
19670606|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670607|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
19837240|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
19837241|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19837242|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
19837243|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837244|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837245|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
19837246|NCT00613626|Etoposide|etoposide|mesh-list
19837247|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837248|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20353370|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670608|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19670609|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
19670610|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670611|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353371|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353372|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353373|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19670612|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19837249|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20353374|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19837250|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19837251|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837252|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837253|NCT00613821|Lidocaine|lidocaine|mesh-list
19837254|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
19837255|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
19837256|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837257|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837258|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
19837259|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837260|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19837261|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19837262|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19837263|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19670613|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
19837264|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837265|NCT00613834|Lidocaine|lidocaine|mesh-list
20179440|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20353375|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
19837266|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
19837267|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
19837268|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837269|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837270|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
19837271|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837272|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19837273|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19837274|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20353376|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20353377|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20353378|NCT00888797|Analgesics|analgesics|mesh-ancestor
19837275|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837276|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837277|NCT00613938|Oxycodone|oxycodone|mesh-list
19837278|NCT00613938|Tapentadol|tapentadol|mesh-list
19837279|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19837280|NCT00613938|Narcotics|narcotics|mesh-ancestor
19837281|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837282|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837283|NCT00613938|Analgesics|analgesics|mesh-ancestor
19837284|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
19837285|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837286|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19837287|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19837288|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19670614|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
19670615|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19670616|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
19670617|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670618|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670619|NCT02150967|Infigratinib|infigratinib|mesh-list
19670620|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837289|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837290|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837291|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179441|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20179442|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179443|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179444|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
20179445|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
20179446|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179447|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179448|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20179449|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20179450|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
20179451|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20179452|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20612449|NCT02251431|Incretins|incretins|mesh-ancestor
19670621|NCT02092571|Progesterone|progesterone|mesh-list
19670622|NCT02092571|Progestins|progestins|mesh-ancestor
19670623|NCT02092571|Hormones|hormones|mesh-ancestor
19670624|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670625|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670626|NCT02062463|Budesonide|budesonide|mesh-list
19670627|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
19670628|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19670629|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670630|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19670631|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
19670632|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670633|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670634|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19670635|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20353379|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
20353380|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353381|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353382|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20353383|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20353384|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20353385|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353386|NCT00888810|Topotecan|topotecan|mesh-list
20353387|NCT00888810|Lapatinib|lapatinib|mesh-list
20353388|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20353389|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20353390|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353391|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353392|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353393|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20353394|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19670636|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
19670637|NCT02062463|Hormones|hormones|mesh-ancestor
19670638|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670639|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19670640|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19670641|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19837292|NCT00613951|Insulin|insulin|mesh-list
19393558|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393559|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393560|NCT03683810|Lactoferrin|lactoferrin|mesh-list
19393561|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
19393562|NCT03683810|Hematinics|hematinics|mesh-ancestor
19837293|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19837294|NCT00613951|Metformin|metformin|mesh-list
19837295|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
20179453|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20179454|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20179455|NCT00183404|Olanzapine|olanzapine|mesh-list
19837296|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
19837297|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19837298|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
19837299|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837300|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837301|NCT00614055|Insulin|insulin|mesh-list
19837302|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19837303|NCT00614055|Metformin|metformin|mesh-list
19837304|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
19837305|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
19837306|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
19837307|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19837308|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837309|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837310|NCT00614120|Metformin|metformin|mesh-list
19837311|NCT00614120|Liraglutide|liraglutide|mesh-list
19837312|NCT00614120|Glimepiride|glimepiride|mesh-list
19837313|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837314|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837315|NCT00614120|Incretins|incretins|mesh-ancestor
19837316|NCT00614120|Hormones|hormones|mesh-ancestor
19837317|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179456|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
20179457|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
20179458|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179459|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179460|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179461|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19393563|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612450|NCT02251431|Hormones|hormones|mesh-ancestor
19393564|NCT03683667|Azithromycin|azithromycin|mesh-list
19837318|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20179462|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20179463|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19273982|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
19273983|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19273984|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19273985|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
19273986|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19273987|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19273988|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
19273989|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
19273990|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20179464|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179465|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20179466|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179467|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179468|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179469|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179470|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
20353395|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353396|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20353397|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20353398|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19273991|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
19273992|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19273993|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
19273994|NCT04438421|Protective Agents|protective agents|mesh-ancestor
19273995|NCT04438577|Lidocaine|lidocaine|mesh-list
19273996|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
19273997|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
19273998|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19273999|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274000|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
20353399|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20353400|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353401|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353402|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353403|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
19274001|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274002|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19274003|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19274004|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19274005|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19274006|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274007|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
19274008|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19274009|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
19274010|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19274011|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19274012|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
19274013|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19274014|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274015|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
19274016|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
19274017|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19274018|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
19274019|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274020|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
19274021|NCT04438434|Protective Agents|protective agents|mesh-ancestor
19274022|NCT04437836|Rifampin|rifampin|mesh-list
19274023|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19274024|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
19274025|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19274026|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274027|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
19274028|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19274029|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274030|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670642|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
19670643|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670644|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670645|NCT02030457|Beclomethasone|beclomethasone|mesh-list
19274031|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19670646|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353404|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20353405|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20353406|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
20353407|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20353408|NCT00888901|Prednisolone|prednisolone|mesh-list
20353409|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
20353410|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20353411|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
20353412|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353413|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
20353414|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
20353415|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353416|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353417|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353418|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
20353419|NCT00888901|Hormones|hormones|mesh-ancestor
20353420|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353421|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20353422|NCT00888901|Protective Agents|protective agents|mesh-ancestor
19274032|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19274033|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19274034|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19274035|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19274036|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19274037|NCT04437758|Ascorbic Acid|ascorbic acid|mesh-list
19274038|NCT04437758|Vitamins|vitamins|mesh-ancestor
20353423|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20353424|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353425|NCT00889018|Carboplatin|carboplatin|mesh-list
20353426|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353427|NCT00889044|Clopidogrel|clopidogrel|mesh-list
20353428|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20353429|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20353430|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20353431|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20353432|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
20353433|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353434|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353435|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353436|NCT00889057|Sorafenib|sorafenib|mesh-list
20353437|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353438|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20353439|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353440|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353441|NCT00889096|Propranolol|propranolol|mesh-list
20353442|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20353443|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20353444|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
20353445|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353446|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274039|NCT04437758|Micronutrients|micronutrients|mesh-ancestor
19274040|NCT04437758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274041|NCT04437758|Antioxidants|antioxidants|mesh-ancestor
19274042|NCT04437758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274043|NCT04437758|Protective Agents|protective agents|mesh-ancestor
19274044|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
19274045|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
19274046|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274047|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274048|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274049|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274050|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274051|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274052|NCT04437654|Apixaban|apixaban|mesh-list
20353447|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353448|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20353449|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20353450|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
20353451|NCT00889135|Droxidopa|droxidopa|mesh-list
19274053|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19274054|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
19274055|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19274056|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
20353452|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20353453|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20179471|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
20179472|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179473|NCT00183612|Olanzapine|olanzapine|mesh-list
20179474|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
20179475|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
20179476|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274057|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837319|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837320|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
19837321|NCT00614198|Caseins|caseins|mesh-list
19837322|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
19837323|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
19837324|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837325|NCT00614380|Amlodipine|amlodipine|mesh-list
19837326|NCT00614380|Telmisartan|telmisartan|mesh-list
19837327|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19837328|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19837329|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19837330|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837331|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837332|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19837333|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837334|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
19837335|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19837336|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19837337|NCT00614393|Irinotecan|irinotecan|mesh-list
19837338|NCT00614393|Cetuximab|cetuximab|mesh-list
19837339|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19837340|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19837341|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19837342|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837343|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837344|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837345|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837346|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
19837347|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837348|NCT00614406|Celecoxib|celecoxib|mesh-list
19837349|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19837350|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19837351|NCT00614406|Analgesics|analgesics|mesh-ancestor
19837352|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
19837353|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837354|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837355|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837356|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837357|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19837358|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19837359|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837360|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848171|NCT00691210|Vorinostat|vorinostat|mesh-list
19848172|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19848173|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848174|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20179477|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179478|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179479|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20179480|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19274058|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274059|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
19274060|NCT04437004|Fenfluramine|fenfluramine|mesh-list
19274061|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19274062|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19274063|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19274064|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353454|NCT00889148|Gabapentin|gabapentin|mesh-list
20353455|NCT00889148|Analgesics|analgesics|mesh-ancestor
20353456|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
19274065|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274066|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
19274067|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274068|NCT04437225|Glycolic acid|glycolic acid|mesh-list
19274069|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
20353457|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274070|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
19274071|NCT04437017|Dexamethasone|dexamethasone|mesh-list
19837361|NCT00614445|Pyridoxine|pyridoxine|mesh-list
19837362|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
19837363|NCT00614445|Doxylamine|doxylamine|mesh-list
20353458|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353459|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
20353460|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20353461|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20353462|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274072|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
19837364|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
19837365|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
19837366|NCT00614445|Vitamins|vitamins|mesh-ancestor
19837367|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
19837368|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837369|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19837370|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
19837371|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
19837372|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837373|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837374|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
19274073|NCT04437017|Olanzapine|olanzapine|mesh-list
19274074|NCT04437017|Serotonin|serotonin|mesh-list
19274075|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274076|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
19274077|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
19837375|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
19837376|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837377|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837378|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
19837379|NCT00614458|Valproic Acid|valproic acid|mesh-list
19837380|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19837381|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19837382|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
19837383|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837384|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20179481|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179482|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179483|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20179484|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179485|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179486|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179487|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179488|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
20179489|NCT00183742|Docetaxel|docetaxel|mesh-list
20179490|NCT00183742|Doxorubicin|doxorubicin|mesh-list
20179491|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20179492|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179493|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
20179494|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
20179495|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
20179496|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179497|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20179498|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20179499|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179500|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179501|NCT00183807|Celecoxib|celecoxib|mesh-list
20179502|NCT00183807|Irinotecan|irinotecan|mesh-list
20179503|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179504|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20179505|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179506|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179507|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179508|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20179509|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20179510|NCT00183807|Analgesics|analgesics|mesh-ancestor
20179511|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
20179512|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179513|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179514|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20179515|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20179516|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19274078|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837385|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19837386|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353463|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837387|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837388|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
19837389|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
19837390|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837391|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837392|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
19837393|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19837394|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837395|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837396|NCT00614484|Paclitaxel|paclitaxel|mesh-list
19837397|NCT00614484|Carboplatin|carboplatin|mesh-list
20353464|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20353465|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20353466|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353467|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353468|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
20353469|NCT00889161|Curcumin|curcumin|mesh-list
20353470|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20353471|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20353472|NCT00889161|Analgesics|analgesics|mesh-ancestor
20353473|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
20353474|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353475|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353476|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353477|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20353478|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353479|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837398|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19274079|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274080|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19274081|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
19274082|NCT04437017|Hormones|hormones|mesh-ancestor
19274083|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274084|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19837399|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837400|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
19837401|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
19837402|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
19837403|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837404|NCT00614614|Vaccines|vaccines|mesh-list
19837405|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
19837406|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837407|NCT00614822|Bevacizumab|bevacizumab|mesh-list
20353480|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353481|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20353482|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
20353483|NCT00889213|Coagulants|coagulants|mesh-ancestor
20353484|NCT00889343|Leucovorin|leucovorin|mesh-list
20353485|NCT00889343|Fluorouracil|fluorouracil|mesh-list
20353486|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
20353487|NCT00889343|Irinotecan|irinotecan|mesh-list
20353488|NCT00889343|Sorafenib|sorafenib|mesh-list
20353489|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
20353490|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353491|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20353492|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353493|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353494|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
19670647|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
20353495|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353496|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20353497|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19670648|NCT02030457|Hormones|hormones|mesh-ancestor
19670649|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670650|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670651|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19670652|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
19670653|NCT01975298|Interferons|interferons|mesh-list
19670654|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
19670655|NCT01975298|Interferon-beta|interferon-beta|mesh-list
19670656|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670657|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
19670658|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670659|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19670660|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
19837408|NCT00614822|Carboplatin|carboplatin|mesh-list
19837409|NCT00614822|Pemetrexed|pemetrexed|mesh-list
19837410|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837411|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837412|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19837413|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19837414|NCT00614822|Growth Substances|growth substances|mesh-ancestor
19837415|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274085|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274086|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19274087|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19274088|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274089|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19274090|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19670661|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670662|NCT01729091|Lenalidomide|lenalidomide|mesh-list
19670663|NCT01729091|Melphalan|melphalan|mesh-list
19274091|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19274092|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19274093|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274094|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274095|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
19274096|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19274097|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
19274098|NCT04437160|Epirubicin|epirubicin|mesh-list
19274099|NCT04437160|Pirarubicin|pirarubicin|mesh-list
19274100|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179517|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20179518|NCT00183820|Gemcitabine|gemcitabine|mesh-list
20179519|NCT00183820|Paclitaxel|paclitaxel|mesh-list
20179520|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
20179521|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20179522|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179523|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
20179524|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
19274101|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
19274102|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274103|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274104|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19274105|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
19274106|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274107|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274108|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19274109|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19274110|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19274111|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19274112|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274113|NCT04436796|Pancrelipase|pancrelipase|mesh-list
19274114|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837416|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837417|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837418|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837419|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19837420|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19837421|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
19837422|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837423|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837424|NCT00614926|Modafinil|modafinil|mesh-list
19837425|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19837426|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837427|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19670664|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
19670665|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19670666|NCT01729091|Elotuzumab|elotuzumab|mesh-list
19670667|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
19670668|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670669|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19670670|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19670671|NCT01729091|Growth Substances|growth substances|mesh-ancestor
19837428|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19837429|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19837430|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179525|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
20353498|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274115|NCT04436601|Lactulose|lactulose|mesh-list
19274116|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179526|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179527|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19274117|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
19274118|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
19274119|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274120|NCT04436419|Protective Agents|protective agents|mesh-ancestor
19274121|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274122|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
19274123|NCT04436419|Vitamins|vitamins|mesh-ancestor
19274124|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
19274125|NCT04436536|Methamphetamine|methamphetamine|mesh-list
19274126|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19274127|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274128|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
19837431|NCT00614939|Saxagliptin|saxagliptin|mesh-list
19837432|NCT00614939|Incretins|incretins|mesh-ancestor
19837433|NCT00614939|Hormones|hormones|mesh-ancestor
19837434|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19837435|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837436|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19837437|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
19837438|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837439|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837440|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837441|NCT00614991|Ritonavir|ritonavir|mesh-list
19837442|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
19837443|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
19837444|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19837445|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19837446|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
19837447|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837448|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837449|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19837450|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19274129|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
19274130|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274131|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
19274132|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274133|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274134|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
19274135|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19274136|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179528|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
20179529|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
20179530|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20179531|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179532|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179533|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
20353499|NCT00889343|Antidotes|antidotes|mesh-ancestor
19274137|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19274138|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19274139|NCT04436172|Anesthetics|anesthetics|mesh-list
19274140|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274141|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274142|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
19274143|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19274144|NCT04436250|Ketamine|ketamine|mesh-list
19274145|NCT04436250|Esketamine|esketamine|mesh-list
20353500|NCT00889343|Protective Agents|protective agents|mesh-ancestor
20353501|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
20353502|NCT00889343|Vitamins|vitamins|mesh-ancestor
20353503|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
20353504|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20353505|NCT00889356|Clindamycin|clindamycin|mesh-list
20353506|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
20353507|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
19274146|NCT04436250|Analgesics|analgesics|mesh-ancestor
19274147|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
19274148|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274149|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274150|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19837451|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
20179534|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179535|NCT00183833|Capecitabine|capecitabine|mesh-list
20353508|NCT00889356|Amphotericin B|amphotericin b|mesh-list
20353509|NCT00889356|Tetracycline|tetracycline|mesh-list
20353510|NCT00889356|Ketoconazole|ketoconazole|mesh-list
20353511|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19274151|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19274152|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
19274153|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
19274154|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274155|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19274156|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19274157|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353512|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353513|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353514|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20353515|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353516|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274158|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274159|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
19274160|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19393565|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393566|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393567|NCT03683563|Citric Acid|citric acid|mesh-list
19393568|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
19393569|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
19393570|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19393571|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
19393572|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
19393573|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670672|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
19670673|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670674|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19670675|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
20353517|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
20353518|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20353519|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20353520|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20353521|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
20353522|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353523|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353524|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20353525|NCT00889356|Amebicides|amebicides|mesh-ancestor
20353526|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20353527|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20353528|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20353529|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20353530|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20353531|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20353532|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353533|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353534|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353535|NCT00889369|Analgesics|analgesics|mesh-ancestor
20353536|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
20353537|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353538|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
20353539|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20353540|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
20424974|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424975|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424976|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424977|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20424978|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20424979|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20424980|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
20424981|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
20424982|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424983|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424984|NCT01272128|Interferons|interferons|mesh-list
20424985|NCT01272128|Interferon-beta|interferon-beta|mesh-list
20424986|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
19670676|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670677|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19393574|NCT03683433|Azacitidine|azacitidine|mesh-list
19393575|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19393576|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
19274161|NCT04436107|Lenalidomide|lenalidomide|mesh-list
19274162|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
19274163|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
19274164|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274165|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19274166|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19274167|NCT04436107|Growth Substances|growth substances|mesh-ancestor
19274168|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
19274169|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274170|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19274171|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274172|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274173|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
19274174|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274175|NCT04435925|Fentanyl|fentanyl|mesh-list
19274176|NCT04435925|Remifentanil|remifentanil|mesh-list
19274177|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19274178|NCT04435925|Narcotics|narcotics|mesh-ancestor
19274179|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274180|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274181|NCT04435925|Analgesics|analgesics|mesh-ancestor
19274182|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
19274183|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274184|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19274185|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19837452|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837453|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19837454|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19837455|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19837456|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19837457|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19837458|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20353541|NCT00889434|Tocotrienols|tocotrienols|mesh-list
20353542|NCT00889434|Vitamin E|vitamin e|mesh-list
20353543|NCT00889434|Tocopherols|tocopherols|mesh-list
20353544|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
20353545|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353546|NCT00889434|Protective Agents|protective agents|mesh-ancestor
20353547|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353548|NCT00889434|Vitamins|vitamins|mesh-ancestor
20353549|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
20353550|NCT00889499|Tropisetron|tropisetron|mesh-list
19837459|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
19837460|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837461|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837462|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19837463|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
19837464|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19837465|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19837466|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19837467|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837468|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837469|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837470|NCT00615056|Leucovorin|leucovorin|mesh-list
19837471|NCT00615056|Bevacizumab|bevacizumab|mesh-list
19837472|NCT00615056|Fluorouracil|fluorouracil|mesh-list
19837473|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
19837474|NCT00615056|Irinotecan|irinotecan|mesh-list
19837475|NCT00615056|Axitinib|axitinib|mesh-list
19274186|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
19274187|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
19837476|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
20179536|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
20179537|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179538|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
20179539|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179540|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179541|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20179542|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179543|NCT00183846|Irinotecan|irinotecan|mesh-list
20179544|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20179545|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179546|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179547|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179548|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179549|NCT00183859|Irinotecan|irinotecan|mesh-list
20179550|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19837477|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837478|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837479|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19837480|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19837481|NCT00615056|Growth Substances|growth substances|mesh-ancestor
19837482|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837483|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837484|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
19274188|NCT04435743|Lenalidomide|lenalidomide|mesh-list
19274189|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
19274190|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274191|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19274192|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19274193|NCT04435743|Growth Substances|growth substances|mesh-ancestor
19274194|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
19274195|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274196|NCT04435704|Oxytocin|oxytocin|mesh-list
19274197|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
19274198|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274199|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274200|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19274201|NCT04435587|Ritonavir|ritonavir|mesh-list
19274202|NCT04435587|Darunavir|darunavir|mesh-list
19274203|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
19274204|NCT04435587|Ivermectin|ivermectin|mesh-list
19274205|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19274206|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19274207|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
19274208|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274209|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837485|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837486|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19837487|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837488|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
19837489|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20179551|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179552|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179553|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179554|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179555|NCT00183885|Mitomycins|mitomycins|mesh-list
19274210|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19274211|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19274212|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
19274213|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274214|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19670678|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670679|NCT01624480|Modafinil|modafinil|mesh-list
19670680|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20179556|NCT00183885|Mitomycin|mitomycin|mesh-list
19670681|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670682|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19670683|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19670684|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20179557|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179558|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20179559|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
20179560|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179561|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20179562|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179563|NCT00183898|Capecitabine|capecitabine|mesh-list
20179564|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
20179565|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179566|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
19670685|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692125|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692126|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692127|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
19692128|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692129|NCT04996134|Domperidone|domperidone|mesh-list
19692130|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
19692131|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
19837490|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19274215|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19274216|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
19837491|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837492|NCT00615056|Antidotes|antidotes|mesh-ancestor
19670686|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
19670687|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670688|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
19670689|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670690|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19670691|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19670692|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
19670693|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670694|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670695|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19670696|NCT01120249|Everolimus|everolimus|mesh-list
19837493|NCT00615056|Protective Agents|protective agents|mesh-ancestor
19837494|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
19837495|NCT00615056|Vitamins|vitamins|mesh-ancestor
19837496|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
19837497|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19837498|NCT00615199|Tofacitinib|tofacitinib|mesh-list
19837499|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19837500|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837501|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837502|NCT00615290|Tipranavir|tipranavir|mesh-list
19837503|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19837504|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19837505|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
19837506|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837507|NCT00615433|Olanzapine|olanzapine|mesh-list
19837508|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19837509|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
19837510|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
19837511|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837512|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274217|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274218|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274219|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274220|NCT04435652|Paclitaxel|paclitaxel|mesh-list
19274221|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19274222|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19274223|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274224|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
19274225|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
19274226|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
19274227|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274228|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
19274229|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274230|NCT04435522|Maraviroc|maraviroc|mesh-list
19274231|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19670697|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837513|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837514|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19837515|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19837516|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837517|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837518|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19837519|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19837520|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837521|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837522|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837523|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
19837524|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19837525|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19837526|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19837527|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837528|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19837529|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19837530|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19837531|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19837532|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
19837533|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
19837534|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19837535|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
19670698|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19274232|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19670699|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
19837536|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837537|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837538|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19837539|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
19837540|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
19837541|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19837542|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
19837543|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837544|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837545|NCT00615472|Remifentanil|remifentanil|mesh-list
19837546|NCT00615472|Propofol|propofol|mesh-list
19837547|NCT00615472|Isoflurane|isoflurane|mesh-list
19837548|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19837549|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837550|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837551|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19837552|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
19837553|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
19837554|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19837555|NCT00615472|Narcotics|narcotics|mesh-ancestor
19837556|NCT00615472|Analgesics|analgesics|mesh-ancestor
19837557|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
19837558|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837559|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19837560|NCT00615550|Progesterone|progesterone|mesh-list
19837561|NCT00615550|Progestins|progestins|mesh-ancestor
19837562|NCT00615550|Hormones|hormones|mesh-ancestor
19837563|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19837564|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837565|NCT00615589|Fludarabine|fludarabine|mesh-list
19837566|NCT00615589|Busulfan|busulfan|mesh-list
19837567|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837568|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837569|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837570|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
20179567|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179568|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179569|NCT00183911|Leucovorin|leucovorin|mesh-list
20179570|NCT00183911|Fluorouracil|fluorouracil|mesh-list
20179571|NCT00183911|Floxuridine|floxuridine|mesh-list
20179572|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
20179573|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179574|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20353551|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
20353552|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
20353553|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353554|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837571|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837572|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
19837573|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20179575|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274233|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274234|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19274235|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19274236|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
19274237|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274238|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20179576|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179577|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
20179578|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179579|NCT00183911|Antidotes|antidotes|mesh-ancestor
20179580|NCT00183911|Protective Agents|protective agents|mesh-ancestor
20179581|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
20179582|NCT00183911|Vitamins|vitamins|mesh-ancestor
20179583|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
20353555|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353556|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20353557|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20353558|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
20353559|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353560|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353561|NCT00889525|Cabergoline|cabergoline|mesh-list
20353562|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20179584|NCT00183924|Carboplatin|carboplatin|mesh-list
19274239|NCT04435574|Lactoferrin|lactoferrin|mesh-list
19274240|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837574|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20179585|NCT00183924|Docetaxel|docetaxel|mesh-list
20179586|NCT00183924|Estramustine|estramustine|mesh-list
19274241|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
19274242|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274243|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274244|NCT04435418|Apixaban|apixaban|mesh-list
19274245|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19274246|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
20353563|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20353564|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
19274247|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19274248|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612451|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612452|NCT02251457|Ranolazine|ranolazine|mesh-list
19274249|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837575|NCT00615784|Bexarotene|bexarotene|mesh-list
19837576|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837577|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19837578|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
19837579|NCT00615836|Coagulants|coagulants|mesh-ancestor
19837580|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19837581|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
19837582|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837583|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
19837584|NCT00615901|Fluorouracil|fluorouracil|mesh-list
19837585|NCT00615901|Methotrexate|methotrexate|mesh-list
20353565|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
20353566|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353567|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353568|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837586|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837587|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
19837588|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837589|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837590|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19837591|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
19837592|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837593|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837594|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19837595|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
19837596|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19837597|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19837598|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
19837599|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19837600|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
19837601|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837602|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19837603|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19837604|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
19274250|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274251|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
19274252|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
19274253|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19274254|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837605|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
19837606|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837607|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19837608|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837609|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837610|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
19837611|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19837612|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
19837613|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20179587|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179588|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
20179589|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
20179590|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
20179591|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179592|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20179593|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
20179594|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20353569|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
19274255|NCT04435028|Ketotifen|ketotifen|mesh-list
19837614|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
20179595|NCT00183937|Docetaxel|docetaxel|mesh-list
19274256|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
19837615|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837616|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837617|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19837618|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
19837619|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
19837620|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19837621|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
19837622|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837623|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837624|NCT00616018|Acetaminophen|acetaminophen|mesh-list
19837625|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19837626|NCT00616018|Analgesics|analgesics|mesh-ancestor
19670700|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670701|NCT01061515|Bevacizumab|bevacizumab|mesh-list
19670702|NCT01061515|Capecitabine|capecitabine|mesh-list
19837627|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
19837628|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274257|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
19274258|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19274259|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
19274260|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
19274261|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274262|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274263|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274264|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19274265|NCT04435210|Hydralazine|hydralazine|mesh-list
19274266|NCT04435210|Nifedipine|nifedipine|mesh-list
19274267|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19274268|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19274269|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274270|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19274271|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274272|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
19274273|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
19274274|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274275|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19274276|NCT04434482|Temozolomide|temozolomide|mesh-list
19837629|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837630|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
19837631|NCT00616109|Sunitinib|sunitinib|mesh-list
19837632|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837633|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19837634|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19837635|NCT00616109|Growth Substances|growth substances|mesh-ancestor
19837636|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837637|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837638|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19837639|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837640|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837641|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
19837642|NCT00616122|Methotrexate|methotrexate|mesh-list
19837643|NCT00616122|Sunitinib|sunitinib|mesh-list
19837644|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837645|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
19837646|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837647|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837648|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19837649|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
19837650|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837651|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837652|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19837653|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19837654|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
19274277|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19274278|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
19670703|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
19670704|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670705|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670706|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19670707|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19670708|NCT01061515|Growth Substances|growth substances|mesh-ancestor
19670709|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670710|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837655|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274279|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274280|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274281|NCT04434560|Nivolumab|nivolumab|mesh-list
19274282|NCT04434560|Ipilimumab|ipilimumab|mesh-list
19837656|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19837657|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
19837658|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
19837659|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837660|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20353570|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20353571|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353572|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20353573|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20353574|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
20353575|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353576|NCT00889616|Antacids|antacids|mesh-ancestor
20353577|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837661|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19837662|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19837663|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19837664|NCT00616122|Growth Substances|growth substances|mesh-ancestor
19837665|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837666|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19274283|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20353578|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353579|NCT00889629|Vitamin D|vitamin d|mesh-list
20353580|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
20353581|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20353582|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
20353583|NCT00889629|Vitamins|vitamins|mesh-ancestor
20353584|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
20353585|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353586|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20353587|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20353588|NCT00889642|Lidocaine|lidocaine|mesh-list
20353589|NCT00889642|Epinephrine|epinephrine|mesh-list
20353590|NCT00889642|Racepinephrine|racepinephrine|mesh-list
20353591|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
19274284|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274285|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19274286|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274287|NCT04434378|Tamsulosin|tamsulosin|mesh-list
19274288|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19274289|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19274290|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19274291|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
19274292|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274293|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274294|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274295|NCT04434378|Urological Agents|urological agents|mesh-ancestor
19274296|NCT04434404|Silymarin|silymarin|mesh-list
19274297|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
19274298|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274299|NCT04434404|Protective Agents|protective agents|mesh-ancestor
19274300|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274301|NCT04434430|Gabapentin|gabapentin|mesh-list
19274302|NCT04434430|Analgesics|analgesics|mesh-ancestor
19274303|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
19274304|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274305|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274306|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
19274307|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19274308|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19274309|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274310|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19274311|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19837667|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
19837668|NCT00616239|Salicylates|salicylates|mesh-list
19837669|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837670|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
19837671|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
19837672|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
20353592|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
20353593|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
20353594|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353595|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353596|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
20353597|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353598|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20353599|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20353600|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20353601|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20353602|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353603|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20353604|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20353605|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
20353606|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837673|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19837674|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19837675|NCT00616239|Analgesics|analgesics|mesh-ancestor
19837676|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
20353607|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20353608|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20353609|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
20353610|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20353611|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
20353612|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
20353613|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
20353614|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20353615|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20179596|NCT00183937|Bortezomib|bortezomib|mesh-list
20179597|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179598|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
19837677|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837678|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837679|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837680|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837681|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19274312|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19274313|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274314|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274315|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
19274316|NCT04434365|Aspirin|aspirin|mesh-list
19274317|NCT04434365|Clopidogrel|clopidogrel|mesh-list
19274318|NCT04434365|Atorvastatin|atorvastatin|mesh-list
19274319|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19274320|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19274321|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19274322|NCT04434365|Analgesics|analgesics|mesh-ancestor
19274323|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
19274324|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274325|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837682|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837683|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353616|NCT00889655|Laxatives|laxatives|mesh-ancestor
20353617|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353618|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
20353619|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353620|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20353621|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20353622|NCT00889694|Analgesics|analgesics|mesh-ancestor
19837684|NCT00616434|Interferons|interferons|mesh-list
19837685|NCT00616434|Interferon-beta|interferon-beta|mesh-list
20179599|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20179600|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20179601|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179602|NCT00183950|Noscapine|noscapine|mesh-list
20179603|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
20179604|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
20179605|NCT00183976|Rituximab|rituximab|mesh-list
20179606|NCT00183976|Doxorubicin|doxorubicin|mesh-list
20179607|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20179608|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20179609|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179610|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
20179611|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274326|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837686|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
20179612|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20179613|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19837687|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837688|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
19837689|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837690|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
19837691|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837692|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19837693|NCT00616655|Eszopiclone|eszopiclone|mesh-list
19837694|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19837695|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837696|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837697|NCT00616772|Choline|choline|mesh-list
20353623|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
20353624|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353625|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353626|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353627|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20353628|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353629|NCT00889733|Cisplatin|cisplatin|mesh-list
20353630|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353631|NCT00889837|Loxapine|loxapine|mesh-list
20353632|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20353633|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20353634|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837698|NCT00616772|Atorvastatin|atorvastatin|mesh-list
19837699|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
19837700|NCT00616772|Fenofibrate|fenofibrate|mesh-list
20179614|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20179615|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179616|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179617|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179618|NCT00183989|Rituximab|rituximab|mesh-list
19837701|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19837702|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19837703|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
19837704|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837705|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19837706|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19837707|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837708|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
19837709|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837710|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
19837711|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
19837712|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19837713|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837714|NCT00616902|Vitamins|vitamins|mesh-ancestor
19837715|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
19837716|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19837717|NCT00616941|Poly ICLC|poly iclc|mesh-list
19837718|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
19837719|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
19837720|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837721|NCT00617058|Metformin|metformin|mesh-list
19837722|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837723|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837724|NCT00617084|Everolimus|everolimus|mesh-list
19837725|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837726|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837727|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
19837728|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837729|NCT00617097|Ketorolac|ketorolac|mesh-list
19837730|NCT00617097|Lidocaine|lidocaine|mesh-list
19837731|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
19837732|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
19837733|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837734|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837735|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
19837736|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837737|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20179619|NCT00183989|Fludarabine|fludarabine|mesh-list
20179620|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
20353635|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837738|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19837739|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19837740|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179621|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20353636|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837741|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837742|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19837743|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19837744|NCT00617097|Analgesics|analgesics|mesh-ancestor
19837745|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837746|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837747|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19837748|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837749|NCT00617123|Vorapaxar|vorapaxar|mesh-list
19837750|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19837751|NCT00617188|Fulvestrant|fulvestrant|mesh-list
20179622|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179623|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
20179624|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179625|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20179626|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179627|NCT00183989|Analgesics|analgesics|mesh-ancestor
20179628|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
20179629|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179630|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20179631|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179632|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179633|NCT00184015|Bevacizumab|bevacizumab|mesh-list
20179634|NCT00184015|Bortezomib|bortezomib|mesh-list
20179635|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20179636|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179637|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20179638|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20179639|NCT00184015|Growth Substances|growth substances|mesh-ancestor
20179640|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179641|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
20179642|NCT00184041|Cytarabine|cytarabine|mesh-list
19837752|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19837753|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837754|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19837755|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19837756|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
19837757|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19837758|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837759|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19837760|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19837761|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19837762|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837763|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837764|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837765|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837766|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837767|NCT00617240|Metformin|metformin|mesh-list
19837768|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837769|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837770|NCT00617305|Ambrisentan|ambrisentan|mesh-list
19837771|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
20353637|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19837772|NCT00617305|Tadalafil|tadalafil|mesh-list
19837773|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
19837774|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19837775|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19837776|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837777|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837778|NCT00617305|Urological Agents|urological agents|mesh-ancestor
19837779|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19837780|NCT00617344|Vaccines|vaccines|mesh-list
19837781|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
19837782|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179643|NCT00184041|Prednisone|prednisone|mesh-list
20179644|NCT00184041|Methotrexate|methotrexate|mesh-list
20179645|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
20179646|NCT00184041|Vincristine|vincristine|mesh-list
20179647|NCT00184041|Daunorubicin|daunorubicin|mesh-list
20179648|NCT00184041|Asparaginase|asparaginase|mesh-list
20179649|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
20179650|NCT00184041|Thioguanine|thioguanine|mesh-list
20353638|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
20179651|NCT00184041|Pegaspargase|pegaspargase|mesh-list
20179652|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20179653|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
20353639|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353640|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353641|NCT00889850|Esomeprazole|esomeprazole|mesh-list
20353642|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20353643|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353644|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20353645|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353646|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353647|NCT00889876|Metformin|metformin|mesh-list
20353648|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20353649|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353650|NCT00890110|Sunitinib|sunitinib|mesh-list
20353651|NCT00890110|Vaccines|vaccines|mesh-list
20353652|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
20353653|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353654|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353655|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20353656|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20353657|NCT00890110|Growth Substances|growth substances|mesh-ancestor
20353658|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837783|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19837784|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
19837785|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837786|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19837787|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19837788|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837789|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837790|NCT00617409|Paclitaxel|paclitaxel|mesh-list
19837791|NCT00617409|Tretinoin|tretinoin|mesh-list
19837792|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19837793|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837794|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
19837795|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
19837796|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
19837797|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837798|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
19837799|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
19837800|NCT00617461|Gabapentin|gabapentin|mesh-list
19837801|NCT00617461|Analgesics|analgesics|mesh-ancestor
19837802|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
20353659|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20353660|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353661|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353662|NCT00890175|Loxapine|loxapine|mesh-list
20353663|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20353664|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20353665|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353666|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353667|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20353668|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20353669|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
20353670|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353671|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353672|NCT00890188|Thalidomide|thalidomide|mesh-list
20612453|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20612454|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20612455|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612456|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
20612457|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20612458|NCT02251483|Antibodies|antibodies|mesh-list
19837803|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837804|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837805|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
19837806|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19837807|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19837808|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19837809|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837810|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19837811|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19837812|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837813|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837814|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
20612459|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
19837815|NCT00617539|Irinotecan|irinotecan|mesh-list
19837816|NCT00617539|Temozolomide|temozolomide|mesh-list
20612460|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837817|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19837818|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19837819|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837820|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837821|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837822|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19837823|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
19837824|NCT00617591|Dexamethasone|dexamethasone|mesh-list
19837825|NCT00617591|Doxorubicin|doxorubicin|mesh-list
19837826|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19837827|NCT00617591|Lenalidomide|lenalidomide|mesh-list
19837828|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837829|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
20179654|NCT00184041|Hormones|hormones|mesh-ancestor
20179655|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179656|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274327|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274328|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19274329|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19274330|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274331|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19274332|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19274333|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274334|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
19274335|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19274336|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19274337|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
19274338|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19274339|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19274340|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19274341|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19274342|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19274343|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
19274344|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274345|NCT04434248|Ritonavir|ritonavir|mesh-list
19274346|NCT04434248|Lopinavir|lopinavir|mesh-list
19274347|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
19274348|NCT04434248|Chloroquine|chloroquine|mesh-list
19274349|NCT04434248|Favipiravir|favipiravir|mesh-list
19274350|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20612461|NCT02251509|Metoprolol|metoprolol|mesh-list
19274351|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19274352|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
19274353|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274354|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274355|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19274356|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19274357|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
19274358|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274359|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19274360|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19274361|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
19274362|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274363|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20179657|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20179658|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179659|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20179660|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
20179661|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20179662|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179663|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
20179664|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179665|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
20179666|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179667|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20179668|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179669|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
20179670|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20179671|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20179672|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19274364|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274365|NCT04434248|Amebicides|amebicides|mesh-ancestor
19837830|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
19837831|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274366|NCT04434105|Triamcinolone|triamcinolone|mesh-list
19274367|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19274368|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20179673|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
20179674|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20179675|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20179676|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
20179677|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
20179678|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
20179679|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
20179680|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612462|NCT02251509|Carvedilol|carvedilol|mesh-list
20612463|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19274369|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19274370|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274371|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
19274372|NCT04434105|Hormones|hormones|mesh-ancestor
19274373|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274374|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274375|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19274376|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
19274377|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274378|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274379|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
19274380|NCT04434144|Azithromycin|azithromycin|mesh-list
19274381|NCT04434144|Doxycycline|doxycycline|mesh-list
19274382|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
19274383|NCT04434144|Ivermectin|ivermectin|mesh-list
19274384|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19274385|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274386|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
19274387|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274388|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274389|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274390|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274391|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274392|NCT04434170|Valsartan|valsartan|mesh-list
19274393|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19274394|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19274395|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19274396|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19274397|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274398|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19274399|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19274400|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19274401|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
19274402|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274403|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19274404|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19274405|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274406|NCT04433780|Tenofovir|tenofovir|mesh-list
19274407|NCT04433780|Lamivudine|lamivudine|mesh-list
19274408|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
19274409|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274410|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19670711|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670712|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
19670713|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670714|NCT00790010|Bevacizumab|bevacizumab|mesh-list
19670715|NCT00790010|Ipilimumab|ipilimumab|mesh-list
19670716|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670717|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670718|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19670719|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19670720|NCT00790010|Growth Substances|growth substances|mesh-ancestor
19670721|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274411|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19274412|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274413|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274414|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19274415|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19274416|NCT04433611|Lidocaine|lidocaine|mesh-list
20179681|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20179682|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19670722|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
19274417|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
19274418|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
19274419|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274420|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274421|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
19274422|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353673|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353674|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
20353675|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274423|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20179683|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179684|NCT00184106|Paroxetine|paroxetine|mesh-list
20179685|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20179686|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20179687|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179688|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670723|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19670724|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670725|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
19274424|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19274425|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19274426|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19274427|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274428|NCT04433481|Dabigatran|dabigatran|mesh-list
19274429|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
19274430|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19274431|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
19274432|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274433|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274434|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
19274435|NCT04433741|Oxytocin|oxytocin|mesh-list
19274436|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
19274437|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274438|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274439|NCT04433572|Sirolimus|sirolimus|mesh-list
19274440|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19274441|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274442|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19670726|NCT00712881|Docetaxel|docetaxel|mesh-list
19670727|NCT00712881|Doxorubicin|doxorubicin|mesh-list
19670728|NCT00712881|Trastuzumab|trastuzumab|mesh-list
19670729|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670730|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
19670731|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670732|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19670733|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20179689|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353676|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
20353677|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353678|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353679|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20353680|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20353681|NCT00890188|Growth Substances|growth substances|mesh-ancestor
20353682|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
20353683|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353684|NCT00890214|Epoprostenol|epoprostenol|mesh-list
20353685|NCT00890214|Heparin|heparin|mesh-list
20353686|NCT00890214|Calcium heparin|calcium heparin|mesh-list
20179690|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
20179691|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179692|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20179693|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
20179694|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19274443|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274444|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
19670734|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
20179695|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20179696|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20179697|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179698|NCT00184171|Budesonide|budesonide|mesh-list
20179699|NCT00184171|Bismuth|bismuth|mesh-list
20353687|NCT00890214|Tezosentan|tezosentan|mesh-list
20353688|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
20353689|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19670735|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670736|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670737|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19670738|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670739|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670740|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670741|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19670742|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19670743|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19670744|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670745|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670746|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19670747|NCT00659126|Hematinics|hematinics|mesh-ancestor
19274445|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19274446|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
19274447|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274448|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
19274449|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
19274450|NCT04433559|Tadalafil|tadalafil|mesh-list
19274451|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
19274452|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19274453|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19274454|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274455|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274456|NCT04433559|Urological Agents|urological agents|mesh-ancestor
19274457|NCT04433169|Tretinoin|tretinoin|mesh-list
19274458|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274459|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
19274460|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
19274461|NCT04433156|Prednisone|prednisone|mesh-list
19274462|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
19274463|NCT04433156|Rituximab|rituximab|mesh-list
19274464|NCT04433156|Bortezomib|bortezomib|mesh-list
19274465|NCT04433156|Epirubicin|epirubicin|mesh-list
19274466|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19274467|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
19274468|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274469|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274470|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19274471|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
19274472|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274473|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274474|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19274475|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19274476|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274477|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
19274478|NCT04433156|Hormones|hormones|mesh-ancestor
19274479|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274480|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19274481|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19274482|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19274483|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19274484|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274485|NCT04433143|Minocycline|minocycline|mesh-list
19274486|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19274487|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274488|NCT04433078|Doxycycline|doxycycline|mesh-list
19274489|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20179700|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20179701|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19274490|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274491|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
19274492|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274493|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274494|NCT04432714|Prednisone|prednisone|mesh-list
19274495|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
19274496|NCT04432714|Rituximab|rituximab|mesh-list
19274497|NCT04432714|Doxorubicin|doxorubicin|mesh-list
19274498|NCT04432714|Etoposide|etoposide|mesh-list
19274499|NCT04432714|Vincristine|vincristine|mesh-list
19274500|NCT04432714|Lenalidomide|lenalidomide|mesh-list
19274501|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179702|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
19274502|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
19274503|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274504|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274505|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19274506|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
19274507|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274508|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274509|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19274510|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19274511|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19274512|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19274513|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19274514|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274515|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274516|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
19274517|NCT04432714|Hormones|hormones|mesh-ancestor
19274518|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274519|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19274520|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19274521|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
19274522|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
19274523|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
19274524|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19274525|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19274526|NCT04432714|Growth Substances|growth substances|mesh-ancestor
19274527|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
19274528|NCT04432974|Anesthetics|anesthetics|mesh-list
19274529|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274530|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274531|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20179703|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179704|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179705|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20179706|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
20179707|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
20179708|NCT00184171|Hormones|hormones|mesh-ancestor
20179709|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274532|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19274533|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19274534|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274535|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274536|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19274537|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19274538|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19274539|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19274540|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19274541|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274542|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274543|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19274544|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19274545|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
19274546|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19274547|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19274548|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
19274549|NCT04432662|Epoetin Alfa|epoetin alfa|mesh-list
19274550|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
20179710|NCT00184171|Antacids|antacids|mesh-ancestor
20179711|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179712|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179713|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
20179714|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20179715|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179716|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179717|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
20179718|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179719|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179720|NCT00184496|Methadone|methadone|mesh-list
19274551|NCT04432662|Hematinics|hematinics|mesh-ancestor
19274552|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
19274553|NCT04432506|Fludarabine|fludarabine|mesh-list
20179721|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20179722|NCT00184496|Narcotics|narcotics|mesh-ancestor
20179723|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20179724|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179725|NCT00184496|Analgesics|analgesics|mesh-ancestor
20179726|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
20179727|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179728|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
19274554|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20179729|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
20179730|NCT00184522|Esomeprazole|esomeprazole|mesh-list
20179731|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20179732|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179733|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20179734|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353690|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20353691|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353692|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20353693|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20353694|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
20353695|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
20353696|NCT00890253|Prednisone|prednisone|mesh-list
20179735|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179736|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
20179737|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
20179738|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179739|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179740|NCT00184574|Metformin|metformin|mesh-list
20179741|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
19837832|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837833|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837834|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
19837835|NCT00617591|Hormones|hormones|mesh-ancestor
20179742|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
20179743|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179744|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179745|NCT00184587|Candesartan|candesartan|mesh-list
20179746|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
20179747|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
20179748|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20179749|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179750|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20179751|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179752|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20179753|NCT00184613|Insulin|insulin|mesh-list
20179754|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20353697|NCT00890253|Prednisolone|prednisolone|mesh-list
20353698|NCT00890253|Everolimus|everolimus|mesh-list
20353699|NCT00890253|Basiliximab|basiliximab|mesh-list
20353700|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837836|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19837837|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19837838|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179755|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
20179756|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
20179757|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179758|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179759|NCT00184626|Insulin|insulin|mesh-list
20179760|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20179761|NCT00184626|Metformin|metformin|mesh-list
20179762|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
20179763|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
20179764|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
20179765|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179766|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179767|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
20179768|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179769|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179770|NCT00184665|Insulin|insulin|mesh-list
20353701|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
19274555|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19274556|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
19274557|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274558|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274559|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20353702|NCT00890253|Hormones|hormones|mesh-ancestor
20353703|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353704|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353705|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19274560|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
19274561|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274562|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179771|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20179772|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
20179773|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
19274563|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19274564|NCT04432415|Fluorides|fluorides|mesh-list
19274565|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
19274566|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
19274567|NCT04432415|Protective Agents|protective agents|mesh-ancestor
19274568|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274569|NCT04432558|Acetaminophen|acetaminophen|mesh-list
19274570|NCT04432558|Diclofenac|diclofenac|mesh-list
19274571|NCT04432558|Tramadol|tramadol|mesh-list
20353706|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353707|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353708|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
20353709|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20353710|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20353711|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
20353712|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353713|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353714|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353715|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274572|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19274573|NCT04432558|Analgesics|analgesics|mesh-ancestor
19274574|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
19274575|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274576|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274577|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
19274578|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19274579|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274580|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274581|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19274582|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274583|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274584|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19274585|NCT04432558|Narcotics|narcotics|mesh-ancestor
19274586|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274587|NCT04432402|Gemcitabine|gemcitabine|mesh-list
19274588|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
19274589|NCT04432402|Lenalidomide|lenalidomide|mesh-list
20353716|NCT00890279|Imidapril|imidapril|mesh-list
20353717|NCT00890279|Cilnidipine|cilnidipine|mesh-list
20353718|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20353719|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19274590|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274591|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
19274592|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274593|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19274594|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
19274595|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274596|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
19274597|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274598|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274599|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19274600|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19274601|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19274602|NCT04432402|Growth Substances|growth substances|mesh-ancestor
19274603|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
19274604|NCT04432428|Sufentanil|sufentanil|mesh-list
19274605|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19274606|NCT04432428|Narcotics|narcotics|mesh-ancestor
19274607|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274608|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274609|NCT04432428|Analgesics|analgesics|mesh-ancestor
20179774|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
20179775|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
20179776|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
20179777|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179778|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179779|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20179780|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20179781|NCT00184795|Norethindrone|norethindrone|mesh-list
20179782|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
20179783|NCT00184795|Estradiol|estradiol|mesh-list
20179784|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20179785|NCT00184795|Estrogens|estrogens|mesh-ancestor
19274610|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
19274611|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274612|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20179786|NCT00184795|Hormones|hormones|mesh-ancestor
19274613|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19274614|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
19274615|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
19274616|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
19274617|NCT04432324|Antibodies|antibodies|mesh-list
19274618|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
19274619|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19274620|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19274621|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
19274622|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274623|NCT04432220|Apixaban|apixaban|mesh-list
19274624|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19274625|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
19274626|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19274627|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
19274628|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274629|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274630|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
19274631|NCT04432259|Dexamethasone|dexamethasone|mesh-list
19274632|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274633|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
19274634|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
19274635|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274636|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274637|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19274638|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
19274639|NCT04432259|Hormones|hormones|mesh-ancestor
19274640|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274641|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19274642|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274643|NCT04432233|Metronidazole|metronidazole|mesh-list
19274644|NCT04432233|Levofloxacin|levofloxacin|mesh-list
19274645|NCT04432233|Ofloxacin|ofloxacin|mesh-list
19274646|NCT04432233|Esomeprazole|esomeprazole|mesh-list
19274647|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274648|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19274649|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274650|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274651|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19274652|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19274653|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19274654|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274655|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179787|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20179788|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179789|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20179790|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
20179791|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274656|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19274657|NCT04432233|Renal Agents|renal agents|mesh-ancestor
19274658|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19274659|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19274660|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274661|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19274662|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19393577|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393578|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393579|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393580|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19393581|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393582|NCT03683277|Dexamethasone|dexamethasone|mesh-list
19393583|NCT03683277|Pomalidomide|pomalidomide|mesh-list
19393584|NCT03683277|Ixazomib|ixazomib|mesh-list
19393585|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393586|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
19393587|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
19393588|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393589|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393590|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179792|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20179793|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20179794|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20179795|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19393591|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
19393592|NCT03683277|Hormones|hormones|mesh-ancestor
19393593|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274663|NCT04432155|Xenon|xenon|mesh-list
19274664|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19274665|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
19274666|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
19274667|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274668|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274669|NCT04432012|Dexamethasone|dexamethasone|mesh-list
19274670|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
19274671|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19274672|NCT04432012|BB 1101|bb 1101|mesh-list
19274673|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274674|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
19274675|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
19274676|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274677|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274678|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19274679|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
19274680|NCT04432012|Hormones|hormones|mesh-ancestor
19274681|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274682|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19274683|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274684|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
19274685|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274686|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274687|NCT04431895|Tofacitinib|tofacitinib|mesh-list
19274688|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19274689|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274690|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274691|NCT04431713|Exenatide|exenatide|mesh-list
19274692|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19274693|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274694|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19274695|NCT04431713|Incretins|incretins|mesh-ancestor
19274696|NCT04431713|Hormones|hormones|mesh-ancestor
19274697|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274698|NCT04431349|Clopidogrel|clopidogrel|mesh-list
19274699|NCT04431349|Ticagrelor|ticagrelor|mesh-list
19274700|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19274701|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19274702|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19274703|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19274704|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
19274705|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274706|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274707|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274708|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
19274709|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
19274710|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
19274711|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274712|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274713|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
19274714|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274715|NCT04431193|Oxytocin|oxytocin|mesh-list
19274716|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
19274717|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274718|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274719|NCT04431245|Entecavir|entecavir|mesh-list
19274720|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
19274721|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274722|NCT04431206|Oxytocin|oxytocin|mesh-list
19274723|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
19274724|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274725|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274726|NCT04430790|Doxapram|doxapram|mesh-list
20179796|NCT00184821|Glyburide|glyburide|mesh-list
20179797|NCT00184821|Adenosine|adenosine|mesh-list
20179798|NCT00184821|Diazoxide|diazoxide|mesh-list
20179799|NCT00184821|Annexin A5|annexin a5|mesh-list
20179800|NCT00184821|Analgesics|analgesics|mesh-ancestor
20179801|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
20179802|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274727|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19274728|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274729|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
19274730|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
19274731|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20179803|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353720|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353721|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19274732|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19274733|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274734|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
19274735|NCT04430777|Coagulants|coagulants|mesh-ancestor
19274736|NCT04430933|Paclitaxel|paclitaxel|mesh-list
19274737|NCT04430933|Docetaxel|docetaxel|mesh-list
19274738|NCT04430933|Carboplatin|carboplatin|mesh-list
19274739|NCT04430933|Pemetrexed|pemetrexed|mesh-list
19274740|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19274741|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274742|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
19274743|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
19274744|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
19274745|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274746|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274747|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19274748|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19274749|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
19274750|NCT04430998|Polaprezinc|polaprezinc|mesh-list
19274751|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19274752|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274753|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
19274754|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19274755|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19274756|NCT04430621|Hormones|hormones|mesh-list
19274757|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19274758|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274759|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274760|NCT04430556|Sertraline|sertraline|mesh-list
19274761|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
19274762|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19274763|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19274764|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19274765|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20353722|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353723|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20353724|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
20353725|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353726|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20353727|NCT00890318|Ketoconazole|ketoconazole|mesh-list
20353728|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
20353729|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353730|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20353731|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20353732|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353733|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353734|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20353735|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
20353736|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353737|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353738|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20353739|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19274766|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274767|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274768|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
19274769|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274770|NCT04430361|Dexamethasone|dexamethasone|mesh-list
19274771|NCT04430361|Megestrol|megestrol|mesh-list
19274772|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
19274773|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274774|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
19274775|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
19274776|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274777|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274778|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19274779|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
19274780|NCT04430361|Hormones|hormones|mesh-ancestor
19274781|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19274782|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19274783|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274784|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20179804|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20179805|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
20179806|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20179807|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
19274785|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19274786|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19274787|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
19274788|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274789|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19274790|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19274791|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
20353740|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
20353741|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
20353742|NCT00890422|Vaccines|vaccines|mesh-list
20353743|NCT00890422|Immunologic Factors|immunologic factors|mesh-ancestor
20353744|NCT00890422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274792|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19274793|NCT04430166|Antibodies|antibodies|mesh-list
19274794|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19274795|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
19274796|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393594|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19837839|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19837840|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19393595|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393596|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
19393597|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19393598|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19393599|NCT03683277|Growth Substances|growth substances|mesh-ancestor
19393600|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
19393601|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
19393602|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393603|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393604|NCT03683108|Resveratrol|resveratrol|mesh-list
19393605|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
19393606|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393607|NCT03683108|Protective Agents|protective agents|mesh-ancestor
19393608|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393609|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393610|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19393611|NCT03683043|Leuprolide|leuprolide|mesh-list
19393612|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19393613|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
19393614|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393615|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393616|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393617|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393618|NCT03682978|Baclofen|baclofen|mesh-list
19393619|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20353745|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
20353746|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20353747|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
20353748|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353749|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
19393620|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393621|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19393622|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393623|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19393624|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
19393625|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
19393626|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393627|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393628|NCT03682952|Alprostadil|alprostadil|mesh-list
19393629|NCT03682952|Beraprost|beraprost|mesh-list
19837841|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20179808|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
20179809|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179810|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179811|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179812|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179813|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179814|NCT00184847|Adenosine|adenosine|mesh-list
20179815|NCT00184847|Acetylcholine|acetylcholine|mesh-list
20179816|NCT00184847|Caffeine|caffeine|mesh-list
20353750|NCT00890487|Protective Agents|protective agents|mesh-ancestor
20353751|NCT00890500|Sirolimus|sirolimus|mesh-list
20353752|NCT00890500|Fludarabine|fludarabine|mesh-list
19274797|NCT04430062|Anesthetics|anesthetics|mesh-list
19274798|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274799|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274800|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
19274801|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
19274802|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274803|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274804|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274805|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274806|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274807|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274808|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19274809|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
19274810|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274811|NCT04429711|Ivermectin|ivermectin|mesh-list
20353753|NCT00890500|Melphalan|melphalan|mesh-list
20353754|NCT00890500|Tacrolimus|tacrolimus|mesh-list
20353755|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20353756|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274812|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274813|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274814|NCT04429633|Candesartan|candesartan|mesh-list
19274815|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19274816|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19274817|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19274818|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837842|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837843|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837844|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
19837845|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19837846|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19837847|NCT00617591|Growth Substances|growth substances|mesh-ancestor
19837848|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
19837849|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
19274827|NCT04429282|Ibuprofen|ibuprofen|mesh-list
19274828|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19274829|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19274830|NCT04429282|Analgesics|analgesics|mesh-ancestor
20353757|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353758|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353759|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
20353760|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353761|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20353762|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353763|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353764|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353765|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19274831|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
19274832|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274833|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274834|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353766|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
20353767|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20353768|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
20353769|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20353770|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
20353771|NCT00890539|Miotics|miotics|mesh-ancestor
20353772|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
19274835|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274836|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19274837|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274838|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274839|NCT04429295|Vaccines|vaccines|mesh-list
19274840|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
19274841|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274842|NCT04429347|Gabapentin|gabapentin|mesh-list
19274843|NCT04429347|Tizanidine|tizanidine|mesh-list
19274844|NCT04429347|Analgesics|analgesics|mesh-ancestor
19274845|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
19274846|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274847|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274848|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
19274849|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19274850|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19274851|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353773|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353774|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353775|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20353776|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20353777|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
20353778|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19274852|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19274853|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19274854|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19274855|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19274856|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274857|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
20353779|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20353780|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
20353781|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353782|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353783|NCT00890565|Granisetron|granisetron|mesh-list
20353784|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
20353785|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
20353786|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353787|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353788|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353789|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20353790|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
19274858|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19274859|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19274860|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
19274861|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
19274862|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19274863|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19274864|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19274865|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
19274866|NCT04429334|Nangibotide|nangibotide|mesh-list
19274867|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274868|NCT04429191|Antibodies|antibodies|mesh-list
19274869|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20179817|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20179818|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179819|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20179820|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274870|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
19274871|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274872|NCT04429152|Tenofovir|tenofovir|mesh-list
19274873|NCT04429152|Lamivudine|lamivudine|mesh-list
19274874|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
19274875|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274876|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19274877|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19274878|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274879|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353791|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353792|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353793|NCT00890604|Acetaminophen|acetaminophen|mesh-list
19274880|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19274881|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19274882|NCT04429035|Vitamin K|vitamin k|mesh-list
19274883|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
19274884|NCT04429035|Vitamins|vitamins|mesh-ancestor
19274885|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
19274886|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274887|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19274888|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19274889|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274890|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
19274891|NCT04429035|Coagulants|coagulants|mesh-ancestor
20179821|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179822|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20179823|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20179824|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
20179825|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353794|NCT00890604|Ibuprofen|ibuprofen|mesh-list
20353795|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19274892|NCT04428879|Topotecan|topotecan|mesh-list
19274893|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19274894|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19274895|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274896|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274897|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274898|NCT04428814|Ustekinumab|ustekinumab|mesh-list
19274899|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
19274900|NCT04428437|Lenvatinib|lenvatinib|mesh-list
19274901|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274902|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20353796|NCT00890604|Analgesics|analgesics|mesh-ancestor
20353797|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
20353798|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353799|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353800|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
20353801|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20353802|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353803|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274903|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274904|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274905|NCT04428671|Cemiplimab|cemiplimab|mesh-list
19274906|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19274907|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274908|NCT04428684|Goserelin|goserelin|mesh-list
19274909|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19274910|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274911|NCT04428268|Chloroquine|chloroquine|mesh-list
20179826|NCT00184847|Analgesics|analgesics|mesh-ancestor
20179827|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
20179828|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179829|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20179830|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
19274912|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19274913|NCT04428268|Losartan|losartan|mesh-list
19274914|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19274915|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19274916|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19274917|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19274918|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274919|NCT04428268|Amebicides|amebicides|mesh-ancestor
19274920|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19274921|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19274922|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274923|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
19274924|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19274925|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19274926|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19274927|NCT04428268|Analgesics|analgesics|mesh-ancestor
19274928|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
19274929|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274930|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274931|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19274932|NCT04428268|Filaricides|filaricides|mesh-ancestor
19274933|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
19274934|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
19274935|NCT04428086|Metformin|metformin|mesh-list
19274936|NCT04428086|Apatinib|apatinib|mesh-list
19274937|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19274938|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19274939|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274940|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19274941|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19274942|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
19274943|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274944|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19274945|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19274946|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179831|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20179832|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
20179833|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20179834|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
20179835|NCT00184886|Methotrexate|methotrexate|mesh-list
20179836|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20353804|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19274947|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274948|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19274949|NCT04428632|Berotralstat|berotralstat|mesh-list
19274950|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274951|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274952|NCT04427709|Oxytocin|oxytocin|mesh-list
19274953|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
19274954|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274955|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353805|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353806|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353807|NCT00890630|Oxytocin|oxytocin|mesh-list
20353808|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
20353809|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20353810|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353811|NCT00890643|Prazosin|prazosin|mesh-list
19274956|NCT04427826|Morphine|morphine|mesh-list
19274957|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19274958|NCT04427826|Narcotics|narcotics|mesh-ancestor
19274959|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19274960|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274961|NCT04427826|Analgesics|analgesics|mesh-ancestor
19274962|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
19274963|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19274964|NCT04427865|Lactoferrin|lactoferrin|mesh-list
19274965|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19274966|NCT04427787|Lanreotide|lanreotide|mesh-list
19274967|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393630|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19393631|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
19393632|NCT03682952|Urological Agents|urological agents|mesh-ancestor
19393633|NCT03682939|Vaccines|vaccines|mesh-list
19393634|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
19393635|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393636|NCT03682718|Misoprostol|misoprostol|mesh-list
19393637|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19393638|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
19393639|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393640|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393641|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19393642|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353812|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20353813|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20353814|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20353815|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19393643|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
19393644|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20179837|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
20179838|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20179839|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179840|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20179841|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
20179842|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179843|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179844|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
20179845|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393645|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19393646|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393647|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393648|NCT03682653|Azithromycin|azithromycin|mesh-list
19393649|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393650|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393651|NCT03682640|Insulin|insulin|mesh-list
19393652|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19393653|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
19393654|NCT03682640|Azithromycin|azithromycin|mesh-list
19393655|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19393656|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393657|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393658|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393659|NCT03682497|Spironolactone|spironolactone|mesh-list
19393660|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19393661|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
19393662|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393663|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393664|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19393665|NCT03682497|Diuretics|diuretics|mesh-ancestor
19393666|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
19404111|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19274968|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
19274969|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19274970|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19274971|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274972|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
19274973|NCT04427618|Coagulants|coagulants|mesh-ancestor
19274974|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
19274975|NCT04427293|Lenvatinib|lenvatinib|mesh-list
19274976|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19274977|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19274978|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19274979|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274980|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274981|NCT04427540|Oxytocin|oxytocin|mesh-list
19274982|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
19274983|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19274984|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274985|NCT04426890|Omalizumab|omalizumab|mesh-list
19274986|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19274987|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19274988|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19274989|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
19274990|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
19274991|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19274992|NCT04427020|Caseins|caseins|mesh-list
19274993|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
19274994|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
19274995|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274996|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19274997|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19274998|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19274999|NCT04427098|Enoxaparin|enoxaparin|mesh-list
19275000|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
19275001|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
20179846|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20179847|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20179848|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
20179849|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20179850|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20179851|NCT00184899|Heparin|heparin|mesh-list
20179852|NCT00184899|Calcium heparin|calcium heparin|mesh-list
20179853|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20179854|NCT00184899|Glycerol|glycerol|mesh-list
20179855|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
19275002|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19275003|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19275004|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275005|NCT04426734|Dexamethasone|dexamethasone|mesh-list
19275006|NCT04426734|Prednisolone|prednisolone|mesh-list
19275007|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19275008|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
19275009|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19275010|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
19275011|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19275012|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
19275013|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275014|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
19275015|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
19275016|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275017|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275018|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20179856|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20179857|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20179858|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179859|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20179860|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20179861|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20179862|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20179863|NCT00184899|Protective Agents|protective agents|mesh-ancestor
20179864|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179865|NCT00184912|Caffeine|caffeine|mesh-list
20179866|NCT00184912|Annexin A5|annexin a5|mesh-list
20179867|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20179868|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179869|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20179870|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275019|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
19275020|NCT04426734|Hormones|hormones|mesh-ancestor
20353816|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
20353817|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20353818|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353819|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353820|NCT00890708|Voriconazole|voriconazole|mesh-list
20353821|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
20353822|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353823|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20353824|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20353825|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353826|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353827|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20353828|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
20424987|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275021|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275022|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19275023|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275024|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19275025|NCT04426734|Protective Agents|protective agents|mesh-ancestor
19275026|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
19275027|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19275028|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
19275029|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275030|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
19275031|NCT04426721|Protective Agents|protective agents|mesh-ancestor
19275032|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
19275033|NCT04426552|Sevoflurane|sevoflurane|mesh-list
19275034|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19275035|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19275036|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275037|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275038|NCT04426552|Analgesics|analgesics|mesh-ancestor
19275039|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
19275040|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275041|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19275042|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19275043|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19275044|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
19275045|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275046|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275047|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19275048|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19275049|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
19275050|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
19275051|NCT04426578|Perhexiline|perhexiline|mesh-list
19275052|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19275053|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19275054|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275055|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19275056|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275057|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
19275058|NCT04426669|Aldesleukin|aldesleukin|mesh-list
19275059|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
19275060|NCT04426669|Fludarabine|fludarabine|mesh-list
19275061|NCT04426669|Interleukin-2|interleukin-2|mesh-list
19275062|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275063|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
19275064|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275065|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275066|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20179871|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179872|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20179873|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20179874|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
20179875|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179876|NCT00184938|Morphine|morphine|mesh-list
20179877|NCT00184938|Naloxone|naloxone|mesh-list
20179878|NCT00184938|Annexin A5|annexin a5|mesh-list
20179879|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20179880|NCT00184938|Narcotics|narcotics|mesh-ancestor
19275067|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
20179881|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353829|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353830|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353831|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20353832|NCT00890747|Sunitinib|sunitinib|mesh-list
20353833|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353834|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20353835|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20353836|NCT00890747|Growth Substances|growth substances|mesh-ancestor
20353837|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353838|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
20353839|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20353840|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353841|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353842|NCT00890786|Bevacizumab|bevacizumab|mesh-list
20353843|NCT00890786|Irinotecan|irinotecan|mesh-list
20353844|NCT00890786|Temozolomide|temozolomide|mesh-list
20353845|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20353846|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275068|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275069|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275070|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19275071|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275072|NCT04426669|Analgesics|analgesics|mesh-ancestor
19275073|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
19275074|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179882|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179883|NCT00184938|Analgesics|analgesics|mesh-ancestor
20179884|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
20179885|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179886|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19670748|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19275075|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19275076|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20353847|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20353848|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20353849|NCT00890786|Growth Substances|growth substances|mesh-ancestor
20353850|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353851|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
20353852|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20353853|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20353854|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353855|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353856|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20353857|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
20353858|NCT00890942|Naloxone|naloxone|mesh-list
20353859|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19275077|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
19275078|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275079|NCT04426422|Metformin|metformin|mesh-list
19275080|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19275081|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275082|NCT04426409|Ofloxacin|ofloxacin|mesh-list
19275083|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19275084|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275085|NCT04426409|Renal Agents|renal agents|mesh-ancestor
19275086|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19275087|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19275088|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19275089|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275090|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179887|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179888|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179889|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20179890|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20179891|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20179892|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
20179893|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179894|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20353860|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353861|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
20612464|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19393667|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
19670749|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19275091|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275092|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19275093|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19275094|NCT04426487|Progesterone|progesterone|mesh-list
19275095|NCT04426487|Progestins|progestins|mesh-ancestor
20353862|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353863|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
20353864|NCT00890955|Amrubicin|amrubicin|mesh-list
20353865|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353866|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
19275096|NCT04426487|Hormones|hormones|mesh-ancestor
19275097|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275098|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275099|NCT04426097|Iodine|iodine|mesh-list
19275100|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20179895|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20179896|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179897|NCT00184977|Fluticasone|fluticasone|mesh-list
20179898|NCT00184977|Xhance|xhance|mesh-list
20179899|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
20179900|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19275101|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275102|NCT04426097|Trace Elements|trace elements|mesh-ancestor
19275103|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
20353867|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353868|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20353869|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20353870|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
19275104|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275105|NCT04425993|Indomethacin|indomethacin|mesh-list
19275106|NCT04425993|Isosorbide|isosorbide|mesh-list
19275107|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19275108|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19275109|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20179901|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20179902|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20179903|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
20179904|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179905|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179906|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20179907|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
20179908|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
20179909|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19275110|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275111|NCT04425993|Analgesics|analgesics|mesh-ancestor
19275112|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
19275113|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275114|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275115|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275116|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275117|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
19275118|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
19275119|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19275120|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275121|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275122|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275123|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19837850|NCT00617604|Alefacept|alefacept|mesh-list
19837851|NCT00617604|Tacrolimus|tacrolimus|mesh-list
19837852|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837853|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
19837854|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837855|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19837856|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837857|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837858|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19837859|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837860|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19837861|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
19837862|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19837863|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837864|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
19837865|NCT00617669|Docetaxel|docetaxel|mesh-list
19275124|NCT04425993|Diuretics|diuretics|mesh-ancestor
19837866|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179910|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
19275125|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
19275126|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
19275127|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19275128|NCT04426955|Paclitaxel|paclitaxel|mesh-list
19275129|NCT04426955|Cisplatin|cisplatin|mesh-list
19275130|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275131|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275132|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
19275133|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
19275134|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
19275135|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275136|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
19275137|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19275138|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19275139|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19275140|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19275141|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275142|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
19275143|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275144|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275145|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19275146|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275147|NCT04425564|Capecitabine|capecitabine|mesh-list
19275148|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
19275149|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19275150|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
19275151|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275152|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275153|NCT04425590|Aspirin|aspirin|mesh-list
20353871|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353872|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353873|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19275154|NCT04425590|Atorvastatin|atorvastatin|mesh-list
19275155|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19275156|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275157|NCT04425590|Analgesics|analgesics|mesh-ancestor
19275158|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
19275159|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275160|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275161|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275162|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275163|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19275164|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19275165|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275166|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19275167|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275168|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275169|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
19275170|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19275171|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19275172|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
19275173|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19275174|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19275175|NCT04425655|Fludarabine|fludarabine|mesh-list
19275176|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275177|NCT04425460|Favipiravir|favipiravir|mesh-list
19275178|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
19275179|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275180|NCT04425642|Methamphetamine|methamphetamine|mesh-list
19275181|NCT04425642|SMOFlipid|smoflipid|mesh-list
19275182|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19275183|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275184|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
19275185|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
19275186|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275187|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
19275188|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275189|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353874|NCT00891033|Bortezomib|bortezomib|mesh-list
20353875|NCT00891033|Panobinostat|panobinostat|mesh-list
20353876|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353877|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20353878|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353879|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275190|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
19275191|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19275192|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19275193|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179911|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20179912|NCT00184977|Expectorants|expectorants|mesh-ancestor
20179913|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20179914|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
20179915|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179916|NCT00184977|Protective Agents|protective agents|mesh-ancestor
20179917|NCT00184977|Antidotes|antidotes|mesh-ancestor
20217208|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20217209|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217210|NCT00308971|Vitamin E|vitamin e|mesh-list
20217211|NCT00308971|Tocopherols|tocopherols|mesh-list
19275194|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19275195|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19275196|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19275197|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20353880|NCT00891072|Acetic Acid|acetic acid|mesh-list
20353881|NCT00891072|Paclitaxel|paclitaxel|mesh-list
19393668|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19393669|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393670|NCT03682276|Nivolumab|nivolumab|mesh-list
19393671|NCT03682276|Ipilimumab|ipilimumab|mesh-list
19393672|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19393673|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393674|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19393675|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393676|NCT03682211|Fentanyl|fentanyl|mesh-list
19393677|NCT03682211|Morphine|morphine|mesh-list
19393678|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19393679|NCT03682211|Narcotics|narcotics|mesh-ancestor
19393680|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393681|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393682|NCT03682211|Analgesics|analgesics|mesh-ancestor
19393683|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
19393684|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393685|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20353882|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
20353883|NCT00891072|Carboplatin|carboplatin|mesh-list
20353884|NCT00891072|Retinol acetate|retinol acetate|mesh-list
20353885|NCT00891072|Gossypol|gossypol|mesh-list
20353886|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20353887|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353888|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
20353889|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
20353890|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
20353891|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353892|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353893|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353894|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19393686|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19393687|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
19393688|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
19393689|NCT03682198|Phenylephrine|phenylephrine|mesh-list
20353895|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
20353896|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353897|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19393690|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
19393691|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19393692|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
19393693|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
19393694|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393695|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670750|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
19670751|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19670752|NCT05117957|Sorafenib|sorafenib|mesh-list
19670753|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670754|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19670755|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670756|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670757|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19670758|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20217212|NCT00308971|Tocotrienols|tocotrienols|mesh-list
20217213|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
20353898|NCT00891072|Protective Agents|protective agents|mesh-ancestor
20217214|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
19275198|NCT04425681|Bevacizumab|bevacizumab|mesh-list
19275199|NCT04425681|Osimertinib|osimertinib|mesh-list
19275200|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275201|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275202|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19275203|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19275204|NCT04425681|Growth Substances|growth substances|mesh-ancestor
19275205|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275206|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19275207|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19275208|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275209|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275210|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
19275211|NCT04425707|Ivermectin|ivermectin|mesh-list
19275212|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
19275213|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19275214|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19275215|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275216|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275217|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275218|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275219|NCT04425824|Rituximab|rituximab|mesh-list
19275220|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275221|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275222|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
19275223|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275224|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275225|NCT04425187|Bevacizumab|bevacizumab|mesh-list
19275226|NCT04425187|Gefitinib|gefitinib|mesh-list
19275227|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275228|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275229|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19275230|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19275231|NCT04425187|Growth Substances|growth substances|mesh-ancestor
19275232|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275233|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
19275234|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20353899|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19275235|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275236|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275237|NCT04425473|Esketamine|esketamine|mesh-list
19275238|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
19275239|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19275240|NCT04425382|Ritonavir|ritonavir|mesh-list
19275241|NCT04425382|Lopinavir|lopinavir|mesh-list
19275242|NCT04425382|Darunavir|darunavir|mesh-list
19275243|NCT04425382|Cobicistat|cobicistat|mesh-list
19275244|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19275245|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19275246|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
19275247|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275248|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275249|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19275250|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19275251|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
19275252|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275253|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19275254|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19275255|NCT04425135|Carboplatin|carboplatin|mesh-list
19275256|NCT04425135|Apatinib|apatinib|mesh-list
19275257|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275258|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19275259|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275260|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275261|NCT04425070|Gemcitabine|gemcitabine|mesh-list
19275262|NCT04425070|Carboplatin|carboplatin|mesh-list
19275263|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
19275264|NCT04425070|Etoposide|etoposide|mesh-list
19275265|NCT04425070|Ifosfamide|ifosfamide|mesh-list
19275266|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275267|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19275268|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
19275269|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275270|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
19275271|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275272|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275273|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275274|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
19275275|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353900|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
20353901|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19275276|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275277|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19275278|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20353902|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20353903|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19275279|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19275280|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
19275281|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
19275282|NCT04425226|Lenvatinib|lenvatinib|mesh-list
19275283|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275284|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353904|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20353905|NCT00891150|Oxytocin|oxytocin|mesh-list
20353906|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
20353907|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20353908|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353909|NCT00891163|Lidocaine|lidocaine|mesh-list
20353910|NCT00891163|Tetracaine|tetracaine|mesh-list
20353911|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
20353912|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
20353913|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353914|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353915|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
20353916|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353917|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20353918|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20353919|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19275285|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19275286|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275287|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275288|NCT04424901|Dipyridamole|dipyridamole|mesh-list
19275289|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19275290|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275291|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275292|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19275293|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
19275294|NCT04424875|Melatonin|melatonin|mesh-list
19275295|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
19275296|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275297|NCT04424875|Protective Agents|protective agents|mesh-ancestor
19275298|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275299|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19275300|NCT04424420|Acetaminophen|acetaminophen|mesh-list
19275301|NCT04424420|Ibuprofen|ibuprofen|mesh-list
19275302|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275303|NCT04424420|Analgesics|analgesics|mesh-ancestor
19275304|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
19275305|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275306|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275307|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
19275308|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20353920|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20353921|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275309|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275310|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275311|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275312|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275313|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275314|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
19275315|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19275316|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19275317|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275318|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
19275319|NCT04424563|Coagulants|coagulants|mesh-ancestor
19275320|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
19275321|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19275322|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353922|NCT00891267|Amlodipine|amlodipine|mesh-list
20353923|NCT00891267|Olmesartan|olmesartan|mesh-list
20353924|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19275323|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
19275324|NCT04424459|Narcotics|narcotics|mesh-ancestor
19275325|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670759|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
19670760|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670761|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19670762|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353925|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20353926|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20353927|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20353928|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353929|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20353930|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353931|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
20353932|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19670763|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670764|NCT05117398|Dalbavancin|dalbavancin|mesh-list
19670765|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20179918|NCT00184990|Pimagedine|pimagedine|mesh-list
19275326|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275327|NCT04424459|Analgesics|analgesics|mesh-ancestor
19275328|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
19275329|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275330|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
19275331|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19275332|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
19275333|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20353933|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20424988|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
20424989|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424990|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
20424991|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424992|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20424993|NCT01272258|Leronlimab|leronlimab|mesh-list
20424994|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20424995|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20424996|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424997|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20424998|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20424999|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
20425000|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425001|NCT01272310|Interferons|interferons|mesh-list
20425002|NCT01272310|Ribavirin|ribavirin|mesh-list
20425003|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
20425004|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
20425005|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20425006|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
20425007|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425008|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
20425009|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425010|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
20425011|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425012|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
20425013|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275334|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
19670766|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670767|NCT05117125|Heparin|heparin|mesh-list
19275335|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275336|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275337|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
19275338|NCT04424264|Tenofovir|tenofovir|mesh-list
19275339|NCT04424264|Lamivudine|lamivudine|mesh-list
20179919|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179920|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179921|NCT00185003|Tolbutamide|tolbutamide|mesh-list
20179922|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
20179923|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179924|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20179925|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179926|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179927|NCT00185055|Valsartan|valsartan|mesh-list
20425014|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
20425015|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19275340|NCT04424264|Emtricitabine|emtricitabine|mesh-list
19670768|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
20425016|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20353934|NCT00891306|Cyclosporine|cyclosporine|mesh-list
20353935|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
20353936|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
20353937|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20353938|NCT00891306|Cyclosporins|cyclosporins|mesh-list
20353939|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20353940|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353941|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20353942|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
20353943|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353944|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
20353945|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353946|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
20353947|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275341|NCT04424264|Efavirenz|efavirenz|mesh-list
19275342|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19275343|NCT04424264|Rifampin|rifampin|mesh-list
19275344|NCT04424264|Isoniazid|isoniazid|mesh-list
19275345|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
19275346|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275347|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19275348|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19275349|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275350|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275351|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19275352|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20353948|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20353949|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20353950|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353951|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20353952|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
20353953|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353954|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20353955|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
20353956|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
20353957|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275353|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19275354|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19275355|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19275356|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19275357|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19275358|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19275359|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20353958|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20353959|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
20353960|NCT00891306|Hormones|hormones|mesh-ancestor
20353961|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20353962|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20353963|NCT00891306|Protective Agents|protective agents|mesh-ancestor
20353964|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20353965|NCT00891332|Leucovorin|leucovorin|mesh-list
20353966|NCT00891332|Antidotes|antidotes|mesh-ancestor
20353967|NCT00891332|Protective Agents|protective agents|mesh-ancestor
20353968|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20353969|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
20353970|NCT00891332|Vitamins|vitamins|mesh-ancestor
20353971|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
20353972|NCT00891384|Lenalidomide|lenalidomide|mesh-list
20353973|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
20353974|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275360|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
19275361|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19275362|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
19275363|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19275364|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20353975|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20353976|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20353977|NCT00891384|Growth Substances|growth substances|mesh-ancestor
20353978|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
20353979|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20353980|NCT00891397|Pregabalin|pregabalin|mesh-list
20353981|NCT00891397|Analgesics|analgesics|mesh-ancestor
20353982|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
20353983|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20353984|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275365|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20179928|NCT00185055|Olmesartan|olmesartan|mesh-list
20179929|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20179930|NCT00185055|Irbesartan|irbesartan|mesh-list
20179931|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179932|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20179933|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20179934|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179935|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20179936|NCT00185068|Olmesartan|olmesartan|mesh-list
19275366|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19275367|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19275368|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
19275369|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19275370|NCT04424303|Tofacitinib|tofacitinib|mesh-list
19275371|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19275372|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275373|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275374|NCT04423926|Prednisolone|prednisolone|mesh-list
19275375|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
19275376|NCT04423926|Doxorubicin|doxorubicin|mesh-list
19275377|NCT04423926|Vincristine|vincristine|mesh-list
19275378|NCT04423926|Lenalidomide|lenalidomide|mesh-list
19275379|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275380|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
19275381|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275382|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275383|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19275384|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
19275385|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275386|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275387|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19275388|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19275389|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19275390|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20353985|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
19275391|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275392|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275393|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
19275394|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
19275395|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
19275396|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19275397|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19275398|NCT04423926|Growth Substances|growth substances|mesh-ancestor
19275399|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
19275400|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275401|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
19275402|NCT04423926|Hormones|hormones|mesh-ancestor
19275403|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275404|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19275405|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19275406|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275407|NCT04424017|Antibodies|antibodies|mesh-list
19275408|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
19275409|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275410|NCT04424134|Spironolactone|spironolactone|mesh-list
19275411|NCT04424134|Bromhexine|bromhexine|mesh-list
19275412|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19275413|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
19275414|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275415|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179937|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20179938|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179939|NCT00185068|Diuretics|diuretics|mesh-ancestor
20179940|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
20179941|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179942|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20179943|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179944|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179945|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20179946|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20179947|NCT00185094|Losartan|losartan|mesh-list
20179948|NCT00185094|Atenolol|atenolol|mesh-list
20179949|NCT00185094|Olmesartan|olmesartan|mesh-list
19275416|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19275417|NCT04424134|Diuretics|diuretics|mesh-ancestor
20353986|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20353987|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20353988|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20353989|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20353990|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19275418|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
19275419|NCT04424134|Expectorants|expectorants|mesh-ancestor
19275420|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
19275421|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20353991|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20353992|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20353993|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20353994|NCT00891423|Meropenem|meropenem|mesh-list
20353995|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20353996|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20353997|NCT00891475|Interferons|interferons|mesh-list
20353998|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
20353999|NCT00891475|Sunitinib|sunitinib|mesh-list
20354000|NCT00891475|Maleic acid|maleic acid|mesh-list
19275422|NCT04423627|Clonidine|clonidine|mesh-list
19275423|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19275424|NCT04423627|Diuretics|diuretics|mesh-ancestor
19275425|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
19275426|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275427|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19275428|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19275429|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275430|NCT04423627|Analgesics|analgesics|mesh-ancestor
19275431|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
19275432|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275433|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
19275434|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
19275435|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19275436|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19275437|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19275438|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
19275439|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275440|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
19275441|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20354001|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354002|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
20354003|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354004|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
20354005|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354006|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20354007|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20354008|NCT00891475|Growth Substances|growth substances|mesh-ancestor
20354009|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
19275442|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393696|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
19393697|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19393698|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
19393699|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
19393700|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19393701|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19393702|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19393703|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
19393704|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393705|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393706|NCT03682198|Protective Agents|protective agents|mesh-ancestor
19393707|NCT03682172|Glucagon|glucagon|mesh-list
19393708|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19393709|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393710|NCT03682172|Hormones|hormones|mesh-ancestor
19393711|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393712|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393713|NCT03682172|Incretins|incretins|mesh-ancestor
19393714|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
19393715|NCT03682029|Vitamins|vitamins|mesh-ancestor
20354010|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19393716|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
19393717|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393718|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
19393719|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354011|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354012|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354013|NCT00891540|Ropivacaine|ropivacaine|mesh-list
20354014|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
20354015|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
20354016|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354017|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354018|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
20354019|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354020|NCT00891579|Pemetrexed|pemetrexed|mesh-list
20354021|NCT00891579|Gefitinib|gefitinib|mesh-list
20354022|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275443|NCT04423731|Leucovorin|leucovorin|mesh-list
19275444|NCT04423731|Gemcitabine|gemcitabine|mesh-list
19275445|NCT04423731|Paclitaxel|paclitaxel|mesh-list
19275446|NCT04423731|Fluorouracil|fluorouracil|mesh-list
19275447|NCT04423731|Folfirinox|folfirinox|mesh-list
20179950|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20179951|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20354023|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354024|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354025|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20354026|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20354027|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354028|NCT00891605|Paclitaxel|paclitaxel|mesh-list
20354029|NCT00891605|Navitoclax|navitoclax|mesh-list
20354030|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20354031|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354032|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
20354033|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
20354034|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
20354035|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354036|NCT00891670|Aspirin|aspirin|mesh-list
20354037|NCT00891670|Cilostazol|cilostazol|mesh-list
20354038|NCT00891670|Clopidogrel|clopidogrel|mesh-list
20354039|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20354040|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354041|NCT00891670|Analgesics|analgesics|mesh-ancestor
20354042|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
20354043|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354044|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354045|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20354046|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20354047|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20354048|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354049|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354050|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20354051|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20354052|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354053|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
20354054|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20354055|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20354056|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20354057|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
19275448|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275449|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275450|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
19275451|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
19275452|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
19275453|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275454|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19275455|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
19275456|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
20179952|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179953|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20179954|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20179955|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179956|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
20179957|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
20179958|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20179959|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179960|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20179961|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20179962|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19275457|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275458|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275459|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275460|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
19275461|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275462|NCT04423731|Antidotes|antidotes|mesh-ancestor
19275463|NCT04423731|Protective Agents|protective agents|mesh-ancestor
19275464|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
19275465|NCT04423731|Vitamins|vitamins|mesh-ancestor
19275466|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
19275467|NCT04423510|Phenol|phenol|mesh-list
19275468|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19275469|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275470|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
19275471|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19275472|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19275473|NCT04423107|Acetaminophen|acetaminophen|mesh-list
19275474|NCT04423107|Ibuprofen|ibuprofen|mesh-list
19275475|NCT04423107|Oxycodone|oxycodone|mesh-list
19275476|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275477|NCT04423107|Analgesics|analgesics|mesh-ancestor
19275478|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
19275479|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275480|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275481|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
19275482|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19275483|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275484|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275485|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275486|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275487|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275488|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19275489|NCT04423107|Narcotics|narcotics|mesh-ancestor
19275490|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19275491|NCT04423276|Donepezil|donepezil|mesh-list
19275492|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19275493|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275494|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354058|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354059|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20354060|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
20354061|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20354062|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
20354063|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354064|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20354065|NCT00891670|Protective Agents|protective agents|mesh-ancestor
20354066|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20354067|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20354068|NCT00891696|Sirolimus|sirolimus|mesh-list
19275495|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
19275496|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275497|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275498|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
19275499|NCT04423185|Atezolizumab|atezolizumab|mesh-list
19275500|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
19275501|NCT04423185|Palbociclib|palbociclib|mesh-list
19275502|NCT04423185|Niraparib|niraparib|mesh-list
19275503|NCT04423185|Vemurafenib|vemurafenib|mesh-list
19275504|NCT04423185|Crizotinib|crizotinib|mesh-list
19275505|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275506|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19275507|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275508|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275509|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19275510|NCT04423367|Dexamethasone|dexamethasone|mesh-list
19275511|NCT04423367|Bortezomib|bortezomib|mesh-list
19275512|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275513|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
19275514|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
19275515|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275516|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275517|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19275518|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
19275519|NCT04423367|Hormones|hormones|mesh-ancestor
20354069|NCT00891696|Nitroprusside|nitroprusside|mesh-list
19275520|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275521|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19275522|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354070|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354071|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354072|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20354073|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354074|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
20354075|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20354076|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
20354077|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354078|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20354079|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354080|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20354081|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354082|NCT00891761|Dexamethasone|dexamethasone|mesh-list
20354083|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
20354084|NCT00891761|Ondansetron|ondansetron|mesh-list
19837867|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
19837868|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19837869|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19837870|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837871|NCT00617734|Cetuximab|cetuximab|mesh-list
19837872|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20354085|NCT00891761|Casopitant|casopitant|mesh-list
19275523|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
19275524|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275525|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19275526|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275527|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354086|NCT00891761|BB 1101|bb 1101|mesh-list
20354087|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275528|NCT04422652|Bupropion|bupropion|mesh-list
19275529|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19275530|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
19275531|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19275532|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19275533|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19275534|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19275535|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275536|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
19275537|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275538|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275539|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19275540|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19275541|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275542|NCT04422275|Budesonide|budesonide|mesh-list
19275543|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275544|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19275545|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
19275546|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275547|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275548|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19275549|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
19275550|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
19275551|NCT04422275|Hormones|hormones|mesh-ancestor
19275552|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275553|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19275554|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19275555|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20354088|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
20354089|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
20354090|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354091|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354092|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20354093|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
20354094|NCT00891761|Hormones|hormones|mesh-ancestor
20354095|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20354096|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20354097|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354098|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
20354099|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354100|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354101|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
20354102|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
20354103|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20354104|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
19275556|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275557|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354105|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354106|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354107|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354108|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354109|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354110|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20354111|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20354112|NCT00892073|Metformin|metformin|mesh-list
20354113|NCT00892073|Diazoxide|diazoxide|mesh-list
20354114|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20354115|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354116|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20354117|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354118|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
20354119|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
20354120|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19275558|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19275559|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19275560|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275561|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
20354121|NCT00892112|Antibodies|antibodies|mesh-list
20354122|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
20354123|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20354124|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
20354125|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354126|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
20354127|NCT00892125|Carbamazepine|carbamazepine|mesh-list
20354128|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20354129|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354130|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354131|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354132|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354133|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20179963|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
20179964|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20179965|NCT00185107|Simvastatin|simvastatin|mesh-list
19275562|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275563|NCT04422392|Paclitaxel|paclitaxel|mesh-list
19275564|NCT04422392|Carboplatin|carboplatin|mesh-list
19275565|NCT04422392|Pemetrexed|pemetrexed|mesh-list
19275566|NCT04422392|Antibodies|antibodies|mesh-list
19275567|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275568|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275569|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
19275570|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
19275571|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
19275572|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275573|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
19275574|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275575|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275576|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19275577|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19275578|NCT04422028|Desogestrel|desogestrel|mesh-list
19275579|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19275580|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20179966|NCT00185107|Ezetimibe|ezetimibe|mesh-list
20179967|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20179968|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20179969|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20179970|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
20612465|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
19275581|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19275582|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
20354134|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20354135|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20354136|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
19275583|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19275584|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275585|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19275586|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19275587|NCT04422028|Progestins|progestins|mesh-ancestor
20179971|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354137|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354138|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354139|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20354140|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20354141|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
20354142|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
20354143|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
20354144|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354145|NCT00892125|Analgesics|analgesics|mesh-ancestor
20354146|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
20354147|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354148|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20354149|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20354150|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20354151|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20354152|NCT00892190|Dasatinib|dasatinib|mesh-list
20354153|NCT00892190|Tretinoin|tretinoin|mesh-list
19275588|NCT04422028|Hormones|hormones|mesh-ancestor
19275589|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275590|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
19275591|NCT04422184|Diuretics|diuretics|mesh-ancestor
19275592|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
19275593|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275594|NCT04422184|Expectorants|expectorants|mesh-ancestor
19275595|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
19275596|NCT04421872|Anesthetics|anesthetics|mesh-list
19275597|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19275598|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275599|NCT04421716|Ursolic acid|ursolic acid|mesh-list
19275600|NCT04421716|Curcumin|curcumin|mesh-list
19275601|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19275602|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275603|NCT04421716|Analgesics|analgesics|mesh-ancestor
19275604|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
19275605|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275606|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275607|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275608|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275609|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275610|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275611|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275612|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275613|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275614|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275615|NCT04421911|Diclofenac|diclofenac|mesh-list
19275616|NCT04421911|Ketoprofen|ketoprofen|mesh-list
19275617|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19275618|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275619|NCT04421911|Analgesics|analgesics|mesh-ancestor
19275620|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
19275621|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275622|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275623|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275624|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275625|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275626|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275627|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275628|NCT04421742|Beclomethasone|beclomethasone|mesh-list
19275629|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
19275630|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19275631|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
19275632|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275633|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275634|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19275635|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
19275636|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19275637|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19275638|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19275639|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
19275640|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354154|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354155|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354156|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354157|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354158|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
19393720|NCT03682029|Protective Agents|protective agents|mesh-ancestor
20354159|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
19275641|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670769|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19670770|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19275642|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275643|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
19275644|NCT04421742|Hormones|hormones|mesh-ancestor
19275645|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275646|NCT04421547|Letrozole|letrozole|mesh-list
19670771|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275647|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275648|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19275649|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19275650|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275651|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275652|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19275653|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
19275654|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275655|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670772|NCT05117021|Bupivacaine|bupivacaine|mesh-list
19670773|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
19670774|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
19670775|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670776|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670777|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
19275662|NCT04421534|Lactoferrin|lactoferrin|mesh-list
19275663|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393721|NCT03681691|Estradiol|estradiol|mesh-list
19393722|NCT03681691|Estrogens|estrogens|mesh-ancestor
19393723|NCT03681691|Hormones|hormones|mesh-ancestor
19393724|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393725|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393726|NCT03681652|Azathioprine|azathioprine|mesh-list
19393727|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393728|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
19393729|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393730|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19393731|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393732|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19393733|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
19393734|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393735|NCT03681639|Cobalt|cobalt|mesh-list
19393736|NCT03681639|Chromium|chromium|mesh-list
19393737|NCT03681639|Trace Elements|trace elements|mesh-ancestor
19393738|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
19393739|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393740|NCT03681613|Pyrantel|pyrantel|mesh-list
19393741|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
19393742|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
19393743|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
19393744|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19393745|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393746|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19670778|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670779|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
19670780|NCT05116995|Ticagrelor|ticagrelor|mesh-list
19670781|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19670782|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19670783|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19670784|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19837873|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837874|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837875|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
20179972|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20179973|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20179974|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179975|NCT00185120|Amlodipine|amlodipine|mesh-list
20179976|NCT00185120|Olmesartan|olmesartan|mesh-list
20179977|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20179978|NCT00185120|Benazepril|benazepril|mesh-list
20179979|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179980|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20179981|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19393747|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19670785|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
20217215|NCT00308971|Vitamins|vitamins|mesh-ancestor
19837876|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837877|NCT00617851|Vaccines|vaccines|mesh-list
19837878|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
19837879|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837880|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19837881|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
19837882|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837883|NCT00617903|Azelaic acid|azelaic acid|mesh-list
19837884|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354160|NCT00892229|Misoprostol|misoprostol|mesh-list
20354161|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20354162|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
19275664|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19275665|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
19275666|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19275667|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19275668|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
19275669|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275670|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
19275671|NCT04421300|Protective Agents|protective agents|mesh-ancestor
19275672|NCT04421209|Propranolol|propranolol|mesh-list
19275673|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19275674|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19275675|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
19275676|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275677|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275678|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275679|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19275680|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19275681|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
19275682|NCT04421079|Resveratrol|resveratrol|mesh-list
19275683|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
19275684|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354163|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20354164|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354165|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20354166|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20354167|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
20354168|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
20354169|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19275685|NCT04421079|Protective Agents|protective agents|mesh-ancestor
19275686|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275687|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275688|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19275689|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19275690|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
19275691|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354170|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354171|NCT00892307|Adenosine|adenosine|mesh-list
20354172|NCT00892307|Analgesics|analgesics|mesh-ancestor
20354173|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
20354174|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354175|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354176|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20354177|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354178|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20354179|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
20354180|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
20354181|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354182|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354183|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20354184|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354185|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354186|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354187|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354188|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354189|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20354190|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20354191|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
20354192|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354193|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275692|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19275693|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19837885|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
19837886|NCT00617929|Rituximab|rituximab|mesh-list
19275694|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
19275695|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275696|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275697|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19275698|NCT04420936|Benzocaine|benzocaine|mesh-list
19275699|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
19275700|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
19275701|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19275702|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275703|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
19275704|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275705|NCT04420871|Capecitabine|capecitabine|mesh-list
19275706|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19275707|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
19275708|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275709|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275716|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
19275717|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
19275718|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275719|NCT04420533|Mirabegron|mirabegron|mesh-list
19275720|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19275721|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19275722|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19275723|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19275724|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275725|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275726|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275727|NCT04420533|Urological Agents|urological agents|mesh-ancestor
19275728|NCT04419948|Ibuprofen|ibuprofen|mesh-list
19275729|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19275730|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275731|NCT04419948|Analgesics|analgesics|mesh-ancestor
19275732|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
19275733|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275734|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275735|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275736|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275737|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275738|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275739|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275740|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19275741|NCT04420299|Bemiparin|bemiparin|mesh-list
19275742|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
19275743|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19275744|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354194|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20354195|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20354196|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
20354197|NCT00892346|Thalidomide|thalidomide|mesh-list
20354198|NCT00892346|Melphalan|melphalan|mesh-list
20354199|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20354200|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
20354201|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354202|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354203|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20354204|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20354205|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
20354206|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670786|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670787|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670788|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670789|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19670790|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
19670791|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19670792|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
19670793|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354207|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
19275745|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670794|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
19670795|NCT05116891|Leucovorin|leucovorin|mesh-list
19670796|NCT05116891|Gemcitabine|gemcitabine|mesh-list
19670797|NCT05116891|Cisplatin|cisplatin|mesh-list
19670798|NCT05116891|Docetaxel|docetaxel|mesh-list
19275746|NCT04420195|Tacrolimus|tacrolimus|mesh-list
19275747|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275748|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
19275749|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354208|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354209|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354210|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20354211|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20354212|NCT00892346|Growth Substances|growth substances|mesh-ancestor
20354213|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
20354214|NCT00892359|Anidulafungin|anidulafungin|mesh-list
20354215|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
20354216|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354217|NCT00892385|Temozolomide|temozolomide|mesh-list
20354218|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20354219|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
20354220|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354221|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354222|NCT00892398|Ranibizumab|ranibizumab|mesh-list
20354223|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20354224|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20354225|NCT00892398|Growth Substances|growth substances|mesh-ancestor
20354226|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354227|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
20354228|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354229|NCT00892424|Sorafenib|sorafenib|mesh-list
20354230|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354231|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354232|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354233|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354234|NCT00892450|Oxybutynin|oxybutynin|mesh-list
20354235|NCT00892450|Darifenacin|darifenacin|mesh-list
20354236|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
20354237|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
19275750|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19275751|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275752|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275753|NCT04420351|Aspirin|aspirin|mesh-list
19275754|NCT04420351|Clopidogrel|clopidogrel|mesh-list
19275755|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19275756|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275757|NCT04420351|Analgesics|analgesics|mesh-ancestor
19275758|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
19275759|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275760|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275761|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275762|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275763|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19275764|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19275765|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275766|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19275767|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19275768|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275769|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
19275770|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19275771|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19275772|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19670799|NCT05116891|Fluorouracil|fluorouracil|mesh-list
19670800|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
19670801|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20179982|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20179983|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20179984|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179985|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
20179986|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20179987|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20217216|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
20354238|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275773|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
19670802|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670803|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
20179988|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19275774|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275775|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
19275776|NCT04420247|Chloroquine|chloroquine|mesh-list
19275777|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
19275778|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19275779|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19275780|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354239|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354240|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20354241|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20354242|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
20354243|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354244|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354245|NCT00892450|Urological Agents|urological agents|mesh-ancestor
20354246|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20354247|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
20354248|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354249|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354250|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354251|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354252|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354253|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
19275781|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275782|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275783|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275784|NCT04420247|Amebicides|amebicides|mesh-ancestor
19275785|NCT04419662|Phenylephrine|phenylephrine|mesh-list
19275786|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
19275787|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19275788|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
19275789|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
19275790|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275791|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275792|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
19275793|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19275794|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
19275795|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
19275796|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19275797|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19275798|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19275799|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
19275800|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275801|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275802|NCT04419662|Protective Agents|protective agents|mesh-ancestor
19275803|NCT04419493|Heparin|heparin|mesh-list
19275804|NCT04419493|Calcium heparin|calcium heparin|mesh-list
19275805|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20179989|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
20179990|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20179991|NCT00185133|Amlodipine|amlodipine|mesh-list
20179992|NCT00185133|Olmesartan|olmesartan|mesh-list
20179993|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20179994|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20179995|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20179996|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20179997|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275806|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
19275807|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19275808|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19275809|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275810|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19275811|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275812|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275813|NCT04419181|Carboplatin|carboplatin|mesh-list
19275814|NCT04419181|Docetaxel|docetaxel|mesh-list
19275815|NCT04419181|Trastuzumab|trastuzumab|mesh-list
19275816|NCT04419181|Pertuzumab|pertuzumab|mesh-list
19275817|NCT04419181|Maytansine|maytansine|mesh-list
19275818|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19837887|NCT00617929|Clofarabine|clofarabine|mesh-list
20179998|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19275819|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275820|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
19275821|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
20354254|NCT00892476|Calcium|calcium|mesh-list
20354255|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20354256|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354257|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20354258|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20354259|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354260|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354261|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19275822|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
19275823|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275824|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275825|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275826|NCT04419259|Erenumab|erenumab|mesh-list
19275827|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19275828|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275829|NCT04419259|Analgesics|analgesics|mesh-ancestor
19275830|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
20354262|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354263|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354264|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20354265|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20354266|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
20354267|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354268|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354269|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20354270|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20354271|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
20354272|NCT00892502|Bismuth|bismuth|mesh-list
20354273|NCT00892502|Antacids|antacids|mesh-ancestor
20354274|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354275|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20354276|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20354277|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354278|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354279|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354280|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354281|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354282|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20354283|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20354284|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
19275831|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275832|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275833|NCT04419389|Rituximab|rituximab|mesh-list
19275834|NCT04419389|Venetoclax|venetoclax|mesh-list
19275835|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
19275836|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275837|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275838|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
19275839|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275840|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393748|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19393749|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393750|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393751|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
19393752|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
19393753|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393754|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393755|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393756|NCT03681548|Doxorubicin|doxorubicin|mesh-list
19393757|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19393758|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19393759|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393760|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19393761|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19393762|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393763|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393764|NCT03681509|Pramipexole|pramipexole|mesh-list
19393765|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
19393766|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393767|NCT03681509|Protective Agents|protective agents|mesh-ancestor
19393768|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393769|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19393770|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20354285|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354286|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354287|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20354288|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20354289|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
20354290|NCT00892658|Sorafenib|sorafenib|mesh-list
20354291|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354292|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354293|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354294|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354295|NCT00892736|Veliparib|veliparib|mesh-list
20354296|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20354297|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354298|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354299|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354300|NCT00892801|Everolimus|everolimus|mesh-list
20354301|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354302|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20354303|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
20354304|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354305|NCT00892827|Rituximab|rituximab|mesh-list
19275841|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
19275842|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19275843|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19275844|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275845|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
19275846|NCT04419246|Coagulants|coagulants|mesh-ancestor
19275847|NCT04419272|Methylphenidate|methylphenidate|mesh-list
19275848|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19275849|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670804|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670805|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
20354306|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275850|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19275851|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19275852|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19275853|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275854|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
19275855|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275856|NCT04419038|Mitomycins|mitomycins|mesh-list
19275857|NCT04419038|Mitomycin|mitomycin|mesh-list
19275858|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19275859|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275860|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
19275861|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275862|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19275863|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275864|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19275865|NCT04418999|Dexamethasone|dexamethasone|mesh-list
19275866|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275867|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
19275868|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
19275869|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275870|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275871|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19275872|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
19275873|NCT04418999|Hormones|hormones|mesh-ancestor
19275874|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275875|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20354307|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354308|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
20354309|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354310|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20354311|NCT00892892|Nitrendipine|nitrendipine|mesh-list
19275876|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275877|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19275878|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
19275879|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19275880|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
19275881|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275882|NCT04419025|Expectorants|expectorants|mesh-ancestor
19670806|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275883|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
19275884|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20354312|NCT00892892|Rilmenidine|rilmenidine|mesh-list
20354313|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20354314|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20354315|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20354316|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354317|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20354318|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275885|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
19275886|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275887|NCT04419025|Protective Agents|protective agents|mesh-ancestor
19275888|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275889|NCT04419025|Antidotes|antidotes|mesh-ancestor
19275890|NCT04418908|Cetrorelix|cetrorelix|mesh-list
19275891|NCT04418908|Estradiol|estradiol|mesh-list
19275892|NCT04418908|Estrogens|estrogens|mesh-ancestor
19275893|NCT04418908|Hormones|hormones|mesh-ancestor
19275894|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19275895|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275896|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19275897|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19275898|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
19275899|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
19275900|NCT04418557|Antibodies|antibodies|mesh-list
19275901|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
19275902|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275903|NCT04418674|Fentanyl|fentanyl|mesh-list
19275904|NCT04418674|Ketamine|ketamine|mesh-list
19275905|NCT04418674|Analgesics|analgesics|mesh-ancestor
19275906|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
19275907|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275908|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275909|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19275910|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19275911|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
19275912|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
19275913|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19275914|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19275915|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19275916|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19275917|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275918|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19275919|NCT04418674|Narcotics|narcotics|mesh-ancestor
19275920|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19275921|NCT04418531|Antibodies|antibodies|mesh-list
19275922|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
19275923|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19275924|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
19275925|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275926|NCT04418154|Paclitaxel|paclitaxel|mesh-list
20354319|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354320|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
20354321|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
20354322|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354323|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20354324|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20354325|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20354326|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
20354327|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354328|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
20354329|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
20354330|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20354331|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20354332|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354333|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354334|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20354335|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20354336|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354337|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354338|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354339|NCT00892996|Dexamethasone|dexamethasone|mesh-list
20354340|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
20354341|NCT00892996|BB 1101|bb 1101|mesh-list
20354342|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19275927|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
19275928|NCT04418154|Epirubicin|epirubicin|mesh-list
19275929|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20354343|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
19275930|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19275931|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275932|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
19275933|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
19275934|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
19275935|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275936|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275937|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
19275938|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275939|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275940|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19275941|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
19275942|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19275943|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19275944|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19275945|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19275946|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275947|NCT04418180|Fenofibrate|fenofibrate|mesh-list
19275948|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19275949|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
19275950|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275951|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19275952|NCT04418219|Interferons|interferons|mesh-list
19275953|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
19275954|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
19275955|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
19275956|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
19275957|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275958|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
19275959|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275960|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275961|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19275962|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
19275963|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275964|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275965|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19275966|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19275967|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
19275968|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19275969|NCT04418128|Nafamostat|nafamostat|mesh-list
19275970|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19275971|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19275972|NCT04418128|Analgesics|analgesics|mesh-ancestor
19275973|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
19275974|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19275975|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19275976|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20354344|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
20354345|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354346|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354347|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20354348|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
20354349|NCT00892996|Hormones|hormones|mesh-ancestor
20354350|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20354351|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20354352|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354353|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
20354354|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275977|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19275978|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
19275979|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
19275980|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275981|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275982|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19275983|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19275984|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19275985|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19275986|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
19275987|NCT04417920|Mitomycins|mitomycins|mesh-list
19275988|NCT04417920|Mitomycin|mitomycin|mesh-list
19275989|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19275990|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19275991|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
19275992|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275993|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19275994|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275995|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
19275996|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19275997|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19275998|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
19275999|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276000|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19276001|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19276002|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276003|NCT04418089|Simvastatin|simvastatin|mesh-list
19276004|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19276005|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19276006|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
19276007|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276008|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19276009|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19276010|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276011|NCT04417582|Liraglutide|liraglutide|mesh-list
19276012|NCT04417582|Orlistat|orlistat|mesh-list
19276013|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19276014|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276015|NCT04417582|Incretins|incretins|mesh-ancestor
19276016|NCT04417582|Hormones|hormones|mesh-ancestor
19276017|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276018|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276019|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276020|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19276021|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19276022|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
19276023|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276024|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276025|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276026|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
19276027|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19276028|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
19276029|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276030|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
19276031|NCT04417192|Olaparib|olaparib|mesh-list
19276032|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19276033|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276034|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19276035|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276036|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276037|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19276038|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19276039|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19276040|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
19276041|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276042|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19276043|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19276044|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276045|NCT04417348|Tretinoin|tretinoin|mesh-list
19276046|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276047|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
19276048|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
19276049|NCT04417543|Memantine|memantine|mesh-list
19276050|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19276051|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19276052|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
19276053|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276054|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276055|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276056|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19276057|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19393771|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
19393772|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
19393773|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354355|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354356|NCT00893009|Theophylline|theophylline|mesh-list
20354357|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20354358|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
20425017|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393774|NCT03681470|Dapsone|dapsone|mesh-list
19276058|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
19276059|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276060|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276061|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276062|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276063|NCT04416334|Acetaminophen|acetaminophen|mesh-list
19276064|NCT04416334|Colchicine|colchicine|mesh-list
19276065|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19276066|NCT04416334|Analgesics|analgesics|mesh-ancestor
19276067|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
19276068|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276069|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276070|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
19276071|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
19276072|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19276073|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
19276074|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
19276075|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
19276076|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276077|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276078|NCT04416399|Budesonide|budesonide|mesh-list
19276079|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19276080|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19276081|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
19276082|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276083|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276084|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19276085|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
19276086|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
19276087|NCT04416399|Hormones|hormones|mesh-ancestor
19276088|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276089|NCT04416607|Menotropins|menotropins|mesh-list
19276090|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19276091|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
19276092|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19276093|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20179999|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354359|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354360|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354361|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20354362|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
20354363|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20354364|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354365|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354366|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354367|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20354368|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20354369|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
20354370|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354371|NCT00893048|Prednisone|prednisone|mesh-list
20354372|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20354373|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
20354374|NCT00893048|Hormones|hormones|mesh-ancestor
20354375|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180000|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
20180001|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20180002|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19276098|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19276099|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19276100|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180003|NCT00185159|Olmesartan|olmesartan|mesh-list
20180004|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20180005|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20180006|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20180007|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20180008|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180009|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20180010|NCT00185172|Olmesartan|olmesartan|mesh-list
20180011|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20180012|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20180013|NCT00185172|Diuretics|diuretics|mesh-ancestor
20180014|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
20180015|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276101|NCT04415944|Carboplatin|carboplatin|mesh-list
19276102|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276103|NCT04415840|Acetic Acid|acetic acid|mesh-list
19276104|NCT04415840|Retinol acetate|retinol acetate|mesh-list
19276105|NCT04415840|Lugol's solution|lugol's solution|mesh-list
19276106|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276107|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276108|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19276109|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
19276110|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276111|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19276112|NCT04415840|Protective Agents|protective agents|mesh-ancestor
19276113|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276114|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
19276115|NCT04415840|Coagulants|coagulants|mesh-ancestor
19276116|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
19276117|NCT04415892|Capsaicin|capsaicin|mesh-list
19276118|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
19276119|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
19276120|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
19276121|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276122|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276123|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19276124|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276125|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19276126|NCT04415892|Protective Agents|protective agents|mesh-ancestor
19276127|NCT04416035|Paclitaxel|paclitaxel|mesh-list
19276128|NCT04416035|Bevacizumab|bevacizumab|mesh-list
19276129|NCT04416035|Carboplatin|carboplatin|mesh-list
19276130|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19276131|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276132|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
19276133|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
19276134|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
19276135|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276136|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19276137|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19276138|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19276139|NCT04416035|Growth Substances|growth substances|mesh-ancestor
19276140|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276141|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
19276142|NCT04415983|Metronidazole|metronidazole|mesh-list
19276143|NCT04415983|Clarithromycin|clarithromycin|mesh-list
19276144|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
19276145|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19276146|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276147|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276148|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19276149|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19276150|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19276151|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276152|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276153|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19276154|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19276155|NCT04415853|Irinotecan|irinotecan|mesh-list
19276156|NCT04415853|Tegafur|tegafur|mesh-list
19276157|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19276158|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19276159|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276160|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276161|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276162|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19276163|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
19276164|NCT04415567|Lenvatinib|lenvatinib|mesh-list
19276165|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276166|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276167|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276168|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276169|NCT04415320|Ensartinib|ensartinib|mesh-list
19276170|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276171|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276172|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354376|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425018|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19276173|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276174|NCT04415385|Apatinib|apatinib|mesh-list
19670807|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354377|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20354378|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354379|NCT00893061|Tamoxifen|tamoxifen|mesh-list
20354380|NCT00893061|Letrozole|letrozole|mesh-list
20354381|NCT00893061|Anastrozole|anastrozole|mesh-list
20354382|NCT00893061|Exemestane|exemestane|mesh-list
19276175|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276176|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276177|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276178|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276179|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
19276180|NCT04415476|Sirolimus|sirolimus|mesh-list
19276181|NCT04415476|Prednisone|prednisone|mesh-list
20354383|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354384|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276182|NCT04415476|Tacrolimus|tacrolimus|mesh-list
19276183|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19276184|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
19276185|NCT04415476|Hormones|hormones|mesh-ancestor
19276186|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276187|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276188|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19276189|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354385|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20354386|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20354387|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354388|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20354389|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
20354390|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276190|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19276191|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
19276192|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19276193|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276194|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276195|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19276196|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19276197|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
19276198|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276199|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276200|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
19276201|NCT04414995|Acetaminophen|acetaminophen|mesh-list
19276202|NCT04414995|Ibuprofen|ibuprofen|mesh-list
20354391|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354392|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20354393|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20354394|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19276203|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19276204|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19276205|NCT04414995|Analgesics|analgesics|mesh-ancestor
19276206|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
19276207|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276208|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276209|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19276210|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180016|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20180017|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20180018|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180019|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20180020|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20180021|NCT00185185|Atenolol|atenolol|mesh-list
20180022|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20180023|NCT00185185|Olmesartan|olmesartan|mesh-list
20180024|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20180025|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20180026|NCT00185185|Diuretics|diuretics|mesh-ancestor
20180027|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
20180028|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180029|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20180030|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20180031|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180032|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19276211|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19276212|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276213|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276214|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
19276215|NCT04414852|Apatinib|apatinib|mesh-list
19276216|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276217|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276218|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276219|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276220|NCT04415008|Cytarabine|cytarabine|mesh-list
19276221|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19276222|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
19276223|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276224|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276225|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
19276226|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276227|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19276228|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
19276229|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393775|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393776|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
19393777|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19393778|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19393779|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19393780|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393781|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393782|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
19393783|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393784|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
19393785|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393786|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393787|NCT03681275|Tofacitinib|tofacitinib|mesh-list
19393788|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354395|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20354396|NCT00893100|Diltiazem|diltiazem|mesh-list
20354397|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20354398|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20354399|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20354400|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354401|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20354402|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354403|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
20425019|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
20425020|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20425021|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20425022|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20425023|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425024|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425025|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
20425026|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425027|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425028|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20425029|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425030|NCT01272531|Valproic Acid|valproic acid|mesh-list
20425031|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
19393789|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393790|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393791|NCT03681197|Metformin|metformin|mesh-list
19393792|NCT03681197|Clomiphene|clomiphene|mesh-list
19393793|NCT03681197|Enclomiphene|enclomiphene|mesh-list
19393794|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
19393795|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19393796|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393797|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19393798|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
19393799|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393800|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19393801|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
19393802|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393803|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19393804|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19393805|NCT03680976|CXA-10|cxa-10|mesh-list
19393806|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393807|NCT03680885|Lidocaine|lidocaine|mesh-list
20425032|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
19393808|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
19276230|NCT04414969|Asparaginase|asparaginase|mesh-list
19276231|NCT04414969|Pegaspargase|pegaspargase|mesh-list
19276232|NCT04414969|Antibodies|antibodies|mesh-list
19276233|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
19276234|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
19276235|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276236|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276237|NCT04415060|Sevoflurane|sevoflurane|mesh-list
19276238|NCT04415060|Isoflurane|isoflurane|mesh-list
19276239|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19276240|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19276241|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
19276242|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
19276243|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276244|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276245|NCT04414956|Vitamin K|vitamin k|mesh-list
19276246|NCT04414956|Agglutinins|agglutinins|mesh-list
20354404|NCT00893217|Interferons|interferons|mesh-list
20354405|NCT00893217|Interferon-beta|interferon-beta|mesh-list
20354406|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
20354407|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354408|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
20354409|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354410|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
20354411|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354412|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20354413|NCT00893256|Risperidone|risperidone|mesh-list
20354414|NCT00893256|Citalopram|citalopram|mesh-list
20354415|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20354416|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
20354417|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354418|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354419|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354420|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354421|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354422|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276247|NCT04414956|Vitamins|vitamins|mesh-ancestor
19276248|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
19276249|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276250|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19276251|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19276252|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276253|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
19276254|NCT04414956|Coagulants|coagulants|mesh-ancestor
19276255|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
19276256|NCT04414800|Fentanyl|fentanyl|mesh-list
19276257|NCT04414800|Ketamine|ketamine|mesh-list
19276258|NCT04414800|Analgesics|analgesics|mesh-ancestor
19276259|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
19276260|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276261|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276262|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19276263|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19276264|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
19276265|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
19276266|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276267|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19276268|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19276269|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276270|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276271|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19276272|NCT04414800|Narcotics|narcotics|mesh-ancestor
19276273|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20354423|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354424|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19276274|NCT04414943|Ketamine|ketamine|mesh-list
19276275|NCT04414943|Esketamine|esketamine|mesh-list
19276276|NCT04414943|Analgesics|analgesics|mesh-ancestor
19276277|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
20354425|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
20354426|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20354427|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20354428|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20354429|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19276278|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276279|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276280|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19276281|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20180033|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20180034|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20180035|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
20180036|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
20180037|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180038|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20354430|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
20354431|NCT00893269|Zolpidem|zolpidem|mesh-list
20354432|NCT00893269|Eszopiclone|eszopiclone|mesh-list
20354433|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20354434|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20354435|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354436|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354437|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20354438|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
20354439|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
20180039|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20180040|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20180041|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
20180042|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180043|NCT00185198|Testosterone|testosterone|mesh-list
20180044|NCT00185198|Androgens|androgens|mesh-ancestor
20180045|NCT00185198|Hormones|hormones|mesh-ancestor
20180046|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180047|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180048|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20180049|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20180050|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20180051|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20180052|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
20180053|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180054|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276282|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
20180055|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20180056|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20180057|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20354440|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354441|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276283|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
19276284|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276285|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19276286|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19276287|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276288|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276289|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
19276290|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276291|NCT04414540|Metformin|metformin|mesh-list
19276292|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
19276293|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19276294|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276295|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19276296|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276297|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19276298|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
19276299|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276300|NCT04414566|Gemcitabine|gemcitabine|mesh-list
19276301|NCT04414566|Cisplatin|cisplatin|mesh-list
19276302|NCT04414566|Docetaxel|docetaxel|mesh-list
20354442|NCT00893373|Sorafenib|sorafenib|mesh-list
20354443|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354444|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354445|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354446|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354447|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
20354448|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20354449|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354450|NCT00893412|Tramadol|tramadol|mesh-list
20354451|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20354452|NCT00893412|Narcotics|narcotics|mesh-ancestor
19276303|NCT04414566|Fluorouracil|fluorouracil|mesh-list
19276304|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276305|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19276306|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
19276307|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354453|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354454|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354455|NCT00893412|Analgesics|analgesics|mesh-ancestor
19276308|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
19276309|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276310|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276311|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19276312|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
19276313|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276314|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
19276315|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
19276316|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
19276317|NCT04414579|Insulin|insulin|mesh-list
19276318|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19276319|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
19276320|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
19276321|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19276322|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19276323|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276324|NCT04414254|Cefprozil|cefprozil|mesh-list
19276325|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276326|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276327|NCT04414267|Vaccines|vaccines|mesh-list
19276328|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
20354456|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
20354457|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354458|NCT00893425|Ramipril|ramipril|mesh-list
20354459|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20354460|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
20354461|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354462|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354463|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20354464|NCT00893451|Vitamin D|vitamin d|mesh-list
20354465|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
20354466|NCT00893451|Vitamins|vitamins|mesh-ancestor
20354467|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
20354468|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354469|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20354470|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19276329|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
19276330|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276331|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19276332|NCT04413734|Gemcitabine|gemcitabine|mesh-list
19276333|NCT04413734|Cisplatin|cisplatin|mesh-list
19276334|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276335|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19276336|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
19276337|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276338|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
19276339|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276340|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276341|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19276342|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
19276343|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276344|NCT04413838|Nivolumab|nivolumab|mesh-list
19276345|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19276346|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276347|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19276348|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276349|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
19276350|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19276351|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276352|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276353|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19276354|NCT04413864|Analgesics|analgesics|mesh-ancestor
19276355|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
19276356|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276357|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19276358|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19276359|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19276360|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
19276361|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276362|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276363|NCT04414020|Progesterone|progesterone|mesh-list
19276364|NCT04414020|Progestins|progestins|mesh-ancestor
19670808|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670809|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
19670810|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276365|NCT04414020|Hormones|hormones|mesh-ancestor
19276366|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276367|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276368|NCT04414137|Daptomycin|daptomycin|mesh-list
19276369|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276370|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276371|NCT04413890|Dinoprostone|dinoprostone|mesh-list
19276372|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
19276373|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19276374|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276375|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19276376|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276377|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19276378|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276379|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276380|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
19276381|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19276382|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
19276383|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276384|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276385|NCT04413227|Docetaxel|docetaxel|mesh-list
19276386|NCT04413227|Endostatins|endostatins|mesh-list
19276387|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276388|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19276389|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19276390|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19276391|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276392|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19276393|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19276394|NCT04413227|Growth Substances|growth substances|mesh-ancestor
19276395|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276396|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
19276397|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19276398|NCT04412876|Imipramine|imipramine|mesh-list
19276399|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19276400|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19276401|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19276402|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276403|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276404|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276405|NCT04412876|Analgesics|analgesics|mesh-ancestor
19276406|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
19276407|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276408|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
19276409|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276410|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
19276411|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19276412|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19276413|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
19276414|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
19276415|NCT04412850|Analgesics|analgesics|mesh-ancestor
19276416|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
19276417|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276418|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276419|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
19276420|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276421|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19276422|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
19276423|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19276424|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19276425|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276426|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19276427|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
19276428|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393809|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
19393810|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393811|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393812|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
19670811|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670812|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
19276429|NCT04412538|Vaccines|vaccines|mesh-list
19276430|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
19276431|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276432|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
19276433|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19276434|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
19276435|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
19276436|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276437|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276438|NCT04412421|Vitamins|vitamins|mesh-list
19276439|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
19276440|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276441|NCT04412304|Dalteparin|dalteparin|mesh-list
19276442|NCT04412304|Tinzaparin|tinzaparin|mesh-list
19276443|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19276444|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
19276445|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19276446|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19276447|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276448|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19276449|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19276450|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276451|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19276452|NCT04412148|Triamcinolone|triamcinolone|mesh-list
19276453|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19276454|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19276455|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19276456|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19276457|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
19276458|NCT04412148|Hormones|hormones|mesh-ancestor
19276459|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276460|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276461|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19276462|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
19276463|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276464|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276465|NCT04411953|Haloperidol|haloperidol|mesh-list
19276466|NCT04411953|Benztropine|benztropine|mesh-list
19276467|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
19276468|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
19276469|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
19276470|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276471|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276472|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19276473|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19276474|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19276475|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276476|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276477|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19276478|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
19276479|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276480|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276481|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19276482|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19276483|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
19276484|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19276485|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19276486|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19276487|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19276488|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19276489|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19276490|NCT04411940|Haloperidol|haloperidol|mesh-list
19276491|NCT04411940|Benztropine|benztropine|mesh-list
19276492|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
19276493|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
19276494|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
19276495|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276496|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276497|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19276498|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19276499|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19276500|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276501|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276502|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19276503|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
19276504|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670813|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
19276505|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276506|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19670814|NCT05116891|Antidotes|antidotes|mesh-ancestor
19670815|NCT05116891|Protective Agents|protective agents|mesh-ancestor
19670816|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
19670817|NCT05116891|Vitamins|vitamins|mesh-ancestor
19670818|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
20354471|NCT00893477|Rituximab|rituximab|mesh-list
20354472|NCT00893477|Sargramostim|sargramostim|mesh-list
20354473|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20354474|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354475|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
20354476|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276507|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19276508|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
19276509|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19276510|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19276511|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
19276512|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19276513|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19276514|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19276515|NCT04412252|Tofacitinib|tofacitinib|mesh-list
19276516|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276517|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276518|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276519|NCT04411875|Amlodipine|amlodipine|mesh-list
19276520|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19276521|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19276522|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19276523|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276524|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19276525|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276526|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
19276527|NCT04411693|Dexamethasone|dexamethasone|mesh-list
19276528|NCT04411693|Aflibercept|aflibercept|mesh-list
19276529|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19276530|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
19276531|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
19276532|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276533|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276534|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19276535|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
19276536|NCT04411693|Hormones|hormones|mesh-ancestor
19276537|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276538|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19276539|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276540|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19276541|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19276542|NCT04411693|Growth Substances|growth substances|mesh-ancestor
19276543|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
19276544|NCT04411706|Capecitabine|capecitabine|mesh-list
19276545|NCT04411706|Apatinib|apatinib|mesh-list
19276546|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19276547|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
19276548|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276549|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276550|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276551|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276552|NCT04411524|Capecitabine|capecitabine|mesh-list
19276553|NCT04411524|Irinotecan|irinotecan|mesh-list
19276554|NCT04411524|Antibodies|antibodies|mesh-list
19276555|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
19276556|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276557|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19276558|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
19276559|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276560|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276561|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19276562|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19276563|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276564|NCT04411862|Choline|choline|mesh-list
19276565|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
19276566|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19276567|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
20354477|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19670819|NCT05116462|Gemcitabine|gemcitabine|mesh-list
19276568|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276569|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19276570|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19276571|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
19276572|NCT04411758|Propolis|propolis|mesh-list
19276573|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276574|NCT04411537|Capecitabine|capecitabine|mesh-list
19276575|NCT04411537|Irinotecan|irinotecan|mesh-list
19276576|NCT04411537|Antibodies|antibodies|mesh-list
19276577|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
19276578|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276579|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19276580|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
19276581|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276582|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276583|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19276584|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19276585|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276586|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
19276587|NCT04411901|Vitamin D|vitamin d|mesh-list
19276588|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19276589|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276590|NCT04411901|Vitamins|vitamins|mesh-ancestor
19276591|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
19276592|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19276593|NCT04411433|Azithromycin|azithromycin|mesh-list
19276594|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
19276595|NCT04411433|Favipiravir|favipiravir|mesh-list
19276596|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276597|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276598|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
19276599|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19276600|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19276601|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276602|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276603|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19276604|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
19276605|NCT04411446|Vitamin D|vitamin d|mesh-list
19276606|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
19276607|NCT04411446|Vitamins|vitamins|mesh-ancestor
19276608|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
19276609|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276610|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19276611|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20354478|NCT00893490|Mitomycins|mitomycins|mesh-list
20354479|NCT00893490|Mitomycin|mitomycin|mesh-list
20354480|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20354481|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354482|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
20354483|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354484|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19276612|NCT04411329|Dexamethasone|dexamethasone|mesh-list
19276613|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
19276614|NCT04411329|Bupivacaine|bupivacaine|mesh-list
19276615|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19276616|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
19276617|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
19276618|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276619|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276620|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19276621|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
19276622|NCT04411329|Hormones|hormones|mesh-ancestor
19276623|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276624|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19276625|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276626|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19276627|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
20180058|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20180059|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20180060|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20180061|NCT00185237|Estradiol|estradiol|mesh-list
20180062|NCT00185237|Estrogens|estrogens|mesh-ancestor
20180063|NCT00185237|Hormones|hormones|mesh-ancestor
20180064|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180065|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180066|NCT00185250|Interferons|interferons|mesh-list
20180067|NCT00185250|Interferon-beta|interferon-beta|mesh-list
19276628|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276629|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
19276630|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19276631|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19276632|NCT04411329|Analgesics|analgesics|mesh-ancestor
19276633|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19276634|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19276635|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19276636|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
19276637|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276638|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276639|NCT04411225|Cannabidiol|cannabidiol|mesh-list
19276640|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
19276641|NCT04411160|Ascorbic Acid|ascorbic acid|mesh-list
19276642|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
20354485|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354486|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
20354487|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20354488|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354489|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20354490|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
20354491|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354492|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354493|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354494|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354495|NCT00893555|Voriconazole|voriconazole|mesh-list
20354496|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
20354497|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354498|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19276643|NCT04411160|Vitamins|vitamins|mesh-ancestor
19276644|NCT04411160|Micronutrients|micronutrients|mesh-ancestor
19276645|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276646|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
19276647|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276648|NCT04411160|Protective Agents|protective agents|mesh-ancestor
19276649|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19276650|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
19276651|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276652|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19276653|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
19276654|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19276655|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276656|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19276657|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
19276658|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
19276659|NCT04411212|Sargramostim|sargramostim|mesh-list
19276660|NCT04411212|Lenograstim|lenograstim|mesh-list
19276661|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
19276662|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276663|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19276664|NCT04411069|Droperidol|droperidol|mesh-list
19276665|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19276666|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
19276667|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
19276668|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276669|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276670|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19276671|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19276672|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19276673|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276674|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276675|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19276676|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19276677|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
19276678|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276679|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276680|NCT04410874|Vaccines|vaccines|mesh-list
19276681|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
19276682|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276683|NCT04410887|Olaparib|olaparib|mesh-list
19276684|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19276685|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276686|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276687|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393813|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276688|NCT04411030|Itraconazole|itraconazole|mesh-list
19276689|NCT04411030|Midazolam|midazolam|mesh-list
19276690|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19276691|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19276692|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276693|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276694|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19276695|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354499|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20354500|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354501|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354502|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20612466|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
20612467|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612468|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276696|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276697|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19276698|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
19276699|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
19276700|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
19276701|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
19276702|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276703|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276704|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
20612469|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20612470|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20612471|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20612472|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
20354503|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
20354504|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20354505|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354506|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20354507|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20354508|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
20354509|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354510|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20354511|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354512|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354513|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354514|NCT00893594|Naproxen|naproxen|mesh-list
20354515|NCT00893594|Sumatriptan|sumatriptan|mesh-list
20354516|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20354517|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20354518|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20354519|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
19276705|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276706|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19276707|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19276708|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276709|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19276710|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
19276711|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276712|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19276713|NCT04410588|Fentanyl|fentanyl|mesh-list
19276714|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
19276715|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19276716|NCT04410588|Narcotics|narcotics|mesh-ancestor
20354520|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354521|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354522|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354523|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20354524|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354525|NCT00893594|Analgesics|analgesics|mesh-ancestor
20354526|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
20354527|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354528|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20354529|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19276717|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276718|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276719|NCT04410588|Analgesics|analgesics|mesh-ancestor
19276720|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
19276721|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276722|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20354530|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
20354531|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20354532|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354533|NCT00893607|Methoxamine|methoxamine|mesh-list
20354534|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
20354535|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
20354536|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354537|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354538|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20354539|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20354540|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20354541|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19276723|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19276724|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
19276725|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
19276726|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
19276727|NCT04410354|Remdesivir|remdesivir|mesh-list
19276728|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
19276729|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276730|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
19276731|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276732|NCT04409912|Sirolimus|sirolimus|mesh-list
19276733|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276734|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276735|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19276736|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276737|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
19276738|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19276739|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
19276740|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276741|NCT04410081|Lazertinib|lazertinib|mesh-list
19276742|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276743|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276744|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276745|NCT04410094|Itraconazole|itraconazole|mesh-list
20180068|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
20180069|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180070|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
20180071|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180072|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
20180073|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180074|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20180075|NCT00185302|Entinostat|entinostat|mesh-list
20180076|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20180077|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180078|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354542|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
20354543|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354544|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354545|NCT00893711|Vitamin D|vitamin d|mesh-list
20354546|NCT00893711|Vitamins|vitamins|mesh-ancestor
20354547|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
20354548|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354549|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20354550|NCT00893724|Tocopherols|tocopherols|mesh-list
20354551|NCT00893724|Vitamin E|vitamin e|mesh-list
20354552|NCT00893724|Tocotrienols|tocotrienols|mesh-list
20354553|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
20354554|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
20354555|NCT00893724|Niacinamide|niacinamide|mesh-list
20354556|NCT00893724|Niacin|niacin|mesh-list
20354557|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
20354558|NCT00893724|Ubiquinone|ubiquinone|mesh-list
20354559|NCT00893724|Minocycline|minocycline|mesh-list
20354560|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
20354561|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20354562|NCT00893724|Vitamins|vitamins|mesh-ancestor
19276746|NCT04410094|Rifampin|rifampin|mesh-list
19276747|NCT04410094|Lazertinib|lazertinib|mesh-list
19276748|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
20180079|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180080|NCT00185315|Iloprost|iloprost|mesh-list
20354563|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
20354564|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354565|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
19276749|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276750|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20354566|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354567|NCT00893724|Protective Agents|protective agents|mesh-ancestor
20354568|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354569|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354570|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
20354571|NCT00893724|Expectorants|expectorants|mesh-ancestor
20354572|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
20354573|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20354574|NCT00893724|Antidotes|antidotes|mesh-ancestor
20354575|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
20354576|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19276751|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19276752|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276753|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276754|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19276755|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
19276756|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276757|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276758|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19276759|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19276760|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
19276761|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276762|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
19276763|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19276764|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19276765|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19276766|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19276767|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19276768|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19276769|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19276770|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276771|NCT04410211|Midazolam|midazolam|mesh-list
19276772|NCT04410211|Sevoflurane|sevoflurane|mesh-list
19276773|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19276774|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19276775|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276776|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276777|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19276778|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19276779|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276780|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19276781|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
19276782|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
19276783|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
19276784|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
19276785|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276786|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276787|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19276788|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19276789|NCT04409522|Melatonin|melatonin|mesh-list
19276790|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
19276791|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276792|NCT04409522|Protective Agents|protective agents|mesh-ancestor
19276793|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276794|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276795|NCT04409431|Epinephrine|epinephrine|mesh-list
19276796|NCT04409431|Racepinephrine|racepinephrine|mesh-list
19276797|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
19276798|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19276799|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19276800|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
19276801|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276802|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276803|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276804|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19276805|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19276806|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
19276807|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276808|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19276809|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
19276810|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
19276811|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
19276812|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19276813|NCT04409691|Sirolimus|sirolimus|mesh-list
19276814|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354577|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
19670820|NCT05116462|Paclitaxel|paclitaxel|mesh-list
19670821|NCT05116462|Docetaxel|docetaxel|mesh-list
19670822|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19670823|NCT05116462|Carboplatin|carboplatin|mesh-list
19670824|NCT05116462|Pemetrexed|pemetrexed|mesh-list
19670825|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670826|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670827|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670828|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670829|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670830|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670831|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670832|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
19670833|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
19276815|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276816|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19276817|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276818|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
19276819|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19276820|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
19276821|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354578|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20180081|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20180082|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
20180083|NCT00185328|Estradiol|estradiol|mesh-list
20180084|NCT00185328|Estrogens|estrogens|mesh-ancestor
20180085|NCT00185328|Hormones|hormones|mesh-ancestor
20180086|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180087|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180088|NCT00185419|Desogestrel|desogestrel|mesh-list
20180089|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180090|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276829|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19276830|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
19276831|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19276832|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19276833|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276834|NCT04409223|Sunitinib|sunitinib|mesh-list
19276835|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354579|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354580|NCT00893841|Pramipexole|pramipexole|mesh-list
20354581|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20354582|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
20354583|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20354584|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19276836|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19276837|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19276838|NCT04409223|Growth Substances|growth substances|mesh-ancestor
19276839|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276840|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
19276841|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19276842|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276843|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276844|NCT04409483|Ritonavir|ritonavir|mesh-list
19276845|NCT04409483|Lopinavir|lopinavir|mesh-list
19276846|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19276847|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19276848|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
19276849|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276850|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180091|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20180092|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20180093|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20180094|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
20180095|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20180096|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20180097|NCT00185419|Progestins|progestins|mesh-ancestor
20180098|NCT00185419|Hormones|hormones|mesh-ancestor
20180099|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180100|NCT00185445|Fludarabine|fludarabine|mesh-list
20180101|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
19276851|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19670834|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354585|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19670835|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425033|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276852|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19276853|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
19276854|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19276855|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19276856|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19276857|NCT04409327|Dactolisib|dactolisib|mesh-list
19276858|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276859|NCT04408586|Topiramate|topiramate|mesh-list
19276860|NCT04408586|Phentermine|phentermine|mesh-list
20354586|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354587|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354588|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
20354589|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354590|NCT00893841|Protective Agents|protective agents|mesh-ancestor
20354591|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20354592|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20354593|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
20354594|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
20354595|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354596|NCT00893854|Triamcinolone|triamcinolone|mesh-list
20354597|NCT00893854|Diclofenac|diclofenac|mesh-list
20354598|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20354599|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
19276861|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
19276862|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19276863|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276864|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19276865|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
19276866|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19276867|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
19276868|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
19276869|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276870|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
19276871|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276872|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276873|NCT04408989|Bevacizumab|bevacizumab|mesh-list
19276874|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19276875|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276876|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19276877|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19276878|NCT04408989|Growth Substances|growth substances|mesh-ancestor
19276879|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276880|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
19276881|NCT04408911|Midazolam|midazolam|mesh-list
19276882|NCT04408911|Lormetazepam|lormetazepam|mesh-list
19276883|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19276884|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19276885|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276886|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276887|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19276888|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19276889|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19276890|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19276891|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
19276892|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
19276893|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
20354600|NCT00893854|Hormones|hormones|mesh-ancestor
20354601|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20354602|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354603|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354604|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354605|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20354606|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354607|NCT00893854|Analgesics|analgesics|mesh-ancestor
20354608|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
19276894|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
19276895|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19276896|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393814|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20354609|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354610|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20354611|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19393815|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19393816|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20354612|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
19276897|NCT04408313|Naltrexone|naltrexone|mesh-list
19276898|NCT04408313|Buprenorphine|buprenorphine|mesh-list
19276899|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19276900|NCT04408313|Narcotics|narcotics|mesh-ancestor
19276901|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276902|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276903|NCT04408313|Analgesics|analgesics|mesh-ancestor
19276904|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
19276905|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276906|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19276907|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19276908|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19276909|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
19276910|NCT04408326|Giapreza|giapreza|mesh-list
19276911|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
19276912|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19276913|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19276914|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19276915|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
19276916|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19276917|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276918|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
19276919|NCT04408144|Progestins|progestins|mesh-ancestor
19276920|NCT04408144|Hormones|hormones|mesh-ancestor
19276921|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276922|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276923|NCT04408443|Vitamin D|vitamin d|mesh-list
19276924|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
19276925|NCT04408443|Vitamins|vitamins|mesh-ancestor
19276926|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
19276927|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276928|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19276929|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19276930|NCT04408235|Enoxaparin|enoxaparin|mesh-list
19276931|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
19276932|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19276933|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19276934|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276935|NCT04407975|Betamethasone|betamethasone|mesh-list
19276936|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19276937|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
19276938|NCT04407975|Hormones|hormones|mesh-ancestor
19276939|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19276940|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276941|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19276942|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
19276943|NCT04407650|Metformin|metformin|mesh-list
19276944|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19276945|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19276946|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276947|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19276948|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19276949|NCT04408118|Paclitaxel|paclitaxel|mesh-list
19276950|NCT04408118|Bevacizumab|bevacizumab|mesh-list
19276951|NCT04408118|Atezolizumab|atezolizumab|mesh-list
19276952|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19276953|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276954|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19276955|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19276956|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19276957|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19276958|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19276959|NCT04408118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19276960|NCT04408118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19276961|NCT04408118|Growth Substances|growth substances|mesh-ancestor
19276962|NCT04408118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276963|NCT04408118|Growth Inhibitors|growth inhibitors|mesh-ancestor
19276964|NCT04407715|Anesthetics|anesthetics|mesh-list
19276965|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19276966|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354613|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20354614|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
20354615|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354616|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354617|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20354618|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
20354619|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20354620|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
20354621|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354622|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354623|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19276990|NCT04407312|Aspirin|aspirin|mesh-list
19276991|NCT04407312|Cilostazol|cilostazol|mesh-list
19276992|NCT04407312|Clopidogrel|clopidogrel|mesh-list
19276993|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19276994|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19276995|NCT04407312|Analgesics|analgesics|mesh-ancestor
19276996|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
20354624|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354625|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
20354626|NCT00893880|Protective Agents|protective agents|mesh-ancestor
20354627|NCT00893906|Vaccines|vaccines|mesh-list
20354628|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
20354629|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354630|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
20354631|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20354632|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354633|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20354634|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
20354635|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354636|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354637|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354638|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354639|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
20354640|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20354641|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19276997|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19276998|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19276999|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277000|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277001|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19277002|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19277003|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277004|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19277005|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19277006|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277007|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
20180102|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180103|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180104|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
20180105|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180106|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180107|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
20180108|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180109|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
20180110|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20354642|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20354643|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
19837888|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
20354644|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354645|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277008|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20180111|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20180112|NCT00185510|Prednisolone|prednisolone|mesh-list
20180113|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
20180114|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
20180115|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20180116|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
20180117|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180118|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
20180119|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
20180120|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180121|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180122|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20180123|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
20180124|NCT00185510|Hormones|hormones|mesh-ancestor
20180125|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180126|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20180127|NCT00185510|Protective Agents|protective agents|mesh-ancestor
20180128|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20180129|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180130|NCT00185562|Adalimumab|adalimumab|mesh-list
20180131|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180132|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180133|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20180134|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20180135|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20180136|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20180137|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180138|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180139|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180140|NCT00185575|Analgesics|analgesics|mesh-ancestor
20180141|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
20180142|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180143|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
20180144|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20180145|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
20180146|NCT00185705|Telmisartan|telmisartan|mesh-list
20180147|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20180148|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20180149|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20180150|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180151|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
20180152|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180153|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20180154|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
20180155|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180156|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180157|NCT00185835|Gefitinib|gefitinib|mesh-list
20180158|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180159|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20180160|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180161|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354646|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354647|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277009|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19277010|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19277011|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
19277012|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277013|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19277014|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
19277015|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19277016|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
19277017|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277018|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19277019|NCT04407312|Protective Agents|protective agents|mesh-ancestor
19277020|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19277021|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19277022|NCT04407247|Infliximab|infliximab|mesh-list
19277023|NCT04407247|Vedolizumab|vedolizumab|mesh-list
20354648|NCT00894010|Carbamazepine|carbamazepine|mesh-list
19277024|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
20180162|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
19277025|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
19277026|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
19277027|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277028|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
19277029|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277030|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20354649|NCT00894010|Levetiracetam|levetiracetam|mesh-list
20612473|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277031|NCT04407234|Acetaminophen|acetaminophen|mesh-list
19277032|NCT04407234|Tirzepatide|tirzepatide|mesh-list
19277033|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19277034|NCT04407234|Analgesics|analgesics|mesh-ancestor
19277035|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
19277036|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277037|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277038|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
19277039|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19277040|NCT04407234|Incretins|incretins|mesh-ancestor
19277041|NCT04407234|Hormones|hormones|mesh-ancestor
19277042|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19277043|NCT04407130|Doxycycline|doxycycline|mesh-list
19277044|NCT04407130|Ivermectin|ivermectin|mesh-list
19277045|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19277046|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277047|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
19277048|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19277049|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19277050|NCT04407078|Neostigmine|neostigmine|mesh-list
19277051|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19277052|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277053|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277054|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
19277055|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277056|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277057|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19277058|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
19277059|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277060|NCT04407390|Niacinamide|niacinamide|mesh-list
19277061|NCT04407390|Niacin|niacin|mesh-list
19277062|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
19277063|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
19277064|NCT04407390|Vitamins|vitamins|mesh-ancestor
19277065|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
19277066|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277067|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19277068|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
19277069|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277070|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19277071|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277072|NCT04406779|Hormones|hormones|mesh-list
19277073|NCT04406779|Autoantibodies|autoantibodies|mesh-list
19277074|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19277075|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277076|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
19277077|NCT04406870|Sirolimus|sirolimus|mesh-list
19277078|NCT04406870|Propranolol|propranolol|mesh-list
19277079|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19277080|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277081|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19277082|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277083|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
19277084|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19277085|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
19277086|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277087|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19277088|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19277089|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
19277090|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277091|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277092|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277093|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19277094|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277095|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19277096|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
19277097|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277098|NCT04407000|Favipiravir|favipiravir|mesh-list
19277099|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
19277100|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354650|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
20354651|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
20354652|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
20354653|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20354654|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277101|NCT04406883|Simvastatin|simvastatin|mesh-list
19277102|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19277103|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19277104|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
19277105|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277106|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19277107|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19277108|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277109|NCT04406272|Bevacizumab|bevacizumab|mesh-list
20354655|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354656|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19277110|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19277111|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277112|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20354657|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354658|NCT00894010|Analgesics|analgesics|mesh-ancestor
20354659|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
20354660|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354661|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20354662|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20354663|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354664|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20354665|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20354666|NCT00894023|Abciximab|abciximab|mesh-list
20354667|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
20354668|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20354669|NCT00894062|Everolimus|everolimus|mesh-list
20354670|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277113|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19277114|NCT04406272|Growth Substances|growth substances|mesh-ancestor
19277115|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277116|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
19393817|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19393818|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393819|NCT03680716|Ropivacaine|ropivacaine|mesh-list
19393820|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
19393821|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
19393822|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393823|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393824|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
19393825|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180163|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180164|NCT00185887|Terbutaline|terbutaline|mesh-list
20180165|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20354671|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20354672|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
20354673|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354674|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
20354675|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20354676|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354677|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20354678|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
20354679|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180166|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
20180167|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180168|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180169|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20180170|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
20180171|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
20180172|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
20180173|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180174|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20180175|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20180176|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20180177|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
19393826|NCT03680638|Allopurinol|allopurinol|mesh-list
19393827|NCT03680638|Tempol|tempol|mesh-list
19393828|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
20354680|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354681|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354682|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354683|NCT00894231|Levocetirizine|levocetirizine|mesh-list
20354684|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20354685|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20354686|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
20354687|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
20354688|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354689|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354690|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354691|NCT00894283|Enoxaparin|enoxaparin|mesh-list
20354692|NCT00894283|PENTA|penta|mesh-list
20354693|NCT00894283|Fondaparinux|fondaparinux|mesh-list
20354694|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
20354695|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20354696|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354697|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354698|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20354699|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
20354700|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20354701|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
20354702|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354703|NCT00894374|Artesunate|artesunate|mesh-list
20354704|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
20354705|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20354706|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20354707|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277117|NCT04406389|Heparin|heparin|mesh-list
19277118|NCT04406389|Calcium heparin|calcium heparin|mesh-list
19277119|NCT04406389|Enoxaparin|enoxaparin|mesh-list
19277120|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
19277121|NCT04406389|Argatroban|argatroban|mesh-list
19277122|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
19277123|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19277124|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19277125|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277126|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
19277127|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19277128|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
19277129|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277130|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19277131|NCT04406376|Prednisone|prednisone|mesh-list
19277132|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277133|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
19277134|NCT04406376|Hormones|hormones|mesh-ancestor
19277135|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19277136|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277137|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19277138|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277139|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
19277140|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19277141|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277142|NCT04406506|Erythromycin|erythromycin|mesh-list
19277143|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
19277144|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19277145|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
19277146|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19277147|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277148|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277149|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19277150|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277151|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277152|NCT04406259|Verapamil|verapamil|mesh-list
19277153|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277154|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19277155|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277156|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277157|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19277158|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277159|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277160|NCT04406025|Anesthetics|anesthetics|mesh-list
19277161|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277162|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670836|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20354708|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354709|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
19277163|NCT04406051|Norepinephrine|norepinephrine|mesh-list
20354710|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
20354711|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20354712|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
20354713|NCT00894439|Piperacillin|piperacillin|mesh-list
20354714|NCT00894439|BLI-489|bli-489|mesh-list
20354715|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354716|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354717|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20354718|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354719|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277164|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19277165|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19277166|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
19277167|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277168|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277169|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277170|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
19277171|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
19277172|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277173|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19277174|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
19277175|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19277176|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19277177|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277178|NCT04405960|Vitamins|vitamins|mesh-ancestor
19277179|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
19277180|NCT04405843|Ivermectin|ivermectin|mesh-list
19277181|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19277182|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277183|NCT04405921|Azithromycin|azithromycin|mesh-list
19277184|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
19277185|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19277186|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277187|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
19277188|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19277189|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19277190|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277191|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277192|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277193|NCT04405596|Ambroxol|ambroxol|mesh-list
19277194|NCT04405596|Expectorants|expectorants|mesh-ancestor
19277195|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
19277196|NCT04405622|Gemcitabine|gemcitabine|mesh-list
19277197|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19277198|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
19277199|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277200|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277201|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
19277202|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277203|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277204|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19277205|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
19277206|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277207|NCT04405505|Paclitaxel|paclitaxel|mesh-list
19277208|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19277209|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354720|NCT00894569|Paclitaxel|paclitaxel|mesh-list
20354721|NCT00894569|Carboplatin|carboplatin|mesh-list
20354722|NCT00894569|Cetuximab|cetuximab|mesh-list
20354723|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20354724|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354725|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
20354726|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
20354727|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
20354728|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354729|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20354730|NCT00894608|Letrozole|letrozole|mesh-list
20354731|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354732|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20354733|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20354734|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354735|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354736|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20354737|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
19277210|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
19277211|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
19277212|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
19277213|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277214|NCT04405375|Dexamethasone|dexamethasone|mesh-list
19277215|NCT04405375|Etoposide|etoposide|mesh-list
19277216|NCT04405375|Pegaspargase|pegaspargase|mesh-list
19277217|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277218|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
19277219|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
19277220|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277221|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277222|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277223|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
19277224|NCT04405375|Hormones|hormones|mesh-ancestor
19277225|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19277226|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19277227|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277228|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19277229|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19277230|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19277231|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277232|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277233|NCT04405206|Capecitabine|capecitabine|mesh-list
19277234|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
19277235|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19277236|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
19277237|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354738|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20354739|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354740|NCT00894621|Norepinephrine|norepinephrine|mesh-list
20354741|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20354742|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20354743|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
20354744|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354745|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277238|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277239|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
19277240|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19277241|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
19277242|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277243|NCT04405193|Expectorants|expectorants|mesh-ancestor
19277244|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19277245|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19277246|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
19277247|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277248|NCT04405193|Protective Agents|protective agents|mesh-ancestor
20354746|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354747|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
20354748|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
20354749|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277249|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277250|NCT04405193|Antidotes|antidotes|mesh-ancestor
19277251|NCT04405271|Tenofovir|tenofovir|mesh-list
19277252|NCT04405271|Emtricitabine|emtricitabine|mesh-list
19277253|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19277254|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
19277255|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277256|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19277257|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19277258|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277259|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277260|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19277261|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19277262|NCT04405154|Cisplatin|cisplatin|mesh-list
19277263|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277264|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19277265|NCT04405245|Latanoprost|latanoprost|mesh-list
19277266|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19277267|NCT04405037|Alvimopan|alvimopan|mesh-list
19277268|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277269|NCT04405011|Entecavir|entecavir|mesh-list
19670837|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
19670838|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670839|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19670840|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19277270|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
19277271|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354750|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20354751|NCT00894634|Brompheniramine|brompheniramine|mesh-list
20354752|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277272|NCT04405323|Itraconazole|itraconazole|mesh-list
19277273|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
19277274|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277275|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19277276|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19277277|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277278|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277279|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19277280|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
19277281|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19277282|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277283|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19277284|NCT04404946|Phenylephrine|phenylephrine|mesh-list
19277285|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
19277286|NCT04404946|Norepinephrine|norepinephrine|mesh-list
19277287|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19277288|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
19277289|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
19277290|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277291|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277292|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
19277293|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19277294|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
19277295|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
19277296|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19277297|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19277298|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19277299|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
19277300|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277301|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277302|NCT04404946|Protective Agents|protective agents|mesh-ancestor
19277303|NCT04404881|Bevacizumab|bevacizumab|mesh-list
19277304|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19277305|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277306|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19277307|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19277308|NCT04404881|Growth Substances|growth substances|mesh-ancestor
19277309|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277310|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
20354753|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20354754|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
20354755|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
20354756|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354757|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354758|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20354759|NCT00894660|Amodiaquine|amodiaquine|mesh-list
20354760|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
20354761|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20354762|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20354763|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277311|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19277312|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277313|NCT04404959|Ropivacaine|ropivacaine|mesh-list
19277314|NCT04404959|Anesthetics|anesthetics|mesh-list
19277315|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
19277316|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277317|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277318|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
20354764|NCT00894673|Heparin|heparin|mesh-list
20354765|NCT00894673|Calcium heparin|calcium heparin|mesh-list
20354766|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
20354767|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20354768|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354769|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354770|NCT00894712|Sulforaphane|sulforaphane|mesh-list
20354771|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20354772|NCT00894712|Protective Agents|protective agents|mesh-ancestor
19277319|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277320|NCT04404751|Folic Acid|folic acid|mesh-list
19277321|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
19277322|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
19277323|NCT04404751|Iron|iron|mesh-list
20354773|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354774|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354775|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
20354776|NCT00894751|Propofol|propofol|mesh-list
20354777|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20354778|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20354779|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354780|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20354781|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
20354782|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
20354783|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354784|NCT00894751|Analgesics|analgesics|mesh-ancestor
20612474|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277324|NCT04404751|Vitamins|vitamins|mesh-ancestor
19277325|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
19277326|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277327|NCT04404751|Trace Elements|trace elements|mesh-ancestor
19277328|NCT04404751|Hematinics|hematinics|mesh-ancestor
19277329|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
19277330|NCT04404686|Indomethacin|indomethacin|mesh-list
19277331|NCT04404686|Nifedipine|nifedipine|mesh-list
19277332|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19277333|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277334|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277335|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19277336|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277337|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277338|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
19277339|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19277340|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19277341|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19277342|NCT04404686|Analgesics|analgesics|mesh-ancestor
19277343|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
19277344|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277345|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277346|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277347|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
19277348|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19277349|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670841|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
19670842|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20180178|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180179|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180180|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20180181|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180182|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277350|NCT04404517|Adalimumab|adalimumab|mesh-list
19277351|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277352|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393829|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180183|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20180184|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180185|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393830|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393831|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
20180186|NCT00185952|Nifedipine|nifedipine|mesh-list
20180187|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20354785|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
20612475|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
20612476|NCT02251509|Protective Agents|protective agents|mesh-ancestor
20612477|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19393832|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393833|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19393834|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
19393835|NCT03680638|Protective Agents|protective agents|mesh-ancestor
19393836|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393837|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19393838|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19393839|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19393840|NCT03680612|Cefepime|cefepime|mesh-list
19393841|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
19393842|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393843|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393844|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19393845|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670843|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
20612478|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277353|NCT04404491|Capecitabine|capecitabine|mesh-list
19277354|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19277355|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
20354786|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354787|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20354788|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20354789|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20354790|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
19277356|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277357|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277358|NCT04404439|Topiramate|topiramate|mesh-list
19277359|NCT04404439|Verapamil|verapamil|mesh-list
19277360|NCT04404439|Paroxetine|paroxetine|mesh-list
19277361|NCT04404439|Nortriptyline|nortriptyline|mesh-list
19277362|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
19277363|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19277364|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277365|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20354791|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354792|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354793|NCT00894829|Heparin|heparin|mesh-list
20354794|NCT00894829|Calcium heparin|calcium heparin|mesh-list
20354795|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
20354796|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20354797|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354798|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425034|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425035|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
20425036|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425037|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425038|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
20425039|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20425040|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425041|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20425042|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
20425043|NCT01272557|Doxorubicin|doxorubicin|mesh-list
20425044|NCT01272557|Sorafenib|sorafenib|mesh-list
20425045|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20425046|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425047|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20425048|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20425049|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425050|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425051|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20425052|NCT01272609|Timolol|timolol|mesh-list
20425053|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20425054|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20425055|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
20425056|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425057|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425058|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425059|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277366|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19277367|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277368|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277369|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277370|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
19277371|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19277372|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
19277373|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19277374|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19277375|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19277376|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277377|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277378|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19277379|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19277380|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277381|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19277382|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19670844|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
19277383|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
19277384|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19277385|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19277386|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277387|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277388|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
19277389|NCT04404387|Vitamins|vitamins|mesh-ancestor
19277390|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
19277391|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277392|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
19277393|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277394|NCT04404387|Protective Agents|protective agents|mesh-ancestor
19277395|NCT04404062|Antibodies|antibodies|mesh-list
19277396|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
19277397|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
19277398|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277399|NCT04404127|Basiliximab|basiliximab|mesh-list
19277400|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19277401|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
19277402|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277403|NCT04403776|Tofacitinib|tofacitinib|mesh-list
19277404|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19277405|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277406|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277407|NCT04403503|Thrombin|thrombin|mesh-list
19277408|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19277409|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
19277410|NCT04403503|Coagulants|coagulants|mesh-ancestor
19277411|NCT04403724|Fentanyl|fentanyl|mesh-list
19277412|NCT04403724|Morphine|morphine|mesh-list
19277413|NCT04403724|Bupivacaine|bupivacaine|mesh-list
19277414|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
20354799|NCT00894920|Biotin|biotin|mesh-list
20354800|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
20354801|NCT00894920|Vitamins|vitamins|mesh-ancestor
20354802|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
20354803|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354804|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
19277415|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
19277416|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277417|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277418|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
19277419|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277420|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19277421|NCT04403724|Narcotics|narcotics|mesh-ancestor
19277422|NCT04403724|Analgesics|analgesics|mesh-ancestor
19277423|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19277424|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19277425|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
19277426|NCT04403568|Ursolic acid|ursolic acid|mesh-list
19277427|NCT04403568|Curcumin|curcumin|mesh-list
19277428|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19277429|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19277430|NCT04403568|Analgesics|analgesics|mesh-ancestor
19277431|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
19277432|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277433|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277434|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277435|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277436|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277437|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277438|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277439|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277440|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19277441|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19277442|NCT04403555|Ivermectin|ivermectin|mesh-list
19277443|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19277444|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277445|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
19277446|NCT04403711|Anesthetics|anesthetics|mesh-list
19277447|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
19277448|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19277449|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277450|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277451|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354805|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277452|NCT04403711|Analgesics|analgesics|mesh-ancestor
19277453|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
19277454|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354806|NCT00894959|Heparin|heparin|mesh-list
19277455|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19837889|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19277456|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19277457|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19277458|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
20354807|NCT00894959|Calcium heparin|calcium heparin|mesh-list
20354808|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
20354809|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20354810|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354811|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354812|NCT00894985|Heparin|heparin|mesh-list
20354813|NCT00894985|Calcium heparin|calcium heparin|mesh-list
20354814|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
20354815|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19277459|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277460|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277461|NCT04403347|Losartan|losartan|mesh-list
19277462|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
19277463|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277464|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19277465|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19277466|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277467|NCT04403087|Trimebutine|trimebutine|mesh-list
19277468|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277469|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
19277470|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
19277471|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277472|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277473|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
19277474|NCT04403334|Levofloxacin|levofloxacin|mesh-list
19277475|NCT04403334|Ofloxacin|ofloxacin|mesh-list
19277476|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19277477|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277478|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19277479|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19277480|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277481|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277482|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277483|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19277484|NCT04403334|Renal Agents|renal agents|mesh-ancestor
19277485|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19277486|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19277487|NCT04403100|Ritonavir|ritonavir|mesh-list
19277488|NCT04403100|Lopinavir|lopinavir|mesh-list
19277489|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
19277490|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19277491|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19277492|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
19277493|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277494|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277495|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19277496|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19277497|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
19277498|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354816|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354817|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354818|NCT00894998|Heparin|heparin|mesh-list
20354819|NCT00894998|Calcium heparin|calcium heparin|mesh-list
20354820|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
20354821|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20354822|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20354823|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354824|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
19277499|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19277500|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19277501|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
19277502|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19277503|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19277504|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277505|NCT04403243|Colchicine|colchicine|mesh-list
19277506|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
19277507|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277508|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19277509|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
20354825|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19277510|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19404112|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277511|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277512|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277513|NCT04403282|Eflornithine|eflornithine|mesh-list
19277514|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277515|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19277516|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19277517|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19277518|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277519|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19277520|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277521|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277522|NCT04403191|Ondansetron|ondansetron|mesh-list
19277523|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
19277524|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
19277525|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277526|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277527|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277528|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
19277529|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19277530|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19277531|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
19277532|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277533|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277534|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19277535|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19277536|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277537|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19277538|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19277539|NCT04403321|Cyclosporine|cyclosporine|mesh-list
19277540|NCT04403321|Tacrolimus|tacrolimus|mesh-list
19277541|NCT04403321|Cyclosporins|cyclosporins|mesh-list
19277542|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19277543|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
19277544|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354826|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20354827|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354828|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
20354829|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277545|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19277546|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277547|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277548|NCT04403321|Antifungal Agents|antifungal agents|mesh-ancestor
19277549|NCT04403321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277550|NCT04403321|Dermatologic Agents|dermatologic agents|mesh-ancestor
19277551|NCT04403321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277552|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
19277553|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
19277554|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19277555|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277556|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277557|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
19277558|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19277559|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277560|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277561|NCT04402762|Enoxaparin|enoxaparin|mesh-list
19277562|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
19277563|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
19277564|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19277565|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19277566|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277567|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
19277568|NCT04402580|Rituximab|rituximab|mesh-list
19277569|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19277570|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277571|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
19277572|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180188|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20180189|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180190|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20180191|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180192|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
20180193|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
20180194|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180195|NCT00185991|Gentamicins|gentamicins|mesh-list
20354830|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354831|NCT00895076|Dexamethasone|dexamethasone|mesh-list
20354832|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20354833|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
20354834|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
20354835|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354836|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354837|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20354838|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
20612479|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20612480|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277573|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277574|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19277575|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19277576|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
19277577|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19277578|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277579|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277580|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277581|NCT04402671|Glutaral|glutaral|mesh-list
19277582|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
19277583|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277584|NCT04402723|Cytarabine|cytarabine|mesh-list
19277585|NCT04402723|Daunorubicin|daunorubicin|mesh-list
19277586|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19277587|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
19277588|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277589|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277590|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
19277591|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277592|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19277593|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
19277594|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277595|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19277596|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19277597|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19277598|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277599|NCT04402320|Midazolam|midazolam|mesh-list
19277600|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19277601|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19277602|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277603|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277604|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19277605|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19277606|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19277607|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19277608|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
19277609|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
19277610|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
19277611|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
19277612|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277613|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277614|NCT04402359|Meropenem|meropenem|mesh-list
19277615|NCT04402359|Ceftazidime|ceftazidime|mesh-list
20612481|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20354839|NCT00895076|Hormones|hormones|mesh-ancestor
20612482|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20612483|NCT02251600|Deflazacort|deflazacort|mesh-list
20612484|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612485|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20612486|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
19277616|NCT04402359|Avibactam|avibactam|mesh-list
19277617|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19277618|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180196|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180197|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180198|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20180199|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180200|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180201|NCT00186082|Cefoxitin|cefoxitin|mesh-list
20180202|NCT00186082|Cefotetan|cefotetan|mesh-list
20180203|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180204|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180205|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
20180206|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20180207|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425060|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20180208|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20180209|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20180210|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277619|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19277620|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277621|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277622|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
19277623|NCT04402411|Narcotics|narcotics|mesh-ancestor
19277624|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277625|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277626|NCT04402411|Analgesics|analgesics|mesh-ancestor
19277627|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
19277628|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277629|NCT04402346|Pancrelipase|pancrelipase|mesh-list
19277630|NCT04402346|Pancreatin|pancreatin|mesh-list
19277631|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393846|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393847|NCT03680573|Allopurinol|allopurinol|mesh-list
19393848|NCT03680573|Nitroprusside|nitroprusside|mesh-list
19393849|NCT03680573|Nitroarginine|nitroarginine|mesh-list
19393850|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
19393851|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
19393852|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393853|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393854|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
19393855|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393856|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19393857|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
19393858|NCT03680573|Protective Agents|protective agents|mesh-ancestor
19393859|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393860|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19393861|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
19393862|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19393863|NCT03680560|Trastuzumab|trastuzumab|mesh-list
19393864|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19393865|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404113|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404114|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19404115|NCT03597477|Analgesics|analgesics|mesh-ancestor
19404116|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
19404117|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404118|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19670845|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19670846|NCT05116371|Estradiol|estradiol|mesh-list
19670847|NCT05116371|Estrogens|estrogens|mesh-ancestor
19670848|NCT05116371|Hormones|hormones|mesh-ancestor
19670849|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670850|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670851|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20180211|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180212|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180213|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404119|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19404120|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19404121|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
19404122|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404123|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404124|NCT03597308|Acetaminophen|acetaminophen|mesh-list
19404125|NCT03597308|Ibuprofen|ibuprofen|mesh-list
19404126|NCT03597308|Oxycodone|oxycodone|mesh-list
19404127|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19404128|NCT03597308|Analgesics|analgesics|mesh-ancestor
19404129|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
19404130|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404131|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404132|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
19404133|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20180214|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20425061|NCT01272778|Lorazepam|lorazepam|mesh-list
20612487|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612488|NCT02251626|Ubiquinone|ubiquinone|mesh-list
20612489|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
19404134|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612490|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
19277632|NCT04402203|Favipiravir|favipiravir|mesh-list
19277633|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
19277634|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277635|NCT04402047|Diclofenac|diclofenac|mesh-list
19277636|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19277637|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19277638|NCT04402047|Analgesics|analgesics|mesh-ancestor
19277639|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
19277640|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277641|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277642|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277643|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19277644|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19277645|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277646|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277647|NCT04402112|Pitavastatin|pitavastatin|mesh-list
19277648|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19277649|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19277650|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19277651|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
19277652|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277653|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277654|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19277655|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
19277656|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277657|NCT04401878|Lidocaine|lidocaine|mesh-list
19277658|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
19277659|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
19277660|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277661|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277662|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
19277663|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277664|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277665|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19277666|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19277667|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277668|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277669|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
19277670|NCT04401852|Analgesics|analgesics|mesh-ancestor
19277671|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
19277672|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277673|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277674|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
19277675|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277676|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277677|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
19277678|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19277679|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277680|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277681|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19277682|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
19277683|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19277684|NCT04401839|Oxytocin|oxytocin|mesh-list
19277685|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
19277686|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19277687|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277688|NCT04401709|Gemcitabine|gemcitabine|mesh-list
19277689|NCT04401709|Capecitabine|capecitabine|mesh-list
19277690|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19277691|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
19277692|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277693|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277694|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
19277695|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277696|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277697|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19277698|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
19277699|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277700|NCT04401774|Nivolumab|nivolumab|mesh-list
19277701|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19277702|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277703|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19277704|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277705|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19277706|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
19277707|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277708|NCT04401657|Adenosine|adenosine|mesh-list
19277709|NCT04401657|Analgesics|analgesics|mesh-ancestor
19277710|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
19277711|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277712|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277713|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277714|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277715|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19277716|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
19277717|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
19277718|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277719|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277720|NCT04401137|Topiramate|topiramate|mesh-list
19277721|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
19277722|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19277723|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277724|NCT04401176|Lidocaine|lidocaine|mesh-list
19277725|NCT04401176|Heparin|heparin|mesh-list
19277726|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
19277727|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
19277728|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277729|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277730|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
19277731|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277732|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277733|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19277734|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19277735|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277736|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277737|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
19277738|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19277739|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19277740|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
20354840|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20354841|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20354842|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354843|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
20354844|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
20354845|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20354846|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20354847|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354848|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20354849|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20612491|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277741|NCT04401345|Bromides|bromides|mesh-list
19277742|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
19277743|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19277744|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19277745|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19670852|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19670853|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19670854|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19670855|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19670856|NCT05116345|Dexamethasone|dexamethasone|mesh-list
19670857|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
19670858|NCT05116345|BB 1101|bb 1101|mesh-list
19670859|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19670860|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
19670861|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
19670862|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612492|NCT02251626|Vitamins|vitamins|mesh-ancestor
20612493|NCT02251691|Tacrolimus|tacrolimus|mesh-list
20612494|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20612495|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
20612496|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612497|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20612498|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612499|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612500|NCT02251769|Ritonavir|ritonavir|mesh-list
19277746|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
19277747|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612501|NCT02251769|Tipranavir|tipranavir|mesh-list
19277748|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277749|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277750|NCT04401085|Antibodies|antibodies|mesh-list
19277751|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
19277752|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277753|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19277754|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19277755|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
19277756|NCT04401007|Lidocaine|lidocaine|mesh-list
19277757|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19277758|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
19277759|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277760|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277761|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
19277762|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277763|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19277764|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19277765|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19277766|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277767|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670863|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670864|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670865|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
19670866|NCT05116345|Hormones|hormones|mesh-ancestor
19670867|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670868|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19670869|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670870|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
19670871|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354850|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354851|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354852|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354853|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20354854|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
20354855|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20354856|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354857|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20354858|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19670872|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670873|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
19837890|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20354859|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19277768|NCT04400747|Vitamin D|vitamin d|mesh-list
19277769|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
19277770|NCT04400747|Vitamins|vitamins|mesh-ancestor
19277771|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
19277772|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277773|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19277774|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20354860|NCT00895115|Vitamin E|vitamin e|mesh-list
20354861|NCT00895115|Vitamins|vitamins|mesh-ancestor
20354862|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
20354863|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354864|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
20354865|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354866|NCT00895115|Protective Agents|protective agents|mesh-ancestor
20354867|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20354868|NCT00895128|Dasatinib|dasatinib|mesh-list
20354869|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354870|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354871|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354872|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354873|NCT00895167|Curcumin|curcumin|mesh-list
20354874|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20354875|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20354876|NCT00895167|Analgesics|analgesics|mesh-ancestor
20354877|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
20354878|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354879|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670874|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19837891|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354880|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19277775|NCT04400721|Ropivacaine|ropivacaine|mesh-list
19277776|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
19277777|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
19277778|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277779|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277780|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
19277781|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277782|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
19277783|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19277784|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19277785|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277786|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
19277787|NCT04400916|Coagulants|coagulants|mesh-ancestor
19277788|NCT04400890|Vitamin D|vitamin d|mesh-list
19277789|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
19277790|NCT04400890|Resveratrol|resveratrol|mesh-list
19277791|NCT04400890|Vitamins|vitamins|mesh-ancestor
19277792|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
19277793|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277794|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19277795|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19277796|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
19277797|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277798|NCT04400890|Protective Agents|protective agents|mesh-ancestor
19277799|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277800|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19277801|NCT04400201|Propofol|propofol|mesh-list
19277802|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19277803|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277804|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277805|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19277806|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
20612502|NCT02251769|Clarithromycin|clarithromycin|mesh-list
20180215|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
20180216|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20180217|NCT00186277|Docetaxel|docetaxel|mesh-list
20180218|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
20180219|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180220|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
20180221|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180222|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180223|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180224|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20180225|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
20180226|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180227|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20180228|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
20354881|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20354882|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354883|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354884|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354885|NCT00895297|Dasatinib|dasatinib|mesh-list
20354886|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354887|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19277807|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
19277808|NCT04400175|Silicon|silicon|mesh-list
19277809|NCT04400175|Trace Elements|trace elements|mesh-ancestor
19277810|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
19277811|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277812|NCT04400188|Temozolomide|temozolomide|mesh-list
19277813|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19277814|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
19277815|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277816|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277817|NCT04400045|Treosulfan|treosulfan|mesh-list
19277818|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19277819|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
19277820|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277821|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277822|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
19277823|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
19277824|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19277825|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20180229|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612503|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19277826|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180230|NCT00186420|Docetaxel|docetaxel|mesh-list
20354888|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354889|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354890|NCT00895323|Antibodies|antibodies|mesh-list
20354891|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20354892|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20354893|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
20354894|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354895|NCT00895362|Cetuximab|cetuximab|mesh-list
20354896|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20354897|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20354898|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354899|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354900|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354901|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354902|NCT00895505|Warfarin|warfarin|mesh-list
20354903|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
20354904|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
20354905|NCT00895544|Vaccines|vaccines|mesh-list
20354906|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
20354907|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354908|NCT00895557|Varenicline|varenicline|mesh-list
20354909|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20354910|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20354911|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
20354912|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354913|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354914|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277827|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277828|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277829|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393866|NCT03680508|Antibodies|antibodies|mesh-list
19393867|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
19393868|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
19393869|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393870|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
19393871|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19393872|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19393873|NCT03680495|Prednisolone|prednisolone|mesh-list
19393874|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
19393875|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19393876|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
19393877|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19393878|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
19393879|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
19393880|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393881|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393882|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393883|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
19393884|NCT03680495|Hormones|hormones|mesh-ancestor
19393885|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19393886|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19393887|NCT03680495|Protective Agents|protective agents|mesh-ancestor
19393888|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19393889|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393890|NCT03680404|Allopurinol|allopurinol|mesh-list
19393891|NCT03680404|Phenylephrine|phenylephrine|mesh-list
19393892|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
19393893|NCT03680404|Tempol|tempol|mesh-list
19393894|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19393895|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
19393896|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
19393897|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393898|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393899|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
19393900|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19393901|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
19393902|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
19393903|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20354915|NCT00895570|Modafinil|modafinil|mesh-list
20354916|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20354917|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354918|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20354919|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20354920|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19393904|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19393905|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20354921|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354922|NCT00895609|Neostigmine|neostigmine|mesh-list
20354923|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20354924|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354925|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354926|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
20354927|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277830|NCT04400136|Lansoprazole|lansoprazole|mesh-list
19277831|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
19277832|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19277833|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277834|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19277835|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277836|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277837|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20180231|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180232|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
20180233|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180234|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180235|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180236|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20180237|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
20180238|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217217|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354928|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277838|NCT04399187|Eusol|eusol|mesh-list
19277839|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
19277840|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19277841|NCT04399213|Histamine|histamine|mesh-list
19277842|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
19837892|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
19837893|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277843|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
19277844|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
19277845|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277846|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277847|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277848|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
19277849|NCT04399226|Ketamine|ketamine|mesh-list
19277850|NCT04399226|Propofol|propofol|mesh-list
19277851|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19277852|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277853|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277854|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19277855|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
19277856|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
19277857|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19277858|NCT04399226|Analgesics|analgesics|mesh-ancestor
19277859|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
19277860|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277861|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19277862|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19277863|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19277864|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
19277865|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277866|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277867|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19277868|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19277869|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19277870|NCT04399395|Naltrexone|naltrexone|mesh-list
19277871|NCT04399395|Bupropion|bupropion|mesh-list
19277872|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19277873|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19277874|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277875|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
19277876|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277877|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19277878|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
19837894|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837895|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837896|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19837897|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
19837898|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277879|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19277880|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19277881|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19277882|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19277883|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277884|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
19277885|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277886|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19277887|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19277888|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277889|NCT04399434|Insulin|insulin|mesh-list
19277890|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20354929|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20354930|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
20354931|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277891|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277892|NCT04399525|Cetirizine|cetirizine|mesh-list
19277893|NCT04399525|Loratadine|loratadine|mesh-list
19277894|NCT04399525|Levocetirizine|levocetirizine|mesh-list
19277895|NCT04399525|Desloratadine|desloratadine|mesh-list
19277896|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19277897|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19277898|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
19277899|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
19277900|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277901|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277902|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837899|NCT00617942|Paclitaxel|paclitaxel|mesh-list
19837900|NCT00617942|Carboplatin|carboplatin|mesh-list
19837901|NCT00617942|Trastuzumab|trastuzumab|mesh-list
19837902|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19837903|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354932|NCT00895648|Pemetrexed|pemetrexed|mesh-list
19277903|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19277904|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19277905|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
19277906|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
19277907|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
19277908|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
20354933|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354934|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354935|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354936|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20354937|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20354938|NCT00895674|Sorafenib|sorafenib|mesh-list
20354939|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354940|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354941|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354942|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354943|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19277909|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19277910|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277911|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277912|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19277913|NCT04399343|Analgesics|analgesics|mesh-ancestor
19277914|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
19277915|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277916|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19277917|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19277918|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19277919|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
19277920|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277921|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277922|NCT04399148|Ketotifen|ketotifen|mesh-list
19277923|NCT04399148|Aprepitant|aprepitant|mesh-list
19277924|NCT04399148|Desloratadine|desloratadine|mesh-list
19277925|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
19277926|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
19277927|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277928|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277929|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19277930|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19277931|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19393906|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837904|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
19837905|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
19277932|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277933|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19277934|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
19277935|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19277936|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19277937|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
19277938|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
19277939|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
19277940|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
19277941|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19277942|NCT04398823|Polidocanol|polidocanol|mesh-list
19277943|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19277944|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19277945|NCT04399070|Ketamine|ketamine|mesh-list
19277946|NCT04399070|Esketamine|esketamine|mesh-list
19277947|NCT04399070|Analgesics|analgesics|mesh-ancestor
19277948|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
19277949|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277950|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277951|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19277952|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19277953|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
19277954|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
19277955|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19277956|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19277957|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19277958|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277959|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277960|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
19277961|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19277962|NCT04398927|Folfirinox|folfirinox|mesh-list
19277963|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277964|NCT04399083|Caffeine|caffeine|mesh-list
19277965|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19277966|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277967|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19277968|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277969|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354944|NCT00895687|Bortezomib|bortezomib|mesh-list
20354945|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354946|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20354947|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354948|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354949|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
20354950|NCT00895713|Antibodies|antibodies|mesh-list
20354951|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
20354952|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20354953|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20354954|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
20354955|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354956|NCT00895739|Cyclosporine|cyclosporine|mesh-list
19277970|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20354957|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
20354958|NCT00895739|Cyclosporins|cyclosporins|mesh-list
20354959|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20354960|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354961|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20354962|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
20354963|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354964|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
20354965|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354966|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
20354967|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20354968|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20354969|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20354970|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19277971|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19277972|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
19277973|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277974|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20354971|NCT00895778|Rocuronium|rocuronium|mesh-list
19277975|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20354972|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20354973|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20354974|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19277976|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
20354975|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20354976|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354977|NCT00895791|Umirolimus|umirolimus|mesh-list
20354978|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20354979|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20354980|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
20354981|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354982|NCT00895804|Pindolol|pindolol|mesh-list
20354983|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20354984|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20354985|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
20612504|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20612505|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
19277977|NCT04398537|Hormones|hormones|mesh-ancestor
19277978|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19277979|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277980|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19277981|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277982|NCT04398719|Capsaicin|capsaicin|mesh-list
19277983|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
19277984|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19277985|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
19277986|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19277987|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19277988|NCT04398771|Valsartan|valsartan|mesh-list
19277989|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19277990|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19277991|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19277992|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
19277993|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19277994|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19277995|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19277996|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19277997|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19277998|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19277999|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19278000|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
19278001|NCT04398589|Ropivacaine|ropivacaine|mesh-list
20612506|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612507|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278002|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19278003|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278004|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20354986|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20354987|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20354988|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278005|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19278006|NCT04398589|Analgesics|analgesics|mesh-ancestor
19278007|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
19278008|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278009|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19278010|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19278011|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19278012|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
19278013|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278014|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278015|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
19278016|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
19278017|NCT04398251|Febuxostat|febuxostat|mesh-list
19278018|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
19278019|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278020|NCT04398108|Margetuximab|margetuximab|mesh-list
19278021|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278022|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
19278023|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19278024|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
19278025|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278026|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278027|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19278028|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
19278029|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19670875|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
20612508|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19278030|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
19278031|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278032|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278033|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19278034|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
19278035|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
19278036|NCT04398290|Protective Agents|protective agents|mesh-ancestor
19278037|NCT04398316|Lidocaine|lidocaine|mesh-list
19278038|NCT04398316|Hydromorphone|hydromorphone|mesh-list
19278039|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
19278040|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
19278041|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278042|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278043|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
19278044|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278045|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19278046|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19278047|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19278048|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19278049|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278050|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19278051|NCT04398316|Narcotics|narcotics|mesh-ancestor
19278052|NCT04398316|Analgesics|analgesics|mesh-ancestor
19278053|NCT04398004|Clarithromycin|clarithromycin|mesh-list
19278054|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19278055|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354989|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20354990|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20354991|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
20354992|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
20354993|NCT00895882|Interferons|interferons|mesh-list
20180239|NCT00186706|Selenium|selenium|mesh-list
20180240|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
20180241|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180242|NCT00186706|Protective Agents|protective agents|mesh-ancestor
20180243|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278056|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19278057|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278058|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278059|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19278060|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19278061|NCT04397770|Temozolomide|temozolomide|mesh-list
19278062|NCT04397770|Apatinib|apatinib|mesh-list
19278063|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19278064|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
19278065|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278066|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278067|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19278068|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393907|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180244|NCT00186706|Trace Elements|trace elements|mesh-ancestor
20354994|NCT00895882|Ribavirin|ribavirin|mesh-list
20354995|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20354996|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
20354997|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20354998|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
20354999|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355000|NCT00895960|Temozolomide|temozolomide|mesh-list
20355001|NCT00895960|Dasatinib|dasatinib|mesh-list
20180245|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
20180246|NCT00186745|Tinzaparin|tinzaparin|mesh-list
20180247|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20180248|NCT00186745|Dalteparin|dalteparin|mesh-list
20180249|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
20180250|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20180251|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20180252|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180253|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
20180254|NCT00186797|Fludarabine|fludarabine|mesh-list
20180255|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180256|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
20355002|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19393908|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180257|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180258|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278069|NCT04397601|Bevacizumab|bevacizumab|mesh-list
20355003|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
20355004|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355005|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355006|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20355007|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355008|NCT00896077|Lisofylline|lisofylline|mesh-list
20355009|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20355010|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
20355011|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355012|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20355013|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19278070|NCT04397601|Aflibercept|aflibercept|mesh-list
19278071|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19278072|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278073|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19278074|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19278075|NCT04397601|Growth Substances|growth substances|mesh-ancestor
19278076|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278077|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
19278078|NCT04397991|Furosemide|furosemide|mesh-list
19278079|NCT04397991|Diuretics|diuretics|mesh-ancestor
19278080|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
19278081|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278082|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19278083|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19278084|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278085|NCT04397653|Ezetimibe|ezetimibe|mesh-list
19278086|NCT04397653|Evolocumab|evolocumab|mesh-list
19278087|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19278088|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19278089|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
19278090|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278091|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19278092|NCT04397679|Chloroquine|chloroquine|mesh-list
19278093|NCT04397679|Temozolomide|temozolomide|mesh-list
19278094|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19278095|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
19278096|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278097|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278098|NCT04397679|Amebicides|amebicides|mesh-ancestor
19278099|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278100|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278101|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278102|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
19278103|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278104|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
19278105|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19278106|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
19278107|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278108|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278109|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19278110|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
19278111|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19278112|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
19278113|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278114|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278115|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19278116|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
19278117|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
19278118|NCT04397692|Protective Agents|protective agents|mesh-ancestor
19278119|NCT04397913|Acetaminophen|acetaminophen|mesh-list
20180259|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180260|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
20180261|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180262|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180263|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180264|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
20180265|NCT00186810|Busulfan|busulfan|mesh-list
20180266|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355014|NCT00896077|Analgesics|analgesics|mesh-ancestor
20355015|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
19278120|NCT04397913|Ibuprofen|ibuprofen|mesh-list
19278121|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19278122|NCT04397913|Analgesics|analgesics|mesh-ancestor
20180267|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
20180268|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180269|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180270|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180271|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
20180272|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180273|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180274|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180275|NCT00186823|Antibodies|antibodies|mesh-list
20180276|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
20180277|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180278|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
20180279|NCT00186849|Ifosfamide|ifosfamide|mesh-list
20180280|NCT00186849|Carboplatin|carboplatin|mesh-list
20180281|NCT00186849|Doxorubicin|doxorubicin|mesh-list
20180282|NCT00186849|Etoposide|etoposide|mesh-list
20180283|NCT00186849|Topotecan|topotecan|mesh-list
20180284|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180285|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
20180286|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180287|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180288|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180289|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
20180290|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180291|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180292|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180293|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180294|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20180295|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180296|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180297|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180298|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20180299|NCT00186862|Interleukin-2|interleukin-2|mesh-list
20180300|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180301|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20180302|NCT00186862|Analgesics|analgesics|mesh-ancestor
20180303|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
20180304|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180305|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180306|NCT00186940|Rasburicase|rasburicase|mesh-list
20180307|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
20180308|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180309|NCT00186966|Cytarabine|cytarabine|mesh-list
20180310|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
20180311|NCT00186966|Melphalan|melphalan|mesh-list
20180312|NCT00186966|Busulfan|busulfan|mesh-list
20180313|NCT00186966|Fludarabine|fludarabine|mesh-list
20180314|NCT00186966|Etoposide|etoposide|mesh-list
20180315|NCT00186966|Daunorubicin|daunorubicin|mesh-list
20180316|NCT00186966|Thioguanine|thioguanine|mesh-list
20180317|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180318|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
20180319|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180320|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180321|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180322|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
20180323|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180324|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180325|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180326|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180327|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
20180328|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180329|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20180330|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180331|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180332|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
20180333|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180334|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180335|NCT00186979|Cefixime|cefixime|mesh-list
20180336|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
20180337|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
20180338|NCT00186979|Irinotecan|irinotecan|mesh-list
20180339|NCT00186979|Vincristine|vincristine|mesh-list
20180340|NCT00186979|Gefitinib|gefitinib|mesh-list
20180341|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20180342|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19278123|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
19278124|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278125|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278126|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
19278127|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19278128|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355016|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355017|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355018|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355019|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355020|NCT00896155|Tamoxifen|tamoxifen|mesh-list
20355021|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20355022|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
20355023|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20355024|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355025|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355026|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355027|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19278129|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278130|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19278131|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355028|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20355029|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20355030|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19278132|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278133|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
19278134|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278135|NCT04397341|Docetaxel|docetaxel|mesh-list
19278136|NCT04397341|Fluorouracil|fluorouracil|mesh-list
19278137|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278138|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
19278139|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
19278140|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
19278141|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355031|NCT00896285|Analgesics|analgesics|mesh-list
20355032|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
20355033|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
20355034|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355035|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278142|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
19278143|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19278144|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278145|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
19278146|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278147|NCT04397458|Dexamethasone|dexamethasone|mesh-list
19278148|NCT04397458|Bupivacaine|bupivacaine|mesh-list
19278149|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278150|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
19278151|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
19278152|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278153|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278154|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19278155|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
19278156|NCT04397458|Hormones|hormones|mesh-ancestor
20355036|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20355037|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355038|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355039|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20355040|NCT00896285|Narcotics|narcotics|mesh-ancestor
20355041|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278157|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278158|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19278159|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278160|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
19278161|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
19278162|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278163|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
19278164|NCT04397510|Heparin|heparin|mesh-list
19278165|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
19278166|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19278167|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19278168|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837906|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
19278169|NCT04397393|Midazolam|midazolam|mesh-list
19670876|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355042|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
20355043|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
19278170|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20355044|NCT00896376|Trastuzumab|trastuzumab|mesh-list
20355045|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20355046|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355047|NCT00896402|Iodine|iodine|mesh-list
20355048|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
20355049|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20355050|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
20355051|NCT00896402|Povidone|povidone|mesh-list
20355052|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20355053|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355054|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
20355055|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
19278171|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19278172|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278173|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278174|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19278175|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19278176|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19278177|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19278178|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
19278179|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
19278180|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
19278181|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
19278182|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278183|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278184|NCT04397289|Heparin|heparin|mesh-list
19278185|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
19278186|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
19278187|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19278188|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19278189|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355056|NCT00896402|Trace Elements|trace elements|mesh-ancestor
20355057|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
20355058|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355059|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
20355060|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
20355061|NCT00896428|Gallopamil|gallopamil|mesh-list
20355062|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20355063|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20355064|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278190|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19278191|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
20612509|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612510|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
20612511|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612512|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19278192|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20355065|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20355066|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355067|NCT00896493|Cyclosporine|cyclosporine|mesh-list
19278193|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
19278194|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278195|NCT04397549|Morphine|morphine|mesh-list
19278196|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19278197|NCT04397549|Narcotics|narcotics|mesh-ancestor
19278198|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278199|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355068|NCT00896493|Cyclosporins|cyclosporins|mesh-list
20355069|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20355070|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355071|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355072|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355073|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
20355074|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355075|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
19278200|NCT04397549|Analgesics|analgesics|mesh-ancestor
19278201|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
19278202|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278203|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
20355076|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355077|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
19278204|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
20355078|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355079|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20355080|NCT00896519|Prednisone|prednisone|mesh-list
20355081|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
20355082|NCT00896519|Rituximab|rituximab|mesh-list
20355083|NCT00896519|Doxorubicin|doxorubicin|mesh-list
20355084|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20355085|NCT00896519|Vincristine|vincristine|mesh-list
20355086|NCT00896519|Sargramostim|sargramostim|mesh-list
20355087|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355088|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
20355089|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355090|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355091|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19278205|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278206|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278207|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355092|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
20355093|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355094|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355095|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20355096|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20355097|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20355098|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20355099|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20355100|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355101|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355102|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
20355103|NCT00896519|Hormones|hormones|mesh-ancestor
20355104|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278208|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278209|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278210|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278211|NCT04396990|Prednisolone|prednisolone|mesh-list
19278212|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278213|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
19278214|NCT04396990|Hormones|hormones|mesh-ancestor
19278215|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278216|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355105|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19278217|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19278218|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278219|NCT04396938|Lamotrigine|lamotrigine|mesh-list
19278220|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
19278221|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19278222|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19278223|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278224|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19278225|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278226|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19278227|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19278228|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278229|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19278230|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19278231|NCT04396730|Cannabidiol|cannabidiol|mesh-list
19278232|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
19278233|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
19278234|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19278235|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19278236|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278237|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
19278238|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19278239|NCT04396743|Clotrimazole|clotrimazole|mesh-list
19278240|NCT04396743|Miconazole|miconazole|mesh-list
19278241|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20180343|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180344|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180345|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180346|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180347|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
20180348|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180349|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180350|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20180351|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20355106|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19278242|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278243|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
19278244|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19278245|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19278246|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278247|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278248|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19278249|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
19278250|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278251|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278252|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19278253|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19278254|NCT04396977|Histamine|histamine|mesh-list
19278255|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
19278256|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
19278257|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278258|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278259|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278260|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
19278261|NCT04396457|Pemetrexed|pemetrexed|mesh-list
19278262|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19278263|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278264|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278265|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278266|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19278267|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19278268|NCT04396496|Daratumumab|daratumumab|mesh-list
19278269|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278270|NCT04396548|Midodrine|midodrine|mesh-list
19278271|NCT04396548|Anesthetics|anesthetics|mesh-list
19278272|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278273|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278274|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
20355107|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
20355108|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
20355109|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
20355110|NCT00896558|Midazolam|midazolam|mesh-list
19278275|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
19278276|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278277|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19278278|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19278279|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19278280|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19278281|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
19278282|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278283|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278284|NCT04396223|Methotrexate|methotrexate|mesh-list
19278285|NCT04396223|Avelumab|avelumab|mesh-list
19278286|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19278287|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
19278288|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19278289|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278290|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19278291|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
19278292|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278293|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278294|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
19278295|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278296|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19278297|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278298|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
19278299|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278300|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19278301|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19278302|NCT04396067|Tretinoin|tretinoin|mesh-list
19278303|NCT04396067|Isotretinoin|isotretinoin|mesh-list
19278304|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278305|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
19278306|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
19278307|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19278308|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19278309|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
19278310|NCT04395768|Vitamin D|vitamin d|mesh-list
20355111|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19670877|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
19670878|NCT05116306|Protective Agents|protective agents|mesh-ancestor
19670879|NCT05116293|Acetaminophen|acetaminophen|mesh-list
19670880|NCT05116293|Digoxin|digoxin|mesh-list
19670881|NCT05116293|Midazolam|midazolam|mesh-list
19670882|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19670883|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19670884|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355112|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20355113|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355114|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355115|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20355116|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20355117|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20355118|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20355119|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
20355120|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
20355121|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
20355122|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
20355123|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670885|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670886|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19670887|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20355124|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355125|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20355126|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20355127|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19278311|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
19278312|NCT04395768|Vitamins|vitamins|mesh-list
19278313|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
19278314|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
19278315|NCT04395768|Hydroxocobalamin|hydroxocobalamin|mesh-list
19278316|NCT04395768|Azithromycin|azithromycin|mesh-list
20355128|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20355129|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
20355130|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20355131|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355132|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20355133|NCT00896571|Estrogens|estrogens|mesh-ancestor
20355134|NCT00896571|Hormones|hormones|mesh-ancestor
20355135|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278317|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
19278318|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
19278319|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278320|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19278321|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278322|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19278323|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19278324|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278325|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
19278326|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278327|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278328|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278329|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278330|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
19278331|NCT04395768|Protective Agents|protective agents|mesh-ancestor
19278332|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
19278333|NCT04395768|Hematinics|hematinics|mesh-ancestor
19837907|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837908|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19278334|NCT04395989|Paclitaxel|paclitaxel|mesh-list
19278335|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19278336|NCT04395989|Capecitabine|capecitabine|mesh-list
19278337|NCT04395989|Everolimus|everolimus|mesh-list
19278338|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19278339|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278340|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
19278341|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
19278342|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
19278343|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278344|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670888|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19278345|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
19670889|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19278346|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278347|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
19670890|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
20355136|NCT00896714|Anesthetics|anesthetics|mesh-list
20355137|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355138|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355139|NCT00896727|Antibodies|antibodies|mesh-list
20355140|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
20355141|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425062|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
20425063|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
20425064|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
20425065|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425066|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425067|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425068|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20425069|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425070|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20425071|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20425072|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20425073|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
20425074|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
20425075|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425076|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425077|NCT01272856|Abatacept|abatacept|mesh-list
20425078|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20425079|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425080|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425081|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425082|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
20425083|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425084|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20425085|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
20425086|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
20425087|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425088|NCT01273051|Capecitabine|capecitabine|mesh-list
20425089|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20425090|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
20425091|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425092|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425093|NCT01273090|Imetelstat|imetelstat|mesh-list
20425094|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
20425095|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425096|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425097|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20425098|NCT01273233|Vaccines|vaccines|mesh-list
20425099|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
20425100|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425101|NCT01273246|Vaccines|vaccines|mesh-list
20425102|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
20425103|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425104|NCT01273298|Bisoprolol|bisoprolol|mesh-list
20425105|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20425106|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
19278348|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393909|NCT03680404|Protective Agents|protective agents|mesh-ancestor
19393910|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
19393911|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393912|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
19393913|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393914|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19393915|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
19393916|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19393917|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19393918|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19393919|NCT03680378|Cefepime|cefepime|mesh-list
19393920|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393921|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393922|NCT03680352|Cefepime|cefepime|mesh-list
19393923|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
19393924|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19393925|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393926|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19393927|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19393928|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393929|NCT03680339|Misoprostol|misoprostol|mesh-list
20425107|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
19393930|NCT03680339|Oxytocin|oxytocin|mesh-list
20425108|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278349|NCT04395612|Niraparib|niraparib|mesh-list
19278350|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19278351|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278352|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278353|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278354|NCT04395638|Vitamin D|vitamin d|mesh-list
19278355|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
19278356|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
19278357|NCT04395638|Vitamins|vitamins|mesh-list
19278358|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
19278359|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278360|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19278361|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19278362|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
19278363|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19278364|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
19278365|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278366|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
19278367|NCT04395417|Protective Agents|protective agents|mesh-ancestor
19278368|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19278369|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19278370|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278371|NCT04395365|Renal Agents|renal agents|mesh-ancestor
19278372|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19278373|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
19278374|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278375|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278376|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
19278377|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19278378|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
19278379|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19278380|NCT04395105|Dexamethasone|dexamethasone|mesh-list
19278381|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278382|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
19278383|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
19278384|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278385|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278386|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19278387|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
19278388|NCT04395105|Hormones|hormones|mesh-ancestor
19278389|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278390|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19278391|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355142|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
20355143|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20355144|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20355145|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355146|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355147|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355148|NCT00896948|Antibodies|antibodies|mesh-list
20355149|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
19278392|NCT04394975|Sunitinib|sunitinib|mesh-list
19278393|NCT04394975|Axitinib|axitinib|mesh-list
19278394|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180352|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180353|NCT00187005|Cytarabine|cytarabine|mesh-list
20180354|NCT00187005|Dexamethasone|dexamethasone|mesh-list
20180355|NCT00187005|Prednisone|prednisone|mesh-list
20180356|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
20180357|NCT00187005|Methotrexate|methotrexate|mesh-list
20180358|NCT00187005|Etoposide|etoposide|mesh-list
20180359|NCT00187005|Vincristine|vincristine|mesh-list
20180360|NCT00187005|Daunorubicin|daunorubicin|mesh-list
20180361|NCT00187005|Asparaginase|asparaginase|mesh-list
20180362|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
20180363|NCT00187005|Idarubicin|idarubicin|mesh-list
20180364|NCT00187005|Pegaspargase|pegaspargase|mesh-list
20180365|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180366|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
20180367|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180368|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180369|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19278395|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19278396|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19278397|NCT04394975|Growth Substances|growth substances|mesh-ancestor
20180370|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
20180371|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278398|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278399|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19278400|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19278401|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278402|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278403|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
19278404|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19278405|NCT04395170|Antibodies|antibodies|mesh-list
19278406|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
19278407|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180372|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180373|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180374|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180375|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
20180376|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
20180377|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180378|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20180379|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
20180380|NCT00187005|Hormones|hormones|mesh-ancestor
20180381|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180382|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20180383|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19278420|NCT04394897|Remifentanil|remifentanil|mesh-list
19278421|NCT04394897|Propofol|propofol|mesh-list
19278422|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19278423|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278424|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278425|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19278426|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
19278427|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
19278428|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19278429|NCT04394897|Narcotics|narcotics|mesh-ancestor
19278430|NCT04394897|Analgesics|analgesics|mesh-ancestor
19278431|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
19278432|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278433|NCT04394728|Trabectedin|trabectedin|mesh-list
19278434|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19278435|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
19278436|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278437|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278438|NCT04394598|Capecitabine|capecitabine|mesh-list
19278439|NCT04394598|Irinotecan|irinotecan|mesh-list
19278440|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19278441|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
19278442|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278443|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180384|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
20180385|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180386|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180387|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
20180388|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
20180389|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278444|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19278445|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19278446|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278447|NCT04394533|Bupivacaine|bupivacaine|mesh-list
19278448|NCT04394533|Prilocaine|prilocaine|mesh-list
19278449|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
19278450|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
19278451|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278452|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278453|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
20355150|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355151|NCT00896987|Lamotrigine|lamotrigine|mesh-list
20355152|NCT00896987|Carbamazepine|carbamazepine|mesh-list
20355153|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
20355154|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20180390|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20180391|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20180392|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180393|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20180394|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20355155|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19278454|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278455|NCT04394234|Warfarin|warfarin|mesh-list
19278456|NCT04394234|Anticoagulants|anticoagulants|mesh-list
20355156|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278457|NCT04394208|Silymarin|silymarin|mesh-list
19278458|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
19278459|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278460|NCT04394208|Protective Agents|protective agents|mesh-ancestor
19278461|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278462|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
19278463|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
19278464|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278465|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278466|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278467|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278468|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278469|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278470|NCT04394390|Vitamin D|vitamin d|mesh-list
19278471|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
19278472|NCT04394390|Vitamins|vitamins|mesh-list
19670891|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
19670892|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
19670893|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
19278473|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
20355157|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20355158|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355159|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20355160|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20355161|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278474|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278475|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19278476|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19278477|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
19278478|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278479|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19278480|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278481|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278482|NCT04394377|Heparin|heparin|mesh-list
19278483|NCT04394377|Enoxaparin|enoxaparin|mesh-list
19278484|NCT04394377|Calcium heparin|calcium heparin|mesh-list
19278485|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
19278486|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
19278487|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
19278488|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19278489|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19278490|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278491|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19278492|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
19278493|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19278494|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
19278495|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278496|NCT04394143|Mannitol|mannitol|mesh-list
20180395|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
20180396|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180397|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19278497|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19278498|NCT04394143|Diuretics|diuretics|mesh-ancestor
19278499|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
19278500|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278501|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
19278502|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19278503|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278504|NCT04393805|Heparin|heparin|mesh-list
19670894|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19670895|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180398|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180399|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180400|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180401|NCT00187031|Topotecan|topotecan|mesh-list
20180402|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20180403|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180404|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180405|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180406|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180407|NCT00187057|Cytarabine|cytarabine|mesh-list
20180408|NCT00187057|Dexamethasone|dexamethasone|mesh-list
19278505|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19278506|NCT04393805|Tinzaparin|tinzaparin|mesh-list
19278507|NCT04393805|Dalteparin|dalteparin|mesh-list
19278508|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
20180409|NCT00187057|Prednisone|prednisone|mesh-list
19278509|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19278510|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19278511|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180410|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
20180411|NCT00187057|Doxorubicin|doxorubicin|mesh-list
20180412|NCT00187057|Methotrexate|methotrexate|mesh-list
20180413|NCT00187057|Etoposide|etoposide|mesh-list
20180414|NCT00187057|Vincristine|vincristine|mesh-list
20180415|NCT00187057|Daunorubicin|daunorubicin|mesh-list
20180416|NCT00187057|Asparaginase|asparaginase|mesh-list
20355162|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20355163|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20355164|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
20355165|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20355166|NCT00896987|Analgesics|analgesics|mesh-ancestor
20355167|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
19278512|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
19278513|NCT04393792|Povidone|povidone|mesh-list
19278514|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
19278515|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
19278516|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19278517|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278518|NCT04393610|Lidocaine|lidocaine|mesh-list
19278519|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
19278520|NCT04393610|Fentanyl|fentanyl|mesh-list
19278521|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
19278522|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
19278523|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278524|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278525|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
19278526|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278527|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19278528|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19278529|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19278530|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19278531|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278532|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19278533|NCT04393610|Narcotics|narcotics|mesh-ancestor
19278534|NCT04393610|Analgesics|analgesics|mesh-ancestor
19278535|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19278536|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19278537|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
19278538|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
19278539|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19278540|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19278541|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
19278542|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19393931|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
19393932|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180417|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
20180418|NCT00187057|Vinblastine|vinblastine|mesh-list
20180419|NCT00187057|Procarbazine|procarbazine|mesh-list
20180420|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180421|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
20180422|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180423|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180424|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180425|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
20180426|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180427|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180428|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180429|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180430|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
20180431|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
20180432|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180433|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20180434|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
20180435|NCT00187057|Hormones|hormones|mesh-ancestor
20180436|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180437|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20180438|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20355168|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393933|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180439|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20180440|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180441|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278543|NCT04393389|Paclitaxel|paclitaxel|mesh-list
19278544|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19278545|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355169|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19278546|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19278547|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
19278548|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
19278549|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278550|NCT04393506|Apatinib|apatinib|mesh-list
19278551|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19278552|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278553|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19278554|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278555|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278556|NCT04393454|Sirolimus|sirolimus|mesh-list
19278557|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19278558|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278559|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19278560|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278561|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
19278562|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278563|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
19278564|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278565|NCT04393584|Leucovorin|leucovorin|mesh-list
19278566|NCT04393584|Docetaxel|docetaxel|mesh-list
19278567|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
19278568|NCT04393584|Irinotecan|irinotecan|mesh-list
19278569|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278570|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
19278571|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
19278572|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
19278573|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278574|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19278575|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19278576|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278577|NCT04393584|Antidotes|antidotes|mesh-ancestor
19278578|NCT04393584|Protective Agents|protective agents|mesh-ancestor
20180442|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20180443|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
20180444|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180445|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670896|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19670897|NCT05116293|Analgesics|analgesics|mesh-ancestor
19670898|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
19278579|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278580|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
19278581|NCT04393584|Vitamins|vitamins|mesh-ancestor
19278582|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
19278583|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
19278584|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19278585|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19278586|NCT04393220|Bevacizumab|bevacizumab|mesh-list
19278587|NCT04393220|Nivolumab|nivolumab|mesh-list
19278588|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19278589|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278590|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19278591|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19278592|NCT04393220|Growth Substances|growth substances|mesh-ancestor
19278593|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278594|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
19278595|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19670899|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670900|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
19670901|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20180446|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
20180447|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
19278596|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278597|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
20180448|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20355170|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19278598|NCT04393246|Ambrisentan|ambrisentan|mesh-list
19670902|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20355171|NCT00897026|Paclitaxel|paclitaxel|mesh-list
19278599|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19670903|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355172|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
19278600|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278601|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19278602|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278603|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19278604|NCT04393207|Bupivacaine|bupivacaine|mesh-list
19278605|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
19278606|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
19278607|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278608|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278609|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
19278610|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278611|NCT04393025|Aspirin|aspirin|mesh-list
19278612|NCT04393025|Clopidogrel|clopidogrel|mesh-list
19278613|NCT04393025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19278614|NCT04393025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19278615|NCT04393025|Analgesics|analgesics|mesh-ancestor
19278616|NCT04393025|Sensory System Agents|sensory system agents|mesh-ancestor
19278617|NCT04393025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278618|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278619|NCT04393025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278620|NCT04393025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278621|NCT04393025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19278622|NCT04393025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19278623|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278624|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19278625|NCT04393025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19278626|NCT04393025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278627|NCT04393025|Antipyretics|antipyretics|mesh-ancestor
19278628|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19278629|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19278630|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19278631|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
19278632|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278633|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
19278634|NCT04392973|Favipiravir|favipiravir|mesh-list
19278635|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
19278636|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278637|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278638|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278639|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278640|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278641|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278642|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
19278643|NCT04392427|Ribavirin|ribavirin|mesh-list
19278644|NCT04392427|Ivermectin|ivermectin|mesh-list
19278645|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
19278646|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
19278647|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278648|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
19278649|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278650|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278651|NCT04392700|Tenofovir|tenofovir|mesh-list
19278652|NCT04392700|Entecavir|entecavir|mesh-list
19278653|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
19278654|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278655|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19278656|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19278657|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278658|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278659|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19670904|NCT05116293|Protective Agents|protective agents|mesh-ancestor
19670905|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
20180449|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20180450|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180451|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
20180452|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180453|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
20180454|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180455|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180456|NCT00187070|Cytarabine|cytarabine|mesh-list
20180457|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20180458|NCT00187070|Dexamethasone|dexamethasone|mesh-list
20180459|NCT00187070|Prednisone|prednisone|mesh-list
19278660|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20180460|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
20180461|NCT00187070|Ifosfamide|ifosfamide|mesh-list
19278661|NCT04392648|Dexamethasone|dexamethasone|mesh-list
19278662|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
19278663|NCT04392648|Bortezomib|bortezomib|mesh-list
19278664|NCT04392648|Pomalidomide|pomalidomide|mesh-list
19278665|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278666|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
19278667|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278668|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278669|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19278670|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
19278671|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278672|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278673|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19278674|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278675|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
19278676|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
19278677|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19670906|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
19670907|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
19670908|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670909|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670910|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
19670911|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692132|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355173|NCT00897026|Doxorubicin|doxorubicin|mesh-list
19278678|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19278679|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
19278680|NCT04392648|Hormones|hormones|mesh-ancestor
19278681|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278682|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19278683|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19278684|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19278685|NCT04392648|Growth Substances|growth substances|mesh-ancestor
19278686|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
19278687|NCT04392479|Aflibercept|aflibercept|mesh-list
19278688|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20355174|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20355175|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20355176|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355177|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
20355178|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
20355179|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
20355180|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355181|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278689|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19278690|NCT04392479|Growth Substances|growth substances|mesh-ancestor
19278691|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278692|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
19278693|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278694|NCT04392557|Metformin|metformin|mesh-list
19278695|NCT04392557|Pioglitazone|pioglitazone|mesh-list
19278696|NCT04392557|Alogliptin|alogliptin|mesh-list
19278697|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19278698|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278699|NCT04392557|Incretins|incretins|mesh-ancestor
19278700|NCT04392557|Hormones|hormones|mesh-ancestor
19278701|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278702|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19278703|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
19278704|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278705|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278706|NCT04392713|Ivermectin|ivermectin|mesh-list
19278707|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278708|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278709|NCT04392375|Nifedipine|nifedipine|mesh-list
19278710|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19278711|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19278712|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278713|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19278714|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278715|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
19278716|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
19692133|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837909|NCT00618072|Metformin|metformin|mesh-list
19278717|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19278718|NCT04392531|Cyclosporine|cyclosporine|mesh-list
19278719|NCT04392531|Cyclosporins|cyclosporins|mesh-list
19278720|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278721|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278722|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278723|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
19278724|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278725|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
19278726|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278727|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
19278728|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278729|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20355182|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
20355183|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355184|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355185|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20355186|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
20355187|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20355188|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20355189|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20355190|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20355191|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355192|NCT00897065|Antibodies|antibodies|mesh-list
20355193|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
20355194|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355195|NCT00897130|Azacitidine|azacitidine|mesh-list
20355196|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20355197|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
19278730|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
19278731|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
19278732|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278733|NCT04392102|Niraparib|niraparib|mesh-list
19278734|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19278735|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278736|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278737|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278738|NCT04392063|Melatonin|melatonin|mesh-list
19278739|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
19278740|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278741|NCT04392063|Protective Agents|protective agents|mesh-ancestor
19278742|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278743|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278744|NCT04392128|Azithromycin|azithromycin|mesh-list
19278745|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
19278746|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19278747|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278748|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
19278749|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20355198|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355199|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355200|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355201|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20355202|NCT00897221|Deferiprone|deferiprone|mesh-list
20355203|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20355204|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
20355205|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
20355206|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355207|NCT00897312|Interferons|interferons|mesh-list
20355208|NCT00897312|Ribavirin|ribavirin|mesh-list
20355209|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
20355210|NCT00897312|Tremelimumab|tremelimumab|mesh-list
20355211|NCT00897312|Infliximab|infliximab|mesh-list
20355212|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278750|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278751|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670912|NCT05076097|Rituximab|rituximab|mesh-list
19670913|NCT05076097|Lenalidomide|lenalidomide|mesh-list
19670914|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670915|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670916|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
19670917|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670918|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19670919|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19670920|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20355213|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
20355214|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355215|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
20355216|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355217|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
20355218|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355219|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
20355220|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355221|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355222|NCT00897377|Temozolomide|temozolomide|mesh-list
19278752|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278753|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278754|NCT04392297|Antibodies|antibodies|mesh-list
20355223|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20355224|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
20425109|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278755|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
19278756|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
19278757|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278758|NCT04392037|Dexamethasone|dexamethasone|mesh-list
19278759|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
19278760|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278761|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
19278762|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278763|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278764|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19278765|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
19278766|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278767|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278768|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19278769|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278770|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
19278771|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
19278772|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278773|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19278774|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
19278775|NCT04392037|Hormones|hormones|mesh-ancestor
19278776|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278777|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19278778|NCT04391998|Metronidazole|metronidazole|mesh-list
19278779|NCT04391998|Albendazole|albendazole|mesh-list
19278780|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278781|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19278782|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19670921|NCT05076097|Growth Substances|growth substances|mesh-ancestor
20180462|NCT00187070|Carboplatin|carboplatin|mesh-list
20180463|NCT00187070|Doxorubicin|doxorubicin|mesh-list
20180464|NCT00187070|Methotrexate|methotrexate|mesh-list
20180465|NCT00187070|Etoposide|etoposide|mesh-list
20180466|NCT00187070|Vincristine|vincristine|mesh-list
20180467|NCT00187070|Vinblastine|vinblastine|mesh-list
20180468|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180469|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
20180470|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180471|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180472|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180473|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
20180474|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180475|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180476|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180477|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180478|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
20180479|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
20180480|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180481|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20180482|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
20180483|NCT00187070|Hormones|hormones|mesh-ancestor
20180484|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180485|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20180486|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180487|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20180488|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180489|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180490|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20180491|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
19278783|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20180492|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19278784|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
19278785|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
19278786|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19278787|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
19278788|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
19278789|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
19278790|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278791|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278792|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
19278793|NCT04391868|Citric Acid|citric acid|mesh-list
19278794|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
19278795|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
19278796|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19278797|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
19278798|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
19278799|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278800|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
19278801|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19278802|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19278803|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278804|NCT04391868|Urological Agents|urological agents|mesh-ancestor
19278805|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
19278806|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19278807|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19278808|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278809|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278810|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278811|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
19278812|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19278813|NCT04391621|Triamcinolone|triamcinolone|mesh-list
19278814|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19278815|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19278816|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19278817|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278818|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
19278819|NCT04391621|Hormones|hormones|mesh-ancestor
19278820|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278821|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278822|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278823|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
19278824|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278825|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278826|NCT04391660|Ethanol|ethanol|mesh-list
19278827|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19278828|NCT04391660|Eusol|eusol|mesh-list
19278829|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19278830|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19278831|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278832|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278833|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278834|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
19393934|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19393935|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
19393936|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19393937|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404135|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355225|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355226|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355227|NCT00897520|Interferons|interferons|mesh-list
20355228|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
20355229|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355230|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
20355231|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355232|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
20355233|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355234|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
20355235|NCT00897871|Carboplatin|carboplatin|mesh-list
20355236|NCT00897871|Etoposide|etoposide|mesh-list
20355237|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
20355238|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355239|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
20355240|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355241|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837910|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
20355242|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20355243|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
19404136|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20355244|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355245|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355246|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20355247|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20355248|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20355249|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20355250|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355251|NCT00897884|Metformin|metformin|mesh-list
20355252|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20355253|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355254|NCT00897975|Red yeast rice|red yeast rice|mesh-list
20355255|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20355256|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20355257|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20355258|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
20355259|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355260|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355261|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20355262|NCT00898287|Gemcitabine|gemcitabine|mesh-list
20355263|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20355264|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
20355265|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355266|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355267|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
20355268|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355269|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355270|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355271|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
20355272|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355273|NCT00898417|Paclitaxel|paclitaxel|mesh-list
20355274|NCT00898417|Bevacizumab|bevacizumab|mesh-list
20355275|NCT00898417|Carboplatin|carboplatin|mesh-list
20355276|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20355277|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355278|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
20355279|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
19278835|NCT04391764|Naltrexone|naltrexone|mesh-list
19278836|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19278837|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19278838|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278839|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
19278840|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355280|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
20355281|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355282|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20355283|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19278841|NCT04391569|Ganaxolone|ganaxolone|mesh-list
19278842|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
19278843|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278844|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278845|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278846|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
19278847|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
19278848|NCT04391478|Milrinone|milrinone|mesh-list
19278849|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
20355284|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20355285|NCT00898417|Growth Substances|growth substances|mesh-ancestor
20355286|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355287|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
20425110|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20425111|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20425112|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20425113|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
20425114|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425115|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425116|NCT01273402|Antibodies|antibodies|mesh-list
20425117|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
20425118|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20425119|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
20425120|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425121|NCT01273441|Amoxicillin|amoxicillin|mesh-list
20425122|NCT01273441|Metronidazole|metronidazole|mesh-list
19278850|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
19278851|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19278852|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20355288|NCT00898508|Antibodies|antibodies|mesh-list
20355289|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
20355290|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355291|NCT00898573|Lapatinib|lapatinib|mesh-list
20355292|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355293|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20355294|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355295|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355296|NCT00898794|Bevacizumab|bevacizumab|mesh-list
20355297|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20355298|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355299|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20355300|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20355301|NCT00898794|Growth Substances|growth substances|mesh-ancestor
20355302|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278853|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278854|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278855|NCT04391478|Urological Agents|urological agents|mesh-ancestor
19278856|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19278857|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19278858|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19278859|NCT04391478|Protective Agents|protective agents|mesh-ancestor
19278860|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278861|NCT04391361|Atropine|atropine|mesh-list
19278862|NCT04391361|Scopolamine|scopolamine|mesh-list
19278863|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
19278864|NCT04391361|Edaravone|edaravone|mesh-list
19278865|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19278866|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19278867|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19278868|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278869|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19278870|NCT04391361|Analgesics|analgesics|mesh-ancestor
19278871|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
19278872|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278873|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19278874|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19278875|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19278876|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
19278877|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19278878|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278879|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19278880|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19278881|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19278882|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
19278883|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19278884|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
19278885|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
19278886|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
19278887|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19278888|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20180493|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180494|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
19278889|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
19278890|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
19278891|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355303|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
20355304|NCT00898846|Tegafur|tegafur|mesh-list
19278892|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19278893|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
20355305|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20355306|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
20425123|NCT01273441|Clarithromycin|clarithromycin|mesh-list
19278894|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19278895|NCT04391361|Protective Agents|protective agents|mesh-ancestor
20180495|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
20180496|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20180497|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20180498|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180499|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
20180500|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180501|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
20180502|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180503|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180504|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20180505|NCT00187070|Renal Agents|renal agents|mesh-ancestor
19278896|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19278897|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19278898|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278899|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
19278900|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19278901|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278902|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278903|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19278904|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19278905|NCT04391231|Protective Agents|protective agents|mesh-ancestor
19278906|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278907|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
19278908|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20355307|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355308|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355309|NCT00898950|Aspirin|aspirin|mesh-list
20355310|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
20355311|NCT00898950|Salicylates|salicylates|mesh-list
20355312|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19278909|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
19278910|NCT04391283|Osimertinib|osimertinib|mesh-list
19278911|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278912|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19278913|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278914|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278915|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
19278916|NCT04391127|Ivermectin|ivermectin|mesh-list
19278917|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
19278918|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19278919|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19278920|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278921|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278922|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278923|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278924|NCT04390789|Calcium|calcium|mesh-list
19278925|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19278926|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278927|NCT04390984|Apatinib|apatinib|mesh-list
19278928|NCT04390984|Gefitinib|gefitinib|mesh-list
19278929|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278930|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19278931|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278932|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278933|NCT04390854|Clotrimazole|clotrimazole|mesh-list
19278934|NCT04390854|Miconazole|miconazole|mesh-list
19278935|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19278936|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278937|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
19278938|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19278939|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19278940|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278941|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278942|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19278943|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
19278944|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278945|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278946|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19278947|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19278948|NCT04390815|Insulin|insulin|mesh-list
19278949|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19278950|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19278951|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278952|NCT04390464|Ravulizumab|ravulizumab|mesh-list
19278953|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20355313|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20355314|NCT00898950|Analgesics|analgesics|mesh-ancestor
20355315|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
20355316|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355317|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355318|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278954|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278955|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
19278956|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355319|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19278957|NCT04390685|Tacrolimus|tacrolimus|mesh-list
19278958|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19278959|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
19278960|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278961|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19278962|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278963|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278964|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
19278965|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20180506|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180507|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
20180508|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20180509|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20180510|NCT00187083|Dexamethasone|dexamethasone|mesh-list
20180511|NCT00187083|Methotrexate|methotrexate|mesh-list
20180512|NCT00187083|Fludarabine|fludarabine|mesh-list
20180513|NCT00187083|Etoposide|etoposide|mesh-list
20180514|NCT00187083|Vincristine|vincristine|mesh-list
20180515|NCT00187083|Topotecan|topotecan|mesh-list
20180516|NCT00187083|Asparaginase|asparaginase|mesh-list
20180517|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
20180518|NCT00187083|Idarubicin|idarubicin|mesh-list
20180519|NCT00187083|Pegaspargase|pegaspargase|mesh-list
20180520|NCT00187083|Teniposide|teniposide|mesh-list
20355320|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20355321|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20355322|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355323|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20355324|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20355325|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355326|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
20355327|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355328|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
20355329|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
19278966|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19278967|NCT04391439|Prednisolone|prednisolone|mesh-list
19278968|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
19278969|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19278970|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
19278971|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19278972|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
19278973|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
19278974|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19278975|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19278976|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19278977|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
19278978|NCT04391439|Hormones|hormones|mesh-ancestor
19278979|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19278980|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19278981|NCT04391439|Protective Agents|protective agents|mesh-ancestor
19278982|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19278983|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19278984|NCT04390334|Efavirenz|efavirenz|mesh-list
20355330|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
20355331|NCT00899197|Tamoxifen|tamoxifen|mesh-list
20355332|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20355333|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
20355334|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20355335|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355336|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355337|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355338|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20355339|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20355340|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20355341|NCT00899483|Insulin|insulin|mesh-list
20355342|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20355343|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355344|NCT00899587|Enalapril|enalapril|mesh-list
20355345|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20355346|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
20355347|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278985|NCT04390334|Famotidine|famotidine|mesh-list
19278986|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20180521|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180522|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
20180523|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
20180524|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217218|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
19278987|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19278988|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19278989|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19278990|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
19278991|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19278992|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19278993|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19278994|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19278995|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19278996|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19278997|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19278998|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19278999|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19279000|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19279001|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
19279002|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
19279003|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279004|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279005|NCT04390594|Nafamostat|nafamostat|mesh-list
19279006|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19279007|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279008|NCT04390594|Analgesics|analgesics|mesh-ancestor
19279009|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
19279010|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279011|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279012|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19279013|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279014|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
19279015|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279016|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279017|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670922|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
19670923|NCT05016895|Azithromycin|azithromycin|mesh-list
19670924|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20355348|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355349|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20355350|NCT00899821|Aldesleukin|aldesleukin|mesh-list
20355351|NCT00899821|Interleukin-12|interleukin-12|mesh-list
20355352|NCT00899821|Sargramostim|sargramostim|mesh-list
20355353|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
20355354|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355355|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355356|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20355357|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20355358|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
20355359|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355360|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20355361|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20355362|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20355363|NCT00899821|Growth Substances|growth substances|mesh-ancestor
20355364|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
20355365|NCT00899951|Fentanyl|fentanyl|mesh-list
20355366|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19670925|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670926|NCT05002530|Vitamin D|vitamin d|mesh-list
19670927|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
19670928|NCT05002530|Vitamins|vitamins|mesh-list
19670929|NCT05002530|Tretinoin|tretinoin|mesh-list
19670930|NCT05002530|Isotretinoin|isotretinoin|mesh-list
19670931|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
19670932|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670933|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19670934|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19670935|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279018|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19279019|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19670936|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
20355367|NCT00899951|Narcotics|narcotics|mesh-ancestor
20355368|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355369|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355370|NCT00899951|Analgesics|analgesics|mesh-ancestor
20355371|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
20355372|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355373|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20355374|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19279020|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19279021|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19279022|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
19279023|NCT04390295|Metformin|metformin|mesh-list
19279024|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19279025|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279026|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19279027|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279028|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279029|NCT04390061|Tofacitinib|tofacitinib|mesh-list
19279030|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
19837911|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19837912|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837913|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
19837914|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19837915|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
19837916|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19279031|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279032|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279033|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279034|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279035|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279036|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279037|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19279038|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
19279039|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19279040|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
19279041|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279042|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
19279043|NCT04389866|Protective Agents|protective agents|mesh-ancestor
19279044|NCT04390152|Ritonavir|ritonavir|mesh-list
19279045|NCT04390152|Lopinavir|lopinavir|mesh-list
19279046|NCT04390152|Azithromycin|azithromycin|mesh-list
19279047|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279048|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19279049|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19279050|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279051|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279052|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279053|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19279054|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19279055|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
19279056|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279057|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19279058|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19279059|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19279060|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
19837917|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
19837918|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20180525|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180526|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20180527|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
20180528|NCT00187083|Hormones|hormones|mesh-ancestor
20180529|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279061|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279062|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279063|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279064|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19279065|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
19279066|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19279067|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
19279068|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279069|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
19279070|NCT04390100|Protective Agents|protective agents|mesh-ancestor
19279071|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
19279072|NCT04390100|Coagulants|coagulants|mesh-ancestor
19279073|NCT04389840|Heparin|heparin|mesh-list
19837919|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20180530|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20180531|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180532|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19279074|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
19279075|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19279076|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279077|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279078|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
19279079|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20355375|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
20355376|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
20355377|NCT00900172|Paclitaxel|paclitaxel|mesh-list
20355378|NCT00900172|Bevacizumab|bevacizumab|mesh-list
19279080|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279081|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279082|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
19279083|NCT04389554|Coagulants|coagulants|mesh-ancestor
19393938|NCT03680183|Entecavir|entecavir|mesh-list
19393939|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
19393940|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393941|NCT03679949|Oxycodone|oxycodone|mesh-list
19393942|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19393943|NCT03679949|Narcotics|narcotics|mesh-ancestor
19393944|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393945|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393946|NCT03679949|Analgesics|analgesics|mesh-ancestor
19393947|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
19393948|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393949|NCT03679897|Ropivacaine|ropivacaine|mesh-list
19393950|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
19393951|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19393952|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
19393953|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
19393954|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19393955|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393956|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
19393957|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393958|NCT03679676|Omalizumab|omalizumab|mesh-list
19393959|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19393960|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19393961|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
19393962|NCT03679546|Infliximab|infliximab|mesh-list
19393963|NCT03679546|Vedolizumab|vedolizumab|mesh-list
19393964|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
19393965|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19393966|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19393967|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
20355379|NCT00900172|Carboplatin|carboplatin|mesh-list
20355380|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20355381|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355382|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
20355383|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
20355384|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
20355385|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355386|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20355387|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20355388|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20355389|NCT00900172|Growth Substances|growth substances|mesh-ancestor
20355390|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355391|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
20425124|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20425125|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393968|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19393969|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19393970|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393971|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
19837920|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
19393972|NCT03679481|Coagulants|coagulants|mesh-ancestor
19393973|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
19670937|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
19670938|NCT04940286|Gemcitabine|gemcitabine|mesh-list
19670939|NCT04940286|Paclitaxel|paclitaxel|mesh-list
19670940|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19670941|NCT04940286|Durvalumab|durvalumab|mesh-list
19670942|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
19670943|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19670944|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
19670945|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19670946|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670947|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
19670948|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
19670949|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
19670950|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393974|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19393975|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19393976|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
20425126|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20180533|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
20180534|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180535|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180536|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
20180537|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279084|NCT04389567|Famotidine|famotidine|mesh-list
19279085|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19279086|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19279087|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19279088|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
20355392|NCT00900445|Prednisone|prednisone|mesh-list
20355393|NCT00900445|Prednisolone|prednisolone|mesh-list
20355394|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20355395|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
20355396|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20355397|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
20355398|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
20355399|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20355400|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20355401|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20355402|NCT00900445|Cortisone|cortisone|mesh-list
20355403|NCT00900445|Vincristine|vincristine|mesh-list
20355404|NCT00900445|Daunorubicin|daunorubicin|mesh-list
20355405|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20355406|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
20355407|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355408|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
20355409|NCT00900445|Hormones|hormones|mesh-ancestor
19279089|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
19279090|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279091|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279092|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279093|NCT04389801|Deferoxamine|deferoxamine|mesh-list
19279094|NCT04389801|Siderophores|siderophores|mesh-ancestor
19279095|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19279096|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
19279097|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
19279098|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279099|NCT04389580|Tamoxifen|tamoxifen|mesh-list
19279100|NCT04389580|Isotretinoin|isotretinoin|mesh-list
19279101|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19279102|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
19279103|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279104|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279105|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19279106|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279107|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19279108|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19279109|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19279110|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
19279111|NCT04389424|Tamoxifen|tamoxifen|mesh-list
19279112|NCT04389424|Anastrozole|anastrozole|mesh-list
19279113|NCT04389424|Exemestane|exemestane|mesh-list
19279114|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19279115|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
19279116|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279117|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279118|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19279119|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279120|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19279121|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19670951|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19670952|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
20180538|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
20180539|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180540|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20180541|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180542|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
20180543|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180544|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20180545|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20355410|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19670953|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
20355411|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425127|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20180546|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20180547|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180548|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
20180549|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19279122|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19279123|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19279124|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19279125|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279126|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279127|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279128|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
19279129|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279130|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279131|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279132|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279133|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279134|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279135|NCT04389411|Montelukast|montelukast|mesh-list
19279136|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19279137|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
19279138|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19279139|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
19279140|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279141|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279142|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19279143|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19279144|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279145|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279146|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
19279147|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279148|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279149|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279150|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279151|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279152|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279153|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
19279154|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19279155|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279156|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
19279157|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279158|NCT04389060|Protective Agents|protective agents|mesh-ancestor
19279159|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279160|NCT04389229|Aldesleukin|aldesleukin|mesh-list
19279161|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
19279162|NCT04389229|Fludarabine|fludarabine|mesh-list
19279163|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19279164|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
19279165|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279166|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279167|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19279168|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
19279169|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279170|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279171|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19279172|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19279173|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19279174|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
19279175|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180550|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19279176|NCT04388774|Ketamine|ketamine|mesh-list
19279177|NCT04388774|Analgesics|analgesics|mesh-ancestor
19279178|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
19279179|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279180|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393977|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19670954|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670955|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670956|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19670957|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
19670958|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180551|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19670959|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20180552|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180553|NCT00187122|Cytarabine|cytarabine|mesh-list
20355412|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355413|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355414|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20355415|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
20355416|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
20355417|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
20355418|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355419|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
20355420|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
20355421|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355422|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355423|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20355424|NCT00900445|Protective Agents|protective agents|mesh-ancestor
20355425|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180554|NCT00187122|Dexamethasone|dexamethasone|mesh-list
20180555|NCT00187122|Prednisone|prednisone|mesh-list
20180556|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
20180557|NCT00187122|Methotrexate|methotrexate|mesh-list
20180558|NCT00187122|Etoposide|etoposide|mesh-list
20180559|NCT00187122|Vincristine|vincristine|mesh-list
19279181|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19279182|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19279183|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
19279184|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
19279185|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279186|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19279187|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19279188|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279189|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279190|NCT04388709|Interferons|interferons|mesh-list
19279191|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279192|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
19279193|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279194|NCT04388176|Compound 21|compound 21|mesh-list
19279195|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19279196|NCT04388904|Tenofovir|tenofovir|mesh-list
19279197|NCT04388904|Emtricitabine|emtricitabine|mesh-list
19279198|NCT04388904|Darunavir|darunavir|mesh-list
20355426|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20355427|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20355428|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355429|NCT00900510|Trimethoprim|trimethoprim|mesh-list
20355430|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20355431|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
20355432|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20355433|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355434|NCT00900510|Renal Agents|renal agents|mesh-ancestor
20355435|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
20355436|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20355437|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20355438|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20355439|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355440|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355441|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20355442|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20355443|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20355444|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20355445|NCT00900744|Tamoxifen|tamoxifen|mesh-list
20180560|NCT00187122|Asparaginase|asparaginase|mesh-list
20180561|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
20180562|NCT00187122|Daunorubicin|daunorubicin|mesh-list
20180563|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180564|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
20612513|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20180565|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180566|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355446|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19279199|NCT04388904|Cobicistat|cobicistat|mesh-list
19279200|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19279201|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
20355447|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
20355448|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180567|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180568|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
19279202|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279203|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20180569|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180570|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180571|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180572|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180573|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
20355449|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355450|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355451|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355452|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20355453|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20355454|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20355455|NCT00900874|Albuterol|albuterol|mesh-list
19279204|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19279205|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279206|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279207|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19279208|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19279209|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19279210|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19279211|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279212|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19279213|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19279214|NCT04388202|Citalopram|citalopram|mesh-list
19279215|NCT04388202|Sertraline|sertraline|mesh-list
19279216|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19279217|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19670960|NCT04753437|Amoxicillin|amoxicillin|mesh-list
19670961|NCT04753437|Clarithromycin|clarithromycin|mesh-list
20355456|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
20355457|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20355458|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
20355459|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355460|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355461|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20355462|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
20355463|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20355464|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20355465|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20612514|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20612515|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20612516|NCT02251795|Aspirin|aspirin|mesh-list
20612517|NCT02251795|Ritonavir|ritonavir|mesh-list
20612518|NCT02251795|Darunavir|darunavir|mesh-list
20612519|NCT02251795|Tipranavir|tipranavir|mesh-list
20612520|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20612521|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612522|NCT02251795|Analgesics|analgesics|mesh-ancestor
20612523|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
20612524|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612525|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612526|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612527|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20612528|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20612529|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279218|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19279219|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279220|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279221|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
19670962|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
19670963|NCT04753437|Esomeprazole|esomeprazole|mesh-list
19670964|NCT04753437|Bismuth|bismuth|mesh-list
19279222|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279223|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19279224|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
19279225|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19279226|NCT04388124|Bosentan|bosentan|mesh-list
19279227|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19279228|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19393978|NCT03679442|Antidotes|antidotes|mesh-list
19670965|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180574|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
20180575|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180576|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670966|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19279229|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279230|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19279231|NCT04388189|Bupropion|bupropion|mesh-list
19279232|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19279233|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
19279234|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19279235|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19279236|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19279237|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19279238|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279239|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
19279240|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279241|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279242|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19279243|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19279244|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279245|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19279246|NCT04388189|Analgesics|analgesics|mesh-ancestor
19279247|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
19279248|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279249|NCT04388111|Morphine|morphine|mesh-list
19279250|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19279251|NCT04388111|Narcotics|narcotics|mesh-ancestor
19279252|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279253|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279254|NCT04388111|Analgesics|analgesics|mesh-ancestor
19279255|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
19279256|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279257|NCT04387786|Albuterol|albuterol|mesh-list
19279258|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19279259|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
19279260|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279261|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279262|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19279263|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
19279264|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
19279265|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19279266|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19279267|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19279268|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19279269|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
19279270|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279271|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279272|NCT04387929|Antibodies|antibodies|mesh-list
19279273|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
19279274|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279275|NCT04387695|Sorafenib|sorafenib|mesh-list
19279276|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279277|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19279278|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279279|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279280|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
19279281|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
19279282|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393979|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393980|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
19393981|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19393982|NCT03679442|Expectorants|expectorants|mesh-ancestor
19393983|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
19393984|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19393985|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
19393986|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393987|NCT03679442|Protective Agents|protective agents|mesh-ancestor
19393988|NCT03679390|Ketamine|ketamine|mesh-list
19393989|NCT03679390|Analgesics|analgesics|mesh-ancestor
19393990|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
19393991|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19393992|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19393993|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19393994|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19393995|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
19393996|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
19393997|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279283|NCT04388033|Temozolomide|temozolomide|mesh-list
19279284|NCT04388033|Interleukin-12|interleukin-12|mesh-list
19279285|NCT04388033|Vaccines|vaccines|mesh-list
19279286|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
19279287|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279288|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19279289|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
19279290|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279291|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279292|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19279293|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19279294|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19279295|NCT04388033|Growth Substances|growth substances|mesh-ancestor
19279296|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
19279297|NCT04387604|Ranibizumab|ranibizumab|mesh-list
19279298|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19279299|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19279300|NCT04387604|Growth Substances|growth substances|mesh-ancestor
19279301|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279302|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
19279303|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279304|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
19279305|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19279306|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279307|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279308|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
19279309|NCT04387305|Coagulants|coagulants|mesh-ancestor
19279310|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
19279311|NCT04387539|Simeprevir|simeprevir|mesh-list
19279312|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
19279313|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279314|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279315|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279316|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279317|NCT04387565|Vanadium|vanadium|mesh-list
19279318|NCT04387565|Trace Elements|trace elements|mesh-ancestor
19279319|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
19279320|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279321|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
19279322|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
19279323|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279324|NCT04387500|Axitinib|axitinib|mesh-list
19279325|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279326|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19670967|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19670968|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19670969|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19279327|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279328|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279329|NCT04387630|Metformin|metformin|mesh-list
19279330|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19279331|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279332|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
19279333|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
19279334|NCT04387201|Dulaglutide|dulaglutide|mesh-list
19279335|NCT04387201|Vitamins|vitamins|mesh-ancestor
19279336|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
19279337|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279338|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
19279339|NCT04387201|Hematinics|hematinics|mesh-ancestor
19279340|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19279341|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
19279342|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19279343|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279344|NCT04387136|Sufentanil|sufentanil|mesh-list
19279345|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19279346|NCT04387136|Narcotics|narcotics|mesh-ancestor
19279347|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279348|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279349|NCT04387136|Analgesics|analgesics|mesh-ancestor
19279350|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
19279351|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279352|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19279353|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19279354|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
19279355|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
19279356|NCT04386876|Ritonavir|ritonavir|mesh-list
19279357|NCT04386876|Lopinavir|lopinavir|mesh-list
19670970|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20612530|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279358|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19279359|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19279360|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279361|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279362|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279363|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19279364|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19279365|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
19279366|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279367|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19279368|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19279369|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
20612531|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20355466|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
20355467|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355468|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279370|NCT04387084|Nivolumab|nivolumab|mesh-list
19279371|NCT04387084|Durvalumab|durvalumab|mesh-list
19279372|NCT04387084|Avelumab|avelumab|mesh-list
19279373|NCT04387084|Cemiplimab|cemiplimab|mesh-list
19279374|NCT04387084|Atezolizumab|atezolizumab|mesh-list
19279375|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
19279376|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19279377|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
19279378|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19279379|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279380|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20355469|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
20355470|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20355471|NCT00900887|Ketorolac|ketorolac|mesh-list
20355472|NCT00900887|Nepafenac|nepafenac|mesh-list
20355473|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20355474|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20355475|NCT00900887|Analgesics|analgesics|mesh-ancestor
20355476|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
20180577|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
20180578|NCT00187122|Hormones|hormones|mesh-ancestor
20180579|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180580|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355477|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355478|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355479|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355480|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355481|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20355482|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279381|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279382|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
19279383|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279384|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19279385|NCT04386850|Calcifediol|calcifediol|mesh-list
19279386|NCT04386850|Vitamins|vitamins|mesh-ancestor
19279387|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
19279388|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279389|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19279390|NCT04386746|Gemcitabine|gemcitabine|mesh-list
19279391|NCT04386746|Docetaxel|docetaxel|mesh-list
19279392|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19279393|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
19279394|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355483|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355484|NCT00900913|Ropivacaine|ropivacaine|mesh-list
19279395|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279396|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
19279397|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837921|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180581|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20180582|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
20180583|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180584|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180585|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
20180586|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
20180587|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180588|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20180589|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20355485|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
20355486|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
20355487|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355488|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355489|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
20355490|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355491|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20355492|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
20355493|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355494|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
20355495|NCT00901069|Rituximab|rituximab|mesh-list
20355496|NCT00901069|Vincristine|vincristine|mesh-list
20355497|NCT00901069|Azacitidine|azacitidine|mesh-list
19279398|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279399|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19279400|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
20355498|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355499|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
20355500|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355501|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355502|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20355503|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
20355504|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355505|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355506|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20355507|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20355508|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20355509|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
19279401|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279402|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
19279403|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
19279404|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
19279405|NCT04387097|Remifentanil|remifentanil|mesh-list
20180590|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180591|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20180592|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180593|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
20180594|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180595|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
20180596|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180597|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180598|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180599|NCT00187161|Cytarabine|cytarabine|mesh-list
20180600|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
20180601|NCT00187161|Doxorubicin|doxorubicin|mesh-list
20180602|NCT00187161|Methotrexate|methotrexate|mesh-list
20180603|NCT00187161|Etoposide|etoposide|mesh-list
20180604|NCT00187161|Vincristine|vincristine|mesh-list
20180605|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180606|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
20180607|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180608|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180609|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180610|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
20180611|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180612|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180613|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20355510|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
20355511|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
20355512|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20355513|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
19279406|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19279407|NCT04387097|Narcotics|narcotics|mesh-ancestor
19279408|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279409|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279410|NCT04387097|Analgesics|analgesics|mesh-ancestor
19279411|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
19279412|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279413|NCT04386499|Folic Acid|folic acid|mesh-list
19279414|NCT04386499|Resveratrol|resveratrol|mesh-list
19279415|NCT04386499|Hematinics|hematinics|mesh-ancestor
20180614|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20355514|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355515|NCT00901147|Bortezomib|bortezomib|mesh-list
19279416|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
19279417|NCT04386499|Vitamins|vitamins|mesh-ancestor
20180615|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19279418|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
19279419|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279420|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
19279421|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279422|NCT04386499|Protective Agents|protective agents|mesh-ancestor
19279423|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279424|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19279425|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
19279426|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19279427|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279428|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279429|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
19279430|NCT04386642|Coagulants|coagulants|mesh-ancestor
19279431|NCT04386577|Vitamin D|vitamin d|mesh-list
19279432|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
19279433|NCT04386577|Vitamins|vitamins|mesh-ancestor
19279434|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
19279435|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279436|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19279437|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19279438|NCT04386122|Loxoprofen|loxoprofen|mesh-list
19279439|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19279440|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279441|NCT04386122|Analgesics|analgesics|mesh-ancestor
19279442|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
19279443|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279444|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279445|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19279446|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355516|NCT00901147|Panobinostat|panobinostat|mesh-list
20355517|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355518|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20355519|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355520|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355521|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
20355522|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
20355523|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20355524|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355525|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20355526|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20355527|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20355528|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
20355529|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355530|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355531|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20355532|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
20355533|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
20355534|NCT00901368|Hormones|hormones|mesh-ancestor
20355535|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279447|NCT04386447|Oxytocin|oxytocin|mesh-list
19279448|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
19279449|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19279450|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279451|NCT04385940|Vitamin D|vitamin d|mesh-list
19279452|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
19279453|NCT04385940|Vitamins|vitamins|mesh-ancestor
19279454|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
19279455|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279456|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20355536|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
20355537|NCT00901381|Lenograstim|lenograstim|mesh-list
20355538|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20355539|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
20355540|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355541|NCT00901407|Lamotrigine|lamotrigine|mesh-list
20355542|NCT00901407|Paroxetine|paroxetine|mesh-list
20355543|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20355544|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20355545|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20355546|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355547|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355548|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
20355549|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279457|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19279458|NCT04385719|Remdesivir|remdesivir|mesh-list
20355550|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20355551|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
19279459|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
19279460|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279461|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
19279462|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279463|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
19279464|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
19279465|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
19279466|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279467|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279468|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
19279469|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279470|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
19279471|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19279472|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279473|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279474|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279475|NCT04385602|Analgesics|analgesics|mesh-ancestor
19279476|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
19279477|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279478|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19279479|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20355552|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20355553|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20355554|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20355555|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355556|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
20355557|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20355558|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20355559|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19279480|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19279481|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
19279482|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355560|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20355561|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355562|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20355563|NCT00901511|Molgramostim|molgramostim|mesh-list
20355564|NCT00901511|Sargramostim|sargramostim|mesh-list
20355565|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
20355566|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355567|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355568|NCT00901524|Interferons|interferons|mesh-list
20355569|NCT00901524|Ribavirin|ribavirin|mesh-list
20355570|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
20355571|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
19670971|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19670972|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19670973|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19670974|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19670975|NCT04753437|Antacids|antacids|mesh-ancestor
19670976|NCT04753437|Diuretics|diuretics|mesh-ancestor
19670977|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
19670978|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670979|NCT04753437|Expectorants|expectorants|mesh-ancestor
19670980|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
20355572|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20355573|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355574|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
20355575|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355576|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
20355577|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355578|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
20355579|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355580|NCT00901537|Azacitidine|azacitidine|mesh-list
20355581|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355582|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20355583|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
20355584|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355585|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355586|NCT00901550|Methotrexate|methotrexate|mesh-list
20355587|NCT00901550|Infliximab|infliximab|mesh-list
20355588|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19279483|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670981|NCT04690504|Melatonin|melatonin|mesh-list
19279484|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19279485|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
19279486|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19279487|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19279488|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279489|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279490|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279491|NCT04385654|Axitinib|axitinib|mesh-list
19279492|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279493|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19279494|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355589|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
20355590|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20355591|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355592|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20355593|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
20355594|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355595|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355596|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
20355597|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355598|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20355599|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19279495|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19393998|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19393999|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19394000|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394001|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394002|NCT03679325|Vitamin D|vitamin d|mesh-list
19394003|NCT03679325|Vitamins|vitamins|mesh-ancestor
19394004|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
19394005|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394006|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19394007|NCT03679182|Olanzapine|olanzapine|mesh-list
19394008|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
20355600|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
20355601|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355602|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20355603|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355604|NCT00901615|Lenalidomide|lenalidomide|mesh-list
20355605|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
20355606|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355607|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19394009|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
19394010|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394011|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394012|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19670982|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
19670983|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19670984|NCT04690504|Protective Agents|protective agents|mesh-ancestor
19670985|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670986|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19670987|NCT04675333|Carboplatin|carboplatin|mesh-list
19670988|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
19670989|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670990|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670991|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
20355608|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19394013|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19394014|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19394015|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394016|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19394017|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19394018|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19394019|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19394020|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394021|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394022|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
19394023|NCT03679065|Acetaminophen|acetaminophen|mesh-list
19394024|NCT03679065|Dexamethasone|dexamethasone|mesh-list
19394025|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
19394026|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19394027|NCT03679065|BB 1101|bb 1101|mesh-list
19394028|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394029|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
19394030|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
19279496|NCT04385563|Docetaxel|docetaxel|mesh-list
19279497|NCT04385563|Trastuzumab|trastuzumab|mesh-list
19279498|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279499|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
19279500|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
19279501|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
19279502|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279503|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19279504|NCT04385550|Paclitaxel|paclitaxel|mesh-list
19279505|NCT04385550|Docetaxel|docetaxel|mesh-list
19279506|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19279507|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279508|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
19279509|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
19279510|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
19279511|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279512|NCT04385290|Cytarabine|cytarabine|mesh-list
19279513|NCT04385290|Daunorubicin|daunorubicin|mesh-list
19279514|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
19279515|NCT04385290|Midostaurin|midostaurin|mesh-list
19279516|NCT04385290|Staurosporine|staurosporine|mesh-list
19279517|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19279518|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
19279519|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279520|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279521|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
19279522|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279523|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19279524|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
19279525|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279526|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19279527|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20355609|NCT00901615|Growth Substances|growth substances|mesh-ancestor
20355610|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
20355611|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355612|NCT00901654|Vaccines|vaccines|mesh-list
20355613|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
20355614|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355615|NCT00901719|Nitroprusside|nitroprusside|mesh-list
20355616|NCT00901719|Acetylcholine|acetylcholine|mesh-list
20355617|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20355618|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
20355619|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20355620|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279528|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19279529|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279530|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19279531|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19279532|NCT04385173|Temozolomide|temozolomide|mesh-list
19279533|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19279534|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
19279535|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279536|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279537|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279538|NCT04385264|Mannitol|mannitol|mesh-list
20355621|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20355622|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
20355623|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355624|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355625|NCT00901732|Calcium|calcium|mesh-list
20355626|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20355627|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355628|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
20355629|NCT00901745|Giapreza|giapreza|mesh-list
20355630|NCT00901745|Norepinephrine|norepinephrine|mesh-list
20355631|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
20355632|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20355633|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20355634|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
20355635|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355636|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355637|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19279539|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
19279540|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279541|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279542|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355638|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20355639|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
20355640|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355641|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355642|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
20355643|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
20355644|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355645|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
20355646|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
20355647|NCT00901784|Topiramate|topiramate|mesh-list
20355648|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
20355649|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20355650|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355651|NCT00901823|Diazoxide|diazoxide|mesh-list
20355652|NCT00901823|Choline|choline|mesh-list
20355653|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
20355654|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20355655|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
20355656|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355657|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355658|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20355659|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
20355660|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20355661|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
20355662|NCT00901849|Sirolimus|sirolimus|mesh-list
20355663|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20355664|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20355665|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355666|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20355667|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355668|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
20355669|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355670|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
20355671|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355672|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19279543|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279544|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279545|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279546|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19279547|NCT04385264|Diuretics|diuretics|mesh-ancestor
19279548|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
19279549|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279550|NCT04385407|Ribavirin|ribavirin|mesh-list
19279551|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
19279552|NCT04385407|Simeprevir|simeprevir|mesh-list
19279553|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
19279554|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279555|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
19279556|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279557|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279558|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279559|NCT04384744|Hormones|hormones|mesh-list
19279560|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279561|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279562|NCT04384783|Hormones|hormones|mesh-list
19279563|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279564|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279565|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19279566|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19279567|NCT04384666|Rotigotine|rotigotine|mesh-list
19279568|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
19279569|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
19279570|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279571|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279572|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279573|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279574|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
19279575|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279576|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279577|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279578|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279579|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279580|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279581|NCT04384653|Furosemide|furosemide|mesh-list
19279582|NCT04384653|Diuretics|diuretics|mesh-ancestor
20355673|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279583|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
20355674|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279584|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279585|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19279586|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19279587|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279588|NCT04384731|Poractant alfa|poractant alfa|mesh-list
19670992|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19670993|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19670994|NCT04671953|Metformin|metformin|mesh-list
20355675|NCT00901875|Buprenorphine|buprenorphine|mesh-list
20355676|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20355677|NCT00901875|Naloxone|naloxone|mesh-list
20355678|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20355679|NCT00901875|Narcotics|narcotics|mesh-ancestor
20355680|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355681|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355682|NCT00901875|Analgesics|analgesics|mesh-ancestor
20355683|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
20355684|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355685|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20355686|NCT00901888|Nitroprusside|nitroprusside|mesh-list
20355687|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20355688|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
20355689|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20355690|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425128|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20425129|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425130|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425131|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20425132|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20425133|NCT01273454|Hydromorphone|hydromorphone|mesh-list
20425134|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20425135|NCT01273454|Narcotics|narcotics|mesh-ancestor
19279589|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19279590|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
19279591|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279592|NCT04384458|Ivermectin|ivermectin|mesh-list
19279593|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
19279594|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279595|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279596|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279597|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279598|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279599|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19670995|NCT04671953|BMS-986165|bms-986165|mesh-list
19670996|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19670997|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19670998|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
19670999|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19671000|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279600|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
19279601|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19279602|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
19279603|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279604|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279605|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19671001|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671002|NCT04585061|Lidocaine|lidocaine|mesh-list
20180616|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20180617|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180618|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20180619|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
20180620|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180621|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180622|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
20180623|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
20180624|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20180625|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20180626|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20180627|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
20180628|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180629|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
20425136|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425137|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671003|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
19279606|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
19279607|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19279608|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
20355691|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20355692|NCT00902031|Sennosides|sennosides|mesh-list
20355693|NCT00902031|Senna Extract|senna extract|mesh-list
20355694|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
20355695|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355696|NCT00902031|Laxatives|laxatives|mesh-ancestor
20355697|NCT00902031|Cathartics|cathartics|mesh-ancestor
20355698|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20355699|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
20355700|NCT00902057|Coagulants|coagulants|mesh-ancestor
20355701|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20355702|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
20355703|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279609|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279610|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279611|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19279612|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
19279613|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
19279614|NCT04384133|Protective Agents|protective agents|mesh-ancestor
19279615|NCT04383990|Insulin|insulin|mesh-list
20355704|NCT00902070|Rocuronium|rocuronium|mesh-list
20355705|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20355706|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20355707|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20355708|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355709|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279616|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19279617|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279618|NCT04383977|Etoposide|etoposide|mesh-list
19279619|NCT04383977|Apatinib|apatinib|mesh-list
19279620|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19279621|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279622|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19279623|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19671004|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
19671005|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671006|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671007|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
19671008|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180630|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
20180631|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
20180632|NCT00187174|Everolimus|everolimus|mesh-list
20180633|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180634|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180635|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
19279624|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279625|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279626|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19279627|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
19279628|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
19279629|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279630|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355710|NCT00902135|Interferons|interferons|mesh-list
20355711|NCT00902135|Interferon-beta|interferon-beta|mesh-list
20355712|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
20355713|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279631|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19279632|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19279633|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19279634|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279635|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279636|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19279637|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19279638|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19671009|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20180636|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180637|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
20180638|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20180639|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
20180640|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355714|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
20355715|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355716|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
19279639|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19279640|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
19279641|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279642|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279643|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19279644|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19279645|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
19279646|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19279647|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19279648|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
19279649|NCT04383717|Azithromycin|azithromycin|mesh-list
19279650|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279651|NCT04383717|Levamisole|levamisole|mesh-list
19279652|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
19279653|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19279654|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279655|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
19279656|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279657|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279658|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279659|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279660|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279661|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19279662|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
19279663|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279664|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
19279665|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
19279666|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
19394031|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394032|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394033|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394034|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
20355717|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355718|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20355719|NCT00902187|Fesoterodine|fesoterodine|mesh-list
20355720|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20355721|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20355722|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
20355723|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394035|NCT03679065|Hormones|hormones|mesh-ancestor
19394036|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394037|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19394038|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394039|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
19394040|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394041|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394042|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19394043|NCT03679065|Analgesics|analgesics|mesh-ancestor
19394044|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
19394045|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
19394046|NCT03679052|Clonidine|clonidine|mesh-list
19394047|NCT03679052|Mirtazapine|mirtazapine|mesh-list
19394048|NCT03679052|Analgesics|analgesics|mesh-ancestor
20355724|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355725|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355726|NCT00902187|Urological Agents|urological agents|mesh-ancestor
20355727|NCT00902395|Midazolam|midazolam|mesh-list
20355728|NCT00902395|Ketamine|ketamine|mesh-list
20355729|NCT00902395|Analgesics|analgesics|mesh-ancestor
20355730|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
20355731|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355732|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394049|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
19394050|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394051|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394052|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19394053|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
19394054|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
19394055|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19394056|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19671010|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20355733|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20355734|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19394057|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19394058|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
19394059|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180641|NCT00187330|Expectorants|expectorants|mesh-ancestor
20180642|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
20180643|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20180644|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
20180645|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180646|NCT00187330|Protective Agents|protective agents|mesh-ancestor
19279667|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
19279668|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19279669|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355735|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
20355736|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
20355737|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355738|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20355739|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20355740|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355741|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355742|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20355743|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19279670|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279671|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279672|NCT04383418|Analgesics|analgesics|mesh-ancestor
19279673|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
19279674|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279675|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19279676|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19279677|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19279678|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
19279679|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279680|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279681|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
20355744|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20355745|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20355746|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20355747|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
20355748|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
20355749|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20355750|NCT00902421|Serotonin|serotonin|mesh-list
20355751|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20180647|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180648|NCT00187330|Antidotes|antidotes|mesh-ancestor
20180649|NCT00187408|Heparin|heparin|mesh-list
20180650|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20180651|NCT00187408|Tinzaparin|tinzaparin|mesh-list
20180652|NCT00187408|Dalteparin|dalteparin|mesh-list
20355752|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20355753|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19279682|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19279683|NCT04383548|Antibodies|antibodies|mesh-list
19279684|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
19279685|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279686|NCT04383093|Tadalafil|tadalafil|mesh-list
19279687|NCT04383093|Tamsulosin|tamsulosin|mesh-list
19279688|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
19279689|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19279690|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19279691|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279692|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279693|NCT04383093|Urological Agents|urological agents|mesh-ancestor
19279694|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19279695|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19279696|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19279697|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
19279698|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279699|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279700|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19279701|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
19279702|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279703|NCT04382768|Ibuprofen|ibuprofen|mesh-list
19279704|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19279705|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279706|NCT04382768|Analgesics|analgesics|mesh-ancestor
19279707|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
20180653|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
20355754|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355755|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355756|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
20355757|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355758|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20355759|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20355760|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
20355761|NCT00902460|Midazolam|midazolam|mesh-list
20355762|NCT00902460|Tofacitinib|tofacitinib|mesh-list
20355763|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20355764|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20355765|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279708|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279709|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279710|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19279711|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279712|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19279713|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279714|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279715|NCT04383275|Capecitabine|capecitabine|mesh-list
19279716|NCT04383275|Trastuzumab|trastuzumab|mesh-list
19279717|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19279718|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
19279719|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279720|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279721|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19279722|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
19279723|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279724|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279725|NCT04383067|Aldesleukin|aldesleukin|mesh-list
19279726|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279727|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19279728|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19279729|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
19279730|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279731|NCT04382950|Tretinoin|tretinoin|mesh-list
19279732|NCT04382950|Isotretinoin|isotretinoin|mesh-list
19279733|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279734|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
19279735|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
19279736|NCT04382859|Bupivacaine|bupivacaine|mesh-list
19279737|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
19279738|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
19279739|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279740|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279741|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
19279742|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279743|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
19279744|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19279745|NCT04382404|Velpatasvir|velpatasvir|mesh-list
20180654|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20180655|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20180656|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180657|NCT00187447|Indomethacin|indomethacin|mesh-list
20180658|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20180659|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20180660|NCT00187447|Analgesics|analgesics|mesh-ancestor
19279746|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
20180661|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
19279747|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279748|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
20355766|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355767|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20355768|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20355769|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20355770|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19279749|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
19279750|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279751|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20180662|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180663|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355771|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
20355772|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
19279752|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279753|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279754|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279755|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355773|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
20355774|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
20355775|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355776|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355777|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20355778|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355779|NCT00902473|Topiramate|topiramate|mesh-list
20355780|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
20355781|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19279756|NCT04382443|Colchicine|colchicine|mesh-list
19279757|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
19279758|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279759|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
19279760|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
19279761|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
19279762|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279763|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279764|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
19279765|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19279766|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279767|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279768|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279769|NCT04382170|Analgesics|analgesics|mesh-ancestor
19279770|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
19279771|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279772|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20355782|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355783|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
19279773|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19279774|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19279775|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
19279776|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279777|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279778|NCT04382079|Propolis|propolis|mesh-list
19279779|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279780|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19279781|NCT04382352|Trastuzumab|trastuzumab|mesh-list
19279782|NCT04382352|Antibodies|antibodies|mesh-list
19279783|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
19279784|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19279785|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
19279786|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355784|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
20355785|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20355786|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20355787|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425138|NCT01273454|Analgesics|analgesics|mesh-ancestor
19279787|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279788|NCT04382209|Meperidine|meperidine|mesh-list
19279789|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19279790|NCT04382209|Narcotics|narcotics|mesh-ancestor
19279791|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279792|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279793|NCT04382209|Analgesics|analgesics|mesh-ancestor
19279794|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
19279795|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279796|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19279797|NCT04382300|Thalidomide|thalidomide|mesh-list
19279798|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19279799|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
19279800|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279801|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
19279802|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19279803|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279804|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19279805|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19279806|NCT04382300|Growth Substances|growth substances|mesh-ancestor
20180664|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180665|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180666|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
20180667|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
20180668|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20180669|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20180670|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180671|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612532|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20180672|NCT00187499|Fluticasone|fluticasone|mesh-list
20180673|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355788|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355789|NCT00902512|Urological Agents|urological agents|mesh-ancestor
20355790|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20355791|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
20355792|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355793|NCT00902603|Iloprost|iloprost|mesh-list
20355794|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20355795|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
20355796|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20355797|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
20355798|NCT00902655|Coagulants|coagulants|mesh-ancestor
20355799|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20355800|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
20355801|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355802|NCT00902681|Fesoterodine|fesoterodine|mesh-list
19279807|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
19279808|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279809|NCT04382027|Vitamins|vitamins|mesh-list
19279810|NCT04382027|Vitamin K|vitamin k|mesh-list
19279811|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
19279812|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
19279813|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279814|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19279815|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279816|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279817|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
19279818|NCT04382027|Coagulants|coagulants|mesh-ancestor
19279819|NCT04381884|Ivermectin|ivermectin|mesh-list
19279820|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279821|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279822|NCT04381962|Azithromycin|azithromycin|mesh-list
19279823|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19279824|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279825|NCT04381910|Irinotecan|irinotecan|mesh-list
19279826|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19279827|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19279828|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279829|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279830|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279831|NCT04381741|Antibodies|antibodies|mesh-list
19279832|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19279833|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
19279834|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279835|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
20180674|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20180675|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
20180676|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180677|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180678|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20180679|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
20180680|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
20180681|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20180682|NCT00187525|Memantine|memantine|mesh-list
20180683|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20180684|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20180685|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
20180686|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180687|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180688|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180689|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20180690|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20180691|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
20180692|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20180693|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20180694|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180695|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20180696|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20180697|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
20180698|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180699|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
20180700|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
20180701|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279836|NCT04381845|Vaccines|vaccines|mesh-list
19279837|NCT04381845|Immunologic Factors|immunologic factors|mesh-ancestor
20180702|NCT00187564|Protective Agents|protective agents|mesh-ancestor
20355803|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19279838|NCT04381845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279839|NCT04382144|Bupivacaine|bupivacaine|mesh-list
19279840|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
19279841|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
19279842|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19279843|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279844|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
19279845|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279846|NCT04382014|Curcumin|curcumin|mesh-list
19279847|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19279848|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279849|NCT04382014|Analgesics|analgesics|mesh-ancestor
19279850|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
19279851|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279852|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279853|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19279854|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279855|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279856|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279857|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279858|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
20355804|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20355805|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
20180703|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180704|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
20180705|NCT00187564|Vitamins|vitamins|mesh-ancestor
20180706|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
20180707|NCT00187577|Bimatoprost|bimatoprost|mesh-list
20180708|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20180709|NCT00187577|Latanoprost|latanoprost|mesh-list
20355806|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355807|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355808|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355809|NCT00902681|Urological Agents|urological agents|mesh-ancestor
20355810|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
20355811|NCT00902707|Guaifenesin|guaifenesin|mesh-list
20355812|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19279859|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19279860|NCT04381858|Antibodies|antibodies|mesh-list
19279861|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
19279862|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394060|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394061|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
19394062|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19394063|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19394064|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
19394065|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
19394066|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19394067|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19394068|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394069|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19671011|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20355813|NCT00902707|Expectorants|expectorants|mesh-ancestor
19394070|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19671012|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20180710|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20180711|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20180712|NCT00187707|Gabapentin|gabapentin|mesh-list
20180713|NCT00187707|Analgesics|analgesics|mesh-ancestor
20180714|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
20180715|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180716|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180717|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
20180718|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20180719|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20180720|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20180721|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20180722|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20180723|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20180724|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180725|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180726|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
20180727|NCT00187746|Adefovir|adefovir|mesh-list
20180728|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19671013|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671014|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19671015|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19671016|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
19671017|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671018|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671019|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671020|NCT04564157|Paclitaxel|paclitaxel|mesh-list
19671021|NCT04564157|Carboplatin|carboplatin|mesh-list
19279863|NCT04381377|Bromides|bromides|mesh-list
19279864|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
19279865|NCT04381234|Citric Acid|citric acid|mesh-list
19279866|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
19279867|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
19279868|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
19279869|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19279870|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
19279871|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
19279872|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279873|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19279874|NCT04380974|Bevacizumab|bevacizumab|mesh-list
19279875|NCT04380974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19279876|NCT04380974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279877|NCT04380974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19279878|NCT04380974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19279879|NCT04380974|Growth Substances|growth substances|mesh-ancestor
19279880|NCT04380974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279881|NCT04380974|Growth Inhibitors|growth inhibitors|mesh-ancestor
19279882|NCT04381104|Acetaminophen|acetaminophen|mesh-list
19279883|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19279884|NCT04381104|Analgesics|analgesics|mesh-ancestor
19279885|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
19279886|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279887|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279888|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
19279889|NCT04380597|Betamethasone|betamethasone|mesh-list
19279890|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
19279891|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19279892|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
19279893|NCT04380597|Calcipotriene|calcipotriene|mesh-list
19279894|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19279895|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19279896|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
19279897|NCT04380597|Hormones|hormones|mesh-ancestor
19279898|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279899|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279900|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19671022|NCT04564157|Nivolumab|nivolumab|mesh-list
19671023|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671024|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355814|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
19279901|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
19279902|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
19279903|NCT04380818|Ritonavir|ritonavir|mesh-list
19279904|NCT04380818|Lopinavir|lopinavir|mesh-list
19279905|NCT04380818|Azithromycin|azithromycin|mesh-list
19279906|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
19279907|NCT04380818|Heparin|heparin|mesh-list
19279908|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19279909|NCT04380818|Tinzaparin|tinzaparin|mesh-list
20355815|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20355816|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20355817|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
20612533|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279910|NCT04380818|Dalteparin|dalteparin|mesh-list
19279911|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19279912|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19279913|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279914|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279915|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279916|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19279917|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20355818|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355819|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355820|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355821|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
20355822|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19279918|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
20612534|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
20612535|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19279919|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19279920|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19279921|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19279922|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
20355823|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
20355824|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
20355825|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355826|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
20355827|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20355828|NCT00902772|Lorazepam|lorazepam|mesh-list
20355829|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
19279923|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19279924|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279925|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19279926|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
19279927|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19279928|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19279929|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19279930|NCT04380857|Dexamethasone|dexamethasone|mesh-list
19279931|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19279932|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
19279933|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
19279934|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279935|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279936|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19279937|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
19279938|NCT04380857|Hormones|hormones|mesh-ancestor
19279939|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19279940|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19279941|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279942|NCT04380402|Atorvastatin|atorvastatin|mesh-list
19279943|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19279944|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19279945|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
19279946|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279947|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19279948|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19279949|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279950|NCT04380467|Vitamin D|vitamin d|mesh-list
19279951|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
19279952|NCT04380467|Vitamins|vitamins|mesh-ancestor
19279953|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
19279954|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279955|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19279956|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19279957|NCT04380220|Protein C|protein c|mesh-list
19279958|NCT04380220|Antithrombins|antithrombins|mesh-list
19279959|NCT04380220|Protein S|protein s|mesh-list
19279960|NCT04380220|Factor VIII|factor viii|mesh-list
19279961|NCT04380220|Complement C3|complement c3|mesh-list
19279962|NCT04380220|Coagulants|coagulants|mesh-ancestor
19279963|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19279964|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
19279965|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19279966|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279967|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
19279968|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19279969|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19279970|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
19279971|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279972|NCT04380376|Melphalan|melphalan|mesh-list
19279973|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19279974|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
19279975|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279976|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19279977|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19279978|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355830|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
20355831|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
20355832|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355833|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279979|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
19404137|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355834|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355835|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20355836|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20355837|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20355838|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20355839|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20355840|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
20355841|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
20355842|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355843|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355844|NCT00902811|Artesunate|artesunate|mesh-list
20355845|NCT00902811|Amodiaquine|amodiaquine|mesh-list
20355846|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
19279980|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279981|NCT04380181|Milrinone|milrinone|mesh-list
19279982|NCT04380181|Epinephrine|epinephrine|mesh-list
19279983|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19279984|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19279985|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
19279986|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19279987|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19279988|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19279989|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19279990|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19279991|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
19279992|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19279993|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19279994|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
19279995|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
19279996|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
19279997|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19279998|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19279999|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19280000|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
19280001|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20355847|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20355848|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20355849|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355850|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355851|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
20355852|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
20355853|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20355854|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
20355855|NCT00902837|Oxycodone|oxycodone|mesh-list
20355856|NCT00902837|Naloxone|naloxone|mesh-list
20355857|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20355858|NCT00902837|Narcotics|narcotics|mesh-ancestor
20355859|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280002|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19280003|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280004|NCT04380181|Protective Agents|protective agents|mesh-ancestor
19280012|NCT04380298|Ketorolac|ketorolac|mesh-list
19280013|NCT04380298|Epinephrine|epinephrine|mesh-list
19280014|NCT04380298|Ropivacaine|ropivacaine|mesh-list
19280015|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
19280016|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
19280017|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280018|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280019|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
19280020|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280021|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19280022|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19280023|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
19280024|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280025|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280026|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19280027|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20355860|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280028|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
20355861|NCT00902837|Analgesics|analgesics|mesh-ancestor
20355862|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
19280029|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19280030|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
19280031|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
19280032|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
19280033|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19280034|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19280035|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280036|NCT04380298|Analgesics|analgesics|mesh-ancestor
19280037|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280038|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280039|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19280040|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180729|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
20180730|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180731|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20180732|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20180733|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180734|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180735|NCT00187759|Cephalexin|cephalexin|mesh-list
20180736|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180737|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280041|NCT04380103|Bevacizumab|bevacizumab|mesh-list
19280042|NCT04380103|Capecitabine|capecitabine|mesh-list
19280043|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
19280044|NCT04380103|Irinotecan|irinotecan|mesh-list
19280045|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19280046|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280047|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19280048|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19280049|NCT04380103|Growth Substances|growth substances|mesh-ancestor
19280050|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280051|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
19280052|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19280053|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
19280054|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280055|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19280056|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19280057|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671025|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
19671026|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
19671027|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19671028|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671029|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19671030|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19671031|NCT04539236|Lenalidomide|lenalidomide|mesh-list
19671032|NCT04539236|Luspatercept|luspatercept|mesh-list
20355863|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355864|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20355865|NCT00902915|Dexamethasone|dexamethasone|mesh-list
20355866|NCT00902915|Lenalidomide|lenalidomide|mesh-list
20355867|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355868|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
20355869|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
20355870|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355871|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355872|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355873|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
20355874|NCT00902915|Hormones|hormones|mesh-ancestor
20355875|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20355876|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355877|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355878|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
20355879|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20355880|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19280058|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
19671033|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
19280059|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280060|NCT04380012|Trastuzumab|trastuzumab|mesh-list
19280061|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20180738|NCT00187798|Metformin|metformin|mesh-list
20180739|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20180740|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180741|NCT00187915|Cyclosporine|cyclosporine|mesh-list
20180742|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
19280062|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280063|NCT04380025|Pycnogenols|pycnogenols|mesh-list
20180743|NCT00187915|Tacrolimus|tacrolimus|mesh-list
19280064|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19280065|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
19280066|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280067|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
19280068|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280069|NCT04380025|Protective Agents|protective agents|mesh-ancestor
19280070|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19280071|NCT04379739|Apatinib|apatinib|mesh-list
19280072|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280073|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19280074|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280075|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280076|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280077|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
19280078|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280079|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280080|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280081|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280082|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280083|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280084|NCT04379180|Bosentan|bosentan|mesh-list
19280085|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
19280086|NCT04379180|Tadalafil|tadalafil|mesh-list
19280087|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
19280088|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19280089|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19280090|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280091|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280092|NCT04379180|Urological Agents|urological agents|mesh-ancestor
19280093|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19280094|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19280095|NCT04379271|Calcium|calcium|mesh-list
19280096|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19280097|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394071|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19394072|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19394073|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19394074|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
19394075|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19394076|NCT03679013|Acetaminophen|acetaminophen|mesh-list
19394077|NCT03679013|Gabapentin|gabapentin|mesh-list
19394078|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19394079|NCT03679013|Analgesics|analgesics|mesh-ancestor
19394080|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
19394081|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394082|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394083|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
19394084|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
19394085|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19394086|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19394087|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394088|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19394089|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19394090|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19394091|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394092|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394093|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
19394094|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
19394095|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19394096|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394097|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19394098|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
19394099|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394100|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394101|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394102|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404138|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404139|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404140|NCT03597308|Narcotics|narcotics|mesh-ancestor
19404141|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404142|NCT03597282|Nivolumab|nivolumab|mesh-list
19404143|NCT03597282|Ipilimumab|ipilimumab|mesh-list
19404144|NCT03597282|Poly ICLC|poly iclc|mesh-list
19404145|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20355881|NCT00902915|Growth Substances|growth substances|mesh-ancestor
20355882|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
20355883|NCT00902941|Rasagiline|rasagiline|mesh-list
20355884|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20355885|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355886|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355887|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20355888|NCT00902941|Protective Agents|protective agents|mesh-ancestor
20355889|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280098|NCT04379219|Methotrexate|methotrexate|mesh-list
19280099|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19280100|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
19280101|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19280102|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280103|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19280104|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
19280105|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280106|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280107|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
20355890|NCT00902954|Letrozole|letrozole|mesh-list
20355891|NCT00902954|Anastrozole|anastrozole|mesh-list
20355892|NCT00902954|Exemestane|exemestane|mesh-list
20355893|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355894|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19280108|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280109|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19280110|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280111|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
19280112|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280113|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19280114|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
19280115|NCT04379310|Calcium|calcium|mesh-list
19280116|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19280117|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19280118|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280119|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
19280120|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280121|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280122|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280123|NCT04378972|Vitamin D|vitamin d|mesh-list
19280124|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
19280125|NCT04378972|Curcumin|curcumin|mesh-list
19280126|NCT04378972|Tramiprosate|tramiprosate|mesh-list
19280127|NCT04378972|Vitamins|vitamins|mesh-ancestor
19280128|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
19280129|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280130|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19280131|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19280132|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19280133|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280134|NCT04378972|Analgesics|analgesics|mesh-ancestor
20355895|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20355896|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355897|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355898|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20355899|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
20355900|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20355901|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355902|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355903|NCT00902967|Atorvastatin|atorvastatin|mesh-list
20355904|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20355905|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20355906|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
20355907|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355908|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20355909|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20355910|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355911|NCT00903045|Propiverine|propiverine|mesh-list
20355912|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
20355913|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
20355914|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280135|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
19394103|NCT03678792|Morphine|morphine|mesh-list
20355915|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355916|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20355917|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20355918|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
20355919|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20355920|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355921|NCT00903045|Urological Agents|urological agents|mesh-ancestor
20355922|NCT00903084|Tenofovir|tenofovir|mesh-list
20355923|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
20355924|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671034|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671035|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19671036|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19671037|NCT04539236|Growth Substances|growth substances|mesh-ancestor
19671038|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
19671039|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671040|NCT04539236|Hematinics|hematinics|mesh-ancestor
19671041|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19671042|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
19671043|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671044|NCT04450498|Vaccines|vaccines|mesh-list
19671045|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
20355925|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20355926|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20355927|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355928|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355929|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20355930|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20355931|NCT00903188|Cyclosporine|cyclosporine|mesh-list
19671046|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692134|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692135|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19692136|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
19692137|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692138|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692139|NCT04996251|Bupivacaine|bupivacaine|mesh-list
19692140|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
20355932|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
20355933|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
20355934|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20355935|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20355936|NCT00903188|Prednisolone|prednisolone|mesh-list
20355937|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
20355938|NCT00903188|Everolimus|everolimus|mesh-list
20355939|NCT00903188|Cyclosporins|cyclosporins|mesh-list
20355940|NCT00903188|Basiliximab|basiliximab|mesh-list
20355941|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20355942|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
20355943|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355944|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355945|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20355946|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
20355947|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355948|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
20355949|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355950|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
20355951|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20355952|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20355953|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280136|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280137|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280138|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280139|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280140|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280141|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280142|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
19280143|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
19280144|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
19280145|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280146|NCT04379102|Anesthetics|anesthetics|mesh-list
19280147|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
19280148|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280149|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612536|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19280150|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
20355954|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355955|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
20355956|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
20355957|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355958|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20355959|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
20355960|NCT00903188|Hormones|hormones|mesh-ancestor
20355961|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20355962|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20180744|NCT00187915|Cyclosporins|cyclosporins|mesh-list
20180745|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180746|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
20180747|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180748|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20180749|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180750|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180751|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
20180752|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180753|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
20180754|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180755|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180756|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180757|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20180758|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
20180759|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180760|NCT00187928|Topiramate|topiramate|mesh-list
20355963|NCT00903188|Protective Agents|protective agents|mesh-ancestor
20355964|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20355965|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20355966|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20355967|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
19280151|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280152|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19280153|NCT04378868|Metronidazole|metronidazole|mesh-list
19280154|NCT04378868|Cefuroxime|cefuroxime|mesh-list
19280155|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
19280156|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19280157|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280158|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
20355968|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20355969|NCT00903214|Riluzole|riluzole|mesh-list
20355970|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
20355971|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20355972|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20355973|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280159|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280160|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280161|NCT04378608|Ribavirin|ribavirin|mesh-list
19280162|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
19280163|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280164|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
19280165|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280166|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19280167|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19280168|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19280169|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280170|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
19280171|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280172|NCT04378231|Amoxicillin|amoxicillin|mesh-list
19280173|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
19280174|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
19280175|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19280176|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280177|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355974|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355975|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355976|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20355977|NCT00903214|Protective Agents|protective agents|mesh-ancestor
19280178|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19280179|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280180|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280181|NCT04378283|Lidocaine|lidocaine|mesh-list
19280182|NCT04378283|Epinephrine|epinephrine|mesh-list
20180761|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
19280183|NCT04378283|Tetracaine|tetracaine|mesh-list
19280184|NCT04378283|Anesthetics|anesthetics|mesh-list
20180762|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20180763|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280185|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
19280186|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280187|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280188|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
19280189|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280190|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19280191|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19280192|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19280193|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280194|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280195|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19280196|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19280197|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
19280198|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280199|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19280200|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19280201|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
19280202|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19280203|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
19280204|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
19280205|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
19280206|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19280207|NCT04377867|Abatacept|abatacept|mesh-list
19280208|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19280209|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280210|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280211|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280212|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
19280213|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280214|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280215|NCT04377789|Quercetin|quercetin|mesh-list
19280216|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
19280217|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280218|NCT04377789|Protective Agents|protective agents|mesh-ancestor
19280219|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280220|NCT04377646|Zinc|zinc|mesh-list
19280221|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280222|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
19280223|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280224|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280225|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280226|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280227|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280228|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280229|NCT04377646|Trace Elements|trace elements|mesh-ancestor
19280230|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
20180764|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
20180765|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20180766|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180767|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20180768|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
20180769|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20180770|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180771|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180772|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180773|NCT00187993|Hormones|hormones|mesh-list
20180774|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180775|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180776|NCT00188006|Heparin|heparin|mesh-list
20180777|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
19280231|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280232|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
20180778|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20180779|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20180780|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180781|NCT00188045|Propranolol|propranolol|mesh-list
20180782|NCT00188045|Spironolactone|spironolactone|mesh-list
20180783|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20180784|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20180785|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
20180786|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180787|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180788|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280233|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
19280234|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280235|NCT04377386|Vitamin D|vitamin d|mesh-list
19280236|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
19280237|NCT04377386|Vitamins|vitamins|mesh-list
19280238|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
19280239|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671047|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19671048|NCT04425174|Anesthetics|anesthetics|mesh-list
19671049|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280240|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19280241|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19280242|NCT04377399|Vitamin D|vitamin d|mesh-list
19280243|NCT04377399|Vitamins|vitamins|mesh-ancestor
19280244|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
19280245|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280246|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20355978|NCT00903227|Fluticasone|fluticasone|mesh-list
20355979|NCT00903227|Xhance|xhance|mesh-list
20355980|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20355981|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20180789|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20180790|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20180791|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
20180792|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20180793|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
20180794|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20180795|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20180796|NCT00188045|Diuretics|diuretics|mesh-ancestor
20180797|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
20180798|NCT00188071|Acetaminophen|acetaminophen|mesh-list
20180799|NCT00188071|Ketoprofen|ketoprofen|mesh-list
20180800|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20180801|NCT00188071|Analgesics|analgesics|mesh-ancestor
20180802|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
20180803|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355982|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
20355983|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20355984|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20355985|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20355986|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
20355987|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
20355988|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20355989|NCT00903279|Retapamulin|retapamulin|mesh-list
20355990|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20355991|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20355992|NCT00903292|Pemetrexed|pemetrexed|mesh-list
20355993|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20355994|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355995|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20355996|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20355997|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20355998|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19280247|NCT04377321|Colchicine|colchicine|mesh-list
19280248|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
19280249|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280250|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
19280251|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
19280252|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
19280253|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280254|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280255|NCT04377087|Olaparib|olaparib|mesh-list
19280256|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19280257|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280258|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280259|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20355999|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356000|NCT00903656|Lapatinib|lapatinib|mesh-list
20356001|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356002|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356003|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280260|NCT04377308|Fluoxetine|fluoxetine|mesh-list
19671050|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280261|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19671051|NCT04418479|Aspirin|aspirin|mesh-list
20356004|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180804|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280262|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19280263|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280264|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280265|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356005|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20356006|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356007|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356008|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356009|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356010|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
20356011|NCT00903747|Prucalopride|prucalopride|mesh-list
20356012|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20356013|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356014|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20356015|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20356016|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356017|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356018|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356019|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356020|NCT00903747|Laxatives|laxatives|mesh-ancestor
20356021|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20356022|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20356023|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20356024|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
20356025|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356026|NCT00903825|Lidocaine|lidocaine|mesh-list
20356027|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
19280266|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
19280267|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280268|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19280269|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
19280270|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19280271|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19280272|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19280273|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394104|NCT03678792|Buprenorphine|buprenorphine|mesh-list
19394105|NCT03678792|Tramadol|tramadol|mesh-list
19394106|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19394107|NCT03678792|Naloxone|naloxone|mesh-list
19394108|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19394109|NCT03678792|Narcotics|narcotics|mesh-ancestor
19671052|NCT04418479|Clopidogrel|clopidogrel|mesh-list
19671053|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671054|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356028|NCT00903825|Anesthetics|anesthetics|mesh-list
19394110|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394111|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394112|NCT03678792|Analgesics|analgesics|mesh-ancestor
19394113|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
19394114|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394115|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19394116|NCT03678675|Ketorolac|ketorolac|mesh-list
19394117|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19394118|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19394119|NCT03678675|Analgesics|analgesics|mesh-ancestor
19394120|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
19394121|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394122|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394123|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394124|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394125|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19394126|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394127|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394128|NCT03678649|Capecitabine|capecitabine|mesh-list
20356029|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356030|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394129|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19394130|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
19394131|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394132|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394133|NCT03678610|Ionomycin|ionomycin|mesh-list
20356031|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
20356032|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671055|NCT04418479|Analgesics|analgesics|mesh-ancestor
19280274|NCT04376970|Fluorometholone|fluorometholone|mesh-list
19280275|NCT04376970|Cyclosporine|cyclosporine|mesh-list
19280276|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19280277|NCT04376970|Cyclosporins|cyclosporins|mesh-list
19280278|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280279|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280280|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280281|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
19280282|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280283|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
19280284|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280285|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
19280286|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280287|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19280288|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19280289|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280290|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
19280291|NCT04376970|Hormones|hormones|mesh-ancestor
19280292|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280293|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19280294|NCT04377048|Gemcitabine|gemcitabine|mesh-list
19280295|NCT04377048|Tegafur|tegafur|mesh-list
19280296|NCT04377048|Nivolumab|nivolumab|mesh-list
19280297|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19280298|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
19280299|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280300|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280301|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
19280302|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280303|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280304|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280305|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
19280306|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280307|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19280308|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19280309|NCT04376788|Methylene Blue|methylene blue|mesh-list
19280310|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280311|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280312|NCT04376528|Cyclosporine|cyclosporine|mesh-list
19280313|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
19280314|NCT04376528|Cyclosporins|cyclosporins|mesh-list
19280315|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280316|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280317|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280318|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
19280319|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280320|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
19280321|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280322|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
19280323|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280324|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19280325|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19280326|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280327|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19280328|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
19280329|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280330|NCT04376814|Ritonavir|ritonavir|mesh-list
19280331|NCT04376814|Lopinavir|lopinavir|mesh-list
19280332|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280333|NCT04376814|Favipiravir|favipiravir|mesh-list
19280334|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19280335|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19280336|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
19280337|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280338|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280339|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20180805|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
20180806|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20180807|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180808|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180809|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20180810|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180811|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280340|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19280341|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
19280342|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356033|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356034|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356035|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356036|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356037|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356038|NCT00903838|Pramipexole|pramipexole|mesh-list
20356039|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
20356040|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356041|NCT00903838|Protective Agents|protective agents|mesh-ancestor
20356042|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356043|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20356044|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20356045|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
20356046|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
20356047|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280343|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19280344|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19280345|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
19280346|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280347|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280348|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356048|NCT00903851|Lidocaine|lidocaine|mesh-list
20356049|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356050|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
20356051|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356052|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356053|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
20356054|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356055|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356056|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19280349|NCT04376554|Amoxicillin|amoxicillin|mesh-list
19280350|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
19280351|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
19280352|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19280353|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280354|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280355|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19280356|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280357|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280358|NCT04376541|Fentanyl|fentanyl|mesh-list
19280359|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19280360|NCT04376541|Narcotics|narcotics|mesh-ancestor
19280361|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280362|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280363|NCT04376541|Analgesics|analgesics|mesh-ancestor
19280364|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
19280365|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280366|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19280367|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19280368|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
19280369|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
19280370|NCT04376307|Anesthetics|anesthetics|mesh-list
19280371|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280372|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280373|NCT04376073|Niraparib|niraparib|mesh-list
20356057|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356058|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356059|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425139|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
20425140|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425141|NCT01273493|Dexamethasone|dexamethasone|mesh-list
20425142|NCT01273493|Trabectedin|trabectedin|mesh-list
19280374|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19280375|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280376|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280377|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280378|NCT04376086|Anesthetics|anesthetics|mesh-list
19280379|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280380|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280381|NCT04376216|Prednisone|prednisone|mesh-list
19280382|NCT04376216|Prednisolone|prednisolone|mesh-list
19280383|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280384|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
19280385|NCT04376216|Hormones|hormones|mesh-ancestor
19280386|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280387|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356060|NCT00903942|Paclitaxel|paclitaxel|mesh-list
20356061|NCT00903942|Carboplatin|carboplatin|mesh-list
20356062|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20356063|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20356064|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356065|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
20356066|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
20356067|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
20356068|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356069|NCT00903994|Ketoprofen|ketoprofen|mesh-list
20356070|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356071|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356072|NCT00903994|Analgesics|analgesics|mesh-ancestor
20356073|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
19280388|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19280389|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280390|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
19280391|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19280392|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
19280393|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280394|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280395|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19280396|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
19280397|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19280398|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
19280399|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280400|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280401|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19280402|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
19280403|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
19280404|NCT04375995|Protective Agents|protective agents|mesh-ancestor
19280405|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19280406|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19280407|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280408|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671056|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
19671057|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671058|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671059|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19671060|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671061|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19671062|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19671063|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671064|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20180812|NCT00188136|Fludarabine|fludarabine|mesh-list
20180813|NCT00188136|Melphalan|melphalan|mesh-list
20356074|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280409|NCT04375852|Autoantibodies|autoantibodies|mesh-list
19280410|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
19280411|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356075|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356076|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356077|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356078|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20356079|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356080|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356081|NCT00904020|Lidocaine|lidocaine|mesh-list
20356082|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356083|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
20356084|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20180814|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180815|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180816|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180817|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
20180818|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180819|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20180820|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
20180821|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20180822|NCT00188227|Midazolam|midazolam|mesh-list
20180823|NCT00188227|Pirinitramide|pirinitramide|mesh-list
20612537|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
19280412|NCT04375605|Leucovorin|leucovorin|mesh-list
19280413|NCT04375605|Docetaxel|docetaxel|mesh-list
19280414|NCT04375605|Fluorouracil|fluorouracil|mesh-list
19280415|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
19280416|NCT04375605|Calcium|calcium|mesh-list
19280417|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
19280418|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280419|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
19280420|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
19280421|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
19280422|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280423|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20356085|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356086|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
20612538|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19280424|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280425|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
19280426|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19280427|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280428|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
19280429|NCT04375605|Antidotes|antidotes|mesh-ancestor
19280430|NCT04375605|Protective Agents|protective agents|mesh-ancestor
19280431|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
19280432|NCT04375605|Vitamins|vitamins|mesh-ancestor
19280433|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
19280434|NCT04374981|Celecoxib|celecoxib|mesh-list
19280435|NCT04374981|Montelukast|montelukast|mesh-list
19280436|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19280437|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280438|NCT04374981|Analgesics|analgesics|mesh-ancestor
19280439|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
19280440|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280441|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280442|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280443|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280444|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19280445|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19280446|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280447|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280448|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19280449|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
19280450|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19280451|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
19280452|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280453|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19280454|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19394134|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
19394135|NCT03678610|Ionophores|ionophores|mesh-ancestor
19394136|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19394137|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394138|NCT03678532|Midazolam|midazolam|mesh-list
19394139|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19394140|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19394141|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394142|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394143|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19394144|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19394145|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19394146|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19394147|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
19394148|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
19394149|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
19394150|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
19394151|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394152|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394153|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19394154|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19394155|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394156|NCT03678428|Leucovorin|leucovorin|mesh-list
19394157|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
19394158|NCT03678428|Irinotecan|irinotecan|mesh-list
19394159|NCT03678428|Floxuridine|floxuridine|mesh-list
19394160|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394161|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19394162|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19394163|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404146|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280455|NCT04375267|Olaparib|olaparib|mesh-list
19280456|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19280457|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19280458|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280459|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280460|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280461|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19280462|NCT04375202|Colchicine|colchicine|mesh-list
19280463|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
19280464|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180824|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20180825|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20180826|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280465|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19280466|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19280467|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19280468|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280469|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280470|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19280471|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
19280472|NCT04374929|Hormones|hormones|mesh-ancestor
19280473|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280474|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280475|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280476|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
19280477|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280478|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280479|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280480|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280481|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280482|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280483|NCT04374604|Mitogens|mitogens|mesh-list
19280484|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
19280485|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280486|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
19280487|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19280488|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280489|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280490|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280491|NCT04374318|Analgesics|analgesics|mesh-ancestor
19280492|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
19280493|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280494|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19280495|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19280496|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19280497|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
19280498|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280499|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280500|NCT04374474|Budesonide|budesonide|mesh-list
19280501|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280502|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19280503|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
19280504|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280505|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280506|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19280507|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
19280508|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
19280509|NCT04374474|Hormones|hormones|mesh-ancestor
19280510|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280511|NCT04374773|Dronabinol|dronabinol|mesh-list
19280512|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
19280513|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280514|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19280515|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280516|NCT04374773|Analgesics|analgesics|mesh-ancestor
19280517|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
19280518|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280519|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19280520|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19280521|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280522|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671065|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20180827|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280523|NCT04374773|Hormones|hormones|mesh-ancestor
19280524|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280525|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
19280526|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19280527|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
19280528|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356087|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356088|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356089|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356090|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356091|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356092|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356093|NCT00904059|Asunaprevir|asunaprevir|mesh-list
20356094|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
20356095|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356096|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356097|NCT00904085|Oxymorphone|oxymorphone|mesh-list
20356098|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20356099|NCT00904085|Narcotics|narcotics|mesh-ancestor
20356100|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356101|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356102|NCT00904085|Analgesics|analgesics|mesh-ancestor
20356103|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
20356104|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356105|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20356106|NCT00904098|Frovatriptan|frovatriptan|mesh-list
20356107|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20356108|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
20356109|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356110|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280529|NCT04374461|Expectorants|expectorants|mesh-ancestor
19280530|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
19280531|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19280532|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
19280533|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280534|NCT04374461|Protective Agents|protective agents|mesh-ancestor
19280535|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280536|NCT04374461|Antidotes|antidotes|mesh-ancestor
20356111|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356112|NCT00904111|Lidocaine|lidocaine|mesh-list
20356113|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356114|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
20356115|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356116|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356117|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
20356118|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356119|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356120|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356121|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356122|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356123|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356124|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
20356125|NCT00904176|Digoxin|digoxin|mesh-list
20356126|NCT00904176|Warfarin|warfarin|mesh-list
20356127|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
20356128|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20356129|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356130|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20356131|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356132|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356133|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20356134|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356135|NCT00904176|Protective Agents|protective agents|mesh-ancestor
19280537|NCT04374799|Heparin|heparin|mesh-list
19280538|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
19280539|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19280540|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19280541|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280542|NCT04374279|Bicalutamide|bicalutamide|mesh-list
19280543|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
19280544|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
20356136|NCT00904202|Lidocaine|lidocaine|mesh-list
19280545|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671066|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356137|NCT00904202|Gabapentin|gabapentin|mesh-list
20356138|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356139|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
20356140|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356141|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356142|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
20356143|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356144|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19280546|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280547|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280548|NCT04374552|Azithromycin|azithromycin|mesh-list
19280549|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280550|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280551|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280552|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
19280553|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280554|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280555|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280556|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356145|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356146|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356147|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356148|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356149|NCT00904202|Analgesics|analgesics|mesh-ancestor
20356150|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
19280557|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280558|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
19280559|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19280560|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19280561|NCT04374071|Prednisolone|prednisolone|mesh-list
19280562|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
19280563|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19280564|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
19280565|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280566|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
19280567|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
19280568|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280569|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280570|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19280571|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
20356151|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20356152|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20356153|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20356154|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20356155|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20356156|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356157|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
20356158|NCT00904280|Oxymorphone|oxymorphone|mesh-list
20356159|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20356160|NCT00904280|Narcotics|narcotics|mesh-ancestor
20356161|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356162|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356163|NCT00904280|Analgesics|analgesics|mesh-ancestor
20356164|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
20356165|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356166|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20356167|NCT00904293|Warfarin|warfarin|mesh-list
20356168|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
20356169|NCT00904306|Chromium|chromium|mesh-list
20356170|NCT00904306|Picolinic acid|picolinic acid|mesh-list
20356171|NCT00904306|Trace Elements|trace elements|mesh-ancestor
20356172|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
20356173|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356174|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20356175|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
20356176|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
19280572|NCT04374071|Hormones|hormones|mesh-ancestor
19280573|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280574|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19280575|NCT04374071|Protective Agents|protective agents|mesh-ancestor
19280576|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19671067|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
20356177|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671068|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20356178|NCT00904397|Celecoxib|celecoxib|mesh-list
19280577|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356179|NCT00904397|Lidocaine|lidocaine|mesh-list
20356180|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356181|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
20356182|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356183|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280578|NCT04373824|Ivermectin|ivermectin|mesh-list
19280579|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280580|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280581|NCT04374006|Propolis|propolis|mesh-list
19280582|NCT04374006|Dienogest|dienogest|mesh-list
19280583|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280584|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19280585|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
19280586|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19280587|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280588|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19280589|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19280590|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19280591|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19280592|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
20356184|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
20356185|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356186|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356187|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356188|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356189|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356190|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356191|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356192|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356193|NCT00904397|Analgesics|analgesics|mesh-ancestor
20356194|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356195|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356196|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20356197|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20356198|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356199|NCT00904436|Ipratropium|ipratropium|mesh-list
20356200|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20356201|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
20356202|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356203|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356204|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20356205|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
20356206|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20356207|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
19280593|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280594|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19280595|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280596|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
19280597|NCT04374188|Levofloxacin|levofloxacin|mesh-list
19280598|NCT04374188|Ofloxacin|ofloxacin|mesh-list
19280599|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280600|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280601|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19280602|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19280603|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280604|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280605|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280606|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19280607|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19280608|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19280609|NCT04374188|Renal Agents|renal agents|mesh-ancestor
19280610|NCT04373967|Metformin|metformin|mesh-list
19280611|NCT04373967|Liraglutide|liraglutide|mesh-list
19280612|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19280613|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280614|NCT04373967|Incretins|incretins|mesh-ancestor
19280615|NCT04373967|Hormones|hormones|mesh-ancestor
19280616|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280617|NCT04373941|Lenograstim|lenograstim|mesh-list
19280618|NCT04373941|Sargramostim|sargramostim|mesh-list
19280619|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19280620|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
19280621|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280622|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19280623|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280624|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280625|NCT04373356|Listerine|listerine|mesh-list
19280626|NCT04373356|Fluorides|fluorides|mesh-list
19280627|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
19280628|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
19280629|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
19280630|NCT04373356|Protective Agents|protective agents|mesh-ancestor
19280631|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280632|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19280633|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394164|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394165|NCT03678428|Antidotes|antidotes|mesh-ancestor
19394166|NCT03678428|Protective Agents|protective agents|mesh-ancestor
19394167|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394168|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
20356208|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356209|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356210|NCT00904449|Oxymorphone|oxymorphone|mesh-list
20356211|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20356212|NCT00904449|Narcotics|narcotics|mesh-ancestor
19394169|NCT03678428|Vitamins|vitamins|mesh-ancestor
19394170|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
19394171|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19394172|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
19394173|NCT03678233|Testosterone|testosterone|mesh-list
19394174|NCT03678233|Androgens|androgens|mesh-ancestor
19394175|NCT03678233|Hormones|hormones|mesh-ancestor
19394176|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394177|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671069|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19671070|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19671071|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
19394178|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19394179|NCT03678142|Vancomycin|vancomycin|mesh-list
19394180|NCT03678142|Imipenem|imipenem|mesh-list
19394181|NCT03678142|Floxacillin|floxacillin|mesh-list
19394182|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394183|NCT03678116|Caffeine|caffeine|mesh-list
19394184|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19394185|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394186|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19394187|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394188|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394189|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19394190|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19394191|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
19394192|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394193|NCT03678090|Plasminogen|plasminogen|mesh-list
19394194|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19394195|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19394196|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19394197|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394198|NCT03678038|Triamcinolone|triamcinolone|mesh-list
19394199|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19394200|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19394201|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19394202|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394203|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
19394204|NCT03678038|Hormones|hormones|mesh-ancestor
19394205|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394206|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394207|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19394208|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
19394209|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394210|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394211|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19394212|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19394213|NCT03678012|Hematinics|hematinics|mesh-ancestor
19394214|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19394215|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19394216|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19394217|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394218|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
20356213|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394219|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19394220|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
19280634|NCT04373083|Cemiplimab|cemiplimab|mesh-list
19280635|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19280636|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280637|NCT04372849|Insulin|insulin|mesh-list
19280638|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19280639|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280640|NCT04372836|Vasopressins|vasopressins|mesh-list
19280641|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
19280642|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
19280643|NCT04372836|Coagulants|coagulants|mesh-ancestor
19280644|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19280645|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19280646|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
19280647|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280648|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280649|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
19280650|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280651|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280652|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280653|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280654|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280655|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280656|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
19280657|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19280658|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19280659|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19280660|NCT04373018|Eusol|eusol|mesh-list
19280661|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19280662|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280663|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
19280664|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
19280665|NCT04372732|Autoantibodies|autoantibodies|mesh-list
19280666|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
19280667|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280668|NCT04372589|Heparin|heparin|mesh-list
19280669|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
19280670|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19280671|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19280672|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280673|NCT04372342|Remifentanil|remifentanil|mesh-list
19280674|NCT04372342|Nalbuphine|nalbuphine|mesh-list
20180828|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20180829|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20180830|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20180831|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20180832|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
20180833|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
20180834|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
20180835|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
20180836|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180837|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180838|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20180839|NCT00188227|Narcotics|narcotics|mesh-ancestor
20180840|NCT00188227|Analgesics|analgesics|mesh-ancestor
20180841|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
20180842|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180843|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20180844|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
20180845|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180846|NCT00188266|Fluorouracil|fluorouracil|mesh-list
20180847|NCT00188266|Cisplatin|cisplatin|mesh-list
20180848|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
20180849|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180850|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20180851|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180852|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180853|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
20180854|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217219|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217220|NCT00308971|Protective Agents|protective agents|mesh-ancestor
20217221|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
20217222|NCT00309049|Epothilones|epothilones|mesh-list
20217223|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
20217224|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
19280675|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19280676|NCT04372342|Narcotics|narcotics|mesh-ancestor
19280677|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217225|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
19280678|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280679|NCT04372342|Analgesics|analgesics|mesh-ancestor
19280680|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
19280681|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280682|NCT04372264|Acetaminophen|acetaminophen|mesh-list
19280683|NCT04372264|Ibuprofen|ibuprofen|mesh-list
20180855|NCT00188383|Amantadine|amantadine|mesh-list
20180856|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20180857|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20180858|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
20180859|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180860|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
20180861|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612539|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20612540|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
19280684|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20180862|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356214|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356215|NCT00904449|Analgesics|analgesics|mesh-ancestor
19280685|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19280686|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280687|NCT04372264|Analgesics|analgesics|mesh-ancestor
19280688|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
19280689|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280690|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280691|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280692|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280693|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19280694|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280695|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280696|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
19280697|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
19280698|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
19280699|NCT04372316|Vitamins|vitamins|mesh-ancestor
19280700|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
19280701|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280702|NCT04372407|Itraconazole|itraconazole|mesh-list
19280703|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
19280704|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280705|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19280706|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19280707|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280708|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280709|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19280710|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
19280711|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280712|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280713|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19280714|NCT04371874|Aspirin|aspirin|mesh-list
19280715|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19280716|NCT04371874|Captopril|captopril|mesh-list
19280717|NCT04371874|Nitrendipine|nitrendipine|mesh-list
19280718|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19280719|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280720|NCT04371874|Analgesics|analgesics|mesh-ancestor
19280721|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
19280722|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280723|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180863|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180864|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20180865|NCT00188383|Analgesics|analgesics|mesh-ancestor
20180866|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
20180867|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180868|NCT00188396|Citalopram|citalopram|mesh-list
20180869|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20180870|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20180871|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20180872|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180873|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180874|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
20180875|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180876|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20180877|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
20612541|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280724|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19280725|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280726|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19280727|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19280728|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280729|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19280730|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19280731|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280732|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
19280733|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19280734|NCT04371874|Diuretics|diuretics|mesh-ancestor
19280735|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
19280736|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19280737|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280738|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19280739|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
19280740|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19280741|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19280742|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
19280743|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
19280744|NCT04371965|Povidone|povidone|mesh-list
19280745|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
19280746|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
19280747|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19280748|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280749|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280750|NCT04372082|Niclosamide|niclosamide|mesh-list
19280751|NCT04372082|Diltiazem|diltiazem|mesh-list
19280752|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
19280753|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280754|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280755|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280756|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280757|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280758|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280759|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19280760|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19280761|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280762|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19280763|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280764|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
19280765|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
19280766|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19280767|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
19280768|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
19280769|NCT04371978|Linagliptin|linagliptin|mesh-list
19280770|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19280771|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280772|NCT04371978|Incretins|incretins|mesh-ancestor
19280773|NCT04371978|Hormones|hormones|mesh-ancestor
19280774|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280775|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19280776|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
19280777|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280778|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280779|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280780|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
19280781|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280782|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280783|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280784|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280785|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280786|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280787|NCT04371757|Doxazosin|doxazosin|mesh-list
19280788|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
19280789|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19280790|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19280791|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19280792|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19280793|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280794|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280795|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280796|NCT04371601|Oseltamivir|oseltamivir|mesh-list
20180878|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19280797|NCT04371601|Hormones|hormones|mesh-list
20356216|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
20356217|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356218|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20356219|NCT00904462|Lidocaine|lidocaine|mesh-list
20356220|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356221|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
20356222|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356223|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356224|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
20356225|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356226|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356227|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356228|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356229|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280798|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19280799|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280800|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
19280801|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280802|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280803|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280804|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280805|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
19280806|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280807|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280808|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280809|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280810|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280811|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280812|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
19280813|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
19280814|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19280815|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
19280816|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280817|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280818|NCT04371224|Leucovorin|leucovorin|mesh-list
19280819|NCT04371224|Fluorouracil|fluorouracil|mesh-list
19280820|NCT04371224|Capecitabine|capecitabine|mesh-list
19280821|NCT04371224|Irinotecan|irinotecan|mesh-list
19280822|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
19280823|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280824|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19280825|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280826|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280827|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
19280828|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280829|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19280830|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19671072|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671073|NCT04379713|Vaccines|vaccines|mesh-list
19671074|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19671075|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
19671076|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671077|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19671078|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
20180879|NCT00188552|Tocopherols|tocopherols|mesh-list
19280831|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280832|NCT04371224|Antidotes|antidotes|mesh-ancestor
19280833|NCT04371224|Protective Agents|protective agents|mesh-ancestor
19280834|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
19280835|NCT04371224|Vitamins|vitamins|mesh-ancestor
19280836|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
19280837|NCT04371575|Carbamazepine|carbamazepine|mesh-list
19280838|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
20180880|NCT00188552|Vitamin E|vitamin e|mesh-list
20180881|NCT00188552|Tocotrienols|tocotrienols|mesh-list
20180882|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
20180883|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
20180884|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20180885|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180886|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180887|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19280839|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
19280840|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
19280841|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19671079|NCT04370379|Aflibercept|aflibercept|mesh-list
20180888|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19280842|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280843|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280844|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19280845|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19280846|NCT04371575|Analgesics|analgesics|mesh-ancestor
19280847|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
19280848|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280849|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19280850|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280851|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280852|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19280853|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19280854|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19280855|NCT04371341|Bupivacaine|bupivacaine|mesh-list
19280856|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
19280857|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
19280858|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19280859|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280860|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
19280861|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19280862|NCT04371367|Avdoralimab|avdoralimab|mesh-list
19280863|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356230|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356231|NCT00904475|Lidocaine|lidocaine|mesh-list
20356232|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356233|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
20356234|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356235|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356236|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
19280864|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
19280865|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280866|NCT04371406|Azithromycin|azithromycin|mesh-list
19280867|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280868|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280869|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356237|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356238|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356239|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356240|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356241|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356242|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280870|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
19280871|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280872|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20356243|NCT00904540|Lidocaine|lidocaine|mesh-list
20356244|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356245|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
20356246|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356247|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356248|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
20356249|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356250|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356251|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20356252|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356253|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356254|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356255|NCT00904605|Celecoxib|celecoxib|mesh-list
20356256|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356257|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356258|NCT00904605|Analgesics|analgesics|mesh-ancestor
20356259|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
20356260|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356261|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356262|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356263|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356264|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20356265|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20356266|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356267|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356268|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
19280873|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280874|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280875|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280876|NCT04371185|Ustekinumab|ustekinumab|mesh-list
19280877|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
20356269|NCT00904631|Salicylates|salicylates|mesh-list
20356270|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356271|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
20356272|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
20356273|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
19280878|NCT04371146|Methylphenidate|methylphenidate|mesh-list
19280879|NCT04371146|Reboxetine|reboxetine|mesh-list
19280880|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19280881|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280882|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19280883|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19671080|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356274|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356275|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671081|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19671082|NCT04370379|Growth Substances|growth substances|mesh-ancestor
20356276|NCT00904631|Analgesics|analgesics|mesh-ancestor
20356277|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
20356278|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356279|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356280|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356281|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356282|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20356283|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356284|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356285|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
20356286|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20356287|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20356288|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
20356289|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356290|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20356291|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20356292|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356293|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356294|NCT00904657|Sunitinib|sunitinib|mesh-list
19280884|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19280885|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671083|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671084|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
19671085|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671086|NCT04305899|BMS-986165|bms-986165|mesh-list
19671087|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
19671088|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19671089|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671090|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280886|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
19671091|NCT04238624|Trametinib|trametinib|mesh-list
19671092|NCT04238624|Dabrafenib|dabrafenib|mesh-list
19671093|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671094|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19671095|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671096|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671097|NCT04153604|Doxycycline|doxycycline|mesh-list
19671098|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671099|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180889|NCT00188552|Protective Agents|protective agents|mesh-ancestor
20180890|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180891|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
20180892|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20180893|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
20180894|NCT00188552|Vitamins|vitamins|mesh-ancestor
20180895|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
20180896|NCT00188565|Celecoxib|celecoxib|mesh-list
20180897|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20180898|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20180899|NCT00188565|Analgesics|analgesics|mesh-ancestor
20180900|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
20180901|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20180902|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180903|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20180904|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20180905|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19280887|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280888|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
19280889|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19280890|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19280891|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
19280892|NCT04370977|Artesunate|artesunate|mesh-list
19280893|NCT04370977|Lumefantrine|lumefantrine|mesh-list
19280894|NCT04370977|Artemether|artemether|mesh-list
20356295|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356296|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356297|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20356298|NCT00904657|Growth Substances|growth substances|mesh-ancestor
20356299|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356300|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
20356301|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19280895|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19280896|NCT04370977|Amodiaquine|amodiaquine|mesh-list
19280897|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
19280898|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280899|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280900|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280901|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280902|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
19280903|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
19280904|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19280905|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
19394221|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394222|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
19394223|NCT03677895|Protective Agents|protective agents|mesh-ancestor
19394224|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
19394225|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19394226|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394227|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394228|NCT03677466|Tenecteplase|tenecteplase|mesh-list
19394229|NCT03677466|Streptokinase|streptokinase|mesh-list
19394230|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19394231|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19837922|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19837923|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20356302|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356303|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356304|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
19394232|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394233|NCT03677336|Progesterone|progesterone|mesh-list
19837924|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19837925|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394234|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
19394235|NCT03677336|Progestins|progestins|mesh-ancestor
19394236|NCT03677336|Hormones|hormones|mesh-ancestor
19394237|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394238|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394239|NCT03677323|Sufentanil|sufentanil|mesh-list
19394240|NCT03677323|Droperidol|droperidol|mesh-list
19394241|NCT03677323|Propofol|propofol|mesh-list
19394242|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19394243|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394244|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394245|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19394246|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
19394247|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
19394248|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19394249|NCT03677323|Narcotics|narcotics|mesh-ancestor
19394250|NCT03677323|Analgesics|analgesics|mesh-ancestor
19394251|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
19394252|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394253|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19394254|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
20356305|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20356306|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20356307|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356308|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
19837926|NCT00618436|Phenytoin|phenytoin|mesh-list
19394255|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
19394256|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394257|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19394258|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19394259|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837927|NCT00618436|Levetiracetam|levetiracetam|mesh-list
20356309|NCT00904709|Coagulants|coagulants|mesh-ancestor
20356310|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
20356311|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
20356312|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356313|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356314|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356315|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356316|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
20356317|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20356318|NCT00904852|Bevacizumab|bevacizumab|mesh-list
19280906|NCT04370782|Azithromycin|azithromycin|mesh-list
19280907|NCT04370782|Doxycycline|doxycycline|mesh-list
19280908|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280909|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
19280910|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280911|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280912|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
19280913|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280914|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280915|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280916|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356319|NCT00904852|Temozolomide|temozolomide|mesh-list
20356320|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356321|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356322|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356323|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20356324|NCT00904852|Growth Substances|growth substances|mesh-ancestor
20356325|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356326|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
20356327|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20356328|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
20356329|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280917|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280918|NCT04370782|Astringents|astringents|mesh-ancestor
19280919|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280920|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
19280921|NCT04371107|Azithromycin|azithromycin|mesh-list
19280922|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19280923|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280924|NCT04370483|Leflunomide|leflunomide|mesh-list
19280925|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280926|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280927|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19280928|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
19280929|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280930|NCT04370431|Edaravone|edaravone|mesh-list
19280931|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19280932|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
19280933|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356330|NCT00904904|Ketorolac|ketorolac|mesh-list
20356331|NCT00904904|Indomethacin|indomethacin|mesh-list
20356332|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20356333|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20356334|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356335|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356336|NCT00904904|Analgesics|analgesics|mesh-ancestor
20356337|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
20356338|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356339|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356340|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356341|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356342|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19280934|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19280935|NCT04370431|Protective Agents|protective agents|mesh-ancestor
19280936|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280937|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
19280938|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19280939|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280940|NCT04370262|Famotidine|famotidine|mesh-list
19280941|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19280942|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19280943|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20356343|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280944|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
19280945|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
19280946|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19280947|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280948|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356344|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356345|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
20356346|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
20356347|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20356348|NCT00905047|Leucovorin|leucovorin|mesh-list
20356349|NCT00905047|Folic Acid|folic acid|mesh-list
20356350|NCT00905047|Tegafur|tegafur|mesh-list
20356351|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
20356352|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356353|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
20356354|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356355|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356356|NCT00905047|Antidotes|antidotes|mesh-ancestor
20356357|NCT00905047|Protective Agents|protective agents|mesh-ancestor
20356358|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356359|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
20356360|NCT00905047|Vitamins|vitamins|mesh-ancestor
20356361|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
20356362|NCT00905047|Hematinics|hematinics|mesh-ancestor
20356363|NCT00905073|Cyclosporine|cyclosporine|mesh-list
20356364|NCT00905073|Methotrexate|methotrexate|mesh-list
20356365|NCT00905073|Cyclosporins|cyclosporins|mesh-list
20356366|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20356367|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
20356368|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20356369|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356370|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19280949|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
19280950|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
19280951|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19280952|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19280953|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280954|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280955|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280956|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19280957|NCT04370288|Ascorbic Acid|ascorbic acid|mesh-list
19280958|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
19280959|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19280960|NCT04370288|Methylene Blue|methylene blue|mesh-list
19280961|NCT04370288|Vitamins|vitamins|mesh-ancestor
19280962|NCT04370288|Micronutrients|micronutrients|mesh-ancestor
19280963|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280964|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
19280965|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19280966|NCT04370288|Protective Agents|protective agents|mesh-ancestor
19280967|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
19280968|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19280969|NCT04370288|Expectorants|expectorants|mesh-ancestor
19280970|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
19280971|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19280972|NCT04370288|Antidotes|antidotes|mesh-ancestor
19280973|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19280974|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
19280975|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19280976|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
19280977|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19280978|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
19280979|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19280980|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19671100|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
20180906|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20180907|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180908|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180909|NCT00188604|Selenious Acid|selenious acid|mesh-list
20180910|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
20180911|NCT00188604|Trace Elements|trace elements|mesh-ancestor
20180912|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
20180913|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180914|NCT00188617|Gefitinib|gefitinib|mesh-list
20180915|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20180916|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20180917|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180918|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356371|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
19671101|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19837928|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
19837929|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
19837930|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19837931|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19837932|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837933|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837934|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19837935|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19837936|NCT00618449|Azithromycin|azithromycin|mesh-list
19837937|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19837938|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837939|NCT00618540|Fludarabine|fludarabine|mesh-list
19837940|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
19837941|NCT00618540|Melphalan|melphalan|mesh-list
19837942|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
19837943|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837944|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19837945|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
19837946|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837947|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837948|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
19837949|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837950|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19837951|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
19837952|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19837953|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19837954|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
20356372|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356373|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281011|NCT04369534|Clopidogrel|clopidogrel|mesh-list
19281012|NCT04369534|Ticagrelor|ticagrelor|mesh-list
19281013|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19281014|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19281015|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19281016|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19281017|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
19281018|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281019|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281020|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281021|NCT04370080|Fluorides|fluorides|mesh-list
19281022|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
19281023|NCT04370080|Protective Agents|protective agents|mesh-ancestor
19281024|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281025|NCT04370392|Anesthetics|anesthetics|mesh-list
19281026|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
19281027|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281028|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281029|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
19281030|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281031|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
19281032|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281033|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281034|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19281035|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19281036|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281037|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281038|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281039|NCT04369222|Acetaminophen|acetaminophen|mesh-list
19281040|NCT04369222|Aspirin|aspirin|mesh-list
19281041|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
19281042|NCT04369222|Salicylates|salicylates|mesh-list
19281043|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20356374|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
20356375|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356376|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20356377|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356378|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
20356379|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356380|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19281044|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19281045|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19281046|NCT04369222|Analgesics|analgesics|mesh-ancestor
19281047|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
19281048|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281049|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281050|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
19281051|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281052|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
19281053|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
19281054|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
19281055|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281056|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19281057|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281058|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281059|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20356381|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
20356382|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356383|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20356384|NCT00905190|Ondansetron|ondansetron|mesh-list
20356385|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
20356386|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
19281060|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19281061|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19281062|NCT04368819|Allopurinol|allopurinol|mesh-list
19281063|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
19281064|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281065|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281066|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
19281067|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281068|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19281069|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
19281070|NCT04368819|Protective Agents|protective agents|mesh-ancestor
19281071|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281072|NCT04368585|Simethicone|simethicone|mesh-list
19281073|NCT04368585|Omeprazole|omeprazole|mesh-list
19281074|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19281075|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19281076|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
19281077|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
19281078|NCT04368585|TEMPO|tempo|mesh-list
19281079|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20356387|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356388|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356389|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20356390|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
20356391|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
20356392|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20356393|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
20356394|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356395|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356396|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20356397|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20356398|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281080|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19281081|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19281082|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281083|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281084|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
20356399|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20356400|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20356401|NCT00905216|Heparin|heparin|mesh-list
20356402|NCT00905216|Calcium heparin|calcium heparin|mesh-list
20356403|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
20356404|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20356405|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20356406|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356407|NCT00905229|Vitamins|vitamins|mesh-list
20356408|NCT00905229|Vitamin K|vitamin k|mesh-list
19281085|NCT04368585|Emollients|emollients|mesh-ancestor
19281086|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
19281087|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19281088|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
19281089|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281090|NCT04368585|Antacids|antacids|mesh-ancestor
19281091|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
19281092|NCT04368585|Protective Agents|protective agents|mesh-ancestor
19281093|NCT04368546|Sunitinib|sunitinib|mesh-list
19281094|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281095|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356409|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
19281096|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19281097|NCT04368546|Growth Substances|growth substances|mesh-ancestor
19281098|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281099|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
19281100|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19281101|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281102|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281103|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
19281104|NCT04368598|Dexamethasone|dexamethasone|mesh-list
19281105|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
19281106|NCT04368598|BB 1101|bb 1101|mesh-list
19281107|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19281108|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281109|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
19281110|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
19281111|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281112|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837955|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19837956|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837957|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
19837958|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19837959|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19837960|NCT00618748|Olanzapine|olanzapine|mesh-list
19837961|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
19837962|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
19837963|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19837964|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281113|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19281114|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
19281115|NCT04368598|Hormones|hormones|mesh-ancestor
19281116|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281117|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19281118|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281119|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281120|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281121|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281122|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
19281123|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281124|NCT04368598|Expectorants|expectorants|mesh-ancestor
19281125|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
19281126|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19281127|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
19281128|NCT04368598|Protective Agents|protective agents|mesh-ancestor
19281129|NCT04368598|Antidotes|antidotes|mesh-ancestor
19281130|NCT04368520|Vitamin D|vitamin d|mesh-list
19281131|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
19281132|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
19281133|NCT04368520|Vitamins|vitamins|mesh-list
19281134|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
19281135|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281136|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19281137|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19394260|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20180919|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
20180920|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20180921|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
19394261|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19394262|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
19394263|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394264|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394265|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19394266|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19394267|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19394268|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
19394269|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394270|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19394271|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19394272|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180922|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180923|NCT00188630|Expectorants|expectorants|mesh-ancestor
20180924|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
20180925|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20180926|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
20180927|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394273|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
19837965|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394274|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19281138|NCT04368377|Aspirin|aspirin|mesh-list
19281139|NCT04368377|PENTA|penta|mesh-list
19281140|NCT04368377|Tirofiban|tirofiban|mesh-list
19281141|NCT04368377|Fondaparinux|fondaparinux|mesh-list
19281142|NCT04368377|Clopidogrel|clopidogrel|mesh-list
20356410|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
20356411|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356412|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20356413|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20356414|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356415|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
20356416|NCT00905229|Coagulants|coagulants|mesh-ancestor
20356417|NCT00905333|Felodipine|felodipine|mesh-list
20180928|NCT00188630|Protective Agents|protective agents|mesh-ancestor
20180929|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180930|NCT00188630|Antidotes|antidotes|mesh-ancestor
20180931|NCT00188643|Lamotrigine|lamotrigine|mesh-list
20180932|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20180933|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19281143|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19281144|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19281145|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19281146|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19281147|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
19281148|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281149|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180934|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20180935|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20180936|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356418|NCT00905333|Candesartan|candesartan|mesh-list
20356419|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
20356420|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20356421|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20356422|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20356423|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356424|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356425|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20356426|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356427|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20356428|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356429|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
20356430|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20356431|NCT00905528|Telmisartan|telmisartan|mesh-list
20356432|NCT00905528|Ramipril|ramipril|mesh-list
20356433|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20356434|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19281150|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281151|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19281152|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19281153|NCT04368377|Analgesics|analgesics|mesh-ancestor
19281154|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
19281155|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281156|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281157|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281158|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19281159|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19281160|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19281161|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281162|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
19281163|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19281164|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
19281165|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19281166|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281167|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
19281168|NCT04368403|Brodalumab|brodalumab|mesh-list
19281169|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
19281170|NCT04368273|Antibodies|antibodies|mesh-list
19281171|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
19281172|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281173|NCT04368078|Lenvatinib|lenvatinib|mesh-list
19281174|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281175|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19281176|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281177|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281178|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19281179|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19281180|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281181|NCT04368351|Azithromycin|azithromycin|mesh-list
19281182|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281183|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281184|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281185|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
19281186|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281187|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281188|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281189|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281190|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837966|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19837967|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19837968|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356435|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20356436|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356437|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19837969|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19837970|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19281191|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
19281192|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19281193|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281194|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281195|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19281196|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19281197|NCT04367935|Protective Agents|protective agents|mesh-ancestor
19281198|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281199|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
19281200|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19281201|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
19281202|NCT04367831|Heparin|heparin|mesh-list
19281203|NCT04367831|Calcium heparin|calcium heparin|mesh-list
19281204|NCT04367831|Enoxaparin|enoxaparin|mesh-list
19281205|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
19281206|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
19281207|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19281208|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19281209|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281210|NCT04367818|Anesthetics|anesthetics|mesh-list
19281211|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
19281212|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281213|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281214|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
19281215|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281216|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
19281217|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19281218|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19281219|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281220|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
19281221|NCT04367155|Coagulants|coagulants|mesh-ancestor
19281222|NCT04367103|Phenylephrine|phenylephrine|mesh-list
19281223|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
19281224|NCT04367103|Norepinephrine|norepinephrine|mesh-list
19281225|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19281226|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
19281227|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
19281228|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281229|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281230|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
19281231|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19281232|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
19281233|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
19281234|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19281235|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19281236|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19281237|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
19281238|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281239|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281240|NCT04367103|Protective Agents|protective agents|mesh-ancestor
19281241|NCT04367051|Spironolactone|spironolactone|mesh-list
19281242|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19281243|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
19281244|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20356438|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
20180937|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180938|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180939|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20180940|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
20180941|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19281245|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281246|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19281247|NCT04367051|Diuretics|diuretics|mesh-ancestor
19281248|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
19281249|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
19281250|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281251|NCT04367168|Colchicine|colchicine|mesh-list
19281252|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
19281253|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281254|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
19281255|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
19281256|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
19281257|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281258|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281259|NCT04366609|Methylphenidate|methylphenidate|mesh-list
19281260|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19281261|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281262|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19281263|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19281264|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19281265|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281266|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
19281267|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281268|NCT04366622|Riociguat|riociguat|mesh-list
19281269|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
19281270|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281271|NCT04366596|Paclitaxel|paclitaxel|mesh-list
19671102|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19671103|NCT04129398|Letermovir|letermovir|mesh-list
20180942|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
20180943|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19281272|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19281273|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281274|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
19281275|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
19281276|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19281277|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281278|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
19281279|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
19281280|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
19281281|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281282|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281283|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19281284|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19281285|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19281286|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281287|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19281288|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19281289|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
19281290|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281291|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281292|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
19281293|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281294|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
19281295|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
19281296|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
19394275|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
19394276|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394277|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
19394278|NCT03677258|Protective Agents|protective agents|mesh-ancestor
19394279|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19394280|NCT03676985|Antibodies|antibodies|mesh-list
19394281|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
19671104|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19671105|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356439|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394282|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19671106|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180944|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20356440|NCT00905541|Simvastatin|simvastatin|mesh-list
20356441|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20356442|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20356443|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
20356444|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356445|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20356446|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20356447|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356448|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19281297|NCT04366726|Abaloparatide|abaloparatide|mesh-list
19281298|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19281299|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281300|NCT04366960|Enoxaparin|enoxaparin|mesh-list
19281301|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
19281302|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19281303|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19281304|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281305|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19281306|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281307|NCT04366089|Azithromycin|azithromycin|mesh-list
19281308|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281309|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281310|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281311|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
19281312|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281313|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281314|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281315|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281316|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281317|NCT04366050|Ramipril|ramipril|mesh-list
19281318|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19281319|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281320|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281321|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281322|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19281323|NCT04365933|Interferons|interferons|mesh-list
19281324|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
19281325|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
19281326|NCT04365933|Entecavir|entecavir|mesh-list
19281327|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19281328|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356449|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20356450|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356451|NCT00905723|Estradiol|estradiol|mesh-list
20356452|NCT00905723|Estrogens|estrogens|mesh-ancestor
20356453|NCT00905723|Hormones|hormones|mesh-ancestor
20356454|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20356455|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356456|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
20356457|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
20356458|NCT00905762|Besifloxacin|besifloxacin|mesh-list
20356459|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20356460|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356461|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20356462|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20356463|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356464|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356465|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356466|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20356467|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20356468|NCT00905814|Axitinib|axitinib|mesh-list
20356469|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356470|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356471|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356472|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356473|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20356474|NCT00905853|Amiodarone|amiodarone|mesh-list
20356475|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
20356476|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20356477|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356478|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356479|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356480|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19281329|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
19281330|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281331|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
19281332|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281333|NCT04365686|Propofol|propofol|mesh-list
19281334|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19281335|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281336|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281337|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19281338|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
19281339|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
19281340|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20356481|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20356482|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356483|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20356484|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20356485|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20356486|NCT00905905|Simvastatin|simvastatin|mesh-list
20356487|NCT00905905|Ezetimibe|ezetimibe|mesh-list
20356488|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19281341|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19281342|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281343|NCT04365517|Incretins|incretins|mesh-ancestor
19281344|NCT04365517|Hormones|hormones|mesh-ancestor
19281345|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281346|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19281347|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281348|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281349|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281350|NCT04365582|Ritonavir|ritonavir|mesh-list
19281351|NCT04365582|Lopinavir|lopinavir|mesh-list
20356489|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20356490|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20356491|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
20356492|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356493|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20356494|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19281352|NCT04365582|Azithromycin|azithromycin|mesh-list
19281353|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281354|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19281355|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19281356|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281357|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281358|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281359|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19281360|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19281361|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
19394283|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
20180945|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20180946|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20180947|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20180948|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20180949|NCT00188669|Tocopherols|tocopherols|mesh-list
20180950|NCT00188669|Vitamin E|vitamin e|mesh-list
20180951|NCT00188669|Tocotrienols|tocotrienols|mesh-list
20180952|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
20180953|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
20180954|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20180955|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180956|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180957|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20180958|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20180959|NCT00188669|Protective Agents|protective agents|mesh-ancestor
20180960|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180961|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
20180962|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20180963|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
20180964|NCT00188669|Vitamins|vitamins|mesh-ancestor
20180965|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
20180966|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
20180967|NCT00188773|Heparin|heparin|mesh-list
20180968|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20180969|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20180970|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
20180971|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20180972|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20356495|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356496|NCT00905918|Vitamin E|vitamin e|mesh-list
20356497|NCT00905918|Vitamins|vitamins|mesh-ancestor
19281362|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281363|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19281364|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19281365|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281366|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
19281367|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281368|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281369|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281370|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
19281371|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19281372|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
19281373|NCT04365270|Chitosan|chitosan|mesh-list
19281374|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19281375|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281376|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
19281377|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
19281378|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19281379|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20356498|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
20356499|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356500|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
20356501|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356502|NCT00905918|Protective Agents|protective agents|mesh-ancestor
20425143|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425144|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
20425145|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
20425146|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425147|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425148|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425149|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
20425150|NCT01273493|Hormones|hormones|mesh-ancestor
20425151|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425152|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20425153|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281380|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
19837971|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19837972|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837973|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281381|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281382|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19281383|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
19281384|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
19281385|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
19281386|NCT04365270|Coagulants|coagulants|mesh-ancestor
19281387|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
19281388|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19281389|NCT04365270|Protective Agents|protective agents|mesh-ancestor
19281390|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281391|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19281392|NCT04365127|Progesterone|progesterone|mesh-list
19281393|NCT04365127|Progestins|progestins|mesh-ancestor
19281394|NCT04365127|Hormones|hormones|mesh-ancestor
19281395|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281396|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281397|NCT04365309|Aspirin|aspirin|mesh-list
19281398|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19281399|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19281400|NCT04365309|Analgesics|analgesics|mesh-ancestor
19281401|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
19281402|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281403|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281404|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281405|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281406|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19281407|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19281408|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281409|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19281410|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19281411|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281412|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
20425154|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20425155|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
19281413|NCT04365231|Azithromycin|azithromycin|mesh-list
19281414|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281415|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281416|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281417|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
19281418|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281419|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281420|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671107|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671108|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
19671109|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19837974|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19837975|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
19837976|NCT00618774|Amlodipine|amlodipine|mesh-list
19281421|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281422|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281423|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
19281424|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
19281425|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19281426|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281427|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19281428|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19281429|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19281430|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19281431|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281432|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281433|NCT04364906|Anesthetics|anesthetics|mesh-list
19281434|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281435|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671110|NCT04126278|Dexamethasone|dexamethasone|mesh-list
19671111|NCT04126278|Cortisone|cortisone|mesh-list
19671112|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19671113|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
19671114|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
19671115|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671116|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671117|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20180973|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180974|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
20180975|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20180976|NCT00188773|Expectorants|expectorants|mesh-ancestor
20180977|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
20180978|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20180979|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
20180980|NCT00188773|Protective Agents|protective agents|mesh-ancestor
20180981|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180982|NCT00188773|Antidotes|antidotes|mesh-ancestor
20180983|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20180984|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20180985|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20180986|NCT00188812|Donepezil|donepezil|mesh-list
20180987|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20180988|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20180989|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20180990|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
20180991|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20180992|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180993|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
20180994|NCT00188825|Basiliximab|basiliximab|mesh-list
20180995|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20180996|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
20180997|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20180998|NCT00188864|Dexamethasone|dexamethasone|mesh-list
19281436|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281437|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
19281438|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281439|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281440|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281441|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671118|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
19671119|NCT04126278|Hormones|hormones|mesh-ancestor
19671120|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671121|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20180999|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19671122|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19837977|NCT00618774|Telmisartan|telmisartan|mesh-list
20356503|NCT00905931|Lycopene|lycopene|mesh-list
20356504|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356505|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
20356506|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356507|NCT00905931|Protective Agents|protective agents|mesh-ancestor
20356508|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356509|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20356510|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20356511|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356512|NCT00905983|Gemcitabine|gemcitabine|mesh-list
20356513|NCT00905983|Docetaxel|docetaxel|mesh-list
20356514|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356515|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
20356516|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356517|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356518|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
20356519|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356520|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356521|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356522|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
20356523|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356524|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
20356525|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
20356526|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
20356527|NCT00905996|Propranolol|propranolol|mesh-list
20356528|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20356529|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20356530|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20356531|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356532|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356533|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356534|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356535|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20356536|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
20356537|NCT00906048|Levofloxacin|levofloxacin|mesh-list
19281442|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281443|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281444|NCT04365049|Gemcitabine|gemcitabine|mesh-list
19281445|NCT04365049|Apatinib|apatinib|mesh-list
19281446|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281447|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19281448|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
19281449|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281450|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
19281451|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281452|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281453|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19281454|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
19281455|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281456|NCT04365049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19281457|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
19281458|NCT04364945|Remifentanil|remifentanil|mesh-list
19281459|NCT04364945|Sevoflurane|sevoflurane|mesh-list
19281460|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19281461|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281462|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281463|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19281464|NCT04364945|Analgesics|analgesics|mesh-ancestor
19281465|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
19281466|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281467|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19281468|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19281469|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19281470|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
19281471|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281472|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281473|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19281474|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19281475|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
19281476|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
19281477|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19281478|NCT04364945|Narcotics|narcotics|mesh-ancestor
19281479|NCT04364802|Iodine|iodine|mesh-list
20356538|NCT00906048|Ofloxacin|ofloxacin|mesh-list
19281480|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
19281481|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
19281482|NCT04364802|Povidone|povidone|mesh-list
20356539|NCT00906048|Rifampin|rifampin|mesh-list
20356540|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20356541|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356542|NCT00906048|Renal Agents|renal agents|mesh-ancestor
20356543|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20356544|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20356545|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20356546|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356547|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356548|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356549|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20356550|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20356551|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20356552|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
20356553|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
20356554|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20356555|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20356556|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20356557|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19281483|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19281484|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281485|NCT04364802|Trace Elements|trace elements|mesh-ancestor
19281486|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
19281487|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356558|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20356559|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20356560|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20356561|NCT00906061|Gemcitabine|gemcitabine|mesh-list
20356562|NCT00906061|Docetaxel|docetaxel|mesh-list
20356563|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356564|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
20356565|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356566|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281488|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
19281489|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
19281490|NCT04364620|Docetaxel|docetaxel|mesh-list
19281491|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281492|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
19281493|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
19281494|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
20356567|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
20356568|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356569|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356570|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356571|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
20356572|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356573|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
20356574|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
20356575|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
20356576|NCT00906113|Melphalan|melphalan|mesh-list
20356577|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20356578|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
20356579|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356580|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356581|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20356582|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356583|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
20356584|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356585|NCT00906126|Misoprostol|misoprostol|mesh-list
20356586|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20356587|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
20356588|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20356589|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281495|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281496|NCT04365036|Gemcitabine|gemcitabine|mesh-list
19281497|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
19281498|NCT04365036|Pegaspargase|pegaspargase|mesh-list
19281499|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356590|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20356591|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20356592|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
19281500|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
20356593|NCT00906139|Fentanyl|fentanyl|mesh-list
19281501|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356594|NCT00906139|Midazolam|midazolam|mesh-list
19281502|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281503|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
19281504|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281505|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281506|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19281507|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
19281508|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356595|NCT00906139|Propofol|propofol|mesh-list
20356596|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20356597|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356598|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356599|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20356600|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
20356601|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
20356602|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20356603|NCT00906139|Narcotics|narcotics|mesh-ancestor
20356604|NCT00906139|Analgesics|analgesics|mesh-ancestor
20356605|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
20356606|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356607|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20356608|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20356609|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20356610|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20356611|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
20356612|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
20356613|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356614|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356615|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
20356616|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
20356617|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19281509|NCT04364516|Vitamin K|vitamin k|mesh-list
19281510|NCT04364516|Anticoagulants|anticoagulants|mesh-list
19281511|NCT04364516|Vitamins|vitamins|mesh-ancestor
19281512|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
19281513|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281514|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19281515|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19281516|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281517|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
19281518|NCT04364516|Coagulants|coagulants|mesh-ancestor
19281519|NCT04364607|Neostigmine|neostigmine|mesh-list
19281520|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19281521|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281522|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281523|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
19281524|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281525|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281526|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19281527|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
19281528|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394284|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394285|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394286|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19394287|NCT03676959|Antibodies|antibodies|mesh-list
19394288|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
19394289|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19394290|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
19394291|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394292|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394293|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19394294|NCT03676946|Antibodies|antibodies|mesh-list
19394295|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
19394296|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19394297|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
19394298|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394299|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394300|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
19394301|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
19394302|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394303|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
19404147|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19404148|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404149|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
19404150|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
19404151|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404152|NCT03597087|Anesthetics|anesthetics|mesh-list
20356618|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19281529|NCT04364399|Vaccines|vaccines|mesh-list
19281530|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
20356619|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356620|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356621|NCT00906269|Urological Agents|urological agents|mesh-ancestor
20356622|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20356623|NCT00906360|Cetuximab|cetuximab|mesh-list
20356624|NCT00906360|Sunitinib|sunitinib|mesh-list
20356625|NCT00906360|Antibodies|antibodies|mesh-list
20356626|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
19281531|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281532|NCT04364477|Anesthetics|anesthetics|mesh-list
19281533|NCT04364477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281534|NCT04364477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281535|NCT04364360|Sulforaphane|sulforaphane|mesh-list
19281536|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19281537|NCT04364360|Protective Agents|protective agents|mesh-ancestor
19281538|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356627|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20356628|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
20356629|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356630|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356631|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356632|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20356633|NCT00906360|Growth Substances|growth substances|mesh-ancestor
20356634|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
20356635|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356636|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356637|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356638|NCT00906386|Varenicline|varenicline|mesh-list
20356639|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20356640|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19281539|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281540|NCT04364451|Asparaginase|asparaginase|mesh-list
19281541|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281542|NCT04364464|Riociguat|riociguat|mesh-list
19281543|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
19281544|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281545|NCT04364425|Triamcinolone|triamcinolone|mesh-list
19281546|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19281547|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19281548|NCT04364425|Lidocaine|lidocaine|mesh-list
19281549|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20356641|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
20356642|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356643|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356644|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356645|NCT00906451|Simvastatin|simvastatin|mesh-list
19281550|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
19281551|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
19281552|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281553|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281554|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
19281555|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281556|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19281557|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19281558|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19281559|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19281560|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356646|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20356647|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20356648|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
20356649|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356650|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20356651|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19281561|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281562|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
19281563|NCT04364425|Hormones|hormones|mesh-ancestor
19281564|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281565|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19281566|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
19281567|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281568|NCT04364321|Diazepam|diazepam|mesh-list
19281569|NCT04364321|Clonazepam|clonazepam|mesh-list
20356652|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356653|NCT00906516|Bevacizumab|bevacizumab|mesh-list
20356654|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356655|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356656|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356657|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20356658|NCT00906516|Growth Substances|growth substances|mesh-ancestor
20356659|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356660|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
20356661|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
20356662|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
20356663|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19281570|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19281571|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
19281572|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
19281573|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
19281574|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281575|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281576|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19281577|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19281578|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281579|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20356664|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356665|NCT00906594|Latanoprost|latanoprost|mesh-list
20356666|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20356667|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19281580|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19281581|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19281582|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19281583|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19281584|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19281585|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
19281586|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
19281587|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
19281588|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
19281589|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281590|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281591|NCT04364139|Metoprolol|metoprolol|mesh-list
19281592|NCT04364139|Amlodipine|amlodipine|mesh-list
19281593|NCT04364139|Ramipril|ramipril|mesh-list
19281594|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19281595|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19281596|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19281597|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281598|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19281599|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281600|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
19281601|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19281602|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
19281603|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
19281604|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281605|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19281606|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19281607|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19281608|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
19281609|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19281610|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19281611|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281612|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281613|NCT04364581|Letrozole|letrozole|mesh-list
19281614|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281615|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19281616|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19281617|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281618|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281619|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19281620|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
19281621|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281622|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281623|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19281624|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281625|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
20356668|NCT00906685|Bevacizumab|bevacizumab|mesh-list
19281626|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
19281627|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20356669|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356670|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356671|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356672|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20356673|NCT00906685|Growth Substances|growth substances|mesh-ancestor
20356674|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356675|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
19281628|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281629|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281630|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281631|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281632|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281633|NCT04364113|Benzocaine|benzocaine|mesh-list
19281634|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
19281635|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
19281636|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281637|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356676|NCT00906724|Insulin|insulin|mesh-list
20356677|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20356678|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356679|NCT00906828|Levodopa|levodopa|mesh-list
19281638|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
19281639|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281640|NCT04364022|Ritonavir|ritonavir|mesh-list
19281641|NCT04364022|Lopinavir|lopinavir|mesh-list
19281642|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19281643|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19281644|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
19281645|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281646|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281647|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19281648|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19281649|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
20356680|NCT00906828|Carbidopa|carbidopa|mesh-list
20356681|NCT00906828|Entacapone|entacapone|mesh-list
20356682|NCT00906828|Tolcapone|tolcapone|mesh-list
20356683|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20356684|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20356685|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
20356686|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356687|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281650|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281651|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19281652|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19281653|NCT04364035|Vesatolimod|vesatolimod|mesh-list
19281654|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
19281655|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281656|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281657|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
19281658|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281659|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281660|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281661|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671123|NCT04016714|Vaccines|vaccines|mesh-list
19671124|NCT04016714|Immunoglobulins|immunoglobulins|mesh-list
19671125|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
19671126|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671127|NCT04014803|Aspirin|aspirin|mesh-list
19671128|NCT04014803|Clopidogrel|clopidogrel|mesh-list
19671129|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19671130|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671131|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671132|NCT04014803|Analgesics|analgesics|mesh-ancestor
19837978|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20356688|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356689|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20356690|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356691|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20356692|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
20356693|NCT00906867|Miotics|miotics|mesh-ancestor
20356694|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
19281662|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281663|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671133|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
19837979|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20356695|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671134|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356696|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356697|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20356698|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20356699|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
20356700|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20356701|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20356702|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
20356703|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356704|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356705|NCT00906880|Eflornithine|eflornithine|mesh-list
20356706|NCT00906880|Nifurtimox|nifurtimox|mesh-list
20356707|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356708|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20356709|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20356710|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20356711|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356712|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20356713|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356714|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356715|NCT00907036|Cyclosporine|cyclosporine|mesh-list
19671135|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671136|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356716|NCT00907036|Fludarabine|fludarabine|mesh-list
20356717|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
20356718|NCT00907036|Melphalan|melphalan|mesh-list
20356719|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
20356720|NCT00907036|Cyclosporins|cyclosporins|mesh-list
20356721|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356722|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356723|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
20356724|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356725|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356726|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
19281664|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
20356727|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356728|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356729|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
20356730|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356731|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
20356732|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356733|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20356734|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20356735|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
20356736|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20356737|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356738|NCT00907114|Ketorolac|ketorolac|mesh-list
20356739|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20356740|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356741|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356742|NCT00907114|Analgesics|analgesics|mesh-ancestor
20356743|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
20356744|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356745|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356746|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356747|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356748|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19281665|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281666|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
19281667|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
19281668|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
19281669|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281670|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
19281671|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281672|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281673|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281674|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281675|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281676|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281677|NCT04363203|Azithromycin|azithromycin|mesh-list
19281678|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281679|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281680|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281681|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
19281682|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281683|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281684|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281685|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281686|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281687|NCT04363255|Cisplatin|cisplatin|mesh-list
19281688|NCT04363255|Carboplatin|carboplatin|mesh-list
19281689|NCT04363255|Etoposide|etoposide|mesh-list
19281690|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
19281691|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281692|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19281693|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19281694|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19281695|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281696|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281697|NCT04363359|Vaccines|vaccines|mesh-list
19281698|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
19281699|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281700|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
19281701|NCT04363216|Vitamins|vitamins|mesh-ancestor
19281702|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
19281703|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281704|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
19281705|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281706|NCT04363216|Protective Agents|protective agents|mesh-ancestor
19281707|NCT04363060|Amoxicillin|amoxicillin|mesh-list
19281708|NCT04363060|Azithromycin|azithromycin|mesh-list
19281709|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
19281710|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
19281711|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19281712|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281713|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281714|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19281715|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281716|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281717|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19281718|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281719|NCT04362735|Vedolizumab|vedolizumab|mesh-list
19281720|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19281721|NCT04362527|Milrinone|milrinone|mesh-list
19281722|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19281723|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19281724|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19281725|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
19281726|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19281727|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19281728|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281729|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281730|NCT04362527|Protective Agents|protective agents|mesh-ancestor
19281731|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837980|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19837981|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281734|NCT04362384|Vitamin E|vitamin e|mesh-list
19281735|NCT04362384|Prednisolone|prednisolone|mesh-list
19281736|NCT04362384|Vitamins|vitamins|mesh-ancestor
19281737|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
19281738|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281739|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281740|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
19281741|NCT04362384|Hormones|hormones|mesh-ancestor
19281742|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281743|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19281744|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281745|NCT04362384|Protective Agents|protective agents|mesh-ancestor
19281746|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
19281747|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394304|NCT03676764|Azithromycin|azithromycin|mesh-list
19394305|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394306|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394307|NCT03676621|Misoprostol|misoprostol|mesh-list
19394308|NCT03676621|Oxytocin|oxytocin|mesh-list
19394309|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
19394310|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19394311|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394312|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20181000|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
19394313|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
19394314|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20181001|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
19394315|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394316|NCT03676556|Lidocaine|lidocaine|mesh-list
19281748|NCT04362241|Prednisolone|prednisolone|mesh-list
20356749|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356750|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356751|NCT00907166|Gemcitabine|gemcitabine|mesh-list
20356752|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356753|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
19281749|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19281750|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
19281751|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19281752|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
19281753|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19281754|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
19281755|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281756|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
19281757|NCT04362241|Hormones|hormones|mesh-ancestor
19281758|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281759|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281760|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19281761|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356754|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356755|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356756|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
20356757|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356758|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356759|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356760|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
20356761|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356762|NCT00907179|Pemetrexed|pemetrexed|mesh-list
20356763|NCT00907179|Panobinostat|panobinostat|mesh-list
20356764|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356765|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356766|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356767|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20356768|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20356769|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20356770|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
20356771|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20356772|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356773|NCT00907270|Vitamins|vitamins|mesh-ancestor
20356774|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
20356775|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20356776|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20356777|NCT00907283|Deferiprone|deferiprone|mesh-list
20356778|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20356779|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
20356780|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
20356781|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356782|NCT00907400|Naproxen|naproxen|mesh-list
20356783|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356784|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356785|NCT00907400|Analgesics|analgesics|mesh-ancestor
20356786|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
20356787|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356788|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356789|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356790|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356791|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
20356792|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20356793|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356794|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281762|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
19281763|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
19281764|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281765|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19281766|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19281767|NCT04362241|Protective Agents|protective agents|mesh-ancestor
19281768|NCT04362293|Sirolimus|sirolimus|mesh-list
19281769|NCT04362293|Plerixafor|plerixafor|mesh-list
19281770|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
19281771|NCT04362293|Thiotepa|thiotepa|mesh-list
19281772|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
19281773|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
19281774|NCT04362293|Azathioprine|azathioprine|mesh-list
19281775|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19281776|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
19281777|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281778|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281779|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19281780|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
19281781|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281782|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281783|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19281784|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281785|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281786|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19281787|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
19281788|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19281789|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
19281790|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281791|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19281792|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
19281793|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19281794|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19281795|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19281796|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
19281797|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281798|NCT04362332|Chloroquine|chloroquine|mesh-list
19281799|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19281800|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
19281801|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281802|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281803|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281804|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281805|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281806|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356795|NCT00907452|Thalidomide|thalidomide|mesh-list
20356796|NCT00907452|Dexamethasone|dexamethasone|mesh-list
20356797|NCT00907452|Prednisone|prednisone|mesh-list
20356798|NCT00907452|Lenalidomide|lenalidomide|mesh-list
20356799|NCT00907452|Melphalan|melphalan|mesh-list
20356800|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356801|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
20356802|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
20356803|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356804|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356805|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20356806|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
20356807|NCT00907452|Hormones|hormones|mesh-ancestor
20356808|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20356809|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20356810|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356811|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
20356812|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20356813|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20356814|NCT00907452|Growth Substances|growth substances|mesh-ancestor
20356815|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
20356816|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20356817|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
20356818|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356819|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20356820|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356821|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
20356822|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20356823|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356824|NCT00907504|Gemcitabine|gemcitabine|mesh-list
20356825|NCT00907504|Cisplatin|cisplatin|mesh-list
20356826|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356827|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356828|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
20356829|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356830|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
20356831|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356832|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356833|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356834|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
20356835|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356836|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
19281807|NCT04362332|Amebicides|amebicides|mesh-ancestor
19281808|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356837|NCT00907608|Hematinics|hematinics|mesh-ancestor
20425156|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425157|NCT01273506|Tapentadol|tapentadol|mesh-list
19281809|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19281810|NCT04362332|Analgesics|analgesics|mesh-ancestor
19281811|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
19281812|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281813|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281814|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281815|NCT04362332|Filaricides|filaricides|mesh-ancestor
19281816|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
19281817|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
19281818|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
19281819|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19281820|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
19281821|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281822|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19281823|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
19281824|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281825|NCT04361825|Durvalumab|durvalumab|mesh-list
19281826|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19281827|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281828|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
19281829|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
19281830|NCT04361708|Leucovorin|leucovorin|mesh-list
19281831|NCT04361708|Docetaxel|docetaxel|mesh-list
19281832|NCT04361708|Fluorouracil|fluorouracil|mesh-list
19281833|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
19281834|NCT04361708|Irinotecan|irinotecan|mesh-list
19281835|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281836|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19281837|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19281838|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19281839|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281840|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
19281841|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19281842|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19281843|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
19281844|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281845|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19281846|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19281847|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181002|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181003|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181004|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181005|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
20181006|NCT00188864|Hormones|hormones|mesh-ancestor
20181007|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20181008|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20181009|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181010|NCT00188877|Fluorouracil|fluorouracil|mesh-list
20181011|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
20181012|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181013|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181014|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181015|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356838|NCT00907751|Rituximab|rituximab|mesh-list
20356839|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356840|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356841|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
19281848|NCT04361708|Antidotes|antidotes|mesh-ancestor
19281849|NCT04361708|Protective Agents|protective agents|mesh-ancestor
19281850|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
19281851|NCT04361708|Vitamins|vitamins|mesh-ancestor
20356842|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356843|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356844|NCT00907764|Regadenoson|regadenoson|mesh-list
20356845|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20356846|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20356847|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
20356848|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
20356849|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356850|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281852|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
19281853|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
19281854|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
19281855|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
19281856|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281857|NCT04361721|Erenumab|erenumab|mesh-list
19281858|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20356851|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356852|NCT00907829|Lidocaine|lidocaine|mesh-list
20356853|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
20356854|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
20356855|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356856|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356857|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
20356858|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356859|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20356860|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20181016|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
20181017|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181018|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
20181019|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
20181020|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356861|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356862|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19281859|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281860|NCT04361721|Analgesics|analgesics|mesh-ancestor
19281861|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
19281862|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281863|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281864|NCT04361812|Omalizumab|omalizumab|mesh-list
19281865|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19281866|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19281867|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19281868|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
19281869|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
19281870|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281871|NCT04361643|Lenalidomide|lenalidomide|mesh-list
19281872|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
19281873|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281874|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19281875|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19281876|NCT04361643|Growth Substances|growth substances|mesh-ancestor
19281877|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
19281878|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281879|NCT04361513|Triamcinolone|triamcinolone|mesh-list
19281880|NCT04361513|Bupivacaine|bupivacaine|mesh-list
19281881|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
19281882|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
19281883|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281884|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281885|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
19281886|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281887|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281888|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
20356863|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356864|NCT00907894|Telbivudine|telbivudine|mesh-list
20356865|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
19281889|NCT04361513|Hormones|hormones|mesh-ancestor
19281890|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281891|NCT04361175|Letrozole|letrozole|mesh-list
19281892|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281893|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281894|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19281895|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19281896|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281897|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19281898|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
19281899|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281900|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181021|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
20356866|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281901|NCT04361461|Azithromycin|azithromycin|mesh-list
20181022|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181023|NCT00188942|Olanzapine|olanzapine|mesh-list
20181024|NCT00188942|Fluoxetine|fluoxetine|mesh-list
20181025|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
20181026|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
20181027|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181028|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181029|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20356867|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19281902|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281903|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19281904|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281905|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
19281906|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281907|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281908|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281909|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281910|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281911|NCT04361279|Rituximab|rituximab|mesh-list
19281912|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19281913|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281914|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
19281915|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281916|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281917|NCT04361188|Anesthetics|anesthetics|mesh-list
19281918|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19281919|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281920|NCT04361422|Isotretinoin|isotretinoin|mesh-list
19281921|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
19281922|NCT04361331|Lenvatinib|lenvatinib|mesh-list
19281923|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281924|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356868|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356869|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356870|NCT00907972|Vitamin D|vitamin d|mesh-list
20356871|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
20356872|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
19281925|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281926|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281927|NCT04361214|Leflunomide|leflunomide|mesh-list
19281928|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281929|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281930|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356873|NCT00907972|Vitamins|vitamins|mesh-list
20356874|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
20356875|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356876|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19281931|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
19281932|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281933|NCT04361305|Tadalafil|tadalafil|mesh-list
19281934|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
19281935|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19281936|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19281937|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281938|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281939|NCT04361305|Urological Agents|urological agents|mesh-ancestor
19281940|NCT04361370|Bevacizumab|bevacizumab|mesh-list
19281941|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
19281942|NCT04361370|Olaparib|olaparib|mesh-list
19281943|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19281944|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281945|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19281946|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19281947|NCT04361370|Growth Substances|growth substances|mesh-ancestor
19281948|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281949|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
19281950|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19281951|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281952|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281953|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
19281954|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
19281955|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
19281956|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19281957|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19281958|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281959|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281960|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281961|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281962|NCT04361149|Capsaicin|capsaicin|mesh-list
19281963|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
19281964|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
19281965|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
19281966|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425158|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19281967|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356877|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19281968|NCT04361474|Budesonide|budesonide|mesh-list
19281969|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19281970|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19281971|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
19281972|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19281973|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281974|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19281975|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
19281976|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
19281977|NCT04361474|Hormones|hormones|mesh-ancestor
20356878|NCT00907985|Lamotrigine|lamotrigine|mesh-list
20356879|NCT00907985|Vofopitant|vofopitant|mesh-list
20356880|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
20356881|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20356882|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20356883|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281978|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19281979|NCT04361058|Nivolumab|nivolumab|mesh-list
19281980|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19281981|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281982|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19281983|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281984|NCT04361409|Gemcitabine|gemcitabine|mesh-list
19281985|NCT04361409|Rituximab|rituximab|mesh-list
19281986|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19281987|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19281988|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
19281989|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19281990|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19281991|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19281992|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
19281993|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19281994|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
19281995|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19281996|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19281997|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19281998|NCT04361162|Nivolumab|nivolumab|mesh-list
19281999|NCT04361162|Ipilimumab|ipilimumab|mesh-list
19282000|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19282001|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282002|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19282003|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282004|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282005|NCT04360759|Chloroquine|chloroquine|mesh-list
19282006|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
19282007|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282008|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282009|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282010|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282011|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282012|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282013|NCT04360759|Amebicides|amebicides|mesh-ancestor
19282014|NCT04361032|Deferoxamine|deferoxamine|mesh-list
19282015|NCT04361032|Siderophores|siderophores|mesh-ancestor
19282016|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19282017|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
19282018|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
19282019|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282020|NCT04360941|Palbociclib|palbociclib|mesh-list
19282021|NCT04360941|Avelumab|avelumab|mesh-list
20181030|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20181031|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20181032|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181033|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181034|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20181035|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181036|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181037|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181038|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181039|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
20181040|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20181041|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
20356884|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19282022|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282023|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19282024|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282025|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282026|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19282027|NCT04360824|Enoxaparin|enoxaparin|mesh-list
19282028|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
19282029|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19282030|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19282031|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282032|NCT04360889|Tocopherols|tocopherols|mesh-list
19282033|NCT04360889|Vitamin E|vitamin e|mesh-list
19282034|NCT04360889|Tocotrienols|tocotrienols|mesh-list
19282035|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
19282036|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
19282037|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282038|NCT04360889|Protective Agents|protective agents|mesh-ancestor
19282039|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282040|NCT04360889|Vitamins|vitamins|mesh-ancestor
19282041|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
19282042|NCT04360785|Methotrexate|methotrexate|mesh-list
19282043|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19282044|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
19282045|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19282046|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282047|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282048|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
19282049|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282050|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282051|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19282052|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282053|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19282054|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282055|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
19282056|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282057|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19282058|NCT04360655|Antibodies|antibodies|mesh-list
19282059|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19282060|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
19282061|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282062|NCT04360317|Docetaxel|docetaxel|mesh-list
19282063|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282064|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
19282065|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
19282066|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
19282067|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394317|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
19394318|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
19394319|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394320|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394321|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
19394322|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394323|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19394324|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19394325|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19394326|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19394327|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394328|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
19394329|NCT03676504|Fludarabine|fludarabine|mesh-list
19394330|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19394331|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
19394332|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181042|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20181043|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20181044|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181045|NCT00188955|Sirolimus|sirolimus|mesh-list
20181046|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20181047|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181048|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20181049|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181050|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
20181051|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181052|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
20181053|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181054|NCT00188994|Insulin|insulin|mesh-list
20356885|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356886|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20356887|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20356888|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20356889|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19282068|NCT04360551|Telmisartan|telmisartan|mesh-list
19282069|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19282070|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19282071|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19282072|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19837982|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20356890|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20356891|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
19282080|NCT04359979|Tamsulosin|tamsulosin|mesh-list
20356892|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
20356893|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356894|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20356895|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20356896|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356897|NCT00908024|Cetuximab|cetuximab|mesh-list
20356898|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356899|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356900|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
20356901|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20356902|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20356903|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19282081|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19282082|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19282083|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19282084|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
19282085|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19282086|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282087|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282088|NCT04359979|Urological Agents|urological agents|mesh-ancestor
19282089|NCT04359953|Azithromycin|azithromycin|mesh-list
19282090|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282091|NCT04359953|Telmisartan|telmisartan|mesh-list
19282092|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282093|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282094|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
19282095|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282096|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282097|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282098|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282099|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282100|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19282101|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19282102|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19282103|NCT04359966|Amoxicillin|amoxicillin|mesh-list
19282104|NCT04359966|Metronidazole|metronidazole|mesh-list
19282105|NCT04359966|Clarithromycin|clarithromycin|mesh-list
19282106|NCT04359966|Levofloxacin|levofloxacin|mesh-list
19282107|NCT04359966|Ofloxacin|ofloxacin|mesh-list
19282108|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19282109|NCT04359966|Esomeprazole|esomeprazole|mesh-list
19282110|NCT04359966|Bismuth|bismuth|mesh-list
19282111|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282112|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282113|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282114|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282115|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19282116|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19282117|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19282118|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282119|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282120|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19282121|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20356904|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19282122|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19282123|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19282124|NCT04359966|Renal Agents|renal agents|mesh-ancestor
19282125|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19282126|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19282127|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282128|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19282129|NCT04359966|Antacids|antacids|mesh-ancestor
19282130|NCT04359862|Propofol|propofol|mesh-list
19282131|NCT04359862|Sevoflurane|sevoflurane|mesh-list
19282132|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20356905|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356906|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
20356907|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20356908|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356909|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20356910|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356911|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
20356912|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
20356913|NCT00908089|Prednisolone|prednisolone|mesh-list
20356914|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20356915|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
20356916|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20356917|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
20356918|NCT00908089|Infliximab|infliximab|mesh-list
20356919|NCT00908089|Naltrexone|naltrexone|mesh-list
19282133|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282134|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282135|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19282136|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
19282137|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
19282138|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20356920|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20356921|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
20356922|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20356923|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
20356924|NCT00908089|Hormones|hormones|mesh-ancestor
20356925|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20356926|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356927|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20356928|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356929|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
20356930|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
20356931|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356932|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20356933|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20356934|NCT00908089|Protective Agents|protective agents|mesh-ancestor
20356935|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
20356936|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20356937|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356938|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20356939|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20356940|NCT00908089|Analgesics|analgesics|mesh-ancestor
20356941|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
20356942|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20356943|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20356944|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
19282139|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19282140|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
19282141|NCT04360031|Tacrolimus|tacrolimus|mesh-list
19282142|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282143|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
19282144|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282145|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19282146|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282147|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282148|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19282149|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282150|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20356945|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20356946|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282151|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
19282152|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282153|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356947|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425159|NCT01273506|Narcotics|narcotics|mesh-ancestor
19282154|NCT04360122|Levamisole|levamisole|mesh-list
19282155|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
19282156|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19282157|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
19282158|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282159|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
19282160|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
19282161|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282162|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282163|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282164|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
19282165|NCT04360135|Acetaminophen|acetaminophen|mesh-list
19282166|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19282167|NCT04360135|Analgesics|analgesics|mesh-ancestor
19282168|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
19282169|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20356948|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356949|NCT00908167|Cytarabine|cytarabine|mesh-list
20356950|NCT00908167|Clofarabine|clofarabine|mesh-list
19671137|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671138|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19282170|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282171|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
19282172|NCT04360356|Ivermectin|ivermectin|mesh-list
19282173|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
19282174|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282175|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282176|NCT04360876|Dexamethasone|dexamethasone|mesh-list
19282177|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
19282178|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282179|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
19282180|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
19282181|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282182|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282183|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19282184|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
19282185|NCT04360876|Hormones|hormones|mesh-ancestor
19282186|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282187|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282188|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282189|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
19282190|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282191|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282192|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282193|NCT04359615|Favipiravir|favipiravir|mesh-list
19282194|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
19282195|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282196|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282197|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282198|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282199|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282200|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282201|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
19282202|NCT04359823|Lovastatin|lovastatin|mesh-list
19282203|NCT04359823|L 647318|l 647318|mesh-list
19282204|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
19282205|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19282206|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19282207|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
19282208|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282209|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19282210|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19282211|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282212|NCT04359576|Hemostatics|hemostatics|mesh-list
19282213|NCT04359576|Coagulants|coagulants|mesh-ancestor
19282214|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282215|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
19282216|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282217|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282218|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282219|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282220|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282221|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671139|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19671140|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282222|NCT04359485|Glycolic acid|glycolic acid|mesh-list
19282223|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
19282224|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
19282225|NCT04359511|Prednisone|prednisone|mesh-list
19282226|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
20356951|NCT00908167|Sorafenib|sorafenib|mesh-list
20356952|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356953|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
20356954|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356955|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356956|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
20356957|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356958|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356959|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
20356960|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356961|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20356962|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356963|NCT00908180|Cytarabine|cytarabine|mesh-list
20356964|NCT00908180|Cyclosporine|cyclosporine|mesh-list
20356965|NCT00908180|Etoposide|etoposide|mesh-list
20356966|NCT00908180|Melphalan|melphalan|mesh-list
20356967|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
20356968|NCT00908180|Carmustine|carmustine|mesh-list
20356969|NCT00908180|Cyclosporins|cyclosporins|mesh-list
20356970|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20356971|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356972|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19282227|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282228|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
19282229|NCT04359511|Hormones|hormones|mesh-ancestor
19282230|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282231|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282232|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282233|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282234|NCT04359550|Antibodies|antibodies|mesh-list
19282235|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20356973|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20356974|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20356975|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356976|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20356977|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
20356978|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
20356979|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20356980|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20356981|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
20356982|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282236|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
19282237|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282238|NCT04359524|Vitamin D|vitamin d|mesh-list
19282239|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
19282240|NCT04359524|Vitamins|vitamins|mesh-ancestor
19282241|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
19282242|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282243|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19282244|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19282245|NCT04359199|Cisplatin|cisplatin|mesh-list
19282246|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
19282247|NCT04359199|Nivolumab|nivolumab|mesh-list
19282248|NCT04359199|Cetuximab|cetuximab|mesh-list
19282249|NCT04359199|Durvalumab|durvalumab|mesh-list
19282250|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282251|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19282252|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19282253|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282254|NCT04359095|Tenofovir|tenofovir|mesh-list
19671141|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20356983|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
20356984|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
19282255|NCT04359095|Emtricitabine|emtricitabine|mesh-list
19671142|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19671143|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671144|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
19671145|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20356985|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282256|NCT04359095|Colchicine|colchicine|mesh-list
19282257|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19282258|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
19282259|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282260|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19692141|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
20356986|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19282261|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19282262|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671146|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19671147|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19671148|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
19282263|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282264|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19282265|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19282266|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19282267|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19282268|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
19282269|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19282270|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19282271|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
19282272|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282273|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
19282274|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
19282275|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
19282276|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282277|NCT04359212|Heparin|heparin|mesh-list
19282278|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19282279|NCT04359212|Tinzaparin|tinzaparin|mesh-list
19282280|NCT04359212|Dalteparin|dalteparin|mesh-list
19282281|NCT04359212|PENTA|penta|mesh-list
19282282|NCT04359212|Fondaparinux|fondaparinux|mesh-list
19282283|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
19282284|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19282285|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20356987|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20356988|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
20356989|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20356990|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356991|NCT00908219|Bevacizumab|bevacizumab|mesh-list
20356992|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20356993|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20356994|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19282286|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282287|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19282288|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
19282289|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19282290|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
19282291|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282292|NCT04359316|Azithromycin|azithromycin|mesh-list
19282293|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282294|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282295|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282296|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
19282297|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282298|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282299|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282300|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282301|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282302|NCT04358965|Misoprostol|misoprostol|mesh-list
19282303|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
19282304|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19282305|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19282306|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282307|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
19282308|NCT04358965|Coagulants|coagulants|mesh-ancestor
19671149|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671150|NCT04006119|Cemiplimab|cemiplimab|mesh-list
19671151|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20181055|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20181056|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181057|NCT00189007|Allopurinol|allopurinol|mesh-list
20181058|NCT00189007|Mannitol|mannitol|mesh-list
20181059|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
20181060|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181061|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181062|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
20181063|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181064|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20181065|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
20356995|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19282309|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19282310|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
20181066|NCT00189007|Protective Agents|protective agents|mesh-ancestor
20181067|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356996|NCT00908219|Growth Substances|growth substances|mesh-ancestor
19282311|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19282312|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282313|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20612542|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19282314|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181068|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19282315|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
19282316|NCT04358614|Ritonavir|ritonavir|mesh-list
19282317|NCT04358614|Lopinavir|lopinavir|mesh-list
19282318|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19837983|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837984|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
20181069|NCT00189007|Diuretics|diuretics|mesh-ancestor
20181070|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
20181071|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20181072|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
19282319|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19282320|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
19282321|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282322|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282323|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19282324|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20181073|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181074|NCT00189033|Psyllium|psyllium|mesh-list
20181075|NCT00189033|Cathartics|cathartics|mesh-ancestor
20181076|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181077|NCT00189059|Amitriptyline|amitriptyline|mesh-list
20181078|NCT00189059|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19282325|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
19282326|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282327|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19282328|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19282329|NCT04358796|Perflubron|perflubron|mesh-list
19282330|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19282331|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
19282332|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19282333|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282334|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282335|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19282336|NCT04358627|Analgesics|analgesics|mesh-ancestor
19282337|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
19282338|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282339|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19282340|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19282341|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19282342|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
19837985|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19837986|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19837987|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
19837988|NCT00618813|Ifosfamide|ifosfamide|mesh-list
19837989|NCT00618813|Doxorubicin|doxorubicin|mesh-list
19837990|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19837991|NCT00618813|Etoposide|etoposide|mesh-list
19837992|NCT00618813|Vincristine|vincristine|mesh-list
19837993|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
19837994|NCT00618813|Topotecan|topotecan|mesh-list
19837995|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19837996|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
19837997|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19837998|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19837999|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19838000|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
20181079|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20181080|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181081|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19282343|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394333|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19838001|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838002|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838003|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19838004|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19838005|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19838006|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19838007|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181082|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20181083|NCT00189059|Analgesics|analgesics|mesh-ancestor
19282344|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20356997|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20356998|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
20356999|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
20357000|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20357001|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282345|NCT04358718|Anesthetics|anesthetics|mesh-list
19282346|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282347|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282348|NCT04358770|Clocortolone|clocortolone|mesh-list
19282349|NCT04358770|Fluocortolone|fluocortolone|mesh-list
19282350|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
19282351|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282352|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
19282353|NCT04358770|Hormones|hormones|mesh-ancestor
19282354|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282355|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282356|NCT04358562|Gefitinib|gefitinib|mesh-list
19282357|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181084|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
20181085|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671152|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671153|NCT03971500|Aspirin|aspirin|mesh-list
19671154|NCT03971500|Ticagrelor|ticagrelor|mesh-list
20181086|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357002|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20357003|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357004|NCT00908297|Ubiquinone|ubiquinone|mesh-list
20357005|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
20357006|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
20357007|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357008|NCT00908297|Vitamins|vitamins|mesh-ancestor
20357009|NCT00908323|Vaccines|vaccines|mesh-list
20357010|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
20357011|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282358|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19282359|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282360|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394334|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19394335|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
19394336|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394337|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394338|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19394339|NCT03676413|Fluticasone|fluticasone|mesh-list
19394340|NCT03676413|Xhance|xhance|mesh-list
20357012|NCT00908336|Docetaxel|docetaxel|mesh-list
20357013|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20357014|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357015|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
20357016|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
20357017|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
20357018|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357019|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20357020|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357021|NCT00908362|Fluticasone|fluticasone|mesh-list
20357022|NCT00908362|Xhance|xhance|mesh-list
20181087|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181088|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181089|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181090|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181091|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181092|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181093|NCT00189059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20181094|NCT00189059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20181095|NCT00189059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181096|NCT00189072|Gabapentin|gabapentin|mesh-list
20181097|NCT00189072|Analgesics|analgesics|mesh-ancestor
19671155|NCT03971500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671156|NCT03971500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671157|NCT03971500|Analgesics|analgesics|mesh-ancestor
20357023|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20357024|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19394341|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19671158|NCT03971500|Sensory System Agents|sensory system agents|mesh-ancestor
19671159|NCT03971500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282361|NCT04358146|Locust bean gum|locust bean gum|mesh-list
19282362|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
19282363|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19282364|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
19282365|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19282366|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282367|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282368|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19282369|NCT04358367|Analgesics|analgesics|mesh-ancestor
19282370|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
19282371|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282372|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19282373|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19282374|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19282375|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
19282376|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19282377|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282378|NCT04358341|Doxorubicin|doxorubicin|mesh-list
19282379|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19282380|NCT04358341|Fluorouracil|fluorouracil|mesh-list
19282381|NCT04358341|Irinotecan|irinotecan|mesh-list
19282382|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19282383|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282384|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19282385|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19282386|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282387|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282388|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
19282389|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282390|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282391|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
19282392|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282393|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19282394|NCT04358432|Ezetimibe|ezetimibe|mesh-list
19282395|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19282396|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19282397|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
20181098|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
20181099|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181100|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181101|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
20181102|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19282398|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282399|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19282400|NCT04358354|Fluorouracil|fluorouracil|mesh-list
19282401|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
19282402|NCT04358354|Irinotecan|irinotecan|mesh-list
19282403|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
19282404|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282405|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282406|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282407|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181103|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20181104|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181105|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181106|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20181107|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20181108|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181109|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181110|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
20181111|NCT00189085|Simvastatin|simvastatin|mesh-list
20181112|NCT00189085|Ezetimibe|ezetimibe|mesh-list
20181113|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20181114|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20181115|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20181116|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
20181117|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181118|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20181119|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20181120|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181121|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20181122|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20181123|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
19282408|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
20181124|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181125|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
20181126|NCT00189150|Valganciclovir|valganciclovir|mesh-list
20181127|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19282409|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282410|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19282411|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19282412|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282413|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
19282414|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
19282415|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282416|NCT04358497|Ibuprofen|ibuprofen|mesh-list
19282417|NCT04358497|Polidocanol|polidocanol|mesh-list
19282418|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19282419|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19282420|NCT04358497|Analgesics|analgesics|mesh-ancestor
19282421|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
19282422|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282423|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282424|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282425|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282426|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19282427|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282428|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282429|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19282430|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19282431|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
19282432|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19282433|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
19282434|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282435|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
19282436|NCT04358120|Protective Agents|protective agents|mesh-ancestor
19671160|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671161|NCT03971500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19671162|NCT03971500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671163|NCT03971500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19671164|NCT03971500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19692142|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357025|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357026|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20357027|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
19282437|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
20612543|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612544|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20612545|NCT02251847|Ezetimibe|ezetimibe|mesh-list
20181128|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282438|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20181129|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20181130|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
20181131|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282439|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
19282440|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282441|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
19282442|NCT04358055|Protective Agents|protective agents|mesh-ancestor
19282443|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
19282444|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282445|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
19282446|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19282447|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19282448|NCT04358016|Terlipressin|terlipressin|mesh-list
19282449|NCT04358016|Somatostatin|somatostatin|mesh-list
19282450|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19282451|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19282452|NCT04358016|Hormones|hormones|mesh-ancestor
19282453|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282454|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282455|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
19282456|NCT04357873|Vorinostat|vorinostat|mesh-list
19282457|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20181132|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357028|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357029|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357030|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20357031|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
19282458|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357032|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
19282459|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19282460|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282461|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282462|NCT04357522|Vaccines|vaccines|mesh-list
19282463|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19282464|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
19282465|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282466|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
19282467|NCT04357535|Giapreza|giapreza|mesh-list
19282468|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19282469|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
19282470|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19282471|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19282472|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282473|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19282474|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19282475|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
19282476|NCT04357483|Thrombin|thrombin|mesh-list
19282477|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
19282478|NCT04357483|Coagulants|coagulants|mesh-ancestor
19282479|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20357033|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20357034|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20181133|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181134|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181135|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
20181136|NCT00189163|Pioglitazone|pioglitazone|mesh-list
20181137|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20181138|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181139|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20357035|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19282480|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282481|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19282482|NCT04357392|Prednisone|prednisone|mesh-list
19282483|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282484|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282485|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
19282486|NCT04357392|Hormones|hormones|mesh-ancestor
19282487|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282488|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282489|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282490|NCT04357093|Listerine|listerine|mesh-list
19282491|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
19282492|NCT04357093|Fluorides|fluorides|mesh-list
19282493|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
19282494|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
20357036|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20357037|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
20357038|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357039|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357040|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
20357041|NCT00908362|Hormones|hormones|mesh-ancestor
20357042|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357043|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
20357044|NCT00908414|TMC-310911|tmc-310911|mesh-list
20357045|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
20357046|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357047|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357048|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
19282495|NCT04357093|Protective Agents|protective agents|mesh-ancestor
19282496|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282497|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19282498|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282499|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19282500|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282501|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
19282502|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282503|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
19282504|NCT04357002|Dinoprostone|dinoprostone|mesh-list
19282505|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19282506|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19282507|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282508|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
20181140|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
19282509|NCT04357002|Coagulants|coagulants|mesh-ancestor
20357049|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
19282510|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
19282511|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19282512|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282513|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19282514|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
19282515|NCT04357015|Carbetocin|carbetocin|mesh-list
19282516|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19282517|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19282518|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282519|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
19282520|NCT04357015|Coagulants|coagulants|mesh-ancestor
19282521|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
19282522|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19282523|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282524|NCT04356872|Doxorubicin|doxorubicin|mesh-list
19282525|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19282526|NCT04356872|Ifosfamide|ifosfamide|mesh-list
19282527|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19282528|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282529|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19282530|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20612546|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20612547|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20612548|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
19282531|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282532|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282533|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19282534|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
19282535|NCT04356729|Bevacizumab|bevacizumab|mesh-list
19282536|NCT04356729|Atezolizumab|atezolizumab|mesh-list
19282537|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19282538|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282539|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19282540|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19282541|NCT04356729|Growth Substances|growth substances|mesh-ancestor
19282542|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282543|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
19282544|NCT04356508|Nivolumab|nivolumab|mesh-list
19282545|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19282546|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282547|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19282548|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282549|NCT04356677|Ribavirin|ribavirin|mesh-list
19282550|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
19282551|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282552|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
19282553|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282554|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19282555|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
19282556|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19282557|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
19282558|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19282559|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282560|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19282561|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282562|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282563|NCT04356833|Plasminogen|plasminogen|mesh-list
19282564|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19282565|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19282566|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19282567|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394342|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19394343|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394344|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19394345|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
19394346|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394347|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394348|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19394349|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
19394350|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
19394351|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20181141|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
20181142|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181143|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282568|NCT04356352|Lidocaine|lidocaine|mesh-list
19282569|NCT04356352|Esmolol|esmolol|mesh-list
19282570|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
19282571|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
19282572|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282573|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282574|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
19282575|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282576|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19282577|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19282578|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19282579|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19282580|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282581|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19282582|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19282583|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19282584|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
19282585|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19282586|NCT04356417|Antimalarials|antimalarials|mesh-list
19282587|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19282588|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19282589|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282590|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282591|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282592|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282593|NCT04356222|Methotrexate|methotrexate|mesh-list
19282594|NCT04356222|Durvalumab|durvalumab|mesh-list
19282595|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19282596|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
19282597|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19282598|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282599|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282600|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
19282601|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282602|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282603|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
19282604|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282605|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19282606|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282607|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
19282608|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282609|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19282610|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19282611|NCT04356144|Thrombin|thrombin|mesh-list
19282612|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
19282613|NCT04356144|Coagulants|coagulants|mesh-ancestor
19282614|NCT04356118|Methotrexate|methotrexate|mesh-list
19282615|NCT04356118|Endostatins|endostatins|mesh-list
19282616|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19282617|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
19282618|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20181144|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20181145|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20181146|NCT00189176|Growth Substances|growth substances|mesh-ancestor
19282619|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282620|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282621|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
19282622|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282623|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282624|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
19282625|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282626|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19282627|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282628|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
19282629|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282630|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19282631|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19282632|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19282633|NCT04356118|Growth Substances|growth substances|mesh-ancestor
19282634|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
19282635|NCT04356170|Docetaxel|docetaxel|mesh-list
20181147|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282636|NCT04356170|Fluorouracil|fluorouracil|mesh-list
19282637|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282638|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
19282639|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
19282640|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
19282641|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282642|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
19282643|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282644|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282645|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
19282646|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282647|NCT04355845|Sumatriptan|sumatriptan|mesh-list
19282648|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19282649|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19282650|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19282651|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
19282652|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19282653|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282654|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282655|NCT04355962|Sevoflurane|sevoflurane|mesh-list
19282656|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19282657|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19282658|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
19282659|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
19282660|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282661|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282662|NCT04355949|Vitamin D|vitamin d|mesh-list
19282663|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
19282664|NCT04355949|Vitamins|vitamins|mesh-list
19282665|NCT04355949|Folic Acid|folic acid|mesh-list
19282666|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
19282667|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
19282668|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
19282669|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
19282670|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282671|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19282672|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19282673|NCT04355949|Hematinics|hematinics|mesh-ancestor
19282674|NCT04355936|Telmisartan|telmisartan|mesh-list
19282675|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19282676|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19282677|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19282678|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282679|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19282680|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20357050|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20357051|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20357052|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357053|NCT00908531|Letrozole|letrozole|mesh-list
20357054|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357055|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20357056|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20357057|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357058|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357059|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20357060|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357061|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357062|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357063|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
20357064|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
20357065|NCT00908661|Coagulants|coagulants|mesh-ancestor
20357066|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
20357067|NCT00908674|Cyproterone|cyproterone|mesh-list
20357068|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
19282681|NCT04355806|Vaccines|vaccines|mesh-list
19282682|NCT04355806|Antibodies|antibodies|mesh-list
19282683|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
19282684|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19282685|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
19282686|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282687|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282688|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282689|NCT04355598|Lidocaine|lidocaine|mesh-list
19282690|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
19282691|NCT04355598|Prilocaine|prilocaine|mesh-list
19282692|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19282693|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
19282694|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
20357069|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357070|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357071|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357072|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357073|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20357074|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
20357075|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20357076|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
20357077|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20357078|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20357079|NCT00908713|Prednisolone|prednisolone|mesh-list
20357080|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
20357081|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20357082|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
20357083|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357084|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
20357085|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
20357086|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357087|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357088|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20357089|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
20357090|NCT00908713|Hormones|hormones|mesh-ancestor
19282695|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282696|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282697|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
19282698|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282699|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19282700|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19282701|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19282702|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19282703|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282704|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19282705|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19282706|NCT04355637|Budesonide|budesonide|mesh-list
19282707|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282708|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19282709|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
19282710|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282711|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282712|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19282713|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
19282714|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
19282715|NCT04355637|Hormones|hormones|mesh-ancestor
19282716|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282717|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
19282718|NCT04355468|Anesthetics|anesthetics|mesh-list
19282719|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282720|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282721|NCT04355468|Narcotics|narcotics|mesh-ancestor
19838008|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19838009|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
19838010|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
19838011|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
19838012|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19838013|NCT00618826|Gemcitabine|gemcitabine|mesh-list
19838014|NCT00618826|Paclitaxel|paclitaxel|mesh-list
19838015|NCT00618826|Bevacizumab|bevacizumab|mesh-list
19838016|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19838017|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838018|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
19838019|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181148|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
20181149|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181150|NCT00189345|Catumaxomab|catumaxomab|mesh-list
20181151|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
20181152|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
20181153|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181154|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181155|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181156|NCT00189358|Tamoxifen|tamoxifen|mesh-list
20181157|NCT00189358|Gefitinib|gefitinib|mesh-list
20181158|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19282722|NCT04355468|Analgesics|analgesics|mesh-ancestor
19838020|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
20181159|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
19282723|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
19282724|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838021|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838022|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838023|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
19838024|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
19838025|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838026|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181160|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282725|NCT04355416|Curcumin|curcumin|mesh-list
19282726|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19282727|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19282728|NCT04355416|Analgesics|analgesics|mesh-ancestor
19282729|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
19282730|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282731|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282732|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282733|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282734|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282735|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282736|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282737|NCT04355494|Eculizumab|eculizumab|mesh-list
19282738|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19282739|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282740|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
19282741|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282742|NCT04355520|Fulvestrant|fulvestrant|mesh-list
19282743|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282744|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282745|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19282746|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19282747|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
19282748|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282749|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282750|NCT04355273|Heparin|heparin|mesh-list
19282751|NCT04355273|Calcium heparin|calcium heparin|mesh-list
19282752|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
19282753|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19282754|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19282755|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282756|NCT04355429|Captopril|captopril|mesh-list
19282757|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19282758|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
19282759|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282760|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282761|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19282762|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
19282763|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19282764|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19282765|NCT04355247|Prednisolone|prednisolone|mesh-list
19282766|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
19282767|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19282768|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
19282769|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282770|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
19282771|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
19838027|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838028|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
19838029|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838030|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838031|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19838032|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838033|NCT00618826|Growth Substances|growth substances|mesh-ancestor
19838034|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
19838035|NCT00618917|Manganese|manganese|mesh-list
20181161|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181162|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20181163|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181164|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20181165|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20181166|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19838036|NCT00618917|Paclitaxel|paclitaxel|mesh-list
19838037|NCT00618917|Carboplatin|carboplatin|mesh-list
19282772|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282773|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282774|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19282775|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
19282776|NCT04355247|Hormones|hormones|mesh-ancestor
20181167|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19282777|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282778|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19282779|NCT04355247|Protective Agents|protective agents|mesh-ancestor
19282780|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282781|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282782|NCT04355455|Citalopram|citalopram|mesh-list
19282783|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19282784|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19282785|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19282786|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282787|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19282788|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
19282789|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282790|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19282791|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
19282792|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19282793|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282794|NCT04355026|Bromhexine|bromhexine|mesh-list
19282795|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
19282796|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282797|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282798|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282799|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181168|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181169|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181170|NCT00189371|Paclitaxel|paclitaxel|mesh-list
20181171|NCT00189371|Carboplatin|carboplatin|mesh-list
20181172|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
20181173|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20181174|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357091|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282800|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282801|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282802|NCT04355026|Expectorants|expectorants|mesh-ancestor
19282803|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
19282804|NCT04355052|Azithromycin|azithromycin|mesh-list
19282805|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282806|NCT04355052|Camostat|camostat|mesh-list
19282807|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282808|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282809|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
19282810|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282811|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282812|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282813|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357092|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20357093|NCT00908713|Protective Agents|protective agents|mesh-ancestor
20357094|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357095|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357096|NCT00908726|Propofol|propofol|mesh-list
19282814|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282815|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
19282816|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19282817|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19282818|NCT04354961|Paclitaxel|paclitaxel|mesh-list
19282819|NCT04354961|Carboplatin|carboplatin|mesh-list
19282820|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20357097|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20357098|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357099|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357100|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20357101|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
19282821|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282822|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
19282823|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181175|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
19282824|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
20181176|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
19838038|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
19282825|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282826|NCT04355039|Dexamethasone|dexamethasone|mesh-list
19282827|NCT04355039|Pomalidomide|pomalidomide|mesh-list
19282828|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282829|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
19282830|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
19282831|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282832|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282833|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19282834|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
19282835|NCT04355039|Hormones|hormones|mesh-ancestor
19282836|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282837|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282838|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282839|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
19282840|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19282841|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19282842|NCT04355039|Growth Substances|growth substances|mesh-ancestor
19282843|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
19282844|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
19282845|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
19282846|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
19282847|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19282848|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282849|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19282850|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19282851|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19282852|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19282853|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19282854|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19282855|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
19282856|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19282857|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282858|NCT04355156|Axitinib|axitinib|mesh-list
19282859|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282860|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19282861|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282862|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282863|NCT04354662|Leucovorin|leucovorin|mesh-list
19282864|NCT04354662|Docetaxel|docetaxel|mesh-list
19282865|NCT04354662|Fluorouracil|fluorouracil|mesh-list
19282866|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
19282867|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282868|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
19282869|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
19282870|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
19282871|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282872|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
19282873|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282874|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282875|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
19282876|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282877|NCT04354662|Antidotes|antidotes|mesh-ancestor
19282878|NCT04354662|Protective Agents|protective agents|mesh-ancestor
19282879|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
19282880|NCT04354662|Vitamins|vitamins|mesh-ancestor
19282881|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
19282882|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282883|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
19282884|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282885|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282886|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282887|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282888|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282889|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282890|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19282891|NCT04354545|Lifitegrast|lifitegrast|mesh-list
19282892|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19282893|NCT04354350|Telmisartan|telmisartan|mesh-list
19282894|NCT04354350|Ramipril|ramipril|mesh-list
19282895|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19282896|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19282897|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19282898|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282899|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19282900|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
20357102|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
20357103|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
20357104|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20357105|NCT00908817|Triamcinolone|triamcinolone|mesh-list
20357106|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20357107|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19282901|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282902|NCT04354428|Folic Acid|folic acid|mesh-list
19282903|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
19282904|NCT04354428|Ritonavir|ritonavir|mesh-list
19282905|NCT04354428|Lopinavir|lopinavir|mesh-list
19282906|NCT04354428|Azithromycin|azithromycin|mesh-list
19282907|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
19282908|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19282909|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19282910|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
19282911|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282912|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282913|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19282914|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19282915|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
19282916|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282917|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19282918|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19282919|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282920|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
19282921|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282922|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282923|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282924|NCT04354428|Hematinics|hematinics|mesh-ancestor
19282925|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
19282926|NCT04354428|Vitamins|vitamins|mesh-ancestor
19282927|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
19282928|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181177|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
20181178|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181179|NCT00189371|Hematinics|hematinics|mesh-ancestor
20181180|NCT00189384|Gentamicins|gentamicins|mesh-list
20181181|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
20181182|NCT00189384|Penicillins|penicillins|mesh-list
20181183|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20357108|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20357109|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20357110|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357111|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
20357112|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
20357113|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357114|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
20357115|NCT00908817|Hormones|hormones|mesh-ancestor
20357116|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357117|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357118|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19282929|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
19282930|NCT04354428|Protective Agents|protective agents|mesh-ancestor
19394352|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19394353|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19394354|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19394355|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
19394356|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394357|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394358|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
19394359|NCT03676413|Hormones|hormones|mesh-ancestor
20181184|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
20181185|NCT00189384|Penicillin G|penicillin g|mesh-list
20181186|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20181187|NCT00189384|Procaine|procaine|mesh-list
20181188|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20181189|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181190|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20181191|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181192|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181193|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20181194|NCT00189384|Renal Agents|renal agents|mesh-ancestor
20181195|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
19394360|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394361|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
19394362|NCT03676374|Prucalopride|prucalopride|mesh-list
19394363|NCT03676374|Laxatives|laxatives|mesh-ancestor
19282931|NCT04354376|Telmisartan|telmisartan|mesh-list
19282932|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
19282933|NCT04354376|Diuretics|diuretics|mesh-list
19282934|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19282935|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
19282936|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19282937|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19282938|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19282939|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282940|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
19282941|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282942|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19282943|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19282944|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19282945|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
19282946|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
19282947|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282948|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
19282949|NCT04353986|Ledipasvir|ledipasvir|mesh-list
19282950|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19282951|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
19282952|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282953|NCT04353817|Ivacaftor|ivacaftor|mesh-list
19282954|NCT04353817|Elexacaftor|elexacaftor|mesh-list
19282955|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19282956|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19282957|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282958|NCT04353505|Dexamethasone|dexamethasone|mesh-list
19282959|NCT04353505|Ketorolac|ketorolac|mesh-list
19282960|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19282961|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
19282962|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
19282963|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181196|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20181197|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20181198|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
19282964|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19282965|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19282966|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
19282967|NCT04353505|Hormones|hormones|mesh-ancestor
19282968|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19282969|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19282970|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282971|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19282972|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19282973|NCT04353505|Analgesics|analgesics|mesh-ancestor
19282974|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
19282975|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19282976|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19282977|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282978|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282979|NCT04353479|Decitabine|decitabine|mesh-list
19282980|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19282981|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19282982|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
19282983|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282984|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282985|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357119|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
20357120|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357121|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357122|NCT00908869|Interferons|interferons|mesh-list
20357123|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
20357124|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
20357125|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
19282986|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20181199|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
20181200|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181201|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181202|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
20181203|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357126|NCT00908869|Vinorelbine|vinorelbine|mesh-list
20357127|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357128|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
19282987|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19282988|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
19282989|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19282990|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19282991|NCT04353362|Amoxicillin|amoxicillin|mesh-list
19282992|NCT04353362|Metronidazole|metronidazole|mesh-list
20357129|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357130|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357131|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20357132|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
20357133|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357134|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19282993|NCT04353362|Ofloxacin|ofloxacin|mesh-list
19282994|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19282995|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19282996|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19282997|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19282998|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19282999|NCT04353362|Renal Agents|renal agents|mesh-ancestor
19283000|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19283001|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19283002|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283003|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283004|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283005|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19283006|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19283007|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19283008|NCT04353713|Laxatives|laxatives|mesh-ancestor
19283009|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283010|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283011|NCT04353336|Chloroquine|chloroquine|mesh-list
19283012|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19283013|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
19283014|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283015|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283016|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283017|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283018|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283019|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283020|NCT04353336|Amebicides|amebicides|mesh-ancestor
19283021|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19283022|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19283023|NCT04353336|Analgesics|analgesics|mesh-ancestor
19283024|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
19283025|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283026|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357135|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20357136|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
20357137|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357138|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20357139|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
20357140|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
20357141|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
20357142|NCT00908921|Glimepiride|glimepiride|mesh-list
20357143|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20357144|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20357145|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357146|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357147|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
19283027|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283028|NCT04353336|Filaricides|filaricides|mesh-ancestor
19283029|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
19283030|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
19283031|NCT04352959|Betadex|betadex|mesh-list
19283032|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
19283033|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283034|NCT04353180|Tretinoin|tretinoin|mesh-list
19283035|NCT04353180|Isotretinoin|isotretinoin|mesh-list
19283036|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283037|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
19283038|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
19283039|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19283040|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
19283041|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283042|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19283043|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19283044|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
19283045|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283046|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283047|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19283048|NCT04353193|Octreotide|octreotide|mesh-list
19283049|NCT04353193|Terlipressin|terlipressin|mesh-list
19283050|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283051|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19283052|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283053|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19283054|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19283055|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283056|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
19283057|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283058|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283059|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283060|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283061|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283062|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283063|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283064|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
19283065|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283066|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283067|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283068|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283069|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283070|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283071|NCT04352855|Tazobactam|tazobactam|mesh-list
19283072|NCT04352855|Ceftolozane|ceftolozane|mesh-list
19283073|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19283074|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283075|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283076|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19283077|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283078|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283079|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19283080|NCT04352855|Renal Agents|renal agents|mesh-ancestor
19283081|NCT04352777|Fulvestrant|fulvestrant|mesh-list
19283082|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19283083|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19283084|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283085|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19283086|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19283087|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
19283088|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283089|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283090|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19283091|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283092|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283093|NCT04352686|Buspirone|buspirone|mesh-list
19283094|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19283095|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19283096|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283097|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283098|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19283099|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19283100|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
19283101|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283102|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283103|NCT04352621|Ketamine|ketamine|mesh-list
19283104|NCT04352621|Analgesics|analgesics|mesh-ancestor
19283105|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
20357148|NCT00908986|Rituximab|rituximab|mesh-list
20357149|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357150|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357151|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
20357152|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357153|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357154|NCT00909051|Acarbose|acarbose|mesh-list
20357155|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20357156|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283106|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283107|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283108|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20357157|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357158|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20357159|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357160|NCT00909077|Dexamethasone|dexamethasone|mesh-list
20357161|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
20357162|NCT00909077|Rituximab|rituximab|mesh-list
20357163|NCT00909077|BB 1101|bb 1101|mesh-list
20357164|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357165|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357166|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
20357167|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357168|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357169|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357170|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
20357171|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
20357172|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357173|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20357174|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
20357175|NCT00909077|Hormones|hormones|mesh-ancestor
20357176|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357177|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357178|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
20357179|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357180|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357181|NCT00909129|Interferons|interferons|mesh-list
20357182|NCT00909129|Ribavirin|ribavirin|mesh-list
19283109|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19283110|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
19283111|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
19283112|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283113|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19283114|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19283115|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283116|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283117|NCT04352400|Nafamostat|nafamostat|mesh-list
19283118|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19283119|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19283120|NCT04352400|Analgesics|analgesics|mesh-ancestor
19283121|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
19283122|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283123|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283124|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283125|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283126|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
19283127|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
19283128|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283129|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283130|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19283131|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19283132|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19283133|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283134|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
19394364|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394365|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19394366|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19394367|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
19394368|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394369|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394370|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357183|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
20357184|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20357185|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357186|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
20357187|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357188|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
20357189|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357190|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
20357191|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357192|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
20357193|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20357194|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357195|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
20357196|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357197|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357198|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20357199|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
20357200|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20357201|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20357202|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357203|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357204|NCT00909233|Urological Agents|urological agents|mesh-ancestor
20357205|NCT00909311|Ritonavir|ritonavir|mesh-list
20357206|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20357207|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20357208|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
20357209|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357210|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357211|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20357212|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20357213|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
20357214|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357215|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19283135|NCT04352153|Febuxostat|febuxostat|mesh-list
19283136|NCT04352153|Citric Acid|citric acid|mesh-list
19283137|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
19283138|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19283139|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
19283140|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
19283141|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283142|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
19283143|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283144|NCT04352205|Thalidomide|thalidomide|mesh-list
20357216|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20357217|NCT00909337|Bosentan|bosentan|mesh-list
20357218|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20357219|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20357220|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357221|NCT00909402|Capecitabine|capecitabine|mesh-list
20357222|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357223|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20357224|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
20357225|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357226|NCT00909454|Vitamin D|vitamin d|mesh-list
19283145|NCT04352205|Dexamethasone|dexamethasone|mesh-list
19283146|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
19283147|NCT04352205|Lenalidomide|lenalidomide|mesh-list
19283148|NCT04352205|Bortezomib|bortezomib|mesh-list
19283149|NCT04352205|Daratumumab|daratumumab|mesh-list
19283150|NCT04352205|Ichthammol|ichthammol|mesh-list
19283151|NCT04352205|BB 1101|bb 1101|mesh-list
19283152|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283153|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
19283154|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
19283155|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283156|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283157|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283158|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
19283159|NCT04352205|Hormones|hormones|mesh-ancestor
19283160|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283161|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19283162|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283163|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
19283164|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283165|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283166|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
19283167|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19283168|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19283169|NCT04352205|Growth Substances|growth substances|mesh-ancestor
19283170|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
19283171|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283172|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
19283173|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283174|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283175|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
19283176|NCT04352465|Methotrexate|methotrexate|mesh-list
19283177|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19283178|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
19283179|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19283180|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283181|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20357227|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
20357228|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
20357229|NCT00909454|Vitamins|vitamins|mesh-list
20357230|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
20357231|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357232|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20357233|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20357234|NCT00909506|Metformin|metformin|mesh-list
20357235|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20357236|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357237|NCT00909519|Naproxen|naproxen|mesh-list
20357238|NCT00909519|Furosemide|furosemide|mesh-list
19283182|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
19283183|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283184|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283185|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
19283186|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283187|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19283188|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283189|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
19283190|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283191|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19283192|NCT04351724|Ritonavir|ritonavir|mesh-list
19283193|NCT04351724|Lopinavir|lopinavir|mesh-list
19283194|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
20181204|NCT00189397|Azathioprine|azathioprine|mesh-list
20181205|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
20181206|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283195|NCT04351724|Chloroquine|chloroquine|mesh-list
20357239|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
20357240|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19283196|NCT04351724|Remdesivir|remdesivir|mesh-list
19283197|NCT04351724|Candesartan|candesartan|mesh-list
19283198|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
19283199|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
19283200|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19283201|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19283202|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
19283203|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283204|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283205|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19283206|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19283207|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
19283208|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283209|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19283210|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19283211|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
19283212|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283213|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283214|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283215|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19283216|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
19283217|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19283218|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
19283219|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19283220|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19283221|NCT04351724|Amebicides|amebicides|mesh-ancestor
19283222|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
19283223|NCT04351763|Amiodarone|amiodarone|mesh-list
19283224|NCT04351763|Verapamil|verapamil|mesh-list
19283225|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19283226|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
20357241|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19283227|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20181207|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181208|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181209|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181210|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
20181211|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181212|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181213|NCT00189410|Carboplatin|carboplatin|mesh-list
20181214|NCT00189410|Doxorubicin|doxorubicin|mesh-list
20181215|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19283228|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19283229|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283230|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20181216|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357242|NCT00909519|Analgesics|analgesics|mesh-ancestor
19283231|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19283232|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19283233|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283234|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19283235|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20357243|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
20357244|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357245|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283236|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19283237|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19283238|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19283239|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283240|NCT04352062|Amoxicillin|amoxicillin|mesh-list
19283241|NCT04352062|Levofloxacin|levofloxacin|mesh-list
19283242|NCT04352062|Ofloxacin|ofloxacin|mesh-list
19283243|NCT04352062|Melatonin|melatonin|mesh-list
19283244|NCT04352062|Pantoprazole|pantoprazole|mesh-list
19283245|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283246|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283247|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
19283248|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283249|NCT04352062|Protective Agents|protective agents|mesh-ancestor
19283250|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283251|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283252|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19283253|NCT04352062|Renal Agents|renal agents|mesh-ancestor
19283254|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19283255|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19283256|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283257|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283258|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19283259|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19283260|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19283261|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283262|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19283263|NCT04351919|Azithromycin|azithromycin|mesh-list
19283264|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283265|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283266|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283267|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
19283268|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20357246|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357247|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357248|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
20357249|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20357250|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357251|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357252|NCT00909519|Diuretics|diuretics|mesh-ancestor
20357253|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
20357254|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20357255|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20357256|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20357257|NCT00909571|Tacrolimus|tacrolimus|mesh-list
20613205|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283269|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283270|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283271|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283272|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283273|NCT04351867|Docetaxel|docetaxel|mesh-list
19283274|NCT04351867|Capecitabine|capecitabine|mesh-list
19283275|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
19283276|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283277|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
19283278|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
19283279|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
19283280|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283281|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19283282|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
19283283|NCT04351737|Dexamethasone|dexamethasone|mesh-list
19283284|NCT04351737|Prednisolone|prednisolone|mesh-list
19283285|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19283286|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
19283287|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19283288|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
20357258|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283289|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19283290|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
19283291|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283292|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
19283293|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
19283294|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283295|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283296|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283297|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
19283298|NCT04351737|Hormones|hormones|mesh-ancestor
19283299|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283300|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19283301|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283302|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19283303|NCT04351737|Protective Agents|protective agents|mesh-ancestor
19283304|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283305|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
19283306|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283307|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283308|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283309|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283310|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283311|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283312|NCT04351412|Fluorides|fluorides|mesh-list
19283313|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
19283314|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
19283315|NCT04351412|Protective Agents|protective agents|mesh-ancestor
19283316|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357259|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
20357260|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357261|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20357262|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357263|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425160|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425161|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425162|NCT01273506|Analgesics|analgesics|mesh-ancestor
20425163|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
20425164|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425165|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20425166|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20425167|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425168|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425169|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
19283317|NCT04351594|Menthol|menthol|mesh-list
19283318|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
19283319|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
19283320|NCT04351347|Ivermectin|ivermectin|mesh-list
19671165|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425170|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425171|NCT01273532|Tapentadol|tapentadol|mesh-list
20425172|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20425173|NCT01273532|Narcotics|narcotics|mesh-ancestor
20425174|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425175|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425176|NCT01273532|Analgesics|analgesics|mesh-ancestor
20612549|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671166|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19671167|NCT03971500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19671168|NCT03971500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181217|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20181218|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20181219|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20181220|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181221|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181222|NCT00189501|Cinacalcet|cinacalcet|mesh-list
20181223|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20181224|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181225|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20181226|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
20181227|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283321|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283322|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283323|NCT04351308|Apatinib|apatinib|mesh-list
19671169|NCT03971500|Antipyretics|antipyretics|mesh-ancestor
20357264|NCT00909688|BLI-489|bli-489|mesh-list
20357265|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20357266|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357267|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357268|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20357269|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357270|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
20357271|NCT00909831|Sirolimus|sirolimus|mesh-list
20357272|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
20357273|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20357274|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20357275|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357276|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357277|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283324|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283325|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19283326|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283327|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671170|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19671171|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20181228|NCT00189514|Pramlintide|pramlintide|mesh-list
20181229|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20181230|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283328|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283329|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
19283330|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283331|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283332|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283333|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283334|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283335|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283336|NCT04351256|Durvalumab|durvalumab|mesh-list
19283337|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19283338|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283339|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
19283340|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19283341|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283342|NCT04351490|Vitamins|vitamins|mesh-ancestor
19283343|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
19283344|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19283345|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283346|NCT04351191|Chloroquine|chloroquine|mesh-list
19283347|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
19283348|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283349|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283350|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283351|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283352|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283353|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283354|NCT04351191|Amebicides|amebicides|mesh-ancestor
19283355|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19283356|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
19283357|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283358|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283359|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
19283360|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19283361|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
19283362|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283363|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
19283364|NCT04351126|Bromocriptine|bromocriptine|mesh-list
19283365|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20181231|NCT00189553|Paclitaxel|paclitaxel|mesh-list
20181232|NCT00189553|Carboplatin|carboplatin|mesh-list
20181233|NCT00189553|Doxorubicin|doxorubicin|mesh-list
20181234|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20181235|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20181236|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181237|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
20181238|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181239|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
20181240|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181241|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20181242|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20357278|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181243|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19283366|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19283367|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
19283368|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283369|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283370|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
19283371|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
19283372|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283373|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283374|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283375|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
19283376|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283377|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
19283378|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19283379|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19283380|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283381|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
19283382|NCT04350645|Coagulants|coagulants|mesh-ancestor
19283383|NCT04350320|Colchicine|colchicine|mesh-list
19283384|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
19283385|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283386|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
19283387|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
19283388|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
19283389|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283390|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283391|NCT04350528|Pentobarbital|pentobarbital|mesh-list
19283392|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
19283393|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
19283394|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
19283395|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283396|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283397|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283398|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19283399|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19283400|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283401|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19283402|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19283403|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
19283404|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283405|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283406|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19283407|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19283408|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
19283409|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
19283410|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
19283411|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19283412|NCT04350580|Antibodies|antibodies|mesh-list
20357279|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20357280|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20357281|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357282|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
20357283|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357284|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
20357285|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357286|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
20357287|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20357288|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20357289|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357290|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
20357291|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357292|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357293|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
20357294|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20357295|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357296|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357297|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20357298|NCT00909935|Analgesics|analgesics|mesh-ancestor
20357299|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
20357300|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357301|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19283413|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
19283414|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283415|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19283416|NCT04350502|Amoxicillin|amoxicillin|mesh-list
20357302|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19283417|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
19283418|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
19283419|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19283420|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283421|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283422|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283423|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19283424|NCT04350684|Interferons|interferons|mesh-list
19283425|NCT04350684|Ritonavir|ritonavir|mesh-list
19283426|NCT04350684|Lopinavir|lopinavir|mesh-list
19283427|NCT04350684|Interferon-beta|interferon-beta|mesh-list
19283428|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
19283429|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283430|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283431|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
19283432|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283433|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19283434|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19283435|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
19283436|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283437|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283438|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19283439|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19283440|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19283441|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19283442|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
19283443|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283444|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283445|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283446|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
19283447|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283448|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19283449|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283450|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
19283451|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283452|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283453|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283454|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283455|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283456|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394371|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19394372|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
19394373|NCT03676361|Coagulants|coagulants|mesh-ancestor
19394374|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19394375|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
19394376|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394377|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19394378|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19394379|NCT03676296|Puerarin|puerarin|mesh-list
19394380|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
19394381|NCT03676192|Bevacizumab|bevacizumab|mesh-list
19394382|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19394383|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394384|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19394385|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19394386|NCT03676192|Growth Substances|growth substances|mesh-ancestor
19394387|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394388|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
19394389|NCT03676140|Azithromycin|azithromycin|mesh-list
19394390|NCT03676140|Ivermectin|ivermectin|mesh-list
19394391|NCT03676140|Albendazole|albendazole|mesh-list
19394392|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
19394393|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394394|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394395|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19394396|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
19394397|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
19394398|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19394399|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19394400|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19394401|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19394402|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19394403|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394404|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394405|NCT03676140|Filaricides|filaricides|mesh-ancestor
19394406|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
19394407|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19394408|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357303|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20357304|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
20357305|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357306|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357307|NCT00909948|Fludarabine|fludarabine|mesh-list
20357308|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357309|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
20357310|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20357311|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357312|NCT00909974|Micronutrients|micronutrients|mesh-list
19283457|NCT04350671|Interferons|interferons|mesh-list
19283458|NCT04350671|Ritonavir|ritonavir|mesh-list
19283459|NCT04350671|Lopinavir|lopinavir|mesh-list
19283460|NCT04350671|Interferon-beta|interferon-beta|mesh-list
19283461|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
19283462|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283463|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283464|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
19283465|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283466|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19283467|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19283468|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
19283469|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283470|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283471|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19283472|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19283473|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19283474|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19283475|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
19283476|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283477|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283478|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357313|NCT00909974|Trace Elements|trace elements|mesh-list
20357314|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357315|NCT00909987|Bevacizumab|bevacizumab|mesh-list
20357316|NCT00909987|Capecitabine|capecitabine|mesh-list
20357317|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
20357318|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357319|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357320|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20357321|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20357322|NCT00909987|Growth Substances|growth substances|mesh-ancestor
20357323|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357324|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
20357325|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20357326|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
20357327|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357328|NCT00910013|Ropivacaine|ropivacaine|mesh-list
20357329|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
20357330|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
20357331|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357332|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357333|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
20357334|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357335|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20357336|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
20357337|NCT00910052|Coagulants|coagulants|mesh-ancestor
20357338|NCT00910065|Aspirin|aspirin|mesh-list
20357339|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
20357340|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20357341|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20357342|NCT00910065|Analgesics|analgesics|mesh-ancestor
20357343|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
20357344|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357345|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357346|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357347|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357348|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20357349|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20357350|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357351|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20357352|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20357353|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357354|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
19283479|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
19283480|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283481|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19283482|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
19283483|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19283484|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283485|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283486|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19283487|NCT04350086|Analgesics|analgesics|mesh-ancestor
19283488|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
19283489|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283490|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20357355|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
20357356|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357357|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357358|NCT00910195|Acetaminophen|acetaminophen|mesh-list
20357359|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20357360|NCT00910195|Analgesics|analgesics|mesh-ancestor
20357361|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
20357362|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357363|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357364|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
20357365|NCT00910221|Atorvastatin|atorvastatin|mesh-list
20357366|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20357367|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20357368|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
20357369|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357370|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20357371|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19283491|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19283492|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19283493|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
19283494|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283495|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283496|NCT04350190|Apatinib|apatinib|mesh-list
19283497|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357372|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357373|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
20357374|NCT00910234|Hematinics|hematinics|mesh-ancestor
19283498|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19283499|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283500|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283501|NCT04350281|Interferons|interferons|mesh-list
19283502|NCT04350281|Interferon-beta|interferon-beta|mesh-list
19283503|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283504|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
19283505|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283506|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
19283507|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283508|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
19283509|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283510|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283511|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283512|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283513|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283514|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
19283515|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357375|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
20357376|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20357377|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357378|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19283516|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19283517|NCT04349930|Cannabidiol|cannabidiol|mesh-list
19283518|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
19283519|NCT04349592|Azithromycin|azithromycin|mesh-list
19283520|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283521|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283522|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283523|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
19283524|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283525|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283526|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283527|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283528|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283529|NCT04349696|Mitiglinide|mitiglinide|mesh-list
19283530|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19394409|NCT03676114|Ketamine|ketamine|mesh-list
20357379|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20357380|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283531|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283532|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283533|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
19283534|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283535|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283536|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283537|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283538|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283539|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283540|NCT04349410|Interferons|interferons|mesh-list
19283541|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
19283542|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
19283543|NCT04349410|Remdesivir|remdesivir|mesh-list
19283544|NCT04349410|Azithromycin|azithromycin|mesh-list
19283545|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283546|NCT04349410|Doxycycline|doxycycline|mesh-list
19283547|NCT04349410|Clindamycin|clindamycin|mesh-list
19283548|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
19283549|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
19283550|NCT04349410|Primaquine|primaquine|mesh-list
19283551|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
19283552|NCT04349410|Losartan|losartan|mesh-list
19283553|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283554|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
19283555|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283556|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283557|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
19283558|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
19283559|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283560|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357381|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357382|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357383|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20357384|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20357385|NCT00910390|Ethylene|ethylene|mesh-list
20357386|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20357387|NCT00910390|Growth Substances|growth substances|mesh-ancestor
20357388|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357389|NCT00910416|Remifentanil|remifentanil|mesh-list
20357390|NCT00910416|Propofol|propofol|mesh-list
20357391|NCT00910416|Sevoflurane|sevoflurane|mesh-list
20357392|NCT00910416|Atracurium|atracurium|mesh-list
20357393|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20357394|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283561|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283562|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
19283563|NCT04349410|Hormones|hormones|mesh-ancestor
19283564|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283565|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19283566|NCT04349410|Protective Agents|protective agents|mesh-ancestor
19283567|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
19283568|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283569|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
19283570|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283571|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283572|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283573|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283574|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283575|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19283576|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19283577|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19283578|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19283579|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19283580|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
19283581|NCT04349241|Favipiravir|favipiravir|mesh-list
19283582|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
19283583|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283584|NCT04349826|Azithromycin|azithromycin|mesh-list
19283585|NCT04349826|Cefixime|cefixime|mesh-list
19283586|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283587|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283588|NCT04348786|Amoxicillin|amoxicillin|mesh-list
19283589|NCT04348786|Doxycycline|doxycycline|mesh-list
19283590|NCT04348786|Levofloxacin|levofloxacin|mesh-list
19283591|NCT04348786|Ofloxacin|ofloxacin|mesh-list
19283592|NCT04348786|Esomeprazole|esomeprazole|mesh-list
19283593|NCT04348786|Bismuth|bismuth|mesh-list
19283594|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19283595|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283596|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283597|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19283598|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283599|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19283600|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283601|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283602|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
19283603|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283604|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283605|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19283606|NCT04348786|Renal Agents|renal agents|mesh-ancestor
19283607|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19283608|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19283609|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283610|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19283611|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19283612|NCT04348786|Antacids|antacids|mesh-ancestor
19283613|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
19283614|NCT04348695|Simvastatin|simvastatin|mesh-list
19283615|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19283616|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19283617|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
19283618|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283619|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19283620|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19283621|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283622|NCT04348877|Antibodies|antibodies|mesh-list
19283623|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
19283624|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357395|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357396|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20357397|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
20357398|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
20357399|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20357400|NCT00910416|Narcotics|narcotics|mesh-ancestor
20357401|NCT00910416|Analgesics|analgesics|mesh-ancestor
19283625|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
19283626|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19283627|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283628|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
19283629|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19283630|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283631|NCT04348370|Vaccines|vaccines|mesh-list
19283632|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
19283633|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
19283634|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283635|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19283636|NCT04348383|Defibrotide|defibrotide|mesh-list
19283637|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20357402|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
20357403|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357404|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20357405|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20357406|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20357407|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19283638|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19283639|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283640|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19283641|NCT04348474|Azithromycin|azithromycin|mesh-list
19283642|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283643|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283644|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283645|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
19283646|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283647|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20181244|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181245|NCT00189566|Paclitaxel|paclitaxel|mesh-list
20181246|NCT00189566|Carboplatin|carboplatin|mesh-list
20181247|NCT00189566|Topotecan|topotecan|mesh-list
20181248|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20181249|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181250|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
20181251|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181252|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
20181253|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181254|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20357408|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19283648|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283649|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283650|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283651|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
19671172|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19671173|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
19671174|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671175|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
19671176|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19671177|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671178|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357409|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20357410|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20357411|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
20357412|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357413|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357414|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
20357415|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20357416|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
19283652|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283653|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394410|NCT03676114|Analgesics|analgesics|mesh-ancestor
19394411|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
19394412|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394413|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394414|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19394415|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19394416|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
19394417|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
19394418|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394419|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19394420|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19394421|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394422|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394423|NCT03676088|Mitogens|mitogens|mesh-list
19394424|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
19394425|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394426|NCT03676049|Cannabidiol|cannabidiol|mesh-list
19394427|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
19394428|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
19394429|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394430|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
19394431|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19394432|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
19394433|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19394434|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19394435|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394436|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
19394437|NCT03676023|Coagulants|coagulants|mesh-ancestor
19394438|NCT03675854|Cefazolin|cefazolin|mesh-list
19394439|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394440|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394441|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
19394442|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
19394443|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19394444|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394445|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
19394446|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394447|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19394448|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19394449|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394450|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394451|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394452|NCT03675815|Ritonavir|ritonavir|mesh-list
19394453|NCT03675815|Darunavir|darunavir|mesh-list
19394454|NCT03675815|Tenofovir|tenofovir|mesh-list
19394455|NCT03675815|Lamivudine|lamivudine|mesh-list
19394456|NCT03675815|Emtricitabine|emtricitabine|mesh-list
19394457|NCT03675815|Dolutegravir|dolutegravir|mesh-list
19394458|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19394459|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19394460|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19394461|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
19671179|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394462|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671180|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19283654|NCT04347915|Clevudine|clevudine|mesh-list
19283655|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
19283656|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283657|NCT04348006|Dexamethasone|dexamethasone|mesh-list
19283658|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
19283659|NCT04348006|Lenalidomide|lenalidomide|mesh-list
19283660|NCT04348006|Bortezomib|bortezomib|mesh-list
19283661|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283662|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
19283663|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283664|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283665|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19283666|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
19283667|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283668|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283669|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19283670|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283671|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
19283672|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
19283673|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283674|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283675|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
19283676|NCT04348006|Hormones|hormones|mesh-ancestor
19283677|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283678|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19283679|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19283680|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19283681|NCT04348006|Growth Substances|growth substances|mesh-ancestor
19283682|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
20357417|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357418|NCT00910442|Expectorants|expectorants|mesh-ancestor
20357419|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
20357420|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20357421|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
20357422|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357423|NCT00910442|Protective Agents|protective agents|mesh-ancestor
20357424|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357425|NCT00910442|Antidotes|antidotes|mesh-ancestor
20357426|NCT00910455|SRX246|srx246|mesh-list
20357427|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20357428|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357429|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
20357430|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357431|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
20357432|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20357433|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357434|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
20357435|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
20357436|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19283683|NCT04347733|Triamcinolone|triamcinolone|mesh-list
19283684|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19283685|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19283686|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19283687|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283688|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
19283689|NCT04347733|Hormones|hormones|mesh-ancestor
19283690|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283691|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283692|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283693|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
19283694|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283695|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283696|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19283697|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19283698|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19283699|NCT04348045|Durvalumab|durvalumab|mesh-list
19283700|NCT04348045|Olaparib|olaparib|mesh-list
19283701|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19283702|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283703|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19283704|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283705|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357437|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
20357438|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357439|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357440|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357441|NCT00910637|Gestodene|gestodene|mesh-list
20357442|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20357443|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20357444|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20357445|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
20357446|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20357447|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357448|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19283706|NCT04347889|Ascorbic Acid|ascorbic acid|mesh-list
19283707|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283708|NCT04347889|Vitamins|vitamins|mesh-ancestor
19283709|NCT04347889|Micronutrients|micronutrients|mesh-ancestor
19283710|NCT04347889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283711|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
19283712|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283713|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283714|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671181|NCT03929029|Nivolumab|nivolumab|mesh-list
19671182|NCT03929029|Ipilimumab|ipilimumab|mesh-list
20357449|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19283715|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283716|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283717|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283718|NCT04347889|Antioxidants|antioxidants|mesh-ancestor
19283719|NCT04347889|Protective Agents|protective agents|mesh-ancestor
19283720|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283721|NCT04347980|Dexamethasone|dexamethasone|mesh-list
19283722|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283723|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
19283724|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
19283725|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283726|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283727|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283728|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
19283729|NCT04347980|Hormones|hormones|mesh-ancestor
19283730|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283731|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19283732|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283733|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
19283734|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283735|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283736|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283737|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283738|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283739|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283740|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283741|NCT04347798|Chloroquine|chloroquine|mesh-list
19283742|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
19283743|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283744|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283745|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283746|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283747|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283748|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283749|NCT04347798|Amebicides|amebicides|mesh-ancestor
19283750|NCT04347720|Acetaminophen|acetaminophen|mesh-list
19283751|NCT04347720|Ibuprofen|ibuprofen|mesh-list
19283752|NCT04347720|Indomethacin|indomethacin|mesh-list
19283753|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19283754|NCT04347720|Analgesics|analgesics|mesh-ancestor
19283755|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
19283756|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283757|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283758|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
19283759|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19283760|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283761|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283762|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19283763|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283764|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283765|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
19283766|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
19283767|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19671183|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357450|NCT00910637|Progestins|progestins|mesh-ancestor
19283768|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20357451|NCT00910637|Hormones|hormones|mesh-ancestor
20357452|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283769|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19283770|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19283771|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19283772|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283773|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283774|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283775|NCT04347577|Analgesics|analgesics|mesh-ancestor
19283776|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
19283777|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283778|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
19283779|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19283780|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
20357453|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20357454|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357455|NCT00910741|Gemcitabine|gemcitabine|mesh-list
20357456|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20357457|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
20357458|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357459|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357460|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
20357461|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357462|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357463|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283781|NCT04347512|Azithromycin|azithromycin|mesh-list
19283782|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283783|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20357464|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
20357465|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357466|NCT00910754|Prednisone|prednisone|mesh-list
20357467|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
20357468|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357469|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
20357470|NCT00910754|Hormones|hormones|mesh-ancestor
20357471|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357472|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357473|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357474|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357475|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20357476|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357477|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357478|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357479|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20357480|NCT00910767|Insulin|insulin|mesh-list
20357481|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20357482|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357483|NCT00910780|Olanzapine|olanzapine|mesh-list
20357484|NCT00910780|Aripiprazole|aripiprazole|mesh-list
20357485|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
20357486|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20357487|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20357488|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20357489|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357490|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357491|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
20357492|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
20357493|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283784|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283785|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
19283786|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283787|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283788|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283789|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283790|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283791|NCT04347252|Glucagon|glucagon|mesh-list
19283792|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19283793|NCT04347252|Hormones|hormones|mesh-ancestor
19283794|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283795|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283796|NCT04346901|Methimazole|methimazole|mesh-list
20357494|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357495|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20357496|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20357497|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
20357498|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20357499|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20357500|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20357501|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20357502|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
20357503|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
19283797|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
19283798|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
19283799|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283800|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283801|NCT04347031|Azithromycin|azithromycin|mesh-list
19283802|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283803|NCT04347031|Mefloquine|mefloquine|mesh-list
19283804|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19283805|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283806|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
19283807|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283808|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283809|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283810|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283811|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283812|NCT04347005|Allopurinol|allopurinol|mesh-list
19283813|NCT04347005|Febuxostat|febuxostat|mesh-list
19283814|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
19283815|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283816|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283817|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
19283818|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283819|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19283820|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
19283821|NCT04347005|Protective Agents|protective agents|mesh-ancestor
19283822|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283823|NCT04347200|Anticoagulants|anticoagulants|mesh-list
19283824|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19283825|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
19283826|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
19283827|NCT04346862|Vitamins|vitamins|mesh-ancestor
19283828|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
19283829|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283830|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
19671184|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671185|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19671186|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671187|NCT03890887|Itraconazole|itraconazole|mesh-list
19671188|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
19671189|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283837|NCT04346823|Sevoflurane|sevoflurane|mesh-list
19283838|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20181255|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20181256|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181257|NCT00189579|Trastuzumab|trastuzumab|mesh-list
20181258|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20181259|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181260|NCT00189618|Aspirin|aspirin|mesh-list
20181261|NCT00189618|Clopidogrel|clopidogrel|mesh-list
20181262|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20181263|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20181264|NCT00189618|Analgesics|analgesics|mesh-ancestor
20181265|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
20181266|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181267|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181268|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20181269|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181270|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20181271|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20181272|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181273|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20181274|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20181275|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181276|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
20181277|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20181278|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20357504|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357505|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20357506|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20357507|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20357508|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20357509|NCT00910806|Nevirapine|nevirapine|mesh-list
20357510|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20357511|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20357512|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357513|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357514|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
20357515|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357516|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20357517|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20357518|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20357519|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19283839|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19283840|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
19283841|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
19283842|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283843|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283844|NCT04347187|Anticoagulants|anticoagulants|mesh-list
19283845|NCT04346797|Eculizumab|eculizumab|mesh-list
19283846|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19283847|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283848|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
19283849|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283850|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283851|NCT04346667|Chloroquine|chloroquine|mesh-list
19283852|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
19283853|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283854|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283855|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283856|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283857|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283858|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283859|NCT04346667|Amebicides|amebicides|mesh-ancestor
19671190|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19671191|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19671192|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283860|NCT04346407|Dronabinol|dronabinol|mesh-list
19283861|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
19283862|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283863|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19283864|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19283865|NCT04346407|Analgesics|analgesics|mesh-ancestor
20357520|NCT00910897|Thalidomide|thalidomide|mesh-list
20357521|NCT00910897|Dexamethasone|dexamethasone|mesh-list
20357522|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
20357523|NCT00910897|Bortezomib|bortezomib|mesh-list
20357524|NCT00910897|BB 1101|bb 1101|mesh-list
20357525|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357526|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
20357527|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
19283866|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
19283867|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283868|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19283869|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19283870|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283871|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283872|NCT04346407|Hormones|hormones|mesh-ancestor
19283873|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283874|NCT04346589|Antibodies|antibodies|mesh-list
19283875|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
19283876|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19283877|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
19283878|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283879|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19283880|NCT04346004|Hematinics|hematinics|mesh-ancestor
19283881|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
19283882|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
19283883|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19671193|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357528|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283884|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283885|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283886|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357529|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283887|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283888|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394463|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394464|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20357530|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20357531|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
20357532|NCT00910897|Hormones|hormones|mesh-ancestor
20357533|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357534|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357535|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357536|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
20357537|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357538|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357539|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357540|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
20357541|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
20357542|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20357543|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357544|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20357545|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20357546|NCT00910897|Growth Substances|growth substances|mesh-ancestor
20357547|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
20357548|NCT00910975|Interferons|interferons|mesh-list
20357549|NCT00910975|Ribavirin|ribavirin|mesh-list
20357550|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
20357551|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
20357552|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20357553|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357554|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
20357555|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357556|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
20357557|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357558|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
20357559|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181279|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20181280|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
20181281|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181282|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
20181283|NCT00189644|Fluorouracil|fluorouracil|mesh-list
20181284|NCT00189644|Epirubicin|epirubicin|mesh-list
20181285|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181286|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
20181287|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181288|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181289|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20181290|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
20181291|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181292|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181293|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20181294|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
20181295|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181296|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20181297|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20181298|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20181299|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181300|NCT00189657|Irinotecan|irinotecan|mesh-list
20181301|NCT00189657|Fluorouracil|fluorouracil|mesh-list
20181302|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20181303|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20181304|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181305|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181306|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181307|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
20357560|NCT00911066|Azacitidine|azacitidine|mesh-list
20357561|NCT00911066|Pevonedistat|pevonedistat|mesh-list
19394465|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19394466|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
19394467|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357562|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20357563|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
20357564|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357565|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181308|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181309|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283889|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
19283890|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19283891|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283892|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283893|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19283894|NCT04346290|Analgesics|analgesics|mesh-ancestor
19283895|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
19283896|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283897|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19283898|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19283899|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19283900|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
19283901|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283902|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283903|NCT04346277|Antibodies|antibodies|mesh-list
19283904|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19283905|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
19283906|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283907|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
19283908|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
19283909|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
19283910|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283911|NCT04345926|Propofol|propofol|mesh-list
19283912|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19283913|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283914|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283915|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19283916|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
19283917|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
19283918|NCT04346030|Triamcinolone|triamcinolone|mesh-list
19283919|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19283920|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19283921|NCT04346030|Lidocaine|lidocaine|mesh-list
19283922|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19283923|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
20181310|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
20181311|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181312|NCT00189683|Capecitabine|capecitabine|mesh-list
20181313|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181314|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
20181315|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181316|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181317|NCT00189709|Fluconazole|fluconazole|mesh-list
19283924|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
19283925|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283926|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283927|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
19283928|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283929|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19283930|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19283931|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19283932|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19671194|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20181318|NCT00189709|Micafungin|micafungin|mesh-list
20181319|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
20181320|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181321|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20181322|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20181323|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181324|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181325|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20181326|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
20181327|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20181328|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181329|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20181330|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20181331|NCT00189722|Tacrolimus|tacrolimus|mesh-list
20181332|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181333|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
20181334|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181335|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19283933|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357566|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357567|NCT00911092|Fluorouracil|fluorouracil|mesh-list
20357568|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357569|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
20357570|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357571|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20357572|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19283934|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283935|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
19283936|NCT04346030|Hormones|hormones|mesh-ancestor
19283937|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19283938|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357573|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
20357574|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357575|NCT00911183|Prednisone|prednisone|mesh-list
20357576|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
20357577|NCT00911183|Rituximab|rituximab|mesh-list
20357578|NCT00911183|Doxorubicin|doxorubicin|mesh-list
20357579|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20357580|NCT00911183|Vincristine|vincristine|mesh-list
19283939|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
19283940|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283941|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19283942|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283943|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283944|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
19283945|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
20357581|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357582|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
20357583|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357584|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357585|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20357586|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
20357587|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357588|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357589|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20357590|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357591|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20357592|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19283946|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283947|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
19283948|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283949|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19283950|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283951|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283952|NCT04345848|Heparin|heparin|mesh-list
19283953|NCT04345848|Enoxaparin|enoxaparin|mesh-list
19283954|NCT04345848|Calcium heparin|calcium heparin|mesh-list
19283955|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
19283956|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19283957|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19283958|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283959|NCT04345783|Apatinib|apatinib|mesh-list
19283960|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19283961|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19283962|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283963|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283964|NCT04345432|Gabapentin|gabapentin|mesh-list
19283965|NCT04345432|Analgesics|analgesics|mesh-ancestor
19283966|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
19283967|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283968|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283969|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
19283970|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19283971|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19283972|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19283973|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19283974|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19283975|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19283976|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19283977|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283978|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
19283979|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
20357593|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20357594|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283980|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
19283981|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19283982|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19283983|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19283984|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19283985|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19283986|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19283987|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
19283988|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19283989|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19283990|NCT04345445|Prednisolone|prednisolone|mesh-list
19283991|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
19283992|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19283993|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
19283994|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19283995|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
19283996|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
19283997|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19283998|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19283999|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284000|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
19284001|NCT04345445|Hormones|hormones|mesh-ancestor
19284002|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284003|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19284004|NCT04345445|Protective Agents|protective agents|mesh-ancestor
19284005|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284006|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284007|NCT04345588|Dexamethasone|dexamethasone|mesh-list
19284008|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
19284009|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284010|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
19284011|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
19284012|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284013|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284014|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284015|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
19284016|NCT04345588|Hormones|hormones|mesh-ancestor
19284017|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284018|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284019|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284020|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
19284021|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19284022|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19284023|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284024|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
20357595|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357596|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
20357597|NCT00911183|Hormones|hormones|mesh-ancestor
20357598|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357599|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357600|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20357601|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
20357602|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
20357603|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
20357604|NCT00911235|Fluconazole|fluconazole|mesh-list
20357605|NCT00911235|Fesoterodine|fesoterodine|mesh-list
19284025|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
19284026|NCT04345458|Etanercept|etanercept|mesh-list
19284027|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19284028|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284029|NCT04345458|Analgesics|analgesics|mesh-ancestor
19284030|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
19284031|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284032|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284033|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284034|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284035|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284036|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19284037|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
19284038|NCT04345419|Remdesivir|remdesivir|mesh-list
19284039|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
20357606|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
20357607|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284040|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284041|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
19284042|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284043|NCT04345406|Chloroquine|chloroquine|mesh-list
19284044|NCT04345406|Enalapril|enalapril|mesh-list
19284045|NCT04345406|Captopril|captopril|mesh-list
19284046|NCT04345406|Amebicides|amebicides|mesh-ancestor
19284047|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284048|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284049|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284050|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
20181336|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181337|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181338|NCT00189748|Tacrolimus|tacrolimus|mesh-list
20181339|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181340|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
20357608|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20357609|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20357610|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357611|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357612|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20357613|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357614|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284051|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284052|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19284053|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
19284054|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284055|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284056|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19284057|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19284058|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19284059|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19284060|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19284061|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284062|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19284063|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284064|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
19284065|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19284066|NCT04344951|Chloroquine|chloroquine|mesh-list
19284067|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19284068|NCT04344951|Amebicides|amebicides|mesh-ancestor
19284069|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284070|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284071|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284072|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
19284073|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284074|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19284075|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284076|NCT04344951|Analgesics|analgesics|mesh-ancestor
19284077|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
19284078|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284079|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284080|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284081|NCT04344951|Filaricides|filaricides|mesh-ancestor
19284082|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
19284083|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
19284084|NCT04345094|Hydroquinone|hydroquinone|mesh-list
19284085|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
19284086|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284087|NCT04345094|Protective Agents|protective agents|mesh-ancestor
19284088|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284089|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19284090|NCT04345146|Bevacizumab|bevacizumab|mesh-list
19284091|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19284092|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284093|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19284094|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19284095|NCT04345146|Growth Substances|growth substances|mesh-ancestor
19284096|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181341|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181342|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20181343|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181344|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181345|NCT00189761|Tacrolimus|tacrolimus|mesh-list
19284097|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
19284098|NCT04345276|Ritonavir|ritonavir|mesh-list
19284099|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19284100|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19284101|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
19284102|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284103|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284104|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19284105|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19284106|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
19284107|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284108|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19284109|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19284110|NCT04345198|Epinephrine|epinephrine|mesh-list
19284111|NCT04345198|Racepinephrine|racepinephrine|mesh-list
19284112|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
19284113|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19284114|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19284115|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
19284116|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19284117|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357615|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357616|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20357617|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20357618|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20357619|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20357620|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
20357621|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357622|NCT00911235|Urological Agents|urological agents|mesh-ancestor
20357623|NCT00911261|Oxymorphone|oxymorphone|mesh-list
20357624|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20357625|NCT00911261|Narcotics|narcotics|mesh-ancestor
20357626|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357627|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357628|NCT00911261|Analgesics|analgesics|mesh-ancestor
20357629|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
20357630|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357631|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20357632|NCT00911287|Oxymorphone|oxymorphone|mesh-list
20357633|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20357634|NCT00911287|Narcotics|narcotics|mesh-ancestor
20357635|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357636|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357637|NCT00911287|Analgesics|analgesics|mesh-ancestor
19284118|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284119|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19284120|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19671195|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
19671196|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671197|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671198|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19671199|NCT03827213|Bupivacaine|bupivacaine|mesh-list
19284121|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
19284122|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284123|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19284124|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
19284125|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
19284126|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
19284127|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19284128|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
19284129|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19284130|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19284131|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284132|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
19284133|NCT04344860|Coagulants|coagulants|mesh-ancestor
19284134|NCT04344821|Calcium|calcium|mesh-list
19284135|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19284136|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284137|NCT04344483|Lidocaine|lidocaine|mesh-list
19284138|NCT04344483|Epinephrine|epinephrine|mesh-list
19284139|NCT04344483|Racepinephrine|racepinephrine|mesh-list
19284140|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
20357638|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
20357639|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284141|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
20357640|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19284142|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
19284143|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357641|NCT00911313|Metformin|metformin|mesh-list
20357642|NCT00911313|Letrozole|letrozole|mesh-list
20357643|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20357644|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357645|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357646|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20357647|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20357648|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357649|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357650|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20357651|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357652|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357653|NCT00911339|Atorvastatin|atorvastatin|mesh-list
20357654|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20357655|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20357656|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
20357657|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284144|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284145|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
19284146|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284147|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19284148|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19284149|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19284150|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19284151|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284152|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19284153|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19284154|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
19284155|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19284156|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19284157|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19284158|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
19284159|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19284160|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
19284161|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
19284162|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
19284163|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19284164|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284165|NCT04344457|Azithromycin|azithromycin|mesh-list
19284166|NCT04344457|Indomethacin|indomethacin|mesh-list
19284167|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
19284168|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284169|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20357658|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20357659|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20357660|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357661|NCT00911521|Vaccines|vaccines|mesh-list
20357662|NCT00911521|Immunologic Factors|immunologic factors|mesh-ancestor
20357663|NCT00911521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357664|NCT00911573|Vancomycin|vancomycin|mesh-list
19284170|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284171|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284172|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284173|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284174|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19284175|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284176|NCT04344457|Analgesics|analgesics|mesh-ancestor
19284177|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
19284178|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284179|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284180|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284181|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
19284182|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
19284183|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19284184|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19284185|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284186|NCT04344756|Heparin|heparin|mesh-list
19284187|NCT04344756|Calcium heparin|calcium heparin|mesh-list
19284188|NCT04344756|Tinzaparin|tinzaparin|mesh-list
19284189|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19284190|NCT04344756|Dalteparin|dalteparin|mesh-list
19284191|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
19284192|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19284193|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19284194|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284195|NCT04344782|Bevacizumab|bevacizumab|mesh-list
19284196|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19284197|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284198|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19284199|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19284200|NCT04344782|Growth Substances|growth substances|mesh-ancestor
19284201|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284202|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
19284203|NCT04344730|Dexamethasone|dexamethasone|mesh-list
19284204|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
19284205|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284206|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
19284207|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
19284208|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284209|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284210|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284211|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
19284212|NCT04344730|Hormones|hormones|mesh-ancestor
19284213|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284214|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284215|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284216|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
19284217|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
19284218|NCT04344236|Povidone|povidone|mesh-list
19284219|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19284220|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284221|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
19284222|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
19284223|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
19284224|NCT04344288|Prednisone|prednisone|mesh-list
19284225|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284226|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
19284227|NCT04344288|Hormones|hormones|mesh-ancestor
19284228|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284229|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284230|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284231|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284232|NCT04344405|Vitamin D|vitamin d|mesh-list
19284233|NCT04344405|Vitamins|vitamins|mesh-ancestor
19284234|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
19284235|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284236|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19394468|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19394469|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19394470|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19394471|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19394472|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19394473|NCT03675802|Misoprostol|misoprostol|mesh-list
19394474|NCT03675802|Dinoprostone|dinoprostone|mesh-list
19394475|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19394476|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
19394477|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19394478|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394479|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19394480|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394481|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
19394482|NCT03675646|Morphine|morphine|mesh-list
19394483|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19394484|NCT03675646|Narcotics|narcotics|mesh-ancestor
19394485|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394486|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394487|NCT03675646|Analgesics|analgesics|mesh-ancestor
19394488|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
19394489|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394490|NCT03675594|Cobalt|cobalt|mesh-list
19394491|NCT03675594|Chromium|chromium|mesh-list
19394492|NCT03675594|Trace Elements|trace elements|mesh-ancestor
19394493|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
19394494|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394495|NCT03675555|Dexamethasone|dexamethasone|mesh-list
19394496|NCT03675555|Mirtazapine|mirtazapine|mesh-list
19394497|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19394498|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394499|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
19394500|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
19394501|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394502|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671200|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
20181346|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181347|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
20181348|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181349|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20181350|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181351|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181352|NCT00189774|Nateglinide|nateglinide|mesh-list
20181353|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20181354|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181355|NCT00189787|Tacrolimus|tacrolimus|mesh-list
20181356|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181357|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
20181358|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181359|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20181360|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181361|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181362|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
20181363|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20181364|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20181365|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
20181366|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181367|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181368|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181369|NCT00189800|Urological Agents|urological agents|mesh-ancestor
20217226|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217227|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217228|NCT00309088|Tacrolimus|tacrolimus|mesh-list
20357665|NCT00911573|Clindamycin|clindamycin|mesh-list
20357666|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
20357667|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
19284237|NCT04344379|Azithromycin|azithromycin|mesh-list
19284238|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284239|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284240|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284241|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
19284242|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284243|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20357668|NCT00911573|Tigecycline|tigecycline|mesh-list
20357669|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20357670|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357671|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20357672|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284244|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284245|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284246|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284247|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
19284248|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19284249|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284250|NCT04344041|Vitamins|vitamins|mesh-ancestor
19284251|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
19284252|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20357673|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425177|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
20425178|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425179|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20425180|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20425181|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425182|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425183|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
20425184|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425185|NCT01273558|Canagliflozin|canagliflozin|mesh-list
20425186|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20425187|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425188|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20425189|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425190|NCT01273571|Metformin|metformin|mesh-list
20425191|NCT01273571|Canagliflozin|canagliflozin|mesh-list
20425192|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20425193|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425194|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20425195|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425196|NCT01273584|Metformin|metformin|mesh-list
19284253|NCT04343976|Interferons|interferons|mesh-list
20357674|NCT00911651|Bromides|bromides|mesh-list
19284254|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284255|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
19284256|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284257|NCT04343885|Docetaxel|docetaxel|mesh-list
19284258|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
19284259|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284260|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
19284261|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
19284262|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
19284263|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284264|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19284265|NCT04344158|Sorafenib|sorafenib|mesh-list
19284266|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284267|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19284268|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284269|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284270|NCT04343872|Metformin|metformin|mesh-list
19284271|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19284272|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284273|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
19284274|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
19284275|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
19284276|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284277|NCT04343768|Interferons|interferons|mesh-list
19284278|NCT04343768|Ritonavir|ritonavir|mesh-list
19284279|NCT04343768|Lopinavir|lopinavir|mesh-list
19284280|NCT04343768|Interferon-beta|interferon-beta|mesh-list
19284281|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
19284282|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284283|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
19284284|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284285|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
19284286|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284287|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19284288|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19284289|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
19284290|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284291|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284292|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19284293|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19284294|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19284295|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19284296|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
19284297|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284298|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19671201|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
19671202|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671203|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671204|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
19671205|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671206|NCT03797469|Niacinamide|niacinamide|mesh-list
19671207|NCT03797469|Vitamins|vitamins|mesh-ancestor
19671208|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
19838039|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19838040|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181370|NCT00189826|Tacrolimus|tacrolimus|mesh-list
19838041|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
19838042|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181371|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181372|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
20181373|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181374|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20181375|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181376|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181377|NCT00189839|Tacrolimus|tacrolimus|mesh-list
20181378|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181379|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
20181380|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181381|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20181382|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181383|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181384|NCT00189878|Methotrexate|methotrexate|mesh-list
19284299|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284300|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
19284301|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671209|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357675|NCT00911651|Albuterol|albuterol|mesh-list
20357676|NCT00911651|Ipratropium|ipratropium|mesh-list
20357677|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
20357678|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20357679|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
20357680|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284302|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19284303|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
19284304|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19284305|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19284306|NCT04343729|Prednisolone|prednisolone|mesh-list
19284307|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
19284308|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20357681|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357682|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20357683|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
20357684|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
20357685|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20357686|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20357687|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20357688|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20357689|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
19284309|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
19284310|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284311|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
19284312|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
19284313|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284314|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357690|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19284315|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284316|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
19284317|NCT04343729|Hormones|hormones|mesh-ancestor
19284318|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284319|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19284320|NCT04343729|Protective Agents|protective agents|mesh-ancestor
19284321|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284322|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284323|NCT04343963|Bromides|bromides|mesh-list
19284324|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19284325|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
19284326|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19284327|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284328|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284329|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
19284330|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19284331|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284332|NCT04343651|Leronlimab|leronlimab|mesh-list
19284333|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19284334|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19284335|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284336|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19284337|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19284338|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
19284339|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284340|NCT04343326|Menthol|menthol|mesh-list
19284341|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
19284342|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
19284343|NCT04343170|Folic Acid|folic acid|mesh-list
19284344|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
19284345|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
19284346|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
19284347|NCT04343170|Vitamins|vitamins|mesh-ancestor
19284348|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
19284349|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284350|NCT04343170|Hematinics|hematinics|mesh-ancestor
19284351|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
19284352|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
19284353|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284354|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284355|NCT04343001|Aspirin|aspirin|mesh-list
19284356|NCT04343001|Losartan|losartan|mesh-list
19284357|NCT04343001|Simvastatin|simvastatin|mesh-list
19284358|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19838043|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
19284359|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284360|NCT04343001|Analgesics|analgesics|mesh-ancestor
19284361|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
19284362|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357691|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181385|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20181386|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
20181387|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20181388|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181389|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19284363|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284364|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284365|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284366|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19284367|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19284368|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284369|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19284370|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19284371|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284372|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
19284373|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19284374|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19284375|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
19284376|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19284377|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19284378|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19284379|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19284380|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19284381|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19284382|NCT04343235|Labetalol|labetalol|mesh-list
19284383|NCT04343235|Furosemide|furosemide|mesh-list
19284384|NCT04343235|Diuretics|diuretics|mesh-ancestor
19284385|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
19284386|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284387|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19284388|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19284389|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671210|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
19671211|NCT03795701|Liraglutide|liraglutide|mesh-list
19671212|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19671213|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671214|NCT03795701|Incretins|incretins|mesh-ancestor
19671215|NCT03795701|Hormones|hormones|mesh-ancestor
19671216|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671217|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19671218|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671219|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671220|NCT03722108|Irinotecan|irinotecan|mesh-list
19671221|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19671222|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19671223|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671224|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671225|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284390|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19284391|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19284392|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
19284393|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19284394|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19284395|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
19284396|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
19284397|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284398|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19284399|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19284400|NCT04343144|Nivolumab|nivolumab|mesh-list
19284401|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19284402|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284403|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19284404|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284405|NCT04342910|Paclitaxel|paclitaxel|mesh-list
19284406|NCT04342910|Irinotecan|irinotecan|mesh-list
19284407|NCT04342910|Apatinib|apatinib|mesh-list
19284408|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19284409|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284410|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
19284411|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
19284412|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
19394503|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19671226|NCT03717129|Tenofovir|tenofovir|mesh-list
20181390|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
19284413|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284414|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19284415|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19284416|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284417|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19284418|NCT04342676|Panitumumab|panitumumab|mesh-list
19284419|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19284420|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284421|NCT04342598|Vitamin D|vitamin d|mesh-list
19284422|NCT04342598|Vitamins|vitamins|mesh-ancestor
19284423|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
19284424|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284425|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19284426|NCT04342858|Listerine|listerine|mesh-list
19284427|NCT04342858|Fluorides|fluorides|mesh-list
19284428|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
19284429|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
19284430|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284431|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
19284432|NCT04342858|Protective Agents|protective agents|mesh-ancestor
20357692|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20357693|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
20357694|NCT00911664|Vitamin D|vitamin d|mesh-list
19284433|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19284434|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284435|NCT04342728|Vitamins|vitamins|mesh-list
19284436|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
19284437|NCT04342728|Zinc|zinc|mesh-list
19284438|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
19284439|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284440|NCT04342728|Trace Elements|trace elements|mesh-ancestor
19284441|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
19284442|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284443|NCT04342728|Protective Agents|protective agents|mesh-ancestor
19284444|NCT04342650|Chloroquine|chloroquine|mesh-list
19284445|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19284446|NCT04342650|Amebicides|amebicides|mesh-ancestor
19284447|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284448|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284449|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284450|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
19284451|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284452|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19284453|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284454|NCT04342650|Analgesics|analgesics|mesh-ancestor
19284455|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
19284456|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284457|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284458|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284459|NCT04342650|Filaricides|filaricides|mesh-ancestor
19284460|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
19284461|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
19284462|NCT04342819|Empagliflozin|empagliflozin|mesh-list
19284463|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19671227|NCT03717129|Emtricitabine|emtricitabine|mesh-list
20181391|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181392|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181393|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612550|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20612551|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19284464|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284465|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19284466|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284467|NCT04342065|Celecoxib|celecoxib|mesh-list
19284468|NCT04342065|Pregabalin|pregabalin|mesh-list
19284469|NCT04342065|Analgesics|analgesics|mesh-ancestor
19284470|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
19284471|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181394|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284472|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181395|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20181396|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181397|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
20181398|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181399|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20357695|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
19284473|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
19284474|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19284475|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19284476|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284477|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19284478|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19284479|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19284480|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19284481|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19284482|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19284483|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284484|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284485|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284486|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19284487|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19284488|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284489|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284490|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
19284491|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20357696|NCT00911664|Vitamins|vitamins|mesh-list
20357697|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
20357698|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357699|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20357700|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20357701|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
19284492|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284493|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284494|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284495|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284496|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284497|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284498|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
19284499|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284500|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284501|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284502|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284503|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284504|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284505|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
19284506|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19284507|NCT04342247|Testosterone|testosterone|mesh-list
19284508|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
19284509|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
19284510|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284511|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284512|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
19284513|NCT04342247|Hormones|hormones|mesh-ancestor
19284514|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284515|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284516|NCT04342247|Androgens|androgens|mesh-ancestor
19284517|NCT04342351|Valsartan|valsartan|mesh-list
19284518|NCT04342351|Perindopril|perindopril|mesh-list
19284519|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19284520|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19284521|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19284522|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284523|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19284524|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
19284525|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284526|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
19284527|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284528|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284529|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19284530|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19284531|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284532|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284533|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394504|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
19394505|NCT03675555|Hormones|hormones|mesh-ancestor
19394506|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394507|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19394508|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394509|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
19394510|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19284534|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
19284535|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284536|NCT04341870|Azithromycin|azithromycin|mesh-list
19284537|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284538|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284539|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284540|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
19284541|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284542|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284543|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284544|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284545|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284546|NCT04341935|Linagliptin|linagliptin|mesh-list
19284547|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19284548|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284549|NCT04341935|Incretins|incretins|mesh-ancestor
19284550|NCT04341935|Hormones|hormones|mesh-ancestor
19284551|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284552|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19284553|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
19284554|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284555|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284556|NCT04341831|Teicoplanin|teicoplanin|mesh-list
19284557|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284558|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284559|NCT04341844|Methylene Blue|methylene blue|mesh-list
19284560|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284561|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284562|NCT04341857|Antibodies|antibodies|mesh-list
19284563|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19284564|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
19284565|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181400|NCT00189982|Factor VIII|factor viii|mesh-list
20181401|NCT00189982|Coagulants|coagulants|mesh-ancestor
20181402|NCT00189995|Haloperidol|haloperidol|mesh-list
20181403|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
20181404|NCT00189995|Clozapine|clozapine|mesh-list
20181405|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
20181406|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
20181407|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284574|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
19284575|NCT04341402|Clotrimazole|clotrimazole|mesh-list
19284576|NCT04341402|Miconazole|miconazole|mesh-list
19284577|NCT04341402|Diclofenac|diclofenac|mesh-list
19284578|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671228|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19284579|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284580|NCT04341402|Analgesics|analgesics|mesh-ancestor
19284581|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
19284582|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284583|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284584|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357702|NCT00911716|Bevacizumab|bevacizumab|mesh-list
20357703|NCT00911716|Docetaxel|docetaxel|mesh-list
20357704|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357705|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
20357706|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357707|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357708|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20357709|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
19284585|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284586|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19284587|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284588|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284589|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284590|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19284591|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19284592|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19284593|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19284594|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357710|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357711|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284595|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20181408|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357712|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19284596|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19284597|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19284598|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19284599|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284600|NCT04341428|Lansoprazole|lansoprazole|mesh-list
19284601|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
19284602|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19284603|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284604|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19284605|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284606|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284607|NCT04341571|Metformin|metformin|mesh-list
19284608|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19284609|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284610|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284611|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
19284612|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
19284613|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284614|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284615|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284616|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284617|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284618|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284619|NCT04341675|Sirolimus|sirolimus|mesh-list
19284620|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284621|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284622|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19284623|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284624|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
19284625|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19284626|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
19284627|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284628|NCT04341818|Vitamin D|vitamin d|mesh-list
19284629|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
19284630|NCT04341818|Vitamins|vitamins|mesh-list
19284631|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
19284632|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284633|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19284634|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19284635|NCT04341727|Azithromycin|azithromycin|mesh-list
19284636|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284637|NCT04341727|Chloroquine|chloroquine|mesh-list
19284638|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19284639|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284640|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284641|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
19284642|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284643|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284644|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284645|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284646|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284647|NCT04341727|Amebicides|amebicides|mesh-ancestor
20357713|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357714|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20357715|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20357716|NCT00911716|Growth Substances|growth substances|mesh-ancestor
20357717|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
20357718|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
19284648|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19284649|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20357719|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
20357720|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
20357721|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
20357722|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20357723|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20357724|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357725|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
20357726|NCT00912119|Coagulants|coagulants|mesh-ancestor
20357727|NCT00912145|Alprazolam|alprazolam|mesh-list
20357728|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20357729|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19284650|NCT04341727|Analgesics|analgesics|mesh-ancestor
19284651|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
19284652|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357730|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357731|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19671229|NCT03717129|Cobicistat|cobicistat|mesh-list
19284653|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284654|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284655|NCT04341727|Filaricides|filaricides|mesh-ancestor
19284656|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
19284657|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
19284658|NCT04341545|Letrozole|letrozole|mesh-list
19284659|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284660|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19284661|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19284662|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284663|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284664|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19284665|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
19284666|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284667|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284668|NCT04341207|Azithromycin|azithromycin|mesh-list
19284669|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284670|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284671|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284672|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
19284673|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284674|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284675|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284676|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284677|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284678|NCT04341181|Trastuzumab|trastuzumab|mesh-list
19284679|NCT04341181|Avelumab|avelumab|mesh-list
19284680|NCT04341181|Pertuzumab|pertuzumab|mesh-list
19284681|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19284682|NCT04341181|Atezolizumab|atezolizumab|mesh-list
19284683|NCT04341181|Axitinib|axitinib|mesh-list
19284684|NCT04341181|Niraparib|niraparib|mesh-list
19284685|NCT04341181|Vemurafenib|vemurafenib|mesh-list
19284686|NCT04341181|Maytansine|maytansine|mesh-list
19284687|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19284688|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284689|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19284690|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284691|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284692|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19284693|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19284694|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
19284695|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
19284696|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
19284697|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
19284698|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19284699|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19284700|NCT04341038|Prednisolone|prednisolone|mesh-list
19284701|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
19284702|NCT04341038|Tacrolimus|tacrolimus|mesh-list
19284703|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19284704|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
19284705|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19284706|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
19284707|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284708|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19284709|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284710|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284711|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284712|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
19284713|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
19284714|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284715|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284716|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
19284717|NCT04341038|Hormones|hormones|mesh-ancestor
19284718|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284719|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19284720|NCT04341038|Protective Agents|protective agents|mesh-ancestor
19284721|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284722|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284723|NCT04341155|Dexamethasone|dexamethasone|mesh-list
19284724|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
19284725|NCT04341155|BB 1101|bb 1101|mesh-list
19284726|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284727|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
19284728|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
19671230|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20357732|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20357733|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19284729|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284730|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284731|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284732|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
19284733|NCT04341155|Hormones|hormones|mesh-ancestor
19284734|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284735|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19284736|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284737|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
19284738|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284739|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284740|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
19671231|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20357734|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
19671232|NCT03717129|Elvitegravir|elvitegravir|mesh-list
19671233|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
19671234|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671235|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19671236|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20357735|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
20357736|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357737|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357738|NCT00912171|Budesonide|budesonide|mesh-list
20357739|NCT00912171|Montelukast|montelukast|mesh-list
20357740|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20357741|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20357742|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
20357743|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357744|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357745|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20357746|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
20357747|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
20357748|NCT00912171|Hormones|hormones|mesh-ancestor
20357749|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357750|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20357751|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357752|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20357753|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20357754|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357755|NCT00912262|Capsaicin|capsaicin|mesh-list
20357756|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
20357757|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
20357758|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
20357759|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357760|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357761|NCT00912275|Vinorelbine|vinorelbine|mesh-list
20357762|NCT00912275|Lapatinib|lapatinib|mesh-list
20357763|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20357764|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357765|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
19671237|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671238|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671239|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19671240|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20357766|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
20357767|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
20357768|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671241|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20181409|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181410|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20181411|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20181412|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181413|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181414|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20181415|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
20181416|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181417|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181418|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20357769|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20357770|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357771|NCT00912327|Cetuximab|cetuximab|mesh-list
19284741|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
19284742|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284743|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284744|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284745|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284746|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284747|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284748|NCT04340869|Theobromine|theobromine|mesh-list
19284749|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19284750|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
19284751|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284752|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284753|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19284754|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
19284755|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
19284756|NCT04340778|Lidocaine|lidocaine|mesh-list
19284757|NCT04340778|Prilocaine|prilocaine|mesh-list
19284758|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19284759|NCT04340778|Dinoprostone|dinoprostone|mesh-list
19284760|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
19284761|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
19284762|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19284763|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284764|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
19284765|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284766|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19284767|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19284768|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19284769|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19284770|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284771|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
19284772|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19284773|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19284774|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
19284775|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19284776|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284777|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19284778|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284779|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
19284780|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19284781|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284782|NCT04340401|Capecitabine|capecitabine|mesh-list
19284783|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
19284784|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19284785|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
19284786|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284787|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284788|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284789|NCT04340349|Bromhexine|bromhexine|mesh-list
19284790|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
19284791|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20357772|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357773|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357774|NCT00912392|Carboplatin|carboplatin|mesh-list
20357775|NCT00912392|Etoposide|etoposide|mesh-list
20357776|NCT00912392|Endostar protein|endostar protein|mesh-list
20357777|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357778|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20357779|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20357780|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20357781|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357782|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357783|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20357784|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20357785|NCT00912392|Growth Substances|growth substances|mesh-ancestor
19284792|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20357786|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357787|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
20357788|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
20357789|NCT00912444|Docetaxel|docetaxel|mesh-list
19284793|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838044|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357790|NCT00912444|Doxorubicin|doxorubicin|mesh-list
20357791|NCT00912444|Epirubicin|epirubicin|mesh-list
19671242|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19671243|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19671244|NCT03636295|Warfarin|warfarin|mesh-list
19671245|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
19671246|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
20357792|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19284794|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284795|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284796|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284797|NCT04340349|Expectorants|expectorants|mesh-ancestor
19284798|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
19284799|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19284800|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284801|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284802|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284803|NCT04340388|Tenofovir|tenofovir|mesh-list
19284804|NCT04340388|Lamivudine|lamivudine|mesh-list
19284805|NCT04340388|Zidovudine|zidovudine|mesh-list
19284806|NCT04340388|Darunavir|darunavir|mesh-list
19284807|NCT04340388|Abacavir|abacavir|mesh-list
19284808|NCT04340388|Dolutegravir|dolutegravir|mesh-list
19284809|NCT04340388|Cobicistat|cobicistat|mesh-list
19284810|NCT04340388|Rilpivirine|rilpivirine|mesh-list
19284811|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19284812|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
19284813|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284814|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19284815|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19284816|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284817|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284818|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19284819|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
19284820|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19284821|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19284822|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
19284823|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19284824|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19284825|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19284826|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19284827|NCT04340141|Leucovorin|leucovorin|mesh-list
19284828|NCT04340141|Fluorouracil|fluorouracil|mesh-list
19284829|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
19284830|NCT04340141|Irinotecan|irinotecan|mesh-list
20357793|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
20357794|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357795|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20357796|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20357797|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
19284831|NCT04340141|Calcium|calcium|mesh-list
19284832|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
19284833|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19284834|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284835|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
19284836|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284837|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19284838|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284839|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19284840|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
19284841|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19284842|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19284843|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284844|NCT04340141|Antidotes|antidotes|mesh-ancestor
19284845|NCT04340141|Protective Agents|protective agents|mesh-ancestor
19284846|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
19284847|NCT04340141|Vitamins|vitamins|mesh-ancestor
19284848|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
19394511|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19394512|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
19394513|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
19394514|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671247|NCT03573700|Fludarabine|fludarabine|mesh-list
19671248|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357798|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671249|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
19394515|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394516|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19671250|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394517|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19284849|NCT04339816|Azithromycin|azithromycin|mesh-list
19284850|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284851|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284852|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284853|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
19284854|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284855|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20357799|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357800|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20357801|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
20357802|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
20357803|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
20357804|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20357805|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20357806|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20357807|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357808|NCT00912457|Donepezil|donepezil|mesh-list
20357809|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20357810|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357811|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357812|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
20357813|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357814|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357815|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
19284856|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284857|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284858|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284859|NCT04339868|Terlipressin|terlipressin|mesh-list
19284860|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20357816|NCT00912483|Heparin|heparin|mesh-list
20357817|NCT00912483|Calcium heparin|calcium heparin|mesh-list
20357818|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
20357819|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20357820|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20357821|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357822|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19284861|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19284862|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19284863|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284864|NCT04339361|Lidocaine|lidocaine|mesh-list
19284865|NCT04339361|Dinoprostone|dinoprostone|mesh-list
19284866|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
19284867|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
19284868|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19284869|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284870|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
19284871|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284872|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19284873|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19284874|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19284875|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19284876|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284877|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
19284878|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19284879|NCT04339062|Sirolimus|sirolimus|mesh-list
20357823|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
20357824|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20357825|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20357826|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20357827|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357828|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357829|NCT00912548|Tamoxifen|tamoxifen|mesh-list
20357830|NCT00912548|Goserelin|goserelin|mesh-list
20357831|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20357832|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
20357833|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20357834|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357835|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357836|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357837|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20357838|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20357839|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20357840|NCT00912574|Molgramostim|molgramostim|mesh-list
19284880|NCT04339062|Prednisone|prednisone|mesh-list
20357841|NCT00912574|Sargramostim|sargramostim|mesh-list
20357842|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
19284881|NCT04339062|Everolimus|everolimus|mesh-list
19284882|NCT04339062|Cemiplimab|cemiplimab|mesh-list
19284883|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284884|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
19284885|NCT04339062|Hormones|hormones|mesh-ancestor
19284886|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19284887|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284888|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357843|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
20357844|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357845|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357846|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20357847|NCT00912639|Paclitaxel|paclitaxel|mesh-list
20357848|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20357849|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357850|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
19284889|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284890|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19284891|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
19284892|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284893|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284894|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19284895|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
20181419|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20181420|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
20181421|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
20181422|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
20181423|NCT00190008|Piracetam|piracetam|mesh-list
20181424|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20181425|NCT00190008|Protective Agents|protective agents|mesh-ancestor
20181426|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181427|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
20181428|NCT00190021|Donepezil|donepezil|mesh-list
20181429|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20357851|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
19284896|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19284897|NCT04339348|Lidocaine|lidocaine|mesh-list
19284898|NCT04339348|Prilocaine|prilocaine|mesh-list
19284899|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20357852|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
20357853|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357854|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
20357855|NCT00912678|Tacrolimus|tacrolimus|mesh-list
20357856|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20357857|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
20357858|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357859|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20357860|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357861|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357862|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20357863|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357864|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20357865|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
20357866|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19284900|NCT04339348|Misoprostol|misoprostol|mesh-list
19284901|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
19284902|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
19284903|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19284904|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284905|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
19284906|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357867|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357868|NCT00912756|Cilostazol|cilostazol|mesh-list
20357869|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20357870|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
20357871|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357872|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284907|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19284908|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19284909|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20181430|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357873|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20357874|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
20357875|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19671251|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181431|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284910|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19284911|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284912|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19284913|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
20357876|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20357877|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357878|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20357879|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
20357880|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20357881|NCT00912756|Protective Agents|protective agents|mesh-ancestor
20357882|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20357883|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20357884|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357885|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
20357886|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19284914|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19284915|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19284916|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19284917|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
19284918|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19284919|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
19284920|NCT04338633|Calcium|calcium|mesh-list
19284921|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19284922|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284923|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19284924|NCT04338711|Tofacitinib|tofacitinib|mesh-list
19284925|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19284926|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284927|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284928|NCT04338763|Gemcitabine|gemcitabine|mesh-list
19284929|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19284930|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
19284931|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284932|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284933|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
19284934|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357887|NCT00912860|Interferons|interferons|mesh-list
20357888|NCT00912860|Interferon-beta|interferon-beta|mesh-list
20357889|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
20357890|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357891|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
20357892|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357893|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
19284935|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284936|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19284937|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
19284938|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284939|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
19284940|NCT04338906|Camostat|camostat|mesh-list
19284941|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
19284942|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19284943|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19284944|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19284945|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284946|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284947|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284948|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
19671252|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19671253|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
19671254|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671255|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181432|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
20181433|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181434|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284949|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20181435|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
20181436|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
20181437|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20181438|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
20181439|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181440|NCT00190034|Expectorants|expectorants|mesh-ancestor
19284950|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19284951|NCT04338802|Nintedanib|nintedanib|mesh-list
19671256|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20181441|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
20357894|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357895|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20357896|NCT00912899|Noscapine|noscapine|mesh-list
20357897|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
20357898|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
20357899|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
20357900|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20357901|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357902|NCT00913029|Timolol|timolol|mesh-list
20357903|NCT00913029|Latanoprost|latanoprost|mesh-list
20357904|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20357905|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20357906|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
20357907|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357908|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357909|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357910|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20357911|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20357912|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20357913|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20357914|NCT00913055|Octreotide|octreotide|mesh-list
20357915|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20357916|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20357917|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357918|NCT00913107|Lamotrigine|lamotrigine|mesh-list
20357919|NCT00913107|Carbamazepine|carbamazepine|mesh-list
20357920|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
20357921|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20357922|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20357923|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357924|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20357925|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357926|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20357927|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19284952|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284953|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19284954|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284955|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284956|NCT04338919|Aspirin|aspirin|mesh-list
19284957|NCT04338919|Ticagrelor|ticagrelor|mesh-list
19284958|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19284959|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19284960|NCT04338919|Analgesics|analgesics|mesh-ancestor
19284961|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
19284962|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284963|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284964|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19284965|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19284966|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19284967|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19284968|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284969|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19284970|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19284971|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19284972|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
19284973|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19284974|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19284975|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19284976|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
19284977|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19284978|NCT04338620|Paclitaxel|paclitaxel|mesh-list
19284979|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20357928|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19284980|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19284981|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19284982|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
19284983|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
19284984|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
19284985|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19284986|NCT04338373|Atropine|atropine|mesh-list
19284987|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19284988|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19284989|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19284990|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
20357929|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20357930|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20357931|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
20357932|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20357933|NCT00913107|Analgesics|analgesics|mesh-ancestor
20357934|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
20357935|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357936|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20357937|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20357938|NCT00913120|Enoxaparin|enoxaparin|mesh-list
19284991|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19284992|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19284993|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19284994|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
19284995|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
19284996|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
19284997|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19284998|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19284999|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
19285000|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285001|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285002|NCT04338191|Leucovorin|leucovorin|mesh-list
20357939|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
20357940|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20357941|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20357942|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357943|NCT00913224|Diclofenac|diclofenac|mesh-list
20357944|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20357945|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20357946|NCT00913224|Analgesics|analgesics|mesh-ancestor
20357947|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
20357948|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20357949|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357950|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285003|NCT04338191|Fluorouracil|fluorouracil|mesh-list
19285004|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
19285005|NCT04338191|Irinotecan|irinotecan|mesh-list
19285006|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
19285007|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
19285008|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285009|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19285010|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285011|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19285012|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
19285013|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285014|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19285015|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19285016|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285017|NCT04338191|Antidotes|antidotes|mesh-ancestor
19285018|NCT04338191|Protective Agents|protective agents|mesh-ancestor
19285019|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
19285020|NCT04338191|Vitamins|vitamins|mesh-ancestor
19285021|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
19285022|NCT04338438|Apatinib|apatinib|mesh-list
19285023|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285024|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19285025|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285026|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285027|NCT04337970|Axitinib|axitinib|mesh-list
19285028|NCT04337970|Talazoparib|talazoparib|mesh-list
19285029|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285030|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19285031|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285032|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285033|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19285034|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
19285035|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19285036|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19285037|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285038|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
19285039|NCT04338126|Coagulants|coagulants|mesh-ancestor
19285040|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
19285041|NCT04337879|Irinotecan|irinotecan|mesh-list
19285042|NCT04337879|Calcium|calcium|mesh-list
19285043|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19285044|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357951|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285045|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285046|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19285047|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19285048|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285049|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394518|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394519|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19394520|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19394521|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19394522|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
19394523|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19394524|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19394525|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
19394526|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19394527|NCT03675191|Orlistat|orlistat|mesh-list
19394528|NCT03675191|Phentermine|phentermine|mesh-list
19394529|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394530|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394531|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19394532|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19394533|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19671257|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19671258|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19671259|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671260|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
19671261|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671262|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19671263|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19671264|NCT03525873|Methylphenidate|methylphenidate|mesh-list
19671265|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20357952|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19394534|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394535|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
19394536|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
19394537|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
19394538|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394539|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19394540|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394541|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
19394542|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394543|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404153|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404154|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404155|NCT03597035|Spironolactone|spironolactone|mesh-list
19404156|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19404157|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
19671266|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671267|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19671268|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20357953|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357954|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357955|NCT00913237|Desipramine|desipramine|mesh-list
20357956|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20357957|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
19404158|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404159|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404160|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19404161|NCT03597035|Diuretics|diuretics|mesh-ancestor
19404162|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
19404163|NCT03596970|Everolimus|everolimus|mesh-list
19404164|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404165|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19404166|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
19404167|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404168|NCT03596957|Tolvaptan|tolvaptan|mesh-list
19404169|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19404170|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404171|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
19404172|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404173|NCT03596918|Vincristine|vincristine|mesh-list
19404174|NCT03596918|Bleomycin|bleomycin|mesh-list
19671269|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20357958|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19285050|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
19285051|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20357959|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20357960|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357961|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20357962|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20357963|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20357964|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
20357965|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357966|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357967|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
20357968|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20357969|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
20357970|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357971|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20357972|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
20357973|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20357974|NCT00913276|Propofol|propofol|mesh-list
20357975|NCT00913276|Sevoflurane|sevoflurane|mesh-list
20357976|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20357977|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20357978|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357979|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20357980|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
20357981|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
20357982|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20357983|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19285052|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19285053|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
19285054|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285055|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20357984|NCT00913315|Tamsulosin|tamsulosin|mesh-list
20357985|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20357986|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20357987|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20357988|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20357989|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
20357990|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20357991|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20357992|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285056|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19285057|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
19285058|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19285059|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
19285060|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285061|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285062|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19285063|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
19285064|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
19285065|NCT04337918|Protective Agents|protective agents|mesh-ancestor
19285066|NCT04337814|Ibuprofen|ibuprofen|mesh-list
19285067|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19285068|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285069|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285070|NCT04337814|Analgesics|analgesics|mesh-ancestor
19285071|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
19285072|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285073|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285074|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285075|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285076|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19285077|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285078|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285079|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
19285080|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
19671270|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671271|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
19671272|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671273|NCT03463408|Nivolumab|nivolumab|mesh-list
19671274|NCT03463408|Ipilimumab|ipilimumab|mesh-list
19671275|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20357993|NCT00913315|Urological Agents|urological agents|mesh-ancestor
20357994|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20357995|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20357996|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
20357997|NCT00913328|Montelukast|montelukast|mesh-list
20357998|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20357999|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358000|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20358001|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
20358002|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358003|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838045|NCT00618917|Trace Elements|trace elements|mesh-ancestor
19838046|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
19838047|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838048|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19838049|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
19838050|NCT00618917|Protective Agents|protective agents|mesh-ancestor
19838051|NCT00618956|Milnacipran|milnacipran|mesh-list
19838052|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
19838053|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19838054|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19838055|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838056|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838057|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181442|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20181443|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
20358004|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20358005|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20358006|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358007|NCT00913341|Alprazolam|alprazolam|mesh-list
20358008|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20358009|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358010|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358011|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20358012|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20358013|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358014|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
19285081|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285082|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19285083|NCT04337593|Pegaspargase|pegaspargase|mesh-list
19285084|NCT04337593|Basiliximab|basiliximab|mesh-list
19285085|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285086|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19285087|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
19285088|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181444|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181445|NCT00190034|Protective Agents|protective agents|mesh-ancestor
20181446|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181447|NCT00190034|Antidotes|antidotes|mesh-ancestor
20181448|NCT00190060|Testosterone|testosterone|mesh-list
20181449|NCT00190060|Androgens|androgens|mesh-ancestor
20358015|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
20358016|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358017|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358018|NCT00913367|Insulin|insulin|mesh-list
20358019|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20358020|NCT00913367|Metformin|metformin|mesh-list
20358021|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
20358022|NCT00913367|Glimepiride|glimepiride|mesh-list
20358023|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20358024|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358025|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19285089|NCT04337632|Paclitaxel|paclitaxel|mesh-list
20181450|NCT00190060|Hormones|hormones|mesh-ancestor
20181451|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20181452|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181453|NCT00190099|Dexamethasone|dexamethasone|mesh-list
20181454|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20181455|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
20181456|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
20181457|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285090|NCT04337632|Carboplatin|carboplatin|mesh-list
20181458|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358026|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358027|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
19285091|NCT04337632|Doxorubicin|doxorubicin|mesh-list
19285092|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19285093|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19285094|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285095|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
19285096|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
19285097|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
19285098|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285099|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19285100|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19285101|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19285102|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285103|NCT04337658|Capecitabine|capecitabine|mesh-list
19285104|NCT04337658|Trastuzumab|trastuzumab|mesh-list
19285105|NCT04337658|Fulvestrant|fulvestrant|mesh-list
19285106|NCT04337658|Pertuzumab|pertuzumab|mesh-list
20358028|NCT00913419|Amitriptyline|amitriptyline|mesh-list
20358029|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
20358030|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20358031|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358032|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358033|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20358034|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285107|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19285108|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
20358035|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20358036|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358037|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20358038|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358039|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20358040|NCT00913419|Analgesics|analgesics|mesh-ancestor
20358041|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
20358042|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20358043|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358044|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358045|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358046|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358047|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358048|NCT00913484|Disulfiram|disulfiram|mesh-list
20358049|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20358050|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20358051|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358052|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425197|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20425198|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425199|NCT01273610|Trastuzumab|trastuzumab|mesh-list
20425200|NCT01273610|Lapatinib|lapatinib|mesh-list
20425201|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20425202|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425203|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20425204|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425205|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425206|NCT01273662|Axitinib|axitinib|mesh-list
20425207|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425208|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20181459|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181460|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
20181461|NCT00190099|Hormones|hormones|mesh-ancestor
20181462|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20181463|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20181464|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181465|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
20181466|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20181467|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425209|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285109|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285110|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285111|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19285112|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19285113|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19285114|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19285115|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
19285116|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425210|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358053|NCT00913497|Insulin|insulin|mesh-list
20358054|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20358055|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
20358056|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
20358057|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20358058|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358059|NCT00913549|Clemastine|clemastine|mesh-list
20358060|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
20358061|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
20358062|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20358063|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
20358064|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
20358065|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358066|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358067|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358068|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20358069|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20358070|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20358071|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20358072|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
20358073|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358074|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19285117|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285118|NCT04337450|Lamivudine|lamivudine|mesh-list
19285119|NCT04337450|Dolutegravir|dolutegravir|mesh-list
19285120|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19285121|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19285122|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285123|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285124|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
19285125|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285126|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19285127|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19285128|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19285129|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19285130|NCT04337606|Decitabine|decitabine|mesh-list
19285131|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19285132|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
20358075|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20358076|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358077|NCT00913588|Fluoxetine|fluoxetine|mesh-list
20358078|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20358079|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358080|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285133|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285134|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285135|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285136|NCT04337268|Glucagon|glucagon|mesh-list
19285137|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19285138|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19285139|NCT04337268|Hormones|hormones|mesh-ancestor
19285140|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19285141|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285142|NCT04337268|Incretins|incretins|mesh-ancestor
19285143|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
19285144|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19285145|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19285146|NCT04336891|Estradiol|estradiol|mesh-list
19285147|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19285148|NCT04336891|Testosterone|testosterone|mesh-list
19285149|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
19285150|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
19285151|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19285152|NCT04336891|Estrogens|estrogens|mesh-ancestor
19285153|NCT04336891|Hormones|hormones|mesh-ancestor
19285154|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19285155|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285156|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19285157|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
19285158|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19285159|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20358081|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358082|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285160|NCT04336891|Androgens|androgens|mesh-ancestor
19285161|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19285162|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285163|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
19285164|NCT04336904|Favipiravir|favipiravir|mesh-list
19285165|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
19285166|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285167|NCT04336917|Lidocaine|lidocaine|mesh-list
19285168|NCT04336917|Bupivacaine|bupivacaine|mesh-list
19285169|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
19285170|NCT04336917|Anesthetics|anesthetics|mesh-list
19285171|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285172|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285173|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
19285174|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285175|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19285176|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19285177|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19285178|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285179|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285180|NCT04337099|Tempol|tempol|mesh-list
19285181|NCT04337099|TEMPO|tempo|mesh-list
19285182|NCT04337099|TEMPOL-H|tempol-h|mesh-list
19285183|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
19285184|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358083|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
20358084|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358085|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20358086|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358087|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358088|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20358089|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20358090|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358091|NCT00913614|SR 46349B|sr 46349b|mesh-list
20358092|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20358093|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20358094|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358095|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20358096|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20358097|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
19285185|NCT04337099|Protective Agents|protective agents|mesh-ancestor
19285186|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285187|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20358098|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358099|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358100|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20358101|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20358102|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358103|NCT00913666|Interferons|interferons|mesh-list
19285188|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285189|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19285190|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19671276|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671277|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20358104|NCT00913666|Interferon-beta|interferon-beta|mesh-list
20358105|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
20358106|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358107|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
20358108|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358109|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
20358110|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358111|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20358112|NCT00913705|Carboplatin|carboplatin|mesh-list
20358113|NCT00913705|Paclitaxel|paclitaxel|mesh-list
20358114|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20358115|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358116|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20358117|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
20358118|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
20358119|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
20358120|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358121|NCT00913718|Fluoxetine|fluoxetine|mesh-list
20358122|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20358123|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19285191|NCT04336566|Melatonin|melatonin|mesh-list
19285192|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
19394544|NCT03674866|Insulin|insulin|mesh-list
20358124|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358125|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358126|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358127|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
20358128|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358129|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20358130|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358131|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358132|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20358133|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20358134|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358135|NCT00913783|Clomipramine|clomipramine|mesh-list
20358136|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20358137|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358138|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358139|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20358140|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358141|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358142|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358143|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358144|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
20358145|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358146|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
20358147|NCT00913796|Diuretics|diuretics|mesh-ancestor
20358148|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
20358149|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358150|NCT00913796|Expectorants|expectorants|mesh-ancestor
20358151|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358152|NCT00913809|Desipramine|desipramine|mesh-list
20358153|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20358154|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358155|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358156|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358157|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358158|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20358159|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358160|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358161|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358162|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358163|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358164|NCT00913822|Desipramine|desipramine|mesh-list
20358165|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20358166|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358167|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358168|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358169|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358170|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20358171|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358172|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358173|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358174|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358175|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358176|NCT00913848|Valproic Acid|valproic acid|mesh-list
20358177|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
20358178|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358179|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358180|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
20358181|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358182|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358183|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
20358184|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20358185|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358186|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358187|NCT00913861|Fentanyl|fentanyl|mesh-list
19285193|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285194|NCT04336566|Protective Agents|protective agents|mesh-ancestor
19285195|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285196|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285197|NCT04336332|Azithromycin|azithromycin|mesh-list
19285198|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285199|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19285200|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358188|NCT00913861|Propofol|propofol|mesh-list
20358189|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20358190|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358191|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358192|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19285201|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
19285202|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285203|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285204|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285205|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285206|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20358193|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
20358194|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
20358195|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20358196|NCT00913861|Narcotics|narcotics|mesh-ancestor
20358197|NCT00913861|Analgesics|analgesics|mesh-ancestor
19285207|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20358198|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
20358199|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358200|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20358201|NCT00913874|Valproic Acid|valproic acid|mesh-list
20358202|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
20358203|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358204|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358205|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
20358206|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358207|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358208|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
20358209|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20358210|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358211|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358212|NCT00913887|Diclofenac|diclofenac|mesh-list
20358213|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20358214|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20358215|NCT00913887|Analgesics|analgesics|mesh-ancestor
20358216|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
20358217|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358218|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358219|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358220|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20358221|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20358222|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358223|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358224|NCT00913952|Clomipramine|clomipramine|mesh-list
20358225|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20358226|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358227|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358228|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20358229|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358230|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358231|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358232|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358233|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
20358234|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358235|NCT00913965|Atenolol|atenolol|mesh-list
20358236|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20358237|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20358238|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
20358239|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
20358240|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358241|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358242|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20358243|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20358244|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20358245|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358246|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358247|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358248|NCT00914004|Desipramine|desipramine|mesh-list
20358249|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20358250|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
19671278|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358251|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358252|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285208|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
19285209|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285210|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
19285211|NCT04336488|Hormones|hormones|mesh-ancestor
19285212|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358253|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358254|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20358255|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358256|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358257|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
19285213|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285214|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19285215|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
19285216|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285217|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358258|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358259|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358260|NCT00914017|Atorvastatin|atorvastatin|mesh-list
20358261|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20358262|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20358263|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
20358264|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358265|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20358266|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20358267|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358268|NCT00914056|Lactulose|lactulose|mesh-list
19285218|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
19285219|NCT04336605|Analgesics|analgesics|mesh-list
19285220|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
19285221|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285222|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285223|NCT04336228|Dexetimide|dexetimide|mesh-list
19285224|NCT04336228|Citalopram|citalopram|mesh-list
19285225|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285226|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19285227|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19285228|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285229|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285230|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285231|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
19285232|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19285233|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
19285234|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19285235|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19285236|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19285237|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
19285238|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
19285239|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285240|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19285241|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19285242|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
19285243|NCT04336046|Bupivacaine|bupivacaine|mesh-list
19285244|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
19285245|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
19285246|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285247|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285248|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
19285249|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285250|NCT04335968|Melatonin|melatonin|mesh-list
20181468|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20181469|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20181470|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181471|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181472|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181473|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20181474|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20181475|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
20181476|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181477|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
20181478|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181479|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181480|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20181481|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
19285251|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
19285252|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285253|NCT04335968|Protective Agents|protective agents|mesh-ancestor
19285254|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285255|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394545|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19394546|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394547|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
19394548|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19394549|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394550|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19394551|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
19394552|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394553|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19394554|NCT03674671|Ketamine|ketamine|mesh-list
19394555|NCT03674671|Analgesics|analgesics|mesh-ancestor
19394556|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
19394557|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394558|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394559|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19394560|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19394561|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
19394562|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
19394563|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394564|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19394565|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20358269|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20358270|NCT00914095|Methylphenidate|methylphenidate|mesh-list
20358271|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20358272|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358273|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20358274|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19671279|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
19671280|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19671281|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
19671282|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358275|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358276|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358277|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
20358278|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394566|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394567|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394568|NCT03674658|Propafenone|propafenone|mesh-list
19394569|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19394570|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19394571|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19394572|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19394573|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671283|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
20181482|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181483|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181484|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20181485|NCT00190268|Amifampridine|amifampridine|mesh-list
20181486|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20181487|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181488|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181489|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20181490|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181491|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181492|NCT00190294|Misoprostol|misoprostol|mesh-list
20181493|NCT00190294|Mifepristone|mifepristone|mesh-list
20181494|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20181495|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
20181496|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20181497|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181498|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20181499|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181500|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
20181501|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20181502|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20181503|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20358279|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
20358280|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20358281|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358282|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20358283|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20358284|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358285|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358286|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358287|NCT00914134|Levodopa|levodopa|mesh-list
20358288|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20358289|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19285256|NCT04335786|Valsartan|valsartan|mesh-list
19285257|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19285258|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19285259|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19285260|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285261|NCT04335461|Anesthetics|anesthetics|mesh-list
19285262|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
19285263|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285264|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285265|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
19285266|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358290|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
20358291|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358292|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358293|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358294|NCT00914160|Diclofenac|diclofenac|mesh-list
20358295|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20358296|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20358297|NCT00914160|Analgesics|analgesics|mesh-ancestor
20358298|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
20358299|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358300|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358301|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285267|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
19285268|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19285269|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19285270|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
19285271|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285272|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19285273|NCT04335383|Antibodies|antibodies|mesh-list
19285274|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
19285275|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285276|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
19285277|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19285278|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285279|NCT04335123|Losartan|losartan|mesh-list
19285280|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19285281|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19285282|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19285283|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19285284|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285285|NCT04335513|Insulin|insulin|mesh-list
19285286|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19285287|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285288|NCT04335006|Paclitaxel|paclitaxel|mesh-list
19285289|NCT04335006|Apatinib|apatinib|mesh-list
19285290|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19285291|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285292|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
19285293|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
19285294|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
19285295|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285296|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19285297|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285298|NCT04334993|Blinatumomab|blinatumomab|mesh-list
19285299|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285300|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19285301|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19285302|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19285303|NCT04334824|Diuretics|diuretics|mesh-ancestor
19285304|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
19285305|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358302|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285306|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19285307|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285308|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285309|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
19285310|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285311|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
19285312|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285313|NCT04334967|Vitamins|vitamins|mesh-ancestor
19285314|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
19285315|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285316|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
20612552|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181504|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20181505|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
20181506|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19285317|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285318|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285319|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285320|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285321|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285322|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285323|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
19285324|NCT04334967|Protective Agents|protective agents|mesh-ancestor
19285325|NCT04334928|Tenofovir|tenofovir|mesh-list
19285326|NCT04334928|Emtricitabine|emtricitabine|mesh-list
19285327|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19285328|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285329|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
19285330|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285331|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19285332|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19285333|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285334|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285335|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19285336|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19285337|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
19285338|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285339|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285340|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671284|NCT03460158|Protective Agents|protective agents|mesh-ancestor
19692143|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692144|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
20181507|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20181508|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
20181509|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20181510|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
20181511|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20181512|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20181513|NCT00190307|Aspirin|aspirin|mesh-list
20181514|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20181515|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20181516|NCT00190307|Analgesics|analgesics|mesh-ancestor
20181517|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
20181518|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181519|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181520|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20181521|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181522|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20181523|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20181524|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181525|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20181526|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20181527|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181528|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
20181529|NCT00190333|Citalopram|citalopram|mesh-list
20181530|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20181531|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181532|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181533|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181534|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181535|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
20181536|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285341|NCT04334863|Tyrphostins|tyrphostins|mesh-list
19838058|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838059|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19838060|NCT00618956|Analgesics|analgesics|mesh-ancestor
19838061|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
20358303|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20358304|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358305|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358306|NCT00914212|Sibutramine|sibutramine|mesh-list
20358307|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358308|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358309|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
20358310|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20358311|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
20358312|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
20358313|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20358314|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20358315|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358316|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358317|NCT00914277|Urological Agents|urological agents|mesh-ancestor
20358318|NCT00914368|Clopidogrel|clopidogrel|mesh-list
20358319|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20358320|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20358321|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19838062|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838063|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
19838064|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838065|NCT00618982|Sorafenib|sorafenib|mesh-list
19838066|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838067|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19838068|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838069|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838070|NCT00618995|Niacin|niacin|mesh-list
19838071|NCT00618995|Niacinamide|niacinamide|mesh-list
19838072|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
19838073|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19838074|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
19838075|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838076|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19838077|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
19838078|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
19838079|NCT00618995|Vitamins|vitamins|mesh-ancestor
19838080|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
19838081|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838082|NCT00619060|Niacin|niacin|mesh-list
19838083|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
19838084|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19838085|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
19838086|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838087|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20358322|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19285342|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285343|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285344|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285345|NCT04334629|Ibuprofen|ibuprofen|mesh-list
19285346|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285347|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285348|NCT04334629|Analgesics|analgesics|mesh-ancestor
19285349|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
19285350|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285351|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285352|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285353|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285354|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19285355|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285356|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285357|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19285358|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285359|NCT04334512|Vitamin D|vitamin d|mesh-list
19285360|NCT04334512|Vitamins|vitamins|mesh-list
19285361|NCT04334512|Ascorbic Acid|ascorbic acid|mesh-list
19285362|NCT04334512|Azithromycin|azithromycin|mesh-list
20358323|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
20358324|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285363|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285364|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
19394574|NCT03674606|Aspirin|aspirin|mesh-list
19838088|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
19285365|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285366|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19285367|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19285368|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285369|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
19285370|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285371|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285372|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285373|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285374|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285375|NCT04334512|Antioxidants|antioxidants|mesh-ancestor
19285376|NCT04334512|Protective Agents|protective agents|mesh-ancestor
19285377|NCT04334382|Azithromycin|azithromycin|mesh-list
20181537|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19285378|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
20181538|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
19285379|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19285380|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285381|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
19285382|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285383|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20358325|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358326|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358327|NCT00914394|Phenylephrine|phenylephrine|mesh-list
20358328|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
20358329|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20358330|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20358331|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
20358332|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
20358333|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358334|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358335|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
20358336|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19285384|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285385|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285386|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285387|NCT04334005|Vitamin D|vitamin d|mesh-list
19285388|NCT04334005|Vitamins|vitamins|mesh-ancestor
19285389|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
19285390|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285391|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19285392|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
19285393|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19285394|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285395|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19285396|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285397|NCT04333992|Remifentanil|remifentanil|mesh-list
19285398|NCT04333992|Propofol|propofol|mesh-list
19285399|NCT04333992|Sevoflurane|sevoflurane|mesh-list
19285400|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19285401|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285402|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285403|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19285404|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
19285405|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
19285406|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19285407|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19285408|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19285409|NCT04333992|Narcotics|narcotics|mesh-ancestor
19285410|NCT04333992|Analgesics|analgesics|mesh-ancestor
19285411|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
19285412|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285413|NCT04333628|Chloroquine|chloroquine|mesh-list
19285414|NCT04333628|Amebicides|amebicides|mesh-ancestor
19285415|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20181539|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181540|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20181541|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181542|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181543|NCT00190411|Celiprolol|celiprolol|mesh-list
20181544|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20358337|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
19285416|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285417|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285418|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
19838089|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
19285419|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285420|NCT04333550|Deferoxamine|deferoxamine|mesh-list
19285421|NCT04333550|Siderophores|siderophores|mesh-ancestor
19285422|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19285423|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
19285424|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
19285425|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285426|NCT04333589|Favipiravir|favipiravir|mesh-list
19285427|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
19285428|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285429|NCT04332978|Fluticasone|fluticasone|mesh-list
19285430|NCT04332978|Xhance|xhance|mesh-list
19285431|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285432|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19285433|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
19285434|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285435|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285436|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19285437|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
19285438|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
19285439|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19285440|NCT04332874|Dactinomycin|dactinomycin|mesh-list
19285441|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
19285442|NCT04332874|Melphalan|melphalan|mesh-list
19285443|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19285444|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285445|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19285446|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
19285447|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285448|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19285449|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19285450|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
19285451|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285452|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19285453|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285454|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19285455|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19285456|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285457|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19285458|NCT04333095|Bupivacaine|bupivacaine|mesh-list
19285459|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
19285460|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
19285461|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285462|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285463|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
19285464|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285465|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
19285466|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19285467|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285468|NCT04332627|Neostigmine|neostigmine|mesh-list
19285469|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19285470|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285471|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285472|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
19285473|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285474|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285475|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19285476|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
19285477|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285478|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19285479|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19285480|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
19285481|NCT04332536|Codeine|codeine|mesh-list
19285482|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19285483|NCT04332536|Narcotics|narcotics|mesh-ancestor
20181545|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20181546|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
20181547|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
20181548|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181549|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181550|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
20181551|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19285484|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285485|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285486|NCT04332536|Analgesics|analgesics|mesh-ancestor
19285487|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
19285488|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285489|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
19285490|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
19285491|NCT04332809|Gentamicins|gentamicins|mesh-list
19285492|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19285493|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285494|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19285495|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285496|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285497|NCT04332276|Dopamine|dopamine|mesh-list
19285498|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19285499|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
20358338|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358339|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20358340|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20358341|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20358342|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358343|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358344|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358345|NCT00914394|Protective Agents|protective agents|mesh-ancestor
20358346|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358347|NCT00914420|Trapidil|trapidil|mesh-list
20358348|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20358349|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285500|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
19285501|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181552|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20181553|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20358350|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285502|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285503|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
19285504|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285505|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285506|NCT04332276|Protective Agents|protective agents|mesh-ancestor
19285507|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
19285508|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285509|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19285510|NCT04332289|Protective Agents|protective agents|mesh-ancestor
19285511|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285512|NCT04332042|Tofacitinib|tofacitinib|mesh-list
19285513|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19285514|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285515|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285516|NCT04332393|Metformin|metformin|mesh-list
19285517|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19285518|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285519|NCT04332094|Azithromycin|azithromycin|mesh-list
19285520|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285521|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19285522|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285523|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
19285524|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285525|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285526|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285527|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285528|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285529|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285530|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
19285531|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285532|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285533|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285534|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285535|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285536|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285537|NCT04331652|Anesthetics|anesthetics|mesh-list
20181554|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181555|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181556|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181557|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
20181558|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20181559|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
20181560|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285538|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285539|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285540|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
20358351|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20358352|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
20358353|NCT00914472|Heparin|heparin|mesh-list
20358354|NCT00914472|Calcium heparin|calcium heparin|mesh-list
20358355|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
20358356|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20358357|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20358358|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358359|NCT00914498|Lidocaine|lidocaine|mesh-list
20358360|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
19285541|NCT04331743|Analgesics|analgesics|mesh-ancestor
19285542|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
19285543|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285544|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285545|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285546|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19285547|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19285548|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358361|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
20358362|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838090|NCT00619060|Vitamins|vitamins|mesh-ancestor
19838091|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
19838092|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838093|NCT00619073|Aspirin|aspirin|mesh-list
19838094|NCT00619073|Clopidogrel|clopidogrel|mesh-list
19838095|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19838096|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19838097|NCT00619073|Analgesics|analgesics|mesh-ancestor
19838098|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
19838099|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838100|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838101|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838102|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19838103|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19838104|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19838105|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838106|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19838107|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19838108|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838109|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
19838110|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20358363|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358364|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
20358365|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358366|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20358367|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20358368|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20358369|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358370|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358371|NCT00914524|Olmesartan|olmesartan|mesh-list
20358372|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19285549|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285550|NCT04331730|Aflibercept|aflibercept|mesh-list
19838111|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19838112|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19838113|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
19838114|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838115|NCT00619099|Decitabine|decitabine|mesh-list
19838116|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838117|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
19838118|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838119|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838120|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838121|NCT00619112|Temozolomide|temozolomide|mesh-list
19838122|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19838123|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
19838124|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838125|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848175|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19848176|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848177|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848178|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20358373|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19285551|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20358374|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20358375|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20358376|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358377|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
20358378|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358379|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358380|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358381|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358382|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
20358383|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20358384|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358385|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285552|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19285553|NCT04331730|Growth Substances|growth substances|mesh-ancestor
19285554|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285555|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
19285556|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285557|NCT04331626|Gemcitabine|gemcitabine|mesh-list
19285558|NCT04331626|Nivolumab|nivolumab|mesh-list
19285559|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19285560|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
19285561|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358386|NCT00914576|Vitamins|vitamins|mesh-list
20358387|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
20358388|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358389|NCT00914641|Apixaban|apixaban|mesh-list
20358390|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20358391|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
19285562|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285563|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
19285564|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285565|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358392|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19285566|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19285567|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
19285568|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285569|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19285570|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19285571|NCT04331691|Amiloride|amiloride|mesh-list
19285572|NCT04331691|Spironolactone|spironolactone|mesh-list
19285573|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19285574|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
19285575|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19285576|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285577|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19285578|NCT04331691|Diuretics|diuretics|mesh-ancestor
19285579|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
19285580|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19285581|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19285582|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285583|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671285|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19671286|NCT03169985|Ezetimibe|ezetimibe|mesh-list
20358393|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
20358394|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358395|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358396|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
20358397|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
20358398|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20358399|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
20358400|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358401|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358402|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20358403|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358404|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19285584|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19285585|NCT04331600|Chloroquine|chloroquine|mesh-list
19285586|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19285587|NCT04331600|Amebicides|amebicides|mesh-ancestor
19285588|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19671287|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19671288|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19671289|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
20358405|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19285589|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20358406|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20358407|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
19285590|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285591|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
19285592|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285593|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285594|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285595|NCT04331600|Analgesics|analgesics|mesh-ancestor
19285596|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
19285597|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285598|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285599|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285600|NCT04331600|Filaricides|filaricides|mesh-ancestor
19285601|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
19285602|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
19285603|NCT04331639|Vitamin D|vitamin d|mesh-list
19285604|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
19285605|NCT04331639|Vitamins|vitamins|mesh-ancestor
19285606|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
19285607|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285608|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19285609|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19285610|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
19285611|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19285612|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285613|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285614|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285615|NCT04331418|Analgesics|analgesics|mesh-ancestor
19285616|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
19285617|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285618|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19285619|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19285620|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19285621|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
19285622|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285623|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285624|NCT04331470|Ritonavir|ritonavir|mesh-list
19285625|NCT04331470|Lopinavir|lopinavir|mesh-list
19285626|NCT04331470|Chloroquine|chloroquine|mesh-list
19285627|NCT04331470|Levamisole|levamisole|mesh-list
19285628|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285629|NCT04331470|Budesonide|budesonide|mesh-list
19285630|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
19285631|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19285632|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19285633|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
19285634|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358408|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358409|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358410|NCT00914667|Warfarin|warfarin|mesh-list
19285635|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285636|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19285637|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19285638|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
19285639|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285640|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19285641|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19285642|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285643|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19285644|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
19285645|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285646|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285647|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19285648|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
19285649|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
19285650|NCT04331470|Hormones|hormones|mesh-ancestor
19285651|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671290|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285652|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19285653|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19285654|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20358411|NCT00914667|Fesoterodine|fesoterodine|mesh-list
19285655|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358412|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
20358413|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20358414|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20358415|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
20358416|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358417|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358418|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358419|NCT00914667|Urological Agents|urological agents|mesh-ancestor
20358420|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20358421|NCT00914693|Gestodene|gestodene|mesh-list
20358422|NCT00914693|Femovan|femovan|mesh-list
19285656|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285657|NCT04331470|Amebicides|amebicides|mesh-ancestor
19285658|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285659|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285660|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
19285661|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285662|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
19285663|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
19285664|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19285665|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
19285666|NCT04331327|Mitogens|mitogens|mesh-list
19285667|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
19285668|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285669|NCT04331197|Letrozole|letrozole|mesh-list
19285670|NCT04331197|Clomiphene|clomiphene|mesh-list
19285671|NCT04331197|Enclomiphene|enclomiphene|mesh-list
19285672|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
19285673|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285674|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285675|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19285676|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19285677|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285678|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19285679|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
19285680|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19285681|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285682|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19285683|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
19285684|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19285685|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19285686|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19394575|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19394576|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19394577|NCT03674606|Analgesics|analgesics|mesh-ancestor
19394578|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
19394579|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394580|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394581|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394582|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394583|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19394584|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19394585|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394586|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20358423|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20358424|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20358425|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20358426|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
20358427|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20358428|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358429|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19394587|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19394588|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394589|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
19394590|NCT03674541|Bromides|bromides|mesh-list
19394591|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19394592|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
19394593|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19394594|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394595|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358430|NCT00914693|Estrogens|estrogens|mesh-ancestor
20358431|NCT00914693|Hormones|hormones|mesh-ancestor
20358432|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394596|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
19394597|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285687|NCT04331210|Diclofenac|diclofenac|mesh-list
19285688|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285689|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285690|NCT04331210|Analgesics|analgesics|mesh-ancestor
19285691|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
19285692|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285693|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285694|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285695|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285696|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19285697|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285698|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285699|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19285700|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19285701|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
19285702|NCT04331132|Tolvaptan|tolvaptan|mesh-list
19285703|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19285704|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285705|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
19285706|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285707|NCT04330872|Aspirin|aspirin|mesh-list
19285708|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285709|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285710|NCT04330872|Analgesics|analgesics|mesh-ancestor
19285711|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
19285712|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285713|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285714|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285715|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285716|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19285717|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19285718|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285719|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19285720|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19285721|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285722|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
20358433|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20358434|NCT00914693|Progestins|progestins|mesh-ancestor
20358435|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20358436|NCT00914771|Vaccines|vaccines|mesh-list
20358437|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
20358438|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358439|NCT00914797|Terbutaline|terbutaline|mesh-list
20358440|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20358441|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
20358442|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358443|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358444|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20358445|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
19285723|NCT04330820|Venetoclax|venetoclax|mesh-list
19285724|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285725|NCT04331093|Apatinib|apatinib|mesh-list
19285726|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285727|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19285728|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285729|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285730|NCT04330729|Aspirin|aspirin|mesh-list
19285731|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285732|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285733|NCT04330729|Analgesics|analgesics|mesh-ancestor
19285734|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
19285735|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285736|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285737|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285738|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285739|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19285740|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19285741|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285742|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19285743|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19285744|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285745|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
19285746|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
19285747|NCT04330755|Simendan|simendan|mesh-list
19285748|NCT04330755|Analgesics|analgesics|mesh-ancestor
19285749|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
19285750|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285751|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285752|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
19285753|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285754|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19285755|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
19285756|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19285757|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285758|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285759|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19285760|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
19285761|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19285762|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19285763|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
19285764|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19285765|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19285766|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285767|NCT04330755|Protective Agents|protective agents|mesh-ancestor
19285768|NCT04330300|Losartan|losartan|mesh-list
19285769|NCT04330300|Verapamil|verapamil|mesh-list
19285770|NCT04330300|Felodipine|felodipine|mesh-list
19285771|NCT04330300|Amlodipine|amlodipine|mesh-list
19285772|NCT04330300|Valsartan|valsartan|mesh-list
19285773|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19285774|NCT04330300|Telmisartan|telmisartan|mesh-list
19285775|NCT04330300|Candesartan|candesartan|mesh-list
19285776|NCT04330300|Ramipril|ramipril|mesh-list
19285777|NCT04330300|Olmesartan|olmesartan|mesh-list
19285778|NCT04330300|Enalapril|enalapril|mesh-list
19285779|NCT04330300|Lisinopril|lisinopril|mesh-list
19285780|NCT04330300|Irbesartan|irbesartan|mesh-list
19285781|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
19285782|NCT04330300|Diltiazem|diltiazem|mesh-list
19285783|NCT04330300|Perindopril|perindopril|mesh-list
19285784|NCT04330300|Benazepril|benazepril|mesh-list
19285785|NCT04330300|Captopril|captopril|mesh-list
19285786|NCT04330300|Indapamide|indapamide|mesh-list
19285787|NCT04330300|Nicardipine|nicardipine|mesh-list
19285788|NCT04330300|Nimodipine|nimodipine|mesh-list
19285789|NCT04330300|Quinapril|quinapril|mesh-list
19285790|NCT04330300|Trandolapril|trandolapril|mesh-list
19285791|NCT04330300|Metolazone|metolazone|mesh-list
19285792|NCT04330300|Fosinopril|fosinopril|mesh-list
19285793|NCT04330300|Eprosartan|eprosartan|mesh-list
19285794|NCT04330300|Nitrendipine|nitrendipine|mesh-list
19285795|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
19285796|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
19285797|NCT04330300|Nifedipine|nifedipine|mesh-list
19285798|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
19285799|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19285800|NCT04330300|Diuretics|diuretics|mesh-list
19285801|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19285802|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19285803|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285804|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19285805|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285806|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285807|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
19285808|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20358446|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
19285809|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19285810|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
19285811|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19285812|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
19285813|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285814|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
19285815|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20358447|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
19285816|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19285817|NCT04330300|Protective Agents|protective agents|mesh-ancestor
19285818|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
19285819|NCT04330547|Analgesics|analgesics|mesh-list
19285820|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
19285821|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285822|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285823|NCT04330586|Ciclesonide|ciclesonide|mesh-list
19285824|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
19285825|NCT04330586|Hormones|hormones|mesh-ancestor
19838126|NCT00619190|Aripiprazole|aripiprazole|mesh-list
19285826|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19285827|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285828|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19285829|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19285830|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
19285831|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285832|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
19285833|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285834|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285835|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285836|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285837|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358448|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20358449|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20358450|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20358451|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20358452|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358453|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358454|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358455|NCT00914836|Betamethasone|betamethasone|mesh-list
20358456|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
20358457|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20358458|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
20358459|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
20358460|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20358461|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358462|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
20358463|NCT00914836|Hormones|hormones|mesh-ancestor
20358464|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358465|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358466|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20358467|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358468|NCT00914888|Metronidazole|metronidazole|mesh-list
20358469|NCT00914888|Clarithromycin|clarithromycin|mesh-list
20358470|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
20358471|NCT00914888|Tigecycline|tigecycline|mesh-list
20358472|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358473|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20358474|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20358475|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20358476|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20358477|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358478|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358479|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20358480|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20358481|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20358482|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20358483|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
20358484|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358485|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358486|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20358487|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358488|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20358489|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20358490|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20358491|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358492|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358493|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285838|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285839|NCT04330677|Oxytocin|oxytocin|mesh-list
19285840|NCT04330677|Estrogens|estrogens|mesh-list
19285841|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
19285842|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19285843|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285844|NCT04330677|Hormones|hormones|mesh-ancestor
19285845|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19285846|NCT04330027|Mitogens|mitogens|mesh-list
19285847|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
19285848|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285849|NCT04330638|Siltuximab|siltuximab|mesh-list
19848179|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
20358494|NCT00914953|Oxytocin|oxytocin|mesh-list
20358495|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
19285850|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19285851|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285852|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285853|NCT04330326|Sorbitol|sorbitol|mesh-list
20358496|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20358497|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358498|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20358499|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20358500|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20358501|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358502|NCT00915083|Amrubicin|amrubicin|mesh-list
20358503|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358504|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
20358505|NCT00915200|Silybin|silybin|mesh-list
20358506|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20358507|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
20358508|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358509|NCT00915200|Expectorants|expectorants|mesh-ancestor
20358510|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358511|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20358512|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
20358513|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285854|NCT04330326|Cathartics|cathartics|mesh-ancestor
19285855|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19285856|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
19285857|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20358514|NCT00915200|Protective Agents|protective agents|mesh-ancestor
20181561|NCT00190437|Amoxicillin|amoxicillin|mesh-list
19285858|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285859|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19285860|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285861|NCT04329624|Simendan|simendan|mesh-list
19285862|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19671291|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19671292|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19671293|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671294|NCT03140670|Rucaparib|rucaparib|mesh-list
19671295|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19671296|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671297|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671298|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181562|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20181563|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181564|NCT00190463|Amphotericin B|amphotericin b|mesh-list
20181565|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20181566|NCT00190463|Amebicides|amebicides|mesh-ancestor
20181567|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20181568|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20181569|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181570|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20181571|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
19285863|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
19285864|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19285865|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19285866|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285867|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285868|NCT04329624|Protective Agents|protective agents|mesh-ancestor
19285869|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671299|NCT03129360|Levetiracetam|levetiracetam|mesh-list
20181572|NCT00190476|Docetaxel|docetaxel|mesh-list
20181573|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671300|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
19671301|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
19671302|NCT02968810|Simvastatin|simvastatin|mesh-list
19671303|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19671304|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19671305|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
20181574|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
20181575|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
20358515|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358516|NCT00915200|Antidotes|antidotes|mesh-ancestor
20358517|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671306|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181576|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
20181577|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285870|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285871|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
19285872|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285873|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285874|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285875|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285876|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285877|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285878|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
19285879|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19285880|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19285881|NCT04329650|Prednisolone|prednisolone|mesh-list
19285882|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
19285883|NCT04329650|Siltuximab|siltuximab|mesh-list
19285884|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19285885|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
19285886|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285887|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
19285888|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
19285889|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285890|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285891|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19285892|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
19285893|NCT04329650|Hormones|hormones|mesh-ancestor
19285894|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19285895|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19285896|NCT04329650|Protective Agents|protective agents|mesh-ancestor
19285897|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19285898|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285899|NCT04329858|Methamphetamine|methamphetamine|mesh-list
19285900|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19285901|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285902|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
19285903|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
19285904|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285905|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
19285906|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285907|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285908|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
19285909|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19285910|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19285911|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285912|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19285913|NCT04329806|Amlodipine|amlodipine|mesh-list
19285914|NCT04329806|Moxonidine|moxonidine|mesh-list
19285915|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19285916|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19285917|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19285918|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181578|NCT00190489|Docetaxel|docetaxel|mesh-list
20181579|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181580|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
20181581|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181582|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19285919|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19285920|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285921|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
19285922|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285923|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
19285924|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285925|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285926|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285927|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285928|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181583|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181584|NCT00190502|Antibodies|antibodies|mesh-list
20181585|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
20181586|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358518|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425211|NCT01273727|Dexamethasone|dexamethasone|mesh-list
20425212|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
19285929|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285930|NCT04329585|Flumazenil|flumazenil|mesh-list
19285931|NCT04329585|Antidotes|antidotes|mesh-ancestor
19285932|NCT04329585|Protective Agents|protective agents|mesh-ancestor
20181587|NCT00190515|Leucovorin|leucovorin|mesh-list
20358519|NCT00915239|Pantoprazole|pantoprazole|mesh-list
19285933|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285934|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
19285935|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
19285936|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285937|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285938|NCT04329572|Azithromycin|azithromycin|mesh-list
19285939|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
19285940|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19285941|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285942|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
19285943|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19285944|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19285945|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358520|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20358521|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20358522|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20358523|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358524|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285946|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285947|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285948|NCT04329403|Adapalene|adapalene|mesh-list
19285949|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285950|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285951|NCT04329403|Analgesics|analgesics|mesh-ancestor
19285952|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
19285953|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358525|NCT00915252|Cytarabine|cytarabine|mesh-list
20358526|NCT00915252|Azacitidine|azacitidine|mesh-list
20358527|NCT00915252|Daunorubicin|daunorubicin|mesh-list
19285954|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285955|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19285956|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285957|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
19285958|NCT04329390|Anticoagulants|anticoagulants|mesh-list
19285959|NCT04329130|Lenalidomide|lenalidomide|mesh-list
19285960|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
19285961|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285962|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19285963|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19285964|NCT04329130|Growth Substances|growth substances|mesh-ancestor
19285965|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
19285966|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285967|NCT04329429|Trastuzumab|trastuzumab|mesh-list
19285968|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19285969|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19285970|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
19285971|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19285972|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19285973|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285974|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285975|NCT04329091|Analgesics|analgesics|mesh-ancestor
19285976|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
19285977|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285978|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19285979|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19285980|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19285981|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
19285982|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19285983|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19285984|NCT04328870|Oxytocin|oxytocin|mesh-list
19285985|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285986|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
19671307|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20358528|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20358529|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
19671308|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20358530|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358531|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358532|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
20358533|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19285987|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19394598|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394599|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
19394600|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
19285988|NCT04328805|Ibuprofen|ibuprofen|mesh-list
19285989|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19285990|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19285991|NCT04328805|Analgesics|analgesics|mesh-ancestor
19285992|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
20358534|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358535|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
20358536|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358537|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358538|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20358539|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20358540|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19285993|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19285994|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19285995|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358541|NCT00915369|Paclitaxel|paclitaxel|mesh-list
20358542|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20358543|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358544|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
20358545|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
20358546|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
20358547|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358548|NCT00915382|Cisplatin|cisplatin|mesh-list
20358549|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358550|NCT00915408|Dexamethasone|dexamethasone|mesh-list
20358551|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
20358552|NCT00915408|Lenalidomide|lenalidomide|mesh-list
20358553|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358554|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
19671309|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671310|NCT02934282|HBOC 201|hboc 201|mesh-list
19671311|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
19285996|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19285997|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19285998|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19285999|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286000|NCT04329000|Esomeprazole|esomeprazole|mesh-list
19671312|NCT02774590|Timolol|timolol|mesh-list
19671313|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20358555|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358556|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20358557|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19286001|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19286002|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19286003|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19286004|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286005|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286006|NCT04328883|Aspirin|aspirin|mesh-list
19286007|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19286008|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286009|NCT04328883|Analgesics|analgesics|mesh-ancestor
19286010|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
19286011|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286012|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286013|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286014|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286015|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20358558|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
20358559|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358560|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286016|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19286017|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286018|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20358561|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20358562|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358563|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
20358564|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
20358565|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358566|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20358567|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
20358568|NCT00915408|Hormones|hormones|mesh-ancestor
20358569|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425213|NCT01273727|BB 1101|bb 1101|mesh-list
19286019|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19671314|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19286020|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286021|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
20181588|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
19286022|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
19286023|NCT04328636|Analgesics|analgesics|mesh-ancestor
19286024|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
19286025|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286026|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286027|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
19286028|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286029|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19286030|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
19286031|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19286032|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19286033|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286034|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19286035|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
19286036|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19286037|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
19286038|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19286039|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286040|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
19286041|NCT04328493|Chloroquine|chloroquine|mesh-list
20181589|NCT00190515|Antidotes|antidotes|mesh-ancestor
20181590|NCT00190515|Protective Agents|protective agents|mesh-ancestor
20181591|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181592|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
20181593|NCT00190515|Vitamins|vitamins|mesh-ancestor
20181594|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
20181595|NCT00190554|Cisplatin|cisplatin|mesh-list
20181596|NCT00190554|Fluorouracil|fluorouracil|mesh-list
20181597|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181598|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
20181599|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181600|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181601|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181602|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
19286042|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19286043|NCT04328493|Amebicides|amebicides|mesh-ancestor
19286044|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286045|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286046|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286047|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
19286048|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286049|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19286050|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286051|NCT04328493|Analgesics|analgesics|mesh-ancestor
19286052|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
19286053|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286054|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286055|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286056|NCT04328493|Filaricides|filaricides|mesh-ancestor
19286057|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
19286058|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
19286059|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
19286060|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19286061|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
19286062|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286063|NCT04328285|Ritonavir|ritonavir|mesh-list
19286064|NCT04328285|Lopinavir|lopinavir|mesh-list
19286065|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
19286066|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19286067|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19286068|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
19286069|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286070|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286071|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19286072|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19286073|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
19286074|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286075|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19286076|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19286077|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
19286078|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286079|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286080|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286081|NCT04328480|Colchicine|colchicine|mesh-list
20181603|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358570|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20358571|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20358572|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20358573|NCT00915408|Growth Substances|growth substances|mesh-ancestor
20358574|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
20358575|NCT00915460|Interferons|interferons|mesh-list
20358576|NCT00915460|Interferon-beta|interferon-beta|mesh-list
20358577|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
20358578|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286082|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
20358579|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
20358580|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358581|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
20358582|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358583|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20358584|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20358585|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20358586|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20358587|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358588|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286083|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286084|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286085|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
19286086|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286087|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286088|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286089|NCT04328272|Azithromycin|azithromycin|mesh-list
19286090|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
19286091|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19286092|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286093|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
19286094|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286095|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286096|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286097|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286098|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286099|NCT04328194|Thrombin|thrombin|mesh-list
20358589|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358590|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20358591|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20358592|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
20358593|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358594|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358595|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20358596|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20358597|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
20358598|NCT00915564|Simeprevir|simeprevir|mesh-list
20358599|NCT00915564|Methadone|methadone|mesh-list
20358600|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20358601|NCT00915564|Narcotics|narcotics|mesh-ancestor
20358602|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358603|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358604|NCT00915564|Analgesics|analgesics|mesh-ancestor
20358605|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
20358606|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286100|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
19286101|NCT04328194|Coagulants|coagulants|mesh-ancestor
20358607|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
20358608|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358609|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
20358610|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358611|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
20358612|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286102|NCT04327791|Baloxavir|baloxavir|mesh-list
19286103|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
19286104|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286105|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286106|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286107|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
19286108|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19286109|NCT04327934|Testosterone|testosterone|mesh-list
20358613|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358614|NCT00915577|Interferons|interferons|mesh-list
20358615|NCT00915577|Interferon-beta|interferon-beta|mesh-list
19286110|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
19286111|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
19286112|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19286113|NCT04327934|Hormones|hormones|mesh-ancestor
19286114|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286115|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286116|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19286117|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286118|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
19286119|NCT04327934|Androgens|androgens|mesh-ancestor
19286120|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
19286121|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19286122|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
19286123|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286124|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
19286125|NCT04327947|Protective Agents|protective agents|mesh-ancestor
19286126|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19286127|NCT04328064|Calcium|calcium|mesh-list
19286128|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19286129|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358616|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
20358617|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358618|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
20358619|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358620|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
20358621|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358622|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20358623|NCT00915616|Melatonin|melatonin|mesh-list
20358624|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
19286130|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19286131|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19286132|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
19286133|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286134|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19286135|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19286136|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286137|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
19286138|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19286139|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358625|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358626|NCT00915616|Protective Agents|protective agents|mesh-ancestor
20358627|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358628|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358629|NCT00915694|Nelfinavir|nelfinavir|mesh-list
19286140|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286141|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286142|NCT04327726|Analgesics|analgesics|mesh-ancestor
19286143|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
19286144|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286145|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19286146|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19286147|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19286148|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
19286149|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19286150|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286151|NCT04327245|Tagatose|tagatose|mesh-list
19286152|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19286153|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
19286154|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
19286155|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286156|NCT04327401|Dexamethasone|dexamethasone|mesh-list
19286157|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286158|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
19286159|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
19286160|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286161|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286162|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19286163|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
19286164|NCT04327401|Hormones|hormones|mesh-ancestor
19286165|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286166|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19286167|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286168|NCT04327427|Aspirin|aspirin|mesh-list
19671315|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
20358630|NCT00915694|Temozolomide|temozolomide|mesh-list
19286169|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671316|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848180|NCT00691210|Vitamins|vitamins|mesh-ancestor
19286170|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286171|NCT04327427|Analgesics|analgesics|mesh-ancestor
19286172|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
19286173|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286174|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286175|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20181604|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181605|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181606|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358631|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20358632|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
20358633|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358634|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358635|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20358636|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20358637|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
20358638|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358639|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20358640|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20358641|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
20358642|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358643|NCT00915733|Aspirin|aspirin|mesh-list
20358644|NCT00915733|Cilostazol|cilostazol|mesh-list
20358645|NCT00915733|Clopidogrel|clopidogrel|mesh-list
20358646|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20358647|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20358648|NCT00915733|Analgesics|analgesics|mesh-ancestor
20358649|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
20358650|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358651|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358652|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358653|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20358654|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20358655|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20358656|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286176|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286177|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19671317|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671318|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671319|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20181607|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181608|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181609|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19286178|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19286179|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286180|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19286181|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19286182|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286183|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
19286184|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19286185|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19286186|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358657|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20358658|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20358659|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358660|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
20358661|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20358662|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20358663|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19286187|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
19286188|NCT04327232|Spironolactone|spironolactone|mesh-list
19286189|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19286190|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
19286191|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286192|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286193|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20181610|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358664|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
20358665|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358666|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20358667|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
19286194|NCT04327232|Diuretics|diuretics|mesh-ancestor
19286195|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
19286196|NCT04326920|Sargramostim|sargramostim|mesh-list
19286197|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
19286198|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286199|NCT04327011|Flucytosine|flucytosine|mesh-list
19286200|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
19286201|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286202|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
19286203|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286204|NCT04326959|Triamcinolone|triamcinolone|mesh-list
19286205|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19286206|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19286207|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19286208|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286209|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
19286210|NCT04326959|Hormones|hormones|mesh-ancestor
19286211|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358668|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20358669|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
20358670|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
20358671|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20358672|NCT00915733|Protective Agents|protective agents|mesh-ancestor
20358673|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20358674|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20358675|NCT00915746|Ketoconazole|ketoconazole|mesh-list
20358676|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
20358677|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358678|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20358679|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20358680|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358681|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286212|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286213|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286214|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
19286215|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286216|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286217|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
19286218|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19286219|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
20358682|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20358683|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
20358684|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358685|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358686|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20358687|NCT00915785|Azacitidine|azacitidine|mesh-list
20358688|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20358689|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
19286220|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286221|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
19286222|NCT04326985|Protective Agents|protective agents|mesh-ancestor
19286223|NCT04326894|Methotrexate|methotrexate|mesh-list
19286224|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19286225|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
19286226|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19286227|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286228|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19286229|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
19286230|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286231|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286232|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
19838127|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
19838128|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838129|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19838130|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19838131|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838132|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838133|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
19838134|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
19838135|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838136|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838137|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19286233|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286234|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19286235|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286236|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
19286237|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286238|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19286239|NCT04326868|Albendazole|albendazole|mesh-list
19286240|NCT04326868|Mebendazole|mebendazole|mesh-list
19286241|NCT04326868|Benzimidazole|benzimidazole|mesh-list
19286242|NCT04326868|Pyrantel|pyrantel|mesh-list
19286243|NCT04326868|Anthelmintics|anthelmintics|mesh-list
19286244|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286245|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286246|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
19286247|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19286248|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286249|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286250|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
19286251|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286252|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286253|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286254|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
19286255|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19286256|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19286257|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19286258|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286259|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286260|NCT04326764|Panobinostat|panobinostat|mesh-list
19286261|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286262|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19286263|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286264|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394601|NCT03674411|Melphalan|melphalan|mesh-list
19394602|NCT03674411|Busulfan|busulfan|mesh-list
19394603|NCT03674411|Fludarabine|fludarabine|mesh-list
19394604|NCT03674411|Tacrolimus|tacrolimus|mesh-list
19394605|NCT03674411|Sargramostim|sargramostim|mesh-list
19394606|NCT03674411|Lenograstim|lenograstim|mesh-list
19394607|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19394608|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
19394609|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394610|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394611|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19394612|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
19394613|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394614|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394615|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20358690|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358691|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358692|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358693|NCT00915811|Fludarabine|fludarabine|mesh-list
20358694|NCT00915811|Busulfan|busulfan|mesh-list
20358695|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
20358696|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20358697|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358698|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358699|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358700|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
20358701|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358702|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
20358703|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20358704|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20358705|NCT00915837|Triamcinolone|triamcinolone|mesh-list
20358706|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20358707|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20358708|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20358709|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358710|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
20358711|NCT00915837|Hormones|hormones|mesh-ancestor
20358712|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358713|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358714|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358715|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
20358716|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358717|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394616|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19394617|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848181|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
19286265|NCT04326790|Colchicine|colchicine|mesh-list
19286266|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
19286267|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286268|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286269|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
19286270|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286271|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286272|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286273|NCT04326803|Vaccines|vaccines|mesh-list
19286274|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
20358718|NCT00915850|Cisplatin|cisplatin|mesh-list
20358719|NCT00915850|Docetaxel|docetaxel|mesh-list
20358720|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358721|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
20358722|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
20358723|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
20358724|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286275|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286276|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
19286277|NCT04326673|Testosterone|testosterone|mesh-list
19286278|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
19286279|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
19286280|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19286281|NCT04326673|Androgens|androgens|mesh-ancestor
19286282|NCT04326673|Hormones|hormones|mesh-ancestor
19286283|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286284|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286285|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19286286|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286287|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
19286288|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
19286289|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
20181611|NCT00190567|Analgesics|analgesics|mesh-ancestor
20181612|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
20181613|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286290|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286291|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286292|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286293|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671320|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19671321|NCT02195947|Hormones|hormones|mesh-list
19692145|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181614|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181615|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19286294|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286295|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286296|NCT04326296|Lenalidomide|lenalidomide|mesh-list
19286297|NCT04326296|Antibodies|antibodies|mesh-list
19286298|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19286299|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
19286300|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286301|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19286302|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19286303|NCT04326296|Growth Substances|growth substances|mesh-ancestor
19286304|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
19286305|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286306|NCT04326439|Cytarabine|cytarabine|mesh-list
19286307|NCT04326439|Etoposide|etoposide|mesh-list
19286308|NCT04326439|Daunorubicin|daunorubicin|mesh-list
19286309|NCT04326439|Sorafenib|sorafenib|mesh-list
19286310|NCT04326439|Asparaginase|asparaginase|mesh-list
19286311|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
19286312|NCT04326439|Calicheamicins|calicheamicins|mesh-list
20181616|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
20181617|NCT00190580|Valsartan|valsartan|mesh-list
20181618|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
20181619|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20181620|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20181621|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181622|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20181623|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20358725|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19286313|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19286314|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358726|NCT00915915|Gestodene|gestodene|mesh-list
20358727|NCT00915915|Femovan|femovan|mesh-list
19286315|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19286316|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19286317|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358728|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20358729|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20358730|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20358731|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
20358732|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20358733|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358734|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20358735|NCT00915915|Estrogens|estrogens|mesh-ancestor
20358736|NCT00915915|Hormones|hormones|mesh-ancestor
20358737|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358738|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20358739|NCT00915915|Progestins|progestins|mesh-ancestor
20358740|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20358741|NCT00916045|Vidarabine|vidarabine|mesh-list
20358742|NCT00916045|Cyclosporine|cyclosporine|mesh-list
20358743|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
20358744|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
20358745|NCT00916045|Melphalan|melphalan|mesh-list
20358746|NCT00916045|Busulfan|busulfan|mesh-list
20358747|NCT00916045|Thiotepa|thiotepa|mesh-list
20358748|NCT00916045|Fludarabine|fludarabine|mesh-list
20358749|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
20358750|NCT00916045|Cyclosporins|cyclosporins|mesh-list
20358751|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
19286318|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286319|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19286320|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
19286321|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
19286322|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286323|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286324|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
19286325|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286326|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20358752|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20358753|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358754|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
20358755|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358756|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20358757|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20358758|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
20358759|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358760|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358761|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20358762|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20358763|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
20358764|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
20358765|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358766|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358767|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
20358768|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
20358769|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20358770|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19286327|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19286328|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20358771|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20358772|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
19286332|NCT04326166|Metformin|metformin|mesh-list
19286333|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19286334|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286335|NCT04325984|Dexamethasone|dexamethasone|mesh-list
19286336|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286337|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
19286338|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
19286339|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286340|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286341|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19286342|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
19286343|NCT04325984|Hormones|hormones|mesh-ancestor
19286344|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286345|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19838138|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20358773|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20358774|NCT00916097|Docetaxel|docetaxel|mesh-list
20358775|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286346|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286347|NCT04325932|Kallikreins|kallikreins|mesh-list
19286348|NCT04325932|Coagulants|coagulants|mesh-ancestor
19286349|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19286350|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
19286351|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19286352|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286353|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
19286354|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
19286355|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286356|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286357|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286358|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286359|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286360|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20358776|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
20358777|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
20358778|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
20358779|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358780|NCT00916123|Prednisone|prednisone|mesh-list
20358781|NCT00916123|Docetaxel|docetaxel|mesh-list
20358782|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358783|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
20358784|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
20358785|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
20358786|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358787|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358788|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
20358789|NCT00916123|Hormones|hormones|mesh-ancestor
20358790|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358791|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358792|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20358793|NCT00916201|Cannabidiol|cannabidiol|mesh-list
20358794|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
20358795|NCT00916253|Modafinil|modafinil|mesh-list
20358796|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20358797|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358798|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20358799|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20358800|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20358801|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358802|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20358803|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20358804|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
20358805|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358806|NCT00916409|Temozolomide|temozolomide|mesh-list
19286361|NCT04325633|Naproxen|naproxen|mesh-list
19286362|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19286363|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286364|NCT04325633|Analgesics|analgesics|mesh-ancestor
19286365|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
19286366|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286367|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286368|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286369|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286370|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
19286371|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19286372|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286373|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286374|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
19286375|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
19286376|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286377|NCT04325503|Levodopa|levodopa|mesh-list
19286378|NCT04325503|Carbidopa|carbidopa|mesh-list
19286379|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19286380|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20358807|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20358808|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
20358809|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358810|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358811|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20358812|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19286381|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
19286382|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19286383|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286384|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286385|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19286386|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286387|NCT04325698|Paclitaxel|paclitaxel|mesh-list
19286388|NCT04325698|Bevacizumab|bevacizumab|mesh-list
19286389|NCT04325698|Carboplatin|carboplatin|mesh-list
19286390|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19286391|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286392|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286393|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
19286394|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286395|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286396|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19286397|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19286398|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19286399|NCT04325698|Growth Substances|growth substances|mesh-ancestor
19286400|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286401|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
19286402|NCT04325581|Liraglutide|liraglutide|mesh-list
19286403|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19286404|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286405|NCT04325581|Incretins|incretins|mesh-ancestor
19286406|NCT04325581|Hormones|hormones|mesh-ancestor
19286407|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286408|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
19286409|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19286410|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286411|NCT04325425|Carboplatin|carboplatin|mesh-list
19286412|NCT04325425|Etoposide|etoposide|mesh-list
19286413|NCT04325425|Folfirinox|folfirinox|mesh-list
19286414|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286415|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19286416|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19286417|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19286418|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286419|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286420|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
19286421|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
19286422|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
19286423|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181624|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
19286424|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286425|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
19286426|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286427|NCT04325191|Melatonin|melatonin|mesh-list
19286428|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
19286429|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286430|NCT04325191|Protective Agents|protective agents|mesh-ancestor
19286431|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286432|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286433|NCT04325061|Dexamethasone|dexamethasone|mesh-list
19286434|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
19286435|NCT04325061|BB 1101|bb 1101|mesh-list
19286436|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286437|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
19286438|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
19286439|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286440|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286441|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19286442|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
19286443|NCT04325061|Hormones|hormones|mesh-ancestor
19286444|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286445|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19286446|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286447|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
19286448|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286449|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286450|NCT04325009|Atorvastatin|atorvastatin|mesh-list
19286451|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19286452|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19286453|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
19286454|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181625|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286455|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19286456|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19286457|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394618|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19394619|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19394620|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
19394621|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394622|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394623|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19394624|NCT03674385|Vitamin E|vitamin e|mesh-list
19394625|NCT03674385|Metformin|metformin|mesh-list
19394626|NCT03674385|Clomiphene|clomiphene|mesh-list
19394627|NCT03674385|Enclomiphene|enclomiphene|mesh-list
19394628|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
19394629|NCT03674385|Vitamins|vitamins|mesh-ancestor
19394630|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
19394631|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394632|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19394633|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394634|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
19671322|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671323|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671324|NCT02175173|Rufinamide|rufinamide|mesh-list
19671325|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
19671326|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19394635|NCT03674385|Protective Agents|protective agents|mesh-ancestor
19394636|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19394637|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
19394638|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394639|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20358813|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20358814|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
20358815|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358816|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394640|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
19394641|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19394642|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19394643|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19394644|NCT03674333|Folic Acid|folic acid|mesh-list
19394645|NCT03674333|Hematinics|hematinics|mesh-ancestor
19394646|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
19394647|NCT03674333|Vitamins|vitamins|mesh-ancestor
19394648|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
19394649|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394650|NCT03674294|Dexamethasone|dexamethasone|mesh-list
19394651|NCT03674294|Aprepitant|aprepitant|mesh-list
19394652|NCT03674294|Palonosetron|palonosetron|mesh-list
19394653|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394654|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
19394655|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
19394656|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394657|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394658|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394659|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
19394660|NCT03674294|Hormones|hormones|mesh-ancestor
19394661|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394662|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19394663|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394664|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19394665|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394666|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394667|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19394668|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19394669|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
19394670|NCT03674242|Gemcitabine|gemcitabine|mesh-list
19394671|NCT03674242|Carboplatin|carboplatin|mesh-list
19394672|NCT03674242|Asparaginase|asparaginase|mesh-list
19394673|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394674|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19394675|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
19394676|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394677|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
20358817|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19394678|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394679|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394680|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19394681|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
20358818|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20358819|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
20358820|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358821|NCT00916461|Minocycline|minocycline|mesh-list
20358822|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20358823|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286458|NCT04324411|Sirolimus|sirolimus|mesh-list
19286459|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19286460|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286461|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19286462|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286463|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
19286464|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286465|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
19286466|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286467|NCT04324346|Paclitaxel|paclitaxel|mesh-list
19286468|NCT04324346|Docetaxel|docetaxel|mesh-list
19286469|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19286470|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286471|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286472|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
20358824|NCT00916500|Cisplatin|cisplatin|mesh-list
20358825|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358826|NCT00916526|Mannitol|mannitol|mesh-list
20358827|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20358828|NCT00916526|Diuretics|diuretics|mesh-ancestor
19286473|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286474|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286475|NCT04324307|Gemcitabine|gemcitabine|mesh-list
19286476|NCT04324307|Paclitaxel|paclitaxel|mesh-list
19286477|NCT04324307|Fluorouracil|fluorouracil|mesh-list
19286478|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
19286479|NCT04324307|Irinotecan|irinotecan|mesh-list
19286480|NCT04324307|Folfirinox|folfirinox|mesh-list
19286481|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19286482|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286483|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286484|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
19286485|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286486|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286487|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19286488|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
20358829|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
20358830|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358831|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
20358832|NCT00916552|Hematinics|hematinics|mesh-ancestor
20358833|NCT00916630|Pemetrexed|pemetrexed|mesh-list
20358834|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358835|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358836|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358837|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19286489|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
20358838|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20358839|NCT00916669|Etoposide|etoposide|mesh-list
20358840|NCT00916669|Enoxaparin|enoxaparin|mesh-list
20358841|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
20358842|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358843|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20358844|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20358845|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20358846|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358847|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358848|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
20358849|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20358850|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20358851|NCT00916695|Everolimus|everolimus|mesh-list
20358852|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286490|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286491|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286492|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286493|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
19286494|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286495|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19286496|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19286497|NCT04324476|Bevacizumab|bevacizumab|mesh-list
19286498|NCT04324476|Capecitabine|capecitabine|mesh-list
19286499|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
20358853|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358854|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
19286500|NCT04324476|Irinotecan|irinotecan|mesh-list
19286501|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19286502|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286503|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19286504|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19286505|NCT04324476|Growth Substances|growth substances|mesh-ancestor
19286506|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286507|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
19286508|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19286509|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
19286510|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286511|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19286512|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19286513|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286514|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
19286515|NCT04324086|Calcium|calcium|mesh-list
19286516|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19286517|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286518|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20358855|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358856|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20358857|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19286519|NCT04324060|Danazol|danazol|mesh-list
19286520|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19286521|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
19286522|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286523|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286524|NCT04324294|Pancrelipase|pancrelipase|mesh-list
19286525|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19286526|NCT04323748|Rituximab|rituximab|mesh-list
19286527|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19286528|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286529|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
19286530|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286531|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286532|NCT04323956|Prednisone|prednisone|mesh-list
19286533|NCT04323956|Cortisone|cortisone|mesh-list
19286534|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
19286535|NCT04323956|Rituximab|rituximab|mesh-list
19286536|NCT04323956|Doxorubicin|doxorubicin|mesh-list
19286537|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19286538|NCT04323956|Vincristine|vincristine|mesh-list
20358858|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
20358859|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358860|NCT00916760|Antacids|antacids|mesh-ancestor
20358861|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358862|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20358863|NCT00916890|Fentanyl|fentanyl|mesh-list
20358864|NCT00916890|Morphine|morphine|mesh-list
20358865|NCT00916890|Oxycodone|oxycodone|mesh-list
20358866|NCT00916890|Buprenorphine|buprenorphine|mesh-list
20358867|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20358868|NCT00916890|Narcotics|narcotics|mesh-ancestor
20358869|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286539|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19286540|NCT04323956|Antibodies|antibodies|mesh-list
19286541|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
19286542|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19286543|NCT04323956|Lenograstim|lenograstim|mesh-list
19286544|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286545|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
19286546|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286547|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286548|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19286549|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
19286550|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286551|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286552|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19286553|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19286554|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19286555|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20358870|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286556|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286557|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358871|NCT00916890|Analgesics|analgesics|mesh-ancestor
19286558|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
19286559|NCT04323956|Hormones|hormones|mesh-ancestor
19286560|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358872|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
20358873|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358874|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20358875|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20358876|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
20358877|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
20358878|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19286561|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19286562|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19286563|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19286564|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286565|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
19286566|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286567|NCT04323761|Remdesivir|remdesivir|mesh-list
19286568|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
19286569|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286570|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
19286571|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286572|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
19286573|NCT04323657|Fludarabine|fludarabine|mesh-list
19286574|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286575|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
19286576|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286577|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286578|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19286579|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
19286580|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286581|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286582|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19286583|NCT04323527|Chloroquine|chloroquine|mesh-list
19286584|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19286585|NCT04323527|Amebicides|amebicides|mesh-ancestor
19286586|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286587|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286588|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286589|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
19286590|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286591|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19286592|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286593|NCT04323527|Analgesics|analgesics|mesh-ancestor
19286594|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
19286595|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286596|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286597|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286598|NCT04323527|Filaricides|filaricides|mesh-ancestor
19286599|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
19286600|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
19286601|NCT04323514|Ascorbic Acid|ascorbic acid|mesh-list
19286602|NCT04323514|Vitamins|vitamins|mesh-ancestor
19286603|NCT04323514|Micronutrients|micronutrients|mesh-ancestor
19286604|NCT04323514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286605|NCT04323514|Antioxidants|antioxidants|mesh-ancestor
19286606|NCT04323514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286607|NCT04323514|Protective Agents|protective agents|mesh-ancestor
19286608|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
19286609|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
19286610|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286611|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286612|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286613|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286614|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671327|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20181626|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181627|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20181628|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20181629|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20181630|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181631|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181632|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181633|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181634|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358879|NCT00916942|Lidocaine|lidocaine|mesh-list
20358880|NCT00916942|Prilocaine|prilocaine|mesh-list
20358881|NCT00916942|Capsaicin|capsaicin|mesh-list
20358882|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
20358883|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
20358884|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20358885|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358886|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
20358887|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358888|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20358889|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20358890|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20358891|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358892|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358893|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
20358894|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
20358895|NCT00917059|Citalopram|citalopram|mesh-list
20358896|NCT00917059|Bupropion|bupropion|mesh-list
20358897|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19286615|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286616|NCT04322955|Nivolumab|nivolumab|mesh-list
19286617|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19286618|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286619|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19286620|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286621|NCT04323280|Dexamethasone|dexamethasone|mesh-list
19286622|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286623|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
19286624|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
19286625|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286626|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286627|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20358898|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20358899|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20358900|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358901|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358902|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
20358903|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358904|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20358905|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358906|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358907|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20358908|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
20358909|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20358910|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20358911|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425214|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425215|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
20181635|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181636|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181637|NCT00190606|Analgesics|analgesics|mesh-ancestor
20181638|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
20181639|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181640|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181641|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181642|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
20425216|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
20425217|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286628|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
19286629|NCT04323280|Hormones|hormones|mesh-ancestor
20425218|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286630|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286631|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20181643|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181644|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19286632|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286633|NCT04323228|Antioxidants|antioxidants|mesh-list
19286634|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286635|NCT04323228|Protective Agents|protective agents|mesh-ancestor
19286636|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286637|NCT04322760|Lidocaine|lidocaine|mesh-list
19286638|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
19286639|NCT04322760|Bupivacaine|bupivacaine|mesh-list
19286640|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
19286641|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
19286642|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286643|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286644|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
19286645|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286646|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19286647|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19286648|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19286649|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19286650|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286651|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19286652|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286653|NCT04322760|Analgesics|analgesics|mesh-ancestor
19286654|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19286655|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19286656|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19286657|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
19286658|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19286659|NCT04322565|Colchicine|colchicine|mesh-list
19286660|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
19286661|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286662|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286663|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
19286664|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
19286665|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286666|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358912|NCT00917163|Sirolimus|sirolimus|mesh-list
20358913|NCT00917163|Everolimus|everolimus|mesh-list
20358914|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358915|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20358916|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
20358917|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358918|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20358919|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358920|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20358921|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
20358922|NCT00917241|Dexamethasone|dexamethasone|mesh-list
20358923|NCT00917241|Methimazole|methimazole|mesh-list
20358924|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286676|NCT04322552|Apatinib|apatinib|mesh-list
19286677|NCT04322552|Digoxin|digoxin|mesh-list
19286678|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286679|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19286680|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286681|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286682|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19286683|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19286684|NCT04322552|Protective Agents|protective agents|mesh-ancestor
19286685|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394682|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394683|NCT03674151|Povidone|povidone|mesh-list
19394684|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
19394685|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
19394686|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
19394687|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19394688|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19394689|NCT03674099|Prednisolone|prednisolone|mesh-list
19394690|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
19394691|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
19394692|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19394693|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
19394694|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358925|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
19394695|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
19394696|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
19394697|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358926|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
20358927|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20358928|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286686|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19286687|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
19286688|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286689|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286690|NCT04322422|Montelukast|montelukast|mesh-list
19286691|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19286692|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
19286693|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19286694|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
19286695|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286696|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286697|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19286698|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19286699|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286700|NCT04322175|Meloxicam|meloxicam|mesh-list
19286701|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19286702|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286703|NCT04322175|Analgesics|analgesics|mesh-ancestor
19286704|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
19286705|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286706|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286707|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20358929|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20358930|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
20358931|NCT00917241|Hormones|hormones|mesh-ancestor
20358932|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20358933|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20358934|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358935|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
20358936|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
20358937|NCT00917254|Enoxaparin|enoxaparin|mesh-list
20358938|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
20358939|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20358940|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20358941|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358942|NCT00917345|Captopril|captopril|mesh-list
20358943|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20358944|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
20358945|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358946|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358947|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20358948|NCT00917358|Interferons|interferons|mesh-list
20358949|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
20358950|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
20358951|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20358952|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286708|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286709|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19286710|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19286711|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286712|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286713|NCT04322214|Cobicistat|cobicistat|mesh-list
19286714|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19286715|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19286716|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
19286717|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286718|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19286719|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19286720|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286721|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358953|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
20358954|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358955|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
20358956|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20358957|NCT00917397|Sertraline|sertraline|mesh-list
20358958|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
20358959|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20358960|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20358961|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19286722|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
19286723|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
19286724|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358962|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19286725|NCT04322240|Protective Agents|protective agents|mesh-ancestor
20358963|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358964|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20358965|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
20358966|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286726|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286727|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
19286728|NCT04322240|Vitamins|vitamins|mesh-ancestor
19286729|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
19286730|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
19286731|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
19286732|NCT04321785|Caffeine|caffeine|mesh-list
19286733|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19286734|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286735|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20181645|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181646|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181647|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181648|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181649|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181650|NCT00190619|Analgesics|analgesics|mesh-ancestor
19286736|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286737|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286738|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20181651|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
19286739|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19286740|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
19286741|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19286742|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
19286743|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286744|NCT04321655|Ibuprofen|ibuprofen|mesh-list
19286745|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19286746|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20358967|NCT00917527|Atorvastatin|atorvastatin|mesh-list
20358968|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20358969|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20358970|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
20358971|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358972|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20358973|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20358974|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358975|NCT00917592|Amoxicillin|amoxicillin|mesh-list
19286747|NCT04321655|Analgesics|analgesics|mesh-ancestor
19286748|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
19286749|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286750|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286751|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612553|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19286752|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286753|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19286754|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286755|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358976|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
20358977|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
20358978|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20358979|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20358980|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20358981|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20358982|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20358983|NCT00917748|Docetaxel|docetaxel|mesh-list
20358984|NCT00917748|Modafinil|modafinil|mesh-list
20358985|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20358986|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
20181652|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181653|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181654|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181655|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
20181656|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20358987|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
20612554|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19286756|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
19286757|NCT04321642|Entonox|entonox|mesh-list
20358988|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
20612555|NCT02251925|Estradiol|estradiol|mesh-list
20612556|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19286758|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19286759|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
19286760|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286761|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286762|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19286763|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
19286764|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286765|NCT04321642|Analgesics|analgesics|mesh-ancestor
19286766|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
19286767|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286768|NCT04321850|Zinc|zinc|mesh-list
19286769|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
19286770|NCT04321850|Trace Elements|trace elements|mesh-ancestor
19286771|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
19286772|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286773|NCT04321850|Astringents|astringents|mesh-ancestor
19286774|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
19286775|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
19286776|NCT04321616|Remdesivir|remdesivir|mesh-list
19286777|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
19286778|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286779|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286780|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286781|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286782|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286783|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286784|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
19286785|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
19286786|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
19286787|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
19286788|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286789|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19286790|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286791|NCT04321837|Vitamin D|vitamin d|mesh-list
19286792|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
19286793|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
19286794|NCT04321837|Vitamins|vitamins|mesh-ancestor
19286795|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
19286796|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286797|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19286798|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19286799|NCT04321551|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19286800|NCT04321551|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19286801|NCT04321551|Hormones|hormones|mesh-list
19286802|NCT04321551|Estradiol|estradiol|mesh-list
19286803|NCT04321551|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19286804|NCT04321551|Progesterone|progesterone|mesh-list
19286805|NCT04321551|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19286806|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286807|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286808|NCT04321551|Estrogens|estrogens|mesh-ancestor
19286809|NCT04321551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19286810|NCT04321551|Contraceptive Agents|contraceptive agents|mesh-ancestor
19286811|NCT04321551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19286812|NCT04321551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19286813|NCT04321551|Progestins|progestins|mesh-ancestor
19286814|NCT04321408|Ziconotide|ziconotide|mesh-list
19286815|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19286816|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19286817|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286818|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19286819|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286820|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19286821|NCT04321408|Protective Agents|protective agents|mesh-ancestor
19286822|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286823|NCT04321408|Analgesics|analgesics|mesh-ancestor
19286824|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
19286825|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286826|NCT04321278|Azithromycin|azithromycin|mesh-list
19286827|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
19286828|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19286829|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286830|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
19286831|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286832|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286833|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286834|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286835|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181657|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181658|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181659|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181660|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181661|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181662|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181663|NCT00190632|Analgesics|analgesics|mesh-ancestor
20358989|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286836|NCT04321070|Clindamycin|clindamycin|mesh-list
19286837|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
19286838|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
19286839|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19286840|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286841|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19286842|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286843|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286844|NCT04321096|Camostat|camostat|mesh-list
19286845|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
19286846|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286847|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286848|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19286849|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19286850|NCT04320914|Ibuprofen|ibuprofen|mesh-list
19286851|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19286852|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20358990|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20358991|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286853|NCT04320914|Analgesics|analgesics|mesh-ancestor
19286854|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
19286855|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286856|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286857|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286858|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286859|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19286860|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286861|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286862|NCT04320706|Oxytocin|oxytocin|mesh-list
19286863|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
19286864|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19286865|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286866|NCT04320745|Testosterone|testosterone|mesh-list
19286867|NCT04320745|Androgens|androgens|mesh-ancestor
19286868|NCT04320745|Hormones|hormones|mesh-ancestor
19286869|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671328|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19671329|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671330|NCT02037048|Leucovorin|leucovorin|mesh-list
19671331|NCT02037048|Paclitaxel|paclitaxel|mesh-list
19671332|NCT02037048|Carboplatin|carboplatin|mesh-list
19671333|NCT02037048|Fluorouracil|fluorouracil|mesh-list
19671334|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
20181664|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
20181665|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286870|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286871|NCT04320602|Eculizumab|eculizumab|mesh-list
19286872|NCT04320602|Ravulizumab|ravulizumab|mesh-list
19286873|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19286874|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286875|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
19671335|NCT02037048|Calcium|calcium|mesh-list
19671336|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
20181666|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181667|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181668|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
20181669|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181670|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181671|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19286876|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286877|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
19671337|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671338|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671339|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
19286878|NCT04320589|Anesthetics|anesthetics|mesh-list
19286879|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
19286880|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19286881|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286882|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286883|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19286884|NCT04320589|Analgesics|analgesics|mesh-ancestor
19286885|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
19286886|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286887|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19286888|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19286889|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19286890|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
19286891|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19286892|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394698|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394699|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19394700|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
19394701|NCT03674099|Hormones|hormones|mesh-ancestor
19394702|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394703|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19394704|NCT03674099|Protective Agents|protective agents|mesh-ancestor
19394705|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19394706|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394707|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19394708|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394709|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394710|NCT03674073|Vaccines|vaccines|mesh-list
19394711|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
19394712|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394713|NCT03674060|Sorafenib|sorafenib|mesh-list
19394714|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394715|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19394716|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394717|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394718|NCT03674008|Propofol|propofol|mesh-list
19394719|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19394720|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394721|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394722|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19394723|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
19394724|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
19394725|NCT03673995|Inositol|inositol|mesh-list
19394726|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
19394727|NCT03673995|Vitamins|vitamins|mesh-ancestor
19394728|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
19394729|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394730|NCT03673735|Durvalumab|durvalumab|mesh-list
19394731|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394732|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20358992|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20358993|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20358994|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20358995|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20358996|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
20358997|NCT00917761|Entecavir|entecavir|mesh-list
20358998|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
20358999|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394733|NCT03673605|Warfarin|warfarin|mesh-list
19394734|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
19394735|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
19394736|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19394737|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
19394738|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19394739|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
19394740|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394741|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394742|NCT03673501|Sunitinib|sunitinib|mesh-list
19394743|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394744|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19394745|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19671340|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
19394746|NCT03673501|Growth Substances|growth substances|mesh-ancestor
19394747|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359000|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
20359001|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181672|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181673|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181674|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359002|NCT00917839|Lamotrigine|lamotrigine|mesh-list
20359003|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
20359004|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20359005|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359006|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359007|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19286893|NCT04320238|Interferons|interferons|mesh-list
19286894|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
19286895|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19286896|NCT04320238|Thymalfasin|thymalfasin|mesh-list
19286897|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286898|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
19286899|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286900|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
19286901|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286902|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19286903|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
20359008|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359009|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20359010|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359011|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359012|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359013|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20359014|NCT00917878|Calcium|calcium|mesh-list
20359015|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20359016|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359017|NCT00917891|Dapivirine|dapivirine|mesh-list
19286904|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286905|NCT04320277|Ritonavir|ritonavir|mesh-list
19286906|NCT04320277|Lopinavir|lopinavir|mesh-list
19286907|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19286908|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19286909|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
19286910|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19286911|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286912|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19286913|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19286914|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
19286915|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286916|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19286917|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19286918|NCT04320225|Dexamethasone|dexamethasone|mesh-list
19286919|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286920|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
19286921|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
19286922|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286923|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286924|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181675|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181676|NCT00190645|Analgesics|analgesics|mesh-ancestor
20181677|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
20181678|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181679|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181680|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181681|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
20181682|NCT00190710|Gemcitabine|gemcitabine|mesh-list
20181683|NCT00190710|Carboplatin|carboplatin|mesh-list
20181684|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181685|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181686|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
19286925|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
19286926|NCT04320225|Hormones|hormones|mesh-ancestor
19286927|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20181687|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181688|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
20181689|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181690|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181691|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181692|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
20359018|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19286928|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19286929|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286930|NCT04319978|Dexamethasone|dexamethasone|mesh-list
19286931|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
19286932|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19286933|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
19286934|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
19286935|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286936|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286937|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19286938|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
19286939|NCT04319978|Hormones|hormones|mesh-ancestor
19286940|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19286941|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19286942|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286943|NCT04320173|Lidocaine|lidocaine|mesh-list
19286944|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
19286945|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
19286946|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286947|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286948|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
19286949|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286950|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19286951|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19286952|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19286953|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359019|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20359020|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
20359021|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359022|NCT00917904|Dapivirine|dapivirine|mesh-list
20359023|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20359024|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20359025|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
20359026|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359027|NCT00918021|Olanzapine|olanzapine|mesh-list
20359028|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
20359029|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
19286954|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286955|NCT04319926|Lidocaine|lidocaine|mesh-list
19286956|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
19286957|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
19286958|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286959|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286960|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
19286961|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286962|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19286963|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19286964|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19286965|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19286966|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286967|NCT04319900|Chloroquine|chloroquine|mesh-list
19286968|NCT04319900|Favipiravir|favipiravir|mesh-list
19286969|NCT04319900|Amebicides|amebicides|mesh-ancestor
19286970|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19286971|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19286972|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19286973|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
19286974|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286975|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
19286976|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
19286977|NCT04319757|Fludarabine|fludarabine|mesh-list
19286978|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19286979|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
19286980|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19286981|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19286982|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19286983|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
20181693|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181694|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20181695|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181696|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181697|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181698|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181699|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181700|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359030|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359031|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359032|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20359033|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20359034|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359035|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359036|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359037|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20612557|NCT02251925|Estrogens|estrogens|mesh-ancestor
19286984|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286985|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286986|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19286987|NCT04319471|Capecitabine|capecitabine|mesh-list
19286988|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19286989|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
19286990|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286991|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19286992|NCT04319588|Anesthetics|anesthetics|mesh-list
19286993|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
19286994|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19286995|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181701|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181702|NCT00190762|Pemetrexed|pemetrexed|mesh-list
20181703|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181704|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181705|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181706|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20181707|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20181708|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20181709|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181710|NCT00190801|Pemetrexed|pemetrexed|mesh-list
20181711|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181712|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181713|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19286996|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
19286997|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19286998|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
19286999|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19287000|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
19287001|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287002|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
19287003|NCT04319770|Protective Agents|protective agents|mesh-ancestor
19287004|NCT04319484|Lenvatinib|lenvatinib|mesh-list
19287005|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287006|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19287007|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287008|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287009|NCT04319601|Rituximab|rituximab|mesh-list
19287010|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19287011|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287012|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
19287013|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287014|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19287015|NCT04319692|Acetic Acid|acetic acid|mesh-list
19287016|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19287017|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287018|NCT04319705|Azithromycin|azithromycin|mesh-list
19287019|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19287020|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287021|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
19287022|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19287023|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19287024|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287025|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
19287026|NCT04319614|Coagulants|coagulants|mesh-ancestor
19287027|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19287028|NCT04319549|Eusol|eusol|mesh-list
19287029|NCT04319549|Ketorolac|ketorolac|mesh-list
19287030|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19287031|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19287032|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19287033|NCT04319549|Analgesics|analgesics|mesh-ancestor
19287034|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
19287035|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287036|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287037|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287038|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359038|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20359039|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359040|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359041|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359042|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
20359043|NCT00918034|Talaporfin|talaporfin|mesh-list
20359044|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359045|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20359046|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359047|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
20359048|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
20359049|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19287039|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19287040|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287041|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287042|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
19287043|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287044|NCT04319289|Vitamin D|vitamin d|mesh-list
19287045|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
19287046|NCT04319289|Vitamins|vitamins|mesh-list
19287047|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
19287048|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287049|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20359050|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20359051|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359052|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359053|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20359054|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20359055|NCT00918086|Vitamin D|vitamin d|mesh-list
19287050|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19287051|NCT04319224|Nivolumab|nivolumab|mesh-list
19287052|NCT04319224|Ipilimumab|ipilimumab|mesh-list
19287053|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19287054|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287055|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19287056|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287057|NCT04319419|Micronutrients|micronutrients|mesh-list
19287058|NCT04319419|Trace Elements|trace elements|mesh-list
19287059|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287060|NCT04318847|Ondansetron|ondansetron|mesh-list
19287061|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
19287062|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
19287063|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287064|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287065|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287066|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
19287067|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359056|NCT00918086|Vitamins|vitamins|mesh-ancestor
20359057|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
20359058|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359059|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20359060|NCT00918177|Levodopa|levodopa|mesh-list
20359061|NCT00918177|Carbidopa|carbidopa|mesh-list
20359062|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20359063|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19287068|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19287069|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
19287070|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287071|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287072|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19287073|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19287074|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287075|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19287076|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19287077|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
19287078|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
19287079|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19287080|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19287081|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287082|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287083|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287084|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359064|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19287085|NCT04318730|Apatinib|apatinib|mesh-list
19287086|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359065|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
19287087|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19287088|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287089|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394748|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
19394749|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20359066|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359067|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359068|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359069|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20359070|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359071|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20359072|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
20359073|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
20359074|NCT00918190|Dexamethasone|dexamethasone|mesh-list
20359075|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
20359076|NCT00918190|Midazolam|midazolam|mesh-list
20359077|NCT00918190|Ondansetron|ondansetron|mesh-list
20359078|NCT00918190|BB 1101|bb 1101|mesh-list
20359079|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359080|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
20359081|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
20359082|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359083|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359084|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20359085|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
20359086|NCT00918190|Hormones|hormones|mesh-ancestor
20359087|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359088|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359089|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359090|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
20359091|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359092|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359093|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20359094|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20359095|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359096|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20359097|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359098|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359099|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20359100|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
20359101|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
20359102|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
20359103|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
19394750|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394751|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404175|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19404176|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404177|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
19404178|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
19404179|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
19404180|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404181|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19404182|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
19404183|NCT03596892|Busulfan|busulfan|mesh-list
19404184|NCT03596892|Decitabine|decitabine|mesh-list
19404185|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19404186|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
19404187|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404188|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404189|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19404190|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
19404191|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404192|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404193|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19404194|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19404195|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
19404196|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404795|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404796|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
19404797|NCT03591900|Insulin|insulin|mesh-list
19404798|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404799|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359104|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404800|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20359105|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
20359106|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
19287090|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
19287091|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19287092|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19287093|NCT04318652|Prednisolone|prednisolone|mesh-list
19287094|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
19287095|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19287096|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19287097|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
19287098|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287099|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
19287100|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
19287101|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287102|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287103|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287104|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
19287105|NCT04318652|Hormones|hormones|mesh-ancestor
19287106|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287107|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19287108|NCT04318652|Protective Agents|protective agents|mesh-ancestor
19287109|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19287110|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287111|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19287112|NCT04318158|Fentanyl|fentanyl|mesh-list
19287113|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
19287114|NCT04318158|Bupivacaine|bupivacaine|mesh-list
19287115|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287116|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
19287117|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287118|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181714|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20181715|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20181716|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181717|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181718|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181719|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181720|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181721|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181722|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181723|NCT00190814|Analgesics|analgesics|mesh-ancestor
20359107|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20359108|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
20359109|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20359110|NCT00918307|Varenicline|varenicline|mesh-list
20359111|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20359112|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20359113|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
20359114|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359115|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359116|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359117|NCT00918320|Temozolomide|temozolomide|mesh-list
20359118|NCT00918320|Topotecan|topotecan|mesh-list
20359119|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20359120|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
20359121|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359122|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359123|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20359124|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20359125|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359126|NCT00918411|Ramosetron|ramosetron|mesh-list
20359127|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
20359128|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
20359129|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359130|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359131|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20359132|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20359133|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
20359134|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359135|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359136|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
20359137|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
20359138|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19287119|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
19394752|NCT03673384|Fluticasone|fluticasone|mesh-list
19287120|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287121|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19287122|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19287123|NCT04318158|Analgesics|analgesics|mesh-ancestor
19287124|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19287125|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19287126|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19287127|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
20359139|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20359140|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359141|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287128|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287129|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287130|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19287131|NCT04318158|Narcotics|narcotics|mesh-ancestor
19287132|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19287133|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19287134|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
19287135|NCT04318223|Palbociclib|palbociclib|mesh-list
20359142|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20359143|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20359144|NCT00918450|Navitoclax|navitoclax|mesh-list
20359145|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359146|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
19287136|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287137|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19287138|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287139|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287140|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19287141|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287142|NCT04318067|Melatonin|melatonin|mesh-list
19287143|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
19287144|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287145|NCT04318067|Protective Agents|protective agents|mesh-ancestor
19287146|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287147|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287148|NCT04317872|Dexamethasone|dexamethasone|mesh-list
19287149|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
19287150|NCT04317872|BB 1101|bb 1101|mesh-list
19287151|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287152|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
19287153|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
19287154|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287155|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287156|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287157|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
20181724|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
20181725|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181726|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181727|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181728|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
20181729|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181730|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19287158|NCT04317872|Hormones|hormones|mesh-ancestor
19287159|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287160|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19287161|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287162|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
19287163|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287164|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287165|NCT04317703|Metformin|metformin|mesh-list
19287166|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19287167|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287168|NCT04317300|Varenicline|varenicline|mesh-list
19287169|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20181731|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181732|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181733|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181734|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181735|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287170|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19287171|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
19394753|NCT03673384|Xhance|xhance|mesh-list
20359147|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
19287172|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287173|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287174|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287175|NCT04317508|Benzocaine|benzocaine|mesh-list
19287176|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287177|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
19287178|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287179|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287180|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
19287181|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287182|NCT04317235|Ropivacaine|ropivacaine|mesh-list
19287183|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287184|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
19287185|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287186|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287187|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
19287188|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287189|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
20359148|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20359149|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359150|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20359151|NCT00918489|Vorinostat|vorinostat|mesh-list
20359152|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359153|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20359154|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359155|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359156|NCT00918528|Mitomycins|mitomycins|mesh-list
20359157|NCT00918528|Mitomycin|mitomycin|mesh-list
20359158|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20359159|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359160|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
20359161|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359162|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20359163|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359164|NCT00918554|Methotrexate|methotrexate|mesh-list
20359165|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20359166|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
20359167|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19287190|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19287191|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
19287192|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287193|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19287194|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20359168|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359169|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20359170|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
20359171|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359172|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359173|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359174|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359175|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20359176|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359177|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
20359178|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359179|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20359180|NCT00918593|Bleomycin|bleomycin|mesh-list
20359181|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20359182|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359183|NCT00918632|Axitinib|axitinib|mesh-list
19287195|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
19287196|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287197|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287198|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19287199|NCT04316936|Dexamethasone|dexamethasone|mesh-list
19287200|NCT04316936|Prednisolone|prednisolone|mesh-list
20359184|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359185|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20359186|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359187|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359188|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20359189|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
19287201|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20359190|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287202|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
20359191|NCT00918853|Pancrelipase|pancrelipase|mesh-list
20359192|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287203|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19287204|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
19287205|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19287206|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
19287207|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287208|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
19287209|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
19287210|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287211|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287212|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287213|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
19287214|NCT04316936|Hormones|hormones|mesh-ancestor
20425219|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425220|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
20425221|NCT01273727|Hormones|hormones|mesh-ancestor
20425222|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287215|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287216|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19287217|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287218|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19287219|NCT04316936|Protective Agents|protective agents|mesh-ancestor
19287220|NCT04317157|Caffeine|caffeine|mesh-list
19287221|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19287222|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287223|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20425223|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20425224|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425225|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
20425226|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425227|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425228|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
20425229|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425230|NCT01273831|Cisatracurium|cisatracurium|mesh-list
20425231|NCT01273831|Atracurium|atracurium|mesh-list
20425232|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20425233|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20425234|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425235|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425236|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20425237|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20425238|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20425239|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
20425240|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425241|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425242|NCT01273844|Bortezomib|bortezomib|mesh-list
20425243|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425244|NCT01273948|Interferons|interferons|mesh-list
20425245|NCT01273948|Bavituximab|bavituximab|mesh-list
20425246|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425247|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
19671341|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
19671342|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671343|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20425248|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425249|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20425250|NCT01273974|Vaccines|vaccines|mesh-list
19287224|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287225|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287226|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19287227|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19287228|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
19287229|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287230|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
19287231|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671344|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671345|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
19671346|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19671347|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19671348|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
20425251|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
19287232|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
19394754|NCT03673384|Histamine|histamine|mesh-list
19838139|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
19838140|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19287233|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287234|NCT04317079|Protective Agents|protective agents|mesh-ancestor
19287235|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287236|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19287237|NCT04317183|Miconazole|miconazole|mesh-list
19287238|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
19287239|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287240|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19287241|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19287242|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287243|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287244|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19838141|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19838142|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19287245|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
19287246|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287247|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287248|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19287249|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19287250|NCT04317001|Modafinil|modafinil|mesh-list
19287251|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19287252|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287253|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19287254|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19287255|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19287256|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287257|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19287258|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19287259|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287260|NCT04316390|Vitamins|vitamins|mesh-list
19287261|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
19287262|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
19287263|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287264|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
19287265|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287266|NCT04316390|Protective Agents|protective agents|mesh-ancestor
19287267|NCT04316676|Regadenoson|regadenoson|mesh-list
19287268|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19287269|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19287270|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
19287271|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
19287272|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838143|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19838144|NCT00619229|Alprostadil|alprostadil|mesh-list
19838145|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19838146|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
19838147|NCT00619229|Urological Agents|urological agents|mesh-ancestor
19838148|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
19838149|NCT00619307|Ibuprofen|ibuprofen|mesh-list
19838150|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19838151|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20181736|NCT00190827|Analgesics|analgesics|mesh-ancestor
20181737|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
20181738|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181739|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
19838152|NCT00619307|Analgesics|analgesics|mesh-ancestor
19838153|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
19838154|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838155|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838156|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838157|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19838158|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19838159|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838160|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838161|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19838162|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
19838163|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181740|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181741|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
20181742|NCT00190840|Pemetrexed|pemetrexed|mesh-list
19287273|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287274|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287275|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
19287276|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
19287277|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19287278|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19287279|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287280|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287281|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287282|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19287283|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19287284|NCT04316702|Analgesics|analgesics|mesh-ancestor
19287285|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
19287286|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287287|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287288|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19287289|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287290|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19287291|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19287292|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19287293|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287294|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
19287295|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
19287296|NCT04316351|Pemetrexed|pemetrexed|mesh-list
19287297|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287298|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287299|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287300|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19287301|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19287302|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
19287303|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
19287304|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394755|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394756|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19394757|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
19394758|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359193|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
20359194|NCT00919022|Cyproterone|cyproterone|mesh-list
20359195|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
20359196|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
20359197|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359198|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359199|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359200|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20359201|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
20359202|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20359203|NCT00919178|Vaccines|vaccines|mesh-list
20359204|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
20359205|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359206|NCT00919204|Axitinib|axitinib|mesh-list
20359207|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359208|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20359209|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359210|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359211|NCT00919243|Prednisone|prednisone|mesh-list
19394759|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394760|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20359212|NCT00919243|Allopurinol|allopurinol|mesh-list
20359213|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359214|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
20359215|NCT00919243|Hormones|hormones|mesh-ancestor
20359216|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359217|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359218|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359219|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359220|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
20359221|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359222|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359223|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
20359224|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359225|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20359226|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
20359227|NCT00919243|Protective Agents|protective agents|mesh-ancestor
19287305|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
19287306|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19287307|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
20359228|NCT00919282|Leucovorin|leucovorin|mesh-list
20359229|NCT00919282|Folic Acid|folic acid|mesh-list
20359230|NCT00919282|Gemcitabine|gemcitabine|mesh-list
20359231|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
20359232|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20359233|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
20359234|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359235|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359236|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
20359237|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359238|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359239|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359240|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
20359241|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359242|NCT00919282|Antidotes|antidotes|mesh-ancestor
20359243|NCT00919282|Protective Agents|protective agents|mesh-ancestor
20359244|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
20359245|NCT00919282|Vitamins|vitamins|mesh-ancestor
19287308|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19287309|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
19287310|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287311|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287312|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
19287313|NCT04316013|Lidocaine|lidocaine|mesh-list
19287314|NCT04316013|Propofol|propofol|mesh-list
19287315|NCT04316013|Sevoflurane|sevoflurane|mesh-list
19287316|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287317|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
20359246|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
20359247|NCT00919282|Hematinics|hematinics|mesh-ancestor
20359248|NCT00919295|Mirtazapine|mirtazapine|mesh-list
20359249|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
20359250|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359251|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20359252|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
19287318|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287319|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287320|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
19287321|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287322|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19287323|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19287324|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19287325|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19287326|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287327|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19287328|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19671349|NCT02037048|Antidotes|antidotes|mesh-ancestor
19671350|NCT02037048|Protective Agents|protective agents|mesh-ancestor
19671351|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
19671352|NCT02037048|Vitamins|vitamins|mesh-ancestor
19671353|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
19671354|NCT02023905|Everolimus|everolimus|mesh-list
19671355|NCT02023905|Temozolomide|temozolomide|mesh-list
19287329|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
19287330|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19287331|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19287332|NCT04316039|Temozolomide|temozolomide|mesh-list
19287333|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19287334|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
19287335|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287336|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287337|NCT04315935|Fentanyl|fentanyl|mesh-list
19287338|NCT04315935|Butorphanol|butorphanol|mesh-list
19287339|NCT04315935|Propofol|propofol|mesh-list
19287340|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19287341|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287342|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287343|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19838164|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
19287344|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
19287345|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
19671356|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359253|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
20359254|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359255|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671357|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19287346|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19287347|NCT04315935|Narcotics|narcotics|mesh-ancestor
19287348|NCT04315935|Analgesics|analgesics|mesh-ancestor
19287349|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
19287350|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359256|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359257|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20359258|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359259|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359260|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20359261|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20359262|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20359263|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
20359264|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20359265|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20359266|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
20359267|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20359268|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20359269|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
20359270|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359271|NCT00919399|Tamoxifen|tamoxifen|mesh-list
20359272|NCT00919399|Exemestane|exemestane|mesh-list
20359273|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20359274|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
20359275|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359276|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359277|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359278|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359279|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20359280|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20359281|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20359282|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20359283|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20359284|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287351|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19287352|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
19287353|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
19287354|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19287355|NCT04315909|Vitamin E|vitamin e|mesh-list
19287356|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19287357|NCT04315909|Vitamins|vitamins|mesh-ancestor
19287358|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
19287359|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287360|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
19287361|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287362|NCT04315909|Protective Agents|protective agents|mesh-ancestor
19287363|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
19287364|NCT04315909|Coagulants|coagulants|mesh-ancestor
19287365|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
19287366|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19287367|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19287368|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19287369|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287370|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287371|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
19287372|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
19287373|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287374|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
19287375|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287376|NCT04315831|Buprenorphine|buprenorphine|mesh-list
19287377|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19287378|NCT04315831|Narcotics|narcotics|mesh-ancestor
19287379|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287380|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287381|NCT04315831|Analgesics|analgesics|mesh-ancestor
19287382|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
19287383|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287384|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19287385|NCT04315558|Bromides|bromides|mesh-list
19287386|NCT04315558|Ipratropium|ipratropium|mesh-list
19287387|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
20359285|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287388|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19287389|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
19287390|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404197|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
20359286|NCT00919438|Diuretics|diuretics|mesh-list
20359287|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
20359288|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359289|NCT00919451|Cyclosporine|cyclosporine|mesh-list
20359290|NCT00919451|Cyclosporins|cyclosporins|mesh-list
19287391|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287392|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19287393|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
19287394|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19287395|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
19287396|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287397|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287398|NCT04315688|Insulin|insulin|mesh-list
19287399|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19287400|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287401|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
19287402|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287403|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
19287404|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287405|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287406|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
20359291|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359292|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359293|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19287407|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287408|NCT04315493|Maleic acid|maleic acid|mesh-list
19287409|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287410|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287411|NCT04315194|Clarithromycin|clarithromycin|mesh-list
19287412|NCT04315194|Oseltamivir|oseltamivir|mesh-list
19287413|NCT04315194|Naproxen|naproxen|mesh-list
19287414|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19287415|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287416|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19287417|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287418|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287419|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19287420|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19287421|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19287422|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19287423|NCT04315194|Analgesics|analgesics|mesh-ancestor
19287424|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
19287425|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359294|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
20359295|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359296|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
20359297|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359298|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359299|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359300|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20359301|NCT00919542|Cyclosporine|cyclosporine|mesh-list
20359302|NCT00919542|Prednisolone|prednisolone|mesh-list
20359303|NCT00919542|Cyclosporins|cyclosporins|mesh-list
20359304|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359305|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359306|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359307|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
20359308|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359309|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
20359310|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287426|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287427|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287428|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19287429|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
19287430|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19287431|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
19287432|NCT04315155|Nivolumab|nivolumab|mesh-list
19287433|NCT04315155|Ipilimumab|ipilimumab|mesh-list
19287434|NCT04315155|Belinostat|belinostat|mesh-list
19287435|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19287436|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359311|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
19287437|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20359312|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19287438|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359313|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20359314|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287439|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19287440|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287441|NCT04315116|Loperamide|loperamide|mesh-list
19287442|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
19287443|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287444|NCT04314713|Scopolamine|scopolamine|mesh-list
19287445|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20181743|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181744|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181745|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181746|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20181747|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20181748|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181749|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181750|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20359315|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
20359316|NCT00919542|Hormones|hormones|mesh-ancestor
20359317|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359318|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359319|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359320|NCT00919555|Pioglitazone|pioglitazone|mesh-list
19287446|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19287447|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
19287448|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
19287449|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287450|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287451|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287452|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
19287453|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19287454|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
19287455|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287456|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287457|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19287458|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
19287459|NCT04314739|Resveratrol|resveratrol|mesh-list
19287460|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
19287461|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287462|NCT04314739|Protective Agents|protective agents|mesh-ancestor
19287463|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287464|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287465|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19287466|NCT04314310|Tenoxicam|tenoxicam|mesh-list
19287467|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20359321|NCT00919555|Tretinoin|tretinoin|mesh-list
20359322|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20359323|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359324|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359325|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
19287468|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19287469|NCT04314310|Analgesics|analgesics|mesh-ancestor
19287470|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
19287471|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287472|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287473|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287474|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19287475|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19287476|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287477|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287478|NCT04314375|Budesonide|budesonide|mesh-list
19287479|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287480|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19287481|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
19287482|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287483|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287484|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19287485|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
19287486|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
19287487|NCT04314375|Hormones|hormones|mesh-ancestor
19287488|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394761|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
19394762|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359326|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359327|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20359328|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
20359329|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359330|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20359331|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359332|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359333|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287489|NCT04314297|Durvalumab|durvalumab|mesh-list
19287490|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19287491|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287492|NCT04314674|Mannitol|mannitol|mesh-list
19287493|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20359334|NCT00919776|Cyclosporine|cyclosporine|mesh-list
20359335|NCT00919776|Prednisolone|prednisolone|mesh-list
20359336|NCT00919776|Cyclosporins|cyclosporins|mesh-list
20359337|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359338|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359339|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359340|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
20359341|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359342|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
20359343|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359344|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
19287494|NCT04314674|Diuretics|diuretics|mesh-ancestor
19287495|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
19287496|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287497|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
19287498|NCT04314505|Narcotics|narcotics|mesh-ancestor
19287499|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287500|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287501|NCT04314505|Analgesics|analgesics|mesh-ancestor
19287502|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
19287503|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287504|NCT04313959|Dexamethasone|dexamethasone|mesh-list
19287505|NCT04313959|Ropivacaine|ropivacaine|mesh-list
19287506|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287507|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
19287508|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
19287509|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287510|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287511|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287512|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
19287513|NCT04313959|Hormones|hormones|mesh-ancestor
19287514|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287515|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19287516|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287517|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287518|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
19287519|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287520|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
19287521|NCT04314193|Prednisolone|prednisolone|mesh-list
19287522|NCT04314193|Methotrexate|methotrexate|mesh-list
19287523|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19287524|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
19287525|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19287526|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287527|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19287528|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
19287529|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287530|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287531|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
19671358|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
20359345|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359346|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20359347|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359348|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
20359349|NCT00919776|Hormones|hormones|mesh-ancestor
20359350|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359351|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359352|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359353|NCT00919815|Cyclosporine|cyclosporine|mesh-list
19287532|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287533|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20359354|NCT00919815|Prednisolone|prednisolone|mesh-list
19287534|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359355|NCT00919815|Cyclosporins|cyclosporins|mesh-list
19287535|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
19287536|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19287537|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19287538|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359356|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359357|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359358|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359359|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
20359360|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359361|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
20359362|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359363|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359364|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359365|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20359366|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359367|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
20359368|NCT00919815|Hormones|hormones|mesh-ancestor
20359369|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359370|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359371|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359372|NCT00919880|Paclitaxel|paclitaxel|mesh-list
20359373|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20359374|NCT00919880|Carboplatin|carboplatin|mesh-list
20359375|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20359376|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359377|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
20359378|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
20359379|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
20359380|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359381|NCT00919919|Progesterone|progesterone|mesh-list
20359382|NCT00919919|Progestins|progestins|mesh-ancestor
20359383|NCT00919919|Hormones|hormones|mesh-ancestor
20359384|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359385|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359386|NCT00919984|Paclitaxel|paclitaxel|mesh-list
20359387|NCT00919984|Carboplatin|carboplatin|mesh-list
20359388|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20359389|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359390|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
20359391|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
19287539|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
19287540|NCT04314193|Hormones|hormones|mesh-ancestor
19287541|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287542|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19287543|NCT04313907|Clonazepam|clonazepam|mesh-list
19287544|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
19287545|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
19287546|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
19287547|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287548|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287549|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287550|NCT04313790|Heparin|heparin|mesh-list
19287551|NCT04313790|Calcium heparin|calcium heparin|mesh-list
19287552|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
20359392|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
20359393|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359394|NCT00920088|Ritonavir|ritonavir|mesh-list
20359395|NCT00920088|Lopinavir|lopinavir|mesh-list
20359396|NCT00920088|Darunavir|darunavir|mesh-list
20359397|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
20359398|NCT00920088|Midazolam|midazolam|mesh-list
20359399|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
20359400|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20359401|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20359402|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359403|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359404|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20359405|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359406|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359407|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20359408|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
20359409|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
19287553|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20359410|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
20359411|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
19287554|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19394763|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20359412|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359413|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287555|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287556|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19287557|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
19287558|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287559|NCT04313764|Bupivacaine|bupivacaine|mesh-list
19287560|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287561|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
19287562|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287563|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287564|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
19287565|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287566|NCT04313504|Niraparib|niraparib|mesh-list
19287567|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19287568|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287569|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287570|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287571|NCT04313452|Insulin|insulin|mesh-list
19287572|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19287573|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287574|NCT04313634|Dasatinib|dasatinib|mesh-list
19287575|NCT04313634|Quercetin|quercetin|mesh-list
19287576|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287577|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19287578|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181751|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359414|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20359415|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20359416|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
20359417|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359418|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20359419|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20359420|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
20359421|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181752|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181753|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181754|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359422|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20359423|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20359424|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
20359425|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
20359426|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20359427|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20359428|NCT00920088|Analgesics|analgesics|mesh-ancestor
20359429|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
20359430|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359431|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20359432|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20359433|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359434|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359435|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20359436|NCT00920101|Atorvastatin|atorvastatin|mesh-list
20359437|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20359438|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20181755|NCT00190853|Analgesics|analgesics|mesh-ancestor
20181756|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
20181757|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181758|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181759|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181760|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
20181761|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181762|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181763|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181764|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181765|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181766|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181767|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181768|NCT00190866|Analgesics|analgesics|mesh-ancestor
20181769|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
20181770|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394764|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
19287579|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287580|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
19287581|NCT04313634|Protective Agents|protective agents|mesh-ancestor
19287582|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287583|NCT04313270|Evolocumab|evolocumab|mesh-list
19287584|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19287585|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19287586|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
19287587|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287588|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19287589|NCT04313218|Misoprostol|misoprostol|mesh-list
19287590|NCT04313218|Carbetocin|carbetocin|mesh-list
19287591|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19287592|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
19287593|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19287594|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287595|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19287596|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287597|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
19287598|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19287599|NCT04313374|Morphine|morphine|mesh-list
19287600|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19287601|NCT04313374|Narcotics|narcotics|mesh-ancestor
19287602|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287603|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287604|NCT04313374|Analgesics|analgesics|mesh-ancestor
19287605|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
19287606|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287607|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19287608|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19287609|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19287610|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181771|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181772|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181773|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
20181774|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20181775|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181776|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181777|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359439|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
20359440|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359441|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19287611|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19671359|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671360|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19671361|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
19671362|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671363|NCT01909414|Vaccines|vaccines|mesh-list
19671364|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
20359442|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19287612|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19287613|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19287614|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19287615|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359443|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359444|NCT00920153|Gemcitabine|gemcitabine|mesh-list
20359445|NCT00920153|Cytarabine|cytarabine|mesh-list
20359446|NCT00920153|Dexamethasone|dexamethasone|mesh-list
20359447|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
20359448|NCT00920153|Doxorubicin|doxorubicin|mesh-list
20359449|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19287616|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287617|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287618|NCT04313335|Analgesics|analgesics|mesh-ancestor
19287619|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
19287620|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287621|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
19287622|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19671365|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671366|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19671367|NCT01698307|Adalimumab|adalimumab|mesh-list
19671368|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20181778|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359450|NCT00920153|Etoposide|etoposide|mesh-list
19287623|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
19287624|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
19287625|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
19287626|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
19287627|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
19287628|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
19287629|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19287630|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19287631|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287632|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
19287633|NCT04312880|Coagulants|coagulants|mesh-ancestor
19287634|NCT04313036|Defibrotide|defibrotide|mesh-list
20359451|NCT00920153|Vincristine|vincristine|mesh-list
20359452|NCT00920153|Melphalan|melphalan|mesh-list
20359453|NCT00920153|Vinorelbine|vinorelbine|mesh-list
20359454|NCT00920153|Ifosfamide|ifosfamide|mesh-list
20359455|NCT00920153|Dacarbazine|dacarbazine|mesh-list
20359456|NCT00920153|Carmustine|carmustine|mesh-list
20359457|NCT00920153|Bleomycin|bleomycin|mesh-list
20359458|NCT00920153|Vindesine|vindesine|mesh-list
19287635|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19287636|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19287637|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287638|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19287639|NCT04312841|Acetic Acid|acetic acid|mesh-list
19287640|NCT04312841|Letermovir|letermovir|mesh-list
19287641|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19287642|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287643|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287644|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287645|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287646|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19287647|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
19287648|NCT04312750|Lidocaine|lidocaine|mesh-list
19287649|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287650|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
19287651|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359459|NCT00920153|Mitoguazone|mitoguazone|mesh-list
20359460|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359461|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359462|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
20359463|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
20359464|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359465|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287652|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287653|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
19287654|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287655|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19287656|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20359466|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20359467|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
20359468|NCT00920153|Hormones|hormones|mesh-ancestor
19287657|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19287658|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19287659|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287660|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
19287661|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
19287662|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
19287663|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287664|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19287665|NCT04312347|Tamoxifen|tamoxifen|mesh-list
19287666|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19671369|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671370|NCT05118984|Azithromycin|azithromycin|mesh-list
19671371|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671372|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671373|NCT05118672|Acetaminophen|acetaminophen|mesh-list
19671374|NCT05118672|Fexofenadine|fexofenadine|mesh-list
19671375|NCT05118672|Phenylephrine|phenylephrine|mesh-list
19671376|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
20359469|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359470|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359471|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20359472|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
20359473|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359474|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
20359475|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287667|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
19287668|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287669|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287670|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19287671|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287672|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19287673|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19287674|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19287675|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
19287676|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19287677|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
19287678|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287679|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287680|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19838165|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838166|NCT00619359|Dexamethasone|dexamethasone|mesh-list
19838167|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
19838168|NCT00619359|Ondansetron|ondansetron|mesh-list
19838169|NCT00619359|Aprepitant|aprepitant|mesh-list
19838170|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
19287681|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
19287682|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19287683|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
19287684|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287685|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287686|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19287687|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
19287688|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
19287689|NCT04312243|Protective Agents|protective agents|mesh-ancestor
19287690|NCT04312438|Caseins|caseins|mesh-list
19287691|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
19287692|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
19287693|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287694|NCT04312360|Metronidazole|metronidazole|mesh-list
19287695|NCT04312360|Fosfomycin|fosfomycin|mesh-list
20359476|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287696|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287697|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19287698|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19287699|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19394765|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
19394766|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394767|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394768|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19394769|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394770|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394771|NCT03673280|Morphine|morphine|mesh-list
19394772|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19394773|NCT03673280|Narcotics|narcotics|mesh-ancestor
19394774|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394775|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394776|NCT03673280|Analgesics|analgesics|mesh-ancestor
19838171|NCT00619359|BB 1101|bb 1101|mesh-list
19838172|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20181779|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181780|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838173|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
19838174|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
20181781|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181782|NCT00190892|Carbamazepine|carbamazepine|mesh-list
20181783|NCT00190892|Olanzapine|olanzapine|mesh-list
20181784|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
20181785|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
20181786|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838175|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838176|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181787|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181788|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20181789|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20181790|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20181791|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20181792|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181793|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20181794|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181795|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359477|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359478|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
19287700|NCT04312204|Gemcitabine|gemcitabine|mesh-list
19287701|NCT04312204|Carboplatin|carboplatin|mesh-list
19287702|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287703|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19287704|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
19287705|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287706|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
19287707|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287708|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287709|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19287710|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
19287711|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287712|NCT04312282|Itraconazole|itraconazole|mesh-list
19287713|NCT04312282|Rifampin|rifampin|mesh-list
19287714|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
19287715|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287716|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19287717|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19287718|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287719|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287720|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19287721|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
19287722|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287723|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287724|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19287725|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19838177|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838178|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
20359479|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20359480|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20359481|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20359482|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19838179|NCT00619359|Hormones|hormones|mesh-ancestor
19287726|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
19287727|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19287728|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
19287729|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19287730|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20359483|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
20359484|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
20359485|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
20359486|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20359487|NCT00920153|Protective Agents|protective agents|mesh-ancestor
20359488|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20359489|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
20359490|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20359491|NCT00920244|Atropine|atropine|mesh-list
20359492|NCT00920244|Amiodarone|amiodarone|mesh-list
20359493|NCT00920244|Epinephrine|epinephrine|mesh-list
20359494|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20359495|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20359496|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
20359497|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359498|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359499|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359500|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20359501|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20359502|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
19287731|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19287732|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19287733|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19287734|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19287735|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19287736|NCT04312152|Vitamins|vitamins|mesh-list
19287737|NCT04312152|Vitamin E|vitamin e|mesh-list
19287738|NCT04312152|Tocopherols|tocopherols|mesh-list
19287739|NCT04312152|Folic Acid|folic acid|mesh-list
19287740|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
19838180|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19838181|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359503|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287741|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
19287742|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287743|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
19287744|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287745|NCT04312152|Protective Agents|protective agents|mesh-ancestor
19287746|NCT04312152|Hematinics|hematinics|mesh-ancestor
19287747|NCT04312009|Losartan|losartan|mesh-list
19287748|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19287749|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19287750|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19287751|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19287752|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287753|NCT04312048|Isosorbide|isosorbide|mesh-list
19287754|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19287755|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19287756|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19287757|NCT04312048|Diuretics|diuretics|mesh-ancestor
19287758|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
19287759|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287760|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
19287761|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19287762|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287763|NCT04312061|Tramadol|tramadol|mesh-list
19287764|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19287765|NCT04312061|Narcotics|narcotics|mesh-ancestor
19287766|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287767|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359504|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20359505|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
20359506|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
20359507|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
20359508|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19287768|NCT04312061|Analgesics|analgesics|mesh-ancestor
19287769|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
19287770|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671377|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671378|NCT05118672|Analgesics|analgesics|mesh-ancestor
19671379|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
19671380|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671381|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671382|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
19671383|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19671384|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
19671385|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
19287780|NCT04311671|Ivermectin|ivermectin|mesh-list
19287781|NCT04311671|Moxidectin|moxidectin|mesh-list
19287782|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19287783|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287784|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
19287785|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
19287786|NCT04311697|Phentolamine|phentolamine|mesh-list
19287787|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
19287788|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19287789|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19287790|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
19287791|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287792|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287793|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287794|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19287795|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19287796|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
19287797|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19287798|NCT04311697|Protective Agents|protective agents|mesh-ancestor
19287799|NCT04311580|Mitomycins|mitomycins|mesh-list
19287800|NCT04311580|Mitomycin|mitomycin|mesh-list
19287801|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19287802|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287803|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
19287804|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287805|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19287806|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287807|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
19287808|NCT04311632|Tacrolimus|tacrolimus|mesh-list
19287809|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838182|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359509|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19287810|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
19287811|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287812|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19287813|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287814|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287815|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19287816|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287817|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19287818|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
19838183|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
19838184|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838185|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838186|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
19838187|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
19287819|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19287820|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287821|NCT04311424|Tirzepatide|tirzepatide|mesh-list
19287822|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19287823|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287824|NCT04311424|Incretins|incretins|mesh-ancestor
19287825|NCT04311424|Hormones|hormones|mesh-ancestor
19287826|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359510|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20359511|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
20359512|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20359513|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20359514|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
19287827|NCT04311658|Isosorbide|isosorbide|mesh-list
19287828|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19287829|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19287830|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19287831|NCT04311658|Diuretics|diuretics|mesh-ancestor
19287832|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
19287833|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287834|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
19287835|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19287836|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287837|NCT04311645|Charcoal|charcoal|mesh-list
19287838|NCT04311645|Antidotes|antidotes|mesh-ancestor
19287839|NCT04311645|Protective Agents|protective agents|mesh-ancestor
19287840|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287841|NCT04311255|Anesthetics|anesthetics|mesh-list
19287842|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287843|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287844|NCT04310943|Paclitaxel|paclitaxel|mesh-list
19287845|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19287846|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287847|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
19287848|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
19287849|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
19287850|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287851|NCT04311099|Ropivacaine|ropivacaine|mesh-list
19287852|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
19287853|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
19287854|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287855|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287856|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
19287857|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287858|NCT04310683|Hormones|hormones|mesh-list
19287859|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287860|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287861|NCT04310579|Midazolam|midazolam|mesh-list
19287862|NCT04310579|Oxycodone|oxycodone|mesh-list
19287863|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19287864|NCT04310579|Paroxetine|paroxetine|mesh-list
19287865|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19287866|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19287867|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359515|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
19287868|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287869|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19287870|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19287871|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838188|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19287872|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19838189|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
20359516|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19287873|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
19838190|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838191|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19838192|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19838193|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359517|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359518|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20359519|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20359520|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20359521|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359522|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20359523|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20359524|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20359525|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20359526|NCT00920270|Colistin|colistin|mesh-list
20359527|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359528|NCT00920283|Cobalt|cobalt|mesh-list
20359529|NCT00920283|Trace Elements|trace elements|mesh-ancestor
20359530|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
20359531|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838194|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20612558|NCT02251925|Hormones|hormones|mesh-ancestor
19287874|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
19671386|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
19671387|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19671388|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
19671389|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
19287875|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
19287876|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
19287877|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287878|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287879|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19287880|NCT04310579|Narcotics|narcotics|mesh-ancestor
19287881|NCT04310579|Analgesics|analgesics|mesh-ancestor
19838195|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19838196|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20359532|NCT00920296|Cabotegravir|cabotegravir|mesh-list
20359533|NCT00920296|Etravirine|etravirine|mesh-list
20359534|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20359535|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20359536|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287882|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
19287883|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287884|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
19287885|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19287886|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19287887|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19287888|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19287889|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
19287890|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19287891|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19287892|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19287893|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287894|NCT04310709|Nivolumab|nivolumab|mesh-list
19287895|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19287896|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287897|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19287898|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287899|NCT04310774|Tegafur|tegafur|mesh-list
19287900|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19287901|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
19287902|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287903|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287904|NCT04310254|Edetic Acid|edetic acid|mesh-list
19287905|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19287906|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
19287907|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
19671390|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19671391|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19671392|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19671393|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
19671394|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671395|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359537|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287908|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19287909|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
19287910|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
19287911|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287912|NCT04310254|Antidotes|antidotes|mesh-ancestor
19287913|NCT04310254|Protective Agents|protective agents|mesh-ancestor
19287914|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287915|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19287916|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
19287917|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19287918|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287919|NCT04310228|Favipiravir|favipiravir|mesh-list
19287920|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
19287921|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19287922|NCT04310176|Bevacizumab|bevacizumab|mesh-list
19287923|NCT04310176|Fluorouracil|fluorouracil|mesh-list
19287924|NCT04310176|Capecitabine|capecitabine|mesh-list
19287925|NCT04310176|Valproic Acid|valproic acid|mesh-list
19287926|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19287927|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287928|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19287929|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19287930|NCT04310176|Growth Substances|growth substances|mesh-ancestor
19287931|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287932|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
19287933|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
19287934|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287935|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19287936|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19287937|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
19287938|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
19287939|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287940|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
19287941|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19287942|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
19287943|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19287944|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19287945|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19394777|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
19394778|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394779|NCT03673163|Lidocaine|lidocaine|mesh-list
19394780|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
19394781|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
20359538|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20359539|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20359540|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
20359541|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359542|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20359543|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20359544|NCT00920413|Ascorbic Acid|ascorbic acid|mesh-list
20359545|NCT00920413|Vitamins|vitamins|mesh-ancestor
20359546|NCT00920413|Micronutrients|micronutrients|mesh-ancestor
20359547|NCT00920413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359548|NCT00920413|Antioxidants|antioxidants|mesh-ancestor
20359549|NCT00920413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359550|NCT00920413|Protective Agents|protective agents|mesh-ancestor
20359551|NCT00920465|Misoprostol|misoprostol|mesh-list
20359552|NCT00920465|Mifepristone|mifepristone|mesh-list
20359553|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20359554|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
20359555|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20359556|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359557|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20359558|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20359559|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
20359560|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20359561|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20359562|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20359563|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20359564|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
20359565|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20359566|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20359567|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
20359568|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394782|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394783|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394784|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
19287946|NCT04310397|Trametinib|trametinib|mesh-list
19287947|NCT04310397|Dabrafenib|dabrafenib|mesh-list
19287948|NCT04310397|Spartalizumab|spartalizumab|mesh-list
19287949|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19287950|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19287951|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19287952|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287953|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19287954|NCT04309838|Treprostinil|treprostinil|mesh-list
19287955|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19287956|NCT04310293|Hormones|hormones|mesh-list
19287957|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287958|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287959|NCT04309929|Analgesics|analgesics|mesh-list
19287960|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
19287961|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19287962|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287963|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
19287964|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19287965|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
19287966|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
19287967|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19287968|NCT04309643|Estradiol|estradiol|mesh-list
19287969|NCT04309643|Estrogens|estrogens|mesh-ancestor
19287970|NCT04309643|Hormones|hormones|mesh-ancestor
20613206|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
20613207|NCT02253966|Hormones|hormones|mesh-ancestor
19287971|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19287972|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287973|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19287974|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19287975|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19287976|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19287977|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19287978|NCT04309708|Nimodipine|nimodipine|mesh-list
19287979|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19287980|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19287981|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19287982|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287983|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19287984|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19287985|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
19671396|NCT05118672|Protective Agents|protective agents|mesh-ancestor
19671397|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19671398|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19287986|NCT04309578|Capecitabine|capecitabine|mesh-list
19287987|NCT04309578|Trastuzumab|trastuzumab|mesh-list
19287988|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671399|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19287989|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19287990|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
19287991|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287992|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19287993|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19287994|NCT04309357|Plasminogen|plasminogen|mesh-list
19287995|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19287996|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19287997|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19287998|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
19287999|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19288000|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
19288001|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19288002|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
19671400|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
19671401|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
20181796|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181797|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181798|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
20181799|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
20181800|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
20181801|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20181802|NCT00190892|Analgesics|analgesics|mesh-ancestor
20181803|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
20181804|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20181805|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19288003|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288004|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288005|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
19288006|NCT04308954|Flumazenil|flumazenil|mesh-list
19288007|NCT04308954|Antidotes|antidotes|mesh-ancestor
19288008|NCT04308954|Protective Agents|protective agents|mesh-ancestor
19288009|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288010|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
19288011|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
19288012|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288013|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288014|NCT04309058|Vitamin D|vitamin d|mesh-list
19288015|NCT04309058|Vitamins|vitamins|mesh-ancestor
19288016|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
19288017|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288018|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19288019|NCT04308551|Aspirin|aspirin|mesh-list
19288020|NCT04308551|Indobufen|indobufen|mesh-list
20359569|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
20359570|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20359571|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20359572|NCT00920608|Methotrexate|methotrexate|mesh-list
20359573|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20359574|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
20359575|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20359576|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288021|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19288022|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19288023|NCT04308551|Analgesics|analgesics|mesh-ancestor
19288024|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
19288025|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288026|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288027|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288028|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19288029|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19288030|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19288031|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288032|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19288033|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19288034|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288035|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
19288036|NCT04308850|Vitamin D|vitamin d|mesh-list
19288037|NCT04308850|Vitamins|vitamins|mesh-ancestor
19288038|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
19288039|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288040|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19288041|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
19288042|NCT04308525|Narcotics|narcotics|mesh-ancestor
19288043|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288044|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288045|NCT04308525|Analgesics|analgesics|mesh-ancestor
19288046|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
19288047|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181806|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20181807|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181808|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181809|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181810|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181811|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181812|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181813|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181814|NCT00190905|Analgesics|analgesics|mesh-ancestor
20181815|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
20181816|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181817|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181818|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181819|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
20181820|NCT00190918|Pemetrexed|pemetrexed|mesh-list
20181821|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181822|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217229|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359577|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288048|NCT04308317|Tetrandrine|tetrandrine|mesh-list
19288049|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
19288050|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19288051|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19288052|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288053|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288054|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288055|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
19288056|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19288057|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19288058|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288059|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19288060|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288061|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288062|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
19288063|NCT04308343|Methotrexate|methotrexate|mesh-list
19288064|NCT04308343|Letrozole|letrozole|mesh-list
19288065|NCT04308343|Cetrorelix|cetrorelix|mesh-list
19288066|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19288067|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
19288068|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288069|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288070|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288071|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
19288072|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288073|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288074|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
19288075|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288076|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19288077|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288078|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
19288079|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19838197|NCT00619476|Gabapentin|gabapentin|mesh-list
19838198|NCT00619476|Analgesics|analgesics|mesh-ancestor
19838199|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
19838200|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838201|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838202|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
19838203|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19838204|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19838205|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838206|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838207|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19838208|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19288080|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19288081|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19288082|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19288083|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19288084|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
19288085|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288086|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19288087|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
19288088|NCT04308174|Durvalumab|durvalumab|mesh-list
19288089|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288090|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394785|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394786|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19394787|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19394788|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19394789|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19394790|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394791|NCT03673137|Gemcitabine|gemcitabine|mesh-list
19394792|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19394793|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
19394794|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394795|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394796|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
19394797|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394798|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394799|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19394800|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
19394801|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394802|NCT03673072|Gemcitabine|gemcitabine|mesh-list
19394803|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394804|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19394805|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
19288091|NCT04308161|Vitamin D|vitamin d|mesh-list
19288092|NCT04308161|Miconazole|miconazole|mesh-list
19288093|NCT04308161|Vitamins|vitamins|mesh-ancestor
19288094|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
19288095|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359578|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
20359579|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359580|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359581|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359582|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359583|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20359584|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359585|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
20359586|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359587|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20359588|NCT00920660|Prednisolone|prednisolone|mesh-list
20359589|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359590|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
20359591|NCT00920660|Hormones|hormones|mesh-ancestor
20359592|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359593|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359594|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359595|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359596|NCT00920725|Insulin|insulin|mesh-list
20359597|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20359598|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
20359599|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20359600|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425252|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425253|NCT01274000|Ramosetron|ramosetron|mesh-list
20425254|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
20425255|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
20425256|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425257|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425258|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425259|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20425260|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
20425261|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425262|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425263|NCT01274026|Verapamil|verapamil|mesh-list
20425264|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20425265|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20425266|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425267|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425268|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20425269|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288096|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19288097|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
19288098|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288099|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19288100|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20425270|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
20425271|NCT01274039|Acetazolamide|acetazolamide|mesh-list
20425272|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
20425273|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20425274|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425275|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425276|NCT01274039|Diuretics|diuretics|mesh-ancestor
19288101|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288102|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838209|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425277|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
20425278|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288103|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19288104|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
20425279|NCT01274104|Vitamin D|vitamin d|mesh-list
20425280|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
20425281|NCT01274104|Vitamins|vitamins|mesh-ancestor
20425282|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
20425283|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425284|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20425285|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20425286|NCT01274130|Metformin|metformin|mesh-list
19288105|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288106|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19288107|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19288108|NCT04308031|Digoxin|digoxin|mesh-list
19288109|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19288110|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19288111|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288112|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288113|NCT04308031|Protective Agents|protective agents|mesh-ancestor
19288114|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288115|NCT04308070|Hemostatics|hemostatics|mesh-list
19288116|NCT04308070|Coagulants|coagulants|mesh-ancestor
19288117|NCT04307693|Ritonavir|ritonavir|mesh-list
19288118|NCT04307693|Lopinavir|lopinavir|mesh-list
19288119|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
19288120|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19288121|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19288122|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
19288123|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288124|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288125|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19288126|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19288127|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
19288128|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288129|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19288130|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19288131|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
19288132|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19288133|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19288134|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19288135|NCT04307550|Ethanol|ethanol|mesh-list
19288136|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19288137|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288138|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288139|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288140|NCT04307238|Anesthetics|anesthetics|mesh-list
19288141|NCT04307238|Propofol|propofol|mesh-list
19288142|NCT04307238|Sevoflurane|sevoflurane|mesh-list
19288143|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288144|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288145|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19288146|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19288147|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
19288148|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19288149|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19288150|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
19288151|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19288152|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288153|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181823|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181824|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20181825|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20181826|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20181827|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181828|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181829|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181830|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181831|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181832|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181833|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181834|NCT00190944|Teriparatide|teriparatide|mesh-list
20181835|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20181836|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181837|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20181838|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20181839|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181840|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181841|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181842|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181843|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
19288154|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19288155|NCT04307290|Analgesics|analgesics|mesh-ancestor
19671402|NCT05118542|Methimazole|methimazole|mesh-list
19288156|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
19288157|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288158|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19288159|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19288160|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19288161|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
19288162|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288163|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288164|NCT04307147|Capecitabine|capecitabine|mesh-list
19288165|NCT04307147|Vinorelbine|vinorelbine|mesh-list
19288166|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288167|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
19288168|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288169|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288170|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288171|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
19288172|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
19288173|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
19288174|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
19288175|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
19288176|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359601|NCT00920803|Resveratrol|resveratrol|mesh-list
20359602|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
20359603|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359604|NCT00920803|Protective Agents|protective agents|mesh-ancestor
20359605|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359606|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288177|NCT04307069|Oxytocin|oxytocin|mesh-list
19288178|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
19288179|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288180|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288181|NCT04306965|Apremilast|apremilast|mesh-list
19288182|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19288183|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19288184|NCT04306965|Analgesics|analgesics|mesh-ancestor
20359607|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20359608|NCT00920868|Bevacizumab|bevacizumab|mesh-list
20359609|NCT00920868|Capecitabine|capecitabine|mesh-list
20359610|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
20359611|NCT00920868|Dasatinib|dasatinib|mesh-list
20359612|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288185|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
19288186|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288187|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288188|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288189|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19288190|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19288191|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19288192|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288193|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288194|NCT04306900|Gemcitabine|gemcitabine|mesh-list
19288195|NCT04306900|Paclitaxel|paclitaxel|mesh-list
19838210|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838211|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
19838212|NCT00619489|Vedolizumab|vedolizumab|mesh-list
19838213|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838214|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19838215|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19838216|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181844|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181845|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181846|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
20181847|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181848|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181849|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181850|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181851|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181852|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181853|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181854|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181855|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359613|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288196|NCT04306900|Docetaxel|docetaxel|mesh-list
19288197|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19288198|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
19288199|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288200|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288201|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
19288202|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
19288203|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
19288204|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288205|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20359614|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20359615|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19288206|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
19288207|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
19288208|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288209|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288210|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288211|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
19288212|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288213|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288214|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
19288215|NCT04306913|Esmolol|esmolol|mesh-list
19288216|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19288217|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19288218|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19671403|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
19671404|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
20359616|NCT00920868|Growth Substances|growth substances|mesh-ancestor
19288219|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
19288220|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288221|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288222|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288223|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19288224|NCT04306666|Anesthetics|anesthetics|mesh-list
19288225|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288226|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288227|NCT04306653|Betamethasone|betamethasone|mesh-list
19288228|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288229|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
19288230|NCT04306653|Hormones|hormones|mesh-ancestor
19288231|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288232|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288233|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19288234|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
19288235|NCT04306731|Trimethoprim|trimethoprim|mesh-list
19288236|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19288237|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288238|NCT04306731|Renal Agents|renal agents|mesh-ancestor
19288239|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
19288240|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19288241|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19288242|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19288243|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288244|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288245|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19288246|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19288247|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19288248|NCT04306692|Inositol|inositol|mesh-list
20181856|NCT00190996|Analgesics|analgesics|mesh-ancestor
20181857|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
20181858|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181859|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181860|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181861|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
20181862|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20181863|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181864|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181865|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359617|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359618|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
20359619|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20359620|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
19288249|NCT04306692|Clomiphene|clomiphene|mesh-list
19671405|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
19838217|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838218|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359621|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359622|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19288250|NCT04306692|Enclomiphene|enclomiphene|mesh-list
19288251|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
19288252|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19288253|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
19288254|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288255|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359623|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359624|NCT00920933|Prednisolone|prednisolone|mesh-list
20359625|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359626|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
20359627|NCT00920933|Hormones|hormones|mesh-ancestor
20359628|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20359629|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359630|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20359631|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359632|NCT00920998|Z 338|z 338|mesh-list
20359633|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20359634|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359635|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359636|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
20359637|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359638|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288256|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19288257|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
19288258|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288259|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19288260|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19288261|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
19288262|NCT04306692|Vitamins|vitamins|mesh-ancestor
19288263|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
19288264|NCT04306627|Amlodipine|amlodipine|mesh-list
19288265|NCT04306627|Perindopril|perindopril|mesh-list
19288266|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19288267|NCT04306627|Atorvastatin|atorvastatin|mesh-list
19288268|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19288269|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19288270|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
19288271|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288272|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19288273|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19288274|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288275|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20359639|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20359640|NCT00921063|Alprazolam|alprazolam|mesh-list
20359641|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20359642|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359643|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359644|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20359645|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359646|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359647|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
20359648|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
20359649|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359650|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359651|NCT00921102|Atropine|atropine|mesh-list
20359652|NCT00921102|Morphine|morphine|mesh-list
20359653|NCT00921102|Bupivacaine|bupivacaine|mesh-list
20359654|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
20359655|NCT00921102|Anesthetics|anesthetics|mesh-list
20359656|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359657|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359658|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
20359659|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359660|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20359661|NCT00921102|Narcotics|narcotics|mesh-ancestor
20359662|NCT00921102|Analgesics|analgesics|mesh-ancestor
20359663|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20359664|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19288276|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19288277|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359665|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19288278|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19288279|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288280|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
19288281|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19288282|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
19288283|NCT04306354|Oxytocin|oxytocin|mesh-list
19288284|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
19288285|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288286|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288287|NCT04306276|Dienogest|dienogest|mesh-list
19288288|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19288289|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
19838219|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838220|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838221|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
19838222|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838223|NCT00619645|Cyclosporine|cyclosporine|mesh-list
19838224|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
19838225|NCT00619645|Fludarabine|fludarabine|mesh-list
19838226|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
19838227|NCT00619645|Busulfan|busulfan|mesh-list
20359666|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
20359667|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20359668|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
20359669|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
20359670|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
19838228|NCT00619645|Cyclosporins|cyclosporins|mesh-list
19838229|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838230|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838231|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
19838232|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288290|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288291|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288292|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19288293|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19288294|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19288295|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19288296|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
19288297|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288298|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19288299|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288300|NCT04306471|Evolocumab|evolocumab|mesh-list
19288301|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19288302|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19288303|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
19288304|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288305|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19288306|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
19288307|NCT04306367|Olaparib|olaparib|mesh-list
19288308|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288309|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288310|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19288311|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288312|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288313|NCT04306159|Anesthetics|anesthetics|mesh-list
19288314|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288315|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288316|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19288317|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19288318|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19288319|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288320|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288321|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19288322|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19288323|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288324|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
19288325|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394806|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394807|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
19394808|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394809|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838233|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838234|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
20425287|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19288326|NCT04305964|Silicon|silicon|mesh-list
19288327|NCT04305964|Trace Elements|trace elements|mesh-ancestor
19288328|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
19288329|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288330|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
19288331|NCT04306042|Nivolumab|nivolumab|mesh-list
19288332|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288333|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288334|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20181866|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181867|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181868|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181869|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181870|NCT00191022|Paroxetine|paroxetine|mesh-list
20181871|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20181872|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19288335|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671406|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671407|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671408|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
19288336|NCT04305691|Ixazomib|ixazomib|mesh-list
19288337|NCT04305691|Glycine|glycine|mesh-list
19288338|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288339|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288340|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
19288341|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288342|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
20359671|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19288343|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288344|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288345|NCT04306081|Evolocumab|evolocumab|mesh-list
19288346|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19288347|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19288348|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
19288349|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288350|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19288351|NCT04305587|Clopidogrel|clopidogrel|mesh-list
19288352|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19288353|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19288354|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19288355|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19288356|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
19288357|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359672|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20359673|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
20359674|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359675|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359676|NCT00921128|Muscimol|muscimol|mesh-list
19288358|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288359|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288360|NCT04305236|Fulvestrant|fulvestrant|mesh-list
19288361|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19288362|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288363|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19288364|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19288365|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
19288366|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288367|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288368|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
19288369|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19288370|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
19288371|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671409|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181873|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181874|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181875|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671410|NCT05118490|Isoniazid|isoniazid|mesh-list
19671411|NCT05118490|Rifapentine|rifapentine|mesh-list
19671412|NCT05118490|Rifampin|rifampin|mesh-list
19671413|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
19671414|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671415|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359677|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20359678|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
20359679|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
20359680|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359681|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288372|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288373|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19288374|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
19288375|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19288376|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
19288377|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288378|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288379|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19288380|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
19288381|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
19288382|NCT04305457|Protective Agents|protective agents|mesh-ancestor
19288383|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
19288384|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19288385|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
19288386|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
19288387|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288388|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288389|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19288390|NCT04305158|Analgesics|analgesics|mesh-ancestor
19288391|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
19288392|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288393|NCT04305028|Aspirin|aspirin|mesh-list
19288394|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
19288395|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19288396|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19288397|NCT04305028|Analgesics|analgesics|mesh-ancestor
19288398|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
19288399|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288400|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359682|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359683|NCT00921154|Ivermectin|ivermectin|mesh-list
20359684|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20359685|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359686|NCT00921167|Bevacizumab|bevacizumab|mesh-list
20359687|NCT00921167|Irinotecan|irinotecan|mesh-list
20359688|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288401|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288402|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19288403|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19288404|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19288405|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288406|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19288407|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19288408|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288409|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
19288410|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19288411|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
19288412|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19288413|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
19288414|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
19288415|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19288416|NCT04304807|Melatonin|melatonin|mesh-list
19288417|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288418|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
19288419|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288420|NCT04304807|Protective Agents|protective agents|mesh-ancestor
19288421|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288422|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288423|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
19288424|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
19288425|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288426|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288427|NCT04305106|Bevacizumab|bevacizumab|mesh-list
19288428|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288429|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288430|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19288431|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19288432|NCT04305106|Growth Substances|growth substances|mesh-ancestor
19288433|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288434|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
20359689|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288435|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
19288436|NCT04305015|Narcotics|narcotics|mesh-ancestor
20181876|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
20181877|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181878|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20181879|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181880|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359690|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20359691|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20359692|NCT00921167|Growth Substances|growth substances|mesh-ancestor
20359693|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359694|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
20359695|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20359696|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20359697|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359698|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359699|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20359700|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
20359701|NCT00921180|Entecavir|entecavir|mesh-list
20359702|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
20359703|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359704|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
20359705|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359706|NCT00921219|Ivermectin|ivermectin|mesh-list
19288437|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288438|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288439|NCT04305015|Analgesics|analgesics|mesh-ancestor
19288440|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
19288441|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288442|NCT04304716|Anesthetics|anesthetics|mesh-list
19288443|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288444|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288445|NCT04305002|Exenatide|exenatide|mesh-list
19288446|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20181881|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20181882|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20181883|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181884|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20181885|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181886|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181887|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181888|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181889|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181890|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181891|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181892|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20181893|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20181894|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181895|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359707|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20359708|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359709|NCT00921245|Darifenacin|darifenacin|mesh-list
20359710|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19288447|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288448|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19288449|NCT04305002|Incretins|incretins|mesh-ancestor
19288450|NCT04305002|Hormones|hormones|mesh-ancestor
19288451|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288452|NCT04304573|Calcium|calcium|mesh-list
19288453|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19288454|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288455|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
19288456|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20359711|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20359712|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
20359713|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359714|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288457|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288458|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19288459|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288460|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
19288461|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19288462|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19288463|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359715|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359716|NCT00921245|Urological Agents|urological agents|mesh-ancestor
20359717|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
20359718|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20359719|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359720|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359721|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20359722|NCT00921284|Analgesics|analgesics|mesh-ancestor
20359723|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
20359724|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359725|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20359726|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20359727|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20359728|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
20359729|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359730|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359731|NCT00921349|Nadolol|nadolol|mesh-list
20359732|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20359733|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20359734|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
20359735|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359736|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359737|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359738|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19288464|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19288465|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288466|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
19288467|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288468|NCT04304209|Capecitabine|capecitabine|mesh-list
19288469|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
19288470|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288471|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
19288472|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288473|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288474|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
19288475|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19288476|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288477|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288478|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19288479|NCT04304157|Analgesics|analgesics|mesh-ancestor
19288480|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
19288481|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288482|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19288483|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19288484|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19288485|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
19288486|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288487|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288488|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
19288489|NCT04304352|Capecitabine|capecitabine|mesh-list
19288490|NCT04304352|Vinorelbine|vinorelbine|mesh-list
19288491|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288492|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
19288493|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288494|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359739|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20359740|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
20359741|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
20359742|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359743|NCT00921388|Varenicline|varenicline|mesh-list
20359744|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20359745|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20359746|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
20359747|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359748|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359749|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359750|NCT00921414|Rituximab|rituximab|mesh-list
20359751|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288495|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19288496|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
19288497|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359752|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359753|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
20359754|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359755|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359756|NCT00921505|Acetaminophen|acetaminophen|mesh-list
20359757|NCT00921505|Ibuprofen|ibuprofen|mesh-list
20359758|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20359759|NCT00921505|Analgesics|analgesics|mesh-ancestor
20359760|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
20359761|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288498|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288499|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19288500|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288501|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
19288502|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288503|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
19288504|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
19288505|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
19288506|NCT04304261|Metformin|metformin|mesh-list
19288507|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
19288508|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19288509|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288510|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19288511|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288512|NCT04304248|Paclitaxel|paclitaxel|mesh-list
19288513|NCT04304248|Carboplatin|carboplatin|mesh-list
19288514|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19288515|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288516|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288517|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19288518|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19288519|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
20359762|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359763|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
20359764|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20359765|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359766|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359767|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20359768|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359769|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359770|NCT00921531|Thalidomide|thalidomide|mesh-list
20359771|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359772|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
20359773|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359774|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
20359775|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20359776|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359777|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19288520|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288521|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
19288522|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288523|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
19288524|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19288525|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19288526|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288527|NCT04304313|Urological Agents|urological agents|mesh-ancestor
19288528|NCT04304196|TEMPO|tempo|mesh-list
19288529|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
19288530|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288531|NCT04304196|Protective Agents|protective agents|mesh-ancestor
19288532|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288533|NCT04303741|Apatinib|apatinib|mesh-list
19288534|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671416|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19671417|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19671418|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
19671419|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671420|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19671421|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19671422|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
19671423|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19671424|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288535|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19288536|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288537|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288538|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19288539|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19288540|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19288541|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
19288542|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359778|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20359779|NCT00921531|Growth Substances|growth substances|mesh-ancestor
20359780|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
20359781|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359782|NCT00921570|Amlodipine|amlodipine|mesh-list
20359783|NCT00921570|Valsartan|valsartan|mesh-list
20359784|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19288543|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19288544|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19288545|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288546|NCT04304040|Antibodies|antibodies|mesh-list
19288547|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19288548|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
19288549|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288550|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
19288551|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288552|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288553|NCT04303845|Erenumab|erenumab|mesh-list
20359785|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20359786|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20359787|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359788|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20359789|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359790|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
20359791|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20359792|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20359793|NCT00921622|Vitamin D|vitamin d|mesh-list
20359794|NCT00921622|Vitamins|vitamins|mesh-list
20359795|NCT00921622|Ascorbic Acid|ascorbic acid|mesh-list
19288554|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19288555|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288556|NCT04303845|Analgesics|analgesics|mesh-ancestor
19288557|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
19288558|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288559|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288560|NCT04303988|Bevacizumab|bevacizumab|mesh-list
19288561|NCT04303988|Carboplatin|carboplatin|mesh-list
19288562|NCT04303988|Temozolomide|temozolomide|mesh-list
19288563|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288564|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359796|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
20359797|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359798|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20359799|NCT00921622|Antioxidants|antioxidants|mesh-ancestor
20359800|NCT00921622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359801|NCT00921622|Protective Agents|protective agents|mesh-ancestor
20359802|NCT00921661|Aflibercept|aflibercept|mesh-list
20359803|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19288565|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19288566|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19288567|NCT04303988|Growth Substances|growth substances|mesh-ancestor
19288568|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288569|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
19288570|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19288571|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
19288572|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394810|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19394811|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
19394812|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394813|NCT03672812|Liraglutide|liraglutide|mesh-list
19394814|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19671425|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19671426|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19671427|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20359804|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20359805|NCT00921661|Growth Substances|growth substances|mesh-ancestor
20359806|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359807|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
20359808|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359809|NCT00921674|Ivermectin|ivermectin|mesh-list
20359810|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20359811|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359812|NCT00921700|Acetaminophen|acetaminophen|mesh-list
20359813|NCT00921700|Ibuprofen|ibuprofen|mesh-list
20359814|NCT00921700|Codeine|codeine|mesh-list
20359815|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671428|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19671429|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20359816|NCT00921700|Analgesics|analgesics|mesh-ancestor
20359817|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
20359818|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359819|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359820|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
20359821|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20359822|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359823|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19288573|NCT04303819|Exenatide|exenatide|mesh-list
19288574|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19288575|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288576|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19288577|NCT04303819|Incretins|incretins|mesh-ancestor
19288578|NCT04303819|Hormones|hormones|mesh-ancestor
19288579|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288580|NCT04303767|Calcium|calcium|mesh-list
19288581|NCT04303767|Caseins|caseins|mesh-list
19288582|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19288583|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288584|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
19288585|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
19288586|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288587|NCT04304014|Sulfalene|sulfalene|mesh-list
19288588|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288589|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19288590|NCT04304014|Renal Agents|renal agents|mesh-ancestor
19288591|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
19288592|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19288593|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19288594|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
19288595|NCT04303520|Fludarabine|fludarabine|mesh-list
20359824|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20359825|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359826|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359827|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20359828|NCT00921700|Narcotics|narcotics|mesh-ancestor
20359829|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359830|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
20359831|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
20359832|NCT00921726|Oseltamivir|oseltamivir|mesh-list
20359833|NCT00921726|Zanamivir|zanamivir|mesh-list
20359834|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
20359835|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359836|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359837|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359838|NCT00921765|Ketamine|ketamine|mesh-list
20359839|NCT00921765|Naloxone|naloxone|mesh-list
20359840|NCT00921765|Analgesics|analgesics|mesh-ancestor
20359841|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
20359842|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359843|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359844|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20359845|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19288596|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288597|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
19288598|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288599|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19288600|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20359846|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
20359847|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
20359848|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288601|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
19288602|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288603|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288604|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19288605|NCT04303377|Evolocumab|evolocumab|mesh-list
19288606|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19288607|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19288608|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
20359849|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20359850|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20359851|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359852|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359853|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20359854|NCT00921804|Risperidone|risperidone|mesh-list
20359855|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20359856|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
20359857|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359858|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288609|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288610|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19288611|NCT04303312|Benzydamine|benzydamine|mesh-list
19288612|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288613|NCT04303494|Vaccines|vaccines|mesh-list
19288614|NCT04303494|Immunologic Factors|immunologic factors|mesh-ancestor
19288615|NCT04303494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288616|NCT04303403|Trametinib|trametinib|mesh-list
19288617|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288618|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19288619|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288620|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288621|NCT04303429|Capecitabine|capecitabine|mesh-list
19288622|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288623|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
19288624|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288625|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288626|NCT04303598|Tenofovir|tenofovir|mesh-list
19288627|NCT04303598|Lamivudine|lamivudine|mesh-list
19288628|NCT04303598|Efavirenz|efavirenz|mesh-list
19288629|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
19288630|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288631|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19288632|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19288633|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288634|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288635|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19288636|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19288637|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19288638|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19288639|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19288640|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19288641|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19288642|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19288643|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
19288644|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20359859|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359860|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20359861|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20359862|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359863|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20359864|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20359865|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
20359866|NCT00921830|Ibuprofen|ibuprofen|mesh-list
20359867|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20359868|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20359869|NCT00921830|Analgesics|analgesics|mesh-ancestor
20359870|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
20359871|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359872|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359873|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20359874|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359875|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20359876|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425288|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288645|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288646|NCT04303130|Endostar protein|endostar protein|mesh-list
19288647|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19288648|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19288649|NCT04303130|Growth Substances|growth substances|mesh-ancestor
19288650|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288651|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
19288652|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288653|NCT04303065|Dexamethasone|dexamethasone|mesh-list
19288654|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288655|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
19288656|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
19288657|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288658|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288659|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20359877|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359878|NCT00921973|Vaccines|vaccines|mesh-list
20359879|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
20359880|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359881|NCT00922129|Cyclosporine|cyclosporine|mesh-list
20359882|NCT00922129|Sirolimus|sirolimus|mesh-list
20359883|NCT00922129|Tacrolimus|tacrolimus|mesh-list
19288660|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
19288661|NCT04303065|Hormones|hormones|mesh-ancestor
19288662|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288663|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19288664|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288665|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
19288666|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19288667|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
19288668|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288669|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288670|NCT04302532|Ubiquinone|ubiquinone|mesh-list
20359884|NCT00922129|Cyclosporins|cyclosporins|mesh-list
20359885|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359886|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
20359887|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359888|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20359889|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359890|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359891|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
20359892|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359893|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
20359894|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20359895|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20359896|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20359897|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425289|NCT01274195|Busulfan|busulfan|mesh-list
20425290|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
20425291|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425292|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288671|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
19288672|NCT04302532|Clomiphene|clomiphene|mesh-list
19288673|NCT04302532|Enclomiphene|enclomiphene|mesh-list
20425293|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
20425294|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288674|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
19288675|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19288676|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
19288677|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288678|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288679|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19288680|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
19288681|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288682|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19288683|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19838235|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838236|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838237|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
19838238|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288684|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
19288685|NCT04302532|Vitamins|vitamins|mesh-ancestor
19288686|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
19288687|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19288688|NCT04302402|Rifaximin|rifaximin|mesh-list
19288689|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19288690|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288691|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838239|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
20425295|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19288692|NCT04302441|Capecitabine|capecitabine|mesh-list
20359898|NCT00922389|Lenograstim|lenograstim|mesh-list
20359899|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20359900|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
19288693|NCT04302441|Vinorelbine|vinorelbine|mesh-list
19288694|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288695|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
19288696|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288697|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288698|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288699|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
19288700|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19288701|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
19288702|NCT04302675|Vaccines|vaccines|mesh-list
19288703|NCT04302675|Immunologic Factors|immunologic factors|mesh-ancestor
19288704|NCT04302675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288705|NCT04302584|Vasopressins|vasopressins|mesh-list
19288706|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
19288707|NCT04302584|Norepinephrine|norepinephrine|mesh-list
19288708|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19288709|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19288710|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
19288711|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288712|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288713|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288714|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
19288715|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
19288716|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288717|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19288718|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
19288719|NCT04302584|Coagulants|coagulants|mesh-ancestor
19288720|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19288721|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
19288722|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
20359901|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359902|NCT00922402|Insulin|insulin|mesh-list
20359903|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20359904|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359905|NCT00922467|Esmolol|esmolol|mesh-list
20359906|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19288723|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19288724|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
19288725|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
19288726|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288727|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671430|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19671431|NCT05094154|Penicillins|penicillins|mesh-list
19671432|NCT05094154|Cephalosporins|cephalosporins|mesh-list
19671433|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671434|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671435|NCT05084534|Midodrine|midodrine|mesh-list
19671436|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
19671437|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
19671438|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671439|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671440|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19671441|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19671442|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19671443|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19671444|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
19671445|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671446|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671447|NCT05081219|Insulin|insulin|mesh-list
19671448|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19671449|NCT05081219|Empagliflozin|empagliflozin|mesh-list
19671450|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19671451|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671452|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19671453|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671454|NCT05038475|Antibodies|antibodies|mesh-list
19288728|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20359907|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19671455|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
19671456|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671457|NCT05025163|Fluorides|fluorides|mesh-list
20359908|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19288729|NCT04302350|Analgesics|analgesics|mesh-ancestor
20181896|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181897|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20181898|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181899|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181900|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181901|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181902|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181903|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181904|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181905|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181906|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181907|NCT00191061|Analgesics|analgesics|mesh-ancestor
20181908|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
20181909|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181910|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181911|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181912|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
20181913|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181914|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181915|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181916|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181917|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181918|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181919|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181920|NCT00191087|Analgesics|analgesics|mesh-ancestor
20181921|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
20181922|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181923|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181924|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181925|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
20181926|NCT00191126|Gemcitabine|gemcitabine|mesh-list
20181927|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181928|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181929|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
20181930|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181931|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
20181932|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181933|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181934|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181935|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
20181936|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181937|NCT00191178|Insulin|insulin|mesh-list
20181938|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20181939|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
20181940|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
20181941|NCT00191178|Protamines|protamines|mesh-list
20181942|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20181943|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181944|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
20181945|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181946|NCT00191178|Coagulants|coagulants|mesh-ancestor
20181947|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20181948|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20181949|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20181950|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20181951|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181952|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20181953|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181954|NCT00191204|Analgesics|analgesics|mesh-ancestor
20181955|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
20181956|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181957|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
20181958|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20181959|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
20181960|NCT00191230|Gemcitabine|gemcitabine|mesh-list
20181961|NCT00191230|Carboplatin|carboplatin|mesh-list
20181962|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181963|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181964|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
20181965|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181966|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
20359909|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
20359910|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359911|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359912|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359913|NCT00922506|Doxazosin|doxazosin|mesh-list
20359914|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19288730|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
19288731|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288732|NCT04302116|Prednisolone|prednisolone|mesh-list
19288733|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19288734|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
19288735|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19288736|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
19288737|NCT04302116|Vigabatrin|vigabatrin|mesh-list
19288738|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19288739|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
19288740|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288741|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
20359915|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20359916|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20359917|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
20359918|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359919|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359920|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359921|NCT00922506|Urological Agents|urological agents|mesh-ancestor
19288742|NCT04302116|Hormones|hormones|mesh-ancestor
19288743|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288744|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288745|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19288746|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359922|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20359923|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20359924|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20359925|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20359926|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
20359927|NCT00922519|Listerine|listerine|mesh-list
20359928|NCT00922519|Fluorides|fluorides|mesh-list
20359929|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
20359930|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
19288747|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
19288748|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
19288749|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288750|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19288751|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19288752|NCT04302116|Protective Agents|protective agents|mesh-ancestor
19288753|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
19288754|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288755|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288756|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
19288757|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288758|NCT04301908|Interferons|interferons|mesh-list
19288759|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288760|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
19288761|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288762|NCT04302181|Ropivacaine|ropivacaine|mesh-list
19288763|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
19288764|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
19288765|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288766|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288767|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
19288768|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288769|NCT04301895|Remifentanil|remifentanil|mesh-list
19288770|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19288771|NCT04301895|Narcotics|narcotics|mesh-ancestor
19288772|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359931|NCT00922519|Protective Agents|protective agents|mesh-ancestor
19288773|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288774|NCT04301895|Analgesics|analgesics|mesh-ancestor
19288775|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
19671458|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
19671459|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
19671460|NCT05025163|Protective Agents|protective agents|mesh-ancestor
19671461|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671462|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19671463|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19692146|NCT04996498|Oxytocin|oxytocin|mesh-list
20359932|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359933|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20359934|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288776|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288777|NCT04301882|Interferons|interferons|mesh-list
19288778|NCT04301882|Ribavirin|ribavirin|mesh-list
19288779|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
19288780|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288781|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288782|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
19288783|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288784|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19288785|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359935|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
20359936|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20359937|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
20359938|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359939|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359940|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20359941|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
20359942|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20359943|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
19288786|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
19288787|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19288788|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19288789|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19288790|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288791|NCT04301492|Vortioxetine|vortioxetine|mesh-list
19288792|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
19288793|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19288794|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19288795|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19288796|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288797|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288798|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19288799|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19288800|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19288801|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288802|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288803|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
19288804|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19288805|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19288806|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19288807|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19394815|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394816|NCT03672812|Incretins|incretins|mesh-ancestor
19394817|NCT03672812|Hormones|hormones|mesh-ancestor
19394818|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394819|NCT03672539|Cytarabine|cytarabine|mesh-list
19394820|NCT03672539|Daunorubicin|daunorubicin|mesh-list
19394821|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
19394822|NCT03672539|Calicheamicins|calicheamicins|mesh-list
19394823|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19394824|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
19394825|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394826|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394827|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
19394828|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394829|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359944|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359945|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20359946|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20359947|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
20359948|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
20359949|NCT00922532|Protective Agents|protective agents|mesh-ancestor
20359950|NCT00922584|Sorafenib|sorafenib|mesh-list
20359951|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359952|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20359953|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359954|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359955|NCT00922597|Factor VIII|factor viii|mesh-list
20359956|NCT00922597|Coagulants|coagulants|mesh-ancestor
19394830|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
20359957|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
20359958|NCT00922610|Hematinics|hematinics|mesh-ancestor
19288808|NCT04301661|Tenofovir|tenofovir|mesh-list
19288809|NCT04301661|Lamivudine|lamivudine|mesh-list
19288810|NCT04301661|Emtricitabine|emtricitabine|mesh-list
19288811|NCT04301661|Abacavir|abacavir|mesh-list
19288812|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
19288813|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288814|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19288815|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19288816|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359959|NCT00922649|Insulin|insulin|mesh-list
20359960|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20359961|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359962|NCT00922844|Sevoflurane|sevoflurane|mesh-list
20359963|NCT00922844|Isoflurane|isoflurane|mesh-list
20359964|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20359965|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20359966|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
20359967|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
20359968|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20359969|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359970|NCT00922896|Gemcitabine|gemcitabine|mesh-list
20359971|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20359972|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359973|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20359974|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
20359975|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359976|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
20359977|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20359978|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20359979|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20359980|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
20359981|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359982|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20359983|NCT00923000|Morphine|morphine|mesh-list
20359984|NCT00923000|Nalbuphine|nalbuphine|mesh-list
20359985|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20359986|NCT00923000|Narcotics|narcotics|mesh-ancestor
20359987|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288817|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288818|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19288819|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19288820|NCT04301739|Paclitaxel|paclitaxel|mesh-list
19288821|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
19288822|NCT04301739|Carboplatin|carboplatin|mesh-list
20359988|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20359989|NCT00923000|Analgesics|analgesics|mesh-ancestor
20359990|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
20359991|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20359992|NCT00923169|Mitogens|mitogens|mesh-list
20359993|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
20359994|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20359995|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
20359996|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20359997|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20359998|NCT00923234|Lenalidomide|lenalidomide|mesh-list
20359999|NCT00923234|Azacitidine|azacitidine|mesh-list
20360000|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
20360001|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360002|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20360003|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20360004|NCT00923234|Growth Substances|growth substances|mesh-ancestor
20360005|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
20360006|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360007|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20360008|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
19288823|NCT04301739|Doxorubicin|doxorubicin|mesh-list
19288824|NCT04301739|Epirubicin|epirubicin|mesh-list
19288825|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288826|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612559|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360009|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360010|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360011|NCT00923247|Bortezomib|bortezomib|mesh-list
20360012|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288827|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
19288828|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
20360013|NCT00923299|Trastuzumab|trastuzumab|mesh-list
20360014|NCT00923299|Cetuximab|cetuximab|mesh-list
20360015|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20360016|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360017|NCT00923390|Aldesleukin|aldesleukin|mesh-list
19288829|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
19288830|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288831|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288832|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
19288833|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288834|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19288835|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19288836|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
19288837|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19288838|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19288839|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19288840|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19288841|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288842|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
19288843|NCT04301583|Procyanidin|procyanidin|mesh-list
19288844|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
19288845|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288846|NCT04301583|Protective Agents|protective agents|mesh-ancestor
19288847|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288848|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19288849|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19288850|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288851|NCT04301557|Capecitabine|capecitabine|mesh-list
19288852|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
19288853|NCT04301557|Antibodies|antibodies|mesh-list
19288854|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
19288855|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288856|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19288857|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
19288858|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288859|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288860|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
19288861|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19288862|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19288863|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19288864|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288865|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
19288866|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19288867|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288868|NCT04301349|Misoprostol|misoprostol|mesh-list
19288869|NCT04301349|Dinoprostone|dinoprostone|mesh-list
20181967|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181968|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181969|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181970|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
20181971|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288870|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19288871|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
19288872|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288873|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288874|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19288875|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19288876|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
19288877|NCT04301336|Zinc|zinc|mesh-list
19288878|NCT04301336|Folic Acid|folic acid|mesh-list
19288879|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
19288880|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
19288881|NCT04301336|Morphine|morphine|mesh-list
19288882|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
19288883|NCT04301336|Simvastatin|simvastatin|mesh-list
19288884|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19288885|NCT04301336|Narcotics|narcotics|mesh-ancestor
19288886|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288887|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181972|NCT00191243|Gemcitabine|gemcitabine|mesh-list
20181973|NCT00191243|Docetaxel|docetaxel|mesh-list
20181974|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181975|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
20360018|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
20360019|NCT00923390|Fludarabine|fludarabine|mesh-list
19288888|NCT04301336|Analgesics|analgesics|mesh-ancestor
19288889|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
19288890|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20181976|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288891|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19288892|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19288893|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
19288894|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288895|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19288896|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19288897|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288898|NCT04301336|Trace Elements|trace elements|mesh-ancestor
19288899|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
19288900|NCT04301336|Hematinics|hematinics|mesh-ancestor
19288901|NCT04301336|Vitamins|vitamins|mesh-ancestor
19288902|NCT04301336|Astringents|astringents|mesh-ancestor
19288903|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
19288904|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288905|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
19288906|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19288907|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
19288908|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19288909|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
19288910|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
19288911|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288912|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288913|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19288914|NCT04301024|Analgesics|analgesics|mesh-ancestor
19288915|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
19288916|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288917|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19288918|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19288919|NCT04300959|Gemcitabine|gemcitabine|mesh-list
19288920|NCT04300959|Cisplatin|cisplatin|mesh-list
19288921|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288922|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20360020|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360021|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
20360022|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360023|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360024|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20360025|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
20360026|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288923|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
19288924|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288925|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
19288926|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19288927|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19288928|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19288929|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
19288930|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288931|NCT04301375|Paclitaxel|paclitaxel|mesh-list
19288932|NCT04301375|Trastuzumab|trastuzumab|mesh-list
19288933|NCT04301375|Pertuzumab|pertuzumab|mesh-list
19288934|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19288935|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19288936|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
19288937|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
19288938|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
19288939|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19288940|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19288941|NCT04300686|Adalimumab|adalimumab|mesh-list
19288942|NCT04300686|Antibodies|antibodies|mesh-list
19288943|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
19288944|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
19288945|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288946|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19288947|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20181977|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181978|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
20181979|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20181980|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20181981|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20181982|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
20181983|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20181984|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
20181985|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181986|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19288948|NCT04300881|Eplerenone|eplerenone|mesh-list
19288949|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20181987|NCT00191256|Gemcitabine|gemcitabine|mesh-list
19288950|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
19288951|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288952|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288953|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19288954|NCT04300881|Diuretics|diuretics|mesh-ancestor
19288955|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
19288956|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19288957|NCT04300452|Carbetocin|carbetocin|mesh-list
19288958|NCT04300452|Ergonovine|ergonovine|mesh-list
19288959|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
19288960|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19288961|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288962|NCT04300374|Anesthetics|anesthetics|mesh-list
19288963|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288964|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288965|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
19288966|NCT04300751|Narcotics|narcotics|mesh-ancestor
19288967|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288968|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288969|NCT04300751|Analgesics|analgesics|mesh-ancestor
19288970|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
19288971|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288972|NCT04300322|Progesterone|progesterone|mesh-list
19288973|NCT04300322|Progestins|progestins|mesh-ancestor
19288974|NCT04300322|Hormones|hormones|mesh-ancestor
19288975|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288976|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288977|NCT04300192|Vaccines|vaccines|mesh-list
19288978|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
19288979|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288980|NCT04300231|Hydromorphone|hydromorphone|mesh-list
19288981|NCT04300231|Bupivacaine|bupivacaine|mesh-list
19288982|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
19288983|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
19288984|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19288985|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288986|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
19288987|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19288988|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19288989|NCT04300231|Narcotics|narcotics|mesh-ancestor
20360027|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360028|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20360029|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20360030|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20360031|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
20360032|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360033|NCT00923494|Ropivacaine|ropivacaine|mesh-list
20360034|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
20360035|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
20360036|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360037|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360038|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
19288990|NCT04300231|Analgesics|analgesics|mesh-ancestor
19288991|NCT04300049|Glucagon|glucagon|mesh-list
19288992|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19288993|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19288994|NCT04300049|Hormones|hormones|mesh-ancestor
19288995|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19288996|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19288997|NCT04300049|Incretins|incretins|mesh-ancestor
19288998|NCT04299971|Methotrexate|methotrexate|mesh-list
19288999|NCT04299971|Tofacitinib|tofacitinib|mesh-list
19289000|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19289001|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
19289002|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19289003|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360039|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360040|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20360041|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20360042|NCT00923533|Diuretics|diuretics|mesh-ancestor
20360043|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
20360044|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289004|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289005|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
19289006|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360045|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19289007|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289008|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
19289009|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289010|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19289011|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289012|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
19289013|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19289014|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19289015|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19394831|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394832|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19394833|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19394834|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19394835|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394836|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20360046|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360047|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360048|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20360049|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20360050|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360051|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
20360052|NCT00923637|Pemetrexed|pemetrexed|mesh-list
20360053|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360054|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360055|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360056|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20360057|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20360058|NCT00923663|Lenalidomide|lenalidomide|mesh-list
20360059|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
20360060|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394837|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
19394838|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
19394839|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
19394840|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19394841|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394842|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
19394843|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394844|NCT03672357|Liver Extracts|liver extracts|mesh-list
19394845|NCT03672357|Hematinics|hematinics|mesh-ancestor
19394846|NCT03672149|Cefazolin|cefazolin|mesh-list
19394847|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19394848|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394849|NCT03672071|Ephedrine|ephedrine|mesh-list
19394850|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
19394851|NCT03672071|Norepinephrine|norepinephrine|mesh-list
19394852|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19394853|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394854|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
19394855|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
19394856|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394857|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19394858|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
19394859|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394860|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394861|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19394862|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19394863|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
19394864|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
19394865|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20181988|NCT00191256|Paclitaxel|paclitaxel|mesh-list
20181989|NCT00191256|Carboplatin|carboplatin|mesh-list
20181990|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20181991|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20181992|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
20181993|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
20181994|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
20181995|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20181996|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20181997|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
20181998|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
20181999|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394866|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19394867|NCT03672045|Carbetocin|carbetocin|mesh-list
20182000|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217230|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
19289016|NCT04299633|Calcium|calcium|mesh-list
19289017|NCT04299633|Sevelamer|sevelamer|mesh-list
19289018|NCT04299633|Calcium acetate|calcium acetate|mesh-list
19289019|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19289020|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289021|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
19289022|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
19289023|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289024|NCT04299854|Dinoprostone|dinoprostone|mesh-list
19289025|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
19289026|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19289027|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289028|NCT04298775|Morphine|morphine|mesh-list
19289029|NCT04298775|Anesthetics|anesthetics|mesh-list
19289030|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289031|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289032|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20360061|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20360062|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20360063|NCT00923663|Growth Substances|growth substances|mesh-ancestor
19289033|NCT04298775|Narcotics|narcotics|mesh-ancestor
19289034|NCT04298775|Analgesics|analgesics|mesh-ancestor
19289035|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
19289036|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289037|NCT04298528|Dronabinol|dronabinol|mesh-list
19289038|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
20612560|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612561|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19289039|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360064|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
19289040|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19289041|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289042|NCT04298528|Analgesics|analgesics|mesh-ancestor
19289043|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
20360065|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360066|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20360067|NCT00923676|Fenofibrate|fenofibrate|mesh-list
20360068|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20360069|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19289044|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289045|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19289046|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19289047|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289048|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289049|NCT04298528|Hormones|hormones|mesh-ancestor
19289050|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289051|NCT04298684|Metformin|metformin|mesh-list
19289052|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19289053|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19289054|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289055|NCT04298684|Incretins|incretins|mesh-ancestor
19289056|NCT04298684|Hormones|hormones|mesh-ancestor
19289057|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289058|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19289059|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
19289060|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289061|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289062|NCT04298372|Lenalidomide|lenalidomide|mesh-list
19289063|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
19289064|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289065|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19289066|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19289067|NCT04298372|Growth Substances|growth substances|mesh-ancestor
19289068|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
19289069|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289070|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19289071|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19289072|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19289073|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289074|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360070|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
19289075|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
19289076|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289077|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19289078|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20360071|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360072|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20360073|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20360074|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360075|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
20360076|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360077|NCT00923806|Aldesleukin|aldesleukin|mesh-list
20360078|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360079|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20360080|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20360081|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
20360082|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360083|NCT00923962|Adenosine|adenosine|mesh-list
20360084|NCT00923962|Glucagon|glucagon|mesh-list
20360085|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19289079|NCT04298021|Durvalumab|durvalumab|mesh-list
19289080|NCT04298021|Olaparib|olaparib|mesh-list
19289081|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19289082|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289083|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19289084|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289085|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612562|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
20612563|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20182001|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182002|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
20182003|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289086|NCT04298008|Durvalumab|durvalumab|mesh-list
19289087|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19289088|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289089|NCT04297839|Heparin|heparin|mesh-list
19289090|NCT04297839|Calcium heparin|calcium heparin|mesh-list
19289091|NCT04297839|Citric Acid|citric acid|mesh-list
19289092|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
19289093|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
19289094|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19289095|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
19289096|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
19289097|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182004|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20182005|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20182006|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182007|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360086|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20360087|NCT00923962|Hormones|hormones|mesh-ancestor
20360088|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360089|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360090|NCT00923962|Incretins|incretins|mesh-ancestor
20360091|NCT00923962|Analgesics|analgesics|mesh-ancestor
20360092|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
20360093|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360094|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20360095|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
20360096|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20360097|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
20360098|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
20360099|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360100|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360101|NCT00924014|Furosemide|furosemide|mesh-list
20360102|NCT00924014|Conivaptan|conivaptan|mesh-list
20360103|NCT00924014|Diuretics|diuretics|mesh-ancestor
19289098|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19289099|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20182008|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182009|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
20182010|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182011|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182012|NCT00191321|Teriparatide|teriparatide|mesh-list
19394868|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
19394869|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19394870|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394871|NCT03671941|Ticagrelor|ticagrelor|mesh-list
19394872|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20360104|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
20360105|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360106|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20360107|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360108|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360109|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20360110|NCT00924079|Nalbuphine|nalbuphine|mesh-list
20360111|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20360112|NCT00924079|Narcotics|narcotics|mesh-ancestor
20360113|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360114|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360115|NCT00924079|Analgesics|analgesics|mesh-ancestor
20360116|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
20360117|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360118|NCT00924222|Propofol|propofol|mesh-list
20360119|NCT00924222|Sevoflurane|sevoflurane|mesh-list
20360120|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20360121|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360122|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360123|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20360124|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
20360125|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
20360126|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20360127|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20360128|NCT00924430|Simvastatin|simvastatin|mesh-list
20360129|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20360130|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19289100|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
19289101|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19289102|NCT04297215|Chitosan|chitosan|mesh-list
19289103|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19289104|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19289105|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
19289106|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289107|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19289108|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
19289109|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
19289110|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
19289111|NCT04297215|Coagulants|coagulants|mesh-ancestor
19289112|NCT04297202|Apatinib|apatinib|mesh-list
19289113|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289114|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19289115|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289116|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289117|NCT04297176|Vancomycin|vancomycin|mesh-list
19289118|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289119|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289120|NCT04297254|Lenvatinib|lenvatinib|mesh-list
19289121|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289122|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19289123|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289124|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289125|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19289126|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
19289127|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289128|NCT04297462|Oseltamivir|oseltamivir|mesh-list
19289129|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
19289130|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289131|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289132|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182013|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20182014|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182015|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20182016|NCT00191347|Gemcitabine|gemcitabine|mesh-list
20182017|NCT00191347|Pemetrexed|pemetrexed|mesh-list
20182018|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182019|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
20182020|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182021|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182022|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
20182023|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182024|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182025|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182026|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
19692147|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
20182027|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360131|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
20360132|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360133|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20360134|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20360135|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289133|NCT04297267|Gemcitabine|gemcitabine|mesh-list
19289134|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289135|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289136|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
19289137|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289138|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
19289139|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289140|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289141|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289142|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
19289143|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289144|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
19289145|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19289146|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
19289147|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19289148|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
19289149|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289150|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289151|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
19289152|NCT04297033|Lovastatin|lovastatin|mesh-list
19289153|NCT04297033|L 647318|l 647318|mesh-list
19289154|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
19289155|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19289156|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19289157|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
19289158|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289159|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19289160|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19289161|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289162|NCT04296851|Niclosamide|niclosamide|mesh-list
19289163|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
19289164|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19289165|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
19289166|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19289167|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289168|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
20182028|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20182029|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20217231|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217232|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20217233|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289169|NCT04296422|Ibuprofen|ibuprofen|mesh-list
19289170|NCT04296422|Diclofenac|diclofenac|mesh-list
19289171|NCT04296422|Naproxen|naproxen|mesh-list
19289172|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19289173|NCT04296422|Piroxicam|piroxicam|mesh-list
19289174|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
19289175|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
19289176|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289177|NCT04296422|Analgesics|analgesics|mesh-ancestor
19289178|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
19289179|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289180|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289181|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289182|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19289183|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19289184|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217234|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217235|NCT00309101|Tacrolimus|tacrolimus|mesh-list
20217236|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217237|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
20217238|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217239|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20217240|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217241|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217242|NCT00309192|Triamcinolone|triamcinolone|mesh-list
20217243|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19289185|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289186|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
19289187|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19289188|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19289189|NCT04296578|Selenious Acid|selenious acid|mesh-list
19289190|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
19289191|NCT04296578|Prednisone|prednisone|mesh-list
20360136|NCT00924573|Metformin|metformin|mesh-list
20360137|NCT00924573|Glimepiride|glimepiride|mesh-list
20360138|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360139|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360140|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20360141|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360142|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
20360143|NCT00924586|Landiolol|landiolol|mesh-list
20360144|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20360145|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20360146|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360147|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360148|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360149|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360150|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20425296|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425297|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20425298|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20425299|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20425300|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289192|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
19289193|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289194|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
19289195|NCT04296578|Hormones|hormones|mesh-ancestor
19289196|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289197|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289198|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19289199|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289200|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19289201|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289202|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289203|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
19289204|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19289205|NCT04296578|Trace Elements|trace elements|mesh-ancestor
19289206|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
19289207|NCT04296695|Tenofovir|tenofovir|mesh-list
19289208|NCT04296695|Efavirenz|efavirenz|mesh-list
19289209|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
19289210|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289211|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19289212|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19289213|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289214|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289215|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19289216|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19289217|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19289218|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19289219|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19289220|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19289221|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19289222|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19289223|NCT04296214|Azacitidine|azacitidine|mesh-list
19289224|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289225|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
20182030|NCT00191373|Gemcitabine|gemcitabine|mesh-list
20182031|NCT00191373|Trastuzumab|trastuzumab|mesh-list
20182032|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182033|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
20182034|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182035|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182036|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
20182037|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182038|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182039|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182040|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
20182041|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182042|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182043|NCT00191399|Olanzapine|olanzapine|mesh-list
20182044|NCT00191399|Fluoxetine|fluoxetine|mesh-list
20182045|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
20360151|NCT00924742|Tazobactam|tazobactam|mesh-list
20360152|NCT00924742|Piperacillin|piperacillin|mesh-list
20360153|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360154|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289226|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289227|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289228|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289229|NCT04296240|Capecitabine|capecitabine|mesh-list
19289230|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
19289231|NCT04296240|Antiemetics|antiemetics|mesh-list
20360155|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20360156|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360157|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360158|NCT00924755|Caffeine|caffeine|mesh-list
20360159|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19289232|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289233|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
19289234|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289235|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289236|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
19289237|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289238|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289239|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19289240|NCT04296370|Apatinib|apatinib|mesh-list
20360160|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360161|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20360162|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360163|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360164|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20360165|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20360166|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
20360167|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360168|NCT00924963|Lidocaine|lidocaine|mesh-list
20360169|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
20360170|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
20360171|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360172|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289241|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289242|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19289243|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289244|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289245|NCT04296383|Azithromycin|azithromycin|mesh-list
19289246|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289247|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289248|NCT04296175|Paclitaxel|paclitaxel|mesh-list
20360173|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
20360174|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360175|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19289249|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19289250|NCT04296175|Carboplatin|carboplatin|mesh-list
19289251|NCT04296175|Epirubicin|epirubicin|mesh-list
19289252|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19289253|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289254|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
19289255|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
19289256|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
19289257|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289258|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671464|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182046|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
20182047|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182048|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182049|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20182050|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20182051|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20182052|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20182053|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20182054|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20182055|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182056|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360176|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20360177|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19289259|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19289260|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19289261|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289262|NCT04296162|Capecitabine|capecitabine|mesh-list
19289263|NCT04296162|Trastuzumab|trastuzumab|mesh-list
19289264|NCT04296162|Vinorelbine|vinorelbine|mesh-list
19289265|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289266|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
19289267|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289268|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289269|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19289270|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19289271|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
19289272|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
20360178|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360179|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360180|NCT00925028|Warfarin|warfarin|mesh-list
20360181|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
20360182|NCT00925093|Vancomycin|vancomycin|mesh-list
20360183|NCT00925093|Linezolid|linezolid|mesh-list
20360184|NCT00925093|Teicoplanin|teicoplanin|mesh-list
20360185|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360186|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360187|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20360188|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360189|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360190|NCT00925106|Celecoxib|celecoxib|mesh-list
20360191|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20360192|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289273|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
19289274|NCT04295993|Norepinephrine|norepinephrine|mesh-list
19289275|NCT04295993|Methylene Blue|methylene blue|mesh-list
19289276|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19289277|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19289278|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
19289279|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289280|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289281|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289282|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
19289283|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
19289284|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289285|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19289286|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289287|NCT04295850|Aspirin|aspirin|mesh-list
19289288|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19289289|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289290|NCT04295850|Analgesics|analgesics|mesh-ancestor
19289291|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
19289292|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289293|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289294|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289295|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19289296|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19289297|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19289298|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289299|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20182057|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360193|NCT00925106|Analgesics|analgesics|mesh-ancestor
20182058|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182059|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
20182060|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20182061|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
20182062|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20182063|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20182064|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182065|NCT00191412|Pemetrexed|pemetrexed|mesh-list
20182066|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182067|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182068|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182069|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20182070|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182071|NCT00191425|Teriparatide|teriparatide|mesh-list
20182072|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20360194|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
19289300|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19289301|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289302|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
19289303|NCT04295967|Formaldehyde|formaldehyde|mesh-list
19289304|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
19289305|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289306|NCT04296149|Octreotide|octreotide|mesh-list
19289307|NCT04296149|Edotreotide|edotreotide|mesh-list
19289308|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19289309|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19289310|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289311|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19289312|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289313|NCT04295408|Ropivacaine|ropivacaine|mesh-list
19289314|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
19289315|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
19289316|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289317|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182073|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20182074|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182075|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20182076|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20182077|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
20182078|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20182079|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20182080|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20182081|NCT00191438|Gemcitabine|gemcitabine|mesh-list
20182082|NCT00191438|Capecitabine|capecitabine|mesh-list
20182083|NCT00191438|Docetaxel|docetaxel|mesh-list
20360195|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289318|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
19289319|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289320|NCT04295317|Capecitabine|capecitabine|mesh-list
19289321|NCT04295317|Antibodies|antibodies|mesh-list
19289322|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
19289323|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
19289324|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289325|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289326|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
19289327|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289328|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394873|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19394874|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19394875|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19394876|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
19394877|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394878|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394879|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394880|NCT03671915|Insulin|insulin|mesh-list
19394881|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19394882|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394883|NCT03671811|Megestrol|megestrol|mesh-list
19394884|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
19394885|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19394886|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19394887|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19394888|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
19394889|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19394890|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394891|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19394892|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19394893|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19394894|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394895|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
20360196|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360197|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20360198|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394896|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20182084|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182085|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
20182086|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182087|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360199|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19289329|NCT04295551|Ritonavir|ritonavir|mesh-list
19289330|NCT04295551|Lopinavir|lopinavir|mesh-list
19289331|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19289332|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19289333|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
19289334|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289335|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289336|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19289337|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19289338|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
19289339|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289340|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19289341|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19289342|NCT04295330|Lidocaine|lidocaine|mesh-list
20182088|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
20182089|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289343|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
19289344|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
19289345|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289346|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289347|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
19289348|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289349|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19289350|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19289351|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19289352|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19289353|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289354|NCT04295629|Anesthetics|anesthetics|mesh-list
19289355|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289356|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289357|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
19289358|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289359|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19289360|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289361|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289362|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
19289363|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289364|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289365|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19289366|NCT04294784|Paclitaxel|paclitaxel|mesh-list
19289367|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19289368|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19289369|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19289370|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289371|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
19671465|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19671466|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182090|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182091|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182092|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
20182093|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182094|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182095|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182096|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182097|NCT00191464|Insulin|insulin|mesh-list
20182098|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20182099|NCT00191464|Metformin|metformin|mesh-list
20182100|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
20182101|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
20182102|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20182103|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182104|NCT00191490|Gemcitabine|gemcitabine|mesh-list
20182105|NCT00191490|Docetaxel|docetaxel|mesh-list
20182106|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182107|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182108|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
20182109|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182110|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
20182111|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182112|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182113|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182114|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
20182115|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289372|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
20360200|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20360201|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360202|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360203|NCT00925314|Vaccines|vaccines|mesh-list
20360204|NCT00925314|Immunologic Factors|immunologic factors|mesh-ancestor
20360205|NCT00925314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360206|NCT00925327|Riboflavin|riboflavin|mesh-list
20360207|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
20360208|NCT00925327|Vitamins|vitamins|mesh-ancestor
20360209|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
20360210|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360211|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20360212|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
20360213|NCT00925392|Doripenem|doripenem|mesh-list
20360214|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360215|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360216|NCT00925457|Domperidone|domperidone|mesh-list
20360217|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20360218|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360219|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360220|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
20360221|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
20360222|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360223|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360224|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20360225|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20360226|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
20360227|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360228|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
20360229|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20360230|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20360231|NCT00925730|Analgesics|analgesics|mesh-ancestor
20360232|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
20360233|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360234|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360235|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20360236|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360237|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
20360238|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289373|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
19289374|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289375|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19289376|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289377|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289378|NCT04294823|Esomeprazole|esomeprazole|mesh-list
19289379|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19289380|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19289381|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19289382|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289383|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289384|NCT04294836|Curcumin|curcumin|mesh-list
19289385|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19289386|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289387|NCT04294836|Analgesics|analgesics|mesh-ancestor
19289388|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
20182116|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182117|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182118|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
19671467|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671468|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671469|NCT05018013|Analgesics|analgesics|mesh-ancestor
19671470|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
19671471|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182119|NCT00191503|Gemcitabine|gemcitabine|mesh-list
20182120|NCT00191503|Pemetrexed|pemetrexed|mesh-list
20182121|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182122|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
19671472|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
19671473|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19671474|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
19692148|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20182123|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360239|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
19838240|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360240|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20182124|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182125|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
20182126|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182127|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182128|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182129|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
19289389|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289390|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289391|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289392|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19289393|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289394|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289395|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289396|NCT04294966|Dronabinol|dronabinol|mesh-list
19289397|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
19289398|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289399|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19289400|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289401|NCT04294966|Analgesics|analgesics|mesh-ancestor
19289402|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
19289403|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289404|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19289405|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19289406|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289407|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289408|NCT04294966|Hormones|hormones|mesh-ancestor
19289409|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289410|NCT04294732|Bupivacaine|bupivacaine|mesh-list
19289411|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
19289412|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
19289413|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289414|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289415|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
19289416|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289417|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19289418|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19289419|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19289420|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19289421|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289422|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289423|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289424|NCT04294953|Analgesics|analgesics|mesh-ancestor
19289425|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
19289426|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289427|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
19289428|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19289429|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
19289430|NCT04294992|Ondansetron|ondansetron|mesh-list
19289431|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
19289432|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
19289433|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289434|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289435|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19289436|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
19289437|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
19289438|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19289439|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
19289440|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360241|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360242|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360243|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
20360244|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
20360245|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360246|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360247|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289441|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289442|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20182130|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182131|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20182132|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182133|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20182134|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19289443|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19289444|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289445|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19289446|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20360248|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
20360249|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20360250|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289447|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19289448|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289449|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289450|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
19289451|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19289452|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360251|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360252|NCT00925873|Vidarabine|vidarabine|mesh-list
20360253|NCT00925873|Fludarabine|fludarabine|mesh-list
20360254|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
20360255|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360256|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20360257|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
20360258|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360259|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360260|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
20360261|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360262|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
20360263|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360264|NCT00925912|Bupivacaine|bupivacaine|mesh-list
20360265|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
20360266|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
20360267|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360268|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289453|NCT04294537|Anesthetics|anesthetics|mesh-list
19289454|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289455|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289456|NCT04294329|Bupivacaine|bupivacaine|mesh-list
19289457|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19289458|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
19289459|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289460|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289461|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
19289462|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360269|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
19289463|NCT04294056|Propofol|propofol|mesh-list
19289464|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19289465|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289466|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289467|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19289468|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
19289469|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
19289470|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
19289471|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19289472|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
19289473|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289474|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671475|NCT04872582|Bevacizumab|bevacizumab|mesh-list
19671476|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19671477|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19671478|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671479|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20182135|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182136|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182137|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182138|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
20182139|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182140|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182141|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20182142|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20182143|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182144|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182145|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182146|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360270|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360271|NCT00925951|Acetaminophen|acetaminophen|mesh-list
20360272|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20360273|NCT00925951|Analgesics|analgesics|mesh-ancestor
20360274|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
20360275|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360276|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360277|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
20360278|NCT00925977|Insulin|insulin|mesh-list
20360279|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20360280|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
20360281|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
20360282|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
20360283|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
20360284|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
19289475|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289476|NCT04293809|Bupivacaine|bupivacaine|mesh-list
19289477|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
19671480|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20182147|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182148|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182149|NCT00191555|Haloperidol|haloperidol|mesh-list
20182150|NCT00191555|Olanzapine|olanzapine|mesh-list
20182151|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
20182152|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
20182153|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
20182154|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182155|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182156|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20182157|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20182158|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20182159|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20182160|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360285|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360286|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289478|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
19289479|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289480|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289481|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
19289482|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289483|NCT04293822|Cetirizine|cetirizine|mesh-list
20360287|NCT00926016|Pioglitazone|pioglitazone|mesh-list
20360288|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360289|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360290|NCT00926055|Simvastatin|simvastatin|mesh-list
20360291|NCT00926055|Ezetimibe|ezetimibe|mesh-list
20360292|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20360293|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20360294|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20360295|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
20360296|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360297|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20360298|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20360299|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360300|NCT00926107|Sirolimus|sirolimus|mesh-list
20360301|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360302|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360303|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20360304|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360305|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
20360306|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360307|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
20360308|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360309|NCT00926302|Levetiracetam|levetiracetam|mesh-list
20360310|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
20360311|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
19289484|NCT04293822|Minoxidil|minoxidil|mesh-list
19289485|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19289486|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19671481|NCT04872582|Growth Substances|growth substances|mesh-ancestor
20182161|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20182162|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182163|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182164|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182165|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360312|NCT00926315|Calcitriol|calcitriol|mesh-list
20360313|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19289487|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19289488|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
19289489|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
19289490|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289491|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289492|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289493|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19289494|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
19289495|NCT04293887|Interferons|interferons|mesh-list
19289496|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289497|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
19289498|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289499|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19289500|NCT04293549|Mitogens|mitogens|mesh-list
19289501|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
19289502|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289503|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19394897|NCT03671759|Caffeine|caffeine|mesh-list
19394898|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19394899|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394900|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19394901|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394902|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394903|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19394904|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19394905|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
19394906|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394907|NCT03671746|Ketorolac|ketorolac|mesh-list
19394908|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19394909|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19394910|NCT03671746|Analgesics|analgesics|mesh-ancestor
19394911|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
19394912|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394913|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394914|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394915|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394916|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19394917|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394918|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394919|NCT03671733|Liraglutide|liraglutide|mesh-list
19394920|NCT03671733|Exenatide|exenatide|mesh-list
19394921|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19394922|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394923|NCT03671733|Incretins|incretins|mesh-ancestor
19394924|NCT03671733|Hormones|hormones|mesh-ancestor
19394925|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19394926|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19394927|NCT03671707|Nicotine|nicotine|mesh-list
19394928|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19394929|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
19394930|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394931|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671482|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671483|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
19671484|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671485|NCT04818372|Dexamethasone|dexamethasone|mesh-list
20360314|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360315|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19394932|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19394933|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19394934|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
19394935|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19394936|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394937|NCT03671655|Paclitaxel|paclitaxel|mesh-list
19394938|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19394939|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394940|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
20360316|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360317|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360318|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20360319|NCT00926315|Vitamins|vitamins|mesh-ancestor
19394941|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
20360320|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
19394942|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
19289504|NCT04293419|Durvalumab|durvalumab|mesh-list
19289505|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19289506|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289507|NCT04293081|Maleic acid|maleic acid|mesh-list
19289508|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360321|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20360322|NCT00926341|Pioglitazone|pioglitazone|mesh-list
20360323|NCT00926341|Telmisartan|telmisartan|mesh-list
20360324|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360325|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360326|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20360327|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20360328|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20360329|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360330|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20360331|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20360332|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
20360333|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360334|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360335|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20360336|NCT00926354|Protective Agents|protective agents|mesh-ancestor
20360337|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20360338|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20360339|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360340|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360341|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
20360342|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360343|NCT00926419|Vaccines|vaccines|mesh-list
20360344|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
19289509|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289510|NCT04293172|Ticagrelor|ticagrelor|mesh-list
19289511|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19289512|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19289513|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19289514|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19289515|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
19289516|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289517|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289518|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289519|NCT04292990|Fentanyl|fentanyl|mesh-list
19289520|NCT04292990|Morphine|morphine|mesh-list
19289521|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19289522|NCT04292990|Narcotics|narcotics|mesh-ancestor
20360345|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425301|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20425302|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20425303|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19289523|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289524|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289525|NCT04292990|Analgesics|analgesics|mesh-ancestor
19289526|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
19289527|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289528|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19289529|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19289530|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
19289531|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
19289532|NCT04292886|Tamoxifen|tamoxifen|mesh-list
19289533|NCT04292886|Ascorbic Acid|ascorbic acid|mesh-list
19289534|NCT04292886|Vitamins|vitamins|mesh-ancestor
19289535|NCT04292886|Micronutrients|micronutrients|mesh-ancestor
19289536|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289537|NCT04292886|Antioxidants|antioxidants|mesh-ancestor
19289538|NCT04292886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289539|NCT04292886|Protective Agents|protective agents|mesh-ancestor
19289540|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19289541|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
19289542|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289543|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19289544|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289545|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19289546|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19289547|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19289548|NCT04292756|Triamcinolone|triamcinolone|mesh-list
19289549|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19289550|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19289551|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19289552|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289553|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
19289554|NCT04292756|Hormones|hormones|mesh-ancestor
19289555|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289556|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289557|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289558|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
19289559|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671486|NCT04818372|Lenalidomide|lenalidomide|mesh-list
19671487|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20360346|NCT00926614|Pioglitazone|pioglitazone|mesh-list
20360347|NCT00926614|Atorvastatin|atorvastatin|mesh-list
20360348|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20360349|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20360350|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
19289560|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289561|NCT04292743|Leucovorin|leucovorin|mesh-list
19289562|NCT04292743|Fluorouracil|fluorouracil|mesh-list
19289563|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
19289564|NCT04292743|Irinotecan|irinotecan|mesh-list
19289565|NCT04292743|Folfirinox|folfirinox|mesh-list
19289566|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
19289567|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289568|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289569|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289570|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289571|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
19289572|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289573|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19289574|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19289575|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289576|NCT04292743|Antidotes|antidotes|mesh-ancestor
19289577|NCT04292743|Protective Agents|protective agents|mesh-ancestor
19289578|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
19289579|NCT04292743|Vitamins|vitamins|mesh-ancestor
19289580|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
19289581|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
20360351|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360352|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20360353|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20360354|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360355|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360356|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360357|NCT00926627|Bosentan|bosentan|mesh-list
20360358|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20360359|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20360360|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360361|NCT00926640|Etoposide|etoposide|mesh-list
20360362|NCT00926640|Belinostat|belinostat|mesh-list
20360363|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360364|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20360365|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20360366|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20360367|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360368|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360369|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20360370|NCT00926653|Citalopram|citalopram|mesh-list
20360371|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19289582|NCT04292418|Tacrolimus|tacrolimus|mesh-list
19289583|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289584|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
19289585|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289586|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19289587|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289588|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671488|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
19671489|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
19671490|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289589|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671491|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671492|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19671493|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
19289590|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289591|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19289592|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
19289593|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289594|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289595|NCT04292457|Propofol|propofol|mesh-list
19289596|NCT04292457|Sevoflurane|sevoflurane|mesh-list
19289597|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19289598|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289599|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289600|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19289601|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
19289602|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
19289603|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19289604|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19289605|NCT04292444|Oxytocin|oxytocin|mesh-list
19289606|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
19289607|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19289608|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289609|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
19289610|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19289611|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
19289612|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
19289613|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289614|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289615|NCT04292691|Ropivacaine|ropivacaine|mesh-list
19289616|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
19289617|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
19289618|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289619|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289620|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
19289621|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289622|NCT04292769|Decitabine|decitabine|mesh-list
19289623|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19289624|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
19289625|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289626|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289627|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289628|NCT04292704|Clotrimazole|clotrimazole|mesh-list
19289629|NCT04292704|Miconazole|miconazole|mesh-list
19289630|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19289631|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289632|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
19289633|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19289634|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19289635|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289636|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289637|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19289638|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
20182166|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
19289639|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289640|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289641|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19289642|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19289643|NCT04292119|Crizotinib|crizotinib|mesh-list
19289644|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289645|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19289646|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289647|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289648|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
19289649|NCT04292184|Antidotes|antidotes|mesh-ancestor
19289650|NCT04292184|Protective Agents|protective agents|mesh-ancestor
19289651|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289652|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
20182167|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20182168|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
20182169|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20182170|NCT00191568|Gemcitabine|gemcitabine|mesh-list
20182171|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
20182172|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182173|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
20182174|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182175|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182176|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
20182177|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289653|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289654|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
19289655|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289656|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289657|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
19289658|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
19289659|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
19289660|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
19289661|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19289662|NCT04292236|Protective Agents|protective agents|mesh-ancestor
19289663|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289664|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289665|NCT04292054|Cefazolin|cefazolin|mesh-list
19289666|NCT04292054|Tazobactam|tazobactam|mesh-list
19289667|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289668|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289669|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19289670|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289671|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289672|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
19289673|NCT04292314|Deferoxamine|deferoxamine|mesh-list
19289674|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289675|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
19289676|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289677|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289678|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19289679|NCT04292314|Siderophores|siderophores|mesh-ancestor
19289680|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19289681|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
19289682|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
19289683|NCT04291794|Propofol|propofol|mesh-list
19289684|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20182178|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182179|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182180|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
19289685|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289686|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289687|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19289688|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
19289689|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
19289690|NCT04291729|Interferons|interferons|mesh-list
19289691|NCT04291729|Ritonavir|ritonavir|mesh-list
19289692|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289693|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
19289694|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289695|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19289696|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19289697|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
19289698|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289699|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289700|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19289701|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19289702|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19289703|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19289704|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19289705|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19289706|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289707|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
19289708|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
19289709|NCT04291755|Nivolumab|nivolumab|mesh-list
19289710|NCT04291755|Ipilimumab|ipilimumab|mesh-list
19289711|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19289712|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289713|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19289714|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289715|NCT04291664|Prednisone|prednisone|mesh-list
19289716|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
19289717|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289718|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
19289719|NCT04291664|Hormones|hormones|mesh-ancestor
19671494|NCT04818372|Hormones|hormones|mesh-ancestor
19671495|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671496|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19671497|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671498|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
19671499|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19289720|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289721|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289722|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19289723|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289724|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19289725|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289726|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289727|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
19289728|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19394943|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404198|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19404199|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404200|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404201|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19404202|NCT03596775|Analgesics|analgesics|mesh-ancestor
19404203|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
19404204|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404205|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20182181|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182182|NCT00191581|Insulin|insulin|mesh-list
20360372|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20360373|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360374|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360375|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360376|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
19404206|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19404207|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19404208|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
19404209|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404210|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404211|NCT03596749|Sevelamer|sevelamer|mesh-list
19404212|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
19404213|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
19404214|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404215|NCT03596502|Warfarin|warfarin|mesh-list
19404216|NCT03596502|Anticoagulants|anticoagulants|mesh-list
19404217|NCT03596294|Rifampin|rifampin|mesh-list
19404218|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19404219|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
19404220|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20182183|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
20182184|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20182185|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
20182186|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360377|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360378|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20360379|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
20360380|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360381|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
19404221|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404222|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
19404223|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19404224|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404225|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404226|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19404227|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19404228|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19404229|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19404230|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19404231|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19404232|NCT03596281|Bevacizumab|bevacizumab|mesh-list
19404233|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
19404234|NCT03596281|Doxorubicin|doxorubicin|mesh-list
19404235|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20182187|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182188|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20182189|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20360382|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
20360383|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
20360384|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289729|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19289730|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19289731|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289732|NCT04291313|Vitamin D|vitamin d|mesh-list
19289733|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
19289734|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
19289735|NCT04291313|Vitamins|vitamins|mesh-list
19289736|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
19289737|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289738|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19289739|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19289740|NCT04291456|Minocycline|minocycline|mesh-list
19289741|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289742|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289743|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
19289744|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19289745|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
19289746|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289747|NCT04291209|Expectorants|expectorants|mesh-ancestor
19289748|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
19289749|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19289750|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
19289751|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289752|NCT04291209|Protective Agents|protective agents|mesh-ancestor
19289753|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289754|NCT04291209|Antidotes|antidotes|mesh-ancestor
19289755|NCT04290819|Caffeine|caffeine|mesh-list
19289756|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19289757|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289758|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19289759|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289760|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289761|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19289762|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19289763|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
19289764|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289765|NCT04290936|Tenofovir|tenofovir|mesh-list
19289766|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
19289767|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289768|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19289769|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19289770|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289771|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289772|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19289773|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20360385|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360386|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
20360387|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360388|NCT00926705|Fentanyl|fentanyl|mesh-list
20360389|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
20360390|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20360391|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360392|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360393|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20182190|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182191|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182192|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182193|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182194|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182195|NCT00191594|Analgesics|analgesics|mesh-ancestor
20182196|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
20182197|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182198|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
20182199|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360394|NCT00926705|Analgesics|analgesics|mesh-ancestor
19289774|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
19289775|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19289776|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
19289777|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289778|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289779|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19289780|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
19289781|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19289782|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
19394944|NCT03671538|Pemetrexed|pemetrexed|mesh-list
19289783|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289784|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289785|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19289786|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
19289787|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
19289788|NCT04290871|Protective Agents|protective agents|mesh-ancestor
19289789|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
19289790|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19289791|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289792|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
19289793|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289794|NCT04291066|Expectorants|expectorants|mesh-ancestor
19289795|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
19289796|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19289797|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
19289798|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289799|NCT04291066|Protective Agents|protective agents|mesh-ancestor
19289800|NCT04291066|Antidotes|antidotes|mesh-ancestor
19289801|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
19289802|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19289803|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19289804|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289805|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
19289806|NCT04290884|Coagulants|coagulants|mesh-ancestor
19289807|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
19289808|NCT04290793|Trastuzumab|trastuzumab|mesh-list
19289809|NCT04290793|Epirubicin|epirubicin|mesh-list
19289810|NCT04290793|Taxane|taxane|mesh-list
19289811|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289812|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
20182200|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
20182201|NCT00191607|Gemcitabine|gemcitabine|mesh-list
20182202|NCT00191607|Doxorubicin|doxorubicin|mesh-list
20182203|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20182204|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182205|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
20182206|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182207|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182208|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
20182209|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182210|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182211|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182212|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
20182213|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182214|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20182215|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20182216|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182217|NCT00191620|Gemcitabine|gemcitabine|mesh-list
20182218|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182219|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182220|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
20182221|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182222|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
20182223|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182224|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182225|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182226|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
20182227|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182228|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20182229|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20182230|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182231|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182232|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182233|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
20182234|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182235|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182236|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20182237|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20182238|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182239|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182240|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182241|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
19289813|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289814|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20182242|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182243|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182244|NCT00191672|Gemcitabine|gemcitabine|mesh-list
20182245|NCT00191672|Paclitaxel|paclitaxel|mesh-list
20182246|NCT00191672|Docetaxel|docetaxel|mesh-list
20182247|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182248|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182249|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182250|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
20360395|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
19289815|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19289816|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
19289817|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289818|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289819|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19289820|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19289821|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19289822|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19289823|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19289824|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289825|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
19289826|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19289827|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
19289828|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289829|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289830|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19289831|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
19289832|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19289833|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
19289834|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289835|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289836|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19289837|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
19289838|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
19289839|NCT04290858|Protective Agents|protective agents|mesh-ancestor
19289840|NCT04291118|Budesonide|budesonide|mesh-list
19289841|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289842|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19289843|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
19289844|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289845|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360396|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360397|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20360398|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20360399|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20360400|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360401|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360402|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360403|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20360404|NCT00926705|Narcotics|narcotics|mesh-ancestor
20360405|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20360406|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20360407|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
20360408|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
20360409|NCT00926718|Remifentanil|remifentanil|mesh-list
20360410|NCT00926718|Rocuronium|rocuronium|mesh-list
20360411|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20360412|NCT00926718|Narcotics|narcotics|mesh-ancestor
20360413|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360414|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360415|NCT00926718|Analgesics|analgesics|mesh-ancestor
20360416|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
20360417|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360418|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20360419|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20360420|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20360421|NCT00926731|Cytarabine|cytarabine|mesh-list
20360422|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20360423|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
20360424|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360425|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182251|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
20360426|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
19289846|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19289847|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
20360427|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360428|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360429|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
20360430|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360431|NCT00926757|Entecavir|entecavir|mesh-list
20360432|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
20360433|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360434|NCT00926809|Amoxicillin|amoxicillin|mesh-list
20360435|NCT00926809|Clarithromycin|clarithromycin|mesh-list
20360436|NCT00926809|Lansoprazole|lansoprazole|mesh-list
20360437|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
20360438|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20360439|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360440|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360441|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20360442|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360443|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360444|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20360445|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20360446|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19289848|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
19289849|NCT04291118|Hormones|hormones|mesh-ancestor
19289850|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289851|NCT04290442|Ropivacaine|ropivacaine|mesh-list
19289852|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
19289853|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
19289854|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289855|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289856|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
19289857|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289858|NCT04290455|Castor Oil|castor oil|mesh-list
19289859|NCT04290455|Cathartics|cathartics|mesh-ancestor
19289860|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19289861|NCT04290429|Teduglutide|teduglutide|mesh-list
19289862|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19289863|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19289864|NCT04290429|Protective Agents|protective agents|mesh-ancestor
19289865|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360447|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20360448|NCT00926835|Lamotrigine|lamotrigine|mesh-list
20360449|NCT00926835|Dexetimide|dexetimide|mesh-list
20360450|NCT00926835|Aripiprazole|aripiprazole|mesh-list
20360451|NCT00926835|Mirtazapine|mirtazapine|mesh-list
20360452|NCT00926835|Citalopram|citalopram|mesh-list
20360453|NCT00926835|Bupropion|bupropion|mesh-list
20360454|NCT00926835|Paroxetine|paroxetine|mesh-list
20360455|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20360456|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20360457|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20360458|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360459|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360460|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360461|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
20360462|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360463|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20360464|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
20360465|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360466|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20360467|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20360468|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
20360469|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
20360470|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360471|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19289866|NCT04290572|Isotretinoin|isotretinoin|mesh-list
19289867|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19289868|NCT04290390|Itraconazole|itraconazole|mesh-list
19289869|NCT04290390|Rifampin|rifampin|mesh-list
19289870|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20360472|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20360473|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
20360474|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20360475|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
20360476|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19289871|NCT04290390|Estradiol|estradiol|mesh-list
19838241|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19289872|NCT04290390|Estrogens|estrogens|mesh-ancestor
20360477|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20360478|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289873|NCT04290390|Hormones|hormones|mesh-ancestor
20182252|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182253|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182254|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
20182255|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
20182256|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182257|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182258|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182259|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
19289874|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289875|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289876|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19289877|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
19289878|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19289879|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19289880|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
20360479|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20360480|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20360481|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360482|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
20360483|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20360484|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20360485|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20360486|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20360487|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20360488|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19289881|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289882|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19289883|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19289884|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289885|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289886|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19289887|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
19289888|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19289889|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19289890|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
19289891|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289892|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
19289893|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19289894|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19289895|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19289896|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19289897|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19289898|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19289899|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19289900|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19289901|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19289902|NCT04290195|Aflibercept|aflibercept|mesh-list
19289903|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19289904|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19289905|NCT04290195|Growth Substances|growth substances|mesh-ancestor
19289906|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289907|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
19289908|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289909|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
19289910|NCT04290013|Norethindrone|norethindrone|mesh-list
19289911|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
19289912|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19289913|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19289914|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289915|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
19289916|NCT04290013|Coagulants|coagulants|mesh-ancestor
19289917|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20182260|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360489|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20360490|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
20360491|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20360492|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20360493|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19289918|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20182261|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20360494|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20360495|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
20360496|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
20360497|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20360498|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20360499|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20360500|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20360501|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360502|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19289919|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19289920|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
19289921|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19289922|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289923|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19289924|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19289925|NCT04290208|Acetaminophen|acetaminophen|mesh-list
19289926|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289927|NCT04290208|Analgesics|analgesics|mesh-ancestor
19289928|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
19289929|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289930|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289931|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
19289932|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
19289933|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19289934|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19289935|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19289936|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19289937|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289938|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
19289939|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289940|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289941|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19289942|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289943|NCT04290104|Ampicillin|ampicillin|mesh-list
19289944|NCT04290104|Sulbactam|sulbactam|mesh-list
20182262|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20182263|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182264|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360503|NCT00926900|Cycloserine|cycloserine|mesh-list
20360504|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20360505|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360506|NCT00926900|Renal Agents|renal agents|mesh-ancestor
20360507|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20360508|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
20360509|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360510|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
19289945|NCT04290104|Sultamicillin|sultamicillin|mesh-list
19289946|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19289947|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289948|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19289949|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289950|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289951|NCT04290026|Metoclopramide|metoclopramide|mesh-list
19289952|NCT04290026|Granisetron|granisetron|mesh-list
19289953|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
19289954|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
19289955|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289956|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289957|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19289958|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19289959|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19289960|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
19289961|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289962|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838242|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20182265|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182266|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182267|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182268|NCT00191685|Analgesics|analgesics|mesh-ancestor
20182269|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
20360511|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360512|NCT00926926|Oxybutynin|oxybutynin|mesh-list
19289963|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20360513|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
20360514|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
20360515|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360516|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360517|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20360518|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20360519|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
20360520|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360521|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360522|NCT00926926|Urological Agents|urological agents|mesh-ancestor
20360523|NCT00926965|Olanzapine|olanzapine|mesh-list
20360524|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
20360525|NCT00926965|Amisulpride|amisulpride|mesh-list
20360526|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
20360527|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
20360528|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360529|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360530|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20360531|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20360532|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360533|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360534|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20360535|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20360536|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360537|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360538|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360539|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
20360540|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20360541|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
20360542|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20360543|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
20360544|NCT00927004|Etoricoxib|etoricoxib|mesh-list
20360545|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20360546|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20360547|NCT00927004|Analgesics|analgesics|mesh-ancestor
20360548|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
20360549|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360550|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360551|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20360552|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360553|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20360554|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20360555|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838243|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19838244|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
19838245|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838246|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
19838247|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19838248|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19838249|NCT00619684|Lenalidomide|lenalidomide|mesh-list
19838250|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
19838251|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838252|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19838253|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838254|NCT00619684|Growth Substances|growth substances|mesh-ancestor
19838255|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
19838256|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838257|NCT00619723|Choline|choline|mesh-list
19838258|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19838259|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
19838260|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20182270|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182271|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
20182272|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20182273|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
20182274|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20182275|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20182276|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182277|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182278|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182279|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360556|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289964|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
20182280|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182281|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182282|NCT00191711|Gemcitabine|gemcitabine|mesh-list
20182283|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20360557|NCT00927030|Melatonin|melatonin|mesh-list
20360558|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
20360559|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360560|NCT00927030|Protective Agents|protective agents|mesh-ancestor
20360561|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360562|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671500|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19671501|NCT04818372|Growth Substances|growth substances|mesh-ancestor
19671502|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
20182284|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
20182285|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360563|NCT00927147|Cetuximab|cetuximab|mesh-list
20360564|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20360565|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360566|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20360567|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20360568|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
20360569|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360570|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360571|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20360572|NCT00927212|Protective Agents|protective agents|mesh-ancestor
20360573|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20360574|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20360575|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360576|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360577|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
19289965|NCT04289805|Letrozole|letrozole|mesh-list
19289966|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289967|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19289968|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19289969|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19289970|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19289971|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19289972|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
19289973|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19289974|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289975|NCT04289675|Interferons|interferons|mesh-list
19289976|NCT04289675|Interferon-beta|interferon-beta|mesh-list
19289977|NCT04289675|Teriflunomide|teriflunomide|mesh-list
19289978|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19289979|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289980|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
19289981|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19289982|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
19289983|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19289984|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
19289985|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19289986|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671503|NCT04784299|Lidocaine|lidocaine|mesh-list
19671504|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
19671505|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
19671506|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671507|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671508|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
20182286|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182287|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
20182288|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182289|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182290|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182291|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
20182292|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182293|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20182294|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20182295|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182296|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182297|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182298|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
20182299|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19289987|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19289988|NCT04289675|Analgesics|analgesics|mesh-ancestor
20360578|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360579|NCT00927225|Ropivacaine|ropivacaine|mesh-list
20360580|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
20360581|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
20360582|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19289989|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
19289990|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19289991|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19289992|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394945|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394946|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394947|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394948|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19394949|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19394950|NCT03671369|Vaccines|vaccines|mesh-list
19394951|NCT03671369|Immunologic Factors|immunologic factors|mesh-ancestor
19394952|NCT03671369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394953|NCT03671265|Apatinib|apatinib|mesh-list
19394954|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394955|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19394956|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394957|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394958|NCT03671174|Aspirin|aspirin|mesh-list
20360583|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360584|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
20360585|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360586|NCT00927290|Pioglitazone|pioglitazone|mesh-list
20360587|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360588|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360589|NCT00927407|Malathion|malathion|mesh-list
20360590|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20360591|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360592|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360593|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
20360594|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360595|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360596|NCT00927498|Cytarabine|cytarabine|mesh-list
20360597|NCT00927498|Daunorubicin|daunorubicin|mesh-list
20360598|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
20360599|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20360600|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360601|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20360602|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20360603|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394959|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
19394960|NCT03671174|Prednisone|prednisone|mesh-list
19394961|NCT03671174|Heparin|heparin|mesh-list
19394962|NCT03671174|Enoxaparin|enoxaparin|mesh-list
19394963|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19394964|NCT03671174|Tinzaparin|tinzaparin|mesh-list
19394965|NCT03671174|Dalteparin|dalteparin|mesh-list
19394966|NCT03671174|Nadroparin|nadroparin|mesh-list
19394967|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19394968|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
19394969|NCT03671174|Hormones|hormones|mesh-ancestor
19394970|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360604|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360605|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20360606|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19394971|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394972|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19394973|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19394974|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19394975|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19394976|NCT03671174|Analgesics|analgesics|mesh-ancestor
19394977|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
19394978|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19394979|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19394980|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19394981|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20360607|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
19394982|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19394983|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20360608|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
19289993|NCT04289974|Fulvestrant|fulvestrant|mesh-list
19289994|NCT04289974|Palbociclib|palbociclib|mesh-list
19289995|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19289996|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19289997|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19289998|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19289999|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
19290000|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290001|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290002|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19290003|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290004|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290005|NCT04289883|Calcium|calcium|mesh-list
19290006|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19290007|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290008|NCT04289792|Gemcitabine|gemcitabine|mesh-list
19290009|NCT04289792|Paclitaxel|paclitaxel|mesh-list
19290010|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19290011|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290012|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
19290013|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
19290014|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
19290015|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290016|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19290017|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
19290018|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
19290019|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290020|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290021|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19290022|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
19290023|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290024|NCT04289103|Inolimomab|inolimomab|mesh-list
19290025|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19290026|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
19290027|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290028|NCT04289467|Fenfluramine|fenfluramine|mesh-list
19290029|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19290030|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19290031|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290032|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290033|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290034|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
19290035|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290036|NCT04289090|Propofol|propofol|mesh-list
19290037|NCT04289090|Sevoflurane|sevoflurane|mesh-list
19290038|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19290039|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290040|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290041|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20360609|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360610|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360611|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
20360612|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360613|NCT00927511|Fulvestrant|fulvestrant|mesh-list
20360614|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20360615|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360616|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20360617|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20360618|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
19290042|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
19290043|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
19290044|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19290045|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19290046|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19290047|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19290048|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290049|NCT04289207|Danazol|danazol|mesh-list
19290050|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19290051|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
19290052|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290053|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838261|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
20360619|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290054|NCT04288999|Capecitabine|capecitabine|mesh-list
19290055|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19290056|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
19290057|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290058|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290059|NCT04288765|Dexamethasone|dexamethasone|mesh-list
19290060|NCT04288765|Lenalidomide|lenalidomide|mesh-list
19290061|NCT04288765|Daratumumab|daratumumab|mesh-list
19290062|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290063|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
20360620|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360621|NCT00927524|Insulin|insulin|mesh-list
20360622|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20360623|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
20360624|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20360625|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360626|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20360627|NCT00927537|Telmisartan|telmisartan|mesh-list
20360628|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20360629|NCT00927537|Diuretics|diuretics|mesh-ancestor
20360630|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
19290064|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
19290065|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290066|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290067|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19290068|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
19290069|NCT04288765|Hormones|hormones|mesh-ancestor
19290070|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290071|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19290072|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290073|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
19290074|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19290075|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19290076|NCT04288765|Growth Substances|growth substances|mesh-ancestor
19290077|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
19290078|NCT04288700|Timolol|timolol|mesh-list
19290079|NCT04288700|Propranolol|propranolol|mesh-list
20360631|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360632|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20360633|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360634|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360635|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20360636|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20360637|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
20360638|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
20360639|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360640|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360641|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360642|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
19290080|NCT04288700|Captopril|captopril|mesh-list
19290081|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19290082|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19290083|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19290084|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19290085|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
19290086|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290087|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838262|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838263|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838264|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19838265|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
19838266|NCT00619801|Levocetirizine|levocetirizine|mesh-list
19290088|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290089|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19290090|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19290091|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360643|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20360644|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360645|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360646|NCT00927602|PENTA|penta|mesh-list
20360647|NCT00927602|Fondaparinux|fondaparinux|mesh-list
20360648|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19290092|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
19290093|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19290094|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
20360649|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
20360650|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20360651|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
20360652|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360653|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360654|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
20360655|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20360656|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20360657|NCT00927615|Abciximab|abciximab|mesh-list
20360658|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
20360659|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20360660|NCT00927654|Iloprost|iloprost|mesh-list
19290095|NCT04288349|Epinephrine|epinephrine|mesh-list
19290096|NCT04288349|Racepinephrine|racepinephrine|mesh-list
19290097|NCT04288349|Ropivacaine|ropivacaine|mesh-list
19290098|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
19290099|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
19290100|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
19290101|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290102|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290103|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
19290104|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290105|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19290106|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19290107|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
19290108|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290109|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290110|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19290111|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19290112|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
19290113|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19290114|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
19290115|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
19290116|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
19290117|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19290118|NCT04288232|Aflibercept|aflibercept|mesh-list
19290119|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19290120|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19290121|NCT04288232|Growth Substances|growth substances|mesh-ancestor
19290122|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290123|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
19290124|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290125|NCT04288219|Nifedipine|nifedipine|mesh-list
19290126|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19290127|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290128|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290129|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19290130|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290131|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
19290132|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
19290133|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19290134|NCT04287894|Pemetrexed|pemetrexed|mesh-list
19290135|NCT04287894|Durvalumab|durvalumab|mesh-list
19290136|NCT04287894|Tremelimumab|tremelimumab|mesh-list
19290137|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290138|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290139|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290140|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19290141|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19290142|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19290143|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
19290144|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20182300|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182301|NCT00191750|Pemetrexed|pemetrexed|mesh-list
20182302|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182303|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182304|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182305|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20182306|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182307|NCT00191763|Gemcitabine|gemcitabine|mesh-list
20182308|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182309|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19290145|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
19290146|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
19290147|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360661|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20360662|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
20360663|NCT00927693|Calcium|calcium|mesh-list
20360664|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20360665|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360666|NCT00927732|Quinidine|quinidine|mesh-list
19290148|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290149|NCT04287777|Mupirocin|mupirocin|mesh-list
19290150|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19290151|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290152|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19290153|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290154|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290155|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
19290156|NCT04287829|Lenvatinib|lenvatinib|mesh-list
19290157|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19290158|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290159|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19290160|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290161|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290162|NCT04287842|Sevoflurane|sevoflurane|mesh-list
19290163|NCT04287842|Desflurane|desflurane|mesh-list
19290164|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19290165|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19290166|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
19290167|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
19290168|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290169|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290170|NCT04287426|Remifentanil|remifentanil|mesh-list
19290171|NCT04287426|Rocuronium|rocuronium|mesh-list
19290172|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19290173|NCT04287426|Narcotics|narcotics|mesh-ancestor
19671509|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671510|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19290174|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290175|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290176|NCT04287426|Analgesics|analgesics|mesh-ancestor
19290177|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
19290178|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290179|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19290180|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19290181|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19394984|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19394985|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19394986|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
19394987|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
19394988|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
19394989|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19394990|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19394991|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19394992|NCT03671161|Insulin|insulin|mesh-list
19394993|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19394994|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19394995|NCT03671109|Piperaquine|piperaquine|mesh-list
19394996|NCT03671109|Artenimol|artenimol|mesh-list
19394997|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
19394998|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19394999|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19395000|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395001|NCT03671070|Epinephrine|epinephrine|mesh-list
19395002|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19395003|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19395004|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
19395005|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395006|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395007|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395008|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19395009|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19395010|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
19395011|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395012|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19395013|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
20360667|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
19395014|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
19395015|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
19395016|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19671511|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19395017|NCT03671057|Midazolam|midazolam|mesh-list
19290182|NCT04287543|Melatonin|melatonin|mesh-list
19290183|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
19290184|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290185|NCT04287543|Protective Agents|protective agents|mesh-ancestor
19290186|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290187|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290188|NCT04287361|Clonazepam|clonazepam|mesh-list
19290189|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
19290190|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
19290191|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
19290192|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290193|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290194|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290195|NCT04287387|Pioglitazone|pioglitazone|mesh-list
19290196|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19290197|NCT04287387|Metformin|metformin|mesh-list
19290198|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
19290199|NCT04287387|Glimepiride|glimepiride|mesh-list
19290200|NCT04287387|Acarbose|acarbose|mesh-list
19290201|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19290202|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290203|NCT04287387|Incretins|incretins|mesh-ancestor
19290204|NCT04287387|Hormones|hormones|mesh-ancestor
19290205|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290206|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19290207|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
19290208|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290209|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290210|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19290211|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20360668|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20360669|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
20360670|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
20360671|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290212|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19290213|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
19290214|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19290215|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
19290216|NCT04287205|Progestins|progestins|mesh-ancestor
19290217|NCT04287205|Hormones|hormones|mesh-ancestor
19290218|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290219|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290220|NCT04286711|Paclitaxel|paclitaxel|mesh-list
19290221|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20360672|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360673|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20360674|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20360675|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360676|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360677|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360678|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
20360679|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20360680|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20360681|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360682|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360683|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20360684|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20360685|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
20360686|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20360687|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20360688|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360689|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20360690|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20360691|NCT00927771|Azelaic acid|azelaic acid|mesh-list
20360692|NCT00927771|Hydroquinone|hydroquinone|mesh-list
19290222|NCT04286711|Apatinib|apatinib|mesh-list
19290223|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19290224|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360693|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360694|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
20360695|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
19290225|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
19290226|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
19290227|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
19848182|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290228|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290229|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19290230|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290231|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19290232|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
19290233|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19290234|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19290235|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19290236|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19290237|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
19290238|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290239|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290240|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290241|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19290242|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19290243|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
19290244|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290245|NCT04286503|Ritonavir|ritonavir|mesh-list
19290246|NCT04286503|Lopinavir|lopinavir|mesh-list
19290247|NCT04286503|Chloroquine|chloroquine|mesh-list
19290248|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19290249|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19290250|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19290251|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
19290252|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290253|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290254|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19290255|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19290256|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
19290257|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290258|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20182310|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
20182311|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290259|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19290260|NCT04286503|Amebicides|amebicides|mesh-ancestor
19290261|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19290262|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19290263|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
19290264|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19290265|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19290266|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19290267|NCT04286503|Analgesics|analgesics|mesh-ancestor
19290268|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
19290269|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290270|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290271|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290272|NCT04286503|Filaricides|filaricides|mesh-ancestor
19290273|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
19290274|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
19290275|NCT04286035|Bupivacaine|bupivacaine|mesh-list
19838267|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19838268|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20182312|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
20182313|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182314|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182315|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182316|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
20182317|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182318|NCT00191802|Teriparatide|teriparatide|mesh-list
20182319|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20182320|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182321|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20182322|NCT00191828|Olanzapine|olanzapine|mesh-list
20182323|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
19838269|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
19838270|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
19838271|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838272|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838273|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838274|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19838275|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
20182324|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
19290276|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
19290277|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
19290278|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290279|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290280|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
19290281|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290282|NCT04286087|Anesthetics|anesthetics|mesh-list
19290283|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290284|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290285|NCT04286152|Mirabegron|mirabegron|mesh-list
19290286|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19290287|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19290288|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19290289|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
19290290|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290291|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290292|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290293|NCT04286152|Urological Agents|urological agents|mesh-ancestor
19290294|NCT04285528|Lidocaine|lidocaine|mesh-list
19290295|NCT04285528|Fentanyl|fentanyl|mesh-list
19290296|NCT04285528|Ketamine|ketamine|mesh-list
19290297|NCT04285528|Propofol|propofol|mesh-list
19290298|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
19290299|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
19290300|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290301|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290302|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
20360696|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360697|NCT00927771|Protective Agents|protective agents|mesh-ancestor
20360698|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360699|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20360700|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
20360701|NCT00927797|Rituximab|rituximab|mesh-list
19671512|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19671513|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19671514|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671515|NCT04682158|Paclitaxel|paclitaxel|mesh-list
19671516|NCT04682158|Carboplatin|carboplatin|mesh-list
20360702|NCT00927797|Pentostatin|pentostatin|mesh-list
20360703|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360704|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
20360705|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360706|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360707|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20360708|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
20360709|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360710|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360711|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20360712|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19290303|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290304|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19671517|NCT04682158|Propranolol|propranolol|mesh-list
19671518|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671519|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182325|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290305|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19290306|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19290307|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290308|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290309|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19290310|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290311|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
20182326|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182327|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20182328|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20182329|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20182330|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20182331|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20182332|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20182333|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182334|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360713|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19290312|NCT04285528|Analgesics|analgesics|mesh-ancestor
19671520|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
20360714|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360715|NCT00927836|Lenograstim|lenograstim|mesh-list
20360716|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19290313|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19290314|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19290315|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19290316|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290317|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19290318|NCT04285528|Narcotics|narcotics|mesh-ancestor
19290319|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19290320|NCT04285450|Vitamin K|vitamin k|mesh-list
19290321|NCT04285450|Vitamins|vitamins|mesh-ancestor
19290322|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
19290323|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290324|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19290325|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19290326|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290327|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
19290328|NCT04285450|Coagulants|coagulants|mesh-ancestor
19290329|NCT04285281|Gabapentin|gabapentin|mesh-list
19290330|NCT04285281|Analgesics|analgesics|mesh-ancestor
19290331|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
19290332|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290333|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290334|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
19290335|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19290336|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19290337|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290338|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19290339|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19290340|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19290341|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290342|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290343|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
19290344|NCT04285073|Paclitaxel|paclitaxel|mesh-list
19290345|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182335|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182336|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182337|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
20182338|NCT00191841|Gemcitabine|gemcitabine|mesh-list
20360717|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
20360718|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360719|NCT00927875|Carboplatin|carboplatin|mesh-list
20360720|NCT00927875|Etoposide|etoposide|mesh-list
20360721|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360722|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20360723|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20360724|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20360725|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360726|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360727|NCT00927966|Everolimus|everolimus|mesh-list
20360728|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360729|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360730|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
20360731|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182339|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182340|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182341|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
20182342|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182343|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
20182344|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182345|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182346|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182347|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
20182348|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182349|NCT00191867|Teriparatide|teriparatide|mesh-list
20182350|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20182351|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182352|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20182353|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20360732|NCT00927979|Ropivacaine|ropivacaine|mesh-list
20360733|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
20360734|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
20360735|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290346|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290347|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
19290348|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
19290349|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
19290350|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290351|NCT04285268|Rituximab|rituximab|mesh-list
19290352|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19290353|NCT04285268|Bortezomib|bortezomib|mesh-list
19290354|NCT04285268|Venetoclax|venetoclax|mesh-list
19290355|NCT04285268|Antibodies|antibodies|mesh-list
19290356|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
19290357|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19290358|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
19290359|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290360|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290361|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395018|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19395019|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19395020|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395021|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395022|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19395023|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19395024|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19395025|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19395026|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
19395027|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
19395028|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
19395029|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
19395030|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395031|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395032|NCT03671044|Docetaxel|docetaxel|mesh-list
19395033|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395034|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
19395035|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395036|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
19395037|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395038|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19671521|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
19671522|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
19671523|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671524|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19671525|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20360736|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360737|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
20360738|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360739|NCT00928148|Amphetamine|amphetamine|mesh-list
20360740|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20360741|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395039|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19395040|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
19395041|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395042|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19395043|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19395044|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
19395045|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
19395046|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395047|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395048|NCT03670901|Rituximab|rituximab|mesh-list
19395049|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19395050|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395051|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
19395052|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395053|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395054|NCT03670888|Rituximab|rituximab|mesh-list
19395055|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19395056|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395057|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
19395058|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395059|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395060|NCT03670875|Curcumin|curcumin|mesh-list
19671526|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
19671527|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671528|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395061|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19395062|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19395063|NCT03670875|Analgesics|analgesics|mesh-ancestor
20360742|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
20360743|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
20360744|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360745|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
20360746|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360747|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290362|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19290363|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19290364|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290365|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
19290366|NCT04285346|Ganaxolone|ganaxolone|mesh-list
19290367|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
19290368|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290369|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290370|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290371|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
19290372|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
19290373|NCT04284839|Warfarin|warfarin|mesh-list
19290374|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
19290375|NCT04284839|Dabigatran|dabigatran|mesh-list
19290376|NCT04284839|Apixaban|apixaban|mesh-list
19290377|NCT04284839|Edoxaban|edoxaban|mesh-list
19290378|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
19290379|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19290380|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
19290381|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19290382|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
19290383|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290384|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290385|NCT04284826|Mitomycins|mitomycins|mesh-list
19290386|NCT04284826|Mitomycin|mitomycin|mesh-list
19290387|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19290388|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290389|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
19290390|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290391|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19290392|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290393|NCT04284644|Propofol|propofol|mesh-list
19290394|NCT04284644|Sevoflurane|sevoflurane|mesh-list
19290395|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19290396|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290397|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360748|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360749|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20360750|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20360751|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20360752|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20360753|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
20360754|NCT00928161|Lansoprazole|lansoprazole|mesh-list
20360755|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20360756|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20360757|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20360758|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360759|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360760|NCT00928213|Heparin|heparin|mesh-list
20360761|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20360762|NCT00928213|Tinzaparin|tinzaparin|mesh-list
20360763|NCT00928213|Dalteparin|dalteparin|mesh-list
20360764|NCT00928213|Progesterone|progesterone|mesh-list
20360765|NCT00928213|Hormones|hormones|mesh-ancestor
19290398|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290399|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
19290400|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
19290401|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19290402|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19290403|NCT04284722|Metformin|metformin|mesh-list
19290404|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19290405|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290406|NCT04284761|Bicalutamide|bicalutamide|mesh-list
19290407|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
19290408|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
19290409|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290410|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290411|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838276|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19290412|NCT04284852|Niraparib|niraparib|mesh-list
19290413|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20428566|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19290414|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290415|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360766|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360767|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360768|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
20360769|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19290416|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290417|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19290418|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19290419|NCT04284215|Paclitaxel|paclitaxel|mesh-list
19290420|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19290421|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19290422|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290423|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
19290424|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
19290425|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
19290426|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290427|NCT04284202|Dasatinib|dasatinib|mesh-list
19290428|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290429|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19290430|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290431|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290432|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
19290433|NCT04284098|Bupivacaine|bupivacaine|mesh-list
19290434|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
19290435|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
19290436|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290437|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290438|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
19290439|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290440|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19290441|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19290442|NCT04284098|Analgesics|analgesics|mesh-ancestor
19290443|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20360770|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20360771|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360772|NCT00928213|Progestins|progestins|mesh-ancestor
20360773|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20360774|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360775|NCT00928330|Trastuzumab|trastuzumab|mesh-list
20360776|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20360777|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20360778|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360779|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
20360780|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
19290444|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19838277|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19838278|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19838279|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838280|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838281|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
19838282|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19838283|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838284|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848183|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20182354|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20182355|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182356|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182357|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182358|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
20182359|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182360|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182361|NCT00191893|Teriparatide|teriparatide|mesh-list
20182362|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20182363|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182364|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20182365|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20182366|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20182367|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182368|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217244|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19290445|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19290446|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
19290447|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290448|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290449|NCT04284150|Midazolam|midazolam|mesh-list
19290450|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
19290451|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19290452|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290453|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290454|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19290455|NCT04284150|Analgesics|analgesics|mesh-ancestor
19290456|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
20360781|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
20360782|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360783|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
20360784|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360785|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20360786|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360787|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425304|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290457|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290458|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19290459|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19290460|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19290461|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
19290462|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290463|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290464|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19290465|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19290466|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19290467|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19290468|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290469|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
19290470|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
19290471|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
19290472|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
19290473|NCT04284059|Vitamin D|vitamin d|mesh-list
19290474|NCT04284059|Vitamins|vitamins|mesh-list
19290475|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
19290476|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290477|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19290478|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
19290479|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19290480|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290481|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290482|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
19290483|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290484|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290485|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
19290486|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19290487|NCT04283747|Antibodies|antibodies|mesh-list
19290488|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
19290489|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290490|NCT04284007|Dexamethasone|dexamethasone|mesh-list
19290491|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
19290492|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
19290493|NCT04284007|BB 1101|bb 1101|mesh-list
19290494|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290495|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
19290496|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
19290497|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290498|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290499|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19290500|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
19290501|NCT04284007|Hormones|hormones|mesh-ancestor
19290502|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290503|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19290504|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290505|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
19290506|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290507|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290508|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19290509|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
19290510|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360788|NCT00928655|Acetazolamide|acetazolamide|mesh-list
20360789|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
20360790|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20360791|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360792|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360793|NCT00928655|Diuretics|diuretics|mesh-ancestor
19290511|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
19290512|NCT04283877|Methylphenidate|methylphenidate|mesh-list
19290513|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19290514|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290515|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19290516|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19290517|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290518|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290519|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
19290520|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290521|NCT04283630|Ascorbic Acid|ascorbic acid|mesh-list
19290522|NCT04283630|Vitamins|vitamins|mesh-ancestor
19290523|NCT04283630|Micronutrients|micronutrients|mesh-ancestor
19290524|NCT04283630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290525|NCT04283630|Antioxidants|antioxidants|mesh-ancestor
19290526|NCT04283630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290527|NCT04283630|Protective Agents|protective agents|mesh-ancestor
19290528|NCT04283604|Methylphenidate|methylphenidate|mesh-list
19290529|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19290530|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290531|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19290532|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19290533|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290534|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290535|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
19290536|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290537|NCT04283487|Levan|levan|mesh-list
19290538|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290539|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
19290540|NCT04283331|Propoxycaine|propoxycaine|mesh-list
19290541|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
19290542|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
19290543|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290544|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290545|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
19290546|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290547|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
19290548|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19290549|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19290550|NCT04283435|Estradiol|estradiol|mesh-list
19290551|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19290552|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290553|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290554|NCT04283435|Estrogens|estrogens|mesh-ancestor
19290555|NCT04283435|Hormones|hormones|mesh-ancestor
19290556|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290557|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19290558|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
19290559|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19290560|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19290561|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
19290562|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19290563|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19290564|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290565|NCT04283435|Urological Agents|urological agents|mesh-ancestor
19290566|NCT04283292|Capsaicin|capsaicin|mesh-list
19290567|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
19290568|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
19290569|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
19290570|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290571|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290572|NCT04283526|Decitabine|decitabine|mesh-list
19838285|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20360794|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
19290573|NCT04283526|Spartalizumab|spartalizumab|mesh-list
19290574|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19290575|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
19395064|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
20360795|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360796|NCT00928798|Sirolimus|sirolimus|mesh-list
20360797|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360798|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360799|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20360800|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360801|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
20360802|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19290576|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290577|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290578|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290579|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19290580|NCT04283513|Ribavirin|ribavirin|mesh-list
19290581|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
19290582|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290583|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
19290584|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290585|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
19290586|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
19290587|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19290588|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19290589|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290590|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290591|NCT04283240|Urological Agents|urological agents|mesh-ancestor
19395065|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395066|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395067|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395068|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395069|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395070|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395071|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395072|NCT03670758|Protein S|protein s|mesh-list
19395073|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
20182369|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182370|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182371|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182372|NCT00191919|Analgesics|analgesics|mesh-ancestor
20182373|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
20182374|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395074|NCT03670706|Analgesics|analgesics|mesh-list
19395075|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
19395076|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838286|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182375|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
20182376|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360803|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
20360804|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360805|NCT00928811|Basiliximab|basiliximab|mesh-list
20360806|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360807|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
20360808|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360809|NCT00928837|Naproxen|naproxen|mesh-list
20360810|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20360811|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20360812|NCT00928837|Analgesics|analgesics|mesh-ancestor
20360813|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
20360814|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360815|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360816|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20360817|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360818|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
20182377|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
20182378|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20182379|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20182380|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182381|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182382|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182383|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182384|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360819|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19395077|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395078|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
19395079|NCT03670212|Yohimbine|yohimbine|mesh-list
19290592|NCT04282902|Pirfenidone|pirfenidone|mesh-list
19290593|NCT04282902|Analgesics|analgesics|mesh-ancestor
19290594|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
19290595|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290596|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290597|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19290598|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19290599|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290600|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19290601|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290602|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
19290603|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
19290604|NCT04283162|Calcium|calcium|mesh-list
19290605|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19290606|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290607|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19290608|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
19290609|NCT04283162|Coagulants|coagulants|mesh-ancestor
19290610|NCT04282824|Edetic Acid|edetic acid|mesh-list
19290611|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19290612|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
19290613|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
19290614|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290615|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
19290616|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19290617|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19290618|NCT04283058|Ketamine|ketamine|mesh-list
19290619|NCT04283058|Anesthetics|anesthetics|mesh-list
19290620|NCT04283058|Analgesics|analgesics|mesh-ancestor
19290621|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
19290622|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290623|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290624|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19290625|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290626|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
19290627|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290628|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19290629|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19290630|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290631|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290632|NCT04282954|Esomeprazole|esomeprazole|mesh-list
19290633|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19290634|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19671529|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19671530|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19290635|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19290636|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290637|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290638|NCT04282941|Ibuprofen|ibuprofen|mesh-list
19290639|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19290640|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19290641|NCT04282941|Analgesics|analgesics|mesh-ancestor
19290642|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
19290643|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290644|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290645|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290646|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19290647|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19290648|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290649|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290650|NCT04283110|Midazolam|midazolam|mesh-list
19290651|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19290652|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19290653|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290654|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290655|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19290656|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19290657|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19290658|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290659|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
19290660|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
19290661|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
19290662|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
19290663|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290664|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290665|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19290666|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290667|NCT04282746|Ketamine|ketamine|mesh-list
19290668|NCT04282746|Analgesics|analgesics|mesh-ancestor
19290669|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
19290670|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290671|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290672|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19290673|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290674|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
19290675|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
19290676|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290677|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19290678|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19290679|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290680|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290681|NCT04282291|Morphine|morphine|mesh-list
19290682|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19290683|NCT04282291|Narcotics|narcotics|mesh-ancestor
19290684|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290685|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290686|NCT04282291|Analgesics|analgesics|mesh-ancestor
19290687|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
19290688|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290689|NCT04282200|Ketorolac|ketorolac|mesh-list
19290690|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19290691|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19290692|NCT04282200|Analgesics|analgesics|mesh-ancestor
19290693|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
19290694|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290695|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290696|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290697|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19290698|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19290699|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290700|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290701|NCT04282096|Caseins|caseins|mesh-list
19290702|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
19290703|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
19290704|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290719|NCT04281862|Prednisolone|prednisolone|mesh-list
19290720|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290721|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
19290722|NCT04281862|Hormones|hormones|mesh-ancestor
19290723|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290724|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290725|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19290726|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290727|NCT04282031|Letrozole|letrozole|mesh-list
19290728|NCT04282031|Fulvestrant|fulvestrant|mesh-list
19290729|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290730|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19290731|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19290732|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290733|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290734|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19290735|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
19290736|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290737|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290738|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19290739|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19290740|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
19290741|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19290742|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19290743|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19290744|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290745|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290746|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
19290747|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290748|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290749|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19290750|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290751|NCT04281576|Capecitabine|capecitabine|mesh-list
19290752|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
19290753|NCT04281576|Trastuzumab|trastuzumab|mesh-list
19671531|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
19671532|NCT04645316|Propofol|propofol|mesh-list
19671533|NCT04645316|Sevoflurane|sevoflurane|mesh-list
19671534|NCT04645316|Desflurane|desflurane|mesh-list
20360820|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290754|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19290755|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
19290756|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290757|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290758|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19290759|NCT04281706|Propofol|propofol|mesh-list
19290760|NCT04281706|Etomidate|etomidate|mesh-list
19290761|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19290762|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290763|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290764|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290765|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
19290766|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
19290767|NCT04281628|Ketamine|ketamine|mesh-list
19290768|NCT04281628|Analgesics|analgesics|mesh-ancestor
19290769|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
19290770|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290771|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290772|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19290773|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19290774|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
19290775|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
19290776|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290777|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19290778|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19290779|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290780|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290781|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20360821|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360822|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20360823|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360824|NCT00928915|Thrombin|thrombin|mesh-list
20360825|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
20360826|NCT00928915|Coagulants|coagulants|mesh-ancestor
20360827|NCT00928967|Interferons|interferons|mesh-list
20360828|NCT00928967|Interferon-beta|interferon-beta|mesh-list
20360829|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
20360830|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360831|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
19290782|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290783|NCT04281680|Octreotide|octreotide|mesh-list
19290784|NCT04281680|Pasireotide|pasireotide|mesh-list
19290785|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19290786|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19290787|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290788|NCT04281680|Hormones|hormones|mesh-ancestor
19290789|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360832|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360833|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
20360834|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360835|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19290790|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290791|NCT04281290|Bleomycin|bleomycin|mesh-list
19671535|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19671536|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360836|NCT00929045|Hormones|hormones|mesh-list
19290792|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19290793|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290794|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
19290795|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19290796|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290797|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20360837|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360838|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360839|NCT00929058|Bevacizumab|bevacizumab|mesh-list
20360840|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20360841|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360842|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19290798|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19290799|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290800|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360843|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20360844|NCT00929058|Growth Substances|growth substances|mesh-ancestor
20360845|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290801|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290802|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19290803|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19290804|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19290805|NCT04281017|Anesthetics|anesthetics|mesh-list
19290806|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290807|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290808|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
19290809|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19290810|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19290811|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19290812|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19290813|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290814|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
19290815|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290816|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290817|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19290818|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290819|NCT04280874|Dinoprostone|dinoprostone|mesh-list
19290820|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
19290821|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19290822|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395080|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395081|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
19395082|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
19395083|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395084|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395085|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19395086|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19395087|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19395088|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
19395089|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395090|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395091|NCT03670212|Urological Agents|urological agents|mesh-ancestor
19395092|NCT03670095|Memantine|memantine|mesh-list
19395093|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19395094|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19395095|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
19395096|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395097|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395098|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395099|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19395100|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19395101|NCT03670043|Metformin|metformin|mesh-list
19671537|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182385|NCT00191932|Analgesics|analgesics|mesh-ancestor
20182386|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
20182387|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182388|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
20182389|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20182390|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
20182391|NCT00191971|Gemcitabine|gemcitabine|mesh-list
20182392|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182393|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
20217245|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20182394|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182395|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182396|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
20182397|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182398|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182399|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182400|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
20182401|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360846|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
19290823|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19290824|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19290825|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360847|NCT00929279|Abciximab|abciximab|mesh-list
20360848|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
20360849|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20360850|NCT00929370|Glycine|glycine|mesh-list
20360851|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
20360852|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360853|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360854|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360855|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20360856|NCT00929591|Tamoxifen|tamoxifen|mesh-list
20360857|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
20360858|NCT00929591|Doxorubicin|doxorubicin|mesh-list
20360859|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19290826|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19290827|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
19290828|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290829|NCT04280289|Cannabidiol|cannabidiol|mesh-list
19290830|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
19290831|NCT04279938|Rituximab|rituximab|mesh-list
19290832|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
19290833|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19290834|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290835|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
19290836|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290837|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19290838|NCT04280263|Caffeine|caffeine|mesh-list
19290839|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19290840|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290841|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19290842|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290843|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290844|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19290845|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19290846|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
19290847|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290848|NCT04280055|Psilocybin|psilocybin|mesh-list
19290849|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
19290850|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290851|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360860|NCT00929591|Fluorouracil|fluorouracil|mesh-list
20360861|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360862|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
20360863|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360864|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360865|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20360866|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
20360867|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360868|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360869|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19290852|NCT04279054|Morphine|morphine|mesh-list
19290853|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19290854|NCT04279054|Narcotics|narcotics|mesh-ancestor
19290855|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290856|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290857|NCT04279054|Analgesics|analgesics|mesh-ancestor
19290858|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
19290859|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360870|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20360871|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20360872|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19290860|NCT04279379|Decitabine|decitabine|mesh-list
19290861|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182402|NCT00191997|Olanzapine|olanzapine|mesh-list
20360873|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360874|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
20360875|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20360876|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20360877|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
20360878|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360879|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19290862|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
19290863|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290864|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290865|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290866|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
19290867|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19290868|NCT04279106|Listerine|listerine|mesh-list
19290869|NCT04279106|Fluorides|fluorides|mesh-list
19290870|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
19290871|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
19290872|NCT04279106|Protective Agents|protective agents|mesh-ancestor
19290873|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290874|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19290875|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290876|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
19290877|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
19290878|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
20182403|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
19671538|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19671539|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
19671540|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
20360880|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20360881|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19671541|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19671542|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19290879|NCT04278950|Povidone|povidone|mesh-list
19290880|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
19290881|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
19290882|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19290883|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290884|NCT04278729|Apixaban|apixaban|mesh-list
20360882|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20360883|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20360884|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
20360885|NCT00929630|Coagulants|coagulants|mesh-ancestor
20360886|NCT00929799|Hormones|hormones|mesh-list
20360887|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360888|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360889|NCT00929812|Glucagon|glucagon|mesh-list
20360890|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20360891|NCT00929812|Hormones|hormones|mesh-ancestor
20360892|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290885|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19290886|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
19290887|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19290888|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
19290889|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290890|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290891|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
19290892|NCT04278859|Antibodies|antibodies|mesh-list
19290893|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19290894|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
19290895|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290896|NCT04278703|Oxycodone|oxycodone|mesh-list
19671543|NCT04620382|Midodrine|midodrine|mesh-list
20182404|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
20182405|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182406|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182407|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20182408|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20182409|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20182410|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20182411|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20182412|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20182413|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20182414|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182415|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182416|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19290897|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19290898|NCT04278703|Narcotics|narcotics|mesh-ancestor
19290899|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290900|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290901|NCT04278703|Analgesics|analgesics|mesh-ancestor
19290902|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
19290903|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290904|NCT04278807|Anesthetics|anesthetics|mesh-list
19290905|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290906|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290907|NCT04278677|Melatonin|melatonin|mesh-list
19290908|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
19290909|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290910|NCT04278677|Protective Agents|protective agents|mesh-ancestor
19290911|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290912|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290913|NCT04278833|Dexamethasone|dexamethasone|mesh-list
19290914|NCT04278833|Triamcinolone|triamcinolone|mesh-list
19290915|NCT04278833|Betamethasone|betamethasone|mesh-list
19290916|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19290917|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
19290918|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
19290919|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290920|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360893|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360894|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
20360895|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20360896|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
20360897|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290921|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19290922|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
19290923|NCT04278833|Hormones|hormones|mesh-ancestor
19290924|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290925|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19290926|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290927|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19290928|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
19290929|NCT04278846|Bupivacaine|bupivacaine|mesh-list
19290930|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
19290931|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
19290932|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19290933|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290934|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
19290935|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395102|NCT03670043|Psyllium|psyllium|mesh-list
19395103|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19395104|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395105|NCT03670043|Cathartics|cathartics|mesh-ancestor
19395106|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395107|NCT03669783|Dactinomycin|dactinomycin|mesh-list
19395108|NCT03669783|Carboplatin|carboplatin|mesh-list
19395109|NCT03669783|Doxorubicin|doxorubicin|mesh-list
19395110|NCT03669783|Etoposide|etoposide|mesh-list
19395111|NCT03669783|Vincristine|vincristine|mesh-list
19395112|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395113|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19395114|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19395115|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19395116|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395117|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395118|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19395119|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20182417|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
20182418|NCT00192049|Gemcitabine|gemcitabine|mesh-list
20182419|NCT00192049|Mitomycins|mitomycins|mesh-list
20182420|NCT00192049|Mitomycin|mitomycin|mesh-list
20182421|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182422|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
20182423|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182424|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182425|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
20182426|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182427|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182428|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182429|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
20182430|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290936|NCT04278599|Zinc|zinc|mesh-list
19290937|NCT04278599|Trace Elements|trace elements|mesh-ancestor
19290938|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
19290939|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290940|NCT04278937|Azithromycin|azithromycin|mesh-list
19290941|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360898|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360899|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20360900|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
20360901|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19290942|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19290943|NCT04278378|Folic Acid|folic acid|mesh-list
19671544|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
19671545|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
19671546|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671547|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671548|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19671549|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19671550|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19671551|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19671552|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
19671553|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671554|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671555|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
19671556|NCT04594382|Narcotics|narcotics|mesh-ancestor
19671557|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671558|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182431|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19290944|NCT04278378|Riboflavin|riboflavin|mesh-list
19290945|NCT04278378|Hematinics|hematinics|mesh-ancestor
19290946|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
19290947|NCT04278378|Vitamins|vitamins|mesh-ancestor
19290948|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
19290949|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290950|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20360902|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20360903|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20360904|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360905|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360906|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360907|NCT00929877|Ketoprofen|ketoprofen|mesh-list
20360908|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20360909|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20360910|NCT00929877|Analgesics|analgesics|mesh-ancestor
20360911|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
20360912|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360913|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360914|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20360915|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20360916|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20360917|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360918|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360919|NCT00929955|Ondansetron|ondansetron|mesh-list
20360920|NCT00929955|Simvastatin|simvastatin|mesh-list
19290951|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
19290952|NCT04278287|Paclitaxel|paclitaxel|mesh-list
19290953|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19290954|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671559|NCT04594382|Analgesics|analgesics|mesh-ancestor
20182432|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
20182433|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182434|NCT00192062|Gemcitabine|gemcitabine|mesh-list
20182435|NCT00192062|Vinorelbine|vinorelbine|mesh-list
20182436|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182437|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
20182438|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182439|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182440|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
20182441|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360921|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20360922|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20360923|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
19290955|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290956|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
19290957|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
19290958|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
20360924|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360925|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20360926|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20360927|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19290959|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290960|NCT04278508|Progesterone|progesterone|mesh-list
19290961|NCT04278508|Progestins|progestins|mesh-ancestor
19290962|NCT04278508|Hormones|hormones|mesh-ancestor
20360928|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
20360929|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
20360930|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19290963|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19290964|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290965|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19290966|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
19290967|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19290968|NCT04278495|Losartan|losartan|mesh-list
19290969|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19290970|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19290971|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19290972|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19290973|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290974|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
19290975|NCT04278547|Valganciclovir|valganciclovir|mesh-list
19290976|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
19290977|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838287|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19838288|NCT00619970|Rifaximin|rifaximin|mesh-list
19838289|NCT00619970|Lactulose|lactulose|mesh-list
19838290|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838291|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838292|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360931|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360932|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20360933|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
20360934|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
20360935|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20360936|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
20360937|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360938|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20360939|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20360940|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360941|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20360942|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20360943|NCT00930020|Minocycline|minocycline|mesh-list
20360944|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20360945|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20360946|NCT00930033|Sunitinib|sunitinib|mesh-list
20360947|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360948|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20360949|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20360950|NCT00930033|Growth Substances|growth substances|mesh-ancestor
20360951|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360952|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
20360953|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20360954|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20360955|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360956|NCT00930072|Clonidine|clonidine|mesh-list
20360957|NCT00930072|Bupivacaine|bupivacaine|mesh-list
20360958|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
20360959|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
19838293|NCT00619983|Gabapentin|gabapentin|mesh-list
19838294|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19838295|NCT00619983|Donepezil|donepezil|mesh-list
19290987|NCT04278040|Melphalan|melphalan|mesh-list
19290988|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19290989|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
19290990|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19290991|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19290992|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19290993|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19290994|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
19290995|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425305|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
19290996|NCT04277884|Firibastat|firibastat|mesh-list
19838296|NCT00619983|Analgesics|analgesics|mesh-ancestor
19290997|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19290998|NCT04277845|Dexamethasone|dexamethasone|mesh-list
19290999|NCT04277845|Bortezomib|bortezomib|mesh-list
19291000|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291001|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
19291002|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
19291003|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291004|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291005|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291006|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
19291007|NCT04277845|Hormones|hormones|mesh-ancestor
19291008|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291009|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19291010|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291011|NCT04277702|Montelukast|montelukast|mesh-list
19291012|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19291013|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
19291014|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19291015|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
19291016|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291017|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291018|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19291019|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20360960|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20360961|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291020|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291021|NCT04277663|Interferons|interferons|mesh-list
19291022|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291023|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
19291024|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291025|NCT04277923|SMOFlipid|smoflipid|mesh-list
19291026|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19291027|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19291028|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19291029|NCT04277533|Calcium|calcium|mesh-list
19291030|NCT04277533|Bilirubin|bilirubin|mesh-list
19291031|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19291032|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291033|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
19291034|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291035|NCT04277533|Protective Agents|protective agents|mesh-ancestor
19291036|NCT04277143|Daptomycin|daptomycin|mesh-list
19291037|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19291038|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291039|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
19291040|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291041|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291042|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291043|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291044|NCT04276883|Analgesics|analgesics|mesh-ancestor
20360962|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
20360963|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20360964|NCT00930072|Analgesics|analgesics|mesh-ancestor
20360965|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20360966|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
20360967|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
20360968|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20360969|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20360970|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20360971|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
20360972|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20360973|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360974|NCT00930098|Clofarabine|clofarabine|mesh-list
20360975|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20360976|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
20360977|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360978|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20360979|NCT00930189|Triamcinolone|triamcinolone|mesh-list
20360980|NCT00930189|Ranibizumab|ranibizumab|mesh-list
20360981|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19291045|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
19291046|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291047|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20360982|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19671560|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
19671561|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671562|NCT04530604|Defibrotide|defibrotide|mesh-list
19671563|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19671564|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19671565|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671566|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19671567|NCT04451863|Caryophyllene|caryophyllene|mesh-list
19671568|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671569|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291048|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19291049|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19291050|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
19291051|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291052|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291053|NCT04276857|Leucovorin|leucovorin|mesh-list
19291054|NCT04276857|Gemcitabine|gemcitabine|mesh-list
19291055|NCT04276857|Paclitaxel|paclitaxel|mesh-list
19291056|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
19291057|NCT04276857|Irinotecan|irinotecan|mesh-list
19291058|NCT04276857|Folfirinox|folfirinox|mesh-list
19291059|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19291060|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291061|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19291062|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19291063|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19291064|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291065|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19291066|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
19291067|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
19291068|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291069|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291070|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19291071|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
19291072|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182442|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182443|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182444|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
20182445|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182446|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182447|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182448|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182449|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19291073|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19291074|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19291075|NCT04276857|Antidotes|antidotes|mesh-ancestor
19291076|NCT04276857|Protective Agents|protective agents|mesh-ancestor
19291077|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
19291078|NCT04276857|Vitamins|vitamins|mesh-ancestor
19291079|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
19291080|NCT04276688|Interferons|interferons|mesh-list
19291081|NCT04276688|Ritonavir|ritonavir|mesh-list
19291082|NCT04276688|Ribavirin|ribavirin|mesh-list
19291083|NCT04276688|Lopinavir|lopinavir|mesh-list
19291084|NCT04276688|Interferon-beta|interferon-beta|mesh-list
19291085|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
19291086|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291087|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
19291088|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291089|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19291090|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19291091|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
19291092|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291093|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291094|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19291095|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19291096|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19291097|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19291098|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
19291099|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
19291100|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360983|NCT00930189|Growth Substances|growth substances|mesh-ancestor
19671570|NCT04451863|Analgesics|analgesics|mesh-ancestor
20182450|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
19291101|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19291102|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
20182451|NCT00192088|Pemetrexed|pemetrexed|mesh-list
19291103|NCT04276649|Antacids|antacids|mesh-ancestor
19671571|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
20360984|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360985|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
20360986|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291104|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182452|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612564|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20612565|NCT02251951|Paclitaxel|paclitaxel|mesh-list
20182453|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291105|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291106|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
19291107|NCT04276636|Antacids|antacids|mesh-ancestor
19291108|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291109|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291110|NCT04276389|Paclitaxel|paclitaxel|mesh-list
19291111|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19291112|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19291113|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291114|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19291115|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
19291116|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
19291117|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395120|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395121|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19395122|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19395123|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
19395124|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395125|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
20360987|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20360988|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
20360989|NCT00930189|Hormones|hormones|mesh-ancestor
20360990|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20360991|NCT00930202|Conivaptan|conivaptan|mesh-list
20360992|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19395126|NCT03669757|Betamethasone|betamethasone|mesh-list
19395127|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
19395128|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19395129|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
19395130|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19395131|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395132|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
19395133|NCT03669757|Hormones|hormones|mesh-ancestor
19395134|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395135|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182454|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360993|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20360994|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
20360995|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20360996|NCT00930241|Tacrolimus|tacrolimus|mesh-list
20360997|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20360998|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
20360999|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361000|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20361001|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361002|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361003|NCT00930306|Tolbutamide|tolbutamide|mesh-list
20361004|NCT00930306|Midazolam|midazolam|mesh-list
20361005|NCT00930306|Caffeine|caffeine|mesh-list
20361006|NCT00930306|Omeprazole|omeprazole|mesh-list
20361007|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20182455|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20182456|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182457|NCT00192101|Gemcitabine|gemcitabine|mesh-list
20182458|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182459|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182460|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
20182461|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182462|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
20182463|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182464|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182465|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182466|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
20361008|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20182467|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612566|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19291118|NCT04276376|Atezolizumab|atezolizumab|mesh-list
19291119|NCT04276376|Rucaparib|rucaparib|mesh-list
19291120|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291121|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19291122|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291123|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291124|NCT04276480|Tazobactam|tazobactam|mesh-list
19291125|NCT04276480|Piperacillin|piperacillin|mesh-list
19291126|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19291127|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19291128|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291129|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19291130|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291131|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291132|NCT04276428|Insulin|insulin|mesh-list
19291133|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19291134|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291135|NCT04276597|Edotreotide|edotreotide|mesh-list
19291136|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19291137|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291138|NCT04276545|Midazolam|midazolam|mesh-list
19291139|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19291140|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291141|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291142|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291143|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19291144|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19291145|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19291146|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19291147|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
19291148|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
19291149|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
19291150|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
19291151|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291152|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291153|NCT04276090|Dexamethasone|dexamethasone|mesh-list
19291154|NCT04276090|Floxuridine|floxuridine|mesh-list
19291155|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291156|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
19291157|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
19291158|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291159|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291160|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291161|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
19291162|NCT04276090|Hormones|hormones|mesh-ancestor
19291163|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291164|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19291165|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291166|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19291167|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
19291168|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291169|NCT04276155|Anticoagulants|anticoagulants|mesh-list
19291170|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19291171|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19291172|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291173|NCT04275960|Selitrectinib|selitrectinib|mesh-list
19291174|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291175|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291176|NCT04275414|Bevacizumab|bevacizumab|mesh-list
20182468|NCT00192413|Vaccines|vaccines|mesh-list
20182469|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
20182470|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182471|NCT00192569|Interferons|interferons|mesh-list
20182472|NCT00192569|Ribavirin|ribavirin|mesh-list
20182473|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
20182474|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
20182475|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20182476|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182477|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
20182478|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182479|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
20182480|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291177|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19291178|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182481|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
20182482|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291179|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19291180|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19291181|NCT04275414|Growth Substances|growth substances|mesh-ancestor
19291182|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291183|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
19291184|NCT04275518|Cytarabine|cytarabine|mesh-list
19291185|NCT04275518|Azacitidine|azacitidine|mesh-list
19291186|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19291187|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
19291188|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291189|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291190|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
19291191|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291192|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19291193|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
19291194|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182483|NCT00192595|Tenofovir|tenofovir|mesh-list
20182484|NCT00192595|Lamivudine|lamivudine|mesh-list
20182485|NCT00192595|Zidovudine|zidovudine|mesh-list
20182486|NCT00192595|Efavirenz|efavirenz|mesh-list
20182487|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
20182488|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182489|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20182490|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182491|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182492|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182493|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20182494|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20182495|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
20182496|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20182497|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20182498|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20182499|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20182500|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20182501|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20182502|NCT00192608|Saquinavir|saquinavir|mesh-list
20182503|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20182504|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20182505|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
20182506|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182507|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182508|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20182509|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20182510|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
20182511|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182512|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20182513|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20182514|NCT00192621|Lamivudine|lamivudine|mesh-list
20182515|NCT00192621|Zidovudine|zidovudine|mesh-list
20182516|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20182517|NCT00192621|Lopinavir|lopinavir|mesh-list
20182518|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20182519|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182520|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182521|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182522|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
20182523|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182524|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20182525|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20182526|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
20182527|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20182528|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20182529|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
20182530|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20182531|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20182532|NCT00192634|Tenofovir|tenofovir|mesh-list
20182533|NCT00192634|Lamivudine|lamivudine|mesh-list
20182534|NCT00192634|Emtricitabine|emtricitabine|mesh-list
20182535|NCT00192634|Abacavir|abacavir|mesh-list
20182536|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
20182537|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182538|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19291195|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182539|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182540|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361009|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361010|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361011|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20361012|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19291196|NCT04275375|Anesthetics|anesthetics|mesh-list
19291197|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291198|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291199|NCT04275388|Interferons|interferons|mesh-list
19291200|NCT04275388|Ritonavir|ritonavir|mesh-list
19291201|NCT04275388|Lopinavir|lopinavir|mesh-list
19291202|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
19291203|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19291204|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291205|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
19291206|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291207|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19291208|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19291209|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
19291210|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291211|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291212|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19291213|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19291214|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19291215|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19291216|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
19291217|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291218|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19291219|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
19291220|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291221|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
19291222|NCT04275258|Narcotics|narcotics|mesh-ancestor
19291223|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291224|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291225|NCT04275258|Analgesics|analgesics|mesh-ancestor
19291226|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
19291227|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291228|NCT04275492|Pramipexole|pramipexole|mesh-list
19291229|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
19291230|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291231|NCT04275492|Protective Agents|protective agents|mesh-ancestor
19291232|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291233|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19291234|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19291235|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
19291236|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
19291237|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291238|NCT04275115|Midazolam|midazolam|mesh-list
19291239|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19291240|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291241|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291242|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291243|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19291244|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19291245|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19291246|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19291247|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
19291248|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
19291249|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
19291250|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
19291251|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291252|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291253|NCT04275180|Argatroban|argatroban|mesh-list
19291254|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
19291255|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19291256|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
19291257|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291258|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291259|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
19291260|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19291261|NCT04274933|Capecitabine|capecitabine|mesh-list
19291262|NCT04274933|Venetoclax|venetoclax|mesh-list
19291263|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20361013|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19291264|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
19291265|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361014|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19291266|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291267|NCT04274920|Calcium|calcium|mesh-list
19291268|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19291269|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291270|NCT04275024|Calcipotriene|calcipotriene|mesh-list
19291271|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
19291272|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
19291273|NCT04274907|Venetoclax|venetoclax|mesh-list
19291274|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19291275|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291276|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
19291277|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19291278|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19291279|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19291280|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19291281|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291282|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
19291283|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291284|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291285|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19291286|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291287|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19291288|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
19291289|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291290|NCT04274816|Tremelimumab|tremelimumab|mesh-list
19291291|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291292|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19291293|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19291294|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19291295|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19395136|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19395137|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404236|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19404237|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404238|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404239|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19404240|NCT03596281|Growth Substances|growth substances|mesh-ancestor
19404241|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404242|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
19404243|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19404244|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19404245|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19404246|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404247|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404248|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
19404249|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19404250|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
19404251|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404252|NCT03596125|Expectorants|expectorants|mesh-ancestor
19404253|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404254|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19404255|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
19404256|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404257|NCT03596125|Protective Agents|protective agents|mesh-ancestor
19404258|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404259|NCT03596125|Antidotes|antidotes|mesh-ancestor
19404260|NCT03596099|Acetic Acid|acetic acid|mesh-list
19404261|NCT03596099|Retinol acetate|retinol acetate|mesh-list
19404262|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19404263|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404264|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19404265|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
19404266|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404267|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19404268|NCT03596099|Protective Agents|protective agents|mesh-ancestor
19404269|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404270|NCT03596060|Fentanyl|fentanyl|mesh-list
19404271|NCT03596060|Morphine|morphine|mesh-list
19404272|NCT03596060|Propofol|propofol|mesh-list
19404273|NCT03596060|Rocuronium|rocuronium|mesh-list
19404274|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19404275|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671572|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404276|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404277|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19848184|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
19291296|NCT04274270|Endostar protein|endostar protein|mesh-list
19291297|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19291298|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19291299|NCT04274270|Growth Substances|growth substances|mesh-ancestor
19291300|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291301|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
19291302|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291303|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19291304|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
19291305|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671573|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20182541|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182542|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20182543|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20182544|NCT00192660|Ritonavir|ritonavir|mesh-list
20182545|NCT00192660|Nelfinavir|nelfinavir|mesh-list
20182546|NCT00192660|Indinavir|indinavir|mesh-list
20182547|NCT00192660|Saquinavir|saquinavir|mesh-list
20182548|NCT00192660|Amprenavir|amprenavir|mesh-list
20182549|NCT00192660|Tenofovir|tenofovir|mesh-list
20182550|NCT00192660|Lamivudine|lamivudine|mesh-list
20182551|NCT00192660|Zidovudine|zidovudine|mesh-list
19291306|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
19291307|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182552|NCT00192660|Nevirapine|nevirapine|mesh-list
20182553|NCT00192660|Abacavir|abacavir|mesh-list
20182554|NCT00192660|Stavudine|stavudine|mesh-list
20182555|NCT00192660|Didanosine|didanosine|mesh-list
20182556|NCT00192660|Tipranavir|tipranavir|mesh-list
20182557|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
20182558|NCT00192660|Efavirenz|efavirenz|mesh-list
20182559|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20182560|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20182561|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
20182562|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182563|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182564|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20182565|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20182566|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
20182567|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182568|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20182569|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20182570|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20182571|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182572|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
20182573|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20182574|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20182575|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20182576|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20182577|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20182578|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20182579|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20182580|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20182581|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
20182582|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20182583|NCT00192673|Asparaginase|asparaginase|mesh-list
20182584|NCT00192673|Pegaspargase|pegaspargase|mesh-list
20182585|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182586|NCT00192712|Gemcitabine|gemcitabine|mesh-list
20182587|NCT00192712|Irinotecan|irinotecan|mesh-list
20182588|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182589|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
20182590|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182591|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182592|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
20182593|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182594|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182595|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182596|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
20182597|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182598|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20361015|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
19395138|NCT03669601|Gemcitabine|gemcitabine|mesh-list
19671574|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20182599|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182600|NCT00192725|Tryptophan|tryptophan|mesh-list
20182601|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20182602|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
19291308|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291309|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291310|NCT04274257|Rituximab|rituximab|mesh-list
19291311|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19291312|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291313|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
19291314|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291315|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19291316|NCT04274179|Lamotrigine|lamotrigine|mesh-list
19291317|NCT04274179|Valproic Acid|valproic acid|mesh-list
19291318|NCT04274179|Ethosuximide|ethosuximide|mesh-list
19291319|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
19291320|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19291321|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19291322|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291323|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19291324|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291325|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19291326|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19291327|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291328|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19291329|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19291330|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291331|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
19291332|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291333|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
19291334|NCT04273997|Metronidazole|metronidazole|mesh-list
19838297|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
19838298|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838299|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838300|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
19838301|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19838302|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19838303|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838304|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838305|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19838306|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20182603|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20182604|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
20182605|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182606|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
20182607|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182608|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20182609|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20182610|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
20182611|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182612|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182613|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20182614|NCT00192777|Capecitabine|capecitabine|mesh-list
20182615|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182616|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
20182617|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182618|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182619|NCT00192803|Candesartan|candesartan|mesh-list
20182620|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20182621|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20182622|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20182623|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182624|NCT00192842|Gemcitabine|gemcitabine|mesh-list
20182625|NCT00192842|Curcumin|curcumin|mesh-list
20182626|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182627|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
20182628|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182629|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182630|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
20182631|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182632|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182633|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182634|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
20182635|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361016|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
19291335|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361017|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
19291336|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19291337|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19291338|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19291339|NCT04273984|Misoprostol|misoprostol|mesh-list
19291340|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19291341|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
19291342|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19291343|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291344|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19291345|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291346|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
19291347|NCT04273776|Zolpidem|zolpidem|mesh-list
20361018|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
20361019|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361020|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361021|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20361022|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361023|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19291348|NCT04273776|Suvorexant|suvorexant|mesh-list
19291349|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19291350|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291351|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291352|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291353|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19291354|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
19291355|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
19291356|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291357|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291358|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19291359|NCT04273763|Interferons|interferons|mesh-list
20361024|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361025|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20361026|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20361027|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20361028|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20361029|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
20361030|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361031|NCT00930332|Methadone|methadone|mesh-list
20361032|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19291360|NCT04273763|Bromhexine|bromhexine|mesh-list
19671575|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20182636|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20182637|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20182638|NCT00192842|Analgesics|analgesics|mesh-ancestor
20182639|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
20182640|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20182641|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20182642|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20182643|NCT00192855|Entacapone|entacapone|mesh-list
20182644|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20182645|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20182646|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20182647|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182648|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217246|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217247|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
20217248|NCT00309192|Hormones|hormones|mesh-ancestor
20217249|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217250|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217251|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217252|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
20217253|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217254|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217255|NCT00309205|Dapivirine|dapivirine|mesh-list
20217256|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20217257|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19291361|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671576|NCT04450394|Insulin|insulin|mesh-list
19671577|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19671578|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671579|NCT04303325|Esketamine|esketamine|mesh-list
19671580|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
19671581|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19671582|NCT04293393|Paclitaxel|paclitaxel|mesh-list
19671583|NCT04293393|Docetaxel|docetaxel|mesh-list
19671584|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
20361033|NCT00930332|Narcotics|narcotics|mesh-ancestor
19291362|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
19291363|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291364|NCT04273763|Expectorants|expectorants|mesh-ancestor
19291365|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
19291366|NCT04273581|Thalidomide|thalidomide|mesh-list
19291367|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19291368|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
19291369|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291370|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
20361034|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361035|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361036|NCT00930332|Analgesics|analgesics|mesh-ancestor
20361037|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
20361038|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361039|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
20361040|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
20361041|NCT00930345|Sunitinib|sunitinib|mesh-list
20361042|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291371|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19291372|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291373|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19291374|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19291375|NCT04273581|Growth Substances|growth substances|mesh-ancestor
19291376|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
19291377|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291378|NCT04273607|Heparin|heparin|mesh-list
19291379|NCT04273607|Calcium heparin|calcium heparin|mesh-list
19291380|NCT04273607|Enoxaparin|enoxaparin|mesh-list
19291381|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
19291382|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19291383|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19291384|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361043|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20361044|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20361045|NCT00930345|Growth Substances|growth substances|mesh-ancestor
20361046|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361047|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
20361048|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20361049|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361050|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361051|NCT00930358|Anesthetics|anesthetics|mesh-list
20361052|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361053|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361054|NCT00930475|Carboplatin|carboplatin|mesh-list
20361055|NCT00930475|Everolimus|everolimus|mesh-list
20361056|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361057|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361058|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
20361059|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361060|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
20361061|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19291385|NCT04273529|Thalidomide|thalidomide|mesh-list
19291386|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19291387|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
19291388|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291389|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
19838307|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838308|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838309|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
19838310|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19838311|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19838312|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20182649|NCT00192959|Propofol|propofol|mesh-list
20182650|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20182651|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20182652|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182653|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20182654|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
20182655|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
20182656|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
20182657|NCT00193011|Docetaxel|docetaxel|mesh-list
20182658|NCT00193011|Fluorouracil|fluorouracil|mesh-list
20182659|NCT00193011|Methotrexate|methotrexate|mesh-list
19291390|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19291391|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291392|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20182660|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182661|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
20182662|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182663|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20182664|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20182665|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
20182666|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182667|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182668|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20182669|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182670|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182671|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182672|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
19291393|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19291394|NCT04273529|Growth Substances|growth substances|mesh-ancestor
19291395|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
19291396|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291397|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
19291398|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19291399|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19291400|NCT04273321|Prednisolone|prednisolone|mesh-list
19291401|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
19291402|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19291403|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
19291404|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291405|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
19291406|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
19291407|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291408|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182673|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182674|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20361062|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20361063|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361064|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20361065|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20361066|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361067|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182675|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
20182676|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20182677|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
20182678|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182679|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20182680|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20182681|NCT00193024|Docetaxel|docetaxel|mesh-list
20182682|NCT00193024|Epirubicin|epirubicin|mesh-list
20182683|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182684|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182685|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182686|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182687|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182688|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20182689|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20182690|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182691|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182692|NCT00193076|Gemcitabine|gemcitabine|mesh-list
20182693|NCT00193076|Carboplatin|carboplatin|mesh-list
20182694|NCT00193076|Trastuzumab|trastuzumab|mesh-list
20182695|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182696|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182697|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
20182698|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182699|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
20182700|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182701|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182702|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182703|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
20182704|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182705|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182706|NCT00193089|Docetaxel|docetaxel|mesh-list
20182707|NCT00193089|Trastuzumab|trastuzumab|mesh-list
20182708|NCT00193089|Vinorelbine|vinorelbine|mesh-list
19291409|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291410|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
20182709|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291411|NCT04273321|Hormones|hormones|mesh-ancestor
19395139|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19291412|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291413|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19291414|NCT04273321|Protective Agents|protective agents|mesh-ancestor
19291415|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19291416|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291417|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
19291418|NCT04273282|Dexamethasone|dexamethasone|mesh-list
19291419|NCT04273282|Prednisolone|prednisolone|mesh-list
19291420|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19291421|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
19291422|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19291423|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
19291424|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19291425|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
19291426|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291427|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
19291428|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
19291429|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291430|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291431|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291432|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
19291433|NCT04273282|Hormones|hormones|mesh-ancestor
19291434|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291435|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19291436|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291437|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19291438|NCT04273282|Protective Agents|protective agents|mesh-ancestor
19291439|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19291440|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291441|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20182710|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182711|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182712|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182713|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182714|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182715|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182716|NCT00193102|Thalidomide|thalidomide|mesh-list
20182717|NCT00193102|Capecitabine|capecitabine|mesh-list
20182718|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182719|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
20182720|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182721|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182722|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182723|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
20182724|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182725|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
20182726|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20182727|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182728|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20182729|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20182730|NCT00193102|Growth Substances|growth substances|mesh-ancestor
20182731|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
20182732|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
20182733|NCT00193115|Docetaxel|docetaxel|mesh-list
20182734|NCT00193115|Doxorubicin|doxorubicin|mesh-list
20182735|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182736|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
20182737|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182738|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20182739|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20182740|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
20182741|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291442|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19291443|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291444|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182742|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182743|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20182744|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182745|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182746|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
19291445|NCT04273256|Inositol|inositol|mesh-list
19291446|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
20182747|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20182748|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20361068|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361069|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20361070|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
20361071|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20361072|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361073|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20361074|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20361075|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19291447|NCT04273256|Vitamins|vitamins|mesh-ancestor
19291448|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
19291449|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291450|NCT04273191|Brexanolone|brexanolone|mesh-list
19291451|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
19291452|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291453|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291454|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291455|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
19291456|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
19291457|NCT04273100|Lenvatinib|lenvatinib|mesh-list
19291458|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291459|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19291460|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291461|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291462|NCT04273035|Midazolam|midazolam|mesh-list
19291463|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20182749|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20361076|NCT00930514|Rituximab|rituximab|mesh-list
20361077|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20361078|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361079|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
20361080|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361081|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361082|NCT00930566|Methoxsalen|methoxsalen|mesh-list
19291464|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291465|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291466|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291467|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19291468|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19291469|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19291470|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20361083|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20361084|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
20361085|NCT00930579|Metformin|metformin|mesh-list
20361086|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361087|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425306|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425307|NCT01274247|Benzocaine|benzocaine|mesh-list
20182750|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182751|NCT00193141|Paclitaxel|paclitaxel|mesh-list
20182752|NCT00193141|Carboplatin|carboplatin|mesh-list
20182753|NCT00193141|Fluorouracil|fluorouracil|mesh-list
20182754|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182755|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182756|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182757|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182758|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182759|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182760|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
20182761|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182762|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182763|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
20182764|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182765|NCT00193154|Bevacizumab|bevacizumab|mesh-list
20182766|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20182767|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182768|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182769|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20182770|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20182771|NCT00193154|Growth Substances|growth substances|mesh-ancestor
20182772|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425308|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
20425309|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
20425310|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20182773|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
20182774|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19291471|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
19291472|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
20361088|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
20361089|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20361090|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361091|NCT00930670|Esomeprazole|esomeprazole|mesh-list
20361092|NCT00930670|Omeprazole|omeprazole|mesh-list
20361093|NCT00930670|Pantoprazole|pantoprazole|mesh-list
20361094|NCT00930670|Ranitidine|ranitidine|mesh-list
20361095|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20361096|NCT00930670|Atorvastatin|atorvastatin|mesh-list
20361097|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19291473|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
19291474|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
19291475|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291476|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291477|NCT04273061|Atezolizumab|atezolizumab|mesh-list
19291478|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291479|NCT04272788|Infliximab|infliximab|mesh-list
19291480|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
19291481|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291482|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19291483|NCT04272645|Atezolizumab|atezolizumab|mesh-list
19291484|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291485|NCT04272567|Norepinephrine|norepinephrine|mesh-list
19291486|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19291487|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19291488|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
19291489|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291490|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291491|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291492|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
19291493|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
19291494|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291495|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19291496|NCT04272476|Fluoxetine|fluoxetine|mesh-list
19291497|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19291498|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19291499|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19291500|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291501|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291502|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
19291503|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291504|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19291505|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
19291506|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19291507|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19291508|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19291509|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395140|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
19395141|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182775|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182776|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361098|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20361099|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20182777|NCT00193167|Topotecan|topotecan|mesh-list
20182778|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182779|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182780|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182781|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182782|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182783|NCT00193193|Paclitaxel|paclitaxel|mesh-list
20182784|NCT00193193|Carboplatin|carboplatin|mesh-list
20182785|NCT00193193|Estramustine|estramustine|mesh-list
20182786|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182787|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182788|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182789|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182790|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182791|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182792|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20182793|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
20361100|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
19395142|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395143|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
20361101|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361102|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20361103|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20361104|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612567|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612568|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612569|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
20612570|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182794|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20182795|NCT00193232|Docetaxel|docetaxel|mesh-list
20182796|NCT00193232|Bortezomib|bortezomib|mesh-list
20182797|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182798|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182799|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182800|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182801|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182802|NCT00193245|Docetaxel|docetaxel|mesh-list
20182803|NCT00193245|Topotecan|topotecan|mesh-list
20182804|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361105|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20361106|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361107|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20361108|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20361109|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
20361110|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
20361111|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361112|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361113|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20361114|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
20361115|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361116|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
20361117|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20361118|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20361119|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20361120|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361121|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361122|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
20361123|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291510|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19671585|NCT04293393|Doxorubicin|doxorubicin|mesh-list
19671586|NCT04293393|Letrozole|letrozole|mesh-list
19671587|NCT04293393|Leuprolide|leuprolide|mesh-list
19671588|NCT04293393|Goserelin|goserelin|mesh-list
19671589|NCT04293393|Taxane|taxane|mesh-list
19671590|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182805|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182806|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182807|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182808|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182809|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182810|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182811|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182812|NCT00193271|Docetaxel|docetaxel|mesh-list
20182813|NCT00193271|Estramustine|estramustine|mesh-list
20182814|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182815|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182816|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182817|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182818|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182819|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20182820|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
20182821|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20182822|NCT00193284|Carboplatin|carboplatin|mesh-list
20182823|NCT00193284|Docetaxel|docetaxel|mesh-list
20182824|NCT00193284|Fluorouracil|fluorouracil|mesh-list
20182825|NCT00193284|Gefitinib|gefitinib|mesh-list
20182826|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182827|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182828|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182829|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182830|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182831|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
20182832|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20612571|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671591|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671592|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182833|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182834|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
19291511|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291512|NCT04272372|Ketoprofen|ketoprofen|mesh-list
19291513|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19291514|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291515|NCT04272372|Analgesics|analgesics|mesh-ancestor
19291516|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
19291517|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291518|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291519|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291520|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19291521|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19291522|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291523|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291524|NCT04272255|Scopolamine|scopolamine|mesh-list
19291525|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19291526|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19291527|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
19291528|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
19291529|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291530|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291531|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291532|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
19291533|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20182835|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182836|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20182837|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182838|NCT00193297|Paclitaxel|paclitaxel|mesh-list
20182839|NCT00193297|Carboplatin|carboplatin|mesh-list
20182840|NCT00193297|Topotecan|topotecan|mesh-list
20182841|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182842|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182843|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182844|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182845|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182846|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182847|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182848|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182849|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182850|NCT00193310|Paclitaxel|paclitaxel|mesh-list
20182851|NCT00193310|Carboplatin|carboplatin|mesh-list
20182852|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182853|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182854|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182855|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182856|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182857|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182858|NCT00193323|Gemcitabine|gemcitabine|mesh-list
20182859|NCT00193323|Docetaxel|docetaxel|mesh-list
20182860|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182861|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
20182862|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182863|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182864|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
20182865|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182866|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182867|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182868|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
20182869|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182870|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182871|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182872|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182873|NCT00193336|Gefitinib|gefitinib|mesh-list
20182874|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182875|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20182876|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182877|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182878|NCT00193349|Carboplatin|carboplatin|mesh-list
20182879|NCT00193349|Irinotecan|irinotecan|mesh-list
20182880|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
20182881|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182882|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182883|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182884|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182885|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182886|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20182887|NCT00193362|Gemcitabine|gemcitabine|mesh-list
20361124|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361125|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20361126|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361127|NCT00930722|Quinapril|quinapril|mesh-list
19291534|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
19291535|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291536|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361128|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20361129|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
20361130|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361131|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361132|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20361133|NCT00930839|Aspirin|aspirin|mesh-list
20361134|NCT00930839|Niacin|niacin|mesh-list
20361135|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
20361136|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20361137|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20361138|NCT00930839|Analgesics|analgesics|mesh-ancestor
20361139|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
19291537|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20182888|NCT00193362|Paclitaxel|paclitaxel|mesh-list
20182889|NCT00193362|Vinorelbine|vinorelbine|mesh-list
20182890|NCT00193362|Carboplatin|carboplatin|mesh-list
20182891|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182892|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182893|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182894|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182895|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182896|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182897|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20182898|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
20182899|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
20182900|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182901|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182902|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182903|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
20182904|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182905|NCT00193388|Topotecan|topotecan|mesh-list
20182906|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182907|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182908|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182909|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182910|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182911|NCT00193401|Topotecan|topotecan|mesh-list
20182912|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182913|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182914|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182915|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182916|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182917|NCT00193440|Rituximab|rituximab|mesh-list
20182918|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182919|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182920|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
20182921|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182922|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20182923|NCT00193466|Rituximab|rituximab|mesh-list
20182924|NCT00193466|Fludarabine|fludarabine|mesh-list
20182925|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182926|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291538|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
19291539|NCT04272086|Bupivacaine|bupivacaine|mesh-list
19291540|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
19291541|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
19291542|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291543|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291544|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
19291545|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291546|NCT04272320|Bupivacaine|bupivacaine|mesh-list
19291547|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
19291548|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
19291549|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404278|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
20182927|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
20182928|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361140|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291550|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291551|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
19291552|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291553|NCT04271839|Fluticasone|fluticasone|mesh-list
19291554|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
19291555|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291556|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19291557|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
19291558|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291559|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291560|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19291561|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
19291562|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
19291563|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19291564|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19291565|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19291566|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19291567|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
19291568|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291569|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291570|NCT04272021|Methylphenidate|methylphenidate|mesh-list
19291571|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19291572|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291573|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19291574|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19291575|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19291576|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291577|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
19291578|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291579|NCT04271332|Baclofen|baclofen|mesh-list
19291580|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19291581|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291582|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19291583|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291584|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19291585|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
19291586|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
19291587|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291588|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291589|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
20361141|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361142|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361143|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361144|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20361145|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20361146|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361147|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20361148|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19291590|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291591|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
19291592|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19291593|NCT04270994|Misoprostol|misoprostol|mesh-list
19291594|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19291595|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
19291596|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19291597|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291598|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19291599|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291600|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
19291601|NCT04271189|Metformin|metformin|mesh-list
19291602|NCT04271189|Pioglitazone|pioglitazone|mesh-list
19291603|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20182929|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19291604|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19291605|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182930|NCT00193505|Rituximab|rituximab|mesh-list
20182931|NCT00193505|Carboplatin|carboplatin|mesh-list
20182932|NCT00193505|Etoposide|etoposide|mesh-list
20182933|NCT00193505|Ifosfamide|ifosfamide|mesh-list
20182934|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182935|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182936|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
20182937|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361149|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182938|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361150|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
20361151|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20361152|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
20361153|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20361154|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
20361155|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
20361156|NCT00930839|Vitamins|vitamins|mesh-ancestor
20361157|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
20361158|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
20361159|NCT00930865|Bumetanide|bumetanide|mesh-list
20361160|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20361161|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291606|NCT04271189|Incretins|incretins|mesh-ancestor
19291607|NCT04271189|Hormones|hormones|mesh-ancestor
19291608|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291609|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19291610|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
19291611|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291612|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291613|NCT04271384|Nivolumab|nivolumab|mesh-list
19291614|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19291615|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291616|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19291617|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291618|NCT04270864|Nivolumab|nivolumab|mesh-list
19291619|NCT04270864|Ipilimumab|ipilimumab|mesh-list
19291620|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19291621|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291622|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19291623|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361162|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361163|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361164|NCT00930865|Diuretics|diuretics|mesh-ancestor
20361165|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
20361166|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20361167|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361168|NCT00930891|Bevacizumab|bevacizumab|mesh-list
20361169|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20361170|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291624|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19291625|NCT04270929|Folfirinox|folfirinox|mesh-list
19291626|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291627|NCT04270656|Insulin|insulin|mesh-list
19291628|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19291629|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291630|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
19291631|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291632|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291633|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182939|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182940|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20182941|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182942|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182943|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182944|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20182945|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
20182946|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
20182947|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182948|NCT00193531|Paclitaxel|paclitaxel|mesh-list
20182949|NCT00193531|Etoposide|etoposide|mesh-list
20182950|NCT00193531|Carboplatin|carboplatin|mesh-list
20182951|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20182952|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182953|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182954|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182955|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
19291634|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291635|NCT04270708|Analgesics|analgesics|mesh-ancestor
19291636|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
20361171|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20361172|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19404279|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
20182956|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361173|NCT00930891|Growth Substances|growth substances|mesh-ancestor
20612572|NCT02251964|Rituximab|rituximab|mesh-list
19291637|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291638|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19291639|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19291640|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19291641|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
19291642|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20182957|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20182958|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182959|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182960|NCT00193544|Thalidomide|thalidomide|mesh-list
20182961|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
20182962|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20182963|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
20182964|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20182965|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
20182966|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20182967|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20182968|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20182969|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20182970|NCT00193544|Growth Substances|growth substances|mesh-ancestor
20182971|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
20182972|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182973|NCT00193557|Bortezomib|bortezomib|mesh-list
20182974|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182975|NCT00193570|Docetaxel|docetaxel|mesh-list
20182976|NCT00193570|Topotecan|topotecan|mesh-list
20182977|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182978|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
20182979|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
20182980|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
20182981|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182982|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182983|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182984|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182985|NCT00193583|Carboplatin|carboplatin|mesh-list
20182986|NCT00193583|Topotecan|topotecan|mesh-list
20182987|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182988|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20182989|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20182990|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20182991|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20182992|NCT00193622|Bevacizumab|bevacizumab|mesh-list
20182993|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20182994|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20182995|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20182996|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20182997|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20182998|NCT00193622|Growth Substances|growth substances|mesh-ancestor
20182999|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183000|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
20183001|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20183002|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183003|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183004|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
20183005|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183006|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183007|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20183008|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
20183009|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183010|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183011|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183012|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183013|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
20183014|NCT00193648|Adalimumab|adalimumab|mesh-list
20183015|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183016|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183017|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20183018|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183019|NCT00193661|Testosterone|testosterone|mesh-list
20183020|NCT00193661|Androgens|androgens|mesh-ancestor
20183021|NCT00193661|Hormones|hormones|mesh-ancestor
20183022|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183023|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183024|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
20183025|NCT00193674|Progestins|progestins|mesh-ancestor
20183026|NCT00193674|Hormones|hormones|mesh-ancestor
20183027|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183028|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183029|NCT00193700|Testosterone|testosterone|mesh-list
20183030|NCT00193700|Androgens|androgens|mesh-ancestor
20183031|NCT00193700|Hormones|hormones|mesh-ancestor
20183032|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361174|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361175|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
20361176|NCT00930943|Oxymorphone|oxymorphone|mesh-list
20361177|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20361178|NCT00930943|Narcotics|narcotics|mesh-ancestor
20361179|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361180|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361181|NCT00930943|Analgesics|analgesics|mesh-ancestor
20361182|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
20361183|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361184|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20361185|NCT00930995|Candesartan|candesartan|mesh-list
20361186|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20361187|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20612573|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20612574|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612575|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
20183033|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183034|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20183035|NCT00193726|Estradiol|estradiol|mesh-list
20183036|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19291643|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291644|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
19291645|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20183037|NCT00193726|Estrogens|estrogens|mesh-ancestor
20183038|NCT00193726|Hormones|hormones|mesh-ancestor
20183039|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183040|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183041|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20183042|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
20183043|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183044|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20183045|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20183046|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20183047|NCT00193739|Paclitaxel|paclitaxel|mesh-list
20183048|NCT00193739|Carboplatin|carboplatin|mesh-list
20183049|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20183050|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183051|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
20183052|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
20183053|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
20183054|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183055|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
20183056|NCT00193856|Leuprolide|leuprolide|mesh-list
20183057|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20183058|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183059|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20183060|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
20183061|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183062|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20183063|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183064|NCT00193869|Dexamethasone|dexamethasone|mesh-list
20183065|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183066|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
20183067|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
20183068|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183069|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183070|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183071|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
20183072|NCT00193869|Hormones|hormones|mesh-ancestor
20183073|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671593|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
19671594|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
20183074|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20183075|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291646|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
19404280|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404281|NCT03596060|Narcotics|narcotics|mesh-ancestor
19291647|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291648|NCT04270487|Octylonium|octylonium|mesh-list
19291649|NCT04270487|Bromides|bromides|mesh-list
19291650|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
19291651|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19291652|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19291653|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291654|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19291655|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291656|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291657|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
19291658|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
19291659|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291660|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19291661|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19291662|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
19671595|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671596|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19671597|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
19671598|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671599|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671600|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19671601|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
19671602|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20183076|NCT00193882|Cisplatin|cisplatin|mesh-list
19291663|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291664|NCT04270370|Atorvastatin|atorvastatin|mesh-list
19291665|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19291666|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19291667|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
19291668|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291669|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19291670|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19291671|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291672|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
19291673|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395144|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395145|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395146|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395147|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
19395148|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395149|NCT03669562|Alprostadil|alprostadil|mesh-list
19395150|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19395151|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395152|NCT03669562|Urological Agents|urological agents|mesh-ancestor
19395153|NCT03669484|Fentanyl|fentanyl|mesh-list
19395154|NCT03669484|Bromides|bromides|mesh-list
19395155|NCT03669484|Propofol|propofol|mesh-list
19395156|NCT03669484|Rocuronium|rocuronium|mesh-list
19395157|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19395158|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395159|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395160|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19395161|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
19395162|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
19395163|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19395164|NCT03669484|Narcotics|narcotics|mesh-ancestor
19395165|NCT03669484|Analgesics|analgesics|mesh-ancestor
19395166|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
19395167|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395168|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19395169|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
19395170|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19395171|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19395172|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19395173|NCT03669445|Dexamethasone|dexamethasone|mesh-list
19395174|NCT03669445|Lenalidomide|lenalidomide|mesh-list
19395175|NCT03669445|Daratumumab|daratumumab|mesh-list
19395176|NCT03669445|Ixazomib|ixazomib|mesh-list
19395177|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395178|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
19395179|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
19395180|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395181|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183077|NCT00193882|Fluorouracil|fluorouracil|mesh-list
20183078|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183079|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
19291674|NCT04270344|Valsartan|valsartan|mesh-list
19291675|NCT04270344|Pitavastatin|pitavastatin|mesh-list
19291676|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19291677|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19291678|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19291679|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291680|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20183080|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361188|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20361189|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361190|NCT00931008|Docetaxel|docetaxel|mesh-list
20612576|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612577|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183081|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183082|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183083|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
20183084|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183085|NCT00193895|Carboplatin|carboplatin|mesh-list
20183086|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183087|NCT00193921|Gemcitabine|gemcitabine|mesh-list
20183088|NCT00193921|Cisplatin|cisplatin|mesh-list
20183089|NCT00193921|Vinorelbine|vinorelbine|mesh-list
20183090|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183091|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183092|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
20183093|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183094|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
20183095|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183096|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183097|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183098|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
20183099|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183100|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20183101|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
20183102|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
20183103|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
20183104|NCT00193973|Methotrexate|methotrexate|mesh-list
20183105|NCT00193973|Idarubicin|idarubicin|mesh-list
20183106|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20183107|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
20183108|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183109|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183110|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183111|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
20183112|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183113|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183114|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
20183115|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183116|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20183117|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183118|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
20183119|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183120|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20183121|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183122|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20183123|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20183124|NCT00194038|Aripiprazole|aripiprazole|mesh-list
20183125|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
20183126|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183127|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20183128|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183129|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183130|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183131|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
20183132|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
20183133|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183134|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183135|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20183136|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20183137|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
20183138|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20183139|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20183140|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19291681|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19291682|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19291683|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
19291684|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291685|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19291686|NCT04270175|Dexamethasone|dexamethasone|mesh-list
19291687|NCT04270175|Daratumumab|daratumumab|mesh-list
20361191|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361192|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20361193|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20361194|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20361195|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291688|NCT04270175|Pomalidomide|pomalidomide|mesh-list
19291689|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291690|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
20183141|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20183142|NCT00194064|Olanzapine|olanzapine|mesh-list
20183143|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
20183144|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
20183145|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183146|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183147|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183148|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20183149|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183150|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183151|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183152|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20183153|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20183154|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20183155|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183156|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361196|NCT00931021|Nicotine|nicotine|mesh-list
20361197|NCT00931021|Varenicline|varenicline|mesh-list
20361198|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20361199|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
19291691|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
20183157|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
20183158|NCT00194090|Celecoxib|celecoxib|mesh-list
20183159|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20183160|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20183161|NCT00194090|Analgesics|analgesics|mesh-ancestor
20183162|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
20183163|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183164|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183165|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183166|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183167|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20183168|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20183169|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183170|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183171|NCT00194272|Methotrexate|methotrexate|mesh-list
20183172|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20183173|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
20183174|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183175|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183176|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183177|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
20183178|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183179|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183180|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
20183181|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183182|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20183183|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183184|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
20183185|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183186|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20361200|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361201|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361202|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20361203|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19291692|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291693|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404282|NCT03596060|Analgesics|analgesics|mesh-ancestor
19404283|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
19404284|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361204|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
19291694|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291695|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
19291696|NCT04270175|Hormones|hormones|mesh-ancestor
19291697|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291698|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19291699|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291700|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
19291701|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19291702|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19291703|NCT04270175|Growth Substances|growth substances|mesh-ancestor
19291704|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
19291705|NCT04269954|Heparin|heparin|mesh-list
19291706|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19291707|NCT04269954|Tinzaparin|tinzaparin|mesh-list
20361205|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361206|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183187|NCT00194324|Miconazole|miconazole|mesh-list
20183188|NCT00194324|Clotrimazole|clotrimazole|mesh-list
20183189|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
20183190|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183191|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20183192|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20183193|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183194|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183195|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20183196|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
20183197|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183198|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183199|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20183200|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20183201|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20183202|NCT00194402|Niacin|niacin|mesh-list
20183203|NCT00194402|Niacinamide|niacinamide|mesh-list
20183204|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
20183205|NCT00194402|Atorvastatin|atorvastatin|mesh-list
20183206|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20183207|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20183208|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
20183209|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183210|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20183211|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20183212|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183213|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
20183214|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
20183215|NCT00194402|Vitamins|vitamins|mesh-ancestor
20183216|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
20183217|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183218|NCT00194467|Valganciclovir|valganciclovir|mesh-list
20183219|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
20183220|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183221|NCT00194480|Interferons|interferons|mesh-list
20183222|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183223|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
20183224|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183225|NCT00194519|Acyclovir|acyclovir|mesh-list
20183226|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
20183227|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217258|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
20217259|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218094|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218095|NCT00311870|Lisinopril|lisinopril|mesh-list
20218096|NCT00311870|Nisoldipine|nisoldipine|mesh-list
20218097|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20218098|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
20218099|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218100|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218101|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218102|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20218103|NCT00311870|Protective Agents|protective agents|mesh-ancestor
20218104|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218105|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20218106|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361207|NCT00931073|Ketoconazole|ketoconazole|mesh-list
20361208|NCT00931073|Omeprazole|omeprazole|mesh-list
19291708|NCT04269954|Dalteparin|dalteparin|mesh-list
19291709|NCT04269954|Batroxobin|batroxobin|mesh-list
19291710|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
19291711|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19291712|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19291713|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291714|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
19291715|NCT04269954|Coagulants|coagulants|mesh-ancestor
19291716|NCT04270318|Pemetrexed|pemetrexed|mesh-list
19291717|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291718|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291719|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291720|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19291721|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19291722|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
19291723|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
19291724|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19291725|NCT04270019|Laxatives|laxatives|mesh-ancestor
19291726|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19291727|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20183228|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
20361209|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20361210|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183229|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183230|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
20183231|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20183232|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20183233|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183234|NCT00194597|Urological Agents|urological agents|mesh-ancestor
20183235|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
20183236|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20183237|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20183238|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20183239|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20183240|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183241|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
20183242|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183243|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183244|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20183245|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183246|NCT00194649|Miglustat|miglustat|mesh-list
20183247|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183248|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183249|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20183250|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20183251|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
20183252|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183253|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20183254|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20183255|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183256|NCT00194714|Vaccines|vaccines|mesh-list
20183257|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
20183258|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183259|NCT00194727|Capecitabine|capecitabine|mesh-list
20183260|NCT00194727|Vinorelbine|vinorelbine|mesh-list
20183261|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183262|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
20183263|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183264|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183265|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20183266|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
20183267|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
20361211|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20361212|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183268|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
20183269|NCT00194740|Docetaxel|docetaxel|mesh-list
20183270|NCT00194740|Vinorelbine|vinorelbine|mesh-list
20183271|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183272|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
20183273|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
20183274|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
20183275|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183276|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20183277|NCT00194753|Paclitaxel|paclitaxel|mesh-list
20361213|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291728|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20361214|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
20361215|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361216|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20361217|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20361218|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19671603|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671604|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20183278|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
20183279|NCT00194753|Doxorubicin|doxorubicin|mesh-list
20183280|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20183281|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183282|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
20183283|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
20183284|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
20183285|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183286|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183287|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
20183288|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183289|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183290|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20183291|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
20183292|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20183293|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183294|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20183295|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20183296|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183297|NCT00194766|Temozolomide|temozolomide|mesh-list
20183298|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20183299|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
20183300|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183301|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183302|NCT00194818|Mesalamine|mesalamine|mesh-list
19671605|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19671606|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671607|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19671608|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20183303|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20183304|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20183305|NCT00194818|Analgesics|analgesics|mesh-ancestor
20183306|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
20183307|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183308|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183309|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183310|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183311|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
20183312|NCT00194857|Hematinics|hematinics|mesh-ancestor
20183313|NCT00194883|Hormones|hormones|mesh-list
20183314|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183315|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183316|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
20183317|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
20183318|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20183319|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20183320|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183321|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183322|NCT00194909|Urological Agents|urological agents|mesh-ancestor
20183323|NCT00194935|Topotecan|topotecan|mesh-list
20183324|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20183325|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20183326|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183327|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183328|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183329|NCT00194948|Citalopram|citalopram|mesh-list
20183330|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20183331|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20183332|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20183333|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183334|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183335|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
20183336|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183337|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19671609|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19671610|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
19291729|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19291730|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291731|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
19291732|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291733|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291734|NCT04269863|Aspirin|aspirin|mesh-list
19291735|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19291736|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291737|NCT04269863|Analgesics|analgesics|mesh-ancestor
19291738|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
19291739|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291740|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183338|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
20183339|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183340|NCT00194961|Hormones|hormones|mesh-list
20183341|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183342|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183343|NCT00194974|Clonidine|clonidine|mesh-list
20183344|NCT00194974|Labetalol|labetalol|mesh-list
20183345|NCT00194974|Methyldopa|methyldopa|mesh-list
20183346|NCT00194974|Nifedipine|nifedipine|mesh-list
20183347|NCT00194974|Analgesics|analgesics|mesh-ancestor
20183348|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
20183349|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183350|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183351|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20183352|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
20361219|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
20361220|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361221|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361222|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20361223|NCT00931086|Belimumab|belimumab|mesh-list
20361224|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361225|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
20361226|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361227|NCT00931125|Ranibizumab|ranibizumab|mesh-list
20361228|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20361229|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20361230|NCT00931125|Growth Substances|growth substances|mesh-ancestor
20361231|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361232|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
20361233|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361234|NCT00931138|Cytarabine|cytarabine|mesh-list
20361235|NCT00931138|Daunorubicin|daunorubicin|mesh-list
20361236|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20361237|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361238|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20183353|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
20183354|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20183355|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20183356|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20183357|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
20183358|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183359|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183360|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20183361|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20183362|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20183363|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
20361239|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20361240|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361241|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361242|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20361243|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
20361244|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
20361245|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361246|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361247|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
20361248|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361249|NCT00931203|Celecoxib|celecoxib|mesh-list
20361250|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20361251|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20361252|NCT00931203|Analgesics|analgesics|mesh-ancestor
20361253|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
20183364|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
19291741|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291742|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19291743|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19291744|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19395182|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361254|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361255|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361256|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361257|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361258|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20361259|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20361260|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361261|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361262|NCT00931229|Entecavir|entecavir|mesh-list
20361263|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
20361264|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361265|NCT00931281|Ritonavir|ritonavir|mesh-list
20361266|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20361267|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20361268|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
20361269|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361270|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361271|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20361272|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20361273|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
20183365|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183366|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20183367|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20183368|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
20183369|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20183370|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20183371|NCT00195000|Cytarabine|cytarabine|mesh-list
20183372|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
20183373|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183374|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
20183375|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183376|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183377|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
20183378|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183379|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183380|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
20183381|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183382|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20183383|NCT00195078|Gefitinib|gefitinib|mesh-list
20183384|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183385|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20361274|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361275|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20361276|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20361277|NCT00931372|Lixisenatide|lixisenatide|mesh-list
20361278|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361279|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361280|NCT00931398|Methylphenidate|methylphenidate|mesh-list
20361281|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20183386|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183387|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183388|NCT00195104|Cytarabine|cytarabine|mesh-list
20183389|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
20183390|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183391|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
20183392|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183393|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183394|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
20183395|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183396|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183397|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
20183398|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183399|NCT00195156|Valproic Acid|valproic acid|mesh-list
20183400|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
20183401|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361282|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361283|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20612578|NCT02251977|Leucovorin|leucovorin|mesh-list
20183402|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361284|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20361285|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361286|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361287|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
20361288|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361289|NCT00931437|Vitamin K|vitamin k|mesh-list
20361290|NCT00931437|Vitamins|vitamins|mesh-ancestor
20361291|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
20361292|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361293|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20361294|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20361295|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183403|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
20183404|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183405|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183406|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
20183407|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183408|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183409|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183410|NCT00195195|Sirolimus|sirolimus|mesh-list
20183411|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183412|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183413|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183414|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183415|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
20183416|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183417|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
20183418|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183419|NCT00195208|Pantoprazole|pantoprazole|mesh-list
20183420|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20183421|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183422|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20183423|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183424|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183425|NCT00195286|Tazobactam|tazobactam|mesh-list
20183426|NCT00195286|Piperacillin|piperacillin|mesh-list
20183427|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20361296|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
20361297|NCT00931437|Coagulants|coagulants|mesh-ancestor
20361298|NCT00931450|Sunitinib|sunitinib|mesh-list
20183428|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183429|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183430|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20183431|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183432|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183433|NCT00195299|Sirolimus|sirolimus|mesh-list
20183434|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183435|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183436|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183437|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183438|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
20183439|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183440|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
20183441|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183442|NCT00195312|Bupivacaine|bupivacaine|mesh-list
20183443|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
20183444|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
20183445|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183446|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183447|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
20183448|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183449|NCT00195364|Etanercept|etanercept|mesh-list
20183450|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20183451|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20183452|NCT00195364|Analgesics|analgesics|mesh-ancestor
20183453|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
20183454|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183455|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183456|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361299|NCT00931450|Exemestane|exemestane|mesh-list
20361300|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361301|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20361302|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20183457|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183458|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361303|NCT00931450|Growth Substances|growth substances|mesh-ancestor
20183459|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183460|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
20183461|NCT00195377|Etanercept|etanercept|mesh-list
20183462|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20183463|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20183464|NCT00195377|Analgesics|analgesics|mesh-ancestor
20183465|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
20183466|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183467|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183468|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183469|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183470|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183471|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183472|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
20183473|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20183474|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
20183475|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183476|NCT00195416|Etanercept|etanercept|mesh-list
20183477|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20183478|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20183479|NCT00195416|Analgesics|analgesics|mesh-ancestor
20183480|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
20183481|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183482|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183483|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183484|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183485|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183486|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183487|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
20183488|NCT00195455|Estradiol|estradiol|mesh-list
20183489|NCT00195455|Estrogens|estrogens|mesh-ancestor
20183490|NCT00195455|Hormones|hormones|mesh-ancestor
20183491|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183492|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183493|NCT00195468|Cyclosporine|cyclosporine|mesh-list
20183494|NCT00195468|Cyclosporins|cyclosporins|mesh-list
20183495|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183496|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183497|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183498|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
20183499|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183500|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
20183501|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183502|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
20183503|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183504|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20183505|NCT00195481|Sirolimus|sirolimus|mesh-list
20183506|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183507|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183508|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183509|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183510|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
20183511|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183512|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
20183513|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183514|NCT00195533|Tazobactam|tazobactam|mesh-list
20183515|NCT00195533|Piperacillin|piperacillin|mesh-list
20183516|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20183517|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183518|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183519|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20183520|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183521|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183522|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
20183523|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20183524|NCT00195559|Estradiol|estradiol|mesh-list
20183525|NCT00195559|Estrogens|estrogens|mesh-ancestor
20183526|NCT00195559|Hormones|hormones|mesh-ancestor
20183527|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183528|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183529|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20183530|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
20183531|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183532|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20183533|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19291745|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291746|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19291747|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19291748|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291749|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
19291750|NCT04269928|Epinephrine|epinephrine|mesh-list
19291751|NCT04269928|Racepinephrine|racepinephrine|mesh-list
19291752|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
19291753|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19291754|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19291755|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
19291756|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291757|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291758|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291759|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19291760|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19291761|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
19291762|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291763|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19291764|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
19291765|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
19291766|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
19291767|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19291768|NCT04269369|Fluorouracil|fluorouracil|mesh-list
19291769|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
19291770|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291771|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19291772|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291773|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19291774|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
19291775|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291776|NCT04269460|Bupivacaine|bupivacaine|mesh-list
19291777|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
19291778|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
19671611|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671612|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19291779|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291780|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291781|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
19291782|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291783|NCT04269187|Theophylline|theophylline|mesh-list
19291784|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19291785|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
19291786|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291787|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291788|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19291789|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
19291790|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19671613|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
19291791|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291792|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291793|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
19291794|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20361304|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291795|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19291796|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
19291797|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291798|NCT04268966|Brincidofovir|brincidofovir|mesh-list
19291799|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
19291800|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183534|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20183535|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20183536|NCT00195572|Leucovorin|leucovorin|mesh-list
20183537|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
20183538|NCT00195572|Antidotes|antidotes|mesh-ancestor
20183539|NCT00195572|Protective Agents|protective agents|mesh-ancestor
20183540|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183541|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
20183542|NCT00195572|Vitamins|vitamins|mesh-ancestor
20183543|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
20183544|NCT00195585|Leucovorin|leucovorin|mesh-list
20183545|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
20361305|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20361306|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19291801|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
20183546|NCT00195585|Antidotes|antidotes|mesh-ancestor
19291802|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291803|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291804|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291805|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291806|NCT04269278|Analgesics|analgesics|mesh-ancestor
19291807|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
19291808|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291809|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19291810|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19291811|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19291812|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
19291813|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291814|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291815|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
19291816|NCT04269109|Narcotics|narcotics|mesh-ancestor
19291817|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291818|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291819|NCT04269109|Analgesics|analgesics|mesh-ancestor
19291820|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
20361307|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361308|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361309|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20361310|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20361311|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20361312|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
20361313|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361314|NCT00931580|Vitamin D|vitamin d|mesh-list
20361315|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
20361316|NCT00931580|Vitamins|vitamins|mesh-ancestor
20361317|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
20361318|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361319|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20361320|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20361321|NCT00931645|Cytarabine|cytarabine|mesh-list
19291821|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291822|NCT04268888|Nivolumab|nivolumab|mesh-list
19291823|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
19291824|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19291825|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291826|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19291827|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291828|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19291829|NCT04268888|Estrogens|estrogens|mesh-ancestor
19291830|NCT04268888|Hormones|hormones|mesh-ancestor
19291831|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291832|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291833|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19291834|NCT04268927|Letrozole|letrozole|mesh-list
19291835|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
19291836|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19291837|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291838|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19291839|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19291840|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291841|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291842|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19291843|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
19291844|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291845|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291846|NCT04268927|Hormones|hormones|mesh-ancestor
19291847|NCT04268602|Anesthetics|anesthetics|mesh-list
19291848|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
20361322|NCT00931645|Dexamethasone|dexamethasone|mesh-list
20361323|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
20361324|NCT00931645|Cisplatin|cisplatin|mesh-list
20361325|NCT00931645|Fludarabine|fludarabine|mesh-list
20361326|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361327|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
20361328|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361329|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361330|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20361331|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
20361332|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361333|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291849|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183547|NCT00195585|Protective Agents|protective agents|mesh-ancestor
20183548|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183549|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
20183550|NCT00195585|Vitamins|vitamins|mesh-ancestor
20183551|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
20183552|NCT00195598|Paroxetine|paroxetine|mesh-list
20183553|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19291850|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291851|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
19291852|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291853|NCT04268407|Amoxicillin|amoxicillin|mesh-list
19291854|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
19291855|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
19291856|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19291857|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19291858|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291859|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19291860|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291861|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291862|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
19291863|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19291864|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291865|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291866|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291867|NCT04268303|Analgesics|analgesics|mesh-ancestor
19291868|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
19291869|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291870|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19291871|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19291872|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19291873|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
19291874|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291875|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291876|NCT04268524|Miltefosine|miltefosine|mesh-list
19291877|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
19291878|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291879|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291880|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19291881|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19291882|NCT04268563|Metformin|metformin|mesh-list
19291883|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19291884|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19291885|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291886|NCT04268563|Incretins|incretins|mesh-ancestor
19291887|NCT04268563|Hormones|hormones|mesh-ancestor
19291888|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291889|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19291890|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
19291891|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291892|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291893|NCT04268472|Darunavir|darunavir|mesh-list
19291894|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19291895|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19291896|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
19291897|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291898|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291899|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19291900|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19291901|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
19291902|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291903|NCT04268537|Antibodies|antibodies|mesh-list
19291904|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
19291905|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
19291906|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183554|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20183555|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20183556|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20183557|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183558|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361334|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19291907|NCT04268394|Metformin|metformin|mesh-list
19671614|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19671615|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19671616|NCT04247750|Sirolimus|sirolimus|mesh-list
19671617|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671618|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671619|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671620|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291908|NCT04268394|Itraconazole|itraconazole|mesh-list
19291909|NCT04268394|Rifampin|rifampin|mesh-list
19291910|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
19291911|NCT04268394|Methotrexate|methotrexate|mesh-list
19291912|NCT04268394|Digoxin|digoxin|mesh-list
19291913|NCT04268394|Midazolam|midazolam|mesh-list
19291914|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19291915|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19291916|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291917|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20183559|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
20183560|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183561|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19291918|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
19291919|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19291920|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19291921|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
19291922|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291923|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19291924|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
19291925|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291926|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19291927|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19291928|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
19291929|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19291930|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19291931|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19291932|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20361335|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361336|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
20361337|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
19291933|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19291934|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19291935|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19291936|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19291937|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19291938|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
19291939|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
19671621|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
19671622|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838313|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
19291940|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
19291941|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
19291942|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19291943|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19291944|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19291945|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19291946|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19291947|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
19291948|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291949|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19291950|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19291951|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19291952|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
19291953|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19291954|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19291955|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19291956|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
20183562|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
20183563|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183564|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20183565|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20183566|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183567|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20612579|NCT02251977|Fluorouracil|fluorouracil|mesh-list
19291957|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671623|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
19838314|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
19291958|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
19291959|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19671624|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671625|NCT04230408|Paclitaxel|paclitaxel|mesh-list
19671626|NCT04230408|Carboplatin|carboplatin|mesh-list
19291960|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19291961|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19291962|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19291963|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19291964|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19291965|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19291966|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19291967|NCT04268394|Protective Agents|protective agents|mesh-ancestor
19291968|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19291969|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19291970|NCT04268394|Analgesics|analgesics|mesh-ancestor
19291971|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
19291972|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291973|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19291974|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395183|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
19395184|NCT03669445|Hormones|hormones|mesh-ancestor
19395185|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395186|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19395187|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395188|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
19395189|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19395190|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19395191|NCT03669445|Growth Substances|growth substances|mesh-ancestor
19395192|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
19395193|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
19395194|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395195|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395196|NCT03669328|Anesthetics|anesthetics|mesh-list
19395197|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395198|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395199|NCT03669263|Fentanyl|fentanyl|mesh-list
19395200|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19395201|NCT03669263|Narcotics|narcotics|mesh-ancestor
19395202|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395203|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395204|NCT03669263|Analgesics|analgesics|mesh-ancestor
19395205|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
19395206|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395207|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19395208|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19395209|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
19395210|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
19395211|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
19395212|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19395213|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19395214|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395215|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
19395216|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
19395217|NCT03669029|Golimumab|golimumab|mesh-list
19395218|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19395219|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19395220|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395221|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395222|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
19395223|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395224|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19395225|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
19395226|NCT03669003|Coagulants|coagulants|mesh-ancestor
19671627|NCT04230408|Durvalumab|durvalumab|mesh-list
20217260|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
20217261|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20217262|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20217263|NCT00309218|Prednisolone|prednisolone|mesh-list
20217264|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
20217265|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20217266|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
20217267|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217268|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
20217269|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
20217270|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19291975|NCT04267991|Tacrolimus|tacrolimus|mesh-list
19291976|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19291977|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
19291978|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291979|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19291980|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19291981|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19291982|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19291983|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19291984|NCT04267653|Lactoferrin|lactoferrin|mesh-list
20361338|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361339|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361340|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
19291985|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19291986|NCT04267679|Cannabidiol|cannabidiol|mesh-list
19291987|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
19291988|NCT04267913|Dexamethasone|dexamethasone|mesh-list
19291989|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
19291990|NCT04267913|Docetaxel|docetaxel|mesh-list
19291991|NCT04267913|Ramucirumab|ramucirumab|mesh-list
19291992|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19291993|NCT04267913|Antibodies|antibodies|mesh-list
19291994|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
19291995|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19291996|NCT04267913|BB 1101|bb 1101|mesh-list
19291997|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
19291998|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19291999|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19292000|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
19292001|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
19292002|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292003|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19292004|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
19292005|NCT04267913|Hormones|hormones|mesh-ancestor
19292006|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19292007|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19292008|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292009|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
19292010|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292011|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292012|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292013|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292014|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292015|NCT04267614|Etanercept|etanercept|mesh-list
19292016|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19292017|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292018|NCT04267614|Analgesics|analgesics|mesh-ancestor
19292019|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
19292020|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292021|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292022|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19292023|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292024|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19292025|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292026|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
19292027|NCT04267497|Amphotericin B|amphotericin b|mesh-list
19292028|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19292029|NCT04267497|Amebicides|amebicides|mesh-ancestor
19292030|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19292031|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19292032|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292033|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19292034|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
20183568|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20183569|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
20183570|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183571|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
20183572|NCT00195637|Antibodies|antibodies|mesh-list
20183573|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
20183574|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20183575|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20183576|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
20183577|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361341|NCT00931645|Hormones|hormones|mesh-ancestor
19292035|NCT04267549|Paclitaxel|paclitaxel|mesh-list
19292036|NCT04267549|Apatinib|apatinib|mesh-list
19292037|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19395227|NCT03668964|Vitamin D|vitamin d|mesh-list
20612580|NCT02251977|Capecitabine|capecitabine|mesh-list
19292038|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292039|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292040|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292041|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292042|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292043|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19292044|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292045|NCT04267237|Atezolizumab|atezolizumab|mesh-list
19292046|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292047|NCT04267224|Ticagrelor|ticagrelor|mesh-list
19292048|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19292049|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19292050|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19292051|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19292052|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
19292053|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292054|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292055|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292056|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
19292057|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19292058|NCT04267250|Estradiol|estradiol|mesh-list
19292059|NCT04267250|PF-06700841|pf-06700841|mesh-list
19292060|NCT04267250|Estrogens|estrogens|mesh-ancestor
19292061|NCT04267250|Hormones|hormones|mesh-ancestor
20361342|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361343|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20361344|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20361345|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
20361346|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
20361347|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361348|NCT00931697|Mefloquine|mefloquine|mesh-list
20361349|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
19292062|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19292063|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292064|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19292065|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
19292066|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19292067|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19292068|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19292069|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19292070|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19292071|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19292072|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292073|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292074|NCT04267042|Budesonide|budesonide|mesh-list
19292075|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19292076|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19292077|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
19292078|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361350|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20361351|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20361352|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361353|NCT00931736|Rifampin|rifampin|mesh-list
20361354|NCT00931736|Isoniazid|isoniazid|mesh-list
20361355|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20361356|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
20361357|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20361358|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292079|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292080|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19292081|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
19292082|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
20183578|NCT00195689|Adalimumab|adalimumab|mesh-list
20183579|NCT00195689|Antibodies|antibodies|mesh-list
20183580|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20183581|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
20183582|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183583|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183584|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183585|NCT00195728|Acetaminophen|acetaminophen|mesh-list
20183586|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20183587|NCT00195728|Hydrocodone|hydrocodone|mesh-list
20361359|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
19292083|NCT04267042|Hormones|hormones|mesh-ancestor
19395228|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
20183588|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292084|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19292085|NCT04267081|Venetoclax|venetoclax|mesh-list
19292086|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361360|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20361361|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361362|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361363|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20361364|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20361365|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20361366|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20361367|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20361368|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20361369|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20361370|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20361371|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
20361372|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20361373|NCT00931775|Pindolol|pindolol|mesh-list
20361374|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20361375|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20361376|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
20361377|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361378|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361379|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361380|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20361381|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20361382|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
20361383|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
20361384|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
19292087|NCT04267146|Nivolumab|nivolumab|mesh-list
19292088|NCT04267146|Temozolomide|temozolomide|mesh-list
19292089|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292090|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292091|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19292092|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292093|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19292094|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
19292095|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19292096|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
19292097|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292098|NCT04266756|Selexipag|selexipag|mesh-list
19292099|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19292100|NCT04266509|Rifampin|rifampin|mesh-list
19292101|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19292102|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
19292103|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19292104|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292105|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
19292106|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19292107|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292108|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292109|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19292110|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19292111|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19292112|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19292113|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19292114|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19292115|NCT04266236|Ropivacaine|ropivacaine|mesh-list
19292116|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
19292117|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292118|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292119|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
19292120|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
19292121|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292122|NCT04266288|Ketamine|ketamine|mesh-list
19292123|NCT04266288|Analgesics|analgesics|mesh-ancestor
19292124|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
19292125|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292126|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292127|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19292128|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20361385|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
20361386|NCT00931827|Etonogestrel|etonogestrel|mesh-list
19292129|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
19292130|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
19292131|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292132|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19292133|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19292134|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292135|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292136|NCT04266132|Bupivacaine|bupivacaine|mesh-list
19292137|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
19292138|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
19292139|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292140|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292141|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
19292142|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292143|NCT04265833|Calcium|calcium|mesh-list
19292144|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19292145|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292146|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19292147|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
19292148|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395229|NCT03668964|Vitamins|vitamins|mesh-list
19395230|NCT03668964|Vitamin E|vitamin e|mesh-list
19395231|NCT03668964|Tocopherols|tocopherols|mesh-list
19395232|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
19395233|NCT03668964|Vitamin A|vitamin a|mesh-list
20183589|NCT00195728|Analgesics|analgesics|mesh-ancestor
20183590|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
20183591|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183592|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183593|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
20183594|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19395234|NCT03668964|Riboflavin|riboflavin|mesh-list
20361387|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20361388|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
20361389|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20361390|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361391|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20361392|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20361393|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20361394|NCT00931840|Irinotecan|irinotecan|mesh-list
20361395|NCT00931840|Cetuximab|cetuximab|mesh-list
20361396|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20361397|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20361398|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361399|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361400|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361401|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20361402|NCT00931866|Diclofenac|diclofenac|mesh-list
20361403|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20361404|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20361405|NCT00931866|Analgesics|analgesics|mesh-ancestor
20361406|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
20361407|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361408|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361409|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361410|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361411|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20361412|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395235|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
19395236|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
19395237|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395238|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19395239|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19395240|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
19395241|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395242|NCT03668964|Protective Agents|protective agents|mesh-ancestor
20183595|NCT00195728|Narcotics|narcotics|mesh-ancestor
20612581|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183596|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183597|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
20183598|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
19395243|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19395244|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
19395245|NCT03668860|Dexamethasone|dexamethasone|mesh-list
20361413|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361414|NCT00931957|Prednisolone|prednisolone|mesh-list
20361415|NCT00931957|Etanercept|etanercept|mesh-list
20361416|NCT00931957|Methotrexate|methotrexate|mesh-list
20361417|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20361418|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
20361419|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20361420|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361421|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20361422|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
20361423|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361424|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361425|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
19292149|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
19292150|NCT04265872|Bortezomib|bortezomib|mesh-list
19292151|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292152|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292153|NCT04265456|Acetaminophen|acetaminophen|mesh-list
19292154|NCT04265456|Pregabalin|pregabalin|mesh-list
19292155|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292156|NCT04265456|Analgesics|analgesics|mesh-ancestor
19292157|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
19292158|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292159|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292160|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
19292161|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
19292162|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19292163|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19292164|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292165|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19292166|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19292167|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19292168|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292169|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19292170|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19292171|NCT04265612|Laxatives|laxatives|mesh-ancestor
19292172|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19292173|NCT04265508|Hemostatics|hemostatics|mesh-list
19292174|NCT04265508|Coagulants|coagulants|mesh-ancestor
19292175|NCT04265274|Copper|copper|mesh-list
19292176|NCT04265274|Disulfiram|disulfiram|mesh-list
19292177|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361426|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361427|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20361428|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361429|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
20361430|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361431|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20361432|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612582|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
19292178|NCT04265274|Trace Elements|trace elements|mesh-ancestor
19292179|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
19292180|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671628|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671629|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361433|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
19292181|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19292182|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19292183|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292184|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
19292185|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19292186|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
19292187|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292188|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
19292189|NCT04265001|Protective Agents|protective agents|mesh-ancestor
19292190|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
19292191|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19292192|NCT04264858|Antibodies|antibodies|mesh-list
19292193|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
19292194|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
19292195|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292196|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
19292197|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
19292198|NCT04264988|Protective Agents|protective agents|mesh-ancestor
19292199|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292200|NCT04265027|Opicapone|opicapone|mesh-list
19292201|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19292202|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292203|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292204|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19292205|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19292206|NCT04264676|Metronidazole|metronidazole|mesh-list
19292207|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292208|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19292209|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19292210|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19292211|NCT04264481|Lidocaine|lidocaine|mesh-list
19292212|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
19292213|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
19292214|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292215|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292216|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
19292217|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292218|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19292219|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19292220|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19292221|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19292222|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292223|NCT04264624|Erythritol|erythritol|mesh-list
19292224|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
19292225|NCT04264078|Fludarabine|fludarabine|mesh-list
19292226|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
19292227|NCT04264078|Melphalan|melphalan|mesh-list
19292228|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292229|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292230|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292231|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
19292232|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292233|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292234|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19292235|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
19292236|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19292237|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19292238|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
19292239|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292240|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19292241|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
19292242|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292243|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292244|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19292245|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19292246|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19292247|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
19292248|NCT04264039|Fludarabine|fludarabine|mesh-list
19292249|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
19292250|NCT04264039|Melphalan|melphalan|mesh-list
19292251|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292252|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292253|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292254|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
19292255|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292256|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292257|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19292258|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
19292259|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19395246|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
19395247|NCT03668860|Betamethasone|betamethasone|mesh-list
19395248|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
19395249|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19395250|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
19395251|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
19395252|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19395253|NCT03668860|BB 1101|bb 1101|mesh-list
19395254|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395255|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
19395256|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
19395257|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395258|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361434|NCT00931957|Hormones|hormones|mesh-ancestor
19395259|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395260|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
19395261|NCT03668860|Hormones|hormones|mesh-ancestor
19671630|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292260|NCT04264260|Colchicine|colchicine|mesh-list
19292261|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
19292262|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292263|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292264|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292265|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292266|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292267|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292268|NCT04264130|Artesunate|artesunate|mesh-list
19292269|NCT04264130|Lumefantrine|lumefantrine|mesh-list
19292270|NCT04264130|Artemether|artemether|mesh-list
19292271|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19292272|NCT04264130|Pyronaridine|pyronaridine|mesh-list
19292273|NCT04264130|Artefenomel|artefenomel|mesh-list
19292274|NCT04264130|Ferroquine|ferroquine|mesh-list
19292275|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
19292276|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19292277|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19292278|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292279|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292280|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
19292281|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
19292282|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19292283|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
19292284|NCT04264286|Esmolol|esmolol|mesh-list
19292285|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19292286|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19292287|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19292288|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
19292289|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292290|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292291|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292292|NCT04263870|Capecitabine|capecitabine|mesh-list
19292293|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
19292294|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292295|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
19292296|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292297|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183599|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20183600|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183601|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183602|NCT00195741|Valproic Acid|valproic acid|mesh-list
20183603|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
20183604|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183605|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183606|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
20183607|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183608|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183609|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
20183610|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183611|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183612|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183613|NCT00195754|Valproic Acid|valproic acid|mesh-list
20183614|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
20183615|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183616|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183617|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
20183618|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183619|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183620|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
20183621|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183622|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183623|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183624|NCT00195767|Valproic Acid|valproic acid|mesh-list
20183625|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
20183626|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183627|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183628|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
20183629|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183630|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183631|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
20183632|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183633|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183634|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19292298|NCT04263844|Midazolam|midazolam|mesh-list
19292299|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
20183635|NCT00195780|Valproic Acid|valproic acid|mesh-list
19292300|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19292301|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292302|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292303|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292304|NCT04263844|Analgesics|analgesics|mesh-ancestor
19292305|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
19292306|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292307|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19292308|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19292309|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19292310|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
19292311|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292312|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292313|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19292314|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19292315|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19292316|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19292317|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19292318|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
19292319|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
19292320|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
19292321|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
19292322|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19292323|NCT04264208|Bombesin|bombesin|mesh-list
19292324|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19292325|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292326|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292327|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183636|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
20183637|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183638|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183639|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
20183640|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292333|NCT04263519|Tacrolimus|tacrolimus|mesh-list
19292334|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292335|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
19292336|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292337|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19292338|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292339|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292340|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
19292341|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20361435|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361436|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20361437|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361438|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361439|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20361440|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20361441|NCT00931957|Analgesics|analgesics|mesh-ancestor
20361442|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
20361443|NCT00932048|Atorvastatin|atorvastatin|mesh-list
20361444|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20361445|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20361446|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
20361447|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361448|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20361449|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20361450|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361451|NCT00932100|Heparin|heparin|mesh-list
20361452|NCT00932100|Calcium heparin|calcium heparin|mesh-list
20361453|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20361454|NCT00932100|Tinzaparin|tinzaparin|mesh-list
19292342|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19292343|NCT04263402|Prednisolone|prednisolone|mesh-list
19292344|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
20183641|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183642|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
20183643|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183644|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183645|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183646|NCT00195793|Atorvastatin|atorvastatin|mesh-list
20183647|NCT00195793|Ezetimibe|ezetimibe|mesh-list
20183648|NCT00195793|Fenofibrate|fenofibrate|mesh-list
20183649|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20183650|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20361455|NCT00932100|Dalteparin|dalteparin|mesh-list
20361456|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
19292345|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19292346|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
19292347|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19292348|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
19292349|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
20183651|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
20361457|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20361458|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20361459|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361460|NCT00932217|Lenograstim|lenograstim|mesh-list
20361461|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20361462|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
20361463|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361464|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
20361465|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20361466|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361467|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361468|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20361469|NCT00932386|Analgesics|analgesics|mesh-ancestor
20183652|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183653|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20183654|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20183655|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183656|NCT00195806|Valproic Acid|valproic acid|mesh-list
20183657|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
20183658|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183659|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183660|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
20183661|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183662|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183663|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
20183664|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20183665|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183666|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183667|NCT00195845|Galantamine|galantamine|mesh-list
19292350|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292351|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292352|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183668|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20183669|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183670|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183671|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
20183672|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183673|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183674|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20183675|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
20361470|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
20361471|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292353|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
19292354|NCT04263402|Hormones|hormones|mesh-ancestor
19292355|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19292356|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19292357|NCT04263402|Protective Agents|protective agents|mesh-ancestor
19292358|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19292359|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292360|NCT04263298|Capecitabine|capecitabine|mesh-list
20361472|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20361473|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20361474|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19292361|NCT04263298|Fulvestrant|fulvestrant|mesh-list
19292362|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292363|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
19292364|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292365|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292366|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19292367|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19292368|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19292369|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
19404285|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19671631|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
19671632|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
19692149|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292370|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19292371|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292372|NCT04262999|Levetiracetam|levetiracetam|mesh-list
19292373|NCT04262999|Valproic Acid|valproic acid|mesh-list
19292374|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
19292375|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
19292376|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292377|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292378|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
19292379|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292380|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292381|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
19292382|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20361475|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
20361476|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361477|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361478|NCT00932529|Olanzapine|olanzapine|mesh-list
20361479|NCT00932529|Risperidone|risperidone|mesh-list
20361480|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20361481|NCT00932529|Ziprasidone|ziprasidone|mesh-list
20361482|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20361483|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
20361484|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361485|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361486|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361487|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20361488|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20361489|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361490|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20361491|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20361492|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
20361493|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
20361494|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
19292383|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292384|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19292385|NCT04262934|Vitamin D|vitamin d|mesh-list
19292386|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
19292387|NCT04262934|Vitamins|vitamins|mesh-ancestor
19292388|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
19292389|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292390|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19292391|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19292392|NCT04262635|Capecitabine|capecitabine|mesh-list
19292393|NCT04262635|Cetuximab|cetuximab|mesh-list
19292394|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292395|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
19292396|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292397|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292398|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292399|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
19292400|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19292401|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292402|NCT04262817|Nicotine|nicotine|mesh-list
19292403|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19292404|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
19292405|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292406|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292407|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19292408|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19292409|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
19292410|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292411|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292412|NCT04262843|Vidarabine|vidarabine|mesh-list
19292413|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
19292414|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
19292415|NCT04262843|Fludarabine|fludarabine|mesh-list
19292416|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
19292417|NCT04262843|Tacrolimus|tacrolimus|mesh-list
19292418|NCT04262843|Lenograstim|lenograstim|mesh-list
19292419|NCT04262843|Sargramostim|sargramostim|mesh-list
19671633|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361495|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361496|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19292420|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292421|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
19292422|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361497|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20361498|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20361499|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361500|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
20425311|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292423|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292424|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19292425|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
19292426|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292427|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292428|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19292429|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292430|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
19292431|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
19292432|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292433|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19292434|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292435|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19292436|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19292437|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
19292438|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19292439|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19292440|NCT04262765|Amlodipine|amlodipine|mesh-list
19292441|NCT04262765|Ramipril|ramipril|mesh-list
19292442|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19292443|NCT04262765|Atorvastatin|atorvastatin|mesh-list
19292444|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19292445|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19292446|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
19292447|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292448|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19292449|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19292450|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292451|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19292452|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19292453|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19292454|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19292455|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292456|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
19292457|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19292458|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
19292459|NCT04262804|Gemcitabine|gemcitabine|mesh-list
19292460|NCT04262804|Capecitabine|capecitabine|mesh-list
19292461|NCT04262804|Trastuzumab|trastuzumab|mesh-list
19292462|NCT04262804|Vinorelbine|vinorelbine|mesh-list
19292463|NCT04262804|Margetuximab|margetuximab|mesh-list
19292464|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292465|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
19292466|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292467|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292468|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
19292469|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292470|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292471|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292472|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
19292473|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292474|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292475|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19292476|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292477|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292478|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292479|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
19292480|NCT04262492|Apixaban|apixaban|mesh-list
19292481|NCT04262492|Edoxaban|edoxaban|mesh-list
19292482|NCT04262492|Dabigatran|dabigatran|mesh-list
19292483|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19292484|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
19292485|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19292486|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
19292487|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292488|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292489|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
19292490|NCT04262388|Durvalumab|durvalumab|mesh-list
19292491|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292492|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361501|NCT00932542|Lidocaine|lidocaine|mesh-list
20361502|NCT00932542|Prilocaine|prilocaine|mesh-list
20361503|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20361504|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
20361505|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361506|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361507|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
20361508|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361509|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20361510|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20361511|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20361512|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361513|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292493|NCT04262375|Durvalumab|durvalumab|mesh-list
19292494|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292495|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292496|NCT04262193|Suvorexant|suvorexant|mesh-list
19292497|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19292498|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19292499|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292500|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292501|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19292502|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292503|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292504|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
19292505|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292506|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292507|NCT04261907|Ritonavir|ritonavir|mesh-list
20361514|NCT00932555|Factor VIII|factor viii|mesh-list
20361515|NCT00932555|Coagulants|coagulants|mesh-ancestor
20361516|NCT00932685|Midazolam|midazolam|mesh-list
20361517|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20361518|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20361519|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361520|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361521|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20361522|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20361523|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20361524|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20361525|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
20361526|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
20361527|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
20361528|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
20361529|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361530|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361531|NCT00932763|Amlodipine|amlodipine|mesh-list
20361532|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20361533|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20361534|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361535|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292508|NCT04261907|Lopinavir|lopinavir|mesh-list
19292509|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19292510|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19292511|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
20361536|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20361537|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361538|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
20361539|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
19292512|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292513|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292514|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19292515|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19292516|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
19292517|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292518|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19292519|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19395262|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395263|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19395264|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395265|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
19395266|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395267|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395268|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19292520|NCT04261855|Avelumab|avelumab|mesh-list
19292521|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19292522|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292523|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292524|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19292525|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292526|NCT04261634|Mitogens|mitogens|mesh-list
19292527|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292528|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292529|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
19292530|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19292531|NCT04261426|Antibodies|antibodies|mesh-list
19292532|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
19292533|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19292534|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
19292535|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292536|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19292537|NCT04261465|Paclitaxel|paclitaxel|mesh-list
19292538|NCT04261465|Carboplatin|carboplatin|mesh-list
19292539|NCT04261465|Olaparib|olaparib|mesh-list
19292540|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19292541|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292542|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
20183676|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183677|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
20183678|NCT00195871|Cytarabine|cytarabine|mesh-list
20183679|NCT00195871|Prednisone|prednisone|mesh-list
20183680|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
19292543|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292544|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292545|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292546|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19292547|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292548|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
19292549|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
19292550|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19292551|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19292552|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361540|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20361541|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20361542|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361543|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20361544|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19292553|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292554|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292555|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292556|NCT04261270|Ritonavir|ritonavir|mesh-list
19292557|NCT04261270|Oseltamivir|oseltamivir|mesh-list
19292558|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19292559|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19292560|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
19292561|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292562|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292563|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19292564|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19292565|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
19292566|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292567|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19292568|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19292569|NCT04261023|Abatacept|abatacept|mesh-list
19292570|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19292571|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292572|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183681|NCT00195871|Methotrexate|methotrexate|mesh-list
20183682|NCT00195871|Etoposide|etoposide|mesh-list
20183683|NCT00195871|Vincristine|vincristine|mesh-list
20183684|NCT00195871|Daunorubicin|daunorubicin|mesh-list
20183685|NCT00195871|Asparaginase|asparaginase|mesh-list
20183686|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183687|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
19292573|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292574|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
19292575|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183688|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183689|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361545|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292576|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292577|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
19292578|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
19292579|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292580|NCT04261036|Protective Agents|protective agents|mesh-ancestor
19292581|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292582|NCT04261036|Vitamins|vitamins|mesh-ancestor
19292583|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
19292584|NCT04260828|Aspirin|aspirin|mesh-list
19292585|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19292586|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292587|NCT04260828|Analgesics|analgesics|mesh-ancestor
19292588|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
19292589|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292590|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292591|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19292592|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292593|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19292594|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19838315|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19838316|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838317|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
19838318|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
19292595|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292596|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19292597|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19292598|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292599|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
19292600|NCT04260711|Interferons|interferons|mesh-list
19292601|NCT04260711|Teriflunomide|teriflunomide|mesh-list
19292602|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
19292603|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19292604|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
19292605|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292606|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
19292607|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292608|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19292609|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
19292610|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292611|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292612|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292613|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19292614|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292615|NCT04260711|Analgesics|analgesics|mesh-ancestor
19292616|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
19292617|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292618|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19292619|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
20361546|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361547|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361548|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20361549|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
20361550|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20361551|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361552|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20361553|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20361554|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20361555|NCT00932867|Telmisartan|telmisartan|mesh-list
20361556|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20361557|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20361558|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20361559|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361560|NCT00932880|Amlodipine|amlodipine|mesh-list
20361561|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20361562|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20361563|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361564|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292620|NCT04260607|Ketamine|ketamine|mesh-list
19292621|NCT04260607|Analgesics|analgesics|mesh-ancestor
19292622|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
19292623|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292624|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292625|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19292626|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19838319|NCT00620061|Lubiprostone|lubiprostone|mesh-list
19292627|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
19292628|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
20183690|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20361565|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20361566|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361567|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
20361568|NCT00932971|Tenofovir|tenofovir|mesh-list
19292629|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292630|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19292631|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19292632|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292633|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292634|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
19292635|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19292636|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
19292637|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292638|NCT04260516|Expectorants|expectorants|mesh-ancestor
19292639|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
19292640|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19292641|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
19292642|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292643|NCT04260516|Protective Agents|protective agents|mesh-ancestor
19292644|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292645|NCT04260516|Antidotes|antidotes|mesh-ancestor
19292646|NCT04260581|Amantadine|amantadine|mesh-list
19292647|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19292648|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19292649|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
19292650|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292651|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
19292652|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292653|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292654|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292655|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292656|NCT04260581|Analgesics|analgesics|mesh-ancestor
19292657|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
19292658|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292659|NCT04260685|Lidocaine|lidocaine|mesh-list
19292660|NCT04260685|Esmolol|esmolol|mesh-list
20361569|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20361570|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
20361571|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
20361572|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20361573|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
20361574|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361575|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20361576|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20361577|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361578|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292661|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
19292662|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
19292663|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292664|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292665|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
19292666|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292667|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19292668|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19292669|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19292670|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19292671|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292672|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20183691|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
20183692|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183693|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183694|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20183695|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20183696|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
20183697|NCT00195871|Hormones|hormones|mesh-ancestor
20183698|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361579|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19292673|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19692150|NCT04996238|Vaccines|vaccines|mesh-list
20361580|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20361581|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
20361582|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361583|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361584|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
20361585|NCT00933023|Betamethasone|betamethasone|mesh-list
20361586|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361587|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
20361588|NCT00933023|Hormones|hormones|mesh-ancestor
20361589|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361590|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361591|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20361592|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
20361593|NCT00933049|Amoxicillin|amoxicillin|mesh-list
20361594|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20361595|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20361596|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361597|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20361598|NCT00933049|Renal Agents|renal agents|mesh-ancestor
20361599|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
20361600|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20361601|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20361602|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
20361603|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20361604|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20361605|NCT00933179|Gestodene|gestodene|mesh-list
20361606|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20361607|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
20361608|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20361609|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361610|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20361611|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20361612|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20361613|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20361614|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20361615|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20361616|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20361617|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20361618|NCT00933179|Progestins|progestins|mesh-ancestor
20361619|NCT00933179|Hormones|hormones|mesh-ancestor
20361620|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361621|NCT00933205|Tipranavir|tipranavir|mesh-list
20361622|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20361623|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20361624|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
20361625|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361626|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
20361627|NCT00933231|Prednisone|prednisone|mesh-list
20361628|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
20361629|NCT00933231|Ramipril|ramipril|mesh-list
20361630|NCT00933231|Irbesartan|irbesartan|mesh-list
20361631|NCT00933231|Tacrolimus|tacrolimus|mesh-list
20361632|NCT00933231|Basiliximab|basiliximab|mesh-list
20361633|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361634|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
20361635|NCT00933231|Hormones|hormones|mesh-ancestor
20361636|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361637|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361638|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20361639|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361640|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361641|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
20361642|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20361643|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361644|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361645|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
20361646|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
20361647|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361648|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361649|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20361650|NCT00933231|Protective Agents|protective agents|mesh-ancestor
20361651|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20361652|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20361653|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
19692151|NCT04996238|Immunologic Factors|immunologic factors|mesh-ancestor
20361654|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19292674|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19292675|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
19292676|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292677|NCT04260360|Docetaxel|docetaxel|mesh-list
19292678|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292679|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292680|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292681|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292682|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292683|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
19292684|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19292685|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
19292686|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19292687|NCT04260035|Protective Agents|protective agents|mesh-ancestor
19292688|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292689|NCT04260269|Trifluridine|trifluridine|mesh-list
19292690|NCT04260269|Fluorouracil|fluorouracil|mesh-list
19292691|NCT04260269|Capecitabine|capecitabine|mesh-list
19292692|NCT04260269|Tegafur|tegafur|mesh-list
19292693|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
19292694|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292695|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20361655|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361656|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20361657|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
20361658|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20361659|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20361660|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20361661|NCT00933283|Methadone|methadone|mesh-list
20361662|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20361663|NCT00933283|Narcotics|narcotics|mesh-ancestor
20361664|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292696|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292697|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292698|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
19292699|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292700|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
19292701|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292702|NCT04260113|Apatinib|apatinib|mesh-list
19292703|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292704|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19292705|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292706|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292707|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
20361665|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361666|NCT00933283|Analgesics|analgesics|mesh-ancestor
20361667|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
20361668|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361669|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
19292708|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19292709|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
19292710|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292711|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292712|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19292713|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
19292714|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19292715|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
19292716|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292717|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292718|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19292719|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
19292720|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
19292721|NCT04259684|Protective Agents|protective agents|mesh-ancestor
19292722|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
19292723|NCT04259606|Antacids|antacids|mesh-ancestor
19292724|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292725|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395269|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
19395270|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19395271|NCT03668808|Insulin|insulin|mesh-list
19395272|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19395273|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
20361670|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
20361671|NCT00933309|Metformin|metformin|mesh-list
19395274|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
19395275|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361672|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
20361673|NCT00933309|Exemestane|exemestane|mesh-list
20361674|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361675|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361676|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361677|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20361678|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20361679|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183699|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20183700|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20183701|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
20183702|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183703|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292726|NCT04259476|Ketamine|ketamine|mesh-list
19292727|NCT04259476|Analgesics|analgesics|mesh-ancestor
19292728|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
19292729|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292730|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292731|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19292732|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19292733|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
19292734|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
19292735|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292736|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19671634|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19671635|NCT04169698|Denosumab|denosumab|mesh-list
19671636|NCT04169698|Alendronate|alendronate|mesh-list
19671637|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19671638|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671639|NCT03906617|Dexamethasone|dexamethasone|mesh-list
19671640|NCT03906617|Epinephrine|epinephrine|mesh-list
19671641|NCT03906617|Bupivacaine|bupivacaine|mesh-list
19671642|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19671643|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
19671644|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
19292737|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19292738|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292739|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361680|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292740|NCT04259333|Acetaminophen|acetaminophen|mesh-list
19292741|NCT04259333|Celecoxib|celecoxib|mesh-list
19292742|NCT04259333|Codeine|codeine|mesh-list
19292743|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292744|NCT04259333|Analgesics|analgesics|mesh-ancestor
19292745|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
19292746|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292747|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292748|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
19292749|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19292750|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19292751|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19292752|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19292753|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19292754|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292755|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292756|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19292757|NCT04259333|Narcotics|narcotics|mesh-ancestor
19292758|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292759|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
19292760|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
19292761|NCT04259073|Pregabalin|pregabalin|mesh-list
19292762|NCT04259073|Analgesics|analgesics|mesh-ancestor
19292763|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
19292764|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292765|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292766|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
19671645|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671646|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671647|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20183704|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
20183705|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
20183706|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183707|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20183708|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20361681|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20361682|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
20361683|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361684|NCT00933374|Paclitaxel|paclitaxel|mesh-list
20361685|NCT00933374|Everolimus|everolimus|mesh-list
20361686|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20361687|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361688|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
20361689|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
20361690|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
20361691|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361692|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361693|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
20361694|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361695|NCT00933387|Paclitaxel|paclitaxel|mesh-list
20361696|NCT00933387|Cetuximab|cetuximab|mesh-list
20361697|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19292767|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19292768|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19292769|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292770|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19292771|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19292772|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19292773|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292774|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19292775|NCT04258956|Avelumab|avelumab|mesh-list
20361698|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361699|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
20361700|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
20361701|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
20361702|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361703|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20361704|NCT00933426|Paclitaxel|paclitaxel|mesh-list
20361705|NCT00933426|Lenalidomide|lenalidomide|mesh-list
20361706|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20361707|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361708|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
20361709|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
20361710|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
20361711|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361712|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
20361713|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361714|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19292776|NCT04258956|Axitinib|axitinib|mesh-list
19292777|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292778|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292779|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19292780|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292781|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292782|NCT04259008|Manganese|manganese|mesh-list
19292783|NCT04259008|Trace Elements|trace elements|mesh-ancestor
19292784|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
19292785|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292786|NCT04258930|Calcium|calcium|mesh-list
19292787|NCT04258930|Calcium acetate|calcium acetate|mesh-list
19292788|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
19292789|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19292790|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292791|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
19292792|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
19292793|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292794|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19292795|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
20361715|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20361716|NCT00933426|Growth Substances|growth substances|mesh-ancestor
20361717|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
19292796|NCT04258657|Paclitaxel|paclitaxel|mesh-list
19292797|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19292798|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292799|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292800|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292801|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292802|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292803|NCT04258553|Antioxidants|antioxidants|mesh-list
19395276|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361718|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20361719|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20361720|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20361721|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361722|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361723|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361724|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361725|NCT00933439|Analgesics|analgesics|mesh-ancestor
20361726|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
20361727|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361728|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
20361729|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19292804|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292805|NCT04258553|Protective Agents|protective agents|mesh-ancestor
19292806|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292807|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
19292808|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
19292809|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292810|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292811|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292812|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
19292813|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
19292814|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
19292815|NCT04258475|Calcium|calcium|mesh-list
19292816|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20361730|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
20361731|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20361732|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20361733|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20361734|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361735|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361736|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361737|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361738|NCT00933452|Analgesics|analgesics|mesh-ancestor
20361739|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
20361740|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361741|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
20361742|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20361743|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
20361744|NCT00933465|Loperamide|loperamide|mesh-list
20361745|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
20361746|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20361747|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
20361748|NCT00933517|Docetaxel|docetaxel|mesh-list
20361749|NCT00933517|Panitumumab|panitumumab|mesh-list
20361750|NCT00933517|Epirubicin|epirubicin|mesh-list
20361751|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361752|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
19292817|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292818|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19292819|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19292820|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
19292821|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292822|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19292823|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19292824|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292825|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292826|NCT04258644|Paclitaxel|paclitaxel|mesh-list
19292827|NCT04258644|Apatinib|apatinib|mesh-list
20361753|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361754|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361755|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20361756|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
20361757|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361758|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361759|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20361760|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
20361761|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
20361762|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
20361763|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292828|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19292829|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292830|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
19292831|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
19292832|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
19292833|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292834|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19292835|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292836|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
19292837|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19292838|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292839|NCT04258631|Hydromorphone|hydromorphone|mesh-list
19292840|NCT04258631|Bupivacaine|bupivacaine|mesh-list
19292841|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
19292842|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
19292843|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292844|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292845|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
19292846|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292847|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19292848|NCT04258631|Narcotics|narcotics|mesh-ancestor
19292849|NCT04258631|Analgesics|analgesics|mesh-ancestor
19292850|NCT04258163|Gemcitabine|gemcitabine|mesh-list
19292851|NCT04258163|Capecitabine|capecitabine|mesh-list
19292852|NCT04258163|Doxorubicin|doxorubicin|mesh-list
19292853|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19292854|NCT04258163|Letrozole|letrozole|mesh-list
19292855|NCT04258163|Fulvestrant|fulvestrant|mesh-list
19292856|NCT04258163|Anastrozole|anastrozole|mesh-list
19292857|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292858|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
19292859|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292860|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292861|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
19292862|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292863|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292864|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19292865|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
19292866|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292867|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19292868|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19292869|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19292870|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19292871|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19292872|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19292873|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
19292874|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19292875|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19292876|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19292877|NCT04258241|Bupivacaine|bupivacaine|mesh-list
19292878|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
19292879|NCT04258241|Anesthetics|anesthetics|mesh-list
19292880|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19292881|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292882|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292883|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
20183709|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20183710|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20183711|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20183712|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
20183713|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
20183714|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
20183715|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
20183716|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183717|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183718|NCT00195910|Morphine|morphine|mesh-list
20183719|NCT00195910|Hydromorphone|hydromorphone|mesh-list
20183720|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20183721|NCT00195910|Narcotics|narcotics|mesh-ancestor
20183722|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183723|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183724|NCT00195910|Analgesics|analgesics|mesh-ancestor
19292884|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292885|NCT04258423|Everolimus|everolimus|mesh-list
19292886|NCT04258423|Tacrolimus|tacrolimus|mesh-list
20183725|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
20183726|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292887|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183727|NCT00195923|Clindamycin|clindamycin|mesh-list
19292888|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
19292889|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292890|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19292891|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292892|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292893|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292894|NCT04258306|Resveratrol|resveratrol|mesh-list
19292895|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
19292896|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292897|NCT04258306|Protective Agents|protective agents|mesh-ancestor
19292898|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292899|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292900|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19292901|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
19292902|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19292903|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361764|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20361765|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20361766|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20361767|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361768|NCT00933582|Naproxen|naproxen|mesh-list
20361769|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20361770|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19292904|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19292905|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292906|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19292907|NCT04258098|Metronidazole|metronidazole|mesh-list
19292908|NCT04258098|Streptomycin|streptomycin|mesh-list
19292909|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292910|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20361771|NCT00933582|Analgesics|analgesics|mesh-ancestor
20361772|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
20361773|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361774|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361775|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361776|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20361777|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
20361778|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19292911|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19292912|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19292913|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292914|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292915|NCT04258111|Antibodies|antibodies|mesh-list
19292916|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
19292917|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
19292918|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361779|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361780|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361781|NCT00933634|Propafenone|propafenone|mesh-list
20361782|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19292919|NCT04258007|Neostigmine|neostigmine|mesh-list
19292920|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19292921|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292922|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292923|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
19292924|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292925|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292926|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19292927|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
19292928|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292929|NCT04257838|Meropenem|meropenem|mesh-list
19292930|NCT04257838|Tazobactam|tazobactam|mesh-list
19292931|NCT04257838|Piperacillin|piperacillin|mesh-list
19292932|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19292933|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19671648|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
19671649|NCT03906617|Hormones|hormones|mesh-ancestor
20183728|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
20183729|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
20183730|NCT00195923|Gentamicins|gentamicins|mesh-list
20183731|NCT00195923|Ceftazidime|ceftazidime|mesh-list
20183732|NCT00195923|Ampicillin|ampicillin|mesh-list
20183733|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183734|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183735|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20183736|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671650|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671651|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19671652|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671653|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
19292934|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292935|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19292936|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292937|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292938|NCT04257851|Sumatriptan|sumatriptan|mesh-list
19292939|NCT04257851|Theophylline|theophylline|mesh-list
19292940|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19292941|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19292942|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19292943|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
19292944|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19292945|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292946|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292947|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19292948|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
19292949|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19292950|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19292951|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
19292952|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19292953|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292954|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
19292955|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19292956|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19292957|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
19292958|NCT04257812|Tazobactam|tazobactam|mesh-list
19292959|NCT04257812|Ceftolozane|ceftolozane|mesh-list
19292960|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19292961|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19292962|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292963|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19292964|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19292965|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292966|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19292967|NCT04257812|Renal Agents|renal agents|mesh-ancestor
19292968|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
20361783|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20361784|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20361785|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361786|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361787|NCT00933777|Everolimus|everolimus|mesh-list
20361788|NCT00933777|Sorafenib|sorafenib|mesh-list
20361789|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361790|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361791|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
20361792|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361793|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20361794|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361795|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361796|NCT00933790|Rifampin|rifampin|mesh-list
20361797|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
20361798|NCT00933790|Ethambutol|ethambutol|mesh-list
20361799|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19292969|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19292970|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19292971|NCT04257461|Capecitabine|capecitabine|mesh-list
19292972|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
19292973|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19292974|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
19292975|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19292976|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292977|NCT04257682|Bupivacaine|bupivacaine|mesh-list
19292978|NCT04257682|Ropivacaine|ropivacaine|mesh-list
19292979|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
19292980|NCT04257682|Mepivacaine|mepivacaine|mesh-list
19292981|NCT04257682|Anesthetics|anesthetics|mesh-list
19292982|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19292983|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671654|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
20361800|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
20361801|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19292984|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
19292985|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395277|NCT03668730|Paclitaxel|paclitaxel|mesh-list
19395278|NCT03668730|Fluorouracil|fluorouracil|mesh-list
19395279|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19395280|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395281|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
19395282|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395283|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
19395284|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395285|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
19395286|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19395287|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395288|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
19395289|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395290|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
19395291|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19395292|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
20361802|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361803|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
20361804|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20361805|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361806|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361807|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20361808|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20361809|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20361810|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20361811|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20361812|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19671655|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671656|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
19671657|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20183737|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361813|NCT00933816|Fluorouracil|fluorouracil|mesh-list
20361814|NCT00933816|Sorafenib|sorafenib|mesh-list
19395293|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395294|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
19395295|NCT03668665|Protective Agents|protective agents|mesh-ancestor
19395296|NCT03668470|Dulaglutide|dulaglutide|mesh-list
19395297|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19395298|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395299|NCT03668431|Trametinib|trametinib|mesh-list
19395300|NCT03668431|Dabrafenib|dabrafenib|mesh-list
19395301|NCT03668431|Spartalizumab|spartalizumab|mesh-list
19395302|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395303|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19395304|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395305|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395306|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19395307|NCT03668418|Gemcitabine|gemcitabine|mesh-list
19395308|NCT03668418|Camptothecin|camptothecin|mesh-list
19395309|NCT03668418|Docetaxel|docetaxel|mesh-list
19395310|NCT03668418|Fluorouracil|fluorouracil|mesh-list
19395311|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
19395312|NCT03668418|Irinotecan|irinotecan|mesh-list
19395313|NCT03668418|Epirubicin|epirubicin|mesh-list
19395314|NCT03668418|Taxane|taxane|mesh-list
20183738|NCT00195936|Cinacalcet|cinacalcet|mesh-list
19395315|NCT03668418|Antimetabolites|antimetabolites|mesh-list
19395316|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20183739|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20183740|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183741|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20183742|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
20183743|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183744|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
20183745|NCT00195988|Tacrolimus|tacrolimus|mesh-list
20183746|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20183747|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
20183748|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183749|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20183750|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183751|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183752|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183753|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19292986|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19292987|NCT04257500|Etonogestrel|etonogestrel|mesh-list
19292988|NCT04257500|NuvaRing|nuvaring|mesh-list
19292989|NCT04257500|Estradiol|estradiol|mesh-list
19292990|NCT04257500|Estrogens|estrogens|mesh-ancestor
19292991|NCT04257500|Hormones|hormones|mesh-ancestor
19292992|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19292993|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19292994|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19292995|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
19292996|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19292997|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19292998|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19292999|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19293000|NCT04257656|Remdesivir|remdesivir|mesh-list
19293001|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
19293002|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293003|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
19293004|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293005|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19293006|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
19293007|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19293008|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
19293009|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293010|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19293011|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19293012|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19293013|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19293014|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293015|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19293016|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293017|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
19293018|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19293019|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293020|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
19293021|NCT04257032|Dabigatran|dabigatran|mesh-list
19293022|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19293023|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19293024|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19293025|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
19293026|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293027|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19293028|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19293029|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293030|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
19293031|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19293032|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293033|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
19293034|NCT04256642|Morphine|morphine|mesh-list
19293035|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19293036|NCT04256642|Narcotics|narcotics|mesh-ancestor
19293037|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293038|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293039|NCT04256642|Analgesics|analgesics|mesh-ancestor
19293040|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
19293041|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293042|NCT04256733|Capsaicin|capsaicin|mesh-list
19293043|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
19293044|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
19293045|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
19293046|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293047|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293048|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19293049|NCT04256473|Saruplase|saruplase|mesh-list
19293050|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19293051|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19293052|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293053|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
19293054|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293055|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19293056|NCT04256343|Protective Agents|protective agents|mesh-ancestor
19293057|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293058|NCT04256252|Rituximab|rituximab|mesh-list
19293059|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293060|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293061|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
19293062|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293063|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293064|NCT04256525|Aspirin|aspirin|mesh-list
19293065|NCT04256525|Heparin|heparin|mesh-list
19293066|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
19671658|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19671659|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
19671660|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671661|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671662|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19671663|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19671664|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20183754|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20361815|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293067|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19293068|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19293069|NCT04256525|Analgesics|analgesics|mesh-ancestor
19293070|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
19293071|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293072|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293073|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293074|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293075|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19293076|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19293077|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293078|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19293079|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19293080|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293081|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
19293082|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
19293083|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19293084|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
19293085|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19293086|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293087|NCT04256200|Dienogest|dienogest|mesh-list
19293088|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
19293089|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
19293090|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19293091|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19293092|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293093|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19293094|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20361816|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
20361817|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361818|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20361819|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361820|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
20361821|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361822|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20361823|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361824|NCT00933894|Citalopram|citalopram|mesh-list
20361825|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20361826|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20361827|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361828|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361829|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361830|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
19671665|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
19293095|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19293096|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19293097|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
19293098|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19293099|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20183755|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
20183756|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183757|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183758|NCT00196131|Morphine|morphine|mesh-list
20183759|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20183760|NCT00196131|Narcotics|narcotics|mesh-ancestor
20183761|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183762|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183763|NCT00196131|Analgesics|analgesics|mesh-ancestor
19293100|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293101|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
19293102|NCT04256057|Analgesics|analgesics|mesh-ancestor
19293103|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
19293104|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293105|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293106|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
19293107|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293108|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19293109|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
19293110|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19293111|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293112|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293113|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19293114|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
19293115|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19293116|NCT04256213|Nivolumab|nivolumab|mesh-list
19293117|NCT04256213|Ipilimumab|ipilimumab|mesh-list
19293118|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293119|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293120|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19293121|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293122|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
19293123|NCT04255992|Vitamin D|vitamin d|mesh-list
19293124|NCT04255992|Calcium|calcium|mesh-list
19293125|NCT04255992|Vitamins|vitamins|mesh-ancestor
19293126|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
19293127|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293128|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19293129|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19293130|NCT04255836|Durvalumab|durvalumab|mesh-list
19293131|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293132|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293133|NCT04255771|Gemcitabine|gemcitabine|mesh-list
19293134|NCT04255771|Cisplatin|cisplatin|mesh-list
19293135|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183764|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
20183765|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217271|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217272|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217273|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
20217274|NCT00309218|Hormones|hormones|mesh-ancestor
20217275|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217276|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20217277|NCT00309218|Protective Agents|protective agents|mesh-ancestor
20217278|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217279|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217280|NCT00309257|Valsartan|valsartan|mesh-list
20217281|NCT00309257|Benazepril|benazepril|mesh-list
20217282|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217283|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20217284|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20217285|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217286|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20217287|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
20217288|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217289|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
20217290|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20217291|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217292|NCT00309283|Somatostatin|somatostatin|mesh-list
20217293|NCT00309283|Hormones|hormones|mesh-ancestor
20217294|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217295|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217296|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
20217297|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20217298|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217299|NCT00309322|Phentolamine|phentolamine|mesh-list
20217300|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20217301|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20217302|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
20217303|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217304|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293136|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19293137|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
19293138|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293139|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
19293140|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293141|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293142|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19293143|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
19293144|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293145|NCT04255589|Ethanol|ethanol|mesh-list
19293146|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19293147|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293148|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293149|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395317|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395318|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
19395319|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395320|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
19395321|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361831|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361832|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19395322|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19395323|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
19395324|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395325|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361833|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
20361834|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20361835|NCT00933985|Doxorubicin|doxorubicin|mesh-list
20361836|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19395326|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395327|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
19395328|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395329|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19395330|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19395331|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19395332|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19395333|NCT03668340|Adavosertib|adavosertib|mesh-list
19395334|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395335|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395336|NCT03668262|Atracurium|atracurium|mesh-list
19395337|NCT03668262|Cisatracurium|cisatracurium|mesh-list
19395338|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19395339|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19395340|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19395341|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395342|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395343|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19395344|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19395345|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
19395346|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395347|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404286|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20361837|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
20361838|NCT00933985|Vincristine|vincristine|mesh-list
20361839|NCT00933985|Razoxane|razoxane|mesh-list
20361840|NCT00933985|Obatoclax|obatoclax|mesh-list
20361841|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20361842|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361843|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20361844|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20361845|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404287|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19404288|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19404289|NCT03595982|Nifedipine|nifedipine|mesh-list
19404290|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19404291|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19404292|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404293|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19404294|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404295|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
19404296|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
19404297|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404298|NCT03595930|Fluticasone|fluticasone|mesh-list
19404299|NCT03595930|Xhance|xhance|mesh-list
20361846|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293150|NCT04255576|Vitamin D|vitamin d|mesh-list
19293151|NCT04255576|Calcium|calcium|mesh-list
20361847|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20361848|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
20361849|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
20361850|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
20361851|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20361852|NCT00933985|Protective Agents|protective agents|mesh-ancestor
20361853|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361854|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
20361855|NCT00933998|Pyridoxal|pyridoxal|mesh-list
20361856|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
20361857|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
20361858|NCT00933998|Vitamins|vitamins|mesh-ancestor
20361859|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
20361860|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361861|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20361862|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20361863|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361864|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
20361865|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20361866|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361867|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20361868|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293152|NCT04255576|Vitamins|vitamins|mesh-ancestor
19293153|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
19838320|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19838321|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838322|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838323|NCT00620074|Voriconazole|voriconazole|mesh-list
19838324|NCT00620074|Anidulafungin|anidulafungin|mesh-list
19838325|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
19838326|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838327|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19838328|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19838329|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838330|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838331|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19838332|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
19838333|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19838334|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838335|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19838336|NCT00620113|Vitamin D|vitamin d|mesh-list
19838337|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
20361869|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361870|NCT00934154|Thalidomide|thalidomide|mesh-list
19293154|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293155|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19293156|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19293157|NCT04255498|Etanercept|etanercept|mesh-list
19293158|NCT04255498|Mifepristone|mifepristone|mesh-list
19293159|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19293160|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19293161|NCT04255498|Analgesics|analgesics|mesh-ancestor
19293162|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
19293163|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293164|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361871|NCT00934154|Prednisolone|prednisolone|mesh-list
20361872|NCT00934154|Melphalan|melphalan|mesh-list
19293165|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293166|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293167|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19293168|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19293169|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
19293170|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19293171|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
19293172|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19293173|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19293174|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19293175|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19293176|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
19293177|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19293178|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20361873|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19293179|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
19293180|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19293181|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
19293182|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19293183|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19293184|NCT04255368|Choline|choline|mesh-list
19293185|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
19293186|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20361874|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
20361875|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293187|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
19293188|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293189|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19293190|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19293191|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
19293192|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
19293193|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19293194|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293195|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19293196|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293197|NCT04255251|Fluorides|fluorides|mesh-list
19293198|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
19293199|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
19293200|NCT04255251|Protective Agents|protective agents|mesh-ancestor
19293201|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293202|NCT04255160|Estradiol|estradiol|mesh-list
19293203|NCT04255160|Estrogens|estrogens|mesh-ancestor
19293204|NCT04255160|Hormones|hormones|mesh-ancestor
19293205|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19293206|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293207|NCT04255134|Adalimumab|adalimumab|mesh-list
19293208|NCT04255134|Abatacept|abatacept|mesh-list
19293209|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293210|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293211|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19293212|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293213|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293214|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19293215|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
19293216|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293217|NCT04255017|Ritonavir|ritonavir|mesh-list
19293218|NCT04255017|Lopinavir|lopinavir|mesh-list
19293219|NCT04255017|Oseltamivir|oseltamivir|mesh-list
19293220|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19293221|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19293222|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293223|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361876|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361877|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20361878|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361879|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
20361880|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361881|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20361882|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
19293224|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293225|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19293226|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19293227|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
19293228|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293229|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19293230|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19293231|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
19293232|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19293233|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293234|NCT04255121|Lidocaine|lidocaine|mesh-list
19293235|NCT04255121|Epinephrine|epinephrine|mesh-list
19293236|NCT04255121|Racepinephrine|racepinephrine|mesh-list
20361883|NCT00934154|Hormones|hormones|mesh-ancestor
19293237|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
19293238|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293239|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
19293240|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293241|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293242|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
19293243|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293244|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19395348|NCT03668054|Bevacizumab|bevacizumab|mesh-list
19293245|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19293246|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19293247|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293248|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293249|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19293250|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19293251|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19293252|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293253|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19293254|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19293255|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
19293256|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20183766|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
19293257|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
19293258|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
19293259|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
19293260|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19293261|NCT04254822|Carvedilol|carvedilol|mesh-list
19293262|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19293263|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19293264|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
19293265|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293266|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293267|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293268|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19293269|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
19293270|NCT04254822|Protective Agents|protective agents|mesh-ancestor
19293271|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19293272|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293273|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19293274|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
19293275|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19293276|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19293277|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
19293278|NCT04255056|Epirubicin|epirubicin|mesh-list
19293279|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19293280|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
19293281|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293282|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293283|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19293284|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
19293285|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293286|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293287|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19293288|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19293289|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19293290|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19293291|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293292|NCT04254913|Edaravone|edaravone|mesh-list
19293293|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19293294|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
19293295|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293296|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19293297|NCT04254913|Protective Agents|protective agents|mesh-ancestor
19293298|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293299|NCT04254874|Interferons|interferons|mesh-list
19293300|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293301|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
19293302|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293303|NCT04254744|Sevoflurane|sevoflurane|mesh-list
19293304|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19293305|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19293306|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
19293307|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
19293308|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20183767|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20183768|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
20183769|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183770|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183771|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19293309|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293310|NCT04254523|Morphine|morphine|mesh-list
19293311|NCT04254523|Bupivacaine|bupivacaine|mesh-list
19293312|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293313|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
19293314|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293315|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293316|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
19293317|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293318|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19293319|NCT04254523|Narcotics|narcotics|mesh-ancestor
19293320|NCT04254523|Analgesics|analgesics|mesh-ancestor
19293321|NCT04254601|Erythromycin|erythromycin|mesh-list
19293322|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
19293323|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19293324|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
19293325|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19293326|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293327|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19293328|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19293329|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293330|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293331|NCT04254692|Bupivacaine|bupivacaine|mesh-list
19293332|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293333|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
19293334|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293335|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293336|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
19293337|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293338|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
19293339|NCT04254679|Analgesics|analgesics|mesh-list
19293340|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19293341|NCT04254679|Narcotics|narcotics|mesh-ancestor
19293342|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293343|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293344|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
19293345|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293346|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
19293347|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19293348|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293349|NCT04254471|Carboplatin|carboplatin|mesh-list
19293350|NCT04254471|Etoposide|etoposide|mesh-list
19293351|NCT04254471|Rabeprazole|rabeprazole|mesh-list
19293352|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293353|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19293354|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19293355|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19293356|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293357|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293358|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19293359|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19293360|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19293361|NCT04254640|Cytarabine|cytarabine|mesh-list
19293362|NCT04254640|Cladribine|cladribine|mesh-list
19293363|NCT04254640|Aclarubicin|aclarubicin|mesh-list
19293364|NCT04254640|Sargramostim|sargramostim|mesh-list
19293365|NCT04254640|Lenograstim|lenograstim|mesh-list
19293366|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19293367|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
19293368|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293369|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293370|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
19293371|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293372|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19293373|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
19293374|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293375|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19293376|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19293377|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19293378|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19293379|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293380|NCT04254042|Perindopril|perindopril|mesh-list
20183772|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20183773|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20183774|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
20183775|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19293381|NCT04254042|Zofenopril|zofenopril|mesh-list
19293382|NCT04254042|Captopril|captopril|mesh-list
19293383|NCT04254042|Calcium|calcium|mesh-list
19293384|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19293385|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293386|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19293387|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293388|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293389|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293390|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19293391|NCT04254081|Lidocaine|lidocaine|mesh-list
20361884|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361885|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20361886|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
20361887|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20361888|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361889|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20361890|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19293392|NCT04254081|Buprenorphine|buprenorphine|mesh-list
19293393|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293394|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
19293395|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293396|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293397|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
19293398|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293399|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19293400|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19293401|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19293402|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293403|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293404|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19293405|NCT04254081|Narcotics|narcotics|mesh-ancestor
19293406|NCT04254081|Analgesics|analgesics|mesh-ancestor
19293407|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19293408|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
19293409|NCT04253912|Povidone|povidone|mesh-list
19293410|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
19293411|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
19293412|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19293413|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293414|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19293415|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19293416|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293417|NCT04253678|Vortioxetine|vortioxetine|mesh-list
19293418|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
19293419|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19293420|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19293421|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19293422|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293423|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293424|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19293425|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19293426|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293427|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293428|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293429|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
19293430|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19293431|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19293432|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19293433|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19293434|NCT04253561|Trastuzumab|trastuzumab|mesh-list
19293435|NCT04253561|Pertuzumab|pertuzumab|mesh-list
19293436|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293437|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293438|NCT04253873|Temozolomide|temozolomide|mesh-list
19293439|NCT04253873|Apatinib|apatinib|mesh-list
19293440|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19293441|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
19293442|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293443|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293444|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20361891|NCT00934154|Growth Substances|growth substances|mesh-ancestor
20361892|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
20425312|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
20425313|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425314|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
20425315|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19293445|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293446|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
19293447|NCT04253132|Analgesics|analgesics|mesh-ancestor
19293448|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
19293449|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293450|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293451|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19293452|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19293453|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293454|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293455|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19293456|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293457|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293458|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19293459|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
19293460|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
19293461|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19293462|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19293463|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
19293464|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293465|NCT04253145|Atezolizumab|atezolizumab|mesh-list
19293466|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395349|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19395350|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395351|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19395352|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19395353|NCT03668054|Growth Substances|growth substances|mesh-ancestor
19395354|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395355|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
19395356|NCT03668041|Gabapentin|gabapentin|mesh-list
19395357|NCT03668041|Trazodone|trazodone|mesh-list
19395358|NCT03668041|Eszopiclone|eszopiclone|mesh-list
19395359|NCT03668041|Analgesics|analgesics|mesh-ancestor
19395360|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
19395361|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395362|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395363|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
19395364|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19395365|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19395366|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395367|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19395368|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19395369|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19395370|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395371|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395372|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
19395373|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19395374|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19395375|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19395376|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395377|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
19395378|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19395379|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
19395380|NCT03668015|Sorbitol|sorbitol|mesh-list
19395381|NCT03668015|Cathartics|cathartics|mesh-ancestor
19395382|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395383|NCT03667963|Lactulose|lactulose|mesh-list
19395384|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395385|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19395386|NCT03667937|Laxatives|laxatives|mesh-ancestor
19395387|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395388|NCT03667703|Famotidine|famotidine|mesh-list
20183776|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
20183777|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20183778|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183779|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20183780|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20183781|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20183782|NCT00196378|Estrogens|estrogens|mesh-list
19395389|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19838338|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
20183783|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20183784|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
20183785|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
20183786|NCT00196378|Hormones|hormones|mesh-ancestor
19293467|NCT04253457|Triamcinolone|triamcinolone|mesh-list
19293468|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293469|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
19293470|NCT04253457|Hormones|hormones|mesh-ancestor
19293471|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19293472|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293473|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19293474|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19293475|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19293476|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
19293477|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293478|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19293479|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19293480|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293481|NCT04253223|Volagidemab|volagidemab|mesh-list
19293482|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19293483|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293484|NCT04252963|Streptokinase|streptokinase|mesh-list
19293485|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19293486|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19293487|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293488|NCT04252664|Remdesivir|remdesivir|mesh-list
19293489|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
19293490|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293491|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
19293492|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293493|NCT04252768|Paclitaxel|paclitaxel|mesh-list
19293494|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19293495|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293496|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
19293497|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
19293498|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
19293499|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293500|NCT04252885|Ritonavir|ritonavir|mesh-list
19293501|NCT04252885|Lopinavir|lopinavir|mesh-list
19293502|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19293503|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19293504|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293505|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293506|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293507|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19293508|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19293509|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
19293510|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293511|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19293512|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19293513|NCT04252586|Cannabidiol|cannabidiol|mesh-list
19293514|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
19293515|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
19293516|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293517|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293518|NCT04252456|Leucovorin|leucovorin|mesh-list
19293519|NCT04252456|Folic Acid|folic acid|mesh-list
19293520|NCT04252456|Fluorouracil|fluorouracil|mesh-list
19293521|NCT04252456|Aflibercept|aflibercept|mesh-list
19293522|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
19293523|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
19293524|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293525|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19293526|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293527|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19293528|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
19293529|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293530|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19293531|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19293532|NCT04252456|Growth Substances|growth substances|mesh-ancestor
19293533|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
19293534|NCT04252456|Antidotes|antidotes|mesh-ancestor
19293535|NCT04252456|Protective Agents|protective agents|mesh-ancestor
19293536|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
19293537|NCT04252456|Vitamins|vitamins|mesh-ancestor
19293538|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
19293539|NCT04252456|Hematinics|hematinics|mesh-ancestor
19293540|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
19293541|NCT04252443|Analgesics|analgesics|mesh-list
19293542|NCT04252443|Narcotics|narcotics|mesh-ancestor
19293543|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293544|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293545|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
19293546|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293547|NCT04252248|Decitabine|decitabine|mesh-list
19293548|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19293549|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
19293550|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293551|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293552|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293553|NCT04252274|Darunavir|darunavir|mesh-list
19293554|NCT04252274|Cobicistat|cobicistat|mesh-list
19293555|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19293556|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19293557|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293558|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293559|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293560|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19293561|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19293562|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
19293563|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293564|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19293565|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19293566|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19293567|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19293568|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19293569|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
19293570|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293571|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19293572|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20361893|NCT00934167|Heparin|heparin|mesh-list
20361894|NCT00934167|Calcium heparin|calcium heparin|mesh-list
20361895|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
20361896|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20361897|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20361898|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361899|NCT00934193|Gabapentin|gabapentin|mesh-list
20361900|NCT00934193|Analgesics|analgesics|mesh-ancestor
20361901|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
20361902|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361903|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361904|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
19293573|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293574|NCT04252261|Sulforaphane|sulforaphane|mesh-list
19293575|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19293576|NCT04252261|Protective Agents|protective agents|mesh-ancestor
19293577|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293578|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293579|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19293580|NCT04252521|Ketoprofen|ketoprofen|mesh-list
20361905|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20361906|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20361907|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20361908|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20361909|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20361910|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20361911|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361912|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361913|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
20361914|NCT00934232|Busulfan|busulfan|mesh-list
20361915|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
20361916|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361917|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361918|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
20361919|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361920|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20361921|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361922|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20361923|NCT00934245|Vaccines|vaccines|mesh-list
20361924|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
20361925|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361926|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20361927|NCT00934258|Fenofibrate|fenofibrate|mesh-list
19293581|NCT04252521|Metoclopramide|metoclopramide|mesh-list
19293582|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
19293583|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
19293584|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293585|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293586|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19293587|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19293588|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19293589|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
19293590|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293591|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293592|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19293593|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19293594|NCT04252521|Analgesics|analgesics|mesh-ancestor
19293595|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
19293596|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293597|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293598|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19293599|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293600|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
19293601|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19293602|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293603|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293604|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19293605|NCT04251910|Analgesics|analgesics|mesh-ancestor
19293606|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
19293607|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293608|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19293609|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19293610|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19293611|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
19293612|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293613|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293614|NCT04251962|Fentanyl|fentanyl|mesh-list
19293615|NCT04251962|Bupivacaine|bupivacaine|mesh-list
19293616|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293617|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
19293618|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293619|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293620|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
19293621|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293622|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19293623|NCT04251962|Narcotics|narcotics|mesh-ancestor
19293624|NCT04251962|Analgesics|analgesics|mesh-ancestor
19293625|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19293626|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19293627|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
19293628|NCT04251871|Interferons|interferons|mesh-list
19293629|NCT04251871|Ritonavir|ritonavir|mesh-list
19293630|NCT04251871|Lopinavir|lopinavir|mesh-list
20183787|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183788|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183789|NCT00196391|Progesterone|progesterone|mesh-list
20183790|NCT00196391|Progestins|progestins|mesh-ancestor
20183791|NCT00196391|Hormones|hormones|mesh-ancestor
20183792|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183793|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183794|NCT00196417|Heparin|heparin|mesh-list
20183795|NCT00196417|Certoparin|certoparin|mesh-list
20183796|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
20183797|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20183798|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20183799|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183800|NCT00196469|Heparin|heparin|mesh-list
20183801|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
20183802|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20183803|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20183804|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183805|NCT00196534|Thrombin|thrombin|mesh-list
20183806|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
20183807|NCT00196534|Coagulants|coagulants|mesh-ancestor
20183808|NCT00196547|Montelukast|montelukast|mesh-list
20183809|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20183810|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
20183811|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20183812|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
19293631|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
19293632|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19293633|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293634|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
19293635|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293636|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19293637|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19293638|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293639|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293640|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293641|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19293642|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19293643|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19293644|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19293645|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
19293646|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293647|NCT04251819|Baclofen|baclofen|mesh-list
19293648|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19293649|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293650|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19293651|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293652|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19293653|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
19293654|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
19293655|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293656|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293657|NCT04251741|Adalimumab|adalimumab|mesh-list
19293658|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293659|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293660|NCT04251845|Melatonin|melatonin|mesh-list
19293661|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
19293662|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293663|NCT04251845|Protective Agents|protective agents|mesh-ancestor
19293664|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293665|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293666|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
19293667|NCT04251832|Antidotes|antidotes|mesh-ancestor
19293668|NCT04251832|Protective Agents|protective agents|mesh-ancestor
19293669|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293670|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
19293671|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293672|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
19293673|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19293674|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293675|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
19293676|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
19293677|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
19293678|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19293679|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19293680|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293681|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
19293682|NCT04251247|Coagulants|coagulants|mesh-ancestor
19395390|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395391|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20361928|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20361929|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20361930|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
20361931|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361932|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20361933|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20361934|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361935|NCT00934323|Metformin|metformin|mesh-list
20361936|NCT00934323|Glimepiride|glimepiride|mesh-list
20361937|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361938|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361939|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20361940|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20361941|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
20361942|NCT00934414|Insulin|insulin|mesh-list
20361943|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20361944|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361945|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
20361946|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
20361947|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
20361948|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
19395392|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
19395393|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
20361949|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
19293683|NCT04251169|Paclitaxel|paclitaxel|mesh-list
19293684|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
19293685|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19293686|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293687|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
19293688|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
19293689|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
19293690|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293691|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293692|NCT04251364|Acetazolamide|acetazolamide|mesh-list
19293693|NCT04251364|Atorvastatin|atorvastatin|mesh-list
19293694|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19293695|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19293696|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
19293697|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671666|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
19671667|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
19671668|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19671669|NCT03897673|Iron|iron|mesh-list
19671670|NCT03897673|Trace Elements|trace elements|mesh-ancestor
19671671|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
19293698|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19293699|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19293700|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293701|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
19293702|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19293703|NCT04251364|Diuretics|diuretics|mesh-ancestor
19293704|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
19293705|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293706|NCT04250948|Capecitabine|capecitabine|mesh-list
19293707|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
19293708|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19293709|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
19293710|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183813|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20183814|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293711|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293712|NCT05253508|Lidocaine|lidocaine|mesh-list
19293713|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293714|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
19293715|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293716|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293717|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
19671672|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671673|NCT03874494|Aripiprazole|aripiprazole|mesh-list
20183815|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20183816|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20183817|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183818|NCT00196586|Interferons|interferons|mesh-list
20183819|NCT00196586|Ribavirin|ribavirin|mesh-list
20183820|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
20183821|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
20183822|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20183823|NCT00196586|Interleukin-2|interleukin-2|mesh-list
20183824|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183825|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
20183826|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183827|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
20183828|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183829|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
20183830|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183831|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20183832|NCT00196586|Analgesics|analgesics|mesh-ancestor
20183833|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
20183834|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183835|NCT00196599|Emtricitabine|emtricitabine|mesh-list
20183836|NCT00196599|Efavirenz|efavirenz|mesh-list
20183837|NCT00196599|Didanosine|didanosine|mesh-list
20183838|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
20183839|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183840|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20183841|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20183842|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183843|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671674|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
20361950|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20361951|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20361952|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293718|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293719|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19293720|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19293721|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19293722|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293723|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293724|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
19293725|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19293726|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19293727|NCT05253118|Pemetrexed|pemetrexed|mesh-list
19293728|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293729|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293730|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293731|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19293732|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19293733|NCT05253066|Docetaxel|docetaxel|mesh-list
19293734|NCT05253066|Epirubicin|epirubicin|mesh-list
19293735|NCT05253066|Exemestane|exemestane|mesh-list
19293736|NCT05253066|Goserelin|goserelin|mesh-list
19293737|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293738|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
19293739|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
19293740|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
19293741|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293742|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19293743|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19293744|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19293745|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361953|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361954|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361955|NCT00934479|Lubiprostone|lubiprostone|mesh-list
20361956|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20361957|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361958|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361959|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20361960|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19293746|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19293747|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19293748|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19293749|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
19293750|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19293751|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293752|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19293753|NCT05253053|Paclitaxel|paclitaxel|mesh-list
19293754|NCT05253053|Atezolizumab|atezolizumab|mesh-list
19293755|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19293756|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293757|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
19293758|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
19293759|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
19293760|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293761|NCT05253014|Acetaminophen|acetaminophen|mesh-list
19293762|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19293763|NCT05253014|Analgesics|analgesics|mesh-ancestor
20183844|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20183845|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20183846|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20183847|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20183848|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20183849|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20183850|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20183851|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20183852|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
20183853|NCT00196612|Emtricitabine|emtricitabine|mesh-list
20183854|NCT00196612|Efavirenz|efavirenz|mesh-list
20183855|NCT00196612|Didanosine|didanosine|mesh-list
20183856|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
20183857|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183858|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20361961|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20361962|NCT00934492|Renal Agents|renal agents|mesh-ancestor
20361963|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20361964|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
20361965|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20361966|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20361967|NCT00934518|Cetuximab|cetuximab|mesh-list
20361968|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20361969|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293764|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
19293765|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293766|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293767|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
19293768|NCT05252845|Vaccines|vaccines|mesh-list
19293769|NCT05252845|Immunologic Factors|immunologic factors|mesh-ancestor
19293770|NCT05252845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671675|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
19671676|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19671677|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19671678|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19671679|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671680|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671681|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
19671682|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
19671683|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671684|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671685|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19671686|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19671687|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
19671688|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19671689|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19671690|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19671691|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19671692|NCT03862859|Warfarin|warfarin|mesh-list
20361970|NCT00934531|Donepezil|donepezil|mesh-list
20361971|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20361972|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20361973|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293790|NCT05252715|Vaccines|vaccines|mesh-list
19293791|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
19293792|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293793|NCT05252598|Psilocybin|psilocybin|mesh-list
19293794|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
20361974|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
20361975|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20361976|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361977|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
20361978|NCT00934570|Metformin|metformin|mesh-list
20361979|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19293795|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293796|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19293797|NCT05252585|Everolimus|everolimus|mesh-list
19293798|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293799|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19293800|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
19293801|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293802|NCT05252546|Loperamide|loperamide|mesh-list
19293803|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
19293804|NCT05252546|Bentonite|bentonite|mesh-list
19293805|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19293806|NCT05252546|Antidotes|antidotes|mesh-ancestor
19293807|NCT05252546|Protective Agents|protective agents|mesh-ancestor
19293808|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293809|NCT05252429|Docetaxel|docetaxel|mesh-list
19293810|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
19293811|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293812|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
19293813|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
19293814|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
19293815|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293816|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293817|NCT05252416|Carboplatin|carboplatin|mesh-list
19293818|NCT05252416|Fulvestrant|fulvestrant|mesh-list
19293819|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293820|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19293821|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19293822|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19293823|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
19293824|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19293825|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293826|NCT05252325|Lidocaine|lidocaine|mesh-list
19293827|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
19293828|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293829|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
19293830|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293831|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293832|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
19671693|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
19671694|NCT03807817|Ethanol|ethanol|mesh-list
19671695|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19671696|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671697|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671698|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361980|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361981|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
20361982|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19293833|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361983|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20361984|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20361985|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20361986|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20361987|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
19293834|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19293835|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19293836|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19293837|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19293838|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293839|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19293840|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
19293841|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
19293842|NCT05252325|Protective Agents|protective agents|mesh-ancestor
19293843|NCT05252117|Mepivacaine|mepivacaine|mesh-list
19293844|NCT05252117|Carticaine|carticaine|mesh-list
19293845|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293846|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
19293847|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293848|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293849|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
19293850|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395394|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395395|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395396|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395397|NCT03667677|Amlodipine|amlodipine|mesh-list
19395398|NCT03667677|Tandospirone|tandospirone|mesh-list
19395399|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19395400|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19395401|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395402|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395403|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19395404|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395405|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395406|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19395407|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19395408|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395409|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19395410|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19395411|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
19395412|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395413|NCT03667352|Fentanyl|fentanyl|mesh-list
19395414|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19395415|NCT03667352|Narcotics|narcotics|mesh-ancestor
19395416|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395417|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395418|NCT03667352|Analgesics|analgesics|mesh-ancestor
19395419|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
19395420|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395421|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19395422|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19395423|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
19395424|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
19671699|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
20361988|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293851|NCT05251766|Paclitaxel|paclitaxel|mesh-list
19293852|NCT05251766|Docetaxel|docetaxel|mesh-list
19293853|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19293854|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20361989|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361990|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20361991|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20361992|NCT00934713|Montelukast|montelukast|mesh-list
20361993|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20361994|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
20361995|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20361996|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
20361997|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20361998|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20361999|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20362000|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20362001|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362002|NCT00934739|Thalidomide|thalidomide|mesh-list
20362003|NCT00934739|Dexamethasone|dexamethasone|mesh-list
20362004|NCT00934739|Celecoxib|celecoxib|mesh-list
20362005|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
20362006|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362007|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
20362008|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362009|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362010|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20362011|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
20362012|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362013|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362014|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20362015|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20362016|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
20362017|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
20362018|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362019|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20362020|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
20362021|NCT00934739|Hormones|hormones|mesh-ancestor
20362022|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362023|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20362024|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
19293855|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
19293856|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
19293857|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
19293858|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293859|NCT05251662|Bevacizumab|bevacizumab|mesh-list
19293860|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293861|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293862|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19293863|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19293864|NCT05251662|Growth Substances|growth substances|mesh-ancestor
19293865|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293866|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
19293867|NCT05251636|Aflibercept|aflibercept|mesh-list
19293868|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19293869|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19293870|NCT05251636|Growth Substances|growth substances|mesh-ancestor
19293871|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293872|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
19293873|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293874|NCT05251610|Propranolol|propranolol|mesh-list
19293875|NCT05251610|Oxytocin|oxytocin|mesh-list
19293876|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
19293877|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19293878|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293879|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19293880|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19293881|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
19293882|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19293883|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293884|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19293885|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19293886|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
19838339|NCT00620113|Calcium|calcium|mesh-list
19293887|NCT05213507|Amikacin|amikacin|mesh-list
19838340|NCT00620113|Vitamins|vitamins|mesh-ancestor
20362025|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19293888|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19293889|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19293890|NCT05194293|Durvalumab|durvalumab|mesh-list
19293891|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
19293892|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19293893|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
19293894|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293895|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293896|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
19293897|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293898|NCT04993352|Antibodies|antibodies|mesh-list
19293899|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20362026|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362027|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20362028|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20362029|NCT00934739|Growth Substances|growth substances|mesh-ancestor
20362030|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
19293900|NCT04993352|Mitogens|mitogens|mesh-list
19293901|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
19293902|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
19293903|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293904|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
19293905|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293906|NCT04993352|Growth Substances|growth substances|mesh-ancestor
20362031|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20362032|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20362033|NCT00934739|Analgesics|analgesics|mesh-ancestor
20362034|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
20362035|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20362036|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20362037|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293921|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
20362038|NCT00934752|Paclitaxel|paclitaxel|mesh-list
20362039|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20362040|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362041|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
20362042|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
20362043|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
20362044|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362045|NCT00934817|Metformin|metformin|mesh-list
20362046|NCT00934817|Glimepiride|glimepiride|mesh-list
19293922|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19293923|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293924|NCT04962503|Afamelanotide|afamelanotide|mesh-list
19293925|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
19293926|NCT04938882|Lidocaine|lidocaine|mesh-list
19293927|NCT04938882|Ropivacaine|ropivacaine|mesh-list
19293928|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
19293929|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
19293930|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293931|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293932|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
19293933|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293934|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19293935|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19293936|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20362047|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20362048|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362049|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19293937|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838341|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
19395425|NCT03667326|Aspirin|aspirin|mesh-list
19293938|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293939|NCT04933903|Nivolumab|nivolumab|mesh-list
19293940|NCT04933903|Ipilimumab|ipilimumab|mesh-list
20362050|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362051|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
20362052|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20362053|NCT00934830|Amoxicillin|amoxicillin|mesh-list
20362054|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362055|NCT00934895|Paclitaxel|paclitaxel|mesh-list
20362056|NCT00934895|Everolimus|everolimus|mesh-list
20362057|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20362058|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20362059|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293941|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19293942|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293943|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19293944|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293945|NCT04911517|Capecitabine|capecitabine|mesh-list
19293946|NCT04911517|Antibodies|antibodies|mesh-list
19293947|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19293948|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
19293949|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293950|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19293951|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
19293952|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293953|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293954|NCT04865978|Warfarin|warfarin|mesh-list
19293955|NCT04865978|Apixaban|apixaban|mesh-list
19293956|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
19293957|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19293958|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
19293959|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19293960|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
19293961|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293962|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293963|NCT04816513|Ustekinumab|ustekinumab|mesh-list
19293964|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
19293965|NCT04740671|Ranibizumab|ranibizumab|mesh-list
19293966|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19293967|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19293968|NCT04740671|Growth Substances|growth substances|mesh-ancestor
19293969|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362060|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
20362061|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
20362062|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
20362063|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362064|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362065|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
20362066|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362067|NCT00934973|Mebeverine|mebeverine|mesh-list
20362068|NCT00934973|Alverine|alverine|mesh-list
20362069|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
20362070|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
20362071|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
20362072|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362073|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362074|NCT00935116|Etoricoxib|etoricoxib|mesh-list
20362075|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19293970|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
19293971|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671700|NCT03797326|Lenvatinib|lenvatinib|mesh-list
20183859|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20183860|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183861|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183862|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20183863|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20183864|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20183865|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20183866|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20183867|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20183868|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20183869|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20362076|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20362077|NCT00935116|Analgesics|analgesics|mesh-ancestor
19293972|NCT04731844|Curcumin|curcumin|mesh-list
20362078|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
19293973|NCT04731844|Piperine|piperine|mesh-list
19293974|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19293975|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19293976|NCT04731844|Analgesics|analgesics|mesh-ancestor
19293977|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
19293978|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293979|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293980|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19293981|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19293982|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19293983|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19293984|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19293985|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19395426|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19395427|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19395428|NCT03667326|Analgesics|analgesics|mesh-ancestor
20362079|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362080|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362081|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395429|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
19395430|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395431|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395432|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395433|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395434|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19395435|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19395436|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395437|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19395438|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19395439|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395440|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
19395441|NCT03667313|Sirolimus|sirolimus|mesh-list
19395442|NCT03667313|Paclitaxel|paclitaxel|mesh-list
19838342|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838343|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19838344|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19838345|NCT00620113|Antacids|antacids|mesh-ancestor
19838346|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838347|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838348|NCT00620191|Metformin|metformin|mesh-list
19838349|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19838350|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838351|NCT00620282|Liraglutide|liraglutide|mesh-list
19838352|NCT00620282|Glimepiride|glimepiride|mesh-list
19395443|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19395444|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395445|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
19395446|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395447|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
19395448|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395449|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19395450|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395451|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671701|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19671702|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671703|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19671704|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671705|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671706|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
19671707|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19671708|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671709|NCT03709446|Leflunomide|leflunomide|mesh-list
19671710|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671711|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183870|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
20183871|NCT00196625|Ritonavir|ritonavir|mesh-list
20183872|NCT00196625|Amprenavir|amprenavir|mesh-list
20183873|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20183874|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20183875|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
20183876|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183877|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183878|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19293986|NCT04674670|Naltrexone|naltrexone|mesh-list
19293987|NCT04674670|Bromocriptine|bromocriptine|mesh-list
19293988|NCT04674670|Amisulpride|amisulpride|mesh-list
19293989|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19293990|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19293991|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19293992|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
19293993|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19293994|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19293995|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19293996|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19293997|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19293998|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19293999|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
19294000|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294001|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294002|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19294003|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
19294004|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19294005|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19294006|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294007|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294008|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
19294009|NCT04669132|Olanzapine|olanzapine|mesh-list
19294010|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
19294011|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
19294012|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294013|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294014|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294015|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19294016|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19294017|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294018|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19294019|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19294020|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19294021|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19294022|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294023|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294024|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
19294025|NCT04648319|Nivolumab|nivolumab|mesh-list
19294026|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294027|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294028|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19294029|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294030|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
19294031|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
19294032|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19294033|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19294034|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294035|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
20183879|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20183880|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
20183881|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183882|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19294036|NCT04625530|Coagulants|coagulants|mesh-ancestor
19294037|NCT04625530|Hematinics|hematinics|mesh-ancestor
19294038|NCT04539873|Colchicine|colchicine|mesh-list
20183883|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20183884|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20183885|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
20183886|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20183887|NCT00196638|Interferons|interferons|mesh-list
20183888|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
20183889|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20183890|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183891|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
20183892|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183893|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
20183894|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183895|NCT00196664|Paroxetine|paroxetine|mesh-list
19294039|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
19294040|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19294041|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
19294042|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
19294043|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
19671712|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19671713|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
19671714|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671715|NCT03683069|Amlodipine|amlodipine|mesh-list
19671716|NCT03683069|Eplerenone|eplerenone|mesh-list
19671717|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19294044|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294045|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294046|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19294047|NCT04538092|Analgesics|analgesics|mesh-list
19294048|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671718|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19671719|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19671720|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671721|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19671722|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671723|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
19671724|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19671725|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
19671726|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671727|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20183896|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20183897|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20183898|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20183899|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183900|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183901|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
20183902|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183903|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20183904|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
20183905|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20183906|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20183907|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20183908|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294049|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
19294050|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294051|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294052|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19294053|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
19294054|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19294055|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
19294056|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294057|NCT04405349|Atezolizumab|atezolizumab|mesh-list
19294058|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294059|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19294060|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
19294061|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
19294062|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294063|NCT04173312|Bupivacaine|bupivacaine|mesh-list
19294064|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
19294065|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
19294066|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294067|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294068|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
19294069|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294070|NCT04171453|Pregabalin|pregabalin|mesh-list
19294071|NCT04171453|Analgesics|analgesics|mesh-ancestor
19294072|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
19294073|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294074|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294075|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
19294076|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19294077|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19294078|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294079|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19294080|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19294081|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19294082|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294083|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19294084|NCT04160325|Azathioprine|azathioprine|mesh-list
19294085|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
20362082|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362083|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20362084|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20362085|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362086|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362087|NCT00935194|Oseltamivir|oseltamivir|mesh-list
20362088|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
20362089|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362090|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362091|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362092|NCT00935246|Dexetimide|dexetimide|mesh-list
20362093|NCT00935246|Citalopram|citalopram|mesh-list
20362094|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20362095|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19294086|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294087|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294088|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294089|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294090|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
19294091|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294092|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19294093|NCT04126083|Lofexidine|lofexidine|mesh-list
19294094|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19294095|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19294096|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294097|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
19294098|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294099|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19294100|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19294101|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19294102|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294103|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294104|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294105|NCT04099797|Cyclophosphamide|cyclophosphamide|mesh-list
19294106|NCT04099797|Fludarabine|fludarabine|mesh-list
19294107|NCT04099797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294108|NCT04099797|Immunologic Factors|immunologic factors|mesh-ancestor
19294109|NCT04099797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294110|NCT04099797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19294111|NCT04099797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19294112|NCT04099797|Alkylating Agents|alkylating agents|mesh-ancestor
19294113|NCT04099797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294114|NCT04099797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294115|NCT04099797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19294116|NCT04004845|Misoprostol|misoprostol|mesh-list
19294117|NCT04004845|Oxytocin|oxytocin|mesh-list
19294118|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
20362096|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362097|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362098|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362099|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
20362100|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362101|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20362102|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
20362103|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362104|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20362105|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20362106|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
20362107|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
20362108|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362109|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20362110|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20362111|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
20362112|NCT00935298|Tacrolimus|tacrolimus|mesh-list
20362113|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362114|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
20362115|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362116|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20362117|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362118|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362119|NCT00935363|Glyburide|glyburide|mesh-list
19294119|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294120|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294121|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19294122|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
20183909|NCT00196677|Vitamins|vitamins|mesh-list
20183910|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
20183911|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183912|NCT00196690|Donepezil|donepezil|mesh-list
20183913|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20183914|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20183915|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294123|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19294124|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294125|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
19294126|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294127|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294128|NCT03854019|Quinidine|quinidine|mesh-list
19294129|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
19294130|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
19294131|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
19294132|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19294133|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19294134|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294135|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294136|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294137|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19294138|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19294139|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294140|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19294141|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
19294142|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20183916|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
20183917|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183918|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183919|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
20183920|NCT00196703|Memantine|memantine|mesh-list
20183921|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20183922|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20183923|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
20183924|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183925|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183926|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183927|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20183928|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20183929|NCT00196755|Calcium|calcium|mesh-list
20183930|NCT00196755|Sevelamer|sevelamer|mesh-list
20183931|NCT00196755|Calcium acetate|calcium acetate|mesh-list
20183932|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20183933|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183934|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
20183935|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
20183936|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183937|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
20183938|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183939|NCT00196820|Capecitabine|capecitabine|mesh-list
20183940|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183941|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
20183942|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183943|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183944|NCT00196846|Goserelin|goserelin|mesh-list
20183945|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20183946|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183947|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
20183948|NCT00196859|Capecitabine|capecitabine|mesh-list
20183949|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20183950|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
20183951|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183952|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183953|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20183954|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183955|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
20183956|NCT00196872|Epirubicin|epirubicin|mesh-list
20183957|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294143|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20183958|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
19294144|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294145|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294146|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19294147|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19294148|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
19294149|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19294150|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19294151|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19294152|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19294153|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19294154|NCT03809429|Cetrorelix|cetrorelix|mesh-list
19294155|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19294156|NCT03809429|Hormones|hormones|mesh-ancestor
20362120|NCT00935363|Rifampin|rifampin|mesh-list
20362121|NCT00935363|Fluconazole|fluconazole|mesh-list
20362122|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20362123|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
20362124|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20362125|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362126|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
20362127|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20362128|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362129|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362130|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20362131|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20362132|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20362133|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20362134|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20362135|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20362136|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
20362137|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20362138|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20362139|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19294157|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294158|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294159|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19294160|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
19294161|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294162|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294163|NCT03737370|Docetaxel|docetaxel|mesh-list
19294164|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294165|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
19294166|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
19294167|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
19294168|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294172|NCT03662022|Rifampin|rifampin|mesh-list
19294173|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19294174|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
19294175|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19294176|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294177|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
19294178|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19294179|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362140|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362141|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362142|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362143|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20362144|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20362145|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20362146|NCT00935415|Montelukast|montelukast|mesh-list
19294180|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294181|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19294182|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19294183|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19294184|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19294185|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19294186|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19294187|NCT03640312|Candesartan|candesartan|mesh-list
19294188|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19294189|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19294190|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19294191|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294192|NCT03568994|Cytarabine|cytarabine|mesh-list
19294193|NCT03568994|Atovaquone|atovaquone|mesh-list
19294194|NCT03568994|Etoposide|etoposide|mesh-list
19294195|NCT03568994|Daunorubicin|daunorubicin|mesh-list
19294196|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
19294197|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20362147|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20362148|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
20362149|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20362150|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362151|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362152|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362153|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20362154|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20362155|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362156|NCT00935467|Saxagliptin|saxagliptin|mesh-list
20362157|NCT00935467|Incretins|incretins|mesh-ancestor
20362158|NCT00935467|Hormones|hormones|mesh-ancestor
19294198|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294199|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19294200|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294201|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294202|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294203|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294204|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
19294205|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
19294206|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294207|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294208|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
19294209|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294210|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19294211|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294212|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
19294213|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19294214|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19294215|NCT03538899|Busulfan|busulfan|mesh-list
19294216|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
19294217|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294218|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294219|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
19294220|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294221|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19294222|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294223|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19294224|NCT03432897|Olaparib|olaparib|mesh-list
19294225|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19294226|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294227|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294228|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362159|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362160|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362161|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20362162|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
19294229|NCT03355157|Tamoxifen|tamoxifen|mesh-list
19294230|NCT03355157|Paclitaxel|paclitaxel|mesh-list
19294231|NCT03355157|Vinorelbine|vinorelbine|mesh-list
19294232|NCT03355157|Capecitabine|capecitabine|mesh-list
19294233|NCT03355157|Letrozole|letrozole|mesh-list
19294234|NCT03355157|Epirubicin|epirubicin|mesh-list
19294235|NCT03355157|Fulvestrant|fulvestrant|mesh-list
19294236|NCT03355157|Palbociclib|palbociclib|mesh-list
19294237|NCT03355157|Exemestane|exemestane|mesh-list
19294238|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19294239|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294240|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
19294241|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
19294242|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19294243|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294244|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294245|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
20362163|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362164|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362165|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20362166|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
20362167|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20362168|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19294246|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19294247|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19294248|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294249|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19294250|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294251|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294252|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294253|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19294254|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19294255|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294256|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19294257|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19294258|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19294259|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19294260|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19294261|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19294262|NCT03324035|Tramadol|tramadol|mesh-list
19294263|NCT03324035|Amitriptyline|amitriptyline|mesh-list
19294264|NCT03324035|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19294265|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19294266|NCT03324035|Narcotics|narcotics|mesh-ancestor
19294267|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294268|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294269|NCT03324035|Analgesics|analgesics|mesh-ancestor
19294270|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
19294271|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294272|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19294273|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
19294274|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19294275|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19294276|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19294277|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19294278|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19294279|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294280|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294281|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294282|NCT03324035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19294283|NCT03324035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19294284|NCT03320018|Minocycline|minocycline|mesh-list
19294285|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19294286|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395452|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
19395453|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395454|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
20183959|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362169|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
20362170|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362171|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20362172|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20362173|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362174|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362175|NCT00935506|Aspirin|aspirin|mesh-list
20362176|NCT00935506|Clopidogrel|clopidogrel|mesh-list
20362177|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20362178|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20362179|NCT00935506|Analgesics|analgesics|mesh-ancestor
20362180|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
20183960|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20183961|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20183962|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
20183963|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183964|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20183965|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20183966|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20183967|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20183968|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294287|NCT03196180|Fluorouracil|fluorouracil|mesh-list
19294288|NCT03196180|Imiquimod|imiquimod|mesh-list
19294289|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
19294290|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294291|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294292|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294293|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294294|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
19294295|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294296|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19294297|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
19294298|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19294299|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294300|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294301|NCT03075423|Nivolumab|nivolumab|mesh-list
19294302|NCT03075423|Ipilimumab|ipilimumab|mesh-list
19294303|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294304|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294305|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19294306|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838353|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20183969|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294307|NCT02980731|Venetoclax|venetoclax|mesh-list
19294308|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294309|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
19294310|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19294311|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294312|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294313|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19294314|NCT02819141|Analgesics|analgesics|mesh-ancestor
20183970|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
20183971|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20183972|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
20183973|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20183974|NCT00196885|Expectorants|expectorants|mesh-ancestor
20183975|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
20183976|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19294315|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
19294316|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294317|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19294318|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19294319|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19294320|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294321|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294322|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294323|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
19294324|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19294325|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294326|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19294327|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294328|NCT02636946|Bimatoprost|bimatoprost|mesh-list
19294329|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19294330|NCT02631941|Budesonide|budesonide|mesh-list
19294331|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
19294332|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19294333|NCT02631941|Charcoal|charcoal|mesh-list
19294334|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19294335|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19294336|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
19838354|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838355|NCT00620282|Incretins|incretins|mesh-ancestor
19838356|NCT00620282|Hormones|hormones|mesh-ancestor
19838357|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19838358|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19838359|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838360|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
19838361|NCT00620321|Cytarabine|cytarabine|mesh-list
19838362|NCT00620321|Idarubicin|idarubicin|mesh-list
20183977|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
20183978|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838363|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838364|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
19294337|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20183979|NCT00196885|Protective Agents|protective agents|mesh-ancestor
20183980|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362181|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362182|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362183|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20362184|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362185|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20362186|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20362187|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362188|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20362189|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20362190|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362191|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
20362192|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20362193|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20362194|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20362195|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
20362196|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362197|NCT00935558|Interleukin-2|interleukin-2|mesh-list
19294338|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294339|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19294340|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
19294341|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
19294342|NCT02631941|Hormones|hormones|mesh-ancestor
19294343|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294344|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19294345|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19294346|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19294347|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294348|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294349|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294350|NCT02631941|Antidotes|antidotes|mesh-ancestor
19294351|NCT02631941|Protective Agents|protective agents|mesh-ancestor
19294352|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
20362198|NCT00935558|Exemestane|exemestane|mesh-list
20362199|NCT00935558|Anastrozole|anastrozole|mesh-list
20362200|NCT00935558|Letrozole|letrozole|mesh-list
20362201|NCT00935558|Lactitol|lactitol|mesh-list
20362202|NCT00935558|Vaccines|vaccines|mesh-list
19294353|NCT02623972|Doxorubicin|doxorubicin|mesh-list
19294354|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19294355|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294356|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
19294357|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294358|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19294359|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19294360|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
19294361|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294362|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294363|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19294364|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19294365|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19294366|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294367|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294368|NCT02562378|Doxorubicin|doxorubicin|mesh-list
20183981|NCT00196885|Antidotes|antidotes|mesh-ancestor
20183982|NCT00196989|Pioglitazone|pioglitazone|mesh-list
20183983|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20183984|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183985|NCT00197080|Ropinirole|ropinirole|mesh-list
20183986|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20183987|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20183988|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
20183989|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
20183990|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20183991|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20183992|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183993|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
20183994|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20183995|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20183996|NCT00197197|Aplaviroc|aplaviroc|mesh-list
20183997|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20183998|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20183999|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362203|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19294369|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19294370|NCT02562378|Trastuzumab|trastuzumab|mesh-list
20362204|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
20362205|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362206|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362207|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20362208|NCT00935558|Analgesics|analgesics|mesh-ancestor
20362209|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
20362210|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362211|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20362212|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362213|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362214|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20362215|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362216|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362217|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20362218|NCT00935558|Cathartics|cathartics|mesh-ancestor
19294371|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19294372|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294373|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19294374|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294375|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294376|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294377|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20362219|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20362220|NCT00935571|Remifentanil|remifentanil|mesh-list
20362221|NCT00935571|Propofol|propofol|mesh-list
20362222|NCT00935571|Sevoflurane|sevoflurane|mesh-list
20362223|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19294378|NCT02387099|Everolimus|everolimus|mesh-list
19294379|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294380|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294381|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
19294382|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294383|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
19294384|NCT02299414|Nifedipine|nifedipine|mesh-list
19294385|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19294386|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19294387|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294388|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19294389|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294390|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
19294391|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
19294392|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294393|NCT02237508|Budesonide|budesonide|mesh-list
19294394|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
19294395|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19294396|NCT02237508|Charcoal|charcoal|mesh-list
19294397|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19294398|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19294399|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
19294400|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294401|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294402|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19294403|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
19294404|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
19294405|NCT02237508|Hormones|hormones|mesh-ancestor
19294406|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294407|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20184000|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20184001|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20184002|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
20184003|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184004|NCT00197249|Vaccines|vaccines|mesh-list
20184005|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
20184006|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184007|NCT00197301|Vaccines|vaccines|mesh-list
20184008|NCT00197301|Immunologic Factors|immunologic factors|mesh-ancestor
20184009|NCT00197301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184010|NCT00197327|Bupivacaine|bupivacaine|mesh-list
20184011|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
20184012|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
20184013|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20184014|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184015|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
19294408|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19294409|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19294410|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294411|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294412|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294413|NCT02237508|Antidotes|antidotes|mesh-ancestor
19294414|NCT02237508|Protective Agents|protective agents|mesh-ancestor
19294415|NCT02197234|Osimertinib|osimertinib|mesh-list
19294416|NCT02197234|Simvastatin|simvastatin|mesh-list
19294417|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19294418|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19294419|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
19294420|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294421|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19671728|NCT03683069|Diuretics|diuretics|mesh-ancestor
19671729|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
19671730|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
19671731|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19671732|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671733|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671734|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671735|NCT03677115|Analgesics|analgesics|mesh-ancestor
19671736|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
19671737|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671738|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19294422|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19294423|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294424|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294425|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19294426|NCT02163733|Osimertinib|osimertinib|mesh-list
19294427|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294428|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19294429|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294430|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294431|NCT02157883|Itraconazole|itraconazole|mesh-list
19294432|NCT02157883|Osimertinib|osimertinib|mesh-list
19294433|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
19294434|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294435|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19294436|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19294437|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294438|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294439|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19294440|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294441|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294442|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294443|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19294444|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294445|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19294446|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19294447|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19294448|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19294449|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
19294450|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294451|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294452|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19294453|NCT01822288|Tibolone|tibolone|mesh-list
19294454|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
19294455|NCT01822288|Estradiol|estradiol|mesh-list
19294456|NCT01822288|Estrogens|estrogens|mesh-ancestor
19294457|NCT01822288|Hormones|hormones|mesh-ancestor
19294458|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294459|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294460|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19294461|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
19294462|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294463|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19294464|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19294465|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19294466|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19294467|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19671739|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19671740|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19671741|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294468|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19294469|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294470|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
19294471|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294472|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19294473|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19294474|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
19294475|NCT01583283|Dexamethasone|dexamethasone|mesh-list
19294476|NCT01583283|Lenalidomide|lenalidomide|mesh-list
19294477|NCT01583283|Ricolinostat|ricolinostat|mesh-list
19294478|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19294479|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19294480|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
19294481|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
20362224|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362225|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362226|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20362227|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
20362228|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
20362229|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20362230|NCT00935571|Narcotics|narcotics|mesh-ancestor
20362231|NCT00935571|Analgesics|analgesics|mesh-ancestor
20362232|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
20362233|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362234|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20362235|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20362236|NCT00935610|Caseins|caseins|mesh-list
19294482|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294483|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294484|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294485|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
19294486|NCT01583283|Hormones|hormones|mesh-ancestor
19294487|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294488|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19294489|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294490|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
19294491|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19294492|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19294493|NCT01583283|Growth Substances|growth substances|mesh-ancestor
19294494|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19294495|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294496|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294497|NCT01341600|Omeprazole|omeprazole|mesh-list
19294498|NCT01341600|Clopidogrel|clopidogrel|mesh-list
19294499|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19294500|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19294501|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19294502|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19294503|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
19294504|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294505|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294506|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294507|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19294508|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294509|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19294510|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294511|NCT01328626|Venetoclax|venetoclax|mesh-list
19294512|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294513|NCT00529113|Gemcitabine|gemcitabine|mesh-list
19294514|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294515|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
19294516|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294517|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294518|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
19671742|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671743|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671744|NCT03673228|Nicotine|nicotine|mesh-list
19671745|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19671746|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
19671747|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671748|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294519|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294520|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294521|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294522|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
19294523|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294524|NCT00288080|Dexamethasone|dexamethasone|mesh-list
19294525|NCT00288080|Prednisone|prednisone|mesh-list
19294526|NCT00288080|Docetaxel|docetaxel|mesh-list
19294527|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
19294528|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19294529|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
19294530|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
19294531|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294532|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294533|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294534|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
19294535|NCT00288080|Hormones|hormones|mesh-ancestor
19294536|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294537|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19294538|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294539|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
19294540|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
19294541|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
19294542|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294543|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294544|NCT00099437|Fulvestrant|fulvestrant|mesh-list
19294545|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19294546|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294547|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19294548|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19294549|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294550|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294551|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294552|NCT04250792|Naltrexone|naltrexone|mesh-list
19294553|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19294554|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19294555|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294556|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
19294557|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294558|NCT04250831|Chromium|chromium|mesh-list
19294559|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
19294560|NCT04250831|Trace Elements|trace elements|mesh-ancestor
19294561|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
19294562|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294563|NCT04250831|Cathartics|cathartics|mesh-ancestor
19294564|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294565|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
19294566|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19294567|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294568|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19294569|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294570|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294571|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294572|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294573|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19294574|NCT04250519|Eusol|eusol|mesh-list
19294575|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
19294576|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294577|NCT04250246|Nivolumab|nivolumab|mesh-list
19294578|NCT04250246|Ipilimumab|ipilimumab|mesh-list
19294579|NCT04250246|Guadecitabine|guadecitabine|mesh-list
19294580|NCT04250246|Azacitidine|azacitidine|mesh-list
19294581|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294582|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294583|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19294584|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294585|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20362237|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
20362238|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
20362239|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294586|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
19294587|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294588|NCT04250142|Methamphetamine|methamphetamine|mesh-list
19294589|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19294590|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294591|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
19294592|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
19294593|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294594|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
19294595|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362240|NCT00935675|Citalopram|citalopram|mesh-list
20362241|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20362242|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20362243|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362244|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362245|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362246|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
19294596|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294597|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294598|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19294599|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19294600|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362247|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362248|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20362249|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
20362250|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362251|NCT00935805|Insulin|insulin|mesh-list
20362252|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20362253|NCT00935805|Metformin|metformin|mesh-list
20362254|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
20362255|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
20362256|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
20362257|NCT00935805|Glyburide|glyburide|mesh-list
20362258|NCT00935805|Propranolol|propranolol|mesh-list
20362259|NCT00935805|Amlodipine|amlodipine|mesh-list
20362260|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20362261|NCT00935805|Captopril|captopril|mesh-list
20362262|NCT00935805|Diuretics|diuretics|mesh-list
20362263|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20362264|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362265|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20362266|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20362267|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362268|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362269|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20362270|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
20362271|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
20362272|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19294601|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19294602|NCT04250116|Apixaban|apixaban|mesh-list
19294603|NCT04250116|Clopidogrel|clopidogrel|mesh-list
19294604|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19294605|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19294606|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19294607|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19294608|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
19294609|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294610|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294611|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294612|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19294613|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
19294614|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19294615|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
19294616|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294617|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
19294618|NCT04250051|Vidarabine|vidarabine|mesh-list
19294619|NCT04250051|Cytarabine|cytarabine|mesh-list
19294620|NCT04250051|Fludarabine|fludarabine|mesh-list
19294621|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
19838365|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362273|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20362274|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19294622|NCT04250051|Ivosidenib|ivosidenib|mesh-list
19294623|NCT04250051|Lenograstim|lenograstim|mesh-list
19294624|NCT04250051|Sargramostim|sargramostim|mesh-list
19294625|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294626|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294627|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
19294628|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294629|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294630|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
19294631|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362275|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
19294632|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
19294633|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362276|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362277|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20362278|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20362279|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
19294634|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19294635|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395455|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395456|NCT03667300|Linagliptin|linagliptin|mesh-list
19395457|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19395458|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395459|NCT03667300|Incretins|incretins|mesh-ancestor
19395460|NCT03667300|Hormones|hormones|mesh-ancestor
19395461|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395462|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19395463|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
19395464|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362280|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425316|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20425317|NCT01274260|Prednisolone|prednisolone|mesh-list
20425318|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
20425319|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20425320|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
19395465|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395466|NCT03667235|Glutaral|glutaral|mesh-list
19395467|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
19395468|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395469|NCT03667222|Minocycline|minocycline|mesh-list
19395470|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19395471|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395472|NCT03667131|Enalapril|enalapril|mesh-list
19395473|NCT03667131|Enalaprilat|enalaprilat|mesh-list
19395474|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19395475|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19395476|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395477|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
19395478|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19395479|NCT03667079|Vaccines|vaccines|mesh-list
20425321|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425322|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
20425323|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
20425324|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425325|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425326|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425327|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
20425328|NCT01274260|Hormones|hormones|mesh-ancestor
20425329|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395480|NCT03667079|Immunologic Factors|immunologic factors|mesh-ancestor
19395481|NCT03667079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395482|NCT03667066|Clopidogrel|clopidogrel|mesh-list
19395483|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19395484|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19395485|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19395486|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19395487|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
19395488|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395489|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395490|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395491|NCT03667001|Lidocaine|lidocaine|mesh-list
19395492|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
19395493|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
19395494|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395495|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395496|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
19395497|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395498|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19395499|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19395500|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19395501|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395502|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671749|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19671750|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20425330|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19395503|NCT03666949|Anesthetics|anesthetics|mesh-list
19395504|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362281|NCT00935961|Docetaxel|docetaxel|mesh-list
19294636|NCT04249713|Brodalumab|brodalumab|mesh-list
19294637|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
19294638|NCT04249908|Maleic acid|maleic acid|mesh-list
19294639|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671751|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
19671752|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671753|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294640|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294641|NCT04249882|Naltrexone|naltrexone|mesh-list
19294642|NCT04249882|Varenicline|varenicline|mesh-list
19294643|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19294644|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19294645|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294646|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
19294647|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294648|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19294649|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19294650|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
19294651|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294652|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294653|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
19294654|NCT04249570|Povidone|povidone|mesh-list
19294655|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
19294656|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
19294657|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19294658|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294659|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
19294660|NCT04249804|Analgesics|analgesics|mesh-ancestor
19294661|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
19294662|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294663|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294664|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
19294665|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294666|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19294667|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
19294668|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19294669|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19294670|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294671|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19294672|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
19294673|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294674|NCT04249531|Amikacin|amikacin|mesh-list
19294675|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19294676|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294677|NCT04249427|Erenumab|erenumab|mesh-list
19294678|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19294679|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294680|NCT04249427|Analgesics|analgesics|mesh-ancestor
19294681|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
19294682|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294683|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294684|NCT04249622|Rifaximin|rifaximin|mesh-list
19294685|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19294686|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294687|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294688|NCT04249154|Leuprolide|leuprolide|mesh-list
19294689|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19294690|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
19294691|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294692|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671754|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20184016|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184017|NCT00197340|Ropivacaine|ropivacaine|mesh-list
20184018|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
20184019|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
20184020|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20184021|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184022|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
20184023|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294693|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19671755|NCT03575403|Methylphenidate|methylphenidate|mesh-list
20184024|NCT00197353|Bupivacaine|bupivacaine|mesh-list
20184025|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
19294694|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362282|NCT00935961|Everolimus|everolimus|mesh-list
19294695|NCT04249284|BMS-986165|bms-986165|mesh-list
19294696|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
19294697|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19294698|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294699|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294700|NCT04248998|Metformin|metformin|mesh-list
19294701|NCT04248998|Paclitaxel|paclitaxel|mesh-list
19294702|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
19294703|NCT04248998|Doxorubicin|doxorubicin|mesh-list
19294704|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19294705|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294706|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
19294707|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
19294708|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
19294709|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294710|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294711|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
19294712|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294713|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19294714|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19294715|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
19294716|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19294717|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19294718|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19294719|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19294720|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294721|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294722|NCT04249063|Lidocaine|lidocaine|mesh-list
20362283|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362284|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
20362285|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
20362286|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
20362287|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362288|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362289|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
20362290|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362291|NCT00936013|Oseltamivir|oseltamivir|mesh-list
20362292|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
20362293|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362294|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362295|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362296|NCT00936091|Vitamin A|vitamin a|mesh-list
20362297|NCT00936091|Vitamins|vitamins|mesh-ancestor
20362298|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
20362299|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362300|NCT00936143|Infliximab|infliximab|mesh-list
20362301|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
20362302|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20362303|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362304|NCT00936156|Carboplatin|carboplatin|mesh-list
20362305|NCT00936156|Etoposide|etoposide|mesh-list
20362306|NCT00936156|Thiotepa|thiotepa|mesh-list
20362307|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362308|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20362309|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20362310|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20362311|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362312|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362313|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19294723|NCT04249063|Anesthetics|anesthetics|mesh-list
19294724|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
19294725|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294726|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294727|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
20184026|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
20184027|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20184028|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184029|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
20184030|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184031|NCT00197379|Roxithromycin|roxithromycin|mesh-list
20184032|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20184033|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184034|NCT00197418|Amoxicillin|amoxicillin|mesh-list
20184035|NCT00197418|Metronidazole|metronidazole|mesh-list
20184036|NCT00197418|Clarithromycin|clarithromycin|mesh-list
20184037|NCT00197418|Rabeprazole|rabeprazole|mesh-list
20184038|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19294728|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294729|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19294730|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19294731|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20362314|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
20362315|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20362316|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362317|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
20362318|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362319|NCT00936182|Fluconazole|fluconazole|mesh-list
20362320|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
20362321|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294732|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19294733|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294734|NCT04249037|Tenofovir|tenofovir|mesh-list
19294735|NCT04249037|Emtricitabine|emtricitabine|mesh-list
19294736|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19294737|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19294738|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
19294739|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294740|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19294741|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19294742|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294743|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294744|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19294745|NCT04248621|Goserelin|goserelin|mesh-list
19294746|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19294747|NCT04248621|Leuprolide|leuprolide|mesh-list
19294748|NCT04248621|Flutamide|flutamide|mesh-list
20362322|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20362323|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20362324|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362325|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362326|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20362327|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362328|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362329|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362330|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20362331|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20362332|NCT00936195|Ritonavir|ritonavir|mesh-list
20362333|NCT00936195|Lopinavir|lopinavir|mesh-list
20362334|NCT00936195|Tenofovir|tenofovir|mesh-list
20362335|NCT00936195|Lamivudine|lamivudine|mesh-list
20362336|NCT00936195|Zidovudine|zidovudine|mesh-list
20362337|NCT00936195|Emtricitabine|emtricitabine|mesh-list
20362338|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20362339|NCT00936195|Efavirenz|efavirenz|mesh-list
20362340|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19294749|NCT04248621|Bicalutamide|bicalutamide|mesh-list
19294750|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
19294751|NCT04248621|Androgens|androgens|mesh-list
19294752|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19294753|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294754|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
19294755|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294756|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294757|NCT04248621|Hormones|hormones|mesh-ancestor
19294758|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
19294759|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19294760|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
19294761|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294762|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19294763|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19294764|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
19294765|NCT04248608|Morphine|morphine|mesh-list
19294766|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19294767|NCT04248608|Narcotics|narcotics|mesh-ancestor
19294768|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294769|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294770|NCT04248608|Analgesics|analgesics|mesh-ancestor
20362341|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20362342|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
20362343|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294771|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
19294772|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294773|NCT04248348|Heparin|heparin|mesh-list
19294774|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19294775|NCT04248348|Tinzaparin|tinzaparin|mesh-list
19294776|NCT04248348|Dalteparin|dalteparin|mesh-list
19294777|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
19294778|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19294779|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19294780|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294781|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
19294782|NCT04248452|Leucovorin|leucovorin|mesh-list
19294783|NCT04248452|Folic Acid|folic acid|mesh-list
19294784|NCT04248452|Fluorouracil|fluorouracil|mesh-list
19294785|NCT04248452|Capecitabine|capecitabine|mesh-list
19294786|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
19294787|NCT04248452|Calcium|calcium|mesh-list
19294788|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
19294789|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19294790|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362344|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362345|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20362346|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19294791|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19294792|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
19294793|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294794|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294795|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294796|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294797|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
19294798|NCT04248452|Antidotes|antidotes|mesh-ancestor
19294799|NCT04248452|Protective Agents|protective agents|mesh-ancestor
19294800|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
19294801|NCT04248452|Vitamins|vitamins|mesh-ancestor
19294802|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
19294803|NCT04248452|Hematinics|hematinics|mesh-ancestor
19294804|NCT04248309|Progesterone|progesterone|mesh-list
19294805|NCT04248309|Progestins|progestins|mesh-ancestor
19294806|NCT04248309|Hormones|hormones|mesh-ancestor
19294807|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19294808|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294809|NCT04248205|Ketamine|ketamine|mesh-list
19294810|NCT04248205|Analgesics|analgesics|mesh-ancestor
19294811|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
19294812|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294813|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294814|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19294815|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19294816|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
19294817|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
19294818|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294819|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19294820|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19294821|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19294822|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294823|NCT04247984|Bevacizumab|bevacizumab|mesh-list
19294824|NCT04247984|Fluorouracil|fluorouracil|mesh-list
19294825|NCT04247984|Capecitabine|capecitabine|mesh-list
19294826|NCT04247984|Irinotecan|irinotecan|mesh-list
19294827|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294828|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294829|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19294830|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19294831|NCT04247984|Growth Substances|growth substances|mesh-ancestor
19294832|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294833|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
19294834|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
19294835|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294836|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294837|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294838|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
19294839|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19294840|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294841|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294842|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
19294843|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19294844|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294845|NCT04248179|Sufentanil|sufentanil|mesh-list
19294846|NCT04248179|Ropivacaine|ropivacaine|mesh-list
19294847|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
19294848|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
19294849|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294850|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294851|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
19294852|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294853|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19294854|NCT04248179|Narcotics|narcotics|mesh-ancestor
19294855|NCT04248179|Analgesics|analgesics|mesh-ancestor
19294856|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20362347|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
20362348|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362349|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19294857|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19294858|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
19395505|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395506|NCT03666884|Cyclosporine|cyclosporine|mesh-list
19395507|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19395508|NCT03666884|Cyclosporins|cyclosporins|mesh-list
19395509|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19395510|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395511|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395512|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395513|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
19395514|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395515|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
19395516|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395517|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
19838366|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838367|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
19838368|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838369|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838370|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
20362350|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19671756|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19671757|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671758|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20362351|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20362352|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19395518|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395519|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19395520|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19671759|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19671760|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395521|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
19395522|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19395523|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395524|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395525|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19395526|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19395527|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19395528|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
19395529|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395530|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395531|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19395532|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19395533|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
19395534|NCT03666650|Edoxaban|edoxaban|mesh-list
19395535|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19395536|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
19395537|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19395538|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
19395539|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395540|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395541|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
19395542|NCT03666546|Methamphetamine|methamphetamine|mesh-list
19395543|NCT03666546|Lactulose|lactulose|mesh-list
19395544|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395545|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19395546|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395547|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
19671761|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671762|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
19838371|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362353|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
19395548|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
20362354|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20362355|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20362356|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19294859|NCT04247633|Palbociclib|palbociclib|mesh-list
19294860|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294861|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19294862|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294863|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294864|NCT04247646|Melatonin|melatonin|mesh-list
19294865|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
19294866|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294867|NCT04247646|Protective Agents|protective agents|mesh-ancestor
19294868|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294869|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294870|NCT04247815|Methotrexate|methotrexate|mesh-list
19294871|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19294872|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
19294873|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19294874|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294875|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294876|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
19294877|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294878|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294879|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19838372|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19838373|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19838374|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19294880|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294881|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19294882|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294883|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
19294884|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19294885|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19294886|NCT04247373|Ropivacaine|ropivacaine|mesh-list
19294887|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
19294888|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
19294889|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294890|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294891|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
19294892|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294893|NCT04247230|Tetracaine|tetracaine|mesh-list
19294894|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
19294895|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
19294896|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294897|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294898|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
19294899|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294900|NCT04247087|Vitamin K|vitamin k|mesh-list
19294901|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
19294902|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20184039|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184040|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20184041|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20184042|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19294903|NCT04247087|Vitamins|vitamins|mesh-ancestor
19294904|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
19294905|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294906|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19294907|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19294908|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294909|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
19294910|NCT04247087|Coagulants|coagulants|mesh-ancestor
19294911|NCT04247165|Gemcitabine|gemcitabine|mesh-list
19838375|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184043|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184044|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184045|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20184046|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20184047|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20184048|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184049|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20184050|NCT00197444|Nedaplatin|nedaplatin|mesh-list
19294912|NCT04247165|Paclitaxel|paclitaxel|mesh-list
19294913|NCT04247165|Nivolumab|nivolumab|mesh-list
19294914|NCT04247165|Ipilimumab|ipilimumab|mesh-list
19294915|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19294916|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294917|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
19294918|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
19294919|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
19294920|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294921|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294922|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
19294923|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
19294924|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294925|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294926|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294927|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
19294928|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294929|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19294930|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20362357|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20362358|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20362359|NCT00936234|Vildagliptin|vildagliptin|mesh-list
20362360|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20362361|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362362|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20362363|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
20362364|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362365|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362366|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20362367|NCT00936260|Alendronate|alendronate|mesh-list
20362368|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20362369|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362370|NCT00936390|Leuprolide|leuprolide|mesh-list
20362371|NCT00936390|Goserelin|goserelin|mesh-list
20362372|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20362373|NCT00936390|Flutamide|flutamide|mesh-list
20362374|NCT00936390|Bicalutamide|bicalutamide|mesh-list
20362375|NCT00936390|Buserelin|buserelin|mesh-list
20362376|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20362377|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
20362378|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20362379|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362380|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20362381|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362382|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-ancestor
19294931|NCT04246905|Sulforaphane|sulforaphane|mesh-list
19294932|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19294933|NCT04246905|Protective Agents|protective agents|mesh-ancestor
19294934|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294935|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294936|NCT04246723|Ritonavir|ritonavir|mesh-list
19294937|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
19294938|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19294939|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19294940|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
20362383|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362384|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362385|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
20362386|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20362387|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
20362388|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20362389|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20362390|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20362391|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
20362392|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362393|NCT00936429|Antacids|antacids|mesh-ancestor
19294941|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19294942|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19294943|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19294944|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19294945|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
19294946|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19294947|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19294948|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19294949|NCT04246684|Leucovorin|leucovorin|mesh-list
19294950|NCT04246684|Folic Acid|folic acid|mesh-list
19294951|NCT04246684|Capecitabine|capecitabine|mesh-list
20362394|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425331|NCT01274260|Protective Agents|protective agents|mesh-ancestor
19294952|NCT04246684|Fluorouracil|fluorouracil|mesh-list
19294953|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
19294954|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
19294955|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19294956|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
19294957|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838376|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20362395|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19294958|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19294959|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19294960|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
19294961|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294962|NCT04246684|Antidotes|antidotes|mesh-ancestor
20362396|NCT00936442|Anastrozole|anastrozole|mesh-list
20362397|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20362398|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362399|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19294963|NCT04246684|Protective Agents|protective agents|mesh-ancestor
19294964|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
19294965|NCT04246684|Vitamins|vitamins|mesh-ancestor
19294966|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
19294967|NCT04246684|Hematinics|hematinics|mesh-ancestor
19294968|NCT04246567|Fentanyl|fentanyl|mesh-list
19294969|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19294970|NCT04246567|Narcotics|narcotics|mesh-ancestor
19294971|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294972|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294973|NCT04246567|Analgesics|analgesics|mesh-ancestor
19294974|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
19294975|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294976|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19294977|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19294978|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
19294979|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
19294980|NCT04246697|Acetaminophen|acetaminophen|mesh-list
19294981|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19294982|NCT04246697|Morphine|morphine|mesh-list
19294983|NCT04246697|Oxycodone|oxycodone|mesh-list
19294984|NCT04246697|Gabapentin|gabapentin|mesh-list
19294985|NCT04246697|Bupivacaine|bupivacaine|mesh-list
19294986|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
19838377|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19838378|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838379|NCT00620425|Sumatriptan|sumatriptan|mesh-list
19838380|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19838381|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19838382|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19838383|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
19838384|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362400|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20362401|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362402|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362403|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20362404|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362405|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362406|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362407|NCT00936520|Lifitegrast|lifitegrast|mesh-list
20362408|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20362409|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20362410|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20362411|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20362412|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
20362413|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20362414|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362415|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362416|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
20362417|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362418|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362419|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19294987|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
19294988|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19294989|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19294990|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
19294991|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19294992|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19294993|NCT04246697|Narcotics|narcotics|mesh-ancestor
19294994|NCT04246697|Analgesics|analgesics|mesh-ancestor
19838385|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184051|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184052|NCT00197483|Pergolide|pergolide|mesh-list
19294995|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
19294996|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19294997|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19294998|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19294999|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19295000|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19295001|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295002|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295003|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
19295004|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19295005|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
19295006|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19295007|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295008|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295009|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19671763|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671764|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19671765|NCT03575403|Analgesics|analgesics|mesh-ancestor
19671766|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
19671767|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362420|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362421|NCT00936546|Rituximab|rituximab|mesh-list
20362422|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20362423|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362424|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
20362425|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295010|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295011|NCT04246502|Capecitabine|capecitabine|mesh-list
19295012|NCT04246502|Trastuzumab|trastuzumab|mesh-list
19295013|NCT04246502|Pertuzumab|pertuzumab|mesh-list
19295014|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295015|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
19295016|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295017|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295018|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19295019|NCT04246255|Lidocaine|lidocaine|mesh-list
19295020|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
19295021|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
19671768|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
19671769|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19671770|NCT03554174|Psilocybin|psilocybin|mesh-list
19671771|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
19671772|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838386|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838387|NCT00620542|Atorvastatin|atorvastatin|mesh-list
19295022|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295023|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295024|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
19295025|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295026|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19295027|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19295028|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19295029|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19295030|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295031|NCT04246229|Bilirubin|bilirubin|mesh-list
19295032|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
19295033|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838388|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19838389|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19838390|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19838391|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
19838392|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184053|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
20184054|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
20184055|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184056|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184057|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184058|NCT00197548|Folic Acid|folic acid|mesh-list
20184059|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
20362426|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362427|NCT00936624|Montelukast|montelukast|mesh-list
20362428|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20362429|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
20362430|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20362431|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362432|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362433|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295034|NCT04246229|Protective Agents|protective agents|mesh-ancestor
19295035|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295036|NCT04245787|Fluorides|fluorides|mesh-list
19295037|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
19295038|NCT04245787|Protective Agents|protective agents|mesh-ancestor
19295039|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295040|NCT04245774|Bupivacaine|bupivacaine|mesh-list
20184060|NCT00197548|Vitamins|vitamins|mesh-ancestor
20184061|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
20184062|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184063|NCT00197548|Hematinics|hematinics|mesh-ancestor
20184064|NCT00197561|Selenium|selenium|mesh-list
20184065|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
20184066|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184067|NCT00197561|Protective Agents|protective agents|mesh-ancestor
20362434|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20362435|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19295041|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
19295042|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
19295043|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
19295044|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295045|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295046|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
19295047|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295048|NCT04245371|Lidocaine|lidocaine|mesh-list
19295049|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
19295050|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
19295051|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295052|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295053|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
19295054|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295055|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19295056|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19295057|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19295058|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19295059|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295060|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
19295061|NCT04245722|Rituximab|rituximab|mesh-list
19295062|NCT04245722|Fludarabine|fludarabine|mesh-list
19295063|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
19295064|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295065|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
19295066|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295067|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295068|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19295069|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
19295070|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295071|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295072|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19295073|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19395549|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395550|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
19395551|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395552|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362436|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362437|NCT00936650|Cinacalcet|cinacalcet|mesh-list
20362438|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20362439|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362440|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20362441|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362442|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362443|NCT00936676|Rasagiline|rasagiline|mesh-list
19395553|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
19395554|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19395555|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19395556|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19671773|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19295074|NCT04245618|Gemcitabine|gemcitabine|mesh-list
19295075|NCT04245618|Cisplatin|cisplatin|mesh-list
19295076|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295077|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295078|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
19295079|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295080|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
19295081|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295082|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295083|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295084|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
19295085|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295086|NCT04245709|Clenbuterol|clenbuterol|mesh-list
19295087|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19295088|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19295089|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
19295090|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295091|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295092|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295093|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19295094|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
20362444|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20362445|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362446|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362447|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20362448|NCT00936676|Protective Agents|protective agents|mesh-ancestor
20362449|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362450|NCT00936689|Doxorubicin|doxorubicin|mesh-list
20362451|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
20362452|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20362453|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295095|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295096|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19295097|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
19295098|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
19295099|NCT04246151|Vancomycin|vancomycin|mesh-list
19295100|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19295101|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295102|NCT04245046|Amlodipine|amlodipine|mesh-list
19295103|NCT04245046|Candesartan|candesartan|mesh-list
20362454|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20362455|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20362456|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362457|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362458|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20362459|NCT00936689|Estrogens|estrogens|mesh-ancestor
20362460|NCT00936689|Hormones|hormones|mesh-ancestor
20362461|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362462|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362463|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20362464|NCT00936767|Artesunate|artesunate|mesh-list
20362465|NCT00936767|Mefloquine|mefloquine|mesh-list
20362466|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
20362467|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20362468|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20362469|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362470|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362471|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
20362472|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
20362473|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20362474|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
20362475|NCT00936780|Paclitaxel|paclitaxel|mesh-list
19295104|NCT04245046|Atorvastatin|atorvastatin|mesh-list
19295105|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19295106|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19295107|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
19295108|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295109|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19295110|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19295111|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295112|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19295113|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19295114|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362476|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19295115|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19295116|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295117|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
19295118|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19295119|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19295120|NCT04245319|Acitretin|acitretin|mesh-list
19295121|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
19295122|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295123|NCT04244981|Thrombin|thrombin|mesh-list
19295124|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
19295125|NCT04244981|Coagulants|coagulants|mesh-ancestor
19295134|NCT04245033|Piperaquine|piperaquine|mesh-list
19295135|NCT04245033|Artenimol|artenimol|mesh-list
19295136|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
19295137|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19295138|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19295139|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295140|NCT04244695|Dexamethasone|dexamethasone|mesh-list
19295141|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295142|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
19295143|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
19295144|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295145|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295146|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19295147|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
19295148|NCT04244695|Hormones|hormones|mesh-ancestor
19295149|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19295150|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19295151|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295152|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
19295153|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19295154|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19295155|NCT04244591|Prednisolone|prednisolone|mesh-list
19295156|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
19295157|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19295158|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
19295159|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295160|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
19295161|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
19295162|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295163|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295164|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19295165|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
19295166|NCT04244591|Hormones|hormones|mesh-ancestor
19295167|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362477|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362478|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
20362479|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
20362480|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20362481|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362482|NCT00936793|Ritonavir|ritonavir|mesh-list
20362483|NCT00936793|Darunavir|darunavir|mesh-list
19295168|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19295169|NCT04244591|Protective Agents|protective agents|mesh-ancestor
19295170|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19295171|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295172|NCT04244708|Temozolomide|temozolomide|mesh-list
19295173|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19295174|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
19295175|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295176|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295177|NCT04244448|Emtricitabine|emtricitabine|mesh-list
19295178|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
20362484|NCT00936793|Beclomethasone|beclomethasone|mesh-list
20362485|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20362486|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20362487|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
19295179|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295180|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20362488|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295181|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19295182|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295183|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295184|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19295185|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19295186|NCT04243954|Morphine|morphine|mesh-list
19295187|NCT04243954|Hydromorphone|hydromorphone|mesh-list
19295188|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19295189|NCT04243954|Narcotics|narcotics|mesh-ancestor
19295190|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295191|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295192|NCT04243954|Analgesics|analgesics|mesh-ancestor
19295193|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
19295194|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295195|NCT04244058|Amantadine|amantadine|mesh-list
19295196|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19295197|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19295198|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
19295199|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295200|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
19295201|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295202|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295203|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295204|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19295205|NCT04244058|Analgesics|analgesics|mesh-ancestor
19295206|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
19295207|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295208|NCT04244097|Bupivacaine|bupivacaine|mesh-list
19295209|NCT04244097|Neostigmine|neostigmine|mesh-list
19295210|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
19295211|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
19295212|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295213|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295214|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
19295215|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295216|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19295217|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295218|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295219|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
19295220|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295221|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19295222|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
19295223|NCT04243993|Calcium|calcium|mesh-list
19295224|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19295225|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295226|NCT04243850|Empagliflozin|empagliflozin|mesh-list
19295227|NCT04243850|Caffeine|caffeine|mesh-list
19295228|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19295229|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295230|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19295231|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295232|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295233|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19295234|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19295235|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
19295236|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295237|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19295238|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295239|NCT04243733|Pemetrexed|pemetrexed|mesh-list
19295240|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295241|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295242|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295243|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19295244|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19395557|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20184068|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395558|NCT03666494|Fentanyl|fentanyl|mesh-list
19395559|NCT03666494|Ketamine|ketamine|mesh-list
19395560|NCT03666494|Propofol|propofol|mesh-list
19395561|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20184069|NCT00197561|Trace Elements|trace elements|mesh-ancestor
19395562|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395563|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395564|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19395565|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
19295245|NCT04243811|Anesthetics|anesthetics|mesh-list
19295246|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295247|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295248|NCT04243434|Prednisone|prednisone|mesh-list
19295249|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
20362489|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362490|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20362491|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20362492|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
20362493|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362494|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20362495|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20362496|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20362497|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
20362498|NCT00936793|Hormones|hormones|mesh-ancestor
20362499|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362500|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362501|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20362502|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
20362503|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
20362504|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20362505|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19295250|NCT04243434|Doxorubicin|doxorubicin|mesh-list
19295251|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19295252|NCT04243434|Vincristine|vincristine|mesh-list
19295253|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295254|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
19295255|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295256|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295257|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19295258|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
19295259|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295260|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295261|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19295262|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19295263|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19295264|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19295265|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295266|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295267|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
19295268|NCT04243434|Hormones|hormones|mesh-ancestor
19295269|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671774|NCT03482297|Midodrine|midodrine|mesh-list
19671775|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
19671776|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
19671777|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671778|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671779|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19671780|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19671781|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19671782|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19671783|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
19671784|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671785|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671786|NCT03235505|Nicotine|nicotine|mesh-list
19671787|NCT03235505|Varenicline|varenicline|mesh-list
19671788|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19671789|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
19671790|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671791|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295270|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19295271|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19295272|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
19295273|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184070|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
20184071|NCT00197587|Nevirapine|nevirapine|mesh-list
20184072|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20184073|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184074|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184075|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184076|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
20184077|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184078|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20184079|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19295274|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
19295275|NCT04243109|Dexamethasone|dexamethasone|mesh-list
20362506|NCT00936832|Leucovorin|leucovorin|mesh-list
20362507|NCT00936832|Fluorouracil|fluorouracil|mesh-list
20362508|NCT00936832|Irinotecan|irinotecan|mesh-list
20362509|NCT00936832|Sunitinib|sunitinib|mesh-list
20362510|NCT00936832|Calcium|calcium|mesh-list
20362511|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
20362512|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19295276|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
19295277|NCT04243109|Pomalidomide|pomalidomide|mesh-list
19295278|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295279|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
19671792|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19671793|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19671794|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
19671795|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671796|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184080|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20362513|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362514|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
20362515|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295280|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295281|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295282|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19295283|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
19295284|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295285|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295286|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19295287|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295288|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
19295289|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
19295290|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295291|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19295292|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
19295293|NCT04243109|Hormones|hormones|mesh-ancestor
19295294|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19295295|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19295296|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19295297|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19295298|NCT04243109|Growth Substances|growth substances|mesh-ancestor
19295299|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
20362516|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295300|NCT04242914|Midazolam|midazolam|mesh-list
19295301|NCT04242914|Ketamine|ketamine|mesh-list
19295302|NCT04242914|Analgesics|analgesics|mesh-ancestor
19295303|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
19295304|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295305|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295306|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19295307|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19295308|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
19295309|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
19295310|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20184081|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20184082|NCT00197613|Lamivudine|lamivudine|mesh-list
20184083|NCT00197613|Zidovudine|zidovudine|mesh-list
20184084|NCT00197613|Efavirenz|efavirenz|mesh-list
20184085|NCT00197613|Nevirapine|nevirapine|mesh-list
20184086|NCT00197613|Stavudine|stavudine|mesh-list
20184087|NCT00197613|Didanosine|didanosine|mesh-list
20184088|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20184089|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184090|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184091|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184092|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
20184093|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184094|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20184095|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20184096|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
20184097|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20184098|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20184099|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20362517|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362518|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395566|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
19295311|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19295312|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19295313|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295314|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295315|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19295316|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19295317|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19295318|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19295319|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19295320|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
19295321|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
19295322|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
19295323|NCT04242927|Niacin|niacin|mesh-list
19295324|NCT04242927|Niacinamide|niacinamide|mesh-list
19295325|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
19295326|NCT04242927|Vitamins|vitamins|mesh-ancestor
19295327|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
19295328|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295329|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19295330|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
19295331|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295332|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19295333|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
19295334|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
19295335|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295336|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
19295337|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19295338|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19295339|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295340|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20184100|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20184101|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20184102|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20184103|NCT00197639|Ritonavir|ritonavir|mesh-list
20184104|NCT00197639|Indinavir|indinavir|mesh-list
20184105|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19295341|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295342|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19295343|NCT04242758|Diuretics|diuretics|mesh-ancestor
19295344|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
19295345|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19295346|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19295347|NCT04242212|Misoprostol|misoprostol|mesh-list
19295348|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19295349|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184106|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20184107|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
20184108|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362519|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
20362520|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20362521|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20362522|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362523|NCT00936832|Antidotes|antidotes|mesh-ancestor
20362524|NCT00936832|Protective Agents|protective agents|mesh-ancestor
20362525|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
20184109|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184110|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20184111|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20184112|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
20184113|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184114|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20184115|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20184116|NCT00197730|Folic Acid|folic acid|mesh-list
20184117|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
20184118|NCT00197730|Vitamins|vitamins|mesh-ancestor
20362526|NCT00936832|Vitamins|vitamins|mesh-ancestor
20362527|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
20362528|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20362529|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20362530|NCT00936832|Growth Substances|growth substances|mesh-ancestor
20362531|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
20362532|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19295350|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19295351|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184119|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
19295352|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20362533|NCT00936923|Furosemide|furosemide|mesh-list
20184120|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184121|NCT00197730|Hematinics|hematinics|mesh-ancestor
20184122|NCT00197743|Vitamin A|vitamin a|mesh-list
20184123|NCT00197743|Beta Carotene|beta carotene|mesh-list
20184124|NCT00197743|Carotenoids|carotenoids|mesh-list
20184125|NCT00197743|Vitamins|vitamins|mesh-ancestor
20184126|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
20184127|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184128|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
20184129|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184130|NCT00197743|Protective Agents|protective agents|mesh-ancestor
20184131|NCT00197743|Provitamins|provitamins|mesh-ancestor
20184132|NCT00197756|Vitamins|vitamins|mesh-list
20184133|NCT00197756|Vitamin A|vitamin a|mesh-list
20184134|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
20184135|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
20184136|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184137|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
20184138|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362534|NCT00936923|Diuretics|diuretics|mesh-list
20362535|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
20362536|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295353|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19295354|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
19295355|NCT04242368|Fluticasone|fluticasone|mesh-list
19295356|NCT04242368|Xhance|xhance|mesh-list
19295357|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295358|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19295359|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
19295360|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295361|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295362|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19295363|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
19295364|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295365|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19295366|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19295367|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
19295368|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19295369|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
19295370|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19295371|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295372|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19295373|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19295374|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295375|NCT04241705|Lumefantrine|lumefantrine|mesh-list
19295376|NCT04241705|Artemether|artemether|mesh-list
19295377|NCT04241705|Primaquine|primaquine|mesh-list
19295378|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19295379|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
19295380|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19295381|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19295382|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295383|NCT04241653|Sevoflurane|sevoflurane|mesh-list
19295384|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
19295385|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295386|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295387|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19295388|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19295389|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
19295390|NCT04241731|Cetuximab|cetuximab|mesh-list
19295391|NCT04241731|Raltitrexed|raltitrexed|mesh-list
19295392|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19295393|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362537|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20362538|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362539|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295394|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295395|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
19295396|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295397|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184139|NCT00197756|Protective Agents|protective agents|mesh-ancestor
20184140|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19295398|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395567|NCT03666494|Analgesics|analgesics|mesh-ancestor
20184141|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184142|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20184143|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
19295399|NCT04241744|Vancomycin|vancomycin|mesh-list
19295400|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19295401|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295402|NCT04241887|Anesthetics|anesthetics|mesh-list
19295403|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295404|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295405|NCT04241601|Aldesleukin|aldesleukin|mesh-list
19295406|NCT04241601|Interleukin-2|interleukin-2|mesh-list
19295407|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362540|NCT00936962|Vaccines|vaccines|mesh-list
20362541|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
20362542|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362543|NCT00936988|Cinacalcet|cinacalcet|mesh-list
20362544|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20362545|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362546|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20362547|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362548|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362549|NCT00937027|Aminopterin|aminopterin|mesh-list
20362550|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20362551|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362552|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362553|NCT00937079|Exenatide|exenatide|mesh-list
19295408|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19295409|NCT04241601|Analgesics|analgesics|mesh-ancestor
19295410|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
19295411|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295412|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295413|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19295414|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20362554|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20362555|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362556|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19295415|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
19295416|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295417|NCT04241523|Lenvatinib|lenvatinib|mesh-list
19295418|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295419|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19295420|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295421|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295422|NCT04241380|Heparin|heparin|mesh-list
19295423|NCT04241380|Anticoagulants|anticoagulants|mesh-list
19295424|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19295425|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19295426|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19295427|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295428|NCT04241211|Denosumab|denosumab|mesh-list
20362557|NCT00937079|Incretins|incretins|mesh-ancestor
19295429|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19295430|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295431|NCT04241458|Midazolam|midazolam|mesh-list
19295432|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19295433|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19295434|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295435|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295436|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19295437|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19295438|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19295439|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19295440|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
19295441|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
19295442|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
19295443|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
19295444|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295445|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295446|NCT04241276|Gemcitabine|gemcitabine|mesh-list
19295447|NCT04241276|Paclitaxel|paclitaxel|mesh-list
19295448|NCT04241276|Tretinoin|tretinoin|mesh-list
19295449|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19295450|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362558|NCT00937079|Hormones|hormones|mesh-ancestor
19295451|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
19295452|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
19295453|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
19295454|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295455|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295456|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
19295457|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
19295458|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295459|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295460|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295461|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
19295462|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295463|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
20362559|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362560|NCT00937092|Dopamine|dopamine|mesh-list
20362561|NCT00937092|Furosemide|furosemide|mesh-list
20362562|NCT00937092|Diuretics|diuretics|mesh-ancestor
19295464|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295465|NCT04240821|Theophylline|theophylline|mesh-list
19295466|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19295467|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
19295468|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295469|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295470|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19295471|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
19295472|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19295473|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295474|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295475|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
19295476|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19295477|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19295478|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
19295479|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295480|NCT04240756|Amphetamine|amphetamine|mesh-list
19295481|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19295482|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295483|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
19295484|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
19295485|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295486|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
19295487|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295488|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295489|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
19295490|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19295491|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19295492|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19295493|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19295494|NCT04240834|Aspirin|aspirin|mesh-list
19295495|NCT04240834|Ticagrelor|ticagrelor|mesh-list
20362563|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
19295496|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19295497|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19295498|NCT04240834|Analgesics|analgesics|mesh-ancestor
19295499|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
19295500|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295501|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295502|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295503|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295504|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19295505|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19295506|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295507|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19295508|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19295509|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295510|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
19295511|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19295512|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19295513|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19295514|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
19295515|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295516|NCT04240496|Clozapine|clozapine|mesh-list
19295517|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19295518|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
19295519|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295520|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295521|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295522|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19295523|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19295524|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295525|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19295526|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
19295527|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
19295528|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19295529|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19295530|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19295531|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295532|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295533|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19295534|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19295535|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295536|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
19295537|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295538|NCT04239794|Propofol|propofol|mesh-list
19295539|NCT04239794|Sevoflurane|sevoflurane|mesh-list
19295540|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19295541|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295542|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295543|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20362564|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362565|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20362566|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362567|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362568|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20362569|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
20362570|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
20362571|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295544|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
19295545|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
19295546|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19295547|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19295548|NCT04239833|Gefitinib|gefitinib|mesh-list
19295549|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295550|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19295551|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295552|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295553|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
19295554|NCT04239872|Calcium|calcium|mesh-list
19295555|NCT04239872|Fluorides|fluorides|mesh-list
19295556|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19295557|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295558|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19295559|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
19295560|NCT04239872|Protective Agents|protective agents|mesh-ancestor
19295561|NCT04240106|Niraparib|niraparib|mesh-list
19295562|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19295563|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19295564|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295565|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295566|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295567|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19295568|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19295569|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
19295570|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19295571|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295572|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19295573|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19295574|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19295575|NCT04239859|Cyclosporine|cyclosporine|mesh-list
20184144|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184145|NCT00197834|Valproic Acid|valproic acid|mesh-list
20184146|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
20184147|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184148|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184149|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
20184150|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184151|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184152|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
20184153|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20184154|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20184155|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20184156|NCT00197886|Norepinephrine|norepinephrine|mesh-list
20184157|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19295576|NCT04239859|Methotrexate|methotrexate|mesh-list
19295577|NCT04239859|Acitretin|acitretin|mesh-list
19295578|NCT04239859|Cyclosporins|cyclosporins|mesh-list
19295579|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20362572|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
20362573|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362574|NCT00937092|Protective Agents|protective agents|mesh-ancestor
20362575|NCT00937131|Rituximab|rituximab|mesh-list
20362576|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20362577|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362578|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
20362579|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362580|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362581|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
20362582|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
20362583|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20362584|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20362585|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362586|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362587|NCT00937144|Urological Agents|urological agents|mesh-ancestor
20362588|NCT00937183|Vaccines|vaccines|mesh-list
20362589|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
20362590|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295580|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
19295581|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19295582|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295583|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295584|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
19295585|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295586|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295587|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295588|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295589|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19295590|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295591|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
19295592|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295593|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19295594|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
19295595|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295596|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19295597|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
19295598|NCT04239560|Boron|boron|mesh-list
19295599|NCT04239560|Trace Elements|trace elements|mesh-ancestor
19295600|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
19295601|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295602|NCT04239599|Leuprolide|leuprolide|mesh-list
19295603|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19295604|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
19295605|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19295606|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295607|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19295608|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295609|NCT04239625|Vitamin A|vitamin a|mesh-list
19295610|NCT04239625|Retinol acetate|retinol acetate|mesh-list
19295611|NCT04239625|Vitamins|vitamins|mesh-ancestor
19295612|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
19295613|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295614|NCT04239625|Protective Agents|protective agents|mesh-ancestor
19295615|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19295616|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295617|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19295618|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
19395568|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
19395569|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395570|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19395571|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19395572|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19395573|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362591|NCT00937261|Risperidone|risperidone|mesh-list
20362592|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20362593|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19395574|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395575|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20362594|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
19395576|NCT03666494|Narcotics|narcotics|mesh-ancestor
19395577|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20362595|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295619|NCT04239586|Glyburide|glyburide|mesh-list
19295620|NCT04239586|Glipizide|glipizide|mesh-list
19295621|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295622|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295623|NCT04239755|Doxycycline|doxycycline|mesh-list
19295624|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19295625|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295626|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
19295627|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19295628|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19295629|NCT04239443|Apatinib|apatinib|mesh-list
19295630|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19295631|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295632|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19295633|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295634|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295635|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19295636|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295637|NCT04238988|Paclitaxel|paclitaxel|mesh-list
19295638|NCT04238988|Carboplatin|carboplatin|mesh-list
19295639|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
19295640|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19295641|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295642|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
19295643|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
19295644|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
19295645|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295646|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19295647|NCT04239118|Hemostatics|hemostatics|mesh-list
19295648|NCT04239118|Coagulants|coagulants|mesh-ancestor
19295649|NCT04239170|Gemcitabine|gemcitabine|mesh-list
19295650|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
19295651|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295652|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
19295653|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295654|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295655|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
19295656|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295657|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295658|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295659|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
19295660|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295661|NCT04239014|Olaparib|olaparib|mesh-list
19295662|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20184158|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20184159|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20184160|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362596|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184161|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184162|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184163|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
20184164|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
20184165|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184166|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20217305|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217306|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217307|NCT00309335|Phentolamine|phentolamine|mesh-list
20217308|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20217309|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20217310|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
20217311|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362597|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362598|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20362599|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20362600|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362601|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362602|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20362603|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
20362604|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19295663|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217312|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295664|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295665|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295666|NCT04238923|Vancomycin|vancomycin|mesh-list
20184167|NCT00197912|Celecoxib|celecoxib|mesh-list
20184168|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
20184169|NCT00197912|Interleukin-2|interleukin-2|mesh-list
20184170|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
20184171|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184172|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184173|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184174|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184175|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
20184176|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184177|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184178|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184179|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19295667|NCT04238923|Gentamicins|gentamicins|mesh-list
19295668|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19295669|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184180|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20184181|NCT00197912|Analgesics|analgesics|mesh-ancestor
20184182|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
20362605|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20362606|NCT00937300|Vidarabine|vidarabine|mesh-list
20362607|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
19295670|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19295671|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295672|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295673|NCT04238975|Vaccines|vaccines|mesh-list
20362608|NCT00937300|Fludarabine|fludarabine|mesh-list
20362609|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
20362610|NCT00937300|Interleukin-2|interleukin-2|mesh-list
20362611|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362612|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
20362613|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295674|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
19295675|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295676|NCT04238767|Dolutegravir|dolutegravir|mesh-list
19295677|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19295678|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19295679|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295680|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295681|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20362614|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362615|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20362616|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
20362617|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362618|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362619|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20362620|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19295682|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19295683|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
19295684|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295685|NCT04238754|Cannabidiol|cannabidiol|mesh-list
19295686|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19295687|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
19295688|NCT04238806|Desflurane|desflurane|mesh-list
19295689|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19295690|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
19295691|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
19295692|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295693|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295694|NCT04238832|Nicotine|nicotine|mesh-list
19295695|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19295696|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
19295697|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295698|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295699|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19295700|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19295701|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
19295702|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295703|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295704|NCT04238884|Voriconazole|voriconazole|mesh-list
19295705|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
19295706|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184183|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295707|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19295708|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19295709|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295710|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295711|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19295712|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
19295713|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19295714|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295715|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19295716|NCT04238702|Empagliflozin|empagliflozin|mesh-list
19295717|NCT04238702|Losartan|losartan|mesh-list
19295718|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19295719|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19295720|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19295721|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19295722|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295723|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19295724|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295725|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295726|NCT04238208|Lidocaine|lidocaine|mesh-list
20184184|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184185|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20362621|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
19295727|NCT04238208|Capsaicin|capsaicin|mesh-list
19295728|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
19295729|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
19295730|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295731|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295732|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
19295733|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295734|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19295735|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19295736|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19295737|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19295738|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295739|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
19295740|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295741|NCT04238221|Doxofylline|doxofylline|mesh-list
19295742|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
19295743|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
19295744|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20362622|NCT00937300|Antiviral Agents|antiviral agents|mesh-ancestor
20362623|NCT00937300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362624|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20362625|NCT00937300|Analgesics|analgesics|mesh-ancestor
20362626|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
20362627|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362628|NCT00937417|Docetaxel|docetaxel|mesh-list
20362629|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362630|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
19295745|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
19295746|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295747|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295748|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19295749|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19295750|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295751|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295752|NCT04238169|Bevacizumab|bevacizumab|mesh-list
19295753|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19295754|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184186|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20184187|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184188|NCT00198055|Aripiprazole|aripiprazole|mesh-list
20184189|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
20184190|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20184191|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20184192|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20184193|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20184194|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184195|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
20184196|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
20184197|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184198|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184199|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20184200|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20362631|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
20362632|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
20362633|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362634|NCT00937482|Cediranib|cediranib|mesh-list
20362635|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362636|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362637|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362638|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20362639|NCT00937508|Varenicline|varenicline|mesh-list
20362640|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19295755|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19295756|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19295757|NCT04238169|Growth Substances|growth substances|mesh-ancestor
20362641|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20362642|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19295758|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295759|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
19295760|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
19295761|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19295762|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295763|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19295764|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19295765|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295766|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295767|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362643|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362644|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362645|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362646|NCT00937625|Vidarabine|vidarabine|mesh-list
20362647|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
20362648|NCT00937625|Fludarabine|fludarabine|mesh-list
19295768|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
19295769|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19295770|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295771|NCT04237987|Cyclosporine|cyclosporine|mesh-list
19295772|NCT04237987|Aldesleukin|aldesleukin|mesh-list
19295773|NCT04237987|Interleukin-2|interleukin-2|mesh-list
19295774|NCT04237987|Cyclosporins|cyclosporins|mesh-list
19295775|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295776|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295777|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295778|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
19295779|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295780|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
19295781|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295782|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295783|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295784|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19295785|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295786|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19295787|NCT04237987|Analgesics|analgesics|mesh-ancestor
19295788|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
19295789|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295790|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19295791|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19295792|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
19295793|NCT04237922|Clopidogrel|clopidogrel|mesh-list
19295794|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20362649|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
20362650|NCT00937625|Interleukin-2|interleukin-2|mesh-list
19295795|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19295796|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19295797|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19295798|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19295799|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
19295800|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295801|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295802|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295803|NCT04237935|Clopidogrel|clopidogrel|mesh-list
19295804|NCT04237935|Ticagrelor|ticagrelor|mesh-list
19295805|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19295806|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19295807|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20362651|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362652|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
19295808|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19295809|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
19295810|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295811|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295812|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295813|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
19295814|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19295815|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295816|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295817|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295818|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
19295819|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19295820|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295821|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295822|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19295823|NCT04237532|Analgesics|analgesics|mesh-ancestor
19295824|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
19295825|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295826|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19295827|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19295828|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19295829|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
19295830|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19295831|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295832|NCT04237675|Anesthetics|anesthetics|mesh-list
19295833|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295834|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395578|NCT03666390|Midazolam|midazolam|mesh-list
19395579|NCT03666390|Ketamine|ketamine|mesh-list
19395580|NCT03666390|Analgesics|analgesics|mesh-ancestor
19395581|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
19395582|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395583|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395584|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19395585|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19395586|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
19395587|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
19395588|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395589|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20184201|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
20184202|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20184203|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20184204|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20184205|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19671813|NCT03003325|Aspirin|aspirin|mesh-list
19671814|NCT03003325|Interferons|interferons|mesh-list
19671815|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838393|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20184206|NCT00198094|Alprazolam|alprazolam|mesh-list
19395590|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19395591|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395592|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395593|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19395594|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19395595|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19395596|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19395597|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19395598|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
19395599|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
19395600|NCT03666351|Losartan|losartan|mesh-list
19395601|NCT03666351|Amlodipine|amlodipine|mesh-list
19395602|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
19395603|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19395604|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19395605|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395606|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395607|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19395608|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395609|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395610|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19671816|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
20184207|NCT00198094|Sertraline|sertraline|mesh-list
20362653|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362654|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362655|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20362656|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
20362657|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362658|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362659|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20362660|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20362661|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
19295835|NCT04237246|Tacrolimus|tacrolimus|mesh-list
19295836|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295837|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
19295838|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295839|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19295840|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295841|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295842|NCT04237376|Tenofovir|tenofovir|mesh-list
19295843|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
19295844|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295845|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19295846|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19295847|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295848|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295849|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19295850|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19295851|NCT04237493|Insulin|insulin|mesh-list
19295852|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19295853|NCT04237493|Metformin|metformin|mesh-list
19295854|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
19295855|NCT04237493|Glimepiride|glimepiride|mesh-list
19295856|NCT04237493|Vildagliptin|vildagliptin|mesh-list
19295857|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295858|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295859|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19295860|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295861|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
19295862|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19671817|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671818|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671819|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671820|NCT03003325|Analgesics|analgesics|mesh-ancestor
19671821|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
19295863|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
19295864|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362662|NCT00937625|Antiviral Agents|antiviral agents|mesh-ancestor
20362663|NCT00937625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362664|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20362665|NCT00937625|Analgesics|analgesics|mesh-ancestor
20362666|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
20362667|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362668|NCT00937664|Gemcitabine|gemcitabine|mesh-list
20362669|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20362670|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
19295865|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184208|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
20184209|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20184210|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20184211|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20184212|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20184213|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184214|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184215|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
20184216|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184217|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20184218|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20184219|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20184220|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20184221|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
20184222|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
20184223|NCT00198120|Cycloserine|cycloserine|mesh-list
20184224|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20184225|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295866|NCT04237480|Vitamin D|vitamin d|mesh-list
19671822|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295867|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
20362671|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362672|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184226|NCT00198120|Renal Agents|renal agents|mesh-ancestor
20184227|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20184228|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
20184229|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20184230|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
20184231|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184232|NCT00198146|Daclizumab|daclizumab|mesh-list
20184233|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362673|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
20362674|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295868|NCT04237480|Vitamins|vitamins|mesh-list
19295869|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
19295870|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295871|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19295872|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19295873|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
19295874|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295875|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295876|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
19295877|NCT04237090|Promethazine|promethazine|mesh-list
19295878|NCT04237090|Cetirizine|cetirizine|mesh-list
19295879|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19295880|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19295881|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295882|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295883|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
19295884|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
20184234|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
20184235|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184236|NCT00198159|Gefitinib|gefitinib|mesh-list
20184237|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184238|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20184239|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184240|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184241|NCT00198172|Epirubicin|epirubicin|mesh-list
20184242|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184243|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184244|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184245|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184246|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184247|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184248|NCT00198198|Aripiprazole|aripiprazole|mesh-list
20184249|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
20362675|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362676|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362677|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
20362678|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362679|NCT00937677|Natalizumab|natalizumab|mesh-list
20362680|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
20362681|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362682|NCT00937807|Sevoflurane|sevoflurane|mesh-list
20362683|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20362684|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20362685|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
20362686|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
20362687|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362688|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184250|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20184251|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20184252|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20184253|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295885|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
19295886|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295887|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
19295888|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
19295889|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19295890|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19295891|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
19295892|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
19295893|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362689|NCT00937820|Darexaban|darexaban|mesh-list
19295894|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362690|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19295895|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19295896|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
19295897|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295898|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19295899|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
19295900|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295901|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295902|NCT04236778|Vancomycin|vancomycin|mesh-list
19295903|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19295904|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295905|NCT04236453|Tenofovir|tenofovir|mesh-list
19295906|NCT04236453|Emtricitabine|emtricitabine|mesh-list
19295907|NCT04236453|Darunavir|darunavir|mesh-list
19295908|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19295909|NCT04236453|Cobicistat|cobicistat|mesh-list
19295910|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19295911|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
19295912|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295913|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19295914|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19295915|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295916|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295917|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19295918|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19295919|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19295920|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19295921|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
19295922|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19295923|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19295924|NCT04236323|Remifentanil|remifentanil|mesh-list
19295925|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19295926|NCT04236323|Narcotics|narcotics|mesh-ancestor
19295927|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295928|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295929|NCT04236323|Analgesics|analgesics|mesh-ancestor
19295930|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
19295931|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295932|NCT04236310|Trastuzumab|trastuzumab|mesh-list
19295933|NCT04236310|Anastrozole|anastrozole|mesh-list
19295934|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19295935|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19295936|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19295937|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19295938|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19295939|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295940|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295941|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19295942|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
19295943|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19295944|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295945|NCT04236219|Rasburicase|rasburicase|mesh-list
19295946|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
19295947|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19295948|NCT04236115|Felypressin|felypressin|mesh-list
19295949|NCT04236115|Carticaine|carticaine|mesh-list
19295950|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
19295951|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
19295952|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19295953|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295954|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
19295955|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19295956|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19295957|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
19295958|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19295959|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19295960|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295961|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
19295962|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
19295963|NCT04235816|Azithromycin|azithromycin|mesh-list
19295964|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19295965|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19295966|NCT04236258|Enalapril|enalapril|mesh-list
19295967|NCT04236258|Nifedipine|nifedipine|mesh-list
19295968|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20362691|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
19295969|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19404300|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295970|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295971|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19295972|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295973|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
19295974|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
19295975|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19295976|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19295977|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
19295978|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19295979|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19295980|NCT04235868|Mitogens|mitogens|mesh-list
19295981|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
19295982|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19295983|NCT04235959|Tirzepatide|tirzepatide|mesh-list
19295984|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19295985|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295986|NCT04235959|Incretins|incretins|mesh-ancestor
19295987|NCT04235959|Hormones|hormones|mesh-ancestor
19295988|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19295989|NCT04235478|Triamcinolone|triamcinolone|mesh-list
19295990|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19295991|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19295992|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
19295993|NCT04235478|Hormones|hormones|mesh-ancestor
19295994|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19295995|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671823|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19295996|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19295997|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
19295998|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
19295999|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
19296000|NCT04235426|Diclofenac|diclofenac|mesh-list
19296001|NCT04235426|Vitamins|vitamins|mesh-ancestor
19296002|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
19296003|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296004|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19296005|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19296006|NCT04235426|Analgesics|analgesics|mesh-ancestor
19296007|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
19296008|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296009|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296010|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296011|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19296012|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296013|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296014|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
19296015|NCT04235426|Hematinics|hematinics|mesh-ancestor
20612583|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612584|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20612585|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612586|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20612587|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
20612588|NCT02251977|Antidotes|antidotes|mesh-ancestor
20612589|NCT02251977|Protective Agents|protective agents|mesh-ancestor
20612590|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
20612591|NCT02251977|Vitamins|vitamins|mesh-ancestor
20612592|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
20612593|NCT02252107|Decitabine|decitabine|mesh-list
20612594|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20612595|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
20612596|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296016|NCT04235569|Enoxaparin|enoxaparin|mesh-list
19296017|NCT04235569|Warfarin|warfarin|mesh-list
19296018|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
19296019|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
19296020|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19296021|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19296022|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296023|NCT04235673|Melatonin|melatonin|mesh-list
19296024|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
19296025|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296026|NCT04235673|Protective Agents|protective agents|mesh-ancestor
19296027|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671824|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612597|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296028|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296029|NCT04235270|Tadalafil|tadalafil|mesh-list
19296030|NCT04235270|Macitentan|macitentan|mesh-list
19296031|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
19296032|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19296033|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19296034|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296035|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296036|NCT04235270|Urological Agents|urological agents|mesh-ancestor
19296037|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19296038|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19296039|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19395611|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19395612|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19395613|NCT03666351|Diuretics|diuretics|mesh-ancestor
19395614|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
19395615|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19395616|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
19395617|NCT03666325|Cetuximab|cetuximab|mesh-list
19395618|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19395619|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395620|NCT03666299|Lidocaine|lidocaine|mesh-list
19395621|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
19395622|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
19395623|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395624|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395625|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
19395626|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395627|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19395628|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19395629|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19395630|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395631|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395632|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
19395633|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19395634|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395635|NCT03666208|Sirolimus|sirolimus|mesh-list
20184254|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184255|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
20184256|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
20184257|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184258|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362692|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19395636|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19395637|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395638|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19395639|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395640|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
19395641|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395642|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
19395643|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395644|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
19395645|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
19395646|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19395647|NCT03666195|Protective Agents|protective agents|mesh-ancestor
19395648|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395649|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
19395650|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19395651|NCT03665779|Pyridoxine|pyridoxine|mesh-list
19395652|NCT03665779|Isosorbide|isosorbide|mesh-list
19395653|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19395654|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19395655|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19395656|NCT03665779|Diuretics|diuretics|mesh-ancestor
20184259|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20184260|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20184261|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
20184262|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20184263|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20184264|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20184265|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20362693|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
19395657|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
19671825|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362694|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362695|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362696|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
20425332|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20425333|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425334|NCT01274273|Interferons|interferons|mesh-list
20425335|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
20425336|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
20425337|NCT01274273|Aldesleukin|aldesleukin|mesh-list
20425338|NCT01274273|Bevacizumab|bevacizumab|mesh-list
20425339|NCT01274273|Interleukin-2|interleukin-2|mesh-list
20425340|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296040|NCT04235296|Mitogens|mitogens|mesh-list
19296041|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
19296042|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296043|NCT04235894|Propofol|propofol|mesh-list
19296044|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19296045|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296046|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296047|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296048|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
19296049|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
19296050|NCT04236050|Rocuronium|rocuronium|mesh-list
19296051|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296052|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19296053|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19296054|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19296055|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296056|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
19296057|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19296058|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296059|NCT04234776|Ketamine|ketamine|mesh-list
19296060|NCT04234776|Aripiprazole|aripiprazole|mesh-list
19296061|NCT04234776|Citalopram|citalopram|mesh-list
19296062|NCT04234776|Analgesics|analgesics|mesh-ancestor
20425341|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425342|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20425343|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20425344|NCT01274273|Growth Substances|growth substances|mesh-ancestor
20425345|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425346|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
20425347|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
20425348|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425349|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
20425350|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20425351|NCT01274273|Analgesics|analgesics|mesh-ancestor
20425352|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
19671826|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19671827|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19671828|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425353|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425354|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20425355|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20425356|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20425357|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20425358|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
20425359|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425360|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425361|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20425362|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
20425363|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
20425364|NCT01274325|Hormones|hormones|mesh-ancestor
20425365|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425366|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
20428567|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428748|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428749|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20428750|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
20428751|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
20428752|NCT01293734|Hormones|hormones|mesh-ancestor
20428753|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428754|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20428755|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428756|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296063|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
19671829|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19296064|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296065|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296066|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19296067|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296068|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
19296069|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
19296070|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671830|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19671831|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671832|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
20184266|NCT00198237|Docetaxel|docetaxel|mesh-list
20184267|NCT00198237|Capecitabine|capecitabine|mesh-list
20184268|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184269|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184270|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184271|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184272|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184273|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184274|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
20184275|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20184276|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20184277|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20184278|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19296071|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20362697|NCT00937911|Darexaban|darexaban|mesh-list
20362698|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20362699|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
20362700|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20362701|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
20362702|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362703|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362704|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
19296072|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19296073|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184279|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184280|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296074|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296075|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19296076|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19296077|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19296078|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
19296079|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19296080|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
19296081|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296082|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19296083|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19296084|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
19296085|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
19296086|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19296087|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19296088|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19296089|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19296090|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19296091|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19296092|NCT04234997|Suvorexant|suvorexant|mesh-list
19296093|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19296094|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19296095|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296096|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296097|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19296098|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296099|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296100|NCT04234932|Latanoprost|latanoprost|mesh-list
19296101|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20184281|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184282|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20184283|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
20184284|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20184285|NCT00198354|Gemcitabine|gemcitabine|mesh-list
20184286|NCT00198354|Paclitaxel|paclitaxel|mesh-list
20362705|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
19296102|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19296103|NCT04234321|Mitogens|mitogens|mesh-list
19296104|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
19296105|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296106|NCT04234594|Panitumumab|panitumumab|mesh-list
19296107|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296108|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296109|NCT04234607|Carboplatin|carboplatin|mesh-list
19296110|NCT04234607|Etoposide|etoposide|mesh-list
19296111|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296112|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19296113|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19296114|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19296115|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296116|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296117|NCT04234516|Morphine|morphine|mesh-list
19296118|NCT04234516|Buprenorphine|buprenorphine|mesh-list
19296119|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19296120|NCT04234516|Naloxone|naloxone|mesh-list
19296121|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19296122|NCT04234516|Narcotics|narcotics|mesh-ancestor
19296123|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296124|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296125|NCT04234516|Analgesics|analgesics|mesh-ancestor
19296126|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
19296127|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362706|NCT00937924|Promethazine|promethazine|mesh-list
20362707|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20362708|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20362709|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362710|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362711|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
20362712|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
19296128|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19296129|NCT04234191|Buprenorphine|buprenorphine|mesh-list
19296130|NCT04234191|Hydromorphone|hydromorphone|mesh-list
19296131|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19296132|NCT04234191|Naloxone|naloxone|mesh-list
19296133|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19296134|NCT04234191|Narcotics|narcotics|mesh-ancestor
19296135|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296136|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296137|NCT04234191|Analgesics|analgesics|mesh-ancestor
19296138|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
19296139|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296140|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19296141|NCT04233996|Meropenem|meropenem|mesh-list
20362713|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
20362714|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362715|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
20362716|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
20362717|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20362718|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20362719|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
20362720|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
20362721|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362722|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362723|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20362724|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
20362725|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
20362726|NCT00938132|Warfarin|warfarin|mesh-list
20362727|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
20362728|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
20362729|NCT00938158|Incretins|incretins|mesh-ancestor
20362730|NCT00938158|Hormones|hormones|mesh-ancestor
20362731|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425367|NCT01274403|Thalidomide|thalidomide|mesh-list
19296142|NCT04233996|Tazobactam|tazobactam|mesh-list
19296143|NCT04233996|Piperacillin|piperacillin|mesh-list
19296144|NCT04233996|Cefepime|cefepime|mesh-list
19296145|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19296146|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19296147|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296148|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19296149|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296150|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296151|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
19296152|NCT04233866|Leucovorin|leucovorin|mesh-list
20362732|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362733|NCT00938171|Anesthetics|anesthetics|mesh-list
20362734|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362735|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362736|NCT00938184|Paroxetine|paroxetine|mesh-list
20362737|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20362738|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20362739|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362740|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362741|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362742|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
20362743|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362744|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20362745|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
19296153|NCT04233866|Folic Acid|folic acid|mesh-list
19296154|NCT04233866|Gemcitabine|gemcitabine|mesh-list
19296155|NCT04233866|Paclitaxel|paclitaxel|mesh-list
19296156|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19296157|NCT04233866|Fluorouracil|fluorouracil|mesh-list
20362746|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362747|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20362748|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20362749|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362750|NCT00938197|Amlodipine|amlodipine|mesh-list
20362751|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20362752|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19296158|NCT04233866|Irinotecan|irinotecan|mesh-list
19296159|NCT04233866|Calcium|calcium|mesh-list
19296160|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
19296161|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19296162|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296163|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
19296164|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
19296165|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
19296166|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296167|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296168|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
19296169|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
19296170|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296171|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296172|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296173|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
19296174|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296175|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19296176|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19296177|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19296178|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19296179|NCT04233866|Antidotes|antidotes|mesh-ancestor
19296180|NCT04233866|Protective Agents|protective agents|mesh-ancestor
19296181|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
19296182|NCT04233866|Vitamins|vitamins|mesh-ancestor
19296183|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
19296184|NCT04233866|Hematinics|hematinics|mesh-ancestor
19296185|NCT04234048|Fenretinide|fenretinide|mesh-list
19296186|NCT04234048|Retinamide|retinamide|mesh-list
19296187|NCT04234048|Tretinoin|tretinoin|mesh-list
19296188|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296189|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19296190|NCT04234048|Protective Agents|protective agents|mesh-ancestor
19296191|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296192|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
19296193|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
19296194|NCT04233697|Romidepsin|romidepsin|mesh-list
19296195|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20612598|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612599|NCT02252263|Elotuzumab|elotuzumab|mesh-list
20612600|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612601|NCT02252302|Albuterol|albuterol|mesh-list
20612602|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20612603|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
20612604|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296196|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296197|NCT04233892|Estrogens|estrogens|mesh-list
19296198|NCT04233892|Hormones|hormones|mesh-ancestor
19296199|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296200|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296201|NCT04233294|Decitabine|decitabine|mesh-list
20612605|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612606|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19296202|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296203|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
19296204|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296205|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296206|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362753|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362754|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296207|NCT04233463|Budesonide|budesonide|mesh-list
19296208|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296209|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19296210|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
19296211|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296212|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296213|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20184287|NCT00198354|Carboplatin|carboplatin|mesh-list
20184288|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184289|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184290|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
19296214|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
19296215|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
19296216|NCT04233463|Hormones|hormones|mesh-ancestor
19296217|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296218|NCT04233346|Ponatinib|ponatinib|mesh-list
19296219|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296220|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19296221|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296222|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296223|NCT04233203|Insulin|insulin|mesh-list
19296224|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19296225|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19296226|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296227|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
19296228|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19296229|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19296230|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296231|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
19296232|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
19296233|NCT04233359|Anesthetics|anesthetics|mesh-list
19296234|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
19296235|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296236|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296237|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
19296238|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296239|NCT04233229|Insulin|insulin|mesh-list
19296240|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19296241|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296242|NCT04233515|Anticoagulants|anticoagulants|mesh-list
19296243|NCT04233502|Melatonin|melatonin|mesh-list
19296244|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
19296245|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296246|NCT04233502|Protective Agents|protective agents|mesh-ancestor
19296247|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296248|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395658|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395659|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395660|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19395661|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395662|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
19395663|NCT03665779|Vitamins|vitamins|mesh-ancestor
19395664|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
19395665|NCT03665766|Cycloserine|cycloserine|mesh-list
19395666|NCT03665766|Tacrolimus|tacrolimus|mesh-list
19395667|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395668|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
20184291|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184292|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184293|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184294|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184295|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
20184296|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
20362755|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20362756|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362757|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
20362758|NCT00938236|Cyclosporine|cyclosporine|mesh-list
19296249|NCT04232800|Riboflavin|riboflavin|mesh-list
19296250|NCT04232800|Vitamins|vitamins|mesh-ancestor
19296251|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
19296252|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296253|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
19296254|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19296255|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
19296256|NCT04232943|Vaccines|vaccines|mesh-list
19296257|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
19296258|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296259|NCT04232813|Estradiol|estradiol|mesh-list
19296260|NCT04232813|Estrogens|estrogens|mesh-ancestor
19296261|NCT04232813|Hormones|hormones|mesh-ancestor
19296262|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296263|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296264|NCT04233021|Osimertinib|osimertinib|mesh-list
19296265|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296266|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19296267|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296268|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296269|NCT04232644|Amphetamine|amphetamine|mesh-list
19296270|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
19296271|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19296272|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296273|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
19296274|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
19296275|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296276|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
19296277|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296278|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296279|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
19296280|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19296281|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19296282|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19296283|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19296284|NCT04232722|Sorafenib|sorafenib|mesh-list
19296285|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296286|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19296287|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296288|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296289|NCT04232332|Mitogens|mitogens|mesh-list
19296290|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
19296291|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296292|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19296293|NCT04232150|Midazolam|midazolam|mesh-list
19296294|NCT04232150|Anesthetics|anesthetics|mesh-list
19296295|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296296|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296297|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19296298|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19296299|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20362759|NCT00938236|Cyclosporins|cyclosporins|mesh-list
20362760|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362761|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362762|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362763|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
20362764|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362765|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
20362766|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362767|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
20362768|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362769|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20362770|NCT00938262|Rifampin|rifampin|mesh-list
20362771|NCT00938262|Ketoconazole|ketoconazole|mesh-list
19296300|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19296301|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296302|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296303|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
20362772|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20362773|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
20362774|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20362775|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362776|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
20362777|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19296304|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
19296305|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
19296306|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296307|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296308|NCT04231864|Durvalumab|durvalumab|mesh-list
19296309|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
19296310|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19296311|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
19296312|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296313|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296314|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
19296315|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296316|NCT04232033|Mitogens|mitogens|mesh-list
19296317|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19296318|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296319|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
19296320|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
19296321|NCT04232085|Melphalan|melphalan|mesh-list
19296322|NCT04232085|Fludarabine|fludarabine|mesh-list
19296323|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
19296324|NCT04232085|Tacrolimus|tacrolimus|mesh-list
19296325|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296326|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
19296327|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296328|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296329|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19296330|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
19296331|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296332|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296333|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19296334|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19296335|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296336|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19296337|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20362778|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362779|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296338|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
20184297|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184298|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184299|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184300|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
20184301|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184302|NCT00198367|Cisplatin|cisplatin|mesh-list
20184303|NCT00198367|Carboplatin|carboplatin|mesh-list
20184304|NCT00198367|Vinorelbine|vinorelbine|mesh-list
20184305|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184306|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362780|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20362781|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20362782|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20362783|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20362784|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20184307|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184308|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184309|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184310|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184311|NCT00198380|Gefitinib|gefitinib|mesh-list
19296339|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19296340|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296341|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20362785|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20362786|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
20362787|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20362788|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20362789|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20362790|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
20362791|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362792|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362793|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20362794|NCT00938353|Beclomethasone|beclomethasone|mesh-list
20362795|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20362796|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
20362797|NCT00938353|Hormones|hormones|mesh-ancestor
20362798|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184312|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296342|NCT04231851|Cytarabine|cytarabine|mesh-list
19296343|NCT04231851|Daunorubicin|daunorubicin|mesh-list
19296344|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296345|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
19296346|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296347|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296348|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
19296349|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296350|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296351|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
19296352|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296353|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19296354|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19296355|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19296356|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296357|NCT04231643|Dronabinol|dronabinol|mesh-list
19296358|NCT04231643|Cannabidiol|cannabidiol|mesh-list
19296359|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
19296360|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296361|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296362|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19296363|NCT04231643|Analgesics|analgesics|mesh-ancestor
19296364|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
19296365|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296366|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19296367|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19296368|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296369|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296370|NCT04231643|Hormones|hormones|mesh-ancestor
19296371|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296372|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
19296373|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
20612607|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612608|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
20612609|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20612610|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20612611|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19296374|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296375|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296376|NCT04231435|Metformin|metformin|mesh-list
19296377|NCT04231435|Digoxin|digoxin|mesh-list
19296378|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19296379|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20184313|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20184314|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184315|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296380|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296381|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19296382|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19296383|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
19296384|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296385|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19296386|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19296387|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296388|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19296389|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19296390|NCT04231435|Protective Agents|protective agents|mesh-ancestor
19296391|NCT04231617|Glyburide|glyburide|mesh-list
19296392|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19296393|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296394|NCT04231682|Denosumab|denosumab|mesh-list
19296395|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19296396|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296397|NCT04231448|Prednisone|prednisone|mesh-list
19296398|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
20184316|NCT00198393|Gemcitabine|gemcitabine|mesh-list
20184317|NCT00198393|Docetaxel|docetaxel|mesh-list
20184318|NCT00198393|Gefitinib|gefitinib|mesh-list
20184319|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184320|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
20184321|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184322|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612612|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19296399|NCT04231448|Rituximab|rituximab|mesh-list
19296400|NCT04231448|Doxorubicin|doxorubicin|mesh-list
19296401|NCT04231448|Vincristine|vincristine|mesh-list
19296402|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296403|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
19296404|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296405|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296406|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19296407|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
19296408|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296409|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296410|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19296411|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296412|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19296413|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19296414|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19296415|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296416|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296417|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
19296418|NCT04231448|Hormones|hormones|mesh-ancestor
19296419|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296420|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19296421|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19296422|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
19296423|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
19296424|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
19296425|NCT04231370|Lenalidomide|lenalidomide|mesh-list
20612613|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
20362799|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362800|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20612614|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296426|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
19296427|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296428|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19296429|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19296430|NCT04231370|Growth Substances|growth substances|mesh-ancestor
19296431|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
19296432|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296433|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
19296434|NCT04231214|Olodaterol|olodaterol|mesh-list
19296435|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19296436|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
19296437|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296438|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296439|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19296440|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
19296441|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
19296442|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19296443|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
20184323|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
20184324|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184325|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184326|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184327|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
20184328|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184329|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
19296444|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296445|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296446|NCT04231123|Anesthetics|anesthetics|mesh-list
19296447|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
19296448|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296449|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296450|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
19296451|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296452|NCT04231279|Secretin|secretin|mesh-list
19296453|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19296454|NCT04231279|Hormones|hormones|mesh-ancestor
20184330|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184331|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184332|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20362801|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
20362802|NCT00938379|Insect Repellents|insect repellents|mesh-list
20362803|NCT00938379|Protective Agents|protective agents|mesh-ancestor
20362804|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362805|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20362806|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20362807|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19296455|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296456|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296457|NCT04230980|Gabapentin|gabapentin|mesh-list
19296458|NCT04230980|Analgesics|analgesics|mesh-ancestor
19296459|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
19296460|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612615|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612616|NCT02252328|Simvastatin|simvastatin|mesh-list
20612617|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19296461|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296462|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
19296463|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19296464|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19296465|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296466|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296467|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19296468|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19296469|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296470|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612618|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20612619|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
19296471|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
19296472|NCT04230564|Azacitidine|azacitidine|mesh-list
19296473|NCT04230564|Venetoclax|venetoclax|mesh-list
19296474|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296475|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
19296476|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296477|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296478|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395669|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395670|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19395671|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395672|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395673|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19395674|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395675|NCT03665766|Renal Agents|renal agents|mesh-ancestor
19395676|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19395677|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
19395678|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19395679|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
19395680|NCT03665753|Ketorolac|ketorolac|mesh-list
19395681|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19395682|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19395683|NCT03665753|Analgesics|analgesics|mesh-ancestor
19395684|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
19395685|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395686|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395687|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395688|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395689|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19395690|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395691|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395692|NCT03665740|Resveratrol|resveratrol|mesh-list
19395693|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
19395694|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395695|NCT03665740|Protective Agents|protective agents|mesh-ancestor
20362808|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
20362809|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362810|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20362811|NCT00938509|Ibuprofen|ibuprofen|mesh-list
20362812|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20362813|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20362814|NCT00938509|Analgesics|analgesics|mesh-ancestor
20362815|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
20362816|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362817|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362818|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20362819|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362820|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20362821|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362822|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362823|NCT00938522|Cilostazol|cilostazol|mesh-list
19395696|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296479|NCT04230759|Fluorouracil|fluorouracil|mesh-list
19296480|NCT04230759|Durvalumab|durvalumab|mesh-list
19296481|NCT04230759|Mitomycins|mitomycins|mesh-list
19296482|NCT04230759|Mitomycin|mitomycin|mesh-list
19296483|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19296484|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
20612620|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612621|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20612622|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20612623|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296485|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296486|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296487|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296488|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296489|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
19296490|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296491|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296492|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19296493|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
19296494|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19296495|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296496|NCT04230460|Ethanol|ethanol|mesh-list
20184333|NCT00198432|Paclitaxel|paclitaxel|mesh-list
19838394|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19838395|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838396|NCT00620555|Gabapentin|gabapentin|mesh-list
19838397|NCT00620555|Analgesics|analgesics|mesh-ancestor
19838398|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
19838399|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838400|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838401|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
20184334|NCT00198432|Vinorelbine|vinorelbine|mesh-list
20184335|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184336|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184337|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184338|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184339|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184340|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184341|NCT00198445|Bromfenac|bromfenac|mesh-list
20184342|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20184343|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20184344|NCT00198445|Analgesics|analgesics|mesh-ancestor
20184345|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
20184346|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184347|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184348|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184349|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184350|NCT00198523|Tobramycin|tobramycin|mesh-list
20184351|NCT00198523|Prednisolone|prednisolone|mesh-list
20184352|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20184353|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
20184354|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20184355|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
20184356|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20184357|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
20184358|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612624|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
19296497|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19296498|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296499|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296500|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838402|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20184359|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
20184360|NCT00198523|Hormones|hormones|mesh-ancestor
20184361|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184362|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184363|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184364|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184365|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
20184366|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
20184367|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184368|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184369|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20184370|NCT00198523|Protective Agents|protective agents|mesh-ancestor
20362824|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20362825|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
20362826|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362827|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362828|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20362829|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
19296501|NCT04230330|Gemcitabine|gemcitabine|mesh-list
19296502|NCT04230330|Dexamethasone|dexamethasone|mesh-list
19296503|NCT04230330|Nivolumab|nivolumab|mesh-list
19296504|NCT04230330|Asparaginase|asparaginase|mesh-list
19296505|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296506|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296507|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
19296508|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
19296509|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296510|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296511|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19296512|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
19296513|NCT04230330|Hormones|hormones|mesh-ancestor
19296514|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296515|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19296516|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296517|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
19296518|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296519|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
19296520|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296521|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296522|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296523|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
19296524|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296525|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19296526|NCT04230083|Dienogest|dienogest|mesh-list
19296527|NCT04230083|Nandrolone|nandrolone|mesh-list
19296528|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19296529|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
19296530|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19296531|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296532|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19296533|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19296534|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19296535|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19296536|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
19296537|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296538|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19296539|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296540|NCT04230083|Androgens|androgens|mesh-ancestor
19296541|NCT04230083|Hormones|hormones|mesh-ancestor
19296542|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
19296543|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19296544|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19296545|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
19296546|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20184371|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20184372|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184373|NCT00198536|Ecabet|ecabet|mesh-list
20184374|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184375|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20184376|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184377|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
20184378|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184379|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184380|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19671854|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
19671855|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19671856|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19671857|NCT02578394|Prednisolone|prednisolone|mesh-list
19671858|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
19671859|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19671860|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19671861|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
19671862|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19671863|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
19671864|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
19296547|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19838403|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20184381|NCT00198536|Protective Agents|protective agents|mesh-ancestor
20184382|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184383|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184384|NCT00198562|Losartan|losartan|mesh-list
20184385|NCT00198562|Amlodipine|amlodipine|mesh-list
20184386|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
20184387|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20184388|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20184389|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184390|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20184391|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184392|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
20184393|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20184394|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20184395|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20184396|NCT00198588|Argatroban|argatroban|mesh-list
20184397|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
20184398|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20184399|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
20184400|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184401|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184402|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
20184403|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20184404|NCT00198601|Gentamicins|gentamicins|mesh-list
20362830|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20362831|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20362832|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362833|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20362834|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
20362835|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20362836|NCT00938522|Protective Agents|protective agents|mesh-ancestor
20362837|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20362838|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20362839|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362840|NCT00938600|Vitamin D|vitamin d|mesh-list
20362841|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
20362842|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
20362843|NCT00938600|Vitamins|vitamins|mesh-list
20362844|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
20362845|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362846|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20362847|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20362848|NCT00938613|Budesonide|budesonide|mesh-list
20362849|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20362850|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20362851|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
20362852|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362853|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362854|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20184405|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20184406|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184407|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20184408|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184409|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184410|NCT00198614|Metoprolol|metoprolol|mesh-list
20184411|NCT00198614|Carvedilol|carvedilol|mesh-list
20184412|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20184413|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20184414|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
20184415|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
20184416|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184417|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184418|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20184419|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20184420|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20184421|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
20184422|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184423|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184424|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
20184425|NCT00198614|Protective Agents|protective agents|mesh-ancestor
20184426|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19296548|NCT04230070|Estradiol|estradiol|mesh-list
19296549|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19296550|NCT04230070|Estrogens|estrogens|mesh-ancestor
19296551|NCT04230070|Hormones|hormones|mesh-ancestor
19296552|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296553|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296554|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19296555|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
19296556|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19296557|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19296558|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19296559|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19296560|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19296561|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19296562|NCT04230187|Leucovorin|leucovorin|mesh-list
19296563|NCT04230187|Bevacizumab|bevacizumab|mesh-list
19296564|NCT04230187|Fluorouracil|fluorouracil|mesh-list
19296565|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
19296566|NCT04230187|Irinotecan|irinotecan|mesh-list
19296567|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
19296568|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296569|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296570|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19296571|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19296572|NCT04230187|Growth Substances|growth substances|mesh-ancestor
19296573|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296574|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
19296575|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
19296576|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296577|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296578|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296579|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
19296580|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19296581|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19296582|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296583|NCT04230187|Antidotes|antidotes|mesh-ancestor
19296584|NCT04230187|Protective Agents|protective agents|mesh-ancestor
19296585|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
19296586|NCT04230187|Vitamins|vitamins|mesh-ancestor
19296587|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
19296588|NCT04229979|Cytarabine|cytarabine|mesh-list
19296589|NCT04229979|Azacitidine|azacitidine|mesh-list
19296590|NCT04229979|Decitabine|decitabine|mesh-list
19296591|NCT04229979|Venetoclax|venetoclax|mesh-list
19296592|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296593|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
19296594|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296595|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296596|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
19296597|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296598|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296599|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
19296600|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296601|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296602|NCT04230213|Adalimumab|adalimumab|mesh-list
19296603|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296604|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296605|NCT04229758|Anticoagulants|anticoagulants|mesh-list
19296606|NCT04229719|Melatonin|melatonin|mesh-list
19296607|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
19296608|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296609|NCT04229719|Protective Agents|protective agents|mesh-ancestor
19296610|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296611|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296612|NCT04229459|Nivolumab|nivolumab|mesh-list
19296613|NCT04229459|Cetuximab|cetuximab|mesh-list
19296614|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296615|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296616|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19296617|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296618|NCT04229212|Cimetidine|cimetidine|mesh-list
19296619|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19296620|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19296621|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19296622|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
19296623|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
19296624|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296625|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296626|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296627|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20362855|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
20362856|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
20362857|NCT00938613|Hormones|hormones|mesh-ancestor
20362858|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296628|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19296629|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296630|NCT04229264|Apixaban|apixaban|mesh-list
19296631|NCT04229264|Clopidogrel|clopidogrel|mesh-list
19296632|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19296633|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20362859|NCT00938626|Antibodies|antibodies|mesh-list
20362860|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20362861|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
20362862|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362863|NCT00938730|Warfarin|warfarin|mesh-list
20362864|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
20362865|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20362866|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20362867|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20362868|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362869|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362870|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
20362871|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362872|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362873|NCT00938821|Morphine|morphine|mesh-list
20362874|NCT00938821|Bupivacaine|bupivacaine|mesh-list
20362875|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
20362876|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
20362877|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362878|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362879|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
20362880|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362881|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20362882|NCT00938821|Narcotics|narcotics|mesh-ancestor
19296634|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19296635|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20362883|NCT00938821|Analgesics|analgesics|mesh-ancestor
20362884|NCT00938899|Simeprevir|simeprevir|mesh-list
20362885|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
20362886|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362887|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
20362888|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362889|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362890|NCT00938990|Midazolam|midazolam|mesh-list
20362891|NCT00938990|Etomidate|etomidate|mesh-list
20362892|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20362893|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20362894|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362895|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362896|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20362897|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20362898|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362899|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20362900|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
20362901|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
20362902|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
20362903|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
20362904|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362905|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362906|NCT00939068|Telbivudine|telbivudine|mesh-list
20362907|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
19296636|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
19296637|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296638|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296639|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296640|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19296641|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
19296642|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19296643|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
19296644|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296645|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
19296646|NCT04229355|Sorafenib|sorafenib|mesh-list
19296647|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
20362908|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20362909|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20362910|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296648|NCT04229355|Lenvatinib|lenvatinib|mesh-list
20362911|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362912|NCT00939133|Tretinoin|tretinoin|mesh-list
20362913|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362914|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
19296649|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19296650|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296651|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19296652|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296653|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296654|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19296655|NCT04229355|Estrogens|estrogens|mesh-ancestor
19296656|NCT04229355|Hormones|hormones|mesh-ancestor
19296657|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296658|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296659|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19296660|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19296661|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20612625|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20612626|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
19671865|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671866|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671867|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19671868|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
19671869|NCT02578394|Hormones|hormones|mesh-ancestor
20362915|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612627|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612628|NCT02252341|Expectorants|expectorants|mesh-ancestor
20612629|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612630|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20612631|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
19296662|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19296663|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19296664|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296665|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296666|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296667|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20362916|NCT00939328|Rituximab|rituximab|mesh-list
20362917|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20362918|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20362919|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362920|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
20362921|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362922|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296668|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
19296669|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296670|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19296671|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296672|NCT04229407|Vitamins|vitamins|mesh-list
19296673|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
19296674|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
19296675|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296676|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19296677|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19395697|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395698|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19395699|NCT03665610|Ozanimod|ozanimod|mesh-list
19395700|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19395701|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395702|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362923|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20362924|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
20362925|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362926|NCT00939458|Lamotrigine|lamotrigine|mesh-list
20362927|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
20362928|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20362929|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20362930|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362931|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20362932|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362933|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20612632|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612633|NCT02252341|Protective Agents|protective agents|mesh-ancestor
20612634|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296678|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
19296679|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19296680|NCT04228757|Estrogens|estrogens|mesh-ancestor
19296681|NCT04228757|Hormones|hormones|mesh-ancestor
19296682|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296683|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296684|NCT04228315|Primaquine|primaquine|mesh-list
19296685|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
19296686|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19296687|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19296688|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296689|NCT04228263|Aspirin|aspirin|mesh-list
19296690|NCT04228263|Folic Acid|folic acid|mesh-list
19296691|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
19296692|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19296693|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19296694|NCT04228263|Analgesics|analgesics|mesh-ancestor
19296695|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
19296696|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296697|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296698|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296699|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296700|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19296701|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19296702|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296703|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19296704|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19296705|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296706|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
19296707|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
19296708|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19296709|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19296710|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296711|NCT04228263|Hematinics|hematinics|mesh-ancestor
19296712|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
19296713|NCT04228263|Vitamins|vitamins|mesh-ancestor
19296714|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
19296715|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
19296716|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
19296717|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296718|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296719|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296720|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296721|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
19296722|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296723|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19296724|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296725|NCT04228289|Oxytocin|oxytocin|mesh-list
19296726|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
19296727|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19296728|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296729|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
19296730|NCT04227990|Docetaxel|docetaxel|mesh-list
19296731|NCT04227990|Doxorubicin|doxorubicin|mesh-list
19296732|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296733|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
19296734|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296735|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296736|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19296737|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
19296738|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296739|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296740|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19296741|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
19296742|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
19296743|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
19296744|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19296745|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19296746|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19296747|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296748|NCT04227886|Capecitabine|capecitabine|mesh-list
19692152|NCT04996238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296749|NCT04227886|Irinotecan|irinotecan|mesh-list
19296750|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296751|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
19296752|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296753|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296754|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19296755|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19296756|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296757|NCT04227808|Lenvatinib|lenvatinib|mesh-list
20184427|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20184428|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20184429|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
20184430|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20184431|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19296758|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296759|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19296760|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296761|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296762|NCT04227704|Ketamine|ketamine|mesh-list
19296763|NCT04227704|Analgesics|analgesics|mesh-ancestor
19296764|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
19296765|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296766|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296767|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19296768|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296769|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
19296770|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
19296771|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296772|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19296773|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19296774|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296775|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296776|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19296777|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296778|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19296779|NCT04227912|Anesthetics|anesthetics|mesh-list
19296780|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
19296781|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296782|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296783|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
19296784|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296785|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19296786|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19296787|NCT04227912|Analgesics|analgesics|mesh-ancestor
19296788|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296789|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296790|NCT04227652|Ibuprofen|ibuprofen|mesh-list
19296791|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19296792|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19296793|NCT04227652|Analgesics|analgesics|mesh-ancestor
19296794|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
19296795|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296796|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296797|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296798|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296799|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19296800|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296801|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296802|NCT04227210|Vaccines|vaccines|mesh-list
19296803|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
19296804|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296805|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
19296806|NCT04227275|Fludarabine|fludarabine|mesh-list
19296807|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20362934|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20362935|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362936|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362937|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20362938|NCT00939497|Risperidone|risperidone|mesh-list
20184432|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20184433|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20184434|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184435|NCT00198627|Renal Agents|renal agents|mesh-ancestor
20184436|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20184437|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
20184438|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20362939|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20362940|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
20362941|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362942|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362943|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362944|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20362945|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20362946|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362947|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362948|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20362949|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
20362950|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
20184439|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20184440|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19296808|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19296809|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
20184441|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184442|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
20184443|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20184444|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184445|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
20184446|NCT00198718|Vitamin A|vitamin a|mesh-list
20184447|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
20184448|NCT00198718|Vitamins|vitamins|mesh-ancestor
20184449|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
20184450|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184451|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
20184452|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184453|NCT00198718|Protective Agents|protective agents|mesh-ancestor
20184454|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20184455|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362951|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
19296810|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296811|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19296812|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19296813|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
19296814|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296815|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296816|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19296817|NCT04227483|Prednisolone|prednisolone|mesh-list
19296818|NCT04227483|Deflazacort|deflazacort|mesh-list
19296819|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296820|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
19296821|NCT04227483|Hormones|hormones|mesh-ancestor
19296822|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296823|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296824|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19296825|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296826|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362952|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
20362953|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20362954|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
20362955|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362956|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20362957|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20362958|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
20362959|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362960|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20362961|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20362962|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20362963|NCT00939588|Valsartan|valsartan|mesh-list
20362964|NCT00939588|Telmisartan|telmisartan|mesh-list
20362965|NCT00939588|Ramipril|ramipril|mesh-list
20362966|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20362967|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20362968|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20362969|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362970|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20362971|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
20362972|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20362973|NCT00939614|Lamotrigine|lamotrigine|mesh-list
20362974|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
20362975|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20362976|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425368|NCT01274403|Prednisone|prednisone|mesh-list
19296827|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
20184456|NCT00198848|Folic Acid|folic acid|mesh-list
20362977|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425369|NCT01274403|Melphalan|melphalan|mesh-list
19296828|NCT04227522|Rucaparib|rucaparib|mesh-list
19296829|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19296830|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296831|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296832|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296833|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
19296834|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19296835|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296836|NCT04227184|Trospium chloride|trospium chloride|mesh-list
19296837|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
19296838|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
19296839|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296840|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296841|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19296842|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19296843|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
19296844|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296845|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296846|NCT04227184|Urological Agents|urological agents|mesh-ancestor
19296847|NCT04227431|Insulin|insulin|mesh-list
19296848|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19296849|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296850|NCT04227093|Acetazolamide|acetazolamide|mesh-list
19296851|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
19296852|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19296853|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19296854|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296855|NCT04227093|Diuretics|diuretics|mesh-ancestor
19296856|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
19296857|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296858|NCT04227041|Capecitabine|capecitabine|mesh-list
19296859|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19296860|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
19296861|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296862|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296863|NCT04226963|Ketamine|ketamine|mesh-list
19296864|NCT04226963|Analgesics|analgesics|mesh-ancestor
19296865|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
19296866|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296867|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296868|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19296869|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296870|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
19296871|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
19296872|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296873|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19296874|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19296875|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296876|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296877|NCT04226885|Fentanyl|fentanyl|mesh-list
19296878|NCT04226885|Midazolam|midazolam|mesh-list
19296879|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
19296880|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19296881|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296882|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296883|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19296884|NCT04226885|Analgesics|analgesics|mesh-ancestor
19296885|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
19296886|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296887|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19296888|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19296889|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20184457|NCT00198848|Hematinics|hematinics|mesh-ancestor
20184458|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
20184459|NCT00198848|Vitamins|vitamins|mesh-ancestor
20184460|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
20184461|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184462|NCT00198978|Cytarabine|cytarabine|mesh-list
20184463|NCT00198978|Dexamethasone|dexamethasone|mesh-list
20184464|NCT00198978|Prednisolone|prednisolone|mesh-list
20184465|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
20184466|NCT00198978|Rituximab|rituximab|mesh-list
20184467|NCT00198978|Methotrexate|methotrexate|mesh-list
20184468|NCT00198978|Vincristine|vincristine|mesh-list
19296890|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
19296891|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296892|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296893|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19296894|NCT04226885|Narcotics|narcotics|mesh-ancestor
19296895|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19296896|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296897|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
19296898|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
19296899|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19296900|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19296901|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296902|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
19296903|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
19296904|NCT04226625|Propofol|propofol|mesh-list
19296905|NCT04226625|Desflurane|desflurane|mesh-list
19296906|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19296907|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296908|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296909|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296910|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
19296911|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
19296912|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19296913|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
19296914|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19296915|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
19296916|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296917|NCT04226456|Expectorants|expectorants|mesh-ancestor
19296918|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
19296919|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19296920|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
19296921|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296922|NCT04226456|Protective Agents|protective agents|mesh-ancestor
19296923|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296924|NCT04226456|Antidotes|antidotes|mesh-ancestor
19395703|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
19395704|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395705|NCT03665545|Poly I-C|poly i-c|mesh-list
19395706|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
19395707|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19395708|NCT03665545|Poly ICLC|poly iclc|mesh-list
19395709|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19395710|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395711|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
19395712|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
20184469|NCT00198978|Asparaginase|asparaginase|mesh-list
20184470|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
20184471|NCT00198978|Idarubicin|idarubicin|mesh-list
20184472|NCT00198978|Sargramostim|sargramostim|mesh-list
20184473|NCT00198978|Lenograstim|lenograstim|mesh-list
20184474|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184475|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
20184476|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184477|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19395713|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395714|NCT03665545|Laxatives|laxatives|mesh-ancestor
19395715|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395716|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
20184478|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184479|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
20184480|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184481|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184482|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184483|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20184484|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184485|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
20184486|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
20184487|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184488|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184489|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
20184490|NCT00198978|Hormones|hormones|mesh-ancestor
20184491|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184492|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19395717|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612635|NCT02252341|Antidotes|antidotes|mesh-ancestor
19395718|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19395719|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19395720|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19296925|NCT04226443|Midazolam|midazolam|mesh-list
19296926|NCT04226443|Remifentanil|remifentanil|mesh-list
19296927|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19296928|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19296929|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296930|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296931|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19296932|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19296933|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296934|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19296935|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
19296936|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
19296937|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
19296938|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
19296939|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296940|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296941|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19296942|NCT04226443|Narcotics|narcotics|mesh-ancestor
19296943|NCT04226443|Analgesics|analgesics|mesh-ancestor
19296944|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
19296945|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296946|NCT04226105|Insulin|insulin|mesh-list
19296947|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19296948|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
19296949|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
19296950|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19296951|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19296952|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19296953|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296954|NCT04226365|Nortriptyline|nortriptyline|mesh-list
19296955|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19296956|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
19296957|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19296958|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19296959|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19296960|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19296961|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296962|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
19296963|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19296964|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296965|NCT04225780|Ganciclovir|ganciclovir|mesh-list
19296966|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19296967|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
19296968|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19296969|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19296970|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671870|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20362978|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19296971|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19296972|NCT04225611|Dexamethasone|dexamethasone|mesh-list
19296973|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19296974|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
19296975|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
19296976|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19296977|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296978|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19296979|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
20362979|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362980|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20362981|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20362982|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20362983|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20362984|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20362985|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
20362986|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
20362987|NCT00939718|Vitamins|vitamins|mesh-ancestor
19296980|NCT04225611|Hormones|hormones|mesh-ancestor
19296981|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19296982|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19296983|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19296984|NCT04225598|Buprenorphine|buprenorphine|mesh-list
19296985|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19296986|NCT04225598|Narcotics|narcotics|mesh-ancestor
19671871|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20362988|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
19296987|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19296988|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296989|NCT04225598|Analgesics|analgesics|mesh-ancestor
19296990|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
19296991|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20362989|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20362990|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
20362991|NCT00939718|Hematinics|hematinics|mesh-ancestor
20362992|NCT00939757|Mirabegron|mirabegron|mesh-list
20362993|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20362994|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20362995|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20362996|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
19296992|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19296993|NCT04225728|Iron|iron|mesh-list
19296994|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19296995|NCT04225728|Teferrol|teferrol|mesh-list
19296996|NCT04225728|Trace Elements|trace elements|mesh-ancestor
19296997|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
19296998|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19296999|NCT04225728|Hematinics|hematinics|mesh-ancestor
20184493|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184494|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184495|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20184496|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184497|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
19297005|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
19297006|NCT04225468|Narcotics|narcotics|mesh-ancestor
19297007|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297008|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297009|NCT04225468|Analgesics|analgesics|mesh-ancestor
19297010|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
19297011|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297012|NCT04225364|Paclitaxel|paclitaxel|mesh-list
19297013|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19297014|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19297015|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297016|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
19297017|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
19297018|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297019|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297020|NCT04225325|Dolutegravir|dolutegravir|mesh-list
19297021|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19297022|NCT04225325|Emtricitabine|emtricitabine|mesh-list
19297023|NCT04225325|Darunavir|darunavir|mesh-list
19297024|NCT04225325|Cobicistat|cobicistat|mesh-list
19297025|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19297026|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19297027|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297028|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297029|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19297030|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19297031|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
19297032|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297033|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19297034|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20362997|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20362998|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20362999|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363000|NCT00939757|Urological Agents|urological agents|mesh-ancestor
20363001|NCT00939835|Dexetimide|dexetimide|mesh-list
19297035|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19297036|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19297037|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
19297038|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19297039|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19297040|NCT04225312|Natalizumab|natalizumab|mesh-list
20184498|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
20363002|NCT00939835|Citalopram|citalopram|mesh-list
20428568|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
19297041|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
19297042|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297043|NCT04224922|Paclitaxel|paclitaxel|mesh-list
20184499|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184500|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184501|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184502|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
19838404|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838405|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838406|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20363003|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20363004|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20363005|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363006|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363007|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363008|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
20363009|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363010|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19838407|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20184503|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363011|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
20363012|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20363013|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20363014|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20363015|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
20363016|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
20363017|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363018|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20363019|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20363020|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
20363021|NCT00939848|Gemcitabine|gemcitabine|mesh-list
20363022|NCT00939848|Cisplatin|cisplatin|mesh-list
20363023|NCT00939848|Cediranib|cediranib|mesh-list
20363024|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363025|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363026|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
19297044|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
19297045|NCT04224922|Epirubicin|epirubicin|mesh-list
19297046|NCT04224922|Carboplatin|carboplatin|mesh-list
19297047|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19297048|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297049|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
19297050|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
19297051|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297052|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297053|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363027|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363028|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
20363029|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363030|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363031|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19297054|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
19297055|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297056|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297057|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19297058|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
19297059|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19297060|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19297061|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19297062|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19297063|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671872|NCT02578394|Protective Agents|protective agents|mesh-ancestor
19671873|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19671874|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671875|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692153|NCT04996160|Dexamethasone|dexamethasone|mesh-list
19692154|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
19692155|NCT04996160|Doxorubicin|doxorubicin|mesh-list
19692156|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19692157|NCT04996160|Bortezomib|bortezomib|mesh-list
19692158|NCT04996160|Palbociclib|palbociclib|mesh-list
19692159|NCT04996160|BB 1101|bb 1101|mesh-list
20184504|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184505|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184506|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184507|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184508|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20184509|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184510|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184511|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19692160|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184512|NCT00198991|Cytarabine|cytarabine|mesh-list
19692161|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
19297064|NCT04225195|Amphotericin B|amphotericin b|mesh-list
19297065|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19297066|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
19297067|NCT04225195|Amebicides|amebicides|mesh-ancestor
19297068|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19297069|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19297070|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297071|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19297072|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
19297073|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19297074|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
19297075|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297076|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297077|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19297078|NCT04225195|Protective Agents|protective agents|mesh-ancestor
19297079|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297080|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297081|NCT04225052|Varenicline|varenicline|mesh-list
19297082|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19297083|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19297084|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
19297085|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297086|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297087|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297088|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
19297089|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
19297090|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19297091|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297092|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
19297093|NCT04224831|Mitogens|mitogens|mesh-list
19297094|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297095|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297096|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20184513|NCT00198991|Dexamethasone|dexamethasone|mesh-list
20184514|NCT00198991|Prednisolone|prednisolone|mesh-list
20184515|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
20184516|NCT00198991|Methotrexate|methotrexate|mesh-list
20184517|NCT00198991|Fludarabine|fludarabine|mesh-list
20184518|NCT00198991|Vincristine|vincristine|mesh-list
20184519|NCT00198991|Doxorubicin|doxorubicin|mesh-list
20184520|NCT00198991|Daunorubicin|daunorubicin|mesh-list
20184521|NCT00198991|Asparaginase|asparaginase|mesh-list
20184522|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
20184523|NCT00198991|Idarubicin|idarubicin|mesh-list
20184524|NCT00198991|Thioguanine|thioguanine|mesh-list
20184525|NCT00198991|Cladribine|cladribine|mesh-list
20184526|NCT00198991|Vindesine|vindesine|mesh-list
20184527|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184528|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
20184529|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184530|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184531|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184532|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
20184533|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184534|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184535|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184536|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184537|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
20184538|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
19297097|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19671876|NCT02341989|Carboplatin|carboplatin|mesh-list
19671877|NCT02341989|Etoposide|etoposide|mesh-list
19671878|NCT02341989|Bleomycin|bleomycin|mesh-list
19671879|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671880|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671881|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19671882|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19671883|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671884|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671885|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671886|NCT02184767|Loxapine|loxapine|mesh-list
19671887|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20184539|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297098|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
20184540|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184541|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
20184542|NCT00198991|Hormones|hormones|mesh-ancestor
20184543|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297099|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19297100|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
19297101|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19297102|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297103|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19297104|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19297105|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297106|NCT04224649|Lidocaine|lidocaine|mesh-list
19297107|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
19297108|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
19297109|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
20184544|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184545|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184546|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184547|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20184548|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184549|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
20184550|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184551|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184552|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184553|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184554|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
20184555|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184556|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184557|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
20363032|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
20363033|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363034|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363035|NCT00939926|Risperidone|risperidone|mesh-list
20363036|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20363037|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
20363038|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363039|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363040|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363041|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20363042|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20363043|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20363044|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20363045|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19297110|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297111|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297112|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
19297113|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297114|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19297115|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20184558|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184559|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297116|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19297117|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297118|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297119|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19297120|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
19297121|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
19297122|NCT04224649|Protective Agents|protective agents|mesh-ancestor
19297123|NCT04224636|Bevacizumab|bevacizumab|mesh-list
19297124|NCT04224636|Atezolizumab|atezolizumab|mesh-list
19297125|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19297126|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297127|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19297128|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19297129|NCT04224636|Growth Substances|growth substances|mesh-ancestor
19297130|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297131|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
19297132|NCT04224571|Rituximab|rituximab|mesh-list
19297133|NCT04224571|Bortezomib|bortezomib|mesh-list
19297134|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19297135|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297136|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
19297137|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297138|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297139|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
19297140|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20184560|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184561|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19297141|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395721|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19395722|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19395723|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
19395724|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395725|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19395726|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19395727|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
19395728|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
19395729|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395730|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395731|NCT03665441|Leucovorin|leucovorin|mesh-list
19395732|NCT03665441|Gemcitabine|gemcitabine|mesh-list
19395733|NCT03665441|Paclitaxel|paclitaxel|mesh-list
19395734|NCT03665441|Irinotecan|irinotecan|mesh-list
19395735|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19395736|NCT03665441|Asparaginase|asparaginase|mesh-list
19395737|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19395738|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395739|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
19395740|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395741|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
19395742|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395743|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19395744|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
19395745|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
19395746|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395747|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395748|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19395749|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
19395750|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395751|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19395752|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20363046|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
20425370|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425371|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
19395753|NCT03665441|Antidotes|antidotes|mesh-ancestor
19395754|NCT03665441|Protective Agents|protective agents|mesh-ancestor
19395755|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
19395756|NCT03665441|Vitamins|vitamins|mesh-ancestor
19395757|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
19395758|NCT03665428|Bismuth|bismuth|mesh-list
19395759|NCT03665428|Antacids|antacids|mesh-ancestor
19395760|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395761|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425372|NCT01274403|Hormones|hormones|mesh-ancestor
20425373|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425374|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425375|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20425376|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425377|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20425378|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
20425379|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425380|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20425381|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425382|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
20425383|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
20425384|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20425385|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425386|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20425387|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20425388|NCT01274403|Growth Substances|growth substances|mesh-ancestor
20425389|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
20425390|NCT01274481|Iloprost|iloprost|mesh-list
19395762|NCT03665402|Isoniazid|isoniazid|mesh-list
19395763|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
19395764|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19395765|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395766|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19395767|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19395768|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
19395769|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395770|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19395771|NCT03665350|Insulin|insulin|mesh-list
19395772|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19395773|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395774|NCT03665181|Bismuth|bismuth|mesh-list
20184562|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184563|NCT00199004|Cytarabine|cytarabine|mesh-list
20184564|NCT00199004|Dexamethasone|dexamethasone|mesh-list
20184565|NCT00199004|Prednisolone|prednisolone|mesh-list
20184566|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
20184567|NCT00199004|Rituximab|rituximab|mesh-list
20363047|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20363048|NCT00939939|Glimepiride|glimepiride|mesh-list
19297142|NCT04224675|Atenolol|atenolol|mesh-list
19297143|NCT04224675|Captopril|captopril|mesh-list
19297144|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19297145|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19297146|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
19297147|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
19297148|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297149|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297150|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19297151|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19297152|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19297153|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
19297154|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297155|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297156|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19297157|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
19297158|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297159|NCT04224337|Doxorubicin|doxorubicin|mesh-list
19297160|NCT04224337|Durvalumab|durvalumab|mesh-list
19297161|NCT04224337|Ifosfamide|ifosfamide|mesh-list
19297162|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19297163|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297164|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19297165|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19297166|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297167|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297168|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19297169|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19297170|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
19297171|NCT04224441|Temozolomide|temozolomide|mesh-list
19297172|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
19297173|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19297174|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
19297175|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363049|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363050|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297176|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297177|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
19297178|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
19297179|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297180|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297181|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19297182|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19297183|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19297184|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297185|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19297186|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19297187|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
19297188|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297189|NCT04224415|Irinotecan|irinotecan|mesh-list
19297190|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19297191|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19297192|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297193|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297194|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297195|NCT04224051|Metformin|metformin|mesh-list
19297196|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19297197|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297198|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
19297199|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19297200|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
19297201|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297202|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184568|NCT00199004|Methotrexate|methotrexate|mesh-list
20184569|NCT00199004|Vincristine|vincristine|mesh-list
20184570|NCT00199004|Doxorubicin|doxorubicin|mesh-list
20184571|NCT00199004|Daunorubicin|daunorubicin|mesh-list
20184572|NCT00199004|Asparaginase|asparaginase|mesh-list
20184573|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
20184574|NCT00199004|Thioguanine|thioguanine|mesh-list
19297203|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19297204|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
19297205|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19297206|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
19297207|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297208|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297209|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19297210|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297211|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
19297212|NCT04224103|Protective Agents|protective agents|mesh-ancestor
19297213|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
19297214|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19297215|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19297216|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297217|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
20363051|NCT00939939|Incretins|incretins|mesh-ancestor
20363052|NCT00939939|Hormones|hormones|mesh-ancestor
20363053|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20363054|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20363055|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
20363056|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363057|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363058|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19297218|NCT04224116|Coagulants|coagulants|mesh-ancestor
19297219|NCT04224350|Tacrolimus|tacrolimus|mesh-list
19297220|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19297221|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
19297222|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297223|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19297224|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297225|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297226|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
19297227|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19297228|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19297229|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
20363059|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363060|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
20363061|NCT00939965|Isotretinoin|isotretinoin|mesh-list
20363062|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
20363063|NCT00940004|Vaccines|vaccines|mesh-list
20363064|NCT00940004|Immunologic Factors|immunologic factors|mesh-ancestor
20363065|NCT00940004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363066|NCT00940069|Pemetrexed|pemetrexed|mesh-list
20363067|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363068|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363069|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363070|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20363071|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20363072|NCT00940121|Mirabegron|mirabegron|mesh-list
20363073|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20363074|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20363075|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20363076|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
20363077|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363078|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363079|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363080|NCT00940121|Urological Agents|urological agents|mesh-ancestor
20363081|NCT00940238|Dexetimide|dexetimide|mesh-list
20363082|NCT00940238|Citalopram|citalopram|mesh-list
20363083|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20363084|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20363085|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363086|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363087|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363088|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
20363089|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363090|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20363091|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
20363092|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20363093|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20363094|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20363095|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
20363096|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
19671888|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19297230|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
19297231|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297232|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297233|NCT04223973|Insulin|insulin|mesh-list
19297234|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19297235|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297236|NCT04223778|Islatravir|islatravir|mesh-list
19297237|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
19297238|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297239|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297240|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297241|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20363097|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363098|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20363099|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19297242|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19297243|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19297244|NCT04223791|Islatravir|islatravir|mesh-list
19297245|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
19297246|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297247|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297248|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297249|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19297250|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19297251|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19297252|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
19297253|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19297254|NCT04223518|Antibodies|antibodies|mesh-list
20363100|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
20363101|NCT00940303|Leucovorin|leucovorin|mesh-list
20363102|NCT00940303|Bevacizumab|bevacizumab|mesh-list
20363103|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
19297255|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
19297256|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297257|NCT04223739|Amiodarone|amiodarone|mesh-list
19297258|NCT04223739|Landiolol|landiolol|mesh-list
19297259|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19297260|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297261|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19297262|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297263|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297264|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19297265|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19297266|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19297267|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297268|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19297269|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20184575|NCT00199004|Vindesine|vindesine|mesh-list
20184576|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184577|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
20184578|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184579|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184580|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184581|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
20184582|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297270|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19297271|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19297272|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19297273|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
19297274|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297275|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297276|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
19297277|NCT04223219|Fentanyl|fentanyl|mesh-list
19297278|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
19297279|NCT04223219|Ketamine|ketamine|mesh-list
19297280|NCT04223219|Propofol|propofol|mesh-list
19297281|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19297282|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297283|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297284|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20363104|NCT00940303|Irinotecan|irinotecan|mesh-list
20363105|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20363106|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363107|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20363108|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20363109|NCT00940303|Growth Substances|growth substances|mesh-ancestor
19297285|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
19297286|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
19297287|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19297288|NCT04223219|Analgesics|analgesics|mesh-ancestor
19297289|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
19297290|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297291|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19297292|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19297293|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19297294|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
19297295|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297296|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297297|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19297298|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19297299|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20184583|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184584|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184585|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20184586|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184587|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
20184588|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
20184589|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184590|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184591|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
20184592|NCT00199004|Hormones|hormones|mesh-ancestor
20184593|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184594|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184595|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184596|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184597|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20184598|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184599|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
20184600|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184601|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184602|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184603|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184604|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
20184605|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184606|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184607|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184608|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184609|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184610|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184611|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184612|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184613|NCT00199017|Cytarabine|cytarabine|mesh-list
20184614|NCT00199017|Dexamethasone|dexamethasone|mesh-list
20184615|NCT00199017|Prednisolone|prednisolone|mesh-list
20184616|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
20184617|NCT00199017|Methotrexate|methotrexate|mesh-list
20184618|NCT00199017|Vincristine|vincristine|mesh-list
20184619|NCT00199017|Doxorubicin|doxorubicin|mesh-list
20184620|NCT00199017|Daunorubicin|daunorubicin|mesh-list
20184621|NCT00199017|Asparaginase|asparaginase|mesh-list
20184622|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
20184623|NCT00199017|Thioguanine|thioguanine|mesh-list
20184624|NCT00199017|Cladribine|cladribine|mesh-list
20184625|NCT00199017|Vindesine|vindesine|mesh-list
20184626|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184627|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
20184628|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184629|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184630|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184631|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
20184632|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184633|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184634|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184635|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184636|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
20184637|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
20184638|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184639|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184640|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
20184641|NCT00199017|Hormones|hormones|mesh-ancestor
20184642|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297300|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19297301|NCT04223219|Narcotics|narcotics|mesh-ancestor
19297302|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19297303|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19297304|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
19297305|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19297306|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297307|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19297308|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
19297309|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19297310|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
19297311|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19297312|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19297313|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297314|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
19297315|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
20363110|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363111|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
20363112|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19297316|NCT04222842|Vorolanib|vorolanib|mesh-list
19297317|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20184643|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184644|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184645|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184646|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20184647|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184648|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
19297318|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297319|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297320|NCT04222855|Diltiazem|diltiazem|mesh-list
19297321|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19297322|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19297323|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297324|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297325|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19297326|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297327|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297328|NCT04222920|Adalimumab|adalimumab|mesh-list
19297329|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19297330|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297331|NCT04222517|Hemostatics|hemostatics|mesh-list
19297332|NCT04222517|Coagulants|coagulants|mesh-ancestor
19297333|NCT04222595|Vaccines|vaccines|mesh-list
19297334|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
20363113|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20363114|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425391|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19297335|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297336|NCT04222686|Losartan|losartan|mesh-list
19297337|NCT04222686|Perindopril|perindopril|mesh-list
19297338|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19297339|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19297340|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19297341|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19297342|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297343|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19297344|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
19297345|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297346|NCT04222062|Carmustine|carmustine|mesh-list
19297347|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19297348|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
19297349|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671889|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19671890|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184649|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184650|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184651|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184652|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184653|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
20184654|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184655|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184656|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184657|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184658|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297350|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297351|NCT04222348|Metformin|metformin|mesh-list
19297352|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
19297353|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19297354|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297355|NCT04222114|Catumaxomab|catumaxomab|mesh-list
19297356|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395775|NCT03665181|Antacids|antacids|mesh-ancestor
19395776|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395777|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395778|NCT03664986|Bupivacaine|bupivacaine|mesh-list
19395779|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
20184659|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184660|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184661|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184662|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
20184663|NCT00199030|Cladribine|cladribine|mesh-list
20184664|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20184665|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184666|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184667|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
20184668|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395780|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
19395781|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395782|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395783|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
19395784|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395785|NCT03664908|Antibodies|antibodies|mesh-list
19395786|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
19395787|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395788|NCT03664895|Goserelin|goserelin|mesh-list
19395789|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19395790|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395791|NCT03664869|Mitomycins|mitomycins|mesh-list
19671891|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19671892|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19671893|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
19671894|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19671895|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184669|NCT00199043|Allopurinol|allopurinol|mesh-list
20184670|NCT00199043|Rasburicase|rasburicase|mesh-list
20184671|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
20184672|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184673|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184674|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
20184675|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184676|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20184677|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
20184678|NCT00199043|Protective Agents|protective agents|mesh-ancestor
20184679|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184680|NCT00199056|Cytarabine|cytarabine|mesh-list
20184681|NCT00199056|Dexamethasone|dexamethasone|mesh-list
20184682|NCT00199056|Prednisolone|prednisolone|mesh-list
20184683|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
20184684|NCT00199056|Ifosfamide|ifosfamide|mesh-list
20184685|NCT00199056|Methotrexate|methotrexate|mesh-list
20184686|NCT00199056|Fludarabine|fludarabine|mesh-list
20184687|NCT00199056|Vincristine|vincristine|mesh-list
20184688|NCT00199056|Doxorubicin|doxorubicin|mesh-list
20184689|NCT00199056|Daunorubicin|daunorubicin|mesh-list
20184690|NCT00199056|Asparaginase|asparaginase|mesh-list
20184691|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
20184692|NCT00199056|Idarubicin|idarubicin|mesh-list
20184693|NCT00199056|Thioguanine|thioguanine|mesh-list
20184694|NCT00199056|Vindesine|vindesine|mesh-list
20184695|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184696|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
20184697|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184698|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184699|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19395792|NCT03664869|Mitomycin|mitomycin|mesh-list
19395793|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671896|NCT02122718|Allopurinol|allopurinol|mesh-list
19671897|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
20184700|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
20184701|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184702|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184703|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184704|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19671898|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671899|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671900|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
19671901|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671902|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19671903|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
19671904|NCT02122718|Protective Agents|protective agents|mesh-ancestor
19297357|NCT04222088|Chloroquine|chloroquine|mesh-list
19297358|NCT04222088|Lumefantrine|lumefantrine|mesh-list
19297359|NCT04222088|Amebicides|amebicides|mesh-ancestor
19297360|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19297361|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19297362|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297363|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
19297364|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297365|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
19297366|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19297367|NCT04222023|Antibodies|antibodies|mesh-list
19297368|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
19297369|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19297370|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
19297371|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297372|NCT04221906|Betamethasone|betamethasone|mesh-list
19297373|NCT04221906|Calcipotriene|calcipotriene|mesh-list
19297374|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19297375|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19297376|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
19297377|NCT04221906|Hormones|hormones|mesh-ancestor
19297378|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297379|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297380|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19297381|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
19297382|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19297383|NCT04222283|Emtricitabine|emtricitabine|mesh-list
19297384|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
19297385|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297386|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19297387|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19297388|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297389|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297390|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19297391|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19297392|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19297393|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19297394|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
19297395|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297396|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297397|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297398|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
19297399|NCT04221971|Fludarabine|fludarabine|mesh-list
20363115|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363116|NCT00940303|Antidotes|antidotes|mesh-ancestor
20363117|NCT00940303|Protective Agents|protective agents|mesh-ancestor
20363118|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
20363119|NCT00940303|Vitamins|vitamins|mesh-ancestor
20363120|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
20363121|NCT00940381|Sirolimus|sirolimus|mesh-list
19297400|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19297401|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
19297402|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297403|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297404|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19297405|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
19297406|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297407|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297408|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19297409|NCT04222010|Anesthetics|anesthetics|mesh-list
19297410|NCT04222010|Ropivacaine|ropivacaine|mesh-list
19297411|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297412|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297413|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
19297414|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
19297415|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297416|NCT04221555|Docetaxel|docetaxel|mesh-list
19297417|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
19297418|NCT04221555|Durvalumab|durvalumab|mesh-list
20363122|NCT00940381|Cetuximab|cetuximab|mesh-list
20425392|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297419|NCT04221555|Tremelimumab|tremelimumab|mesh-list
19297420|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19297421|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297422|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
19297423|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
19297424|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297425|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297426|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19297427|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
20363123|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20363124|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363125|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20363126|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363127|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20363128|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
20363129|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363130|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
20363131|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363132|NCT00940420|Ribavirin|ribavirin|mesh-list
20363133|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20363134|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
19297428|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297429|NCT04221672|Terlipressin|terlipressin|mesh-list
19297430|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19297431|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19297432|NCT04221503|Niraparib|niraparib|mesh-list
19297433|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19297434|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297435|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297436|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297437|NCT04221438|Alovudine|alovudine|mesh-list
19297438|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
19297439|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297440|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19297441|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
19297442|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19297443|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19297444|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297445|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297446|NCT04221256|Citalopram|citalopram|mesh-list
19297447|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19297448|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19297449|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297450|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297451|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297452|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
19297453|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297454|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19297455|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
19297456|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19297457|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
19297458|NCT04221165|Narcotics|narcotics|mesh-ancestor
19297459|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297460|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297461|NCT04221165|Analgesics|analgesics|mesh-ancestor
19297462|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
19297463|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297464|NCT04221321|Atorvastatin|atorvastatin|mesh-list
19297465|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19297466|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19297467|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
19671905|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671906|NCT01882816|Doxorubicin|doxorubicin|mesh-list
19671907|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19671908|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297468|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297469|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19297470|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19297471|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297472|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19297473|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19671909|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19671910|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19671911|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671912|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671913|NCT01758614|Aspirin|aspirin|mesh-list
19671914|NCT01758614|Clopidogrel|clopidogrel|mesh-list
20363135|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
20363136|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363137|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
20363138|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363139|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
20363140|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363141|NCT00940472|Metformin|metformin|mesh-list
20363142|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363143|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363144|NCT00940498|Gedatolisib|gedatolisib|mesh-list
20363145|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363146|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363147|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363148|NCT00940524|Cytarabine|cytarabine|mesh-list
19671915|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19671916|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19671917|NCT01758614|Analgesics|analgesics|mesh-ancestor
19671918|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
19671919|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19671920|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671921|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838408|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838409|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297474|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
19297475|NCT04221529|Atezolizumab|atezolizumab|mesh-list
19297476|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297477|NCT04221152|Empagliflozin|empagliflozin|mesh-list
19297478|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19297479|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297480|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19297481|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297482|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
19297483|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19297484|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297485|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363149|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
20363150|NCT00940524|Methotrexate|methotrexate|mesh-list
20363151|NCT00940524|Etoposide|etoposide|mesh-list
20363152|NCT00940524|Asparaginase|asparaginase|mesh-list
20363153|NCT00940524|Dasatinib|dasatinib|mesh-list
20363154|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
19297486|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
19297487|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297488|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297489|NCT04220996|Vortioxetine|vortioxetine|mesh-list
19297490|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
19297491|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838410|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
19838411|NCT00620659|Modafinil|modafinil|mesh-list
19838412|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20363155|NCT00940524|Pegaspargase|pegaspargase|mesh-list
20363156|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363157|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
20363158|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297492|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19838413|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838414|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19838415|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19838416|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19838417|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838418|NCT00620750|Naltrexone|naltrexone|mesh-list
19838419|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19838420|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19838421|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297493|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20363159|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363160|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20363161|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
19838422|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
20363162|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425393|NCT01274624|Leucovorin|leucovorin|mesh-list
20363163|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363164|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20363165|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20363166|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
20363167|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20363168|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363169|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
20363170|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
20363171|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363172|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20363173|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20363174|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20363175|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20363176|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20363177|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
20363178|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363179|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363180|NCT00940524|Analgesics|analgesics|mesh-ancestor
20363181|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
19297494|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297495|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297496|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19297497|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19297498|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297499|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297500|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297501|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
19297502|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19297503|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19297504|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19297505|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19297506|NCT04220827|Paclitaxel|paclitaxel|mesh-list
20363182|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363183|NCT00940550|Melatonin|melatonin|mesh-list
20363184|NCT00940550|Zolpidem|zolpidem|mesh-list
19297507|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19297508|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19297509|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297510|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
19297511|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
19297512|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297513|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297514|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
19297515|NCT04220892|Pemetrexed|pemetrexed|mesh-list
19297516|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19297517|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297518|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297519|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297520|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19297521|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19671922|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19671923|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19671924|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19671925|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671926|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19671927|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19671928|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671929|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
19838423|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184705|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
20184706|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
20184707|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184708|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184709|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
20184710|NCT00199056|Hormones|hormones|mesh-ancestor
20184711|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184712|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184713|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184714|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184715|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20184716|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363185|NCT00940550|Temazepam|temazepam|mesh-list
20363186|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
20363187|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363188|NCT00940550|Protective Agents|protective agents|mesh-ancestor
20363189|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671930|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19297522|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
19297523|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19297524|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297525|NCT04220528|Capecitabine|capecitabine|mesh-list
19297526|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363190|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20363191|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20363192|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20363193|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20363194|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
20363195|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
20363196|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363197|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20363198|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20363199|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19297527|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
19297528|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297529|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297530|NCT04220398|Hormones|hormones|mesh-list
19297531|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297532|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297533|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
19297534|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297535|NCT04220632|Prednisone|prednisone|mesh-list
19297536|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
19297537|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19297538|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19297539|NCT04220632|Prednisolone|prednisolone|mesh-list
19297540|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
19297541|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19297542|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
19297543|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19297544|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
19297545|NCT04220632|Hormones|hormones|mesh-ancestor
19297546|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297547|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297548|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19297549|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297550|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
19297551|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
19297552|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297553|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19297554|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19297555|NCT04220632|Protective Agents|protective agents|mesh-ancestor
19297556|NCT04220476|Letrozole|letrozole|mesh-list
19297557|NCT04220476|Palbociclib|palbociclib|mesh-list
20363200|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
20363201|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
19297558|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297559|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19297560|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19297561|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297562|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297563|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19297564|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
19297565|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297566|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297567|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19297568|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
19297569|NCT04220281|Propofol|propofol|mesh-list
19297570|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19297571|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297572|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297573|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19297574|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
19297575|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
19297576|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
19692162|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
20363202|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395794|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363203|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363204|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363205|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363206|NCT00940628|Orlistat|orlistat|mesh-list
20363207|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363208|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363209|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20363210|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20363211|NCT00940654|Acetaminophen|acetaminophen|mesh-list
20363212|NCT00940654|Antipyretics|antipyretics|mesh-list
20363213|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20363214|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20363215|NCT00940654|Analgesics|analgesics|mesh-ancestor
20363216|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
19297577|NCT04220008|Gemcitabine|gemcitabine|mesh-list
19297578|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
19297579|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
19297580|NCT04220008|Busulfan|busulfan|mesh-list
19297581|NCT04220008|Rituximab|rituximab|mesh-list
19297582|NCT04220008|Vorinostat|vorinostat|mesh-list
19297583|NCT04220008|Clofarabine|clofarabine|mesh-list
19297584|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19297585|NCT04220008|Tacrolimus|tacrolimus|mesh-list
19297586|NCT04220008|Antibodies|antibodies|mesh-list
19297587|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
19297588|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19297589|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19297590|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
19297591|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297592|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297593|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19297594|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
19297595|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297596|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297597|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19297598|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19297599|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
19297600|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
19297601|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297602|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297603|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19297604|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19297605|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19297606|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
19297607|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19297608|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19297609|NCT04220021|Metformin|metformin|mesh-list
19297610|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19297611|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297612|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
19297613|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19297614|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19297615|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297616|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
19297617|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
19297618|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297619|NCT04220073|Antibodies|antibodies|mesh-list
19297620|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19297621|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
20363217|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363218|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363219|NCT00940667|Losartan|losartan|mesh-list
20363220|NCT00940667|Amlodipine|amlodipine|mesh-list
20363221|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20363222|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19297622|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297623|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
19297624|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20363223|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363224|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363225|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20363226|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297625|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19297626|NCT04219995|Prednisolone|prednisolone|mesh-list
19297627|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
19297628|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19297629|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
20184717|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
20184718|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184719|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184720|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184721|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184722|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
20184723|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363227|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297630|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19297631|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
19297632|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
19297633|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297634|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297635|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19297636|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
19297637|NCT04219995|Hormones|hormones|mesh-ancestor
19297638|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297639|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19297640|NCT04219995|Protective Agents|protective agents|mesh-ancestor
19297641|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19297642|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297643|NCT04219865|Edaravone|edaravone|mesh-list
19297644|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19297645|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
19297646|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297647|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19297648|NCT04219865|Protective Agents|protective agents|mesh-ancestor
19297649|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297650|NCT04219982|Scopolamine|scopolamine|mesh-list
19297651|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19297652|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19297653|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
19297654|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
20363228|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20363229|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20363230|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20363231|NCT00940680|Losartan|losartan|mesh-list
20363232|NCT00940680|Amlodipine|amlodipine|mesh-list
20363233|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20363234|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20363235|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363236|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363237|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20363238|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363239|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297655|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297656|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297657|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19297658|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
19297659|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19297660|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
19297661|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297662|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297663|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19297664|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
19297665|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
19297666|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20363240|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20363241|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19297667|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19297668|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297669|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
19297670|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
19297671|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297672|NCT04219579|Antithrombins|antithrombins|mesh-list
19297673|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
19297674|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19297675|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
19297676|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297677|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297678|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
19297679|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
20184724|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19297680|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20363242|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20363243|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20363244|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20363245|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20363246|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363247|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363248|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363249|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363250|NCT00940693|Analgesics|analgesics|mesh-ancestor
20363251|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
20363252|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363253|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
19297684|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
19297685|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19297686|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297687|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19297688|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297689|NCT04219358|Imiquimod|imiquimod|mesh-list
19297690|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
20363254|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20363255|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
20363256|NCT00940719|Vitamin D|vitamin d|mesh-list
20363257|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
20363258|NCT00940719|Vitamins|vitamins|mesh-ancestor
20363259|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
20363260|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363261|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20363262|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20363263|NCT00940784|Aspirin|aspirin|mesh-list
20363264|NCT00940784|Clopidogrel|clopidogrel|mesh-list
20363265|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20363266|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20363267|NCT00940784|Analgesics|analgesics|mesh-ancestor
20363268|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
20363269|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363270|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363271|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20363272|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363273|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20363274|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20363275|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363276|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20363277|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20363278|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363279|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
20363280|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20363281|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20363282|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20363283|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
20363284|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363285|NCT00940836|Acetaminophen|acetaminophen|mesh-list
20363286|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
20363287|NCT00940836|Phenylephrine|phenylephrine|mesh-list
20363288|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19297691|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19297692|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
19297693|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297694|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297695|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
19297696|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19297697|NCT04219358|Protective Agents|protective agents|mesh-ancestor
19297698|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
19297699|NCT04219280|Methylphenidate|methylphenidate|mesh-list
19297700|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19297701|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297702|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19297703|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19297704|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297705|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297706|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
19297707|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363289|NCT00940836|Analgesics|analgesics|mesh-ancestor
20363290|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
20363291|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363292|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363293|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
19297708|NCT04219046|Naloxegol|naloxegol|mesh-list
19297709|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19297710|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297711|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
19297712|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297713|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
19297714|NCT04218890|Thromboplastin|thromboplastin|mesh-list
19297715|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19297716|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19297717|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297718|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
19297719|NCT04218890|Coagulants|coagulants|mesh-ancestor
19297720|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
19297721|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19297722|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
19297723|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297724|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19297725|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
19297726|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
19297727|NCT04218981|Paroxetine|paroxetine|mesh-list
19297728|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19297729|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19297730|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297731|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297732|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297733|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
19297734|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297735|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19297736|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
19297737|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19297738|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19297739|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19297740|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297741|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19297742|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297743|NCT04218968|Carvedilol|carvedilol|mesh-list
19297744|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19297745|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19297746|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
19297747|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363294|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20363295|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
20363296|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
20363297|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
20363298|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20363299|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
20363300|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
20363301|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20363302|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19297748|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297749|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297750|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19297751|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
19297752|NCT04218968|Protective Agents|protective agents|mesh-ancestor
19297753|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19297754|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297755|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19297756|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297757|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19297758|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19297759|NCT04218513|Edaravone|edaravone|mesh-list
19297760|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19297761|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
19297762|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297763|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19297764|NCT04218513|Protective Agents|protective agents|mesh-ancestor
20363303|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20363304|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
20363305|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363306|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363307|NCT00940836|Protective Agents|protective agents|mesh-ancestor
20363308|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
20363309|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
20363310|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20363311|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
20363312|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
20363313|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20363314|NCT00940862|Adalimumab|adalimumab|mesh-list
20363315|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20363316|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363317|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
20363318|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20363319|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363320|NCT00940940|Vaccines|vaccines|mesh-list
20363321|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
20363322|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363323|NCT00940953|Azelastine|azelastine|mesh-list
20363324|NCT00940953|Budesonide|budesonide|mesh-list
20363325|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20363326|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20363327|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
20363328|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363329|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363330|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20363331|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
20363332|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
20363333|NCT00940953|Hormones|hormones|mesh-ancestor
20363334|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20363335|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20363336|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363337|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363338|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20363339|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19297765|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297766|NCT04218500|Niacinamide|niacinamide|mesh-list
19297767|NCT04218500|Niacin|niacin|mesh-list
19297768|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
19297769|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
19297770|NCT04218500|Vitamins|vitamins|mesh-ancestor
19297771|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
20363340|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20363341|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
20363342|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
20363343|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363344|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
20363345|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
20363346|NCT00941057|Dienogest|dienogest|mesh-list
20363347|NCT00941057|Calcium|calcium|mesh-list
20363348|NCT00941057|Nandrolone|nandrolone|mesh-list
19297772|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297773|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19297774|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
19297775|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297776|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19297777|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297778|NCT04218435|Valsartan|valsartan|mesh-list
19297779|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19297780|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19297781|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19297782|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297783|NCT04218760|Isosorbide|isosorbide|mesh-list
19297784|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19297785|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19297786|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19297787|NCT04218760|Diuretics|diuretics|mesh-ancestor
19297788|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
19297789|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297790|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297791|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19297792|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297793|NCT04218552|Amlodipine|amlodipine|mesh-list
20363349|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20363350|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363351|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19297794|NCT04218552|Telmisartan|telmisartan|mesh-list
19297795|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19297796|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19297797|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297798|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297799|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19297800|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297801|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297802|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19297803|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20363352|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20363353|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
20363354|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20363355|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20363356|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20363357|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20363358|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20363359|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
20363360|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20363361|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20363362|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363363|NCT00941057|Androgens|androgens|mesh-ancestor
20363364|NCT00941057|Hormones|hormones|mesh-ancestor
20363365|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
20363366|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
20363367|NCT00941057|Vitamins|vitamins|mesh-ancestor
20363368|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
20363369|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
20363370|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20363371|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20363372|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
20363373|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363374|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20363375|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20363376|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363377|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363378|NCT00941096|Timolol|timolol|mesh-list
20363379|NCT00941096|Bimatoprost|bimatoprost|mesh-list
19297804|NCT04218734|Metformin|metformin|mesh-list
19297805|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19297806|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297807|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
19297808|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19297809|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297810|NCT04218149|Bupivacaine|bupivacaine|mesh-list
19297811|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
19297812|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
20363380|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20363381|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20363382|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
20363383|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363384|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363385|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363386|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20363387|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20363388|NCT00941109|Decitabine|decitabine|mesh-list
20363389|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363390|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
20363391|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363392|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363393|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363394|NCT00941135|Docetaxel|docetaxel|mesh-list
20363395|NCT00941135|Cetuximab|cetuximab|mesh-list
20363396|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297813|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297814|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297815|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
19297816|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297817|NCT04218162|Lasmiditan|lasmiditan|mesh-list
19297818|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19297819|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
19297820|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395795|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
20363397|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
20363398|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
20363399|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
20363400|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363401|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20363402|NCT00941148|Insulin|insulin|mesh-list
20363403|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20363404|NCT00941148|Metformin|metformin|mesh-list
20363405|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
20184725|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184726|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184727|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184728|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184729|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20363406|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
20363407|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
20363408|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
20363409|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363410|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363411|NCT00941161|Metformin|metformin|mesh-list
20363412|NCT00941161|Glimepiride|glimepiride|mesh-list
20184730|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184731|NCT00199069|Cytarabine|cytarabine|mesh-list
20184732|NCT00199069|Dexamethasone|dexamethasone|mesh-list
20184733|NCT00199069|Prednisolone|prednisolone|mesh-list
20184734|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
19297821|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297822|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395796|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395797|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19395798|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404301|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404302|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
19404303|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363413|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363414|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363415|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20363416|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363417|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
20363418|NCT00941174|Leucovorin|leucovorin|mesh-list
20363419|NCT00941174|Calcium|calcium|mesh-list
20363420|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
20363421|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20363422|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404304|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404305|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19404306|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404307|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
19404308|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19404309|NCT03595852|Cefazolin|cefazolin|mesh-list
19404310|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19404311|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404312|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
19404313|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19404314|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404315|NCT03595514|Dexamethasone|dexamethasone|mesh-list
19404316|NCT03595514|Lidocaine|lidocaine|mesh-list
19404317|NCT03595514|Epinephrine|epinephrine|mesh-list
19404318|NCT03595514|Bupivacaine|bupivacaine|mesh-list
19404319|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404320|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
19404321|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
19404322|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404323|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404324|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404325|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
19404326|NCT03595514|Hormones|hormones|mesh-ancestor
20184735|NCT00199069|Ifosfamide|ifosfamide|mesh-list
20184736|NCT00199069|Methotrexate|methotrexate|mesh-list
20184737|NCT00199069|Vincristine|vincristine|mesh-list
20184738|NCT00199069|Doxorubicin|doxorubicin|mesh-list
20184739|NCT00199069|Daunorubicin|daunorubicin|mesh-list
20184740|NCT00199069|Asparaginase|asparaginase|mesh-list
20184741|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
20184742|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
19404801|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20184743|NCT00199069|Thioguanine|thioguanine|mesh-list
19404802|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19404803|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19404804|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20363423|NCT00941174|Antidotes|antidotes|mesh-ancestor
20363424|NCT00941174|Protective Agents|protective agents|mesh-ancestor
20363425|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
19671931|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19671932|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19671933|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
19671934|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297823|NCT04217733|Ethosuximide|ethosuximide|mesh-list
19297824|NCT04217733|Mebeverine|mebeverine|mesh-list
19297825|NCT04217733|Alverine|alverine|mesh-list
19297826|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
19297827|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
19297828|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
19297829|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297830|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297831|NCT04217798|Etoposide|etoposide|mesh-list
19297832|NCT04217798|Niraparib|niraparib|mesh-list
19297833|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19297834|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297835|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19297836|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19297837|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297838|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297839|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19297840|NCT04217668|Isosorbide|isosorbide|mesh-list
19297841|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19297842|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19297843|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19297844|NCT04217668|Diuretics|diuretics|mesh-ancestor
19297845|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
19297846|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297847|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
19297848|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19297849|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297850|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19297851|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19297852|NCT04217265|Letrozole|letrozole|mesh-list
19297853|NCT04217265|Misoprostol|misoprostol|mesh-list
19297854|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297855|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19297856|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20363426|NCT00941174|Vitamins|vitamins|mesh-ancestor
20363427|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
20363428|NCT00941239|Metformin|metformin|mesh-list
20363429|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363430|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297857|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297858|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297859|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19297860|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
19297861|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297862|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297863|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19297864|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
19297865|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19297866|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19297867|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19297868|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
19297869|NCT04217447|Aspirin|aspirin|mesh-list
19297870|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19297871|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19297872|NCT04217447|Analgesics|analgesics|mesh-ancestor
19297873|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
19297874|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297875|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363431|NCT00941252|Imiquimod|imiquimod|mesh-list
20363432|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20363433|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
20363434|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363435|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363436|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
20363437|NCT00941265|Levodopa|levodopa|mesh-list
19297876|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19297877|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297878|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19297879|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19297880|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297881|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20363438|NCT00941265|Benserazide|benserazide|mesh-list
20363439|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20363440|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20363441|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
20363442|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363443|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363444|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363445|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363446|NCT00941343|Alfuzosin|alfuzosin|mesh-list
20363447|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20363448|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19297882|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19297883|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297884|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
19297885|NCT04217421|Allopurinol|allopurinol|mesh-list
19297886|NCT04217421|Mannitol|mannitol|mesh-list
19297887|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
19297888|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297889|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297890|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
19297891|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19297892|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19297893|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
19297894|NCT04217421|Protective Agents|protective agents|mesh-ancestor
19297895|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297896|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19297897|NCT04217421|Diuretics|diuretics|mesh-ancestor
19297898|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
19297899|NCT04217512|Pantoprazole|pantoprazole|mesh-list
19297900|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19297901|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19297902|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19297903|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297904|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297905|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
19297906|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297907|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
19297908|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297909|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297910|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19297911|NCT04217148|Dexamethasone|dexamethasone|mesh-list
19297912|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
19297913|NCT04217148|Tretinoin|tretinoin|mesh-list
19297914|NCT04217148|BB 1101|bb 1101|mesh-list
19297915|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19297916|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
19297917|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
19297918|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297919|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297920|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19297921|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
19297922|NCT04217148|Hormones|hormones|mesh-ancestor
19297923|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19297924|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19297925|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297926|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
19297927|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19297928|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297929|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
19297930|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
19297931|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
19297932|NCT04216836|Antacids|antacids|mesh-ancestor
19297933|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297934|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20363449|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20363450|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
20363451|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363452|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363453|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363454|NCT00941343|Urological Agents|urological agents|mesh-ancestor
20363455|NCT00941369|Insulin|insulin|mesh-list
20363456|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
20363457|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
19297935|NCT04217096|Paclitaxel|paclitaxel|mesh-list
19297936|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19297937|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297938|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
19297939|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
19297940|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297941|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297942|NCT04216758|Gemcitabine|gemcitabine|mesh-list
19297943|NCT04216758|Paclitaxel|paclitaxel|mesh-list
19297944|NCT04216758|Tegafur|tegafur|mesh-list
20363458|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
20363459|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
20363460|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363461|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363462|NCT00941382|Metformin|metformin|mesh-list
20363463|NCT00941382|Sibutramine|sibutramine|mesh-list
20363464|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363465|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363466|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
20363467|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19297945|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19297946|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19297947|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
19297948|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
19297949|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
19297950|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297951|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363468|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
20363469|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20363470|NCT00941460|Temozolomide|temozolomide|mesh-list
20363471|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20363472|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
20363473|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363474|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363475|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20363476|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20363477|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
20363478|NCT00941473|Hormones|hormones|mesh-ancestor
20363479|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20363480|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363481|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363482|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
20363483|NCT00941499|Leucovorin|leucovorin|mesh-list
20363484|NCT00941499|Bevacizumab|bevacizumab|mesh-list
20363485|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20363486|NCT00941499|Cetuximab|cetuximab|mesh-list
20363487|NCT00941499|Fluorouracil|fluorouracil|mesh-list
20363488|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
20363489|NCT00941499|Antibodies|antibodies|mesh-list
20363490|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
20363491|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20363492|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363493|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20363494|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20363495|NCT00941499|Growth Substances|growth substances|mesh-ancestor
20363496|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363497|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
20363498|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
20363499|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
20363500|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363501|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363502|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363503|NCT00941499|Antidotes|antidotes|mesh-ancestor
20363504|NCT00941499|Protective Agents|protective agents|mesh-ancestor
20363505|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
20363506|NCT00941499|Vitamins|vitamins|mesh-ancestor
20363507|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
20363508|NCT00941525|Latanoprost|latanoprost|mesh-list
20363509|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20363510|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20425394|NCT01274624|Bevacizumab|bevacizumab|mesh-list
20425395|NCT01274624|Fluorouracil|fluorouracil|mesh-list
20425396|NCT01274624|Irinotecan|irinotecan|mesh-list
20425397|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20425398|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425399|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20425400|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20425401|NCT01274624|Growth Substances|growth substances|mesh-ancestor
19297952|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
20425402|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425403|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
20425404|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
19297953|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
19297954|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19297955|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363511|NCT00941616|Factor VIII|factor viii|mesh-list
20363512|NCT00941616|Coagulants|coagulants|mesh-ancestor
19297956|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19297957|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
19297958|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297959|NCT04216784|Furosemide|furosemide|mesh-list
19297960|NCT04216784|Diuretics|diuretics|mesh-ancestor
19297961|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
19297962|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297963|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19297964|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297965|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297966|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
19297967|NCT04216706|Sympatholytics|sympatholytics|mesh-list
19297968|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19297969|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297970|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19297971|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297972|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
19297973|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297974|NCT04216888|Ketamine|ketamine|mesh-list
19297975|NCT04216888|Analgesics|analgesics|mesh-ancestor
19297976|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
19297977|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19297978|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297979|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19297980|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19297981|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
19297982|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
19297983|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19297984|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19297985|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19297986|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19297987|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297988|NCT04216628|Oxytocin|oxytocin|mesh-list
19297989|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
19297990|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19297991|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297992|NCT04216693|Digoxin|digoxin|mesh-list
19297993|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19297994|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19297995|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363513|NCT00941785|Amodiaquine|amodiaquine|mesh-list
20363514|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
20363515|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20363516|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20363517|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363518|NCT00941811|Imiquimod|imiquimod|mesh-list
20363519|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20363520|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
20363521|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363522|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363523|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
20363524|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
20363525|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20363526|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363527|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20363528|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
20363529|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20363530|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363531|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363532|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297996|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19297997|NCT04216693|Protective Agents|protective agents|mesh-ancestor
19297998|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19297999|NCT04216511|Autoantibodies|autoantibodies|mesh-list
19298000|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
19298001|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298002|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
20363533|NCT00941967|Gemcitabine|gemcitabine|mesh-list
19298003|NCT04216459|Ascorbic Acid|ascorbic acid|mesh-list
20363534|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
20363535|NCT00941967|Sorafenib|sorafenib|mesh-list
19298004|NCT04216459|Thiamine|thiamine|mesh-list
19298005|NCT04216459|Vitamins|vitamins|mesh-ancestor
19298006|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
19298007|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298008|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19298009|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19298010|NCT04216459|Antioxidants|antioxidants|mesh-ancestor
19298011|NCT04216459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298012|NCT04216459|Protective Agents|protective agents|mesh-ancestor
19298013|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
19298014|NCT04216355|Azacitidine|azacitidine|mesh-list
19298015|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298016|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
19298017|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298018|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298019|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298020|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19298021|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19298022|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19298023|NCT04216771|Cytarabine|cytarabine|mesh-list
19298024|NCT04216771|Idarubicin|idarubicin|mesh-list
19298025|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298026|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
19298027|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184744|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184745|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
20184746|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184747|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184748|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184749|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
20184750|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184751|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184752|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184753|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184754|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
20184755|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
20184756|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184757|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184758|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
20184759|NCT00199069|Hormones|hormones|mesh-ancestor
20184760|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184761|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184762|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19298028|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298029|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
19298030|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298031|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298032|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
19298033|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298034|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19298035|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298036|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298037|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298038|NCT04216550|Apatinib|apatinib|mesh-list
19298039|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298040|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19298041|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298042|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298043|NCT04216472|Paclitaxel|paclitaxel|mesh-list
19298044|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19298045|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
20184763|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184764|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20184765|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184766|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
20184767|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184768|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184769|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184770|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184771|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
20184772|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184773|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184774|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298046|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298047|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298048|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298049|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298050|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20363536|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363537|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
20363538|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363539|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363540|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
20363541|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363542|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363543|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363544|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
20363545|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363546|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363547|NCT00942006|Doxycycline|doxycycline|mesh-list
20363548|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
20363549|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20363550|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363551|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
20363552|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20363553|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20363554|NCT00942136|Dolutegravir|dolutegravir|mesh-list
20363555|NCT00942136|Omeprazole|omeprazole|mesh-list
20363556|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20363557|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20363558|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20363559|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298051|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671935|NCT01593241|Carboplatin|carboplatin|mesh-list
19671936|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363560|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363561|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20363562|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20363563|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20363564|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20363565|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
20363566|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363567|NCT00942201|Dexamethasone|dexamethasone|mesh-list
20363568|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
19298052|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395799|NCT03664622|Ketamine|ketamine|mesh-list
19395800|NCT03664622|Morphine|morphine|mesh-list
19395801|NCT03664622|Analgesics|analgesics|mesh-ancestor
19395802|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
19395803|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395804|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395805|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19395806|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19395807|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
19395808|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
19395809|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395810|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19395811|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19395812|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395813|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395814|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19395815|NCT03664622|Narcotics|narcotics|mesh-ancestor
19395816|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19395817|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19395818|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395819|NCT03664440|Nevirapine|nevirapine|mesh-list
19395820|NCT03664440|Rilpivirine|rilpivirine|mesh-list
19395821|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19395822|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19671937|NCT01515527|Cytarabine|cytarabine|mesh-list
19671938|NCT01515527|Decitabine|decitabine|mesh-list
19671939|NCT01515527|Cladribine|cladribine|mesh-list
19671940|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19671941|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
20363569|NCT00942201|BB 1101|bb 1101|mesh-list
19671942|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363570|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20363571|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
20363572|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
19671943|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298053|NCT04216186|Ubiquinone|ubiquinone|mesh-list
19298054|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
19298055|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19298056|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20184775|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184776|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298057|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19298058|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19298059|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298060|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
19298061|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298062|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298063|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
19298064|NCT04216186|Vitamins|vitamins|mesh-ancestor
19298065|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
19298066|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20363573|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363574|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363575|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20363576|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
20363577|NCT00942201|Hormones|hormones|mesh-ancestor
20363578|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20363579|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20363580|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363581|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
20363582|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298067|NCT04215653|Rabeprazole|rabeprazole|mesh-list
19671944|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
19671945|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671946|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184777|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184778|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184779|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20612636|NCT02252367|Tadalafil|tadalafil|mesh-list
19671947|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
19671948|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671949|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671950|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19671951|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19671952|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671953|NCT01097746|Paclitaxel|paclitaxel|mesh-list
19671954|NCT01097746|Bevacizumab|bevacizumab|mesh-list
19671955|NCT01097746|Carboplatin|carboplatin|mesh-list
19671956|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20363583|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363584|NCT00942214|Natalizumab|natalizumab|mesh-list
20363585|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
19298068|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19298069|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19298070|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19298071|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298072|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298073|NCT04215731|Leucovorin|leucovorin|mesh-list
19298074|NCT04215731|Bevacizumab|bevacizumab|mesh-list
19298075|NCT04215731|Fluorouracil|fluorouracil|mesh-list
19298076|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
19298077|NCT04215731|Irinotecan|irinotecan|mesh-list
19298078|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
19298079|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298080|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298081|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19298082|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19298083|NCT04215731|Growth Substances|growth substances|mesh-ancestor
19298084|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671957|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20184780|NCT00199069|Analgesics|analgesics|mesh-ancestor
20184781|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
20184782|NCT00199082|Cytarabine|cytarabine|mesh-list
20184783|NCT00199082|Dexamethasone|dexamethasone|mesh-list
20184784|NCT00199082|Prednisolone|prednisolone|mesh-list
20184785|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
20184786|NCT00199082|Ifosfamide|ifosfamide|mesh-list
20184787|NCT00199082|Rituximab|rituximab|mesh-list
20184788|NCT00199082|Methotrexate|methotrexate|mesh-list
20184789|NCT00199082|Vincristine|vincristine|mesh-list
19298085|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
20184790|NCT00199082|Doxorubicin|doxorubicin|mesh-list
20184791|NCT00199082|Vindesine|vindesine|mesh-list
20363586|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363587|NCT00942253|Dopamine|dopamine|mesh-list
20363588|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
20363589|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20363590|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
20363591|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
20363592|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363593|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363594|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
19298086|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
19298087|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298088|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298089|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298090|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
19298091|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19298092|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298093|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298094|NCT04215731|Antidotes|antidotes|mesh-ancestor
19298095|NCT04215731|Protective Agents|protective agents|mesh-ancestor
19298096|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
19298097|NCT04215731|Vitamins|vitamins|mesh-ancestor
19298098|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
19298099|NCT04215614|Lidocaine|lidocaine|mesh-list
19298100|NCT04215614|Bupivacaine|bupivacaine|mesh-list
19298101|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
19298102|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
19298103|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298104|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298105|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
19298106|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298107|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19298108|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19298109|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19298110|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19298111|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298112|NCT04215588|Hemostatics|hemostatics|mesh-list
19298113|NCT04215588|Coagulants|coagulants|mesh-ancestor
19298114|NCT04215835|Letrozole|letrozole|mesh-list
19298115|NCT04215835|Misoprostol|misoprostol|mesh-list
19298116|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298117|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19298118|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19298119|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184792|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298120|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298121|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19298122|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
19298123|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298124|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298125|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19298126|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
19298127|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19298128|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19298129|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184793|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
20184794|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184795|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184796|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184797|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
20184798|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184799|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184800|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184801|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20184802|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184803|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
20184804|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
20184805|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184806|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184807|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
20184808|NCT00199082|Hormones|hormones|mesh-ancestor
20184809|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184810|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20363595|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363596|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298130|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
19298131|NCT04215770|Penicillins|penicillins|mesh-list
19298132|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19298133|NCT04215770|Penicillin G|penicillin g|mesh-list
19298134|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19298135|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
19298136|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20184811|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184812|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184813|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20363597|NCT00942253|Protective Agents|protective agents|mesh-ancestor
20363598|NCT00942318|Insulin|insulin|mesh-list
20363599|NCT00942318|Metformin|metformin|mesh-list
20363600|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
19298137|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298138|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19298139|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298140|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298141|NCT04215536|Empagliflozin|empagliflozin|mesh-list
19298142|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19298143|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19298144|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298145|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19298146|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298147|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
19298148|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298149|NCT04215471|Antibodies|antibodies|mesh-list
19298150|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
19298151|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
19298152|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298153|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19298154|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19298155|NCT04215159|Gemcitabine|gemcitabine|mesh-list
19298156|NCT04215159|Trastuzumab|trastuzumab|mesh-list
19298157|NCT04215159|Irinotecan|irinotecan|mesh-list
19298158|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298159|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
19298160|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298161|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298162|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
19298163|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298164|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298165|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298166|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
19298167|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298168|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298169|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19298170|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298171|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
19298172|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19298173|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19298174|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298175|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19298176|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298177|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
19298178|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298179|NCT04215445|Empagliflozin|empagliflozin|mesh-list
19298180|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19298181|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298182|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19298183|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298184|NCT04215432|Propolis|propolis|mesh-list
19298185|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671958|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
19671959|NCT01097746|Antibodies|antibodies|mesh-list
19671960|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
20184814|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184815|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
20184816|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184817|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184818|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184819|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19298186|NCT04215237|Atorvastatin|atorvastatin|mesh-list
19671961|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19671962|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
20363601|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363602|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363603|NCT00942344|Losartan|losartan|mesh-list
20363604|NCT00942344|Amlodipine|amlodipine|mesh-list
20363605|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20363606|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20363607|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363608|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363609|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20363610|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363611|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
20363612|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20363613|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20363614|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20363615|NCT00942435|Darexaban|darexaban|mesh-list
20363616|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20363617|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
20363618|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20363619|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
20363620|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363621|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363622|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
19671963|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671964|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671965|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184820|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
20184821|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184822|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184823|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184824|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184825|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184826|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184827|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184828|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184829|NCT00199095|Cytarabine|cytarabine|mesh-list
20184830|NCT00199095|Dexamethasone|dexamethasone|mesh-list
20184831|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
20363623|NCT00942487|Nebivolol|nebivolol|mesh-list
19298187|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19298188|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19298189|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
19671966|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
19671967|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
19671968|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671969|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19671970|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19298190|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298191|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19298192|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19298193|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298194|NCT04214938|Lidocaine|lidocaine|mesh-list
19298195|NCT04214938|Xylometazoline|xylometazoline|mesh-list
19298196|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
19298197|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
19298198|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298199|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298200|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
19298201|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298202|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19298203|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19298204|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19298205|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19298206|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298207|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
19298208|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19298209|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
19298210|NCT04214990|Aspirin|aspirin|mesh-list
19298211|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19298212|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19298213|NCT04214990|Analgesics|analgesics|mesh-ancestor
19298214|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
19395823|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184832|NCT00199095|Ifosfamide|ifosfamide|mesh-list
20184833|NCT00199095|Methotrexate|methotrexate|mesh-list
19298215|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298216|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298217|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298218|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363624|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20363625|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
20363626|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20363627|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20363628|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20363629|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
20363630|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363631|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363632|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363633|NCT00942526|Nystatin|nystatin|mesh-list
20363634|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20363635|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363636|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
20363637|NCT00942526|Ionophores|ionophores|mesh-ancestor
20363638|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363639|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363640|NCT00942539|Midazolam|midazolam|mesh-list
20363641|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19298219|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19298220|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19298221|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298222|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19298223|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19298224|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298225|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
19298226|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
19298227|NCT04214886|Fludarabine|fludarabine|mesh-list
19298228|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298229|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
19298230|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298231|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404805|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
20184834|NCT00199095|Vincristine|vincristine|mesh-list
20184835|NCT00199095|Doxorubicin|doxorubicin|mesh-list
20184836|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
20184837|NCT00199095|Idarubicin|idarubicin|mesh-list
20184838|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184839|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
20184840|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184841|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184842|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184843|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
20184844|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184845|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184846|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184847|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184848|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
20184849|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
20184850|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184851|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184852|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
20184853|NCT00199095|Hormones|hormones|mesh-ancestor
20184854|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184855|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184856|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184857|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184858|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20184859|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184860|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
20184861|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184862|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184863|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184864|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184865|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
20184866|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184867|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184868|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184869|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184870|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298232|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19298233|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
19671971|NCT01097746|Growth Substances|growth substances|mesh-ancestor
19671972|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671973|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
19671974|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
19671975|NCT00307242|Adefovir|adefovir|mesh-list
19671976|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19671977|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
19671978|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19671979|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20363642|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20363643|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20363644|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363645|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20363646|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20363647|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20363648|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20363649|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
20363650|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
20363651|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
20363652|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
20363653|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363654|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671980|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19671981|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19671982|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19671983|NCT05120687|Cyclosporine|cyclosporine|mesh-list
19671984|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
19671985|NCT05120687|Adalimumab|adalimumab|mesh-list
19671986|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
19671987|NCT05120687|Methotrexate|methotrexate|mesh-list
19671988|NCT05120687|Cyclosporins|cyclosporins|mesh-list
19671989|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363655|NCT00942565|Acetaminophen|acetaminophen|mesh-list
20363656|NCT00942565|Tramadol|tramadol|mesh-list
20363657|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20363658|NCT00942565|Analgesics|analgesics|mesh-ancestor
20363659|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
20363660|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363661|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363662|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
19298234|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298235|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298236|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19298237|NCT04214977|Anesthetics|anesthetics|mesh-list
19298238|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298239|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298240|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
19298241|NCT04214821|Levofloxacin|levofloxacin|mesh-list
19298242|NCT04214821|Ofloxacin|ofloxacin|mesh-list
19298243|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20363663|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20363664|NCT00942565|Narcotics|narcotics|mesh-ancestor
20363665|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20363666|NCT00942591|Interferons|interferons|mesh-list
20363667|NCT00942591|Interferon-beta|interferon-beta|mesh-list
20363668|NCT00942591|Atorvastatin|atorvastatin|mesh-list
20363669|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
20363670|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612637|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
19298244|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19298245|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19298246|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298247|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298248|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298249|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298250|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298251|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298252|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19298253|NCT04214821|Renal Agents|renal agents|mesh-ancestor
19671990|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
19671991|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19671992|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363671|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
20363672|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298254|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20428569|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
19298255|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19298256|NCT04214808|Dutasteride|dutasteride|mesh-list
19671993|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19671994|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
19671995|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298257|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19298258|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19298259|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298260|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298261|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
19298262|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19671996|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19671997|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19671998|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19298263|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363673|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20363674|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20363675|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
20363676|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612638|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19298264|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
19298265|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
19298266|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298267|NCT04214665|Protective Agents|protective agents|mesh-ancestor
19298268|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298269|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
19298270|NCT04214665|Vitamins|vitamins|mesh-ancestor
19298271|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
19298272|NCT04214834|Morphine|morphine|mesh-list
19298273|NCT04214834|Methadone|methadone|mesh-list
19298274|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19298275|NCT04214834|Narcotics|narcotics|mesh-ancestor
19298276|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298277|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298278|NCT04214834|Analgesics|analgesics|mesh-ancestor
19298279|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
19298280|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298281|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
19298282|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
19298283|NCT04214626|Prednisone|prednisone|mesh-list
19298284|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
19298285|NCT04214626|Rituximab|rituximab|mesh-list
19298286|NCT04214626|Methotrexate|methotrexate|mesh-list
19298287|NCT04214626|Vincristine|vincristine|mesh-list
19298288|NCT04214626|Lenalidomide|lenalidomide|mesh-list
19298289|NCT04214626|Epirubicin|epirubicin|mesh-list
19298290|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298291|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
19298292|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298293|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19298294|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19298295|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
19298296|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298297|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298298|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19298299|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298300|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298301|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
19298302|NCT04214626|Hormones|hormones|mesh-ancestor
19298303|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298304|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19298305|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19298306|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
19298307|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19298308|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298309|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
19298310|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
19298311|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298312|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19298313|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19298314|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19671999|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
19672000|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20612639|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19298315|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298316|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298317|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298318|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19298319|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19298320|NCT04214626|Growth Substances|growth substances|mesh-ancestor
19298321|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
19298322|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19298323|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298324|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298325|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19298326|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19298327|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
19298328|NCT04214678|Hormones|hormones|mesh-ancestor
19298329|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298330|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298331|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298332|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298333|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19298334|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19298335|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395824|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395825|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
19395826|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395827|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19395828|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19395829|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19395830|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19395831|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
19395832|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19395833|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395834|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395835|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19395836|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19395837|NCT03664414|Protective Agents|protective agents|mesh-ancestor
19395838|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395839|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395840|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19395841|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
19395842|NCT03664388|Clopidogrel|clopidogrel|mesh-list
19395843|NCT03664388|Ticagrelor|ticagrelor|mesh-list
19395844|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19395845|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19395846|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19395847|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19395848|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
19395849|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395850|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395851|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395852|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
19395853|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19395854|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19395855|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19395856|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395857|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395858|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
19395859|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395860|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395861|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19395862|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395863|NCT03664115|Itraconazole|itraconazole|mesh-list
19395864|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
19395865|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395866|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19395867|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19395868|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395869|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395870|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19395871|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
19395872|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395873|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363677|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20363678|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20363679|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363680|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
20363681|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363682|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20363683|NCT00942617|Aspirin|aspirin|mesh-list
20363684|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20363685|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19298336|NCT04214145|Phenylephrine|phenylephrine|mesh-list
19298337|NCT04214145|Vasopressins|vasopressins|mesh-list
19298338|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
19298339|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
19298340|NCT04214145|Norepinephrine|norepinephrine|mesh-list
19298341|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19298342|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
19298343|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
19298344|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298345|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298346|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
19298347|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19298348|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
19298349|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
19298350|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19298351|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19298352|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19298353|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
19298354|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298355|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298356|NCT04214145|Protective Agents|protective agents|mesh-ancestor
19298357|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
19298358|NCT04214145|Coagulants|coagulants|mesh-ancestor
19298359|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19298360|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
19298361|NCT04214444|Vaccines|vaccines|mesh-list
19298362|NCT04214444|Immunologic Factors|immunologic factors|mesh-ancestor
19298363|NCT04214444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298364|NCT04214106|Thiamine|thiamine|mesh-list
19298365|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
19298366|NCT04214106|Vitamins|vitamins|mesh-ancestor
19298367|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
19298368|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298369|NCT04213924|Ibuprofen|ibuprofen|mesh-list
20363686|NCT00942617|Analgesics|analgesics|mesh-ancestor
20363687|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
20363688|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363689|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363690|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20363691|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363692|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19298370|NCT04213924|Lidocaine|lidocaine|mesh-list
19298371|NCT04213924|Bupivacaine|bupivacaine|mesh-list
19672001|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672002|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
20363693|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20363694|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363695|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20363696|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19298372|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
19298373|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
19298374|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298375|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298376|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
19298377|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298378|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19298379|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19298380|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20612640|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298381|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19298382|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298383|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19298384|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19298385|NCT04213924|Analgesics|analgesics|mesh-ancestor
19672003|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
19298386|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298387|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363697|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363698|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
20363699|NCT00942682|Sorafenib|sorafenib|mesh-list
20363700|NCT00942682|Everolimus|everolimus|mesh-list
20363701|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363702|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363703|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363704|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363705|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363706|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
20363707|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363708|NCT00942747|Sirolimus|sirolimus|mesh-list
20363709|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20363710|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363711|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20363712|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363713|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
20363714|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363715|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
20363716|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298388|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19298389|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298390|NCT04213937|Paclitaxel|paclitaxel|mesh-list
19298391|NCT04213937|Topotecan|topotecan|mesh-list
19298392|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298393|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298394|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298395|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298396|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298397|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298398|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19298399|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298400|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298401|NCT04214054|Calcium|calcium|mesh-list
19298402|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19298403|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298404|NCT04213898|Paclitaxel|paclitaxel|mesh-list
19298405|NCT04213898|Epirubicin|epirubicin|mesh-list
19298406|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19298407|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298408|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298409|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298410|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298411|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298412|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298413|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19298414|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298415|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298416|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298417|NCT04213833|Lidocaine|lidocaine|mesh-list
19298418|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
19298419|NCT04213833|Propofol|propofol|mesh-list
19298420|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
19298421|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
19298422|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298423|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298424|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
19298425|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298426|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19298427|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19298428|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19298429|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19298430|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363717|NCT00942773|Voriconazole|voriconazole|mesh-list
20363718|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
20363719|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363720|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20363721|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20363722|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363723|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363724|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20363725|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
20363726|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298431|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19298432|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19298433|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
19298434|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19298435|NCT04213833|Analgesics|analgesics|mesh-ancestor
19298436|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20363727|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363728|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20363729|NCT00942838|Cisplatin|cisplatin|mesh-list
20363730|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363731|NCT00942864|Ranibizumab|ranibizumab|mesh-list
20363732|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20363733|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20363734|NCT00942864|Growth Substances|growth substances|mesh-ancestor
20363735|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363736|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
20363737|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363738|NCT00943059|Acipimox|acipimox|mesh-list
20363739|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20363740|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
20363741|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363742|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20363743|NCT00943137|Fluorouracil|fluorouracil|mesh-list
20363744|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
20363745|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363746|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20363747|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363748|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363749|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
20363750|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363751|NCT00943176|Modafinil|modafinil|mesh-list
19298437|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19298438|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19298439|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
19298440|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298441|NCT04213781|Sufentanil|sufentanil|mesh-list
19298442|NCT04213781|Propofol|propofol|mesh-list
19298443|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19298444|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298445|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298446|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19298447|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
19298448|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
19298449|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19298450|NCT04213781|Narcotics|narcotics|mesh-ancestor
19298451|NCT04213781|Analgesics|analgesics|mesh-ancestor
19298452|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
19298453|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298454|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19298455|NCT04213885|Riboflavin|riboflavin|mesh-list
19298456|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
19298457|NCT04213885|Vitamins|vitamins|mesh-ancestor
19298458|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
19298459|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298460|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19298461|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
19298462|NCT04213378|Paclitaxel|paclitaxel|mesh-list
19298463|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19298464|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298465|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298466|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298467|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298468|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298469|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298470|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
19298471|NCT04213716|Calcium|calcium|mesh-list
19298472|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19298473|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298474|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19298475|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
19298476|NCT04213612|Doxorubicin|doxorubicin|mesh-list
19298477|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20363752|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20363753|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298478|NCT04213612|Vincristine|vincristine|mesh-list
19298479|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298480|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
19672004|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363754|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20363755|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20363756|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20363757|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363758|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
20363759|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20363760|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363761|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20363762|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
20363763|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20363764|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298481|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298482|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19298483|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19298484|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
19298485|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298486|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298487|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19298488|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19298489|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298490|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298491|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298492|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298493|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298494|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298495|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298496|NCT04213495|Anesthetics|anesthetics|mesh-list
19298497|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298498|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298499|NCT04213170|Bevacizumab|bevacizumab|mesh-list
19298500|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298501|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298502|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19298503|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19298504|NCT04213170|Growth Substances|growth substances|mesh-ancestor
19298505|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298506|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
19298507|NCT04213573|Fluorides|fluorides|mesh-list
19298508|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
19298509|NCT04213573|Protective Agents|protective agents|mesh-ancestor
19298510|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298511|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19298512|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298513|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19298514|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19298515|NCT04213287|Analgesics|analgesics|mesh-ancestor
19298516|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
19298517|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298518|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298519|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19298520|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19298521|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298522|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298523|NCT04213391|Sulforaphane|sulforaphane|mesh-list
19298524|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19298525|NCT04213391|Protective Agents|protective agents|mesh-ancestor
19298526|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298527|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298528|NCT04213222|Bevacizumab|bevacizumab|mesh-list
19298529|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298530|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298531|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19298532|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19298533|NCT04213222|Growth Substances|growth substances|mesh-ancestor
19298534|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298535|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
19298536|NCT04213105|Denosumab|denosumab|mesh-list
19298537|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19298538|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298539|NCT04212793|Bevacizumab|bevacizumab|mesh-list
20363765|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298540|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672005|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19298541|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298542|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19298543|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19298544|NCT04212793|Growth Substances|growth substances|mesh-ancestor
19298545|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672006|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19672007|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
19672008|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672009|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19672010|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19672011|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19672012|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
19672013|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19672014|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672015|NCT05120622|Tremelimumab|tremelimumab|mesh-list
19672016|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672017|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
19672018|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672019|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184871|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184872|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298546|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
19298547|NCT04212832|Bupivacaine|bupivacaine|mesh-list
19298548|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
19298549|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
19298550|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298551|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298552|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
19298553|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298554|NCT04212845|Dexamethasone|dexamethasone|mesh-list
19298555|NCT04212845|Bupivacaine|bupivacaine|mesh-list
19298556|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298557|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
19298558|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
19298559|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298560|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298561|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19298562|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
19298563|NCT04212845|Hormones|hormones|mesh-ancestor
20184873|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184874|NCT00199108|Dexamethasone|dexamethasone|mesh-list
20184875|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184876|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
20184877|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
19298564|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298565|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19298566|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298567|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
19298568|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
19298569|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298570|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
19298571|NCT04212702|Everolimus|everolimus|mesh-list
19298572|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363766|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363767|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20363768|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363769|NCT00943293|Fludarabine|fludarabine|mesh-list
19298573|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298574|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
19298575|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395874|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19395875|NCT03664063|Azithromycin|azithromycin|mesh-list
19395876|NCT03664063|Ivermectin|ivermectin|mesh-list
19395877|NCT03664063|Albendazole|albendazole|mesh-list
19395878|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
19395879|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19395880|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395881|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19395882|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
20184878|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184879|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184880|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19395883|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
19395884|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19395885|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20184881|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
20184882|NCT00199108|Hormones|hormones|mesh-ancestor
20363770|NCT00943293|Melphalan|melphalan|mesh-list
20363771|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
20363772|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363773|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363774|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363775|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
20363776|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363777|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20363778|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
19298576|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
19298577|NCT04212429|Levofloxacin|levofloxacin|mesh-list
19298578|NCT04212429|Ofloxacin|ofloxacin|mesh-list
19298579|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19298580|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19298581|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19298582|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298583|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298584|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298585|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298586|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298587|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298588|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19298589|NCT04212429|Renal Agents|renal agents|mesh-ancestor
19298590|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19298591|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19298592|NCT04212416|Leflunomide|leflunomide|mesh-list
19298593|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298594|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298595|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298596|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
19298597|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298598|NCT04212650|Losartan|losartan|mesh-list
19298599|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19298600|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19298601|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19298602|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19298603|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298604|NCT04212403|Levofloxacin|levofloxacin|mesh-list
19298605|NCT04212403|Ofloxacin|ofloxacin|mesh-list
19298606|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19298607|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298608|NCT04212403|Renal Agents|renal agents|mesh-ancestor
19298609|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19298610|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298611|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20363779|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20363780|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20363781|NCT00943345|Indomethacin|indomethacin|mesh-list
20363782|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20363783|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20363784|NCT00943345|Analgesics|analgesics|mesh-ancestor
20363785|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
20363786|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363787|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363788|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20363789|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20363790|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
20363791|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
20363792|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20363793|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20363794|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363795|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363796|NCT00943358|Vaccines|vaccines|mesh-list
20363797|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
20363798|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363799|NCT00943410|Trastuzumab|trastuzumab|mesh-list
20363800|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20363801|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363802|NCT00943449|Sorafenib|sorafenib|mesh-list
20363803|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363804|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363805|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298612|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298613|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298614|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298615|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19298616|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19298617|NCT04212533|Vitamin D|vitamin d|mesh-list
19298618|NCT04212533|Vitamins|vitamins|mesh-ancestor
19298619|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
19298620|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298621|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19298622|NCT04211896|Nivolumab|nivolumab|mesh-list
19298623|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298624|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298625|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19298626|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298627|NCT04212026|Nivolumab|nivolumab|mesh-list
19298628|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298629|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298630|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19298631|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298632|NCT04212039|Bupivacaine|bupivacaine|mesh-list
20363806|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363807|NCT00943462|Temozolomide|temozolomide|mesh-list
20363808|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20363809|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
20363810|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363811|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363812|NCT00943501|Liraglutide|liraglutide|mesh-list
20363813|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363814|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363815|NCT00943501|Incretins|incretins|mesh-ancestor
20363816|NCT00943501|Hormones|hormones|mesh-ancestor
20363817|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298633|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
19298634|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
19298635|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298636|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298637|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
19298638|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363818|NCT00943540|Lamivudine|lamivudine|mesh-list
20363819|NCT00943540|Emtricitabine|emtricitabine|mesh-list
20363820|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
20363821|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20363822|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20363823|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20363824|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363825|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363826|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
20363827|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363828|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20363829|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20363830|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19298639|NCT04212078|Levofloxacin|levofloxacin|mesh-list
19298640|NCT04212078|Ofloxacin|ofloxacin|mesh-list
19298641|NCT04212078|Cefuroxime|cefuroxime|mesh-list
19298642|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
19298643|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19298644|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298645|NCT04212078|Renal Agents|renal agents|mesh-ancestor
19298646|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19298647|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298648|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298649|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298650|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298651|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298652|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19298653|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19298654|NCT04211961|Scopolamine|scopolamine|mesh-list
19298655|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19298656|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19298657|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
19298658|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
19298659|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298660|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298661|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19298662|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
19298663|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19298664|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
19298665|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298666|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298667|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19298668|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
19298669|NCT04211987|Cytarabine|cytarabine|mesh-list
19298670|NCT04211987|Methotrexate|methotrexate|mesh-list
19298671|NCT04211987|Etoposide|etoposide|mesh-list
19298672|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298673|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
19298674|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298675|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298676|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
19298677|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298678|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298679|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
19298680|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298681|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298682|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19298683|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19298684|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298685|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19298686|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
19298687|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19298688|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
19298689|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19298690|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19298691|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19298692|NCT04212065|Buprenorphine|buprenorphine|mesh-list
19298693|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19298694|NCT04212065|Narcotics|narcotics|mesh-ancestor
19298695|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298696|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298697|NCT04212065|Analgesics|analgesics|mesh-ancestor
19298698|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
19298699|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363831|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20363832|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20363833|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20363834|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
20363835|NCT00943553|Decitabine|decitabine|mesh-list
20363836|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298700|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19298701|NCT04212000|Ketoconazole|ketoconazole|mesh-list
19298702|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
19298703|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298704|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19298705|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19298706|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298707|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298708|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19298709|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
19298710|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298711|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298712|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19298713|NCT04211805|Tenofovir|tenofovir|mesh-list
19298714|NCT04211805|Vaccines|vaccines|mesh-list
19298715|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
20363837|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
20363838|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298716|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298717|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
19298718|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298719|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19298720|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19298721|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363839|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363840|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363841|NCT00943566|Sufentanil|sufentanil|mesh-list
19298722|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363842|NCT00943566|Morphine|morphine|mesh-list
20363843|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20363844|NCT00943566|Narcotics|narcotics|mesh-ancestor
19298723|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20363845|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20363846|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363847|NCT00943566|Analgesics|analgesics|mesh-ancestor
20363848|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
20363849|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363850|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20363851|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20363852|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
20363853|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
20425405|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425406|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19298724|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19298725|NCT04211558|Ozanimod|ozanimod|mesh-list
19298726|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19298727|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298728|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19298729|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
19298730|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298731|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
19298732|NCT04211844|Ledipasvir|ledipasvir|mesh-list
19298733|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
19298734|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298735|NCT04211545|Rabeprazole|rabeprazole|mesh-list
19298736|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19298737|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425407|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425408|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
20425409|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20425410|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20425411|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298738|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19298739|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298740|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672020|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
19672021|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19672022|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20425412|NCT01274624|Antidotes|antidotes|mesh-ancestor
20425413|NCT01274624|Protective Agents|protective agents|mesh-ancestor
20425414|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
20425415|NCT01274624|Vitamins|vitamins|mesh-ancestor
20425416|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
20425417|NCT01274780|Ritonavir|ritonavir|mesh-list
20425418|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20425419|NCT01274780|Darunavir|darunavir|mesh-list
19672023|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672024|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
19672025|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
19672026|NCT05120076|Dexamethasone|dexamethasone|mesh-list
19672027|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
19672028|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672029|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
19672030|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
19672031|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672032|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672033|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672034|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
20425420|NCT01274780|Tenofovir|tenofovir|mesh-list
20425421|NCT01274780|Emtricitabine|emtricitabine|mesh-list
20425422|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20425423|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20425424|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
20425425|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425426|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425427|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20425428|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20425429|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
20425430|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425431|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20425432|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20425433|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20425434|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19672035|NCT05120076|Hormones|hormones|mesh-ancestor
19672036|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672037|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19672038|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425435|NCT01274793|Mosapride|mosapride|mesh-list
20428570|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19672039|NCT05119712|Terbinafine|terbinafine|mesh-list
19672040|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
19672041|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672042|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672043|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184883|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184884|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184885|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184886|NCT00199121|Zidovudine|zidovudine|mesh-list
20184887|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
20184888|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184889|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20184890|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20363854|NCT00943709|Insulin|insulin|mesh-list
19672044|NCT05119452|Adalimumab|adalimumab|mesh-list
19672045|NCT05119452|Etanercept|etanercept|mesh-list
19298771|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
19298772|NCT04211298|Propofol|propofol|mesh-list
19298773|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19298774|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298775|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298776|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19298777|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
19298778|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
19298779|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19298780|NCT04211298|Analgesics|analgesics|mesh-ancestor
19298781|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
19298782|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298783|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19298784|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19298785|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19298786|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
19298787|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298788|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298789|NCT04211012|Paclitaxel|paclitaxel|mesh-list
19298790|NCT04211012|Cisplatin|cisplatin|mesh-list
19298791|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298792|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298793|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298794|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298795|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
19298796|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298797|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
19298798|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19298799|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395886|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19395887|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395888|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19395889|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395890|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395891|NCT03664063|Filaricides|filaricides|mesh-ancestor
19395892|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
19395893|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19395894|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395895|NCT03664050|Letrozole|letrozole|mesh-list
19395896|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395897|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19395898|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19395899|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395900|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395901|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19395902|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
19395903|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672046|NCT05119452|Golimumab|golimumab|mesh-list
19672047|NCT05119452|Infliximab|infliximab|mesh-list
19672048|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
19672049|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
19672050|NCT05119452|Tofacitinib|tofacitinib|mesh-list
19672051|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672052|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
19672053|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672054|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19672055|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19672056|NCT05119452|Analgesics|analgesics|mesh-ancestor
19672057|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
19298800|NCT04211168|Lenvatinib|lenvatinib|mesh-list
19298801|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298802|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19298803|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298804|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298805|NCT04211090|Carboplatin|carboplatin|mesh-list
19298806|NCT04211090|Pemetrexed|pemetrexed|mesh-list
19298807|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298808|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298809|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298810|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19298811|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19298812|NCT04210713|Minocycline|minocycline|mesh-list
19298813|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19298814|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298815|NCT04210739|Betamethasone|betamethasone|mesh-list
19298816|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
19298817|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19298818|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
19298819|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19298820|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
19298821|NCT04210739|Hormones|hormones|mesh-ancestor
19298822|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298823|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298824|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298825|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19298826|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
19298827|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19298828|NCT04210427|Laxatives|laxatives|mesh-ancestor
19298829|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19298830|NCT04210453|Ascorbic Acid|ascorbic acid|mesh-list
19298831|NCT04210453|Vitamins|vitamins|mesh-ancestor
19298832|NCT04210453|Micronutrients|micronutrients|mesh-ancestor
20363855|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20363856|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
19298833|NCT04210453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298834|NCT04210453|Antioxidants|antioxidants|mesh-ancestor
19298835|NCT04210453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298836|NCT04210453|Protective Agents|protective agents|mesh-ancestor
19298837|NCT04210765|Clomiphene|clomiphene|mesh-list
19298838|NCT04210765|Enclomiphene|enclomiphene|mesh-list
19298839|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
19298840|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20184891|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363857|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19298841|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
19298842|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298843|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298844|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19298845|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
19298846|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19298847|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19298848|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19298849|NCT04210544|Caseins|caseins|mesh-list
19298850|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
19298851|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
19298852|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298853|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
19298854|NCT04209933|Bismuth|bismuth|mesh-list
19298855|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184892|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
20363858|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363859|NCT00943748|Deferiprone|deferiprone|mesh-list
20363860|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20363861|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
20363862|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
19298856|NCT04209933|Antacids|antacids|mesh-ancestor
20184893|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184894|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20184895|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20184896|NCT00199134|Letrozole|letrozole|mesh-list
20184897|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363863|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298857|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19298858|NCT04209933|Diuretics|diuretics|mesh-ancestor
20184898|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20363864|NCT00943839|Sunitinib|sunitinib|mesh-list
19298859|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
19298860|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298861|NCT04209933|Expectorants|expectorants|mesh-ancestor
19298862|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
19298863|NCT04209920|Chromium|chromium|mesh-list
19298864|NCT04209920|Nickel|nickel|mesh-list
19298865|NCT04209920|Trace Elements|trace elements|mesh-ancestor
20363865|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363866|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20363867|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20363868|NCT00943839|Growth Substances|growth substances|mesh-ancestor
20363869|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363870|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
20363871|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363872|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363873|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363874|NCT00943930|Dronabinol|dronabinol|mesh-list
20363875|NCT00943930|Amphetamine|amphetamine|mesh-list
20363876|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
20363877|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20363878|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363879|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
20363880|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
20363881|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363882|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
20363883|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363884|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363885|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
20363886|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20363887|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20363888|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363889|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20363890|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
20363891|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20363892|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20363893|NCT00943930|Analgesics|analgesics|mesh-ancestor
20363894|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
20363895|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20363896|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20363897|NCT00943930|Hormones|hormones|mesh-ancestor
20363898|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20363899|NCT00943943|Plerixafor|plerixafor|mesh-list
20363900|NCT00943943|Sorafenib|sorafenib|mesh-list
20363901|NCT00943943|Sargramostim|sargramostim|mesh-list
19672058|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20363902|NCT00943943|Lenograstim|lenograstim|mesh-list
20363903|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363904|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363905|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298866|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
19298867|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298868|NCT04209699|BMS-986165|bms-986165|mesh-list
19298869|NCT04209699|Famotidine|famotidine|mesh-list
19298870|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19298871|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19298872|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19298873|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
19298874|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
19298875|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298876|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298877|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298878|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
19298879|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19298880|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298881|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19298882|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298883|NCT04209959|Nifekalant|nifekalant|mesh-list
19298884|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19298885|NCT04209803|Minoxidil|minoxidil|mesh-list
19298886|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19298887|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
19298888|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19298889|NCT04209439|Bupivacaine|bupivacaine|mesh-list
19298890|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672059|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298891|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
19298892|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298893|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298894|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
19298895|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298896|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19298897|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19298898|NCT04209439|Analgesics|analgesics|mesh-ancestor
19298899|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298900|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19298901|NCT04209478|Morphine|morphine|mesh-list
19298902|NCT04209478|Tramadol|tramadol|mesh-list
19298903|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19298904|NCT04209478|Narcotics|narcotics|mesh-ancestor
19298905|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298906|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298907|NCT04209478|Analgesics|analgesics|mesh-ancestor
19298908|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
19298909|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298910|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
19298911|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
19298912|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19298913|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298914|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298915|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
19298916|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19298917|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298918|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298919|NCT04209426|Tacrine|tacrine|mesh-list
19298920|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19298921|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19298922|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298923|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
19298924|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298925|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672060|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19672061|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
20363906|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363907|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
20363908|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363909|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20363910|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20363911|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20363912|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
20363913|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363914|NCT00943956|Everolimus|everolimus|mesh-list
20363915|NCT00943956|Leuprolide|leuprolide|mesh-list
20363916|NCT00943956|Bicalutamide|bicalutamide|mesh-list
20363917|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363918|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20363919|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
20184899|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20184900|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184901|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184902|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20184903|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
20184904|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184905|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184906|NCT00199147|Cytarabine|cytarabine|mesh-list
20184907|NCT00199147|Fludarabine|fludarabine|mesh-list
20184908|NCT00199147|Etoposide|etoposide|mesh-list
20184909|NCT00199147|Idarubicin|idarubicin|mesh-list
20184910|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184911|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184912|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
20184913|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184914|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184915|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
20184916|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363920|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363921|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20363922|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
20363923|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20363924|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19298926|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19672062|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20363925|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
20363926|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
20363927|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20363928|NCT00943982|Interferons|interferons|mesh-list
20363929|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
20363930|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20363931|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
20363932|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20363933|NCT00944177|Metformin|metformin|mesh-list
20363934|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363935|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363936|NCT00944242|Sertraline|sertraline|mesh-list
20363937|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
20363938|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20363939|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20363940|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20184917|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184918|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184919|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184920|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184921|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
19298927|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
19298928|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298929|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
19298930|NCT04209218|Dexamethasone|dexamethasone|mesh-list
19298931|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
19298932|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19298933|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
19298934|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
19298935|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298936|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298937|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19298938|NCT04209218|Hormones|hormones|mesh-ancestor
19298939|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19298940|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19298941|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298942|NCT04209166|Norepinephrine|norepinephrine|mesh-list
19298943|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19298944|NCT04209166|Serotonin|serotonin|mesh-list
19298945|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20363941|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20363942|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363943|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363944|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
20363945|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363946|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
20363947|NCT00944307|Antacids|antacids|mesh-list
20363948|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
20363949|NCT00944307|TEMPO|tempo|mesh-list
20363950|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20363951|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19298946|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
19298947|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
19298948|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19298949|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19298950|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19298951|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19298952|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298953|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19298954|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19298955|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19298956|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20184922|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184923|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184924|NCT00199160|Sorafenib|sorafenib|mesh-list
20184925|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184926|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20184927|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184928|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184929|NCT00199186|Cytarabine|cytarabine|mesh-list
20184930|NCT00199186|Dexamethasone|dexamethasone|mesh-list
20184931|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
20363952|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
20363953|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298957|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184932|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
20363954|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20363955|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20363956|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363957|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363958|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20363959|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
20363960|NCT00944307|Protective Agents|protective agents|mesh-ancestor
20363961|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363962|NCT00944333|Clopidogrel|clopidogrel|mesh-list
20363963|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20363964|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20363965|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20363966|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20363967|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
20363968|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20363969|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363970|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363971|NCT00944346|Metformin|metformin|mesh-list
20363972|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20363973|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363974|NCT00944359|Zinc|zinc|mesh-list
20363975|NCT00944359|Trace Elements|trace elements|mesh-ancestor
20363976|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
20363977|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363978|NCT00944385|Urinastatin|urinastatin|mesh-list
20363979|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20363980|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20363981|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
20363982|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20363983|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20363984|NCT00944398|Vitamins|vitamins|mesh-list
19298958|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
19298959|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
19298960|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298961|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19298962|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19298963|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
19298964|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19298965|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19298966|NCT04209075|Metformin|metformin|mesh-list
19298967|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19298968|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298969|NCT04209192|Amikacin|amikacin|mesh-list
19298970|NCT04209192|Fosfomycin|fosfomycin|mesh-list
20363985|NCT00944398|Zinc|zinc|mesh-list
20363986|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
20363987|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
20363988|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
20363989|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363990|NCT00944398|Trace Elements|trace elements|mesh-ancestor
20363991|NCT00944398|Astringents|astringents|mesh-ancestor
20363992|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
20363993|NCT00944424|Vitamin D|vitamin d|mesh-list
20363994|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
20363995|NCT00944424|Vitamins|vitamins|mesh-list
20363996|NCT00944424|Docetaxel|docetaxel|mesh-list
20363997|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
20363998|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20363999|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364000|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
20364001|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
20364002|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
20364003|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298971|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19298972|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298973|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
19298974|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19298975|NCT04208854|Vinorelbine|vinorelbine|mesh-list
19298976|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19298977|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19298978|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
19298979|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
19298980|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
20364004|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20364005|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19298981|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298982|NCT04208776|Propranolol|propranolol|mesh-list
19298983|NCT04208776|Midodrine|midodrine|mesh-list
19298984|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20364006|NCT00944463|Gemcitabine|gemcitabine|mesh-list
20364007|NCT00944463|Simvastatin|simvastatin|mesh-list
20364008|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20364009|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
20364010|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364011|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364012|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
20364013|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364014|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364015|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364016|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
20364017|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364018|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20364019|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20364020|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20364021|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20364022|NCT00944502|Dexamethasone|dexamethasone|mesh-list
20364023|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364024|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
20364025|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
20364026|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364027|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364028|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364029|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
20364030|NCT00944502|Hormones|hormones|mesh-ancestor
20364031|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364032|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20364033|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364034|NCT00944515|Azithromycin|azithromycin|mesh-list
19298985|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19298986|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
19298987|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19298988|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19298989|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19298990|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19298991|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19298992|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
19298993|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
19298994|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
19298995|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19298996|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19298997|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19298998|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19298999|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19299000|NCT04208945|Colistin|colistin|mesh-list
19299001|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299002|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299003|NCT04208958|Vancomycin|vancomycin|mesh-list
19299004|NCT04208958|Nivolumab|nivolumab|mesh-list
19299005|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19299006|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299007|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19299008|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299009|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299010|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299011|NCT04208594|Propranolol|propranolol|mesh-list
19299012|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19299013|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19299014|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299015|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299016|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299017|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299018|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19299019|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19299020|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395904|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395905|NCT03664037|Dexamethasone|dexamethasone|mesh-list
19395906|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19395907|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19395908|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
19395909|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
19395910|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395911|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364035|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20364036|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364037|NCT00944541|Maraviroc|maraviroc|mesh-list
20364038|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19299021|NCT04208555|Terconazole|terconazole|mesh-list
19299022|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
19299023|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299024|NCT04208763|Imipenem|imipenem|mesh-list
19299025|NCT04208763|Colistin|colistin|mesh-list
19299026|NCT04208763|Tigecycline|tigecycline|mesh-list
19299027|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299028|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299029|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19299030|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299031|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299032|NCT04208373|Itraconazole|itraconazole|mesh-list
19299033|NCT04208373|Etravirine|etravirine|mesh-list
19299034|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
19299035|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299036|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19299037|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299038|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299039|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299040|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19299041|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
19299042|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299043|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299044|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19299045|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20184933|NCT00199186|Methotrexate|methotrexate|mesh-list
20184934|NCT00199186|Vincristine|vincristine|mesh-list
20184935|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
20184936|NCT00199186|Idarubicin|idarubicin|mesh-list
20184937|NCT00199186|BB 1101|bb 1101|mesh-list
20184938|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20184939|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
20364039|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20364040|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364041|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20364042|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20364043|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
20364044|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364045|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20364046|NCT00944606|Vitamin D|vitamin d|mesh-list
20364047|NCT00944606|Vitamins|vitamins|mesh-ancestor
20364048|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
20364049|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364050|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20364051|NCT00944619|Insulin|insulin|mesh-list
20364052|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364053|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364054|NCT00944684|Ribavirin|ribavirin|mesh-list
20364055|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
20364056|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364057|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
20184940|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184941|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20184942|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20184943|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
20364058|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299046|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19299047|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
19299048|NCT04208581|Fluticasone|fluticasone|mesh-list
19299049|NCT04208581|Xhance|xhance|mesh-list
19299050|NCT04208581|Budesonide|budesonide|mesh-list
19299051|NCT04208581|Bromides|bromides|mesh-list
19299052|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
19299053|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
19299054|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19299055|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19299056|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299057|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19299058|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
19299059|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364059|NCT00944723|Vitamins|vitamins|mesh-list
19299060|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184944|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364060|NCT00944723|Zinc|zinc|mesh-list
20364061|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
20364062|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
20364063|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
20364064|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364065|NCT00944723|Trace Elements|trace elements|mesh-ancestor
20364066|NCT00944723|Astringents|astringents|mesh-ancestor
20364067|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364068|NCT00944801|Doxorubicin|doxorubicin|mesh-list
20364069|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19299061|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19299062|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
19299063|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
19299064|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19299065|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
19299066|NCT04208581|Hormones|hormones|mesh-ancestor
19299067|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299068|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19299069|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19299070|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19299071|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299072|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299073|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299074|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
19299075|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19299076|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19299077|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
19299078|NCT04208334|Curcumin|curcumin|mesh-list
19299079|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299080|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299081|NCT04208334|Analgesics|analgesics|mesh-ancestor
19299082|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
19299083|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299084|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299085|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299086|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364070|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20364071|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364072|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20364073|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20364074|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364075|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364076|NCT00944814|Zinc|zinc|mesh-list
20364077|NCT00944814|Trace Elements|trace elements|mesh-ancestor
20364078|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
20364079|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364080|NCT00944840|Amodiaquine|amodiaquine|mesh-list
20364081|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
20364082|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20364083|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20364084|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364085|NCT00944853|Zinc|zinc|mesh-list
20364086|NCT00944853|Trace Elements|trace elements|mesh-ancestor
20364087|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
20364088|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364089|NCT00944918|Fulvestrant|fulvestrant|mesh-list
20364090|NCT00944918|Anastrozole|anastrozole|mesh-list
20364091|NCT00944918|Exemestane|exemestane|mesh-list
19299087|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299088|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299089|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299090|NCT04208516|Dexamethasone|dexamethasone|mesh-list
19299091|NCT04208516|Lidocaine|lidocaine|mesh-list
19299092|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
19299093|NCT04208516|Ropivacaine|ropivacaine|mesh-list
19299094|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299095|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
19299096|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
19299097|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299098|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364092|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20364093|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364094|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20364095|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20364096|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
20364097|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299099|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364098|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672063|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672064|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672065|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19672066|NCT05119439|Misoprostol|misoprostol|mesh-list
19672067|NCT05119439|Mifepristone|mifepristone|mesh-list
19672068|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19672069|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
20364099|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20364100|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20364101|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672070|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19672071|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672072|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19672073|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299100|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
19299101|NCT04208516|Hormones|hormones|mesh-ancestor
19299102|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299103|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19672074|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
19672075|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19672076|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19672077|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19672078|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19672079|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
19672080|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19672081|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19672082|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
19672083|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672084|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
19672085|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20364102|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364103|NCT00944957|Efavirenz|efavirenz|mesh-list
20364104|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
20364105|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19299104|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299105|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
19299106|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
19299107|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299108|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
20364106|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20364107|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364108|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364109|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
20364110|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184945|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184946|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20184947|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20184948|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
20184949|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
20184950|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20184951|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20184952|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
20184953|NCT00199186|Hormones|hormones|mesh-ancestor
20184954|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20184955|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20364111|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20364112|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20364113|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20364114|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20364115|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20364116|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20364117|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20364118|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20364119|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20364120|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20364121|NCT00944996|Citalopram|citalopram|mesh-list
20364122|NCT00944996|Fluoxetine|fluoxetine|mesh-list
20364123|NCT00944996|Paroxetine|paroxetine|mesh-list
19299109|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19299110|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19299111|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19672086|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19299112|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299113|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299114|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19299115|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299116|NCT04208516|Analgesics|analgesics|mesh-ancestor
19299117|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19299118|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19299119|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19299120|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299121|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299122|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
19299123|NCT04208347|Apatinib|apatinib|mesh-list
19299124|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299125|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19299126|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299127|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299128|NCT04208061|Ritonavir|ritonavir|mesh-list
19299129|NCT04208061|Darunavir|darunavir|mesh-list
19299130|NCT04208061|Dabigatran|dabigatran|mesh-list
19299131|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19299132|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19299133|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
19299134|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299135|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299136|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19299137|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19299138|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
20364124|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20364125|NCT00944996|Sertraline|sertraline|mesh-list
20364126|NCT00944996|Clomipramine|clomipramine|mesh-list
19299139|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299140|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19299141|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299142|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
19299143|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19299144|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
19299145|NCT04207957|Olorofim|olorofim|mesh-list
19299146|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
19299147|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299148|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
19299149|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19299150|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19299151|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19299152|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299153|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299154|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
19299155|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299156|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299157|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19299158|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299159|NCT04207684|Testosterone|testosterone|mesh-list
19299160|NCT04207684|Androgens|androgens|mesh-ancestor
20364127|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20364128|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20364129|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20364130|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364131|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364132|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
20364133|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364134|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20364135|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
20364136|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364137|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19299161|NCT04207684|Hormones|hormones|mesh-ancestor
19299162|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299163|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672087|NCT05119257|Antibodies|antibodies|mesh-list
19672088|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19672089|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
19672090|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672091|NCT05108155|Tacrine|tacrine|mesh-list
20364138|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299164|NCT04207411|Lidocaine|lidocaine|mesh-list
19299165|NCT04207411|Bupivacaine|bupivacaine|mesh-list
19672092|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20364139|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364140|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20364141|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20364142|NCT00945022|Anesthetics|anesthetics|mesh-list
20364143|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364144|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672093|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299166|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
19299167|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
19299168|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299169|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299170|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
19299171|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299172|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19299173|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19299174|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19299175|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299176|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299177|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19299178|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19299179|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19299180|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299181|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299182|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299183|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299184|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19299185|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
19299186|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19299187|NCT04207515|Anesthetics|anesthetics|mesh-list
19299188|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299189|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299190|NCT04207450|Glutaral|glutaral|mesh-list
19299191|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
19299192|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299193|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19299194|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19299195|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299196|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299197|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299198|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299199|NCT04207723|Paroxetine|paroxetine|mesh-list
19299200|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19299201|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19299202|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299203|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299204|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299205|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
19299206|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299207|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19299208|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
19299209|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19299210|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19299211|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299212|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299213|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
19299214|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
19299215|NCT04207112|Linezolid|linezolid|mesh-list
19299216|NCT04207112|Bedaquiline|bedaquiline|mesh-list
19299217|NCT04207112|Clofazimine|clofazimine|mesh-list
19299218|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299219|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299220|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19299221|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19299222|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299223|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299224|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672094|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364145|NCT00945152|Vancomycin|vancomycin|mesh-list
20364146|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20364147|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672095|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
20364148|NCT00945178|Naproxen|naproxen|mesh-list
20364149|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364150|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20364151|NCT00945178|Analgesics|analgesics|mesh-ancestor
20364152|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
20364153|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364154|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299225|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19299226|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
19299227|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299228|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
19299229|NCT04207021|Curcumin|curcumin|mesh-list
19299230|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299231|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299232|NCT04207021|Analgesics|analgesics|mesh-ancestor
19299233|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
19299234|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299235|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299236|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299237|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299238|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299239|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299240|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299241|NCT04206865|Valsartan|valsartan|mesh-list
19299242|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
19299243|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19299244|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19299245|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19299246|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19299247|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299248|NCT04206618|Denosumab|denosumab|mesh-list
19299249|NCT04206618|Teriparatide|teriparatide|mesh-list
19299250|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19299251|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299252|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19299253|NCT04206631|Doxycycline|doxycycline|mesh-list
19299254|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299255|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299256|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
19299257|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20364155|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364156|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364157|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
20364158|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20364159|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364160|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364161|NCT00945308|Eptifibatide|eptifibatide|mesh-list
20364162|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20364163|NCT00945347|Miglustat|miglustat|mesh-list
20364164|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364165|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364166|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20364167|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20364168|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
20364169|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364170|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20364171|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364172|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364173|NCT00945360|Letrozole|letrozole|mesh-list
20364174|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20364175|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364176|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20364177|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299258|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19672096|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672097|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672098|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19672099|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
19672100|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672101|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
20364178|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364179|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19395912|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364180|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
19299259|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19299260|NCT04206228|Hematinics|hematinics|mesh-ancestor
19299261|NCT04206358|Molgramostim|molgramostim|mesh-list
19299262|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299263|NCT04206046|Anesthetics|anesthetics|mesh-list
19299264|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299265|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299266|NCT04206176|Ticagrelor|ticagrelor|mesh-list
19299267|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20364181|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364182|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364183|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
19299268|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19299269|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19299270|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19299271|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
19299272|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299273|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299274|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299275|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
19299276|NCT04205916|Dexamethasone|dexamethasone|mesh-list
19299277|NCT04205916|Ketorolac|ketorolac|mesh-list
19299278|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299279|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
19299280|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
19299281|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299282|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299283|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299284|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
19299285|NCT04205916|Hormones|hormones|mesh-ancestor
20364184|NCT00945373|Calcium|calcium|mesh-list
20364185|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20364186|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364187|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
20364188|NCT00945373|Coagulants|coagulants|mesh-ancestor
20364189|NCT00945438|Vaccines|vaccines|mesh-list
20364190|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
20364191|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364192|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
20364193|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20364194|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
20364195|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364196|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364197|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20364198|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
20364199|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20364200|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
20364201|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299286|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299287|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19299288|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299289|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299290|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299291|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19299292|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19299293|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299294|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299295|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299296|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299297|NCT04205916|Analgesics|analgesics|mesh-ancestor
19299298|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
19299299|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299300|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19299301|NCT04205903|Paclitaxel|paclitaxel|mesh-list
19299302|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19299303|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19299304|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299305|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
19299306|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
19299307|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
19299308|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299309|NCT04205929|Curcumin|curcumin|mesh-list
19299310|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364202|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364203|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20364204|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
20364205|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
20364206|NCT00945529|Protective Agents|protective agents|mesh-ancestor
20425436|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425437|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425438|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20425439|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
20425440|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425441|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425442|NCT01274988|Methadone|methadone|mesh-list
20425443|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20425444|NCT01274988|Narcotics|narcotics|mesh-ancestor
20425445|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425446|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425447|NCT01274988|Analgesics|analgesics|mesh-ancestor
20425448|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
20425449|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425450|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
20425451|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
20425452|NCT01275014|Dexamethasone|dexamethasone|mesh-list
20425453|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425454|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
20425455|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
20425456|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425457|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425458|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425459|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
20425460|NCT01275014|Hormones|hormones|mesh-ancestor
19299311|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299312|NCT04205929|Analgesics|analgesics|mesh-ancestor
19299313|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
19299314|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299315|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299316|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299317|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299318|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299319|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299320|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299321|NCT04205643|Infliximab|infliximab|mesh-list
19299322|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
19299323|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299324|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299325|NCT04205890|Ketamine|ketamine|mesh-list
19299326|NCT04205890|Analgesics|analgesics|mesh-ancestor
19299327|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
19299328|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299329|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299330|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19299331|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19299332|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
19299333|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
19299334|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299335|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19299336|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19299337|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299338|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299339|NCT04205682|Cannabidiol|cannabidiol|mesh-list
19299340|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
19299341|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19299342|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19299343|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19299344|NCT04205578|Protective Agents|protective agents|mesh-ancestor
19299345|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299346|NCT04205565|Oxiracetam|oxiracetam|mesh-list
19299347|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19299348|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
19299349|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
19299350|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19299351|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299352|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299353|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20425461|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299354|NCT04205539|Analgesics|analgesics|mesh-ancestor
19299355|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
19672102|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
19672103|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672104|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672105|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672106|NCT05065918|Ethanol|ethanol|mesh-list
19672107|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19672108|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672109|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672110|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672111|NCT05061992|Lactulose|lactulose|mesh-list
19672112|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672113|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
19299356|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299357|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19299358|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19299359|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19299360|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299361|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299362|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299363|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
19299364|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
19299365|NCT04205240|Melphalan|melphalan|mesh-list
19299366|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
19299367|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19299368|NCT04205240|Fludarabine|fludarabine|mesh-list
19299369|NCT04205240|Daratumumab|daratumumab|mesh-list
19299370|NCT04205240|Tacrolimus|tacrolimus|mesh-list
20364207|NCT00945542|Hemostatics|hemostatics|mesh-list
20364208|NCT00945542|Coagulants|coagulants|mesh-ancestor
20364209|NCT00945620|Ropivacaine|ropivacaine|mesh-list
20364210|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
20364211|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
20364212|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364213|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364214|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
20364215|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364216|NCT00945724|Cytarabine|cytarabine|mesh-list
20364217|NCT00945724|Prednisolone|prednisolone|mesh-list
20364218|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
19299371|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19299372|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
19299373|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299374|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299375|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19299376|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
19299377|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299378|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299379|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19299380|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20184956|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
20184957|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184958|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20184959|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
20184960|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19299381|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299382|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19672114|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20184961|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20184962|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
20184963|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
20184964|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20184965|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20184966|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20184967|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
20184968|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
20184969|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
20184970|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
20184971|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184972|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20184973|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20184974|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20364219|NCT00945724|Rituximab|rituximab|mesh-list
20364220|NCT00945724|Doxorubicin|doxorubicin|mesh-list
19299383|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19299384|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
19299385|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299386|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299387|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19299388|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19299389|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19299390|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19299391|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19299392|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299393|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299394|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299395|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299396|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
19299397|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19299398|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299399|NCT04205305|Labetalol|labetalol|mesh-list
19299400|NCT04205305|Nicardipine|nicardipine|mesh-list
19299401|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19299402|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19299403|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299404|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299405|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299406|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299407|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19299408|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
19299409|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
19299410|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299411|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19299412|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19299413|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19299414|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299415|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19299416|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
19299417|NCT04205344|Bupivacaine|bupivacaine|mesh-list
19299418|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
19299419|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
19299420|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299421|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299422|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
19299423|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299424|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
19299425|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299426|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299427|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299428|NCT04205357|Analgesics|analgesics|mesh-ancestor
19299429|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
19299430|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364221|NCT00945724|Methotrexate|methotrexate|mesh-list
20364222|NCT00945724|Vincristine|vincristine|mesh-list
20364223|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364224|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
19299431|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299432|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299433|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299434|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299435|NCT04205097|Neostigmine|neostigmine|mesh-list
19299436|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19299437|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299438|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299439|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
19299440|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299441|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299442|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19299443|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
19299444|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299445|NCT04204837|Nivolumab|nivolumab|mesh-list
19299446|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19299447|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299448|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19299449|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299450|NCT04204980|Daratumumab|daratumumab|mesh-list
19299451|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19299452|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364225|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364226|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299453|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
19299454|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299455|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
19299456|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
19299457|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299458|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299459|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19299460|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19299461|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299462|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299463|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299464|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19299465|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299466|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19299467|NCT04205058|Caffeine|caffeine|mesh-list
20364227|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20364228|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
20364229|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364230|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184975|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184976|NCT00199212|Trastuzumab|trastuzumab|mesh-list
20184977|NCT00199212|Bortezomib|bortezomib|mesh-list
20184978|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20184979|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184980|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
20184981|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20364231|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19299468|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19299469|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299470|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19299471|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299472|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364232|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20364233|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20364234|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19299473|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19299474|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19299475|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
19299476|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299477|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
19299478|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19299479|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299480|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299481|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299482|NCT04204798|Analgesics|analgesics|mesh-ancestor
19299483|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
19299484|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299485|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19299486|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19299487|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20364235|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20364236|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299488|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299489|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299490|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299491|NCT04204772|Charcoal|charcoal|mesh-list
19299492|NCT04204772|Antidotes|antidotes|mesh-ancestor
20364237|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19299493|NCT04204772|Protective Agents|protective agents|mesh-ancestor
19299494|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299495|NCT04204577|Apatinib|apatinib|mesh-list
19299496|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299497|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19299498|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299499|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299500|NCT04204902|Tepotinib|tepotinib|mesh-list
20184982|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184983|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20184984|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20184985|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20184986|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20184987|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20184988|NCT00199264|Albaconazole|albaconazole|mesh-list
20364238|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
20364239|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20364240|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19299501|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395913|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
19395914|NCT03664037|Hormones|hormones|mesh-ancestor
19395915|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395916|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19395917|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395918|NCT03663751|Decitabine|decitabine|mesh-list
19395919|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20364241|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
19395920|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
19395921|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395922|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395923|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395924|NCT03663673|Decanoic acid|decanoic acid|mesh-list
19395925|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
19395926|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19395927|NCT03663543|Estrogens|estrogens|mesh-list
19395928|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19395929|NCT03663543|Hormones|hormones|mesh-ancestor
19395930|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19395931|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395932|NCT03663478|Ropivacaine|ropivacaine|mesh-list
19395933|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
19395934|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
19395935|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395936|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395937|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
19395938|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395939|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
19395940|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19395941|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19395942|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395943|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19395944|NCT03663114|Lenvatinib|lenvatinib|mesh-list
19395945|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395946|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19395947|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19395948|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395949|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
20364242|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364243|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20364244|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20364245|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
20364246|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364247|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19395950|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19395951|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
19395952|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364248|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
20364249|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
19395953|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19395954|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19395955|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19395956|NCT03662958|Leuprolide|leuprolide|mesh-list
19395957|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19395958|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
19395959|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19395960|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395961|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19395962|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395963|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19395964|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19395965|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
19395966|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19395967|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395968|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404327|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404328|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19404329|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404330|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
19404331|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
20364250|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
20364251|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364252|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
20364253|NCT00945724|Hormones|hormones|mesh-ancestor
20364254|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364255|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20184989|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
20184990|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20184991|NCT00199277|Iron|iron|mesh-list
20184992|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20184993|NCT00199277|Trace Elements|trace elements|mesh-ancestor
20184994|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
20184995|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20184996|NCT00199277|Hematinics|hematinics|mesh-ancestor
20184997|NCT00199316|Morphine|morphine|mesh-list
20184998|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20184999|NCT00199316|Narcotics|narcotics|mesh-ancestor
20185000|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364256|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
19299502|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
19299503|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19299504|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
19299505|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299506|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
19299507|NCT04204278|Protective Agents|protective agents|mesh-ancestor
19299508|NCT04204382|Levofloxacin|levofloxacin|mesh-list
19299509|NCT04204382|Ofloxacin|ofloxacin|mesh-list
19299510|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19299511|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299512|NCT04204382|Renal Agents|renal agents|mesh-ancestor
19299513|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299514|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19299515|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19299516|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299517|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299518|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299519|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19299520|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299521|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19299522|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
19299523|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19299524|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19299525|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
19299526|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299527|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299528|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
19299529|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19299530|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
19299531|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299532|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
19299533|NCT04204083|Protective Agents|protective agents|mesh-ancestor
19299534|NCT04204096|Vaccines|vaccines|mesh-list
19299535|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
19299536|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299537|NCT04204304|Isotretinoin|isotretinoin|mesh-list
19299538|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
19299539|NCT04204044|Folic Acid|folic acid|mesh-list
19299540|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
19299541|NCT04204044|Inositol|inositol|mesh-list
19299542|NCT04204044|Metformin|metformin|mesh-list
19299543|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19299544|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299545|NCT04204044|Hematinics|hematinics|mesh-ancestor
19299546|NCT04204044|Vitamins|vitamins|mesh-ancestor
19299547|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
19299548|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
19299549|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19299550|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
19299551|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299552|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
19672115|NCT05021861|Estradiol|estradiol|mesh-list
20185001|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364257|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
19299553|NCT04204265|Protective Agents|protective agents|mesh-ancestor
19299554|NCT04203732|Anesthetics|anesthetics|mesh-list
19299555|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299556|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185002|NCT00199316|Analgesics|analgesics|mesh-ancestor
20185003|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
20364258|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20364259|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
20364260|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364261|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364262|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20364263|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
20364264|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20364265|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
20185004|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185005|NCT00199329|Ondansetron|ondansetron|mesh-list
20364266|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364267|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364268|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20364269|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
20364270|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
20364271|NCT00945789|Protective Agents|protective agents|mesh-ancestor
20364272|NCT00945789|Hematinics|hematinics|mesh-ancestor
20364273|NCT00945919|Oxymorphone|oxymorphone|mesh-list
20364274|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20364275|NCT00945919|Narcotics|narcotics|mesh-ancestor
20364276|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364277|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364278|NCT00945919|Analgesics|analgesics|mesh-ancestor
20364279|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
20364280|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299557|NCT04203771|Ibuprofen|ibuprofen|mesh-list
19299558|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299559|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299560|NCT04203771|Analgesics|analgesics|mesh-ancestor
19299561|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
19299562|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299563|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299564|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299565|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299566|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19299567|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299568|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299569|NCT04203914|Empagliflozin|empagliflozin|mesh-list
20364281|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20364282|NCT00945997|Misoprostol|misoprostol|mesh-list
20364283|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20364284|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
20364285|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20364286|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364287|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20364288|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364289|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
20364290|NCT00946036|Sertraline|sertraline|mesh-list
20364291|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
20364292|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364293|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20364294|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20364295|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20364296|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364297|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364298|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
20364299|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364300|NCT00946166|Simvastatin|simvastatin|mesh-list
20364301|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20364302|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20364303|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
19395969|NCT03662763|Guanfacine|guanfacine|mesh-list
20185006|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
20185007|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
20185008|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185009|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185010|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185011|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
20185012|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364304|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185013|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20185014|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
20185015|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364305|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20425462|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19299570|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19299571|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299572|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19299573|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299574|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
19299575|NCT04203680|Tryptophan|tryptophan|mesh-list
19299576|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19299577|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19299578|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
19299579|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19299580|NCT04203186|Lumefantrine|lumefantrine|mesh-list
19299581|NCT04203186|Artemether|artemether|mesh-list
19299582|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19299583|NCT04203186|Atovaquone|atovaquone|mesh-list
19299584|NCT04203186|Proguanil|proguanil|mesh-list
19299585|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19299586|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
19299587|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19299588|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19299589|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299590|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299591|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299592|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
19299593|NCT04203342|Ketoconazole|ketoconazole|mesh-list
19299594|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
19299595|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299596|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20428571|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19299597|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299598|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299599|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299600|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19299601|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
19299602|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299603|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299604|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19299605|NCT04203368|Adenosine|adenosine|mesh-list
19299606|NCT04203368|Verapamil|verapamil|mesh-list
19299607|NCT04203368|Analgesics|analgesics|mesh-ancestor
19299608|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
19299609|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299610|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299611|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19299612|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
19299613|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19299614|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
19299615|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
19299616|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299617|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299618|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19299619|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299620|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19299621|NCT04203212|Goserelin|goserelin|mesh-list
19299622|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19299623|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299624|NCT04203056|Aripiprazole|aripiprazole|mesh-list
19299625|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
19299626|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
19299627|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19299628|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19299629|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19299630|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299631|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299632|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
19299633|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
19299634|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299635|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672116|NCT05021861|Cyproterone|cyproterone|mesh-list
19672117|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
19672118|NCT05021861|Estrogens|estrogens|mesh-ancestor
19672119|NCT05021861|Hormones|hormones|mesh-ancestor
19672120|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672121|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299636|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19299637|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19299638|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
19299639|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19299640|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19299641|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19299642|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19299643|NCT04203043|Pycnogenols|pycnogenols|mesh-list
19299644|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19299645|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
19299646|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299647|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
19299648|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299649|NCT04203043|Protective Agents|protective agents|mesh-ancestor
19299650|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19299651|NCT04202809|Durvalumab|durvalumab|mesh-list
19299652|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19299653|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299654|NCT04202978|Capecitabine|capecitabine|mesh-list
19299655|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
19299656|NCT04202978|Apatinib|apatinib|mesh-list
19299657|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19299658|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
19299659|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299660|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299661|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19299662|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299663|NCT04203511|Paclitaxel|paclitaxel|mesh-list
19299664|NCT04203511|Etoposide|etoposide|mesh-list
19299665|NCT04203511|Carboplatin|carboplatin|mesh-list
19299666|NCT04203511|Pemetrexed|pemetrexed|mesh-list
19299667|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19299668|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299669|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
19299670|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
19299671|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
19299672|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299673|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19299674|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19299675|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299676|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19299677|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19299678|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
19299679|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
19299680|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299681|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
19299682|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
19838424|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19838425|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19838426|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19838427|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838428|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838429|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838430|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838431|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20185016|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185017|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19299683|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19299684|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19299685|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
19299686|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299687|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299688|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19299689|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
19299690|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299691|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299692|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19299693|NCT04203485|Paclitaxel|paclitaxel|mesh-list
19299694|NCT04203485|Carboplatin|carboplatin|mesh-list
19299695|NCT04203485|Pemetrexed|pemetrexed|mesh-list
19299696|NCT04203485|Apatinib|apatinib|mesh-list
19299697|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19299698|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299699|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
20364306|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20364307|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364308|NCT00946179|Vaccines|vaccines|mesh-list
20364309|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
20185018|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185019|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185020|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185021|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20185022|NCT00199342|Ecromeximab|ecromeximab|mesh-list
20185023|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20185024|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185025|NCT00199355|Istradefylline|istradefylline|mesh-list
20185026|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20185027|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20364310|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299700|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
19299701|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
19299702|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299703|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299704|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19299705|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19299706|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19395970|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19395971|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19395972|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19395973|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20185028|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20364311|NCT00946335|Temozolomide|temozolomide|mesh-list
20364312|NCT00946335|Veliparib|veliparib|mesh-list
20364313|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20364314|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
20364315|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364316|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364317|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20364318|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364319|NCT00946374|Cyclosporine|cyclosporine|mesh-list
20364320|NCT00946374|Doxorubicin|doxorubicin|mesh-list
20364321|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20364322|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364323|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20364324|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20364325|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364326|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364327|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
20364328|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364329|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364330|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364331|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
20364332|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364333|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364334|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20364335|NCT00946387|Ondansetron|ondansetron|mesh-list
20364336|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
20364337|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
20364338|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364339|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364340|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364341|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
20364342|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364343|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20364344|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
20364345|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364346|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364347|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20364348|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20364349|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364350|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364351|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20364352|NCT00946465|Ramipril|ramipril|mesh-list
20364353|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20364354|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
20364355|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364356|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299707|NCT04202887|Fentanyl|fentanyl|mesh-list
19299708|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19299709|NCT04202887|Narcotics|narcotics|mesh-ancestor
19299710|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299711|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299712|NCT04202887|Analgesics|analgesics|mesh-ancestor
19299713|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
19299714|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299715|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19299716|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19299717|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
19299718|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
19299719|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19299720|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299721|NCT04202536|Tenofovir|tenofovir|mesh-list
19299722|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
19299723|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299724|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19299725|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19299726|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299727|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299728|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19299729|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19299730|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
19299731|NCT04202484|Tegafur|tegafur|mesh-list
20364357|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20364358|NCT00946491|Haloperidol|haloperidol|mesh-list
20364359|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
20364360|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
20364361|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
20364362|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364363|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299732|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299733|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19299734|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
19299735|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299736|NCT04202380|Azithromycin|azithromycin|mesh-list
19299737|NCT04202380|Ampicillin|ampicillin|mesh-list
19299738|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299739|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299740|NCT04202367|Bupivacaine|bupivacaine|mesh-list
19299741|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
19299742|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
19299743|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299744|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299745|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
19299746|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299747|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
19299748|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19299749|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299750|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
19299751|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
19299752|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19299753|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299754|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299755|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19299756|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19299757|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
19299758|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19299759|NCT04202406|Acetaminophen|acetaminophen|mesh-list
19299760|NCT04202406|Codeine|codeine|mesh-list
19299761|NCT04202406|Caffeine|caffeine|mesh-list
19299762|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299763|NCT04202406|Analgesics|analgesics|mesh-ancestor
19299764|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
19299765|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299766|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299767|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
19299768|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19299769|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19299770|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299771|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299772|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20364364|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299773|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19299774|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
20364365|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19299775|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299776|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19299777|NCT04202406|Narcotics|narcotics|mesh-ancestor
19299778|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299779|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
19299780|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
19299781|NCT04202224|Acetaminophen|acetaminophen|mesh-list
19299782|NCT04202224|Ibuprofen|ibuprofen|mesh-list
19299783|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299784|NCT04202224|Analgesics|analgesics|mesh-ancestor
19299785|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
19299786|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299787|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299788|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
19299789|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299790|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299791|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299792|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19299793|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299794|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672122|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19672123|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
19672124|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19672125|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19299799|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
19299800|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19299801|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19299802|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299803|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
19299804|NCT04201951|Coagulants|coagulants|mesh-ancestor
19299805|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
19299806|NCT04202068|Sulbactam|sulbactam|mesh-list
19299807|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19299808|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299809|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19299810|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299811|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299812|NCT04201808|Tenofovir|tenofovir|mesh-list
19299813|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
20364366|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20364367|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364368|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364369|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19299814|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299815|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19299816|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19299817|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299818|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299819|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19299820|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19299821|NCT04201860|Hemostatics|hemostatics|mesh-list
19299822|NCT04201860|Coagulants|coagulants|mesh-ancestor
19299823|NCT04201990|Apatinib|apatinib|mesh-list
19299824|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299825|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19299826|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299827|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299828|NCT04201665|Oxytocin|oxytocin|mesh-list
19299829|NCT04201665|Carbetocin|carbetocin|mesh-list
19299830|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
19299831|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19299832|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299833|NCT04201678|Anesthetics|anesthetics|mesh-list
19299834|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299835|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299836|NCT04201769|Dexamethasone|dexamethasone|mesh-list
19299837|NCT04201769|Palonosetron|palonosetron|mesh-list
19299838|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299839|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
19299840|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
19299841|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299842|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299843|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299844|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
19299845|NCT04201769|Hormones|hormones|mesh-ancestor
19299846|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672126|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19299847|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19299848|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299849|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19299850|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19299851|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
19299852|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299853|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299854|NCT04201561|Selenious Acid|selenious acid|mesh-list
19299855|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
19299856|NCT04201561|Paclitaxel|paclitaxel|mesh-list
19299857|NCT04201561|Carboplatin|carboplatin|mesh-list
19299858|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19299859|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299860|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
19299861|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
19299862|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
19299863|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299864|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299865|NCT04201561|Trace Elements|trace elements|mesh-ancestor
19299866|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
19299867|NCT04201652|Anesthetics|anesthetics|mesh-list
19299868|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
19299869|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299870|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299871|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
19299872|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299873|NCT04201054|Fluconazole|fluconazole|mesh-list
19299874|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
20364370|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
20364371|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299875|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299876|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19299877|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19299878|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299879|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299880|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19299881|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
19299882|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299883|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299884|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19299885|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19299886|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
19299887|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19299888|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299889|NCT04201249|Piroxicam|piroxicam|mesh-list
19299890|NCT04201249|Lidocaine|lidocaine|mesh-list
20364372|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364373|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20364374|NCT00946504|Glipizide|glipizide|mesh-list
20364375|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364376|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364377|NCT00946556|Valacyclovir|valacyclovir|mesh-list
20364378|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
20364379|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364380|NCT00946595|Ritonavir|ritonavir|mesh-list
20364381|NCT00946595|Lopinavir|lopinavir|mesh-list
20364382|NCT00946595|Tenofovir|tenofovir|mesh-list
20364383|NCT00946595|Efavirenz|efavirenz|mesh-list
20364384|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20364385|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20364386|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
20364387|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364388|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364389|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20364390|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20364391|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
20364392|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364393|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19299891|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
19299892|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
19299893|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299894|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299895|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
20364394|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20428757|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
20364395|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20364396|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20364397|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20364398|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19299896|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299897|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19299898|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19299899|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19299900|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19299901|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299902|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299903|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299904|NCT04201249|Analgesics|analgesics|mesh-ancestor
19299905|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299906|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299907|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19299908|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19299909|NCT04200885|Dexamethasone|dexamethasone|mesh-list
19299910|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19299911|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19672127|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19672128|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
19672129|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
19672130|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299912|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19299913|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
19299914|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
19299915|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299916|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299917|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299918|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
19299919|NCT04200885|Hormones|hormones|mesh-ancestor
19299920|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19299921|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19299922|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299923|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19299924|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299925|NCT04200885|Analgesics|analgesics|mesh-ancestor
19299926|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
19299927|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19299928|NCT04200599|Oxytocin|oxytocin|mesh-list
19299929|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
19299930|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19299931|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395974|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
19395975|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672131|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19395976|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364399|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20364400|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20364401|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20364402|NCT00946608|Loratadine|loratadine|mesh-list
20364403|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
20364404|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364405|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20364406|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20364407|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20364408|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
20364409|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
20364410|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364411|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364412|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364413|NCT00946621|Ramipril|ramipril|mesh-list
20364414|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20364415|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
20364416|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364417|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364418|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20364419|NCT00946673|Vorinostat|vorinostat|mesh-list
20364420|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364421|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19692163|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364422|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364423|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364424|NCT00946686|Leflunomide|leflunomide|mesh-list
20364425|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364426|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364427|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364428|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
20364429|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364430|NCT00946725|Atenolol|atenolol|mesh-list
20185029|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
20185030|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185031|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185032|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185033|NCT00199368|Istradefylline|istradefylline|mesh-list
20185034|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20185035|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19299932|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
19299933|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19299934|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185036|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19299935|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19299936|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299937|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
19299938|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19299939|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299940|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299941|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299942|NCT04200235|Analgesics|analgesics|mesh-ancestor
19299943|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
19299944|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299945|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19299946|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19299947|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19299948|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
19299949|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299950|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299951|NCT04200092|Granisetron|granisetron|mesh-list
19299952|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
19299953|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
19299954|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299955|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299956|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19299957|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19299958|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
19299959|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19299960|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299961|NCT04200222|Vanadium|vanadium|mesh-list
19299962|NCT04200222|Trace Elements|trace elements|mesh-ancestor
20185037|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
20185038|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185039|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185040|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217313|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217314|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217315|NCT00309361|Phentolamine|phentolamine|mesh-list
20217316|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20364431|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20364432|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20364433|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
20364434|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
20364435|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364436|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364437|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20364438|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20364439|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20364440|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
20364441|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364442|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364443|NCT00946751|Levetiracetam|levetiracetam|mesh-list
20364444|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
20364445|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
20364446|NCT00946764|Imipramine|imipramine|mesh-list
20364447|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20364448|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
20364449|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364450|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19299963|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
19299964|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299965|NCT04200040|Dacarbazine|dacarbazine|mesh-list
19299966|NCT04200040|Molgramostim|molgramostim|mesh-list
19299967|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19299968|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
19299969|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299970|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19299971|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19299972|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19299973|NCT04199364|Poractant alfa|poractant alfa|mesh-list
19299974|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19299975|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
19299976|NCT04199325|Uric Acid|uric acid|mesh-list
19299977|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
19299978|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19299979|NCT04199325|Protective Agents|protective agents|mesh-ancestor
19299980|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299981|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
19299982|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19299983|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
19299984|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
19299985|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299986|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299987|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19299988|NCT04199143|Analgesics|analgesics|mesh-ancestor
19299989|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
19299990|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299991|NCT04199013|Fentanyl|fentanyl|mesh-list
19299992|NCT04199013|Ropivacaine|ropivacaine|mesh-list
19299993|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
19299994|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
19299995|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19299996|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19299997|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
19299998|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19299999|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19300000|NCT04199013|Narcotics|narcotics|mesh-ancestor
19300001|NCT04199013|Analgesics|analgesics|mesh-ancestor
19300002|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19300003|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20185041|NCT00199394|Istradefylline|istradefylline|mesh-list
20185042|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20185043|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20185044|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20185045|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
20185046|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185047|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185048|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185049|NCT00199407|Istradefylline|istradefylline|mesh-list
20185050|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20185051|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20185052|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20185053|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
20185054|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185055|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185056|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185057|NCT00199420|Istradefylline|istradefylline|mesh-list
20185058|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20185059|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20185060|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20185061|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
20185062|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185063|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185064|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185065|NCT00199433|Istradefylline|istradefylline|mesh-list
19300004|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
19300005|NCT04199169|Vaccines|vaccines|mesh-list
19300006|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
20364451|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20364452|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20364453|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364454|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
20364455|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364456|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300007|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300008|NCT04198844|Warfarin|warfarin|mesh-list
19300009|NCT04198844|Apixaban|apixaban|mesh-list
19300010|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
19300011|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19300012|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
19300013|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19300014|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
19300015|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300016|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300017|NCT04198662|Epinephrine|epinephrine|mesh-list
19300018|NCT04198662|Ropivacaine|ropivacaine|mesh-list
19300019|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
19300020|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
19300021|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300022|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300023|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
19300024|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300025|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19300026|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19300027|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
19300028|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300029|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300030|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19300031|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19300032|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
19300033|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19300034|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
19300035|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
19300036|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
19300037|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19300038|NCT04198727|Capecitabine|capecitabine|mesh-list
19300039|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20364457|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
20364458|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
20364459|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20364460|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20364461|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300040|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
19300041|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300042|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300043|NCT04198506|Tacrolimus|tacrolimus|mesh-list
19300044|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19300045|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
19300046|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300047|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19300048|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300049|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300050|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19300051|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19300052|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300053|NCT04198636|Denosumab|denosumab|mesh-list
19300054|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19300055|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300056|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
19300057|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19300058|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
19300059|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300060|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
19300061|NCT04198467|Protective Agents|protective agents|mesh-ancestor
19300062|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19300063|NCT04198129|Amoxicillin|amoxicillin|mesh-list
19300064|NCT04198129|Clindamycin|clindamycin|mesh-list
19300065|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
19300066|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
19300067|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19300068|NCT04198129|Ampicillin|ampicillin|mesh-list
19300069|NCT04198129|Sultamicillin|sultamicillin|mesh-list
19300070|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20364462|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364463|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364464|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19300071|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300072|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
19300073|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19300074|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300075|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300076|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19395977|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395978|NCT03662724|Venetoclax|venetoclax|mesh-list
19395979|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19395980|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
19395981|NCT03662711|Olodaterol|olodaterol|mesh-list
19395982|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
19395983|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19395984|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395985|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19395986|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
19395987|NCT03662620|Amlodipine|amlodipine|mesh-list
19395988|NCT03662620|Telmisartan|telmisartan|mesh-list
19395989|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
19395990|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19395991|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19395992|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19395993|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19395994|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19395995|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19395996|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
19395997|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19395998|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19395999|NCT03662620|Diuretics|diuretics|mesh-ancestor
20364465|NCT00946829|Telmisartan|telmisartan|mesh-list
20364466|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20364467|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20364468|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20364469|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364470|NCT00946907|Aspirin|aspirin|mesh-list
20364471|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364472|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20364473|NCT00946907|Analgesics|analgesics|mesh-ancestor
20364474|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
20364475|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364476|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364477|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364478|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396000|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
19396001|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19396002|NCT03662568|Ritonavir|ritonavir|mesh-list
19396003|NCT03662568|Tenofovir|tenofovir|mesh-list
19396004|NCT03662568|Entecavir|entecavir|mesh-list
19396005|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19396006|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19396007|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
19396008|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396009|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612641|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612642|NCT02252367|Urological Agents|urological agents|mesh-ancestor
20612643|NCT02252419|Acetaminophen|acetaminophen|mesh-list
20612644|NCT02252419|Dexamethasone|dexamethasone|mesh-list
20612645|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396010|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19396011|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20185066|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20185067|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20185068|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20185069|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
20185070|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185071|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185072|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364479|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20612646|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
19396012|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
19396013|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300077|NCT04198233|Diazepam|diazepam|mesh-list
19300078|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19300079|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
19300080|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
19300081|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
19300082|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364480|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20364481|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364482|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20364483|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20364484|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364485|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
20364486|NCT00946946|Mesalamine|mesalamine|mesh-list
20364487|NCT00946946|Azathioprine|azathioprine|mesh-list
20364488|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
20364489|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364490|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19300083|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300084|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19300085|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19300086|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300087|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19300088|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19300089|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19300090|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19300091|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19300092|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19300093|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
19300094|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
19300095|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
19300096|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
19300097|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300098|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300099|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19300100|NCT04197817|Antibodies|antibodies|mesh-list
19300101|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
19300102|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19300103|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
19300104|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300105|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300106|NCT04197752|Anesthetics|anesthetics|mesh-list
19300107|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300108|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300109|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
19300110|NCT04197570|Analgesics|analgesics|mesh-list
19300111|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19300112|NCT04197570|Anesthetics|anesthetics|mesh-list
19300113|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300114|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300115|NCT04197570|Narcotics|narcotics|mesh-ancestor
19300116|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
19300117|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300118|NCT04197882|Molgramostim|molgramostim|mesh-list
19300119|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300120|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19300121|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19300122|NCT04197622|Diuretics|diuretics|mesh-ancestor
19300123|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
19300124|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300125|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19300126|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19300127|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300128|NCT04197739|Amikacin|amikacin|mesh-list
19300129|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19300130|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300131|NCT04197323|Alprostadil|alprostadil|mesh-list
19300132|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19300133|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
19300134|NCT04197323|Urological Agents|urological agents|mesh-ancestor
19300135|NCT04197349|Sumatriptan|sumatriptan|mesh-list
19300136|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19300137|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20364491|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300138|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19300139|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
19300140|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612647|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
20612648|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612649|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612650|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612651|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
20612652|NCT02252419|Hormones|hormones|mesh-ancestor
19300141|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300142|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300143|NCT04197089|Vitamin D|vitamin d|mesh-list
19300144|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
19300145|NCT04197089|Vitamins|vitamins|mesh-ancestor
19300146|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
19300147|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300148|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19300149|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19300150|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
19300151|NCT04197219|Axitinib|axitinib|mesh-list
19300152|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300153|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300154|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19300155|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300156|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300157|NCT04196855|Teriparatide|teriparatide|mesh-list
19300158|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19300159|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300160|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19838432|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
19300161|NCT04196829|Fluorides|fluorides|mesh-list
19300162|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
19300163|NCT04196829|Protective Agents|protective agents|mesh-ancestor
19300164|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300165|NCT04196946|Fentanyl|fentanyl|mesh-list
19300166|NCT04196946|Alfentanil|alfentanil|mesh-list
19300167|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19300168|NCT04196946|Narcotics|narcotics|mesh-ancestor
19300169|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300170|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300171|NCT04196946|Analgesics|analgesics|mesh-ancestor
19300172|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
19300173|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300174|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19300175|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19300176|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
19300177|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
19300178|NCT04197050|Valsartan|valsartan|mesh-list
19300179|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19300180|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19300181|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20185073|NCT00199446|Istradefylline|istradefylline|mesh-list
20185074|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20185075|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20185076|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20185077|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
20185078|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300182|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300183|NCT04197115|Vitamins|vitamins|mesh-list
19300184|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
19300185|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
19300186|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
19300187|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19300188|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19300189|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19300190|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
20185079|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185080|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185081|NCT00199472|Diuretics|diuretics|mesh-list
20185082|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
20185083|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185084|NCT00199511|Mannitol|mannitol|mesh-list
20185085|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20185086|NCT00199511|Diuretics|diuretics|mesh-ancestor
20185087|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
19300191|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300192|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300193|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
19672132|NCT04995874|Micronutrients|micronutrients|mesh-list
19672133|NCT04995874|Trace Elements|trace elements|mesh-list
19672134|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672135|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
19672136|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672137|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672138|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
19672139|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19672140|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672141|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672142|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19672143|NCT04824144|Analgesics|analgesics|mesh-ancestor
19672144|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
19672145|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672146|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19672147|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19672148|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19672149|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
19672150|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672151|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672152|NCT04814745|Morphine|morphine|mesh-list
19300194|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300195|NCT04197115|Protective Agents|protective agents|mesh-ancestor
19300196|NCT04196998|Tenofovir|tenofovir|mesh-list
19300197|NCT04196998|Entecavir|entecavir|mesh-list
19300198|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
19300199|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300200|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19300201|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19300202|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300203|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300204|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19300205|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19300206|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
19300207|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19300208|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19300209|NCT04196452|Ipilimumab|ipilimumab|mesh-list
19300210|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300211|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300212|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19300213|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300214|NCT04196400|Betamethasone|betamethasone|mesh-list
19300215|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300216|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
19300217|NCT04196400|Hormones|hormones|mesh-ancestor
19300218|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300219|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300220|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19300221|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
19300222|NCT04196426|Calcium|calcium|mesh-list
19300223|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19300224|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300225|NCT04196309|Heparin|heparin|mesh-list
19300226|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19300227|NCT04196309|Tinzaparin|tinzaparin|mesh-list
19300228|NCT04196309|Dalteparin|dalteparin|mesh-list
19300229|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
19300230|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19300231|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19300232|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300233|NCT04196608|Tazobactam|tazobactam|mesh-list
19300234|NCT04196608|Imipenem|imipenem|mesh-list
19300235|NCT04196608|Ceftolozane|ceftolozane|mesh-list
19300236|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19672153|NCT04814745|Tramadol|tramadol|mesh-list
19672154|NCT04814745|Ropivacaine|ropivacaine|mesh-list
20364492|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364493|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
20364494|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364495|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364496|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364497|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19672155|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19672156|NCT04814745|Narcotics|narcotics|mesh-ancestor
19300237|NCT04196608|Relebactam|relebactam|mesh-list
19300238|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19300239|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300240|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20364498|NCT00946946|Analgesics|analgesics|mesh-ancestor
20364499|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
20364500|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364501|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364502|NCT00947024|Glipizide|glipizide|mesh-list
20364503|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364504|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364505|NCT00947063|Promethazine|promethazine|mesh-list
20364506|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
20364507|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
20364508|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364509|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20364510|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
20364511|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
20364512|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364513|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364514|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300241|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300242|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300243|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19300244|NCT04196608|Renal Agents|renal agents|mesh-ancestor
19300245|NCT04196270|Ropivacaine|ropivacaine|mesh-list
19300246|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
19300247|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
19300248|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300249|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300250|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
19300251|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300252|NCT04196439|Anesthetics|anesthetics|mesh-list
19300253|NCT04196439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300254|NCT04196439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396014|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19396015|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19396016|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19396017|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19396018|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
19396019|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19396020|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
19396021|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
19396022|NCT03662516|Estradiol|estradiol|mesh-list
19396023|NCT03662516|Abrocitinib|abrocitinib|mesh-list
19396024|NCT03662516|Estrogens|estrogens|mesh-ancestor
19396025|NCT03662516|Hormones|hormones|mesh-ancestor
19396026|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396027|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185088|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185089|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
20185090|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185091|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20185092|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20364515|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20364516|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20364517|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20364518|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364519|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
20364520|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
20364521|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
19396028|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19396029|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20185093|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185094|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185095|NCT00199563|Urological Agents|urological agents|mesh-ancestor
20185096|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
20185097|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20185098|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20185099|NCT00199576|Prednisolone|prednisolone|mesh-list
20185100|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
20185101|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20185102|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
20185103|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20185104|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
20185105|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
20185106|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185107|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300255|NCT04196231|Insulin|insulin|mesh-list
19300256|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19300257|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19300258|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300259|NCT04195997|Heparin|heparin|mesh-list
19300260|NCT04195997|Bivalirudin|bivalirudin|mesh-list
19300261|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
19300262|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20185108|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185109|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
20185110|NCT00199576|Hormones|hormones|mesh-ancestor
20185111|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185112|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20185113|NCT00199576|Protective Agents|protective agents|mesh-ancestor
20185114|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20185115|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185116|NCT00199602|Heparin|heparin|mesh-list
20185117|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
20185118|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19300263|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19300264|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300265|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
19300266|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19300267|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
19300268|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300269|NCT04195828|Paclitaxel|paclitaxel|mesh-list
19300270|NCT04195828|Apatinib|apatinib|mesh-list
19300271|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19300272|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300273|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
19300274|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
19300275|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
20364522|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364523|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
20364524|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
20364525|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364526|NCT00947076|Fluoxetine|fluoxetine|mesh-list
20364527|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19300276|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300277|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19300278|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300279|NCT04195698|Upadacitinib|upadacitinib|mesh-list
19300280|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19300281|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19300282|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300283|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300284|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19300285|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19300286|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20364528|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20364529|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19300287|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
19300288|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300289|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300290|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19300291|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
19300292|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19300293|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19300294|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19300295|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
19300296|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364530|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364531|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364532|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
20364533|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300297|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300298|NCT04195373|Flucytosine|flucytosine|mesh-list
19300299|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
19300300|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364534|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20364535|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
20364536|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364537|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19300301|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
19300302|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300303|NCT04195139|Nivolumab|nivolumab|mesh-list
19300304|NCT04195139|Temozolomide|temozolomide|mesh-list
20364538|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20364539|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364540|NCT00947128|Ondansetron|ondansetron|mesh-list
20364541|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
20364542|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
20364543|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364544|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300305|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300306|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300307|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19300308|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300309|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19300310|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
19300311|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
19300312|NCT04195243|Empagliflozin|empagliflozin|mesh-list
19300313|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19300314|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300315|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19300316|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300317|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19300318|NCT04195100|Pilocarpine|pilocarpine|mesh-list
19300319|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19300320|NCT04195100|Miotics|miotics|mesh-ancestor
19300321|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
19300322|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300323|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300324|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19300325|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19300326|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
19300327|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300328|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300329|NCT04195321|Phenylephrine|phenylephrine|mesh-list
19300330|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
20364545|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364546|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
20364547|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
19300331|NCT04195321|Norepinephrine|norepinephrine|mesh-list
19300332|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19300333|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
19300334|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
19300335|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300336|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300337|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
19300338|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19300339|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
19300340|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
19300341|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19300342|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19300343|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19300344|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
19300345|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300346|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300347|NCT04195321|Protective Agents|protective agents|mesh-ancestor
19672157|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672158|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672159|NCT04814745|Analgesics|analgesics|mesh-ancestor
19672160|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
19672161|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672162|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672163|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
20185119|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20185120|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185121|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
20185122|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20185123|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185124|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20185125|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
20185126|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20185127|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185128|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185129|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300348|NCT04195074|Tenofovir|tenofovir|mesh-list
20364548|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20364549|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
20364550|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364551|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364552|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19300349|NCT04195074|Entecavir|entecavir|mesh-list
19300350|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
19300351|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300352|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19300353|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19300354|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300355|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300356|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19300357|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19300358|NCT04194827|Adalimumab|adalimumab|mesh-list
19300359|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300360|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19300361|NCT04194957|Fluorouracil|fluorouracil|mesh-list
19300362|NCT04194957|Capecitabine|capecitabine|mesh-list
19300363|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
19300364|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300365|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19300366|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300367|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19300368|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
19300369|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300370|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19300371|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19300372|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
19300373|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19300374|NCT04194905|Estradiol|estradiol|mesh-list
19300375|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19300376|NCT04194905|Estrogens|estrogens|mesh-ancestor
20185130|NCT00199719|Ribavirin|ribavirin|mesh-list
20185131|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
20185132|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185133|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
20185134|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185135|NCT00199745|Atorvastatin|atorvastatin|mesh-list
20185136|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19300377|NCT04194905|Hormones|hormones|mesh-ancestor
19300378|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300379|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300380|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19672164|NCT04752527|Sorafenib|sorafenib|mesh-list
19672165|NCT04752527|Decitabine|decitabine|mesh-list
19838433|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838434|NCT00620815|Vaccines|vaccines|mesh-list
19838435|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20185137|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20185138|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
20185139|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185140|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20185141|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20185142|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185143|NCT00199758|Gemcitabine|gemcitabine|mesh-list
20185144|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185145|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20185146|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
20364553|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19672166|NCT04752527|Venetoclax|venetoclax|mesh-list
19672167|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672168|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19672169|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672170|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672171|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672172|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
19838436|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
19838437|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838438|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20185147|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185148|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
20364554|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300381|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
19672173|NCT04716335|Harmine|harmine|mesh-list
19300382|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19300383|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19300384|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19300385|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19300386|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19300387|NCT04194658|Letrozole|letrozole|mesh-list
19300388|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300389|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19300390|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19300391|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300392|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300393|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19300394|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
19300395|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300396|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364555|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364556|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20364557|NCT00947141|Valganciclovir|valganciclovir|mesh-list
20364558|NCT00947141|Ganciclovir|ganciclovir|mesh-list
20364559|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19300397|NCT04194684|Paclitaxel|paclitaxel|mesh-list
19300398|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19300399|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300400|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
19300401|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
19300402|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
19300403|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300404|NCT04194515|Metformin|metformin|mesh-list
19300405|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19300406|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300407|NCT04194359|Capecitabine|capecitabine|mesh-list
19300408|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
19300409|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300410|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19300411|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
19300412|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300413|NCT04194424|Metformin|metformin|mesh-list
19300414|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19300415|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300416|NCT04194294|Lidocaine|lidocaine|mesh-list
19300417|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
19300418|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
19300419|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300420|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300421|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
19300422|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300423|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19300424|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19300425|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19300426|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19300427|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300428|NCT04194125|Edotreotide|edotreotide|mesh-list
20364560|NCT00947141|Foscarnet|foscarnet|mesh-list
20364561|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20364562|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
20364563|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364564|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20364565|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364566|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364567|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20364568|NCT00947323|Simvastatin|simvastatin|mesh-list
20364569|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20364570|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19300429|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19300430|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300431|NCT04194086|Posaconazole|posaconazole|mesh-list
19300432|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
19300433|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300434|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19300435|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19300436|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19300437|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19300438|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20364571|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
19300439|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300440|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300441|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19300442|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
19300443|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300444|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300445|NCT04194216|Clindamycin|clindamycin|mesh-list
19300446|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
19300447|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
19300448|NCT04194216|Cephalexin|cephalexin|mesh-list
19300449|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19300450|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300451|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19300452|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300453|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300454|NCT04194034|Flucytosine|flucytosine|mesh-list
19300455|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
19300456|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300457|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
19300458|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396030|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19396031|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19396032|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19396033|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19396034|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396035|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396036|NCT03662425|Oxytocin|oxytocin|mesh-list
19396037|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
19396038|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19396039|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396040|NCT03662412|Sirolimus|sirolimus|mesh-list
19396041|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396042|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396043|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19396044|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396045|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
19396046|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19396047|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
19396048|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396049|NCT03662269|Indomethacin|indomethacin|mesh-list
19396050|NCT03662269|Omeprazole|omeprazole|mesh-list
19396051|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19396052|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396053|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19396054|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396055|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396056|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19396057|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396058|NCT03662269|Analgesics|analgesics|mesh-ancestor
19396059|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
19396060|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396061|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396062|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396063|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396064|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
19396065|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
19396066|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19396067|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19396068|NCT03662113|Domperidone|domperidone|mesh-list
19396069|NCT03662113|Simethicone|simethicone|mesh-list
19396070|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
19396071|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
19396072|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396073|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396074|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396075|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19396076|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
19396077|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396078|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396079|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
19396080|NCT03662113|Emollients|emollients|mesh-ancestor
19396081|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
19672174|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
19396082|NCT03662100|Mirikizumab|mirikizumab|mesh-list
19404332|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364572|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300459|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
19300460|NCT04194255|Trace Elements|trace elements|mesh-ancestor
19300461|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
19300462|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300463|NCT04193930|Letrozole|letrozole|mesh-list
19300464|NCT04193930|Menotropins|menotropins|mesh-list
19300465|NCT04193930|Hormones|hormones|mesh-list
19300466|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19300467|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300468|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364573|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20364574|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20364575|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364576|NCT00947336|Norfloxacin|norfloxacin|mesh-list
20364577|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19300469|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672175|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364578|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364579|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19300470|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19300471|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19300472|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300473|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300474|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19300475|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
19300476|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19300477|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
19300478|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19300479|NCT04193878|Budesonide|budesonide|mesh-list
19300480|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
19300481|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300482|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19300483|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
19300484|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300485|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364580|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20364581|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364582|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364583|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364584|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20364585|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20364586|NCT00947375|Lamotrigine|lamotrigine|mesh-list
20364587|NCT00947375|Haloperidol|haloperidol|mesh-list
20364588|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
20364589|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
20364590|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
20364591|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364592|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364593|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364594|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20364595|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20364596|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364597|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364598|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20364599|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
20364600|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364601|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364602|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20364603|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
20364604|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20364605|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20364606|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20364607|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20364608|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20364609|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
20364610|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20364611|NCT00947388|Antibodies|antibodies|mesh-list
20364612|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
19300486|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19300487|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
19300488|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
19300489|NCT04193878|Hormones|hormones|mesh-ancestor
19300490|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300491|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19300492|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19300493|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19300494|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
19300495|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300496|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300497|NCT04193982|Vitamin E|vitamin e|mesh-list
19300498|NCT04193982|Vitamins|vitamins|mesh-ancestor
19300499|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
19300500|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300501|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
19300502|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300503|NCT04193982|Protective Agents|protective agents|mesh-ancestor
19300504|NCT04193852|Dienogest|dienogest|mesh-list
19300505|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19300506|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19300507|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19300508|NCT04193852|Estradiol|estradiol|mesh-list
19300509|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19300510|NCT04193852|Nandrolone|nandrolone|mesh-list
19300511|NCT04193852|Estrogens|estrogens|mesh-ancestor
19300512|NCT04193852|Hormones|hormones|mesh-ancestor
19300513|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300514|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300515|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19300516|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
19300517|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19300518|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19300519|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19300520|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19300521|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19300522|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
19300523|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19300524|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300525|NCT04193852|Androgens|androgens|mesh-ancestor
19300526|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
19300527|NCT04193631|Cannabidiol|cannabidiol|mesh-list
19300528|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
19300529|NCT04193592|Pirfenidone|pirfenidone|mesh-list
19300530|NCT04193592|Analgesics|analgesics|mesh-ancestor
19300531|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
19300532|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300533|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300534|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19300535|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19300536|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300537|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19300538|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300539|NCT04193501|Melatonin|melatonin|mesh-list
19300540|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
19300541|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300542|NCT04193501|Protective Agents|protective agents|mesh-ancestor
19300543|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300544|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300545|NCT04193553|Lenvatinib|lenvatinib|mesh-list
19300546|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300547|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19300548|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300549|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300550|NCT04193319|Fluconazole|fluconazole|mesh-list
19300551|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
19300552|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300553|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19300554|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19300555|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300556|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364613|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20364614|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
19300557|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19300558|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
19300559|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300560|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300561|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19300562|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19300563|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
19300564|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19300565|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300566|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19300567|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300568|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
19300569|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19300570|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300571|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300572|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300573|NCT04193215|Vaccines|vaccines|mesh-list
19300574|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
19300575|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300576|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
19300577|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19300578|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300579|NCT04192981|GDC-0084|gdc-0084|mesh-list
19300580|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300581|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300582|NCT04193137|Captopril|captopril|mesh-list
19300583|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19300584|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
19300585|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300586|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300587|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19300588|NCT04193059|Paclitaxel|paclitaxel|mesh-list
19300589|NCT04193059|Docetaxel|docetaxel|mesh-list
19300590|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
19300591|NCT04193059|Carboplatin|carboplatin|mesh-list
19300592|NCT04193059|Trastuzumab|trastuzumab|mesh-list
19300593|NCT04193059|Epirubicin|epirubicin|mesh-list
19300594|NCT04193059|Pertuzumab|pertuzumab|mesh-list
19300595|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19300596|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300597|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
20364615|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364616|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300598|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
19300599|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
19300600|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300601|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19300602|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
19300603|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300604|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19300605|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19300606|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
19300607|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19300608|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300609|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19300610|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19300611|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19300612|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300613|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
19300614|NCT04192916|Apixaban|apixaban|mesh-list
19300615|NCT04192916|Edoxaban|edoxaban|mesh-list
19300616|NCT04192916|Dabigatran|dabigatran|mesh-list
19838439|NCT00620854|Calcitonin|calcitonin|mesh-list
19838440|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
19838441|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19838442|NCT00620854|Katacalcin|katacalcin|mesh-list
19838443|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20185149|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300617|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19300618|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
19300619|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20185150|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185151|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185152|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
20185153|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185154|NCT00199771|Dextrans|dextrans|mesh-list
20185155|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
20185156|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
20185157|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
20185158|NCT00199784|Phenylephrine|phenylephrine|mesh-list
20185159|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
19300620|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
19300621|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672176|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19672177|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19672178|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672179|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672180|NCT04663308|Volixibat|volixibat|mesh-list
19672181|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19300622|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300623|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
19300624|NCT04192812|Leuprolide|leuprolide|mesh-list
19300625|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19300626|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
19300627|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19300628|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300629|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19300630|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300631|NCT04192617|Methotrexate|methotrexate|mesh-list
19300632|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19300633|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
19300634|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19300635|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300636|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19300637|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
19300638|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300639|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300640|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
19300641|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300642|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19300643|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19672182|NCT04640571|Metformin|metformin|mesh-list
19672183|NCT04640571|Valacyclovir|valacyclovir|mesh-list
19672184|NCT04640571|Enalaprilat|enalaprilat|mesh-list
19300644|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
19300645|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19300646|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19300647|NCT04192773|Lidocaine|lidocaine|mesh-list
19300648|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
19300649|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
19300650|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300651|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364617|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20364618|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
20364619|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425463|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425464|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
20425465|NCT01275183|Cisplatin|cisplatin|mesh-list
20425466|NCT01275183|Docetaxel|docetaxel|mesh-list
19300652|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
19672185|NCT04640571|Enalapril|enalapril|mesh-list
19672186|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19672187|NCT04640571|Pravastatin|pravastatin|mesh-list
19672188|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19672189|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672190|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19672191|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19672192|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
19672193|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300653|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300654|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19300655|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19300656|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19300657|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19300658|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300659|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
19300660|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19300661|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19300662|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300663|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
19300664|NCT04192643|Coagulants|coagulants|mesh-ancestor
19300665|NCT04192266|Estradiol|estradiol|mesh-list
19300666|NCT04192266|Estrogens|estrogens|mesh-ancestor
20425467|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300667|NCT04192266|Hormones|hormones|mesh-ancestor
19672194|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19672195|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19672196|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300668|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300669|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300670|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
19300671|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19300672|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20612653|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612654|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20612655|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612656|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612657|NCT02252419|Analgesics|analgesics|mesh-ancestor
19300673|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300674|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
19300675|NCT04192435|Coagulants|coagulants|mesh-ancestor
19300676|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19300677|NCT04192292|Gliclazide|gliclazide|mesh-list
19300678|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19300679|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19300680|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300681|NCT04192292|Incretins|incretins|mesh-ancestor
19300682|NCT04192292|Hormones|hormones|mesh-ancestor
19300683|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300684|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
19300685|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300686|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300687|NCT04192253|Paclitaxel|paclitaxel|mesh-list
19300688|NCT04192253|Carboplatin|carboplatin|mesh-list
19300689|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19300690|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300691|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
19300692|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
19300693|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
19300694|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300695|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
19300696|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19300697|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19300698|NCT04192656|Prednisolone|prednisolone|mesh-list
19300699|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
19300700|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19300701|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
19300702|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300703|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
19300704|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
19300705|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300706|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300707|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19300708|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
19300709|NCT04192656|Hormones|hormones|mesh-ancestor
19300710|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300711|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19300712|NCT04192656|Protective Agents|protective agents|mesh-ancestor
19300713|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19300714|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300715|NCT04191954|Fasudil|fasudil|mesh-list
19300716|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19300717|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
19300718|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19300719|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19300720|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19300721|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672197|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
20185160|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20185161|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
20185162|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
20185163|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185164|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185165|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
20185166|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20185167|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
20185168|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
20185169|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20185170|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20185171|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20185172|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185173|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300722|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19300723|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300724|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
19300725|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19300726|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300727|NCT04192032|Nicotine|nicotine|mesh-list
20364620|NCT00947453|Montelukast|montelukast|mesh-list
20364621|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20364622|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
20364623|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20364624|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
20364625|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364626|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364627|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20364628|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20364629|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364630|NCT00947466|Buprenorphine|buprenorphine|mesh-list
20364631|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20364632|NCT00947466|Narcotics|narcotics|mesh-ancestor
20364633|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300728|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19300729|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
19300730|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300731|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185174|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185175|NCT00199784|Protective Agents|protective agents|mesh-ancestor
20185176|NCT00199940|Ziprasidone|ziprasidone|mesh-list
20185177|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20185178|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
20185179|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364634|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364635|NCT00947466|Analgesics|analgesics|mesh-ancestor
20364636|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
20185180|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185181|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185182|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20185183|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185184|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185185|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19300732|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19300733|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19300734|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
19300735|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300736|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396083|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364637|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364638|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20364639|NCT00947596|Atropine|atropine|mesh-list
20364640|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20364641|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20364642|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19396084|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396085|NCT03662100|Analgesics|analgesics|mesh-ancestor
19396086|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
19396087|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396088|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396089|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396090|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396091|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20364643|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
20364644|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364645|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364646|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20364647|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
20364648|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
20364649|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
20364650|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19396092|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396093|NCT03662035|Apatinib|apatinib|mesh-list
19396094|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396095|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20185186|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20425468|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
19396096|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300737|NCT04192331|Paclitaxel|paclitaxel|mesh-list
19300738|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19300739|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19300740|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300741|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
19300742|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
19300743|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
19300744|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300745|NCT04191694|Ondansetron|ondansetron|mesh-list
19300746|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
19300747|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
19300748|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300749|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300750|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19300751|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
19300752|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
19300753|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19300754|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
19300755|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300756|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300757|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19300758|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19300759|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300760|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19300761|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19300762|NCT04191681|Valsartan|valsartan|mesh-list
19300763|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19300764|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19300765|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19300766|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19300767|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300768|NCT04191863|Valproic Acid|valproic acid|mesh-list
20364651|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20364652|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
20364653|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364654|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364655|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20364656|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20364657|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364658|NCT00947739|Camptothecin|camptothecin|mesh-list
20364659|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20364660|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364661|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20364662|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20364663|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364664|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185187|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
20185188|NCT00199953|Rabeprazole|rabeprazole|mesh-list
20185189|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20185190|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185191|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20185192|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185193|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185194|NCT00199966|Valproic Acid|valproic acid|mesh-list
20185195|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
19300769|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
19300770|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300771|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300772|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
19300773|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300774|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300775|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
19300776|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19300777|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300778|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19300779|NCT04191447|Budesonide|budesonide|mesh-list
19300780|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
19300781|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19300782|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300783|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20185196|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185197|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300784|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
20364665|NCT00947843|Aspirin|aspirin|mesh-list
20364666|NCT00947843|Clopidogrel|clopidogrel|mesh-list
20364667|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364668|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20364669|NCT00947843|Analgesics|analgesics|mesh-ancestor
20364670|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
20364671|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364672|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364673|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364674|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364675|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20364676|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20364677|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364678|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20364679|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20364680|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364681|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
19300785|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300786|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300787|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19300788|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
19300789|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
19300790|NCT04191447|Hormones|hormones|mesh-ancestor
19300791|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300792|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19300793|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19300794|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19300795|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
19300796|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300797|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300798|NCT04191434|Budesonide|budesonide|mesh-list
19300799|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
19300800|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19300801|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19300802|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19300803|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
19300804|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300805|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300806|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19300807|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
19300808|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
19300809|NCT04191434|Hormones|hormones|mesh-ancestor
19300810|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300811|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19300812|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19300813|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19300814|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
19300815|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300816|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300817|NCT04190927|Estradiol|estradiol|mesh-list
19300818|NCT04190927|Progesterone|progesterone|mesh-list
19300819|NCT04190927|Estrogens|estrogens|mesh-ancestor
19300820|NCT04190927|Hormones|hormones|mesh-ancestor
19300821|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300822|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300823|NCT04190927|Progestins|progestins|mesh-ancestor
19300824|NCT04191135|Gemcitabine|gemcitabine|mesh-list
19300825|NCT04191135|Carboplatin|carboplatin|mesh-list
19300826|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
19300827|NCT04191135|Olaparib|olaparib|mesh-list
19300828|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300829|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19300830|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
19300831|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300832|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
19300833|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300834|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364682|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20364683|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20364684|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20364685|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
20364686|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364687|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
19300835|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364688|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20364689|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20364690|NCT00947895|Prednisolone|prednisolone|mesh-list
20364691|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
20364692|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20364693|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
20364694|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20364695|NCT00947895|Hormones|hormones|mesh-ancestor
20364696|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364697|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364698|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364699|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
20364700|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
20364701|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364702|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364703|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
20364704|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19300836|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
19300837|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300838|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300839|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19300840|NCT04191278|Varenicline|varenicline|mesh-list
19300841|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19300842|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19300843|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
20185198|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
19672198|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672199|NCT04640571|Cathartics|cathartics|mesh-ancestor
19672200|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185199|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185200|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185201|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
20185202|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185203|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300844|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300845|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300846|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300847|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
19300848|NCT04191096|Androgens|androgens|mesh-list
19300849|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300850|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300851|NCT04191096|Hormones|hormones|mesh-ancestor
19300852|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300853|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300854|NCT04190745|Paclitaxel|paclitaxel|mesh-list
19300855|NCT04190745|Apatinib|apatinib|mesh-list
19300856|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20185204|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185205|NCT00199979|Nevirapine|nevirapine|mesh-list
20185206|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20185207|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20185208|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185209|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185210|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
20185211|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185212|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20185213|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20185214|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20185215|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20185216|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19300857|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300858|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
19300859|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
19300860|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
19300861|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300862|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19300863|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300864|NCT04190173|Prucalopride|prucalopride|mesh-list
19300865|NCT04190173|Laxatives|laxatives|mesh-ancestor
19300866|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19300867|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19300868|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20364705|NCT00947895|Protective Agents|protective agents|mesh-ancestor
20185217|NCT00200174|Exemestane|exemestane|mesh-list
19300869|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
19300870|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300871|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300872|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300873|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19300874|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
19300875|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19300876|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
19300877|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19300878|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300879|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19300880|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19300881|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300882|NCT04190160|Xultophy|xultophy|mesh-list
20364706|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19300883|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19300884|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300885|NCT04190160|Incretins|incretins|mesh-ancestor
19300886|NCT04190160|Hormones|hormones|mesh-ancestor
19300887|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19300888|NCT04190004|Vasopressins|vasopressins|mesh-list
19300889|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
19300890|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
19300891|NCT04190004|Coagulants|coagulants|mesh-ancestor
19300892|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19300893|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19300894|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
19300895|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396097|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396098|NCT03661892|Dronabinol|dronabinol|mesh-list
19396099|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
19396100|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396101|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19396102|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396103|NCT03661892|Analgesics|analgesics|mesh-ancestor
19396104|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
19396105|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396106|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19396107|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19396108|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396109|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396110|NCT03661892|Hormones|hormones|mesh-ancestor
19396111|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396112|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19396113|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19396114|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19396115|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19396116|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396117|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
19396118|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396119|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396120|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
19396121|NCT03661775|Analgesics|analgesics|mesh-ancestor
19396122|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
19396123|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396124|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396125|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
19396126|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396127|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19396128|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
19396129|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19396130|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20185218|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185219|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20185220|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20185221|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185222|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185223|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20185224|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
20185225|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185226|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364707|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300896|NCT04189744|Metronidazole|metronidazole|mesh-list
19300897|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
19300898|NCT04189744|Piperaquine|piperaquine|mesh-list
19300899|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
19300900|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19300901|NCT04189744|Artenimol|artenimol|mesh-list
19300902|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300903|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19300904|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19300905|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19300906|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
19300907|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19300908|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300909|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300910|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19300911|NCT04189744|Renal Agents|renal agents|mesh-ancestor
19300912|NCT04189783|Bupivacaine|bupivacaine|mesh-list
19300913|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
19300914|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
19300915|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300916|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300917|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
19300918|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300919|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
19300920|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
19300921|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300922|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
19300923|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
19300924|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300925|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
19300926|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300927|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300928|NCT04189484|Evolocumab|evolocumab|mesh-list
19300929|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19300930|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19300931|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19300932|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
19300933|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300934|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19300935|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
19300936|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300937|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
19300938|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
19300939|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
19300940|NCT04189211|Trastuzumab|trastuzumab|mesh-list
19300941|NCT04189211|Maytansine|maytansine|mesh-list
19300942|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300943|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300944|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19300945|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
19300946|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
19300947|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
19300948|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672201|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20612658|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
19300949|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19300950|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
19300951|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300952|NCT04189094|Etoposide|etoposide|mesh-list
19672202|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
19672203|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19672204|NCT04572100|Paclitaxel|paclitaxel|mesh-list
19672205|NCT04572100|Carboplatin|carboplatin|mesh-list
19672206|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19672207|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185227|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20185228|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20185229|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20185230|NCT00200187|Anesthetics|anesthetics|mesh-list
20185231|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185232|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185233|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
20185234|NCT00200226|Pyridoxal|pyridoxal|mesh-list
20185235|NCT00200226|Pyridoxine|pyridoxine|mesh-list
19672208|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612659|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
19300953|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364708|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
20364709|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
20364710|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20364711|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19300954|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19300955|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19300956|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19300957|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300958|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300959|NCT04189055|Irinotecan|irinotecan|mesh-list
19300960|NCT04189055|Cetuximab|cetuximab|mesh-list
19300961|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20364712|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
20364713|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20364714|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
20364715|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
20612660|NCT02252458|Fentanyl|fentanyl|mesh-list
19300962|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19300963|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300964|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300965|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300966|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300967|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
19300968|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19300969|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19300970|NCT04188782|Sevoflurane|sevoflurane|mesh-list
19300971|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19300972|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19300973|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
19300974|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
19300975|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300976|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300977|NCT04189666|Melatonin|melatonin|mesh-list
19300978|NCT04189666|Rivastigmine|rivastigmine|mesh-list
19300979|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
19300980|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19300981|NCT04189666|Protective Agents|protective agents|mesh-ancestor
19300982|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300983|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300984|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19300985|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19300986|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
19300987|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19300988|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19300989|NCT04189198|Bupivacaine|bupivacaine|mesh-list
19300990|NCT04189198|Carticaine|carticaine|mesh-list
19300991|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
19300992|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
19300993|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19300994|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19300995|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
19300996|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19300997|NCT04188730|Lofexidine|lofexidine|mesh-list
19300998|NCT04188730|Clonidine|clonidine|mesh-list
19300999|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301000|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19301001|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301002|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
19301003|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301004|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19301005|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19301006|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19301007|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
19301008|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301009|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301010|NCT04188730|Analgesics|analgesics|mesh-ancestor
19301011|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
19301012|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
19301013|NCT04188691|Vaccines|vaccines|mesh-list
19301014|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
19301015|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301016|NCT04188483|Selenium|selenium|mesh-list
19301017|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301018|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
20425469|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
19404333|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
19301019|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301020|NCT04188483|Protective Agents|protective agents|mesh-ancestor
19301021|NCT04188483|Trace Elements|trace elements|mesh-ancestor
19672209|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
20185236|NCT00200226|Misoprostol|misoprostol|mesh-list
20185237|NCT00200226|Vitamins|vitamins|mesh-ancestor
19301022|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
19301023|NCT04188431|Dexamethasone|dexamethasone|mesh-list
19301024|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301025|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
19301026|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
19301027|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301028|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301029|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301030|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
19301031|NCT04188431|Hormones|hormones|mesh-ancestor
20364716|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364717|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364718|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20364719|NCT00948103|Analgesics|analgesics|mesh-ancestor
20364720|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
20364721|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364722|NCT00948168|Exenatide|exenatide|mesh-list
20364723|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364724|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364725|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20364726|NCT00948168|Incretins|incretins|mesh-ancestor
20364727|NCT00948168|Hormones|hormones|mesh-ancestor
20364728|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364729|NCT00948220|Ribavirin|ribavirin|mesh-list
19301032|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19301033|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19301034|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301035|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
19301036|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19301037|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
19301038|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301039|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
19301040|NCT04188561|Protective Agents|protective agents|mesh-ancestor
19301041|NCT04188353|Mannitol|mannitol|mesh-list
19301042|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19301043|NCT04188353|Diuretics|diuretics|mesh-ancestor
19301044|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
19301045|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301046|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
19301047|NCT04188106|Varenicline|varenicline|mesh-list
19301048|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19301049|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20364730|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19301050|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
19301051|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301052|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301053|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301054|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
19301055|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
19301056|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19301057|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
19301058|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
20185238|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
20185239|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185240|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20185241|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
20185242|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20185243|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20185244|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185245|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
20185246|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185247|NCT00200252|Oxytocin|oxytocin|mesh-list
19301059|NCT04188249|Golimumab|golimumab|mesh-list
19301060|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19301061|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301062|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364731|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
20425470|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
19301063|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
19301064|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185248|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
20185249|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19301065|NCT04188119|Aspirin|aspirin|mesh-list
19301066|NCT04188119|Avelumab|avelumab|mesh-list
19301067|NCT04188119|Lansoprazole|lansoprazole|mesh-list
19301068|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
19301069|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19301070|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19301071|NCT04188119|Analgesics|analgesics|mesh-ancestor
19301072|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
19301073|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301074|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301075|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301076|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301077|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19301078|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301079|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301080|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19301081|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19301082|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301083|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
19301084|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19301085|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301086|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19301087|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301088|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19301089|NCT04188158|Capecitabine|capecitabine|mesh-list
19301090|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
19301091|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19301092|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
19301093|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301094|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301095|NCT04188184|Epinephrine|epinephrine|mesh-list
19301096|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
19672210|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
19672211|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672212|NCT04551885|Aldesleukin|aldesleukin|mesh-list
19672213|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
19672214|NCT04551885|Fludarabine|fludarabine|mesh-list
19672215|NCT04551885|Avelumab|avelumab|mesh-list
19672216|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19672217|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
20364732|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301097|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19301098|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19301099|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
19301100|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301101|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301102|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301103|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19301104|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19301105|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
19301106|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301107|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19301108|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
19301109|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
20185250|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364733|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
20364734|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364735|NCT00948272|Vaccines|vaccines|mesh-list
20364736|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
20364737|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364738|NCT00948402|Metformin|metformin|mesh-list
20364739|NCT00948402|Biguanides|biguanides|mesh-list
20364740|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
20364741|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
20364742|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364743|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185251|NCT00200382|Bortezomib|bortezomib|mesh-list
20185252|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185253|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20185254|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185255|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20185256|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185257|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672218|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364744|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19301110|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
19301111|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19301112|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19301113|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301114|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
19301115|NCT04188184|Coagulants|coagulants|mesh-ancestor
19301116|NCT04188171|Polidocanol|polidocanol|mesh-list
19301117|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19301118|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19301119|NCT04188223|Vaccines|vaccines|mesh-list
19301120|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
19301121|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301122|NCT04188314|Desflurane|desflurane|mesh-list
19301123|NCT04188314|Isoflurane|isoflurane|mesh-list
19301124|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19301125|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
19301126|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
19301127|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364745|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20364746|NCT00948480|Sargramostim|sargramostim|mesh-list
20364747|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
20364748|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364749|NCT00948493|Insulin|insulin|mesh-list
20364750|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20364751|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364752|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364753|NCT00948584|Insulin|insulin|mesh-list
20364754|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20364755|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
20364756|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364757|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364758|NCT00948649|Varenicline|varenicline|mesh-list
20364759|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20364760|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20364761|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
20364762|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20364763|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364764|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364765|NCT00948662|Ketoconazole|ketoconazole|mesh-list
19301128|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301129|NCT04187755|Ceftazidime|ceftazidime|mesh-list
19301130|NCT04187755|Cefepime|cefepime|mesh-list
19301131|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19301132|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396131|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396132|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19396133|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
19396134|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19396135|NCT03661684|Prednisone|prednisone|mesh-list
19396136|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396137|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
19396138|NCT03661684|Hormones|hormones|mesh-ancestor
19396139|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396140|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396141|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19396142|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396143|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
19396144|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19396145|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19396146|NCT03661567|Prednisolone|prednisolone|mesh-list
19396147|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
19396148|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19396149|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
20364766|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
20364767|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364768|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20364769|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19396150|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396151|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
19396152|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
19396153|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396154|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396155|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396156|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
19396157|NCT03661567|Hormones|hormones|mesh-ancestor
20612661|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19396158|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396159|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20364770|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364771|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364772|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20364773|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
20364774|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364775|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364776|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20364777|NCT00948727|Cyclosporine|cyclosporine|mesh-list
20364778|NCT00948727|Cyclosporins|cyclosporins|mesh-list
20364779|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364780|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364781|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364782|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
20364783|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364784|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
20364785|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364786|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
20364787|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364788|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20364789|NCT00948740|Vitamin D|vitamin d|mesh-list
20364790|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
20364791|NCT00948740|Vitamins|vitamins|mesh-ancestor
20364792|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
20364793|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364794|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19301133|NCT04187807|Melatonin|melatonin|mesh-list
19301134|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
19301135|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301136|NCT04187807|Protective Agents|protective agents|mesh-ancestor
19301137|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301138|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301139|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
19301140|NCT04187898|Docetaxel|docetaxel|mesh-list
19301141|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301142|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
19301143|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301144|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672219|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672220|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19672221|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
19672222|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672223|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672224|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19672225|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19672226|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19672227|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
19672228|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672229|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672230|NCT04497870|Peppermint oil|peppermint oil|mesh-list
19672231|NCT04497870|Menthol|menthol|mesh-list
19672232|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
19301145|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19301146|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
19672233|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
19672234|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
19672235|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
19672236|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672237|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672238|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672239|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
20364795|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20364796|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20364797|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20364798|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364799|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
20364800|NCT00948805|Goserelin|goserelin|mesh-list
20364801|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20364802|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20364803|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364804|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20364805|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364806|NCT00948987|Aspirin|aspirin|mesh-list
19672240|NCT04487041|Vaccines|vaccines|mesh-list
19672241|NCT04487041|Immunologic Factors|immunologic factors|mesh-ancestor
20364807|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364808|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20364809|NCT00948987|Analgesics|analgesics|mesh-ancestor
20364810|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
20364811|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364812|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364813|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364814|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364815|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20364816|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20364817|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301147|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301148|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301149|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19301150|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
19301151|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
19301152|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
19301153|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
20364818|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20364819|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20364820|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364821|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
20364822|NCT00949026|Sirolimus|sirolimus|mesh-list
20364823|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20364824|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364825|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20364826|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364827|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
20364828|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364829|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
20364830|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364831|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
20364832|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20364833|NCT00949065|Antibodies|antibodies|mesh-list
20364834|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
19301154|NCT04187469|Rifampin|rifampin|mesh-list
19301155|NCT04187469|Isoniazid|isoniazid|mesh-list
19301156|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
19301157|NCT04187469|Ethambutol|ethambutol|mesh-list
20364835|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20364836|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
20364837|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364838|NCT00949130|Linezolid|linezolid|mesh-list
20364839|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20364840|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364841|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20364842|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364843|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364844|NCT00949182|Doxorubicin|doxorubicin|mesh-list
20364845|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20364846|NCT00949182|Mitomycins|mitomycins|mesh-list
20364847|NCT00949182|Mitomycin|mitomycin|mesh-list
20364848|NCT00949182|Sorafenib|sorafenib|mesh-list
20364849|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20364850|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364851|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20364852|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20364853|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364854|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364855|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20364856|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
20364857|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20364858|NCT00949247|Bevacizumab|bevacizumab|mesh-list
20364859|NCT00949247|Trastuzumab|trastuzumab|mesh-list
20364860|NCT00949247|Carboplatin|carboplatin|mesh-list
20364861|NCT00949247|Docetaxel|docetaxel|mesh-list
20364862|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20364863|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364864|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20364865|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20364866|NCT00949247|Growth Substances|growth substances|mesh-ancestor
20364867|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364868|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
19301158|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20364869|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
20364870|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
20364871|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
20612662|NCT02252458|Narcotics|narcotics|mesh-ancestor
20612663|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838444|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838445|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19838446|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
19838447|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
19838448|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19838449|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19838450|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
20364872|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301159|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301160|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19301161|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19301162|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301163|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301164|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301165|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19301166|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
19301167|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
19301168|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20425471|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425472|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20425473|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20425474|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
20425475|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425476|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20425477|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20425478|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425479|NCT01275248|Ondansetron|ondansetron|mesh-list
20425480|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
20425481|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
20425482|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425483|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301169|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19301170|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19301171|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19301172|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19301173|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19301174|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19301175|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19301176|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19301177|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
19301178|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19301179|NCT04187703|Azacitidine|azacitidine|mesh-list
19301180|NCT04187703|Decitabine|decitabine|mesh-list
19301181|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19301182|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
19301183|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301184|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301185|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301186|NCT04187417|Tetracaine|tetracaine|mesh-list
19301187|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
20425484|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425485|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
20425486|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
20425487|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20425488|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
20425489|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425490|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425491|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20425492|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20425493|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301188|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
19301189|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301190|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301191|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
19301192|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301193|NCT04187456|Midazolam|midazolam|mesh-list
19301194|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19301195|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19301196|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301197|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301198|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19838451|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425494|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20364873|NCT00949299|Buprenorphine|buprenorphine|mesh-list
20364874|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20364875|NCT00949299|Narcotics|narcotics|mesh-ancestor
20364876|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364877|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364878|NCT00949299|Analgesics|analgesics|mesh-ancestor
20364879|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
19301199|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19301200|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19301201|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19301202|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
19301203|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
19301204|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
20364880|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364881|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20364882|NCT00949364|Pomalidomide|pomalidomide|mesh-list
20364883|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
20364884|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301205|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
19301206|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301207|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301208|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
19301209|NCT04187105|Fludarabine|fludarabine|mesh-list
19301210|NCT04187105|Tacrolimus|tacrolimus|mesh-list
19301211|NCT04187105|Complement Factor H|complement factor h|mesh-list
19301212|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301213|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
19301214|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301215|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301216|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19301217|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
19301218|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301219|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301220|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19301221|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20364885|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20364886|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20364887|NCT00949364|Growth Substances|growth substances|mesh-ancestor
20364888|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
20364889|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364890|NCT00949377|Bromides|bromides|mesh-list
20364891|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
20364892|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
20364893|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20364894|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364895|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
20364896|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364897|NCT00949442|Insulin|insulin|mesh-list
20364898|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20364899|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
20364900|NCT00949442|Glimepiride|glimepiride|mesh-list
20364901|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20364902|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364903|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20364904|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364905|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
20364906|NCT00949455|Lapatinib|lapatinib|mesh-list
20364907|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364908|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19301222|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301223|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19301224|NCT04186702|Ranibizumab|ranibizumab|mesh-list
19301225|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20364909|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364910|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364911|NCT00949494|Hylan|hylan|mesh-list
20364912|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
20364913|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
20364914|NCT00949494|Protective Agents|protective agents|mesh-ancestor
20364915|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364916|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20364917|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
19301226|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19301227|NCT04186702|Growth Substances|growth substances|mesh-ancestor
19396160|NCT03661567|Protective Agents|protective agents|mesh-ancestor
20364918|NCT00949546|Etanercept|etanercept|mesh-list
20364919|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20364920|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19301228|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301229|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
19301230|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301231|NCT04186936|Simethicone|simethicone|mesh-list
19301232|NCT04186936|Loperamide|loperamide|mesh-list
19301233|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
19301234|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301235|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
19301236|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301237|NCT04186936|Emollients|emollients|mesh-ancestor
20364921|NCT00949546|Analgesics|analgesics|mesh-ancestor
20364922|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
20364923|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20364924|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364925|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20364926|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20364927|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364928|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364929|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
20364930|NCT00949572|Vaccines|vaccines|mesh-list
20364931|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
20364932|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
20364933|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364934|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20364935|NCT00949598|Tamoxifen|tamoxifen|mesh-list
20364936|NCT00949598|Letrozole|letrozole|mesh-list
20364937|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364938|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364939|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20364940|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20364941|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364942|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20364943|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
20364944|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364945|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364946|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19301238|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
19838452|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838453|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838454|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301242|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
19301243|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
19301244|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19301245|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301246|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301247|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
19301248|NCT04187014|Coagulants|coagulants|mesh-ancestor
19301249|NCT04186598|Nifedipine|nifedipine|mesh-list
19301250|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19301251|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19301252|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301253|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19301254|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301255|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19301256|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
19301257|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19301258|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
19301259|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19301260|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301261|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301262|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19301263|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20364947|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20364948|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20364949|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20364950|NCT00949624|Docetaxel|docetaxel|mesh-list
20364951|NCT00949624|Axitinib|axitinib|mesh-list
20364952|NCT00949624|Crenolanib|crenolanib|mesh-list
20364953|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364954|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
20364955|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
20364956|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
20364957|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301264|NCT04186559|Protective Agents|protective agents|mesh-ancestor
20364958|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20364959|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364960|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20364961|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20364962|NCT00949663|Incretins|incretins|mesh-ancestor
19301265|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301266|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
19301267|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19301268|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
19301269|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
19301270|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301271|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
19301272|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
19301273|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
19301274|NCT04186299|Clonidine|clonidine|mesh-list
19301275|NCT04186299|Epinephrine|epinephrine|mesh-list
19301276|NCT04186299|Carticaine|carticaine|mesh-list
19301277|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20364963|NCT00949663|Hormones|hormones|mesh-ancestor
20364964|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20364965|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364966|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20364967|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
20364968|NCT00949728|Coagulants|coagulants|mesh-ancestor
20364969|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
20364970|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20364971|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20364972|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364973|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
20364974|NCT00949832|Vitamin D|vitamin d|mesh-list
20364975|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
20364976|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
20364977|NCT00949832|Vitamins|vitamins|mesh-list
20364978|NCT00949832|Calcium|calcium|mesh-list
20364979|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
20364980|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364981|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19301278|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19301279|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
19301280|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301281|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301282|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301283|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19301284|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19301285|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
19301286|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301287|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19301288|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
19301289|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
19301290|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
19301291|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19301292|NCT04186299|Analgesics|analgesics|mesh-ancestor
19301293|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
19301294|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301295|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
19301296|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19301297|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
19301298|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
19301299|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301300|NCT04186013|Atezolizumab|atezolizumab|mesh-list
19301301|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301302|NCT04186026|Glucagon|glucagon|mesh-list
19301303|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19301304|NCT04186026|Incretins|incretins|mesh-ancestor
19301305|NCT04186026|Hormones|hormones|mesh-ancestor
19301306|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19301307|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301308|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301309|NCT04185857|Olmesartan|olmesartan|mesh-list
19301310|NCT04185857|Canrenone|canrenone|mesh-list
19301311|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301312|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19301313|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19301314|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301315|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19301316|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
20364982|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19301317|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19301318|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301319|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19301320|NCT04185857|Diuretics|diuretics|mesh-ancestor
19301321|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
19301322|NCT04185675|Anesthetics|anesthetics|mesh-list
19301323|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301324|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301325|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19301326|NCT04185831|Everolimus|everolimus|mesh-list
19301327|NCT04185831|Atezolizumab|atezolizumab|mesh-list
19301328|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301329|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301330|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
19301331|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396161|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19396162|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396163|NCT03661515|Cytarabine|cytarabine|mesh-list
19396164|NCT03661515|Fludarabine|fludarabine|mesh-list
19396165|NCT03661515|Idarubicin|idarubicin|mesh-list
19396166|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396167|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19396168|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
19396169|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396170|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364983|NCT00949949|Gemcitabine|gemcitabine|mesh-list
20364984|NCT00949949|Everolimus|everolimus|mesh-list
20364985|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20364986|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20364987|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
20364988|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20364989|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
20364990|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20364991|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20364992|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20364993|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
20364994|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20364995|NCT00949962|Leuprolide|leuprolide|mesh-list
20364996|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
20364997|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20364998|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
20364999|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20365000|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365001|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20365002|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365003|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
20365004|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365005|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
20365006|NCT00950027|Povidone|povidone|mesh-list
20365007|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
20365008|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
20365009|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20365010|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365011|NCT00950066|Amlodipine|amlodipine|mesh-list
20365012|NCT00950066|Irbesartan|irbesartan|mesh-list
20365013|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20365014|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20365015|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365016|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365017|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20365018|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365019|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
20365020|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20365021|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20365022|NCT00950105|Semapimod|semapimod|mesh-list
20365023|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20365024|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365025|NCT00950105|Analgesics|analgesics|mesh-ancestor
19396171|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
19396172|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396173|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
19396174|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365026|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
19396175|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19396176|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19301332|NCT04185649|Capecitabine|capecitabine|mesh-list
19301333|NCT04185649|Lapatinib|lapatinib|mesh-list
19301334|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19301335|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
19301336|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301337|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301338|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19301339|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301340|NCT04185350|Exenatide|exenatide|mesh-list
19301341|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19301342|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301343|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19301344|NCT04185350|Incretins|incretins|mesh-ancestor
19301345|NCT04185350|Hormones|hormones|mesh-ancestor
19301346|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19301347|NCT04185402|Azithromycin|azithromycin|mesh-list
19301348|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19301349|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301350|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
19301351|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19301352|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
19301353|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
19301354|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365027|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365028|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365029|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365030|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365031|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365032|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
19301355|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301356|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19301357|NCT04185233|Analgesics|analgesics|mesh-ancestor
19301358|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
19301359|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301360|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19301361|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301362|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19301363|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301364|NCT04185077|Heparin|heparin|mesh-list
19301365|NCT04185077|Calcium heparin|calcium heparin|mesh-list
19301366|NCT04185077|Bivalirudin|bivalirudin|mesh-list
19301367|NCT04185077|Antithrombins|antithrombins|mesh-list
19301368|NCT04185077|Thrombin|thrombin|mesh-list
19301369|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
19301370|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19301371|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301372|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301373|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
19301374|NCT04185077|Coagulants|coagulants|mesh-ancestor
19301375|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19301376|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
19301377|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301378|NCT04185194|Lidocaine|lidocaine|mesh-list
19301379|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
19301380|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
19301381|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301382|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301383|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
19301384|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301385|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19301386|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19301387|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19301388|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19301389|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301390|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19301391|NCT04184869|Belinostat|belinostat|mesh-list
19301392|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20365033|NCT00950196|Amantadine|amantadine|mesh-list
20365034|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20365035|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19301393|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19301394|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
19301395|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301396|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301397|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20365036|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
20365037|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365038|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
20365039|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365040|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365041|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365042|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365043|NCT00950196|Analgesics|analgesics|mesh-ancestor
20365044|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
20365045|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365046|NCT00950209|Heparin|heparin|mesh-list
20365047|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
20365048|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20365049|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20365050|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365051|NCT00950222|Imipenem|imipenem|mesh-list
20365052|NCT00950222|Amikacin|amikacin|mesh-list
20365053|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20365054|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365055|NCT00950261|Cisplatin|cisplatin|mesh-list
20365056|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365057|NCT00950339|Omeprazole|omeprazole|mesh-list
20365058|NCT00950339|Pantoprazole|pantoprazole|mesh-list
20365059|NCT00950339|Famotidine|famotidine|mesh-list
20365060|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20365061|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365062|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20365063|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365064|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365065|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20365066|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
20365067|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
19301398|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19301399|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
19301400|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301401|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301402|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19301403|NCT04185103|Valsartan|valsartan|mesh-list
19301404|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19301405|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301406|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19301407|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19301408|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301409|NCT04184921|Aspirin|aspirin|mesh-list
19301410|NCT04184921|Osimertinib|osimertinib|mesh-list
19301411|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19301412|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19301413|NCT04184921|Analgesics|analgesics|mesh-ancestor
20365068|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365069|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365070|NCT00950391|Tacrolimus|tacrolimus|mesh-list
20365071|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365072|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
20365073|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301414|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
19301415|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365074|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20365075|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365076|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365077|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
20365078|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
20365079|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20365080|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20365081|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365082|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365083|NCT00950404|Urological Agents|urological agents|mesh-ancestor
20365084|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
20365085|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365086|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365087|NCT00950430|Corticosterone|corticosterone|mesh-list
20365088|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365089|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
20365090|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19301416|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301417|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301418|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301419|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19301420|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301421|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301422|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19301423|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19301424|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301425|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
19301426|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301427|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19301428|NCT04184518|Durvalumab|durvalumab|mesh-list
19301429|NCT04184518|Cediranib|cediranib|mesh-list
19301430|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365091|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365092|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
20365093|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
20365094|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
20365095|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20365096|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20365097|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365098|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365099|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365100|NCT00950625|Lidocaine|lidocaine|mesh-list
20365101|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
20365102|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
20365103|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365104|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365105|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
20365106|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365107|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20365108|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19301431|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301432|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301433|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301434|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19301435|NCT04184466|Insulin|insulin|mesh-list
19301436|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19301437|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
19301438|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
19301439|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19301440|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19301441|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301442|NCT04184492|Insulin|insulin|mesh-list
19301443|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19301444|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
19301445|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
19301446|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19301447|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
19301448|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19301449|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
19301450|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19301451|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301452|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19301453|NCT04184505|Azacitidine|azacitidine|mesh-list
19301454|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19301455|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
19301456|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301457|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301458|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301459|NCT04183881|Brodalumab|brodalumab|mesh-list
19301460|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
19838455|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
19838456|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
19838457|NCT00621023|Decitabine|decitabine|mesh-list
19838458|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
19301461|NCT04184141|Alprazolam|alprazolam|mesh-list
19301462|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
19301463|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19301464|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301465|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301466|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19301467|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19301468|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20365109|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19301469|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
19301470|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
19301471|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301472|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301473|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
19301474|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
19301475|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19301476|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
19301477|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
19301478|NCT04184115|Scopolamine|scopolamine|mesh-list
19301479|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19301480|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
19301481|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
19301482|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301483|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301484|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301485|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
20365110|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365111|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365112|NCT00950677|Exenatide|exenatide|mesh-list
20365113|NCT00950677|Pramlintide|pramlintide|mesh-list
20365114|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20365115|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365116|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20365117|NCT00950677|Incretins|incretins|mesh-ancestor
20365118|NCT00950677|Hormones|hormones|mesh-ancestor
20365119|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365120|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20365121|NCT00950794|Tulobuterol|tulobuterol|mesh-list
20365122|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20365123|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
20365124|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365125|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301486|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19301487|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
19301488|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301489|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301490|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19301491|NCT04183634|Rotigotine|rotigotine|mesh-list
19301492|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
19301493|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
19301494|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301495|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301496|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396177|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19396178|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396179|NCT03661489|Propofol|propofol|mesh-list
19396180|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19396181|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396182|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396183|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19396184|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
19396185|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
19396186|NCT03661463|Aspirin|aspirin|mesh-list
20365126|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20365127|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
20365128|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19396187|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19396188|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396189|NCT03661463|Analgesics|analgesics|mesh-ancestor
19396190|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
19396191|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396192|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396193|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396194|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396195|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19396196|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19396197|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396198|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19396199|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19396200|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396201|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
19396202|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
19396203|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19396204|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
19672242|NCT04487041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672243|NCT04431141|Empagliflozin|empagliflozin|mesh-list
19301497|NCT04183556|Naproxen|naproxen|mesh-list
19301498|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19301499|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19301500|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19301501|NCT04183556|Analgesics|analgesics|mesh-ancestor
19301502|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
19301503|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301504|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301505|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301506|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
19301507|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19301508|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301509|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301510|NCT04183725|Oseltamivir|oseltamivir|mesh-list
19301511|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
19672244|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19672245|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365129|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20365130|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20365131|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
20365132|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365133|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672246|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19672247|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672248|NCT04412395|Lactoferrin|lactoferrin|mesh-list
19672249|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301512|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301513|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301514|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301515|NCT04183608|Adalimumab|adalimumab|mesh-list
19301516|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301517|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301518|NCT04183738|Ritonavir|ritonavir|mesh-list
19301519|NCT04183738|Darunavir|darunavir|mesh-list
19301520|NCT04183738|Dolutegravir|dolutegravir|mesh-list
19301521|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19301522|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19301523|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
19301524|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301525|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301526|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19301527|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19301528|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
19301529|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301530|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19301531|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19301532|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19301533|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19301534|NCT04183491|Interferons|interferons|mesh-list
19301535|NCT04183491|Interferon-beta|interferon-beta|mesh-list
19301536|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
19301537|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301538|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
19301539|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301540|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
19301541|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301542|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19301543|NCT04183361|Cortisone|cortisone|mesh-list
19301544|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301545|NCT04183192|Reslizumab|reslizumab|mesh-list
19301546|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19301547|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
19301548|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19301549|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
19301550|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301551|NCT04183387|Simvastatin|simvastatin|mesh-list
19301552|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19301553|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19301554|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
19301555|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301556|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19301557|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19301558|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301559|NCT04183114|Vaccines|vaccines|mesh-list
19301560|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
19301561|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301562|NCT04183075|Vitamins|vitamins|mesh-list
19301563|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
19301564|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
20365134|NCT00950820|Capecitabine|capecitabine|mesh-list
20365135|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
20365136|NCT00950820|Panitumumab|panitumumab|mesh-list
20365137|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365138|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
20365139|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365140|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365141|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365142|NCT00950898|Caffeine|caffeine|mesh-list
20365143|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20365144|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365145|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20365146|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365147|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365148|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20365149|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20365150|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
20365151|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425495|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20425496|NCT01275274|Tretinoin|tretinoin|mesh-list
20425497|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425498|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
20425499|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
20425500|NCT01275287|Eculizumab|eculizumab|mesh-list
20425501|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20425502|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425503|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
20425504|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425505|NCT01275352|Eplerenone|eplerenone|mesh-list
20425506|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20425507|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
20425508|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425509|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425510|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20425511|NCT01275352|Diuretics|diuretics|mesh-ancestor
19672250|NCT04310748|Anesthetics|anesthetics|mesh-list
19672251|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672252|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672253|NCT04304768|Vaccines|vaccines|mesh-list
20612664|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301565|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425512|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
20425513|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20425514|NCT01275443|Rilpivirine|rilpivirine|mesh-list
20425515|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20612665|NCT02252458|Analgesics|analgesics|mesh-ancestor
19301566|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
19301567|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301568|NCT04183075|Protective Agents|protective agents|mesh-ancestor
19301569|NCT04183257|Vitamin D|vitamin d|mesh-list
19301570|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
19301571|NCT04183257|Vitamins|vitamins|mesh-list
19301572|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
19301573|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301574|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19301575|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19301576|NCT04183296|Propofol|propofol|mesh-list
19301577|NCT04183296|Sevoflurane|sevoflurane|mesh-list
19301578|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19301579|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301580|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301581|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19301582|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
19301583|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
19301584|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19301585|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19301586|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
19301587|NCT04182984|Prednisone|prednisone|mesh-list
19301588|NCT04182984|Azathioprine|azathioprine|mesh-list
19301589|NCT04182984|Bromides|bromides|mesh-list
19301590|NCT04182984|Tacrolimus|tacrolimus|mesh-list
19301591|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19301592|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20365152|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
20365153|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20365154|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
19301593|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301594|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
19301595|NCT04182984|Hormones|hormones|mesh-ancestor
19301596|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19301597|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301598|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19301599|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301600|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
19301601|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19301602|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301603|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301604|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19301605|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19301606|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
19301607|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19301608|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301609|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
19301610|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
19301611|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19301612|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301613|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19301614|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
19301615|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301616|NCT04182932|Vaccines|vaccines|mesh-list
19301617|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
19301618|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301619|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
19301620|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19301621|NCT04182737|Antibodies|antibodies|mesh-list
19301622|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
19301623|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301624|NCT04182568|Paclitaxel|paclitaxel|mesh-list
19301625|NCT04182568|Docetaxel|docetaxel|mesh-list
19301626|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
19301627|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19301628|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301629|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
19301630|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
19301631|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
19301632|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301633|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301634|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
20365155|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20365156|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20365157|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365158|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20365159|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365160|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301635|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301636|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301637|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19301638|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
19301639|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19301640|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19301641|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301642|NCT04182854|Diuretics|diuretics|mesh-ancestor
19301643|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
19301644|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301645|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19301646|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19301647|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301648|NCT04182724|Paclitaxel|paclitaxel|mesh-list
19301649|NCT04182724|Apatinib|apatinib|mesh-list
19301650|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19301651|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301652|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
20365161|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19301653|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
19301654|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
19301655|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301656|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19301657|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301658|NCT04182555|Bilirubin|bilirubin|mesh-list
19301659|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
19301660|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301661|NCT04182555|Protective Agents|protective agents|mesh-ancestor
19301662|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301663|NCT04182828|Lidocaine|lidocaine|mesh-list
19301664|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
19301665|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
19301666|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301667|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301668|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
19301669|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301670|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19301671|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19301672|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20612666|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
20612667|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612668|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20612669|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20612670|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
20612671|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
20612672|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
20612673|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20612674|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301673|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19672254|NCT04304768|Immunologic Factors|immunologic factors|mesh-ancestor
19672255|NCT04304768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672256|NCT04294498|Entecavir|entecavir|mesh-list
19672257|NCT04294498|Durvalumab|durvalumab|mesh-list
19672258|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672259|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672260|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
19672261|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672262|NCT04206488|Digoxin|digoxin|mesh-list
19672263|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19672264|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19672265|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672266|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838459|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838460|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
19301674|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301675|NCT04182191|Tenoxicam|tenoxicam|mesh-list
19301676|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19301677|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19301678|NCT04182191|Analgesics|analgesics|mesh-ancestor
19301679|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
19301680|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301681|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301682|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301683|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301684|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19301685|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301686|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301687|NCT04182399|Zonisamide|zonisamide|mesh-list
19301688|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
19301689|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19301690|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19301691|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301692|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19301693|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672267|NCT04206488|Protective Agents|protective agents|mesh-ancestor
19672268|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672269|NCT04188418|Fentanyl|fentanyl|mesh-list
19672270|NCT04188418|Morphine|morphine|mesh-list
20185258|NCT00200421|Atenolol|atenolol|mesh-list
19672271|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19672272|NCT04188418|Narcotics|narcotics|mesh-ancestor
19672273|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185259|NCT00200421|Nebivolol|nebivolol|mesh-list
20185260|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19672274|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672275|NCT04188418|Analgesics|analgesics|mesh-ancestor
20185261|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301694|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19301695|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19301696|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301697|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19301698|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19301699|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20185262|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
20185263|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
20185264|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185265|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185266|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20185267|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20185268|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20185269|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185270|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185271|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301700|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301701|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
19301702|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301703|NCT04181645|Gemcitabine|gemcitabine|mesh-list
19301704|NCT04181645|Paclitaxel|paclitaxel|mesh-list
19301705|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19301706|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301707|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
19301708|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
19301709|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
19301710|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301711|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19301712|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
19301713|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
19301714|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301715|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301716|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301717|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
19301718|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301719|NCT04181567|S 20098|s 20098|mesh-list
19301720|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19301721|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301722|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396205|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396206|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396207|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19396208|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
19396209|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19396210|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
20185272|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185273|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20185274|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20185275|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20185276|NCT00200434|Nebivolol|nebivolol|mesh-list
20185277|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20185278|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185279|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20185280|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20185281|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20185282|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185283|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185284|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185285|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185286|NCT00200447|Carbidopa|carbidopa|mesh-list
20185287|NCT00200447|Levodopa|levodopa|mesh-list
20185288|NCT00200447|Entacapone|entacapone|mesh-list
20185289|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20185290|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20185291|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20185292|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
20185293|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185294|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185295|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185296|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20185297|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185298|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19301723|NCT04181736|Guanfacine|guanfacine|mesh-list
19301724|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19301725|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19301726|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19301727|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19301728|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
19301729|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301730|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301731|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301732|NCT04181749|Aspirin|aspirin|mesh-list
19301733|NCT04181749|Atorvastatin|atorvastatin|mesh-list
19301734|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19301735|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19301736|NCT04181749|Analgesics|analgesics|mesh-ancestor
19301737|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
19301738|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301739|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301740|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301741|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301742|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19301743|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20365162|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20365163|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20365164|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
20365165|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365166|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20365167|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20365168|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365169|NCT00951223|Interferons|interferons|mesh-list
20365170|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
20365171|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301744|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301745|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19301746|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19301747|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301748|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
19301749|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19301750|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19301751|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
19301752|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19301753|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19301754|NCT04181385|Bromocriptine|bromocriptine|mesh-list
20365172|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
20365173|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365174|NCT00951236|Cortisone|cortisone|mesh-list
20365175|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365176|NCT00951431|Esomeprazole|esomeprazole|mesh-list
20365177|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20365178|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365179|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20365180|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365181|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365182|NCT00951444|Gemcitabine|gemcitabine|mesh-list
20365183|NCT00951444|Carboplatin|carboplatin|mesh-list
20365184|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365185|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365186|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
20365187|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365188|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
20365189|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365190|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365191|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365192|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
19301755|NCT04181385|Olanzapine|olanzapine|mesh-list
19301756|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
19301757|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
19301758|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301759|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301760|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301761|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19301762|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19301763|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301764|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20365193|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365194|NCT00951574|Nadroparin|nadroparin|mesh-list
20365195|NCT00951574|Calcium|calcium|mesh-list
20365196|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20365197|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365198|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
20365199|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20365200|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20365201|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365202|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
20365203|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
19301765|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19301766|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19301767|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19301768|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301769|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301770|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
19301771|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19301772|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19301773|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
19301774|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19301775|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
19301776|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
19301777|NCT04181489|Prednisolone|prednisolone|mesh-list
19301778|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
19301779|NCT04181489|Rituximab|rituximab|mesh-list
19301780|NCT04181489|Doxorubicin|doxorubicin|mesh-list
20365204|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20365205|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20365206|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365207|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365208|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20365209|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20365210|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20365211|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
20365212|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365213|NCT00951834|Protective Agents|protective agents|mesh-ancestor
20365214|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365215|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20365216|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20365217|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365218|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20365219|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
20365220|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
20365221|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20365222|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20365223|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365224|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365225|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20365226|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20365227|NCT00952003|Bevacizumab|bevacizumab|mesh-list
20365228|NCT00952003|Docetaxel|docetaxel|mesh-list
20365229|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
20365230|NCT00952003|Irinotecan|irinotecan|mesh-list
20365231|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365232|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365233|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20365234|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20365235|NCT00952003|Growth Substances|growth substances|mesh-ancestor
19301781|NCT04181489|Vincristine|vincristine|mesh-list
19301782|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301783|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
19301784|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301785|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301786|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19301787|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
19301788|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301789|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301790|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19301791|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19301792|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19301793|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19301794|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19301795|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301796|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19301797|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19301798|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19301799|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19301800|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19301801|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
19301802|NCT04181489|Hormones|hormones|mesh-ancestor
19301803|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185299|NCT00200460|Nebivolol|nebivolol|mesh-list
20185300|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20185301|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185302|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20185303|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20185304|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20185305|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
19301804|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19301805|NCT04181346|Pregabalin|pregabalin|mesh-list
19301806|NCT04181346|Analgesics|analgesics|mesh-ancestor
19301807|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
19301808|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301809|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301810|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
19301811|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19301812|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19301813|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301814|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19301815|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19301816|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19301817|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301818|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19301819|NCT04181203|Leuprolide|leuprolide|mesh-list
19301820|NCT04181203|Goserelin|goserelin|mesh-list
19301821|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19301822|NCT04181203|Hormones|hormones|mesh-list
19301823|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19301824|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301825|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19301826|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
19301827|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19301828|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19301829|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301830|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
19301831|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19301832|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
19301833|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19301834|NCT04180982|Febuxostat|febuxostat|mesh-list
19301835|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
19301836|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301837|NCT04180657|Protein C|protein c|mesh-list
19301838|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
19301839|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19301840|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301841|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301842|NCT04180384|Paclitaxel|paclitaxel|mesh-list
19301843|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19301844|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19301845|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301846|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
19301847|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
19301848|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
19301849|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301850|NCT04180072|Bevacizumab|bevacizumab|mesh-list
19301851|NCT04180072|Atezolizumab|atezolizumab|mesh-list
19301852|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672276|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
19672277|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185306|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185307|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185308|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185309|NCT00200473|Nebivolol|nebivolol|mesh-list
19301853|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672278|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19672279|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19672280|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
19672281|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
20185310|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20365236|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301854|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19301855|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19301856|NCT04180072|Growth Substances|growth substances|mesh-ancestor
19301857|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301858|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
19301859|NCT04180150|Entecavir|entecavir|mesh-list
19301860|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
19301861|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301862|NCT04180007|Apatinib|apatinib|mesh-list
19301863|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301864|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19301865|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301866|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301867|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
19301868|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301869|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
19301870|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19301871|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19301872|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301873|NCT04179747|Urological Agents|urological agents|mesh-ancestor
19301874|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
19301875|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19301876|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
19301877|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301878|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301879|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19301880|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
19301881|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19301882|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
19301883|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301884|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301885|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19301886|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
19301887|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
19301888|NCT04179942|Protective Agents|protective agents|mesh-ancestor
19301889|NCT04179604|Simendan|simendan|mesh-list
19301890|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19301891|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
19301892|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19301893|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19301894|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301895|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301896|NCT04179604|Protective Agents|protective agents|mesh-ancestor
19301897|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301898|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
19301899|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
19301900|NCT04179500|Bedaquiline|bedaquiline|mesh-list
19301901|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19301902|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301903|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19301904|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19301905|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301906|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301907|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301908|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
19396211|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396212|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396213|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19396214|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
19396215|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
19396216|NCT03661385|Protective Agents|protective agents|mesh-ancestor
19396217|NCT03661307|Decitabine|decitabine|mesh-list
19396218|NCT03661307|Venetoclax|venetoclax|mesh-list
19396219|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19396220|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
19396221|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396222|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396223|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396224|NCT03661125|Saracatinib|saracatinib|mesh-list
19396225|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396226|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396227|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404334|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20365237|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
20365238|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
20365239|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
19301909|NCT04179513|Methotrexate|methotrexate|mesh-list
19301910|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19301911|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
19301912|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19301913|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301914|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19301915|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
19301916|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301917|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301918|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
20365240|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
20365241|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365242|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20365243|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20365244|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365245|NCT00952016|Methotrexate|methotrexate|mesh-list
20365246|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20365247|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
20365248|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19301919|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301920|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19301921|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301922|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
19301923|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19301924|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19301925|NCT04179617|Nicotine|nicotine|mesh-list
19301926|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19301927|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
19301928|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19301929|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301930|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19301931|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19301932|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
19301933|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301934|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301935|NCT04179071|Famotidine|famotidine|mesh-list
19301936|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19301937|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301938|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19301939|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
20365249|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365250|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365251|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
20365252|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301940|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
19301941|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301942|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301943|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301944|NCT04178863|Timolol|timolol|mesh-list
19301945|NCT04178863|Latanoprost|latanoprost|mesh-list
19301946|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19301947|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19301948|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
19301949|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19301950|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301951|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301952|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19301953|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19838461|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838462|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838463|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838464|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
20365253|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301954|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19301955|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19301956|NCT04179045|Sirolimus|sirolimus|mesh-list
20365254|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
20365255|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301957|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19301958|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365256|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19301959|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19301960|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19301961|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
19301962|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19301963|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
20365257|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365258|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
20365259|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365260|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20365261|NCT00952029|Leucovorin|leucovorin|mesh-list
20365262|NCT00952029|Bevacizumab|bevacizumab|mesh-list
20365263|NCT00952029|Fluorouracil|fluorouracil|mesh-list
20365264|NCT00952029|Irinotecan|irinotecan|mesh-list
20365265|NCT00952029|Calcium|calcium|mesh-list
20365266|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
20365267|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365268|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365269|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20365270|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19301964|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301965|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
19301966|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19301967|NCT04178980|Simvastatin|simvastatin|mesh-list
19301968|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19301969|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19301970|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
19301971|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301972|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20365271|NCT00952029|Growth Substances|growth substances|mesh-ancestor
20365272|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365273|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
20365274|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20365275|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
20365276|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365277|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672282|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19672283|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
19672284|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19672285|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
20365278|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365279|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
20365280|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20365281|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20365282|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365283|NCT00952029|Antidotes|antidotes|mesh-ancestor
20365284|NCT00952029|Protective Agents|protective agents|mesh-ancestor
20365285|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
20365286|NCT00952029|Vitamins|vitamins|mesh-ancestor
20365287|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
20365288|NCT00952094|Cinacalcet|cinacalcet|mesh-list
20365289|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20365290|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365291|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20365292|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
20365293|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365294|NCT00952159|Tramadol|tramadol|mesh-list
20365295|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
20365296|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20365297|NCT00952159|Narcotics|narcotics|mesh-ancestor
20365298|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365299|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365300|NCT00952159|Analgesics|analgesics|mesh-ancestor
20365301|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
20365302|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365303|NCT00952185|Antibodies|antibodies|mesh-list
20365304|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
20365305|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365306|NCT00952302|Iron|iron|mesh-list
20365307|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20365308|NCT00952302|Trace Elements|trace elements|mesh-ancestor
19301973|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19301974|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19301975|NCT04178850|Folic Acid|folic acid|mesh-list
20365309|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
19672286|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365310|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365311|NCT00952302|Hematinics|hematinics|mesh-ancestor
20365312|NCT00952432|Carbamazepine|carbamazepine|mesh-list
19301976|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
19301977|NCT04178850|Infliximab|infliximab|mesh-list
19301978|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
19301979|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19301980|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365313|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
20365314|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
20365315|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20365316|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365317|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365318|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19301981|NCT04178850|Hematinics|hematinics|mesh-ancestor
19301982|NCT04178850|Vitamins|vitamins|mesh-ancestor
19301983|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
19672287|NCT04177355|Antacids|antacids|mesh-ancestor
19672288|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672289|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672290|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19692164|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301984|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365319|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365320|NCT00952432|Analgesics|analgesics|mesh-ancestor
20365321|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
20365322|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365323|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20365324|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365325|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365326|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20365327|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19301985|NCT04178876|Ethanol|ethanol|mesh-list
19301986|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19301987|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19301988|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19301989|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19301990|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
19301991|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19301992|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19301993|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19301994|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
19301995|NCT04178655|Coagulants|coagulants|mesh-ancestor
19301996|NCT04178785|Remifentanil|remifentanil|mesh-list
19301997|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19301998|NCT04178785|Narcotics|narcotics|mesh-ancestor
19301999|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302000|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302001|NCT04178785|Analgesics|analgesics|mesh-ancestor
19302002|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
19302003|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302004|NCT04178642|Idarubicin|idarubicin|mesh-list
19302005|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
19302006|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19302007|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302008|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19302009|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19302010|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302011|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302012|NCT04178291|Erythritol|erythritol|mesh-list
19302013|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
19302014|NCT04178512|Dexamethasone|dexamethasone|mesh-list
19302015|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
19302016|NCT04178512|Fentanyl|fentanyl|mesh-list
19302017|NCT04178512|BB 1101|bb 1101|mesh-list
19302018|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19302019|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
19302020|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
19302021|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692165|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692166|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
19692167|NCT04996160|Hormones|hormones|mesh-ancestor
19692168|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692169|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19692170|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302022|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302023|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19302024|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
19302025|NCT04178512|Hormones|hormones|mesh-ancestor
19302026|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302027|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19302028|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302029|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
19302030|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302031|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302032|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19302033|NCT04178512|Narcotics|narcotics|mesh-ancestor
19302034|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302035|NCT04178512|Analgesics|analgesics|mesh-ancestor
19302036|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
19302037|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19302038|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19302039|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
19302040|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
20365328|NCT00952497|Capecitabine|capecitabine|mesh-list
20365329|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365330|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365331|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
20365332|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365333|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
19302041|NCT04178148|Amikacin|amikacin|mesh-list
19302042|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302043|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302044|NCT04178200|Lidocaine|lidocaine|mesh-list
19302045|NCT04178200|Bupivacaine|bupivacaine|mesh-list
19302046|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19302047|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
20365334|NCT00952562|Vitamins|vitamins|mesh-ancestor
20365335|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
20365336|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365337|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20365338|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20365339|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
20365340|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20365341|NCT00952575|Antibodies|antibodies|mesh-list
20365342|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20365343|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
20365344|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
20365345|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365346|NCT00952627|Pycnogenols|pycnogenols|mesh-list
20365347|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20365348|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
19302048|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
19302049|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302050|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302051|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
19302052|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302053|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19302054|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19302055|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19302056|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19302057|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302058|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19302059|NCT04178057|Antibodies|antibodies|mesh-list
19302060|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
19302061|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19302062|NCT04178057|Mitogens|mitogens|mesh-list
19302063|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
19302064|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
19302065|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302066|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302067|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
19302068|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302069|NCT04178057|Growth Substances|growth substances|mesh-ancestor
19302070|NCT04177875|Paclitaxel|paclitaxel|mesh-list
19302071|NCT04177875|Docetaxel|docetaxel|mesh-list
19302072|NCT04177875|Cisplatin|cisplatin|mesh-list
19302073|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20365349|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302074|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19302075|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365350|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
19302076|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
19302077|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
20365351|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365352|NCT00952627|Protective Agents|protective agents|mesh-ancestor
20365353|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19302078|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
19302079|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302080|NCT04177641|Antioxidants|antioxidants|mesh-list
19302081|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302082|NCT04177641|Protective Agents|protective agents|mesh-ancestor
19672291|NCT03912363|Insulin|insulin|mesh-list
19672292|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19672293|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672294|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20365354|NCT00952640|Vitamin A|vitamin a|mesh-list
20365355|NCT00952640|Vitamins|vitamins|mesh-ancestor
20365356|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
20365357|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365358|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
20365359|NCT00952796|Ampicillin|ampicillin|mesh-list
20365360|NCT00952796|Sulbactam|sulbactam|mesh-list
20365361|NCT00952796|Sultamicillin|sultamicillin|mesh-list
20365362|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20365363|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365364|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20365365|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20365366|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365367|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365368|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365369|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20365370|NCT00952861|Doxycycline|doxycycline|mesh-list
20365371|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20365372|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365373|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
20365374|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20365375|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20365376|NCT00952913|Lansoprazole|lansoprazole|mesh-list
20365377|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
20365378|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20365379|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365380|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20365381|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365382|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425516|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20425517|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425518|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425519|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
20425520|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425521|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20425522|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20425523|NCT01275508|Adalimumab|adalimumab|mesh-list
20425524|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425525|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672295|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19672296|NCT03901131|Norethindrone|norethindrone|mesh-list
19672297|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
19302083|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302084|NCT04178109|Acetaminophen|acetaminophen|mesh-list
19302085|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19302086|NCT04178109|Tramadol|tramadol|mesh-list
19302087|NCT04178109|Ropivacaine|ropivacaine|mesh-list
20185311|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185312|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20185313|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20185314|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19302088|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
19302089|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672298|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
20185315|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185316|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185317|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185318|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185319|NCT00200499|Nebivolol|nebivolol|mesh-list
19302090|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
20425526|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20425527|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20425528|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672299|NCT03901131|Estradiol|estradiol|mesh-list
19302091|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672300|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20365383|NCT00952952|Mesalamine|mesalamine|mesh-list
20365384|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20365385|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365386|NCT00952952|Analgesics|analgesics|mesh-ancestor
20365387|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
20365388|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365389|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365390|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365391|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365392|NCT00952978|Omeprazole|omeprazole|mesh-list
20365393|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20365394|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365395|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19302092|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302093|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
19302094|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302095|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19302096|NCT04178109|Analgesics|analgesics|mesh-ancestor
19302097|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
19302098|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19302099|NCT04178109|Narcotics|narcotics|mesh-ancestor
19302100|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19302101|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19302102|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302103|NCT04177719|Oxytocin|oxytocin|mesh-list
19302104|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
19302105|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19302106|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302107|NCT04177602|Trifluridine|trifluridine|mesh-list
20365396|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365397|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365398|NCT00952991|Vildagliptin|vildagliptin|mesh-list
19302108|NCT04177602|Capecitabine|capecitabine|mesh-list
19302109|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19302110|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
19302111|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302112|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302113|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
19302114|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302115|NCT04177498|ON 01910|on 01910|mesh-list
19302116|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302117|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19302118|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302119|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396228|NCT03660917|Riluzole|riluzole|mesh-list
19396229|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
19396230|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20365399|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20365400|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365401|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20365402|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
20365403|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365404|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365405|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20365406|NCT00953108|Citalopram|citalopram|mesh-list
20365407|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20365408|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20365409|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365410|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365411|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365412|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
20365413|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365414|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19396231|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19396232|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396233|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396234|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396235|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20365415|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
20365416|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20365417|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20365418|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19396236|NCT03660917|Protective Agents|protective agents|mesh-ancestor
19396237|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19302120|NCT04177342|Fentanyl|fentanyl|mesh-list
19302121|NCT04177342|Oxycodone|oxycodone|mesh-list
19302122|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19302123|NCT04177342|Narcotics|narcotics|mesh-ancestor
19302124|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302125|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302126|NCT04177342|Analgesics|analgesics|mesh-ancestor
19302127|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
19302128|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302129|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19302130|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19302131|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
19302132|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
19302133|NCT04177173|Methotrexate|methotrexate|mesh-list
19302134|NCT04177173|Simvastatin|simvastatin|mesh-list
19302135|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19302136|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
19302137|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19302138|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302139|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19302140|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
19302141|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302142|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302143|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
19302144|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302145|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19302146|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302147|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
20185320|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20185321|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185322|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20185323|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20185324|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20185325|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185326|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185327|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185328|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185329|NCT00200512|Apomorphine|apomorphine|mesh-list
20185330|NCT00200512|Emetics|emetics|mesh-ancestor
20185331|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365419|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302148|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302149|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19302150|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19302151|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19302152|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19302153|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19302154|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
19302155|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19302156|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19302157|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302158|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
19302159|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302160|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302161|NCT04177004|Sirolimus|sirolimus|mesh-list
19302162|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
19302163|NCT04177004|Etoposide|etoposide|mesh-list
19302164|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
19302165|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
19302166|NCT04177004|Tacrolimus|tacrolimus|mesh-list
19302167|NCT04177004|Mitogens|mitogens|mesh-list
19302168|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302169|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
19302170|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365420|NCT00953134|Folic Acid|folic acid|mesh-list
20365421|NCT00953134|Micronutrients|micronutrients|mesh-list
20365422|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
20365423|NCT00953134|Trace Elements|trace elements|mesh-list
20365424|NCT00953134|Hematinics|hematinics|mesh-ancestor
20365425|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
20365426|NCT00953134|Vitamins|vitamins|mesh-ancestor
20365427|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365428|NCT00953303|Dexamethasone|dexamethasone|mesh-list
19302171|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185332|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
20365429|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
20365430|NCT00953303|Prednisone|prednisone|mesh-list
20365431|NCT00953303|Torsemide|torsemide|mesh-list
20185333|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185334|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185335|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
20185336|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
19302172|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19302173|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
19302174|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302175|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302176|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19302177|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19302178|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19302179|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19302180|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302181|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19302182|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302183|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302184|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19302185|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
19302186|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19302187|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
19302188|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
19302189|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19302190|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19302191|NCT04177303|Metformin|metformin|mesh-list
19302192|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19302193|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302194|NCT04177043|Antibodies|antibodies|mesh-list
19302195|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
19302196|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
19302197|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302198|NCT04177082|Riboflavin|riboflavin|mesh-list
19302199|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
19302200|NCT04177082|Vitamins|vitamins|mesh-ancestor
19302201|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
19302202|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302203|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19302204|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
19302205|NCT04176835|Oxytocin|oxytocin|mesh-list
19302206|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
19302207|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19302208|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302209|NCT04177095|Sirolimus|sirolimus|mesh-list
19302210|NCT04177095|Prednisone|prednisone|mesh-list
19302211|NCT04177095|Everolimus|everolimus|mesh-list
19302212|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19302213|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
19302214|NCT04177095|Hormones|hormones|mesh-ancestor
19302215|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302216|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302217|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19302218|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302219|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302220|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
19302221|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19302222|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302223|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302224|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
19672301|NCT03901131|Estrogens|estrogens|mesh-ancestor
19672302|NCT03901131|Hormones|hormones|mesh-ancestor
19302225|NCT04176887|Phenytoin|phenytoin|mesh-list
19302226|NCT04176887|Levetiracetam|levetiracetam|mesh-list
19302227|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
20185337|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185338|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185339|NCT00200525|Apomorphine|apomorphine|mesh-list
20185340|NCT00200525|Emetics|emetics|mesh-ancestor
20185341|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185342|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
20185343|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185344|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185345|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
20185346|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
19302228|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
19302229|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19302230|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19302231|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19692171|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
20185347|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302232|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302233|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20365432|NCT00953303|Dobutamine|dobutamine|mesh-list
20365433|NCT00953303|Dopamine|dopamine|mesh-list
20365434|NCT00953303|Furosemide|furosemide|mesh-list
20365435|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
20365436|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
20365437|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20365438|NCT00953303|BB 1101|bb 1101|mesh-list
20365439|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365440|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
20612675|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612676|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
20612677|NCT02252497|Coagulants|coagulants|mesh-ancestor
20613208|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613209|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19302234|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19302235|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19302236|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19302237|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19302238|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
19302239|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302240|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19302241|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19302242|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302243|NCT04176354|Letrozole|letrozole|mesh-list
19302244|NCT04176354|Palbociclib|palbociclib|mesh-list
19302245|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19302246|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302247|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19302248|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302249|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302250|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19302251|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
19302252|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302253|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302254|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19302255|NCT04176224|Edaravone|edaravone|mesh-list
19302256|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19302257|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
19838465|NCT00621023|Protective Agents|protective agents|mesh-ancestor
19838466|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185348|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185349|NCT00200538|Memantine|memantine|mesh-list
19302258|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302259|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19302260|NCT04176224|Protective Agents|protective agents|mesh-ancestor
19302261|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302262|NCT04176393|Ivosidenib|ivosidenib|mesh-list
19302263|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302264|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302265|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302266|NCT04176367|Nicergoline|nicergoline|mesh-list
19302267|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19302268|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19302269|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185350|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20185351|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20185352|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
20185353|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185354|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185355|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185356|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20185357|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20185358|NCT00200551|Cyclosporine|cyclosporine|mesh-list
20185359|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
20185360|NCT00200551|Cyclosporins|cyclosporins|mesh-list
20185361|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20185362|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185363|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365441|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
20365442|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365443|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302270|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302271|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302272|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302273|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
19302274|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
19302275|NCT04176016|Edetic Acid|edetic acid|mesh-list
19302276|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
19302277|NCT04176016|Antidotes|antidotes|mesh-ancestor
19302278|NCT04176016|Protective Agents|protective agents|mesh-ancestor
19302279|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302280|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
19302281|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
19302282|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302283|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19302284|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
19302285|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19302286|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
19302287|NCT04175990|Progestins|progestins|mesh-ancestor
19302288|NCT04175990|Hormones|hormones|mesh-ancestor
19302289|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302290|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365444|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365445|NCT00953303|Hormones|hormones|mesh-ancestor
20365446|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302291|NCT04176328|Teicoplanin|teicoplanin|mesh-list
19302292|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302293|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302294|NCT04176055|Haloperidol|haloperidol|mesh-list
19302295|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
19302296|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
19302297|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
20365447|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20365448|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365449|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
20365450|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365451|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302298|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302299|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302300|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19302301|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19302302|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19302303|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302304|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19302305|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19302306|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
19302307|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302308|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302309|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19302310|NCT04176068|Calcium|calcium|mesh-list
19302311|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19302312|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302322|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19302323|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
19302324|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19302325|NCT04175522|Antibodies|antibodies|mesh-list
19302326|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
19302327|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
19302328|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302329|NCT04175587|Tretinoin|tretinoin|mesh-list
19302330|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
19302331|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302332|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
19302333|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
19396238|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
19396239|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19396240|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
19396241|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19302334|NCT04175171|Trastuzumab|trastuzumab|mesh-list
19302335|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302336|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302337|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
19302338|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302339|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302340|NCT04175158|Bevacizumab|bevacizumab|mesh-list
19302341|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
19302342|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302343|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302344|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19302345|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19302346|NCT04175158|Growth Substances|growth substances|mesh-ancestor
19302347|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302348|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
19302349|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19302350|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302351|NCT04175067|Antioxidants|antioxidants|mesh-list
19302352|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302353|NCT04175067|Protective Agents|protective agents|mesh-ancestor
19302354|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302355|NCT04175002|Progesterone|progesterone|mesh-list
19302356|NCT04175002|Progestins|progestins|mesh-ancestor
19302357|NCT04175002|Hormones|hormones|mesh-ancestor
19302358|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302359|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302360|NCT04174872|Midazolam|midazolam|mesh-list
19302361|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
19302362|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19302363|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302364|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302365|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19302366|NCT04174872|Analgesics|analgesics|mesh-ancestor
19302367|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
19302368|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302369|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19302370|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19302371|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19672303|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672304|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692172|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185364|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185365|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
20185366|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185367|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
20185368|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185369|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
20185370|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185371|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20185372|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20185373|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185374|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20185375|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
20185376|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20185377|NCT00200564|Ketamine|ketamine|mesh-list
20185378|NCT00200564|Analgesics|analgesics|mesh-ancestor
20185379|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
20185380|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185381|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185382|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20185383|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20185384|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
20185385|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
20185386|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185387|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20185388|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20185389|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185390|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185391|NCT00200590|Acetaminophen|acetaminophen|mesh-list
20185392|NCT00200590|Morphine|morphine|mesh-list
20185393|NCT00200590|Nalbuphine|nalbuphine|mesh-list
20185394|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20185395|NCT00200590|Narcotics|narcotics|mesh-ancestor
20365452|NCT00953303|Diuretics|diuretics|mesh-ancestor
19302372|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
19302373|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302374|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302375|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19302376|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19302377|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19302378|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185396|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185397|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185398|NCT00200590|Analgesics|analgesics|mesh-ancestor
20185399|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
20185400|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185401|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365453|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
20365454|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20612678|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
19302379|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19302380|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
19302381|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
19302382|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
19302383|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
19302384|NCT04174339|Apatinib|apatinib|mesh-list
19302385|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302386|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19302387|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302388|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302389|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19302390|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
19302391|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19302392|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
19302393|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19302394|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302395|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19302396|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19302397|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302398|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
19302399|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
19302400|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302401|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612679|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20612680|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302402|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302403|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
19302404|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
19302405|NCT04174352|Tamoxifen|tamoxifen|mesh-list
19302406|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19302407|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
19302408|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302409|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302410|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19302411|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302412|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19302413|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19302414|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19302415|NCT04174261|Clopidogrel|clopidogrel|mesh-list
19302416|NCT04174261|Ticagrelor|ticagrelor|mesh-list
19302417|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19302418|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19302419|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19302420|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19302421|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
20185402|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
20185403|NCT00200603|Calcium|calcium|mesh-list
20185404|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20185405|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185406|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
20185407|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20185408|NCT00200629|Adenosine|adenosine|mesh-list
20185409|NCT00200629|Analgesics|analgesics|mesh-ancestor
20185410|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
19302422|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838467|NCT00621023|Vitamins|vitamins|mesh-ancestor
20185411|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185412|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302423|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302424|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302425|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
19302426|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19302427|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19302428|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302429|NCT04173832|Amantadine|amantadine|mesh-list
19302430|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19302431|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19302432|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
19302433|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302434|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
19302435|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302436|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672305|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19672306|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
19672307|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19838468|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
19302437|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302438|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19302439|NCT04173832|Analgesics|analgesics|mesh-ancestor
19302440|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
19302441|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302442|NCT04174131|Lidocaine|lidocaine|mesh-list
19302443|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
19302444|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
19302445|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
19302446|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302447|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302448|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
19302449|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302450|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19302451|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19302452|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19302453|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19302454|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302455|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19302456|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
19302457|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
19302458|NCT04174131|Protective Agents|protective agents|mesh-ancestor
19838469|NCT00621049|Bevacizumab|bevacizumab|mesh-list
19838470|NCT00621049|Carboplatin|carboplatin|mesh-list
19838471|NCT00621049|Docetaxel|docetaxel|mesh-list
20613210|NCT02253966|Protective Agents|protective agents|mesh-ancestor
19302459|NCT04173858|Naloxegol|naloxegol|mesh-list
19302460|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19302461|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302462|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
19302463|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302464|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
19302465|NCT04173988|Fludarabine|fludarabine|mesh-list
19302466|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302467|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
19302468|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302469|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302470|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19302471|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
19302472|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302473|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302474|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19302475|NCT04173793|Ezetimibe|ezetimibe|mesh-list
19302476|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19302477|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19302478|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
19302479|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302480|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19302481|NCT04173780|Atropine|atropine|mesh-list
19672308|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19672309|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19672310|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19672311|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19672312|NCT03814317|Treprostinil|treprostinil|mesh-list
19672313|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19672314|NCT03688633|Candesartan|candesartan|mesh-list
19838472|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19302482|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19302483|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19302484|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19302485|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
19302486|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302487|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302488|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19302489|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
19302490|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
19302491|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
19302492|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19302493|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19302494|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
19302495|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302496|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302497|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
19302498|NCT04173416|Narcotics|narcotics|mesh-ancestor
19302499|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302500|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302501|NCT04173416|Analgesics|analgesics|mesh-ancestor
19302502|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
19302503|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185413|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20185414|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185415|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20185416|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
20185417|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
20185418|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185419|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302504|NCT04173403|Ezetimibe|ezetimibe|mesh-list
19302505|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19302506|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19302507|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
19302508|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302509|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19302510|NCT04173585|Bortezomib|bortezomib|mesh-list
19302511|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
19302512|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302513|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302514|NCT04173390|Pregabalin|pregabalin|mesh-list
19302515|NCT04173390|Analgesics|analgesics|mesh-ancestor
19302516|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
19302517|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838473|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838474|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838475|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19838476|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838477|NCT00621049|Growth Substances|growth substances|mesh-ancestor
19838478|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838479|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
19838480|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
19838481|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
19838482|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
19838483|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838484|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19838485|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185420|NCT00200655|Pravastatin|pravastatin|mesh-list
20185421|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20185422|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20185423|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
20185424|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185425|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20185426|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20185427|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185428|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20185429|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20185430|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185431|NCT00200681|Bortezomib|bortezomib|mesh-list
20185432|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185433|NCT00200694|Valsartan|valsartan|mesh-list
20185434|NCT00200694|Ramipril|ramipril|mesh-list
20185435|NCT00200694|Furosemide|furosemide|mesh-list
20185436|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20185437|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20185438|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19672315|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19302518|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302519|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
19302520|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19302521|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19302522|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302523|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19302524|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19302525|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19302526|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302527|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19302528|NCT04173611|Bupivacaine|bupivacaine|mesh-list
19302529|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672316|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19672317|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19672318|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672319|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19672320|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
19672321|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672322|NCT03441750|Metformin|metformin|mesh-list
19672323|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19672324|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672325|NCT03423264|Gabapentin|gabapentin|mesh-list
20365455|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365456|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
20365457|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20365458|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
19672326|NCT03423264|Analgesics|analgesics|mesh-ancestor
19672327|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
19672328|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838486|NCT00621140|Linagliptin|linagliptin|mesh-list
19838487|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19838488|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838489|NCT00621140|Incretins|incretins|mesh-ancestor
19838490|NCT00621140|Hormones|hormones|mesh-ancestor
20185439|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672329|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672330|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
19672331|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19302530|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
19302531|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672332|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19672333|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672334|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19672335|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19672336|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19672337|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672338|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302532|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672339|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
19672340|NCT03367715|Nivolumab|nivolumab|mesh-list
19672341|NCT03367715|Ipilimumab|ipilimumab|mesh-list
19672342|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672343|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672344|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19672345|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672346|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
19672347|NCT03225547|Mifepristone|mifepristone|mesh-list
19672348|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20185440|NCT00200694|Diuretics|diuretics|mesh-ancestor
20185441|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
20185442|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185443|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20185444|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20185445|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20185446|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
19838491|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19838492|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19838493|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
19838494|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302533|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
19302534|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302535|NCT04173364|Ropivacaine|ropivacaine|mesh-list
19302536|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19302537|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
19302538|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
19302539|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302540|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302541|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
19302542|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302543|NCT04173325|Nivolumab|nivolumab|mesh-list
19302544|NCT04173325|Irinotecan|irinotecan|mesh-list
19302545|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302546|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302547|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19302548|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185447|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612681|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612682|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20185448|NCT00200941|Topiramate|topiramate|mesh-list
20185449|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
20185450|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20185451|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217317|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20217318|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
20217319|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217320|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217321|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217322|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217323|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20217324|NCT00309374|Simvastatin|simvastatin|mesh-list
20217325|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20217326|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20217327|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
20217328|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365459|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19302549|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19302550|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19302551|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365460|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20365461|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20365462|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
20365463|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365464|NCT00953303|Protective Agents|protective agents|mesh-ancestor
20612683|NCT02252523|Analgesics|analgesics|mesh-ancestor
19396242|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396243|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19396244|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19396245|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396246|NCT03660761|Apatinib|apatinib|mesh-list
19396247|NCT03660761|Temozolomide|temozolomide|mesh-list
19396248|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396249|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19396250|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396251|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396252|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19396253|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
19396254|NCT03660488|Penicillins|penicillins|mesh-list
19396255|NCT03660488|Cefixime|cefixime|mesh-list
19396256|NCT03660488|Penicillin G|penicillin g|mesh-list
19396257|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19396258|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
19396259|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396260|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396261|NCT03660475|Naltrexone|naltrexone|mesh-list
19396262|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19396263|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19396264|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396265|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
19396266|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396267|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
19396268|NCT03660436|BMS-986165|bms-986165|mesh-list
20217329|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20612684|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
19396269|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19396270|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302552|NCT04173039|Antibodies|antibodies|mesh-list
19302553|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
19302554|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302555|NCT04172961|Cyclosporine|cyclosporine|mesh-list
19302556|NCT04172961|Lifitegrast|lifitegrast|mesh-list
19302557|NCT04172961|Cyclosporins|cyclosporins|mesh-list
19302558|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302559|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302560|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185452|NCT00201305|Leucovorin|leucovorin|mesh-list
20185453|NCT00201305|Gemcitabine|gemcitabine|mesh-list
20185454|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20185455|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
20185456|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185457|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185458|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
20185459|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185460|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185461|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185462|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
20185463|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185464|NCT00201305|Antidotes|antidotes|mesh-ancestor
20185465|NCT00201305|Protective Agents|protective agents|mesh-ancestor
20185466|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185467|NCT00201305|Vitamins|vitamins|mesh-ancestor
19302561|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
19302562|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302563|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
19302564|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302565|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
19302566|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302567|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19302568|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19302569|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19302570|NCT04172987|Tirzepatide|tirzepatide|mesh-list
19302571|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20365465|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
19302572|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302573|NCT04172987|Incretins|incretins|mesh-ancestor
19302574|NCT04172987|Hormones|hormones|mesh-ancestor
19302575|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302576|NCT04172922|Sirolimus|sirolimus|mesh-list
19302577|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302578|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302579|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19302580|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302581|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
19302582|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302583|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
19302584|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302585|NCT04172727|Bupivacaine|bupivacaine|mesh-list
19302586|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
19302587|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
19302588|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302589|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302590|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
19302591|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185468|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
20185469|NCT00201318|Lamivudine|lamivudine|mesh-list
20185470|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
19838495|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838496|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19838497|NCT00621153|Candesartan|candesartan|mesh-list
19838498|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
19838499|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19838500|NCT00621153|Diuretics|diuretics|mesh-ancestor
19838501|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
20185471|NCT00201318|Doxorubicin|doxorubicin|mesh-list
20185472|NCT00201318|Vincristine|vincristine|mesh-list
20185473|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185474|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
20185475|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185476|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302592|NCT04172844|Azacitidine|azacitidine|mesh-list
19302593|NCT04172844|Venetoclax|venetoclax|mesh-list
19302594|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20185477|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20185478|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
20365466|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20365467|NCT00953355|Metformin|metformin|mesh-list
20185479|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302595|NCT04172844|Pevonedistat|pevonedistat|mesh-list
19302596|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19302597|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
19302598|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302599|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302600|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
19302601|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19302602|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
19302603|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19302604|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19302605|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302606|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19302607|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302608|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19302609|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302610|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19302611|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302612|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365468|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20365469|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365470|NCT00953381|Omeprazole|omeprazole|mesh-list
20365471|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20365472|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365473|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20365474|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365475|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365476|NCT00953394|Octreotide|octreotide|mesh-list
20365477|NCT00953394|Fluorouracil|fluorouracil|mesh-list
20365478|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365479|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20365480|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365481|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
20365482|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302613|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302614|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302615|NCT04172740|Calcium|calcium|mesh-list
19302616|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19302617|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302618|NCT04172363|Octenidine|octenidine|mesh-list
19302619|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302620|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19302621|NCT04172311|Levetiracetam|levetiracetam|mesh-list
19302622|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
19672349|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185480|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185481|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20185482|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20185483|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20185484|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20185485|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185486|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20185487|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
20185488|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
20185489|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
20185490|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20185491|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20185492|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
20185493|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185494|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20185495|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20185496|NCT00201331|Leucovorin|leucovorin|mesh-list
20185497|NCT00201331|Antidotes|antidotes|mesh-ancestor
20185498|NCT00201331|Protective Agents|protective agents|mesh-ancestor
20185499|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185500|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185501|NCT00201331|Vitamins|vitamins|mesh-ancestor
20185502|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
20185503|NCT00201344|Leucovorin|leucovorin|mesh-list
20185504|NCT00201344|Antidotes|antidotes|mesh-ancestor
19672350|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20185505|NCT00201344|Protective Agents|protective agents|mesh-ancestor
20365483|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365484|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302623|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
19302624|NCT04172220|Midazolam|midazolam|mesh-list
19302625|NCT04172220|Anesthetics|anesthetics|mesh-list
19302626|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302627|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672351|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
19672352|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19672353|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672354|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19672355|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19302628|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19302629|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20365485|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
20365486|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365487|NCT00953459|Sunitinib|sunitinib|mesh-list
20365488|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20365489|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302630|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19302631|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19302632|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19302633|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19302634|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
19302635|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
19672356|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19672357|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
19672358|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19672359|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19672360|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
19672361|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672362|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
19672363|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19302636|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
19302637|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302638|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302639|NCT04172064|Dobutamine|dobutamine|mesh-list
19302640|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19302641|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
19302642|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
19302643|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302644|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302645|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19302646|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19302647|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19672364|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19672365|NCT03132454|Dexamethasone|dexamethasone|mesh-list
20365490|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20365491|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20365492|NCT00953459|Growth Substances|growth substances|mesh-ancestor
20365493|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365494|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
20365495|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365496|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365497|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365498|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20365499|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20365500|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
20365501|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365502|NCT00953498|Pioglitazone|pioglitazone|mesh-list
20365503|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
20365504|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20365505|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672366|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
19672367|NCT03132454|Sorafenib|sorafenib|mesh-list
19672368|NCT03132454|Decitabine|decitabine|mesh-list
19672369|NCT03132454|Palbociclib|palbociclib|mesh-list
19672370|NCT03132454|Ichthammol|ichthammol|mesh-list
19672371|NCT03132454|BB 1101|bb 1101|mesh-list
19672372|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672373|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
19672374|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
19672375|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365506|NCT00953537|Capecitabine|capecitabine|mesh-list
19302648|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
19302649|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302650|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672376|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365507|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365508|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
20365509|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365510|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365511|NCT00953550|Rocuronium|rocuronium|mesh-list
20365512|NCT00953550|Succinylcholine|succinylcholine|mesh-list
20365513|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20365514|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20365515|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20365516|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365517|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365518|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20365519|NCT00953589|Ribavirin|ribavirin|mesh-list
20365520|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
20365521|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365522|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
20365523|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365524|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20365525|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20365526|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365527|NCT00953641|Misoprostol|misoprostol|mesh-list
20185506|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185507|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185508|NCT00201344|Vitamins|vitamins|mesh-ancestor
19302651|NCT04172064|Protective Agents|protective agents|mesh-ancestor
19302652|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
19302653|NCT04172259|Docetaxel|docetaxel|mesh-list
19302654|NCT04172259|Doxorubicin|doxorubicin|mesh-list
19302655|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19302656|NCT04172259|Trastuzumab|trastuzumab|mesh-list
19302657|NCT04172259|Epirubicin|epirubicin|mesh-list
19302658|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302659|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
19302660|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302661|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302662|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19302663|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
19302664|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302665|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302666|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20185509|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
20185510|NCT00201357|Thalidomide|thalidomide|mesh-list
20185511|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185512|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
20185513|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185514|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
20185515|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20185516|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185517|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20365528|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20365529|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
20365530|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20365531|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365532|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20365533|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19302667|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
19302668|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
19302669|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
19302670|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19302671|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19302672|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19302673|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302674|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302675|NCT04171791|Venetoclax|venetoclax|mesh-list
19302676|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302677|NCT04171726|Edoxaban|edoxaban|mesh-list
19302678|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19302679|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
20185518|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19302680|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19302681|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
19302682|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302683|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302684|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
19302685|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
20185519|NCT00201357|Growth Substances|growth substances|mesh-ancestor
19302686|NCT04171622|Lenvatinib|lenvatinib|mesh-list
19302687|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302688|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302689|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19302690|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302691|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302692|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
19302693|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19302694|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302695|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
20365534|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
20365535|NCT00953771|Danazol|danazol|mesh-list
20365536|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20365537|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
20365538|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365539|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365540|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20365541|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20365542|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365543|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365544|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
20365545|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365546|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365547|NCT00954005|Gemcitabine|gemcitabine|mesh-list
20365548|NCT00954005|Rituximab|rituximab|mesh-list
20365549|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
20365550|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838502|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838503|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19302696|NCT04171687|Clopidogrel|clopidogrel|mesh-list
19302697|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19302698|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19302699|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19838504|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838505|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838506|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19838507|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19838508|NCT00621179|Leuprolide|leuprolide|mesh-list
19838509|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19838510|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
19838511|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19838512|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302700|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19302701|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
19838513|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19838514|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838515|NCT00621192|Meropenem|meropenem|mesh-list
19838516|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838517|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838518|NCT00621244|Panobinostat|panobinostat|mesh-list
19838519|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838520|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19838521|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838522|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302702|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302703|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302704|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302705|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
19302706|NCT04171843|Fludarabine|fludarabine|mesh-list
19302707|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302708|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
19302709|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302710|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672377|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672378|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
19672379|NCT03132454|Hormones|hormones|mesh-ancestor
19672380|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672381|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19672382|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672383|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
19672384|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838523|NCT00621257|Vitamin D|vitamin d|mesh-list
20365551|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302711|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19302712|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
19302713|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302714|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302715|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19302716|NCT04171388|Micronutrients|micronutrients|mesh-list
19302717|NCT04171388|Trace Elements|trace elements|mesh-list
19302718|NCT04171388|Azithromycin|azithromycin|mesh-list
19302719|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302720|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302721|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302722|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
19302723|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
19302724|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19302725|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302726|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302727|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
19302728|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19302729|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302730|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302731|NCT04171739|Itraconazole|itraconazole|mesh-list
19302732|NCT04171739|Olorofim|olorofim|mesh-list
19302733|NCT04171739|Rifampin|rifampin|mesh-list
19302734|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
19302735|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302736|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19302737|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19302738|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302739|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302740|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19302741|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
19302742|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302743|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302744|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19302745|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19302746|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
19302747|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302748|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
19302749|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19302750|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19302751|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19302752|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19302753|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19302754|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19302755|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19302756|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
19302757|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19302758|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19302759|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302760|NCT04171466|Metronidazole|metronidazole|mesh-list
19302761|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
19302762|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302763|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838524|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
19838525|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
19838526|NCT00621257|Vitamins|vitamins|mesh-list
20365552|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
20365553|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365554|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365555|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365556|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
20365557|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365558|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
20365559|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365560|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838527|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
19838528|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838529|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19838530|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19838531|NCT00621309|Rifampin|rifampin|mesh-list
20365561|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302764|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19302765|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19838532|NCT00621309|Rifamycins|rifamycins|mesh-list
19302766|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19302767|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19302768|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302769|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302770|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302771|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19302772|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19302773|NCT04171180|Budesonide|budesonide|mesh-list
19302774|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
19302775|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19302776|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19302777|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
19302778|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302779|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365562|NCT00954096|Nicotine|nicotine|mesh-list
20365563|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20365564|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
20365565|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302780|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19302781|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
19302782|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
19302783|NCT04171180|Hormones|hormones|mesh-ancestor
19302784|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302785|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19302786|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19302787|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19302788|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
19302789|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302790|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302791|NCT04171193|Isoflurane|isoflurane|mesh-list
19302792|NCT04171193|Sertraline|sertraline|mesh-list
19302793|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
19302794|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19302795|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19302796|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19302797|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20365566|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365567|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20365568|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20365569|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
20365570|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365571|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365572|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
20365573|NCT00954135|Sorafenib|sorafenib|mesh-list
20365574|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365575|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
20365576|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302798|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302799|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302800|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
19302801|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302802|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19302803|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
19302804|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
19302805|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302806|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
19302807|NCT04171349|Carticaine|carticaine|mesh-list
19302808|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19302809|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302810|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302811|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19302812|NCT04171349|Analgesics|analgesics|mesh-ancestor
19302813|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
19302814|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302815|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19302816|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19302817|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19302818|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
19302819|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302820|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365577|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365578|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19302821|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
20365579|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
20365580|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365581|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365582|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20365583|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365584|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365585|NCT00954200|Ibuprofen|ibuprofen|mesh-list
20365586|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20365587|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365588|NCT00954200|Analgesics|analgesics|mesh-ancestor
20365589|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
20365590|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302822|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
19396271|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19396272|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
19396273|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396274|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396275|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396276|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396277|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
19396278|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19396279|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
19396280|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
19396281|NCT03660306|Anesthetics|anesthetics|mesh-list
19396282|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396283|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396284|NCT03660306|Narcotics|narcotics|mesh-ancestor
19396285|NCT03660306|Analgesics|analgesics|mesh-ancestor
19396286|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
19396287|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396288|NCT03660293|Captopril|captopril|mesh-list
20185520|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
20185521|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185522|NCT00201383|Cisplatin|cisplatin|mesh-list
20185523|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185524|NCT00201396|Leucovorin|leucovorin|mesh-list
20185525|NCT00201396|Fluorouracil|fluorouracil|mesh-list
20185526|NCT00201396|Epirubicin|epirubicin|mesh-list
19396289|NCT03660293|Atorvastatin|atorvastatin|mesh-list
19396290|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19396291|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19396292|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
19396293|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396294|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19396295|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19396296|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396297|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19396298|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
19396299|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19396300|NCT03660267|Caffeine|caffeine|mesh-list
19396301|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19396302|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396303|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19396304|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396305|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396306|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19396307|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19396308|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
19396309|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396310|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19396311|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
19396312|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
20365591|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365592|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365593|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365594|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20365595|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365596|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365597|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
20365598|NCT00954252|Analgesics|analgesics|mesh-ancestor
19396313|NCT03660046|Etonogestrel|etonogestrel|mesh-list
19672385|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185527|NCT00201396|Mitomycins|mitomycins|mesh-list
20185528|NCT00201396|Mitomycin|mitomycin|mesh-list
20365599|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
20185529|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302823|NCT04171284|Docetaxel|docetaxel|mesh-list
19302824|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302825|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
19302826|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
19302827|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
19302828|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302829|NCT04171050|Anesthetics|anesthetics|mesh-list
19302830|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
19302831|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302832|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302833|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
19302834|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302835|NCT04170855|Furosemide|furosemide|mesh-list
19302836|NCT04170855|Diuretics|diuretics|mesh-ancestor
19302837|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
19302838|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302839|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19302840|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19302841|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302842|NCT04170751|Vasopressins|vasopressins|mesh-list
19302843|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
19302844|NCT04170751|Norepinephrine|norepinephrine|mesh-list
19302845|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19302846|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19302847|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
19302848|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19302849|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302850|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302851|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
19302852|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
19302853|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302854|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19302855|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
19302856|NCT04170751|Coagulants|coagulants|mesh-ancestor
19302857|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19302858|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
19302859|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
19302860|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302861|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302862|NCT04170959|Metformin|metformin|mesh-list
19302863|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19302864|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302865|NCT04170595|Trastuzumab|trastuzumab|mesh-list
20185530|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
20185531|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185532|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20185533|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302866|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302867|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302868|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
19302869|NCT04170530|Irinotecan|irinotecan|mesh-list
19302870|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302871|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19302872|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19302873|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302874|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302875|NCT04170790|Saxagliptin|saxagliptin|mesh-list
19302876|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
19302877|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
19302878|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19302879|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19302880|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302881|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302882|NCT04170790|Urological Agents|urological agents|mesh-ancestor
19302883|NCT04170790|Incretins|incretins|mesh-ancestor
19302884|NCT04170790|Hormones|hormones|mesh-ancestor
19302885|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302886|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302887|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19302888|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
19302889|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19302890|NCT04170647|Plasminogen|plasminogen|mesh-list
19302891|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19302892|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19396314|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19302893|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302894|NCT04170439|Chromium|chromium|mesh-list
19302895|NCT04170439|Metformin|metformin|mesh-list
19302896|NCT04170439|Citric Acid|citric acid|mesh-list
19302897|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
19302898|NCT04170439|Clomiphene|clomiphene|mesh-list
19302899|NCT04170439|Enclomiphene|enclomiphene|mesh-list
19302900|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
19302901|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19302902|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302903|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
19302904|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19302905|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
19302906|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
19302907|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302908|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19302909|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
19302910|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19302911|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19302912|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
19302913|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19302914|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19302915|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19302916|NCT04170439|Trace Elements|trace elements|mesh-ancestor
19302917|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
19302918|NCT04170504|Methotrexate|methotrexate|mesh-list
19302919|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19302920|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
19302921|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19302922|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302923|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19302924|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
19302925|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302926|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302927|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
19302928|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365600|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365601|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365602|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20365603|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19302929|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19302930|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302931|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
19302932|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302933|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19302934|NCT04170270|Omeprazole|omeprazole|mesh-list
19302935|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19302936|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19302937|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19302938|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302939|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302940|NCT04170179|Lenvatinib|lenvatinib|mesh-list
19302941|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302942|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19302943|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302944|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302945|NCT04170465|Metformin|metformin|mesh-list
19302946|NCT04170465|Paclitaxel|paclitaxel|mesh-list
19302947|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
19302948|NCT04170465|Doxorubicin|doxorubicin|mesh-list
19302949|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20365604|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365605|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302950|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302951|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
19302952|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
19302953|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
19302954|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302955|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19302956|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
19302957|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838533|NCT00621309|Sulforaphane|sulforaphane|mesh-list
19302958|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19302959|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19302960|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
19302961|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19302962|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19302963|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19302964|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19302965|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19302966|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19302967|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
19302968|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19302969|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20365606|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20365607|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365608|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365609|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20365610|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20365611|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365612|NCT00954278|Sorafenib|sorafenib|mesh-list
20365613|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302970|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19302971|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
19672386|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19672387|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672388|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
19302972|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19302973|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19302974|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302975|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
19302976|NCT04170088|Coagulants|coagulants|mesh-ancestor
19302977|NCT04169945|Erythritol|erythritol|mesh-list
19302978|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
19302979|NCT04169867|Nivolumab|nivolumab|mesh-list
20185534|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
20185535|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185536|NCT00201396|Antidotes|antidotes|mesh-ancestor
20185537|NCT00201396|Protective Agents|protective agents|mesh-ancestor
20185538|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185539|NCT00201396|Vitamins|vitamins|mesh-ancestor
20185540|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
20365614|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365615|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365616|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365617|NCT00954304|Loperamide|loperamide|mesh-list
20365618|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
20365619|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185541|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20185542|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20185543|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20185544|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185545|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
20185546|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20185547|NCT00201422|Amoxicillin|amoxicillin|mesh-list
19302980|NCT04169867|Ipilimumab|ipilimumab|mesh-list
19302981|NCT04169867|Atezolizumab|atezolizumab|mesh-list
19302982|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19302983|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19302984|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19672389|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
19672390|NCT03121677|Poly I-C|poly i-c|mesh-list
19302985|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302986|NCT04169854|Lidocaine|lidocaine|mesh-list
19302987|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
19302988|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
19302989|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19302990|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19302991|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
19302992|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19302993|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19302994|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19302995|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19302996|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19302997|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19302998|NCT04169841|Durvalumab|durvalumab|mesh-list
19302999|NCT04169841|Olaparib|olaparib|mesh-list
19672391|NCT03121677|Rituximab|rituximab|mesh-list
19303000|NCT04169841|Tremelimumab|tremelimumab|mesh-list
19396315|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
19672392|NCT03121677|Nivolumab|nivolumab|mesh-list
20185548|NCT00201422|Clarithromycin|clarithromycin|mesh-list
20185549|NCT00201422|Omeprazole|omeprazole|mesh-list
20365620|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
20365621|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
20365622|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20365623|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20365624|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365625|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
20365626|NCT00954395|Coagulants|coagulants|mesh-ancestor
20365627|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
20365628|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
20365629|NCT00954486|Hematinics|hematinics|mesh-ancestor
20365630|NCT00954525|Ascorbic Acid|ascorbic acid|mesh-list
20365631|NCT00954525|Gemcitabine|gemcitabine|mesh-list
20365632|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20365633|NCT00954525|Vitamins|vitamins|mesh-ancestor
20365634|NCT00954525|Micronutrients|micronutrients|mesh-ancestor
20365635|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365636|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20365637|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
20365638|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365639|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365640|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
20365641|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365642|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365643|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19303001|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19303002|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303003|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19303004|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303005|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303006|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
19303007|NCT04169919|Povidone|povidone|mesh-list
19303008|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
19303009|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
19303010|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19303011|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303012|NCT04169763|Nelfinavir|nelfinavir|mesh-list
19303013|NCT04169763|Cisplatin|cisplatin|mesh-list
19303014|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303015|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19303016|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19303017|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
19303018|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303019|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303020|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20365644|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
20365645|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20185550|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20185551|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185552|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20185553|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185554|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20185555|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185556|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185557|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20185558|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20185559|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20185560|NCT00201435|Paclitaxel|paclitaxel|mesh-list
20185561|NCT00201435|Docetaxel|docetaxel|mesh-list
20185562|NCT00201435|Capecitabine|capecitabine|mesh-list
20185563|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20185564|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185565|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
20185566|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
20185567|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
20185568|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185569|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20185570|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
19303021|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19303022|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
19303023|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303024|NCT04169256|Bupivacaine|bupivacaine|mesh-list
19303025|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
20185571|NCT00201539|Morphine|morphine|mesh-list
19303026|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
20185572|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20365646|NCT00954525|Antioxidants|antioxidants|mesh-ancestor
20365647|NCT00954525|Protective Agents|protective agents|mesh-ancestor
19303027|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303028|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303029|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
19303030|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303031|NCT04169347|Leucovorin|leucovorin|mesh-list
19303032|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
19303033|NCT04169347|Irinotecan|irinotecan|mesh-list
19303034|NCT04169347|Panitumumab|panitumumab|mesh-list
19303035|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303036|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19303037|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20365648|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20365649|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20365650|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365651|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365652|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20365653|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
20365654|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365655|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365656|NCT00954603|Haloperidol|haloperidol|mesh-list
20365657|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20365658|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
20365659|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
20365660|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20365661|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20365662|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20365663|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365664|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365665|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
20365666|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
20365667|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365668|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365669|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20365670|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
20365671|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365672|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365673|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20365674|NCT00954642|Paclitaxel|paclitaxel|mesh-list
20365675|NCT00954642|Bevacizumab|bevacizumab|mesh-list
20365676|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20365677|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365678|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
20365679|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
20365680|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
20365681|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365682|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365683|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19303038|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303039|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303040|NCT04169347|Antidotes|antidotes|mesh-ancestor
19303041|NCT04169347|Protective Agents|protective agents|mesh-ancestor
19303042|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303043|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
19303044|NCT04169347|Vitamins|vitamins|mesh-ancestor
19303045|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
19303046|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19303047|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
19303048|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
19303049|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396316|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19396317|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396318|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19396319|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19396320|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19396321|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19396322|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19396323|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19396324|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396325|NCT03660020|Anesthetics|anesthetics|mesh-list
19396326|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
19396327|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396328|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396329|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
19396330|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303050|NCT04169230|Citalopram|citalopram|mesh-list
19303051|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19303052|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19303053|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303054|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303055|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303056|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
19303057|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303058|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19303059|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
19303060|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303061|NCT04169269|Enoxaparin|enoxaparin|mesh-list
19303062|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
19303063|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19303064|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
19303065|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19303066|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
19303067|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303068|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303069|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
19303070|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19303071|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19303072|NCT04168879|Bupivacaine|bupivacaine|mesh-list
20365684|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20365685|NCT00954642|Growth Substances|growth substances|mesh-ancestor
20365686|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365687|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
20365688|NCT00954785|Diclofenac|diclofenac|mesh-list
20365689|NCT00954785|Etoricoxib|etoricoxib|mesh-list
20365690|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20365691|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365692|NCT00954785|Analgesics|analgesics|mesh-ancestor
20365693|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
20365694|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365695|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365696|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365697|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365698|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19303073|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303074|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
19303075|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303076|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303077|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
19303078|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303079|NCT04168944|Lenvatinib|lenvatinib|mesh-list
19303080|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19303081|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303082|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19303083|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303084|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303085|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
19303086|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303087|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
19303088|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19303089|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20365699|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365700|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365701|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20365702|NCT00954798|Vaccines|vaccines|mesh-list
20365703|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
20365704|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365705|NCT00954811|Progesterone|progesterone|mesh-list
20365706|NCT00954811|Progestins|progestins|mesh-ancestor
20365707|NCT00954811|Hormones|hormones|mesh-ancestor
20365708|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365709|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425529|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425530|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19303090|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303091|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19303092|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19303093|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303094|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365710|NCT00954889|Tamsulosin|tamsulosin|mesh-list
19303095|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303096|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19303097|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
19303098|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19303099|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303100|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19303101|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19303102|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19303103|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19303104|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303105|NCT04168619|Methotrexate|methotrexate|mesh-list
20365711|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20365712|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20365713|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19303106|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19303107|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
19303108|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19303109|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303110|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303111|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
19303112|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303113|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303114|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
19303115|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303116|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19303117|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19303118|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
19303119|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303120|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19303121|NCT04168203|Apixaban|apixaban|mesh-list
19303122|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19303123|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
19303124|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19303125|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
19303126|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303127|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303128|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
19303129|NCT04168294|Propofol|propofol|mesh-list
19303130|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19303131|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303132|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303133|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19303134|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
19303135|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
19303136|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20365714|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
20365715|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365716|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365717|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365718|NCT00954889|Urological Agents|urological agents|mesh-ancestor
20365719|NCT00954902|Antioxidants|antioxidants|mesh-list
20365720|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365721|NCT00954902|Protective Agents|protective agents|mesh-ancestor
20365722|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365723|NCT00955045|Istradefylline|istradefylline|mesh-list
20365724|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20365725|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20365726|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20365727|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
20365728|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425531|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303137|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
19303138|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303139|NCT04168138|Cytarabine|cytarabine|mesh-list
19303140|NCT04168138|Decitabine|decitabine|mesh-list
19303141|NCT04168138|Aclarubicin|aclarubicin|mesh-list
19303142|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303143|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
19303144|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303145|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303146|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
19303147|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303148|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365729|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365730|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365731|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20365732|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365733|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365734|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365735|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365736|NCT00955162|Buprenorphine|buprenorphine|mesh-list
19303149|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
19303150|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303151|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303152|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19303153|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19303154|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19303155|NCT04168099|Cefotaxime|cefotaxime|mesh-list
19303156|NCT04168099|Cefoxitin|cefoxitin|mesh-list
20185573|NCT00201539|Narcotics|narcotics|mesh-ancestor
20185574|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185575|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185576|NCT00201539|Analgesics|analgesics|mesh-ancestor
20185577|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
20185578|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185579|NCT00201630|Alfuzosin|alfuzosin|mesh-list
20185580|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19303157|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
19303158|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303159|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303160|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19303161|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19303162|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303163|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303164|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303165|NCT04167774|Paclitaxel|paclitaxel|mesh-list
19672393|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19672394|NCT03121677|Poly ICLC|poly iclc|mesh-list
19672395|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672396|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672397|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
19672398|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672399|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672400|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19672401|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672402|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
19672403|NCT03121677|Laxatives|laxatives|mesh-ancestor
19672404|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672405|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
19672406|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672407|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
19672408|NCT03107182|Promethazine|promethazine|mesh-list
19672409|NCT03107182|Dexamethasone|dexamethasone|mesh-list
19672410|NCT03107182|Paclitaxel|paclitaxel|mesh-list
19672411|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19672412|NCT03107182|Carboplatin|carboplatin|mesh-list
19672413|NCT03107182|Nivolumab|nivolumab|mesh-list
19672414|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
19672415|NCT03107182|Famotidine|famotidine|mesh-list
19672416|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19838534|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19838535|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
20185581|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20185582|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20185583|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185584|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185585|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185586|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185587|NCT00201630|Urological Agents|urological agents|mesh-ancestor
20185588|NCT00201669|Clofarabine|clofarabine|mesh-list
20185589|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20185590|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
20185591|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185592|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185593|NCT00201682|Etanercept|etanercept|mesh-list
20185594|NCT00201682|Rituximab|rituximab|mesh-list
19396331|NCT03659851|Simendan|simendan|mesh-list
19672417|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672418|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
19303166|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19303167|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19303168|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303169|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
19303170|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
19303171|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
19303172|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303173|NCT04167982|Isotretinoin|isotretinoin|mesh-list
19303174|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19303175|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
19303176|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19303177|NCT04167566|Artemisinins|artemisinins|mesh-list
19303178|NCT04167566|Artemisinin|artemisinin|mesh-list
19303179|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
19303180|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19303181|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19303182|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303183|NCT04167306|Bupropion|bupropion|mesh-list
19303184|NCT04167306|Varenicline|varenicline|mesh-list
19303185|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19303186|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
19303187|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303188|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19303189|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19303190|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303191|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303192|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
19303193|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303194|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303195|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19303196|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19303197|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303198|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19303199|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19303200|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
19303201|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
19303202|NCT04167696|Fludarabine|fludarabine|mesh-list
19303203|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
19303204|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19303205|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
19303206|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303207|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303208|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19303209|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
20365737|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20365738|NCT00955162|Naloxone|naloxone|mesh-list
20365739|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20365740|NCT00955162|Narcotics|narcotics|mesh-ancestor
20365741|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365742|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365743|NCT00955162|Analgesics|analgesics|mesh-ancestor
20365744|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
20365745|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365746|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20365747|NCT00955214|Paclitaxel|paclitaxel|mesh-list
20365748|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20365749|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365750|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
20365751|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
20365752|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
20365753|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365754|NCT00955227|Ezetimibe|ezetimibe|mesh-list
20365755|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20365756|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20365757|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
20365758|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365759|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20365760|NCT00955240|Fluorouracil|fluorouracil|mesh-list
20365761|NCT00955240|Cetuximab|cetuximab|mesh-list
20365762|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365763|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
20365764|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365765|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303210|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396332|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19303211|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303212|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19303213|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303214|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
19303215|NCT04167592|Benzydamine|benzydamine|mesh-list
20365766|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365767|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
20365768|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365769|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365770|NCT00955318|Apomorphine|apomorphine|mesh-list
20365771|NCT00955318|Emetics|emetics|mesh-ancestor
19303216|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303217|NCT04167137|Atezolizumab|atezolizumab|mesh-list
19303218|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365772|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365773|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
20365774|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365775|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365776|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
20365777|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
20365778|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365779|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365780|NCT00955526|Istradefylline|istradefylline|mesh-list
20365781|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20365782|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20365783|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20365784|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
19303219|NCT04167228|Ceftazidime|ceftazidime|mesh-list
19303220|NCT04167228|Avibactam|avibactam|mesh-list
19303221|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19303222|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303223|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303224|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19303225|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303226|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303227|NCT04167280|Ipratropium|ipratropium|mesh-list
19303228|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19303229|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
19303230|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303231|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303232|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19303233|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
19303234|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19303235|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
19303236|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303237|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396333|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
19396334|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19396335|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20365785|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365786|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365787|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365788|NCT00955604|Rasagiline|rasagiline|mesh-list
20365789|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
20365790|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20365791|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19396336|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396337|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365792|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365793|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365794|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20365795|NCT00955604|Protective Agents|protective agents|mesh-ancestor
19396338|NCT03659851|Protective Agents|protective agents|mesh-ancestor
19396339|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396340|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
19396341|NCT03659734|Narcotics|narcotics|mesh-ancestor
19396342|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396343|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396344|NCT03659734|Analgesics|analgesics|mesh-ancestor
19396345|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
19396346|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396347|NCT03659435|Rivastigmine|rivastigmine|mesh-list
19396348|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19303238|NCT04167085|Doxycycline|doxycycline|mesh-list
19303239|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303240|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303241|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
19303242|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19303243|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19838536|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838537|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838538|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
19838539|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19838540|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838541|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185595|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19303251|NCT04166721|Atezolizumab|atezolizumab|mesh-list
19303252|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303253|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
19303254|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19303255|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303256|NCT04166890|Epinephrine|epinephrine|mesh-list
19303257|NCT04166890|Carticaine|carticaine|mesh-list
19303258|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19303259|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19303260|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
19303261|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303262|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303263|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303264|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19303265|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19303266|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
19303267|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303268|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19303269|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
19303270|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
19303271|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
19303272|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19303273|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303274|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
19303275|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303276|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
19303277|NCT04166604|Trifluridine|trifluridine|mesh-list
19303278|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
19303279|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303280|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
19303281|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303282|NCT04167007|Gemcitabine|gemcitabine|mesh-list
19303283|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303284|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
19303285|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303286|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303287|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
19303288|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303289|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303290|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185596|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185597|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
20185598|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185599|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185600|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19303291|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
19303292|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303293|NCT04166786|Ethanol|ethanol|mesh-list
19303294|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
19303295|NCT04166786|Petrolatum|petrolatum|mesh-list
19303296|NCT04166786|Testosterone|testosterone|mesh-list
19303297|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
19303298|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
19303299|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19303300|NCT04166786|Androgens|androgens|mesh-ancestor
19303301|NCT04166786|Hormones|hormones|mesh-ancestor
19303302|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19303303|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303304|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19303305|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303306|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
20185601|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20185602|NCT00201682|Analgesics|analgesics|mesh-ancestor
19303307|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19303308|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303309|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303310|NCT04166786|Emollients|emollients|mesh-ancestor
19303311|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
19303312|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
19303313|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19303314|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
19303315|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303316|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303317|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19303318|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
19303319|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19303320|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
19303321|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303322|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303323|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19303324|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
19303325|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
19303326|NCT04166812|Protective Agents|protective agents|mesh-ancestor
19303327|NCT04166578|Lidocaine|lidocaine|mesh-list
19303328|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303329|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
19303330|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303331|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303332|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
19303333|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303334|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19303335|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19303336|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19303337|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303338|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303339|NCT04166396|Resveratrol|resveratrol|mesh-list
19303340|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
19303341|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303342|NCT04166396|Protective Agents|protective agents|mesh-ancestor
19303343|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303344|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303345|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20365796|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365797|NCT00955630|Ranibizumab|ranibizumab|mesh-list
20365798|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20365799|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20365800|NCT00955630|Growth Substances|growth substances|mesh-ancestor
19303346|NCT04166565|Dexamethasone|dexamethasone|mesh-list
19303347|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
19303348|NCT04166565|Bortezomib|bortezomib|mesh-list
19303349|NCT04166565|Daratumumab|daratumumab|mesh-list
19303350|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19303351|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
19303352|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303353|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303354|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19303355|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
19303356|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303357|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303358|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19303359|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303360|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
19303361|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
19303362|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303363|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19303364|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
19303365|NCT04166565|Hormones|hormones|mesh-ancestor
19303366|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19303367|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19303368|NCT04166006|Interleukin-2|interleukin-2|mesh-list
19396349|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672419|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
19672420|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
19672421|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672422|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672423|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
19672424|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
19303369|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303370|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19303371|NCT04166006|Analgesics|analgesics|mesh-ancestor
19303372|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
20365801|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365802|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
20365803|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303373|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303374|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303375|NCT04166253|Vitamin D|vitamin d|mesh-list
19303376|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
19303377|NCT04166253|Vitamins|vitamins|mesh-ancestor
19303378|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
19303379|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303380|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19303381|NCT04165967|Nivolumab|nivolumab|mesh-list
19303382|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19303383|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365804|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20365805|NCT00955695|Gefitinib|gefitinib|mesh-list
20365806|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365807|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365808|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365809|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365810|NCT00955773|Everolimus|everolimus|mesh-list
20365811|NCT00955773|Trametinib|trametinib|mesh-list
20365812|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365813|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20365814|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
20365815|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365816|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365817|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365818|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365819|NCT00955851|Vaccines|vaccines|mesh-list
20365820|NCT00955851|Immunologic Factors|immunologic factors|mesh-ancestor
20365821|NCT00955851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365822|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
20365823|NCT00955890|Razoxane|razoxane|mesh-list
20365824|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365825|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20365826|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20365827|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20365828|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365829|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365830|NCT00955890|Protective Agents|protective agents|mesh-ancestor
20365831|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365832|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20365833|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
20365834|NCT00956007|Cetuximab|cetuximab|mesh-list
20365835|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20365836|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365837|NCT00956046|Vaccines|vaccines|mesh-list
20365838|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
20365839|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365840|NCT00956059|Prednisone|prednisone|mesh-list
20365841|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365842|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
20365843|NCT00956059|Hormones|hormones|mesh-ancestor
20365844|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365845|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365846|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19303384|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19303385|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303386|NCT04166318|Fluorouracil|fluorouracil|mesh-list
19303387|NCT04166318|Capecitabine|capecitabine|mesh-list
19303388|NCT04166318|Mitomycins|mitomycins|mesh-list
19303389|NCT04166318|Mitomycin|mitomycin|mesh-list
20365847|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365848|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
20365849|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365850|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19303390|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
20365851|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303391|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303392|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303393|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303394|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19303395|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
19303396|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303397|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19303398|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
19303399|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19303400|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303401|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
19303402|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19303403|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
19303404|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303405|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
19303406|NCT04165902|Protective Agents|protective agents|mesh-ancestor
19303407|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
19303408|NCT04165850|Celecoxib|celecoxib|mesh-list
19303409|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19303410|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19303411|NCT04165850|Analgesics|analgesics|mesh-ancestor
19303412|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
19303413|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303414|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303415|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303416|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365852|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365853|NCT00956098|Oltipraz|oltipraz|mesh-list
20365854|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
20365855|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365856|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
20365857|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20365858|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
20365859|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20365860|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20365861|NCT00956098|Protective Agents|protective agents|mesh-ancestor
20365862|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365863|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365864|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20365865|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20365866|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365867|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365868|NCT00956111|Vaccines|vaccines|mesh-list
20365869|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
20365870|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365871|NCT00956150|Rifaximin|rifaximin|mesh-list
20365872|NCT00956150|Lactulose|lactulose|mesh-list
20365873|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303417|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19303418|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19303419|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303420|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303421|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303422|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303423|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19303424|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19303425|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303426|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19303427|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19303428|NCT04165512|Triamcinolone|triamcinolone|mesh-list
19303429|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19303430|NCT04165512|Bupivacaine|bupivacaine|mesh-list
19303431|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303432|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
19303433|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303434|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303435|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
20365874|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365875|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365876|NCT00956163|Diphosphonates|diphosphonates|mesh-list
20365877|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
20365878|NCT00956163|Listerine|listerine|mesh-list
20365879|NCT00956163|Fluorides|fluorides|mesh-list
20365880|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
20365881|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
19303436|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365882|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
20365883|NCT00956163|Protective Agents|protective agents|mesh-ancestor
20365884|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365885|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20365886|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365887|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20365888|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365889|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19303437|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303438|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
19303439|NCT04165512|Hormones|hormones|mesh-ancestor
19303440|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19303441|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19303442|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
19303443|NCT04165629|Aspirin|aspirin|mesh-list
19303444|NCT04165629|Clopidogrel|clopidogrel|mesh-list
19303445|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19303446|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19303447|NCT04165629|Analgesics|analgesics|mesh-ancestor
19303448|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
19303449|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303450|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303451|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303452|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303453|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19303454|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19303455|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303456|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19303457|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19303458|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303459|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
19303460|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19303461|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19303462|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19303463|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
19303464|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303465|NCT04165174|Apatinib|apatinib|mesh-list
19303466|NCT04165174|Antibodies|antibodies|mesh-list
19303467|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19303468|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
19303469|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303470|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303471|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19303472|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303473|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396350|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396351|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
19396352|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396353|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396354|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19396355|NCT03659435|Protective Agents|protective agents|mesh-ancestor
19396356|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20365890|NCT00956176|Cidofovir|cidofovir|mesh-list
20365891|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
20365892|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365893|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365894|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396357|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396358|NCT03659305|Bevacizumab|bevacizumab|mesh-list
19396359|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19396360|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396361|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19396362|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19396363|NCT03659305|Growth Substances|growth substances|mesh-ancestor
19396364|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396365|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
19396366|NCT03659292|Anesthetics|anesthetics|mesh-list
19396367|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396368|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404335|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19404336|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19404337|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19404338|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404339|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20365895|NCT00956189|Aripiprazole|aripiprazole|mesh-list
19303474|NCT04164823|Analgesics|analgesics|mesh-list
19303475|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
19303476|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303477|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303478|NCT04164615|Capecitabine|capecitabine|mesh-list
19303479|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303480|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
19303481|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303482|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303483|NCT04164524|Gentamicins|gentamicins|mesh-list
19303484|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303485|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303486|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19303487|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303488|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303489|NCT04164797|Endostar protein|endostar protein|mesh-list
19303490|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19303491|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19303492|NCT04164797|Growth Substances|growth substances|mesh-ancestor
19303493|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303494|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
19303495|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303496|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
19303497|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838542|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19838543|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19838544|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19303498|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303499|NCT04164459|Latanoprost|latanoprost|mesh-list
19303500|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19303501|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19303502|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
19303503|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19303504|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
19303505|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303506|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19303507|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303508|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19303509|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303510|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19303511|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303512|NCT04164693|Heparin|heparin|mesh-list
19303513|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19838545|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19838546|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19838547|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19838548|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19838549|NCT00621309|Protective Agents|protective agents|mesh-ancestor
19838550|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838551|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838552|NCT00621322|Vaccines|vaccines|mesh-list
19838553|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
19838554|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838555|NCT00621504|Clarithromycin|clarithromycin|mesh-list
19303514|NCT04164693|Tinzaparin|tinzaparin|mesh-list
19303515|NCT04164693|Dalteparin|dalteparin|mesh-list
19838556|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
19838557|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19303516|NCT04164693|Warfarin|warfarin|mesh-list
19303517|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
19303518|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19303519|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19303520|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303521|NCT04164238|Paclitaxel|paclitaxel|mesh-list
19303522|NCT04164238|Carboplatin|carboplatin|mesh-list
20185603|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
20185604|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185605|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20185606|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185607|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185608|NCT00201695|Dexamethasone|dexamethasone|mesh-list
20185609|NCT00201695|Doxorubicin|doxorubicin|mesh-list
20185610|NCT00201695|Vincristine|vincristine|mesh-list
19303523|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20185611|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
19303524|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303525|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
19303526|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
19303527|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
19303528|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303529|NCT04164212|Vaccines|vaccines|mesh-list
19303530|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
19303531|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185612|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20185613|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
20185614|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
20185615|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185616|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185617|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185618|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
20185619|NCT00201695|Hormones|hormones|mesh-ancestor
20185620|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185621|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20185622|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185623|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20185624|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20185625|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20185626|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185627|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185628|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20185629|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
20185630|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
20185631|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
20185632|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
20185633|NCT00201708|Docetaxel|docetaxel|mesh-list
20185634|NCT00201708|Doxorubicin|doxorubicin|mesh-list
20185635|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185636|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
20185637|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185638|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185639|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20185640|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
20185641|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303532|NCT04164355|Tadalafil|tadalafil|mesh-list
19303533|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
19303534|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19303535|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19303536|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303537|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185642|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185643|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20185644|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
20185645|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19303538|NCT04164355|Urological Agents|urological agents|mesh-ancestor
19303539|NCT04164368|Lenalidomide|lenalidomide|mesh-list
19303540|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
20365896|NCT00956189|Amisulpride|amisulpride|mesh-list
19303541|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303542|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19303543|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19672425|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672426|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672427|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672428|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
20185646|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
20185647|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20185648|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20185649|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20185650|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185651|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
20185652|NCT00201721|Rituximab|rituximab|mesh-list
20185653|NCT00201721|Pentostatin|pentostatin|mesh-list
20185654|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185655|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
20185656|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185657|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185658|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20185659|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
20185660|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303544|NCT04164368|Growth Substances|growth substances|mesh-ancestor
20365897|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
20365898|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20365899|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19672429|NCT03107182|Hormones|hormones|mesh-ancestor
19672430|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672431|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19672432|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672433|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19672434|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
20185661|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303545|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
19303546|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303547|NCT04164329|Anesthetics|anesthetics|mesh-list
19303548|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
19303549|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303550|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303551|NCT04164264|Propofol|propofol|mesh-list
19303552|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19303553|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185662|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20185663|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20185664|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20185665|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185666|NCT00201747|Mitomycins|mitomycins|mesh-list
20185667|NCT00201747|Mitomycin|mitomycin|mesh-list
20185668|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20185669|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185670|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
20365900|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20365901|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365902|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365903|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
20365904|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
20365905|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365906|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365907|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20365908|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20365909|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
20365910|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20185671|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185672|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20185673|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185674|NCT00201786|Pentostatin|pentostatin|mesh-list
20185675|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303554|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303555|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19303556|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
19303557|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
19303558|NCT04163978|Budesonide|budesonide|mesh-list
19303559|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
19303560|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303561|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19303562|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
20185676|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20185677|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185678|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185679|NCT00201799|Infliximab|infliximab|mesh-list
20365911|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20365912|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20365913|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20365914|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20365915|NCT00956202|Vaccines|vaccines|mesh-list
20365916|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
20365917|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185680|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
20185681|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185682|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185683|NCT00201812|Dexamethasone|dexamethasone|mesh-list
20185684|NCT00201812|Etanercept|etanercept|mesh-list
20185685|NCT00201812|Docetaxel|docetaxel|mesh-list
19303563|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185686|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
20185687|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303564|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303565|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19303566|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
20365918|NCT00956215|Aprepitant|aprepitant|mesh-list
20365919|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
20365920|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
20365921|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
20365922|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365923|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303567|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
19303568|NCT04163978|Hormones|hormones|mesh-ancestor
19303569|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19303570|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19303571|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
19303572|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303573|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303574|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19303575|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
19303576|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
20365924|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365925|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20365926|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365927|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365928|NCT00956267|Letrozole|letrozole|mesh-list
20365929|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365930|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20365931|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20365932|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365933|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672435|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672436|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19672437|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19672438|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19672439|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672440|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672441|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
19672442|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
19672443|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19672444|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
19672445|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
19672446|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303577|NCT04163978|Protective Agents|protective agents|mesh-ancestor
19303578|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
19303579|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303580|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19303581|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303582|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303583|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
19303584|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19303585|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19303586|NCT04163536|Prednisolone|prednisolone|mesh-list
19303587|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
19303588|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19303589|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
19303590|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303591|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
19303592|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
19303593|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303594|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303595|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19303596|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
19303597|NCT04163536|Hormones|hormones|mesh-ancestor
19303598|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19303599|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19303600|NCT04163536|Protective Agents|protective agents|mesh-ancestor
19303601|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19303602|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303603|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
19303604|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303605|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19303606|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303607|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672447|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19672448|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
19672449|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
20365934|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19672450|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19303608|NCT04163419|Tanezumab|tanezumab|mesh-list
19303609|NCT04163419|Analgesics|analgesics|mesh-ancestor
19303610|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
20365935|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
20365936|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365937|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365938|NCT00956306|Udenafil|udenafil|mesh-list
20365939|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20365940|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20365941|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365942|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365943|NCT00956319|Estazolam|estazolam|mesh-list
19303611|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303612|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303613|NCT04163471|Hemostatics|hemostatics|mesh-list
19303614|NCT04163471|Coagulants|coagulants|mesh-ancestor
19303615|NCT04163354|Listerine|listerine|mesh-list
19303616|NCT04163354|Fluorides|fluorides|mesh-list
19303617|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
19303618|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
19303619|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
19303620|NCT04163354|Protective Agents|protective agents|mesh-ancestor
19303621|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303622|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19303623|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303624|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19303625|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19303626|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303627|NCT04163588|Metolazone|metolazone|mesh-list
19303628|NCT04163588|Diuretics|diuretics|mesh-list
19303629|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19303630|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
19303631|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303632|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303633|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303634|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19303635|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19303636|NCT04163237|Sorafenib|sorafenib|mesh-list
19303637|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303638|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19303639|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303640|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396369|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
19396370|NCT03659162|Clotrimazole|clotrimazole|mesh-list
19396371|NCT03659162|Miconazole|miconazole|mesh-list
19396372|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396373|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19396374|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19396375|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19396376|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396377|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396378|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19838558|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20185688|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
20185689|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
20185690|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185691|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185692|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185693|NCT00201812|Hormones|hormones|mesh-ancestor
20185694|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185695|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20185696|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185697|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20185698|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20185699|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20185700|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185701|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20185702|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20185703|NCT00201812|Analgesics|analgesics|mesh-ancestor
20185704|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
20185705|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185706|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19396379|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
19404340|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20185707|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
20185708|NCT00201955|Rebamipide|rebamipide|mesh-list
20185709|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19303641|NCT04162743|Trazodone|trazodone|mesh-list
19303642|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19303643|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19303644|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303645|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303646|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303647|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19303648|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19303649|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303650|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303651|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303652|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
19303653|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19303654|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
19303655|NCT04162834|Papaverine|papaverine|mesh-list
19303656|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19303657|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303658|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303659|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
19303660|NCT04162834|Urological Agents|urological agents|mesh-ancestor
19303661|NCT04162873|Celecoxib|celecoxib|mesh-list
19303662|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
19303663|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19303664|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19303665|NCT04162873|Analgesics|analgesics|mesh-ancestor
19303666|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
19303667|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303668|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303669|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303670|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303671|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19303672|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19303673|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303674|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303675|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19303676|NCT04162535|Lidocaine|lidocaine|mesh-list
19303677|NCT04162535|Propofol|propofol|mesh-list
19303678|NCT04162535|Sevoflurane|sevoflurane|mesh-list
19303679|NCT04162535|Anesthetics|anesthetics|mesh-list
19303680|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19303681|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303682|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303683|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303684|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
19303685|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303686|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19303687|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19303688|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19303689|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303690|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303691|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19303692|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
19303693|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19303694|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19303695|NCT04162522|Citalopram|citalopram|mesh-list
19672451|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19672452|NCT02969837|Dexamethasone|dexamethasone|mesh-list
19672453|NCT02969837|Lenalidomide|lenalidomide|mesh-list
19838559|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185710|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672454|NCT02969837|Elotuzumab|elotuzumab|mesh-list
19672455|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672456|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
19672457|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
19672458|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185711|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
19303696|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
19303697|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19672459|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672460|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185712|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185713|NCT00201955|Protective Agents|protective agents|mesh-ancestor
19303698|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19303699|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303700|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303701|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303702|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
19303703|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303704|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19303705|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
19303706|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303707|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
19303708|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
19303709|NCT04162028|Ketamine|ketamine|mesh-list
19303710|NCT04162028|Analgesics|analgesics|mesh-ancestor
20185714|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185715|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185716|NCT00201981|Rebamipide|rebamipide|mesh-list
20185717|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20185718|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185719|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
20185720|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185721|NCT00201981|Protective Agents|protective agents|mesh-ancestor
20185722|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185723|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185724|NCT00201994|Tolvaptan|tolvaptan|mesh-list
20185725|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20185726|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185727|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
20185728|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185729|NCT00202007|Risperidone|risperidone|mesh-list
20185730|NCT00202007|Aripiprazole|aripiprazole|mesh-list
20185731|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20185732|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
20185733|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185734|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185735|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185736|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20185737|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185738|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185739|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185740|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20185741|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
20185742|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
20185743|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
20185744|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20185745|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20185746|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19303711|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
19303712|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303713|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303714|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19303715|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19303716|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
19303717|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
19303718|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303719|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19303720|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19303721|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672461|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
20185747|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20185748|NCT00202020|Aspirin|aspirin|mesh-list
20185749|NCT00202020|Cilostazol|cilostazol|mesh-list
20185750|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20185751|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20185752|NCT00202020|Analgesics|analgesics|mesh-ancestor
20185753|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
20185754|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185755|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185756|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20185757|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185758|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20185759|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20185760|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185761|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20365944|NCT00956319|Zolpidem|zolpidem|mesh-list
20365945|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20365946|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20365947|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20365948|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365949|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20365950|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
20365951|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
20365952|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20365953|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365954|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
20365955|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20365956|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19303722|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303723|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
19303724|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19303725|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303726|NCT04161768|Norfloxacin|norfloxacin|mesh-list
19303727|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303728|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303729|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19303730|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19303731|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303732|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303733|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303734|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19303735|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19303736|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19303737|NCT04161690|Ropivacaine|ropivacaine|mesh-list
20365957|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20365958|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
20365959|NCT00956397|Rifaximin|rifaximin|mesh-list
20365960|NCT00956397|Lactulose|lactulose|mesh-list
20365961|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20365962|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20365963|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365964|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20365965|NCT00956436|Sorafenib|sorafenib|mesh-list
20365966|NCT00956436|Liver Extracts|liver extracts|mesh-list
20365967|NCT00956436|Antibodies|antibodies|mesh-list
19303738|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303739|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
19303740|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303741|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303742|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
19303743|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303744|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19303745|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19303746|NCT04161690|Analgesics|analgesics|mesh-ancestor
19303747|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303748|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303749|NCT04161664|Paclitaxel|paclitaxel|mesh-list
19303750|NCT04161664|Carboplatin|carboplatin|mesh-list
19303751|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19303752|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303753|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
19303754|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
19303755|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
19303756|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303757|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
19303758|NCT04161729|Analgesics|analgesics|mesh-ancestor
19672462|NCT02969837|Hormones|hormones|mesh-ancestor
20185762|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20185763|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185764|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
20185765|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20185766|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
20185767|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20185768|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
20185769|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185770|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20365968|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
19303759|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
20185771|NCT00202020|Protective Agents|protective agents|mesh-ancestor
20365969|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20365970|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
20365971|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303760|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185772|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20185773|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20185774|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
20185775|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20185776|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185777|NCT00202124|Tryptophan|tryptophan|mesh-list
20185778|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20185779|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
20185780|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185781|NCT00202163|Testosterone|testosterone|mesh-list
20185782|NCT00202163|Androgens|androgens|mesh-ancestor
20185783|NCT00202163|Hormones|hormones|mesh-ancestor
20185784|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185785|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185786|NCT00202176|Bromides|bromides|mesh-list
20185787|NCT00202176|Ipratropium|ipratropium|mesh-list
20185788|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
20185789|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20185790|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
20185791|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185792|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185793|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20185794|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
20185795|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20185796|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
20185797|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185798|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185799|NCT00202189|Budesonide|budesonide|mesh-list
20365972|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365973|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20365974|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365975|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365976|NCT00956436|Hematinics|hematinics|mesh-ancestor
20365977|NCT00956462|Dexamethasone|dexamethasone|mesh-list
20365978|NCT00956462|Ketorolac|ketorolac|mesh-list
20365979|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20365980|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20365981|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
20365982|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
20365983|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20365984|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20365985|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20365986|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
20365987|NCT00956462|Hormones|hormones|mesh-ancestor
20365988|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20365989|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20365990|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20365991|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20365992|NCT00956462|Analgesics|analgesics|mesh-ancestor
20365993|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
20365994|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20365995|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20365996|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20365997|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20365998|NCT00956644|Amlodipine|amlodipine|mesh-list
20365999|NCT00956644|Irbesartan|irbesartan|mesh-list
20366000|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20366001|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20366002|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366003|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366004|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20612685|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303761|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303762|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
19303763|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303764|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19303765|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
19303766|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19303767|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303768|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303769|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19303770|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
20366005|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366006|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
20366007|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20366008|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20425532|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425533|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
20425534|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425535|NCT01275547|Midazolam|midazolam|mesh-list
20425536|NCT01275547|Ketamine|ketamine|mesh-list
20425537|NCT01275547|Morphine|morphine|mesh-list
20425538|NCT01275547|Esketamine|esketamine|mesh-list
20425539|NCT01275547|Analgesics|analgesics|mesh-ancestor
20425540|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
20425541|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425542|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303771|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19303772|NCT04161586|Prilocaine|prilocaine|mesh-list
19303773|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
19303774|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303775|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303776|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303777|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
19303778|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425543|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20425544|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20425545|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
20425546|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
20425547|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425548|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20425549|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20425550|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425551|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425552|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19303779|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
19303780|NCT04161508|Neostigmine|neostigmine|mesh-list
19303781|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19303782|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303783|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303784|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19303785|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303786|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303787|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19303788|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
19303789|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303790|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19303791|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19303792|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19303793|NCT04161560|Cetuximab|cetuximab|mesh-list
19303794|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19303795|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303796|NCT04161482|Furosemide|furosemide|mesh-list
19303797|NCT04161482|Diuretics|diuretics|mesh-ancestor
19303798|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
19303799|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303800|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19303801|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303802|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303803|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
19303804|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
19303805|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19303806|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19303807|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303808|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303809|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303810|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303811|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
19303812|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19303813|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303814|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19672463|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672464|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19672465|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425553|NCT01275547|Narcotics|narcotics|mesh-ancestor
20425554|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20185800|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20185801|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20185802|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
19303815|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19303816|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303817|NCT04161430|Incretins|incretins|mesh-ancestor
19303818|NCT04161430|Hormones|hormones|mesh-ancestor
19303819|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19303820|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19303821|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
19303822|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303823|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303824|NCT04161404|Metformin|metformin|mesh-list
20366009|NCT00956696|Topiramate|topiramate|mesh-list
20366010|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
20366011|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20366012|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366013|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
19303825|NCT04161404|Andrographolide|andrographolide|mesh-list
19672466|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
19672467|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19303826|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19303827|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303828|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303829|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19303830|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19303831|NCT04161404|Analgesics|analgesics|mesh-ancestor
19303832|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
19303833|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303834|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303835|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19303836|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19303837|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303838|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
19303839|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19303840|NCT04161209|Citalopram|citalopram|mesh-list
19303841|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19303842|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19303843|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303844|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303845|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303846|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
19303847|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303848|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19303849|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
19303850|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303851|NCT04161014|Nintedanib|nintedanib|mesh-list
19303852|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303853|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19303854|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303855|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303856|NCT04161053|Rifaximin|rifaximin|mesh-list
19303857|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
19303858|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19303859|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303860|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19303861|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19303862|NCT04161001|Amlodipine|amlodipine|mesh-list
19303863|NCT04161001|Olmesartan|olmesartan|mesh-list
19303864|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19404341|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
19672468|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19672469|NCT02969837|Growth Substances|growth substances|mesh-ancestor
19672470|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
19672471|NCT02802852|Lenograstim|lenograstim|mesh-list
19672472|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19672473|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
19838560|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20185803|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185804|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185805|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20185806|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
20185807|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
20185808|NCT00202189|Hormones|hormones|mesh-ancestor
19838561|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366014|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
20366015|NCT00956748|Dexamethasone|dexamethasone|mesh-list
19838562|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838563|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19838564|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19838565|NCT00621517|Bupropion|bupropion|mesh-list
19838566|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20366016|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303865|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
19303866|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19303867|NCT04161001|Ezetimibe|ezetimibe|mesh-list
20366017|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
20366018|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
20366019|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366020|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366021|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20366022|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
20366023|NCT00956748|Hormones|hormones|mesh-ancestor
20366024|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366025|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20366026|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366027|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366028|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366029|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
20366030|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366031|NCT00956748|Expectorants|expectorants|mesh-ancestor
20366032|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
20366033|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20366034|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
20366035|NCT00956748|Protective Agents|protective agents|mesh-ancestor
20366036|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20366037|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20366038|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366039|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20366040|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20366041|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
20366042|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20366043|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366044|NCT00956982|Interferons|interferons|mesh-list
20366045|NCT00956982|Ribavirin|ribavirin|mesh-list
20366046|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
19303868|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19303869|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19303870|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303871|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303872|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19303873|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303874|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
19303875|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19303876|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19303877|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
19672474|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672475|NCT02789020|Rasagiline|rasagiline|mesh-list
19672476|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19672477|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672478|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672479|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19672480|NCT02789020|Protective Agents|protective agents|mesh-ancestor
19672481|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672482|NCT02524275|Docetaxel|docetaxel|mesh-list
19672483|NCT02524275|Capecitabine|capecitabine|mesh-list
19672484|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672485|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
19672486|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
19672487|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
19672488|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672489|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672490|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
19672491|NCT02473042|Promethazine|promethazine|mesh-list
19672492|NCT02473042|Dexamethasone|dexamethasone|mesh-list
19672493|NCT02473042|Ondansetron|ondansetron|mesh-list
19672494|NCT02473042|Famotidine|famotidine|mesh-list
19672495|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672496|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
19672497|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
19672498|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303878|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19303879|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19303880|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303881|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19303882|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19303883|NCT04160936|Ropivacaine|ropivacaine|mesh-list
19303884|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
19303885|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
20366047|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
20366048|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20366049|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366050|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
20366051|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366052|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
20366053|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303886|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303887|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303888|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
19303889|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396380|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396381|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396382|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20366054|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
20366055|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366056|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20366057|NCT00957060|Glimepiride|glimepiride|mesh-list
20366058|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20366059|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366060|NCT00957060|Incretins|incretins|mesh-ancestor
20366061|NCT00957060|Hormones|hormones|mesh-ancestor
20366062|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366063|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20366064|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
20366065|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366066|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366067|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20366068|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366069|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
20366070|NCT00957125|Bevacizumab|bevacizumab|mesh-list
20366071|NCT00957125|Docetaxel|docetaxel|mesh-list
20366072|NCT00957125|Epirubicin|epirubicin|mesh-list
20366073|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366074|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366075|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20366076|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20366077|NCT00957125|Growth Substances|growth substances|mesh-ancestor
20366078|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366079|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
20366080|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19396383|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19396384|NCT03659084|Deferasirox|deferasirox|mesh-list
19396385|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19396386|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
19396387|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
19396388|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396389|NCT03659058|Colchicine|colchicine|mesh-list
19396390|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19396391|NCT03659058|Antioxidants|antioxidants|mesh-list
19396392|NCT03659058|Silymarin|silymarin|mesh-list
19396393|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
19396394|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396395|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
19396396|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
19396397|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
19396398|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396399|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396400|NCT03659058|Protective Agents|protective agents|mesh-ancestor
19396401|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396402|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19396403|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396404|NCT03658993|Rifaximin|rifaximin|mesh-list
19396405|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20366081|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
20366082|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19303890|NCT04161027|Pregabalin|pregabalin|mesh-list
19303891|NCT04161027|Analgesics|analgesics|mesh-ancestor
20366083|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366084|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20366085|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20366086|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366087|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366088|NCT00957177|Pregabalin|pregabalin|mesh-list
19303892|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
19303893|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303894|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303895|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
19303896|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19303897|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19303898|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303899|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19303900|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19303901|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19303902|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303903|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303904|NCT04160897|Tenofovir|tenofovir|mesh-list
19303905|NCT04160897|Entecavir|entecavir|mesh-list
19303906|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
19303907|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303908|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19303909|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19303910|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303911|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303912|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19303913|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19303914|NCT04160598|Fentanyl|fentanyl|mesh-list
19303915|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19303916|NCT04160598|Narcotics|narcotics|mesh-ancestor
19303917|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303918|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303919|NCT04160598|Analgesics|analgesics|mesh-ancestor
19303920|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
19303921|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303922|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19303923|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19303924|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
19303925|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
19303926|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
19303927|NCT04160676|Thiamine|thiamine|mesh-list
19303928|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
19303929|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19303930|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
19303931|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303932|NCT04160676|Protective Agents|protective agents|mesh-ancestor
19303933|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303934|NCT04160676|Vitamins|vitamins|mesh-ancestor
19303935|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
19672499|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672500|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185809|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19303936|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
19303937|NCT04160416|Capecitabine|capecitabine|mesh-list
19303938|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
19672501|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
19672502|NCT02473042|Hormones|hormones|mesh-ancestor
20185810|NCT00202228|Riboflavin|riboflavin|mesh-list
20185811|NCT00202228|Thiamine|thiamine|mesh-list
20185812|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185813|NCT00202228|Vitamins|vitamins|mesh-ancestor
20185814|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
20185815|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185816|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20185817|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
20185818|NCT00202241|Testosterone|testosterone|mesh-list
20185819|NCT00202241|Androgens|androgens|mesh-ancestor
20185820|NCT00202241|Hormones|hormones|mesh-ancestor
20185821|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185822|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185823|NCT00202280|Folic Acid|folic acid|mesh-list
19303939|NCT04160416|Irinotecan|irinotecan|mesh-list
19303940|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19303941|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
20185824|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
19303942|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366089|NCT00957177|Analgesics|analgesics|mesh-ancestor
20366090|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
20366091|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366092|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366093|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
19303943|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303944|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19303945|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19303946|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19303947|NCT04160520|Morphine|morphine|mesh-list
19303948|NCT04160520|Pramipexole|pramipexole|mesh-list
19303949|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19303950|NCT04160520|Narcotics|narcotics|mesh-ancestor
19303951|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366094|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20366095|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366096|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366097|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20366098|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20366099|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20366100|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366101|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20366102|NCT00957190|Timolol|timolol|mesh-list
20366103|NCT00957190|Dorzolamide|dorzolamide|mesh-list
20366104|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20366105|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20366106|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
20366107|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366108|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366109|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366110|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20366111|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20366112|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20366113|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366114|NCT00957203|Istradefylline|istradefylline|mesh-list
20366115|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20366116|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20366117|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20366118|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
20366119|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366120|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366121|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366122|NCT00957216|Ubiquinone|ubiquinone|mesh-list
20366123|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
20366124|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
20366125|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366126|NCT00957216|Vitamins|vitamins|mesh-ancestor
20366127|NCT00957320|Sirolimus|sirolimus|mesh-list
20366128|NCT00957320|Asparaginase|asparaginase|mesh-list
20366129|NCT00957320|Pegaspargase|pegaspargase|mesh-list
20366130|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20366131|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366132|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20366133|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303952|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303953|NCT04160520|Analgesics|analgesics|mesh-ancestor
19303954|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
19303955|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19303956|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
19303957|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303958|NCT04160520|Protective Agents|protective agents|mesh-ancestor
19303959|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19303960|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19303961|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
19303962|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
19303963|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303964|NCT04160611|Midazolam|midazolam|mesh-list
19303965|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19303966|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19303967|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19303968|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303969|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19303970|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20366134|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
19303971|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19303972|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19303973|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
19303974|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
19303975|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
19303976|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
19303977|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19303978|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303979|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
19303980|NCT04160195|Fludarabine|fludarabine|mesh-list
19303981|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19303982|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
19303983|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19303984|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19303985|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19303986|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
19303987|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19303988|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19303989|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19303990|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
19303991|NCT04160026|Piperaquine|piperaquine|mesh-list
19303992|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
19303993|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19303994|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
19303995|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19303996|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19303997|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19303998|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19303999|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304000|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304001|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19304002|NCT04160026|Renal Agents|renal agents|mesh-ancestor
19304003|NCT04159870|Rifaximin|rifaximin|mesh-list
19304004|NCT04159870|Norfloxacin|norfloxacin|mesh-list
19304005|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19304006|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304007|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20366135|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366136|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
20366137|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366138|NCT00957346|Misoprostol|misoprostol|mesh-list
20366139|NCT00957346|Mifepristone|mifepristone|mesh-list
20366140|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20366141|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
20366142|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20366143|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366144|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20366145|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20366146|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
20366147|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20366148|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19304008|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19304009|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19304010|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304011|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304012|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304013|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19304014|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19304015|NCT04160117|Colchicine|colchicine|mesh-list
19304016|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
19304017|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304018|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304019|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304020|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
20366149|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20366150|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19304021|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304022|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304023|NCT04159896|Nivolumab|nivolumab|mesh-list
19304024|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304025|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304026|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19304027|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304028|NCT04159649|Letrozole|letrozole|mesh-list
19304029|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304030|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19304031|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19304032|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304033|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304034|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19304035|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
19304036|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366151|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
20366152|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20366153|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20366154|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
20366155|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366156|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
20366157|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19304037|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304038|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19304039|NCT04159597|Upadacitinib|upadacitinib|mesh-list
19304040|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19304041|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19304042|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304043|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304044|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304045|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
19304046|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19304047|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19304048|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19304049|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
19304050|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304051|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304052|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304053|NCT04159181|Lactulose|lactulose|mesh-list
20366158|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20366159|NCT00957385|Lenalidomide|lenalidomide|mesh-list
19304054|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
19304055|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304056|NCT04159181|Cathartics|cathartics|mesh-ancestor
19304057|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
19304058|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
19304059|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304060|NCT04159155|Paclitaxel|paclitaxel|mesh-list
19304061|NCT04159155|Carboplatin|carboplatin|mesh-list
19304062|NCT04159155|Niraparib|niraparib|mesh-list
19304063|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19304064|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304065|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304066|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304067|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304068|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304069|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19304070|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304071|NCT04159142|Paclitaxel|paclitaxel|mesh-list
19304072|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19304073|NCT04159142|Carboplatin|carboplatin|mesh-list
19304074|NCT04159142|Capecitabine|capecitabine|mesh-list
19304075|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19304076|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304077|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304078|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304079|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304080|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304081|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19304082|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
19304083|NCT04159077|Tamsulosin|tamsulosin|mesh-list
19304084|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19304085|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19304086|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19304087|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
19304088|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304089|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304090|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304091|NCT04159077|Urological Agents|urological agents|mesh-ancestor
19304092|NCT04158934|Factor VIII|factor viii|mesh-list
19304093|NCT04158934|BAX 855|bax 855|mesh-list
19304094|NCT04158934|Coagulants|coagulants|mesh-ancestor
19304095|NCT04158947|Trastuzumab|trastuzumab|mesh-list
20366160|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
20366161|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366162|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20366163|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20366164|NCT00957385|Growth Substances|growth substances|mesh-ancestor
20366165|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
20366166|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366167|NCT00957411|Cetuximab|cetuximab|mesh-list
20366168|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366169|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366170|NCT00957554|Amlodipine|amlodipine|mesh-list
20366171|NCT00957554|Irbesartan|irbesartan|mesh-list
19304096|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19304097|NCT04158947|Afatinib|afatinib|mesh-list
19304098|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304099|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304100|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19304101|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304102|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304103|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
20366172|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20366173|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20366174|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366175|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366176|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20366177|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366178|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
20366179|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20366180|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20366181|NCT00957866|Interferons|interferons|mesh-list
20366182|NCT00957866|Ribavirin|ribavirin|mesh-list
20366183|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366184|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
20366185|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366186|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
20366187|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366188|NCT00957879|Calcitriol|calcitriol|mesh-list
20366189|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
20366190|NCT00957879|Vitamin D|vitamin d|mesh-list
20366191|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20366192|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366193|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20366194|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366195|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366196|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20366197|NCT00957879|Vitamins|vitamins|mesh-ancestor
20366198|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
20366199|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20366200|NCT00958022|Carboplatin|carboplatin|mesh-list
20366201|NCT00958022|Etoposide|etoposide|mesh-list
20366202|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
20366203|NCT00958022|Panobinostat|panobinostat|mesh-list
20366204|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
20366205|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366206|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20366207|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19304104|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304105|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
19396406|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396407|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20366208|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366209|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366210|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396408|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19396409|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19396410|NCT03658850|Diuretics|diuretics|mesh-ancestor
20366211|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20366212|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
20366213|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
19396411|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
19396412|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396413|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19396414|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366214|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
20366215|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304106|NCT04158674|Simendan|simendan|mesh-list
19304107|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19304108|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
19304109|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19304110|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19304111|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304112|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304113|NCT04158674|Protective Agents|protective agents|mesh-ancestor
19304114|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304115|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20366216|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304116|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
19304117|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304118|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304119|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
19304120|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304121|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304122|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19304123|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19304124|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304125|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
19304126|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
19304127|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304128|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304129|NCT04158713|Piperaquine|piperaquine|mesh-list
19304130|NCT04158713|Artenimol|artenimol|mesh-list
19304131|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
19304132|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19304133|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19304134|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304135|NCT04158830|Aspirin|aspirin|mesh-list
19304136|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19304137|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19304138|NCT04158830|Analgesics|analgesics|mesh-ancestor
19304139|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
19304140|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304141|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304142|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304143|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304144|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19304145|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19304146|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304147|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19304148|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19304149|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304150|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
19304151|NCT04158856|Trastuzumab|trastuzumab|mesh-list
19304152|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304153|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304154|NCT04158076|Amlodipine|amlodipine|mesh-list
19304155|NCT04158076|Telmisartan|telmisartan|mesh-list
19304156|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19304157|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19304158|NCT04158076|Ezetimibe|ezetimibe|mesh-list
19304159|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19304160|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20185825|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
20185826|NCT00202280|Vitamins|vitamins|mesh-ancestor
20185827|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
20185828|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185829|NCT00202280|Hematinics|hematinics|mesh-ancestor
20185830|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185831|NCT00202293|Olanzapine|olanzapine|mesh-list
20185832|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
20185833|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
20185834|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
20185835|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185836|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185837|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185838|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20185839|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185840|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185841|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185842|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20185843|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20185844|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304161|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304162|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304163|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19304164|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304165|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
19304166|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19304167|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19304168|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
19304169|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19304170|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19304171|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304172|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19304173|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19304174|NCT04158102|Bupivacaine|bupivacaine|mesh-list
19304175|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
19304176|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
19304177|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304178|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304179|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
19304180|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304181|NCT04158167|Oxytocin|oxytocin|mesh-list
19304182|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
19304183|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20366217|NCT00958100|Tenofovir|tenofovir|mesh-list
20366218|NCT00958100|Lamivudine|lamivudine|mesh-list
20366219|NCT00958100|Emtricitabine|emtricitabine|mesh-list
20366220|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
20366221|NCT00958100|Abacavir|abacavir|mesh-list
20366222|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
20366223|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
20366224|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366225|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20366226|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20366227|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366228|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366229|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20366230|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20366231|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20366232|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19304184|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304185|NCT04158050|Omalizumab|omalizumab|mesh-list
19304186|NCT04158050|Antibodies|antibodies|mesh-list
19304187|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
19304188|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366233|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
20366234|NCT00958139|Permethrin|permethrin|mesh-list
19304189|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19304190|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19304191|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
19304192|NCT04158388|Tryptophan|tryptophan|mesh-list
20366235|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366236|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366237|NCT00958204|Fluoxetine|fluoxetine|mesh-list
20366238|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20366239|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20366240|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366241|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366242|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366243|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
20366244|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366245|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20366246|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
20366247|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20366248|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20366249|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20366250|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366251|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20366252|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20366253|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366254|NCT00958269|Incretins|incretins|mesh-ancestor
20366255|NCT00958269|Hormones|hormones|mesh-ancestor
19304193|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19304194|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
20366256|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672503|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19304195|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304196|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
19304197|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304198|NCT04157803|Acetic Acid|acetic acid|mesh-list
19304199|NCT04157803|Retinol acetate|retinol acetate|mesh-list
19304200|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19304201|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304202|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19304203|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
19304204|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304205|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19304206|NCT04157803|Protective Agents|protective agents|mesh-ancestor
19304207|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304208|NCT04157959|Febuxostat|febuxostat|mesh-list
19304209|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
19304210|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304211|NCT04157751|Empagliflozin|empagliflozin|mesh-list
19304212|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19304213|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304214|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19304215|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304216|NCT04157998|Metoclopramide|metoclopramide|mesh-list
19304217|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
19304218|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
19304219|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304220|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304221|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304222|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19304223|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19304224|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
19304225|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304226|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304227|NCT04157491|Antibodies|antibodies|mesh-list
19304228|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
19304229|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304230|NCT04157478|Temozolomide|temozolomide|mesh-list
19304231|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19304232|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
19304233|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304234|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304235|NCT04157699|Tenofovir|tenofovir|mesh-list
19672504|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19672505|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672506|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
19672507|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
19672508|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19672509|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
19672510|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672511|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672512|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19672513|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19672514|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672515|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185845|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366257|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20366258|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
20366259|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304236|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
19304237|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185846|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185847|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
20185848|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20185849|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
20185850|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
20185851|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
20366260|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366261|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20366262|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20185852|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185853|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672516|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19304238|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19304239|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19304240|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304241|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304242|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19304243|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19304244|NCT04157257|Tenofovir|tenofovir|mesh-list
19304245|NCT04157257|Entecavir|entecavir|mesh-list
19304246|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
19304247|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304248|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20366263|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366264|NCT00958386|Irinotecan|irinotecan|mesh-list
20366265|NCT00958386|Panitumumab|panitumumab|mesh-list
20366266|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20366267|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366268|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366269|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366270|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366271|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366272|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
20366273|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19304249|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19304250|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304251|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304252|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19304253|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19304254|NCT04156984|Golimumab|golimumab|mesh-list
19304255|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19304256|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304257|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304258|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
19304259|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304260|NCT04157010|Methotrexate|methotrexate|mesh-list
19304261|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19304262|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
19304263|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19304264|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304265|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19304266|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
19304267|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304268|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304269|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
19304270|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304271|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19304272|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304273|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
19304274|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304275|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19396415|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396416|NCT03658785|Aldesleukin|aldesleukin|mesh-list
19396417|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
19396418|NCT03658785|Fludarabine|fludarabine|mesh-list
19396419|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366274|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
20366275|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366276|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
20366277|NCT00958425|Protective Agents|protective agents|mesh-ancestor
20366278|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
20366279|NCT00958451|Vitamin D|vitamin d|mesh-list
20366280|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20366281|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366282|NCT00958451|Vitamins|vitamins|mesh-ancestor
20366283|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
20366284|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20366285|NCT05352373|Calcium|calcium|mesh-list
20366286|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20366287|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366288|NCT05352321|Gemcitabine|gemcitabine|mesh-list
20366289|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366290|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20366291|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
20366292|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396420|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
19396421|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396422|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304276|NCT04157036|Ibuprofen|ibuprofen|mesh-list
20366293|NCT05352321|Antiviral Agents|antiviral agents|mesh-ancestor
20366294|NCT05352321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304277|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
19304278|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19304279|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19304280|NCT04157036|Prednisolone|prednisolone|mesh-list
19304281|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
19304282|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19304283|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
19304284|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19304285|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19304286|NCT04157036|Analgesics|analgesics|mesh-ancestor
20366295|NCT05352321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304287|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
19304288|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304289|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304290|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304291|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304292|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19304293|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304294|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304295|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
19304296|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
19304297|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304298|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
19304299|NCT04157036|Hormones|hormones|mesh-ancestor
19304300|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19304301|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19304302|NCT04157036|Protective Agents|protective agents|mesh-ancestor
19304303|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19304304|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304305|NCT04156750|Metformin|metformin|mesh-list
19304306|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19304307|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304308|NCT04156555|Amoxicillin|amoxicillin|mesh-list
19304309|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
19304310|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
19304311|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19304312|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19304313|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304314|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19304315|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304316|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304317|NCT04156815|Isotretinoin|isotretinoin|mesh-list
19304318|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19304319|NCT04156425|Golimumab|golimumab|mesh-list
19304320|NCT04156425|Dexetimide|dexetimide|mesh-list
19304321|NCT04156425|Citalopram|citalopram|mesh-list
19304322|NCT04156425|Calcium|calcium|mesh-list
19304323|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19304324|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304325|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19304326|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19304327|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304328|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304329|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304330|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
19304331|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19304332|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
19304333|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304334|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20185854|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185855|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
20185856|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185857|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185858|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185859|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20185860|NCT00202345|Hematinics|hematinics|mesh-ancestor
20185861|NCT00202358|Atenolol|atenolol|mesh-list
20185862|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20185863|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19304335|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19304336|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
20185864|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
19304337|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
19304338|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304339|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19304340|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19304341|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
19304342|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19304343|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304344|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304345|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
19304346|NCT04156451|Furosemide|furosemide|mesh-list
19304347|NCT04156451|Diuretics|diuretics|mesh-ancestor
19304348|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
19304349|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304350|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19304351|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304352|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304353|NCT04156464|Lorazepam|lorazepam|mesh-list
19304354|NCT04156464|Phenobarbital|phenobarbital|mesh-list
19304355|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
19304356|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
19304357|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
19304358|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304359|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304360|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304361|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19304362|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304363|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19304364|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19304365|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304366|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
20366296|NCT05352321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366297|NCT05352321|Immunologic Factors|immunologic factors|mesh-ancestor
20366298|NCT05352321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366299|NCT05352282|Fentanyl|fentanyl|mesh-list
20366300|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20366301|NCT05352282|Narcotics|narcotics|mesh-ancestor
20366302|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366303|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366304|NCT05352282|Analgesics|analgesics|mesh-ancestor
19304367|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
19304368|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304369|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185865|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
20185866|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185867|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185868|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20185869|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20185870|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20185871|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185872|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185873|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185874|NCT00202397|Riluzole|riluzole|mesh-list
20366305|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
19304370|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19304371|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19304372|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19304373|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19304374|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19304375|NCT04156204|Tacrolimus|tacrolimus|mesh-list
19304376|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304377|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
19304378|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304379|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19304380|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304381|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304382|NCT04156347|Topotecan|topotecan|mesh-list
19304383|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19304384|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19304385|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304386|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304387|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304388|NCT04156035|Lamotrigine|lamotrigine|mesh-list
20366306|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366307|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20366308|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20366309|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
20366310|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
19304389|NCT04156035|Ketamine|ketamine|mesh-list
19304390|NCT04156035|Analgesics|analgesics|mesh-ancestor
19304391|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
20425555|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20425556|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20425557|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20425558|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20425559|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
20425560|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
20425561|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
20425562|NCT01275560|Metronidazole|metronidazole|mesh-list
20425563|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425564|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20425565|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19304392|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304393|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304394|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19304395|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19304396|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
19304397|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
19304398|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304399|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19304400|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19304401|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304402|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304403|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
19304404|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19304405|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304406|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19304407|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19304408|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185875|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
20185876|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20185877|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20185878|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185879|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185880|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185881|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20425566|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20425567|NCT01275599|Buprenorphine|buprenorphine|mesh-list
20425568|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20425569|NCT01275599|Naloxone|naloxone|mesh-list
20425570|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20425571|NCT01275599|Narcotics|narcotics|mesh-ancestor
20425572|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425573|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425574|NCT01275599|Analgesics|analgesics|mesh-ancestor
20425575|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
20425576|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425577|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20425578|NCT01275638|Prednisolone|prednisolone|mesh-list
20185882|NCT00202397|Protective Agents|protective agents|mesh-ancestor
20185883|NCT00202423|Nabiximols|nabiximols|mesh-list
20185884|NCT00202423|Analgesics|analgesics|mesh-ancestor
20425579|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20425580|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
19304409|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304410|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20185885|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
20425581|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20425582|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
20425583|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20425584|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
20425585|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425586|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
20425587|NCT01275638|Hormones|hormones|mesh-ancestor
20425588|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425589|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425590|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20425591|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425592|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
20425593|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
20425594|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304411|NCT04156152|Listerine|listerine|mesh-list
19304412|NCT04156152|Fluorides|fluorides|mesh-list
19304413|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
19304414|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
19304415|NCT04156152|Protective Agents|protective agents|mesh-ancestor
19304416|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304417|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19304418|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304419|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19304420|NCT04155814|Hematinics|hematinics|mesh-ancestor
19304421|NCT04155879|Colchicine|colchicine|mesh-list
19304422|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
19304423|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304424|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304425|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304426|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304427|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366311|NCT05352191|Beclomethasone|beclomethasone|mesh-list
20612686|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19304428|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304429|NCT04155983|Ropivacaine|ropivacaine|mesh-list
19304430|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
19304431|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
19304432|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304433|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304434|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
19304435|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304436|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
19304437|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19304438|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
19304439|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304440|NCT04155632|Expectorants|expectorants|mesh-ancestor
19304441|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
19304442|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19304443|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
19304444|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304445|NCT04155632|Protective Agents|protective agents|mesh-ancestor
19304446|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304447|NCT04155632|Antidotes|antidotes|mesh-ancestor
19304448|NCT04155658|Fluorides|fluorides|mesh-list
19304449|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
19304450|NCT04155658|Protective Agents|protective agents|mesh-ancestor
19304451|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304452|NCT04155918|Allopurinol|allopurinol|mesh-list
19304453|NCT04155918|Febuxostat|febuxostat|mesh-list
19304454|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
19304455|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304456|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672517|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19304457|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
19304458|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304459|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19304460|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
19672518|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19672519|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
19672520|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
19672521|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20185886|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304461|NCT04155918|Protective Agents|protective agents|mesh-ancestor
19304462|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304463|NCT04155697|Ethanol|ethanol|mesh-list
19304464|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
19304465|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19304466|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304467|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672522|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20185887|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185888|NCT00202462|Testosterone|testosterone|mesh-list
20185889|NCT00202462|Androgens|androgens|mesh-ancestor
20185890|NCT00202462|Hormones|hormones|mesh-ancestor
20185891|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20185892|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185893|NCT00202514|Valproic Acid|valproic acid|mesh-list
19304468|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304469|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
19304470|NCT04155554|Tenofovir|tenofovir|mesh-list
19304471|NCT04155554|Lamivudine|lamivudine|mesh-list
19304472|NCT04155554|Emtricitabine|emtricitabine|mesh-list
19672523|NCT02333149|Melatonin|melatonin|mesh-list
19304473|NCT04155554|Abacavir|abacavir|mesh-list
19304474|NCT04155554|Dolutegravir|dolutegravir|mesh-list
19304475|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19304476|NCT04155554|Triumeq|triumeq|mesh-list
19304477|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
19304478|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304479|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19304480|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19304481|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304482|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304483|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19304484|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19304485|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19304486|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19304487|NCT04155515|Ribavirin|ribavirin|mesh-list
19304488|NCT04155515|Yimitasvir|yimitasvir|mesh-list
19304489|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
19304490|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304491|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
19304492|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304493|NCT04155229|Acetaminophen|acetaminophen|mesh-list
19304494|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19304495|NCT04155229|Oxycodone|oxycodone|mesh-list
19304496|NCT04155229|Hydrocodone|hydrocodone|mesh-list
19304497|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19304498|NCT04155229|Analgesics|analgesics|mesh-ancestor
19304499|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
19304500|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304501|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304502|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
19304503|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19304504|NCT04155229|Narcotics|narcotics|mesh-ancestor
19304505|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304506|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
19304507|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
19304508|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20366312|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366313|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
20366314|NCT05352191|Hormones|hormones|mesh-ancestor
20366315|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366316|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366317|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20366318|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
20366319|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
20366320|NCT05352165|Fluorouracil|fluorouracil|mesh-list
19304509|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304510|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304511|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
20185894|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
20366321|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366322|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366323|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
20366324|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366325|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19304512|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19304513|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
19304514|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
19304515|NCT04154852|Folic Acid|folic acid|mesh-list
20185895|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304516|NCT04154852|Adalimumab|adalimumab|mesh-list
20185896|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185897|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
20185898|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185899|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185900|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
20185901|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20185902|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20185903|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20185904|NCT00202553|Perindopril|perindopril|mesh-list
20185905|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20185906|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
20185907|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185908|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185909|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19304517|NCT04154852|Methotrexate|methotrexate|mesh-list
19672524|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
20366326|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366327|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
20366328|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366329|NCT05352126|Disinfectants|disinfectants|mesh-list
20366330|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304518|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19304519|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
19304520|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19304521|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304522|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19304523|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
19304524|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304525|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304526|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
19304527|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366331|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
20366332|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20366333|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20366334|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20366335|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20366336|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366337|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366338|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
20366339|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366340|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366341|NCT05351801|Dronabinol|dronabinol|mesh-list
20366342|NCT05351801|Nabiximols|nabiximols|mesh-list
20366343|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
20366344|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366345|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304528|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19304529|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304530|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
19304531|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304532|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19304533|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366346|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20366347|NCT05351801|Analgesics|analgesics|mesh-ancestor
20366348|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
20366349|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366350|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19304534|NCT04154852|Hematinics|hematinics|mesh-ancestor
19304535|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
19304536|NCT04154852|Vitamins|vitamins|mesh-ancestor
19304537|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
19304538|NCT04154813|Topiramate|topiramate|mesh-list
19304539|NCT04154813|Fluoxetine|fluoxetine|mesh-list
19304540|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
19304541|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19304542|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304543|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19304544|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19304545|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304546|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304547|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304548|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
19304549|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19304550|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
19304551|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304552|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19304553|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19304554|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304555|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
19304556|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19304557|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
19304558|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304559|NCT04154982|Expectorants|expectorants|mesh-ancestor
19304560|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
20366351|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20366352|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366353|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366354|NCT05351801|Hormones|hormones|mesh-ancestor
20612687|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19304561|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19304562|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
20185910|NCT00202592|Perindopril|perindopril|mesh-list
20185911|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20185912|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
20185913|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185914|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185915|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20185916|NCT00202605|Amphetamine|amphetamine|mesh-list
20185917|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
20366355|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366356|NCT05351788|Carboplatin|carboplatin|mesh-list
20366357|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366358|NCT05351762|Paclitaxel|paclitaxel|mesh-list
20366359|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
19304563|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304564|NCT04154982|Protective Agents|protective agents|mesh-ancestor
19304565|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304566|NCT04154982|Antidotes|antidotes|mesh-ancestor
19304567|NCT04154748|Omeprazole|omeprazole|mesh-list
19304568|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19304569|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304570|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19304571|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304572|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304573|NCT04155008|Dexamethasone|dexamethasone|mesh-list
19304574|NCT04155008|Dronabinol|dronabinol|mesh-list
20366360|NCT05351762|Nedaplatin|nedaplatin|mesh-list
20366361|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20366362|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366363|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
20366364|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
20366365|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
20366366|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366367|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366368|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20366369|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20366370|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20366371|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366372|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612688|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19304575|NCT04155008|Mirtazapine|mirtazapine|mesh-list
19304576|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304577|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
19304578|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
19304579|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304580|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304581|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304582|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
19304583|NCT04155008|Hormones|hormones|mesh-ancestor
19304584|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19304585|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19304586|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304587|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
19304588|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304589|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19304590|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
19304591|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
19304592|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304593|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304594|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19304595|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19304596|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304597|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19304598|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19304599|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19304600|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
19304601|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19304602|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19304603|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
19304604|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19304605|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
19304606|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20185918|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19304607|NCT04155008|Analgesics|analgesics|mesh-ancestor
19304608|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
20366373|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20366374|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20366375|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20366376|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20366377|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
20366378|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366379|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366380|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20366381|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20366382|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
20366383|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20366384|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20366385|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
20366386|NCT05351684|Dolutegravir|dolutegravir|mesh-list
20366387|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20366388|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20366389|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366390|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366391|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20366392|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20366393|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
20366394|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366395|NCT05351606|Bupropion|bupropion|mesh-list
20366396|NCT05351606|Nicotine|nicotine|mesh-list
20185919|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185920|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
19304609|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19304610|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19304611|NCT04154735|Rifaximin|rifaximin|mesh-list
19304612|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
19304613|NCT04154735|Fludarabine|fludarabine|mesh-list
19304614|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
20185921|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
20185922|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185923|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
20185924|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20185925|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366397|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20366398|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
19304615|NCT04154735|Tacrolimus|tacrolimus|mesh-list
19304616|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304617|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
19304618|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304619|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304620|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19304621|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
19304622|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304623|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304624|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19304625|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19304626|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672525|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672526|NCT02333149|Protective Agents|protective agents|mesh-ancestor
20366399|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366400|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366401|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20366402|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20366403|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
20366404|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366405|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366406|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20366407|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
20366408|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20366409|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20366410|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20366411|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366412|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
20366413|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19304627|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304628|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20185926|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
20185927|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20185928|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19672527|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672528|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672529|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
20185929|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304629|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304630|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304631|NCT04154722|Azithromycin|azithromycin|mesh-list
19304632|NCT04154722|Meropenem|meropenem|mesh-list
19304633|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19304634|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304635|NCT04154449|Insulin|insulin|mesh-list
19304636|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19304637|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396423|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19396424|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
19396425|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396426|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396427|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19396428|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19396429|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19396430|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
19396431|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396432|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19396433|NCT03658746|Amoxicillin|amoxicillin|mesh-list
19396434|NCT03658746|Metronidazole|metronidazole|mesh-list
19396435|NCT03658746|Clarithromycin|clarithromycin|mesh-list
19396436|NCT03658746|Levofloxacin|levofloxacin|mesh-list
19396437|NCT03658746|Ofloxacin|ofloxacin|mesh-list
19396438|NCT03658746|Tetracycline|tetracycline|mesh-list
19396439|NCT03658746|Tinidazole|tinidazole|mesh-list
19396440|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19396441|NCT03658746|Furazolidone|furazolidone|mesh-list
19396442|NCT03658746|Bismuth|bismuth|mesh-list
19396443|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19396444|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396445|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
19396446|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19396447|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19396448|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19396449|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396450|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396451|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19396452|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19396453|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19396454|NCT03658746|Renal Agents|renal agents|mesh-ancestor
19396455|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19396456|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19396457|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396458|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19396459|NCT03658746|Antacids|antacids|mesh-ancestor
19396460|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396461|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
19396462|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19396463|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19396464|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19396465|NCT03658733|Amoxicillin|amoxicillin|mesh-list
19396466|NCT03658733|Tetracycline|tetracycline|mesh-list
19396467|NCT03658733|Furazolidone|furazolidone|mesh-list
20185930|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20185931|NCT00202618|Amlodipine|amlodipine|mesh-list
20185932|NCT00202618|Valsartan|valsartan|mesh-list
20185933|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20185934|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19396468|NCT03658733|Esomeprazole|esomeprazole|mesh-list
19396469|NCT03658733|Rabeprazole|rabeprazole|mesh-list
19672530|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19396470|NCT03658733|Bismuth|bismuth|mesh-list
19396471|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396472|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185935|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20185936|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185937|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20185938|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185939|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
20185940|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20185941|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20185942|NCT00202696|Nalmefene|nalmefene|mesh-list
19304638|NCT04154319|Vaccines|vaccines|mesh-list
19304639|NCT04154319|Immunologic Factors|immunologic factors|mesh-ancestor
19304640|NCT04154319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304641|NCT04154293|Isotretinoin|isotretinoin|mesh-list
20366414|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20366415|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366416|NCT05351593|Lenalidomide|lenalidomide|mesh-list
20366417|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
20366418|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304642|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
19304643|NCT04153968|Retinol acetate|retinol acetate|mesh-list
19304644|NCT04153968|Protective Agents|protective agents|mesh-ancestor
19304645|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304646|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19304647|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
19304648|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19304649|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304650|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
19304651|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19304652|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304653|NCT04154033|Naltrexone|naltrexone|mesh-list
19304654|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19304655|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19304656|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304657|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
19304658|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304659|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
20366419|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20366420|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20366421|NCT05351593|Growth Substances|growth substances|mesh-ancestor
20366422|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
20366423|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366424|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20366425|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
20366426|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366427|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
20366428|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19304660|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19304661|NCT04153708|Antibodies|antibodies|mesh-list
19304662|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
19304663|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
19304664|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
19304665|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304666|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
19304667|NCT04153487|Vitamins|vitamins|mesh-ancestor
19304668|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
19304669|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304670|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
19304671|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304672|NCT04153487|Protective Agents|protective agents|mesh-ancestor
19304673|NCT04153734|Paclitaxel|paclitaxel|mesh-list
19304674|NCT04153734|Carboplatin|carboplatin|mesh-list
19304675|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
19304676|NCT04153734|Pemetrexed|pemetrexed|mesh-list
19304677|NCT04153734|Cisplatin|cisplatin|mesh-list
19304678|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19304679|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304680|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304681|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304682|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304683|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304684|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304685|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304686|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19304687|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19304688|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
19838567|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
19838568|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304689|NCT04153201|Antimalarials|antimalarials|mesh-list
20185943|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20185944|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185945|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
20185946|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185947|NCT00202774|Fluorouracil|fluorouracil|mesh-list
20185948|NCT00202774|Capecitabine|capecitabine|mesh-list
20185949|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
20185950|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
20185951|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672531|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672532|NCT02213575|Minocycline|minocycline|mesh-list
20366429|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
20366430|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366431|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366432|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20366433|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
20366434|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20366435|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
20366436|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366437|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366438|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20366439|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
20366440|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
19672533|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19304690|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19304691|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19304692|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304693|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304694|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304695|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304696|NCT04153383|Milrinone|milrinone|mesh-list
19304697|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19304698|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19304699|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
19304700|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19304701|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19304702|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304703|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304704|NCT04153383|Protective Agents|protective agents|mesh-ancestor
19304705|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304706|NCT04153253|Aflibercept|aflibercept|mesh-list
19304707|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19304708|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19304709|NCT04153253|Growth Substances|growth substances|mesh-ancestor
19304710|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304711|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
19672534|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672535|NCT02192021|Doxorubicin|doxorubicin|mesh-list
19304712|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304713|NCT04153123|Epinephrine|epinephrine|mesh-list
19304714|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19304715|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19304716|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
19304717|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304718|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304719|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304720|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19304721|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19304722|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
19304723|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304724|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19304725|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
19304726|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
19304727|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
19304728|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19304729|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
19304730|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19304731|NCT04153084|Cathartics|cathartics|mesh-ancestor
19304732|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304733|NCT04153084|Laxatives|laxatives|mesh-ancestor
19304734|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
19304735|NCT04152655|Idebenone|idebenone|mesh-list
19304736|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
19304737|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304738|NCT04152655|Vitamins|vitamins|mesh-ancestor
19304739|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
19304740|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304741|NCT04152655|Protective Agents|protective agents|mesh-ancestor
19304742|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19304743|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19304744|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304745|NCT04152681|Apatinib|apatinib|mesh-list
19304746|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672536|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19304747|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19838569|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19838570|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19838571|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838572|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838573|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
19838574|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838575|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838576|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19838577|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19838578|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838579|NCT00621530|Ketorolac|ketorolac|mesh-list
20366441|NCT05351502|Protective Agents|protective agents|mesh-ancestor
20366442|NCT05351346|Prednisone|prednisone|mesh-list
20366443|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
20366444|NCT05351346|Rituximab|rituximab|mesh-list
20366445|NCT05351346|Doxorubicin|doxorubicin|mesh-list
20366446|NCT05351346|Vincristine|vincristine|mesh-list
20366447|NCT05351346|Lenalidomide|lenalidomide|mesh-list
20366448|NCT05351346|Decitabine|decitabine|mesh-list
20366449|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366450|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
20366451|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366452|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20366453|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20366454|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
20366455|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366456|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366457|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20366458|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366459|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20366460|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19838580|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19838581|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19838582|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20366461|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366462|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366463|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366464|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
20366465|NCT05351346|Hormones|hormones|mesh-ancestor
20366466|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366467|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20366468|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19838583|NCT00621530|Analgesics|analgesics|mesh-ancestor
19838584|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
19838585|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185952|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19304748|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612689|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
20612690|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612691|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612692|NCT02252614|Acetaminophen|acetaminophen|mesh-list
20612693|NCT02252614|Naproxen|naproxen|mesh-list
20612694|NCT02252614|Codeine|codeine|mesh-list
20612695|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19304749|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304750|NCT04152759|Golimumab|golimumab|mesh-list
20185953|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185954|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185955|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
20185956|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185957|NCT00202787|Leucovorin|leucovorin|mesh-list
20185958|NCT00202787|Cetuximab|cetuximab|mesh-list
20185959|NCT00202787|Fluorouracil|fluorouracil|mesh-list
20185960|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
20185961|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20185962|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185963|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
20185964|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366469|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304751|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19304752|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366470|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
20366471|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
20612696|NCT02252614|Analgesics|analgesics|mesh-ancestor
20366472|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19304753|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304754|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
19304755|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304756|NCT04153032|Diltiazem|diltiazem|mesh-list
19304757|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19304758|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19304759|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304760|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304761|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19304762|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304763|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
19304764|NCT04152889|Docetaxel|docetaxel|mesh-list
19304765|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304766|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304767|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304768|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304769|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396473|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19396474|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396475|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19396476|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396477|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396478|NCT03658733|Antacids|antacids|mesh-ancestor
19396479|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19396480|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19396481|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19396482|NCT03658733|Renal Agents|renal agents|mesh-ancestor
19396483|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19396484|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19396485|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19396486|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19396487|NCT03658720|Ibuprofen|ibuprofen|mesh-list
19396488|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19396489|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396490|NCT03658720|Analgesics|analgesics|mesh-ancestor
19396491|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
19396492|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396493|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396494|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396495|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396496|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19396497|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366473|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20366474|NCT05351346|Growth Substances|growth substances|mesh-ancestor
20366475|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
20366476|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20366477|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
19396498|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396499|NCT03658590|Dexamethasone|dexamethasone|mesh-list
19396500|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396501|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
19396502|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
19396503|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396504|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185965|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20185966|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185967|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
20185968|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185969|NCT00202787|Antidotes|antidotes|mesh-ancestor
20185970|NCT00202787|Protective Agents|protective agents|mesh-ancestor
20185971|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
20185972|NCT00202787|Vitamins|vitamins|mesh-ancestor
20185973|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
20185974|NCT00202800|Gemcitabine|gemcitabine|mesh-list
20185975|NCT00202800|Etoposide|etoposide|mesh-list
20185976|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20185977|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
20185978|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20185979|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20185980|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
20185981|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20185982|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20185983|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20185984|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
20366478|NCT05351229|Morphine|morphine|mesh-list
20366479|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20366480|NCT05351229|Narcotics|narcotics|mesh-ancestor
20366481|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366482|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366483|NCT05351229|Analgesics|analgesics|mesh-ancestor
20366484|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
20366485|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366486|NCT05351151|Lidocaine|lidocaine|mesh-list
20366487|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
20366488|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
20366489|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366490|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366491|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
20366492|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366493|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20366494|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20366495|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20366496|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366497|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366498|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
20366499|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20366500|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
20366501|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
20366502|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366503|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366504|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366505|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20366506|NCT05351086|Analgesics|analgesics|mesh-ancestor
20366507|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
20366508|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366509|NCT05351021|Metformin|metformin|mesh-list
20366510|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20366511|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366512|NCT05350943|Gemcitabine|gemcitabine|mesh-list
20366513|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
20366514|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20366515|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
20366516|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304770|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
19304771|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19304772|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304773|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304774|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19304775|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19304776|NCT04152980|Protective Agents|protective agents|mesh-ancestor
19304777|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304778|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
19304779|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19304780|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
19304781|NCT04152564|Bupivacaine|bupivacaine|mesh-list
19304782|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
19304783|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
19304784|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
19304785|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304786|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304787|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
19304788|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20185985|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20185986|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20185987|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20185988|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20185989|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
20185990|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20185991|NCT00202852|Infliximab|infliximab|mesh-list
20185992|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
20185993|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185994|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185995|NCT00202865|Infliximab|infliximab|mesh-list
20185996|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
20185997|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20185998|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20185999|NCT00202891|Sisomicin|sisomicin|mesh-list
20186000|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186001|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366517|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304789|NCT04152434|Erenumab|erenumab|mesh-list
19304790|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19304791|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304792|NCT04152434|Analgesics|analgesics|mesh-ancestor
19304793|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
19304794|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304795|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304796|NCT04152629|Methylphenidate|methylphenidate|mesh-list
19304797|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19304798|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19304799|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304800|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19304801|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19304802|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304803|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304804|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
19304805|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304806|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19304807|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19304808|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19304809|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
19304810|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19304811|NCT04152317|Misoprostol|misoprostol|mesh-list
19304812|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19304813|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
19304814|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19304815|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304816|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19304817|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304818|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
19304819|NCT04152356|Sorafenib|sorafenib|mesh-list
19304820|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304821|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19304822|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304823|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304824|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
19304825|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19304826|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
19304827|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304828|NCT04152057|Paclitaxel|paclitaxel|mesh-list
19304829|NCT04152057|Trastuzumab|trastuzumab|mesh-list
19304830|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19304831|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304832|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304833|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304834|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304835|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304836|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304837|NCT04151823|Vitamin D|vitamin d|mesh-list
19304838|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
19304839|NCT04151823|Vitamins|vitamins|mesh-ancestor
19304840|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
19304841|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304842|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20366518|NCT05350943|Antiviral Agents|antiviral agents|mesh-ancestor
20366519|NCT05350943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366520|NCT05350943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366521|NCT05350943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366522|NCT05350943|Immunologic Factors|immunologic factors|mesh-ancestor
20366523|NCT05350943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366524|NCT05350592|Dobutamine|dobutamine|mesh-list
20366525|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20366526|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
20366527|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
19304843|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19304844|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19304845|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304846|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19304847|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304848|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
19304849|NCT04151680|Apixaban|apixaban|mesh-list
19304850|NCT04151680|Edoxaban|edoxaban|mesh-list
20366528|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304851|NCT04151680|Dabigatran|dabigatran|mesh-list
19304852|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19304853|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
19304854|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19304855|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
19304856|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304857|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304858|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
19304859|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
19304860|NCT04151706|Busulfan|busulfan|mesh-list
19304861|NCT04151706|Thiotepa|thiotepa|mesh-list
19304862|NCT04151706|Fludarabine|fludarabine|mesh-list
20366529|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366530|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20366531|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19304863|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304864|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
19304865|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304866|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19304867|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19304868|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
19304869|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304870|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366532|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20366533|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
20366534|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366535|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366536|NCT05350592|Protective Agents|protective agents|mesh-ancestor
20366537|NCT05350501|Nivolumab|nivolumab|mesh-list
20366538|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19304871|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19304872|NCT04151472|Ubiquinone|ubiquinone|mesh-list
19304873|NCT04151472|Idebenone|idebenone|mesh-list
19304874|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
19304875|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304876|NCT04151472|Protective Agents|protective agents|mesh-ancestor
19304877|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304878|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
19304879|NCT04151719|Bromides|bromides|mesh-list
19304880|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
19304881|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
19304882|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19304883|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304884|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
19304885|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304886|NCT04151459|Metformin|metformin|mesh-list
19304887|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19304888|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304889|NCT04151355|Atorvastatin|atorvastatin|mesh-list
19304890|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19304891|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19304892|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
19304893|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304894|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19304895|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19304896|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304897|NCT04151381|Aminophylline|aminophylline|mesh-list
19304898|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19304899|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
20366539|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366540|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20366541|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425595|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425596|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20425597|NCT01275638|Protective Agents|protective agents|mesh-ancestor
20425598|NCT01275729|Furosemide|furosemide|mesh-list
20425599|NCT01275729|Diuretics|diuretics|mesh-ancestor
20425600|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
19304900|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304901|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304902|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20425601|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304903|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
19304904|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19304905|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19304906|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396505|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304907|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304908|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19838586|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838587|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838588|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19838589|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19838590|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838591|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838592|NCT00621543|Copper|copper|mesh-list
19838593|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
19838594|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19838595|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
19838596|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19838597|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304909|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19304910|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
19304911|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304912|NCT04151381|Protective Agents|protective agents|mesh-ancestor
19304913|NCT04151147|Mitogens|mitogens|mesh-list
19304914|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304915|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304916|NCT04150965|Thalidomide|thalidomide|mesh-list
20366542|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
20366543|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20366544|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20366545|NCT05350384|Prednisolone|prednisolone|mesh-list
20366546|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
20366547|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20366548|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
20366549|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366550|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
20366551|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
20366552|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366553|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838598|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19838599|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19838600|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19838601|NCT00621543|Trace Elements|trace elements|mesh-ancestor
19838602|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
19838603|NCT00621686|Bevacizumab|bevacizumab|mesh-list
19838604|NCT00621686|Sorafenib|sorafenib|mesh-list
19838605|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838606|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838607|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19838608|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838609|NCT00621686|Growth Substances|growth substances|mesh-ancestor
20186002|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20366554|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20366555|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
19304917|NCT04150965|Dexamethasone|dexamethasone|mesh-list
19304918|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
19304919|NCT04150965|Pomalidomide|pomalidomide|mesh-list
19304920|NCT04150965|Elotuzumab|elotuzumab|mesh-list
19304921|NCT04150965|BB 1101|bb 1101|mesh-list
19304922|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304923|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
19304924|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
19304925|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304926|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304927|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304928|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
20186003|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186004|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186005|NCT00202917|Fludarabine|fludarabine|mesh-list
20186006|NCT00202917|Melphalan|melphalan|mesh-list
20186007|NCT00202917|Thiotepa|thiotepa|mesh-list
20186008|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186009|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186010|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186011|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
20186012|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186013|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20186014|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
20186015|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20186016|NCT00202969|Cisplatin|cisplatin|mesh-list
20366556|NCT05350384|Hormones|hormones|mesh-ancestor
19304929|NCT04150965|Hormones|hormones|mesh-ancestor
19304930|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19304931|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19304932|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304933|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
19304934|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19304935|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304936|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
19304937|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19304938|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19304939|NCT04150965|Growth Substances|growth substances|mesh-ancestor
19304940|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
19304941|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19304942|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
19304943|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19304944|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19304945|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
19304946|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304947|NCT04150575|Paclitaxel|paclitaxel|mesh-list
19304948|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19304949|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19304950|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304951|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
19304952|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
19304953|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
19304954|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396506|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
19396507|NCT03658590|Hormones|hormones|mesh-ancestor
19396508|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396509|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19396510|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396511|NCT03658473|Naproxen|naproxen|mesh-list
19396512|NCT03658473|Rabeprazole|rabeprazole|mesh-list
19672537|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19672538|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838610|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838611|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
19838612|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19838613|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838614|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838615|NCT00621764|Vaccines|vaccines|mesh-list
19838616|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
19838617|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186017|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186018|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
20186019|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
20186020|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20186021|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
20186022|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186023|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186024|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672539|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19672540|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19672541|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672542|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672543|NCT02144857|Cyclosporine|cyclosporine|mesh-list
19672544|NCT02144857|Etanercept|etanercept|mesh-list
19672545|NCT02144857|Apremilast|apremilast|mesh-list
19672546|NCT02144857|Ustekinumab|ustekinumab|mesh-list
19672547|NCT02144857|Cyclosporins|cyclosporins|mesh-list
19672548|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672549|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672550|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19672551|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
19672552|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672553|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
19672554|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672555|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
19672556|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672557|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19672558|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19672559|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19672560|NCT02144857|Analgesics|analgesics|mesh-ancestor
20186025|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
20186026|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
20366557|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366558|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20366559|NCT05350384|Protective Agents|protective agents|mesh-ancestor
19304955|NCT04150614|Dexamethasone|dexamethasone|mesh-list
19304956|NCT04150614|Ondansetron|ondansetron|mesh-list
19304957|NCT04150614|Granisetron|granisetron|mesh-list
19304958|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19304959|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
19304960|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
19304961|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304962|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304963|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19304964|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
19304965|NCT04150614|Hormones|hormones|mesh-ancestor
19304966|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19304967|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19304968|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19304969|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
19304970|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
19304971|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19304972|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
19304973|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19304974|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304975|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19304976|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19304977|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304978|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19304979|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19304980|NCT04150536|Lidocaine|lidocaine|mesh-list
19304981|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
19304982|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
19304983|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19304984|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19304985|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
19304986|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19304987|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19304988|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19304989|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19304990|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19304991|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19304992|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19304993|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19304994|NCT04150731|Estradiol|estradiol|mesh-list
19304995|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19304996|NCT04150731|Estrogens|estrogens|mesh-ancestor
19304997|NCT04150731|Hormones|hormones|mesh-ancestor
19304998|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19304999|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305000|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19305001|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
19305002|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19305003|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19305004|NCT04150757|Ketamine|ketamine|mesh-list
19305005|NCT04150757|Analgesics|analgesics|mesh-ancestor
19305006|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
19305007|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305008|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305009|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19672561|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
19672562|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186027|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
20186028|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20186029|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
20186030|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186031|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186032|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186033|NCT00203034|Rasagiline|rasagiline|mesh-list
20186034|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20186035|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186036|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186037|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20186038|NCT00203034|Protective Agents|protective agents|mesh-ancestor
20186039|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186040|NCT00203060|Rasagiline|rasagiline|mesh-list
19305010|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19305011|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
19305012|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
19305013|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305014|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19305015|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19305016|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305017|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305018|NCT04150289|Panobinostat|panobinostat|mesh-list
19305019|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305020|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19305021|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305022|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305023|NCT04150367|Rifampin|rifampin|mesh-list
19305024|NCT04150367|Isoniazid|isoniazid|mesh-list
19305025|NCT04150367|Ethambutol|ethambutol|mesh-list
19305026|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19305027|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20186041|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19305028|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
19305029|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19305030|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305031|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
19305032|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19305033|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305034|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305035|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19305036|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19305037|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19305038|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19305039|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19305040|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19305041|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20186042|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186043|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186044|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20186045|NCT00203060|Protective Agents|protective agents|mesh-ancestor
20186046|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186047|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
20186048|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
20186049|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
20186050|NCT00203073|Analgesics|analgesics|mesh-ancestor
20186051|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
20186052|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186053|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186054|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186055|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20186056|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19305042|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19305043|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
19305044|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19305045|NCT04150172|Rebamipide|rebamipide|mesh-list
19305046|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19305047|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305048|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
19305049|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305050|NCT04150172|Protective Agents|protective agents|mesh-ancestor
19305051|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305052|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305053|NCT04149938|Lidocaine|lidocaine|mesh-list
19305054|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
19305055|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
19305056|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305057|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838618|NCT00621777|Varenicline|varenicline|mesh-list
19838619|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19838620|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19838621|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
19838622|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838623|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186057|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305058|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
20186058|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305059|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305060|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19305061|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19305062|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19305063|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305064|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305065|NCT04150146|Rebamipide|rebamipide|mesh-list
19305066|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19305067|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305068|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
20366560|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20366561|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366562|NCT05350371|Pirfenidone|pirfenidone|mesh-list
20366563|NCT05350371|Analgesics|analgesics|mesh-ancestor
20366564|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
20366565|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366566|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366567|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20366568|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20366569|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366570|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20366571|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366572|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20366573|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366574|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366575|NCT05328440|Fulvestrant|fulvestrant|mesh-list
20366576|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20366577|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366578|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20366579|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20366580|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
20366581|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366582|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366583|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
20366584|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20366585|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366586|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20366587|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366588|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
20366589|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
20366590|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366591|NCT05280457|Nivolumab|nivolumab|mesh-list
20366592|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366593|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366594|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20366595|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366596|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20366597|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19305069|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305070|NCT04150146|Protective Agents|protective agents|mesh-ancestor
19305071|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305072|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305073|NCT04150107|Insulin|insulin|mesh-list
19305074|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305075|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305076|NCT04149483|Atorvastatin|atorvastatin|mesh-list
19305077|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19305078|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19305079|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
19305080|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305081|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19305082|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19305083|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305084|NCT04149678|Cyclosporine|cyclosporine|mesh-list
19305085|NCT04149678|Cyclosporins|cyclosporins|mesh-list
19305086|NCT04149678|Ozanimod|ozanimod|mesh-list
19305087|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305088|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305089|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19305090|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
19305091|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305092|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
19305093|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305094|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
19305095|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19305096|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19305097|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19305098|NCT04149626|Midazolam|midazolam|mesh-list
19305099|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
19305100|NCT04149626|Remifentanil|remifentanil|mesh-list
19305101|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19305102|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305103|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305104|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305105|NCT04149626|Analgesics|analgesics|mesh-ancestor
19305106|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
19305107|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305108|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19305109|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19305110|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19305111|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
19305112|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305113|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305114|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19305115|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19305116|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19305117|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19305118|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19305119|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
19305120|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
19305121|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
19305122|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
19305123|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19305124|NCT04149626|Narcotics|narcotics|mesh-ancestor
19305125|NCT04149470|Omeprazole|omeprazole|mesh-list
19305126|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19305127|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305128|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19305129|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305130|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305131|NCT04149444|Trifluridine|trifluridine|mesh-list
19305132|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
19305133|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305134|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
19305135|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305136|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
19305137|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305138|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305139|NCT04149275|Nivolumab|nivolumab|mesh-list
19305140|NCT04149275|Ipilimumab|ipilimumab|mesh-list
19305141|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20186059|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20186060|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
20186061|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186062|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186063|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
20186064|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
20186065|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19305142|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305143|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19305144|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305145|NCT04148963|Loxapine|loxapine|mesh-list
19305146|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19305147|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19305148|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305149|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305150|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19305151|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19305152|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
20186066|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
20186067|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
20186068|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186069|NCT00203099|Expectorants|expectorants|mesh-ancestor
20186070|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
20186071|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20186072|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
20186073|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396513|NCT03658473|Rebamipide|rebamipide|mesh-list
20186074|NCT00203099|Protective Agents|protective agents|mesh-ancestor
19305153|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305154|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305155|NCT04149327|Amoxicillin|amoxicillin|mesh-list
19305156|NCT04149327|Metronidazole|metronidazole|mesh-list
19305157|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19305158|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305159|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19305160|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19305161|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19305162|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
19305163|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305164|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305165|NCT04149067|Incretins|incretins|mesh-ancestor
19305166|NCT04149067|Hormones|hormones|mesh-ancestor
19305167|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305168|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19305169|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
19305170|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305171|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305172|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19305173|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
19305174|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
19305175|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19305176|NCT04149106|Amodiaquine|amodiaquine|mesh-list
19305177|NCT04149106|Artenimol|artenimol|mesh-list
19305178|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
19305179|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19305180|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19305181|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305182|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19305183|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305184|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305185|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19305186|NCT04149106|Renal Agents|renal agents|mesh-ancestor
19305187|NCT04149015|Paclitaxel|paclitaxel|mesh-list
19305188|NCT04149015|Fluorouracil|fluorouracil|mesh-list
19305189|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
19305190|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19305191|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305192|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
19305193|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
19305194|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
19305195|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305196|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
19305197|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19305198|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19305199|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
19305200|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305201|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
19305202|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19305203|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19305204|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305205|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
19305206|NCT04149171|Coagulants|coagulants|mesh-ancestor
19305207|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
19305208|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19305209|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
19305210|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305211|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186075|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305212|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19305213|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
19305214|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19305215|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
19305216|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305217|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672563|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672564|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19672565|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19672566|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19672567|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
19672568|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672569|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672570|NCT01462578|Azacitidine|azacitidine|mesh-list
19672571|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19305218|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19305219|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
19305220|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
19305221|NCT04149132|Protective Agents|protective agents|mesh-ancestor
19305222|NCT04148898|Bevacizumab|bevacizumab|mesh-list
19305223|NCT04148898|Osimertinib|osimertinib|mesh-list
19305224|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19305225|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305226|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19305227|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19305228|NCT04148898|Growth Substances|growth substances|mesh-ancestor
19305229|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305230|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
19305231|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19305232|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305233|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305234|NCT04148885|Paclitaxel|paclitaxel|mesh-list
19305235|NCT04148885|Carboplatin|carboplatin|mesh-list
19305236|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19305237|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305238|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
19305239|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
19305240|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
19305241|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305242|NCT04148820|Aspirin|aspirin|mesh-list
19305243|NCT04148820|Perindopril|perindopril|mesh-list
19305244|NCT04148820|Atorvastatin|atorvastatin|mesh-list
19305245|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19305246|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305247|NCT04148820|Analgesics|analgesics|mesh-ancestor
19305248|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
20366598|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366599|NCT05275426|Gemcitabine|gemcitabine|mesh-list
20366600|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20366601|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
20366602|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366603|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366604|NCT05275426|Antiviral Agents|antiviral agents|mesh-ancestor
20366605|NCT05275426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366606|NCT05275426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366607|NCT05275426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366608|NCT05275426|Immunologic Factors|immunologic factors|mesh-ancestor
20366609|NCT05275426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366610|NCT05254106|Paclitaxel|paclitaxel|mesh-list
20366611|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20366612|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366613|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
19672572|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
19672573|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672574|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366614|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
20366615|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
20366616|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366617|NCT05249569|Avelumab|avelumab|mesh-list
20366618|NCT05249569|Bavituximab|bavituximab|mesh-list
20366619|NCT05249569|Axitinib|axitinib|mesh-list
19305249|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305250|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305251|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305252|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19305253|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19305254|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19305255|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305256|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19305257|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19672575|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366620|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366621|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366622|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20366623|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366624|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366625|NCT05242458|Ustekinumab|ustekinumab|mesh-list
19305258|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305259|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
19672576|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
19305260|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19305261|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19305262|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
19305263|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19305264|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19305265|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19305266|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
19305267|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19305268|NCT04148833|Paclitaxel|paclitaxel|mesh-list
20366626|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
20366627|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20366628|NCT05236738|Cobicistat|cobicistat|mesh-list
20366629|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20366630|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20366631|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
20366632|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366633|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366634|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20366635|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20366636|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
20366637|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366638|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20366639|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20366640|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20366641|NCT05228314|Vaccines|vaccines|mesh-list
20366642|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
20366643|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
19305269|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19305270|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305271|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
19305272|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
19305273|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
19305274|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305275|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
19305276|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19672577|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19672578|NCT01219075|Estrogens|estrogens|mesh-ancestor
19672579|NCT01219075|Hormones|hormones|mesh-ancestor
19672580|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672581|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672582|NCT00876031|Etoposide|etoposide|mesh-list
19305277|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305278|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305279|NCT04148599|Lidocaine|lidocaine|mesh-list
19305280|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
19305281|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
19305282|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
19305283|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305284|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305285|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
19305286|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305287|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19305288|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19305289|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19305290|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19672583|NCT00876031|Idarubicin|idarubicin|mesh-list
19672584|NCT00876031|Trofosfamide|trofosfamide|mesh-list
20186076|NCT00203099|Antidotes|antidotes|mesh-ancestor
20186077|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20186078|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
20186079|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186080|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186081|NCT00203112|Minocycline|minocycline|mesh-list
20186082|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
20186083|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
20186084|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186085|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186086|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20186087|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
20186088|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186089|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186090|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186091|NCT00203125|Rasagiline|rasagiline|mesh-list
20186092|NCT00203125|Tyramine|tyramine|mesh-list
20186093|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20186094|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305291|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305292|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19305293|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305294|NCT04148599|Analgesics|analgesics|mesh-ancestor
19305295|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19305296|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19305297|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19305298|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
19305299|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396514|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19396515|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396516|NCT03658473|Analgesics|analgesics|mesh-ancestor
19396517|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
19396518|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396519|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396520|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396521|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396522|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
19396523|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19396524|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396525|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396526|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19396527|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396528|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19396529|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
19396530|NCT03658473|Protective Agents|protective agents|mesh-ancestor
19396531|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
19396532|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19396533|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396534|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
19396535|NCT03658421|Morphine|morphine|mesh-list
19396536|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19396537|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396538|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396539|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396540|NCT03658421|Analgesics|analgesics|mesh-ancestor
19396541|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
19396542|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396543|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19396544|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19396545|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19396546|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
19396547|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396548|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396549|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19396550|NCT03658421|Narcotics|narcotics|mesh-ancestor
19396551|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
20366644|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366645|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20366646|NCT05228314|Antacids|antacids|mesh-ancestor
19396552|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19396553|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19396554|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396555|NCT03658330|Naltrexone|naltrexone|mesh-list
19396556|NCT03658330|Ketamine|ketamine|mesh-list
19396557|NCT03658330|Analgesics|analgesics|mesh-ancestor
19396558|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
19396559|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396560|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396561|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19396562|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19396563|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
20186095|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186096|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20186097|NCT00203125|Protective Agents|protective agents|mesh-ancestor
20186098|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186099|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
20186100|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
20186101|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396564|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
19396565|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186102|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20186103|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19305300|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19305301|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19305302|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305303|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305304|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19305305|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305306|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305307|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
19305308|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305309|NCT04148846|Dexamethasone|dexamethasone|mesh-list
19305310|NCT04148846|Ketoprofen|ketoprofen|mesh-list
19305311|NCT04148846|Theophylline|theophylline|mesh-list
19305312|NCT04148846|Gabapentin|gabapentin|mesh-list
19305313|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305314|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
19305315|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
19305316|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305317|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305318|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305319|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
19305320|NCT04148846|Hormones|hormones|mesh-ancestor
19305321|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305322|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19305323|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366647|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366648|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20366649|NCT05213728|Vaccines|vaccines|mesh-list
20366650|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
20366651|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366652|NCT05212012|Methadone|methadone|mesh-list
20366653|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20366654|NCT05212012|Narcotics|narcotics|mesh-ancestor
19305324|NCT04148846|Analgesics|analgesics|mesh-ancestor
19305325|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
19305326|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
19305327|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19305328|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19305329|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305330|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19305331|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19305332|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19305333|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305334|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305335|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
20366655|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366656|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366657|NCT05212012|Analgesics|analgesics|mesh-ancestor
20366658|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
20366659|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366660|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
20366661|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
20366662|NCT05211895|Durvalumab|durvalumab|mesh-list
20366663|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366664|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366665|NCT05199051|Cytarabine|cytarabine|mesh-list
20366666|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
20366667|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20366668|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
20366669|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366670|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366671|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
20366672|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366673|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366674|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
20366675|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305336|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19305337|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305338|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19305339|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19305340|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305341|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20366676|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19305342|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19305343|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
20366677|NCT05194969|Petrolatum|petrolatum|mesh-list
19305344|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19305345|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
19305346|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19305347|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19305348|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
19305349|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
19305350|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20366678|NCT05194969|Emollients|emollients|mesh-ancestor
20366679|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
20366680|NCT05192889|Leucovorin|leucovorin|mesh-list
20366681|NCT05192889|Cytarabine|cytarabine|mesh-list
20366682|NCT05192889|Dexamethasone|dexamethasone|mesh-list
20366683|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
20366684|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
20366685|NCT05192889|Methotrexate|methotrexate|mesh-list
20366686|NCT05192889|Etoposide|etoposide|mesh-list
20366687|NCT05192889|Vincristine|vincristine|mesh-list
20366688|NCT05192889|Asparaginase|asparaginase|mesh-list
20366689|NCT05192889|Dasatinib|dasatinib|mesh-list
20366690|NCT05192889|Venetoclax|venetoclax|mesh-list
20366691|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
20366692|NCT05192889|Pegaspargase|pegaspargase|mesh-list
20366693|NCT05192889|Blinatumomab|blinatumomab|mesh-list
20366694|NCT05192889|Navitoclax|navitoclax|mesh-list
20366695|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366696|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
20366697|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366698|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20366699|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20366700|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
20186104|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20186105|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
20186106|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186107|NCT00203138|Rasagiline|rasagiline|mesh-list
20186108|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20186109|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186110|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186111|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20186112|NCT00203138|Protective Agents|protective agents|mesh-ancestor
20186113|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366701|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305351|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19305352|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19305353|NCT04148261|Epinephrine|epinephrine|mesh-list
19305354|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19305355|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19305356|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
19305357|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305358|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305359|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305360|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19305361|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19305362|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
19305363|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305364|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19305365|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
19305366|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
19305367|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
19305368|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19305369|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305370|NCT04148183|Metformin|metformin|mesh-list
19305371|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
19305372|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305373|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305374|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
19305375|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19305376|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
19305377|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305378|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305379|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19305380|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
19305381|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
19305382|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19672585|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20366702|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366703|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20366704|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366705|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
20366706|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
19305383|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
19305384|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305385|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305386|NCT04147806|Dexamethasone|dexamethasone|mesh-list
19305387|NCT04147806|Tamsulosin|tamsulosin|mesh-list
19305388|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366707|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366708|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20366709|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
20366710|NCT05192889|Hormones|hormones|mesh-ancestor
20366711|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366712|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20366713|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20366714|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
20366715|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20366716|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20366717|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
19305389|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
19305390|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
19305391|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305392|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305393|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305394|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
19305395|NCT04147806|Hormones|hormones|mesh-ancestor
19305396|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305397|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19305398|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305399|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19305400|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20366718|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
19305401|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19305402|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
19305403|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305404|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305405|NCT04147806|Urological Agents|urological agents|mesh-ancestor
19305406|NCT04147754|Morphine|morphine|mesh-list
19305407|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305408|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305409|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19305410|NCT04147754|Narcotics|narcotics|mesh-ancestor
19305411|NCT04147754|Analgesics|analgesics|mesh-ancestor
19305412|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
19305413|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305414|NCT04147845|Triamcinolone|triamcinolone|mesh-list
19305415|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19305416|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19305417|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19305418|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305419|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
19305420|NCT04147845|Hormones|hormones|mesh-ancestor
19305421|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305422|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305423|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19305424|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
19305425|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305426|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305427|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19305428|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19305429|NCT04147728|Growth Substances|growth substances|mesh-ancestor
19305430|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305431|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
19305432|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305433|NCT04147286|Atorvastatin|atorvastatin|mesh-list
19305434|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19305435|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19305436|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
19305437|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305438|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19305439|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19305440|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838624|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366719|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366720|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19305441|NCT04147208|Ritonavir|ritonavir|mesh-list
19305442|NCT04147208|Entecavir|entecavir|mesh-list
19305443|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19305444|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19305445|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
19305446|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305447|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305448|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19305449|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19305450|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
19305451|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305452|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19305453|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19305454|NCT04147481|Anesthetics|anesthetics|mesh-list
19305455|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
19305456|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366721|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20366722|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20366723|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20366724|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366725|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
20366726|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366727|NCT05192889|Antidotes|antidotes|mesh-ancestor
20366728|NCT05192889|Protective Agents|protective agents|mesh-ancestor
20366729|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
20366730|NCT05192889|Vitamins|vitamins|mesh-ancestor
20366731|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
19305457|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305458|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
19305459|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186114|NCT00203164|Rasagiline|rasagiline|mesh-list
20186115|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20186116|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186117|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186118|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20186119|NCT00203164|Protective Agents|protective agents|mesh-ancestor
20186120|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186121|NCT00203177|Rasagiline|rasagiline|mesh-list
20186122|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20186123|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186124|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305460|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
19305461|NCT04147390|Tacrolimus|tacrolimus|mesh-list
19305462|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19305463|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
19305464|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305465|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19305466|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305467|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305468|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19672586|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672587|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19672588|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20186125|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20186126|NCT00203177|Protective Agents|protective agents|mesh-ancestor
20186127|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186128|NCT00203190|Topiramate|topiramate|mesh-list
20186129|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
20186130|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20186131|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186132|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
19672589|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672590|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672591|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19672592|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19672593|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
19672594|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672595|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19672596|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
19838625|NCT00621842|Lamotrigine|lamotrigine|mesh-list
19838626|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
20186133|NCT00203281|Tacrolimus|tacrolimus|mesh-list
20186134|NCT00203281|Daclizumab|daclizumab|mesh-list
20186135|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
20186136|NCT00203281|Antibodies|antibodies|mesh-list
20366732|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
19305469|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305470|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19305471|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
19305472|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19305473|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305474|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
19838627|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19838628|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838629|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838630|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20186137|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
20186138|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20186139|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20186140|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186141|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
19305475|NCT04147533|Dasatinib|dasatinib|mesh-list
19305476|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366733|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
20366734|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
20366735|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20366736|NCT05178550|Heparin|heparin|mesh-list
20366737|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
20366738|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20366739|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20366740|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425602|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20425603|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425604|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425605|NCT01275859|Letrozole|letrozole|mesh-list
20425606|NCT01275859|Lapatinib|lapatinib|mesh-list
19305477|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19305478|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305479|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305480|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
19305481|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19305482|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305483|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19305484|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19305485|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305486|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305487|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305488|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19305489|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19305490|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19305491|NCT04146883|Cephalexin|cephalexin|mesh-list
19305492|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186142|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186143|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20186144|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186145|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186146|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186147|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186148|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20186149|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
20186150|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186151|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186152|NCT00203320|Etanercept|etanercept|mesh-list
20186153|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20186154|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20186155|NCT00203320|Analgesics|analgesics|mesh-ancestor
20186156|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
20186157|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425607|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425608|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20186158|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186159|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186160|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186161|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425609|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20425610|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425611|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425612|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20425613|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
20366741|NCT05131061|Fludrocortisone|fludrocortisone|mesh-list
20366742|NCT05131061|Captopril|captopril|mesh-list
20366743|NCT05131061|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20366744|NCT05131061|Protease Inhibitors|protease inhibitors|mesh-ancestor
20186162|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186163|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
20186164|NCT00203359|Etanercept|etanercept|mesh-list
20186165|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20186166|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20186167|NCT00203359|Analgesics|analgesics|mesh-ancestor
20186168|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
20186169|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186170|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186171|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186172|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186173|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186174|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186175|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
19838631|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838632|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19838633|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19838634|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838635|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838636|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19838637|NCT00621855|Dabigatran|dabigatran|mesh-list
19838638|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
19838639|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19838640|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
19838641|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186176|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
20186177|NCT00203372|Bevacizumab|bevacizumab|mesh-list
20366745|NCT05131061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186178|NCT00203372|Docetaxel|docetaxel|mesh-list
19305500|NCT04146610|Antibodies|antibodies|mesh-list
19305501|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
19305502|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
19305503|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396566|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19396567|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19838642|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838643|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
19838644|NCT00621946|Dexetimide|dexetimide|mesh-list
19838645|NCT00621946|Citalopram|citalopram|mesh-list
19838646|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19838647|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19838648|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19838649|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838650|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838651|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
20366746|NCT05131061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396568|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396569|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396570|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19396571|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19396572|NCT03658317|Uric Acid|uric acid|mesh-list
19396573|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
19396574|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396575|NCT03658317|Protective Agents|protective agents|mesh-ancestor
19396576|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396577|NCT03658291|Levofloxacin|levofloxacin|mesh-list
19396578|NCT03658291|Ofloxacin|ofloxacin|mesh-list
19396579|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19396580|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396581|NCT03658291|Renal Agents|renal agents|mesh-ancestor
19396582|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396583|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19396584|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19396585|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396586|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396587|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396588|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20366747|NCT05131061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19396589|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19838652|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186179|NCT00203372|Doxorubicin|doxorubicin|mesh-list
19305504|NCT04146220|Prednisolone|prednisolone|mesh-list
19305505|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305506|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
19305507|NCT04146220|Hormones|hormones|mesh-ancestor
19305508|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305509|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305510|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19305511|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305512|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
19305513|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19305514|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19305515|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305516|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
19305517|NCT04146376|Coagulants|coagulants|mesh-ancestor
19305518|NCT04146493|Heparin|heparin|mesh-list
19305519|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
19305520|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19305521|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19305522|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305523|NCT04146532|Aspirin|aspirin|mesh-list
19305524|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19305525|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305526|NCT04146532|Analgesics|analgesics|mesh-ancestor
19305527|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
19305528|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305529|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305530|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305531|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19305532|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19305533|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19305534|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305535|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19305536|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19305537|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305538|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
19305539|NCT04146155|Liraglutide|liraglutide|mesh-list
19305540|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305541|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305542|NCT04146155|Incretins|incretins|mesh-ancestor
19305543|NCT04146155|Hormones|hormones|mesh-ancestor
19305544|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305545|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
19305546|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19305547|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
19305548|NCT04146259|Calcium|calcium|mesh-list
19305549|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19305550|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305551|NCT04146259|Antacids|antacids|mesh-ancestor
19305552|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305553|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305554|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19305555|NCT04146259|Vitamins|vitamins|mesh-ancestor
19305556|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
19305557|NCT04145856|Simethicone|simethicone|mesh-list
20366748|NCT05131061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20366749|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
20366750|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
20366751|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366752|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366753|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366754|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
20366755|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
20366756|NCT05108870|Paclitaxel|paclitaxel|mesh-list
20186180|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186181|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
20186182|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186183|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186184|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20186185|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
20186186|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186187|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186188|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20186189|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366757|NCT05108870|Carboplatin|carboplatin|mesh-list
19305558|NCT04145856|Alverine|alverine|mesh-list
19305559|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
19305560|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305561|NCT04145856|Emollients|emollients|mesh-ancestor
19305562|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
19305563|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
19305564|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
19305565|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305566|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305567|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
19305568|NCT04146116|Povidone|povidone|mesh-list
19305569|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
19305570|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
19305571|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19305572|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305573|NCT04145804|Insulin|insulin|mesh-list
19305574|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305575|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305576|NCT04145583|Voriconazole|voriconazole|mesh-list
19305577|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
19305578|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305579|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19305580|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19305581|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305582|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305583|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19305584|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
19305585|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305586|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305587|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19305588|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19305589|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305590|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19305591|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305592|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305593|NCT04145492|Vitamin D|vitamin d|mesh-list
19305594|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
19305595|NCT04145492|Vitamins|vitamins|mesh-list
19305596|NCT04145492|Vitamin K|vitamin k|mesh-list
19305597|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
19305598|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
19305599|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305600|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19305601|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19305602|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19305603|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19305604|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838653|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19838654|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
20366758|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19305605|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
19305606|NCT04145492|Coagulants|coagulants|mesh-ancestor
19305607|NCT04145921|Tacrine|tacrine|mesh-list
19305608|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20366759|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366760|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
20366761|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
20366762|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
20366763|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366764|NCT05102721|Avelumab|avelumab|mesh-list
20366765|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366766|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366767|NCT05100654|Doxycycline|doxycycline|mesh-list
20366768|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
20366769|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20366770|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20366771|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20366772|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366773|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
20366774|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20366775|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19305609|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305610|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305611|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
20366776|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20366777|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366778|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366779|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366780|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366781|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19305612|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305613|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305614|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19305615|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
19305616|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305617|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
19305618|NCT04145687|Metformin|metformin|mesh-list
19305619|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305620|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366782|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20366783|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20366784|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20366785|NCT05100654|Renal Agents|renal agents|mesh-ancestor
20366786|NCT05100628|Doxorubicin|doxorubicin|mesh-list
20366787|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20366788|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305634|NCT04145193|Leucovorin|leucovorin|mesh-list
19305635|NCT04145193|Fluorouracil|fluorouracil|mesh-list
19305636|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
19305637|NCT04145193|Durvalumab|durvalumab|mesh-list
19305638|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19305639|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
19305640|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305641|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20366789|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20366790|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20366791|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366792|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366793|NCT05096481|Temozolomide|temozolomide|mesh-list
20366794|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20366795|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
20366796|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366797|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366807|NCT05030766|Nicotine|nicotine|mesh-list
20366808|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20366809|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
20366810|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20366811|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366812|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20366813|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20366814|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
20366815|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366816|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305642|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305643|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19305644|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
19305645|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366822|NCT05014061|Adenosine|adenosine|mesh-list
20366823|NCT05014061|Analgesics|analgesics|mesh-ancestor
19305646|NCT04145193|Antidotes|antidotes|mesh-ancestor
19305647|NCT04145193|Protective Agents|protective agents|mesh-ancestor
19305648|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
19305649|NCT04145193|Vitamins|vitamins|mesh-ancestor
19305650|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
19305651|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19305652|NCT04145258|Aspirin|aspirin|mesh-list
20366824|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
19305653|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19305654|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305655|NCT04145258|Analgesics|analgesics|mesh-ancestor
19305656|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
19305657|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305658|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305659|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305660|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19305661|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19305662|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19305663|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305664|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19305665|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19305666|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305667|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
19305668|NCT04145102|Propolis|propolis|mesh-list
19305669|NCT04145102|Fluorides|fluorides|mesh-list
20186190|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20186191|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20186192|NCT00203372|Growth Substances|growth substances|mesh-ancestor
19305670|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
19305671|NCT04145102|Protective Agents|protective agents|mesh-ancestor
19305672|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305673|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19305674|NCT04145336|Indomethacin|indomethacin|mesh-list
19305675|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19305676|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305677|NCT04145336|Analgesics|analgesics|mesh-ancestor
19305678|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
19305679|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305680|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305681|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305682|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19305683|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
19305684|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
19305685|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19305686|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19305687|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305688|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186193|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
20186194|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
20186195|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
19838655|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838656|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19838657|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19838658|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
19838659|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
20186196|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
20186197|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186198|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20186199|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20186200|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186201|NCT00203385|Valproic Acid|valproic acid|mesh-list
20186202|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
20186203|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366825|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186204|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612697|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
19305689|NCT04145232|Nivolumab|nivolumab|mesh-list
19305690|NCT04145232|Ipilimumab|ipilimumab|mesh-list
19838660|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305691|NCT04145232|Atezolizumab|atezolizumab|mesh-list
19305692|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19305693|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305694|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19305695|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305696|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
19305697|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19305698|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19305699|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
19305700|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305701|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305702|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305703|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
19305704|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
19305705|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305706|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
19305707|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20366826|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366827|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20366828|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
20366829|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19305708|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
19305709|NCT04144712|Caffeine|caffeine|mesh-list
19305710|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
19305711|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305712|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19305713|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305714|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19305715|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305716|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19305717|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19305718|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
19305719|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305720|NCT04144933|Acetaminophen|acetaminophen|mesh-list
19305721|NCT04144933|Dexamethasone|dexamethasone|mesh-list
19672597|NCT05122494|Capecitabine|capecitabine|mesh-list
19672598|NCT05122494|Lapatinib|lapatinib|mesh-list
19672599|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672600|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
19672601|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672602|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672603|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19672604|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672605|NCT05122455|Edoxaban|edoxaban|mesh-list
19672606|NCT05122455|Clopidogrel|clopidogrel|mesh-list
19672607|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19672608|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20366830|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
20366831|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
20366832|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366833|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366834|NCT05003245|Ranibizumab|ranibizumab|mesh-list
20366835|NCT05003245|Antibodies|antibodies|mesh-list
20366836|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20366837|NCT05003245|Mitogens|mitogens|mesh-list
20366838|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
20366839|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
20366840|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366841|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
19672609|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19672610|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19672611|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
19672612|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20366842|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366843|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20366844|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19305722|NCT04144933|Lidocaine|lidocaine|mesh-list
19305723|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
20366845|NCT05003245|Growth Substances|growth substances|mesh-ancestor
20366846|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
20366847|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672613|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305724|NCT04144933|Sufentanil|sufentanil|mesh-list
19305725|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
19305726|NCT04144933|Ketamine|ketamine|mesh-list
20366848|NCT04994977|Carboplatin|carboplatin|mesh-list
20366849|NCT04994977|Melphalan|melphalan|mesh-list
20366850|NCT04994977|Topotecan|topotecan|mesh-list
20366851|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366852|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20366853|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
20366854|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366855|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20366856|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366857|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
20366858|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366859|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20366860|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20186205|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
20186206|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186207|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186208|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
20186209|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186210|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186211|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186212|NCT00203450|Zonisamide|zonisamide|mesh-list
20186213|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
20186214|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19305727|NCT04144933|Gabapentin|gabapentin|mesh-list
19305728|NCT04144933|Dsuvia|dsuvia|mesh-list
19305729|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
19305730|NCT04144933|Ondansetron|ondansetron|mesh-list
19305731|NCT04144933|Sevoflurane|sevoflurane|mesh-list
19305732|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19305733|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305734|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
19305735|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
19305736|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305737|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305738|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305739|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
19305740|NCT04144933|Hormones|hormones|mesh-ancestor
19305741|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305742|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19305743|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305744|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
19305745|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
19305746|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305747|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
19305748|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19305749|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19305750|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19305751|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305752|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305753|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19305754|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305755|NCT04144933|Analgesics|analgesics|mesh-ancestor
19305756|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19305757|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19305758|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19305759|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
19305760|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305761|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19305762|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19305763|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
19305764|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19305765|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19305766|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
19305767|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19672614|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366861|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366862|NCT04966663|Gemcitabine|gemcitabine|mesh-list
20366863|NCT04966663|Carboplatin|carboplatin|mesh-list
20366864|NCT04966663|Nivolumab|nivolumab|mesh-list
20366865|NCT04966663|Pemetrexed|pemetrexed|mesh-list
20366866|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186215|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366867|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19305768|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20366868|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
20366869|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305769|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
19305770|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19305771|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19305772|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19305773|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
19305774|NCT04144933|Narcotics|narcotics|mesh-ancestor
19305775|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
19305776|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
19305777|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19305778|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
19305779|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19305780|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20366870|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
20366871|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366872|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20366873|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366874|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
20366875|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366876|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366877|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20366878|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20366879|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20366880|NCT04965493|Rituximab|rituximab|mesh-list
20366881|NCT04965493|Venetoclax|venetoclax|mesh-list
20366882|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20366883|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366884|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
20366885|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366886|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20366887|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
20366888|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20366889|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366890|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
20366891|NCT04919369|Vitamins|vitamins|mesh-list
20366892|NCT04919369|Vitamin A|vitamin a|mesh-list
20366893|NCT04919369|Atezolizumab|atezolizumab|mesh-list
20366894|NCT04919369|Tretinoin|tretinoin|mesh-list
20366895|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
20366896|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20366897|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
20366898|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366899|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366900|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
19305781|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19305782|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
19305783|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19305784|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19396590|NCT03658213|Goserelin|goserelin|mesh-list
19396591|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19396592|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396593|NCT03658109|Lidocaine|lidocaine|mesh-list
19396594|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
19396595|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
19396596|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20366901|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
20366902|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
20366903|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
20366904|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366905|NCT04919369|Protective Agents|protective agents|mesh-ancestor
20366906|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20366907|NCT04919226|Leucovorin|leucovorin|mesh-list
19396597|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396598|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
19396599|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396600|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19396601|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19396602|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20366908|NCT04919226|Folic Acid|folic acid|mesh-list
20366909|NCT04919226|Fluorouracil|fluorouracil|mesh-list
20366910|NCT04919226|Capecitabine|capecitabine|mesh-list
20366911|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
20366912|NCT04919226|Everolimus|everolimus|mesh-list
20366913|NCT04919226|Temozolomide|temozolomide|mesh-list
19396603|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20366914|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20366915|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
19396604|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366916|NCT04919226|Edotreotide|edotreotide|mesh-list
20366917|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
20366918|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366919|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19305785|NCT04144439|Butyric Acid|butyric acid|mesh-list
19305786|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
19305787|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
19305788|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305789|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305790|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305791|NCT04144218|Lacosamide|lacosamide|mesh-list
20366920|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366921|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366922|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
20366923|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366924|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20366925|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
20366926|NCT04919226|Antidotes|antidotes|mesh-ancestor
20366927|NCT04919226|Protective Agents|protective agents|mesh-ancestor
20366928|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
20366929|NCT04919226|Vitamins|vitamins|mesh-ancestor
20366930|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
20366931|NCT04919226|Hematinics|hematinics|mesh-ancestor
20366932|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20366933|NCT04916613|Androgens|androgens|mesh-list
20366934|NCT04916613|Hormones|hormones|mesh-ancestor
20366935|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366936|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366937|NCT04913805|Niacinamide|niacinamide|mesh-list
20366938|NCT04913805|Niacin|niacin|mesh-list
20366939|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
20366940|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
20366941|NCT04913805|Vitamins|vitamins|mesh-ancestor
20366942|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
20366943|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366944|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20366945|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
20366946|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366947|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20366948|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
20366949|NCT04901377|Dienogest|dienogest|mesh-list
19305792|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
19305793|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19305794|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19305795|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305796|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305797|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
19305798|NCT04144153|Anesthetics|anesthetics|mesh-list
19305799|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305800|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305801|NCT04144153|Narcotics|narcotics|mesh-ancestor
19305802|NCT04144153|Analgesics|analgesics|mesh-ancestor
19305803|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
19305804|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305805|NCT04144101|Etoricoxib|etoricoxib|mesh-list
20366950|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20366951|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19305806|NCT04144101|Aceclofenac|aceclofenac|mesh-list
19305807|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19305808|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305809|NCT04144101|Analgesics|analgesics|mesh-ancestor
19305810|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
19305811|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305812|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305813|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19305814|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19305815|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19305816|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19305817|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305818|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305819|NCT04143880|Progesterone|progesterone|mesh-list
19305820|NCT04143880|Progestins|progestins|mesh-ancestor
19305821|NCT04143880|Hormones|hormones|mesh-ancestor
19305822|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305823|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366952|NCT04901377|Estradiol|estradiol|mesh-list
20366953|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20366954|NCT04901377|Estrogens|estrogens|mesh-ancestor
20366955|NCT04901377|Hormones|hormones|mesh-ancestor
20366956|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20366957|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366958|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20366959|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
20366960|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20366961|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20366962|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20366963|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20366964|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20366965|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
20366966|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20366967|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305824|NCT04143906|Gemcitabine|gemcitabine|mesh-list
19305825|NCT04143906|Carboplatin|carboplatin|mesh-list
19305826|NCT04143906|Vinorelbine|vinorelbine|mesh-list
19305827|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305828|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19305829|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
19305830|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305831|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
19305832|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672615|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19672616|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
19672617|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19672618|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
19672619|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672620|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
19672621|NCT05122377|Goserelin|goserelin|mesh-list
19305833|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305834|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19305835|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
19305836|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305837|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19305838|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
19305839|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
19305840|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
19305841|NCT04144192|Lidocaine|lidocaine|mesh-list
19305842|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
19305843|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
19305844|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305845|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305846|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
19305847|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305848|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19305849|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19305850|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19305851|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305852|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305853|NCT04143802|Dulaglutide|dulaglutide|mesh-list
19305854|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305855|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305856|NCT04143685|Misoprostol|misoprostol|mesh-list
19305857|NCT04143685|Oxytocin|oxytocin|mesh-list
19305858|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
19305859|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19305860|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305861|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19305862|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
19305863|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19305864|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186216|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186217|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20186218|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186219|NCT00203463|Topiramate|topiramate|mesh-list
20186220|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
19305870|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
19305871|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19672622|NCT05122377|Leuprolide|leuprolide|mesh-list
19672623|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20186221|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20186222|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186223|NCT00203528|Valproic Acid|valproic acid|mesh-list
20186224|NCT00203528|Risperidone|risperidone|mesh-list
20186225|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20366976|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
20366977|NCT04880434|Fludarabine|fludarabine|mesh-list
19305872|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19305873|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19305874|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305875|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305876|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
19305877|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305878|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305879|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19305880|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305881|NCT04143581|Empagliflozin|empagliflozin|mesh-list
19305882|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19305883|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305884|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305885|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366978|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20366979|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
20366980|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366981|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20366982|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20366983|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
20366984|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20366985|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20366986|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20425614|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425615|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425616|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19305886|NCT04143451|Imiquimod|imiquimod|mesh-list
19305887|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19305888|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
19305889|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305890|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305891|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
20425617|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
20425618|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20425619|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425620|NCT01275885|Vitamins|vitamins|mesh-ancestor
20425621|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
19305892|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
19305893|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19305894|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19305895|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19838661|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19838662|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19305896|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305897|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305898|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
19305899|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305900|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305901|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19305902|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305903|NCT04143321|Empagliflozin|empagliflozin|mesh-list
19305904|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19305905|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305906|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19305907|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305908|NCT04143165|Lidocaine|lidocaine|mesh-list
19305909|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
19305910|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
19305911|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305912|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305913|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
19838663|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
19838664|NCT00621959|Levocetirizine|levocetirizine|mesh-list
20186226|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
20366987|NCT04817345|Plerixafor|plerixafor|mesh-list
20366988|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20366989|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20366990|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
20366991|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366992|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20366993|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
20366994|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20366995|NCT04785924|Imipenem|imipenem|mesh-list
20366996|NCT04785924|Relebactam|relebactam|mesh-list
20366997|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20366998|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20366999|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20367000|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367001|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367002|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20367003|NCT04773353|Hormones|hormones|mesh-ancestor
20367004|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367005|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186227|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612698|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612699|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305914|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186228|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186229|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186230|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186231|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186232|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367006|NCT04770493|Lamotrigine|lamotrigine|mesh-list
20367007|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
20367008|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20367009|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20367010|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367011|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20186233|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186234|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20186235|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
20186236|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
19672624|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672625|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19672626|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
19672627|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19672628|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672629|NCT05122351|Acetaminophen|acetaminophen|mesh-list
19672630|NCT05122351|Bupivacaine|bupivacaine|mesh-list
19672631|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672632|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
19672633|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186237|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186238|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
20186239|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
20186240|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20186241|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
20367012|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367013|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20367014|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20367015|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367016|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20367017|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20367018|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
20367019|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367020|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367021|NCT04767061|Propranolol|propranolol|mesh-list
20367022|NCT04767061|Metoprolol|metoprolol|mesh-list
20367023|NCT04767061|Atenolol|atenolol|mesh-list
20367024|NCT04767061|Sotalol|sotalol|mesh-list
20367025|NCT04767061|Nadolol|nadolol|mesh-list
20367026|NCT04767061|Acebutolol|acebutolol|mesh-list
20367027|NCT04767061|Carvedilol|carvedilol|mesh-list
20367028|NCT04767061|Nebivolol|nebivolol|mesh-list
19672634|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367029|NCT04767061|Bisoprolol|bisoprolol|mesh-list
20367030|NCT04767061|Labetalol|labetalol|mesh-list
20367031|NCT04767061|Pindolol|pindolol|mesh-list
19672635|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
20186242|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20367032|NCT04767061|Betaxolol|betaxolol|mesh-list
20367033|NCT04767061|Penbutolol|penbutolol|mesh-list
19672636|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672637|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19672638|NCT05122351|Analgesics|analgesics|mesh-ancestor
19672639|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
20186243|NCT00203554|Protective Agents|protective agents|mesh-ancestor
20186244|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186245|NCT00203567|Carbamazepine|carbamazepine|mesh-list
20186246|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
20186247|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
20186248|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186249|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186250|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305915|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19305916|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20612700|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
20186251|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19305917|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19305918|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19305919|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305920|NCT04143256|Menthol|menthol|mesh-list
19305921|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
19305922|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
19305923|NCT04143412|Ramipril|ramipril|mesh-list
19305924|NCT04143412|Eplerenone|eplerenone|mesh-list
19305925|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19305926|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
19305927|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305928|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305929|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19305930|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19305931|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
19305932|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305933|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305934|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19305935|NCT04143412|Diuretics|diuretics|mesh-ancestor
19305936|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
19305937|NCT04143191|Sorafenib|sorafenib|mesh-list
19305938|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672640|NCT05122338|Lidocaine|lidocaine|mesh-list
20186252|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20186253|NCT00203567|Analgesics|analgesics|mesh-ancestor
19672641|NCT05122338|Ropivacaine|ropivacaine|mesh-list
19672642|NCT05122338|Esketamine|esketamine|mesh-list
19672643|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672644|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
20612701|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20612702|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186254|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
20186255|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672645|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672646|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672647|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
19672648|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672649|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19672650|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19672651|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19672652|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19672653|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672654|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
19672655|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186256|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20186257|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20612703|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692173|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692174|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186258|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186259|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20186260|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20186261|NCT00203580|Tinzaparin|tinzaparin|mesh-list
20186262|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20186263|NCT00203580|Dalteparin|dalteparin|mesh-list
20367034|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20612704|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
19305939|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19305940|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305941|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305942|NCT04142931|Nivolumab|nivolumab|mesh-list
19305943|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19305944|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19305945|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19305946|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396605|NCT03658057|Rocuronium|rocuronium|mesh-list
19396606|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19396607|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19396608|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19396609|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396610|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396611|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
19396612|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19396613|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396614|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20367035|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20367036|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
20367037|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367038|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367039|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367040|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20367041|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20367042|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
20367043|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
20367044|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
20367045|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367046|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20367047|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
20367048|NCT04767061|Protective Agents|protective agents|mesh-ancestor
20367049|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20367050|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20367051|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20367052|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20367053|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20367054|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20367055|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20367056|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20367057|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
20367058|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20367059|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
20367060|NCT04757584|Propranolol|propranolol|mesh-list
20367061|NCT04757584|Metoprolol|metoprolol|mesh-list
20367062|NCT04757584|Atenolol|atenolol|mesh-list
20367063|NCT04757584|Sotalol|sotalol|mesh-list
20367064|NCT04757584|Nadolol|nadolol|mesh-list
20367065|NCT04757584|Acebutolol|acebutolol|mesh-list
20367066|NCT04757584|Carvedilol|carvedilol|mesh-list
20367067|NCT04757584|Nebivolol|nebivolol|mesh-list
19396615|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396616|NCT03657979|Ropivacaine|ropivacaine|mesh-list
19396617|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
19396618|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
19396619|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396620|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396621|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
19396622|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396623|NCT03657966|Gemcitabine|gemcitabine|mesh-list
19396624|NCT03657966|Paclitaxel|paclitaxel|mesh-list
20367068|NCT04757584|Bisoprolol|bisoprolol|mesh-list
20367069|NCT04757584|Labetalol|labetalol|mesh-list
20367070|NCT04757584|Pindolol|pindolol|mesh-list
20367071|NCT04757584|Betaxolol|betaxolol|mesh-list
20367072|NCT04757584|Penbutolol|penbutolol|mesh-list
20367073|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20367074|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20367075|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
20367076|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367077|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367078|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367079|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20367080|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20367081|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
20367082|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
19305947|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
19305948|NCT04142840|Propofol|propofol|mesh-list
19305949|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19305950|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305951|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305952|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19305953|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
19305954|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
19305955|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19305956|NCT04142840|Analgesics|analgesics|mesh-ancestor
19305957|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
19305958|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19305959|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19305960|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19305961|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19305962|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
19305963|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305964|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305965|NCT04142762|Itraconazole|itraconazole|mesh-list
19305966|NCT04142762|Rifampin|rifampin|mesh-list
19305967|NCT04142762|Midazolam|midazolam|mesh-list
19305968|NCT04142762|Esomeprazole|esomeprazole|mesh-list
19305969|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
19305970|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19305971|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19305972|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
19305973|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
19305974|NCT04142762|Estradiol|estradiol|mesh-list
19305975|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19305976|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19305977|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19305978|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19305979|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19305980|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19305981|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19305982|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19305983|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
19305984|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
19305985|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
19305986|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
19305987|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19305988|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19305989|NCT04142762|Estrogens|estrogens|mesh-ancestor
19305990|NCT04142762|Hormones|hormones|mesh-ancestor
19305991|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19305992|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19305993|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19305994|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19305995|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19305996|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19305997|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19305998|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19305999|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
19306000|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306001|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19306002|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19306003|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19306004|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
19306005|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19306006|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19306007|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19306008|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
19306009|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19306010|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
19306011|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19306012|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19306013|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19306014|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19306015|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19306016|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19306017|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19306018|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19672656|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
19672657|NCT05122221|Fludarabine|fludarabine|mesh-list
19672658|NCT05122221|Interleukin-2|interleukin-2|mesh-list
20367083|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
20367084|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367085|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20367086|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
20367087|NCT04757584|Protective Agents|protective agents|mesh-ancestor
20367088|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20367089|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20367090|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20367091|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20367092|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20367093|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20367094|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20367095|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20367096|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
20367097|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20367098|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
20367099|NCT04722718|Paclitaxel|paclitaxel|mesh-list
20367100|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19306019|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19306020|NCT04142749|Oltipraz|oltipraz|mesh-list
19306021|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
19306022|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306023|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
19306024|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19306025|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
19306026|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19306027|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19306028|NCT04142749|Protective Agents|protective agents|mesh-ancestor
19306029|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306030|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306031|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19306032|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19306033|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306034|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306035|NCT04142151|Aspirin|aspirin|mesh-list
19306036|NCT04142151|Clopidogrel|clopidogrel|mesh-list
19306037|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19306038|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19306039|NCT04142151|Analgesics|analgesics|mesh-ancestor
19306040|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
19306041|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306042|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306043|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19306044|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306045|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19306046|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19306047|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306048|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20367101|NCT04722718|Carboplatin|carboplatin|mesh-list
20367102|NCT04722718|Apatinib|apatinib|mesh-list
20367103|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306049|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19306050|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306051|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
19306052|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19306053|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19306054|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19306055|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
19306056|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306057|NCT04141995|Leucovorin|leucovorin|mesh-list
19306058|NCT04141995|Fluorouracil|fluorouracil|mesh-list
19306059|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
19306060|NCT04141995|Irinotecan|irinotecan|mesh-list
19306061|NCT04141995|Camptothecin|camptothecin|mesh-list
19306062|NCT04141995|Digoxin|digoxin|mesh-list
19306063|NCT04141995|Calcium|calcium|mesh-list
19306064|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
19306065|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20367104|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367105|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612705|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20612706|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613211|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19306066|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306067|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
19306068|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306069|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19306070|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612707|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612708|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20612709|NCT02252614|Narcotics|narcotics|mesh-ancestor
20612710|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612711|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
20367106|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367107|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
20367108|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367109|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367110|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367111|NCT04720547|Zolpidem|zolpidem|mesh-list
20367112|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20367113|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20367114|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367115|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367116|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20367117|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
20367118|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
20367119|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367120|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367121|NCT04718285|Favipiravir|favipiravir|mesh-list
20612712|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612713|NCT02252627|Phenylephrine|phenylephrine|mesh-list
20612714|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
20612715|NCT02252627|Ephedrine|ephedrine|mesh-list
20612716|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20612717|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
20612718|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
20612719|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612720|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612721|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
20612722|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19306071|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19306072|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
19306073|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19306074|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19306075|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306076|NCT04141995|Antidotes|antidotes|mesh-ancestor
19306077|NCT04141995|Protective Agents|protective agents|mesh-ancestor
19306078|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
19306079|NCT04141995|Vitamins|vitamins|mesh-ancestor
19306080|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
19306081|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19306082|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19306083|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306084|NCT04142411|Insulin|insulin|mesh-list
20367122|NCT04718285|Montelukast|montelukast|mesh-list
20367123|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20367124|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
20367125|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20367126|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
20367127|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367128|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367129|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20367130|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20367131|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367132|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
20367133|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367134|NCT04699604|Levocetirizine|levocetirizine|mesh-list
20367135|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20367136|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20367137|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
20367138|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
20367139|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367140|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367141|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367142|NCT04692831|Pertuzumab|pertuzumab|mesh-list
20367143|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20612723|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
19306085|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19306086|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
20612724|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
19306087|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19306088|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306089|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19306090|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
19306091|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
19306092|NCT04142411|Protective Agents|protective agents|mesh-ancestor
19306093|NCT04141904|Tofacitinib|tofacitinib|mesh-list
19306094|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19306095|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306096|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306097|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19306098|NCT04141787|Cefazolin|cefazolin|mesh-list
19306099|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
19306100|NCT04141787|Daptomycin|daptomycin|mesh-list
20612725|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20612726|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19306101|NCT04141787|Cloxacillin|cloxacillin|mesh-list
19306102|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306103|NCT04141410|Simendan|simendan|mesh-list
19306104|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20612727|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20612728|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20612729|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367144|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367145|NCT04687800|Dexamethasone|dexamethasone|mesh-list
20367146|NCT04687800|Difluprednate|difluprednate|mesh-list
20367147|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367148|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
20367149|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
20367150|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367151|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367152|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367153|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
20367154|NCT04687800|Hormones|hormones|mesh-ancestor
20612730|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306105|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
19306106|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19306107|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19306108|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306109|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306110|NCT04141410|Protective Agents|protective agents|mesh-ancestor
19306111|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306112|NCT04141553|Diltiazem|diltiazem|mesh-list
19306113|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19306114|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19306115|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19306116|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306117|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19306118|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306119|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
19306120|NCT04141319|Ketorolac|ketorolac|mesh-list
19306121|NCT04141319|Epinephrine|epinephrine|mesh-list
19306122|NCT04141319|Ropivacaine|ropivacaine|mesh-list
19306123|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
19306124|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
19306125|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306126|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306127|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
19306128|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306129|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19306130|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19306131|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
19306132|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306133|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306134|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19306135|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19306136|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
19306137|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19306138|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
19306139|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
19306140|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
19306141|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19306142|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20367155|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306143|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19306144|NCT04141319|Analgesics|analgesics|mesh-ancestor
19306145|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19306146|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306147|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19306148|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306149|NCT04141163|Metformin|metformin|mesh-list
19306150|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19306151|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306152|NCT04140786|Gentamicins|gentamicins|mesh-list
19306153|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19306154|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306155|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19306156|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306157|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306158|NCT04140578|Ertapenem|ertapenem|mesh-list
19306159|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19306160|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306161|NCT04140487|Azacitidine|azacitidine|mesh-list
19306162|NCT04140487|Venetoclax|venetoclax|mesh-list
19306163|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19306164|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
19306165|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306166|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367156|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367157|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367160|NCT04678089|Bortezomib|bortezomib|mesh-list
20367161|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367162|NCT04673175|Tazobactam|tazobactam|mesh-list
20367163|NCT04673175|Ceftolozane|ceftolozane|mesh-list
20367164|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20367165|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20367166|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367167|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20367168|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367169|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367170|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20367171|NCT04673175|Renal Agents|renal agents|mesh-ancestor
20367172|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
20367173|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
20367174|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367175|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367176|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367177|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367178|NCT04619082|Tenofovir|tenofovir|mesh-list
20367179|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
20367180|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367181|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20367182|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20367183|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367184|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367185|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20367186|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20367187|NCT04591431|Nivolumab|nivolumab|mesh-list
20367188|NCT04591431|Trastuzumab|trastuzumab|mesh-list
20367189|NCT04591431|Ipilimumab|ipilimumab|mesh-list
20367190|NCT04591431|Pertuzumab|pertuzumab|mesh-list
20367191|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20367192|NCT04591431|Everolimus|everolimus|mesh-list
20367193|NCT04591431|Atezolizumab|atezolizumab|mesh-list
20367194|NCT04591431|Lapatinib|lapatinib|mesh-list
20367195|NCT04591431|Palbociclib|palbociclib|mesh-list
20367196|NCT04591431|Vemurafenib|vemurafenib|mesh-list
20367197|NCT04591431|Maytansine|maytansine|mesh-list
20367198|NCT04591431|Ponatinib|ponatinib|mesh-list
20367199|NCT04591431|Entrectinib|entrectinib|mesh-list
20367200|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367201|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367202|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20367203|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367204|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367205|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
20367206|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367207|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367208|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306167|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367209|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306168|NCT04140448|Ranibizumab|ranibizumab|mesh-list
19306169|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19306170|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19306171|NCT04140448|Growth Substances|growth substances|mesh-ancestor
19306172|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306173|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
19306174|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306175|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
19306176|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19306177|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19306178|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306179|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
19306180|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
19306181|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306182|NCT04140461|Amphotericin B|amphotericin b|mesh-list
19306183|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19306184|NCT04140461|Flucytosine|flucytosine|mesh-list
19306185|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306186|NCT04140461|Amebicides|amebicides|mesh-ancestor
19306187|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19306188|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19306189|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19306190|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
19306191|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
19306192|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306193|NCT04140591|Propranolol|propranolol|mesh-list
19306194|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19306195|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19306196|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19306197|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
19306198|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306199|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306200|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306201|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19306202|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19306203|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
19306204|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306205|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19306206|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19396625|NCT03657966|Carboplatin|carboplatin|mesh-list
19396626|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19396627|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396628|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
19396629|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
19396630|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
19396631|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396632|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19396633|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
19396634|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
19396635|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396636|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396637|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19396638|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
19396639|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396640|NCT03657862|Fluorides|fluorides|mesh-list
19396641|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
19396642|NCT03657862|Protective Agents|protective agents|mesh-ancestor
19396643|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396644|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19396645|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396646|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19396647|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19396648|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19396649|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
19396650|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396651|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19396652|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19396653|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396654|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
19396655|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19396656|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404342|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404343|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19404344|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404345|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19404346|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
19306207|NCT04140409|Octreotide|octreotide|mesh-list
20367210|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
20367211|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367212|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
20367213|NCT04588948|Aflibercept|aflibercept|mesh-list
20367214|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20367215|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20367216|NCT04588948|Growth Substances|growth substances|mesh-ancestor
20367217|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367218|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
20367219|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367220|NCT04577014|Gemcitabine|gemcitabine|mesh-list
20367221|NCT04577014|Docetaxel|docetaxel|mesh-list
20367222|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20367223|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
20367224|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367225|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367226|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
20367227|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367228|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367229|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367230|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
20367231|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367232|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
20367233|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367234|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
20367235|NCT04562129|Aldesleukin|aldesleukin|mesh-list
20367236|NCT04562129|Nivolumab|nivolumab|mesh-list
20367237|NCT04562129|Ipilimumab|ipilimumab|mesh-list
20367238|NCT04562129|Interleukin-2|interleukin-2|mesh-list
20367239|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367240|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367241|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20367242|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367243|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20367244|NCT04562129|Analgesics|analgesics|mesh-ancestor
20367245|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
20367246|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367247|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367248|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20367249|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20367250|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
20367251|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367252|NCT04544293|Molgramostim|molgramostim|mesh-list
20367253|NCT04544293|Sargramostim|sargramostim|mesh-list
20367254|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
20367255|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367256|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367257|NCT04534023|Idebenone|idebenone|mesh-list
20367258|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
20367259|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367260|NCT04534023|Protective Agents|protective agents|mesh-ancestor
20367261|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367262|NCT04524663|Camostat|camostat|mesh-list
20367263|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
20367264|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367265|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367266|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20367267|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20367268|NCT04513522|Nivolumab|nivolumab|mesh-list
20367269|NCT04513522|Ipilimumab|ipilimumab|mesh-list
20367270|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19306208|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19306209|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19306210|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367271|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367272|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20367273|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425622|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20425623|NCT01275911|Remifentanil|remifentanil|mesh-list
20425624|NCT01275911|Esmolol|esmolol|mesh-list
20612731|NCT02252627|Protective Agents|protective agents|mesh-ancestor
20612732|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19306211|NCT04140318|Paclitaxel|paclitaxel|mesh-list
19396657|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
20425625|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20425626|NCT01275911|Narcotics|narcotics|mesh-ancestor
20425627|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306212|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306213|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306214|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306215|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306216|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
19306217|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306218|NCT04140006|Alendronate|alendronate|mesh-list
19306219|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19306220|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306221|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
19306222|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
19306223|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306224|NCT04139928|Cathartics|cathartics|mesh-ancestor
19306225|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19306226|NCT04139928|Antacids|antacids|mesh-ancestor
20367274|NCT04492956|Ecopipam|ecopipam|mesh-list
20367275|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20367276|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20367277|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367278|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367279|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20367280|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20367281|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
20367282|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367283|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306227|NCT04140292|Vitamin D|vitamin d|mesh-list
19306228|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
19306229|NCT04140292|Vitamins|vitamins|mesh-ancestor
19306230|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
19306231|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306232|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19306233|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19306234|NCT04139915|Dactolisib|dactolisib|mesh-list
19306235|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367284|NCT04488952|Anesthetics|anesthetics|mesh-list
20367285|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367286|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367287|NCT04479072|Aspirin|aspirin|mesh-list
20367288|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20367289|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19306236|NCT04139941|Antibodies|antibodies|mesh-list
19306237|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
19306238|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
19306239|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306240|NCT04140058|Ondansetron|ondansetron|mesh-list
19306241|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
19306242|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
19306243|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306244|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306245|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19306246|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
19306247|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
19306248|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19306249|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
19306250|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367290|NCT04479072|Analgesics|analgesics|mesh-ancestor
20367291|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
20367292|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367293|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367294|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367295|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367296|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20367297|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20367298|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306251|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306252|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19306253|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19306254|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306255|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19306256|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19306257|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
19306258|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20367299|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19306259|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306260|NCT04140136|Tocotrienols|tocotrienols|mesh-list
20367300|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20367301|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367302|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
20367303|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
19306261|NCT04140136|Vitamin E|vitamin e|mesh-list
19306262|NCT04140136|Tocopherols|tocopherols|mesh-list
19306263|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
19306264|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306265|NCT04140136|Protective Agents|protective agents|mesh-ancestor
19306266|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306267|NCT04140136|Vitamins|vitamins|mesh-ancestor
19306268|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
19306269|NCT04140201|Simvastatin|simvastatin|mesh-list
19306270|NCT04140201|Fenofibrate|fenofibrate|mesh-list
19306271|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19306272|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20367304|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20367305|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
20367306|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367307|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367308|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20367309|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
20367310|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19306273|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
19306274|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306275|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19306276|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19306277|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306278|NCT04139824|Naproxen|naproxen|mesh-list
19306279|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19306280|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19306281|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19306282|NCT04139824|Analgesics|analgesics|mesh-ancestor
19306283|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
19306284|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306285|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306286|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306287|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
19306288|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19306289|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306290|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306291|NCT04139668|Naltrexone|naltrexone|mesh-list
19306292|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19306293|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19306294|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306295|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
19306296|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306297|NCT04139525|Heparin|heparin|mesh-list
19306298|NCT04139525|Calcium heparin|calcium heparin|mesh-list
19306299|NCT04139525|Citric Acid|citric acid|mesh-list
19306300|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
19306301|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
19306302|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19306303|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
19306304|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
19306305|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306306|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19306307|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19306308|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
19672659|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19672660|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
19672661|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672662|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672663|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20367311|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
19306309|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306310|NCT04139772|Docetaxel|docetaxel|mesh-list
19306311|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
19306312|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306313|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306314|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306315|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
19306316|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367312|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306317|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19306318|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672664|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
19306319|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
19306320|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306321|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306322|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19306323|NCT04139395|Citric Acid|citric acid|mesh-list
19306324|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
19306325|NCT04139395|Gallium citrate|gallium citrate|mesh-list
19306326|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
19306327|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19306328|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
19306329|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
19306330|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306331|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19306332|NCT04139629|Antibodies|antibodies|mesh-list
19306333|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
19306334|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306335|NCT04139681|Menthol|menthol|mesh-list
19306336|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
20612733|NCT02252692|Enalapril|enalapril|mesh-list
20612734|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19306337|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
19306338|NCT04139213|Naltrexone|naltrexone|mesh-list
19306339|NCT04139213|Buprenorphine|buprenorphine|mesh-list
19306340|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19306341|NCT04139213|Naloxone|naloxone|mesh-list
19306342|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19306343|NCT04139213|Narcotics|narcotics|mesh-ancestor
19306344|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306345|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306346|NCT04139213|Analgesics|analgesics|mesh-ancestor
19306347|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
19306348|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306349|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19306350|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19306351|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
19306352|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19306353|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
19306354|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306355|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306356|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19306357|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
19306358|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306359|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306360|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19306361|NCT04138992|Bevacizumab|bevacizumab|mesh-list
19306362|NCT04138992|Cisplatin|cisplatin|mesh-list
19306363|NCT04138992|Docetaxel|docetaxel|mesh-list
19306364|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19306365|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306366|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19306367|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19306368|NCT04138992|Growth Substances|growth substances|mesh-ancestor
19306369|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306370|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19306371|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306372|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306373|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19306374|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306375|NCT04139070|Bleomycin|bleomycin|mesh-list
19306376|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19306377|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306378|NCT04138901|Ropivacaine|ropivacaine|mesh-list
19306379|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672665|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186264|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
19306380|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
19306381|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186265|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20186266|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20186267|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186268|NCT00203606|Interferons|interferons|mesh-list
20186269|NCT00203606|Ribavirin|ribavirin|mesh-list
20186270|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
20186271|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
20186272|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20186273|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367313|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367314|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20367315|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
20367316|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
20367317|NCT04476992|Protective Agents|protective agents|mesh-ancestor
20367318|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
20367319|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367320|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
20367321|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
20367322|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20367323|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
20367324|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20367325|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
19306382|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306383|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
19306384|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186274|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
20186275|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186276|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
20186277|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186278|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
20186279|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186280|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
20186281|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20186282|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367326|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672666|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672667|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19672668|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19672669|NCT05122221|Analgesics|analgesics|mesh-ancestor
19672670|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
19672671|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672672|NCT05122117|Methylene Blue|methylene blue|mesh-list
19672673|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672674|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672675|NCT05122026|Isoniazid|isoniazid|mesh-list
19306385|NCT04138628|Atezolizumab|atezolizumab|mesh-list
19306386|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306387|NCT04138420|Bevacizumab|bevacizumab|mesh-list
19306388|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19306389|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306390|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19306391|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19306392|NCT04138420|Growth Substances|growth substances|mesh-ancestor
19306393|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306394|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
19306395|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
19306396|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306397|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19306398|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306399|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306400|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19306401|NCT04138888|Olmesartan|olmesartan|mesh-list
19306402|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19306403|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19306404|NCT04138888|Diuretics|diuretics|mesh-ancestor
19306405|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
19306406|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306407|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19306408|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19306409|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306410|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19306411|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19306412|NCT04138836|Itraconazole|itraconazole|mesh-list
19306413|NCT04138836|Midazolam|midazolam|mesh-list
19306414|NCT04138836|Esomeprazole|esomeprazole|mesh-list
19306415|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19306416|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19306417|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306418|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367327|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306419|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19306420|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19306421|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19672676|NCT05122026|Rifapentine|rifapentine|mesh-list
20186283|NCT00203658|Tinzaparin|tinzaparin|mesh-list
19306422|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19306423|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
19306424|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
19306425|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
19306426|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
19306427|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306428|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306429|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19306430|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19306431|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19306432|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306433|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
19306434|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306435|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19306436|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19306437|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19306438|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
19306439|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306440|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19396658|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19396659|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
19396660|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19396661|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396662|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19396663|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19396664|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19396665|NCT03657550|Niacin|niacin|mesh-list
19396666|NCT03657550|Amlodipine|amlodipine|mesh-list
19396667|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19396668|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19396669|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19396670|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396671|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19396672|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396673|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
19396674|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19396675|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
19396676|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19396677|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
19396678|NCT03657550|Vitamins|vitamins|mesh-ancestor
19396679|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
19396680|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19396681|NCT03657472|Atorvastatin|atorvastatin|mesh-list
19396682|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19396683|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19396684|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
20367328|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
20367329|NCT04426825|Bevacizumab|bevacizumab|mesh-list
20367330|NCT04426825|Atezolizumab|atezolizumab|mesh-list
20367331|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367332|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367333|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20367334|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20367335|NCT04426825|Growth Substances|growth substances|mesh-ancestor
20367336|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367337|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
20367338|NCT04413799|Lidocaine|lidocaine|mesh-list
20367339|NCT04413799|Ketamine|ketamine|mesh-list
19396685|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396686|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19396687|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19396688|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396689|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19396690|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
19396691|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396692|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396693|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19396694|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19396695|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396696|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396697|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396698|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20367340|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
20367341|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
20612735|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19306441|NCT04138719|Paclitaxel|paclitaxel|mesh-list
19306442|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20186284|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19306443|NCT04138719|Carboplatin|carboplatin|mesh-list
19306444|NCT04138719|Epirubicin|epirubicin|mesh-list
19306445|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306446|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306447|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306448|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306449|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
19306450|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306451|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19306452|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19306453|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19306454|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306455|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
19306456|NCT04138277|Miglustat|miglustat|mesh-list
19306457|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306458|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306459|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19306460|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19306461|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
19306462|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306463|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19306464|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19306465|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306466|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
19306467|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19306468|NCT04138472|Lidocaine|lidocaine|mesh-list
19306469|NCT04138472|Fentanyl|fentanyl|mesh-list
19306470|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
19306471|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
19306472|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
19306473|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306474|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306475|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
19306476|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306477|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19306478|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19306479|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19306480|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19306481|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306482|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19306483|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19306484|NCT04138472|Analgesics|analgesics|mesh-ancestor
19306485|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19306486|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19306487|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19306488|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
19306489|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306490|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19306491|NCT04138472|Narcotics|narcotics|mesh-ancestor
19306492|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19306493|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19306494|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
19306495|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
19306496|NCT04138264|Narcotics|narcotics|mesh-ancestor
19306497|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306498|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306499|NCT04138264|Analgesics|analgesics|mesh-ancestor
19306500|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
19306501|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306502|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
19306503|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
19306504|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306505|NCT04138251|Empagliflozin|empagliflozin|mesh-list
19306506|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19306507|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306508|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19306509|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306510|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
19306511|NCT04137978|Diuretics|diuretics|mesh-ancestor
19306512|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
19306513|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306514|NCT04137978|Expectorants|expectorants|mesh-ancestor
19306515|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
19306516|NCT04138004|Lubiprostone|lubiprostone|mesh-list
19306517|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19306518|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19306519|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306520|NCT04138238|Sirolimus|sirolimus|mesh-list
19306521|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19306522|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306523|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19306524|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306525|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
19306526|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19306527|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
19306528|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306529|NCT04138212|Paclitaxel|paclitaxel|mesh-list
19306530|NCT04138212|Cisplatin|cisplatin|mesh-list
19306531|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306532|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306533|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306534|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306535|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
19306536|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306537|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
19306538|NCT04137640|Docetaxel|docetaxel|mesh-list
19306539|NCT04137640|Letrozole|letrozole|mesh-list
19306540|NCT04137640|Epirubicin|epirubicin|mesh-list
19306541|NCT04137640|Palbociclib|palbociclib|mesh-list
19306542|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19306543|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
19306544|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367342|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367343|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367344|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
20367345|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367346|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20367347|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20367348|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20367349|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20367350|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367351|NCT04413799|Analgesics|analgesics|mesh-ancestor
20367352|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20367353|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19306545|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306546|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19306547|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
19306548|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306549|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306550|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19306551|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306552|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306553|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
19306554|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19306555|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19306556|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306557|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19306558|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
19306559|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306560|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19306561|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19306562|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19306563|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19306564|NCT04137536|Antibodies|antibodies|mesh-list
19306565|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19306566|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
19306567|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306568|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19306569|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19306570|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306571|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306572|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19306573|NCT04137588|Growth Substances|growth substances|mesh-ancestor
19306574|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367354|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
19306575|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
19306576|NCT04137653|Paclitaxel|paclitaxel|mesh-list
19306577|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19306578|NCT04137653|Carboplatin|carboplatin|mesh-list
19306579|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306580|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306581|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306582|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306583|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
20367355|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20367356|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20367357|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672677|NCT05122026|Rifampin|rifampin|mesh-list
19672678|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
20186285|NCT00203658|Dalteparin|dalteparin|mesh-list
20186286|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
20186287|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20186288|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20186289|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186290|NCT00203684|Flunisolide|flunisolide|mesh-list
20186291|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186292|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20186293|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
20186294|NCT00203697|Minocycline|minocycline|mesh-list
20186295|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186296|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186297|NCT00203723|Risperidone|risperidone|mesh-list
20186298|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20186299|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
20186300|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186301|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186302|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186303|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186304|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186305|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186306|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186307|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20186308|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
20186309|NCT00203736|Artesunate|artesunate|mesh-list
20186310|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
20186311|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
20186312|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20186313|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
20186314|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20186315|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20186316|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186317|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186318|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
20186319|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
20186320|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20186321|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
20186322|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20186323|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186324|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186325|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20186326|NCT00203736|Renal Agents|renal agents|mesh-ancestor
20186327|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20186328|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
20186329|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186330|NCT00203775|Risperidone|risperidone|mesh-list
20186331|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20186332|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
19672679|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19672680|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672681|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19672682|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19672683|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
19672684|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672685|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19672686|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19672687|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
20186333|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186334|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396699|NCT03657433|Hematinics|hematinics|mesh-ancestor
20186335|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186336|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19306584|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306585|NCT04137432|Oxytocin|oxytocin|mesh-list
19306586|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
19306587|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19306588|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306589|NCT04137198|Sufentanil|sufentanil|mesh-list
19306590|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19306591|NCT04137198|Narcotics|narcotics|mesh-ancestor
19306592|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306593|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306594|NCT04137198|Analgesics|analgesics|mesh-ancestor
19306595|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
19306596|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306597|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19306598|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19306599|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
19306600|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
19306601|NCT04137185|Hormones|hormones|mesh-list
19306602|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306603|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306604|NCT04137328|Liraglutide|liraglutide|mesh-list
19306605|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19306606|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306607|NCT04137328|Incretins|incretins|mesh-ancestor
19306608|NCT04137328|Hormones|hormones|mesh-ancestor
19306609|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306610|NCT04137276|Vitamins|vitamins|mesh-list
19306611|NCT04137276|Ascorbic Acid|ascorbic acid|mesh-list
19306612|NCT04137276|Thiamine|thiamine|mesh-list
19306613|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
19306614|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
19306615|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306616|NCT04137276|Antioxidants|antioxidants|mesh-ancestor
19306617|NCT04137276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306618|NCT04137276|Protective Agents|protective agents|mesh-ancestor
19306619|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
19306620|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19306621|NCT04137380|Mirikizumab|mirikizumab|mesh-list
19306622|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19306623|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19306624|NCT04137380|Analgesics|analgesics|mesh-ancestor
19306625|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
19306626|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306627|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306628|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19306629|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306630|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19672688|NCT05122026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19672689|NCT05122026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672690|NCT05122026|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19672691|NCT05122026|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19672692|NCT05122026|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19306631|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19306632|NCT04137029|Bromides|bromides|mesh-list
19306633|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
19306634|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
20186337|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186338|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186339|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186340|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20186341|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
20186342|NCT00203788|Risperidone|risperidone|mesh-list
20186343|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20186344|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
20186345|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186346|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186347|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186348|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186349|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186350|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186351|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186352|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20186353|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
20186354|NCT00203801|Artesunate|artesunate|mesh-list
20186355|NCT00203801|Lumefantrine|lumefantrine|mesh-list
20186356|NCT00203801|Artemether|artemether|mesh-list
20186357|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
19672693|NCT05122026|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19672694|NCT05122026|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20367380|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
20367381|NCT04370509|Axitinib|axitinib|mesh-list
20367382|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367383|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672695|NCT05122026|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19672696|NCT05121883|Edaravone|edaravone|mesh-list
19672697|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19672698|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
19672699|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672700|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20367384|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367385|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306635|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19306636|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
19306637|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306638|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306639|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19306640|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
19306641|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19306642|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19306643|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19306644|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
19306645|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306646|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306647|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
19306648|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19306649|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
19306650|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
20367386|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367387|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
20367388|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
20367389|NCT04355130|Vitamins|vitamins|mesh-ancestor
20367390|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
20367391|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367392|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
20367393|NCT04355130|Hematinics|hematinics|mesh-ancestor
20367394|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19306651|NCT04136886|Cisplatin|cisplatin|mesh-list
19306652|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306653|NCT04136613|Copper|copper|mesh-list
19306654|NCT04136613|Trace Elements|trace elements|mesh-ancestor
19306655|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
19306656|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306657|NCT04136743|Dexamethasone|dexamethasone|mesh-list
19306658|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19306659|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
19306660|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
19306661|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306662|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306663|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19306664|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
19306665|NCT04136743|Hormones|hormones|mesh-ancestor
20367395|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367396|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
19306666|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306667|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19306668|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306669|NCT04136782|Paclitaxel|paclitaxel|mesh-list
19306670|NCT04136782|Docetaxel|docetaxel|mesh-list
19306671|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19306672|NCT04136782|Carboplatin|carboplatin|mesh-list
19306673|NCT04136782|Epirubicin|epirubicin|mesh-list
19306674|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306675|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306676|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306677|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306678|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
20186358|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
20186359|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20186360|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20186361|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
20186362|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20186363|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20186364|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186365|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306679|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306680|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19306681|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19306682|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19306683|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306684|NCT04136535|Carboplatin|carboplatin|mesh-list
19306685|NCT04136535|Pemetrexed|pemetrexed|mesh-list
19306686|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306687|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306688|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306689|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19306690|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19396700|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19396701|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19396702|NCT03657420|Dexamethasone|dexamethasone|mesh-list
19396703|NCT03657420|Pomalidomide|pomalidomide|mesh-list
19396704|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396705|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
19396706|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
19396707|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396708|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396709|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186366|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
20186367|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
20186368|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20186369|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
20186370|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20186371|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186372|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186373|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20186374|NCT00203801|Renal Agents|renal agents|mesh-ancestor
20186375|NCT00203814|Artesunate|artesunate|mesh-list
19396710|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
19396711|NCT03657420|Hormones|hormones|mesh-ancestor
19396712|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396713|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19396714|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186376|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
20186377|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
20186378|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20186379|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
20186380|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20186381|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20186382|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186383|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186384|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
20186385|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
20186386|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20186387|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
20186388|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20186389|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186390|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186391|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19396715|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
20186392|NCT00203814|Renal Agents|renal agents|mesh-ancestor
20186393|NCT00203905|Bevacizumab|bevacizumab|mesh-list
20186394|NCT00203905|Fluorouracil|fluorouracil|mesh-list
20186395|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
20186396|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20186397|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367397|NCT04340505|Hormones|hormones|mesh-ancestor
20367398|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367399|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367400|NCT04327206|Vaccines|vaccines|mesh-list
20367401|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
20367402|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
20367403|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367404|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20367405|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20367406|NCT04291105|Cemiplimab|cemiplimab|mesh-list
20367407|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367408|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367409|NCT04270409|Dexamethasone|dexamethasone|mesh-list
20367410|NCT04270409|Lenalidomide|lenalidomide|mesh-list
20367411|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367412|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
20367413|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
20367414|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367415|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367416|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367417|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
20367418|NCT04270409|Hormones|hormones|mesh-ancestor
20367419|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367420|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367421|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367422|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
20367423|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20367424|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20367425|NCT04270409|Growth Substances|growth substances|mesh-ancestor
20367426|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
20367427|NCT04237012|Dexamethasone|dexamethasone|mesh-list
20367428|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
20367429|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367430|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
20367431|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
20367432|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367433|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367434|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367435|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
20367436|NCT04237012|Hormones|hormones|mesh-ancestor
20367437|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367438|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367439|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367440|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20367441|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20367442|NCT04234360|Prednisone|prednisone|mesh-list
20367443|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367444|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
19672701|NCT05121883|Protective Agents|protective agents|mesh-ancestor
19672702|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186398|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20186399|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20186400|NCT00203905|Growth Substances|growth substances|mesh-ancestor
20186401|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186402|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
20186403|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
20186404|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186405|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20186406|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186407|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
20186408|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
20186409|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186410|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20186411|NCT00203957|Istradefylline|istradefylline|mesh-list
20186412|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20186413|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20367445|NCT04234360|Hormones|hormones|mesh-ancestor
20186414|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20186415|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
19306691|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
19306692|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
19306693|NCT04136639|Fluorides|fluorides|mesh-list
19306694|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
19306695|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
19306696|NCT04136639|Protective Agents|protective agents|mesh-ancestor
19306697|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306698|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306699|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306700|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306701|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
19306702|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367446|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367447|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367448|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367449|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367450|NCT04232306|Bupivacaine|bupivacaine|mesh-list
20367451|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
20367452|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
20367453|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367454|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306703|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19306704|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19306705|NCT04136470|Nivolumab|nivolumab|mesh-list
19306706|NCT04136470|Ipilimumab|ipilimumab|mesh-list
19306707|NCT04136470|Atezolizumab|atezolizumab|mesh-list
19306708|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19306709|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306710|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19306711|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306712|NCT04136600|Antibodies|antibodies|mesh-list
19306713|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
19306714|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306715|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19306716|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
19306717|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19306718|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306719|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19306720|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306721|NCT04135846|Doxazosin|doxazosin|mesh-list
19306722|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19306723|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19306724|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19306725|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19306726|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
19306727|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306728|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306729|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306730|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19306731|NCT04136015|Dasatinib|dasatinib|mesh-list
19306732|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306733|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19306734|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306735|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306736|NCT04135898|Bevacizumab|bevacizumab|mesh-list
19306737|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19306738|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306739|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19306740|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19306741|NCT04135898|Growth Substances|growth substances|mesh-ancestor
19306742|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306743|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
19306744|NCT04135885|Folic Acid|folic acid|mesh-list
19306745|NCT04135885|Hematinics|hematinics|mesh-ancestor
19306746|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
19672703|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19672704|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19306747|NCT04135885|Vitamins|vitamins|mesh-ancestor
19306748|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
19306749|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306750|NCT04135833|Itraconazole|itraconazole|mesh-list
19672705|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672706|NCT05121324|Midazolam|midazolam|mesh-list
19306751|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19306752|NCT04135833|Rifampin|rifampin|mesh-list
20367455|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
19306753|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
19306754|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306755|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19306756|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19306757|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306758|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306759|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19306760|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
19306761|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306762|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306763|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19306764|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19306765|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
19306766|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19306767|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
19306768|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19306769|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19306770|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19306771|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19306772|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19306773|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19306774|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19306775|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
19306776|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19306777|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
19306778|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19306779|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
19306780|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306781|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306782|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
19306783|NCT04135781|Paclitaxel|paclitaxel|mesh-list
19306784|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19306785|NCT04135781|Capecitabine|capecitabine|mesh-list
19306786|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
19306787|NCT04135781|Tegafur|tegafur|mesh-list
19306788|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19306789|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306790|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
19306791|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
19306792|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
19306793|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306794|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19306795|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
19306796|NCT04135508|Adalimumab|adalimumab|mesh-list
19306797|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19306798|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306799|NCT04135313|Capecitabine|capecitabine|mesh-list
19306800|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
19306801|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19306802|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
19306803|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306804|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306805|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
19306806|NCT04135378|Vitamins|vitamins|mesh-ancestor
19306807|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
19306808|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306809|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
19306810|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306811|NCT04135378|Protective Agents|protective agents|mesh-ancestor
19306812|NCT04135690|Sorafenib|sorafenib|mesh-list
19306813|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306814|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19306815|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306816|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306817|NCT04135456|Mannitol|mannitol|mesh-list
19306818|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19306819|NCT04135456|Diuretics|diuretics|mesh-ancestor
19306820|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
19306821|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306822|NCT04134884|Talazoparib|talazoparib|mesh-list
20612736|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306823|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19306824|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306825|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367456|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367457|NCT04225221|Leuprolide|leuprolide|mesh-list
20367458|NCT04225221|Estradiol|estradiol|mesh-list
20367459|NCT04225221|Progesterone|progesterone|mesh-list
20367460|NCT04225221|Estrogens|estrogens|mesh-ancestor
20367461|NCT04225221|Hormones|hormones|mesh-ancestor
20367462|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306826|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306827|NCT04134923|Corticosterone|corticosterone|mesh-list
19306828|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19306829|NCT04134897|Capecitabine|capecitabine|mesh-list
19306830|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
19306831|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19306832|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
19306833|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306834|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306835|NCT04135014|Midazolam|midazolam|mesh-list
19306836|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
19306837|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19306838|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306839|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306840|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19306841|NCT04135014|Analgesics|analgesics|mesh-ancestor
19306842|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
19306843|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306844|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19306845|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19306846|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19306847|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
19306848|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306849|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306850|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19306851|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19306852|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19306853|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19306854|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19306855|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
19306856|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
19306857|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
19306858|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
19396716|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19396717|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19396718|NCT03657420|Growth Substances|growth substances|mesh-ancestor
19396719|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
19396720|NCT03657381|Antibodies|antibodies|mesh-list
19396721|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19396722|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
19396723|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396724|NCT03657355|Zolpidem|zolpidem|mesh-list
19396725|NCT03657355|Suvorexant|suvorexant|mesh-list
19396726|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19396727|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19396728|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396729|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396730|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19396731|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
19396732|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
19396733|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396734|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396735|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19396736|NCT03657212|Zolpidem|zolpidem|mesh-list
19396737|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19396738|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19396739|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396740|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396741|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19396742|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
19396743|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
19396744|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396745|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396746|NCT03656965|Acyclovir|acyclovir|mesh-list
19396747|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
19396748|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396749|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
19396750|NCT03656952|PF-06700841|pf-06700841|mesh-list
19396751|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20367463|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306859|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
19306860|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19306861|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
19306862|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306863|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
19306864|NCT04134611|Protective Agents|protective agents|mesh-ancestor
19306865|NCT04134650|Metformin|metformin|mesh-list
19306866|NCT04134650|Linagliptin|linagliptin|mesh-list
19306867|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19306868|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306869|NCT04134650|Incretins|incretins|mesh-ancestor
20367464|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20367465|NCT04225221|Progestins|progestins|mesh-ancestor
20367466|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20367467|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
20367468|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367469|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367470|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20367471|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
20367472|NCT04206163|Edotreotide|edotreotide|mesh-list
20367473|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20367474|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367475|NCT04170153|Niraparib|niraparib|mesh-list
20367476|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20367477|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367478|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367479|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367480|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
20367481|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367482|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
20367483|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306870|NCT04134650|Hormones|hormones|mesh-ancestor
19306871|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306872|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19306873|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
19306874|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306875|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306876|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
19306877|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
19306878|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19306879|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306880|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19306881|NCT04134468|Gemcitabine|gemcitabine|mesh-list
19306882|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19306883|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19306884|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
19306885|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672707|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19672708|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19672709|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672710|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672711|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19306886|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672712|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19672713|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186416|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186417|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186418|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186419|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
20186420|NCT00204022|Azathioprine|azathioprine|mesh-list
20186421|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186422|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186423|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20186424|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
20186425|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186426|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186427|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186428|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186429|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
20367484|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367485|NCT04140305|Ozanimod|ozanimod|mesh-list
19306887|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
19306888|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672714|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19306889|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306890|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19306891|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
19306892|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306893|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
19306894|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19306895|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306896|NCT04134416|Donepezil|donepezil|mesh-list
19306897|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19306898|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306899|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306900|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
19306901|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306902|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306903|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
19306904|NCT04134182|Nivolumab|nivolumab|mesh-list
19306905|NCT04134182|Ipilimumab|ipilimumab|mesh-list
19306906|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19306907|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306908|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19306909|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306910|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
19306911|NCT04134130|Testosterone|testosterone|mesh-list
19306912|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
19306913|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
19306914|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19306915|NCT04134130|Androgens|androgens|mesh-ancestor
19306916|NCT04134130|Hormones|hormones|mesh-ancestor
19306917|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306918|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306919|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19306920|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306921|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
19306922|NCT04134273|Clindamycin|clindamycin|mesh-list
19306923|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
19306924|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
19306925|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19306926|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19306927|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19306928|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306929|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306930|NCT04134598|Tamoxifen|tamoxifen|mesh-list
20186430|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20186431|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186432|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
20186433|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186434|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19306931|NCT04134598|Letrozole|letrozole|mesh-list
19306932|NCT04134598|Anastrozole|anastrozole|mesh-list
19306933|NCT04134598|Exemestane|exemestane|mesh-list
19306934|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19306935|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19306936|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19306937|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306938|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306939|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19306940|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
19306941|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19306942|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306943|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20186435|NCT00204061|Amisulpride|amisulpride|mesh-list
20186436|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186437|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186438|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186439|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186440|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186441|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20186442|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
20186443|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186444|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186445|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20186446|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
20186447|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20186448|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20367486|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20367487|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367488|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367489|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
20367490|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367491|NCT04137068|Benzocaine|benzocaine|mesh-list
20367492|NCT04137068|Anesthetics, Local|anesthetics, local|mesh-ancestor
20367493|NCT04137068|Anesthetics|anesthetics|mesh-ancestor
20367494|NCT04137068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367495|NCT04137068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367496|NCT04137068|Sensory System Agents|sensory system agents|mesh-ancestor
20367497|NCT04137068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367498|NCT04136353|Hormones|hormones|mesh-list
20367499|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20367500|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367501|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367502|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
20367503|NCT04119024|Fludarabine|fludarabine|mesh-list
20367504|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
20367505|NCT04119024|Interleukin-2|interleukin-2|mesh-list
20367506|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367507|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
20367508|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367509|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367510|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20367511|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
20367512|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367513|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367514|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20367515|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20367516|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
20367517|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20367518|NCT04119024|Analgesics|analgesics|mesh-ancestor
20367519|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
20367520|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367521|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20367522|NCT04113382|Laxatives|laxatives|mesh-ancestor
19306944|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19306945|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19306946|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19306947|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
20367523|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367524|NCT04102098|Bevacizumab|bevacizumab|mesh-list
20367525|NCT04102098|Atezolizumab|atezolizumab|mesh-list
20367526|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367527|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367528|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20367529|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20367530|NCT04102098|Growth Substances|growth substances|mesh-ancestor
20367531|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367532|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
20367533|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20367534|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20367535|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367536|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367537|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
20367538|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367539|NCT04085276|Paclitaxel|paclitaxel|mesh-list
20367540|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20367541|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20367542|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367543|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
20367544|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367545|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
20367546|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367547|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20367548|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
20367549|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367550|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20367551|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20367552|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19306948|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19306949|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
19306950|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306951|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306952|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19306953|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
19306954|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19306955|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
19306956|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306957|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367553|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367554|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20367555|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20367556|NCT04065841|Licogliflozin|licogliflozin|mesh-list
20367557|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20367558|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367559|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20367560|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367561|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20367562|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20367563|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
20367564|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306958|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19306959|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
19306960|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
19306961|NCT04134078|Protective Agents|protective agents|mesh-ancestor
19306962|NCT04134065|Vitamin D|vitamin d|mesh-list
19306963|NCT04134065|Vitamins|vitamins|mesh-ancestor
19306964|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
19306965|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306966|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19306967|NCT04134052|Midazolam|midazolam|mesh-list
19306968|NCT04134052|Ketamine|ketamine|mesh-list
19306969|NCT04134052|Analgesics|analgesics|mesh-ancestor
19306970|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
19306971|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19306972|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306973|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19306974|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19306975|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
19306976|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
19306977|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19306978|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19306979|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19306980|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19306981|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306982|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19306983|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19306984|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19306985|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19306986|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19306987|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
19306988|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
19306989|NCT04133961|Phenylephrine|phenylephrine|mesh-list
19306990|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
19306991|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19306992|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
19306993|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
20367565|NCT04009824|Antacids|antacids|mesh-ancestor
20367566|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367567|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425628|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425629|NCT01275911|Analgesics|analgesics|mesh-ancestor
20425630|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
20425631|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425632|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20425633|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20425634|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20425635|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
20425636|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425637|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19306994|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425638|NCT01275937|Esomeprazole|esomeprazole|mesh-list
19306995|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19306996|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
19404347|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
19306997|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19306998|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
19306999|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
19307000|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19307001|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19307002|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19307003|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
19307004|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307005|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307006|NCT04133961|Protective Agents|protective agents|mesh-ancestor
19307007|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
19307008|NCT04134026|Hematinics|hematinics|mesh-ancestor
19307009|NCT04133974|Methadone|methadone|mesh-list
19307010|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19307011|NCT04133974|Narcotics|narcotics|mesh-ancestor
19307012|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307013|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307014|NCT04133974|Analgesics|analgesics|mesh-ancestor
19307015|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
19307016|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307017|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
19307018|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
19307019|NCT04134637|Bupivacaine|bupivacaine|mesh-list
19307020|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
19307021|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
19307022|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307023|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307024|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
19307025|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307026|NCT04133571|Lidocaine|lidocaine|mesh-list
19307027|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
19307028|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
19307029|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307030|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307031|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
19307032|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307033|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19307034|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19307035|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19307036|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19307037|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307038|NCT04133428|Valsartan|valsartan|mesh-list
19307039|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19307040|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20367568|NCT03975231|Trametinib|trametinib|mesh-list
20367569|NCT03975231|Dabrafenib|dabrafenib|mesh-list
20367570|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367571|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367572|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367573|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367574|NCT03973177|Phenol|phenol|mesh-list
20367575|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
20367576|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20367577|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20367578|NCT03973177|Prednisolone|prednisolone|mesh-list
20367579|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
20367580|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20367581|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
20367582|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367583|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
20367584|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
20367585|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367586|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367587|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367588|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
20367589|NCT03973177|Hormones|hormones|mesh-ancestor
20367590|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367591|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20367592|NCT03973177|Protective Agents|protective agents|mesh-ancestor
20367593|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367594|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307041|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19838665|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20367595|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19307042|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19307043|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307044|NCT04133155|Gemcitabine|gemcitabine|mesh-list
19307045|NCT04133155|Paclitaxel|paclitaxel|mesh-list
19307046|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19307047|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307048|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
19307049|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367596|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367597|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
20367598|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20367599|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20367600|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
20367601|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20367602|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367603|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
20367604|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20367605|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367606|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
20367607|NCT03916003|Primaquine|primaquine|mesh-list
20367608|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
20367609|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20367610|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20367611|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307050|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
19307051|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307052|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20367612|NCT03913559|Acetaminophen|acetaminophen|mesh-list
20367613|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
20367614|NCT03913559|Promethazine|promethazine|mesh-list
20367615|NCT03913559|Cytarabine|cytarabine|mesh-list
20367616|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
20367617|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20367618|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
20367619|NCT03913559|Methotrexate|methotrexate|mesh-list
20367620|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20367621|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20367622|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
20367623|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20367624|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367625|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20367626|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
20367627|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367628|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367629|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
20367630|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367631|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20367632|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367633|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
20367634|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367635|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19307053|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
19307054|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
19307055|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307056|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307057|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186449|NCT00204074|Estradiol|estradiol|mesh-list
20186450|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20186451|NCT00204074|Estrogens|estrogens|mesh-ancestor
20186452|NCT00204074|Hormones|hormones|mesh-ancestor
20186453|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186454|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186455|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20186456|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
20186457|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20186458|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20186459|NCT00204152|Vaccines|vaccines|mesh-list
20186460|NCT00204152|Immunologic Factors|immunologic factors|mesh-ancestor
20186461|NCT00204152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186462|NCT00204191|Tacrolimus|tacrolimus|mesh-list
20367636|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
20367637|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367638|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20367639|NCT03913559|Analgesics|analgesics|mesh-ancestor
20367640|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
19307058|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
20186463|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307059|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186464|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
20367641|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367642|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
20367643|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367644|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
20367645|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
20367646|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367647|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
20367648|NCT03913559|Hormones|hormones|mesh-ancestor
20367649|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367650|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20367651|NCT03913559|Protective Agents|protective agents|mesh-ancestor
20367652|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367653|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20367654|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20186465|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186466|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19307063|NCT04133337|Apatinib|apatinib|mesh-list
19307064|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307065|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20186467|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186468|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217330|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20367655|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367656|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
20367657|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
20367658|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20367659|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
20367660|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
20367661|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20367662|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20367663|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
20367664|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367665|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20367666|NCT03908437|Buprenorphine|buprenorphine|mesh-list
19307066|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307067|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307068|NCT04133506|Aspirin|aspirin|mesh-list
19307069|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307070|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307071|NCT04133506|Analgesics|analgesics|mesh-ancestor
20367667|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20367668|NCT03908437|Naloxone|naloxone|mesh-list
20367669|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20367670|NCT03908437|Narcotics|narcotics|mesh-ancestor
19307072|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
19307073|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307074|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307075|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307076|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307077|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19307078|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19307079|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307080|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19307081|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19307082|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672715|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
20217331|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367671|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367672|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367673|NCT03908437|Analgesics|analgesics|mesh-ancestor
20367674|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
20217332|NCT00309413|Cannabidiol|cannabidiol|mesh-list
20217333|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
20217334|NCT00309478|Tamoxifen|tamoxifen|mesh-list
20217335|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
20217336|NCT00309478|Fluorouracil|fluorouracil|mesh-list
20217337|NCT00309478|Methotrexate|methotrexate|mesh-list
20217338|NCT00309478|Goserelin|goserelin|mesh-list
20217339|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367675|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307083|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
19672716|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
19672717|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
19672718|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
19307084|NCT04133194|Mesalamine|mesalamine|mesh-list
19307085|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307086|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307087|NCT04133194|Analgesics|analgesics|mesh-ancestor
19307088|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
20367676|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20367677|NCT03891446|Bimatoprost|bimatoprost|mesh-list
20367678|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19307089|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307090|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307091|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307092|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307093|NCT04133259|Tenofovir|tenofovir|mesh-list
19307094|NCT04133259|Entecavir|entecavir|mesh-list
19307095|NCT04133259|Antibodies|antibodies|mesh-list
19307096|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19307097|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
19307098|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307099|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
19307100|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307101|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19307102|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19307103|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307104|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307105|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19307106|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19307107|NCT04133480|Cannabidiol|cannabidiol|mesh-list
19307108|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
19307109|NCT04133051|Bupivacaine|bupivacaine|mesh-list
19307110|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
19307111|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
19307112|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367679|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
20367680|NCT03867383|Calcium|calcium|mesh-list
20367681|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20367682|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367683|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20367684|NCT03866499|Gefitinib|gefitinib|mesh-list
20367685|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367686|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367687|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367688|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367689|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
20367690|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367691|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307113|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307114|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
19307115|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396752|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396753|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19396754|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19396755|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396756|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396757|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396758|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19396759|NCT03656783|Tenofovir|tenofovir|mesh-list
19396760|NCT03656783|Emtricitabine|emtricitabine|mesh-list
19396761|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19396762|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
19396763|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396764|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19396765|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19396766|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396767|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396768|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20367692|NCT03824561|Vedolizumab|vedolizumab|mesh-list
20367693|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367694|NCT03776071|Temozolomide|temozolomide|mesh-list
20367695|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20367696|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
20367697|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367698|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396769|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20367699|NCT03741101|Trametinib|trametinib|mesh-list
19396770|NCT03656679|Iodine|iodine|mesh-list
20367700|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307116|NCT04132583|Diclofenac|diclofenac|mesh-list
19307117|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307118|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307119|NCT04132583|Analgesics|analgesics|mesh-ancestor
19307120|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
19307121|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307122|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307123|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307124|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307125|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19307126|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307127|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307128|NCT04132479|Amoxicillin|amoxicillin|mesh-list
19307129|NCT04132479|Clarithromycin|clarithromycin|mesh-list
19307130|NCT04132479|Tinidazole|tinidazole|mesh-list
19307131|NCT04132479|Rabeprazole|rabeprazole|mesh-list
19307132|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19307133|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307134|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19307135|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307136|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307137|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19307138|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19307139|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19307140|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19307141|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19307142|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
19307143|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19307144|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19307145|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19307146|NCT04132674|Tenofovir|tenofovir|mesh-list
20367701|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367702|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367703|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367704|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
20367705|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20367706|NCT03641547|Capecitabine|capecitabine|mesh-list
20367707|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367708|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307147|NCT04132674|Emtricitabine|emtricitabine|mesh-list
19672719|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672720|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672721|NCT05121233|Diclofenac|diclofenac|mesh-list
19672722|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19672723|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19672724|NCT05121233|Analgesics|analgesics|mesh-ancestor
19672725|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
19672726|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672727|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672728|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672729|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672730|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19672731|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672732|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367709|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
20367710|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367711|NCT03581240|Eflornithine|eflornithine|mesh-list
20367712|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367713|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20367714|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19307148|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19307149|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
19307150|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307151|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19307152|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19307153|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307154|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307155|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19307156|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19307157|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
19307158|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
19307159|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19307160|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19307161|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367715|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19307162|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307163|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307164|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307165|NCT04132713|Capecitabine|capecitabine|mesh-list
19307166|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307167|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
19307168|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307169|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307170|NCT04132635|Mitogens|mitogens|mesh-list
19307171|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
19307172|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307173|NCT04132648|Curcumin|curcumin|mesh-list
19307174|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307175|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307176|NCT04132648|Analgesics|analgesics|mesh-ancestor
19307177|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
19307178|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307179|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307180|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307181|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367716|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367717|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20367718|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367719|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367720|NCT03549715|Durvalumab|durvalumab|mesh-list
20367721|NCT03549715|Tremelimumab|tremelimumab|mesh-list
20367722|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367723|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367724|NCT03466411|Ustekinumab|ustekinumab|mesh-list
20367725|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20367726|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
20367727|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
19307182|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307183|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307184|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307185|NCT04132570|Budesonide|budesonide|mesh-list
19307186|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307187|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19307188|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
19307189|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307190|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307191|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19307192|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
19307193|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
19307194|NCT04132570|Hormones|hormones|mesh-ancestor
19307195|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307196|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
19307197|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19307198|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
19307199|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19307200|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307201|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19307202|NCT04132557|Methylphenidate|methylphenidate|mesh-list
19307203|NCT04132557|Amphetamine|amphetamine|mesh-list
19307204|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19307205|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
19307206|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19307207|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19307208|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307209|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19307210|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19307211|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19307212|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307213|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
19307214|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307215|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19307216|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
19307217|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
19307218|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
19307219|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307220|NCT04132063|Levetiracetam|levetiracetam|mesh-list
20367728|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367729|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
19307221|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
19307222|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
19307223|NCT04132115|Vancomycin|vancomycin|mesh-list
20367730|NCT03449758|Chloroquine|chloroquine|mesh-list
20367731|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
20367732|NCT03449758|Methotrexate|methotrexate|mesh-list
20367733|NCT03449758|Azathioprine|azathioprine|mesh-list
20367734|NCT03449758|Leflunomide|leflunomide|mesh-list
19307224|NCT04132115|Gentamicins|gentamicins|mesh-list
19307225|NCT04132115|Meropenem|meropenem|mesh-list
19307226|NCT04132115|Tazobactam|tazobactam|mesh-list
19307227|NCT04132115|Linezolid|linezolid|mesh-list
19307228|NCT04132115|Piperacillin|piperacillin|mesh-list
19307229|NCT04132115|Daptomycin|daptomycin|mesh-list
19307230|NCT04132115|Amikacin|amikacin|mesh-list
19307231|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19307232|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
19307233|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19307234|NCT04132115|Acyclovir|acyclovir|mesh-list
19307235|NCT04132115|Ganciclovir|ganciclovir|mesh-list
19307236|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19307237|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307238|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19307239|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307240|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307241|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19307242|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
19307243|NCT04132011|Morphine|morphine|mesh-list
19307244|NCT04132011|Oxycodone|oxycodone|mesh-list
19307245|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
19307246|NCT04132011|Hydromorphone|hydromorphone|mesh-list
19307247|NCT04132011|Narcotics|narcotics|mesh-ancestor
19307248|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307249|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307250|NCT04132011|Analgesics|analgesics|mesh-ancestor
19307251|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
19307252|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367735|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20367736|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
20367737|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20367738|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367739|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307253|NCT04132102|Afatinib|afatinib|mesh-list
19307254|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307255|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307256|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307257|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307258|NCT04131829|Fluoxetine|fluoxetine|mesh-list
19307259|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19307260|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19307261|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19307262|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307263|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307264|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
19307265|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307266|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19307267|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
19307268|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19307269|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19307270|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19307271|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307272|NCT04131621|Nivolumab|nivolumab|mesh-list
19307273|NCT04131621|Ipilimumab|ipilimumab|mesh-list
19307274|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20186469|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
20186470|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186471|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186472|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20186473|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
20186474|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186475|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186476|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367740|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
19307275|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307276|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19307277|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217340|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
20367741|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307278|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
19307279|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19307280|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20367742|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367743|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
20367744|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367745|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20367746|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367747|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
20367748|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367749|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20367750|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
20367751|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20367752|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19307281|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19307282|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19307283|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307284|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
19307285|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307286|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307287|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19307288|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307289|NCT04131582|Metformin|metformin|mesh-list
19307290|NCT04131582|Empagliflozin|empagliflozin|mesh-list
19307291|NCT04131582|Linagliptin|linagliptin|mesh-list
19307292|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19307293|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307294|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19307295|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307296|NCT04131582|Incretins|incretins|mesh-ancestor
19307297|NCT04131582|Hormones|hormones|mesh-ancestor
19307298|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307299|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19307300|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
19307301|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307302|NCT04131283|Epinephrine|epinephrine|mesh-list
19307303|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19307304|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19307305|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
19307306|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307307|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307308|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307309|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19307310|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19307311|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
19307312|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307313|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19307314|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
19307315|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
19307316|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
19307317|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19307318|NCT04131309|Dexamethasone|dexamethasone|mesh-list
19307319|NCT04131309|Bortezomib|bortezomib|mesh-list
19307320|NCT04131309|Daratumumab|daratumumab|mesh-list
20367753|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367754|NCT03449758|Amebicides|amebicides|mesh-ancestor
20367755|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20367756|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20367757|NCT03449758|Analgesics|analgesics|mesh-ancestor
20367758|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
20367759|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307321|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307322|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
19307323|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
19307324|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307325|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307326|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19307327|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
19307328|NCT04131309|Hormones|hormones|mesh-ancestor
19307329|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307330|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19307331|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367760|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425639|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19307332|NCT04131231|Aldesleukin|aldesleukin|mesh-list
19307333|NCT04131231|Methotrexate|methotrexate|mesh-list
19307334|NCT04131231|Interleukin-2|interleukin-2|mesh-list
19307335|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19307336|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
19307337|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19307338|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307339|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307340|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
19307341|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307342|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307343|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
19307344|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307345|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19307346|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307347|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
19307348|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307349|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19307350|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307351|NCT04131231|Analgesics|analgesics|mesh-ancestor
19307352|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
19307353|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307354|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19307355|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19307356|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
19307357|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307358|NCT04131322|Adalimumab|adalimumab|mesh-list
19307359|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19307360|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307361|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307362|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19307363|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19307364|NCT04130698|Nicotine|nicotine|mesh-list
19307365|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19307366|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
19307367|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307368|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307369|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19307370|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19307371|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
19307372|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307373|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307374|NCT04130815|Furosemide|furosemide|mesh-list
19307375|NCT04130815|Diuretics|diuretics|mesh-ancestor
19307376|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
19307377|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307378|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19307379|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19307380|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307381|NCT04130672|Hemostatics|hemostatics|mesh-list
19307382|NCT04130672|Coagulants|coagulants|mesh-ancestor
19396771|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19396772|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396773|NCT03656679|Trace Elements|trace elements|mesh-ancestor
19396774|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
19396775|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396776|NCT03656666|Thalidomide|thalidomide|mesh-list
19396777|NCT03656666|Apremilast|apremilast|mesh-list
19396778|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19396779|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396780|NCT03656666|Analgesics|analgesics|mesh-ancestor
19396781|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
19396782|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396783|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396784|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19396785|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396786|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19396787|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19396788|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396789|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396790|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19396791|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
19396792|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
19396793|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396794|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396795|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20367761|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19307383|NCT04130464|Ketorolac|ketorolac|mesh-list
19307384|NCT04130464|Ropivacaine|ropivacaine|mesh-list
19307385|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
19307386|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
19307387|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307388|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307389|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
19307390|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186477|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186478|NCT00204243|Naltrexone|naltrexone|mesh-list
20186479|NCT00204243|Methadone|methadone|mesh-list
20186480|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20186481|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20186482|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186483|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
20186484|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307391|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307392|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307393|NCT04130464|Analgesics|analgesics|mesh-ancestor
19307394|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307395|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307396|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19307397|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307398|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307399|NCT04130399|Folfirinox|folfirinox|mesh-list
19307400|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307401|NCT04130438|Nebivolol|nebivolol|mesh-list
19307402|NCT04130438|Diltiazem|diltiazem|mesh-list
19307403|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19307404|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
19307405|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19307406|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19307407|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19307408|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
19307409|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307410|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307411|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186485|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20186486|NCT00204243|Narcotics|narcotics|mesh-ancestor
20186487|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186488|NCT00204243|Analgesics|analgesics|mesh-ancestor
20186489|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
20186490|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
20186491|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20186492|NCT00204256|Hematinics|hematinics|mesh-ancestor
20186493|NCT00204269|Testosterone|testosterone|mesh-list
20186494|NCT00204269|Androgens|androgens|mesh-ancestor
20186495|NCT00204269|Hormones|hormones|mesh-ancestor
20186496|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186497|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186498|NCT00204308|Tenofovir|tenofovir|mesh-list
20186499|NCT00204308|Emtricitabine|emtricitabine|mesh-list
20186500|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
20186501|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186502|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20186503|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20186504|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186505|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186506|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20186507|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20186508|NCT00204321|Sirolimus|sirolimus|mesh-list
20186509|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186510|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186511|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186512|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186513|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
20186514|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186515|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
20186516|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186517|NCT00204347|Risperidone|risperidone|mesh-list
20186518|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19307412|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19307413|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20186519|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
20186520|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307414|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19307415|NCT04130477|Nickel|nickel|mesh-list
19307416|NCT04130477|Trace Elements|trace elements|mesh-ancestor
19307417|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
19307418|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307419|NCT04130230|Choline|choline|mesh-list
19307420|NCT04130230|Neostigmine|neostigmine|mesh-list
19307421|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
19307422|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19307423|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
19307424|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307425|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19307426|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19307427|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
19307428|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19307429|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307430|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
19307431|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307432|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307433|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19307434|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
19307435|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307436|NCT04130152|Letrozole|letrozole|mesh-list
19307437|NCT04130152|Palbociclib|palbociclib|mesh-list
19307438|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307439|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19307440|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19307441|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307442|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307443|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19307444|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
19307445|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307446|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307447|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307448|NCT04130087|Selegiline|selegiline|mesh-list
19307449|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
19307450|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19307451|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19307452|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19307453|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19307454|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307455|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307456|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19307457|NCT04130087|Protective Agents|protective agents|mesh-ancestor
19307458|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186521|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186522|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186523|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186524|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19307459|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
19307460|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19307461|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
19307462|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307463|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
19307464|NCT04130100|Protective Agents|protective agents|mesh-ancestor
19307465|NCT04129697|Dexamethasone|dexamethasone|mesh-list
19307466|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
19307467|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19307468|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19307469|NCT04129697|Prednisolone|prednisolone|mesh-list
19307470|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
19307471|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19307472|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
19307473|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307474|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
19307475|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
19307476|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307477|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307478|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186525|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186526|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186527|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20186528|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
20186529|NCT00204386|Topiramate|topiramate|mesh-list
20186530|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
19307479|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
19307480|NCT04129697|Hormones|hormones|mesh-ancestor
19307481|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307482|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20367762|NCT03387761|Nivolumab|nivolumab|mesh-list
19307483|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307484|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19307485|NCT04129697|Protective Agents|protective agents|mesh-ancestor
19838666|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19838667|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
20367763|NCT03387761|Ipilimumab|ipilimumab|mesh-list
19307486|NCT04129736|Teriflunomide|teriflunomide|mesh-list
19307487|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307488|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307489|NCT04129736|Analgesics|analgesics|mesh-ancestor
19307490|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
19307491|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367764|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367765|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367766|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20367767|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367768|NCT03284502|Cetuximab|cetuximab|mesh-list
20367769|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367770|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367771|NCT03282799|Etonogestrel|etonogestrel|mesh-list
20367772|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20367773|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
20367774|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20367775|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367776|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20367777|NCT03280030|Midostaurin|midostaurin|mesh-list
20367778|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367779|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307492|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307493|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307494|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307495|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307496|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
19307497|NCT04129710|Rituximab|rituximab|mesh-list
19307498|NCT04129710|Methotrexate|methotrexate|mesh-list
20367780|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367781|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367782|NCT03246347|Docetaxel|docetaxel|mesh-list
20367783|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367784|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
20367785|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367786|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
20367787|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367788|NCT03187262|Daratumumab|daratumumab|mesh-list
20367789|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367790|NCT03047070|Lidocaine|lidocaine|mesh-list
19307499|NCT04129710|Etoposide|etoposide|mesh-list
19307500|NCT04129710|Lenalidomide|lenalidomide|mesh-list
19307501|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307502|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307503|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
19307504|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672733|NCT05120960|Osimertinib|osimertinib|mesh-list
19672734|NCT05120960|Tepotinib|tepotinib|mesh-list
19672735|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672736|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19672737|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367791|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
20367792|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
20367793|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20367794|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367795|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
20367796|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367797|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19672738|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672739|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19672740|NCT05120934|Amitriptyline|amitriptyline|mesh-list
19672741|NCT05120934|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19672742|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19672743|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19838668|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
20367798|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20367799|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20367800|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20367801|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367802|NCT03040778|Vitamin E|vitamin e|mesh-list
20367803|NCT03040778|Tocopherols|tocopherols|mesh-list
20367804|NCT03040778|Tocotrienols|tocotrienols|mesh-list
20367805|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
20367806|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
20367807|NCT03040778|Vitamins|vitamins|mesh-ancestor
20367808|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
20367809|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367810|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
20367811|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367812|NCT03040778|Protective Agents|protective agents|mesh-ancestor
20367813|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20367814|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367815|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20367816|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20367817|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
20367818|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20367819|NCT03032328|Vitamin D|vitamin d|mesh-list
20367820|NCT03032328|Vitamins|vitamins|mesh-ancestor
20367821|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
20367822|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367823|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20367824|NCT03024684|Atorvastatin|atorvastatin|mesh-list
20367825|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20367826|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20367827|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
20367828|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367829|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20367830|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20367831|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367832|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
20367833|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367834|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307505|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307506|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19307507|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
19307508|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19838669|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838670|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838671|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307509|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307510|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
19307511|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307512|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
19307513|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307514|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19307515|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307516|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19307517|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19307518|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19307519|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19307520|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19307521|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19307522|NCT04129710|Growth Substances|growth substances|mesh-ancestor
19307523|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
19307524|NCT04129424|Insulin|insulin|mesh-list
19307525|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19307526|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307527|NCT04129255|Octreotide|octreotide|mesh-list
19307528|NCT04129255|Somatostatin|somatostatin|mesh-list
19838672|NCT00621985|Dexamethasone|dexamethasone|mesh-list
19838673|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
20186531|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20186532|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186533|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20186534|NCT00204438|Desogestrel|desogestrel|mesh-list
20186535|NCT00204438|Estradiol|estradiol|mesh-list
20186536|NCT00204438|Estrogens|estrogens|mesh-ancestor
20186537|NCT00204438|Hormones|hormones|mesh-ancestor
20186538|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186539|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367835|NCT03000439|Tofacitinib|tofacitinib|mesh-list
20367836|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367837|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367838|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367839|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
20367840|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20367841|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
20367842|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20367843|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367844|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20367845|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20367846|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20367847|NCT02968108|Ustekinumab|ustekinumab|mesh-list
20367848|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
20367849|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20367850|NCT02942095|Ixazomib|ixazomib|mesh-list
20367851|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367852|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367853|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367854|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367855|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
20367856|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20367857|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20367858|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20367859|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
20367860|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612737|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307529|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19307530|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19307531|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307532|NCT04129255|Hormones|hormones|mesh-ancestor
19307533|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307534|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307535|NCT04129489|Cannabidiol|cannabidiol|mesh-list
19307536|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
19307537|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
19307538|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307539|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307540|NCT04128891|Valsartan|valsartan|mesh-list
19307541|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19307542|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19307543|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19307544|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19307545|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307546|NCT04128787|Omeprazole|omeprazole|mesh-list
19307547|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19307548|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19307549|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19307550|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307551|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307552|NCT04128800|Apatinib|apatinib|mesh-list
19307553|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307554|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307555|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307556|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307557|NCT04129008|Aspirin|aspirin|mesh-list
19307558|NCT04129008|Indobufen|indobufen|mesh-list
19307559|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307560|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307561|NCT04129008|Analgesics|analgesics|mesh-ancestor
19307562|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
19307563|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307564|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307565|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307566|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307567|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19307568|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19307569|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307570|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19307571|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19307572|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307573|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
19307574|NCT04129112|Propofol|propofol|mesh-list
19307575|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
19307576|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307577|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307578|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19307579|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19307580|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
19307581|NCT04128878|Sotalol|sotalol|mesh-list
19307582|NCT04128878|Dofetilide|dofetilide|mesh-list
19307583|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19307584|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19307585|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
19307586|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307587|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307588|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307589|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19307590|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
19307591|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
19307592|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307593|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19307594|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19307595|NCT04128748|Cytarabine|cytarabine|mesh-list
19307596|NCT04128748|Daunorubicin|daunorubicin|mesh-list
19307597|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307598|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
19307599|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307600|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307601|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
19307602|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307603|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307604|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
19307605|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307606|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19307607|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19307608|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19307609|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307610|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
19307611|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307612|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
19307613|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307614|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307615|NCT04128683|Bromocriptine|bromocriptine|mesh-list
19307616|NCT04128683|Amisulpride|amisulpride|mesh-list
19307617|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19307618|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19307619|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307620|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307621|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19307622|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19307623|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
20186540|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20186541|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
20186542|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20186543|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20186544|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20186545|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20186546|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20186547|NCT00204438|Progestins|progestins|mesh-ancestor
20186548|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
20186549|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20186550|NCT00204451|Estradiol|estradiol|mesh-list
20186551|NCT00204451|Estrogens|estrogens|mesh-ancestor
20186552|NCT00204451|Hormones|hormones|mesh-ancestor
20186553|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186554|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186555|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20186556|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
20186557|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20186558|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20186559|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20186560|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19307624|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307625|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307626|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19307627|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
19307628|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19307629|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19307630|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
19307631|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307632|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
19396796|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19396797|NCT03656666|Growth Substances|growth substances|mesh-ancestor
19396798|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
19396799|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396800|NCT03656627|Nivolumab|nivolumab|mesh-list
19396801|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367861|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367862|NCT02940522|Progestins|progestins|mesh-ancestor
20367863|NCT02940522|Hormones|hormones|mesh-ancestor
20367864|NCT02938923|Testosterone|testosterone|mesh-list
20367865|NCT02938923|Androgens|androgens|mesh-ancestor
20367866|NCT02938923|Hormones|hormones|mesh-ancestor
20367867|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367868|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367869|NCT02923739|Paclitaxel|paclitaxel|mesh-list
20367870|NCT02923739|Bevacizumab|bevacizumab|mesh-list
20367871|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20367872|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20367873|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
20367874|NCT02923739|Antibodies|antibodies|mesh-list
20367875|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
20367876|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20367877|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
20367878|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20367879|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672744|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19672745|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672746|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396802|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396803|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19396804|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396805|NCT03656614|Neostigmine|neostigmine|mesh-list
19396806|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19396807|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396808|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396809|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
19396810|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396811|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396812|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19396813|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
19396814|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396815|NCT03656588|Iodine|iodine|mesh-list
19396816|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
19396817|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19396818|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
19396819|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19396820|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19396821|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396822|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
19672747|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672748|NCT05120934|Analgesics|analgesics|mesh-ancestor
19672749|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
19672750|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672751|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
19672752|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19672753|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
20367880|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
19396823|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
19396824|NCT03656588|Trace Elements|trace elements|mesh-ancestor
19396825|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
19396826|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396827|NCT03656549|Pemetrexed|pemetrexed|mesh-list
19396828|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396829|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396830|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672754|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20367881|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367882|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
19396831|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20425640|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20367883|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186561|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20186562|NCT00204503|Valproic Acid|valproic acid|mesh-list
20186563|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
20186564|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186565|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186566|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
20186567|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186568|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367884|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20367885|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19307633|NCT04128254|Apixaban|apixaban|mesh-list
19307634|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19307635|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
19307636|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19307637|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
19307638|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307639|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307640|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
19307641|NCT04128540|Fentanyl|fentanyl|mesh-list
19307642|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20367886|NCT02923739|Growth Substances|growth substances|mesh-ancestor
20367887|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367888|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
20367889|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
20367890|NCT02913313|Nivolumab|nivolumab|mesh-list
19307643|NCT04128540|Narcotics|narcotics|mesh-ancestor
19307644|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307645|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307646|NCT04128540|Analgesics|analgesics|mesh-ancestor
19307647|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
19307648|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307649|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19307650|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19307651|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
19307652|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
20367891|NCT02913313|Ipilimumab|ipilimumab|mesh-list
20367892|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367893|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367894|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20367895|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367896|NCT02897778|Entinostat|entinostat|mesh-list
20367897|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367898|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20367899|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367900|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367901|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
20367902|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367903|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367904|NCT02879409|Insulin|insulin|mesh-list
20367905|NCT02879409|Metformin|metformin|mesh-list
20367906|NCT02879409|Pioglitazone|pioglitazone|mesh-list
20367907|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20367908|NCT02879409|Liraglutide|liraglutide|mesh-list
20367909|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
20367910|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20367911|NCT02879409|Gliclazide|gliclazide|mesh-list
20367912|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20367913|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367914|NCT02879409|Incretins|incretins|mesh-ancestor
20367915|NCT02879409|Hormones|hormones|mesh-ancestor
20367916|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20367917|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20367918|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
20367919|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367920|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367921|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20367922|NCT02826486|Leucovorin|leucovorin|mesh-list
20367923|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
20367924|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20367925|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367926|NCT02826486|Antidotes|antidotes|mesh-ancestor
20367927|NCT02826486|Protective Agents|protective agents|mesh-ancestor
19307653|NCT04128501|Azacitidine|azacitidine|mesh-list
19307654|NCT04128501|Venetoclax|venetoclax|mesh-list
20367928|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307655|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20367929|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
20367930|NCT02826486|Vitamins|vitamins|mesh-ancestor
19307656|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
19307657|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307658|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307659|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307660|NCT04128176|Omalizumab|omalizumab|mesh-list
19307661|NCT04128176|Rituximab|rituximab|mesh-list
19307662|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307663|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307664|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
19307665|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307666|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307667|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19307668|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19307669|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19307670|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
19307671|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307672|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
19307673|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307674|NCT04127747|Rituximab|rituximab|mesh-list
19307675|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307676|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307677|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
19307678|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307679|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307680|NCT04127851|Cyclosporine|cyclosporine|mesh-list
19307681|NCT04127851|Cyclosporins|cyclosporins|mesh-list
19307682|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307683|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307684|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307685|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
19307686|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307687|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
19307688|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307689|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
19307690|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307691|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19307692|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19307693|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186569|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
20186570|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186571|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186572|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186573|NCT00204529|Interferons|interferons|mesh-list
20186574|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
20186575|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
20186576|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20186577|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186578|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
20186579|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186580|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
20186581|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367931|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
20367932|NCT02815592|Carboplatin|carboplatin|mesh-list
20367933|NCT02815592|Etoposide|etoposide|mesh-list
19307694|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19307695|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
19307696|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307697|NCT04128020|Nivolumab|nivolumab|mesh-list
19307698|NCT04128020|Azacitidine|azacitidine|mesh-list
19307699|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307700|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307701|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19307702|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307703|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307704|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
19307705|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307706|NCT04127721|Methotrexate|methotrexate|mesh-list
19307707|NCT04127721|Fludarabine|fludarabine|mesh-list
19672755|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20186582|NCT00204542|Diclofenac|diclofenac|mesh-list
19307708|NCT04127721|Busulfan|busulfan|mesh-list
19307709|NCT04127721|Tacrolimus|tacrolimus|mesh-list
19307710|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20186583|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20367934|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307711|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
19307712|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19307713|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367935|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20367936|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20367937|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20367938|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367939|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367940|NCT02748707|Celecoxib|celecoxib|mesh-list
20367941|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20367942|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367943|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20367944|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367945|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367946|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20367947|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20367948|NCT02748707|Analgesics|analgesics|mesh-ancestor
20367949|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
20367950|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367951|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367952|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20367953|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367954|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20367955|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20367956|NCT02711137|Gemcitabine|gemcitabine|mesh-list
20367957|NCT02711137|Paclitaxel|paclitaxel|mesh-list
20367958|NCT02711137|Azacitidine|azacitidine|mesh-list
20367959|NCT02711137|Rucaparib|rucaparib|mesh-list
20367960|NCT02711137|INCB057643|incb057643|mesh-list
20367961|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20367962|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367963|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
20367964|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
20367965|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
20367966|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367967|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20367968|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
19307714|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307715|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
19307716|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307717|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307718|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19307719|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307720|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19307721|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307722|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
19307723|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20367969|NCT02711137|Antiviral Agents|antiviral agents|mesh-ancestor
20367970|NCT02711137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367971|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367972|NCT02711137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20367973|NCT02711137|Immunologic Factors|immunologic factors|mesh-ancestor
20367974|NCT02711137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367975|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20367976|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20367977|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20367978|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367979|NCT02679144|Eflornithine|eflornithine|mesh-list
20367980|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367981|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20367982|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20367983|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20367984|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20367985|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19307724|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19307725|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19307726|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
19307727|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19307728|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19307729|NCT04127396|Sorafenib|sorafenib|mesh-list
19307730|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
19307731|NCT04127396|Lenvatinib|lenvatinib|mesh-list
19307732|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20367986|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20367987|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367988|NCT02630459|Erenumab|erenumab|mesh-list
20367989|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20367990|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20367991|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20367992|NCT02630459|Analgesics|analgesics|mesh-ancestor
19307733|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307734|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307735|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307736|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19307737|NCT04127396|Estrogens|estrogens|mesh-ancestor
19307738|NCT04127396|Hormones|hormones|mesh-ancestor
19307739|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307740|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307741|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19307742|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
19307743|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19307744|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307745|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367993|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
20367994|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20367995|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20367996|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
20367997|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
20367998|NCT02630043|Tolcapone|tolcapone|mesh-list
20367999|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368000|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20368001|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20368002|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20368003|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368004|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307746|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307747|NCT04127500|Analgesics|analgesics|mesh-ancestor
19307748|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
19307749|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307750|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19307751|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19307752|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19307753|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
19307754|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307755|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368005|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
20368006|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368007|NCT02573324|Temozolomide|temozolomide|mesh-list
20368008|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
20368009|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368010|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
20368011|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368012|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307756|NCT04127357|Fluorides|fluorides|mesh-list
19307757|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
19307758|NCT04127357|Protective Agents|protective agents|mesh-ancestor
19307759|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307760|NCT04127084|Empagliflozin|empagliflozin|mesh-list
19307761|NCT04127084|Canagliflozin|canagliflozin|mesh-list
19307762|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19307763|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307764|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19307765|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307766|NCT04126941|Calcium|calcium|mesh-list
19307767|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19307768|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307769|NCT04127058|Iloperidone|iloperidone|mesh-list
19307770|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19307771|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19307772|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307773|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368013|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
20368014|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368015|NCT02559778|Eflornithine|eflornithine|mesh-list
20368016|NCT02559778|Sorafenib|sorafenib|mesh-list
20368017|NCT02559778|Dasatinib|dasatinib|mesh-list
20368018|NCT02559778|Vorinostat|vorinostat|mesh-list
19307774|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19307775|NCT04127019|Paclitaxel|paclitaxel|mesh-list
19307776|NCT04127019|Docetaxel|docetaxel|mesh-list
19307777|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
19307778|NCT04127019|Fluorouracil|fluorouracil|mesh-list
19307779|NCT04127019|Epirubicin|epirubicin|mesh-list
19307780|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19307781|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307782|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
19307783|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
19307784|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
19307785|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307786|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307787|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
19307788|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307789|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307790|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19307791|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
19307792|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19307793|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
19307794|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307795|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19307796|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19307797|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19307798|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307799|NCT04126993|Apatinib|apatinib|mesh-list
19307800|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307801|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307802|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368019|NCT02559778|Ceritinib|ceritinib|mesh-list
20368020|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307803|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368021|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20368022|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368023|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307804|NCT04127227|Gemcitabine|gemcitabine|mesh-list
19307805|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
19307806|NCT04127227|Pegaspargase|pegaspargase|mesh-list
19307807|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19307808|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
19307809|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307810|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307811|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
19307812|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307813|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307814|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307815|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
19307816|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307817|NCT04126811|Apatinib|apatinib|mesh-list
19307818|NCT04126811|Ifosfamide|ifosfamide|mesh-list
19307819|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
19307820|NCT04126811|Pirarubicin|pirarubicin|mesh-list
19307821|NCT04126811|Doxorubicin|doxorubicin|mesh-list
19307822|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307823|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307824|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307825|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307826|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19307827|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
19307828|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19307829|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19307830|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19307831|NCT04126668|Vorolanib|vorolanib|mesh-list
19307832|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307833|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307834|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396832|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19396833|NCT03656484|Metronidazole|metronidazole|mesh-list
19396834|NCT03656484|Tetracycline|tetracycline|mesh-list
19396835|NCT03656484|Melatonin|melatonin|mesh-list
19396836|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
19396837|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368024|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19396838|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396839|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19396840|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19396841|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
20368025|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20368026|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20368027|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20368028|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368029|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20368030|NCT02545868|Vaccines|vaccines|mesh-list
20368031|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
20368032|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307835|NCT04126681|Interferons|interferons|mesh-list
19307836|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
19307837|NCT04126681|Dasatinib|dasatinib|mesh-list
19307838|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
19307839|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
19307840|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307841|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
19307842|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307843|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19307844|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307845|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307846|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
19307847|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19307848|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19307849|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19307850|NCT04126330|Vitamin D|vitamin d|mesh-list
19307851|NCT04126330|Vitamins|vitamins|mesh-ancestor
19307852|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
19307853|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307854|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19307855|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19307856|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
19307857|NCT04126720|Vitamin E|vitamin e|mesh-list
19307858|NCT04126720|Vitamins|vitamins|mesh-ancestor
19307859|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
19307860|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307861|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
19307862|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307863|NCT04126720|Protective Agents|protective agents|mesh-ancestor
19307864|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19307865|NCT04126304|Azithromycin|azithromycin|mesh-list
19307866|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307867|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
19307868|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307869|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
19307870|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19307871|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19307872|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307873|NCT04126252|Urological Agents|urological agents|mesh-ancestor
19307874|NCT04126044|Bevacizumab|bevacizumab|mesh-list
19307875|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307876|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307877|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19307878|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19307879|NCT04126044|Growth Substances|growth substances|mesh-ancestor
19307880|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307881|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
19307882|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19307883|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19307884|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186584|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20186585|NCT00204542|Analgesics|analgesics|mesh-ancestor
20186586|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
20186587|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186588|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186589|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186590|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186591|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20368033|NCT02520154|Paclitaxel|paclitaxel|mesh-list
20368034|NCT02520154|Carboplatin|carboplatin|mesh-list
20368035|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
20368036|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19307885|NCT04125719|Nivolumab|nivolumab|mesh-list
20186592|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186593|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368037|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19307886|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307887|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368038|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368039|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
20368040|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368041|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
20368042|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368043|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368044|NCT02507687|Bimatoprost|bimatoprost|mesh-list
20368045|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20368046|NCT02505984|Oxytocin|oxytocin|mesh-list
20368047|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
19307888|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19307889|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307890|NCT04125706|Metronidazole|metronidazole|mesh-list
19307891|NCT04125706|Minocycline|minocycline|mesh-list
19307892|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307893|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19307894|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19307895|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19307896|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19307897|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19307898|NCT04125082|Insulin|insulin|mesh-list
19307899|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19307900|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19307901|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307902|NCT04124991|Durvalumab|durvalumab|mesh-list
19307903|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19307904|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307905|NCT04125121|Propofol|propofol|mesh-list
19307906|NCT04125121|Sevoflurane|sevoflurane|mesh-list
19307907|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19307908|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19307909|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307910|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19307911|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
19307912|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
19307913|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19307914|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20368048|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20368049|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368050|NCT02470091|Denosumab|denosumab|mesh-list
20368051|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20368052|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368053|NCT02465138|Ketorolac|ketorolac|mesh-list
20368054|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20368055|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20368056|NCT02465138|Analgesics|analgesics|mesh-ancestor
20368057|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
20368058|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368059|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368060|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368061|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307915|NCT04124822|Prednisolone|prednisolone|mesh-list
19307916|NCT04124822|Piroxicam|piroxicam|mesh-list
19307917|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19307918|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
19307919|NCT04124822|Hormones|hormones|mesh-ancestor
19307920|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307921|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307922|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19307923|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307924|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307925|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19307926|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19307927|NCT04124822|Analgesics|analgesics|mesh-ancestor
20368062|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20368063|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368064|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368065|NCT02440425|Paclitaxel|paclitaxel|mesh-list
20368066|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
20368067|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20368068|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368069|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
20368070|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368071|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
19307928|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
19307929|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19307930|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19672756|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19672757|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
19672758|NCT05120934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19307931|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307932|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307933|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
19307934|NCT04124887|Listerine|listerine|mesh-list
19307935|NCT04124887|Calcium|calcium|mesh-list
19307936|NCT04124887|Fluorides|fluorides|mesh-list
20186594|NCT00204555|Imiquimod|imiquimod|mesh-list
20186595|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20186596|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
20186597|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186598|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186599|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
20186600|NCT00204568|Doxorubicin|doxorubicin|mesh-list
20186601|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20186602|NCT00204568|Trofosfamide|trofosfamide|mesh-list
19307937|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
19307938|NCT04124887|Caseins|caseins|mesh-list
19307939|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19307940|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307941|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19307942|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
19307943|NCT04124887|Protective Agents|protective agents|mesh-ancestor
19307944|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19307945|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19307946|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
19307947|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
19307948|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307949|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19307950|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19307951|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19307952|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307953|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307954|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19307955|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19307956|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307957|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
19307958|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19307959|NCT04124913|Progesterone|progesterone|mesh-list
19307960|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
19307961|NCT04124913|Progestins|progestins|mesh-ancestor
19307962|NCT04124913|Hormones|hormones|mesh-ancestor
19307963|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19307964|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307965|NCT04124926|Lansoprazole|lansoprazole|mesh-list
19307966|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
19307967|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19307968|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19307969|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19307970|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19307971|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19307972|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
19307973|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19307974|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
19307975|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307976|NCT04124757|Rocuronium|rocuronium|mesh-list
19307977|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19307978|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20186603|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186604|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19307979|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19307980|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19307981|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307982|NCT04124198|Nimorazole|nimorazole|mesh-list
19307983|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19307984|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19307985|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19307986|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396842|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396843|NCT03656484|Protective Agents|protective agents|mesh-ancestor
19672759|NCT05120934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186605|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20186606|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19307987|NCT04124302|Insulin|insulin|mesh-list
19307988|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19307989|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
19307990|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
19307991|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
19307992|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19307993|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307994|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
19307995|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19307996|NCT04124367|Protective Agents|protective agents|mesh-ancestor
19307997|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19307998|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
19307999|NCT04124432|Nicotine|nicotine|mesh-list
19308000|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19308001|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
19308002|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308003|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308004|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19308005|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19308006|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
19308007|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308008|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308009|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20368072|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368073|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368074|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
20368075|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368076|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20368077|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672760|NCT05120934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672761|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19672762|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
19672763|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
19672764|NCT05114720|Docetaxel|docetaxel|mesh-list
19672765|NCT05114720|Doxorubicin|doxorubicin|mesh-list
19672766|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19672767|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20368078|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368079|NCT02304458|Nivolumab|nivolumab|mesh-list
20368080|NCT02304458|Ipilimumab|ipilimumab|mesh-list
19308010|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19308011|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19308012|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
19308013|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308014|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19308015|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19308016|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308017|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
19308018|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19308019|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308020|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
19308021|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368081|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368082|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368083|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20368084|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308022|NCT04124016|Protective Agents|protective agents|mesh-ancestor
19308023|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308024|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19308025|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19308026|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308027|NCT04124094|Fluticasone|fluticasone|mesh-list
19308028|NCT04124094|Xhance|xhance|mesh-list
19308029|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19308030|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19308031|NCT04124094|Charcoal|charcoal|mesh-list
19308032|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308033|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19308034|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
19308035|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308036|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308037|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19672768|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368085|NCT02296684|Cisplatin|cisplatin|mesh-list
19308038|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
19308039|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308040|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19308041|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19308042|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19308043|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19308044|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
19308045|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308046|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308047|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
19308048|NCT04124094|Hormones|hormones|mesh-ancestor
19308049|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308050|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
19308051|NCT04124094|Antidotes|antidotes|mesh-ancestor
19308052|NCT04124094|Protective Agents|protective agents|mesh-ancestor
19308053|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19308054|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19308055|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308056|NCT04124081|Entecavir|entecavir|mesh-list
19308057|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
19308058|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308059|NCT04123925|Nivolumab|nivolumab|mesh-list
19308060|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19308061|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308062|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19308063|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308064|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19308065|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308066|NCT04123717|Acetaminophen|acetaminophen|mesh-list
19308067|NCT04123717|Ibuprofen|ibuprofen|mesh-list
19308068|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308069|NCT04123717|Analgesics|analgesics|mesh-ancestor
19308070|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
19308071|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308072|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308073|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
19308074|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19308075|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308076|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308077|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19308078|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308079|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308080|NCT04123652|Lidocaine|lidocaine|mesh-list
19308081|NCT04123652|Ketamine|ketamine|mesh-list
19308082|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
19308083|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
19308084|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308085|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308086|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
19308087|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308088|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19308089|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19308090|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19308091|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19308092|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308093|NCT04123652|Analgesics|analgesics|mesh-ancestor
19308094|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19308095|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19308096|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
19308097|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19308098|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19308099|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308100|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
19308101|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19308102|NCT04123743|Protective Agents|protective agents|mesh-ancestor
19308103|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308104|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308105|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
19308106|NCT04123392|Busulfan|busulfan|mesh-list
19308107|NCT04123392|Decitabine|decitabine|mesh-list
19308108|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308109|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
19308110|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308111|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308112|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19308113|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
19308114|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308115|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308116|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19308117|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308118|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
19308119|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308120|NCT04123288|ACT-709478|act-709478|mesh-list
19308121|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19308122|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19308123|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308124|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19308125|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308126|NCT04123210|Vitamin A|vitamin a|mesh-list
19308127|NCT04123210|Vitamins|vitamins|mesh-ancestor
19308128|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
19308129|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308130|NCT04123041|Nicotine|nicotine|mesh-list
19308131|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19308132|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
19308133|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308134|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308135|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19308136|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19308137|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
19308138|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308139|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308140|NCT04123249|Propofol|propofol|mesh-list
19308141|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19308142|NCT04123249|Sevoflurane|sevoflurane|mesh-list
19308143|NCT04123249|Anesthetics|anesthetics|mesh-list
19308144|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19308145|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308146|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308147|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
19308148|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19308149|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19308150|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
19308151|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308152|NCT04122911|Temozolomide|temozolomide|mesh-list
19308153|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19308154|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
19308155|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308156|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308157|NCT04122599|Melatonin|melatonin|mesh-list
19308158|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
19308159|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308160|NCT04122599|Protective Agents|protective agents|mesh-ancestor
19308161|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308162|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308163|NCT04122716|Liraglutide|liraglutide|mesh-list
19308164|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368086|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
20368087|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368088|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368089|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
20368090|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20368091|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368092|NCT02139397|Eflornithine|eflornithine|mesh-list
20368093|NCT02139397|Bortezomib|bortezomib|mesh-list
20368094|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368095|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20368096|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20368097|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20368098|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368099|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20368100|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368101|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368102|NCT02066415|Erenumab|erenumab|mesh-list
20368103|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20368104|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368105|NCT02066415|Analgesics|analgesics|mesh-ancestor
19404348|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
19672769|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
20368106|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
19308165|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308166|NCT04122716|Incretins|incretins|mesh-ancestor
19308167|NCT04122716|Hormones|hormones|mesh-ancestor
19308168|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308169|NCT04122560|Fluconazole|fluconazole|mesh-list
19308170|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
19308171|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308172|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19308173|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19308174|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308175|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308176|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19308177|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
19308178|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308179|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308180|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19308181|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19396844|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396845|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396846|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19396847|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
19396848|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
19396849|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19396850|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396851|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
19396852|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19396853|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19396854|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396855|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
19396856|NCT03656445|Coagulants|coagulants|mesh-ancestor
19396857|NCT03656432|Fluorides|fluorides|mesh-list
19396858|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
19396859|NCT03656432|Protective Agents|protective agents|mesh-ancestor
19396860|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396861|NCT03656393|Carboplatin|carboplatin|mesh-list
19396862|NCT03656393|Vinorelbine|vinorelbine|mesh-list
19396863|NCT03656393|Gefitinib|gefitinib|mesh-list
19396864|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396865|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19396866|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
19396867|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
19396868|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
19396869|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396870|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19396871|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396872|NCT03656289|Etonogestrel|etonogestrel|mesh-list
19396873|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19396874|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
19396875|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19396876|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396877|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19396878|NCT03656094|Docetaxel|docetaxel|mesh-list
19396879|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
19396880|NCT03656094|Pemetrexed|pemetrexed|mesh-list
19396881|NCT03656094|Vinorelbine|vinorelbine|mesh-list
19396882|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186607|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186608|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368107|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368108|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368109|NCT02008292|Physostigmine|physostigmine|mesh-list
20368110|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20368111|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368112|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368113|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
20186609|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186610|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
20186611|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186612|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20186613|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
20186614|NCT00204581|Aldesleukin|aldesleukin|mesh-list
20186615|NCT00204581|Interleukin-2|interleukin-2|mesh-list
19396883|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
19396884|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
19308182|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
19308183|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
19308184|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308185|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
19308186|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
19308187|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19308188|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19308189|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308190|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308191|NCT04122105|Urological Agents|urological agents|mesh-ancestor
19308192|NCT04122222|Vaccines|vaccines|mesh-list
19308193|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
19308194|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308195|NCT04121975|Endostar protein|endostar protein|mesh-list
19308196|NCT04121975|Endostatins|endostatins|mesh-list
19308197|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308198|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19308199|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19308200|NCT04121975|Growth Substances|growth substances|mesh-ancestor
19308201|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308202|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19308203|NCT04122040|Roxithromycin|roxithromycin|mesh-list
19308204|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308205|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308206|NCT04121910|Itraconazole|itraconazole|mesh-list
19308207|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
19308208|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308209|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19308210|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19308211|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308212|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308213|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19308214|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
19308215|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308216|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308217|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19308218|NCT04121767|Warfarin|warfarin|mesh-list
19308219|NCT04121767|Edoxaban|edoxaban|mesh-list
19308220|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
19308221|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19308222|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
19308223|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19308224|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
19308225|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308226|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308227|NCT04121689|Caseins|caseins|mesh-list
19308228|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
19308229|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
19308230|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308231|NCT04121611|Aspirin|aspirin|mesh-list
19308232|NCT04121611|Heparin|heparin|mesh-list
19308233|NCT04121611|Calcium heparin|calcium heparin|mesh-list
19308234|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
19308235|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19308236|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20186616|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186617|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20186618|NCT00204581|Analgesics|analgesics|mesh-ancestor
20186619|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
20186620|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186621|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186622|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20186623|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20186624|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
20186625|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186626|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20186627|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20186628|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
20186629|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186630|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186631|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
20186632|NCT00204633|Hematinics|hematinics|mesh-ancestor
19308237|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396885|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
20186633|NCT00204646|Carboplatin|carboplatin|mesh-list
19308238|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19308239|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308240|NCT04121611|Analgesics|analgesics|mesh-ancestor
19308241|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
19308242|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308243|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308244|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308245|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308246|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19308247|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19308248|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308249|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
19308250|NCT04121819|Cytarabine|cytarabine|mesh-list
19308251|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308252|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
19308253|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308254|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308255|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
20368114|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368115|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368116|NCT02008292|Miotics|miotics|mesh-ancestor
20368117|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
20368118|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368119|NCT01952574|Erenumab|erenumab|mesh-list
20368120|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20368121|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20368122|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368123|NCT01952574|Analgesics|analgesics|mesh-ancestor
20612738|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19308256|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308257|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308258|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
19308259|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308260|NCT04121780|Hormones|hormones|mesh-list
19308261|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308262|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308263|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
19308264|NCT04121507|Thiotepa|thiotepa|mesh-list
19308265|NCT04121507|Fludarabine|fludarabine|mesh-list
19308266|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308267|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
19308268|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308269|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308270|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19308271|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
19308272|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308273|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308274|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19308275|NCT04121533|Vitamin D|vitamin d|mesh-list
19308276|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
19308277|NCT04121533|Vitamins|vitamins|mesh-ancestor
19308278|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
19308279|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308280|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19308281|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19308282|NCT04121416|Sufentanil|sufentanil|mesh-list
19308283|NCT04121416|Oxycodone|oxycodone|mesh-list
19308284|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19308285|NCT04121416|Narcotics|narcotics|mesh-ancestor
19308286|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308287|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308288|NCT04121416|Analgesics|analgesics|mesh-ancestor
19308289|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
19672770|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186634|NCT00204646|Etoposide|etoposide|mesh-list
20186635|NCT00204646|Doxorubicin|doxorubicin|mesh-list
20186636|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20186637|NCT00204646|Ifosfamide|ifosfamide|mesh-list
20186638|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186639|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20186640|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20186641|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20186642|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186643|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368124|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
19308290|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308291|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19308292|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19308293|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
19308294|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
19308295|NCT04121039|Apatinib|apatinib|mesh-list
19308296|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308297|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19308298|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308299|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308300|NCT04121338|Bupivacaine|bupivacaine|mesh-list
19308301|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
19308302|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
19308303|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308304|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308305|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
19308306|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308307|NCT04121091|Pramipexole|pramipexole|mesh-list
19308308|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
19308309|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308310|NCT04121091|Protective Agents|protective agents|mesh-ancestor
19308311|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308312|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19308313|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19308314|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
19308315|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
19308316|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308317|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
19308318|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
19308319|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20368125|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368126|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368127|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
20368128|NCT01795586|Carboplatin|carboplatin|mesh-list
20368129|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368130|NCT01696734|Domperidone|domperidone|mesh-list
20368131|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
20368132|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
20368133|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368134|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368135|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20368136|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19308320|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19308321|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308322|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308323|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308324|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308325|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
19308326|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308327|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19308328|NCT04120987|Lifitegrast|lifitegrast|mesh-list
19308329|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19308330|NCT04120753|Amlodipine|amlodipine|mesh-list
19308331|NCT04120753|Olmesartan|olmesartan|mesh-list
19308332|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19308333|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19308334|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19308335|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308336|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19308337|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308338|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
20368137|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
20368138|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368139|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368140|NCT01659151|Aldesleukin|aldesleukin|mesh-list
20368141|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
20368142|NCT01659151|Fludarabine|fludarabine|mesh-list
20368143|NCT01659151|Interleukin-2|interleukin-2|mesh-list
20368144|NCT01659151|Vemurafenib|vemurafenib|mesh-list
20368145|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20368146|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308339|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20368147|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
19308340|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19308341|NCT04120974|Insulin|insulin|mesh-list
20368148|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368149|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368150|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368151|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
20368152|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368153|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368154|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20368155|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20368156|NCT01659151|Analgesics|analgesics|mesh-ancestor
20368157|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
20368158|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368159|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20368160|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20368161|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
19308342|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19308343|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368162|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368163|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20368164|NCT01590069|Aldesleukin|aldesleukin|mesh-list
20368165|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308344|NCT04120805|Hemostatics|hemostatics|mesh-list
19308345|NCT04120805|Coagulants|coagulants|mesh-ancestor
19308346|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
19308347|NCT04120922|Calcium|calcium|mesh-list
19308348|NCT04120922|Sevelamer|sevelamer|mesh-list
19308349|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19308350|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308351|NCT04120922|Antacids|antacids|mesh-ancestor
19308352|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308353|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308354|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
19308355|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
19308356|NCT04120831|Abatacept|abatacept|mesh-list
19308357|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308358|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
19308359|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308360|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308361|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19308362|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308363|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308364|NCT04120961|Hirudins|hirudins|mesh-list
19308365|NCT04120961|Bivalirudin|bivalirudin|mesh-list
19308366|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
20368166|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20368167|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20368168|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
20368169|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368170|NCT01572662|Vidarabine|vidarabine|mesh-list
20368171|NCT01572662|Methotrexate|methotrexate|mesh-list
20368172|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
20368173|NCT01572662|Fludarabine|fludarabine|mesh-list
20368174|NCT01572662|Busulfan|busulfan|mesh-list
19308367|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19308368|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
19308369|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308370|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308371|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
19308372|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19308373|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19308374|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
19308375|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
19308376|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19308377|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308378|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19308379|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308380|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
19308381|NCT04120363|Testosterone|testosterone|mesh-list
19308382|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
19308383|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
20368175|NCT01572662|Tacrolimus|tacrolimus|mesh-list
20368176|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20368177|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
20368178|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20368179|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368180|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308384|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20368181|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
20612739|NCT02252731|Warfarin|warfarin|mesh-list
20368182|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672771|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672772|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19672773|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
19672774|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672775|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672776|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19672777|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
19308385|NCT04120363|Androgens|androgens|mesh-ancestor
19308386|NCT04120363|Hormones|hormones|mesh-ancestor
19308387|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308388|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308389|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19308390|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308391|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
19308392|NCT04120311|Dexamethasone|dexamethasone|mesh-list
19308393|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
19308394|NCT04120311|BB 1101|bb 1101|mesh-list
19308395|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308396|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
19308397|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
19308398|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368183|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368184|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20368185|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308399|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308400|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308401|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
19308402|NCT04120311|Hormones|hormones|mesh-ancestor
19308403|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308404|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19308405|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308406|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
19308407|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308408|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308409|NCT04120259|Metformin|metformin|mesh-list
19308410|NCT04120259|Acetic Acid|acetic acid|mesh-list
19308411|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19308412|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308413|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308414|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308415|NCT04120350|Rituximab|rituximab|mesh-list
19308416|NCT04120350|Methotrexate|methotrexate|mesh-list
19308417|NCT04120350|Lenalidomide|lenalidomide|mesh-list
19308418|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19308419|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308420|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
19308421|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308422|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308423|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19308424|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
19308425|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19308426|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308427|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
19308428|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308429|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308430|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308431|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19308432|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308433|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19308434|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19308435|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19308436|NCT04120350|Growth Substances|growth substances|mesh-ancestor
19308437|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
19396886|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396887|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19396888|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396889|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19396890|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19396891|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19396892|NCT03656042|Lenograstim|lenograstim|mesh-list
19672778|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368186|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19396893|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19396894|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
19308438|NCT04120519|Thalidomide|thalidomide|mesh-list
19308439|NCT04120519|Dexamethasone|dexamethasone|mesh-list
19308440|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
19308441|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308442|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
19308443|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308444|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308445|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19308446|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
19308447|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308448|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308449|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19308450|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308451|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
20368187|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368188|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
20368189|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368190|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20368191|NCT01572662|Antiviral Agents|antiviral agents|mesh-ancestor
20368192|NCT01572662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368193|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20368194|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
20368195|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368196|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20368197|NCT01529593|Metformin|metformin|mesh-list
20368198|NCT01529593|Sirolimus|sirolimus|mesh-list
20368199|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368200|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368201|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20368202|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368203|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20368204|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368205|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
20368206|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368207|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
20368208|NCT01446133|Rituximab|rituximab|mesh-list
20368209|NCT01446133|Lenalidomide|lenalidomide|mesh-list
20368210|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368211|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308452|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
19308453|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308454|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308455|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
19308456|NCT04120519|Hormones|hormones|mesh-ancestor
19308457|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308458|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19308459|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
19308460|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308461|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308462|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19308463|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19308464|NCT04120519|Growth Substances|growth substances|mesh-ancestor
19308465|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
19308466|NCT04120415|Vedolizumab|vedolizumab|mesh-list
19308467|NCT04120415|Vaccines|vaccines|mesh-list
19308468|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
19308469|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308470|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308471|NCT04120337|Lidocaine|lidocaine|mesh-list
19308472|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
19308473|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
19308474|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308475|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308476|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
19308477|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308478|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19308479|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19308480|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19308481|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19308482|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308483|NCT04119921|Ketorolac|ketorolac|mesh-list
19308484|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19308485|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
20368212|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
20368213|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368214|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308486|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19308487|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308488|NCT04119921|Analgesics|analgesics|mesh-ancestor
19308489|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
19308490|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308491|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308492|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308493|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308494|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19308495|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308496|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308497|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19308498|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19308499|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
19308500|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19308501|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308502|NCT04120064|Vitamins|vitamins|mesh-ancestor
19308503|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
20368215|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20368216|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20368217|NCT01446133|Growth Substances|growth substances|mesh-ancestor
20368218|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
20368219|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20368220|NCT01264679|Hematinics|hematinics|mesh-ancestor
20368221|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20368222|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20425641|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20425642|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425643|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425644|NCT01275976|Complement C1s|complement c1s|mesh-list
20425645|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20425646|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20425647|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
20425648|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425649|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20425650|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425651|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
20425652|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20425653|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20425654|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20425655|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425656|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425657|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
19308504|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19308505|NCT04119752|Curcumin|curcumin|mesh-list
19308506|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19308507|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308508|NCT04119752|Analgesics|analgesics|mesh-ancestor
19308509|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
19308510|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308511|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308512|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308513|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308514|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308515|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308516|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308517|NCT04119622|Capecitabine|capecitabine|mesh-list
19308518|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
19308519|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308520|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
19308521|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425658|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425659|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425660|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20425661|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425662|NCT01276067|Donepezil|donepezil|mesh-list
20425663|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20425664|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425665|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425666|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
20425667|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308522|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308523|NCT04119674|Temozolomide|temozolomide|mesh-list
19308524|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19308525|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
19308526|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308527|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308528|NCT04119297|Heparinoids|heparinoids|mesh-list
19308529|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308530|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
19308531|NCT04119739|Ibuprofen|ibuprofen|mesh-list
19308532|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20186644|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186645|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20186646|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
20186647|NCT00204659|Rituximab|rituximab|mesh-list
20186648|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20186649|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186650|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
20186651|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186652|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20186653|NCT00204698|Rabeprazole|rabeprazole|mesh-list
19308533|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308534|NCT04119739|Analgesics|analgesics|mesh-ancestor
19308535|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
19308536|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308537|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308538|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308539|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308540|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19308541|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308542|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308543|NCT04118920|Insulin|insulin|mesh-list
19308544|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19308545|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19308546|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672779|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
20186654|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20186655|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186656|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20186657|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186658|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186659|NCT00204737|Prednisone|prednisone|mesh-list
20186660|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186661|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
20186662|NCT00204737|Hormones|hormones|mesh-ancestor
20186663|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186664|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186665|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20186666|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186667|NCT00204776|Capecitabine|capecitabine|mesh-list
20186668|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
20186669|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20186670|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
20186671|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186672|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186673|NCT00204789|Eflornithine|eflornithine|mesh-list
20186674|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186675|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20186676|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20186677|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20186678|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186679|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20186680|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186681|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186682|NCT00204893|Calcium|calcium|mesh-list
20186683|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20186684|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186685|NCT00204906|Vitamin D|vitamin d|mesh-list
20186686|NCT00204906|Vitamins|vitamins|mesh-ancestor
20186687|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
20186688|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186689|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20186690|NCT00204919|Vitamin D|vitamin d|mesh-list
20186691|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
20186692|NCT00204919|Vitamins|vitamins|mesh-ancestor
20186693|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
20186694|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186695|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20186696|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20186697|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20186698|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
20186699|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308547|NCT04119336|Dexamethasone|dexamethasone|mesh-list
19308548|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
19308549|NCT04119336|Nivolumab|nivolumab|mesh-list
19308550|NCT04119336|Ixazomib|ixazomib|mesh-list
19308551|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308552|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
19308553|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308554|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308555|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19308556|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
19308557|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308558|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308559|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19308560|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308561|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
19308562|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
19308563|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308564|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308565|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
19308566|NCT04119336|Hormones|hormones|mesh-ancestor
19308567|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308568|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19308569|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19308570|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19308571|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
19308572|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308573|NCT04119037|Morphine|morphine|mesh-list
19308574|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19308575|NCT04119037|Narcotics|narcotics|mesh-ancestor
19308576|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308577|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308578|NCT04119037|Analgesics|analgesics|mesh-ancestor
19308579|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
19308580|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308581|NCT04118855|Axitinib|axitinib|mesh-list
19308582|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308583|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19308584|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308585|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308586|NCT04118842|Rifampin|rifampin|mesh-list
20186700|NCT00204984|Hydralazine|hydralazine|mesh-list
20368223|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
20368224|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20368225|NCT01155388|Hematinics|hematinics|mesh-ancestor
20368226|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20368227|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20368228|NCT01155388|Trace Elements|trace elements|mesh-ancestor
20368229|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
20368230|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368231|NCT01095003|Capecitabine|capecitabine|mesh-list
20368232|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20368233|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
20368234|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368235|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368236|NCT01026220|Prednisone|prednisone|mesh-list
20368237|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
20368238|NCT01026220|Ifosfamide|ifosfamide|mesh-list
20368239|NCT01026220|Doxorubicin|doxorubicin|mesh-list
20368240|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20368241|NCT01026220|Etoposide|etoposide|mesh-list
20186701|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20186702|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
20186703|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186704|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20186705|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
20186706|NCT00205166|Caffeine|caffeine|mesh-list
20186707|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20368242|NCT01026220|Vincristine|vincristine|mesh-list
20368243|NCT01026220|Vinorelbine|vinorelbine|mesh-list
19308587|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20368244|NCT01026220|Bleomycin|bleomycin|mesh-list
19308588|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
19308589|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308590|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308591|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
19308592|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19308593|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308594|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308595|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19308596|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19308597|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19308598|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19308599|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19308600|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19308601|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
19308602|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19308603|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308604|NCT04118556|Sirolimus|sirolimus|mesh-list
19308605|NCT04118556|Etanercept|etanercept|mesh-list
19308606|NCT04118556|Everolimus|everolimus|mesh-list
20368245|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
20368246|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368247|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
20368248|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368249|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368250|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368251|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
20368252|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368253|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368254|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20368255|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19308607|NCT04118556|Infliximab|infliximab|mesh-list
19308608|NCT04118556|Vedolizumab|vedolizumab|mesh-list
19308609|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308610|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308611|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
19308612|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308613|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308614|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308615|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19308616|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
19308617|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308618|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308619|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308620|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19308621|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308622|NCT04118556|Analgesics|analgesics|mesh-ancestor
19308623|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
19308624|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308625|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308626|NCT04118699|Rifaximin|rifaximin|mesh-list
19308627|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308628|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308629|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308630|NCT04118777|Ropivacaine|ropivacaine|mesh-list
19308631|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
19308632|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
19308633|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308634|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308635|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
19308636|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396895|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396896|NCT03655964|Olmesartan|olmesartan|mesh-list
19396897|NCT03655964|Nebivolol|nebivolol|mesh-list
19396898|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
19396899|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19396900|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19396901|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396902|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
19396903|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19396904|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19396905|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19396906|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
20368256|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19396907|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308637|NCT04118153|Abatacept|abatacept|mesh-list
19308638|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19838674|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838675|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
19838676|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
19838677|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308639|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308640|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308641|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308642|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
19308643|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308644|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308645|NCT04117919|Triamcinolone|triamcinolone|mesh-list
19308646|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19308647|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19308648|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
19308649|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19308650|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19308651|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19308652|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19308653|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308654|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
19308655|NCT04117919|Hormones|hormones|mesh-ancestor
19308656|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308657|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308658|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308659|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
19308660|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308661|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308662|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19308663|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
19308664|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19308665|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19308666|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19308667|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308668|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308669|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308670|NCT04117893|Analgesics|analgesics|mesh-ancestor
19308671|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
19308672|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308673|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
19308674|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19308675|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
19308676|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19308677|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
19308678|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
19308679|NCT04117893|Protective Agents|protective agents|mesh-ancestor
19308680|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
19308681|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19308682|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19308683|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308684|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
19308685|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308686|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
19308687|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
19308688|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19308689|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308690|NCT04117750|Vitamins|vitamins|mesh-ancestor
19308691|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
19308692|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19308693|NCT04117750|Antacids|antacids|mesh-ancestor
19308694|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308695|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308696|NCT04117698|Ethambutol|ethambutol|mesh-list
19838678|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838679|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838680|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
20186708|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186709|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20186710|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186711|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612740|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
19308697|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
19308698|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20368257|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368258|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368259|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368260|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
20368261|NCT01026220|Hormones|hormones|mesh-ancestor
20368262|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368263|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20368264|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19308699|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308700|NCT04118322|Peppermint oil|peppermint oil|mesh-list
19308701|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
19308702|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
19308703|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308704|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308705|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308706|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
19308707|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19308708|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19308709|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308710|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308711|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19308712|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19308713|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308714|NCT04117178|Memantine|memantine|mesh-list
19308715|NCT04117178|Donepezil|donepezil|mesh-list
19308716|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19308717|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308718|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308719|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
19308720|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308721|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308722|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
19308723|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19308724|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19308725|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
19308726|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19308727|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19308728|NCT04117009|Remifentanil|remifentanil|mesh-list
19308729|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19308730|NCT04117009|Narcotics|narcotics|mesh-ancestor
19308731|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308732|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308733|NCT04117009|Analgesics|analgesics|mesh-ancestor
19308734|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
19308735|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368265|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
20368266|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368267|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
20368268|NCT00601003|Nifurtimox|nifurtimox|mesh-list
20368269|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
20368270|NCT00601003|Topotecan|topotecan|mesh-list
19672780|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20368271|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368272|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
20368273|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368274|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368275|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368276|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
20368277|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368278|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308736|NCT04117243|Misoprostol|misoprostol|mesh-list
19308737|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
19308738|NCT04117243|Oxytocin|oxytocin|mesh-list
19308739|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
19308740|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19308741|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308742|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19308743|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19308744|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308745|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
20368279|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19308746|NCT04117243|Coagulants|coagulants|mesh-ancestor
19308747|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19308748|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
19308749|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19308750|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308751|NCT04117191|Tryptophan|tryptophan|mesh-list
19308752|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19308753|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
19308754|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19308755|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
19308756|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19308757|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308758|NCT04116931|Clopidogrel|clopidogrel|mesh-list
19308759|NCT04116931|Ticagrelor|ticagrelor|mesh-list
19308760|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19308761|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19308762|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19308763|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19308764|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
19308765|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308766|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308767|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308768|NCT04116554|Bupivacaine|bupivacaine|mesh-list
19308769|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
19308770|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
19308771|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308772|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368280|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20368281|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368282|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368283|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20368284|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20368285|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20368286|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368287|NCT00567567|Vitamin A|vitamin a|mesh-list
20368288|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
20368289|NCT00567567|Melphalan|melphalan|mesh-list
20368290|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
20368291|NCT00567567|Thiotepa|thiotepa|mesh-list
20368292|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20368293|NCT00567567|Cisplatin|cisplatin|mesh-list
20368294|NCT00567567|Carboplatin|carboplatin|mesh-list
20368295|NCT00567567|Doxorubicin|doxorubicin|mesh-list
20368296|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20368297|NCT00567567|Etoposide|etoposide|mesh-list
20368298|NCT00567567|Vincristine|vincristine|mesh-list
19308773|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
19308774|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308775|NCT04116528|Ketamine|ketamine|mesh-list
19308776|NCT04116528|Buprenorphine|buprenorphine|mesh-list
20368299|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
20368300|NCT00567567|Topotecan|topotecan|mesh-list
20368301|NCT00567567|Tretinoin|tretinoin|mesh-list
20368302|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
20368303|NCT00567567|Isotretinoin|isotretinoin|mesh-list
20368304|NCT00567567|Lenograstim|lenograstim|mesh-list
20368305|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368306|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
20368307|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368308|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308777|NCT04116528|Analgesics|analgesics|mesh-ancestor
19308778|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
19308779|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308780|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308781|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19308782|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19308783|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
19308784|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
19308785|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368309|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368310|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
20368311|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368312|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368313|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19308786|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20368314|NCT00567567|Vitamins|vitamins|mesh-ancestor
19308787|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19308788|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368315|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
20368316|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20368317|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20368318|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368319|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368320|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20368321|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20368322|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
20368323|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368324|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
20368325|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20368326|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
20368327|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
20368328|NCT00450450|Lenograstim|lenograstim|mesh-list
20368329|NCT00450450|Sargramostim|sargramostim|mesh-list
20368330|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19308789|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308790|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19308791|NCT04116528|Narcotics|narcotics|mesh-ancestor
19308792|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19308793|NCT04116827|Tamoxifen|tamoxifen|mesh-list
20368331|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
20368332|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368333|NCT00392821|Everolimus|everolimus|mesh-list
19308794|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19308795|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
19308796|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19308797|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308798|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19308799|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308800|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19308801|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19308802|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19308803|NCT04116411|Valganciclovir|valganciclovir|mesh-list
19308804|NCT04116411|Temozolomide|temozolomide|mesh-list
19308805|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19308806|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
19308807|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308808|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308809|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
19308810|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308811|NCT04116359|Cisplatin|cisplatin|mesh-list
19308812|NCT04116359|Etoposide|etoposide|mesh-list
19308813|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
19308814|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
19308815|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308816|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19308817|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19308818|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19308819|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308820|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308821|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
19308822|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308823|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
19308824|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
19308825|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
19308826|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
19308827|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19308828|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308829|NCT04115982|Vitamins|vitamins|mesh-ancestor
19308830|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
19308831|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19308832|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
19308833|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308834|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
19308835|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
20368334|NCT00392821|Sorafenib|sorafenib|mesh-list
20368335|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368336|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368337|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
20368338|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368339|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20368340|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368341|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368342|NCT00346164|Doxorubicin|doxorubicin|mesh-list
20368343|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20368344|NCT00346164|Ifosfamide|ifosfamide|mesh-list
20368345|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19308836|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308837|NCT04115904|Ibuprofen|ibuprofen|mesh-list
20368346|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308838|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19308839|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308840|NCT04115904|Analgesics|analgesics|mesh-ancestor
19308841|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
19308842|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308843|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308844|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308845|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308846|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19308847|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308848|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308849|NCT04116320|Imiquimod|imiquimod|mesh-list
19308850|NCT04116320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19308851|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
19672781|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19672782|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19672783|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308852|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308853|NCT04116320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308854|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
19308855|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
19308856|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
19308857|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19396908|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404349|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19404350|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
19404351|NCT03595397|Fentanyl|fentanyl|mesh-list
19404352|NCT03595397|Bupivacaine|bupivacaine|mesh-list
19404353|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
19404354|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
19404355|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404356|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404357|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
19404358|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186712|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20186713|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20186714|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
20186715|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186716|NCT00205231|Etanercept|etanercept|mesh-list
20186717|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20186718|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20186719|NCT00205231|Analgesics|analgesics|mesh-ancestor
20186720|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
20186721|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186722|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186723|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186724|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404359|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404360|NCT03595397|Narcotics|narcotics|mesh-ancestor
19672784|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672785|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19672786|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
19672787|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19672788|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19672789|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19672790|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19404361|NCT03595397|Analgesics|analgesics|mesh-ancestor
19404362|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19404363|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404364|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
19404365|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19404366|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
19404367|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19404368|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19404369|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404370|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19404371|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
19404372|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404373|NCT03595371|Dapansutrile|dapansutrile|mesh-list
19404374|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19672791|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
19672792|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838681|NCT00621985|Hormones|hormones|mesh-ancestor
19404375|NCT03595319|Sevoflurane|sevoflurane|mesh-list
19404376|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19672793|NCT05112211|Doxycycline|doxycycline|mesh-list
19672794|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20368347|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20368348|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368349|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368350|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368351|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368352|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
20368353|NCT00082706|Leucovorin|leucovorin|mesh-list
20368354|NCT00082706|Gemcitabine|gemcitabine|mesh-list
20368355|NCT00082706|Cisplatin|cisplatin|mesh-list
20368356|NCT00082706|Fluorouracil|fluorouracil|mesh-list
20368357|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368358|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20368359|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
20368360|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368361|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
19672795|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672796|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
19672797|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20368362|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368363|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368364|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368365|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
20368366|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368367|NCT00082706|Antidotes|antidotes|mesh-ancestor
20368368|NCT00082706|Protective Agents|protective agents|mesh-ancestor
20368369|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
20368370|NCT00082706|Vitamins|vitamins|mesh-ancestor
20368371|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
20368372|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
20368373|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20368374|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368375|NCT00958633|Citalopram|citalopram|mesh-list
20368376|NCT00958633|Bupropion|bupropion|mesh-list
20368377|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20368378|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20368379|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20368380|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368381|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368382|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
20368383|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368384|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20368385|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
19308858|NCT04116203|Metformin|metformin|mesh-list
19308859|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19308860|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308861|NCT04115878|Oxybutynin|oxybutynin|mesh-list
19308862|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19308863|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19308864|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19308865|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19308866|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308867|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
19308868|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308869|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672798|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20186725|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186726|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186727|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
20186728|NCT00205283|Nelfinavir|nelfinavir|mesh-list
20186729|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20186730|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20186731|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
20186732|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186733|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186734|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20186735|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20186736|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
20186737|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186738|NCT00205322|Leucovorin|leucovorin|mesh-list
20186739|NCT00205322|Capecitabine|capecitabine|mesh-list
19308870|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
20186740|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
19672799|NCT05111717|Desflurane|desflurane|mesh-list
20186741|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20186742|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
19308871|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
19308872|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308873|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19308874|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19308875|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
19308876|NCT04115878|Urological Agents|urological agents|mesh-ancestor
19308877|NCT04115800|Sirolimus|sirolimus|mesh-list
19308878|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308879|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308880|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19308881|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308882|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
19308883|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308884|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
19308885|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308886|NCT04115423|Adalimumab|adalimumab|mesh-list
20368386|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20368387|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20368388|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
20368389|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20368390|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20368391|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368392|NCT00958750|Minoxidil|minoxidil|mesh-list
20368393|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20368394|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
20368395|NCT00958854|Thalidomide|thalidomide|mesh-list
20368396|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
20368397|NCT00958854|Fludarabine|fludarabine|mesh-list
20368398|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
20368399|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368400|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
20368401|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368402|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368403|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368404|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
20368405|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368406|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368407|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20368408|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308887|NCT04115423|Etanercept|etanercept|mesh-list
19308888|NCT04115423|Golimumab|golimumab|mesh-list
19308889|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19308890|NCT04115423|Infliximab|infliximab|mesh-list
19308891|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19308892|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308893|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
19308894|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19308895|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19308896|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308897|NCT04115423|Analgesics|analgesics|mesh-ancestor
19308898|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
19308899|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308900|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308901|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308902|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
19308903|NCT04115631|Cytarabine|cytarabine|mesh-list
19308904|NCT04115631|Rituximab|rituximab|mesh-list
19308905|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19308906|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19308907|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
19308908|NCT04115631|Antibodies|antibodies|mesh-list
19308909|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
19308910|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19308911|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
19308912|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308913|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308914|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19308915|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308916|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
19308917|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308918|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
19308919|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368409|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
19308920|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308921|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368410|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
19308922|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
20368411|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19308923|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
19308924|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19308925|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308926|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308927|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19308928|NCT04115449|Analgesics|analgesics|mesh-ancestor
19308929|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
19308930|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308931|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19308932|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19838682|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19838683|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19838684|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838685|NCT00622284|Glimepiride|glimepiride|mesh-list
19838686|NCT00622284|Linagliptin|linagliptin|mesh-list
19838687|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19838688|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19838689|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838690|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838691|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
19308933|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19308934|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
19308935|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308936|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308937|NCT04115410|Gemcitabine|gemcitabine|mesh-list
19308938|NCT04115410|Cisplatin|cisplatin|mesh-list
19308939|NCT04115410|Carboplatin|carboplatin|mesh-list
19308940|NCT04115410|Docetaxel|docetaxel|mesh-list
19308941|NCT04115410|Pemetrexed|pemetrexed|mesh-list
19308942|NCT04115410|Vinorelbine|vinorelbine|mesh-list
19308943|NCT04115410|Gefitinib|gefitinib|mesh-list
19308944|NCT04115410|Mitomycins|mitomycins|mesh-list
19308945|NCT04115410|Mitomycin|mitomycin|mesh-list
19308946|NCT04115410|Vinblastine|vinblastine|mesh-list
19308947|NCT04115410|Osimertinib|osimertinib|mesh-list
19308948|NCT04115410|Afatinib|afatinib|mesh-list
19308949|NCT04115410|Crizotinib|crizotinib|mesh-list
19308950|NCT04115410|Ceritinib|ceritinib|mesh-list
19308951|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
19308952|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19308953|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19308954|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
19308955|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308956|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
19308957|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308958|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19308959|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19308960|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
19308961|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308962|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
19308963|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
19308964|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
19308965|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19308966|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19308967|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19308968|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19308969|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19308970|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
19308971|NCT04115462|Morphine|morphine|mesh-list
19308972|NCT04115462|Histamine|histamine|mesh-list
19308973|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
19308974|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19308975|NCT04115462|Narcotics|narcotics|mesh-ancestor
19308976|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19308977|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19308978|NCT04115462|Analgesics|analgesics|mesh-ancestor
19308979|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
19308980|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19308981|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
19308982|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
19838692|NCT00622284|Incretins|incretins|mesh-ancestor
19308983|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19308984|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19308985|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
19308986|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19308987|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838693|NCT00622284|Hormones|hormones|mesh-ancestor
20368412|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19308988|NCT04115111|Durvalumab|durvalumab|mesh-list
19308989|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368413|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20368414|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20368415|NCT00958854|Growth Substances|growth substances|mesh-ancestor
20368416|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
19308990|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308991|NCT04115163|Gemcitabine|gemcitabine|mesh-list
19308992|NCT04115163|Paclitaxel|paclitaxel|mesh-list
19308993|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19308994|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19308995|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19308996|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19308997|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19308998|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19308999|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309000|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19309001|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
19309002|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
19309003|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309004|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309005|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19309006|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
19309007|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309008|NCT04115020|Naltrexone|naltrexone|mesh-list
19309009|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19309010|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19309011|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309012|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
19309013|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309014|NCT04115072|Praziquantel|praziquantel|mesh-list
19309015|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
19309016|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19309017|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309018|NCT04114643|Thrombin|thrombin|mesh-list
19309019|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
19309020|NCT04114643|Coagulants|coagulants|mesh-ancestor
19309021|NCT04114630|Erenumab|erenumab|mesh-list
19309022|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19309023|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309024|NCT04114630|Analgesics|analgesics|mesh-ancestor
19309025|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
19309026|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309027|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309028|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
19309029|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309030|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19309031|NCT04114383|Protective Agents|protective agents|mesh-ancestor
19309032|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309033|NCT04114526|Nicotine|nicotine|mesh-list
19309034|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19309035|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
19309036|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309037|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309038|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20368417|NCT00958906|Infliximab|infliximab|mesh-list
20368418|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
20368419|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20368420|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368421|NCT00959062|Clonidine|clonidine|mesh-list
20368422|NCT00959062|Analgesics|analgesics|mesh-ancestor
20368423|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
19309039|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19309040|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
19309041|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309042|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309043|NCT04114461|Tofacitinib|tofacitinib|mesh-list
19309044|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309045|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19309046|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309047|NCT04114396|Antibodies|antibodies|mesh-list
19309048|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
19309049|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309050|NCT04114188|Prednisolone|prednisolone|mesh-list
19309051|NCT04114188|Infliximab|infliximab|mesh-list
20368424|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368425|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368426|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20368427|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
20368428|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
20368429|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20368430|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20368431|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20368432|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
20368433|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368434|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309052|NCT04114188|Tacrolimus|tacrolimus|mesh-list
19309053|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
19309054|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19309055|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
19309056|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19309057|NCT04114188|Antibodies|antibodies|mesh-list
19309058|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19309059|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
19309060|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309061|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19309062|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309063|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309064|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309065|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
19309066|NCT04114188|Hormones|hormones|mesh-ancestor
19309067|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309068|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19309069|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368435|NCT00959075|Thiamine|thiamine|mesh-list
20368436|NCT00959075|Vitamins|vitamins|mesh-ancestor
20368437|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
20368438|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368439|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
20368440|NCT00959101|Metformin|metformin|mesh-list
20368441|NCT00959101|Repaglinide|repaglinide|mesh-list
20368442|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368443|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368444|NCT00959218|Dronabinol|dronabinol|mesh-list
20368445|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
20368446|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368447|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20368448|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20368449|NCT00959218|Analgesics|analgesics|mesh-ancestor
20368450|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
20368451|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368452|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20368453|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20368454|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368455|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309070|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19309071|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
19309072|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309073|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
19309074|NCT04114149|Narcotics|narcotics|mesh-ancestor
19309075|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309076|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309077|NCT04114149|Analgesics|analgesics|mesh-ancestor
19309078|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
19309079|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309080|NCT04113772|Nitisinone|nitisinone|mesh-list
19309081|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309082|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309083|NCT04113863|Anastrozole|anastrozole|mesh-list
19309084|NCT04113863|Tretinoin|tretinoin|mesh-list
19309085|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19309086|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309087|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19309088|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19309089|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309090|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309091|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20368456|NCT00959218|Hormones|hormones|mesh-ancestor
19309092|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
19309093|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368457|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309094|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309095|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
19309096|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
19309097|NCT04113954|Prilocaine|prilocaine|mesh-list
19309098|NCT04113954|Mepivacaine|mepivacaine|mesh-list
19309099|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
19309100|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
19309101|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309102|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309103|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
19309104|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309105|NCT04113915|Cyclosporine|cyclosporine|mesh-list
19309106|NCT04113915|Dexamethasone|dexamethasone|mesh-list
19309107|NCT04113915|Cyclosporins|cyclosporins|mesh-list
19309108|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309109|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
19309110|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309111|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309112|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309113|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
19309114|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
19309115|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309116|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19309117|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
19309118|NCT04113915|Hormones|hormones|mesh-ancestor
19309119|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309120|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19309121|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309122|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309123|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19309124|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
19309125|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309126|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
19309127|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19309128|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
19309129|NCT04113889|Metformin|metformin|mesh-list
19309130|NCT04113889|Pioglitazone|pioglitazone|mesh-list
19309131|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19309132|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186743|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186744|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186745|NCT00205322|Antidotes|antidotes|mesh-ancestor
20186746|NCT00205322|Protective Agents|protective agents|mesh-ancestor
20186747|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186748|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
20186749|NCT00205322|Vitamins|vitamins|mesh-ancestor
20186750|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
20186751|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20186752|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
20186753|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186754|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20186755|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20186756|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20186757|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20186758|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186759|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186760|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186761|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20186762|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
20186763|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186764|NCT00205634|Clarithromycin|clarithromycin|mesh-list
20186765|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186766|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186767|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20186768|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186769|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186770|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20186771|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20217341|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217342|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309133|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
19309134|NCT04113889|Vitamins|vitamins|mesh-ancestor
19309135|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
19309136|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
20368458|NCT00959231|Cyclosporine|cyclosporine|mesh-list
20368459|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
20368460|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
20368461|NCT00959231|Fludarabine|fludarabine|mesh-list
20368462|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
20368463|NCT00959231|Cyclosporins|cyclosporins|mesh-list
20368464|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368465|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
20368466|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309137|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
19309138|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
19309139|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309140|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19309141|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396909|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
19396910|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19396911|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396912|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396913|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396914|NCT03655847|Analgesics|analgesics|mesh-ancestor
19396915|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
19396916|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396917|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19396918|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19396919|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19396920|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
19396921|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396922|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396923|NCT03655834|Pemetrexed|pemetrexed|mesh-list
19396924|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396925|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19396926|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396927|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19396928|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19396929|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
19396930|NCT03655717|Ethanol|ethanol|mesh-list
19396931|NCT03655717|Dronabinol|dronabinol|mesh-list
19396932|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20368467|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368468|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368469|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
20368470|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368471|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368472|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20368473|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20368474|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
20368475|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368476|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
20368477|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368478|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
19396933|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396934|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19396935|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396936|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
19396937|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19396938|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19396939|NCT03655717|Analgesics|analgesics|mesh-ancestor
19396940|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
19396941|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396942|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19396943|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19396944|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396945|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396946|NCT03655717|Hormones|hormones|mesh-ancestor
19396947|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19396948|NCT03655665|Ofloxacin|ofloxacin|mesh-list
19396949|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19396950|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19396951|NCT03655665|Renal Agents|renal agents|mesh-ancestor
19396952|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19396953|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20368479|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19396954|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368480|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20186772|NCT00205725|Olanzapine|olanzapine|mesh-list
20368481|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20368482|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
20368483|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20368484|NCT00959335|Bicalutamide|bicalutamide|mesh-list
20368485|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
20368486|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
20368487|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368488|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368489|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368490|NCT00959387|Paclitaxel|paclitaxel|mesh-list
20368491|NCT00959387|Cisplatin|cisplatin|mesh-list
20368492|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20368493|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368494|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
20368495|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368496|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
20368497|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368498|NCT00959400|Fentanyl|fentanyl|mesh-list
20368499|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20368500|NCT00959400|Narcotics|narcotics|mesh-ancestor
20368501|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368502|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368503|NCT00959400|Analgesics|analgesics|mesh-ancestor
20368504|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
20368505|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368506|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20368507|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20368508|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
20368509|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
20368510|NCT00959439|Naproxen|naproxen|mesh-list
20368511|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20368512|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20368513|NCT00959439|Analgesics|analgesics|mesh-ancestor
20368514|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
20368515|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368516|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368517|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368518|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368519|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
20368520|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20368521|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368522|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368523|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
20368524|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
20368525|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368526|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
20368527|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368528|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309142|NCT04114097|Betamethasone|betamethasone|mesh-list
19309143|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
19309144|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19309145|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
19309146|NCT04114097|Tacrolimus|tacrolimus|mesh-list
19309147|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19309148|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19309149|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
19309150|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309151|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19309152|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186773|NCT00205725|Ziprasidone|ziprasidone|mesh-list
20186774|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
20186775|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
20186776|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186777|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186778|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186779|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186780|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186781|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186782|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186783|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19309153|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186784|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20368529|NCT00959517|Artesunate|artesunate|mesh-list
20368530|NCT00959517|Chloroquine|chloroquine|mesh-list
19309154|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309155|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
19309156|NCT04114097|Hormones|hormones|mesh-ancestor
19309157|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309158|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19309159|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
19309160|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19309161|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19309162|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309163|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309164|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19309165|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19309166|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309167|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
19309168|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309169|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
19309170|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19309171|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19309172|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
19309173|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309174|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309175|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19309176|NCT04113668|Diflunisal|diflunisal|mesh-list
19309177|NCT04113668|BMS-986165|bms-986165|mesh-list
19309178|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
19309179|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19309180|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309181|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309182|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19309183|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309184|NCT04113668|Analgesics|analgesics|mesh-ancestor
19309185|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
19309186|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309187|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309188|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309189|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309190|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19309191|NCT04113551|Guanfacine|guanfacine|mesh-list
19672800|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19672801|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
19672802|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
19672803|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672804|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672805|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19672806|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
20368531|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
20368532|NCT00959517|Primaquine|primaquine|mesh-list
20368533|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
20368534|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20368535|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
20368536|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20368537|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20368538|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368539|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368540|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
20368541|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
20368542|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20368543|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
20368544|NCT00959517|Amebicides|amebicides|mesh-ancestor
20368545|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368546|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20368547|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368548|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368549|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20368550|NCT00959517|Renal Agents|renal agents|mesh-ancestor
20368551|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20368552|NCT00959569|Esmolol|esmolol|mesh-list
20368553|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20368554|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
20368555|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368556|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672807|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672808|NCT05077488|Lidocaine|lidocaine|mesh-list
20368557|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672809|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
19672810|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
19672811|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672812|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672813|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
19672814|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672815|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19672816|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19309192|NCT04113551|Methylphenidate|methylphenidate|mesh-list
19309193|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19309194|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19309195|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20186785|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20368558|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20368559|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20368560|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20368561|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368562|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20368563|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
20368564|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
20368565|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368566|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368567|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
20368568|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186786|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186787|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186788|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
20186789|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20368569|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20368570|NCT00959621|Aspirin|aspirin|mesh-list
20186790|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19309196|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19309197|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309198|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309199|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309200|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309201|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19309202|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19309203|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
19309204|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19309205|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19309206|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19309207|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19309208|NCT04113538|Aflibercept|aflibercept|mesh-list
19309209|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19309210|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19309211|NCT04113538|Growth Substances|growth substances|mesh-ancestor
19309212|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309213|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
19309214|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309215|NCT04113226|Rituximab|rituximab|mesh-list
19309216|NCT04113226|Lenalidomide|lenalidomide|mesh-list
19309217|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19309218|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309219|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
19309220|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309221|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368571|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20368572|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20368573|NCT00959621|Analgesics|analgesics|mesh-ancestor
19309222|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19309223|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19309224|NCT04113226|Growth Substances|growth substances|mesh-ancestor
19309225|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
19309226|NCT04113109|Icatibant|icatibant|mesh-list
19309227|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19309228|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19309229|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672817|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20186791|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
20186792|NCT00205738|Olanzapine|olanzapine|mesh-list
20186793|NCT00205738|Risperidone|risperidone|mesh-list
20368574|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
20368575|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368576|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309230|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19309231|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309232|NCT04113109|Analgesics|analgesics|mesh-ancestor
19309233|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
19309234|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309235|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309236|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309237|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309238|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19309239|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19309240|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19309241|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19309242|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
19309243|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19309244|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
19309245|NCT04113005|Coagulants|coagulants|mesh-ancestor
19309246|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19309247|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
19309248|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309249|NCT04112823|Dexamethasone|dexamethasone|mesh-list
19309250|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
19309251|NCT04112823|BB 1101|bb 1101|mesh-list
19309252|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309253|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
19309254|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
19309255|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309256|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309257|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19309258|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
19309259|NCT04112823|Hormones|hormones|mesh-ancestor
19309260|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309261|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19309262|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309263|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
19309264|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309265|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368577|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368578|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368579|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20368580|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20368581|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368582|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20368583|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20368584|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368585|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
20368586|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20368587|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368588|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
20368589|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368590|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368591|NCT00959725|Infliximab|infliximab|mesh-list
20368592|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
19309266|NCT04112550|Acetaminophen|acetaminophen|mesh-list
19309267|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19309268|NCT04112550|Oxycodone|oxycodone|mesh-list
19309269|NCT04112550|Methadone|methadone|mesh-list
19309270|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309271|NCT04112550|Analgesics|analgesics|mesh-ancestor
19309272|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
19309273|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309274|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309275|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
19309276|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19309277|NCT04112550|Narcotics|narcotics|mesh-ancestor
20368593|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20368594|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368595|NCT00959777|Lenograstim|lenograstim|mesh-list
20368596|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20368597|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
19309278|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309279|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
19396955|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672818|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20186794|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20186795|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
20186796|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186797|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186798|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186799|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186800|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186801|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186802|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186803|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20186804|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
20186805|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
20186806|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
20186807|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186808|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186809|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20368598|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368599|NCT00959881|Donepezil|donepezil|mesh-list
20368600|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20368601|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368602|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368603|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
19309280|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
19309281|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19309282|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309283|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309284|NCT04112212|Vedolizumab|vedolizumab|mesh-list
19309285|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19309286|NCT04112368|Estradiol|estradiol|mesh-list
19309287|NCT04112368|Progesterone|progesterone|mesh-list
19309288|NCT04112368|Estrogens|estrogens|mesh-ancestor
19309289|NCT04112368|Hormones|hormones|mesh-ancestor
19309290|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309291|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309292|NCT04112368|Progestins|progestins|mesh-ancestor
19309293|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19309294|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
19309295|NCT04112147|Ubiquinone|ubiquinone|mesh-list
19309296|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
19309297|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309298|NCT04112043|Niacinamide|niacinamide|mesh-list
19309299|NCT04112043|Niacin|niacin|mesh-list
19309300|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
19309301|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
19309302|NCT04112043|Vitamins|vitamins|mesh-ancestor
19309303|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
20368604|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368605|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368606|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
20368607|NCT00959933|Ribavirin|ribavirin|mesh-list
20368608|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
20368609|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368610|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
20368611|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368612|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
20368613|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368614|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368615|NCT00959972|Nicotine|nicotine|mesh-list
20368616|NCT00959972|Varenicline|varenicline|mesh-list
20368617|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20368618|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
20368619|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368620|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368621|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20368622|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19309304|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672819|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672820|NCT05073484|Antibodies|antibodies|mesh-list
19672821|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
20186810|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20186811|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20368623|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
19309305|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19309306|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
19309307|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309308|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19309309|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
19309310|NCT04112498|Nivolumab|nivolumab|mesh-list
19309311|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368624|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368625|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368626|NCT00960037|Vitamin D|vitamin d|mesh-list
20368627|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
20368628|NCT00960037|Vitamins|vitamins|mesh-ancestor
19309312|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309313|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19309314|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309315|NCT04112394|Anesthetics|anesthetics|mesh-list
19309316|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
20368629|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
20368630|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368631|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20368632|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20425668|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425669|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
20425670|NCT01276080|Donepezil|donepezil|mesh-list
20425671|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20425672|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425673|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425674|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
19838694|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309317|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309318|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309319|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
19309320|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309321|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
19309322|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19309323|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19309324|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309325|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
19309326|NCT04111822|Coagulants|coagulants|mesh-ancestor
19396956|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396957|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396958|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19396959|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19838695|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19838696|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
19838697|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838698|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838699|NCT00622336|Lenalidomide|lenalidomide|mesh-list
20425675|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425676|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425677|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
20428572|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428573|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428574|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428575|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20428576|NCT01292460|Timolol|timolol|mesh-list
19396960|NCT03655535|PAZ320|paz320|mesh-list
19396961|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19396962|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396963|NCT03655457|Poractant alfa|poractant alfa|mesh-list
19396964|NCT03655457|Beractant|beractant|mesh-list
19396965|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19396966|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
19396967|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
19396968|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19396969|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
19396970|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19396971|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396972|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19396973|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
19396974|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19838700|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
19838701|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838702|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19396975|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
19404377|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19309327|NCT04111614|Tofacitinib|tofacitinib|mesh-list
20368633|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
20368634|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20368635|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368636|NCT00960232|Vitamins|vitamins|mesh-ancestor
20368637|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
20368638|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20368639|NCT00960245|Nadolol|nadolol|mesh-list
20368640|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20368641|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20368642|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309328|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19309329|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309330|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309331|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
20368643|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368644|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368645|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368646|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20368647|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20368648|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
20368649|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
20368650|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368651|NCT00960284|Gemcitabine|gemcitabine|mesh-list
20368652|NCT00960284|Fluorouracil|fluorouracil|mesh-list
20368653|NCT00960284|Capecitabine|capecitabine|mesh-list
20368654|NCT00960284|Epirubicin|epirubicin|mesh-list
20368655|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368656|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20368657|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
20368658|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368659|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
20368660|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368661|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368662|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368663|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
20368664|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368665|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20368666|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20368667|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368668|NCT00960310|Bicalutamide|bicalutamide|mesh-list
20368669|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
20368670|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
19309332|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19309333|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19309334|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
19309335|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309336|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309337|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19309338|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
19309339|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19309340|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
19309341|NCT04111484|Protective Agents|protective agents|mesh-ancestor
19309342|NCT04111432|Vaccines|vaccines|mesh-list
19309343|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
19309344|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309345|NCT04111328|Sufentanil|sufentanil|mesh-list
19309346|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
19309347|NCT04111328|Dsuvia|dsuvia|mesh-list
19309348|NCT04111328|Hydromorphone|hydromorphone|mesh-list
19309349|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19309350|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309351|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309352|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309353|NCT04111328|Analgesics|analgesics|mesh-ancestor
19309354|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
19309355|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309356|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19309357|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19309358|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19309359|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309360|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368671|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425678|NCT01276093|Amiodarone|amiodarone|mesh-list
19309361|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309362|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19309363|NCT04111328|Narcotics|narcotics|mesh-ancestor
19309364|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19309365|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19309366|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
19309367|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
19309368|NCT04111159|Propofol|propofol|mesh-list
19309369|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19309370|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368672|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368673|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368674|NCT00960336|Doxorubicin|doxorubicin|mesh-list
20368675|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19309371|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309372|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19309373|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
19309374|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
20368676|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20368677|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368678|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20368679|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368680|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368681|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368682|NCT00960349|Cisplatin|cisplatin|mesh-list
20368683|NCT00960349|Capecitabine|capecitabine|mesh-list
19309375|NCT04111315|Dipyrone|dipyrone|mesh-list
19309376|NCT04111315|Ibuprofen|ibuprofen|mesh-list
19309377|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19309378|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309379|NCT04111315|Analgesics|analgesics|mesh-ancestor
19309380|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
19309381|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309382|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309383|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309384|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309385|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19309386|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309387|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309388|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
19309389|NCT04111302|Dezocine|dezocine|mesh-list
19309390|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19309391|NCT04111302|Narcotics|narcotics|mesh-ancestor
19309392|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309393|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309394|NCT04111302|Analgesics|analgesics|mesh-ancestor
19309395|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
19309396|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309397|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19309398|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19309399|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309400|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309401|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309402|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309403|NCT04111848|Ketamine|ketamine|mesh-list
20186812|NCT00205751|Thalidomide|thalidomide|mesh-list
20186813|NCT00205751|Dexamethasone|dexamethasone|mesh-list
20186814|NCT00205751|Prednisone|prednisone|mesh-list
20186815|NCT00205751|Melphalan|melphalan|mesh-list
20186816|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186817|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
20186818|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
20186819|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186820|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186821|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20368684|NCT00960349|Cediranib|cediranib|mesh-list
20368685|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368686|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20368687|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
20368688|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368689|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20368690|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368691|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20368692|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368693|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309404|NCT04111848|Analgesics|analgesics|mesh-ancestor
20186822|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
20186823|NCT00205751|Hormones|hormones|mesh-ancestor
20217343|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19309405|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
19309406|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309407|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309408|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19309409|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19309410|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
19309411|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
19309412|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309413|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19309414|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19309415|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309416|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309417|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
19309418|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
19309419|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309420|NCT04111003|Anesthetics|anesthetics|mesh-list
19309421|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309422|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309423|NCT04110665|Acetaminophen|acetaminophen|mesh-list
19309424|NCT04110665|Morphine|morphine|mesh-list
20368694|NCT00960453|Incretins|incretins|mesh-ancestor
20368695|NCT00960453|Hormones|hormones|mesh-ancestor
20368696|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368697|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20368698|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
20368699|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368700|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368701|NCT00960479|Ribavirin|ribavirin|mesh-list
20368702|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
20368703|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368704|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
20368705|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368706|NCT00960492|Temozolomide|temozolomide|mesh-list
20368707|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368708|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
20368709|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368710|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368711|NCT00960518|Adefovir|adefovir|mesh-list
20368712|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
20368713|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368714|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20368715|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20368716|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368717|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368718|NCT00960544|Capecitabine|capecitabine|mesh-list
20368719|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20368720|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
20368721|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368722|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368723|NCT00960557|Combretastatin|combretastatin|mesh-list
20368724|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20368725|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368726|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
20368727|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368728|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
20368729|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309425|NCT04110665|Oxycodone|oxycodone|mesh-list
19309426|NCT04110665|Tramadol|tramadol|mesh-list
19309427|NCT04110665|Nefopam|nefopam|mesh-list
19309428|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19309429|NCT04110665|Narcotics|narcotics|mesh-ancestor
19309430|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368730|NCT00960635|Vitamin D|vitamin d|mesh-list
20368731|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
20368732|NCT00960635|Calcitriol|calcitriol|mesh-list
20368733|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
20368734|NCT00960635|Vitamins|vitamins|mesh-ancestor
20368735|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
20368736|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368737|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20368738|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20368739|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20368740|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19309431|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309432|NCT04110665|Analgesics|analgesics|mesh-ancestor
19309433|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
19309434|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368741|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368742|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20368743|NCT00960713|Rituximab|rituximab|mesh-list
20368744|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368745|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368746|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
20368747|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368748|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368749|NCT00960739|Topotecan|topotecan|mesh-list
20368750|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20368751|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20368752|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19309435|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309436|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
19309437|NCT04110873|Ubiquinone|ubiquinone|mesh-list
19309438|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
19309439|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309440|NCT04110834|Itraconazole|itraconazole|mesh-list
19309441|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19309442|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
19309443|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309444|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19309445|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20368753|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368754|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368755|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368756|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20368757|NCT00960817|Aspirin|aspirin|mesh-list
20368758|NCT00960817|Dipyridamole|dipyridamole|mesh-list
20368759|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20368760|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20368761|NCT00960817|Analgesics|analgesics|mesh-ancestor
20368762|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
20368763|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368764|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368765|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368766|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20368767|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20368768|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20368769|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309446|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309447|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309448|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19309449|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
19309450|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309451|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309452|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19309453|NCT04110860|Voriconazole|voriconazole|mesh-list
19309454|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
19309455|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309456|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19309457|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19309458|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309459|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309460|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19309461|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
19309462|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186824|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186825|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20186826|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186827|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20186828|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
20186829|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186830|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20186831|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186832|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
20186833|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
20368770|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19309463|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309464|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19309465|NCT04110808|Phentolamine|phentolamine|mesh-list
19309466|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
19309467|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
19309468|NCT04110808|Anesthetics|anesthetics|mesh-list
19309469|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309470|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309471|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
19309472|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19309473|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19309474|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309475|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309476|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309477|NCT04111380|Paclitaxel|paclitaxel|mesh-list
19309478|NCT04111380|Cisplatin|cisplatin|mesh-list
19309479|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19309480|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309481|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
19309482|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368771|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20368772|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368773|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
20368774|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20368775|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
19309483|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
19309484|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309485|NCT04111289|Tirofiban|tirofiban|mesh-list
19309486|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19309487|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19309488|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309489|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19309490|NCT04110535|Midazolam|midazolam|mesh-list
19309491|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20368776|NCT00960830|Mirtazapine|mirtazapine|mesh-list
19309492|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19309493|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309494|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309495|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19309496|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19309497|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19309498|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19309499|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
19309500|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
19309501|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
19309502|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
19309503|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309504|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309505|NCT04110418|Terlipressin|terlipressin|mesh-list
19309506|NCT04110418|Methylene Blue|methylene blue|mesh-list
19309507|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309508|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309509|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19309510|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19309511|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19309512|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19309513|NCT04110587|Analgesics|analgesics|mesh-list
19309514|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
19309515|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309516|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19309517|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
19309518|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309519|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
20186834|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186835|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186836|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20186837|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20186838|NCT00205751|Growth Substances|growth substances|mesh-ancestor
20186839|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
20186840|NCT00205764|Melphalan|melphalan|mesh-list
20186841|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20186842|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
19309520|NCT04110587|Protective Agents|protective agents|mesh-ancestor
19309521|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
20217344|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
20368777|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
20368778|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20368779|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20368780|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
20368781|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
20368782|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368783|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368784|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368785|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20368786|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20368787|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368788|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20368789|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20368790|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20368791|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309522|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309523|NCT04110132|Bupivacaine|bupivacaine|mesh-list
19309524|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
19309525|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
19309526|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309527|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309528|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
19309529|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309530|NCT04110028|Niacinamide|niacinamide|mesh-list
20368792|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20368793|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20368794|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
20368795|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20368796|NCT00960921|Iron|iron|mesh-list
20368797|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20368798|NCT00960921|Trace Elements|trace elements|mesh-ancestor
20368799|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
20368800|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368801|NCT00960921|Hematinics|hematinics|mesh-ancestor
20368802|NCT00960960|Paclitaxel|paclitaxel|mesh-list
20368803|NCT00960960|Bevacizumab|bevacizumab|mesh-list
20368804|NCT00960960|Trastuzumab|trastuzumab|mesh-list
20368805|NCT00960960|Letrozole|letrozole|mesh-list
20368806|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20368807|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368808|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
19309531|NCT04110028|Niacin|niacin|mesh-list
19309532|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
19309533|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
19309534|NCT04110028|Vitamins|vitamins|mesh-ancestor
19309535|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
19309536|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309537|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19309538|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
19309539|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309540|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19309541|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
19309542|NCT04110210|Morphine|morphine|mesh-list
19309543|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19309544|NCT04110210|Narcotics|narcotics|mesh-ancestor
19309545|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309546|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309547|NCT04110210|Analgesics|analgesics|mesh-ancestor
19309548|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
19309549|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309550|NCT04110301|Lenalidomide|lenalidomide|mesh-list
19309551|NCT04110301|Antibodies|antibodies|mesh-list
19309552|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19309553|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
19309554|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309555|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19309556|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19309557|NCT04110301|Growth Substances|growth substances|mesh-ancestor
19309558|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
19309559|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309560|NCT04110288|Paclitaxel|paclitaxel|mesh-list
19309561|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19309562|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309563|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
19309564|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
19309565|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
20368809|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
20368810|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
20425679|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19309566|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309567|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
19309568|NCT04110340|Streptomycin|streptomycin|mesh-list
19309569|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19309570|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309571|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19309572|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19309573|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309574|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309575|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309576|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19309577|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19309578|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19309579|NCT04110275|Plasminogen|plasminogen|mesh-list
19309580|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19309581|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19309582|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19309583|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309584|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19309585|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309586|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309587|NCT04110119|Diclofenac|diclofenac|mesh-list
19309588|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19309589|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309590|NCT04110119|Analgesics|analgesics|mesh-ancestor
19309591|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
19309592|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309593|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309594|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309595|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309596|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19309597|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309598|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309599|NCT04109872|Lenalidomide|lenalidomide|mesh-list
19309600|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
19309601|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368811|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368812|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20368813|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19309602|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19309603|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19309604|NCT04109872|Growth Substances|growth substances|mesh-ancestor
19309605|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
19309606|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309607|NCT04109742|Curcumin|curcumin|mesh-list
19309608|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19309609|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309610|NCT04109742|Analgesics|analgesics|mesh-ancestor
19309611|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
19309612|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309613|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309614|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309615|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309616|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309617|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309618|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309619|NCT04109859|Methylene Blue|methylene blue|mesh-list
19309620|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309621|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396976|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396977|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19396978|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19396979|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
19396980|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
19396981|NCT03655392|Protective Agents|protective agents|mesh-ancestor
19396982|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
19396983|NCT03655002|Nivolumab|nivolumab|mesh-list
19396984|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19396985|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
19396986|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396987|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19396988|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368814|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20368815|NCT00960960|Growth Substances|growth substances|mesh-ancestor
20368816|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368817|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
20368818|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20368819|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20368820|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368821|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19309622|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19309623|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309624|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
20368822|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
20368823|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368824|NCT00960973|Menatetrenone|menatetrenone|mesh-list
20368825|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
20368826|NCT00960973|Coagulants|coagulants|mesh-ancestor
20368827|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
20368828|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20368829|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368830|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19309625|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19309626|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672822|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
19672823|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672824|NCT05230303|Caffeine|caffeine|mesh-list
19672825|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19672826|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672827|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19672828|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672829|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672830|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19309627|NCT04109261|Palbociclib|palbociclib|mesh-list
19309628|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309629|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19309630|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309631|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309632|NCT04109339|Oxytocin|oxytocin|mesh-list
19309633|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
19309634|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19309635|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309636|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
19309637|NCT04109534|Miotics|miotics|mesh-ancestor
19309638|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
19309639|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309640|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309641|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19309642|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19309643|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
19309644|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19309645|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19309646|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
19309647|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309648|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309649|NCT04108897|Doxycycline|doxycycline|mesh-list
19309650|NCT04108897|Ivermectin|ivermectin|mesh-list
19309651|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19309652|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309653|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
19309654|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19309655|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19309656|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19309657|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
19309658|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309659|NCT04108468|Golimumab|golimumab|mesh-list
19309660|NCT04108468|Methotrexate|methotrexate|mesh-list
19309661|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19309662|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
19309663|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19309664|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309665|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672831|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19672832|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
19672833|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309666|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
19396989|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
19672834|NCT05229991|Ritonavir|ritonavir|mesh-list
19672835|NCT05229991|Lonafarnib|lonafarnib|mesh-list
19672836|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19672837|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19672838|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
19672839|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672840|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672841|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19672842|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20368831|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20368832|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368833|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368834|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309667|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672843|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
19672844|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838703|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19309668|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309669|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
19309670|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309671|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19309672|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19309673|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
19309674|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309675|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19309676|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19309677|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309678|NCT04108676|Omeprazole|omeprazole|mesh-list
19309679|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19309680|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19309681|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19309682|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309683|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309684|NCT04108637|Penicillins|penicillins|mesh-list
19309685|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19309686|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309687|NCT04108234|Ketamine|ketamine|mesh-list
19309688|NCT04108234|Analgesics|analgesics|mesh-ancestor
19309689|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
19309690|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309691|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309692|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19309693|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19309694|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
19309695|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
19309696|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309697|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19309698|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19309699|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309700|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309701|NCT04108013|Paclitaxel|paclitaxel|mesh-list
19309702|NCT04108013|Carboplatin|carboplatin|mesh-list
19309703|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19309704|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309705|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
19309706|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
19309707|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
19309708|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309709|NCT04107896|Tamsulosin|tamsulosin|mesh-list
19309710|NCT04107896|Silodosin|silodosin|mesh-list
19309711|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19309712|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19309713|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19309714|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309715|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309716|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309717|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309718|NCT04107896|Urological Agents|urological agents|mesh-ancestor
19309719|NCT04107805|Midazolam|midazolam|mesh-list
19309720|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19309721|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19309722|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309723|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672845|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19309724|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19309725|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19309726|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19309727|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19309728|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
19309729|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
19309730|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
19309731|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
19309732|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309733|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309734|NCT04107740|TA 0910|ta 0910|mesh-list
19309735|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
19309736|NCT04107428|Somatostatin|somatostatin|mesh-list
19309737|NCT04107428|Hormones|hormones|mesh-ancestor
19309738|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19309739|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309740|NCT04107779|Menthol|menthol|mesh-list
19309741|NCT04107779|Nicotine|nicotine|mesh-list
19309742|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19309743|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
19309744|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20368835|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20368836|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20368837|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
20368838|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368839|NCT00961142|Fludarabine|fludarabine|mesh-list
20368840|NCT00961142|Melphalan|melphalan|mesh-list
20368841|NCT00961142|Thiotepa|thiotepa|mesh-list
20368842|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
20368843|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368844|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368845|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368846|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
20368847|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309745|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309746|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19309747|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19309748|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
19309749|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309750|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309751|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
19309752|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
19396990|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19396991|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19396992|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19396993|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19396994|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19396995|NCT03654937|Vaccines|vaccines|mesh-list
19396996|NCT03654937|Immunologic Factors|immunologic factors|mesh-ancestor
19396997|NCT03654937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19396998|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19396999|NCT03654794|Tacrolimus|tacrolimus|mesh-list
19397000|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397001|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
19397002|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397003|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19397004|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397005|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397006|NCT03654716|Cytarabine|cytarabine|mesh-list
19397007|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19397008|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
19397009|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397010|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397011|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
19397012|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397013|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397014|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
19672846|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19672847|NCT05229913|Esketamine|esketamine|mesh-list
19672848|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
19672849|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19672850|NCT05229796|Empagliflozin|empagliflozin|mesh-list
19672851|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19397015|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838704|NCT00622336|Growth Substances|growth substances|mesh-ancestor
20368848|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19672852|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672853|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19672854|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692175|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19692176|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19692177|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20368849|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
19309753|NCT04107480|Dopamine|dopamine|mesh-list
19309754|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
19309755|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19309756|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
19309757|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
19309758|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309759|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309760|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
19309761|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309762|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309763|NCT04107480|Protective Agents|protective agents|mesh-ancestor
19309764|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
19309765|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19309766|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309767|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309768|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309769|NCT04106999|Analgesics|analgesics|mesh-ancestor
19309770|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
19309771|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309772|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19309773|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19309774|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19309775|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309776|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309777|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309778|NCT04107194|Amoxicillin|amoxicillin|mesh-list
19309779|NCT04107194|Metronidazole|metronidazole|mesh-list
19309780|NCT04107194|Clarithromycin|clarithromycin|mesh-list
19309781|NCT04107194|Levofloxacin|levofloxacin|mesh-list
19309782|NCT04107194|Tetracycline|tetracycline|mesh-list
19309783|NCT04107194|Rifabutin|rifabutin|mesh-list
19309784|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19309785|NCT04107194|Pantoprazole|pantoprazole|mesh-list
19309786|NCT04107194|Bismuth|bismuth|mesh-list
19309787|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19309788|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309789|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19309790|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19309791|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19309792|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309793|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309794|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19309795|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19309796|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19309797|NCT04107194|Renal Agents|renal agents|mesh-ancestor
19309798|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19309799|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19309800|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309801|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19309802|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19309803|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19309804|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19309805|NCT04107194|Antacids|antacids|mesh-ancestor
19309806|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19309807|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
20368850|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20368851|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
20368852|NCT00961155|Montelukast|montelukast|mesh-list
20368853|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20368854|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
20368855|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309808|NCT04107220|Valsartan|valsartan|mesh-list
19309809|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19309810|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19693094|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368856|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309811|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19397016|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
19309812|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368857|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20368858|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
20368859|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20368860|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20368861|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20368862|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
20368863|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368864|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309813|NCT04107103|Nivolumab|nivolumab|mesh-list
19309814|NCT04107103|Pemetrexed|pemetrexed|mesh-list
19309815|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19309816|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309817|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19309818|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309819|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309820|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19309821|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19309822|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
19309823|NCT04106830|Azathioprine|azathioprine|mesh-list
19309824|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309825|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
19838705|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
19838706|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838707|NCT00622388|Ofatumumab|ofatumumab|mesh-list
19838708|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838709|NCT00622401|Interleukin-12|interleukin-12|mesh-list
19309826|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309827|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309828|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19309829|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19309830|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
19309831|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19309832|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309833|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309834|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309835|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
19309836|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19309837|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19309838|NCT04106752|Caffeine|caffeine|mesh-list
19309839|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19309840|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309841|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19309842|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309843|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309844|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19309845|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19309846|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
19309847|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838710|NCT00622401|Vaccines|vaccines|mesh-list
19838711|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
19838712|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838713|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19838714|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19309848|NCT04106700|Apixaban|apixaban|mesh-list
19838715|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838716|NCT00622401|Growth Substances|growth substances|mesh-ancestor
20186843|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186844|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186845|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20186846|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186847|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
20186848|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186849|NCT00205816|Tigecycline|tigecycline|mesh-list
20186850|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20186851|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20186852|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20186853|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186854|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186855|NCT00205842|Alvimopan|alvimopan|mesh-list
20186856|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186857|NCT00205946|Bupropion|bupropion|mesh-list
20186858|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19309849|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19309850|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
19309851|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19309852|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
19309853|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19309854|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309855|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
19309856|NCT04106804|Abatacept|abatacept|mesh-list
19309857|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19309858|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309859|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309860|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368865|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20368866|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
20368867|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368868|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20368869|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20368870|NCT00961194|Ketamine|ketamine|mesh-list
20368871|NCT00961194|Analgesics|analgesics|mesh-ancestor
20368872|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
20368873|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309861|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
19309862|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309863|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19309864|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19309865|NCT04106557|Gaboxadol|gaboxadol|mesh-list
19309866|NCT04106557|Analgesics|analgesics|mesh-ancestor
19309867|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
19309868|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309869|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309870|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
19309871|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
20368874|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368875|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20368876|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20368877|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
20368878|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
20368879|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368880|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20368881|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20368882|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368883|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368884|NCT00961324|Insulin|insulin|mesh-list
20368885|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20368886|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
20368887|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368888|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368889|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20368890|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19309872|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
19309873|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309874|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309875|NCT04106726|Ivermectin|ivermectin|mesh-list
19309876|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19309877|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309878|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19309879|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309880|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19309881|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
19309882|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
19309883|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309884|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
19309885|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309886|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309887|NCT04106362|Cisplatin|cisplatin|mesh-list
19309888|NCT04106362|Cetuximab|cetuximab|mesh-list
19309889|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19309890|NCT04106362|Antibodies|antibodies|mesh-list
19309891|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
19309892|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19309893|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
19309894|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309895|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309896|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
19309897|NCT04105985|Tetracaine|tetracaine|mesh-list
19309898|NCT04105985|Carticaine|carticaine|mesh-list
19309899|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
19309900|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
19309901|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309902|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309903|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
19309904|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309905|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19309906|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19309907|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309908|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309909|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309910|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
19672855|NCT05229627|Methylphenidate|methylphenidate|mesh-list
20186859|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
20425680|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
19309911|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
19309912|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
19309913|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19309914|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
19309915|NCT04106011|Gabapentin|gabapentin|mesh-list
19309916|NCT04106011|Analgesics|analgesics|mesh-ancestor
19309917|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
19309918|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309919|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309920|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
19309921|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19309922|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19309923|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309924|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19309925|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19309926|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19309927|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309928|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309929|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
19309930|NCT04106050|Lidocaine|lidocaine|mesh-list
19309931|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
19309932|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
19309933|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309934|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309935|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
19309936|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309937|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19309938|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19309939|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19309940|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19309941|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309942|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
19309943|NCT04105946|Remifentanil|remifentanil|mesh-list
19309944|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19309945|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19309946|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309947|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19309948|NCT04105946|Analgesics|analgesics|mesh-ancestor
19309949|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
19309950|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309951|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19309952|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20186860|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186861|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20186862|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20186863|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20186864|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186865|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
20186866|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186867|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186868|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20186869|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20186870|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186871|NCT00206024|Esomeprazole|esomeprazole|mesh-list
20186872|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20186873|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186874|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19672856|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19309953|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19309954|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
19309955|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309956|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309957|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19309958|NCT04105946|Narcotics|narcotics|mesh-ancestor
19309959|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19309960|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
19309961|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19309962|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
19309963|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309964|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
19309965|NCT04105920|Protective Agents|protective agents|mesh-ancestor
19309966|NCT04105764|Bromides|bromides|mesh-list
20368891|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368892|NCT00961363|Incretins|incretins|mesh-ancestor
20368893|NCT00961363|Hormones|hormones|mesh-ancestor
20368894|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368895|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20368896|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
20368897|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368898|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368899|NCT00961467|Thalidomide|thalidomide|mesh-list
20368900|NCT00961467|Prednisone|prednisone|mesh-list
20368901|NCT00961467|Melphalan|melphalan|mesh-list
20368902|NCT00961467|Lenalidomide|lenalidomide|mesh-list
20368903|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368904|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
20368905|NCT00961467|Hormones|hormones|mesh-ancestor
19309967|NCT04105764|Rocuronium|rocuronium|mesh-list
19309968|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19309969|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
19309970|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19309971|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19309972|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309973|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397017|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397018|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
19397019|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397020|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397021|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19397022|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
19397023|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397024|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397025|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19672857|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19672858|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368906|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368907|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368908|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20368909|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368910|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368911|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
20368912|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368913|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20368914|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20368915|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
20368916|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20368917|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20368918|NCT00961467|Growth Substances|growth substances|mesh-ancestor
20368919|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
20368920|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
19672859|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19672860|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19672861|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19692178|NCT04995354|Mitogens|mitogens|mesh-list
20368921|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20368922|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20368923|NCT00961480|Metformin|metformin|mesh-list
19397026|NCT03654612|Apatinib|apatinib|mesh-list
19397027|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397028|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19397029|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397030|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186875|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186876|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186877|NCT00206050|Esomeprazole|esomeprazole|mesh-list
20186878|NCT00206050|Pantoprazole|pantoprazole|mesh-list
19309974|NCT04105374|Flucytosine|flucytosine|mesh-list
19309975|NCT04105374|Temozolomide|temozolomide|mesh-list
19309976|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19309977|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
19309978|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309979|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19309980|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
19309981|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19309982|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
19309983|NCT04105426|Antioxidants|antioxidants|mesh-list
20186879|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20186880|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186881|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20186882|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368924|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20368925|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368926|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368927|NCT00961480|Incretins|incretins|mesh-ancestor
20368928|NCT00961480|Hormones|hormones|mesh-ancestor
20368929|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368930|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20368931|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
20368932|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368933|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368934|NCT00961753|Ibuprofen|ibuprofen|mesh-list
20368935|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20368936|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20368937|NCT00961753|Analgesics|analgesics|mesh-ancestor
20368938|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
19309984|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309985|NCT04105426|Protective Agents|protective agents|mesh-ancestor
19309986|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309987|NCT04105140|Oxytocin|oxytocin|mesh-list
19309988|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
19309989|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19309990|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309991|NCT04105231|Cannabidiol|cannabidiol|mesh-list
20186883|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186884|NCT00206063|Ximelagatran|ximelagatran|mesh-list
20186885|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
20186886|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20186887|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
20186888|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186889|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186890|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
20186891|NCT00206089|Ximelagatran|ximelagatran|mesh-list
20186892|NCT00206089|Melagatran|melagatran|mesh-list
20186893|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
20186894|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20186895|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
20186896|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186897|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186898|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
20186899|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20186900|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
20186901|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186902|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186903|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186904|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186905|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186906|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20186907|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
20186908|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186909|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186910|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186911|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368939|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19309992|NCT04105231|Risperidone|risperidone|mesh-list
19309993|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19309994|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
20186912|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368940|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368941|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19309995|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19309996|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19309997|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19309998|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19309999|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19310000|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19672862|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672863|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
19838717|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
19838718|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838719|NCT00622466|Paclitaxel|paclitaxel|mesh-list
19838720|NCT00622466|Sorafenib|sorafenib|mesh-list
19838721|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19838722|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186913|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20186914|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
20186915|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20186916|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20186917|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20186918|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20186919|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186920|NCT00206154|Budesonide|budesonide|mesh-list
20186921|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
20186922|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20186923|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20186924|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
20186925|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20186926|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186927|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20186928|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
20186929|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
20186930|NCT00206154|Hormones|hormones|mesh-ancestor
20186931|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186932|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20186933|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20186934|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20186935|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
20186936|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186937|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186938|NCT00206167|Budesonide|budesonide|mesh-list
19672864|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186939|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
20186940|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368942|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19672865|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19672866|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
19672867|NCT05229536|Vaccines|vaccines|mesh-list
19672868|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
19672869|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672870|NCT05229510|Ribavirin|ribavirin|mesh-list
19672871|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
19672872|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672873|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
19672874|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19672875|NCT05229497|Carboplatin|carboplatin|mesh-list
19672876|NCT05229497|Fluorouracil|fluorouracil|mesh-list
19672877|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672878|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
19672879|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672880|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672881|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19672882|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
19672883|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672884|NCT05229276|Bone wax|bone wax|mesh-list
19672885|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
19672886|NCT05229276|Coagulants|coagulants|mesh-ancestor
19672887|NCT05229042|Ricolinostat|ricolinostat|mesh-list
19672888|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672889|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19672890|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672891|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838723|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
19838724|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
19838725|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
19838726|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838727|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19310001|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19310002|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19310003|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
19310004|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
19310005|NCT04105205|Apramycin|apramycin|mesh-list
19310006|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19310007|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310008|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
19310009|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19310010|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310011|NCT04105023|Genistein|genistein|mesh-list
19310012|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19310013|NCT04105023|Protective Agents|protective agents|mesh-ancestor
19310014|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310015|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310016|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19310017|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310018|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672892|NCT05228951|Trastuzumab|trastuzumab|mesh-list
19672893|NCT05228951|Letrozole|letrozole|mesh-list
19672894|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19672895|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838728|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838729|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
19838730|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19838731|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838732|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19838733|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19838734|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
19838735|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838736|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186941|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20186942|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
20186943|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672896|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19672897|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19672898|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186944|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186945|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20186946|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
20186947|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
20186948|NCT00206167|Hormones|hormones|mesh-ancestor
20186949|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186950|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20186951|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20186952|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20186953|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
20186954|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20186955|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186956|NCT00206180|Esomeprazole|esomeprazole|mesh-list
20186957|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20186958|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20186959|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20186960|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20186961|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186962|NCT00206193|Misoprostol|misoprostol|mesh-list
20186963|NCT00206193|Sulprostone|sulprostone|mesh-list
20186964|NCT00206193|Mifepristone|mifepristone|mesh-list
20186965|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20186966|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
20186967|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19672899|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672900|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19672901|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
19672902|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19672903|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672904|NCT05228925|Vitamin D|vitamin d|mesh-list
19672905|NCT05228925|Vitamins|vitamins|mesh-ancestor
19672906|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
20368943|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20368944|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368945|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368946|NCT00961844|Temozolomide|temozolomide|mesh-list
20368947|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20368948|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
20368949|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368950|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368951|NCT00961857|Metformin|metformin|mesh-list
19310019|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
19310020|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19310021|NCT04105023|Estrogens|estrogens|mesh-ancestor
19310022|NCT04105023|Hormones|hormones|mesh-ancestor
19310023|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310024|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
19310025|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19310026|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310027|NCT04104867|Domperidone|domperidone|mesh-list
19310028|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
19310029|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
19310030|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310031|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310032|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310033|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19310034|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
20368952|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20368953|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368954|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368955|NCT00961857|Incretins|incretins|mesh-ancestor
20368956|NCT00961857|Hormones|hormones|mesh-ancestor
20368957|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368958|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20368959|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
20368960|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368961|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368962|NCT00961909|Metformin|metformin|mesh-list
20368963|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20368964|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310035|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310036|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310037|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
19310038|NCT04104984|Progesterone|progesterone|mesh-list
19310039|NCT04104984|Progestins|progestins|mesh-ancestor
19310040|NCT04104984|Hormones|hormones|mesh-ancestor
19310041|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310042|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310043|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19310044|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
19310045|NCT04104789|Tetracaine|tetracaine|mesh-list
19310046|NCT04104789|Carticaine|carticaine|mesh-list
19310047|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
19310048|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
19310049|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310050|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310051|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
19310052|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310053|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19310054|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19310055|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
19310056|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20368965|NCT00962026|Rilonacept|rilonacept|mesh-list
20368966|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425681|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20425682|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19310057|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310058|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
19310059|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
19310060|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
19310061|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19310062|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
19310063|NCT04104204|Morphine|morphine|mesh-list
19310064|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19310065|NCT04104204|Narcotics|narcotics|mesh-ancestor
19310066|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310067|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310068|NCT04104204|Analgesics|analgesics|mesh-ancestor
19310069|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
19310070|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310071|NCT04104438|Everolimus|everolimus|mesh-list
19310072|NCT04104438|Basiliximab|basiliximab|mesh-list
19310073|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310074|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19310075|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
19310076|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310077|NCT04104334|Remifentanil|remifentanil|mesh-list
19310078|NCT04104334|Desflurane|desflurane|mesh-list
19310079|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
19310080|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310081|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310082|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19310083|NCT04104334|Narcotics|narcotics|mesh-ancestor
19310084|NCT04104334|Analgesics|analgesics|mesh-ancestor
19310085|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
19310086|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310087|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19310088|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
19310089|NCT04103684|Dexamethasone|dexamethasone|mesh-list
19310090|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
19310091|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19310092|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19310093|NCT04103684|Prednisolone|prednisolone|mesh-list
19310094|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
19310095|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19310096|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
19310097|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310098|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
19310099|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
19310100|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310101|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310102|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310103|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
19310104|NCT04103684|Hormones|hormones|mesh-ancestor
19310105|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310106|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19310107|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310108|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19310109|NCT04103684|Protective Agents|protective agents|mesh-ancestor
19397031|NCT03654365|Caffeine|caffeine|mesh-list
19397032|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19397033|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397034|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19397035|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397036|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397037|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19397038|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19397039|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
19397040|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397041|NCT03654274|Norethindrone|norethindrone|mesh-list
19397042|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
19397043|NCT03654274|Estradiol|estradiol|mesh-list
19397044|NCT03654274|Relugolix|relugolix|mesh-list
19397045|NCT03654274|Estrogens|estrogens|mesh-ancestor
19397046|NCT03654274|Hormones|hormones|mesh-ancestor
19397047|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397048|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397049|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19397050|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
19397051|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19397052|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19397053|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19397054|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19397055|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19397056|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
19397057|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
19397058|NCT03654170|BI 425809|bi 425809|mesh-list
19397059|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
19397060|NCT03654144|Dienogest|dienogest|mesh-list
19397061|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
19397062|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
19397063|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19672907|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397064|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20368967|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20368968|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
20368969|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
20368970|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
20368971|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368972|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20368973|NCT00962234|Protective Agents|protective agents|mesh-ancestor
20368974|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368975|NCT00962286|Furosemide|furosemide|mesh-list
20368976|NCT00962286|Diuretics|diuretics|mesh-ancestor
20368977|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
20368978|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368979|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20368980|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20368981|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368982|NCT00962299|Beclomethasone|beclomethasone|mesh-list
20368983|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20368984|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
20368985|NCT00962299|Hormones|hormones|mesh-ancestor
20368986|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20368987|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368988|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20368989|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
20368990|NCT00962312|Capecitabine|capecitabine|mesh-list
20368991|NCT00962312|Lapatinib|lapatinib|mesh-list
19310110|NCT04103905|Antibodies|antibodies|mesh-list
19310111|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19310112|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
19310113|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310114|NCT04103697|Capecitabine|capecitabine|mesh-list
19310115|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
19310116|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310117|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
19310118|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310119|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310120|NCT04103489|Eculizumab|eculizumab|mesh-list
19310121|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19310122|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19310123|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
19310124|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310125|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
19310126|NCT04103476|Estrogens|estrogens|mesh-list
19310127|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19310128|NCT04103476|Hormones|hormones|mesh-ancestor
19310129|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310130|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310131|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19310132|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19310133|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
19310134|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19310135|NCT04103398|Sorafenib|sorafenib|mesh-list
19310136|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
19310137|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310138|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19310139|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310140|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310141|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19310142|NCT04103398|Estrogens|estrogens|mesh-ancestor
19310143|NCT04103398|Hormones|hormones|mesh-ancestor
19310144|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310145|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310146|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19310147|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
19310148|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19310149|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
19310150|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310151|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
19310152|NCT04103125|Protective Agents|protective agents|mesh-ancestor
19310153|NCT04102995|Pregnanolone|pregnanolone|mesh-list
19310154|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
19310155|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20368992|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310156|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20368993|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
20612741|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
20368994|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20368995|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20368996|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20368997|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20368998|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
20368999|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20369000|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
20369001|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369002|NCT00962442|Expectorants|expectorants|mesh-ancestor
20369003|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
20369004|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20369005|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
20369006|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369007|NCT00962442|Protective Agents|protective agents|mesh-ancestor
20369008|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369009|NCT00962442|Antidotes|antidotes|mesh-ancestor
20369010|NCT00962507|Everolimus|everolimus|mesh-list
20369011|NCT00962507|Panobinostat|panobinostat|mesh-list
19310157|NCT04102878|Anesthetics|anesthetics|mesh-list
19310158|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
19310159|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310160|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310161|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
19310162|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310163|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
19310164|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310165|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19310166|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
19310167|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
19310168|NCT04102670|Protective Agents|protective agents|mesh-ancestor
19310169|NCT04102943|Tacrolimus|tacrolimus|mesh-list
19310170|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19310171|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
19310172|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310173|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19310174|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310175|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310176|NCT04102592|Permethrin|permethrin|mesh-list
19310177|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310178|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310179|NCT04102267|Epinephrine|epinephrine|mesh-list
19310180|NCT04102267|Bupivacaine|bupivacaine|mesh-list
19310181|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
19310182|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
19310183|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310184|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310185|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
19310186|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310187|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19310188|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19310189|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
19310190|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310191|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310192|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19310193|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19310194|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
20369012|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369013|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20369014|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
20369015|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369016|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20369017|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369018|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369019|NCT00962533|Telbivudine|telbivudine|mesh-list
20369020|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
20369021|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369022|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20369023|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369024|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369025|NCT00962624|Vaccines|vaccines|mesh-list
20369026|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
20369027|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310195|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20369028|NCT00962637|Citric Acid|citric acid|mesh-list
20369029|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
20369030|NCT00962637|Enclomiphene|enclomiphene|mesh-list
19310196|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
19310197|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
19310198|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
19310199|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19310200|NCT04102449|Apremilast|apremilast|mesh-list
19310201|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19310202|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19310203|NCT04102449|Analgesics|analgesics|mesh-ancestor
19310204|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
19310205|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310206|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310207|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20369031|NCT00962637|Clomiphene|clomiphene|mesh-list
20369032|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
20369033|NCT00962637|Testosterone|testosterone|mesh-list
20369034|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
20369035|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20369036|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
20369037|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
20369038|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369039|NCT00962637|Androgens|androgens|mesh-ancestor
20369040|NCT00962637|Hormones|hormones|mesh-ancestor
20369041|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369042|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369043|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20369044|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
20369045|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20369046|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
20369047|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20369048|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20369049|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19310208|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19310209|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19310210|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19310211|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310212|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310213|NCT04102566|Ibuprofen|ibuprofen|mesh-list
19310214|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20369050|NCT00962663|Ibuprofen|ibuprofen|mesh-list
20369051|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20369052|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369053|NCT00962663|Analgesics|analgesics|mesh-ancestor
19310215|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19310216|NCT04102566|Analgesics|analgesics|mesh-ancestor
19310217|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
19310218|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310219|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310220|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310221|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19310222|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19310223|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310224|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369054|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
20369055|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369056|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369057|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20369058|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369059|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20369060|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369061|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310225|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
19310226|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
19310227|NCT04102176|Protective Agents|protective agents|mesh-ancestor
19310228|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310229|NCT04101929|Irinotecan|irinotecan|mesh-list
19310230|NCT04101929|Apatinib|apatinib|mesh-list
19310231|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19310232|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19310233|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310234|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310235|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310236|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19310237|NCT04102072|Dobutamine|dobutamine|mesh-list
19310238|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20369062|NCT00962715|Interferons|interferons|mesh-list
19310239|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
19310240|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
19310241|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310242|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310243|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19310244|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19310245|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20369063|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
20369064|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
20369065|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19310246|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19310247|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310248|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310249|NCT04102072|Protective Agents|protective agents|mesh-ancestor
20186968|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186969|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20186970|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310253|NCT04101812|Doxorubicin|doxorubicin|mesh-list
19310254|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19310255|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19310256|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310257|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19310258|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19310259|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310260|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310261|NCT04101500|Aminophylline|aminophylline|mesh-list
19310262|NCT04101500|Bromides|bromides|mesh-list
19310263|NCT04101500|Ipratropium|ipratropium|mesh-list
19310264|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
19310265|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19310266|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
19310267|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310268|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310269|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19310270|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
19310271|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19310272|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
19310273|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310274|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310275|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19310276|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19310277|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310278|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19310279|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19310280|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
19310281|NCT04101500|Protective Agents|protective agents|mesh-ancestor
19310282|NCT04101474|Ketamine|ketamine|mesh-list
19310283|NCT04101474|Analgesics|analgesics|mesh-ancestor
19310284|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
19310285|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310286|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310287|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19310288|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19310289|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
19310290|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
20186971|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
20186972|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20186973|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20186974|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20186975|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20186976|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
20186977|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20186978|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20186979|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
20186980|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186981|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
20186982|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20186983|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20186984|NCT00206219|Methotrexate|methotrexate|mesh-list
20186985|NCT00206219|Gefitinib|gefitinib|mesh-list
20186986|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20186987|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
19310291|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369066|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310292|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19310293|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19310294|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310295|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310296|NCT04101682|Bupivacaine|bupivacaine|mesh-list
19310297|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
19310298|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
19310299|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310300|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310301|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
19310302|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310303|NCT04101578|Cyclosporine|cyclosporine|mesh-list
19310304|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
19310305|NCT04101578|Prednisone|prednisone|mesh-list
19310306|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
19310307|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
19310308|NCT04101578|Methotrexate|methotrexate|mesh-list
19310309|NCT04101578|Azathioprine|azathioprine|mesh-list
19310310|NCT04101578|Bromides|bromides|mesh-list
19310311|NCT04101578|Tacrolimus|tacrolimus|mesh-list
19310312|NCT04101578|Cyclosporins|cyclosporins|mesh-list
19310313|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19310314|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
19310315|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19310316|NCT04101578|Antibodies|antibodies|mesh-list
19310317|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
19310318|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19310319|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19310320|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
19310321|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310322|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19310323|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19838737|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20369067|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
19310324|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
19310325|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310326|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310327|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19310328|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310329|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
19310330|NCT04101578|Hormones|hormones|mesh-ancestor
19310331|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310332|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19310333|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19310334|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
19310335|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19310336|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310337|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
19310338|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
19310339|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310340|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19310341|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19310342|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19310343|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
19310344|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310345|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19310346|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19310347|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
19310348|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19310349|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
19310350|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
19310351|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310352|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310353|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19310354|NCT04101578|Protective Agents|protective agents|mesh-ancestor
19310355|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
19310356|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19310357|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
19310358|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397065|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397066|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19397067|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19397068|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19397069|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19397070|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
19404378|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
19310359|NCT04101708|Amoxicillin|amoxicillin|mesh-list
19310360|NCT04101708|Clarithromycin|clarithromycin|mesh-list
19310361|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19310362|NCT04101708|Lansoprazole|lansoprazole|mesh-list
19310363|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
19310364|NCT04101708|Bismuth|bismuth|mesh-list
19310365|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19310366|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310367|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19310368|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310369|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310370|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19310371|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19310372|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19310373|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310374|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19310375|NCT04101708|Antacids|antacids|mesh-ancestor
19310376|NCT04101760|Sargramostim|sargramostim|mesh-list
19310377|NCT04101760|Lenograstim|lenograstim|mesh-list
19310378|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
19310379|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310380|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19310381|NCT04101370|Bosentan|bosentan|mesh-list
19310382|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19310383|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19310384|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310385|NCT04101227|Ondansetron|ondansetron|mesh-list
19310386|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
19310387|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
19310388|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310389|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310390|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310391|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
19310392|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
19310393|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19310394|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
19310395|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310396|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310397|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19310398|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19310399|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310400|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19310401|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19310402|NCT04101136|Atorvastatin|atorvastatin|mesh-list
19310403|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19310404|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19310405|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
19310406|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310407|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19672908|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19672909|NCT05228743|Paclitaxel|paclitaxel|mesh-list
19672910|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19672911|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672912|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
19672913|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
19672914|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
19672915|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672916|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
19672917|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19310408|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19310409|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310410|NCT04101019|Lidocaine|lidocaine|mesh-list
19310411|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
19310412|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
19310413|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310414|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310415|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
19310416|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310417|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19310418|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19310419|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19310420|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19672918|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310421|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672919|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
20369068|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369069|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
20369070|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369071|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
20369072|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20369073|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369074|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
20369075|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
20369076|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20369077|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20369078|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369079|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369080|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369081|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369082|NCT00962936|Pidilizumab|pidilizumab|mesh-list
20369083|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19310422|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
19310423|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
19310424|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19310425|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19310426|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310427|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310428|NCT04100759|Urological Agents|urological agents|mesh-ancestor
19310429|NCT04100772|Vaccines|vaccines|mesh-list
19310430|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
19310431|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310432|NCT04100655|Molgramostim|molgramostim|mesh-list
19310433|NCT04100655|Estradiol|estradiol|mesh-list
19310434|NCT04100655|Sargramostim|sargramostim|mesh-list
19310435|NCT04100655|Estrogens|estrogens|mesh-ancestor
19310436|NCT04100655|Hormones|hormones|mesh-ancestor
19310437|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310438|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310439|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
19310440|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310441|NCT04101383|Insulin|insulin|mesh-list
20369084|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369085|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20369086|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
20369087|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369088|NCT00963001|Treprostinil|treprostinil|mesh-list
20369089|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369090|NCT00963027|Treprostinil|treprostinil|mesh-list
20369091|NCT00963027|Esomeprazole|esomeprazole|mesh-list
20369092|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20369093|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20369094|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20369095|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369096|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369097|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369098|NCT00963040|Oxytocin|oxytocin|mesh-list
20369099|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
20369100|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20369101|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369102|NCT00963131|Antioxidants|antioxidants|mesh-list
20369103|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369104|NCT00963131|Protective Agents|protective agents|mesh-ancestor
20369105|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369106|NCT00963209|Tamoxifen|tamoxifen|mesh-list
20369107|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20369108|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
20369109|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369110|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369111|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20369112|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310442|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19310443|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
19310444|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19310445|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369113|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20369114|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19310446|NCT04100824|Nimodipine|nimodipine|mesh-list
20369115|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20369116|NCT00963222|Vitamin A|vitamin a|mesh-list
20369117|NCT00963222|Vitamins|vitamins|mesh-ancestor
20369118|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
19310447|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19310448|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19310449|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19310450|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310451|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19310452|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310453|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
19310454|NCT04100330|Cytarabine|cytarabine|mesh-list
20369119|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369120|NCT00963274|Bortezomib|bortezomib|mesh-list
20369121|NCT00963274|Romidepsin|romidepsin|mesh-list
20369122|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369123|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20369124|NCT00963313|Adalimumab|adalimumab|mesh-list
20369125|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310455|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310456|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
19310457|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310458|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369126|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369127|NCT00963443|Aspirin|aspirin|mesh-list
20369128|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
20369129|NCT00963443|Ephedrine|ephedrine|mesh-list
20369130|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20369131|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369132|NCT00963443|Analgesics|analgesics|mesh-ancestor
20369133|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
20369134|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369135|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369136|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20369137|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369138|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20369139|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20369140|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369141|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20369142|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20369143|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369144|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
20369145|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20369146|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
20369147|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20369148|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
20369149|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
20369150|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20369151|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20369152|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
20369153|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369154|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369155|NCT00963534|Rituximab|rituximab|mesh-list
20369156|NCT00963534|Lenalidomide|lenalidomide|mesh-list
19310459|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
19310460|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310461|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19310462|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
19310463|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310464|NCT04100473|Insulin|insulin|mesh-list
19310465|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19310466|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
19310467|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19310468|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310469|NCT04100226|Vitamin D|vitamin d|mesh-list
19310470|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
19310471|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
19310472|NCT04100226|Vitamins|vitamins|mesh-ancestor
19310473|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
19310474|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310475|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19672920|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19672921|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19310476|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19310477|NCT04100226|Antacids|antacids|mesh-ancestor
19310478|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672922|NCT05228431|Capecitabine|capecitabine|mesh-list
20369157|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20369158|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19310479|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20369159|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369160|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
19310480|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
19310481|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19310482|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19310483|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310484|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
19310485|NCT04100447|Coagulants|coagulants|mesh-ancestor
19310486|NCT04100434|Evolocumab|evolocumab|mesh-list
19310487|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19310488|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19310489|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
19310490|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310491|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19310492|NCT04100083|Spironolactone|spironolactone|mesh-list
19310493|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19310494|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
19310495|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310496|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310497|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19310498|NCT04100083|Diuretics|diuretics|mesh-ancestor
19310499|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
19310500|NCT04099771|Ketamine|ketamine|mesh-list
19310501|NCT04099771|Analgesics|analgesics|mesh-ancestor
19310502|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
19310503|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310504|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310505|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19310506|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19310507|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
19310508|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
19310509|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310510|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19310511|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19310512|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310513|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310514|NCT04099563|Abrocitinib|abrocitinib|mesh-list
19310515|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19310516|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310517|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310518|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
19310519|NCT04099641|Bavituximab|bavituximab|mesh-list
19310520|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19310521|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310522|NCT04099732|Dabigatran|dabigatran|mesh-list
19310523|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19310524|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19310525|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19310526|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
19672923|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19672924|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
19672925|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672926|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672927|NCT05228418|Naltrexone|naltrexone|mesh-list
19672928|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19672929|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19672930|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838738|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
20186988|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19310527|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310528|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19310529|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19310530|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310531|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
19310532|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19310533|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
20186989|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310534|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
19397071|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20186990|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20186991|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
20186992|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20186993|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20186994|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
20186995|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310535|NCT04099407|Pirfenidone|pirfenidone|mesh-list
19310536|NCT04099407|Analgesics|analgesics|mesh-ancestor
19310537|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
19310538|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310539|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310540|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19310541|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19310542|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310543|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19310544|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310545|NCT04099238|Warfarin|warfarin|mesh-list
19310546|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
19310547|NCT04099238|Dabigatran|dabigatran|mesh-list
19310548|NCT04099238|Apixaban|apixaban|mesh-list
19310549|NCT04099238|Edoxaban|edoxaban|mesh-list
19310550|NCT04099238|Anticoagulants|anticoagulants|mesh-list
19310551|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
19310552|NCT04099238|Phenindione|phenindione|mesh-list
19310553|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19310554|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
19310555|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19310556|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
19310557|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310558|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310559|NCT04099069|Anesthetics|anesthetics|mesh-list
19310560|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310561|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310562|NCT04099303|Vaccines|vaccines|mesh-list
19310563|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
19310564|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310565|NCT04098861|Timolol|timolol|mesh-list
19310566|NCT04098861|Latanoprost|latanoprost|mesh-list
19310567|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19310568|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19310569|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
19310570|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310571|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310572|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310573|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19310574|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19310575|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19310576|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19310577|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
19310578|NCT04098653|Busulfan|busulfan|mesh-list
19310579|NCT04098653|Decitabine|decitabine|mesh-list
19310580|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19310581|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
19310582|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310583|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19310584|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19310585|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
19310586|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310587|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310588|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19310589|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310590|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
19310591|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310592|NCT04098874|Bupropion|bupropion|mesh-list
19310593|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19310594|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
19310595|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19310596|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20369161|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369162|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369163|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20369164|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20369165|NCT00963534|Growth Substances|growth substances|mesh-ancestor
20369166|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
19310597|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19310598|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19310599|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310600|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
20369167|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19310601|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310602|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310603|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19310604|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19310605|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310606|NCT04098718|Prednisolone|prednisolone|mesh-list
19310607|NCT04098718|Benralizumab|benralizumab|mesh-list
19310608|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310609|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
19310610|NCT04098718|Hormones|hormones|mesh-ancestor
19310611|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310612|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310613|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19310614|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310615|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19310616|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
19310617|NCT04098796|Antibodies|antibodies|mesh-list
19310618|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
19310619|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20186996|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20186997|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20186998|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
20186999|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20187000|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19310625|NCT04098302|Dutasteride|dutasteride|mesh-list
19310626|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19310627|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19310628|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310629|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310630|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
19310631|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310632|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310633|NCT04098081|Gemcitabine|gemcitabine|mesh-list
19310634|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
19310635|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310636|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
19310637|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310638|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310639|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
19310640|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310641|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310642|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19310643|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
19310644|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310645|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
19310646|NCT04097847|Tocopherols|tocopherols|mesh-list
19310647|NCT04097847|Vitamin E|vitamin e|mesh-list
19310648|NCT04097847|Tocotrienols|tocotrienols|mesh-list
19310649|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
19310650|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
19310651|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19310652|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310653|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310654|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19310655|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19310656|NCT04097847|Protective Agents|protective agents|mesh-ancestor
19310657|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310658|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
19310659|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19310660|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
19310661|NCT04097847|Vitamins|vitamins|mesh-ancestor
19310662|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
19310663|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19310664|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
19310665|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19310666|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19310667|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
19310668|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310669|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19310670|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19310671|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310672|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672931|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
20187001|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20187002|NCT00206232|Spironolactone|spironolactone|mesh-list
20187003|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20187004|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
19310673|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19310674|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19310675|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
19310676|NCT04097613|Budesonide|budesonide|mesh-list
19310677|NCT04097613|Povidone|povidone|mesh-list
19310678|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310679|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19310680|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
19310681|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310682|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310683|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19310684|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
19310685|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
19310686|NCT04097613|Hormones|hormones|mesh-ancestor
19310687|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310688|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
19310689|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
19310690|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19310691|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310692|NCT04097574|Menthol|menthol|mesh-list
19310693|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
19310694|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
19310695|NCT04097444|Leucovorin|leucovorin|mesh-list
19310696|NCT04097444|Bevacizumab|bevacizumab|mesh-list
19310697|NCT04097444|Fluorouracil|fluorouracil|mesh-list
19310698|NCT04097444|Capecitabine|capecitabine|mesh-list
19310699|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
19310700|NCT04097444|Irinotecan|irinotecan|mesh-list
19310701|NCT04097444|Calcium|calcium|mesh-list
19310702|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
19310703|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19310704|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310705|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19310706|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19310707|NCT04097444|Growth Substances|growth substances|mesh-ancestor
19310708|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310709|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
19310710|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19310711|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
19310712|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310713|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310714|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19310715|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
19310716|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19310717|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19310718|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310719|NCT04097444|Antidotes|antidotes|mesh-ancestor
19310720|NCT04097444|Protective Agents|protective agents|mesh-ancestor
19310721|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
19310722|NCT04097444|Vitamins|vitamins|mesh-ancestor
19310723|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
19310724|NCT04097288|Dexetimide|dexetimide|mesh-list
19310725|NCT04097288|Citalopram|citalopram|mesh-list
19310726|NCT04097288|Reboxetine|reboxetine|mesh-list
19310727|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19310728|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19310729|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19310730|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310731|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838739|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19838740|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19838741|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19838742|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
19838743|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369168|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
19310732|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
19310733|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310734|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19310735|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
19310736|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19310737|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19310738|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19310739|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
19310740|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
19310741|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310742|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20428577|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19310743|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19310744|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
19310745|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19310746|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
19397072|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19397073|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397074|NCT03654105|Aspirin|aspirin|mesh-list
19397075|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397076|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397077|NCT03654105|Analgesics|analgesics|mesh-ancestor
19397078|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
19397079|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397080|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397081|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397082|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397083|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19397084|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19397085|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397086|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19397087|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19397088|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397089|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
19397090|NCT03654053|Simvastatin|simvastatin|mesh-list
19397091|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19397092|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19397093|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
19397094|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397095|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19397096|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19397097|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369169|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369170|NCT00963573|Loratadine|loratadine|mesh-list
19397098|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
19397099|NCT03654040|Everolimus|everolimus|mesh-list
19397100|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397101|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
19397102|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397103|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397104|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19397105|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
19397106|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397107|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397108|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19397109|NCT03654027|Docetaxel|docetaxel|mesh-list
19397110|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397111|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
19397112|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
19397113|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
19397114|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404379|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
19404380|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187005|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187006|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187007|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20187008|NCT00206232|Diuretics|diuretics|mesh-ancestor
20187009|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
20187010|NCT00206258|Pramlintide|pramlintide|mesh-list
20187011|NCT00206258|Glucagon|glucagon|mesh-list
20187012|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187013|NCT00206258|Hormones|hormones|mesh-ancestor
19404381|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404382|NCT03595254|Nicotine|nicotine|mesh-list
19404383|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19404384|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
19404385|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404386|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404387|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19404388|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19404389|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
19404390|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404391|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404392|NCT03595189|Cilastatin|cilastatin|mesh-list
19404393|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
19404394|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369171|NCT00963573|Betamethasone|betamethasone|mesh-list
20369172|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310747|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
19310748|NCT04096768|Ketamine|ketamine|mesh-list
19310749|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19310750|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310751|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310752|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19310753|NCT04096768|Analgesics|analgesics|mesh-ancestor
19310754|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
19310755|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310756|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19310757|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19310758|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19310759|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
19310760|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310761|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310762|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19310763|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19310764|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
19310765|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
19310766|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19310767|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19310768|NCT04097028|Trifluridine|trifluridine|mesh-list
19310769|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
19672932|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369173|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
20369174|NCT00963573|Hormones|hormones|mesh-ancestor
20369175|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310770|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310771|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
19310772|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310773|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
19310774|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310775|NCT04096599|Fluorides|fluorides|mesh-list
19310776|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
19310777|NCT04096599|Protective Agents|protective agents|mesh-ancestor
19310778|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310779|NCT04096742|Tretinoin|tretinoin|mesh-list
19310780|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310781|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
19310782|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
19310783|NCT04096638|Atezolizumab|atezolizumab|mesh-list
19310784|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310785|NCT04096690|Pegaspargase|pegaspargase|mesh-list
19310786|NCT04096690|Antibodies|antibodies|mesh-list
19310787|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19310788|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
19310789|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310790|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310791|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
19310792|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19310793|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
19310794|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19310795|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
19310796|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310797|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310798|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
19310799|NCT04096157|Isavuconazole|isavuconazole|mesh-list
19310800|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
19310801|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310802|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19310803|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19310804|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310805|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310806|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
19310807|NCT04095754|Anesthetics|anesthetics|mesh-list
19310808|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310809|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310810|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19310811|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19310812|NCT04095754|Analgesics|analgesics|mesh-ancestor
19310813|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
19310814|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310815|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19310816|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19310817|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19310818|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
19310819|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369176|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369177|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20369178|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
20369179|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
19310820|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310821|NCT04095715|Hemostatics|hemostatics|mesh-list
19310822|NCT04095715|Coagulants|coagulants|mesh-ancestor
19310823|NCT04096027|Cabergoline|cabergoline|mesh-list
19310824|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19310825|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19310826|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
19310827|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
19310828|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310829|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310830|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310831|NCT04095832|Anesthetics|anesthetics|mesh-list
19310832|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310833|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310834|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
19310835|NCT04095624|Narcotics|narcotics|mesh-ancestor
19310836|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310837|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310838|NCT04095624|Analgesics|analgesics|mesh-ancestor
19310839|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
19310840|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310841|NCT04095312|Pancrelipase|pancrelipase|mesh-list
19310842|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310843|NCT04095390|Capecitabine|capecitabine|mesh-list
19310844|NCT04095390|Letrozole|letrozole|mesh-list
19310845|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310846|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
20187014|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187015|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187016|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20187017|NCT00206297|Pramlintide|pramlintide|mesh-list
20187018|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20187019|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187020|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20187021|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20187022|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20187023|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
20187024|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187025|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20187026|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20187027|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187028|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
20187029|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20187030|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
20187031|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187032|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20187033|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20187034|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
19310847|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310848|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310849|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19310850|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19310851|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310852|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19310853|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
19310854|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310855|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310856|NCT04095455|Ketamine|ketamine|mesh-list
19310857|NCT04095455|Analgesics|analgesics|mesh-ancestor
19310858|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
20187035|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187036|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187037|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20187038|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
20369180|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
19310859|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310860|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310861|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19310862|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19310863|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
19310864|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
19310865|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310866|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19310867|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20369181|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20369182|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20369183|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20369184|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
20369185|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
20369186|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369187|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369188|NCT00963664|Interferons|interferons|mesh-list
20369189|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
19310868|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310869|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310870|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19310871|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
19310872|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19310873|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19310874|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19310875|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310876|NCT04095299|Capecitabine|capecitabine|mesh-list
19310877|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19310878|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
19310879|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310880|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310881|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
19310882|NCT04095169|Complement C3|complement c3|mesh-list
19310883|NCT04095169|Complement C3d|complement c3d|mesh-list
19310884|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
19310885|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310886|NCT04094948|Clenbuterol|clenbuterol|mesh-list
19310887|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19310888|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19310889|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
19310890|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310891|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310892|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310893|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19310894|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
19310895|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310896|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19310897|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
19310898|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
19310899|NCT04095013|Fentanyl|fentanyl|mesh-list
19310900|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
19310901|NCT04095013|Bupivacaine|bupivacaine|mesh-list
19310902|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
19310903|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
19310904|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310905|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369190|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
20369191|NCT00963664|Lovastatin|lovastatin|mesh-list
20369192|NCT00963664|L 647318|l 647318|mesh-list
20369193|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
20369194|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369195|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
20369196|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369197|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
20369198|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369199|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19310906|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
19310907|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310908|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19310909|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19310910|NCT04095013|Analgesics|analgesics|mesh-ancestor
19310911|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19310912|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19838744|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310913|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19310914|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
19838745|NCT00622700|Teriflunomide|teriflunomide|mesh-list
20369200|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19310915|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19310916|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310917|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19310918|NCT04095013|Narcotics|narcotics|mesh-ancestor
19310919|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19310920|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19310921|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
19397115|NCT03653845|Epinephrine|epinephrine|mesh-list
19397116|NCT03653845|Racepinephrine|racepinephrine|mesh-list
19397117|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
19397118|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19397119|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19397120|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
19397121|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397122|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397123|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397124|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19397125|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19397126|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
19397127|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397128|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19397129|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
19397130|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
19397131|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
19397132|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19397133|NCT03653663|Simvastatin|simvastatin|mesh-list
19397134|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19397135|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19397136|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
19397137|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397138|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19397139|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19397140|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397141|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19397142|NCT03653546|Gefitinib|gefitinib|mesh-list
19397143|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369201|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
20369202|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369203|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20369204|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20369205|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369206|NCT00963690|Hemostatics|hemostatics|mesh-list
20369207|NCT00963690|Coagulants|coagulants|mesh-ancestor
20369208|NCT00963703|Rituximab|rituximab|mesh-list
20369209|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20369210|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369211|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
20369212|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369213|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397144|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19397145|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397146|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397147|NCT03653520|Diazepam|diazepam|mesh-list
19397148|NCT03653520|Tramadol|tramadol|mesh-list
19397149|NCT03653520|Ondansetron|ondansetron|mesh-list
19397150|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
19397151|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
19397152|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397153|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397154|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19397155|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
19397156|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
19397157|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19397158|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
19397159|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397160|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397161|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19397162|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19397163|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397164|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397165|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19397166|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19397167|NCT03653520|Narcotics|narcotics|mesh-ancestor
20369214|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
19397168|NCT03653520|Analgesics|analgesics|mesh-ancestor
19397169|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
20369215|NCT00963729|Docetaxel|docetaxel|mesh-list
19310922|NCT04094805|Calcitriol|calcitriol|mesh-list
19310923|NCT04094805|Dexamethasone|dexamethasone|mesh-list
19310924|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19310925|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
19310926|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
19310927|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310928|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310929|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19310930|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
19310931|NCT04094805|Hormones|hormones|mesh-ancestor
19310932|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310933|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19310934|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310935|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19310936|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19310937|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19310938|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310939|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19310940|NCT04094805|Vitamins|vitamins|mesh-ancestor
19310941|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
19310942|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19310943|NCT04094909|Paclitaxel|paclitaxel|mesh-list
19310944|NCT04094909|Cisplatin|cisplatin|mesh-list
19310945|NCT04094909|Carboplatin|carboplatin|mesh-list
19310946|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
19310947|NCT04094909|Pemetrexed|pemetrexed|mesh-list
19310948|NCT04094909|Endostatins|endostatins|mesh-list
19310949|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19310950|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310951|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19310952|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187039|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19310953|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
19310954|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19310955|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19310956|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19310957|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19310958|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19310959|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19310960|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19310961|NCT04094909|Growth Substances|growth substances|mesh-ancestor
19310962|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310963|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
19310964|NCT04094727|Lumefantrine|lumefantrine|mesh-list
19310965|NCT04094727|Artemether|artemether|mesh-list
19310966|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19310967|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
19310968|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19310969|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19310970|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310971|NCT04094584|Naltrexone|naltrexone|mesh-list
19310972|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19310973|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19310974|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310975|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
19310976|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310977|NCT04094597|Lactoferrin|lactoferrin|mesh-list
19310978|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19310979|NCT04094532|Bupivacaine|bupivacaine|mesh-list
19310980|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
19310981|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
19310982|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310983|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310984|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
19310985|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19310986|NCT04094467|Leuprolide|leuprolide|mesh-list
19310987|NCT04094467|Cetrorelix|cetrorelix|mesh-list
19310988|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19310989|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
19310990|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19310991|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19310992|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19310993|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19310994|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
19310995|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19310996|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
19310997|NCT04094701|Narcotics|narcotics|mesh-ancestor
19310998|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19310999|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311000|NCT04094701|Analgesics|analgesics|mesh-ancestor
19311001|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
19311002|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311003|NCT04094090|Riboflavin|riboflavin|mesh-list
19311004|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
19311005|NCT04094090|Vitamins|vitamins|mesh-ancestor
19311006|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
19311007|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311008|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19311009|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
19311010|NCT04094142|Lenalidomide|lenalidomide|mesh-list
19311011|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
19311012|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311013|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
19311014|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311015|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19311016|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19311017|NCT04094142|Growth Substances|growth substances|mesh-ancestor
19311018|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
19311019|NCT04093895|Taurolidine|taurolidine|mesh-list
19838746|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19838747|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19838748|NCT00622700|Analgesics|analgesics|mesh-ancestor
19838749|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
19838750|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838751|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838752|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311020|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311021|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19311022|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311023|NCT04093518|Estradiol|estradiol|mesh-list
19311024|NCT04093518|Estrogens|estrogens|mesh-ancestor
19311025|NCT04093518|Hormones|hormones|mesh-ancestor
19311026|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311027|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311028|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
19311029|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311030|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311031|NCT04093531|Ustekinumab|ustekinumab|mesh-list
19311032|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
19311033|NCT04093713|Nordefrin|nordefrin|mesh-list
19311034|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19311035|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
19311036|NCT04093648|Fludarabine|fludarabine|mesh-list
19311037|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19311038|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
19311039|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311040|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19311041|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19311042|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
19311043|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311044|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311045|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19311046|NCT04093206|Vitamins|vitamins|mesh-list
19311047|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
19311048|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
19311049|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311050|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
19311051|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311052|NCT04093206|Protective Agents|protective agents|mesh-ancestor
19311053|NCT04093219|Acetaminophen|acetaminophen|mesh-list
19311054|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19311055|NCT04093219|Analgesics|analgesics|mesh-ancestor
19311056|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
19311057|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311058|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311059|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
19311060|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
19311061|NCT04093271|Promethazine|promethazine|mesh-list
19311062|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19311063|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19311064|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311065|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311066|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311067|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
19311068|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
19311069|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311070|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
19311071|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
19311072|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311073|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19311074|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
19311075|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
19311076|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311077|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311078|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19311079|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
19311080|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
19311081|NCT04093050|Vasopressins|vasopressins|mesh-list
19311082|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
19311083|NCT04093050|Coagulants|coagulants|mesh-ancestor
19311084|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19311085|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19311086|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
19311087|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311088|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
19311089|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
19311090|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397170|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19397171|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
19397172|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19397173|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19397174|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19397175|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19397176|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
19397177|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
19397178|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
19397179|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
19397180|NCT03653260|Lidocaine|lidocaine|mesh-list
19397181|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
19397182|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
19397183|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397184|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397185|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
19397186|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397187|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19397188|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19397189|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19397190|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397191|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397192|NCT03653052|Durvalumab|durvalumab|mesh-list
19397193|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397194|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397195|NCT03653000|Anesthetics|anesthetics|mesh-list
19397196|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
20369216|NCT00963729|Fluorouracil|fluorouracil|mesh-list
20369217|NCT00963729|Letrozole|letrozole|mesh-list
20369218|NCT00963729|Epirubicin|epirubicin|mesh-list
20369219|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20369220|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
20369221|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369222|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369223|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20369224|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
19397197|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397198|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397199|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
19397200|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397201|NCT03652974|Valproic Acid|valproic acid|mesh-list
19397202|NCT03652974|Clozapine|clozapine|mesh-list
19397203|NCT03652974|Amisulpride|amisulpride|mesh-list
19397204|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
20187040|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187041|NCT00206414|Gefitinib|gefitinib|mesh-list
20187042|NCT00206414|Fulvestrant|fulvestrant|mesh-list
20187043|NCT00206414|Anastrozole|anastrozole|mesh-list
20187044|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187045|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20187046|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187047|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187048|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19397205|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428578|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19311091|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
19311092|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
19311093|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311094|NCT04092868|Protamines|protamines|mesh-list
19311095|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
19311096|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311097|NCT04092868|Coagulants|coagulants|mesh-ancestor
19311098|NCT04092621|Amiodarone|amiodarone|mesh-list
19311099|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19311100|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
19311101|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19311102|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311103|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311104|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19311105|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19311106|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19311107|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311108|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19311109|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19311110|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19311111|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19311112|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19311113|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19311114|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
19311115|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311116|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19311117|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19311118|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311119|NCT04092387|Nicotine|nicotine|mesh-list
19311120|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19311121|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
19311122|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311123|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369225|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369226|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369227|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20369228|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
20369229|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
20369230|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
20369231|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
20369232|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20369233|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20369234|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20369235|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369236|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20369237|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
20369238|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369239|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20369240|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20369241|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20369242|NCT00963768|Canagliflozin|canagliflozin|mesh-list
20369243|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20369244|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369245|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369246|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369247|NCT00963833|Interferons|interferons|mesh-list
20369248|NCT00963833|Interferon-beta|interferon-beta|mesh-list
20369249|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
20369250|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369251|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
20369252|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311124|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19311125|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19311126|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
19311127|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311128|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311129|NCT04092478|Anesthetics|anesthetics|mesh-list
19311130|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311131|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311132|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
19311133|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
19838753|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369253|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
20187049|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20187050|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19311134|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
19311135|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311136|NCT04092309|Valsartan|valsartan|mesh-list
19311137|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19311138|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19311139|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19311140|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19311141|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19311142|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311143|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
19311144|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311145|NCT04091971|Ketamine|ketamine|mesh-list
19311146|NCT04091971|Analgesics|analgesics|mesh-ancestor
19311147|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
19311148|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311149|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311150|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19311151|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19311152|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
19311153|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
19311154|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311155|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19311156|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19311157|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311158|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311159|NCT04092101|Nicotine|nicotine|mesh-list
20369254|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369255|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20369256|NCT00963846|Huperzine A|huperzine a|mesh-list
20369257|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20369258|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369259|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369260|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
20369261|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369262|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369263|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20369264|NCT00963846|Protective Agents|protective agents|mesh-ancestor
20369265|NCT00963976|Enalapril|enalapril|mesh-list
20369266|NCT00963976|Hydralazine|hydralazine|mesh-list
20369267|NCT00963976|Labetalol|labetalol|mesh-list
20369268|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19311160|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19311161|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
19311162|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311163|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311164|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19311165|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19311166|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
19311167|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311168|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311169|NCT04091880|Vaccines|vaccines|mesh-list
19311170|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
19311171|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311172|NCT04091815|Anesthetics|anesthetics|mesh-list
19311173|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311174|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311175|NCT04091698|Ubiquinone|ubiquinone|mesh-list
19311176|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
19311177|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
19311178|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311179|NCT04091698|Vitamins|vitamins|mesh-ancestor
19311180|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
19311181|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20187051|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
20187052|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187053|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187054|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20187055|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20187056|NCT00206453|Docetaxel|docetaxel|mesh-list
20187057|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311182|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20369269|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
20369270|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369271|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311183|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311184|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311185|NCT04091763|Polidocanol|polidocanol|mesh-list
19311186|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19311187|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19311188|NCT04091503|Temozolomide|temozolomide|mesh-list
19311189|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19311190|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
19311191|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311192|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311193|NCT04091490|Nivolumab|nivolumab|mesh-list
19311194|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311195|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311196|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19311197|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311198|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19311199|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19311200|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19311201|NCT04091412|Protective Agents|protective agents|mesh-ancestor
19311202|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311203|NCT04091204|Olaparib|olaparib|mesh-list
19311204|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19311205|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311206|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311207|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311208|NCT04091074|Clopidogrel|clopidogrel|mesh-list
19311209|NCT04091074|Ticagrelor|ticagrelor|mesh-list
19311210|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19311211|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19311212|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19311213|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19311214|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
19311215|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838754|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838755|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
19311216|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311217|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311218|NCT04091178|Vitamin D|vitamin d|mesh-list
19311219|NCT04091178|Vitamins|vitamins|mesh-ancestor
19838756|NCT00622713|Rivastigmine|rivastigmine|mesh-list
19311220|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
19311221|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311222|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19311223|NCT04091009|Buprenorphine|buprenorphine|mesh-list
19311224|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19311225|NCT04091009|Naloxone|naloxone|mesh-list
19311226|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19311227|NCT04091009|Narcotics|narcotics|mesh-ancestor
19838757|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19838758|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187058|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
20187059|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187060|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187061|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187062|NCT00206466|Docetaxel|docetaxel|mesh-list
20187063|NCT00206466|Doxorubicin|doxorubicin|mesh-list
20187064|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
20187065|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20187066|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187067|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
20187068|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
19311228|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311229|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311230|NCT04091009|Analgesics|analgesics|mesh-ancestor
19311231|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
19311232|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311233|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19311234|NCT04090879|Nicotine|nicotine|mesh-list
19311235|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19311236|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
19311237|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311238|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311239|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19311240|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19311241|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
19311242|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311243|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311244|NCT04090697|Oxandrolone|oxandrolone|mesh-list
19311245|NCT04090697|Androgens|androgens|mesh-ancestor
19311246|NCT04090697|Hormones|hormones|mesh-ancestor
19311247|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311248|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311249|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
19311250|NCT04090736|Azacitidine|azacitidine|mesh-list
19311251|NCT04090736|Pevonedistat|pevonedistat|mesh-list
19311252|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311253|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
19311254|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311255|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311256|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397206|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369272|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369273|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
20369274|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20369275|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20369276|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369277|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369278|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369279|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
20369280|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
20369281|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369282|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20369283|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20369284|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20369285|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
19397207|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
19397208|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397209|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397210|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
19397211|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19397212|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397213|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397214|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19397215|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
19397216|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19397217|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
19397218|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19397219|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
19397220|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19397221|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
20369286|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
20369287|NCT00964041|Cycloserine|cycloserine|mesh-list
20369288|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20369289|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369290|NCT00964041|Renal Agents|renal agents|mesh-ancestor
20369291|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20369292|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
20369293|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20369294|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
20369295|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425683|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425684|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19397222|NCT03652961|Abatacept|abatacept|mesh-list
19397223|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19397224|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311257|NCT04090801|Ethanol|ethanol|mesh-list
19311258|NCT04090801|Minoxidil|minoxidil|mesh-list
19311259|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19311260|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311261|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311262|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311263|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19311264|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
19311265|NCT04090112|Lidocaine|lidocaine|mesh-list
19311266|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311267|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
19311268|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311269|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311270|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
19311271|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311272|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19311273|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19311274|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19311275|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311276|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311277|NCT04090047|Itraconazole|itraconazole|mesh-list
19311278|NCT04090047|PF-06700841|pf-06700841|mesh-list
19311279|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
19311280|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311281|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19311282|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19311283|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311284|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311285|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19311286|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
19311287|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311288|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311289|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19311290|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19311291|NCT04090021|Amoxicillin|amoxicillin|mesh-list
19311292|NCT04090021|Metronidazole|metronidazole|mesh-list
19311293|NCT04090021|Clarithromycin|clarithromycin|mesh-list
19311294|NCT04090021|Levofloxacin|levofloxacin|mesh-list
19311295|NCT04090021|Ofloxacin|ofloxacin|mesh-list
19311296|NCT04090021|Rifabutin|rifabutin|mesh-list
19311297|NCT04090021|Esomeprazole|esomeprazole|mesh-list
19311298|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19311299|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311300|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19311301|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19311302|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19311303|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311304|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19311305|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311306|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187069|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187070|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369296|NCT00964080|Leucovorin|leucovorin|mesh-list
20369297|NCT00964080|Fluorouracil|fluorouracil|mesh-list
20369298|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
20369299|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
20369300|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369301|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20369302|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369303|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20369304|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
20369305|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369306|NCT00964080|Antidotes|antidotes|mesh-ancestor
20369307|NCT00964080|Protective Agents|protective agents|mesh-ancestor
19311307|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20187071|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20187072|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20187073|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20187074|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187075|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20187076|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
20187077|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187078|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369308|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
20369309|NCT00964080|Vitamins|vitamins|mesh-ancestor
20369310|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
20369311|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
20369312|NCT00964106|Rifampin|rifampin|mesh-list
20369313|NCT00964106|Fluconazole|fluconazole|mesh-list
20369314|NCT00964106|Ketoconazole|ketoconazole|mesh-list
20369315|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
20369316|NCT00964106|Midazolam|midazolam|mesh-list
20369317|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
19311308|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19311309|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19311310|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19311311|NCT04090021|Renal Agents|renal agents|mesh-ancestor
19311312|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19311313|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19311314|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311315|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19311316|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19311317|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
19311318|NCT04089657|Apatinib|apatinib|mesh-list
19311319|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311320|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19311321|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311322|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311323|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
19311324|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19311325|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311326|NCT04089813|Metformin|metformin|mesh-list
19311327|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19311328|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311329|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
19311330|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19311331|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
19311332|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
20369318|NCT00964106|Caffeine|caffeine|mesh-list
20369319|NCT00964106|Omeprazole|omeprazole|mesh-list
20369320|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20369321|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20369322|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20369323|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369324|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369325|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20369326|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20369327|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20369328|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20369329|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
20369330|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
20369331|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
20369332|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
20369333|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369334|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369335|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20369336|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20369337|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
20369338|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20369339|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20369340|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369341|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19311333|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311334|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311335|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19311336|NCT04089852|Analgesics|analgesics|mesh-ancestor
20369342|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311337|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
19311338|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311339|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
19311340|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311341|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311342|NCT04089631|Capecitabine|capecitabine|mesh-list
19311343|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311344|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
19311345|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692179|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
20369343|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20369344|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20369345|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19311346|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311347|NCT04089605|Dexamethasone|dexamethasone|mesh-list
19311348|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
19311349|NCT04089605|Ranibizumab|ranibizumab|mesh-list
19311350|NCT04089605|BB 1101|bb 1101|mesh-list
19311351|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311352|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
19311353|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
19311354|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311355|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311356|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311357|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
19311358|NCT04089605|Hormones|hormones|mesh-ancestor
19311359|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311360|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19311361|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311362|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
19311363|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311364|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369346|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20369347|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20369348|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
20369349|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20369350|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
20369351|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20369352|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369353|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
20187079|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20187080|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
20187081|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20187082|NCT00206492|Tamoxifen|tamoxifen|mesh-list
20187083|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20187084|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
20187085|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187086|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187087|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19311365|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19311366|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19311367|NCT04089605|Growth Substances|growth substances|mesh-ancestor
19311368|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
19311369|NCT04089592|Fentanyl|fentanyl|mesh-list
19311370|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
19311371|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19311372|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311373|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311374|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19311375|NCT04089592|Analgesics|analgesics|mesh-ancestor
19311376|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
19311377|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311378|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19311379|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19311380|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19311381|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
19311382|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311383|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311384|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19311385|NCT04089592|Narcotics|narcotics|mesh-ancestor
20369354|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19311386|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19311387|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19311388|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
19311389|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
19311390|NCT04089345|Ustekinumab|ustekinumab|mesh-list
19311391|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
19311392|NCT04089163|Flucytosine|flucytosine|mesh-list
19311393|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
19311394|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311395|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
19838759|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838760|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
19838761|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369355|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20369356|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19311396|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311397|NCT04089072|Phenylephrine|phenylephrine|mesh-list
19311398|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
19311399|NCT04089072|Methylene Blue|methylene blue|mesh-list
19311400|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19311401|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
19311402|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
19311403|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311404|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311405|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
19311406|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19311407|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
19311408|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
19311409|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19311410|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19311411|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19311412|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19311413|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311414|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311415|NCT04089072|Protective Agents|protective agents|mesh-ancestor
19311416|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311417|NCT04089176|Oxytocin|oxytocin|mesh-list
19311418|NCT04089176|Carbetocin|carbetocin|mesh-list
19311419|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
19311420|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19311421|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311422|NCT04088851|Metformin|metformin|mesh-list
19311423|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19311424|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311425|NCT04088903|Daratumumab|daratumumab|mesh-list
19311426|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311427|NCT04088604|Fluorouracil|fluorouracil|mesh-list
19311428|NCT04088604|Irinotecan|irinotecan|mesh-list
19311429|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
19311430|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311431|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311432|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311433|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19311434|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
19311435|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311436|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19311437|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19311438|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397225|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397226|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397227|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
19397228|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369357|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20369358|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20369359|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19397229|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397230|NCT03652896|Liver Extracts|liver extracts|mesh-list
19397231|NCT03652896|Hematinics|hematinics|mesh-ancestor
19397232|NCT03652870|Dexetimide|dexetimide|mesh-list
19397233|NCT03652870|Citalopram|citalopram|mesh-list
19397234|NCT03652870|Nortriptyline|nortriptyline|mesh-list
19397235|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19397236|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19397237|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397238|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397239|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397240|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
19397241|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397242|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19397243|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
19397244|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397245|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19397246|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19397247|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
19838762|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311439|NCT04088461|Metformin|metformin|mesh-list
19311440|NCT04088461|Linagliptin|linagliptin|mesh-list
19311441|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369360|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20369361|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19311442|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311443|NCT04088461|Incretins|incretins|mesh-ancestor
19311444|NCT04088461|Hormones|hormones|mesh-ancestor
19311445|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311446|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19311447|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
19311448|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311449|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311450|NCT04088448|Metformin|metformin|mesh-list
19311451|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19311452|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311453|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19311454|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19311455|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19311456|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311457|NCT04088266|Buprenorphine|buprenorphine|mesh-list
19311458|NCT04088266|Naloxone|naloxone|mesh-list
19311459|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19311460|NCT04088266|Narcotics|narcotics|mesh-ancestor
19311461|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311462|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311463|NCT04088266|Analgesics|analgesics|mesh-ancestor
19311464|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
19311465|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311466|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19311467|NCT04088032|Durvalumab|durvalumab|mesh-list
19311468|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19311469|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311470|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311471|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19311472|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311473|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369362|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
20369363|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20369364|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20369365|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20369366|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
20369367|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369368|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20369369|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20369370|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20369371|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
20369372|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
20369373|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20369374|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20369375|NCT00964106|Analgesics|analgesics|mesh-ancestor
20369376|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
20369377|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369378|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20428579|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
19311474|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19311475|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
19311476|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311477|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311478|NCT04088175|Menthol|menthol|mesh-list
19311479|NCT04088175|Nicotine|nicotine|mesh-list
19311480|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19311481|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
19311482|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311483|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311484|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19311485|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19311486|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
19311487|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311488|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311489|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
19311490|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
19311491|NCT04087915|Evolocumab|evolocumab|mesh-list
19311492|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19311493|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19311494|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
19311495|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311496|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19311497|NCT04088084|Palmidrol|palmidrol|mesh-list
19311498|NCT04088084|Analgesics|analgesics|mesh-ancestor
19311499|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
19311500|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311501|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311502|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19311503|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369379|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369380|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20369381|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369382|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20369383|NCT00964171|Efavirenz|efavirenz|mesh-list
20369384|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20369385|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20369386|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369387|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369388|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
19311504|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311505|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19311506|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
19311507|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311508|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19311509|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19311510|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311511|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311512|NCT04088084|Hormones|hormones|mesh-ancestor
19311513|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311514|NCT04088110|Trastuzumab|trastuzumab|mesh-list
19311515|NCT04088110|Letrozole|letrozole|mesh-list
19311516|NCT04088110|Anastrozole|anastrozole|mesh-list
20369389|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369390|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20369391|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20369392|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20369393|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20369394|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20369395|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20369396|NCT00964184|Metformin|metformin|mesh-list
20369397|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369398|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369399|NCT00964262|Exenatide|exenatide|mesh-list
20369400|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19311517|NCT04088110|Exemestane|exemestane|mesh-list
19311518|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19311519|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311520|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311521|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19311522|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311523|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311524|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19311525|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
19311526|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311527|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311528|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19311529|NCT04087746|Ranibizumab|ranibizumab|mesh-list
19311530|NCT04087746|Aflibercept|aflibercept|mesh-list
19311531|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19311532|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19311533|NCT04087746|Growth Substances|growth substances|mesh-ancestor
19311534|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311535|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
19311536|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311537|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
20369401|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311538|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19311539|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
19311540|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311541|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
19311542|NCT04088006|Protective Agents|protective agents|mesh-ancestor
19311543|NCT04087967|Cytarabine|cytarabine|mesh-list
19311544|NCT04087967|Decitabine|decitabine|mesh-list
19311545|NCT04087967|Idarubicin|idarubicin|mesh-list
19311546|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311547|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
19311548|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311549|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311550|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
19311551|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311552|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19311553|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
19311554|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311555|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311556|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19311557|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19311558|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19311559|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
19311560|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
19311561|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19311562|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
19311563|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311564|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311565|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19311566|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
19311567|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20369402|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20369403|NCT00964262|Incretins|incretins|mesh-ancestor
20369404|NCT00964262|Hormones|hormones|mesh-ancestor
19311568|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19311569|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19311570|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
19311571|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311572|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311573|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19311574|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19311575|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19311576|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
19311577|NCT04087460|Vaccines|vaccines|mesh-list
19311578|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19311579|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
19311580|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311581|NCT04087668|Anesthetics|anesthetics|mesh-list
19311582|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311583|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311584|NCT04087759|Bedaquiline|bedaquiline|mesh-list
19311585|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
19311586|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
19311587|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20187088|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187089|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20187090|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20187091|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20187092|NCT00206505|Docetaxel|docetaxel|mesh-list
20187093|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187094|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
20187095|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187096|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187097|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187098|NCT00206544|Tamoxifen|tamoxifen|mesh-list
20187099|NCT00206544|Progesterone|progesterone|mesh-list
20187100|NCT00206544|Progestins|progestins|mesh-ancestor
20187101|NCT00206544|Hormones|hormones|mesh-ancestor
20187102|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187103|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187104|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20187105|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
19311588|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311589|NCT04087421|Glycerol|glycerol|mesh-list
20187106|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20369405|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187107|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187108|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20187109|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20187110|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20187111|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20187112|NCT00206557|Estradiol|estradiol|mesh-list
20187113|NCT00206557|Estrogens|estrogens|mesh-ancestor
20187114|NCT00206557|Hormones|hormones|mesh-ancestor
19311590|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19311591|NCT04087421|Protective Agents|protective agents|mesh-ancestor
19311592|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311593|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19311594|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
19311595|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187115|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311596|NCT04086940|Esmolol|esmolol|mesh-list
19311597|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19311598|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19311599|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19311600|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
19311601|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311602|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311603|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311604|NCT04087317|Acetaminophen|acetaminophen|mesh-list
19311605|NCT04087317|Ibuprofen|ibuprofen|mesh-list
19311606|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19311607|NCT04087317|Analgesics|analgesics|mesh-ancestor
19311608|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
19311609|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311610|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311611|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
19311612|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19311613|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311614|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19311615|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19311616|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311617|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311618|NCT04086537|Hepcidins|hepcidins|mesh-list
19311619|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311620|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
19311621|NCT04086719|BMS-986165|bms-986165|mesh-list
19311622|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
19311623|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19311624|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19311625|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311626|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19311627|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311628|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311629|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19311630|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19397248|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
19397249|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397250|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19397251|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19397252|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
19397253|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20187116|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187117|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20187118|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
20187119|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20187120|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20187121|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20187122|NCT00206570|Estradiol|estradiol|mesh-list
20187123|NCT00206570|Estrogens|estrogens|mesh-ancestor
20187124|NCT00206570|Hormones|hormones|mesh-ancestor
20187125|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187126|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187127|NCT00206596|Sargramostim|sargramostim|mesh-list
20187128|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
20187129|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187130|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20187131|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19397254|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20187132|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
20187133|NCT00206622|Estradiol|estradiol|mesh-list
19311631|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
19311632|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
19311633|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311634|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311635|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311636|NCT04086290|Androgens|androgens|mesh-list
20369406|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20369407|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20369408|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369409|NCT00964288|Lidocaine|lidocaine|mesh-list
20369410|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
20369411|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
20369412|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369413|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369414|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
20369415|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311637|NCT04086290|Hormones|hormones|mesh-ancestor
19311638|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311639|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311640|NCT04086264|Azacitidine|azacitidine|mesh-list
19311641|NCT04086264|Decitabine|decitabine|mesh-list
19311642|NCT04086264|Venetoclax|venetoclax|mesh-list
19311643|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311644|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
20369416|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20369417|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20369418|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20369419|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20369420|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369421|NCT00964327|Darunavir|darunavir|mesh-list
19311645|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311646|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311647|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311648|NCT04086186|Bupivacaine|bupivacaine|mesh-list
19311649|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311650|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
19311651|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311652|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369422|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20369423|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20369424|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
20369425|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311653|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
19311654|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311655|NCT04086238|Decitabine|decitabine|mesh-list
19311656|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
20369426|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311657|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311658|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
19311659|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311660|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311661|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311662|NCT04085913|Lidocaine|lidocaine|mesh-list
19311663|NCT04085913|Epinephrine|epinephrine|mesh-list
19311664|NCT04085913|Racepinephrine|racepinephrine|mesh-list
19311665|NCT04085913|Bupivacaine|bupivacaine|mesh-list
19311666|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
19311667|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311668|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
19311669|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311670|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311671|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
19311672|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311673|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19311674|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19311675|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19311676|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311677|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311678|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19311679|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19311680|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
19311681|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311682|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19311683|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19311684|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
19311685|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19311686|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
19311687|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
19311688|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
19311689|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19311690|NCT04085562|Amlodipine|amlodipine|mesh-list
19311691|NCT04085562|Bisoprolol|bisoprolol|mesh-list
19311692|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19311693|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19311694|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311695|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311696|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19311697|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311698|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
19311699|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
19311700|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
19311701|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311702|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19311703|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19311704|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19311705|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
19311706|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311707|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
19311708|NCT04085744|Lidocaine|lidocaine|mesh-list
19311709|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311710|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
19311711|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311712|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311713|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
19311714|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311715|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19311716|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19311717|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19311718|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187134|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20187135|NCT00206622|Estrogens|estrogens|mesh-ancestor
20187136|NCT00206622|Hormones|hormones|mesh-ancestor
20187137|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369427|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20369428|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20369429|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
20369430|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187138|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187139|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20187140|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
20187141|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20187142|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19311719|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311720|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311721|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
20369431|NCT00964418|Insulin|insulin|mesh-list
20369432|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20369433|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
20369434|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369435|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369436|NCT00964457|Cetuximab|cetuximab|mesh-list
20369437|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311722|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19311723|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
19311724|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19311725|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
19311726|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19311727|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19311728|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311729|NCT04085770|Vitamins|vitamins|mesh-ancestor
19311730|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
20187143|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20187144|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19311731|NCT04085757|Dinoprostone|dinoprostone|mesh-list
20369438|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369439|NCT00964535|Budesonide|budesonide|mesh-list
19311732|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
19311733|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19311734|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311735|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
19311736|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19311737|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19311738|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311739|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
19311740|NCT04085575|Coagulants|coagulants|mesh-ancestor
20369440|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
20369441|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20369442|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20369443|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20369444|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
20369445|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369446|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369447|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20369448|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
20369449|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
20369450|NCT00964535|Hormones|hormones|mesh-ancestor
20369451|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369452|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20369453|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20369454|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20369455|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369456|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369457|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369458|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20369459|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
20369460|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20369461|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369462|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
19311741|NCT04085627|Amlodipine|amlodipine|mesh-list
19311742|NCT04085627|Valsartan|valsartan|mesh-list
19311743|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19311744|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19311745|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19311746|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311747|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311748|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19311749|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311750|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
19311751|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19311752|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19311753|NCT04085393|Granisetron|granisetron|mesh-list
19311754|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
19311755|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
19672964|NCT05222256|Simendan|simendan|mesh-list
19672965|NCT05222256|Epinephrine|epinephrine|mesh-list
19672966|NCT05222256|Racepinephrine|racepinephrine|mesh-list
19672967|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
19672968|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19672969|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20187145|NCT00206635|Interferons|interferons|mesh-list
20187146|NCT00206635|Interferon-beta|interferon-beta|mesh-list
20187147|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
20187148|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187149|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
19672970|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19672971|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672972|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19672973|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672974|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20187150|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187151|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
20187152|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187153|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20187154|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
20187155|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20187156|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
20187157|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187158|NCT00206661|Molgramostim|molgramostim|mesh-list
19672975|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19672976|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
19672977|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19672978|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19672979|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
19672980|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
19672981|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
19672982|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19672983|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20187159|NCT00206661|Sargramostim|sargramostim|mesh-list
19311756|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311757|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311758|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311759|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19311760|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
19311761|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311762|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311763|NCT04085640|Ropivacaine|ropivacaine|mesh-list
19311764|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311765|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
19311766|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311767|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311768|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
19311769|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311770|NCT04085094|Pilocarpine|pilocarpine|mesh-list
19311771|NCT04085094|Miotics|miotics|mesh-ancestor
19311772|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
19311773|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311774|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311775|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19311776|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19311777|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
19311778|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311779|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311780|NCT04085354|Vitamins|vitamins|mesh-list
19311781|NCT04085354|Folic Acid|folic acid|mesh-list
20187160|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
20187161|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187162|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187163|NCT00206674|Sargramostim|sargramostim|mesh-list
20187164|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
20187165|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187166|NCT00206700|Sargramostim|sargramostim|mesh-list
20187167|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
20369463|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20369464|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20369465|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369466|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369467|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369468|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20369469|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20369470|NCT00964574|Insulin|insulin|mesh-list
20369471|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20369472|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
20369473|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
20369474|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19311782|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
20187168|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187169|NCT00206713|Sargramostim|sargramostim|mesh-list
19311783|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
19311784|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
19311785|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311786|NCT04085354|Hematinics|hematinics|mesh-ancestor
19311787|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
19311788|NCT04085172|Guanfacine|guanfacine|mesh-list
19311789|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19311790|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19311791|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19311792|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311793|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311794|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
20187170|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
19311795|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19672984|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
20187171|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187172|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
19672985|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19672986|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19672987|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672988|NCT05222256|Protective Agents|protective agents|mesh-ancestor
19672989|NCT05220410|Psilocybin|psilocybin|mesh-list
19672990|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
19672991|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672992|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19672993|NCT05207644|Letrozole|letrozole|mesh-list
19672994|NCT05207644|Misoprostol|misoprostol|mesh-list
20369475|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369476|NCT00964626|Paclitaxel|paclitaxel|mesh-list
20369477|NCT00964626|Cisplatin|cisplatin|mesh-list
20369478|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20369479|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369480|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
20369481|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
20369482|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
20369483|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369484|NCT00964639|Ropivacaine|ropivacaine|mesh-list
20369485|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
20369486|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
20369487|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369488|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19672995|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19672996|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19672997|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19672998|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19672999|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673000|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19673001|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
19673002|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673003|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673004|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19673005|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
19673006|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19673007|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19673008|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311796|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311797|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369489|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
19311798|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19311799|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19311800|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19311801|NCT04085120|Dexamethasone|dexamethasone|mesh-list
19311802|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
19311803|NCT04085120|Lidocaine|lidocaine|mesh-list
19311804|NCT04085120|Ropivacaine|ropivacaine|mesh-list
19311805|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311806|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
19311807|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
19311808|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311809|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311810|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673009|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
20187173|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
20187174|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
20187175|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20187176|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20187177|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187178|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20187179|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187180|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187181|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20187182|NCT00206739|Renal Agents|renal agents|mesh-ancestor
20187183|NCT00206765|Risperidone|risperidone|mesh-list
20187184|NCT00206765|Paroxetine|paroxetine|mesh-list
20187185|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20187186|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
20187187|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187188|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187189|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187190|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20369490|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311811|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
19311812|NCT04085120|Hormones|hormones|mesh-ancestor
19311813|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311814|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19311815|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311816|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311817|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
19311818|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311819|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
19311820|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19311821|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19311822|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19311823|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311824|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311825|NCT04085250|Nivolumab|nivolumab|mesh-list
19311826|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311827|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311828|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19311829|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311830|NCT04085315|Osimertinib|osimertinib|mesh-list
19311831|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311832|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19311833|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311834|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311835|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
19311836|NCT04085419|Denosumab|denosumab|mesh-list
19311837|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19311838|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311839|NCT04085237|Ropivacaine|ropivacaine|mesh-list
19311840|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311841|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
19311842|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311843|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311844|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
19311845|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311846|NCT04084977|Antibodies|antibodies|mesh-list
19311847|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
19311848|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311849|NCT04084912|Dexamethasone|dexamethasone|mesh-list
19311850|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
19311851|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19311852|NCT04084912|BB 1101|bb 1101|mesh-list
19311853|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311854|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
19311855|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
19311856|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311857|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311858|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311859|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
19311860|NCT04084912|Hormones|hormones|mesh-ancestor
19311861|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19311862|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19311863|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311864|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
19311865|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311866|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838763|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19838764|NCT00622713|Protective Agents|protective agents|mesh-ancestor
19838765|NCT00622726|Bevacizumab|bevacizumab|mesh-list
19838766|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838767|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838768|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19838769|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838770|NCT00622726|Growth Substances|growth substances|mesh-ancestor
19838771|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838772|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
19838773|NCT00622739|Ziprasidone|ziprasidone|mesh-list
20187191|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187192|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187193|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187194|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187195|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
20187196|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20187197|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187198|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187199|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20187200|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187201|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20187202|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19311867|NCT04084496|Folfirinox|folfirinox|mesh-list
19311868|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311869|NCT04084158|Paclitaxel|paclitaxel|mesh-list
19311870|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19311871|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19311872|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311873|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
19311874|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
19311875|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
19311876|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397255|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
19397256|NCT03652857|Apatinib|apatinib|mesh-list
19397257|NCT03652857|Vinorelbine|vinorelbine|mesh-list
19397258|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397259|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19397260|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397261|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397262|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19397263|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19397264|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19397265|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19397266|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19397267|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19397268|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19397269|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397270|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
19397271|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19397272|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
19397273|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397274|NCT03652753|Expectorants|expectorants|mesh-ancestor
19397275|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
19397276|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19397277|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
19397278|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397279|NCT03652753|Protective Agents|protective agents|mesh-ancestor
19397280|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397281|NCT03652753|Antidotes|antidotes|mesh-ancestor
19397282|NCT03652714|Anesthetics|anesthetics|mesh-list
19397283|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
19397284|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397285|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397286|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
19397287|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369491|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20369492|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
20369493|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
20369494|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369495|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
20369496|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369497|NCT00964691|Chloroquine|chloroquine|mesh-list
20369498|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
20369499|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
20369500|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19397288|NCT03652571|Nortriptyline|nortriptyline|mesh-list
19397289|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19397290|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
19397291|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187203|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187204|NCT00206778|Lamotrigine|lamotrigine|mesh-list
20187205|NCT00206778|Valproic Acid|valproic acid|mesh-list
20187206|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
20187207|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20187208|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187209|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187210|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20187211|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187212|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20369501|NCT00964691|Amebicides|amebicides|mesh-ancestor
20369502|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20369503|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19397292|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20369504|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369505|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
20369506|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369507|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20369508|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369509|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673010|NCT05188053|Ketorolac|ketorolac|mesh-list
19673011|NCT05188053|Epinephrine|epinephrine|mesh-list
19311877|NCT04084171|Insulin|insulin|mesh-list
19311878|NCT04084171|Pancrelipase|pancrelipase|mesh-list
19311879|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19311880|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311881|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19311882|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19311883|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
19311884|NCT04083898|Prednisone|prednisone|mesh-list
19311885|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19311886|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19311887|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
19673012|NCT05188053|Ropivacaine|ropivacaine|mesh-list
19673013|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
19673014|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
19673015|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19673016|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673017|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
19673018|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673019|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19673020|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19673021|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673022|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673023|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673024|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19673025|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19673026|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
19673027|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19673028|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
19311888|NCT04083898|Hormones|hormones|mesh-ancestor
19311889|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369510|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20369511|NCT00964691|Renal Agents|renal agents|mesh-ancestor
20369512|NCT00964704|Bevacizumab|bevacizumab|mesh-list
20369513|NCT00964704|Trastuzumab|trastuzumab|mesh-list
20369514|NCT00964704|Docetaxel|docetaxel|mesh-list
20369515|NCT00964704|Capecitabine|capecitabine|mesh-list
20369516|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20369517|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369518|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20369519|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20369520|NCT00964704|Growth Substances|growth substances|mesh-ancestor
19311890|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311891|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19311892|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311893|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20369521|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369522|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
19311894|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
19311895|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311896|NCT04083911|Cytarabine|cytarabine|mesh-list
19311897|NCT04083911|Decitabine|decitabine|mesh-list
19311898|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
19311899|NCT04083911|Aclarubicin|aclarubicin|mesh-list
19311900|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311901|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
19311902|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311903|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311904|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
19311905|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311906|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19311907|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
19311908|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311909|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673029|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
19838774|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20369523|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
20369524|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673030|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
19673031|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19838775|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
19838776|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838777|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838778|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838779|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19838780|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19673032|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19673033|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19673034|NCT05188053|Analgesics|analgesics|mesh-ancestor
19673035|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673036|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673037|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19673038|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692180|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369525|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
20369526|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369527|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19692181|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19692182|NCT04995263|Caffeine|caffeine|mesh-list
19692183|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19692184|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838781|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838782|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838783|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19311910|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19311911|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19311912|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19311913|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19311914|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19311915|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19311916|NCT04083807|Thrombin|thrombin|mesh-list
19311917|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
19311918|NCT04083807|Coagulants|coagulants|mesh-ancestor
19311919|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
19311920|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
19311921|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
19311922|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369528|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
20369529|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
20369530|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20369531|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311923|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311924|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
19311925|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311926|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19311927|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19311928|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311929|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
19311930|NCT04083755|Hematinics|hematinics|mesh-ancestor
19311931|NCT04083599|Gemcitabine|gemcitabine|mesh-list
19311932|NCT04083599|Paclitaxel|paclitaxel|mesh-list
19311933|NCT04083599|Carboplatin|carboplatin|mesh-list
19311934|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
19692185|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19692186|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692187|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838784|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
19838785|NCT00622869|Everolimus|everolimus|mesh-list
19838786|NCT00622869|Tacrolimus|tacrolimus|mesh-list
20187213|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187214|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187215|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187216|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20187217|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187218|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
20187219|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187220|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
20187221|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20187222|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
20187223|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187224|NCT00206934|Dexetimide|dexetimide|mesh-list
20187225|NCT00206934|Citalopram|citalopram|mesh-list
19692188|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20187226|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20187227|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187228|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673039|NCT05183412|Methamphetamine|methamphetamine|mesh-list
19673040|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20187229|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187230|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187231|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
20187232|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187233|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20187234|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187235|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187236|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20187237|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20187238|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
20187239|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
20187240|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187241|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20369532|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20369533|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20369534|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369535|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369536|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369537|NCT00964756|Ganciclovir|ganciclovir|mesh-list
19311935|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19311936|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19311937|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
19311938|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
19311939|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
19311940|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311941|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19311942|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
19311943|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
19311944|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311945|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19311946|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19311947|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
19311948|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311949|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19311950|NCT04083651|Bromides|bromides|mesh-list
19311951|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
19311952|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
19311953|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19311954|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311955|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
19311956|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311957|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19311958|NCT04083417|Penicillins|penicillins|mesh-list
19311959|NCT04083417|Penicillin V|penicillin v|mesh-list
19311960|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311961|NCT04083664|Hepcidins|hepcidins|mesh-list
19311962|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19311963|NCT04083625|Carbetocin|carbetocin|mesh-list
19673041|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673042|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
19673043|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
19673044|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673045|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
19673046|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673047|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673048|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673049|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19673050|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19673051|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673052|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19673053|NCT05174858|Hemostatics|hemostatics|mesh-list
19673054|NCT05174858|Coagulants|coagulants|mesh-ancestor
19673055|NCT05168683|Rasburicase|rasburicase|mesh-list
19673056|NCT05168683|Uric Acid|uric acid|mesh-list
19673057|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
19673058|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673059|NCT05168683|Protective Agents|protective agents|mesh-ancestor
19673060|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673061|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
19673062|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369538|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19311964|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
19311965|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19311966|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311967|NCT04083144|Varenicline|varenicline|mesh-list
19311968|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19311969|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19311970|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
19311971|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311972|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311973|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311974|NCT04083105|Midazolam|midazolam|mesh-list
19311975|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
19311976|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19311977|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19311978|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311979|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311980|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19311981|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19311982|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19311983|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19311984|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
19311985|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
19311986|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
19311987|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
19311988|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19311989|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19311990|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19311991|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19311992|NCT04083105|Analgesics|analgesics|mesh-ancestor
19311993|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
20187242|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20187243|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
20187244|NCT00206947|Ziprasidone|ziprasidone|mesh-list
20187245|NCT00206947|Donepezil|donepezil|mesh-list
20187246|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20187247|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187248|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187249|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
20187250|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187251|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187252|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
20187253|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20187254|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
20187255|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187256|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187257|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187258|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187259|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187260|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
20369539|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
20369540|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369541|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19311994|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19311995|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
19311996|NCT04083209|Narcotics|narcotics|mesh-ancestor
19311997|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19311998|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19311999|NCT04083209|Analgesics|analgesics|mesh-ancestor
20369542|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312000|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
19312001|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312002|NCT04083066|Cytarabine|cytarabine|mesh-list
19312003|NCT04083066|Dexamethasone|dexamethasone|mesh-list
19312004|NCT04083066|Rituximab|rituximab|mesh-list
19312005|NCT04083066|Methotrexate|methotrexate|mesh-list
19312006|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19312007|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312008|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
19312009|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312010|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312011|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312012|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
19312013|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
19312014|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312015|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187261|NCT00206960|Risperidone|risperidone|mesh-list
19312016|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
20187262|NCT00206960|Clopenthixol|clopenthixol|mesh-list
19312017|NCT04083066|Hormones|hormones|mesh-ancestor
19312018|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312019|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19312020|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19312021|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
19312022|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312023|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312024|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
19312025|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369543|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369544|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20369545|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
20369546|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369547|NCT00964808|Oxycodone|oxycodone|mesh-list
20369548|NCT00964808|Buprenorphine|buprenorphine|mesh-list
20369549|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20369550|NCT00964808|Narcotics|narcotics|mesh-ancestor
20369551|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369552|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369553|NCT00964808|Analgesics|analgesics|mesh-ancestor
20369554|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
20369555|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369556|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20369557|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20369558|NCT00964834|Doxycycline|doxycycline|mesh-list
19312026|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
19312027|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312028|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19312029|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312030|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20369559|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20369560|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369561|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
20369562|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
19312031|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
19312032|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312033|NCT04083118|Listerine|listerine|mesh-list
19312034|NCT04083118|Fluorides|fluorides|mesh-list
19312035|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
19312036|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
19312037|NCT04083118|Protective Agents|protective agents|mesh-ancestor
19312038|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312039|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19312040|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312041|NCT04083235|Leucovorin|leucovorin|mesh-list
19312042|NCT04083235|Gemcitabine|gemcitabine|mesh-list
19312043|NCT04083235|Paclitaxel|paclitaxel|mesh-list
19312044|NCT04083235|Fluorouracil|fluorouracil|mesh-list
19312045|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
20369563|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20369564|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20369565|NCT00964964|Insulin|insulin|mesh-list
19312046|NCT04083235|Irinotecan|irinotecan|mesh-list
19312047|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19312048|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312049|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
19312050|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
19312051|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
19312052|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312053|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312054|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
19312055|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
19312056|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312057|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312058|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312059|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
19312060|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838787|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838788|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
19838789|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838790|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19838791|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369566|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20369567|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
19312061|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19312062|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19312063|NCT04083235|Antidotes|antidotes|mesh-ancestor
19838792|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838793|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838794|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
19838795|NCT00622895|Fludarabine|fludarabine|mesh-list
19838796|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
19838797|NCT00622895|Tacrolimus|tacrolimus|mesh-list
19838798|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838799|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838800|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
19838801|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838802|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838803|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
20187263|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19312064|NCT04083235|Protective Agents|protective agents|mesh-ancestor
19312065|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
19312066|NCT04083235|Vitamins|vitamins|mesh-ancestor
19312067|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
19312068|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19312069|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
19312070|NCT04082949|Coagulants|coagulants|mesh-ancestor
20187264|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
20187265|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187266|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187267|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187268|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187269|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20369568|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369569|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312071|NCT04082962|Dexamethasone|dexamethasone|mesh-list
19312072|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312073|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
19312074|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
19312075|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312076|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312077|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312078|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
19312079|NCT04082962|Hormones|hormones|mesh-ancestor
19312080|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312081|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19312082|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312083|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20369570|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
20369571|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20369572|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20369573|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369574|NCT00965107|Thiopental|thiopental|mesh-list
20369575|NCT00965107|Propofol|propofol|mesh-list
20369576|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20369577|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369578|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369579|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20369580|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
20369581|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
20369582|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
20369583|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
20369584|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
20369585|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369586|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369587|NCT00965120|Bradykinin|bradykinin|mesh-list
20369588|NCT00965120|Kininogens|kininogens|mesh-list
20369589|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
20369590|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
20369591|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20369592|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
19312084|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19312085|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312086|NCT04082897|Atezolizumab|atezolizumab|mesh-list
19312087|NCT04082897|Venetoclax|venetoclax|mesh-list
19312088|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
19312089|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312090|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19312091|NCT04082650|Vitamin D|vitamin d|mesh-list
19312092|NCT04082650|Vitamins|vitamins|mesh-ancestor
19838804|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369593|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312093|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
19312094|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312095|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19312096|NCT04082715|Celecoxib|celecoxib|mesh-list
19312097|NCT04082715|Levodopa|levodopa|mesh-list
19312098|NCT04082715|Carbidopa|carbidopa|mesh-list
19312099|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19312100|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19312101|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312102|NCT04082715|Analgesics|analgesics|mesh-ancestor
19312103|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
19312104|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312105|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312106|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312107|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312108|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19312109|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19312110|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312111|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312112|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19312113|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19312114|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
19312115|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312116|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19312117|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19312118|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
19312119|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
19312120|NCT04082858|Midazolam|midazolam|mesh-list
19312121|NCT04082858|Ketamine|ketamine|mesh-list
19312122|NCT04082858|Analgesics|analgesics|mesh-ancestor
19312123|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
19312124|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312125|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312126|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19312127|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19312128|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
19312129|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
19312130|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19838805|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19312131|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19312132|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19312133|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838806|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838807|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19838808|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19838809|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
19838810|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838811|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838812|NCT00622908|Besifloxacin|besifloxacin|mesh-list
19312134|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312135|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19312136|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19312137|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19312138|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19312139|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19312140|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
19312141|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
19312142|NCT04082793|Diclofenac|diclofenac|mesh-list
19312143|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19312144|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312145|NCT04082793|Analgesics|analgesics|mesh-ancestor
19312146|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
19312147|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312148|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312149|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838813|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838814|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838815|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19312150|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312151|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19312152|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312153|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312154|NCT04082767|Midazolam|midazolam|mesh-list
19312155|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
20187270|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187271|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187272|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19838816|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19838817|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838818|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838819|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838820|NCT00623012|Sirolimus|sirolimus|mesh-list
19838821|NCT00623012|Tacrolimus|tacrolimus|mesh-list
19838822|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838823|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
19838824|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838825|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19838826|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838827|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838828|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838829|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673063|NCT05136326|Capecitabine|capecitabine|mesh-list
19673064|NCT05136326|Temozolomide|temozolomide|mesh-list
19673065|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19673066|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
19673067|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673068|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673069|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19673070|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
19673071|NCT05121974|Azithromycin|azithromycin|mesh-list
19673072|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
19312156|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19312157|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312158|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312159|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312160|NCT04082767|Analgesics|analgesics|mesh-ancestor
19312161|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
20369594|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369595|NCT00965172|Calcium|calcium|mesh-list
20369596|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20369597|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369598|NCT00965224|Vaccines|vaccines|mesh-list
20369599|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
20369600|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369601|NCT00965289|Rituximab|rituximab|mesh-list
20369602|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20369603|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369604|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
20369605|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369606|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369607|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20369608|NCT00965315|Fenofibrate|fenofibrate|mesh-list
20369609|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19312162|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312163|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19312164|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19312165|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19312166|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
19312167|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312168|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312169|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19312170|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19312171|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19312172|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19312173|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19312174|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
19838830|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19838831|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838832|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
19838833|NCT00623103|Rivastigmine|rivastigmine|mesh-list
19838834|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19838835|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838836|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838837|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
19838838|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838839|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838840|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19838841|NCT00623103|Protective Agents|protective agents|mesh-ancestor
19838842|NCT00623181|Vaccines|vaccines|mesh-list
19312175|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
19673073|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19838843|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
19838844|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312176|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
19312177|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
19312178|NCT04082598|Amoxicillin|amoxicillin|mesh-list
19312179|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
19312180|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
19312181|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19312182|NCT04082598|Lactoferrin|lactoferrin|mesh-list
19312183|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312184|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312185|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19312186|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312187|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312188|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19312189|NCT04082559|Metronidazole|metronidazole|mesh-list
19838845|NCT00623194|Insulin|insulin|mesh-list
19838846|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19838847|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
19838848|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
19838849|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19312190|NCT04082559|Doxycycline|doxycycline|mesh-list
19312191|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
19312192|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19312193|NCT04082559|Complement Factor H|complement factor h|mesh-list
19312194|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312195|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
19312196|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19312197|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19312198|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
19312199|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19312200|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20369610|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20369611|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
20369612|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369613|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20369614|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20369615|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369616|NCT00965393|Bradykinin|bradykinin|mesh-list
20369617|NCT00965393|Kininogens|kininogens|mesh-list
20369618|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
20369619|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
20369620|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20369621|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
20369622|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369623|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369624|NCT00965406|Insulin|insulin|mesh-list
20369625|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369626|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369627|NCT00965549|Insulin|insulin|mesh-list
20369628|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19312201|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312202|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312203|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312204|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19312205|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19312206|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19312207|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312208|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
19312209|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312210|NCT04082286|Antibodies|antibodies|mesh-list
19312211|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19312212|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
19312213|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312214|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
19312215|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19312216|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397293|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19397294|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397295|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397296|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
19397297|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369629|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
19838850|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838851|NCT00623233|Gemcitabine|gemcitabine|mesh-list
19838852|NCT00623233|Bevacizumab|bevacizumab|mesh-list
19838853|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838854|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312217|NCT04082182|Vaccines|vaccines|mesh-list
19312218|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
19312219|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312220|NCT04081909|Fentanyl|fentanyl|mesh-list
19312221|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
19312222|NCT04081909|Ketamine|ketamine|mesh-list
19312223|NCT04081909|Remifentanil|remifentanil|mesh-list
19312224|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19312225|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312226|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312227|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369630|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
20369631|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
20369632|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369633|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369634|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
19312228|NCT04081909|Analgesics|analgesics|mesh-ancestor
19312229|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
19312230|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312231|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19312232|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19312233|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19312234|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
19312235|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312236|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312237|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19312238|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19312239|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
19312240|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
19312241|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19312242|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19312243|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19312244|NCT04081909|Narcotics|narcotics|mesh-ancestor
19312245|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19312246|NCT04081805|Estradiol|estradiol|mesh-list
19312247|NCT04081805|Estrogens|estrogens|mesh-ancestor
19312248|NCT04081805|Hormones|hormones|mesh-ancestor
19312249|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312250|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312251|NCT04081389|Interferons|interferons|mesh-list
19312252|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
19673074|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673075|NCT05102149|Vildagliptin|vildagliptin|mesh-list
19673076|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19673077|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673078|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19673079|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
19673080|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673081|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673082|NCT05060991|Antimetabolites|antimetabolites|mesh-list
19673083|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673084|NCT05057247|Docetaxel|docetaxel|mesh-list
19673085|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673086|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673087|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673088|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187273|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
20187274|NCT00206973|Mannitol|mannitol|mesh-list
19312253|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
19312254|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20187275|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20187276|NCT00206973|Diuretics|diuretics|mesh-ancestor
20187277|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
20187278|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187279|NCT00206986|Clonidine|clonidine|mesh-list
20187280|NCT00206986|Analgesics|analgesics|mesh-ancestor
20187281|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
20187282|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187283|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187284|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20187285|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
20187286|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
20187287|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20187288|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20187289|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20187290|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
20187291|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838855|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19838856|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838857|NCT00623233|Growth Substances|growth substances|mesh-ancestor
19838858|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838859|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
19312255|NCT04081389|Celecoxib|celecoxib|mesh-list
19312256|NCT04081389|Paclitaxel|paclitaxel|mesh-list
19312257|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
19312258|NCT04081389|Doxorubicin|doxorubicin|mesh-list
19312259|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19312260|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20369635|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20369636|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20369637|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369638|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
20369639|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369640|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369641|NCT00965653|Folic Acid|folic acid|mesh-list
20369642|NCT00965653|Methotrexate|methotrexate|mesh-list
20369643|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20369644|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
20369645|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20369646|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369647|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20369648|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
19312261|NCT04081389|Daunorubicin|daunorubicin|mesh-list
19312262|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
19312263|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19312264|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312265|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19312266|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
19312267|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187292|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187293|NCT00206999|Imipramine|imipramine|mesh-list
19312268|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312269|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312270|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
19312271|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312272|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312273|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19312274|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
19312275|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19312276|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19312277|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19312278|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19312279|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312280|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
19312281|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312282|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19312283|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312284|NCT04081389|Analgesics|analgesics|mesh-ancestor
19312285|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
19312286|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838860|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838861|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
19838862|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838863|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
19838864|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838865|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838866|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838867|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
19838868|NCT00623363|Piclozotan|piclozotan|mesh-list
20187294|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20187295|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187296|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187297|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20187298|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187299|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187300|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187301|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
20187302|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187303|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312287|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312288|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19838869|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19838870|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19838871|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
19838872|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838873|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838874|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838875|NCT00623428|Ribavirin|ribavirin|mesh-list
19838876|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19838877|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
19838878|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838879|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
19312289|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19312290|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19312291|NCT04081376|Hydromorphone|hydromorphone|mesh-list
19312292|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19312293|NCT04081376|Narcotics|narcotics|mesh-ancestor
19312294|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312295|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312296|NCT04081376|Analgesics|analgesics|mesh-ancestor
19312297|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
19312298|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312299|NCT04081480|Valacyclovir|valacyclovir|mesh-list
19312300|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
19838880|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848185|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19848186|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
19848187|NCT00691301|Pemetrexed|pemetrexed|mesh-list
19848188|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848189|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848190|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848191|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19848192|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20187304|NCT00207051|Cetuximab|cetuximab|mesh-list
20187305|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20187306|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187307|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20187308|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187309|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187310|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187311|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187312|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187313|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187314|NCT00207077|Cetuximab|cetuximab|mesh-list
20187315|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20187316|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20187317|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187318|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20187319|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187320|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187321|NCT00207116|Cetuximab|cetuximab|mesh-list
20187322|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20187323|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187324|NCT00207129|Capecitabine|capecitabine|mesh-list
20187325|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20187326|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
20187327|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187328|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187329|NCT00207155|Cetuximab|cetuximab|mesh-list
20187330|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20187331|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217345|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217346|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217347|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20217348|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
20217349|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20217350|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20217351|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
19848193|NCT00691483|Varenicline|varenicline|mesh-list
20217352|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312301|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312302|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
19312303|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19312304|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
19848194|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19312305|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312306|NCT04081012|Expectorants|expectorants|mesh-ancestor
19312307|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
19312308|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19312309|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
19312310|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312311|NCT04081012|Protective Agents|protective agents|mesh-ancestor
20187332|NCT00207311|Interferons|interferons|mesh-list
20187333|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
20187334|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
20187335|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20187336|NCT00207311|Orlistat|orlistat|mesh-list
20187337|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312312|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312313|NCT04081012|Antidotes|antidotes|mesh-ancestor
19312314|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
19312315|NCT04081077|Linezolid|linezolid|mesh-list
19312316|NCT04081077|Bedaquiline|bedaquiline|mesh-list
19312317|NCT04081077|Clofazimine|clofazimine|mesh-list
19312318|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312319|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312320|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19312321|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19838881|NCT00623480|Factor VIII|factor viii|mesh-list
20187338|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
20187339|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187340|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
20187341|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187342|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187343|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187344|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20369649|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312322|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312323|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312324|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312325|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19312326|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
19312327|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312328|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
19312329|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19312330|NCT04080908|Hematinics|hematinics|mesh-ancestor
19312331|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19312332|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19312333|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
19312334|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19312335|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312336|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19312337|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312338|NCT04080726|Esomeprazole|esomeprazole|mesh-list
19312339|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19312340|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312341|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19312342|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312343|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312344|NCT04080375|Dinoprostone|dinoprostone|mesh-list
19312345|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
19312346|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312347|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312348|NCT04080388|Diuretics|diuretics|mesh-list
19312349|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
19312350|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312351|NCT04080713|Budesonide|budesonide|mesh-list
19312352|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312353|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19673089|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673090|NCT05036421|Empagliflozin|empagliflozin|mesh-list
19673091|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19673092|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673093|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19673094|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673095|NCT05035186|Amoxicillin|amoxicillin|mesh-list
19673096|NCT05035186|Clarithromycin|clarithromycin|mesh-list
19673097|NCT05035186|Levofloxacin|levofloxacin|mesh-list
19673098|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19673099|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673100|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19312354|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
19312355|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312356|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312357|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19312358|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
19312359|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
19312360|NCT04080713|Hormones|hormones|mesh-ancestor
19312361|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312362|NCT04080622|Selenium|selenium|mesh-list
19312363|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
19312364|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312365|NCT04080622|Protective Agents|protective agents|mesh-ancestor
19312366|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312367|NCT04080622|Trace Elements|trace elements|mesh-ancestor
19312368|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
19312369|NCT04080349|Misoprostol|misoprostol|mesh-list
19312370|NCT04080349|Dinoprostone|dinoprostone|mesh-list
19312371|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19312372|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
19312373|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312374|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312375|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19312376|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312377|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
19312378|NCT04080323|Dinoprostone|dinoprostone|mesh-list
19312379|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
19312380|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312381|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312382|NCT04080336|Misoprostol|misoprostol|mesh-list
19312383|NCT04080336|Dinoprostone|dinoprostone|mesh-list
19312384|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19312385|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
19312386|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312387|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312388|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19312389|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312390|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
20369650|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369651|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
20369652|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369653|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20369654|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20369655|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
20369656|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369657|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20369658|NCT00965653|Hematinics|hematinics|mesh-ancestor
20369659|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
20369660|NCT00965653|Vitamins|vitamins|mesh-ancestor
20369661|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
20369662|NCT00965666|Etanercept|etanercept|mesh-list
20369663|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20369664|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369665|NCT00965666|Analgesics|analgesics|mesh-ancestor
20369666|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
20369667|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369668|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369669|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312391|NCT04080310|Ezetimibe|ezetimibe|mesh-list
19312392|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19312393|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19312394|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19312395|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
20369670|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369671|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20369672|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20369673|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
20369674|NCT00965796|Lidocaine|lidocaine|mesh-list
20369675|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
20369676|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
20369677|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369678|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369679|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
20369680|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369681|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19312396|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312397|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20369682|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20369683|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19312398|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397298|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397299|NCT03652493|Carboplatin|carboplatin|mesh-list
19397300|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397301|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
19397302|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19397303|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19397304|NCT03652480|Prednisolone|prednisolone|mesh-list
19397305|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
19397306|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19397307|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
19397308|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838882|NCT00623480|Coagulants|coagulants|mesh-ancestor
19838883|NCT00623545|Exenatide|exenatide|mesh-list
19838884|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19838885|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838886|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19838887|NCT00623545|Incretins|incretins|mesh-ancestor
19838888|NCT00623545|Hormones|hormones|mesh-ancestor
19838889|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19838890|NCT00623597|Ritonavir|ritonavir|mesh-list
19838891|NCT00623597|Saquinavir|saquinavir|mesh-list
19838892|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19838893|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19838894|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
19838895|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838896|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838897|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20187345|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20187346|NCT00207363|Interferons|interferons|mesh-list
20187347|NCT00207363|Ribavirin|ribavirin|mesh-list
20187348|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
20187349|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
20187350|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20187351|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187352|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
20187353|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187354|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
20187355|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187356|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
20187357|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187358|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
20187359|NCT00207402|Interferons|interferons|mesh-list
20187360|NCT00207402|Ribavirin|ribavirin|mesh-list
20369684|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20369685|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397309|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
19397310|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
19397311|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397312|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397313|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673101|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673102|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369686|NCT00965809|Dronabinol|dronabinol|mesh-list
20369687|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
20369688|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369689|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20369690|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369691|NCT00965809|Analgesics|analgesics|mesh-ancestor
19397314|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
19673103|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19673104|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19673105|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19673106|NCT05035186|Renal Agents|renal agents|mesh-ancestor
19673107|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19673108|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19673109|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673110|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19673111|NCT04987099|Choline|choline|mesh-list
19673112|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
19673113|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19673114|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
19693095|NCT04983160|Allopurinol|allopurinol|mesh-list
19838898|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20187361|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
20369692|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
20369693|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369694|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20369695|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20369696|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673115|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673116|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673117|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19673118|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
20369697|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312399|NCT04080869|Vitamin A|vitamin a|mesh-list
19312400|NCT04080869|Tretinoin|tretinoin|mesh-list
19312401|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
19312402|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312403|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
19312404|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
19312405|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
19312406|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312407|NCT04080869|Protective Agents|protective agents|mesh-ancestor
19312408|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312409|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19312410|NCT04080869|Vitamins|vitamins|mesh-ancestor
19312411|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
19312412|NCT04079933|Nicotine|nicotine|mesh-list
19312413|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20369698|NCT00965809|Hormones|hormones|mesh-ancestor
20369699|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20369700|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
20369701|NCT00965874|Analgesics|analgesics|mesh-ancestor
20369702|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
19312414|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
19673119|NCT04968015|Cytarabine|cytarabine|mesh-list
20369703|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369704|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369705|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
20369706|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369707|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20369708|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
20369709|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19838899|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
19838900|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19838901|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19838902|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19838903|NCT00623623|Enoxaparin|enoxaparin|mesh-list
19838904|NCT00623623|Tenecteplase|tenecteplase|mesh-list
19838905|NCT00623623|Clopidogrel|clopidogrel|mesh-list
19838906|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19838907|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19838908|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19838909|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19838910|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
19673120|NCT04968015|Venetoclax|venetoclax|mesh-list
19673121|NCT04968015|Idarubicin|idarubicin|mesh-list
19673122|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20187362|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187363|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
20187364|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187365|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
20187366|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187367|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20187368|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187369|NCT00207428|Carbamazepine|carbamazepine|mesh-list
20369710|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20369711|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673123|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
19673124|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838911|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19838912|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312415|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312416|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312417|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19673125|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187370|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
20187371|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
20187372|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187373|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187374|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187375|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187376|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20187377|NCT00207428|Analgesics|analgesics|mesh-ancestor
20369712|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20369713|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
20369714|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20369715|NCT00965900|Propranolol|propranolol|mesh-list
20369716|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20369717|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20369718|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369719|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369720|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369721|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369722|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20369723|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369724|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
20425685|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20425686|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20425687|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425688|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20425689|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20425690|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20425691|NCT01276210|Sorafenib|sorafenib|mesh-list
20425692|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425693|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20425694|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425695|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425696|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
20187378|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
20187379|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187380|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19673126|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
19673127|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673128|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673129|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
19673130|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673131|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19673132|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19673133|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19673134|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673135|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
19673136|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19673137|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673138|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19673139|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673140|NCT04884035|Prednisone|prednisone|mesh-list
19673141|NCT04884035|Prednisolone|prednisolone|mesh-list
19673142|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
19673143|NCT04884035|Rituximab|rituximab|mesh-list
19673144|NCT04884035|Doxorubicin|doxorubicin|mesh-list
19673145|NCT04884035|Vincristine|vincristine|mesh-list
19673146|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673147|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
19673148|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673149|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673150|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19673151|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
19673152|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673153|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673154|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19673155|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673156|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19673157|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19673158|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19673159|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673160|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673161|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
19838913|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673162|NCT04884035|Hormones|hormones|mesh-ancestor
20187381|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187382|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838914|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
19838915|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19838916|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19838917|NCT00623714|Fluticasone|fluticasone|mesh-list
19838918|NCT00623714|Xhance|xhance|mesh-list
19838919|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838920|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19838921|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
19312418|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19312419|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
19312420|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312421|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312422|NCT04080076|Tacrolimus|tacrolimus|mesh-list
19312423|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312424|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
19312425|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312426|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19312427|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312428|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312429|NCT04079517|Tamoxifen|tamoxifen|mesh-list
19312430|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19312431|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
19312432|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312433|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312434|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19312435|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312436|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19312437|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20187383|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20187384|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19673163|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673164|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19312438|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19312439|NCT04079686|Cefazolin|cefazolin|mesh-list
19312440|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312441|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312442|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
19838922|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838923|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838924|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19838925|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
19838926|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
19838927|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19838928|NCT00623727|Factor VIII|factor viii|mesh-list
19838929|NCT00623727|Coagulants|coagulants|mesh-ancestor
19312443|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19312444|NCT04079725|Mitomycins|mitomycins|mesh-list
19312445|NCT04079725|Mitomycin|mitomycin|mesh-list
19838930|NCT00623766|Dexamethasone|dexamethasone|mesh-list
19838931|NCT00623766|Prednisone|prednisone|mesh-list
19838932|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
19838933|NCT00623766|Prednisolone|prednisolone|mesh-list
19838934|NCT00623766|Triamcinolone|triamcinolone|mesh-list
20187385|NCT00207532|Folic Acid|folic acid|mesh-list
19673165|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19673166|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673167|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673168|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
19673169|NCT04833946|Andrographolide|andrographolide|mesh-list
20187386|NCT00207532|Hematinics|hematinics|mesh-ancestor
20187387|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
20187388|NCT00207532|Vitamins|vitamins|mesh-ancestor
20187389|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
20187390|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187391|NCT00207558|Folic Acid|folic acid|mesh-list
20187392|NCT00207558|Hematinics|hematinics|mesh-ancestor
20187393|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
20187394|NCT00207558|Vitamins|vitamins|mesh-ancestor
20187395|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
19312446|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19673170|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838935|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
19838936|NCT00623766|Betamethasone|betamethasone|mesh-list
19838937|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
20187396|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187397|NCT00207584|Doxycycline|doxycycline|mesh-list
20369725|NCT00965913|Nicotine|nicotine|mesh-list
20369726|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20369727|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
20369728|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369729|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369730|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20369731|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20369732|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
20369733|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369734|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838938|NCT00623766|Ipilimumab|ipilimumab|mesh-list
19838939|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838940|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
19838941|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
19838942|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19838943|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312447|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312448|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
19312449|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838944|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19838945|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
19838946|NCT00623766|Hormones|hormones|mesh-ancestor
19838947|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19838948|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20369735|NCT00965926|Mirabegron|mirabegron|mesh-list
20369736|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20369737|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20369738|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20369739|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369740|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369741|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369742|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369743|NCT00965926|Urological Agents|urological agents|mesh-ancestor
20369744|NCT00965991|Metformin|metformin|mesh-list
20369745|NCT00965991|Glyburide|glyburide|mesh-list
20369746|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369747|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369748|NCT00966004|Mirabegron|mirabegron|mesh-list
20369749|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20369750|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20369751|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20369752|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20369753|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369754|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369755|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312450|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19312451|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312452|NCT04079413|Insulin|insulin|mesh-list
19673171|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19673172|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19673173|NCT04833946|Analgesics|analgesics|mesh-ancestor
19673174|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
19673175|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673176|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673177|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673178|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19673179|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19838949|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838950|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838951|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19838952|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848195|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19673180|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673181|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
19673182|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20187398|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20187399|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187400|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
20187401|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20187402|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20187403|NCT00207662|Infliximab|infliximab|mesh-list
20187404|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20369756|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187405|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312453|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19312454|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
19312455|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
19312456|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19312457|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19312458|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312459|NCT04079192|Umirolimus|umirolimus|mesh-list
19312460|NCT04079192|Paclitaxel|paclitaxel|mesh-list
19312461|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19312462|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312463|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
19312464|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
19312465|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
19312466|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312467|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312468|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312469|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
19312470|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312471|NCT04079231|Aflibercept|aflibercept|mesh-list
19312472|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19312473|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19312474|NCT04079231|Growth Substances|growth substances|mesh-ancestor
19312475|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312476|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
19312477|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312478|NCT04079374|Etanercept|etanercept|mesh-list
19312479|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19312480|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312481|NCT04079374|Analgesics|analgesics|mesh-ancestor
19312482|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
19312483|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312484|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312485|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312486|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312487|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312488|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312489|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
19312490|NCT04079257|Eculizumab|eculizumab|mesh-list
19312491|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19312492|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312493|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
19312494|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312495|NCT04079088|Interferons|interferons|mesh-list
19312496|NCT04079088|Interferon-beta|interferon-beta|mesh-list
19312497|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
19312498|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
19312499|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
19312500|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312501|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
19312502|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312503|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
19312504|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312505|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19312506|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312507|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312508|NCT04079140|Dinoprostone|dinoprostone|mesh-list
19312509|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
19312510|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312511|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312512|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
19312513|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19312514|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
19312515|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838953|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19838954|NCT00623766|Protective Agents|protective agents|mesh-ancestor
19838955|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20187406|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20187407|NCT00207675|Infliximab|infliximab|mesh-list
20187408|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
20187409|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187410|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20187411|NCT00207688|Infliximab|infliximab|mesh-list
20187412|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
19312516|NCT04078711|Losartan|losartan|mesh-list
19312517|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19312518|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20187413|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187414|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369757|NCT00966004|Urological Agents|urological agents|mesh-ancestor
20369758|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20369759|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20369760|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
20369761|NCT00966056|Mitomycins|mitomycins|mesh-list
20369762|NCT00966056|Mitomycin|mitomycin|mesh-list
20369763|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20369764|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369765|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
20369766|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369767|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20369768|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369769|NCT00966082|Propranolol|propranolol|mesh-list
20369770|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20369771|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20369772|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369773|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369774|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369775|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369776|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20369777|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369778|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
20369779|NCT00966121|Propranolol|propranolol|mesh-list
20369780|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20369781|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20369782|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19312519|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19312520|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19312521|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369783|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312522|NCT04078659|Lidocaine|lidocaine|mesh-list
19312523|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
19312524|NCT04078659|Fentanyl|fentanyl|mesh-list
19673183|NCT04804540|Vedolizumab|vedolizumab|mesh-list
19673184|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673185|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19673186|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
19673187|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19673188|NCT04795869|Antibodies|antibodies|mesh-list
19673189|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
19673190|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19673191|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
19673192|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
19673193|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673194|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673195|NCT04772209|Heparin|heparin|mesh-list
19673196|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
19673197|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19673198|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19673199|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673200|NCT04746495|Eplerenone|eplerenone|mesh-list
19673201|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19673202|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
19673203|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673204|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673205|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19673206|NCT04746495|Diuretics|diuretics|mesh-ancestor
19673207|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
19673208|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19673212|NCT04680988|Gemcitabine|gemcitabine|mesh-list
19673213|NCT04680988|Paclitaxel|paclitaxel|mesh-list
19673214|NCT04680988|Pemetrexed|pemetrexed|mesh-list
19673215|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19673216|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19673217|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673218|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673219|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673220|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
19673221|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673222|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20369784|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673223|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
19312525|NCT04078659|Propofol|propofol|mesh-list
19312526|NCT04078659|Atracurium|atracurium|mesh-list
19312527|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
19312528|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
19312529|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312530|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312531|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
19838956|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
19838957|NCT00623779|Aspirin|aspirin|mesh-list
19838958|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19838959|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19838960|NCT00623779|Analgesics|analgesics|mesh-ancestor
19838961|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
19312532|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312533|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19312534|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19312535|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19312536|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19312537|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312538|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19838962|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312539|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19312540|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
19312541|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19312542|NCT04078659|Narcotics|narcotics|mesh-ancestor
19312543|NCT04078659|Analgesics|analgesics|mesh-ancestor
19312544|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19312545|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
19312546|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19312547|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19312548|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
19312549|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19312550|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19312551|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19312552|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19312553|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19312554|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19312555|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
19312556|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312557|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
19312558|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
19312559|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838963|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838964|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19838965|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19838966|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19838967|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19838968|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838969|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19838970|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19838971|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19838972|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
19838973|NCT00623805|Bevacizumab|bevacizumab|mesh-list
19312560|NCT04078880|Protective Agents|protective agents|mesh-ancestor
19312561|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312562|NCT04078880|Vitamins|vitamins|mesh-ancestor
19312563|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
19312564|NCT04078399|Interferons|interferons|mesh-list
19312565|NCT04078399|Azacitidine|azacitidine|mesh-list
19312566|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312567|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
19312568|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312569|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312570|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
19312571|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312572|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312573|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19312574|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
19312575|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312576|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312577|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19312578|NCT04078425|Diuretics|diuretics|mesh-ancestor
19838974|NCT00623805|Capecitabine|capecitabine|mesh-list
19312579|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
19312580|NCT04078269|Vaccines|vaccines|mesh-list
19312581|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
19312582|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312583|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19312584|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19312585|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19312586|NCT04078204|Protective Agents|protective agents|mesh-ancestor
19312587|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397315|NCT03652480|Hormones|hormones|mesh-ancestor
19397316|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397317|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19397318|NCT03652480|Protective Agents|protective agents|mesh-ancestor
19397319|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19397320|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397321|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
19397322|NCT03652467|Deferoxamine|deferoxamine|mesh-list
20369785|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369786|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20369787|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369788|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
20369789|NCT00966160|Ritonavir|ritonavir|mesh-list
19397323|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19397324|NCT03652467|Estrogens|estrogens|mesh-ancestor
19397325|NCT03652467|Hormones|hormones|mesh-ancestor
19397326|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397327|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397328|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19397329|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397330|NCT03652467|Siderophores|siderophores|mesh-ancestor
19397331|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19397332|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
19397333|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
19397334|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397335|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19397336|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397337|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397338|NCT03652428|Gemcitabine|gemcitabine|mesh-list
19397339|NCT03652428|Paclitaxel|paclitaxel|mesh-list
19397340|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19397341|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838975|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
19838976|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19838977|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369790|NCT00966160|Lopinavir|lopinavir|mesh-list
20369791|NCT00966160|Lamivudine|lamivudine|mesh-list
20369792|NCT00966160|Zidovudine|zidovudine|mesh-list
20369793|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20369794|NCT00966160|Efavirenz|efavirenz|mesh-list
20369795|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20369796|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20369797|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
20369798|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369799|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369800|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20369801|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20369802|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
20369803|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369804|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20369805|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20369806|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19397342|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19397343|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19397344|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19397345|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397346|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19397347|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
19397348|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
19397349|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397350|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397351|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397352|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
19397353|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369807|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19397354|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
19397355|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19397356|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20369808|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
20369809|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19312588|NCT04078048|Vitamins|vitamins|mesh-list
19312589|NCT04078048|Ascorbic Acid|ascorbic acid|mesh-list
19312590|NCT04078048|Vitamin E|vitamin e|mesh-list
19312591|NCT04078048|Antioxidants|antioxidants|mesh-list
19312592|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
19312593|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312594|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312595|NCT04078048|Protective Agents|protective agents|mesh-ancestor
19312596|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19312597|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19312598|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19312599|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
19312600|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312601|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312602|NCT04077853|Progestins|progestins|mesh-ancestor
19312603|NCT04077853|Hormones|hormones|mesh-ancestor
19312604|NCT04077827|Propofol|propofol|mesh-list
19312605|NCT04077827|Desflurane|desflurane|mesh-list
19312606|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19312607|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312608|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312609|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19312610|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
19312611|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
19312612|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19312613|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
19312614|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
19312615|NCT04077957|Etanercept|etanercept|mesh-list
19312616|NCT04077957|Methotrexate|methotrexate|mesh-list
19312617|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19312618|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
19312619|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19838978|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19838979|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19838980|NCT00623805|Growth Substances|growth substances|mesh-ancestor
19838981|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19838982|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
20369810|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19838983|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19838984|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
19838985|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838986|NCT00623935|Fludarabine|fludarabine|mesh-list
19838987|NCT00623935|Busulfan|busulfan|mesh-list
19838988|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19838989|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19838990|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838991|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
19838992|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187415|NCT00207701|Infliximab|infliximab|mesh-list
19312620|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312621|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312622|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
19312623|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312624|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312625|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
19312626|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187416|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20187417|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187418|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312627|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20187419|NCT00207753|Ivermectin|ivermectin|mesh-list
20187420|NCT00207753|Albendazole|albendazole|mesh-list
20187421|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20187422|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187423|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
20187424|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
20187425|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20187426|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20187427|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
20187428|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187429|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187430|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187431|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187432|NCT00207766|Infliximab|infliximab|mesh-list
19312628|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312629|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
19312630|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312631|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19312632|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
19312633|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19312634|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19312635|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312636|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19312637|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312638|NCT04077957|Analgesics|analgesics|mesh-ancestor
19312639|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
19312640|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369811|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20369812|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20369813|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20369814|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
19312641|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312642|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312643|NCT04077892|Budesonide|budesonide|mesh-list
19312644|NCT04077892|Montelukast|montelukast|mesh-list
19312645|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312646|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19312647|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
19312648|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312649|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312650|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19312651|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
19312652|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
19312653|NCT04077892|Hormones|hormones|mesh-ancestor
19312654|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312655|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19312656|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
19312657|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19838993|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
19838994|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19838995|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19838996|NCT00624013|Sertraline|sertraline|mesh-list
20369815|NCT00966251|Pidilizumab|pidilizumab|mesh-list
19312658|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19312659|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312660|NCT04077866|Temozolomide|temozolomide|mesh-list
19312661|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19312662|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
19312663|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312664|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369816|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20369817|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369818|NCT00966290|Warfarin|warfarin|mesh-list
20369819|NCT00966290|Anticoagulants|anticoagulants|mesh-list
20369820|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
20369821|NCT00966290|Fluindione|fluindione|mesh-list
20369822|NCT00966290|Phenindione|phenindione|mesh-list
20369823|NCT00966316|Aspirin|aspirin|mesh-list
20369824|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20369825|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369826|NCT00966316|Analgesics|analgesics|mesh-ancestor
20369827|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
20369828|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312665|NCT04077983|Gemcitabine|gemcitabine|mesh-list
19312666|NCT04077983|Paclitaxel|paclitaxel|mesh-list
19312667|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19312668|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312669|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
19312670|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
19312671|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
19312672|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312673|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312674|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
19312675|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
19312676|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312677|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312678|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19838997|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
20369829|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312679|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
19312680|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312681|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
19312682|NCT04077905|Doxorubicin|doxorubicin|mesh-list
19312683|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19312684|NCT04077905|Etoposide|etoposide|mesh-list
19312685|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19312686|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312687|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19312688|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19838998|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19838999|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19839000|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19839001|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839002|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839003|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839004|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
19839005|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839006|NCT00624052|Amlodipine|amlodipine|mesh-list
19839007|NCT00624052|Telmisartan|telmisartan|mesh-list
19839008|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19839009|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19839010|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848196|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
20187433|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
20187434|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187435|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20187436|NCT00207779|Heparin|heparin|mesh-list
20187437|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
19312689|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312690|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312691|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19312692|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312693|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
19312694|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
19312695|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312696|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312697|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312698|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
19312699|NCT04077905|Hormones|hormones|mesh-ancestor
19312700|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312701|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19312702|NCT04077905|Protective Agents|protective agents|mesh-ancestor
19312703|NCT04077736|Aldesleukin|aldesleukin|mesh-list
19312704|NCT04077736|Interleukin-2|interleukin-2|mesh-list
19312705|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312706|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312707|NCT04077736|Analgesics|analgesics|mesh-ancestor
19312708|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
19312709|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312710|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312711|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19312712|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19312713|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
19312714|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312715|NCT04077944|Trace Elements|trace elements|mesh-list
19312716|NCT04077944|Micronutrients|micronutrients|mesh-list
19312717|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312718|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19312719|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
19312720|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
19312721|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19312722|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
20187438|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20187439|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20187440|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187441|NCT00207792|Lenograstim|lenograstim|mesh-list
19312723|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312724|NCT04077515|Sirolimus|sirolimus|mesh-list
19312725|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312726|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312727|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19312728|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312729|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
19312730|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19312731|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
19312732|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312733|NCT04077580|Methenamine|methenamine|mesh-list
19312734|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
19312735|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
19312736|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19312737|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312738|NCT04077580|Renal Agents|renal agents|mesh-ancestor
19312739|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312740|NCT04077684|Interleukin-2|interleukin-2|mesh-list
19312741|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312742|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312743|NCT04077684|Analgesics|analgesics|mesh-ancestor
19312744|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
19312745|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312746|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312747|NCT04077398|Ropivacaine|ropivacaine|mesh-list
19312748|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
19312749|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
19312750|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312751|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312752|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
19312753|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839011|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839012|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19839013|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839014|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
19839015|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19839016|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19839017|NCT00624065|Carvedilol|carvedilol|mesh-list
19839018|NCT00624065|Lisinopril|lisinopril|mesh-list
19839019|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19839020|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19839021|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839022|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839023|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839024|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839025|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19839026|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
19839027|NCT00624065|Protective Agents|protective agents|mesh-ancestor
19839028|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19839029|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839030|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19312754|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19312755|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19839031|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
19839032|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19839033|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19312756|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19312757|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312758|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
19312759|NCT04077190|Cortisone|cortisone|mesh-list
19312760|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312761|NCT04076865|Lidocaine|lidocaine|mesh-list
19312762|NCT04076865|Histamine|histamine|mesh-list
19312763|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
19312764|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
19312765|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312766|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312767|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
19312768|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839034|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19839035|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
19839036|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839037|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19839038|NCT00624195|Etravirine|etravirine|mesh-list
20187442|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20187443|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
20187444|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187445|NCT00207831|Tegafur|tegafur|mesh-list
20187446|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20187447|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
20217353|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19312769|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19312770|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20369830|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20369831|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369832|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20369833|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20369834|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369835|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20369836|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20369837|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369838|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
20369839|NCT00966329|Maraviroc|maraviroc|mesh-list
20369840|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20369841|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20369842|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369843|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20369844|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19312771|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19312772|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19312773|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312774|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
19312775|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
19312776|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312777|NCT04077255|Paclitaxel|paclitaxel|mesh-list
19312778|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19312779|NCT04077255|Antibodies|antibodies|mesh-list
19312780|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19312781|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312782|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
19312783|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
19312784|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
19312785|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312786|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
19312787|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312788|NCT04077125|Rifaximin|rifaximin|mesh-list
19312789|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312790|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312791|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312792|NCT04076436|Fosfomycin|fosfomycin|mesh-list
19312793|NCT04076436|Lactams|lactams|mesh-list
19312794|NCT04076436|beta-Lactams|beta-lactams|mesh-list
19312795|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312796|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312797|NCT04076709|Anesthetics|anesthetics|mesh-list
19312798|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312799|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312800|NCT04076826|Midazolam|midazolam|mesh-list
19312801|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
19312802|NCT04076826|Propofol|propofol|mesh-list
19312803|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19312804|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312805|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312806|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19312807|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
19312808|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
19312809|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312810|NCT04076826|Analgesics|analgesics|mesh-ancestor
19312811|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
19312812|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312813|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19312814|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19312815|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19312816|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
19312817|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312818|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312819|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19673224|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
19673225|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673226|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673227|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673228|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
19673229|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673230|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19673231|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19692189|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19839039|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19839040|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19312820|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20369845|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
20369846|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369847|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20369848|NCT00966368|Insulin|insulin|mesh-list
20369849|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20369850|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
20369851|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20369852|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369853|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20369854|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20369855|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312821|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19312822|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19839041|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19839042|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839043|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839044|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
19839045|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839046|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
19839047|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19839048|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
19839049|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839050|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839051|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839052|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839053|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
19839054|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19839055|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
19839056|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369856|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20369857|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369858|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369859|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20369860|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19839057|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839058|NCT00624416|Prednisolone|prednisolone|mesh-list
19839059|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19312823|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
19312824|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
19312825|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19312826|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19312827|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20369861|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
20369862|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20369863|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20369864|NCT00966576|Timolol|timolol|mesh-list
20369865|NCT00966576|Brinzolamide|brinzolamide|mesh-list
20369866|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20369867|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20369868|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
20369869|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369870|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397357|NCT03652376|Benralizumab|benralizumab|mesh-list
19397358|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19397359|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
19397360|NCT03652233|Nivolumab|nivolumab|mesh-list
19397361|NCT03652233|Afatinib|afatinib|mesh-list
19397362|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397363|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397364|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19839060|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
20369871|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369872|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20369873|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20369874|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369875|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19839061|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19839062|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
19839063|NCT00624416|Cortisone|cortisone|mesh-list
20369876|NCT00966602|Ivacaftor|ivacaftor|mesh-list
20369877|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20369878|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397365|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397366|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19839064|NCT00624416|Isoproterenol|isoproterenol|mesh-list
19839065|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19839066|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
19839067|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839068|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
19839069|NCT00624416|Hormones|hormones|mesh-ancestor
19312828|NCT04076371|Olanzapine|olanzapine|mesh-list
19312829|NCT04076371|Risperidone|risperidone|mesh-list
19312830|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19312831|NCT04076371|Ziprasidone|ziprasidone|mesh-list
19312832|NCT04076371|Sertraline|sertraline|mesh-list
19312833|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19312834|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
19312835|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312836|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312837|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312838|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19312839|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19312840|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312841|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19312842|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19839070|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839071|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839072|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19312843|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
19312844|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
19312845|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
19312846|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312847|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312848|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19312849|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19312850|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19312851|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
19312852|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19312853|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19312854|NCT04076098|Minocycline|minocycline|mesh-list
19312855|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19312856|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312857|NCT04076137|Decitabine|decitabine|mesh-list
19312858|NCT04076137|Antibodies|antibodies|mesh-list
19312859|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19312860|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
19312861|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312862|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312863|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
19312864|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312865|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312866|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839073|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839074|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
19839075|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
19839076|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839077|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839078|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19839079|NCT00624416|Protective Agents|protective agents|mesh-ancestor
19312867|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
19312868|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19312869|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312870|NCT04075955|Olanzapine|olanzapine|mesh-list
19312871|NCT04075955|Aprepitant|aprepitant|mesh-list
19312872|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
19312873|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
19312874|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312875|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312876|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312877|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19312878|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19312879|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312880|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19312881|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19312882|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19312883|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19312884|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839080|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19312885|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839081|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19312886|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
19839082|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839083|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20369879|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369880|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
20369881|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20369882|NCT00966680|Anesthetics|anesthetics|mesh-list
20369883|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20369884|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839084|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839085|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19839086|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839087|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839088|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19839089|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
19839090|NCT00624559|Celecoxib|celecoxib|mesh-list
19312887|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19312888|NCT04075721|Dexamethasone|dexamethasone|mesh-list
19312889|NCT04075721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312890|NCT04075721|Antiemetics|antiemetics|mesh-ancestor
19312891|NCT04075721|Autonomic Agents|autonomic agents|mesh-ancestor
19312892|NCT04075721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312893|NCT04075721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312894|NCT04075721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312895|NCT04075721|Glucocorticoids|glucocorticoids|mesh-ancestor
19312896|NCT04075721|Hormones|hormones|mesh-ancestor
19312897|NCT04075721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312898|NCT04075721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19312899|NCT04075721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312900|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19312901|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19312902|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839091|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19839092|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19839093|NCT00624559|Analgesics|analgesics|mesh-ancestor
19839094|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
19839095|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839096|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839097|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839098|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839099|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19839100|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19839101|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839102|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839103|NCT00624585|Dasatinib|dasatinib|mesh-list
19839104|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839105|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19839106|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839107|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839108|NCT00624780|Pregabalin|pregabalin|mesh-list
19839109|NCT00624780|Lorazepam|lorazepam|mesh-list
19839110|NCT00624780|Analgesics|analgesics|mesh-ancestor
19839111|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
19839112|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839113|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839114|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
19839115|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19839116|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839117|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839118|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19839119|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19839120|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19839121|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839122|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19839123|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
20369885|NCT00966706|Gemcitabine|gemcitabine|mesh-list
20369886|NCT00966706|Docetaxel|docetaxel|mesh-list
20369887|NCT00966706|Capecitabine|capecitabine|mesh-list
20369888|NCT00966706|Epirubicin|epirubicin|mesh-list
20369889|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839124|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
19312903|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312904|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397367|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312905|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312906|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19312907|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19312908|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19312909|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312910|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312911|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19312912|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19312913|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312914|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
19312915|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839125|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839126|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19839127|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
19839128|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
19839129|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839130|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19839131|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
19839132|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312916|NCT04075474|Listerine|listerine|mesh-list
19312917|NCT04075474|Fluorides|fluorides|mesh-list
19312918|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
19312919|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
19312920|NCT04075474|Protective Agents|protective agents|mesh-ancestor
19312921|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312922|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19312923|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312924|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19312925|NCT04075227|Dexamethasone|dexamethasone|mesh-list
19312926|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312927|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
19312928|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
19312929|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312930|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312931|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19312932|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
19312933|NCT04075227|Hormones|hormones|mesh-ancestor
19312934|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312935|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19312936|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839133|NCT00624832|Omalizumab|omalizumab|mesh-list
19839134|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19839135|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839136|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839137|NCT00624910|Bupivacaine|bupivacaine|mesh-list
19839138|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
20369890|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312937|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19312938|NCT04075006|Ketamine|ketamine|mesh-list
19312939|NCT04075006|Analgesics|analgesics|mesh-ancestor
19312940|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
19312941|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312942|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312943|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19312944|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19839139|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
19839140|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839141|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839142|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
19839143|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187448|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187449|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187450|NCT00207844|Selenium|selenium|mesh-list
20187451|NCT00207844|Selenious Acid|selenious acid|mesh-list
20187452|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
20187453|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
20187454|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187455|NCT00207844|Protective Agents|protective agents|mesh-ancestor
20187456|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187457|NCT00207844|Trace Elements|trace elements|mesh-ancestor
20187458|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
20187459|NCT00207948|Ritonavir|ritonavir|mesh-list
20369891|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
20369892|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187460|NCT00207948|Lopinavir|lopinavir|mesh-list
19312945|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
19839144|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19839145|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
19839146|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19839147|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19839148|NCT00624923|Analgesics|analgesics|mesh-ancestor
19839149|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
19839150|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839151|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839152|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839153|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839154|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19312946|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
19312947|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19312948|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19312949|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19312950|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397368|NCT03652142|Nivolumab|nivolumab|mesh-list
19839155|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839156|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839157|NCT00625131|Bupropion|bupropion|mesh-list
19839158|NCT00625131|Nicotine|nicotine|mesh-list
19839159|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19839160|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
19839161|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839162|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839163|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19839164|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19839165|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
19839166|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839167|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839168|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19839169|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
19839170|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19839171|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19839172|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19839173|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839174|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
19839175|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19839176|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19839177|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839178|NCT00625183|Selenium|selenium|mesh-list
19839179|NCT00625183|Capecitabine|capecitabine|mesh-list
19839180|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
19839181|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19839182|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
20187461|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20187462|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20187463|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
20187464|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187465|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187466|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20187467|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20187468|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
20187469|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187470|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20187471|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20187472|NCT00208039|Calfactant|calfactant|mesh-list
20187473|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20187474|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
20187475|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
20187476|NCT00208065|Ephedrine|ephedrine|mesh-list
20187477|NCT00208065|Almotriptan|almotriptan|mesh-list
20187478|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20187479|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
20187480|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187481|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187482|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20187483|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
20187484|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
20187485|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20187486|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20369893|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
20369894|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848197|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19312951|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312952|NCT04075149|Spironolactone|spironolactone|mesh-list
19312953|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19312954|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
19312955|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19312956|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312957|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19312958|NCT04075149|Diuretics|diuretics|mesh-ancestor
19312959|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
19312960|NCT04075240|Aspirin|aspirin|mesh-list
19312961|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
19312962|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19312963|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19312964|NCT04075240|Analgesics|analgesics|mesh-ancestor
19312965|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
19312966|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19312967|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312968|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19312969|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19312970|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19312971|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19312972|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19312973|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19312974|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19839183|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839184|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839185|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
19839186|NCT00625183|Protective Agents|protective agents|mesh-ancestor
19839187|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839188|NCT00625183|Trace Elements|trace elements|mesh-ancestor
19839189|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
19839190|NCT00625404|Tenofovir|tenofovir|mesh-list
19839191|NCT00625404|Emtricitabine|emtricitabine|mesh-list
19839192|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19839193|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
19839194|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839195|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19312975|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19312976|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
19312977|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19312978|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
19312979|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19312980|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
19312981|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
19312982|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
19312983|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19312984|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19312985|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
19312986|NCT04075188|Aflibercept|aflibercept|mesh-list
19839196|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19839197|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839198|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839199|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19839200|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19839201|NCT00625729|Aldesleukin|aldesleukin|mesh-list
19839202|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
19839203|NCT00625729|Rituximab|rituximab|mesh-list
19839204|NCT00625729|Fludarabine|fludarabine|mesh-list
19839205|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
19839206|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839207|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
19839208|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839209|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839210|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19839211|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
19839212|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839213|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839214|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19839215|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19839216|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19312987|NCT04075188|Verteporfin|verteporfin|mesh-list
19312988|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19839217|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
19839218|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19312989|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19312990|NCT04075188|Growth Substances|growth substances|mesh-ancestor
19312991|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19312992|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
19312993|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19312994|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19312995|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
19312996|NCT04075604|Nivolumab|nivolumab|mesh-list
19312997|NCT04075604|Palbociclib|palbociclib|mesh-list
19312998|NCT04075604|Anastrozole|anastrozole|mesh-list
19312999|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313000|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313001|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19313002|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313003|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19313004|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313005|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19313006|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19313007|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19313008|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19313009|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
19313010|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19313011|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313012|NCT04075201|Vaccines|vaccines|mesh-list
19313013|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
19313014|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839219|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19839220|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
19839221|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839222|NCT00625820|Ascorbic Acid|ascorbic acid|mesh-list
19839223|NCT00625820|Vitamins|vitamins|mesh-ancestor
19839224|NCT00625820|Micronutrients|micronutrients|mesh-ancestor
19839225|NCT00625820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839226|NCT00625820|Antioxidants|antioxidants|mesh-ancestor
19839227|NCT00625820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839228|NCT00625820|Protective Agents|protective agents|mesh-ancestor
19839229|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
19839230|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19839231|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
19839232|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839233|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839234|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839235|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839236|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19839237|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
19839238|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313015|NCT04074746|Vidarabine|vidarabine|mesh-list
19313016|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
19313017|NCT04074746|Fludarabine|fludarabine|mesh-list
19313018|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
19313019|NCT04074746|Antibodies|antibodies|mesh-list
19839239|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839240|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19839241|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
19839242|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
19839243|NCT00626028|Protective Agents|protective agents|mesh-ancestor
19839244|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
19839245|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
19839246|NCT00626197|Azathioprine|azathioprine|mesh-list
20369895|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369896|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20369897|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
20369898|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369899|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
20369900|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
20369901|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
20369902|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20369903|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20369904|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20369905|NCT00966745|Milrinone|milrinone|mesh-list
20369906|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20369907|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20369908|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
19313020|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19839247|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
20369909|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20369910|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19839248|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839249|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
20369911|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369912|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369913|NCT00966745|Protective Agents|protective agents|mesh-ancestor
20369914|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369915|NCT00966771|Copper|copper|mesh-list
20369916|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
20369917|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20369918|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
20369919|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20369920|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369921|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19839250|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839251|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20369922|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20369923|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20369924|NCT00966771|Trace Elements|trace elements|mesh-ancestor
20369925|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
20369926|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
20369927|NCT00966836|Valganciclovir|valganciclovir|mesh-list
20369928|NCT00966836|Everolimus|everolimus|mesh-list
20369929|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369930|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20369931|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
20369932|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369933|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20369934|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20369935|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
20369936|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20369937|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20369938|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369939|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313021|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19313022|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
19313023|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369940|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
19313024|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19313025|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19313026|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
19313027|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313028|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313029|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19313030|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19313031|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
19313032|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
19313033|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313034|NCT04074473|Propranolol|propranolol|mesh-list
19313035|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19313036|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19313037|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
19313038|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313039|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369941|NCT00966901|Nicotine|nicotine|mesh-list
20369942|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20369943|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
20369944|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20369945|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369946|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20369947|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20369948|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
20369949|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673232|NCT04582591|Cannabidiol|cannabidiol|mesh-list
19673233|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
19673234|NCT04542200|Antibodies|antibodies|mesh-list
19673235|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
19673236|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673237|NCT04538534|Nicardipine|nicardipine|mesh-list
19673238|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19673239|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19673240|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673241|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673242|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19673243|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673244|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673245|NCT04497883|Maribavir|maribavir|mesh-list
20369950|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369951|NCT00966914|Paclitaxel|paclitaxel|mesh-list
20369952|NCT00966914|Docetaxel|docetaxel|mesh-list
20369953|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20369954|NCT00966914|Cisplatin|cisplatin|mesh-list
20369955|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
20369956|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19839252|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19839253|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
19313040|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313041|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19313042|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19313043|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
19313044|NCT04074603|Insulin|insulin|mesh-list
19313045|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19313046|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313047|NCT04074564|Apatinib|apatinib|mesh-list
19313048|NCT04074564|Antibodies|antibodies|mesh-list
19313049|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
19313050|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313051|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313052|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19313053|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313054|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313055|NCT04074460|Propofol|propofol|mesh-list
19313056|NCT04074460|Sevoflurane|sevoflurane|mesh-list
19313057|NCT04074460|Desflurane|desflurane|mesh-list
19313058|NCT04074460|Isoflurane|isoflurane|mesh-list
19313059|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19313060|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313061|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313062|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19839254|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839255|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839256|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19839257|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19839258|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19839259|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
19839260|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20187487|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
20187488|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
20187489|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187490|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187491|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20187492|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
20187493|NCT00208117|Sertraline|sertraline|mesh-list
20187494|NCT00208117|Simvastatin|simvastatin|mesh-list
20187495|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20187496|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20187497|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
20187498|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187499|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20187500|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20187501|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187502|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187503|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187504|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20187505|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187506|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217354|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369957|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313063|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
19313064|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
19673246|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
19673247|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673248|NCT04441762|Ketorolac|ketorolac|mesh-list
19673249|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19673250|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19673251|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19673252|NCT04441762|Analgesics|analgesics|mesh-ancestor
19673253|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
19673254|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673255|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673256|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673257|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839261|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839262|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839263|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
19839264|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19839265|NCT00626210|Modafinil|modafinil|mesh-list
19313065|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19313066|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19313067|NCT04074551|Losartan|losartan|mesh-list
20369958|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
20369959|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
20369960|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
20369961|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369962|NCT00966914|Protective Agents|protective agents|mesh-ancestor
20369963|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369964|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
20369965|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20369966|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
19313068|NCT04074551|Amlodipine|amlodipine|mesh-list
19313069|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19313070|NCT04074551|Ezetimibe|ezetimibe|mesh-list
19313071|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19313072|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19313073|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19313074|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313075|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19313076|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313077|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
19313078|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19313079|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19839266|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19839267|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839268|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19839269|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19839270|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19839271|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839272|NCT00626275|Naproxen|naproxen|mesh-list
19839273|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20369967|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369968|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20369969|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20369970|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20369971|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369972|NCT00967031|Capecitabine|capecitabine|mesh-list
20369973|NCT00967031|Lapatinib|lapatinib|mesh-list
20369974|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19313080|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
19313081|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19313082|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19313083|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313084|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19313085|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19313086|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19313087|NCT04074421|Rifaximin|rifaximin|mesh-list
19313088|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313089|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313090|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19397369|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397370|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397371|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20369975|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
19397372|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397373|NCT03652116|Meperidine|meperidine|mesh-list
19397374|NCT03652116|Bupivacaine|bupivacaine|mesh-list
19397375|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
19397376|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
19692190|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
19692191|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692192|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692193|NCT04995497|Lidocaine|lidocaine|mesh-list
19692194|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
19692195|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
19692196|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692197|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369976|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20369977|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369978|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20369979|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20369980|NCT00967057|Dexamethasone|dexamethasone|mesh-list
20369981|NCT00967057|Methotrexate|methotrexate|mesh-list
20369982|NCT00967057|Vincristine|vincristine|mesh-list
20369983|NCT00967057|Asparaginase|asparaginase|mesh-list
20369984|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
20369985|NCT00967057|Idarubicin|idarubicin|mesh-list
20369986|NCT00967057|Pegaspargase|pegaspargase|mesh-list
20369987|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20369988|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
20369989|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
19313091|NCT04074213|Clozapine|clozapine|mesh-list
19313092|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19313093|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
19313094|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313095|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313096|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313097|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19313098|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19313099|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313100|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19313101|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
19313102|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
19313103|NCT04073953|Primaquine|primaquine|mesh-list
19313104|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
19313105|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19313106|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19313107|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313108|NCT04074317|Insulin|insulin|mesh-list
19313109|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19313110|NCT04074317|Pramlintide|pramlintide|mesh-list
20369990|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313111|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19313112|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313113|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
19313114|NCT04073849|Hematinics|hematinics|mesh-ancestor
19313115|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
19313116|NCT04073758|Remifentanil|remifentanil|mesh-list
19313117|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19313118|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313119|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313120|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19313121|NCT04073758|Analgesics|analgesics|mesh-ancestor
19313122|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
19313123|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839274|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20369991|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20369992|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20369993|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
20369994|NCT00967057|Hormones|hormones|mesh-ancestor
20369995|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839275|NCT00626275|Analgesics|analgesics|mesh-ancestor
19839276|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
19839277|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839278|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313124|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19313125|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19313126|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19313127|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19313128|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313129|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313130|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19313131|NCT04073758|Narcotics|narcotics|mesh-ancestor
19313132|NCT04073797|Evolocumab|evolocumab|mesh-list
19313133|NCT04073797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19313134|NCT04073797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19313135|NCT04073797|Antimetabolites|antimetabolites|mesh-ancestor
19313136|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313137|NCT04073797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839279|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313138|NCT04073550|Topotecan|topotecan|mesh-list
19313139|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20369996|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19313140|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20369997|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20369998|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20369999|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
20370000|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19839280|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839281|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
19313141|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313142|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313143|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313144|NCT04073537|Paclitaxel|paclitaxel|mesh-list
19313145|NCT04073537|Carboplatin|carboplatin|mesh-list
19313146|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19313147|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313148|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19313149|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19313150|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19313151|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313152|NCT04073719|Acetic Acid|acetic acid|mesh-list
19313153|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19839282|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19839283|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839284|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839285|NCT00626340|Fluoxetine|fluoxetine|mesh-list
19839286|NCT00626340|Estrogens|estrogens|mesh-list
19839287|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19839288|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19839289|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839290|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839291|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839292|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
19839293|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839294|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19839295|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
19839296|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19313154|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313155|NCT04073602|Trastuzumab|trastuzumab|mesh-list
19313156|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313157|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313158|NCT04073680|Canagliflozin|canagliflozin|mesh-list
19313159|NCT04073680|Serabelisib|serabelisib|mesh-list
19313160|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19839297|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19839298|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19839299|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839300|NCT00626340|Hormones|hormones|mesh-ancestor
19839301|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839302|NCT00626392|Aspirin|aspirin|mesh-list
19839303|NCT00626392|Niacin|niacin|mesh-list
19839304|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19839305|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19839306|NCT00626392|Analgesics|analgesics|mesh-ancestor
19839307|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
19839308|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370001|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20370002|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
20370003|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370004|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
19839309|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839310|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839311|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839312|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19839313|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19839314|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839315|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19839316|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19839317|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839318|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
19839319|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19839320|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
19839321|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839322|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
19839323|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
19313161|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839324|NCT00626392|Vitamins|vitamins|mesh-ancestor
19839325|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
19839326|NCT00626405|Paclitaxel|paclitaxel|mesh-list
19313162|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19313163|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313164|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313165|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
19313166|NCT04073173|Analgesics|analgesics|mesh-list
19839327|NCT00626405|Bevacizumab|bevacizumab|mesh-list
19839328|NCT00626405|Carboplatin|carboplatin|mesh-list
19839329|NCT00626405|Temozolomide|temozolomide|mesh-list
19839330|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19839331|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19313167|NCT04073173|Narcotics|narcotics|mesh-ancestor
20370005|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370006|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20370007|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370008|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
20370009|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370010|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20370011|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370012|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
20370013|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
20370014|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
20370015|NCT00967057|Analgesics|analgesics|mesh-ancestor
20370016|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
20370017|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20370018|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370019|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20370020|NCT00967070|Nicotine|nicotine|mesh-list
19313168|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313169|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313170|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
19313171|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313172|NCT04074265|Ketorolac|ketorolac|mesh-list
19313173|NCT04074265|Epinephrine|epinephrine|mesh-list
19313174|NCT04074265|Ropivacaine|ropivacaine|mesh-list
19313175|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
19313176|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
19313177|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313178|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313179|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
19313180|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313181|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19313182|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19313183|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
19313184|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313185|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839332|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839333|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
19839334|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
19839335|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
19839336|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839337|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19839338|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19839339|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370021|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20370022|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
20370023|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370024|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370025|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19839340|NCT00626405|Growth Substances|growth substances|mesh-ancestor
19839341|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839342|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
19839343|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19839344|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
19839345|NCT00626431|Leuprolide|leuprolide|mesh-list
19839346|NCT00626431|Hormones|hormones|mesh-list
19839347|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19839348|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839349|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313186|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19313187|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19313188|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
19839350|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19839351|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
20370026|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20370027|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
20370028|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370029|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370030|NCT00967096|Rifaximin|rifaximin|mesh-list
19313189|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19313190|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
19673258|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19673259|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673260|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673261|NCT04412694|Dexamethasone|dexamethasone|mesh-list
20187507|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313191|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
19839352|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19839353|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19839354|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839355|NCT00626522|Bromides|bromides|mesh-list
19839356|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
19839357|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19839358|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
19839359|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839360|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839361|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839362|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839363|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19839364|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19839365|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19839366|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839367|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187508|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
20187509|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187510|NCT00208130|Topiramate|topiramate|mesh-list
20187511|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
20187512|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20187513|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187514|NCT00208143|Risperidone|risperidone|mesh-list
20370031|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20370032|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313192|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
20187515|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20187516|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19313193|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19313194|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19313195|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19313196|NCT04074265|Analgesics|analgesics|mesh-ancestor
19313197|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313198|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19313199|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19313200|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313201|NCT04073160|Durvalumab|durvalumab|mesh-list
19673262|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
19673263|NCT04412694|BB 1101|bb 1101|mesh-list
19673264|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673265|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
19673266|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
19673267|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673268|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673269|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673270|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
19673271|NCT04412694|Hormones|hormones|mesh-ancestor
19673272|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673273|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19673274|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673275|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
19673276|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673277|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673278|NCT04351438|Heparin|heparin|mesh-list
19673279|NCT04351438|Citric Acid|citric acid|mesh-list
19673280|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
19673281|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
19673282|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19673283|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
19673284|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
20187517|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
20187518|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370033|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673285|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187519|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187520|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187521|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19313202|NCT04073160|Tremelimumab|tremelimumab|mesh-list
19313203|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313204|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313205|NCT04073134|Evolocumab|evolocumab|mesh-list
19313206|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19313207|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19313208|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
19313209|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313210|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839368|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839369|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
19839370|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
19839371|NCT00626574|Hematinics|hematinics|mesh-ancestor
19839372|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
19839373|NCT00626626|Clofarabine|clofarabine|mesh-list
19839374|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
19839375|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19839376|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839377|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19839378|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
19839379|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839380|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839381|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
19839382|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839383|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839384|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19839385|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
19839386|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19839387|NCT00626639|Cisplatin|cisplatin|mesh-list
19839388|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839389|NCT00626743|Amlodipine|amlodipine|mesh-list
19839390|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19673286|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19673287|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19673288|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19673289|NCT04278651|Hematinics|hematinics|mesh-ancestor
19673290|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19673291|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19673292|NCT04270643|Vitamin D|vitamin d|mesh-list
19839391|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19839392|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839393|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839394|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19839395|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839396|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
20187522|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187523|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187524|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19313211|NCT04074122|Adenosine|adenosine|mesh-list
19313212|NCT04074122|Isoproterenol|isoproterenol|mesh-list
19313213|NCT04074122|Epinephrine|epinephrine|mesh-list
19313214|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19313215|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19313216|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
19313217|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313218|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313219|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313220|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19313221|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20370034|NCT00967135|Pregabalin|pregabalin|mesh-list
20370035|NCT00967135|Analgesics|analgesics|mesh-ancestor
20370036|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
20370037|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313222|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
19313223|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673293|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
20187525|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187526|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
20187527|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
19673294|NCT04270643|Vitamins|vitamins|mesh-ancestor
19839397|NCT00626782|Ranibizumab|ranibizumab|mesh-list
19313224|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839398|NCT00626782|Mitomycins|mitomycins|mesh-list
19313225|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
19313226|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
19313227|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
19313228|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19313229|NCT04074122|Analgesics|analgesics|mesh-ancestor
19313230|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
19313231|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19313232|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
20370038|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370039|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
20370040|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20370041|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370042|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370043|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20370044|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20370045|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20370046|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370047|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370048|NCT00967148|Tinzaparin|tinzaparin|mesh-list
20370049|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19313233|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19313234|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
19313235|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
19313236|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19313237|NCT04074122|Protective Agents|protective agents|mesh-ancestor
19313238|NCT04073927|Butyric Acid|butyric acid|mesh-list
19313239|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
19313240|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
19313241|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313242|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313243|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313244|NCT04073316|Warfarin|warfarin|mesh-list
19313245|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
20370050|NCT00967148|Dalteparin|dalteparin|mesh-list
20370051|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
20370052|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20370053|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19313246|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
19313247|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19313248|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
19313249|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19313250|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
19313251|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313252|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313253|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
19313254|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19313255|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19313256|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19313257|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19313258|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313259|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
19313260|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313261|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313262|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19313263|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313264|NCT04073056|Bupivacaine|bupivacaine|mesh-list
19313265|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
20187528|NCT00208156|Mifepristone|mifepristone|mesh-list
20187529|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20187530|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
20187531|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20187532|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187533|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20187534|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20187535|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20187536|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
20187537|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20187538|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20187539|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
20187540|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187541|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
20187542|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20187543|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20187544|NCT00208169|Aripiprazole|aripiprazole|mesh-list
19839399|NCT00626782|Mitomycin|mitomycin|mesh-list
19839400|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19839401|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19839402|NCT00626782|Growth Substances|growth substances|mesh-ancestor
19839403|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839404|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
19839405|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839406|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19839407|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
19839408|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839409|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19839410|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839411|NCT00626795|Mupirocin|mupirocin|mesh-list
19839412|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19839413|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839414|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19839415|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839416|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839417|NCT00626886|Bupivacaine|bupivacaine|mesh-list
19839418|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
19839419|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
19839420|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839421|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839422|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
19839423|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839424|NCT00626925|Topiramate|topiramate|mesh-list
19839425|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
19839426|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19313266|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
19313267|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313268|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313269|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
19313270|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313271|NCT04072640|Voriconazole|voriconazole|mesh-list
19313272|NCT04072640|Amphotericin B|amphotericin b|mesh-list
19313273|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19313274|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
19313275|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
19313276|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
19313277|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313278|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19313279|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19313280|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313281|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313282|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19313283|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
19313284|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19313285|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313286|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19313287|NCT04072640|Amebicides|amebicides|mesh-ancestor
19313288|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19839427|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839428|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
19839429|NCT00627016|Lansoprazole|lansoprazole|mesh-list
19313289|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19313290|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313291|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19313292|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19313293|NCT04072770|Caseins|caseins|mesh-list
19313294|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
19313295|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
19397377|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839430|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19839431|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839432|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19839433|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839434|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839435|NCT00627042|Ramucirumab|ramucirumab|mesh-list
20187545|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187546|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187547|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187548|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187549|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187550|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370054|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313296|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313297|NCT04072900|Imiquimod|imiquimod|mesh-list
19839436|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19839437|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839438|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
19839439|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839440|NCT00627367|Hydromorphone|hydromorphone|mesh-list
19839441|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19839442|NCT00627367|Narcotics|narcotics|mesh-ancestor
19839443|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839444|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839445|NCT00627367|Analgesics|analgesics|mesh-ancestor
19839446|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
19839447|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839448|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
19839449|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19839450|NCT00627393|Dexamethasone|dexamethasone|mesh-list
19839451|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839452|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
19839453|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
19839454|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839455|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839456|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839457|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
19839458|NCT00627393|Hormones|hormones|mesh-ancestor
19839459|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839460|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19313298|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19313299|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
19313300|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313301|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313302|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
19839461|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839462|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19839463|NCT00627406|Buserelin|buserelin|mesh-list
19313303|NCT04072601|Atorvastatin|atorvastatin|mesh-list
19313304|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19313305|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19313306|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
19313307|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313308|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839464|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19839465|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839466|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19839467|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
19839468|NCT00627445|Insulin|insulin|mesh-list
19313309|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19839469|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19839470|NCT00627445|Metformin|metformin|mesh-list
19839471|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
19839472|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
19839473|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20187551|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
20187552|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
20187553|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187554|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187555|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20187556|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20187557|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
20187558|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20187559|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20187560|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20187561|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187562|NCT00208182|Risperidone|risperidone|mesh-list
20187563|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20370055|NCT00967174|Nicotine|nicotine|mesh-list
20370056|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20370057|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
20370058|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370059|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370060|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20370061|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20370062|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
20370063|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370064|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370065|NCT00967213|Ranibizumab|ranibizumab|mesh-list
20370066|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370067|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370068|NCT00967213|Growth Substances|growth substances|mesh-ancestor
20370069|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370070|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370071|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370072|NCT00967252|Atorvastatin|atorvastatin|mesh-list
20370073|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20370074|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20370075|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
20370076|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839474|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
19839475|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20612742|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20612743|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
20612744|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612745|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612746|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20612747|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612748|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20612749|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
19673295|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
19673296|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673297|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19673298|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20370077|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20370078|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20370079|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370080|NCT00967291|Ifosfamide|ifosfamide|mesh-list
20370081|NCT00967291|Mitomycins|mitomycins|mesh-list
20370082|NCT00967291|Mitomycin|mitomycin|mesh-list
20370083|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370084|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
20370085|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370086|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612750|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673299|NCT04203498|Nabiximols|nabiximols|mesh-list
19673300|NCT04203498|Analgesics|analgesics|mesh-ancestor
19673301|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
19673302|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673303|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673304|NCT04200248|Aflibercept|aflibercept|mesh-list
20612751|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370087|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20612752|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20612753|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
20612754|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
20612755|NCT02252770|Protective Agents|protective agents|mesh-ancestor
20612756|NCT02252796|Paclitaxel|paclitaxel|mesh-list
20612757|NCT02252796|Carboplatin|carboplatin|mesh-list
20612758|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19313310|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839476|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19839477|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839478|NCT00627458|Vaccines|vaccines|mesh-list
19839479|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
19839480|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839481|NCT00627679|Budesonide|budesonide|mesh-list
19839482|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839483|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19839484|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
19839485|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839486|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313311|NCT04072497|Vaccines|vaccines|mesh-list
19313312|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
19313313|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313314|NCT04072263|Interferons|interferons|mesh-list
19313315|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
19313316|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
19839487|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19313317|NCT04072263|Paclitaxel|paclitaxel|mesh-list
19313318|NCT04072263|Carboplatin|carboplatin|mesh-list
19313319|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19313320|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313321|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
19313322|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187564|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
20187565|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187566|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187567|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187568|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187569|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187570|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370088|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20370089|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370090|NCT00967382|Dalteparin|dalteparin|mesh-list
20370091|NCT00967382|Tinzaparin|tinzaparin|mesh-list
20370092|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20370093|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
20370094|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19313323|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
19313324|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313325|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
19313326|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313327|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
19313328|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313329|NCT04072471|Lesinurad|lesinurad|mesh-list
19313330|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
20370095|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20370096|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370097|NCT00967408|Citalopram|citalopram|mesh-list
20370098|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20370099|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20370100|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370101|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370102|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370103|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
20370104|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313331|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19313332|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
19673305|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370105|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20370106|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
20370107|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370108|NCT00967421|Ethanol|ethanol|mesh-list
20370109|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20370110|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370111|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370112|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370113|NCT00967434|Atorvastatin|atorvastatin|mesh-list
20370114|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20370115|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20370116|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
20370117|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370118|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20370119|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20370120|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370121|NCT00967512|Cytarabine|cytarabine|mesh-list
20370122|NCT00967512|Idarubicin|idarubicin|mesh-list
19673306|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20187571|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187572|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187573|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
20187574|NCT00208195|Valproic Acid|valproic acid|mesh-list
20187575|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
20187576|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187577|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187578|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
20370123|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20370124|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
19673307|NCT04200248|Growth Substances|growth substances|mesh-ancestor
19673308|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673309|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
20187579|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313333|NCT04072471|Renal Agents|renal agents|mesh-ancestor
19313334|NCT04072068|Edoxaban|edoxaban|mesh-list
19313335|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19313336|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
19313337|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19313338|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
19313339|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313340|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313341|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
19313342|NCT04072198|Leucovorin|leucovorin|mesh-list
19313343|NCT04072198|Bevacizumab|bevacizumab|mesh-list
19839488|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839489|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
19839490|NCT00627679|Hormones|hormones|mesh-ancestor
19839491|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839492|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
19839493|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19839494|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
19839495|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839496|NCT00627705|Expectorants|expectorants|mesh-ancestor
19839497|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839498|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19839499|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
19839500|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839501|NCT00627705|Protective Agents|protective agents|mesh-ancestor
19839502|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313344|NCT04072198|Nivolumab|nivolumab|mesh-list
19313345|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
19313346|NCT04072198|Irinotecan|irinotecan|mesh-list
19313347|NCT04072198|Fluorouracil|fluorouracil|mesh-list
19313348|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313349|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370125|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370126|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313350|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19313351|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19313352|NCT04072198|Growth Substances|growth substances|mesh-ancestor
20370127|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
20370128|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313353|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313354|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
19313355|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19313356|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313357|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19313358|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19313359|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313360|NCT04072198|Antidotes|antidotes|mesh-ancestor
19839503|NCT00627705|Antidotes|antidotes|mesh-ancestor
19839504|NCT00627861|Metoprolol|metoprolol|mesh-list
19839505|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19839506|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20187580|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187581|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
20187582|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187583|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187584|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187585|NCT00208208|Ziprasidone|ziprasidone|mesh-list
20187586|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20187587|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
20187588|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187589|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839507|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
19839508|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
19839509|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839510|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839511|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19839512|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19839513|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19839514|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839515|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839516|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839517|NCT00627926|Interferons|interferons|mesh-list
19839518|NCT00627926|Ribavirin|ribavirin|mesh-list
20187590|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313361|NCT04072198|Protective Agents|protective agents|mesh-ancestor
19313362|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
19839519|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
19839520|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
19839521|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19839522|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839523|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
19839524|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313363|NCT04072198|Vitamins|vitamins|mesh-ancestor
19313364|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
19313365|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
19313366|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19313367|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19313368|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
19397378|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397379|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
19397380|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397381|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19397382|NCT03652116|Narcotics|narcotics|mesh-ancestor
19397383|NCT03652116|Analgesics|analgesics|mesh-ancestor
19397384|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19397385|NCT03652103|Bupivacaine|bupivacaine|mesh-list
19397386|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
19397387|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
19397388|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397389|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397390|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
19397391|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397392|NCT03651947|Denosumab|denosumab|mesh-list
19397393|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19397394|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397395|NCT03651934|Iron|iron|mesh-list
19397396|NCT03651934|Selenium|selenium|mesh-list
19397397|NCT03651934|Trace Elements|trace elements|mesh-ancestor
19397398|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
19397399|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839525|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
19839526|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839527|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
20187591|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19397400|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
19397401|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397402|NCT03651934|Protective Agents|protective agents|mesh-ancestor
19397403|NCT03651882|Oxytocin|oxytocin|mesh-list
19397404|NCT03651882|Carbetocin|carbetocin|mesh-list
19397405|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
19397406|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19397407|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397408|NCT03651726|Palmidrol|palmidrol|mesh-list
19397409|NCT03651726|Dronabinol|dronabinol|mesh-list
19397410|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
19397411|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397412|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397413|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20187592|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187593|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187594|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187595|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187596|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
20187597|NCT00208221|Telmisartan|telmisartan|mesh-list
20187598|NCT00208221|Ramipril|ramipril|mesh-list
20187599|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20187600|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20187601|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20187602|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187603|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20187604|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
20187605|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187606|NCT00208234|Omalizumab|omalizumab|mesh-list
20187607|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20187608|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20187609|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20187610|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
20187611|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
20187612|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187613|NCT00208260|Leucovorin|leucovorin|mesh-list
20187614|NCT00208260|Fluorouracil|fluorouracil|mesh-list
20187615|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
20187616|NCT00208260|Folfirinox|folfirinox|mesh-list
20187617|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
20187618|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313369|NCT04071756|Tazarotene|tazarotene|mesh-list
19313370|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
19313371|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
20187619|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20187620|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187621|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20187622|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
20187623|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313372|NCT04072328|Midazolam|midazolam|mesh-list
19313373|NCT04072328|Propofol|propofol|mesh-list
19313374|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19313375|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313376|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313377|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19313378|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
19313379|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
19313380|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19313381|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19313382|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19313383|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19313384|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
19313385|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
19313386|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313387|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313388|NCT04071639|Ubiquinone|ubiquinone|mesh-list
19313389|NCT04071639|Haloperidol|haloperidol|mesh-list
19313390|NCT04071639|Risperidone|risperidone|mesh-list
19313391|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
19313392|NCT04071639|Sertraline|sertraline|mesh-list
19839528|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839529|NCT00628108|Levocetirizine|levocetirizine|mesh-list
20187624|NCT00208260|Antidotes|antidotes|mesh-ancestor
20187625|NCT00208260|Protective Agents|protective agents|mesh-ancestor
20187626|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
20187627|NCT00208260|Vitamins|vitamins|mesh-ancestor
20187628|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
20187629|NCT00208273|Letrozole|letrozole|mesh-list
20187630|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187631|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20187632|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20187633|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187634|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187635|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20187636|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
20187637|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187638|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187639|NCT00208299|Adenosine|adenosine|mesh-list
20187640|NCT00208299|Regadenoson|regadenoson|mesh-list
20187641|NCT00208299|Analgesics|analgesics|mesh-ancestor
20187642|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
20187643|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187644|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187645|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20187646|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
20187647|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20187648|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
20187649|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
20187650|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187651|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187652|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20187653|NCT00208312|Adenosine|adenosine|mesh-list
20187654|NCT00208312|Regadenoson|regadenoson|mesh-list
20187655|NCT00208312|Analgesics|analgesics|mesh-ancestor
20187656|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
20187657|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187658|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187659|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20187660|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
20187661|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20187662|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
20187663|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
20187664|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187665|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313393|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
19313394|NCT04071639|Idebenone|idebenone|mesh-list
19313395|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20370129|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370130|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
20370131|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370132|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20370133|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20370134|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370135|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370136|NCT00967538|Etanercept|etanercept|mesh-list
20370137|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20370138|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370139|NCT00967538|Analgesics|analgesics|mesh-ancestor
20370140|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
20370141|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370142|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370143|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839530|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20612759|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612760|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612761|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
20612762|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
20612763|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612764|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
19313396|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
19313397|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313398|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313399|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313400|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19313401|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19313402|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313403|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370144|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370145|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370146|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370147|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
20370148|NCT00967603|Sunitinib|sunitinib|mesh-list
20370149|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370150|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19313404|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19313405|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
19313406|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
19313407|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19313408|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20370151|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370152|NCT00967603|Growth Substances|growth substances|mesh-ancestor
20370153|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370154|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370155|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20370156|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370157|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370158|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
20370159|NCT00967629|Calcium|calcium|mesh-list
20370160|NCT00967629|Sevelamer|sevelamer|mesh-list
19313409|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19313410|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
19313411|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
19313412|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313413|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19313414|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19313415|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
19839531|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19839532|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
19839533|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
19839534|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839535|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839536|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839537|NCT00628134|Calfactant|calfactant|mesh-list
19839538|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19839539|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839540|NCT00628251|Doxorubicin|doxorubicin|mesh-list
19839541|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19839542|NCT00628251|Olaparib|olaparib|mesh-list
19839543|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19839544|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313416|NCT04071639|Protective Agents|protective agents|mesh-ancestor
20612765|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19313417|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
19313418|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19313419|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
19313420|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19313421|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19313422|NCT04071574|Cetrorelix|cetrorelix|mesh-list
19313423|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19313424|NCT04071574|Hormones|hormones|mesh-ancestor
19313425|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19313426|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313427|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
19313428|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19313429|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
19313430|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19313431|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19313432|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19313433|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313434|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19839545|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19839546|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19839547|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839548|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839549|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19839550|NCT00628355|Lidocaine|lidocaine|mesh-list
19839551|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
19839552|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
19839553|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839554|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839555|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
19839556|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839557|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19839558|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19839559|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19839560|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839561|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313435|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
19313436|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
19313437|NCT04071262|Prednisolone|prednisolone|mesh-list
19313438|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
19313439|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313440|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
19313441|NCT04071262|Hormones|hormones|mesh-ancestor
19313442|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19313443|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313444|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19313445|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313446|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19313447|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313448|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313449|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
19313450|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19313451|NCT04071353|Interferons|interferons|mesh-list
19313452|NCT04071353|Ribavirin|ribavirin|mesh-list
19313453|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839562|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19839563|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19839564|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19839565|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839566|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839567|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839568|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839569|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839570|NCT00628498|Defibrotide|defibrotide|mesh-list
19839571|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20187666|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20187667|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20187668|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
20187669|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20187670|NCT00208403|Protective Agents|protective agents|mesh-ancestor
20187671|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187672|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
20187673|NCT00208442|Diuretics|diuretics|mesh-ancestor
19313454|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
19839572|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19839573|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839574|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19839575|NCT00628589|Loxapine|loxapine|mesh-list
19313455|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313456|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
19313457|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313458|NCT04071106|Betamethasone|betamethasone|mesh-list
19313459|NCT04071106|Calcipotriene|calcipotriene|mesh-list
19313460|NCT04071106|Petrolatum|petrolatum|mesh-list
20370161|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20370162|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370163|NCT00967629|Antacids|antacids|mesh-ancestor
20370164|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370165|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370166|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
20370167|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
20370168|NCT00967642|Insulin|insulin|mesh-list
20370169|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20370170|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425697|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20425698|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19313461|NCT04071106|Turmeric extract|turmeric extract|mesh-list
19313462|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313463|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
19313464|NCT04071106|Hormones|hormones|mesh-ancestor
19313465|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19313466|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313467|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19313468|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
19313469|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
19313470|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
19313471|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313472|NCT04071106|Protective Agents|protective agents|mesh-ancestor
19313473|NCT04071106|Emollients|emollients|mesh-ancestor
19313474|NCT04070742|Minocycline|minocycline|mesh-list
19313475|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313476|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425699|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
20425700|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19313477|NCT04070755|Minocycline|minocycline|mesh-list
19313478|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313479|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187674|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
20187675|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187676|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20187677|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187678|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187679|NCT00208520|Lamotrigine|lamotrigine|mesh-list
20187680|NCT00208520|Carbamazepine|carbamazepine|mesh-list
20187681|NCT00208520|Levetiracetam|levetiracetam|mesh-list
20187682|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
20187683|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
20187684|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20187685|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187686|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187687|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20187688|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187689|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187690|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187691|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187692|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187693|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20187694|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
20187695|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20187696|NCT00208520|Analgesics|analgesics|mesh-ancestor
20187697|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
20187698|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187699|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20187700|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20187701|NCT00208533|Aripiprazole|aripiprazole|mesh-list
19313480|NCT04070794|Metformin|metformin|mesh-list
19313481|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20187702|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187703|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187704|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187705|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187706|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187707|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370171|NCT00967655|Capecitabine|capecitabine|mesh-list
20370172|NCT00967655|Irinotecan|irinotecan|mesh-list
20370173|NCT00967655|Panitumumab|panitumumab|mesh-list
20370174|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20370175|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
20370176|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370177|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370178|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20370179|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370180|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370181|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370182|NCT00967707|Gabapentin|gabapentin|mesh-list
20370183|NCT00967707|Donepezil|donepezil|mesh-list
20370184|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20370185|NCT00967707|Analgesics|analgesics|mesh-ancestor
20370186|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
20370187|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370188|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370189|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
20370190|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20370191|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20370192|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370193|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370194|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20370195|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20370196|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370197|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370198|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
20370199|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20370200|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370201|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
20370202|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
20370203|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20370204|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187708|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
20187709|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
20187710|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187711|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187712|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20187713|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20187714|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
20187715|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20370205|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370206|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20370207|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
20370208|NCT00967772|Naftopidil|naftopidil|mesh-list
20370209|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20370210|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20370211|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
20370212|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370213|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370214|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370215|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20370216|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20370217|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370218|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20370219|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20370220|NCT00967837|Insulin|insulin|mesh-list
20370221|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20370222|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20370223|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370224|NCT00967850|Verteporfin|verteporfin|mesh-list
20370225|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20370226|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
20370227|NCT00967928|Everolimus|everolimus|mesh-list
20370228|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187716|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19313482|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313483|NCT04070833|Vitamin D|vitamin d|mesh-list
19313484|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
19313485|NCT04070833|Vitamins|vitamins|mesh-list
19313486|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
19313487|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313488|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19313489|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20370229|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370230|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
20370231|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370232|NCT00967954|Hormones|hormones|mesh-list
20370233|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
20370234|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370235|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370236|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
20370237|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
20370238|NCT00967967|Desloratadine|desloratadine|mesh-list
20370239|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370240|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
20370241|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20370242|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20370243|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
19313490|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
19313491|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19313492|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
19313493|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19313494|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
19313495|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313496|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
19313497|NCT04070729|Protective Agents|protective agents|mesh-ancestor
19313498|NCT04070495|Clarithromycin|clarithromycin|mesh-list
19313499|NCT04070495|Rifampin|rifampin|mesh-list
19313500|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313501|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313502|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19313503|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313504|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313505|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19313506|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19313507|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19313508|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
19313509|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
19313510|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19313511|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19313512|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19313513|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19313514|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19313515|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19313516|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19313517|NCT04070469|Amoxicillin|amoxicillin|mesh-list
19313518|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313519|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313520|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
19313521|NCT04070391|Pyridoxal|pyridoxal|mesh-list
19313522|NCT04070391|Pyridoxine|pyridoxine|mesh-list
19313523|NCT04070391|Vitamins|vitamins|mesh-ancestor
19839576|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19839577|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19839578|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839579|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839580|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19839581|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19839582|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
19839583|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839584|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839585|NCT00628628|Rasburicase|rasburicase|mesh-list
19839586|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
19313524|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
19313525|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839587|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370244|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370245|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313526|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
19313527|NCT04070482|Tenofovir|tenofovir|mesh-list
19313528|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
19313529|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313530|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19313531|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19313532|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313533|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313534|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19313535|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19313536|NCT04070079|Tenofovir|tenofovir|mesh-list
19313537|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
19313538|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313539|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19313540|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19839588|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19839589|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
19839590|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19839591|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839592|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839593|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19839594|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
19839595|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839596|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370246|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313541|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313542|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313543|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19313544|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19313545|NCT04070001|Ibuprofen|ibuprofen|mesh-list
19313546|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19313547|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19313548|NCT04070001|Analgesics|analgesics|mesh-ancestor
19313549|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
19313550|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313551|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313552|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313553|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19313554|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19313555|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313556|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313557|NCT04069949|Sorafenib|sorafenib|mesh-list
19313558|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370247|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20370248|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20370249|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
20370250|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
20370251|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20370252|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20370253|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370254|NCT00968006|Incretins|incretins|mesh-ancestor
20370255|NCT00968006|Hormones|hormones|mesh-ancestor
20370256|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370257|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20370258|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
20370259|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370260|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370261|NCT00968110|Omalizumab|omalizumab|mesh-list
20370262|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20370263|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20370264|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
20370265|NCT00968162|Fludarabine|fludarabine|mesh-list
20370266|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370267|NCT00968240|Bevacizumab|bevacizumab|mesh-list
20370268|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370269|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370270|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370271|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19313559|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19313560|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313561|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397414|NCT03651726|Analgesics|analgesics|mesh-ancestor
19397415|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
19397416|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397417|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20370272|NCT00968240|Growth Substances|growth substances|mesh-ancestor
19313562|NCT04069936|Nivolumab|nivolumab|mesh-list
19313563|NCT04069936|Tadalafil|tadalafil|mesh-list
19313564|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313565|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313566|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19313567|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313568|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
19313569|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19313570|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19313571|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313572|NCT04069936|Urological Agents|urological agents|mesh-ancestor
19839597|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19839598|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19839599|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19839600|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839601|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839602|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839603|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
19839604|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19839605|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
19839606|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839607|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839608|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19839609|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
19839610|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19839611|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19839612|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19839613|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839614|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313573|NCT04069845|Doxorubicin|doxorubicin|mesh-list
19313574|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19313575|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19313576|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313577|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19313578|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19313579|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313580|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313581|NCT04069858|Entecavir|entecavir|mesh-list
19313582|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
19313583|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313584|NCT04069234|Clopidogrel|clopidogrel|mesh-list
19313585|NCT04069234|Ticagrelor|ticagrelor|mesh-list
19313586|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20370273|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370274|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370275|NCT00968331|Rituximab|rituximab|mesh-list
20370276|NCT00968331|Lenalidomide|lenalidomide|mesh-list
20370277|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370278|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370279|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
20370280|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370281|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370282|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370283|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370284|NCT00968331|Growth Substances|growth substances|mesh-ancestor
20370285|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
19313587|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19313588|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19313589|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19313590|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
19313591|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313592|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313593|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313594|NCT04069169|Lidocaine|lidocaine|mesh-list
19313595|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
19313596|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
19313597|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313598|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313599|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
19313600|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839615|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370286|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20370287|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20187717|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20187718|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187719|NCT00208546|Bevacizumab|bevacizumab|mesh-list
20187720|NCT00208546|Cetuximab|cetuximab|mesh-list
20187721|NCT00208546|Capecitabine|capecitabine|mesh-list
19839616|NCT00629122|Clotrimazole|clotrimazole|mesh-list
19839617|NCT00629122|Miconazole|miconazole|mesh-list
19839618|NCT00629122|Nystatin|nystatin|mesh-list
19839619|NCT00629122|Tacrolimus|tacrolimus|mesh-list
19839620|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839621|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
19313601|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19313602|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19313603|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19313604|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839622|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839623|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19839624|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839625|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839626|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19839627|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839628|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
19839629|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20187722|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
20187723|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370288|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
20370289|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
20370290|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20370291|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
20370292|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370293|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370294|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370295|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370296|NCT00968396|Melphalan|melphalan|mesh-list
20370297|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370298|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
20370299|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370300|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370301|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20370302|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370303|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
20370304|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370305|NCT00968435|Bevacizumab|bevacizumab|mesh-list
20370306|NCT00968435|Cetuximab|cetuximab|mesh-list
20370307|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370308|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370309|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370310|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19839630|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19839631|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19839632|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
19839633|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839634|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19839635|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19839636|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19839637|NCT00629122|Ionophores|ionophores|mesh-ancestor
19839638|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839639|NCT00629499|Paclitaxel|paclitaxel|mesh-list
19839640|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
20187724|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370311|NCT00968435|Growth Substances|growth substances|mesh-ancestor
20370312|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370313|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370314|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
20370315|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370316|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370317|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19839641|NCT00629499|Trastuzumab|trastuzumab|mesh-list
19839642|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20187725|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20187726|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20187727|NCT00208546|Growth Substances|growth substances|mesh-ancestor
20187728|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370318|NCT00968461|Protective Agents|protective agents|mesh-ancestor
20370319|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370320|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370321|NCT00968565|Citric Acid|citric acid|mesh-list
20370322|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
20370323|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
20370324|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20370325|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
20370326|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
20370327|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370328|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
20370329|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20370330|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20370331|NCT00968578|Prednisolone|prednisolone|mesh-list
20370332|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
20370333|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20370334|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
20370335|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370336|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
20370337|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
20370338|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370339|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370340|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370341|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
20370342|NCT00968578|Hormones|hormones|mesh-ancestor
20370343|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370344|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20370345|NCT00968578|Protective Agents|protective agents|mesh-ancestor
20370346|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20370347|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370348|NCT00968591|Everolimus|everolimus|mesh-list
20370349|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370350|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370351|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
20370352|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370353|NCT00968682|Trastuzumab|trastuzumab|mesh-list
20370354|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370355|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370356|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
20370357|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20370358|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370359|NCT00968734|Vitamins|vitamins|mesh-ancestor
20370360|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
20370361|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20370362|NCT00968760|Cytarabine|cytarabine|mesh-list
20370363|NCT00968760|Etoposide|etoposide|mesh-list
20370364|NCT00968760|Melphalan|melphalan|mesh-list
20370365|NCT00968760|Interleukin-2|interleukin-2|mesh-list
20370366|NCT00968760|Carmustine|carmustine|mesh-list
20370367|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370368|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370369|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20370370|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370371|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370372|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370373|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20370374|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
20370375|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
20370376|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370377|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370378|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
20370379|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370380|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370381|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
20370382|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20370383|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370384|NCT00968760|Analgesics|analgesics|mesh-ancestor
20370385|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
20370386|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370387|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
20370388|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20370389|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370390|NCT00968877|Vitamins|vitamins|mesh-ancestor
20370391|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
19693096|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
20370392|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20370393|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
20370394|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19839643|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839644|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
19839645|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
19839646|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
19839647|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313605|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313606|NCT04069208|Cytarabine|cytarabine|mesh-list
19313607|NCT04069208|Idarubicin|idarubicin|mesh-list
19313608|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19313609|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
19313610|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313611|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313612|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
19313613|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313614|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19313615|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
19313616|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313617|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19313618|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19313619|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19313620|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313621|NCT04069325|Febuxostat|febuxostat|mesh-list
19313622|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
19313623|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19313624|NCT04069429|Heparin|heparin|mesh-list
19313625|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
19839648|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839649|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
19839650|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839651|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839652|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19839653|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
19839654|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19839655|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19839656|NCT00629525|Everolimus|everolimus|mesh-list
19313626|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19313627|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19313628|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370395|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20370396|NCT00968903|Prednisolone|prednisolone|mesh-list
20370397|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
20370398|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20370399|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
19313629|NCT04069286|Amoxicillin|amoxicillin|mesh-list
19313630|NCT04069286|Omeprazole|omeprazole|mesh-list
19313631|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313632|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313633|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19313634|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839657|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839658|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839659|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
19839660|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839661|NCT00629772|Infliximab|infliximab|mesh-list
20370400|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370401|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
20370402|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
19839662|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
19839663|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839664|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839665|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
19839666|NCT00630032|Docetaxel|docetaxel|mesh-list
19313635|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19313636|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313637|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313638|NCT04069078|Scopolamine|scopolamine|mesh-list
19313639|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19839667|NCT00630032|Fluorouracil|fluorouracil|mesh-list
20370403|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313640|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19313641|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
19839668|NCT00630032|Epirubicin|epirubicin|mesh-list
19313642|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
20370404|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370405|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370406|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
19313643|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313644|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313645|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19313646|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
19313647|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19313648|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
19313649|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313650|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313651|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19313652|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
19313653|NCT04069065|Tacrolimus|tacrolimus|mesh-list
19313654|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19313655|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
19313656|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839669|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839670|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
19839671|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839672|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839673|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19839674|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
19839675|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839676|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839677|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19839678|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
19839679|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
19839680|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
19839681|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
19673310|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673311|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
19673312|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673313|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673314|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19673315|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19673316|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673317|NCT04169191|Urological Agents|urological agents|mesh-ancestor
19673318|NCT04164732|Valsartan|valsartan|mesh-list
19673319|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19839682|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19839683|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19839684|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19839685|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19839686|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839687|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
19839688|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
19839689|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19839690|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19839691|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
19839692|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839693|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
19839694|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839695|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313657|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19313658|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313659|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313660|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
19313661|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19313662|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
19313663|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313664|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313665|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19313666|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
19313667|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19313668|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
19313669|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313670|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673320|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19839696|NCT00630253|Cyclosporine|cyclosporine|mesh-list
19839697|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
19839698|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
20370407|NCT00968903|Hormones|hormones|mesh-ancestor
20370408|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839699|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
19839700|NCT00630253|Fludarabine|fludarabine|mesh-list
19839701|NCT00630253|Cyclosporins|cyclosporins|mesh-list
20370409|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20370410|NCT00968903|Protective Agents|protective agents|mesh-ancestor
20370411|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20370412|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370413|NCT00968929|Streptokinase|streptokinase|mesh-list
20370414|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19839702|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19839703|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19313671|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19313672|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
19313673|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
19839704|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
19839705|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839706|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839707|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19839708|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
19839709|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839710|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839711|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19839712|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839713|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
19839714|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839715|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
19839716|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19839717|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19839718|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19839719|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
20370415|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20370416|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370417|NCT00968955|Ropivacaine|ropivacaine|mesh-list
20370418|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
20370419|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
20370420|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370421|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370422|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
20370423|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370424|NCT00968994|Petrolatum|petrolatum|mesh-list
20370425|NCT00968994|Emollients|emollients|mesh-ancestor
19839720|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19839721|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839722|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
20187729|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
19313674|NCT04069052|Protective Agents|protective agents|mesh-ancestor
19313675|NCT04068766|Bupivacaine|bupivacaine|mesh-list
19313676|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
19313677|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
19313678|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313679|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313680|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
19313681|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313682|NCT04068974|Apatinib|apatinib|mesh-list
20370426|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
20370427|NCT00969033|Irinotecan|irinotecan|mesh-list
20370428|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19313683|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313684|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19313685|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313686|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313687|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
19839723|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
20187730|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20187731|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
20187732|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187733|NCT00208559|Ziprasidone|ziprasidone|mesh-list
20187734|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20187735|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
20187736|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187737|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187738|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187739|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187740|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20370429|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370430|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313688|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19313689|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313690|NCT04068948|Midazolam|midazolam|mesh-list
19313691|NCT04068948|Meperidine|meperidine|mesh-list
19313692|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
19313693|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19839724|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839725|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839726|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
19839727|NCT00630253|Hormones|hormones|mesh-ancestor
19313694|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19313695|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313696|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313697|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19313698|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19313699|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19313700|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19313701|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
19313702|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
19313703|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
19313704|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
19313705|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313706|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313707|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19313708|NCT04068948|Narcotics|narcotics|mesh-ancestor
19313709|NCT04068948|Analgesics|analgesics|mesh-ancestor
19313710|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
19313711|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313712|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
19839728|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839729|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19839730|NCT00630253|Protective Agents|protective agents|mesh-ancestor
19839731|NCT00630331|Vaccines|vaccines|mesh-list
19839732|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
19839733|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839734|NCT00630344|Everolimus|everolimus|mesh-list
19839735|NCT00630344|Bicalutamide|bicalutamide|mesh-list
19839736|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839737|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370431|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370432|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370433|NCT00969046|Epothilone B|epothilone b|mesh-list
20370434|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370435|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
20370436|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
20370437|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
20370438|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370439|NCT00969072|Dutasteride|dutasteride|mesh-list
20370440|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20370441|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20370442|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313713|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
19839738|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
19839739|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839740|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
19839741|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
19839742|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839743|NCT00630396|Minocycline|minocycline|mesh-list
19839744|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19839745|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839746|NCT00630409|Gemcitabine|gemcitabine|mesh-list
19839747|NCT00630409|Doxorubicin|doxorubicin|mesh-list
19839748|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19839749|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
19839750|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839751|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370443|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313714|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19313715|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
19313716|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
19313717|NCT04068610|Leucovorin|leucovorin|mesh-list
19313718|NCT04068610|Bevacizumab|bevacizumab|mesh-list
19313719|NCT04068610|Durvalumab|durvalumab|mesh-list
19313720|NCT04068610|Fluorouracil|fluorouracil|mesh-list
19313721|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
19313722|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313723|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370444|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
20370445|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370446|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370447|NCT00969085|Curcumin|curcumin|mesh-list
20370448|NCT00969085|Turmeric extract|turmeric extract|mesh-list
20370449|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20370450|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370451|NCT00969085|Analgesics|analgesics|mesh-ancestor
20370452|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
20370453|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370454|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313724|NCT04068610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19313725|NCT04068610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19313726|NCT04068610|Growth Substances|growth substances|mesh-ancestor
19313727|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313728|NCT04068610|Growth Inhibitors|growth inhibitors|mesh-ancestor
19313729|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
19313730|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313731|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19313732|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19313733|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
19313734|NCT04068610|Antidotes|antidotes|mesh-ancestor
19313735|NCT04068610|Protective Agents|protective agents|mesh-ancestor
19313736|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
19313737|NCT04068610|Vitamins|vitamins|mesh-ancestor
19313738|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
19313739|NCT04068506|Gabapentin|gabapentin|mesh-list
19313740|NCT04068506|Analgesics|analgesics|mesh-ancestor
19313741|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
19839752|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
19839753|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839754|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839755|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839756|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
19839757|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839758|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19839759|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20370455|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370456|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370457|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370458|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370459|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370460|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
20370461|NCT00969085|Protective Agents|protective agents|mesh-ancestor
20370462|NCT00969137|Nicotine|nicotine|mesh-list
19839760|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370463|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20370464|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
20370465|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370466|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370467|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20370468|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20370469|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
20370470|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370471|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370472|NCT00969163|Testosterone|testosterone|mesh-list
20370473|NCT00969163|Androgens|androgens|mesh-ancestor
20370474|NCT00969163|Hormones|hormones|mesh-ancestor
20370475|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370476|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370477|NCT00969176|Acetaminophen|acetaminophen|mesh-list
20370478|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370479|NCT00969176|Analgesics|analgesics|mesh-ancestor
20370480|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
19313742|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673321|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19673322|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19673323|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673324|NCT04138615|Morphine|morphine|mesh-list
19673325|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19673326|NCT04138615|Narcotics|narcotics|mesh-ancestor
19673327|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19673328|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839761|NCT00630539|Tamoxifen|tamoxifen|mesh-list
19839762|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20187741|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187742|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187743|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187744|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
19839763|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
19313743|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313744|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
19313745|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19313746|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19313747|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313748|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19313749|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19313750|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19313751|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313752|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313753|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
19313754|NCT04068272|Bosentan|bosentan|mesh-list
19313755|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19313756|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19313757|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313758|NCT04068207|Minocycline|minocycline|mesh-list
19313759|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313760|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313761|NCT04067986|Apatinib|apatinib|mesh-list
19313762|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313763|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19313764|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839764|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839765|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839766|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19839767|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839768|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19839769|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19839770|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19839771|NCT00630734|Ritonavir|ritonavir|mesh-list
19839772|NCT00630734|Darunavir|darunavir|mesh-list
19839773|NCT00630734|Pravastatin|pravastatin|mesh-list
19839774|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19839775|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19839776|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
19839777|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839778|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839779|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19839780|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19839781|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
19839782|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839783|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19839784|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19839785|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19839786|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19839787|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
19839788|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839789|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19839790|NCT00630786|Panitumumab|panitumumab|mesh-list
19839791|NCT00630786|Conatumumab|conatumumab|mesh-list
19839792|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19839793|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187745|NCT00208572|Citalopram|citalopram|mesh-list
20187746|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20187747|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187748|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187749|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187750|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187751|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
20187752|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187753|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20187754|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187755|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187756|NCT00208585|Sertraline|sertraline|mesh-list
20187757|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187758|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187759|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20187760|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19839794|NCT00630812|Mannitol|mannitol|mesh-list
19839795|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19839796|NCT00630812|Diuretics|diuretics|mesh-ancestor
19839797|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
19839798|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370481|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370482|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370483|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
19839799|NCT00630825|Dulaglutide|dulaglutide|mesh-list
19839800|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19839801|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839802|NCT00630877|Aspirin|aspirin|mesh-list
19839803|NCT00630877|Niacin|niacin|mesh-list
19839804|NCT00630877|Niacinamide|niacinamide|mesh-list
19839805|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
19839806|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19839807|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19839808|NCT00630877|Analgesics|analgesics|mesh-ancestor
19839809|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
19839810|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839811|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370484|NCT00969293|Ecallantide|ecallantide|mesh-list
19839812|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839813|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19839814|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19839815|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19839816|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839817|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19839818|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19839819|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839820|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
19839821|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19839822|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
19839823|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839824|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
19839825|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
19839826|NCT00630877|Vitamins|vitamins|mesh-ancestor
19839827|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
19839828|NCT00630955|Memantine|memantine|mesh-list
19839829|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19839830|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19839831|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
19839832|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839833|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370485|NCT00969293|Analgesics|analgesics|mesh-ancestor
20370486|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
20370487|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370488|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370489|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20370490|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370491|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370492|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370493|NCT00969306|Chloroquine|chloroquine|mesh-list
19839834|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839835|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19839836|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19839837|NCT00630994|Decitabine|decitabine|mesh-list
19839838|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19839839|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
19839840|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839841|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839842|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839843|NCT00631007|Pioglitazone|pioglitazone|mesh-list
19839844|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19839845|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839846|NCT00631163|Deferasirox|deferasirox|mesh-list
19839847|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19839848|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
19839849|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
19839850|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313765|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313766|NCT04067791|Melatonin|melatonin|mesh-list
19313767|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
19313768|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370494|NCT00969306|Amebicides|amebicides|mesh-ancestor
19839851|NCT00631189|Atorvastatin|atorvastatin|mesh-list
19839852|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19313769|NCT04067791|Protective Agents|protective agents|mesh-ancestor
19313770|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313771|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313772|NCT04067817|Phenylephrine|phenylephrine|mesh-list
19839853|NCT00631189|Pravastatin|pravastatin|mesh-list
20370495|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20370496|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20370497|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370498|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
20370499|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370500|NCT00969319|Factor VIII|factor viii|mesh-list
20370501|NCT00969319|Coagulants|coagulants|mesh-ancestor
20370502|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
20370503|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370504|NCT00969397|Growth Substances|growth substances|mesh-ancestor
20370505|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370506|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370507|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313773|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
19313774|NCT04067817|Norepinephrine|norepinephrine|mesh-list
19313775|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19313776|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19313777|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
19313778|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
19313779|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313780|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313781|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
19313782|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
20425701|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425702|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20425703|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20425704|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20425705|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20425706|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20425707|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20425708|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20425709|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20425710|NCT01276431|Buprenorphine|buprenorphine|mesh-list
20425711|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20425712|NCT01276431|Narcotics|narcotics|mesh-ancestor
20425713|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425714|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425715|NCT01276431|Analgesics|analgesics|mesh-ancestor
20425716|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
20425717|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425718|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19313783|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19313784|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19313785|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19313786|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19313787|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
19313788|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313789|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313790|NCT04067817|Protective Agents|protective agents|mesh-ancestor
19397418|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19397419|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397420|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673329|NCT04138615|Analgesics|analgesics|mesh-ancestor
20425719|NCT01276496|Paclitaxel|paclitaxel|mesh-list
20425720|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20425721|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20425722|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425723|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673330|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
19673331|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673332|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19673333|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
19673334|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673335|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673336|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
19673337|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425724|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
19397421|NCT03651726|Hormones|hormones|mesh-ancestor
19404806|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839854|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19313791|NCT04067856|Dexamethasone|dexamethasone|mesh-list
19313792|NCT04067856|Bevacizumab|bevacizumab|mesh-list
19313793|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313794|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313795|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19313796|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19313797|NCT04067856|Growth Substances|growth substances|mesh-ancestor
19313798|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313799|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
19313800|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313801|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
19313802|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
19313803|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313804|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19313805|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
19313806|NCT04067856|Hormones|hormones|mesh-ancestor
19313807|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19313808|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19313809|NCT04067531|Clindamycin|clindamycin|mesh-list
19313810|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
19313811|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
19313812|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313813|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313814|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19313815|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313816|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839855|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19839856|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
20187761|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187762|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370508|NCT00969449|Naproxen|naproxen|mesh-list
20370509|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20370510|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370511|NCT00969449|Analgesics|analgesics|mesh-ancestor
20370512|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
20370513|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313817|NCT04067518|Pegaspargase|pegaspargase|mesh-list
19313818|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313819|NCT04067115|Alovudine|alovudine|mesh-list
19313820|NCT04067115|Irinotecan|irinotecan|mesh-list
19313821|NCT04067115|Trabectedin|trabectedin|mesh-list
19313822|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19313823|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19673338|NCT04084314|Erenumab|erenumab|mesh-list
19673339|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19673340|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673341|NCT04084314|Analgesics|analgesics|mesh-ancestor
19673342|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
19673343|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673344|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673345|NCT04082728|Dipyrone|dipyrone|mesh-list
19673346|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19673347|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19673348|NCT04082728|Analgesics|analgesics|mesh-ancestor
19673349|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
19673350|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187763|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187764|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
20187765|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187766|NCT00208611|Vitamins|vitamins|mesh-list
20187767|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
20187768|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
20187769|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
20187770|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
20187771|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187772|NCT00208611|Hematinics|hematinics|mesh-ancestor
20187773|NCT00208702|Sertraline|sertraline|mesh-list
20187774|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187775|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187776|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20187777|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187778|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187779|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187780|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187781|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
19839857|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839858|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839859|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19839860|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313824|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313825|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313826|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313827|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19313828|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
19313829|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
19313830|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313831|NCT04067505|Nadroparin|nadroparin|mesh-list
19313832|NCT04067505|Warfarin|warfarin|mesh-list
20370514|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370515|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370516|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370517|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
20370518|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19313833|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
19313834|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
19313835|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19313836|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
19313837|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19313838|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
19313839|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839861|NCT00631319|Hydromorphone|hydromorphone|mesh-list
19839862|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19839863|NCT00631319|Narcotics|narcotics|mesh-ancestor
20370519|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370520|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370521|NCT00969462|Doxorubicin|doxorubicin|mesh-list
20370522|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20370523|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370524|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20370525|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370526|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839864|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839865|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839866|NCT00631319|Analgesics|analgesics|mesh-ancestor
19839867|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
19839868|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839869|NCT00631358|Dexamethasone|dexamethasone|mesh-list
19839870|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19839871|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
19839872|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
19839873|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370527|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839874|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839875|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19839876|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
20187782|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187783|NCT00208715|Modafinil|modafinil|mesh-list
20187784|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20187785|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187786|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20187787|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20187788|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20187789|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370528|NCT00969566|Metformin|metformin|mesh-list
19839877|NCT00631358|Hormones|hormones|mesh-ancestor
19839878|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839879|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19839880|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839881|NCT00631371|Interferons|interferons|mesh-list
19839882|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
19839883|NCT00631371|Sirolimus|sirolimus|mesh-list
19839884|NCT00631371|Bevacizumab|bevacizumab|mesh-list
19839885|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19839886|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839887|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19839888|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19839889|NCT00631371|Growth Substances|growth substances|mesh-ancestor
19313840|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839890|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370529|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20370530|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20370531|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839891|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
20187790|NCT00208741|Tiagabine|tiagabine|mesh-list
20187791|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
20187792|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20187793|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187794|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187795|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187796|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
20187797|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187798|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187799|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
19313841|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19313842|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19313843|NCT04067492|Diclofenac|diclofenac|mesh-list
19313844|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19313845|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19313846|NCT04067492|Analgesics|analgesics|mesh-ancestor
19313847|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
19313848|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313849|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313850|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313851|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19313852|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19313853|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313854|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313855|NCT04067024|Anesthetics|anesthetics|mesh-list
19313856|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313857|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313858|NCT04067102|Paclitaxel|paclitaxel|mesh-list
19313859|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19313860|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
19313861|NCT04067102|Carboplatin|carboplatin|mesh-list
19313862|NCT04067102|Epirubicin|epirubicin|mesh-list
19313863|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19313864|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313865|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
19313866|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187800|NCT00208793|Vitamin D|vitamin d|mesh-list
20187801|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
20187802|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
20187803|NCT00208793|Vitamins|vitamins|mesh-list
19313867|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
19313868|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313869|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19313870|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
19313871|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313872|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19313873|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19313874|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
19673351|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187804|NCT00208793|Calcium|calcium|mesh-list
20187805|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
20187806|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187807|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20187808|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20187809|NCT00208819|Valproic Acid|valproic acid|mesh-list
20187810|NCT00208819|Olanzapine|olanzapine|mesh-list
20370532|NCT00969566|Incretins|incretins|mesh-ancestor
20370533|NCT00969566|Hormones|hormones|mesh-ancestor
19313875|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19673352|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673353|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673354|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
19673355|NCT04049786|Metoprolol|metoprolol|mesh-list
19673356|NCT04049786|Carvedilol|carvedilol|mesh-list
19673357|NCT04049786|Midazolam|midazolam|mesh-list
19673358|NCT04049786|Simvastatin|simvastatin|mesh-list
19673359|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19673360|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19673361|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19673362|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673363|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20187811|NCT00208819|Risperidone|risperidone|mesh-list
20187812|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19313876|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19313877|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19673364|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19673365|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19673366|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19313878|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19313879|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313880|NCT04067037|Vincristine|vincristine|mesh-list
19313881|NCT04067037|Epirubicin|epirubicin|mesh-list
19313882|NCT04067037|Dacarbazine|dacarbazine|mesh-list
19313883|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19313884|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313885|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
19313886|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
19313887|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
19313888|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313889|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19313890|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19313891|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19313892|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313893|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19313894|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
19313895|NCT04066803|Folic Acid|folic acid|mesh-list
19313896|NCT04066803|Hematinics|hematinics|mesh-ancestor
19313897|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
19313898|NCT04066803|Vitamins|vitamins|mesh-ancestor
19313899|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
19313900|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313901|NCT04066790|Paclitaxel|paclitaxel|mesh-list
19313902|NCT04066790|Trastuzumab|trastuzumab|mesh-list
19313903|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370534|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370535|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20370536|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
20370537|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370538|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370539|NCT00969592|Insulin|insulin|mesh-list
20370540|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20370541|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
20370542|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
19313904|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313905|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
19313906|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
19313907|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
19313908|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313909|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19313910|NCT04066764|Nadroparin|nadroparin|mesh-list
19313911|NCT04066764|Warfarin|warfarin|mesh-list
19313912|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
19313913|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
19313914|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19313915|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
19313916|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19673367|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
20370543|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20370544|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
20370545|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19313917|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
19673368|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
19673369|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
19673370|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
19673371|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673372|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673373|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19673374|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19673375|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
19673376|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19673377|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19673378|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673379|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19673380|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19673381|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
19673382|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
19313918|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313919|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673383|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839892|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
19839893|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313920|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19313921|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19313922|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19313923|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313924|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313925|NCT04066881|Vaccines|vaccines|mesh-list
20370546|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370547|NCT00969631|Metformin|metformin|mesh-list
20370548|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20370549|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370550|NCT00969696|Galantamine|galantamine|mesh-list
20187813|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20187814|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
20187815|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187816|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370551|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20370552|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370553|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370554|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
20370555|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370556|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370557|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20370558|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
20370559|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313926|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
19313927|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313928|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
19313929|NCT04066621|Sulbactam|sulbactam|mesh-list
20370560|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
20370561|NCT00969813|Tofacitinib|tofacitinib|mesh-list
20370562|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19313930|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313931|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313932|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19313933|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839894|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
19839895|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19839896|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19839897|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
19839898|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19839899|NCT00631410|Sunitinib|sunitinib|mesh-list
19839900|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839901|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19839902|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19839903|NCT00631410|Growth Substances|growth substances|mesh-ancestor
19839904|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839905|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
19839906|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20187817|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187818|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20187819|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187820|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20187821|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187822|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20187823|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
20187824|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
20187825|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
20187826|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187827|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187828|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20370563|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370564|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370565|NCT00969852|Sertraline|sertraline|mesh-list
20370566|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
20370567|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370568|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20370569|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19839907|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425725|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
19313934|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187829|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19313935|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19848290|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19313936|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19313937|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
19313938|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313939|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
19313940|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19313941|NCT04066452|Antibodies|antibodies|mesh-list
19313942|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
19313943|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313944|NCT04066179|Prednisolone|prednisolone|mesh-list
19313945|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19313946|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
19313947|NCT04066179|Hormones|hormones|mesh-ancestor
19313948|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19313949|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313950|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19313951|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19839908|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839909|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
19839910|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19839911|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19839912|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
20370570|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370571|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370572|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839913|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839914|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19839915|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19839916|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839917|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839918|NCT00631475|Bosentan|bosentan|mesh-list
19839919|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19839920|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19839921|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839922|NCT00631488|Metformin|metformin|mesh-list
19839923|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19839924|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19839925|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839926|NCT00631488|Incretins|incretins|mesh-ancestor
19839927|NCT00631488|Hormones|hormones|mesh-ancestor
19839928|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19839929|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19313952|NCT04066296|Bupivacaine|bupivacaine|mesh-list
19313953|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
19313954|NCT04066296|Anesthetics|anesthetics|mesh-list
19313955|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19313956|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313957|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
19313958|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19313959|NCT04066257|Metronidazole|metronidazole|mesh-list
19313960|NCT04066257|Tetracycline|tetracycline|mesh-list
19313961|NCT04066257|Bismuth|bismuth|mesh-list
19313962|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313963|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313964|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19839930|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
19839931|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839932|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839933|NCT00631566|Mupirocin|mupirocin|mesh-list
19839934|NCT00631566|Triclosan|triclosan|mesh-list
19839935|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
19839936|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19839937|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19839938|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19839939|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839940|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839941|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19839942|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19839943|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19839944|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
19839945|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19839946|NCT00631657|Mirtazapine|mirtazapine|mesh-list
19839947|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
19313965|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19313966|NCT04066257|Antacids|antacids|mesh-ancestor
19313967|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370573|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
20370574|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370575|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
20370576|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20370577|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
20370578|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370579|NCT00969904|Expectorants|expectorants|mesh-ancestor
20187830|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187831|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187832|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
20370580|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
20370581|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20370582|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
20370583|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370584|NCT00969904|Protective Agents|protective agents|mesh-ancestor
20370585|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370586|NCT00969904|Antidotes|antidotes|mesh-ancestor
20370587|NCT00969982|Misoprostol|misoprostol|mesh-list
20370588|NCT00969982|Mifepristone|mifepristone|mesh-list
20370589|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20370590|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
20370591|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20370592|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370593|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20370594|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370595|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
20370596|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20370597|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20370598|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20370599|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20370600|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
20370601|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20370602|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20370603|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
20370604|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370605|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
20370606|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20370607|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20370608|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
20370609|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20370610|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370611|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
20370612|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370613|NCT00970086|Bupivacaine|bupivacaine|mesh-list
19673384|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19673385|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19673386|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19673387|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673388|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
19673389|NCT04049786|Protective Agents|protective agents|mesh-ancestor
19673390|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19673391|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673392|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19673393|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673394|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20187833|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187834|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
20187835|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
20187836|NCT00208858|Topiramate|topiramate|mesh-list
20187837|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
20187838|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20187839|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673395|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19673396|NCT04045613|Atezolizumab|atezolizumab|mesh-list
19673397|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19673398|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673399|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
19673400|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673401|NCT04034238|Tofacitinib|tofacitinib|mesh-list
19673402|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673403|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673404|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187840|NCT00208897|Fluoxetine|fluoxetine|mesh-list
20187841|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20370614|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
19673405|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
20370615|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
20370616|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
20370617|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370618|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370619|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
20370620|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370621|NCT00970138|Apatinib|apatinib|mesh-list
20370622|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370623|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673406|NCT04023253|Mirabegron|mirabegron|mesh-list
19673407|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19673408|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19673409|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
19673410|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839948|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19839949|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19839950|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
19839951|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
19839952|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19839953|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839954|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839955|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19839956|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19839957|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839958|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19839959|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20370624|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839960|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19839961|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
19839962|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19839963|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19839964|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
20187842|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187843|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673411|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673412|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673413|NCT04023253|Urological Agents|urological agents|mesh-ancestor
19673414|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19673415|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19673416|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19673417|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692198|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
19692199|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692200|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19692201|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19692202|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19692203|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19692204|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692205|NCT04995133|Colistin|colistin|mesh-list
19692206|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19692207|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692208|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20187844|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187845|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692209|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19692210|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19692211|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19692212|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692213|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
19692214|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692215|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187846|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
19692216|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19692217|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692218|NCT04994951|Triamcinolone|triamcinolone|mesh-list
19692219|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19839965|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19839966|NCT00631696|Pregabalin|pregabalin|mesh-list
20187847|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187848|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20370625|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370626|NCT00970450|Acetaminophen|acetaminophen|mesh-list
20370627|NCT00970450|Tropisetron|tropisetron|mesh-list
20370628|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19839967|NCT00631696|Analgesics|analgesics|mesh-ancestor
19839968|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
19839969|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19839970|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839971|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
19839972|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19839973|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19839974|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673418|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
19839975|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19839976|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19839977|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19839978|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839979|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19839980|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19839981|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
19839982|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19839983|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19673419|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19673420|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
19673421|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673422|NCT04005053|Expectorants|expectorants|mesh-ancestor
19673423|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
19673424|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19673425|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
19673426|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673427|NCT04005053|Protective Agents|protective agents|mesh-ancestor
19673428|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673429|NCT04005053|Antidotes|antidotes|mesh-ancestor
19673430|NCT03970382|Aldesleukin|aldesleukin|mesh-list
19673431|NCT03970382|Nivolumab|nivolumab|mesh-list
19673432|NCT03970382|Interleukin-2|interleukin-2|mesh-list
19673433|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673434|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673435|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19673436|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673437|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19673438|NCT03970382|Analgesics|analgesics|mesh-ancestor
19673439|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
19673440|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673441|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673442|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19673443|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19839984|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20187849|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187850|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187851|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19313968|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19313969|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19313970|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19313971|NCT04066231|Erythromycin|erythromycin|mesh-list
19313972|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
19313973|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19313974|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
19313975|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
19313976|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19313977|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19313978|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19313979|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19673444|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
20187852|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20187853|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187854|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
20187855|NCT00208923|Busulfan|busulfan|mesh-list
20187856|NCT00208923|Fludarabine|fludarabine|mesh-list
20187857|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20187858|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
20187859|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313980|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673445|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187860|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370629|NCT00970450|Analgesics|analgesics|mesh-ancestor
20370630|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
19313981|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313982|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
19313983|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
19313984|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19313985|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313986|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19313987|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
19313988|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
19313989|NCT04066660|Fucoidan|fucoidan|mesh-list
19313990|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19313991|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19313992|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
19313993|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19313994|NCT04066088|Guanfacine|guanfacine|mesh-list
19313995|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20370631|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370632|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370633|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
20370634|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
20370635|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
20370636|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370637|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20370638|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20370639|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
20370640|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370641|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19313996|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19313997|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19313998|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19313999|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
19314000|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314001|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314002|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314003|NCT04065906|Methylphenidate|methylphenidate|mesh-list
19314004|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19314005|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19314006|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314007|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19314008|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19314009|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19314010|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314011|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
19314012|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314013|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19314014|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
19314015|NCT04065919|Epinephrine|epinephrine|mesh-list
20187861|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20187862|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
20187863|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187864|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187865|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20187866|NCT00208936|Fluorouracil|fluorouracil|mesh-list
20187867|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187868|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
20187869|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187870|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20187871|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20187872|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
20187873|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187874|NCT00209014|Thalidomide|thalidomide|mesh-list
20187875|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370642|NCT00970528|Acarbose|acarbose|mesh-list
20370643|NCT00970528|Voglibose|voglibose|mesh-list
19314016|NCT04065919|Bupivacaine|bupivacaine|mesh-list
19673446|NCT03952143|Insulin|insulin|mesh-list
19673447|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19673448|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
19673449|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
19673450|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19673451|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673452|NCT03932643|TIC10 compound|tic10 compound|mesh-list
19673453|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673454|NCT03931642|Blinatumomab|blinatumomab|mesh-list
19673455|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370644|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20370645|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370646|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370647|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20370648|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370649|NCT00970567|Insulin|insulin|mesh-list
20370650|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19839985|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19839986|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19839987|NCT00631917|Ramipril|ramipril|mesh-list
19839988|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19839989|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
19839990|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839991|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19839992|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19839993|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19839994|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
19839995|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19839996|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19839997|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19839998|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314017|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
19314018|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
19314019|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314020|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314021|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
20370651|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370652|NCT00970580|Paclitaxel|paclitaxel|mesh-list
20370653|NCT00970580|Carboplatin|carboplatin|mesh-list
20370654|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
20370655|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370656|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370657|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
20370658|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
20370659|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
20370660|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370661|NCT00970697|Becaplermin|becaplermin|mesh-list
20370662|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
20370663|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20370664|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370665|NCT00970697|Growth Substances|growth substances|mesh-ancestor
20370666|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370667|NCT00970762|Rocuronium|rocuronium|mesh-list
20370668|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
20370669|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19839999|NCT00631969|Urological Agents|urological agents|mesh-ancestor
19840000|NCT00632099|Progesterone|progesterone|mesh-list
19840001|NCT00632099|Progestins|progestins|mesh-ancestor
19840002|NCT00632099|Hormones|hormones|mesh-ancestor
19840003|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840004|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840005|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
19840006|NCT00632125|Hematinics|hematinics|mesh-ancestor
19840007|NCT00632203|Temozolomide|temozolomide|mesh-list
19840008|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19840009|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
19840010|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840011|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840012|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19840013|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19840014|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19840015|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840016|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314022|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314023|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19840017|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19840018|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19840019|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19840020|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
20370670|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20370671|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20370672|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314024|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20370673|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370674|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20370675|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20370676|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
20370677|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370678|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370679|NCT00970879|Mefloquine|mefloquine|mesh-list
20370680|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19840021|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840022|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840023|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19840024|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19840025|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
19840026|NCT00632359|Lenalidomide|lenalidomide|mesh-list
19840027|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
19840028|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840029|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19840030|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370681|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
20370682|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20370683|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20370684|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370685|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20370686|NCT00970879|Renal Agents|renal agents|mesh-ancestor
20370687|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20370688|NCT00970892|Warfarin|warfarin|mesh-list
20370689|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
20370690|NCT00970905|Ondansetron|ondansetron|mesh-list
20370691|NCT00970905|Aprepitant|aprepitant|mesh-list
20370692|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
20370693|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
20370694|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370695|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370696|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370697|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
20370698|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
20370699|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20370700|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
20370701|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370702|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840031|NCT00632359|Growth Substances|growth substances|mesh-ancestor
20187876|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
20187877|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314025|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
19314026|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314027|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314028|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19314029|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19314030|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
19314031|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19314032|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
19314033|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
19314034|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
19314035|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19314036|NCT04065932|BMS-986165|bms-986165|mesh-list
19314037|NCT04065932|Famotidine|famotidine|mesh-list
19314038|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19314039|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19314040|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19314041|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
19314042|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
19314043|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314044|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314045|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187878|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
20187879|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20187880|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187881|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20187882|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20187883|NCT00209014|Growth Substances|growth substances|mesh-ancestor
20187884|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
20187885|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370703|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20370704|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19314046|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
19314047|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19314048|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314049|NCT04065529|Zinc|zinc|mesh-list
19314050|NCT04065529|Trace Elements|trace elements|mesh-ancestor
19314051|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
19840032|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840033|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840034|NCT00632411|Nicotine|nicotine|mesh-list
19840035|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19840036|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
19840037|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840038|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840039|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19840040|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19840041|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
19840042|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840043|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840044|NCT00632489|Capecitabine|capecitabine|mesh-list
19840045|NCT00632489|Lapatinib|lapatinib|mesh-list
19840046|NCT00632489|Panobinostat|panobinostat|mesh-list
19840047|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840048|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
19840049|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840050|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840051|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19840052|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840053|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19840054|NCT00632541|Bevacizumab|bevacizumab|mesh-list
19840055|NCT00632541|Sorafenib|sorafenib|mesh-list
19840056|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840057|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370705|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370706|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370707|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19314052|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397422|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397423|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397424|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397425|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397426|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
19397427|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397428|NCT03651674|Olanzapine|olanzapine|mesh-list
19397429|NCT03651674|Clozapine|clozapine|mesh-list
19397430|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
19397431|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
19397432|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397433|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673456|NCT03930953|Rituximab|rituximab|mesh-list
19397434|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673457|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
19673458|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673459|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673460|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
19673461|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673462|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673463|NCT03915769|Ozanimod|ozanimod|mesh-list
19673464|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19673465|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673466|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673467|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
19673468|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673469|NCT03863288|Oxytocin|oxytocin|mesh-list
19673470|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
19673471|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19673472|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397435|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19673473|NCT03829514|Fenofibrate|fenofibrate|mesh-list
19840058|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20187886|NCT00209079|Docetaxel|docetaxel|mesh-list
20187887|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
20187888|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20187889|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
20187890|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187891|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187892|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187893|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19840059|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19840060|NCT00632541|Growth Substances|growth substances|mesh-ancestor
19840061|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840062|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
19314053|NCT04065451|Epinephrine|epinephrine|mesh-list
20370708|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20370709|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
20370710|NCT00970931|Amiloride|amiloride|mesh-list
20370711|NCT00970931|Diuretics|diuretics|mesh-list
20370712|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
19314054|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19314055|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19314056|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
19314057|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314058|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314059|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314060|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19314061|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19314062|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
19314063|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314064|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19840063|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19840064|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840065|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840066|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19840067|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314065|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
19314066|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
19314067|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
19314068|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19314069|NCT04065581|Metformin|metformin|mesh-list
19314070|NCT04065581|Acarbose|acarbose|mesh-list
19314071|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19314072|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314073|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19314074|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314075|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314076|NCT04065555|Cetuximab|cetuximab|mesh-list
19314077|NCT04065555|Avelumab|avelumab|mesh-list
19840068|NCT00632632|Cycloserine|cycloserine|mesh-list
19840069|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19840070|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840071|NCT00632632|Renal Agents|renal agents|mesh-ancestor
19840072|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19840073|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
19840074|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19840075|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
19840076|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840077|NCT00632736|Ropinirole|ropinirole|mesh-list
19840078|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19840079|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19840080|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
19840081|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
19840082|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840083|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840084|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840085|NCT00632749|Cytarabine|cytarabine|mesh-list
19840086|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840087|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
19840088|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840089|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840090|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
20187894|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187895|NCT00209118|Paroxetine|paroxetine|mesh-list
20187896|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20187897|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20187898|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187899|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187900|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20187901|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
20187902|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187903|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20370713|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314078|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19314079|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314080|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314081|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
19314082|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314083|NCT04065230|Tenofovir|tenofovir|mesh-list
19314084|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
19314085|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314086|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19314087|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19314088|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314089|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314090|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19314091|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19314092|NCT04065165|Lanreotide|lanreotide|mesh-list
19314093|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314094|NCT04065308|Daratumumab|daratumumab|mesh-list
19314095|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314096|NCT04065282|Capecitabine|capecitabine|mesh-list
19314097|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
19314098|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20370714|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20370715|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20370716|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370717|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370718|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20370719|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20370720|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20370721|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20370722|NCT00970957|Bevacizumab|bevacizumab|mesh-list
20370723|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370724|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370725|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370726|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370727|NCT00970957|Growth Substances|growth substances|mesh-ancestor
20370728|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370729|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370730|NCT00970970|Bevacizumab|bevacizumab|mesh-list
20370731|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20370732|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370733|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370734|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370735|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370736|NCT00970970|Growth Substances|growth substances|mesh-ancestor
20370737|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314099|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
19840091|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840092|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840093|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
19840094|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840095|NCT00632814|Factor VIII|factor viii|mesh-list
19840096|NCT00632814|Coagulants|coagulants|mesh-ancestor
19840097|NCT00632827|Leucovorin|leucovorin|mesh-list
19840098|NCT00632827|Gemcitabine|gemcitabine|mesh-list
19840099|NCT00632827|Cytarabine|cytarabine|mesh-list
19840100|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
19840101|NCT00632827|Carmustine|carmustine|mesh-list
19840102|NCT00632827|Doxorubicin|doxorubicin|mesh-list
19840103|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19840104|NCT00632827|Methotrexate|methotrexate|mesh-list
19840105|NCT00632827|Etoposide|etoposide|mesh-list
19840106|NCT00632827|Vincristine|vincristine|mesh-list
19840107|NCT00632827|Vinorelbine|vinorelbine|mesh-list
19840108|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
19840109|NCT00632827|Lenograstim|lenograstim|mesh-list
19840110|NCT00632827|Sargramostim|sargramostim|mesh-list
19840111|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840112|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
19840113|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840114|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840115|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370738|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370739|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19840116|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
19397436|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19840117|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840118|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840119|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19840120|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840121|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
19840122|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
19840123|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840124|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840125|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19840126|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19840127|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19840128|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19840129|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
19840130|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19314100|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314101|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314102|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19314103|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314104|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314105|NCT04065269|Olaparib|olaparib|mesh-list
19314106|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19314107|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314108|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314109|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314110|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
19314111|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19314112|NCT04065035|Protective Agents|protective agents|mesh-ancestor
19314113|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314114|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
19840131|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19840132|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20612766|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20612767|NCT02252809|Prednisolone|prednisolone|mesh-list
20612768|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
19314115|NCT04065009|Ropivacaine|ropivacaine|mesh-list
19314116|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
19314117|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
19314118|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314119|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314120|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
19314121|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370740|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370741|NCT00970996|Interferons|interferons|mesh-list
20370742|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
20370743|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
19840133|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19840134|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19840135|NCT00632827|Antidotes|antidotes|mesh-ancestor
20370744|NCT00970996|Paclitaxel|paclitaxel|mesh-list
20370745|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19314127|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
19314128|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19314129|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19314130|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
19314131|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314132|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314133|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314134|NCT04064619|Urological Agents|urological agents|mesh-ancestor
19314135|NCT04064632|Darunavir|darunavir|mesh-list
19314136|NCT04064632|Cobicistat|cobicistat|mesh-list
19314137|NCT04064632|Rilpivirine|rilpivirine|mesh-list
19314138|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19314139|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19314140|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
19314141|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314142|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314143|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19314144|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19314145|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
19314146|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370746|NCT00970996|Cisplatin|cisplatin|mesh-list
20370747|NCT00970996|Temozolomide|temozolomide|mesh-list
20370748|NCT00970996|Interleukin-2|interleukin-2|mesh-list
20370749|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370750|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370751|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
20370752|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
19314147|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20370753|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
20370754|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370755|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
20370756|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370757|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370758|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
20370759|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
19673474|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19673475|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
19673476|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673477|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19673478|NCT03808090|Calcium|calcium|mesh-list
20370760|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370761|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370762|NCT00970996|Analgesics|analgesics|mesh-ancestor
20370763|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
20370764|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370765|NCT00971074|Hylan|hylan|mesh-list
20370766|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
20370767|NCT00971074|Protective Agents|protective agents|mesh-ancestor
20370768|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370769|NCT00971126|Thalidomide|thalidomide|mesh-list
20370770|NCT00971126|Sorafenib|sorafenib|mesh-list
20370771|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370772|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673479|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19673480|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673481|NCT03801200|Apatinib|apatinib|mesh-list
19673482|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370773|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370774|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370775|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370776|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
20370777|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370778|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
19314148|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19314149|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19314150|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19314151|NCT04064554|Vaccines|vaccines|mesh-list
19673483|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673484|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673485|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673486|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
19673487|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19673488|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19673489|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673490|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
19673491|NCT03801122|Coagulants|coagulants|mesh-ancestor
19673492|NCT03788291|Rituximab|rituximab|mesh-list
19673493|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
19673494|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673495|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673496|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
19673497|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673498|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673499|NCT03771157|Vaccines|vaccines|mesh-list
19673500|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
19673501|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673502|NCT03752918|Niacin|niacin|mesh-list
19673503|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
19673504|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19673505|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19673506|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
19673507|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673508|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19673509|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673510|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
19673511|NCT03752918|Vitamins|vitamins|mesh-ancestor
19673512|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
19673513|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673514|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
20370779|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20370780|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673515|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19673516|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
19314152|NCT04064554|Immunologic Factors|immunologic factors|mesh-ancestor
19314153|NCT04064554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314154|NCT04064190|Durvalumab|durvalumab|mesh-list
19314155|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314156|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314157|NCT04064125|Minocycline|minocycline|mesh-list
20370781|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370782|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370783|NCT00971126|Growth Substances|growth substances|mesh-ancestor
20370784|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370785|NCT00971152|Menotropins|menotropins|mesh-list
20370786|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20370787|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
20370788|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20370789|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425726|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425727|NCT01276548|Carboplatin|carboplatin|mesh-list
20425728|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314158|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314159|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314160|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
19314161|NCT04063839|Grazoprevir|grazoprevir|mesh-list
19314162|NCT04063839|Ledipasvir|ledipasvir|mesh-list
19314163|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
19314164|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314165|NCT04064138|Anesthetics|anesthetics|mesh-list
19314166|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314167|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314168|NCT04064073|Metformin|metformin|mesh-list
19314169|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19314170|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425729|NCT01276600|Tenofovir|tenofovir|mesh-list
19314171|NCT04063904|Misoprostol|misoprostol|mesh-list
19314172|NCT04063904|Mifepristone|mifepristone|mesh-list
19314173|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19314174|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
19314175|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19314176|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314177|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19314178|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425730|NCT01276600|Emtricitabine|emtricitabine|mesh-list
20425731|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
20425732|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425733|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20425734|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20425735|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425736|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425737|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20425738|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20425739|NCT01276613|Gemcitabine|gemcitabine|mesh-list
20425740|NCT01276613|Losartan|losartan|mesh-list
20425741|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20425742|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
20425743|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425744|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425745|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
20425746|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425747|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425748|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425749|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
20425750|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425751|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20425752|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20425753|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20425754|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19314179|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
20425755|NCT01276691|Aspirin|aspirin|mesh-list
20425756|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20425757|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20425758|NCT01276691|Analgesics|analgesics|mesh-ancestor
20425759|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
20612769|NCT02252809|Adalimumab|adalimumab|mesh-list
19314180|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19314181|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20612770|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19314182|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19314183|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20370790|NCT00971165|Losartan|losartan|mesh-list
20370791|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
19314184|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
19314185|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19314186|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19314187|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
19314188|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314189|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
19314190|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19314191|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19314192|NCT04063865|Everolimus|everolimus|mesh-list
19314193|NCT04063865|Tacrolimus|tacrolimus|mesh-list
19314194|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19314195|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
19314196|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314197|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19314198|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314199|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314200|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397437|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397438|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397439|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19397440|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19397441|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187904|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
20187905|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20187906|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20187907|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20187908|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673517|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673518|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19673519|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19673520|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673521|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673522|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20370792|NCT00971165|Amiloride|amiloride|mesh-list
20370793|NCT00971165|Diuretics|diuretics|mesh-list
20370794|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20370795|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20370796|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20370797|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20370798|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370799|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
20187909|NCT00209144|Insulin|insulin|mesh-list
20187910|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20187911|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187912|NCT00209209|Interferons|interferons|mesh-list
20187913|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
20187914|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
19397442|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397443|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397444|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
19397445|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19397446|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
19397447|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
19397448|NCT03651661|Insulin|insulin|mesh-list
19397449|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19397450|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19397451|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370800|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370801|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20370802|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370803|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20370804|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19673523|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
20612771|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
19840136|NCT00632827|Protective Agents|protective agents|mesh-ancestor
20187915|NCT00209209|Prednisone|prednisone|mesh-list
19673524|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
19673525|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673526|NCT03716180|Paclitaxel|paclitaxel|mesh-list
19673527|NCT03716180|Trastuzumab|trastuzumab|mesh-list
19673528|NCT03716180|Pertuzumab|pertuzumab|mesh-list
20187916|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
19840137|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
19840138|NCT00632827|Vitamins|vitamins|mesh-ancestor
19840139|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
19840140|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
19840141|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
19840142|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
19840143|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19840144|NCT00632931|Vorinostat|vorinostat|mesh-list
19840145|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840146|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19840147|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840148|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840149|NCT00632970|Ritonavir|ritonavir|mesh-list
19840150|NCT00632970|Lopinavir|lopinavir|mesh-list
19840151|NCT00632970|Tenofovir|tenofovir|mesh-list
19840152|NCT00632970|Emtricitabine|emtricitabine|mesh-list
19840153|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
19840154|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19840155|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19840156|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19840157|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
19840158|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840159|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840160|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19840161|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19840162|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
19840163|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840164|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19840165|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19840166|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19840167|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19840168|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19840169|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19840170|NCT00633074|Vaccines|vaccines|mesh-list
19840171|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
19840172|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840173|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19840174|NCT00633126|Cephalosporins|cephalosporins|mesh-list
19314201|NCT04063683|Paclitaxel|paclitaxel|mesh-list
19314202|NCT04063683|Cisplatin|cisplatin|mesh-list
19314203|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19314204|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314205|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
20187917|NCT00209209|Rituximab|rituximab|mesh-list
20187918|NCT00209209|Doxorubicin|doxorubicin|mesh-list
20187919|NCT00209209|Fludarabine|fludarabine|mesh-list
19314206|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
19314207|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
19314208|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314209|NCT04063527|Paclitaxel|paclitaxel|mesh-list
19314210|NCT04063527|Carboplatin|carboplatin|mesh-list
19314211|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19314212|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314213|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
19314214|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
19840175|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19840176|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840177|NCT00633152|Linezolid|linezolid|mesh-list
19840178|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19840179|NCT00633152|Cephalosporins|cephalosporins|mesh-list
19840180|NCT00633152|Aztreonam|aztreonam|mesh-list
19840181|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19840182|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840183|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19840184|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840185|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840186|NCT00633217|Fluticasone|fluticasone|mesh-list
20187920|NCT00209209|Vincristine|vincristine|mesh-list
20187921|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20187922|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
19840187|NCT00633217|Xhance|xhance|mesh-list
19314215|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
19314216|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840188|NCT00633217|Norflurane|norflurane|mesh-list
19840189|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19840190|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19840191|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20187923|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840192|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19840193|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
19840194|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840195|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840196|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19840197|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
19840198|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
19840199|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19840200|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19840201|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19840202|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19840203|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
19840204|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840205|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840206|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
19840207|NCT00633217|Hormones|hormones|mesh-ancestor
19840208|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840209|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
19840210|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
19840211|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840212|NCT00633256|Isoniazid|isoniazid|mesh-list
19840213|NCT00633256|Cycloserine|cycloserine|mesh-list
19840214|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
19840215|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19840216|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840217|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19840218|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19840219|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
19840220|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840221|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19840222|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19840223|NCT00633256|Renal Agents|renal agents|mesh-ancestor
19840224|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19840225|NCT00633360|Drospirenone|drospirenone|mesh-list
20187924|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20187925|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20187926|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
20187927|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187928|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840226|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19840227|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19840228|NCT00633360|Estradiol|estradiol|mesh-list
19840229|NCT00633360|Estrogens|estrogens|mesh-ancestor
19314217|NCT04063540|Amiloride|amiloride|mesh-list
19314218|NCT04063540|Diuretics|diuretics|mesh-ancestor
19314219|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
19314220|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314221|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19314222|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19314223|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19314224|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840230|NCT00633360|Hormones|hormones|mesh-ancestor
19840231|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840232|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840233|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19840234|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
19840235|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840236|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19840237|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19840238|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19840239|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19840240|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
19840241|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19840242|NCT00633360|Diuretics|diuretics|mesh-ancestor
19840243|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
20187929|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19314225|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19314226|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20187930|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20187931|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20187932|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19314227|NCT04063267|Nicotine|nicotine|mesh-list
19314228|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19314229|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
19314230|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314231|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314232|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19314233|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19314234|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
19314235|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314236|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840244|NCT00633399|Ziprasidone|ziprasidone|mesh-list
19840245|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19840246|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
19840247|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840248|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370805|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20370806|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20370807|NCT00971399|Ondansetron|ondansetron|mesh-list
20370808|NCT00971399|Ramosetron|ramosetron|mesh-list
20370809|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
20370810|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
20370811|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314237|NCT04063449|Endostar protein|endostar protein|mesh-list
19314238|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19314239|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19314240|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19314241|NCT04063449|Growth Substances|growth substances|mesh-ancestor
19314242|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314243|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840249|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840250|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19840251|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19840252|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840253|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19840254|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19840255|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
19314244|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314245|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314246|NCT04063358|Ranibizumab|ranibizumab|mesh-list
19314247|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19840256|NCT00633464|Cetuximab|cetuximab|mesh-list
19840257|NCT00633464|Epothilones|epothilones|mesh-list
19840258|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840259|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840260|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
19840261|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
19840262|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
19840263|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840264|NCT00633594|Rituximab|rituximab|mesh-list
19840265|NCT00633594|Lenalidomide|lenalidomide|mesh-list
19840266|NCT00633594|Bortezomib|bortezomib|mesh-list
19840267|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840268|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840269|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
19840270|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840271|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840272|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19840273|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20187933|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20187934|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187935|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20187936|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
20187937|NCT00209209|Hormones|hormones|mesh-ancestor
20187938|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187939|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20187940|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
20187941|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187942|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20187943|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20187944|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187945|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187946|NCT00209222|Cytarabine|cytarabine|mesh-list
20187947|NCT00209222|Dexamethasone|dexamethasone|mesh-list
20187948|NCT00209222|Prednisone|prednisone|mesh-list
20187949|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
19840274|NCT00633594|Growth Substances|growth substances|mesh-ancestor
20187950|NCT00209222|Melphalan|melphalan|mesh-list
20370812|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370813|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370814|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
20370815|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
20370816|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20370817|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
20370818|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370819|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370820|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20370821|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20370822|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370823|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370824|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20370825|NCT00971581|Ketoprofen|ketoprofen|mesh-list
20370826|NCT00971581|Omeprazole|omeprazole|mesh-list
20370827|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20370828|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370829|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20370830|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370831|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370832|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20370833|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20370834|NCT00971581|Analgesics|analgesics|mesh-ancestor
20370835|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
19314248|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19314249|NCT04063358|Growth Substances|growth substances|mesh-ancestor
19314250|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314251|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
19314252|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314253|NCT04063189|Clarithromycin|clarithromycin|mesh-list
19840275|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840276|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19840277|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840278|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19840279|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840280|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370836|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370837|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370838|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370839|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370840|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20370841|NCT00971607|Sevoflurane|sevoflurane|mesh-list
20370842|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20370843|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20370844|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
20370845|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
20370846|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20370847|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370848|NCT00971659|Insulin|insulin|mesh-list
20370849|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20370850|NCT00971659|Metformin|metformin|mesh-list
20370851|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
20370852|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20370853|NCT00971659|Exenatide|exenatide|mesh-list
20370854|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20370855|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370856|NCT00971659|Incretins|incretins|mesh-ancestor
20370857|NCT00971659|Hormones|hormones|mesh-ancestor
20370858|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370859|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20370860|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
20370861|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370862|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370863|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20370864|NCT00971685|Dexamethasone|dexamethasone|mesh-list
20370865|NCT00971685|Lenalidomide|lenalidomide|mesh-list
20370866|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370867|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
20370868|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
20370869|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370870|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370871|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370872|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
20370873|NCT00971685|Hormones|hormones|mesh-ancestor
19314254|NCT04063189|Dexamethasone|dexamethasone|mesh-list
19314255|NCT04063189|Lenalidomide|lenalidomide|mesh-list
19840281|NCT00633880|Droxidopa|droxidopa|mesh-list
20425760|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840282|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19840283|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19840284|NCT00633893|Apixaban|apixaban|mesh-list
19840285|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19840286|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
19840287|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19840288|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
19840289|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840290|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840291|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
19840292|NCT00633919|Prednisone|prednisone|mesh-list
19840293|NCT00633919|Budesonide|budesonide|mesh-list
19840294|NCT00633919|Albuterol|albuterol|mesh-list
19840295|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
20370874|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370875|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20370876|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370877|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
20370878|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20370879|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20370880|NCT00971685|Growth Substances|growth substances|mesh-ancestor
20370881|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
20370882|NCT00971724|Prednisolone|prednisolone|mesh-list
20370883|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370884|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
20370885|NCT00971724|Hormones|hormones|mesh-ancestor
20370886|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840296|NCT00633919|Desloratadine|desloratadine|mesh-list
19840297|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840298|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
19840299|NCT00633919|Hormones|hormones|mesh-ancestor
19840300|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840301|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840302|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20370887|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370888|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20370889|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840303|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840304|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19840305|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
19840306|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840307|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19840308|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
19840309|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19840310|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19840311|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19840312|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
19840313|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370890|NCT00971763|Gemcitabine|gemcitabine|mesh-list
20370891|NCT00971763|Prednisolone|prednisolone|mesh-list
20370892|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
20370893|NCT00971763|Rituximab|rituximab|mesh-list
19840314|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840315|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
19840316|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840317|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19840318|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
19840319|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20370894|NCT00971763|Vincristine|vincristine|mesh-list
20370895|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370896|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
19840320|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19840321|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
19840322|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
19840323|NCT00633932|Esomeprazole|esomeprazole|mesh-list
19840324|NCT00633932|Omeprazole|omeprazole|mesh-list
19840325|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19840326|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19840327|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19840328|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840329|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370897|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840330|NCT00633945|Lenalidomide|lenalidomide|mesh-list
20612772|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840331|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
19840332|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370898|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370899|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370900|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
20370901|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370902|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370903|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20370904|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20370905|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20370906|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
20370907|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
20370908|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840333|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19840334|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19840335|NCT00633945|Growth Substances|growth substances|mesh-ancestor
19840336|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840337|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840338|NCT00633984|Cycloserine|cycloserine|mesh-list
19840339|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19840340|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840341|NCT00633984|Renal Agents|renal agents|mesh-ancestor
19840342|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19840343|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
19840344|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19840345|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
19840346|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840347|NCT00634036|Pioglitazone|pioglitazone|mesh-list
19840348|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19840349|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840350|NCT00634049|Isavuconazole|isavuconazole|mesh-list
19840351|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
19840352|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840353|NCT00634088|Capecitabine|capecitabine|mesh-list
19314256|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314257|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
19314258|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
19314259|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370909|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20370910|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370911|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
20370912|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
20370913|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
20370914|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370915|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
20370916|NCT00971763|Hormones|hormones|mesh-ancestor
20370917|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370918|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20370919|NCT00971815|Dexetimide|dexetimide|mesh-list
19314260|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314261|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19314262|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
19314263|NCT04063189|Hormones|hormones|mesh-ancestor
19314264|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314265|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19314266|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314267|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
19314268|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19314269|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19314270|NCT04063189|Growth Substances|growth substances|mesh-ancestor
20370920|NCT00971815|Citalopram|citalopram|mesh-list
20370921|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20370922|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20370923|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20370924|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370925|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20370926|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
20370927|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370928|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20370929|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
20370930|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20370931|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20370932|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20370933|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
19314271|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840354|NCT00634088|Lapatinib|lapatinib|mesh-list
19840355|NCT00634088|Epothilones|epothilones|mesh-list
19314272|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314273|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314274|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19314275|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314276|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314277|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19314278|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19314279|NCT04063163|Carboplatin|carboplatin|mesh-list
19314280|NCT04063163|Etoposide|etoposide|mesh-list
19314281|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314282|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370934|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
20370935|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370936|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20370937|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20370938|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
20370939|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
20370940|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20370941|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20370942|NCT00971893|Prednisolone|prednisolone|mesh-list
20370943|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
20370944|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20370945|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
20370946|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370947|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
20370948|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
20370949|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20370950|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370951|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20370952|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
20370953|NCT00971893|Hormones|hormones|mesh-ancestor
20370954|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20370955|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20370956|NCT00971893|Protective Agents|protective agents|mesh-ancestor
20370957|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20370958|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370959|NCT00972075|Melatonin|melatonin|mesh-list
19314283|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19314284|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19314285|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314286|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314287|NCT04063046|Anesthetics|anesthetics|mesh-list
19314288|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314289|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840356|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840357|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
19840358|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840359|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840360|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19840361|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840362|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
19840363|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
19840364|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
19840365|NCT00634114|Esomeprazole|esomeprazole|mesh-list
19840366|NCT00634114|Omeprazole|omeprazole|mesh-list
19314290|NCT04063124|Dasatinib|dasatinib|mesh-list
19314291|NCT04063124|Quercetin|quercetin|mesh-list
19314292|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314293|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19314294|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314295|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314296|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
19314297|NCT04063124|Protective Agents|protective agents|mesh-ancestor
19314298|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314299|NCT04062760|Diuretics|diuretics|mesh-list
20370960|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
20370961|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370962|NCT00972075|Protective Agents|protective agents|mesh-ancestor
20370963|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370964|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840367|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19840368|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19840369|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19314300|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
19314301|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840370|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840371|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840372|NCT00634166|Vancomycin|vancomycin|mesh-list
19840373|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19840374|NCT00634166|Cefazolin|cefazolin|mesh-list
19840375|NCT00634166|Tazobactam|tazobactam|mesh-list
19840376|NCT00634166|Piperacillin|piperacillin|mesh-list
19840377|NCT00634166|Amphotericin B|amphotericin b|mesh-list
19840378|NCT00634166|Nystatin|nystatin|mesh-list
19840379|NCT00634166|Bacitracin|bacitracin|mesh-list
19840380|NCT00634166|Sulfadiazine|sulfadiazine|mesh-list
19840381|NCT00634166|Mafenide|mafenide|mesh-list
19840382|NCT00634166|Fluconazole|fluconazole|mesh-list
19840383|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
19314302|NCT04062890|Vigabatrin|vigabatrin|mesh-list
19314303|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
19314304|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314305|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314306|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
19314307|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840384|NCT00634166|Clotrimazole|clotrimazole|mesh-list
19840385|NCT00634166|Miconazole|miconazole|mesh-list
19840386|NCT00634166|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19840387|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
19840388|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19840389|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19840390|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840391|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840392|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19840393|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
19840394|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840395|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840396|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19840397|NCT00634166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19840398|NCT00634166|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19840399|NCT00634166|Amebicides|amebicides|mesh-ancestor
19314308|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314309|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
19314310|NCT04063033|Hematinics|hematinics|mesh-ancestor
19840400|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19840401|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19840402|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19840403|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19840404|NCT00634166|Ionophores|ionophores|mesh-ancestor
19840405|NCT00634166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20187951|NCT00209222|Rituximab|rituximab|mesh-list
20187952|NCT00209222|Doxorubicin|doxorubicin|mesh-list
20187953|NCT00209222|Etoposide|etoposide|mesh-list
20187954|NCT00209222|Vincristine|vincristine|mesh-list
20187955|NCT00209222|Cisplatin|cisplatin|mesh-list
20187956|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20187957|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
20187958|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314311|NCT04062695|Tofacitinib|tofacitinib|mesh-list
19314312|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19314313|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314314|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673529|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19673530|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673531|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673532|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673533|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
19673534|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673535|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673536|NCT03713801|Metformin|metformin|mesh-list
19673537|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19673538|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673539|NCT03704688|Trametinib|trametinib|mesh-list
19673540|NCT03704688|Ponatinib|ponatinib|mesh-list
19673541|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673542|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673543|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187959|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19314315|NCT04062656|Leucovorin|leucovorin|mesh-list
19840406|NCT00634166|Coccidiostats|coccidiostats|mesh-ancestor
19840407|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19314316|NCT04062656|Folic Acid|folic acid|mesh-list
20187960|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370965|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
20370966|NCT00972101|Rituximab|rituximab|mesh-list
20370967|NCT00972101|Fludarabine|fludarabine|mesh-list
20370968|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
20370969|NCT00972101|Etoposide|etoposide|mesh-list
20370970|NCT00972101|Melphalan|melphalan|mesh-list
20370971|NCT00972101|Thiotepa|thiotepa|mesh-list
20370972|NCT00972101|Tacrolimus|tacrolimus|mesh-list
20370973|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19314317|NCT04062656|Docetaxel|docetaxel|mesh-list
19314318|NCT04062656|Fluorouracil|fluorouracil|mesh-list
19314319|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
19314320|NCT04062656|Nivolumab|nivolumab|mesh-list
19314321|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314322|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
19314323|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
19314324|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187961|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
20187962|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187963|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314325|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314326|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
19314327|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19314328|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19314329|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
19314330|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314331|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314332|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19314333|NCT04062656|Antidotes|antidotes|mesh-ancestor
19314334|NCT04062656|Protective Agents|protective agents|mesh-ancestor
19314335|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
19314336|NCT04062656|Vitamins|vitamins|mesh-ancestor
19314337|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
19314338|NCT04062656|Hematinics|hematinics|mesh-ancestor
19314339|NCT04062175|Azithromycin|azithromycin|mesh-list
19314340|NCT04062175|Cephalosporins|cephalosporins|mesh-list
19314341|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314342|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314343|NCT04062591|Piroxicam|piroxicam|mesh-list
19314344|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19314345|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19840408|NCT00634179|Prednisone|prednisone|mesh-list
19840409|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
19840410|NCT00634179|Rituximab|rituximab|mesh-list
19840411|NCT00634179|Doxorubicin|doxorubicin|mesh-list
19840412|NCT00634179|Vincristine|vincristine|mesh-list
19840413|NCT00634179|Bortezomib|bortezomib|mesh-list
19840414|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840415|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
19840416|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840417|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840418|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19840419|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
19840420|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20187964|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20187965|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20187966|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20187967|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
20187968|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
20187969|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187970|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20187971|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
20187972|NCT00209222|Hormones|hormones|mesh-ancestor
20187973|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20187974|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20187975|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20187976|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20187977|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20187978|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20187979|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20187980|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
20370974|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314346|NCT04062591|Analgesics|analgesics|mesh-ancestor
19314347|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
19314348|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840421|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20370975|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840422|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19840423|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840424|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19840425|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19840426|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19840427|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840428|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840429|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
19840430|NCT00634179|Hormones|hormones|mesh-ancestor
19840431|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840432|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840433|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19840434|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
19840435|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
19840436|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
19840437|NCT00634244|Cytarabine|cytarabine|mesh-list
19840438|NCT00634244|Sirolimus|sirolimus|mesh-list
19314349|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314350|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314351|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19314352|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19314353|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314354|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673544|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673545|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
19840439|NCT00634244|Carboplatin|carboplatin|mesh-list
19840440|NCT00634244|Etoposide|etoposide|mesh-list
19840441|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
19840442|NCT00634244|Topotecan|topotecan|mesh-list
19840443|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
19840444|NCT00634244|Alvocidib|alvocidib|mesh-list
19840445|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840446|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19840447|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19840448|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19840449|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840450|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840451|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840452|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
19840453|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
19840454|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840455|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840456|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
19840457|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840458|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20187981|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
20187982|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
20187983|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20187984|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
20187985|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
20187986|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20187987|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20187988|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
20187989|NCT00209261|Coagulants|coagulants|mesh-ancestor
20187990|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19673546|NCT03684213|Norepinephrine|norepinephrine|mesh-list
19673547|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
19673548|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
19673549|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673550|NCT03684213|Protective Agents|protective agents|mesh-ancestor
19673551|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673552|NCT03684213|Vitamins|vitamins|mesh-ancestor
19673553|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
19673554|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19673555|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19673556|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673557|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673558|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
19673559|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
19673560|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673561|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20187991|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
19314355|NCT04062565|Treprostinil|treprostinil|mesh-list
19314356|NCT04062565|Riociguat|riociguat|mesh-list
19673562|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840459|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20370976|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
19840460|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
20370977|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20370978|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20370979|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840461|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19840462|NCT00634244|Analgesics|analgesics|mesh-ancestor
19840463|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
19840464|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840465|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840466|NCT00634244|Growth Substances|growth substances|mesh-ancestor
19840467|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848198|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848199|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848200|NCT00691600|Trimethoprim|trimethoprim|mesh-list
19848201|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
19848202|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19848203|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370980|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
19848204|NCT00691600|Renal Agents|renal agents|mesh-ancestor
19848205|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
19848206|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19848207|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19848208|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19848209|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848210|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848211|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20370981|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370982|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20370983|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20370984|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20370985|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20370986|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20370987|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848212|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19848213|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19848214|NCT00691665|Fluticasone|fluticasone|mesh-list
19848215|NCT00691665|Xhance|xhance|mesh-list
19848216|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19848217|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20370988|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20370989|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20370990|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19314357|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19314358|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
19314359|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20370991|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
20370992|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20370993|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20370994|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
20370995|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20370996|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
19314360|NCT04062201|Levofloxacin|levofloxacin|mesh-list
19314361|NCT04062201|Ofloxacin|ofloxacin|mesh-list
19314362|NCT04062201|Isoniazid|isoniazid|mesh-list
19314363|NCT04062201|Linezolid|linezolid|mesh-list
19314364|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
19314365|NCT04062201|Ethambutol|ethambutol|mesh-list
19314366|NCT04062201|Bedaquiline|bedaquiline|mesh-list
19314367|NCT04062201|Clofazimine|clofazimine|mesh-list
19314368|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20370997|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20370998|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
20370999|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371000|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371001|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20371002|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
20371003|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19314369|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314370|NCT04062201|Renal Agents|renal agents|mesh-ancestor
19314371|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314372|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19848218|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19848219|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
19314373|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19314374|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397452|NCT03651557|Salicylates|salicylates|mesh-list
19314375|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314376|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314377|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19314378|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19314379|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
19314380|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19840468|NCT00634270|Sirolimus|sirolimus|mesh-list
19840469|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314381|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19314382|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
19314383|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19314384|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19314385|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314386|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
19314387|NCT04062370|Ranibizumab|ranibizumab|mesh-list
19314388|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19314389|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19314390|NCT04062370|Growth Substances|growth substances|mesh-ancestor
19314391|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314392|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
19314393|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314394|NCT04062357|Lidocaine|lidocaine|mesh-list
19314395|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
19314396|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
19314397|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314398|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314399|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
19314400|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314401|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19840470|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840471|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19840472|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840473|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
19840474|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840475|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
19840476|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840477|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19840478|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19840479|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20371004|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20371005|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20371006|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
20371007|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371008|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371009|NCT00972218|Adalimumab|adalimumab|mesh-list
20371010|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840480|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371011|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20371012|NCT00972257|Timolol|timolol|mesh-list
20371013|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20371014|NCT00972257|Dorzolamide|dorzolamide|mesh-list
19840481|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840482|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840483|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840484|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19840485|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
20371015|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19314402|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19314403|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19314404|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19314405|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314406|NCT04061824|Olmesartan|olmesartan|mesh-list
19314407|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
19314408|NCT04061824|Giapreza|giapreza|mesh-list
19314409|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19314410|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
19314411|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20371016|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20371017|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
19314412|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19314413|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19314414|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
19404828|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314415|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314416|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19673563|NCT03679780|Nitroprusside|nitroprusside|mesh-list
19840486|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19840487|NCT00634504|Leucovorin|leucovorin|mesh-list
19840488|NCT00634504|Methotrexate|methotrexate|mesh-list
19840489|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
19840490|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19840491|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
19840492|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840493|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673564|NCT03679780|BQ 788|bq 788|mesh-list
19673565|NCT03679780|Nitroarginine|nitroarginine|mesh-list
19840494|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840495|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
19840496|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840497|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840498|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
19840499|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840500|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19840501|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840502|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
19840503|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840504|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19840505|NCT00634504|Antidotes|antidotes|mesh-ancestor
19840506|NCT00634504|Protective Agents|protective agents|mesh-ancestor
19840507|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
19840508|NCT00634504|Vitamins|vitamins|mesh-ancestor
19840509|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
19840510|NCT00634543|Acetaminophen|acetaminophen|mesh-list
19840511|NCT00634543|Gabapentin|gabapentin|mesh-list
19840512|NCT00634543|Tramadol|tramadol|mesh-list
19840513|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19840514|NCT00634543|Analgesics|analgesics|mesh-ancestor
19840515|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
19840516|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840517|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840518|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
19840519|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
19840520|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20371018|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371019|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371020|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371021|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20371022|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20371023|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20371024|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20371025|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20371026|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20371027|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371028|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
20371029|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19840521|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19840522|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371030|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371031|NCT00972387|Prednisone|prednisone|mesh-list
20371032|NCT00972387|Prednisolone|prednisolone|mesh-list
20371033|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
20371034|NCT00972387|Doxorubicin|doxorubicin|mesh-list
20371035|NCT00972387|Vincristine|vincristine|mesh-list
19840523|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19840524|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20371036|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371037|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
20371038|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673566|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
19673567|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19673568|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673569|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19673570|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673571|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19673572|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19840525|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20371039|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840526|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371040|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20371041|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
20371042|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371043|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371044|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19840527|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840528|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
19840529|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19840530|NCT00634543|Narcotics|narcotics|mesh-ancestor
19840531|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
19840532|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19840533|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19840534|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
19840535|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840536|NCT00634647|Prednisone|prednisone|mesh-list
19840537|NCT00634647|Satraplatin|satraplatin|mesh-list
19840538|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840539|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
19840540|NCT00634647|Hormones|hormones|mesh-ancestor
19840541|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840542|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840543|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840544|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840545|NCT00634751|Capecitabine|capecitabine|mesh-list
19840546|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
19840547|NCT00634751|Sorafenib|sorafenib|mesh-list
19840548|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840549|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
19840550|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840551|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840552|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19840553|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840554|NCT00634803|Buprenorphine|buprenorphine|mesh-list
19840555|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19840556|NCT00634803|Narcotics|narcotics|mesh-ancestor
19840557|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840558|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840559|NCT00634803|Analgesics|analgesics|mesh-ancestor
19840560|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
19840561|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840562|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19840563|NCT00634842|Insulin|insulin|mesh-list
19840564|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20187992|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20187993|NCT00209300|Mesalamine|mesalamine|mesh-list
20187994|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20187995|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20187996|NCT00209300|Analgesics|analgesics|mesh-ancestor
20187997|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
20187998|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20187999|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188000|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20188001|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20188002|NCT00209313|Acyclovir|acyclovir|mesh-list
20188003|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
20188004|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188005|NCT00209352|Acyclovir|acyclovir|mesh-list
20188006|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
20188007|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371045|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20371046|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20371047|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20371048|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371049|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371050|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
19673573|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673574|NCT03672773|Temozolomide|temozolomide|mesh-list
19673575|NCT03672773|Talazoparib|talazoparib|mesh-list
19673576|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19673577|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
19673578|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673579|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673580|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19673581|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673582|NCT03667690|Fluconazole|fluconazole|mesh-list
19673583|NCT03667690|Caspofungin|caspofungin|mesh-list
19673584|NCT03667690|Rezafungin|rezafungin|mesh-list
19673585|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
19840565|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
19840566|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19840567|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840568|NCT00634907|Warfarin|warfarin|mesh-list
19840569|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
19840570|NCT00634920|Cyclosporine|cyclosporine|mesh-list
19840571|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
19840572|NCT00634920|Prednisolone|prednisolone|mesh-list
19840573|NCT00634920|Everolimus|everolimus|mesh-list
19840574|NCT00634920|Cyclosporins|cyclosporins|mesh-list
19840575|NCT00634920|Basiliximab|basiliximab|mesh-list
19840576|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840577|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840578|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840579|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
19840580|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673586|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673587|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19673588|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19840581|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
19840582|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840583|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
19840584|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840585|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19840586|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840587|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19840588|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19840589|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
19840590|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314417|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19314418|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314419|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19314420|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19314421|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19314422|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19314423|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
19314424|NCT04061772|Prednisone|prednisone|mesh-list
19314425|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
19314426|NCT04061772|Etoposide|etoposide|mesh-list
19314427|NCT04061772|Bortezomib|bortezomib|mesh-list
19314428|NCT04061772|Epirubicin|epirubicin|mesh-list
19314429|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19314430|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
19314431|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314432|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673589|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673590|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314433|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19314434|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
19314435|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314436|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314437|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19314438|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314439|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
19314440|NCT04061772|Hormones|hormones|mesh-ancestor
19314441|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314442|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19314443|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19314444|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19314445|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19314446|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314447|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19314448|NCT04062019|Aldesleukin|aldesleukin|mesh-list
19314449|NCT04062019|Interleukin-2|interleukin-2|mesh-list
19673591|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19673592|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
19673593|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673594|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673595|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19673596|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19840591|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840592|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
19314450|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840593|NCT00634920|Hormones|hormones|mesh-ancestor
20188008|NCT00209469|Alendronate|alendronate|mesh-list
19314451|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19314452|NCT04062019|Analgesics|analgesics|mesh-ancestor
19314453|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
19314454|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314455|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314456|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19314457|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19314458|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
19314459|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314460|NCT04062045|Ropivacaine|ropivacaine|mesh-list
19314461|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
19314462|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
19314463|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314464|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314465|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
19314466|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314467|NCT04061798|Heparin|heparin|mesh-list
19314468|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
19314469|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19314470|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19314471|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314472|NCT04061863|Nivolumab|nivolumab|mesh-list
19314473|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314474|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314475|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19314476|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397453|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397454|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397455|NCT03651557|Analgesics|analgesics|mesh-ancestor
19397456|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
19397457|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397458|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397459|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397460|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397461|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19397462|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397463|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397464|NCT03651531|Metformin|metformin|mesh-list
19397465|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19397466|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397467|NCT03651427|Estradiol|estradiol|mesh-list
19397468|NCT03651427|Estrogens|estrogens|mesh-ancestor
19397469|NCT03651427|Hormones|hormones|mesh-ancestor
19397470|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397471|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397472|NCT03651219|Irinotecan|irinotecan|mesh-list
19397473|NCT03651219|Apatinib|apatinib|mesh-list
19397474|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19397475|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19397476|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397477|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397478|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397479|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19397480|NCT03650998|Ropivacaine|ropivacaine|mesh-list
19397481|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
19397482|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
19397483|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397484|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397485|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
20188009|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20188010|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188011|NCT00209482|Metformin|metformin|mesh-list
19840594|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840595|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840596|NCT00634933|Prednisone|prednisone|mesh-list
19840597|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
19840598|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20188012|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188013|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397486|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397487|NCT03650881|Adapalene|adapalene|mesh-list
19397488|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20188014|NCT00209495|Dexamethasone|dexamethasone|mesh-list
20188015|NCT00209495|Pregabalin|pregabalin|mesh-list
20188016|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314477|NCT04062006|Aldesleukin|aldesleukin|mesh-list
19314478|NCT04062006|Interleukin-2|interleukin-2|mesh-list
19314479|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314480|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19314481|NCT04062006|Analgesics|analgesics|mesh-ancestor
19314482|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
19314483|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314484|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314485|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19314486|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19314487|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
19314488|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314489|NCT04061512|Dexamethasone|dexamethasone|mesh-list
19314490|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
19314491|NCT04061512|Rituximab|rituximab|mesh-list
19314492|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19314493|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
19314494|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314495|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19314496|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19314497|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
19314498|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314499|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314500|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19314501|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314502|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314503|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
19314504|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
19314505|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314506|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19314507|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
19314508|NCT04061512|Hormones|hormones|mesh-ancestor
19314509|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314510|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19314511|NCT04061655|Iron|iron|mesh-list
19314512|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19314513|NCT04061655|Trace Elements|trace elements|mesh-ancestor
19314514|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
19314515|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314516|NCT04061655|Hematinics|hematinics|mesh-ancestor
19314517|NCT04061447|Clarithromycin|clarithromycin|mesh-list
19314518|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314519|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314520|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19314521|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314522|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314523|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19314524|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19314525|NCT04061265|Lidocaine|lidocaine|mesh-list
19314526|NCT04061265|Epinephrine|epinephrine|mesh-list
19314527|NCT04061265|Carticaine|carticaine|mesh-list
19314528|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
19314529|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
19314530|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314531|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314532|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
19314533|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314534|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19314535|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19314536|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19314537|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19314538|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314539|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19314540|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19314541|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
19314542|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314543|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19314544|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19314545|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
19314546|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19314547|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
19314548|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
19314549|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
19314550|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19314551|NCT04061538|Zinc|zinc|mesh-list
19314552|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
19314553|NCT04061538|Trace Elements|trace elements|mesh-ancestor
19314554|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
19314555|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314556|NCT04061538|Astringents|astringents|mesh-ancestor
19314557|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
19314558|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19314559|NCT04061473|Empagliflozin|empagliflozin|mesh-list
19314560|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19314561|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314562|NCT04061473|Incretins|incretins|mesh-ancestor
19314563|NCT04061473|Hormones|hormones|mesh-ancestor
19314564|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314565|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19314566|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
19314567|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314568|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314569|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19314570|NCT04061200|Empagliflozin|empagliflozin|mesh-list
19314571|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19314572|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314573|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19314574|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314575|NCT04061161|Bromides|bromides|mesh-list
19314576|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
19314577|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19314578|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
20371051|NCT00972387|Hormones|hormones|mesh-ancestor
20371052|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371053|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371054|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20371055|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
20371056|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
20371057|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
20371058|NCT00972426|Timolol|timolol|mesh-list
20371059|NCT00972426|Carteolol|carteolol|mesh-list
20371060|NCT00972426|Latanoprost|latanoprost|mesh-list
20371061|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20371062|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20371063|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
20371064|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371065|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371066|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314579|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314580|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314581|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19314582|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
19314583|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
19314584|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19314585|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
19314586|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314587|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314588|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
19314589|NCT04060888|Ustekinumab|ustekinumab|mesh-list
19314590|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
19314591|NCT04061057|Lidocaine|lidocaine|mesh-list
19314592|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
19314593|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
19314594|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314595|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314596|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
19314597|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314598|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19314599|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19314600|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19314601|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19314602|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314603|NCT04061239|Cytarabine|cytarabine|mesh-list
19314604|NCT04061239|Azacitidine|azacitidine|mesh-list
19314605|NCT04061239|Daunorubicin|daunorubicin|mesh-list
19314606|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19314607|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
19314608|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314609|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314610|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
19314611|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673597|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19673598|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673599|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673600|NCT03624101|Ivacaftor|ivacaftor|mesh-list
19673601|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19673602|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371067|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20371068|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20371069|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20371070|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20371071|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
20371072|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
20371073|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673603|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673604|NCT03600350|Nivolumab|nivolumab|mesh-list
19673605|NCT03600350|Sargramostim|sargramostim|mesh-list
19673606|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20188017|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
20371074|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
19314612|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19314613|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
19314614|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314615|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314616|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19314617|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20371075|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371076|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371077|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20371078|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
20371079|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371080|NCT00972660|Cyclosporine|cyclosporine|mesh-list
19314618|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19314619|NCT04060914|Clopidogrel|clopidogrel|mesh-list
19314620|NCT04060914|Ticagrelor|ticagrelor|mesh-list
19314621|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19314622|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19314623|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19314624|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19314625|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
19314626|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314627|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314628|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314629|NCT04060771|Dexamethasone|dexamethasone|mesh-list
19314630|NCT04060771|Palonosetron|palonosetron|mesh-list
19314631|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314632|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
19314633|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
19397489|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
20188018|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
20188019|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188020|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188021|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20188022|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
20188023|NCT00209495|Hormones|hormones|mesh-ancestor
20188024|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20188025|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20188026|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188027|NCT00209495|Analgesics|analgesics|mesh-ancestor
20188028|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
20188029|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
20188030|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20188031|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20188032|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188033|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20188034|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20188035|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188036|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188037|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188038|NCT00209521|Propofol|propofol|mesh-list
20188039|NCT00209521|Fospropofol|fospropofol|mesh-list
20188040|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20188041|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188042|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371081|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
20371082|NCT00972660|Prednisone|prednisone|mesh-list
20371083|NCT00972660|Cyclosporins|cyclosporins|mesh-list
20371084|NCT00972660|Tacrolimus|tacrolimus|mesh-list
19314634|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314635|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314636|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19314637|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
19314638|NCT04060771|Hormones|hormones|mesh-ancestor
19314639|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314640|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371085|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371086|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
20371087|NCT00972660|Hormones|hormones|mesh-ancestor
20371088|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371089|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371090|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371091|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371092|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371093|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371094|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371095|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
20371096|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
20371097|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371098|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
20371099|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20371100|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20371101|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20371102|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19314641|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314642|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19314643|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20371103|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
20371104|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20371105|NCT00972712|Bortezomib|bortezomib|mesh-list
20371106|NCT00972712|Tipifarnib|tipifarnib|mesh-list
20371107|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371108|NCT00972790|Bupivacaine|bupivacaine|mesh-list
20371109|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
20371110|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
20371111|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371112|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371113|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
20371114|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371115|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
20371116|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19314644|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
19314645|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314646|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314647|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
19314648|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20188043|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20188044|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
20188045|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
20188046|NCT00209534|Fospropofol|fospropofol|mesh-list
20188047|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19314649|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314650|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
19314651|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19314652|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
19314653|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314654|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371117|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371118|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
19314655|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19314656|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
19314657|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19314658|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
20188048|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188049|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188050|NCT00209547|Fospropofol|fospropofol|mesh-list
20188051|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20371119|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20188052|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371120|NCT00972829|Ezetimibe|ezetimibe|mesh-list
20371121|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19314659|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314660|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314661|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19314662|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
19314663|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
19314664|NCT04060979|Protective Agents|protective agents|mesh-ancestor
19314665|NCT04060836|Factor VIII|factor viii|mesh-list
19314666|NCT04060836|Coagulants|coagulants|mesh-ancestor
19314667|NCT04060719|Rifampin|rifampin|mesh-list
19314668|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19314669|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
19314670|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314671|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314672|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
19314673|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19314674|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314675|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314676|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19314677|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19314678|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19314679|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19314680|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19314681|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19314682|NCT04060381|Ibuprofen|ibuprofen|mesh-list
19314683|NCT04060381|Dopamine|dopamine|mesh-list
19314684|NCT04060381|Epinephrine|epinephrine|mesh-list
19314685|NCT04060381|Norepinephrine|norepinephrine|mesh-list
19314686|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19314687|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19314688|NCT04060381|Analgesics|analgesics|mesh-ancestor
19314689|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
19314690|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314691|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314692|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314693|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19314694|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19314695|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314696|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314697|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19314698|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19314699|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
19314700|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314701|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19314702|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20371122|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20371123|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
20371124|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371125|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20371126|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20371127|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371128|NCT00972842|Lenalidomide|lenalidomide|mesh-list
20371129|NCT00972842|Vorinostat|vorinostat|mesh-list
20371130|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
20371131|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371132|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19314703|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
19314704|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19314705|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
19314706|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
19314707|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
19314708|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19314709|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19314710|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
19314711|NCT04060381|Protective Agents|protective agents|mesh-ancestor
19314712|NCT04060472|Paclitaxel|paclitaxel|mesh-list
19314713|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
19314714|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19314715|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19314716|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314717|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19314718|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19314719|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20371133|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19314720|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314721|NCT04060459|Paclitaxel|paclitaxel|mesh-list
20371134|NCT00972842|Growth Substances|growth substances|mesh-ancestor
20371135|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
20371136|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371137|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20371138|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371139|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371140|NCT00972855|Bicalutamide|bicalutamide|mesh-list
20371141|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
20371142|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
20371143|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371144|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371145|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371146|NCT00972881|Capecitabine|capecitabine|mesh-list
20371147|NCT00972881|Irinotecan|irinotecan|mesh-list
20371148|NCT00972881|Cetuximab|cetuximab|mesh-list
20371149|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371150|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
20371151|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371152|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371153|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20371154|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20371155|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371156|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371157|NCT00972907|Nifedipine|nifedipine|mesh-list
19314722|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19314723|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314724|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
19314725|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
19314726|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
19314727|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314728|NCT04060407|Nivolumab|nivolumab|mesh-list
19314729|NCT04060407|Ipilimumab|ipilimumab|mesh-list
19314730|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314731|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314732|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19314733|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314734|NCT04060277|Acetic Acid|acetic acid|mesh-list
19314735|NCT04060277|Letermovir|letermovir|mesh-list
19314736|NCT04060277|Vaccines|vaccines|mesh-list
19314737|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
19314738|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314739|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314740|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314741|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314742|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314743|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314744|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19314745|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
19314746|NCT04060264|Eculizumab|eculizumab|mesh-list
19314747|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19314748|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19314749|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
19314750|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314751|NCT04060550|Omalizumab|omalizumab|mesh-list
19314752|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19314753|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19314754|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
19314755|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19314756|NCT04059770|Amphotericin B|amphotericin b|mesh-list
19314757|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
19314758|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314759|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19314760|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19314761|NCT04059770|Amebicides|amebicides|mesh-ancestor
19314762|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19314763|NCT04060043|Goserelin|goserelin|mesh-list
19314764|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19314765|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314766|NCT04060095|Anesthetics|anesthetics|mesh-list
19314767|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840599|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19840600|NCT00634933|Prednisolone|prednisolone|mesh-list
19314768|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314769|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
19314770|NCT04060017|Leucovorin|leucovorin|mesh-list
19314771|NCT04060017|Calcium|calcium|mesh-list
19840601|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
19840602|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19314772|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
19314773|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19314774|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314775|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19314776|NCT04060017|Antidotes|antidotes|mesh-ancestor
19314777|NCT04060017|Protective Agents|protective agents|mesh-ancestor
19314778|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
19314779|NCT04060017|Vitamins|vitamins|mesh-ancestor
19314780|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
19314781|NCT04059887|Atezolizumab|atezolizumab|mesh-list
19314782|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314783|NCT04059978|Remifentanil|remifentanil|mesh-list
19314784|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19314785|NCT04059978|Narcotics|narcotics|mesh-ancestor
19314786|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314787|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371158|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20371159|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371160|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371161|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20371162|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371163|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
20371164|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
20371165|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20371166|NCT00972933|Ipilimumab|ipilimumab|mesh-list
20371167|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371168|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371169|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20371170|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371171|NCT00972946|Dextrans|dextrans|mesh-list
20371172|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
20371173|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
20371174|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
19314788|NCT04059978|Analgesics|analgesics|mesh-ancestor
19314789|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
19314790|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314791|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
19314792|NCT04060030|Leucovorin|leucovorin|mesh-list
19314793|NCT04060030|Calcium|calcium|mesh-list
19314794|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
19314795|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19314796|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314797|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19314798|NCT04060030|Antidotes|antidotes|mesh-ancestor
19314799|NCT04060030|Protective Agents|protective agents|mesh-ancestor
19314800|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
19314801|NCT04060030|Vitamins|vitamins|mesh-ancestor
19314802|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
19314803|NCT04059679|Aspirin|aspirin|mesh-list
19314804|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
19314805|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19314806|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19314807|NCT04059679|Analgesics|analgesics|mesh-ancestor
19314808|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
19314809|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314810|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314811|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314812|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19314813|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19314814|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19314815|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314816|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19314817|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19314818|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314819|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
19314820|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19314821|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
19314822|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19840603|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
19314823|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
19314824|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
19397490|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397491|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397492|NCT03650881|Analgesics|analgesics|mesh-ancestor
19397493|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
19314825|NCT04059536|Aspirin|aspirin|mesh-list
19314826|NCT04059536|Heparin|heparin|mesh-list
19314827|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19314828|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19314829|NCT04059536|Analgesics|analgesics|mesh-ancestor
20371175|NCT00972985|Lorazepam|lorazepam|mesh-list
20371176|NCT00972985|Methylphenidate|methylphenidate|mesh-list
20371177|NCT00972985|Modafinil|modafinil|mesh-list
20371178|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20371179|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314830|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
19314831|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314832|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314833|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314834|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19314835|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19314836|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19314837|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371180|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20371181|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20371182|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371183|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371184|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
20371185|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371186|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20371187|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20371188|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20371189|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
20371190|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
20371191|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
20371192|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371193|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19314838|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19314839|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19314840|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314841|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
19314842|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
19314843|NCT04059523|Tretinoin|tretinoin|mesh-list
19314844|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314845|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
19314846|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
19314847|NCT04059224|Trametinib|trametinib|mesh-list
19314848|NCT04059224|Dabrafenib|dabrafenib|mesh-list
19314849|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314850|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19314851|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314852|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314853|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
19314854|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314855|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314856|NCT04059198|Tenofovir|tenofovir|mesh-list
19314857|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
19314858|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19314859|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19314860|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19314861|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314862|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314863|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19314864|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19314865|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
19314866|NCT04058899|Nalbuphine|nalbuphine|mesh-list
19314867|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19314868|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314869|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314870|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19314871|NCT04058899|Analgesics|analgesics|mesh-ancestor
19314872|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
19314873|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314874|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19314875|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19314876|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19314877|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
20371194|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19314878|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314879|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314880|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19314881|NCT04058899|Narcotics|narcotics|mesh-ancestor
20371195|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371196|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20371197|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20371198|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19314882|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
19314883|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314884|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314885|NCT04058522|Triamcinolone|triamcinolone|mesh-list
19314886|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314887|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
19314888|NCT04058522|Hormones|hormones|mesh-ancestor
19314889|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314890|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314891|NCT04058678|Danazol|danazol|mesh-list
19314892|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19314893|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
19314894|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314895|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314896|NCT04058717|Nicotine|nicotine|mesh-list
19314897|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19314898|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
19314899|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314900|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314901|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19314902|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19314903|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
19314904|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314905|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314906|NCT04058743|Cobalt|cobalt|mesh-list
19314907|NCT04058743|Chromium|chromium|mesh-list
19314908|NCT04058743|Nickel|nickel|mesh-list
19314909|NCT04058743|Trace Elements|trace elements|mesh-ancestor
19673607|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673608|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20188053|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188054|NCT00209573|Fospropofol|fospropofol|mesh-list
20188055|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20188056|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188057|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188058|NCT00209586|Fospropofol|fospropofol|mesh-list
20188059|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20188060|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188061|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188062|NCT00209599|Fospropofol|fospropofol|mesh-list
20188063|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20188064|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188065|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188066|NCT00209612|Paclitaxel|paclitaxel|mesh-list
20188067|NCT00209612|Irinotecan|irinotecan|mesh-list
20188068|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20188069|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188070|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
20188071|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
20188072|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
20188073|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188074|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20188075|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20188076|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188077|NCT00209625|Leucovorin|leucovorin|mesh-list
20188078|NCT00209625|Fluorouracil|fluorouracil|mesh-list
20188079|NCT00209625|Irinotecan|irinotecan|mesh-list
20188080|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
20188081|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188082|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371199|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
19673609|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188083|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314910|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
19314911|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314912|NCT04058236|Polygeline|polygeline|mesh-list
19314913|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
20371200|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
19314914|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
19314915|NCT04058145|Plerixafor|plerixafor|mesh-list
19314916|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
19314917|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314918|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673610|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
19673611|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314919|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19314920|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19314921|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
19314922|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371201|NCT00973037|Tamoxifen|tamoxifen|mesh-list
20371202|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20371203|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
20371204|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371205|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371206|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371207|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371208|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20371209|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20371210|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20425761|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425762|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425763|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20425764|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20425765|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19314923|NCT04058210|Ivacaftor|ivacaftor|mesh-list
19314924|NCT04058210|Elexacaftor|elexacaftor|mesh-list
19314925|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19314926|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19314927|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314928|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
19314929|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314930|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
19314931|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19314932|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19314933|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19314934|NCT04058132|Urological Agents|urological agents|mesh-ancestor
19314935|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
19314936|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19314937|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19314938|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19314939|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19314940|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314941|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
19314942|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314943|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314944|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19314945|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314946|NCT04058054|Histamine|histamine|mesh-list
19314947|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
19314948|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
19314949|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314950|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314951|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314952|NCT04057989|Ketamine|ketamine|mesh-list
19314953|NCT04057989|Analgesics|analgesics|mesh-ancestor
19314954|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
19314955|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314956|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314957|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19314958|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19314959|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
19314960|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
19314961|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314962|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19314963|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19314964|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19314965|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397494|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397495|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397496|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397497|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397498|NCT03650777|Warfarin|warfarin|mesh-list
19673612|NCT03598270|Gemcitabine|gemcitabine|mesh-list
19314966|NCT04057365|Nivolumab|nivolumab|mesh-list
19314967|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19314968|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314969|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19314970|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314971|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19314972|NCT04057456|Nabilone|nabilone|mesh-list
19840604|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840605|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
19840606|NCT00634933|Hormones|hormones|mesh-ancestor
19840607|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840608|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840609|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840610|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840611|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
19840612|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
19840613|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371211|NCT00973050|Bicalutamide|bicalutamide|mesh-list
20371212|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
20371213|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
20371214|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371215|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371216|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371217|NCT00973115|Simvastatin|simvastatin|mesh-list
20371218|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20371219|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20371220|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
20371221|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371222|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20371223|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20371224|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371225|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19840614|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19840615|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19840616|NCT00634933|Protective Agents|protective agents|mesh-ancestor
19840617|NCT00635024|Melphalan|melphalan|mesh-list
19840618|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19840619|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19840620|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
19840621|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19314973|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
19314974|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
19314975|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19314976|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314977|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19314978|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19314979|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19314980|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19314981|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20371226|NCT00973128|Sargramostim|sargramostim|mesh-list
20371227|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
20371228|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371229|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20371230|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20371231|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371232|NCT00973154|Prednisone|prednisone|mesh-list
20371233|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371234|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
20371235|NCT00973154|Hormones|hormones|mesh-ancestor
19314982|NCT04057261|Liraglutide|liraglutide|mesh-list
19314983|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19314984|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19314985|NCT04057261|Incretins|incretins|mesh-ancestor
19314986|NCT04057261|Hormones|hormones|mesh-ancestor
19314987|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19314988|NCT04057300|Aspirin|aspirin|mesh-list
19314989|NCT04057300|Clopidogrel|clopidogrel|mesh-list
19314990|NCT04057300|Ticagrelor|ticagrelor|mesh-list
19314991|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19314992|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19314993|NCT04057300|Analgesics|analgesics|mesh-ancestor
19314994|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
19314995|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840622|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19314996|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612773|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
19673613|NCT03598270|Paclitaxel|paclitaxel|mesh-list
19314997|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19314998|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19314999|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19315000|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19315001|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315002|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19315003|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19315004|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315005|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
19315006|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19315007|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19315008|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19315009|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
19315010|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315011|NCT04057326|Pancreatin|pancreatin|mesh-list
19315012|NCT04057326|Pancrelipase|pancrelipase|mesh-list
19673614|NCT03598270|Carboplatin|carboplatin|mesh-list
19673615|NCT03598270|Doxorubicin|doxorubicin|mesh-list
19673616|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19673617|NCT03598270|Atezolizumab|atezolizumab|mesh-list
19840623|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19840624|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673618|NCT03598270|Niraparib|niraparib|mesh-list
19673619|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19673620|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19315013|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19315014|NCT04057482|Dequalinium|dequalinium|mesh-list
19840625|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
19840626|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840627|NCT00635050|Paclitaxel|paclitaxel|mesh-list
19315015|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19315016|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315017|NCT04056923|Methylene Blue|methylene blue|mesh-list
19315018|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315019|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315020|NCT04056949|Paclitaxel|paclitaxel|mesh-list
19673621|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188084|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188085|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
19315021|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19315022|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19315023|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315024|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19315025|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19315026|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19315027|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315028|NCT04056897|Teriflunomide|teriflunomide|mesh-list
19315029|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19315030|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315031|NCT04056897|Analgesics|analgesics|mesh-ancestor
19315032|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
19315033|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315034|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315035|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315036|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315037|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19315038|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
19315039|NCT04057014|Amoxicillin|amoxicillin|mesh-list
19315040|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315041|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315042|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19315043|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19315044|NCT04056975|Antibodies|antibodies|mesh-list
19315045|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
19315046|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315047|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
19315048|NCT04056806|Terlipressin|terlipressin|mesh-list
19315049|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315050|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840628|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
20188086|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188087|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19315051|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19673622|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673623|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673624|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
19315052|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19315053|NCT04056845|Acetaminophen|acetaminophen|mesh-list
19315054|NCT04056845|Diclofenac|diclofenac|mesh-list
19315055|NCT04056845|Analgesics|analgesics|mesh-list
20371236|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371237|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371238|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371239|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315056|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19315057|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315058|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
19315059|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315060|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315061|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315062|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315063|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19315064|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315065|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315066|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
19315067|NCT04056650|Caffeine|caffeine|mesh-list
19315068|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19315069|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315070|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19315071|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315072|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315073|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19315074|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19315075|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
19315076|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315077|NCT04056754|Prednisone|prednisone|mesh-list
19315078|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
19315079|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315080|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
19315081|NCT04056754|Hormones|hormones|mesh-ancestor
19315082|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315083|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371240|NCT00973193|Panitumumab|panitumumab|mesh-list
20371241|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371242|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315084|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19315085|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371243|NCT00973219|Interferons|interferons|mesh-list
20371244|NCT00973219|Tenofovir|tenofovir|mesh-list
20371245|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
20371246|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
19315086|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20188088|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20188089|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188090|NCT00209625|Antidotes|antidotes|mesh-ancestor
20188091|NCT00209625|Protective Agents|protective agents|mesh-ancestor
20188092|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
20188093|NCT00209625|Vitamins|vitamins|mesh-ancestor
20188094|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
20188095|NCT00209638|Irinotecan|irinotecan|mesh-list
20188096|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20188097|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20188098|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315087|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315088|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315089|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
19315090|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19315091|NCT04056442|Cannabidiol|cannabidiol|mesh-list
19315092|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
19315093|NCT04056325|Ivermectin|ivermectin|mesh-list
19315094|NCT04056325|Moxidectin|moxidectin|mesh-list
19315095|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19315096|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315097|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
19315098|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
19315099|NCT04056702|Ivacaftor|ivacaftor|mesh-list
19315100|NCT04056702|Elexacaftor|elexacaftor|mesh-list
19315101|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19315102|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397499|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
20188099|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188100|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371247|NCT00973219|Adefovir|adefovir|mesh-list
19315103|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371248|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20371249|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20371250|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371251|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
20371252|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371253|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20371254|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20371255|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371256|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371257|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19315104|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19315105|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
19315106|NCT04056039|Colchicine|colchicine|mesh-list
19315107|NCT04056039|Atorvastatin|atorvastatin|mesh-list
19315108|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19315109|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19315110|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
19315111|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315112|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19315113|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19315114|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315115|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
19315116|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315117|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
19315118|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
19315119|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
19315120|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315121|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
19315122|NCT04056143|Apixaban|apixaban|mesh-list
19315123|NCT04056143|Edoxaban|edoxaban|mesh-list
19315124|NCT04056143|Dabigatran|dabigatran|mesh-list
19315125|NCT04056143|Thromboplastin|thromboplastin|mesh-list
19315126|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19315127|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
19315128|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19315129|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
19315130|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315131|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315132|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
19315133|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
19315134|NCT04056143|Coagulants|coagulants|mesh-ancestor
19315135|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19315136|NCT04056169|Ezetimibe|ezetimibe|mesh-list
19315137|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19315138|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19315139|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
19315140|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315141|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19315142|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19315143|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315144|NCT04056000|Caffeine|caffeine|mesh-list
19315145|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19315146|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315147|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19315148|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315149|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315150|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19315151|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19315152|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
19315153|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397500|NCT03650738|Paclitaxel|paclitaxel|mesh-list
19397501|NCT03650738|Carboplatin|carboplatin|mesh-list
19397502|NCT03650738|Apatinib|apatinib|mesh-list
19397503|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19397504|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397505|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
19397506|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
19397507|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
19397508|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397509|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19397510|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397511|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19397512|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19397513|NCT03650582|Glucagon|glucagon|mesh-list
19397514|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19397515|NCT03650582|Hormones|hormones|mesh-ancestor
19315154|NCT04055480|Insulin|insulin|mesh-list
19315155|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19315156|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
19315157|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
19315158|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315159|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315160|NCT04055506|Ritonavir|ritonavir|mesh-list
19315161|NCT04055506|BMS-986165|bms-986165|mesh-list
19315162|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19315163|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19315164|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
19315165|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315166|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315167|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19315168|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19315169|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
19315170|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315171|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19315172|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19315173|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
19315174|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19315175|NCT04055623|Aldesleukin|aldesleukin|mesh-list
19315176|NCT04055623|Interleukin-2|interleukin-2|mesh-list
19315177|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315178|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315179|NCT04055623|Analgesics|analgesics|mesh-ancestor
19315180|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
19315181|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315182|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315183|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19315184|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19315185|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
19315186|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315187|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
19315188|NCT04055415|Expectorants|expectorants|mesh-list
19315189|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
19315190|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315191|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315192|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19315193|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
19315194|NCT04054960|Levodopa|levodopa|mesh-list
19315195|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19315196|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19315197|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
19315198|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315199|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315200|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315201|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
19315202|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19315203|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19315204|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315205|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
19673625|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840629|NCT00635050|Bevacizumab|bevacizumab|mesh-list
19840630|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19840631|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840632|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
19840633|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
19840634|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
19673626|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19673627|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
19673628|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
19673629|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673630|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673631|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673632|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
19673633|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673634|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19673635|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19840635|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840636|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840637|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
19840638|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315206|NCT04055194|Coagulants|coagulants|mesh-ancestor
19315207|NCT04055142|Cidofovir|cidofovir|mesh-list
19315208|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
19673636|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19673637|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19673638|NCT03580525|Nicotine|nicotine|mesh-list
19673639|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19673640|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
19673641|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673642|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673643|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19673644|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19673645|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
19673646|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315209|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315210|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315211|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371258|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20371259|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
20371260|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371261|NCT00973232|Acetaminophen|acetaminophen|mesh-list
20371262|NCT00973232|Tramadol|tramadol|mesh-list
19315212|NCT04055233|Biguanides|biguanides|mesh-list
19315213|NCT04055233|Polihexanide|polihexanide|mesh-list
19315214|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315215|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
19673647|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673648|NCT03560297|Nitrazepam|nitrazepam|mesh-list
19673649|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
19673650|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19673651|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19673652|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673653|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19673654|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19673655|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19673656|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
19673657|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
19315216|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315217|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315218|NCT04054830|Diclofenac|diclofenac|mesh-list
19315219|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19315220|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315221|NCT04054830|Analgesics|analgesics|mesh-ancestor
19315222|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
19315223|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315224|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315225|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315226|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315227|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19315228|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315229|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315230|NCT04054531|Paclitaxel|paclitaxel|mesh-list
19315231|NCT04054531|Carboplatin|carboplatin|mesh-list
19673658|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673659|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315232|NCT04054531|Pemetrexed|pemetrexed|mesh-list
19315233|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19673660|NCT03554707|Bevacizumab|bevacizumab|mesh-list
19673661|NCT03554707|Irinotecan|irinotecan|mesh-list
19673662|NCT03554707|Temozolomide|temozolomide|mesh-list
19673663|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673664|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673665|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19315234|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315235|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
19315236|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
20188101|NCT00209651|Irinotecan|irinotecan|mesh-list
20188102|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20188103|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20188104|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188105|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188106|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188107|NCT00209664|Irinotecan|irinotecan|mesh-list
20188108|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19673666|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19673667|NCT03554707|Growth Substances|growth substances|mesh-ancestor
20371263|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315237|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
20188109|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20371264|NCT00973232|Analgesics|analgesics|mesh-ancestor
19315238|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315239|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315240|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19315241|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19315242|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
19315243|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19315244|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19315245|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315246|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
19315247|NCT04054687|Coagulants|coagulants|mesh-ancestor
19315248|NCT04054635|Fluorides|fluorides|mesh-list
19315249|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
19315250|NCT04054635|Protective Agents|protective agents|mesh-ancestor
19315251|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315252|NCT04054518|Durvalumab|durvalumab|mesh-list
19315253|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19315254|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315255|NCT04054362|Gemcitabine|gemcitabine|mesh-list
19315256|NCT04054362|Paclitaxel|paclitaxel|mesh-list
19315257|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19315258|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19315259|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315260|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
19315261|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
19315262|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
19315263|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315264|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19315265|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
19315266|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
19315267|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315268|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315269|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19315270|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
19315271|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315272|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19315273|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315274|NCT04054206|Ibudilast|ibudilast|mesh-list
19315275|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19315276|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
19315277|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315278|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315279|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19315280|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
19315281|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19315282|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315283|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315284|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19315285|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
19315286|NCT04054024|Erenumab|erenumab|mesh-list
20188110|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188111|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188112|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315287|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19315288|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315289|NCT04054024|Analgesics|analgesics|mesh-ancestor
19315290|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
19315291|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315292|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315293|NCT04054089|Tenofovir|tenofovir|mesh-list
19315294|NCT04054089|Lamivudine|lamivudine|mesh-list
19315295|NCT04054089|Emtricitabine|emtricitabine|mesh-list
19315296|NCT04054089|Dolutegravir|dolutegravir|mesh-list
19315297|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
19315298|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315299|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19315300|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19315301|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315302|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315303|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19315304|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19315305|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19673668|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188113|NCT00209677|Gemcitabine|gemcitabine|mesh-list
19315306|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19315307|NCT04054063|Etomidate|etomidate|mesh-list
19315308|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19315309|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371265|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
20371266|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315310|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315311|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315312|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
19315313|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
19315314|NCT04053959|Insulin|insulin|mesh-list
19315315|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19315316|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315317|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315318|NCT04053972|Lenvatinib|lenvatinib|mesh-list
19315319|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315320|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19315321|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315322|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315323|NCT04054115|Alprostadil|alprostadil|mesh-list
19315324|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19315325|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
19315326|NCT04054115|Urological Agents|urological agents|mesh-ancestor
19315327|NCT04054128|Heparin|heparin|mesh-list
19315328|NCT04054128|Calcium heparin|calcium heparin|mesh-list
19315329|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
19315330|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19315331|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19315332|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315333|NCT04053985|Lenvatinib|lenvatinib|mesh-list
19315334|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315335|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19315336|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315337|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315338|NCT04053712|Glucagon|glucagon|mesh-list
19315339|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19315340|NCT04053712|Hormones|hormones|mesh-ancestor
19315341|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315342|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673669|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
19673670|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19673671|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19673672|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673673|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840639|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315343|NCT04053699|Factor VIII|factor viii|mesh-list
19315344|NCT04053699|Coagulants|coagulants|mesh-ancestor
19315345|NCT04053621|Thiamine|thiamine|mesh-list
19315346|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
19315347|NCT04053621|Metformin|metformin|mesh-list
19315348|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315349|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315350|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
19315351|NCT04053621|Vitamins|vitamins|mesh-ancestor
19315352|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
19315353|NCT04053543|CXA-10|cxa-10|mesh-list
20188114|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188115|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
20188116|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188117|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188118|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
20188119|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188120|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188121|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188122|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
20188123|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188124|NCT00209690|Cisplatin|cisplatin|mesh-list
20188125|NCT00209690|Docetaxel|docetaxel|mesh-list
20188126|NCT00209690|Fluorouracil|fluorouracil|mesh-list
20188127|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188128|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
20188129|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19315354|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371267|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397516|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397517|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397518|NCT03650543|Amoxicillin|amoxicillin|mesh-list
19397519|NCT03650543|Clarithromycin|clarithromycin|mesh-list
19397520|NCT03650543|Omeprazole|omeprazole|mesh-list
19315355|NCT04053400|Ketamine|ketamine|mesh-list
19315356|NCT04053400|Analgesics|analgesics|mesh-ancestor
19315357|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
19315358|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315359|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315360|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19315361|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20371268|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
20371269|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20371270|NCT00973232|Narcotics|narcotics|mesh-ancestor
20371271|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371272|NCT00973245|Warfarin|warfarin|mesh-list
20371273|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
20371274|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
20371275|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20371276|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
20371277|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20371278|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
20371279|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315362|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
19315363|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
19315364|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315365|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19315366|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19315367|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315368|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315369|NCT04053491|Anesthetics|anesthetics|mesh-list
19315370|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315371|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315372|NCT04053140|Penicillins|penicillins|mesh-list
19315373|NCT04053140|Penicillin G|penicillin g|mesh-list
19315374|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19315375|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
19315376|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315377|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315378|NCT04052932|Allopurinol|allopurinol|mesh-list
19315379|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
19315380|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315381|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315382|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
19315383|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315384|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19315385|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
19315386|NCT04052932|Protective Agents|protective agents|mesh-ancestor
19315387|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315388|NCT04052711|Minocycline|minocycline|mesh-list
19315389|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315390|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315391|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
19315392|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315393|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19315394|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315395|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315396|NCT04052867|Lidocaine|lidocaine|mesh-list
19315397|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
19315398|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
19315399|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315400|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315401|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
19315402|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188130|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
20188131|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188132|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
20188133|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188134|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188135|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
20188136|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188137|NCT00209703|Leucovorin|leucovorin|mesh-list
20188138|NCT00209703|Fluorouracil|fluorouracil|mesh-list
20188139|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
20188140|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
20188141|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
20371280|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188142|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188143|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371281|NCT00973271|Atorvastatin|atorvastatin|mesh-list
19315403|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19315404|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19315405|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19315406|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19315407|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315408|NCT04053205|Paclitaxel|paclitaxel|mesh-list
19315409|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19315410|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315411|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
19315412|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
19315413|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
19315414|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371282|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
20371283|NCT00973271|Fenofibrate|fenofibrate|mesh-list
20371284|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20371285|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20371286|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
20371287|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371288|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20371289|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20371290|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371291|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20371292|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371293|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20371294|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371295|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371296|NCT00973323|Warfarin|warfarin|mesh-list
20371297|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
20371298|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
20371299|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20371300|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
20371301|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20371302|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
20371303|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371304|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371305|NCT00973336|Vitamin D|vitamin d|mesh-list
20371306|NCT00973336|Calcium|calcium|mesh-list
20371307|NCT00973336|Vitamins|vitamins|mesh-ancestor
20371308|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
20371309|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371310|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20371311|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20371312|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
20371313|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20612774|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
19673674|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19673675|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
19673676|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
19673677|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19315436|NCT04052659|Azacitidine|azacitidine|mesh-list
19315437|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19315438|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
19315439|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673678|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19673679|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673680|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
19673681|NCT03505723|Coagulants|coagulants|mesh-ancestor
19673682|NCT03472092|Amitriptyline|amitriptyline|mesh-list
19673683|NCT03472092|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19673684|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19673685|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
19673686|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19673687|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19673688|NCT03472092|Analgesics|analgesics|mesh-ancestor
19673689|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
19673690|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673691|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673692|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19673693|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19673694|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673695|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673696|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673697|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315440|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315441|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315442|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
19315443|NCT04052269|Tadalafil|tadalafil|mesh-list
19315444|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
20188144|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188145|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188146|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
19315445|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20371314|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315446|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19315447|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371315|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20371316|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20371317|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371318|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371319|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371320|NCT00973401|Insulin|insulin|mesh-list
19315448|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315449|NCT04052269|Urological Agents|urological agents|mesh-ancestor
19315450|NCT04052178|Capsaicin|capsaicin|mesh-list
19315451|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
19315452|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
19315453|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
19315454|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315455|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315456|NCT04051723|Dexamethasone|dexamethasone|mesh-list
19315457|NCT04051723|Ropivacaine|ropivacaine|mesh-list
19315458|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315459|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
19315460|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
19315461|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315462|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315463|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19315464|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
19315465|NCT04051723|Hormones|hormones|mesh-ancestor
19315466|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315467|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19315468|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315469|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
19315470|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
20188147|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188148|NCT00209703|Antidotes|antidotes|mesh-ancestor
20188149|NCT00209703|Protective Agents|protective agents|mesh-ancestor
20188150|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
20188151|NCT00209703|Vitamins|vitamins|mesh-ancestor
20188152|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
20188153|NCT00209716|Cisplatin|cisplatin|mesh-list
20188154|NCT00209716|Docetaxel|docetaxel|mesh-list
20188155|NCT00209716|Fluorouracil|fluorouracil|mesh-list
20188156|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188157|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
20188158|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
20188159|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
20188160|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315471|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315472|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
19315473|NCT04051853|Sorafenib|sorafenib|mesh-list
19315474|NCT04051853|Midazolam|midazolam|mesh-list
19315475|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19315476|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19315477|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315478|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315479|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19315480|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19315481|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19315482|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315483|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
19315484|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
19315485|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
20188161|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
20371321|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315486|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
19315487|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315488|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315489|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188162|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188163|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19315490|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20371322|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371323|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
20371324|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371325|NCT00973505|Anastrozole|anastrozole|mesh-list
19315491|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315492|NCT04051827|Midazolam|midazolam|mesh-list
19315493|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19315494|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19315495|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371326|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20371327|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371328|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19315496|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315497|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19315498|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19315499|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19315500|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315501|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
19315502|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
19315503|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
19315504|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
19315505|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315506|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315507|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19315508|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
19315509|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315510|NCT04051632|Insulin|insulin|mesh-list
19315511|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315512|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315513|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
19315514|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19315515|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19315516|NCT04051567|Aspirin|aspirin|mesh-list
19315517|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19315518|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315519|NCT04051567|Analgesics|analgesics|mesh-ancestor
19315520|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
19315521|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315522|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315523|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315524|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315525|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19315526|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19315527|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315528|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19315529|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19315530|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315531|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
19315532|NCT04051255|Metronidazole|metronidazole|mesh-list
19315533|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315534|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315535|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19315536|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19397521|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19397522|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397523|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19397524|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19397525|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19397526|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397527|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397528|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19397529|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19397530|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19397531|NCT03650361|Adapalene|adapalene|mesh-list
19397532|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397533|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397534|NCT03650361|Analgesics|analgesics|mesh-ancestor
19397535|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
19673698|NCT03472092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19673699|NCT03472092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19673700|NCT03472092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19673701|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
19397536|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673702|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20371329|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315537|NCT04051047|Gemcitabine|gemcitabine|mesh-list
19315538|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19315539|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
19315540|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315541|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315542|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
19315543|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315544|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315545|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19315546|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
19315547|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315548|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
19315549|NCT04051099|Bupivacaine|bupivacaine|mesh-list
19315550|NCT04051099|Propofol|propofol|mesh-list
19315551|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
19315552|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
19315553|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315554|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315555|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
19315556|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315557|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19315558|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315559|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
19315560|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315561|NCT04051099|Analgesics|analgesics|mesh-ancestor
19315562|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19315563|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19315564|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19315565|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
19315566|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315567|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315568|NCT04050592|Estradiol|estradiol|mesh-list
19315569|NCT04050592|Estrogens|estrogens|mesh-ancestor
20371330|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371331|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20371332|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
20371333|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371334|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371335|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371336|NCT00973583|Vitamin D|vitamin d|mesh-list
20371337|NCT00973583|Vitamins|vitamins|mesh-ancestor
20371338|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
19840640|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19840641|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
19840642|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19840643|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840644|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19840645|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19315570|NCT04050592|Hormones|hormones|mesh-ancestor
19315571|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315572|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315573|NCT04050670|Tirzepatide|tirzepatide|mesh-list
19315574|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315575|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315576|NCT04050670|Incretins|incretins|mesh-ancestor
19315577|NCT04050670|Hormones|hormones|mesh-ancestor
19315578|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315579|NCT04050826|Lidocaine|lidocaine|mesh-list
19315580|NCT04050826|Prilocaine|prilocaine|mesh-list
19315581|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
19315582|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
19315583|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840646|NCT00635050|Growth Substances|growth substances|mesh-ancestor
19840647|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840648|NCT00635089|Reslizumab|reslizumab|mesh-list
19840649|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19840650|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
19840651|NCT00635102|Cycloserine|cycloserine|mesh-list
19840652|NCT00635102|Glycine|glycine|mesh-list
19840653|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19840654|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315584|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840655|NCT00635102|Renal Agents|renal agents|mesh-ancestor
19840656|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19840657|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
19315585|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
19315586|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315587|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19315588|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20188164|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
20188165|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673703|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
19673704|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673705|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
19315589|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19315590|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19315591|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673706|NCT03431584|Protective Agents|protective agents|mesh-ancestor
19673707|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
19673708|NCT03410875|Vemurafenib|vemurafenib|mesh-list
19673709|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19315592|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
19315593|NCT04050488|Astringents|astringents|mesh-ancestor
19315594|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315595|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
19315596|NCT04050761|Nivolumab|nivolumab|mesh-list
19315597|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19315598|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315599|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19315600|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315601|NCT04050735|Ethanol|ethanol|mesh-list
19315602|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19673710|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673711|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673712|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673713|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673714|NCT03401320|Letrozole|letrozole|mesh-list
19673715|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673716|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19673717|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19673718|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673719|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673720|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19673721|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
19673722|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673723|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315603|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315604|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315605|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315606|NCT04050215|Edetic Acid|edetic acid|mesh-list
19315607|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19315608|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
19315609|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
19315610|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315611|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
19315612|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19315613|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19315614|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
19315615|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19315616|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
19315617|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
19315618|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315619|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315620|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315621|NCT04050267|Analgesics|analgesics|mesh-ancestor
19673724|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
19673725|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673726|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673727|NCT03321019|Capsaicin|capsaicin|mesh-list
19673728|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
19673729|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
19673730|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
19673731|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315622|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
19673732|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673733|NCT03317613|Capsaicin|capsaicin|mesh-list
20188166|NCT00209729|Docetaxel|docetaxel|mesh-list
20188167|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188168|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
20188169|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
20188170|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
19315623|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315624|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19315625|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315626|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315627|NCT04050059|Lidocaine|lidocaine|mesh-list
19315628|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19315629|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
19315630|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
19315631|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315632|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315633|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
19315634|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315635|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19315636|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19315637|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19315638|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19315639|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315640|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19315641|NCT04049916|Artesunate|artesunate|mesh-list
19315642|NCT04049916|Piperaquine|piperaquine|mesh-list
19315643|NCT04049916|Primaquine|primaquine|mesh-list
19315644|NCT04049916|Artenimol|artenimol|mesh-list
19315645|NCT04049916|Pyronaridine|pyronaridine|mesh-list
19315646|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
19315647|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19315648|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19315649|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315650|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188171|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188172|NCT00209742|Leucovorin|leucovorin|mesh-list
20188173|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
20188174|NCT00209742|Tegafur|tegafur|mesh-list
20188175|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
20188176|NCT00209742|Antidotes|antidotes|mesh-ancestor
20188177|NCT00209742|Protective Agents|protective agents|mesh-ancestor
20188178|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188179|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
20188180|NCT00209742|Vitamins|vitamins|mesh-ancestor
19315651|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
19315652|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
19315653|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19315654|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
19315655|NCT04050098|Metformin|metformin|mesh-list
19315656|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315657|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315658|NCT04049747|Bicalutamide|bicalutamide|mesh-list
19315659|NCT04049747|Finasteride|finasteride|mesh-list
19315660|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
19315661|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
19315662|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315663|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188181|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
20188182|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188183|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
20188184|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188185|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188186|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20188187|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
20188188|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20188189|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
20188190|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188191|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
20188192|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20188193|NCT00209755|Ribavirin|ribavirin|mesh-list
20188194|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
20188195|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188196|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
20188197|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188198|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
20188199|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
20188200|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20188201|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
20188202|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19315664|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315665|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19315666|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19315667|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315668|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315669|NCT04049747|Urological Agents|urological agents|mesh-ancestor
19315670|NCT04049409|Trastuzumab|trastuzumab|mesh-list
19315671|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19315672|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315673|NCT04049539|Cytarabine|cytarabine|mesh-list
19315674|NCT04049539|Daunorubicin|daunorubicin|mesh-list
19315675|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19315676|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
19315677|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315678|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315679|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
19315680|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315681|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19315682|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
19315683|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315684|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19315685|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19315686|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19315687|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315688|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
19315689|NCT04049513|Fludarabine|fludarabine|mesh-list
19315690|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19315691|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
19315692|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315693|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315694|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19315695|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
19315696|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315697|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315698|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19315699|NCT04049266|Aflibercept|aflibercept|mesh-list
19315700|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19315701|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19315702|NCT04049266|Growth Substances|growth substances|mesh-ancestor
19315703|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315704|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
19315705|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315706|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
19315707|NCT04049344|Decitabine|decitabine|mesh-list
19315708|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673734|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
20188203|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20188204|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188205|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20188206|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188207|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188208|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20188209|NCT00209781|Renal Agents|renal agents|mesh-ancestor
20188210|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
20188211|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
20188212|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20188213|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
20188214|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19673735|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
19673736|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
19673737|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673738|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692220|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19692221|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19692222|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692223|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
19692224|NCT04994951|Hormones|hormones|mesh-ancestor
19692225|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692226|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692227|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19692228|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
19692229|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692230|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692231|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
19692232|NCT04995016|Axitinib|axitinib|mesh-list
19692233|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20188215|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19315709|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19315710|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
19315711|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315712|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315713|NCT04049201|Midazolam|midazolam|mesh-list
19315714|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19315715|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19673739|NCT03310619|Nivolumab|nivolumab|mesh-list
19673740|NCT03310619|Durvalumab|durvalumab|mesh-list
19673741|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673742|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673743|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19673744|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673745|NCT03302910|Torsemide|torsemide|mesh-list
20371339|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371340|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20371341|NCT00973609|Folic Acid|folic acid|mesh-list
20371342|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
20371343|NCT00973609|Bevacizumab|bevacizumab|mesh-list
20371344|NCT00973609|Fluorouracil|fluorouracil|mesh-list
20371345|NCT00973609|Capecitabine|capecitabine|mesh-list
20371346|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371347|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371348|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20371349|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20371350|NCT00973609|Growth Substances|growth substances|mesh-ancestor
20371351|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371352|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
20371353|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
20371354|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371355|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371356|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371357|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
20371358|NCT00973609|Hematinics|hematinics|mesh-ancestor
20371359|NCT00973609|Vitamins|vitamins|mesh-ancestor
20371360|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
20371361|NCT00973687|Dexamethasone|dexamethasone|mesh-list
20371362|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371363|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
20371364|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
19673746|NCT03302910|Furosemide|furosemide|mesh-list
19673747|NCT03302910|Bumetanide|bumetanide|mesh-list
19673748|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
19673749|NCT03302910|Diuretics|diuretics|mesh-list
19673750|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19673751|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
19673752|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371365|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371366|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315716|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315717|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315718|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19315719|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19315720|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19315721|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315722|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
19315723|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
19315724|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
19315725|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
19315726|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315727|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397537|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397538|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371367|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20371368|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
20371369|NCT00973687|Hormones|hormones|mesh-ancestor
19397539|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397540|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
19397541|NCT03650348|Atezolizumab|atezolizumab|mesh-list
19397542|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404395|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673753|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673754|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404396|NCT03595163|Folic Acid|folic acid|mesh-list
20371370|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371371|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19315728|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19315729|NCT04048889|Ropivacaine|ropivacaine|mesh-list
19315730|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19315731|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19315732|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
19315733|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315734|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315735|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
19315736|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315737|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
19315738|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19315739|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315740|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315741|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315742|NCT04049227|Letrozole|letrozole|mesh-list
19315743|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315744|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19315745|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19315746|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371372|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371373|NCT00973713|Everolimus|everolimus|mesh-list
20371374|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371375|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371376|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
20371377|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371378|NCT00973778|Capecitabine|capecitabine|mesh-list
20371379|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371380|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
20371381|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371382|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371383|NCT00973804|Sirolimus|sirolimus|mesh-list
20371384|NCT00973804|Tacrolimus|tacrolimus|mesh-list
20371385|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371386|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
20371387|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371388|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19315747|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315748|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19315749|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
20371389|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371390|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371391|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20371392|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315750|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315751|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315752|NCT04049045|Empagliflozin|empagliflozin|mesh-list
19315753|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19315754|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315755|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19840658|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20188216|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188217|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20188218|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188219|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188220|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20188221|NCT00209794|Renal Agents|renal agents|mesh-ancestor
20188222|NCT00209807|Citalopram|citalopram|mesh-list
20188223|NCT00209807|Reboxetine|reboxetine|mesh-list
20188224|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20188225|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20188226|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20188227|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188228|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188229|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
20188230|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188231|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20188232|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
20188233|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188234|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20188235|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
20188236|NCT00209833|Cytarabine|cytarabine|mesh-list
20371393|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19315756|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315757|NCT04048863|Imidacloprid|imidacloprid|mesh-list
19315758|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
19315759|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315760|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315761|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315762|NCT04048811|Propofol|propofol|mesh-list
19315763|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19315764|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315765|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315766|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315767|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
19315768|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
19315769|NCT04048850|Grazoprevir|grazoprevir|mesh-list
19315770|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19315771|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
19315772|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315773|NCT04048577|Natalizumab|natalizumab|mesh-list
19315774|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
19315775|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371394|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371395|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
20371396|NCT00973869|Curcumin|curcumin|mesh-list
20371397|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20371398|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315776|NCT04048655|Neostigmine|neostigmine|mesh-list
19315777|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19315778|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315779|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315780|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
19315781|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315782|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315783|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19315784|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
19315785|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315786|NCT04048707|Octreotide|octreotide|mesh-list
19315787|NCT04048707|Midodrine|midodrine|mesh-list
19315788|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
19315789|NCT04048707|Giapreza|giapreza|mesh-list
19315790|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
19315791|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19315792|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19315793|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315794|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
19315795|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
19315796|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315797|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315798|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19315799|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19315800|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19315801|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19315802|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
19315803|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315804|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315805|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19315806|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
19315807|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315808|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19315809|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
19315810|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315811|NCT04048317|Doxorubicin|doxorubicin|mesh-list
20188237|NCT00209833|Fludarabine|fludarabine|mesh-list
20188238|NCT00209833|Etoposide|etoposide|mesh-list
20188239|NCT00209833|Idarubicin|idarubicin|mesh-list
20188240|NCT00209833|Daunorubicin|daunorubicin|mesh-list
20188241|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188242|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188243|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
20188244|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371399|NCT00973869|Analgesics|analgesics|mesh-ancestor
19315812|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19315813|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
19315814|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19315815|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188245|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371400|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
19315816|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20371401|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371402|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371403|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371404|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20371405|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371406|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371407|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371408|NCT00973882|Carboplatin|carboplatin|mesh-list
20371409|NCT00973882|Etoposide|etoposide|mesh-list
20371410|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371411|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20371412|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20371413|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20371414|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371415|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371416|NCT00973986|Atorvastatin|atorvastatin|mesh-list
20371417|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20371418|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20371419|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
20371420|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371421|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20371422|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20371423|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371424|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
20371425|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20371426|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371427|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371428|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
20371429|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371430|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371431|NCT00974012|Valproic Acid|valproic acid|mesh-list
20371432|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
20371433|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315817|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19315818|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315819|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315820|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
19315821|NCT04048226|Ketamine|ketamine|mesh-list
19315822|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
19315823|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315824|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315825|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19315826|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315827|NCT04048226|Analgesics|analgesics|mesh-ancestor
19315828|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
19315829|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315830|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19315831|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19315832|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19315833|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
19315834|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315835|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315836|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19315837|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315838|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
19315839|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19315840|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19315841|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19315842|NCT04048304|Vancomycin|vancomycin|mesh-list
19315843|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315844|NCT04048200|Fentanyl|fentanyl|mesh-list
20188246|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
20188247|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188248|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20188249|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20188250|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20188251|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188252|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
20188253|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188254|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20188255|NCT00209846|Gaboxadol|gaboxadol|mesh-list
20188256|NCT00209846|Analgesics|analgesics|mesh-ancestor
20188257|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
19315845|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
19315846|NCT04048200|Ketamine|ketamine|mesh-list
19315847|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
19315848|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
19315849|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315850|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315851|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19315852|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315853|NCT04048200|Analgesics|analgesics|mesh-ancestor
19315854|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
19315855|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315856|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20371434|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371435|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
20371436|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371437|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371438|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
20371439|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19315857|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19315858|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19315859|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
19315860|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19315861|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315862|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19315863|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19840659|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
19840660|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840661|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
20371440|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371441|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20371442|NCT00974025|Ascorbic Acid|ascorbic acid|mesh-list
20371443|NCT00974025|Vitamins|vitamins|mesh-ancestor
20371444|NCT00974025|Micronutrients|micronutrients|mesh-ancestor
19840662|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840663|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840664|NCT00635154|Dexamethasone|dexamethasone|mesh-list
19840665|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
19840666|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19840667|NCT00635154|BB 1101|bb 1101|mesh-list
19840668|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840669|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
19315864|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
19315865|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19315866|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19315867|NCT04048200|Narcotics|narcotics|mesh-ancestor
19315868|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19315869|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
19315870|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19315871|NCT04048070|Sufentanil|sufentanil|mesh-list
19315872|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19315873|NCT04048070|Narcotics|narcotics|mesh-ancestor
19315874|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371445|NCT00974025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371446|NCT00974025|Antioxidants|antioxidants|mesh-ancestor
20371447|NCT00974025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371448|NCT00974025|Protective Agents|protective agents|mesh-ancestor
20371449|NCT00974155|Dexetimide|dexetimide|mesh-list
20371450|NCT00974155|Citalopram|citalopram|mesh-list
20371451|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20371452|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20371453|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20371454|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371455|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371456|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371457|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
20371458|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371459|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20371460|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
19840670|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
20371461|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20371462|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20371463|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19315875|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840671|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840672|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315876|NCT04048070|Analgesics|analgesics|mesh-ancestor
19315877|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
19315878|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315879|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19315880|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19315881|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
19315882|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
19315883|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19315884|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19315885|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315886|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19315887|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19315888|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188258|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188259|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188260|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
20188261|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
20188262|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
20188263|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188264|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188265|NCT00209859|Cyclosporine|cyclosporine|mesh-list
20188266|NCT00209859|Betamethasone|betamethasone|mesh-list
20188267|NCT00209859|Methotrexate|methotrexate|mesh-list
20188268|NCT00209859|Cyclosporins|cyclosporins|mesh-list
20188269|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20188270|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
20188271|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20188272|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188273|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188274|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
20188275|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188276|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188277|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
20188278|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188279|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20188280|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188281|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
20188282|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20188283|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20188284|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
20188285|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188286|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20188287|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20188288|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
20188289|NCT00209859|Hormones|hormones|mesh-ancestor
20188290|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20188291|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20188292|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
20188293|NCT00209872|Lidocaine|lidocaine|mesh-list
20188294|NCT00209872|Ketamine|ketamine|mesh-list
20188295|NCT00209872|Gabapentin|gabapentin|mesh-list
20188296|NCT00209872|Esketamine|esketamine|mesh-list
20188297|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
20188298|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
20188299|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188300|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188301|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
20188302|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188303|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20188304|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20188305|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20188306|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20188307|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188308|NCT00209872|Analgesics|analgesics|mesh-ancestor
20188309|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20188310|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20188311|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
20188312|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20188313|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20188314|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188315|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
20188316|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20188317|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188318|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19315889|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315890|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
19315891|NCT04048161|Tacrolimus|tacrolimus|mesh-list
19315892|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19315893|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
19315894|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315895|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19315896|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315897|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315898|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19315899|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315900|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19673755|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673756|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19673757|NCT03267498|Nivolumab|nivolumab|mesh-list
19315901|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
19315902|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315903|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315904|NCT04047654|Anticoagulants|anticoagulants|mesh-list
19315905|NCT04047706|Nivolumab|nivolumab|mesh-list
19315906|NCT04047706|Temozolomide|temozolomide|mesh-list
19315907|NCT04047706|Linrodostat|linrodostat|mesh-list
19315908|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19315909|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315910|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19315911|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315912|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19315913|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
19315914|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315915|NCT04047940|Metformin|metformin|mesh-list
19315916|NCT04047940|Valsartan|valsartan|mesh-list
19315917|NCT04047940|Atorvastatin|atorvastatin|mesh-list
19315918|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19315919|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315920|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19315921|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19315922|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
19315923|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315924|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19315925|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19315926|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315927|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19315928|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19315929|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20371464|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
20371465|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
20371466|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315930|NCT04047758|Letrozole|letrozole|mesh-list
19315931|NCT04047758|Palbociclib|palbociclib|mesh-list
19315932|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315933|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19315934|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20371467|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20371468|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20371469|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
20371470|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20371471|NCT00974181|Paclitaxel|paclitaxel|mesh-list
19315935|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315936|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315937|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19315938|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
19315939|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315940|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315941|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19315942|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19315943|NCT04047849|Amoxicillin|amoxicillin|mesh-list
20371472|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20371473|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20371474|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371475|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
19315944|NCT04047849|Azithromycin|azithromycin|mesh-list
19315945|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315946|NCT04047914|Mupirocin|mupirocin|mesh-list
20371476|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673758|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315947|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315948|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315949|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19315950|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315951|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315952|NCT04047875|Norethindrone|norethindrone|mesh-list
19315953|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
19315954|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19315955|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19315956|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20371477|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
20371478|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371479|NCT00974272|Exenatide|exenatide|mesh-list
20371480|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20371481|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371482|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19315957|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
19315958|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19315959|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315960|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19315961|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19315962|NCT04047745|Bupivacaine|bupivacaine|mesh-list
19315963|NCT04047745|Ropivacaine|ropivacaine|mesh-list
19315964|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
19315965|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
19315966|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19315967|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315968|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
19315969|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19315970|NCT04047680|Ritonavir|ritonavir|mesh-list
19315971|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
19315972|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19315973|NCT04047680|Grazoprevir|grazoprevir|mesh-list
19315974|NCT04047680|Ledipasvir|ledipasvir|mesh-list
19315975|NCT04047680|Velpatasvir|velpatasvir|mesh-list
19315976|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19315977|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19315978|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
19315979|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19315980|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19315981|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19315982|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19315983|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
19315984|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315985|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19315986|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19315987|NCT04047576|Sirolimus|sirolimus|mesh-list
19315988|NCT04047576|Prednisone|prednisone|mesh-list
19315989|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19315990|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
19315991|NCT04047576|Hormones|hormones|mesh-ancestor
19315992|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19315993|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19315994|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19315995|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19315996|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19315997|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19315998|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19315999|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
19316000|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19316001|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
19316002|NCT04047797|Rituximab|rituximab|mesh-list
19316003|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19316004|NCT04047797|Ixazomib|ixazomib|mesh-list
19316005|NCT04047797|Antibodies|antibodies|mesh-list
19316006|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
19316007|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19316008|NCT04047797|Glycine|glycine|mesh-list
19316009|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
19316010|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316011|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316012|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316013|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316014|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
19316015|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316016|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
19397543|NCT03650270|Phenytoin|phenytoin|mesh-list
19316017|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316018|NCT04047329|Anesthetics|anesthetics|mesh-list
19316019|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316020|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316021|NCT04047394|Rasburicase|rasburicase|mesh-list
19316022|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
19316023|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316024|NCT04047355|Propranolol|propranolol|mesh-list
19316025|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19316026|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19316027|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
19316028|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316029|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316030|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316031|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19316032|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20371483|NCT00974272|Incretins|incretins|mesh-ancestor
20371484|NCT00974272|Hormones|hormones|mesh-ancestor
19316033|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
19316034|NCT04047446|Dexamethasone|dexamethasone|mesh-list
19316035|NCT04047446|Bupivacaine|bupivacaine|mesh-list
19316036|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316037|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
19316038|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
19316039|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316040|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316041|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316042|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
19316043|NCT04047446|Hormones|hormones|mesh-ancestor
19316044|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316045|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19316046|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316047|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
19316048|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
19316049|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316050|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
19397544|NCT03650270|Midazolam|midazolam|mesh-list
19397545|NCT03650270|Phenobarbital|phenobarbital|mesh-list
19397546|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19397547|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19397548|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397549|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397550|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19397551|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19397552|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397553|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19397554|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
19397555|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
19397556|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
19397557|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
19397558|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371485|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371486|NCT00974324|Endostar protein|endostar protein|mesh-list
20371487|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20371488|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20371489|NCT00974324|Growth Substances|growth substances|mesh-ancestor
20371490|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371491|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
20371492|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371493|NCT00974389|Bevacizumab|bevacizumab|mesh-list
20371494|NCT00974389|Tegafur|tegafur|mesh-list
20371495|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371496|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371497|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20371498|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20371499|NCT00974389|Growth Substances|growth substances|mesh-ancestor
20371500|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371501|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
20371502|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371503|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
20371504|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397559|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397560|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
20371505|NCT00974428|Wobenzym|wobenzym|mesh-list
20371506|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20371507|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
20371508|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371509|NCT00974441|Valproic Acid|valproic acid|mesh-list
20371510|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
20371511|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371512|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371513|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
19316051|NCT04047017|Apatinib|apatinib|mesh-list
19316052|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316053|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19316054|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316055|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316056|NCT04046874|Analgesics|analgesics|mesh-list
20371514|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371515|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371516|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
20371517|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20371518|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371519|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20371520|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
20371521|NCT00974532|Calcium|calcium|mesh-list
20371522|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19316057|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
19316058|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316059|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316060|NCT04046744|Lidocaine|lidocaine|mesh-list
19316061|NCT04046744|Analgesics|analgesics|mesh-list
19316062|NCT04046744|Ropivacaine|ropivacaine|mesh-list
19316063|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
19316064|NCT04046744|Anesthetics|anesthetics|mesh-list
19316065|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316066|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316067|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
19316068|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371523|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371524|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20371525|NCT00974584|Paclitaxel|paclitaxel|mesh-list
20371526|NCT00974584|Bevacizumab|bevacizumab|mesh-list
20371527|NCT00974584|Carboplatin|carboplatin|mesh-list
20371528|NCT00974584|Pemetrexed|pemetrexed|mesh-list
20371529|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20371530|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316069|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19316070|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19316071|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19316072|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19316073|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371531|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
20371532|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
20371533|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
20371534|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371535|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371536|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20371537|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20371538|NCT00974584|Growth Substances|growth substances|mesh-ancestor
20371539|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371540|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
20371541|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371542|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20371543|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20371544|NCT00974740|Atorvastatin|atorvastatin|mesh-list
20371545|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20371546|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20371547|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
20371548|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371549|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20371550|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20371551|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316074|NCT04047186|Nivolumab|nivolumab|mesh-list
19316075|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316076|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316077|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19316078|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371552|NCT00974753|Ketorolac|ketorolac|mesh-list
20371553|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19316079|NCT04047004|Doxorubicin|doxorubicin|mesh-list
19316080|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316081|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19316082|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19316083|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19316084|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316085|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316086|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
19316087|NCT04046861|Vitamins|vitamins|mesh-ancestor
19316088|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
19316089|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316090|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
19316091|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316092|NCT04046861|Protective Agents|protective agents|mesh-ancestor
19316093|NCT04046822|Liraglutide|liraglutide|mesh-list
19316094|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19316095|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316096|NCT04046822|Incretins|incretins|mesh-ancestor
20371554|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20371555|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20371556|NCT00974753|Analgesics|analgesics|mesh-ancestor
20371557|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
20371558|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371559|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371560|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371561|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20371562|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20371563|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371564|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371565|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
20371566|NCT00974766|Hormones|hormones|mesh-ancestor
20371567|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371568|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371569|NCT00974792|Leucovorin|leucovorin|mesh-list
20371570|NCT00974792|Cytarabine|cytarabine|mesh-list
20371571|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
20371572|NCT00974792|Ifosfamide|ifosfamide|mesh-list
20371573|NCT00974792|Rituximab|rituximab|mesh-list
20371574|NCT00974792|Doxorubicin|doxorubicin|mesh-list
20371575|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20371576|NCT00974792|Methotrexate|methotrexate|mesh-list
20371577|NCT00974792|Etoposide|etoposide|mesh-list
20371578|NCT00974792|Vincristine|vincristine|mesh-list
20371579|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
20371580|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
20371581|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371582|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
20371583|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371584|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20371585|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20371586|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
20371587|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371588|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316097|NCT04046822|Hormones|hormones|mesh-ancestor
20371589|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20371590|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371591|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20371592|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20371593|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20371594|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371595|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20371596|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
20371597|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20371598|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371599|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
20371600|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
20371601|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20371602|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20371603|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20371604|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
19316098|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316099|NCT04046510|Oxytocin|oxytocin|mesh-list
19316100|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
19316101|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404397|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
20371605|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316102|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316103|NCT04046653|Sulforaphane|sulforaphane|mesh-list
19316104|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19316105|NCT04046653|Protective Agents|protective agents|mesh-ancestor
19840673|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19840674|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
19840675|NCT00635154|Hormones|hormones|mesh-ancestor
19840676|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840677|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840678|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840679|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840680|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
19840681|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840682|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840683|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19316106|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316107|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316108|NCT04046679|Bleomycin|bleomycin|mesh-list
19316109|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19316110|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316111|NCT04046029|Heparin|heparin|mesh-list
19316112|NCT04046029|Bivalirudin|bivalirudin|mesh-list
19316113|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
19316114|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19316115|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19316116|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316117|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
19316118|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19316119|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
19316120|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316121|NCT04046016|Paclitaxel|paclitaxel|mesh-list
19316122|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19316123|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316124|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
19316125|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
19316126|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
19316127|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316128|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
19316129|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
19316130|NCT04046289|Calcium|calcium|mesh-list
19316131|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19316132|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316133|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19316134|NCT04046289|Antacids|antacids|mesh-ancestor
19316135|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316136|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20188319|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
20188320|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
20188321|NCT00209885|Lidocaine|lidocaine|mesh-list
20188322|NCT00209885|Droperidol|droperidol|mesh-list
19316137|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
19316138|NCT04046133|Capecitabine|capecitabine|mesh-list
19316139|NCT04046133|Mitomycins|mitomycins|mesh-list
19316140|NCT04046133|Mitomycin|mitomycin|mesh-list
19316141|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316142|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316143|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19316144|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
19316145|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316146|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19316147|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
19316148|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19316149|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316150|NCT04046302|Dinoprostone|dinoprostone|mesh-list
19316151|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
19840684|NCT00635219|Vortioxetine|vortioxetine|mesh-list
19840685|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20188323|NCT00209885|Ketamine|ketamine|mesh-list
20188324|NCT00209885|Gabapentin|gabapentin|mesh-list
20188325|NCT00209885|Esketamine|esketamine|mesh-list
20188326|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
20188327|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
20188328|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188329|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188330|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
20188331|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316152|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19316153|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316154|NCT04045678|Rotigotine|rotigotine|mesh-list
20371606|NCT00974792|Antidotes|antidotes|mesh-ancestor
20371607|NCT00974792|Protective Agents|protective agents|mesh-ancestor
20371608|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
20371609|NCT00974792|Vitamins|vitamins|mesh-ancestor
20371610|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
20371611|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
20371612|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
20371613|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
20425766|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425767|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20425768|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20425769|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425770|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
20425771|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
20425772|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
20425773|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20425774|NCT01276704|Estrogens|estrogens|mesh-ancestor
20425775|NCT01276704|Hormones|hormones|mesh-ancestor
20425776|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673759|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673760|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20425777|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425778|NCT01276717|Vorinostat|vorinostat|mesh-list
20425779|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425780|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20425781|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425782|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425783|NCT01276730|Interferons|interferons|mesh-list
20425784|NCT01276730|Tretinoin|tretinoin|mesh-list
20425785|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425786|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
20425787|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425788|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
20425789|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
20425790|NCT01276769|Paclitaxel|paclitaxel|mesh-list
20425791|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20425792|NCT01276769|Carboplatin|carboplatin|mesh-list
20425793|NCT01276769|Epirubicin|epirubicin|mesh-list
20425794|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20425795|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316155|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
19316156|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
19316157|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316158|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316159|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316160|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
19316161|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316162|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316163|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19316164|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19316165|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316166|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316167|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316168|NCT04045730|Gemcitabine|gemcitabine|mesh-list
19316169|NCT04045730|Paclitaxel|paclitaxel|mesh-list
19316170|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
19316171|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19316172|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316173|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
20188332|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20188333|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20188334|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20188335|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20188336|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188337|NCT00209885|Analgesics|analgesics|mesh-ancestor
20188338|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20188339|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20188340|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
20188341|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20425796|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
20425797|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
20425798|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
20371614|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20371615|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20371616|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
20371617|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371618|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371619|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20371620|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
20371621|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
20371622|NCT00974805|Hormones|hormones|mesh-ancestor
20371623|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371624|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
20371625|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20371626|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20371627|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
20371628|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371629|NCT00974935|Antacids|antacids|mesh-ancestor
20371630|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371631|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20371632|NCT00974961|Bupivacaine|bupivacaine|mesh-list
20371633|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
20371634|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
20371635|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
20371636|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371637|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371638|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
20371639|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371640|NCT00974987|Temozolomide|temozolomide|mesh-list
20371641|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20371642|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
20371643|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371644|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371645|NCT00975052|Metformin|metformin|mesh-list
20371646|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20371647|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20371648|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371649|NCT00975052|Incretins|incretins|mesh-ancestor
20371650|NCT00975052|Hormones|hormones|mesh-ancestor
20371651|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371652|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20371653|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
20371654|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371655|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371656|NCT00975065|Metformin|metformin|mesh-list
20371657|NCT00975065|Vildagliptin|vildagliptin|mesh-list
20371658|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20371659|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371660|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20371661|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
20371662|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371663|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371664|NCT00975078|Prednisone|prednisone|mesh-list
20371665|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371666|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
19316174|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
19316175|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
19316176|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316177|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19316178|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
19673761|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188342|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20188343|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188344|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
20188345|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20188346|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188347|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188348|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
20188349|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
20188350|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20188351|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
20188352|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
20188353|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20188354|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20188355|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20188356|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20371667|NCT00975078|Hormones|hormones|mesh-ancestor
20371668|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371669|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371670|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371671|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371672|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20371673|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
20371674|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316179|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
19316180|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316181|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316182|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19316183|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
19316184|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316185|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316186|NCT04045821|Plerixafor|plerixafor|mesh-list
19316187|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19316188|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19316189|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
19316190|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371675|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20371676|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371677|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19316191|NCT04045548|Dinoprostone|dinoprostone|mesh-list
19316192|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
19316193|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19316194|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316195|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
19316196|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19316197|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316198|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20188357|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
20188358|NCT00209924|Gaboxadol|gaboxadol|mesh-list
20188359|NCT00209924|Analgesics|analgesics|mesh-ancestor
20188360|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
20188361|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188362|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188363|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
20188364|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
20188365|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
20188366|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188367|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188368|NCT00209937|Gaboxadol|gaboxadol|mesh-list
20188369|NCT00209937|Analgesics|analgesics|mesh-ancestor
20188370|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
20188371|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188372|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188373|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
20188374|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
20188375|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
20188376|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188377|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188378|NCT00209950|Gaboxadol|gaboxadol|mesh-list
20188379|NCT00209950|Analgesics|analgesics|mesh-ancestor
20188380|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
20371678|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371679|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371680|NCT00975299|Bombesin|bombesin|mesh-list
20371681|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371682|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371683|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371684|NCT00975312|Tretinoin|tretinoin|mesh-list
20371685|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371686|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
20371687|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
20371688|NCT00975325|Yohimbine|yohimbine|mesh-list
20371689|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
20371690|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
20371691|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371692|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316199|NCT04046185|Progesterone|progesterone|mesh-list
19316200|NCT04046185|Progestins|progestins|mesh-ancestor
19316201|NCT04046185|Hormones|hormones|mesh-ancestor
19316202|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20188381|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188382|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316203|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316204|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316205|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316206|NCT04046159|Tamoxifen|tamoxifen|mesh-list
19316207|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19316208|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
19316209|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316210|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316211|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19316212|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316213|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19316214|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19316215|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19316216|NCT04045431|Hylan|hylan|mesh-list
19316217|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
19316218|NCT04045431|Protective Agents|protective agents|mesh-ancestor
19316219|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316220|NCT04045093|Warfarin|warfarin|mesh-list
19316221|NCT04045093|Dabigatran|dabigatran|mesh-list
19316222|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
19316223|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
19316224|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19316225|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
19316226|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316227|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397561|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19397562|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19397563|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397564|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19397565|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19397566|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19397567|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19397568|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19397569|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19397570|NCT03650257|Temozolomide|temozolomide|mesh-list
20188383|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
20188384|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
20188385|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
20188386|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188387|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188388|NCT00209963|Gaboxadol|gaboxadol|mesh-list
20188389|NCT00209963|Analgesics|analgesics|mesh-ancestor
20188390|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
20188391|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188392|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188393|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
20188394|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
20188395|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
20188396|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188397|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188398|NCT00209989|Tipifarnib|tipifarnib|mesh-list
20188399|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188400|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
20188401|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20188402|NCT00210002|Hematinics|hematinics|mesh-ancestor
20188403|NCT00210028|Tamoxifen|tamoxifen|mesh-list
20188404|NCT00210028|Tipifarnib|tipifarnib|mesh-list
20188405|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20188406|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
20188407|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20188408|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188409|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20188410|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188411|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20188412|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20188413|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20188414|NCT00210041|Gemcitabine|gemcitabine|mesh-list
20188415|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188416|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188417|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
20188418|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188419|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
19316228|NCT04044976|Caffeine|caffeine|mesh-list
19316229|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
19316230|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316231|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19316232|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316233|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20371693|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20371694|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20371695|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20371696|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
20371697|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371698|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371699|NCT00975325|Urological Agents|urological agents|mesh-ancestor
20371700|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
19316234|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316235|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19316236|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19316237|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
19316238|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316239|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
19316240|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19316241|NCT04044690|Antibodies|antibodies|mesh-list
19316242|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
19316243|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
19316244|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316245|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
19316246|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840686|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19840687|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19840688|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840689|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188420|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316247|NCT04044651|Nivolumab|nivolumab|mesh-list
19316248|NCT04044651|Lenvatinib|lenvatinib|mesh-list
19316249|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316250|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316251|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19316252|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316253|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19316254|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316255|NCT04044703|Vancomycin|vancomycin|mesh-list
19316256|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316257|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316258|NCT04044378|Ifosfamide|ifosfamide|mesh-list
19316259|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19316260|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
19316261|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316262|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316263|NCT04044430|Nivolumab|nivolumab|mesh-list
19316264|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316265|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316266|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19316267|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316268|NCT04044417|Curcumin|curcumin|mesh-list
19316269|NCT04044417|Simvastatin|simvastatin|mesh-list
19316270|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19316271|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19316272|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
19316273|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316274|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19316275|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19316276|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316277|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19316278|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19316279|NCT04044417|Analgesics|analgesics|mesh-ancestor
20188421|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188422|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188423|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
20188424|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188425|NCT00210132|Ropivacaine|ropivacaine|mesh-list
20188426|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
20188427|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
20188428|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316280|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
19316281|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316282|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316283|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316284|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316285|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316286|NCT04044547|Rotigotine|rotigotine|mesh-list
19316287|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
19316288|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
19316289|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316290|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316291|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316292|NCT04044313|Lenvatinib|lenvatinib|mesh-list
19316293|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316294|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19316295|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316296|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316297|NCT04044287|Misoprostol|misoprostol|mesh-list
20371701|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371702|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
20371703|NCT00975351|Vitamins|vitamins|mesh-ancestor
20371704|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
20371705|NCT00975390|Caffeine|caffeine|mesh-list
20371706|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19316298|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19316299|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
19316300|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19316301|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316302|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20371707|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371708|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20371709|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371710|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371711|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19316303|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316304|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
19316305|NCT04043897|Rifaximin|rifaximin|mesh-list
19316306|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316307|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316308|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316309|NCT04043858|Midodrine|midodrine|mesh-list
19316310|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
19316311|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
19316312|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316313|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316314|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19316315|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19316316|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19316317|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19316318|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
19316319|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316320|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316321|NCT04044131|Sorbitol|sorbitol|mesh-list
19316322|NCT04044131|Cathartics|cathartics|mesh-ancestor
19316323|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316324|NCT04044079|Misoprostol|misoprostol|mesh-list
19316325|NCT04044079|Dinoprostone|dinoprostone|mesh-list
19404398|NCT03595163|Propofol|propofol|mesh-list
19840690|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840691|NCT00635219|Analgesics|analgesics|mesh-ancestor
19840692|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
19840693|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840694|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
19840695|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19840696|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
19840697|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19840698|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19840699|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840700|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19840701|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
19840702|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19840703|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19840704|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19840705|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20371712|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19840706|NCT00635232|Irbesartan|irbesartan|mesh-list
19840707|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19316326|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19316327|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
19316328|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19316329|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316330|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19316331|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316332|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
19316333|NCT04044222|Carboplatin|carboplatin|mesh-list
19316334|NCT04044222|Etoposide|etoposide|mesh-list
19316335|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
19316336|NCT04044222|Ifosfamide|ifosfamide|mesh-list
19316337|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
19316338|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316339|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19316340|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20371713|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
20371714|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371715|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
20371716|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
20371717|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20371718|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20371719|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371720|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371721|NCT00975494|Urological Agents|urological agents|mesh-ancestor
20371722|NCT00975533|Insulin|insulin|mesh-list
20371723|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20371724|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371725|NCT00975572|Vaccines|vaccines|mesh-list
20371726|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
20371727|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371728|NCT00975663|Tacrolimus|tacrolimus|mesh-list
20371729|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371730|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
20371731|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371732|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20371733|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371734|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371735|NCT00975728|Antioxidants|antioxidants|mesh-list
20371736|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371737|NCT00975728|Protective Agents|protective agents|mesh-ancestor
20371738|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371739|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
20371740|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371741|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
20371742|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20371743|NCT00975754|Budesonide|budesonide|mesh-list
20371744|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371745|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20371746|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
20371747|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371748|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371749|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20371750|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
20371751|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
20371752|NCT00975754|Hormones|hormones|mesh-ancestor
20371753|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371754|NCT00975767|Docetaxel|docetaxel|mesh-list
20371755|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20371756|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371757|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
20371758|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
20371759|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
20371760|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371761|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20371762|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371763|NCT00975819|Sirolimus|sirolimus|mesh-list
20371764|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316341|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19316342|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316343|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316344|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20371765|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316345|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
19316346|NCT04043676|Ponatinib|ponatinib|mesh-list
19316347|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371766|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20371767|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371768|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
20371769|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371770|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
20371771|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371772|NCT00975897|Leucovorin|leucovorin|mesh-list
20371773|NCT00975897|Bevacizumab|bevacizumab|mesh-list
20371774|NCT00975897|Cetuximab|cetuximab|mesh-list
20371775|NCT00975897|Fluorouracil|fluorouracil|mesh-list
20371776|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
20371777|NCT00975897|Irinotecan|irinotecan|mesh-list
20371778|NCT00975897|Calcium|calcium|mesh-list
20371779|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
20371780|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316348|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19316349|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316350|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316351|NCT04043520|Estradiol|estradiol|mesh-list
19316352|NCT04043520|Estrogens|estrogens|mesh-list
19316353|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19316354|NCT04043520|Hormones|hormones|mesh-ancestor
19316355|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316356|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316357|NCT04043806|Ivacaftor|ivacaftor|mesh-list
19316358|NCT04043806|Elexacaftor|elexacaftor|mesh-list
19316359|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19316360|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19316361|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316362|NCT04043702|Topiramate|topiramate|mesh-list
19316363|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
19316364|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19316365|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316366|NCT04043624|Lidocaine|lidocaine|mesh-list
19316367|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
19316368|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
19316369|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316370|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316371|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
19316372|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316373|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19316374|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19316375|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19316376|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19316377|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316378|NCT04043494|Cytarabine|cytarabine|mesh-list
19316379|NCT04043494|Dexamethasone|dexamethasone|mesh-list
19316380|NCT04043494|Prednisone|prednisone|mesh-list
19316381|NCT04043494|Prednisolone|prednisolone|mesh-list
19316382|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
20188429|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188430|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
20188431|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316383|NCT04043494|Ifosfamide|ifosfamide|mesh-list
19316384|NCT04043494|Doxorubicin|doxorubicin|mesh-list
19316385|NCT04043494|Methotrexate|methotrexate|mesh-list
19316386|NCT04043494|Vincristine|vincristine|mesh-list
19316387|NCT04043494|Daunorubicin|daunorubicin|mesh-list
19316388|NCT04043494|Asparaginase|asparaginase|mesh-list
19316389|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
20371781|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371782|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20371783|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19316390|NCT04043494|Thioguanine|thioguanine|mesh-list
19316391|NCT04043494|Pegaspargase|pegaspargase|mesh-list
19316392|NCT04043494|Vindesine|vindesine|mesh-list
19316393|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19316394|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
19404399|NCT03595163|Sevoflurane|sevoflurane|mesh-list
20188432|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
20188433|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20188434|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
20188435|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
20188436|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188437|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188438|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20188439|NCT00210158|Analgesics|analgesics|mesh-ancestor
20188440|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
19316395|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316396|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316397|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19316398|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
19316399|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316400|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316401|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19316402|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316403|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
19316404|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
19316405|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316406|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316407|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
19316408|NCT04043494|Hormones|hormones|mesh-ancestor
19316409|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316410|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19316411|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19316412|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19316413|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19316414|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316415|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19316416|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
19316417|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19316418|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19316419|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
19316420|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
19316421|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19316422|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19316423|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
19316424|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316425|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19316426|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
19316427|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
19316428|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
19316429|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
19316430|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316431|NCT04043325|Antibodies|antibodies|mesh-list
19316432|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
19316433|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316434|NCT04042948|Acetaminophen|acetaminophen|mesh-list
19316435|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19316436|NCT04042948|Analgesics|analgesics|mesh-ancestor
19316437|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
19316438|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316439|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316440|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
19316441|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
19316442|NCT04043195|Nivolumab|nivolumab|mesh-list
19316443|NCT04043195|Ipilimumab|ipilimumab|mesh-list
19316444|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316445|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371784|NCT00975897|Growth Substances|growth substances|mesh-ancestor
20371785|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371786|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
20371787|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20371788|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
20371789|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371790|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371791|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371792|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
20371793|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20371794|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20371795|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371796|NCT00975897|Antidotes|antidotes|mesh-ancestor
20371797|NCT00975897|Protective Agents|protective agents|mesh-ancestor
20371798|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
20371799|NCT00975897|Vitamins|vitamins|mesh-ancestor
20371800|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
20371801|NCT00975910|Lidocaine|lidocaine|mesh-list
20371802|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
20371803|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
20371804|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371805|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371806|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
19316446|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19673762|NCT03251729|Progesterone|progesterone|mesh-list
19316447|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316448|NCT04042974|Dinoprostone|dinoprostone|mesh-list
19316449|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
19316450|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19316451|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397571|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19397572|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
19397573|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397574|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397575|NCT03650023|Chitosan|chitosan|mesh-list
19397576|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19397577|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19397578|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
19397579|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397580|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19397581|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
19397582|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
19397583|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
19397584|NCT03650023|Coagulants|coagulants|mesh-ancestor
19397585|NCT03649945|Docetaxel|docetaxel|mesh-list
19397586|NCT03649945|Endostar protein|endostar protein|mesh-list
19397587|NCT03649945|Nedaplatin|nedaplatin|mesh-list
19397588|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397589|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
19397590|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
19397591|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
19397592|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397593|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19397594|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19397595|NCT03649945|Growth Substances|growth substances|mesh-ancestor
19397596|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397597|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
19397598|NCT03649763|Lidocaine|lidocaine|mesh-list
20188441|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188442|NCT00210210|Ketamine|ketamine|mesh-list
20188443|NCT00210210|Analgesics|analgesics|mesh-ancestor
20188444|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
20188445|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188446|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188447|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20188448|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20188449|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
20188450|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
19397599|NCT03649763|Bupivacaine|bupivacaine|mesh-list
19397600|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
19397601|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
20371807|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371808|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20371809|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20371810|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20371811|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371812|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371813|NCT00975936|Ketoconazole|ketoconazole|mesh-list
20371814|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
20371815|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371816|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19397602|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397603|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397604|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
19397605|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397606|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19397607|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19397608|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19397609|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397610|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397611|NCT03649724|Leuprolide|leuprolide|mesh-list
19397612|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19397613|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
19397614|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19397615|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397616|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19397617|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188451|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397618|NCT03649711|Aspirin|aspirin|mesh-list
19316452|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
19316453|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19316454|NCT04042805|Lenvatinib|lenvatinib|mesh-list
19316455|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316456|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19316457|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316458|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316459|NCT04042506|Nivolumab|nivolumab|mesh-list
19316460|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316461|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316462|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19316463|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371817|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20371818|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371819|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371820|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20371821|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
20371822|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371823|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371824|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20371825|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20371826|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20371827|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20371828|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371829|NCT00975988|Lapatinib|lapatinib|mesh-list
20371830|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371831|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20371832|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371833|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371834|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20371835|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
20371836|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371837|NCT00976066|Naltrexone|naltrexone|mesh-list
20371838|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20371839|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20371840|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371841|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
20371842|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371843|NCT00976092|Heparin|heparin|mesh-list
20371844|NCT00976092|Calcium heparin|calcium heparin|mesh-list
20371845|NCT00976092|Bivalirudin|bivalirudin|mesh-list
20371846|NCT00976092|Clopidogrel|clopidogrel|mesh-list
20371847|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20371848|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20371849|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20371850|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20371851|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20371852|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
20371853|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371854|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371855|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371856|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
20371857|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20371858|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20371859|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
20371860|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20371861|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
20371862|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316464|NCT04042441|Insulin|insulin|mesh-list
19316465|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
19316466|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19316467|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316468|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
19316469|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19316470|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19316471|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371863|NCT00976105|Zolpidem|zolpidem|mesh-list
20371864|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20371865|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20371866|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371867|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316472|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
19316473|NCT04042688|Coagulants|coagulants|mesh-ancestor
19316474|NCT04042558|Bevacizumab|bevacizumab|mesh-list
19316475|NCT04042558|Carboplatin|carboplatin|mesh-list
20371868|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20371869|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
20371870|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
20371871|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371872|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371873|NCT00976131|Ubiquinone|ubiquinone|mesh-list
20371874|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
20371875|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
20371876|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371877|NCT00976131|Vitamins|vitamins|mesh-ancestor
20371878|NCT00976170|Sorafenib|sorafenib|mesh-list
20371879|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371880|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20371881|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371882|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371883|NCT00976222|Ranibizumab|ranibizumab|mesh-list
20371884|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20371885|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20371886|NCT00976222|Growth Substances|growth substances|mesh-ancestor
20371887|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371888|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
20371889|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371890|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19316476|NCT04042558|Pemetrexed|pemetrexed|mesh-list
19316477|NCT04042558|Atezolizumab|atezolizumab|mesh-list
19316478|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19316479|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19316480|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316481|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19316482|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19316483|NCT04042558|Growth Substances|growth substances|mesh-ancestor
19316484|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316485|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
19316486|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316487|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316488|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19316489|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19316490|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
19316491|NCT04042714|Trifluridine|trifluridine|mesh-list
19316492|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
19316493|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316494|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
19316495|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316496|NCT04042233|Vancomycin|vancomycin|mesh-list
19316497|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316498|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316499|NCT04041934|Tryptophan|tryptophan|mesh-list
19316500|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19316501|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
20188452|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20371891|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20371892|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371893|NCT00976261|Incretins|incretins|mesh-ancestor
20371894|NCT00976261|Hormones|hormones|mesh-ancestor
20371895|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20371896|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20371897|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
20371898|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316502|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188453|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20188454|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188455|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217355|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20217356|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20217357|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20217358|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
20217359|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217360|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20371899|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316503|NCT04042051|Trastuzumab|trastuzumab|mesh-list
20371900|NCT00976300|Cyclosporine|cyclosporine|mesh-list
19316504|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19316505|NCT04042051|Maytansine|maytansine|mesh-list
19316506|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20188456|NCT00210301|Modafinil|modafinil|mesh-list
20188457|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20188458|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316507|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316508|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19316509|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
19316510|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
19316511|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
19316512|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316513|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
19316514|NCT04042220|Hormones|hormones|mesh-ancestor
19316515|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316516|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316517|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
19316518|NCT04041856|Povidone|povidone|mesh-list
19316519|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
19316520|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
19316521|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19316522|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316523|NCT04042142|Glucagon|glucagon|mesh-list
19316524|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316525|NCT04042142|Hormones|hormones|mesh-ancestor
19316526|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316527|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316528|NCT04041843|Apixaban|apixaban|mesh-list
19316529|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19316530|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
19316531|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19316532|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
19316533|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316534|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316535|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
19316536|NCT04041492|Vitamin D|vitamin d|mesh-list
19316537|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
19316538|NCT04041492|Vitamins|vitamins|mesh-ancestor
19316539|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
19316540|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316541|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19316542|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19316543|NCT04041791|Amoxicillin|amoxicillin|mesh-list
19316544|NCT04041791|Gentamicins|gentamicins|mesh-list
19316545|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
19316546|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
19316547|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
19316548|NCT04041791|Penicillins|penicillins|mesh-list
19316549|NCT04041791|Ampicillin|ampicillin|mesh-list
19316550|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19316551|NCT04041791|Penicillin G|penicillin g|mesh-list
19316552|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19316553|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
19316554|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316555|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316556|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19316557|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316558|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316559|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19316560|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19316561|NCT04041362|UB-421|ub-421|mesh-list
19316562|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
19316563|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316564|NCT04041349|Mitogens|mitogens|mesh-list
19316565|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
19316566|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316567|NCT04041427|Albendazole|albendazole|mesh-list
19316568|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
19316569|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19316570|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316571|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
19316572|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19316573|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20188459|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20188460|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20188461|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20188462|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188463|NCT00210314|Cytarabine|cytarabine|mesh-list
20188464|NCT00210314|Methotrexate|methotrexate|mesh-list
20371901|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
20371902|NCT00976300|Cyclosporins|cyclosporins|mesh-list
20371903|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19316574|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
19316575|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
19316576|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
19316577|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316578|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316579|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
19316580|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
19316581|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316582|NCT04041167|Protective Agents|protective agents|mesh-ancestor
19316583|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316584|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
19316585|NCT04041167|Vitamins|vitamins|mesh-ancestor
19316586|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
19316587|NCT04041128|Olaparib|olaparib|mesh-list
19316588|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19316589|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316590|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316591|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316592|NCT04041648|Treprostinil|treprostinil|mesh-list
19316593|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19316594|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19397619|NCT03649711|Clopidogrel|clopidogrel|mesh-list
19397620|NCT03649711|Ticagrelor|ticagrelor|mesh-list
19397621|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397622|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397623|NCT03649711|Analgesics|analgesics|mesh-ancestor
19397624|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
19397625|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397626|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397627|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371904|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
20371905|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371906|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20371907|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20371908|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
19397628|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397629|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19397630|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19397631|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397632|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19397633|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19397634|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397635|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
19397636|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19397637|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19397638|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19397639|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
19397640|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397641|NCT03649659|Fluorides|fluorides|mesh-list
19397642|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
19397643|NCT03649659|Protective Agents|protective agents|mesh-ancestor
19397644|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397645|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
19397646|NCT03649334|Ketorolac|ketorolac|mesh-list
19397647|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19397648|NCT03649334|Fentanyl|fentanyl|mesh-list
19397649|NCT03649334|Ketamine|ketamine|mesh-list
19397650|NCT03649334|Analgesics|analgesics|mesh-ancestor
19397651|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
19397652|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397653|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397654|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19397655|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19397656|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
19397657|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
19397658|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397659|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19397660|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19397661|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673763|NCT03251729|Progestins|progestins|mesh-ancestor
19673764|NCT03251729|Hormones|hormones|mesh-ancestor
19397662|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428580|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188465|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20188466|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
20188467|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20188468|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188469|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188470|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
20188471|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371909|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371910|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371911|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20371912|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371913|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
20371914|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371915|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
20371916|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20371917|NCT00976326|Insulin|insulin|mesh-list
20371918|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20371919|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371920|NCT00976469|Vaccines|vaccines|mesh-list
20371921|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
20371922|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371923|NCT00976651|Menotropins|menotropins|mesh-list
20371924|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20371925|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
20371926|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20371927|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371928|NCT00976690|Mesalamine|mesalamine|mesh-list
20371929|NCT00976690|Azathioprine|azathioprine|mesh-list
20371930|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
20371931|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371932|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371933|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316595|NCT04040491|Gemcitabine|gemcitabine|mesh-list
19316596|NCT04040491|Lenalidomide|lenalidomide|mesh-list
19316597|NCT04040491|Antibodies|antibodies|mesh-list
19316598|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
19316599|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
19316600|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316601|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19316602|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
19316603|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316604|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316605|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
19673765|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673766|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673767|NCT03206073|Durvalumab|durvalumab|mesh-list
19673768|NCT03206073|Tremelimumab|tremelimumab|mesh-list
19673769|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673770|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673771|NCT03186404|Atorvastatin|atorvastatin|mesh-list
19673772|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19673773|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19673774|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
19673775|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188472|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188473|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
20188474|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188475|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19673776|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19673777|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19673778|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673779|NCT03098836|Prednisone|prednisone|mesh-list
19673780|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
19673781|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673782|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
20188476|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188477|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
20188478|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20188479|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20188480|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
20188481|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673783|NCT03098836|Hormones|hormones|mesh-ancestor
20188482|NCT00210327|Bortezomib|bortezomib|mesh-list
20371934|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19316606|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20371935|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
20371936|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371937|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20371938|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20371939|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20371940|NCT00976690|Analgesics|analgesics|mesh-ancestor
20371941|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
20371942|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371943|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20371944|NCT00976755|Everolimus|everolimus|mesh-list
20371945|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371946|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371947|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
20371948|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371949|NCT00976768|Fluorouracil|fluorouracil|mesh-list
19673784|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673785|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673786|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19673787|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673788|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19673789|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673790|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673791|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
19316607|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316608|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19316609|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19316610|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19316611|NCT04040491|Growth Substances|growth substances|mesh-ancestor
19316612|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
19316613|NCT04040322|Iloprost|iloprost|mesh-list
19316614|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19316615|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
19316616|NCT04040465|Aspirin|aspirin|mesh-list
19673792|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19673793|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
19673794|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20371950|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
20371951|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
19316617|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19316618|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19316619|NCT04040465|Analgesics|analgesics|mesh-ancestor
19316620|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
19316621|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316622|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316623|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316624|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316625|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19316626|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19316627|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316628|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19316629|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19316630|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316631|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
19316632|NCT04040452|Ketorolac|ketorolac|mesh-list
19316633|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19316634|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19316635|NCT04040452|Analgesics|analgesics|mesh-ancestor
19316636|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
19316637|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316638|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316639|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316640|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316641|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19316642|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316643|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371952|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371953|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371954|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20371955|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371956|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
20371957|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673795|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428758|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19316644|NCT04040309|Lidocaine|lidocaine|mesh-list
19316645|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
19316646|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
19316647|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316648|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316649|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
19316650|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316651|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19316652|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19316653|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19316654|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19316655|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316656|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19316657|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
19316658|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
19316659|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316660|NCT04039854|Propofol|propofol|mesh-list
19316661|NCT04039854|Sevoflurane|sevoflurane|mesh-list
19316662|NCT04039854|Desflurane|desflurane|mesh-list
19316663|NCT04039854|Isoflurane|isoflurane|mesh-list
19316664|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19316665|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316666|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316667|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19316668|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
19316669|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
19316670|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19316671|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20188483|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188484|NCT00210340|Rituximab|rituximab|mesh-list
20188485|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20188486|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188487|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
19316672|NCT04039828|Zinc|zinc|mesh-list
19316673|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
20188488|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188489|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20188490|NCT00210366|Idarubicin|idarubicin|mesh-list
20188491|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20188492|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188493|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20188494|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20188495|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188496|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188497|NCT00210379|Rituximab|rituximab|mesh-list
20188498|NCT00210379|Methotrexate|methotrexate|mesh-list
20188499|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20188500|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188501|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
20188502|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188503|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20188504|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20188505|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
20188506|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20188507|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20188508|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
20188509|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188510|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
20188511|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188512|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20188513|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20188514|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20188515|NCT00210392|Bortezomib|bortezomib|mesh-list
20188516|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188517|NCT00210405|Micronutrients|micronutrients|mesh-list
20188518|NCT00210405|Trace Elements|trace elements|mesh-list
20188519|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188520|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
20188521|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20188522|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20188523|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19316674|NCT04039828|Trace Elements|trace elements|mesh-ancestor
20188524|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19316675|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
19316676|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316677|NCT04039828|Astringents|astringents|mesh-ancestor
20371958|NCT00976794|Carbamazepine|carbamazepine|mesh-list
20371959|NCT00976794|Valproic Acid|valproic acid|mesh-list
20371960|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
20371961|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
20371962|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20371963|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20371964|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371965|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
20371966|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20371967|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371968|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20371969|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
20371970|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
20371971|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20371972|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20371973|NCT00976794|Analgesics|analgesics|mesh-ancestor
20371974|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
20371975|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20371976|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20371977|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20371978|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20371979|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20371980|NCT00976963|Fosfomycin|fosfomycin|mesh-list
20371981|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20371982|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316678|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
19316679|NCT04039880|Olorofim|olorofim|mesh-list
20371983|NCT00976976|Cisplatin|cisplatin|mesh-list
20371984|NCT00976976|Docetaxel|docetaxel|mesh-list
20371985|NCT00976976|Capecitabine|capecitabine|mesh-list
20371986|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316680|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
19316681|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316682|NCT04040023|Vitamins|vitamins|mesh-list
19316683|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
19316684|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316685|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
19316686|NCT04039815|Thiamine|thiamine|mesh-list
19316687|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
19316688|NCT04039815|Vitamins|vitamins|mesh-ancestor
19316689|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
19316690|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316691|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316692|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
19316693|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
19316694|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316695|NCT04039815|Protective Agents|protective agents|mesh-ancestor
19316696|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
19316697|NCT04039698|Velpatasvir|velpatasvir|mesh-list
19316698|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
19316699|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316700|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19316701|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
19316702|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316703|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
19316704|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19316705|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316706|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19316707|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
19316708|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316709|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316710|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316711|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316712|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19316713|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19316714|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316715|NCT04039126|Iodine|iodine|mesh-list
19316716|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
19316717|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
19316718|NCT04039126|Tetracycline|tetracycline|mesh-list
19316719|NCT04039126|Povidone|povidone|mesh-list
19316720|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19316721|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316722|NCT04039126|Trace Elements|trace elements|mesh-ancestor
19316723|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
19397663|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20371987|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
20371988|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
19316724|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316725|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
19316726|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
19316727|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316728|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19316729|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316730|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316731|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
19316732|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
19316733|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19316734|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19316735|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316736|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316737|NCT04039087|Urological Agents|urological agents|mesh-ancestor
19316738|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19316739|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316740|NCT04038970|Methotrexate|methotrexate|mesh-list
19316741|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19316742|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
19316743|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19316744|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316745|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19316746|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
19316747|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316748|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316749|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
19316750|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316751|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19316752|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20371989|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
20371990|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20371991|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20371992|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
20371993|NCT00977028|Lidocaine|lidocaine|mesh-list
20371994|NCT00977028|Epinephrine|epinephrine|mesh-list
20371995|NCT00977028|Racepinephrine|racepinephrine|mesh-list
20371996|NCT00977028|Anesthetics|anesthetics|mesh-list
19316753|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
19316754|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316755|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19316756|NCT04038853|Vitamin D|vitamin d|mesh-list
19316757|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
19316758|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19316759|NCT04038853|Vitamins|vitamins|mesh-ancestor
19316760|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
19316761|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316762|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19316763|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19397664|NCT03649334|Narcotics|narcotics|mesh-ancestor
19397665|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19397666|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397667|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397668|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397669|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397670|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19397671|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397672|NCT03649269|Bezafibrate|bezafibrate|mesh-list
19397673|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19397674|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
19397675|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397676|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19397677|NCT03649243|Propolis|propolis|mesh-list
19397678|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397679|NCT03649230|Palonosetron|palonosetron|mesh-list
20188525|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188526|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
20188527|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188528|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188529|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20188530|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188531|NCT00210457|Lanreotide|lanreotide|mesh-list
20188532|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188533|NCT00210483|Almotriptan|almotriptan|mesh-list
20188534|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20371997|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
19316764|NCT04038749|Cabergoline|cabergoline|mesh-list
19316765|NCT04038749|Bromocriptine|bromocriptine|mesh-list
19316766|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19316767|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19316768|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
19316769|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
19316770|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316771|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316772|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316773|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
19316774|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316775|NCT04038411|Etoposide|etoposide|mesh-list
19316776|NCT04038411|Lenalidomide|lenalidomide|mesh-list
19316777|NCT04038411|Antibodies|antibodies|mesh-list
19316778|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
19316779|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316780|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19316781|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316782|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19316783|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19316784|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316785|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316786|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19316787|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19316788|NCT04038411|Growth Substances|growth substances|mesh-ancestor
19316789|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
19316790|NCT04038437|Venetoclax|venetoclax|mesh-list
19316791|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316792|NCT04038619|Loperamide|loperamide|mesh-list
19316793|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
19316794|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316795|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
19316796|NCT04038320|Ledipasvir|ledipasvir|mesh-list
19316797|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
19316798|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316799|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
19316800|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19316801|NCT04038671|Charcoal|charcoal|mesh-list
19316802|NCT04038671|Antidotes|antidotes|mesh-ancestor
19316803|NCT04038671|Protective Agents|protective agents|mesh-ancestor
19316804|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316805|NCT04038307|Acetaminophen|acetaminophen|mesh-list
19316806|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19316807|NCT04038307|Analgesics|analgesics|mesh-ancestor
19316808|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
19316809|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316810|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316811|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
19316812|NCT04038008|Fluconazole|fluconazole|mesh-list
19316813|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
19316814|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316815|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19316816|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19316817|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316818|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316819|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19316820|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
20188535|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
20188536|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188537|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188538|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188539|NCT00210496|Topiramate|topiramate|mesh-list
20188540|NCT00210496|Almotriptan|almotriptan|mesh-list
20188541|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
20188542|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188543|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188544|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20188545|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
20188546|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188547|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188548|NCT00210509|Almotriptan|almotriptan|mesh-list
20188549|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19316821|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20188550|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
19316822|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316823|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19316824|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19316825|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
19316826|NCT04038034|Vitamins|vitamins|mesh-ancestor
19316827|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
19316828|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316829|NCT04037878|Tramadol|tramadol|mesh-list
19316830|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19316831|NCT04037878|Narcotics|narcotics|mesh-ancestor
19316832|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20371998|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
20371999|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372000|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372001|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
20372002|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372003|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20372004|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20372005|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20372006|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20372007|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372008|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20372009|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20372010|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
20372011|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316833|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316834|NCT04037878|Analgesics|analgesics|mesh-ancestor
19316835|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
19316836|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316837|NCT04038125|Dexamethasone|dexamethasone|mesh-list
19316838|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316839|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
19316840|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
19316841|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316842|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673796|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19673797|NCT03076164|Trametinib|trametinib|mesh-list
20372012|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20372013|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20372014|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
20372015|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20372016|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
19316843|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19316844|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
19316845|NCT04038125|Hormones|hormones|mesh-ancestor
19316846|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316847|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20372017|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
20372018|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
20372019|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20372020|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20372021|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
20372022|NCT00977054|Ribavirin|ribavirin|mesh-list
20372023|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
20372024|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19316848|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316849|NCT04038073|Antibodies|antibodies|mesh-list
19316850|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
19316851|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
19316852|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316853|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
19316854|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19316855|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316856|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316857|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19316858|NCT04037774|Analgesics|analgesics|mesh-ancestor
19316859|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
19316860|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316861|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19316862|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19316863|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19316864|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673798|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673799|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673800|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673801|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673802|NCT03073070|Biotin|biotin|mesh-list
19673803|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
19316865|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316866|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316867|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
19316868|NCT04037566|Fludarabine|fludarabine|mesh-list
20372025|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
20372026|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372027|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
19316869|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19316870|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
19316871|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316872|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316873|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19316874|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
19316875|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316876|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316877|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19316878|NCT04037657|Propofol|propofol|mesh-list
19316879|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19316880|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316881|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316882|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19316883|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
19316884|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
19316885|NCT04037176|Omalizumab|omalizumab|mesh-list
19316886|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19316887|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19316888|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19316889|NCT04037514|Acetaminophen|acetaminophen|mesh-list
19316890|NCT04037514|Ibuprofen|ibuprofen|mesh-list
19316891|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19316892|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19316893|NCT04037514|Analgesics|analgesics|mesh-ancestor
19316894|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
19316895|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316896|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188551|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188552|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188553|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188554|NCT00210535|Topiramate|topiramate|mesh-list
20188555|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
20188556|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188557|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188558|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20188559|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20188560|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188561|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188562|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188563|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188564|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20188565|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20188566|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
20188567|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188568|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188569|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20188570|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20188571|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
20188572|NCT00210561|Acetaminophen|acetaminophen|mesh-list
20188573|NCT00210561|Tramadol|tramadol|mesh-list
20188574|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20188575|NCT00210561|Analgesics|analgesics|mesh-ancestor
20188576|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
20188577|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188578|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188579|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
20188580|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20188581|NCT00210561|Narcotics|narcotics|mesh-ancestor
20188582|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188583|NCT00210574|Topiramate|topiramate|mesh-list
20188584|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
20188585|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188586|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188587|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
19316897|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20188588|NCT00210587|Hematinics|hematinics|mesh-ancestor
20188589|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
20188590|NCT00210600|Hematinics|hematinics|mesh-ancestor
20188591|NCT00210665|Trabectedin|trabectedin|mesh-list
20188592|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20188593|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
19316898|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19316899|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19316900|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316901|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316902|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
19316903|NCT04037085|Ketamine|ketamine|mesh-list
19316904|NCT04037085|Analgesics|analgesics|mesh-ancestor
19316905|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
19316906|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316907|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316908|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19316909|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19316910|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
19316911|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
19316912|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316913|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19316914|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19316915|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316916|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397680|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
19397681|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
19397682|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397683|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397684|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372028|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372029|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
20372030|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372031|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372032|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
20372033|NCT00977093|Antidotes|antidotes|mesh-ancestor
20372034|NCT00977093|Protective Agents|protective agents|mesh-ancestor
20372035|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372036|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
20372037|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
20372038|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372039|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20372040|NCT00977132|Lenalidomide|lenalidomide|mesh-list
20372041|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
20372042|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372043|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20372044|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20372045|NCT00977132|Growth Substances|growth substances|mesh-ancestor
20372046|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
20372047|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372048|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
20372049|NCT00977145|Vaccines|vaccines|mesh-list
20372050|NCT00977145|Immunologic Factors|immunologic factors|mesh-ancestor
19397685|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19397686|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19397687|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
19397688|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397689|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397690|NCT03649165|Acetaminophen|acetaminophen|mesh-list
19673804|NCT03073070|Vitamins|vitamins|mesh-ancestor
19673805|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
19673806|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673807|NCT03063944|Azacitidine|azacitidine|mesh-list
19673808|NCT03063944|Decitabine|decitabine|mesh-list
20188594|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188595|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188596|NCT00210691|Risperidone|risperidone|mesh-list
20188597|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20188598|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
20188599|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188600|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188601|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188602|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20188603|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188604|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188605|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188606|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19673809|NCT03063944|Venetoclax|venetoclax|mesh-list
19673810|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19673811|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
19673812|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673813|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316917|NCT04036721|Prednisone|prednisone|mesh-list
19316918|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19316919|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
20372051|NCT00977145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372052|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
20372053|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372054|NCT00977223|Aprepitant|aprepitant|mesh-list
20372055|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
20372056|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
20372057|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
20372058|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372059|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372060|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372061|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20372062|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372063|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316920|NCT04036721|Hormones|hormones|mesh-ancestor
19316921|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316922|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316923|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19316924|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316925|NCT04036890|Minocycline|minocycline|mesh-list
19316926|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19316927|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19316928|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
19316929|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19316930|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19316931|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19316932|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19316933|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316934|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
19316935|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19316936|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316937|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19316938|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316939|NCT04036487|Propofol|propofol|mesh-list
19316940|NCT04036487|Desflurane|desflurane|mesh-list
19316941|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19316942|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316943|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316944|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19316945|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
19316946|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
19316947|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19316948|NCT04036500|Estradiol|estradiol|mesh-list
19316949|NCT04036500|Estrogens|estrogens|mesh-ancestor
19316950|NCT04036500|Hormones|hormones|mesh-ancestor
19316951|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19316952|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316953|NCT04036448|Lenalidomide|lenalidomide|mesh-list
19316954|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
19316955|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316956|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19316957|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19316958|NCT04036448|Growth Substances|growth substances|mesh-ancestor
19316959|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
19316960|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19316961|NCT04036526|Vaccines|vaccines|mesh-list
19316962|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
20372064|NCT00977249|Varenicline|varenicline|mesh-list
20372065|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20372066|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20372067|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
20372068|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372069|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372070|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673814|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673815|NCT03060577|Evolocumab|evolocumab|mesh-list
20372071|NCT00977288|Atorvastatin|atorvastatin|mesh-list
20372072|NCT00977288|Anacetrapib|anacetrapib|mesh-list
19316963|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372073|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20372074|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20372075|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
20372076|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372077|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20372078|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20372079|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19316964|NCT04036305|Lidocaine|lidocaine|mesh-list
19316965|NCT04036305|Bupivacaine|bupivacaine|mesh-list
19316966|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
19316967|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
19316968|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316969|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316970|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
19316971|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316972|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19316973|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19316974|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19316975|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19316976|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19316977|NCT04036201|Bupivacaine|bupivacaine|mesh-list
19316978|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
19316979|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
19316980|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
19316981|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316982|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316983|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
19316984|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19316985|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19316986|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
19316987|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
19316988|NCT04036201|Protective Agents|protective agents|mesh-ancestor
19316989|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
19316990|NCT04036253|Hematinics|hematinics|mesh-ancestor
19316991|NCT04035850|Vortioxetine|vortioxetine|mesh-list
19316992|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
19316993|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19316994|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19316995|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19316996|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19316997|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19316998|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19316999|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19317000|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19317001|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317002|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317003|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
19317004|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19317005|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19317006|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19317007|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19317008|NCT04035876|Apatinib|apatinib|mesh-list
19317009|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317010|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19317011|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317012|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317013|NCT04035889|Melatonin|melatonin|mesh-list
19317014|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
19317015|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317016|NCT04035889|Protective Agents|protective agents|mesh-ancestor
19317017|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317018|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317019|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19317020|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317021|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19317022|NCT04035798|Memantine|memantine|mesh-list
19317023|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19317024|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19317025|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
19317026|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317027|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317028|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372080|NCT00977301|Ritonavir|ritonavir|mesh-list
19317029|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19317030|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19317031|NCT04035707|Rocuronium|rocuronium|mesh-list
19317032|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317033|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19317034|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19317035|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19317036|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317037|NCT04035603|Cycloserine|cycloserine|mesh-list
19317038|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19317039|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317040|NCT04035603|Renal Agents|renal agents|mesh-ancestor
19317041|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19317042|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
19317043|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19317044|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
19317045|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372081|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
20372082|NCT00977301|Olanzapine|olanzapine|mesh-list
20372083|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20372084|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20372085|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
20372086|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372087|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372088|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20372089|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20372090|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
20372091|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372092|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20372093|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20372094|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
20372095|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
20372096|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372097|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372098|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372099|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20372100|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20372101|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372102|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20372103|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20372104|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20372105|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20372106|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372107|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
20372108|NCT00977353|Citalopram|citalopram|mesh-list
19317046|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
19317047|NCT04035525|Ubiquinone|ubiquinone|mesh-list
19317048|NCT04035525|Vitamins|vitamins|mesh-ancestor
19317049|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
19317050|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317051|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
19317052|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19317053|NCT04035135|Antibodies|antibodies|mesh-list
19317054|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
19317055|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19317056|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
19317057|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840708|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19840709|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19840710|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840711|NCT00635349|Acetaminophen|acetaminophen|mesh-list
19840712|NCT00635349|Meloxicam|meloxicam|mesh-list
19840713|NCT00635349|Aceclofenac|aceclofenac|mesh-list
19840714|NCT00635349|Tramadol|tramadol|mesh-list
19840715|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19840716|NCT00635349|Analgesics|analgesics|mesh-ancestor
19840717|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
19840718|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840719|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840720|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
20372109|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20372110|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19840721|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20372111|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19840722|NCT00635349|Narcotics|narcotics|mesh-ancestor
19840723|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188607|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
20188608|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20188609|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20372112|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372113|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372114|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
20372115|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372116|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19317072|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
19317073|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19317074|NCT04035330|Eusol|eusol|mesh-list
19317075|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
19317076|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317077|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19317078|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317079|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
19317080|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
19317081|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317082|NCT04035096|Protective Agents|protective agents|mesh-ancestor
19317083|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317084|NCT04035096|Vitamins|vitamins|mesh-ancestor
19317085|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
19317086|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19317087|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317088|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
19317089|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
19317090|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673816|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19673817|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19673818|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
19673819|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673820|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19673821|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
19673822|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
19673823|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19673824|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19840724|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20188610|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19317091|NCT04034823|Docetaxel|docetaxel|mesh-list
19317092|NCT04034823|Trastuzumab|trastuzumab|mesh-list
19317093|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317094|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
19317095|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
19317096|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
19317097|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317098|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317099|NCT04035070|Clindamycin|clindamycin|mesh-list
19317100|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
19317101|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
19317102|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19317103|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19317104|NCT04035070|Eusol|eusol|mesh-list
19317105|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19317106|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317107|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20188611|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188612|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188613|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188614|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20188615|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20188616|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
20188617|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188618|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188619|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20188620|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20188621|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
20188622|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
20188623|NCT00210730|Hematinics|hematinics|mesh-ancestor
20188624|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
20372117|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
20372118|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19317108|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840725|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840726|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840727|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20188625|NCT00210743|Hematinics|hematinics|mesh-ancestor
20188626|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
20188627|NCT00210756|Hematinics|hematinics|mesh-ancestor
20188628|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20188629|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20188630|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188631|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317109|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317110|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
19317111|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19397691|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397692|NCT03649165|Analgesics|analgesics|mesh-ancestor
19397693|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
19397694|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397695|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397696|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
19397697|NCT03649152|Proxigermanium|proxigermanium|mesh-list
19397698|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397699|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
19397700|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
19397701|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397702|NCT03649048|Cisplatin|cisplatin|mesh-list
19397703|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397704|NCT03649009|Thiamine|thiamine|mesh-list
19397705|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
19397706|NCT03649009|Metoclopramide|metoclopramide|mesh-list
19397707|NCT03649009|Vitamins|vitamins|mesh-ancestor
19397708|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
19397709|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397710|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397711|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
19397712|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
19397713|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
19397714|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397715|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19397716|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19397717|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19397718|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
19397719|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397720|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397721|NCT03648996|Allopurinol|allopurinol|mesh-list
19397722|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
19397723|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397724|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397725|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
19397726|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397727|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19397728|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
19397729|NCT03648996|Protective Agents|protective agents|mesh-ancestor
19397730|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397731|NCT03648970|Pravastatin|pravastatin|mesh-list
19397732|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19397733|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19397734|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
19397735|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397736|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19397737|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19397738|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372119|NCT00977405|Gentamicins|gentamicins|mesh-list
20372120|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20372121|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372122|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20372123|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372124|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397739|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
19397740|NCT03648697|Fludarabine|fludarabine|mesh-list
19397741|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397742|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
19397743|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397744|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20188632|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188633|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188634|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20188635|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20188636|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
20188637|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188638|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372125|NCT00977444|Prednisolone|prednisolone|mesh-list
20372126|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20372127|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
20372128|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20372129|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
20372130|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20372131|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
20372132|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372133|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
20372134|NCT00977444|Hormones|hormones|mesh-ancestor
20372135|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372136|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372137|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20372138|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372139|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
20372140|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
20372141|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372142|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372143|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20372144|NCT00977444|Protective Agents|protective agents|mesh-ancestor
20372145|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19317112|NCT04034771|Propofol|propofol|mesh-list
19317113|NCT04034771|Melatonin|melatonin|mesh-list
19317114|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317115|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317116|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317117|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317118|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
19317119|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
19317120|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
20372146|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372147|NCT00977756|Ritonavir|ritonavir|mesh-list
20372148|NCT00977756|Lopinavir|lopinavir|mesh-list
20372149|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20372150|NCT00977756|Darunavir|darunavir|mesh-list
20372151|NCT00977756|Tenofovir|tenofovir|mesh-list
20372152|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
20372153|NCT00977756|Maraviroc|maraviroc|mesh-list
20372154|NCT00977756|Etravirine|etravirine|mesh-list
20372155|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20372156|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20372157|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
20372158|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372159|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317121|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317122|NCT04034771|Protective Agents|protective agents|mesh-ancestor
19317123|NCT04034836|Parecoxib|parecoxib|mesh-list
19317124|NCT04034836|Ropivacaine|ropivacaine|mesh-list
19317125|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
19317126|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
19317127|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317128|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372160|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20372161|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19317129|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
19317130|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317131|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19317132|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19317133|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317134|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317135|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19317136|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317137|NCT04034836|Analgesics|analgesics|mesh-ancestor
19317138|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317139|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317140|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
19317141|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19317142|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317143|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19317144|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317145|NCT04034524|Insulin|insulin|mesh-list
19317146|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19317147|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372162|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
20372163|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372164|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20372165|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20372166|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20372167|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20372168|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19317148|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317149|NCT04034589|Fulvestrant|fulvestrant|mesh-list
19317150|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19317151|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317152|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19317153|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19317154|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
19317155|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19317156|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317157|NCT04034485|Evolocumab|evolocumab|mesh-list
20372169|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19317158|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19673825|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673826|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673827|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673828|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673829|NCT02939742|Betamethasone|betamethasone|mesh-list
19673830|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673831|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
19673832|NCT02939742|Hormones|hormones|mesh-ancestor
19673833|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673834|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188639|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19317159|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19317160|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
19317161|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317162|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19317163|NCT04034368|Tenofovir|tenofovir|mesh-list
19317164|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
19317165|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317166|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19317167|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19317168|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317169|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317170|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19317171|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19317172|NCT04034173|Leucovorin|leucovorin|mesh-list
19317173|NCT04034173|Folic Acid|folic acid|mesh-list
19317174|NCT04034173|Irinotecan|irinotecan|mesh-list
19317175|NCT04034173|Panitumumab|panitumumab|mesh-list
19317176|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
19317177|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19317178|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19317179|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317180|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317181|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317182|NCT04034173|Antidotes|antidotes|mesh-ancestor
19317183|NCT04034173|Protective Agents|protective agents|mesh-ancestor
19317184|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317185|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
19317186|NCT04034173|Vitamins|vitamins|mesh-ancestor
19317187|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
19317188|NCT04034173|Hematinics|hematinics|mesh-ancestor
19317189|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317190|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
19317191|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317192|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317193|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
20188640|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20188641|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
20188642|NCT00210782|Topiramate|topiramate|mesh-list
20188643|NCT00210782|Phenytoin|phenytoin|mesh-list
20188644|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
20188645|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188646|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188647|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20188648|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20188649|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20188650|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188651|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19317194|NCT04034199|Denosumab|denosumab|mesh-list
19317195|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19317196|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317197|NCT04033939|Propofol|propofol|mesh-list
19317198|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317199|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317200|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317201|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317202|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
19317203|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
19317204|NCT04033575|Listerine|listerine|mesh-list
19317205|NCT04033575|Fluorides|fluorides|mesh-list
19673835|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19673836|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
19673837|NCT02905214|Sirolimus|sirolimus|mesh-list
20372170|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20372171|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20372172|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20372173|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20372174|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20372175|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
20372176|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
19317206|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
19317207|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
19317208|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
19317209|NCT04033575|Protective Agents|protective agents|mesh-ancestor
19317210|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317211|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20372177|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20372178|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372179|NCT00977873|Vitamins|vitamins|mesh-ancestor
20372180|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
20372181|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20372182|NCT00977964|Caseins|caseins|mesh-list
20372183|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
20372184|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
20372185|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372186|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19317212|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317213|NCT04033562|Lidocaine|lidocaine|mesh-list
19317214|NCT04033562|Bupivacaine|bupivacaine|mesh-list
19317215|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
19317216|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
19317217|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317218|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317219|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
19317220|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317221|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19317222|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19317223|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19317224|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19317225|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317226|NCT04033471|Midazolam|midazolam|mesh-list
19317227|NCT04033471|Morphine|morphine|mesh-list
19317228|NCT04033471|Bupivacaine|bupivacaine|mesh-list
19317229|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
19317230|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
20372187|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20372188|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
20372189|NCT00978107|Flucytosine|flucytosine|mesh-list
20372190|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
20372191|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372192|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
20372193|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372194|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
20372195|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372196|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
20372197|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372198|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372199|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19317231|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317232|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317233|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
19317234|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317235|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19317236|NCT04033471|Narcotics|narcotics|mesh-ancestor
19317237|NCT04033471|Analgesics|analgesics|mesh-ancestor
20372200|NCT00978159|Esomeprazole|esomeprazole|mesh-list
19317238|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19317239|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317240|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19317241|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19317242|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19317243|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317244|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
19317245|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
19317246|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
19317247|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317248|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317249|NCT04033250|Bisacodyl|bisacodyl|mesh-list
19317250|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
19317251|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
19317252|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
19317253|NCT04033250|Citric Acid|citric acid|mesh-list
19317254|NCT04033250|Cathartics|cathartics|mesh-ancestor
19317255|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317256|NCT04033250|Laxatives|laxatives|mesh-ancestor
19317257|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
19317258|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19317259|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
19317260|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
19317261|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317262|NCT04033250|Antacids|antacids|mesh-ancestor
19317263|NCT04033172|Fulvestrant|fulvestrant|mesh-list
19317264|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19317265|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317266|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19317267|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19317268|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
19317269|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19317270|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317271|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19317272|NCT04033029|Tazobactam|tazobactam|mesh-list
19317273|NCT04033029|Piperacillin|piperacillin|mesh-list
19317274|NCT04033029|Daptomycin|daptomycin|mesh-list
19317275|NCT04033029|Ceftazidime|ceftazidime|mesh-list
19317276|NCT04033029|Cefepime|cefepime|mesh-list
19317277|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19317278|NCT04033029|Ceftolozane|ceftolozane|mesh-list
19317279|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317280|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19317281|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317282|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317283|NCT04033055|Ropivacaine|ropivacaine|mesh-list
19317284|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
19317285|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
19317286|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317287|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317288|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
19317289|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317290|NCT04033094|Morphine|morphine|mesh-list
19317291|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19317292|NCT04033094|Narcotics|narcotics|mesh-ancestor
19317293|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317294|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317295|NCT04033094|Analgesics|analgesics|mesh-ancestor
19317296|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
19317297|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317298|NCT04033276|Rituximab|rituximab|mesh-list
19317299|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
19317300|NCT04033276|Antibodies|antibodies|mesh-list
20188652|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20188653|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
20188654|NCT00210795|Hematinics|hematinics|mesh-ancestor
20188655|NCT00210808|Topiramate|topiramate|mesh-list
20188656|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
20188657|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188658|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188659|NCT00210821|Topiramate|topiramate|mesh-list
20188660|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
20188661|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188662|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317301|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
19317302|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19317303|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19317304|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317305|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317306|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
19317307|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317308|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317309|NCT04032691|Clonidine|clonidine|mesh-list
19317310|NCT04032691|Analgesics|analgesics|mesh-ancestor
19317311|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
19317312|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317313|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317314|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19317315|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
19317316|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
19317317|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19317318|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19317319|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19317320|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
19317321|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317322|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397745|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19397746|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
19397747|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397748|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397749|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19397750|NCT03648684|Caffeine|caffeine|mesh-list
19397751|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19397752|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397753|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19397754|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397755|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397756|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19397757|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19397758|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
19397759|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397760|NCT03648671|Rasagiline|rasagiline|mesh-list
19397761|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19397762|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397763|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397764|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19673838|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19673839|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673840|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19673841|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397765|NCT03648671|Protective Agents|protective agents|mesh-ancestor
19397766|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397767|NCT03648658|Acetaminophen|acetaminophen|mesh-list
19397768|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397769|NCT03648658|Analgesics|analgesics|mesh-ancestor
19397770|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
19397771|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397772|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397773|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
19397774|NCT03648554|Dulaglutide|dulaglutide|mesh-list
19397775|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19397776|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404400|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19404401|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404402|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404403|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404404|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
19404405|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
19404406|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19404407|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19404408|NCT03595163|Hematinics|hematinics|mesh-ancestor
19404409|NCT03595163|Vitamins|vitamins|mesh-ancestor
19404410|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
19404411|NCT03595085|Streptokinase|streptokinase|mesh-list
19404412|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19404413|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19404414|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404415|NCT03595046|Dexamethasone|dexamethasone|mesh-list
19404416|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
19404417|NCT03595046|Ropivacaine|ropivacaine|mesh-list
19404418|NCT03595046|BB 1101|bb 1101|mesh-list
19404419|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673842|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
19404420|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
19404421|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
19317323|NCT04032860|Tenofovir|tenofovir|mesh-list
19317324|NCT04032860|Entecavir|entecavir|mesh-list
19317325|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
19317326|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372201|NCT00978159|Famotidine|famotidine|mesh-list
20372202|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20372203|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372204|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20372205|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372206|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372207|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20372208|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
20372209|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
20372210|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372211|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372212|NCT00978172|Artesunate|artesunate|mesh-list
20372213|NCT00978172|Mefloquine|mefloquine|mesh-list
20372214|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
20372215|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20372216|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20372217|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317327|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19317328|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19317329|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317330|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317331|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19317332|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19317333|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
19317334|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19317335|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
19317336|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19317337|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
19317338|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317339|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317340|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
19317341|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
19317342|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317343|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317344|NCT04032834|Budesonide|budesonide|mesh-list
19317345|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317346|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20372218|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372219|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
20372220|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
20372221|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20372222|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
20372223|NCT00978211|Octreotide|octreotide|mesh-list
20372224|NCT00978211|Somatostatin|somatostatin|mesh-list
19317347|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
19317348|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317349|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317350|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19317351|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
19317352|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
19317353|NCT04032834|Hormones|hormones|mesh-ancestor
19317354|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372225|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372226|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20372227|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372228|NCT00978211|Hormones|hormones|mesh-ancestor
20372229|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372230|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372231|NCT00978263|Metformin|metformin|mesh-list
20372232|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20372233|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372234|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
20372235|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19317355|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
19317356|NCT04032548|Propolis|propolis|mesh-list
19317357|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19317358|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317359|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
19317360|NCT04032236|Caffeine|caffeine|mesh-list
19317361|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19317362|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372236|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317363|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20372237|NCT00978315|Vitamins|vitamins|mesh-ancestor
20372238|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
20372239|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20372240|NCT00978328|Oxycodone|oxycodone|mesh-list
20372241|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20372242|NCT00978328|Narcotics|narcotics|mesh-ancestor
20372243|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372244|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372245|NCT00978328|Analgesics|analgesics|mesh-ancestor
20372246|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
20372247|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372248|NCT00978354|Furosemide|furosemide|mesh-list
20372249|NCT00978354|Diuretics|diuretics|mesh-ancestor
20372250|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
20372251|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372252|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20372253|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20372254|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372255|NCT00978393|Liraglutide|liraglutide|mesh-list
20372256|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372257|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372258|NCT00978393|Incretins|incretins|mesh-ancestor
20372259|NCT00978393|Hormones|hormones|mesh-ancestor
19317364|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317365|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317366|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19317367|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19317368|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
19317369|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317370|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
19317371|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19317372|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
19317373|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372260|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372261|NCT00978471|Thiotepa|thiotepa|mesh-list
20372262|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20372263|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
20372264|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372265|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372266|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20372267|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372268|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
20372269|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372270|NCT00978549|Docetaxel|docetaxel|mesh-list
20372271|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372272|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
20372273|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
20372274|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
20372275|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372276|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20372277|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
20372278|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
20372279|NCT00978601|Analgesics|analgesics|mesh-list
20372280|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
20372281|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372282|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372283|NCT00978653|Allopurinol|allopurinol|mesh-list
20372284|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
20372285|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372286|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372287|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
20372288|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372289|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20372290|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
20372291|NCT00978653|Protective Agents|protective agents|mesh-ancestor
20372292|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425799|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425800|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20425801|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20425802|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20425803|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425804|NCT01276834|Everolimus|everolimus|mesh-list
20425805|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317374|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372293|NCT00978718|Selenium|selenium|mesh-list
20372294|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
20372295|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317375|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19317376|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
19317377|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19317378|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
19317379|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317380|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317381|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19317382|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
19317383|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
19317384|NCT04032366|Protective Agents|protective agents|mesh-ancestor
19317385|NCT04032132|Curcumin|curcumin|mesh-list
19317386|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19317387|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317388|NCT04032132|Analgesics|analgesics|mesh-ancestor
20372296|NCT00978718|Protective Agents|protective agents|mesh-ancestor
20372297|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372298|NCT00978718|Trace Elements|trace elements|mesh-ancestor
20372299|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
20372300|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20372301|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372302|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372303|NCT00978796|Incretins|incretins|mesh-ancestor
20372304|NCT00978796|Hormones|hormones|mesh-ancestor
19317389|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
19317390|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317391|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317392|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317393|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317394|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317395|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317396|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317397|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
19317398|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19317399|NCT04032184|Fluorides|fluorides|mesh-list
19317400|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
19317401|NCT04032184|Protective Agents|protective agents|mesh-ancestor
19317402|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317403|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19317404|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317405|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
19317406|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
19317407|NCT04032119|Epinephrine|epinephrine|mesh-list
19317408|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19317409|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19317410|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
19317411|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317412|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317413|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317414|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19317415|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19840728|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19840729|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317416|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
19317417|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317418|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19317419|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
19317420|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
19317421|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
20188663|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
20188664|NCT00210834|Hematinics|hematinics|mesh-ancestor
20188665|NCT00210847|Acetaminophen|acetaminophen|mesh-list
20188666|NCT00210847|Tramadol|tramadol|mesh-list
20188667|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20188668|NCT00210847|Analgesics|analgesics|mesh-ancestor
20188669|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
20188670|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188671|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188672|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
20372305|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372306|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19317422|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19317423|NCT04032210|Zinc|zinc|mesh-list
20188673|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20188674|NCT00210847|Narcotics|narcotics|mesh-ancestor
20372307|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
20372308|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372309|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372310|NCT00978822|Clevidipine|clevidipine|mesh-list
20372311|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20372312|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20372313|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372314|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20372315|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317424|NCT04032210|Fluorides|fluorides|mesh-list
19317425|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
19317426|NCT04032210|Protective Agents|protective agents|mesh-ancestor
19317427|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317428|NCT04032210|Trace Elements|trace elements|mesh-ancestor
19317429|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
19317430|NCT04031859|Aspirin|aspirin|mesh-list
19317431|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19317432|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317433|NCT04031859|Analgesics|analgesics|mesh-ancestor
20372316|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20372317|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20372318|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372319|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
20372320|NCT00978913|Vaccines|vaccines|mesh-list
20372321|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
20372322|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372323|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372324|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372325|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20372326|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
20372327|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372328|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317434|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
19317435|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317436|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317437|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317438|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317439|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19317440|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19317441|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372329|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20372330|NCT00978978|Fentanyl|fentanyl|mesh-list
20372331|NCT00978978|Midazolam|midazolam|mesh-list
20372332|NCT00978978|Propofol|propofol|mesh-list
20372333|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20372334|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372335|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372336|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20372337|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
20372338|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
20372339|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20372340|NCT00978978|Narcotics|narcotics|mesh-ancestor
20372341|NCT00978978|Analgesics|analgesics|mesh-ancestor
19317442|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19317443|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19317444|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372342|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
20372343|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372344|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20372345|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20372346|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20372347|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20372348|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
20372349|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
20372350|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372351|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673843|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673844|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
19673845|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673846|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
19673847|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673848|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20372352|NCT00979056|Rifaximin|rifaximin|mesh-list
20372353|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19317445|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
19317446|NCT04031872|Capecitabine|capecitabine|mesh-list
19317447|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19317448|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
19317449|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317450|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317451|NCT04031755|Minocycline|minocycline|mesh-list
19317452|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19317453|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317454|NCT04031703|Paclitaxel|paclitaxel|mesh-list
19317455|NCT04031703|Docetaxel|docetaxel|mesh-list
19317456|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
19317457|NCT04031703|Carboplatin|carboplatin|mesh-list
19317458|NCT04031703|Fluorouracil|fluorouracil|mesh-list
19673849|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19673850|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673851|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372354|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372355|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372356|NCT00979160|Dasatinib|dasatinib|mesh-list
20372357|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372358|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372359|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372360|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372361|NCT00979186|Hemostatics|hemostatics|mesh-list
20372362|NCT00979186|Coagulants|coagulants|mesh-ancestor
20372363|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
20372364|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20372365|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372366|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20372367|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19317459|NCT04031703|Epirubicin|epirubicin|mesh-list
19317460|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19317461|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317462|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
19317463|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
19317464|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
19317465|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372368|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372369|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372370|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317466|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19317467|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
20372371|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
20372372|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20372373|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20372374|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
20372375|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372376|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372377|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372378|NCT00979472|Urological Agents|urological agents|mesh-ancestor
20372379|NCT00979537|Nisoldipine|nisoldipine|mesh-list
20372380|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372381|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20372382|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20372383|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372384|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20372385|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372386|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
20372387|NCT00979563|Irinotecan|irinotecan|mesh-list
20372388|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20372389|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20372390|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372391|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372392|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372393|NCT00979589|Aspirin|aspirin|mesh-list
20372394|NCT00979589|Clopidogrel|clopidogrel|mesh-list
20372395|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19317468|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317469|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372396|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20372397|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20372398|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20372399|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
19317470|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19317471|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
20372400|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372401|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372402|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372403|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20372404|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20372405|NCT00979589|Analgesics|analgesics|mesh-ancestor
20372406|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
20372407|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372408|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372409|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372410|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20372411|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20372412|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20372413|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317472|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19317473|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
19317474|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19317475|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19317476|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19317477|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19317478|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317479|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
19317480|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19317481|NCT04031027|Apremilast|apremilast|mesh-list
19317482|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19317483|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317484|NCT04031027|Analgesics|analgesics|mesh-ancestor
19317485|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
19317486|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372414|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
20372415|NCT00979641|Docetaxel|docetaxel|mesh-list
20372416|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372417|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
20372418|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
20372419|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
20372420|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372421|NCT00979667|Oseltamivir|oseltamivir|mesh-list
20372422|NCT00979667|Zanamivir|zanamivir|mesh-list
20372423|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
20372424|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372425|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372426|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372427|NCT00979693|Psilocybin|psilocybin|mesh-list
20372428|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
20372429|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372430|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20372431|NCT00979706|Cyclosporine|cyclosporine|mesh-list
20372432|NCT00979706|Interleukin-2|interleukin-2|mesh-list
20372433|NCT00979706|Cyclosporins|cyclosporins|mesh-list
20372434|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372435|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317487|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317488|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317489|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317490|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19317491|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19317492|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317493|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317494|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
20188675|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188676|NCT00210860|Topiramate|topiramate|mesh-list
20188677|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
19317495|NCT04030663|Papaverine|papaverine|mesh-list
19317496|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
19317497|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19317498|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188678|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188679|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188680|NCT00210873|Topiramate|topiramate|mesh-list
20188681|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
20188682|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372436|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372437|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
20372438|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317499|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317500|NCT04030663|Urological Agents|urological agents|mesh-ancestor
19317501|NCT04030988|Dexamethasone|dexamethasone|mesh-list
19317502|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317503|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
19317504|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
19317505|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317506|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317507|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317508|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
19317509|NCT04030988|Hormones|hormones|mesh-ancestor
19317510|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19317511|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19317512|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397777|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
19397778|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19397779|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397780|NCT03648528|Vitamins|vitamins|mesh-ancestor
19397781|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
19397782|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19397783|NCT03648437|Acetaminophen|acetaminophen|mesh-list
19397784|NCT03648437|Ibuprofen|ibuprofen|mesh-list
19397785|NCT03648437|Indomethacin|indomethacin|mesh-list
20372439|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
20372440|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372441|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
20372442|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372443|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20372444|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397786|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19397787|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19397788|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397789|NCT03648437|Analgesics|analgesics|mesh-ancestor
19397790|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
19397791|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372445|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20372446|NCT00979706|Analgesics|analgesics|mesh-ancestor
19397792|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397793|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397794|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19397795|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19397796|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397797|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397798|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
20372447|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
20372448|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372449|NCT00979758|Atorvastatin|atorvastatin|mesh-list
20372450|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20372451|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20372452|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
20372453|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372454|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20372455|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20372456|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372457|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
20372458|NCT00979836|Calcium|calcium|mesh-list
20372459|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20372460|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397799|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
19397800|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
19397801|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19397802|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19397803|NCT03648333|Niacin|niacin|mesh-list
19397804|NCT03648333|Amlodipine|amlodipine|mesh-list
19397805|NCT03648333|Valsartan|valsartan|mesh-list
19397806|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19397807|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19397808|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19397809|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19673852|NCT02812433|Urological Agents|urological agents|mesh-ancestor
20372461|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
20372462|NCT00979836|Coagulants|coagulants|mesh-ancestor
20372463|NCT00979862|Cediranib|cediranib|mesh-list
20372464|NCT00979862|Maleic acid|maleic acid|mesh-list
20372465|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397810|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397811|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20372466|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317513|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19317514|NCT04030715|Bismuth|bismuth|mesh-list
19317515|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317516|NCT04030715|Antacids|antacids|mesh-ancestor
19317517|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317518|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317519|NCT04030741|Metronidazole|metronidazole|mesh-list
19317520|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317521|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19317522|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19317523|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19317524|NCT04030442|Morphine|morphine|mesh-list
19317525|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19317526|NCT04030442|Narcotics|narcotics|mesh-ancestor
19317527|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317528|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317529|NCT04030442|Analgesics|analgesics|mesh-ancestor
19317530|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
19317531|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317532|NCT04030533|Ustekinumab|ustekinumab|mesh-list
19317533|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19317534|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
19317535|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
19317536|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317537|NCT04030572|Clonidine|clonidine|mesh-list
19317538|NCT04030572|Analgesics|analgesics|mesh-ancestor
19317539|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
19317540|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317541|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317542|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19317543|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
19317544|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
19317545|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19317546|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19317547|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19317548|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
19317549|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317550|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317551|NCT04030481|Anesthetics|anesthetics|mesh-list
19317552|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317553|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317554|NCT04030260|Nivolumab|nivolumab|mesh-list
19317555|NCT04030260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317556|NCT04030260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317557|NCT04030260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19317558|NCT04030260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317559|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
19317560|NCT04030195|Fludarabine|fludarabine|mesh-list
19317561|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372467|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372468|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372469|NCT00979966|Sirolimus|sirolimus|mesh-list
20372470|NCT00979966|Sunitinib|sunitinib|mesh-list
20372471|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372472|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20372473|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20372474|NCT00979966|Growth Substances|growth substances|mesh-ancestor
20372475|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372476|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
20372477|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372478|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372479|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372480|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20372481|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372482|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20372483|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
20372484|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372485|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
20372486|NCT00980031|Eplerenone|eplerenone|mesh-list
20372487|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20372488|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
19317562|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
19317563|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372489|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19317564|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317565|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19317566|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
19317567|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317568|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317569|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19317570|NCT04030039|Interferons|interferons|mesh-list
19317571|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317572|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
19317573|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317574|NCT04030429|Crizotinib|crizotinib|mesh-list
19317575|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317576|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19317577|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317578|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317579|NCT04030455|Cisplatin|cisplatin|mesh-list
19317580|NCT04030455|Carboplatin|carboplatin|mesh-list
19317581|NCT04030455|Docetaxel|docetaxel|mesh-list
19317582|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
19317583|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317584|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
19317585|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
19317586|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
19317587|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317588|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317589|NCT04030091|Insulin|insulin|mesh-list
19317590|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19317591|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
19317592|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19317593|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317594|NCT04029831|Ketamine|ketamine|mesh-list
19317595|NCT04029831|Propofol|propofol|mesh-list
19317596|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317597|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317598|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317599|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317600|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
19317601|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
19317602|NCT04029831|Analgesics|analgesics|mesh-ancestor
19317603|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
19317604|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317605|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19317606|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19317607|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19317608|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317609|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317610|NCT04029675|Ascorbic Acid|ascorbic acid|mesh-list
19317611|NCT04029675|Vitamins|vitamins|mesh-ancestor
19317612|NCT04029675|Micronutrients|micronutrients|mesh-ancestor
20372490|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372491|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20372492|NCT00980031|Diuretics|diuretics|mesh-ancestor
20372493|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
20372494|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372495|NCT00980109|Oseltamivir|oseltamivir|mesh-list
20372496|NCT00980109|Zanamivir|zanamivir|mesh-list
20372497|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
20372498|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372499|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372500|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372501|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
20372502|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372503|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20372504|NCT00980187|Indapamide|indapamide|mesh-list
20372505|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372506|NCT00980187|Diuretics|diuretics|mesh-ancestor
20372507|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
20372508|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372509|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20372510|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20372511|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372512|NCT00980213|Sunitinib|sunitinib|mesh-list
19317613|NCT04029675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372513|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317614|NCT04029675|Antioxidants|antioxidants|mesh-ancestor
19317615|NCT04029675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317616|NCT04029675|Protective Agents|protective agents|mesh-ancestor
19317617|NCT04029636|Xenon|xenon|mesh-list
19317618|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19317619|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
19317620|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
19317621|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317622|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317623|NCT04029428|Octreotide|octreotide|mesh-list
19317624|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19317625|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19317626|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317627|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317628|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19317629|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317630|NCT04029350|Osimertinib|osimertinib|mesh-list
19317631|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317632|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19317633|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317634|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317635|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
19317636|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317637|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317638|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317639|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317640|NCT04029467|Analgesics|analgesics|mesh-ancestor
19317641|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
19317642|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317643|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19317644|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19317645|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19317646|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
19317647|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317648|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317649|NCT04029090|Edaravone|edaravone|mesh-list
19317650|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19317651|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
19317652|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317653|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19317654|NCT04029090|Protective Agents|protective agents|mesh-ancestor
19317655|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317656|NCT04029272|Metformin|metformin|mesh-list
19317657|NCT04029272|Exenatide|exenatide|mesh-list
19317658|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19317659|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372514|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20372515|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20372516|NCT00980213|Growth Substances|growth substances|mesh-ancestor
20372517|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372518|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
20372519|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372520|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372521|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372522|NCT00980239|Bevacizumab|bevacizumab|mesh-list
20372523|NCT00980239|Cetuximab|cetuximab|mesh-list
20372524|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
20372525|NCT00980239|Irinotecan|irinotecan|mesh-list
20372526|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20372527|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372528|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20372529|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20372530|NCT00980239|Growth Substances|growth substances|mesh-ancestor
20372531|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372532|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
20372533|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20372534|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20372535|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372536|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372537|NCT00980304|Rituximab|rituximab|mesh-list
20372538|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19317660|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19317661|NCT04029272|Incretins|incretins|mesh-ancestor
19317662|NCT04029272|Hormones|hormones|mesh-ancestor
19317663|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19317664|NCT04028778|Gefitinib|gefitinib|mesh-list
19317665|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372539|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372540|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
20372541|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372542|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372543|NCT00980356|Vildagliptin|vildagliptin|mesh-list
20372544|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372545|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317666|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19317667|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317668|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317669|NCT04028856|Interferons|interferons|mesh-list
19317670|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317671|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
19317672|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317673|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19317674|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19317675|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317676|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
19317677|NCT04028765|Misoprostol|misoprostol|mesh-list
19317678|NCT04028765|Oxytocin|oxytocin|mesh-list
19317679|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
19317680|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19317681|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317682|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19317683|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
19317684|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19317685|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317686|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
19317687|NCT04028804|Fluorides|fluorides|mesh-list
19317688|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
19317689|NCT04028804|Protective Agents|protective agents|mesh-ancestor
19317690|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317691|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
19317692|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317693|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
19317694|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317695|NCT04028739|Curcumin|curcumin|mesh-list
19317696|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19317697|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317698|NCT04028739|Analgesics|analgesics|mesh-ancestor
19317699|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
19317700|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317701|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317702|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317703|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317704|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317705|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317706|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317707|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
19317708|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397812|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397813|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
19397814|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19397815|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20372546|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20372547|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
20372548|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372549|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372550|NCT00980382|Docetaxel|docetaxel|mesh-list
20372551|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372552|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
20372553|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
20372554|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
20372555|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372556|NCT00980408|Cycloserine|cycloserine|mesh-list
20372557|NCT00980408|Memantine|memantine|mesh-list
20372558|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20372559|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20372560|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
20372561|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372562|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397816|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19397817|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
19397818|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20372563|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372564|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19317709|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
19317710|NCT04029038|Fludarabine|fludarabine|mesh-list
19317711|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19317712|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
19317713|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317714|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317715|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19317716|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
19317717|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317718|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317719|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19317720|NCT04028622|Anesthetics|anesthetics|mesh-list
19317721|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317722|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317723|NCT04028596|Acetaminophen|acetaminophen|mesh-list
19317724|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317725|NCT04028596|Analgesics|analgesics|mesh-ancestor
19317726|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
19317727|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317728|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317729|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
19317730|NCT04028505|Terlipressin|terlipressin|mesh-list
19317731|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19317732|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19317733|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19317734|NCT04028518|Plasminogen|plasminogen|mesh-list
19317735|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19317736|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19317737|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317738|NCT04028323|Octreotide|octreotide|mesh-list
19317739|NCT04028323|Terlipressin|terlipressin|mesh-list
19317740|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317741|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19317742|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317743|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19317744|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19317745|NCT04028466|Omeprazole|omeprazole|mesh-list
19317746|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19317747|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317748|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19317749|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317750|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317751|NCT04028141|Ketamine|ketamine|mesh-list
19317752|NCT04028141|Propofol|propofol|mesh-list
19317753|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317754|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317755|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317756|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20188683|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188684|NCT00210886|Levofloxacin|levofloxacin|mesh-list
20188685|NCT00210886|Ofloxacin|ofloxacin|mesh-list
20188686|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20188687|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188688|NCT00210886|Renal Agents|renal agents|mesh-ancestor
20188689|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20188690|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20188691|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20188692|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188693|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188694|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188695|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20188696|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20188697|NCT00210899|Vancomycin|vancomycin|mesh-list
20188698|NCT00210899|Ceftazidime|ceftazidime|mesh-list
20188699|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
20188700|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20188701|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20188702|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188703|NCT00210912|Topiramate|topiramate|mesh-list
20188704|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
20188705|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188706|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317757|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
19317758|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
19317759|NCT04028141|Analgesics|analgesics|mesh-ancestor
20188707|NCT00210925|Topiramate|topiramate|mesh-list
20188708|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
19317760|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
19317761|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317762|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19317763|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19317764|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19317765|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317766|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317767|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
19317768|NCT04027972|Neostigmine|neostigmine|mesh-list
19317769|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19317770|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317771|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317772|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
19317773|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317774|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317775|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19317776|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
19317777|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317778|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19317779|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19317780|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19317781|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
19317782|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317783|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317784|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317785|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317786|NCT04027829|Analgesics|analgesics|mesh-ancestor
19317787|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
19317788|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317789|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19317790|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19317791|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19317792|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
19317793|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317794|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317795|NCT04027764|Paclitaxel|paclitaxel|mesh-list
19317796|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19317797|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317798|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
19317799|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
19317800|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
19317801|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317802|NCT04027751|Tropisetron|tropisetron|mesh-list
19317803|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
19317804|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
19317805|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317806|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317807|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317808|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19317809|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19317810|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
19317811|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317812|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317813|NCT04028024|Urinastatin|urinastatin|mesh-list
19317814|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19317815|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19317816|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
19317817|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317818|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317819|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
19317820|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
19317821|NCT04027959|Vitamins|vitamins|mesh-ancestor
19317822|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
19317823|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317824|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
19317825|NCT04027959|Hematinics|hematinics|mesh-ancestor
19317826|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
19317827|NCT04027517|Hematinics|hematinics|mesh-ancestor
19317828|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
19317829|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19317830|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317831|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188709|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188710|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317832|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317833|NCT04027322|Dexamethasone|dexamethasone|mesh-list
19317834|NCT04027322|Budesonide|budesonide|mesh-list
19317835|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317836|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
19317837|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
19317838|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317839|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317840|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19317841|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
19317842|NCT04027322|Hormones|hormones|mesh-ancestor
19317843|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19317844|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19317845|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317846|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19317847|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19317848|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
19317849|NCT04027192|Midazolam|midazolam|mesh-list
19317850|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19317851|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317852|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317853|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317854|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19317855|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19317856|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19317857|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317858|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
19317859|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
19317860|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
19317861|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
19317862|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317863|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317864|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
19317865|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19317866|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19317867|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317868|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
19317869|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
19317870|NCT04026958|Clarithromycin|clarithromycin|mesh-list
19317871|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19673853|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19673854|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
19673855|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673856|NCT02737046|Interferons|interferons|mesh-list
19673857|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
19673858|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
19673859|NCT02737046|Zidovudine|zidovudine|mesh-list
19673860|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19673861|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19673862|NCT02737046|Belinostat|belinostat|mesh-list
19673863|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673864|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
19317872|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19317873|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19317874|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317875|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317876|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19317877|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19317878|NCT04027166|Methadone|methadone|mesh-list
19317879|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19317880|NCT04027166|Narcotics|narcotics|mesh-ancestor
19317881|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19673865|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19673866|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
19673867|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673868|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
19673869|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317882|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317883|NCT04027166|Analgesics|analgesics|mesh-ancestor
19317884|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
19317885|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317886|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
19673870|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19673871|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19673872|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317887|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
20372565|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20372566|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20372567|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372568|NCT00980408|Renal Agents|renal agents|mesh-ancestor
20372569|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20372570|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
20372571|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19317888|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
19317889|NCT04026880|Testosterone|testosterone|mesh-list
19317890|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
19317891|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
19317892|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19317893|NCT04026880|Androgens|androgens|mesh-ancestor
19317894|NCT04026880|Hormones|hormones|mesh-ancestor
19317895|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19317896|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317897|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19317898|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317899|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
19317900|NCT04027283|Erythritol|erythritol|mesh-list
19317901|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
19317902|NCT04026841|Antibodies|antibodies|mesh-list
19317903|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
19317904|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397819|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
19397820|NCT03648333|Vitamins|vitamins|mesh-ancestor
19397821|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
19397822|NCT03648229|Timolol|timolol|mesh-list
19397823|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19397824|NCT03648229|Latanoprost|latanoprost|mesh-list
19397825|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19397826|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19397827|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19397828|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
19397829|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397830|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397831|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397832|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19397833|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19397834|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
19397835|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397836|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
19397837|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
19397838|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
19397839|NCT03648034|Ropivacaine|ropivacaine|mesh-list
19397840|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
19397841|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
19397842|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397843|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397844|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
19397845|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397846|NCT03648008|Morphine|morphine|mesh-list
19397847|NCT03648008|Hydromorphone|hydromorphone|mesh-list
19397848|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19397849|NCT03648008|Narcotics|narcotics|mesh-ancestor
19397850|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397851|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397852|NCT03648008|Analgesics|analgesics|mesh-ancestor
19397853|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
20188711|NCT00210938|Doripenem|doripenem|mesh-list
20188712|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20188713|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188714|NCT00210990|Doripenem|doripenem|mesh-list
20188715|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20188716|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188717|NCT00211003|Doripenem|doripenem|mesh-list
20188718|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20188719|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188720|NCT00211016|Doripenem|doripenem|mesh-list
20188721|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20188722|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188723|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
20188724|NCT00211120|Hematinics|hematinics|mesh-ancestor
20188725|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
20372572|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
19397854|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397855|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20188726|NCT00211133|Hematinics|hematinics|mesh-ancestor
20188727|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
20372573|NCT00980473|Timolol|timolol|mesh-list
19317905|NCT04026776|Allopurinol|allopurinol|mesh-list
19317906|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
19317907|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317908|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19317909|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
19317910|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19317911|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19317912|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
19317913|NCT04026776|Protective Agents|protective agents|mesh-ancestor
19317914|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317915|NCT04026685|Phenylephrine|phenylephrine|mesh-list
19317916|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
19317917|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19317918|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
19317919|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
19317920|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317921|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317922|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
19317923|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19317924|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
19317925|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
19317926|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19317927|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19317928|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19317929|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
19317930|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317931|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317932|NCT04026685|Protective Agents|protective agents|mesh-ancestor
19317933|NCT04026451|Propofol|propofol|mesh-list
19317934|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19317935|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317936|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317937|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317938|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
19317939|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
19317940|NCT04026464|Acetaminophen|acetaminophen|mesh-list
20372574|NCT00980473|Travoprost|travoprost|mesh-list
20372575|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20372576|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20372577|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
20372578|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372579|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372580|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372581|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20372582|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372583|NCT00980551|Carboplatin|carboplatin|mesh-list
20372584|NCT00980551|Vincristine|vincristine|mesh-list
20372585|NCT00980551|Topotecan|topotecan|mesh-list
20372586|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19317941|NCT04026464|Ibuprofen|ibuprofen|mesh-list
19317942|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19317943|NCT04026464|Analgesics|analgesics|mesh-ancestor
19317944|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
19317945|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317946|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317947|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
19317948|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19317949|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19317950|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372587|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20372588|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
20372589|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
20372590|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
20372591|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372592|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20372593|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20372594|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372595|NCT00980603|Docetaxel|docetaxel|mesh-list
20372596|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372597|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
20372598|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
20372599|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
19317951|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19317952|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372600|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317953|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317954|NCT04026074|Clonidine|clonidine|mesh-list
19317955|NCT04026074|Fentanyl|fentanyl|mesh-list
19317956|NCT04026074|Remifentanil|remifentanil|mesh-list
19317957|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20372601|NCT00980616|Ropivacaine|ropivacaine|mesh-list
20372602|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
19317958|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19317959|NCT04026074|Narcotics|narcotics|mesh-ancestor
19317960|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372603|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
20372604|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372605|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372606|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
20372607|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372608|NCT00980707|Fluticasone|fluticasone|mesh-list
20372609|NCT00980707|Xhance|xhance|mesh-list
20372610|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372611|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20372612|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
20372613|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372614|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372615|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20372616|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
20372617|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
20372618|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20425806|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425807|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
20425808|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425809|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20425810|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425811|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
20425812|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19317961|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317962|NCT04026074|Analgesics|analgesics|mesh-ancestor
19317963|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
19317964|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425813|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425814|NCT01276925|Bupivacaine|bupivacaine|mesh-list
20425815|NCT01276925|Ropivacaine|ropivacaine|mesh-list
20425816|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
20425817|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
20425818|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425819|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425820|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
19317965|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19317966|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317967|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
19317968|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
19317969|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19317970|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
19317971|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
19317972|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19317973|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19317974|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19317975|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
19317976|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19317977|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19317978|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
19317979|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19317980|NCT04026022|Fentanyl|fentanyl|mesh-list
19317981|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19317982|NCT04026022|Narcotics|narcotics|mesh-ancestor
19317983|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19317984|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19317985|NCT04026022|Analgesics|analgesics|mesh-ancestor
19317986|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
19317987|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317988|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19317989|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19317990|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
19317991|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
19317992|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20425821|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19317993|NCT04026282|Hormones|hormones|mesh-ancestor
19317994|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425822|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
20425823|NCT01276977|Eletriptan|eletriptan|mesh-list
19317995|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840730|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840731|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
19840732|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19840733|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
19318001|NCT04026230|Atorvastatin|atorvastatin|mesh-list
19318002|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19318003|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19318004|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
19318005|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318006|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19318007|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19318008|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318009|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
19318010|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19318011|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19318012|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318013|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
19318014|NCT04025736|Coagulants|coagulants|mesh-ancestor
19318015|NCT04025671|Naloxone|naloxone|mesh-list
19318016|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19318017|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318018|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
19318019|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318020|NCT04025840|Dexamethasone|dexamethasone|mesh-list
19318021|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
19318022|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318023|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
19318024|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
19318025|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318026|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318027|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318028|NCT04025840|Hormones|hormones|mesh-ancestor
19318029|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318030|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19318031|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318032|NCT04025918|Phenylephrine|phenylephrine|mesh-list
19318033|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
19318034|NCT04025918|Ephedrine|ephedrine|mesh-list
19318035|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19318036|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19318037|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
19318038|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
19318039|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318040|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318041|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
19318042|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
19318043|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
19318044|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19318045|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19318046|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19318047|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
19318048|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318049|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318050|NCT04025918|Protective Agents|protective agents|mesh-ancestor
19318051|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19318052|NCT04025567|Vancomycin|vancomycin|mesh-list
19318053|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318054|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318055|NCT04025593|Prednisone|prednisone|mesh-list
19318056|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
19318057|NCT04025593|Rituximab|rituximab|mesh-list
19318058|NCT04025593|Doxorubicin|doxorubicin|mesh-list
19318059|NCT04025593|Vincristine|vincristine|mesh-list
19318060|NCT04025593|Lenalidomide|lenalidomide|mesh-list
19318061|NCT04025593|Decitabine|decitabine|mesh-list
19318062|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318063|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
19318064|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318065|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318066|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19318067|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
19318068|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318069|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318070|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19397856|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19318071|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318072|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19318073|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19318074|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19318075|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318076|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318077|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
19318078|NCT04025593|Hormones|hormones|mesh-ancestor
19318079|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318080|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19318081|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19318082|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
19318083|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
19318084|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
19318085|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19318086|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19318087|NCT04025593|Growth Substances|growth substances|mesh-ancestor
19318088|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
19318089|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19318090|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
19318091|NCT04025203|Ibuprofen|ibuprofen|mesh-list
19318092|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
19318093|NCT04025203|Gabapentin|gabapentin|mesh-list
19318094|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19318095|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318096|NCT04025203|Analgesics|analgesics|mesh-ancestor
19318097|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
19318098|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318099|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318100|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318101|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318102|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19318103|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318104|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318105|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
19318106|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19318107|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19318108|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318109|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19318110|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19318111|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19318112|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318113|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
19318114|NCT04025177|Indomethacin|indomethacin|mesh-list
19318115|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19318116|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318117|NCT04025177|Analgesics|analgesics|mesh-ancestor
19318118|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
19318119|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318120|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318121|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372619|NCT00980850|Vaccines|vaccines|mesh-list
20372620|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
20372621|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372622|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
20372623|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
20372624|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318122|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318123|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
19318124|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
19318125|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19318126|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19318127|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318128|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318129|NCT04025489|Vitamin D|vitamin d|mesh-list
19318130|NCT04025489|Vitamins|vitamins|mesh-ancestor
19318131|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
19318132|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318133|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19318134|NCT04024683|Ropivacaine|ropivacaine|mesh-list
19318135|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
19318136|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
19318137|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318138|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372625|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318139|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
19318140|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318141|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
19318142|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318143|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318144|NCT04024696|Abexinostat|abexinostat|mesh-list
19318145|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19318146|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318147|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397857|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397858|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397859|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19397860|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19397861|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397862|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
19397863|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397864|NCT03647969|Nivolumab|nivolumab|mesh-list
19397865|NCT03647969|Ipilimumab|ipilimumab|mesh-list
19397866|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397867|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397868|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19397869|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397870|NCT03647956|Bevacizumab|bevacizumab|mesh-list
19397871|NCT03647956|Carboplatin|carboplatin|mesh-list
19397872|NCT03647956|Pemetrexed|pemetrexed|mesh-list
19397873|NCT03647956|Atezolizumab|atezolizumab|mesh-list
19397874|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397875|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397876|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19397877|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19397878|NCT03647956|Growth Substances|growth substances|mesh-ancestor
19397879|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397880|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
19397881|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397882|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397883|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19397884|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19397885|NCT03647839|Nivolumab|nivolumab|mesh-list
19397886|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397887|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397888|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20372626|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372627|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20372628|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20372629|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372630|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372631|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372632|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20372633|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20372634|NCT00981006|Mitogens|mitogens|mesh-list
19397889|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397890|NCT03647670|Midazolam|midazolam|mesh-list
19397891|NCT03647670|Abrocitinib|abrocitinib|mesh-list
19397892|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19397893|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19397894|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19397895|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397896|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19397897|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19397898|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397899|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19397900|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
19397901|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
19397902|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
19397903|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
19397904|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397905|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397906|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19397907|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397908|NCT03647579|Midazolam|midazolam|mesh-list
19397909|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
19397910|NCT03647579|Ketamine|ketamine|mesh-list
19397911|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20372635|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
20372636|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372637|NCT00981162|Everolimus|everolimus|mesh-list
20372638|NCT00981162|Sorafenib|sorafenib|mesh-list
20372639|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372640|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372641|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
20372642|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318148|NCT04024865|Domperidone|domperidone|mesh-list
19318149|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
19318150|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
19318151|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318152|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318153|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318154|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19318155|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
19318156|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318157|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318158|NCT04024813|Seladelpar|seladelpar|mesh-list
19318159|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19318160|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
19318161|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318162|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19318163|NCT04024527|Amoxicillin|amoxicillin|mesh-list
19318164|NCT04024527|Metronidazole|metronidazole|mesh-list
19318165|NCT04024527|Esomeprazole|esomeprazole|mesh-list
19318166|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318167|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318168|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19318169|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19318170|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19318171|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318172|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19318173|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318174|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318175|NCT04024878|Nivolumab|nivolumab|mesh-list
19318176|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318177|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318178|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19318179|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318180|NCT04024891|Phentolamine|phentolamine|mesh-list
19318181|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19318182|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19318183|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19318184|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19318185|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
19318186|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318187|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318188|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318189|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19318190|NCT04024384|Daratumumab|daratumumab|mesh-list
19318191|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318192|NCT04024241|Cytarabine|cytarabine|mesh-list
19318193|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
19318194|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19318195|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
19318196|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318197|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318198|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
19318199|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318200|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318201|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
20372643|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372644|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372645|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372646|NCT00981201|Celecoxib|celecoxib|mesh-list
20372647|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20372648|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20372649|NCT00981201|Analgesics|analgesics|mesh-ancestor
19318202|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318203|NCT04024241|Analgesics|analgesics|mesh-ancestor
19318204|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
20372650|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
19318205|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318206|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20372651|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372652|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372653|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372654|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372655|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20372656|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20372657|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372658|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372659|NCT00981318|Ritonavir|ritonavir|mesh-list
20372660|NCT00981318|Lopinavir|lopinavir|mesh-list
20372661|NCT00981318|Maraviroc|maraviroc|mesh-list
20372662|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20372663|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20372664|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
20372665|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372666|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372667|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20372668|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20372669|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
20372670|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372671|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20372672|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20372673|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20372674|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20372675|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20372676|NCT00981487|Ondansetron|ondansetron|mesh-list
20372677|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
20372678|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
20372679|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372680|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372681|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372682|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
20372683|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
20372684|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20372685|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
20372686|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372687|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372688|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20372689|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20372690|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372691|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20372692|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20372693|NCT00981513|Vaccines|vaccines|mesh-list
19318207|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19318208|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318209|NCT04024163|Benzonidazole|benzonidazole|mesh-list
19318210|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318211|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
20372694|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
20372695|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372696|NCT00981591|Iloprost|iloprost|mesh-list
20372697|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20372698|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
20372699|NCT00981708|Dexamethasone|dexamethasone|mesh-list
20372700|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
20372701|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
20372702|NCT00981708|Lenalidomide|lenalidomide|mesh-list
20372703|NCT00981708|BB 1101|bb 1101|mesh-list
20372704|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372705|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
20372706|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372707|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318212|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318213|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19318214|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19318215|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19318216|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318217|NCT04024072|Brinzolamide|brinzolamide|mesh-list
19318218|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19318219|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318220|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318221|NCT04023760|Apixaban|apixaban|mesh-list
19318222|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20372708|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20372709|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
19318223|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
19318224|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19318225|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
19318226|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318227|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318228|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
19318229|NCT04023565|Perindopril|perindopril|mesh-list
19318230|NCT04023565|Moxonidine|moxonidine|mesh-list
19318231|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19318232|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
19318233|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318234|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318235|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19318236|NCT04023617|Docetaxel|docetaxel|mesh-list
19318237|NCT04023617|Nivolumab|nivolumab|mesh-list
19318238|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318239|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
19318240|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
19318241|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
19318242|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318243|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318244|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19318245|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
19318246|NCT04023630|Clopidogrel|clopidogrel|mesh-list
19318247|NCT04023630|Ticagrelor|ticagrelor|mesh-list
19318248|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19318249|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19318250|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19318251|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19318252|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
19318253|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318254|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318255|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318256|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19318257|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
19318258|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19318259|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
19318260|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318261|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
19318262|NCT04023149|Aldesleukin|aldesleukin|mesh-list
19318263|NCT04023149|Interleukin-2|interleukin-2|mesh-list
19318264|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318265|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318266|NCT04023149|Analgesics|analgesics|mesh-ancestor
19318267|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
19318268|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318269|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318270|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19318271|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19318272|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
19318273|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318274|NCT04023331|Copper|copper|mesh-list
19318275|NCT04023331|Trace Elements|trace elements|mesh-ancestor
19318276|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
19318277|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318278|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
19318279|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318280|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318281|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
19318282|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19318283|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
19318284|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318285|NCT04023266|Expectorants|expectorants|mesh-ancestor
19318286|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
19318287|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19318288|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
19318289|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318290|NCT04023266|Protective Agents|protective agents|mesh-ancestor
19318291|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318292|NCT04023266|Antidotes|antidotes|mesh-ancestor
19318293|NCT04023292|Tamoxifen|tamoxifen|mesh-list
19318294|NCT04023292|Letrozole|letrozole|mesh-list
19318295|NCT04023292|Exemestane|exemestane|mesh-list
19318296|NCT04023292|Anastrozole|anastrozole|mesh-list
19318297|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318298|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19318299|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19318300|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318301|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318302|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19318303|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
19318304|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318305|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318306|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19318307|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19318308|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19318309|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19318310|NCT04023305|Sevoflurane|sevoflurane|mesh-list
19318311|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19318312|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19318313|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
19318314|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
19318315|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318316|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318317|NCT04023110|Carvedilol|carvedilol|mesh-list
19318318|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19318319|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19318320|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
19318321|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318322|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318323|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318324|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19318325|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
19318326|NCT04023110|Protective Agents|protective agents|mesh-ancestor
19318327|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19318328|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19318329|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19318330|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
19318331|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19318332|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19318333|NCT04022837|Pantoprazole|pantoprazole|mesh-list
19318334|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19318335|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318336|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19318337|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318338|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318339|NCT04023019|Thrombin|thrombin|mesh-list
19318340|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
19318341|NCT04023019|Coagulants|coagulants|mesh-ancestor
19318342|NCT04022811|Tobramycin|tobramycin|mesh-list
19318343|NCT04022811|Dexamethasone|dexamethasone|mesh-list
19318344|NCT04022811|Bromfenac|bromfenac|mesh-list
20372710|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372711|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372712|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20372713|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372714|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
20372715|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
20372716|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372717|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372718|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
20372719|NCT00981708|Hormones|hormones|mesh-ancestor
20372720|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372721|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20372722|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
20372723|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372724|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20372725|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20372726|NCT00981708|Growth Substances|growth substances|mesh-ancestor
20372727|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
20372728|NCT00981721|Cediranib|cediranib|mesh-list
20372729|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372730|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372731|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372732|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372733|NCT00981773|Maraviroc|maraviroc|mesh-list
20372734|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20372735|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20372736|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372737|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20372738|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20372739|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
19318345|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
19318346|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318347|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
19318348|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
19318349|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318350|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318351|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318352|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
19318353|NCT04022811|Hormones|hormones|mesh-ancestor
19318354|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318355|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20372740|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372741|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20372742|NCT00981786|Timolol|timolol|mesh-list
20372743|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20372744|NCT00981786|Travoprost|travoprost|mesh-list
20372745|NCT00981786|Brinzolamide|brinzolamide|mesh-list
20372746|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20372747|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20372748|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
19318356|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318357|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318358|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318359|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19318360|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
19318361|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
19318362|NCT04022811|Protective Agents|protective agents|mesh-ancestor
19318363|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19318364|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318365|NCT04022811|Analgesics|analgesics|mesh-ancestor
19318366|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
19318367|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318368|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
19318369|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
19318370|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318371|NCT04022785|Azacitidine|azacitidine|mesh-list
19318372|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19318373|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
19318374|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318375|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318376|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397912|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372749|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397913|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397914|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19397915|NCT03647579|Analgesics|analgesics|mesh-ancestor
19397916|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
19397917|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397918|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19397919|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19397920|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19397921|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
19397922|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397923|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397924|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19397925|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19397926|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
19397927|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
19397928|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19397929|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19397930|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19397931|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19397932|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19397933|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19397934|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
19397935|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
19397936|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19397937|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397938|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
20372750|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397939|NCT03647423|Cetuximab|cetuximab|mesh-list
19397940|NCT03647423|Avelumab|avelumab|mesh-list
19397941|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19397942|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
19397943|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397944|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372751|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318377|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
19318378|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19318379|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318380|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318381|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
19318382|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318383|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318384|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19318385|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
19318386|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318387|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
19318388|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318389|NCT04022525|Leflunomide|leflunomide|mesh-list
19318390|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318391|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318392|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318393|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
19318394|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318395|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
19318396|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19318397|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
19318398|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318399|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318400|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19318401|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
19318402|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19318403|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
19318404|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318405|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318406|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19318407|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
19318408|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
19318409|NCT04022161|Protective Agents|protective agents|mesh-ancestor
19318410|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
19318411|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
19318412|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19318413|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19318414|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318415|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318416|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318417|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318418|NCT04022096|Lansoprazole|lansoprazole|mesh-list
19318419|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
19318420|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19318421|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318422|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19318423|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318424|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318425|NCT04022291|Insulin|insulin|mesh-list
19318426|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19318427|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318428|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318429|NCT04022317|Insulin|insulin|mesh-list
19318430|NCT04022317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19318431|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318432|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318433|NCT04022226|Ketamine|ketamine|mesh-list
19318434|NCT04022226|Methohexital|methohexital|mesh-list
19318435|NCT04022226|Analgesics|analgesics|mesh-ancestor
19318436|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
19318437|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318438|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318439|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19318440|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19318441|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
19318442|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
19318443|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318444|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19318445|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19318446|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318447|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318448|NCT04022135|Folic Acid|folic acid|mesh-list
19318449|NCT04022135|Hematinics|hematinics|mesh-ancestor
19318450|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
19318451|NCT04022135|Vitamins|vitamins|mesh-ancestor
19318452|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
19318453|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318454|NCT04021992|Gemcitabine|gemcitabine|mesh-list
19318455|NCT04021992|Rituximab|rituximab|mesh-list
19318456|NCT04021992|Doxorubicin|doxorubicin|mesh-list
19318457|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19318458|NCT04021992|Vinorelbine|vinorelbine|mesh-list
19318459|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318460|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318461|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
19318462|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318463|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318464|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19318465|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
19318466|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318467|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
19318468|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318469|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318470|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318471|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19318472|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19318473|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19318474|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19318475|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
19318476|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
19318477|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
19318478|NCT04022005|Gemcitabine|gemcitabine|mesh-list
19318479|NCT04022005|Rituximab|rituximab|mesh-list
19318480|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
19318481|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318482|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318483|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
19318484|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318485|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318486|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19318487|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
19318488|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318489|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
19318490|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318491|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318492|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318493|NCT04021498|Simvastatin|simvastatin|mesh-list
19318494|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19318495|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19318496|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
19318497|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318498|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19840734|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20188728|NCT00211146|Hematinics|hematinics|mesh-ancestor
20188729|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
20188730|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188731|NCT00211224|Riluzole|riluzole|mesh-list
20188732|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
20188733|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20188734|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20188735|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188736|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188737|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188738|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20188739|NCT00211224|Protective Agents|protective agents|mesh-ancestor
20188740|NCT00211250|Valproic Acid|valproic acid|mesh-list
20188741|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
20188742|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188743|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188744|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
20188745|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188746|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188747|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
20188748|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188749|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188750|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188751|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
20188752|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318499|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20188753|NCT00211302|Aripiprazole|aripiprazole|mesh-list
20188754|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
20372752|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20372753|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372754|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20372755|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20372756|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20372757|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20372758|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372759|NCT00981838|Rituximab|rituximab|mesh-list
20372760|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20372761|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372762|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
20372763|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372764|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20372765|NCT00981851|Albuterol|albuterol|mesh-list
19318500|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318501|NCT04021433|Ketamine|ketamine|mesh-list
19318502|NCT04021433|Analgesics|analgesics|mesh-ancestor
19318503|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
19318504|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318505|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318506|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19318507|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19318508|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
19318509|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
19318510|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318511|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19318512|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19318513|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318514|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318515|NCT04021420|Nivolumab|nivolumab|mesh-list
19318516|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318517|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318518|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19318519|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318520|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19318521|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20188755|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188756|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20188757|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188758|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188759|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188760|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
20188761|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
20188762|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188763|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188764|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20188765|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20188766|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
20372766|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
20372767|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19318536|NCT04021108|Nivolumab|nivolumab|mesh-list
19318537|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318538|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318539|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19318540|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318541|NCT04021121|Linezolid|linezolid|mesh-list
20372768|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
20372769|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372770|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372771|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20372772|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
20372773|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
20372774|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20372775|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
20372776|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372777|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318542|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318543|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318544|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19318545|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318546|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318547|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19318548|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20372778|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
20372779|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20372780|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19318549|NCT04021017|Estradiol|estradiol|mesh-list
19318550|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19318551|NCT04021017|Estrogens|estrogens|mesh-ancestor
19318552|NCT04021017|Hormones|hormones|mesh-ancestor
19318553|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318554|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318555|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19318556|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
20188767|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20188768|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19318557|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19318558|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19318559|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
19318560|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19318561|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19318562|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318563|NCT04020666|Kallikreins|kallikreins|mesh-list
19318564|NCT04020666|Coagulants|coagulants|mesh-ancestor
19318565|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19318566|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
19318567|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19318568|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318569|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
19318570|NCT04020653|Lumefantrine|lumefantrine|mesh-list
19318571|NCT04020653|Artemether|artemether|mesh-list
19318572|NCT04020653|Artemisinins|artemisinins|mesh-list
19318573|NCT04020653|Artemisinin|artemisinin|mesh-list
19318574|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19318575|NCT04020653|Citric Acid|citric acid|mesh-list
19318576|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
19318577|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
19318578|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19318579|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
19318580|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
19318581|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318582|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
19318583|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19318584|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19318585|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318586|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19318587|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
19318588|NCT04020653|Trace Elements|trace elements|mesh-ancestor
19318589|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
19318590|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318591|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19318592|NCT04021043|Nivolumab|nivolumab|mesh-list
19318593|NCT04021043|Ipilimumab|ipilimumab|mesh-list
19318594|NCT04021043|Antibodies|antibodies|mesh-list
19318595|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
19318596|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19318597|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
19318598|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318599|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318600|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19318601|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397945|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19397946|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
19397947|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397948|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397949|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19397950|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19397951|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19397952|NCT03647280|Epirubicin|epirubicin|mesh-list
19397953|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188769|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20188770|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20188771|NCT00211315|Anecortave|anecortave|mesh-list
20188772|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188773|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188774|NCT00211315|Growth Substances|growth substances|mesh-ancestor
20372781|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19397954|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397955|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19318602|NCT04020588|Minocycline|minocycline|mesh-list
19318603|NCT04020588|Celecoxib|celecoxib|mesh-list
19318604|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19318605|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318606|NCT04020588|Analgesics|analgesics|mesh-ancestor
19318607|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
19318608|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318609|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318610|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318611|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318612|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19318613|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19318614|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318615|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318616|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318617|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318618|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19318619|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19318620|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19318621|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
19318622|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19318623|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318624|NCT04020380|Azithromycin|azithromycin|mesh-list
19318625|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318626|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318627|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19318628|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318629|NCT04020445|Insulin|insulin|mesh-list
19318630|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318631|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318632|NCT04020328|Prednisone|prednisone|mesh-list
19318633|NCT04020328|Leflunomide|leflunomide|mesh-list
19318634|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318635|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
19318636|NCT04020328|Hormones|hormones|mesh-ancestor
19318637|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318638|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318639|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19318640|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318641|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318642|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318643|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318644|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
19318645|NCT04020263|Simendan|simendan|mesh-list
19318646|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19318647|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
19318648|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19318649|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19318650|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318651|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318652|NCT04020263|Protective Agents|protective agents|mesh-ancestor
19318653|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318654|NCT04020094|Atezolizumab|atezolizumab|mesh-list
19318655|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318656|NCT04020016|Nalbuphine|nalbuphine|mesh-list
19318657|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19318658|NCT04020016|Narcotics|narcotics|mesh-ancestor
19318659|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318660|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318661|NCT04020016|Analgesics|analgesics|mesh-ancestor
19318662|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
19318663|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318664|NCT04020003|Simendan|simendan|mesh-list
19318665|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20372782|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20372783|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
20372784|NCT00981890|Sunitinib|sunitinib|mesh-list
20372785|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372786|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20372787|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20372788|NCT00981890|Growth Substances|growth substances|mesh-ancestor
20372789|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372790|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
20372791|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372792|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318666|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
19318667|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19318668|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19318669|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372793|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318670|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318671|NCT04020003|Protective Agents|protective agents|mesh-ancestor
19318672|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318673|NCT04020133|Epinephrine|epinephrine|mesh-list
19318674|NCT04020133|Bupivacaine|bupivacaine|mesh-list
19318675|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
19318676|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
19318677|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372794|NCT00981903|Tinzaparin|tinzaparin|mesh-list
20372795|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20372796|NCT00981903|Dalteparin|dalteparin|mesh-list
20372797|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
20372798|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20372799|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20372800|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372801|NCT00981929|Losartan|losartan|mesh-list
20372802|NCT00981929|Tramadol|tramadol|mesh-list
20372803|NCT00981929|Caffeine|caffeine|mesh-list
20372804|NCT00981929|Omeprazole|omeprazole|mesh-list
20372805|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20372806|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372807|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20372808|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20372809|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372810|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20372811|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372812|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20372813|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372814|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20372815|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372816|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20372817|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20372818|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20372819|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
20372820|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372821|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20372822|NCT00981929|Narcotics|narcotics|mesh-ancestor
19318678|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318679|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
19318680|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318681|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19318682|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19318683|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
19318684|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318685|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318686|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19318687|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19318688|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
19318689|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19318690|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
19318691|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
19318692|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
19318693|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19318694|NCT04019782|Hylan|hylan|mesh-list
20372823|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372824|NCT00981929|Analgesics|analgesics|mesh-ancestor
20372825|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
19318695|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
19318696|NCT04019782|Protective Agents|protective agents|mesh-ancestor
19318697|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318698|NCT04019496|Calcitonin|calcitonin|mesh-list
19318699|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
19318700|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19318701|NCT04019496|Antibodies|antibodies|mesh-list
19318702|NCT04019496|Katacalcin|katacalcin|mesh-list
19318703|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
19318704|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318705|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19318706|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19318707|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
19673873|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20372826|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372827|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
20372828|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372829|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20372830|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372831|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372832|NCT00981955|Caffeine|caffeine|mesh-list
20372833|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20188775|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188776|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188777|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188778|NCT00211328|Anecortave|anecortave|mesh-list
20188779|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19318708|NCT04019548|Cisplatin|cisplatin|mesh-list
19318709|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318710|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19318711|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
19318712|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318713|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
19318714|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318715|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318716|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19318717|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19318718|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318719|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318720|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318721|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
19318722|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19318723|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318724|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372834|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372835|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20372836|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372837|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372838|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20372839|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20372840|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
20372841|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372842|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
20372843|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20372844|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318725|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19318726|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19318727|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318728|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318729|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318730|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19318731|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
19318732|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19318733|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318734|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19318735|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19318736|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19318737|NCT04018937|Fludarabine|fludarabine|mesh-list
19318738|NCT04018937|Melphalan|melphalan|mesh-list
19318739|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
19318740|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318741|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318742|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19318743|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
20188780|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188781|NCT00211328|Growth Substances|growth substances|mesh-ancestor
20188782|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188783|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188784|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188785|NCT00211341|Vitamin A|vitamin a|mesh-list
20188786|NCT00211341|Vitamins|vitamins|mesh-ancestor
20188787|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
20188788|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188789|NCT00211354|Anecortave|anecortave|mesh-list
20188790|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19318744|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673874|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20188791|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19318745|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19318746|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
19318747|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19318748|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318749|NCT04019106|Budesonide|budesonide|mesh-list
19318750|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19318751|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318752|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19318753|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
19318754|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318755|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318756|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19318757|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
19318758|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
19318759|NCT04019106|Hormones|hormones|mesh-ancestor
19318760|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318761|NCT04018833|Ranibizumab|ranibizumab|mesh-list
19318762|NCT04018833|Aflibercept|aflibercept|mesh-list
19318763|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19318764|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19318765|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19318766|NCT04018833|Growth Substances|growth substances|mesh-ancestor
19318767|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188792|NCT00211354|Growth Substances|growth substances|mesh-ancestor
20188793|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372845|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19318768|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
19318769|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318770|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
19318771|NCT04018482|Povidone|povidone|mesh-list
20188794|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
19318772|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
19318773|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
19318774|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19318775|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318776|NCT04018703|Midazolam|midazolam|mesh-list
19318777|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
19318778|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19318779|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318780|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318781|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318782|NCT04018703|Analgesics|analgesics|mesh-ancestor
19318783|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
19318784|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318785|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19318786|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19318787|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20188795|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188796|NCT00211367|Anecortave|anecortave|mesh-list
20188797|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188798|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188799|NCT00211367|Growth Substances|growth substances|mesh-ancestor
20188800|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188801|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188802|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188803|NCT00211380|Aripiprazole|aripiprazole|mesh-list
20188804|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
20188805|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188806|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20188807|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188808|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188809|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188810|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
20188811|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
20188812|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188813|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188814|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20188815|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20188816|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
20188817|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20188818|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19318788|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
20188819|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20188820|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20372846|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
19318789|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318790|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318791|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19318792|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19318793|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20372847|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20372848|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372849|NCT00982202|Pioglitazone|pioglitazone|mesh-list
20372850|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372851|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372852|NCT00982215|Acetaminophen|acetaminophen|mesh-list
20372853|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20372854|NCT00982215|Analgesics|analgesics|mesh-ancestor
20372855|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
20372856|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372857|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372858|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
20372859|NCT00982254|Insulin|insulin|mesh-list
20372860|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20372861|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372862|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372863|NCT00982332|Betamethasone|betamethasone|mesh-list
20372864|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
20372865|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372866|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
20372867|NCT00982332|Hormones|hormones|mesh-ancestor
20372868|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372869|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372870|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20372871|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
20372872|NCT00982358|Valsartan|valsartan|mesh-list
20372873|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372874|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20372875|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20372876|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372877|NCT00982436|Carboplatin|carboplatin|mesh-list
20372878|NCT00982436|Docetaxel|docetaxel|mesh-list
20372879|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372880|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
20372881|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
20372882|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
20372883|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372884|NCT00982449|Fialuridine|fialuridine|mesh-list
20372885|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
20372886|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372887|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20372888|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372889|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372890|NCT00982527|Fenoldopam|fenoldopam|mesh-list
20372891|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20372892|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
20372893|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
20372894|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
20372895|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425824|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19673875|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19673876|NCT02723864|Veliparib|veliparib|mesh-list
19673877|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673878|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19673879|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673880|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673881|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
19673882|NCT02676791|Povidone|povidone|mesh-list
19673883|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
19840735|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318794|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19318795|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19318796|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
19318797|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
19318798|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
19318799|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
19397956|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19397957|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19397958|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673884|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
19318800|NCT04018690|Triamcinolone|triamcinolone|mesh-list
19318801|NCT04018690|Ropivacaine|ropivacaine|mesh-list
19318802|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
19318803|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
19318804|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318805|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318806|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
19318807|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318808|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318809|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
19318810|NCT04018690|Hormones|hormones|mesh-ancestor
20372896|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372897|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372898|NCT00982540|Caspofungin|caspofungin|mesh-list
20372899|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
20372900|NCT00982540|Clotrimazole|clotrimazole|mesh-list
20372901|NCT00982540|Miconazole|miconazole|mesh-list
20372902|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372903|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372904|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372905|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20372906|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20372907|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20372908|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20372909|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
20372910|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20372911|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372912|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20372913|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20372914|NCT00982566|Navitoclax|navitoclax|mesh-list
20372915|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372916|NCT00982618|Lidocaine|lidocaine|mesh-list
20372917|NCT00982618|Morphine|morphine|mesh-list
20372918|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
20372919|NCT00982618|Anesthetics|anesthetics|mesh-list
19318811|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318812|NCT04018417|Amphotericin B|amphotericin b|mesh-list
19318813|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19318814|NCT04018417|Amebicides|amebicides|mesh-ancestor
20372920|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372921|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372922|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
20372923|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372924|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20372925|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20372926|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20372927|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20372928|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372929|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20372930|NCT00982618|Narcotics|narcotics|mesh-ancestor
20372931|NCT00982618|Analgesics|analgesics|mesh-ancestor
20372932|NCT00982631|Sirolimus|sirolimus|mesh-list
20372933|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20372934|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372935|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20372936|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20372937|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
20372938|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20372939|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
20372940|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372941|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
20372942|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
20372943|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
20372944|NCT00982722|Calcium|calcium|mesh-list
20372945|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20372946|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372947|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20372948|NCT00982722|Vitamins|vitamins|mesh-ancestor
20372949|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
20372950|NCT00982722|Antacids|antacids|mesh-ancestor
20372951|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372952|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20372953|NCT00982800|Gabapentin|gabapentin|mesh-list
19318815|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19318816|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19397959|NCT03647150|Amoxicillin|amoxicillin|mesh-list
20372954|NCT00982800|Analgesics|analgesics|mesh-ancestor
20372955|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
20372956|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20372957|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372958|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
20372959|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20372960|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20372961|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372962|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20372963|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20372964|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20372965|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20372966|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372967|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
20372968|NCT00982891|Morphine|morphine|mesh-list
20372969|NCT00982891|Hydromorphone|hydromorphone|mesh-list
20372970|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20372971|NCT00982891|Narcotics|narcotics|mesh-ancestor
19318817|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318818|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19318819|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
19318820|NCT04018365|Empagliflozin|empagliflozin|mesh-list
19318821|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19318822|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318823|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318824|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318825|NCT04018768|Acetaminophen|acetaminophen|mesh-list
19318826|NCT04018768|Ibuprofen|ibuprofen|mesh-list
19318827|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19318828|NCT04018768|Oxycodone|oxycodone|mesh-list
19318829|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318830|NCT04018768|Analgesics|analgesics|mesh-ancestor
19318831|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
19318832|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318833|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318834|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
19318835|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19318836|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318837|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318838|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19318839|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318840|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318841|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19318842|NCT04018768|Narcotics|narcotics|mesh-ancestor
19318843|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372972|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20372973|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372974|NCT00982891|Analgesics|analgesics|mesh-ancestor
19318844|NCT04018378|Varenicline|varenicline|mesh-list
19318845|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19318846|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19318847|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
19318848|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318849|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318850|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318851|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
19318852|NCT04018157|Ketamine|ketamine|mesh-list
19318853|NCT04018157|Propofol|propofol|mesh-list
19318854|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19318855|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318856|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318857|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19318858|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
19318859|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
19318860|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318861|NCT04018157|Analgesics|analgesics|mesh-ancestor
19318862|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
19318863|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318864|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19318865|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19318866|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19318867|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
19318868|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397960|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20372975|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
19318869|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318870|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20372976|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425825|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20425826|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
20425827|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425828|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425829|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425830|NCT01277016|Melphalan|melphalan|mesh-list
20425831|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20425832|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
20425833|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425834|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425835|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20425836|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425837|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
20425838|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425839|NCT01277107|Zaleplon|zaleplon|mesh-list
20425840|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
20425841|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20425842|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425843|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425844|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
20425845|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
19318871|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19318872|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19318873|NCT04018313|Omalizumab|omalizumab|mesh-list
19318874|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19318875|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19318876|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19318877|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
19318878|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
19318879|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318880|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
19318881|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19318882|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
19318883|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
19318884|NCT04018274|Estradiol|estradiol|mesh-list
19318885|NCT04018274|Estrogens|estrogens|mesh-ancestor
19318886|NCT04018274|Hormones|hormones|mesh-ancestor
19318887|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318888|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318889|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19318890|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19318891|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19318892|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19318893|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19318894|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
19318895|NCT04017897|Nivolumab|nivolumab|mesh-list
19318896|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19318897|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318898|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19318899|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318900|NCT04018105|Metformin|metformin|mesh-list
19318901|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19318902|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318903|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
19318904|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19318905|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19318906|NCT04017741|Prednisolone|prednisolone|mesh-list
19318907|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
20425846|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20425847|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425848|NCT01277172|Rituximab|rituximab|mesh-list
20425849|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20425850|NCT01277172|Antibodies|antibodies|mesh-list
19318908|NCT04017741|Lidocaine|lidocaine|mesh-list
19318909|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19318910|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
19318911|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
19318912|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
19318913|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20425851|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
19318914|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425852|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20372977|NCT00983021|Insulin|insulin|mesh-list
20372978|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20372979|NCT00983021|Liraglutide|liraglutide|mesh-list
20372980|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
20372981|NCT00983021|Xultophy|xultophy|mesh-list
20372982|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20372983|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20372984|NCT00983021|Incretins|incretins|mesh-ancestor
20372985|NCT00983021|Hormones|hormones|mesh-ancestor
20372986|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318915|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
19318916|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318917|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19318918|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19318919|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19318920|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19318921|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318922|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20372987|NCT00983034|Amoxicillin|amoxicillin|mesh-list
20372988|NCT00983034|Clarithromycin|clarithromycin|mesh-list
19318923|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
19318924|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
19318925|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318926|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
19318927|NCT04017741|Hormones|hormones|mesh-ancestor
19318928|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19318929|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19318930|NCT04017741|Protective Agents|protective agents|mesh-ancestor
19318931|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19318932|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318933|NCT04018131|Cimetidine|cimetidine|mesh-list
19318934|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19318935|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318936|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19318937|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
19318938|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
19318939|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318940|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318941|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318942|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19318943|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19318944|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19318945|NCT04017845|Tribenoside|tribenoside|mesh-list
19318946|NCT04017845|Lidocaine|lidocaine|mesh-list
19318947|NCT04017845|Diltiazem|diltiazem|mesh-list
19318948|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
19318949|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
19318950|NCT04017845|Bisacodyl|bisacodyl|mesh-list
19318951|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
19318952|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
19318953|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318954|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318955|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
19318956|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318957|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19318958|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19318959|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19318960|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19318961|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188821|NCT00211393|Ketoconazole|ketoconazole|mesh-list
20188822|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
20188823|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188824|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20188825|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20188826|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188827|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188828|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20188829|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
20188830|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20188831|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188832|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20188833|NCT00211406|Anecortave|anecortave|mesh-list
20372989|NCT00983034|Lansoprazole|lansoprazole|mesh-list
20372990|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
19318962|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19318963|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
19318964|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19318965|NCT04017845|Cathartics|cathartics|mesh-ancestor
19318966|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19318967|NCT04017845|Laxatives|laxatives|mesh-ancestor
19318968|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19318969|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19318970|NCT04017845|Analgesics|analgesics|mesh-ancestor
19318971|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19318972|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19318973|NCT04017988|Ethanol|ethanol|mesh-list
19318974|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19318975|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19318976|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19318977|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318978|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19318979|NCT04017650|Nivolumab|nivolumab|mesh-list
19318980|NCT04017650|Cetuximab|cetuximab|mesh-list
19318981|NCT04017650|Antibodies|antibodies|mesh-list
19318982|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
19318983|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19318984|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
19318985|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318986|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19318987|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19318988|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318989|NCT04017624|Nicotine|nicotine|mesh-list
19318990|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19318991|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
19318992|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19318993|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19318994|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19318995|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19318996|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
19318997|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19318998|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19318999|NCT04017377|Paclitaxel|paclitaxel|mesh-list
19319000|NCT04017377|Cisplatin|cisplatin|mesh-list
20188834|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188835|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188836|NCT00211406|Growth Substances|growth substances|mesh-ancestor
20188837|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188838|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188839|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319001|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19319002|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319003|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
19319004|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
19319005|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
20188840|NCT00211419|Triamcinolone|triamcinolone|mesh-list
20188841|NCT00211419|Anecortave|anecortave|mesh-list
19319006|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319007|NCT04017598|Iron|iron|mesh-list
19319008|NCT04017598|Trace Elements|trace elements|mesh-ancestor
19319009|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
19319010|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319011|NCT04017455|Bevacizumab|bevacizumab|mesh-list
19319012|NCT04017455|Atezolizumab|atezolizumab|mesh-list
19319013|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19319014|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319015|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188842|NCT00211419|Verteporfin|verteporfin|mesh-list
20188843|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20188844|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
20188845|NCT00211419|Hormones|hormones|mesh-ancestor
20188846|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20188847|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188848|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20188849|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
20188850|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188851|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188852|NCT00211419|Growth Substances|growth substances|mesh-ancestor
19319016|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19319017|NCT04017455|Growth Substances|growth substances|mesh-ancestor
20188853|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
19319018|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319019|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
19319020|NCT04017338|Ezetimibe|ezetimibe|mesh-list
19319021|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19319022|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19319023|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
19319024|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319025|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19319026|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20372991|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19319027|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
19319028|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319029|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319030|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319031|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840736|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19840737|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19840738|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19840739|NCT00635492|Insulin|insulin|mesh-list
19840740|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19840741|NCT00635492|Exenatide|exenatide|mesh-list
19840742|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19840743|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840744|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19840745|NCT00635492|Incretins|incretins|mesh-ancestor
19840746|NCT00635492|Hormones|hormones|mesh-ancestor
20188854|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188855|NCT00211432|Anecortave|anecortave|mesh-list
20188856|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20372992|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20372993|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20372994|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20372995|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20372996|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20372997|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20372998|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20372999|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20373000|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20373001|NCT00983047|Docetaxel|docetaxel|mesh-list
20373002|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
20188857|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188858|NCT00211432|Growth Substances|growth substances|mesh-ancestor
20188859|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188860|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188861|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188862|NCT00211445|Verteporfin|verteporfin|mesh-list
20188863|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20188864|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
20373003|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373004|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
20373005|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
20373006|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
20373007|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373008|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20373009|NCT00983112|Thrombin|thrombin|mesh-list
20373010|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
20373011|NCT00983112|Coagulants|coagulants|mesh-ancestor
20373012|NCT00983125|Clonidine|clonidine|mesh-list
20373013|NCT00983125|Analgesics|analgesics|mesh-ancestor
20373014|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
20373015|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373016|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373017|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20373018|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
20373019|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
20373020|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20373021|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20373022|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20373023|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
20373024|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188865|NCT00211458|Anecortave|anecortave|mesh-list
20188866|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188867|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188868|NCT00211458|Growth Substances|growth substances|mesh-ancestor
20373025|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848220|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188869|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188870|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188871|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188872|NCT00211471|Anecortave|anecortave|mesh-list
20188873|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188874|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188875|NCT00211471|Growth Substances|growth substances|mesh-ancestor
20188876|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188877|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188878|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188879|NCT00211484|Anecortave|anecortave|mesh-list
20188880|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20188881|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20188882|NCT00211484|Growth Substances|growth substances|mesh-ancestor
20188883|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188884|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
20188885|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188886|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
20188887|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188888|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
20188889|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188890|NCT00211562|Vitamin E|vitamin e|mesh-list
20188891|NCT00211562|Olanzapine|olanzapine|mesh-list
20188892|NCT00211562|Vitamins|vitamins|mesh-ancestor
20373026|NCT00983138|Asparaginase|asparaginase|mesh-list
20373027|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848221|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319044|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19319045|NCT04016922|Hematinics|hematinics|mesh-ancestor
19319046|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19319047|NCT04017104|Edotreotide|edotreotide|mesh-list
19319048|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19319049|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397961|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19397962|NCT03647072|Famotidine|famotidine|mesh-list
19397963|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19397964|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19397965|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19397966|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
19397967|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
19397968|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19397969|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397970|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397971|NCT03646916|Dexamethasone|dexamethasone|mesh-list
19397972|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
19397973|NCT03646916|BB 1101|bb 1101|mesh-list
19397974|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19397975|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
19397976|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
19397977|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19397978|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397979|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19397980|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
19397981|NCT03646916|Hormones|hormones|mesh-ancestor
19397982|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397983|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19397984|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19397985|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
19397986|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19397987|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397988|NCT03646825|Antioxidants|antioxidants|mesh-list
19397989|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19397990|NCT03646825|Protective Agents|protective agents|mesh-ancestor
20373028|NCT00983151|Tramadol|tramadol|mesh-list
20373029|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20373030|NCT00983151|Narcotics|narcotics|mesh-ancestor
20373031|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373032|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373033|NCT00983151|Analgesics|analgesics|mesh-ancestor
20373034|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
20373035|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373036|NCT00983164|Antioxidants|antioxidants|mesh-list
19397991|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188893|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
20188894|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188895|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
20425853|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
19319061|NCT04016389|Paclitaxel|paclitaxel|mesh-list
19319062|NCT04016389|Carboplatin|carboplatin|mesh-list
19319063|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19319064|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319065|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19319066|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
19319067|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
19319068|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319069|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
19319070|NCT04016740|Ketamine|ketamine|mesh-list
19319071|NCT04016740|Remifentanil|remifentanil|mesh-list
19319072|NCT04016740|Propofol|propofol|mesh-list
19319073|NCT04016740|Ropivacaine|ropivacaine|mesh-list
19319074|NCT04016740|Sevoflurane|sevoflurane|mesh-list
19319075|NCT04016740|Rocuronium|rocuronium|mesh-list
19319076|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19319077|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319078|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319079|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19319080|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
19319081|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
19319082|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319083|NCT04016740|Analgesics|analgesics|mesh-ancestor
19319084|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
19319085|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319086|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19319087|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19319088|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19319089|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19319090|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319091|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319092|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19319093|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19319094|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19319095|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
19319096|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19319097|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19319098|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19319099|NCT04016740|Narcotics|narcotics|mesh-ancestor
19319100|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19319101|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19319102|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19319103|NCT04016246|Propofol|propofol|mesh-list
19319104|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19319105|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319106|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319107|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19319108|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
19319109|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
19319110|NCT04016233|Tenofovir|tenofovir|mesh-list
19673885|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19673886|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188896|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
20188897|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188898|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20188899|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20188900|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188901|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188902|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188903|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19319111|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
19319112|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188904|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19319113|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19319114|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19319115|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319116|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319117|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19319118|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19319119|NCT04016051|Clarithromycin|clarithromycin|mesh-list
19319120|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19319121|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319122|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19319123|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319124|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319125|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19319126|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19319127|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
19319128|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19319129|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319130|NCT04016090|Folic Acid|folic acid|mesh-list
19319131|NCT04016090|Hematinics|hematinics|mesh-ancestor
19319132|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
19319133|NCT04016090|Vitamins|vitamins|mesh-ancestor
19319134|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
19319135|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319136|NCT04016220|Budesonide|budesonide|mesh-list
19319137|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319138|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19319139|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
20373037|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373038|NCT00983164|Protective Agents|protective agents|mesh-ancestor
20373039|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373040|NCT00983177|Colchicine|colchicine|mesh-list
20373041|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
20373042|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373043|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
20373044|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
20373045|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
20373046|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373047|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319140|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319141|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319142|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19319143|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
19319144|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
19319145|NCT04016220|Hormones|hormones|mesh-ancestor
19319146|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319147|NCT04015908|Acetaminophen|acetaminophen|mesh-list
19319148|NCT04015908|Celecoxib|celecoxib|mesh-list
19319149|NCT04015908|Pregabalin|pregabalin|mesh-list
19319150|NCT04015908|Oxycodone|oxycodone|mesh-list
19319151|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319152|NCT04015908|Analgesics|analgesics|mesh-ancestor
19319153|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
19319154|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319155|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319156|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
19319157|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
19319158|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19319159|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19319160|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319161|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19319162|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19319163|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19319164|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319165|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19319166|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19319167|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319168|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319169|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19319170|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19319171|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319172|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19319173|NCT04015908|Narcotics|narcotics|mesh-ancestor
19319174|NCT04016207|Guanfacine|guanfacine|mesh-list
20373048|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19319175|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20188905|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20188906|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188907|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319176|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19319177|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19319178|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19319179|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
19319180|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319181|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319182|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319183|NCT04015869|Pregnanolone|pregnanolone|mesh-list
19319184|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
19319185|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319186|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319187|NCT04015596|Naproxen|naproxen|mesh-list
19319188|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20188908|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
20188909|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
20188910|NCT00211562|Protective Agents|protective agents|mesh-ancestor
20188911|NCT00211588|Galantamine|galantamine|mesh-list
20373049|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
19319189|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319190|NCT04015596|Analgesics|analgesics|mesh-ancestor
19319191|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
19673887|NCT02673996|Phenylephrine|phenylephrine|mesh-list
19673888|NCT02673996|Isoproterenol|isoproterenol|mesh-list
19673889|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
20373050|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20373051|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
20373052|NCT00983255|Tedizolid|tedizolid|mesh-list
20373053|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
20373054|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19319192|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319193|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319194|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319195|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319196|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
19319197|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19319198|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319199|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319200|NCT04015414|Varenicline|varenicline|mesh-list
19319201|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19319202|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19319203|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
19319204|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319205|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319206|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319207|NCT04015700|Coal Tar|coal tar|mesh-list
19319208|NCT04015700|Vaccines|vaccines|mesh-list
19319209|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
19319210|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319211|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
19319212|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
19319213|NCT04015557|Acetaminophen|acetaminophen|mesh-list
19319214|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
19319215|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19319216|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319217|NCT04015557|Analgesics|analgesics|mesh-ancestor
19319218|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
19319219|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319220|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319221|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
19319222|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
19319223|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319224|NCT04015557|Expectorants|expectorants|mesh-ancestor
20188912|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20188913|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373055|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319225|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
19319226|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19673890|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19673891|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
19673892|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
19673893|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673894|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373056|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20373057|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373058|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373059|NCT00983268|Capecitabine|capecitabine|mesh-list
20373060|NCT00983268|Vorinostat|vorinostat|mesh-list
20373061|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20373062|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
20373063|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373064|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373065|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20373066|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373067|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20373068|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
20373069|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20373070|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20373071|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20373072|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373073|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373074|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
20373075|NCT00983398|Carboplatin|carboplatin|mesh-list
19319227|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
19319228|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319229|NCT04015557|Protective Agents|protective agents|mesh-ancestor
19319230|NCT04015557|Antidotes|antidotes|mesh-ancestor
19319231|NCT04015492|Factor VIII|factor viii|mesh-list
19319232|NCT04015492|BAX 855|bax 855|mesh-list
19319233|NCT04015492|Coagulants|coagulants|mesh-ancestor
19319234|NCT04015687|Lamotrigine|lamotrigine|mesh-list
19319235|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
19319236|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20373076|NCT00983398|Melphalan|melphalan|mesh-list
20373077|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
20373078|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20373079|NCT00983398|Mannitol|mannitol|mesh-list
20373080|NCT00983398|Antidotes|antidotes|mesh-list
20373081|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373082|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20373083|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
20373084|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373085|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20373086|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373087|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
20373088|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373089|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20373090|NCT00983398|Diuretics|diuretics|mesh-ancestor
20373091|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
20373092|NCT00983398|Protective Agents|protective agents|mesh-ancestor
20373093|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
20373094|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
20373095|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20373096|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373097|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
20373098|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
20373099|NCT00983424|Cyclosporine|cyclosporine|mesh-list
20373100|NCT00983424|Paclitaxel|paclitaxel|mesh-list
20373101|NCT00983424|Cyclosporins|cyclosporins|mesh-list
20373102|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19319237|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19319238|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319239|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20373103|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373104|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
19319240|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319241|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19319242|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20373105|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
20373106|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
20373107|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373108|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373109|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373110|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
19319243|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319244|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19673895|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
20373111|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373112|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
19673896|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20373113|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373114|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
20188914|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188915|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
20188916|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188917|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319245|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19319246|NCT04015778|Paclitaxel|paclitaxel|mesh-list
19319247|NCT04015778|Carboplatin|carboplatin|mesh-list
19319248|NCT04015778|Nivolumab|nivolumab|mesh-list
19319249|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19319250|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319251|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
19319252|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
19319253|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
19673897|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
20188918|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20188919|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
19319254|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319255|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19319256|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19319257|NCT04015661|Paclitaxel|paclitaxel|mesh-list
19319258|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19319259|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19319260|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319261|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
19319262|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
19319263|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
19319264|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319265|NCT04015375|Dapsone|dapsone|mesh-list
19319266|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319267|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
19319268|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19319269|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19319270|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19319271|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319272|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319273|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
19319274|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19319275|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19319276|NCT04015219|Lifitegrast|lifitegrast|mesh-list
19319277|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19397992|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19397993|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19397994|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19397995|NCT03646721|Incretins|incretins|mesh-ancestor
19397996|NCT03646721|Hormones|hormones|mesh-ancestor
19397997|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19397998|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19397999|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
19398000|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398001|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188920|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398002|NCT03646526|Amitriptyline|amitriptyline|mesh-list
19398003|NCT03646526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19398004|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19398005|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
19398006|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19398007|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398008|NCT03646526|Analgesics|analgesics|mesh-ancestor
19398009|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
19398010|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398011|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398012|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19673898|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
19673899|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19673900|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19673901|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19673902|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
19673903|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673904|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673905|NCT02673996|Protective Agents|protective agents|mesh-ancestor
19673906|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19673907|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19673908|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19319278|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
19319279|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19319280|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19319281|NCT04014634|Prednisolone|prednisolone|mesh-list
19319282|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
19319283|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19319284|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
20373115|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373116|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20373117|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20373118|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20373119|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
19319285|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319286|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
19319287|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
19319288|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319289|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319290|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19319291|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
20373120|NCT00983450|Hormones|hormones|mesh-ancestor
20373121|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373122|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373123|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373124|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373125|NCT00983554|Anastrozole|anastrozole|mesh-list
20373126|NCT00983554|Testosterone|testosterone|mesh-list
20373127|NCT00983554|Dutasteride|dutasteride|mesh-list
20373128|NCT00983554|Androgens|androgens|mesh-ancestor
20373129|NCT00983554|Hormones|hormones|mesh-ancestor
20373130|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373131|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373132|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19319292|NCT04014634|Hormones|hormones|mesh-ancestor
19319293|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840747|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840748|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
19840749|NCT00635570|NuvaRing|nuvaring|mesh-list
19840750|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19840751|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19840752|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
19840753|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840754|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840755|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20373133|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373134|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20373135|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20373136|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319294|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19319295|NCT04014634|Protective Agents|protective agents|mesh-ancestor
20188921|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
20188922|NCT00211614|Lansoprazole|lansoprazole|mesh-list
20188923|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
20188924|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20188925|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20188926|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20188927|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188928|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188929|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
20188930|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20188931|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
20188932|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188933|NCT00211653|Expectorants|expectorants|mesh-ancestor
20188934|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
20188935|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20188936|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
20188937|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188938|NCT00211653|Protective Agents|protective agents|mesh-ancestor
20188939|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188940|NCT00211653|Antidotes|antidotes|mesh-ancestor
20188941|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
20188942|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20188943|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20188944|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20188945|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20373137|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373138|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
20373139|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20373140|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20188946|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188947|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
20188948|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188949|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188950|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20188951|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188952|NCT00211705|Pravastatin|pravastatin|mesh-list
20188953|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20188954|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20188955|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
20188956|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188957|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20188958|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20188959|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188960|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
20188961|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20188962|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20373141|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19319296|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19319297|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319298|NCT04014855|Lactoferrin|lactoferrin|mesh-list
19319299|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319300|NCT04014556|Aflibercept|aflibercept|mesh-list
19319301|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19319302|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19319303|NCT04014556|Growth Substances|growth substances|mesh-ancestor
19319304|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319305|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
19319306|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319307|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
19319308|NCT04014192|Empagliflozin|empagliflozin|mesh-list
20188963|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20188964|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20188965|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188966|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
20188967|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188968|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188969|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20373142|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20373143|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373144|NCT00983736|Tramadol|tramadol|mesh-list
20373145|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20373146|NCT00983736|Narcotics|narcotics|mesh-ancestor
19319309|NCT04014192|Canagliflozin|canagliflozin|mesh-list
19319310|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19319311|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319312|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319313|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319314|NCT04014101|Apatinib|apatinib|mesh-list
19319315|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673909|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
19673910|NCT02600949|Imiquimod|imiquimod|mesh-list
19673911|NCT02600949|Vaccines|vaccines|mesh-list
19673912|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673913|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673914|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19673915|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
19673916|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673917|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
19673918|NCT02597062|Dexamethasone|dexamethasone|mesh-list
19673919|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
19673920|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673921|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
19673922|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673923|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673924|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19673925|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
19673926|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673927|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373147|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373148|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373149|NCT00983736|Analgesics|analgesics|mesh-ancestor
20373150|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
20373151|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373152|NCT00983788|Bezafibrate|bezafibrate|mesh-list
20373153|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20373154|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
19319316|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19319317|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373155|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373156|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20373157|NCT00983944|Prednisone|prednisone|mesh-list
20373158|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
20373159|NCT00983944|Rituximab|rituximab|mesh-list
20373160|NCT00983944|Doxorubicin|doxorubicin|mesh-list
20373161|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20373162|NCT00983944|Etoposide|etoposide|mesh-list
20373163|NCT00983944|Vincristine|vincristine|mesh-list
20373164|NCT00983944|Bleomycin|bleomycin|mesh-list
20373165|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373166|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
20373167|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373168|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373169|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20373170|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
20373171|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319318|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319319|NCT04014244|Triamcinolone|triamcinolone|mesh-list
19319320|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19319321|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19319322|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19319323|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319324|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
19319325|NCT04014244|Hormones|hormones|mesh-ancestor
19319326|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319327|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319328|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19319329|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
19319330|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319331|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319332|NCT04014361|Itraconazole|itraconazole|mesh-list
19319333|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
19319334|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319335|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19319336|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19319337|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319338|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319339|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19319340|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
19319341|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319342|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319343|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19319344|NCT04014283|Selenium|selenium|mesh-list
19319345|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
19319346|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319347|NCT04014283|Protective Agents|protective agents|mesh-ancestor
19319348|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319349|NCT04014283|Trace Elements|trace elements|mesh-ancestor
19319350|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
19319351|NCT04013815|Ropivacaine|ropivacaine|mesh-list
19319352|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
20373172|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373173|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20373174|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20373175|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20373176|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20373177|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19319353|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
19319354|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319355|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373178|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373179|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20373180|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
19319356|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
19319357|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319358|NCT04013581|Empagliflozin|empagliflozin|mesh-list
19319359|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19319360|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319361|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319362|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319363|NCT04013919|Insulin|insulin|mesh-list
19319364|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19319365|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319366|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319367|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
19319368|NCT04013646|Hematinics|hematinics|mesh-ancestor
19319369|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19319370|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20373181|NCT00983944|Hormones|hormones|mesh-ancestor
20373182|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373183|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20373184|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20373185|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
20373186|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
20373187|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
20373188|NCT00983996|Alendronate|alendronate|mesh-list
19319371|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319372|NCT04013620|Abatacept|abatacept|mesh-list
19319373|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19319374|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319375|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319376|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19319377|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
19319378|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319379|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319380|NCT04013958|Ketamine|ketamine|mesh-list
19319381|NCT04013958|Analgesics|analgesics|mesh-ancestor
19319382|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
19319383|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319384|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319385|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19319386|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19319387|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
19319388|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
19319389|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19673928|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19673929|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673930|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
19673931|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
19840756|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20188970|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20188971|NCT00211744|Topiramate|topiramate|mesh-list
20188972|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
20188973|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20188974|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217361|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20217362|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20217363|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20217364|NCT00309491|Tamoxifen|tamoxifen|mesh-list
20217365|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
20217366|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20217367|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
20217368|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217369|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217370|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217371|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217372|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20217373|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20217374|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20217375|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20217376|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20217377|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217378|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217379|NCT00309517|Leucovorin|leucovorin|mesh-list
20217380|NCT00309517|Edrecolomab|edrecolomab|mesh-list
20217381|NCT00309517|Antidotes|antidotes|mesh-ancestor
19673932|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19673933|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19673934|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
19673935|NCT02597062|Hormones|hormones|mesh-ancestor
19673936|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19673937|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20373189|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19319390|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19319391|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19319392|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319393|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319394|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
19319395|NCT04013672|Sargramostim|sargramostim|mesh-list
19319396|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19319397|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319398|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
19319399|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319400|NCT04013880|Decitabine|decitabine|mesh-list
19319401|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19319402|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
19319403|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319404|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319405|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319406|NCT04013542|Nivolumab|nivolumab|mesh-list
19319407|NCT04013542|Ipilimumab|ipilimumab|mesh-list
19319408|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19319409|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319410|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19319411|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319412|NCT04013386|Dexamethasone|dexamethasone|mesh-list
19319413|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
19319414|NCT04013386|Aprepitant|aprepitant|mesh-list
19319415|NCT04013386|Mirtazapine|mirtazapine|mesh-list
19319416|NCT04013386|BB 1101|bb 1101|mesh-list
19319417|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319418|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
20373190|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373191|NCT00984152|Efavirenz|efavirenz|mesh-list
20373192|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20373193|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
20373194|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20373195|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373196|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373197|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319419|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
19319420|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319421|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319422|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19319423|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
20373198|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
20373199|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373200|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20373201|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20373202|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20373203|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19319424|NCT04013386|Hormones|hormones|mesh-ancestor
19319425|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319426|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19319427|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319428|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
19319429|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319430|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319431|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19319432|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319433|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
19319434|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19319435|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19319436|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
19319437|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
19319438|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19319439|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19673938|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
19319440|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319441|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19319442|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19319443|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19319444|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
19319445|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19319446|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19319447|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
19319448|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19319449|NCT04013334|Nivolumab|nivolumab|mesh-list
19319450|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19319451|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319452|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19319453|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319454|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19319455|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19319456|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
19319457|NCT04013438|Estradiol|estradiol|mesh-list
19319458|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19319459|NCT04013438|Estrogens|estrogens|mesh-ancestor
19319460|NCT04013438|Hormones|hormones|mesh-ancestor
19319461|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319462|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319463|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19319464|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
19319465|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19319466|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19319467|NCT04013438|Urological Agents|urological agents|mesh-ancestor
19673939|NCT02498912|Fludarabine|fludarabine|mesh-list
19673940|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19673941|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
19673942|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673943|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19673944|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19673945|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
19673946|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319468|NCT04013477|Donepezil|donepezil|mesh-list
19319469|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19319470|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319471|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319472|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
19319473|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319474|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319475|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
19319476|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
19319477|NCT04013243|Analgesics|analgesics|mesh-ancestor
19319478|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
19319479|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319480|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319481|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
19319482|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319483|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19319484|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
19319485|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19319486|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19319487|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319488|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19319489|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
19319490|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19319491|NCT04013464|Citalopram|citalopram|mesh-list
19319492|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19673947|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673948|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19319493|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19319494|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19319495|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319496|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319497|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
19319498|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319499|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19319500|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
19319501|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19319502|NCT04012918|Capecitabine|capecitabine|mesh-list
20373204|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19319503|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19319504|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19319505|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
19319506|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319507|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373205|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20373206|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20373207|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20373208|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20373209|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20373210|NCT00984178|Sargramostim|sargramostim|mesh-list
20373211|NCT00984178|Immunologic Factors|immunologic factors|mesh-ancestor
20373212|NCT00984178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373213|NCT00984217|Panitumumab|panitumumab|mesh-list
20373214|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20373215|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373216|NCT00984230|Lactoferrin|lactoferrin|mesh-list
20373217|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373218|NCT00984347|Oxytocin|oxytocin|mesh-list
19319508|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19319509|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319510|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19319511|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
19319512|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319513|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319514|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19840757|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19840758|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19840759|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840760|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19840761|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19840762|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840763|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840764|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373219|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
20373220|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20373221|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373222|NCT00984360|Naltrexone|naltrexone|mesh-list
20373223|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20373224|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20373225|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373226|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
20373227|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373228|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20373229|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20373230|NCT00984386|Estradiol|estradiol|mesh-list
20373231|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20373232|NCT00984386|Estrogens|estrogens|mesh-ancestor
20373233|NCT00984386|Hormones|hormones|mesh-ancestor
20373234|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373235|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373236|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20373237|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
19398013|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20188975|NCT00211796|Valproic Acid|valproic acid|mesh-list
20188976|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
20188977|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20188978|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188979|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
20188980|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20188981|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188982|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
20188983|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20188984|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20188985|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20188986|NCT00211848|Interferons|interferons|mesh-list
20188987|NCT00211848|Ribavirin|ribavirin|mesh-list
20188988|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20188989|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
20188990|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20188991|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
20188992|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373238|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20373239|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20373240|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19319515|NCT04012619|Cisplatin|cisplatin|mesh-list
19319516|NCT04012619|Carboplatin|carboplatin|mesh-list
19319517|NCT04012619|Pemetrexed|pemetrexed|mesh-list
19319518|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319519|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319520|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319521|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19319522|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19319523|NCT04012775|Insulin|insulin|mesh-list
19319524|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19319525|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319526|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319527|NCT04012606|Carboplatin|carboplatin|mesh-list
19319528|NCT04012606|Etoposide|etoposide|mesh-list
19319529|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319530|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19319531|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19319532|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19319533|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319534|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319535|NCT04012450|Anesthetics|anesthetics|mesh-list
19319536|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319537|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319538|NCT04012424|Curcumin|curcumin|mesh-list
19319539|NCT04012424|Analgesics|analgesics|mesh-list
19319540|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19319541|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319542|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
19319543|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319544|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319545|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319546|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319547|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373241|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19319548|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319549|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319550|NCT04012307|Candesartan|candesartan|mesh-list
19319551|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
19319552|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19319553|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19319554|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19319555|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319556|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19319557|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19319558|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319559|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319560|NCT04012268|Aspirin|aspirin|mesh-list
19319561|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19319562|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319563|NCT04012268|Analgesics|analgesics|mesh-ancestor
19319564|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
19319565|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319566|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319567|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319568|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373242|NCT00984399|Estradiol|estradiol|mesh-list
20373243|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20373244|NCT00984399|Estrogens|estrogens|mesh-ancestor
20373245|NCT00984399|Hormones|hormones|mesh-ancestor
20373246|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373247|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373248|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20373249|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
20373250|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20373251|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20373252|NCT00984425|Sorafenib|sorafenib|mesh-list
20373253|NCT00984425|Lapatinib|lapatinib|mesh-list
20373254|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373255|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20373256|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373257|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373258|NCT00984438|Bevacizumab|bevacizumab|mesh-list
19319569|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19319570|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19319571|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20188993|NCT00211939|Atorvastatin|atorvastatin|mesh-list
20373259|NCT00984438|Irinotecan|irinotecan|mesh-list
19319572|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19319573|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19319574|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319575|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
19319576|NCT04012047|Cromakalim|cromakalim|mesh-list
19319577|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20188994|NCT00211939|Calcium|calcium|mesh-list
20188995|NCT00211939|Sevelamer|sevelamer|mesh-list
20188996|NCT00211939|Calcium acetate|calcium acetate|mesh-list
19319578|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19319579|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
19319580|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319581|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319582|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19319583|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
19319584|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
19319585|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
19319586|NCT04012294|Allopurinol|allopurinol|mesh-list
19319587|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
19319588|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319589|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319590|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
19319591|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319592|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19319593|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
19319594|NCT04012294|Protective Agents|protective agents|mesh-ancestor
19319595|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319596|NCT04011930|Vitamin D|vitamin d|mesh-list
19319597|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
19319598|NCT04011930|Calcitriol|calcitriol|mesh-list
19319599|NCT04011930|Vitamins|vitamins|mesh-ancestor
19319600|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
19319601|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319602|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19319603|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19319604|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20188997|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20188998|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20188999|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19319605|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19319606|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319607|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19319608|NCT04011813|Antioxidants|antioxidants|mesh-list
19319609|NCT04011813|Hypotaurine|hypotaurine|mesh-list
19319610|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319611|NCT04011813|Protective Agents|protective agents|mesh-ancestor
19319612|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319613|NCT04011670|Caffeine|caffeine|mesh-list
19319614|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19319615|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319616|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20189000|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20189001|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
20189002|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189003|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20189004|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20189005|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189006|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
20189007|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
20189008|NCT00211952|Celecoxib|celecoxib|mesh-list
20189009|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20189010|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20189011|NCT00211952|Analgesics|analgesics|mesh-ancestor
20189012|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
20217382|NCT00309517|Protective Agents|protective agents|mesh-ancestor
19319617|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19673949|NCT02130882|Benralizumab|benralizumab|mesh-list
19673950|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19673951|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
19840765|NCT00635609|Doxycycline|doxycycline|mesh-list
19673952|NCT02130453|Regadenoson|regadenoson|mesh-list
19319618|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319619|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20189013|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189014|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189015|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20189016|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189017|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20189018|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20189019|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189020|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189021|NCT00211978|Calcium|calcium|mesh-list
20189022|NCT00211978|Calcium acetate|calcium acetate|mesh-list
19319620|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19319621|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
19319622|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319623|NCT04011748|Minoxidil|minoxidil|mesh-list
19319624|NCT04011748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19319625|NCT04011748|Vasodilator Agents|vasodilator agents|mesh-ancestor
19319626|NCT04011878|Mitomycins|mitomycins|mesh-list
19319627|NCT04011878|Mitomycin|mitomycin|mesh-list
19319628|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19319629|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319630|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
19319631|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319632|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19319633|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319634|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
19319635|NCT04011475|Olodaterol|olodaterol|mesh-list
19319636|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19319637|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
19319638|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319639|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319640|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19319641|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
19319642|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
19319643|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19319644|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
19319645|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319646|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319647|NCT04011345|Folic Acid|folic acid|mesh-list
19319648|NCT04011345|Hematinics|hematinics|mesh-ancestor
19319649|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
19319650|NCT04011345|Vitamins|vitamins|mesh-ancestor
19319651|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
19319652|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319653|NCT04011280|Varenicline|varenicline|mesh-list
19319654|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19319655|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19319656|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
19319657|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319658|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319659|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319660|NCT04011124|Rifampin|rifampin|mesh-list
19319661|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19319662|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
19319663|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19319664|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319665|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
19673953|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19673954|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19673955|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
19673956|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
19673957|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19673958|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673959|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189023|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20189024|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189025|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
20189026|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
20189027|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189028|NCT00212004|Pioglitazone|pioglitazone|mesh-list
20189029|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319666|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19319667|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319668|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189030|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189031|NCT00212017|Voglibose|voglibose|mesh-list
20189032|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20189033|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189034|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20189035|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189036|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189037|NCT00212030|Nicorandil|nicorandil|mesh-list
20189038|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20373260|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20373261|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373262|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20373263|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19319669|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19319670|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19319671|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19319672|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19319673|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19319674|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20373264|NCT00984438|Growth Substances|growth substances|mesh-ancestor
20373265|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319675|NCT04010955|Edoxaban|edoxaban|mesh-list
19319676|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19319677|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
19319678|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19319679|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
19840766|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20373266|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
20373267|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20373268|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20373269|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373270|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373271|NCT00984451|Vaccines|vaccines|mesh-list
20373272|NCT00984451|Immunologic Factors|immunologic factors|mesh-ancestor
20373273|NCT00984451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373274|NCT00984464|Paclitaxel|paclitaxel|mesh-list
20373275|NCT00984464|Carboplatin|carboplatin|mesh-list
20373276|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20373277|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373278|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
20373279|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
20373280|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
20373281|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373282|NCT00984633|Bromides|bromides|mesh-list
20373283|NCT00984633|Propofol|propofol|mesh-list
20373284|NCT00984633|Sevoflurane|sevoflurane|mesh-list
20373285|NCT00984633|Rocuronium|rocuronium|mesh-list
20373286|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20373287|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373288|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373289|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20373290|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
20373291|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
20373292|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20373293|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20373294|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
20373295|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20373296|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20373297|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20373298|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373299|NCT00984724|Nicotine|nicotine|mesh-list
20373300|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20373301|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
20373302|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373303|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373304|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20373305|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20373306|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
20373307|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373308|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373309|NCT00984737|Insulin|insulin|mesh-list
20373310|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20373311|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319680|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319681|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319682|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
19319683|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
19319684|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
19319685|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19319686|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19319687|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319688|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319689|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319690|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319691|NCT04011241|Itraconazole|itraconazole|mesh-list
19319692|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
19319693|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319694|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19319695|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19319696|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319697|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319698|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19319699|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
19319700|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319701|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319702|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20373312|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
20373313|NCT00984750|Simvastatin|simvastatin|mesh-list
20373314|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20373315|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20373316|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
20373317|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373318|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20373319|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20373320|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373321|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
20373322|NCT00984750|Vitamins|vitamins|mesh-ancestor
20373323|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
20373324|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373325|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
20373326|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20373327|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20373328|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
20373329|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373330|NCT00984763|Antacids|antacids|mesh-ancestor
20373331|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373332|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20373333|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20373334|NCT00984789|Gestodene|gestodene|mesh-list
20373335|NCT00984789|Norelgestromin|norelgestromin|mesh-list
19319703|NCT04011098|Fentanyl|fentanyl|mesh-list
19319704|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19319705|NCT04011098|Narcotics|narcotics|mesh-ancestor
19319706|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319707|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319708|NCT04011098|Analgesics|analgesics|mesh-ancestor
20373336|NCT00984789|Femovan|femovan|mesh-list
19319709|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
19319710|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319711|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19319712|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19319713|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
19319714|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
19319715|NCT04010968|Venetoclax|venetoclax|mesh-list
20373337|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20373338|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20373339|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20373340|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
20373341|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20373342|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373343|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20373344|NCT00984789|Estrogens|estrogens|mesh-ancestor
20373345|NCT00984789|Hormones|hormones|mesh-ancestor
19319716|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319717|NCT04011163|Morphine|morphine|mesh-list
20373346|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319718|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20373347|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19319719|NCT04011163|Narcotics|narcotics|mesh-ancestor
19319720|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373348|NCT00984789|Progestins|progestins|mesh-ancestor
20373349|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20373350|NCT00984828|Bortezomib|bortezomib|mesh-list
20373351|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373352|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
20373353|NCT00984893|Diphosphonates|diphosphonates|mesh-list
20373354|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20373355|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373356|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19319721|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319722|NCT04011163|Analgesics|analgesics|mesh-ancestor
19319723|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
19319724|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319725|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
19319726|NCT04011033|Interleukin-2|interleukin-2|mesh-list
19319727|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19319728|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
19319729|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319730|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319731|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20189039|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19319732|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
19319733|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319734|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319735|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19319736|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319737|NCT04011033|Analgesics|analgesics|mesh-ancestor
19319738|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
19319739|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319740|NCT04010929|Pemetrexed|pemetrexed|mesh-list
19319741|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319742|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319743|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319744|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19319745|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19398014|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19398015|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398016|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398017|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398018|NCT03646526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19398019|NCT03646526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19398020|NCT03646526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398021|NCT03646500|Remifentanil|remifentanil|mesh-list
19398022|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19398023|NCT03646500|Narcotics|narcotics|mesh-ancestor
20373357|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20373358|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19840767|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840768|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
20189040|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
19398024|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398025|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398026|NCT03646500|Analgesics|analgesics|mesh-ancestor
19398027|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
19398028|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189041|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
20189042|NCT00212030|Vitamins|vitamins|mesh-ancestor
20189043|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
20189044|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189045|NCT00212043|Gemcitabine|gemcitabine|mesh-list
20189046|NCT00212043|Carboplatin|carboplatin|mesh-list
20189047|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189048|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189049|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
20189050|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189051|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
20189052|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189053|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398029|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
19398030|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19840769|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20189054|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189055|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
20373359|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
19319746|NCT04010942|Metformin|metformin|mesh-list
20373360|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373361|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20373362|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20373363|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425854|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425855|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425856|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20425857|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
20425858|NCT01277185|Calcium|calcium|mesh-list
20425859|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20425860|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425861|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20425862|NCT01277289|Dexamethasone|dexamethasone|mesh-list
20425863|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425864|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
20425865|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
20425866|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425867|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319747|NCT04010942|Clomiphene|clomiphene|mesh-list
19319748|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319749|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319750|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19319751|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
19673960|NCT02055963|Minocycline|minocycline|mesh-list
19673961|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20425868|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19319752|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319753|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19319754|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
19319755|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19319756|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19319757|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19319758|NCT04010903|Insulin|insulin|mesh-list
19319759|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319760|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425869|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
20425870|NCT01277289|Hormones|hormones|mesh-ancestor
20425871|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319761|NCT04010669|Somatostatin|somatostatin|mesh-list
19319762|NCT04010669|Hormones|hormones|mesh-ancestor
19319763|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319764|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319765|NCT04010578|Vitamin D|vitamin d|mesh-list
19319766|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
19319767|NCT04010578|Vitamins|vitamins|mesh-ancestor
19319768|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
20425872|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20425873|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425874|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20425875|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20425876|NCT01277484|Decitabine|decitabine|mesh-list
20425877|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20425878|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
20425879|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425880|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425881|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425882|NCT01277497|Calcium|calcium|mesh-list
20425883|NCT01277497|Sevelamer|sevelamer|mesh-list
20425884|NCT01277497|Calcium acetate|calcium acetate|mesh-list
20425885|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20425886|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425887|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
20425888|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
20425889|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425890|NCT01277627|Efavirenz|efavirenz|mesh-list
20425891|NCT01277627|Nevirapine|nevirapine|mesh-list
20425892|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20425893|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
20425894|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19319769|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319770|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19319771|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19673962|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373364|NCT00984945|Vaccines|vaccines|mesh-list
20373365|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
20373366|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373367|NCT00984971|Tenofovir|tenofovir|mesh-list
20373368|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
20373369|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373370|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20373371|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373372|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373373|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373374|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20373375|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20373376|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
20373377|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20373378|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20373379|NCT00984984|Prednisolone|prednisolone|mesh-list
20373380|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
20373381|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20373382|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
20373383|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20373384|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
20373385|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
20373386|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373387|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373388|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20373389|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
20373390|NCT00984984|Hormones|hormones|mesh-ancestor
20373391|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373392|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20373393|NCT00984984|Protective Agents|protective agents|mesh-ancestor
20373394|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20373395|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373396|NCT00984997|Etoposide|etoposide|mesh-list
20373397|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373398|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20373399|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19319772|NCT04010318|Anesthetics|anesthetics|mesh-list
19319773|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319774|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319775|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
19319776|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19319777|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319778|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319779|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319780|NCT04010305|Analgesics|analgesics|mesh-ancestor
19319781|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
19319782|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319783|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19319784|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19673963|NCT01976169|Palbociclib|palbociclib|mesh-list
19673964|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19673965|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373400|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20373401|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319785|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19319786|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
19319787|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319788|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319789|NCT04010071|Axitinib|axitinib|mesh-list
19319790|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319791|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19319792|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319793|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319794|NCT04009759|Ketamine|ketamine|mesh-list
19319795|NCT04009759|Morphine|morphine|mesh-list
19319796|NCT04009759|Analgesics|analgesics|mesh-ancestor
19319797|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
19319798|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319799|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319800|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19319801|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20373402|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373403|NCT00985244|Azithromycin|azithromycin|mesh-list
19319802|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
19319803|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
19319804|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319805|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19319806|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19319807|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319808|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373404|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20373405|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373406|NCT00985270|Rifampin|rifampin|mesh-list
20373407|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20373408|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
20373409|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20373410|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319809|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19319810|NCT04009759|Narcotics|narcotics|mesh-ancestor
19319811|NCT04009772|Metronidazole|metronidazole|mesh-list
19319812|NCT04009772|Cefuroxime|cefuroxime|mesh-list
19319813|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
19319814|NCT04009772|Cefepime|cefepime|mesh-list
19319815|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319816|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19319817|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19319818|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19319819|NCT04009889|Silicon|silicon|mesh-list
19319820|NCT04009889|Trace Elements|trace elements|mesh-ancestor
19319821|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
19319822|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319823|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
19319824|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19319825|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373411|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
20373412|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373413|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373414|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373415|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20373416|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20373417|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20373418|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20373419|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20373420|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20373421|NCT00985322|Ramipril|ramipril|mesh-list
20373422|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
20373423|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20373424|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
20373425|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373426|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373427|NCT00985348|Levetiracetam|levetiracetam|mesh-list
20373428|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
19319826|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
19319827|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
19319828|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319829|NCT04009603|Metformin|metformin|mesh-list
19319830|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319831|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319832|NCT04009525|Cyclosporine|cyclosporine|mesh-list
19319833|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
19673966|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19673967|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373429|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
20373430|NCT00985361|Vitamin D|vitamin d|mesh-list
20373431|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
20373432|NCT00985361|Vitamins|vitamins|mesh-list
19673968|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673969|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19319834|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
19319835|NCT04009525|Busulfan|busulfan|mesh-list
19319836|NCT04009525|Methotrexate|methotrexate|mesh-list
19319837|NCT04009525|Fludarabine|fludarabine|mesh-list
19319838|NCT04009525|Tacrolimus|tacrolimus|mesh-list
19319839|NCT04009525|Cyclosporins|cyclosporins|mesh-list
19319840|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
19319841|NCT04009525|Basiliximab|basiliximab|mesh-list
19319842|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19319843|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
19319844|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319845|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373433|NCT00985361|Ascorbic Acid|ascorbic acid|mesh-list
19319846|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19319847|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
19319848|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319849|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319850|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19673970|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673971|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673972|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
19673973|NCT01827111|Paclitaxel|paclitaxel|mesh-list
19673974|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19840770|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20373434|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
20373435|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373436|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20373437|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20373438|NCT00985361|Antioxidants|antioxidants|mesh-ancestor
20373439|NCT00985361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373440|NCT00985361|Protective Agents|protective agents|mesh-ancestor
20373441|NCT00985374|Everolimus|everolimus|mesh-list
19319851|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19319852|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
19319853|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19319854|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19319855|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
19319856|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
20373442|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373443|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373444|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
20373445|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373446|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
19319857|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319858|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19319859|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373447|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20373448|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20373449|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
20373450|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373451|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373452|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373453|NCT00985387|Urological Agents|urological agents|mesh-ancestor
20373454|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
20373455|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373456|NCT00985556|Capecitabine|capecitabine|mesh-list
19319860|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19319861|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
19319862|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19319863|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19319864|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19319865|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
19319866|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19319867|NCT04009317|Crizotinib|crizotinib|mesh-list
19319868|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319869|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19319870|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319871|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319872|NCT04008979|Aspirin|aspirin|mesh-list
19319873|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19319874|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19319875|NCT04008979|Analgesics|analgesics|mesh-ancestor
19319876|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
19319877|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319878|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319879|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19673975|NCT01827111|Ipilimumab|ipilimumab|mesh-list
19673976|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19673977|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19673978|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
19673979|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
19673980|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
19673981|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19673982|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19673983|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19673984|NCT01631292|Vitamin D|vitamin d|mesh-list
20373457|NCT00985556|Tegafur|tegafur|mesh-list
20373458|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
20373459|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19319880|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19319881|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19319882|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20373460|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
20373461|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373462|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373463|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20373464|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20373465|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373466|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
20373467|NCT00985647|Lamivudine|lamivudine|mesh-list
20373468|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20373469|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373470|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373471|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319883|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319884|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19319885|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19319886|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319887|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
19319888|NCT04009018|Anesthetics|anesthetics|mesh-list
19319889|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19319890|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319891|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
19319892|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
19319893|NCT04009044|Tamoxifen|tamoxifen|mesh-list
19319894|NCT04009044|Afimoxifene|afimoxifene|mesh-list
19319895|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19319896|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
19319897|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319898|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319899|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19319900|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319901|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19319902|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19319903|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19319904|NCT04008784|Triamcinolone|triamcinolone|mesh-list
19319905|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19319906|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20373472|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
20373473|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373474|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19319907|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19319908|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319909|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
19319910|NCT04008784|Hormones|hormones|mesh-ancestor
19319911|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319912|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319913|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19319914|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
19319915|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319916|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398031|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19398032|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398033|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
19398034|NCT03646474|Coagulants|coagulants|mesh-ancestor
19398035|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
19398036|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
19398037|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398038|NCT03646370|Tenofovir|tenofovir|mesh-list
19398039|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
19398040|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398041|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19398042|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19398043|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398044|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398045|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20373475|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20373476|NCT00985660|Nisoldipine|nisoldipine|mesh-list
20373477|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20373478|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19673985|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
19398046|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19398047|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19673986|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
19673987|NCT01631292|Vitamins|vitamins|mesh-list
19673988|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
19673989|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673990|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19673991|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19673992|NCT01437111|Vitamin D|vitamin d|mesh-list
19673993|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
19673994|NCT01437111|Alendronate|alendronate|mesh-list
19673995|NCT01437111|Vitamins|vitamins|mesh-ancestor
19840771|NCT00635648|Caspofungin|caspofungin|mesh-list
19319917|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19319918|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19319919|NCT04008966|Cetrorelix|cetrorelix|mesh-list
19319920|NCT04008966|Progesterone|progesterone|mesh-list
19319921|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19319922|NCT04008966|Progestins|progestins|mesh-ancestor
19319923|NCT04008966|Hormones|hormones|mesh-ancestor
19319924|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319925|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319926|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
19319927|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19319928|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
19319929|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19319930|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19319931|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19319932|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319933|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19319934|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
19319935|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
19319936|NCT04008888|Dexamethasone|dexamethasone|mesh-list
19319937|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
19319938|NCT04008888|Fludarabine|fludarabine|mesh-list
19319939|NCT04008888|Melphalan|melphalan|mesh-list
19319940|NCT04008888|BB 1101|bb 1101|mesh-list
19319941|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19319942|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
19319943|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
19319944|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319945|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319946|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19319947|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
19319948|NCT04008888|Hormones|hormones|mesh-ancestor
19319949|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319950|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19319951|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840772|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
19840773|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840774|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840775|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840776|NCT00635700|Ziprasidone|ziprasidone|mesh-list
19840777|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19840778|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
19840779|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840780|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840781|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373479|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20373480|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319952|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
19319953|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19319954|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319955|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19319956|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
19319957|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19319958|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
19319959|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20373481|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20373482|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373483|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
20373484|NCT00985777|Vitamin E|vitamin e|mesh-list
20373485|NCT00985777|Tocopherols|tocopherols|mesh-list
20373486|NCT00985777|Tocotrienols|tocotrienols|mesh-list
19319960|NCT04008511|Capecitabine|capecitabine|mesh-list
19319961|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
19319962|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19319963|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
19673996|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
19673997|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19673998|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19319964|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319965|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19319966|NCT04008290|Liraglutide|liraglutide|mesh-list
19319967|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319968|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319969|NCT04008290|Incretins|incretins|mesh-ancestor
19319970|NCT04008290|Hormones|hormones|mesh-ancestor
19319971|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19319972|NCT04008264|Scopolamine|scopolamine|mesh-list
19319973|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19319974|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19319975|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
19319976|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
19319977|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19319978|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319979|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19319980|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
19319981|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19319982|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
19319983|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19319984|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19319985|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19319986|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
19319987|NCT04008186|Metformin|metformin|mesh-list
19319988|NCT04008186|Repaglinide|repaglinide|mesh-list
19319989|NCT04008186|Itraconazole|itraconazole|mesh-list
19319990|NCT04008186|Digoxin|digoxin|mesh-list
19319991|NCT04008186|Verapamil|verapamil|mesh-list
19319992|NCT04008186|Midazolam|midazolam|mesh-list
19319993|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19319994|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
19319995|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19319996|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19319997|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19319998|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19319999|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320000|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19320001|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20189056|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189057|NCT00212069|Gemcitabine|gemcitabine|mesh-list
20189058|NCT00212069|Carboplatin|carboplatin|mesh-list
20189059|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189060|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20373487|NCT00985777|Vitamins|vitamins|mesh-ancestor
19320002|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19320003|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19320004|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
19320005|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
19320006|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
19320007|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
19320008|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320009|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320010|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19320011|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19320012|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
19320013|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19320014|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19320015|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320016|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
19320017|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320018|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19320019|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19320020|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19320021|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
19320022|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320023|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19320024|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19320025|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19673999|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19674000|NCT01364597|Brivaracetam|brivaracetam|mesh-list
20189061|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
19320026|NCT04008186|Protective Agents|protective agents|mesh-ancestor
19320027|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19320028|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19320029|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19320030|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
19320031|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19320032|NCT04008433|Lidocaine|lidocaine|mesh-list
19320033|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
19320034|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
19320035|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320036|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320037|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
19320038|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320039|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19840782|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19840783|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19840784|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840785|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20373488|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
20373489|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320040|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19320041|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19320042|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19320043|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320044|NCT04008316|Colchicine|colchicine|mesh-list
19320045|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
19320046|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320047|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
19320048|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
19320049|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320050|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320051|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320052|NCT04008043|Acetaminophen|acetaminophen|mesh-list
19320053|NCT04008043|Dexamethasone|dexamethasone|mesh-list
19320054|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19320055|NCT04008043|Hydrocodone|hydrocodone|mesh-list
19320056|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320057|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
19320058|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
19320059|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320060|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320061|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320062|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
19320063|NCT04008043|Hormones|hormones|mesh-ancestor
19320064|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320065|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19320066|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320067|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19320068|NCT04008043|Analgesics|analgesics|mesh-ancestor
19320069|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
19320070|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
19320071|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19840786|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20373490|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
20373491|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373492|NCT00985777|Protective Agents|protective agents|mesh-ancestor
20373493|NCT00985855|Etoposide|etoposide|mesh-list
20373494|NCT00985855|Cetuximab|cetuximab|mesh-list
20373495|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320072|NCT04008043|Narcotics|narcotics|mesh-ancestor
19320073|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320074|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
19320075|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
19320076|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19320077|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320078|NCT04007809|Glucagon|glucagon|mesh-list
19320079|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320080|NCT04007809|Hormones|hormones|mesh-ancestor
19320081|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320082|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320083|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
19320084|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19320085|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320086|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19320087|NCT04007835|Gefitinib|gefitinib|mesh-list
19840787|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
19840788|NCT00635817|Leuprolide|leuprolide|mesh-list
20373496|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19320088|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320089|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19320090|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320091|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320092|NCT04008030|Leucovorin|leucovorin|mesh-list
19320093|NCT04008030|Bevacizumab|bevacizumab|mesh-list
19320094|NCT04008030|Nivolumab|nivolumab|mesh-list
19320095|NCT04008030|Cetuximab|cetuximab|mesh-list
19320096|NCT04008030|Ipilimumab|ipilimumab|mesh-list
19320097|NCT04008030|Fluorouracil|fluorouracil|mesh-list
19320098|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
19320099|NCT04008030|Irinotecan|irinotecan|mesh-list
19320100|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19320101|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320102|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19320103|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19320104|NCT04008030|Growth Substances|growth substances|mesh-ancestor
19320105|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320106|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
19320107|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
19320108|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320109|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19320110|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320111|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
19320112|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19320113|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19320114|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19320115|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320116|NCT04008030|Antidotes|antidotes|mesh-ancestor
19320117|NCT04008030|Protective Agents|protective agents|mesh-ancestor
20373497|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20373498|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20373499|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373500|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373501|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20373502|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
20373503|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20373504|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19320118|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
19320119|NCT04008030|Vitamins|vitamins|mesh-ancestor
19320120|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
19320121|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
19320122|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
19320123|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320124|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
19320125|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
19320126|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19320127|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19320128|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320129|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320130|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320131|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320132|NCT04007588|Nivolumab|nivolumab|mesh-list
19320133|NCT04007588|Ipilimumab|ipilimumab|mesh-list
19320134|NCT04007588|Linrodostat|linrodostat|mesh-list
19320135|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19320136|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320137|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19320138|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320139|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320140|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
19320141|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19320142|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19320143|NCT04007328|Prednisolone|prednisolone|mesh-list
19320144|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
19320145|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19320146|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
19320147|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320148|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
19320149|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
19320150|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320151|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320152|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320153|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
19320154|NCT04007328|Hormones|hormones|mesh-ancestor
19320155|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320156|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19320157|NCT04007328|Protective Agents|protective agents|mesh-ancestor
19320158|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19320159|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320160|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
19320161|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19320162|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320163|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320164|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19320165|NCT04007341|Analgesics|analgesics|mesh-ancestor
19320166|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
19320167|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320168|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19320169|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19674001|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
19674002|NCT01349101|Vidarabine|vidarabine|mesh-list
19674003|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
19674004|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
19674005|NCT01349101|Busulfan|busulfan|mesh-list
19674006|NCT01349101|Fludarabine|fludarabine|mesh-list
20189062|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320170|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19320171|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
19320172|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320173|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320174|NCT04007393|Topiramate|topiramate|mesh-list
19320175|NCT04007393|Phentermine|phentermine|mesh-list
19320176|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
19320177|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19320178|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320179|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19320180|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
19320181|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19320182|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
19320183|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
19320184|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320185|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
19320186|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320187|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320188|NCT04007003|Insulin|insulin|mesh-list
19320189|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19320190|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320191|NCT04007055|Ticagrelor|ticagrelor|mesh-list
19320192|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19320193|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19320194|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19320195|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19320196|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
19320197|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320198|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320199|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320200|NCT04006873|Ivacaftor|ivacaftor|mesh-list
19320201|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19320202|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19320203|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320204|NCT04006847|Dasatinib|dasatinib|mesh-list
19320205|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320206|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19320207|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320208|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320209|NCT04006821|Apatinib|apatinib|mesh-list
19320210|NCT04006821|Antibodies|antibodies|mesh-list
19320211|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
19320212|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320213|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320214|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19320215|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320216|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320217|NCT04006470|Fluorides|fluorides|mesh-list
19320218|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
19320219|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
19320220|NCT04006470|Protective Agents|protective agents|mesh-ancestor
19674007|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
19320221|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674008|NCT01349101|Tacrolimus|tacrolimus|mesh-list
19674009|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320222|NCT04006639|Analgesics|analgesics|mesh-list
19320223|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
19320224|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320225|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398048|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19398049|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
20373505|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373506|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
20373507|NCT00985920|Coagulants|coagulants|mesh-ancestor
20373508|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
20373509|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19398050|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398051|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398052|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398053|NCT03646318|Ketanserin|ketanserin|mesh-list
19398054|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20373510|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373511|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20373512|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
20373513|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373514|NCT00986050|Sirolimus|sirolimus|mesh-list
20373515|NCT00986050|Abciximab|abciximab|mesh-list
20373516|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20373517|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373518|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20373519|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373520|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
20373521|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373522|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
20373523|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373524|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
20373525|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20373526|NCT00986076|Enoxaparin|enoxaparin|mesh-list
20373527|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
20373528|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20373529|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19398055|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19398056|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19398057|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
19398058|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398059|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398060|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373530|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373531|NCT00986115|Memantine|memantine|mesh-list
20373532|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20373533|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20373534|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
20373535|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373536|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373537|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373538|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20373539|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20373540|NCT00986128|Topiramate|topiramate|mesh-list
20373541|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
20373542|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20373543|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373544|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19674010|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
19674011|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674012|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19674013|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19674014|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
19674015|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373545|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
19398061|NCT03646292|Pioglitazone|pioglitazone|mesh-list
19398062|NCT03646292|Empagliflozin|empagliflozin|mesh-list
19398063|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19398064|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398065|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19398066|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398067|NCT03646266|Bromides|bromides|mesh-list
19398068|NCT03646266|Rocuronium|rocuronium|mesh-list
19398069|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
19674016|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373546|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19840789|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19840790|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
19320226|NCT04006483|Fluorides|fluorides|mesh-list
19320227|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
19320228|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
20373547|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20373548|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20373549|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373550|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373551|NCT00986284|Gefitinib|gefitinib|mesh-list
20373552|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373553|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20373554|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373555|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373556|NCT00986336|Topiramate|topiramate|mesh-list
20373557|NCT00986336|Risperidone|risperidone|mesh-list
20373558|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20373559|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
20373560|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373561|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320229|NCT04006483|Protective Agents|protective agents|mesh-ancestor
19320230|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373562|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373563|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20373564|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20373565|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373566|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20373567|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20373568|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
20373569|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
20373570|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20373571|NCT00986466|Vitamin D|vitamin d|mesh-list
20373572|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
20373573|NCT00986466|Vitamins|vitamins|mesh-list
20373574|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
20373575|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373576|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20373577|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20373578|NCT00986505|Lidocaine|lidocaine|mesh-list
20373579|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
20373580|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
20373581|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373582|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373583|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
20373584|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373585|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20373586|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20373587|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19320231|NCT04006262|Nivolumab|nivolumab|mesh-list
19320232|NCT04006262|Ipilimumab|ipilimumab|mesh-list
19320233|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19320234|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320235|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19320236|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320237|NCT04006691|Mitomycins|mitomycins|mesh-list
19320238|NCT04006691|Mitomycin|mitomycin|mesh-list
19320239|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19320240|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320241|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
19320242|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373588|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20373589|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373590|NCT00986557|Ganciclovir|ganciclovir|mesh-list
20373591|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20373592|NCT00986557|Foscarnet|foscarnet|mesh-list
19320243|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19320244|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320245|NCT04006080|Vedolizumab|vedolizumab|mesh-list
19320246|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320247|NCT04006093|Apixaban|apixaban|mesh-list
19320248|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19320249|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
19320250|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19320251|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
19320252|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398070|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19320253|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320254|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
19320255|NCT04006041|Paclitaxel|paclitaxel|mesh-list
19320256|NCT04006041|Cisplatin|cisplatin|mesh-list
19320257|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19320258|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320259|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
19320260|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
19320261|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320262|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320263|NCT04006353|Rifampin|rifampin|mesh-list
19320264|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19320265|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
19320266|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19320267|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320268|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
19320269|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19320270|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320271|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320272|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19320273|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19320274|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19320275|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19320276|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19320277|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19320278|NCT04006054|Midazolam|midazolam|mesh-list
19320279|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
19320280|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19320281|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320282|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320283|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19320284|NCT04006054|Analgesics|analgesics|mesh-ancestor
19320285|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
20373593|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20373594|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
20373595|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20373596|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320286|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320287|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19320288|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19320289|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19320290|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
19320291|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320292|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320293|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19320294|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20189063|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
20189064|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189065|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189066|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189067|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
20189068|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189069|NCT00212082|Docetaxel|docetaxel|mesh-list
20189070|NCT00212082|Doxorubicin|doxorubicin|mesh-list
20189071|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189072|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189073|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189074|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189075|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189076|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20189077|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20189078|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20189079|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189080|NCT00212095|Ketoconazole|ketoconazole|mesh-list
20189081|NCT00212095|Docetaxel|docetaxel|mesh-list
20189082|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189083|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189084|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189085|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189086|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189087|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
20189088|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189089|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19320295|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19320296|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19320297|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19320298|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
19320299|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
19320300|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
19320301|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
19320302|NCT04005872|Calcium|calcium|mesh-list
19320303|NCT04005872|Fluorides|fluorides|mesh-list
19320304|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19320305|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320306|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
19320307|NCT04005872|Protective Agents|protective agents|mesh-ancestor
20189090|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20189091|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189092|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19320308|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
19320309|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
19320310|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19320311|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19320312|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320313|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320314|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320315|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320316|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
19320317|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
19320318|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19320319|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19320320|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320321|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320322|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320323|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320324|NCT04005612|Vitamin D|vitamin d|mesh-list
19320325|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
19320326|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
19320327|NCT04005612|Vitamins|vitamins|mesh-list
19320328|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
19320329|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320330|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19320331|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20189093|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
20189094|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189095|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189096|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20189097|NCT00212108|Celecoxib|celecoxib|mesh-list
20189098|NCT00212108|Gefitinib|gefitinib|mesh-list
20189099|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20189100|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20189101|NCT00212108|Analgesics|analgesics|mesh-ancestor
20189102|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
19320342|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19320343|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320344|NCT04005664|Phenylephrine|phenylephrine|mesh-list
19320345|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
19320346|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19320347|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
19320348|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
19320349|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189103|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189104|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189105|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20189106|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189107|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20189108|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20189109|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189110|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189111|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189112|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20189113|NCT00212147|Anesthetics|anesthetics|mesh-list
20189114|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189115|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320350|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320351|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
19320352|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19320353|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
20373597|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
20373598|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373599|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373600|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373601|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373602|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20373603|NCT00986596|Vitamin D|vitamin d|mesh-list
20373604|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
20373605|NCT00986596|Vitamins|vitamins|mesh-ancestor
20373606|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
20373607|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373608|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20373609|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20373610|NCT00986609|Poly I-C|poly i-c|mesh-list
20373611|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20373612|NCT00986609|Vaccines|vaccines|mesh-list
20373613|NCT00986609|Poly ICLC|poly iclc|mesh-list
20373614|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
19320354|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
19320355|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19320356|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19320357|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19320358|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
19320359|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320360|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320361|NCT04005664|Protective Agents|protective agents|mesh-ancestor
19320362|NCT04005469|Treprostinil|treprostinil|mesh-list
19320363|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19320364|NCT04005430|Dexamethasone|dexamethasone|mesh-list
19320365|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
19320366|NCT04005430|BB 1101|bb 1101|mesh-list
19320367|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320368|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
19320369|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
19320370|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320371|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320372|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320373|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
19320374|NCT04005430|Hormones|hormones|mesh-ancestor
19320375|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320376|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19320377|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674017|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19674018|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189116|NCT00212173|Sibutramine|sibutramine|mesh-list
20189117|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
20189118|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20189119|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
20189120|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20189121|NCT00212186|Selenium|selenium|mesh-list
20189122|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
19674019|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
19674020|NCT01349101|Antiviral Agents|antiviral agents|mesh-ancestor
20189123|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189124|NCT00212186|Protective Agents|protective agents|mesh-ancestor
20189125|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189126|NCT00212186|Trace Elements|trace elements|mesh-ancestor
20189127|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
20189128|NCT00212199|Orlistat|orlistat|mesh-list
20189129|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189130|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189131|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20189132|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20189133|NCT00212212|Selenium|selenium|mesh-list
20189134|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
20189135|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189136|NCT00212212|Protective Agents|protective agents|mesh-ancestor
20189137|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189138|NCT00212212|Trace Elements|trace elements|mesh-ancestor
20189139|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
20189140|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20189141|NCT00212277|Norethindrone|norethindrone|mesh-list
20189142|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
20189143|NCT00212277|Estradiol|estradiol|mesh-list
20189144|NCT00212277|Estrogens|estrogens|mesh-ancestor
20189145|NCT00212277|Hormones|hormones|mesh-ancestor
20217383|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320378|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
19320379|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320380|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320381|NCT04005365|Propranolol|propranolol|mesh-list
19320382|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19320383|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19320384|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
19320385|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320386|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320387|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320388|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19320389|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19320390|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
19320391|NCT04005326|Anesthetics|anesthetics|mesh-list
19320392|NCT04005326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320393|NCT04005326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320394|NCT04005222|Selenium|selenium|mesh-list
19320395|NCT04005222|Melatonin|melatonin|mesh-list
19320396|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
19320397|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320398|NCT04005222|Protective Agents|protective agents|mesh-ancestor
19320399|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320400|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320401|NCT04005222|Trace Elements|trace elements|mesh-ancestor
19320402|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
19320403|NCT04005417|Fluorides|fluorides|mesh-list
19320404|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
19320405|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
19320406|NCT04005417|Protective Agents|protective agents|mesh-ancestor
19320407|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320408|NCT04004754|Miltefosine|miltefosine|mesh-list
19320409|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
19320410|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320411|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320412|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19320413|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19320414|NCT04005170|Paclitaxel|paclitaxel|mesh-list
19320415|NCT04005170|Cisplatin|cisplatin|mesh-list
19320416|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19320417|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320418|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
19320419|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
19320420|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320421|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320422|NCT04004871|Paclitaxel|paclitaxel|mesh-list
19320423|NCT04004871|Cisplatin|cisplatin|mesh-list
19320424|NCT04004871|Fluorouracil|fluorouracil|mesh-list
19320425|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19320426|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320427|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
19674021|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674022|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20189146|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189147|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189148|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19320428|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19320429|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320430|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320431|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
19320432|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19320433|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320434|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
19320435|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320436|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
19320437|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20189149|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
20189150|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20189151|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20189152|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20189153|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20189154|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19674023|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320438|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
19320439|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19320440|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373615|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320441|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19320442|NCT04004988|Tirzepatide|tirzepatide|mesh-list
19320443|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19320444|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320445|NCT04004988|Incretins|incretins|mesh-ancestor
19320446|NCT04004988|Hormones|hormones|mesh-ancestor
19320447|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373616|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
20373617|NCT00986609|Laxatives|laxatives|mesh-ancestor
20373618|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20373619|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
20373620|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320448|NCT04004702|Levetiracetam|levetiracetam|mesh-list
19320449|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
19320450|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
19320451|NCT04004507|Phentolamine|phentolamine|mesh-list
19320452|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19320453|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19320454|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19320455|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19320456|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
19320457|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320458|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320459|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674024|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19674025|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19674026|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
19674027|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19674028|NCT01163383|Iodine|iodine|mesh-list
19674029|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
19674030|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19674031|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19674032|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674033|NCT01163383|Trace Elements|trace elements|mesh-ancestor
19320460|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19398071|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19398072|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19398073|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398074|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398075|NCT03646188|Doxorubicin|doxorubicin|mesh-list
19398076|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19398077|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19398078|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398079|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19398080|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19398081|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398082|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398083|NCT03646006|Bupivacaine|bupivacaine|mesh-list
19398084|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
19398085|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
19398086|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398087|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398088|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
19398089|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398090|NCT03645980|Sorafenib|sorafenib|mesh-list
19398091|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398092|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19398093|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398094|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398095|NCT03645876|Capecitabine|capecitabine|mesh-list
19398096|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
19398097|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674034|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
19674035|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674036|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674037|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674038|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674039|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19674040|NCT01057121|Lenalidomide|lenalidomide|mesh-list
19674041|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
19674042|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674043|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19398098|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
19674044|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20373621|NCT00986713|Amphotericin B|amphotericin b|mesh-list
19320461|NCT04004572|Pegaspargase|pegaspargase|mesh-list
19320462|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320463|NCT04004234|Manganese|manganese|mesh-list
19320464|NCT04004234|Gemcitabine|gemcitabine|mesh-list
19320465|NCT04004234|Paclitaxel|paclitaxel|mesh-list
19320466|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19320467|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19320468|NCT04004234|Antibodies|antibodies|mesh-list
19320469|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
19320470|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19320471|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320472|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
19320473|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
19320474|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320475|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320476|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
19320477|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320478|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19320479|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
19320480|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
19320481|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320482|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320483|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320484|NCT04004234|Trace Elements|trace elements|mesh-ancestor
19320485|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
19320486|NCT04003987|Bupivacaine|bupivacaine|mesh-list
19320487|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
19320488|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
19320489|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320490|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320491|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
19320492|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320493|NCT04004117|Fentanyl|fentanyl|mesh-list
19320494|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19320495|NCT04004117|Narcotics|narcotics|mesh-ancestor
19320496|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320497|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320498|NCT04004117|Analgesics|analgesics|mesh-ancestor
19320499|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
19320500|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320501|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19320502|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19320503|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
19320504|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
19320505|NCT04003948|Ibogaine|ibogaine|mesh-list
19320506|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
19320507|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320508|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19320509|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19320510|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19320511|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320512|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320513|NCT04003844|Aspirin|aspirin|mesh-list
19320514|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
19320515|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19320516|NCT04003844|Antibodies|antibodies|mesh-list
19320517|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
19320518|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
19320519|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373622|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20373623|NCT00986713|Amebicides|amebicides|mesh-ancestor
20373624|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19320520|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19320521|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19320522|NCT04003844|Analgesics|analgesics|mesh-ancestor
19320523|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
19320524|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320525|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320526|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320527|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19320528|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19320529|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320530|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19320531|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19320532|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320533|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
19320534|NCT04003922|Adalimumab|adalimumab|mesh-list
19320535|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320536|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320537|NCT04003792|Bevacizumab|bevacizumab|mesh-list
19320538|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
19320539|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19320540|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320541|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19320542|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19320543|NCT04003792|Growth Substances|growth substances|mesh-ancestor
19320544|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320545|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
19320546|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
19320547|NCT04003688|Analgesics|analgesics|mesh-ancestor
19320548|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
19320549|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320550|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320551|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
19320552|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320553|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19320554|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
19320555|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19320556|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19320557|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320558|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19320559|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
19320560|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19320561|NCT04003376|Vitamin D|vitamin d|mesh-list
19320562|NCT04003376|Triamcinolone|triamcinolone|mesh-list
19320563|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19320564|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19320565|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19320566|NCT04003376|Vitamins|vitamins|mesh-ancestor
19320567|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
19320568|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320569|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20373625|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20373626|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373627|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19320570|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320571|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
19320572|NCT04003376|Hormones|hormones|mesh-ancestor
19320573|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320574|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320575|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
19320576|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320577|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320578|NCT04003467|Teriparatide|teriparatide|mesh-list
19320579|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19320580|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320581|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19320582|NCT04003402|Ethanol|ethanol|mesh-list
19320583|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19320584|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320585|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320586|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840791|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840792|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840793|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840794|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840795|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
19840796|NCT00636155|Rituximab|rituximab|mesh-list
19840797|NCT00636155|Fludarabine|fludarabine|mesh-list
19840798|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840799|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
19840800|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840801|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840802|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19840803|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
19848222|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19320601|NCT04003350|Acetaminophen|acetaminophen|mesh-list
19320602|NCT04003350|Meloxicam|meloxicam|mesh-list
19320603|NCT04003350|Oxycodone|oxycodone|mesh-list
19320604|NCT04003350|Tramadol|tramadol|mesh-list
19320605|NCT04003350|Gabapentin|gabapentin|mesh-list
19320606|NCT04003350|Esomeprazole|esomeprazole|mesh-list
19320607|NCT04003350|Metaxalone|metaxalone|mesh-list
19320608|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19320609|NCT04003350|Narcotics|narcotics|mesh-ancestor
19320610|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320611|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320612|NCT04003350|Analgesics|analgesics|mesh-ancestor
19320613|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
19320614|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320615|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
19320616|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19320617|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19320618|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19320619|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19320620|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19320621|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320622|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373628|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
20373629|NCT00986765|Aspirin|aspirin|mesh-list
20373630|NCT00986765|Enoxaparin|enoxaparin|mesh-list
20373631|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20373632|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20373633|NCT00986765|Analgesics|analgesics|mesh-ancestor
20373634|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
20373635|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373636|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373637|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20373638|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373639|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20373640|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20373641|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373642|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20373643|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20373644|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373645|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
20373646|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
20373647|NCT00986778|Lamivudine|lamivudine|mesh-list
20373648|NCT00986778|Adefovir|adefovir|mesh-list
20373649|NCT00986778|Entecavir|entecavir|mesh-list
20373650|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20373651|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373652|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373653|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373654|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
20373655|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373656|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20373657|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19320623|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
19320624|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19320625|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320626|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19320627|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320628|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19320629|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
19320630|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19320631|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320632|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320633|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19320634|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19320635|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19320636|NCT04003246|Durvalumab|durvalumab|mesh-list
19320637|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19320638|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19320639|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320640|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
19320641|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320642|NCT04003207|Hormones|hormones|mesh-list
19320643|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320644|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320645|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19320646|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
19320647|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320648|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320649|NCT04003012|Lidocaine|lidocaine|mesh-list
19320650|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
19320651|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
20373658|NCT00986804|Decitabine|decitabine|mesh-list
20373659|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20373660|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
20425895|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20373661|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373662|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320652|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320653|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320654|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
19320655|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320656|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19320657|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20373663|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373664|NCT00986817|Terlipressin|terlipressin|mesh-list
20373665|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20373666|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20373667|NCT00986843|Irinotecan|irinotecan|mesh-list
20373668|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20373669|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19320658|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19320659|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19320660|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320661|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19320662|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
19320663|NCT04002635|Letrozole|letrozole|mesh-list
19320664|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19320665|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19320666|NCT04002635|Estradiol|estradiol|mesh-list
19320667|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19320668|NCT04002635|Progesterone|progesterone|mesh-list
19320669|NCT04002635|Estrogens|estrogens|mesh-ancestor
19320670|NCT04002635|Hormones|hormones|mesh-ancestor
19674045|NCT01057121|Growth Substances|growth substances|mesh-ancestor
19840804|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840805|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840806|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19840807|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840808|NCT00636168|Ipilimumab|ipilimumab|mesh-list
19674046|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
19674047|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674048|NCT01004263|Rizatriptan|rizatriptan|mesh-list
19674049|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19674050|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
19674051|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674052|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674053|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189155|NCT00212290|Pioglitazone|pioglitazone|mesh-list
20189156|NCT00212290|Nateglinide|nateglinide|mesh-list
19840809|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840810|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840811|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19840812|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189157|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20189158|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674054|NCT01001234|Rizatriptan|rizatriptan|mesh-list
19674055|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19674056|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
19674057|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674058|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674059|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674060|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
19674061|NCT00961792|Promethazine|promethazine|mesh-list
19674062|NCT00961792|Ethanol|ethanol|mesh-list
19674063|NCT00961792|Caffeine|caffeine|mesh-list
19674064|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19674065|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674066|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19674067|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189159|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20189160|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189161|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20189162|NCT00212342|Norethindrone|norethindrone|mesh-list
20189163|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
20189164|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20189165|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20189166|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20189167|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
20189168|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840813|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19840814|NCT00636207|Montelukast|montelukast|mesh-list
19840815|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19840816|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
19840817|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19320671|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320672|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320673|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19320674|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
19320675|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19320676|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19320677|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320678|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19320679|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19320680|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320681|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373670|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373671|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373672|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373673|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20373674|NCT00986960|Hormones|hormones|mesh-ancestor
20373675|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320682|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19320683|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
19320684|NCT04002635|Progestins|progestins|mesh-ancestor
19320685|NCT04002323|Lamivudine|lamivudine|mesh-list
19320686|NCT04002323|Dolutegravir|dolutegravir|mesh-list
19320687|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19320688|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19320689|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373676|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373677|NCT00987038|Midazolam|midazolam|mesh-list
20373678|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20373679|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20373680|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373681|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373682|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20373683|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20373684|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20373685|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20373686|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
20373687|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
20373688|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
20373689|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
19320690|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320691|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
19320692|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320693|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19320694|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19320695|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19320696|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19320697|NCT04002271|Propofol|propofol|mesh-list
19320698|NCT04002271|Sevoflurane|sevoflurane|mesh-list
19320699|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
19320700|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320701|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320702|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19320703|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19320704|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
19320705|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19320706|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19320707|NCT04002700|Haloperidol|haloperidol|mesh-list
19320708|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
19320709|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
19320710|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
19320711|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
19320712|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320713|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320714|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320715|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19320716|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840818|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
20373690|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840819|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320717|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19320718|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19320719|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
19320720|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320721|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320722|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19320723|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19320724|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320725|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
19320726|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19320727|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19320728|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19320729|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320730|NCT04002349|Budesonide|budesonide|mesh-list
19320731|NCT04002349|Levocabastine|levocabastine|mesh-list
19320732|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320733|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19320734|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
19320735|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320736|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320737|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19320738|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
19320739|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
19320740|NCT04002349|Hormones|hormones|mesh-ancestor
19320741|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320742|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19320743|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19320744|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
19320745|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
19320746|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320747|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398099|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398100|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398101|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19398102|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19398103|NCT03645668|Meropenem|meropenem|mesh-list
19398104|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19398105|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840820|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840821|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19840822|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19840823|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840824|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19840825|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
19840826|NCT00636441|Docetaxel|docetaxel|mesh-list
19840827|NCT00636441|Doxorubicin|doxorubicin|mesh-list
19840828|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19840829|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840830|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
19840831|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840832|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840833|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19840834|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
19840835|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840836|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840837|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19840838|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
19840839|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
19398106|NCT03645642|Midodrine|midodrine|mesh-list
19398107|NCT03645642|Diuretics|diuretics|mesh-list
19398108|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
19398109|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398110|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
19398111|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
19398112|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398113|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19398114|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19398115|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19398116|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19398117|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398118|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398119|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840840|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320748|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
19320749|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
19320750|NCT04002115|Busulfan|busulfan|mesh-list
19320751|NCT04002115|Fludarabine|fludarabine|mesh-list
19674068|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674069|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19674070|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19674071|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
19674072|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674073|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19674074|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674075|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840841|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19320752|NCT04002115|Clofarabine|clofarabine|mesh-list
19320753|NCT04002115|Tacrolimus|tacrolimus|mesh-list
19320754|NCT04002115|Sargramostim|sargramostim|mesh-list
19320755|NCT04002115|Lenograstim|lenograstim|mesh-list
19320756|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320757|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
19840842|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20373691|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425896|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425897|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425898|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
20425899|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425900|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20425901|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20425902|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20425903|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20425904|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20425905|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20425906|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20425907|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20425908|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20425909|NCT01277640|Dapivirine|dapivirine|mesh-list
20425910|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20425911|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19320758|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320759|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320760|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19320761|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
19320762|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320763|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320764|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19320765|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19320766|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
19320767|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19320768|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320769|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19320770|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19320771|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
19320772|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19320773|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320774|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19320775|NCT04002141|Letrozole|letrozole|mesh-list
19320776|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320777|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19320778|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19320779|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320780|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320781|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19320782|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
19320783|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840843|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19840844|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840845|NCT00636610|Bevacizumab|bevacizumab|mesh-list
19840846|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840847|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320784|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320785|NCT04001959|Fluorides|fluorides|mesh-list
19320786|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
19320787|NCT04001959|Protective Agents|protective agents|mesh-ancestor
19320788|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840848|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19840849|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19840850|NCT00636610|Growth Substances|growth substances|mesh-ancestor
20373692|NCT00987103|Tacrolimus|tacrolimus|mesh-list
20373693|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373694|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
20373695|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320789|NCT04002089|Bupivacaine|bupivacaine|mesh-list
19320790|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
19320791|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
19320792|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320793|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320794|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
19320795|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320796|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19320797|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320798|NCT04002011|Warfarin|warfarin|mesh-list
19320799|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
19320800|NCT04002011|Dabigatran|dabigatran|mesh-list
19320801|NCT04002011|Apixaban|apixaban|mesh-list
19320802|NCT04002011|Edoxaban|edoxaban|mesh-list
20373696|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20373697|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373698|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373699|NCT00987116|Prednisone|prednisone|mesh-list
19320803|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
19320804|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19320805|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
19320806|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19320807|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
19320808|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320809|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320810|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
19320811|NCT04002024|Salicylates|salicylates|mesh-list
19320812|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320813|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
20189169|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189170|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20189171|NCT00212342|Estrogens|estrogens|mesh-ancestor
20189172|NCT00212342|Hormones|hormones|mesh-ancestor
20189173|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189174|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19320814|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
19320815|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
19320816|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19320817|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19320818|NCT04002024|Analgesics|analgesics|mesh-ancestor
19320819|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
19320820|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320821|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320822|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320823|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19320824|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19320825|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320826|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320827|NCT04001712|Caffeine|caffeine|mesh-list
19320828|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
19320829|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320830|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19320831|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320832|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19320833|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320834|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19320835|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19320836|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
20189175|NCT00212472|Factor VIII|factor viii|mesh-list
20189176|NCT00212472|Coagulants|coagulants|mesh-ancestor
20189177|NCT00212589|Leucovorin|leucovorin|mesh-list
20189178|NCT00212589|Folic Acid|folic acid|mesh-list
20189179|NCT00212589|Fluorouracil|fluorouracil|mesh-list
20189180|NCT00212589|Capecitabine|capecitabine|mesh-list
19840851|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373700|NCT00987116|Azathioprine|azathioprine|mesh-list
19320837|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189181|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
20189182|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
20373701|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20373702|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
20373703|NCT00987116|Hormones|hormones|mesh-ancestor
20373704|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373705|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373706|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20373707|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373708|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
20373709|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373710|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20373711|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320838|NCT04001855|Acetic Acid|acetic acid|mesh-list
19320839|NCT04001855|Retinol acetate|retinol acetate|mesh-list
19320840|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19320841|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320842|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19320843|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
19320844|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320845|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19320846|NCT04001855|Protective Agents|protective agents|mesh-ancestor
19320847|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320848|NCT04001725|Metformin|metformin|mesh-list
19320849|NCT04001725|Dexamethasone|dexamethasone|mesh-list
19320850|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320851|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
19320852|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
19320853|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320854|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320855|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20189183|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189184|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20373712|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
19320856|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
19320857|NCT04001725|Hormones|hormones|mesh-ancestor
19320858|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320859|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19320860|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320861|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19320862|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
19320863|NCT04001647|Nitroprusside|nitroprusside|mesh-list
19320864|NCT04001647|Acetylcholine|acetylcholine|mesh-list
19320865|NCT04001647|Vitamins|vitamins|mesh-ancestor
19320866|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
19320867|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320868|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
19320869|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320870|NCT04001647|Protective Agents|protective agents|mesh-ancestor
19320871|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19320872|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
19320873|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19320874|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19320875|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
19320876|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320877|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
19320878|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
19320879|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19320880|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
19320881|NCT04001465|Miotics|miotics|mesh-ancestor
19674076|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20189185|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189186|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189187|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
20189188|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189189|NCT00212589|Antidotes|antidotes|mesh-ancestor
20189190|NCT00212589|Protective Agents|protective agents|mesh-ancestor
20189191|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
20189192|NCT00212589|Vitamins|vitamins|mesh-ancestor
20189193|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
20189194|NCT00212589|Hematinics|hematinics|mesh-ancestor
20189195|NCT00212602|Aprepitant|aprepitant|mesh-list
20373713|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373714|NCT00987168|Octreotide|octreotide|mesh-list
19320882|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
19320883|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320884|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320885|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19674077|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20189196|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
20189197|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
19320886|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19320887|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
19320888|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19320889|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20373715|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20373716|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20373717|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373718|NCT00987207|Cyclosporine|cyclosporine|mesh-list
20373719|NCT00987207|Cyclosporins|cyclosporins|mesh-list
20373720|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373721|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373722|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373723|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
20373724|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373725|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
19320890|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
19320891|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320892|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320893|NCT04001231|Exenatide|exenatide|mesh-list
19320894|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19320895|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320896|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19320897|NCT04001231|Incretins|incretins|mesh-ancestor
19320898|NCT04001231|Hormones|hormones|mesh-ancestor
19320899|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320900|NCT04001400|Rabeprazole|rabeprazole|mesh-list
19320901|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19320902|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320903|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19320904|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320905|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320906|NCT04001387|Anesthetics|anesthetics|mesh-list
19320907|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320908|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320909|NCT04001413|Durvalumab|durvalumab|mesh-list
19320910|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19320911|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320912|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19320913|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
19320914|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19320915|NCT04001374|Ticagrelor|ticagrelor|mesh-list
19320916|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19320917|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19320918|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19320919|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19320920|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
19320921|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320922|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320923|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320924|NCT04001322|Vaccines|vaccines|mesh-list
19840852|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
19840853|NCT00636636|Gabapentin|gabapentin|mesh-list
20373726|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373727|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
20373728|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373729|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20373730|NCT00987220|Donepezil|donepezil|mesh-list
20373731|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20373732|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373733|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373734|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
20373735|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840854|NCT00636636|Analgesics|analgesics|mesh-ancestor
19840855|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
19840856|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840857|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840858|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
19840859|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19840860|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19840861|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840862|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19320925|NCT04001322|Immunologic Factors|immunologic factors|mesh-ancestor
19840863|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20373736|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373737|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
19320926|NCT04001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320927|NCT04001569|Paclitaxel|paclitaxel|mesh-list
19320928|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19320929|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320930|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
19320931|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
19320932|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320933|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320934|NCT04001348|Diazepam|diazepam|mesh-list
19320935|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19320936|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
19320937|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
19320938|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
19320939|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320940|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320941|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19320942|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19320943|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840864|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19840865|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840866|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320944|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19320945|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19320946|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19320947|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19320948|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19320949|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19320950|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
19320951|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
19840867|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
19840868|NCT00636649|Citalopram|citalopram|mesh-list
19840869|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19840870|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19840871|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19840872|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320952|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
19320953|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
19320954|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320955|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320956|NCT04000919|Carbidopa|carbidopa|mesh-list
19840873|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840874|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
20373738|NCT00987233|Triamcinolone|triamcinolone|mesh-list
20373739|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20373740|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20373741|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20373742|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20373743|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
20373744|NCT00987233|Hormones|hormones|mesh-ancestor
19320957|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19320958|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19320959|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
19320960|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19320961|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320962|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320963|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19320964|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19320965|NCT04000789|Vitamins|vitamins|mesh-list
19320966|NCT04000789|Vitamin E|vitamin e|mesh-list
19320967|NCT04000789|Vitamin A|vitamin a|mesh-list
19320968|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
19320969|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
19320970|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320971|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
19320972|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320973|NCT04000789|Protective Agents|protective agents|mesh-ancestor
19320974|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20373745|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20373746|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373747|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19320975|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
19320976|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
19320977|NCT04000906|Paclitaxel|paclitaxel|mesh-list
19320978|NCT04000906|Cisplatin|cisplatin|mesh-list
19320979|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19320980|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19320981|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
19320982|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
19320983|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
19320984|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19320985|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
19320986|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19320987|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
19320988|NCT04000932|Hormones|hormones|mesh-ancestor
19320989|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19320990|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320991|NCT04000633|Lidocaine|lidocaine|mesh-list
19320992|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
19320993|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
19320994|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19320995|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19320996|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
19320997|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19320998|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19320999|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19321000|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19321001|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321002|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321003|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
19321004|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
19321005|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
19321006|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19321007|NCT04000386|Protective Agents|protective agents|mesh-ancestor
19321008|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321009|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19321010|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
19321011|NCT04000295|Paclitaxel|paclitaxel|mesh-list
19321012|NCT04000295|Etoposide|etoposide|mesh-list
19321013|NCT04000295|Apatinib|apatinib|mesh-list
19321014|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19321015|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321016|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
19321017|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
19321018|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
19321019|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321020|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19321021|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19321022|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321023|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19398120|NCT03645304|Ropivacaine|ropivacaine|mesh-list
19398121|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
19398122|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
20373748|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
20373749|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373750|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373751|NCT00987376|Choline|choline|mesh-list
20373752|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
20373753|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20373754|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
20373755|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373756|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20373757|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20373758|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
20373759|NCT00987441|Sufentanil|sufentanil|mesh-list
20373760|NCT00987441|Dsuvia|dsuvia|mesh-list
20373761|NCT00987441|Ropivacaine|ropivacaine|mesh-list
20373762|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
20373763|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
19398123|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398124|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398125|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
19398126|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398127|NCT03645200|Apatinib|apatinib|mesh-list
19398128|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398129|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19398130|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398131|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373764|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398132|NCT03645187|Celecoxib|celecoxib|mesh-list
20373765|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373766|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
19321024|NCT04000126|Lidocaine|lidocaine|mesh-list
19321025|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
19321026|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
20373767|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373768|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20373769|NCT00987441|Narcotics|narcotics|mesh-ancestor
19321027|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321028|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321029|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
19321030|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321031|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19321032|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19321033|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19321034|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321035|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321036|NCT03999580|Vitamin D|vitamin d|mesh-list
19321037|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
19321038|NCT03999580|Vitamins|vitamins|mesh-ancestor
19321039|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
19321040|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321041|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19321042|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19321043|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
19321044|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
19321045|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
19321046|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
19321047|NCT03999775|Vitamin D|vitamin d|mesh-list
19321048|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
19321049|NCT03999775|Vitamins|vitamins|mesh-list
19321050|NCT03999775|Calcium|calcium|mesh-list
19321051|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
19321052|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321053|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19321054|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19321055|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
19321056|NCT03999723|Vitamins|vitamins|mesh-ancestor
19321057|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
19321058|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321059|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
19321060|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321061|NCT03999723|Protective Agents|protective agents|mesh-ancestor
19321062|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
19321063|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19321064|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
19321065|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321066|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
19321067|NCT03999372|Protective Agents|protective agents|mesh-ancestor
19321068|NCT03999437|Terbinafine|terbinafine|mesh-list
19321069|NCT03999437|Butenafine|butenafine|mesh-list
19321070|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
19321071|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373770|NCT00987441|Analgesics|analgesics|mesh-ancestor
20373771|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20373772|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20373773|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
20373774|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
20373775|NCT00987454|Hematinics|hematinics|mesh-ancestor
20373776|NCT00987493|Rituximab|rituximab|mesh-list
20373777|NCT00987493|Lenalidomide|lenalidomide|mesh-list
20373778|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20373779|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20373780|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373781|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
20373782|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373783|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373784|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20373785|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20373786|NCT00987493|Growth Substances|growth substances|mesh-ancestor
20373787|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
20373788|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20373789|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
19321072|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321073|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321074|NCT03999099|Suvorexant|suvorexant|mesh-list
19321075|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19321076|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20373790|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373791|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
20373792|NCT00987636|Diphosphonates|diphosphonates|mesh-list
20373793|NCT00987636|Busulfan|busulfan|mesh-list
20373794|NCT00987636|Treosulfan|treosulfan|mesh-list
20373795|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
20373796|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373797|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373798|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
20373799|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321077|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321078|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321079|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19321080|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321081|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321082|NCT03999216|Diuretics|diuretics|mesh-list
19321083|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19321084|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
19321085|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
19321086|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321087|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321088|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321089|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
19321090|NCT03999203|Citric Acid|citric acid|mesh-list
19321091|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
19321092|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19321093|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
19321094|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321095|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321096|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19321097|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
19321098|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19321099|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
19321100|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321101|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321102|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19321103|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
19321104|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
19321105|NCT03999203|Protective Agents|protective agents|mesh-ancestor
19321106|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
19321107|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19321108|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
19321109|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
19321110|NCT03999190|Raclopride|raclopride|mesh-list
19321111|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
19321112|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19321113|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321114|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20373800|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20373801|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373802|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20373803|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20373804|NCT00987662|Amlodipine|amlodipine|mesh-list
20373805|NCT00987662|Irbesartan|irbesartan|mesh-list
20373806|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20373807|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20373808|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20373809|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373810|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20373811|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373812|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
20373813|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20373814|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20373815|NCT00987766|Gemcitabine|gemcitabine|mesh-list
20373816|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
20373817|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20373818|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20373819|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
20373820|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373821|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373822|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
20373823|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373824|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373825|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373826|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
19321115|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19321116|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321117|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321118|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
19321119|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321120|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19321121|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19321122|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321123|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19321124|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19321125|NCT03999008|Budesonide|budesonide|mesh-list
19321126|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321127|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19674078|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
19674079|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
19674080|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
19674081|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674082|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
19674083|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
19674084|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674085|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19674086|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
19840875|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321128|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
19321129|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321130|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321131|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19321132|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
19321133|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
19321134|NCT03999008|Hormones|hormones|mesh-ancestor
19321135|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321136|NCT03999125|Dexamethasone|dexamethasone|mesh-list
19321137|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
20373827|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373828|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20373829|NCT00987779|Gabapentin|gabapentin|mesh-list
20373830|NCT00987779|Analgesics|analgesics|mesh-ancestor
20373831|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
20373832|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373833|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373834|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
19840876|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19840877|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
19840878|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19840879|NCT00636792|Rituximab|rituximab|mesh-list
19840880|NCT00636792|Bortezomib|bortezomib|mesh-list
19840881|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20373835|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20373836|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20373837|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373838|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20373839|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20373840|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20373841|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373842|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373843|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
20373844|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
20373845|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20373846|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20373847|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373848|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20373849|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20373850|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373851|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373852|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373853|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20373854|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
20373855|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20373856|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373857|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19321138|NCT03999125|Ranibizumab|ranibizumab|mesh-list
19321139|NCT03999125|Aflibercept|aflibercept|mesh-list
19674087|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
19321140|NCT03999125|BB 1101|bb 1101|mesh-list
19321141|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321142|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
19321143|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
19321144|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321145|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321146|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321147|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
19321148|NCT03999125|Hormones|hormones|mesh-ancestor
19321149|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321150|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19321151|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321152|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
19321153|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321154|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321155|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19321156|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19321157|NCT03999125|Growth Substances|growth substances|mesh-ancestor
19321158|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
19321159|NCT03998982|Dexamethasone|dexamethasone|mesh-list
19321160|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
19321161|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321162|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
19321163|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
19321164|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321165|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321166|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321167|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
19321168|NCT03998982|Hormones|hormones|mesh-ancestor
19321169|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321170|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19321171|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321172|NCT03998969|Pantoprazole|pantoprazole|mesh-list
19321173|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19321174|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321175|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19321176|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321177|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321178|NCT03998696|Cisplatin|cisplatin|mesh-list
19321179|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321180|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20373858|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20373859|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20373860|NCT00987844|Prucalopride|prucalopride|mesh-list
20373861|NCT00987844|Laxatives|laxatives|mesh-ancestor
19321181|NCT03998709|Somatostatin|somatostatin|mesh-list
19321182|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321183|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19321184|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19321185|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19321186|NCT03998709|Hormones|hormones|mesh-ancestor
19321187|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321188|NCT03998670|Methamphetamine|methamphetamine|mesh-list
19321189|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19321190|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321191|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
19321192|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
19321193|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321194|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
19321195|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321196|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321197|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
19321198|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19321199|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19321200|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321201|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19321202|NCT03998761|Progesterone|progesterone|mesh-list
19321203|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
20373862|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20373863|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20373864|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20373865|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
20373866|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373867|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321204|NCT03998761|Progestins|progestins|mesh-ancestor
19321205|NCT03998761|Hormones|hormones|mesh-ancestor
19321206|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321207|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321208|NCT03998826|Piroxicam|piroxicam|mesh-list
19321209|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19321210|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19321211|NCT03998826|Analgesics|analgesics|mesh-ancestor
19321212|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
19321213|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321214|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321215|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321216|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321217|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19321218|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373868|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373869|NCT00987870|Betamethasone|betamethasone|mesh-list
20373870|NCT00987870|Calcipotriene|calcipotriene|mesh-list
20373871|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20373872|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
20373873|NCT00987870|Hormones|hormones|mesh-ancestor
20373874|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321219|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321220|NCT03998592|Vaccines|vaccines|mesh-list
19321221|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
19321222|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321223|NCT03998215|Vaccines|vaccines|mesh-list
19321224|NCT03998215|Immunologic Factors|immunologic factors|mesh-ancestor
19321225|NCT03998215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321226|NCT03998449|Vaccines|vaccines|mesh-list
19321227|NCT03998449|Immunologic Factors|immunologic factors|mesh-ancestor
19321228|NCT03998449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398133|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19398134|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398135|NCT03645187|Analgesics|analgesics|mesh-ancestor
19398136|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
20373875|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373876|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20373877|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
20373878|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
20373879|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
20373880|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373881|NCT00987974|Atorvastatin|atorvastatin|mesh-list
20373882|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20373883|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20373884|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20373885|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
20373886|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373887|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20373888|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20373889|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373890|NCT00988026|Minocycline|minocycline|mesh-list
20373891|NCT00988026|Lymecycline|lymecycline|mesh-list
20373892|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20373893|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373894|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
20373895|NCT00988039|Lopinavir|lopinavir|mesh-list
20373896|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20373897|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20373898|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
19398137|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398138|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398139|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398140|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19398141|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19398142|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20373899|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373900|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20373901|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20373902|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373903|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373904|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20373905|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20373906|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
20373907|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19398143|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373908|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20373909|NCT00988078|Metformin|metformin|mesh-list
20373910|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20373911|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373912|NCT00988195|Doxorubicin|doxorubicin|mesh-list
20373913|NCT00988195|BCT-100|bct-100|mesh-list
20373914|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20373915|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373916|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20373917|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19321229|NCT03998436|Esmolol|esmolol|mesh-list
19321230|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19321231|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19321232|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19321233|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
19321234|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321235|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321236|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321237|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
19321238|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321239|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19321240|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321241|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321242|NCT03997864|Prazosin|prazosin|mesh-list
19321243|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19321244|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19321245|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19321246|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19321247|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
19321248|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321249|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321250|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321251|NCT03997539|Vinorelbine|vinorelbine|mesh-list
19321252|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19321253|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321254|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
19321255|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
19321256|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
19321257|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321258|NCT03997500|Norepinephrine|norepinephrine|mesh-list
19321259|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19321260|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19321261|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
19321262|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321263|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321264|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321265|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
19321266|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
19321267|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321268|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19321269|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19321270|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19321271|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19321272|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321273|NCT03997279|Amoxicillin|amoxicillin|mesh-list
19321274|NCT03997279|Metronidazole|metronidazole|mesh-list
19321275|NCT03997279|Clarithromycin|clarithromycin|mesh-list
19321276|NCT03997279|Rabeprazole|rabeprazole|mesh-list
19321277|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19321278|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321279|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19321280|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19321281|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19321282|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321283|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321284|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19321285|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19321286|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19321287|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321288|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19321289|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
19321290|NCT03997019|Narcotics|narcotics|mesh-ancestor
19674088|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20373918|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373919|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373920|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20373921|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
20373922|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373923|NCT00988364|Simvastatin|simvastatin|mesh-list
20373924|NCT00988364|Ezetimibe|ezetimibe|mesh-list
20373925|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20373926|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20373927|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20373928|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
20373929|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373930|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20373931|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19321291|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321292|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321293|NCT03997019|Analgesics|analgesics|mesh-ancestor
19321294|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
19321295|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321296|NCT03997006|Atropine|atropine|mesh-list
19321297|NCT03997006|Aminophylline|aminophylline|mesh-list
19321298|NCT03997006|Acefyllin piperazinate|acefyllin piperazinate|mesh-list
19321299|NCT03997006|Neostigmine|neostigmine|mesh-list
20373932|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373933|NCT00988403|Levan|levan|mesh-list
20373934|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373935|NCT00988481|Topiramate|topiramate|mesh-list
20373936|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
20373937|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20373938|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373939|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20373940|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20373941|NCT00988507|Artesunate|artesunate|mesh-list
20373942|NCT00988507|Ferroquine|ferroquine|mesh-list
20373943|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
19321300|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19321301|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19321302|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19321303|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
19321304|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321305|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321306|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19321307|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
19321308|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
19674089|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
19674090|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
19674091|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
19674092|NCT00950846|Busulfan|busulfan|mesh-list
20373944|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20373945|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20373946|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373947|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373948|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
20373949|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
20373950|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20373951|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
20373952|NCT00988520|Bromides|bromides|mesh-list
20373953|NCT00988520|Propofol|propofol|mesh-list
20373954|NCT00988520|Sevoflurane|sevoflurane|mesh-list
20373955|NCT00988520|Rocuronium|rocuronium|mesh-list
20373956|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20373957|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20373958|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373959|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20373960|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
20373961|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
20373962|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20373963|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20373964|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
20373965|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20373966|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20373967|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20373968|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20373969|NCT00988663|Memantine|memantine|mesh-list
20373970|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19321309|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
19674093|NCT00950846|Fludarabine|fludarabine|mesh-list
20373971|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19674094|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20373972|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
19674095|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
19674096|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674097|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189198|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
20189199|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189200|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189201|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20189202|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20189203|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189204|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189205|NCT00212615|Capecitabine|capecitabine|mesh-list
20189206|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
20189207|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189208|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
20189209|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321310|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19321311|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19321312|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
19321313|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321314|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321315|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19321316|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321317|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19321318|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19321319|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19321320|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19321321|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19321322|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
19321323|NCT03997006|Protective Agents|protective agents|mesh-ancestor
19321324|NCT03997058|Estazolam|estazolam|mesh-list
19321325|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
19321326|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19321327|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19321328|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321329|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321330|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19321331|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
19321332|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
19321333|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321334|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321335|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
19321336|NCT03996772|Apixaban|apixaban|mesh-list
19321337|NCT03996772|Edoxaban|edoxaban|mesh-list
19321338|NCT03996772|Dabigatran|dabigatran|mesh-list
19321339|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19321340|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
19321341|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19321342|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
19321343|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321344|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674098|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19674099|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
19674100|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674101|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674102|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19674103|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
19674104|NCT00924170|Fludarabine|fludarabine|mesh-list
19674105|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674106|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
19674107|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674108|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840882|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19840883|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840884|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
19840885|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840886|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19840887|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19840888|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
19840889|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840890|NCT00636805|Dexamethasone|dexamethasone|mesh-list
19840891|NCT00636805|Palonosetron|palonosetron|mesh-list
19840892|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19840893|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
19840894|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
19321345|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
19321346|NCT03996993|Bicalutamide|bicalutamide|mesh-list
19321347|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
19321348|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
19321349|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321350|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321351|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321352|NCT03996538|Metformin|metformin|mesh-list
19321353|NCT03996538|Vaccines|vaccines|mesh-list
19321354|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
19321355|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321356|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19321357|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
19321358|NCT03996421|Trace Elements|trace elements|mesh-ancestor
19321359|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
19321360|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840895|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840896|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840897|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19840898|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
19840899|NCT00636805|Hormones|hormones|mesh-ancestor
19840900|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840901|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840902|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840903|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19321361|NCT03996577|Lidocaine|lidocaine|mesh-list
19321362|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
19321363|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
19321364|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321365|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321366|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
19321367|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321368|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19321369|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19321370|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19321371|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321372|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321373|NCT03996603|Estrogens|estrogens|mesh-list
19321374|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19321375|NCT03996603|Hormones|hormones|mesh-ancestor
19321376|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321377|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321378|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
19321379|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
19321380|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
19321381|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19321382|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
19321383|NCT03996486|Paraproteins|paraproteins|mesh-list
19321384|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
19321385|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189210|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189211|NCT00212654|Landiolol|landiolol|mesh-list
20189212|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20189213|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20189214|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189215|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189216|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189217|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189218|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20189219|NCT00212680|Landiolol|landiolol|mesh-list
20189220|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20189221|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20189222|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189223|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189224|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189225|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189226|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20189227|NCT00212810|Topiramate|topiramate|mesh-list
20189228|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
20189229|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20425912|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
19321386|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
20189230|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189231|NCT00212823|Almotriptan|almotriptan|mesh-list
19321387|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19321388|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19321389|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321390|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19321391|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
19321392|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321393|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19321394|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
19321395|NCT03996564|Acetaminophen|acetaminophen|mesh-list
19321396|NCT03996564|Diclofenac|diclofenac|mesh-list
19321397|NCT03996564|Ketorolac|ketorolac|mesh-list
19321398|NCT03996564|Diazepam|diazepam|mesh-list
19321399|NCT03996564|Hydrocodone|hydrocodone|mesh-list
19321400|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19321401|NCT03996564|Analgesics|analgesics|mesh-ancestor
19321402|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
19321403|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321404|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321405|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
19321406|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19321407|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321408|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321409|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19321410|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321411|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321412|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19321413|NCT03996564|Narcotics|narcotics|mesh-ancestor
19321414|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321415|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
19321416|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
19321417|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19321418|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
19321419|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
19321420|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
19321421|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321422|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19321423|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19321424|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20373973|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20373974|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20373975|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373976|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20373977|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20373978|NCT00988715|Cyclosporine|cyclosporine|mesh-list
20373979|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
20373980|NCT00988715|Fludarabine|fludarabine|mesh-list
20373981|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
20373982|NCT00988715|Cyclosporins|cyclosporins|mesh-list
20373983|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20373984|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20373985|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
20373986|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321425|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19321426|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19321427|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19321428|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19321429|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
19321430|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
19321431|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
19321432|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
19321433|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321434|NCT03996434|Cetrorelix|cetrorelix|mesh-list
19321435|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19321436|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
19321437|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19321438|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321439|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
19321440|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321441|NCT03996655|Neostigmine|neostigmine|mesh-list
19321442|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19321443|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373987|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321444|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321445|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
19321446|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321447|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321448|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19321449|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
19321450|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321451|NCT03996057|Methenamine|methenamine|mesh-list
19321452|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
19321453|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
19321454|NCT03996057|Estrogens|estrogens|mesh-list
19321455|NCT03996057|Hormones|hormones|mesh-ancestor
19321456|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321457|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840904|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19840905|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
19840906|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840907|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840908|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20189232|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20189233|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
19321458|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19321459|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321460|NCT03996057|Renal Agents|renal agents|mesh-ancestor
19321461|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19398144|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398145|NCT03645109|Vitamin D|vitamin d|mesh-list
19398146|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
19398147|NCT03645109|Vitamins|vitamins|mesh-ancestor
19398148|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
19398149|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398150|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19398151|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19398152|NCT03645057|Tacrolimus|tacrolimus|mesh-list
19398153|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398154|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
19398155|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398156|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19398157|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398158|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398159|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19398160|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404422|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404423|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404424|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404425|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
19404426|NCT03595046|Hormones|hormones|mesh-ancestor
19404427|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404428|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19404429|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404430|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
19404431|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404432|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189234|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189235|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189236|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189237|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
20189238|NCT00212875|Hematinics|hematinics|mesh-ancestor
19404433|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
20189239|NCT00213070|Miglitol|miglitol|mesh-list
20189240|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373988|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
20189241|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189242|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20189243|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189244|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20189245|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20189246|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20189247|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
20189248|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20189249|NCT00213096|ST 1435|st 1435|mesh-list
20189250|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
20189251|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
20189252|NCT00213096|Estradiol|estradiol|mesh-list
20189253|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19404434|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
20189254|NCT00213096|Estrogens|estrogens|mesh-ancestor
20189255|NCT00213096|Hormones|hormones|mesh-ancestor
20373989|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20373990|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20373991|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
20373992|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20373993|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
20373994|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20373995|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20373996|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20373997|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20373998|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
20373999|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374000|NCT00988728|Olanzapine|olanzapine|mesh-list
20374001|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
20374002|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
20374003|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374004|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374005|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374006|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20374007|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20374008|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374009|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20374010|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20374011|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20374012|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374013|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374014|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374015|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
20374016|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20374017|NCT00988780|Efavirenz|efavirenz|mesh-list
20374018|NCT00988780|Maraviroc|maraviroc|mesh-list
20374019|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20374020|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20374021|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374022|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374023|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
19321462|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
19321463|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19321464|NCT03996252|Calcitriol|calcitriol|mesh-list
19321465|NCT03996252|Fluorouracil|fluorouracil|mesh-list
19321466|NCT03996252|Calcipotriene|calcipotriene|mesh-list
19321467|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
19321468|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321469|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19321470|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321471|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321472|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
19321473|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321474|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
19321475|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19321476|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19321477|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321478|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19321479|NCT03996252|Vitamins|vitamins|mesh-ancestor
19321480|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
19321481|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19321482|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
19321483|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
19321484|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321485|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321486|NCT03995628|Dexamethasone|dexamethasone|mesh-list
19321487|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321488|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
19321489|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
20374024|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374025|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20374026|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20374027|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20374028|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20374029|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20374030|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20374031|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20374032|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19321490|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321491|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321492|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321493|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
19321494|NCT03995628|Hormones|hormones|mesh-ancestor
19321495|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321496|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19321497|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321498|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
19321499|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
19321500|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321501|NCT03995563|Dexamethasone|dexamethasone|mesh-list
19321502|NCT03995563|Ropivacaine|ropivacaine|mesh-list
19321503|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321504|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
19321505|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
19321506|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321507|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321508|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321509|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
19321510|NCT03995563|Hormones|hormones|mesh-ancestor
19321511|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321512|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19321513|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321514|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
19321515|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
19321516|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321517|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
19674109|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19674110|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
19674111|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674112|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674113|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19321518|NCT03995251|Testosterone|testosterone|mesh-list
19321519|NCT03995251|Androgens|androgens|mesh-ancestor
19321520|NCT03995251|Hormones|hormones|mesh-ancestor
19321521|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321522|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321523|NCT03995147|Prednisone|prednisone|mesh-list
19321524|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
19321525|NCT03995147|Doxorubicin|doxorubicin|mesh-list
19321526|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
19321527|NCT03995147|Vincristine|vincristine|mesh-list
19321528|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321529|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
19321530|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321531|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321532|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19321533|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
19321534|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321535|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321536|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19321537|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321538|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19321539|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19321540|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19321541|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321542|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321543|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
19321544|NCT03995147|Hormones|hormones|mesh-ancestor
19321545|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321546|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19321547|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19321548|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
19321549|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
19321550|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
19321551|NCT03995277|Biotin|biotin|mesh-list
19321552|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
19321553|NCT03995277|Vitamins|vitamins|mesh-ancestor
19321554|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
19321555|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321556|NCT03995134|Remifentanil|remifentanil|mesh-list
19321557|NCT03995134|Propofol|propofol|mesh-list
19321558|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19674114|NCT00894556|Sumatriptan|sumatriptan|mesh-list
19321559|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321560|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321561|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19321562|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
19321563|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
19321564|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19321565|NCT03995134|Narcotics|narcotics|mesh-ancestor
19321566|NCT03995134|Analgesics|analgesics|mesh-ancestor
19321567|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
19321568|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321569|NCT03994965|Pimavanserin|pimavanserin|mesh-list
19321570|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19321571|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20374033|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20374034|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20374035|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20374036|NCT00988806|Simendan|simendan|mesh-list
20374037|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20374038|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
20374039|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20374040|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20374041|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321572|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19321573|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19321574|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374042|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374043|NCT00988806|Protective Agents|protective agents|mesh-ancestor
20374044|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425913|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425914|NCT01277705|Vaccines|vaccines|mesh-list
19321575|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321576|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19321577|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20425915|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
20425916|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425917|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
20425918|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20425919|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20425920|NCT01277731|Prednisolone|prednisolone|mesh-list
20425921|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
20425922|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20425923|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
19321578|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19321579|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
19321580|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321581|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321582|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
19321583|NCT03994783|Rituximab|rituximab|mesh-list
19321584|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
19321585|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19321586|NCT03994783|Antibodies|antibodies|mesh-list
19321587|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
19321588|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19321589|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321590|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425924|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321591|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
19321592|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321593|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321594|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321595|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
19321596|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
19674115|NCT00894556|Rizatriptan|rizatriptan|mesh-list
19674116|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19674117|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20189256|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189257|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189258|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20189259|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20189260|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20189261|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20189262|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20189263|NCT00213109|Miglitol|miglitol|mesh-list
20189264|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189265|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425925|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
20425926|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
19321597|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321598|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321599|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
19321600|NCT03994783|Hormones|hormones|mesh-ancestor
19321601|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321602|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19321603|NCT03994783|Protective Agents|protective agents|mesh-ancestor
19321604|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
19321605|NCT03994705|Fludarabine|fludarabine|mesh-list
19321606|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321607|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
19321608|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321609|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321610|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19321611|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
19321612|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321613|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321614|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19321615|NCT03994692|Ether|ether|mesh-list
19674118|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20189266|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20189267|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189268|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19321616|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19321617|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
19674119|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
19674120|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674121|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321618|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
19321619|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321620|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321621|NCT03994744|Metformin|metformin|mesh-list
19321622|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19321623|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19321624|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321625|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321626|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321627|NCT03994211|Itraconazole|itraconazole|mesh-list
19321628|NCT03994211|Rifampin|rifampin|mesh-list
19321629|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
19321630|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321631|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19321632|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19321633|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321634|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321635|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19321636|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
19321637|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321638|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321639|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19321640|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19321641|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
19321642|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19321643|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
19321644|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19321645|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19321646|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19321647|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19321648|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19321649|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19321650|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19321651|NCT03994107|Paclitaxel|paclitaxel|mesh-list
19321652|NCT03994107|Doxorubicin|doxorubicin|mesh-list
19321653|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19321654|NCT03994107|Trastuzumab|trastuzumab|mesh-list
19321655|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19321656|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19674122|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674123|NCT00840177|Cytarabine|cytarabine|mesh-list
20189269|NCT00213122|Miglitol|miglitol|mesh-list
20189270|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189271|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189272|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20217384|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
19674124|NCT00840177|Idarubicin|idarubicin|mesh-list
20189273|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321657|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321658|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19321659|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
19321660|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19321661|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321662|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19321663|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19321664|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19321665|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321666|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321667|NCT03994055|Antioxidants|antioxidants|mesh-list
19321668|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321669|NCT03994055|Protective Agents|protective agents|mesh-ancestor
19321670|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398161|NCT03644823|Atezolizumab|atezolizumab|mesh-list
19398162|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674125|NCT00840177|Pravastatin|pravastatin|mesh-list
19674126|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674127|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
19398163|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
19398164|NCT03644706|Diuretics|diuretics|mesh-ancestor
19398165|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
19398166|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398167|NCT03644706|Expectorants|expectorants|mesh-ancestor
19398168|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398169|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
19398170|NCT03644667|Prednisone|prednisone|mesh-list
19398171|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
19398172|NCT03644667|Tacrolimus|tacrolimus|mesh-list
19398173|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19398174|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398175|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
19398176|NCT03644667|Hormones|hormones|mesh-ancestor
19398177|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398178|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398179|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19398180|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398181|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398182|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
19398183|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398184|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398185|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19398186|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19398187|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
19674128|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674129|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674130|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
19674131|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674132|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674133|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
19674134|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674135|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19674136|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19674137|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19674138|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674139|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19674140|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19674141|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20189274|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20189275|NCT00213200|Morphine|morphine|mesh-list
20189276|NCT00213200|Tetracaine|tetracaine|mesh-list
20189277|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20189278|NCT00213200|Narcotics|narcotics|mesh-ancestor
20189279|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189280|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189281|NCT00213200|Analgesics|analgesics|mesh-ancestor
20189282|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
20189283|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189284|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
20189285|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
20189286|NCT00213226|Dexamethasone|dexamethasone|mesh-list
19674142|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19398188|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20189287|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374045|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
20374046|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20374047|NCT00988845|Protective Agents|protective agents|mesh-ancestor
20374048|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374049|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374050|NCT00988897|Leucovorin|leucovorin|mesh-list
20374051|NCT00988897|Bevacizumab|bevacizumab|mesh-list
20374052|NCT00988897|Fluorouracil|fluorouracil|mesh-list
20374053|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
19321671|NCT03994393|Durvalumab|durvalumab|mesh-list
19321672|NCT03994393|Tremelimumab|tremelimumab|mesh-list
19321673|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321674|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321675|NCT03993431|Methamphetamine|methamphetamine|mesh-list
19321676|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19321677|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321678|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
19321679|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
19321680|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321681|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
19321682|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321683|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321684|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
19321685|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19321686|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19321687|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321688|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19321689|NCT03993626|Nivolumab|nivolumab|mesh-list
19321690|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321691|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321692|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19321693|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321694|NCT03993327|Iodine|iodine|mesh-list
19321695|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19321696|NCT03993327|Antibodies|antibodies|mesh-list
19321697|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
19321698|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19321699|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
19321700|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321701|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321702|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19321703|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321704|NCT03993327|Trace Elements|trace elements|mesh-ancestor
19321705|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
19321706|NCT03993366|Pramlintide|pramlintide|mesh-list
19321707|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
19321708|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19321709|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321710|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
19321711|NCT03993353|Tadalafil|tadalafil|mesh-list
19321712|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321713|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321714|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
19321715|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19321716|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19321717|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374054|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20374055|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374056|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20374057|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20374058|NCT00988897|Growth Substances|growth substances|mesh-ancestor
20374059|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374060|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
20374061|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
20374062|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374063|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20374064|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321718|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321719|NCT03993353|Urological Agents|urological agents|mesh-ancestor
19674143|NCT00820950|Betamethasone|betamethasone|mesh-list
20374065|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
19321720|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19321721|NCT03993236|Ezetimibe|ezetimibe|mesh-list
19321722|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19321723|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19321724|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
19321725|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321726|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19321727|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19321728|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321729|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
19321730|NCT03992937|Progesterone|progesterone|mesh-list
20374066|NCT00988897|Antidotes|antidotes|mesh-ancestor
20374067|NCT00988897|Protective Agents|protective agents|mesh-ancestor
20374068|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
20374069|NCT00988897|Vitamins|vitamins|mesh-ancestor
20374070|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
20374071|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
20374072|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
20374073|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20374074|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19321731|NCT03992937|Progestins|progestins|mesh-ancestor
19321732|NCT03992937|Hormones|hormones|mesh-ancestor
19321733|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321734|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321735|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19321736|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
19321737|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19321738|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19321739|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19321740|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19321741|NCT03992885|Pemetrexed|pemetrexed|mesh-list
19321742|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321743|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321744|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374075|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374076|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20374077|NCT00988949|Spiradoline|spiradoline|mesh-list
20374078|NCT00988949|Analgesics|analgesics|mesh-ancestor
20374079|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
20374080|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374081|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374082|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20374083|NCT00988949|Diuretics|diuretics|mesh-ancestor
20374084|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
20374085|NCT00989027|Oxytocin|oxytocin|mesh-list
20374086|NCT00989027|Ergonovine|ergonovine|mesh-list
20374087|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
20374088|NCT00989027|Carboprost|carboprost|mesh-list
20374089|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
20374090|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20374091|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374092|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20374093|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
20374094|NCT00989053|Citalopram|citalopram|mesh-list
20374095|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20374096|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20374097|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374098|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374099|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374100|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
20374101|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374102|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20374103|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
20374104|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20374105|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
20374106|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20374107|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374108|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20374109|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374110|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
20374111|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20374112|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20374113|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19321745|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19321746|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19321747|NCT03992911|Carboplatin|carboplatin|mesh-list
20374114|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374115|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374116|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
19321748|NCT03992911|Etoposide|etoposide|mesh-list
19321749|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
19321750|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321751|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19321752|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19321753|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19840909|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19840910|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19840911|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19840912|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840913|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189288|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
20374117|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321754|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321755|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321756|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19321757|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
19321758|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
19321759|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321760|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321761|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
19321762|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321763|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19321764|NCT03992586|Methamphetamine|methamphetamine|mesh-list
19321765|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19321766|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321767|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
19321768|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
19321769|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321770|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
19321771|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321772|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321773|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
19321774|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19321775|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19321776|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321777|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19321778|NCT03992755|Treprostinil|treprostinil|mesh-list
19321779|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19321780|NCT03992170|Daratumumab|daratumumab|mesh-list
19321781|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321782|NCT03992131|Rucaparib|rucaparib|mesh-list
19321783|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19321784|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321785|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321786|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374118|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374119|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20374120|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374121|NCT00989274|Vaccines|vaccines|mesh-list
20374122|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
20374123|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374124|NCT00989300|Omeprazole|omeprazole|mesh-list
20374125|NCT00989300|Rabeprazole|rabeprazole|mesh-list
20374126|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20374127|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374128|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20374129|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374130|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374131|NCT00989352|Rituximab|rituximab|mesh-list
20374132|NCT00989352|Methotrexate|methotrexate|mesh-list
20374133|NCT00989352|Lomustine|lomustine|mesh-list
19321787|NCT03992144|Amoxicillin|amoxicillin|mesh-list
19321788|NCT03992144|Metronidazole|metronidazole|mesh-list
20189289|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
20189290|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189291|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189292|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20189293|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
20189294|NCT00213226|Hormones|hormones|mesh-ancestor
20189295|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189296|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20189297|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189298|NCT00213252|Prednisolone|prednisolone|mesh-list
19840914|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19840915|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374134|NCT00989352|Procarbazine|procarbazine|mesh-list
20374135|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20374136|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374137|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
19321789|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19321790|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321791|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19321792|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19321793|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
19321794|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
19321795|NCT03992066|Hematinics|hematinics|mesh-ancestor
19321796|NCT03992196|Rotigotine|rotigotine|mesh-list
19321797|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
19321798|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
19321799|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321800|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321801|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321802|NCT03992261|Halobetasol|halobetasol|mesh-list
19321803|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19321804|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
19321805|NCT03992326|Fludarabine|fludarabine|mesh-list
19321806|NCT03992326|Interleukin-2|interleukin-2|mesh-list
19321807|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321808|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
19321809|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321810|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321811|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19674144|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
19674145|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19674146|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
19674147|NCT00820950|Calcipotriene|calcipotriene|mesh-list
19674148|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19674149|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19674150|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
19321812|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
19321813|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321814|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321815|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19321816|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19321817|NCT03992326|Analgesics|analgesics|mesh-ancestor
19321818|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
19321819|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398189|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398190|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
19398191|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
19398192|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398193|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19398194|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19398195|NCT03644667|Protective Agents|protective agents|mesh-ancestor
19398196|NCT03644641|Propofol|propofol|mesh-list
19398197|NCT03644641|Desflurane|desflurane|mesh-list
19398198|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19398199|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398200|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398201|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19398202|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
19398203|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
19398204|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19398205|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
19398206|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
19398207|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
19398208|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398209|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19398210|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
19398211|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398212|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
19398213|NCT03644576|Ephedrine|ephedrine|mesh-list
19398214|NCT03644576|Ozanimod|ozanimod|mesh-list
19398215|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19398216|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
19398217|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674151|NCT00820950|Hormones|hormones|mesh-ancestor
19840916|NCT00637000|Buprenorphine|buprenorphine|mesh-list
19398218|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398219|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19840917|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19321820|NCT03992365|Bisacodyl|bisacodyl|mesh-list
19321821|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
19321822|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19321823|NCT03992365|Cathartics|cathartics|mesh-ancestor
19321824|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19321825|NCT03992365|Laxatives|laxatives|mesh-ancestor
19321826|NCT03991936|Triamcinolone|triamcinolone|mesh-list
19321827|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19321828|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19321829|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19321830|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321831|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
19321832|NCT03991936|Hormones|hormones|mesh-ancestor
19321833|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321834|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374138|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374139|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374140|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20374141|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
19321835|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19321836|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
19321837|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321838|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321839|NCT03991845|Levocetirizine|levocetirizine|mesh-list
19321840|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19321841|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20189299|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20189300|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
20189301|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20189302|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
19321842|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
19321843|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
19321844|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321845|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321846|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321847|NCT03991910|Ramipril|ramipril|mesh-list
19321848|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19321849|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
19321850|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321851|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321852|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19321853|NCT03991442|Amlodipine|amlodipine|mesh-list
19321854|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19840918|NCT00637000|Naloxone|naloxone|mesh-list
19840919|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19840920|NCT00637000|Narcotics|narcotics|mesh-ancestor
19840921|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19840922|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840923|NCT00637000|Analgesics|analgesics|mesh-ancestor
19840924|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
19840925|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840926|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19840927|NCT00637195|Vaccines|vaccines|mesh-list
19840928|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
19840929|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840930|NCT00637247|Gemcitabine|gemcitabine|mesh-list
20189303|NCT00213252|Montelukast|montelukast|mesh-list
20189304|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20189305|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
20189306|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20189307|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
20189308|NCT00213252|Hormones|hormones|mesh-ancestor
20189309|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189310|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189311|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20189312|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189313|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
20189314|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
20189315|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189316|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217385|NCT00309517|Vitamins|vitamins|mesh-ancestor
19321855|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19840931|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19840932|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
19848223|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
20374142|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20374143|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20374144|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
20374145|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374146|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
20374147|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374148|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20374149|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20374150|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20374151|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20374152|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
19321856|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321857|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321858|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19321859|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321860|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
19321861|NCT03991364|Methamphetamine|methamphetamine|mesh-list
19321862|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19321863|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321864|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
19321865|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
19321866|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321867|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
19321868|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19321869|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321870|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
19321871|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19321872|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19321873|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321874|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19321875|NCT03991559|Manganese|manganese|mesh-list
19321876|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19321877|NCT03991559|Antibodies|antibodies|mesh-list
19321878|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
19321879|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
19321880|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321881|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321882|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321883|NCT03991559|Trace Elements|trace elements|mesh-ancestor
19321884|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
19321885|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20374153|NCT00989404|Zanamivir|zanamivir|mesh-list
20374154|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
20374155|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374156|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374157|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374158|NCT00989443|Cidofovir|cidofovir|mesh-list
20374159|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
20374160|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374161|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374162|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374163|NCT00989469|Irinotecan|irinotecan|mesh-list
20374164|NCT00989469|Sorafenib|sorafenib|mesh-list
20374165|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20374166|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20374167|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374168|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374169|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374170|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20374171|NCT00989508|Perhexiline|perhexiline|mesh-list
20374172|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20374173|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374174|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374175|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20374176|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321886|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321887|NCT03991312|Itraconazole|itraconazole|mesh-list
19321888|NCT03991312|Rifampin|rifampin|mesh-list
19321889|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
19848224|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
20374177|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
20374178|NCT00989625|Naproxen|naproxen|mesh-list
19321890|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321891|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19321892|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19321893|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19321894|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321895|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19321896|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
19321897|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19321898|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321899|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19321900|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19321901|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
19321902|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19321903|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
19321904|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19321905|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19321906|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19321907|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19321908|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19321909|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19321910|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19321911|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
19321912|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19321913|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19321914|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
19321915|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19321916|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19321917|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19321918|NCT03991130|Nivolumab|nivolumab|mesh-list
19321919|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321920|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321921|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19321922|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321923|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
19321924|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321925|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
19321926|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321927|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321928|NCT03990701|Metomidate|metomidate|mesh-list
19321929|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19321930|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321931|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321932|NCT03990922|Morphine|morphine|mesh-list
19321933|NCT03990922|Ropivacaine|ropivacaine|mesh-list
19321934|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19321935|NCT03990922|Narcotics|narcotics|mesh-ancestor
19321936|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321937|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321938|NCT03990922|Analgesics|analgesics|mesh-ancestor
19321939|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
19321940|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321941|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
19321942|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
19840933|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840934|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374179|NCT00989625|Sumatriptan|sumatriptan|mesh-list
19321943|NCT03990480|Amlodipine|amlodipine|mesh-list
20374180|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20374181|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19321944|NCT03990480|Valsartan|valsartan|mesh-list
19321945|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19321946|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19321947|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19321948|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321949|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19321950|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321951|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
19321952|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19321953|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19321954|NCT03990623|Liver Extracts|liver extracts|mesh-list
19321955|NCT03990623|Hematinics|hematinics|mesh-ancestor
19321956|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19840935|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
19321957|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19321958|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
19321959|NCT03990129|Dipyrone|dipyrone|mesh-list
19321960|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19321961|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19321962|NCT03990129|Analgesics|analgesics|mesh-ancestor
19321963|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
19321964|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19321965|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374182|NCT00989625|Analgesics|analgesics|mesh-ancestor
20374183|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
20374184|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374185|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374186|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374187|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374188|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
20374189|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20374190|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374191|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374192|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20374193|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20374194|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20374195|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
20374196|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374197|NCT00989651|Paclitaxel|paclitaxel|mesh-list
20374198|NCT00989651|Bevacizumab|bevacizumab|mesh-list
20374199|NCT00989651|Cisplatin|cisplatin|mesh-list
20374200|NCT00989651|Carboplatin|carboplatin|mesh-list
20374201|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20374202|NCT00989651|Veliparib|veliparib|mesh-list
20374203|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19321966|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19321967|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19321968|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
19321969|NCT03990194|Leuprolide|leuprolide|mesh-list
19321970|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19321971|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
19321972|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19321973|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321974|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19321975|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374204|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
20374205|NCT00989651|Antibodies|antibodies|mesh-list
20374206|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
20374207|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20374208|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
20374209|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20374210|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374211|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374212|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
20374213|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
20374214|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374215|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20374216|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20374217|NCT00989651|Growth Substances|growth substances|mesh-ancestor
19321976|NCT03990103|Paclitaxel|paclitaxel|mesh-list
19321977|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19321978|NCT03990103|Bevacizumab|bevacizumab|mesh-list
19321979|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
19321980|NCT03990103|Tegafur|tegafur|mesh-list
19321981|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19321982|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19321983|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
19321984|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
19321985|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
19321986|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19321987|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19321988|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19321989|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20374218|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374219|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
20374220|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
20374221|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20374222|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374223|NCT00989690|Docetaxel|docetaxel|mesh-list
19321990|NCT03990103|Growth Substances|growth substances|mesh-ancestor
20374224|NCT00989690|Pemetrexed|pemetrexed|mesh-list
19321991|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19321992|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
19321993|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19321994|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
19321995|NCT03990038|Ropivacaine|ropivacaine|mesh-list
19321996|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
19321997|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
19321998|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19321999|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322000|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
19322001|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398220|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398221|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
19398222|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19398223|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19398224|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
19398225|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398226|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398227|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398228|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19398229|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398230|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
19398231|NCT03644511|Sorafenib|sorafenib|mesh-list
19398232|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398233|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19398234|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398235|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398236|NCT03644446|Bisoprolol|bisoprolol|mesh-list
19398237|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19398238|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
19398239|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
19398240|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374225|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20374226|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374227|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374228|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19398241|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398242|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19398243|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19398244|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20374229|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
20374230|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374231|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374232|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20374233|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20374234|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20374235|NCT00989703|Methotrexate|methotrexate|mesh-list
20374236|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20374237|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
20374238|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20374239|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374240|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19398245|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398246|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398247|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398248|NCT03644264|Sevelamer|sevelamer|mesh-list
19398249|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
19398250|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
19398251|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398252|NCT03644147|Acetaminophen|acetaminophen|mesh-list
19398253|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398254|NCT03644147|Analgesics|analgesics|mesh-ancestor
19398255|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
19398256|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398257|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398258|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
19398259|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19398260|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19840936|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19840937|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840938|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19840939|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
19398261|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322002|NCT03990571|Avelumab|avelumab|mesh-list
19322003|NCT03990571|Axitinib|axitinib|mesh-list
19322004|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19322005|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322006|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322007|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19322008|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322009|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322010|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
19322011|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322012|NCT03989609|Midazolam|midazolam|mesh-list
19322013|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
19322014|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19322015|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322016|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322017|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322018|NCT03989609|Analgesics|analgesics|mesh-ancestor
19322019|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
19840940|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840941|NCT00637273|Pioglitazone|pioglitazone|mesh-list
19840942|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20189317|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20189318|NCT00213252|Protective Agents|protective agents|mesh-ancestor
20189319|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189320|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189321|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20189322|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
20189323|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19840943|NCT00637273|Exenatide|exenatide|mesh-list
19840944|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19840945|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189324|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20374241|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
20374242|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374243|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374244|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
20374245|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322020|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322021|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19322022|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19322023|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19322024|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19322025|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322026|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322027|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19322028|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19322029|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19322030|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19322031|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19322032|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
19322033|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
19322034|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
19322035|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
19322036|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
19322037|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322038|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
19322039|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19322040|NCT03989817|Protective Agents|protective agents|mesh-ancestor
19322041|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322042|NCT03989778|Vitamin D|vitamin d|mesh-list
19322043|NCT03989778|Vitamins|vitamins|mesh-ancestor
19322044|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
19322045|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840946|NCT00637273|Incretins|incretins|mesh-ancestor
20189325|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189326|NCT00213265|Vaccines|vaccines|mesh-list
20189327|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20189328|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
20374246|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19840947|NCT00637273|Hormones|hormones|mesh-ancestor
19840948|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840949|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19322046|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19322047|NCT03989830|Endostatins|endostatins|mesh-list
19840950|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
20374247|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19322048|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19322049|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19322050|NCT03989830|Growth Substances|growth substances|mesh-ancestor
19322051|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322052|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
19322053|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322054|NCT03989336|Manganese|manganese|mesh-list
19322055|NCT03989336|Paclitaxel|paclitaxel|mesh-list
19322056|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19322057|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19322058|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19840951|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19840952|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19840953|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19840954|NCT00637377|Ranibizumab|ranibizumab|mesh-list
19840955|NCT00637377|Aflibercept|aflibercept|mesh-list
19840956|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19840957|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19840958|NCT00637377|Growth Substances|growth substances|mesh-ancestor
19840959|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840960|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
19322059|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322060|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
19322061|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
19322062|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
19322063|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322064|NCT03989336|Trace Elements|trace elements|mesh-ancestor
19322065|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
19322066|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322067|NCT03989310|Manganese|manganese|mesh-list
19322068|NCT03989310|Gemcitabine|gemcitabine|mesh-list
19322069|NCT03989310|Paclitaxel|paclitaxel|mesh-list
19322070|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19322071|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19322072|NCT03989310|Antibodies|antibodies|mesh-list
19322073|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
19322074|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19322075|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840961|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840962|NCT00637494|Mifepristone|mifepristone|mesh-list
19840963|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19840964|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
19840965|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840966|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19840967|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19840968|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19840969|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19840970|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
19840971|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19840972|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19840973|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
19840974|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19840975|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
19840976|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19840977|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19840978|NCT00637572|Megestrol|megestrol|mesh-list
20189329|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189330|NCT00213278|Vinblastine|vinblastine|mesh-list
20189331|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20189332|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189333|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189334|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189335|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189336|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189337|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
20189338|NCT00213291|Hematinics|hematinics|mesh-ancestor
20217386|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
20217387|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20217388|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
20217389|NCT00309530|Interferons|interferons|mesh-list
20217390|NCT00309530|Fluorouracil|fluorouracil|mesh-list
20217391|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
20217392|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322076|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
19322077|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
19322078|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
19322079|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322080|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
19322081|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322082|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19322083|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
19322084|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
20374248|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
20374249|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374250|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20374251|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
20374252|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
20374253|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
20374254|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
20374255|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20374256|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20374257|NCT00989729|Prednisolone|prednisolone|mesh-list
20374258|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
20374259|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20374260|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
20374261|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374262|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
20374263|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
20374264|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840979|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
19322085|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322086|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322087|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19322088|NCT03989310|Trace Elements|trace elements|mesh-ancestor
20189339|NCT00213486|Irinotecan|irinotecan|mesh-list
20189340|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20189341|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20189342|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189343|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189344|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840980|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19840981|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19840982|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20189345|NCT00213512|Rituximab|rituximab|mesh-list
20189346|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20189347|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189348|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
20189349|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322089|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
19322090|NCT03989700|Thiamine|thiamine|mesh-list
19840983|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
19840984|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19840985|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322091|NCT03989700|Vitamins|vitamins|mesh-ancestor
19322092|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
19840986|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19840987|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19840988|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19840989|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19840990|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
20374265|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322093|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322094|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
19322095|NCT03989557|Aspirin|aspirin|mesh-list
19322096|NCT03989557|Clopidogrel|clopidogrel|mesh-list
19322097|NCT03989557|Ticagrelor|ticagrelor|mesh-list
19322098|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19322099|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322100|NCT03989557|Analgesics|analgesics|mesh-ancestor
19322101|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
19322102|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322103|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322104|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322105|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19322106|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19322107|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19322108|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322109|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19848225|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20374266|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322110|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19322111|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322112|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
19322113|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19322114|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19322115|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19322116|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
19322117|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322118|NCT03989271|Quercetin|quercetin|mesh-list
19322119|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
19322120|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322121|NCT03989271|Protective Agents|protective agents|mesh-ancestor
19322122|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322123|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19322124|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
19322125|NCT03989466|Antibodies|antibodies|mesh-list
19322126|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
19322127|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19322128|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
19322129|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322130|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322131|NCT03989115|Osimertinib|osimertinib|mesh-list
20189350|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189351|NCT00213538|Methotrexate|methotrexate|mesh-list
20189352|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20189353|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19840991|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19840992|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
19840993|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322132|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322133|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19322134|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322135|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322136|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
19322137|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322138|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322139|NCT03989037|Carboplatin|carboplatin|mesh-list
19322140|NCT03989037|Docetaxel|docetaxel|mesh-list
19322141|NCT03989037|Trastuzumab|trastuzumab|mesh-list
19322142|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322143|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
19322144|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
19322145|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
19322146|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322147|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322148|NCT03989024|Clomiphene|clomiphene|mesh-list
19840994|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19840995|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19840996|NCT00637780|Analgesics|analgesics|mesh-ancestor
19840997|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
19840998|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19840999|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841000|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841001|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189354|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
20189355|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20189356|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189357|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189358|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
20189359|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189360|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189361|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
20189362|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189363|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20189364|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189365|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
20189366|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189367|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20189368|NCT00213551|Antioxidants|antioxidants|mesh-list
20189369|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189370|NCT00213551|Protective Agents|protective agents|mesh-ancestor
20189371|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374267|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
19841002|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322149|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19322150|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19322151|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
19322152|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322153|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322154|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19322155|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
19322156|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19322157|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19322158|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19322159|NCT03989024|Hormones|hormones|mesh-ancestor
19322160|NCT03988725|Vitamin E|vitamin e|mesh-list
19322161|NCT03988725|Vitamins|vitamins|mesh-ancestor
19322162|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
19322163|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322164|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
19322165|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322166|NCT03988725|Protective Agents|protective agents|mesh-ancestor
19322167|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
19322168|NCT03988530|Scopolamine|scopolamine|mesh-list
19322169|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19322170|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19322171|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
19322172|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
19322173|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322174|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322175|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322176|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
19322177|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19322178|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
19322179|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322180|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322181|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19322182|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
19322183|NCT03988387|Tenofovir|tenofovir|mesh-list
19322184|NCT03988387|Emtricitabine|emtricitabine|mesh-list
19322185|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
19322186|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322187|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19322188|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19322189|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322190|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322191|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19322192|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19322193|NCT03988231|Enoxaparin|enoxaparin|mesh-list
19322194|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
19322195|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19322196|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19322197|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692234|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189372|NCT00213564|Methotrexate|methotrexate|mesh-list
20189373|NCT00213564|Infliximab|infliximab|mesh-list
20189374|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20189375|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
20189376|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20189377|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189378|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189379|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
20189380|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189381|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189382|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
20189383|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189384|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20189385|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189386|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
20189387|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189388|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20189389|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20189390|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
20189391|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20189392|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189393|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322198|NCT03988205|Cytarabine|cytarabine|mesh-list
19322199|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19322200|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
19322201|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322202|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322203|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
19322204|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322205|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20374268|NCT00989729|Hormones|hormones|mesh-ancestor
20374269|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20374270|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20374271|NCT00989729|Protective Agents|protective agents|mesh-ancestor
20374272|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20374273|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374274|NCT00989742|Doxycycline|doxycycline|mesh-list
20374275|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374276|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374277|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
20374278|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20374279|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20374280|NCT00989807|Aztreonam|aztreonam|mesh-list
20374281|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374282|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374283|NCT00989820|Coal Tar|coal tar|mesh-list
20374284|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
20374285|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
20374286|NCT00989898|Insulin|insulin|mesh-list
20374287|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322206|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
19322207|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322208|NCT03988452|Ritonavir|ritonavir|mesh-list
19322209|NCT03988452|Darunavir|darunavir|mesh-list
19674152|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20374288|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374289|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20374290|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20374291|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20374292|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
19674153|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674154|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20374293|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374294|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20374295|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20374296|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374297|NCT00990054|Plerixafor|plerixafor|mesh-list
20374298|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20374299|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20374300|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
20374301|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374302|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20374303|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20374304|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20374305|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20374306|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374307|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374308|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374309|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374310|NCT00990067|Analgesics|analgesics|mesh-ancestor
20374311|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
20374312|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374313|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
20374314|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20374315|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
20374316|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
20374317|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
20374318|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20374319|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
20374320|NCT00990158|Vitamin K|vitamin k|mesh-list
20374321|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
19674155|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
19674156|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
19674157|NCT00806416|Vitamin D|vitamin d|mesh-list
19674158|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
19674159|NCT00806416|Alendronate|alendronate|mesh-list
19674160|NCT00806416|Vitamins|vitamins|mesh-ancestor
20374322|NCT00990158|Vitamins|vitamins|mesh-ancestor
19841003|NCT00637923|Ribavirin|ribavirin|mesh-list
19322210|NCT03988452|Tenofovir|tenofovir|mesh-list
20374323|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
20374324|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374325|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20374326|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19322211|NCT03988452|Lamivudine|lamivudine|mesh-list
19322212|NCT03988452|Zidovudine|zidovudine|mesh-list
19322213|NCT03988452|Dolutegravir|dolutegravir|mesh-list
19322214|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19322215|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19322216|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
19322217|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322218|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322219|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19674161|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
19674162|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674163|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19674164|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19674165|NCT00748904|Rifaximin|rifaximin|mesh-list
19674166|NCT00748904|Lactulose|lactulose|mesh-list
19674167|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19674168|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674169|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674170|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
19674171|NCT00729651|Alendronate|alendronate|mesh-list
19674172|NCT00729651|Calcium|calcium|mesh-list
19674173|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19674174|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322220|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19322221|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
19322222|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322223|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19322224|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19322225|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19322226|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19322227|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
19322228|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19322229|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19322230|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19322231|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19322232|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19322233|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
19322234|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322235|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19322236|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19322237|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322238|NCT03988010|Amantadine|amantadine|mesh-list
19322239|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19322240|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19322241|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
19322242|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322243|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
19322244|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322245|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322246|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322247|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322248|NCT03988010|Analgesics|analgesics|mesh-ancestor
19674175|NCT00729651|Vitamins|vitamins|mesh-ancestor
19674176|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
19674177|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19674178|NCT00698815|Pemetrexed|pemetrexed|mesh-list
19674179|NCT00698815|Sunitinib|sunitinib|mesh-list
20189394|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
20189395|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189396|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189397|NCT00213590|Cyclosporine|cyclosporine|mesh-list
20189398|NCT00213590|Cyclosporins|cyclosporins|mesh-list
20189399|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189400|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189401|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189402|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
20189403|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189404|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
20189405|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189406|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
19674180|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674181|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189407|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19322249|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
19674182|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674183|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19674184|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19674185|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19674186|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19322250|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322251|NCT03987867|Paclitaxel|paclitaxel|mesh-list
19322252|NCT03987867|Carboplatin|carboplatin|mesh-list
19322253|NCT03987867|Pemetrexed|pemetrexed|mesh-list
19322254|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19322255|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19322256|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374327|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322257|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
19322258|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
19322259|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
19322260|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322261|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322262|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19322263|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19322264|NCT03988075|Acetaminophen|acetaminophen|mesh-list
19322265|NCT03988075|Ibuprofen|ibuprofen|mesh-list
19322266|NCT03988075|Hydrocodone|hydrocodone|mesh-list
19322267|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322268|NCT03988075|Analgesics|analgesics|mesh-ancestor
19322269|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
19322270|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322271|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322272|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
19322273|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19322274|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322275|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19322276|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19322277|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322278|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322279|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19322280|NCT03988075|Narcotics|narcotics|mesh-ancestor
19322281|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322282|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
19322283|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398262|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398263|NCT03643900|Indomethacin|indomethacin|mesh-list
19398264|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19398265|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398266|NCT03643900|Analgesics|analgesics|mesh-ancestor
19398267|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
19674187|NCT00698815|Growth Substances|growth substances|mesh-ancestor
19674188|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674189|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
19674190|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20189408|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20189409|NCT00213694|Celecoxib|celecoxib|mesh-list
19674191|NCT00698022|Risperidone|risperidone|mesh-list
19674192|NCT00698022|Mifepristone|mifepristone|mesh-list
19674193|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19674194|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
19674195|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674196|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674197|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674198|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19674199|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19674200|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674201|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674202|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19674203|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
19674204|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19674205|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
20189410|NCT00213694|Docetaxel|docetaxel|mesh-list
20189411|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189412|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189413|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189414|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189415|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322284|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20374328|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
20374329|NCT00990158|Coagulants|coagulants|mesh-ancestor
20374330|NCT00990197|Nicotine|nicotine|mesh-list
20374331|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20374332|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
20374333|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374334|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374335|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20374336|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20374337|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
20374338|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374339|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374340|NCT00990223|Eplerenone|eplerenone|mesh-list
20374341|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20374342|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
19322285|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
19322286|NCT03988036|Trastuzumab|trastuzumab|mesh-list
19322287|NCT03988036|Pertuzumab|pertuzumab|mesh-list
19322288|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322289|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322290|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19322291|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20374343|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20374344|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374345|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20374346|NCT00990223|Diuretics|diuretics|mesh-ancestor
20374347|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
20374348|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20374349|NCT00990275|Ethanol|ethanol|mesh-list
20374350|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20374351|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374352|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374353|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374354|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20374355|NCT00990301|Moexipril|moexipril|mesh-list
20374356|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20374357|NCT00990301|Diuretics|diuretics|mesh-ancestor
20374358|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
20374359|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374360|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19322292|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322293|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322294|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19322295|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
19322296|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20374361|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374362|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374363|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20374364|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
20374365|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322297|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322298|NCT03987893|Lactulose|lactulose|mesh-list
19322299|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19322300|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322301|NCT03987893|Laxatives|laxatives|mesh-ancestor
20374366|NCT00990392|Polymyxins|polymyxins|mesh-list
20374367|NCT00990392|Bacitracin|bacitracin|mesh-list
20374368|NCT00990392|Polymyxin B|polymyxin b|mesh-list
20374369|NCT00990392|Gramicidin|gramicidin|mesh-list
20374370|NCT00990392|Petrolatum|petrolatum|mesh-list
20374371|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374372|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374373|NCT00990392|Emollients|emollients|mesh-ancestor
20374374|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
20374375|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20374376|NCT00990405|Amoxicillin|amoxicillin|mesh-list
20374377|NCT00990405|Clarithromycin|clarithromycin|mesh-list
20374378|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374379|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374380|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19322302|NCT03987815|Nivolumab|nivolumab|mesh-list
20374381|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374382|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374383|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19322303|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322304|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322305|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19322306|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322307|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19322308|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322309|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322310|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
19322311|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322312|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322313|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19322314|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
19322315|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322316|NCT03987529|Propofol|propofol|mesh-list
19322317|NCT03987529|Sevoflurane|sevoflurane|mesh-list
19322318|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19322319|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674206|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19674207|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19674208|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19674209|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19674210|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
19674211|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19674212|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19674213|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
19674214|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19674215|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
19674216|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19674217|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19692235|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19692236|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692237|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692238|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
19692239|NCT04994860|Zamicastat|zamicastat|mesh-list
19692240|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
19692241|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19692242|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19692243|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693188|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841004|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19841005|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
20374384|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19322320|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322321|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19322322|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
19322323|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
19322324|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19322325|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19322326|NCT03987152|Sirolimus|sirolimus|mesh-list
19841006|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
19841007|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841008|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
19841009|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841010|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19322327|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322328|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322329|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19322330|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322331|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
19322332|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19322333|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
19322334|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322335|NCT03986970|Tenofovir|tenofovir|mesh-list
19322336|NCT03986970|Emtricitabine|emtricitabine|mesh-list
19322337|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
19322338|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322339|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19322340|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19322341|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322342|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322343|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19322344|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19322345|NCT03986996|Amoxicillin|amoxicillin|mesh-list
19841011|NCT00638027|Memantine|memantine|mesh-list
19322346|NCT03986996|Metronidazole|metronidazole|mesh-list
20374385|NCT00990418|Fentanyl|fentanyl|mesh-list
20374386|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20374387|NCT00990418|Narcotics|narcotics|mesh-ancestor
20374388|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322347|NCT03986996|Doxycycline|doxycycline|mesh-list
19322348|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322349|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322350|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19322351|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19322352|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
19322353|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
19322354|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
19322355|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374389|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374390|NCT00990418|Analgesics|analgesics|mesh-ancestor
20374391|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
20374392|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374393|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20374394|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20374395|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
20374396|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
20374397|NCT00990444|Insulin|insulin|mesh-list
20374398|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20374399|NCT00990444|Dextrans|dextrans|mesh-list
20374400|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322356|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374401|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374402|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
20374403|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
20374404|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
20374405|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
20374406|NCT00990496|Fludarabine|fludarabine|mesh-list
19322357|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322358|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322359|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19322360|NCT03986905|Scopolamine|scopolamine|mesh-list
19322361|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19322362|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19322363|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
20374407|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20374408|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
20374409|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374410|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374411|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20374412|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
20374413|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374414|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374415|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20374416|NCT00990535|Octreotide|octreotide|mesh-list
19322364|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
19322365|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322366|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322367|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322368|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
19322369|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19322370|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
19322371|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322372|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322373|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19322374|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
19322375|NCT03986515|Apatinib|apatinib|mesh-list
20374417|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374418|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20374419|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425927|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425928|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425929|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20425930|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
20425931|NCT01277731|Hormones|hormones|mesh-ancestor
20425932|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20425933|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20425934|NCT01277731|Protective Agents|protective agents|mesh-ancestor
20425935|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20425936|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425937|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
19322376|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322377|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20374420|NCT00990574|Anesthetics|anesthetics|mesh-list
20374421|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374422|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374423|NCT00990587|Ciclopirox|ciclopirox|mesh-list
20374424|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
20374425|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374426|NCT00990600|Tenofovir|tenofovir|mesh-list
19322378|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322379|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322380|NCT03986268|Vitamin D|vitamin d|mesh-list
19322381|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
19322382|NCT03986268|Vitamins|vitamins|mesh-ancestor
19322383|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
19322384|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322385|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19322386|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19322387|NCT03986385|Capecitabine|capecitabine|mesh-list
19674218|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
20189416|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20189417|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20189418|NCT00213694|Analgesics|analgesics|mesh-ancestor
20189419|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
19322388|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
19322389|NCT03986385|Apatinib|apatinib|mesh-list
19322390|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19322391|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
19322392|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322393|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322394|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19322395|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322396|NCT03986294|Leucovorin|leucovorin|mesh-list
19322397|NCT03986294|Antidotes|antidotes|mesh-ancestor
19322398|NCT03986294|Protective Agents|protective agents|mesh-ancestor
19322399|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322400|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
19322401|NCT03986294|Vitamins|vitamins|mesh-ancestor
19322402|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
20189420|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189421|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189422|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20189423|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189424|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20189425|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20189426|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189427|NCT00213759|Lenograstim|lenograstim|mesh-list
20189428|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20189429|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
20189430|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189431|NCT00214032|Pycnogenols|pycnogenols|mesh-list
20189432|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20189433|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
20189434|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189435|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
20189436|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189437|NCT00214032|Protective Agents|protective agents|mesh-ancestor
20189438|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20189439|NCT00214058|Carboplatin|carboplatin|mesh-list
20189440|NCT00214058|Docetaxel|docetaxel|mesh-list
20189441|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189442|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189443|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189444|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189445|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189446|NCT00214084|Allopurinol|allopurinol|mesh-list
20189447|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
20189448|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189449|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189450|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
20189451|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189452|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20189453|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
20189454|NCT00214084|Protective Agents|protective agents|mesh-ancestor
20189455|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374427|NCT00990600|Emtricitabine|emtricitabine|mesh-list
20374428|NCT00990600|Efavirenz|efavirenz|mesh-list
20189456|NCT00214110|Tamoxifen|tamoxifen|mesh-list
20189457|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19322403|NCT03986073|Linagliptin|linagliptin|mesh-list
19322404|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322405|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322406|NCT03986073|Incretins|incretins|mesh-ancestor
20189458|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
20189459|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189460|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322407|NCT03986073|Hormones|hormones|mesh-ancestor
19322408|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322409|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19322410|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
19322411|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322412|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322413|NCT03985891|Antibodies|antibodies|mesh-list
19322414|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19322415|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
19322416|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322417|NCT03986008|Liraglutide|liraglutide|mesh-list
19322418|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322419|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322420|NCT03986008|Incretins|incretins|mesh-ancestor
19322421|NCT03986008|Hormones|hormones|mesh-ancestor
19322422|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322423|NCT03985969|Indomethacin|indomethacin|mesh-list
19322424|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19322425|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322426|NCT03985969|Analgesics|analgesics|mesh-ancestor
19322427|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
19322428|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322429|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322430|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322431|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19322432|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
19322433|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
19322434|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19322435|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19322436|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322437|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398268|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398269|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398270|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398271|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19398272|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
19398273|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
19398274|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398275|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19674219|NCT00692913|Alendronate|alendronate|mesh-list
20189461|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20189462|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189463|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20189464|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20189465|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20189466|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
19398276|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398277|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398278|NCT03643874|Albuterol|albuterol|mesh-list
19398279|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19398280|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
19398281|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398282|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398283|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19398284|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398285|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
19398286|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398287|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19398288|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19398289|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19398290|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398291|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398292|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398293|NCT03643757|Bupivacaine|bupivacaine|mesh-list
19398294|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
19398295|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
19322438|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
19322439|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19322440|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19322441|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19322442|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19322443|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322444|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
19322445|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322446|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322447|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19322448|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322449|NCT03985865|Quinine|quinine|mesh-list
19322450|NCT03985865|Denatonium|denatonium|mesh-list
19322451|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
19322452|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19322453|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19322454|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322455|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19322456|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322457|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19322458|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322459|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322460|NCT03985865|Analgesics|analgesics|mesh-ancestor
19322461|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
19322462|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
19322463|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322464|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
19322465|NCT03985735|Anesthetics|anesthetics|mesh-list
19322466|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322467|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322468|NCT03985722|Trabectedin|trabectedin|mesh-list
19322469|NCT03985722|Olaratumab|olaratumab|mesh-list
19322470|NCT03985722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20374429|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
20374430|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374431|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19322471|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19322472|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
19322473|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322474|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322475|NCT03985722|Immunologic Factors|immunologic factors|mesh-ancestor
19322476|NCT03985722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322477|NCT03985319|Esomeprazole|esomeprazole|mesh-list
19322478|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19322479|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322480|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19322481|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322482|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322483|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
19322484|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322485|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322486|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19322487|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19322488|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322489|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322490|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322491|NCT03985280|Anesthetics|anesthetics|mesh-list
19322492|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
19322493|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322494|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322495|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
19322496|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322497|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19322498|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
19322499|NCT03985514|Tazobactam|tazobactam|mesh-list
19322500|NCT03985514|Piperacillin|piperacillin|mesh-list
19322501|NCT03985514|Metronidazole|metronidazole|mesh-list
19322502|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19322503|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19322504|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322505|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
20374432|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19322506|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19322507|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20374433|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322508|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322509|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322510|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322511|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19322512|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19322513|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19322514|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19322515|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19322516|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
19322517|NCT03985358|Narcotics|narcotics|mesh-ancestor
19322518|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322519|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322520|NCT03985358|Analgesics|analgesics|mesh-ancestor
19322521|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
20374434|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374435|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20374436|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20374437|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20374438|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20374439|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20374440|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20374441|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20374442|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20374443|NCT00990639|Candesartan|candesartan|mesh-list
20374444|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20374445|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20374446|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20374447|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374448|NCT00990678|Vitamin D|vitamin d|mesh-list
20374449|NCT00990678|Calcitriol|calcitriol|mesh-list
20374450|NCT00990678|Calcium|calcium|mesh-list
20374451|NCT00990678|Vitamins|vitamins|mesh-ancestor
20374452|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
20374453|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374454|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20374455|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20374456|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20374457|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374458|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374459|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20374460|NCT00990691|Desipramine|desipramine|mesh-list
20374461|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20374462|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
20374463|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20374464|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322522|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322523|NCT03984955|Mannitol|mannitol|mesh-list
19322524|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
20374465|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374466|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20374467|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20374468|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374469|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
20374470|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374471|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374472|NCT00990795|Cyclosporine|cyclosporine|mesh-list
20374473|NCT00990795|Cyclosporins|cyclosporins|mesh-list
20374474|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374475|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374476|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20374477|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
20374478|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374479|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
20374480|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322525|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19322526|NCT03984955|Diuretics|diuretics|mesh-ancestor
19322527|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
19322528|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322529|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19322530|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
19322531|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
19322532|NCT03984955|Protective Agents|protective agents|mesh-ancestor
19322533|NCT03984656|Lidocaine|lidocaine|mesh-list
19322534|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
19322535|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
19322536|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322537|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322538|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
19322539|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189467|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20189468|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189469|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
20189470|NCT00214240|Antibodies|antibodies|mesh-list
20189471|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
20189472|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20189473|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20189474|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
20189475|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189476|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19322540|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19322541|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19322542|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19322543|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19322544|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322545|NCT03984760|Sevelamer|sevelamer|mesh-list
19322546|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
19322547|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
19322548|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189477|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20189478|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189479|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
20189480|NCT00214266|Rituximab|rituximab|mesh-list
20189481|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
19322549|NCT03984591|Eplerenone|eplerenone|mesh-list
19322550|NCT03984591|Spironolactone|spironolactone|mesh-list
19322551|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19322552|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
19322553|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322554|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322555|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19322556|NCT03984591|Diuretics|diuretics|mesh-ancestor
19322557|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
19322558|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19322559|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
19322560|NCT03984578|Capecitabine|capecitabine|mesh-list
19322561|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322562|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322563|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19322564|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
19322565|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322566|NCT03984526|Atropine|atropine|mesh-list
19322567|NCT03984526|Ephedrine|ephedrine|mesh-list
19322568|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19322569|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19322570|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19322571|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
19322572|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322573|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322574|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19322575|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
19322576|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
19322577|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
19674220|NCT00692913|Calcium|calcium|mesh-list
19674221|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19674222|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674223|NCT00692913|Vitamins|vitamins|mesh-ancestor
19674224|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
19674225|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19674226|NCT00617708|Gemcitabine|gemcitabine|mesh-list
19674227|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19674228|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19674229|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674230|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
20189482|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20189483|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322578|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19322579|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20189484|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
19322580|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
19322581|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322582|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322583|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19322584|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
19322585|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19322586|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19322587|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
19322588|NCT03984409|Diuretics|diuretics|mesh-ancestor
19322589|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
19322590|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322591|NCT03984409|Expectorants|expectorants|mesh-ancestor
19322592|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
19322593|NCT03984110|Dexamethasone|dexamethasone|mesh-list
19322594|NCT03984110|Aflibercept|aflibercept|mesh-list
19322595|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322596|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
19322597|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
19322598|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322599|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322600|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322601|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
19322602|NCT03984110|Hormones|hormones|mesh-ancestor
19322603|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322604|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19322605|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322606|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19322607|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19322608|NCT03984110|Growth Substances|growth substances|mesh-ancestor
19322609|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
19322610|NCT03984357|Gemcitabine|gemcitabine|mesh-list
19322611|NCT03984357|Antibodies|antibodies|mesh-list
19322612|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
20189485|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189486|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189487|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19322613|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
19322614|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322615|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322616|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19322617|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
19322618|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322619|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
19322620|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322621|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374481|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
20374482|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374483|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20374484|NCT00990808|Atorvastatin|atorvastatin|mesh-list
20374485|NCT00990808|Anacetrapib|anacetrapib|mesh-list
20374486|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20189488|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20189489|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
20189490|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20189491|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189492|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189493|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189494|NCT00214318|Metoprolol|metoprolol|mesh-list
20374487|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20374488|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
20374489|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374490|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20374491|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20374492|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374493|NCT00990834|Simvastatin|simvastatin|mesh-list
20374494|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20374495|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20374496|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
20374497|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374498|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20374499|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19322622|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19322623|NCT03984097|Dexamethasone|dexamethasone|mesh-list
19322624|NCT03984097|Lenalidomide|lenalidomide|mesh-list
19322625|NCT03984097|Bortezomib|bortezomib|mesh-list
20374500|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374501|NCT00990847|Procaterol|procaterol|mesh-list
20374502|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20374503|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
20374504|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189495|NCT00214318|Carvedilol|carvedilol|mesh-list
20189496|NCT00214318|Terbutaline|terbutaline|mesh-list
20189497|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20189498|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20189499|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
20189500|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
20189501|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189502|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189503|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20189504|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20189505|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20189506|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189507|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374505|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322626|NCT03984097|Pomalidomide|pomalidomide|mesh-list
20374506|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19841012|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19841013|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19841014|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
19322627|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322628|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
19322629|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
19322630|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322631|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322632|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322633|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
19322634|NCT03984097|Hormones|hormones|mesh-ancestor
19322635|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322636|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19322637|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322638|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
19322639|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19322640|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19322641|NCT03984097|Growth Substances|growth substances|mesh-ancestor
19322642|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
19322643|NCT03983954|Durvalumab|durvalumab|mesh-list
19322644|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
19322645|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19322646|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
19322647|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322648|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322649|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
19322650|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322651|NCT03983889|Fentanyl|fentanyl|mesh-list
19322652|NCT03983889|Midazolam|midazolam|mesh-list
19322653|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
19322654|NCT03983889|Remifentanil|remifentanil|mesh-list
19322655|NCT03983889|Propofol|propofol|mesh-list
19322656|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19322657|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322658|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322659|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19322660|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
19322661|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
19322662|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322663|NCT03983889|Analgesics|analgesics|mesh-ancestor
19322664|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
19322665|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322666|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19322667|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19322668|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19322669|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
19322670|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322671|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322672|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19841015|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841016|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374507|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
19322673|NCT03983889|Narcotics|narcotics|mesh-ancestor
19322674|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20374508|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
19322675|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19322676|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19322677|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19322678|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
19322679|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
19398296|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398297|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398298|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
19841017|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841018|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19841019|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19841020|NCT00638157|Gentamicins|gentamicins|mesh-list
19841021|NCT00638157|Daptomycin|daptomycin|mesh-list
19841022|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19841023|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841024|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19841025|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374509|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20374510|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20374511|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20374512|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
20374513|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398299|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398300|NCT03643666|Dexamethasone|dexamethasone|mesh-list
19398301|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
19398302|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398303|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
19398304|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
19398305|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398306|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398307|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19398308|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
20374514|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841026|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841027|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
19841028|NCT00638443|Promethazine|promethazine|mesh-list
19841029|NCT00638443|Pregabalin|pregabalin|mesh-list
19841030|NCT00638443|Analgesics|analgesics|mesh-ancestor
19841031|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
20374515|NCT00990860|Doxorubicin|doxorubicin|mesh-list
20374516|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20374517|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398309|NCT03643666|Hormones|hormones|mesh-ancestor
19398310|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398311|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19398312|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398313|NCT03643666|Analgesics|analgesics|mesh-ancestor
19398314|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
19398315|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
19398316|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374518|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20374519|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20374520|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374521|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374522|NCT00990886|Oxybutynin|oxybutynin|mesh-list
19398317|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19398318|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
19398319|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19398320|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19398321|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398322|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19398323|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
19398324|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398325|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
19398326|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19398327|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
19398328|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398329|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
19398330|NCT03643588|Protective Agents|protective agents|mesh-ancestor
19398331|NCT03643549|Temozolomide|temozolomide|mesh-list
19398332|NCT03643549|Bortezomib|bortezomib|mesh-list
19398333|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19841032|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374523|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
20374524|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
19398334|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
19398335|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322680|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
19322681|NCT03983915|Remifentanil|remifentanil|mesh-list
19322682|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19322683|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322684|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322685|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322686|NCT03983915|Analgesics|analgesics|mesh-ancestor
19322687|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
19322688|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322689|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19322690|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19322691|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20374525|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374526|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374527|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20374528|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20374529|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
20374530|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374531|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374532|NCT00990886|Urological Agents|urological agents|mesh-ancestor
20374533|NCT00990990|Linezolid|linezolid|mesh-list
20374534|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
20374535|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322692|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
19322693|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322694|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322695|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19322696|NCT03983915|Narcotics|narcotics|mesh-ancestor
19322697|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20374536|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374537|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20374538|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374539|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374540|NCT00991055|Pioglitazone|pioglitazone|mesh-list
20374541|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20374542|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374543|NCT00991133|Clofarabine|clofarabine|mesh-list
20374544|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374545|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374546|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20374547|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
20374548|NCT00991159|Bococizumab|bococizumab|mesh-list
20374549|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19322698|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
19322699|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322700|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322701|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322702|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322703|NCT03983460|Betamethasone|betamethasone|mesh-list
19322704|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
19322705|NCT03983460|Clobetasol|clobetasol|mesh-list
19322706|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322707|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
19322708|NCT03983460|Hormones|hormones|mesh-ancestor
20374550|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20374551|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
20374552|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374553|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20374554|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
19322709|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322710|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322711|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19322712|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
19322713|NCT03983239|Efavirenz|efavirenz|mesh-list
19322714|NCT03983239|Rifampin|rifampin|mesh-list
19322715|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19322716|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19322717|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322718|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322719|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
19322720|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322721|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19322722|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20374555|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19322723|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19322724|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19322725|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19322726|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19322727|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19322728|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
19322729|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322730|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
19322731|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19322732|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19322733|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19322734|NCT03982992|Blinatumomab|blinatumomab|mesh-list
19322735|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322736|NCT03983057|Antibodies|antibodies|mesh-list
19322737|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19322738|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
19322739|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322740|NCT03982862|Triamcinolone|triamcinolone|mesh-list
19322741|NCT03982862|Lidocaine|lidocaine|mesh-list
19322742|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
19322743|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19322744|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19322745|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
19322746|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
19322747|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189508|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189509|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
20189510|NCT00214318|Protective Agents|protective agents|mesh-ancestor
20189511|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20189512|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189513|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20189514|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
20189515|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19322748|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322749|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
19322750|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322751|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19322752|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19322753|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20189516|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20189517|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189518|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189519|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189520|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
20189521|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
20189522|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20189523|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189524|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189525|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189526|NCT00214331|Azithromycin|azithromycin|mesh-list
20189527|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
19322754|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19322755|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322756|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19322757|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
19322758|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322759|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322760|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
19322761|NCT03982862|Hormones|hormones|mesh-ancestor
19322762|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322763|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19322764|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
19322765|NCT03982771|Bortezomib|bortezomib|mesh-list
19322766|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19322767|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
19322768|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322769|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19322770|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19322771|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
19322772|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841033|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189528|NCT00214331|Gentamicins|gentamicins|mesh-list
20189529|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19674231|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674232|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674233|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
19674234|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674235|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322773|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322774|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20189530|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189531|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20189532|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20189533|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189534|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189535|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189536|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20374556|NCT00991211|Doxorubicin|doxorubicin|mesh-list
20374557|NCT00991211|Vincristine|vincristine|mesh-list
20374558|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189537|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20189538|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20189539|NCT00214370|Fentanyl|fentanyl|mesh-list
20189540|NCT00214370|Propofol|propofol|mesh-list
20189541|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20189542|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189543|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189544|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20189545|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
20189546|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
20189547|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20189548|NCT00214370|Narcotics|narcotics|mesh-ancestor
20189549|NCT00214370|Analgesics|analgesics|mesh-ancestor
20189550|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
20189551|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189552|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20189553|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20189554|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
20189555|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189556|NCT00214552|Rabeprazole|rabeprazole|mesh-list
20189557|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20189558|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20189559|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20189560|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189561|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674236|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674237|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
19674238|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674239|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20189562|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20189563|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
20189564|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20189565|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20189566|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20189567|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189568|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189569|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20189570|NCT00214604|Pravastatin|pravastatin|mesh-list
20189571|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20189572|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20189573|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
20189574|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189575|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19322775|NCT03982849|Silymarin|silymarin|mesh-list
19322776|NCT03982849|Hydroquinone|hydroquinone|mesh-list
19322777|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
19322778|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322779|NCT03982849|Protective Agents|protective agents|mesh-ancestor
19322780|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322781|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19322782|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19674240|NCT00516737|Rizatriptan|rizatriptan|mesh-list
19322783|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19322784|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322785|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
19322786|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
20189576|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19322787|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19322788|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
20189577|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189578|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20189579|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20189580|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20189581|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
20189582|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189583|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20189584|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20189585|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189586|NCT00214630|Atorvastatin|atorvastatin|mesh-list
20189587|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19322789|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322790|NCT03982537|Expectorants|expectorants|mesh-ancestor
19322791|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
19841034|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
20189588|NCT00214630|Calcium|calcium|mesh-list
20189589|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20189590|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322792|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19322793|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
19322794|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322795|NCT03982537|Protective Agents|protective agents|mesh-ancestor
19322796|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322797|NCT03982537|Antidotes|antidotes|mesh-ancestor
19322798|NCT03982784|Morphine|morphine|mesh-list
19322799|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19322800|NCT03982784|Narcotics|narcotics|mesh-ancestor
19322801|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322802|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322803|NCT03982784|Analgesics|analgesics|mesh-ancestor
19322804|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
19322805|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322806|NCT03982381|Metformin|metformin|mesh-list
19322807|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
19322808|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322809|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322810|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19322811|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322812|NCT03982680|Gemcitabine|gemcitabine|mesh-list
19322813|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19322814|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
19322815|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322816|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322817|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
19322818|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322819|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322820|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19322821|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
19322822|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322823|NCT03982134|Panobinostat|panobinostat|mesh-list
19322824|NCT03982134|Spartalizumab|spartalizumab|mesh-list
19322825|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322826|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19322827|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322828|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322829|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19322830|NCT03982277|Rifampin|rifampin|mesh-list
19322831|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19322832|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
19322833|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19674241|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19674242|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
19674243|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674244|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674245|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674246|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
19674247|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19674248|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
19674249|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19674250|NCT00326898|Sorafenib|sorafenib|mesh-list
19674251|NCT00326898|Sunitinib|sunitinib|mesh-list
19674252|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674253|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19674254|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674255|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322834|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322835|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
19322836|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19322837|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322838|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322839|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19322840|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19322841|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19322842|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19322843|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19322844|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19322845|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
19322846|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19322847|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
19322848|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322849|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20374559|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
20374560|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374561|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374562|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20374563|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
20374564|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374565|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374566|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20374567|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19322850|NCT03982173|Durvalumab|durvalumab|mesh-list
19322851|NCT03982173|Tremelimumab|tremelimumab|mesh-list
19322852|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322853|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322854|NCT03982238|Metformin|metformin|mesh-list
19322855|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
19322856|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322857|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322858|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19322859|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322860|NCT03982121|Nivolumab|nivolumab|mesh-list
19322861|NCT03982121|Ipilimumab|ipilimumab|mesh-list
19322862|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322863|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322864|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19322865|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322866|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
19322867|NCT03982004|Imiquimod|imiquimod|mesh-list
19322868|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322869|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322870|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19322871|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
19322872|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322873|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
19322874|NCT03981887|Nafithromycin|nafithromycin|mesh-list
19322875|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322876|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322877|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19322878|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322879|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322880|NCT03981900|Tofacitinib|tofacitinib|mesh-list
19322881|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19322882|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322883|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398336|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398337|NCT03643510|Fulvestrant|fulvestrant|mesh-list
19398338|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19398339|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398340|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19398341|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19398342|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
19398343|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398344|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398345|NCT03643497|Meropenem|meropenem|mesh-list
19398346|NCT03643497|Linezolid|linezolid|mesh-list
19398347|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
19398348|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322884|NCT03981601|Lovastatin|lovastatin|mesh-list
19322885|NCT03981601|L 647318|l 647318|mesh-list
19322886|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
19322887|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19322888|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19322889|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
19322890|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322891|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19322892|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19322893|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322894|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
19322895|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322896|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322897|NCT03981770|Anesthetics|anesthetics|mesh-list
19322898|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322899|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322900|NCT03981484|Thrombin|thrombin|mesh-list
19322901|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
19322902|NCT03981484|Coagulants|coagulants|mesh-ancestor
19322903|NCT03981523|Benzonidazole|benzonidazole|mesh-list
19322904|NCT03981523|Nifurtimox|nifurtimox|mesh-list
19322905|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19322906|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
19322907|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322908|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19322909|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19322910|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19322911|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322912|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
19322913|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19322914|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
19322915|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322916|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
19322917|NCT03981458|Protective Agents|protective agents|mesh-ancestor
19322918|NCT03981146|Nivolumab|nivolumab|mesh-list
19322919|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322920|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322921|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19322922|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322923|NCT03981068|Nimorazole|nimorazole|mesh-list
19322924|NCT03981068|Cisplatin|cisplatin|mesh-list
19322925|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322926|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19322927|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19322928|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19841035|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19841036|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19841037|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841038|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19322929|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322930|NCT03981081|Prednisone|prednisone|mesh-list
19322931|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322932|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
19322933|NCT03981081|Hormones|hormones|mesh-ancestor
19322934|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19322935|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322936|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19322937|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322938|NCT03981094|Pirfenidone|pirfenidone|mesh-list
19322939|NCT03981094|Analgesics|analgesics|mesh-ancestor
19322940|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
19322941|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322942|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322943|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20374568|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20374569|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20374570|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374571|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20374572|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374573|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
20374574|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
20374575|NCT00991250|Temozolomide|temozolomide|mesh-list
19322944|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19322945|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19322946|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19322947|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322948|NCT03981029|Folic Acid|folic acid|mesh-list
20189591|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19322949|NCT03981029|Hematinics|hematinics|mesh-ancestor
19322950|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
19322951|NCT03981029|Vitamins|vitamins|mesh-ancestor
19322952|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
19322953|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322954|NCT03980847|Alendronate|alendronate|mesh-list
19322955|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19322956|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322957|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
19322958|NCT03980951|Narcotics|narcotics|mesh-ancestor
19322959|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19322960|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189592|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20189593|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
20189594|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189595|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19322961|NCT03980951|Analgesics|analgesics|mesh-ancestor
19322962|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
19322963|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19322964|NCT03980990|Metformin|metformin|mesh-list
19322965|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19322966|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322967|NCT03980756|Esomeprazole|esomeprazole|mesh-list
19322968|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19322969|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322970|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19322971|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322972|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322973|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
19322974|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322975|NCT03980379|Rituximab|rituximab|mesh-list
19322976|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19322977|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19322978|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
19322979|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189596|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20189597|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322980|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19322981|NCT03980496|Omeprazole|omeprazole|mesh-list
19322982|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20189598|NCT00214643|Clindamycin|clindamycin|mesh-list
20189599|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
20189600|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
20189601|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
20189602|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20189603|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189604|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20189605|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189606|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189607|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
20189608|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
20189609|NCT00214682|Vitamins|vitamins|mesh-ancestor
20189610|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
20189611|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189612|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
20189613|NCT00214682|Hematinics|hematinics|mesh-ancestor
20189614|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
20189615|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20189616|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
20189617|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20189618|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20189619|NCT00214825|Eplerenone|eplerenone|mesh-list
20189620|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20189621|NCT00214825|Diuretics|diuretics|mesh-ancestor
20189622|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
20189623|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189624|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20189625|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189626|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189627|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20189628|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
20189629|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20189630|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20217393|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19322983|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19322984|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19322985|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19322986|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374576|NCT00991250|Dacarbazine|dacarbazine|mesh-list
20374577|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20374578|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
20374579|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374580|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374581|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
20374582|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20374583|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20374584|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374585|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20374586|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374587|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
20374588|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
20374589|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374590|NCT00991627|Atropine|atropine|mesh-list
20374591|NCT00991627|Ephedrine|ephedrine|mesh-list
20374592|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
20374593|NCT00991627|Morphine|morphine|mesh-list
20374594|NCT00991627|Bupivacaine|bupivacaine|mesh-list
20374595|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
20374596|NCT00991627|Anesthetics|anesthetics|mesh-list
20374597|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374598|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19322987|NCT03980223|Doxycycline|doxycycline|mesh-list
19322988|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19322989|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19322990|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
19322991|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19322992|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19322993|NCT03980249|Carvedilol|carvedilol|mesh-list
19322994|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19322995|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19322996|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
19322997|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19322998|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19322999|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323000|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19323001|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
19323002|NCT03980249|Protective Agents|protective agents|mesh-ancestor
20189631|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20189632|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189633|NCT00214864|Docetaxel|docetaxel|mesh-list
20189634|NCT00214864|Capecitabine|capecitabine|mesh-list
19841039|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19841040|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841041|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841042|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841043|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19841044|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19841045|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
19841046|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
19841047|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
19841048|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
20374599|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
20189635|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189636|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374600|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189637|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189638|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
19323003|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19323004|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323005|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19323006|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
19323007|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19323008|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19323009|NCT03980041|Nivolumab|nivolumab|mesh-list
19323010|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19841049|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374601|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20374602|NCT00991627|Narcotics|narcotics|mesh-ancestor
19323011|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841050|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20189639|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189640|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189641|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
20189642|NCT00214877|Methylene Blue|methylene blue|mesh-list
20189643|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189644|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189645|NCT00214942|Fentanyl|fentanyl|mesh-list
20189646|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20189647|NCT00214942|Narcotics|narcotics|mesh-ancestor
20189648|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189649|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374603|NCT00991627|Analgesics|analgesics|mesh-ancestor
20374604|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20374605|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20374606|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19323012|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19323013|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323014|NCT03980184|Guanfacine|guanfacine|mesh-list
19323015|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19323016|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19323017|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19323018|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19323019|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323020|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323021|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323022|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323023|NCT03979976|Ramipril|ramipril|mesh-list
19323024|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19323025|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20374607|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
20374608|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20374609|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
20374610|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
20374611|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
20374612|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20374613|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20374614|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
20374615|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374616|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374617|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20374618|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
20374619|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20374620|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20374621|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
20374622|NCT00991705|Atorvastatin|atorvastatin|mesh-list
20374623|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20374624|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20374625|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
20374626|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374627|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20374628|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20374629|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374630|NCT00991744|Cytarabine|cytarabine|mesh-list
20374631|NCT00991744|Cortisone|cortisone|mesh-list
20374632|NCT00991744|Prednisolone|prednisolone|mesh-list
20374633|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20374634|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
20374635|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20374636|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
20374637|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19323026|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
19323027|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323028|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19323029|NCT03980171|Lenalidomide|lenalidomide|mesh-list
19323030|NCT03980171|Venetoclax|venetoclax|mesh-list
19323031|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
19841051|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
20374638|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
20374639|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20374640|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
20374641|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374642|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323032|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
20189650|NCT00214942|Analgesics|analgesics|mesh-ancestor
19841052|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
19674256|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19674257|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19674258|NCT00326898|Growth Substances|growth substances|mesh-ancestor
19674259|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374643|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
19323033|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323034|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19323035|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19323036|NCT03980171|Growth Substances|growth substances|mesh-ancestor
19323037|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
19323038|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323039|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323040|NCT03980002|Thalidomide|thalidomide|mesh-list
19323041|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19323042|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
19323043|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323044|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
19323045|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19323046|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323047|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19323048|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19323049|NCT03980002|Growth Substances|growth substances|mesh-ancestor
19323050|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
19323051|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398349|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19398350|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398351|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398352|NCT03643276|Cytarabine|cytarabine|mesh-list
19398353|NCT03643276|Dexamethasone|dexamethasone|mesh-list
19398354|NCT03643276|Prednisone|prednisone|mesh-list
20374644|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374645|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20374646|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
20374647|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374648|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374649|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
20374650|NCT00991744|Hormones|hormones|mesh-ancestor
19398355|NCT03643276|Prednisolone|prednisolone|mesh-list
19398356|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
19398357|NCT03643276|Ifosfamide|ifosfamide|mesh-list
19398358|NCT03643276|Doxorubicin|doxorubicin|mesh-list
19398359|NCT03643276|Methotrexate|methotrexate|mesh-list
19398360|NCT03643276|Fludarabine|fludarabine|mesh-list
19398361|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
19398362|NCT03643276|Etoposide|etoposide|mesh-list
19398363|NCT03643276|Vincristine|vincristine|mesh-list
19398364|NCT03643276|Bortezomib|bortezomib|mesh-list
19398365|NCT03643276|Daunorubicin|daunorubicin|mesh-list
19398366|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
19398367|NCT03643276|Pegaspargase|pegaspargase|mesh-list
19398368|NCT03643276|Blinatumomab|blinatumomab|mesh-list
19398369|NCT03643276|Vindesine|vindesine|mesh-list
19398370|NCT03643276|Asparaginase|asparaginase|mesh-list
19398371|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398372|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
19398373|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398374|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19398375|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19398376|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
19398377|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398378|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398379|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19398380|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398381|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
19398382|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
19398383|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398384|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19398385|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
19398386|NCT03643276|Hormones|hormones|mesh-ancestor
19398387|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398388|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19398389|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19674260|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
19674261|NCT00156065|Haloperidol|haloperidol|mesh-list
19398390|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19398391|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19674262|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
19398392|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674263|NCT00156065|Asenapine|asenapine|mesh-list
19323052|NCT03979859|Nafithromycin|nafithromycin|mesh-list
19323053|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19323054|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323055|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19323056|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323057|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323058|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19323059|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189651|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
20189652|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189653|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20189654|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20189655|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
20189656|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
20189657|NCT00214955|Fentanyl|fentanyl|mesh-list
19323060|NCT03979989|Tapentadol|tapentadol|mesh-list
19323061|NCT03979989|Omeprazole|omeprazole|mesh-list
19323062|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19323063|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323064|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19323065|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323066|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323067|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19323068|NCT03979989|Narcotics|narcotics|mesh-ancestor
19323069|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323070|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323071|NCT03979989|Analgesics|analgesics|mesh-ancestor
19323072|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
19323073|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323074|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19323075|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19323076|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323077|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323078|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323079|NCT03979664|Dexamethasone|dexamethasone|mesh-list
19323080|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323081|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
19323082|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
19323083|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323084|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323085|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323086|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
19323087|NCT03979664|Hormones|hormones|mesh-ancestor
19323088|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323089|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19323090|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323091|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
19323092|NCT03979651|Trametinib|trametinib|mesh-list
19323093|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
19323094|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19323095|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19323096|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323097|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323098|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323099|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19323100|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323101|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19323102|NCT03979456|Rituximab|rituximab|mesh-list
19323103|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323104|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323105|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
19323106|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323107|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189658|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20189659|NCT00214955|Narcotics|narcotics|mesh-ancestor
20189660|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189661|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189662|NCT00214955|Analgesics|analgesics|mesh-ancestor
20189663|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
20189664|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189665|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20189666|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20189667|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
20189668|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
20189669|NCT00214981|Modafinil|modafinil|mesh-list
20189670|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19323108|NCT03979469|Fentanyl|fentanyl|mesh-list
19323109|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
19323110|NCT03979469|Ketamine|ketamine|mesh-list
19323111|NCT03979469|Remifentanil|remifentanil|mesh-list
19323112|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19323113|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323114|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323115|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19323116|NCT03979469|Analgesics|analgesics|mesh-ancestor
19323117|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
19323118|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323119|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19323120|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19323121|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19323122|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323123|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323124|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323125|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19323126|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19323127|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
19323128|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
19323129|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19323130|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19323131|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19323132|NCT03979469|Narcotics|narcotics|mesh-ancestor
19323133|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19323134|NCT03979248|BMS-986165|bms-986165|mesh-list
19323135|NCT03979248|Rabeprazole|rabeprazole|mesh-list
19323136|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19323137|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323138|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19323139|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323140|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323141|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
19323142|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19323143|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
19323144|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20374651|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20374652|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20374653|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
20374654|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
20374655|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374656|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374657|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20374658|NCT00991744|Protective Agents|protective agents|mesh-ancestor
20374659|NCT00991783|Digoxin|digoxin|mesh-list
20374660|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20374661|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20374662|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374663|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374664|NCT00991783|Protective Agents|protective agents|mesh-ancestor
19323145|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
19323146|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323147|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
19323148|NCT03979586|Protective Agents|protective agents|mesh-ancestor
19323149|NCT03979352|Empagliflozin|empagliflozin|mesh-list
19323150|NCT03979352|Pancrelipase|pancrelipase|mesh-list
19323151|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20374665|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374666|NCT00991796|Paclitaxel|paclitaxel|mesh-list
20374667|NCT00991796|Carboplatin|carboplatin|mesh-list
20374668|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20374669|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374670|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374671|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
20374672|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
20374673|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374674|NCT00991822|Timolol|timolol|mesh-list
20374675|NCT00991822|Dorzolamide|dorzolamide|mesh-list
20374676|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19323152|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374677|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19323153|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19323154|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374678|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323155|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323156|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
20189671|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189672|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20189673|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20189674|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20189675|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189676|NCT00214994|Tiagabine|tiagabine|mesh-list
19323157|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
19323158|NCT03979599|Analgesics|analgesics|mesh-ancestor
19323159|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
19323160|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323161|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323162|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
19323163|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323164|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19323165|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
19323166|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19323167|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323168|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323169|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19323170|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
19323171|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19323172|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
19323173|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
19323174|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323175|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
19323176|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20189677|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
20189678|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20189679|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19323177|NCT03978988|Aspirin|aspirin|mesh-list
19323178|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19323179|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19323180|NCT03978988|Analgesics|analgesics|mesh-ancestor
19323181|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
19323182|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323183|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323184|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323185|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19323186|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19323187|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19323188|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323189|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19323190|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19323191|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323192|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
19323193|NCT03979105|Ketamine|ketamine|mesh-list
19323194|NCT03979105|Analgesics|analgesics|mesh-ancestor
19323195|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
19323196|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323197|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323198|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19323199|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19323200|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
19323201|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
19323202|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674264|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
19674265|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
20189680|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189681|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189682|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
20189683|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189684|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189685|NCT00215007|Levofloxacin|levofloxacin|mesh-list
20189686|NCT00215007|Ofloxacin|ofloxacin|mesh-list
20189687|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20189688|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189689|NCT00215007|Renal Agents|renal agents|mesh-ancestor
20189690|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20189691|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20189692|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20189693|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323203|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19674266|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674267|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674268|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674269|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19674270|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19674271|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674272|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674273|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19674274|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
19323204|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19323205|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323206|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323207|NCT03978884|Losartan|losartan|mesh-list
19323208|NCT03978884|Amlodipine|amlodipine|mesh-list
19323209|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19323210|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20189694|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189695|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189696|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20189697|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20189698|NCT00215046|Methotrexate|methotrexate|mesh-list
20189699|NCT00215046|Vinblastine|vinblastine|mesh-list
19323211|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19323212|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323213|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323214|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19323215|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323216|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
19323217|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19323218|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19323219|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19323220|NCT03978884|Diuretics|diuretics|mesh-ancestor
19323221|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
19323222|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19323223|NCT03979131|Avelumab|avelumab|mesh-list
19323224|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323225|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323226|NCT03978845|Lidocaine|lidocaine|mesh-list
19323227|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
19323228|NCT03978845|Anesthetics|anesthetics|mesh-list
19323229|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323230|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323231|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
19323232|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323233|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19323234|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19323235|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20374679|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374680|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374681|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374682|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20374683|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20374684|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20374685|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374686|NCT00991848|Lidocaine|lidocaine|mesh-list
20374687|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
20374688|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
20374689|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374690|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323236|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323237|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323238|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
19323239|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323240|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674275|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189700|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20189701|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
20189702|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20189703|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374691|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
19323241|NCT03978442|Bupropion|bupropion|mesh-list
19323242|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19693189|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20189704|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189705|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
20189706|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189707|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189708|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
20189709|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612775|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323243|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
19323244|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19323245|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19323246|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19323247|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323248|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323249|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
19323250|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323251|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323252|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19323253|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19323254|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323255|NCT03978494|Tacrolimus|tacrolimus|mesh-list
19323256|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19323257|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
19323258|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323259|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19323260|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323261|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323262|NCT03978559|Trimethoprim|trimethoprim|mesh-list
19323263|NCT03978559|Caspofungin|caspofungin|mesh-list
19323264|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
19323265|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
19323266|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323267|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
19323268|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
19323269|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323270|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323271|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323272|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
19323273|NCT03978559|Hormones|hormones|mesh-ancestor
19323274|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323275|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19323276|NCT03978559|Protective Agents|protective agents|mesh-ancestor
19841053|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841054|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19841055|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
19841056|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
19841057|NCT00638456|Budesonide|budesonide|mesh-list
19841058|NCT00638456|Lansoprazole|lansoprazole|mesh-list
19841059|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
19841060|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841061|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19841062|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
19841063|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841064|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841065|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19841066|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
19841067|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
19841068|NCT00638456|Hormones|hormones|mesh-ancestor
19841069|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19841070|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19841071|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612776|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612777|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20612778|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
20612779|NCT02252809|Hormones|hormones|mesh-ancestor
20612780|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612781|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20612782|NCT02252809|Protective Agents|protective agents|mesh-ancestor
20612783|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20612784|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841072|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20189710|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20189711|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19841073|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189712|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
19841074|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841075|NCT00638508|Ketorolac|ketorolac|mesh-list
19841076|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19841077|NCT00638508|Ropivacaine|ropivacaine|mesh-list
19841078|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
19841079|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
19841080|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841081|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841082|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
19841083|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323277|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19323278|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323279|NCT03978559|Renal Agents|renal agents|mesh-ancestor
19323280|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
19323281|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19323282|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19323283|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19323284|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323285|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323286|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19323287|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19323288|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19323289|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
19323290|NCT03978364|Azacitidine|azacitidine|mesh-list
19323291|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19323292|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
19323293|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323294|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323295|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323296|NCT03978286|Vortioxetine|vortioxetine|mesh-list
19323297|NCT03978286|Sertraline|sertraline|mesh-list
19323298|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
19323299|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19323300|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19323301|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19323302|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323303|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323304|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323305|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
19323306|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323307|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19323308|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19323309|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323310|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19323311|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19323312|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19323313|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19323314|NCT03978208|Naproxen|naproxen|mesh-list
19323315|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19323316|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19323317|NCT03978208|Analgesics|analgesics|mesh-ancestor
19323318|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
19323319|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323320|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323321|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323322|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19323323|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
19323324|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19323325|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841084|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19841085|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20189713|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189714|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20189715|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20189716|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189717|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189718|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189719|NCT00215124|Lenograstim|lenograstim|mesh-list
20189720|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20189721|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
20189722|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189723|NCT00215163|Paroxetine|paroxetine|mesh-list
20189724|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19323326|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323327|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19323328|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
19323329|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323330|NCT03978052|Protective Agents|protective agents|mesh-ancestor
19323331|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323332|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19323333|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19323334|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323335|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19323336|NCT03978156|Dronabinol|dronabinol|mesh-list
19323337|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
19323338|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323339|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19323340|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19323341|NCT03978156|Analgesics|analgesics|mesh-ancestor
19323342|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
19323343|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323344|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19323345|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19323346|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323347|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323348|NCT03978156|Hormones|hormones|mesh-ancestor
19323349|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323350|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19323351|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19323352|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19323353|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323354|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323355|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
19323356|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323357|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374692|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374693|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19323358|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19323359|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323360|NCT03977675|Ketamine|ketamine|mesh-list
19323361|NCT03977675|Analgesics|analgesics|mesh-ancestor
19323362|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
19323363|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323364|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323365|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19323366|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19323367|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
19323368|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
19323369|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323370|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19323371|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19323372|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323373|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323374|NCT03977792|Docosanol|docosanol|mesh-list
19323375|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
19323376|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323377|NCT03977649|Erenumab|erenumab|mesh-list
19323378|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19323379|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323380|NCT03977649|Analgesics|analgesics|mesh-ancestor
19323381|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
19323382|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323383|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398393|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19398394|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
19398395|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398396|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19398397|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
19398398|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
19398399|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19398400|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19398401|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20374694|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20374695|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19323384|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19323385|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19323386|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612785|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19323387|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323388|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19323389|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323390|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323391|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
19323392|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323393|NCT03977441|Pramipexole|pramipexole|mesh-list
19323394|NCT03977441|S 20098|s 20098|mesh-list
19323395|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
19323396|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323397|NCT03977441|Protective Agents|protective agents|mesh-ancestor
19323398|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323399|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19323400|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19323401|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
19323402|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
19323403|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323404|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19323405|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323406|NCT03977571|Nivolumab|nivolumab|mesh-list
19323407|NCT03977571|Ipilimumab|ipilimumab|mesh-list
19323408|NCT03977571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323409|NCT03977571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189725|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20189726|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189727|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189728|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189729|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
20189730|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189731|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20189732|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
20189733|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20189734|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20189735|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20189736|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189737|NCT00215176|Modafinil|modafinil|mesh-list
20189738|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20612786|NCT02252887|Gemcitabine|gemcitabine|mesh-list
20612787|NCT02252887|Trastuzumab|trastuzumab|mesh-list
19323410|NCT03977571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20189739|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189740|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20189741|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20189742|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20189743|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189744|NCT00215202|Gefitinib|gefitinib|mesh-list
20189745|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189746|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20189747|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189748|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189749|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20189750|NCT00215228|Citalopram|citalopram|mesh-list
20189751|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20189752|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20189753|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189754|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189755|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189756|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
20189757|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189758|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20189759|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
20189760|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20425938|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20425939|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
20425940|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425941|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20425942|NCT01277835|Lidocaine|lidocaine|mesh-list
20374696|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20374697|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374698|NCT00991926|Orlistat|orlistat|mesh-list
19323411|NCT03977571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323412|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
19323413|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19323414|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323415|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
19841086|NCT00638508|Analgesics|analgesics|mesh-ancestor
20374699|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374700|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323416|NCT03977220|Paclitaxel|paclitaxel|mesh-list
19323417|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19323418|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323419|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
19323420|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
19323421|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
19323422|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323423|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
19323424|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19323425|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323426|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
19323427|NCT03977454|Ropivacaine|ropivacaine|mesh-list
19323428|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
19323429|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
19323430|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323431|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323432|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
19323433|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323434|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
19323435|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19323436|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323437|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
19323438|NCT03977012|Buprenorphine|buprenorphine|mesh-list
19323439|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19323440|NCT03977012|Narcotics|narcotics|mesh-ancestor
19323441|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323442|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323443|NCT03977012|Analgesics|analgesics|mesh-ancestor
19323444|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
19323445|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323446|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19323447|NCT03977233|Leucovorin|leucovorin|mesh-list
19323448|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
19323449|NCT03977233|Irinotecan|irinotecan|mesh-list
19323450|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323451|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19323452|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19323453|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323454|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323455|NCT03977233|Antidotes|antidotes|mesh-ancestor
19323456|NCT03977233|Protective Agents|protective agents|mesh-ancestor
19323457|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323458|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
19323459|NCT03977233|Vitamins|vitamins|mesh-ancestor
19323460|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
19323461|NCT03976713|Bromides|bromides|mesh-list
19323462|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
19323463|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19323464|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
19323465|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323466|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323467|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20374701|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20374702|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20374703|NCT00991978|Bevacizumab|bevacizumab|mesh-list
20374704|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20374705|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20374706|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374707|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20374708|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20374709|NCT00991978|Growth Substances|growth substances|mesh-ancestor
20612788|NCT02252887|Pertuzumab|pertuzumab|mesh-list
19323468|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
19323469|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
19323470|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19323471|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
19323472|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323473|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323474|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
19323475|NCT03976518|Atezolizumab|atezolizumab|mesh-list
19323476|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323477|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19323478|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19323479|NCT03976544|Estradiol|estradiol|mesh-list
19323480|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19323481|NCT03976544|Progesterone|progesterone|mesh-list
19323482|NCT03976544|Estrogens|estrogens|mesh-ancestor
19323483|NCT03976544|Hormones|hormones|mesh-ancestor
19323484|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323485|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323486|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19323487|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
19323488|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19841087|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841088|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841089|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19841090|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841091|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841092|NCT00638651|Imiquimod|imiquimod|mesh-list
20374710|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374711|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
20374712|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20374713|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374714|NCT00992004|Turmeric extract|turmeric extract|mesh-list
20374715|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
19323489|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19323490|NCT03976544|Progestins|progestins|mesh-ancestor
19323491|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19323492|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323493|NCT03976102|Rituximab|rituximab|mesh-list
19323494|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323495|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323496|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
19323497|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323498|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19323499|NCT03976063|Nifedipine|nifedipine|mesh-list
19323500|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19323501|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323502|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323503|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19323504|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323505|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
19323506|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
19323507|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19323508|NCT03976037|Misoprostol|misoprostol|mesh-list
19323509|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19323510|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
19323511|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19323512|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323513|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19323514|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323515|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
19398402|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
19398403|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398404|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
19398405|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
19398406|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
19404435|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404436|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
19404807|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404808|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404809|NCT03591757|Tolcapone|tolcapone|mesh-list
19404810|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19404811|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19404812|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19404813|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404814|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841093|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19404815|NCT03591744|Dexamethasone|dexamethasone|mesh-list
19404816|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
19323516|NCT03975374|Tobramycin|tobramycin|mesh-list
19323517|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19323518|NCT03975374|Dexamethasone|dexamethasone|mesh-list
19323519|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19323520|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323521|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
19323522|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
19323523|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323524|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323525|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323526|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
19323527|NCT03975374|Hormones|hormones|mesh-ancestor
19323528|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323529|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19323530|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323531|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19323532|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323533|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19323534|NCT03975283|Bupivacaine|bupivacaine|mesh-list
19323535|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
19323536|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
19323537|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323538|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189761|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189762|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20189763|NCT00215228|Analgesics|analgesics|mesh-ancestor
20189764|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
19323539|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
19323540|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323541|NCT03975270|Paclitaxel|paclitaxel|mesh-list
19323542|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19323543|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323544|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
19323545|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
19323546|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
19323547|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323548|NCT03975114|Durvalumab|durvalumab|mesh-list
19323549|NCT03975114|Tremelimumab|tremelimumab|mesh-list
19323550|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323551|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323552|NCT03975088|Ranibizumab|ranibizumab|mesh-list
19323553|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19323554|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19323555|NCT03975088|Growth Substances|growth substances|mesh-ancestor
19323556|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323557|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
19323558|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323559|NCT03975166|Fluticasone|fluticasone|mesh-list
19323560|NCT03975166|Xhance|xhance|mesh-list
19323561|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19323562|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19323563|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323564|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19323565|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
19323566|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323567|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323568|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189765|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
20189766|NCT00215241|Risperidone|risperidone|mesh-list
20189767|NCT00215241|Sertraline|sertraline|mesh-list
20189768|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20189769|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
20189770|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189771|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189772|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189773|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20189774|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20189775|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189776|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20189777|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20189778|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
20189779|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
19323569|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
19323570|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
19323571|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19323572|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19323573|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19323574|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19323575|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323576|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323577|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323578|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
19323579|NCT03975166|Hormones|hormones|mesh-ancestor
19323580|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323581|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
19323582|NCT03975205|Doxorubicin|doxorubicin|mesh-list
19323583|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19323584|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323585|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19323586|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19323587|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323588|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323589|NCT03975036|Antibodies|antibodies|mesh-list
19323590|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
19323591|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323592|NCT03975010|Naltrexone|naltrexone|mesh-list
20374716|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374717|NCT00992004|Protective Agents|protective agents|mesh-ancestor
20374718|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374719|NCT00992030|Rituximab|rituximab|mesh-list
20374720|NCT00992030|Doxorubicin|doxorubicin|mesh-list
20374721|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20374722|NCT00992030|Dacarbazine|dacarbazine|mesh-list
20374723|NCT00992030|Bleomycin|bleomycin|mesh-list
20374724|NCT00992030|Vinblastine|vinblastine|mesh-list
20374725|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20374726|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374727|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
20374728|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374729|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374730|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20374731|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20374732|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20374733|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374734|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374735|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20374736|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
20374737|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20374738|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374739|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
20374740|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
20374741|NCT00992069|Efavirenz|efavirenz|mesh-list
20374742|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20374743|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20374744|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374745|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374746|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
20374747|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374748|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20374749|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20374750|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20374751|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20374752|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20374753|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20374754|NCT00992082|Ketorolac|ketorolac|mesh-list
20374755|NCT00992082|Epinephrine|epinephrine|mesh-list
20374756|NCT00992082|Morphine|morphine|mesh-list
20374757|NCT00992082|Ropivacaine|ropivacaine|mesh-list
20374758|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20374759|NCT00992082|Narcotics|narcotics|mesh-ancestor
20374760|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374761|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323593|NCT03975010|Buprenorphine|buprenorphine|mesh-list
19323594|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19323595|NCT03975010|Narcotics|narcotics|mesh-ancestor
19323596|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323597|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323598|NCT03975010|Analgesics|analgesics|mesh-ancestor
19323599|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
20374762|NCT00992082|Analgesics|analgesics|mesh-ancestor
19323600|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323601|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19323602|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19323603|NCT03975062|Dabigatran|dabigatran|mesh-list
20189780|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19323604|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
19323605|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19323606|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
19323607|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323608|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323609|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
19323610|NCT03974984|Anesthetics|anesthetics|mesh-list
20189781|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20189782|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189783|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20189784|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
20189785|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19323611|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323612|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323613|NCT03974789|Dexamethasone|dexamethasone|mesh-list
19323614|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323615|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
19323616|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
19323617|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323618|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323619|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323620|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
19323621|NCT03974789|Hormones|hormones|mesh-ancestor
19323622|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323623|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19323624|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323625|NCT03974932|Acetaminophen|acetaminophen|mesh-list
19323626|NCT03974932|Ibuprofen|ibuprofen|mesh-list
19323627|NCT03974932|Celecoxib|celecoxib|mesh-list
19323628|NCT03974932|Bupivacaine|bupivacaine|mesh-list
19323629|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
19323630|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
19323631|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323632|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323633|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
19323634|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323635|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19323636|NCT03974932|Analgesics|analgesics|mesh-ancestor
19323637|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
19323638|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19323639|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323640|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19323641|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19323642|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323643|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323644|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20189786|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20189787|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20189788|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189789|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189790|NCT00215267|Praziquantel|praziquantel|mesh-list
20189791|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
20189792|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20189793|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189794|NCT00215280|Ivermectin|ivermectin|mesh-list
20189795|NCT00215280|Albendazole|albendazole|mesh-list
20189796|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20189797|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189798|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
20189799|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
20189800|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20189801|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20189802|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189803|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189804|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
19323645|NCT03974685|Niacinamide|niacinamide|mesh-list
19323646|NCT03974685|Niacin|niacin|mesh-list
19323647|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
19323648|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
20189805|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323649|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
20374763|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
20374764|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374765|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
20374766|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
20374767|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20374768|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20374769|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
20374770|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374771|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374772|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19323650|NCT03974685|Vitamins|vitamins|mesh-ancestor
19323651|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
19323652|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323653|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19323654|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
19323655|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374773|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20374774|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
20374775|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20374776|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
20374777|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
20374778|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
20374779|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19323656|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19323657|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
19323658|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323659|NCT03974867|Prednisone|prednisone|mesh-list
19323660|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
19323661|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19323662|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19323663|NCT03974867|Prednisolone|prednisolone|mesh-list
19323664|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
19323665|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19323666|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
19323667|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323668|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
19323669|NCT03974867|Hormones|hormones|mesh-ancestor
19323670|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323671|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323672|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19323673|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323674|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
19323675|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
19323676|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323677|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323678|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19323679|NCT03974867|Protective Agents|protective agents|mesh-ancestor
19323680|NCT03974217|Talazoparib|talazoparib|mesh-list
19323681|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19323682|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323683|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323684|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323685|NCT03974360|Erenumab|erenumab|mesh-list
19323686|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19323687|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323688|NCT03974360|Analgesics|analgesics|mesh-ancestor
19323689|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
19323690|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323691|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189806|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189807|NCT00215345|Celecoxib|celecoxib|mesh-list
20189808|NCT00215345|Docetaxel|docetaxel|mesh-list
20189809|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189810|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189811|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189812|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189813|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189814|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20189815|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20189816|NCT00215345|Analgesics|analgesics|mesh-ancestor
20189817|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
20374780|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19323692|NCT03974425|Aflibercept|aflibercept|mesh-list
20189818|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374781|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19323693|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19323694|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19323695|NCT03974425|Growth Substances|growth substances|mesh-ancestor
19323696|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323697|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
19323698|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323699|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
19323700|NCT03973840|Testosterone|testosterone|mesh-list
19323701|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
19323702|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
19323703|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19323704|NCT03973840|Androgens|androgens|mesh-ancestor
19323705|NCT03973840|Hormones|hormones|mesh-ancestor
19323706|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323707|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323708|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19323709|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374782|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374783|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374784|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20374785|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374786|NCT00992095|Buprenorphine|buprenorphine|mesh-list
19323710|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
19323711|NCT03973775|Permethrin|permethrin|mesh-list
19323712|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323713|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323714|NCT03973879|Atezolizumab|atezolizumab|mesh-list
19323715|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398407|NCT03643107|Prednisolone|prednisolone|mesh-list
19398408|NCT03643107|Irofulven|irofulven|mesh-list
19398409|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398410|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
19398411|NCT03643107|Hormones|hormones|mesh-ancestor
19398412|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398413|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398414|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19398415|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398416|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19398417|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
20374787|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19398418|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398419|NCT03642990|Niacinamide|niacinamide|mesh-list
19398420|NCT03642990|Niacin|niacin|mesh-list
19398421|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
19398422|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
19398423|NCT03642990|Vitamins|vitamins|mesh-ancestor
19398424|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
19398425|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398426|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19398427|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
19398428|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398429|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19398430|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
19398431|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19841094|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
19841095|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841096|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398432|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
19398433|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398434|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19398435|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19398436|NCT03642665|Estradiol|estradiol|mesh-list
19398437|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19398438|NCT03642665|Progesterone|progesterone|mesh-list
19398439|NCT03642665|Estrogens|estrogens|mesh-ancestor
19398440|NCT03642665|Hormones|hormones|mesh-ancestor
19398441|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398442|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404437|NCT03594968|Progesterone|progesterone|mesh-list
19841097|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
19841098|NCT00638690|Prednisone|prednisone|mesh-list
19841099|NCT00638690|Prednisolone|prednisolone|mesh-list
19841100|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
19841101|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841102|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
19841103|NCT00638690|Hormones|hormones|mesh-ancestor
20374788|NCT00992095|Narcotics|narcotics|mesh-ancestor
19323716|NCT03973957|Fentanyl|fentanyl|mesh-list
19323717|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19323718|NCT03973957|Narcotics|narcotics|mesh-ancestor
19323719|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323720|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323721|NCT03973957|Analgesics|analgesics|mesh-ancestor
19323722|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
19323723|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323724|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19323725|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19323726|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
19323727|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
19323728|NCT03974035|Ropivacaine|ropivacaine|mesh-list
19323729|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
19841104|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19841105|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841106|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19841107|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841108|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19841109|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374789|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374790|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374791|NCT00992095|Analgesics|analgesics|mesh-ancestor
20374792|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
20374793|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374794|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19841110|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841111|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
19841112|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19323730|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
19323731|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189819|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189820|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20189821|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20189822|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20189823|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20189824|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189825|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
20189826|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189827|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
20189828|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189829|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189830|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189831|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189832|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189833|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189834|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20374795|NCT00992121|Bevacizumab|bevacizumab|mesh-list
20374796|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323732|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323733|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
19323734|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323735|NCT03973489|Methamphetamine|methamphetamine|mesh-list
19323736|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19323737|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323738|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
19323739|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
19323740|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323741|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
19323742|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323743|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323744|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323745|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19323746|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19323747|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323748|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19323749|NCT03973567|Norepinephrine|norepinephrine|mesh-list
19323750|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
19323751|NCT03973567|Serotonin|serotonin|mesh-list
19841113|NCT00638820|Busulfan|busulfan|mesh-list
19841114|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
19841115|NCT00638820|Clofarabine|clofarabine|mesh-list
19841116|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
19323752|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19323753|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19323754|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19323755|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
19323756|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323757|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323758|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323759|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20374797|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374798|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20374799|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20374800|NCT00992121|Growth Substances|growth substances|mesh-ancestor
19841117|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841118|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19323760|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19323761|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323762|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
19323763|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
19323764|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841119|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
19841120|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841121|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19841122|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841123|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19841124|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19841125|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19841126|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
19841127|NCT00638937|Saracatinib|saracatinib|mesh-list
20189835|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189836|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189837|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189838|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
20189839|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19323765|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19323766|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19323767|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19323768|NCT03973138|Ranibizumab|ranibizumab|mesh-list
19323769|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19323770|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19323771|NCT03973138|Growth Substances|growth substances|mesh-ancestor
19323772|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323773|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
20189840|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
20189841|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189842|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189843|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189844|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
19323774|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323775|NCT03973411|Ondansetron|ondansetron|mesh-list
19323776|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
19323777|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
19323778|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323779|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323780|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19841128|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841129|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841130|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841131|NCT00638963|Temozolomide|temozolomide|mesh-list
20425943|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
19323781|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
19323782|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
19323783|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19323784|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
19323785|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323786|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323787|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19323788|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19323789|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323790|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19323791|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19323792|NCT03973203|Niacin|niacin|mesh-list
19323793|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
19323794|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19323795|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
19323796|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323797|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19323798|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
19323799|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
19323800|NCT03973203|Vitamins|vitamins|mesh-ancestor
19323801|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
19323802|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323803|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
19323804|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19323805|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19323806|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323807|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323808|NCT03973086|Protective Agents|protective agents|mesh-ancestor
19323809|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323810|NCT03972748|Itraconazole|itraconazole|mesh-list
19323811|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
19323812|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323813|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19323814|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19323815|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323816|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323817|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19323818|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
19323819|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323820|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323821|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19323822|NCT03972982|Insulin|insulin|mesh-list
19323823|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19323824|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19323825|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841132|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19841133|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
19841134|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374801|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374802|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
20374803|NCT00992134|Cytarabine|cytarabine|mesh-list
20374804|NCT00992134|Rituximab|rituximab|mesh-list
19323826|NCT03973047|Ondansetron|ondansetron|mesh-list
19323827|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
19323828|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
19323829|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323830|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323831|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323832|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
19323833|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
19323834|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19323835|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
19323836|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323837|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323838|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19323839|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19323840|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323841|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19323842|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19323843|NCT03972592|Sirolimus|sirolimus|mesh-list
19323844|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19323845|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323846|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19323847|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841135|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189845|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189846|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189847|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189848|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189849|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189850|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189851|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
20189852|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189853|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
20189854|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189855|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374805|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19323848|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
19323849|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19323850|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
20189856|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189857|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189858|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19323851|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323852|NCT03972683|Atropine|atropine|mesh-list
19323853|NCT03972683|Adenosine|adenosine|mesh-list
19323854|NCT03972683|Nitroprusside|nitroprusside|mesh-list
19323855|NCT03972683|Phenylephrine|phenylephrine|mesh-list
19323856|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
19323857|NCT03972683|Acetylcholine|acetylcholine|mesh-list
19323858|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19323859|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
19323860|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
19323861|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323862|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323863|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
19323864|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19323865|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
19323866|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
19323867|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19323868|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19323869|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19323870|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
19323871|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19323872|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323873|NCT03972683|Protective Agents|protective agents|mesh-ancestor
20189859|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189860|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189861|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189862|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189863|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189864|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
20189865|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189866|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
20189867|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189868|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189869|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189870|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189871|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189872|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189873|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189874|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189875|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189876|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189877|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
20189878|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189879|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
20189880|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189881|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189882|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189883|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189884|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189885|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189886|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189887|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189888|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189889|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189890|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
20189891|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189892|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
20189893|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189894|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189895|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189896|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189897|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189898|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189899|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189900|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189901|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189902|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189903|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
19323874|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19323875|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20189904|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189905|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
20189906|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20189907|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189908|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189909|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189910|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189911|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189912|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189913|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189914|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189915|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189916|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
20189917|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20189918|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
20189919|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323876|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19323877|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19323878|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
19323879|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19323880|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19323881|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
19323882|NCT03972683|Analgesics|analgesics|mesh-ancestor
19323883|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
19323884|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
19323885|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19323886|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
19323887|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
19323888|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19323889|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19323890|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19323891|NCT03972397|Bupivacaine|bupivacaine|mesh-list
19323892|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
19323893|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
19323894|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323895|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323896|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
19323897|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323898|NCT03972358|Misoprostol|misoprostol|mesh-list
19323899|NCT03972358|Mifepristone|mifepristone|mesh-list
19323900|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19323901|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
19323902|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19323903|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323904|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19323905|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323906|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
19323907|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19323908|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19323909|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19323910|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19323911|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
19323912|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19323913|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19323914|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
19323915|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323916|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
19323917|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19323918|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19323919|NCT03972462|Sirolimus|sirolimus|mesh-list
19323920|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19323921|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19323922|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19323923|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323924|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
19674276|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674277|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19674278|NCT00150176|Asenapine|asenapine|mesh-list
19323925|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19323926|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
19323927|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674279|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20189920|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323928|NCT03972046|Trametinib|trametinib|mesh-list
19323929|NCT03972046|Dabrafenib|dabrafenib|mesh-list
19323930|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19323931|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323932|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19323933|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323934|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323935|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323936|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
19323937|NCT03971604|Vitamins|vitamins|mesh-list
20189921|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20189922|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
20189923|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20189924|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20189925|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20189926|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
20189927|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841136|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19841137|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
19323938|NCT03971604|Vitamin E|vitamin e|mesh-list
20189928|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189929|NCT00215462|Vinorelbine|vinorelbine|mesh-list
20189930|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20189931|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189932|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189933|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189934|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189935|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323939|NCT03971604|Vitamin A|vitamin a|mesh-list
19323940|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
19323941|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323942|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
19323943|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323944|NCT03971604|Protective Agents|protective agents|mesh-ancestor
19398443|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19398444|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
19398445|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398446|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19398447|NCT03642665|Progestins|progestins|mesh-ancestor
19398448|NCT03642626|Vidarabine|vidarabine|mesh-list
19398449|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
19398450|NCT03642626|Fludarabine|fludarabine|mesh-list
19398451|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
19398452|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398453|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
19398454|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398455|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19398456|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19398457|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
19398458|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398459|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398460|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19398461|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19398462|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
19398463|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
19398464|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398465|NCT03642600|Folic Acid|folic acid|mesh-list
19398466|NCT03642600|Inositol|inositol|mesh-list
19398467|NCT03642600|Liraglutide|liraglutide|mesh-list
19398468|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841138|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841139|NCT00639002|Dexamethasone|dexamethasone|mesh-list
19841140|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841141|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
19841142|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
19841143|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841144|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841145|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20189936|NCT00215501|Fluorouracil|fluorouracil|mesh-list
20189937|NCT00215501|Capecitabine|capecitabine|mesh-list
20189938|NCT00215501|Irinotecan|irinotecan|mesh-list
20189939|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189940|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
20374806|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19398469|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398470|NCT03642600|Incretins|incretins|mesh-ancestor
19398471|NCT03642600|Hormones|hormones|mesh-ancestor
19323945|NCT03971409|Doxorubicin|doxorubicin|mesh-list
19323946|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19323947|NCT03971409|Avelumab|avelumab|mesh-list
19841146|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
19841147|NCT00639002|Hormones|hormones|mesh-ancestor
19841148|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19841149|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19841150|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841151|NCT00639158|Choline|choline|mesh-list
19841152|NCT00639158|Atorvastatin|atorvastatin|mesh-list
19841153|NCT00639158|Ezetimibe|ezetimibe|mesh-list
19841154|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
19841155|NCT00639158|Fenofibrate|fenofibrate|mesh-list
19841156|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19841157|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19841158|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
19841159|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841160|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19841161|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19841162|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841163|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
19841164|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20189941|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189942|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189943|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19323948|NCT03971409|Camptothecin|camptothecin|mesh-list
19323949|NCT03971409|Antibodies|antibodies|mesh-list
19323950|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19323951|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
19323952|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
20189944|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
20189945|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189946|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19323953|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
19674280|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19674281|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674282|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674283|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674284|NCT00148629|Mebendazole|mebendazole|mesh-list
19674285|NCT00148629|Piperazine|piperazine|mesh-list
19674286|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
19674287|NCT00148629|DMP 777|dmp 777|mesh-list
19674288|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
19674289|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
19674290|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19674291|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20189947|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19323954|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323955|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19323956|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323957|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19323958|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19323959|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323960|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323961|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19323962|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19323963|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19323964|NCT03971370|Vaccines|vaccines|mesh-list
19323965|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
19323966|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323967|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
19323968|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
20189948|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189949|NCT00215514|Fluorouracil|fluorouracil|mesh-list
20189950|NCT00215514|Epirubicin|epirubicin|mesh-list
20189951|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189952|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
20189953|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189954|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20189955|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20189956|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
19323969|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323970|NCT03971201|Sorafenib|sorafenib|mesh-list
19674292|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
19674293|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
19841165|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
19841166|NCT00639223|Pravastatin|pravastatin|mesh-list
19323971|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323972|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19323973|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19323974|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323975|NCT03971279|Dexamethasone|dexamethasone|mesh-list
19323976|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19323977|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
19323978|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
19323979|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19323980|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374807|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374808|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
19323981|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19323982|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
19323983|NCT03971279|Hormones|hormones|mesh-ancestor
19323984|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19323985|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19323986|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323987|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19323988|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19323989|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19323990|NCT03970798|Midazolam|midazolam|mesh-list
19323991|NCT03970798|Caffeine|caffeine|mesh-list
19323992|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19323993|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19323994|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19323995|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19323996|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19323997|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19323998|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19323999|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19324000|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19324001|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
19324002|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
19324003|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
19324004|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
19324005|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674294|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
19674295|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674296|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674297|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674298|NCT00145509|Asenapine|asenapine|mesh-list
19674299|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19674300|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841167|NCT00639223|Red yeast rice|red yeast rice|mesh-list
19841168|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19324006|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324007|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19324008|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19324009|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
19324010|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19324011|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19324012|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324013|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19324014|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19324015|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19324016|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19674301|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674302|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189957|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189958|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20189959|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19674303|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674304|NCT00145496|Olanzapine|olanzapine|mesh-list
20189960|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20189961|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189962|NCT00215579|Risperidone|risperidone|mesh-list
20189963|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20189964|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
19841169|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19841170|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
20189965|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20189966|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189967|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324017|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
19324018|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
19324019|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
19324020|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19324021|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
19324022|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324023|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19324024|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19324025|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
20189968|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20189969|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20189970|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20189971|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20189972|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20189973|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
20189974|NCT00215592|Zonisamide|zonisamide|mesh-list
20189975|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
20189976|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20189977|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20189978|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324026|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324027|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324028|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19324029|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19324030|NCT03970772|Glucagon|glucagon|mesh-list
20374809|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374810|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374811|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20374812|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
20374813|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374814|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
20374815|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374816|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20374817|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20374818|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
19324031|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19324032|NCT03970772|Hormones|hormones|mesh-ancestor
19324033|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324034|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324035|NCT03970616|Durvalumab|durvalumab|mesh-list
19324036|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19324037|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324038|NCT03970694|Capecitabine|capecitabine|mesh-list
19324039|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
19324040|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19324041|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
19324042|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324043|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324044|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
19324045|NCT03971019|Atorvastatin|atorvastatin|mesh-list
19324046|NCT03971019|Simvastatin|simvastatin|mesh-list
19324047|NCT03971019|Calcium|calcium|mesh-list
19324048|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19324049|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189979|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20189980|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20189981|NCT00215631|Tadalafil|tadalafil|mesh-list
20374819|NCT00992160|Vestipitant|vestipitant|mesh-list
19324050|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19324051|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19324052|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19324053|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
19324054|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324055|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19324056|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19324057|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324058|NCT03970759|Fluorides|fluorides|mesh-list
19324059|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
19324060|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
19324061|NCT03970759|Protective Agents|protective agents|mesh-ancestor
19324062|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324063|NCT03970577|Prednisone|prednisone|mesh-list
19324064|NCT03970577|Rituximab|rituximab|mesh-list
20189982|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
20374820|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20374821|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20374822|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374823|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374824|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20374825|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374826|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374827|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374828|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20374829|NCT00992199|Fluorouracil|fluorouracil|mesh-list
19324065|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19324066|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324067|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
19324068|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324069|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19324070|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19324071|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
19324072|NCT03970577|Hormones|hormones|mesh-ancestor
19324073|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324074|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19324075|NCT03970668|Insulin|insulin|mesh-list
19324076|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19324077|NCT03970668|Linagliptin|linagliptin|mesh-list
19324078|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19324079|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324080|NCT03970668|Incretins|incretins|mesh-ancestor
19324081|NCT03970668|Hormones|hormones|mesh-ancestor
19324082|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324083|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19324084|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
19324085|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324086|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324087|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
19324088|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19324089|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19324090|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324091|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
19324092|NCT03970213|Coagulants|coagulants|mesh-ancestor
19324093|NCT03970239|Ketanserin|ketanserin|mesh-list
19324094|NCT03970239|Fluorides|fluorides|mesh-list
19324095|NCT03970239|Altanserin|altanserin|mesh-list
19324096|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
19324097|NCT03970239|Protective Agents|protective agents|mesh-ancestor
19324098|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324099|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19324100|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
19324101|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324102|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324103|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19324104|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19324105|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
19324106|NCT03970044|Exenatide|exenatide|mesh-list
19324107|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19324108|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324109|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19324110|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324111|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19324112|NCT03970044|Incretins|incretins|mesh-ancestor
19324113|NCT03970044|Hormones|hormones|mesh-ancestor
19324114|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324115|NCT03969823|Osimertinib|osimertinib|mesh-list
19324116|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324117|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19324118|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324119|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324120|NCT03969758|Metronidazole|metronidazole|mesh-list
19324121|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
19324122|NCT03969758|Cefixime|cefixime|mesh-list
20374830|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374831|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
20374832|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374833|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19324123|NCT03969758|Liver Extracts|liver extracts|mesh-list
19324124|NCT03969758|Hematinics|hematinics|mesh-ancestor
19324125|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324126|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324127|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19324128|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19324129|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19324130|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19324131|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324132|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324133|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324134|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19324135|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19398472|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398473|NCT03642600|Hematinics|hematinics|mesh-ancestor
19398474|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
19398475|NCT03642600|Vitamins|vitamins|mesh-ancestor
19398476|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
19398477|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19398478|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19398479|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
19398480|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
19398481|NCT03642509|Apixaban|apixaban|mesh-list
19398482|NCT03642509|Edoxaban|edoxaban|mesh-list
19398483|NCT03642509|Dabigatran|dabigatran|mesh-list
19398484|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19398485|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
19398486|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19398487|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
19398488|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398489|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398490|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
19398491|NCT03642353|Listerine|listerine|mesh-list
19398492|NCT03642353|Triclosan|triclosan|mesh-list
19398493|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
19398494|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
19398495|NCT03642353|Protective Agents|protective agents|mesh-ancestor
19398496|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398497|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19398498|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398499|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19398500|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19398501|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
19398502|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398503|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19398504|NCT03642184|Empagliflozin|empagliflozin|mesh-list
19398505|NCT03642184|Linagliptin|linagliptin|mesh-list
19398506|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19398507|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398508|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19398509|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398510|NCT03642184|Incretins|incretins|mesh-ancestor
19674305|NCT00145496|Asenapine|asenapine|mesh-list
19674306|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
19674307|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
20189983|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20189984|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20189985|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20189986|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189987|NCT00215631|Urological Agents|urological agents|mesh-ancestor
20189988|NCT00215709|Docetaxel|docetaxel|mesh-list
20189989|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189990|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
20189991|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
20189992|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
20189993|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20189994|NCT00215722|Cetuximab|cetuximab|mesh-list
20189995|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20189996|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20189997|NCT00215748|Dexamethasone|dexamethasone|mesh-list
20189998|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20189999|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
20190000|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
20190001|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374834|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398511|NCT03642184|Hormones|hormones|mesh-ancestor
19398512|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398513|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19674308|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324136|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19324137|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19324138|NCT03969017|Interferons|interferons|mesh-list
19324139|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324140|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
19324141|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324142|NCT03968835|Bacitracin|bacitracin|mesh-list
19324143|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19324144|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324145|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324146|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
19324147|NCT03968640|Vitamins|vitamins|mesh-ancestor
19324148|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
19324149|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324150|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
19324151|NCT03968588|Tacrolimus|tacrolimus|mesh-list
19324152|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19324153|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
19324154|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324155|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19324156|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324157|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324158|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20190002|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190003|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190004|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
20190005|NCT00215748|Hormones|hormones|mesh-ancestor
19324159|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324160|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19324161|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
19324162|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324163|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324164|NCT03968861|Xenon|xenon|mesh-list
19324165|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19324166|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
19324167|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
19324168|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324169|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324170|NCT03968263|Hydrocodone|hydrocodone|mesh-list
19324171|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19324172|NCT03968263|Narcotics|narcotics|mesh-ancestor
19324173|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324174|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324175|NCT03968263|Analgesics|analgesics|mesh-ancestor
19324176|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
19324177|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324178|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
19324179|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
19324180|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19324181|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324182|NCT03968185|Analgesics|analgesics|mesh-list
19324183|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
19324184|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190006|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20190007|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20190008|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190009|NCT00215774|Flecainide|flecainide|mesh-list
20190010|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20190011|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20190012|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20190013|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190014|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190015|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
20190016|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
20190017|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190018|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
20190019|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
20190020|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190021|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
20190022|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324185|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324186|NCT03968146|Acetaminophen|acetaminophen|mesh-list
19324187|NCT03968146|Ketorolac|ketorolac|mesh-list
19324188|NCT03968146|Fentanyl|fentanyl|mesh-list
19324189|NCT03968146|Meperidine|meperidine|mesh-list
19324190|NCT03968146|Morphine|morphine|mesh-list
19674309|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324191|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19324192|NCT03968146|Narcotics|narcotics|mesh-ancestor
20374835|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
20374836|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374837|NCT00992238|Flavoxate|flavoxate|mesh-list
20374838|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
20374839|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
20374840|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324193|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674310|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190023|NCT00215839|Ribavirin|ribavirin|mesh-list
19324194|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324195|NCT03968146|Analgesics|analgesics|mesh-ancestor
19324196|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
19324197|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190024|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
20190025|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190026|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
20190027|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190028|NCT00215865|Ribavirin|ribavirin|mesh-list
20190029|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19324198|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19324199|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19324200|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
19324201|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
19324202|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19324203|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
19324204|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19324205|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19324206|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19324207|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19324208|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324209|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324210|NCT03968224|Metformin|metformin|mesh-list
19324211|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
19324212|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19324213|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324214|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19324215|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324216|NCT03968237|Buprenorphine|buprenorphine|mesh-list
19324217|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19324218|NCT03968237|Naloxone|naloxone|mesh-list
19324219|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19324220|NCT03968237|Narcotics|narcotics|mesh-ancestor
19324221|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324222|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324223|NCT03968237|Analgesics|analgesics|mesh-ancestor
20374841|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324224|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
19324225|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324226|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19324227|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
19324228|NCT03967964|Testosterone|testosterone|mesh-list
19324229|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
19324230|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
19324231|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20190030|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
20190031|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190032|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
20190033|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190034|NCT00215891|Interferons|interferons|mesh-list
20190035|NCT00215891|Ribavirin|ribavirin|mesh-list
20190036|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190037|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
20190038|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190039|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
20190040|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190041|NCT00215956|Topotecan|topotecan|mesh-list
20374842|NCT00992238|Urological Agents|urological agents|mesh-ancestor
20425944|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
19324232|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19324233|NCT03967964|Androgens|androgens|mesh-ancestor
19674311|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19324234|NCT03967964|Hormones|hormones|mesh-ancestor
20190042|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20190043|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19324235|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324236|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190044|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190045|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190046|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190047|NCT00215982|Capecitabine|capecitabine|mesh-list
20190048|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
20190049|NCT00215982|Irinotecan|irinotecan|mesh-list
20190050|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190051|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
20190052|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190053|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190054|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20190055|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190056|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190057|NCT00215995|Cisplatin|cisplatin|mesh-list
20190058|NCT00215995|Irinotecan|irinotecan|mesh-list
19841171|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841172|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19841173|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19841174|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841175|NCT00639418|Vaccines|vaccines|mesh-list
19841176|NCT00639418|Immunologic Factors|immunologic factors|mesh-ancestor
19841177|NCT00639418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841178|NCT00639457|Pioglitazone|pioglitazone|mesh-list
20190059|NCT00215995|Gefitinib|gefitinib|mesh-list
19324237|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19841179|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841180|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841181|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19841182|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
19841183|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848226|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19848227|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19848228|NCT00691665|Analgesics|analgesics|mesh-ancestor
20190060|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190061|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20190062|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190063|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190064|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190065|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20190066|NCT00216008|Docetaxel|docetaxel|mesh-list
20190067|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190068|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20190069|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20190070|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20190071|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190072|NCT00216021|Capecitabine|capecitabine|mesh-list
20190073|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
20190074|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190075|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
20190076|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190077|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190078|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
20190079|NCT00216034|Tegafur|tegafur|mesh-list
20190080|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190081|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
20190082|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190083|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190084|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20190085|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
20190086|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190087|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20190088|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
20190089|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190090|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
20190091|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20190092|NCT00216034|Protective Agents|protective agents|mesh-ancestor
20190093|NCT00216047|Trastuzumab|trastuzumab|mesh-list
20190094|NCT00216047|Vatalanib|vatalanib|mesh-list
20190095|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20190096|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848229|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
19848230|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190097|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20190098|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190099|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190100|NCT00216073|Capecitabine|capecitabine|mesh-list
20190101|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
20190102|NCT00216073|Trastuzumab|trastuzumab|mesh-list
20190103|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190104|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
20190105|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324238|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841184|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19841185|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
19841186|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841187|NCT00639717|Etanercept|etanercept|mesh-list
19841188|NCT00639717|Methoxsalen|methoxsalen|mesh-list
19841189|NCT00639717|Tacrolimus|tacrolimus|mesh-list
19841190|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19841191|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
19841192|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374843|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
20374844|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374845|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374846|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20374847|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19841193|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19841194|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841195|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841196|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19841197|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20190106|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190107|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20190108|NCT00216112|Docetaxel|docetaxel|mesh-list
19324239|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
19674312|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19674313|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674314|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674315|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19674316|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19324240|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19324241|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
19324242|NCT03967977|Gemcitabine|gemcitabine|mesh-list
19324243|NCT03967977|Carboplatin|carboplatin|mesh-list
19324244|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324245|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674317|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190109|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
20190110|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190111|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
20190112|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
20190113|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
20190114|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190115|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20190116|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190117|NCT00216138|Docetaxel|docetaxel|mesh-list
20190118|NCT00216138|Capecitabine|capecitabine|mesh-list
20190119|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190120|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
20190121|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
20190122|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
20190123|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190124|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190125|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
20190126|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
20190127|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20190128|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190129|NCT00216164|Gemcitabine|gemcitabine|mesh-list
20190130|NCT00216164|Rituximab|rituximab|mesh-list
19674318|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674319|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674320|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
19674321|NCT00145470|Asenapine|asenapine|mesh-list
19674322|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19674323|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841198|NCT00639717|Analgesics|analgesics|mesh-ancestor
19324246|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
20374848|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374849|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374850|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324247|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674324|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674325|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674326|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674327|NCT00129402|Simvastatin|simvastatin|mesh-list
19324248|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
19324249|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324250|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324251|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19324252|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
19324253|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324254|NCT03967886|Esomeprazole|esomeprazole|mesh-list
19324255|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19324256|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19324257|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19324258|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324259|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324260|NCT03968042|Thiamine|thiamine|mesh-list
19324261|NCT03968042|Edaravone|edaravone|mesh-list
19324262|NCT03968042|Mitogens|mitogens|mesh-list
19324263|NCT03968042|Vitamins|vitamins|mesh-ancestor
19324264|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
19324265|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324266|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
19324267|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324268|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
19324269|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19324270|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
19324271|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19324272|NCT03968042|Protective Agents|protective agents|mesh-ancestor
19324273|NCT03967938|Olaparib|olaparib|mesh-list
19324274|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19324275|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324276|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324277|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324278|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
19324279|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19324280|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
19324281|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324282|NCT03967665|Expectorants|expectorants|mesh-ancestor
19324283|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
19324284|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19324285|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
19324286|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324287|NCT03967665|Protective Agents|protective agents|mesh-ancestor
19324288|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324289|NCT03967665|Antidotes|antidotes|mesh-ancestor
19398514|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
19398515|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398516|NCT03642145|Deflazacort|deflazacort|mesh-list
19398517|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398518|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398519|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
19398520|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398521|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
19398522|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19674328|NCT00129402|Ezetimibe|ezetimibe|mesh-list
19674329|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19398523|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19398524|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19398525|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19398526|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398527|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
19398528|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674330|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19674331|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
20374851|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19398529|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398530|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19693190|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19398531|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398532|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
20374852|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20374853|NCT00992355|Tobramycin|tobramycin|mesh-list
20374854|NCT00992355|Dexamethasone|dexamethasone|mesh-list
20374855|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
20374856|NCT00992355|Ketorolac|ketorolac|mesh-list
19324290|NCT03967392|Lidocaine|lidocaine|mesh-list
19324291|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19324292|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
19324293|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324294|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324295|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
19324296|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324297|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20190131|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20190132|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190133|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
20190134|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190135|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190136|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190137|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
20190138|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190139|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
20190140|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374857|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20374858|NCT00992355|BB 1101|bb 1101|mesh-list
20374859|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374860|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
20374861|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
20374862|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374863|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374864|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374865|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
20374866|NCT00992355|Hormones|hormones|mesh-ancestor
20190141|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190142|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190143|NCT00216177|Adalimumab|adalimumab|mesh-list
20190144|NCT00216177|Infliximab|infliximab|mesh-list
20190145|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190146|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190147|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
20190148|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190149|NCT00216190|Midazolam|midazolam|mesh-list
20190150|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
20374867|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20374868|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20374869|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374870|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
20374871|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374872|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374873|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20374874|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20374875|NCT00992355|Analgesics|analgesics|mesh-ancestor
20374876|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
19324298|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19324299|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19324300|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19324301|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324302|NCT03967054|Ivermectin|ivermectin|mesh-list
19324303|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19324304|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324305|NCT03967171|Oxytocin|oxytocin|mesh-list
19324306|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
19324307|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19324308|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324309|NCT03967496|Metformin|metformin|mesh-list
19674332|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674333|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19674334|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19674335|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674336|NCT00101439|Ezetimibe|ezetimibe|mesh-list
19674337|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19674338|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19674339|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
19674340|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190151|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20374877|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19674341|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19674342|NCT00096200|Paclitaxel|paclitaxel|mesh-list
19674343|NCT00096200|Carboplatin|carboplatin|mesh-list
19674344|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19674345|NCT00096200|Sorafenib|sorafenib|mesh-list
19674346|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19674347|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674348|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
19674349|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
19674350|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
19674351|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674352|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19674353|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674354|NCT00089245|Iodine|iodine|mesh-list
19674355|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
19674356|NCT00089245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19674357|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19674358|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324310|NCT03967496|Amlodipine|amlodipine|mesh-list
19324311|NCT03967496|Lisinopril|lisinopril|mesh-list
19324312|NCT03967496|Bisoprolol|bisoprolol|mesh-list
19324313|NCT03967496|Hydralazine|hydralazine|mesh-list
19324314|NCT03967496|Anesthetics|anesthetics|mesh-list
19324315|NCT03967496|Atorvastatin|atorvastatin|mesh-list
19324316|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19324317|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324318|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324319|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19324320|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19324321|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
19324322|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324323|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19324324|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19324325|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324326|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19324327|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19324328|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19324329|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19324330|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
19324331|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19324332|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
19324333|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19324334|NCT03967496|Protective Agents|protective agents|mesh-ancestor
19324335|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
19324336|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
19324337|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324338|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19324339|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20190152|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190153|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324340|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19324341|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
19324342|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674359|NCT00089245|Trace Elements|trace elements|mesh-ancestor
19674360|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
19674361|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674362|NCT00089245|Immunologic Factors|immunologic factors|mesh-ancestor
19674363|NCT05065970|Felzartamab|felzartamab|mesh-list
19674364|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674365|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
19674366|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674367|NCT05037994|Prednisolone|prednisolone|mesh-list
19674368|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19674369|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
19674370|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19674371|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
19674372|NCT05037994|Gabapentin|gabapentin|mesh-list
20190154|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20190155|NCT00216190|Analgesics|analgesics|mesh-ancestor
19324343|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20190156|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
20190157|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324344|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19324345|NCT03967327|Morphine|morphine|mesh-list
19674373|NCT05037994|Bupivacaine|bupivacaine|mesh-list
19674374|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19674375|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
19324346|NCT03967327|Buprenorphine|buprenorphine|mesh-list
19324347|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19324348|NCT03967327|Narcotics|narcotics|mesh-ancestor
19324349|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324350|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324351|NCT03967327|Analgesics|analgesics|mesh-ancestor
19324352|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
19324353|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324354|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19324355|NCT03967288|Bupivacaine|bupivacaine|mesh-list
19324356|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
19324357|NCT03967288|Procaine|procaine|mesh-list
19324358|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
19324359|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
19324360|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324361|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324362|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
19324363|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324364|NCT03967197|Lidocaine|lidocaine|mesh-list
19324365|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
19324366|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
19324367|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324368|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324369|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
19841199|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
19841200|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841201|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841202|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20612789|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19324370|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324371|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19324372|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19324373|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19324374|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19324375|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324376|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19324377|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19324378|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324379|NCT03966560|Timolol|timolol|mesh-list
19324380|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19324381|NCT03966560|Bimatoprost|bimatoprost|mesh-list
19324382|NCT03966560|Travoprost|travoprost|mesh-list
19324383|NCT03966560|Dorzolamide|dorzolamide|mesh-list
19324384|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19324385|NCT03966560|Latanoprost|latanoprost|mesh-list
19324386|NCT03966560|Brinzolamide|brinzolamide|mesh-list
19324387|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19324388|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19324389|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19324390|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
19324391|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324392|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324393|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324394|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19324395|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19841203|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19841204|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19324396|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841205|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
19841206|NCT00639769|Cisplatin|cisplatin|mesh-list
19841207|NCT00639769|Irinotecan|irinotecan|mesh-list
19841208|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841209|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19841210|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19674376|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19674377|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
19674378|NCT05037994|Hormones|hormones|mesh-ancestor
19674379|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19674380|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674381|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19674382|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674383|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
19674384|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
19674385|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841211|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612790|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
20612791|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324397|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20190158|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20190159|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20190160|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20190161|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
20190162|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190163|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190164|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20190165|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20190166|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190167|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190168|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20190169|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
20190170|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
20190171|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
20190172|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
20190173|NCT00216216|Pemetrexed|pemetrexed|mesh-list
20190174|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190175|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190176|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190177|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20190178|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20190179|NCT00216268|Ribavirin|ribavirin|mesh-list
20190180|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
20190181|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190182|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
20190183|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324398|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19324399|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19324400|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19324401|NCT03966859|Atorvastatin|atorvastatin|mesh-list
19324402|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19324403|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19324404|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
19324405|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190184|NCT00216281|Clozapine|clozapine|mesh-list
19841212|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841213|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19841214|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
19324406|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19324407|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19324408|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324409|NCT03966950|Melatonin|melatonin|mesh-list
19324410|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
19324411|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324412|NCT03966950|Protective Agents|protective agents|mesh-ancestor
19841215|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841216|NCT00640042|Morphine|morphine|mesh-list
19841217|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19841218|NCT00640042|Narcotics|narcotics|mesh-ancestor
19841219|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841220|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841221|NCT00640042|Analgesics|analgesics|mesh-ancestor
19841222|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
19841223|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841224|NCT00640146|Bromides|bromides|mesh-list
19841225|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
19841226|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
20190185|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20190186|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20190187|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190188|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190189|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190190|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
20190191|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190192|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190193|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20190194|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
20190195|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20190196|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190197|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374878|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19324413|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374879|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20374880|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374881|NCT00992381|Naproxen|naproxen|mesh-list
20374882|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20374883|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20374884|NCT00992381|Analgesics|analgesics|mesh-ancestor
19324414|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324415|NCT03966547|Anesthetics|anesthetics|mesh-list
19324416|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
19324417|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674386|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674387|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19674388|NCT05037994|Protective Agents|protective agents|mesh-ancestor
19674389|NCT05037994|Analgesics|analgesics|mesh-ancestor
19674390|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
19674391|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
19324418|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324419|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
19324420|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190198|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19324421|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
19324422|NCT03966378|Calcium|calcium|mesh-list
19324423|NCT03966378|Caseins|caseins|mesh-list
19324424|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19324425|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324426|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
19324427|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
19324428|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324429|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19324430|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324431|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
19324432|NCT03966378|Protective Agents|protective agents|mesh-ancestor
19324433|NCT03966898|Letrozole|letrozole|mesh-list
19324434|NCT03966898|Anastrozole|anastrozole|mesh-list
19324435|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324436|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19324437|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19324438|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324439|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324440|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19324441|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
19324442|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324443|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324444|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19324445|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19674392|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19674393|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190199|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
20190200|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
20190201|NCT00216294|Secretin|secretin|mesh-list
20190202|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190203|NCT00216294|Hormones|hormones|mesh-ancestor
20190204|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20190205|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190206|NCT00216346|Amphotericin B|amphotericin b|mesh-list
20190207|NCT00216346|Paromomycin|paromomycin|mesh-list
20190208|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20190209|NCT00216346|Amebicides|amebicides|mesh-ancestor
20190210|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20190211|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20190212|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190213|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20190214|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
20190215|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20190216|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
20190217|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
20190218|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190219|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20190220|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20190221|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190222|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20374885|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
20612792|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674394|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841227|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19841228|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374886|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374887|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374888|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374889|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20374890|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
20374891|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20374892|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374893|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374894|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
20374895|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
20374896|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
20374897|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374898|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374899|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19841229|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
19841230|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841231|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
19841232|NCT00640224|Drospirenone|drospirenone|mesh-list
19841233|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19841234|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19841235|NCT00640224|Estradiol|estradiol|mesh-list
19841236|NCT00640224|Estrogens|estrogens|mesh-ancestor
19841237|NCT00640224|Hormones|hormones|mesh-ancestor
19841238|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19841239|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841240|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19841241|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
19841242|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19841243|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19841244|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841245|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19841246|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19841247|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19841248|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
19841249|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19841250|NCT00640224|Diuretics|diuretics|mesh-ancestor
19841251|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
19841252|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
19841253|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19841254|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19841255|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841256|NCT00640315|Riociguat|riociguat|mesh-list
19841257|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
19841258|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841259|NCT00640328|Ofatumumab|ofatumumab|mesh-list
19841260|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19841261|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841262|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
19841263|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841264|NCT00640393|Etanercept|etanercept|mesh-list
19841265|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19841266|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19841267|NCT00640393|Analgesics|analgesics|mesh-ancestor
19841268|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
19841269|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841270|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841271|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841272|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841273|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190223|NCT00216372|Lanreotide|lanreotide|mesh-list
20190224|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190225|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
20190226|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20190227|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190228|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20190229|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20190230|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20190231|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190232|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190233|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190234|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190235|NCT00216398|Lanreotide|lanreotide|mesh-list
20374900|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19324446|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
19324447|NCT03966326|Fentanyl|fentanyl|mesh-list
19324448|NCT03966326|Anesthetics|anesthetics|mesh-list
19324449|NCT03966326|Sevoflurane|sevoflurane|mesh-list
19324450|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190236|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190237|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
20190238|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20190239|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20190240|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20190241|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190242|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190243|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
20190244|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190245|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190246|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20190247|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324451|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324452|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19324453|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19324454|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
19324455|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20190248|NCT00216424|Capecitabine|capecitabine|mesh-list
20190249|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190250|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
20190251|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190252|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190253|NCT00216437|Capecitabine|capecitabine|mesh-list
20190254|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19324456|NCT03966326|Narcotics|narcotics|mesh-ancestor
19324457|NCT03966326|Analgesics|analgesics|mesh-ancestor
19324458|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
19324459|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324460|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19324461|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19324462|NCT03966235|Melatonin|melatonin|mesh-list
19324463|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
19674395|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674396|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19674397|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19674398|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674399|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324464|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324465|NCT03966235|Protective Agents|protective agents|mesh-ancestor
19324466|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324467|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324468|NCT03966079|Plasminogen|plasminogen|mesh-list
19324469|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19324470|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19324471|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19324472|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374901|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20374902|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20374903|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20374904|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20374905|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
20374906|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324473|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19324474|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324475|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674400|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
19324476|NCT03966040|Vaccines|vaccines|mesh-list
19324477|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
19324478|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324479|NCT03965871|Esketamine|esketamine|mesh-list
19324480|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
20190255|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
20190256|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190257|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190258|NCT00216450|Rabeprazole|rabeprazole|mesh-list
20190259|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20190260|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190261|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20374907|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324481|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19324482|NCT03966118|Paclitaxel|paclitaxel|mesh-list
19324483|NCT03966118|Avelumab|avelumab|mesh-list
19324484|NCT03966118|Ramucirumab|ramucirumab|mesh-list
19324485|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19324486|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324487|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19324488|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19324489|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19324490|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324491|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19324492|NCT03965949|Hormones|hormones|mesh-list
19324493|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324494|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324495|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
19324496|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19324497|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19324498|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324499|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
19324500|NCT03965767|Coagulants|coagulants|mesh-ancestor
19324501|NCT03965858|Esketamine|esketamine|mesh-list
19324502|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
19324503|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19324504|NCT03965819|Acetaminophen|acetaminophen|mesh-list
20190262|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374908|NCT00992524|Misoprostol|misoprostol|mesh-list
20374909|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20374910|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
20374911|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20374912|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374913|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20374914|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374915|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
20374916|NCT00992537|Insulin|insulin|mesh-list
20374917|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20374918|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
20374919|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
20374920|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20374921|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20374922|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374923|NCT00992576|Hydromorphone|hydromorphone|mesh-list
20374924|NCT00992576|Naloxone|naloxone|mesh-list
20374925|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20374926|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374927|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
20374928|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374929|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20374930|NCT00992576|Narcotics|narcotics|mesh-ancestor
20190263|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190264|NCT00216463|Mipomersen|mipomersen|mesh-list
20190265|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20190266|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20190267|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
20190268|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190269|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20190270|NCT00216489|Rabeprazole|rabeprazole|mesh-list
20190271|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20190272|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190273|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20190274|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190275|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217394|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217395|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217396|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
20217397|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217398|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
20217399|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217400|NCT00309543|Leucovorin|leucovorin|mesh-list
20217401|NCT00309543|Fluorouracil|fluorouracil|mesh-list
20217402|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
20374931|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612793|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
19324505|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612794|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324506|NCT03965819|Analgesics|analgesics|mesh-ancestor
20217403|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374932|NCT00992576|Analgesics|analgesics|mesh-ancestor
19674401|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
20190276|NCT00216502|Galantamine|galantamine|mesh-list
20190277|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20190278|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190279|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190280|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
19324507|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
19324508|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324509|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324510|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
20374933|NCT00992654|Maraviroc|maraviroc|mesh-list
20374934|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20374935|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20374936|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374937|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20374938|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20374939|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
20612795|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324511|NCT03966066|Erythromycin|erythromycin|mesh-list
19324512|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
19324513|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19324514|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
19324515|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324516|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324517|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19324518|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19324519|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324520|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324521|NCT03965546|Sorafenib|sorafenib|mesh-list
19324522|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324523|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19324524|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324525|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674402|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
19674403|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
19674404|NCT05036434|Lenvatinib|lenvatinib|mesh-list
19674405|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674406|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674407|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19674408|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674409|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674410|NCT04984616|Atorvastatin|atorvastatin|mesh-list
19674411|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19674412|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19674413|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
19674414|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674415|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19674416|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19674417|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674418|NCT04972396|Metformin|metformin|mesh-list
19674419|NCT04972396|Digoxin|digoxin|mesh-list
19674420|NCT04972396|Warfarin|warfarin|mesh-list
20190281|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190282|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190283|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20190284|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
20190285|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190286|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
20190287|NCT00216515|Galantamine|galantamine|mesh-list
20190288|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20190289|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190290|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190291|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
20190292|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190293|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190294|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20190295|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
20190296|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190297|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
20190298|NCT00216528|Risperidone|risperidone|mesh-list
19674421|NCT04972396|Atorvastatin|atorvastatin|mesh-list
19674422|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
20190299|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20190300|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
20374940|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374941|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19674423|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19674424|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19674425|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324526|NCT03965624|Ixazomib|ixazomib|mesh-list
19324527|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324528|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
19324529|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324530|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324531|NCT03965442|Esmolol|esmolol|mesh-list
19324532|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19324533|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19324534|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19324535|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
20190301|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324536|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324537|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324538|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324539|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
19324540|NCT03965637|Vitamins|vitamins|mesh-ancestor
19324541|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
19324542|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324543|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
19324544|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324545|NCT03965637|Protective Agents|protective agents|mesh-ancestor
19398533|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19398534|NCT03641651|Frovatriptan|frovatriptan|mesh-list
19398535|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19398536|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
19398537|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398538|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398539|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398540|NCT03641456|Dexamethasone|dexamethasone|mesh-list
19398541|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
19398542|NCT03641456|Lenalidomide|lenalidomide|mesh-list
19398543|NCT03641456|Bortezomib|bortezomib|mesh-list
19398544|NCT03641456|BB 1101|bb 1101|mesh-list
19398545|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398546|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
19398547|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
19398548|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398549|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398550|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19398551|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
19398552|NCT03641456|Hormones|hormones|mesh-ancestor
19398553|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19398554|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20190302|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190303|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190304|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20190305|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190306|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190307|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190308|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20190309|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
20190310|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
20190311|NCT00216541|Hematinics|hematinics|mesh-ancestor
20190312|NCT00216554|Risperidone|risperidone|mesh-list
20190313|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20190314|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
20190315|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190316|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190317|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190318|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20190319|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190320|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190321|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190322|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20190323|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
20190324|NCT00216567|Topiramate|topiramate|mesh-list
20190325|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
20190326|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20190327|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190328|NCT00216580|Risperidone|risperidone|mesh-list
19398555|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398556|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
20190329|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19324546|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
20190330|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
20190331|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190332|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190333|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190334|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20190335|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190336|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190337|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190338|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20190339|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
20190340|NCT00216606|Topiramate|topiramate|mesh-list
20190341|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
20190342|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20190343|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190344|NCT00216619|Topiramate|topiramate|mesh-list
20190345|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
19324547|NCT03965286|Ledipasvir|ledipasvir|mesh-list
19324548|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19324549|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
20190346|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20190347|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190348|NCT00216632|Risperidone|risperidone|mesh-list
20190349|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20190350|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
20190351|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190352|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190353|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190354|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20190355|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190356|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190357|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190358|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20190359|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
19324550|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324551|NCT03965117|Norepinephrine|norepinephrine|mesh-list
19324552|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19324553|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19324554|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
19324555|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324556|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324557|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324558|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
19324559|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
19324560|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324561|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19324562|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19324563|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19324564|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19324565|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
19324566|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
19324567|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19324568|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190360|NCT00216645|Doxorubicin|doxorubicin|mesh-list
20190361|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20190362|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20190363|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190364|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19324569|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324570|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
19324571|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19324572|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324573|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324574|NCT03965208|Heparin|heparin|mesh-list
19324575|NCT03965208|Calcium heparin|calcium heparin|mesh-list
19324576|NCT03965208|Bivalirudin|bivalirudin|mesh-list
19324577|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
19324578|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19324579|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19324580|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324581|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
19324582|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19324583|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
19324584|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190365|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190366|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374942|NCT00992667|Acetovanillone|acetovanillone|mesh-list
19324585|NCT03964935|Minocycline|minocycline|mesh-list
19324586|NCT03964935|Lycopene|lycopene|mesh-list
19324587|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324588|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324589|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19324590|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
19324591|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324592|NCT03964935|Protective Agents|protective agents|mesh-ancestor
19324593|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841274|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19841275|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
19841276|NCT00640510|Olanzapine|olanzapine|mesh-list
19841277|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
19324594|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19324595|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19324596|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324597|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
19324598|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19324599|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324600|NCT03965195|Vaccines|vaccines|mesh-list
19324601|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
19324602|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324603|NCT03964753|Paclitaxel|paclitaxel|mesh-list
19324604|NCT03964753|Cisplatin|cisplatin|mesh-list
19324605|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19324606|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324607|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
19324608|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
19324609|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
19324610|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324611|NCT03964779|Antibodies|antibodies|mesh-list
19324612|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
19324613|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
19324614|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324615|NCT03964493|Vancomycin|vancomycin|mesh-list
19324616|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324617|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324618|NCT03964350|Ethanol|ethanol|mesh-list
19324619|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19324620|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324621|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324622|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841278|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
19841279|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841280|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841281|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19841282|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19841283|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841284|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841285|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841286|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19324623|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
19324624|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19324625|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
19324626|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324627|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190367|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190368|NCT00216658|Fentanyl|fentanyl|mesh-list
20190369|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20190370|NCT00216658|Narcotics|narcotics|mesh-ancestor
20190371|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190372|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190373|NCT00216658|Analgesics|analgesics|mesh-ancestor
20190374|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
20190375|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190376|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20190377|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20190378|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
20190379|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
20190380|NCT00216684|Fentanyl|fentanyl|mesh-list
20190381|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20190382|NCT00216684|Narcotics|narcotics|mesh-ancestor
19324628|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19324629|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
19324630|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19841287|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20612796|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20612797|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
20612798|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374943|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19841288|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19324631|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
19324632|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324633|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324634|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19324635|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
19324636|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
19324637|NCT03964324|Protective Agents|protective agents|mesh-ancestor
19324638|NCT03964051|Omalizumab|omalizumab|mesh-list
19324639|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19324640|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19324641|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
19841289|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841290|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841291|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
19324642|NCT03963752|Megestrol|megestrol|mesh-list
19324643|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
19324644|NCT03963752|Leuprolide|leuprolide|mesh-list
19324645|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19324646|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19324647|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19324648|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
19324649|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19841292|NCT00640562|Risperidone|risperidone|mesh-list
19841293|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19841294|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19841295|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
20374944|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20374945|NCT00992667|Analgesics|analgesics|mesh-ancestor
20374946|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
19324650|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324651|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19324652|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19324653|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19324654|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374947|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20374948|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374949|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20374950|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19324655|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
19324656|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19324657|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19324658|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
19324659|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
19324660|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19324661|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
19324662|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324663|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324664|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19324665|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
19324666|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19324667|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
19324668|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674426|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19674427|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19674428|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
19674429|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674430|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19674431|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19674432|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674433|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
19674434|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19674435|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
19674436|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19674437|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19841296|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674438|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20374951|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
20425945|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674439|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19674440|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20190383|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190384|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324669|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324670|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19324671|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
19324672|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
19324673|NCT03963648|Protective Agents|protective agents|mesh-ancestor
19324674|NCT03963375|Cladribine|cladribine|mesh-list
19324675|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324676|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19324677|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
19324678|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324679|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
19324680|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19324681|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19324682|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324683|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
19324684|NCT03963466|Coagulants|coagulants|mesh-ancestor
19324685|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
19324686|NCT03963479|Pyridoxal|pyridoxal|mesh-list
19324687|NCT03963479|Pyridoxine|pyridoxine|mesh-list
19324688|NCT03963479|Vitamins|vitamins|mesh-ancestor
19324689|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
19324690|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324691|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
19324692|NCT03963336|Acetazolamide|acetazolamide|mesh-list
19324693|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
19324694|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19324695|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324696|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324697|NCT03963336|Diuretics|diuretics|mesh-ancestor
19324698|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
19324699|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324700|NCT03963193|Cisplatin|cisplatin|mesh-list
19324701|NCT03963193|Irinotecan|irinotecan|mesh-list
19324702|NCT03963193|Etoposide|etoposide|mesh-list
19324703|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324704|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19324705|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19324706|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324707|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324708|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20190385|NCT00216684|Analgesics|analgesics|mesh-ancestor
20190386|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
20190387|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190388|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20190389|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20190390|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
20190391|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
20190392|NCT00216697|Bortezomib|bortezomib|mesh-list
20190393|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190394|NCT00216723|Aripiprazole|aripiprazole|mesh-list
20190395|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
20190396|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190397|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20190398|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190399|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190400|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190401|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
20190402|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
20190403|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190404|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190405|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20190406|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20190407|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
20190408|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20190409|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20190410|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20190411|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20190412|NCT00216762|Rituximab|rituximab|mesh-list
19324709|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19398557|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398558|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398559|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
20190413|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20190414|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190415|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
20190416|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190417|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19324710|NCT03963115|Epinephrine|epinephrine|mesh-list
19324711|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19674441|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19674442|NCT04972396|Protective Agents|protective agents|mesh-ancestor
19674443|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19674444|NCT04972396|Estrogens|estrogens|mesh-ancestor
19674445|NCT04972396|Hormones|hormones|mesh-ancestor
19674446|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19674447|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
19674448|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19674449|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
19674450|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674451|NCT04904952|Expectorants|expectorants|mesh-ancestor
19324712|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19324713|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
19324714|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324715|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324716|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324717|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19324718|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19324719|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
19324720|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324721|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19324722|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
19324723|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
19324724|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
19324725|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19324726|NCT03963024|Treosulfan|treosulfan|mesh-list
19324727|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19324728|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
19324729|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324730|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324731|NCT03963128|Vitamin D|vitamin d|mesh-list
19324732|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
19324733|NCT03963128|Vitamins|vitamins|mesh-ancestor
19324734|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
19324735|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324736|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19324737|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19324738|NCT03962881|Vaccines|vaccines|mesh-list
19324739|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
19324740|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324741|NCT03962920|Tigecycline|tigecycline|mesh-list
19324742|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324743|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324744|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19324745|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324746|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324747|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
19324748|NCT03962907|Mupirocin|mupirocin|mesh-list
19324749|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20190418|NCT00216775|Interferons|interferons|mesh-list
20190419|NCT00216775|Ribavirin|ribavirin|mesh-list
20190420|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
20190421|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
20190422|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190423|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
20190424|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190425|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
20190426|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190427|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
20190428|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190429|NCT00216788|Esomeprazole|esomeprazole|mesh-list
20190430|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20190431|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20374952|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324750|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324751|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
19674452|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
19674453|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20190432|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19324752|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324753|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19324754|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324755|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324756|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
19324757|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19324758|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
19324759|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324760|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374953|NCT00992667|Protective Agents|protective agents|mesh-ancestor
20374954|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374955|NCT00992693|Ribavirin|ribavirin|mesh-list
20374956|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
20374957|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374958|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
20374959|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20374960|NCT00992706|Doxorubicin|doxorubicin|mesh-list
20374961|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20374962|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20374963|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374964|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20374965|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20374966|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20374967|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374968|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
20374969|NCT00992758|Antibodies|antibodies|mesh-list
20374970|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
19324761|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324762|NCT03962647|Letrozole|letrozole|mesh-list
19324763|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324764|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19324765|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19324766|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324767|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324768|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19324769|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
19324770|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324771|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324772|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
19324773|NCT03962725|Ketamine|ketamine|mesh-list
20190433|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190434|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190435|NCT00216827|Betamethasone|betamethasone|mesh-list
20190436|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
20190437|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19324774|NCT03962725|Propofol|propofol|mesh-list
19324775|NCT03962725|Anesthetics|anesthetics|mesh-list
19324776|NCT03962725|Rocuronium|rocuronium|mesh-list
19324777|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19324778|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19324779|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324780|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324781|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19324782|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
19324783|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19324784|NCT03962725|Analgesics|analgesics|mesh-ancestor
19324785|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
20374971|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374972|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20374973|NCT00992771|Varenicline|varenicline|mesh-list
20374974|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19324786|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190438|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
20190439|NCT00216827|Calcipotriene|calcipotriene|mesh-list
20190440|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19324787|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19324788|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19324789|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19324790|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
20374975|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20374976|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
19324791|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674454|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
20612799|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20374977|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190441|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190442|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
20190443|NCT00216827|Hormones|hormones|mesh-ancestor
20190444|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20374978|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20374979|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374980|NCT00992797|Vitamin D|vitamin d|mesh-list
20374981|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
20374982|NCT00992797|Vitamins|vitamins|mesh-ancestor
20374983|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
20374984|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374985|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20374986|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20374987|NCT00992823|Iron|iron|mesh-list
20374988|NCT00992823|Trace Elements|trace elements|mesh-ancestor
20374989|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
20190445|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190446|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20190447|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
20190448|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
20190449|NCT00216840|Betamethasone|betamethasone|mesh-list
20190450|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
20190451|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20190452|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
20190453|NCT00216840|Calcipotriene|calcipotriene|mesh-list
20190454|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20190455|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190456|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
20190457|NCT00216840|Hormones|hormones|mesh-ancestor
20190458|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20190459|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190460|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20190461|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
20374990|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374991|NCT00992849|Bevacizumab|bevacizumab|mesh-list
20374992|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19324792|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324793|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19324794|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19324795|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19324796|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19324797|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19324798|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
19324799|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19324800|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324801|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
19324802|NCT03962803|Vaccines|vaccines|mesh-list
19324803|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
19324804|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324805|NCT03962816|Vaccines|vaccines|mesh-list
19324806|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
19324807|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324808|NCT03962686|Metformin|metformin|mesh-list
19324809|NCT03962686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19324810|NCT03962686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324811|NCT03962114|Niacinamide|niacinamide|mesh-list
19324812|NCT03962114|Vitamins|vitamins|mesh-ancestor
19324813|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
19324814|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324815|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
19324816|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
19324817|NCT03962296|Calcium|calcium|mesh-list
19324818|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19324819|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324820|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
19324821|NCT03962296|Coagulants|coagulants|mesh-ancestor
19324822|NCT03962283|Rifaximin|rifaximin|mesh-list
19324823|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324824|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324825|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19324826|NCT03961867|Docetaxel|docetaxel|mesh-list
19324827|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
20374993|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324828|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612800|NCT02252913|Docetaxel|docetaxel|mesh-list
19324829|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
19324830|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
19324831|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
19324832|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324833|NCT03961958|Propofol|propofol|mesh-list
19324834|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19324835|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324836|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324837|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19324838|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
19324839|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
19324840|NCT03961919|Fludarabine|fludarabine|mesh-list
19324841|NCT03961919|Treosulfan|treosulfan|mesh-list
19324842|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324843|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324844|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19324845|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
19324846|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
19324847|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324848|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
19324849|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19324850|NCT03961828|Ledipasvir|ledipasvir|mesh-list
19324851|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
19324852|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324853|NCT03961659|Metformin|metformin|mesh-list
19324854|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
19324855|NCT03961659|Acarbose|acarbose|mesh-list
19324856|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19324857|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324858|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19324859|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324860|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19324861|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324862|NCT03961464|Cycloserine|cycloserine|mesh-list
19324863|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19324864|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324865|NCT03961464|Renal Agents|renal agents|mesh-ancestor
19324866|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19324867|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
19324868|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324869|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
19324870|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324871|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19324872|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19324873|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
19324874|NCT03961503|Vancomycin|vancomycin|mesh-list
20190462|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
20190463|NCT00216866|Dalteparin|dalteparin|mesh-list
20190464|NCT00216866|Tinzaparin|tinzaparin|mesh-list
20190465|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20190466|NCT00216866|Warfarin|warfarin|mesh-list
19324875|NCT03961503|Daptomycin|daptomycin|mesh-list
19324876|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324877|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19324878|NCT03961698|Paclitaxel|paclitaxel|mesh-list
19324879|NCT03961698|Bevacizumab|bevacizumab|mesh-list
19324880|NCT03961698|Atezolizumab|atezolizumab|mesh-list
19324881|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20190467|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
20190468|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20190469|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20190470|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190471|NCT00216879|Betamethasone|betamethasone|mesh-list
20190472|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
20190473|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20190474|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
20190475|NCT00216879|Calcipotriene|calcipotriene|mesh-list
20190476|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20190477|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190478|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
20190479|NCT00216879|Hormones|hormones|mesh-ancestor
20190480|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20190481|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190482|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20190483|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
20190484|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612801|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324882|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19324883|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
20374994|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20374995|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20374996|NCT00992849|Growth Substances|growth substances|mesh-ancestor
20374997|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20374998|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
20374999|NCT00992862|Moexipril|moexipril|mesh-list
20375000|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20375001|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
20375002|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375003|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375004|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20375005|NCT00992901|Atropine|atropine|mesh-list
20375006|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19324884|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
19324885|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
19324886|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324887|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19324888|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19324889|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19324890|NCT03961698|Growth Substances|growth substances|mesh-ancestor
20375007|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20375008|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20375009|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20375010|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
20375011|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375012|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375013|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20375014|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
20375015|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
20375016|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
20375017|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20375018|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20375019|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
20375020|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375021|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375022|NCT00992901|Incretins|incretins|mesh-ancestor
20375023|NCT00992901|Hormones|hormones|mesh-ancestor
20375024|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375025|NCT00992914|Lidocaine|lidocaine|mesh-list
20375026|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
20375027|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
20375028|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324891|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324892|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
19324893|NCT03961360|Aspirin|aspirin|mesh-list
19324894|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19324895|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19324896|NCT03961360|Analgesics|analgesics|mesh-ancestor
20375029|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375030|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
20375031|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375032|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20375033|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20375034|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20375035|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375036|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375037|NCT00993057|Insulin|insulin|mesh-list
20375038|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20375039|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375040|NCT00993070|Capsaicin|capsaicin|mesh-list
20375041|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
20375042|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375043|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
20375044|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375045|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375046|NCT00993096|Insulin|insulin|mesh-list
20375047|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20375048|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
20375049|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
20375050|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19324897|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
20375051|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
20375052|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19324898|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324899|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324900|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19324901|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190485|NCT00216892|Betamethasone|betamethasone|mesh-list
20190486|NCT00216892|Calcipotriene|calcipotriene|mesh-list
20190487|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190488|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
20190489|NCT00216892|Hormones|hormones|mesh-ancestor
20190490|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20190491|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190492|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20190493|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
20190494|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
20190495|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20190496|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20190497|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190498|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190499|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324902|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19324903|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19324904|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324905|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19324906|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19324907|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324908|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
19324909|NCT03960970|Azithromycin|azithromycin|mesh-list
19324910|NCT03960970|Cefoxitin|cefoxitin|mesh-list
19324911|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324912|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398560|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19398561|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20190500|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
20190501|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190502|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398562|NCT03641456|Growth Substances|growth substances|mesh-ancestor
19398563|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
19404438|NCT03594968|Progestins|progestins|mesh-ancestor
19404439|NCT03594968|Hormones|hormones|mesh-ancestor
19404440|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404441|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190503|NCT00216931|Iloprost|iloprost|mesh-list
20190504|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20190505|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
20190506|NCT00217009|Furocoumarins|furocoumarins|mesh-list
20190507|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20190508|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20190509|NCT00217048|Yohimbine|yohimbine|mesh-list
20190510|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
19404442|NCT03594825|Valsartan|valsartan|mesh-list
19404443|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19404444|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19404445|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19404446|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404447|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
19404448|NCT03594604|Norethindrone|norethindrone|mesh-list
19404449|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
19404450|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
19841297|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841298|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841299|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19841300|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841301|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841302|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841303|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20190511|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
19404451|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19404452|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404453|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404454|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19404455|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19404456|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20190512|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375053|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
19324913|NCT03961334|Aspirin|aspirin|mesh-list
19324914|NCT03961334|Dabigatran|dabigatran|mesh-list
19324915|NCT03961334|Apixaban|apixaban|mesh-list
19324916|NCT03961334|Edoxaban|edoxaban|mesh-list
19324917|NCT03961334|Clopidogrel|clopidogrel|mesh-list
19324918|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19324919|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19324920|NCT03961334|Analgesics|analgesics|mesh-ancestor
19324921|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
19324922|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324923|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324924|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19324925|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19324926|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19324927|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19324928|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324929|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20375054|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20375055|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375056|NCT00993109|Valsartan|valsartan|mesh-list
20375057|NCT00993109|Nifedipine|nifedipine|mesh-list
20375058|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20375059|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20375060|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20375061|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375062|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20375063|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375064|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20375065|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375066|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
19324930|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19324931|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19324932|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
19324933|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19324934|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19324935|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19324936|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
19324937|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324938|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
19324939|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19324940|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
19324941|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
19324942|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19324943|NCT03961126|Clobetasol|clobetasol|mesh-list
19324944|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19324945|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
19324946|NCT03961126|Hormones|hormones|mesh-ancestor
19324947|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19324948|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324949|NCT03961048|Ropivacaine|ropivacaine|mesh-list
19324950|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19324951|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
19324952|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
19324953|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324954|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375067|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
20375068|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375069|NCT00993122|Ribavirin|ribavirin|mesh-list
20375070|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
20375071|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375072|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
20375073|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375074|NCT00993135|Methotrexate|methotrexate|mesh-list
20375075|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20375076|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
20375077|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375078|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375079|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375080|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
19324955|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
19324956|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324957|NCT03960905|Meropenem|meropenem|mesh-list
19324958|NCT03960905|Ceftazidime|ceftazidime|mesh-list
19324959|NCT03960905|Cefepime|cefepime|mesh-list
19324960|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
20425946|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375081|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375082|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375083|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
19324961|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19324962|NCT03961087|Ubiquinone|ubiquinone|mesh-list
19324963|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
19324964|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
19324965|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
20190513|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190514|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20190515|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20190516|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20190517|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20190518|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190519|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190520|NCT00217048|Urological Agents|urological agents|mesh-ancestor
20375084|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375085|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20375086|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20375087|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
20375088|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20375089|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20375090|NCT00993304|Liraglutide|liraglutide|mesh-list
20375091|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20375092|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375093|NCT00993304|Incretins|incretins|mesh-ancestor
20375094|NCT00993304|Hormones|hormones|mesh-ancestor
20375095|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375096|NCT00993343|Cyclosporine|cyclosporine|mesh-list
20190521|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
20190522|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20375097|NCT00993343|Sirolimus|sirolimus|mesh-list
19324966|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324967|NCT03961087|Vitamins|vitamins|mesh-ancestor
19324968|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19324969|NCT03961087|Protective Agents|protective agents|mesh-ancestor
19324970|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
19324971|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
19324972|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19324973|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324974|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324975|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19324976|NCT03960775|Analgesics|analgesics|mesh-ancestor
19324977|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
19324978|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19324979|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19324980|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19324981|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19324982|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
19324983|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324984|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324985|NCT03960866|Phentolamine|phentolamine|mesh-list
19324986|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19324987|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19324988|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19324989|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19324990|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375098|NCT00993343|Methotrexate|methotrexate|mesh-list
20375099|NCT00993343|Tacrolimus|tacrolimus|mesh-list
20375100|NCT00993343|Cyclosporins|cyclosporins|mesh-list
20375101|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19324991|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19324992|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19324993|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19324994|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19324995|NCT03960801|Remifentanil|remifentanil|mesh-list
19324996|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19324997|NCT03960801|Narcotics|narcotics|mesh-ancestor
19674455|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674456|NCT04904952|Protective Agents|protective agents|mesh-ancestor
20375102|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
20375103|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19324998|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19324999|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325000|NCT03960801|Analgesics|analgesics|mesh-ancestor
19325001|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
19325002|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325003|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
19325004|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19325005|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325006|NCT03960671|Midazolam|midazolam|mesh-list
20375104|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375105|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375106|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
20375107|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375108|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375109|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375110|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375111|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19325007|NCT03960671|Diazepam|diazepam|mesh-list
19325008|NCT03960671|Propofol|propofol|mesh-list
19325009|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19325010|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325011|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325012|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19325013|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
19325014|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
19325015|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20375112|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20375113|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
20375114|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20375115|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20375116|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20375117|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
20375118|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375119|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20375120|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20375121|NCT00993356|Lanreotide|lanreotide|mesh-list
20375122|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375123|NCT00993408|Selexipag|selexipag|mesh-list
20375124|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20375125|NCT00993512|Bleomycin|bleomycin|mesh-list
20375126|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20375127|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375128|NCT00993525|Ranibizumab|ranibizumab|mesh-list
20375129|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20375130|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19325016|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19841304|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
19841305|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
19841306|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19841307|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
19841308|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841309|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19841310|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841311|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841312|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841313|NCT00640822|Calcitriol|calcitriol|mesh-list
19841314|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
19841315|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19841316|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19841317|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19841318|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
19841319|NCT00640822|Calcipotriene|calcipotriene|mesh-list
19841320|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841321|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
19841322|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19841323|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841324|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19841325|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190523|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190524|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20190525|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
20190526|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20190527|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190528|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190529|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190530|NCT00217178|Folic Acid|folic acid|mesh-list
20190531|NCT00217178|Vitamins|vitamins|mesh-ancestor
20190532|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
20190533|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190534|NCT00217178|Hematinics|hematinics|mesh-ancestor
20190535|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
20190536|NCT00217191|Ibuprofen|ibuprofen|mesh-list
20190537|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20375131|NCT00993525|Growth Substances|growth substances|mesh-ancestor
20375132|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190538|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325017|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19325018|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19325019|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
19325020|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
19325021|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325022|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325023|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
19325024|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
19325025|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
19325026|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325027|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325028|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19325029|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19325030|NCT03960268|Brodalumab|brodalumab|mesh-list
19325031|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
19325032|NCT03960411|Doxycycline|doxycycline|mesh-list
20190539|NCT00217191|Analgesics|analgesics|mesh-ancestor
20190540|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
20190541|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190542|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190543|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190544|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190545|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19674457|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674458|NCT04904952|Antidotes|antidotes|mesh-ancestor
19674459|NCT04810910|Molgramostim|molgramostim|mesh-list
19841326|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190546|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325033|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325034|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325035|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
19325036|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19325037|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19325038|NCT03960151|Dexamethasone|dexamethasone|mesh-list
19325039|NCT03960151|Olanzapine|olanzapine|mesh-list
19325040|NCT03960151|Palonosetron|palonosetron|mesh-list
19325041|NCT03960151|Rolapitant|rolapitant|mesh-list
19325042|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325043|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
19325044|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
19325045|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325046|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325047|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325048|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
19325049|NCT03960151|Hormones|hormones|mesh-ancestor
19674460|NCT04810910|Sargramostim|sargramostim|mesh-list
19674461|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
19674462|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674463|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674464|NCT04746989|Allopurinol|allopurinol|mesh-list
19674465|NCT04746989|Probenecid|probenecid|mesh-list
19674466|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
19674467|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674468|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674469|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
19841327|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19841328|NCT00640822|Vitamins|vitamins|mesh-ancestor
19841329|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
19841330|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19841331|NCT00640835|Buprenorphine|buprenorphine|mesh-list
19841332|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19841333|NCT00640835|Naloxone|naloxone|mesh-list
19841334|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19841335|NCT00640835|Narcotics|narcotics|mesh-ancestor
19841336|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190547|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375133|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
19325050|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325051|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19674470|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19674471|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19325052|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325053|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19325054|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19325055|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375134|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325056|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19325057|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19325058|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19325059|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375135|NCT00993642|Panobinostat|panobinostat|mesh-list
20375136|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375137|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20375138|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325060|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325061|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325062|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
19325063|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19325064|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19325065|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19325066|NCT03959852|Fentanyl|fentanyl|mesh-list
19325067|NCT03959852|Ketamine|ketamine|mesh-list
19325068|NCT03959852|Analgesics|analgesics|mesh-ancestor
19325069|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
20375139|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375140|NCT00993681|Vaccines|vaccines|mesh-list
20375141|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
20375142|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375143|NCT00993694|Dapsone|dapsone|mesh-list
19325070|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325071|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325072|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19325073|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19325074|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
20375144|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375145|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
20375146|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20375147|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19325075|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
19325076|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325077|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19325078|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19325079|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325080|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325081|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19325082|NCT03959852|Narcotics|narcotics|mesh-ancestor
19325083|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19325084|NCT03959761|Nivolumab|nivolumab|mesh-list
19325085|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325086|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325087|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19325088|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375148|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20375149|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375150|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375151|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
20375152|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325089|NCT03959969|Ibuprofen|ibuprofen|mesh-list
19325090|NCT03959969|Oxycodone|oxycodone|mesh-list
19325091|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19325092|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325093|NCT03959969|Analgesics|analgesics|mesh-ancestor
19325094|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
19325095|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325096|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325097|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325098|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325099|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19325100|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325101|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674472|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
19674473|NCT04746989|Protective Agents|protective agents|mesh-ancestor
20375153|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
20375154|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19325102|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19325103|NCT03959969|Narcotics|narcotics|mesh-ancestor
19325104|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325105|NCT03959865|Glucagon|glucagon|mesh-list
19325106|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19325107|NCT03959865|Incretins|incretins|mesh-ancestor
19325108|NCT03959865|Hormones|hormones|mesh-ancestor
19325109|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325110|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325111|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325112|NCT03959527|Azithromycin|azithromycin|mesh-list
19325113|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
19325114|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325115|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325116|NCT03959436|Carbetocin|carbetocin|mesh-list
19325117|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
19325118|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19325119|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325120|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19325121|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325122|NCT03959540|Levodopa|levodopa|mesh-list
19325123|NCT03959540|Opicapone|opicapone|mesh-list
19325124|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19325125|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19325126|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
19325127|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325128|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190548|NCT00217204|Pancrelipase|pancrelipase|mesh-list
20190549|NCT00217204|Pancreatin|pancreatin|mesh-list
20190550|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20190551|NCT00217243|Lidocaine|lidocaine|mesh-list
20190552|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
20190553|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
20190554|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190555|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190556|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
20190557|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190558|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20190559|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20190560|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20190561|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190562|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190563|NCT00217282|Gemcitabine|gemcitabine|mesh-list
20190564|NCT00217282|Bevacizumab|bevacizumab|mesh-list
20190565|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
20375155|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
20375156|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375157|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
20375158|NCT00993707|Protective Agents|protective agents|mesh-ancestor
20375159|NCT00993720|Liraglutide|liraglutide|mesh-list
19325129|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190566|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20190567|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190568|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20190569|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20190570|NCT00217282|Growth Substances|growth substances|mesh-ancestor
20190571|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190572|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
20190573|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190574|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
20190575|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190576|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
20190577|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190578|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190579|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190580|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
20190581|NCT00217295|Topiramate|topiramate|mesh-list
20190582|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
20190583|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20190584|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190585|NCT00217373|Interferons|interferons|mesh-list
20190586|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
20190587|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
19325130|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20190588|NCT00217373|Metronidazole|metronidazole|mesh-list
20190589|NCT00217373|Vaccines|vaccines|mesh-list
20190590|NCT00217373|Sargramostim|sargramostim|mesh-list
20190591|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
20375160|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20190592|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190593|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190594|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
20190595|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190596|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20190597|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20190598|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20190599|NCT00217386|Etanercept|etanercept|mesh-list
20190600|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20190601|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20190602|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20190603|NCT00217386|Analgesics|analgesics|mesh-ancestor
20190604|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
20190605|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190606|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190607|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190608|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190609|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325131|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375161|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325132|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19325133|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
19325134|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19325135|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325136|NCT03959501|Incretins|incretins|mesh-ancestor
19325137|NCT03959501|Hormones|hormones|mesh-ancestor
19325138|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325139|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19325140|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
19325141|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325142|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325143|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19325144|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
19325145|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19325146|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325147|NCT03959384|Poractant alfa|poractant alfa|mesh-list
19325148|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19325149|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
19325150|NCT03959293|Durvalumab|durvalumab|mesh-list
19325151|NCT03959293|Tremelimumab|tremelimumab|mesh-list
19325152|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325153|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325154|NCT03959397|Paclitaxel|paclitaxel|mesh-list
19325155|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19325156|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19325157|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325158|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
19325159|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
19325160|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
19325161|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325162|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19325163|NCT03959176|Phenylephrine|phenylephrine|mesh-list
19325164|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
19325165|NCT03959176|Tropicamide|tropicamide|mesh-list
19325166|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19325167|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
19325168|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
19325169|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375162|NCT00993720|Incretins|incretins|mesh-ancestor
20375163|NCT00993720|Hormones|hormones|mesh-ancestor
20375164|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375165|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
20375166|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20375167|NCT00993746|Lidocaine|lidocaine|mesh-list
19325170|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325171|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
19325172|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19325173|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
19325174|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19325175|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19325176|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19325177|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19325178|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19325179|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375168|NCT00993746|Bupivacaine|bupivacaine|mesh-list
19325180|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325181|NCT03959176|Protective Agents|protective agents|mesh-ancestor
19325182|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19325183|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19325184|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19325185|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19325186|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
19325187|NCT03959150|Capecitabine|capecitabine|mesh-list
19325188|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19325189|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
19325190|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325191|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398564|NCT03641404|Ergothioneine|ergothioneine|mesh-list
19398565|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
19398566|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398567|NCT03641404|Protective Agents|protective agents|mesh-ancestor
19398568|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398569|NCT03641209|Acetaminophen|acetaminophen|mesh-list
19398570|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19398571|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398572|NCT03641209|Analgesics|analgesics|mesh-ancestor
19398573|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
19398574|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398575|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398576|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
19398577|NCT03641053|Iodine|iodine|mesh-list
19398578|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
19398579|NCT03641053|Povidone|povidone|mesh-list
19398580|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19398581|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190610|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190611|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
20190612|NCT00217412|Vorinostat|vorinostat|mesh-list
20190613|NCT00217412|Isotretinoin|isotretinoin|mesh-list
20190614|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190615|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19398582|NCT03641053|Trace Elements|trace elements|mesh-ancestor
19398583|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
19398584|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398585|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
19398586|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
19398587|NCT03640728|Tenofovir|tenofovir|mesh-list
19398588|NCT03640728|Entecavir|entecavir|mesh-list
19398589|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
19398590|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398591|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20375169|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
20375170|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
20375171|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375172|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375173|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
20375174|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375175|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20375176|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20375177|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20375178|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375179|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375180|NCT00993863|Ibuprofen|ibuprofen|mesh-list
19398592|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19398593|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398594|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398595|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19398596|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19398597|NCT03640650|Triamcinolone|triamcinolone|mesh-list
19398598|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19398599|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19398600|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19398601|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19398602|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19398603|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
19398604|NCT03640650|Hormones|hormones|mesh-ancestor
19398605|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20190616|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190617|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398606|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398607|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190618|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
19325192|NCT03958942|Bupivacaine|bupivacaine|mesh-list
19325193|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
19325194|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
19325195|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325196|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325197|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
19325198|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325199|NCT03959124|Memantine|memantine|mesh-list
19325200|NCT03959124|Rivastigmine|rivastigmine|mesh-list
19325201|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19325202|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19325203|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
19325204|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325205|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325206|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325207|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19325208|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19325209|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19325210|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325211|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
19325212|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19325213|NCT03959124|Protective Agents|protective agents|mesh-ancestor
19325214|NCT03958721|Capecitabine|capecitabine|mesh-list
19325215|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19325216|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
19325217|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325218|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325219|NCT03958708|Rifaximin|rifaximin|mesh-list
19325220|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325221|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325222|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325223|NCT03958513|Bupivacaine|bupivacaine|mesh-list
19325224|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
20375181|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20375182|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20375183|NCT00993863|Analgesics|analgesics|mesh-ancestor
20375184|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
20375185|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325225|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
19325226|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325227|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325228|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
19325229|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325230|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
19325231|NCT03958500|Methylene Blue|methylene blue|mesh-list
19325232|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325233|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325234|NCT03958344|Prednisolone|prednisolone|mesh-list
19325235|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19325236|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
19325237|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19325238|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
19325239|NCT03958344|Triamcinolone|triamcinolone|mesh-list
19325240|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19325241|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
19325242|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325243|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
19325244|NCT03958344|Hormones|hormones|mesh-ancestor
19325245|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325246|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325247|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19325248|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325249|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
20375186|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375187|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375188|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20375189|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20375190|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375191|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375192|NCT00993876|Citalopram|citalopram|mesh-list
20375193|NCT00993876|Reboxetine|reboxetine|mesh-list
19325250|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
19325251|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325252|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325253|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20375194|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20375195|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20375196|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375197|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375198|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375199|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
19674474|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674475|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
19674476|NCT04746989|Renal Agents|renal agents|mesh-ancestor
19674477|NCT04729049|Morphine|morphine|mesh-list
20375200|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375201|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19325254|NCT03958344|Protective Agents|protective agents|mesh-ancestor
19325255|NCT03958201|Rocuronium|rocuronium|mesh-list
19325256|NCT03958201|Neostigmine|neostigmine|mesh-list
19325257|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19325258|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19325259|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19325260|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325261|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325262|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19325263|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325264|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325265|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
19325266|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325267|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19325268|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
19325269|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
19325270|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19325271|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325272|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325273|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19325274|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19325275|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325276|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325277|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325278|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19325279|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
19325280|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19325281|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325282|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19325283|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19325284|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19325285|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19325286|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19325287|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325288|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
19325289|NCT03958396|Remifentanil|remifentanil|mesh-list
19325290|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19325291|NCT03958396|Narcotics|narcotics|mesh-ancestor
19325292|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325293|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325294|NCT03958396|Analgesics|analgesics|mesh-ancestor
19674478|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19674479|NCT04729049|Narcotics|narcotics|mesh-ancestor
19674480|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674481|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674482|NCT04729049|Analgesics|analgesics|mesh-ancestor
20190619|NCT00217451|Clindamycin|clindamycin|mesh-list
20190620|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
20190621|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
20190622|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
20190623|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20190624|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190625|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20190626|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190627|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190628|NCT00217477|Gemcitabine|gemcitabine|mesh-list
20190629|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190630|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
20190631|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674483|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
19674484|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325295|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
19325296|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325297|NCT03958097|Antibodies|antibodies|mesh-list
19325298|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
19325299|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325300|NCT03957902|Aspirin|aspirin|mesh-list
19325301|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19325302|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325303|NCT03957902|Analgesics|analgesics|mesh-ancestor
19325304|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
19325305|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325306|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325307|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325308|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325309|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19325310|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19325311|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325312|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19325313|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19325314|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325315|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
19325316|NCT03958045|Nivolumab|nivolumab|mesh-list
19325317|NCT03958045|Rucaparib|rucaparib|mesh-list
19325318|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325319|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325320|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19325321|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325322|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19325323|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325324|NCT03957720|Penicillamine|penicillamine|mesh-list
19325325|NCT03957720|Succimer|succimer|mesh-list
19325326|NCT03957720|Antidotes|antidotes|mesh-ancestor
19325327|NCT03957720|Protective Agents|protective agents|mesh-ancestor
19325328|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325329|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
19325330|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
20190632|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190633|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
20190634|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190635|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190636|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190637|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
20190638|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190639|NCT00217503|Zidovudine|zidovudine|mesh-list
20190640|NCT00217503|Valganciclovir|valganciclovir|mesh-list
20190641|NCT00217503|Ganciclovir|ganciclovir|mesh-list
20190642|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
20190643|NCT00217503|Bevacizumab|bevacizumab|mesh-list
20190644|NCT00217503|Doxorubicin|doxorubicin|mesh-list
20190645|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20190646|NCT00217503|Etoposide|etoposide|mesh-list
20190647|NCT00217503|Bortezomib|bortezomib|mesh-list
20190648|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190649|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
20190650|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190651|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190652|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20190653|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
20190654|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190655|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190656|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20190657|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20190658|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20190659|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20190660|NCT00217503|Growth Substances|growth substances|mesh-ancestor
20190661|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
20190662|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20190663|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20190664|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190665|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190666|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20190667|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
20190668|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20190669|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20190670|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
20375202|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
20375203|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20375204|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20375205|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375206|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
20375207|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
20375208|NCT00994006|Levulinic acid|levulinic acid|mesh-list
20375209|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375210|NCT00994006|Cathartics|cathartics|mesh-ancestor
20375211|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20375212|NCT00994006|Antacids|antacids|mesh-ancestor
20375213|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375214|NCT00994071|Temozolomide|temozolomide|mesh-list
20375215|NCT00994071|Veliparib|veliparib|mesh-list
20375216|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20375217|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
20190671|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190672|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20190673|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20190674|NCT00217516|Selenium|selenium|mesh-list
20190675|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
20190676|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190677|NCT00217516|Protective Agents|protective agents|mesh-ancestor
20190678|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190679|NCT00217516|Trace Elements|trace elements|mesh-ancestor
19674485|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
19674486|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19674487|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19674488|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
20190680|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
20190681|NCT00217529|Carboplatin|carboplatin|mesh-list
20190682|NCT00217529|Docetaxel|docetaxel|mesh-list
20190683|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19325331|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325332|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19674489|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19674490|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674491|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
19674492|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
19674493|NCT04688931|Mitomycins|mitomycins|mesh-list
19674494|NCT04688931|Mitomycin|mitomycin|mesh-list
19674495|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20190684|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398608|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
19398609|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398610|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398611|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19398612|NCT03640468|Lidocaine|lidocaine|mesh-list
19398613|NCT03640468|Midazolam|midazolam|mesh-list
19398614|NCT03640468|Ketamine|ketamine|mesh-list
19674496|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190685|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
20190686|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
20190687|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
20190688|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190689|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20190690|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190691|NCT00217542|Interferons|interferons|mesh-list
20190692|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
20190693|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
20190694|NCT00217542|Azacitidine|azacitidine|mesh-list
20190695|NCT00217542|Amifostine|amifostine|mesh-list
20190696|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190697|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
20190698|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190699|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190700|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
20190701|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190702|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190703|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
20190704|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190705|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19398615|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
20190706|NCT00217542|Protective Agents|protective agents|mesh-ancestor
19398616|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
19404817|NCT03591744|Doxorubicin|doxorubicin|mesh-list
19674497|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
20190707|NCT00217555|Gemcitabine|gemcitabine|mesh-list
20190708|NCT00217555|Topotecan|topotecan|mesh-list
20375218|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375219|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375220|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20375221|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375222|NCT00994097|Gemcitabine|gemcitabine|mesh-list
20375223|NCT00994097|Pemetrexed|pemetrexed|mesh-list
20375224|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375225|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375226|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
20375227|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325333|NCT03957681|Brodalumab|brodalumab|mesh-list
19325334|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
19325335|NCT03957668|Lactulose|lactulose|mesh-list
19325336|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19325337|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325338|NCT03957668|Laxatives|laxatives|mesh-ancestor
19325339|NCT03957499|Dexamethasone|dexamethasone|mesh-list
19325340|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
19325341|NCT03957499|Bupivacaine|bupivacaine|mesh-list
19325342|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325343|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
19325344|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
19325345|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325346|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325347|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325348|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
19325349|NCT03957499|Hormones|hormones|mesh-ancestor
19325350|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325351|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19325352|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325353|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
19325354|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
19325355|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325356|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
19325357|NCT03957499|Analgesics|analgesics|mesh-ancestor
19325358|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19325359|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
19325360|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19325361|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375228|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
20375229|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375230|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375231|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20375232|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
19325362|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325363|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19325364|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
19325365|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19325366|NCT03957629|Interferons|interferons|mesh-list
19325367|NCT03957629|Tenofovir|tenofovir|mesh-list
19325368|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
20375233|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375234|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20375235|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20375236|NCT00994149|Diazoxide|diazoxide|mesh-list
20375237|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19325369|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
19325370|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20190709|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190710|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
20190711|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190712|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190713|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
20190714|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190715|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190716|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190717|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
20190718|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190719|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20190720|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190721|NCT00217568|Carboplatin|carboplatin|mesh-list
20190722|NCT00217568|Docetaxel|docetaxel|mesh-list
20190723|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190724|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
20190725|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
19325371|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325372|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
19325373|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325374|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19325375|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19325376|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325377|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325378|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19325379|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19325380|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
19325381|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325382|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
19325383|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325384|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841337|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841338|NCT00640835|Analgesics|analgesics|mesh-ancestor
19841339|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
19841340|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841341|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19841342|NCT00640926|Radezolid|radezolid|mesh-list
19841343|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
19841344|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19841345|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190726|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
20190727|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190728|NCT00217607|Paclitaxel|paclitaxel|mesh-list
20190729|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20190730|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190731|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
20190732|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
20190733|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
20190734|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190735|NCT00217646|Sorafenib|sorafenib|mesh-list
20190736|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190737|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20190738|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190739|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190740|NCT00217659|Anastrozole|anastrozole|mesh-list
20190741|NCT00217659|Goserelin|goserelin|mesh-list
20190742|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20190743|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190744|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20190745|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20190746|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190747|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190748|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20190749|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
20190750|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20190751|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190752|NCT00217698|Gemcitabine|gemcitabine|mesh-list
20190753|NCT00217698|Gefitinib|gefitinib|mesh-list
20190754|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190755|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190756|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
20190757|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190758|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
20190759|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190760|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190761|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20190762|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
20190763|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190764|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20190765|NCT00217711|Capecitabine|capecitabine|mesh-list
20190766|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
20190767|NCT00217711|Irinotecan|irinotecan|mesh-list
20190768|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20190769|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
20190770|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190771|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190772|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20190773|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190774|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190775|NCT00217815|Efungumab|efungumab|mesh-list
20190776|NCT00217815|Docetaxel|docetaxel|mesh-list
20190777|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190778|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
19325385|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
19325386|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19325387|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
19325388|NCT03957291|Povidone|povidone|mesh-list
19325389|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19325390|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325391|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
19325392|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375238|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
20425947|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
20425948|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425949|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20425950|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20425951|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20425952|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20425953|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425954|NCT01277913|Vitamin D|vitamin d|mesh-list
20425955|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
20425956|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
20425957|NCT01277913|Vitamins|vitamins|mesh-list
19325393|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
19325394|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
19325395|NCT03957174|Rivastigmine|rivastigmine|mesh-list
19325396|NCT03957174|Reboxetine|reboxetine|mesh-list
19325397|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19325398|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325399|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325400|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
19325401|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325402|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325403|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19325404|NCT03957174|Protective Agents|protective agents|mesh-ancestor
19325405|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
19325406|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19325407|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20425958|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
20425959|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425960|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20425961|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20428581|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428582|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428583|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20428584|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20428585|NCT01292525|Tacrolimus|tacrolimus|mesh-list
20428586|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20428587|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
20428588|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428589|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20428590|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428591|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428592|NCT01292551|Bosentan|bosentan|mesh-list
20428593|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20428594|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20428595|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428596|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
20428597|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20428598|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20428599|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20428600|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
20428601|NCT01292694|Losartan|losartan|mesh-list
20428602|NCT01292694|Captopril|captopril|mesh-list
20428603|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20428604|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20428605|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20428606|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20428607|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428608|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19325408|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19325409|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19325410|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
19325411|NCT03957057|Iron|iron|mesh-list
19325412|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20428609|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
19325413|NCT03957057|Trace Elements|trace elements|mesh-ancestor
19325414|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
19325415|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325416|NCT03957057|Hematinics|hematinics|mesh-ancestor
19325417|NCT03956966|Dexamethasone|dexamethasone|mesh-list
19325418|NCT03956966|Bupivacaine|bupivacaine|mesh-list
19325419|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325420|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
19325421|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
19325422|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325423|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325424|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325425|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
19325426|NCT03956966|Hormones|hormones|mesh-ancestor
19325427|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325428|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19325429|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325430|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
19325431|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
20190779|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
20190780|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
20190781|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190782|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
19674498|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674499|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19674500|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674501|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19674502|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19674503|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674504|NCT04663711|Anesthetics|anesthetics|mesh-list
19674505|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674506|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190783|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20190784|NCT00217828|Citalopram|citalopram|mesh-list
20190785|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20190786|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190787|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190788|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190789|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190790|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
20375239|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20375240|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20190791|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375241|NCT00994253|Diuretics|diuretics|mesh-ancestor
20190792|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20190793|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
20190794|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190795|NCT00217932|Valproic Acid|valproic acid|mesh-list
20190796|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
20190797|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190798|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190799|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
20190800|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190801|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190802|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
20190803|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190804|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190805|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190806|NCT00218049|Vanoxerine|vanoxerine|mesh-list
20190807|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20190808|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190809|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190810|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190811|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
20190812|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190813|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190814|NCT00218075|Levodopa|levodopa|mesh-list
20190815|NCT00218075|Carbidopa|carbidopa|mesh-list
20190816|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20190817|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20190818|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
20190819|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217404|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375242|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
20612802|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
19325432|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375243|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375244|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20375245|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375246|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375247|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
20375248|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20375249|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
19325433|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
19398617|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375250|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375251|NCT00994305|Expectorants|expectorants|mesh-ancestor
20375252|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398618|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398619|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
19398620|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398621|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19398622|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19398623|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19398624|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19398625|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398626|NCT03640468|Analgesics|analgesics|mesh-ancestor
19398627|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19398628|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19398629|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
19398630|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19398631|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19398632|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398633|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19398634|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19398635|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19398636|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19398637|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19398638|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
19398639|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
20375253|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20375254|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
20375255|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375256|NCT00994305|Protective Agents|protective agents|mesh-ancestor
20375257|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398640|NCT03640403|Artesunate|artesunate|mesh-list
19398641|NCT03640403|Piperaquine|piperaquine|mesh-list
19398642|NCT03640403|Amodiaquine|amodiaquine|mesh-list
19398643|NCT03640403|Artenimol|artenimol|mesh-list
19398644|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
19398645|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19398646|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19398647|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398648|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375258|NCT00994305|Antidotes|antidotes|mesh-ancestor
20375259|NCT00994344|Ritonavir|ritonavir|mesh-list
19841346|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19841347|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841348|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841349|NCT00640978|Everolimus|everolimus|mesh-list
20375260|NCT00994344|Lopinavir|lopinavir|mesh-list
19398649|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
19398650|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
19398651|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19398652|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
19398653|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
19398654|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
19398655|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19841350|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19841351|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841352|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19841353|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
20375261|NCT00994344|Darunavir|darunavir|mesh-list
20375262|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19841354|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841355|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19841356|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375263|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19398656|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375264|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
19398657|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404818|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19325434|NCT03957109|Anesthetics|anesthetics|mesh-list
19325435|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325436|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325437|NCT03956953|BMS-986165|bms-986165|mesh-list
19325438|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
19325439|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19325440|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325441|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325442|NCT03956732|Vitamin D|vitamin d|mesh-list
19325443|NCT03956732|Caseins|caseins|mesh-list
19325444|NCT03956732|Vitamins|vitamins|mesh-ancestor
19325445|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
19325446|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325447|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19325448|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
19325449|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
19325450|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325451|NCT03956823|Amlodipine|amlodipine|mesh-list
19325452|NCT03956823|Telmisartan|telmisartan|mesh-list
19325453|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19325454|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19325455|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19325456|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325457|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19325458|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325459|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
19325460|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19325461|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19325462|NCT03957083|Oxytocin|oxytocin|mesh-list
19325463|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
19325464|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375265|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325465|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325466|NCT03956797|Anesthetics|anesthetics|mesh-list
19325467|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325468|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325469|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
19325470|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19325471|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
19325472|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325473|NCT03956888|Expectorants|expectorants|mesh-ancestor
19325474|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
19325475|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19325476|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
19325477|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325478|NCT03956888|Protective Agents|protective agents|mesh-ancestor
19325479|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325480|NCT03956888|Antidotes|antidotes|mesh-ancestor
19841357|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841358|NCT00641043|Pioglitazone|pioglitazone|mesh-list
19841359|NCT00641043|Linagliptin|linagliptin|mesh-list
20190820|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190821|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190822|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20190823|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190824|NCT00218101|Buprenorphine|buprenorphine|mesh-list
20190825|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20190826|NCT00218101|Narcotics|narcotics|mesh-ancestor
20190827|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190828|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190829|NCT00218101|Analgesics|analgesics|mesh-ancestor
20190830|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
20190831|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190832|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20217405|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217406|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217407|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
20217408|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217409|NCT00309543|Antidotes|antidotes|mesh-ancestor
20217410|NCT00309543|Protective Agents|protective agents|mesh-ancestor
20217411|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
19325481|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
19841360|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841361|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325482|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
19325483|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
19325484|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325485|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325486|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
19325487|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325488|NCT03956212|Doxycycline|doxycycline|mesh-list
19325489|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325490|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325491|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
19325492|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19325493|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19325494|NCT03956017|Ubiquinone|ubiquinone|mesh-list
19325495|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
19325496|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
19325497|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325498|NCT03956017|Vitamins|vitamins|mesh-ancestor
19325499|NCT03955939|Midazolam|midazolam|mesh-list
19325500|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19325501|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19325502|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325503|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325504|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19325505|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19325506|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19325507|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19325508|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
19325509|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
19325510|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
19325511|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
19325512|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325513|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325514|NCT03955809|Ketamine|ketamine|mesh-list
19325515|NCT03955809|Analgesics|analgesics|mesh-ancestor
19325516|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
19325517|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325518|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325519|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19325520|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19325521|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
19325522|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
19325523|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841362|NCT00641043|Incretins|incretins|mesh-ancestor
19841363|NCT00641043|Hormones|hormones|mesh-ancestor
19841364|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19841365|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19841366|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
19841367|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841368|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841369|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
19841370|NCT00641056|Exenatide|exenatide|mesh-list
19841371|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841372|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841373|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19841374|NCT00641056|Incretins|incretins|mesh-ancestor
19841375|NCT00641056|Hormones|hormones|mesh-ancestor
20190833|NCT00218114|Valproic Acid|valproic acid|mesh-list
20190834|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
20190835|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190836|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190837|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
20190838|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190839|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190840|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
20190841|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190842|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190843|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190844|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
20190845|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20190846|NCT00218127|Narcotics|narcotics|mesh-ancestor
20190847|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190848|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190849|NCT00218127|Analgesics|analgesics|mesh-ancestor
20190850|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
19325524|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19841376|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325525|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19325526|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325527|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325528|NCT03956134|Tapentadol|tapentadol|mesh-list
19325529|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19325530|NCT03956134|Narcotics|narcotics|mesh-ancestor
19325531|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325532|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325533|NCT03956134|Analgesics|analgesics|mesh-ancestor
19325534|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
19325535|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325536|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19325537|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19325538|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190851|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190852|NCT00218140|Nicotine|nicotine|mesh-list
20190853|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20190854|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
20190855|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190856|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190857|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20190858|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20190859|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
20190860|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190861|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325539|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325540|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19325541|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325542|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19325543|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325544|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
19325545|NCT03956121|Analgesics|analgesics|mesh-ancestor
19325546|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
19325547|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325548|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325549|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
19325550|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325551|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19325552|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
19325553|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19325554|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19325555|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841377|NCT00641147|Curcumin|curcumin|mesh-list
19841378|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19841379|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19841380|NCT00641147|Analgesics|analgesics|mesh-ancestor
19841381|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
19841382|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325556|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19325557|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
19325558|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19325559|NCT03955575|Liraglutide|liraglutide|mesh-list
19325560|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19325561|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19325562|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325563|NCT03955575|Incretins|incretins|mesh-ancestor
19325564|NCT03955575|Hormones|hormones|mesh-ancestor
19325565|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325566|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19325567|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19325568|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
19325569|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325570|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19325571|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
19404819|NCT03591744|Lenalidomide|lenalidomide|mesh-list
19841383|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841384|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841385|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841386|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841387|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841388|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841389|NCT00641563|Midazolam|midazolam|mesh-list
19841390|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
20375266|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375267|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20375268|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19325572|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19325573|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
19325574|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325575|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325576|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19325577|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
19325578|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325579|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325580|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19325581|NCT03955705|Nefopam|nefopam|mesh-list
19325582|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325583|NCT03955705|Analgesics|analgesics|mesh-ancestor
19325584|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
19325585|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325586|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325587|NCT03955406|Anesthetics|anesthetics|mesh-list
19325588|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325589|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325590|NCT03955354|Apatinib|apatinib|mesh-list
19325591|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325592|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19325593|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325594|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325595|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
19325596|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19325597|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325598|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
19841391|NCT00641563|Remifentanil|remifentanil|mesh-list
19841392|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19841393|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841394|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841395|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325599|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19325600|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19325601|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325602|NCT03955458|Bupivacaine|bupivacaine|mesh-list
19325603|NCT03955458|Ropivacaine|ropivacaine|mesh-list
19325604|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
19325605|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
19325606|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325607|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375269|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
20375270|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375271|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20375272|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20375273|NCT00994383|Morphine|morphine|mesh-list
20375274|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20375275|NCT00994383|Narcotics|narcotics|mesh-ancestor
20375276|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375277|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375278|NCT00994383|Analgesics|analgesics|mesh-ancestor
20375279|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
20375280|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375281|NCT00994396|Vitamin D|vitamin d|mesh-list
20375282|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
20375283|NCT00994396|Vitamins|vitamins|mesh-ancestor
20375284|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
20375285|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375286|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20375287|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20375288|NCT00994500|Bortezomib|bortezomib|mesh-list
20375289|NCT00994500|Vorinostat|vorinostat|mesh-list
19325608|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
19325609|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841396|NCT00641563|Analgesics|analgesics|mesh-ancestor
19841397|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
19841398|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841399|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19841400|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19841401|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20375290|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325610|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
19841402|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375291|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20375292|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375293|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375294|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
20375295|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
20375296|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375297|NCT00994513|Protective Agents|protective agents|mesh-ancestor
19841403|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841404|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375298|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375299|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
19325611|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20190862|NCT00218153|Naltrexone|naltrexone|mesh-list
20190863|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20190864|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20190865|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190866|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
20190867|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190868|NCT00218166|Triazolam|triazolam|mesh-list
20190869|NCT00218166|Tiagabine|tiagabine|mesh-list
20190870|NCT00218166|Baclofen|baclofen|mesh-list
20190871|NCT00218166|GABA Agonists|gaba agonists|mesh-list
20190872|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20190873|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190874|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20190875|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190876|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20190877|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
20190878|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190879|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190880|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20190881|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20375300|NCT00994513|Vitamins|vitamins|mesh-ancestor
20375301|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
20375302|NCT00994526|Vitamin E|vitamin e|mesh-list
20375303|NCT00994526|Calcium|calcium|mesh-list
20375304|NCT00994526|Vitamins|vitamins|mesh-ancestor
20190882|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20190883|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190884|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190885|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
20190886|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
20190887|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20190888|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190889|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190890|NCT00218205|Celecoxib|celecoxib|mesh-list
20190891|NCT00218205|Epirubicin|epirubicin|mesh-list
20190892|NCT00218205|Estramustine|estramustine|mesh-list
20190893|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20375305|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
20375306|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375307|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19325612|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
19325613|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325614|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
19325615|NCT03955497|Protective Agents|protective agents|mesh-ancestor
19325616|NCT03954990|Metronidazole|metronidazole|mesh-list
19325617|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375308|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
20375309|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375310|NCT00994526|Protective Agents|protective agents|mesh-ancestor
20375311|NCT00994539|Morphine|morphine|mesh-list
20375312|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20375313|NCT00994539|Narcotics|narcotics|mesh-ancestor
20375314|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375315|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375316|NCT00994539|Analgesics|analgesics|mesh-ancestor
20375317|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
20375318|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375319|NCT00994617|Losartan|losartan|mesh-list
19325618|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20190894|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20190895|NCT00218205|Analgesics|analgesics|mesh-ancestor
20190896|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
20190897|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375320|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20375321|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20375322|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20375323|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19325619|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19325620|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19398658|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398659|NCT03640390|Analgesics|analgesics|mesh-ancestor
19398660|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
19398661|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398662|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19398663|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19398664|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19398665|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398666|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398667|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398668|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
19398669|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19398670|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
19398671|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19398672|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19398673|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19398674|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
19398675|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398676|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19398677|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19398678|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
19398679|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19398680|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
19398681|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398682|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
19398683|NCT03640351|Protective Agents|protective agents|mesh-ancestor
19398684|NCT03640273|Loratadine|loratadine|mesh-list
19398685|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
19398686|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
20190898|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375324|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20375325|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375326|NCT00994617|Diuretics|diuretics|mesh-ancestor
20190899|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190900|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20190901|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20190902|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20190903|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190904|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398687|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19398688|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19398689|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19398690|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
19398691|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
19398692|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398693|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398694|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398695|NCT03640247|Acetaminophen|acetaminophen|mesh-list
19398696|NCT03640247|Ibuprofen|ibuprofen|mesh-list
19398697|NCT03640247|Oxycodone|oxycodone|mesh-list
20190905|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20190906|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190907|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20190908|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20190909|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20612803|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
19398698|NCT03640247|Tramadol|tramadol|mesh-list
19398699|NCT03640247|Hydrocodone|hydrocodone|mesh-list
19398700|NCT03640247|Narcotics|narcotics|mesh-list
20190910|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
20190911|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20190912|NCT00218218|Nicotine|nicotine|mesh-list
20190913|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20190914|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
20190915|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398701|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398702|NCT03640247|Analgesics|analgesics|mesh-ancestor
19398703|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
20190916|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404820|NCT03591744|Bortezomib|bortezomib|mesh-list
19325621|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
19325622|NCT03954964|Narcotics|narcotics|mesh-ancestor
19325623|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325624|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325625|NCT03954964|Analgesics|analgesics|mesh-ancestor
19325626|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
19325627|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325628|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
19325629|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19325630|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19325631|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325632|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
19325633|NCT03954860|Coagulants|coagulants|mesh-ancestor
19325634|NCT03954873|Glucagon|glucagon|mesh-list
19325635|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19325636|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325637|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325638|NCT03954873|Hormones|hormones|mesh-ancestor
19325639|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325640|NCT03954873|Incretins|incretins|mesh-ancestor
19325641|NCT03954639|Bupivacaine|bupivacaine|mesh-list
19325642|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
19325643|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
19325644|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325645|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325646|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
19325647|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325648|NCT03954756|Apatinib|apatinib|mesh-list
19325649|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325650|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19325651|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325652|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325653|NCT03954483|Triazolam|triazolam|mesh-list
19325654|NCT03954483|Buspirone|buspirone|mesh-list
19325655|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19325656|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19325657|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325658|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325659|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19325660|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19325661|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
19325662|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325663|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375327|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
20375328|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375329|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20375330|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375331|NCT00994695|Vaccines|vaccines|mesh-list
20375332|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
20375333|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375334|NCT00994708|Esomeprazole|esomeprazole|mesh-list
20375335|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20375336|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20375337|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20375338|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375339|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375340|NCT00994734|Mifepristone|mifepristone|mesh-list
20375341|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20375342|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
20375343|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375344|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375345|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20375346|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20375347|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20375348|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
20375349|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19325664|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19325665|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
20375350|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20375351|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
20375352|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375353|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
19325666|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
19325667|NCT03954197|Hormones|hormones|mesh-list
19398704|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325668|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325669|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325670|NCT03953989|Ranolazine|ranolazine|mesh-list
19325671|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20375354|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20375355|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20375356|NCT00994773|Tenofovir|tenofovir|mesh-list
20375357|NCT00994773|Entecavir|entecavir|mesh-list
20375358|NCT00994773|Simvastatin|simvastatin|mesh-list
20375359|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
20375360|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375361|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20375362|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20375363|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375364|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375365|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20375366|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20375367|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20375368|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20375369|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
20375370|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19325672|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19325673|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325674|NCT03953950|Losartan|losartan|mesh-list
19325675|NCT03953950|Spironolactone|spironolactone|mesh-list
19325676|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19325677|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19325678|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19325679|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19325680|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325681|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19325682|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
19325683|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325684|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325685|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19325686|NCT03953950|Diuretics|diuretics|mesh-ancestor
19325687|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
19325688|NCT03953833|Antibodies|antibodies|mesh-list
19325689|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19325690|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
19325691|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325692|NCT03954262|Propofol|propofol|mesh-list
19325693|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19325694|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325695|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325696|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19325697|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
19325698|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
19325699|NCT03953807|Dexamethasone|dexamethasone|mesh-list
19325700|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325701|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
19325702|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
19325703|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325704|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325705|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325706|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
19325707|NCT03953807|Hormones|hormones|mesh-ancestor
19325708|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325709|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19325710|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325711|NCT03953781|Levetiracetam|levetiracetam|mesh-list
19325712|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
19325713|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
19325714|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
19325715|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19325716|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19325717|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325718|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325719|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20375371|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20375372|NCT00994786|Pregabalin|pregabalin|mesh-list
20375373|NCT00994786|Analgesics|analgesics|mesh-ancestor
19325720|NCT03953677|Analgesics|analgesics|mesh-ancestor
20375374|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
19841405|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19841406|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19841407|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841408|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841409|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19325721|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
19325722|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325723|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19325724|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19325725|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19325726|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
19325727|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325728|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325729|NCT03953729|Ibuprofen|ibuprofen|mesh-list
19325730|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19325731|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325732|NCT03953729|Analgesics|analgesics|mesh-ancestor
19325733|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
19325734|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325735|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375375|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375376|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325736|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325737|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325738|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19325739|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325740|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325741|NCT03953716|Desogestrel|desogestrel|mesh-list
19325742|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19325743|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19325744|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19325745|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
19325746|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19325747|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325748|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19325749|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19325750|NCT03953716|Progestins|progestins|mesh-ancestor
19325751|NCT03953716|Hormones|hormones|mesh-ancestor
19325752|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325753|NCT03953261|Curcumin|curcumin|mesh-list
19325754|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19325755|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325756|NCT03953261|Analgesics|analgesics|mesh-ancestor
19841410|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
19841411|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
19841412|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
19841413|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
19841414|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19841415|NCT00641563|Narcotics|narcotics|mesh-ancestor
19841416|NCT00641641|Tenofovir|tenofovir|mesh-list
19841417|NCT00641641|Emtricitabine|emtricitabine|mesh-list
19841418|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
19841419|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
19841420|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841421|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19841422|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19841423|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841424|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841425|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19841426|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19841427|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20190917|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20190918|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20190919|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
20190920|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190921|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190922|NCT00218231|Bupropion|bupropion|mesh-list
20190923|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20190924|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
20190925|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20190926|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19841428|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19841429|NCT00641667|Fentanyl|fentanyl|mesh-list
19841430|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19841431|NCT00641667|Narcotics|narcotics|mesh-ancestor
19325757|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
19325758|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325759|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325760|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20190927|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190928|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190929|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325761|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325762|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325763|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325764|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325765|NCT03953300|Benralizumab|benralizumab|mesh-list
19325766|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19325767|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
19325768|NCT03953326|Nitroprusside|nitroprusside|mesh-list
19325769|NCT03953326|Acetylcholine|acetylcholine|mesh-list
19325770|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19325771|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
19325772|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19325773|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325774|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19325775|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
19325776|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325777|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325778|NCT03953235|Nivolumab|nivolumab|mesh-list
19325779|NCT03953235|Ipilimumab|ipilimumab|mesh-list
19325780|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325781|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325782|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19325783|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325784|NCT03953170|Teduglutide|teduglutide|mesh-list
19325785|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19325786|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19325787|NCT03953170|Protective Agents|protective agents|mesh-ancestor
19325788|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325789|NCT03953001|Lidocaine|lidocaine|mesh-list
19325790|NCT03953001|Epinephrine|epinephrine|mesh-list
19325791|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
19325792|NCT03953001|Anesthetics|anesthetics|mesh-list
19325793|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325794|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325795|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
19325796|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325797|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19325798|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19325799|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19325800|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19325801|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325802|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19325803|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19325804|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
19325805|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19325806|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19325807|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19325808|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
19325809|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19325810|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
19325811|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
19325812|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
19325813|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19325814|NCT03953287|Acetaminophen|acetaminophen|mesh-list
20190930|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
20190931|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190932|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674521|NCT04582448|Insulin|insulin|mesh-list
19674522|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19674523|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674524|NCT04562558|Leucovorin|leucovorin|mesh-list
19674525|NCT04562558|Dactinomycin|dactinomycin|mesh-list
19674526|NCT04562558|Methotrexate|methotrexate|mesh-list
19674527|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674528|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19674529|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
19674530|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404821|NCT03591744|Daratumumab|daratumumab|mesh-list
19841432|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841433|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375377|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
20375378|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20375379|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375380|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325815|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325816|NCT03953287|Analgesics|analgesics|mesh-ancestor
19325817|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
19325818|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325819|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325820|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
19325821|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19325822|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
19325823|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
19325824|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325825|NCT03953209|Spironolactone|spironolactone|mesh-list
19325826|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19325827|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
19325828|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325829|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375381|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20375382|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20375383|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20375384|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375385|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20375386|NCT00994799|Ranibizumab|ranibizumab|mesh-list
20375387|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20375388|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20375389|NCT00994799|Growth Substances|growth substances|mesh-ancestor
20375390|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375391|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
20375392|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325830|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19325831|NCT03953209|Diuretics|diuretics|mesh-ancestor
19325832|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
19398705|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398706|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
19398707|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19398708|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398709|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19398710|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19398711|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398712|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375393|NCT00994812|Metformin|metformin|mesh-list
20375394|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20375395|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375396|NCT00994825|Simendan|simendan|mesh-list
20375397|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20375398|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
20375399|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20375400|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20375401|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375402|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398713|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19398714|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398715|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
19398716|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398717|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
20375403|NCT00994825|Protective Agents|protective agents|mesh-ancestor
20375404|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375405|NCT00994903|Simvastatin|simvastatin|mesh-list
20375406|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19398718|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19398719|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19398720|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
19398721|NCT03640221|Diuretics|diuretics|mesh-ancestor
19398722|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
19398723|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398724|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20375407|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20375408|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
19325833|NCT03953066|Melatonin|melatonin|mesh-list
19325834|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
19325835|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325836|NCT03953066|Protective Agents|protective agents|mesh-ancestor
19325837|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325838|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325839|NCT03952715|Ibuprofen|ibuprofen|mesh-list
19325840|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20190933|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20190934|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20190935|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20190936|NCT00218244|Lobeline|lobeline|mesh-list
20190937|NCT00218244|Nicotine|nicotine|mesh-list
20190938|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20190939|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
20190940|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190941|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190942|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20190943|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20190944|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
20190945|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190946|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190947|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
20190948|NCT00218283|Nicotine|nicotine|mesh-list
20190949|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19325841|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325842|NCT03952715|Analgesics|analgesics|mesh-ancestor
19325843|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
19325844|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325845|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325846|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325847|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325848|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19325849|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325850|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325851|NCT03953118|Azithromycin|azithromycin|mesh-list
19325852|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325853|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325854|NCT03952832|Leflunomide|leflunomide|mesh-list
19325855|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325856|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325857|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19325858|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
19325859|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325860|NCT03952650|Chloroquine|chloroquine|mesh-list
19325861|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19325862|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
19325863|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19325864|NCT03952650|Ibuprofen|ibuprofen|mesh-list
19325865|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19325866|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19325867|NCT03952650|Analgesics|analgesics|mesh-ancestor
19325868|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
19325869|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19325870|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325871|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325872|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325873|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19325874|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325875|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325876|NCT03952650|Amebicides|amebicides|mesh-ancestor
19325877|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19325878|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19325879|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325880|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
19325881|NCT03952650|Filaricides|filaricides|mesh-ancestor
19325882|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
19325883|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
19325884|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19325885|NCT03952572|Prednisone|prednisone|mesh-list
19325886|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
19325887|NCT03952572|Doxorubicin|doxorubicin|mesh-list
19325888|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19325889|NCT03952572|Vincristine|vincristine|mesh-list
20190950|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
20190951|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375409|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375410|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20375411|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20375412|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375413|NCT00994916|Amifampridine|amifampridine|mesh-list
19325890|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19325891|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
19325892|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325893|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19325894|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19325895|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
19325896|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325897|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325898|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19325899|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19325900|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19325901|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19325902|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325903|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19325904|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
19325905|NCT03952572|Hormones|hormones|mesh-ancestor
19325906|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325907|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19325908|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20375414|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19325909|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
19325910|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
19325911|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
19325912|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19325913|NCT03952481|Lifitegrast|lifitegrast|mesh-list
19325914|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19325915|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
19325916|NCT03952325|Nivolumab|nivolumab|mesh-list
19325917|NCT03952325|Atezolizumab|atezolizumab|mesh-list
19325918|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325919|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325920|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19325921|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325922|NCT03952273|Sirolimus|sirolimus|mesh-list
20375415|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375416|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375417|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20375418|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375419|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375420|NCT00994942|Morphine|morphine|mesh-list
19325923|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325924|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325925|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19325926|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325927|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
19325928|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19325929|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
19325930|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325931|NCT03952260|Anesthetics|anesthetics|mesh-list
19325932|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19325933|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325934|NCT03951987|Charcoal|charcoal|mesh-list
19325935|NCT03951987|Antidotes|antidotes|mesh-ancestor
19325936|NCT03951987|Protective Agents|protective agents|mesh-ancestor
19325937|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190952|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190953|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20190954|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20190955|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
20190956|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190957|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190958|NCT00218309|Hydromorphone|hydromorphone|mesh-list
19325938|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20190959|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20190960|NCT00218309|Narcotics|narcotics|mesh-ancestor
20190961|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190962|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325939|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19325940|NCT03951558|Diuretics|diuretics|mesh-ancestor
19325941|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
19325942|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325943|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19325944|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19325945|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325946|NCT03951831|Docetaxel|docetaxel|mesh-list
19325947|NCT03951831|Leuprolide|leuprolide|mesh-list
19325948|NCT03951831|Cemiplimab|cemiplimab|mesh-list
19325949|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20190963|NCT00218309|Analgesics|analgesics|mesh-ancestor
20190964|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
20190965|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190966|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19325950|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
19325951|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
19325952|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
19325953|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325954|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19325955|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
19325956|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19325957|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325958|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19325959|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325960|NCT03951636|Chlorhexidine|chlorhexidine|mesh-list
19325961|NCT03951636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19325962|NCT03951636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325963|NCT03951636|Disinfectants|disinfectants|mesh-ancestor
19325964|NCT03951753|Tirzepatide|tirzepatide|mesh-list
19325965|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19325966|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325967|NCT03951753|Incretins|incretins|mesh-ancestor
19325968|NCT03951753|Hormones|hormones|mesh-ancestor
19325969|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19325970|NCT03951597|Gemcitabine|gemcitabine|mesh-list
19325971|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
19325972|NCT03951597|Lenvatinib|lenvatinib|mesh-list
19325973|NCT03951597|Antibodies|antibodies|mesh-list
19325974|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
19325975|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19325976|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19325977|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
19325978|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325979|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325980|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
19325981|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325982|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325983|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19325984|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19325985|NCT03951415|Durvalumab|durvalumab|mesh-list
20190967|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20190968|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190969|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190970|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190971|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
20190972|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190973|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190974|NCT00218348|Amphetamine|amphetamine|mesh-list
20190975|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
20190976|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20190977|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190978|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
20190979|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
20190980|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190981|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
20190982|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20190983|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20190984|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
20190985|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20190986|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190987|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20190988|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20375421|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19325986|NCT03951415|Olaparib|olaparib|mesh-list
19325987|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20375422|NCT00994942|Narcotics|narcotics|mesh-ancestor
20375423|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375424|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375425|NCT00994942|Analgesics|analgesics|mesh-ancestor
20375426|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
20375427|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375428|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
20375429|NCT00994968|Docetaxel|docetaxel|mesh-list
20375430|NCT00994968|Doxorubicin|doxorubicin|mesh-list
20375431|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20375432|NCT00994968|Tegafur|tegafur|mesh-list
20375433|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20375434|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
20375435|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375436|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20375437|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19325988|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19325989|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19325990|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19325991|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19325992|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
19325993|NCT03951402|Tapentadol|tapentadol|mesh-list
19325994|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19325995|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19325996|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19325997|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19325998|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19325999|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326000|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326001|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326002|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19326003|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
19326004|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19326005|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375438|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
20375439|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375440|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326006|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19326007|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19326008|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20375441|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20375442|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
20375443|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
20375444|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
20375445|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20375446|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20375447|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20375448|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375449|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375450|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
20375451|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
20375452|NCT00994981|Analgesics|analgesics|mesh-ancestor
20375453|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
20375454|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375455|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326009|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19326010|NCT03951402|Narcotics|narcotics|mesh-ancestor
19326011|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326012|NCT03951402|Analgesics|analgesics|mesh-ancestor
19326013|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
19326014|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326015|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19326016|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19326017|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326018|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
19326019|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326020|NCT03951285|Niacinamide|niacinamide|mesh-list
19326021|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
19326022|NCT03951285|Vitamins|vitamins|mesh-ancestor
20375456|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
20375457|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375458|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20375459|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
20375460|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20375461|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375462|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375463|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20375464|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
20375465|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375466|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
20375467|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
20375468|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
20375469|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20375470|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375471|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
20375472|NCT00994994|Coagulants|coagulants|mesh-ancestor
20375473|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
20375474|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20375475|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20375476|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375477|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20375478|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20375479|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375480|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375481|NCT00995033|Varenicline|varenicline|mesh-list
20375482|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20375483|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20375484|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
20375485|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375486|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375487|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375488|NCT00995046|Factor VIII|factor viii|mesh-list
20375489|NCT00995046|Coagulants|coagulants|mesh-ancestor
20375490|NCT00995059|Sirolimus|sirolimus|mesh-list
20375491|NCT00995059|Bortezomib|bortezomib|mesh-list
20375492|NCT00995059|Melphalan|melphalan|mesh-list
20375493|NCT00995059|Tacrolimus|tacrolimus|mesh-list
19326023|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
19326024|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326025|NCT03951207|Amlodipine|amlodipine|mesh-list
19841434|NCT00641667|Analgesics|analgesics|mesh-ancestor
19841435|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
19841436|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841437|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19841438|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19841439|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
19326026|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19326027|NCT03951207|Atorvastatin|atorvastatin|mesh-list
19326028|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19326029|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19326030|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
19326031|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326032|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19326033|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19326034|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326035|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19326036|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19326037|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326038|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19326039|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326040|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
19326041|NCT03950830|Disulfiram|disulfiram|mesh-list
19326042|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19326043|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19326044|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326045|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326046|NCT03950960|Itraconazole|itraconazole|mesh-list
19326047|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
19326048|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326049|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19326050|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19326051|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326052|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326053|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19326054|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
19398725|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19841440|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
19841441|NCT00641706|Bortezomib|bortezomib|mesh-list
20375494|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
20375495|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19326055|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326056|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326057|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19326058|NCT03951051|Olmesartan|olmesartan|mesh-list
19326059|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19326060|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19326061|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19326062|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19326063|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326064|NCT03950700|Epinephrine|epinephrine|mesh-list
19326065|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19326066|NCT03950700|Bupivacaine|bupivacaine|mesh-list
19326067|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19326068|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
19326069|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
19326070|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326071|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326072|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
19326073|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326074|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20375496|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
20375497|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20375498|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
19326075|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19326076|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
19326077|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326078|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326079|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19326080|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326081|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
19326082|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19326083|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
19326084|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
19326085|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
19326086|NCT03950804|Eculizumab|eculizumab|mesh-list
19326087|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19326088|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19326089|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
19326090|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398726|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398727|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19398728|NCT03640156|Oxytocin|oxytocin|mesh-list
19398729|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
19398730|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398731|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398732|NCT03640026|Tacrolimus|tacrolimus|mesh-list
19398733|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398734|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
19398735|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398736|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19398737|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398738|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398739|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
19398740|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398741|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19398742|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841442|NCT00641706|Vorinostat|vorinostat|mesh-list
19841443|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841444|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19841445|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841446|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841447|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19841448|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19841449|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20190989|NCT00218361|Hydromorphone|hydromorphone|mesh-list
20190990|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20190991|NCT00218361|Narcotics|narcotics|mesh-ancestor
20190992|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20190993|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20190994|NCT00218361|Analgesics|analgesics|mesh-ancestor
20190995|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
20190996|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20190997|NCT00218374|Gabapentin|gabapentin|mesh-list
20190998|NCT00218374|Analgesics|analgesics|mesh-ancestor
20190999|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
20191000|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326091|NCT03950505|Pioglitazone|pioglitazone|mesh-list
19326092|NCT03950505|Alogliptin|alogliptin|mesh-list
19326093|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19326094|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326095|NCT03950505|Incretins|incretins|mesh-ancestor
19326096|NCT03950505|Hormones|hormones|mesh-ancestor
19326097|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326098|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19326099|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
19326100|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326101|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326102|NCT03950518|Levamisole|levamisole|mesh-list
19326103|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19326104|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
19326105|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326106|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
19326107|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
19326108|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19326109|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326110|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326111|NCT03950427|Bupropion|bupropion|mesh-list
19326112|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19326113|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
19326114|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19326115|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19326116|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19326117|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326118|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326119|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
19326120|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326121|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326122|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19326123|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19326124|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326125|NCT03950544|Meropenem|meropenem|mesh-list
19326126|NCT03950544|Fosfomycin|fosfomycin|mesh-list
19326127|NCT03950544|Tigecycline|tigecycline|mesh-list
19326128|NCT03950544|Polymyxins|polymyxins|mesh-list
19326129|NCT03950544|Polymyxin B|polymyxin b|mesh-list
19326130|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19326131|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674531|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674532|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
19674533|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674534|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674535|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
19674536|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674537|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19674538|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674539|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
19674540|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19674541|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19674542|NCT04562558|Antidotes|antidotes|mesh-ancestor
19674543|NCT04562558|Protective Agents|protective agents|mesh-ancestor
19674544|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
19674545|NCT04562558|Vitamins|vitamins|mesh-ancestor
19674546|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
19674547|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19674548|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674549|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19674550|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19674551|NCT04529876|Abatacept|abatacept|mesh-list
19674552|NCT04529876|Tofacitinib|tofacitinib|mesh-list
19674553|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19674554|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674555|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674556|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20191001|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326132|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19674557|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
19674558|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674559|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326133|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841450|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375499|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375500|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20375501|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375502|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375503|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375504|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20375505|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375506|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20375507|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
20375508|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20375509|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
20375510|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20375511|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19326134|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326135|NCT03950141|Apatinib|apatinib|mesh-list
19326136|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326137|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19326138|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326139|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326140|NCT03950362|Avelumab|avelumab|mesh-list
19326141|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20375512|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
20375513|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20375514|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
20375515|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375516|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375517|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20375518|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20375519|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20375520|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
20375521|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20375522|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20375523|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
20375524|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375525|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20375526|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20375527|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375528|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375529|NCT00995293|Docetaxel|docetaxel|mesh-list
20375530|NCT00995293|Fluorouracil|fluorouracil|mesh-list
20375531|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326142|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326143|NCT03950154|Bevacizumab|bevacizumab|mesh-list
19326144|NCT03950154|Capecitabine|capecitabine|mesh-list
19326145|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
19326146|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19326147|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326148|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19326149|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19326150|NCT03950154|Growth Substances|growth substances|mesh-ancestor
19326151|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326152|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
19326153|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19326154|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
19326155|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326156|NCT03950271|Capecitabine|capecitabine|mesh-list
19326157|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
19326158|NCT03950271|Trastuzumab|trastuzumab|mesh-list
19326159|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19326160|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
19326161|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326162|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326163|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19326164|NCT03950050|Ambroxol|ambroxol|mesh-list
19326165|NCT03950050|Expectorants|expectorants|mesh-ancestor
20375532|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
20375533|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
20375534|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326166|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
19841451|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841452|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841453|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425962|NCT01278004|Ethosuximide|ethosuximide|mesh-list
20191002|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
20191003|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19326167|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
19326168|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19326169|NCT03949764|Velpatasvir|velpatasvir|mesh-list
19326170|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
19326171|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326172|NCT03949985|Hemostatics|hemostatics|mesh-list
19326173|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
19326174|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19326175|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326176|NCT03949985|Coagulants|coagulants|mesh-ancestor
19326177|NCT03949855|Rituximab|rituximab|mesh-list
19326178|NCT03949855|Belimumab|belimumab|mesh-list
19326179|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19326180|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326181|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
19326182|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326183|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326184|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19326185|NCT03949686|Bupivacaine|bupivacaine|mesh-list
19326186|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
19326187|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
19326188|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326189|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326190|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
19326191|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326192|NCT03949842|Fluticasone|fluticasone|mesh-list
19326193|NCT03949842|Xhance|xhance|mesh-list
19326194|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
19326195|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
19326196|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19326197|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326198|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326199|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
19326200|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326201|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326202|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19326203|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
19326204|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
19326205|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19326206|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326207|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326208|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19326209|NCT03949517|Piperidine|piperidine|mesh-list
19326210|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19326211|NCT03949517|Bombesin|bombesin|mesh-list
19326212|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326213|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19326214|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326215|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326216|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19326217|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326218|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19326219|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19326220|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19326221|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19326222|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
19326223|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326224|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19326225|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19326226|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326227|NCT03949634|Paclitaxel|paclitaxel|mesh-list
19326228|NCT03949634|Docetaxel|docetaxel|mesh-list
19326229|NCT03949634|Doxorubicin|doxorubicin|mesh-list
19326230|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326231|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326232|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
19326233|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
19326234|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326235|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326236|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19674560|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19674561|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326237|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20191004|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19326238|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19326239|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326240|NCT03949478|Ibuprofen|ibuprofen|mesh-list
19326241|NCT03949478|Nifedipine|nifedipine|mesh-list
19326242|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19326243|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20375535|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375536|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
20375537|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375538|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20375539|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
20375540|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326244|NCT03949478|Analgesics|analgesics|mesh-ancestor
19326245|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
19326246|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326247|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326248|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326249|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326250|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19326251|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326252|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326253|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19326254|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326255|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19326256|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
19326257|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
19326258|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19326259|NCT03949101|Atropine|atropine|mesh-list
19326260|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20375541|NCT00995306|Capsaicin|capsaicin|mesh-list
20375542|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
20375543|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
19326261|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19326262|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19326263|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19326264|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326265|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
19326266|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326267|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326268|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19326269|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
19326270|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
19326271|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
19326272|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19326273|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19326274|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
19326275|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326276|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326277|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19326278|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
19326279|NCT03949062|Rituximab|rituximab|mesh-list
19326280|NCT03949062|Lenalidomide|lenalidomide|mesh-list
19326281|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19326282|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326283|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
19326284|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326285|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326286|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19326287|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19326288|NCT03949062|Growth Substances|growth substances|mesh-ancestor
19326289|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
19326290|NCT03949075|Enalapril|enalapril|mesh-list
19326291|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19326292|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
19326293|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326294|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326295|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19326296|NCT03948685|Carvedilol|carvedilol|mesh-list
19326297|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19326298|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19326299|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
19326300|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841454|NCT00641719|Analgesics|analgesics|mesh-ancestor
19326301|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326302|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375544|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
20375545|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375546|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375547|NCT00995332|Cytarabine|cytarabine|mesh-list
20375548|NCT00995332|Tretinoin|tretinoin|mesh-list
20375549|NCT00995332|Valproic Acid|valproic acid|mesh-list
20375550|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375551|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
20375552|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375553|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375554|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
20375555|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375556|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20375557|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
20375558|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375559|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
20375560|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
19326303|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19326304|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
19326305|NCT03948685|Protective Agents|protective agents|mesh-ancestor
19326306|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19326307|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326308|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19326309|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
19326310|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19326311|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19326312|NCT03948737|Tocopherols|tocopherols|mesh-list
19326313|NCT03948737|Vitamin E|vitamin e|mesh-list
20375561|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
20375562|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375563|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
20375564|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375565|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
20375566|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20375567|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375568|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20375569|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
20375570|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20375571|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20375572|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
20375573|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
20375574|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375575|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375576|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326314|NCT03948737|Tocotrienols|tocotrienols|mesh-list
19326315|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
19326316|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
19326317|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326318|NCT03948737|Protective Agents|protective agents|mesh-ancestor
19326319|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674562|NCT04529863|Abatacept|abatacept|mesh-list
19674563|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20375577|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
20375578|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375579|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20375580|NCT00995423|Paclitaxel|paclitaxel|mesh-list
20375581|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19674564|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674565|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674566|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674567|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
19674568|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674569|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841455|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
20191005|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191006|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191007|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20191008|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20191009|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191010|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191011|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
20191012|NCT00218413|Vaccines|vaccines|mesh-list
20191013|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
20191014|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191015|NCT00218504|Dronabinol|dronabinol|mesh-list
20191016|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
19326320|NCT03948737|Vitamins|vitamins|mesh-ancestor
19326321|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
19398743|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398744|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
19398745|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19398746|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841456|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841457|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
19841458|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19398747|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398748|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398749|NCT03639896|Analgesics|analgesics|mesh-ancestor
19398750|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
19398751|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398752|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19398753|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19398754|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19398755|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398756|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841459|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
19841460|NCT00641745|Risperidone|risperidone|mesh-list
19841461|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19841462|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19841463|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
19841464|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841465|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841466|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841467|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19841468|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841469|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398757|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398758|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19398759|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
19398760|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398761|NCT03639727|Mannitol|mannitol|mesh-list
19398762|NCT03639727|Citric Acid|citric acid|mesh-list
19398763|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
19398764|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19398765|NCT03639727|Diuretics|diuretics|mesh-ancestor
19398766|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
19398767|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398768|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
19398769|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19398770|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
19398771|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
19398772|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841470|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841471|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19841472|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
19841473|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19841474|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19841475|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19841476|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
19841477|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19841478|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19398773|NCT03639714|Nivolumab|nivolumab|mesh-list
19398774|NCT03639714|Ipilimumab|ipilimumab|mesh-list
19398775|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19398776|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398777|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20191017|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191018|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191019|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191020|NCT00218504|Analgesics|analgesics|mesh-ancestor
20191021|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
20191022|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191023|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20191024|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20191025|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191026|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398778|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404457|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19841479|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
19841480|NCT00641797|Promethazine|promethazine|mesh-list
19326322|NCT03948620|Penicillins|penicillins|mesh-list
19326323|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19326324|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326325|NCT03948477|Pantoprazole|pantoprazole|mesh-list
19326326|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19326327|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326328|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19326329|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326330|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326331|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19326332|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19326333|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
19326334|NCT03948243|Tolbutamide|tolbutamide|mesh-list
19326335|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
19326336|NCT03948243|Alprazolam|alprazolam|mesh-list
19326337|NCT03948243|Caffeine|caffeine|mesh-list
19326338|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19326339|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326340|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19326341|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326342|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326343|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19326344|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19326345|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
19326346|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326347|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
19326348|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
19326349|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19326350|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19326351|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19326352|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326353|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19326354|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19326355|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19326356|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
19326357|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
19326358|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19326359|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
19326360|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
19326361|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19326362|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19326363|NCT03948191|Prednisolone|prednisolone|mesh-list
19326364|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
19326365|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19326366|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
19326367|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
19326368|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326369|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
19326370|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
19326371|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326372|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326373|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326374|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
19326375|NCT03948191|Hormones|hormones|mesh-ancestor
19326376|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326377|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19326378|NCT03948191|Protective Agents|protective agents|mesh-ancestor
19326379|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19326380|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326381|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19326382|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19326383|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326384|NCT03947775|Vaccines|vaccines|mesh-list
19326385|NCT03947775|Immunologic Factors|immunologic factors|mesh-ancestor
19326386|NCT03947775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326387|NCT03948178|Simendan|simendan|mesh-list
19326388|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19326389|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
19326390|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19326391|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19326392|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326393|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375582|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326394|NCT03948178|Protective Agents|protective agents|mesh-ancestor
19326395|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326396|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
20375583|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
20375584|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
20375585|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
20375586|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375587|NCT00995618|Tranilast|tranilast|mesh-list
20375588|NCT00995618|Febuxostat|febuxostat|mesh-list
19326397|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19326398|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19326399|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375589|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
20375590|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20375591|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20375592|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20375593|NCT00995618|Analgesics|analgesics|mesh-ancestor
19326400|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20375594|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
20375595|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326401|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19326402|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
19326403|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326404|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326405|NCT03947242|Trastuzumab|trastuzumab|mesh-list
19326406|NCT03947242|Vinorelbine|vinorelbine|mesh-list
19326407|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19326408|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326409|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326410|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
19326411|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
19326412|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326413|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326414|NCT03947229|Clopidogrel|clopidogrel|mesh-list
19326415|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19326416|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19326417|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19326418|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19326419|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
19326420|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841481|NCT00641797|Meclizine|meclizine|mesh-list
19326421|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326422|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326423|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
19326424|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19326425|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19326426|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326427|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19326428|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19326429|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
19326430|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326431|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326432|NCT03947411|Oseltamivir|oseltamivir|mesh-list
19326433|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
19326434|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326435|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326436|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326437|NCT03947125|Buprenorphine|buprenorphine|mesh-list
19326438|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19326439|NCT03947125|Narcotics|narcotics|mesh-ancestor
19326440|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326441|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326442|NCT03947125|Analgesics|analgesics|mesh-ancestor
19326443|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
19326444|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326445|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19841482|NCT00641797|Lorazepam|lorazepam|mesh-list
19841483|NCT00641797|Ondansetron|ondansetron|mesh-list
19326446|NCT03946878|Venetoclax|venetoclax|mesh-list
19841484|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
19841485|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
19841486|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841487|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841488|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19841489|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
19841490|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375596|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841491|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19841492|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
19841493|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841494|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326447|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
19326448|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326449|NCT03946657|Anesthetics|anesthetics|mesh-list
19326450|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19326451|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326452|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326453|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
19398779|NCT03639571|Ibuprofen|ibuprofen|mesh-list
19398780|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19398781|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398782|NCT03639571|Analgesics|analgesics|mesh-ancestor
19398783|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
19398784|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398785|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398786|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19398787|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19398788|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19398789|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398790|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398791|NCT03639558|Promethazine|promethazine|mesh-list
19398792|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
19398793|NCT03639558|Haloperidol|haloperidol|mesh-list
19398794|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
19398795|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
19398796|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
19398797|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
19398798|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398799|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398800|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19398801|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19398802|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19398803|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398804|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19398805|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19398806|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
19398807|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398808|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398809|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19398810|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
19398811|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
19398812|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19398813|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
19398814|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
19398815|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19398816|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19398817|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19398818|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
19398819|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
19398820|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
19398821|NCT03639545|Metformin|metformin|mesh-list
19841495|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19841496|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191027|NCT00218504|Hormones|hormones|mesh-ancestor
20191028|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20191029|NCT00218517|Selegiline|selegiline|mesh-list
19398822|NCT03639545|Empagliflozin|empagliflozin|mesh-list
19841497|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841498|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841499|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19841500|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19841501|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19841502|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
19841503|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
19841504|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
19841505|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19841506|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
19841507|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
19841508|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19841509|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
19841510|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
20191030|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
20191031|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19398823|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841511|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
19841512|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
19841513|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
19841514|NCT00641862|Vitamins|vitamins|mesh-ancestor
20191032|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20191033|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20191034|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20191035|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191036|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191037|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20191038|NCT00218517|Protective Agents|protective agents|mesh-ancestor
20191039|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191040|NCT00218530|Lofexidine|lofexidine|mesh-list
20191041|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20191042|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20191043|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191044|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
20191045|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191046|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20191047|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20191048|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20191049|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
20191050|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191051|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191052|NCT00218569|Naltrexone|naltrexone|mesh-list
20191053|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20191054|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20191055|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191056|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
20191057|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191058|NCT00218608|Disulfiram|disulfiram|mesh-list
20191059|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20191060|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20191061|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191062|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191063|NCT00218621|Buprenorphine|buprenorphine|mesh-list
20191064|NCT00218621|Methadone|methadone|mesh-list
20191065|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19841515|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
19841516|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841517|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
19841518|NCT00641862|Hematinics|hematinics|mesh-ancestor
19841519|NCT00642018|Prednisone|prednisone|mesh-list
19841520|NCT00642018|Docetaxel|docetaxel|mesh-list
19841521|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841522|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19841523|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19841524|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19841525|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841526|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841527|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
20191066|NCT00218621|Narcotics|narcotics|mesh-ancestor
20191067|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191068|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191069|NCT00218621|Analgesics|analgesics|mesh-ancestor
20191070|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
20191071|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191072|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20191073|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
20375597|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375598|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20375599|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375600|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375601|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20375602|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20375603|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
20375604|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
20375605|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375606|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20375607|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20612804|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
20191074|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
19841528|NCT00642018|Hormones|hormones|mesh-ancestor
19841529|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20191075|NCT00218660|Naltrexone|naltrexone|mesh-list
20191076|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20191077|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19326454|NCT03946826|Halometasone|halometasone|mesh-list
19326455|NCT03946826|Petrolatum|petrolatum|mesh-list
19326456|NCT03946826|Emollients|emollients|mesh-ancestor
19326457|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
19326458|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326459|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
19326460|NCT03946826|Hormones|hormones|mesh-ancestor
19326461|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326462|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326463|NCT03946514|Losartan|losartan|mesh-list
19326464|NCT03946514|Amlodipine|amlodipine|mesh-list
19326465|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19326466|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19326467|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19326468|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326469|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326470|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19326471|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326472|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
19326473|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19326474|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19326475|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19326476|NCT03946514|Diuretics|diuretics|mesh-ancestor
19326477|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
19326478|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19326479|NCT03946358|Atezolizumab|atezolizumab|mesh-list
19326480|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326481|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
19326482|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19326483|NCT03945903|Golimumab|golimumab|mesh-list
19326484|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19326485|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326486|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19326487|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
19326488|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326489|NCT03945656|Insulin|insulin|mesh-list
19326490|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19326491|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
19326492|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19326493|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326494|NCT03945955|Melatonin|melatonin|mesh-list
19326495|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
19326496|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326497|NCT03945955|Protective Agents|protective agents|mesh-ancestor
19326498|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326499|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326500|NCT03945539|Itraconazole|itraconazole|mesh-list
19326501|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
19326502|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326503|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19326504|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20191078|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191079|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
20191080|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191081|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
20191082|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20191083|NCT00218855|Thalidomide|thalidomide|mesh-list
20191084|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20191085|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
20191086|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191087|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
20191088|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20191089|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326505|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326506|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612805|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326507|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20375608|NCT00995657|Fluticasone|fluticasone|mesh-list
20375609|NCT00995657|Xhance|xhance|mesh-list
20375610|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375611|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326508|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
19326509|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375612|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
19326510|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326511|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19326512|NCT03945513|Dienogest|dienogest|mesh-list
19841530|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375613|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375614|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375615|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20375616|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
20375617|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375618|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20375619|NCT00995800|Fluticasone|fluticasone|mesh-list
20375620|NCT00995800|Xhance|xhance|mesh-list
20375621|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
20375622|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375623|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20375624|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
20375625|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375626|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375627|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20375628|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
20375629|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375630|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20375631|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20375632|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20375633|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20375634|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375635|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375636|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375637|NCT00995826|Laninamivir|laninamivir|mesh-list
20375638|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
20375639|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375640|NCT00995839|Terlipressin|terlipressin|mesh-list
20375641|NCT00995839|Vasopressins|vasopressins|mesh-list
20375642|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
20375643|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
20375644|NCT00995839|Coagulants|coagulants|mesh-ancestor
20375645|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19326513|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19326514|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19326515|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19326516|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19326517|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
19326518|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19326519|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326520|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19326521|NCT03945513|Estrogens|estrogens|mesh-ancestor
19326522|NCT03945513|Hormones|hormones|mesh-ancestor
19326523|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326524|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19326525|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
19326526|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19326527|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375646|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20375647|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
20375648|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375649|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20375650|NCT00995917|Vitamin K|vitamin k|mesh-list
20375651|NCT00995917|Vitamins|vitamins|mesh-ancestor
19326528|NCT03945604|Apatinib|apatinib|mesh-list
19326529|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326530|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19326531|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326532|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326533|NCT03945227|Spartalizumab|spartalizumab|mesh-list
19326534|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19326535|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326536|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326537|NCT03945019|Infliximab|infliximab|mesh-list
19326538|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
19326539|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326540|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326541|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
20375652|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
20375653|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375654|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20375655|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20375656|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375657|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
20375658|NCT00995917|Coagulants|coagulants|mesh-ancestor
20375659|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
20375660|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19326542|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326543|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
19326544|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326545|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326546|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19326547|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
19326548|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
19326549|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19326550|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
19326551|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326552|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326553|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
19326554|NCT03945396|Antacids|antacids|mesh-ancestor
19326555|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326556|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326557|NCT03944980|Docetaxel|docetaxel|mesh-list
19326558|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375661|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425963|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
20425964|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
20425965|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20425966|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20425967|NCT01278056|Deferasirox|deferasirox|mesh-list
20425968|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20425969|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
20425970|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
20425971|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425972|NCT01278082|Budesonide|budesonide|mesh-list
20425973|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20425974|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326559|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
20191090|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20191091|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20191092|NCT00218855|Growth Substances|growth substances|mesh-ancestor
20191093|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
20191094|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191095|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
20191096|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20191097|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191098|NCT00219232|Rivastigmine|rivastigmine|mesh-list
20191099|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20191100|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326560|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
19326561|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326562|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326563|NCT03944889|Capsaicin|capsaicin|mesh-list
19326564|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
19326565|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
19326566|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
19326567|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326568|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425975|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
20425976|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425977|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425978|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20191101|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191102|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
20191103|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191104|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191105|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20191106|NCT00219232|Protective Agents|protective agents|mesh-ancestor
20191107|NCT00219245|Rivastigmine|rivastigmine|mesh-list
20191108|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20191109|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191110|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191111|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
20191112|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191113|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425979|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
19326569|NCT03944915|Paclitaxel|paclitaxel|mesh-list
19326570|NCT03944915|Carboplatin|carboplatin|mesh-list
19326571|NCT03944915|Fluorouracil|fluorouracil|mesh-list
19326572|NCT03944915|Nivolumab|nivolumab|mesh-list
20191114|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20191115|NCT00219245|Protective Agents|protective agents|mesh-ancestor
20191116|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
20191117|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20191118|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191119|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
20191120|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20191121|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191122|NCT00219310|Famciclovir|famciclovir|mesh-list
20191123|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
20191124|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191125|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20191126|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191127|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191128|NCT00219323|Omalizumab|omalizumab|mesh-list
20191129|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20191130|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20375662|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
20375663|NCT00996021|Dolutegravir|dolutegravir|mesh-list
20375664|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20375665|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20375666|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375667|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20375668|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19326573|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
19326574|NCT03944915|Lenograstim|lenograstim|mesh-list
19326575|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326576|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326577|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
19326578|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
19326579|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326580|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326581|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
19326582|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19326583|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19326584|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
19326585|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375669|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375670|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375671|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375672|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20375673|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
19326586|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19326587|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19326588|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19326589|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
19326590|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326591|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19326592|NCT03944733|Iron|iron|mesh-list
19326593|NCT03944733|Trace Elements|trace elements|mesh-ancestor
19326594|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
19326595|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326596|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19326597|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398824|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398825|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19674570|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19674571|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19674572|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19674573|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674574|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674575|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19674576|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19674577|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674578|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
19674579|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674580|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
19674581|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19674582|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19404458|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19674583|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20375674|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375675|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375676|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20375677|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20375678|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20375679|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20375680|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20375681|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20375682|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20375683|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
19674584|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19674585|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674586|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
19674587|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674588|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674589|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19674590|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674591|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
19674592|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674593|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326598|NCT03944655|Anesthetics|anesthetics|mesh-list
19326599|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326600|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326601|NCT03944681|Droperidol|droperidol|mesh-list
19326602|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19326603|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
19326604|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
19326605|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326606|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326607|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326608|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19326609|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19326610|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326611|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19326612|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19326613|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19326614|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
19326615|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326616|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326617|NCT03944473|Neostigmine|neostigmine|mesh-list
19326618|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19326619|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326620|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326621|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
19326622|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326623|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326624|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19326625|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
19326626|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326627|NCT03944512|Pravastatin|pravastatin|mesh-list
19326628|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19326629|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19326630|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
19326631|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326632|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19326633|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19326634|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674594|NCT04421092|Lidocaine|lidocaine|mesh-list
20191131|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
20191132|NCT00219375|Sivelestat|sivelestat|mesh-list
20191133|NCT00219375|Glycine|glycine|mesh-list
20191134|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20191135|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
20191136|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191137|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191138|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
20191139|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191140|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191141|NCT00219388|Simendan|simendan|mesh-list
20191142|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20191143|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
20375684|NCT00996060|Hydralazine|hydralazine|mesh-list
20191144|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20375685|NCT00996060|Valproic Acid|valproic acid|mesh-list
19674595|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
20375686|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
20375687|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375688|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375689|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
20375690|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375691|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375692|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
20375693|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20375694|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375695|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20375696|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20375697|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
20375698|NCT00996099|Insulin|insulin|mesh-list
20375699|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20375700|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20375701|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375702|NCT00996151|Testosterone|testosterone|mesh-list
20191145|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20191146|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191147|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326635|NCT03944317|Azithromycin|azithromycin|mesh-list
19326636|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
19326637|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
19326638|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19326639|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19326640|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674596|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
19674597|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191148|NCT00219388|Protective Agents|protective agents|mesh-ancestor
20191149|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191150|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20191151|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
20191152|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191153|NCT00219440|Metformin|metformin|mesh-list
20191154|NCT00219440|Pioglitazone|pioglitazone|mesh-list
20191155|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20191156|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191157|NCT00219466|Zinc|zinc|mesh-list
20191158|NCT00219466|Tocopherols|tocopherols|mesh-list
20191159|NCT00219466|Vitamin E|vitamin e|mesh-list
20191160|NCT00219466|Tocotrienols|tocotrienols|mesh-list
20191161|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
20191162|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
20375703|NCT00996151|Androgens|androgens|mesh-ancestor
20375704|NCT00996151|Hormones|hormones|mesh-ancestor
20375705|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375706|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375707|NCT00996177|Fentanyl|fentanyl|mesh-list
20375708|NCT00996177|Morphine|morphine|mesh-list
20375709|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20375710|NCT00996177|Narcotics|narcotics|mesh-ancestor
20375711|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375712|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375713|NCT00996177|Analgesics|analgesics|mesh-ancestor
19674598|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674599|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
19674600|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674601|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19674602|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20375714|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
20375715|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375716|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20375717|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20375718|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
19674603|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20191163|NCT00219466|Trace Elements|trace elements|mesh-ancestor
20375719|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
20375720|NCT00996190|Phenylephrine|phenylephrine|mesh-list
20375721|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
20375722|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20375723|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
20375724|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
20375725|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375726|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191164|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
20375727|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
20375728|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20191165|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191166|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
20191167|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326641|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
19326642|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19326643|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19326644|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19326645|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326646|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326647|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19326648|NCT03944317|Renal Agents|renal agents|mesh-ancestor
19326649|NCT03944291|Bupivacaine|bupivacaine|mesh-list
19326650|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
19326651|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
19326652|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326653|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326654|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
19326655|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326656|NCT03944304|Paclitaxel|paclitaxel|mesh-list
19326657|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326658|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326659|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
19326660|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
19326661|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326662|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326663|NCT03944252|Cetuximab|cetuximab|mesh-list
19326664|NCT03944252|Avelumab|avelumab|mesh-list
19326665|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19326666|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326667|NCT03944070|Ranibizumab|ranibizumab|mesh-list
19326668|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19326669|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19326670|NCT03944070|Growth Substances|growth substances|mesh-ancestor
19326671|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326672|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
19326673|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326674|NCT03943888|Atropine|atropine|mesh-list
19326675|NCT03943888|Neostigmine|neostigmine|mesh-list
19326676|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19326677|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19326678|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326679|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
19326680|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326681|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674604|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191168|NCT00219466|Protective Agents|protective agents|mesh-ancestor
20612806|NCT02252926|Acetaminophen|acetaminophen|mesh-list
19674605|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674606|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
19674607|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674608|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674609|NCT04402385|Aspirin|aspirin|mesh-list
19674610|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19674611|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612807|NCT02252926|Lidocaine|lidocaine|mesh-list
20612808|NCT02252926|Morphine|morphine|mesh-list
20375729|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
20191169|NCT00219466|Vitamins|vitamins|mesh-ancestor
20191170|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
20191171|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
20191172|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20191173|NCT00219479|Phenytoin|phenytoin|mesh-list
20191174|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
20191175|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20191176|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20191177|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375730|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
20375731|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20375732|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20375733|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20375734|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375735|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612809|NCT02252926|Gabapentin|gabapentin|mesh-list
19326682|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19326683|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612810|NCT02252926|Bupivacaine|bupivacaine|mesh-list
20191178|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191179|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20191180|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20375736|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375737|NCT00996190|Protective Agents|protective agents|mesh-ancestor
20375738|NCT00996229|Resveratrol|resveratrol|mesh-list
20191181|NCT00219570|Clindamycin|clindamycin|mesh-list
20191182|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
20191183|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
20191184|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
20191185|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20191186|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191187|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20191188|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191189|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191190|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20191191|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191192|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191193|NCT00219596|Timolol|timolol|mesh-list
20191194|NCT00219596|Latanoprost|latanoprost|mesh-list
20375739|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
20375740|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375741|NCT00996229|Protective Agents|protective agents|mesh-ancestor
20375742|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375743|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375744|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20375745|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
20375746|NCT00996385|Bortezomib|bortezomib|mesh-list
20375747|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375748|NCT00996411|Salvinorin A|salvinorin a|mesh-list
20375749|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
20375750|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375751|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20375752|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
20375753|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20375754|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
20375755|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375756|NCT00996424|Expectorants|expectorants|mesh-ancestor
20375757|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
20375758|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20375759|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
20375760|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191195|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20191196|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20191197|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
20191198|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191199|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191200|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375761|NCT00996424|Protective Agents|protective agents|mesh-ancestor
20375762|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375763|NCT00996424|Antidotes|antidotes|mesh-ancestor
20375764|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20375765|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20375766|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20375767|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674612|NCT04402385|Analgesics|analgesics|mesh-ancestor
19674613|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
19674614|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674615|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674616|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19674617|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20191201|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20191202|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20191203|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20191204|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20217412|NCT00309543|Vitamins|vitamins|mesh-ancestor
20375768|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
20375769|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19674618|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19674619|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19674620|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217413|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
20375770|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
20217414|NCT00309556|Docetaxel|docetaxel|mesh-list
20375771|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20375772|NCT00996515|Azacitidine|azacitidine|mesh-list
20191205|NCT00219700|Ibuprofen|ibuprofen|mesh-list
20191206|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20191207|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191208|NCT00219700|Analgesics|analgesics|mesh-ancestor
20191209|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
20191210|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674621|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19674622|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20191211|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191212|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191213|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20191214|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20191215|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375773|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375774|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20375775|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375776|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375777|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20375778|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
20375779|NCT00996567|Cetuximab|cetuximab|mesh-list
20375780|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20375781|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375782|NCT00996684|Plasminogen|plasminogen|mesh-list
20375783|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20375784|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20375785|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375786|NCT00996697|Budesonide|budesonide|mesh-list
20375787|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
20375788|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
20375789|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20375790|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375791|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20375792|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
20375793|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375794|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375795|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20375796|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
20375797|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
20375798|NCT00996697|Hormones|hormones|mesh-ancestor
20375799|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375800|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20375801|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20375802|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20375803|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375804|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375805|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375806|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
20375807|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20375808|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
20375809|NCT00996723|Dasatinib|dasatinib|mesh-list
20375810|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375811|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20375812|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375813|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375814|NCT00996762|Lapatinib|lapatinib|mesh-list
20375815|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375816|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20375817|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375818|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375819|NCT00996788|Rebamipide|rebamipide|mesh-list
19326684|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
19674623|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674624|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
19674625|NCT04393103|Atropine|atropine|mesh-list
19674626|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19674627|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19674628|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19674629|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19674630|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
19674631|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674632|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674633|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20191216|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375820|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20375821|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20375822|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
19326685|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
19326686|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19326687|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19326688|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
20375823|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375824|NCT00996788|Protective Agents|protective agents|mesh-ancestor
20375825|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375826|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326689|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326690|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326691|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19326692|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326693|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19326694|NCT03944005|Anesthetics|anesthetics|mesh-list
19326695|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326696|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326697|NCT03943992|Esomeprazole|esomeprazole|mesh-list
19326698|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19326699|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326700|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19326701|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326702|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326703|NCT03943459|Atorvastatin|atorvastatin|mesh-list
19326704|NCT03943459|Quercetin|quercetin|mesh-list
19326705|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19326706|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19326707|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
19326708|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326709|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19326710|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19326711|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326712|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
20375827|NCT00996866|Vitamin D|vitamin d|mesh-list
20375828|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
20375829|NCT00996866|Vitamins|vitamins|mesh-ancestor
19326713|NCT03943459|Protective Agents|protective agents|mesh-ancestor
19326714|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326715|NCT03943537|Insulin|insulin|mesh-list
19326716|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19326717|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326718|NCT03943784|Propranolol|propranolol|mesh-list
19326719|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19326720|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19326721|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
19326722|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326723|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326724|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375830|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
20375831|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375832|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20375833|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20375834|NCT00996879|Midazolam|midazolam|mesh-list
20375835|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20375836|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20375837|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20375838|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375839|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20375840|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20375841|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20375842|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20375843|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
20375844|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
20375845|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
20375846|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
20375847|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375848|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375849|NCT00996983|Ziconotide|ziconotide|mesh-list
20375850|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20375851|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20375852|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326725|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19326726|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19674634|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
19674635|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
19674636|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
19674637|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19674638|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19674639|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
19674640|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674641|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674642|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19674643|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19674644|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19674645|NCT04347616|Aldesleukin|aldesleukin|mesh-list
19674646|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674647|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19674648|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19674649|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
19674650|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674651|NCT04331002|Triamcinolone|triamcinolone|mesh-list
20375853|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19326727|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
19326728|NCT03943823|Estrogens|estrogens|mesh-list
19326729|NCT03943823|Hormones|hormones|mesh-ancestor
19326730|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326731|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326732|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
19326733|NCT03943472|Fludarabine|fludarabine|mesh-list
19326734|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19326735|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
19326736|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326737|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326738|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19326739|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
19326740|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326741|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326742|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19326743|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
19326744|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19326745|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
19326746|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326747|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
19326748|NCT03943186|Protective Agents|protective agents|mesh-ancestor
19326749|NCT03943407|Imiquimod|imiquimod|mesh-list
19326750|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
19326751|NCT03943407|Doxepin|doxepin|mesh-list
19326752|NCT03943407|Menthol|menthol|mesh-list
19326753|NCT03943407|Histamine|histamine|mesh-list
20191217|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
20191218|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20191219|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
20191220|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
20191221|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326754|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
19326755|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
20375854|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375855|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20375856|NCT00996983|Protective Agents|protective agents|mesh-ancestor
19326756|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
19326757|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
19326758|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326759|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191222|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191223|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191224|NCT00219713|Analgesics|analgesics|mesh-ancestor
20191225|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
20191226|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191227|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
20191228|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191229|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20191230|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191231|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191232|NCT00219739|Interferons|interferons|mesh-list
20191233|NCT00219739|Cytarabine|cytarabine|mesh-list
19326760|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326761|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19326762|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
19326763|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191234|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
20191235|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191236|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
20191237|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191238|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191239|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
20191240|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191241|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20191242|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
20191243|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191244|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20191245|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326764|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
19326765|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326766|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19326767|NCT03943407|Protective Agents|protective agents|mesh-ancestor
19326768|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19326769|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19326770|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326771|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19326772|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
19326773|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19326774|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
19326775|NCT03943043|Gemcitabine|gemcitabine|mesh-list
19326776|NCT03943043|Paclitaxel|paclitaxel|mesh-list
19326777|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
19326778|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326779|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326780|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
19326781|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
19326782|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326783|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326784|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19841531|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19841532|NCT00642174|Clopidogrel|clopidogrel|mesh-list
19841533|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19841534|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19841535|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19841536|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19841537|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19841538|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
19841539|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841540|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841541|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841542|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19841543|NCT00642278|Canagliflozin|canagliflozin|mesh-list
19841544|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841545|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841546|NCT00642278|Incretins|incretins|mesh-ancestor
19841547|NCT00642278|Hormones|hormones|mesh-ancestor
19841548|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20191246|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
20191247|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191248|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20191249|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191250|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191251|NCT00219765|Cytarabine|cytarabine|mesh-list
20191252|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
20191253|NCT00219765|Daunorubicin|daunorubicin|mesh-list
20191254|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191255|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
20191256|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191257|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191258|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
20191259|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191260|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20191261|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
20191262|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191263|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20191264|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191265|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20191266|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20191267|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191268|NCT00219778|Mifepristone|mifepristone|mesh-list
20375857|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20375858|NCT00996983|Analgesics|analgesics|mesh-ancestor
20375859|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
20375860|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375861|NCT00997009|Paclitaxel|paclitaxel|mesh-list
19326785|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
19326786|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
19326787|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326788|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326789|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19326790|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
19326791|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326792|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
19326793|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19326794|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19326795|NCT03942861|Prednisolone|prednisolone|mesh-list
19326796|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
19326797|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19326798|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
20375862|NCT00997009|Carboplatin|carboplatin|mesh-list
20375863|NCT00997009|Cetuximab|cetuximab|mesh-list
20375864|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326799|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326800|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
19326801|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
19326802|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326803|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326804|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326805|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
19326806|NCT03942861|Hormones|hormones|mesh-ancestor
19326807|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326808|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19326809|NCT03942861|Protective Agents|protective agents|mesh-ancestor
19326810|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19326811|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326812|NCT03942991|Mepivacaine|mepivacaine|mesh-list
19326813|NCT03942991|Carticaine|carticaine|mesh-list
19326814|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
19326815|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
19326816|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326817|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326818|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
19326819|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326820|NCT03942757|Bilirubin|bilirubin|mesh-list
19326821|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
19326822|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326823|NCT03942757|Protective Agents|protective agents|mesh-ancestor
19326824|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326825|NCT03942926|Sirolimus|sirolimus|mesh-list
19326826|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19326827|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326828|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19326829|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326830|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
19674652|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19674653|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19674654|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19674655|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19674656|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
19674657|NCT04331002|Hormones|hormones|mesh-ancestor
20191269|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20191270|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
20191271|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20191272|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191273|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20191274|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20191275|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20191276|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
20191277|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20191278|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20375865|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375866|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
19326831|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674658|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326832|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
19326833|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674659|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674660|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674661|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
19674662|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674663|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674664|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
19674665|NCT04245839|Fludarabine|fludarabine|mesh-list
19674666|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674667|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
20191279|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
20375867|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
20375868|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
20375869|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375870|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20375871|NCT00997022|Sorafenib|sorafenib|mesh-list
20375872|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375873|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20375874|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375875|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375876|NCT00997061|Topotecan|topotecan|mesh-list
20375877|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20375878|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20375879|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375880|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375881|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375882|NCT00997074|Ibuprofen|ibuprofen|mesh-list
20375883|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20375884|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19326834|NCT03942796|Pregabalin|pregabalin|mesh-list
19326835|NCT03942796|Analgesics|analgesics|mesh-ancestor
19326836|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
19326837|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326838|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326839|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
19326840|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19326841|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19326842|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326843|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19326844|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19326845|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19326846|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841549|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19841550|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
19841551|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841552|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841553|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20191280|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20191281|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
20191282|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20191283|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20191284|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
20191285|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20191286|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20191287|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191288|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841554|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
19841555|NCT00642304|Hematinics|hematinics|mesh-ancestor
19841556|NCT00642356|Levodopa|levodopa|mesh-list
19841557|NCT00642356|Carbidopa|carbidopa|mesh-list
19841558|NCT00642356|Entacapone|entacapone|mesh-list
19841559|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19841560|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19841561|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19841562|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
19841563|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841564|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841565|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841566|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19841567|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191289|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375885|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20375886|NCT00997074|Analgesics|analgesics|mesh-ancestor
20375887|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
20375888|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326847|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19326848|NCT03942601|Sirolimus|sirolimus|mesh-list
19841568|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19841569|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19674668|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674669|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19674670|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19674671|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
19674672|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841570|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
20375889|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375890|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20375891|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20375892|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375893|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375894|NCT00997087|Flumazenil|flumazenil|mesh-list
20375895|NCT00997087|Antidotes|antidotes|mesh-ancestor
20375896|NCT00997087|Protective Agents|protective agents|mesh-ancestor
20375897|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375898|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
20375899|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
20375900|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375901|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375902|NCT00997191|Triamcinolone|triamcinolone|mesh-list
20375903|NCT00997191|Bevacizumab|bevacizumab|mesh-list
20375904|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20375905|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375906|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20375907|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20375908|NCT00997191|Growth Substances|growth substances|mesh-ancestor
20375909|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375910|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
20375911|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375912|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
20375913|NCT00997191|Hormones|hormones|mesh-ancestor
20375914|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375915|NCT00997269|Ubiquinone|ubiquinone|mesh-list
20375916|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
20375917|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
20375918|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375919|NCT00997269|Vitamins|vitamins|mesh-ancestor
20375920|NCT00997347|Misoprostol|misoprostol|mesh-list
19326849|NCT03942601|Dexamethasone|dexamethasone|mesh-list
19674673|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674674|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19674675|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
19674676|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19674677|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19674678|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
19674679|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674680|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19674681|NCT04209868|Bupivacaine|bupivacaine|mesh-list
19674682|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
19674683|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
19674684|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
19674685|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674686|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674687|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
19674688|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674689|NCT04209504|Bupivacaine|bupivacaine|mesh-list
19674690|NCT04209504|Ropivacaine|ropivacaine|mesh-list
19674691|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
19674692|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
19674693|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674694|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674695|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
19674696|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674697|NCT04167176|Lidocaine|lidocaine|mesh-list
19674698|NCT04167176|Bupivacaine|bupivacaine|mesh-list
19674699|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
20375921|NCT00997347|Mifepristone|mifepristone|mesh-list
19326850|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
19674700|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
19326851|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19326852|NCT03942601|BB 1101|bb 1101|mesh-list
19326853|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326854|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
19326855|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
19326856|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326857|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326858|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19326859|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
19326860|NCT03942601|Hormones|hormones|mesh-ancestor
19326861|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326862|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19326863|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326864|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20375922|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20375923|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
20375924|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20375925|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326865|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326866|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19326867|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
20375926|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20375927|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20375928|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
20375929|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20375930|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20375931|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20375932|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20375933|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
20375934|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20375935|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19326868|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19326869|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
19326870|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
19326871|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326872|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398826|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398827|NCT03639532|Tacrine|tacrine|mesh-list
19398828|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19398829|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398830|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398831|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
19398832|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398833|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398834|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19398835|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
19398836|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398837|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
19398838|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
19398839|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
19398840|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375936|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
20375937|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375938|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
20375939|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20375940|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20375941|NCT00997399|Panobinostat|panobinostat|mesh-list
20375942|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375943|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20375944|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20425980|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
19398841|NCT03639519|Protective Agents|protective agents|mesh-ancestor
19398842|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398843|NCT03639519|Vitamins|vitamins|mesh-ancestor
19398844|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
19398845|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19398846|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19398847|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19674701|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674702|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398848|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19398849|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
19398850|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326873|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
19326874|NCT03942354|Linezolid|linezolid|mesh-list
19326875|NCT03942354|Bedaquiline|bedaquiline|mesh-list
19326876|NCT03942354|Clofazimine|clofazimine|mesh-list
19326877|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19326878|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326879|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19326880|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19326881|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326882|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326883|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326884|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19326885|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
19326886|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19326887|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
19326888|NCT03942289|Norepinephrine|norepinephrine|mesh-list
19326889|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19326890|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19326891|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
19326892|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326893|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326894|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326895|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
19326896|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
19326897|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326898|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19326899|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
19326900|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19326901|NCT03941925|Levan|levan|mesh-list
19326902|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326903|NCT03941964|Azacitidine|azacitidine|mesh-list
19326904|NCT03941964|Decitabine|decitabine|mesh-list
19326905|NCT03941964|Venetoclax|venetoclax|mesh-list
20375945|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375946|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
20375947|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20375948|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20375949|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20375950|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
20375951|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20375952|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20375953|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375954|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375955|NCT00997477|Budesonide|budesonide|mesh-list
20375956|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
20375957|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375958|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19326906|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19326907|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
19326908|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326909|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326910|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326911|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
20375959|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
20375960|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375961|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375962|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20375963|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
20375964|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
20375965|NCT00997477|Hormones|hormones|mesh-ancestor
20375966|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20375967|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20375968|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20375969|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20375970|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
20375971|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20375972|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375973|NCT00997542|Allopurinol|allopurinol|mesh-list
20375974|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
20375975|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375976|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375977|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
20375978|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20425981|NCT01278082|Hormones|hormones|mesh-ancestor
19326912|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19326913|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
19326914|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
19326915|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326916|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326917|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19326918|NCT03941990|Analgesics|analgesics|mesh-ancestor
19326919|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
19326920|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326921|NCT03942029|Fluconazole|fluconazole|mesh-list
19326922|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
19326923|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19326924|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19326925|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19326926|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191290|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191291|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191292|NCT00219856|Propofol|propofol|mesh-list
20375979|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20375980|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
20375981|NCT00997542|Protective Agents|protective agents|mesh-ancestor
20375982|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375983|NCT00997581|Apremilast|apremilast|mesh-list
20375984|NCT00997581|Indomethacin|indomethacin|mesh-list
19326927|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191293|NCT00219856|Desflurane|desflurane|mesh-list
20191294|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20191295|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191296|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191297|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19326928|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19326929|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
19326930|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19326931|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326932|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19326933|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19326934|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
19326935|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
20191298|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
20191299|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
20191300|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20191301|NCT00219869|Galantamine|galantamine|mesh-list
20191302|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20191303|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191304|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326936|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
19326937|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19326938|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326939|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
19326940|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326941|NCT03941886|Aspirin|aspirin|mesh-list
20191305|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
20191306|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326942|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19326943|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19326944|NCT03941886|Analgesics|analgesics|mesh-ancestor
19326945|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
19326946|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19326947|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326948|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191307|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326949|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19326950|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20191308|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19326951|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19326952|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674703|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
19674704|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674705|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19674706|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19674707|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19674708|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19674709|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674710|NCT04083365|Capecitabine|capecitabine|mesh-list
20428610|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326953|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19326954|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20375985|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20375986|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20375987|NCT00997581|Analgesics|analgesics|mesh-ancestor
20375988|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
19326955|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326956|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
19326957|NCT03942068|Paclitaxel|paclitaxel|mesh-list
19326958|NCT03942068|Apatinib|apatinib|mesh-list
19326959|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20375989|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20375990|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20375991|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20375992|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20375993|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20375994|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20375995|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20375996|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20375997|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
20375998|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
20375999|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20376000|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20376001|NCT00997607|Vaccines|vaccines|mesh-list
20376002|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
20376003|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376004|NCT00997659|Chromium|chromium|mesh-list
20376005|NCT00997659|Picolinic acid|picolinic acid|mesh-list
19326960|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19326961|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326962|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
19326963|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
19326964|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
19326965|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326966|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19326967|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326968|NCT03942458|Clopidogrel|clopidogrel|mesh-list
19326969|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19326970|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19326971|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19326972|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19326973|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
19326974|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19326975|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326976|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326977|NCT03941561|Tegafur|tegafur|mesh-list
19326978|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19326979|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
19326980|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326981|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326982|NCT03941795|Axitinib|axitinib|mesh-list
19326983|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326984|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19326985|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19326986|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19326987|NCT03941587|Aflibercept|aflibercept|mesh-list
19326988|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19326989|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19326990|NCT03941587|Growth Substances|growth substances|mesh-ancestor
19326991|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326992|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
19326993|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19326994|NCT03941535|Vitamin K|vitamin k|mesh-list
19326995|NCT03941535|Vitamins|vitamins|mesh-ancestor
19326996|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
19326997|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19326998|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19326999|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19327000|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327001|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
19327002|NCT03941535|Coagulants|coagulants|mesh-ancestor
20376006|NCT00997659|Trace Elements|trace elements|mesh-ancestor
19327003|NCT03941340|Aflutinib|aflutinib|mesh-list
20376007|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
20376008|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327004|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19327005|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327006|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191309|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
20191310|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327009|NCT03940976|Afatinib|afatinib|mesh-list
19327010|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327011|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19327012|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327013|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327014|NCT03940742|Tirzepatide|tirzepatide|mesh-list
19327015|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19327016|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327017|NCT03940742|Incretins|incretins|mesh-ancestor
19327018|NCT03940742|Hormones|hormones|mesh-ancestor
19327019|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327020|NCT03940664|Formaldehyde|formaldehyde|mesh-list
20376009|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20376010|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
20376011|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
20376012|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376013|NCT00997685|Capecitabine|capecitabine|mesh-list
20376014|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
20376015|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20376016|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
20376017|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841571|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
19841572|NCT00642369|Haloperidol|haloperidol|mesh-list
19841573|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19841574|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
19327021|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
19327022|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327023|NCT03940807|Estradiol|estradiol|mesh-list
19327024|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19327025|NCT03940807|Estrogens|estrogens|mesh-ancestor
19327026|NCT03940807|Hormones|hormones|mesh-ancestor
19327027|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327028|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327029|NCT03940651|Anesthetics|anesthetics|mesh-list
19841575|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
19327030|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
19841576|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841577|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19841578|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841579|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841580|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841581|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
19841582|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
19841583|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841584|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19841585|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19841586|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
19841587|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841588|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841589|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19841590|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19841591|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19841592|NCT00642460|Methotrexate|methotrexate|mesh-list
19841593|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19841594|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
19327031|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327032|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841595|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20191311|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
20191312|NCT00219882|Turmeric extract|turmeric extract|mesh-list
20191313|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
20191314|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191315|NCT00219882|Protective Agents|protective agents|mesh-ancestor
20191316|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191317|NCT00219895|Ibuprofen|ibuprofen|mesh-list
20191318|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20191319|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191320|NCT00219895|Analgesics|analgesics|mesh-ancestor
20191321|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
19327033|NCT03940378|Levamisole|levamisole|mesh-list
19327034|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19327035|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
19327036|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327037|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
19327038|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
19327039|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19327040|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327041|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376018|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376019|NCT00997711|Sirolimus|sirolimus|mesh-list
20376020|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376021|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376022|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20376023|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376024|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
20376025|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376026|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
20376027|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376028|NCT00997750|Lornoxicam|lornoxicam|mesh-list
19327042|NCT03940235|Androgens|androgens|mesh-list
20191322|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191323|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191324|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191325|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20191326|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19327043|NCT03940235|Hormones|hormones|mesh-ancestor
19327044|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327045|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327046|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
19327047|NCT03940391|Midazolam|midazolam|mesh-list
19327048|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19327049|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19327050|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327051|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327052|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19327053|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19327054|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19327055|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19327056|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
19327057|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
19327058|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
19327059|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
19327060|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327061|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327062|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
19327063|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
19327064|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19327065|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
19327066|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
19327067|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19327068|NCT03940430|Lactoferrin|lactoferrin|mesh-list
19327069|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327070|NCT03940469|Dexamethasone|dexamethasone|mesh-list
19327071|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
19327072|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
19327073|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19327074|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
19327075|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
19327076|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327077|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327078|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327079|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
19327080|NCT03940469|Hormones|hormones|mesh-ancestor
19327081|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327082|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19327083|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327084|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19327085|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327086|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19327087|NCT03940469|Analgesics|analgesics|mesh-ancestor
19327088|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
19327089|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19327090|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20191327|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191328|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327091|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19327092|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
19327093|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327094|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327095|NCT03939663|Misoprostol|misoprostol|mesh-list
19327096|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19327097|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
19327098|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20191329|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
20191330|NCT00219908|Analgesics|analgesics|mesh-ancestor
20191331|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
20191332|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191333|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191334|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191335|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20191336|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191337|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191338|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191339|NCT00219921|Morphine|morphine|mesh-list
20191340|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20191341|NCT00219921|Narcotics|narcotics|mesh-ancestor
20191342|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327099|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327100|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19327101|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327102|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
19327103|NCT03939884|Diclofenac|diclofenac|mesh-list
19327104|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19327105|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19327106|NCT03939884|Analgesics|analgesics|mesh-ancestor
19327107|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
19327108|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327109|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327110|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19327111|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19327112|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19327113|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327114|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327115|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
19327116|NCT03939923|Rocuronium|rocuronium|mesh-list
19327117|NCT03939923|Neostigmine|neostigmine|mesh-list
19327118|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19327119|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19327120|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19327121|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327122|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327123|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19327124|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327125|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327126|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
19327127|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191343|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191344|NCT00219921|Analgesics|analgesics|mesh-ancestor
20191345|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
20191346|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191347|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20191348|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
20191349|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191350|NCT00219973|Bemiparin|bemiparin|mesh-list
20191351|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
20191352|NCT00220051|Capecitabine|capecitabine|mesh-list
19327128|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19327129|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
19327130|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19327131|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19327132|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19327133|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
19674711|NCT04083365|Durvalumab|durvalumab|mesh-list
19674712|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674713|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
20191353|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
20191354|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191355|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
20191356|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327134|NCT03939637|Antibodies|antibodies|mesh-list
19674714|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327135|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
19327136|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19327137|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19327138|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
19327139|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327140|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
19327141|NCT03939975|Nivolumab|nivolumab|mesh-list
19327142|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20191357|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191358|NCT00220064|Leucovorin|leucovorin|mesh-list
20191359|NCT00220064|Fluorouracil|fluorouracil|mesh-list
20191360|NCT00220064|Irinotecan|irinotecan|mesh-list
20191361|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
19327143|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327144|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19327145|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327146|NCT03939871|Vinorelbine|vinorelbine|mesh-list
19327147|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20191362|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191363|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191364|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191365|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376029|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376030|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376031|NCT00997750|Analgesics|analgesics|mesh-ancestor
20376032|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
19327148|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327149|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
19327150|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327151|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19327152|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327153|NCT03940001|Paclitaxel|paclitaxel|mesh-list
19327154|NCT03940001|Carboplatin|carboplatin|mesh-list
19327155|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19327156|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327157|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
20376033|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376034|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376035|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376036|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376037|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
20376038|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20376039|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20376040|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19327158|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327159|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
19327160|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327161|NCT03939806|Oxytocin|oxytocin|mesh-list
19327162|NCT03939806|Carbetocin|carbetocin|mesh-list
19327163|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
19327164|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19327165|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327166|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19327167|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327168|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327169|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674715|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674716|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674717|NCT04012827|Doxorubicin|doxorubicin|mesh-list
19674718|NCT04012827|Apatinib|apatinib|mesh-list
19674719|NCT04012827|Ifosfamide|ifosfamide|mesh-list
19674720|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19674721|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674722|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19674723|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19841596|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841597|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19841598|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
19841599|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841600|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841601|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19327170|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404822|NCT03591744|Ichthammol|ichthammol|mesh-list
19674724|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191366|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
19674725|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674726|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19674727|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19674728|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
19674729|NCT04008797|Lenvatinib|lenvatinib|mesh-list
20376041|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376042|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191367|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191368|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19327171|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327172|NCT03939273|Metronidazole|metronidazole|mesh-list
19327173|NCT03939273|Vancomycin|vancomycin|mesh-list
19327174|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
19327175|NCT03939273|Fluconazole|fluconazole|mesh-list
19327176|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327177|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19327178|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19327179|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19327180|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19327181|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19327182|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191369|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191370|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191371|NCT00220064|Antidotes|antidotes|mesh-ancestor
20191372|NCT00220064|Protective Agents|protective agents|mesh-ancestor
20191373|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
20191374|NCT00220064|Vitamins|vitamins|mesh-ancestor
20191375|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
19327183|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327184|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327185|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19327186|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19327187|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
19327188|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19327189|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19327190|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
19327191|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327192|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327193|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19327194|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19327195|NCT03938740|Insulin|insulin|mesh-list
19327196|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19327197|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
19327198|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
19327199|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19327200|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327201|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
19327202|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19674730|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674731|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19841602|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841603|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20191376|NCT00220103|Capecitabine|capecitabine|mesh-list
20191377|NCT00220103|Epirubicin|epirubicin|mesh-list
20191378|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191379|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191380|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
20191381|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191382|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20191383|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20191384|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191385|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191386|NCT00220116|Capecitabine|capecitabine|mesh-list
20191387|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
20191388|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191389|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
20191390|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191391|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191392|NCT00220129|Capecitabine|capecitabine|mesh-list
20191393|NCT00220129|Epirubicin|epirubicin|mesh-list
20191394|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376043|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
19674732|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841604|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217415|NCT00309556|Capecitabine|capecitabine|mesh-list
19327203|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
19327204|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191395|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191396|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
20191397|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327205|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
19327206|NCT03938883|Protective Agents|protective agents|mesh-ancestor
19398851|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19398852|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19398853|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398854|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19398855|NCT03639480|Amlodipine|amlodipine|mesh-list
19398856|NCT03639480|Valsartan|valsartan|mesh-list
19398857|NCT03639480|Atorvastatin|atorvastatin|mesh-list
19398858|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19398859|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19398860|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
19398861|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398862|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19398863|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19398864|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398865|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19398866|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19398867|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19398868|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19398869|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398870|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
19398871|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19398872|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19398873|NCT03639467|Gemcitabine|gemcitabine|mesh-list
19398874|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398875|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19398876|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
19398877|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398878|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
19398879|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398880|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19398881|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19398882|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
19398883|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398884|NCT03639428|Midazolam|midazolam|mesh-list
19398885|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19398886|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19398887|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398888|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398889|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19398890|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19398891|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19398892|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19398893|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
19398894|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
19398895|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
19398896|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
19398897|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398898|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398899|NCT03639415|Oxycodone|oxycodone|mesh-list
19398900|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19398901|NCT03639415|Narcotics|narcotics|mesh-ancestor
19398902|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398903|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398904|NCT03639415|Analgesics|analgesics|mesh-ancestor
19398905|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
19398906|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398907|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
19398908|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19398909|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19398910|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398911|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
19398912|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
19398913|NCT03639168|Cisplatin|cisplatin|mesh-list
19398914|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398915|NCT03639155|Glycine|glycine|mesh-list
19398916|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
19398917|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398918|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327207|NCT03938662|Choline|choline|mesh-list
19327208|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
19327209|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19327210|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
19327211|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327212|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327213|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19327214|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
19327215|NCT03938389|Valsartan|valsartan|mesh-list
19327216|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19327217|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20191398|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20191399|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20191400|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191401|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191402|NCT00220155|Gemcitabine|gemcitabine|mesh-list
20191403|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191404|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
20191405|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191406|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191407|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
20191408|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327218|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19327219|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20191409|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191410|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20191411|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
20191412|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191413|NCT00220168|Capecitabine|capecitabine|mesh-list
19674733|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674734|NCT03977194|Paclitaxel|paclitaxel|mesh-list
19674735|NCT03977194|Carboplatin|carboplatin|mesh-list
19674736|NCT03977194|Atezolizumab|atezolizumab|mesh-list
19674737|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20191414|NCT00220168|Irinotecan|irinotecan|mesh-list
20191415|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19327220|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327221|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19327222|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327223|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
19327224|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19327225|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19327226|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327227|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
20191416|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
20191417|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191418|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191419|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20191420|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191421|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191422|NCT00220194|Leuprolide|leuprolide|mesh-list
19327228|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327229|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327230|NCT03937843|Carboplatin|carboplatin|mesh-list
19327231|NCT03937843|Etoposide|etoposide|mesh-list
19327232|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327233|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19327234|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19327235|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19327236|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327237|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327238|NCT03938259|Fentanyl|fentanyl|mesh-list
19327239|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19327240|NCT03938259|Narcotics|narcotics|mesh-ancestor
19327241|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327242|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327243|NCT03938259|Analgesics|analgesics|mesh-ancestor
19327244|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
19327245|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327246|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19327247|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19327248|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
20191423|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20191424|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
19327249|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
19327250|NCT03937869|Secnidazole|secnidazole|mesh-list
19327251|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19327252|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19327253|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327254|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
19327255|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20191425|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20191426|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191427|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20191428|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191429|NCT00220220|Amlodipine|amlodipine|mesh-list
20191430|NCT00220220|Olmesartan|olmesartan|mesh-list
19327256|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327257|NCT03937687|Caffeine|caffeine|mesh-list
19327258|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19327259|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327260|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19327261|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327262|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327263|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19327264|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19674738|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674739|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
19674740|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
19674741|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
19674742|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674743|NCT03874091|Epinephrine|epinephrine|mesh-list
19674744|NCT03874091|Racepinephrine|racepinephrine|mesh-list
19674745|NCT03874091|Morphine|morphine|mesh-list
19674746|NCT03874091|Bupivacaine|bupivacaine|mesh-list
19327265|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
19327266|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327267|NCT03937609|Infliximab|infliximab|mesh-list
19327268|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
19327269|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327270|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19327271|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
19327272|NCT03937544|Fludarabine|fludarabine|mesh-list
19327273|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19327274|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
19327275|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327276|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19327277|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19327278|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
19327279|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327280|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327281|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19327282|NCT03937648|Lasmiditan|lasmiditan|mesh-list
19327283|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19327284|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
19327285|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191431|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20191432|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20191433|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20191434|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191435|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191436|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20191437|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191438|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
19327286|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327287|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327288|NCT03937401|Oxytocin|oxytocin|mesh-list
19327289|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
19327290|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19327291|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327292|NCT03937258|Probenecid|probenecid|mesh-list
19327293|NCT03937258|Abrocitinib|abrocitinib|mesh-list
20376044|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376045|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327294|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
19327295|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
19674747|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
19327296|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19327297|NCT03937258|Renal Agents|renal agents|mesh-ancestor
19674748|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
19327298|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19327299|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327300|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327301|NCT03936907|Nabiximols|nabiximols|mesh-list
19327302|NCT03936907|Analgesics|analgesics|mesh-ancestor
19327303|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
19327304|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327305|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327306|NCT03936777|Fenfluramine|fenfluramine|mesh-list
19327307|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19327308|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20376046|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20376047|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376048|NCT00997828|Everolimus|everolimus|mesh-list
20376049|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376050|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376051|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
20376052|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376053|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
20376054|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20376055|NCT00997880|Calcium|calcium|mesh-list
20376056|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20376057|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376058|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20376059|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20376060|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20376061|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
20376062|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376063|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20376064|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20376065|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376066|NCT00997906|Gemcitabine|gemcitabine|mesh-list
20376067|NCT00997906|Paclitaxel|paclitaxel|mesh-list
20376068|NCT00997906|Carboplatin|carboplatin|mesh-list
20376069|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20376070|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376071|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
20376072|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327309|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19327310|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327311|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327312|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
19327313|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327314|NCT03936517|Prednisolone|prednisolone|mesh-list
19327315|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
20376073|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376074|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376075|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20376076|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
20376077|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
19327316|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19327317|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
19327318|NCT03936517|Hormones|hormones|mesh-ancestor
19327319|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327320|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327321|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19327322|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327323|NCT03936491|Methylphenidate|methylphenidate|mesh-list
19327324|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19327325|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19327326|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327327|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19327328|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19327329|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19327330|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327331|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
19327332|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327333|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19327334|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398919|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398920|NCT03638960|Bupivacaine|bupivacaine|mesh-list
20376078|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376079|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376080|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376081|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
20376082|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327335|NCT03936426|Copper|copper|mesh-list
19327336|NCT03936426|Trace Elements|trace elements|mesh-ancestor
19327337|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
19327338|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327339|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19327340|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19327341|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327342|NCT03936062|Incretins|incretins|mesh-ancestor
19327343|NCT03936062|Hormones|hormones|mesh-ancestor
19327344|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327345|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19327346|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327347|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327348|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327349|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19327350|NCT03936374|Omeprazole|omeprazole|mesh-list
19327351|NCT03936374|Linrodostat|linrodostat|mesh-list
19327352|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19327353|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327354|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19327355|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327356|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327357|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
19327358|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19327359|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327360|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327361|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19327362|NCT03936205|Analgesics|analgesics|mesh-ancestor
19327363|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
19327364|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327365|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20191439|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20191440|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20191441|NCT00220233|Amlodipine|amlodipine|mesh-list
20191442|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20191443|NCT00220233|Olmesartan|olmesartan|mesh-list
20191444|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20191445|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20191446|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20376083|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20376084|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
20376085|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425982|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20191447|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191448|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191449|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20191450|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191451|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
20191452|NCT00220233|Diuretics|diuretics|mesh-ancestor
20191453|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
20191454|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20191455|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20191456|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20191457|NCT00220259|Fluticasone|fluticasone|mesh-list
20191458|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191459|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20191460|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
20425983|NCT01278186|Paclitaxel|paclitaxel|mesh-list
20425984|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20425985|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20425986|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
20425987|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
20425988|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
19327366|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19327367|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19327368|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19327369|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327370|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327371|NCT03936049|Liraglutide|liraglutide|mesh-list
19327372|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19327373|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19327374|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327375|NCT03936049|Incretins|incretins|mesh-ancestor
19327376|NCT03936049|Hormones|hormones|mesh-ancestor
19327377|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327378|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327379|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191461|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191462|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191463|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20191464|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
20191465|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
20191466|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19327380|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327381|NCT03936153|Abexinostat|abexinostat|mesh-list
20376086|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
20376087|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20376088|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376089|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20376090|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
20376091|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376092|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376093|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376094|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376095|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
20376096|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20376097|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376098|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376099|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20376100|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19327382|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19327383|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327384|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327385|NCT03936140|Iloprost|iloprost|mesh-list
19327386|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19327387|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
19327388|NCT03936036|Linagliptin|linagliptin|mesh-list
19327389|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20191467|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20191468|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
20191469|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191470|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
19327390|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327391|NCT03936036|Incretins|incretins|mesh-ancestor
20191471|NCT00220298|Testosterone|testosterone|mesh-list
20191472|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
20191473|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
20191474|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20191475|NCT00220298|Androgens|androgens|mesh-ancestor
19327392|NCT03936036|Hormones|hormones|mesh-ancestor
19327393|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327394|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19327395|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327396|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327397|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327398|NCT03936023|Saxagliptin|saxagliptin|mesh-list
19327399|NCT03936023|Incretins|incretins|mesh-ancestor
20191476|NCT00220298|Hormones|hormones|mesh-ancestor
20376101|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376102|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376103|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376104|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20376105|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
20376106|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20376107|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376108|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20376109|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20376110|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20376111|NCT00998036|Sirolimus|sirolimus|mesh-list
20376112|NCT00998036|Cisplatin|cisplatin|mesh-list
20376113|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20376114|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376115|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20191477|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376116|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376117|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376118|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376119|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376120|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20191478|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191479|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20191480|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191481|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
20191482|NCT00220311|Fludarabine|fludarabine|mesh-list
20191483|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
20191484|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191485|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191486|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
20191487|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191488|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20191489|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
19327400|NCT03936023|Hormones|hormones|mesh-ancestor
19327401|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327402|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327403|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20191490|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191491|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20191492|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20191493|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20191494|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20191495|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
20191496|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20191497|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376121|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
20376122|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376123|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
20191498|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20191499|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20191500|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20191501|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19674749|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
19674750|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191502|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20191503|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20191504|NCT00220337|Lacosamide|lacosamide|mesh-list
20191505|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
20191506|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20191507|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20376124|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376125|NCT00998075|Aspirin|aspirin|mesh-list
20376126|NCT00998075|Esomeprazole|esomeprazole|mesh-list
20376127|NCT00998075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376128|NCT00998075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376129|NCT00998075|Analgesics|analgesics|mesh-ancestor
20191508|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19327404|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327405|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674751|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191509|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191510|NCT00220350|Leuprolide|leuprolide|mesh-list
20191511|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20191512|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
20191513|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20191514|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191515|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20191516|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191517|NCT00220428|Vaccines|vaccines|mesh-list
20191518|NCT00220428|Immunologic Factors|immunologic factors|mesh-ancestor
20191519|NCT00220428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191520|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
20191521|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20191522|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20191523|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20191524|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191525|NCT00220480|Citalopram|citalopram|mesh-list
20191526|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19327406|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327407|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19327408|NCT03936010|Canagliflozin|canagliflozin|mesh-list
19327409|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19327410|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19327411|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327412|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376130|NCT00998075|Sensory System Agents|sensory system agents|mesh-ancestor
20376131|NCT00998075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376132|NCT00998075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376133|NCT00998075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376134|NCT00998075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376135|NCT00998075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20376136|NCT00998075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20376137|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376138|NCT00998075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20376139|NCT00998075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20376140|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376141|NCT00998075|Antipyretics|antipyretics|mesh-ancestor
20376142|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20376143|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376144|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20376145|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
20376146|NCT00998088|Hematinics|hematinics|mesh-ancestor
20376147|NCT00998101|Carboplatin|carboplatin|mesh-list
20376148|NCT00998101|Cetuximab|cetuximab|mesh-list
20376149|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376150|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20376151|NCT00998166|Bevacizumab|bevacizumab|mesh-list
20376152|NCT00998166|Pemetrexed|pemetrexed|mesh-list
20376153|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19327413|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327414|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327415|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327416|NCT03935685|Mirtazapine|mirtazapine|mesh-list
19327417|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
19327418|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19327419|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19327420|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
19327421|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
19327422|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327423|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327424|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674752|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
19674753|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674754|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19674755|NCT03874091|Narcotics|narcotics|mesh-ancestor
19674756|NCT03874091|Analgesics|analgesics|mesh-ancestor
19674757|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19674758|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19674759|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
19674760|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674761|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674762|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19674763|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19674764|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
19674765|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19674766|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
19674767|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
19674768|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
19674769|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19674770|NCT03773276|Norepinephrine|norepinephrine|mesh-list
19674771|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19674772|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19674773|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
19674774|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674775|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674776|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674777|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
19674778|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
19674779|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674780|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20376154|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612811|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
20376155|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20376156|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20376157|NCT00998166|Growth Substances|growth substances|mesh-ancestor
20376158|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376159|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
20376160|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376161|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376162|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20376163|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20376164|NCT00998192|Paclitaxel|paclitaxel|mesh-list
20376165|NCT00998192|Carboplatin|carboplatin|mesh-list
20376166|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20376167|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376168|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
20376169|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
20376170|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376171|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376172|NCT00998218|Ranolazine|ranolazine|mesh-list
20376173|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20376174|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376175|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376176|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20376177|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
20376178|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376179|NCT00998322|Gemcitabine|gemcitabine|mesh-list
20376180|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20376181|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
20376182|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376183|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376184|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
20376185|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376186|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376187|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376188|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
20376189|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376190|NCT00998439|Paclitaxel|paclitaxel|mesh-list
20376191|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20376192|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376193|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
20376194|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
20376195|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376196|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376197|NCT00998504|Resveratrol|resveratrol|mesh-list
20376198|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
19674781|NCT03738696|Bupivacaine|bupivacaine|mesh-list
19674782|NCT03738696|Ropivacaine|ropivacaine|mesh-list
19674783|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
19674784|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
19674785|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674786|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674787|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
19674788|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674789|NCT03712787|Tilavonemab|tilavonemab|mesh-list
19674790|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
19674791|NCT03704610|Infliximab|infliximab|mesh-list
19674792|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
19674793|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674794|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19674795|NCT03679650|Decitabine|decitabine|mesh-list
19674796|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674797|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
19674798|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674799|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674800|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327425|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19327426|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19327427|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327428|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19327429|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19327430|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20376199|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674801|NCT03662815|Molgramostim|molgramostim|mesh-list
19674802|NCT03662815|Sargramostim|sargramostim|mesh-list
19674803|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
20376200|NCT00998504|Protective Agents|protective agents|mesh-ancestor
20376201|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327431|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
19327432|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20376202|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376203|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20376204|NCT00998556|Bromocriptine|bromocriptine|mesh-list
20376205|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20376206|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20376207|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
20376208|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376209|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376210|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
20376211|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
19327433|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19327434|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
19327435|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19327436|NCT03935815|Ropivacaine|ropivacaine|mesh-list
19327437|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
19327438|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
19327439|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376212|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376213|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376214|NCT00998608|Risperidone|risperidone|mesh-list
20376215|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20376216|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
20376217|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376218|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376219|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327440|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327441|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
19327442|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327443|NCT03935984|Calcitonin|calcitonin|mesh-list
19327444|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
19327445|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19327446|NCT03935984|Katacalcin|katacalcin|mesh-list
19327447|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19327448|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376220|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20376221|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20376222|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376223|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20376224|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20376225|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
20376226|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
20376227|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
20376228|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20376229|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376230|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376231|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
20376232|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20376233|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376234|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376235|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20376236|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376237|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376238|NCT00998686|Incretins|incretins|mesh-ancestor
20376239|NCT00998686|Hormones|hormones|mesh-ancestor
20376240|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376241|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20376242|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
20376243|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376244|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376245|NCT00998816|Pregabalin|pregabalin|mesh-list
20376246|NCT00998816|Analgesics|analgesics|mesh-ancestor
20376247|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
20376248|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376249|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376250|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
20376251|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20376252|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376253|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376254|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20376255|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19327449|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19327450|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
19327451|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
20191527|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20191528|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191529|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327452|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327453|NCT03935646|Adderall|adderall|mesh-list
19327454|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19327455|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327456|NCT03935451|Apixaban|apixaban|mesh-list
19327457|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19327458|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
19327459|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19327460|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327461|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327462|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376256|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20376257|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376258|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20376259|NCT00998920|Equol|equol|mesh-list
20376260|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
20376261|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20376262|NCT00998920|Estrogens|estrogens|mesh-ancestor
20376263|NCT00998920|Hormones|hormones|mesh-ancestor
20376264|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376265|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376266|NCT00998933|Testosterone|testosterone|mesh-list
20376267|NCT00998933|Androgens|androgens|mesh-ancestor
20376268|NCT00998933|Hormones|hormones|mesh-ancestor
20376269|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376270|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376271|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
19327463|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
19327464|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
19327465|NCT03935152|Progestins|progestins|mesh-ancestor
19327466|NCT03935152|Hormones|hormones|mesh-ancestor
19327467|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327468|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327469|NCT03935139|Glycerol|glycerol|mesh-list
19327470|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19327471|NCT03935139|Protective Agents|protective agents|mesh-ancestor
19327472|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327473|NCT03935217|Secnidazole|secnidazole|mesh-list
19327474|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19327475|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19327476|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327477|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20376272|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20376273|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
20376274|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376275|NCT00998972|Expectorants|expectorants|mesh-ancestor
20376276|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
20376277|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19327478|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19327479|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20191530|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191531|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
20191532|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191533|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20191534|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
20191535|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191536|NCT00220493|Methylphenidate|methylphenidate|mesh-list
20191537|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20191538|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191539|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20191540|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20191541|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191542|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191543|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
20217416|NCT00309556|Trastuzumab|trastuzumab|mesh-list
20376278|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
19327480|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376279|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327481|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327482|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
19327483|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327484|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327485|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19327486|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327487|NCT03935074|Melphalan|melphalan|mesh-list
19327488|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19327489|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
19327490|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327491|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327492|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19327493|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19327494|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
19327495|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327496|NCT03935347|Vidarabine|vidarabine|mesh-list
19327497|NCT03935347|Aldesleukin|aldesleukin|mesh-list
19327498|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
19327499|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
19327500|NCT03935347|Fludarabine|fludarabine|mesh-list
19327501|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
19327502|NCT03935347|Interleukin-2|interleukin-2|mesh-list
19327503|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
19327504|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
19327505|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19327506|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
19327507|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327508|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19327509|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19327510|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
19327511|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327512|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327513|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19327514|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19327515|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19327516|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
19327517|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
19327518|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327519|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19327520|NCT03935347|Analgesics|analgesics|mesh-ancestor
19327521|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
19327522|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327523|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19327524|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19327525|NCT03935256|Paclitaxel|paclitaxel|mesh-list
19327526|NCT03935256|Carboplatin|carboplatin|mesh-list
19327527|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19327528|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327529|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19327530|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327531|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19327532|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327533|NCT03934710|Serotonin|serotonin|mesh-list
19327534|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
19327535|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
19327536|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327537|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327538|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398921|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
19398922|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
19398923|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398924|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398925|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
19398926|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398927|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
19398928|NCT03638947|Povidone|povidone|mesh-list
19398929|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
20612812|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
19398930|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
19398931|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19398932|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19398933|NCT03638869|Methadone|methadone|mesh-list
19398934|NCT03638869|D-methadone|d-methadone|mesh-list
19398935|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19674804|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398936|NCT03638869|Narcotics|narcotics|mesh-ancestor
19404823|NCT03591744|BB 1101|bb 1101|mesh-list
20376280|NCT00998972|Protective Agents|protective agents|mesh-ancestor
20376281|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327539|NCT03934450|Primaquine|primaquine|mesh-list
19327540|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
19327541|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19327542|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20191544|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191545|NCT00220506|Modafinil|modafinil|mesh-list
20191546|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20191547|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191548|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20191549|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20191550|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20191551|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191552|NCT00220532|Folic Acid|folic acid|mesh-list
20191553|NCT00220532|Riboflavin|riboflavin|mesh-list
20191554|NCT00220532|Hematinics|hematinics|mesh-ancestor
20191555|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
20191556|NCT00220532|Vitamins|vitamins|mesh-ancestor
20191557|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
20376282|NCT00998972|Antidotes|antidotes|mesh-ancestor
20376283|NCT00999128|Rabeprazole|rabeprazole|mesh-list
20376284|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20376285|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376286|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20376287|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191558|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191559|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20191560|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
20376288|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376289|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
20376290|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20376291|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20376292|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20376293|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376294|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376295|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
20376296|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376297|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376298|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20376299|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376300|NCT00999206|Vaccines|vaccines|mesh-list
20376301|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
20376302|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191561|NCT00220584|Donepezil|donepezil|mesh-list
20191562|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20191563|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191564|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191565|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
20191566|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376303|NCT00999219|Zolpidem|zolpidem|mesh-list
20376304|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20376305|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20376306|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376307|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376308|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20376309|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
20376310|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
20376311|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376312|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376313|NCT00999232|Erythromycin|erythromycin|mesh-list
20376314|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
20376315|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20376316|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
20376317|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20191567|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191568|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
20191569|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
20191570|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191571|NCT00220649|Leucovorin|leucovorin|mesh-list
19327543|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327544|NCT03934411|Tramadol|tramadol|mesh-list
19327545|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20191572|NCT00220649|Gemcitabine|gemcitabine|mesh-list
20191573|NCT00220649|Fluorouracil|fluorouracil|mesh-list
19327546|NCT03934411|Narcotics|narcotics|mesh-ancestor
19327547|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191574|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
19327548|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327549|NCT03934411|Analgesics|analgesics|mesh-ancestor
19327550|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
19327551|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327552|NCT03934216|BMS-986165|bms-986165|mesh-list
19327553|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
19327554|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19327555|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327556|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327557|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
19327558|NCT03934203|BI 409306|bi 409306|mesh-list
19327559|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19327560|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327561|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19327562|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19327563|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327564|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327565|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327566|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19327567|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
19327568|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19327569|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19327570|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327571|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
19327572|NCT03934047|Coagulants|coagulants|mesh-ancestor
19327573|NCT03934294|Metoclopramide|metoclopramide|mesh-list
19327574|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
19327575|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
19327576|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327577|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327578|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327579|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19327580|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19327581|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
19327582|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327583|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327584|NCT03933956|Empagliflozin|empagliflozin|mesh-list
19327585|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19327586|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327587|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19327588|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327589|NCT03934333|Budesonide|budesonide|mesh-list
19327590|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19327591|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19327592|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
19327593|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327594|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327595|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19327596|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
19327597|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
19327598|NCT03934333|Hormones|hormones|mesh-ancestor
19327599|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327600|NCT03933982|Vinorelbine|vinorelbine|mesh-list
19327601|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19674805|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674806|NCT03645148|Molgramostim|molgramostim|mesh-list
20191575|NCT00220649|Irinotecan|irinotecan|mesh-list
20191576|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20191577|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
20191578|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191579|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191580|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
20191581|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191582|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191583|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20191584|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
20191585|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191586|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20191587|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20191588|NCT00220649|Antidotes|antidotes|mesh-ancestor
20191589|NCT00220649|Protective Agents|protective agents|mesh-ancestor
20191590|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
20191591|NCT00220649|Vitamins|vitamins|mesh-ancestor
20191592|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
19327602|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327603|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19327604|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327605|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376318|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376319|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376320|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20376321|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376322|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376323|NCT00999258|Sirolimus|sirolimus|mesh-list
20376324|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376325|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376326|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20376327|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376328|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
20376329|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376330|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
20376331|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376332|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20376333|NCT00999271|Hormones|hormones|mesh-list
20376334|NCT00999271|Incretins|incretins|mesh-list
20376335|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376336|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376337|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376338|NCT00999297|Capsaicin|capsaicin|mesh-list
20376339|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
20376340|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
20376341|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
19327606|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327607|NCT03933865|Ketamine|ketamine|mesh-list
19327608|NCT03933865|Hydromorphone|hydromorphone|mesh-list
19327609|NCT03933865|Analgesics|analgesics|mesh-ancestor
19327610|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
19327611|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327612|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327613|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19327614|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19327615|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
19327616|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
19327617|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327618|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19327619|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19327620|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327621|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327622|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19327623|NCT03933865|Narcotics|narcotics|mesh-ancestor
19327624|NCT03933631|Ofloxacin|ofloxacin|mesh-list
19841605|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
19841606|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841607|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19841608|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19841609|NCT00642460|Analgesics|analgesics|mesh-ancestor
19841610|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
19841611|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841612|NCT00642473|Metronidazole|metronidazole|mesh-list
19841613|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19841614|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841615|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19841616|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191593|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
20191594|NCT00220675|Hematinics|hematinics|mesh-ancestor
20191595|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
20191596|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191597|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191598|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191599|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191600|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
20191601|NCT00220766|Antibodies|antibodies|mesh-list
20191602|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
20191603|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20191604|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20191605|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
20191606|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
20191607|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191608|NCT00220818|Lansoprazole|lansoprazole|mesh-list
20191609|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
20376342|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376343|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376344|NCT00999336|Betrixaban|betrixaban|mesh-list
20376345|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20376346|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
20376347|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20376348|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
20191610|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19327625|NCT03933631|Prednisolone|prednisolone|mesh-list
19327626|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
19327627|NCT03933631|Pilocarpine|pilocarpine|mesh-list
19327628|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19327629|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
19327630|NCT03933631|Hormones|hormones|mesh-ancestor
19327631|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376349|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376350|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376351|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
20376352|NCT00999349|Silymarin|silymarin|mesh-list
20376353|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
20376354|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376355|NCT00999349|Protective Agents|protective agents|mesh-ancestor
20376356|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376357|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
20376358|NCT00999427|Povidone|povidone|mesh-list
20376359|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
20376360|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
20376361|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20376362|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327632|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327633|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19327634|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327635|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
19327636|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327637|NCT03933631|Miotics|miotics|mesh-ancestor
19327638|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19327639|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19327640|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
19327641|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327642|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327643|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19327644|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327645|NCT03933631|Renal Agents|renal agents|mesh-ancestor
19327646|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19327647|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20191611|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20191612|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19327648|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19327649|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327650|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19327651|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19327652|NCT03933787|Saxagliptin|saxagliptin|mesh-list
19327653|NCT03933787|Incretins|incretins|mesh-ancestor
19327654|NCT03933787|Hormones|hormones|mesh-ancestor
19327655|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327656|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327657|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19327658|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
19327659|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327660|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327661|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19327662|NCT03933748|Teicoplanin|teicoplanin|mesh-list
19327663|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20191613|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191614|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191615|NCT00220831|Vitamin E|vitamin e|mesh-list
20191616|NCT00220831|Vitamins|vitamins|mesh-ancestor
20191617|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
20191618|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191619|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
20191620|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191621|NCT00220831|Protective Agents|protective agents|mesh-ancestor
20376363|NCT00999440|Methadone|methadone|mesh-list
20376364|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20376365|NCT00999440|Narcotics|narcotics|mesh-ancestor
20428611|NCT01292720|Vitamin D|vitamin d|mesh-list
20376366|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841617|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376367|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376368|NCT00999440|Analgesics|analgesics|mesh-ancestor
20376369|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
19327664|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327665|NCT03933501|Amoxicillin|amoxicillin|mesh-list
19327666|NCT03933501|Metronidazole|metronidazole|mesh-list
19327667|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19327668|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327669|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19327670|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20191622|NCT00220844|Amitriptyline|amitriptyline|mesh-list
20191623|NCT00220844|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20191624|NCT00220844|Desipramine|desipramine|mesh-list
20191625|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20191626|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
20191627|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191628|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191629|NCT00220844|Analgesics|analgesics|mesh-ancestor
20376370|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327680|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
19327681|NCT03933280|Nalbuphine|nalbuphine|mesh-list
19327682|NCT03933280|Propofol|propofol|mesh-list
19327683|NCT03933280|Benoxinate|benoxinate|mesh-list
19327684|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19327685|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
19327686|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327687|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327688|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19327689|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19327690|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
19327691|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19327692|NCT03933280|Analgesics|analgesics|mesh-ancestor
19327693|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
19327694|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327695|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19327696|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19327697|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19327698|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
19327699|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327700|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376371|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
20376372|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
19327701|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19327702|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19327703|NCT03933280|Narcotics|narcotics|mesh-ancestor
19327704|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
19327705|NCT03933605|Midazolam|midazolam|mesh-list
19327706|NCT03933605|Palonosetron|palonosetron|mesh-list
19327707|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19327708|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19327709|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376373|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
19327710|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327711|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19674807|NCT03645148|Sargramostim|sargramostim|mesh-list
19674808|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
19327712|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19674809|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674810|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674811|NCT03612921|Amantadine|amantadine|mesh-list
19674812|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19674813|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19674814|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
19674815|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19674816|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
19674817|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674818|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674819|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674820|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19674821|NCT03612921|Analgesics|analgesics|mesh-ancestor
19327713|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841618|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327714|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19327715|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
19674822|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
20191630|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
20191631|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376374|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20376375|NCT00999479|Norethindrone|norethindrone|mesh-list
20376376|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
20376377|NCT00999479|Estradiol|estradiol|mesh-list
20376378|NCT00999479|Estrogens|estrogens|mesh-ancestor
19327716|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
19327717|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
19327718|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
19327719|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327720|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327721|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
19327722|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
19327723|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327724|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327725|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19327726|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19327727|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
19327728|NCT03933293|Ezetimibe|ezetimibe|mesh-list
19327729|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19327730|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19327731|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
19327732|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327733|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19327734|NCT03933345|Naloxone|naloxone|mesh-list
19327735|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19327736|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327737|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
20191632|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327738|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327739|NCT03933358|Hormones|hormones|mesh-list
19327740|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327741|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327742|NCT03933319|Doxorubicin|doxorubicin|mesh-list
19327743|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19327744|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19327745|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327746|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19327747|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19327748|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327749|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327750|NCT03932916|Donepezil|donepezil|mesh-list
19327751|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19327752|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376379|NCT00999479|Hormones|hormones|mesh-ancestor
20376380|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376381|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376382|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19327753|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327754|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
19327755|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327756|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327757|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
19327758|NCT03932864|Plerixafor|plerixafor|mesh-list
19327759|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19674823|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674824|NCT03603808|Vaccines|vaccines|mesh-list
19674825|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
19674826|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674827|NCT03534453|Olaparib|olaparib|mesh-list
19674828|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19674829|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674830|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674831|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674832|NCT03501576|Vaccines|vaccines|mesh-list
19674833|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
20191633|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20191634|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20191635|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191636|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191637|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
20191638|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191639|NCT00220844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20376383|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
19327760|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19327761|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
19327762|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327763|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
19327764|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19327765|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
19327766|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
19327767|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327768|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191640|NCT00220844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191641|NCT00220844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191642|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191643|NCT00220857|Rabeprazole|rabeprazole|mesh-list
20191644|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20191645|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20191646|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20376384|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20376385|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20376386|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20376387|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20376388|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20376389|NCT00999479|Trace Elements|trace elements|mesh-ancestor
20376390|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
20376391|NCT00999505|Amantadine|amantadine|mesh-list
20376392|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20191647|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191648|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191649|NCT00220896|Donepezil|donepezil|mesh-list
19327769|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19327770|NCT03932825|Analgesics|analgesics|mesh-ancestor
19327771|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
19327772|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327773|NCT03932981|Temozolomide|temozolomide|mesh-list
19327774|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19327775|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
19327776|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327777|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327778|NCT03933098|Vaccines|vaccines|mesh-list
19327779|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
19327780|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327781|NCT03932578|Atropine|atropine|mesh-list
19327782|NCT03932578|Metoclopramide|metoclopramide|mesh-list
19327783|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19327784|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19327785|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19327786|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
19327787|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327788|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327789|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19327790|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
19327791|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
19327792|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
19327793|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20191650|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20376393|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20376394|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
20376395|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376396|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
20376397|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376398|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376399|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376400|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376401|NCT00999505|Analgesics|analgesics|mesh-ancestor
19327794|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19327795|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
19327796|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327797|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327798|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
19327799|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327800|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20376402|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
20376403|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376404|NCT00999557|Bimatoprost|bimatoprost|mesh-list
20376405|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20612813|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191651|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376406|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20376407|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20425989|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20425990|NCT01278238|Phenylephrine|phenylephrine|mesh-list
20425991|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
20425992|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20425993|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
20425994|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
20425995|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20425996|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20425997|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
20425998|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20425999|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
20426000|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
20426001|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20426002|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20426003|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20426004|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
20426005|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426006|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426007|NCT01278238|Protective Agents|protective agents|mesh-ancestor
20426008|NCT01278264|Ropivacaine|ropivacaine|mesh-list
20426009|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
20426010|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
20426011|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426012|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426013|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
20426014|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426015|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20426016|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19327801|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19327802|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
20191652|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191653|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
19327803|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
19327804|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19398937|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398938|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398939|NCT03638869|Analgesics|analgesics|mesh-ancestor
19398940|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
19398941|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398942|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
19398943|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398944|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19398945|NCT03638856|Misoprostol|misoprostol|mesh-list
19398946|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19398947|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
19398948|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19398949|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398950|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19398951|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19398952|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
19398953|NCT03638726|Atropine|atropine|mesh-list
19398954|NCT03638726|Phenylephrine|phenylephrine|mesh-list
19398955|NCT03638726|Epinephrine|epinephrine|mesh-list
19398956|NCT03638726|Racepinephrine|racepinephrine|mesh-list
19398957|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
19398958|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
19398959|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
19398960|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19398961|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19398962|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
19398963|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19398964|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191654|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191655|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191656|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
20191657|NCT00220909|Lansoprazole|lansoprazole|mesh-list
20191658|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
20191659|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20191660|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20191661|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19398965|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398966|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19398967|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19398968|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
20376408|NCT00999700|Cisplatin|cisplatin|mesh-list
20376409|NCT00999700|Docetaxel|docetaxel|mesh-list
20376410|NCT00999700|Fluorouracil|fluorouracil|mesh-list
19327805|NCT03932721|Evolocumab|evolocumab|mesh-list
19327806|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19327807|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19327808|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
19327809|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327810|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19327811|NCT03932292|Calcium|calcium|mesh-list
19327812|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19327813|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327814|NCT03932409|Paclitaxel|paclitaxel|mesh-list
19327815|NCT03932409|Carboplatin|carboplatin|mesh-list
19327816|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
19327817|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19327818|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327819|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
19327820|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327821|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
19327822|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327823|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19327824|NCT03932526|Apatinib|apatinib|mesh-list
19327825|NCT03932526|Vinorelbine|vinorelbine|mesh-list
19327826|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327827|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19327828|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327829|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327830|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19327831|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
19327832|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327833|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
19327834|NCT03932123|Vancomycin|vancomycin|mesh-list
19327835|NCT03932123|Meropenem|meropenem|mesh-list
19327836|NCT03932123|Tazobactam|tazobactam|mesh-list
19327837|NCT03932123|Piperacillin|piperacillin|mesh-list
19327838|NCT03932123|Cefotaxime|cefotaxime|mesh-list
19327839|NCT03932123|Cefoxitin|cefoxitin|mesh-list
19327840|NCT03932123|Azlocillin|azlocillin|mesh-list
19327841|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19327842|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19327843|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19327844|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327845|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327846|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19327847|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19327848|NCT03932266|Docetaxel|docetaxel|mesh-list
19327849|NCT03932266|Endostar protein|endostar protein|mesh-list
19674834|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692244|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692245|NCT04994860|Urological Agents|urological agents|mesh-ancestor
20191662|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692246|NCT04994626|Rituximab|rituximab|mesh-list
19692247|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19692248|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692249|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
19692250|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191663|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191664|NCT00220922|Ethanol|ethanol|mesh-list
19692251|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692252|NCT04994743|Cortisone|cortisone|mesh-list
20191665|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20191666|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191667|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191668|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191669|NCT00220987|Insulin|insulin|mesh-list
20191670|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20191671|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376411|NCT00999700|Cetuximab|cetuximab|mesh-list
19327850|NCT03932266|Endostatins|endostatins|mesh-list
19327851|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376412|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327852|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
19327853|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
19327854|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
19327855|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692253|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376413|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
19327856|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19327857|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19327858|NCT03932266|Growth Substances|growth substances|mesh-ancestor
19327859|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327860|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
19327861|NCT03931915|Leuprolide|leuprolide|mesh-list
19327862|NCT03931915|Relugolix|relugolix|mesh-list
19327863|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19327864|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
19327865|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19327866|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327867|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19327868|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327869|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
19327870|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
19327871|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327872|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
19327873|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19674835|NCT03490903|Fentanyl|fentanyl|mesh-list
19674836|NCT03490903|Midazolam|midazolam|mesh-list
19674837|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19674838|NCT03490903|Narcotics|narcotics|mesh-ancestor
19327874|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327875|NCT03931668|Maleic acid|maleic acid|mesh-list
19327876|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327877|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674839|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191672|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191673|NCT00221000|Methoxsalen|methoxsalen|mesh-list
20191674|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20191675|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
20191676|NCT00221026|Methoxsalen|methoxsalen|mesh-list
20191677|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20191678|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
20191679|NCT00221039|Methoxsalen|methoxsalen|mesh-list
20191680|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20191681|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
20191682|NCT00221052|Diclofenac|diclofenac|mesh-list
20191683|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20191684|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191685|NCT00221052|Analgesics|analgesics|mesh-ancestor
20191686|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
20191687|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191688|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191689|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191690|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20191691|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20191692|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191693|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217417|NCT00309556|Epirubicin|epirubicin|mesh-list
20217418|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217419|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
20217420|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20217421|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
20217422|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217423|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20217424|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
20217425|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20217426|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20217427|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20217428|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217429|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217430|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
20217431|NCT00309569|Fluorouracil|fluorouracil|mesh-list
20217432|NCT00309569|Methotrexate|methotrexate|mesh-list
20217433|NCT00309569|Epirubicin|epirubicin|mesh-list
20217434|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217435|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
20217436|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217437|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20217438|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20217439|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
20217440|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217441|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327878|NCT03931863|Ondansetron|ondansetron|mesh-list
19327879|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
19327880|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
19327881|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327882|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327883|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20191694|NCT00221156|Acarbose|acarbose|mesh-list
20191695|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20191696|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191697|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191698|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376414|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
20376415|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376416|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376417|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
20376418|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20376419|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376420|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
19327884|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
19327885|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
19327886|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19327887|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
19327888|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327889|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327890|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19327891|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19327892|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327893|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19327894|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19674840|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674841|NCT03490903|Analgesics|analgesics|mesh-ancestor
19674842|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
19674843|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674844|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19674845|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19674846|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
19841619|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19841620|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19841621|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19327895|NCT03931928|Tamoxifen|tamoxifen|mesh-list
19674847|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
20191699|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191700|NCT00221260|Anesthetics|anesthetics|mesh-list
20191701|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191702|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191703|NCT00221286|Interferons|interferons|mesh-list
20191704|NCT00221286|Tenofovir|tenofovir|mesh-list
20191705|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
20191706|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
20191707|NCT00221286|Emtricitabine|emtricitabine|mesh-list
20191708|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20191709|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191710|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
20191711|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191712|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20191713|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20191714|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191715|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191716|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19674848|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19841622|NCT00642616|Insulin|insulin|mesh-list
19841623|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841624|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841625|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
19841626|NCT00642668|Hematinics|hematinics|mesh-ancestor
19841627|NCT00642694|Dexetimide|dexetimide|mesh-list
19841628|NCT00642694|Citalopram|citalopram|mesh-list
19841629|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19841630|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19841631|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19841632|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841633|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841634|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
19841635|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841636|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19841637|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
20376421|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376422|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20376423|NCT00999739|Vaccines|vaccines|mesh-list
20376424|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20376425|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
20376426|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376427|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19327896|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19327897|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
19327898|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327899|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327900|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19327901|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327902|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19327903|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19327904|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20191717|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20191718|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
19327905|NCT03931889|Vitamin D|vitamin d|mesh-list
19327906|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
19327907|NCT03931889|Vitamins|vitamins|mesh-ancestor
20376428|NCT00999752|Nebivolol|nebivolol|mesh-list
20376429|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20376430|NCT00999752|Diuretics|diuretics|mesh-ancestor
20376431|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
20376432|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376433|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20376434|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376435|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376436|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
20376437|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20376438|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20376439|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20376440|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
20376441|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376442|NCT00999791|Diclofenac|diclofenac|mesh-list
20376443|NCT00999791|Bevacizumab|bevacizumab|mesh-list
20376444|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20376445|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327908|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
19327909|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327910|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19327911|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20191719|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191720|NCT00221312|Alendronate|alendronate|mesh-list
20191721|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20191722|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191723|NCT00221325|Rituximab|rituximab|mesh-list
20191724|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20191725|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191726|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
20191727|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191728|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20191729|NCT00221364|Azithromycin|azithromycin|mesh-list
20191730|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20191731|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191732|NCT00221390|Ropinirole|ropinirole|mesh-list
20191733|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20191734|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20191735|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
20191736|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
20376446|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20376447|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19327912|NCT03931343|Epinephrine|epinephrine|mesh-list
19327913|NCT03931343|Racepinephrine|racepinephrine|mesh-list
19674849|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19327914|NCT03931343|Bupivacaine|bupivacaine|mesh-list
19327915|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
19327916|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
19327917|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
19327918|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327919|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327920|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
19327921|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191737|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327922|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19327923|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20191738|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191739|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191740|NCT00221416|Aripiprazole|aripiprazole|mesh-list
20191741|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
20191742|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19327924|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
20376448|NCT00999791|Growth Substances|growth substances|mesh-ancestor
20376449|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376450|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
20376451|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376452|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376453|NCT00999791|Analgesics|analgesics|mesh-ancestor
20376454|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
20376455|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376456|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376457|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376458|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20376459|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327925|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327926|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327927|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19327928|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19327929|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
19327930|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19327931|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
19327932|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
19327933|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
19327934|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19327935|NCT03931239|Vaccines|vaccines|mesh-list
19327936|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
19327937|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327938|NCT03931317|Timolol|timolol|mesh-list
19327939|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20191743|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20191744|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191745|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191746|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191747|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
20191748|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
20376460|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376461|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
19327940|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19327941|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
19327942|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376462|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
20376463|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
20376464|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20376465|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20376466|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376467|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376468|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376469|NCT00999843|Sorafenib|sorafenib|mesh-list
20376470|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376471|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20376472|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376473|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376474|NCT00999869|Triamcinolone|triamcinolone|mesh-list
20376475|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20376476|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20376477|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
20376478|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20376479|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20376480|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20376481|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20376482|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376483|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376484|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
20376485|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327943|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327944|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327945|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19327946|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19327947|NCT03931135|Dexamethasone|dexamethasone|mesh-list
19327948|NCT03931135|Morphine|morphine|mesh-list
19327949|NCT03931135|Cyclizine|cyclizine|mesh-list
19327950|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19327951|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
20191749|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191750|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191751|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19327952|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
19674850|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19674851|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19674852|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
19674853|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
19674854|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674855|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327953|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327954|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327955|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19327956|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
20191752|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20191753|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
20191754|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20191755|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20191756|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20191757|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20191758|NCT00221429|Valproic Acid|valproic acid|mesh-list
20191759|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191760|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191761|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674856|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
19674857|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19674858|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
19674859|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191762|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
20376486|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191763|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191764|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376487|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376488|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
20376489|NCT00999869|Hormones|hormones|mesh-ancestor
20376490|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376491|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376492|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
20376493|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191765|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327957|NCT03931135|Hormones|hormones|mesh-ancestor
19327958|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19327959|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19327960|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19327961|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19327962|NCT03931135|Narcotics|narcotics|mesh-ancestor
19327963|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19327964|NCT03931135|Analgesics|analgesics|mesh-ancestor
19327965|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
19327966|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19327967|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
19327968|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
20376494|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20376495|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376496|NCT00999973|Mitomycins|mitomycins|mesh-list
20376497|NCT00999973|Mitomycin|mitomycin|mesh-list
20376498|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19327969|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19327970|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327971|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
20191766|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
20191767|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
20191768|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191769|NCT00221442|Zonisamide|zonisamide|mesh-list
20191770|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
19327972|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20191771|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19674860|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
20191772|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376499|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376500|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
20376501|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376502|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20376503|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376504|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
20376505|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376506|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
20376507|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376508|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376509|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20376510|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
20376511|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376512|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376513|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20376514|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20376515|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
20376516|NCT01000116|Coagulants|coagulants|mesh-ancestor
20376517|NCT01000220|Omeprazole|omeprazole|mesh-list
20376518|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20376519|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376520|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20376521|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376522|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376523|NCT01000233|Inositol|inositol|mesh-list
20376524|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
20376525|NCT01000233|Vitamins|vitamins|mesh-ancestor
19327973|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327974|NCT03931369|Tolvaptan|tolvaptan|mesh-list
19327975|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19327976|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327977|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
19327978|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327979|NCT03930875|Aspirin|aspirin|mesh-list
19327980|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19327981|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19327982|NCT03930875|Analgesics|analgesics|mesh-ancestor
19327983|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
19327984|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19327985|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19327986|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19327987|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19327988|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19327989|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19327990|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19327991|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19327992|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19327993|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19327994|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
19327995|NCT03931161|Evolocumab|evolocumab|mesh-list
19327996|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19327997|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19327998|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
19674861|NCT03200288|Protective Agents|protective agents|mesh-ancestor
19674862|NCT03164772|Durvalumab|durvalumab|mesh-list
19674863|NCT03164772|Tremelimumab|tremelimumab|mesh-list
19674864|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674865|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674866|NCT03132532|Paclitaxel|paclitaxel|mesh-list
20191773|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191774|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20191775|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191776|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20191777|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
20191778|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191779|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20191780|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191781|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191782|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191783|NCT00221481|Valproic Acid|valproic acid|mesh-list
20191784|NCT00221481|Olanzapine|olanzapine|mesh-list
19674867|NCT03132532|Carboplatin|carboplatin|mesh-list
19674868|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19674869|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376526|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
20376527|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841638|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841639|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19841640|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19841641|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
19841642|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
19841643|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841644|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19841645|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19841646|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
19841647|NCT00642707|Leronlimab|leronlimab|mesh-list
19841648|NCT00642707|Antibodies|antibodies|mesh-list
19327999|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328000|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19398969|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398970|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19398971|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
19398972|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
19398973|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
19398974|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19398975|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19398976|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
19398977|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19398978|NCT03638726|Protective Agents|protective agents|mesh-ancestor
19398979|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19398980|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19398981|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
19398982|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19398983|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19398984|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
19398985|NCT03638648|Capecitabine|capecitabine|mesh-list
19398986|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19398987|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
19398988|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19398989|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398990|NCT03638440|Naloxegol|naloxegol|mesh-list
19398991|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19398992|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19398993|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
19398994|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19398995|NCT03638401|Morphine|morphine|mesh-list
19674870|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
19674871|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
19674872|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
19674873|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674874|NCT03122496|Durvalumab|durvalumab|mesh-list
19674875|NCT03122496|Tremelimumab|tremelimumab|mesh-list
19674876|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674877|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19398996|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19398997|NCT03638401|Narcotics|narcotics|mesh-ancestor
19398998|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19398999|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399000|NCT03638401|Analgesics|analgesics|mesh-ancestor
19399001|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
19399002|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399003|NCT03638375|Interferons|interferons|mesh-list
19399004|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
19399005|NCT03638375|Nivolumab|nivolumab|mesh-list
19399006|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674878|NCT03066739|Remifentanil|remifentanil|mesh-list
19841649|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19841650|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
19841651|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841652|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19841653|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19841654|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841655|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20191785|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
20191786|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
20191787|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191788|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191789|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674879|NCT03066739|Naloxone|naloxone|mesh-list
19674880|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19674881|NCT03066739|Narcotics|narcotics|mesh-ancestor
19841656|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20191790|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20376528|NCT01000298|Amoxicillin|amoxicillin|mesh-list
20376529|NCT01000298|Cefdinir|cefdinir|mesh-list
20376530|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376531|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376532|NCT01000415|Cisplatin|cisplatin|mesh-list
20376533|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376534|NCT01000441|Adalimumab|adalimumab|mesh-list
20376535|NCT01000441|Etanercept|etanercept|mesh-list
20376536|NCT01000441|Rituximab|rituximab|mesh-list
20376537|NCT01000441|Abatacept|abatacept|mesh-list
20376538|NCT01000441|Infliximab|infliximab|mesh-list
19674882|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674883|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674884|NCT03066739|Analgesics|analgesics|mesh-ancestor
19674885|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
19674886|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674887|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19674888|NCT03061474|Niacinamide|niacinamide|mesh-list
20191791|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191792|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376539|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20376540|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376541|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
20376542|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376543|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376544|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376545|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
20376546|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376547|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376548|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376549|NCT01000441|Analgesics|analgesics|mesh-ancestor
20376550|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
20376551|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376552|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376553|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20376554|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376555|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
20376556|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
20376557|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20376558|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
20376559|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376560|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20376561|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20376562|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20376563|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376564|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376565|NCT01000597|Fluticasone|fluticasone|mesh-list
20376566|NCT01000597|Xhance|xhance|mesh-list
20376567|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376568|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20376569|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
20376570|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376571|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376572|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20376573|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
20376574|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
20376575|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19328001|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19328002|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19328003|NCT03930706|Estradiol|estradiol|mesh-list
19328004|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19328005|NCT03930706|Estrogens|estrogens|mesh-ancestor
19328006|NCT03930706|Hormones|hormones|mesh-ancestor
20191793|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191794|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20191795|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20191796|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191797|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191798|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191799|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
20191800|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
20376576|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19674889|NCT03061474|Niacin|niacin|mesh-list
20376577|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19328007|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19674890|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
19674891|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
19674892|NCT03061474|Vitamins|vitamins|mesh-ancestor
19674893|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
19674894|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674895|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19674896|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
19674897|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674898|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19674899|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
19674900|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
19674901|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674902|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674903|NCT02963831|Durvalumab|durvalumab|mesh-list
19674904|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674905|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674906|NCT02929485|Bromocriptine|bromocriptine|mesh-list
19674907|NCT02929485|Tolcapone|tolcapone|mesh-list
19674908|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19674909|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19674910|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
20191801|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191802|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
20191803|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
20191804|NCT00221494|Pindolol|pindolol|mesh-list
20191805|NCT00221494|Citalopram|citalopram|mesh-list
20191806|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20191807|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20191808|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191809|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191810|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674911|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19674912|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674913|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
19674914|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
19674915|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674916|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674917|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19674918|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674919|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
19674920|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19674921|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19674922|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19674923|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
19674924|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674925|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674926|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674927|NCT02849639|Scopolamine|scopolamine|mesh-list
19674928|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19674929|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20191811|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
20191812|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191813|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20191814|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
20191815|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191816|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20191817|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20191818|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
20191819|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20191820|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20191821|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
20191822|NCT00221520|Midazolam|midazolam|mesh-list
20191823|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20191824|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20191825|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191826|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191827|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20191828|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191829|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19328008|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328009|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19328010|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
19328011|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19328012|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19328013|NCT03930433|Nebivolol|nebivolol|mesh-list
19328014|NCT03930433|Diltiazem|diltiazem|mesh-list
19328015|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19328016|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
19328017|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19328018|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19328019|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19328020|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19328021|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191830|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20191831|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
20376578|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20376579|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20376580|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376581|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376582|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376583|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20376584|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
20376585|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20376586|NCT01000688|Vildagliptin|vildagliptin|mesh-list
20376587|NCT01000688|Acarbose|acarbose|mesh-list
20376588|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376589|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376590|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20376591|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
20376592|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376593|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376594|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20376595|NCT01000779|Propranolol|propranolol|mesh-list
20376596|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20376597|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20376598|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
20376599|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376600|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376601|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376602|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20191832|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
20191833|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
20191834|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
20376603|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20376604|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
20376605|NCT01000792|Cetirizine|cetirizine|mesh-list
20376606|NCT01000792|Levocetirizine|levocetirizine|mesh-list
20376607|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20376608|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20191835|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191836|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328022|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674930|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
20191837|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
20191838|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19674931|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
19674932|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674933|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376609|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
20376610|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
20376611|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376612|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376613|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376614|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20376615|NCT01000831|Vaccines|vaccines|mesh-list
20376616|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
19674934|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674935|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
19674936|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19674937|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
20376617|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376618|NCT01000857|Paroxetine|paroxetine|mesh-list
20376619|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20376620|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19674938|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376621|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426017|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
19328023|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191839|NCT00221611|Baclofen|baclofen|mesh-list
20191840|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20376622|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191841|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191842|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20191843|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191844|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20191845|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
20191846|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
20191847|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191848|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191849|NCT00221624|Ribavirin|ribavirin|mesh-list
20191850|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20191851|NCT00221624|Amantadine|amantadine|mesh-list
20376623|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376624|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
20376625|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376626|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20376627|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
20376628|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20376629|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20376630|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20376631|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376632|NCT01000896|Paclitaxel|paclitaxel|mesh-list
20376633|NCT01000896|Carboplatin|carboplatin|mesh-list
20191852|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
20191853|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328024|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19328025|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328026|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328027|NCT03930069|Vasopressins|vasopressins|mesh-list
19328028|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
19328029|NCT03930069|Misoprostol|misoprostol|mesh-list
19328030|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19328031|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
19328032|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19328033|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328034|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19328035|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328036|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
19328037|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
19328038|NCT03930069|Coagulants|coagulants|mesh-ancestor
19328039|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19328040|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19328041|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
19328042|NCT03930212|Progesterone|progesterone|mesh-list
19328043|NCT03930212|Progestins|progestins|mesh-ancestor
19328044|NCT03930212|Hormones|hormones|mesh-ancestor
19328045|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328046|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376634|NCT01000896|Saracatinib|saracatinib|mesh-list
20376635|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20376636|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328047|NCT03929861|Fluconazole|fluconazole|mesh-list
20191854|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
20376637|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
20376638|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
20376639|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376640|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376641|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376642|NCT01001013|Pioglitazone|pioglitazone|mesh-list
20376643|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376644|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376645|NCT01001130|Fluticasone|fluticasone|mesh-list
20376646|NCT01001130|Xhance|xhance|mesh-list
20376647|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376648|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20376649|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
20376650|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376651|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376652|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20376653|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
20376654|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
20376655|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20376656|NCT01001143|Decitabine|decitabine|mesh-list
20376657|NCT01001143|Bexarotene|bexarotene|mesh-list
19328048|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
20191855|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191856|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20376658|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20376659|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
20376660|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376661|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376662|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376663|NCT01001247|Rilpivirine|rilpivirine|mesh-list
20376664|NCT01001247|Omeprazole|omeprazole|mesh-list
20376665|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20376666|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328049|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328050|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19328051|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19328052|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328053|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328054|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19328055|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
19328056|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328057|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328058|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19328059|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19328060|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
19328061|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19328062|NCT03929835|Protective Agents|protective agents|mesh-ancestor
19328063|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328064|NCT03929419|Insulin|insulin|mesh-list
19328065|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19328066|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328067|NCT03929640|Acetaminophen|acetaminophen|mesh-list
19328068|NCT03929640|Ibuprofen|ibuprofen|mesh-list
19328069|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328070|NCT03929640|Analgesics|analgesics|mesh-ancestor
19328071|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
20191857|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20191858|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
20191859|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328072|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328073|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328074|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
19328075|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19328076|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328077|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19328078|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19328079|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328080|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328081|NCT03929744|Midazolam|midazolam|mesh-list
19328082|NCT03929744|Atorvastatin|atorvastatin|mesh-list
19328083|NCT03929744|Simvastatin|simvastatin|mesh-list
19328084|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19328085|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19328086|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
19328087|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328088|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19328089|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19328090|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328091|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19328092|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19328093|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328094|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191860|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191861|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191862|NCT00221624|Analgesics|analgesics|mesh-ancestor
20191863|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
20191864|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191865|NCT00221637|Valproic Acid|valproic acid|mesh-list
20191866|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
20191867|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191868|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191869|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
20191870|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191871|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191872|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
20191873|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20376667|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20376668|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376669|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376670|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20376671|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20376672|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
20376673|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376674|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20376675|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20376676|NCT01001260|Aspirin|aspirin|mesh-list
19328095|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19328096|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19328097|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19328098|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328099|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
19328100|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
20376677|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376678|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376679|NCT01001260|Analgesics|analgesics|mesh-ancestor
20376680|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
20376681|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376682|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376683|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376684|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376685|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20376686|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20376687|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376688|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20376689|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19328101|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
19328102|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
19328103|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328104|NCT03929575|Calcium|calcium|mesh-list
19328105|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328106|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328107|NCT03929224|Bacitracin|bacitracin|mesh-list
19328108|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19328109|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328110|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19328111|NCT03929094|Gemcitabine|gemcitabine|mesh-list
19328112|NCT03929094|Paclitaxel|paclitaxel|mesh-list
19328113|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19328114|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20191874|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191875|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191876|NCT00221650|Ribavirin|ribavirin|mesh-list
20191877|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20191878|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
20191879|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191880|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
20191881|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376690|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376691|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
20376692|NCT01001364|Budesonide|budesonide|mesh-list
20376693|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
20376694|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191882|NCT00221689|Baclofen|baclofen|mesh-list
20191883|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20191884|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376695|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19328115|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328116|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
20376696|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
20376697|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376698|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376699|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19328117|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
20376700|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
20376701|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
20376702|NCT01001364|Hormones|hormones|mesh-ancestor
20376703|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328118|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
19328119|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328120|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19328121|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
20191885|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19328122|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
19328123|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328124|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328125|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19328126|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
19328127|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328128|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
20191886|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191887|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20191888|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
20191889|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
20191890|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191891|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191892|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20191893|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
19674939|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674940|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19674941|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
19674942|NCT02829502|Exenatide|exenatide|mesh-list
19674943|NCT02829502|Glucagon|glucagon|mesh-list
19674944|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19674945|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20191894|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191895|NCT00221754|Pravastatin|pravastatin|mesh-list
20191896|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20191897|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20191898|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
19674946|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674947|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19674948|NCT02829502|Incretins|incretins|mesh-ancestor
19674949|NCT02829502|Hormones|hormones|mesh-ancestor
19674950|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19674951|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674952|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
19674953|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
19674954|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19674955|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19674956|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674957|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674958|NCT02795351|Urological Agents|urological agents|mesh-ancestor
19674959|NCT02735239|Leucovorin|leucovorin|mesh-list
19674960|NCT02735239|Paclitaxel|paclitaxel|mesh-list
19674961|NCT02735239|Docetaxel|docetaxel|mesh-list
19674962|NCT02735239|Carboplatin|carboplatin|mesh-list
19674963|NCT02735239|Fluorouracil|fluorouracil|mesh-list
19674964|NCT02735239|Capecitabine|capecitabine|mesh-list
19674965|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
19674966|NCT02735239|Durvalumab|durvalumab|mesh-list
19674967|NCT02735239|Tremelimumab|tremelimumab|mesh-list
19674968|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20191899|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191900|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20376704|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20191901|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20191902|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191903|NCT00221845|Telmisartan|telmisartan|mesh-list
20191904|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20191905|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20191906|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20191907|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191908|NCT00221871|Ketamine|ketamine|mesh-list
20191909|NCT00221871|Analgesics|analgesics|mesh-ancestor
20191910|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
20191911|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191912|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191913|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20191914|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20191915|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
20376705|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20376706|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20376707|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
20376708|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328129|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
19674969|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19674970|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
19674971|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
20426018|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19328130|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20191916|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
20191917|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191918|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20191919|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20191920|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20191921|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191922|NCT00221962|Aripiprazole|aripiprazole|mesh-list
20191923|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
20191924|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191925|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20191926|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191927|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20191928|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191929|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
20191930|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
20191931|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19674972|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
19674973|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19674974|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
19674975|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19674976|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19674977|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
20191932|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191933|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20191934|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20191935|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
20191936|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20191937|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20191938|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20191939|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20191940|NCT00221975|Lamotrigine|lamotrigine|mesh-list
20191941|NCT00221975|Valproic Acid|valproic acid|mesh-list
20191942|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20191943|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19674978|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674979|NCT02735239|Antidotes|antidotes|mesh-ancestor
19674980|NCT02735239|Protective Agents|protective agents|mesh-ancestor
20191944|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191945|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
20191946|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20191947|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19674981|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
19674982|NCT02735239|Vitamins|vitamins|mesh-ancestor
19674983|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
19674984|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19674985|NCT02733133|Testosterone|testosterone|mesh-list
19674986|NCT02733133|Androgens|androgens|mesh-ancestor
19674987|NCT02733133|Hormones|hormones|mesh-ancestor
19674988|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19674989|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674990|NCT02697383|Dexamethasone|dexamethasone|mesh-list
19674991|NCT02697383|Ixazomib|ixazomib|mesh-list
19674992|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19674993|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
19674994|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
19674995|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19674996|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19674997|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19674998|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
19674999|NCT02697383|Hormones|hormones|mesh-ancestor
19675000|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20191948|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191949|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
20191950|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20191951|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20191952|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20191953|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20191954|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20191955|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
20191956|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376709|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376710|NCT01001585|Sevoflurane|sevoflurane|mesh-list
20191957|NCT00222053|Thalidomide|thalidomide|mesh-list
19675001|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19675002|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675003|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
20376711|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20376712|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20376713|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
20376714|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
20376715|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376716|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376717|NCT01001624|Hydroquinone|hydroquinone|mesh-list
20376718|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
20376719|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376720|NCT01001624|Protective Agents|protective agents|mesh-ancestor
20376721|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376722|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20376723|NCT01001637|Curcumin|curcumin|mesh-list
20376724|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376725|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376726|NCT01001637|Analgesics|analgesics|mesh-ancestor
20376727|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
20376728|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376729|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376730|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376731|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376732|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376733|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376734|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376735|NCT01001676|Paclitaxel|paclitaxel|mesh-list
20376736|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20376737|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675004|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675005|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675006|NCT02683265|Methylphenidate|methylphenidate|mesh-list
19675007|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19675008|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191958|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376738|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
19675009|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20191959|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
20191960|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191961|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
20191962|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20191963|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20191964|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20191965|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20191966|NCT00222053|Growth Substances|growth substances|mesh-ancestor
20191967|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
20191968|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191969|NCT00222079|Esomeprazole|esomeprazole|mesh-list
20191970|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20191971|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19675010|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19675011|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675012|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675013|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
20191972|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20191973|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20191974|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191975|NCT00222144|Docetaxel|docetaxel|mesh-list
20191976|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
20191977|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20191978|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
19675014|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675015|NCT02604446|Oxycodone|oxycodone|mesh-list
19675016|NCT02604446|Tapentadol|tapentadol|mesh-list
19675017|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19675018|NCT02604446|Narcotics|narcotics|mesh-ancestor
19675019|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675020|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675021|NCT02604446|Analgesics|analgesics|mesh-ancestor
19675022|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
19675023|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841657|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
20191979|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
20191980|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
20191981|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675024|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19675025|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19675026|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675027|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675028|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
19675029|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376739|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
20376740|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376741|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426019|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
20426020|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20426021|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426022|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20426023|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20426024|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426025|NCT01278290|Hormones|hormones|mesh-ancestor
20426026|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426027|NCT01278446|Caseins|caseins|mesh-list
20426028|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
20426029|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
20426030|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426031|NCT01278459|Atorvastatin|atorvastatin|mesh-list
20426032|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19675030|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
19675031|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19675032|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
19675033|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19675034|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
19675035|NCT02529813|Fludarabine|fludarabine|mesh-list
19675036|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
19675037|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675038|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
19675039|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675040|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675041|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19675042|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
19675043|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675044|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675045|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19675046|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20426033|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20426034|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
20426035|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426036|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20426037|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20426038|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426039|NCT01278498|Citalopram|citalopram|mesh-list
20426040|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20426041|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20426042|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426043|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426044|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426045|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
20426046|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426047|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20426048|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
20426049|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20426050|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
19675047|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
19675048|NCT02341625|Nivolumab|nivolumab|mesh-list
19675049|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675050|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675051|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19675052|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675053|NCT02117076|Gabapentin|gabapentin|mesh-list
19675054|NCT02117076|Analgesics|analgesics|mesh-ancestor
19675055|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
19675056|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675057|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675058|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
19675059|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19328131|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20191982|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20191983|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675060|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19675061|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675062|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675063|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19675064|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19675065|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675066|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675067|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
20191984|NCT00222170|Rabeprazole|rabeprazole|mesh-list
20191985|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20191986|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20191987|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20191988|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328132|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328133|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328134|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328135|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19328136|NCT03929068|Levodopa|levodopa|mesh-list
19328137|NCT03929068|Carbidopa|carbidopa|mesh-list
19328138|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19328139|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20191989|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20191990|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
20191991|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20191992|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20191993|NCT00222183|Analgesics|analgesics|mesh-ancestor
20191994|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
20191995|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20191996|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20191997|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20191998|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20191999|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
20192000|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675073|NCT01710176|Gemcitabine|gemcitabine|mesh-list
19675074|NCT01710176|Docetaxel|docetaxel|mesh-list
20192001|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
20192002|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20192003|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192004|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192005|NCT00222235|Cycloserine|cycloserine|mesh-list
20192006|NCT00222235|Glycine|glycine|mesh-list
20192007|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20192008|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192009|NCT00222235|Renal Agents|renal agents|mesh-ancestor
19328140|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19328141|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
19328142|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328143|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328144|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328145|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19328146|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328147|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19328148|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
19328149|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
19328150|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19328151|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19328152|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19328153|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328154|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328155|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
19328156|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328157|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192010|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20192011|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
19328158|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19328159|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399007|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399008|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20192012|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20192013|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
20192014|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675075|NCT01710176|Etoposide|etoposide|mesh-list
20376742|NCT01001754|Ribavirin|ribavirin|mesh-list
20376743|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20376744|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
20376745|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376746|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
20376747|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376748|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
20376749|NCT01001780|Rituximab|rituximab|mesh-list
20376750|NCT01001780|Pentostatin|pentostatin|mesh-list
20376751|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376752|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
20376753|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376754|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376755|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20376756|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
20376757|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376758|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376759|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20376760|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20376761|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20376762|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376763|NCT01001845|Vitamin E|vitamin e|mesh-list
20376764|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
20376765|NCT01001845|Tocopherols|tocopherols|mesh-list
20376766|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
20376767|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376768|NCT01001845|Protective Agents|protective agents|mesh-ancestor
20376769|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376770|NCT01001845|Vitamins|vitamins|mesh-ancestor
20376771|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
20376772|NCT01001871|Vitamins|vitamins|mesh-list
20376773|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
20376774|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376775|NCT01001897|Misoprostol|misoprostol|mesh-list
20376776|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20376777|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
20376778|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20376779|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675076|NCT01710176|Epirubicin|epirubicin|mesh-list
19675077|NCT01710176|Ifosfamide|ifosfamide|mesh-list
19675078|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
19675079|NCT01710176|Dacarbazine|dacarbazine|mesh-list
19675080|NCT01710176|Trabectedin|trabectedin|mesh-list
19675081|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19675082|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
19675083|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675084|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675085|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
19675086|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675087|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675088|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675089|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
19675090|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675091|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
19675092|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
19675093|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
19675094|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19675095|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19675096|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19675097|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19675098|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19675099|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
19675100|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19675101|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20376780|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20376781|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376782|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
20376783|NCT01001962|Metformin|metformin|mesh-list
20376784|NCT01001962|Empagliflozin|empagliflozin|mesh-list
20376785|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19675102|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376786|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376787|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20428612|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
19675103|NCT00584246|Pregabalin|pregabalin|mesh-list
19675104|NCT00584246|Analgesics|analgesics|mesh-ancestor
19675105|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
20376788|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192015|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
20192016|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841658|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841659|NCT00642746|Leucovorin|leucovorin|mesh-list
19841660|NCT00642746|Fluorouracil|fluorouracil|mesh-list
19841661|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
19841662|NCT00642746|Irinotecan|irinotecan|mesh-list
19841663|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19841664|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
19841665|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841666|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20192017|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192018|NCT00222261|Aspirin|aspirin|mesh-list
20192019|NCT00222261|Clopidogrel|clopidogrel|mesh-list
20192020|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192021|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192022|NCT00222261|Analgesics|analgesics|mesh-ancestor
20192023|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
20192024|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192025|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192026|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328160|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
19328161|NCT03928691|Analgesics|analgesics|mesh-ancestor
19328162|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
19328163|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328164|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328165|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
19328166|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328167|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20192027|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192028|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192029|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20192030|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192031|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20192032|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20192033|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192034|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
20192035|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20192036|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20376789|NCT01002079|Rifampin|rifampin|mesh-list
20376790|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20376791|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
19675106|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675107|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675108|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
19675109|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19675110|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675111|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675112|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19841667|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192037|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20376792|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376793|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376794|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
20376795|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20376796|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192038|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
20192039|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192040|NCT00222443|Irinotecan|irinotecan|mesh-list
20192041|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20192042|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20376797|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376798|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20192043|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192044|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192045|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376799|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20376800|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20376801|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19328168|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
20192046|NCT00222469|Gemcitabine|gemcitabine|mesh-list
20192047|NCT00222469|Bevacizumab|bevacizumab|mesh-list
20192048|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
20192049|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20192050|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192051|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20192052|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20192053|NCT00222469|Growth Substances|growth substances|mesh-ancestor
20192054|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192055|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
20192056|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20192057|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
20192058|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192059|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
20192060|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328169|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19328170|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328171|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328172|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328173|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
19328174|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19675113|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19675114|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19675115|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675116|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675117|NCT00584025|Levetiracetam|levetiracetam|mesh-list
19675118|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
19675119|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
19675120|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
19675121|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19675122|NCT05124353|Protective Agents|protective agents|mesh-ancestor
19675123|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675124|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
19675125|NCT05124314|Misoprostol|misoprostol|mesh-list
19675126|NCT05124314|Mifepristone|mifepristone|mesh-list
19675127|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19675128|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
19675129|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19675130|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675131|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19675132|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19675133|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
19328175|NCT03928340|Metformin|metformin|mesh-list
19328176|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19328177|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328178|NCT03928353|Ticagrelor|ticagrelor|mesh-list
19328179|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19328180|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19328181|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19328182|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19328183|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
19328184|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328185|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675134|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19675135|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19675136|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19675137|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19675138|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
19675139|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19675140|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19675141|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
19675142|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675143|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
19328186|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328187|NCT03928366|Remifentanil|remifentanil|mesh-list
19328188|NCT03928366|Propofol|propofol|mesh-list
19328189|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19328190|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328191|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328192|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328193|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
19328194|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
19328195|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19675144|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19675145|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19328196|NCT03928366|Narcotics|narcotics|mesh-ancestor
19328197|NCT03928366|Analgesics|analgesics|mesh-ancestor
19328198|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
19328199|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328200|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19328201|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
19328202|NCT03928145|Amiloride|amiloride|mesh-list
19328203|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19675146|NCT05123976|Olanzapine|olanzapine|mesh-list
20376802|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20376803|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20376804|NCT01002092|Endostar protein|endostar protein|mesh-list
20376805|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20376806|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20376807|NCT01002092|Growth Substances|growth substances|mesh-ancestor
20376808|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376809|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
20376810|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376811|NCT01002157|Vitamin K|vitamin k|mesh-list
20376812|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
20376813|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
20376814|NCT01002157|Vitamins|vitamins|mesh-ancestor
20376815|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
20376816|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376817|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20376818|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20376819|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376820|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
20376821|NCT01002157|Coagulants|coagulants|mesh-ancestor
20376822|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
20376823|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19675147|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
19675148|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
20376824|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376825|NCT01002300|Oxytocin|oxytocin|mesh-list
20376826|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
20376827|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20376828|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376829|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20376830|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
20376831|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20376832|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20376833|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376834|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376835|NCT01002534|Urological Agents|urological agents|mesh-ancestor
20376836|NCT01002690|Etoricoxib|etoricoxib|mesh-list
20376837|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376838|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376839|NCT01002690|Analgesics|analgesics|mesh-ancestor
20376840|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
20376841|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328204|NCT03928145|Diuretics|diuretics|mesh-ancestor
19328205|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
19328206|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328207|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19328208|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328209|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328210|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19328211|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19328212|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19328213|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19328214|NCT03928262|Benralizumab|benralizumab|mesh-list
19328215|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19328216|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
19328217|NCT03928275|Aldesleukin|aldesleukin|mesh-list
19328218|NCT03928275|Interleukin-2|interleukin-2|mesh-list
19328219|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
19328220|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328221|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328222|NCT03928275|Analgesics|analgesics|mesh-ancestor
19328223|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
19675149|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328224|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328225|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328226|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20376842|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376843|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376844|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376845|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20376846|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20376847|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376848|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376849|NCT01002703|Prednisone|prednisone|mesh-list
19328227|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19328228|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
19328229|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328230|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19328231|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
19328232|NCT03928288|Cabergoline|cabergoline|mesh-list
19328233|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19328234|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19328235|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
19328236|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
19328237|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328238|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328239|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328240|NCT03928210|Digoxin|digoxin|mesh-list
19328241|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19328242|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19328243|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328244|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328245|NCT03928210|Protective Agents|protective agents|mesh-ancestor
19328246|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328247|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
19328248|NCT03927963|Propofol|propofol|mesh-list
19328249|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19328250|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841668|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192061|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192062|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192063|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
20192064|NCT00222482|Valproic Acid|valproic acid|mesh-list
20192065|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
20192066|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192067|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192068|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
20192069|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192070|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192071|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
20192072|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192073|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192074|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192075|NCT00222495|Olanzapine|olanzapine|mesh-list
20376850|NCT01002703|Lenalidomide|lenalidomide|mesh-list
20376851|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20376852|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376853|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
20376854|NCT01002703|Hormones|hormones|mesh-ancestor
20376855|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376856|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376857|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20376858|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376859|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
20376860|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20376861|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20376862|NCT01002703|Growth Substances|growth substances|mesh-ancestor
20376863|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
20376864|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20376865|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
19841669|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
19841670|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841671|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19841672|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19841673|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841674|NCT00642746|Antidotes|antidotes|mesh-ancestor
19841675|NCT00642746|Protective Agents|protective agents|mesh-ancestor
19841676|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
19841677|NCT00642746|Vitamins|vitamins|mesh-ancestor
19841678|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
19841679|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19841680|NCT00642759|Paclitaxel|paclitaxel|mesh-list
19841681|NCT00642759|Bevacizumab|bevacizumab|mesh-list
19841682|NCT00642759|Carboplatin|carboplatin|mesh-list
20192076|NCT00222495|Risperidone|risperidone|mesh-list
20192077|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19328251|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328252|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328253|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
19328254|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
20192078|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20192079|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
20192080|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192081|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192082|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192083|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192084|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192085|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328255|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328256|NCT03927963|Analgesics|analgesics|mesh-ancestor
19328257|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
19328258|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328259|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19328260|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19328261|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19328262|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
20192086|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675150|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675151|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19675152|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19675153|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19675154|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192087|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20192088|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
20192089|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
20192090|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
20192091|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376866|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612814|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328263|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328264|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675155|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675156|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19675157|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19675158|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675159|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675160|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376867|NCT01002716|Vaccines|vaccines|mesh-list
19328265|NCT03928093|Pregabalin|pregabalin|mesh-list
19328266|NCT03928093|Analgesics|analgesics|mesh-ancestor
19328267|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
19328268|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328269|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328270|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
19328271|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19328272|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328273|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328274|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328275|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19328276|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19328277|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328278|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20376868|NCT01002716|Immunologic Factors|immunologic factors|mesh-ancestor
19328279|NCT03927807|Misoprostol|misoprostol|mesh-list
19328280|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19328281|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
19328282|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19328283|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328284|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19328285|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328286|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
19328287|NCT03928015|Analgesics|analgesics|mesh-list
19328288|NCT03928015|Dronabinol|dronabinol|mesh-list
19328289|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
19328290|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675161|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
20192092|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20376869|NCT01002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328291|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328292|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
19328293|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841683|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19841684|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841685|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
19841686|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
19841687|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376870|NCT01002729|Oseltamivir|oseltamivir|mesh-list
20376871|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
20376872|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376873|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376874|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376875|NCT01002768|Insulin|insulin|mesh-list
20376876|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20376877|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
20376878|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376879|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376880|NCT01002807|Metformin|metformin|mesh-list
20376881|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
20376882|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20376883|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376884|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20376885|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376886|NCT01002898|Ritonavir|ritonavir|mesh-list
20376887|NCT01002898|Lopinavir|lopinavir|mesh-list
20376888|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20376889|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20376890|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
20612815|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
20612816|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612817|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19328294|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328295|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19328296|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19328297|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328298|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328299|NCT03928015|Hormones|hormones|mesh-ancestor
19328300|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328301|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
19328302|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19328303|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
19328304|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
19328305|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328306|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328307|NCT03927352|Adalimumab|adalimumab|mesh-list
19328308|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328309|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19328310|NCT03927456|Fulvestrant|fulvestrant|mesh-list
19328311|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19328312|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328313|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19841688|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841689|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19841690|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20192093|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20192094|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192095|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192096|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192097|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
20192098|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20192099|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217442|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20217443|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
20217444|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20217445|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20217446|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
20217447|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20217448|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
20217449|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217450|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20217451|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20376891|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675162|NCT05123781|Metformin|metformin|mesh-list
19675163|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19675164|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692254|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19692255|NCT04994314|Fluorides|fluorides|mesh-list
19692256|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692257|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
19692258|NCT04994314|Protective Agents|protective agents|mesh-ancestor
19692259|NCT04994262|Menthol|menthol|mesh-list
19692260|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
19692261|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
19692262|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
19692263|NCT04994574|Olodaterol|olodaterol|mesh-list
19692264|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19692265|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
19692266|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692267|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328314|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19328315|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
19328316|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692268|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19692269|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
19692270|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
19692271|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19692272|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
19692273|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692274|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192100|NCT00222534|Acetazolamide|acetazolamide|mesh-list
20192101|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
20192102|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20192103|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192104|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692275|NCT04994236|Leucovorin|leucovorin|mesh-list
19692276|NCT04994236|Fluorouracil|fluorouracil|mesh-list
19692277|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
19692278|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
19692279|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692280|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19692281|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192105|NCT00222534|Diuretics|diuretics|mesh-ancestor
19328317|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328318|NCT03927495|Paclitaxel|paclitaxel|mesh-list
19328319|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19328320|NCT03927495|Cisplatin|cisplatin|mesh-list
19328321|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19328322|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328323|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
19328324|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
19328325|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
20192106|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
20192107|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192108|NCT00222547|Vitamin A|vitamin a|mesh-list
20192109|NCT00222547|Albendazole|albendazole|mesh-list
19328326|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328327|NCT03927118|Dexamethasone|dexamethasone|mesh-list
19328328|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
19328329|NCT03927118|BB 1101|bb 1101|mesh-list
19328330|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328331|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
19328332|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
19328333|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328334|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328335|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328336|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
19328337|NCT03927118|Hormones|hormones|mesh-ancestor
19328338|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192110|NCT00222547|Vitamins|vitamins|mesh-ancestor
20192111|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
20192112|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426051|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19328339|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19692282|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19692283|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
19692284|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692285|NCT04994236|Antidotes|antidotes|mesh-ancestor
20192113|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675165|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19675166|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675167|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675168|NCT05123092|Morphine|morphine|mesh-list
19675169|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19675170|NCT05123092|Narcotics|narcotics|mesh-ancestor
19675171|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675172|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675173|NCT05123092|Analgesics|analgesics|mesh-ancestor
19675174|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
19675175|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675176|NCT05123053|Amifampridine|amifampridine|mesh-list
19675177|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19675178|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675179|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675180|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19841691|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19841692|NCT00642759|Growth Substances|growth substances|mesh-ancestor
19841693|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328340|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328341|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
19328342|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328343|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328344|NCT03927170|Metformin|metformin|mesh-list
19328345|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19328346|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19328347|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328348|NCT03927170|Incretins|incretins|mesh-ancestor
19328349|NCT03927170|Hormones|hormones|mesh-ancestor
19328350|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328351|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19841694|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
19841695|NCT00642811|Aspirin|aspirin|mesh-list
19328352|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
19675181|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675182|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675183|NCT05122884|Milrinone|milrinone|mesh-list
19675184|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19675185|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19675186|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
19675187|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19675188|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19841696|NCT00642811|Clopidogrel|clopidogrel|mesh-list
19841697|NCT00642811|Ticagrelor|ticagrelor|mesh-list
19328353|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328354|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328355|NCT03927313|Aspirin|aspirin|mesh-list
19328356|NCT03927313|Rifampin|rifampin|mesh-list
19328357|NCT03927313|Linezolid|linezolid|mesh-list
19328358|NCT03927313|Dexamethasone|dexamethasone|mesh-list
19328359|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328360|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
19328361|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
19328362|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328363|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328364|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328365|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
19328366|NCT03927313|Hormones|hormones|mesh-ancestor
19328367|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328368|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19328369|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328370|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19328371|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328372|NCT03927313|Analgesics|analgesics|mesh-ancestor
19328373|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
19328374|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19328375|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19328376|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19328377|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328378|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19328379|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19328380|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426052|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19328381|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
19328382|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20376892|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376893|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20376894|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20376895|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
20376896|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376897|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20376898|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20376899|NCT01002911|Cefazolin|cefazolin|mesh-list
20376900|NCT01002911|Cephalexin|cephalexin|mesh-list
20376901|NCT01002911|Bacitracin|bacitracin|mesh-list
19328383|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
19328384|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376902|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20376903|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20376904|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20376905|NCT01003002|Levodopa|levodopa|mesh-list
20376906|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20376907|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19328385|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328386|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
19328387|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19328388|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19675189|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376908|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
20376909|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675190|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192114|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192115|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
20192116|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20192117|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192118|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
20192119|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20192120|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20192121|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
20192122|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
20192123|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
20192124|NCT00222573|Metoprolol|metoprolol|mesh-list
20192125|NCT00222573|Clopidogrel|clopidogrel|mesh-list
20192126|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20192127|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20192128|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19675191|NCT05122884|Protective Agents|protective agents|mesh-ancestor
19675192|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675193|NCT05122780|Acetylcholine|acetylcholine|mesh-list
19675194|NCT05122780|Anticoagulants|anticoagulants|mesh-list
19675195|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19675196|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19848291|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192129|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20192130|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
20192131|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192132|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192133|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192134|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20192135|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20192136|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
20192137|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
20192138|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192139|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20192140|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20192141|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20192142|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
20192143|NCT00222638|Vaccines|vaccines|mesh-list
20192144|NCT00222638|Immunologic Factors|immunologic factors|mesh-ancestor
20192145|NCT00222638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192146|NCT00222651|Tenecteplase|tenecteplase|mesh-list
20192147|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192148|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20192149|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192150|NCT00222677|Aspirin|aspirin|mesh-list
20192151|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192152|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376910|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376911|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376912|NCT01003028|Remifentanil|remifentanil|mesh-list
20376913|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20376914|NCT01003028|Narcotics|narcotics|mesh-ancestor
20376915|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376916|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376917|NCT01003028|Analgesics|analgesics|mesh-ancestor
20376918|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
20376919|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376920|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
20192153|NCT00222677|Analgesics|analgesics|mesh-ancestor
20192154|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
20192155|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192156|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192157|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192158|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192159|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192160|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19328389|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19328390|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19328391|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19328392|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19328393|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19328394|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19328395|NCT03927222|Temozolomide|temozolomide|mesh-list
19328396|NCT03927222|Molgramostim|molgramostim|mesh-list
19328397|NCT03927222|Sargramostim|sargramostim|mesh-list
19328398|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
19328399|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192161|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192162|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20192163|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20192164|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376921|NCT01003054|Busulfan|busulfan|mesh-list
20376922|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
20376923|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376924|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
20376925|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376926|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20376927|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20376928|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
20376929|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376930|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376931|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20376932|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20376933|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192165|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
20192166|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20192167|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20192168|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192169|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192170|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376934|NCT01003158|Paclitaxel|paclitaxel|mesh-list
20376935|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20376936|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376937|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
19328400|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19328401|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
19328402|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328403|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328404|NCT03927248|Nivolumab|nivolumab|mesh-list
19328405|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19328406|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675197|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19675198|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
20376938|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
20376939|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
20376940|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376941|NCT01003314|Vaccines|vaccines|mesh-list
20376942|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
19328407|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19675199|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675200|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692286|NCT04994236|Protective Agents|protective agents|mesh-ancestor
19675201|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675202|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
19675203|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19675204|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
19675205|NCT05122767|Dolutegravir|dolutegravir|mesh-list
19675206|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19675207|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19675208|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675209|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675210|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19328408|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376943|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376944|NCT01003483|Orlistat|orlistat|mesh-list
20376945|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20376946|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376947|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20376948|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20426053|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20426054|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426055|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426056|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
20426057|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426058|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426059|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20426060|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328409|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19328410|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19675211|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19675212|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
19675213|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675214|NCT05122741|Aspirin|aspirin|mesh-list
19675215|NCT05122741|Clopidogrel|clopidogrel|mesh-list
19675216|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192171|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
20192172|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192173|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192174|NCT00222820|Citalopram|citalopram|mesh-list
20192175|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20192176|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192177|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328411|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328412|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
19328413|NCT03926780|Warfarin|warfarin|mesh-list
20192178|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192179|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192180|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
20192181|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192182|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20192183|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192184|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192185|NCT00222833|Aripiprazole|aripiprazole|mesh-list
19328414|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
19328415|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
19328416|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19328417|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
19328418|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19675217|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192186|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192187|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19328419|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
20192188|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20426061|NCT01278602|Rituximab|rituximab|mesh-list
20192189|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192190|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192191|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192192|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
20192193|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
20192194|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192195|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192196|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20426062|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19328420|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675218|NCT05122741|Analgesics|analgesics|mesh-ancestor
19675219|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
19328421|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328422|NCT03926806|Vitamins|vitamins|mesh-list
19328423|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
19675220|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675221|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675222|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19675223|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675224|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20376949|NCT01003522|Anesthetics|anesthetics|mesh-list
20376950|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
20376951|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376952|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376953|NCT01003561|Anesthetics|anesthetics|mesh-list
20376954|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20376955|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376956|NCT01003613|Tranilast|tranilast|mesh-list
20376957|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20376958|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20376959|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20376960|NCT01003613|Analgesics|analgesics|mesh-ancestor
19675225|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19675226|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376961|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
20376962|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20376963|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376964|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20376965|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675227|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19675228|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19675229|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675230|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
19675231|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19675232|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19675233|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19675234|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
19675235|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675236|NCT05115773|Anesthetics|anesthetics|mesh-list
19675237|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675238|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675239|NCT05089630|Vaccines|vaccines|mesh-list
19675240|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
19675241|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675242|NCT05073718|Aspirin|aspirin|mesh-list
20192197|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20192198|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
20376966|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20376967|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192199|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20192200|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20192201|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20192202|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20192203|NCT00222872|Hormones|hormones|mesh-list
20192204|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
20192205|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
19328424|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
19328425|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192206|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192207|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192208|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20192209|NCT00222976|Naproxen|naproxen|mesh-list
20192210|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192211|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192212|NCT00222976|Analgesics|analgesics|mesh-ancestor
20376968|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376969|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20376970|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20376971|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
20376972|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
20376973|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20376974|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20376975|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19692287|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
20376976|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
20376977|NCT01003613|Coagulants|coagulants|mesh-ancestor
20376978|NCT01003678|Clofarabine|clofarabine|mesh-list
20376979|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20376980|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
20376981|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376982|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20376983|NCT01003847|Fenofibrate|fenofibrate|mesh-list
20192213|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
20192214|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192215|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192216|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192217|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192218|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
20192219|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20192220|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192221|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192222|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
20192223|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20376984|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20376985|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
20376986|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376987|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20376988|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
20376989|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20376990|NCT01004068|Clomiphene|clomiphene|mesh-list
20376991|NCT01004068|Enclomiphene|enclomiphene|mesh-list
20376992|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
20192224|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192225|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
20192226|NCT00223015|Tacrolimus|tacrolimus|mesh-list
20192227|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192228|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
20192229|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192230|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20192231|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192232|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192233|NCT00223028|Sirolimus|sirolimus|mesh-list
20192234|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20192235|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192236|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20192237|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192238|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
20192239|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192240|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
20192241|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192242|NCT00223054|Cyclosporine|cyclosporine|mesh-list
20192243|NCT00223054|Sirolimus|sirolimus|mesh-list
20192244|NCT00223054|Everolimus|everolimus|mesh-list
20192245|NCT00223054|Tacrolimus|tacrolimus|mesh-list
20192246|NCT00223054|Cyclosporins|cyclosporins|mesh-list
20192247|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20376993|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19328426|NCT03926962|Nafithromycin|nafithromycin|mesh-list
19328427|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19328428|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328429|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19328430|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328431|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20376994|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
20376995|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20376996|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20376997|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20376998|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
20376999|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20377000|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20377001|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20377002|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20377003|NCT01004224|Infigratinib|infigratinib|mesh-list
20377004|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377005|NCT01004237|Valsartan|valsartan|mesh-list
20377006|NCT01004237|Pravastatin|pravastatin|mesh-list
19328432|NCT03926936|Fulvestrant|fulvestrant|mesh-list
19328433|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19328434|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377007|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20192248|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
20192249|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328435|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19675243|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19675244|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19675245|NCT05073718|Analgesics|analgesics|mesh-ancestor
19675246|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
19675247|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675248|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675249|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19675250|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675251|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19675252|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19675253|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675254|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19675255|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19328436|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19328437|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
19328438|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328439|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328440|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
19328441|NCT03926663|Bupivacaine|bupivacaine|mesh-list
19328442|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
19328443|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
19328444|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328445|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328446|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
19328447|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328448|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19675256|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675257|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
19675258|NCT05069974|Linezolid|linezolid|mesh-list
19328449|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328450|NCT03926663|Analgesics|analgesics|mesh-ancestor
19328451|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19328452|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19328453|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19328454|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
19328455|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328456|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328457|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19328458|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399009|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399010|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
19399011|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399012|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
19399013|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675259|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399014|NCT03638310|Gentamicins|gentamicins|mesh-list
19399015|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399016|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399017|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19399018|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399019|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399020|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
19399021|NCT03638297|Antibodies|antibodies|mesh-list
19399022|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
19399023|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399024|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399025|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399026|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19399027|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19399028|NCT03638297|Analgesics|analgesics|mesh-ancestor
19399029|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
19399030|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399031|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19399032|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19399033|NCT03638076|Ritonavir|ritonavir|mesh-list
19399034|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19399035|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19399036|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
19399037|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399038|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675260|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675261|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19675262|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675263|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675264|NCT05062031|Atropine|atropine|mesh-list
19675265|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19675266|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19675267|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19675268|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19675269|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
19675270|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675271|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675272|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19675273|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
20192250|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20192251|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192252|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192253|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
20192254|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675274|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
19675275|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
19675276|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19675277|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19675278|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
19675279|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675280|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675281|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19675282|NCT05052099|Bevacizumab|bevacizumab|mesh-list
19675283|NCT05052099|Atezolizumab|atezolizumab|mesh-list
19675284|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675285|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675286|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19675287|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19675288|NCT05052099|Growth Substances|growth substances|mesh-ancestor
19675289|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675290|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
19675291|NCT05041920|Omeprazole|omeprazole|mesh-list
19675292|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19675293|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19675294|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19675295|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675296|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675297|NCT05001802|Ropivacaine|ropivacaine|mesh-list
19675298|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
19675299|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
19675300|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192255|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
20192256|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192257|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192258|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20192259|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19328459|NCT03926559|Morphine|morphine|mesh-list
19328460|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19328461|NCT03926559|Narcotics|narcotics|mesh-ancestor
19328462|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328463|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328464|NCT03926559|Analgesics|analgesics|mesh-ancestor
19328465|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
19328466|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328467|NCT03926377|Clobetasol|clobetasol|mesh-list
19328468|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328469|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
19328470|NCT03926377|Hormones|hormones|mesh-ancestor
19328471|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328472|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328473|NCT03926403|Anesthetics|anesthetics|mesh-list
19328474|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841698|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19841699|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19841700|NCT00642811|Analgesics|analgesics|mesh-ancestor
19841701|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
19841702|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841703|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841704|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19841705|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675301|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675302|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
19675303|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675304|NCT04975958|Atezolizumab|atezolizumab|mesh-list
19675305|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675306|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19692288|NCT04994236|Vitamins|vitamins|mesh-ancestor
19692289|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
19692290|NCT04994119|Warfarin|warfarin|mesh-list
19692291|NCT04994119|Zamicastat|zamicastat|mesh-list
19692292|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
19692293|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692294|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693097|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693098|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693099|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
19693100|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693101|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19693102|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
19693103|NCT04983160|Protective Agents|protective agents|mesh-ancestor
19693104|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693105|NCT04982861|Cefixime|cefixime|mesh-list
19693106|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19693107|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693108|NCT04982874|Furosemide|furosemide|mesh-list
19693109|NCT04982874|Diuretics|diuretics|mesh-ancestor
19693110|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
19693111|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693112|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19693113|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693114|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693115|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19693116|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19693117|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693118|NCT04982705|Incretins|incretins|mesh-ancestor
19693119|NCT04982705|Hormones|hormones|mesh-ancestor
19328475|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328476|NCT03926338|Celecoxib|celecoxib|mesh-list
19328477|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
19328478|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19328479|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19328480|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328481|NCT03926338|Analgesics|analgesics|mesh-ancestor
19328482|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
19693120|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693121|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19693122|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
19693123|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693124|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693125|NCT04982809|Dexamethasone|dexamethasone|mesh-list
19693126|NCT04982809|Prednisolone|prednisolone|mesh-list
19693127|NCT04982809|Betamethasone|betamethasone|mesh-list
19693128|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192260|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20192261|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192262|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192263|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192264|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192265|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192266|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192267|NCT00223223|Levetiracetam|levetiracetam|mesh-list
20192268|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
20192269|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
20192270|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20192271|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192272|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192273|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192274|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192275|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192276|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192277|NCT00223275|Naltrexone|naltrexone|mesh-list
20192278|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20426063|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328483|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693129|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
20192279|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19328484|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328485|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377008|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20377009|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20377010|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377011|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20377012|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20377013|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
20377014|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20377015|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20377016|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377017|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20377018|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20377019|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19328486|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19328487|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19328488|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328489|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328490|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328491|NCT03926182|Aflutinib|aflutinib|mesh-list
19328492|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19328493|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192280|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192281|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
20192282|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192283|NCT00223288|Citalopram|citalopram|mesh-list
20192284|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20192285|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192286|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192287|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192288|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192289|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
20192290|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328494|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328495|NCT03926156|Warfarin|warfarin|mesh-list
19328496|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
20377020|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
20377021|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377022|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377023|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328497|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
19328498|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19328499|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
19328500|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20377024|NCT01004315|Urological Agents|urological agents|mesh-ancestor
20377025|NCT01004380|Carboplatin|carboplatin|mesh-list
20377026|NCT01004380|Farletuzumab|farletuzumab|mesh-list
20377027|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377028|NCT01004419|Fulvestrant|fulvestrant|mesh-list
20377029|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20192291|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20192292|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192293|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192294|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
19675307|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
19675308|NCT04921189|Thiamine|thiamine|mesh-list
19675309|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
19675310|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
19675311|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675312|NCT04921189|Protective Agents|protective agents|mesh-ancestor
19675313|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675314|NCT04921189|Vitamins|vitamins|mesh-ancestor
19675315|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
19675316|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
20377030|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377031|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20377032|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20377033|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
20377034|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426064|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
19675317|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19675318|NCT04875871|Copper|copper|mesh-list
19675319|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19675320|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19692295|NCT04993209|Vaccines|vaccines|mesh-list
19675321|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377035|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377036|NCT01004445|Amikacin|amikacin|mesh-list
20377037|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20377038|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192295|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20192296|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328501|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
19328502|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328503|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328504|NCT03926000|Pregabalin|pregabalin|mesh-list
19675322|NCT04875871|Trace Elements|trace elements|mesh-ancestor
19675323|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
19675324|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675325|NCT04828538|Vitamin D|vitamin d|mesh-list
19675326|NCT04828538|Vitamins|vitamins|mesh-list
19675327|NCT04828538|Ascorbic Acid|ascorbic acid|mesh-list
19675328|NCT04828538|Folic Acid|folic acid|mesh-list
19675329|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
19675330|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
19675331|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675332|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19675333|NCT04828538|Antioxidants|antioxidants|mesh-ancestor
19675334|NCT04828538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675335|NCT04828538|Protective Agents|protective agents|mesh-ancestor
19675336|NCT04828538|Hematinics|hematinics|mesh-ancestor
19675337|NCT04827030|Ropivacaine|ropivacaine|mesh-list
19675338|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
19675339|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
19675340|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675341|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675342|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
19675343|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675344|NCT04781725|Cisplatin|cisplatin|mesh-list
19675345|NCT04781725|Vinblastine|vinblastine|mesh-list
19675346|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675347|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19675348|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
19675349|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
19675350|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
19675351|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675352|NCT04737603|Buprenorphine|buprenorphine|mesh-list
19675353|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19675354|NCT04737603|Naloxone|naloxone|mesh-list
19675355|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19675356|NCT04737603|Narcotics|narcotics|mesh-ancestor
19675357|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675358|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675359|NCT04737603|Analgesics|analgesics|mesh-ancestor
19841706|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19841707|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19841708|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841709|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19841710|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19841711|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841712|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
19841713|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19841714|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20192297|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20192298|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
20192299|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20192300|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192301|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192302|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192303|NCT00223418|Aripiprazole|aripiprazole|mesh-list
20192304|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192305|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192306|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192307|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192308|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377039|NCT01004497|Cytarabine|cytarabine|mesh-list
20377040|NCT01004497|Dexamethasone|dexamethasone|mesh-list
20377041|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
20377042|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
19675360|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
19675361|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675362|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19675363|NCT04637620|Sertraline|sertraline|mesh-list
19675364|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
19675365|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675366|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19675367|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19675368|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675369|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675370|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377043|NCT01004497|Vincristine|vincristine|mesh-list
20377044|NCT01004497|Daunorubicin|daunorubicin|mesh-list
20377045|NCT01004497|Dasatinib|dasatinib|mesh-list
20377046|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
20377047|NCT01004497|BB 1101|bb 1101|mesh-list
20377048|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377049|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
20377050|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377051|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377052|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20377053|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
20377054|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377055|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377056|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20377057|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377058|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
20377059|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
20377060|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675371|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
19675372|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675373|NCT04595994|Gemcitabine|gemcitabine|mesh-list
19675374|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19675375|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
19675376|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675377|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675378|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
19675379|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675380|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675381|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675382|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
19675383|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675384|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
19675385|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19675386|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675387|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19675388|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19675389|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675390|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675391|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675392|NCT04563559|Prednisolone|prednisolone|mesh-list
19675393|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19675394|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
19675395|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19675396|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
19675397|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19675398|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
19675399|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19675400|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
19675401|NCT04563559|Hormones|hormones|mesh-ancestor
19675402|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675403|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675404|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19675405|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675406|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
19675407|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
19675408|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377061|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377062|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
20377063|NCT01004497|Hormones|hormones|mesh-ancestor
20377064|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377065|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20377066|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
20377067|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377068|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19675409|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377069|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
20377070|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
20377071|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377072|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20377073|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
20377074|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
19675410|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19675411|NCT04563559|Protective Agents|protective agents|mesh-ancestor
19675412|NCT04359017|Lidocaine|lidocaine|mesh-list
19675413|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
19675414|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
19675415|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675416|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675417|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
19675418|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675419|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19675420|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19675421|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19675422|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675423|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675424|NCT04353310|Curcumin|curcumin|mesh-list
19675425|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19675426|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19675427|NCT04353310|Analgesics|analgesics|mesh-ancestor
19675428|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
19675429|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675430|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377075|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
20377076|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20377077|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20377078|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20377079|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377080|NCT01004497|Analgesics|analgesics|mesh-ancestor
20377081|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
20377082|NCT01004575|Cobalt|cobalt|mesh-list
20377083|NCT01004575|Chromium|chromium|mesh-list
19675431|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377084|NCT01004575|Trace Elements|trace elements|mesh-ancestor
19328505|NCT03926000|Analgesics|analgesics|mesh-ancestor
19328506|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
20377085|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
20377086|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377087|NCT01004601|Docetaxel|docetaxel|mesh-list
20377088|NCT01004601|Pemetrexed|pemetrexed|mesh-list
20377089|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377090|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
20377091|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
19328507|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328508|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328509|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
19328510|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19328511|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328512|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328513|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328514|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19328515|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19328516|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328517|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19328518|NCT03925818|Metronidazole|metronidazole|mesh-list
19328519|NCT03925818|Tetracycline|tetracycline|mesh-list
19328520|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19328521|NCT03925818|Pantoprazole|pantoprazole|mesh-list
19328522|NCT03925818|Bismuth|bismuth|mesh-list
19328523|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328524|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19328525|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19328526|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19328527|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19328528|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328529|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19328530|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328531|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328532|NCT03925818|Antacids|antacids|mesh-ancestor
19328533|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19841715|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20377092|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
20377093|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377094|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377095|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20377096|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20377097|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
20377098|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377099|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
20377100|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
20377101|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
20377102|NCT01004731|Gemcitabine|gemcitabine|mesh-list
20377103|NCT01004731|Carboplatin|carboplatin|mesh-list
20377104|NCT01004731|Cetuximab|cetuximab|mesh-list
20377105|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377106|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20377107|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
20377108|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377109|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
20377110|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377111|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377112|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377113|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
20377114|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377115|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20377116|NCT01004809|Dutasteride|dutasteride|mesh-list
20377117|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20377118|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20377119|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377120|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377121|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
20377122|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377123|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377124|NCT01004900|Timolol|timolol|mesh-list
20377125|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20377126|NCT01004900|Travoprost|travoprost|mesh-list
20377127|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20377128|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20377129|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
20377130|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377131|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377132|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377133|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20377134|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20377135|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20377136|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20377137|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20377138|NCT01005095|Vitamin D|vitamin d|mesh-list
19675432|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675433|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675434|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675435|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675436|NCT04345341|Bupivacaine|bupivacaine|mesh-list
20377139|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
20377140|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
20377141|NCT01005095|Vitamins|vitamins|mesh-list
20377142|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
20377143|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675437|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
19675438|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
19675439|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675440|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192309|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192310|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
20192311|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
20192312|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192313|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192314|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20192315|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20192316|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
20192317|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20192318|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20192319|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20192320|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20192321|NCT00223509|Lamotrigine|lamotrigine|mesh-list
20192322|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
20377144|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20192323|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20192324|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192325|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192326|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20192327|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192328|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192329|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192330|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328534|NCT03925714|Metformin|metformin|mesh-list
19328535|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19328536|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328537|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
19328538|NCT03925779|Remifentanil|remifentanil|mesh-list
19328539|NCT03925779|Propofol|propofol|mesh-list
19328540|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19328541|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328542|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328543|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328544|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
19328545|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
19328546|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328547|NCT03925779|Analgesics|analgesics|mesh-ancestor
19328548|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
19328549|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328550|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19328551|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19328552|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19328553|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
19328554|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192331|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20377145|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20377146|NCT01005121|Colchicine|colchicine|mesh-list
20377147|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
20377148|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377149|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
20377150|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
20377151|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
20377152|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377153|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377154|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
20377155|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20377156|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20377157|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377158|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
20377159|NCT01005147|Coagulants|coagulants|mesh-ancestor
19675441|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
20192332|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20192333|NCT00223548|Mesna|mesna|mesh-list
20192334|NCT00223548|Protective Agents|protective agents|mesh-ancestor
20192335|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192336|NCT00223561|Methylphenidate|methylphenidate|mesh-list
20192337|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20192338|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192339|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20192340|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192341|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675442|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675443|NCT04330625|Volagidemab|volagidemab|mesh-list
19675444|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19675445|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675446|NCT04234022|Pomalidomide|pomalidomide|mesh-list
19675447|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
19675448|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675449|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19675450|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20192342|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192343|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
20192344|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192345|NCT00223613|Insulin|insulin|mesh-list
20192346|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20377160|NCT01005160|Metformin|metformin|mesh-list
19399039|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20192347|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377161|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20377162|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377163|NCT01005199|Everolimus|everolimus|mesh-list
20377164|NCT01005199|Sorafenib|sorafenib|mesh-list
20377165|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377166|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377167|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
19675451|NCT04234022|Growth Substances|growth substances|mesh-ancestor
19675452|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
19675453|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675454|NCT04165993|Docetaxel|docetaxel|mesh-list
19675455|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675456|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19675457|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
19675458|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19675459|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675460|NCT04158635|Gemcitabine|gemcitabine|mesh-list
19675461|NCT04158635|Paclitaxel|paclitaxel|mesh-list
19675462|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19675463|NCT04158635|Bosentan|bosentan|mesh-list
19675464|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19675465|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675466|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
19675467|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
19675468|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
19675469|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675470|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19675471|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
19675472|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
20377168|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377169|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377170|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377171|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377172|NCT01005238|Lamivudine|lamivudine|mesh-list
19328555|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328556|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20377173|NCT01005238|Telbivudine|telbivudine|mesh-list
20377174|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20377175|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19675473|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675474|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675475|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675476|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
19675477|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675478|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19675479|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19675480|NCT04070378|Daratumumab|daratumumab|mesh-list
19675481|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675482|NCT03991988|Montelukast|montelukast|mesh-list
19675483|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19675484|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
19675485|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19675486|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
19675487|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675488|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675489|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19675490|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19675491|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675492|NCT03984045|Lidocaine|lidocaine|mesh-list
19675493|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
19675494|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
19675495|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
19675496|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675497|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675498|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
19675499|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675500|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19675501|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19675502|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19675503|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675504|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675505|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
19675506|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
19675507|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377176|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377177|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377178|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
20377179|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377180|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20377181|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20377182|NCT01005303|Vitamin D|vitamin d|mesh-list
20377183|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
19841716|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
19841717|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841718|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
19841719|NCT00642850|Hematinics|hematinics|mesh-ancestor
19841720|NCT00642954|Dexamethasone|dexamethasone|mesh-list
20377184|NCT01005303|Vitamins|vitamins|mesh-ancestor
20377185|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
20377186|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377187|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20377188|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20377189|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
20377190|NCT01005381|Vitamin D|vitamin d|mesh-list
20377191|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
19675508|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19675509|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19675510|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675511|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19675512|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
19841721|NCT00642954|Lenalidomide|lenalidomide|mesh-list
19675513|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192348|NCT00223626|Topiramate|topiramate|mesh-list
20192349|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
19692296|NCT04993209|Immunologic Factors|immunologic factors|mesh-ancestor
19841722|NCT00642954|Vorinostat|vorinostat|mesh-list
20192350|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20192351|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192352|NCT00223639|Topiramate|topiramate|mesh-list
20192353|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
20192354|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20192355|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192356|NCT00223691|Acarbose|acarbose|mesh-list
20192357|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
20192358|NCT00223691|Promethazine|promethazine|mesh-list
20192359|NCT00223691|Ibuprofen|ibuprofen|mesh-list
20192360|NCT00223691|Celecoxib|celecoxib|mesh-list
20192361|NCT00223691|Indomethacin|indomethacin|mesh-list
20192362|NCT00223691|Octreotide|octreotide|mesh-list
20192363|NCT00223691|Phenylephrine|phenylephrine|mesh-list
20192364|NCT00223691|Acetazolamide|acetazolamide|mesh-list
20192365|NCT00223691|Midodrine|midodrine|mesh-list
20192366|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
20192367|NCT00223691|Ephedrine|ephedrine|mesh-list
20192368|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
20192369|NCT00223691|Ergotamine|ergotamine|mesh-list
20192370|NCT00223691|Bromides|bromides|mesh-list
20192371|NCT00223691|Levodopa|levodopa|mesh-list
20192372|NCT00223691|Carbidopa|carbidopa|mesh-list
20192373|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20192374|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
20192375|NCT00223691|Methylphenidate|methylphenidate|mesh-list
20192376|NCT00223691|Caffeine|caffeine|mesh-list
20192377|NCT00223691|Modafinil|modafinil|mesh-list
20192378|NCT00223691|Rivastigmine|rivastigmine|mesh-list
20192379|NCT00223691|Ranitidine|ranitidine|mesh-list
20192380|NCT00223691|Yohimbine|yohimbine|mesh-list
20192381|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20192382|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20192383|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192384|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192385|NCT00223691|Analgesics|analgesics|mesh-ancestor
19692297|NCT04993209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692298|NCT04993365|Vaccines|vaccines|mesh-list
19692299|NCT04993365|Immunologic Factors|immunologic factors|mesh-ancestor
19692300|NCT04993365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692301|NCT04993222|Amphotericin B|amphotericin b|mesh-list
19692302|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19841723|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192386|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
20192387|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192388|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192389|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192390|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192391|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20192392|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377192|NCT01005381|Calcium|calcium|mesh-list
20377193|NCT01005381|Vitamins|vitamins|mesh-ancestor
19675514|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
19675515|NCT03930602|BMS-986165|bms-986165|mesh-list
20192393|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192394|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20192395|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20192396|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20377194|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
20377195|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328557|NCT03925779|Narcotics|narcotics|mesh-ancestor
19328558|NCT03925740|Listerine|listerine|mesh-list
19328559|NCT03925740|Fluorides|fluorides|mesh-list
19328560|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
20192397|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192398|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192399|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
20192400|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192401|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20192402|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20192403|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20192404|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
20192405|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
20192406|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19328561|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
19328562|NCT03925740|Protective Agents|protective agents|mesh-ancestor
19328563|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328564|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19328565|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328566|NCT03925701|Metformin|metformin|mesh-list
20192407|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19328567|NCT03925701|Vildagliptin|vildagliptin|mesh-list
19328568|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19328569|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328570|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19328571|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
19328572|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328573|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328574|NCT03925662|Mebendazole|mebendazole|mesh-list
19328575|NCT03925662|Piperazine|piperazine|mesh-list
19328576|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
20192408|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377196|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328577|NCT03925662|Bevacizumab|bevacizumab|mesh-list
19328578|NCT03925662|DMP 777|dmp 777|mesh-list
19328579|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19328580|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328581|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19328582|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19328583|NCT03925662|Growth Substances|growth substances|mesh-ancestor
19328584|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328585|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
19328586|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
19328587|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
19328588|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19328589|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328590|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
19328591|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
19328592|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
19328593|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328594|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328595|NCT03925233|Tamoxifen|tamoxifen|mesh-list
19328596|NCT03925233|Toremifene|toremifene|mesh-list
19328597|NCT03925233|Gemcitabine|gemcitabine|mesh-list
19328598|NCT03925233|Vinorelbine|vinorelbine|mesh-list
19328599|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
19328600|NCT03925233|Bevacizumab|bevacizumab|mesh-list
19328601|NCT03925233|Carboplatin|carboplatin|mesh-list
19328602|NCT03925233|Doxorubicin|doxorubicin|mesh-list
19328603|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19328604|NCT03925233|Fluorouracil|fluorouracil|mesh-list
19328605|NCT03925233|Capecitabine|capecitabine|mesh-list
19328606|NCT03925233|Methotrexate|methotrexate|mesh-list
19675516|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19328607|NCT03925233|Trastuzumab|trastuzumab|mesh-list
19328608|NCT03925233|Letrozole|letrozole|mesh-list
19328609|NCT03925233|Apatinib|apatinib|mesh-list
19328610|NCT03925233|Epirubicin|epirubicin|mesh-list
19328611|NCT03925233|Olaparib|olaparib|mesh-list
19328612|NCT03925233|Fulvestrant|fulvestrant|mesh-list
19328613|NCT03925233|Anastrozole|anastrozole|mesh-list
19328614|NCT03925233|Exemestane|exemestane|mesh-list
19675517|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19675518|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19675519|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675520|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675521|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20377197|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20377198|NCT01005381|Antacids|antacids|mesh-ancestor
20377199|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377200|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377201|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
20377202|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20377203|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377204|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377205|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20377206|NCT01005433|Analgesics|analgesics|mesh-ancestor
20377207|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
20377208|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675522|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19675523|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675524|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377209|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20377210|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20377211|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20377212|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
20377213|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377214|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328615|NCT03925233|Endostatins|endostatins|mesh-list
20377215|NCT01005472|Temozolomide|temozolomide|mesh-list
20377216|NCT01005472|Sunitinib|sunitinib|mesh-list
20377217|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20377218|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
20377219|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328616|NCT03925233|Pirarubicin|pirarubicin|mesh-list
19328617|NCT03925233|Citric Acid|citric acid|mesh-list
19328618|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
19328619|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19328620|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328621|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
19328622|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
19328623|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
19328624|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328625|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19328626|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
19328627|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328628|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377220|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377221|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20377222|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20377223|NCT01005472|Growth Substances|growth substances|mesh-ancestor
20377224|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377225|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
20377226|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377227|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328629|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19328630|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
19328631|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19328632|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19328633|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19328634|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19328635|NCT03925233|Growth Substances|growth substances|mesh-ancestor
19328636|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
19328637|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19328638|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
19328639|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
19328640|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328641|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328642|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19328643|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19328644|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19328645|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19328646|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
19328647|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19328648|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
20377228|NCT01005537|Aldesleukin|aldesleukin|mesh-list
20377229|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
20377230|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377231|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
20377232|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377233|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377234|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20377235|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
20377236|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377237|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377238|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19328649|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19328650|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20377239|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20377240|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20377241|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
20377242|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377243|NCT01005550|Ropivacaine|ropivacaine|mesh-list
20377244|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
20377245|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
20377246|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377247|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377248|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
20377249|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377250|NCT01005628|Bortezomib|bortezomib|mesh-list
20377251|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377252|NCT01005641|Lapatinib|lapatinib|mesh-list
20377253|NCT01005641|Exemestane|exemestane|mesh-list
20377254|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377255|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377256|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328651|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
19328652|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19328653|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
19328654|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
19328655|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19328656|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19675525|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675526|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
19675527|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19675528|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
19675529|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19675530|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19675531|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675532|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19675533|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
19675534|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19675535|NCT03927144|Erenumab|erenumab|mesh-list
19675536|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19675537|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675538|NCT03927144|Analgesics|analgesics|mesh-ancestor
19675539|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
19675540|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675541|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675542|NCT03889795|Metformin|metformin|mesh-list
19675543|NCT03889795|Digoxin|digoxin|mesh-list
19675544|NCT03889795|Simvastatin|simvastatin|mesh-list
19675545|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19675546|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675547|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19675548|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19675549|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
19675550|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675551|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19675552|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20377257|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377258|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20377259|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20377260|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20377261|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
20377262|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377263|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675553|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328657|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19675554|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19675555|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19675556|NCT03889795|Protective Agents|protective agents|mesh-ancestor
19675557|NCT03872791|Paclitaxel|paclitaxel|mesh-list
19675558|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19328658|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
19328659|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192409|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20192410|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192411|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19328660|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19328661|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19328662|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19328663|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19328664|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19328665|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19328666|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19328667|NCT03925285|Bevacizumab|bevacizumab|mesh-list
19328668|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19328669|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328670|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19328671|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19328672|NCT03925285|Growth Substances|growth substances|mesh-ancestor
19328673|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377264|NCT01005758|Cytarabine|cytarabine|mesh-list
20377265|NCT01005758|Dexamethasone|dexamethasone|mesh-list
20377266|NCT01005758|Prednisone|prednisone|mesh-list
20377267|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
20377268|NCT01005758|Prednisolone|prednisolone|mesh-list
20377269|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
20377270|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20377271|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20377272|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20377273|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
20377274|NCT01005758|Doxorubicin|doxorubicin|mesh-list
20377275|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20377276|NCT01005758|Methotrexate|methotrexate|mesh-list
20377277|NCT01005758|Etoposide|etoposide|mesh-list
20377278|NCT01005758|Vincristine|vincristine|mesh-list
20377279|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
20377280|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
20377281|NCT01005758|Pegaspargase|pegaspargase|mesh-list
20377282|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
20377283|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377284|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
19328674|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
20192412|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20192413|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
19675559|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675560|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
19675561|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
20192414|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20192415|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20377285|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328675|NCT03925428|Entinostat|entinostat|mesh-list
19328676|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19328677|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328678|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328679|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328680|NCT03925090|Cisplatin|cisplatin|mesh-list
20377286|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377287|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19328681|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328682|NCT03925155|Iodine|iodine|mesh-list
19328683|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
19328684|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20377288|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
20377289|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377290|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377291|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20377292|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328685|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328686|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
19328687|NCT03925155|Trace Elements|trace elements|mesh-ancestor
20377293|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
20377294|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
20377295|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328688|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
19675562|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
19675563|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675564|NCT03843151|Itraconazole|itraconazole|mesh-list
19675565|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
19675566|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192416|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192417|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
20192418|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
20192419|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
20192420|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
19675567|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19675568|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19675569|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675570|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675571|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19675572|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
19675573|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192421|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20192422|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
19328689|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328690|NCT03925051|Denosumab|denosumab|mesh-list
19328691|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19328692|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328693|NCT03924544|Mitomycins|mitomycins|mesh-list
19328694|NCT03924544|Mitomycin|mitomycin|mesh-list
19328695|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19328696|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328697|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
19328698|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328699|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19328700|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328701|NCT03924596|Boswellic acid|boswellic acid|mesh-list
19328702|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19328703|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328704|NCT03924596|Analgesics|analgesics|mesh-ancestor
19328705|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
19328706|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328707|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328708|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328709|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19328710|NCT03924323|Citalopram|citalopram|mesh-list
19328711|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19328712|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19328713|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328714|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328715|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328716|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
19328717|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328718|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19328719|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
19328720|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19328721|NCT03924518|Granisetron|granisetron|mesh-list
19328722|NCT03924518|Serotonin|serotonin|mesh-list
19328723|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
19328724|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
19328725|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328726|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328727|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328728|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19328729|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
19328730|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328731|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328732|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19399040|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19399041|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
19399042|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399043|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19399044|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19399045|NCT03638063|Adenosine|adenosine|mesh-list
19399046|NCT03638063|Capsaicin|capsaicin|mesh-list
20192423|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
19399047|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
20192424|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20377296|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328733|NCT03924245|Olaparib|olaparib|mesh-list
19328734|NCT03924245|Entinostat|entinostat|mesh-list
19328735|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19328736|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192425|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
20192426|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
20192427|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20192428|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19675574|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675575|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19675576|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
19675577|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19675578|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20192429|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20192430|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
19328737|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328738|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328739|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19328740|NCT03924492|Pregnanolone|pregnanolone|mesh-list
20192431|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
19328741|NCT03924492|Brexanolone|brexanolone|mesh-list
19328742|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
19328743|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328744|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675579|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675580|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
19675581|NCT03822793|Coagulants|coagulants|mesh-ancestor
19675582|NCT03748134|Paclitaxel|paclitaxel|mesh-list
19675583|NCT03748134|Fluorouracil|fluorouracil|mesh-list
19675584|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19675585|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328745|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328746|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
19328747|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
19328748|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
19328749|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328750|NCT03923881|Cetuximab|cetuximab|mesh-list
19328751|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19328752|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328753|NCT03923842|Denosumab|denosumab|mesh-list
19328754|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19328755|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328756|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
19328757|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19328758|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19328759|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328760|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
19328761|NCT03923959|Coagulants|coagulants|mesh-ancestor
19328762|NCT03923803|Calcitonin|calcitonin|mesh-list
19328763|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
19328764|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19328765|NCT03923803|Katacalcin|katacalcin|mesh-list
19328766|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328767|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328768|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19328769|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
19328770|NCT03923556|Neostigmine|neostigmine|mesh-list
19328771|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19328772|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328773|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328774|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
19328775|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328776|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328777|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19328778|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
19841724|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
19328779|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192432|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20377297|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
20377298|NCT01005758|Hormones|hormones|mesh-ancestor
19328780|NCT03923829|Zinc|zinc|mesh-list
19328781|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
19328782|NCT03923829|Trace Elements|trace elements|mesh-ancestor
19675586|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
19841725|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
20428613|NCT01292720|Vitamins|vitamins|mesh-ancestor
20377299|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377300|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20377301|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20377302|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20377303|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20377304|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377305|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20377306|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
20377307|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19328783|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
19328784|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328785|NCT03923829|Astringents|astringents|mesh-ancestor
19328786|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
19328787|NCT03923751|Anesthetics|anesthetics|mesh-list
19328788|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328789|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328790|NCT03923114|Exenatide|exenatide|mesh-list
19328791|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19328792|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328793|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19328794|NCT03923114|Incretins|incretins|mesh-ancestor
19328795|NCT03923114|Hormones|hormones|mesh-ancestor
19328796|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328797|NCT03923166|Capecitabine|capecitabine|mesh-list
19328798|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19328799|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
19328800|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328801|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328802|NCT03923361|Propofol|propofol|mesh-list
19328803|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19328804|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328805|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675587|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
19328806|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328807|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
20377308|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20377309|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
20377310|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
19328808|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
19328809|NCT03923218|Vitamin D|vitamin d|mesh-list
19328810|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
19328811|NCT03923218|Vitamins|vitamins|mesh-ancestor
19328812|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
19328813|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328814|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19328815|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19675588|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
19675589|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675590|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
19675591|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19675592|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675593|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
19675594|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675595|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
19675596|NCT03710421|Fludarabine|fludarabine|mesh-list
19675597|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675598|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
19675599|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675600|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675601|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19675602|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
19692303|NCT04993222|Amebicides|amebicides|mesh-ancestor
20192433|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20192434|NCT00223691|Diuretics|diuretics|mesh-ancestor
20192435|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
20192436|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20192437|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20192438|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20192439|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
20192440|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20192441|NCT00223691|Protective Agents|protective agents|mesh-ancestor
20192442|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
20377311|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19328816|NCT03923140|Tranilast|tranilast|mesh-list
19328817|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19328818|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328819|NCT03923140|Analgesics|analgesics|mesh-ancestor
19328820|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
19328821|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328822|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328823|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19328824|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19328825|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19328826|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328827|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328828|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19328829|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19328830|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
19328831|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
19328832|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328833|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19328834|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19328835|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
19328836|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19328837|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328838|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328839|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19328840|NCT03923075|Analgesics|analgesics|mesh-ancestor
19328841|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
19328842|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328843|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19328844|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19328845|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19328846|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
19328847|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328848|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328849|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19328850|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19328851|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328852|NCT03923231|Ritonavir|ritonavir|mesh-list
19328853|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19328854|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19328855|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19675603|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675604|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675605|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19675606|NCT03703492|Estradiol|estradiol|mesh-list
19675607|NCT03703492|Estrogens|estrogens|mesh-ancestor
19675608|NCT03703492|Hormones|hormones|mesh-ancestor
19675609|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675610|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675611|NCT03663166|Nivolumab|nivolumab|mesh-list
19675612|NCT03663166|Ipilimumab|ipilimumab|mesh-list
20377312|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20428614|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
19328856|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
19675613|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675614|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675615|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19692304|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19841726|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328857|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328858|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328859|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19328860|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19328861|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
19328862|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328863|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19328864|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19328865|NCT03923179|Etoposide|etoposide|mesh-list
19328866|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19328867|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328868|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19328869|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19328870|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328871|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328872|NCT03923010|Itraconazole|itraconazole|mesh-list
19328873|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
19328874|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328875|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19328876|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19328877|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675616|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675617|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19675618|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19675619|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19675620|NCT03554317|Nivolumab|nivolumab|mesh-list
19675621|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
19675622|NCT03554317|Testosterone|testosterone|mesh-list
19675623|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
19328878|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328879|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19328880|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
19328881|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19328882|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328883|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19328884|NCT03922815|Fentanyl|fentanyl|mesh-list
19328885|NCT03922815|Propofol|propofol|mesh-list
19328886|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20192443|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20192444|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20192445|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20192446|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20192447|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20192448|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
20192449|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
19328887|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328888|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328889|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328890|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
19328891|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
19328892|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19328893|NCT03922815|Narcotics|narcotics|mesh-ancestor
19328894|NCT03922815|Analgesics|analgesics|mesh-ancestor
19328895|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
19328896|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19328897|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19328898|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
19328899|NCT03922919|Cefotaxime|cefotaxime|mesh-list
19328900|NCT03922919|Cefoxitin|cefoxitin|mesh-list
19328901|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19328902|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328903|NCT03923036|Cetuximab|cetuximab|mesh-list
19328904|NCT03923036|Panitumumab|panitumumab|mesh-list
19328905|NCT03923036|Aflibercept|aflibercept|mesh-list
19328906|NCT03923036|Capecitabine|capecitabine|mesh-list
19328907|NCT03923036|Irinotecan|irinotecan|mesh-list
19328908|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
19328909|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675624|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
20192450|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20192451|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20192452|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
20192453|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
20192454|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20192455|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
20192456|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20192457|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20192458|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20192459|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20192460|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20192461|NCT00223691|Urological Agents|urological agents|mesh-ancestor
20192462|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192463|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192464|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20192465|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20192466|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192467|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
20192468|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20192469|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
19328910|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19328911|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20192470|NCT00223717|Aspirin|aspirin|mesh-list
20192471|NCT00223717|Losartan|losartan|mesh-list
20192472|NCT00223717|Metoprolol|metoprolol|mesh-list
20377313|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20377314|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
20377315|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675625|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19675626|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675627|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675628|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19675629|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675630|NCT03554317|Androgens|androgens|mesh-ancestor
19675631|NCT03554317|Hormones|hormones|mesh-ancestor
19675632|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675633|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675634|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19675635|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
19675636|NCT03434418|Osimertinib|osimertinib|mesh-list
19675637|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675638|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19675639|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675640|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675641|NCT03430063|Ipilimumab|ipilimumab|mesh-list
19675642|NCT03430063|Cemiplimab|cemiplimab|mesh-list
19675643|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675644|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675645|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19328912|NCT03923036|Growth Substances|growth substances|mesh-ancestor
19328913|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328914|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
19328915|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19328916|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
19675646|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192473|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20192474|NCT00223717|Clonidine|clonidine|mesh-list
20192475|NCT00223717|Eplerenone|eplerenone|mesh-list
19675650|NCT03422731|Alovudine|alovudine|mesh-list
19675651|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
19675652|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675653|NCT03306394|Trifluridine|trifluridine|mesh-list
19675654|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
19675655|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675656|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
19675657|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328917|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377316|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
20377317|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
20377318|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
20377319|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20377320|NCT01005758|Protective Agents|protective agents|mesh-ancestor
20377321|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377322|NCT01005784|Cetrorelix|cetrorelix|mesh-list
20377323|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20377324|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
20377325|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20377326|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377327|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
20426065|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328918|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19328919|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19328920|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328921|NCT03922542|Riboflavin|riboflavin|mesh-list
19675658|NCT03290950|Dexamethasone|dexamethasone|mesh-list
20192476|NCT00223717|Nebivolol|nebivolol|mesh-list
20192477|NCT00223717|Bosentan|bosentan|mesh-list
20192478|NCT00223717|Diltiazem|diltiazem|mesh-list
20192479|NCT00223717|Guanfacine|guanfacine|mesh-list
20192480|NCT00223717|Prazosin|prazosin|mesh-list
20192481|NCT00223717|Hydralazine|hydralazine|mesh-list
20192482|NCT00223717|Captopril|captopril|mesh-list
20192483|NCT00223717|Nifedipine|nifedipine|mesh-list
20192484|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20192485|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
20192486|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
20192487|NCT00223717|Dipyridamole|dipyridamole|mesh-list
20192488|NCT00223717|Carbidopa|carbidopa|mesh-list
20192489|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20192490|NCT00223717|Tamsulosin|tamsulosin|mesh-list
20192491|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192492|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192493|NCT00223717|Analgesics|analgesics|mesh-ancestor
19328922|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
19328923|NCT03922542|Vitamins|vitamins|mesh-ancestor
19675659|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
19675660|NCT03290950|Lenalidomide|lenalidomide|mesh-list
19675661|NCT03290950|Daratumumab|daratumumab|mesh-list
19328924|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
19328925|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328926|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19675662|NCT03290950|BB 1101|bb 1101|mesh-list
19328927|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
19399048|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
20377328|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377329|NCT01005797|Sorafenib|sorafenib|mesh-list
20377330|NCT01005797|Panobinostat|panobinostat|mesh-list
20377331|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377332|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377333|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377334|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377335|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20377336|NCT01005927|Calcium|calcium|mesh-list
20377337|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20377338|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377339|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
20377340|NCT01005979|Rituximab|rituximab|mesh-list
20377341|NCT01005979|Lenalidomide|lenalidomide|mesh-list
20377342|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377343|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
20377344|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377345|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377346|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19399049|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
19399050|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399051|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399052|NCT03638063|Analgesics|analgesics|mesh-ancestor
19399053|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19399054|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
19399055|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19399056|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
19399057|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
19399058|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399059|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399060|NCT03638037|Vitamin D|vitamin d|mesh-list
19399061|NCT03638037|Vitamins|vitamins|mesh-ancestor
19399062|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
19399063|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675663|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19675664|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
19675665|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
19675666|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675667|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675668|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19675669|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
19675670|NCT03290950|Hormones|hormones|mesh-ancestor
19675671|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675672|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19675673|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675674|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
19675675|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675676|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192494|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
20192495|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192496|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192497|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192498|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192499|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192500|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20192501|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192502|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20192503|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20377347|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
20377348|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675677|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
19692305|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19399064|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20192504|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675678|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19675679|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19675680|NCT03290950|Growth Substances|growth substances|mesh-ancestor
19675681|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
19675682|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
19675683|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19328928|NCT03922373|Benzonatate|benzonatate|mesh-list
19328929|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
19328930|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
19328931|NCT03921684|Capecitabine|capecitabine|mesh-list
19328932|NCT03921684|Nivolumab|nivolumab|mesh-list
19328933|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19328934|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
19328935|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328936|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19328937|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19328938|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19328939|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19328940|NCT03921736|Perindopril|perindopril|mesh-list
19328941|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19328942|NCT03921736|Diuretics|diuretics|mesh-ancestor
19328943|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
19328944|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328945|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19328946|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328947|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328948|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19328949|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
19328950|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19328951|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19328952|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19328953|NCT03921671|Paclitaxel|paclitaxel|mesh-list
19328954|NCT03921671|Carboplatin|carboplatin|mesh-list
19328955|NCT03921671|Ramucirumab|ramucirumab|mesh-list
19328956|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19328957|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675684|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19675685|NCT03249844|Prednisolone|prednisolone|mesh-list
19675686|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
19675687|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19675688|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
19675689|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19675690|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
19675691|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
19675692|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675693|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675694|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19675695|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
19675696|NCT03249844|Hormones|hormones|mesh-ancestor
19675697|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675698|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19675699|NCT03249844|Protective Agents|protective agents|mesh-ancestor
19675700|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19675701|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192505|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
20192506|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20192507|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20192508|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20192509|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20192510|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
20192511|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20192512|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20192513|NCT00223717|Urological Agents|urological agents|mesh-ancestor
20192514|NCT00223717|Diuretics|diuretics|mesh-ancestor
20192515|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
20192516|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20192517|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192518|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
19328958|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
20192519|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
19328959|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
19328960|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
19328961|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328962|NCT03921593|Pancrelipase|pancrelipase|mesh-list
19328963|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19328964|NCT03921567|Lidocaine|lidocaine|mesh-list
19328965|NCT03921567|Ketamine|ketamine|mesh-list
19328966|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
19328967|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
20377349|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377350|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20377351|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20377352|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20377353|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20377354|NCT01005979|Growth Substances|growth substances|mesh-ancestor
20377355|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
20377356|NCT01006031|Interferons|interferons|mesh-list
20377357|NCT01006031|Ribavirin|ribavirin|mesh-list
19675720|NCT03172754|Nivolumab|nivolumab|mesh-list
19675721|NCT03172754|Axitinib|axitinib|mesh-list
19675722|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675723|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675724|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19675725|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675726|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19675727|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675728|NCT03044977|Octreotide|octreotide|mesh-list
19675729|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377358|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
20377359|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
20377360|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20377361|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377362|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
20377363|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377364|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
19675730|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19675731|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675732|NCT02755272|Gemcitabine|gemcitabine|mesh-list
19675733|NCT02755272|Carboplatin|carboplatin|mesh-list
19675734|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
19675735|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675736|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19675737|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
19675738|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675739|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
19675740|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675741|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675742|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675743|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
19675744|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675745|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675746|NCT02359513|Fluoxetine|fluoxetine|mesh-list
19675747|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
19675748|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19675749|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19841727|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613212|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675750|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19675751|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377365|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328968|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377366|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
20377367|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377368|NCT01006057|Insulin|insulin|mesh-list
20377369|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20377370|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
20377371|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19675752|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675753|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
19675754|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377372|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377373|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20377374|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377375|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377376|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377377|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377378|NCT01006187|Lidocaine|lidocaine|mesh-list
20377379|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
20377380|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
20377381|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377382|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377383|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
20377384|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377385|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20377386|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20377387|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20377388|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20377389|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377390|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
20377391|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20377392|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377393|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
20377394|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20377395|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377396|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377397|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20377398|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20377399|NCT01006499|Protective Agents|protective agents|mesh-ancestor
20377400|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377401|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
20377402|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19675755|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19675756|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675757|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19675758|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19675759|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675760|NCT02267343|Nivolumab|nivolumab|mesh-list
19675761|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20377403|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
20377404|NCT01006525|Zolpidem|zolpidem|mesh-list
20377405|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20377406|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19675762|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675763|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19675764|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675765|NCT02261285|Nivolumab|nivolumab|mesh-list
19675766|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675767|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675768|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19675769|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675770|NCT02256800|Leucovorin|leucovorin|mesh-list
19675771|NCT02256800|Bevacizumab|bevacizumab|mesh-list
19675772|NCT02256800|Irinotecan|irinotecan|mesh-list
19675773|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20192520|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20192521|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20192522|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20192523|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
20192524|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192525|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20192526|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20192527|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20192528|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19675774|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675775|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19675776|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19675777|NCT02256800|Growth Substances|growth substances|mesh-ancestor
19675778|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675779|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19675780|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20377407|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377408|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377409|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20377410|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
20377411|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
20377412|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377413|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377414|NCT01006551|Ziprasidone|ziprasidone|mesh-list
20377415|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20377416|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
20377417|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377418|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377419|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377420|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20377421|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20377422|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377423|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20377424|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20377425|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
20377426|NCT01006668|Propofol|propofol|mesh-list
20377427|NCT01006668|Sevoflurane|sevoflurane|mesh-list
20377428|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20377429|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377430|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377431|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20377432|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
20377433|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
20377434|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20377435|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19328969|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328970|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
19328971|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192529|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20192530|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20192531|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20192532|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
20192533|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20192534|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20192535|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20192536|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
20192537|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19675781|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19675782|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675783|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675784|NCT02256800|Antidotes|antidotes|mesh-ancestor
19675785|NCT02256800|Protective Agents|protective agents|mesh-ancestor
19675786|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
19675787|NCT02256800|Vitamins|vitamins|mesh-ancestor
19675788|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
19675789|NCT02203682|Doxycycline|doxycycline|mesh-list
19675790|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19675791|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675792|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
19675793|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19675794|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19675795|NCT02116335|Bosentan|bosentan|mesh-list
19675796|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20377436|NCT01006681|Vaccines|vaccines|mesh-list
20377437|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20377438|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
19328972|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19328973|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19328974|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19675797|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19675798|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675799|NCT01903486|Prednisone|prednisone|mesh-list
19675800|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377439|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377440|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20377441|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
20377442|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20377443|NCT01006720|Neostigmine|neostigmine|mesh-list
20377444|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20377445|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377446|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377447|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
20377448|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377449|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377450|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20377451|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
20377452|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377453|NCT01006798|Vaccines|vaccines|mesh-list
20377454|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
20377455|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377456|NCT01006863|Phenylephrine|phenylephrine|mesh-list
20377457|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
20377458|NCT01006863|Ephedrine|ephedrine|mesh-list
20377459|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20377460|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
20377461|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
20377462|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377463|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328975|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19328976|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19328977|NCT03921567|Analgesics|analgesics|mesh-ancestor
19328978|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19328979|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328980|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
19328981|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19328982|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19328983|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675801|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
19675802|NCT01903486|Hormones|hormones|mesh-ancestor
19675803|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377464|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
20377465|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20377466|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
20377467|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
20377468|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20377469|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20377470|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20377471|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
20377472|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19328984|NCT03921775|Propofol|propofol|mesh-list
19328985|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19328986|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328987|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328988|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19328989|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
19328990|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
19328991|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
19328992|NCT03921177|Micronutrients|micronutrients|mesh-list
19328993|NCT03921177|Trace Elements|trace elements|mesh-list
19328994|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19328995|NCT03921034|Ropivacaine|ropivacaine|mesh-list
19328996|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
19328997|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
19328998|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19328999|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329000|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
19329001|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329002|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
19329003|NCT03921099|Vitamins|vitamins|mesh-ancestor
19329004|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
19329005|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329006|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
19329007|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329008|NCT03921099|Protective Agents|protective agents|mesh-ancestor
19329009|NCT03920657|Deferasirox|deferasirox|mesh-list
19329010|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20377473|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377474|NCT01006863|Protective Agents|protective agents|mesh-ancestor
19329011|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
19329012|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
20377475|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20377476|NCT01006876|Warfarin|warfarin|mesh-list
20377477|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
20377478|NCT01007019|Esomeprazole|esomeprazole|mesh-list
20377479|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20377480|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377481|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20377482|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377483|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377484|NCT01007084|Propranolol|propranolol|mesh-list
20377485|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20377486|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20377487|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
20377488|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377489|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377490|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377491|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20377492|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20377493|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
20377494|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20377495|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20377496|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20377497|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
20377498|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377499|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20377500|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20377501|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426066|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426067|NCT01278758|Vadimezan|vadimezan|mesh-list
20426068|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426069|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
20426070|NCT01278784|Chitosan|chitosan|mesh-list
20426071|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20426072|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20426073|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19675804|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675805|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19675806|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675807|NCT01811368|Cyclosporine|cyclosporine|mesh-list
19675808|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
19329013|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426074|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
20426075|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675809|NCT01811368|Rituximab|rituximab|mesh-list
19675810|NCT01811368|Cyclosporins|cyclosporins|mesh-list
19675811|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
19675812|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19675813|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
19675814|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675815|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675816|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
19675817|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675818|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675819|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675820|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675821|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675822|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
19675823|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675824|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19675825|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19675826|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19675827|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19675828|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
19675829|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19675830|NCT01611116|Sirolimus|sirolimus|mesh-list
19675831|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19675832|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675833|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19675834|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675835|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
19675836|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19675837|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
19675838|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426076|NCT01278784|Expectorants|expectorants|mesh-ancestor
19675839|NCT01288625|Amifostine|amifostine|mesh-list
19675840|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19329014|NCT03920631|Nivolumab|nivolumab|mesh-list
19329015|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329016|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329017|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19329018|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675841|NCT01288625|Protective Agents|protective agents|mesh-ancestor
19675842|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675843|NCT00848328|Rituximab|rituximab|mesh-list
19675844|NCT00848328|Lenalidomide|lenalidomide|mesh-list
19675845|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675846|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675847|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
19675848|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675849|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675850|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19675851|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19675852|NCT00848328|Growth Substances|growth substances|mesh-ancestor
19675853|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
19675854|NCT00599170|Rituximab|rituximab|mesh-list
19675855|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19675856|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675857|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
19675858|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675859|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692306|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329019|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
20377502|NCT01007500|Dexamethasone|dexamethasone|mesh-list
20377503|NCT01007500|Ondansetron|ondansetron|mesh-list
20377504|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377505|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
20377506|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
20377507|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377508|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377509|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377510|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
20377511|NCT01007500|Hormones|hormones|mesh-ancestor
20377512|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377513|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19329020|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
19399065|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
19692307|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19841728|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377514|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377515|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
20377516|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
20377517|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20377518|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
20377519|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377520|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377521|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20377522|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20377523|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377524|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20377525|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20377526|NCT01007539|Choline|choline|mesh-list
20377527|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20377528|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
20377529|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20377530|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
20377531|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377532|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377533|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20377534|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
20377535|NCT01007565|Anesthetics|anesthetics|mesh-list
20377536|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377537|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377538|NCT01007578|Paclitaxel|paclitaxel|mesh-list
20377539|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20377540|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377541|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
20377542|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
20377543|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
20377544|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613213|NCT02254005|Maytansine|maytansine|mesh-list
19692308|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
19692309|NCT04993014|Trastuzumab|trastuzumab|mesh-list
19675860|NCT05128292|Selenium|selenium|mesh-list
19675861|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
19675862|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675863|NCT05128292|Protective Agents|protective agents|mesh-ancestor
19675864|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675865|NCT05128292|Trace Elements|trace elements|mesh-ancestor
19675866|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
19675867|NCT05128175|Levodopa|levodopa|mesh-list
19675868|NCT05128175|Carbidopa|carbidopa|mesh-list
19675869|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19675870|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19675871|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19675872|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
19675873|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675874|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675875|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675876|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19675877|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675878|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19675879|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
19675880|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
19675881|NCT05128162|Psilocybin|psilocybin|mesh-list
19675882|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
19675883|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675884|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675885|NCT05127980|Antibodies|antibodies|mesh-list
19675886|NCT05127980|Autoantibodies|autoantibodies|mesh-list
19675887|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
19675888|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675889|NCT05127746|Donepezil|donepezil|mesh-list
19675890|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19675891|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675892|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675893|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
19675894|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675895|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675896|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
19675897|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
19675898|NCT05127707|Narcotics|narcotics|mesh-ancestor
19675899|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192538|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20192539|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
20192540|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192541|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20192542|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20192543|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20192544|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20192545|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
20192546|NCT00223717|Coagulants|coagulants|mesh-ancestor
20192547|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20192548|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20192549|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
20192550|NCT00223743|Zonisamide|zonisamide|mesh-list
20192551|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
20192552|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20192553|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192554|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192555|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20192556|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192557|NCT00223769|Oxandrolone|oxandrolone|mesh-list
20192558|NCT00223769|Androgens|androgens|mesh-ancestor
20192559|NCT00223769|Hormones|hormones|mesh-ancestor
20192560|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192561|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192562|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
20192563|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20192564|NCT00223860|Hormones|hormones|mesh-list
20192565|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20192566|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192567|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192568|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20192569|NCT00223925|Maribavir|maribavir|mesh-list
19675900|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675901|NCT05127707|Analgesics|analgesics|mesh-ancestor
20192570|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
20192571|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192572|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
20192573|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
20192574|NCT00223938|Hematinics|hematinics|mesh-ancestor
20192575|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
20192576|NCT00223964|Hematinics|hematinics|mesh-ancestor
20192577|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
20192578|NCT00224068|Hematinics|hematinics|mesh-ancestor
20192579|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
20192580|NCT00224081|Hematinics|hematinics|mesh-ancestor
20192581|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20192582|NCT00224094|Estrogens|estrogens|mesh-ancestor
20192583|NCT00224094|Hormones|hormones|mesh-ancestor
20377545|NCT01007630|Rasagiline|rasagiline|mesh-list
20377546|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20192584|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675902|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
19675903|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329021|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329022|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19329023|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329024|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329025|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
19329026|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329027|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19329028|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192585|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192586|NCT00224146|Oxybutynin|oxybutynin|mesh-list
19675904|NCT05127395|Acyclovir|acyclovir|mesh-list
19675905|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
19675906|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675907|NCT05127369|Fluoxetine|fluoxetine|mesh-list
19675908|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19675909|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192587|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
20192588|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
20192589|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192590|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192591|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20192592|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20192593|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
20192594|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192595|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192596|NCT00224146|Urological Agents|urological agents|mesh-ancestor
20217452|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20217453|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20217454|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217455|NCT00309621|Alitretinoin|alitretinoin|mesh-list
20217456|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217457|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
20217458|NCT00309634|Vaccines|vaccines|mesh-list
20217459|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
20217460|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217461|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
20217462|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20217463|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217464|NCT00309673|Lidocaine|lidocaine|mesh-list
20217465|NCT00309673|Prilocaine|prilocaine|mesh-list
20217466|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20217467|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
20217468|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
20217469|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217470|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217471|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
20217472|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217473|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20217474|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20217475|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20217476|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217477|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675910|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217478|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20217479|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20377547|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377548|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377549|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20377550|NCT01007630|Protective Agents|protective agents|mesh-ancestor
20377551|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377552|NCT01007695|Valproic Acid|valproic acid|mesh-list
20377553|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
20377554|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377555|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377556|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
20377557|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377558|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192597|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20192598|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20192599|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192600|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20377559|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
20377560|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20377561|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377562|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20377563|NCT01007773|Fentanyl|fentanyl|mesh-list
20377564|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
20377565|NCT01007773|Propofol|propofol|mesh-list
20377566|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19675911|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675912|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675913|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
19675914|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675915|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19675916|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
20377567|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377568|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377569|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20377570|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
20377571|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
20377572|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20377573|NCT01007773|Analgesics|analgesics|mesh-ancestor
20377574|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
20192601|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329036|NCT03920878|Aflibercept|aflibercept|mesh-list
19329037|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19329038|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19329039|NCT03920878|Growth Substances|growth substances|mesh-ancestor
19329040|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329041|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
19329042|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329043|NCT03920618|Tenofovir|tenofovir|mesh-list
19675917|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19675918|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19675919|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19675920|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675921|NCT05126901|Ferric maltol|ferric maltol|mesh-list
19675922|NCT05126901|Hematinics|hematinics|mesh-ancestor
19675923|NCT05126836|Cilostazol|cilostazol|mesh-list
19675924|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19675925|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
19675926|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192602|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192603|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192604|NCT00224302|Analgesics|analgesics|mesh-ancestor
20192605|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
20192606|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19675927|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675928|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19675929|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
20192607|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192608|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192609|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
20192610|NCT00224315|Risperidone|risperidone|mesh-list
20192611|NCT00224315|Ziprasidone|ziprasidone|mesh-list
20192612|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20192613|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
20192614|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192615|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217480|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20377575|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192616|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377576|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20377577|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19675930|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19675931|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19675932|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675933|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19675934|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
19675935|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20192617|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192618|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20192619|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192620|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192621|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20192622|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
20192623|NCT00224354|Interleukin-2|interleukin-2|mesh-list
20192624|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
20192625|NCT00224354|Immunotoxins|immunotoxins|mesh-list
19675936|NCT05126836|Protective Agents|protective agents|mesh-ancestor
20377578|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20377579|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
20192626|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192627|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192628|NCT00224354|Analgesics|analgesics|mesh-ancestor
20192629|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
20192630|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329044|NCT03920618|Entecavir|entecavir|mesh-list
19329045|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
19329046|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329047|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19329048|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19329049|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329050|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329051|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19329052|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19329053|NCT03920839|Gemcitabine|gemcitabine|mesh-list
19329054|NCT03920839|Paclitaxel|paclitaxel|mesh-list
19329055|NCT03920839|Carboplatin|carboplatin|mesh-list
19329056|NCT03920839|Pemetrexed|pemetrexed|mesh-list
19329057|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19329058|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377580|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377581|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377582|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20377583|NCT01007773|Narcotics|narcotics|mesh-ancestor
20377584|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20377585|NCT01007799|Vitamin D|vitamin d|mesh-list
20377586|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
20377587|NCT01007799|Vitamins|vitamins|mesh-list
20377588|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
20377589|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377590|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20377591|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20377592|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20377593|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
20377594|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20377595|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
20377596|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20377597|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377598|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20377599|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20377600|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377601|NCT01007864|Pramipexole|pramipexole|mesh-list
20377602|NCT01007864|Ropinirole|ropinirole|mesh-list
19329059|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
19329060|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19329061|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19329062|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329063|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19329064|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
19329065|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
19692310|NCT04993014|Pertuzumab|pertuzumab|mesh-list
20377603|NCT01007864|Piribedil|piribedil|mesh-list
20192631|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329066|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377604|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
20377605|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329067|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329068|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377606|NCT01007864|Protective Agents|protective agents|mesh-ancestor
20377607|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377608|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20377609|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20377610|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
20377611|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
20377612|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377613|NCT01007968|Panobinostat|panobinostat|mesh-list
20377614|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377615|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20377616|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377617|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377618|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20377619|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
19329069|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
19329070|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675937|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19675938|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19675939|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675940|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
19675941|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20192632|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
20192633|NCT00224393|Etanercept|etanercept|mesh-list
20377620|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329071|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19329072|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19329073|NCT03920644|Scopolamine|scopolamine|mesh-list
19329074|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19329075|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19329076|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
20377621|NCT01008020|Protective Agents|protective agents|mesh-ancestor
20377622|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377623|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20377624|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20377625|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377626|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20377627|NCT01008046|Metformin|metformin|mesh-list
20377628|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
20377629|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20377630|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20377631|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377632|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
20377633|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377634|NCT01008046|Expectorants|expectorants|mesh-ancestor
20377635|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
20377636|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20377637|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
20377638|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377639|NCT01008046|Protective Agents|protective agents|mesh-ancestor
19329077|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
19329078|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329079|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329080|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19329081|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
19329082|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19329083|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
19329084|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329085|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329086|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19329087|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
19329088|NCT03920605|Tenofovir|tenofovir|mesh-list
19329089|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20192634|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192635|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192636|NCT00224393|Analgesics|analgesics|mesh-ancestor
20192637|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
20192638|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192639|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329090|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19329091|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
19675942|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192640|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329092|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329093|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19329094|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19329095|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377640|NCT01008046|Antidotes|antidotes|mesh-ancestor
20377641|NCT01008098|Citalopram|citalopram|mesh-list
20377642|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20377643|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20377644|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20377645|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377646|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377647|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
20377648|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377649|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20377650|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
20377651|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20377652|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20377653|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20377654|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377655|NCT01008137|Vaccines|vaccines|mesh-list
20377656|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
20377657|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377658|NCT01008293|Lactulose|lactulose|mesh-list
20377659|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377660|NCT01008345|Ezetimibe|ezetimibe|mesh-list
20377661|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20377662|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20377663|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
20377664|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377665|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20377666|NCT01008358|Tremelimumab|tremelimumab|mesh-list
19329096|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329097|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19329098|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19329099|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
19329100|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19329101|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
19329102|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329103|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
19329104|NCT03920553|Protective Agents|protective agents|mesh-ancestor
19675943|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192641|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192642|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20192643|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192644|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
20192645|NCT00224419|Nicotine|nicotine|mesh-list
20192646|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20192647|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
20192648|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192649|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192650|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20192651|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19675944|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
19675945|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19675946|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675947|NCT05126602|Vitamin D|vitamin d|mesh-list
19675948|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
19675949|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
19675950|NCT05126602|Vitamins|vitamins|mesh-list
19675951|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
19675952|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675953|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19692311|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20377667|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192652|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
20377668|NCT01008384|Vitamin D|vitamin d|mesh-list
20377669|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
20377670|NCT01008384|Vitamins|vitamins|mesh-ancestor
20377671|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
20377672|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377673|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20377674|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20377675|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20377676|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329105|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19329106|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20192653|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192654|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192655|NCT00224445|Ritonavir|ritonavir|mesh-list
20192656|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20192657|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20192658|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20192659|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20192660|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
20192661|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192662|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329107|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329108|NCT03920150|Vitamin D|vitamin d|mesh-list
19329109|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
19329110|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
19329111|NCT03920150|Vitamins|vitamins|mesh-list
19329112|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
19329113|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329114|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19329115|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19329116|NCT03920137|Nicotine|nicotine|mesh-list
19329117|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19675954|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19675955|NCT05126342|Niraparib|niraparib|mesh-list
19675956|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19675957|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675958|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675959|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329118|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
19329119|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329120|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329121|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19675960|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
19675961|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
19675962|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19675963|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19675964|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675965|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675966|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675967|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19675968|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
19675969|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19675970|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675971|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
19675972|NCT05126004|Azacitidine|azacitidine|mesh-list
19675973|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19675974|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19675975|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
19675976|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19675977|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675978|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19675979|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
20192663|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20192664|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20192665|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
20192666|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192667|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20192668|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20192669|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20192670|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20192671|NCT00224458|Efavirenz|efavirenz|mesh-list
20192672|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20192673|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20192674|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20192675|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192676|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192677|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
20192678|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192679|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20192680|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20192681|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19329122|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19675980|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19675981|NCT05126004|Expectorants|expectorants|mesh-ancestor
19675982|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
19675983|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19675984|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
19675985|NCT05126004|Protective Agents|protective agents|mesh-ancestor
19675986|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675987|NCT05126004|Antidotes|antidotes|mesh-ancestor
19675988|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
19675989|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19675990|NCT05125640|Progesterone|progesterone|mesh-list
19675991|NCT05125640|Progestins|progestins|mesh-ancestor
19675992|NCT05125640|Hormones|hormones|mesh-ancestor
19675993|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675994|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19675995|NCT05125627|Progesterone|progesterone|mesh-list
19329123|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
19329124|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329125|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399066|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20377677|NCT01008527|Poly ICLC|poly iclc|mesh-list
20377678|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
20377679|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
20377680|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377681|NCT01008566|Sorafenib|sorafenib|mesh-list
19399067|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19675996|NCT05125627|Progestins|progestins|mesh-ancestor
19675997|NCT05125627|Hormones|hormones|mesh-ancestor
19675998|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19675999|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676000|NCT05125588|Meloxicam|meloxicam|mesh-list
19676001|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19676002|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676003|NCT05125588|Analgesics|analgesics|mesh-ancestor
19676004|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
19676005|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676006|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676007|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676008|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192682|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20377682|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20377683|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377684|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19399068|NCT03637790|Rifampin|rifampin|mesh-list
19399069|NCT03637790|Abrocitinib|abrocitinib|mesh-list
19399070|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19399071|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
19399072|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399073|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399074|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
19399075|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20192683|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20192684|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19399076|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399077|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399078|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19399079|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20192685|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20192686|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20192687|NCT00224471|Vaccines|vaccines|mesh-list
20192688|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
19399080|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19399081|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19399082|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19399083|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19399084|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19399085|NCT03637582|Lidocaine|lidocaine|mesh-list
19399086|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
19399087|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
19399088|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399089|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676009|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20192689|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192690|NCT00224510|Lamotrigine|lamotrigine|mesh-list
20377685|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676010|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20377686|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377687|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
20377688|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377689|NCT01008592|Levocetirizine|levocetirizine|mesh-list
20377690|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20377691|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20377692|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
20377693|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
19676011|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676012|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676013|NCT05125575|Metformin|metformin|mesh-list
19676014|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19676015|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329126|NCT03920475|Sertraline|sertraline|mesh-list
19329127|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19329128|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
19329129|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19329130|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19329131|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19841729|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
20377694|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377695|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377696|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377697|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
20377698|NCT01008631|Antidotes|antidotes|mesh-ancestor
20377699|NCT01008631|Protective Agents|protective agents|mesh-ancestor
20377700|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377701|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
20377702|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377703|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
20377704|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20377705|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377706|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
20377707|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
20377708|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20377709|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19841730|NCT00642954|Hormones|hormones|mesh-ancestor
19841731|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19329132|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329133|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676016|NCT05125549|Clopidogrel|clopidogrel|mesh-list
19676017|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19676018|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19676019|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19676020|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19676021|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
19676022|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676023|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676024|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676025|NCT05125380|Acetic Acid|acetic acid|mesh-list
19676026|NCT05125380|Retinol acetate|retinol acetate|mesh-list
19676027|NCT05125380|Lugol's solution|lugol's solution|mesh-list
19676028|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19676029|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676030|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19676031|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
19676032|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676033|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19841732|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19841733|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841734|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
19841735|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20192691|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
20192692|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20192693|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192694|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192695|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20192696|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192697|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192698|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20217481|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20377710|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
20377711|NCT01008709|Hormones|hormones|mesh-ancestor
20377712|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377713|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329134|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329135|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
19329136|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329137|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19329138|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19329139|NCT03920319|Bupropion|bupropion|mesh-list
19329140|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19329141|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
19329142|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19329143|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19329144|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19329145|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329146|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329147|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
19329148|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329149|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329150|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19329151|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19329152|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329153|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
19329154|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19329155|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377714|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377715|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377716|NCT01008761|Azithromycin|azithromycin|mesh-list
20377717|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20377718|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377719|NCT01008813|Vaccines|vaccines|mesh-list
20377720|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
20377721|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377722|NCT01008917|Sirolimus|sirolimus|mesh-list
20377723|NCT01008917|Sorafenib|sorafenib|mesh-list
20377724|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377725|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377726|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377727|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377728|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20377729|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377730|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20377731|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
20377732|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377733|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
20377734|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377735|NCT01008982|Belimumab|belimumab|mesh-list
20377736|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377737|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
20377738|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377739|NCT01009021|Diclofenac|diclofenac|mesh-list
19329156|NCT03920397|Vitamins|vitamins|mesh-ancestor
19329157|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
19329158|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19329159|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
19329160|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19329161|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329162|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329163|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
19329164|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329165|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841736|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19841737|NCT00642954|Growth Substances|growth substances|mesh-ancestor
19841738|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
19841739|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19841740|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841741|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841742|NCT00643097|Temozolomide|temozolomide|mesh-list
19841743|NCT00643097|Sargramostim|sargramostim|mesh-list
19841744|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19841745|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
20377740|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20377741|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20377742|NCT01009021|Analgesics|analgesics|mesh-ancestor
20377743|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
20377744|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377745|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377746|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377747|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377748|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20377749|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377750|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377751|NCT01009073|Irinotecan|irinotecan|mesh-list
20377752|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20377753|NCT01009073|Navitoclax|navitoclax|mesh-list
20377754|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20377755|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20377756|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377757|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329166|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
19329167|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19329168|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329169|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19329170|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
19329171|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20377758|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377759|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20377760|NCT01009177|Bosentan|bosentan|mesh-list
20377761|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20377762|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20377763|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377764|NCT01009190|Carboplatin|carboplatin|mesh-list
20377765|NCT01009190|Rucaparib|rucaparib|mesh-list
20377766|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377767|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20377768|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377769|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426077|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
20426078|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20426079|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
20426080|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426081|NCT01278784|Protective Agents|protective agents|mesh-ancestor
20426082|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426083|NCT01278784|Antidotes|antidotes|mesh-ancestor
20426084|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20426085|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20426086|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
20426087|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20426088|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
20426089|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
20426090|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
20426091|NCT01278784|Coagulants|coagulants|mesh-ancestor
20426092|NCT01278849|Vadimezan|vadimezan|mesh-list
19329172|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329173|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329174|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329175|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19329176|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329177|NCT03919786|Anesthetics|anesthetics|mesh-list
19329178|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329179|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329180|NCT03919955|Oxybutynin|oxybutynin|mesh-list
19329181|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19329182|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19676034|NCT05125380|Protective Agents|protective agents|mesh-ancestor
19676035|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676036|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
19676037|NCT05125380|Coagulants|coagulants|mesh-ancestor
19676038|NCT05125328|Remifentanil|remifentanil|mesh-list
19676039|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19676040|NCT05125328|Narcotics|narcotics|mesh-ancestor
19676041|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676042|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676043|NCT05125328|Analgesics|analgesics|mesh-ancestor
19676044|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
19676045|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329183|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19329184|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329185|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329186|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329187|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329188|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329189|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
19329190|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
19329191|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329192|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19329193|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19329194|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
19329195|NCT03919955|Urological Agents|urological agents|mesh-ancestor
19329196|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
19329197|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19329198|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329199|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
19329200|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
19329201|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19329202|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329203|NCT03919812|Vitamins|vitamins|mesh-ancestor
20377770|NCT01009437|Ritonavir|ritonavir|mesh-list
20377771|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20377772|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20377773|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
20377774|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377775|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377776|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20377777|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20377778|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
20377779|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377780|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20377781|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20377782|NCT01009476|Nicergoline|nicergoline|mesh-list
20377783|NCT01009476|Piracetam|piracetam|mesh-list
20377784|NCT01009476|Galantamine|galantamine|mesh-list
20377785|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
20377786|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20377787|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329204|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
19329205|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20192699|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192700|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192701|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20192702|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
20192703|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192704|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
20192705|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20192706|NCT00224549|Amlodipine|amlodipine|mesh-list
20192707|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20192708|NCT00224549|Irbesartan|irbesartan|mesh-list
20192709|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20192710|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20192711|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192712|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192713|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20192714|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377788|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377789|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
19329206|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
19329207|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19676046|NCT05125276|Aspirin|aspirin|mesh-list
19676047|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19676048|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676049|NCT05125276|Analgesics|analgesics|mesh-ancestor
19676050|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
19676051|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676052|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676053|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676054|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377790|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329208|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329209|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19329210|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329211|NCT03919552|Cisplatin|cisplatin|mesh-list
19329212|NCT03919552|Carboplatin|carboplatin|mesh-list
20377791|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377792|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20377793|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
20377794|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377795|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19329213|NCT03919552|Docetaxel|docetaxel|mesh-list
19329214|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329215|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
19329216|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
19329217|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
19329218|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329219|NCT03919565|Tenofovir|tenofovir|mesh-list
19329220|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19329221|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19329222|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
19329223|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329224|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19329225|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19329226|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329227|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329228|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19329229|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19329230|NCT03919253|Paclitaxel|paclitaxel|mesh-list
19329231|NCT03919253|Maleic acid|maleic acid|mesh-list
19329232|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19329233|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329234|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
19329235|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
19329236|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
19329237|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377796|NCT01009476|Protective Agents|protective agents|mesh-ancestor
20377797|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20377798|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20377799|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
20377800|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
20377801|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20377802|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20377803|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20377804|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377805|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
20377806|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20377807|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
20377808|NCT01009541|Pregabalin|pregabalin|mesh-list
20377809|NCT01009541|Analgesics|analgesics|mesh-ancestor
20377810|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
20377811|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377812|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329238|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329239|NCT03919383|Lenvatinib|lenvatinib|mesh-list
19329240|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329241|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19329242|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329243|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329244|NCT03919448|Bevacizumab|bevacizumab|mesh-list
19329245|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329246|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329247|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20192715|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
20192716|NCT00224549|Diuretics|diuretics|mesh-ancestor
20192717|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
20192718|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20192719|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20192720|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20192721|NCT00224588|Ketamine|ketamine|mesh-list
20192722|NCT00224588|Analgesics|analgesics|mesh-ancestor
20192723|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
20192724|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192725|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192726|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20377813|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
19329248|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19329249|NCT03919448|Growth Substances|growth substances|mesh-ancestor
19329250|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192727|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20377814|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20377815|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20377816|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377817|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20377818|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20377819|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20377820|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377821|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20377822|NCT01009567|Cabergoline|cabergoline|mesh-list
20377823|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19329251|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
20192728|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
20192729|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
20377824|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20377825|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
20377826|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
20377827|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377828|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377829|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377830|NCT01009593|Sorafenib|sorafenib|mesh-list
20377831|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377832|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20192730|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192731|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20192732|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20192733|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192734|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192735|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
20377833|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329252|NCT03919084|Nicotine|nicotine|mesh-list
19329253|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19329254|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
19329255|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329256|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329257|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19329258|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19329259|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
19329260|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329261|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329262|NCT03919461|Etodolac|etodolac|mesh-list
19329263|NCT03919461|Propranolol|propranolol|mesh-list
19329264|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19676055|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19676056|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19676057|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676058|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19676059|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19676060|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676061|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
19676062|NCT05125055|Paclitaxel|paclitaxel|mesh-list
19676063|NCT05125055|Docetaxel|docetaxel|mesh-list
19676064|NCT05125055|Fluorouracil|fluorouracil|mesh-list
19676065|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20192736|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
20192737|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
19329265|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19329266|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329267|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329268|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329269|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329270|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19329271|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19329272|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
19329273|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329274|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329275|NCT03919461|Analgesics|analgesics|mesh-ancestor
19329276|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
19329277|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329278|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329279|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329280|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19329281|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19329282|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676066|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377834|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377835|NCT01009697|Codeine|codeine|mesh-list
20377836|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20377837|NCT01009697|Narcotics|narcotics|mesh-ancestor
20377838|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377839|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377840|NCT01009697|Analgesics|analgesics|mesh-ancestor
20377841|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
20377842|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612818|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20612819|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20612820|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20612821|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612822|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20612823|NCT02252926|Narcotics|narcotics|mesh-ancestor
20612824|NCT02252926|Analgesics|analgesics|mesh-ancestor
20612825|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612826|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
20612827|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
20612828|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20612829|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19329283|NCT03919175|Rituximab|rituximab|mesh-list
19329284|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329285|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329286|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
19329287|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329288|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329289|NCT03918993|Tadalafil|tadalafil|mesh-list
19329290|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
19329291|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19329292|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19329293|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329294|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329295|NCT03918993|Urological Agents|urological agents|mesh-ancestor
19329296|NCT03918616|Dopamine|dopamine|mesh-list
19329297|NCT03918616|Memantine|memantine|mesh-list
19329298|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
19329299|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19329300|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19329301|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
19329302|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329303|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329304|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329305|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19329306|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19329307|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20192738|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192739|NCT00224679|Aspirin|aspirin|mesh-list
20192740|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20192741|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192742|NCT00224679|Analgesics|analgesics|mesh-ancestor
20192743|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
20192744|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192745|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192746|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192747|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192748|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192749|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20192750|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192751|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20192752|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20192753|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192754|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
20192755|NCT00224692|Ketamine|ketamine|mesh-list
20192756|NCT00224692|Analgesics|analgesics|mesh-ancestor
20192757|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
20192758|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192759|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192760|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20192761|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20192762|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
20192763|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
20377843|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
20612830|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19329308|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
19329309|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
19329310|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329311|NCT03918616|Protective Agents|protective agents|mesh-ancestor
19329312|NCT03918590|Nepafenac|nepafenac|mesh-list
19329313|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19329314|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329315|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329316|NCT03918590|Analgesics|analgesics|mesh-ancestor
19329317|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
19329318|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329319|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329320|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329321|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329322|NCT03918590|Laxatives|laxatives|mesh-ancestor
19329323|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19329324|NCT03918694|Ascorbic Acid|ascorbic acid|mesh-list
19329325|NCT03918694|Vitamins|vitamins|mesh-ancestor
19329326|NCT03918694|Micronutrients|micronutrients|mesh-ancestor
19329327|NCT03918694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329328|NCT03918694|Antioxidants|antioxidants|mesh-ancestor
19329329|NCT03918694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329330|NCT03918694|Protective Agents|protective agents|mesh-ancestor
19329331|NCT03918889|Midazolam|midazolam|mesh-list
19329332|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
20612831|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19329333|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20377844|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
20377845|NCT01009788|Temozolomide|temozolomide|mesh-list
20377846|NCT01009788|Veliparib|veliparib|mesh-list
20377847|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20377848|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
20377849|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377850|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377851|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19329334|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329335|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329336|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329337|NCT03918889|Analgesics|analgesics|mesh-ancestor
19329338|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
19329339|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329340|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19329341|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19329342|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19329343|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329344|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329345|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329346|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19329347|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19329348|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19329349|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19329350|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19329351|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
19329352|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
19329353|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
19329354|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
19329355|NCT03918551|Febuxostat|febuxostat|mesh-list
19329356|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
19676067|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
19676068|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
19676069|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
20613214|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
19329357|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329358|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
19329359|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
19329360|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329361|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
19329362|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329363|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329364|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19329365|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
19329366|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329367|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329368|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19676070|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676071|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
19676072|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19676073|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676074|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
19676075|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377852|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377853|NCT01009801|Doxorubicin|doxorubicin|mesh-list
20377854|NCT01009801|Everolimus|everolimus|mesh-list
20377855|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20377856|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377857|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20377858|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20377859|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377860|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377861|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377862|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
20377863|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377864|NCT01009853|Codeine|codeine|mesh-list
20377865|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20377866|NCT01009853|Narcotics|narcotics|mesh-ancestor
20377867|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377868|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377869|NCT01009853|Analgesics|analgesics|mesh-ancestor
19329369|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329370|NCT03918265|Tacrolimus|tacrolimus|mesh-list
19329371|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329372|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
19329373|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329374|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19329375|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329376|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329377|NCT03918252|Nivolumab|nivolumab|mesh-list
20377870|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
20377871|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377872|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
20377873|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
20377874|NCT01009879|Etanercept|etanercept|mesh-list
20377875|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20377876|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20377877|NCT01009879|Analgesics|analgesics|mesh-ancestor
20377878|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
20377879|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329378|NCT03918252|Ipilimumab|ipilimumab|mesh-list
19329379|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329380|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329381|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19329382|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399090|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
19399091|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399092|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19399093|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19399094|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19399095|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399096|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399097|NCT03637543|Nivolumab|nivolumab|mesh-list
19399098|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676076|NCT05125042|Amiodarone|amiodarone|mesh-list
20192764|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192765|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20192766|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20192767|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377880|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377881|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377882|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192768|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192769|NCT00224809|Aspirin|aspirin|mesh-list
20192770|NCT00224809|Spironolactone|spironolactone|mesh-list
20192771|NCT00224809|Clopidogrel|clopidogrel|mesh-list
20192772|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20192773|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20192774|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20377883|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377884|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377885|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
20377886|NCT01009892|Codeine|codeine|mesh-list
20377887|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19329383|NCT03918187|Midazolam|midazolam|mesh-list
19329384|NCT03918187|Nalbuphine|nalbuphine|mesh-list
20192775|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19676077|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19676078|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
19676079|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19676080|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19676081|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676082|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19676083|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19676084|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19676085|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676086|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19676087|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19676088|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19676089|NCT05124951|Carboplatin|carboplatin|mesh-list
19676090|NCT05124951|Etoposide|etoposide|mesh-list
19676091|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
19329385|NCT03918187|Bupivacaine|bupivacaine|mesh-list
19676092|NCT05124951|Ifosfamide|ifosfamide|mesh-list
20612832|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19329386|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
19329387|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
19329388|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329389|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329390|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
19329391|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676093|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676094|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676095|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19676096|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20192776|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329392|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19329393|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19329394|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19329395|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19329396|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192777|NCT00224809|Analgesics|analgesics|mesh-ancestor
20192778|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
20192779|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192780|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329397|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19329398|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
19329399|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
19329400|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
19329401|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192781|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192782|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329402|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329403|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19329404|NCT03918187|Narcotics|narcotics|mesh-ancestor
19329405|NCT03918187|Analgesics|analgesics|mesh-ancestor
19329406|NCT03917914|Bisoprolol|bisoprolol|mesh-list
19329407|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19329408|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
19329409|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
19329410|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329411|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329412|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19329413|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19329414|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19329415|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329416|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329417|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329418|NCT03918135|Acetaminophen|acetaminophen|mesh-list
19329419|NCT03918135|Ibuprofen|ibuprofen|mesh-list
19329420|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329421|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329422|NCT03918135|Analgesics|analgesics|mesh-ancestor
19329423|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
19329424|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192783|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192784|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19676097|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676098|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676099|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19676100|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
19676101|NCT05124938|Hormones|hormones|mesh-list
19676102|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19676103|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676104|NCT05124730|Metformin|metformin|mesh-list
19841746|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329425|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329426|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329427|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329428|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19329429|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329430|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329431|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
20192785|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192786|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20192787|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20192788|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
20192789|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20192790|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19329432|NCT03917940|Glimepiride|glimepiride|mesh-list
19329433|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19329434|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19329435|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329436|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329437|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
19329438|NCT03917784|Curcumin|curcumin|mesh-list
19329439|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329440|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329441|NCT03917784|Analgesics|analgesics|mesh-ancestor
19676105|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19676106|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676107|NCT05124717|Metformin|metformin|mesh-list
19676108|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19676109|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676110|NCT05124431|Everolimus|everolimus|mesh-list
19676111|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676112|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676113|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
19841747|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841748|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
19676114|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676115|NCT05118620|Bupivacaine|bupivacaine|mesh-list
19676116|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
19841749|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841750|NCT00643123|Allopurinol|allopurinol|mesh-list
19841751|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
19841752|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841753|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841754|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
19841755|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841756|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19841757|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
19841758|NCT00643123|Protective Agents|protective agents|mesh-ancestor
19841759|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192791|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20192792|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
19676117|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
19676118|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676119|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676120|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
19676121|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676122|NCT05115591|Anesthetics|anesthetics|mesh-list
19841760|NCT00643162|Citalopram|citalopram|mesh-list
20192793|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192794|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20192795|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
20192796|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192797|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20192798|NCT00224809|Diuretics|diuretics|mesh-ancestor
20192799|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
20377888|NCT01009892|Narcotics|narcotics|mesh-ancestor
20377889|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377890|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377891|NCT01009892|Analgesics|analgesics|mesh-ancestor
19841761|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19676123|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676124|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676125|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19676126|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676127|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
19676128|NCT05109949|Empagliflozin|empagliflozin|mesh-list
19676129|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19676130|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676131|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19676132|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676133|NCT05104918|Vortioxetine|vortioxetine|mesh-list
19676134|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19676135|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19676136|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19841762|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19841763|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19841764|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676137|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19676138|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676139|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676140|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676141|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19676142|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
19676143|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19676144|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19841765|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841766|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
20377892|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
20377893|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377894|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
20377895|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
19329442|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
19329443|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329444|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329445|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329446|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329447|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329448|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329449|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329450|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
19329451|NCT03917758|Empagliflozin|empagliflozin|mesh-list
19329452|NCT03917758|Canagliflozin|canagliflozin|mesh-list
19329453|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20377896|NCT01009944|Atenolol|atenolol|mesh-list
20377897|NCT01009944|Lisinopril|lisinopril|mesh-list
20377898|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20377899|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20377900|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377901|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377902|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20377903|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20377904|NCT01009944|Protective Agents|protective agents|mesh-ancestor
20377905|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377906|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20377907|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
20377908|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
20377909|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377910|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20377911|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20377912|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20377913|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
20377914|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377915|NCT01009957|Everolimus|everolimus|mesh-list
20377916|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377917|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329454|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329455|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19329456|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329457|NCT03917459|Enalapril|enalapril|mesh-list
19329458|NCT03917459|Enalaprilat|enalaprilat|mesh-list
19329459|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20377918|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
20377919|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377920|NCT01009970|Prednisone|prednisone|mesh-list
20377921|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
20377922|NCT01009970|Rituximab|rituximab|mesh-list
20377923|NCT01009970|Doxorubicin|doxorubicin|mesh-list
20377924|NCT01009970|Vincristine|vincristine|mesh-list
20377925|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20377926|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
20377927|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377928|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20377929|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20377930|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
20377931|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377932|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20377933|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20377934|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329460|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19329461|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
19329462|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329463|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329464|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19329465|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19329466|NCT03917446|Propofol|propofol|mesh-list
19329467|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19329468|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329469|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329470|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19329471|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
19329472|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
19329473|NCT03917537|Nivolumab|nivolumab|mesh-list
20192800|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
20192801|NCT00224822|Aripiprazole|aripiprazole|mesh-list
20192802|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
20377935|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20377936|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20377937|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20377938|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377939|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20377940|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
20377941|NCT01009970|Hormones|hormones|mesh-ancestor
20377942|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377943|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20377944|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20377945|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20377946|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
19676145|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19676146|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20377947|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20192803|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192804|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20192805|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20377948|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20377949|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
20192806|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192807|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192808|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
20192809|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
20192810|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192811|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676147|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19676148|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
19676149|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19676150|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19676151|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19676152|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19676153|NCT05089942|Insulin|insulin|mesh-list
20377950|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
19676154|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20377951|NCT01010048|Nifedipine|nifedipine|mesh-list
20377952|NCT01010048|Bromides|bromides|mesh-list
19676155|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19676156|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676157|NCT05087914|Naproxen|naproxen|mesh-list
19676158|NCT05087914|Levodopa|levodopa|mesh-list
19676159|NCT05087914|Carbidopa|carbidopa|mesh-list
19329474|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329475|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329476|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19329477|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329478|NCT03917628|Adalimumab|adalimumab|mesh-list
19329479|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329480|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329481|NCT03917420|Tenofovir|tenofovir|mesh-list
19329482|NCT03917420|Emtricitabine|emtricitabine|mesh-list
19329483|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19329484|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
19329485|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329486|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19329487|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19329488|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329489|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329490|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19329491|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19329492|NCT03917303|Adalimumab|adalimumab|mesh-list
19329493|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676160|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19676161|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19676162|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676163|NCT05087914|Analgesics|analgesics|mesh-ancestor
19676164|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
19329494|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676165|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676166|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676167|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676168|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676169|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
19676170|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19676171|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841767|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329495|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
19329496|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
19329497|NCT03917095|Mesalamine|mesalamine|mesh-list
19329498|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329499|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329500|NCT03917095|Analgesics|analgesics|mesh-ancestor
19329501|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
19329502|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329503|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329504|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329505|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329506|NCT03916926|Fluorides|fluorides|mesh-list
19329507|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
19329508|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
19329509|NCT03916926|Protective Agents|protective agents|mesh-ancestor
19329510|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329511|NCT03917134|Metronidazole|metronidazole|mesh-list
19329512|NCT03917134|Cephalosporins|cephalosporins|mesh-list
19329513|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329514|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19329515|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19329516|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19329517|NCT03917082|Tamoxifen|tamoxifen|mesh-list
19329518|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19329519|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192812|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20192813|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20192814|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
20192815|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20192816|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19329520|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19676172|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676173|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20192817|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20192818|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20192819|NCT00224978|Chloroquine|chloroquine|mesh-list
20192820|NCT00224978|Amebicides|amebicides|mesh-ancestor
20377953|NCT01010048|Propantheline|propantheline|mesh-list
20377954|NCT01010048|Tamsulosin|tamsulosin|mesh-list
20377955|NCT01010048|Progesterone|progesterone|mesh-list
20377956|NCT01010048|Progestins|progestins|mesh-ancestor
20377957|NCT01010048|Hormones|hormones|mesh-ancestor
20377958|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20377959|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377960|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
20377961|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20377962|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20377963|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20377964|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20377965|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20377966|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192821|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20192822|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20192823|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192824|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
20192825|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192826|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
20192827|NCT00225043|Phenylephrine|phenylephrine|mesh-list
20192828|NCT00225043|Epinephrine|epinephrine|mesh-list
20192829|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
20192830|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20192831|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20192832|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329521|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
19329522|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19329523|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329524|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19329525|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329526|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19329527|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19329528|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19329529|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19329530|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329531|NCT03917394|Iron|iron|mesh-list
19329532|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19329533|NCT03917394|Trace Elements|trace elements|mesh-ancestor
19329534|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
19329535|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329536|NCT03917394|Hematinics|hematinics|mesh-ancestor
19329537|NCT03917186|Sevoflurane|sevoflurane|mesh-list
19329538|NCT03917186|Desflurane|desflurane|mesh-list
19329539|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19329540|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19329541|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
19329542|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
19329543|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329544|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329545|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
19329546|NCT03916679|Fludarabine|fludarabine|mesh-list
19329547|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329548|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
19329549|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329550|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329551|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19329552|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
19329553|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329554|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329555|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19329556|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
19329557|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19329558|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329559|NCT03916250|Petrolatum|petrolatum|mesh-list
19329560|NCT03916250|PF-06700841|pf-06700841|mesh-list
19329561|NCT03916250|Emollients|emollients|mesh-ancestor
19329562|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19329563|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19329564|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329565|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192833|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693130|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
20192834|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377967|NCT01010048|Urological Agents|urological agents|mesh-ancestor
19329566|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19329567|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19329568|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
19329569|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19329570|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329571|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19329572|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19329573|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19329574|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329575|NCT03916510|Capecitabine|capecitabine|mesh-list
19329576|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19329577|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
19329578|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329579|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329580|NCT03916432|Sirolimus|sirolimus|mesh-list
20377968|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20377969|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20377970|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20377971|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
20377972|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
20377973|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20377974|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20377975|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20377976|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20377977|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20377978|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
20377979|NCT01010087|Oseltamivir|oseltamivir|mesh-list
20377980|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
20377981|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20377982|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377983|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377984|NCT01010100|Acarbose|acarbose|mesh-list
20377985|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20377986|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20377987|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20377988|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20377989|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377990|NCT01010139|Codeine|codeine|mesh-list
20377991|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20377992|NCT01010139|Narcotics|narcotics|mesh-ancestor
20377993|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329581|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19329582|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329583|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19841768|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19841769|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
20377994|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20377995|NCT01010139|Analgesics|analgesics|mesh-ancestor
20377996|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
20377997|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20377998|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
20377999|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
20378000|NCT01010152|Codeine|codeine|mesh-list
20378001|NCT01010152|Analgesics|analgesics|mesh-ancestor
19329584|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329585|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
19329586|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329587|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
19329588|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329589|NCT03916406|Midazolam|midazolam|mesh-list
19329590|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19329591|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19329592|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329593|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329594|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19676174|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19676175|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
19676176|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676177|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19676178|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19676179|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
19676180|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
19676181|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19676182|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19329595|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19329596|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19329597|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19329598|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
19329599|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
19329600|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
19329601|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
19329602|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329603|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399099|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399100|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19399101|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399102|NCT03637400|Doxycycline|doxycycline|mesh-list
19399103|NCT03637400|Trimethoprim|trimethoprim|mesh-list
19399104|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
19399105|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399106|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399107|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
19399108|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19399109|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20378002|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
20378003|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378004|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378005|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20378006|NCT01010152|Narcotics|narcotics|mesh-ancestor
20378007|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20378008|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
20378009|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
20378010|NCT01010178|Theophylline|theophylline|mesh-list
20378011|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20378012|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
20378013|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378014|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378015|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20378016|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
20378017|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20378018|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378019|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378020|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378021|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20378022|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20378023|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
20378024|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378025|NCT01010243|Pioglitazone|pioglitazone|mesh-list
20378026|NCT01010243|Dexamethasone|dexamethasone|mesh-list
20378027|NCT01010243|Lenalidomide|lenalidomide|mesh-list
20378028|NCT01010243|Treosulfan|treosulfan|mesh-list
20378029|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378030|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
20378031|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
20378032|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378033|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378034|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20378035|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
19399110|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19399111|NCT03637400|Renal Agents|renal agents|mesh-ancestor
19676183|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19676184|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192835|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192836|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20192837|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20192838|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
20192839|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192840|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20192841|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
20192842|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
20192843|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
20192844|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20192845|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20192846|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
20378036|NCT01010243|Hormones|hormones|mesh-ancestor
19399112|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19399113|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399114|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676185|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676186|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676187|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676188|NCT05086393|Analgesics|analgesics|mesh-ancestor
19676189|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
19676190|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676191|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
19676192|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19676193|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
19676194|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
19676195|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19676196|NCT05073172|Petrolatum|petrolatum|mesh-list
19676197|NCT05073172|Mineral Oil|mineral oil|mesh-list
19676198|NCT05073172|Emollients|emollients|mesh-ancestor
19676199|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
19676200|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20192847|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20192848|NCT00225043|Protective Agents|protective agents|mesh-ancestor
20192849|NCT00225056|Docetaxel|docetaxel|mesh-list
20192850|NCT00225056|Capecitabine|capecitabine|mesh-list
20192851|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676201|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676202|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19676203|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19676204|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
19676205|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19676206|NCT05055323|Pyrvinium|pyrvinium|mesh-list
19676207|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
19329604|NCT03916068|Vitamin E|vitamin e|mesh-list
19329605|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
19329606|NCT03916068|Vitamins|vitamins|mesh-ancestor
19329607|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
19329608|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676208|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19676209|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192852|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
20192853|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
20192854|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
20192855|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192856|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20192857|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
20192858|NCT00225108|Tinzaparin|tinzaparin|mesh-list
20192859|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20192860|NCT00225108|Dalteparin|dalteparin|mesh-list
20192861|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
20192862|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192863|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20192864|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192865|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
20192866|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
20192867|NCT00225160|Vitamins|vitamins|mesh-ancestor
20192868|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
20192869|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192870|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
20192871|NCT00225173|Gemcitabine|gemcitabine|mesh-list
20192872|NCT00225173|Prednisone|prednisone|mesh-list
20192873|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
20192874|NCT00225173|Doxorubicin|doxorubicin|mesh-list
20192875|NCT00225173|Etoposide|etoposide|mesh-list
20192876|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
20192877|NCT00225173|Vincristine|vincristine|mesh-list
20192878|NCT00225173|Vinorelbine|vinorelbine|mesh-list
20192879|NCT00225173|Bleomycin|bleomycin|mesh-list
20192880|NCT00225173|Vinblastine|vinblastine|mesh-list
20192881|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192882|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
20192883|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192884|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20192885|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19676210|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
19676211|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20192886|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
20192887|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192888|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329609|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
19676212|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676213|NCT05047718|Vaccines|vaccines|mesh-list
20192889|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20192890|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20192891|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
20192892|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
20378037|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378038|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378039|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329610|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329611|NCT03916068|Protective Agents|protective agents|mesh-ancestor
19676214|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
19676215|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676216|NCT05044936|Cannabidiol|cannabidiol|mesh-list
19676217|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
19676218|NCT04979910|Ixekizumab|ixekizumab|mesh-list
19676219|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19676220|NCT04960709|Durvalumab|durvalumab|mesh-list
19676221|NCT04960709|Tremelimumab|tremelimumab|mesh-list
19676222|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676223|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676224|NCT04943627|Gemcitabine|gemcitabine|mesh-list
19676225|NCT04943627|Irinotecan|irinotecan|mesh-list
19676226|NCT04943627|Pemetrexed|pemetrexed|mesh-list
19676227|NCT04943627|Topotecan|topotecan|mesh-list
19676228|NCT04943627|Vinorelbine|vinorelbine|mesh-list
19676229|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19676230|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
19676231|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676232|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676233|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
19676234|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676235|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676236|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676237|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
19676238|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676239|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19676240|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19676241|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19676242|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19676243|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676244|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
20378040|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
19676245|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
20378041|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20378042|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20378043|NCT01010243|Growth Substances|growth substances|mesh-ancestor
20378044|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
20378045|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20378046|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20378047|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
20378048|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378049|NCT01010295|Doxycycline|doxycycline|mesh-list
19676246|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
19676247|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
19676248|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19676249|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676250|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676251|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329612|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19329613|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329614|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19329615|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19329616|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378050|NCT01010295|Tetracycline|tetracycline|mesh-list
20378051|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378052|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378053|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
20378054|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20378055|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20378056|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20378057|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378058|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378059|NCT01010308|Nadolol|nadolol|mesh-list
20378060|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20378061|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19329617|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19676252|NCT04941508|Analgesics|analgesics|mesh-ancestor
19676253|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
19676254|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676255|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20378062|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
20378063|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329618|NCT03915964|Adalimumab|adalimumab|mesh-list
19329619|NCT03915964|Etanercept|etanercept|mesh-list
19329620|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19329621|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329622|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329623|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329624|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676256|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19676257|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19676258|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19676259|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676260|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676261|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
19676262|NCT04933331|Fluorides|fluorides|mesh-list
19676263|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
19676264|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
19676265|NCT04933331|Protective Agents|protective agents|mesh-ancestor
19676266|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676267|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19676268|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676269|NCT04932213|Tropicamide|tropicamide|mesh-list
19676270|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
19676271|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
19676272|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676273|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676274|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19676275|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19676276|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
19676277|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676278|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378064|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329625|NCT03915964|Analgesics|analgesics|mesh-ancestor
19329626|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
19329627|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329628|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329629|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19329630|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329631|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
19329632|NCT03915938|Ketamine|ketamine|mesh-list
19329633|NCT03915938|Analgesics|analgesics|mesh-ancestor
19329634|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
19329635|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329636|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329637|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19329638|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19329639|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
19329640|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
20378065|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378066|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20378067|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20378068|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
20378069|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
20378070|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329641|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329642|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19329643|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19329644|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329645|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329646|NCT03915366|Valganciclovir|valganciclovir|mesh-list
19329647|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
19329648|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
19329649|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329650|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19329651|NCT03915444|Gemcitabine|gemcitabine|mesh-list
20378071|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20378072|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20378073|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
20378074|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378075|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329652|NCT03915444|Paclitaxel|paclitaxel|mesh-list
19329653|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19329654|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692312|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329655|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
19329656|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
19329657|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
19329658|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329659|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19329660|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
19329661|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
20378076|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20378077|NCT01010373|Protective Agents|protective agents|mesh-ancestor
20378078|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20378079|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20378080|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378081|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378082|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
20378083|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378084|NCT01010425|Hormones|hormones|mesh-list
20378085|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378086|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329662|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329663|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329664|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329665|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
19329666|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329667|NCT03915561|Parecoxib|parecoxib|mesh-list
19329668|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19329669|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19329670|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329671|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329672|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329673|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329674|NCT03915561|Analgesics|analgesics|mesh-ancestor
19329675|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
19329676|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329677|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329678|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329679|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841770|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841771|NCT00643201|Enoxaparin|enoxaparin|mesh-list
19841772|NCT00643201|Warfarin|warfarin|mesh-list
19841773|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
19329680|NCT03915340|Propafenone|propafenone|mesh-list
19329681|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19329682|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19329683|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19329684|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329685|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329686|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19329687|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
19329688|NCT03914963|Coagulants|coagulants|mesh-ancestor
19329689|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
19329690|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329691|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329692|NCT03914755|Tucatinib|tucatinib|mesh-list
19329693|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676279|NCT04909853|Ritonavir|ritonavir|mesh-list
19676280|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19676281|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19676282|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
19676283|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676284|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676285|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19676286|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19676287|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
19676288|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676289|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19676290|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19676291|NCT04901988|Nivolumab|nivolumab|mesh-list
19676292|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676293|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676294|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19676295|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676296|NCT04880876|Eluxadoline|eluxadoline|mesh-list
19841774|NCT00643201|Apixaban|apixaban|mesh-list
19841775|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
19676297|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19676298|NCT04874831|Avelumab|avelumab|mesh-list
19329694|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19329695|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329696|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329697|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
19329698|NCT03914690|Hematinics|hematinics|mesh-ancestor
19329699|NCT03914638|Albuterol|albuterol|mesh-list
19329700|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19329701|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
19329702|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329703|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329704|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19329705|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
19329706|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
19329707|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19329708|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19329709|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19329710|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19329711|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329712|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329713|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329714|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
19329715|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
19329716|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329717|NCT03914404|Protective Agents|protective agents|mesh-ancestor
19329718|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329719|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
19329720|NCT03914404|Vitamins|vitamins|mesh-ancestor
19329721|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
19329722|NCT03914677|Mecamylamine|mecamylamine|mesh-list
19329723|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19329724|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19329725|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
19329726|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329727|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329728|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19329729|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19329730|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
19329731|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329732|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329733|NCT03914534|Valproic Acid|valproic acid|mesh-list
19329734|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
19329735|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329736|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192893|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676299|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676300|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676301|NCT04869358|Ofatumumab|ofatumumab|mesh-list
19676302|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676303|NCT04862260|Atorvastatin|atorvastatin|mesh-list
19676304|NCT04862260|Ezetimibe|ezetimibe|mesh-list
19676305|NCT04862260|Evolocumab|evolocumab|mesh-list
19676306|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20192894|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192895|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20192896|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20192897|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20192898|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20192899|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
20192900|NCT00225173|Hormones|hormones|mesh-ancestor
20192901|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192902|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20192903|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20192904|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
20192905|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
20192906|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
20192907|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
20192908|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20192909|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192910|NCT00225238|Esomeprazole|esomeprazole|mesh-list
19329737|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
19676307|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19676308|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
19676309|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192911|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20192912|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20192913|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20192914|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192915|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192916|NCT00225264|Pioglitazone|pioglitazone|mesh-list
20192917|NCT00225264|Glimepiride|glimepiride|mesh-list
20192918|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19329738|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329739|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329740|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
19329741|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19329742|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329743|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19329744|NCT03914352|Antibodies|antibodies|mesh-list
19329745|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
19329746|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329747|NCT03914118|Modafinil|modafinil|mesh-list
19329748|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19329749|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676310|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19676311|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19676312|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676313|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19676314|NCT04846218|Progesterone|progesterone|mesh-list
19676315|NCT04846218|Progestins|progestins|mesh-ancestor
19676316|NCT04846218|Hormones|hormones|mesh-ancestor
19676317|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19676318|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676319|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
19676320|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19676321|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
19676322|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19676323|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19676324|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378087|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
20378088|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20378089|NCT01010451|Calcium|calcium|mesh-list
20378090|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19329750|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19676325|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676326|NCT04841499|Niacinamide|niacinamide|mesh-list
19676327|NCT04841499|Niacin|niacin|mesh-list
19676328|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
19676329|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
19841776|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20192919|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192920|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20192921|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192922|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
20192923|NCT00225290|Thalidomide|thalidomide|mesh-list
20192924|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20192925|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
20192926|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192927|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
20192928|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20192929|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192930|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20192931|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20192932|NCT00225290|Growth Substances|growth substances|mesh-ancestor
20192933|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
20192934|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20192935|NCT00225303|Etravirine|etravirine|mesh-list
20192936|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20192937|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20192938|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20192939|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192940|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
20192941|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20192942|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
20192943|NCT00225342|Gliclazide|gliclazide|mesh-list
20192944|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20192945|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192946|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
20192947|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20378091|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329751|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19329752|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19329753|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378092|NCT01010490|Dipivefrin|dipivefrin|mesh-list
20378093|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20378094|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
20378095|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378096|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378097|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378098|NCT01010516|Niacin|niacin|mesh-list
20378099|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20378100|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20378101|NCT01010516|Fenofibrate|fenofibrate|mesh-list
20378102|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20378103|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20378104|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
20378105|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378106|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20378107|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378108|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378109|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
20378110|NCT01010516|Vitamins|vitamins|mesh-ancestor
20378111|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
19399115|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19399116|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19399117|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19399118|NCT03637361|Methadone|methadone|mesh-list
19399119|NCT03637361|D-methadone|d-methadone|mesh-list
19399120|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19399121|NCT03637361|Narcotics|narcotics|mesh-ancestor
19676330|NCT04841499|Vitamins|vitamins|mesh-ancestor
19676331|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
19676332|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676333|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19676334|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
19676335|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676336|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19676337|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
19676338|NCT04833582|Gemcitabine|gemcitabine|mesh-list
20378112|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378113|NCT01010581|Folic Acid|folic acid|mesh-list
20378114|NCT01010581|Methotrexate|methotrexate|mesh-list
19676339|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19676340|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
19676341|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676342|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676343|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
20378115|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20378116|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
19399122|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399123|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399124|NCT03637361|Analgesics|analgesics|mesh-ancestor
19399125|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
19676344|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378117|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20378118|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378119|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20378120|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
20378121|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378122|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378123|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
20378124|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378125|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20378126|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378127|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
20378128|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20378129|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20378130|NCT01010581|Hematinics|hematinics|mesh-ancestor
20378131|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
20378132|NCT01010581|Vitamins|vitamins|mesh-ancestor
20378133|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
20378134|NCT01010646|Ribavirin|ribavirin|mesh-list
19399126|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676345|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378135|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
20378136|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
19329754|NCT03914092|Triamcinolone|triamcinolone|mesh-list
19329755|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19329756|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19329757|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19329758|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329759|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
19329760|NCT03914092|Hormones|hormones|mesh-ancestor
19329761|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19329762|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329763|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19329764|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
19329765|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329766|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329767|NCT03913884|Mitogens|mitogens|mesh-list
19329768|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
19329769|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329770|NCT03914235|Lidocaine|lidocaine|mesh-list
19329771|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
19329772|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
19329773|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329774|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329775|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
19329776|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329777|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19329778|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19329779|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19329780|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329781|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329782|NCT03913858|Anesthetics|anesthetics|mesh-list
19329783|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329784|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329785|NCT03913650|Bupivacaine|bupivacaine|mesh-list
19329786|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
19329787|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
19329788|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329789|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329790|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
19329791|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329792|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
19329793|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19329794|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19329795|NCT03913702|Prednisolone|prednisolone|mesh-list
19329796|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
19329797|NCT03913702|Ketorolac|ketorolac|mesh-list
19329798|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20192948|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329799|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19329800|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
19329801|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19329802|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
19329803|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
19329804|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329805|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329806|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19329807|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
19329808|NCT03913702|Hormones|hormones|mesh-ancestor
19329809|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19329810|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19329811|NCT03913702|Protective Agents|protective agents|mesh-ancestor
19329812|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19329813|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329814|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19329815|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329816|NCT03913702|Analgesics|analgesics|mesh-ancestor
20192949|NCT00225381|Anesthetics|anesthetics|mesh-list
20192950|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20192951|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192952|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20192953|NCT00225433|Ganirelix|ganirelix|mesh-list
20192954|NCT00225433|Hormones|hormones|mesh-ancestor
19329817|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
19329818|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19329819|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19329820|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329821|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329822|NCT03913806|Bevacizumab|bevacizumab|mesh-list
19329823|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329824|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378137|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20378138|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
20378139|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378140|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
20378141|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378142|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
20378143|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378144|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329825|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19329826|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19329827|NCT03913806|Growth Substances|growth substances|mesh-ancestor
19329828|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329829|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
19329830|NCT03913455|Carboplatin|carboplatin|mesh-list
19329831|NCT03913455|Guadecitabine|guadecitabine|mesh-list
19329832|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329833|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
19329834|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
19329835|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329836|NCT03913468|Protective Agents|protective agents|mesh-ancestor
19329837|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329838|NCT03913468|Vitamins|vitamins|mesh-ancestor
19329839|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
19329840|NCT03913221|Caffeine|caffeine|mesh-list
19329841|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
19329842|NCT03913221|Citric Acid|citric acid|mesh-list
19676346|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676347|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
19329843|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
19329844|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
19329845|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19329846|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
19329847|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
19329848|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329849|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19329850|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329851|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19329852|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329853|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19329854|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19329855|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
19329856|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329857|NCT03912974|Citalopram|citalopram|mesh-list
19329858|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19329859|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19329860|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329861|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329862|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329863|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
19329864|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329865|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19676348|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676349|NCT04825678|Erenumab|erenumab|mesh-list
19676350|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19676351|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676352|NCT04825678|Analgesics|analgesics|mesh-ancestor
19676353|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
19676354|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20192955|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20192956|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192957|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
20192958|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20192959|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20192960|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20378145|NCT01010672|Sirolimus|sirolimus|mesh-list
20378146|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378147|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19329866|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
19676355|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676356|NCT04773405|Lidocaine|lidocaine|mesh-list
19676357|NCT04773405|Epinephrine|epinephrine|mesh-list
19676358|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
19676359|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
19676360|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
19676361|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676362|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329867|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19329868|NCT03912857|Apatinib|apatinib|mesh-list
19329869|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329870|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19329871|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329872|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329873|NCT03912909|Empagliflozin|empagliflozin|mesh-list
19329874|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19329875|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378148|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20378149|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378150|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
19676363|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
19676364|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676365|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19676366|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19676367|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19676368|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19676369|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329876|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19329877|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329878|NCT03913182|Apatinib|apatinib|mesh-list
19329879|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329880|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19329881|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329882|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329883|NCT03913052|Viscosupplements|viscosupplements|mesh-list
20192961|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192962|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192963|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192964|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192965|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20192966|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
19676370|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19676371|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20378151|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378152|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
20378153|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378154|NCT01010698|Acyclovir|acyclovir|mesh-list
20378155|NCT01010698|Cimetidine|cimetidine|mesh-list
20378156|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
20378157|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378158|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20378159|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20378160|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20378161|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
20378162|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
20378163|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378164|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378165|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378166|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20378167|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20378168|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378169|NCT01010789|Modafinil|modafinil|mesh-list
20378170|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20378171|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378172|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19329884|NCT03913052|Protective Agents|protective agents|mesh-ancestor
20192967|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192968|NCT00225511|Milnacipran|milnacipran|mesh-list
20192969|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20192970|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
20192971|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19399127|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
19676372|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
19676373|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676374|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19676375|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19676376|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
19676377|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19676378|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
19676379|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
19676380|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
19676381|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19676382|NCT04766996|Aspirin|aspirin|mesh-list
19676383|NCT04766996|Acetaminophen|acetaminophen|mesh-list
19676384|NCT04766996|Prednisone|prednisone|mesh-list
19676385|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19676386|NCT04766996|Meloxicam|meloxicam|mesh-list
19676387|NCT04766996|Diclofenac|diclofenac|mesh-list
19676388|NCT04766996|Lidocaine|lidocaine|mesh-list
19676389|NCT04766996|Pregabalin|pregabalin|mesh-list
19676390|NCT04766996|Tramadol|tramadol|mesh-list
19676391|NCT04766996|Bupivacaine|bupivacaine|mesh-list
19676392|NCT04766996|Propofol|propofol|mesh-list
19676393|NCT04766996|Omeprazole|omeprazole|mesh-list
19676394|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
19676395|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
19676396|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
19676397|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676398|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676399|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
19676400|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329885|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329886|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
19329887|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
20378173|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20378174|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20378175|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378176|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
20378177|NCT01010802|Hematinics|hematinics|mesh-ancestor
20378178|NCT01010893|Vaccines|vaccines|mesh-list
20378179|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
20378180|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378181|NCT01010945|Gemcitabine|gemcitabine|mesh-list
20378182|NCT01010945|Paclitaxel|paclitaxel|mesh-list
20378183|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20192972|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192973|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192974|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192975|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20192976|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192977|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20192978|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192979|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192980|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20192981|NCT00225511|Analgesics|analgesics|mesh-ancestor
20192982|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
20192983|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676401|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19676402|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19676403|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19676404|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19676405|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192984|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20192985|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20192986|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20192987|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20192988|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20192989|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378184|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20378185|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378186|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
20378187|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
20378188|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
20426093|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329888|NCT03912766|Coagulants|coagulants|mesh-ancestor
19676406|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676407|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
19676408|NCT04766996|Hormones|hormones|mesh-ancestor
19692313|NCT04993040|Paclitaxel|paclitaxel|mesh-list
20378189|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378190|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20378191|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
20378192|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
20378193|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378194|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378195|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378196|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
20378197|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192990|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192991|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20192992|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
20192993|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20192994|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20192995|NCT00225589|Calcium|calcium|mesh-list
20192996|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20192997|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20192998|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20192999|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20193000|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
20193001|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193002|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20378198|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20378199|NCT01010958|Valproic Acid|valproic acid|mesh-list
20378200|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
20378201|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378202|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378203|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
20378204|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378205|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378206|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
20378207|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20378208|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20378209|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20378210|NCT01011010|Doxorubicin|doxorubicin|mesh-list
20378211|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20378212|NCT01011010|Mitomycins|mitomycins|mesh-list
20378213|NCT01011010|Mitomycin|mitomycin|mesh-list
20378214|NCT01011010|Sorafenib|sorafenib|mesh-list
20378215|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20378216|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378217|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20378218|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20378219|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193003|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20193004|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193005|NCT00225615|Verapamil|verapamil|mesh-list
20193006|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20193007|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20193008|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193009|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193010|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20193011|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193012|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
20193013|NCT00225667|Irbesartan|irbesartan|mesh-list
20193014|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20193015|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20193016|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20193017|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217482|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676409|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19676410|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19676411|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676412|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19329889|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19329890|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19329891|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
19329892|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329893|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
20378220|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378221|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20378222|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
19676413|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20378223|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20378224|NCT01011036|Clonazepam|clonazepam|mesh-list
20378225|NCT01011036|Clobazam|clobazam|mesh-list
20378226|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20193018|NCT00225706|Ibuprofen|ibuprofen|mesh-list
19329894|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
19329895|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329896|NCT03912727|Protective Agents|protective agents|mesh-ancestor
19329897|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329898|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
19329899|NCT03912727|Vitamins|vitamins|mesh-ancestor
19329900|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
19329901|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
19329902|NCT03912740|Remifentanil|remifentanil|mesh-list
19329903|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19329904|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329905|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193019|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20193020|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193021|NCT00225706|Analgesics|analgesics|mesh-ancestor
20193022|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
20193023|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329906|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19329907|NCT03912740|Analgesics|analgesics|mesh-ancestor
19329908|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
19329909|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329910|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19329911|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19329912|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19329913|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329914|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329915|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329916|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19329917|NCT03912740|Narcotics|narcotics|mesh-ancestor
19329918|NCT03912402|Paclitaxel|paclitaxel|mesh-list
19329919|NCT03912402|Bevacizumab|bevacizumab|mesh-list
19329920|NCT03912402|Carboplatin|carboplatin|mesh-list
19329921|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19329922|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329923|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
19329924|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
19329925|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
19329926|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329927|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329928|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19329929|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19329930|NCT03912402|Growth Substances|growth substances|mesh-ancestor
19329931|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329932|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
19329933|NCT03912389|Carboplatin|carboplatin|mesh-list
19329934|NCT03912389|Pemetrexed|pemetrexed|mesh-list
19329935|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329936|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193024|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193025|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193026|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193027|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20193028|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19329937|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329938|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19329939|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19329940|NCT03912220|Niacinamide|niacinamide|mesh-list
20378227|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20378228|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20378229|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
20378230|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378231|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378232|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329941|NCT03912220|Niacin|niacin|mesh-list
19329942|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
19329943|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
19329944|NCT03912220|Vitamins|vitamins|mesh-ancestor
19329945|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
19676414|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
20378233|NCT01011036|Urological Agents|urological agents|mesh-ancestor
19329946|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329947|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19329948|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
19329949|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378234|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
20378235|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
20378236|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
20378237|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20378238|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20378239|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20378240|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20378241|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20378242|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
20378243|NCT01011062|Losartan|losartan|mesh-list
20378244|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20378245|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20378246|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20378247|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20378248|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426094|NCT01279083|Timolol|timolol|mesh-list
20426095|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20426096|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20426097|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20426098|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
20426099|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426100|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329950|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19329951|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
19676415|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19676416|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676417|NCT04766996|Analgesics|analgesics|mesh-ancestor
19676418|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676419|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19676420|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19676421|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19676422|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20193029|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193030|NCT00225797|Oxymorphone|oxymorphone|mesh-list
20193031|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19329952|NCT03912415|Paclitaxel|paclitaxel|mesh-list
19329953|NCT03912415|Bevacizumab|bevacizumab|mesh-list
19329954|NCT03912415|Carboplatin|carboplatin|mesh-list
19329955|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19329956|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329957|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
19329958|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
19329959|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
19329960|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329961|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19329962|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19329963|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19329964|NCT03912415|Growth Substances|growth substances|mesh-ancestor
19329965|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193032|NCT00225797|Narcotics|narcotics|mesh-ancestor
20193033|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193034|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193035|NCT00225797|Analgesics|analgesics|mesh-ancestor
20193036|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
20193037|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193038|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20193039|NCT00225849|Aspirin|aspirin|mesh-list
20193040|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20193041|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193042|NCT00225849|Analgesics|analgesics|mesh-ancestor
20193043|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
20193044|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193045|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193046|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193047|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193048|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19676423|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676424|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
20193049|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20426101|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329966|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
19329967|NCT03912285|Losartan|losartan|mesh-list
19329968|NCT03912285|Amlodipine|amlodipine|mesh-list
19329969|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19329970|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20193050|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193051|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20193052|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20193053|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193054|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
20193055|NCT00225862|Ropinirole|ropinirole|mesh-list
20193056|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20193057|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20193058|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
20193059|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
20378249|NCT01011114|Cinacalcet|cinacalcet|mesh-list
20378250|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20378251|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378252|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20378253|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
20378254|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19329971|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19329972|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19329973|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19329974|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329975|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
19329976|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19329977|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19329978|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19329979|NCT03911817|Midodrine|midodrine|mesh-list
19329980|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
19329981|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
19329982|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329983|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329984|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20378255|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20378256|NCT01011127|Pravastatin|pravastatin|mesh-list
20378257|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20378258|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20378259|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
20378260|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378261|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20378262|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20378263|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378264|NCT01011166|Ribavirin|ribavirin|mesh-list
20378265|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20378266|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
20378267|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378268|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
20378269|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378270|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
20378271|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
20378272|NCT01011205|Tacrolimus|tacrolimus|mesh-list
20378273|NCT01011205|Basiliximab|basiliximab|mesh-list
20378274|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378275|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
20378276|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329985|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20193060|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193061|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193062|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193063|NCT00225875|Rituximab|rituximab|mesh-list
20193064|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20193065|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193066|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
20193067|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193068|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193069|NCT00225901|Mitogens|mitogens|mesh-list
20193070|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
20193071|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378277|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20378278|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193072|NCT00225914|Paroxetine|paroxetine|mesh-list
20378279|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193073|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20193074|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19676425|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19676426|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
19676427|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19676428|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19676429|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19329986|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19329987|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19329988|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
19329989|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19329990|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676430|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19676431|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19676432|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19676433|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
19676434|NCT04766996|Coagulants|coagulants|mesh-ancestor
19676435|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19676436|NCT04766996|Narcotics|narcotics|mesh-ancestor
19676437|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20193075|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193076|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193077|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193078|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
19399128|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193079|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193080|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20193081|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193082|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193083|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20193084|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20193085|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193086|NCT00225979|Octreotide|octreotide|mesh-list
19399129|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19399130|NCT03637335|Carboplatin|carboplatin|mesh-list
19399131|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399132|NCT03637283|Bevacizumab|bevacizumab|mesh-list
20193087|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20193088|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19399133|NCT03637283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399134|NCT03637283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399135|NCT03637283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20193089|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193090|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
20193091|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193092|NCT00226005|Vatalanib|vatalanib|mesh-list
20193093|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20193094|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193095|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193096|NCT00226044|Omeprazole|omeprazole|mesh-list
19399136|NCT03637283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19399137|NCT03637283|Growth Substances|growth substances|mesh-ancestor
19399138|NCT03637283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399139|NCT03637283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19399140|NCT03637075|Insulin|insulin|mesh-list
19399141|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19399142|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399143|NCT03637049|Midazolam|midazolam|mesh-list
19399144|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19399145|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399146|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399147|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399148|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19399149|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399150|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19399151|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19399152|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
19399153|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
19399154|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
19399155|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
19399156|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399157|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399158|NCT03636971|Mannitol|mannitol|mesh-list
19676438|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19399159|NCT03636971|Sorbitol|sorbitol|mesh-list
19676439|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19676440|NCT04754061|Psilocybin|psilocybin|mesh-list
19676441|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
19676442|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676443|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19676444|NCT04722601|Azacitidine|azacitidine|mesh-list
19676445|NCT04722601|Venetoclax|venetoclax|mesh-list
19676446|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
19676447|NCT04722601|Cc-486|cc-486|mesh-list
19676448|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19676449|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
19676450|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676451|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19329991|NCT03911648|Lidocaine|lidocaine|mesh-list
19329992|NCT03911648|Bupivacaine|bupivacaine|mesh-list
19329993|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
19329994|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
19329995|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19329996|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19329997|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
19329998|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19329999|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19330000|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20193097|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19330001|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19330002|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330003|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330004|NCT03911440|Azithromycin|azithromycin|mesh-list
19330005|NCT03911440|Doxycycline|doxycycline|mesh-list
19330006|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193098|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20193099|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20193100|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330007|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330008|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
19330009|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19330010|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19330011|NCT03911336|Acetaminophen|acetaminophen|mesh-list
19330012|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19330013|NCT03911336|Ketoprofen|ketoprofen|mesh-list
19330014|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19330015|NCT03911336|Analgesics|analgesics|mesh-ancestor
19330016|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
19330017|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330018|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330019|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
19330020|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19330021|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330022|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19330023|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330024|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330025|NCT03911570|Acetaminophen|acetaminophen|mesh-list
19330026|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19330027|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19330028|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19330029|NCT03911570|Analgesics|analgesics|mesh-ancestor
19330030|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
19676452|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676453|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676454|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
19676455|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19676456|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676457|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193101|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193102|NCT00226096|Metoprolol|metoprolol|mesh-list
20193103|NCT00226096|Clonidine|clonidine|mesh-list
20193104|NCT00226096|Nitroprusside|nitroprusside|mesh-list
20193105|NCT00226096|Hydralazine|hydralazine|mesh-list
19330031|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676458|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676459|NCT04700514|Analgesics|analgesics|mesh-ancestor
19676460|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
19676461|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676462|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20193106|NCT00226096|Labetalol|labetalol|mesh-list
20193107|NCT00226096|Nicardipine|nicardipine|mesh-list
19399160|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
20378280|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20378281|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378282|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20378283|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
20378284|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378285|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378286|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378287|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
20378288|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
20378289|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378290|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20378291|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
20378292|NCT01011205|Hormones|hormones|mesh-ancestor
20378293|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378294|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20378295|NCT01011205|Protective Agents|protective agents|mesh-ancestor
20378296|NCT01011257|Clopidogrel|clopidogrel|mesh-list
20378297|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20378298|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20378299|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20378300|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20378301|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
19330032|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330033|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
19330034|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20378302|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378303|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378304|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378305|NCT01011348|Ubiquinone|ubiquinone|mesh-list
20378306|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
20378307|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
20378308|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378309|NCT01011348|Vitamins|vitamins|mesh-ancestor
20378310|NCT01011374|Ranibizumab|ranibizumab|mesh-list
20378311|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20378312|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20378313|NCT01011374|Growth Substances|growth substances|mesh-ancestor
19330035|NCT03911557|Durvalumab|durvalumab|mesh-list
19330036|NCT03911557|Tremelimumab|tremelimumab|mesh-list
19330037|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676463|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19676464|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19676465|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
19676466|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676467|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330038|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330039|NCT03911414|Inositol|inositol|mesh-list
19330040|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
19330041|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19330042|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
19330043|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330044|NCT03911414|Expectorants|expectorants|mesh-ancestor
19330045|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193108|NCT00226096|Phentolamine|phentolamine|mesh-list
20193109|NCT00226096|Urapidil|urapidil|mesh-list
20193110|NCT00226096|Enalaprilat|enalaprilat|mesh-list
20193111|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
20193112|NCT00226096|Esmolol|esmolol|mesh-list
20193113|NCT00226096|Glycerol|glycerol|mesh-list
20193114|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20193115|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20193116|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
19330046|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19330047|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
19330048|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330049|NCT03911414|Protective Agents|protective agents|mesh-ancestor
19330050|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330051|NCT03911414|Antidotes|antidotes|mesh-ancestor
19330052|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
19330053|NCT03911414|Vitamins|vitamins|mesh-ancestor
19330054|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
19330055|NCT03911271|Atropine|atropine|mesh-list
19676468|NCT04693468|Palbociclib|palbociclib|mesh-list
19676469|NCT04693468|Axitinib|axitinib|mesh-list
19676470|NCT04693468|Crizotinib|crizotinib|mesh-list
19676471|NCT04693468|Talazoparib|talazoparib|mesh-list
20193117|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
20193118|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378314|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378315|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
19330056|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19330057|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19330058|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20378316|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378317|NCT01011426|Bisacodyl|bisacodyl|mesh-list
20378318|NCT01011426|Cathartics|cathartics|mesh-ancestor
20378319|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20378320|NCT01011426|Laxatives|laxatives|mesh-ancestor
20378321|NCT01011452|Montelukast|montelukast|mesh-list
19330059|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
19330060|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330061|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330062|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19330063|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
19330064|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
19330065|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
20378322|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20378323|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
20378324|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20378325|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
20378326|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378327|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378328|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20378329|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20378330|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330066|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19330067|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19330068|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
19330069|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330070|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330071|NCT03910803|Brodalumab|brodalumab|mesh-list
20378331|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20378332|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20378333|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20378334|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
20378335|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378336|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20378337|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20378338|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378339|NCT01011530|Pevonedistat|pevonedistat|mesh-list
20378340|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378341|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378342|NCT01011621|Prednisolone|prednisolone|mesh-list
20378343|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20378344|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
20378345|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20378346|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
20378347|NCT01011621|Betamethasone|betamethasone|mesh-list
19330072|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
19676472|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676473|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19676474|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676475|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676476|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19676477|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19676478|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19676479|NCT04654312|Diuretics|diuretics|mesh-ancestor
19676480|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
20193119|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193120|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20193121|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20193122|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20193123|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
20193124|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193125|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193126|NCT00226096|Analgesics|analgesics|mesh-ancestor
20193127|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
20193128|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20193129|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20193130|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20193131|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378348|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
19330073|NCT03910647|Pantoprazole|pantoprazole|mesh-list
20378349|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19841777|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19841778|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841779|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19841780|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
19841781|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19841782|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
19841783|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841784|NCT00643565|Bevacizumab|bevacizumab|mesh-list
19841785|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19841786|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193132|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19330074|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19330075|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330076|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20193133|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20193134|NCT00226096|Protective Agents|protective agents|mesh-ancestor
20193135|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
20193136|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20193137|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20193138|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20193139|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193140|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20193141|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20193142|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
20193143|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20378350|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
20378351|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19841787|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20193144|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
20193145|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378352|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
20378353|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20378354|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378355|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
20378356|NCT01011621|Hormones|hormones|mesh-ancestor
20378357|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378358|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378359|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378360|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378361|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
20378362|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
20378363|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378364|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330077|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330078|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330079|NCT03910634|Carboplatin|carboplatin|mesh-list
19330080|NCT03910634|Fluorouracil|fluorouracil|mesh-list
19330081|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330082|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
19330083|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330084|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19330085|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19330086|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
19330087|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330088|NCT03910712|Trastuzumab|trastuzumab|mesh-list
19330089|NCT03910712|Letrozole|letrozole|mesh-list
20193146|NCT00226109|Spironolactone|spironolactone|mesh-list
20193147|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20193148|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
20193149|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193150|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193151|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20193152|NCT00226109|Diuretics|diuretics|mesh-ancestor
20193153|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
20193154|NCT00226122|Indomethacin|indomethacin|mesh-list
20193155|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20193156|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193157|NCT00226122|Analgesics|analgesics|mesh-ancestor
20193158|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
20193159|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330090|NCT03910712|Anastrozole|anastrozole|mesh-list
19330091|NCT03910712|Exemestane|exemestane|mesh-list
19330092|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20193160|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193161|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193162|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193163|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
20193164|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
19676481|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676482|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19676483|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19676484|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676485|NCT04635644|Morphine|morphine|mesh-list
19676486|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19330093|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19330094|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330095|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19330096|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330097|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330098|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19330099|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
19330100|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330101|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330102|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330103|NCT03910556|Propofol|propofol|mesh-list
19330104|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19330105|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330106|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330107|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19330108|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
19330109|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
19330110|NCT03910543|Tofacitinib|tofacitinib|mesh-list
19330111|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19330112|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330113|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330114|NCT03910361|Pioglitazone|pioglitazone|mesh-list
19330115|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19330116|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330117|NCT03910504|Rocuronium|rocuronium|mesh-list
19330118|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19330119|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19330120|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19330121|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676487|NCT04635644|Narcotics|narcotics|mesh-ancestor
19676488|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676489|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676490|NCT04635644|Analgesics|analgesics|mesh-ancestor
19676491|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
19676492|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676493|NCT04633226|Vaccines|vaccines|mesh-list
19676494|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
20193165|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19676495|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676496|NCT04623931|Temozolomide|temozolomide|mesh-list
19676497|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19676498|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
20378365|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20378366|NCT01011621|Protective Agents|protective agents|mesh-ancestor
20378367|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20378368|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
20378369|NCT01011660|Amlodipine|amlodipine|mesh-list
20378370|NCT01011660|Telmisartan|telmisartan|mesh-list
20378371|NCT01011660|Amiloride|amiloride|mesh-list
20378372|NCT01011660|Simvastatin|simvastatin|mesh-list
20378373|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20378374|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20378375|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19676499|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676500|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676501|NCT04617067|Gemcitabine|gemcitabine|mesh-list
20193166|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20193167|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193168|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193169|NCT00226135|Lamotrigine|lamotrigine|mesh-list
20193170|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20378376|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676502|NCT04617067|Paclitaxel|paclitaxel|mesh-list
19676503|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676504|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676505|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
19676506|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
19676507|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
19676508|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676509|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19676510|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
19676511|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
19676512|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676513|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676514|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676515|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
19676516|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676517|NCT04610684|Carboplatin|carboplatin|mesh-list
20378377|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20378378|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378379|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378380|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20378381|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20378382|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
20378383|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20378384|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20378385|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676518|NCT04610684|Etoposide|etoposide|mesh-list
19676519|NCT04610684|Atezolizumab|atezolizumab|mesh-list
19676520|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676521|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676522|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19676523|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19676524|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676525|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676526|NCT04584567|Doxycycline|doxycycline|mesh-list
19676527|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193171|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378386|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20378387|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20378388|NCT01011660|Diuretics|diuretics|mesh-ancestor
20378389|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
20378390|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20378391|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20378392|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20378393|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20378394|NCT01011699|Niacinamide|niacinamide|mesh-list
20378395|NCT01011699|Niacin|niacin|mesh-list
20378396|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
20378397|NCT01011699|Sevelamer|sevelamer|mesh-list
20378398|NCT01011699|Cinacalcet|cinacalcet|mesh-list
20378399|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
20378400|NCT01011699|Vitamins|vitamins|mesh-ancestor
20378401|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
20378402|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378403|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20378404|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
20378405|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378406|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19676528|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378407|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378408|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
20378409|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
20378410|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19676529|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
20193172|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20193173|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193174|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193175|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
20193176|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20193177|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193178|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20193179|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20193180|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20193181|NCT00226200|Omalizumab|omalizumab|mesh-list
20193182|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19676530|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19841788|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19841789|NCT00643565|Growth Substances|growth substances|mesh-ancestor
19841790|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841791|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
19841792|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
19841793|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19841794|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
19841795|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841796|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841797|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19841798|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
19841799|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19841800|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19676531|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19676532|NCT04578886|Guanfacine|guanfacine|mesh-list
19676533|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19676534|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19676535|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19676536|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19676537|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
19676538|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676539|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676540|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676541|NCT04576325|Voriconazole|voriconazole|mesh-list
19676542|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
19676543|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676544|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19676545|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19676546|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676547|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676548|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19676549|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
19676550|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19676551|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676552|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19676553|NCT04572828|Naproxen|naproxen|mesh-list
19676554|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19676555|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676556|NCT04572828|Analgesics|analgesics|mesh-ancestor
19676557|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
19676558|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676559|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676560|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676561|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676562|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
19676563|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19676564|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676565|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378411|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20378412|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
20378413|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378414|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20378415|NCT01011751|Leuprolide|leuprolide|mesh-list
20378416|NCT01011751|Flutamide|flutamide|mesh-list
20378417|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
20378418|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20378419|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
20378420|NCT01011751|Cyproterone|cyproterone|mesh-list
20378421|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20378422|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20378423|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20378424|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676566|NCT04564625|Vitamin D|vitamin d|mesh-list
19676567|NCT04564625|Vitamins|vitamins|mesh-ancestor
19676568|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
19676569|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676570|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19692314|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19692315|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692316|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
19841801|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19841802|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
19676571|NCT04558112|Levodopa|levodopa|mesh-list
19330122|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330123|NCT03910231|Tolvaptan|tolvaptan|mesh-list
19330124|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20378425|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378426|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378427|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20378428|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
20378429|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330125|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330126|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
19330127|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330128|NCT03910088|Acetaminophen|acetaminophen|mesh-list
19676572|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19676573|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19676574|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
19676575|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676576|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676577|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676578|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19676579|NCT04549311|Amoxicillin|amoxicillin|mesh-list
19676580|NCT04549311|Metronidazole|metronidazole|mesh-list
19676581|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
19676582|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
19676583|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
19676584|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19676585|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19676586|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676587|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
19676588|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19676589|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19676590|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19676591|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19676592|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676593|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676594|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676595|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19676596|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19676597|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20193183|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20193184|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193185|NCT00226317|Aripiprazole|aripiprazole|mesh-list
20193186|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
20378430|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20378431|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20378432|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20378433|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
20378434|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20378435|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20378436|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20378437|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20378438|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378439|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378440|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20378441|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
20378442|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
20378443|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
19330129|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
19330130|NCT03910088|Diclofenac|diclofenac|mesh-list
19330131|NCT03910088|Pregabalin|pregabalin|mesh-list
19330132|NCT03910088|Caffeine|caffeine|mesh-list
19330133|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19330134|NCT03910088|Analgesics|analgesics|mesh-ancestor
20193187|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193188|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20193189|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19330135|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
20193190|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193191|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193192|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
20193193|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
20193194|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193195|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193196|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19676604|NCT04473716|Paclitaxel|paclitaxel|mesh-list
19676605|NCT04473716|Cisplatin|cisplatin|mesh-list
19676606|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676607|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676608|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
19676609|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
19676610|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
19676611|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676612|NCT04471233|Pregabalin|pregabalin|mesh-list
19676613|NCT04471233|Analgesics|analgesics|mesh-ancestor
19676614|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
19676615|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676616|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676617|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
19676618|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19676619|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19676620|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676621|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19676622|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19676623|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20378444|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378445|NCT01011920|Cytarabine|cytarabine|mesh-list
20378446|NCT01011920|Rituximab|rituximab|mesh-list
20378447|NCT01011920|Methotrexate|methotrexate|mesh-list
20378448|NCT01011920|Thiotepa|thiotepa|mesh-list
20378449|NCT01011920|Carmustine|carmustine|mesh-list
19676624|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676625|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19676626|NCT04435691|Azacitidine|azacitidine|mesh-list
19676627|NCT04435691|Venetoclax|venetoclax|mesh-list
19676628|NCT04435691|Magrolimab|magrolimab|mesh-list
19676629|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19330136|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330137|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330138|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
19330139|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
20193197|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20193198|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
20193199|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20193200|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20193201|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20193202|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20193203|NCT00226330|Pioglitazone|pioglitazone|mesh-list
20193204|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20378450|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19330140|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19330141|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330142|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330143|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19330144|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19330145|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19330146|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330147|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330148|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19330149|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19330150|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330151|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19676630|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
19676631|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676632|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676633|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676634|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676635|NCT04422743|Tramiprosate|tramiprosate|mesh-list
19676636|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19676637|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
19676638|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
19676639|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
19676640|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
19676641|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19676642|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676643|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378451|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676644|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
19676645|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20378452|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
20378453|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378454|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20378455|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20378456|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
20378457|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20378458|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20378459|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
20378460|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378461|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
20378462|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378463|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20378464|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378465|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20378466|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
20193205|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193206|NCT00226343|Valproic Acid|valproic acid|mesh-list
20378467|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378468|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20378469|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
20378470|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20378471|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
20378472|NCT01011998|Valproic Acid|valproic acid|mesh-list
20378473|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378474|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20378475|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378476|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378477|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
20378478|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
20378479|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378480|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378481|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
20378482|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20378483|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20378484|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20378485|NCT01012011|Sorafenib|sorafenib|mesh-list
20378486|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378487|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20378488|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378489|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378490|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
20378491|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20378492|NCT01012063|Hematinics|hematinics|mesh-ancestor
20378493|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
20378494|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20378495|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
20378496|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378497|NCT01012141|Docetaxel|docetaxel|mesh-list
20378498|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378499|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
19330152|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330153|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19330154|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19330155|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19330156|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19330157|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
19676646|NCT04413526|Estrogens|estrogens|mesh-ancestor
20193207|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
20193208|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193209|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193210|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
20193211|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193212|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378500|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
20378501|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
20378502|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378503|NCT01012193|Cilostazol|cilostazol|mesh-list
20378504|NCT01012193|Clopidogrel|clopidogrel|mesh-list
20378505|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20378506|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20378507|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19676647|NCT04413526|Hormones|hormones|mesh-ancestor
19676648|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19676649|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692317|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
20193213|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
20193214|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20193215|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676650|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19676651|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676652|NCT04373733|Favipiravir|favipiravir|mesh-list
19676653|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
19676654|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676655|NCT04334070|Clofazimine|clofazimine|mesh-list
19676656|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676657|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
19676658|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19676659|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676660|NCT04302324|Clarithromycin|clarithromycin|mesh-list
19676661|NCT04302324|Dexamethasone|dexamethasone|mesh-list
19676662|NCT04302324|Daratumumab|daratumumab|mesh-list
19676663|NCT04302324|Pomalidomide|pomalidomide|mesh-list
19676664|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676665|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
19676666|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
19676667|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676668|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676669|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19676670|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
19676671|NCT04302324|Hormones|hormones|mesh-ancestor
19676672|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19676673|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19676674|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193216|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193217|NCT00226356|Betaine|betaine|mesh-list
20193218|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20193219|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
20378508|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20378509|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
20378510|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378511|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193220|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20193221|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
19330158|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330159|NCT03909776|Cisplatin|cisplatin|mesh-list
19330160|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399161|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19399162|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
20193222|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193223|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20193224|NCT00226382|Interferons|interferons|mesh-list
20193225|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
19399163|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399164|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
19399165|NCT03636971|Protective Agents|protective agents|mesh-ancestor
19399166|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19676675|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19676676|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841803|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841804|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841805|NCT00643604|Treprostinil|treprostinil|mesh-list
20378512|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399167|NCT03636971|Diuretics|diuretics|mesh-ancestor
19399168|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
19399169|NCT03636971|Cathartics|cathartics|mesh-ancestor
19399170|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399171|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
19399172|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
19399173|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19399174|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
19399175|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399176|NCT03636932|Expectorants|expectorants|mesh-ancestor
19399177|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
19399178|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19399179|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
19676677|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19676678|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676679|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193226|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
20193227|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19399180|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193228|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378513|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20378514|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
20378515|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378516|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20378517|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19841806|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19841807|NCT00643760|Pregabalin|pregabalin|mesh-list
19841808|NCT00643760|Gabapentin|gabapentin|mesh-list
19841809|NCT00643760|Analgesics|analgesics|mesh-ancestor
19841810|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
19841811|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841812|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841813|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
19841814|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20193229|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
20378518|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20378519|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20378520|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
19676680|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19676681|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19676682|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
19676683|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19676684|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19676685|NCT04302324|Growth Substances|growth substances|mesh-ancestor
19676686|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
19676687|NCT04266912|Avelumab|avelumab|mesh-list
19676688|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19676689|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676690|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676691|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
19676692|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676693|NCT04264663|Tinidazole|tinidazole|mesh-list
19676694|NCT04264663|Furazolidone|furazolidone|mesh-list
20378521|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20378522|NCT01012193|Protective Agents|protective agents|mesh-ancestor
19676695|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
19676696|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676697|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193230|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193231|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
19676698|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676699|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19676700|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19676701|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19676702|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19676703|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19676704|NCT04264663|Renal Agents|renal agents|mesh-ancestor
19676705|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19676706|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676707|NCT04256434|Nalbuphine|nalbuphine|mesh-list
19676708|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19676709|NCT04256434|Narcotics|narcotics|mesh-ancestor
19676710|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676711|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676712|NCT04256434|Analgesics|analgesics|mesh-ancestor
19676713|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
19676714|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676715|NCT04253262|Rucaparib|rucaparib|mesh-list
19676716|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19676717|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676718|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676719|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676720|NCT04185012|Benralizumab|benralizumab|mesh-list
19676721|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19676722|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
19676723|NCT04139655|Colchicine|colchicine|mesh-list
19841815|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193232|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193233|NCT00226395|Oxymorphone|oxymorphone|mesh-list
20193234|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20193235|NCT00226395|Narcotics|narcotics|mesh-ancestor
19841816|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193236|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676724|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
20193237|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378523|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20193238|NCT00226395|Analgesics|analgesics|mesh-ancestor
20193239|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
20193240|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193241|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20193242|NCT00226408|Interferons|interferons|mesh-list
20193243|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
20193244|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
20193245|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193246|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
19330161|NCT03909594|Ketamine|ketamine|mesh-list
19330162|NCT03909594|Bupivacaine|bupivacaine|mesh-list
19330163|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
20378524|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20378525|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378526|NCT01012232|Ropivacaine|ropivacaine|mesh-list
20378527|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
20378528|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
20378529|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20378530|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378531|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
20193247|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193248|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
20193249|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193250|NCT00226421|Oxymorphone|oxymorphone|mesh-list
20193251|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20193252|NCT00226421|Narcotics|narcotics|mesh-ancestor
20193253|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193254|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193255|NCT00226421|Analgesics|analgesics|mesh-ancestor
20193256|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
20193257|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193258|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20378532|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378533|NCT01012284|Bedaquiline|bedaquiline|mesh-list
20378534|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
20378535|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378536|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378537|NCT01012349|Aspirin|aspirin|mesh-list
20378538|NCT01012349|Citric Acid|citric acid|mesh-list
20378539|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
20612833|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330164|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
19330165|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330166|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330167|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
19330168|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330169|NCT03909594|Analgesics|analgesics|mesh-ancestor
19330170|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19330171|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19330172|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
19330173|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19330174|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19330175|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330176|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330177|NCT03909477|Xenon|xenon|mesh-list
19676725|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193259|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19330178|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19330179|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
19330180|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
20193260|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
20193261|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193262|NCT00226447|Interferons|interferons|mesh-list
20193263|NCT00226447|Lamivudine|lamivudine|mesh-list
20193264|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193265|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
20193266|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193267|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20193268|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20193269|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193270|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193271|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20193272|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20378540|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19330181|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193273|NCT00226473|Dacarbazine|dacarbazine|mesh-list
20193274|NCT00226473|Vindesine|vindesine|mesh-list
19676726|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
19676727|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
19676728|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
19676729|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676730|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676731|NCT04122287|Levofloxacin|levofloxacin|mesh-list
19676732|NCT04122287|Ofloxacin|ofloxacin|mesh-list
19676733|NCT04122287|Tinidazole|tinidazole|mesh-list
19676734|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19676735|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676736|NCT04122287|Renal Agents|renal agents|mesh-ancestor
20378541|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20378542|NCT01012349|Analgesics|analgesics|mesh-ancestor
20378543|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
20378544|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378545|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378546|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676737|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19676738|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19676739|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19676740|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676741|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676742|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676743|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19676744|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19676745|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
19676746|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19676747|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19676748|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20193275|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193276|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20193277|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
20193278|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193279|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19330182|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330183|NCT03909724|Sunitinib|sunitinib|mesh-list
19330184|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330185|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19330186|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20378547|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20378548|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20378549|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20378550|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378551|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20378552|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20378553|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378554|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
20378555|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
20378556|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20378557|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
20378558|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
20378559|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20378560|NCT01012479|Candesartan|candesartan|mesh-list
20378561|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
20378562|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20378563|NCT01012479|Diuretics|diuretics|mesh-ancestor
20378564|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
19330187|NCT03909724|Growth Substances|growth substances|mesh-ancestor
19330188|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330189|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
19330190|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20193280|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
20193281|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
20193282|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
20193283|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
20193284|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20193285|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193286|NCT00226538|Fluconazole|fluconazole|mesh-list
20193287|NCT00226538|Rifampin|rifampin|mesh-list
20193288|NCT00226538|Diclofenac|diclofenac|mesh-list
20193289|NCT00226538|Phenytoin|phenytoin|mesh-list
20193290|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20378565|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378566|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19676749|NCT04095858|Methotrexate|methotrexate|mesh-list
20378567|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330191|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193291|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193292|NCT00226538|Analgesics|analgesics|mesh-ancestor
20193293|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
20193294|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193295|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193296|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193297|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193298|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19330192|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330193|NCT03909737|Azithromycin|azithromycin|mesh-list
19330194|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19330195|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330196|NCT03909529|Digoxin|digoxin|mesh-list
19330197|NCT03909529|Spironolactone|spironolactone|mesh-list
19330198|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20193299|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676750|NCT04095858|Tacrolimus|tacrolimus|mesh-list
19676751|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19676752|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
19676753|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19676754|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676755|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19676756|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
19676757|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676758|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676759|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
19676760|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676761|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19676762|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676763|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
19676764|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676765|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19676766|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19676767|NCT04040621|Ceftazidime|ceftazidime|mesh-list
19676768|NCT04040621|Avibactam|avibactam|mesh-list
19676769|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19676770|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19676771|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676772|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19676773|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676774|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676775|NCT04030000|Paclitaxel|paclitaxel|mesh-list
19676776|NCT04030000|Carboplatin|carboplatin|mesh-list
19676777|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676778|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676779|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
19676780|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
20193300|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378568|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378569|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20378570|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20378571|NCT01012544|Clopidogrel|clopidogrel|mesh-list
20378572|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20378573|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20378574|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20378575|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20378576|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
20378577|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378578|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378579|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378580|NCT01012570|Adalimumab|adalimumab|mesh-list
20378581|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378582|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20378583|NCT01012687|Perindopril|perindopril|mesh-list
20378584|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20378585|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
20378586|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378587|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378588|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19330199|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
19399181|NCT03636932|Protective Agents|protective agents|mesh-ancestor
19676781|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
19676782|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676783|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20193301|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
20193302|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193303|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20193304|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20193305|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20193306|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
20193307|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193308|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20193309|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20193310|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20193311|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
20193312|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378589|NCT01012700|Poly ICLC|poly iclc|mesh-list
20378590|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
19676784|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
19676785|NCT04028115|Ixazomib|ixazomib|mesh-list
19676786|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676787|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
19676788|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330200|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330201|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330202|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19676789|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676790|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
19676791|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19676792|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19676793|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
19676794|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
19676795|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19676796|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378591|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
20378592|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378593|NCT01012830|Huperzine A|huperzine a|mesh-list
20378594|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20378595|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378596|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692318|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
19692319|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692320|NCT04992507|Anesthetics|anesthetics|mesh-list
19692321|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692322|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692323|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19330203|NCT03909529|Diuretics|diuretics|mesh-ancestor
19330204|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
19330205|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19330206|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20193313|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
20193314|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20193315|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20378597|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
20378598|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378599|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378600|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20378601|NCT01012830|Protective Agents|protective agents|mesh-ancestor
20378602|NCT01012843|Amoxicillin|amoxicillin|mesh-list
20378603|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
20378604|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
20378605|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20378606|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378607|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378608|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20378609|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378610|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378611|NCT01012869|Everolimus|everolimus|mesh-list
20378612|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378613|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378614|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
20378615|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612834|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
19330207|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193316|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20193317|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20193318|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19330208|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330209|NCT03909529|Protective Agents|protective agents|mesh-ancestor
19330210|NCT03909412|Dexamethasone|dexamethasone|mesh-list
19330211|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
19330212|NCT03909412|Sargramostim|sargramostim|mesh-list
19330213|NCT03909412|Lenograstim|lenograstim|mesh-list
19330214|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19330215|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
19330216|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330217|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330218|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20193319|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20193320|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20193321|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
20193322|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20193323|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20193324|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193325|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19676797|NCT03965234|Cisplatin|cisplatin|mesh-list
19676798|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676799|NCT03952091|Dexamethasone|dexamethasone|mesh-list
19676800|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
19676801|NCT03952091|Lenalidomide|lenalidomide|mesh-list
19676802|NCT03952091|BB 1101|bb 1101|mesh-list
19676803|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676804|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
19676805|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
19676806|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676807|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676808|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19676809|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
19676810|NCT03952091|Hormones|hormones|mesh-ancestor
19676811|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19676812|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19676813|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676814|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
19676815|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676816|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676817|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
19676818|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19676819|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19676820|NCT03952091|Growth Substances|growth substances|mesh-ancestor
19676821|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
19676822|NCT03946527|Lanreotide|lanreotide|mesh-list
19676823|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676824|NCT03943173|Olaparib|olaparib|mesh-list
19676825|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19676826|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676827|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676828|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676829|NCT03933163|Resveratrol|resveratrol|mesh-list
19676830|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
19676831|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330219|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
19330220|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330221|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330222|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19330223|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19330224|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
19330225|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
19330226|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676832|NCT03933163|Protective Agents|protective agents|mesh-ancestor
19676833|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193326|NCT00226551|Isoproterenol|isoproterenol|mesh-list
20193327|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20193328|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20193329|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
20193330|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193331|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193332|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676834|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378616|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
20378617|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378618|NCT01012934|Alendronate|alendronate|mesh-list
20378619|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20378620|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378621|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
20378622|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20378623|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378624|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
20378625|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378626|NCT01013012|Dexamethasone|dexamethasone|mesh-list
20378627|NCT01013012|Ramosetron|ramosetron|mesh-list
20378628|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378629|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
20378630|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
20378631|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378632|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378633|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20378634|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
20378635|NCT01013012|Hormones|hormones|mesh-ancestor
20378636|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378637|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378638|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378639|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20378640|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
20378641|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378642|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426102|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20426103|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20426104|NCT01279096|Dexamethasone|dexamethasone|mesh-list
20426105|NCT01279096|Etoposide|etoposide|mesh-list
20426106|NCT01279096|Asparaginase|asparaginase|mesh-list
20426107|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
20426108|NCT01279096|Clofarabine|clofarabine|mesh-list
20426109|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426110|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
20426111|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
20426112|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426113|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426114|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426115|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
20426116|NCT01279096|Hormones|hormones|mesh-ancestor
20426117|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426118|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20426119|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426120|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426121|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426122|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20426123|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20426124|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20426125|NCT01279096|Analgesics|analgesics|mesh-ancestor
20426126|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
20426127|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20426128|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
20426129|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20426130|NCT01279213|Clozapine|clozapine|mesh-list
20426131|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20426132|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20426133|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426134|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426135|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20426136|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20426137|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20426138|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
20426139|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426140|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426141|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20426142|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20426143|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
20426144|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
20426145|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
19330227|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330228|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
20426146|NCT01279252|Metronidazole|metronidazole|mesh-list
19330229|NCT03909412|Hormones|hormones|mesh-ancestor
19399182|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378643|NCT01013103|Atorvastatin|atorvastatin|mesh-list
20378644|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20378645|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20378646|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
20378647|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378648|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20378649|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20378650|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378651|NCT01013155|Perindopril|perindopril|mesh-list
20378652|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20378653|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
20378654|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378655|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378656|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20378657|NCT01013272|Lamivudine|lamivudine|mesh-list
20378658|NCT01013272|Entecavir|entecavir|mesh-list
20378659|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20378660|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20378661|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378662|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378663|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
20378664|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378665|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20378666|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20378667|NCT01013402|Insulin|insulin|mesh-list
20378668|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20378669|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20378670|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378671|NCT01013454|Varenicline|varenicline|mesh-list
20378672|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20378673|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20378674|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
20378675|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378676|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378677|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378678|NCT01013480|Baclofen|baclofen|mesh-list
20378679|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20378680|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378681|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19330230|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193333|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20193334|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
19330231|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330232|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19330233|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
19330234|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
19330235|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330236|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
19330237|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330238|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330239|NCT03909646|Fluorouracil|fluorouracil|mesh-list
19330240|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19330241|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19330242|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
19676835|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19676836|NCT03927443|Bimatoprost|bimatoprost|mesh-list
19330243|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330244|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19330245|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330246|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676837|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19676838|NCT03913247|Metronidazole|metronidazole|mesh-list
19676839|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676840|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19676841|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20193335|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193336|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20193337|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193338|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20193339|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
20193340|NCT00226551|Protective Agents|protective agents|mesh-ancestor
20193341|NCT00226564|Alfentanil|alfentanil|mesh-list
20378682|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193342|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19676842|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19676843|NCT03912337|Erenumab|erenumab|mesh-list
19676844|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19676845|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676846|NCT03912337|Analgesics|analgesics|mesh-ancestor
19676847|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
19676848|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330247|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
19330248|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330249|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19330250|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
19330251|NCT03909152|Anastrozole|anastrozole|mesh-list
19330252|NCT03909152|Onapristone|onapristone|mesh-list
19330253|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330254|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330255|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19676849|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676850|NCT03828045|Apremilast|apremilast|mesh-list
19676851|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19676852|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19676853|NCT03828045|Analgesics|analgesics|mesh-ancestor
19330256|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19330257|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330258|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330259|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19330260|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
19330261|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330262|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330263|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19330264|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
19330265|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19841817|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19841818|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20193343|NCT00226564|Narcotics|narcotics|mesh-ancestor
19330269|NCT03908892|Tetracycline|tetracycline|mesh-list
19330270|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19330271|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330272|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19330273|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330274|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330275|NCT03908944|Methadone|methadone|mesh-list
19330276|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19330277|NCT03908944|Narcotics|narcotics|mesh-ancestor
19330278|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330279|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330280|NCT03908944|Analgesics|analgesics|mesh-ancestor
19330281|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
19330282|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330283|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
19330284|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
19330285|NCT03908619|Esomeprazole|esomeprazole|mesh-list
19330286|NCT03908619|Omeprazole|omeprazole|mesh-list
19330287|NCT03908619|Rabeprazole|rabeprazole|mesh-list
19330288|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19330289|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330290|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20193344|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330291|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330292|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330293|NCT03908736|Picolinic acid|picolinic acid|mesh-list
19330294|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19330295|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
19330296|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
19330297|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330298|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19330299|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19330300|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330301|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330302|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19330303|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330304|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676854|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
20193345|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193346|NCT00226564|Analgesics|analgesics|mesh-ancestor
20193347|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
20193348|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193349|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19676855|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19676856|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676857|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19676858|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676859|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19676860|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19676861|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676862|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676863|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20378683|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20378684|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
20378685|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
20378686|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193350|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
20378687|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378688|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20378689|NCT01013506|Letrozole|letrozole|mesh-list
20378690|NCT01013506|Goserelin|goserelin|mesh-list
20378691|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378692|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20378693|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193351|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
20193352|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20193353|NCT00226668|Hormones|hormones|mesh-ancestor
20193354|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193355|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193356|NCT00226694|Citalopram|citalopram|mesh-list
20193357|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20193358|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19330305|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
19676864|NCT03825874|Amikacin|amikacin|mesh-list
19676865|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676866|NCT03805841|Bromides|bromides|mesh-list
19676867|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
19676868|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19676869|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19676870|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676871|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676872|NCT03745729|Allopurinol|allopurinol|mesh-list
19676873|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
19676874|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676875|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676876|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
19676877|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676878|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19676879|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
19676880|NCT03745729|Protective Agents|protective agents|mesh-ancestor
19676881|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676882|NCT03744793|Pemetrexed|pemetrexed|mesh-list
19676883|NCT03744793|Avelumab|avelumab|mesh-list
19676884|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19676885|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676886|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676887|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676888|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20193359|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193360|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193361|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193362|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
19330306|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330307|NCT03908593|Pantoprazole|pantoprazole|mesh-list
20193363|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193364|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20193365|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193366|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193367|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
20193368|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20378694|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330308|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19676889|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19330309|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330310|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19330311|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330312|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330313|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
20378695|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20378696|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20378697|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20378698|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
20378699|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330314|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
19330315|NCT03908528|Doxorubicin|doxorubicin|mesh-list
19330316|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19330317|NCT03908528|Paclitaxel|paclitaxel|mesh-list
19330318|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20378700|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378701|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378702|NCT01013532|Aspirin|aspirin|mesh-list
20378703|NCT01013532|Cilostazol|cilostazol|mesh-list
20378704|NCT01013532|Probucol|probucol|mesh-list
20378705|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20378706|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20378707|NCT01013532|Analgesics|analgesics|mesh-ancestor
20378708|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
20378709|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378710|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378711|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378712|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20378713|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20378714|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20378715|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378716|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20378717|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19676890|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676891|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
19676892|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676893|NCT03719430|Doxorubicin|doxorubicin|mesh-list
19676894|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19676895|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676896|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19676897|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19676898|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676899|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676900|NCT03693807|Gemcitabine|gemcitabine|mesh-list
19676901|NCT03693807|Fluorouracil|fluorouracil|mesh-list
19676902|NCT03693807|Floxuridine|floxuridine|mesh-list
19676903|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
20378718|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378719|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
20378720|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20378721|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
20378722|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20426147|NCT01279252|Clarithromycin|clarithromycin|mesh-list
19330319|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19330320|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
19330321|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330322|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330323|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19676904|NCT03693807|Irinotecan|irinotecan|mesh-list
19676905|NCT03693807|Cetuximab|cetuximab|mesh-list
19676906|NCT03693807|Panitumumab|panitumumab|mesh-list
19676907|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19676908|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
19676909|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676910|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676911|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
19330324|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
19330325|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676912|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19676913|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676914|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676915|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
19676916|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330326|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330327|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19676917|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20378723|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
20378724|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378725|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20378726|NCT01013532|Protective Agents|protective agents|mesh-ancestor
20378727|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20378728|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20378729|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20378730|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20378731|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
19330328|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19330329|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19330330|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19330331|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330332|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19330333|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
19330334|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
19330335|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
19330336|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
19330337|NCT03908528|Protective Agents|protective agents|mesh-ancestor
19330338|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
19330339|NCT03908528|Vitamins|vitamins|mesh-ancestor
19330340|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
19330341|NCT03908814|Antibodies|antibodies|mesh-list
19330342|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
20378732|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20378733|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
20378734|NCT01013558|Remifentanil|remifentanil|mesh-list
19330343|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330344|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
19330345|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
19330346|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330347|NCT03908489|Protective Agents|protective agents|mesh-ancestor
19330348|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330349|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19330350|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330351|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19330352|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330353|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
19676918|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19676919|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676920|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
19676921|NCT03693014|Nivolumab|nivolumab|mesh-list
19676922|NCT03693014|Ipilimumab|ipilimumab|mesh-list
19676923|NCT03693014|Atezolizumab|atezolizumab|mesh-list
19676924|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676925|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676926|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19676927|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193369|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193370|NCT00226707|Analgesics|analgesics|mesh-ancestor
20193371|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
20193372|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193373|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676933|NCT03635632|Cyclophosphamide|cyclophosphamide|mesh-list
19676934|NCT03635632|Fludarabine|fludarabine|mesh-list
19676935|NCT03635632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676936|NCT03635632|Immunologic Factors|immunologic factors|mesh-ancestor
19330354|NCT03908333|Gemcitabine|gemcitabine|mesh-list
20193374|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193375|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193376|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
20193377|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193378|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
20193379|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20193380|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193381|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193382|NCT00226746|Gemcitabine|gemcitabine|mesh-list
20193383|NCT00226746|Paclitaxel|paclitaxel|mesh-list
20193384|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20193385|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193386|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
20193387|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
20193388|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
20378735|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19330355|NCT03908333|Paclitaxel|paclitaxel|mesh-list
19330356|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19676937|NCT03635632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676938|NCT03635632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193389|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193390|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193391|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
20193392|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
20193393|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193394|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676939|NCT03635632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19676940|NCT03635632|Alkylating Agents|alkylating agents|mesh-ancestor
19676941|NCT03635632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676942|NCT03635632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676943|NCT03635632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19676944|NCT03631043|Lenalidomide|lenalidomide|mesh-list
19676945|NCT03631043|Vaccines|vaccines|mesh-list
19676946|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
19676947|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676948|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19676949|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19676950|NCT03631043|Growth Substances|growth substances|mesh-ancestor
19676951|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
19676952|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676953|NCT03595592|Paclitaxel|paclitaxel|mesh-list
19676954|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19676955|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
19676956|NCT03595592|Carboplatin|carboplatin|mesh-list
20193395|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193396|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
20193397|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193398|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
20193399|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20193400|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193401|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193402|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193403|NCT00226785|Analgesics|analgesics|mesh-ancestor
20193404|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
20193405|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193406|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20378736|NCT01013558|Narcotics|narcotics|mesh-ancestor
20378737|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20378738|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378739|NCT01013558|Analgesics|analgesics|mesh-ancestor
20378740|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
20378741|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378742|NCT01013571|Insulin|insulin|mesh-list
20378743|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20378744|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
20378745|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
20378746|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20378747|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378748|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
20378749|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19330357|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19330358|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193407|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20193408|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19330359|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
19330360|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
19330361|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
19330362|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330363|NCT03908333|Vitamins|vitamins|mesh-ancestor
19330364|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
19330365|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330366|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19330367|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
19330368|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
19330369|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330370|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330371|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19330372|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
19330373|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
19330374|NCT03908333|Protective Agents|protective agents|mesh-ancestor
19330375|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
20378750|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378751|NCT01013584|Vitamins|vitamins|mesh-ancestor
19330376|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330377|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399183|NCT03636932|Antidotes|antidotes|mesh-ancestor
19330378|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330379|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19330380|NCT03908060|Morphine|morphine|mesh-list
19330381|NCT03908060|Methadone|methadone|mesh-list
19330382|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19330383|NCT03908060|Narcotics|narcotics|mesh-ancestor
19330384|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330385|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330386|NCT03908060|Analgesics|analgesics|mesh-ancestor
19330387|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
20193409|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
20193410|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193411|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193412|NCT00226798|Capecitabine|capecitabine|mesh-list
20193413|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193414|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
20193415|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193416|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193417|NCT00226824|Galantamine|galantamine|mesh-list
20193418|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20193419|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193420|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193421|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
20193422|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193423|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193424|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20378752|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
20378753|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19330388|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330389|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
19330390|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
19330391|NCT03908372|Docetaxel|docetaxel|mesh-list
19330392|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330393|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
20378754|NCT01013675|Vaccines|vaccines|mesh-list
20378755|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
20378756|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378757|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
20378758|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20378759|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378760|NCT01013779|Carboplatin|carboplatin|mesh-list
20378761|NCT01013779|Etoposide|etoposide|mesh-list
20378762|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378763|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20378764|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20378765|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20378766|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378767|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378768|NCT01013805|Leucovorin|leucovorin|mesh-list
20378769|NCT01013805|Fluorouracil|fluorouracil|mesh-list
19330394|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
19330395|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
19330396|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330397|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
19330398|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19330399|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19330400|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19330401|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330402|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330403|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
19330404|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330405|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330406|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19330407|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330408|NCT03907800|Paclitaxel|paclitaxel|mesh-list
19330409|NCT03907800|Carboplatin|carboplatin|mesh-list
19330410|NCT03907800|Trastuzumab|trastuzumab|mesh-list
19330411|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19330412|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330413|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
19676957|NCT03595592|Doxorubicin|doxorubicin|mesh-list
19676958|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19330414|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
19676959|NCT03595592|Trastuzumab|trastuzumab|mesh-list
20378770|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
20378771|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
20378772|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378773|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20378774|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378775|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378776|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
20378777|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378778|NCT01013805|Antidotes|antidotes|mesh-ancestor
20378779|NCT01013805|Protective Agents|protective agents|mesh-ancestor
20378780|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
20378781|NCT01013805|Vitamins|vitamins|mesh-ancestor
20378782|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
20378783|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20378784|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378785|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20378786|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378787|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330415|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
19330416|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330417|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19330418|NCT03907813|Bupivacaine|bupivacaine|mesh-list
19330419|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
19330420|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
19330421|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330422|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330423|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
19676960|NCT03595592|Atezolizumab|atezolizumab|mesh-list
19676961|NCT03595592|Pertuzumab|pertuzumab|mesh-list
19676962|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676963|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676964|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
19676965|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
19676966|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
19676967|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676968|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676969|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
19676970|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19676971|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676972|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19676973|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
19676974|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19676975|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19676976|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19676977|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19676978|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676979|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19676980|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
19676981|NCT03577431|Everolimus|everolimus|mesh-list
19676982|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19676983|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
19676984|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330424|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399184|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19399185|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399186|NCT03636685|Paclitaxel|paclitaxel|mesh-list
19399187|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19676985|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19676986|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19676987|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
19676988|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676989|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676990|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19676991|NCT03568929|Idelalisib|idelalisib|mesh-list
19676992|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676993|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19676994|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19676995|NCT03537690|Paclitaxel|paclitaxel|mesh-list
19676996|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19676997|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19676998|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19676999|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677000|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677001|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
19692324|NCT04992468|Hormones|hormones|mesh-ancestor
19399188|NCT03636685|Carboplatin|carboplatin|mesh-list
19399189|NCT03636685|Pemetrexed|pemetrexed|mesh-list
19677002|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677003|NCT03536728|Eflornithine|eflornithine|mesh-list
19677004|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677005|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20193425|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
20193426|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330425|NCT03907423|Metformin|metformin|mesh-list
19330426|NCT03907423|Glimepiride|glimepiride|mesh-list
19330427|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19330428|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19330429|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330430|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19330431|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19330432|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
19330433|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330434|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19330435|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19330436|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330437|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19330438|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19330439|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
19330440|NCT03907371|Donepezil|donepezil|mesh-list
19330441|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19677006|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19677007|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19677008|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677009|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19677010|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677011|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677012|NCT03510390|Metformin|metformin|mesh-list
19677013|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19677014|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677015|NCT03449108|Aldesleukin|aldesleukin|mesh-list
19677016|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
19677017|NCT03449108|Nivolumab|nivolumab|mesh-list
19677018|NCT03449108|Fludarabine|fludarabine|mesh-list
19677019|NCT03449108|Ipilimumab|ipilimumab|mesh-list
19677020|NCT03449108|Interleukin-2|interleukin-2|mesh-list
19677021|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677022|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
19841819|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20378788|NCT01013909|Terbinafine|terbinafine|mesh-list
20378789|NCT01013909|Bifonazole|bifonazole|mesh-list
20193427|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
20193428|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
20193429|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20193430|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
19841820|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841821|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841822|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19841823|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19841824|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841825|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
19841826|NCT00643851|Metformin|metformin|mesh-list
20193431|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
20193432|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193433|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193434|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193435|NCT00226837|Analgesics|analgesics|mesh-ancestor
20193436|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
20193437|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193438|NCT00226889|Bosentan|bosentan|mesh-list
20193439|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20193440|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20193441|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193442|NCT00226915|Paclitaxel|paclitaxel|mesh-list
20193443|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20193444|NCT00226915|Carboplatin|carboplatin|mesh-list
20193445|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20193446|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193447|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
20378790|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
19677023|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330442|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677024|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193448|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
20378791|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841827|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
19841828|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841829|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841830|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19841831|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193449|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
20193450|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193451|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
20193452|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20193453|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193454|NCT00226967|Octreotide|octreotide|mesh-list
19677025|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19677026|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
19677027|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378792|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378793|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378794|NCT01013987|Ritonavir|ritonavir|mesh-list
20378795|NCT01013987|Darunavir|darunavir|mesh-list
20378796|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
20378797|NCT01013987|Maraviroc|maraviroc|mesh-list
20378798|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20378799|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20378800|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
20378801|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378802|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378803|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20378804|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19677028|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677029|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19677030|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677031|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19330443|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330444|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
19330445|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330446|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193455|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20378805|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
20378806|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378807|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20378808|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20378809|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20378810|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20378811|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20378812|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20378813|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20378814|NCT01014052|Retinol acetate|retinol acetate|mesh-list
20378815|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20378816|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
20378817|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378818|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20378819|NCT01014052|Protective Agents|protective agents|mesh-ancestor
20378820|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378821|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
20378822|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20378823|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20378824|NCT01014104|Prednisolone|prednisolone|mesh-list
20378825|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
19330447|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
19330448|NCT03907098|Endostar protein|endostar protein|mesh-list
19330449|NCT03907098|Endostatins|endostatins|mesh-list
19330450|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19677032|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19677033|NCT03449108|Analgesics|analgesics|mesh-ancestor
19677034|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
19677035|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841832|NCT00644059|Vaccines|vaccines|mesh-list
19841833|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
19841834|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841835|NCT00644189|Clofarabine|clofarabine|mesh-list
20193456|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20193457|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193458|NCT00226980|Thalidomide|thalidomide|mesh-list
20193459|NCT00226980|Capecitabine|capecitabine|mesh-list
20378826|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19330451|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19330452|NCT03907098|Growth Substances|growth substances|mesh-ancestor
19330453|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330454|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
19330455|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841836|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19841837|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
19677036|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20193460|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193461|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
20193462|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193463|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378827|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
20193464|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193465|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
20193466|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378828|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378829|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
20378830|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
20378831|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378832|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378833|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20378834|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
20378835|NCT01014104|Hormones|hormones|mesh-ancestor
20378836|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378837|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20378838|NCT01014104|Protective Agents|protective agents|mesh-ancestor
20378839|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378840|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378841|NCT01014156|Epoprostenol|epoprostenol|mesh-list
20378842|NCT01014156|Tezosentan|tezosentan|mesh-list
20378843|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20378844|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20378845|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
20378846|NCT01014221|Prednisolone|prednisolone|mesh-list
20378847|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378848|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
20378849|NCT01014221|Hormones|hormones|mesh-ancestor
20378850|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20378851|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378852|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378853|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378854|NCT01014234|Cyclosporine|cyclosporine|mesh-list
20378855|NCT01014234|Sirolimus|sirolimus|mesh-list
20378856|NCT01014234|Cyclosporins|cyclosporins|mesh-list
20378857|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378858|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378859|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193467|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
20193468|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193469|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193470|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20193471|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20378860|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
19677037|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19677038|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
19677039|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677040|NCT03442088|Apremilast|apremilast|mesh-list
19677041|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19677042|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19677043|NCT03442088|Analgesics|analgesics|mesh-ancestor
19677044|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
19677045|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677046|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677047|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677048|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677049|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19677050|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19677051|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677052|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677053|NCT03291990|Temozolomide|temozolomide|mesh-list
19677054|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20378861|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193472|NCT00226980|Growth Substances|growth substances|mesh-ancestor
20378862|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
20378863|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378864|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
20378865|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20378866|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20378867|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378868|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20378869|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378870|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
20378871|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20378872|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378873|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378874|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20378875|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20378876|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378877|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378878|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378879|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20378880|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
20378881|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20378882|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378883|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20378884|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20378885|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20378886|NCT01014260|Doxycycline|doxycycline|mesh-list
19677055|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
19677056|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677057|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677058|NCT03277924|Doxorubicin|doxorubicin|mesh-list
19677059|NCT03277924|Methotrexate|methotrexate|mesh-list
19677060|NCT03277924|Nivolumab|nivolumab|mesh-list
19677061|NCT03277924|Sunitinib|sunitinib|mesh-list
20378887|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20378888|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378889|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
20378890|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20378891|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20378892|NCT01014338|Fosinopril|fosinopril|mesh-list
20378893|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20378894|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
20378895|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378896|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378897|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20378898|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
20378899|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20378900|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19841838|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841839|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193473|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
19330462|NCT03906916|Micafungin|micafungin|mesh-list
19330463|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
19330464|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677062|NCT03277924|Epirubicin|epirubicin|mesh-list
20193474|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20193475|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193476|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20193477|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193478|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193479|NCT00227084|Hemostatics|hemostatics|mesh-list
20193480|NCT00227084|Coagulants|coagulants|mesh-ancestor
20193481|NCT00227097|Anticoagulants|anticoagulants|mesh-list
20193482|NCT00227110|Pioglitazone|pioglitazone|mesh-list
20193483|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20193484|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193485|NCT00227123|Risperidone|risperidone|mesh-list
20193486|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20193487|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20193488|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
20193489|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193490|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193491|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330465|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
19330466|NCT03907215|Citalopram|citalopram|mesh-list
19677063|NCT03277924|Ifosfamide|ifosfamide|mesh-list
19677064|NCT03277924|Dacarbazine|dacarbazine|mesh-list
19677065|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193492|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20378901|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20378902|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20378903|NCT01014416|Tolvaptan|tolvaptan|mesh-list
20193493|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20193494|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677066|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677067|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19841840|NCT00644280|Ranibizumab|ranibizumab|mesh-list
19841841|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19841842|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19841843|NCT00644280|Growth Substances|growth substances|mesh-ancestor
20378904|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20378905|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378906|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
20378907|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378908|NCT01014468|Bevacizumab|bevacizumab|mesh-list
20378909|NCT01014468|Ranibizumab|ranibizumab|mesh-list
19677068|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20378910|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20378911|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378912|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20378913|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20378914|NCT01014468|Growth Substances|growth substances|mesh-ancestor
20378915|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378916|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
20378917|NCT01014481|Tenofovir|tenofovir|mesh-list
20378918|NCT01014481|Lamivudine|lamivudine|mesh-list
20378919|NCT01014481|Efavirenz|efavirenz|mesh-list
20378920|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
20378921|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378922|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20378923|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20378924|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378925|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378926|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20378927|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20378928|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20378929|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20378930|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19677069|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378931|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20378932|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20378933|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20378934|NCT01014507|Goserelin|goserelin|mesh-list
20378935|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
19330467|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19330468|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19330469|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330470|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330471|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330472|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
20378936|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
20378937|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20378938|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677070|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677071|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19677072|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
19677073|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19677074|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841844|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841845|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
19841846|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841847|NCT00644332|Ranolazine|ranolazine|mesh-list
19841848|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19841849|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193495|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193496|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20193497|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
20193498|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193499|NCT00227136|Serotonin|serotonin|mesh-list
20193500|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20193501|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
20193502|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378939|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20378940|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378941|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20378942|NCT01014520|Gabapentin|gabapentin|mesh-list
20378943|NCT01014520|Amitriptyline|amitriptyline|mesh-list
20378944|NCT01014520|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20378945|NCT01014520|Analgesics|analgesics|mesh-ancestor
19330473|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330474|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19330475|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
19330476|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330477|NCT03907163|Dronabinol|dronabinol|mesh-list
19330478|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
19330479|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330480|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330481|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19330482|NCT03907163|Analgesics|analgesics|mesh-ancestor
19330483|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
19330484|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330485|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19330486|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19330487|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330488|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330489|NCT03907163|Hormones|hormones|mesh-ancestor
19330490|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330491|NCT03907111|Chitosan|chitosan|mesh-list
19330492|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19330493|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19330494|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
19330495|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677075|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193503|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193504|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193505|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20193506|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
20193507|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217483|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217484|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20378946|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
20378947|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217485|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20217486|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20378948|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677076|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
19677077|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
19677078|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19677079|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20378949|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
20378950|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20378951|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20378952|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677080|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
19677081|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677082|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19677083|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677084|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19677085|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19677086|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19677087|NCT03277924|Growth Substances|growth substances|mesh-ancestor
19677088|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
19841850|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841851|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19841852|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
19841853|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841854|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19841855|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19841856|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19841857|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841858|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841859|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
19841860|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330496|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19330497|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
19330498|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
19330499|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
19330500|NCT03907111|Coagulants|coagulants|mesh-ancestor
19330501|NCT03906838|Ropivacaine|ropivacaine|mesh-list
19330502|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
19330503|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
19330504|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330505|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330506|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
19330507|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330508|NCT03906669|Tamoxifen|tamoxifen|mesh-list
19330509|NCT03906669|Letrozole|letrozole|mesh-list
19330510|NCT03906669|Progesterone|progesterone|mesh-list
19677089|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19677090|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19677091|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
19677092|NCT03258853|Pancrelipase|pancrelipase|mesh-list
19677093|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19677094|NCT03257267|Cemiplimab|cemiplimab|mesh-list
19677095|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677096|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677097|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
19677098|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
19677099|NCT03247088|Busulfan|busulfan|mesh-list
19677100|NCT03247088|Fludarabine|fludarabine|mesh-list
19330511|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330512|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19330513|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19330514|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330515|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677101|NCT03247088|Sorafenib|sorafenib|mesh-list
19677102|NCT03247088|Tacrolimus|tacrolimus|mesh-list
19677103|NCT03247088|Lenograstim|lenograstim|mesh-list
19677104|NCT03247088|Sargramostim|sargramostim|mesh-list
19677105|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193508|NCT00227253|Hormones|hormones|mesh-list
20193509|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193510|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193511|NCT00227292|Citalopram|citalopram|mesh-list
20193512|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20193513|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20193514|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193515|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193516|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193517|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
20193518|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193519|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20193520|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193521|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193522|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
20193523|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20193524|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20193525|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20193526|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193527|NCT00227331|Amoxicillin|amoxicillin|mesh-list
20193528|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193529|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193530|NCT00227357|Buprenorphine|buprenorphine|mesh-list
20193531|NCT00227357|Methadone|methadone|mesh-list
20193532|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20193533|NCT00227357|Naloxone|naloxone|mesh-list
20193534|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20193535|NCT00227357|Narcotics|narcotics|mesh-ancestor
20193536|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193537|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193538|NCT00227357|Analgesics|analgesics|mesh-ancestor
20193539|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
20193540|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193541|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19330516|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19677106|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
19677107|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677108|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330517|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
20378953|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20378954|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20378955|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20378956|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20378957|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378958|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
20378959|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20378960|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
20378961|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20378962|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20378963|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19677109|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19677110|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
19677111|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677112|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378964|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20378965|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
20378966|NCT01014520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20378967|NCT01014546|Vitamins|vitamins|mesh-list
20378968|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
20378969|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
19330518|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330519|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330520|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330521|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19330522|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19330523|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19330524|NCT03906669|Progestins|progestins|mesh-ancestor
19330525|NCT03906669|Hormones|hormones|mesh-ancestor
19330526|NCT03905798|Lorazepam|lorazepam|mesh-list
19330527|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
19330528|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
19330529|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
19330530|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330531|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330532|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330533|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19330534|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330535|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19330536|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19330537|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19677113|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20378970|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
20378971|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378972|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
20378973|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20378974|NCT01014546|Protective Agents|protective agents|mesh-ancestor
20378975|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378976|NCT01014559|Oxycodone|oxycodone|mesh-list
20378977|NCT01014559|Naloxone|naloxone|mesh-list
20378978|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20378979|NCT01014559|Narcotics|narcotics|mesh-ancestor
20378980|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20378981|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20378982|NCT01014559|Analgesics|analgesics|mesh-ancestor
20378983|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
20378984|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20378985|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20378986|NCT01014598|Cisplatin|cisplatin|mesh-list
20378987|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20378988|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
19677114|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19677115|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19677116|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677117|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677118|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19677119|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
19677120|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19677121|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677122|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20378989|NCT01014637|Clotrimazole|clotrimazole|mesh-list
20378990|NCT01014637|Miconazole|miconazole|mesh-list
19330538|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
19330539|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
20378991|NCT01014637|Amorolfine|amorolfine|mesh-list
20378992|NCT01014637|Ciclopirox|ciclopirox|mesh-list
19330540|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330541|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330542|NCT03905837|Lidocaine|lidocaine|mesh-list
19330543|NCT03905837|Piperidine|piperidine|mesh-list
19330544|NCT03905837|Remifentanil|remifentanil|mesh-list
19330545|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
19330546|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
19330547|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330548|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330549|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
19677123|NCT03206151|Leucovorin|leucovorin|mesh-list
19677124|NCT03206151|Folic Acid|folic acid|mesh-list
19677125|NCT03206151|Fluorouracil|fluorouracil|mesh-list
19677126|NCT03206151|Irinotecan|irinotecan|mesh-list
19677127|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
19677128|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
19677129|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677130|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19677131|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677132|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677133|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
19677134|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677135|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19677136|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19677137|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677138|NCT03206151|Antidotes|antidotes|mesh-ancestor
20378993|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
20378994|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20378995|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20378996|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20378997|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20378998|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20378999|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677139|NCT03206151|Protective Agents|protective agents|mesh-ancestor
19677140|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
19677141|NCT03206151|Vitamins|vitamins|mesh-ancestor
19677142|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
19677143|NCT03206151|Hematinics|hematinics|mesh-ancestor
19677144|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
19677145|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
20379000|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20379001|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
20379002|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426148|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
19677146|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19677147|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19677148|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677149|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677150|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677151|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677152|NCT03131726|Simvastatin|simvastatin|mesh-list
19677153|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19677154|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19677155|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
19677156|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677157|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19677158|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19677159|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677160|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
19677161|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677162|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677163|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
19677164|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677165|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677166|NCT03023631|Vaccines|vaccines|mesh-list
19677167|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
19677168|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677169|NCT03023462|Droperidol|droperidol|mesh-list
19677170|NCT03023462|Oxycodone|oxycodone|mesh-list
19677171|NCT03023462|Ondansetron|ondansetron|mesh-list
19677172|NCT03023462|Ropivacaine|ropivacaine|mesh-list
19841861|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19677173|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
19677174|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
19677175|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677176|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330550|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379003|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379004|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20379005|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20379006|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
20379007|NCT01014650|Glycine|glycine|mesh-list
20379008|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
20379009|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677177|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
19677178|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330551|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19330552|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19330553|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19330554|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330555|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330556|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19330557|NCT03905837|Narcotics|narcotics|mesh-ancestor
19330558|NCT03905837|Analgesics|analgesics|mesh-ancestor
19330559|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19330560|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19330561|NCT03905941|Metformin|metformin|mesh-list
19330562|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
19330563|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19330564|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330565|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19330566|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19330567|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19330568|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19330569|NCT03906123|Protective Agents|protective agents|mesh-ancestor
19330570|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330571|NCT03905967|Lenvatinib|lenvatinib|mesh-list
20379010|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677179|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19677180|NCT03023462|Narcotics|narcotics|mesh-ancestor
19677181|NCT03023462|Analgesics|analgesics|mesh-ancestor
19677182|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
19677183|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
19677184|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379011|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379012|NCT01014793|Cabergoline|cabergoline|mesh-list
20379013|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19330572|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330573|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19677185|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
19677186|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
19677187|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19677188|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
19677189|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677190|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379014|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20379015|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
20379016|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
20379017|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379018|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330574|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677191|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19677192|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19677193|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19677194|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19677195|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19677196|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19677197|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19841862|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19841863|NCT00644592|Fenofibrate|fenofibrate|mesh-list
19841864|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19841865|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
19841866|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841867|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20193542|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
20193543|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193544|NCT00227409|Edetic Acid|edetic acid|mesh-list
20193545|NCT00227409|Calcium|calcium|mesh-list
20193546|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
20193547|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20193548|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193549|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
19677198|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
19692325|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692326|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692327|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
19692328|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20379019|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379020|NCT01014832|Insulin|insulin|mesh-list
20379021|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20379022|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20379023|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379024|NCT01014845|Vaccines|vaccines|mesh-list
20379025|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
20379026|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379027|NCT01014858|Donepezil|donepezil|mesh-list
19692329|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19692330|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692331|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692332|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692333|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692334|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
19692335|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
19692336|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692337|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
19692338|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19692339|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
19692340|NCT04992481|Fluorides|fluorides|mesh-list
19692341|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
19692342|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
19692343|NCT04992481|Protective Agents|protective agents|mesh-ancestor
19692344|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692345|NCT04992182|Vaccines|vaccines|mesh-list
19692346|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
19692347|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692348|NCT04992052|Bone wax|bone wax|mesh-list
19692349|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
19692350|NCT04992052|Coagulants|coagulants|mesh-ancestor
19692351|NCT04992143|Sorafenib|sorafenib|mesh-list
19692352|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692353|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20379028|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20379029|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379030|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379031|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
20379032|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379033|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379034|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
20426149|NCT01279252|Lansoprazole|lansoprazole|mesh-list
20426150|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
20426151|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426152|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20426153|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20426154|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19330575|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330576|NCT03905759|Colchicine|colchicine|mesh-list
19330577|NCT03905759|Amiodarone|amiodarone|mesh-list
19330578|NCT03905759|Dronedarone|dronedarone|mesh-list
19330579|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
19692354|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193550|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20193551|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
20193552|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
20193553|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193554|NCT00227409|Antidotes|antidotes|mesh-ancestor
20193555|NCT00227409|Protective Agents|protective agents|mesh-ancestor
20193556|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20193557|NCT00227448|Phenylephrine|phenylephrine|mesh-list
20193558|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
20193559|NCT00227448|Midodrine|midodrine|mesh-list
20193560|NCT00227448|Norepinephrine|norepinephrine|mesh-list
20193561|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20193562|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
20193563|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
19330580|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692355|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692356|NCT04992026|Prednisone|prednisone|mesh-list
20193564|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193565|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330581|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
20379035|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
20379036|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20379037|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19677199|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
19677200|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19677201|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
19677202|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677203|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677204|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19677205|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
19677206|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19677207|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
19677208|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677209|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677210|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19677211|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
19677212|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
19677213|NCT03023449|Protective Agents|protective agents|mesh-ancestor
19677214|NCT02994069|Cisplatin|cisplatin|mesh-list
19677215|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677216|NCT02987686|Infliximab|infliximab|mesh-list
19677217|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
19677218|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19677219|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677220|NCT02963064|Antibodies|antibodies|mesh-list
19677221|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19677222|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
19677223|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677224|NCT02909686|Curcumin|curcumin|mesh-list
19677225|NCT02909686|Resveratrol|resveratrol|mesh-list
19677226|NCT02909686|Pycnogenols|pycnogenols|mesh-list
19677227|NCT02909686|Turmeric extract|turmeric extract|mesh-list
19677228|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19677229|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19677230|NCT02909686|Analgesics|analgesics|mesh-ancestor
19677231|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
19677232|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677233|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677234|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19330582|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
19330583|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
20379038|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
20379039|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379040|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379041|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379042|NCT01015040|Urological Agents|urological agents|mesh-ancestor
20379043|NCT01015053|Ropivacaine|ropivacaine|mesh-list
20379044|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
20379045|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
20379046|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379047|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379048|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
20379049|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379050|NCT01015066|Naltrexone|naltrexone|mesh-list
20379051|NCT01015066|Buprenorphine|buprenorphine|mesh-list
20379052|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20379053|NCT01015066|Naloxone|naloxone|mesh-list
19330584|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330585|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330586|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19677235|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193566|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
20193567|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20193568|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
20193569|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193570|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20193571|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20193572|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20193573|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
20193574|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193575|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193576|NCT00227448|Protective Agents|protective agents|mesh-ancestor
20193577|NCT00227461|Levetiracetam|levetiracetam|mesh-list
20379054|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19677236|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677237|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193578|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
20193579|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
20193580|NCT00227474|Vaccines|vaccines|mesh-list
20193581|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
19677238|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677239|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
19677240|NCT02909686|Protective Agents|protective agents|mesh-ancestor
19677241|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19677242|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19677243|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
19677244|NCT02865928|Bupivacaine|bupivacaine|mesh-list
19677245|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
19677246|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
19677247|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677248|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677249|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
19677250|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379055|NCT01015066|Narcotics|narcotics|mesh-ancestor
20379056|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379057|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379058|NCT01015066|Analgesics|analgesics|mesh-ancestor
20379059|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
20379060|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379061|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20379062|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20379063|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
20379064|NCT01015183|Astringents|astringents|mesh-ancestor
20379065|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379066|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
20379067|NCT01015196|Daunorubicin|daunorubicin|mesh-list
20379068|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20379069|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379070|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19677251|NCT02860091|Ropivacaine|ropivacaine|mesh-list
19677252|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
19677253|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
19677254|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677255|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677256|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
19677257|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677258|NCT02825641|Oxytocin|oxytocin|mesh-list
19677259|NCT02825641|Dinoprostone|dinoprostone|mesh-list
19677260|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
19677261|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19677262|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677263|NCT02824952|Osimertinib|osimertinib|mesh-list
20379071|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20379072|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379073|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379074|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
20379075|NCT01015209|Chitosan|chitosan|mesh-list
20379076|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20379077|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20379078|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20379079|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
19677264|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677265|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19677266|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677267|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677268|NCT02812420|Durvalumab|durvalumab|mesh-list
19677269|NCT02812420|Ipilimumab|ipilimumab|mesh-list
19677270|NCT02812420|Tremelimumab|tremelimumab|mesh-list
19677271|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
19677272|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19677273|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
19677274|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677275|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677276|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
20193582|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193583|NCT00227500|Pravastatin|pravastatin|mesh-list
20193584|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20193585|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20379080|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677277|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692357|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
20193586|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
20217487|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
20379081|NCT01015209|Expectorants|expectorants|mesh-ancestor
20612835|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
19677278|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19677279|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330587|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
20193587|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193588|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20193589|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20193590|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193591|NCT00227513|Bortezomib|bortezomib|mesh-list
19330588|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19330589|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330590|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19330591|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19330592|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19330593|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330594|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19330595|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19330596|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19330597|NCT03905603|Cosyntropin|cosyntropin|mesh-list
19677280|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
19677281|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19677282|NCT02730325|Antibodies|antibodies|mesh-list
19677283|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
19677284|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677285|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
19677286|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677287|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677288|NCT02514382|Dexamethasone|dexamethasone|mesh-list
19677289|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
19677290|NCT02514382|Bortezomib|bortezomib|mesh-list
19677291|NCT02514382|Ichthammol|ichthammol|mesh-list
19677292|NCT02514382|BB 1101|bb 1101|mesh-list
19677293|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677294|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
19677295|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
19677296|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677297|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677298|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19677299|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
19330598|NCT03905603|Hormones|hormones|mesh-ancestor
19330599|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330600|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399190|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19399191|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399192|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
19399193|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677300|NCT02514382|Hormones|hormones|mesh-ancestor
19677301|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677302|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19677303|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677304|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
19677305|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677306|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677307|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
19677308|NCT02512692|Gemcitabine|gemcitabine|mesh-list
19677309|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677310|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19677311|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
19677312|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677313|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
20193592|NCT00227513|Vorinostat|vorinostat|mesh-list
20379082|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
20379083|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20379084|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
20379085|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379086|NCT01015209|Protective Agents|protective agents|mesh-ancestor
20379087|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379088|NCT01015209|Antidotes|antidotes|mesh-ancestor
20379089|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19677314|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677315|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193593|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193594|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20379090|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20379091|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
19677316|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677317|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
19677318|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677319|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
19330601|NCT03905317|Bevacizumab|bevacizumab|mesh-list
19330602|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19330603|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330604|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19330605|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19330606|NCT03905317|Growth Substances|growth substances|mesh-ancestor
19330607|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330608|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
19330609|NCT03905486|Pregabalin|pregabalin|mesh-list
19330610|NCT03905486|Analgesics|analgesics|mesh-ancestor
19330611|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
19330612|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330613|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330614|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
19677320|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19677321|NCT02460445|Cyproterone|cyproterone|mesh-list
19677322|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19677323|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19677324|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19677325|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
19677326|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19677327|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677328|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19677329|NCT02460445|Estrogens|estrogens|mesh-ancestor
19677330|NCT02460445|Hormones|hormones|mesh-ancestor
19677331|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677332|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
20379092|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20379093|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
20379094|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
20379095|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
20379096|NCT01015209|Coagulants|coagulants|mesh-ancestor
20379097|NCT01015235|Ketorolac|ketorolac|mesh-list
19330615|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19330616|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19677333|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
19677334|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677335|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19677336|NCT02432404|NuvaRing|nuvaring|mesh-list
19677337|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19677338|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
19677339|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19677340|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677341|NCT02429557|Midodrine|midodrine|mesh-list
19330617|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330618|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19330619|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19330620|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19330621|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330622|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330623|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
19330624|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19330625|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330626|NCT03905564|Pyridoxine|pyridoxine|mesh-list
19677342|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
19677343|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
19841868|NCT00644657|Clopidogrel|clopidogrel|mesh-list
19841869|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20193595|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193596|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193597|NCT00227565|Carboplatin|carboplatin|mesh-list
20193598|NCT00227565|Pemetrexed|pemetrexed|mesh-list
20193599|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193600|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193601|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193602|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20193603|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20193604|NCT00227630|Pemetrexed|pemetrexed|mesh-list
20193605|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677344|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379098|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20193606|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677345|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677346|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19677347|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19677348|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19677349|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19677350|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
19677351|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677352|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677353|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
19677354|NCT02419495|Leucovorin|leucovorin|mesh-list
19677355|NCT02419495|Folic Acid|folic acid|mesh-list
19677356|NCT02419495|Paclitaxel|paclitaxel|mesh-list
19677357|NCT02419495|Camptothecin|camptothecin|mesh-list
19677358|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
19677359|NCT02419495|Carboplatin|carboplatin|mesh-list
19677360|NCT02419495|Doxorubicin|doxorubicin|mesh-list
19677361|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19677362|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
19677363|NCT02419495|Fluorouracil|fluorouracil|mesh-list
19677364|NCT02419495|Capecitabine|capecitabine|mesh-list
19677365|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
19677366|NCT02419495|Nivolumab|nivolumab|mesh-list
19677367|NCT02419495|Irinotecan|irinotecan|mesh-list
20379099|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20379100|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20379101|NCT01015235|Analgesics|analgesics|mesh-ancestor
20379102|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
20379103|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677368|NCT02419495|Pemetrexed|pemetrexed|mesh-list
19677369|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19841870|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19841871|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19841872|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19841873|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
19841874|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841875|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677370|NCT02419495|Ipilimumab|ipilimumab|mesh-list
19841876|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841877|NCT00644787|Fentanyl|fentanyl|mesh-list
19841878|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19841879|NCT00644787|Narcotics|narcotics|mesh-ancestor
19841880|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841881|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841882|NCT00644787|Analgesics|analgesics|mesh-ancestor
19841883|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
19841884|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677371|NCT02419495|Topotecan|topotecan|mesh-list
19677372|NCT02419495|Daunorubicin|daunorubicin|mesh-list
19677373|NCT02419495|Olaparib|olaparib|mesh-list
19677374|NCT02419495|Calcium|calcium|mesh-list
19677375|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
19677376|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20193607|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193608|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20193609|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20193610|NCT00227656|Interferons|interferons|mesh-list
20193611|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
20193612|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
20193613|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20193614|NCT00227656|Capecitabine|capecitabine|mesh-list
20193615|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193616|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
20193617|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193618|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193619|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
20193620|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193621|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
20193622|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193623|NCT00227669|Gemcitabine|gemcitabine|mesh-list
20193624|NCT00227669|Docetaxel|docetaxel|mesh-list
20193625|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193626|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
20193627|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193628|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193629|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
20193630|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193631|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193632|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677377|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677378|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677379|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677380|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677381|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677382|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677383|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
19677384|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677385|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677386|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19677387|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
19677388|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19677389|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677390|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19677391|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19677392|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677393|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20379104|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379105|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20379106|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379107|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20379108|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379109|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379110|NCT01015248|Rituximab|rituximab|mesh-list
20379111|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20379112|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20379113|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379114|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
20379115|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379116|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379117|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379118|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
20379119|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677394|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19677395|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677396|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
19677397|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19677398|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19677399|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19677400|NCT02419495|Antidotes|antidotes|mesh-ancestor
19677401|NCT02419495|Protective Agents|protective agents|mesh-ancestor
19677402|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
19677403|NCT02419495|Vitamins|vitamins|mesh-ancestor
19677404|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
19677405|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19677406|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19677407|NCT02419495|Hematinics|hematinics|mesh-ancestor
19677408|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19677409|NCT02247349|Nivolumab|nivolumab|mesh-list
19677410|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677411|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677412|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19677413|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379120|NCT01015300|Bevacizumab|bevacizumab|mesh-list
20379121|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20379122|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379123|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20379124|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20379125|NCT01015300|Growth Substances|growth substances|mesh-ancestor
20379126|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677414|NCT02214407|Decitabine|decitabine|mesh-list
19677415|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
19677416|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19677417|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
19677418|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677419|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677420|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677421|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
19677422|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19677423|NCT01899989|Carboplatin|carboplatin|mesh-list
19677424|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677425|NCT01869114|Sirolimus|sirolimus|mesh-list
20379127|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
20379128|NCT01015339|Paclitaxel|paclitaxel|mesh-list
20379129|NCT01015339|Capecitabine|capecitabine|mesh-list
20379130|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20379131|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379132|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
20379133|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
20379134|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
20379135|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379136|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379137|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
20379138|NCT01015352|Azacitidine|azacitidine|mesh-list
20379139|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
20379140|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379141|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
20379142|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379143|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379144|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379145|NCT01015352|Hematinics|hematinics|mesh-ancestor
20379146|NCT01015391|Azathioprine|azathioprine|mesh-list
20379147|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
20379148|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379149|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379150|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379151|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379152|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
20379153|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379154|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379155|NCT01015417|Amoxicillin|amoxicillin|mesh-list
20379156|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20379157|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
20379158|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
20379159|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379160|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379161|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19677426|NCT01869114|Azacitidine|azacitidine|mesh-list
19677427|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193633|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
20193634|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193635|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
20379162|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379163|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379164|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
20379165|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
20379166|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193636|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677428|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
19677429|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677430|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677431|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677432|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19677433|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677434|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677435|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
19677436|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379167|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
19677437|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
19677438|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677439|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19677440|NCT01594398|Exemestane|exemestane|mesh-list
20193637|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
20193638|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
20193639|NCT00227682|Thalidomide|thalidomide|mesh-list
20193640|NCT00227682|Dexamethasone|dexamethasone|mesh-list
20193641|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
20193642|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193643|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
20193644|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
20193645|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193646|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193647|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379168|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677441|NCT01594398|Entinostat|entinostat|mesh-list
20193648|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
20379169|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677442|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193649|NCT00227682|Hormones|hormones|mesh-ancestor
20193650|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193651|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20193652|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193653|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193654|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
20193655|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
20379170|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379171|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
20379172|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379173|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379174|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20379175|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20379176|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20379177|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
20379178|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379179|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379180|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379181|NCT01015482|Midazolam|midazolam|mesh-list
20379182|NCT01015482|Remifentanil|remifentanil|mesh-list
20379183|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20379184|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20379185|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379186|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379187|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20379188|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20379189|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20379190|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20379191|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
20193656|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193657|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193658|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20193659|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20193660|NCT00227682|Growth Substances|growth substances|mesh-ancestor
20193661|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
20193662|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
20193663|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193664|NCT00227682|Protective Agents|protective agents|mesh-ancestor
20193665|NCT00227682|Vitamins|vitamins|mesh-ancestor
20193666|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
20193667|NCT00227695|Rituximab|rituximab|mesh-list
20193668|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20193669|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193670|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
20193671|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193672|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193673|NCT00227708|Docetaxel|docetaxel|mesh-list
20193674|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193675|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
20193676|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
20193677|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
20193678|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193679|NCT00227734|Capecitabine|capecitabine|mesh-list
20193680|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
20379192|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
20379193|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
20379194|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
20379195|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379196|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193681|NCT00227734|Cetuximab|cetuximab|mesh-list
20193682|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20193683|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
20193684|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193685|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193686|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20193687|NCT00227747|Capecitabine|capecitabine|mesh-list
20193688|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
20193689|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379197|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20379198|NCT01015482|Narcotics|narcotics|mesh-ancestor
19677443|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19677444|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677445|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677446|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20193690|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
20379199|NCT01015482|Analgesics|analgesics|mesh-ancestor
20379200|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
19677447|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19677448|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19677449|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
19677450|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677451|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677452|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19677453|NCT01573429|Bisphenol A|bisphenol a|mesh-list
19677454|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19677455|NCT01573429|Estrogens|estrogens|mesh-ancestor
19677456|NCT01573429|Hormones|hormones|mesh-ancestor
19677457|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677458|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677459|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19677460|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
19677461|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379201|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379202|NCT01015495|Ranibizumab|ranibizumab|mesh-list
20379203|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20379204|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20379205|NCT01015495|Growth Substances|growth substances|mesh-ancestor
20379206|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379207|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
20379208|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379209|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
20379210|NCT01015547|Methotrexate|methotrexate|mesh-list
20379211|NCT01015547|Infliximab|infliximab|mesh-list
19677462|NCT01573429|Protective Agents|protective agents|mesh-ancestor
19677463|NCT01478542|Rituximab|rituximab|mesh-list
19677464|NCT01478542|Vincristine|vincristine|mesh-list
19841885|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19841886|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19841887|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
20379212|NCT01015547|Naltrexone|naltrexone|mesh-list
20379213|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20379214|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
20379215|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20379216|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379217|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379218|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
20379219|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379220|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841888|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
19841889|NCT00644969|Varenicline|varenicline|mesh-list
19841890|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19841891|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19677465|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677466|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677467|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
19677468|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677469|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677470|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19677471|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677472|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677473|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677474|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677475|NCT00819221|Doxorubicin|doxorubicin|mesh-list
19841892|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
19841893|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841894|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841895|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841896|NCT00645099|Olanzapine|olanzapine|mesh-list
19841897|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19841898|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
19841899|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
19841900|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841901|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841902|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19841903|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19841904|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19841905|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841906|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19841907|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19841908|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19841909|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19677476|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19677477|NCT00819221|Olaparib|olaparib|mesh-list
19677478|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677479|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677480|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19677481|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19677482|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677483|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677484|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19677485|NCT00807651|Insulin|insulin|mesh-list
19677486|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19677487|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19677488|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677489|NCT00700791|Vitamins|vitamins|mesh-list
19677490|NCT00700791|Vitamin E|vitamin e|mesh-list
19677491|NCT00700791|Tocopherols|tocopherols|mesh-list
19677492|NCT00700791|Tocotrienols|tocotrienols|mesh-list
19677493|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
19677494|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
19841910|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379221|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
20379222|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379223|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20379224|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379225|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
19841911|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841912|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
19841913|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19841914|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20379226|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379227|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20379228|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379229|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330627|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
19330628|NCT03905564|Doxylamine|doxylamine|mesh-list
19330629|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
19330630|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
19330631|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
19330632|NCT03905564|Vitamins|vitamins|mesh-ancestor
19330633|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
19330634|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841915|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19841916|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19841917|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
19841918|NCT00645333|Docetaxel|docetaxel|mesh-list
19841919|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193691|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193692|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193693|NCT00227773|Octreotide|octreotide|mesh-list
20193694|NCT00227773|Hormones|hormones|mesh-list
20193695|NCT00227773|Somatostatin|somatostatin|mesh-list
19841920|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
19841921|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
19841922|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
19841923|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841924|NCT00645411|Vaccines|vaccines|mesh-list
19841925|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
19841926|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841927|NCT00645450|Propranolol|propranolol|mesh-list
19841928|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19841929|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19841930|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
19841931|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19841932|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841933|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841934|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19841935|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19841936|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
19841937|NCT00645528|Insulin|insulin|mesh-list
20193696|NCT00227773|Mitogens|mitogens|mesh-list
20193697|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20193698|NCT00227773|Vatalanib|vatalanib|mesh-list
19330635|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19677495|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677496|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
20193699|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193700|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193701|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
20193702|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330636|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
19330637|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
19330638|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379230|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20379231|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20379232|NCT01015547|Analgesics|analgesics|mesh-ancestor
20379233|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
20379234|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379235|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20379236|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20379237|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20379238|NCT01015651|Remifentanil|remifentanil|mesh-list
20379239|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20379240|NCT01015651|Narcotics|narcotics|mesh-ancestor
20379241|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379242|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379243|NCT01015651|Analgesics|analgesics|mesh-ancestor
20379244|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
20379245|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379246|NCT01015664|Sirolimus|sirolimus|mesh-list
20379247|NCT01015664|Cetuximab|cetuximab|mesh-list
20379248|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379249|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20379250|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379251|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379252|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20379253|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
20379254|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379255|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
20379256|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379257|NCT01015729|Aspirin|aspirin|mesh-list
20379258|NCT01015729|Esomeprazole|esomeprazole|mesh-list
20379259|NCT01015729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20379260|NCT01015729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20379261|NCT01015729|Analgesics|analgesics|mesh-ancestor
20379262|NCT01015729|Sensory System Agents|sensory system agents|mesh-ancestor
20379263|NCT01015729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379264|NCT01015729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379265|NCT01015729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20379266|NCT01015729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379267|NCT01015729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20379268|NCT01015729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20379269|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330639|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193703|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20193704|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20193705|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193706|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20193707|NCT00227812|Bupropion|bupropion|mesh-list
20193708|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20193709|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193710|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193711|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20193712|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20193713|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20379270|NCT01015729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19330640|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
19330641|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
19330642|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330643|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379271|NCT01015729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20379272|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379273|NCT01015729|Antipyretics|antipyretics|mesh-ancestor
20379274|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20379275|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379276|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20379277|NCT01015794|Ephedrine|ephedrine|mesh-list
20379278|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
20379279|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20379280|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330644|NCT03904849|Cannabidiol|cannabidiol|mesh-list
20379281|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
19330645|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
20379282|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
20379283|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379284|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19330646|NCT03905018|Tadalafil|tadalafil|mesh-list
19330647|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
19330648|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19330649|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19677497|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677498|NCT00700791|Protective Agents|protective agents|mesh-ancestor
19677499|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
19677500|NCT05129748|Mannitol|mannitol|mesh-list
19677501|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19677502|NCT05129748|Diuretics|diuretics|mesh-ancestor
19330650|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330651|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330652|NCT03905018|Urological Agents|urological agents|mesh-ancestor
19330653|NCT03904836|Tobramycin|tobramycin|mesh-list
19330654|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19330655|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330656|NCT03904888|Anesthetics|anesthetics|mesh-list
19330657|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
19330658|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330659|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330660|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
19330661|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330662|NCT03904680|Vitamin D|vitamin d|mesh-list
19330663|NCT03904680|Methotrexate|methotrexate|mesh-list
19330664|NCT03904680|Vitamins|vitamins|mesh-ancestor
19330665|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
19330666|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330667|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19330668|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19330669|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
19677503|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
19677504|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677505|NCT05129748|Antidotes|antidotes|mesh-ancestor
19677506|NCT05129748|Protective Agents|protective agents|mesh-ancestor
19677507|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
19677508|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677509|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
19677510|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19677511|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677512|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
19677513|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
19677514|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
19677515|NCT05129670|Antacids|antacids|mesh-ancestor
19677516|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677517|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19677518|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
19677519|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19330670|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19330671|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19330672|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
19330673|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330674|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677520|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677521|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20193714|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193715|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
20193716|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193717|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193718|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20193719|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20193720|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193721|NCT00227942|Zolpidem|zolpidem|mesh-list
20193722|NCT00227942|Estrogens|estrogens|mesh-list
20193723|NCT00227942|Hormones|hormones|mesh-ancestor
20193724|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193725|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379285|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
19677522|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
19330675|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
19677523|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19677524|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677525|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677526|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379286|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379287|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379288|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20379289|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20379290|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
19692358|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692359|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
19692360|NCT04992026|Hormones|hormones|mesh-ancestor
19692361|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692362|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692363|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19692364|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692365|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19692366|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692367|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692368|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
19692369|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19692370|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
19692371|NCT04991597|Lidocaine|lidocaine|mesh-list
19692372|NCT04991597|Epinephrine|epinephrine|mesh-list
19692373|NCT04991597|Racepinephrine|racepinephrine|mesh-list
19692374|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
19692375|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
19692376|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
19692377|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692378|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692379|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
19692380|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692381|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19692382|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19692383|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19692384|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193726|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20379291|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
20379292|NCT01015937|Losartan|losartan|mesh-list
19692385|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692386|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19692387|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19692388|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692389|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692390|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19692391|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19692392|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
19692393|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19692394|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193727|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20193728|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379293|NCT01015937|Enalapril|enalapril|mesh-list
20379294|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
20379295|NCT01015937|Giapreza|giapreza|mesh-list
20379296|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20379297|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
19330676|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193729|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20193730|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
20193731|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
20193732|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193733|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193734|NCT00227955|Imipramine|imipramine|mesh-list
20193735|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20193736|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193737|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193738|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20193739|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20193740|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193741|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193742|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
20193743|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193744|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193745|NCT00227981|Fluoxetine|fluoxetine|mesh-list
20379298|NCT01015937|Turmeric extract|turmeric extract|mesh-list
20379299|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20379300|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20379301|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20379302|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20379303|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379304|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
20379305|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379306|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
20379307|NCT01015937|Protective Agents|protective agents|mesh-ancestor
19677527|NCT05129085|Dexamethasone|dexamethasone|mesh-list
19677528|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677529|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
20193746|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19330677|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19330678|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19330679|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
19330680|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330681|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19330682|NCT03904719|Vorolanib|vorolanib|mesh-list
19330683|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19330684|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330685|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330686|NCT03904446|Methylergonovine|methylergonovine|mesh-list
19330687|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
19330688|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19330689|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330690|NCT03904745|Atosiban|atosiban|mesh-list
19330691|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
19330692|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330693|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330694|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
19330695|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19330696|NCT03904563|Bevacizumab|bevacizumab|mesh-list
19330697|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19330698|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330699|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19330700|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19330701|NCT03904563|Growth Substances|growth substances|mesh-ancestor
19330702|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330703|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
19330704|NCT03904732|Aspirin|aspirin|mesh-list
20193747|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20193748|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193749|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379308|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379309|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20379310|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20379311|NCT01016002|Temoporfin|temoporfin|mesh-list
20379312|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379313|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20379314|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
20379315|NCT01016041|Paclitaxel|paclitaxel|mesh-list
20379316|NCT01016041|Everolimus|everolimus|mesh-list
20379317|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20379318|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379319|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
20379320|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
20379321|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
20379322|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379323|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379324|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
20379325|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379326|NCT01016054|Gemcitabine|gemcitabine|mesh-list
20379327|NCT01016054|Carboplatin|carboplatin|mesh-list
20193750|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193751|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
20379328|NCT01016054|Doxorubicin|doxorubicin|mesh-list
20379329|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20379330|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399194|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677530|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
20193752|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193753|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19677531|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193754|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193755|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193756|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20193757|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20193758|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193759|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
20193760|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19677532|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677533|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19677534|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
20193761|NCT00228020|Cyclosporine|cyclosporine|mesh-list
20193762|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
20379331|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19677535|NCT05129085|Hormones|hormones|mesh-ancestor
19677536|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677537|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19677538|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677539|NCT05129033|Omalizumab|omalizumab|mesh-list
19677540|NCT05129033|Itraconazole|itraconazole|mesh-list
19677541|NCT05129033|Prednisone|prednisone|mesh-list
19677542|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677543|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
19677544|NCT05129033|Hormones|hormones|mesh-ancestor
19677545|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677546|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677547|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19677548|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677549|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
19677550|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677551|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19677552|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19677553|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677554|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677555|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19677556|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
19677557|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20193763|NCT00228020|Prednisone|prednisone|mesh-list
20193764|NCT00228020|Cyclosporins|cyclosporins|mesh-list
19330705|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19330706|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19330707|NCT03904732|Analgesics|analgesics|mesh-ancestor
19330708|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
19330709|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330710|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330711|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193765|NCT00228020|Basiliximab|basiliximab|mesh-list
19677558|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19677559|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19677560|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
19677561|NCT05128916|Terbinafine|terbinafine|mesh-list
19677562|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
19677563|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677564|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677565|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677566|NCT05128734|Temozolomide|temozolomide|mesh-list
19677567|NCT05128734|Olaparib|olaparib|mesh-list
19677568|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19677569|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
19677570|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677571|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677572|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20193766|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193767|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
20379332|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
20379333|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379334|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
20379335|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379336|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193768|NCT00228020|Hormones|hormones|mesh-ancestor
20193769|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193770|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193771|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20193772|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677573|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677574|NCT05128721|Vaccines|vaccines|mesh-list
20379337|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379338|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
20379339|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379340|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20379341|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20379342|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20379343|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
20379344|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20379345|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379346|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
20379347|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20379348|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19677575|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
19677576|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677577|NCT05128630|Durvalumab|durvalumab|mesh-list
19677578|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677579|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330712|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330713|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19677580|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19677581|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19677582|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
19677583|NCT05126511|Hormones|hormones|mesh-ancestor
19677584|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677585|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677586|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677587|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677588|NCT05097794|Indapamide|indapamide|mesh-list
19677589|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19677590|NCT05097794|Diuretics|diuretics|mesh-ancestor
19677591|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
19677592|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677593|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19677594|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19677595|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677596|NCT05073562|Folic Acid|folic acid|mesh-list
19677597|NCT05073562|Mebendazole|mebendazole|mesh-list
19677598|NCT05073562|Piperazine|piperazine|mesh-list
19677599|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
19677600|NCT05073562|DMP 777|dmp 777|mesh-list
19677601|NCT05073562|Hematinics|hematinics|mesh-ancestor
19677602|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
19677603|NCT05073562|Vitamins|vitamins|mesh-ancestor
19677604|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
19677605|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677606|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
19677607|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
19677608|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19677609|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677610|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677611|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677612|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677613|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677614|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677615|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677616|NCT04969731|Gemcitabine|gemcitabine|mesh-list
20193773|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193774|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193775|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193776|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
20193777|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
20193778|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193779|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
20193780|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193781|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20193782|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20193783|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20193784|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
20193785|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193786|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
20193787|NCT00228033|Calcium|calcium|mesh-list
20193788|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20193789|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193790|NCT00228033|Antacids|antacids|mesh-ancestor
19677617|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19677618|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
19677619|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677620|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677621|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
19677622|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677623|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677624|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677625|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
19677626|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677627|NCT04955938|Ivosidenib|ivosidenib|mesh-list
19677628|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677629|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677630|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677631|NCT04930991|Omeprazole|omeprazole|mesh-list
19677632|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19677633|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20193791|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193792|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20193793|NCT00228046|Valproic Acid|valproic acid|mesh-list
20193794|NCT00228046|Methylphenidate|methylphenidate|mesh-list
20193795|NCT00228046|Amphetamine|amphetamine|mesh-list
19677634|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19677635|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677636|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677637|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19677638|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677639|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677640|NCT04779216|Alendronate|alendronate|mesh-list
19677641|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19677642|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677643|NCT04773184|Capsaicin|capsaicin|mesh-list
19677644|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
19677645|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
19677646|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
19677647|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677648|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330714|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19330715|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692395|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
19692396|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
19692397|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19692398|NCT04991584|Amoxicillin|amoxicillin|mesh-list
19692399|NCT04991584|Levofloxacin|levofloxacin|mesh-list
19692400|NCT04991584|Ofloxacin|ofloxacin|mesh-list
19692401|NCT04991584|Tetracycline|tetracycline|mesh-list
19692402|NCT04991584|Furazolidone|furazolidone|mesh-list
19692403|NCT04991584|Esomeprazole|esomeprazole|mesh-list
19692404|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19692405|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193796|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
19330716|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19330717|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20193797|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20193798|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193799|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19330718|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330719|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
19330720|NCT03904537|Antibodies|antibodies|mesh-list
19330721|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
19330722|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330723|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19330724|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19330725|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330726|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19330727|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19330728|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330729|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
19330730|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
19692406|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20193800|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20193801|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193802|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692407|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692408|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20379349|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379350|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379351|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20379352|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20379353|NCT01016184|Vitamin D|vitamin d|mesh-list
19677649|NCT04437888|Ketamine|ketamine|mesh-list
19677650|NCT04437888|Analgesics|analgesics|mesh-ancestor
19677651|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
19677652|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677653|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193803|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
20193804|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193805|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
20193806|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
20193807|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677654|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19677655|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19677656|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
19677657|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
19677658|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677659|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19677660|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19677661|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677662|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677663|NCT04405674|Paclitaxel|paclitaxel|mesh-list
19677664|NCT04405674|Bevacizumab|bevacizumab|mesh-list
19677665|NCT04405674|Carboplatin|carboplatin|mesh-list
19677666|NCT04405674|Pemetrexed|pemetrexed|mesh-list
19677667|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19677668|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677669|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
20379354|NCT01016184|Vitamins|vitamins|mesh-ancestor
20379355|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
20379356|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379357|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20379358|NCT01016223|Beclomethasone|beclomethasone|mesh-list
19677670|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677671|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677672|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677673|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677674|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19677675|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19677676|NCT04405674|Growth Substances|growth substances|mesh-ancestor
19677677|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677678|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
19677679|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677680|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19677681|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19677682|NCT04366518|Scopolamine|scopolamine|mesh-list
19677683|NCT04366518|Rivastigmine|rivastigmine|mesh-list
19677684|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19677685|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19677686|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677687|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677688|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
19677689|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677690|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677691|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19677692|NCT04366518|Protective Agents|protective agents|mesh-ancestor
19677693|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19677694|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
19677695|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
19692409|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193808|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
20193809|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20193810|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
20193811|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193812|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
20193813|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
20193814|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20193815|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193816|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193817|NCT00228163|Teriflunomide|teriflunomide|mesh-list
20193818|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20379359|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20379360|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
20379361|NCT01016223|Hormones|hormones|mesh-ancestor
20379362|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20379363|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379364|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19330731|NCT03903952|Vitamins|vitamins|mesh-ancestor
19330732|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
19330733|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330734|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
19330735|NCT03903952|Hematinics|hematinics|mesh-ancestor
19841938|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19841939|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330738|NCT03904225|Tegafur|tegafur|mesh-list
19330739|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19330740|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
19677696|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677697|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19677698|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
19677699|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19677700|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19677701|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
19677702|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
19677703|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19677704|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19677705|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677706|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
19677707|NCT04360629|Coagulants|coagulants|mesh-ancestor
19677708|NCT04330664|Adagrasib|adagrasib|mesh-list
19677709|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677710|NCT04237649|Spartalizumab|spartalizumab|mesh-list
19677711|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19677712|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677713|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677714|NCT04227314|Apremilast|apremilast|mesh-list
19677715|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19677716|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19677717|NCT04227314|Analgesics|analgesics|mesh-ancestor
19677718|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
19677719|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677720|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330741|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330742|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330743|NCT03903835|Prednisone|prednisone|mesh-list
19330744|NCT03903835|Carboplatin|carboplatin|mesh-list
19677721|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677722|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677723|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19677724|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19677725|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193819|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193820|NCT00228163|Analgesics|analgesics|mesh-ancestor
20193821|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
20193822|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193823|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193824|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193825|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193826|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193827|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
20193828|NCT00228228|Vaccines|vaccines|mesh-list
20193829|NCT00228228|Immunologic Factors|immunologic factors|mesh-ancestor
20193830|NCT00228228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193831|NCT00228254|Vitamin A|vitamin a|mesh-list
20193832|NCT00228254|Vitamins|vitamins|mesh-ancestor
20193833|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
20193834|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193835|NCT00228267|Propofol|propofol|mesh-list
20193836|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20193837|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193838|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193839|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20193840|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
20193841|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
19330745|NCT03903835|Docetaxel|docetaxel|mesh-list
19330746|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
19330747|NCT03903835|Niraparib|niraparib|mesh-list
19330748|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20193842|NCT00228319|Vitamins|vitamins|mesh-list
20193843|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
19330749|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19330750|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330751|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20193844|NCT00228319|Vitamin E|vitamin e|mesh-list
20193845|NCT00228319|Vitamin A|vitamin a|mesh-list
20193846|NCT00228319|Carboplatin|carboplatin|mesh-list
20193847|NCT00228319|Carotenoids|carotenoids|mesh-list
20193848|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330752|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
19330753|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
19330754|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330755|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677726|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677727|NCT04223648|Nivolumab|nivolumab|mesh-list
19677728|NCT04223648|Ipilimumab|ipilimumab|mesh-list
19677729|NCT04223648|Durvalumab|durvalumab|mesh-list
19677730|NCT04223648|Tremelimumab|tremelimumab|mesh-list
19677731|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677732|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677733|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19677734|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677735|NCT04220775|Atezolizumab|atezolizumab|mesh-list
19677736|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677737|NCT04218708|Nicotine|nicotine|mesh-list
19677738|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19677739|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
19677740|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330756|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
19330757|NCT03903835|Hormones|hormones|mesh-ancestor
19330758|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677741|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677742|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19677743|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19677744|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
19677745|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677746|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677747|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
19677748|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
19677749|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19330759|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330760|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330761|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19330762|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677750|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677751|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677752|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19677753|NCT04113720|Analgesics|analgesics|mesh-ancestor
19677754|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
19677755|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677756|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19677757|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19677758|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19677759|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
19677760|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677761|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677762|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
19677763|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
19677764|NCT04094675|Sirolimus|sirolimus|mesh-list
19677765|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19677766|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677767|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677768|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193849|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193850|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
20193851|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193852|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
20193853|NCT00228319|Protective Agents|protective agents|mesh-ancestor
20193854|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
20193855|NCT00228358|Interleukin-2|interleukin-2|mesh-list
20193856|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
20193857|NCT00228358|Immunotoxins|immunotoxins|mesh-list
20193858|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677769|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
20193859|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
20193860|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193861|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19330763|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
20379365|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
20379366|NCT01016249|Epinephrine|epinephrine|mesh-list
20379367|NCT01016249|Racepinephrine|racepinephrine|mesh-list
20379368|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
19330764|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19330765|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19330766|NCT03904056|Ranibizumab|ranibizumab|mesh-list
19330767|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19330768|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19330769|NCT03904056|Growth Substances|growth substances|mesh-ancestor
19330770|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677770|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379369|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20379370|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20379371|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
20379372|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379373|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379374|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379375|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20379376|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20379377|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
20379378|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379379|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20379380|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
20379381|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
20379382|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
19677771|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
19677772|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677773|NCT04076748|Sufentanil|sufentanil|mesh-list
19677774|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20379383|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20379384|NCT01016509|Insulin|insulin|mesh-list
19330771|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
19330772|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330773|NCT03903887|Antibodies|antibodies|mesh-list
19330774|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
19330775|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330776|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
19330777|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19330778|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330779|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330780|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
19330781|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330782|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330783|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
19330784|NCT03903809|Hematinics|hematinics|mesh-ancestor
19330785|NCT03903718|Oseltamivir|oseltamivir|mesh-list
19330786|NCT03903718|MEDI8852|medi8852|mesh-list
19330787|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
19330788|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330789|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330790|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330791|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
20379385|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20379386|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20379387|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379388|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
20379389|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20379390|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379391|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20379392|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
20379393|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379394|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379395|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379396|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379397|NCT01016639|Capecitabine|capecitabine|mesh-list
20379398|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
20379399|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379400|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
20379401|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379402|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379403|NCT01016665|Anastrozole|anastrozole|mesh-list
19677775|NCT04076748|Narcotics|narcotics|mesh-ancestor
20379404|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330792|NCT03903783|Cefotaxime|cefotaxime|mesh-list
19841940|NCT00645593|Gemcitabine|gemcitabine|mesh-list
19677776|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677777|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677778|NCT04076748|Analgesics|analgesics|mesh-ancestor
19677779|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
19677780|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677781|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19677782|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19677783|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
19677784|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
19330793|NCT03903783|Cefoxitin|cefoxitin|mesh-list
19330794|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19330795|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399195|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399196|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399197|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19399198|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20193862|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20193863|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
20379405|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379406|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20379407|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20379408|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379409|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379410|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19399199|NCT03636659|Amphotericin B|amphotericin b|mesh-list
19399200|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19399201|NCT03636659|Amebicides|amebicides|mesh-ancestor
19399202|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19399203|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19399204|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399205|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399206|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
20193864|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193865|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193866|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20193867|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193868|NCT00228358|Analgesics|analgesics|mesh-ancestor
19399207|NCT03636555|Oxytocin|oxytocin|mesh-list
19677785|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
19677786|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19677787|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19399208|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
19399209|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19399210|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399211|NCT03636542|Bupivacaine|bupivacaine|mesh-list
19399212|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
19399213|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
19399214|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399215|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399216|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
19399217|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399218|NCT03636477|Nivolumab|nivolumab|mesh-list
19399219|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399220|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399221|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19399222|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399223|NCT03636373|Triamcinolone|triamcinolone|mesh-list
19399224|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19399225|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19399226|NCT03636373|Etanercept|etanercept|mesh-list
20193869|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
20193870|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193871|NCT00228397|Sirolimus|sirolimus|mesh-list
20193872|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193873|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677788|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19677789|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19677790|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20193874|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20193875|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193876|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
20193877|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193878|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
20193879|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841941|NCT00645593|Cetuximab|cetuximab|mesh-list
20193880|NCT00228410|Vancomycin|vancomycin|mesh-list
20193881|NCT00228410|Tigecycline|tigecycline|mesh-list
20193882|NCT00228410|Aztreonam|aztreonam|mesh-list
20193883|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193884|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193885|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20193886|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193887|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193888|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20193889|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
20193890|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20193891|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20193892|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20193893|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193894|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330796|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19330797|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19330798|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330799|NCT03903367|Fentanyl|fentanyl|mesh-list
19330800|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19330801|NCT03903367|Narcotics|narcotics|mesh-ancestor
19330802|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330803|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330804|NCT03903367|Analgesics|analgesics|mesh-ancestor
19677791|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677792|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
19677793|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193895|NCT00228475|Budesonide|budesonide|mesh-list
20193896|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20193897|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20193898|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
20193899|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193900|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193901|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20193902|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
20193903|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
20193904|NCT00228475|Hormones|hormones|mesh-ancestor
20193905|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193906|NCT00228488|Gefitinib|gefitinib|mesh-list
20193907|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193908|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20193909|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677794|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677795|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19677796|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193910|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193911|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20193912|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20193913|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20193914|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
20193915|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193916|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20193917|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20193918|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677797|NCT04047862|Paclitaxel|paclitaxel|mesh-list
20193919|NCT00228527|Esomeprazole|esomeprazole|mesh-list
20193920|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20193921|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379411|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
20379412|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193922|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20193923|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20193924|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193925|NCT00228540|Modafinil|modafinil|mesh-list
20193926|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20193927|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193928|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20193929|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20193930|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20193931|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20193932|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
20193933|NCT00228592|Antibodies|antibodies|mesh-list
20379413|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330805|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
19677798|NCT04047862|Etoposide|etoposide|mesh-list
19677799|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19677800|NCT04047862|Carboplatin|carboplatin|mesh-list
19677801|NCT04047862|Fluorouracil|fluorouracil|mesh-list
19677802|NCT04047862|Capecitabine|capecitabine|mesh-list
19677803|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
19677804|NCT04047862|Pemetrexed|pemetrexed|mesh-list
19677805|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19677806|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677807|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677808|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677809|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677810|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677811|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
19677812|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19330806|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20193934|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
20193935|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20193936|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20193937|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
20193938|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193939|NCT00228605|Fentanyl|fentanyl|mesh-list
20379414|NCT01016717|Omeprazole|omeprazole|mesh-list
19677813|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677814|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
20379415|NCT01016717|Pantoprazole|pantoprazole|mesh-list
20379416|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20379417|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379418|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20379419|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379420|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426155|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20426156|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426157|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426158|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20426159|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20426160|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20426161|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19330807|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19677815|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677816|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19677817|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19677818|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677819|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19677820|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19677821|NCT04038489|Aspirin|aspirin|mesh-list
19677822|NCT04038489|Tamoxifen|tamoxifen|mesh-list
19677823|NCT04038489|Paclitaxel|paclitaxel|mesh-list
19677824|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
19677825|NCT04038489|Doxorubicin|doxorubicin|mesh-list
19677826|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19677827|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677828|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677829|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677830|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677831|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677832|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677833|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
19677834|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677835|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677836|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19330808|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19330809|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
19677837|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
19677838|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19677839|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677840|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19677841|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19677842|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677843|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19677844|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20193940|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20193941|NCT00228605|Narcotics|narcotics|mesh-ancestor
19677845|NCT04038489|Analgesics|analgesics|mesh-ancestor
19677846|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
19677847|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677848|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677849|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19677850|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19677851|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19677852|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19677853|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
19677854|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19677855|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
19677856|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677857|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19677858|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20379421|NCT01016730|Bortezomib|bortezomib|mesh-list
20379422|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379423|NCT01016795|Lenograstim|lenograstim|mesh-list
20379424|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20379425|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
20379426|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379427|NCT01016821|Oxycodone|oxycodone|mesh-list
20379428|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19677859|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19677860|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19677861|NCT03956368|Atorvastatin|atorvastatin|mesh-list
19677862|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19677863|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19677864|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
20193942|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20193943|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193944|NCT00228605|Analgesics|analgesics|mesh-ancestor
20193945|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
20193946|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330810|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
19330811|NCT03903458|Nivolumab|nivolumab|mesh-list
19330812|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19330813|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330814|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19330815|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330816|NCT03903302|Valproic Acid|valproic acid|mesh-list
19677865|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379429|NCT01016821|Narcotics|narcotics|mesh-ancestor
20379430|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379431|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330817|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
19330818|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330819|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330820|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
19330821|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330822|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330823|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
19330824|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19330825|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379432|NCT01016821|Analgesics|analgesics|mesh-ancestor
19330826|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330827|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
19677866|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19677867|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19677868|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677869|NCT03933007|Fexofenadine|fexofenadine|mesh-list
19677870|NCT03933007|Colchicine|colchicine|mesh-list
19677871|NCT03933007|Midazolam|midazolam|mesh-list
19677872|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19677873|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19677874|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677875|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193947|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20193948|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20193949|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
20193950|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
20193951|NCT00228839|Infliximab|infliximab|mesh-list
20193952|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
20193953|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20193954|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20193955|NCT00228852|Fludarabine|fludarabine|mesh-list
20193956|NCT00228852|Busulfan|busulfan|mesh-list
20193957|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217488|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379433|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
19677876|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19677877|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19677878|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330828|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19330829|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19330830|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20379434|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379435|NCT01016860|Irinotecan|irinotecan|mesh-list
20379436|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20379437|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20379438|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379439|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379440|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330831|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330832|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330833|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
19330834|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20193958|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379441|NCT01016886|Bisoprolol|bisoprolol|mesh-list
20379442|NCT01016886|Perindopril|perindopril|mesh-list
20379443|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20379444|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
20379445|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
20379446|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379447|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379448|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20379449|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19330835|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330836|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19330837|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330838|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
19330839|NCT03903185|Ledipasvir|ledipasvir|mesh-list
19330840|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19330841|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
19330842|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330843|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19330844|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19330845|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19330846|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
19330847|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330848|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19330849|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19330850|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330851|NCT03903133|Vitamin E|vitamin e|mesh-list
19330852|NCT03903133|Antioxidants|antioxidants|mesh-list
19330853|NCT03903133|Vitamins|vitamins|mesh-ancestor
19330854|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
19330855|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330856|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330857|NCT03903133|Protective Agents|protective agents|mesh-ancestor
19330858|NCT03902912|Prednisolone|prednisolone|mesh-list
19330859|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19330860|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
19330861|NCT03902912|Hormones|hormones|mesh-ancestor
19330862|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330863|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330864|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330865|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330866|NCT03902925|Lidocaine|lidocaine|mesh-list
19330867|NCT03902925|Ropivacaine|ropivacaine|mesh-list
19330868|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
19330869|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
19330870|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330871|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330872|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
20193959|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20193960|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
20193961|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193962|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
20193963|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20193964|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20193965|NCT00228865|Insulin|insulin|mesh-list
20379450|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20379451|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20193966|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20193967|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
20193968|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20193969|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193970|NCT00228878|Insulin|insulin|mesh-list
20193971|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
20193972|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20193973|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193974|NCT00228891|Insulin|insulin|mesh-list
20193975|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20193976|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20193977|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193978|NCT00228904|Insulin|insulin|mesh-list
20193979|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
20193980|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
20193981|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20193982|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19677879|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19677880|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
19677881|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
20193983|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330873|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330874|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19330875|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19330876|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19330877|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19330878|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330879|NCT03902782|Dexamethasone|dexamethasone|mesh-list
19330880|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
19330881|NCT03902782|Epinephrine|epinephrine|mesh-list
19330882|NCT03902782|Bupivacaine|bupivacaine|mesh-list
20193984|NCT00228930|Tamoxifen|tamoxifen|mesh-list
20193985|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20193986|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
19330883|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19330884|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
20193987|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20193988|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20193989|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20193990|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20193991|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20193992|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20193993|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20217489|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217490|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20217491|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20217492|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
20217493|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20217494|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20217495|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
20217496|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20217497|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20217498|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20217499|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217500|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217501|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20217502|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20217503|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
20217504|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217505|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217506|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20217507|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20217508|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
20217509|NCT00309712|Simvastatin|simvastatin|mesh-list
20217510|NCT00309712|Fenofibrate|fenofibrate|mesh-list
20217511|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20217512|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20217513|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
20217514|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217515|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20217516|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19330885|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
19677882|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
19677883|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
19330886|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330887|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330888|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330889|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
19330890|NCT03902782|Hormones|hormones|mesh-ancestor
19330891|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330892|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330893|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19330894|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
19677884|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677885|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677886|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
19677887|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677888|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677889|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677890|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677891|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677892|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19677893|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20379452|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379453|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379454|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20379455|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
20379456|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379457|NCT01016990|Valproic Acid|valproic acid|mesh-list
20379458|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
19677894|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19677895|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
19677896|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
19677897|NCT03875287|Decitabine|decitabine|mesh-list
19677898|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19677899|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
19677900|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677901|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677902|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330895|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
19330896|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330897|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
19330898|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19330899|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19330900|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
19330901|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330902|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330903|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19677903|NCT03805581|Defibrotide|defibrotide|mesh-list
19677904|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19677905|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19677906|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677907|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19677908|NCT03791593|Evolocumab|evolocumab|mesh-list
19677909|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19677910|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19677911|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
19677912|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677913|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19692410|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692411|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20379459|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19330904|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19330905|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19692412|NCT04991584|Renal Agents|renal agents|mesh-ancestor
19692413|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19692414|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19692415|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692416|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19330906|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
19330907|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
19330908|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
19330909|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19692417|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20379460|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379461|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
20379462|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379463|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379464|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
20379465|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20379466|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379467|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20379468|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19330920|NCT03902522|Leronlimab|leronlimab|mesh-list
19330921|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19330922|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19330923|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330924|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19330925|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19677914|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
19677915|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677916|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677917|NCT03665506|Trifluridine|trifluridine|mesh-list
19677918|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
19677919|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677920|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
19677921|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19677922|NCT03412643|Paclitaxel|paclitaxel|mesh-list
19330926|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
19330927|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19330928|NCT03902106|Albuterol|albuterol|mesh-list
19330929|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19330930|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
19330931|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379469|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20379470|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379471|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20379472|NCT01017107|Protein C|protein c|mesh-list
20379473|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
20379474|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19330932|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330933|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19330934|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
19330935|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
19330936|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19330937|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19330938|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19330939|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19330940|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
19330941|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19330942|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330943|NCT03902340|Analgesics|analgesics|mesh-list
19330944|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
19330945|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330946|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677923|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
19677924|NCT03412643|Doxorubicin|doxorubicin|mesh-list
19677925|NCT03412643|Trastuzumab|trastuzumab|mesh-list
20193994|NCT00228982|Vancomycin|vancomycin|mesh-list
20193995|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
19330947|NCT03902249|Dexamethasone|dexamethasone|mesh-list
19330948|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677926|NCT03412643|Pertuzumab|pertuzumab|mesh-list
20193996|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20193997|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20193998|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20193999|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
20194000|NCT00228995|Hematinics|hematinics|mesh-ancestor
20194001|NCT00229060|Doripenem|doripenem|mesh-list
20379475|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19330949|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
19330950|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
19677927|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20194002|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19330951|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330952|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330953|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330954|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
19330955|NCT03902249|Hormones|hormones|mesh-ancestor
19330956|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19330957|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19330958|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399227|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19399228|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19399229|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
19399230|NCT03636373|Hormones|hormones|mesh-ancestor
19399231|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399232|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399233|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19399234|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
19399235|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399236|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399237|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19399238|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19399239|NCT03636373|Analgesics|analgesics|mesh-ancestor
19399240|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
19399241|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399242|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19399243|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399244|NCT03636308|Gemcitabine|gemcitabine|mesh-list
19399245|NCT03636308|Paclitaxel|paclitaxel|mesh-list
20194003|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194004|NCT00229112|Tazobactam|tazobactam|mesh-list
20194005|NCT00229112|Piperacillin|piperacillin|mesh-list
20194006|NCT00229112|Ertapenem|ertapenem|mesh-list
20194007|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20194008|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399246|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19399247|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19399248|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399249|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
19399250|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677928|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677929|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
19677930|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
19677931|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
19677932|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677933|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19677934|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
20194009|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19677935|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677936|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19677937|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19677938|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
19677939|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19677940|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19677941|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19677942|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19677943|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677944|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677945|NCT03389022|Ketamine|ketamine|mesh-list
19677946|NCT03389022|Analgesics|analgesics|mesh-ancestor
19677947|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
19677948|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19677949|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194010|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194011|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20194012|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194013|NCT00229125|Gabapentin|gabapentin|mesh-list
20194014|NCT00229125|Lorazepam|lorazepam|mesh-list
20194015|NCT00229125|Analgesics|analgesics|mesh-ancestor
20194016|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
20194017|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194018|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194019|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
20194020|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20194021|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194022|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194023|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194024|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20194025|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20194026|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194027|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194028|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
19677950|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20379476|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330959|NCT03901716|Fentanyl|fentanyl|mesh-list
19330960|NCT03901716|Midazolam|midazolam|mesh-list
19330961|NCT03901716|Sufentanil|sufentanil|mesh-list
19330962|NCT03901716|Remifentanil|remifentanil|mesh-list
19330963|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19330964|NCT03901716|Narcotics|narcotics|mesh-ancestor
19330965|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379477|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379478|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
20379479|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20379480|NCT01017133|Fluorides|fluorides|mesh-list
20379481|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19330966|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330967|NCT03901716|Analgesics|analgesics|mesh-ancestor
19330968|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
19330969|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330970|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19330971|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19677951|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19677952|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
19677953|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
19677954|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19677955|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19677956|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20379482|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379483|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
20379484|NCT01017133|Protective Agents|protective agents|mesh-ancestor
19677957|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19677958|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19677959|NCT03344159|Spironolactone|spironolactone|mesh-list
19677960|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19677961|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
19677962|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19677963|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677964|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19677965|NCT03344159|Diuretics|diuretics|mesh-ancestor
19677966|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
19677967|NCT03336333|Rituximab|rituximab|mesh-list
19677968|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19677969|NCT03336333|Venetoclax|venetoclax|mesh-list
19677970|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
19677971|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677972|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19677973|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
19677974|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677975|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379485|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330972|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
19330973|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
19330974|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19330975|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19330976|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19330977|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19330978|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
19677976|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19677977|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
19677978|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194029|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
20194030|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
20194031|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20194032|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20194033|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
20194034|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
20194035|NCT00229138|Tacrolimus|tacrolimus|mesh-list
20379486|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
19330979|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
19330980|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399251|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
19330981|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19330982|NCT03901612|Ropivacaine|ropivacaine|mesh-list
19330983|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
19330984|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
19330985|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19330986|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330987|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
19330988|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330989|NCT03901768|Dexamethasone|dexamethasone|mesh-list
19330990|NCT03901768|Triamcinolone|triamcinolone|mesh-list
19330991|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677979|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20194036|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194037|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
20194038|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379487|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
20379488|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379489|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
20379490|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20379491|NCT01017159|Antibodies|antibodies|mesh-list
20379492|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
20379493|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379494|NCT01017198|Antacids|antacids|mesh-list
20379495|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379496|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379497|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20194039|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20194040|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194041|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379498|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20379499|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379500|NCT01017354|Calcifediol|calcifediol|mesh-list
20379501|NCT01017354|Vitamins|vitamins|mesh-ancestor
20379502|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
20379503|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379504|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20379505|NCT01017367|Antibodies|antibodies|mesh-list
20379506|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
20379507|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379508|NCT01017380|Celecoxib|celecoxib|mesh-list
19677980|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19677981|NCT03319459|Trastuzumab|trastuzumab|mesh-list
19677982|NCT03319459|Cetuximab|cetuximab|mesh-list
19677983|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19677984|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194042|NCT00229216|Tinidazole|tinidazole|mesh-list
20194043|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
20194044|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194045|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20194046|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194047|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20194048|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20194049|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19677985|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
19677986|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20379509|NCT01017380|Etoricoxib|etoricoxib|mesh-list
20379510|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20379511|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20379512|NCT01017380|Analgesics|analgesics|mesh-ancestor
20379513|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
20379514|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379515|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379516|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19677987|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
19677988|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19677989|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
19677990|NCT03318874|Protective Agents|protective agents|mesh-ancestor
19677991|NCT03269136|Thalidomide|thalidomide|mesh-list
19677992|NCT03269136|Dexamethasone|dexamethasone|mesh-list
19677993|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
19677994|NCT03269136|Lenalidomide|lenalidomide|mesh-list
20194050|NCT00229242|Diuretics|diuretics|mesh-list
19330992|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
19677995|NCT03269136|Pomalidomide|pomalidomide|mesh-list
20379517|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379518|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20379519|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19677996|NCT03269136|Antibodies|antibodies|mesh-list
20194051|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
20194052|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194053|NCT00229333|Citalopram|citalopram|mesh-list
20194054|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19330993|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
19330994|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19330995|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19330996|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19330997|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
20194055|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20194056|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194057|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194058|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194059|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
20194060|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194061|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20194062|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194063|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194064|NCT00229385|Ziprasidone|ziprasidone|mesh-list
20194065|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20194066|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
20194067|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194068|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194069|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194070|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19330998|NCT03901768|Hormones|hormones|mesh-ancestor
19330999|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331000|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19331001|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331002|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
19331003|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19331004|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
19331005|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
19331006|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331007|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331008|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331009|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331010|NCT03901482|Analgesics|analgesics|mesh-ancestor
19331011|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
19331012|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331013|NCT03901690|Imiquimod|imiquimod|mesh-list
19331014|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19331015|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
19331016|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331017|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331018|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
19331019|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
19331020|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331021|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331022|NCT03901118|Paclitaxel|paclitaxel|mesh-list
19331023|NCT03901118|Etoposide|etoposide|mesh-list
20194071|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194072|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194073|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194074|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20194075|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
20194076|NCT00229424|Famotidine|famotidine|mesh-list
20194077|NCT00229424|Lafutidine|lafutidine|mesh-list
20194078|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20194079|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20194080|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20194081|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
20194082|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
20194083|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194084|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194085|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194086|NCT00229450|Estrogens|estrogens|mesh-list
20194087|NCT00229450|Hormones|hormones|mesh-ancestor
20194088|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194089|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194090|NCT00229476|Sertraline|sertraline|mesh-list
19331024|NCT03901118|Chiauranib|chiauranib|mesh-list
20194091|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
19331025|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19677997|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
20379520|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379521|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379522|NCT01017393|Ketamine|ketamine|mesh-list
20379523|NCT01017393|Analgesics|analgesics|mesh-ancestor
20379524|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
20379525|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379526|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331026|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331027|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19331028|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19331029|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19331030|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331031|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19331032|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19677998|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19677999|NCT03269136|BB 1101|bb 1101|mesh-list
19678000|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
19678001|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678002|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678003|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
19678004|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
19678005|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678006|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678007|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
19678008|NCT03269136|Hormones|hormones|mesh-ancestor
19678009|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678010|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19678011|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678012|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
19678013|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678014|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678015|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19331033|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678016|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20194092|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194093|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20194094|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20379527|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20379528|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20379529|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
20379530|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
20379531|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678017|NCT03269136|Growth Substances|growth substances|mesh-ancestor
19678018|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
19678019|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678020|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
19678021|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678022|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678023|NCT03259698|Tenofovir|tenofovir|mesh-list
19678024|NCT03259698|Emtricitabine|emtricitabine|mesh-list
19678025|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19678026|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
19678027|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678028|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19678029|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19678030|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678031|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678032|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19678033|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19678034|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
19678035|NCT03222531|Velpatasvir|velpatasvir|mesh-list
20194095|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194096|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194097|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194098|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
20194099|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194100|NCT00229515|Sirolimus|sirolimus|mesh-list
20194101|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
20194102|NCT00229515|Tirofiban|tirofiban|mesh-list
20194103|NCT00229515|Abciximab|abciximab|mesh-list
20194104|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20194105|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678036|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
19678037|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678038|NCT03137771|Gemcitabine|gemcitabine|mesh-list
19678039|NCT03137771|Docetaxel|docetaxel|mesh-list
19678040|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
20379532|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20379533|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20379534|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379535|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379536|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
20379537|NCT01017458|Testosterone|testosterone|mesh-list
20379538|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
20379539|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
20379540|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20379541|NCT01017458|Androgens|androgens|mesh-ancestor
20379542|NCT01017458|Hormones|hormones|mesh-ancestor
20379543|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20379544|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331034|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19331035|NCT03901170|Letrozole|letrozole|mesh-list
19331036|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331037|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19331038|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19331039|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194106|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20194107|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194108|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
19331040|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678041|NCT03137771|Pemetrexed|pemetrexed|mesh-list
19678042|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19678043|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678044|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
19678045|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678046|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678047|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
19678048|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678049|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678050|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678051|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
19678052|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678053|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678054|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
19678055|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678056|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678057|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19331041|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20379545|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20379546|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194109|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194110|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
20194111|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194112|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
20194113|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20194114|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20194115|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20194116|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194117|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20194118|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
20194119|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
20194120|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20379547|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
20379548|NCT01017640|Mitomycins|mitomycins|mesh-list
20379549|NCT01017640|Mitomycin|mitomycin|mesh-list
20379550|NCT01017640|Veliparib|veliparib|mesh-list
20379551|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20379552|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379553|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
20379554|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379555|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20379556|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379557|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20379558|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
20379559|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20379560|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19331042|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
20194121|NCT00229515|Protective Agents|protective agents|mesh-ancestor
20379561|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20379562|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
19331043|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331044|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331045|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
19331046|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19331047|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
19331048|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331049|NCT03900988|Expectorants|expectorants|mesh-ancestor
20379563|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379564|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379565|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379566|NCT01017679|Gefitinib|gefitinib|mesh-list
20379567|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379568|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20379569|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379570|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379571|NCT01017744|Anesthetics|anesthetics|mesh-list
20379572|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379573|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379574|NCT01017770|Artesunate|artesunate|mesh-list
20379575|NCT01017770|Lumefantrine|lumefantrine|mesh-list
20379576|NCT01017770|Artemether|artemether|mesh-list
19331050|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
19331051|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19331052|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
20379577|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20379578|NCT01017770|Amodiaquine|amodiaquine|mesh-list
20379579|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
20379580|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20379581|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19331053|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678058|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19678059|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19678060|NCT03124355|Bromides|bromides|mesh-list
19678061|NCT03124355|Galantamine|galantamine|mesh-list
19678062|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19678063|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
19678064|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19678065|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678066|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379582|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379583|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379584|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
20379585|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
20379586|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20379587|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
20379588|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
20379589|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
20379590|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20379591|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
20379592|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379593|NCT01017796|Expectorants|expectorants|mesh-ancestor
20379594|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
19678067|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
19678068|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678069|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678070|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20379595|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20379596|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
20379597|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379598|NCT01017796|Protective Agents|protective agents|mesh-ancestor
20379599|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379600|NCT01017796|Antidotes|antidotes|mesh-ancestor
19678071|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
19678072|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678073|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
19678074|NCT03056339|Vidarabine|vidarabine|mesh-list
19678075|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
19678076|NCT03056339|Fludarabine|fludarabine|mesh-list
20379601|NCT01017796|Vitamins|vitamins|mesh-ancestor
20379602|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
20379603|NCT01017809|Aprepitant|aprepitant|mesh-list
19331054|NCT03900988|Protective Agents|protective agents|mesh-ancestor
19678077|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
19678078|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379604|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
20379605|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
19678079|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
19678080|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678081|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678082|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379606|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379607|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379608|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379609|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20379610|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379611|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379612|NCT01017822|Gemcitabine|gemcitabine|mesh-list
19678083|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
19678084|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678085|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678086|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19678087|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678088|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
19678089|NCT03056339|Antiviral Agents|antiviral agents|mesh-ancestor
19678090|NCT03056339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678091|NCT02937571|Dexamethasone|dexamethasone|mesh-list
19678092|NCT02937571|Lenalidomide|lenalidomide|mesh-list
19331055|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331056|NCT03900988|Antidotes|antidotes|mesh-ancestor
19331057|NCT03901001|Sirolimus|sirolimus|mesh-list
19331058|NCT03901001|Oseltamivir|oseltamivir|mesh-list
19331059|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19331060|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379613|NCT01017822|Capecitabine|capecitabine|mesh-list
20379614|NCT01017822|Conatumumab|conatumumab|mesh-list
20379615|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379616|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
20379617|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379618|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379619|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
20379620|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379621|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379622|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379623|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
20379624|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379625|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20379626|NCT01017926|Triazolam|triazolam|mesh-list
20379627|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20379628|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20379629|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19331061|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19331062|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331063|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
19331064|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331065|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
19331066|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331067|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
19678093|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20379630|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379631|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379632|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20379633|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
20379634|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
20379635|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379636|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379637|NCT01017939|Prednisone|prednisone|mesh-list
20379638|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
20379639|NCT01017939|Theophylline|theophylline|mesh-list
20379640|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
20379641|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20379642|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
20379643|NCT01017939|Hormones|hormones|mesh-ancestor
20379644|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20379645|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379646|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20379647|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379648|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19331068|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331069|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379649|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331070|NCT03900871|Aspirin|aspirin|mesh-list
20379650|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379651|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
20379652|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19331071|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19331072|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331073|NCT03900871|Analgesics|analgesics|mesh-ancestor
19678094|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
19678095|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
19678096|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678097|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678098|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678099|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
19678100|NCT02937571|Hormones|hormones|mesh-ancestor
19678101|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678102|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19678103|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678104|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
19678105|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19678106|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19678107|NCT02937571|Growth Substances|growth substances|mesh-ancestor
19678108|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
19678109|NCT02648581|Ustekinumab|ustekinumab|mesh-list
19678110|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
19678111|NCT02609815|Metformin|metformin|mesh-list
19678112|NCT02609815|Glimepiride|glimepiride|mesh-list
19678113|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19331074|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
19331075|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379653|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
20379654|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
20379655|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20379656|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20379657|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379658|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20379659|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
20379660|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379661|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20379662|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20379663|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
20379664|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20379665|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20379666|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
20379667|NCT01018160|Rabeprazole|rabeprazole|mesh-list
20379668|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20379669|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379670|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20379671|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379672|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379673|NCT01018225|Darifenacin|darifenacin|mesh-list
20379674|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20379675|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20379676|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
20379677|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379678|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379679|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379680|NCT01018225|Urological Agents|urological agents|mesh-ancestor
20379681|NCT01018251|Alovudine|alovudine|mesh-list
20379682|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
20379683|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379684|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
20379685|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20379686|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379687|NCT01018342|Renal Agents|renal agents|mesh-ancestor
20379688|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379689|NCT01018368|Rifampin|rifampin|mesh-list
20379690|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20379691|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
20379692|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379693|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331076|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678114|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678115|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19678116|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678117|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
20379694|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
19331077|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331078|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331079|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19331080|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19331081|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331082|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20194122|NCT00229528|Paroxetine|paroxetine|mesh-list
19331083|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20379695|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20379696|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379697|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331084|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331085|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
19331086|NCT03900858|Isoniazid|isoniazid|mesh-list
19331087|NCT03900858|Rifapentine|rifapentine|mesh-list
19331088|NCT03900858|Rifampin|rifampin|mesh-list
19331089|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
19331090|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19331091|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331092|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19331093|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19331094|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
19678118|NCT02502786|Antibodies|antibodies|mesh-list
19678119|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
19678120|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678121|NCT02464878|Etanercept|etanercept|mesh-list
20194123|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19678122|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
19678123|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20194124|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20194125|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194126|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194127|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194128|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
19678124|NCT02464878|Basiliximab|basiliximab|mesh-list
19678125|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19331095|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678126|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
19678127|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19678128|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19678129|NCT02464878|Analgesics|analgesics|mesh-ancestor
19678130|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
20194129|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194130|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20194131|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194132|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194133|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20194134|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20194135|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194136|NCT00229567|Lidocaine|lidocaine|mesh-list
20194137|NCT00229567|Ketamine|ketamine|mesh-list
20379698|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20379699|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20379700|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20379701|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20194138|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
20194139|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
20194140|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331096|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19331097|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19331098|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
19331099|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19331100|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331101|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19331102|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19331103|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19331104|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19331105|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19331106|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19331107|NCT03900624|Dexamethasone|dexamethasone|mesh-list
19331108|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331109|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
19678131|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379702|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20379703|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20379704|NCT01018381|Ethanol|ethanol|mesh-list
20379705|NCT01018381|Entecavir|entecavir|mesh-list
20379706|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20379707|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379708|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379709|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379710|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
20379711|NCT01018446|Busulfan|busulfan|mesh-list
20379712|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
20379713|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379714|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379715|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
20379716|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678132|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678133|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678134|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678135|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678136|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678137|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
19678138|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20379717|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379718|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379719|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20379720|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
20379721|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20379722|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20379723|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20379724|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20379725|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194141|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194142|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
20194143|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194144|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20194145|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20194146|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20194147|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194148|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194149|NCT00229567|Analgesics|analgesics|mesh-ancestor
20194150|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20194151|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20194152|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
20194153|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20194154|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20194155|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194156|NCT00229593|ST 1435|st 1435|mesh-list
20194157|NCT00229593|Testosterone|testosterone|mesh-list
19678139|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19678140|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
19678141|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678142|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678143|NCT02250937|Fludarabine|fludarabine|mesh-list
20194158|NCT00229593|Androgens|androgens|mesh-ancestor
20194159|NCT00229593|Hormones|hormones|mesh-ancestor
20379726|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
19331110|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
19331111|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331112|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331113|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19331114|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
19331115|NCT03900624|Hormones|hormones|mesh-ancestor
19331116|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331117|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19331118|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331119|NCT03900637|Letrozole|letrozole|mesh-list
19331120|NCT03900637|Leuprolide|leuprolide|mesh-list
19331121|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331122|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19331123|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19678144|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
20379727|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331124|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379728|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678145|NCT02250937|Busulfan|busulfan|mesh-list
19678146|NCT02250937|Venetoclax|venetoclax|mesh-list
19678147|NCT02250937|Cladribine|cladribine|mesh-list
19678148|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19331125|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331126|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19331127|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
20194160|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194161|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194162|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20194163|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
20194164|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19331128|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331129|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379729|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20379730|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426162|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426163|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20426164|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20426165|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426166|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20426167|NCT01279291|Gemcitabine|gemcitabine|mesh-list
20426168|NCT01279291|Paclitaxel|paclitaxel|mesh-list
20426169|NCT01279291|Carboplatin|carboplatin|mesh-list
20426170|NCT01279291|Doxorubicin|doxorubicin|mesh-list
20426171|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19331130|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19331131|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
19331132|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19331133|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19331134|NCT03900377|Rituximab|rituximab|mesh-list
19331135|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331136|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331137|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
19331138|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331139|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331140|NCT03900026|Evolocumab|evolocumab|mesh-list
19331141|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19331142|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19331143|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
19331144|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331145|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19399252|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399253|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19399254|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
19399255|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
19399256|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399257|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399258|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19399259|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
19399260|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399261|NCT03636178|Daminozide|daminozide|mesh-list
19399262|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19399263|NCT03636178|Growth Substances|growth substances|mesh-ancestor
19678149|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678150|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678151|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
19678152|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678153|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678154|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
19678155|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678156|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
19678157|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19678158|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19678159|NCT02010606|Bevacizumab|bevacizumab|mesh-list
19678160|NCT02010606|Temozolomide|temozolomide|mesh-list
20194165|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20194166|NCT00229632|Idebenone|idebenone|mesh-list
20194167|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
20194168|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194169|NCT00229632|Protective Agents|protective agents|mesh-ancestor
20426172|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19678161|NCT02010606|Vaccines|vaccines|mesh-list
20217517|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426173|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678162|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678163|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678164|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19678165|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20194170|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331146|NCT03899675|Caffeine|caffeine|mesh-list
19331147|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19331148|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331149|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19331150|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194171|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20194172|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194173|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194174|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19331151|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379731|NCT01018602|Vildagliptin|vildagliptin|mesh-list
20379732|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19331152|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19331153|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20194175|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20379733|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379734|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20379735|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
20379736|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379737|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379738|NCT01018615|Silymarin|silymarin|mesh-list
20379739|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
20379740|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194176|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194177|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194178|NCT00229684|Pioglitazone|pioglitazone|mesh-list
20194179|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194180|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194181|NCT00229697|Tamoxifen|tamoxifen|mesh-list
20194182|NCT00229697|Gefitinib|gefitinib|mesh-list
19678166|NCT02010606|Growth Substances|growth substances|mesh-ancestor
19678167|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678168|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
20379741|NCT01018615|Protective Agents|protective agents|mesh-ancestor
20379742|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194183|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20194184|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
20194185|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194186|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379743|NCT01018758|Palonosetron|palonosetron|mesh-list
19331154|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
19331155|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331156|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
19331157|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331158|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331159|NCT03899610|Durvalumab|durvalumab|mesh-list
19331160|NCT03899610|Tremelimumab|tremelimumab|mesh-list
19331161|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331162|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331163|NCT03899506|Midazolam|midazolam|mesh-list
19331164|NCT03899506|Olanzapine|olanzapine|mesh-list
19331165|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19331166|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19331167|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331168|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331169|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19331170|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19331171|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19331172|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19331173|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
19331174|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
19331175|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
19331176|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
19331177|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331178|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331179|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
19331180|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
19331181|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331182|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19331183|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19331184|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19331185|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19331186|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331187|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
19331188|NCT03899337|Prednisolone|prednisolone|mesh-list
19331189|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
19331190|NCT03899337|Rituximab|rituximab|mesh-list
19331191|NCT03899337|Doxorubicin|doxorubicin|mesh-list
19331192|NCT03899337|Vincristine|vincristine|mesh-list
19331193|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
19331194|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331195|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
19331196|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331197|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331198|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379744|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
20379745|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
20379746|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379747|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379748|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379749|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20379750|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20379751|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
20379752|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379753|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379754|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
19331199|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
19331200|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331201|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331202|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19331203|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331204|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19331205|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19331206|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19331207|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331208|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19331209|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
19331210|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
19331211|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
19331212|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331213|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
19331214|NCT03899337|Hormones|hormones|mesh-ancestor
19331215|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331216|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19331217|NCT03899246|Capsaicin|capsaicin|mesh-list
20379755|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20379756|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379757|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20379758|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379759|NCT01018836|Riluzole|riluzole|mesh-list
20379760|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
20379761|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20379762|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20379763|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20379764|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379765|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379766|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20379767|NCT01018836|Protective Agents|protective agents|mesh-ancestor
20379768|NCT01018849|Vitamin D|vitamin d|mesh-list
20379769|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
20379770|NCT01018849|Vitamins|vitamins|mesh-ancestor
20379771|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
19331218|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
19331219|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
19331220|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
19331221|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331222|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331223|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
19331224|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19331225|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331226|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331227|NCT03899571|Oseltamivir|oseltamivir|mesh-list
19331228|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
19331229|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379772|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379773|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20379774|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19331230|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331231|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331232|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
19331233|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19331234|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331235|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19331236|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331237|NCT03899597|Oxytocin|oxytocin|mesh-list
19331238|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
19331239|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19331240|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331241|NCT03899324|Bumetanide|bumetanide|mesh-list
19678169|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19678170|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
19678171|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331242|NCT03899324|Diuretics|diuretics|mesh-ancestor
19331243|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
19331244|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331245|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19331246|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331247|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331248|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
19331249|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19331250|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19331251|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331252|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
19331253|NCT03899233|Coagulants|coagulants|mesh-ancestor
19331254|NCT03899194|Citalopram|citalopram|mesh-list
19331255|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19331256|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19331257|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331258|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678172|NCT02010606|Immunologic Factors|immunologic factors|mesh-ancestor
19678173|NCT01794520|Dexamethasone|dexamethasone|mesh-list
19678174|NCT01794520|Venetoclax|venetoclax|mesh-list
19678175|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678176|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
19678177|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
19678178|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678179|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678180|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678181|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
19678182|NCT01794520|Hormones|hormones|mesh-ancestor
19678183|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678184|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19678185|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194187|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20194188|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194189|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20194190|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20194191|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20194192|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20194193|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194194|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194195|NCT00229775|Chloroquine|chloroquine|mesh-list
20194196|NCT00229775|Artemether|artemether|mesh-list
20194197|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
20194198|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
20379775|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
20379776|NCT01018914|Tacrolimus|tacrolimus|mesh-list
20379777|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379778|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
20379779|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379780|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19678186|NCT01737502|Sirolimus|sirolimus|mesh-list
19678187|NCT01737502|Auranofin|auranofin|mesh-list
19678188|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678189|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194199|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19331259|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331260|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
19678190|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19678191|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678192|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
19678193|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678194|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
19678195|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678196|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194200|NCT00229775|Amebicides|amebicides|mesh-ancestor
20194201|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19678197|NCT01701986|Gemcitabine|gemcitabine|mesh-list
19678198|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
19678199|NCT01701986|Rituximab|rituximab|mesh-list
19678200|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19678201|NCT01701986|Busulfan|busulfan|mesh-list
19678202|NCT01701986|Clofarabine|clofarabine|mesh-list
19678203|NCT01701986|Antibodies|antibodies|mesh-list
19678204|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
19678205|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19678206|NCT01701986|Tacrolimus|tacrolimus|mesh-list
19678207|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
19678208|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19678209|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
19678210|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678211|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678212|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678213|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678214|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
19678215|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331261|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331262|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19331263|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194202|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20194203|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194204|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
20194205|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331264|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19331265|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
19331266|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19331267|NCT03899142|Antibodies|antibodies|mesh-list
19331268|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
19331269|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331270|NCT03899077|Goserelin|goserelin|mesh-list
19331271|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19331272|NCT03899077|Leuprolide|leuprolide|mesh-list
19331273|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19331274|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331275|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
19331276|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19331277|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
19331278|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19331279|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331280|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19331281|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19331282|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
19331283|NCT03899038|Anesthetics|anesthetics|mesh-list
19678216|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
19678217|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678218|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678219|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678220|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19678221|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19678222|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19678223|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
19678224|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678225|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
19678226|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20194206|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20194207|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194208|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194209|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20379781|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194210|NCT00229775|Renal Agents|renal agents|mesh-ancestor
19331284|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678227|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19678228|NCT00754949|Azithromycin|azithromycin|mesh-list
19678229|NCT00754949|Dexamethasone|dexamethasone|mesh-list
20379782|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379783|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20379784|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379785|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20379786|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
20379787|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379788|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379789|NCT01019070|Asunaprevir|asunaprevir|mesh-list
20379790|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20379791|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379792|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379793|NCT01019083|Zinc|zinc|mesh-list
20379794|NCT01019083|Albendazole|albendazole|mesh-list
20379795|NCT01019083|Secnidazole|secnidazole|mesh-list
20379796|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
20379797|NCT01019083|Trace Elements|trace elements|mesh-ancestor
19678230|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
20379798|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
20379799|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379800|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
19331285|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331286|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
19331287|NCT03898752|Vitamins|vitamins|mesh-ancestor
19331288|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
19331289|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331290|NCT03899285|Citalopram|citalopram|mesh-list
19331291|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19331292|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19331293|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331294|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331295|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331296|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
19331297|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331298|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19331299|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
19331300|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19331301|NCT03898882|Oxytocin|oxytocin|mesh-list
19331302|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
19331303|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19331304|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331305|NCT03898635|Linezolid|linezolid|mesh-list
19331306|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19331307|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331308|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20379801|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20379802|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379803|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
19331309|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331310|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331311|NCT03898583|Calcitriol|calcitriol|mesh-list
19331312|NCT03898583|Betamethasone|betamethasone|mesh-list
19331313|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
19331314|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19331315|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
19678231|NCT00754949|BB 1101|bb 1101|mesh-list
19678232|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194211|NCT00229918|Triamcinolone|triamcinolone|mesh-list
20194212|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20194213|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19678233|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
19678234|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
19678235|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331316|NCT03898583|Calcipotriene|calcipotriene|mesh-list
19331317|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20194214|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20194215|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194216|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
20194217|NCT00229918|Hormones|hormones|mesh-ancestor
20194218|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194219|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194220|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678236|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194221|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
20379804|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20379805|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20379806|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678237|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678238|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
19678239|NCT00754949|Hormones|hormones|mesh-ancestor
19678240|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678241|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19678242|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678243|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
19678244|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678245|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678246|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678247|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841942|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194222|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194223|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194224|NCT00229944|Azithromycin|azithromycin|mesh-list
20194225|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20194226|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194227|NCT00229996|Leuprolide|leuprolide|mesh-list
20194228|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
20194229|NCT00229996|Norethindrone|norethindrone|mesh-list
20194230|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
20194231|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
20194232|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20194233|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331318|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331319|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
19331320|NCT03898583|Hormones|hormones|mesh-ancestor
20612836|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19331321|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331322|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331323|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19331324|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
19331325|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
19841943|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19841944|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
19841945|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841946|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
19841947|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841948|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194234|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19331326|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19331327|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19331328|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194235|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
20194236|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20194237|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194238|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20194239|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20194240|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20194241|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20194242|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
20194243|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
20194244|NCT00230035|Rituximab|rituximab|mesh-list
20194245|NCT00230035|Methotrexate|methotrexate|mesh-list
20194246|NCT00230035|Azathioprine|azathioprine|mesh-list
20194247|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
20194248|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20194249|NCT00230035|Antibodies|antibodies|mesh-list
20379807|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
20379808|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
20379809|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379810|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379811|NCT01019083|Astringents|astringents|mesh-ancestor
20379812|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
20379813|NCT01019109|Cobalt|cobalt|mesh-list
20379814|NCT01019109|Trace Elements|trace elements|mesh-ancestor
20379815|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
20379816|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379817|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
19678248|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
19841949|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19841950|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
20194250|NCT00230035|Sargramostim|sargramostim|mesh-list
20379818|NCT01019174|Lenalidomide|lenalidomide|mesh-list
20379819|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20612837|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379820|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
20379821|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379822|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379823|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379824|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
19331329|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331330|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19331331|NCT03898583|Vitamins|vitamins|mesh-ancestor
19331332|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
19331333|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19331334|NCT03898193|Montelukast|montelukast|mesh-list
19331335|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19331336|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19331337|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19331338|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
20379825|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379826|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379827|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20379828|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20379829|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20379830|NCT01019174|Growth Substances|growth substances|mesh-ancestor
20379831|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
20379832|NCT01019265|Buprenorphine|buprenorphine|mesh-list
20379833|NCT01019265|Tramadol|tramadol|mesh-list
20379834|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20379835|NCT01019265|Narcotics|narcotics|mesh-ancestor
20379836|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379837|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379838|NCT01019265|Analgesics|analgesics|mesh-ancestor
20379839|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
20379840|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379841|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19331339|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331340|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331341|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19331342|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19331343|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331344|NCT03898466|Fluticasone|fluticasone|mesh-list
19331345|NCT03898466|Xhance|xhance|mesh-list
19331346|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331347|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19331348|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
19331349|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678249|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678250|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
19678251|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678252|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678253|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19678254|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
19678255|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379842|NCT01019278|Cisplatin|cisplatin|mesh-list
19331350|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331351|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19331352|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
19331353|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
19331354|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19331355|NCT03898011|Lamotrigine|lamotrigine|mesh-list
19331356|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
19331357|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19331358|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331359|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331360|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19331361|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331362|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19331363|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19331364|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331365|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19331366|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19331367|NCT03898128|Immunotoxins|immunotoxins|mesh-list
19678256|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379843|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379844|NCT01019291|Formaldehyde|formaldehyde|mesh-list
20379845|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
20379846|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678257|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19678258|NCT05132023|Metformin|metformin|mesh-list
19678259|NCT05132023|Empagliflozin|empagliflozin|mesh-list
20379847|NCT01019382|Gemcitabine|gemcitabine|mesh-list
20379848|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20379849|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
20379850|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379851|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379852|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
20379853|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379854|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379855|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379856|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
20379857|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379858|NCT01019395|Daptomycin|daptomycin|mesh-list
20379859|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20379860|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379861|NCT01019408|Chloroquine|chloroquine|mesh-list
20379862|NCT01019408|Amebicides|amebicides|mesh-ancestor
20379863|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20379864|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20379865|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379866|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
20379867|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379868|NCT01019434|Sirolimus|sirolimus|mesh-list
20379869|NCT01019434|Temozolomide|temozolomide|mesh-list
20379870|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379871|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
20379872|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331368|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
19331369|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331370|NCT03898336|Micronutrients|micronutrients|mesh-list
19331371|NCT03898336|Trace Elements|trace elements|mesh-list
19331372|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399264|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404459|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404460|NCT03594565|Fluticasone|fluticasone|mesh-list
19404461|NCT03594565|Xhance|xhance|mesh-list
19678260|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19678261|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678262|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19678263|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678264|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
19678265|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
19678266|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678267|NCT05131893|Tamoxifen|tamoxifen|mesh-list
19678268|NCT05131893|Docetaxel|docetaxel|mesh-list
19678269|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
19678270|NCT05131893|Capecitabine|capecitabine|mesh-list
20194251|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19404462|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404463|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404464|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
19404465|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404466|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404467|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19404468|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404469|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
19404470|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19404471|NCT03594513|Dipyrone|dipyrone|mesh-list
20194252|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
20194253|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20194254|NCT00230035|Leflunomide|leflunomide|mesh-list
20194255|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
20194256|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20194257|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20194258|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194259|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
20194260|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194261|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194262|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20194263|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
20379873|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404472|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
19678271|NCT05131893|Trastuzumab|trastuzumab|mesh-list
19678272|NCT05131893|Letrozole|letrozole|mesh-list
19678273|NCT05131893|Epirubicin|epirubicin|mesh-list
20379874|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678274|NCT05131893|Pertuzumab|pertuzumab|mesh-list
20194264|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20194265|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20194266|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
20194267|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194268|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
20194269|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194270|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20194271|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20194272|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20194273|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19331373|NCT03897660|Vitamins|vitamins|mesh-list
19331374|NCT03897660|Vitamin K|vitamin k|mesh-list
19331375|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
19331376|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
19331377|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331378|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19331379|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19331380|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331381|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
19331382|NCT03897660|Coagulants|coagulants|mesh-ancestor
19331383|NCT03897868|Losartan|losartan|mesh-list
19331384|NCT03897868|Amlodipine|amlodipine|mesh-list
19331385|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19331386|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19331387|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331388|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331389|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19331390|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331391|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
19331392|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19331393|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19331394|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19331395|NCT03897309|Vaccines|vaccines|mesh-list
19331396|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
19331397|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331398|NCT03897413|Antacids|antacids|mesh-list
19331399|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
19331400|NCT03897413|Calcium|calcium|mesh-list
19331401|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19331402|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331403|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331404|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19331405|NCT03897452|Fentanyl|fentanyl|mesh-list
19331406|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19331407|NCT03897452|Narcotics|narcotics|mesh-ancestor
19331408|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331409|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194274|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
20194275|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20194276|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194277|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194278|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
20194279|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
19331410|NCT03897452|Analgesics|analgesics|mesh-ancestor
19331411|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
20194280|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194281|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20194282|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
20194283|NCT00230035|Hormones|hormones|mesh-ancestor
20194284|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194285|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20194286|NCT00230035|Protective Agents|protective agents|mesh-ancestor
20194287|NCT00230204|Antibodies|antibodies|mesh-list
20194288|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
20194289|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194290|NCT00230217|Rasburicase|rasburicase|mesh-list
20194291|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
20379875|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379876|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19331412|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331413|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19331414|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19331415|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
20194292|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678275|NCT05131893|Goserelin|goserelin|mesh-list
20379877|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
20379878|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379879|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
20379880|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379881|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
20379882|NCT01019447|Triclosan|triclosan|mesh-list
19331416|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
19678276|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678277|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678278|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
19678279|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678280|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678281|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678282|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
19678283|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678284|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678285|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19678286|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
19678287|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19678288|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678289|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
19678290|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678291|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20379883|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19331417|NCT03896971|Cyclosporine|cyclosporine|mesh-list
19331418|NCT03896971|Cyclosporins|cyclosporins|mesh-list
19331419|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331420|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331421|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331422|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
19331423|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331424|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
19331425|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20379884|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20379885|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20379886|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20379887|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
19331426|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
19331427|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331428|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19331429|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
19331430|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19331431|NCT03896932|Antibodies|antibodies|mesh-list
19331432|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
19331433|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19331434|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
19331435|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331436|NCT03897062|Suvorexant|suvorexant|mesh-list
19331437|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19331438|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19331439|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331440|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678292|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19678293|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678294|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19678295|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
19678296|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678297|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19678298|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19678299|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19678300|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19678301|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19678302|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19678303|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19678304|NCT05131841|Vinorelbine|vinorelbine|mesh-list
20194293|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
20194294|NCT00230321|Hematinics|hematinics|mesh-ancestor
20194295|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
20194296|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194297|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20194298|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194299|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194300|NCT00230373|Imiquimod|imiquimod|mesh-list
20194301|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20194302|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
19331441|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20379888|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379889|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20379890|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20379891|NCT01019590|Olmesartan|olmesartan|mesh-list
20379892|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20379893|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20379894|NCT01019590|Diuretics|diuretics|mesh-ancestor
20379895|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
20379896|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379897|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20379898|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20379899|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379900|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20379901|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20379902|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
20379903|NCT01019603|Tazarotene|tazarotene|mesh-list
20379904|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
20379905|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
19331442|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678305|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19678306|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678307|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678308|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
19678309|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678310|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678311|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
19678312|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19678313|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678314|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
19678315|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
19678316|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678317|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692418|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19692419|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19692420|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19692421|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19692422|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19692423|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19692424|NCT04991896|Metoprolol|metoprolol|mesh-list
19692425|NCT04991896|Sotalol|sotalol|mesh-list
19692426|NCT04991896|Flecainide|flecainide|mesh-list
19692427|NCT04991896|Bisoprolol|bisoprolol|mesh-list
19692428|NCT04991896|Betaxolol|betaxolol|mesh-list
19692429|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19692430|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19692431|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
19692432|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
19692433|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692434|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692435|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19692436|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19692437|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19692438|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692439|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692440|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692441|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19692442|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19692443|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19692444|NCT04991181|Zamicastat|zamicastat|mesh-list
20194303|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194304|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194305|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
20194306|NCT00230399|Celecoxib|celecoxib|mesh-list
20194307|NCT00230399|Capecitabine|capecitabine|mesh-list
20194308|NCT00230399|Irinotecan|irinotecan|mesh-list
20194309|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20194310|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
20194311|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194312|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194313|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20194314|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20194315|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194316|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19678318|NCT05131295|Dapsone|dapsone|mesh-list
19678319|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19678320|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678321|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
19678322|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19678323|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19678324|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19678325|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678326|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678327|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
19678328|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678329|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19678330|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
19678331|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678332|NCT05131295|Antacids|antacids|mesh-ancestor
19678333|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20379906|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
20379907|NCT01019603|Vitamins|vitamins|mesh-ancestor
20379908|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
20379909|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379910|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
20379911|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20379912|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379913|NCT01019642|Vitamins|vitamins|mesh-ancestor
20379914|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
20379915|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20379916|NCT01019655|Nadroparin|nadroparin|mesh-list
20379917|NCT01019655|Calcium|calcium|mesh-list
19678334|NCT05131178|Bupivacaine|bupivacaine|mesh-list
19678335|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
19678336|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
19678337|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331443|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331444|NCT03896893|Emollients|emollients|mesh-list
19331445|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
19331446|NCT03896737|Thalidomide|thalidomide|mesh-list
19331447|NCT03896737|Dexamethasone|dexamethasone|mesh-list
19331448|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
20379918|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20379919|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379920|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
20379921|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20379922|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20379923|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331449|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
19331450|NCT03896737|Bortezomib|bortezomib|mesh-list
19331451|NCT03896737|Daratumumab|daratumumab|mesh-list
19331452|NCT03896737|BB 1101|bb 1101|mesh-list
19331453|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331454|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
19331455|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379924|NCT01019668|Verteporfin|verteporfin|mesh-list
20379925|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20379926|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
20379927|NCT01019746|Propofol|propofol|mesh-list
20379928|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20379929|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20379930|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379931|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20379932|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
20379933|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
20379934|NCT01019772|Vaccines|vaccines|mesh-list
20379935|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
20379936|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379937|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
20379938|NCT01019785|Vitamin D|vitamin d|mesh-list
20379939|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20379940|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379941|NCT01019785|Vitamins|vitamins|mesh-ancestor
20379942|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
20379943|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20379944|NCT01019798|Docetaxel|docetaxel|mesh-list
20379945|NCT01019798|Sunitinib|sunitinib|mesh-list
19678338|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331456|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331457|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19331458|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
19678339|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
20379946|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379947|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
20379948|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
20379949|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
20379950|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379951|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20379952|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20379953|NCT01019798|Growth Substances|growth substances|mesh-ancestor
20379954|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379955|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
20379956|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20379957|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379958|NCT01019850|Vorinostat|vorinostat|mesh-list
19331459|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331460|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331461|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19331462|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331463|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
19678340|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678341|NCT05130892|Tranilast|tranilast|mesh-list
19331464|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
19331465|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331466|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19331467|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
19331468|NCT03896737|Hormones|hormones|mesh-ancestor
19331469|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331470|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19331471|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
19331472|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331473|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
19331474|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19331475|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331476|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19331477|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19331478|NCT03896737|Growth Substances|growth substances|mesh-ancestor
19331479|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
19331480|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
19331481|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
19678342|NCT05130892|Colchicine|colchicine|mesh-list
19678343|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
19678344|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678345|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678346|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
19678347|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678348|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678349|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678350|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19678351|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19678352|NCT05130892|Analgesics|analgesics|mesh-ancestor
19678353|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
19678354|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678355|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841951|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194317|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20194318|NCT00230399|Analgesics|analgesics|mesh-ancestor
20194319|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
20194320|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194321|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194322|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194323|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194324|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20194325|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20194326|NCT00230451|Paclitaxel|paclitaxel|mesh-list
20194327|NCT00230451|Fluorouracil|fluorouracil|mesh-list
20194328|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20194329|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194330|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
20194331|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
20194332|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
20194333|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194334|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
20194335|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20194336|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194337|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
20194338|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841952|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19841953|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19841954|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20379959|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20379960|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379961|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20379962|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379963|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379964|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20379965|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
20379966|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379967|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
20379968|NCT01019876|Fludarabine|fludarabine|mesh-list
19678356|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678357|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19678358|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19678359|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20379969|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20379970|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
20379971|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379972|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20379973|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20379974|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
20379975|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379976|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379977|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20379978|NCT01019941|Docetaxel|docetaxel|mesh-list
20379979|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379980|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
20379981|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
20379982|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
20379983|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379984|NCT01020136|Axitinib|axitinib|mesh-list
20379985|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20379986|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20379987|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20379988|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20379989|NCT01020162|Gabapentin|gabapentin|mesh-list
20379990|NCT01020162|Amitriptyline|amitriptyline|mesh-list
20379991|NCT01020162|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20379992|NCT01020162|Analgesics|analgesics|mesh-ancestor
20379993|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
20379994|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20379995|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379996|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
20379997|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20379998|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19331482|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
19399265|NCT03636048|Bupivacaine|bupivacaine|mesh-list
19678360|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19678361|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
19678362|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
19678363|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678364|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19678365|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19678366|NCT05130684|Paclitaxel|paclitaxel|mesh-list
19678367|NCT05130684|Cisplatin|cisplatin|mesh-list
19841955|NCT00645710|Gemcitabine|gemcitabine|mesh-list
19841956|NCT00645710|Floxuridine|floxuridine|mesh-list
19841957|NCT00645710|Antibodies|antibodies|mesh-list
19841958|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19841959|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
19841960|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841961|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19841962|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
20194339|NCT00230464|Vildagliptin|vildagliptin|mesh-list
20194340|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194341|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194342|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20194343|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
20194344|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194345|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194346|NCT00230477|Lamivudine|lamivudine|mesh-list
20194347|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20194348|NCT00230477|Adefovir|adefovir|mesh-list
20194349|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19678368|NCT05130684|Nivolumab|nivolumab|mesh-list
19678369|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20194350|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20194351|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194352|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194353|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
20194354|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194355|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20194356|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20194357|NCT00230490|Adefovir|adefovir|mesh-list
20194358|NCT00230490|Pradefovir|pradefovir|mesh-list
20194359|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
20194360|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194361|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20194362|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20194363|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194364|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194365|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20217518|NCT00309725|Galantamine|galantamine|mesh-list
20217519|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20217520|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217521|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678370|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678371|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678372|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
19678373|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678374|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678375|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678376|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19678377|NCT05130619|Ethanol|ethanol|mesh-list
19678378|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19678379|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678380|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678381|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678382|NCT05130515|Niraparib|niraparib|mesh-list
19678383|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19678384|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678385|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678386|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678387|NCT05130398|Vaccines|vaccines|mesh-list
19678388|NCT05130398|Immunologic Factors|immunologic factors|mesh-ancestor
19678389|NCT05130398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217522|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
19399266|NCT03636048|Anesthetics|anesthetics|mesh-list
19678390|NCT05107557|Vaccines|vaccines|mesh-list
19678391|NCT05107557|Immunologic Factors|immunologic factors|mesh-ancestor
19678392|NCT05107557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678393|NCT05065554|Rituximab|rituximab|mesh-list
19678394|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
19678395|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678396|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678397|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
20217523|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678398|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678399|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678400|NCT05045950|Memantine|memantine|mesh-list
19678401|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19678402|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19678403|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
19678404|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678405|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678406|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692445|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217524|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20379999|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380000|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380001|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20380002|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20380003|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380004|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380005|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
20380006|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20380007|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
19678407|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19678408|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19678409|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19678410|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19678411|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19678412|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
19678413|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380008|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20380009|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20380010|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20380011|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20380012|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
20380013|NCT01020162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20380014|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20380015|NCT01020214|Olmesartan|olmesartan|mesh-list
20380016|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20380017|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20380018|NCT01020214|Diuretics|diuretics|mesh-ancestor
20380019|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
20380020|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380021|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20380022|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20380023|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380024|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20380025|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20380026|NCT01020253|Alendronate|alendronate|mesh-list
20380027|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
20380028|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20380029|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20380030|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380031|NCT01020253|Vitamins|vitamins|mesh-ancestor
20380032|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
20426174|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20426175|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20426176|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20426177|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426178|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20426179|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
20426180|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
20426181|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331483|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194366|NCT00230503|Adefovir|adefovir|mesh-list
19678414|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19678415|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19678416|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678417|NCT05041101|Halichondrin B|halichondrin b|mesh-list
20194367|NCT00230503|Pradefovir|pradefovir|mesh-list
19331484|NCT03896321|Anticoagulants|anticoagulants|mesh-list
19331485|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19331486|NCT03896256|Ketamine|ketamine|mesh-list
19331487|NCT03896256|Analgesics|analgesics|mesh-ancestor
19331488|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
19331489|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331490|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331491|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19331492|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19331493|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
19331494|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
19331495|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331496|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20194368|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
20194369|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194370|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20194371|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20194372|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194373|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194374|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20194375|NCT00230516|Lansoprazole|lansoprazole|mesh-list
20194376|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20194377|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20194378|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20194379|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399267|NCT03636048|Propofol|propofol|mesh-list
20217525|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20380033|NCT01020279|Celecoxib|celecoxib|mesh-list
20380034|NCT01020279|Ketoprofen|ketoprofen|mesh-list
20380035|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20380036|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20380037|NCT01020279|Analgesics|analgesics|mesh-ancestor
20380038|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
19841963|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841964|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380039|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331497|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19331498|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331499|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380040|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380041|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380042|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331500|NCT03896113|Celecoxib|celecoxib|mesh-list
19331501|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19331502|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331503|NCT03896113|Analgesics|analgesics|mesh-ancestor
19331504|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
19331505|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331506|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331507|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331508|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678418|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678419|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
19678420|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678421|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678422|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678423|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
20194380|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678424|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
19678425|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19331509|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19331510|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19331511|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331512|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331513|NCT03896074|Bevacizumab|bevacizumab|mesh-list
19331514|NCT03896074|Atezolizumab|atezolizumab|mesh-list
19331515|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331516|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678426|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678427|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678428|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
19678429|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20194381|NCT00230529|Infliximab|infliximab|mesh-list
19331517|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19331518|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20194382|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
19331519|NCT03896074|Growth Substances|growth substances|mesh-ancestor
19331520|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331521|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
19331522|NCT03896269|Cytarabine|cytarabine|mesh-list
19331523|NCT03896269|Daunorubicin|daunorubicin|mesh-list
19331524|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678430|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20194383|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20194384|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194385|NCT00230542|Carboplatin|carboplatin|mesh-list
20194386|NCT00230542|Pemetrexed|pemetrexed|mesh-list
20194387|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194388|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194389|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194390|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19678431|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678432|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
19678433|NCT05024253|Coagulants|coagulants|mesh-ancestor
19678434|NCT05008536|Fludarabine|fludarabine|mesh-list
19678435|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
19678436|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19841965|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
19331525|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
19399268|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
20380043|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19331526|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380044|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20380045|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380046|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380047|NCT01020292|Nelfinavir|nelfinavir|mesh-list
20380048|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20380049|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20380050|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
20380051|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380052|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380053|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20380054|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20380055|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
20380056|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380057|NCT01020331|Memantine|memantine|mesh-list
20380058|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20380059|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20380060|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
19678437|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678438|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678439|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
19678440|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678441|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678442|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19678443|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
19678444|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19678445|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
19678446|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19678447|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331527|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380061|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380062|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380063|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426182|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331528|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
19331529|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331530|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331531|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
19331532|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331533|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19331534|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19678448|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19678449|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678450|NCT04983901|Vancomycin|vancomycin|mesh-list
20194391|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20194392|NCT00230568|Donepezil|donepezil|mesh-list
20194393|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19678451|NCT04983901|Meropenem|meropenem|mesh-list
19678452|NCT04983901|Tazobactam|tazobactam|mesh-list
19678453|NCT04983901|Linezolid|linezolid|mesh-list
19841966|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841967|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194394|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194395|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194396|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
20194397|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194398|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194399|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
20194400|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20194401|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
20194402|NCT00230594|Coagulants|coagulants|mesh-ancestor
20194403|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20194404|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
20194405|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194406|NCT00230698|Topiramate|topiramate|mesh-list
20194407|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
20194408|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194409|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194410|NCT00230763|Timolol|timolol|mesh-list
20194411|NCT00230763|Latanoprost|latanoprost|mesh-list
20194412|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20194413|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20194414|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
20194415|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217526|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
19331535|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19331536|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331537|NCT03895892|Caffeine|caffeine|mesh-list
19331538|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19331539|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331540|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19678454|NCT04983901|Piperacillin|piperacillin|mesh-list
19678455|NCT04983901|Daptomycin|daptomycin|mesh-list
19678456|NCT04983901|Imipenem|imipenem|mesh-list
19678457|NCT04983901|Cefepime|cefepime|mesh-list
19678458|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19678459|NCT04983901|Relebactam|relebactam|mesh-list
19678460|NCT04983901|Cilastatin|cilastatin|mesh-list
19678461|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678462|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678463|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19678464|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678465|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678466|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19678467|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
19678468|NCT04982848|Talazoparib|talazoparib|mesh-list
19331541|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331542|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331543|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19331544|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19331545|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
19331546|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331547|NCT03896217|Simvastatin|simvastatin|mesh-list
19331548|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19331549|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19331550|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
19331551|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331552|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19331553|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19331554|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331555|NCT03895788|Niraparib|niraparib|mesh-list
19331556|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19331557|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331558|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331559|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331560|NCT03895801|Prednisone|prednisone|mesh-list
19331561|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
19331562|NCT03895801|Vilobelimab|vilobelimab|mesh-list
19331563|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678469|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19678470|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678471|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678472|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678473|NCT04968899|Dexamethasone|dexamethasone|mesh-list
19678474|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
19678475|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19678476|NCT04968899|Antibodies|antibodies|mesh-list
19678477|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
19678478|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19678479|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678480|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
19678481|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
19678482|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678483|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678484|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678485|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
19678486|NCT04968899|Hormones|hormones|mesh-ancestor
19678487|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678488|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19678489|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678490|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
19678491|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19678492|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19678493|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19678494|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678495|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678496|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380064|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19678497|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19678498|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19678499|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
19678500|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678501|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678502|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19678503|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19678504|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
19678505|NCT04884412|Anesthetics|anesthetics|mesh-list
19678506|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678507|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331564|NCT03895801|Hormones|hormones|mesh-ancestor
19331565|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331566|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331567|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19331568|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331569|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19331570|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331571|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
19331572|NCT03895671|Azacitidine|azacitidine|mesh-list
19331573|NCT03895671|Ponatinib|ponatinib|mesh-list
19331574|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19331575|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
20380065|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20380066|NCT01020357|Caffeine|caffeine|mesh-list
20380067|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
20380068|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380069|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20380070|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380071|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20380072|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380073|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20380074|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20380075|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
20380076|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380077|NCT01020383|Abciximab|abciximab|mesh-list
20380078|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
20380079|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19678508|NCT04868409|Rocuronium|rocuronium|mesh-list
19678509|NCT04868409|Succinylcholine|succinylcholine|mesh-list
19678510|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19678511|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19678512|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19678513|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678514|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678515|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19678516|NCT04859465|Doxorubicin|doxorubicin|mesh-list
19678517|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19678518|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19678519|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19678520|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678521|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19678522|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19678523|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678524|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692446|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692447|NCT04991402|Dolutegravir|dolutegravir|mesh-list
19692448|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19692449|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20194416|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612838|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20612839|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19399269|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194417|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194418|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20194419|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20194420|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20194421|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20194422|NCT00230776|Pregabalin|pregabalin|mesh-list
20194423|NCT00230776|Analgesics|analgesics|mesh-ancestor
20194424|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
20380080|NCT01020396|Metronidazole|metronidazole|mesh-list
20380081|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380082|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380083|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19678525|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
19678526|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678527|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678528|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
19678529|NCT04691505|Methotrexate|methotrexate|mesh-list
19678530|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19678531|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
19678532|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19678533|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678534|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678535|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
19678536|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678537|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678538|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
19678539|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331576|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331577|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380084|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20380085|NCT01020539|Fludarabine|fludarabine|mesh-list
20380086|NCT01020539|Busulfan|busulfan|mesh-list
20380087|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
20380088|NCT01020539|Isotretinoin|isotretinoin|mesh-list
20380089|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
20380090|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19331578|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678540|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19678541|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678542|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
19678543|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678544|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19678545|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
19678546|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19678547|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19678548|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678549|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
19678550|NCT04678401|Thiotepa|thiotepa|mesh-list
19678551|NCT04678401|Fludarabine|fludarabine|mesh-list
19678552|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678553|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
19678554|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678555|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678556|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19678557|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
19678558|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678559|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678560|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20194425|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194426|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194427|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
20194428|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20194429|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194430|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194431|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20380091|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380092|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331579|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20380093|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380094|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
20380095|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380096|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
20380097|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20380098|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19331580|NCT03895528|Lonafarnib|lonafarnib|mesh-list
19678561|NCT04635826|Adderall|adderall|mesh-list
19678562|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19678563|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678564|NCT04590586|Thalidomide|thalidomide|mesh-list
19678565|NCT04590586|Apremilast|apremilast|mesh-list
20194432|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20380099|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
20380100|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380101|NCT01020630|Sunitinib|sunitinib|mesh-list
19678566|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19678567|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19692450|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20380102|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380103|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20380104|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20380105|NCT01020630|Growth Substances|growth substances|mesh-ancestor
20380106|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380107|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
19331581|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380108|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20380109|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380110|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380111|NCT01020643|Propofol|propofol|mesh-list
20380112|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20380113|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380114|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380115|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20380116|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
20380117|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
20380118|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
20380119|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20380120|NCT01020708|Mesalamine|mesalamine|mesh-list
20380121|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20380122|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
20380123|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380124|NCT01020708|Expectorants|expectorants|mesh-ancestor
19331582|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331583|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
19678568|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19678569|NCT04590586|Analgesics|analgesics|mesh-ancestor
19678570|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
19678571|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678572|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678573|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678574|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678575|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19678576|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19678577|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678578|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678579|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678580|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
20194433|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194434|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194435|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194436|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20194437|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20194438|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20194439|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
20194440|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194441|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194442|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194443|NCT00230789|Urological Agents|urological agents|mesh-ancestor
20194444|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20194445|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20194446|NCT00230815|Hormones|hormones|mesh-ancestor
20194447|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194448|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194449|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20194450|NCT00230867|Acyclovir|acyclovir|mesh-list
20194451|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
20194452|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194453|NCT00230958|Interferons|interferons|mesh-list
20194454|NCT00230958|Ribavirin|ribavirin|mesh-list
20194455|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
20194456|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
20194457|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20194458|NCT00230958|Taribavirin|taribavirin|mesh-list
20194459|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194460|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
20194461|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194462|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
20194463|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194464|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
20194465|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194466|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
20380125|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
19331584|NCT03895970|Lenvatinib|lenvatinib|mesh-list
19678581|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
19678582|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678583|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678584|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19678585|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19678586|NCT04590586|Growth Substances|growth substances|mesh-ancestor
19841968|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19841969|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
19841970|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19841971|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19841972|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19841973|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19331585|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331586|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331587|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19331588|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331589|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331590|NCT03895502|Edoxaban|edoxaban|mesh-list
19331591|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19331592|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
19331593|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19678587|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
19678588|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331594|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
19331595|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331596|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331597|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
19331598|NCT03895229|Empagliflozin|empagliflozin|mesh-list
19331599|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19331600|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331601|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19331602|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399270|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399271|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
19399272|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399273|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399274|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19399275|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
19678589|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19678590|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19678591|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678592|NCT04543071|Gemcitabine|gemcitabine|mesh-list
19678593|NCT04543071|Paclitaxel|paclitaxel|mesh-list
19678594|NCT04543071|Cemiplimab|cemiplimab|mesh-list
19678595|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19678596|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678597|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678598|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
19678599|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678600|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678601|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678602|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
19678603|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
19678604|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678605|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678606|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678607|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
19678608|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678609|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678610|NCT04535141|Olanzapine|olanzapine|mesh-list
19678611|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
19678612|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
19678613|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399276|NCT03635931|Mitogens|mitogens|mesh-list
19399277|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19399278|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399279|NCT03635905|Gabapentin|gabapentin|mesh-list
19678614|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841974|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678615|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20194467|NCT00230984|Testosterone|testosterone|mesh-list
20194468|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
20194469|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
20194470|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20194471|NCT00230984|Androgens|androgens|mesh-ancestor
19331603|NCT03895411|Sotalol|sotalol|mesh-list
19331604|NCT03895411|Propafenone|propafenone|mesh-list
19331605|NCT03895411|Metoprolol|metoprolol|mesh-list
19331606|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19331607|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19678616|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19678617|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19678618|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678619|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19678620|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19678621|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19678622|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19678623|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678624|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678625|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
19678626|NCT04530630|Emtricitabine|emtricitabine|mesh-list
19678627|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
19678628|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678629|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19678630|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19678631|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678632|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678633|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19678634|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19678635|NCT04530149|Acetaminophen|acetaminophen|mesh-list
19678636|NCT04530149|Bupivacaine|bupivacaine|mesh-list
19678637|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
19678638|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
19678639|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678640|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678641|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
19678642|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678643|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19678644|NCT04530149|Analgesics|analgesics|mesh-ancestor
19678645|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
19678646|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19678647|NCT04529902|Abatacept|abatacept|mesh-list
19678648|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19678649|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678650|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678651|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678652|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
19678653|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678654|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678655|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678656|NCT04486118|Lisinopril|lisinopril|mesh-list
19678657|NCT04486118|Benazepril|benazepril|mesh-list
19331608|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
19331609|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678658|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19678659|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
19678660|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678661|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678662|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19678663|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19331610|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331611|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331612|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19331613|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
19331614|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
19331615|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331616|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20194472|NCT00230984|Hormones|hormones|mesh-ancestor
20194473|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194474|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194475|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20194476|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194477|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
20194478|NCT00230997|Galantamine|galantamine|mesh-list
20194479|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19678664|NCT04486118|Protective Agents|protective agents|mesh-ancestor
19692451|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194480|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331617|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19331618|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331619|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19331620|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19331621|NCT03894904|Heparin|heparin|mesh-list
19331622|NCT03894904|Papaverine|papaverine|mesh-list
19331623|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
19331624|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19331625|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19331626|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331627|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19331628|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331629|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
19331630|NCT03894904|Urological Agents|urological agents|mesh-ancestor
19331631|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
19331632|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19331633|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19331634|NCT03894839|Glutaral|glutaral|mesh-list
20194481|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194482|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
20194483|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194484|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331635|NCT03894839|Eusol|eusol|mesh-list
19331636|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19331637|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331638|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
19331639|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
19331640|NCT03894826|Vorinostat|vorinostat|mesh-list
19841975|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841976|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380126|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20380127|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
20380128|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380129|NCT01020708|Protective Agents|protective agents|mesh-ancestor
19841977|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19841978|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19841979|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19841980|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19841981|NCT00645853|Warfarin|warfarin|mesh-list
19841982|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
19848231|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19848232|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19848233|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
19848234|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
19848235|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194485|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20380130|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331641|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331642|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19331643|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380131|NCT01020708|Antidotes|antidotes|mesh-ancestor
20380132|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20380133|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331644|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331645|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
19331646|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19331647|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380134|NCT01020708|Analgesics|analgesics|mesh-ancestor
20380135|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
20380136|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380137|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380138|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380139|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
19331648|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
19331649|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19331650|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20194486|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
20194487|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194488|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
20194489|NCT00231023|Triamcinolone|triamcinolone|mesh-list
20194490|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20194491|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20194492|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20194493|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331651|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19331652|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19678665|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678666|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19678667|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
19678668|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678669|NCT04353128|Melatonin|melatonin|mesh-list
19678670|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
19678671|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678672|NCT04353128|Protective Agents|protective agents|mesh-ancestor
20380140|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380141|NCT01020734|Cyclosporine|cyclosporine|mesh-list
20380142|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
20380143|NCT01020734|Busulfan|busulfan|mesh-list
20380144|NCT01020734|Methotrexate|methotrexate|mesh-list
20380145|NCT01020734|Fludarabine|fludarabine|mesh-list
20380146|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
20380147|NCT01020734|Cyclosporins|cyclosporins|mesh-list
20380148|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20380149|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380150|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
19678673|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678674|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678675|NCT04340076|Ixekizumab|ixekizumab|mesh-list
19678676|NCT04340076|Brodalumab|brodalumab|mesh-list
19678677|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
19678678|NCT04325880|Tamsulosin|tamsulosin|mesh-list
19678679|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
19678680|NCT04325880|Mirabegron|mirabegron|mesh-list
19678681|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19678682|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19678683|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19678684|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19678685|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678686|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678687|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678688|NCT04325880|Urological Agents|urological agents|mesh-ancestor
19678689|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19678690|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19678691|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
19678692|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19678693|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19678694|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19678695|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19678696|NCT04263350|Cobicistat|cobicistat|mesh-list
20380151|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331653|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331654|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
19331655|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331656|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331657|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19331658|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331659|NCT03894800|Fentanyl|fentanyl|mesh-list
19331660|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
19331661|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19331662|NCT03894800|Narcotics|narcotics|mesh-ancestor
19331663|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331664|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331665|NCT03894800|Analgesics|analgesics|mesh-ancestor
19331666|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
19331667|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331668|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19331669|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19331670|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
19331671|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
19331672|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19331673|NCT03894683|Melatonin|melatonin|mesh-list
19331674|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
19331675|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331676|NCT03894683|Protective Agents|protective agents|mesh-ancestor
20380152|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380153|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20380154|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
20380155|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380156|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331677|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399280|NCT03635905|Analgesics|analgesics|mesh-ancestor
20380157|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20612840|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678697|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19678698|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19678699|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
19331678|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331679|NCT03894189|Theophylline|theophylline|mesh-list
19331680|NCT03894189|Doxapram|doxapram|mesh-list
19678700|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678701|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678702|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19678703|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19678704|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
19678705|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331681|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19331682|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
19331683|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678706|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19678707|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19678708|NCT04227028|Bevacizumab|bevacizumab|mesh-list
19331684|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331685|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20194494|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
20194495|NCT00231023|Hormones|hormones|mesh-ancestor
20194496|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194497|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194498|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194499|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
20194500|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194501|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380158|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19331686|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
19331687|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19331688|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331689|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331690|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
19331691|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19331692|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19678709|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19678710|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
19678711|NCT04227028|Antibodies|antibodies|mesh-list
19678712|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
19678713|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19678714|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
19678715|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678716|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19678717|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19678718|NCT04227028|Growth Substances|growth substances|mesh-ancestor
19678719|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678720|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
19678721|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
19678722|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
19678723|NCT04207086|Lenvatinib|lenvatinib|mesh-list
19678724|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678725|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678726|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20380159|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
20380160|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20380161|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20380162|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
20380163|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
20380164|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380165|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20380166|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20380167|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
20380168|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380169|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20380170|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20380171|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
20380172|NCT01020825|Coagulants|coagulants|mesh-ancestor
20380173|NCT01020864|Carboplatin|carboplatin|mesh-list
20380174|NCT01020864|Cetuximab|cetuximab|mesh-list
20380175|NCT01020864|Vinorelbine|vinorelbine|mesh-list
19331693|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
19678727|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678728|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380176|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678729|NCT04202458|Tenecteplase|tenecteplase|mesh-list
19678730|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19678731|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19678732|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678733|NCT04184453|Deferiprone|deferiprone|mesh-list
19678734|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19678735|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
19678736|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
19678737|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678738|NCT04101643|Evolocumab|evolocumab|mesh-list
19678739|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19678740|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19678741|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
19678742|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194502|NCT00231075|Paclitaxel|paclitaxel|mesh-list
20194503|NCT00231075|Carboplatin|carboplatin|mesh-list
20194504|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20194505|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380177|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380178|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20380179|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
20380180|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
20380181|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
20380182|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380183|NCT01020955|Mecasermin|mecasermin|mesh-list
20380184|NCT01020955|Growth Substances|growth substances|mesh-ancestor
20380185|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380186|NCT01021150|Cisplatin|cisplatin|mesh-list
20380187|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380188|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
20194506|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
20194507|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
20194508|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
20194509|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194510|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20194511|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194512|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194513|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20194514|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194515|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380189|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20380190|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
20380191|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380192|NCT01021163|Expectorants|expectorants|mesh-ancestor
20380193|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
20380194|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20380195|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
20380196|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380197|NCT01021163|Protective Agents|protective agents|mesh-ancestor
20380198|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380199|NCT01021163|Antidotes|antidotes|mesh-ancestor
20380200|NCT01021176|Diltiazem|diltiazem|mesh-list
20194516|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194517|NCT00231140|Thalidomide|thalidomide|mesh-list
20194518|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194519|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
20194520|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194521|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
20194522|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678743|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19678744|NCT03873493|Venetoclax|venetoclax|mesh-list
19678745|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678746|NCT03844048|Venetoclax|venetoclax|mesh-list
19678747|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692452|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692453|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19692454|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
19692455|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194523|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194524|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20194525|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20194526|NCT00231140|Growth Substances|growth substances|mesh-ancestor
20380201|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19693131|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841983|NCT00645944|Eszopiclone|eszopiclone|mesh-list
20380202|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19331694|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331695|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20380203|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20380204|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380205|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20380206|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380207|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
20380208|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
20380209|NCT01021267|Urological Agents|urological agents|mesh-ancestor
20380210|NCT01021358|Ketoconazole|ketoconazole|mesh-list
20380211|NCT01021358|Navitoclax|navitoclax|mesh-list
20380212|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
20380213|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380214|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19331696|NCT03894085|Paroxetine|paroxetine|mesh-list
19331697|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19331698|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19331699|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331700|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380215|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20380216|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380217|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380218|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20380219|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
20380220|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20380221|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678748|NCT03667846|Topiramate|topiramate|mesh-list
20380222|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20380223|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380224|NCT01021436|Amikacin|amikacin|mesh-list
20380225|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380226|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380227|NCT01021475|Domperidone|domperidone|mesh-list
20380228|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
20380229|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
20380230|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380231|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380232|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380233|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19678749|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
19678750|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19678751|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678752|NCT03580928|Venetoclax|venetoclax|mesh-list
20380234|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
20380235|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426183|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678753|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
19678754|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
19678755|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678756|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678757|NCT03534323|Venetoclax|venetoclax|mesh-list
19678758|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678759|NCT03520231|Vitamin D|vitamin d|mesh-list
19841984|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20194527|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
19678760|NCT03520231|Denosumab|denosumab|mesh-list
19678761|NCT03520231|Gemcitabine|gemcitabine|mesh-list
19678762|NCT03520231|Carboplatin|carboplatin|mesh-list
20194528|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194529|NCT00231192|Repaglinide|repaglinide|mesh-list
20194530|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194531|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194532|NCT00231218|Ascorbic Acid|ascorbic acid|mesh-list
20194533|NCT00231218|Propolis|propolis|mesh-list
20194534|NCT00231218|Vitamins|vitamins|mesh-ancestor
20194535|NCT00231218|Micronutrients|micronutrients|mesh-ancestor
20194536|NCT00231218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194537|NCT00231218|Antioxidants|antioxidants|mesh-ancestor
20194538|NCT00231218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194539|NCT00231218|Protective Agents|protective agents|mesh-ancestor
20194540|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194541|NCT00231244|Sirolimus|sirolimus|mesh-list
20194542|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20194543|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194544|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20194545|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678763|NCT03520231|Calcium|calcium|mesh-list
19678764|NCT03520231|Vitamins|vitamins|mesh-ancestor
19331701|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331702|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
19331703|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331704|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19331705|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
19331706|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19331707|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19678765|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
19678766|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331708|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19331709|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331710|NCT03894345|Prazosin|prazosin|mesh-list
19331711|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19331712|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19331713|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19331714|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19331715|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
19331716|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678767|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678768|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678769|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
19678770|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678771|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
19678772|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678773|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678774|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194546|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
20194547|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194548|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
20194549|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194550|NCT00231322|Praziquantel|praziquantel|mesh-list
20194551|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
20194552|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20194553|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194554|NCT00231335|Citalopram|citalopram|mesh-list
20194555|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20194556|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20194557|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194558|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194559|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678775|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
20194560|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
20194561|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194562|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20194563|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194564|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194565|NCT00231348|Nefazodone|nefazodone|mesh-list
20194566|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20194567|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20194568|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194569|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194570|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194571|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194572|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20194573|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194574|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194575|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20194576|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20194577|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
20194578|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
19678776|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19678777|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19678778|NCT03451578|alpha-MSH|alpha-msh|mesh-list
19678779|NCT03451578|Hormones|hormones|mesh-ancestor
19678780|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678781|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678782|NCT03171805|Propranolol|propranolol|mesh-list
19678783|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19678784|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19678785|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692456|NCT04991207|Bosentan|bosentan|mesh-list
20194579|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194580|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194581|NCT00231452|Artesunate|artesunate|mesh-list
20194582|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
20194583|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
20194584|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20194585|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
20194586|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20194587|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20194588|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194589|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194590|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
19841985|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19841986|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841987|NCT00646451|Pregabalin|pregabalin|mesh-list
19841988|NCT00646451|Analgesics|analgesics|mesh-ancestor
19841989|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
19678786|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678787|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678788|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678789|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19678790|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20380236|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380237|NCT01021488|Enoxaparin|enoxaparin|mesh-list
20380238|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20380239|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20380240|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20380241|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
20380242|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380243|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20380244|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20380245|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380246|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
20380247|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20380248|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20380249|NCT01021501|Nifedipine|nifedipine|mesh-list
20380250|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20380251|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19678791|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
19678792|NCT03107416|Bumetanide|bumetanide|mesh-list
19678793|NCT03107416|Diuretics|diuretics|mesh-ancestor
19678794|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
19678795|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678796|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19678797|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19678798|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678799|NCT03094234|Propranolol|propranolol|mesh-list
20380252|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380253|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20380254|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841990|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19841991|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19841992|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
19841993|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19841994|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19841995|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19841996|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20194591|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
20194592|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20380255|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
20380256|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
20380257|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20380258|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20380259|NCT01021540|Hormones|hormones|mesh-ancestor
19678800|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19841997|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20194593|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
20194594|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20194595|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841998|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194596|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194597|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20426184|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
19678801|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19678802|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
19678803|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678804|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194598|NCT00231452|Renal Agents|renal agents|mesh-ancestor
20194599|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
20194600|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20194601|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20194602|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20194603|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194604|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194605|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
20194606|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194607|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194608|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20194609|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678805|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678806|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19678807|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19678808|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
19678809|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19678810|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
20194610|NCT00231517|Morphine|morphine|mesh-list
20194611|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20194612|NCT00231517|Narcotics|narcotics|mesh-ancestor
20194613|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194614|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194615|NCT00231517|Analgesics|analgesics|mesh-ancestor
20194616|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
20194617|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194618|NCT00231530|Topiramate|topiramate|mesh-list
20194619|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
20194620|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194621|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194622|NCT00231556|Topiramate|topiramate|mesh-list
20194623|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
20194624|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194625|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194626|NCT00231569|Mipomersen|mipomersen|mesh-list
20194627|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20194628|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20194629|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
20194630|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194631|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20194632|NCT00231582|Paclitaxel|paclitaxel|mesh-list
20194633|NCT00231582|Etoposide|etoposide|mesh-list
20194634|NCT00231582|Carboplatin|carboplatin|mesh-list
20194635|NCT00231582|Epirubicin|epirubicin|mesh-list
20194636|NCT00231582|Ifosfamide|ifosfamide|mesh-list
20194637|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20194638|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194639|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20380260|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194640|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20194641|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20194642|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194643|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19331717|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331718|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194644|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20194645|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194646|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20194647|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20194648|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
20194649|NCT00231595|Topiramate|topiramate|mesh-list
19331719|NCT03894280|Fluticasone|fluticasone|mesh-list
19678811|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20194650|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
20194651|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194652|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194653|NCT00231608|Topiramate|topiramate|mesh-list
20194654|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
19331720|NCT03894280|Xhance|xhance|mesh-list
20194655|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194656|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194657|NCT00231621|Topiramate|topiramate|mesh-list
20194658|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
19331721|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19331722|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20194659|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194660|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194661|NCT00231634|Topiramate|topiramate|mesh-list
20194662|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
20194663|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20380261|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380262|NCT01021566|Methadone|methadone|mesh-list
20380263|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20380264|NCT01021566|Narcotics|narcotics|mesh-ancestor
20380265|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331723|NCT03894280|Charcoal|charcoal|mesh-list
19331724|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331725|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19331726|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
19331727|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331728|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331729|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19331730|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
19331731|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
19331732|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19331733|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19331734|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19331735|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19331736|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
19678812|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678813|NCT03034564|Droxidopa|droxidopa|mesh-list
19678814|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19331737|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331738|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331739|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
20194664|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194665|NCT00231647|Topiramate|topiramate|mesh-list
19678815|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19678816|NCT03034538|Zonisamide|zonisamide|mesh-list
19678817|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
19678818|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19678819|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19678820|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678821|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19678822|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678823|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
19678824|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678825|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194666|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
20194667|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194668|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678826|NCT02819518|Gemcitabine|gemcitabine|mesh-list
19678827|NCT02819518|Paclitaxel|paclitaxel|mesh-list
19331740|NCT03894280|Hormones|hormones|mesh-ancestor
19331741|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678828|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20380266|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380267|NCT01021566|Analgesics|analgesics|mesh-ancestor
20380268|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
20380269|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380270|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
20380271|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
20380272|NCT01021579|Metformin|metformin|mesh-list
20380273|NCT01021579|Simvastatin|simvastatin|mesh-list
20380274|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19678829|NCT02819518|Carboplatin|carboplatin|mesh-list
19678830|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
19678831|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19678832|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331742|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
19331743|NCT03894280|Antidotes|antidotes|mesh-ancestor
19331744|NCT03894280|Protective Agents|protective agents|mesh-ancestor
19331745|NCT03894046|Imipenem|imipenem|mesh-list
19331746|NCT03894046|Colistin|colistin|mesh-list
19678833|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
19331747|NCT03894046|Sulbactam|sulbactam|mesh-list
20380275|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331748|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678834|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
20194669|NCT00231660|Topiramate|topiramate|mesh-list
19331749|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331750|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19331751|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331752|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331753|NCT03894007|Maytansine|maytansine|mesh-list
19331754|NCT03894007|Docetaxel|docetaxel|mesh-list
19331755|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19331756|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
19331757|NCT03894007|Carboplatin|carboplatin|mesh-list
19331758|NCT03894007|Trastuzumab|trastuzumab|mesh-list
19331759|NCT03894007|Atezolizumab|atezolizumab|mesh-list
19331760|NCT03894007|Epirubicin|epirubicin|mesh-list
19331761|NCT03894007|Pertuzumab|pertuzumab|mesh-list
19331762|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19331763|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331764|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
19331765|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
19331766|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
19331767|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331768|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331769|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
19331770|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331771|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331772|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19331773|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
19331774|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19331775|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331776|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19331777|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19331778|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19331779|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19841999|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842000|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19331780|NCT03893695|Nivolumab|nivolumab|mesh-list
19842001|NCT00646581|Insulin|insulin|mesh-list
19678835|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
19678836|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678837|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678838|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
19678839|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
19678840|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678841|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678842|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678843|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
19678844|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678845|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19678846|NCT02549833|Poly I-C|poly i-c|mesh-list
19678847|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19678848|NCT02549833|Poly ICLC|poly iclc|mesh-list
19842002|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19842003|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19842004|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842005|NCT00646646|Midazolam|midazolam|mesh-list
19331781|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331782|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331783|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19331784|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331785|NCT03893734|Methadone|methadone|mesh-list
19678849|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
19678850|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
19678851|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678852|NCT02549833|Laxatives|laxatives|mesh-ancestor
19678853|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20194670|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
20194671|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19331786|NCT03893734|Hydromorphone|hydromorphone|mesh-list
19331787|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19678854|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
19692457|NCT04991207|Zamicastat|zamicastat|mesh-list
19842006|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
20194672|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194673|NCT00231673|Topiramate|topiramate|mesh-list
20194674|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
20194675|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194676|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194677|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
20194678|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20380276|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20380277|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20380278|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
20380279|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380280|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20380281|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20380282|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380283|NCT01021592|Bortezomib|bortezomib|mesh-list
20380284|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380285|NCT01021696|Acetaminophen|acetaminophen|mesh-list
20380286|NCT01021696|Pregabalin|pregabalin|mesh-list
20380287|NCT01021696|Morphine|morphine|mesh-list
20380288|NCT01021696|Buprenorphine|buprenorphine|mesh-list
20380289|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20380290|NCT01021696|Narcotics|narcotics|mesh-ancestor
20380291|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331788|NCT03893734|Narcotics|narcotics|mesh-ancestor
19331789|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331790|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331791|NCT03893734|Analgesics|analgesics|mesh-ancestor
19331792|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
19331793|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331794|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
19331795|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
19842007|NCT00646646|Propofol|propofol|mesh-list
19842008|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19678855|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678856|NCT02468180|Polidocanol|polidocanol|mesh-list
19678857|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19678858|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19331796|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19842009|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842010|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194679|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194680|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20194681|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20194682|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20194683|NCT00231764|Daclizumab|daclizumab|mesh-list
19331797|NCT03893591|Dalteparin|dalteparin|mesh-list
19331798|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
19331799|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19331800|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19331801|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331802|NCT03893864|Ubiquinone|ubiquinone|mesh-list
19331803|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
19331804|NCT03893864|Antioxidants|antioxidants|mesh-list
19678859|NCT02207465|Paclitaxel|paclitaxel|mesh-list
19678860|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20380292|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380293|NCT01021696|Analgesics|analgesics|mesh-ancestor
20380294|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
20380295|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380296|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
20380297|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20380298|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331805|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331806|NCT03893864|Protective Agents|protective agents|mesh-ancestor
19678861|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19678862|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678863|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678864|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
19842011|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19842012|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
19842013|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
20194684|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194685|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
20194686|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194687|NCT00231829|Celecoxib|celecoxib|mesh-list
20194688|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20194689|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842014|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842015|NCT00646646|Analgesics|analgesics|mesh-ancestor
19842016|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
19842017|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842018|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20380299|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842019|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19842020|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19842021|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
19842022|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842023|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842024|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19842025|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19331807|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331808|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
19331809|NCT03893864|Vitamins|vitamins|mesh-ancestor
19331810|NCT03893630|Aspirin|aspirin|mesh-list
19331811|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19331812|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331813|NCT03893630|Analgesics|analgesics|mesh-ancestor
19331814|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
19331815|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331816|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380300|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20380301|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20380302|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20380303|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380304|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20380305|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
20380306|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20380307|NCT01021735|Adalimumab|adalimumab|mesh-list
20380308|NCT01021735|Etanercept|etanercept|mesh-list
20380309|NCT01021735|Rituximab|rituximab|mesh-list
20380310|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380311|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380312|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
20380313|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380314|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380315|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380316|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20380317|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20380318|NCT01021735|Analgesics|analgesics|mesh-ancestor
20380319|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
20380320|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380321|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380322|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380323|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
20380324|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
20380325|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20380326|NCT01021787|Protective Agents|protective agents|mesh-ancestor
20380327|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380328|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
20380329|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20380330|NCT01021865|Glucagon|glucagon|mesh-list
20380331|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20380332|NCT01021865|Regadenoson|regadenoson|mesh-list
20380333|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380334|NCT01021865|Hormones|hormones|mesh-ancestor
20380335|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20380336|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380337|NCT01021865|Incretins|incretins|mesh-ancestor
20380338|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20380339|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20380340|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
19331817|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331818|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331819|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19331820|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19331821|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331822|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19331823|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19842026|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20380341|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
20380342|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380343|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380344|NCT01021891|Insulin|insulin|mesh-list
20380345|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20380346|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380347|NCT01021930|Sirolimus|sirolimus|mesh-list
19331824|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331825|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
19331826|NCT03893747|Vaccines|vaccines|mesh-list
20380348|NCT01021930|Paclitaxel|paclitaxel|mesh-list
20380349|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20380350|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331827|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
19331828|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678865|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
20194690|NCT00231829|Analgesics|analgesics|mesh-ancestor
20194691|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
20194692|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194693|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194694|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194695|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194696|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20194697|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19678866|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678867|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
19678868|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
19678869|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
19678870|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678871|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678872|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678873|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19678874|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
20380351|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
20380352|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
20380353|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
20380354|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380355|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380356|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380357|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20380358|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
20380359|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380360|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
20380361|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380362|NCT01021943|Spironolactone|spironolactone|mesh-list
19678875|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
19678876|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678877|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380363|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20380364|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
20380365|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20380366|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380367|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20380368|NCT01021943|Diuretics|diuretics|mesh-ancestor
20380369|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
20380370|NCT01022021|Rituximab|rituximab|mesh-list
20380371|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20380372|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380373|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380374|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
20380375|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380376|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380377|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20380378|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
20380379|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380380|NCT01022047|Budesonide|budesonide|mesh-list
19678878|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
19678879|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19678880|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19842027|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194698|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380381|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380382|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20380383|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
20380384|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380385|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380386|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20380387|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
20380388|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
20380389|NCT01022047|Hormones|hormones|mesh-ancestor
20380390|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331829|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19331830|NCT03893526|Valsartan|valsartan|mesh-list
19678881|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678882|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19678883|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19678884|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
19678885|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678886|NCT01308190|Capecitabine|capecitabine|mesh-list
19678887|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678888|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
19678889|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678890|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678891|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
19678892|NCT01210768|Doxorubicin|doxorubicin|mesh-list
19678893|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19678894|NCT01210768|Epirubicin|epirubicin|mesh-list
19678895|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678896|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
19678897|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678898|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678899|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19678900|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
19678901|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678902|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678903|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19678904|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19678905|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19678906|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19678907|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678908|NCT00719225|Abatacept|abatacept|mesh-list
19678909|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20194699|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194700|NCT00231855|Docetaxel|docetaxel|mesh-list
19678910|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331831|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19331832|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19678911|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678912|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19678913|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
19678914|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678915|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19678916|NCT00516373|Olaparib|olaparib|mesh-list
19678917|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19678918|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678919|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678920|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678921|NCT00094016|Beclomethasone|beclomethasone|mesh-list
19678922|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19678923|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
19678924|NCT00094016|Hormones|hormones|mesh-ancestor
19678925|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678926|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678927|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19678928|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
19678929|NCT05134350|Omeprazole|omeprazole|mesh-list
19678930|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19678931|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19678932|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19678933|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678934|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678935|NCT05134337|Itraconazole|itraconazole|mesh-list
19678936|NCT05134337|Rifampin|rifampin|mesh-list
19678937|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
20194701|NCT00231855|Topotecan|topotecan|mesh-list
20194702|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194703|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
20194704|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
20194705|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
20194706|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194707|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20194708|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20194709|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194710|NCT00231959|Pramipexole|pramipexole|mesh-list
20194711|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
20194712|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842028|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
20380391|NCT01022125|Simeprevir|simeprevir|mesh-list
20380392|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
20380393|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380394|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
20380395|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380396|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380397|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
20380398|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380399|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
20380400|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380401|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194713|NCT00231959|Protective Agents|protective agents|mesh-ancestor
20194714|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194715|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20194716|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20194717|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
20194718|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
20194719|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19678938|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678939|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19678940|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19678941|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678942|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678943|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19678944|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
19678945|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19678946|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678947|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19678948|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19678949|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
19678950|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678951|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
20194720|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
20194721|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20194722|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20194723|NCT00231998|Analgesics|analgesics|mesh-ancestor
19331833|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331834|NCT03893526|Incretins|incretins|mesh-ancestor
19331835|NCT03893526|Hormones|hormones|mesh-ancestor
19331836|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331837|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19331838|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
19331839|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331840|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331841|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20194724|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
20194725|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194726|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194727|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194728|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194729|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
20194730|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194731|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
20194732|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20380402|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20380403|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
20380404|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380405|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380406|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19331842|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19331843|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19331844|NCT03893435|Valsartan|valsartan|mesh-list
19331845|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19331846|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19399281|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
19842029|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
20380407|NCT01022151|Aminophylline|aminophylline|mesh-list
20380408|NCT01022151|Doxapram|doxapram|mesh-list
20380409|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20380410|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
20380411|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380412|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194733|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194734|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331847|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19331848|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19331849|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399282|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678952|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19678953|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19678954|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19678955|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19399283|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399284|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
19399285|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19399286|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399287|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399288|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19399289|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19399290|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19399291|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380413|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20380414|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
20380415|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20380416|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20380417|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380418|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380419|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20380420|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20380421|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
20380422|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380423|NCT01022151|Protective Agents|protective agents|mesh-ancestor
20380424|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20380425|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20380426|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
20380427|NCT01022164|Coagulants|coagulants|mesh-ancestor
20380428|NCT01022229|Vitamins|vitamins|mesh-list
20380429|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
20380430|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
20380431|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380432|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
20380433|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20380434|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20380435|NCT01022333|Protective Agents|protective agents|mesh-ancestor
20380436|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380437|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399292|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678956|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19678957|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19678958|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19678959|NCT05134298|Meropenem|meropenem|mesh-list
19678960|NCT05134298|Tazobactam|tazobactam|mesh-list
19678961|NCT05134298|Piperacillin|piperacillin|mesh-list
19678962|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19678963|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19678964|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194735|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
20194736|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20380438|NCT01022463|Atenolol|atenolol|mesh-list
19399293|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
19399294|NCT03635827|Xenon|xenon|mesh-list
19399295|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19399296|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
19399297|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
20380439|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20380440|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20380441|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
19399298|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194737|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20194738|NCT00232011|Analgesics|analgesics|mesh-ancestor
20194739|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
20194740|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194741|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194742|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380442|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
20380443|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331850|NCT03893097|Artesunate|artesunate|mesh-list
19331851|NCT03893097|Mefloquine|mefloquine|mesh-list
19331852|NCT03893097|Praziquantel|praziquantel|mesh-list
20380444|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380445|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20380446|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20380447|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20380448|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
20380449|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380450|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380451|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
20380452|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20380453|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20380454|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
20380455|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380456|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20380457|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20380458|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331853|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
19331854|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19331855|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19331856|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331857|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678965|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19678966|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19678967|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678968|NCT05134220|Calcium|calcium|mesh-list
19678969|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19678970|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678971|NCT05134194|Gemcitabine|gemcitabine|mesh-list
19331858|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
19331859|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
19331860|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19331861|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
19331862|NCT03893032|Modafinil|modafinil|mesh-list
19331863|NCT03893032|Amphetamine|amphetamine|mesh-list
19678972|NCT05134194|Capecitabine|capecitabine|mesh-list
19678973|NCT05134194|Vinorelbine|vinorelbine|mesh-list
19678974|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19678975|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
19678976|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19678977|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678978|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
19678979|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19678980|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380459|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380460|NCT01022528|Dexamethasone|dexamethasone|mesh-list
19331864|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19331865|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331866|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19331867|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19678981|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380461|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
20380462|NCT01022528|BB 1101|bb 1101|mesh-list
20380463|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380464|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
20380465|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
20380466|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380467|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380468|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380469|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
20380470|NCT01022528|Hormones|hormones|mesh-ancestor
20380471|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20380472|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20380473|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380474|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
20380475|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380476|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380477|NCT01022541|Bevacizumab|bevacizumab|mesh-list
20380478|NCT01022541|Capecitabine|capecitabine|mesh-list
20380479|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
19331868|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19331869|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380480|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380481|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380482|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20380483|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20380484|NCT01022541|Growth Substances|growth substances|mesh-ancestor
20380485|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380486|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
20380487|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20380488|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
20380489|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380490|NCT01022632|Curcumin|curcumin|mesh-list
20380491|NCT01022632|Fluoxetine|fluoxetine|mesh-list
19678982|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
19678983|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678984|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19678985|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
19678986|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
19331870|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
19331871|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
19331872|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331873|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
19331874|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380492|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20380493|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20380494|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20380495|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380496|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380497|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
20380498|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380499|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20380500|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
20380501|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380502|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20380503|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20380504|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380505|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20380506|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20380507|NCT01022632|Analgesics|analgesics|mesh-ancestor
20380508|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
20380509|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331875|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
19331876|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19331877|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19331878|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19331879|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19331880|NCT03893136|Leflunomide|leflunomide|mesh-list
19331881|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331882|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331883|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19331884|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
19331885|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380510|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380511|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380512|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380513|NCT01022645|Copper|copper|mesh-list
20380514|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
20380515|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20380516|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
20380517|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19331886|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19331887|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19331888|NCT03893045|Hematinics|hematinics|mesh-ancestor
19331889|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19331890|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19331891|NCT03893240|Antibodies|antibodies|mesh-list
19331892|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
19678987|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
20380518|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380519|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20380520|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20380521|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20380522|NCT01022645|Trace Elements|trace elements|mesh-ancestor
20380523|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
20380524|NCT01022658|Insulin|insulin|mesh-list
19331893|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
19678988|NCT05133791|Annexin A5|annexin a5|mesh-list
20380525|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
20380526|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
20380527|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20380528|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380529|NCT01022671|Belotecan|belotecan|mesh-list
20380530|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20380531|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20380532|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380533|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380534|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380535|NCT01022736|Gabapentin|gabapentin|mesh-list
20380536|NCT01022736|Analgesics|analgesics|mesh-ancestor
19331894|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331895|NCT03892902|Zopiclone|zopiclone|mesh-list
19331896|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19331897|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331898|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331899|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
19331900|NCT03892668|Oxytocin|oxytocin|mesh-list
19331901|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
19331902|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19331903|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331904|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19331905|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20380537|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
20380538|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380539|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380540|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
20380541|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20380542|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20380543|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380544|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380545|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20380546|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20380547|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380548|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380549|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
20380550|NCT01022749|Vaccines|vaccines|mesh-list
20380551|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
20380552|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380553|NCT01022840|Ketamine|ketamine|mesh-list
20380554|NCT01022840|Esketamine|esketamine|mesh-list
19331906|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331907|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
19331908|NCT03892668|Coagulants|coagulants|mesh-ancestor
19331909|NCT03892525|Atezolizumab|atezolizumab|mesh-list
19331910|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19678989|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380555|NCT01022840|Analgesics|analgesics|mesh-ancestor
20380556|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
20380557|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331911|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
19331912|NCT03892928|Propofol|propofol|mesh-list
19678990|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692458|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19692459|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19692460|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692461|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692462|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
19692463|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
19692464|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19692465|NCT04991064|Protective Agents|protective agents|mesh-ancestor
19692466|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194743|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194744|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
20194745|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194746|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
20194747|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20194748|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194749|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194750|NCT00232024|Tegaserod|tegaserod|mesh-list
20194751|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20194752|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
20194753|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194754|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194755|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194756|NCT00232037|Tegaserod|tegaserod|mesh-list
20194757|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19842030|NCT00646763|Lenograstim|lenograstim|mesh-list
19842031|NCT00646763|Sargramostim|sargramostim|mesh-list
19842032|NCT00646763|Mitogens|mitogens|mesh-list
19842033|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19842034|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
20194758|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
19331913|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19331914|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331915|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331916|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19678991|NCT05133687|Bupivacaine|bupivacaine|mesh-list
19678992|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
19678993|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
19678994|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19678995|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19678996|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
19678997|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19678998|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
19678999|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19679000|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19679001|NCT05133635|Prednisolone|prednisolone|mesh-list
19679002|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
19679003|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19679004|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
19679005|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679006|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
19679007|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
19679008|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679009|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679010|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679011|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
19679012|NCT05133635|Hormones|hormones|mesh-ancestor
19679013|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679014|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19679015|NCT05133635|Protective Agents|protective agents|mesh-ancestor
19679016|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19679017|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679018|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
19679019|NCT05133258|Dexamethasone|dexamethasone|mesh-list
19679020|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679021|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
19679022|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
19679023|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679024|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679025|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19842035|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842036|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
20194759|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194760|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194761|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194762|NCT00232050|Omalizumab|omalizumab|mesh-list
20194763|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19331917|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
19331918|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
19331919|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331920|NCT03892928|Analgesics|analgesics|mesh-ancestor
19331921|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
19331922|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194764|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20194765|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
20194766|NCT00232063|Cyclosporine|cyclosporine|mesh-list
20194767|NCT00232063|Cyclosporins|cyclosporins|mesh-list
20194768|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194769|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194770|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194771|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
20194772|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194773|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
19842037|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194774|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842038|NCT00646776|Ritonavir|ritonavir|mesh-list
20194775|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
19679026|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
20380558|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380559|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20380560|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20380561|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
19679027|NCT05133258|Hormones|hormones|mesh-ancestor
19679028|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679029|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19679030|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679031|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19679032|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380562|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
20380563|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380564|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20380565|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20380566|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380567|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380568|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
20380569|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380570|NCT01022918|Bevacizumab|bevacizumab|mesh-list
20380571|NCT01022918|Temozolomide|temozolomide|mesh-list
20380572|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380573|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380574|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20380575|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20380576|NCT01022918|Growth Substances|growth substances|mesh-ancestor
20380577|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380578|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
20380579|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20380580|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
20426185|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331923|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19331924|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19331925|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19331926|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679033|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19679034|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19679035|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679036|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679037|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19679038|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19679039|NCT05133050|Ramipril|ramipril|mesh-list
19679040|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19679041|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
19679042|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679043|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679044|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679045|NCT05132777|Osimertinib|osimertinib|mesh-list
19679046|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679047|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679048|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194776|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194777|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20194778|NCT00232076|Cyclosporine|cyclosporine|mesh-list
19331927|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331928|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331929|NCT03892499|Itraconazole|itraconazole|mesh-list
19331930|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
19331931|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19331932|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20194779|NCT00232076|Cyclosporins|cyclosporins|mesh-list
20194780|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194781|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194782|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194783|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
20194784|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194785|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
20194786|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194787|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
20194788|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331933|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19331934|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194789|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20380581|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380582|NCT01022983|Simendan|simendan|mesh-list
20380583|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20380584|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
20380585|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20380586|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20380587|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380588|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380589|NCT01022983|Protective Agents|protective agents|mesh-ancestor
20380590|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380591|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20380592|NCT01023087|Colistin|colistin|mesh-list
20380593|NCT01023087|Polymyxins|polymyxins|mesh-list
20380594|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19331935|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331936|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19331937|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
20194790|NCT00232089|Tegaserod|tegaserod|mesh-list
20194791|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20194792|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
20194793|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194794|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194795|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217527|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217528|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
19331938|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19331939|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331940|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19331941|NCT03892447|Ferulic acid|ferulic acid|mesh-list
19331942|NCT03892447|Dopamine|dopamine|mesh-list
19331943|NCT03892447|Alprostadil|alprostadil|mesh-list
19331944|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19331945|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
19331946|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
19331947|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679049|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679050|NCT05132712|Losartan|losartan|mesh-list
19679051|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19679052|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679053|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19679054|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19679055|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679056|NCT05132413|Bevacizumab|bevacizumab|mesh-list
19679057|NCT05132413|Cisplatin|cisplatin|mesh-list
19331948|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331949|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
19331950|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19331951|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679058|NCT05132413|Carboplatin|carboplatin|mesh-list
19679059|NCT05132413|Pemetrexed|pemetrexed|mesh-list
19331952|NCT03892447|Protective Agents|protective agents|mesh-ancestor
19331953|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20380595|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380596|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
20380597|NCT01023100|Tofacitinib|tofacitinib|mesh-list
20380598|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20380599|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380600|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380601|NCT01023139|Sibutramine|sibutramine|mesh-list
20380602|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
20380603|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380604|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
20380605|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19679060|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679061|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679062|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19679063|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19679064|NCT05132413|Growth Substances|growth substances|mesh-ancestor
19679065|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679066|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
19679067|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842039|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19842040|NCT00646776|Rifabutin|rifabutin|mesh-list
20380606|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
19331954|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
19331955|NCT03892447|Urological Agents|urological agents|mesh-ancestor
19331956|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20194796|NCT00232102|Tegaserod|tegaserod|mesh-list
20194797|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20194798|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
20194799|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194800|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194801|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194802|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
20194803|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20194804|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19679068|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679069|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19679070|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20194805|NCT00232115|Analgesics|analgesics|mesh-ancestor
19331957|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331958|NCT03892447|Analgesics|analgesics|mesh-ancestor
19331959|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
19331960|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331961|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331962|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
19331963|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19331964|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19331965|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19331966|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19331967|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
19331968|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
19331969|NCT03892512|Esmolol|esmolol|mesh-list
19331970|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19331971|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19331972|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331973|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331974|NCT03892512|Analgesics|analgesics|mesh-ancestor
19331975|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
19331976|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19331977|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20380607|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
20380608|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20380609|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380610|NCT01023230|Entecavir|entecavir|mesh-list
20380611|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
20380612|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380613|NCT01023243|Aspirin|aspirin|mesh-list
20380614|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19331978|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19331979|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19331980|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
19331981|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679071|NCT05132270|Thalidomide|thalidomide|mesh-list
20194806|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
20194807|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380615|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19331982|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19331983|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19331984|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20380616|NCT01023243|Analgesics|analgesics|mesh-ancestor
20380617|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
20380618|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380619|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380620|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194808|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194809|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194810|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20194811|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
20194812|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20194813|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
20194814|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20380621|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19331985|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19331986|NCT03892434|Dexamethasone|dexamethasone|mesh-list
19331987|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
19331988|NCT03892434|Bevacizumab|bevacizumab|mesh-list
19331989|NCT03892434|BB 1101|bb 1101|mesh-list
20194815|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380622|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20380623|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20380624|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380625|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20380626|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20380627|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19331990|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19331991|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19331992|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19331993|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19331994|NCT03892434|Growth Substances|growth substances|mesh-ancestor
19331995|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19331996|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
19331997|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19331998|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
19331999|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
19679072|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
19679073|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842041|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19842042|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19842043|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
19679074|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
19679075|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679076|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
19679077|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19679078|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679079|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19679080|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19679081|NCT05132270|Growth Substances|growth substances|mesh-ancestor
19679082|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
19679083|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842044|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194816|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679084|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
19679085|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679086|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679087|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19679088|NCT05132101|Palbociclib|palbociclib|mesh-list
19679089|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679090|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679091|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679092|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679093|NCT05129176|Metronidazole|metronidazole|mesh-list
19679094|NCT05129176|Levofloxacin|levofloxacin|mesh-list
19679095|NCT05129176|Ofloxacin|ofloxacin|mesh-list
19679096|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679097|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19842045|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380628|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
20194817|NCT00232154|Azithromycin|azithromycin|mesh-list
20194818|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20194819|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194820|NCT00232167|Indiplon|indiplon|mesh-list
20194821|NCT00232167|Sertraline|sertraline|mesh-list
20194822|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
20380629|NCT01023334|Lidocaine|lidocaine|mesh-list
20380630|NCT01023334|Anesthetics|anesthetics|mesh-list
20380631|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
20380632|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380633|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380634|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
20380635|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842046|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19842047|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19842048|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
19842049|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842050|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19842051|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19842052|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19842053|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19842054|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
19842055|NCT00646906|Aspirin|aspirin|mesh-list
19842056|NCT00646906|Acetaminophen|acetaminophen|mesh-list
20194823|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19332000|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842057|NCT00646906|Ibuprofen|ibuprofen|mesh-list
20380636|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20380637|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20380638|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20380639|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20380640|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679098|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19679099|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19679100|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19679101|NCT05129176|Renal Agents|renal agents|mesh-ancestor
19332001|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19332002|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
19332003|NCT03892434|Hormones|hormones|mesh-ancestor
19332004|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19332005|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19332006|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
19332007|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332008|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332009|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
19332010|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
19332011|NCT03892330|Doxorubicin|doxorubicin|mesh-list
19332012|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19332013|NCT03892330|Vincristine|vincristine|mesh-list
19332014|NCT03892330|Pirarubicin|pirarubicin|mesh-list
19332015|NCT03892330|Epirubicin|epirubicin|mesh-list
19332016|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332017|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
19332018|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332019|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332020|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19332021|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
19332022|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332023|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332024|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19332025|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19679102|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19679103|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19679104|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332026|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19332027|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19332028|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332029|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19332030|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
19332031|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
20194824|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20194825|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20194826|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194827|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194828|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679105|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679106|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679107|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19679108|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19679109|NCT05122546|Nivolumab|nivolumab|mesh-list
19679110|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679111|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679112|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19842058|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20194829|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
20194830|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332032|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
19332033|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332034|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332035|NCT03892421|Cytarabine|cytarabine|mesh-list
19332036|NCT03892421|Dexamethasone|dexamethasone|mesh-list
19332037|NCT03892421|Rituximab|rituximab|mesh-list
19332038|NCT03892421|Carboplatin|carboplatin|mesh-list
19332039|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19332040|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332041|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
20194831|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19332042|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332043|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332044|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380641|NCT01023347|Paclitaxel|paclitaxel|mesh-list
20380642|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20380643|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20380644|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380645|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
19332045|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
19332046|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
19332047|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332048|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679113|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194832|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194833|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
20194834|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
19679114|NCT05121038|Leucovorin|leucovorin|mesh-list
19679115|NCT05121038|Fluorouracil|fluorouracil|mesh-list
19679116|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
19679117|NCT05121038|Irinotecan|irinotecan|mesh-list
19679118|NCT05121038|Panitumumab|panitumumab|mesh-list
19679119|NCT05121038|Folfirinox|folfirinox|mesh-list
19679120|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
19679121|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679122|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19679123|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679124|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19679125|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
19679126|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679127|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19679128|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19679129|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679130|NCT05121038|Antidotes|antidotes|mesh-ancestor
19679131|NCT05121038|Protective Agents|protective agents|mesh-ancestor
19679132|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
19679133|NCT05121038|Vitamins|vitamins|mesh-ancestor
19679134|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
20380646|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
20380647|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
20380648|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380649|NCT01023360|Esomeprazole|esomeprazole|mesh-list
20380650|NCT01023360|Rabeprazole|rabeprazole|mesh-list
20380651|NCT01023360|Pantoprazole|pantoprazole|mesh-list
20380652|NCT01023360|Clopidogrel|clopidogrel|mesh-list
20380653|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20380654|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20380655|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20380656|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19679135|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679136|NCT05062837|Apatinib|apatinib|mesh-list
19679137|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679138|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679139|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679140|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679141|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
20380657|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20380658|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
20380659|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380660|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380661|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380662|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20380663|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380664|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380665|NCT01023399|Artesunate|artesunate|mesh-list
20380666|NCT01023399|Amodiaquine|amodiaquine|mesh-list
20194835|NCT00232206|Docetaxel|docetaxel|mesh-list
20194836|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194837|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
20194838|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
20194839|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
20194840|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380667|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
19679142|NCT05033756|Olaparib|olaparib|mesh-list
19679143|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679144|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679145|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20380668|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20194841|NCT00232271|Enoxaparin|enoxaparin|mesh-list
20194842|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
19332049|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
19332050|NCT03892421|Hormones|hormones|mesh-ancestor
19679146|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679147|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679148|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
19679149|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
19679150|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
20194843|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20194844|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20194845|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194846|NCT00232284|Sertraline|sertraline|mesh-list
20194847|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194848|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194849|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20194850|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20194851|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194852|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332051|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19332052|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19332053|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19332054|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
19332055|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332056|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
19332057|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380669|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20380670|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380671|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332058|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332059|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
19332060|NCT03892122|Propofol|propofol|mesh-list
19332061|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19332062|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332063|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332064|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19332065|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
19332066|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
19332067|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332068|NCT03892122|Analgesics|analgesics|mesh-ancestor
19332069|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
19332070|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332071|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19332072|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19332073|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19332074|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
19332075|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332076|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332077|NCT03892395|Vitamin D|vitamin d|mesh-list
19332078|NCT03892395|Ergocalciferols|ergocalciferols|mesh-list
19332079|NCT03892395|Vitamins|vitamins|mesh-list
19332080|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
19332081|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
19332082|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332083|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19332084|NCT03892395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19679151|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19332085|NCT03892213|Benzonidazole|benzonidazole|mesh-list
19332086|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332087|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
19332088|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332089|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19332090|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20194853|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194854|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
20194855|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194856|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20194857|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194858|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194859|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20194860|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194861|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194862|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194863|NCT00232349|Galantamine|galantamine|mesh-list
20380672|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
20380673|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
20380674|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19332091|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20380675|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
20194864|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20194865|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194866|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194867|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
19679152|NCT05031442|Protective Agents|protective agents|mesh-ancestor
19679153|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679154|NCT05030857|Midazolam|midazolam|mesh-list
19679155|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20194868|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194869|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194870|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20194871|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
20194872|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194873|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
20194874|NCT00232362|Pioglitazone|pioglitazone|mesh-list
20194875|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
20194876|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20194877|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194878|NCT00232375|Insulin|insulin|mesh-list
20194879|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20194880|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194881|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20194882|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194883|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194884|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20194885|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194886|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194887|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194888|NCT00232492|Ketamine|ketamine|mesh-list
20194889|NCT00232492|Analgesics|analgesics|mesh-ancestor
20194890|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
19679156|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19679157|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679158|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380676|NCT01023425|Donepezil|donepezil|mesh-list
20380677|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20380678|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380679|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380680|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
20380681|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380682|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380683|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
20380684|NCT01023464|Emollients|emollients|mesh-list
20380685|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20380686|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20380687|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
20380688|NCT01023490|Vitamin D|vitamin d|mesh-list
20380689|NCT01023490|Vitamins|vitamins|mesh-ancestor
20380690|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
20380691|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380692|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20380693|NCT01023542|Everolimus|everolimus|mesh-list
20380694|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380695|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380696|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
20380697|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380698|NCT01023607|Atorvastatin|atorvastatin|mesh-list
20380699|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20380700|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20380701|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20380702|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
20380703|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380704|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20380705|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20380706|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380707|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
20380708|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380709|NCT01023750|Fenofibrate|fenofibrate|mesh-list
20380710|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20380711|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
20380712|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380713|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19679159|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19679160|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20380714|NCT01023867|Donepezil|donepezil|mesh-list
20194891|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194892|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194893|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20194894|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20194895|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
20380715|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20380716|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380717|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380718|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
20380719|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380720|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332092|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679161|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19679162|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19679163|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
19679164|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
19679165|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
19679166|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
19679167|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332093|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20380721|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
20380722|NCT01023919|Sirolimus|sirolimus|mesh-list
20380723|NCT01023919|Paclitaxel|paclitaxel|mesh-list
20380724|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19332094|NCT03892148|Furosemide|furosemide|mesh-list
19332095|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19332096|NCT03892148|Diuretics|diuretics|mesh-ancestor
19332097|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
19332098|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679168|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679169|NCT05027360|Nitroprusside|nitroprusside|mesh-list
19679170|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679171|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
19679172|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19679173|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679174|NCT05027100|Irinotecan|irinotecan|mesh-list
19679175|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19679176|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19679177|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679178|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679179|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679180|NCT05026606|Nivolumab|nivolumab|mesh-list
19679181|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679182|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679183|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19679184|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679185|NCT05025800|Rituximab|rituximab|mesh-list
19679186|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19679187|NCT05025800|Lenalidomide|lenalidomide|mesh-list
19679188|NCT05025800|Antibodies|antibodies|mesh-list
19679189|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
19679190|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19679191|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
19679192|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679193|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679194|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19679195|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19679196|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19679197|NCT05025800|Growth Substances|growth substances|mesh-ancestor
19679198|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19679199|NCT05010772|Decitabine|decitabine|mesh-list
19679200|NCT05010772|Venetoclax|venetoclax|mesh-list
19679201|NCT05010772|Ivosidenib|ivosidenib|mesh-list
19679202|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19679203|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
19679204|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679205|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194896|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
20194897|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194898|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20194899|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20194900|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194901|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194902|NCT00232531|Niacin|niacin|mesh-list
20380725|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332099|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19679206|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679207|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
19679208|NCT04924374|Atezolizumab|atezolizumab|mesh-list
19679209|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19679210|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679211|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679212|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
19679213|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679214|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
19679215|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19679216|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679217|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679218|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20194903|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
20194904|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20194905|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
19332100|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19332101|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332102|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19332103|NCT03892044|Nivolumab|nivolumab|mesh-list
19332104|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19332105|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332106|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19332107|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332108|NCT03891979|Metronidazole|metronidazole|mesh-list
19679219|NCT04912518|Analgesics|analgesics|mesh-ancestor
20194906|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194907|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20194908|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
20194909|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
20194910|NCT00232531|Vitamins|vitamins|mesh-ancestor
20194911|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
20194912|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194913|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20194914|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194915|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194916|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20380726|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
20380727|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
20380728|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
20380729|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194917|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194918|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194919|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380730|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380731|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380732|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20380733|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
19332109|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
19332110|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
19332111|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19332112|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332113|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332114|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332115|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19332116|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19332117|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19332118|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19679220|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
20612841|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612842|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679221|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194920|NCT00232622|Streptokinase|streptokinase|mesh-list
20194921|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20194922|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20194923|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194924|NCT00232648|Budesonide|budesonide|mesh-list
20194925|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194926|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20194927|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
20194928|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194929|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194930|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20194931|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612843|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20612844|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612845|NCT02253004|Cilostazol|cilostazol|mesh-list
20612846|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20612847|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
20612848|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612849|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612850|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20612851|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
20612852|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20612853|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19332119|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332120|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332121|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19332122|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19332123|NCT03892070|Mannitol|mannitol|mesh-list
19332124|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19332125|NCT03892070|Diuretics|diuretics|mesh-ancestor
19332126|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
19332127|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380734|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380735|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
20380736|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380737|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
20380738|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20380739|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380740|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19332128|NCT03892161|Ritonavir|ritonavir|mesh-list
19679222|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19679223|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19679224|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19679225|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679226|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679227|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332129|NCT03892161|Darunavir|darunavir|mesh-list
19332130|NCT03892161|Rifampin|rifampin|mesh-list
19332131|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19332132|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19679228|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
19679229|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679230|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
19679231|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19679232|NCT04818320|Favipiravir|favipiravir|mesh-list
19679233|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
19679234|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194932|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
20194933|NCT00232648|Hormones|hormones|mesh-ancestor
20194934|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679235|NCT04793906|Iron|iron|mesh-list
19842059|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842060|NCT00646906|Analgesics|analgesics|mesh-ancestor
19842061|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
19842062|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842063|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842064|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842065|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842066|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19842067|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19842068|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842069|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19842070|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19842071|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842072|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
19842073|NCT00646958|Linezolid|linezolid|mesh-list
20194935|NCT00232661|Tamoxifen|tamoxifen|mesh-list
20194936|NCT00232661|Anastrozole|anastrozole|mesh-list
20194937|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20194938|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
20194939|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194940|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380741|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426186|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20613215|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19842074|NCT00646958|Radezolid|radezolid|mesh-list
19679236|NCT04793906|Trace Elements|trace elements|mesh-ancestor
20194941|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19679237|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
19679238|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679239|NCT04741204|Metformin|metformin|mesh-list
19679240|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19679241|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679242|NCT04738318|Dexamethasone|dexamethasone|mesh-list
19679243|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
19679244|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
19679245|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679246|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
19679247|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
19679248|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679249|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679250|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679251|NCT04738318|Hormones|hormones|mesh-ancestor
19679252|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679253|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19679254|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679255|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19679256|NCT04738318|Protective Agents|protective agents|mesh-ancestor
19679257|NCT04656964|Midazolam|midazolam|mesh-list
19679258|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19679259|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19679260|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679261|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194942|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194943|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20194944|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20194945|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20194946|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20194947|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20194948|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20194949|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194950|NCT00232674|Budesonide|budesonide|mesh-list
20194951|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20194952|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20194953|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
20194954|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20194955|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194956|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20194957|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
20194958|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
20194959|NCT00232674|Hormones|hormones|mesh-ancestor
20194960|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20194961|NCT00232687|Aripiprazole|aripiprazole|mesh-list
20194962|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194963|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194964|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20194965|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20194966|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20194967|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194968|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
20194969|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
20194970|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20194971|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194972|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20194973|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20194974|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
20194975|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20194976|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20194977|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20194978|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20194979|NCT00232700|Citalopram|citalopram|mesh-list
20194980|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20194981|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20194982|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20194983|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194984|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380742|NCT01024075|Dexamethasone|dexamethasone|mesh-list
19679262|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19679263|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19679264|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194985|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
20194986|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194987|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20194988|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
20194989|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20194990|NCT00232765|Sirolimus|sirolimus|mesh-list
20194991|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380743|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380744|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
20380745|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
20380746|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380747|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380748|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380749|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
20380750|NCT01024075|Hormones|hormones|mesh-ancestor
20380751|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20380752|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20380753|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380754|NCT01024140|Citalopram|citalopram|mesh-list
20380755|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20380756|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20380757|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20380758|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20194992|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20194993|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20194994|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20194995|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
20194996|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19679265|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19679266|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
19679267|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
19679268|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
19679269|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
19679270|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380759|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380760|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
20380761|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380762|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20380763|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
20380764|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380765|NCT01024179|Sirolimus|sirolimus|mesh-list
19679271|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679272|NCT04605796|Bevacizumab|bevacizumab|mesh-list
19679273|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679274|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679275|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19679276|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19679277|NCT04605796|Growth Substances|growth substances|mesh-ancestor
19679278|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679279|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
20380766|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380767|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380768|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20194997|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
20380769|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380770|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
20380771|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380772|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
20380773|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380774|NCT01024192|Zolpidem|zolpidem|mesh-list
20380775|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20380776|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20380777|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380778|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380779|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20194998|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20194999|NCT00232817|Nicotine|nicotine|mesh-list
20380780|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
19332133|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
19332134|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679280|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
20195000|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19679281|NCT04599868|Analgesics|analgesics|mesh-ancestor
20380781|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
20195001|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
19679282|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
19679283|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380782|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380783|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380784|NCT01024205|Sunitinib|sunitinib|mesh-list
20380785|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380786|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20380787|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20380788|NCT01024205|Growth Substances|growth substances|mesh-ancestor
20380789|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195002|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195003|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195004|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20195005|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20195006|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
20195007|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195008|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195009|NCT00232856|Sirolimus|sirolimus|mesh-list
20195010|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195011|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195012|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195013|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380790|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
19332135|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679284|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332136|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19332137|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19332138|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
19332139|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332140|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19332141|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19332142|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19332143|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
19332144|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332145|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
20380791|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20380792|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380793|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380794|NCT01024270|Misoprostol|misoprostol|mesh-list
20380795|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20380796|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
20380797|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20380798|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380799|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20380800|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380801|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
19332146|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19332147|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19679285|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
19679286|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679287|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19679288|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
19679289|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19679290|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19679291|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679292|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19679293|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
20380802|NCT01024322|Diclofenac|diclofenac|mesh-list
20380803|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
19332148|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19332149|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19332150|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20380804|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20380805|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
20380806|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20380807|NCT01024322|Prednisolone|prednisolone|mesh-list
20380808|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20380809|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
20380810|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20380811|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332151|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20380812|NCT01024322|Analgesics|analgesics|mesh-ancestor
19332152|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19332153|NCT03891667|Disulfiram|disulfiram|mesh-list
19332154|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19332155|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19332156|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332157|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332158|NCT03891615|Niraparib|niraparib|mesh-list
19332159|NCT03891615|Osimertinib|osimertinib|mesh-list
19332160|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19332161|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332162|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332163|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332164|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19332165|NCT03891472|Fluorouracil|fluorouracil|mesh-list
19332166|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
19332167|NCT03891472|Irinotecan|irinotecan|mesh-list
19332168|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
19332169|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380813|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
20380814|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380815|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380816|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380817|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380818|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19332170|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19332171|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332172|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332173|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
19332174|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332175|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19332176|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19332177|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332178|NCT03891524|Enoxaparin|enoxaparin|mesh-list
19332179|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
19332180|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19332181|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19679294|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19679295|NCT04513951|Leucovorin|leucovorin|mesh-list
19679296|NCT04513951|Fluorouracil|fluorouracil|mesh-list
19679297|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
19679298|NCT04513951|Irinotecan|irinotecan|mesh-list
19332182|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332183|NCT03891420|Galidesivir|galidesivir|mesh-list
19332184|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
19332185|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332186|NCT03891433|Meropenem|meropenem|mesh-list
19332187|NCT03891433|Tazobactam|tazobactam|mesh-list
19332188|NCT03891433|Piperacillin|piperacillin|mesh-list
19332189|NCT03891433|Ertapenem|ertapenem|mesh-list
19332190|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20380819|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380820|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380821|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
20380822|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
20380823|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20380824|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
20380825|NCT01024322|Hormones|hormones|mesh-ancestor
20380826|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20380827|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20380828|NCT01024322|Protective Agents|protective agents|mesh-ancestor
19332191|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332192|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19332193|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332194|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332195|NCT03891576|Niraparib|niraparib|mesh-list
19332196|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19332197|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679299|NCT04513951|Cetuximab|cetuximab|mesh-list
19679300|NCT04513951|Avelumab|avelumab|mesh-list
20380829|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20380830|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380831|NCT01024348|Acetaminophen|acetaminophen|mesh-list
20380832|NCT01024348|Tramadol|tramadol|mesh-list
20380833|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19399299|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679301|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
20380834|NCT01024348|Analgesics|analgesics|mesh-ancestor
19679302|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
20380835|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
20380836|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380837|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332198|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332199|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332200|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19332201|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
19332202|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399300|NCT03635684|Acetaminophen|acetaminophen|mesh-list
19399301|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19399302|NCT03635684|Analgesics|analgesics|mesh-ancestor
19399303|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
19399304|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399305|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399306|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
19679303|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679304|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19679305|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679306|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19679307|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
19679308|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679309|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19679310|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19679311|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679312|NCT04513951|Antidotes|antidotes|mesh-ancestor
19399307|NCT03635567|Paclitaxel|paclitaxel|mesh-list
19399308|NCT03635567|Bevacizumab|bevacizumab|mesh-list
19399309|NCT03635567|Carboplatin|carboplatin|mesh-list
19399310|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
19399311|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19399312|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195014|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
20195015|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380838|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
20380839|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20380840|NCT01024348|Narcotics|narcotics|mesh-ancestor
20380841|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380842|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20380843|NCT01024413|Gefitinib|gefitinib|mesh-list
20380844|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380845|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20380846|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380847|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380848|NCT01024491|Paroxetine|paroxetine|mesh-list
20380849|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20380850|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20380851|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20380852|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380853|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380854|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
20380855|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380856|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20380857|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
20380858|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20380859|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20380860|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20380861|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380862|NCT01024504|Bevacizumab|bevacizumab|mesh-list
20380863|NCT01024504|Capecitabine|capecitabine|mesh-list
20380864|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
20380865|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380866|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380867|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20380868|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20380869|NCT01024504|Growth Substances|growth substances|mesh-ancestor
19399313|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
20195016|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
20195017|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195018|NCT00232882|Atenolol|atenolol|mesh-list
20195019|NCT00232882|Candesartan|candesartan|mesh-list
20195020|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
20195021|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20195022|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217529|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
20380870|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380871|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
20195023|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19679313|NCT04513951|Protective Agents|protective agents|mesh-ancestor
19679314|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
19679315|NCT04513951|Vitamins|vitamins|mesh-ancestor
19679316|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
19679317|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679318|NCT04313608|Gemcitabine|gemcitabine|mesh-list
19679319|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
19679320|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
19679321|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19679322|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
19679323|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679324|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679325|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
19679326|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679327|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195024|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20195025|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195026|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195027|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
20195028|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
20195029|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195030|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195031|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20195032|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20195033|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20380872|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20380873|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
20380874|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380875|NCT01024543|Phenylephrine|phenylephrine|mesh-list
20380876|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
20380877|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
20380878|NCT01024543|Giapreza|giapreza|mesh-list
20380879|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
20380880|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19332203|NCT03891316|Sevoflurane|sevoflurane|mesh-list
19332204|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19332205|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19332206|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
19332207|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
19332208|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332209|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679328|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19679329|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
19679330|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679331|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679332|NCT04311710|Nivolumab|nivolumab|mesh-list
19679333|NCT04311710|Ipilimumab|ipilimumab|mesh-list
19679334|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679335|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679336|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19679337|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679338|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19679339|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679340|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679341|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19679342|NCT04305327|Ustekinumab|ustekinumab|mesh-list
19679343|NCT04305327|Brodalumab|brodalumab|mesh-list
19679344|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
19679345|NCT04244877|Rifaximin|rifaximin|mesh-list
19679346|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332210|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
19332211|NCT03891277|Hematinics|hematinics|mesh-ancestor
19332212|NCT03891095|Oxytocin|oxytocin|mesh-list
19332213|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
19332214|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19332215|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332216|NCT03891238|Avelumab|avelumab|mesh-list
19332217|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679347|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679348|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679349|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
19679350|NCT04215120|Hematinics|hematinics|mesh-ancestor
19679351|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
20380881|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
20380882|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
20380883|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612854|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332218|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679352|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19679353|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19679354|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19679355|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19679356|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679357|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
19679358|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679359|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679360|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19679361|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679362|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
19679363|NCT04012957|Hematinics|hematinics|mesh-ancestor
19679364|NCT03883581|Quinidine|quinidine|mesh-list
19679365|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
19679366|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
19679367|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
19679368|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
19679369|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19332219|NCT03890952|Bevacizumab|bevacizumab|mesh-list
19332220|NCT03890952|Nivolumab|nivolumab|mesh-list
19332221|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19332222|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19332223|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332224|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19332225|NCT03890952|Growth Substances|growth substances|mesh-ancestor
19332226|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332227|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
19332228|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19332229|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332230|NCT03891173|Vinorelbine|vinorelbine|mesh-list
19679370|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19679371|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195034|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
19332231|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332232|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19332233|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
19332234|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
19332235|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
19332236|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332237|NCT03890809|BMS-986165|bms-986165|mesh-list
19332238|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
19332239|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19332240|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332241|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332242|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
19332243|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19332244|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19332245|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19332246|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19332247|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332248|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
19332249|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332250|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332251|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19332252|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332253|NCT03891043|Selenium|selenium|mesh-list
19332254|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
19332255|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332256|NCT03891043|Protective Agents|protective agents|mesh-ancestor
19332257|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332258|NCT03891043|Trace Elements|trace elements|mesh-ancestor
20195035|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195036|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195037|NCT00232882|Diuretics|diuretics|mesh-ancestor
20195038|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
20195039|NCT00232895|Propofol|propofol|mesh-list
20195040|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20195041|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195042|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380884|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380885|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
20380886|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20380887|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
20380888|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
20380889|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20195043|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20195044|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
20195045|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
20195046|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
20195047|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20195048|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20195049|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195050|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19332259|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
19332260|NCT03890770|BMS-986165|bms-986165|mesh-list
19332261|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
19332262|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19332263|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332264|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332265|NCT03890341|Drospirenone|drospirenone|mesh-list
20195051|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20195052|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
20380890|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20380891|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20380892|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
20380893|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380894|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380895|NCT01024543|Protective Agents|protective agents|mesh-ancestor
20380896|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20195053|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20380897|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
19332266|NCT03890341|Midazolam|midazolam|mesh-list
19332267|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19332268|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19332269|NCT03890341|Betadex|betadex|mesh-list
19332270|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19332271|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19332272|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332273|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332274|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19332275|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19332276|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19332277|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20380898|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380899|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
20380900|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20380901|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
20380902|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380903|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380904|NCT01024660|Donepezil|donepezil|mesh-list
20380905|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20380906|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380907|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380908|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
19332278|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
19332279|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
19332280|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
19332281|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
19332282|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332283|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332284|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19332285|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19332286|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20380909|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332287|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
19679372|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679373|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679374|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19679375|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19679376|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679377|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20380910|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332288|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19399314|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
20380911|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
20380912|NCT01024712|Paclitaxel|paclitaxel|mesh-list
20380913|NCT01024712|Carboplatin|carboplatin|mesh-list
20380914|NCT01024712|Gefitinib|gefitinib|mesh-list
20380915|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20380916|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380917|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
20380918|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
20380919|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
19679378|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
19679379|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19679380|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19679381|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679382|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679383|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19679384|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19679385|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19679386|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19679387|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19679388|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19679389|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19679390|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19679391|NCT03854578|Citalopram|citalopram|mesh-list
19679392|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19679393|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19679394|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19679395|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679396|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679397|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
19679398|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679399|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19679400|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
19679401|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19679402|NCT03844412|Lidocaine|lidocaine|mesh-list
19679403|NCT03844412|Nortriptyline|nortriptyline|mesh-list
19679404|NCT03844412|Estradiol|estradiol|mesh-list
19679405|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
19679406|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
19679407|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332289|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19332290|NCT03890341|Estrogens|estrogens|mesh-ancestor
19332291|NCT03890341|Hormones|hormones|mesh-ancestor
19332292|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19332293|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19332294|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
19332295|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19332296|NCT03890341|Diuretics|diuretics|mesh-ancestor
19332297|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
19332298|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
20380920|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380921|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19332299|NCT03890406|Rocuronium|rocuronium|mesh-list
19332300|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19332301|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19332302|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20380922|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380923|NCT01024777|Vitamin D|vitamin d|mesh-list
20380924|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
20380925|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
20380926|NCT01024777|Vitamins|vitamins|mesh-list
20380927|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
20380928|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380929|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20380930|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20380931|NCT01024868|Ropivacaine|ropivacaine|mesh-list
20380932|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
20380933|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
20380934|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380935|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380936|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
19332303|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332304|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679408|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842075|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
20380937|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380938|NCT01025102|Sufentanil|sufentanil|mesh-list
20380939|NCT01025102|Ropivacaine|ropivacaine|mesh-list
20380940|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20380941|NCT01025102|Narcotics|narcotics|mesh-ancestor
20380942|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380943|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380944|NCT01025102|Analgesics|analgesics|mesh-ancestor
20380945|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
19332305|NCT03890510|Anesthetics|anesthetics|mesh-list
19332306|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332307|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332308|NCT03890094|Sufentanil|sufentanil|mesh-list
19332309|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19332310|NCT03890094|Narcotics|narcotics|mesh-ancestor
19679409|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
19679410|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679411|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19679412|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19679413|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19679414|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19679415|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679416|NCT03844412|Estrogens|estrogens|mesh-ancestor
19679417|NCT03844412|Hormones|hormones|mesh-ancestor
19679418|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679419|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19679420|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
19679421|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19679422|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19679423|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19679424|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679425|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195054|NCT00232934|Thalidomide|thalidomide|mesh-list
20195055|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195056|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
20380946|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380947|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20380948|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19332311|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195057|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195058|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
20195059|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195060|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195061|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20195062|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19692467|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
19332312|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332313|NCT03890094|Analgesics|analgesics|mesh-ancestor
20195063|NCT00232934|Growth Substances|growth substances|mesh-ancestor
19332314|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
19332315|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332316|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19332317|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19332318|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
19332319|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
19332320|NCT03889717|Vitamin D|vitamin d|mesh-list
19332321|NCT03889717|Vitamins|vitamins|mesh-ancestor
19332322|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
19332323|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332324|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19332325|NCT03889808|Antitoxins|antitoxins|mesh-list
19332326|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
19332327|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332328|NCT03890042|Dienogest|dienogest|mesh-list
19332329|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19692468|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19692469|NCT04991155|Zamicastat|zamicastat|mesh-list
20195064|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
20195065|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195066|NCT00232947|Vaccines|vaccines|mesh-list
20195067|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
20195068|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195069|NCT00233012|Topiramate|topiramate|mesh-list
19332330|NCT03890042|Gestodene|gestodene|mesh-list
20195070|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
20195071|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19332331|NCT03890042|Femovan|femovan|mesh-list
19332332|NCT03890042|Estradiol|estradiol|mesh-list
19332333|NCT03890042|Estrogens|estrogens|mesh-ancestor
19692470|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332334|NCT03890042|Hormones|hormones|mesh-ancestor
19332335|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679435|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
19679436|NCT03660059|Peficitinib|peficitinib|mesh-list
19679437|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679438|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679439|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19679440|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
19679441|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679442|NCT03512119|Ivacaftor|ivacaftor|mesh-list
19679443|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19332336|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332337|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19332338|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
19332339|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19332340|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19332341|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19332342|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19332343|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19332344|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
19332345|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19842076|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19842077|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842078|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19842079|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842080|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842081|NCT00647270|Adalimumab|adalimumab|mesh-list
19842082|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842083|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20380949|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
20380950|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
19332346|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332347|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19332348|NCT03890042|Progestins|progestins|mesh-ancestor
19679444|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19679445|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679446|NCT03502148|Cisplatin|cisplatin|mesh-list
19332349|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19332350|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19332351|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20380951|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
20380952|NCT01025128|Vitamin D|vitamin d|mesh-list
20380953|NCT01025128|Vitamins|vitamins|mesh-ancestor
20380954|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
20380955|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380956|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20380957|NCT01025245|Remifentanil|remifentanil|mesh-list
20380958|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20380959|NCT01025245|Narcotics|narcotics|mesh-ancestor
19332352|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
19332353|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20380960|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380961|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380962|NCT01025245|Analgesics|analgesics|mesh-ancestor
20380963|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
20380964|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20380965|NCT01025349|Bevacizumab|bevacizumab|mesh-list
20380966|NCT01025349|Docetaxel|docetaxel|mesh-list
20380967|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20380968|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380969|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20380970|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20380971|NCT01025349|Growth Substances|growth substances|mesh-ancestor
20380972|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380973|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
20380974|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
20380975|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
20380976|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
20380977|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679447|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679448|NCT03450772|Pancrelipase|pancrelipase|mesh-list
19679449|NCT03450772|Pancreatin|pancreatin|mesh-list
19842084|NCT00647296|Pramipexole|pramipexole|mesh-list
20380978|NCT01025466|Memantine|memantine|mesh-list
19679450|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679451|NCT03445728|Nicorandil|nicorandil|mesh-list
20380979|NCT01025466|Rivastigmine|rivastigmine|mesh-list
19332354|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332355|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
20380980|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20380981|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20380982|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
20380983|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20380984|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20380985|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20380986|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20380987|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20380988|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20380989|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20380990|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
20380991|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20380992|NCT01025466|Protective Agents|protective agents|mesh-ancestor
20380993|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
20380994|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20380995|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19332356|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
19332357|NCT03889288|Analgesics|analgesics|mesh-list
19332358|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
19332359|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332360|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332361|NCT03889379|Albuterol|albuterol|mesh-list
19332362|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19332363|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
19332364|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332365|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332366|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19332367|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
19332368|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
19332369|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19332370|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20380996|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332371|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19332372|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19332373|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
19332374|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332375|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332376|NCT03889626|Capecitabine|capecitabine|mesh-list
19332377|NCT03889626|Apatinib|apatinib|mesh-list
19332378|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19332379|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
19332380|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679452|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195072|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195073|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20195074|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19679453|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679454|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
19679455|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
19679456|NCT03445728|Vitamins|vitamins|mesh-ancestor
19679457|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
19679458|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195075|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20195076|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195077|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195078|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195079|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195080|NCT00233025|Analgesics|analgesics|mesh-ancestor
20195081|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
20195082|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195083|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
20195084|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20195085|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
20195086|NCT00233038|Ethanol|ethanol|mesh-list
20195087|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20195088|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195089|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20380997|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332381|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332382|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679459|NCT03424460|Hemostatics|hemostatics|mesh-list
19679460|NCT03424460|Coagulants|coagulants|mesh-ancestor
19679461|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
19679462|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679463|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679464|NCT03278691|Ketorolac|ketorolac|mesh-list
19679465|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19679466|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19679467|NCT03278691|Analgesics|analgesics|mesh-ancestor
19679468|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
19679469|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679470|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679471|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20380998|NCT01025544|Vaccines|vaccines|mesh-list
20380999|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
20381000|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381001|NCT01025570|Gemcitabine|gemcitabine|mesh-list
20381002|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381003|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
20381004|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381005|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381006|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
20381007|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381008|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332383|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399315|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
19399316|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399317|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399318|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19399319|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19399320|NCT03635567|Growth Substances|growth substances|mesh-ancestor
19399321|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399322|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
19399323|NCT03635437|Alprazolam|alprazolam|mesh-list
19399324|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
19399325|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399326|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399327|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399328|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19399329|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399330|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19399331|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
19679472|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195090|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679473|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19679474|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679475|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679476|NCT03274375|Rituximab|rituximab|mesh-list
19679477|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679478|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195091|NCT00233051|Fluticasone|fluticasone|mesh-list
20195092|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20195093|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195094|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20195095|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
20195096|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195097|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195098|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20195099|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
20195100|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195101|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20195102|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20195103|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20195104|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20195105|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
20195106|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195107|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195108|NCT00233155|Capsaicin|capsaicin|mesh-list
20195109|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
20195110|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195111|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
20195112|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381009|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19399332|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
20195113|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381010|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
19332384|NCT03889366|Aprepitant|aprepitant|mesh-list
19332385|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
19332386|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
19332387|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332388|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332389|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19332390|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19332391|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332392|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332393|NCT03888924|Vaccines|vaccines|mesh-list
19332394|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
19332395|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
19332396|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332397|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19332398|NCT03888846|Colchicine|colchicine|mesh-list
19332399|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
19332400|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
19332401|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332402|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19332403|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19332404|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19332405|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381011|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679479|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
19679480|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679481|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19679482|NCT03257761|Durvalumab|durvalumab|mesh-list
19679483|NCT03257761|Guadecitabine|guadecitabine|mesh-list
19679484|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679485|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679486|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
19679487|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679488|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679489|NCT02959619|Ensartinib|ensartinib|mesh-list
19679490|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679491|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679492|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679493|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381012|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20381013|NCT01025700|Nabilone|nabilone|mesh-list
20381014|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
20381015|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
20381016|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332406|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332407|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19332408|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332409|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19679494|NCT02795520|OTS167|ots167|mesh-list
19679495|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679496|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679497|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679498|NCT02645149|Trametinib|trametinib|mesh-list
19679499|NCT02645149|Ceritinib|ceritinib|mesh-list
19679500|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679501|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679502|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679503|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381017|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381018|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381019|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20612855|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19332410|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19679504|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
19842085|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
19332411|NCT03888846|Protective Agents|protective agents|mesh-ancestor
20195114|NCT00233337|Artemether|artemether|mesh-list
20195115|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20195116|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
20195117|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20195118|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20195119|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195120|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20195121|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20195122|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195123|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
20195124|NCT00233532|Verapamil|verapamil|mesh-list
19679505|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19332412|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332413|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
19332414|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19332415|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
19842086|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842087|NCT00647296|Protective Agents|protective agents|mesh-ancestor
20381020|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381021|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381022|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381023|NCT01025765|Metformin|metformin|mesh-list
20381024|NCT01025765|Pioglitazone|pioglitazone|mesh-list
20381025|NCT01025765|Acarbose|acarbose|mesh-list
20381026|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20381027|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381028|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20381029|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381030|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381031|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
20381032|NCT01025778|Thiotepa|thiotepa|mesh-list
20381033|NCT01025778|Etoposide|etoposide|mesh-list
20381034|NCT01025778|Clofarabine|clofarabine|mesh-list
20381035|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381036|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
20381037|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381038|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381039|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20381040|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
19679506|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679507|NCT02620579|Propranolol|propranolol|mesh-list
19679508|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19679509|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19679510|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679511|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679512|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679513|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679514|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20381041|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381042|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381043|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20381044|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20381045|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20381046|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20381047|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381048|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381049|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
19679515|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679516|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
19332416|NCT03889145|Amlodipine|amlodipine|mesh-list
19332417|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19332418|NCT03889145|Telmisartan|telmisartan|mesh-list
19332419|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19332420|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19332421|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19332422|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332423|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19332424|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332425|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
19332426|NCT03889145|Diuretics|diuretics|mesh-ancestor
19332427|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
19332428|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19332429|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19332430|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19332431|NCT03889106|Ribavirin|ribavirin|mesh-list
19332432|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
19332433|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332434|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
19332435|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332436|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
19332437|NCT03888677|Epirubicin|epirubicin|mesh-list
19679517|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20426187|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19332438|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332439|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
20381050|NCT01025882|Gemcitabine|gemcitabine|mesh-list
20381051|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381052|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
20381053|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381054|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381055|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
20381056|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381057|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381058|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332440|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332441|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332442|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19332443|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
19332444|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332445|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332446|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19332447|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19332448|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19332449|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19332450|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332451|NCT03888664|Interferons|interferons|mesh-list
19332452|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
19332453|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679518|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679519|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679520|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679521|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679522|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
19679523|NCT02420314|Paclitaxel|paclitaxel|mesh-list
19679524|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19679525|NCT02420314|Carboplatin|carboplatin|mesh-list
19679526|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19679527|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679528|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
19679529|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
19679530|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
19679531|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679532|NCT02420314|Vitamins|vitamins|mesh-ancestor
19679533|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
19679534|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381059|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
20381060|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381061|NCT01025921|Colistin|colistin|mesh-list
20381062|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381063|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381064|NCT01025934|Bevacizumab|bevacizumab|mesh-list
20381065|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19332454|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
19679535|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
19679536|NCT02420314|Protective Agents|protective agents|mesh-ancestor
19679537|NCT02370589|Vaccines|vaccines|mesh-list
19679538|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
19679539|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679540|NCT02313194|Buspirone|buspirone|mesh-list
19679541|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19679542|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19679543|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679544|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332455|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332456|NCT03888729|Velpatasvir|velpatasvir|mesh-list
19332457|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
19332458|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332459|NCT03888534|Ixazomib|ixazomib|mesh-list
19332460|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332461|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
19332462|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332463|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332464|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
19332465|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19332466|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19332467|NCT03888157|Liraglutide|liraglutide|mesh-list
19679545|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19679546|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19679547|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
19679548|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381066|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381067|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19332468|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19332469|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332470|NCT03888157|Incretins|incretins|mesh-ancestor
19332471|NCT03888157|Hormones|hormones|mesh-ancestor
19332472|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19332473|NCT03888144|Ketorolac|ketorolac|mesh-list
19332474|NCT03888144|Oxycodone|oxycodone|mesh-list
19332475|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19332476|NCT03888144|Narcotics|narcotics|mesh-ancestor
19332477|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332478|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332479|NCT03888144|Analgesics|analgesics|mesh-ancestor
19332480|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
19332481|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332482|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19332483|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332484|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19332485|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332486|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19332487|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332488|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332489|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19332490|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19332491|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
19332492|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19332493|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19332494|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
19332495|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332496|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19332497|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19679549|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842088|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842089|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20381068|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20381069|NCT01025934|Growth Substances|growth substances|mesh-ancestor
20381070|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381071|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
19332498|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
19332499|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
19842090|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19842091|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
19842092|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
20195125|NCT00233532|Trandolapril|trandolapril|mesh-list
19679550|NCT02100956|Oxytocin|oxytocin|mesh-list
19679551|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
19679552|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19679553|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679554|NCT01752049|Timolol|timolol|mesh-list
19679555|NCT01752049|Maleic acid|maleic acid|mesh-list
19679556|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19679557|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19679558|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679559|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679560|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679561|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679562|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19679563|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679564|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679565|NCT01316523|Rituximab|rituximab|mesh-list
19679566|NCT01316523|Lenalidomide|lenalidomide|mesh-list
19679567|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679568|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679569|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
19842093|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195126|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195127|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20195128|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195129|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195130|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20195131|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195132|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195133|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20195134|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
20381072|NCT01026064|Azithromycin|azithromycin|mesh-list
20381073|NCT01026064|Cantharidin|cantharidin|mesh-list
20381074|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381075|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381076|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381077|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381078|NCT01026090|Dronedarone|dronedarone|mesh-list
20381079|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20381080|NCT01026116|Paclitaxel|paclitaxel|mesh-list
20381081|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
20381082|NCT01026116|Epirubicin|epirubicin|mesh-list
20381083|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20381084|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381085|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
20381086|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
20381087|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
20381088|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381089|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381090|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
20381091|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381092|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381093|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20381094|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
20381095|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20381096|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19679570|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679571|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19679572|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19679573|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19679574|NCT01316523|Growth Substances|growth substances|mesh-ancestor
19679575|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
19679576|NCT00085774|Albuterol|albuterol|mesh-list
19679577|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19679578|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
19679579|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679580|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679581|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19679582|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
19679583|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
20381097|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20381098|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20381099|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381100|NCT01026129|Lidocaine|lidocaine|mesh-list
20381101|NCT01026129|Remifentanil|remifentanil|mesh-list
20381102|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
20381103|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
20381104|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381105|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381106|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
20381107|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381108|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20381109|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20381110|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20381111|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381112|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381113|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20381114|NCT01026129|Narcotics|narcotics|mesh-ancestor
20381115|NCT01026129|Analgesics|analgesics|mesh-ancestor
20381116|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20381117|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20381118|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381119|NCT01026285|Risperidone|risperidone|mesh-list
20381120|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
20381121|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20381122|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
19679584|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19679585|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19679586|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19679587|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19679588|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679589|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679590|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612856|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
19679591|NCT00071552|Fluticasone|fluticasone|mesh-list
20381123|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679592|NCT00071552|Xhance|xhance|mesh-list
19679593|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679594|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19679595|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
19679596|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679597|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679598|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19842094|NCT00647348|Simvastatin|simvastatin|mesh-list
19842095|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19332500|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332501|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381124|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381125|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381126|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381127|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381128|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381129|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20381130|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
20381131|NCT01026311|Ubiquinone|ubiquinone|mesh-list
20381132|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
20381133|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
20381134|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381135|NCT01026311|Vitamins|vitamins|mesh-ancestor
20381136|NCT01026337|Sunitinib|sunitinib|mesh-list
20381137|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332502|NCT03887650|Dexamethasone|dexamethasone|mesh-list
19332503|NCT03887650|Epinephrine|epinephrine|mesh-list
19332504|NCT03887650|Bupivacaine|bupivacaine|mesh-list
19332505|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19332506|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
19332507|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
19332508|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332509|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332510|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19332511|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
19842096|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19842097|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
19842098|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679599|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
20195135|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195136|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20381138|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20381139|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20381140|NCT01026337|Growth Substances|growth substances|mesh-ancestor
20381141|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381142|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381143|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20381144|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381145|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381146|NCT01026350|Antibodies|antibodies|mesh-list
20381147|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
20381148|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381149|NCT01026363|Vitamin D|vitamin d|mesh-list
20381150|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
20381151|NCT01026363|Calcitriol|calcitriol|mesh-list
20381152|NCT01026363|Vitamins|vitamins|mesh-list
20381153|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
19842099|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20195137|NCT00233545|Miltefosine|miltefosine|mesh-list
19842100|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19842101|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842102|NCT00647400|Adalimumab|adalimumab|mesh-list
19842103|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195138|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
20195139|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195140|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195141|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20195142|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20195143|NCT00233558|Adalimumab|adalimumab|mesh-list
20195144|NCT00233558|Methotrexate|methotrexate|mesh-list
20195145|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20195146|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
20195147|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20381154|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381155|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19332512|NCT03887650|Hormones|hormones|mesh-ancestor
20381156|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20195148|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195149|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195150|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
20195151|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195152|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195153|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195154|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842104|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381157|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20381158|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381159|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381160|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20381161|NCT01026376|Decitabine|decitabine|mesh-list
20381162|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381163|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
20381164|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381165|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381166|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381167|NCT01026415|Rifampin|rifampin|mesh-list
19332513|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19332514|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19332515|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332516|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332517|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
19332518|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
19332519|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332520|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
19332521|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19332522|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19332523|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19332524|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332525|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19332526|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19332527|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19332528|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
19332529|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
19332530|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
19332531|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19332532|NCT03887754|Risperidone|risperidone|mesh-list
19332533|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19332534|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
19332535|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332536|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332537|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332538|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19332539|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19332540|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332541|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19332542|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19332543|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
19332544|NCT03887871|Tamsulosin|tamsulosin|mesh-list
19332545|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19332546|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19332547|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19332548|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
19332549|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332550|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332551|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332552|NCT03887871|Urological Agents|urological agents|mesh-ancestor
19842105|NCT00647556|Adapalene|adapalene|mesh-list
19842106|NCT00647556|Tretinoin|tretinoin|mesh-list
19842107|NCT00647556|Emollients|emollients|mesh-list
19842108|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19842109|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842110|NCT00647556|Analgesics|analgesics|mesh-ancestor
19842111|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
19842112|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842113|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842114|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842115|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842116|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842117|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842118|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
19842119|NCT00647699|Riboflavin|riboflavin|mesh-list
20381168|NCT01026415|Ketoconazole|ketoconazole|mesh-list
20381169|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20381170|NCT01026415|Midazolam|midazolam|mesh-list
19332553|NCT03887858|Tamsulosin|tamsulosin|mesh-list
19332554|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19332555|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19332556|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20195155|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20195156|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195157|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
20195158|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195159|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20195160|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195161|NCT00233571|Adalimumab|adalimumab|mesh-list
20195162|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381171|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20381172|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20381173|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20381174|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381175|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381176|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20381177|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381178|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381179|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20381180|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
20381181|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
20381182|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
19679600|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
19679601|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19679602|NCT05136066|Peppermint oil|peppermint oil|mesh-list
19679603|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
19679604|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
19679605|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679606|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679607|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679608|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
19842120|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19842121|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19842122|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
19842123|NCT00647699|Vitamins|vitamins|mesh-ancestor
19842124|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
19842125|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842126|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19842127|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842128|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
19842129|NCT00647998|Hematinics|hematinics|mesh-ancestor
19842130|NCT00648037|Rituximab|rituximab|mesh-list
19842131|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19842132|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842133|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
19842134|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842135|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842136|NCT00648375|Propranolol|propranolol|mesh-list
19842137|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19842138|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19842139|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
19842140|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842141|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842142|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842143|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19842144|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19842145|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
19842146|NCT00648648|Gemcitabine|gemcitabine|mesh-list
19842147|NCT00648648|Carboplatin|carboplatin|mesh-list
19842148|NCT00648648|Adavosertib|adavosertib|mesh-list
19842149|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842150|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19842151|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
19842152|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195163|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381183|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
19679609|NCT05125146|Trazodone|trazodone|mesh-list
19679610|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19842153|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
19842154|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842155|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381184|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195164|NCT00233584|Budesonide|budesonide|mesh-list
20195165|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842156|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842157|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
19842158|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842159|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
19842160|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19842161|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842162|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842163|NCT00649220|Memantine|memantine|mesh-list
19842164|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19842165|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19842166|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
19842167|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842168|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195166|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20381185|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381186|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20381187|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
20381188|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381189|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381190|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
20381191|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20381192|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381193|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20381194|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20381195|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20381196|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20195167|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
19679611|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19679612|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679613|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679614|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19679615|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19679616|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19679617|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693132|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195168|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195169|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195170|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20195171|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
20195172|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
20195173|NCT00233584|Hormones|hormones|mesh-ancestor
20195174|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195175|NCT00233610|Tamoxifen|tamoxifen|mesh-list
20381197|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20381198|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19332557|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
20381199|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20381200|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381201|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
20381202|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
20381203|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20381204|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20381205|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20381206|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
20381207|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381208|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20381209|NCT01026428|Levodopa|levodopa|mesh-list
20381210|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20381211|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19332558|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381212|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
20381213|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381214|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381215|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381216|NCT01026467|Carboplatin|carboplatin|mesh-list
20381217|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381218|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
19332559|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195176|NCT00233610|Bicalutamide|bicalutamide|mesh-list
19332560|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332561|NCT03887858|Urological Agents|urological agents|mesh-ancestor
19332562|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
19332563|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19332564|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332565|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19332566|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399333|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399334|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679618|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679619|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679620|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
19679621|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19679622|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
19692471|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692472|NCT04991298|Fentanyl|fentanyl|mesh-list
19692473|NCT04991298|Midazolam|midazolam|mesh-list
19692474|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19692475|NCT04991298|Narcotics|narcotics|mesh-ancestor
19692476|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381219|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20381220|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381221|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381222|NCT01026584|Aripiprazole|aripiprazole|mesh-list
20381223|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
20381224|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381225|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20381226|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381227|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381228|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381229|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
20381230|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
20381231|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381232|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381233|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19692477|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692478|NCT04991298|Analgesics|analgesics|mesh-ancestor
19692479|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
20381234|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20381235|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
19692480|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692481|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19692482|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19692483|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
19692484|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
19399335|NCT03635411|Niacinamide|niacinamide|mesh-list
19399336|NCT03635411|Niacin|niacin|mesh-list
19399337|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
19842169|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842170|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20381236|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19399338|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
19399339|NCT03635411|Vitamins|vitamins|mesh-ancestor
19692485|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19842171|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19842172|NCT00649389|Amlodipine|amlodipine|mesh-list
19842173|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19842174|NCT00649389|Olmesartan|olmesartan|mesh-list
19692486|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19692487|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19692488|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19692489|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
19692490|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
19692491|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842175|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19842176|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195177|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20195178|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
20195179|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195180|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195181|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20195182|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195183|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19693133|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679623|NCT05136534|Anesthetics|anesthetics|mesh-list
19679624|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679625|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679626|NCT05136521|Trazodone|trazodone|mesh-list
19679627|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19679628|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19332567|NCT03887260|Fentanyl|fentanyl|mesh-list
20381237|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20381238|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20381239|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20381240|NCT01026610|Entecavir|entecavir|mesh-list
20381241|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
20381242|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381243|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
20381244|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19332568|NCT03887260|Morphine|morphine|mesh-list
19679629|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679630|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679631|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19679632|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19332569|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19332570|NCT03887260|Narcotics|narcotics|mesh-ancestor
19332571|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332572|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332573|NCT03887260|Analgesics|analgesics|mesh-ancestor
19332574|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
19332575|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332576|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19332577|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19332578|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
20381245|NCT01026636|Cephalosporins|cephalosporins|mesh-list
20381246|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381247|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332579|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
19332580|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
19332581|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
19332582|NCT03887169|Vitamins|vitamins|mesh-ancestor
19332583|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
19332584|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332585|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
19332586|NCT03887169|Hematinics|hematinics|mesh-ancestor
19332587|NCT03887130|Gemcitabine|gemcitabine|mesh-list
19332588|NCT03887130|Paclitaxel|paclitaxel|mesh-list
19332589|NCT03887130|Vinorelbine|vinorelbine|mesh-list
19332590|NCT03887130|Docetaxel|docetaxel|mesh-list
19332591|NCT03887130|Capecitabine|capecitabine|mesh-list
19332592|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19332593|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332594|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
19332595|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
19332596|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
19332597|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332598|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19332599|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
19332600|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
19679633|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19679634|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19679635|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679636|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679637|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
19679638|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19679639|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
19679640|NCT05136508|Propofol|propofol|mesh-list
19679641|NCT05136508|Sevoflurane|sevoflurane|mesh-list
19679642|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19679643|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679644|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332601|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679645|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19679646|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
19679647|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
19679648|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20381248|NCT01026701|Bortezomib|bortezomib|mesh-list
20381249|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332602|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332603|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332604|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
20381250|NCT01026714|Fluconazole|fluconazole|mesh-list
20381251|NCT01026714|Rifampin|rifampin|mesh-list
19332605|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332606|NCT03886896|Lidocaine|lidocaine|mesh-list
19332607|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
19332608|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
19332609|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332610|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332611|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
19332612|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332613|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19332614|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19332615|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19332616|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19332617|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332618|NCT03886779|Nepafenac|nepafenac|mesh-list
19332619|NCT03886779|Bromfenac|bromfenac|mesh-list
19332620|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19332621|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332622|NCT03886779|Analgesics|analgesics|mesh-ancestor
19332623|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
19332624|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332625|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332626|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19332627|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332628|NCT03886948|Mirikizumab|mirikizumab|mesh-list
19332629|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19332630|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332631|NCT03886948|Analgesics|analgesics|mesh-ancestor
19332632|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
19332633|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332634|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332635|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19332636|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332637|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19332638|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19332639|NCT03886922|Cromakalim|cromakalim|mesh-list
19332640|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679649|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19679650|NCT05135858|Methotrexate|methotrexate|mesh-list
19679651|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19679652|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
19679653|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20195184|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20195185|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20195186|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
20195187|NCT00233623|Leucovorin|leucovorin|mesh-list
20195188|NCT00233623|Fluorouracil|fluorouracil|mesh-list
20195189|NCT00233623|Irinotecan|irinotecan|mesh-list
20195190|NCT00233623|Gefitinib|gefitinib|mesh-list
20195191|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
20195192|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195193|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195194|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195195|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195196|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
20195197|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195198|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20195199|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20195200|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195201|NCT00233623|Antidotes|antidotes|mesh-ancestor
20195202|NCT00233623|Protective Agents|protective agents|mesh-ancestor
20195203|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
20195204|NCT00233623|Vitamins|vitamins|mesh-ancestor
20195205|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
20195206|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20195207|NCT00233636|Gefitinib|gefitinib|mesh-list
20195208|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195209|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20195210|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195211|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195212|NCT00233662|Alefacept|alefacept|mesh-list
20195213|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195214|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
20195215|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195216|NCT00233675|Tiagabine|tiagabine|mesh-list
19693134|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
20195217|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
19332641|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19332642|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
19332643|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332644|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332645|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19332646|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
19332647|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
20195218|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20195219|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20195220|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195221|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195222|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
20195223|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195224|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217530|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
20217531|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20217532|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20217533|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217534|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217535|NCT00309790|Urological Agents|urological agents|mesh-ancestor
19332648|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
20381252|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
20381253|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
20381254|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381255|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20381256|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20381257|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381258|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381259|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20381260|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
20381261|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381262|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381263|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20381264|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19332649|NCT03887013|Trimetazidine|trimetazidine|mesh-list
19332650|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
19332651|NCT03886766|Efavirenz|efavirenz|mesh-list
19332652|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20217536|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
20217537|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
20217538|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20217539|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20217540|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217541|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217542|NCT00309816|Urological Agents|urological agents|mesh-ancestor
20217543|NCT00309855|Anastrozole|anastrozole|mesh-list
20381265|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20381266|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
20381267|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381268|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
20381269|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20381270|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20381271|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20381272|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19332653|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20217544|NCT00309855|Testosterone|testosterone|mesh-list
20217545|NCT00309855|Dutasteride|dutasteride|mesh-list
20217546|NCT00309855|Androgens|androgens|mesh-ancestor
20217547|NCT00309855|Hormones|hormones|mesh-ancestor
19332654|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332655|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332656|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
19332657|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332658|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19332659|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19332660|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19332661|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19332662|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19332663|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19332664|NCT03886441|Beclomethasone|beclomethasone|mesh-list
19332665|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19332666|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
19332667|NCT03886441|Hormones|hormones|mesh-ancestor
19332668|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19332669|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195225|NCT00233714|Sirolimus|sirolimus|mesh-list
20195226|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195227|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195228|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195229|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195230|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
20195231|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195232|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
20195233|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381273|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20381274|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20381275|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20381276|NCT01026714|Analgesics|analgesics|mesh-ancestor
20381277|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
20381278|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381279|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20381280|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20195234|NCT00233766|Sirolimus|sirolimus|mesh-list
20195235|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195236|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195237|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195238|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195239|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
20195240|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195241|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
20195242|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195243|NCT00233779|Sirolimus|sirolimus|mesh-list
20195244|NCT00233779|Heparin|heparin|mesh-list
20195245|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195246|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381281|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381282|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381283|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20381284|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20195247|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195248|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195249|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
19332670|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19332671|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
19332672|NCT03886662|LB100|lb100|mesh-list
19332673|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332674|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332675|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332676|NCT03886311|Nivolumab|nivolumab|mesh-list
19332677|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19332678|NCT03886311|Trabectedin|trabectedin|mesh-list
19679654|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679655|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19679656|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
19679657|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679658|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679659|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
19679660|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679661|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19679662|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195250|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381285|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
19332679|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20195251|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
20195252|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195253|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
20195254|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20195255|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20195256|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195257|NCT00233792|Sirolimus|sirolimus|mesh-list
20195258|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195259|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195260|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19332680|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332681|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19399340|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
20381286|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381287|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
20381288|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20381289|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381290|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381291|NCT01026961|Acetaminophen|acetaminophen|mesh-list
20381292|NCT01026961|Dimethindene|dimethindene|mesh-list
20381293|NCT01026961|Phenylephrine|phenylephrine|mesh-list
20381294|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
20381295|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381296|NCT01026961|Analgesics|analgesics|mesh-ancestor
20381297|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
19679663|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
19679664|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19679665|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20381298|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381299|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381300|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
20381301|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381302|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20381303|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
20381304|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
19679666|NCT05135637|Vaccines|vaccines|mesh-list
19679667|NCT05135637|Immunologic Factors|immunologic factors|mesh-ancestor
19679668|NCT05135637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679669|NCT05135442|Bortezomib|bortezomib|mesh-list
19679670|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679671|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20381305|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
20381306|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20381307|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
20381308|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
20381309|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20381310|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20381311|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20381312|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
20381313|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381314|NCT01026961|Protective Agents|protective agents|mesh-ancestor
20381315|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
20381316|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
20381317|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20381318|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
20381319|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
20381320|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20381321|NCT01026987|Plerixafor|plerixafor|mesh-list
20381322|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20381323|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19679672|NCT05135286|Carbachol|carbachol|mesh-list
19679673|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19679674|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19679675|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19679676|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19679677|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679678|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679679|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679680|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679681|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19679682|NCT05135286|Miotics|miotics|mesh-ancestor
19679683|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
19679684|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679685|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20381324|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
20381325|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381326|NCT01027065|Tenofovir|tenofovir|mesh-list
20381327|NCT01027065|Entecavir|entecavir|mesh-list
20381328|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
20381329|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679686|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
20381330|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20381331|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20381332|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381333|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679687|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381334|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20381335|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20381336|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
19679688|NCT05135286|Analgesics|analgesics|mesh-ancestor
19679689|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
19679690|NCT05135286|Protective Agents|protective agents|mesh-ancestor
20381337|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
20381338|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19679691|NCT05135273|Vaccines|vaccines|mesh-list
19679692|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
19679693|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679694|NCT05135013|Drospirenone|drospirenone|mesh-list
19679695|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20381339|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20381340|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381341|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332682|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332683|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19332684|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
19332685|NCT03885947|Fludarabine|fludarabine|mesh-list
19332686|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
19332687|NCT03885947|Thiotepa|thiotepa|mesh-list
19332688|NCT03885947|Valproic Acid|valproic acid|mesh-list
19332689|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332690|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332691|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332692|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
19332693|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332694|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332695|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19332696|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
19332697|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19332698|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
19332699|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332700|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
19332701|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332702|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
19332703|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19332704|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332705|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19332706|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
19332707|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19332708|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19332709|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332710|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
19332711|NCT03885895|Coagulants|coagulants|mesh-ancestor
19332712|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19332713|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
19332714|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332715|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
19332716|NCT03885830|Dasatinib|dasatinib|mesh-list
19332717|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332718|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19332719|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332720|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332721|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
19332722|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19332723|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332724|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332725|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332726|NCT03885804|Analgesics|analgesics|mesh-ancestor
19332727|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
19332728|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332729|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19332730|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19332731|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19332732|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
19332733|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332734|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332735|NCT03885258|Melatonin|melatonin|mesh-list
19332736|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
20195261|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195262|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
20195263|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195264|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
20195265|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195266|NCT00233805|Sirolimus|sirolimus|mesh-list
20195267|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195268|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332737|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195269|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19332738|NCT03885258|Protective Agents|protective agents|mesh-ancestor
19332739|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381342|NCT01027117|Urological Agents|urological agents|mesh-ancestor
20381343|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
20381344|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20381345|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20381346|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
20381347|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381348|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20381349|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20381350|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381351|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381352|NCT01027377|Factor VIII|factor viii|mesh-list
20381353|NCT01027377|Coagulants|coagulants|mesh-ancestor
20381354|NCT01027429|Amoxicillin|amoxicillin|mesh-list
19332740|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195270|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195271|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
20195272|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195273|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
20195274|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195275|NCT00233818|Sirolimus|sirolimus|mesh-list
20195276|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381355|NCT01027429|Gentamicins|gentamicins|mesh-list
20381356|NCT01027429|Penicillins|penicillins|mesh-list
20381357|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
20381358|NCT01027429|Penicillin G|penicillin g|mesh-list
20381359|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20381360|NCT01027429|Procaine|procaine|mesh-list
20381361|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381362|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195277|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195278|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195279|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195280|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
20195281|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195282|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
20195283|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195284|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
20195285|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20195286|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20195287|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195288|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20195289|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19679696|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19679697|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19679698|NCT05135013|Norethindrone|norethindrone|mesh-list
19679699|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
19679700|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19679701|NCT05135013|Estradiol|estradiol|mesh-list
19679702|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19679703|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
19679704|NCT05135013|Estrogens|estrogens|mesh-ancestor
19679705|NCT05135013|Hormones|hormones|mesh-ancestor
20195290|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
19332741|NCT03885427|Ketamine|ketamine|mesh-list
19332742|NCT03885427|Analgesics|analgesics|mesh-ancestor
19332743|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
19332744|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332745|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332746|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19332747|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19679706|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679707|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381363|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19332748|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
19332749|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
19332750|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332751|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19332752|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19332753|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842177|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20381364|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381365|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381366|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
19399341|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679708|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19332754|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679709|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
20195291|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195292|NCT00233896|Beclomethasone|beclomethasone|mesh-list
20195293|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195294|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
20195295|NCT00233896|Hormones|hormones|mesh-ancestor
19679710|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19679711|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19679712|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19842178|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842179|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842180|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19842181|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679713|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19679714|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19679715|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
19679716|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19679717|NCT05135013|Diuretics|diuretics|mesh-ancestor
19679718|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
19679719|NCT05135013|Progestins|progestins|mesh-ancestor
20195296|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195297|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195298|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20195299|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
20195300|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
20195301|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20195302|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195303|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20195304|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
20195305|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195306|NCT00233935|Protective Agents|protective agents|mesh-ancestor
20195307|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195308|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20195309|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20195310|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195311|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20195312|NCT00233961|Lenograstim|lenograstim|mesh-list
20195313|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20195314|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
20195315|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195316|NCT00234000|Azacitidine|azacitidine|mesh-list
20195317|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
20195318|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195319|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
20195320|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195321|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195322|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195323|NCT00234026|Gemcitabine|gemcitabine|mesh-list
19679720|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19842182|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
19679721|NCT05134922|Gedatolisib|gedatolisib|mesh-list
20195324|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195325|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
20195326|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195327|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195328|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
19679722|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19842183|NCT00649389|Diuretics|diuretics|mesh-ancestor
19842184|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
19842185|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19842186|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19842187|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19842188|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
19842189|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19842190|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842191|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842192|NCT00649961|Melatonin|melatonin|mesh-list
19842193|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
19842194|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842195|NCT00649961|Protective Agents|protective agents|mesh-ancestor
20195329|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381367|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
20381368|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381369|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381370|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
20381371|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381372|NCT01027481|Ranibizumab|ranibizumab|mesh-list
20381373|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20381374|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20381375|NCT01027481|Growth Substances|growth substances|mesh-ancestor
20381376|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381377|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381378|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381379|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
20381380|NCT01027494|Dexamethasone|dexamethasone|mesh-list
20381381|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381382|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
20381383|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
20381384|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195330|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195331|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195332|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
19679723|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679724|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679725|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
19679726|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19679727|NCT05134792|Antibodies|antibodies|mesh-list
19679728|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
19679729|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19679730|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
19679731|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679732|NCT05134558|Xenon|xenon|mesh-list
19679733|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19679734|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
19679735|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
19679736|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679737|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679738|NCT05134519|Trastuzumab|trastuzumab|mesh-list
19679739|NCT05134519|Antibodies|antibodies|mesh-list
19679740|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19679741|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
19679742|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381385|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381386|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19679743|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679744|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679745|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19679746|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19679747|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679748|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
19679749|NCT05122169|Iodine|iodine|mesh-list
19679750|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
19679751|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19679752|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
19679753|NCT05122169|Povidone|povidone|mesh-list
19679754|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19679755|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679756|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
20195333|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381387|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
20381388|NCT01027494|Hormones|hormones|mesh-ancestor
20381389|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679757|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195334|NCT00234091|Ritonavir|ritonavir|mesh-list
20195335|NCT00234091|Lopinavir|lopinavir|mesh-list
20195336|NCT00234091|Nelfinavir|nelfinavir|mesh-list
20195337|NCT00234091|Lamivudine|lamivudine|mesh-list
20195338|NCT00234091|Zidovudine|zidovudine|mesh-list
20195339|NCT00234091|Nevirapine|nevirapine|mesh-list
20195340|NCT00234091|Abacavir|abacavir|mesh-list
20195341|NCT00234091|Efavirenz|efavirenz|mesh-list
20195342|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20195343|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20381390|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20381391|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679758|NCT05122169|Trace Elements|trace elements|mesh-ancestor
19679759|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
19679760|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195344|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195345|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195346|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195347|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20195348|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20195349|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
19332755|NCT03885219|Paclitaxel|paclitaxel|mesh-list
19332756|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19332757|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332758|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
19332759|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
19332760|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
19332761|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332762|NCT03885180|Warfarin|warfarin|mesh-list
19332763|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
19332764|NCT03885388|Dactinomycin|dactinomycin|mesh-list
19332765|NCT03885388|Methotrexate|methotrexate|mesh-list
19332766|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19332767|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
19332768|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19332769|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332770|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19332771|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
19332772|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332773|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332774|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
19332775|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332776|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19332777|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332778|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
19332779|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332780|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19332781|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19679761|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
19679762|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
19679763|NCT05121571|Sorafenib|sorafenib|mesh-list
19679764|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679765|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679766|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332782|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332783|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195350|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195351|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20195352|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20195353|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20195354|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20195355|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
20195356|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20195357|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20381392|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381393|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332784|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19332785|NCT03885297|Liraglutide|liraglutide|mesh-list
19332786|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19332787|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332788|NCT03885297|Incretins|incretins|mesh-ancestor
19332789|NCT03885297|Hormones|hormones|mesh-ancestor
19332790|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19332791|NCT03884881|Meropenem|meropenem|mesh-list
19332792|NCT03884881|Imipenem|imipenem|mesh-list
19332793|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332794|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332795|NCT03885141|Zolpidem|zolpidem|mesh-list
19332796|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19332797|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19332798|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332799|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332800|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19332801|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
20381394|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20381395|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20381396|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381397|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679767|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332802|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
19332803|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679768|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19679769|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679770|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679771|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679772|NCT05120141|Listerine|listerine|mesh-list
19332804|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332805|NCT03884972|Venetoclax|venetoclax|mesh-list
19332806|NCT03884972|Trabectedin|trabectedin|mesh-list
19332807|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195358|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20195359|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20195360|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20381398|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20381399|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20381400|NCT01027520|Monensin|monensin|mesh-list
20381401|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
20381402|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381403|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20381404|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20381405|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
20195361|NCT00234117|Rabeprazole|rabeprazole|mesh-list
19332808|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19332809|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
19332810|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332811|NCT03884491|Vortioxetine|vortioxetine|mesh-list
20195362|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20195363|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20195364|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20195365|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195366|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195367|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
20195368|NCT00234143|Hematinics|hematinics|mesh-ancestor
20381406|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
19332812|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
19332813|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19332814|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19332815|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19332816|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332817|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332818|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19332819|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19332820|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19332821|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332822|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332823|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
19332824|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19332825|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19332826|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19332827|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19332828|NCT03884348|Amoxicillin|amoxicillin|mesh-list
19332829|NCT03884348|Metronidazole|metronidazole|mesh-list
19332830|NCT03884348|Clarithromycin|clarithromycin|mesh-list
19332831|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19332832|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332833|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332834|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19332835|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19332836|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19332837|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332838|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332839|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19332840|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19332841|NCT03884465|Treprostinil|treprostinil|mesh-list
19332842|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195369|NCT00234182|Interferons|interferons|mesh-list
20381407|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
20381408|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332843|NCT03884530|Aspirin|aspirin|mesh-list
19332844|NCT03884530|Ticagrelor|ticagrelor|mesh-list
19332845|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19332846|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332847|NCT03884530|Analgesics|analgesics|mesh-ancestor
19332848|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
19679773|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19679774|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381409|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381410|NCT01027520|Ionophores|ionophores|mesh-ancestor
20381411|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381412|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
20381413|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
20381414|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20381415|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20381416|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381417|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
20381418|NCT01027546|Coagulants|coagulants|mesh-ancestor
20381419|NCT01027611|Lidocaine|lidocaine|mesh-list
20381420|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
19679775|NCT05087862|Anesthetics|anesthetics|mesh-list
19679776|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
19679777|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381421|NCT01027611|Propoxycaine|propoxycaine|mesh-list
20381422|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
20381423|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
20381424|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381425|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381426|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
20381427|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381428|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20381429|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19679778|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679779|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
19679780|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692492|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332849|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332850|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332851|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19332852|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19332853|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19332854|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19332855|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332856|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19332857|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19332858|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332859|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
19332860|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19332861|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19332862|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20195370|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
20195371|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
20195372|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195373|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
20195374|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195375|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
20195376|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195377|NCT00234195|Bupropion|bupropion|mesh-list
20195378|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20195379|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
20195380|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20195381|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20195382|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20195383|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195384|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195385|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
20195386|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195387|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612857|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20612858|NCT02253004|Protective Agents|protective agents|mesh-ancestor
20195388|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20195389|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20195390|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195391|NCT00234234|Adalimumab|adalimumab|mesh-list
20612859|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20195392|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195393|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195394|NCT00234299|Aspirin|aspirin|mesh-list
20381430|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19679781|NCT05060523|Tolvaptan|tolvaptan|mesh-list
20381431|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381432|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426188|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20426189|NCT01279434|Vitamins|vitamins|mesh-list
20426190|NCT01279434|Vitamin E|vitamin e|mesh-list
20426191|NCT01279434|Tocopherols|tocopherols|mesh-list
20426192|NCT01279434|Tocotrienols|tocotrienols|mesh-list
20426193|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
20426194|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
20426195|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426196|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
20426197|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426198|NCT01279434|Protective Agents|protective agents|mesh-ancestor
20426199|NCT01279499|Remifentanil|remifentanil|mesh-list
19332863|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
19332864|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332865|NCT03884127|Orlistat|orlistat|mesh-list
19332866|NCT03884127|Ezetimibe|ezetimibe|mesh-list
19332867|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19332868|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19332869|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
19332870|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332871|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19332872|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332873|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19332874|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19332875|NCT03883841|Hematinics|hematinics|mesh-ancestor
19332876|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19332877|NCT03883880|Capsaicin|capsaicin|mesh-list
19332878|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
19332879|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
19332880|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
19332881|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679782|NCT05060523|Midodrine|midodrine|mesh-list
19679783|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19679784|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679785|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
19679786|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679787|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
19679788|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
19679789|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426200|NCT01279499|Propofol|propofol|mesh-list
20426201|NCT01279499|Sevoflurane|sevoflurane|mesh-list
20426202|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19679790|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19679791|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19679792|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19679793|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19679794|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679795|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679796|NCT05024773|Paclitaxel|paclitaxel|mesh-list
19679797|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
19679798|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19679799|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679800|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
19679801|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
19679802|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
19679803|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679804|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19842196|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842197|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842198|NCT00650078|Prednisone|prednisone|mesh-list
19842199|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842200|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
19842201|NCT00650078|Hormones|hormones|mesh-ancestor
19842202|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842203|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842204|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19842205|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842206|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
19842207|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19842208|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
20426203|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332882|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332883|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
19679805|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
19679806|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332884|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332885|NCT03883880|Protective Agents|protective agents|mesh-ancestor
19332886|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19332887|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19332888|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332889|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19332890|NCT03883919|Vitamin D|vitamin d|mesh-list
20381433|NCT01027689|Alprazolam|alprazolam|mesh-list
20381434|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19332891|NCT03883919|Leucovorin|leucovorin|mesh-list
19332892|NCT03883919|Fluorouracil|fluorouracil|mesh-list
19332893|NCT03883919|Irinotecan|irinotecan|mesh-list
19332894|NCT03883919|Vitamins|vitamins|mesh-ancestor
19332895|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
19332896|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332897|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19332898|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
19332899|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195395|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20195396|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20195397|NCT00234299|Analgesics|analgesics|mesh-ancestor
20195398|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
20195399|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195400|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195401|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195402|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195403|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20195404|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20195405|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195406|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20195407|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20195408|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195409|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
20195410|NCT00234312|Citalopram|citalopram|mesh-list
20195411|NCT00234312|Sertraline|sertraline|mesh-list
20195412|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20195413|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20195414|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195415|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195416|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195417|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
20195418|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195419|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20195420|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
20195421|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20195422|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20195423|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
20195424|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381435|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381436|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381437|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20381438|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20195425|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20195426|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381439|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19332900|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19679807|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
19679808|NCT05024773|Protective Agents|protective agents|mesh-ancestor
19679809|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
19332901|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332902|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19332903|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
19332904|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19332905|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19332906|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332907|NCT03883919|Antidotes|antidotes|mesh-ancestor
19332908|NCT03883919|Protective Agents|protective agents|mesh-ancestor
19332909|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
19332910|NCT03884101|Paclitaxel|paclitaxel|mesh-list
19332911|NCT03884101|Carboplatin|carboplatin|mesh-list
19679810|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332912|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
19332913|NCT03884101|Lenvatinib|lenvatinib|mesh-list
19399342|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20381440|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
20381441|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
19332914|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19332915|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332916|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
19332917|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
19332918|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
19332919|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195427|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195428|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332920|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19332921|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19332922|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332923|NCT03884036|Vitamin D|vitamin d|mesh-list
19332924|NCT03884036|Vitamins|vitamins|mesh-ancestor
19679811|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
19679812|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679813|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679814|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19679815|NCT05014334|Amoxicillin|amoxicillin|mesh-list
19679816|NCT05014334|Clarithromycin|clarithromycin|mesh-list
19679817|NCT05014334|Rabeprazole|rabeprazole|mesh-list
19679818|NCT05014334|Bismuth|bismuth|mesh-list
19679819|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19679820|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332925|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
19332926|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381442|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381443|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381444|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
20381445|NCT01027832|Tazobactam|tazobactam|mesh-list
20381446|NCT01027832|Piperacillin|piperacillin|mesh-list
19332927|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19332928|NCT03883984|Cysteamine|cysteamine|mesh-list
19332929|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19332930|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332931|NCT03883776|Octreotide|octreotide|mesh-list
19332932|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19332933|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19332934|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19332935|NCT03883763|Bupivacaine|bupivacaine|mesh-list
19332936|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
19679821|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19679822|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332937|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
19332938|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332939|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332940|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
19332941|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332942|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
19332943|NCT03883347|Remifentanil|remifentanil|mesh-list
19332944|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19332945|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19332946|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679823|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679824|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19679825|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19679826|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19679827|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20195429|NCT00234390|Budesonide|budesonide|mesh-list
19332947|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19332948|NCT03883347|Analgesics|analgesics|mesh-ancestor
19332949|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
19679828|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20195430|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195431|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20195432|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
20195433|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195434|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195435|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20195436|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
20195437|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
19332950|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679829|NCT05014334|Antacids|antacids|mesh-ancestor
20195438|NCT00234390|Hormones|hormones|mesh-ancestor
20381447|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19332951|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19332952|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20381448|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381449|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381450|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20381451|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381452|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381453|NCT01027923|Cytarabine|cytarabine|mesh-list
20381454|NCT01027923|Plerixafor|plerixafor|mesh-list
20381455|NCT01027923|Etoposide|etoposide|mesh-list
20381456|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
20381457|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20381458|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381459|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20381460|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20381461|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381462|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381463|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381464|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
20381465|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
19332953|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19332954|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
19332955|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19332956|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332957|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19679830|NCT05014087|Digoxin|digoxin|mesh-list
19679831|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19679832|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20381466|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381467|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381468|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
20381469|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381470|NCT01027923|Analgesics|analgesics|mesh-ancestor
20381471|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
20381472|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381473|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20381474|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20381475|NCT01028079|Aspirin|aspirin|mesh-list
20381476|NCT01028079|Ibuprofen|ibuprofen|mesh-list
20381477|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20381478|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381479|NCT01028079|Analgesics|analgesics|mesh-ancestor
20381480|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
20381481|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381482|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381483|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381484|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381485|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20381486|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20381487|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381488|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20381489|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19332958|NCT03883347|Narcotics|narcotics|mesh-ancestor
19399343|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
19399344|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399345|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19399346|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
20381490|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842209|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842210|NCT00650091|Expectorants|expectorants|mesh-ancestor
20381491|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
20381492|NCT01028092|Cyclosporine|cyclosporine|mesh-list
19399347|NCT03635398|Midazolam|midazolam|mesh-list
19679833|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679834|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679835|NCT05014087|Protective Agents|protective agents|mesh-ancestor
19679836|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679837|NCT05002192|Eucalyptol|eucalyptol|mesh-list
19679838|NCT05002192|Ambroxol|ambroxol|mesh-list
19679839|NCT05002192|Expectorants|expectorants|mesh-list
19679840|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
20381493|NCT01028092|Everolimus|everolimus|mesh-list
20381494|NCT01028092|Interleukin-2|interleukin-2|mesh-list
19679841|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381495|NCT01028092|Cyclosporins|cyclosporins|mesh-list
20381496|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
20381497|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332959|NCT03883360|Cannabidiol|cannabidiol|mesh-list
19332960|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
19332961|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
19332962|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
19332963|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332964|NCT03883269|Ethanol|ethanol|mesh-list
19332965|NCT03883269|Clindamycin|clindamycin|mesh-list
19332966|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
19332967|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
19332968|NCT03883269|Erythromycin|erythromycin|mesh-list
19332969|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
19332970|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19332971|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
20195439|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195440|NCT00234403|Fulvestrant|fulvestrant|mesh-list
20195441|NCT00234403|Gefitinib|gefitinib|mesh-list
20195442|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20195443|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195444|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20195445|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20195446|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
19332972|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19332973|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19332974|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195447|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195448|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195449|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20195450|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195451|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195452|NCT00234416|Gemcitabine|gemcitabine|mesh-list
20195453|NCT00234416|Gefitinib|gefitinib|mesh-list
20195454|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195455|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
20195456|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195457|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195458|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
19332975|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332976|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332977|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19332978|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19332979|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332980|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19332981|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
19332982|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19332983|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
19332984|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332985|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
19332986|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381498|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381499|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381500|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
20381501|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381502|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
20381503|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381504|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
20381505|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381506|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19332987|NCT03883022|Vancomycin|vancomycin|mesh-list
19332988|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19332989|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195459|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195460|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195461|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195462|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
20195463|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195464|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20195465|NCT00234429|Gefitinib|gefitinib|mesh-list
20381507|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381508|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381509|NCT01028092|Analgesics|analgesics|mesh-ancestor
20381510|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
19332990|NCT03883204|Risperidone|risperidone|mesh-list
19332991|NCT03883204|Aripiprazole|aripiprazole|mesh-list
20195466|NCT00234429|Raltitrexed|raltitrexed|mesh-list
20381511|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19332992|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20381512|NCT01028170|Furosemide|furosemide|mesh-list
20195467|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195468|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679842|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
19679843|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
19679844|NCT05002192|Protective Agents|protective agents|mesh-ancestor
19679845|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842211|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
19842212|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19842213|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
19842214|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381513|NCT01028170|Diuretics|diuretics|mesh-ancestor
20381514|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
20381515|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381516|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20381517|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381518|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381519|NCT01028248|Ranibizumab|ranibizumab|mesh-list
20381520|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20381521|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20381522|NCT01028248|Growth Substances|growth substances|mesh-ancestor
20381523|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381524|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381525|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381526|NCT01028261|CKD732|ckd732|mesh-list
19842215|NCT00650091|Protective Agents|protective agents|mesh-ancestor
19842216|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842217|NCT00650091|Antidotes|antidotes|mesh-ancestor
19842218|NCT00650104|Ropinirole|ropinirole|mesh-list
20381527|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19332993|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
19679846|NCT04975347|Naloxone|naloxone|mesh-list
19679847|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679848|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19679849|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
19679850|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679851|NCT04975334|Naloxone|naloxone|mesh-list
19679852|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19679853|NCT04975334|Hormones|hormones|mesh-ancestor
19679854|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679855|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679856|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19679857|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
19332994|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195469|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195470|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195471|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195472|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
20195473|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20195474|NCT00234442|Gefitinib|gefitinib|mesh-list
20195475|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381528|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19332995|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19332996|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19332997|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19332998|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19332999|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333000|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333001|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19333002|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
19333003|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
19333004|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
19333005|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19333006|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19333007|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19333008|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19333009|NCT03882710|Metoprolol|metoprolol|mesh-list
19333010|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19333011|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19333012|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
19842219|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19333013|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
19842220|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20195476|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19333014|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333015|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333016|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19333017|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19333018|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19333019|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
19333020|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333021|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333022|NCT03882814|Meperidine|meperidine|mesh-list
19333023|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19333024|NCT03882814|Narcotics|narcotics|mesh-ancestor
19333025|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333026|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333027|NCT03882814|Analgesics|analgesics|mesh-ancestor
19333028|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
19333029|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333030|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19333031|NCT03882775|Heparin|heparin|mesh-list
19333032|NCT03882775|Bivalirudin|bivalirudin|mesh-list
19333033|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
19333034|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19333035|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19333036|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333037|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
19333038|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19333039|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
19333040|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333041|NCT03882788|Fentanyl|fentanyl|mesh-list
20381529|NCT01028261|Growth Substances|growth substances|mesh-ancestor
20381530|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381531|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381532|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381533|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20381534|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20381535|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
20381536|NCT01028287|Hormones|hormones|mesh-ancestor
20381537|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381538|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381539|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381540|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381541|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
19333042|NCT03882788|Isoflurane|isoflurane|mesh-list
19333043|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19333044|NCT03882788|Narcotics|narcotics|mesh-ancestor
19333045|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333046|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333047|NCT03882788|Analgesics|analgesics|mesh-ancestor
19333048|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
19333049|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333050|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19333051|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19333052|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
19333053|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
19333054|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19333055|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
19333056|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333057|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
19333058|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333059|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333060|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
19333061|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679858|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679859|NCT04973020|Efavirenz|efavirenz|mesh-list
19679860|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20195477|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195478|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195479|NCT00234455|Sirolimus|sirolimus|mesh-list
20195480|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195481|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195482|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195483|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195484|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
20195485|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19333062|NCT03882541|Midazolam|midazolam|mesh-list
19333063|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20195486|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
19333064|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19333065|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333066|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333067|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19333068|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19333069|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333070|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19333071|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
19333072|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
19333073|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
19333074|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
19333075|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333076|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333077|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
19333078|NCT03882099|Vitamin D|vitamin d|mesh-list
20195487|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195488|NCT00234468|Gefitinib|gefitinib|mesh-list
20195489|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195490|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20195491|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195492|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195493|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
20195494|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20195495|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20195496|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20195497|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19333079|NCT03882099|Vitamins|vitamins|mesh-ancestor
19333080|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
19333081|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195498|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333082|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19333083|NCT03882164|Tacrolimus|tacrolimus|mesh-list
19333084|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19333085|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
19333086|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333087|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19333088|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333089|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333090|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
19333091|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
19333092|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333093|NCT03882255|Propranolol|propranolol|mesh-list
19333094|NCT03882255|Ponesimod|ponesimod|mesh-list
19333095|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19333096|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19333097|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
19679861|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19679862|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679863|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679864|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
19679865|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679866|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19679867|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19842221|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
19842222|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
19842223|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842224|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842225|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842226|NCT00650546|Exenatide|exenatide|mesh-list
19842227|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19842228|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842229|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19842230|NCT00650546|Incretins|incretins|mesh-ancestor
19842231|NCT00650546|Hormones|hormones|mesh-ancestor
19842232|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842233|NCT00650806|Canagliflozin|canagliflozin|mesh-list
19842234|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19842235|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842236|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19842237|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842238|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19333098|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195499|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
20195500|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333099|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333100|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333101|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195501|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195502|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20195503|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195504|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
20195505|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20195506|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20195507|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20195508|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195509|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381542|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20381543|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20381544|NCT01028313|Prednisolone|prednisolone|mesh-list
20381545|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
20381546|NCT01028313|Panobinostat|panobinostat|mesh-list
20381547|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20381548|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
19333102|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195510|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
20195511|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195512|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195513|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20195514|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679868|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19679869|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19679870|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19679871|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19679872|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
19679873|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19679874|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679875|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679876|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19679877|NCT04955249|Analgesics|analgesics|mesh-ancestor
19679878|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
19679879|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679880|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19679881|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19679882|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19333103|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195515|NCT00234572|Lanreotide|lanreotide|mesh-list
20195516|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195517|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
20195518|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20195519|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20195520|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195521|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
20195522|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195523|NCT00234637|Memantine|memantine|mesh-list
20195524|NCT00234637|Rivastigmine|rivastigmine|mesh-list
20195525|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19333104|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19333105|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19333106|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
19333107|NCT03882008|Abatacept|abatacept|mesh-list
19333108|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19333109|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333110|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333111|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19333112|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
19333113|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333114|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333115|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
19333116|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19333117|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333118|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
19333119|NCT03882060|Hematinics|hematinics|mesh-ancestor
19333120|NCT03881943|Aspirin|aspirin|mesh-list
19679883|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
20195526|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20195527|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
20381549|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333121|NCT03881943|Ticagrelor|ticagrelor|mesh-list
19333122|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20381550|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
20381551|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
20381552|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333123|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19333124|NCT03881943|Analgesics|analgesics|mesh-ancestor
19333125|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
19333126|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333127|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333128|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333129|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333130|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19333131|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19333132|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333133|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19333134|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19333135|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333136|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
19333137|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19333138|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19333139|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19333140|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
19333141|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333142|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19333143|NCT03881904|Gestodene|gestodene|mesh-list
19333144|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19333145|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19333146|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19333147|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
19333148|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19333149|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333150|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19333151|NCT03881904|Estrogens|estrogens|mesh-ancestor
19333152|NCT03881904|Hormones|hormones|mesh-ancestor
19333153|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333154|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19333155|NCT03881904|Progestins|progestins|mesh-ancestor
19333156|NCT03881644|Sumatriptan|sumatriptan|mesh-list
19333157|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
19333158|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19333159|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19333160|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19333161|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
19333162|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679884|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679885|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679886|NCT04908787|Paclitaxel|paclitaxel|mesh-list
19679887|NCT04908787|Doxorubicin|doxorubicin|mesh-list
19679888|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20195528|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679889|NCT04908787|Topotecan|topotecan|mesh-list
19679890|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19679891|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679892|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
19679893|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
19679894|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
19679895|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679896|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19679897|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20195529|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195530|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195531|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20195532|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20195533|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20195534|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195535|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
20195536|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20195537|NCT00234637|Protective Agents|protective agents|mesh-ancestor
20195538|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20195539|NCT00234676|Estrogens|estrogens|mesh-ancestor
20195540|NCT00234676|Hormones|hormones|mesh-ancestor
20195541|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381553|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381554|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381555|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
19679898|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19679899|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679900|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19679901|NCT04908449|Bupivacaine|bupivacaine|mesh-list
19679902|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
20381556|NCT01028313|Hormones|hormones|mesh-ancestor
20381557|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381558|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20381559|NCT01028313|Protective Agents|protective agents|mesh-ancestor
20381560|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20381561|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381562|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20381563|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381564|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381565|NCT01028339|Mannitol|mannitol|mesh-list
20381566|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20381567|NCT01028339|Diuretics|diuretics|mesh-ancestor
20381568|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
19679903|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
20381569|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381570|NCT01028404|Insulin|insulin|mesh-list
20381571|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20381572|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
20381573|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
20381574|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20381575|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20381576|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381577|NCT01028443|Cyclosporine|cyclosporine|mesh-list
20381578|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
20381579|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381580|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
20381581|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381582|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333163|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333164|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679904|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679905|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679906|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
19679907|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679908|NCT04886453|Morphine|morphine|mesh-list
19679909|NCT04886453|Anesthetics|anesthetics|mesh-list
19679910|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19679911|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842239|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
19333165|NCT03881644|Growth Substances|growth substances|mesh-ancestor
19333166|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
19333167|NCT03881787|Cetuximab|cetuximab|mesh-list
19333168|NCT03881787|Antibodies|antibodies|mesh-list
19333169|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19333170|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
19333171|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333172|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19333173|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399348|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19679912|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19842240|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
19842241|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842242|NCT00650858|Plasminogen|plasminogen|mesh-list
19842243|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19679913|NCT04886453|Narcotics|narcotics|mesh-ancestor
19679914|NCT04886453|Analgesics|analgesics|mesh-ancestor
19679915|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
19679916|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679917|NCT04849832|Fesoterodine|fesoterodine|mesh-list
19679918|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19679919|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19842244|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19842245|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19842246|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399349|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19842247|NCT00651040|Prednisone|prednisone|mesh-list
19842248|NCT00651040|Prednisolone|prednisolone|mesh-list
20381583|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381584|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
20381585|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381586|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381587|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20381588|NCT01028482|Sertraline|sertraline|mesh-list
20381589|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
20381590|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381591|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20381592|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19333174|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
19333175|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333176|NCT03881423|Bromides|bromides|mesh-list
19333177|NCT03881423|Rocuronium|rocuronium|mesh-list
19333178|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19333179|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
19679920|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
19679921|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19679922|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679923|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679924|NCT04849832|Urological Agents|urological agents|mesh-ancestor
19679925|NCT04780932|Macitentan|macitentan|mesh-list
19679926|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19679927|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19679928|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679929|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19679930|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
19679931|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19679932|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
19679933|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679934|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
19679935|NCT04769453|Protective Agents|protective agents|mesh-ancestor
19679936|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
19679937|NCT04745988|Lenvatinib|lenvatinib|mesh-list
20381593|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381594|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381595|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333180|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19333181|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19333182|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333183|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333184|NCT03881293|Lidocaine|lidocaine|mesh-list
19333185|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333186|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
19333187|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333188|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333189|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
19333190|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381596|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
20381597|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381598|NCT01028495|Gemcitabine|gemcitabine|mesh-list
20381599|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381600|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
20381601|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381602|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381603|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
20381604|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381605|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381606|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381607|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
19333191|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19333192|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19333193|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19333194|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19333195|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333196|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
19333197|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333198|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19333199|NCT03881449|Aripiprazole|aripiprazole|mesh-list
19333200|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
19333201|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333202|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19333203|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381608|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679938|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679939|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679940|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19679941|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679942|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679943|NCT04717154|Nivolumab|nivolumab|mesh-list
19679944|NCT04717154|Ipilimumab|ipilimumab|mesh-list
19679945|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19679946|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195542|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195543|NCT00234689|Naltrexone|naltrexone|mesh-list
20195544|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20195545|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20195546|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195547|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
20195548|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195549|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
20195550|NCT00234819|Estrogens|estrogens|mesh-list
20195551|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20195552|NCT00234819|Hormones|hormones|mesh-ancestor
20195553|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195554|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195555|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20195556|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20195557|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
20195558|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20195559|NCT00234845|Adalimumab|adalimumab|mesh-list
20195560|NCT00234845|Methotrexate|methotrexate|mesh-list
20195561|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20195562|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
19679947|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19679948|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679949|NCT04702464|Fluconazole|fluconazole|mesh-list
19679950|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
19679951|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19679952|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19679953|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19679954|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679955|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381609|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20381610|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
20381611|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381612|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381613|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381614|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20381615|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20381616|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381617|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381618|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20381619|NCT01028534|Olmesartan|olmesartan|mesh-list
20381620|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20381621|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
20381622|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
20381623|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20381624|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20381625|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381626|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20381627|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20381628|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381629|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20381630|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381631|NCT01028547|Dexamethasone|dexamethasone|mesh-list
20381632|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679956|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19679957|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
19679958|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19679959|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679960|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20195563|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20195564|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679961|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19679962|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
19679963|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
19679964|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20195565|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195566|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
20195567|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195568|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195569|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195570|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195571|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20195572|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195573|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
20195574|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195575|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20195576|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381633|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
19333204|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333205|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333206|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
19333207|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
19333208|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333209|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333210|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19333211|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19333212|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
19333213|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19333214|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19333215|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19333216|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19333217|NCT03881345|Anticoagulants|anticoagulants|mesh-list
19333218|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
20381634|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
20381635|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381636|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333219|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
19333220|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19679965|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19679966|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195577|NCT00234858|Losartan|losartan|mesh-list
20195578|NCT00234858|Verapamil|verapamil|mesh-list
20195579|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19679967|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679968|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679969|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195580|NCT00234858|Trandolapril|trandolapril|mesh-list
20381637|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381638|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
20381639|NCT01028547|Hormones|hormones|mesh-ancestor
20381640|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195581|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195582|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195583|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20195584|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20195585|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195586|NCT00234858|Diuretics|diuretics|mesh-ancestor
20381641|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19679970|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
20195587|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
20195588|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195589|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20195590|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195591|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20195592|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20195593|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195594|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20195595|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
19679971|NCT04664972|Docetaxel|docetaxel|mesh-list
19679972|NCT04664972|Doxorubicin|doxorubicin|mesh-list
19679973|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195596|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195597|NCT00234871|Verapamil|verapamil|mesh-list
19679974|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
19692493|NCT04991194|Zamicastat|zamicastat|mesh-list
20195598|NCT00234871|Amlodipine|amlodipine|mesh-list
20195599|NCT00234871|Benazepril|benazepril|mesh-list
19333221|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333222|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19333223|NCT03880981|Acetaminophen|acetaminophen|mesh-list
19333224|NCT03880981|Ibuprofen|ibuprofen|mesh-list
19333225|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19333226|NCT03880981|Analgesics|analgesics|mesh-ancestor
19333227|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
19333228|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333229|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333230|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
19333231|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19333232|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333233|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333234|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19679975|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195600|NCT00234871|Trandolapril|trandolapril|mesh-list
20195601|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195602|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20195603|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195604|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195605|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20195606|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195607|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195608|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195609|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20195610|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195611|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195612|NCT00234897|Adalimumab|adalimumab|mesh-list
20195613|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195614|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195615|NCT00234910|Ritonavir|ritonavir|mesh-list
20195616|NCT00234910|Lopinavir|lopinavir|mesh-list
20195617|NCT00234910|Tenofovir|tenofovir|mesh-list
20195618|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20195619|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20195620|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195621|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195622|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195623|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20195624|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20195625|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
20195626|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195627|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20195628|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20195629|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20195630|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20195631|NCT00234923|Ritonavir|ritonavir|mesh-list
20195632|NCT00234923|Lopinavir|lopinavir|mesh-list
20195633|NCT00234923|Lamivudine|lamivudine|mesh-list
20195634|NCT00234923|Zidovudine|zidovudine|mesh-list
20195635|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20195636|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20195637|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20195638|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195639|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195640|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195641|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20195642|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20195643|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
20195644|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195645|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20195646|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20195647|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20195648|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20195649|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
20195650|NCT00234936|Adalimumab|adalimumab|mesh-list
20195651|NCT00234936|Methotrexate|methotrexate|mesh-list
20195652|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20195653|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
20195654|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20195655|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195656|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381642|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381643|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20381644|NCT01028573|Laxatives|laxatives|mesh-ancestor
20381645|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381646|NCT01028638|Bevacizumab|bevacizumab|mesh-list
20381647|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20381648|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20381649|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381650|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20381651|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19333235|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333236|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333237|NCT03880903|Albuterol|albuterol|mesh-list
19333238|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19333239|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
19333240|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333241|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333242|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19333243|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
19679976|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19679977|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20381652|NCT01028638|Growth Substances|growth substances|mesh-ancestor
20381653|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381654|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381655|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20381656|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381657|NCT01028729|Gemcitabine|gemcitabine|mesh-list
20381658|NCT01028729|Endostar protein|endostar protein|mesh-list
20381659|NCT01028729|Endostatins|endostatins|mesh-list
20381660|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381661|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381662|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
20381663|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381664|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
20381665|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381666|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381667|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381668|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
20381669|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381670|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20381671|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20381672|NCT01028729|Growth Substances|growth substances|mesh-ancestor
20381673|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381674|NCT01028768|Teduglutide|teduglutide|mesh-list
20381675|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381676|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20381677|NCT01028768|Protective Agents|protective agents|mesh-ancestor
20381678|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381679|NCT01028781|Thalidomide|thalidomide|mesh-list
20381680|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381681|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
19679978|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
19679979|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19679980|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679981|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19679982|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
19679983|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
19679984|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
19679985|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19679986|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20195657|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
20195658|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195659|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195660|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195661|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195662|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20195663|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195664|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
20195665|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195666|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20381682|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381683|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
19679987|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20381684|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381685|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381686|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20381687|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20381688|NCT01028781|Growth Substances|growth substances|mesh-ancestor
20381689|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381690|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19679988|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19679989|NCT04652544|Vitamin D|vitamin d|mesh-list
19679990|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
19679991|NCT04652544|Vitamins|vitamins|mesh-ancestor
19679992|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
19679993|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19679994|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19679995|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20381691|NCT01028846|Diazoxide|diazoxide|mesh-list
20381692|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20381693|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
20381694|NCT01028924|Teduglutide|teduglutide|mesh-list
20381695|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333244|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
19333245|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19333246|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19333247|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19333248|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19333249|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
19333250|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333251|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333252|NCT03880968|Etanercept|etanercept|mesh-list
19333253|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19333254|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381696|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20381697|NCT01028924|Protective Agents|protective agents|mesh-ancestor
20381698|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381699|NCT01028950|Darexaban|darexaban|mesh-list
20381700|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20381701|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
20381702|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20381703|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
20381704|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381705|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381706|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
20381707|NCT01028963|Pioglitazone|pioglitazone|mesh-list
20381708|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20381709|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381710|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
20381711|NCT01028976|Vitamins|vitamins|mesh-ancestor
20381712|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
20381713|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381714|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
20381715|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381716|NCT01028976|Protective Agents|protective agents|mesh-ancestor
20381717|NCT01029002|Vitamin D|vitamin d|mesh-list
20381718|NCT01029002|Vitamins|vitamins|mesh-ancestor
20381719|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
20381720|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381721|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20381722|NCT01029132|Galantamine|galantamine|mesh-list
20381723|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20381724|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381725|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381726|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
20381727|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381728|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381729|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19333255|NCT03880968|Analgesics|analgesics|mesh-ancestor
19333256|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
19333257|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333258|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333259|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679996|NCT04644705|Niclosamide|niclosamide|mesh-list
19842249|NCT00651040|Methotrexate|methotrexate|mesh-list
19842250|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19679997|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
20381730|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
20381731|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381732|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
19692494|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333260|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333261|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333262|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19333263|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
19333264|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19333265|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19333266|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19333267|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842251|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
19842252|NCT00651040|Hormones|hormones|mesh-ancestor
19842253|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842254|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381733|NCT01029223|Metoprolol|metoprolol|mesh-list
19333268|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333269|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381734|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20381735|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20381736|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
20381737|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
20381738|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381739|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381740|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20381741|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20381742|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20381743|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
20381744|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381745|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381746|NCT01029275|Octreotide|octreotide|mesh-list
20381747|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381748|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20381749|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381750|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20381751|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381752|NCT01029418|Sorafenib|sorafenib|mesh-list
20381753|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381754|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20381755|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381756|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426204|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426205|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20426206|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
19333270|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333271|NCT03880916|Analgesics|analgesics|mesh-ancestor
19333272|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
19333273|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19679998|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19679999|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
19680000|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19680001|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680002|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
19692495|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692496|NCT04991012|Triamcinolone|triamcinolone|mesh-list
19692497|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20426207|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
20426208|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19333274|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
19333275|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333276|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
19333277|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
19333278|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19333279|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333280|NCT03880734|Vitamins|vitamins|mesh-ancestor
20426209|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20426210|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20426211|NCT01279499|Narcotics|narcotics|mesh-ancestor
20426212|NCT01279499|Analgesics|analgesics|mesh-ancestor
20426213|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
20426214|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426215|NCT01279512|Metformin|metformin|mesh-list
20426216|NCT01279512|Acarbose|acarbose|mesh-list
20426217|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19333281|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
19842255|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20426218|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381757|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
20381758|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20381759|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381760|NCT01029522|Atorvastatin|atorvastatin|mesh-list
20381761|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20381762|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20381763|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
20381764|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381765|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20381766|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20381767|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381768|NCT01029613|Adalimumab|adalimumab|mesh-list
20381769|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381770|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381771|NCT01029639|Insulin|insulin|mesh-list
20381772|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
20381773|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20381774|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20381775|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381776|NCT01029678|Vinorelbine|vinorelbine|mesh-list
20381777|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381778|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20381779|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
20381780|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
20381781|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
20381782|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381783|NCT01029743|Aspirin|aspirin|mesh-list
20381784|NCT01029743|PENTA|penta|mesh-list
20381785|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
20381786|NCT01029743|Fondaparinux|fondaparinux|mesh-list
20381787|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20381788|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381789|NCT01029743|Analgesics|analgesics|mesh-ancestor
20381790|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
20381791|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333282|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19333283|NCT03880877|Leucovorin|leucovorin|mesh-list
19333284|NCT03880877|Antidotes|antidotes|mesh-ancestor
19333285|NCT03880877|Protective Agents|protective agents|mesh-ancestor
19333286|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333287|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
19333288|NCT03880877|Vitamins|vitamins|mesh-ancestor
19680003|NCT04637555|Valsartan|valsartan|mesh-list
19680004|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19680005|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19680006|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19680007|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680008|NCT04607122|Landiolol|landiolol|mesh-list
19680009|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19680010|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19680011|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680012|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680013|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680014|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680015|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19680016|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
19842256|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381792|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381793|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333289|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
19333290|NCT03880695|Doxorubicin|doxorubicin|mesh-list
19333291|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19333292|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19333293|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333294|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19333295|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19333296|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333297|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333298|NCT03880448|Metronidazole|metronidazole|mesh-list
19333299|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333300|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19333301|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19333302|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19842257|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19842258|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
20381794|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333306|NCT03880487|Oxycodone|oxycodone|mesh-list
19333307|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20381795|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20381796|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20381797|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381798|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20381799|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19842259|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19842260|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20381800|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333308|NCT03880487|Narcotics|narcotics|mesh-ancestor
19680017|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680018|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680019|NCT04576663|Phenylephrine|phenylephrine|mesh-list
19680020|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
19680021|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19680022|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
19680023|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
19680024|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680025|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680026|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
19680027|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19680028|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
19680029|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
19680030|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19680031|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19680032|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19680033|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680034|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680035|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680036|NCT04576663|Protective Agents|protective agents|mesh-ancestor
19680037|NCT04556357|Phenylephrine|phenylephrine|mesh-list
19680038|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
20381801|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
20381802|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20381803|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
19333309|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680039|NCT04556357|Norepinephrine|norepinephrine|mesh-list
19680040|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19680041|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19680042|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
19680043|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
19680044|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680045|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680046|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
19680047|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
19680048|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
19680049|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19680050|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19680051|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19680052|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680053|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680054|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680055|NCT04556357|Protective Agents|protective agents|mesh-ancestor
19680056|NCT04553939|Gemcitabine|gemcitabine|mesh-list
19842261|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
19842262|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842263|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842264|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842265|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19842266|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195667|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195668|NCT00234949|Cephalexin|cephalexin|mesh-list
20195669|NCT00234949|Cefdinir|cefdinir|mesh-list
20195670|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195671|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195672|NCT00234962|Ritonavir|ritonavir|mesh-list
20195673|NCT00234962|Lopinavir|lopinavir|mesh-list
19680057|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19842267|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
19842268|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842269|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19842270|NCT00651118|Fluticasone|fluticasone|mesh-list
19842271|NCT00651118|Xhance|xhance|mesh-list
20381804|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19680058|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
20195674|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20195675|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19680059|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680060|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680061|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
19680062|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195676|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195677|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195678|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195679|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20195680|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20381805|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
19333310|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333311|NCT03880487|Analgesics|analgesics|mesh-ancestor
19333312|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
19333313|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333314|NCT03880825|Metformin|metformin|mesh-list
19333315|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19333316|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333317|NCT03880357|Betamethasone|betamethasone|mesh-list
19333318|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
19333319|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19333320|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
20381806|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
20381807|NCT01029769|Olanzapine|olanzapine|mesh-list
20381808|NCT01029769|Amisulpride|amisulpride|mesh-list
20381809|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
20381810|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
19333321|NCT03880357|Calcipotriene|calcipotriene|mesh-list
19333322|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19333323|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333324|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
19333325|NCT03880357|Hormones|hormones|mesh-ancestor
19333326|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333327|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333328|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19333329|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
19333330|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195681|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
19333331|NCT03880396|Cisplatin|cisplatin|mesh-list
20195682|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195683|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20195684|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20195685|NCT00234975|Ritonavir|ritonavir|mesh-list
20195686|NCT00234975|Lopinavir|lopinavir|mesh-list
20195687|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19333332|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333333|NCT03880409|Lidocaine|lidocaine|mesh-list
19333334|NCT03880409|Epinephrine|epinephrine|mesh-list
19333335|NCT03880409|Racepinephrine|racepinephrine|mesh-list
19333336|NCT03880409|Carticaine|carticaine|mesh-list
19333337|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
19333338|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333339|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
19333340|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333341|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333342|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
19333343|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333344|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19333345|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19333346|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19333347|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19333348|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333349|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19333350|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19333351|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
19333352|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333353|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19680063|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680064|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680065|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
19680066|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680067|NCT04547946|Trametinib|trametinib|mesh-list
19680068|NCT04547946|Dabrafenib|dabrafenib|mesh-list
20195688|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19333354|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19680069|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381811|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381812|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333355|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
19333356|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19333357|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
19333358|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
20381813|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381814|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20381815|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381816|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381817|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381818|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20381819|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20381820|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381821|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381822|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381823|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
20381824|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20381825|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
20381826|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20381827|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
20381828|NCT01029821|Heparin|heparin|mesh-list
20381829|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20381830|NCT01029821|Tinzaparin|tinzaparin|mesh-list
19333359|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
19333360|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19333361|NCT03880045|Vasopressins|vasopressins|mesh-list
19333362|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
19333363|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
19333364|NCT03880045|Coagulants|coagulants|mesh-ancestor
20381831|NCT01029821|Dalteparin|dalteparin|mesh-list
20381832|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
20381833|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19333365|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19333366|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19680070|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19680071|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680072|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680073|NCT04515901|Lidocaine|lidocaine|mesh-list
19680074|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
19680075|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
19680076|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680077|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680078|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
19680079|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680080|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19680081|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19680082|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19680083|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680084|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680085|NCT04501939|Venetoclax|venetoclax|mesh-list
19680086|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381834|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20381835|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381836|NCT01029847|Adalimumab|adalimumab|mesh-list
20381837|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381838|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381839|NCT01030016|Atenolol|atenolol|mesh-list
20381840|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19333367|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
19333368|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680087|NCT04468425|Tofacitinib|tofacitinib|mesh-list
19680088|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680089|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19680090|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680091|NCT04434326|Vorolanib|vorolanib|mesh-list
19680092|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19680093|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680094|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680095|NCT04426968|Interferons|interferons|mesh-list
19680096|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381841|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19333369|NCT03879889|Nicotine|nicotine|mesh-list
20381842|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
20381843|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333370|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19333371|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
19333372|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333373|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333374|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19680097|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
19680098|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680099|NCT04400695|Paclitaxel|paclitaxel|mesh-list
19680100|NCT04400695|Vinorelbine|vinorelbine|mesh-list
19680101|NCT04400695|Docetaxel|docetaxel|mesh-list
19333375|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19333376|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
19333377|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333378|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333379|NCT03880123|Ixazomib|ixazomib|mesh-list
19333380|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333381|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
19333382|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333383|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333384|NCT03879837|Fluticasone|fluticasone|mesh-list
19333385|NCT03879837|Xhance|xhance|mesh-list
19333386|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333387|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19333388|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
19333389|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333390|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333391|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19333392|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
19333393|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
19680102|NCT04400695|Capecitabine|capecitabine|mesh-list
19680103|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19680104|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680105|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680106|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
20195689|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195690|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195691|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195692|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20195693|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20195694|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
20195695|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195696|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20195697|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20195698|NCT00234988|Sibutramine|sibutramine|mesh-list
20195699|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
20195700|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20195701|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
20195702|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20195703|NCT00235001|Verapamil|verapamil|mesh-list
20195704|NCT00235001|Trandolapril|trandolapril|mesh-list
20195705|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195706|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20195707|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195708|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195709|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20195710|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195711|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195712|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20195713|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195714|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195715|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195716|NCT00235014|Verapamil|verapamil|mesh-list
20195717|NCT00235014|Trandolapril|trandolapril|mesh-list
20195718|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20195719|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20195720|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195721|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195722|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20195723|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195724|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195725|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20195726|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195727|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195728|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19333394|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19680107|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
19680108|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426219|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19680109|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19680110|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
19680111|NCT04359329|Estradiol|estradiol|mesh-list
19680112|NCT04359329|Estrogens|estrogens|mesh-ancestor
19680113|NCT04359329|Hormones|hormones|mesh-ancestor
19680114|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680115|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680116|NCT04328506|Vorolanib|vorolanib|mesh-list
19680117|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19680118|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680119|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680120|NCT04303689|Colchicine|colchicine|mesh-list
19680121|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
19680122|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680123|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680124|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
19680125|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
19680126|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680127|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680128|NCT04287855|Dexamethasone|dexamethasone|mesh-list
19680129|NCT04287855|Pomalidomide|pomalidomide|mesh-list
19680130|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680131|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
19680132|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
19680133|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680134|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680135|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19680136|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
19842272|NCT00651118|Azelastine|azelastine|mesh-list
19842273|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680137|NCT04287855|Hormones|hormones|mesh-ancestor
20195729|NCT00235053|Fluticasone|fluticasone|mesh-list
20195730|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20195731|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20195732|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842274|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19842275|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
19842276|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842277|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842278|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19842279|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
19842280|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842281|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20195733|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20195734|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
20195735|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195736|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195737|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20195738|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
20195739|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195740|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20195741|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20195742|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20195743|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20195744|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
20195745|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195746|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195747|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
20195748|NCT00235053|Hormones|hormones|mesh-ancestor
19680138|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195749|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195750|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
20195751|NCT00235079|Colchicine|colchicine|mesh-list
20195752|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
20195753|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195754|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
20195755|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
20195756|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
20195757|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195758|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195759|NCT00235092|Sirolimus|sirolimus|mesh-list
19333395|NCT03879811|Nivolumab|nivolumab|mesh-list
19680139|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20195760|NCT00235092|Paclitaxel|paclitaxel|mesh-list
19680140|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195761|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20195762|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333396|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19333397|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333398|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19333399|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333400|NCT03879707|Melatonin|melatonin|mesh-list
19333401|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
20426220|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333402|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333403|NCT03879707|Protective Agents|protective agents|mesh-ancestor
19333404|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333405|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333406|NCT03879746|Paroxetine|paroxetine|mesh-list
19333407|NCT03879746|Tamsulosin|tamsulosin|mesh-list
19333408|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19333409|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19333410|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19333411|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333412|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333413|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
19333414|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333415|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19333416|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
19333417|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333418|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19333419|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19680141|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
19680142|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19680143|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19680144|NCT04287855|Growth Substances|growth substances|mesh-ancestor
19680145|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
19680146|NCT04264897|Metformin|metformin|mesh-list
19680147|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19680148|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680149|NCT04253964|Paclitaxel|paclitaxel|mesh-list
19680150|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19680151|NCT04253964|Carboplatin|carboplatin|mesh-list
19333420|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333421|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19680152|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
19680153|NCT04253964|Pemetrexed|pemetrexed|mesh-list
19680154|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19680155|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680156|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680157|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
19680158|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
19680159|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680160|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20195763|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
20195764|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
20195765|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
20195766|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195767|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195768|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195769|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195770|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
20195771|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195772|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
20195773|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195774|NCT00235105|Adalimumab|adalimumab|mesh-list
20195775|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195776|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195777|NCT00235144|Sirolimus|sirolimus|mesh-list
20195778|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195779|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195780|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195781|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195782|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
20195783|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195784|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
20195785|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333422|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19333423|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19333424|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
19333425|NCT03879746|Urological Agents|urological agents|mesh-ancestor
19333426|NCT03879590|Budesonide|budesonide|mesh-list
19680161|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680162|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19680163|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19680164|NCT04246060|Cysteamine|cysteamine|mesh-list
19680165|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19680166|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333427|NCT03879590|Doxofylline|doxofylline|mesh-list
20381844|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381845|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381846|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20381847|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20381848|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
20381849|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
20381850|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381851|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20381852|NCT01030042|Leucovorin|leucovorin|mesh-list
20381853|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
19333428|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333429|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19333430|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
19333431|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333432|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333433|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19333434|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
19680167|NCT04235140|Ivacaftor|ivacaftor|mesh-list
19680168|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19680169|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680170|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680171|NCT04203875|Abatacept|abatacept|mesh-list
19680172|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20381854|NCT01030042|Irinotecan|irinotecan|mesh-list
20381855|NCT01030042|Cetuximab|cetuximab|mesh-list
20381856|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381857|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20381858|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20381859|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381860|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381861|NCT01030042|Antidotes|antidotes|mesh-ancestor
19680173|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680174|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680175|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680176|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
19680177|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680178|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680179|NCT04199026|Sirolimus|sirolimus|mesh-list
19680180|NCT04199026|Doxorubicin|doxorubicin|mesh-list
19680181|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19680182|NCT04199026|Daunorubicin|daunorubicin|mesh-list
19680183|NCT04199026|Irinotecan|irinotecan|mesh-list
19680184|NCT04199026|Vincristine|vincristine|mesh-list
19680185|NCT04199026|Everolimus|everolimus|mesh-list
19680186|NCT04199026|Temozolomide|temozolomide|mesh-list
19680187|NCT04199026|Ifosfamide|ifosfamide|mesh-list
19680188|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
19680189|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20381862|NCT01030042|Protective Agents|protective agents|mesh-ancestor
20381863|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381864|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
20381865|NCT01030042|Vitamins|vitamins|mesh-ancestor
20381866|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
20381867|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20381868|NCT01030081|Amlodipine|amlodipine|mesh-list
20381869|NCT01030081|Nifedipine|nifedipine|mesh-list
20381870|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20381871|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19333435|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
19680190|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19680191|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680192|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19680193|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20381872|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381873|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333436|NCT03879590|Hormones|hormones|mesh-ancestor
19680194|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333437|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381874|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20381875|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381876|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
20381877|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
20381878|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19333438|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
19333439|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19333440|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333441|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333442|NCT03879460|Naltrexone|naltrexone|mesh-list
19333443|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19333444|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19333445|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333446|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
19333447|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333448|NCT03879564|Ketamine|ketamine|mesh-list
19333449|NCT03879564|Analgesics|analgesics|mesh-ancestor
20195786|NCT00235157|Sirolimus|sirolimus|mesh-list
20195787|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195788|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195789|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195790|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680195|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680196|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19680197|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19680198|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680199|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
19680200|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
19680201|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680202|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
19680203|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680204|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19680205|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
19680206|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19680207|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195791|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
20195792|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195793|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
19333450|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
19333451|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680208|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
19680209|NCT04114539|Ecopipam|ecopipam|mesh-list
19680210|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19680211|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19680212|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680213|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680214|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680215|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19680216|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
19680217|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195794|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195795|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
20195796|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20217548|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217549|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217550|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217551|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217552|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20217553|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20217554|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217555|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217556|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
20217557|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20217558|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20217559|NCT00309881|Prednisone|prednisone|mesh-list
20217560|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
20217561|NCT00309881|Rituximab|rituximab|mesh-list
20217562|NCT00309881|Doxorubicin|doxorubicin|mesh-list
20217563|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20217564|NCT00309881|Vincristine|vincristine|mesh-list
20217565|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842282|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19333452|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381879|NCT01030094|Topiramate|topiramate|mesh-list
20381880|NCT01030094|Carbamazepine|carbamazepine|mesh-list
20381881|NCT01030094|Valproic Acid|valproic acid|mesh-list
20381882|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
20381883|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20381884|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381885|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381886|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381887|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
19333453|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19333454|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19680218|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680219|NCT04094298|FX006|fx006|mesh-list
19680220|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680221|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
19680222|NCT04094298|Hormones|hormones|mesh-ancestor
19680223|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680224|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680225|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680226|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
19692498|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19692499|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19692500|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692501|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
19692502|NCT04991012|Hormones|hormones|mesh-ancestor
19692503|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842283|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842284|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842285|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20195797|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
20195798|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20195799|NCT00235222|Stavudine|stavudine|mesh-list
20381888|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381889|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
20381890|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20381891|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20381892|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20381893|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381894|NCT01030094|Analgesics|analgesics|mesh-ancestor
20381895|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
20381896|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381897|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20381898|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20381899|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20381900|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20381901|NCT01030120|Etanercept|etanercept|mesh-list
20381902|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20381903|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20381904|NCT01030120|Analgesics|analgesics|mesh-ancestor
19333455|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
19333456|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
19333457|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333458|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19692504|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842286|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19842287|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
19842288|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
19842289|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842290|NCT00651183|Pramipexole|pramipexole|mesh-list
19842291|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
19842292|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842293|NCT00651183|Protective Agents|protective agents|mesh-ancestor
19842294|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842295|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20195800|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
20195801|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195802|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20195803|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20195804|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195805|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
20381905|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
20381906|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381907|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195806|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680227|NCT04003636|Gemcitabine|gemcitabine|mesh-list
19680228|NCT04003636|Cisplatin|cisplatin|mesh-list
19333459|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19333460|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333461|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399350|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399351|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399352|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19399353|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399354|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19399355|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19399356|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
19399357|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
19399358|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
19399359|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
19399360|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399361|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399362|NCT03635372|Sucralfate|sucralfate|mesh-list
19399363|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
19399364|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19399365|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399366|NCT03635372|Antacids|antacids|mesh-ancestor
19680229|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
19680230|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680231|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19680232|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
19680233|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399367|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399368|NCT03635333|Nicotine|nicotine|mesh-list
19399369|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19399370|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
19399371|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680234|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
19680235|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399372|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399373|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19399374|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19399375|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
19399376|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399377|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680236|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680237|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680238|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
19680239|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680240|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680241|NCT03976934|Tamsulosin|tamsulosin|mesh-list
19680242|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19680243|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19680244|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19680245|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680246|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680247|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195807|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20195808|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20195809|NCT00235235|Gemcitabine|gemcitabine|mesh-list
20195810|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
20195811|NCT00235235|Doxorubicin|doxorubicin|mesh-list
20195812|NCT00235235|Capecitabine|capecitabine|mesh-list
20195813|NCT00235235|Vinorelbine|vinorelbine|mesh-list
20195814|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195815|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
20195816|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195817|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195818|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20195819|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
20195820|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195821|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195822|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20195823|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195824|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
20195825|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
20195826|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399378|NCT03635125|Metoprolol|metoprolol|mesh-list
19680248|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195827|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195828|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19680249|NCT03976934|Urological Agents|urological agents|mesh-ancestor
19680250|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
19680251|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381908|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381909|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381910|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381911|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20381912|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
20381913|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20381914|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
19680252|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
19680253|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680254|NCT03939897|Fulvestrant|fulvestrant|mesh-list
19680255|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20195829|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20195830|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20195831|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19680256|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680257|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19842296|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19842297|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
19842298|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
20381915|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20381916|NCT01030302|Bortezomib|bortezomib|mesh-list
20381917|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381918|NCT01030328|Fenofibrate|fenofibrate|mesh-list
20381919|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20381920|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
19842299|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842300|NCT00651261|Cytarabine|cytarabine|mesh-list
19842301|NCT00651261|Dexamethasone|dexamethasone|mesh-list
19842302|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
19842303|NCT00651261|Daunorubicin|daunorubicin|mesh-list
20195832|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680258|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19680259|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
20195833|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
20381921|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381922|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20381923|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20381924|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20381925|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381926|NCT01030510|Rocuronium|rocuronium|mesh-list
20381927|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20381928|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20381929|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20381930|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381931|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381932|NCT01030601|Dexamethasone|dexamethasone|mesh-list
20381933|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
20381934|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20381935|NCT01030601|BB 1101|bb 1101|mesh-list
20381936|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20381937|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
20381938|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
20381939|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381940|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381941|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20381942|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
20381943|NCT01030601|Hormones|hormones|mesh-ancestor
19842304|NCT00651261|Midostaurin|midostaurin|mesh-list
20195834|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
20195835|NCT00235248|Aspirin|aspirin|mesh-list
20195836|NCT00235248|Warfarin|warfarin|mesh-list
20195837|NCT00235248|Clopidogrel|clopidogrel|mesh-list
20195838|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20195839|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20195840|NCT00235248|Analgesics|analgesics|mesh-ancestor
20195841|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
20195842|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381944|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195843|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381945|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19842305|NCT00651261|BB 1101|bb 1101|mesh-list
19842306|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842307|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
20195844|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195845|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333462|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
19333463|NCT03879486|Formaldehyde|formaldehyde|mesh-list
19333464|NCT03879486|Povidone|povidone|mesh-list
19333465|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
19333466|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
19333467|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19333468|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333469|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
19333470|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
19680260|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680261|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680262|NCT03909217|Dexetimide|dexetimide|mesh-list
19680263|NCT03909217|Citalopram|citalopram|mesh-list
19680264|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19680265|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19680266|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680267|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680268|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680269|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
19680270|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680271|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19680272|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
19680273|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680274|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19680275|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19680276|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
19680277|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
19680278|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680279|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19680280|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19680281|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
19680282|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
19680283|NCT03890289|Idelalisib|idelalisib|mesh-list
19680284|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680285|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680286|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680287|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680288|NCT03870529|Vitamins|vitamins|mesh-list
19680289|NCT03870529|Vitamin A|vitamin a|mesh-list
19680290|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
19680291|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
19333471|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19333472|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
19333473|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333474|NCT03879356|Expectorants|expectorants|mesh-ancestor
19333475|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
19333476|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19333477|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
19333478|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333479|NCT03879356|Protective Agents|protective agents|mesh-ancestor
19333480|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333481|NCT03879356|Antidotes|antidotes|mesh-ancestor
19333482|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
19333483|NCT03879382|Fludarabine|fludarabine|mesh-list
19333484|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680292|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
19680293|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680294|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
19680295|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680296|NCT03870529|Protective Agents|protective agents|mesh-ancestor
20195846|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20195847|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20195848|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195849|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20195850|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19680297|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19680298|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680299|NCT03770546|Betamethasone|betamethasone|mesh-list
19333485|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
19333486|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680300|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195851|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195852|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
19333487|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20381946|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333488|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19333489|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
20195853|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20195854|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20195855|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20195856|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
20195857|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195858|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
20195859|NCT00235261|Dexamethasone|dexamethasone|mesh-list
20195860|NCT00235261|Pregabalin|pregabalin|mesh-list
19680301|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
19680302|NCT03770546|Hormones|hormones|mesh-ancestor
19680303|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680304|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680305|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19680306|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
19680307|NCT03763643|Rituximab|rituximab|mesh-list
19680308|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680309|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680310|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
19680311|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680312|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680313|NCT03749187|Temozolomide|temozolomide|mesh-list
19680314|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19680315|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19680316|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
19680317|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680318|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680319|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680320|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19680321|NCT03712202|Nivolumab|nivolumab|mesh-list
19680322|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19680323|NCT03712202|Doxorubicin|doxorubicin|mesh-list
19680324|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19680325|NCT03712202|Daunorubicin|daunorubicin|mesh-list
19680326|NCT03712202|Bleomycin|bleomycin|mesh-list
19680327|NCT03712202|Dacarbazine|dacarbazine|mesh-list
19680328|NCT03712202|Vinblastine|vinblastine|mesh-list
19680329|NCT03712202|Antibodies|antibodies|mesh-list
19680330|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
19680331|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19680332|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
19680333|NCT03712202|Imidazole|imidazole|mesh-list
19680334|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
19333490|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333491|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842308|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
19842309|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333492|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19333493|NCT03879174|Tamoxifen|tamoxifen|mesh-list
19333494|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
19333495|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19333496|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680335|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680336|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680337|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19680338|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19680339|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19680340|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680341|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680342|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19680343|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19680344|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
19680345|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19680346|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680347|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19680348|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19680349|NCT03659539|Propofol|propofol|mesh-list
19680350|NCT03659539|Desflurane|desflurane|mesh-list
19842310|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381947|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
20381948|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680351|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19842311|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693135|NCT04982809|Hormones|hormones|mesh-ancestor
20381949|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381950|NCT01030614|Dexamethasone|dexamethasone|mesh-list
20381951|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680352|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680353|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680354|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19680355|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
19680356|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
19680357|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20381952|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
20381953|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
20381954|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381955|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333497|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19333498|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
19842312|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
19842313|NCT00651261|Hormones|hormones|mesh-ancestor
19842314|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842315|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19842316|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842317|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19842318|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
20381956|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333499|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381957|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
20381958|NCT01030614|Hormones|hormones|mesh-ancestor
20381959|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381960|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19333500|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333501|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19333502|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19333503|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19333504|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19333505|NCT03879122|Docetaxel|docetaxel|mesh-list
19333506|NCT03879122|Nivolumab|nivolumab|mesh-list
19333507|NCT03879122|Ipilimumab|ipilimumab|mesh-list
19333508|NCT03879122|Androgens|androgens|mesh-list
19333509|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381961|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381962|NCT01030640|Tanezumab|tanezumab|mesh-list
19333510|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
19333511|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
19333512|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
19333513|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680358|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
19333514|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19333515|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19333516|NCT03879122|Hormones|hormones|mesh-ancestor
19333517|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333518|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333519|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
19333520|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
19333521|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
19333522|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333523|NCT03879057|Antibodies|antibodies|mesh-list
19333524|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19333525|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
19333526|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333527|NCT03878888|Bupivacaine|bupivacaine|mesh-list
19333528|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333529|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
19399379|NCT03635125|Nebivolol|nebivolol|mesh-list
19680359|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19680360|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19842319|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842320|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
19842321|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842322|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842323|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
19842324|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19842325|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19842326|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19842327|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842328|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20381963|NCT01030640|Analgesics|analgesics|mesh-ancestor
20381964|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
20381965|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20381966|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381967|NCT01030692|Rivastigmine|rivastigmine|mesh-list
20381968|NCT01030692|Huperzine A|huperzine a|mesh-list
19333530|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680361|NCT03627858|Beclomethasone|beclomethasone|mesh-list
19680362|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
19680363|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
20381969|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20381970|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381971|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381972|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
20381973|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381974|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381975|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20381976|NCT01030692|Protective Agents|protective agents|mesh-ancestor
20381977|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
20381978|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20381979|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20381980|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20381981|NCT01030770|Ranibizumab|ranibizumab|mesh-list
20381982|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20381983|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20381984|NCT01030770|Growth Substances|growth substances|mesh-ancestor
20381985|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381986|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
20381987|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20381988|NCT01030796|Caffeine|caffeine|mesh-list
20381989|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19680364|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19680365|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
19680366|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680367|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680368|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19680369|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
19680370|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19680371|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19680372|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19680373|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680374|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680375|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680376|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680377|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
19680378|NCT03627858|Hormones|hormones|mesh-ancestor
19680379|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680380|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19680381|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19680382|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19680383|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
19680384|NCT03620123|Docetaxel|docetaxel|mesh-list
19680385|NCT03620123|Nivolumab|nivolumab|mesh-list
19680386|NCT03620123|Ipilimumab|ipilimumab|mesh-list
19680387|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680388|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680389|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
19680390|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
19680391|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680392|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680393|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19680394|NCT03601637|Ivacaftor|ivacaftor|mesh-list
19680395|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19680396|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680397|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381990|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20381991|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20381992|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20381993|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20381994|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20381995|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19333531|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680398|NCT03552692|Venetoclax|venetoclax|mesh-list
19680399|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680400|NCT03370172|Factor VIII|factor viii|mesh-list
19333532|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
19333533|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333534|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
19333535|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19333536|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333537|NCT03878771|Clobetasol|clobetasol|mesh-list
19333538|NCT03878771|Benzocaine|benzocaine|mesh-list
19333539|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680401|NCT03370172|Coagulants|coagulants|mesh-ancestor
19680402|NCT03292146|Denosumab|denosumab|mesh-list
19680403|NCT03292146|Alendronate|alendronate|mesh-list
19680404|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19680405|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842329|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
19842330|NCT00651313|Lidocaine|lidocaine|mesh-list
19842331|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
19680436|NCT03270501|Golimumab|golimumab|mesh-list
19680437|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19680438|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680439|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680440|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
19680441|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680442|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
19680443|NCT03251651|Propofol|propofol|mesh-list
20195861|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195862|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
20195863|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
20195864|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195865|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195866|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20195867|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
20195868|NCT00235261|Hormones|hormones|mesh-ancestor
20195869|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612860|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20612861|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612862|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20612863|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195870|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20195871|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195872|NCT00235261|Analgesics|analgesics|mesh-ancestor
20217566|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
19333540|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
19680444|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19680445|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842332|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
19842333|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195873|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
20195874|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
20195875|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20195876|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20195877|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195878|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20195879|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19333541|NCT03878771|Hormones|hormones|mesh-ancestor
19333542|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20381996|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
20381997|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20381998|NCT01030900|Rituximab|rituximab|mesh-list
20381999|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
20382000|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20382001|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382002|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
20382003|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382004|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382005|NCT01030926|Insulin|insulin|mesh-list
20382006|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19333543|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333544|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333545|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
19333546|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333547|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
19333548|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333549|NCT03878784|Sumatriptan|sumatriptan|mesh-list
19333550|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19333551|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19333552|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19333553|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
19333554|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382007|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
20382008|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20382009|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382010|NCT01031017|Progesterone|progesterone|mesh-list
20382011|NCT01031017|Progestins|progestins|mesh-ancestor
20382012|NCT01031017|Hormones|hormones|mesh-ancestor
20382013|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195880|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20195881|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195882|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382014|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382015|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
20382016|NCT01031030|Fluorouracil|fluorouracil|mesh-list
20382017|NCT01031030|Methotrexate|methotrexate|mesh-list
20195883|NCT00235274|Secretin|secretin|mesh-list
20195884|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20195885|NCT00235274|Hormones|hormones|mesh-ancestor
20195886|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20195887|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195888|NCT00235287|Candesartan|candesartan|mesh-list
20195889|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
20195890|NCT00235287|Enalapril|enalapril|mesh-list
20195891|NCT00235287|Enalaprilat|enalaprilat|mesh-list
20195892|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195893|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20195894|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20195895|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382018|NCT01031030|Epirubicin|epirubicin|mesh-list
19680446|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399380|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19680447|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19680448|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
19680449|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
19680450|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19680451|NCT03251651|Analgesics|analgesics|mesh-ancestor
19680452|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
19680453|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680454|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19680455|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19680456|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20195896|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20382019|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382020|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
19680457|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680458|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680459|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680460|NCT03159000|Lidocaine|lidocaine|mesh-list
19680461|NCT03159000|Bupivacaine|bupivacaine|mesh-list
19680462|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
19680463|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
19680464|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680465|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680466|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
19680467|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680468|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19680469|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19680470|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19680471|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680472|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680473|NCT03126643|Nivolumab|nivolumab|mesh-list
19680474|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680475|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680476|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19680477|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680478|NCT03126617|Elotuzumab|elotuzumab|mesh-list
19680479|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680480|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19680481|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19680482|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680483|NCT03016819|Dacarbazine|dacarbazine|mesh-list
20382021|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382022|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382023|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19680484|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19680485|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
19680486|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680487|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680488|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
19680489|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19680490|NCT02951364|Ledipasvir|ledipasvir|mesh-list
19680491|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
19680492|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680493|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
19680494|NCT02889237|Vitamin D|vitamin d|mesh-list
19680495|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
19680496|NCT02889237|Vitamins|vitamins|mesh-list
20382024|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
19333555|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333556|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333557|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19333558|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
19333559|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333560|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19333561|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333562|NCT03878693|Fomepizole|fomepizole|mesh-list
19333563|NCT03878693|Antidotes|antidotes|mesh-ancestor
19680497|NCT02889237|Calcium|calcium|mesh-list
20195897|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
20195898|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195899|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
20195900|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20195901|NCT00235300|Basiliximab|basiliximab|mesh-list
20195902|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
20195903|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195904|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195905|NCT00235313|Nicotine|nicotine|mesh-list
20195906|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20195907|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
20195908|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195909|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195910|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20195911|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20195912|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
20195913|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195914|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195915|NCT00235508|Eszopiclone|eszopiclone|mesh-list
20382025|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680498|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
19680499|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680500|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19680501|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19692505|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19692506|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
19692507|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692508|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692509|NCT04990830|Heparin|heparin|mesh-list
19692510|NCT04990830|Enoxaparin|enoxaparin|mesh-list
19692511|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19692512|NCT04990830|Tinzaparin|tinzaparin|mesh-list
19692513|NCT04990830|Dalteparin|dalteparin|mesh-list
19692514|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
19692515|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
19692516|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19692517|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19692518|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692519|NCT04990869|Niacinamide|niacinamide|mesh-list
19692520|NCT04990869|Niacin|niacin|mesh-list
19692521|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
19692522|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
19333564|NCT03878693|Protective Agents|protective agents|mesh-ancestor
19333565|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333566|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333567|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333568|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
19333569|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
19333570|NCT03878667|Calcium|calcium|mesh-list
19333571|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19692523|NCT04990869|Vitamins|vitamins|mesh-ancestor
19692524|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
19692525|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382026|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382027|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19333572|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333573|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20382028|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
20382029|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20382030|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20382031|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
20382032|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20382033|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
20382034|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382035|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20382036|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20382037|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20382038|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20382039|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20382040|NCT01031212|Acetic Acid|acetic acid|mesh-list
20382041|NCT01031212|Paclitaxel|paclitaxel|mesh-list
20382042|NCT01031212|Carboplatin|carboplatin|mesh-list
20382043|NCT01031212|Cetuximab|cetuximab|mesh-list
20382044|NCT01031212|Vadimezan|vadimezan|mesh-list
20382045|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20382046|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382047|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
20382048|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
20382049|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
20382050|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382051|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20382052|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382053|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426221|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426222|NCT01279551|Lidocaine|lidocaine|mesh-list
20426223|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
20426224|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
20426225|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
20426226|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426227|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426228|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
20426229|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426230|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19692526|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19692527|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
19692528|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692529|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19333574|NCT03878667|Antacids|antacids|mesh-ancestor
19333575|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333576|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333577|NCT03878264|Cortisone|cortisone|mesh-list
19333578|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333579|NCT03878069|Elapegademase|elapegademase|mesh-list
19333580|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19333581|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333582|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333583|NCT03878082|Acetaminophen|acetaminophen|mesh-list
19333584|NCT03878082|Propacetamol|propacetamol|mesh-list
19333585|NCT03878082|Analgesics|analgesics|mesh-ancestor
19333586|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
19333587|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333588|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333589|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19333590|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19333591|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333592|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333593|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
19333594|NCT03877705|Listerine|listerine|mesh-list
19333595|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
19333596|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19333597|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333598|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
19333599|NCT03877705|Protective Agents|protective agents|mesh-ancestor
19333600|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333601|NCT03877718|Promethazine|promethazine|mesh-list
19333602|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
19333603|NCT03877718|Sumatriptan|sumatriptan|mesh-list
19333604|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19333605|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19333606|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19333607|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
20382054|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
20382055|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
20382056|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20382057|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20382058|NCT01031355|Calcium|calcium|mesh-list
20382059|NCT01031355|Estradiol|estradiol|mesh-list
20382060|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20382061|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19333608|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333609|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333610|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333611|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
19333612|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
19333613|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19333614|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
19333615|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
19333616|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19333617|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19333618|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19333619|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333620|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333621|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
19333622|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
19333623|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333624|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
20195916|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20195917|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20195918|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195919|NCT00235521|Iloprost|iloprost|mesh-list
20195920|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20195921|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195922|NCT00235560|Sirolimus|sirolimus|mesh-list
20195923|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195924|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195925|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195926|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195927|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
20195928|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195929|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
20195930|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195931|NCT00235651|Amphotericin B|amphotericin b|mesh-list
20382062|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333625|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
19333626|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333627|NCT03877965|Digoxin|digoxin|mesh-list
19333628|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19333629|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19333630|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680502|NCT02856438|Dexamethasone|dexamethasone|mesh-list
19680503|NCT02856438|Lenalidomide|lenalidomide|mesh-list
19680504|NCT02856438|Elotuzumab|elotuzumab|mesh-list
19680505|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680506|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
19680507|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
19333631|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333632|NCT03877965|Protective Agents|protective agents|mesh-ancestor
19333633|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333634|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19333635|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19333636|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19333637|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
19333638|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333639|NCT03877549|Dexamethasone|dexamethasone|mesh-list
19333640|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333641|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
19333642|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
19333643|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333644|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680508|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680509|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680510|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19680511|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
19680512|NCT02856438|Hormones|hormones|mesh-ancestor
19680513|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20382063|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20382064|NCT01031355|Estrogens|estrogens|mesh-ancestor
20382065|NCT01031355|Hormones|hormones|mesh-ancestor
20382066|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20382067|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20382068|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
20382069|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20382070|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20382071|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
20382072|NCT01031355|Vitamins|vitamins|mesh-ancestor
20382073|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
20382074|NCT01031368|Cytarabine|cytarabine|mesh-list
20382075|NCT01031368|Clofarabine|clofarabine|mesh-list
20382076|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20382077|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
20382078|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382079|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382080|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
20382081|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382082|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382083|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
20382084|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382085|NCT01031459|Interferons|interferons|mesh-list
20382086|NCT01031459|Interferon-beta|interferon-beta|mesh-list
20382087|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
20382088|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382089|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
20382090|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382091|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
20382092|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382093|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20382094|NCT01031589|Rilpivirine|rilpivirine|mesh-list
20382095|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19333645|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333646|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
19333647|NCT03877549|Hormones|hormones|mesh-ancestor
19333648|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333649|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19333650|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333651|NCT03877874|Terbutaline|terbutaline|mesh-list
19333652|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19333653|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
19680514|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19680515|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612864|NCT02253095|Micronutrients|micronutrients|mesh-list
19680516|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
19680517|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19680518|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19680519|NCT02856438|Growth Substances|growth substances|mesh-ancestor
19680520|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
19680521|NCT02808182|Niacin|niacin|mesh-list
19333654|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333655|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382096|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20382097|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382098|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382099|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
20382100|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382101|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19333656|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19333657|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
19333658|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
19333659|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
19333660|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19333661|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19333662|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19333663|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19333664|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
19333665|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333666|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333667|NCT03877692|Labetalol|labetalol|mesh-list
19333668|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19333669|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19333670|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680522|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
20382102|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19333671|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333672|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333673|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333674|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19333675|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
19333676|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
19333677|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333678|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19333679|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19333680|NCT03877679|Triamcinolone|triamcinolone|mesh-list
19333681|NCT03877679|Curcumin|curcumin|mesh-list
19333682|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20382103|NCT01031667|Cilostazol|cilostazol|mesh-list
20382104|NCT01031667|Probucol|probucol|mesh-list
20382105|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19333683|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
19333684|NCT03877679|Hormones|hormones|mesh-ancestor
19333685|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333686|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333687|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333688|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333689|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19680523|NCT02808182|Niacinamide|niacinamide|mesh-list
20195932|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20195933|NCT00235651|Amebicides|amebicides|mesh-ancestor
20195934|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20195935|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20195936|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195937|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195938|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
20195939|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
20195940|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20195941|NCT00235729|Lofexidine|lofexidine|mesh-list
20195942|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20195943|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20195944|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195945|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
20195946|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20195947|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20195948|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19680524|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20195949|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20382106|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
20612865|NCT02253095|Trace Elements|trace elements|mesh-list
19680525|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
19680526|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680527|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20382107|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382108|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382109|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20382110|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
20382111|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19333690|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19333691|NCT03877679|Analgesics|analgesics|mesh-ancestor
19333692|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
19333693|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333694|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333695|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333696|NCT03877562|Olanzapine|olanzapine|mesh-list
19333697|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
19333698|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
19680528|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
20195950|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
20195951|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20195952|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195953|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
20195954|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
20195955|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195956|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195957|NCT00235794|Sirolimus|sirolimus|mesh-list
20382112|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20382113|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382114|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20382115|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
20382116|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20382117|NCT01031667|Protective Agents|protective agents|mesh-ancestor
20382118|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20382119|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20382120|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382121|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20382122|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20382123|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
20382124|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20382125|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
20382126|NCT01031719|Vaccines|vaccines|mesh-list
20382127|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
20195958|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20195959|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195960|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20195961|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195962|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
20195963|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195964|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
20195965|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195966|NCT00235820|Adalimumab|adalimumab|mesh-list
20195967|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195968|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195969|NCT00235859|Adalimumab|adalimumab|mesh-list
20195970|NCT00235859|Methotrexate|methotrexate|mesh-list
20195971|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20195972|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
20195973|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19680529|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
19680530|NCT02808182|Vitamins|vitamins|mesh-ancestor
19680531|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
19680532|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195974|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195975|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20195976|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
20195977|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195978|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195979|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
20195980|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20195981|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20195982|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20195983|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
20382128|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382129|NCT01031732|Tacrine|tacrine|mesh-list
19333699|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333700|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195984|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195985|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20195986|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20195987|NCT00235885|Adalimumab|adalimumab|mesh-list
20195988|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680533|NCT02689167|Sunitinib|sunitinib|mesh-list
19680534|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680535|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19680536|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19680537|NCT02689167|Growth Substances|growth substances|mesh-ancestor
20382130|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20382131|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382132|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382133|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
20382134|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680538|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680539|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
19680540|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19680541|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680542|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680543|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19680544|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
19680545|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680546|NCT02582697|Cisplatin|cisplatin|mesh-list
20382135|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382136|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20382137|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
20382138|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382139|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
20195989|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20195990|NCT00235898|Leucovorin|leucovorin|mesh-list
20195991|NCT00235898|Fluorouracil|fluorouracil|mesh-list
20382140|NCT01031849|Lopinavir|lopinavir|mesh-list
20382141|NCT01031849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20382142|NCT01031849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20382143|NCT01031849|Protease Inhibitors|protease inhibitors|mesh-ancestor
20382144|NCT01031849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680547|NCT02582697|Etoposide|etoposide|mesh-list
19680548|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
19680549|NCT02582697|Bleomycin|bleomycin|mesh-list
19680550|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680551|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19680552|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19680553|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19680554|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680555|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680556|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19680557|NCT02535221|Epirubicin|epirubicin|mesh-list
19680558|NCT02535221|Goserelin|goserelin|mesh-list
20195992|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
20195993|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20195994|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20382145|NCT01031849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382146|NCT01031849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20382147|NCT01031849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20382148|NCT01031849|Antiviral Agents|antiviral agents|mesh-ancestor
20382149|NCT01031849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20195995|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20195996|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680559|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19680560|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680561|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20195997|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
20195998|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20195999|NCT00235898|Antidotes|antidotes|mesh-ancestor
19680562|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19680563|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680564|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680565|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19680566|NCT02529904|Vaccines|vaccines|mesh-list
19680567|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
20382150|NCT01031849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20382151|NCT01031849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19680568|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196000|NCT00235898|Protective Agents|protective agents|mesh-ancestor
19680569|NCT02525796|Eplerenone|eplerenone|mesh-list
19680570|NCT02525796|Amiloride|amiloride|mesh-list
19680571|NCT02525796|Cinacalcet|cinacalcet|mesh-list
20196001|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
20196002|NCT00235898|Vitamins|vitamins|mesh-ancestor
20382152|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20382153|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20382154|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382155|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20382156|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20382157|NCT01031901|Sirolimus|sirolimus|mesh-list
20382158|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382159|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382160|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20382161|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382162|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
20382163|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382164|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
20382165|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382166|NCT01031927|Glycine|glycine|mesh-list
20382167|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
20382168|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382169|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382170|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382171|NCT01031966|Thymalfasin|thymalfasin|mesh-list
20382172|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20382173|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
20382174|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382175|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
20382176|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20382177|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20382178|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382179|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
20382180|NCT01031992|Coagulants|coagulants|mesh-ancestor
20382181|NCT01032031|Ascorbic Acid|ascorbic acid|mesh-list
20196003|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
20196004|NCT00235911|Budesonide|budesonide|mesh-list
20196005|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
20196006|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196007|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20196008|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
20196009|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196010|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196011|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20196012|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
20196013|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
20196014|NCT00235911|Hormones|hormones|mesh-ancestor
20196015|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196016|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20196017|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20196018|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20196019|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
20196020|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196021|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196022|NCT00235937|Anastrozole|anastrozole|mesh-list
20196023|NCT00235937|Goserelin|goserelin|mesh-list
20196024|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20196025|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196026|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20196027|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20196028|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196029|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196030|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20196031|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
20196032|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196033|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196034|NCT00235950|Clopidogrel|clopidogrel|mesh-list
20196035|NCT00235950|Atorvastatin|atorvastatin|mesh-list
20196036|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20196037|NCT00235950|Simvastatin|simvastatin|mesh-list
20196038|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20196039|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20382182|NCT01032031|Vitamins|vitamins|mesh-ancestor
20196040|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
20217567|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680572|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19680573|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
19680574|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196041|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196042|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19680575|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680576|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19680577|NCT02525796|Diuretics|diuretics|mesh-ancestor
19680578|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
20196043|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20196044|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196045|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20196046|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20196047|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19333701|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333702|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19333703|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19333704|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333705|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333706|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19333707|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19333708|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680579|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19680580|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19680581|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20196048|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20196049|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
20196050|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196051|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680582|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19680583|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19680584|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680585|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680586|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19680587|NCT02217345|Hormones|hormones|mesh-list
19680588|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680589|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680590|NCT02101944|Dexamethasone|dexamethasone|mesh-list
19680591|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
19680592|NCT02101944|Ichthammol|ichthammol|mesh-list
19680593|NCT02101944|BB 1101|bb 1101|mesh-list
19680594|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680595|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
19680596|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
19680597|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680598|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680599|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19680600|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
19680601|NCT02101944|Hormones|hormones|mesh-ancestor
19680602|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680603|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19680604|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680605|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
19680606|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680607|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680608|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
19680609|NCT01996605|Oxytocin|oxytocin|mesh-list
19680610|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
19680611|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19680612|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680613|NCT01669915|Vitamin D|vitamin d|mesh-list
19680614|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
19680615|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
19680616|NCT01669915|Vitamins|vitamins|mesh-list
19680617|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
19680618|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680619|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19680620|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19680621|NCT01503489|Norepinephrine|norepinephrine|mesh-list
19680622|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
19680623|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
19680624|NCT01503489|Serotonin|serotonin|mesh-list
20196052|NCT00235963|Simvastatin|simvastatin|mesh-list
20196053|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20196054|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19680625|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19680626|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19680627|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19680628|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680629|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196055|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
20196056|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196057|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20196058|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20196059|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196060|NCT00236002|Alendronate|alendronate|mesh-list
20196061|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20196062|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196063|NCT00236015|Tiagabine|tiagabine|mesh-list
20382183|NCT01032031|Micronutrients|micronutrients|mesh-ancestor
20382184|NCT01032031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196064|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
20196065|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20382185|NCT01032031|Antioxidants|antioxidants|mesh-ancestor
20382186|NCT01032031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382187|NCT01032031|Protective Agents|protective agents|mesh-ancestor
20382188|NCT01032057|Gemcitabine|gemcitabine|mesh-list
20382189|NCT01032057|Capecitabine|capecitabine|mesh-list
20382190|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20382191|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
20382192|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382193|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382194|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
20382195|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382196|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196066|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20196067|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196068|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382197|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382198|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
20196069|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
20196070|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196071|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196072|NCT00236028|Infliximab|infliximab|mesh-list
20196073|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
20196074|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196075|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20196076|NCT00236054|Tiagabine|tiagabine|mesh-list
20196077|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
20196078|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20196079|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20196080|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20382199|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382200|NCT01032083|Citalopram|citalopram|mesh-list
20382201|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20382202|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20382203|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20382204|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382205|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382206|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
20382207|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382208|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20382209|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
20382210|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382211|NCT01032109|Bevacizumab|bevacizumab|mesh-list
20382212|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20382213|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382214|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20196081|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196082|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
20196083|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196084|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196085|NCT00236067|Tiagabine|tiagabine|mesh-list
20196086|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
20196087|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20196088|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20382215|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20382216|NCT01032109|Growth Substances|growth substances|mesh-ancestor
20196089|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196090|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196091|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
20196092|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196093|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196094|NCT00236093|Fentanyl|fentanyl|mesh-list
20196095|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196096|NCT00236093|Narcotics|narcotics|mesh-ancestor
20196097|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196098|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196099|NCT00236093|Analgesics|analgesics|mesh-ancestor
20196100|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
20196101|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196102|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20196103|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20196104|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
20196105|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
20196106|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
19333709|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333710|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680630|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196107|NCT00236106|Tacrolimus|tacrolimus|mesh-list
20196108|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20196109|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
20196110|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196111|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20196112|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196113|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196114|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196115|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
20196116|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20196117|NCT00236145|Fentanyl|fentanyl|mesh-list
20196118|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196119|NCT00236145|Narcotics|narcotics|mesh-ancestor
20196120|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196121|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196122|NCT00236145|Analgesics|analgesics|mesh-ancestor
20196123|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
20196124|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196125|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20196126|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20196127|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
20196128|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
20196129|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
20196130|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196131|NCT00236223|Dexamethasone|dexamethasone|mesh-list
20196132|NCT00236223|Ketamine|ketamine|mesh-list
20196133|NCT00236223|Gabapentin|gabapentin|mesh-list
20196134|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196135|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
20196136|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
20196137|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196138|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196139|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196140|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
20196141|NCT00236223|Hormones|hormones|mesh-ancestor
20196142|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196143|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20196144|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196145|NCT00236223|Analgesics|analgesics|mesh-ancestor
20196146|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
19680631|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680632|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
19680633|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
19680634|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680635|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19680636|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680637|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19680638|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
19680639|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19680640|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196147|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20196148|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20196149|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
20196150|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
20217568|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20196151|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196152|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20196153|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20196154|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196155|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196156|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
20196157|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19680641|NCT01019616|Paclitaxel|paclitaxel|mesh-list
19680642|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19680643|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196158|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196159|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196160|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
19680644|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19680645|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19680646|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19680647|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680648|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
19680649|NCT00000587|Hematinics|hematinics|mesh-ancestor
19680650|NCT05138146|Doxorubicin|doxorubicin|mesh-list
20382217|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382218|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
20382219|NCT01032122|Rituximab|rituximab|mesh-list
20382220|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20382221|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382222|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
20382223|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382224|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382225|NCT01032148|Panobinostat|panobinostat|mesh-list
20382226|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382227|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20382228|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382229|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382230|NCT01032187|Amphotericin B|amphotericin b|mesh-list
20382231|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20382232|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20382233|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20382234|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
20382235|NCT01032187|Amebicides|amebicides|mesh-ancestor
20382236|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20382237|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20382238|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382239|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382240|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
20382241|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20382242|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20382243|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
20382244|NCT01032213|Analgesics|analgesics|mesh-ancestor
20196161|NCT00236249|Lidocaine|lidocaine|mesh-list
20196162|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
20382245|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
20382246|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680651|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19680652|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19680653|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680654|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19680655|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20382247|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382248|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
20382249|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20382250|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20382251|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
20382252|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20382253|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20382254|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382255|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20382256|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
20382257|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20382258|NCT01032304|Erdosteine|erdosteine|mesh-list
19680656|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382259|NCT01032304|Expectorants|expectorants|mesh-ancestor
20382260|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
20382261|NCT01032434|Sertraline|sertraline|mesh-list
20382262|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
19333711|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
19692530|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
19680657|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196163|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
20196164|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196165|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382263|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382264|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20382265|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19842334|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382266|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680658|NCT05137964|Vitamin D|vitamin d|mesh-list
19680659|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19680660|NCT05137964|Vitamins|vitamins|mesh-ancestor
19680661|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
19680662|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680663|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19680664|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
20196166|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
20196167|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382267|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382268|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382269|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
20382270|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382271|NCT01032486|Rasagiline|rasagiline|mesh-list
20382272|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20382273|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382274|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382275|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20382276|NCT01032486|Protective Agents|protective agents|mesh-ancestor
20382277|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382278|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
20382279|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382280|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382281|NCT01032668|Clopidogrel|clopidogrel|mesh-list
20382282|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20382283|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20382284|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20382285|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20382286|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
20382287|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382288|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382289|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382290|NCT01032798|Mepivacaine|mepivacaine|mesh-list
19333712|NCT03877601|Bevacizumab|bevacizumab|mesh-list
19333713|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19333714|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333715|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19333716|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19333717|NCT03877601|Growth Substances|growth substances|mesh-ancestor
20196168|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20196169|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19333718|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333719|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
19333720|NCT03877315|Cimetidine|cimetidine|mesh-list
19333721|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19333722|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19680665|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842335|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
19842336|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842337|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19842338|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19842339|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19842340|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196170|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20196171|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196172|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196173|NCT00236275|Telbivudine|telbivudine|mesh-list
20196174|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
20196175|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196176|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20382291|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
20382292|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
20382293|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196177|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333723|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19333724|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
19333725|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
19333726|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333727|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333728|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382294|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382295|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
20382296|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382297|NCT01033058|Atorvastatin|atorvastatin|mesh-list
19333729|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19333730|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19333731|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399381|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19399382|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
19399383|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
19399384|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399385|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399386|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19399387|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19399388|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19399389|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
19399390|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399391|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382298|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20382299|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20382300|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
20382301|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382302|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20382303|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20382304|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382305|NCT01033084|Sertraline|sertraline|mesh-list
20382306|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
20382307|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382308|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20382309|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20382310|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20382311|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382312|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382313|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
19399392|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
19399393|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19399394|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19399395|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19399396|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
19399397|NCT03634917|Acamprosate|acamprosate|mesh-list
19399398|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
19399399|NCT03634917|Calcium|calcium|mesh-list
19399400|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19399401|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399402|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19399403|NCT03634917|Antacids|antacids|mesh-ancestor
19399404|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399405|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399406|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19399407|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
19399408|NCT03634852|Dexamethasone|dexamethasone|mesh-list
19399409|NCT03634852|Triamcinolone|triamcinolone|mesh-list
19399410|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19399411|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20196178|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196179|NCT00236288|Bupropion|bupropion|mesh-list
20196180|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20196181|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
20196182|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196183|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20196184|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20196185|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196186|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196187|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
20612866|NCT02253095|Albendazole|albendazole|mesh-list
20382314|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382315|NCT01033097|Betamethasone|betamethasone|mesh-list
20382316|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20382317|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
20382318|NCT01033097|Hormones|hormones|mesh-ancestor
20382319|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20382320|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382321|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20382322|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
20382323|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
20382324|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20382325|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
20382326|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382327|NCT01033149|Expectorants|expectorants|mesh-ancestor
20382328|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
20382329|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19333732|NCT03877406|Empagliflozin|empagliflozin|mesh-list
19333733|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19333734|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19333735|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333736|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333737|NCT03877120|Diazepam|diazepam|mesh-list
19333738|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
19333739|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19333740|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333741|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680666|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
19680667|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19680668|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19680669|NCT05137522|Prednisolone|prednisolone|mesh-list
19680670|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
19680671|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19680672|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
19680673|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680674|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
19680675|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
19680676|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680677|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680678|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20382330|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
20382331|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333742|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19333743|NCT03877120|Analgesics|analgesics|mesh-ancestor
19333744|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
19333745|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333746|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19333747|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19333748|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19333749|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
19333750|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333751|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333752|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19333753|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
19333754|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
19333755|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
19333756|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333757|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19333758|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19333759|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19333760|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19333761|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333762|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19333763|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
19333764|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
20382332|NCT01033149|Protective Agents|protective agents|mesh-ancestor
20382333|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382334|NCT01033149|Antidotes|antidotes|mesh-ancestor
20426231|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20426232|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20426233|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426234|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426235|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
19333765|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
19680679|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
20426236|NCT01279629|Tazarotene|tazarotene|mesh-list
19680680|NCT05137522|Hormones|hormones|mesh-ancestor
19333766|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
19333767|NCT03877003|Choline|choline|mesh-list
19333768|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
19333769|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19333770|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
19333771|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333772|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333773|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19333774|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
19333775|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
19333776|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19333777|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19333778|NCT03876899|Analgesics|analgesics|mesh-ancestor
20196188|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196189|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196190|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20196191|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20382335|NCT01033279|Warfarin|warfarin|mesh-list
20382336|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
20382337|NCT01033305|Cyclosporine|cyclosporine|mesh-list
20382338|NCT01033305|Cyclosporins|cyclosporins|mesh-list
20382339|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382340|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382341|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382342|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
20382343|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382344|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
20382345|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382346|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
20382347|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382348|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20382349|NCT01033318|Losartan|losartan|mesh-list
20382350|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20382351|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20382352|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20382353|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20382354|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382355|NCT01033370|Clevidipine|clevidipine|mesh-list
20382356|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20382357|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196192|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333779|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
19333780|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333781|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333782|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333783|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333784|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19333785|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
19333786|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333787|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19333788|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
19333789|NCT03876704|Vitamins|vitamins|mesh-list
19333790|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
19333791|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333792|NCT03876938|Olanzapine|olanzapine|mesh-list
19333793|NCT03876938|Aprepitant|aprepitant|mesh-list
19333794|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
19333795|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
19333796|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382358|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382359|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20382360|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382361|NCT01033396|Fexofenadine|fexofenadine|mesh-list
20382362|NCT01033396|Terfenadine|terfenadine|mesh-list
20382363|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19333797|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196193|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20196194|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20196195|NCT00236301|Estradiol|estradiol|mesh-list
20196196|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20196197|NCT00236301|Estrogens|estrogens|mesh-ancestor
20196198|NCT00236301|Hormones|hormones|mesh-ancestor
20382364|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20382365|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19333798|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20382366|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
19680681|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680682|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19680683|NCT05137522|Protective Agents|protective agents|mesh-ancestor
19680684|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19680685|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680686|NCT05137288|Atropine|atropine|mesh-list
20196199|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196200|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196201|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20382367|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
20382368|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382369|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382370|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382371|NCT01033409|Vaccines|vaccines|mesh-list
20382372|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
20382373|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382374|NCT01033461|Calcium|calcium|mesh-list
20382375|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20382376|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382377|NCT01033500|Abatacept|abatacept|mesh-list
20382378|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20382379|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382380|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382381|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382382|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
20382383|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382384|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382385|NCT01033526|Aspirin|aspirin|mesh-list
20382386|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20382387|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20382388|NCT01033526|Analgesics|analgesics|mesh-ancestor
20382389|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
20382390|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382391|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382392|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196202|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
20196203|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20196204|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20196205|NCT00236327|Fentanyl|fentanyl|mesh-list
20196206|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196207|NCT00236327|Narcotics|narcotics|mesh-ancestor
20382393|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382394|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20382395|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20382396|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382397|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20382398|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20382399|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382400|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
20382401|NCT01033656|Methotrexate|methotrexate|mesh-list
20382402|NCT01033656|Azathioprine|azathioprine|mesh-list
20382403|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19333799|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19333800|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19333801|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333802|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19333803|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19680687|NCT05137288|Ondansetron|ondansetron|mesh-list
19680688|NCT05137288|Bupivacaine|bupivacaine|mesh-list
19333804|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19333805|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19333806|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333807|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333808|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
19333809|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19333810|NCT03876886|Paclitaxel|paclitaxel|mesh-list
19333811|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19333812|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
19333813|NCT03876886|Carboplatin|carboplatin|mesh-list
19333814|NCT03876886|Epirubicin|epirubicin|mesh-list
19333815|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20196208|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333816|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680689|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333817|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
19333818|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
19333819|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
19333820|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333821|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19333822|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
19333823|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333824|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19333825|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19333826|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
19333827|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19333828|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19333829|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19333830|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19333831|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842341|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842342|NCT00651482|Bevacizumab|bevacizumab|mesh-list
19842343|NCT00651482|Everolimus|everolimus|mesh-list
19842344|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19842345|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842346|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19842347|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19842348|NCT00651482|Growth Substances|growth substances|mesh-ancestor
19842349|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842350|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
19842351|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842352|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
19842353|NCT00651755|Prednisone|prednisone|mesh-list
19842354|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
20382404|NCT01033656|Leflunomide|leflunomide|mesh-list
19680690|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
19680691|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680692|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680693|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
19333832|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
19333833|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19333834|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19333835|NCT03876444|Prednisolone|prednisolone|mesh-list
19333836|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
19333837|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19333838|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
19333839|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333840|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
19333841|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
19333842|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382405|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20382406|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
20382407|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20382408|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382409|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20382410|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
20382411|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382412|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333843|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333844|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333845|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
19333846|NCT03876444|Hormones|hormones|mesh-ancestor
19333847|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333848|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19680694|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680695|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
19680696|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
19842355|NCT00651755|Rituximab|rituximab|mesh-list
20382413|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
19333849|NCT03876444|Protective Agents|protective agents|mesh-ancestor
19333850|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19333851|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333852|NCT03876548|Iodine|iodine|mesh-list
19333853|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
19333854|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19333855|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333856|NCT03876548|Trace Elements|trace elements|mesh-ancestor
19333857|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
19680697|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19842356|NCT00651755|Doxorubicin|doxorubicin|mesh-list
19842357|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19333858|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333859|NCT03876587|Docetaxel|docetaxel|mesh-list
19333860|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333861|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
19333862|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19333863|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
19333864|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333865|NCT03876574|Gemcitabine|gemcitabine|mesh-list
19333866|NCT03876574|Dexamethasone|dexamethasone|mesh-list
19333867|NCT03876574|Floxuridine|floxuridine|mesh-list
19333868|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333869|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
19333870|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
19333871|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333872|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333873|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333874|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
19333875|NCT03876574|Hormones|hormones|mesh-ancestor
19333876|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333877|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19333878|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333879|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19333880|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
19333881|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333882|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
19333883|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333884|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333885|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19333886|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
19333887|NCT03876041|Dexamethasone|dexamethasone|mesh-list
19333888|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
19333889|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
19333890|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19333891|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19333892|NCT03876041|BB 1101|bb 1101|mesh-list
19333893|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19333894|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
19333895|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
19333896|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333897|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333898|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19333899|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
19333900|NCT03876041|Hormones|hormones|mesh-ancestor
19333901|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19333902|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19333903|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333904|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
19333905|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333906|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333907|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19333908|NCT03876041|Protective Agents|protective agents|mesh-ancestor
19333909|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19333910|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19333911|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
19680698|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
19680699|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
19680700|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196209|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196210|NCT00236327|Analgesics|analgesics|mesh-ancestor
19333912|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19333913|NCT03875911|Mitomycins|mitomycins|mesh-list
19333914|NCT03875911|Mitomycin|mitomycin|mesh-list
19333915|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19333916|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333917|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
19680701|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
20196211|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
20196212|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196213|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20196214|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20196215|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
20196216|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
20196217|NCT00236353|Risperidone|risperidone|mesh-list
20196218|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196219|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
20196220|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382414|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333918|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333919|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19333920|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333921|NCT03875872|Propofol|propofol|mesh-list
19333922|NCT03875872|Anesthetics|anesthetics|mesh-list
19333923|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
19333924|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19333925|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333926|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333927|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19333928|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
19333929|NCT03875755|Inositol|inositol|mesh-list
19333930|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
19333931|NCT03875755|Vitamins|vitamins|mesh-ancestor
19333932|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
19333933|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333934|NCT03875274|Morphine|morphine|mesh-list
19333935|NCT03875274|Ropivacaine|ropivacaine|mesh-list
19333936|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19333937|NCT03875274|Narcotics|narcotics|mesh-ancestor
19333938|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333939|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333940|NCT03875274|Analgesics|analgesics|mesh-ancestor
19333941|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
19333942|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333943|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333944|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
19333945|NCT03874975|Vitamin D|vitamin d|mesh-list
19333946|NCT03874975|Vitamins|vitamins|mesh-ancestor
19333947|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
19333948|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333949|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19333950|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
19333951|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19333952|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
19333953|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
19333954|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333955|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196221|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333956|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333957|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19333958|NCT03874832|Analgesics|analgesics|mesh-ancestor
19333959|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
19333960|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333961|NCT03874884|Olaparib|olaparib|mesh-list
19333962|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19333963|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19333964|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333965|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399412|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19399413|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19399414|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19680702|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680703|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680704|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19680705|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19680706|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680707|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19680708|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19680709|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19680710|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19680711|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20196222|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196223|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196224|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196225|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196226|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196227|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196228|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
20196229|NCT00236366|Fentanyl|fentanyl|mesh-list
20196230|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196231|NCT00236366|Narcotics|narcotics|mesh-ancestor
20196232|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196233|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399415|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20382415|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20382416|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382417|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
19680712|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
19680713|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
19680714|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
19680715|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19680716|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19680717|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
19680718|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
20196234|NCT00236366|Analgesics|analgesics|mesh-ancestor
20196235|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
20196236|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196237|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19680719|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680720|NCT05137184|Fentanyl|fentanyl|mesh-list
19680721|NCT05137184|Morphine|morphine|mesh-list
19680722|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
19680723|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19333966|NCT03874806|Ropivacaine|ropivacaine|mesh-list
19333967|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19333968|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333969|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
19333970|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333971|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333972|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
19333973|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333974|NCT03874741|Cetuximab|cetuximab|mesh-list
19333975|NCT03874741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19333976|NCT03874741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333977|NCT03874585|Nicotine|nicotine|mesh-list
19680724|NCT05137184|Narcotics|narcotics|mesh-ancestor
19680725|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680726|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680727|NCT05137184|Analgesics|analgesics|mesh-ancestor
19680728|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
19680729|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680730|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19680731|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19680732|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
20196238|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20196239|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
20196240|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
20382418|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382419|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20382420|NCT01033760|Ritonavir|ritonavir|mesh-list
20382421|NCT01033760|Darunavir|darunavir|mesh-list
20382422|NCT01033760|Tenofovir|tenofovir|mesh-list
20382423|NCT01033760|Emtricitabine|emtricitabine|mesh-list
20382424|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
20382425|NCT01033760|Maraviroc|maraviroc|mesh-list
20382426|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20382427|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20382428|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
20382429|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382430|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382431|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20382432|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20382433|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
20382434|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382435|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20382436|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20382437|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19333978|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20196241|NCT00236379|Olanzapine|olanzapine|mesh-list
20196242|NCT00236379|Risperidone|risperidone|mesh-list
20196243|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196244|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
20196245|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196246|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196247|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196248|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196249|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19333979|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
19680733|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
19680734|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19680735|NCT05137145|Linaclotide|linaclotide|mesh-list
20382438|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19333980|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333981|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333982|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19333983|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19333984|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
19842358|NCT00651755|Vincristine|vincristine|mesh-list
19842359|NCT00651755|Ondansetron|ondansetron|mesh-list
19842360|NCT00651755|Aprepitant|aprepitant|mesh-list
19842361|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842362|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
19333985|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19333986|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333987|NCT03874364|Lidocaine|lidocaine|mesh-list
19333988|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
19333989|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
19333990|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19333991|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19333992|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
19680736|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19680737|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
19680738|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680739|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19680740|NCT05136976|Rituximab|rituximab|mesh-list
19842363|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842364|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842365|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19842366|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
19842367|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842368|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19333993|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19333994|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19333995|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19333996|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19333997|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19333998|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19333999|NCT03874273|Crizotinib|crizotinib|mesh-list
19334000|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334001|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19334002|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334003|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334004|NCT03874130|Scopolamine|scopolamine|mesh-list
19680741|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680742|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196250|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196251|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196252|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19334005|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19334006|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19334007|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
19334008|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
19334009|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334010|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334011|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19334012|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
19334013|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19334014|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
19334015|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334016|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680743|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
20196253|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
20196254|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
19680744|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680745|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680746|NCT05136924|Varenicline|varenicline|mesh-list
19680747|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19680748|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19680749|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
19842369|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20196255|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
20196256|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196257|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196258|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19680750|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196259|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20382439|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20196260|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20382440|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20382441|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20382442|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20382443|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20382444|NCT01033877|Vaccines|vaccines|mesh-list
20382445|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
20382446|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382447|NCT01033903|Misoprostol|misoprostol|mesh-list
20382448|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20382449|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
20382450|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20382451|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382452|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20382453|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20382454|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
20382455|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20382456|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20382457|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20382458|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
20382459|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382460|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19680751|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680752|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680753|NCT05135715|Trastuzumab|trastuzumab|mesh-list
20196261|NCT00236392|Rabeprazole|rabeprazole|mesh-list
20196262|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20196263|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196264|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20196265|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196266|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196267|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
20196268|NCT00236405|Hematinics|hematinics|mesh-ancestor
20196269|NCT00236418|Topiramate|topiramate|mesh-list
20196270|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
20196271|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196272|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196273|NCT00236431|Galantamine|galantamine|mesh-list
20382461|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20382462|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382463|NCT01033981|Sunitinib|sunitinib|mesh-list
20382464|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382465|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20382466|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20382467|NCT01033981|Growth Substances|growth substances|mesh-ancestor
20382468|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382469|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
20382470|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20382471|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382472|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382473|NCT01033994|Mitogens|mitogens|mesh-list
20382474|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
19334017|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19334018|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
19334019|NCT03874260|Fenofibrate|fenofibrate|mesh-list
19334020|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19334021|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
19334022|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382475|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382476|NCT01034020|Nicotine|nicotine|mesh-list
20382477|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20382478|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
20382479|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382480|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334023|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19334024|NCT03874000|Metformin|metformin|mesh-list
19334025|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334026|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680754|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334027|NCT03874026|Cetuximab|cetuximab|mesh-list
20196274|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19334028|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334029|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196275|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382481|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20196276|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196277|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
20196278|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196279|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196280|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20382482|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20382483|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
20382484|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680755|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680756|NCT05135182|Metronidazole|metronidazole|mesh-list
19680757|NCT05135182|Furazolidone|furazolidone|mesh-list
19680758|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680759|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19680760|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19680761|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19680762|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19680763|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19680764|NCT05135182|Renal Agents|renal agents|mesh-ancestor
19680765|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19680766|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19680767|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680768|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680769|NCT05135143|Antioxidants|antioxidants|mesh-list
19680770|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680771|NCT05135143|Protective Agents|protective agents|mesh-ancestor
19680772|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382485|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382486|NCT01034124|Vitamin K|vitamin k|mesh-list
20382487|NCT01034124|Midazolam|midazolam|mesh-list
20382488|NCT01034124|Warfarin|warfarin|mesh-list
20382489|NCT01034124|Vitamins|vitamins|mesh-ancestor
19334030|NCT03874156|Atorvastatin|atorvastatin|mesh-list
19334031|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19334032|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19334033|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
19334034|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334035|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20382490|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
20382491|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382492|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20382493|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19334036|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19334037|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334038|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
19334039|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
19334040|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
19334041|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334042|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
19334043|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334044|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334045|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
19334046|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
19334047|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334048|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
19842370|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19842371|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19842372|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19842373|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19842374|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842375|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842376|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
19842377|NCT00651755|Hormones|hormones|mesh-ancestor
19334049|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19334050|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
19334051|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196281|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
20196282|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196283|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
20196284|NCT00236444|Risperidone|risperidone|mesh-list
20196285|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196286|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
19680773|NCT05133453|Pirfenidone|pirfenidone|mesh-list
19680774|NCT05133453|Analgesics|analgesics|mesh-ancestor
20196287|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382494|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334052|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334053|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19334054|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
19334055|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19334056|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
19334057|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334058|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334059|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19334060|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
19334061|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
19334062|NCT03873298|Protective Agents|protective agents|mesh-ancestor
19334063|NCT03873740|Vaccines|vaccines|mesh-list
20382495|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20382496|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20382497|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382498|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20382499|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
20382500|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
20382501|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
20382502|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
20382503|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382504|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382505|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
20382506|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20382507|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20382508|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
20382509|NCT01034124|Coagulants|coagulants|mesh-ancestor
20382510|NCT01034189|Paclitaxel|paclitaxel|mesh-list
20382511|NCT01034189|Cetuximab|cetuximab|mesh-list
20382512|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19334064|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
19334065|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334066|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
19334067|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334068|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334069|NCT03872661|Bevacizumab|bevacizumab|mesh-list
19334070|NCT03872661|Carboplatin|carboplatin|mesh-list
19334071|NCT03872661|Pemetrexed|pemetrexed|mesh-list
19334072|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334073|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334074|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19334075|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19334076|NCT03872661|Growth Substances|growth substances|mesh-ancestor
19334077|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334078|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
19334079|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334080|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334081|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19334082|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19399416|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
19399417|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
19399418|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399419|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399420|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399421|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
19399422|NCT03634852|Hormones|hormones|mesh-ancestor
19399423|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399424|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19680775|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
19680776|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680777|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680778|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19680779|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19680780|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680781|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680782|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680783|NCT05125978|Dipyrone|dipyrone|mesh-list
19680784|NCT05125978|Tramadol|tramadol|mesh-list
19680785|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19680786|NCT05125978|Narcotics|narcotics|mesh-ancestor
19680787|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680788|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382513|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399425|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382514|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
20382515|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
19334083|NCT03872700|Fentanyl|fentanyl|mesh-list
19334084|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19334085|NCT03872700|Narcotics|narcotics|mesh-ancestor
19334086|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334087|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334088|NCT03872700|Analgesics|analgesics|mesh-ancestor
19334089|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
19334090|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334091|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19334092|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19334093|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
19334094|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
19334095|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
19334096|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334097|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334098|NCT03872830|Analgesics|analgesics|mesh-ancestor
19334099|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
19334100|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382516|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
20382517|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382518|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20382519|NCT01034345|Sirolimus|sirolimus|mesh-list
20382520|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20382521|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382522|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382523|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20382524|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382525|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
20382526|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382527|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
20382528|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382529|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382530|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382531|NCT01034410|Cytarabine|cytarabine|mesh-list
20382532|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19334101|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334102|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334103|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334104|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19334105|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
19334106|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19334107|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19334108|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19334109|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334110|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334111|NCT03872570|Phenylephrine|phenylephrine|mesh-list
19334112|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
19334113|NCT03872570|Norepinephrine|norepinephrine|mesh-list
19334114|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19334115|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
19334116|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
19334117|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334118|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334119|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
19334120|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19334121|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
19334122|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
19334123|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19334124|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19334125|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19334126|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
19334127|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334128|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680789|NCT05125978|Analgesics|analgesics|mesh-ancestor
19680790|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
19680791|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680792|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19680793|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19680794|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680795|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680796|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
20382533|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
19334129|NCT03872570|Protective Agents|protective agents|mesh-ancestor
19334130|NCT03872505|Paclitaxel|paclitaxel|mesh-list
19334131|NCT03872505|Carboplatin|carboplatin|mesh-list
19680797|NCT05125185|Insulin|insulin|mesh-list
19334132|NCT03872505|Durvalumab|durvalumab|mesh-list
19334133|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20382534|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382535|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612867|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
20612868|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19334134|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334135|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
19334136|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
19334137|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
19334138|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334139|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334140|NCT03872336|Labetalol|labetalol|mesh-list
19334141|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19334142|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19334143|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
19334144|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334145|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334146|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334147|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19334148|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
19334149|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
19334150|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334151|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19334152|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19334153|NCT03873415|BMS-986165|bms-986165|mesh-list
19334154|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
19334155|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19334156|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334157|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334158|NCT03873532|Capecitabine|capecitabine|mesh-list
19680798|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19680799|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842378|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842379|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19842380|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19842381|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
19842382|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
19842383|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
19842384|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
19842385|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
19842386|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842387|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692531|NCT04990713|Ropivacaine|ropivacaine|mesh-list
19692532|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
19692533|NCT04990713|Anesthetics|anesthetics|mesh-list
19692534|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692535|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692536|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
19692537|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692538|NCT04990791|Aspirin|aspirin|mesh-list
19692539|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
19692540|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19692541|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19692542|NCT04990791|Analgesics|analgesics|mesh-ancestor
19842388|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
19692543|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
19692544|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692545|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692546|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692547|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692548|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19692549|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19692550|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692551|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19692552|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20382536|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
20382537|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382538|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382539|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
20382540|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382541|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
20382542|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19680800|NCT05306028|Metformin|metformin|mesh-list
19680801|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19680802|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196288|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196289|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196290|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196291|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196292|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196293|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196294|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196295|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
20196296|NCT00236457|Risperidone|risperidone|mesh-list
20196297|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196298|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
19334159|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19334160|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
19334161|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334162|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334163|NCT03872232|Telmisartan|telmisartan|mesh-list
19334164|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19334165|NCT03872232|Ezetimibe|ezetimibe|mesh-list
19334166|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19334167|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19334168|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
19334169|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334170|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19334171|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19334172|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334173|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19334174|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19334175|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19334176|NCT03871972|Sirolimus|sirolimus|mesh-list
19334177|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19334178|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334179|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19334180|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334181|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
19334182|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334183|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
19334184|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334185|NCT03872011|Vitamins|vitamins|mesh-list
19334186|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
19334187|NCT03872011|Thiamine|thiamine|mesh-list
19334188|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
19334189|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
19334190|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334191|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334192|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
19334193|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334194|NCT03872011|Protective Agents|protective agents|mesh-ancestor
19334195|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
20196299|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196300|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196301|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382543|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680803|NCT05306002|Antioxidants|antioxidants|mesh-list
20382544|NCT01034683|Leucovorin|leucovorin|mesh-list
20382545|NCT01034683|Antidotes|antidotes|mesh-ancestor
20382546|NCT01034683|Protective Agents|protective agents|mesh-ancestor
20382547|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382548|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
20382549|NCT01034683|Vitamins|vitamins|mesh-ancestor
20382550|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
20382551|NCT01034787|Tremelimumab|tremelimumab|mesh-list
20382552|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334196|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
19680804|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680805|NCT05306002|Protective Agents|protective agents|mesh-ancestor
20196302|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19334197|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19334198|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334199|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
19334200|NCT03871621|Metformin|metformin|mesh-list
19334201|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
19334202|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20382553|NCT01034878|Sunitinib|sunitinib|mesh-list
19334203|NCT03871621|Meglitinide|meglitinide|mesh-list
20382554|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382555|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20382556|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20382557|NCT01034878|Growth Substances|growth substances|mesh-ancestor
20382558|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382559|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
20382560|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20382561|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382562|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382563|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20382564|NCT01034917|Etravirine|etravirine|mesh-list
19680806|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680807|NCT05305924|Fulvestrant|fulvestrant|mesh-list
19680808|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19680809|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680810|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19680811|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19680812|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
19334204|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19334205|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334206|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19334207|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680813|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19680814|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680815|NCT05305898|Metformin|metformin|mesh-list
20196303|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196304|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334208|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19334209|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19334210|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
19334211|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334212|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334213|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334214|NCT03871517|Aspirin|aspirin|mesh-list
19334215|NCT03871517|Indobufen|indobufen|mesh-list
19334216|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334217|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334218|NCT03871517|Analgesics|analgesics|mesh-ancestor
19842389|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842390|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19842391|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
19842392|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842393|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19842394|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19842395|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842396|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680816|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196305|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196306|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196307|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
20196308|NCT00236470|Risperidone|risperidone|mesh-list
20196309|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19842397|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19842398|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19842399|NCT00651937|Melphalan|melphalan|mesh-list
19842400|NCT00651937|Sargramostim|sargramostim|mesh-list
20196310|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
20196311|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196312|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196313|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196314|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196315|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196316|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196317|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196318|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196319|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
20196320|NCT00236483|Acetaminophen|acetaminophen|mesh-list
20382565|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
19680817|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680818|NCT05305885|Pemetrexed|pemetrexed|mesh-list
19680819|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680820|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842401|NCT00651937|Lenograstim|lenograstim|mesh-list
20382566|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196321|NCT00236483|Tramadol|tramadol|mesh-list
20196322|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20196323|NCT00236483|Analgesics|analgesics|mesh-ancestor
20196324|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
20196325|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196326|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382567|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20382568|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20382569|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382570|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382571|NCT01034956|Calcium|calcium|mesh-list
20382572|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
20382573|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20382574|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382575|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20196327|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
20196328|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196329|NCT00236483|Narcotics|narcotics|mesh-ancestor
20196330|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196331|NCT00236496|Topiramate|topiramate|mesh-list
20196332|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
20196333|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196334|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334219|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
20382576|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
20382577|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
20382578|NCT01034956|Protective Agents|protective agents|mesh-ancestor
20426237|NCT01279629|Calcipotriene|calcipotriene|mesh-list
20196335|NCT00236509|Topiramate|topiramate|mesh-list
20196336|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
20196337|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334220|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334221|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334222|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334223|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20196338|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196339|NCT00236522|Levofloxacin|levofloxacin|mesh-list
20196340|NCT00236522|Ofloxacin|ofloxacin|mesh-list
20426238|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
20426239|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
20428615|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428616|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334224|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19334225|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19334226|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334227|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19334228|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19334229|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334230|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
19334231|NCT03871361|Abatacept|abatacept|mesh-list
19334232|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19334233|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334234|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196341|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20428617|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19680821|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680822|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19334235|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334236|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
19334237|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334238|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334239|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
19334240|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19334241|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
19334242|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334243|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
19334244|NCT03871218|Protective Agents|protective agents|mesh-ancestor
19334245|NCT03871322|Vitamin D|vitamin d|mesh-list
19334246|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
19680823|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19680824|NCT05305859|Azacitidine|azacitidine|mesh-list
19680825|NCT05305859|Venetoclax|venetoclax|mesh-list
19680826|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19680827|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
19692553|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196342|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196343|NCT00236522|Renal Agents|renal agents|mesh-ancestor
19680828|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680829|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680830|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680831|NCT05305794|Insulin|insulin|mesh-list
19680832|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19680833|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334247|NCT03871322|Vitamins|vitamins|mesh-list
19334248|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
19680834|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680835|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19680836|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19680837|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680838|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680839|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19680840|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19680841|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680842|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
19334249|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334250|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334251|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19334252|NCT03871478|Lidocaine|lidocaine|mesh-list
19334253|NCT03871478|Bupivacaine|bupivacaine|mesh-list
19334254|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
20382579|NCT01034995|Citalopram|citalopram|mesh-list
20382580|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20382581|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20382582|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20382583|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382584|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382585|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
20382586|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382587|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20382588|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
20382589|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382590|NCT01035021|Rocuronium|rocuronium|mesh-list
20382591|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20382592|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20382593|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20382594|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382595|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382596|NCT01035190|Budesonide|budesonide|mesh-list
20382597|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680843|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680844|NCT05305560|Ivermectin|ivermectin|mesh-list
19680845|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19680846|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680847|NCT05305495|Empagliflozin|empagliflozin|mesh-list
19680848|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19680849|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382598|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20382599|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
20382600|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382601|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382602|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20382603|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
20382604|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
20382605|NCT01035190|Hormones|hormones|mesh-ancestor
19334255|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
19334256|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334257|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334258|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
20382606|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19334259|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334260|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19334261|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19334262|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19334263|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19334264|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334265|NCT03871036|Paclitaxel|paclitaxel|mesh-list
19334266|NCT03871036|Durvalumab|durvalumab|mesh-list
19334267|NCT03871036|Tremelimumab|tremelimumab|mesh-list
19334268|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20382607|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
20382608|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20382609|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
20382610|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382611|NCT01035281|Nabilone|nabilone|mesh-list
20382612|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
20382613|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
19334269|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334270|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
19334271|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
19334272|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
19334273|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334274|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334275|NCT03871062|Anesthetics|anesthetics|mesh-list
19334276|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334277|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334278|NCT03871114|Triamcinolone|triamcinolone|mesh-list
19334279|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19680850|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19680851|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680852|NCT05305456|Vitamins|vitamins|mesh-list
19680853|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
19680854|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
19334280|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19334281|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19334282|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334283|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
19334284|NCT03871114|Hormones|hormones|mesh-ancestor
19334285|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19334286|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334287|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334288|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
19334289|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334290|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334291|NCT03871153|Paclitaxel|paclitaxel|mesh-list
19334292|NCT03871153|Carboplatin|carboplatin|mesh-list
19334293|NCT03871153|Durvalumab|durvalumab|mesh-list
19334294|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19334295|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334296|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
19334297|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
19334298|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
19334299|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334300|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334301|NCT03870581|Warfarin|warfarin|mesh-list
19334302|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
19399426|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399427|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399428|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19399429|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19399430|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399431|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399432|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19399433|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
19399434|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19399435|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19399436|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19399437|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19399438|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19399439|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
19399440|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19399441|NCT03634735|Thiamine|thiamine|mesh-list
19399442|NCT03634735|Vitamins|vitamins|mesh-ancestor
19399443|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
19399444|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399445|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
20382614|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399446|NCT03634605|Tetracycline|tetracycline|mesh-list
19399447|NCT03634605|Lidocaine|lidocaine|mesh-list
19399448|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
19399449|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
20382615|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382616|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399450|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399451|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399452|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
19680855|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334303|NCT03870711|Lidocaine|lidocaine|mesh-list
19334304|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
20382617|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20382618|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20382619|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20382620|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382621|NCT01035320|Simvastatin|simvastatin|mesh-list
20382622|NCT01035320|Ezetimibe|ezetimibe|mesh-list
20382623|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20382624|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20382625|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
20382626|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382627|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20382628|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20382629|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382630|NCT01035450|Sirolimus|sirolimus|mesh-list
20382631|NCT01035450|Everolimus|everolimus|mesh-list
20382632|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382633|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334305|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
19334306|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334307|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334308|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
19334309|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334310|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19334311|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19334312|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19334313|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19334314|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334315|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
19334316|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19334317|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
19334318|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334319|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
19334320|NCT03870646|Protective Agents|protective agents|mesh-ancestor
19334321|NCT03870503|Misoprostol|misoprostol|mesh-list
19334322|NCT03870503|Oxytocin|oxytocin|mesh-list
19334323|NCT03870503|Carbetocin|carbetocin|mesh-list
19334324|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
19334325|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19334326|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680856|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
19680857|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680858|NCT05305456|Protective Agents|protective agents|mesh-ancestor
19680859|NCT05305404|Dexamethasone|dexamethasone|mesh-list
19680860|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
19680861|NCT05305404|BB 1101|bb 1101|mesh-list
19334327|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19334328|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
19334329|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19334330|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19334331|NCT03870490|Cefepime|cefepime|mesh-list
19334332|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19334333|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334334|NCT03870256|Misoprostol|misoprostol|mesh-list
19334335|NCT03870256|Carbetocin|carbetocin|mesh-list
19334336|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19334337|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
19334338|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20196344|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19334339|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334340|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19334341|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19334342|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
19334343|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
19334344|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
19334345|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334346|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
19680862|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196345|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20196346|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196347|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196348|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196349|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196350|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20382634|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
19334347|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334348|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334349|NCT03869996|Cytarabine|cytarabine|mesh-list
19334350|NCT03869996|Methotrexate|methotrexate|mesh-list
20382635|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382636|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382637|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382638|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20382639|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
20382640|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
20382641|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20382642|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20382643|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20382644|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
20382645|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382646|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382647|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382648|NCT01035528|Metformin|metformin|mesh-list
19680863|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
19680864|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
19680865|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680866|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680867|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19680868|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
19680869|NCT05305404|Hormones|hormones|mesh-ancestor
19334351|NCT03869996|Etoposide|etoposide|mesh-list
19334352|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19842402|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19842403|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
19842404|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334353|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
19334354|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334355|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334356|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
19334357|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334358|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334359|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
19334360|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334361|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19334362|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19334363|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19334364|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334365|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19334366|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
19334367|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19334368|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
19334369|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19334370|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334371|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19334372|NCT03869931|Fenofibrate|fenofibrate|mesh-list
19334373|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19334374|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
19334375|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334376|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19334377|NCT03869762|Denosumab|denosumab|mesh-list
19334378|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334379|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334380|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
19334381|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19334382|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
19842405|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842406|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19842407|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842408|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
19842409|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842410|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19842411|NCT00652028|Fentanyl|fentanyl|mesh-list
19842412|NCT00652028|Midazolam|midazolam|mesh-list
19842413|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
19842414|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19680870|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842415|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334383|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
20196351|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20196352|NCT00236535|Acetaminophen|acetaminophen|mesh-list
20196353|NCT00236535|Tramadol|tramadol|mesh-list
20196354|NCT00236535|Hydrocodone|hydrocodone|mesh-list
20196355|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20196356|NCT00236535|Analgesics|analgesics|mesh-ancestor
19334384|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842416|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842417|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19680871|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19680872|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334385|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334386|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20382649|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
20382650|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19680873|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
19680874|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382651|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382652|NCT01035580|Curcumin|curcumin|mesh-list
20382653|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19680875|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680876|NCT05305300|Vaccines|vaccines|mesh-list
19680877|NCT05305300|Somatomedin B|somatomedin b|mesh-list
19680878|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
19842418|NCT00652028|Analgesics|analgesics|mesh-ancestor
19842419|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
19842420|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196357|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
20196358|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196359|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196360|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
20196361|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196362|NCT00236535|Narcotics|narcotics|mesh-ancestor
20196363|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196364|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
20196365|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
20196366|NCT00236548|Risperidone|risperidone|mesh-list
20196367|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196368|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
20196369|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196370|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196371|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196372|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196373|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196374|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196375|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196376|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196377|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
20196378|NCT00236561|Topiramate|topiramate|mesh-list
20196379|NCT00236561|Propranolol|propranolol|mesh-list
20196380|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20196381|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20196382|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
20196383|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196384|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196385|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196386|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20196387|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19680879|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842421|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19842422|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19842423|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19842424|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
19842425|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842426|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842427|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19842428|NCT00652028|Narcotics|narcotics|mesh-ancestor
19842429|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19842430|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19842431|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
20196388|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
20196389|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
20196390|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196391|NCT00236574|Galantamine|galantamine|mesh-list
20196392|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19842432|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
19842433|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19842434|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196393|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196394|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196395|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
20196396|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196397|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382654|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20382655|NCT01035580|Analgesics|analgesics|mesh-ancestor
20382656|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
20382657|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382658|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196398|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20196399|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
20196400|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196401|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
19334387|NCT03869736|Analgesics|analgesics|mesh-ancestor
19334388|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
19334389|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334390|NCT03869528|Lidocaine|lidocaine|mesh-list
19334391|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
19334392|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
19334393|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334394|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334395|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
19334396|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334397|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19334398|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19334399|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19334400|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19334401|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334402|NCT03869281|Pancrelipase|pancrelipase|mesh-list
19334403|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19334404|NCT03869398|Calcitriol|calcitriol|mesh-list
19334405|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19334406|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334407|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20382659|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20382660|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382661|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382662|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382663|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382664|NCT01035619|Moxidectin|moxidectin|mesh-list
20196402|NCT00236587|Risperidone|risperidone|mesh-list
20196403|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196404|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
19842435|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19842436|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
19842437|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
19842438|NCT00652093|Acetaminophen|acetaminophen|mesh-list
19842439|NCT00652093|Oxymorphone|oxymorphone|mesh-list
19842440|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
19842441|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
19842442|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
19842443|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842444|NCT00652093|Analgesics|analgesics|mesh-ancestor
19842445|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
20196405|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196406|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382665|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
20196407|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196408|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20382666|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20382667|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382668|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
20382669|NCT01035671|Vitamin E|vitamin e|mesh-list
19334408|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196409|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196410|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196411|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382670|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
20382671|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
20382672|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19842446|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612869|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612870|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
20612871|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19334409|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334410|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19334411|NCT03869398|Vitamins|vitamins|mesh-ancestor
19334412|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
19334413|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334414|NCT03869268|Aspirin|aspirin|mesh-list
19334415|NCT03869268|Ticagrelor|ticagrelor|mesh-list
19680880|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19680881|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19842447|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842448|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
19842449|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19842450|NCT00652093|Narcotics|narcotics|mesh-ancestor
19842451|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842452|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19842453|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
19842454|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
19842455|NCT00652145|Mesalamine|mesalamine|mesh-list
19842456|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19842457|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842458|NCT00652145|Analgesics|analgesics|mesh-ancestor
19842459|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
19842460|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842461|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334416|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334417|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334418|NCT03869268|Analgesics|analgesics|mesh-ancestor
19334419|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
19334420|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334421|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334422|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334423|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842462|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842463|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842464|NCT00652314|Thrombin|thrombin|mesh-list
19842465|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
20196412|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19680882|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
19680883|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680884|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680885|NCT05305287|Pioglitazone|pioglitazone|mesh-list
19680886|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19680887|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680888|NCT05305183|Alendronate|alendronate|mesh-list
19680889|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19680890|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680891|NCT05305131|Gemcitabine|gemcitabine|mesh-list
19680892|NCT05305131|Bevacizumab|bevacizumab|mesh-list
19680893|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
20196413|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
20196414|NCT00236600|Topiramate|topiramate|mesh-list
20612872|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19334424|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19334425|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19334426|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334427|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19334428|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19334429|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612873|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20612874|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
19334430|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
19334431|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19334432|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19334433|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19680894|NCT05305131|Cisplatin|cisplatin|mesh-list
19842466|NCT00652314|Coagulants|coagulants|mesh-ancestor
19692554|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
20196415|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
20196416|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196417|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196418|NCT00236613|Topiramate|topiramate|mesh-list
20196419|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
20196420|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196421|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196422|NCT00236626|Topiramate|topiramate|mesh-list
20382673|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
20382674|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382675|NCT01035671|Protective Agents|protective agents|mesh-ancestor
20382676|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382677|NCT01035671|Vitamins|vitamins|mesh-ancestor
20382678|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
20382679|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
20382680|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20382681|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382682|NCT01035853|Colistin|colistin|mesh-list
20382683|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19334434|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
19334435|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196423|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
20196424|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196425|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334436|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
19334437|NCT03869047|Bupivacaine|bupivacaine|mesh-list
19334438|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
19334439|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
19334440|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334441|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334442|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
19334443|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334444|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19334445|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334446|NCT03869047|Analgesics|analgesics|mesh-ancestor
19334447|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19334448|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19334449|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19334450|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
19334451|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334452|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334453|NCT03868852|Apatinib|apatinib|mesh-list
19334454|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334455|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19334456|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334457|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334458|NCT03869073|Evolocumab|evolocumab|mesh-list
19334459|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19334460|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19334461|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
19334462|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334463|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19334464|NCT03868969|Fosfomycin|fosfomycin|mesh-list
19334465|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19334466|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334467|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
19334468|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19334469|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
19334470|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
19334471|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334472|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334473|NCT03868722|Venetoclax|venetoclax|mesh-list
19334474|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
19334475|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399453|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399454|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19399455|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19399456|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19399457|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399458|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399459|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196426|NCT00236639|Topiramate|topiramate|mesh-list
20196427|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
20196428|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196429|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196430|NCT00236652|Levofloxacin|levofloxacin|mesh-list
20196431|NCT00236652|Ofloxacin|ofloxacin|mesh-list
20196432|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20196433|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196434|NCT00236652|Renal Agents|renal agents|mesh-ancestor
20196435|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382684|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382685|NCT01035983|Frovatriptan|frovatriptan|mesh-list
20196436|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20426240|NCT01279668|Montelukast|montelukast|mesh-list
20382686|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20382687|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
19334476|NCT03868072|Tofacitinib|tofacitinib|mesh-list
19334477|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19334478|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196437|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196438|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196439|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196440|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196441|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20196442|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20196443|NCT00236665|Topiramate|topiramate|mesh-list
20196444|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
20382688|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334479|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334480|NCT03868124|Travoprost|travoprost|mesh-list
19334481|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19334482|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19334483|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19334484|NCT03868137|Ibuprofen|ibuprofen|mesh-list
19334485|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334486|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334487|NCT03868137|Analgesics|analgesics|mesh-ancestor
19334488|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
19334489|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334490|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334491|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334492|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334493|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19334494|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196445|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196446|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196447|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
20196448|NCT00236678|Hematinics|hematinics|mesh-ancestor
20196449|NCT00236691|Topiramate|topiramate|mesh-list
20196450|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
20196451|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196452|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196453|NCT00236704|Topiramate|topiramate|mesh-list
20196454|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
20382689|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428618|NCT01292785|Hormones|hormones|mesh-list
20196455|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196456|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196457|NCT00236717|Topiramate|topiramate|mesh-list
20196458|NCT00236717|Carbamazepine|carbamazepine|mesh-list
19334495|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334496|NCT03868111|Sufentanil|sufentanil|mesh-list
20196459|NCT00236717|Valproic Acid|valproic acid|mesh-list
20196460|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
19334497|NCT03868111|Remifentanil|remifentanil|mesh-list
19334498|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19334499|NCT03868111|Narcotics|narcotics|mesh-ancestor
19334500|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334501|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334502|NCT03868111|Analgesics|analgesics|mesh-ancestor
19334503|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
19334504|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334505|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19334506|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19334507|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
19334508|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
19334509|NCT03868202|Estradiol|estradiol|mesh-list
19334510|NCT03868202|Progesterone|progesterone|mesh-list
19334511|NCT03868202|Estrogens|estrogens|mesh-ancestor
19334512|NCT03868202|Hormones|hormones|mesh-ancestor
19692555|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19692556|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
19692557|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19692558|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
19692559|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
19692560|NCT04990752|Urinastatin|urinastatin|mesh-list
19692561|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19692562|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19692563|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
19692564|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692565|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692566|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20382690|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382691|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20382692|NCT01036035|Pilocarpine|pilocarpine|mesh-list
20382693|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20382694|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20382695|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
20382696|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382697|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382698|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382699|NCT01036035|Urological Agents|urological agents|mesh-ancestor
20382700|NCT01036035|Miotics|miotics|mesh-ancestor
20382701|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
20382702|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382703|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20382704|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20382705|NCT01036087|Paclitaxel|paclitaxel|mesh-list
20382706|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20382707|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
20382708|NCT01036087|Carboplatin|carboplatin|mesh-list
20382709|NCT01036087|Fluorouracil|fluorouracil|mesh-list
19334513|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19334514|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334515|NCT03868202|Progestins|progestins|mesh-ancestor
19334516|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
19334517|NCT03868033|Denosumab|denosumab|mesh-list
19334518|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334519|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334520|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19334521|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334522|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334523|NCT03867929|Vitamin D|vitamin d|mesh-list
19334524|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19334525|NCT03867929|Calcifediol|calcifediol|mesh-list
19334526|NCT03867929|Vitamins|vitamins|mesh-ancestor
19334527|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
19334528|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334529|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334530|NCT03867994|Carvedilol|carvedilol|mesh-list
19334531|NCT03867994|Atorvastatin|atorvastatin|mesh-list
19334532|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19334533|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19842467|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20382710|NCT01036087|Epirubicin|epirubicin|mesh-list
20382711|NCT01036087|Panitumumab|panitumumab|mesh-list
20382712|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20382713|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382714|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
20382715|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
19334534|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
19334535|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334536|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19334537|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19334538|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334539|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19334540|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19334541|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
19334542|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334543|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382716|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20382717|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382718|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382719|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
20382720|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382721|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334544|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19334545|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
19334546|NCT03867994|Protective Agents|protective agents|mesh-ancestor
19334547|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19334548|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19334549|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19334550|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
19334551|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19842468|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842469|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20382722|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19334552|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19334553|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19334554|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
19334555|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334556|NCT03867695|Ropivacaine|ropivacaine|mesh-list
19334557|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
19334558|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
19334559|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334560|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334561|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
19334562|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842470|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842471|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842472|NCT00652366|Gemcitabine|gemcitabine|mesh-list
19842473|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19842474|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19680895|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19680896|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19680897|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19680898|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19680899|NCT05305131|Growth Substances|growth substances|mesh-ancestor
19680900|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680901|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
19680902|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19680903|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
20196461|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196462|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196463|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196464|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196465|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
20196466|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196467|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
20196468|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196469|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196470|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196471|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20196472|NCT00236717|Analgesics|analgesics|mesh-ancestor
20196473|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
20196474|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196475|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20196476|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196477|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20196478|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20196479|NCT00236730|Topiramate|topiramate|mesh-list
20196480|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
20196481|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196482|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196483|NCT00236743|Topiramate|topiramate|mesh-list
20196484|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
20196485|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196486|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196487|NCT00236756|Topiramate|topiramate|mesh-list
20196488|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
20196489|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196490|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217569|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20217570|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
20217571|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217572|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217573|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20217574|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20217575|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20217576|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20217577|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217578|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217579|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217580|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
20217581|NCT00309881|Hormones|hormones|mesh-ancestor
20217582|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20382723|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
20382724|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19334568|NCT03867851|Heparin|heparin|mesh-list
19692567|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334569|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
19334570|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19334571|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19334572|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334573|NCT03867097|Iloprost|iloprost|mesh-list
19334574|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19334575|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
19334576|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
19334577|NCT03867071|Hematinics|hematinics|mesh-ancestor
19334578|NCT03867370|Lenvatinib|lenvatinib|mesh-list
19334579|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334580|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19334581|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334582|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196491|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20196492|NCT00236769|Norelgestromin|norelgestromin|mesh-list
20196493|NCT00236769|Estradiol|estradiol|mesh-list
19334586|NCT03867214|Tranexamic Acid|tranexamic acid|mesh-list
19334587|NCT03867214|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19334588|NCT03867214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19334589|NCT03867214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334590|NCT03867214|Hemostatics|hemostatics|mesh-ancestor
19334591|NCT03867214|Coagulants|coagulants|mesh-ancestor
19334592|NCT03867123|Temozolomide|temozolomide|mesh-list
19334593|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19334594|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
20612875|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
20612876|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612877|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334595|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334596|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334597|NCT03867240|Gabapentin|gabapentin|mesh-list
19334598|NCT03867240|Analgesics|analgesics|mesh-ancestor
19334599|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
19334600|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334601|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334602|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
19334603|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19334604|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19334605|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334606|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19334607|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19334608|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19334609|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196494|NCT00236769|Estrogens|estrogens|mesh-ancestor
20196495|NCT00236769|Hormones|hormones|mesh-ancestor
20382725|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
20382726|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20382727|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20382728|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20382729|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20382730|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382731|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20382732|NCT01036399|Lenalidomide|lenalidomide|mesh-list
20382733|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
19334610|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334611|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
19334612|NCT03866980|Carboplatin|carboplatin|mesh-list
19334613|NCT03866980|Pemetrexed|pemetrexed|mesh-list
19334614|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334615|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196496|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196497|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196498|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20196499|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
20196500|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20196501|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19334616|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196502|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20196503|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20196504|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20196505|NCT00236782|Norelgestromin|norelgestromin|mesh-list
20196506|NCT00236782|Estradiol|estradiol|mesh-list
20382734|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196507|NCT00236782|Estrogens|estrogens|mesh-ancestor
20382735|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20382736|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20382737|NCT01036399|Growth Substances|growth substances|mesh-ancestor
20382738|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
20382739|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382740|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
20382741|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20382742|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20382743|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334617|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19334618|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19334619|NCT03866993|Paclitaxel|paclitaxel|mesh-list
19334620|NCT03866993|Carboplatin|carboplatin|mesh-list
19334621|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19334622|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334623|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19334624|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
19334625|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19334626|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334627|NCT03866928|Stiripentol|stiripentol|mesh-list
19334628|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
19334629|NCT03866746|Aflibercept|aflibercept|mesh-list
19334630|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19334631|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19680904|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382744|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
20382745|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
20382746|NCT01036659|Ecallantide|ecallantide|mesh-list
20382747|NCT01036659|Bradykinin|bradykinin|mesh-list
20382748|NCT01036659|Kallikreins|kallikreins|mesh-list
20382749|NCT01036659|Kininogens|kininogens|mesh-list
20382750|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
20382751|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20382752|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
20382753|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382754|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334632|NCT03866746|Growth Substances|growth substances|mesh-ancestor
19334633|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334634|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
19334635|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196508|NCT00236782|Hormones|hormones|mesh-ancestor
20196509|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196510|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196511|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20196512|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
19680905|NCT05305131|Antiviral Agents|antiviral agents|mesh-ancestor
19680906|NCT05305131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680907|NCT05305131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680908|NCT05305131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680909|NCT05305131|Immunologic Factors|immunologic factors|mesh-ancestor
19680910|NCT05305066|Adalimumab|adalimumab|mesh-list
19680911|NCT05305066|Etanercept|etanercept|mesh-list
19680912|NCT05305066|Golimumab|golimumab|mesh-list
20196513|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20196514|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20196515|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20196516|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20196517|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20196518|NCT00236795|Norelgestromin|norelgestromin|mesh-list
20196519|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20196520|NCT00236795|Estradiol|estradiol|mesh-list
20196521|NCT00236795|Estrogens|estrogens|mesh-ancestor
20196522|NCT00236795|Hormones|hormones|mesh-ancestor
20196523|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196524|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196525|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20196526|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
20196527|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20196528|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20196529|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20196530|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20196531|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20196532|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20382755|NCT01036659|Analgesics|analgesics|mesh-ancestor
19334641|NCT03866681|Sirolimus|sirolimus|mesh-list
19680913|NCT05305066|Upadacitinib|upadacitinib|mesh-list
19680914|NCT05305066|Tofacitinib|tofacitinib|mesh-list
20382756|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
20382757|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382758|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334642|NCT03866681|Warfarin|warfarin|mesh-list
19334643|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19334644|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334645|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19334646|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334647|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
19334648|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334649|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
19334650|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334651|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
19334652|NCT03866629|Lifitegrast|lifitegrast|mesh-list
19334653|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19334654|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19334655|NCT03866733|Narcotics|narcotics|mesh-list
19334656|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334657|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680915|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680916|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680917|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19680918|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19680919|NCT05305066|Analgesics|analgesics|mesh-ancestor
19680920|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
19334658|NCT03866733|Analgesics|analgesics|mesh-ancestor
19334659|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
19334660|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334661|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
19334662|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19334663|NCT03866577|Antibodies|antibodies|mesh-list
19334664|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
19334665|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19334666|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
19334667|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334668|NCT03866772|Misoprostol|misoprostol|mesh-list
19334669|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19334670|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
19334671|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19334672|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334673|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19334674|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19334675|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
19334676|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
19334677|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19680921|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842475|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
19842476|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842477|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842478|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
19680922|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680923|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19680924|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19680925|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
19680926|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19680927|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680928|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196533|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20196534|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20196535|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20196536|NCT00236808|Levofloxacin|levofloxacin|mesh-list
20196537|NCT00236808|Ofloxacin|ofloxacin|mesh-list
20196538|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20196539|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196540|NCT00236808|Renal Agents|renal agents|mesh-ancestor
20196541|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196542|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20196543|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196544|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196545|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196546|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334678|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334679|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19334680|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19842479|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196547|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20196548|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20196549|NCT00236821|Levofloxacin|levofloxacin|mesh-list
19334681|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334682|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334683|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399460|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399461|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20196550|NCT00236821|Ofloxacin|ofloxacin|mesh-list
20196551|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20196552|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196553|NCT00236821|Renal Agents|renal agents|mesh-ancestor
20196554|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399462|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399463|NCT03634514|Hormones|hormones|mesh-list
20196555|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19680929|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19680930|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19680931|NCT05304871|Cefazolin|cefazolin|mesh-list
19680932|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19680933|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680934|NCT05304845|Aspirin|aspirin|mesh-list
19680935|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19680936|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19680937|NCT05304845|Analgesics|analgesics|mesh-ancestor
19680938|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
19399464|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399465|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680939|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680940|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680941|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19680942|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19680943|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19680944|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19680945|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680946|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19680947|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19680948|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19680949|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
19680950|NCT05304767|Xanomeline|xanomeline|mesh-list
19680951|NCT05304767|Trospium chloride|trospium chloride|mesh-list
19680952|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
19680953|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
19680954|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680955|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680956|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19842480|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842481|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842482|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
19842483|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842484|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19842485|NCT00652626|Azacitidine|azacitidine|mesh-list
19842486|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20196556|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196557|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196558|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196559|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196560|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20196561|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20196562|NCT00236834|Levofloxacin|levofloxacin|mesh-list
20196563|NCT00236834|Ofloxacin|ofloxacin|mesh-list
20196564|NCT00236834|Imipenem|imipenem|mesh-list
20196565|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20196566|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196567|NCT00236834|Renal Agents|renal agents|mesh-ancestor
20196568|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196569|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20196570|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196571|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196572|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404473|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19680957|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19842487|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
20382759|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19680958|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
19680959|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196573|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196574|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20196575|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20196576|NCT00236847|Topiramate|topiramate|mesh-list
20196577|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
20196578|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20382760|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20382761|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20382762|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382763|NCT01036659|Coagulants|coagulants|mesh-ancestor
20382764|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
20382765|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
20382766|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20382767|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20382768|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
20382769|NCT01036841|Coagulants|coagulants|mesh-ancestor
20382770|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20382771|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
20382772|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382773|NCT01036854|Ondansetron|ondansetron|mesh-list
20382774|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
20382775|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
20382776|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334684|NCT03866525|Irinotecan|irinotecan|mesh-list
20196579|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196580|NCT00236860|Topiramate|topiramate|mesh-list
20196581|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
20196582|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196583|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196584|NCT00236873|Topiramate|topiramate|mesh-list
20196585|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
20196586|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196587|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196588|NCT00236886|Topiramate|topiramate|mesh-list
20196589|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
20196590|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196591|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196592|NCT00236912|Metronidazole|metronidazole|mesh-list
20196593|NCT00236912|Levofloxacin|levofloxacin|mesh-list
20196594|NCT00236912|Ofloxacin|ofloxacin|mesh-list
19680960|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680961|NCT05304767|Urological Agents|urological agents|mesh-ancestor
19680962|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19680963|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680964|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19680965|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19680966|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
19680967|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19680968|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680969|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680970|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19680971|NCT05304598|Analgesics|analgesics|mesh-ancestor
19680972|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
20196595|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196596|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196597|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20196598|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20196599|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19680973|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680974|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19680975|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20196600|NCT00236912|Renal Agents|renal agents|mesh-ancestor
20196601|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20196602|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196603|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196604|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196605|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196606|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20196607|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20196608|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
20196609|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196610|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
20382777|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382778|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196611|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20196612|NCT00236964|Hematinics|hematinics|mesh-ancestor
19334685|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19334686|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196613|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
20196614|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
20196615|NCT00237016|Doxycycline|doxycycline|mesh-list
20196616|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196617|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196618|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
20196619|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20196620|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20196621|NCT00237068|Lansoprazole|lansoprazole|mesh-list
20196622|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
19842488|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842489|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842490|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842491|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
19842492|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19842493|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842494|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19842495|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
19842496|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196623|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20196624|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196625|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20196626|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382779|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
20382780|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
20382781|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20382782|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
20382783|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382784|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382785|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20382786|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20382787|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842497|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842498|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842499|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196627|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196628|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
20196629|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196630|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20196631|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196632|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196633|NCT00237133|Letrozole|letrozole|mesh-list
19334687|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334688|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334689|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334690|NCT03866408|Pioglitazone|pioglitazone|mesh-list
19334691|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334692|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334693|NCT03866447|Vitamin D|vitamin d|mesh-list
19334694|NCT03866447|Adapalene|adapalene|mesh-list
19334695|NCT03866447|Vitamins|vitamins|mesh-ancestor
19334696|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
19334697|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334698|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334699|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334700|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334701|NCT03866447|Analgesics|analgesics|mesh-ancestor
19334702|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
19334703|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334704|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334705|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334706|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
19334707|NCT03865992|Curcumin|curcumin|mesh-list
19334708|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334709|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334710|NCT03865992|Analgesics|analgesics|mesh-ancestor
19334711|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
20196634|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382788|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19334712|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196635|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20196636|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19680976|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19680977|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
19680978|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680979|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19680980|NCT05304559|Ketamine|ketamine|mesh-list
19680981|NCT05304559|Esketamine|esketamine|mesh-list
19680982|NCT05304559|Analgesics|analgesics|mesh-ancestor
19680983|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
19680984|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19680985|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19680986|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19680987|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20196637|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196638|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196639|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20196640|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
20196641|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196642|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196643|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
20196644|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20196645|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196646|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
20196647|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20196648|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196649|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
20196650|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196651|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20196652|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196653|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196654|NCT00237198|Letrozole|letrozole|mesh-list
20196655|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196656|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20196657|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20196658|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196659|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196660|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20196661|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
20196662|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196663|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196664|NCT00237211|Letrozole|letrozole|mesh-list
20382789|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20382790|NCT01036893|Prucalopride|prucalopride|mesh-list
19680988|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
19680989|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
19680990|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680991|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19680992|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20382791|NCT01036893|Laxatives|laxatives|mesh-ancestor
19334713|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334714|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334715|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334716|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334717|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334718|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334719|NCT03865888|Cyclosporine|cyclosporine|mesh-list
19334720|NCT03865888|Tacrolimus|tacrolimus|mesh-list
19334721|NCT03865888|Cyclosporins|cyclosporins|mesh-list
19334722|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334723|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
19334724|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334725|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19334726|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334727|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334728|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
19334729|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334730|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
19334731|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334732|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19334733|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19334734|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19680993|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19680994|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334735|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
19334736|NCT03865615|Oxytocin|oxytocin|mesh-list
19334737|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
19334738|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19334739|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334740|NCT03865550|Ketamine|ketamine|mesh-list
19334741|NCT03865550|Analgesics|analgesics|mesh-ancestor
20382792|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20382793|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20382794|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20382795|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
20382796|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382797|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382798|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382799|NCT01036932|Sargramostim|sargramostim|mesh-list
20382800|NCT01036932|Lenograstim|lenograstim|mesh-list
20382801|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
20382802|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382803|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20382804|NCT01037023|Topotecan|topotecan|mesh-list
20382805|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20382806|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20382807|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382808|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382809|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382810|NCT01037101|Cycloserine|cycloserine|mesh-list
20382811|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20382812|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382813|NCT01037101|Renal Agents|renal agents|mesh-ancestor
20382814|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20382815|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
20382816|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382817|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
20382818|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382819|NCT01037140|Vitamin D|vitamin d|mesh-list
20382820|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
20382821|NCT01037140|Vitamins|vitamins|mesh-ancestor
19334742|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
19334743|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334744|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334745|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19334746|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19334747|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
19334748|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
19334749|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334750|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19334751|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19334752|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334753|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334754|NCT03865563|Gemcitabine|gemcitabine|mesh-list
19334755|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
19334756|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20196665|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382822|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
20382823|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382824|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20382825|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19334757|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
20196666|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20196667|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20196668|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196669|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196670|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20196671|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
20196672|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196673|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196674|NCT00237224|Letrozole|letrozole|mesh-list
20196675|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196676|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20196677|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20382826|NCT01037322|Cannabidiol|cannabidiol|mesh-list
20382827|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
20382828|NCT01037335|Morphine|morphine|mesh-list
20382829|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19680995|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
19334758|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382830|NCT01037335|Narcotics|narcotics|mesh-ancestor
20382831|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20382832|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382833|NCT01037335|Analgesics|analgesics|mesh-ancestor
20382834|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
20382835|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382836|NCT01037348|Ranibizumab|ranibizumab|mesh-list
20382837|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20382838|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20382839|NCT01037348|Growth Substances|growth substances|mesh-ancestor
20382840|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382841|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
20382842|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382843|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
19334759|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334760|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
19334761|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334762|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382844|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
20382845|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382846|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334763|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334764|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
19334765|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334766|NCT03865680|Fluorides|fluorides|mesh-list
19334767|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
19334768|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
19334769|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
19334770|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334771|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
19334772|NCT03865680|Protective Agents|protective agents|mesh-ancestor
19334773|NCT03865732|Pregnanolone|pregnanolone|mesh-list
19334774|NCT03865732|Ganaxolone|ganaxolone|mesh-list
19334775|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
19334776|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334777|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382847|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20382848|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
20382849|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
20382850|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20382851|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
20382852|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382853|NCT01037465|Expectorants|expectorants|mesh-ancestor
19334778|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334779|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
19334780|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
19334781|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
19334782|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19680996|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19680997|NCT05304533|Itraconazole|itraconazole|mesh-list
19680998|NCT05304533|Verapamil|verapamil|mesh-list
19680999|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
19681000|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196678|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196679|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196680|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20196681|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
20196682|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196683|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196684|NCT00237237|Vildagliptin|vildagliptin|mesh-list
20196685|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196686|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196687|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20196688|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
20196689|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196690|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196691|NCT00237250|Vildagliptin|vildagliptin|mesh-list
20196692|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196693|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382854|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
20382855|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19334783|NCT03865511|Osimertinib|osimertinib|mesh-list
19334784|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382856|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
19334785|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19334786|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334787|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334788|NCT03865160|Atropine|atropine|mesh-list
19334789|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20382857|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382858|NCT01037465|Protective Agents|protective agents|mesh-ancestor
20382859|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382860|NCT01037465|Antidotes|antidotes|mesh-ancestor
20382861|NCT01037491|Aspirin|aspirin|mesh-list
19334790|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19334791|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19334792|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19334793|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19334794|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
19334795|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334796|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334797|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19334798|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
19334799|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
19334800|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
19334801|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19334802|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19334803|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
19334804|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334805|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681001|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19681002|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19681003|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382862|NCT01037491|Rabeprazole|rabeprazole|mesh-list
20382863|NCT01037491|Clopidogrel|clopidogrel|mesh-list
20382864|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20382865|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20382866|NCT01037491|Analgesics|analgesics|mesh-ancestor
20382867|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
20382868|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382869|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334806|NCT03865004|Acetaminophen|acetaminophen|mesh-list
19334807|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19334808|NCT03865004|Morphine|morphine|mesh-list
19334809|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19334810|NCT03865004|Narcotics|narcotics|mesh-ancestor
19334811|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334812|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334813|NCT03865004|Analgesics|analgesics|mesh-ancestor
19334814|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
19334815|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681004|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681005|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19681006|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
19681007|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681008|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681009|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19681010|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19681011|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20196694|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20196695|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
20196696|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196697|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196698|NCT00237263|Entacapone|entacapone|mesh-list
20196699|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20196700|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20196701|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20196702|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196703|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196704|NCT00237289|Topiramate|topiramate|mesh-list
20196705|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
20196706|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196707|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196708|NCT00237302|Topiramate|topiramate|mesh-list
20196709|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
20196710|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20382870|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20382871|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382872|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20382873|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20382874|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382875|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20382876|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20382877|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382878|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
20382879|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20382880|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20382881|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20382882|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
20382883|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20382884|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20382885|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20382886|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20382887|NCT01037517|Plerixafor|plerixafor|mesh-list
20382888|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20382889|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20382890|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
20382891|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382892|NCT01037530|Ramipril|ramipril|mesh-list
20382893|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20382894|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
20382895|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382896|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334816|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334817|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
19334818|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334819|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334820|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334821|NCT03864913|Testosterone|testosterone|mesh-list
20382897|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20426241|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20426242|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
20426243|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20426244|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
20426245|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426246|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426247|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20426248|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20426249|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426250|NCT01279694|Prednisone|prednisone|mesh-list
20426251|NCT01279694|Melphalan|melphalan|mesh-list
20426252|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426253|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
19334822|NCT03864913|Androgens|androgens|mesh-ancestor
19334823|NCT03864913|Hormones|hormones|mesh-ancestor
19334824|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19334825|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334826|NCT03865147|Acetaminophen|acetaminophen|mesh-list
19334827|NCT03865147|Cetrimonium|cetrimonium|mesh-list
19334828|NCT03865147|Ibuprofen|ibuprofen|mesh-list
19334829|NCT03865147|Lidocaine|lidocaine|mesh-list
19334830|NCT03865147|Epinephrine|epinephrine|mesh-list
19334831|NCT03865147|Racepinephrine|racepinephrine|mesh-list
19334832|NCT03865147|Bupivacaine|bupivacaine|mesh-list
19334833|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19334834|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
19334835|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
19334836|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
19334837|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334838|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334839|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
19334840|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334841|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19334842|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19334843|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19334844|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19334845|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334846|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334847|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842500|NCT00652899|Vidarabine|vidarabine|mesh-list
20426254|NCT01279694|Hormones|hormones|mesh-ancestor
19334848|NCT03865147|Analgesics|analgesics|mesh-ancestor
19334849|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20382898|NCT01037595|Turmeric extract|turmeric extract|mesh-list
20382899|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
20382900|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382901|NCT01037595|Protective Agents|protective agents|mesh-ancestor
20382902|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382903|NCT01037608|Nabiximols|nabiximols|mesh-list
20382904|NCT01037608|Analgesics|analgesics|mesh-ancestor
20382905|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
19334850|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334851|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19334852|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334853|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
19334854|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19334855|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20382906|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20382907|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382908|NCT01037621|Valacyclovir|valacyclovir|mesh-list
20382909|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
20382910|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382911|NCT01037634|Oseltamivir|oseltamivir|mesh-list
19334856|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
19334857|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19334858|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19334859|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19334860|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
19334861|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19334862|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
19334863|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
19334864|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
19334865|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19334866|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20196711|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681012|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681013|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19681014|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
19681015|NCT05304520|Natalizumab|natalizumab|mesh-list
19681016|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
19681017|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681018|NCT05304351|Vaccines|vaccines|mesh-list
19681019|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
19681020|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681021|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
19681022|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19842501|NCT00652899|Aldesleukin|aldesleukin|mesh-list
20196712|NCT00237328|Heparin|heparin|mesh-list
20196713|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
20196714|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20196715|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20382912|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
19334867|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19334868|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334869|NCT03865121|Nicotine|nicotine|mesh-list
19334870|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19334871|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
19334872|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334873|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334874|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20196716|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196717|NCT00237341|Fentanyl|fentanyl|mesh-list
20382913|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382914|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382915|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382916|NCT01037660|Metformin|metformin|mesh-list
19334875|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19334876|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
19681023|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681024|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
19842502|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
20196718|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196719|NCT00237341|Narcotics|narcotics|mesh-ancestor
20196720|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196721|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334877|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399466|NCT03634345|Fluconazole|fluconazole|mesh-list
20196722|NCT00237341|Analgesics|analgesics|mesh-ancestor
20382917|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334878|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334879|NCT03864978|Rifaximin|rifaximin|mesh-list
19334880|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196723|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
20196724|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196725|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19334881|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19334882|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19334883|NCT03864783|Curcumin|curcumin|mesh-list
19334884|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334885|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334886|NCT03864783|Analgesics|analgesics|mesh-ancestor
19334887|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
19334888|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334889|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334890|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334891|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19334892|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334893|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334894|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334895|NCT03864666|Cilostazol|cilostazol|mesh-list
19334896|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19334897|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
19334898|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334899|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334900|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19334901|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
19334902|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19334903|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19334904|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334905|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20196726|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20196727|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
20196728|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
20196729|NCT00237367|Rabeprazole|rabeprazole|mesh-list
20196730|NCT00237367|Pantoprazole|pantoprazole|mesh-list
20196731|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20196732|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196733|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20196734|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196735|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196736|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20196737|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
19681025|NCT05304273|Letrozole|letrozole|mesh-list
19681026|NCT05304273|Misoprostol|misoprostol|mesh-list
19681027|NCT05304273|Mifepristone|mifepristone|mesh-list
19681028|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196738|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19334906|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
19334907|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19334908|NCT03864666|Protective Agents|protective agents|mesh-ancestor
19334909|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19334910|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20196739|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196740|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196741|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196742|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196743|NCT00237419|Infliximab|infliximab|mesh-list
20196744|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
20196745|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196746|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20196747|NCT00237445|Azithromycin|azithromycin|mesh-list
20196748|NCT00237445|Telithromycin|telithromycin|mesh-list
20196749|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20196750|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196751|NCT00237471|Insulin|insulin|mesh-list
20196752|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20196753|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196754|NCT00237484|Interferons|interferons|mesh-list
20196755|NCT00237484|Ribavirin|ribavirin|mesh-list
19334911|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681029|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19681030|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19681031|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196756|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
20196757|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
20196758|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20196759|NCT00237484|Infliximab|infliximab|mesh-list
20196760|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196761|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
20196762|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196763|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
20196764|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196765|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
20196766|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842503|NCT00652899|Fludarabine|fludarabine|mesh-list
19842504|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
20196767|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
20196768|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196769|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20196770|NCT00237497|Zopiclone|zopiclone|mesh-list
20196771|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19842505|NCT00652899|Interleukin-2|interleukin-2|mesh-list
19842506|NCT00652899|Allopurinol|allopurinol|mesh-list
19842507|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842508|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
19842509|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842510|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382918|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382919|NCT01037699|Hormones|hormones|mesh-list
20382920|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19334912|NCT03864705|Metformin|metformin|mesh-list
19334913|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334914|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334915|NCT03864250|Prednisone|prednisone|mesh-list
20196772|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196773|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196774|NCT00237510|Terazosin|terazosin|mesh-list
20196775|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20196776|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20196777|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20196778|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
20196779|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196780|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196781|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196782|NCT00237510|Urological Agents|urological agents|mesh-ancestor
20196783|NCT00237523|Iodine|iodine|mesh-list
20196784|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
20196785|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20196786|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196787|NCT00237523|Trace Elements|trace elements|mesh-ancestor
19334916|NCT03864250|Tacrolimus|tacrolimus|mesh-list
19842511|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19842512|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
19842513|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842514|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842515|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19842516|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19842517|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
19334917|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334918|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
19334919|NCT03864250|Hormones|hormones|mesh-ancestor
19842518|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
19842519|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842520|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334920|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19334921|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334922|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19334923|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334924|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19334925|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
19334926|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19334927|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334928|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334929|NCT03864523|Pioglitazone|pioglitazone|mesh-list
19842521|NCT00652899|Analgesics|analgesics|mesh-ancestor
19842522|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
19842523|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196788|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
20196789|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428759|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19334930|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334931|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334932|NCT03864588|Ropivacaine|ropivacaine|mesh-list
19334933|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
19334934|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
19334935|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334936|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334937|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
19334938|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334939|NCT03864575|Celecoxib|celecoxib|mesh-list
19334940|NCT03864575|Nivolumab|nivolumab|mesh-list
19334941|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334942|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334943|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20196790|NCT00237536|Lonidamine|lonidamine|mesh-list
19681032|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681033|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19681034|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
19681035|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20382921|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20382922|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382923|NCT01037712|Valacyclovir|valacyclovir|mesh-list
20382924|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
20382925|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382926|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
20382927|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382928|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20382929|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382930|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382931|NCT01037842|Mitiglinide|mitiglinide|mesh-list
20382932|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19334944|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334945|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19334946|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19334947|NCT03864575|Analgesics|analgesics|mesh-ancestor
19334948|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
19334949|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334950|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334951|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334952|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681036|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681037|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19681038|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
19334953|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19334954|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19334955|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399467|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
19399468|NCT03634345|Abrocitinib|abrocitinib|mesh-list
19399469|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
19399470|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399471|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19399472|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19399473|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399474|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399475|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19399476|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
19399477|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399478|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399479|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19399480|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19399481|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19399482|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399483|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842524|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19842525|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20196791|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196792|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20196793|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196794|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20196795|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
20196796|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20196797|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20382933|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382934|NCT01037959|Norfloxacin|norfloxacin|mesh-list
19334956|NCT03864185|Rituximab|rituximab|mesh-list
19334957|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19334958|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334959|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
19334960|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334961|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382935|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20382936|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382937|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20382938|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20382939|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382940|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382941|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382942|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20382943|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20382944|NCT01037998|Gefitinib|gefitinib|mesh-list
20382945|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382946|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20382947|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382948|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382949|NCT01038024|Antioxidants|antioxidants|mesh-list
20382950|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382951|NCT01038024|Protective Agents|protective agents|mesh-ancestor
20382952|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382953|NCT01038037|Carboplatin|carboplatin|mesh-list
20382954|NCT01038037|Vinorelbine|vinorelbine|mesh-list
20382955|NCT01038037|Panitumumab|panitumumab|mesh-list
19334962|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
19334963|NCT03864172|Calcium|calcium|mesh-list
19334964|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19334965|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334966|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19334967|NCT03864068|Inositol|inositol|mesh-list
19334968|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
19334969|NCT03864068|Vitamins|vitamins|mesh-ancestor
19334970|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
19334971|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334972|NCT03863925|Propofol|propofol|mesh-list
19334973|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19334974|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19334975|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334976|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19334977|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
19334978|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
19334979|NCT03863977|Dexamethasone|dexamethasone|mesh-list
19334980|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
19334981|NCT03863977|Bupivacaine|bupivacaine|mesh-list
19334982|NCT03863977|BB 1101|bb 1101|mesh-list
19334983|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19334984|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
19334985|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
19334986|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19334987|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19334988|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19334989|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
19334990|NCT03863977|Hormones|hormones|mesh-ancestor
19334991|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19334992|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19334993|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19334994|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
19334995|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19334996|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19334997|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
19334998|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
19334999|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196798|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20196799|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20196800|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196801|NCT00237575|Gemcitabine|gemcitabine|mesh-list
20196802|NCT00237575|Sargramostim|sargramostim|mesh-list
20196803|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196804|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20196805|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
20196806|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196807|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
20196808|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196809|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196810|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20196811|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
20196812|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196813|NCT00237588|Losartan|losartan|mesh-list
20196814|NCT00237588|Amlodipine|amlodipine|mesh-list
20196815|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20196816|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20382956|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20382957|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20382958|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
20382959|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
20382960|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
20382961|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382962|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19335000|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
19335001|NCT03864016|Sufentanil|sufentanil|mesh-list
19335002|NCT03864016|Dsuvia|dsuvia|mesh-list
19335003|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
19335004|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335005|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382963|NCT01038063|Lumefantrine|lumefantrine|mesh-list
20382964|NCT01038063|Artemether|artemether|mesh-list
20382965|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20382966|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
20382967|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20382968|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19335006|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19335007|NCT03864016|Narcotics|narcotics|mesh-ancestor
19335008|NCT03864016|Analgesics|analgesics|mesh-ancestor
19335009|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
19335010|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335011|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19335012|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19335013|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
19335014|NCT03863899|Anesthetics|anesthetics|mesh-list
19335015|NCT03863899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335016|NCT03863899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335017|NCT03863691|Amisulpride|amisulpride|mesh-list
19335018|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19335019|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19335020|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196817|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196818|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196819|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20196820|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196821|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
20196822|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20196823|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20196824|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20196825|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
20196826|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20196827|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
20196828|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196829|NCT00237614|Expectorants|expectorants|mesh-ancestor
20196830|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
20196831|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20196832|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
20196833|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196834|NCT00237614|Protective Agents|protective agents|mesh-ancestor
20196835|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196836|NCT00237614|Antidotes|antidotes|mesh-ancestor
20196837|NCT00237627|Doxorubicin|doxorubicin|mesh-list
20196838|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20196839|NCT00237627|Bortezomib|bortezomib|mesh-list
20196840|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20196841|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196842|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20196843|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20196844|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196845|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196846|NCT00237653|Valganciclovir|valganciclovir|mesh-list
19335021|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335022|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196847|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
20382969|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382970|NCT01038089|Resveratrol|resveratrol|mesh-list
20382971|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
19335023|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19335024|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
19335025|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335026|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335027|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19681039|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19681040|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19681041|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19681042|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
19681043|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19681044|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19681045|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19681046|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19681047|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
19681048|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19681049|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19681050|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
19681051|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19335028|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
19335029|NCT03863405|Metformin|metformin|mesh-list
19335030|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19335031|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681052|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19681053|NCT05304169|Leuprolide|leuprolide|mesh-list
19335032|NCT03863392|Misoprostol|misoprostol|mesh-list
19335033|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19335034|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
19335035|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335036|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335037|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19335038|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335039|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
19335040|NCT03863626|Furosemide|furosemide|mesh-list
19335041|NCT03863626|Diuretics|diuretics|mesh-ancestor
19681054|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19681055|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
20196848|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196849|NCT00237705|Metoclopramide|metoclopramide|mesh-list
20196850|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
20196851|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
20196852|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196853|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196854|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19842526|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842527|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
19842528|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19842529|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
19842530|NCT00652899|Protective Agents|protective agents|mesh-ancestor
20196855|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19681056|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19681057|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842531|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19842532|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
20382972|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382973|NCT01038089|Protective Agents|protective agents|mesh-ancestor
20382974|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382975|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382976|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19842533|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382977|NCT01038154|Pravastatin|pravastatin|mesh-list
20382978|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20382979|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20382980|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
20382981|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382982|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20382983|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20382984|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382985|NCT01038167|Cyclosporine|cyclosporine|mesh-list
19335042|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
19842534|NCT00653159|Copper|copper|mesh-list
20382986|NCT01038167|Tacrolimus|tacrolimus|mesh-list
19842535|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
20382987|NCT01038167|Cyclosporins|cyclosporins|mesh-list
19335043|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335044|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19335045|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335046|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335047|NCT03863613|Progesterone|progesterone|mesh-list
19335048|NCT03863613|Progestins|progestins|mesh-ancestor
19335049|NCT03863613|Hormones|hormones|mesh-ancestor
19335050|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20196856|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196857|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
20196858|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196859|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196860|NCT00237731|Morphine|morphine|mesh-list
20196861|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20196862|NCT00237731|Narcotics|narcotics|mesh-ancestor
20196863|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196864|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196865|NCT00237731|Analgesics|analgesics|mesh-ancestor
20196866|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
20196867|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196868|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
20196869|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20196870|NCT00237861|Olanzapine|olanzapine|mesh-list
20196871|NCT00237861|Risperidone|risperidone|mesh-list
20196872|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20196873|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196874|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
20196875|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196876|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196877|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196878|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19335051|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335052|NCT03863366|Prucalopride|prucalopride|mesh-list
19335053|NCT03863366|Laxatives|laxatives|mesh-ancestor
19335054|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335055|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19335056|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19335057|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
19335058|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335059|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335060|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335061|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19335062|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335063|NCT03863223|Docetaxel|docetaxel|mesh-list
19335064|NCT03863223|Trastuzumab|trastuzumab|mesh-list
19335065|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335066|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
19335067|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
19335068|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
19335069|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335070|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19335071|NCT03862950|Metformin|metformin|mesh-list
19335072|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19335073|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335074|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19335075|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19335076|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335077|NCT03862768|Sunitinib|sunitinib|mesh-list
19335078|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
19335079|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335080|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19335081|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19335082|NCT03862768|Growth Substances|growth substances|mesh-ancestor
19335083|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335084|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
19335085|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19681058|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20196879|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196880|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196881|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196882|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196883|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
20196884|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
20428760|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
19335086|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335087|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335088|NCT03862456|Azithromycin|azithromycin|mesh-list
19335089|NCT03862456|Metronidazole|metronidazole|mesh-list
19335090|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19335091|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681059|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681060|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
19681061|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19681062|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
19681063|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681064|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681065|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19681066|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
19681067|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19681068|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
19681069|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681070|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681071|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19681072|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
19681073|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
19681074|NCT05304039|Protective Agents|protective agents|mesh-ancestor
19681075|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
19681076|NCT05303987|Propofol|propofol|mesh-list
19681077|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19681078|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681079|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681080|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19335092|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19335093|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20382988|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20382989|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
20382990|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20382991|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20382992|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20382993|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20382994|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
19335094|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
19335095|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19335096|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
19335097|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335098|NCT03862586|Expectorants|expectorants|mesh-ancestor
19335099|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
19335100|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19335101|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
19335102|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335103|NCT03862586|Protective Agents|protective agents|mesh-ancestor
19335104|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335105|NCT03862586|Antidotes|antidotes|mesh-ancestor
19335106|NCT03862651|Cangrelor|cangrelor|mesh-list
19335107|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19335108|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19335109|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19335110|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19335111|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
19681081|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
19681082|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
19681083|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19335112|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335113|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681084|NCT05303987|Analgesics|analgesics|mesh-ancestor
19681085|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
19681086|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681087|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19681088|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20196885|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
20196886|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196887|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196888|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20196889|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20196890|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196891|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
20196892|NCT00237874|Aripiprazole|aripiprazole|mesh-list
19399484|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20382995|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20382996|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
20382997|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20382998|NCT01038349|Methotrexate|methotrexate|mesh-list
20382999|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20383000|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
20383001|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20383002|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383003|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19681089|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19681090|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383004|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
20383005|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383006|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383007|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
20383008|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383009|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20383010|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383011|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
20383012|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20383013|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20383014|NCT01038388|Dexamethasone|dexamethasone|mesh-list
20383015|NCT01038388|Lenalidomide|lenalidomide|mesh-list
20383016|NCT01038388|Bortezomib|bortezomib|mesh-list
20383017|NCT01038388|Vorinostat|vorinostat|mesh-list
20383018|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383019|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
20383020|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
20383021|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383022|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383023|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383024|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
20383025|NCT01038388|Hormones|hormones|mesh-ancestor
20383026|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383027|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20383028|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383029|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
19335114|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335115|NCT03862612|Anesthetics|anesthetics|mesh-list
19335116|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383030|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20383031|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20383032|NCT01038388|Growth Substances|growth substances|mesh-ancestor
20383033|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
20383034|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20383035|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383036|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383037|NCT01038453|Vitamin D|vitamin d|mesh-list
20383038|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
20383039|NCT01038453|Vitamins|vitamins|mesh-ancestor
20383040|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
20383041|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383042|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20383043|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20383044|NCT01038505|Sirolimus|sirolimus|mesh-list
20383045|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
19335117|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335118|NCT03862404|Epinephrine|epinephrine|mesh-list
19335119|NCT03862404|Bupivacaine|bupivacaine|mesh-list
19335120|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
19335121|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
19335122|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335123|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335124|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
19335125|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335126|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19335127|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20383046|NCT01038505|Tacrolimus|tacrolimus|mesh-list
20383047|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383048|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
20383049|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335128|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
19335129|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383050|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20383051|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383052|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335130|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335131|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19335132|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19335133|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
19335134|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19335135|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
19335136|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
19335137|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
19335138|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19335139|NCT03862391|Analgesics|analgesics|mesh-list
19335140|NCT03862391|Antiemetics|antiemetics|mesh-list
19335141|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
19681091|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681092|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681093|NCT05303961|Rebamipide|rebamipide|mesh-list
19681094|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19681095|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19681096|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
19681097|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681098|NCT05303961|Protective Agents|protective agents|mesh-ancestor
19681099|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681100|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681101|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
19681102|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19681103|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
19681104|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19681105|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19681106|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681107|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681108|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
19681109|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19681110|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19681111|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19681112|NCT05303688|Analgesics|analgesics|mesh-ancestor
19681113|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
19681114|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20196893|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
20196894|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20383053|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20383054|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383055|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20383056|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383057|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
20383058|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20383059|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
20383060|NCT01038570|Oxytocin|oxytocin|mesh-list
20383061|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
20383062|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20196895|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196896|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196897|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196898|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196899|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
20196900|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
20196901|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196902|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196903|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20196904|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20196905|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
20196906|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20383063|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383064|NCT01038583|Aspirin|aspirin|mesh-list
20383065|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20383066|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20383067|NCT01038583|Analgesics|analgesics|mesh-ancestor
19335142|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681115|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196907|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196908|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20196909|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19681116|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19681117|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681118|NCT05303597|Lidocaine|lidocaine|mesh-list
19681119|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
20383068|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
19681120|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
19681121|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681122|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335143|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335144|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
19335145|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399485|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19399486|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19399487|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399488|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399489|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
19399490|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19399491|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
19399492|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19399493|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19399494|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
19399495|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399496|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399497|NCT03634202|Capecitabine|capecitabine|mesh-list
20196910|NCT00237887|Adalimumab|adalimumab|mesh-list
20196911|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20196912|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20383069|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383070|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399498|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19399499|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
19399500|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399501|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399502|NCT03634189|Cannabidiol|cannabidiol|mesh-list
19399503|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
19399504|NCT03634137|Afamelanotide|afamelanotide|mesh-list
19399505|NCT03634137|alpha-MSH|alpha-msh|mesh-list
19399506|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
19399507|NCT03634137|Hormones|hormones|mesh-ancestor
19399508|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399509|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399510|NCT03634111|Morphine|morphine|mesh-list
19399511|NCT03634111|Ropivacaine|ropivacaine|mesh-list
19399512|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19399513|NCT03634111|Narcotics|narcotics|mesh-ancestor
19399514|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399515|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399516|NCT03634111|Analgesics|analgesics|mesh-ancestor
19399517|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
19399518|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399519|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
19399520|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
19399521|NCT03634059|Apatinib|apatinib|mesh-list
19399522|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399523|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19399524|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399525|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399526|NCT03634020|Sirolimus|sirolimus|mesh-list
19399527|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399528|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399529|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19681123|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
19681124|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681125|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19681126|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19681127|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19681128|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19692568|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
20196913|NCT00237900|Leucovorin|leucovorin|mesh-list
20196914|NCT00237900|Fluorouracil|fluorouracil|mesh-list
20196915|NCT00237900|Gefitinib|gefitinib|mesh-list
20196916|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
20196917|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196918|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20196919|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196920|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20196921|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
20196922|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196923|NCT00237900|Antidotes|antidotes|mesh-ancestor
19399530|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335146|NCT03862287|Lidocaine|lidocaine|mesh-list
19335147|NCT03862287|Bupivacaine|bupivacaine|mesh-list
19335148|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
19335149|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
19335150|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335151|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335152|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
19335153|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681129|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681130|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
19681131|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
19681132|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681133|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19681134|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681135|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19681136|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
19681137|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681138|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
19681139|NCT05303272|Abatacept|abatacept|mesh-list
19681140|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19681141|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681142|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19681143|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
19681144|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19681145|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383071|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383072|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20383073|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20383074|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20383075|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383076|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20383077|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19681146|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681147|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681148|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19681149|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19681150|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
19681151|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681152|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681153|NCT05303259|Bevacizumab|bevacizumab|mesh-list
20383078|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383079|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
20383080|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20383081|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20383082|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383083|NCT01038648|Incretins|incretins|mesh-ancestor
20383084|NCT01038648|Hormones|hormones|mesh-ancestor
20383085|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383086|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20383087|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
20383088|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383089|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383090|NCT01038661|Docetaxel|docetaxel|mesh-list
20383091|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383092|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
20383093|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
20196924|NCT00237900|Protective Agents|protective agents|mesh-ancestor
20196925|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
20196926|NCT00237900|Vitamins|vitamins|mesh-ancestor
20383094|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
19335154|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20196927|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
20196928|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20196929|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20196930|NCT00237913|Olanzapine|olanzapine|mesh-list
20196931|NCT00237913|Risperidone|risperidone|mesh-list
20196932|NCT00237913|Aripiprazole|aripiprazole|mesh-list
20196933|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20196934|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196935|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
19335155|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19681154|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20196936|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196937|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196938|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196939|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19335156|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20196940|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196941|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196942|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20383095|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383096|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
20383097|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
19335157|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335158|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335159|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19335160|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19335161|NCT03862079|Tazobactam|tazobactam|mesh-list
19335162|NCT03862079|Piperacillin|piperacillin|mesh-list
19335163|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19842536|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19335164|NCT03862079|Nystatin|nystatin|mesh-list
19335165|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19335166|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681155|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681156|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19681157|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19681158|NCT05303259|Growth Substances|growth substances|mesh-ancestor
19681159|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681160|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
19681161|NCT05303090|Lenvatinib|lenvatinib|mesh-list
19681162|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681163|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19681164|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681165|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196943|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196944|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
20196945|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
20196946|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
19842537|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
19842538|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335167|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19335168|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335169|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335170|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
19335171|NCT03862079|Ionophores|ionophores|mesh-ancestor
19335172|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335173|NCT03862144|Palonosetron|palonosetron|mesh-list
19335174|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
19335175|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
19335176|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335177|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335178|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335179|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19335180|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19335181|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
19335182|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335183|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335184|NCT03861598|Carvedilol|carvedilol|mesh-list
19335185|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19335186|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19335187|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
19335188|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196947|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842539|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842540|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19842541|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20196948|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20196949|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20196950|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20196951|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20196952|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
20196953|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
20196954|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20196955|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20196956|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19335189|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335190|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335191|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19335192|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
19335193|NCT03861598|Protective Agents|protective agents|mesh-ancestor
19335194|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19335195|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335196|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19335197|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19335198|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19335199|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19335214|NCT03861299|Anesthetics|anesthetics|mesh-list
19335215|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335216|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335217|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
19335218|NCT03861403|Avelumab|avelumab|mesh-list
19335219|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19335220|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
19335221|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335222|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19335223|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19335224|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
19335225|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335226|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335227|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19335228|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19335229|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19335230|NCT03861364|Propofol|propofol|mesh-list
19335231|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19335232|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335233|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335234|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19335235|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
19335236|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
19335237|NCT03860870|Clenbuterol|clenbuterol|mesh-list
19335238|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19335239|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20196957|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20196958|NCT00237939|Aripiprazole|aripiprazole|mesh-list
20196959|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
20196960|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20196961|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20196962|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20196963|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20196964|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196965|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
20196966|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
20196967|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196968|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196969|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20196970|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20196971|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
20196972|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20196973|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20196974|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20196975|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20196976|NCT00237952|Chelating Agents|chelating agents|mesh-list
20196977|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
19335240|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
20196978|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196979|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
20383098|NCT01038817|Protective Agents|protective agents|mesh-ancestor
20383099|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383100|NCT01038882|Midazolam|midazolam|mesh-list
20383101|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20383102|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20383103|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383104|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383105|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20383106|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20383107|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20383108|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20383109|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
20196980|NCT00238004|Niacin|niacin|mesh-list
20196981|NCT00238004|Niacinamide|niacinamide|mesh-list
20196982|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
20196983|NCT00238004|Vitamins|vitamins|mesh-ancestor
20196984|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
20196985|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20196986|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19335241|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335242|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335243|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383110|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
20383111|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
20196987|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
20196988|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20196989|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19681182|NCT05302999|Gabapentin|gabapentin|mesh-list
19681183|NCT05302999|Analgesics|analgesics|mesh-ancestor
19681184|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
20196990|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
20196991|NCT00238017|Artesunate|artesunate|mesh-list
20196992|NCT00238017|Amodiaquine|amodiaquine|mesh-list
20196993|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
20196994|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19681185|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681186|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681187|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
19681188|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19681189|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19681190|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681191|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681192|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20383112|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
20383113|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335244|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19335245|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
19335246|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335247|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19335248|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
19335249|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
19335250|NCT03860597|Memantine|memantine|mesh-list
19335251|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19335252|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19335253|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
19681193|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19681194|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20196995|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20196996|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20196997|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20196998|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
20196999|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
20197000|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20197001|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
20197002|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
20197003|NCT00238043|Hematinics|hematinics|mesh-ancestor
20197004|NCT00238056|Domperidone|domperidone|mesh-list
20197005|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
20197006|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
20197007|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197008|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197009|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19842542|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20197010|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20197011|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
20197012|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335254|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335255|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335256|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335257|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19335258|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19335259|NCT03860831|Midazolam|midazolam|mesh-list
19335260|NCT03860831|Ketamine|ketamine|mesh-list
19335261|NCT03860831|Analgesics|analgesics|mesh-ancestor
19335262|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
20383114|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383115|NCT01038895|Ramipril|ramipril|mesh-list
20383116|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20383117|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
20383118|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383119|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383120|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19335263|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335264|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335265|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19335266|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19335267|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
19335268|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
19335269|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335270|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19335271|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19335272|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335273|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335274|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19335275|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19335276|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19335277|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19335278|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19335279|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
19335280|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
19335281|NCT03860662|Baclofen|baclofen|mesh-list
19335282|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19681195|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681196|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
19681197|NCT05302921|Nivolumab|nivolumab|mesh-list
19681198|NCT05302921|Ipilimumab|ipilimumab|mesh-list
19681199|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681200|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681201|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19681202|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681203|NCT05302856|Antibodies|antibodies|mesh-list
19681204|NCT05302856|Testosterone|testosterone|mesh-list
19681205|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
19681206|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681207|NCT05302856|Androgens|androgens|mesh-ancestor
19681208|NCT05302856|Hormones|hormones|mesh-ancestor
19681209|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681210|NCT05302817|Xenon|xenon|mesh-list
19681211|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19681212|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
19681213|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
19681214|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681215|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335283|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335284|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19335285|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681216|NCT05302726|Estrogens|estrogens|mesh-list
19681217|NCT05302726|Hormones|hormones|mesh-ancestor
19681218|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681219|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681220|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
19681221|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
19681222|NCT05302713|Calcium|calcium|mesh-list
19681223|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19681224|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681225|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19681226|NCT05302713|Antacids|antacids|mesh-ancestor
19681227|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335286|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19681228|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19681229|NCT05302531|Amoxicillin|amoxicillin|mesh-list
19681230|NCT05302531|Levofloxacin|levofloxacin|mesh-list
19681231|NCT05302531|Ofloxacin|ofloxacin|mesh-list
19681232|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20383121|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
20383122|NCT01039025|Melphalan|melphalan|mesh-list
20383123|NCT01039025|Topotecan|topotecan|mesh-list
20383124|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383125|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
20383126|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383127|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681233|NCT05302531|Trimethoprim|trimethoprim|mesh-list
20197013|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197014|NCT00238082|Beclomethasone|beclomethasone|mesh-list
20197015|NCT00238082|Norflurane|norflurane|mesh-list
20197016|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197017|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
20197018|NCT00238082|Hormones|hormones|mesh-ancestor
20197019|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335287|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
19335288|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
19335289|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335290|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335291|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20383128|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20383129|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
20383130|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383131|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383132|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20383133|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20383134|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20383135|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335292|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19335293|NCT03860636|Estradiol|estradiol|mesh-list
19335294|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19335295|NCT03860636|Progesterone|progesterone|mesh-list
20197020|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197021|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197022|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197023|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
20197024|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20197025|NCT00238147|Carboplatin|carboplatin|mesh-list
20197026|NCT00238147|Docetaxel|docetaxel|mesh-list
20197027|NCT00238147|Capecitabine|capecitabine|mesh-list
20197028|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197029|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
20197030|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
20197031|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
20197032|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197033|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20197034|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
20197035|NCT00238160|Fluorouracil|fluorouracil|mesh-list
20197036|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681234|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
19681235|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19681236|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681237|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19681238|NCT05302531|Renal Agents|renal agents|mesh-ancestor
19681239|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19681240|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19681241|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681242|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681243|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681244|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19681245|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19681246|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
19681247|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19681248|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19681249|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19681250|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19681251|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20197037|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
19335296|NCT03860636|Estrogens|estrogens|mesh-ancestor
19335297|NCT03860636|Hormones|hormones|mesh-ancestor
20197038|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383136|NCT01039090|Dopamine|dopamine|mesh-list
20383137|NCT01039090|Apomorphine|apomorphine|mesh-list
20383138|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
20383139|NCT01039090|Emetics|emetics|mesh-ancestor
20383140|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383141|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
20383142|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383143|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383144|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
20383145|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383146|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383147|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20383148|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
20383149|NCT01039090|Protective Agents|protective agents|mesh-ancestor
20383150|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
20383151|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20383152|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20383153|NCT01039103|Prednisolone|prednisolone|mesh-list
20383154|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
20383155|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20383156|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
20383157|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383158|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
20383159|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
19681252|NCT05302466|Silicon|silicon|mesh-list
19681253|NCT05302466|Trace Elements|trace elements|mesh-ancestor
19681254|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
19681255|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692569|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692570|NCT04990258|Infliximab|infliximab|mesh-list
19692571|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
19692572|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692573|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842543|NCT00653159|Trace Elements|trace elements|mesh-ancestor
19842544|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
19335298|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335299|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335300|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19335301|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
19335302|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335303|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19842545|NCT00653224|Levocetirizine|levocetirizine|mesh-list
20383160|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383161|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383162|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383163|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
20383164|NCT01039103|Hormones|hormones|mesh-ancestor
20383165|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383166|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20383167|NCT01039103|Protective Agents|protective agents|mesh-ancestor
20383168|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19842546|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19842547|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19842548|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
19842549|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
19842550|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842551|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842552|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842553|NCT00653328|Doxorubicin|doxorubicin|mesh-list
19842554|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19842555|NCT00653328|Atrasentan|atrasentan|mesh-list
19842556|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19842557|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842558|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19842559|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19842560|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692574|NCT04990167|Bromides|bromides|mesh-list
20197039|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19692575|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
19692576|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197040|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197041|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
20197042|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197043|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
20197044|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
20197045|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
20197046|NCT00238173|Carboplatin|carboplatin|mesh-list
19681256|NCT05302271|Prednisone|prednisone|mesh-list
19681257|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19335304|NCT03860636|Progestins|progestins|mesh-ancestor
19335305|NCT03860480|Bupivacaine|bupivacaine|mesh-list
19335306|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
19335307|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
19335308|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335309|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335310|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
19335311|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399531|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
19399532|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19681258|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
19681259|NCT05302271|Hormones|hormones|mesh-ancestor
20197047|NCT00238173|Etoposide|etoposide|mesh-list
20197048|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
20197049|NCT00238173|Mannitol|mannitol|mesh-list
20197050|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20197051|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197052|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
19399533|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
19399534|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399535|NCT03633994|Heparin|heparin|mesh-list
19399536|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
19399537|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19399538|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19399539|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399540|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19399541|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19399542|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
19399543|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399544|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399545|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399546|NCT03633747|Propranolol|propranolol|mesh-list
19399547|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19399548|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19399549|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
20197053|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197054|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197055|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20197056|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
19681260|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681261|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197057|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197058|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197059|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20197060|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19399550|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197061|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20197062|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19399551|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681262|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19681263|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681264|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19681265|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
19399552|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399553|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19681266|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19681267|NCT05302232|Prednisolone|prednisolone|mesh-list
19681268|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
19681269|NCT05302232|Lidocaine|lidocaine|mesh-list
19681270|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19681271|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
19681272|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
19681273|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
19681274|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681275|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681276|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
19681277|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681278|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19681279|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19681280|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19681281|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197063|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383169|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383170|NCT01039142|Acitretin|acitretin|mesh-list
20383171|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
20383172|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
20383173|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
20383174|NCT01039155|Azacitidine|azacitidine|mesh-list
20383175|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383176|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20383177|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
20383178|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383179|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383180|NCT01039181|Vitamin D|vitamin d|mesh-list
20383181|NCT01039181|Calcitriol|calcitriol|mesh-list
20383182|NCT01039181|Vitamins|vitamins|mesh-ancestor
20383183|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
20383184|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383185|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20383186|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20383187|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19335312|NCT03860012|Folic Acid|folic acid|mesh-list
19335313|NCT03860012|Hematinics|hematinics|mesh-ancestor
19335314|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
19335315|NCT03860012|Vitamins|vitamins|mesh-ancestor
19335316|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
19335317|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335318|NCT03860129|Sevoflurane|sevoflurane|mesh-list
19335319|NCT03860129|Desflurane|desflurane|mesh-list
19335320|NCT03860129|Isoflurane|isoflurane|mesh-list
19335321|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19335322|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19681282|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681283|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19681284|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
19681285|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
19681286|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19842561|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383188|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335323|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
19335324|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
19335325|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335326|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335327|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19335328|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19335329|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19335330|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
19335331|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335332|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19335333|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19335334|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19335335|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681287|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
19681288|NCT05302232|Hormones|hormones|mesh-ancestor
19681289|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681290|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19681291|NCT05302232|Protective Agents|protective agents|mesh-ancestor
20197064|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
20197065|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197066|NCT00238173|Expectorants|expectorants|mesh-ancestor
20197067|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197068|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20197069|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
20197070|NCT00238173|Protective Agents|protective agents|mesh-ancestor
20197071|NCT00238173|Antidotes|antidotes|mesh-ancestor
20197072|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20197073|NCT00238173|Diuretics|diuretics|mesh-ancestor
20197074|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
20197075|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197076|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197077|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
20197078|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
20197079|NCT00238199|Calcitriol|calcitriol|mesh-list
20197080|NCT00238199|Docetaxel|docetaxel|mesh-list
20197081|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197082|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
20197083|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
20197084|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
20197085|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383189|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383190|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20383191|NCT01039194|Galantamine|galantamine|mesh-list
20383192|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20383193|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383194|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383195|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
20383196|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383197|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383198|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20383199|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
20383200|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383201|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
20426255|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426256|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426257|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20426258|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426259|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20426260|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
20426261|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426262|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20426263|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426264|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
20426265|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20426266|NCT01279707|Epratuzumab|epratuzumab|mesh-list
20426267|NCT01279707|Veltuzumab|veltuzumab|mesh-list
20426268|NCT01279707|Antibodies|antibodies|mesh-list
20426269|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
20426270|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20426271|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
20426272|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426273|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426274|NCT01279811|Dopamine|dopamine|mesh-list
20426275|NCT01279811|Norepinephrine|norepinephrine|mesh-list
20426276|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19335336|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19335337|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335338|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19335339|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335340|NCT03860207|Antibodies|antibodies|mesh-list
19335341|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
19335342|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19335343|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
19335344|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335345|NCT03859934|Melatonin|melatonin|mesh-list
19335346|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
19335347|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335348|NCT03859934|Protective Agents|protective agents|mesh-ancestor
19335349|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335350|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426277|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20426278|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20426279|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
20426280|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426281|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426282|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426283|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
20426284|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
20426285|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426286|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20426287|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
20426288|NCT01279811|Protective Agents|protective agents|mesh-ancestor
20426289|NCT01279876|Melatonin|melatonin|mesh-list
20426290|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
20426291|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426292|NCT01279876|Protective Agents|protective agents|mesh-ancestor
20426293|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426294|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426295|NCT01279902|Rituximab|rituximab|mesh-list
20426296|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20426297|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426298|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
20426299|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335351|NCT03859908|Ethanol|ethanol|mesh-list
19335352|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
19335353|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19335354|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19335355|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383202|NCT01039233|Bicalutamide|bicalutamide|mesh-list
20383203|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
20383204|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
19335356|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335357|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335358|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
19335359|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
19335360|NCT03860077|Nicotine|nicotine|mesh-list
19335361|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19335362|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
19335363|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335364|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335365|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19335366|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19335367|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
19335368|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335369|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335370|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
19335371|NCT03859921|Progestins|progestins|mesh-ancestor
19335372|NCT03859921|Hormones|hormones|mesh-ancestor
19335373|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335374|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335375|NCT03859856|Hormones|hormones|mesh-list
19335376|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335377|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335378|NCT03859583|Capsaicin|capsaicin|mesh-list
19681292|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19681293|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681294|NCT05301660|Nicotine|nicotine|mesh-list
19335379|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
19335380|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
19335381|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
19335382|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335383|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335384|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
19335385|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19335386|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335387|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335388|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19335389|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19335390|NCT03859570|Protective Agents|protective agents|mesh-ancestor
19335391|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335392|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
19681295|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19681296|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
19681297|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681298|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681299|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19681300|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20197086|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20197087|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197088|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20197089|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197090|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20197091|NCT00238199|Vitamins|vitamins|mesh-ancestor
20197092|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
20197093|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20197094|NCT00238212|Sorafenib|sorafenib|mesh-list
20383205|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383206|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383207|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383208|NCT01039285|Poractant alfa|poractant alfa|mesh-list
20383209|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20383210|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
20383211|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
19335393|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19335394|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
19335395|NCT03859687|Vitamins|vitamins|mesh-list
19681301|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197095|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681302|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681303|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681304|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
19681305|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19681306|NCT05287984|Rituximab|rituximab|mesh-list
19681307|NCT05287984|Fludarabine|fludarabine|mesh-list
20197096|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197097|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197098|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197099|NCT00238225|Calcitriol|calcitriol|mesh-list
19681308|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
19681309|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19681310|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
19681311|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681312|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681313|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20383212|NCT01039350|Hematinics|hematinics|mesh-ancestor
20383213|NCT01039363|Cytarabine|cytarabine|mesh-list
20383214|NCT01039363|Vorinostat|vorinostat|mesh-list
20383215|NCT01039363|Idarubicin|idarubicin|mesh-list
20383216|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
20383217|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20383218|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
20383219|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383220|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383221|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
20383222|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681314|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
20197100|NCT00238225|Ketoconazole|ketoconazole|mesh-list
20197101|NCT00238225|Dexamethasone|dexamethasone|mesh-list
20197102|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842562|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19842563|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19842564|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
19842565|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19842566|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
19842567|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842568|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
19842569|NCT00653432|Protective Agents|protective agents|mesh-ancestor
19842570|NCT00653861|Lidocaine|lidocaine|mesh-list
20383223|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383224|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
20383225|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383226|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20383227|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383228|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20383229|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19335396|NCT03859687|Vitamin A|vitamin a|mesh-list
19335397|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
19842571|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
19842572|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
19842573|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842574|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197103|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
20197104|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
20383230|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19335398|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
19335399|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335400|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
19335401|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335402|NCT03859687|Protective Agents|protective agents|mesh-ancestor
19335403|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19335404|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681315|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681316|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681317|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19681318|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681319|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19681320|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681321|NCT05287308|Paclitaxel|paclitaxel|mesh-list
19681322|NCT05287308|Docetaxel|docetaxel|mesh-list
19681323|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19335405|NCT03859635|Bupivacaine|bupivacaine|mesh-list
19335406|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
19842575|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
20197105|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197106|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335407|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
19335408|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335409|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335410|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
19335411|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335412|NCT03859362|Ertapenem|ertapenem|mesh-list
19335413|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19335414|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335415|NCT03859375|Disinfectants|disinfectants|mesh-list
19335416|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335417|NCT03859141|Vaccines|vaccines|mesh-list
19335418|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
19335419|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335420|NCT03859102|Acetaminophen|acetaminophen|mesh-list
19335421|NCT03859102|Dexamethasone|dexamethasone|mesh-list
19335422|NCT03859102|Gabapentin|gabapentin|mesh-list
19335423|NCT03859102|Ondansetron|ondansetron|mesh-list
19335424|NCT03859102|Anesthetics|anesthetics|mesh-list
19335425|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
19335426|NCT03859102|Lansoprazole|lansoprazole|mesh-list
19335427|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
19335428|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19335429|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
19681324|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
19681325|NCT05287308|Doxorubicin|doxorubicin|mesh-list
19681326|NCT05287308|Epirubicin|epirubicin|mesh-list
19681327|NCT05287308|Pirarubicin|pirarubicin|mesh-list
20383231|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20383232|NCT01039441|Bupivacaine|bupivacaine|mesh-list
20383233|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
20383234|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
19681328|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19681329|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681330|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
19681331|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
19681332|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
19681333|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681334|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197107|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20197108|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
20197109|NCT00238225|Hormones|hormones|mesh-ancestor
20197110|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197111|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20197112|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197113|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
19335430|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
19335431|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335432|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335433|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335434|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
19335435|NCT03859102|Hormones|hormones|mesh-ancestor
19335436|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335437|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19335438|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335439|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19335440|NCT03859102|Analgesics|analgesics|mesh-ancestor
19335441|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
19335442|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
19335443|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335444|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
19335445|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19335446|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19335447|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19335448|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19335449|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19335450|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335451|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681335|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
19335452|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
19335453|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
19335454|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
19335455|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19335456|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
19335457|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20197114|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197115|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20197116|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20197117|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197118|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197119|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20197120|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
20197121|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20197122|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20383235|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335458|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19335459|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19335460|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335461|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
19335462|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19335463|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
19335464|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335465|NCT03858972|Capecitabine|capecitabine|mesh-list
19335466|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19335467|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
19335468|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335469|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335470|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
19335471|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19335472|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335473|NCT03858465|Phenylephrine|phenylephrine|mesh-list
19335474|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
19335475|NCT03858465|Ephedrine|ephedrine|mesh-list
19335476|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19335477|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
19335478|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
19335479|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335480|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335481|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
19335482|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19335483|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
19335484|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
19335485|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19335486|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19335487|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19335488|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
19335489|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335490|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335491|NCT03858465|Protective Agents|protective agents|mesh-ancestor
19335492|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19335493|NCT03858491|Cobicistat|cobicistat|mesh-list
19335494|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19335495|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19335496|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
19335497|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335498|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20383236|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383237|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
20383238|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383239|NCT01039506|Irinotecan|irinotecan|mesh-list
20383240|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20383241|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20383242|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383243|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335499|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19692577|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
20197123|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20197124|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197125|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20197126|NCT00238225|Vitamins|vitamins|mesh-ancestor
20197127|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
20197128|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20197129|NCT00238251|Temozolomide|temozolomide|mesh-list
20197130|NCT00238251|Gefitinib|gefitinib|mesh-list
20197131|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20197132|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
20197133|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197134|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197135|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197136|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335500|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335501|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335502|NCT03858387|Meropenem|meropenem|mesh-list
19335503|NCT03858387|Imipenem|imipenem|mesh-list
19335504|NCT03858387|Cilastatin|cilastatin|mesh-list
19335505|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19335506|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335507|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
19335508|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335509|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335510|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19335511|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335512|NCT03858270|Memantine|memantine|mesh-list
19335513|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19335514|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19842576|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842577|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20197137|NCT00238277|Temozolomide|temozolomide|mesh-list
19335515|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
19335516|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197138|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20197139|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
20197140|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197141|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197142|NCT00238290|Trastuzumab|trastuzumab|mesh-list
20197143|NCT00238290|Letrozole|letrozole|mesh-list
20197144|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20197145|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197146|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20197147|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20197148|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197149|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197150|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20197151|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
20197152|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197153|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197154|NCT00238316|Letrozole|letrozole|mesh-list
20197155|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681336|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681337|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681338|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19681339|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
19681340|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19681341|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19681342|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19681343|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19681344|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842578|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20197156|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20383244|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383245|NCT01039545|Norfloxacin|norfloxacin|mesh-list
20383246|NCT01039545|Diclofenac|diclofenac|mesh-list
20197157|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20197158|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197159|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197160|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20383247|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20383248|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842579|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20197161|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
20197162|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197163|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197164|NCT00238329|Interferons|interferons|mesh-list
20197165|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
20197166|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
20197167|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20197168|NCT00238329|Thalidomide|thalidomide|mesh-list
20197169|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197170|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
20197171|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383249|NCT01039545|Analgesics|analgesics|mesh-ancestor
19335517|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681345|NCT05285800|Bupivacaine|bupivacaine|mesh-list
19842580|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842581|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842582|NCT00653939|Paclitaxel|paclitaxel|mesh-list
19681346|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
19681347|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
19681348|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681349|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681350|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
19681351|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681352|NCT05284656|Folic Acid|folic acid|mesh-list
19681353|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
19681354|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
19681355|NCT05284656|Hematinics|hematinics|mesh-ancestor
19681356|NCT05284656|Vitamins|vitamins|mesh-ancestor
19681357|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
19681358|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681359|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19335518|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335519|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19335520|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19399554|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19399555|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
19399556|NCT03633734|Folfirinox|folfirinox|mesh-list
19399557|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399558|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
19399559|NCT03633630|Antacids|antacids|mesh-ancestor
19399560|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842583|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
19842584|NCT00653939|Combretastatin|combretastatin|mesh-list
20383250|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
20383251|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383252|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383253|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383254|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20383255|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19842585|NCT00653939|Bevacizumab|bevacizumab|mesh-list
19842586|NCT00653939|Carboplatin|carboplatin|mesh-list
19842587|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19842588|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842589|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
20383256|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399561|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399562|NCT03633604|HBOC 201|hboc 201|mesh-list
19399563|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
19399564|NCT03633591|Tolcapone|tolcapone|mesh-list
19399565|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19399566|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19399567|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19399568|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399569|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399570|NCT03633565|Prednisolone|prednisolone|mesh-list
19399571|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19399572|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
19399573|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19399574|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
19399575|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
20383257|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383258|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20383259|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383260|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19399576|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19399577|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
19399578|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
19399579|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383261|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19399580|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
19399581|NCT03633565|Hormones|hormones|mesh-ancestor
19842590|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
19399582|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399583|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842591|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
19681360|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197172|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
20197173|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197174|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197175|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
20197176|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197177|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20197178|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20197179|NCT00238329|Growth Substances|growth substances|mesh-ancestor
20197180|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
20197181|NCT00238368|Cytarabine|cytarabine|mesh-list
19335521|NCT03858062|Insulin|insulin|mesh-list
19335522|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19335523|NCT03858062|Pancrelipase|pancrelipase|mesh-list
19335524|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19335525|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335526|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335527|NCT03857854|Pirfenidone|pirfenidone|mesh-list
19335528|NCT03857854|Analgesics|analgesics|mesh-ancestor
19335529|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
19335530|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335531|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335532|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19335533|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19335534|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19335535|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19335536|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335537|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19335538|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335539|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335540|NCT03857399|Caspofungin|caspofungin|mesh-list
19335541|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
19335542|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692578|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197182|NCT00238368|Prednisone|prednisone|mesh-list
20197183|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
20197184|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
20197185|NCT00238368|Busulfan|busulfan|mesh-list
20197186|NCT00238368|Rituximab|rituximab|mesh-list
20197187|NCT00238368|Doxorubicin|doxorubicin|mesh-list
20197188|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20197189|NCT00238368|Etoposide|etoposide|mesh-list
20197190|NCT00238368|Vincristine|vincristine|mesh-list
20197191|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20612878|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612879|NCT02253108|Everolimus|everolimus|mesh-list
20612880|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197192|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197193|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
20197194|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197195|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197196|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20197197|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
20197198|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197199|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197200|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20197201|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20197202|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197203|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20197204|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20197205|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197206|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197207|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
20197208|NCT00238368|Hormones|hormones|mesh-ancestor
20197209|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197210|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20197211|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20197212|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20197213|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
20197214|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
20197215|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197216|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20197217|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20197218|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20197219|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
19335543|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197220|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
20426300|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426301|NCT01279915|Linaclotide|linaclotide|mesh-list
20426302|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20426303|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
20426304|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426305|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426306|NCT01279980|Anesthetics|anesthetics|mesh-list
20383262|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335544|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335545|NCT03857711|Amiodarone|amiodarone|mesh-list
19335546|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19335547|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
19335548|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19335549|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20383263|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20383264|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20383265|NCT01039558|Ecabet|ecabet|mesh-list
20383266|NCT01039558|Lansoprazole|lansoprazole|mesh-list
20383267|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
20383268|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20383269|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383270|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19335550|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335551|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19335552|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19335553|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19335554|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335555|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19335556|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19335557|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19335558|NCT03857763|Paclitaxel|paclitaxel|mesh-list
19335559|NCT03857763|Apatinib|apatinib|mesh-list
19335560|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19335561|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335562|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
19335563|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
19335564|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
19335565|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335566|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19335567|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335568|NCT03857386|Anesthetics|anesthetics|mesh-list
19335569|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335570|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335571|NCT03857815|Antibodies|antibodies|mesh-list
19335572|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
19335573|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335574|NCT03857581|Olanzapine|olanzapine|mesh-list
19335575|NCT03857581|Clozapine|clozapine|mesh-list
19335576|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
19335577|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
19335578|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335579|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335580|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335581|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19335582|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19335583|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335584|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19335585|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19335586|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19335587|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335588|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335589|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335590|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
19335591|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19335592|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
19335593|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
19335594|NCT03857334|Cortivazol|cortivazol|mesh-list
19335595|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19335596|NCT03856853|Pirfenidone|pirfenidone|mesh-list
19335597|NCT03856853|Analgesics|analgesics|mesh-ancestor
19335598|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
19335599|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335600|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842592|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842593|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19842594|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19842595|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19335601|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19335602|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19335603|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383271|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335604|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19335605|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335606|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
19335607|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
19335608|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19335609|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19335610|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335611|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335612|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335613|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19335614|NCT03856970|Glyburide|glyburide|mesh-list
19335615|NCT03856970|Digoxin|digoxin|mesh-list
19335616|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19335617|NCT03856970|Norethindrone|norethindrone|mesh-list
19335618|NCT03856970|Estradiol|estradiol|mesh-list
19335619|NCT03856970|Estrogens|estrogens|mesh-ancestor
19335620|NCT03856970|Hormones|hormones|mesh-ancestor
19335621|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335622|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335623|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19335624|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
19335625|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335626|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19335627|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19335628|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19335629|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19335630|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19335631|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335632|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335633|NCT03856970|Protective Agents|protective agents|mesh-ancestor
19335634|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19335635|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19335636|NCT03856658|Floxuridine|floxuridine|mesh-list
19335637|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19335638|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
19335639|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335640|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335641|NCT03856671|Metronidazole|metronidazole|mesh-list
19335642|NCT03856671|Neomycin|neomycin|mesh-list
19335643|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335644|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19335645|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19335646|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19335647|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19335648|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335649|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335650|NCT03856697|Gefitinib|gefitinib|mesh-list
19335651|NCT03856697|Maleic acid|maleic acid|mesh-list
19335652|NCT03856697|Abivertinib|abivertinib|mesh-list
19335653|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335654|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335655|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335656|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19335657|NCT03856502|Dexamethasone|dexamethasone|mesh-list
19335658|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
19335659|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
19335660|NCT03856502|BB 1101|bb 1101|mesh-list
19335661|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19335662|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
19335663|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
19335664|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335665|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335666|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20197221|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197222|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20197223|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20197224|NCT00238368|Protective Agents|protective agents|mesh-ancestor
20197225|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20217583|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217584|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20217585|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
20217586|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19335667|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
19335668|NCT03856502|Hormones|hormones|mesh-ancestor
19335669|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383272|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383273|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335670|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19335671|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335672|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
19335673|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335674|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335675|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
20383274|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
20383275|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20383276|NCT01039558|Protective Agents|protective agents|mesh-ancestor
20383277|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383278|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383279|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
20383280|NCT01039610|Linezolid|linezolid|mesh-list
19335676|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
19335677|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335678|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
19399584|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19399585|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399586|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
19399587|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
19399588|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399589|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399590|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19399591|NCT03633565|Protective Agents|protective agents|mesh-ancestor
19399592|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
19399593|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19399594|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399595|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399596|NCT03633565|Urological Agents|urological agents|mesh-ancestor
19399597|NCT03633552|Temozolomide|temozolomide|mesh-list
19399598|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19399599|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
19399600|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399601|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399602|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19399603|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399604|NCT03633266|Bevacizumab|bevacizumab|mesh-list
19399605|NCT03633266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399606|NCT03633266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399607|NCT03633266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19399608|NCT03633266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19399609|NCT03633266|Growth Substances|growth substances|mesh-ancestor
19399610|NCT03633266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399611|NCT03633266|Growth Inhibitors|growth inhibitors|mesh-ancestor
19399612|NCT03633175|Progesterone|progesterone|mesh-list
19399613|NCT03633175|Progestins|progestins|mesh-ancestor
19681361|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399614|NCT03633175|Hormones|hormones|mesh-ancestor
19399615|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399616|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399617|NCT03632915|Lacosamide|lacosamide|mesh-list
19399618|NCT03632915|Phenytoin|phenytoin|mesh-list
19399619|NCT03632915|Ketamine|ketamine|mesh-list
19399620|NCT03632915|Levetiracetam|levetiracetam|mesh-list
19399621|NCT03632915|Valproic Acid|valproic acid|mesh-list
19399622|NCT03632915|Phenobarbital|phenobarbital|mesh-list
19399623|NCT03632915|Analgesics|analgesics|mesh-ancestor
19399624|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
19399625|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399626|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399627|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19399628|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19399629|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
19399630|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
19399631|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399632|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19681362|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19681363|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19681364|NCT05284656|Protective Agents|protective agents|mesh-ancestor
19681365|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
20383281|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399633|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19335679|NCT03856242|Tamsulosin|tamsulosin|mesh-list
19335680|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19335681|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19335682|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19335683|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
19335684|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335685|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335686|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335687|NCT03856242|Urological Agents|urological agents|mesh-ancestor
19335688|NCT03856112|Dexamethasone|dexamethasone|mesh-list
19335689|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
19335690|NCT03856112|Venetoclax|venetoclax|mesh-list
19335691|NCT03856112|Ixazomib|ixazomib|mesh-list
19335692|NCT03856112|Ichthammol|ichthammol|mesh-list
19335693|NCT03856112|BB 1101|bb 1101|mesh-list
19335694|NCT03856112|Glycine|glycine|mesh-list
19335695|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19335696|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
19335697|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
19842596|NCT00653939|Growth Substances|growth substances|mesh-ancestor
20383282|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383283|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20383284|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20383285|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842597|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335698|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681366|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19681367|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
19681368|NCT05284474|Mitogens|mitogens|mesh-list
19681369|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
19681370|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335699|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335700|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335701|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
19335702|NCT03856112|Hormones|hormones|mesh-ancestor
19335703|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335704|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19335705|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335706|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335707|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19335708|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335709|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
19335710|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335711|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
19335712|NCT03855865|Vortioxetine|vortioxetine|mesh-list
19335713|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
19335714|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19335715|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19335716|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19335717|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681371|NCT05283356|Ticagrelor|ticagrelor|mesh-list
19681372|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19681373|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19681374|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20197226|NCT00238394|Cediranib|cediranib|mesh-list
20197227|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197228|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197229|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197230|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197231|NCT00238407|Docetaxel|docetaxel|mesh-list
20197232|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197233|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
20197234|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
20197235|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
20197236|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197237|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20197238|NCT00238459|Vaccines|vaccines|mesh-list
20197239|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
20197240|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197241|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
19335718|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842598|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
20197242|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197243|NCT00238472|Nateglinide|nateglinide|mesh-list
20197244|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20383286|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681375|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19681376|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
19681377|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681378|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335719|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19335720|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19335721|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335722|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335723|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335724|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
19335725|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19335726|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19335727|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19335728|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19335729|NCT03855826|Amiodarone|amiodarone|mesh-list
19335730|NCT03855826|Nifekalant|nifekalant|mesh-list
19335731|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19335732|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
19335733|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19335734|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335735|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335736|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19335737|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19335738|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19335739|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335740|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19335741|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19335742|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19335743|NCT03855501|Calcium|calcium|mesh-list
19335744|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19335745|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335746|NCT03855579|Simendan|simendan|mesh-list
19335747|NCT03855579|Milrinone|milrinone|mesh-list
19335748|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19335749|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
19335750|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19335751|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19335752|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335753|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335754|NCT03855579|Protective Agents|protective agents|mesh-ancestor
19335755|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335756|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19335757|NCT03855423|Tocotrienols|tocotrienols|mesh-list
19335758|NCT03855423|Vitamin E|vitamin e|mesh-list
19335759|NCT03855423|Tocopherols|tocopherols|mesh-list
19335760|NCT03855423|Tocovid|tocovid|mesh-list
19335761|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
20383287|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383288|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20383289|NCT01039740|Mirtazapine|mirtazapine|mesh-list
20383290|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
20383291|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20383292|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20383293|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
20383294|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
20383295|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383296|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383297|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383298|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20383299|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20383300|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383301|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20383302|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20383303|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20383304|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19335762|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335763|NCT03855423|Protective Agents|protective agents|mesh-ancestor
19335764|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335765|NCT03855423|Vitamins|vitamins|mesh-ancestor
19335766|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
19681379|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426307|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
19335767|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
20383305|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20383306|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19335768|NCT03855527|Fluorides|fluorides|mesh-list
19335769|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
19335770|NCT03855527|Protective Agents|protective agents|mesh-ancestor
19335771|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335772|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19335773|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335774|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
19335775|NCT03855306|Glyburide|glyburide|mesh-list
19335776|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19335777|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335778|NCT03855384|Cisplatin|cisplatin|mesh-list
20383307|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
20383308|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20383309|NCT01039766|Oxytocin|oxytocin|mesh-list
20383310|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
20383311|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20383312|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383313|NCT01039844|Paclitaxel|paclitaxel|mesh-list
20383314|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20383315|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383316|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
20383317|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
20383318|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
20383319|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383320|NCT01039883|Albaconazole|albaconazole|mesh-list
19335779|NCT03855384|Carboplatin|carboplatin|mesh-list
19335780|NCT03855384|Fluorouracil|fluorouracil|mesh-list
19335781|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335782|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
19335783|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335784|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19335785|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19335786|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
19335787|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335788|NCT03855332|Cilostazol|cilostazol|mesh-list
19335789|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
19335790|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
19335791|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19335792|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19335793|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335794|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335795|NCT03855332|Urological Agents|urological agents|mesh-ancestor
19681380|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
20383321|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
20383322|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383323|NCT01039948|Gefitinib|gefitinib|mesh-list
20383324|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383325|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20383326|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383327|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383328|NCT01039974|Ketoconazole|ketoconazole|mesh-list
20383329|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
20383330|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383331|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20383332|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20383333|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383334|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383335|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20383336|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
19681381|NCT05282901|Lenvatinib|lenvatinib|mesh-list
19681382|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681383|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383337|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383338|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335796|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19335797|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
19335798|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335799|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335800|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19335801|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
19681384|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19335802|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19681385|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383339|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20383340|NCT01040078|Vaccines|vaccines|mesh-list
20383341|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
20383342|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383343|NCT01040091|Tenofovir|tenofovir|mesh-list
20383344|NCT01040091|Emtricitabine|emtricitabine|mesh-list
20383345|NCT01040091|Efavirenz|efavirenz|mesh-list
20383346|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20197245|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197246|NCT00238498|Vildagliptin|vildagliptin|mesh-list
20197247|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20197248|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681386|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681387|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
19681388|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681389|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19681390|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681391|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681392|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
19681393|NCT05281562|Vitamins|vitamins|mesh-ancestor
19681394|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
19681395|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681396|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
20383347|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
20383348|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383349|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20383350|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20383351|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383352|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383353|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20383354|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20383355|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19681397|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681398|NCT05281562|Protective Agents|protective agents|mesh-ancestor
19681399|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19681400|NCT05281549|Tenecteplase|tenecteplase|mesh-list
20197249|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19335803|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19335804|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19335805|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19335806|NCT03855332|Protective Agents|protective agents|mesh-ancestor
19335807|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19335808|NCT03855267|Propofol|propofol|mesh-list
19335809|NCT03855267|Etomidate|etomidate|mesh-list
19335810|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19681401|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19681402|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19681403|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681404|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
19681405|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681406|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681407|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20197250|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
20197251|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197252|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197253|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20197254|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19681408|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
19681409|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681410|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681411|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
19681412|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681413|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681414|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20197255|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20197256|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197257|NCT00238563|Triamcinolone|triamcinolone|mesh-list
20197258|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197259|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
20197260|NCT00238563|Hormones|hormones|mesh-ancestor
20217587|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
19335811|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335812|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335813|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19335814|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
19335815|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
19335816|NCT03855371|Decitabine|decitabine|mesh-list
19335817|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
19335818|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19335819|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
19335820|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335821|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335822|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335823|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
19335824|NCT03855007|Prednisone|prednisone|mesh-list
19335825|NCT03855007|Methotrexate|methotrexate|mesh-list
19335826|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383356|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20383357|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20383358|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19335827|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
19335828|NCT03855007|Hormones|hormones|mesh-ancestor
19335829|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335830|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335831|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19335832|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335833|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19335834|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
19335835|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335836|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19335837|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
19335838|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335839|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
19335840|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335841|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19335842|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19335843|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
19335844|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19335845|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20383359|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19335846|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
19335847|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19335848|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19335849|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19335850|NCT03854799|Capecitabine|capecitabine|mesh-list
19335851|NCT03854799|Avelumab|avelumab|mesh-list
19335852|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19681415|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19681416|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681417|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
19681418|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
19681419|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
19681420|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19681421|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20197261|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197262|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197263|NCT00238628|Bexarotene|bexarotene|mesh-list
20197264|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197265|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
20197266|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
20197267|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20197268|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20197269|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20197270|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197271|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197272|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197273|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197274|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197275|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20197276|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197277|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19335853|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
19335854|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335855|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681422|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19335856|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19335857|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
19335858|NCT03854812|Fentanyl|fentanyl|mesh-list
19335859|NCT03854812|Propofol|propofol|mesh-list
19335860|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19335861|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335862|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335863|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20197278|NCT00238667|Aspirin|aspirin|mesh-list
20197279|NCT00238667|Heparin|heparin|mesh-list
20197280|NCT00238667|Calcium heparin|calcium heparin|mesh-list
20197281|NCT00238667|Dipyridamole|dipyridamole|mesh-list
20197282|NCT00238667|Warfarin|warfarin|mesh-list
20197283|NCT00238667|Anticoagulants|anticoagulants|mesh-list
20197284|NCT00238667|Clopidogrel|clopidogrel|mesh-list
20197285|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20197286|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20197287|NCT00238667|Analgesics|analgesics|mesh-ancestor
20197288|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
20197289|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197290|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335864|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
19335865|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
19335866|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19335867|NCT03854812|Narcotics|narcotics|mesh-ancestor
19335868|NCT03854812|Analgesics|analgesics|mesh-ancestor
19335869|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
19335870|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335871|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19335872|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19335873|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
19335874|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19335875|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197291|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197292|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197293|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20197294|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20197295|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197296|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20197297|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20197298|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197299|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
20197300|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20197301|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20197302|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20197303|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
20197304|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197305|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20197306|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
20197307|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20197308|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20197309|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20197310|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335876|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335877|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19335878|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
20197311|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335879|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335880|NCT03854942|Naltrexone|naltrexone|mesh-list
19335881|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19335882|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19335883|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335884|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
19335885|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335886|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
19335887|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335888|NCT03854708|Hormones|hormones|mesh-ancestor
19335889|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335890|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335891|NCT03854383|Isosorbide|isosorbide|mesh-list
19335892|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19335893|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20197312|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217588|NCT00309894|Ketoconazole|ketoconazole|mesh-list
19335894|NCT03854383|Misoprostol|misoprostol|mesh-list
20197313|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197314|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20197315|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
20197316|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20197317|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
20197318|NCT00238732|Estrogens|estrogens|mesh-list
19842599|NCT00654030|Vaccines|vaccines|mesh-list
20383360|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19335895|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19335896|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
19335897|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335898|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335899|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19335900|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19335901|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
20383361|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
20383362|NCT01040195|Methotrexate|methotrexate|mesh-list
20383363|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20383364|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
20383365|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20383366|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383367|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20383368|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
20383369|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383370|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383371|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
20383372|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383373|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20383374|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383375|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
20383376|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20383377|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20383378|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
20383379|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20383380|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20383381|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383382|NCT01040234|Bupivacaine|bupivacaine|mesh-list
19335902|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19335903|NCT03854383|Diuretics|diuretics|mesh-ancestor
19335904|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
19335905|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
19335906|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19335907|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335908|NCT03854617|Vinorelbine|vinorelbine|mesh-list
19335909|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19335910|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335911|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
19335912|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
19335913|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
19335914|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335915|NCT03854409|Aripiprazole|aripiprazole|mesh-list
19335916|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
19335917|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19335918|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19335919|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19335920|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335921|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335922|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
19335923|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
19335924|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19335925|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335926|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19335927|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19335928|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
19335929|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19335930|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19335931|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19335932|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19335933|NCT03854344|Lidocaine|lidocaine|mesh-list
19335934|NCT03854344|Bupivacaine|bupivacaine|mesh-list
19335935|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
20197319|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19335936|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
19335937|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20197320|NCT00238732|Hormones|hormones|mesh-ancestor
20217589|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
19335938|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335939|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
20383383|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
20197321|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197322|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197323|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20197324|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20197325|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
20197326|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20197327|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
20197328|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20197329|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20197330|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
20383384|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
20383385|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335940|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19335941|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20383386|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681423|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681424|NCT05275725|Urological Agents|urological agents|mesh-ancestor
19692579|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692580|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19692581|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
19692582|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
19692583|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19335942|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19335943|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19335944|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19335945|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335946|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19335947|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19335948|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
19335949|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399634|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399635|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399636|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
19399637|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
20383387|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
20383388|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383389|NCT01040273|Bupivacaine|bupivacaine|mesh-list
20383390|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
20383391|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
20383392|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383393|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383394|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
19399638|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399639|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
19399640|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
19399641|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399642|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19399643|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19399644|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19399645|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399646|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19399647|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19399648|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399649|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
19399650|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19399651|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19842600|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
19842601|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842602|NCT00654069|Niacin|niacin|mesh-list
19399652|NCT03632876|Vitamin A|vitamin a|mesh-list
19399653|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
19399654|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
19399655|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399656|NCT03632876|Protective Agents|protective agents|mesh-ancestor
19399657|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399658|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19842603|NCT00654069|Niacinamide|niacinamide|mesh-list
19842604|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
19399659|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335950|NCT03854266|Heparin|heparin|mesh-list
19335951|NCT03854266|Calcium heparin|calcium heparin|mesh-list
19335952|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19335953|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
19335954|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19335955|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19335956|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335957|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
19681425|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
19681426|NCT05271084|Dexetimide|dexetimide|mesh-list
19681427|NCT05271084|Citalopram|citalopram|mesh-list
19681428|NCT05271084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19681429|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19681430|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681431|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335958|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19335959|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19335960|NCT03854175|Estradiol|estradiol|mesh-list
19335961|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19335962|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19335963|NCT03854175|Estrogens|estrogens|mesh-ancestor
19335964|NCT03854175|Hormones|hormones|mesh-ancestor
19335965|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19335966|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335967|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19335968|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
19335969|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19335970|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19681432|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681433|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
19335971|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
19335972|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19335973|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19335974|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383395|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383396|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
20383397|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
20383398|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20383399|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383400|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
20383401|NCT01040286|Analgesics|analgesics|mesh-ancestor
20383402|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
19335975|NCT03854175|Urological Agents|urological agents|mesh-ancestor
19335976|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
19335977|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19335978|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
19335979|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
19335980|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19335981|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335982|NCT03853993|Vaccines|vaccines|mesh-list
19335983|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
19335984|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19335985|NCT03853785|Podophyllin|podophyllin|mesh-list
19335986|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19335987|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19335988|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
19335989|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19335990|NCT03853707|Paclitaxel|paclitaxel|mesh-list
19335991|NCT03853707|Carboplatin|carboplatin|mesh-list
19335992|NCT03853707|Capecitabine|capecitabine|mesh-list
19335993|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19335994|NCT03853707|Atezolizumab|atezolizumab|mesh-list
19335995|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19335996|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19335997|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842605|NCT00654069|Oxycodone|oxycodone|mesh-list
19842606|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20383403|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383404|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383405|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20383406|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19335998|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
19335999|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
19336000|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
19399660|NCT03632876|Vitamins|vitamins|mesh-ancestor
19681434|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383407|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383408|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20383409|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20383410|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426308|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336001|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336002|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19336003|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
19336004|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
19336005|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336006|NCT03853525|Petrolatum|petrolatum|mesh-list
19336007|NCT03853525|Emollients|emollients|mesh-ancestor
19336008|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336009|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
19842607|NCT00654069|Narcotics|narcotics|mesh-ancestor
19842608|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20197331|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681435|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19681436|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
19681437|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681438|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19681439|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19681440|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
19681441|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
20197332|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197333|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20197334|NCT00238784|Budesonide|budesonide|mesh-list
20197335|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
19336010|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19336011|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
19336012|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336013|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197336|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197337|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197338|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
20197339|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197340|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197341|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19336014|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19336015|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
19336016|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19336017|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
19336018|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336019|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336020|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19336021|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
19336022|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
19336023|NCT03853642|Protective Agents|protective agents|mesh-ancestor
19336024|NCT03853538|Petrolatum|petrolatum|mesh-list
19336025|NCT03853538|Emollients|emollients|mesh-ancestor
19336026|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336027|NCT03853694|Morphine|morphine|mesh-list
19336028|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19336029|NCT03853694|Narcotics|narcotics|mesh-ancestor
19336030|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336031|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336032|NCT03853694|Analgesics|analgesics|mesh-ancestor
19336033|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
19681442|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681443|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19681444|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19681445|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
19681446|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19681447|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681448|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19681449|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19681450|NCT05271084|Protective Agents|protective agents|mesh-ancestor
19681451|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
19681452|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19681453|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
19681454|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
19681455|NCT05265507|Ondansetron|ondansetron|mesh-list
19681456|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
19681457|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
19681458|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336034|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336035|NCT03853304|Folic Acid|folic acid|mesh-list
20383411|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336036|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
19336037|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
19336038|NCT03853304|Vitamins|vitamins|mesh-ancestor
19336039|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
19336040|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336041|NCT03853304|Hematinics|hematinics|mesh-ancestor
19336042|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
19336043|NCT03853512|Petrolatum|petrolatum|mesh-list
19336044|NCT03853512|Emollients|emollients|mesh-ancestor
19336045|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336046|NCT03853369|Nifekalant|nifekalant|mesh-list
19336047|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19336048|NCT03853395|Antibodies|antibodies|mesh-list
19336049|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
19336050|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336051|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
19336052|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19336053|NCT03853200|Acetic Acid|acetic acid|mesh-list
19336054|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
19336055|NCT03853200|Edetic Acid|edetic acid|mesh-list
19336056|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
19336057|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19336058|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336059|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
19336060|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336061|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
19336062|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19336063|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
19336064|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
19336065|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336066|NCT03853200|Antidotes|antidotes|mesh-ancestor
19336067|NCT03853200|Protective Agents|protective agents|mesh-ancestor
20197342|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197343|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
20197344|NCT00238784|Hormones|hormones|mesh-ancestor
20197345|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197346|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20197347|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20197348|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20197349|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
20197350|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197351|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197352|NCT00238797|Gefitinib|gefitinib|mesh-list
20197353|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197354|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197355|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197356|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197357|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
20197358|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197359|NCT00238901|Basiliximab|basiliximab|mesh-list
20197360|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197361|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
20197362|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197363|NCT00238914|Naltrexone|naltrexone|mesh-list
20197364|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20197365|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20197366|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197367|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
20197368|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197369|NCT00238927|Fluticasone|fluticasone|mesh-list
20197370|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197371|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197372|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
20197373|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197374|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197375|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197376|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197377|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
20197378|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20197379|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
20197380|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19336068|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336069|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19336070|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19336071|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
20197381|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383412|NCT01040312|Cisplatin|cisplatin|mesh-list
20383413|NCT01040312|Carboplatin|carboplatin|mesh-list
20383414|NCT01040312|Nedaplatin|nedaplatin|mesh-list
20383415|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383416|NCT01040325|Vaccines|vaccines|mesh-list
20383417|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
20383418|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383419|NCT01040338|Nicotine|nicotine|mesh-list
20383420|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20383421|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
20383422|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383423|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383424|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20383425|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20383426|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
20383427|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383428|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383429|NCT01040429|Clonidine|clonidine|mesh-list
20383430|NCT01040429|Analgesics|analgesics|mesh-ancestor
20383431|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
20383432|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383433|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383434|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20383435|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
20383436|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
20383437|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20383438|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20383439|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20383440|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383441|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383442|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383443|NCT01040455|Lansoprazole|lansoprazole|mesh-list
20383444|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
20383445|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20383446|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383447|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20383448|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383449|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383450|NCT01040559|Idarubicin|idarubicin|mesh-list
20383451|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20383452|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383453|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20383454|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20383455|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383456|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383457|NCT01040585|Linezolid|linezolid|mesh-list
20197382|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20197383|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197384|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197385|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197386|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336072|NCT03853096|Cefazolin|cefazolin|mesh-list
19336073|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19336074|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383458|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20383459|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383460|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20383461|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336075|NCT03852979|Paclitaxel|paclitaxel|mesh-list
19336076|NCT03852979|Carboplatin|carboplatin|mesh-list
19336077|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19336078|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336079|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
19336080|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
19336081|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
19336082|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197387|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197388|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
20197389|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197390|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197391|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20197392|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
20383462|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383463|NCT01040598|Omalizumab|omalizumab|mesh-list
20383464|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19336083|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
20383465|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20383466|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
20383467|NCT01040702|Methylphenidate|methylphenidate|mesh-list
20383468|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20383469|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383470|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20383471|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20383472|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20383473|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383474|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
20383475|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336084|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19336085|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
19336086|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336087|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
19336088|NCT03852914|Protective Agents|protective agents|mesh-ancestor
19336089|NCT03852797|Ketamine|ketamine|mesh-list
19336090|NCT03852797|Propofol|propofol|mesh-list
19336091|NCT03852797|Etomidate|etomidate|mesh-list
19336092|NCT03852797|Oxytocin|oxytocin|mesh-list
20426309|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426310|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
20426311|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336093|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19336094|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336095|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336096|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19336097|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
19336098|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
19336099|NCT03852797|Analgesics|analgesics|mesh-ancestor
19336100|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
19336101|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197393|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197394|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197395|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197396|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426312|NCT01280006|Celecoxib|celecoxib|mesh-list
20426313|NCT01280006|Indomethacin|indomethacin|mesh-list
20426314|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20426315|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20426316|NCT01280006|Analgesics|analgesics|mesh-ancestor
20426317|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
20426318|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426319|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426320|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426321|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426322|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20426323|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20426324|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426325|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426326|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
20426327|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
20426328|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20426329|NCT01280071|Aminophylline|aminophylline|mesh-list
20426330|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20426331|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
20426332|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336102|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20197397|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
20197398|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19681459|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681460|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20197399|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197400|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20197401|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197402|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197403|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197404|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197405|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197406|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
20197407|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197408|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197409|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19336103|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20383476|NCT01040936|Atorvastatin|atorvastatin|mesh-list
19681461|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
19681462|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
19681463|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19681464|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
19681465|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681466|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681467|NCT05265507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19681468|NCT05265507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20197410|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197411|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197412|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197413|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197414|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197415|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
20197416|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197417|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197418|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20197419|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197420|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197421|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197422|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197423|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197424|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
20197425|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197426|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197427|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20383477|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20383478|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20383479|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
20383480|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197428|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197429|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20383481|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19336104|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19336105|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336106|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336107|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
19336108|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19336109|NCT03852628|Naltrexone|naltrexone|mesh-list
19336110|NCT03852628|Buprenorphine|buprenorphine|mesh-list
19336111|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19336112|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19336113|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336114|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
19336115|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336116|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19336117|NCT03852628|Narcotics|narcotics|mesh-ancestor
19336118|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336119|NCT03852628|Analgesics|analgesics|mesh-ancestor
19336120|NCT03852303|Ivermectin|ivermectin|mesh-list
19336121|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
19336122|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19336123|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336124|NCT03852602|Analgesics|analgesics|mesh-list
19336125|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
19336126|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383482|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20383483|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383484|NCT01041027|Paclitaxel|paclitaxel|mesh-list
20383485|NCT01041027|Carboplatin|carboplatin|mesh-list
20383486|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20383487|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383488|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
20383489|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
20383490|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
20383491|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383492|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
20383493|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19336127|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336128|NCT03852446|Tryptophan|tryptophan|mesh-list
19336129|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19681469|NCT05265507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383494|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383495|NCT01041066|Labetalol|labetalol|mesh-list
19336130|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
19842609|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197430|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197431|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336131|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19336132|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
19336133|NCT03852407|Melphalan|melphalan|mesh-list
19336134|NCT03852407|Fludarabine|fludarabine|mesh-list
19336135|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
19336136|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19336137|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
19336138|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336139|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336140|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19336141|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
19336142|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336143|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336144|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19336145|NCT03852563|Petrolatum|petrolatum|mesh-list
19336146|NCT03852563|Emollients|emollients|mesh-ancestor
19336147|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336148|NCT03852251|Capecitabine|capecitabine|mesh-list
19336149|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
19336150|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19336151|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
19336152|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336153|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399661|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
19399662|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
19399663|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19399664|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19399665|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399666|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
19399667|NCT03632824|Coagulants|coagulants|mesh-ancestor
19399668|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
19399669|NCT03632772|Mirabegron|mirabegron|mesh-list
19399670|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19399671|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19399672|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
19399673|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399674|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399675|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399676|NCT03632772|Urological Agents|urological agents|mesh-ancestor
19399677|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19399678|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19399679|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19399680|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
19399681|NCT03632733|Tetracycline|tetracycline|mesh-list
19399682|NCT03632733|Clotrimazole|clotrimazole|mesh-list
19399683|NCT03632733|Miconazole|miconazole|mesh-list
20197432|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197433|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
19399684|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19681470|NCT05265507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681471|NCT05265507|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19681472|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19681473|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19681474|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19681475|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
19399685|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399686|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19399687|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399688|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399689|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19399690|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
19399691|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19399692|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19399693|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19399694|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
20197434|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197435|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197436|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20197437|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
19681476|NCT05265052|Oxycodone|oxycodone|mesh-list
19681477|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19681478|NCT05265052|Narcotics|narcotics|mesh-ancestor
19842610|NCT00654069|Analgesics|analgesics|mesh-ancestor
19681479|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681480|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681481|NCT05265052|Analgesics|analgesics|mesh-ancestor
19681482|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
19681483|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681484|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19336154|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19336155|NCT03852160|Mirtazapine|mirtazapine|mesh-list
19336156|NCT03852160|Trazodone|trazodone|mesh-list
19336157|NCT03852160|S 20098|s 20098|mesh-list
19336158|NCT03852160|Citalopram|citalopram|mesh-list
19336159|NCT03852160|Bupropion|bupropion|mesh-list
19336160|NCT03852160|Sertraline|sertraline|mesh-list
19336161|NCT03852160|Esketamine|esketamine|mesh-list
19336162|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19336163|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19336164|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19336165|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336166|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336167|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
19336168|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336169|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19336170|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
19336171|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19336172|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336173|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19336174|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
19336175|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19336176|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19336177|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336178|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19336179|NCT03852160|Analgesics|analgesics|mesh-ancestor
19336180|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
19336181|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19336182|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
19336183|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
19336184|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19336185|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19336186|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336187|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19336188|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19336189|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19336190|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
19336191|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19336192|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19336193|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19336194|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19336195|NCT03852056|Fluorides|fluorides|mesh-list
19336196|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
19336197|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
19336198|NCT03852056|Protective Agents|protective agents|mesh-ancestor
20197438|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197439|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197440|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197441|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197442|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
19336199|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681485|NCT05263388|Hormones|hormones|mesh-ancestor
19681486|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692584|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197443|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197444|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197445|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20197446|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197447|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197448|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197449|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197450|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197451|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
20197452|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197453|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197454|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19336200|NCT03851835|Ondansetron|ondansetron|mesh-list
19336201|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
20383496|NCT01041066|Nicardipine|nicardipine|mesh-list
20383497|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20383498|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20383499|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383500|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681487|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681488|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
19681489|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681490|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197455|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
19336202|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
19336203|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336204|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336205|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336206|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
19336207|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336208|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19336209|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
19336210|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336211|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336212|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19336213|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19336214|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336215|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19336216|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19336217|NCT03851731|Naltrexone|naltrexone|mesh-list
19336218|NCT03851731|Naloxone|naloxone|mesh-list
19336219|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19336220|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19336221|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336222|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
19336223|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336224|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19336225|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
19336226|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336227|NCT03851432|Metformin|metformin|mesh-list
19336228|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19336229|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336230|NCT03851562|Alprostadil|alprostadil|mesh-list
19336231|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19336232|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
19336233|NCT03851562|Urological Agents|urological agents|mesh-ancestor
19336234|NCT03851289|Calcium|calcium|mesh-list
19336235|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19336236|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336237|NCT03851341|Metformin|metformin|mesh-list
19336238|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19336239|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19336240|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336241|NCT03851341|Incretins|incretins|mesh-ancestor
19336242|NCT03851341|Hormones|hormones|mesh-ancestor
19336243|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336244|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20197456|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197457|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197458|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336245|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
19681491|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
20197459|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197460|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
20197461|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197462|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197463|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20197464|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
20197465|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197466|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197467|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197468|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197469|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
20197470|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197471|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197472|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20383501|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336246|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336247|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336248|NCT03851172|Ketorolac|ketorolac|mesh-list
19336249|NCT03851172|Nepafenac|nepafenac|mesh-list
19336250|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
19336251|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19336252|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19336253|NCT03851172|Analgesics|analgesics|mesh-ancestor
19336254|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
19336255|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336256|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336257|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336258|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336259|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19336260|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336261|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336262|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
19336263|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
19336264|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
19336265|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19336266|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19336267|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
19336268|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336269|NCT03851393|Citric Acid|citric acid|mesh-list
19681492|NCT05257655|Narcotics|narcotics|mesh-ancestor
19681493|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681494|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681495|NCT05257655|Analgesics|analgesics|mesh-ancestor
19336270|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
19336271|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
19336272|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19336273|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
19336274|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
19336275|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336276|NCT03851263|Evolocumab|evolocumab|mesh-list
19336277|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19336278|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19336279|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
19336280|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336281|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19336282|NCT03850886|Niacinamide|niacinamide|mesh-list
19336283|NCT03850886|Niacin|niacin|mesh-list
19336284|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
19336285|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19336286|NCT03850886|Vitamins|vitamins|mesh-ancestor
19336287|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
19336288|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336289|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
19336290|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19336291|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
19336292|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336293|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19336294|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
19336295|NCT03850769|Paclitaxel|paclitaxel|mesh-list
19336296|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19336297|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336298|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
19336299|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
19336300|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
19336301|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336302|NCT03850561|Ubiquinone|ubiquinone|mesh-list
19336303|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
19336304|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
19336305|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336306|NCT03850561|Vitamins|vitamins|mesh-ancestor
19336307|NCT03850652|Iron|iron|mesh-list
19336308|NCT03850652|Trace Elements|trace elements|mesh-ancestor
19336309|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
19336310|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336311|NCT03850483|PF-06700841|pf-06700841|mesh-list
19336312|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19336313|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336314|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681496|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
19681497|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681498|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
19681499|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19336315|NCT03850587|Celecoxib|celecoxib|mesh-list
19681500|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
19336316|NCT03850587|Tramadol|tramadol|mesh-list
19336317|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19336318|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19336319|NCT03850587|Analgesics|analgesics|mesh-ancestor
19336320|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
20383502|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383503|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20383504|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
20383505|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
20383506|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383507|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20383508|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20383509|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20383510|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20383511|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20383512|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
20383513|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20383514|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20383515|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
20383516|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383517|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383518|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20383519|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20383520|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20383521|NCT01041170|Rimonabant|rimonabant|mesh-list
20383522|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20383523|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20383524|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20383525|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383526|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383527|NCT01041170|Hormones|hormones|mesh-ancestor
20383528|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383529|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383530|NCT01041183|Ramosetron|ramosetron|mesh-list
20383531|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
20383532|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
19336321|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336322|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336323|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336324|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336325|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19336326|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19336327|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336328|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336329|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20383533|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383534|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383535|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383536|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20383537|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
20383538|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383539|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383540|NCT01041235|Docetaxel|docetaxel|mesh-list
19336330|NCT03850587|Narcotics|narcotics|mesh-ancestor
19336331|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336332|NCT03850535|Cytarabine|cytarabine|mesh-list
19336333|NCT03850535|Daunorubicin|daunorubicin|mesh-list
19336334|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19336335|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
19336336|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336337|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336338|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
19336339|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336340|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19336341|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
19336342|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336343|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19336344|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19336345|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19336346|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399695|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197473|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
20383541|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383542|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
20383543|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
20383544|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
20383545|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383546|NCT01041313|Memantine|memantine|mesh-list
20383547|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19336347|NCT03850314|Glycine|glycine|mesh-list
19336348|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
19336349|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336350|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336351|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336352|NCT03850301|Etifoxine|etifoxine|mesh-list
19336353|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19336354|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19336355|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336356|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336357|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20383548|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20383549|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
20383550|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383551|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383552|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383553|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20383554|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20383555|NCT01041378|Dexamethasone|dexamethasone|mesh-list
20383556|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383557|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
20383558|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
20383559|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383560|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383561|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383562|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
20383563|NCT01041378|Hormones|hormones|mesh-ancestor
20383564|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383565|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19336358|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19336359|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336360|NCT03850028|Atezolizumab|atezolizumab|mesh-list
19336361|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336362|NCT03849833|Vitamin D|vitamin d|mesh-list
19336363|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
19336364|NCT03849833|Vitamins|vitamins|mesh-ancestor
19336365|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
19336366|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336367|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19336368|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19336369|NCT03849508|Phenylephrine|phenylephrine|mesh-list
19336370|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
19336371|NCT03849508|Norepinephrine|norepinephrine|mesh-list
19336372|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19336373|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
19336374|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
20197474|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197475|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197476|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197477|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197478|NCT00239096|Losartan|losartan|mesh-list
20197479|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20197480|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20197481|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20197482|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20197483|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197484|NCT00239109|Olanzapine|olanzapine|mesh-list
20197485|NCT00239109|Ziprasidone|ziprasidone|mesh-list
20197486|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
20197487|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
20197488|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197489|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197490|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336375|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336376|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336377|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
19336378|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20197491|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20197492|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19336379|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
19336380|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
19336381|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19336382|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19681501|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
19681502|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681503|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681504|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19681505|NCT05255146|Analgesics|analgesics|mesh-ancestor
19681506|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
19681507|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681508|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
19681509|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19681510|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336383|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19336384|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19336385|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336386|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336387|NCT03849508|Protective Agents|protective agents|mesh-ancestor
19336388|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
19336389|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19336390|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336391|NCT03849664|Riboflavin|riboflavin|mesh-list
19336392|NCT03849664|Niacinamide|niacinamide|mesh-list
19336393|NCT03849664|Niacin|niacin|mesh-list
19336394|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
19336395|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
19336396|NCT03849664|Povidone|povidone|mesh-list
19336397|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19336398|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336399|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
19336400|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
19336401|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
19336402|NCT03849664|Vitamins|vitamins|mesh-ancestor
19336403|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
19681511|NCT05245006|Antibodies|antibodies|mesh-list
19681512|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
19681513|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
19681514|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681515|NCT05243186|Methylphenidate|methylphenidate|mesh-list
19681516|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19681517|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681518|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19681519|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19681520|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681521|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681522|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
19681523|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681524|NCT05239169|Capecitabine|capecitabine|mesh-list
19681525|NCT05239169|Durvalumab|durvalumab|mesh-list
19681526|NCT05239169|Tremelimumab|tremelimumab|mesh-list
19681527|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20197493|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20197494|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20197495|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20197496|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20197497|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19336404|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19336405|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336406|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19336407|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
19336408|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336409|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19336410|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
19336411|NCT03849729|Phentermine|phentermine|mesh-list
20197498|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197499|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197500|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
20197501|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20197502|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20197503|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
20197504|NCT00239161|Levofloxacin|levofloxacin|mesh-list
19336412|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19336413|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336414|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
19336415|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19336416|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
19336417|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
20197505|NCT00239161|Ofloxacin|ofloxacin|mesh-list
20197506|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20197507|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197508|NCT00239161|Renal Agents|renal agents|mesh-ancestor
20197509|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197510|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20197511|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20197512|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197513|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197514|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197515|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20197516|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20197517|NCT00239174|Surinabant|surinabant|mesh-list
19336418|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336419|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
19336420|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336421|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336422|NCT03849404|Adalimumab|adalimumab|mesh-list
19336423|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336424|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336425|NCT03849209|Pancrelipase|pancrelipase|mesh-list
19336426|NCT03849209|Pancreatin|pancreatin|mesh-list
19336427|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336428|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
19336429|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
19336430|NCT03849235|Glucagon|glucagon|mesh-list
19336431|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336432|NCT03849235|Hormones|hormones|mesh-ancestor
19336433|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336434|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336435|NCT03849196|Bisacodyl|bisacodyl|mesh-list
19336436|NCT03849196|Cathartics|cathartics|mesh-ancestor
19336437|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336438|NCT03849196|Laxatives|laxatives|mesh-ancestor
19336439|NCT03849170|Vaccines|vaccines|mesh-list
19336440|NCT03849170|Immunologic Factors|immunologic factors|mesh-ancestor
19336441|NCT03849170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336442|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
19336443|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19336444|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
19336445|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
19842611|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
19842612|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842613|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19842614|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
19842615|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842616|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19842617|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
19842618|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
19842619|NCT00654069|Vitamins|vitamins|mesh-ancestor
19842620|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
19842621|NCT00654147|Ritonavir|ritonavir|mesh-list
19842622|NCT00654147|Lopinavir|lopinavir|mesh-list
19842623|NCT00654147|Tenofovir|tenofovir|mesh-list
19842624|NCT00654147|Emtricitabine|emtricitabine|mesh-list
19842625|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
20197518|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20197519|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20197520|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197521|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197522|NCT00239174|Hormones|hormones|mesh-ancestor
20197523|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197524|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197525|NCT00239200|Lapatinib|lapatinib|mesh-list
20197526|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383566|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842626|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19842627|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19336446|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336447|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336448|NCT03848611|Vorolanib|vorolanib|mesh-list
19842628|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
19842629|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842630|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842631|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19842632|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19842633|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
19842634|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842635|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19842636|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19842637|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19336449|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19336450|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336451|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336452|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
19336453|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19336454|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197527|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197528|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197529|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197530|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
19336455|NCT03848806|Calcitriol|calcitriol|mesh-list
19336456|NCT03848806|Calcipotriene|calcipotriene|mesh-list
19336457|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336458|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19336459|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336460|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19336461|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19336462|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336463|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19336464|NCT03848806|Vitamins|vitamins|mesh-ancestor
19336465|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
19336466|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19336467|NCT03848533|Metformin|metformin|mesh-list
19336468|NCT03848533|Melatonin|melatonin|mesh-list
19336469|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19336470|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336471|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
19336472|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336473|NCT03848533|Protective Agents|protective agents|mesh-ancestor
19336474|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336475|NCT03848182|Gemcitabine|gemcitabine|mesh-list
19336476|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19336477|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
19336478|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197531|NCT00239239|Hematinics|hematinics|mesh-ancestor
20197532|NCT00239252|Interferons|interferons|mesh-list
20197533|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
20197534|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197535|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
20197536|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197537|NCT00239278|Prednisolone|prednisolone|mesh-list
20197538|NCT00239278|Budesonide|budesonide|mesh-list
20197539|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
20197540|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197541|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
20197542|NCT00239278|Hormones|hormones|mesh-ancestor
20383567|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
19681528|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
19681529|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681530|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681531|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20383568|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
20197543|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197544|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336479|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336480|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
19336481|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336482|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336483|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19336484|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
19336485|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681532|NCT05239091|Lidocaine|lidocaine|mesh-list
19681533|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
19681534|NCT05239091|Anesthetics|anesthetics|mesh-list
19681535|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681536|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383569|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383570|NCT01041482|Sorafenib|sorafenib|mesh-list
20383571|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383572|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20383573|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383574|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383575|NCT01041508|Cyclosporine|cyclosporine|mesh-list
20383576|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
20383577|NCT01041508|Clofarabine|clofarabine|mesh-list
20383578|NCT01041508|Cyclosporins|cyclosporins|mesh-list
20383579|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383580|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383581|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383582|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
20383583|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197545|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20197546|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197547|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
20197548|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197549|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197550|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197551|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197552|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20197553|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20197554|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20383584|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
20383585|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383586|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
20383587|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20383588|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20383589|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20383590|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383591|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19336486|NCT03848780|Desflurane|desflurane|mesh-list
19336487|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19336488|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
19336489|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
19336490|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336491|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336492|NCT03848234|Estradiol|estradiol|mesh-list
20383592|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
20383593|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20383594|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20383595|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
20383596|NCT01041625|Apremilast|apremilast|mesh-list
20383597|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20383598|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20383599|NCT01041625|Analgesics|analgesics|mesh-ancestor
20383600|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
20383601|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383602|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383603|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336493|NCT03848234|Estrogens|estrogens|mesh-ancestor
19336494|NCT03848234|Hormones|hormones|mesh-ancestor
19681537|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
19681538|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681539|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19681540|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19681541|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19336495|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336496|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399696|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399697|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19399698|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19399699|NCT03632681|Insulin|insulin|mesh-list
19399700|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19399701|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19399702|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399703|NCT03632642|Floxacillin|floxacillin|mesh-list
19399704|NCT03632642|Penicillin G|penicillin g|mesh-list
19399705|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19681542|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399706|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
20383604|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336497|NCT03848104|Cefoxitin|cefoxitin|mesh-list
19336498|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19336499|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336500|NCT03848065|Vaccines|vaccines|mesh-list
19336501|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
19336502|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336503|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19336504|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336505|NCT03848039|Vaccines|vaccines|mesh-list
19336506|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
19336507|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336508|NCT03847818|Carboplatin|carboplatin|mesh-list
19336509|NCT03847818|Docetaxel|docetaxel|mesh-list
19336510|NCT03847818|Trastuzumab|trastuzumab|mesh-list
19336511|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336512|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
19336513|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
19336514|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
19336515|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336516|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19336517|NCT03847792|Dexamethasone|dexamethasone|mesh-list
19336518|NCT03847792|Fentanyl|fentanyl|mesh-list
19336519|NCT03847792|Bupivacaine|bupivacaine|mesh-list
19336520|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336521|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
19336522|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
19336523|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336524|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336525|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336526|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
19336527|NCT03847792|Hormones|hormones|mesh-ancestor
19336528|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336529|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19336530|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336531|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
19336532|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
19336533|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336534|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
19336535|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19336536|NCT03847792|Narcotics|narcotics|mesh-ancestor
19336537|NCT03847792|Analgesics|analgesics|mesh-ancestor
19336538|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19336539|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19336540|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
19336541|NCT03847571|Acetazolamide|acetazolamide|mesh-list
19336542|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
19336543|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20383605|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20383606|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20383607|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383608|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383609|NCT01041690|Bevacizumab|bevacizumab|mesh-list
20383610|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19336544|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336545|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336546|NCT03847571|Diuretics|diuretics|mesh-ancestor
19336547|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
19336548|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336549|NCT03847922|Lidocaine|lidocaine|mesh-list
19336550|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
19336551|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
19336552|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
19336553|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336554|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336555|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
19336556|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336557|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19336558|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19336559|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19336560|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19336561|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336562|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19336563|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
19336564|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19336565|NCT03847922|Analgesics|analgesics|mesh-ancestor
19336566|NCT03847896|Budesonide|budesonide|mesh-list
19336567|NCT03847896|Albuterol|albuterol|mesh-list
19336568|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336569|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20383611|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383612|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20383613|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20383614|NCT01041690|Growth Substances|growth substances|mesh-ancestor
20383615|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383616|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
20383617|NCT01041729|Atorvastatin|atorvastatin|mesh-list
20383618|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20383619|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20383620|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
20383621|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383622|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20383623|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20383624|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383625|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
20383626|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20383627|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20383628|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383629|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383630|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383631|NCT01041872|Lidocaine|lidocaine|mesh-list
20383632|NCT01041872|Propofol|propofol|mesh-list
20383633|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
19336570|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
19336571|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336572|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336573|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19336574|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
19336575|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
19336576|NCT03847896|Hormones|hormones|mesh-ancestor
19336577|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336578|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
19336579|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19336580|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19336581|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19336582|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19336583|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19336584|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383634|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
20383635|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383636|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383637|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
20383638|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383639|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20383640|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20383641|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20383642|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20383643|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383644|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20383645|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20383646|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
20383647|NCT01041963|Losartan|losartan|mesh-list
19336585|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336586|NCT03847623|Curcumin|curcumin|mesh-list
19336587|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19336588|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19336589|NCT03847623|Analgesics|analgesics|mesh-ancestor
19336590|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
19336591|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336592|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336593|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336594|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336595|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336596|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336597|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842638|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19842639|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19842640|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19842641|NCT00654186|Lenalidomide|lenalidomide|mesh-list
20383648|NCT01041963|Enalapril|enalapril|mesh-list
20383649|NCT01041963|Enalaprilat|enalaprilat|mesh-list
19336598|NCT03847558|Hormones|hormones|mesh-list
19336599|NCT03847558|Testosterone|testosterone|mesh-list
19336600|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19336601|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336602|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336603|NCT03847558|Androgens|androgens|mesh-ancestor
19336604|NCT03847363|Anesthetics|anesthetics|mesh-list
20383650|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20383651|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20383652|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20383653|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20383654|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383655|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20383656|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
20383657|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383658|NCT01042028|Capecitabine|capecitabine|mesh-list
20383659|NCT01042028|Irinotecan|irinotecan|mesh-list
20383660|NCT01042028|Cetuximab|cetuximab|mesh-list
20383661|NCT01042028|Everolimus|everolimus|mesh-list
20383662|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
20383663|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20383664|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
20383665|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383666|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383667|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20383668|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20383669|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336605|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336606|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336607|NCT03847207|Pasireotide|pasireotide|mesh-list
19336608|NCT03847207|Hormones|hormones|mesh-ancestor
19336609|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336610|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336611|NCT03847246|Entecavir|entecavir|mesh-list
19336612|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
19336613|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336614|NCT03847155|Nicotine|nicotine|mesh-list
19336615|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19336616|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
19336617|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336618|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336619|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19336620|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19681543|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681544|NCT05237726|Heparin|heparin|mesh-list
19681545|NCT05237726|Enoxaparin|enoxaparin|mesh-list
19681546|NCT05237726|Calcium heparin|calcium heparin|mesh-list
20383670|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19336621|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
19336622|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336623|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336624|NCT03847272|Prednisone|prednisone|mesh-list
19336625|NCT03847272|Ustekinumab|ustekinumab|mesh-list
19336626|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19336627|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
19336628|NCT03847272|Hormones|hormones|mesh-ancestor
19336629|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336630|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336631|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19336632|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336633|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336634|NCT03847441|Vitamin D|vitamin d|mesh-list
19336635|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
19336636|NCT03847441|Calcipotriene|calcipotriene|mesh-list
19336637|NCT03847441|Vitamins|vitamins|mesh-ancestor
19336638|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
19336639|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336640|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19336641|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19336642|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336643|NCT03847376|Rilpivirine|rilpivirine|mesh-list
19336644|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20383671|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383672|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
19336645|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19336646|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336647|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681547|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
19681548|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
20383673|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383674|NCT01042041|Doxorubicin|doxorubicin|mesh-list
20383675|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20383676|NCT01042041|Sorafenib|sorafenib|mesh-list
20383677|NCT01042041|Mitomycins|mitomycins|mesh-list
20383678|NCT01042041|Mitomycin|mitomycin|mesh-list
20383679|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383680|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20383681|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20383682|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20383683|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681549|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19681550|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19681551|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336648|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
19336649|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336650|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19336651|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20383684|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383685|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20383686|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
20383687|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20383688|NCT01042314|Donepezil|donepezil|mesh-list
20383689|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20383690|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336652|NCT03846739|Oxytocin|oxytocin|mesh-list
19336653|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
20383691|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383692|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
20383693|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383694|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383695|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
20383696|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
20383697|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20383698|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336654|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19336655|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336656|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
19336657|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19336658|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19336659|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336660|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
19336661|NCT03846973|Coagulants|coagulants|mesh-ancestor
19336662|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
19336663|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19336664|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19336665|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
19336666|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336667|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336668|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19336669|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
19336670|NCT03846765|Phenylephrine|phenylephrine|mesh-list
19336671|NCT03846765|Dobutamine|dobutamine|mesh-list
19336672|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
19336673|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19336674|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
19336675|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
19336676|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681552|NCT05236530|Metformin|metformin|mesh-list
19681553|NCT05236530|Repaglinide|repaglinide|mesh-list
19681554|NCT05236530|Lumefantrine|lumefantrine|mesh-list
19681555|NCT05236530|Dolutegravir|dolutegravir|mesh-list
19681556|NCT05236530|Midazolam|midazolam|mesh-list
19681557|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
19681558|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19681559|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19681560|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383699|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19681561|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19336677|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336678|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
19336679|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19681562|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19681563|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20197555|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
20197556|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197557|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197558|NCT00239291|Gefitinib|gefitinib|mesh-list
20383700|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
20383701|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197559|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197560|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197561|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336680|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
19336681|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
19336682|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19336683|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19336684|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19336685|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
19336686|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336687|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336688|NCT03846765|Protective Agents|protective agents|mesh-ancestor
19336689|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20383702|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383703|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383704|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383705|NCT01042561|Vitamin D|vitamin d|mesh-list
20383706|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
20383707|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
20383708|NCT01042561|Vitamins|vitamins|mesh-list
19336690|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19336691|NCT03846271|Oxytocin|oxytocin|mesh-list
19336692|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
19336693|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19336694|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336695|NCT03846388|Hormones|hormones|mesh-list
19336696|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19336697|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336698|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336699|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19336700|NCT03846583|Trastuzumab|trastuzumab|mesh-list
19336701|NCT03846583|Tucatinib|tucatinib|mesh-list
19842642|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
19842643|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842644|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19842645|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20197562|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197563|NCT00239304|Gefitinib|gefitinib|mesh-list
20197564|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197565|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197566|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197567|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197568|NCT00239330|Atorvastatin|atorvastatin|mesh-list
20197569|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20197570|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20197571|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20197572|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
20197573|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197574|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19336702|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19336703|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20197575|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20197576|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197577|NCT00239343|Gefitinib|gefitinib|mesh-list
20197578|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197579|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197580|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197581|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197582|NCT00239369|Telmisartan|telmisartan|mesh-list
20197583|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20197584|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20197585|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20197586|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20197587|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383709|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
20383710|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842646|NCT00654186|Growth Substances|growth substances|mesh-ancestor
19336704|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336705|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20383711|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20383712|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20383713|NCT01042574|Clevidipine|clevidipine|mesh-list
20383714|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19336706|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336707|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336708|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19336709|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
19336710|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336711|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336712|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19336713|NCT03846180|Octreotide|octreotide|mesh-list
19336714|NCT03846180|Terlipressin|terlipressin|mesh-list
19336715|NCT03846180|Somatostatin|somatostatin|mesh-list
19336716|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336717|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19336718|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336719|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20197588|NCT00239369|Diuretics|diuretics|mesh-ancestor
19681564|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19681565|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19681566|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681567|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19681568|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
19681569|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
19681570|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
19842647|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
19842648|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842649|NCT00654238|Sorafenib|sorafenib|mesh-list
19336720|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19336721|NCT03846180|Hormones|hormones|mesh-ancestor
19336722|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336723|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336724|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
19336725|NCT03846284|Bupivacaine|bupivacaine|mesh-list
19336726|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
19336727|NCT03846284|Anesthetics|anesthetics|mesh-list
19336728|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
20197589|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
20197590|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197591|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19842650|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842651|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20197592|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197593|NCT00239382|Meloxicam|meloxicam|mesh-list
20197594|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20383715|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20383716|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383717|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20383718|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197595|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20197596|NCT00239382|Analgesics|analgesics|mesh-ancestor
20197597|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
20197598|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197599|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197600|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197601|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197602|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20197603|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20197604|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197605|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197606|NCT00239395|Meloxicam|meloxicam|mesh-list
20197607|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20197608|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20426333|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426334|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20426335|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
20426336|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20426337|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19681571|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
19681572|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842652|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681573|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681574|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19681575|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19681576|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
19681577|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19681578|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20197609|NCT00239395|Analgesics|analgesics|mesh-ancestor
20197610|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
20197611|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336729|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336730|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336731|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
19336732|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336733|NCT03846284|Analgesics|analgesics|mesh-ancestor
19336734|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19336735|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
19336736|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19336737|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19336738|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336739|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19336740|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
19336741|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19336742|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19336743|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19336744|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399707|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399708|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383719|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
20383720|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20383721|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20383722|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
20383723|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383724|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20383725|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20383726|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383727|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383728|NCT01042665|Latanoprost|latanoprost|mesh-list
20383729|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20383730|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20383731|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
20383732|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399709|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
19399710|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
19399711|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
19399712|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399713|NCT03632590|Analgesics|analgesics|mesh-ancestor
19399714|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
19399715|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399716|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399717|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
19399718|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399719|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19399720|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
19399721|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19399722|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399723|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19399724|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
19399725|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19399726|NCT03632590|Cathartics|cathartics|mesh-ancestor
19399727|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19681579|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197612|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197613|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197614|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197615|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20197616|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20197617|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197618|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383733|NCT01042704|Aspirin|aspirin|mesh-list
20383734|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20197619|NCT00239408|Bromides|bromides|mesh-list
19399728|NCT03632590|Antacids|antacids|mesh-ancestor
20383735|NCT01042704|Dexamethasone|dexamethasone|mesh-list
20383736|NCT01042704|Lenalidomide|lenalidomide|mesh-list
19336745|NCT03846102|Acetaminophen|acetaminophen|mesh-list
19336746|NCT03846102|Morphine|morphine|mesh-list
19336747|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
19681580|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
19681581|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19681582|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19681583|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681584|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19681585|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19681586|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19336748|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19336749|NCT03846102|Narcotics|narcotics|mesh-ancestor
19336750|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336751|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336752|NCT03846102|Analgesics|analgesics|mesh-ancestor
19336753|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
20383737|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20383738|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383739|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
19336754|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336755|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19336756|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
19336757|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
19336758|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
19336759|NCT03845699|Fentanyl|fentanyl|mesh-list
19336760|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19336761|NCT03845699|Narcotics|narcotics|mesh-ancestor
19336762|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336763|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336764|NCT03845699|Analgesics|analgesics|mesh-ancestor
19336765|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
19336766|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336767|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19336768|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19336769|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
19336770|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
19336771|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19336772|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336773|NCT03845881|Oxycodone|oxycodone|mesh-list
19336774|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19681587|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19336775|NCT03845881|Narcotics|narcotics|mesh-ancestor
19336776|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336777|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681588|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
19681589|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
19681590|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
19681591|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19681592|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19681593|NCT05229055|Ketamine|ketamine|mesh-list
19681594|NCT05229055|Analgesics|analgesics|mesh-ancestor
19336778|NCT03845881|Analgesics|analgesics|mesh-ancestor
19336779|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
19336780|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197620|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
20197621|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197622|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
20197623|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197624|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336786|NCT03845673|Psyllium|psyllium|mesh-list
19336787|NCT03845673|Cathartics|cathartics|mesh-ancestor
19336788|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19336789|NCT03845387|Pramipexole|pramipexole|mesh-list
19336790|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
19336791|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336792|NCT03845387|Protective Agents|protective agents|mesh-ancestor
19336793|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336794|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19336795|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19681595|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
19681596|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336796|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
19336797|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
19336798|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336799|NCT03845348|Ketoconazole|ketoconazole|mesh-list
19681597|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197625|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197626|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197627|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
19336800|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
19336801|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336802|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19336803|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19336804|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336805|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336806|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19336807|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
19336808|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336809|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681598|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19681599|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19681600|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
19681601|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
19681602|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681603|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19681604|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19681605|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681606|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681607|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
19681608|NCT05217758|Mifepristone|mifepristone|mesh-list
19336810|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19336811|NCT03845322|Curcumin|curcumin|mesh-list
19336812|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19336813|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20383740|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
20383741|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383742|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383743|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20383744|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
20383745|NCT01042704|Hormones|hormones|mesh-ancestor
20383746|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383747|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20383748|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383749|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20383750|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20383751|NCT01042704|Analgesics|analgesics|mesh-ancestor
20383752|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
20383753|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336814|NCT03845322|Analgesics|analgesics|mesh-ancestor
19336815|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
19681609|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19681610|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
19681611|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19681612|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681613|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19681614|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19681615|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19681616|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
19681617|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19681618|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19681619|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
19681620|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197628|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20197629|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197630|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197631|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197632|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
19681621|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
20197633|NCT00239421|Fluticasone|fluticasone|mesh-list
20197634|NCT00239421|Xhance|xhance|mesh-list
20197635|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
20197636|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
20197637|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20197638|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197639|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197640|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
20197641|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197642|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197643|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197644|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197645|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
19681622|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19336816|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336817|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336818|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383754|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20383755|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20383756|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383757|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20383758|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20383759|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383760|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
20383761|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
20383762|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20383763|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19336819|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336820|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336821|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336822|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681623|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20383764|NCT01042704|Growth Substances|growth substances|mesh-ancestor
20383765|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
20383766|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681624|NCT05216770|Bupivacaine|bupivacaine|mesh-list
19681625|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
19681626|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
19681627|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681628|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383767|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20383768|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
20383769|NCT01042717|Plerixafor|plerixafor|mesh-list
20383770|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20383771|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20383772|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
20383773|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383774|NCT01042730|Pitavastatin|pitavastatin|mesh-list
20383775|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20383776|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20383777|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20383778|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
19681629|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
19681630|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681631|NCT05205499|Sirolimus|sirolimus|mesh-list
19681632|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19681633|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681634|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20197646|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20197647|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20197648|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20197649|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20197650|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
20197651|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197652|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197653|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
20197654|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20197655|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197656|NCT00239434|Bromides|bromides|mesh-list
20197657|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
20197658|NCT00239434|Ipratropium|ipratropium|mesh-list
20197659|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197660|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
20197661|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197662|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197663|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197664|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197665|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
20197666|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20197667|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197668|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197669|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197670|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
20383779|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197671|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
20197672|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19681635|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197673|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
20197674|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197675|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197676|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197677|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
19681636|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
19681637|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19681638|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
19681639|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681640|NCT05200286|Olorofim|olorofim|mesh-list
19681641|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
19681642|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197678|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
20197679|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20197680|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
20383780|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383781|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20383782|NCT01042782|Everolimus|everolimus|mesh-list
20383783|NCT01042782|Mitomycin|mitomycin|mesh-list
20383784|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383785|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383786|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
20383787|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383788|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
20383789|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383790|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20383791|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20383792|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383793|NCT01042873|Dobutamine|dobutamine|mesh-list
20383794|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20383795|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
20383796|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
20383797|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383798|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383799|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20383800|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20383801|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20383802|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383803|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383804|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383805|NCT01042873|Protective Agents|protective agents|mesh-ancestor
20383806|NCT01042951|Vaccines|vaccines|mesh-list
20383807|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
20383808|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383809|NCT01043172|Gemcitabine|gemcitabine|mesh-list
20383810|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20383811|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
20383812|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383813|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383814|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
20383815|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383816|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383817|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20383818|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
20383819|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383820|NCT01043211|Lidocaine|lidocaine|mesh-list
20383821|NCT01043211|Epinephrine|epinephrine|mesh-list
20197681|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197682|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197683|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
20197684|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197685|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
20197686|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383822|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
20383823|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
20383824|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383825|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383826|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
20383827|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383828|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20383829|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20383830|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20383831|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681643|NCT05192798|Paclitaxel|paclitaxel|mesh-list
20197687|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383832|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383833|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20383834|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19336823|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19336824|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19336825|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19336826|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336827|NCT03845179|Incretins|incretins|mesh-ancestor
20383835|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383836|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383837|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20383838|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20383839|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
20383840|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197688|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197689|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197690|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
20197691|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20197692|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197693|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197694|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197695|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20197696|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
20197697|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197698|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
20197699|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383841|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
20383842|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
19336828|NCT03845179|Hormones|hormones|mesh-ancestor
19336829|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19336830|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
19336831|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336832|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336833|NCT03845153|Metformin|metformin|mesh-list
19336834|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19336835|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336836|NCT03845010|Verapamil|verapamil|mesh-list
20383843|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
20383844|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20383845|NCT01043224|Clobetasol|clobetasol|mesh-list
20383846|NCT01043224|Calcipotriene|calcipotriene|mesh-list
20383847|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20383848|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
20383849|NCT01043224|Hormones|hormones|mesh-ancestor
20383850|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20383851|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383852|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
20383853|NCT01043341|Vaccines|vaccines|mesh-list
20383854|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
19336837|NCT03845010|Sotalol|sotalol|mesh-list
19336838|NCT03845010|Flecainide|flecainide|mesh-list
19336839|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19336840|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19336841|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19336842|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336843|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19336844|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336845|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
19336846|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19336847|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19336848|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383855|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383856|NCT01043380|Atorvastatin|atorvastatin|mesh-list
20383857|NCT01043380|Ezetimibe|ezetimibe|mesh-list
20383858|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20383859|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20383860|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
20383861|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336849|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336850|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
19336851|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
19336852|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383862|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20383863|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20383864|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336853|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19336854|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19336855|NCT03845049|Aflibercept|aflibercept|mesh-list
19336856|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19336857|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19336858|NCT03845049|Growth Substances|growth substances|mesh-ancestor
19336859|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336860|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
19336861|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336862|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
19336863|NCT03844841|Propofol|propofol|mesh-list
19336864|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19336865|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336866|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336867|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19336868|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
19336869|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
19336870|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19336871|NCT03844841|Analgesics|analgesics|mesh-ancestor
20383865|NCT01043419|Xenon|xenon|mesh-list
20383866|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20383867|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
20383868|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
19336872|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
19336873|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336874|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19336875|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19336876|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19336877|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
19336878|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336879|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336880|NCT03844984|Lidocaine|lidocaine|mesh-list
19336881|NCT03844984|Midazolam|midazolam|mesh-list
19336882|NCT03844984|Ketamine|ketamine|mesh-list
19336883|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
19336884|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
19336885|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336886|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336887|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
19336888|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336889|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19336890|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19336891|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19336892|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197700|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336893|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336894|NCT03844984|Analgesics|analgesics|mesh-ancestor
19336895|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19336896|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19336897|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
19336898|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19336899|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19336900|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383869|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383870|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383871|NCT01043445|Glycerol|glycerol|mesh-list
20383872|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19336901|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19336902|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19336903|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19336904|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19336905|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20197701|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197702|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197703|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
20197704|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20197705|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197706|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197707|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197708|NCT00239486|Pramipexole|pramipexole|mesh-list
20197709|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
20197710|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383873|NCT01043445|Protective Agents|protective agents|mesh-ancestor
19336906|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
19336907|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
19336908|NCT03844932|Cyclosporine|cyclosporine|mesh-list
19336909|NCT03844932|Cyclosporins|cyclosporins|mesh-list
19336910|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336911|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336912|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19336913|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
19336914|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336915|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
19336916|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336917|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336918|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19336919|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19336920|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
19336921|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336922|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
19336923|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
19336924|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
19336925|NCT03844581|Propiverine|propiverine|mesh-list
20197711|NCT00239486|Protective Agents|protective agents|mesh-ancestor
20197712|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197713|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19336926|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
19336927|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
19336928|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336929|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336930|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19336931|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19336932|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19336933|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336934|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336935|NCT03844581|Urological Agents|urological agents|mesh-ancestor
19336936|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19336937|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
19842653|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842654|NCT00654329|Fentanyl|fentanyl|mesh-list
19842655|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
19842656|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19842657|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842658|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842659|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842660|NCT00654329|Analgesics|analgesics|mesh-ancestor
20197714|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20197715|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
20197716|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
20197717|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197718|NCT00239499|Fluticasone|fluticasone|mesh-list
20197719|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
20197720|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20197721|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197722|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19336938|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19336939|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
19336940|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19336941|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336942|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19336943|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19842661|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
20197723|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
20197724|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336944|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19336945|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19336946|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19336947|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19681644|NCT05192798|Bevacizumab|bevacizumab|mesh-list
19681645|NCT05192798|Apatinib|apatinib|mesh-list
19681646|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19681647|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19681648|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681649|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
19681650|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
19681651|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
19681652|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681653|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681654|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20197725|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336948|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19336949|NCT03844451|Epinephrine|epinephrine|mesh-list
19336950|NCT03844451|Bupivacaine|bupivacaine|mesh-list
19336951|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
19336952|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
19336953|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336954|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336955|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
19336956|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336957|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19336958|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19336959|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
19336960|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19336961|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336962|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19336963|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19336964|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
19336965|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19336966|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
19336967|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
19336968|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
19336969|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19336970|NCT03844776|Acetaminophen|acetaminophen|mesh-list
19336971|NCT03844776|Amoxicillin|amoxicillin|mesh-list
19336972|NCT03844776|Metronidazole|metronidazole|mesh-list
19336973|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19336974|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
19336975|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19336976|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336977|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19336978|NCT03844776|Analgesics|analgesics|mesh-ancestor
19336979|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
19336980|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19336981|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19336982|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
19336983|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19336984|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
19336985|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19336986|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19336987|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19681655|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19681656|NCT05192798|Growth Substances|growth substances|mesh-ancestor
19681657|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681658|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
19681659|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19681660|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681661|NCT05191225|Rituximab|rituximab|mesh-list
19681662|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19336988|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336989|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19336990|NCT03844620|Trifluridine|trifluridine|mesh-list
19336991|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
19336992|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681663|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681664|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
19681665|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681666|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681667|NCT05185167|Propofol|propofol|mesh-list
19681668|NCT05185167|Anesthetics|anesthetics|mesh-list
19681669|NCT05185167|Desflurane|desflurane|mesh-list
19681670|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
19681671|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19336993|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
20197726|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197727|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197728|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
20197729|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20197730|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
20197731|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20197732|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
20197733|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197734|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426338|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19336994|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19336995|NCT03844529|Lidocaine|lidocaine|mesh-list
19336996|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
19681672|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336997|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
19336998|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19336999|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337000|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
19337001|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337002|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337003|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19337004|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19337005|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337006|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337007|NCT03844594|Eptifibatide|eptifibatide|mesh-list
19337008|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19337009|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
19337010|NCT03844763|Avelumab|avelumab|mesh-list
19337011|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19337012|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
19337013|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337014|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19337015|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19337016|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
19337017|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337018|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337019|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19337020|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337021|NCT03844139|Glycerol|glycerol|mesh-list
19337022|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19337023|NCT03844139|Protective Agents|protective agents|mesh-ancestor
19337024|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337025|NCT03844256|Capecitabine|capecitabine|mesh-list
19337026|NCT03844256|Nivolumab|nivolumab|mesh-list
19337027|NCT03844256|Ipilimumab|ipilimumab|mesh-list
19337028|NCT03844256|Mitomycins|mitomycins|mesh-list
19337029|NCT03844256|Mitomycin|mitomycin|mesh-list
19337030|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19337031|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
19337032|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337033|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337034|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337035|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19337036|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19337037|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
19337038|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19337039|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337040|NCT03844217|Tryptophan|tryptophan|mesh-list
19337041|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19842662|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197735|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20197736|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20197737|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20197738|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383874|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337042|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
19337043|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681673|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681674|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19681675|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19681676|NCT05185089|Maleic acid|maleic acid|mesh-list
20197739|NCT00239512|Ibuprofen|ibuprofen|mesh-list
19681677|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681678|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692585|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197740|NCT00239512|Indomethacin|indomethacin|mesh-list
20197741|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20197742|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20197743|NCT00239512|Analgesics|analgesics|mesh-ancestor
19337044|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
19337045|NCT03844360|Bortezomib|bortezomib|mesh-list
19337046|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
19337047|NCT03844360|Dasatinib|dasatinib|mesh-list
19692586|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692587|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
19692588|NCT04989413|Dronabinol|dronabinol|mesh-list
19692589|NCT04989413|Cannabidiol|cannabidiol|mesh-list
20197744|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
20383875|NCT01043484|Bevacizumab|bevacizumab|mesh-list
19337048|NCT03844360|Pegaspargase|pegaspargase|mesh-list
20197745|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197746|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197747|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197748|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197749|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20197750|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197751|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337049|NCT03844360|Sargramostim|sargramostim|mesh-list
19337050|NCT03844360|Lenograstim|lenograstim|mesh-list
19337051|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337052|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19337053|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337054|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383876|NCT01043484|Capecitabine|capecitabine|mesh-list
20383877|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20383878|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337055|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
19337056|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337057|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19399729|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19399730|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
19399731|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19399732|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19399733|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
19399734|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399735|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399736|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
19399737|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399738|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399739|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399740|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19399741|NCT03632460|Analgesics|analgesics|mesh-ancestor
19399742|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
19399743|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399744|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19399745|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19399746|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19399747|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
19399748|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399749|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404474|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404475|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
19404476|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19404477|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19404478|NCT03594513|Analgesics|analgesics|mesh-ancestor
19404479|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
19404480|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404481|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404482|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404483|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404484|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
19404485|NCT03594461|Aflibercept|aflibercept|mesh-list
19404486|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404487|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20197752|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
20197753|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
20197754|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20197755|NCT00239538|Valsartan|valsartan|mesh-list
19681679|NCT05176483|Nivolumab|nivolumab|mesh-list
19681680|NCT05176483|Ipilimumab|ipilimumab|mesh-list
19681681|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20197756|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20197757|NCT00239538|Telmisartan|telmisartan|mesh-list
20197758|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20197759|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20197760|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20197761|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197762|NCT00239538|Diuretics|diuretics|mesh-ancestor
20197763|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
20383879|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404488|NCT03594461|Growth Substances|growth substances|mesh-ancestor
19681682|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197764|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383880|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20197765|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20197766|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197767|NCT00239551|Lansoprazole|lansoprazole|mesh-list
20197768|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20197769|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20197770|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20197771|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337058|NCT03844243|Mitogens|mitogens|mesh-list
19337059|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19337060|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337061|NCT03843749|Trastuzumab|trastuzumab|mesh-list
19337062|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337063|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337064|NCT03844178|Tetracaine|tetracaine|mesh-list
19337065|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
19337066|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
19337067|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337068|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337069|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
20197772|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197773|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20197774|NCT00239616|Hematinics|hematinics|mesh-ancestor
20197775|NCT00239629|Teriparatide|teriparatide|mesh-list
20197776|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
20197777|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20197778|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197779|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20197780|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20197781|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20197782|NCT00239707|Incretins|incretins|mesh-ancestor
20197783|NCT00239707|Hormones|hormones|mesh-ancestor
20197784|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197785|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197786|NCT00239746|Ibuprofen|ibuprofen|mesh-list
20197787|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19681683|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19681684|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681685|NCT05173896|Tadalafil|tadalafil|mesh-list
19681686|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
19681687|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19681688|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19681689|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681690|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842663|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19842664|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19842665|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19842666|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
20197788|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20197789|NCT00239746|Analgesics|analgesics|mesh-ancestor
20197790|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
20197791|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197792|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197793|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20197794|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197795|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20197796|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197797|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197798|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20197799|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20197800|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197801|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197802|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
20197803|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197804|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20197805|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20197806|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197807|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197808|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
20197809|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681691|NCT05173896|Urological Agents|urological agents|mesh-ancestor
20197810|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20383881|NCT01043484|Growth Substances|growth substances|mesh-ancestor
19337070|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337071|NCT03843853|Bevacizumab|bevacizumab|mesh-list
19337072|NCT03843853|Pemetrexed|pemetrexed|mesh-list
19337073|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337074|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337075|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19337076|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19337077|NCT03843853|Growth Substances|growth substances|mesh-ancestor
19337078|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337079|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
19337080|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337081|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197811|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20197812|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197813|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197814|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
20197815|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337082|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19337083|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19337084|NCT03843879|Lidocaine|lidocaine|mesh-list
19337085|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
19337086|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
19337087|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337088|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337089|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
19337090|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337091|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337092|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19337093|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19337094|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337095|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337096|NCT03843736|Drospirenone|drospirenone|mesh-list
19337097|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
19337098|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19337099|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
19337100|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19337101|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19337102|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337103|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19337104|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19337105|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19337106|NCT03843736|Estrogens|estrogens|mesh-ancestor
19337107|NCT03843736|Hormones|hormones|mesh-ancestor
19337108|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337109|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19337110|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
20197816|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20197817|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20197818|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197819|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197820|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
20197821|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197822|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20197823|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20197824|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197825|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197826|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
20197827|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197828|NCT00239889|Calcitonin|calcitonin|mesh-list
20197829|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
20197830|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20197831|NCT00239889|Katacalcin|katacalcin|mesh-list
20197832|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20197833|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197834|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20197835|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
20197836|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20197837|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19337111|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19337112|NCT03843736|Diuretics|diuretics|mesh-ancestor
19337113|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
19337114|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
19337115|NCT03843541|Ambroxol|ambroxol|mesh-list
19337116|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19337117|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
19337118|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337119|NCT03843541|Expectorants|expectorants|mesh-ancestor
19842667|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842668|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842669|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19842670|NCT00654329|Narcotics|narcotics|mesh-ancestor
19842671|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19842672|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19842673|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
19842674|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
19842675|NCT00654355|Tacrolimus|tacrolimus|mesh-list
19842676|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842677|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
19842678|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842679|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19842680|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842681|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842682|NCT00654368|Etanercept|etanercept|mesh-list
19842683|NCT00654368|Methotrexate|methotrexate|mesh-list
19681692|NCT05171075|Dalteparin|dalteparin|mesh-list
19681693|NCT05171075|Tinzaparin|tinzaparin|mesh-list
19681694|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19681695|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
19681696|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19681697|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19681698|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681699|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19681700|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
19681701|NCT05169658|Antibodies|antibodies|mesh-list
19681702|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
19337120|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337121|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19337122|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
19337123|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337124|NCT03843541|Protective Agents|protective agents|mesh-ancestor
19337125|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337126|NCT03843541|Antidotes|antidotes|mesh-ancestor
19337127|NCT03843528|Azacitidine|azacitidine|mesh-list
19337128|NCT03843528|Vorinostat|vorinostat|mesh-list
19337129|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19337130|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
19337131|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337132|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337133|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337134|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19337135|NCT03843281|Acetaminophen|acetaminophen|mesh-list
19337136|NCT03843281|Morphine|morphine|mesh-list
19337137|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19337138|NCT03843281|Narcotics|narcotics|mesh-ancestor
19337139|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337140|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337141|NCT03843281|Analgesics|analgesics|mesh-ancestor
19337142|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
19337143|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337144|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19337145|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
19337146|NCT03843294|Nivolumab|nivolumab|mesh-list
19337147|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337148|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337149|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19337150|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337151|NCT03843229|Bufanolides|bufanolides|mesh-list
19337152|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19842684|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19842685|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
19337153|NCT03843229|Protective Agents|protective agents|mesh-ancestor
19337154|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337155|NCT03843515|Nivolumab|nivolumab|mesh-list
19337156|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337157|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681703|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20383882|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337158|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19337159|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337160|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
20383883|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
20383884|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20383885|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
20383886|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383887|NCT01043510|Insulin|insulin|mesh-list
20383888|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20383889|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
20383890|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20383891|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383892|NCT01043536|Temozolomide|temozolomide|mesh-list
19337161|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337162|NCT03843060|Itraconazole|itraconazole|mesh-list
19337163|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
19337164|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337165|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19337166|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19337167|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337168|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337169|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19337170|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
19337171|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337172|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337173|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19337174|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
19337175|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19337176|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337177|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337178|NCT03843047|Nicotine|nicotine|mesh-list
19337179|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19337180|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
19337181|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337182|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337183|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19337184|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19337185|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
19337186|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337187|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337188|NCT03842800|Ketamine|ketamine|mesh-list
19337189|NCT03842800|Analgesics|analgesics|mesh-ancestor
19337190|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
19337191|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337192|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337193|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19337194|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19337195|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
19337196|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
19337197|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337198|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19337199|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19337200|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337201|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337202|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
19337203|NCT03842839|Olodaterol|olodaterol|mesh-list
19337204|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19337205|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
19337206|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681704|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
19681705|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19681706|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
19681707|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681708|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383893|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19681709|NCT05168930|Venetoclax|venetoclax|mesh-list
19681710|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
19681711|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681712|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19681713|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842686|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20383894|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
19681714|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681715|NCT05128617|Paclitaxel|paclitaxel|mesh-list
19681716|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
19681717|NCT05128617|Epirubicin|epirubicin|mesh-list
19681718|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19681719|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681720|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
19681721|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
19681722|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
19681723|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681724|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19681725|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
20197838|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197839|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19337207|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337208|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19337209|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337210|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
19337211|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19337212|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
19337213|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337214|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337215|NCT03842631|Timolol|timolol|mesh-list
19337216|NCT03842631|Maleic acid|maleic acid|mesh-list
19337217|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19337218|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19337219|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
19337220|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337221|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337222|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337223|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337224|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19337225|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337226|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
19337227|NCT03842488|Darunavir|darunavir|mesh-list
19337228|NCT03842488|Cobicistat|cobicistat|mesh-list
19337229|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19337230|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19337231|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
19337232|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337233|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20383895|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383896|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20383897|NCT01043575|Rifampin|rifampin|mesh-list
20383898|NCT01043575|Rifapentine|rifapentine|mesh-list
20383899|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20383900|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
20383901|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20383902|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20383903|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
20383904|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20383905|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383906|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383907|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20383908|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20383909|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20383910|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19337234|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20197840|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
20197841|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217590|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20217591|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20217592|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20217593|NCT00309894|Sargramostim|sargramostim|mesh-list
20217594|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217595|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
20217596|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217597|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
20217598|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217599|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20217600|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20217601|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383911|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20383912|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20383913|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
20383914|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20383915|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
20383916|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383917|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337235|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20383918|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20383919|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
20383920|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20383921|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20383922|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20383923|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383924|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383925|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383926|NCT01043666|Mirabegron|mirabegron|mesh-list
20383927|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20383928|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20383929|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20383930|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20383931|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
20383932|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20383933|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383934|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383935|NCT01043666|Urological Agents|urological agents|mesh-ancestor
20383936|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20383937|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20383938|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
20383939|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20383940|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
20383941|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19337236|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337237|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19337238|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19337239|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
19337240|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20383942|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20383943|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20383944|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383945|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383946|NCT01043744|Lumefantrine|lumefantrine|mesh-list
20383947|NCT01043744|Artemether|artemether|mesh-list
20383948|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20383949|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
19337241|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19337242|NCT03842423|Anesthetics|anesthetics|mesh-list
19337243|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337244|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337245|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
19337246|NCT03842254|Hematinics|hematinics|mesh-ancestor
19337247|NCT03842046|Phenylephrine|phenylephrine|mesh-list
19337248|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
19337249|NCT03842046|Norepinephrine|norepinephrine|mesh-list
19337250|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19337251|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
19337252|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
19337253|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337254|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337255|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
19337256|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19337257|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
19337258|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197842|NCT00239954|Citalopram|citalopram|mesh-list
20197843|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20197844|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20197845|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197846|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197847|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197848|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
20197849|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197850|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20197851|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
19337259|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20383950|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20383951|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20383952|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20197852|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20197853|NCT00239967|Rimonabant|rimonabant|mesh-list
20383953|NCT01043952|Remifentanil|remifentanil|mesh-list
20383954|NCT01043952|Propofol|propofol|mesh-list
20383955|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20383956|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20383957|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383958|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20383959|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
20197854|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20197855|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20197856|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20197857|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197858|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197859|NCT00239967|Hormones|hormones|mesh-ancestor
20383960|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
20383961|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20383962|NCT01043952|Narcotics|narcotics|mesh-ancestor
20383963|NCT01043952|Analgesics|analgesics|mesh-ancestor
20383964|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
19337260|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19337261|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19337262|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
19337263|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337264|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337265|NCT03842046|Protective Agents|protective agents|mesh-ancestor
20383965|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20383966|NCT01043965|Metformin|metformin|mesh-list
20383967|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20383968|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383969|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
20383970|NCT01043991|Hematinics|hematinics|mesh-ancestor
20383971|NCT01044004|Modafinil|modafinil|mesh-list
20383972|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20383973|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383974|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20383975|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20383976|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20383977|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383978|NCT01044095|Vaccines|vaccines|mesh-list
20383979|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
20383980|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383981|NCT01044186|Deferasirox|deferasirox|mesh-list
19337266|NCT03842020|Amiodarone|amiodarone|mesh-list
19337267|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337268|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
19337269|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19337270|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337271|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337272|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19337273|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19681726|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681727|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681728|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19681729|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
19681730|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19681731|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19681732|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19681733|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19681734|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681735|NCT05128344|Vigabatrin|vigabatrin|mesh-list
19681736|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
19681737|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681738|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681739|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
19681740|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681741|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681742|NCT05121168|Bupivacaine|bupivacaine|mesh-list
19681743|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
19681744|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
19681745|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681746|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197860|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20197861|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197862|NCT00239980|Dalteparin|dalteparin|mesh-list
20197863|NCT00239980|Tinzaparin|tinzaparin|mesh-list
20197864|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20197865|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
20197866|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20197867|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20197868|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197869|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
20197870|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
20197871|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20197872|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
20383982|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19337274|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19337275|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337276|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19337277|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19337278|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19399750|NCT03632408|Zopiclone|zopiclone|mesh-list
19399751|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399752|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399753|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399754|NCT03632369|Xenon|xenon|mesh-list
20383983|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
20383984|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
20383985|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383986|NCT01044199|Vaccines|vaccines|mesh-list
19399755|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19399756|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
19399757|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
19399758|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399759|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399760|NCT03632330|Midazolam|midazolam|mesh-list
19399761|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
19399762|NCT03632330|Propofol|propofol|mesh-list
19399763|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399764|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399765|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399766|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19399767|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
19399768|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
19399769|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20383987|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
20383988|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383989|NCT01044225|Cetuximab|cetuximab|mesh-list
20383990|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20383991|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399770|NCT03632330|Analgesics|analgesics|mesh-ancestor
19399771|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
19399772|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399773|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19399774|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19399775|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19399776|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
19399777|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399778|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383992|NCT01044238|Methylphenidate|methylphenidate|mesh-list
20383993|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20383994|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20383995|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20383996|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20383997|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399779|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19399780|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19399781|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399782|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19399783|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
19399784|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
19399785|NCT03632317|Everolimus|everolimus|mesh-list
19399786|NCT03632317|Panobinostat|panobinostat|mesh-list
19399787|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399788|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19399789|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
20197873|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337279|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
19337280|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19337281|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
19337282|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19337283|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19337284|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337285|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19337286|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337287|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19337288|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337289|NCT03841890|Tolnaftate|tolnaftate|mesh-list
19337290|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
19337291|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337292|NCT03841721|Linezolid|linezolid|mesh-list
19337293|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19337294|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337295|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19337296|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337297|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337298|NCT03841747|Paclitaxel|paclitaxel|mesh-list
19337299|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
19337300|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19337301|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337302|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
19337303|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
19337304|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
19337305|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337306|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337307|NCT03841526|Glucagon|glucagon|mesh-list
19337308|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19337309|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337310|NCT03841526|Hormones|hormones|mesh-ancestor
19337311|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337312|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337313|NCT03841526|Incretins|incretins|mesh-ancestor
19337314|NCT03841812|Propofol|propofol|mesh-list
19337315|NCT03841812|Sevoflurane|sevoflurane|mesh-list
19337316|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19337317|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337318|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337319|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19337320|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
19337321|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
19337322|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19337323|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19337324|NCT03841591|Metformin|metformin|mesh-list
19337325|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19337326|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337327|NCT03841383|Dipyridamole|dipyridamole|mesh-list
19337328|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19337329|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337330|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337331|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19337332|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
19337333|NCT03841305|Liver Extracts|liver extracts|mesh-list
19337334|NCT03841305|Hematinics|hematinics|mesh-ancestor
19337335|NCT03841357|Abatacept|abatacept|mesh-list
19337336|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19337337|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337338|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337339|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19337340|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
19337341|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337342|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19337343|NCT03841474|Citalopram|citalopram|mesh-list
19337344|NCT03841474|Sertraline|sertraline|mesh-list
19337345|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19337346|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19337347|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337348|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337349|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337350|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
19337351|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337352|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19337353|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
19337354|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681747|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
19681748|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681749|NCT05118945|Insulin|insulin|mesh-list
19681750|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19681751|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19681752|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681753|NCT05117489|Cortisone|cortisone|mesh-list
19681754|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19681755|NCT05111821|Deferiprone|deferiprone|mesh-list
19681756|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19681757|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
19681758|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
19337355|NCT03841136|Etoposide|etoposide|mesh-list
19337356|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19337357|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337358|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19337359|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19337360|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337361|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337362|NCT03840122|Anesthetics|anesthetics|mesh-list
19337363|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
19337364|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337365|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337366|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
20383998|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337367|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337368|NCT03839888|Atropine|atropine|mesh-list
19337369|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19337370|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337371|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19681759|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681760|NCT05108649|Nicotine|nicotine|mesh-list
19337372|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
19337373|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337374|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337375|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19337376|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337377|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
19337378|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
19337379|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19337380|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19337381|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
19337382|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337383|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337384|NCT03840057|Azithromycin|azithromycin|mesh-list
19337385|NCT03840057|Metoclopramide|metoclopramide|mesh-list
19337386|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19337387|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337388|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
19337389|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
19337390|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337391|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337392|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337393|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19337394|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19337395|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
19337396|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337397|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399790|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399791|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19399792|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399793|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399794|NCT03632304|Anesthetics|anesthetics|mesh-list
19399795|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681761|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19681762|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
19681763|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681764|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681765|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19842687|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681766|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19681767|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
19681768|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337398|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
19337399|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19337400|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
19337401|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337402|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
19337403|NCT03840070|Protective Agents|protective agents|mesh-ancestor
19681769|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681770|NCT05100862|Rituximab|rituximab|mesh-list
19681771|NCT05100862|Lenalidomide|lenalidomide|mesh-list
19681772|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
19681773|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681774|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681775|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
19681776|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681777|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19681778|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20197874|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197875|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197876|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20197877|NCT00240019|Furosemide|furosemide|mesh-list
20197878|NCT00240019|Diuretics|diuretics|mesh-ancestor
20197879|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
20197880|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681779|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19681780|NCT05100862|Growth Substances|growth substances|mesh-ancestor
19681781|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
19681782|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19681783|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681784|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681785|NCT05099913|Flupenthixol|flupenthixol|mesh-list
19681786|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19681787|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19681788|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681789|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681790|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681791|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19681792|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
19681793|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681794|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681795|NCT05097274|Choline|choline|mesh-list
19681796|NCT05097274|Lipotropic Agents|lipotropic agents|mesh-ancestor
19681797|NCT05097274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19681798|NCT05097274|Antimetabolites|antimetabolites|mesh-ancestor
19337404|NCT03839771|Ivosidenib|ivosidenib|mesh-list
19337405|NCT03839771|Glycine|glycine|mesh-list
19337406|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337407|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337408|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337409|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
19337410|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337411|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337412|NCT03839940|Dexamethasone|dexamethasone|mesh-list
20197881|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20197882|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20197883|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197884|NCT00240032|Cetirizine|cetirizine|mesh-list
20197885|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
20197886|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
20197887|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20197888|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20197889|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20197890|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
20197891|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
20197892|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197893|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197894|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197895|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20197896|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
20197897|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197898|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20197899|NCT00240045|Octreotide|octreotide|mesh-list
20197900|NCT00240045|Midodrine|midodrine|mesh-list
20197901|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337413|NCT03839940|Everolimus|everolimus|mesh-list
19681799|NCT05097274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20383999|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
20384000|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384001|NCT01044251|Frovatriptan|frovatriptan|mesh-list
20384002|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20384003|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
19681800|NCT05097274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19681801|NCT05097274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19681802|NCT05097274|Nootropic Agents|nootropic agents|mesh-ancestor
19681803|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19681804|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19681805|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19681806|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19681807|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681808|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384004|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384005|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384006|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681809|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
19681810|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197902|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20197903|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337414|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337415|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
19337416|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
19337417|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337418|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337419|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337420|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
19337421|NCT03839940|Hormones|hormones|mesh-ancestor
19337422|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337423|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19337424|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337425|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19681811|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681812|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19681813|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681814|NCT05095116|Fluticasone|fluticasone|mesh-list
19681815|NCT05095116|Xhance|xhance|mesh-list
19681816|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19681817|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19681818|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
19681819|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681820|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681821|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19681822|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
19681823|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
19681824|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19681825|NCT05084651|Itraconazole|itraconazole|mesh-list
19681826|NCT05084651|Lumefantrine|lumefantrine|mesh-list
20384007|NCT01044329|Triamcinolone|triamcinolone|mesh-list
20384008|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20384009|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20384010|NCT01044329|Bevacizumab|bevacizumab|mesh-list
20384011|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20384012|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384013|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384014|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19337426|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
19337427|NCT03839550|Apatinib|apatinib|mesh-list
20197904|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
20197905|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
20197906|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197907|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197908|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20197909|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20197910|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20197911|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20197912|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
20197913|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197914|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197915|NCT00240058|Phenylephrine|phenylephrine|mesh-list
20197916|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
20197917|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
19681827|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
20197918|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19681828|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681829|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19681830|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19681831|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681832|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681833|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19681834|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
19681835|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681836|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681837|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19681838|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
19681839|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19681840|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19681841|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
19681842|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681843|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681844|NCT05083312|Fluticasone|fluticasone|mesh-list
19681845|NCT05083312|Xhance|xhance|mesh-list
19681846|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19681847|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197919|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
20197920|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
20197921|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197922|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197923|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
20197924|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20197925|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
20197926|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
20197927|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20197928|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20197929|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20197930|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
20197931|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197932|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197933|NCT00240058|Protective Agents|protective agents|mesh-ancestor
20197934|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20197935|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20197936|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20197937|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
20197938|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20197939|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
20197940|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
19337428|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337429|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19337430|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337431|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681848|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
19681849|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681850|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681851|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19337432|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
19337433|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
19337434|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19337435|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
19337436|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337437|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337438|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19337439|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337440|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19337441|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
19337442|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337443|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337444|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19337445|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
19337446|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
19337447|NCT03839537|Protective Agents|protective agents|mesh-ancestor
19337448|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
19337449|NCT03839498|Axitinib|axitinib|mesh-list
19337450|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681852|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
19681853|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842688|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20197941|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20197942|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
19337451|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19337452|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337453|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337454|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19337455|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19337456|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337457|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
19337458|NCT03839251|Aripiprazole|aripiprazole|mesh-list
19337459|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
19337460|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681854|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20197943|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197944|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
19337461|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19337462|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19337463|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337464|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337465|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
20384015|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20384016|NCT01044329|Growth Substances|growth substances|mesh-ancestor
20384017|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384018|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
20384019|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384020|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
20384021|NCT01044329|Hormones|hormones|mesh-ancestor
20384022|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384023|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384024|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
20384025|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384026|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384027|NCT01044342|Donepezil|donepezil|mesh-list
20384028|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20384029|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384030|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337466|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
19337467|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337468|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337469|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19337470|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19337471|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
19337472|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19337473|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19337474|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19337475|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19337476|NCT03839459|Denosumab|denosumab|mesh-list
19337477|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19337478|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337479|NCT03839160|Morphine|morphine|mesh-list
19337480|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19337481|NCT03839160|Narcotics|narcotics|mesh-ancestor
19337482|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337483|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337484|NCT03839160|Analgesics|analgesics|mesh-ancestor
19337485|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
19337486|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337487|NCT03839134|Lidocaine|lidocaine|mesh-list
19337488|NCT03839134|Epinephrine|epinephrine|mesh-list
19337489|NCT03839134|Racepinephrine|racepinephrine|mesh-list
19337490|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
19337491|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
19337492|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
19337493|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337494|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197945|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20197946|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20197947|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20197948|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197949|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
20197950|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
20197951|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
19337495|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
19337496|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337497|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19692590|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
20384031|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
20384032|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384033|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384034|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
20384035|NCT01044394|Bisacodyl|bisacodyl|mesh-list
20384036|NCT01044394|Cathartics|cathartics|mesh-ancestor
20384037|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384038|NCT01044394|Laxatives|laxatives|mesh-ancestor
20426339|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426340|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20426341|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20426342|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
20426343|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337498|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19337499|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19337500|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337501|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337502|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19337503|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19337504|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19337505|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337506|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19337507|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19337508|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
19337509|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19337510|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337511|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
19337512|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
19337513|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19337514|NCT03839433|Ciclesonide|ciclesonide|mesh-list
19337515|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
19337516|NCT03839433|Hormones|hormones|mesh-ancestor
19337517|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337518|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337519|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19337520|NCT03838926|Trichostatin A|trichostatin a|mesh-list
19337521|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
19337522|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337523|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19337524|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337525|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337526|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19337527|NCT03838783|Insulin|insulin|mesh-list
19337528|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19337529|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337530|NCT03838796|Lenvatinib|lenvatinib|mesh-list
19337531|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337532|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19337533|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337534|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337535|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20426344|NCT01280071|Protective Agents|protective agents|mesh-ancestor
19337536|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
19337537|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337538|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
19337539|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20197952|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197953|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
20197954|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
20197955|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20197956|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20197957|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
20197958|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
20197959|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20197960|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197961|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20197962|NCT00240149|Insulin|insulin|mesh-list
20197963|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20197964|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20197965|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197966|NCT00240214|Sirolimus|sirolimus|mesh-list
20426345|NCT01280149|Substance P|substance p|mesh-list
19337540|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20197967|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20197968|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337541|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197969|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19337542|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
19337543|NCT03838328|Coagulants|coagulants|mesh-ancestor
19337544|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
19337545|NCT03838575|Gentamicins|gentamicins|mesh-list
19337546|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
19337547|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19337548|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19337549|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
19337550|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19337551|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337552|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337553|NCT03838068|Anesthetics|anesthetics|mesh-list
19337554|NCT03838068|Procaine|procaine|mesh-list
19337555|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
19337556|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337557|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337558|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
20197970|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20197971|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
20197972|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20197973|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
19337559|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20197974|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197975|NCT00240253|Pramlintide|pramlintide|mesh-list
20197976|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20197977|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20197978|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20197979|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20197980|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20197981|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
20197982|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197983|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20197984|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20197985|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197986|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20197987|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20197988|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20197989|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
20197990|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197991|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20197992|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20197993|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20197994|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20197995|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20197996|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20197997|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
20197998|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20197999|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20198000|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20198001|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198002|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20198003|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20198004|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20198005|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
20198006|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198007|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20198008|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20198009|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198010|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20198011|NCT00240318|Calcium|calcium|mesh-list
20198012|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20198013|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198014|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20198015|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20198016|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
20198017|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198018|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20384039|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
19337560|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
19337561|NCT03837886|Calcium|calcium|mesh-list
20198019|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20198020|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198021|NCT00240396|Narcotics|narcotics|mesh-list
20198022|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20198023|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198024|NCT00240396|Analgesics|analgesics|mesh-ancestor
20198025|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
20198026|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198027|NCT00240409|Pramipexole|pramipexole|mesh-list
20198028|NCT00240409|Bromocriptine|bromocriptine|mesh-list
20198029|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
20198030|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198031|NCT00240409|Protective Agents|protective agents|mesh-ancestor
20198032|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198033|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20198034|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20384040|NCT01044446|Icodextrin|icodextrin|mesh-list
19337562|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19337563|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337564|NCT03837886|Antacids|antacids|mesh-ancestor
19337565|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337566|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337567|NCT03838094|Calcium|calcium|mesh-list
19337568|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19337569|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337570|NCT03838133|Bupivacaine|bupivacaine|mesh-list
19337571|NCT03838133|Ropivacaine|ropivacaine|mesh-list
19337572|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
19337573|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
19337574|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337575|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337576|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
19337577|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399796|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399797|NCT03632213|Losartan|losartan|mesh-list
19399798|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19399799|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19399800|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19399801|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19399802|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399803|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
19399804|NCT03632161|Bupivacaine|bupivacaine|mesh-list
19399805|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
19399806|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
19399807|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399808|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399809|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
19399810|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399811|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399812|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19399813|NCT03632161|Analgesics|analgesics|mesh-ancestor
19399814|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19399815|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19399816|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19399817|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
19399818|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399819|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399820|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19399821|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19399822|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19399823|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399824|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
19399825|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399826|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399827|NCT03631953|Trametinib|trametinib|mesh-list
19399828|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399829|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19399830|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399831|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399832|NCT03631901|Diazepam|diazepam|mesh-list
19399833|NCT03631901|Melatonin|melatonin|mesh-list
19399834|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
20384041|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20384042|NCT01044485|Docetaxel|docetaxel|mesh-list
19337578|NCT03838029|Etodolac|etodolac|mesh-list
19337579|NCT03838029|Propranolol|propranolol|mesh-list
19337580|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19337581|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19337582|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
19337583|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337584|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337585|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337586|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337587|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19337588|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
19337589|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19337590|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19337591|NCT03838029|Analgesics|analgesics|mesh-ancestor
19337592|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
19337593|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337594|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337595|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19337596|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19337597|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20384043|NCT01044485|Lapatinib|lapatinib|mesh-list
20384044|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384045|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
20384046|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
20384047|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
19337598|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337599|NCT03837938|Dipropizine|dipropizine|mesh-list
19337600|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
20384048|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384049|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20384050|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337601|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337602|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
19337603|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337604|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337605|NCT03837470|Furosemide|furosemide|mesh-list
19337606|NCT03837470|Diuretics|diuretics|mesh-ancestor
19337607|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
19337608|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337609|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19337610|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337611|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337612|NCT03836807|Ketoprofen|ketoprofen|mesh-list
19337613|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
19337614|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19337615|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19337616|NCT03836807|Analgesics|analgesics|mesh-ancestor
19337617|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
19337618|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337619|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337620|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337621|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19337622|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19337623|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337624|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337625|NCT03836703|Iron|iron|mesh-list
19337626|NCT03836703|Trace Elements|trace elements|mesh-ancestor
19842689|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
20198035|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
20198036|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
20198037|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198038|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
20198039|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198040|NCT00240422|Telmisartan|telmisartan|mesh-list
20198041|NCT00240422|Ramipril|ramipril|mesh-list
20198042|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198043|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198044|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198045|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384051|NCT01044719|Meropenem|meropenem|mesh-list
20384052|NCT01044719|Tobramycin|tobramycin|mesh-list
19842690|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842691|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384053|NCT01044719|Ceftazidime|ceftazidime|mesh-list
19337627|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
20198046|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20384054|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20384055|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198047|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
19681855|NCT05066308|Cannabidiol|cannabidiol|mesh-list
19681856|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
19681857|NCT05065957|Capecitabine|capecitabine|mesh-list
19681858|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19681859|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
19681860|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337628|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337629|NCT03836885|Apremilast|apremilast|mesh-list
19337630|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19337631|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19337632|NCT03836885|Analgesics|analgesics|mesh-ancestor
19337633|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
19337634|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337635|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337636|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337637|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19337638|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19337639|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19337640|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337641|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337642|NCT03836833|Lamivudine|lamivudine|mesh-list
19337643|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19337644|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19337645|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337646|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337647|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
19337648|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337649|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19337650|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19337651|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
19337652|NCT03836781|Ketorolac|ketorolac|mesh-list
19337653|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19337654|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337655|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
19337656|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19337657|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19681861|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681862|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
19681863|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681864|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681865|NCT05049057|Erenumab|erenumab|mesh-list
19681866|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19681867|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681868|NCT05049057|Analgesics|analgesics|mesh-ancestor
19681869|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
19681870|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692591|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
20198048|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198049|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20198050|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
20198051|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19337658|NCT03836781|Analgesics|analgesics|mesh-ancestor
19337659|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
19337660|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337661|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337662|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337663|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19337664|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19337665|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337666|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337667|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
19337668|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19337669|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198052|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
20198053|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198054|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198055|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20198056|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
20384056|NCT01044810|Efavirenz|efavirenz|mesh-list
20198057|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
19337670|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337671|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
19337672|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337673|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337674|NCT03836599|Allopurinol|allopurinol|mesh-list
19337675|NCT03836599|Verinurad|verinurad|mesh-list
19337676|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
19337677|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337678|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337679|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
19337680|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198058|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20198059|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
20198060|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198061|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198062|NCT00240448|Valsartan|valsartan|mesh-list
20198063|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20198064|NCT00240448|Telmisartan|telmisartan|mesh-list
20198065|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20384057|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19681871|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384058|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20384059|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384060|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384061|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
20384062|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384063|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20384064|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20384065|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20384066|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19681872|NCT05044962|Rilpivirine|rilpivirine|mesh-list
19681873|NCT05044962|Cabotegravir|cabotegravir|mesh-list
19681874|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19681875|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
19681876|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
20384067|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20384068|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20384069|NCT01044888|Heparin|heparin|mesh-list
20384070|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
20384071|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20384072|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20384073|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384074|NCT01044992|Levodopa|levodopa|mesh-list
20384075|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20384076|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20384077|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
20384078|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384079|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384080|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384081|NCT01045018|Mesalamine|mesalamine|mesh-list
19337681|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19337682|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
19337683|NCT03836599|Protective Agents|protective agents|mesh-ancestor
19337684|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337685|NCT03836560|Nicotine|nicotine|mesh-list
19337686|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19337687|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
19337688|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337689|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384082|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20384083|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20384084|NCT01045018|Analgesics|analgesics|mesh-ancestor
20384085|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
20384086|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384087|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384088|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384089|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384090|NCT01045083|Methylphenidate|methylphenidate|mesh-list
20384091|NCT01045083|Citalopram|citalopram|mesh-list
19337690|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19337691|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19681877|NCT05044962|Etonogestrel|etonogestrel|mesh-list
19681878|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20198066|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19337692|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
19337693|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19681879|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
19681880|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19681881|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681882|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19681883|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19681884|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19681885|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19681886|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19681887|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19681888|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681889|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19337694|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337695|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
19337696|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19337697|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337698|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384092|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20384093|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20384094|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20384095|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384096|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384097|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
20384098|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384099|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20384100|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
20384101|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20384102|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20384103|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19337699|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19337700|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19337701|NCT03836222|Protective Agents|protective agents|mesh-ancestor
19337702|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337703|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
19337704|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19337705|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
19337706|NCT03836157|Bevacizumab|bevacizumab|mesh-list
19337707|NCT03836157|Maytansine|maytansine|mesh-list
19337708|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337709|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337710|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19337711|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19337712|NCT03836157|Growth Substances|growth substances|mesh-ancestor
19337713|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681890|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20384104|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
20384105|NCT01045109|Vitamin D|vitamin d|mesh-list
19337714|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
19337715|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19337716|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
19337717|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
19337718|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19337719|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399835|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681891|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19681892|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681893|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
19681894|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681895|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19399836|NCT03631901|Protective Agents|protective agents|mesh-ancestor
20198067|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198068|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198069|NCT00240448|Diuretics|diuretics|mesh-ancestor
20198070|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
20198071|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198072|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20198073|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198074|NCT00240474|Amlodipine|amlodipine|mesh-list
20198075|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20198076|NCT00240474|Telmisartan|telmisartan|mesh-list
19337720|NCT03836014|Dexamethasone|dexamethasone|mesh-list
19337721|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
19337722|NCT03836014|Lenalidomide|lenalidomide|mesh-list
19337723|NCT03836014|Daratumumab|daratumumab|mesh-list
19337724|NCT03836014|BB 1101|bb 1101|mesh-list
19337725|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20198077|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20384106|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
19337726|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337727|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
19337728|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
20384107|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
20384108|NCT01045109|Vitamins|vitamins|mesh-list
20384109|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
20384110|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384111|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20384112|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384113|NCT01045278|Interferons|interferons|mesh-list
20384114|NCT01045278|Ribavirin|ribavirin|mesh-list
20384115|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
20384116|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
20384117|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20384118|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384119|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
20384120|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384121|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
19337729|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337730|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337731|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337732|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
19337733|NCT03836014|Hormones|hormones|mesh-ancestor
19337734|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337735|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19337736|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337737|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
20384122|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337738|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337739|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337740|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
19337741|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19337742|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19337743|NCT03836014|Growth Substances|growth substances|mesh-ancestor
19337744|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
19337745|NCT03835676|Treprostinil|treprostinil|mesh-list
19337746|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19337747|NCT03835715|Vortioxetine|vortioxetine|mesh-list
19337748|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
19337749|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19337750|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19337751|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19337752|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20198078|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20198079|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198080|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198081|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20198082|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198083|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
20198084|NCT00240474|Diuretics|diuretics|mesh-ancestor
20198085|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
20198086|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20198087|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20384123|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
20384124|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384125|NCT01045304|Gemcitabine|gemcitabine|mesh-list
20384126|NCT01045304|Carboplatin|carboplatin|mesh-list
19337753|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337754|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19337755|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19337756|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337757|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337758|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337759|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
20384127|NCT01045304|Iniparib|iniparib|mesh-list
20384128|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842692|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19337760|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19681896|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19681897|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19681898|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19681899|NCT05043714|Nivolumab|nivolumab|mesh-list
19842693|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337761|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19337762|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19337763|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19337764|NCT03835442|Baclofen|baclofen|mesh-list
19337765|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19337766|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337767|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20384129|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384130|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
20384131|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384132|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
20384133|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384134|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337768|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337769|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19337770|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
19337771|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
19337772|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337773|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337774|NCT03835871|Beclomethasone|beclomethasone|mesh-list
19337775|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337776|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
19337777|NCT03835871|Hormones|hormones|mesh-ancestor
19337778|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337779|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337780|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19337781|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337782|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
19337783|NCT03835507|Hematinics|hematinics|mesh-ancestor
19337784|NCT03835533|Nivolumab|nivolumab|mesh-list
19337785|NCT03835533|Poly ICLC|poly iclc|mesh-list
19337786|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337787|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337788|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19337789|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337790|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
19337791|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
19337792|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337793|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
19337794|NCT03835286|Vitamins|vitamins|mesh-ancestor
19337795|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
19337796|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337797|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
19337798|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337799|NCT03835286|Protective Agents|protective agents|mesh-ancestor
19337800|NCT03834766|Amphetamine|amphetamine|mesh-list
19337801|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19337802|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337803|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
19337804|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
19337805|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337806|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
19337807|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337808|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337809|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
19337810|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19337811|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19337812|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337813|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19337814|NCT03834831|Selenium|selenium|mesh-list
19337815|NCT03834831|Ubiquinone|ubiquinone|mesh-list
19337816|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
19681900|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19681901|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19681902|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19681903|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681904|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
19337817|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
20384135|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19337818|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198088|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198089|NCT00240513|Minocycline|minocycline|mesh-list
20198090|NCT00240513|Tretinoin|tretinoin|mesh-list
19681905|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
19681906|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681907|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19681908|NCT05019222|Anesthetics|anesthetics|mesh-list
19681909|NCT05019222|Sevoflurane|sevoflurane|mesh-list
19681910|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681911|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681912|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19681913|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19681914|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
20198091|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20198092|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198093|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198094|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
20198095|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
20198096|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
20198097|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20198098|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20198099|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
20198100|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198101|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198102|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20198103|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19337819|NCT03834831|Protective Agents|protective agents|mesh-ancestor
19337820|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337821|NCT03834831|Trace Elements|trace elements|mesh-ancestor
19337822|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
19337823|NCT03834831|Vitamins|vitamins|mesh-ancestor
19337824|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
19337825|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19337826|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19337827|NCT03834935|Analgesics|analgesics|mesh-ancestor
19337828|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
19337829|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337830|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198104|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
20198105|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19337831|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337832|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19337833|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
19337834|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19337835|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
19337836|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19842694|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20384136|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
20384137|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384138|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20384139|NCT01045369|Etravirine|etravirine|mesh-list
19681915|NCT05010148|Lidocaine|lidocaine|mesh-list
19337837|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842695|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842696|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
19337838|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337839|NCT03834883|Ibutilide|ibutilide|mesh-list
19337840|NCT03834883|Progesterone|progesterone|mesh-list
19337841|NCT03834883|Progestins|progestins|mesh-ancestor
19337842|NCT03834883|Hormones|hormones|mesh-ancestor
19337843|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842697|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198106|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
20198107|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20384140|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842698|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19842699|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19842700|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19842701|NCT00654368|Analgesics|analgesics|mesh-ancestor
19842702|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
19842703|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337844|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198108|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198109|NCT00240617|Naproxen|naproxen|mesh-list
20198110|NCT00240617|Sumatriptan|sumatriptan|mesh-list
19337845|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337846|NCT03835065|Calpastatin|calpastatin|mesh-list
19337847|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19337848|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
19337849|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337850|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337851|NCT03834610|Tadalafil|tadalafil|mesh-list
19337852|NCT03834610|Testosterone|testosterone|mesh-list
19337853|NCT03834610|Androgens|androgens|mesh-ancestor
19337854|NCT03834610|Hormones|hormones|mesh-ancestor
19337855|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337856|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337857|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
19337858|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19337859|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19337860|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337861|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337862|NCT03834610|Urological Agents|urological agents|mesh-ancestor
19337863|NCT03834454|Bupivacaine|bupivacaine|mesh-list
19337864|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
20384141|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384142|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
20384143|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384144|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20384145|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20384146|NCT01045434|Omeprazole|omeprazole|mesh-list
20384147|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20384148|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384149|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19337865|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
19337866|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337867|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337868|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
19337869|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337870|NCT03834506|Dexamethasone|dexamethasone|mesh-list
19337871|NCT03834506|Prednisone|prednisone|mesh-list
19337872|NCT03834506|Docetaxel|docetaxel|mesh-list
20198111|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20198112|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198113|NCT00240617|Analgesics|analgesics|mesh-ancestor
20198114|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
20198115|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198116|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198117|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384150|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384151|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384152|NCT01045538|Capecitabine|capecitabine|mesh-list
20384153|NCT01045538|Vorinostat|vorinostat|mesh-list
19337873|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
19337874|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337875|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
19337876|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
19337877|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337878|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337879|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337880|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
19337881|NCT03834506|Hormones|hormones|mesh-ancestor
20198118|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198119|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
20198120|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20198121|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198122|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198123|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20198124|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20198125|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20198126|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
20198127|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198128|NCT00240630|Naproxen|naproxen|mesh-list
20198129|NCT00240630|Sumatriptan|sumatriptan|mesh-list
20198130|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20198131|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198132|NCT00240630|Analgesics|analgesics|mesh-ancestor
20384154|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337882|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337883|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19337884|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337885|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
19337886|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
19337887|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
19337888|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337889|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337890|NCT03834571|Paclitaxel|paclitaxel|mesh-list
19337891|NCT03834571|Cisplatin|cisplatin|mesh-list
19337892|NCT03834571|Carboplatin|carboplatin|mesh-list
19337893|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19337894|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19337895|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337896|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
19337897|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
19337898|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
19337899|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337900|NCT03834233|Nivolumab|nivolumab|mesh-list
19337901|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19337902|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337903|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19337904|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337905|NCT03833999|Ondansetron|ondansetron|mesh-list
19337906|NCT03833999|Lactulose|lactulose|mesh-list
19337907|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
19337908|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
19337909|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337910|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198133|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
20198134|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198135|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337911|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337912|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
19337913|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
19337914|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19337915|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
19337916|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337917|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337918|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19337919|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19337920|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337921|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19337922|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19337923|NCT03834012|Beclomethasone|beclomethasone|mesh-list
19337924|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337925|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
19337926|NCT03834012|Hormones|hormones|mesh-ancestor
19337927|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337928|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337929|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19337930|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198136|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198137|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198138|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
20198139|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20198140|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198141|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337931|NCT03833921|Prednisone|prednisone|mesh-list
19337932|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
19337933|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337934|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
19337935|NCT03833921|Hormones|hormones|mesh-ancestor
19337936|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337937|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337938|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19337939|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337940|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19337941|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19337942|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337943|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
19681916|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
19681917|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
19681918|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681919|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681920|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
20198142|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20198143|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20198144|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20198145|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
20198146|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198147|NCT00240656|Carvedilol|carvedilol|mesh-list
19337944|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19337945|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
19337946|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19337947|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337948|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384155|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384156|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
20384157|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337949|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19337950|NCT03834129|Analgesics|analgesics|mesh-ancestor
19337951|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
19337952|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337953|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19337954|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19337955|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19337956|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
19337957|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198148|NCT00240656|Captopril|captopril|mesh-list
20384158|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20384159|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384160|NCT01045642|Omeprazole|omeprazole|mesh-list
20384161|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20384162|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384163|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20384164|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384165|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384166|NCT01045681|Dexamethasone|dexamethasone|mesh-list
19842704|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198149|NCT00240656|Spironolactone|spironolactone|mesh-list
20198150|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20384167|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
20384168|NCT01045681|Bortezomib|bortezomib|mesh-list
20384169|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20384170|NCT01045681|BB 1101|bb 1101|mesh-list
20384171|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384172|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
19337958|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337959|NCT03833895|Phenylephrine|phenylephrine|mesh-list
19337960|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
19337961|NCT03833895|Norepinephrine|norepinephrine|mesh-list
19337962|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19337963|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
19337964|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
19337965|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337966|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337967|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
19337968|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19337969|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
19337970|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
19337971|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19337972|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19337973|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19337974|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
19337975|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19337976|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19337977|NCT03833895|Protective Agents|protective agents|mesh-ancestor
19337978|NCT03833947|Dexamethasone|dexamethasone|mesh-list
19337979|NCT03833947|Lidocaine|lidocaine|mesh-list
19337980|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19337981|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
19681921|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19681922|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19681923|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19681924|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19681925|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19681926|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681927|NCT05004896|Midazolam|midazolam|mesh-list
20198151|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
20384173|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
20426346|NCT01280149|Neurokinin A|neurokinin a|mesh-list
19337982|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
19337983|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19337984|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19337985|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19337986|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
19337987|NCT03833947|Hormones|hormones|mesh-ancestor
19337988|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19337989|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20384174|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384175|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384176|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384177|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
19337990|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19337991|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
19337992|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
20198152|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198153|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384178|NCT01045681|Hormones|hormones|mesh-ancestor
20384179|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384180|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20198154|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20198155|NCT00240656|Diuretics|diuretics|mesh-ancestor
20198156|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
20198157|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20198158|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20198159|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
20198160|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198161|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198162|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198163|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
20198164|NCT00240656|Protective Agents|protective agents|mesh-ancestor
20198165|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20198166|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198167|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20198168|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
19337993|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19337994|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
19337995|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19337996|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19337997|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19337998|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19337999|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399837|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399838|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384181|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384182|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
20384183|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198169|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20198170|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20198171|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20198172|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
20384184|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681928|NCT05004896|Ketamine|ketamine|mesh-list
19681929|NCT05004896|Analgesics|analgesics|mesh-ancestor
19681930|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
19681931|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399839|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19399840|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
19399841|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
19399842|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
19399843|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399844|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399845|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399846|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19399847|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19399848|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19399849|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399850|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19399851|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19399852|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
19681932|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681933|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19681934|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19681935|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
19681936|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
19681937|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19681938|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19681939|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19681940|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338000|NCT03833596|Prednisone|prednisone|mesh-list
19338001|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338002|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
19338003|NCT03833596|Hormones|hormones|mesh-ancestor
19338004|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338005|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338006|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19338007|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338008|NCT03833466|Metformin|metformin|mesh-list
19338009|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19338010|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338011|NCT03833570|Melatonin|melatonin|mesh-list
19681941|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681942|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19681943|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19681944|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19681945|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19681946|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19681947|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
19681948|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
19681949|NCT04989660|Phenol|phenol|mesh-list
19681950|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19681951|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681952|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
19681953|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19681954|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19681955|NCT04969237|Vitamin D|vitamin d|mesh-list
19681956|NCT04969237|Vitamins|vitamins|mesh-ancestor
19681957|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
19681958|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338012|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
19338013|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338014|NCT03833570|Protective Agents|protective agents|mesh-ancestor
19338015|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338016|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338017|NCT03833362|Interferons|interferons|mesh-list
19338018|NCT03833362|Ritonavir|ritonavir|mesh-list
19338019|NCT03833362|Ribavirin|ribavirin|mesh-list
19338020|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
19338021|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
19338022|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19338023|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19338024|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338025|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
19338026|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338027|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19338028|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19338029|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
19338030|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338031|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338032|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19681959|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19681960|NCT04965454|Choline|choline|mesh-list
19842705|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198173|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198174|NCT00240682|Cetuximab|cetuximab|mesh-list
20198175|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20198176|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198177|NCT00240695|Galantamine|galantamine|mesh-list
20198178|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20198179|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198180|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198181|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
20198182|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198183|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198184|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20384185|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19338033|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19681961|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
19338034|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19338035|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19338036|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
19338037|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
19338038|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338039|NCT03833440|Docetaxel|docetaxel|mesh-list
19338040|NCT03833440|Durvalumab|durvalumab|mesh-list
19338041|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338042|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
19338043|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
19338044|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
19338045|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338046|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338047|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20198185|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
20384186|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
19681962|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19681963|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
19338048|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19338049|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
19338050|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19338051|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19338052|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19338053|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19338054|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681964|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19681965|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198186|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198187|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
20198188|NCT00240708|Risperidone|risperidone|mesh-list
20198189|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20198190|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
20384187|NCT01045772|Rilonacept|rilonacept|mesh-list
20384188|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384189|NCT01045837|Prednisolone|prednisolone|mesh-list
20384190|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384191|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
20384192|NCT01045837|Hormones|hormones|mesh-ancestor
20384193|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384194|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338055|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
19338056|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338057|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384195|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20384196|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384197|NCT01045876|Dexamethasone|dexamethasone|mesh-list
20384198|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384199|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
20384200|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
19338058|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19338059|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384201|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338060|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20198191|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198192|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198193|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198194|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20198195|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20198196|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384202|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384203|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338061|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19338062|NCT03832894|Estradiol|estradiol|mesh-list
19338063|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19338064|NCT03832894|Progesterone|progesterone|mesh-list
19338065|NCT03832894|Estrogens|estrogens|mesh-ancestor
19338066|NCT03832894|Hormones|hormones|mesh-ancestor
19338067|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338068|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338069|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20384204|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
19338070|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
19338071|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20198197|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20384205|NCT01045876|Hormones|hormones|mesh-ancestor
20384206|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384207|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19338072|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20384208|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384209|NCT01045889|Prednisone|prednisone|mesh-list
20384210|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
20384211|NCT01045889|Melphalan|melphalan|mesh-list
20384212|NCT01045889|Rituximab|rituximab|mesh-list
20384213|NCT01045889|Etoposide|etoposide|mesh-list
20384214|NCT01045889|Vincristine|vincristine|mesh-list
20384215|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384216|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
20384217|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384218|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384219|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19338073|NCT03832894|Progestins|progestins|mesh-ancestor
19338074|NCT03832660|Valsartan|valsartan|mesh-list
19338075|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19338076|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19338077|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19338078|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338079|NCT03832816|Dronabinol|dronabinol|mesh-list
20612881|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20612882|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
19338080|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
19338081|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338082|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19338083|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338084|NCT03832816|Analgesics|analgesics|mesh-ancestor
19338085|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
19338086|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338087|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19338088|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19338089|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338090|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338091|NCT03832816|Hormones|hormones|mesh-ancestor
19338092|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338093|NCT03832621|Nivolumab|nivolumab|mesh-list
19338094|NCT03832621|Ipilimumab|ipilimumab|mesh-list
19338095|NCT03832621|Temozolomide|temozolomide|mesh-list
19338096|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338097|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338098|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19338099|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338100|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19338101|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
19338102|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
19338103|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384220|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
20384221|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384222|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384223|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20384224|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384225|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384226|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
20384227|NCT01045889|Hormones|hormones|mesh-ancestor
20384228|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384229|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19338104|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338105|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
20198198|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20198199|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
20198200|NCT00240721|Topiramate|topiramate|mesh-list
20198201|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
20198202|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19338106|NCT03832699|Progesterone|progesterone|mesh-list
19338107|NCT03832699|Progestins|progestins|mesh-ancestor
19338108|NCT03832699|Hormones|hormones|mesh-ancestor
19338109|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198203|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198204|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
20198205|NCT00240734|Hematinics|hematinics|mesh-ancestor
19338110|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198206|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
20198207|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20198208|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198209|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20198210|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198211|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198212|NCT00240760|Memantine|memantine|mesh-list
20198213|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20198214|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20198215|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
20198216|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198217|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198218|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198219|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20198220|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20198221|NCT00240773|Acetaminophen|acetaminophen|mesh-list
20198222|NCT00240773|Naproxen|naproxen|mesh-list
20198223|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198224|NCT00240773|Analgesics|analgesics|mesh-ancestor
20198225|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
20198226|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198227|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198228|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
19338111|NCT03832465|Levofloxacin|levofloxacin|mesh-list
19681966|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19681967|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
19681968|NCT04952727|Vaccines|vaccines|mesh-list
19681969|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
19681970|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19681971|NCT04951986|Levofloxacin|levofloxacin|mesh-list
19681972|NCT04951986|Ofloxacin|ofloxacin|mesh-list
19681973|NCT04951986|Rifampin|rifampin|mesh-list
19681974|NCT04951986|Isoniazid|isoniazid|mesh-list
19681975|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
19681976|NCT04951986|Ethambutol|ethambutol|mesh-list
19681977|NCT04951986|Prednisone|prednisone|mesh-list
19681978|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19681979|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
19681980|NCT04951986|Hormones|hormones|mesh-ancestor
19338112|NCT03832465|Ofloxacin|ofloxacin|mesh-list
19338113|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19338114|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19338115|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338116|NCT03832465|Renal Agents|renal agents|mesh-ancestor
19338117|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338118|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19338119|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19338120|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338121|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338122|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338123|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19338124|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19338125|NCT03832361|Maytansine|maytansine|mesh-list
19338126|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19338127|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338128|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
19338129|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
19338130|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
19338131|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338132|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
19338133|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
19338134|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338135|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338136|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19338137|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19338138|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338139|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338140|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338141|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
19338142|NCT03832426|Ritonavir|ritonavir|mesh-list
19338143|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19338144|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19338145|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
19681981|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19681982|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198229|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19681983|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19681984|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842706|NCT00654381|Inositol|inositol|mesh-list
20384230|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20612883|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612884|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
20612885|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20612886|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612887|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384231|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20384232|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20384233|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384234|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
20384235|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
20384236|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
20384237|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
20384238|NCT01045902|Ampicillin|ampicillin|mesh-list
20384239|NCT01045902|Sulbactam|sulbactam|mesh-list
20384240|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20384241|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20384242|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384243|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20384244|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20384245|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384246|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384247|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384248|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20384249|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
20384250|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20384251|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384252|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20384253|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20384254|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20384255|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20384256|NCT01045928|Rituximab|rituximab|mesh-list
20384257|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20384258|NCT01045928|Lenalidomide|lenalidomide|mesh-list
19338146|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338147|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338148|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19338149|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19338150|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
19338151|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681985|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19681986|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19681987|NCT04951986|Renal Agents|renal agents|mesh-ancestor
19681988|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19681989|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19681990|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19681991|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198230|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198231|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198232|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
20198233|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20198234|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198235|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198236|NCT00240786|Acetaminophen|acetaminophen|mesh-list
20198237|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198238|NCT00240786|Analgesics|analgesics|mesh-ancestor
20612888|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20612889|NCT02253199|Analgesics|analgesics|mesh-ancestor
19338152|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20384259|NCT01045928|Antibodies|antibodies|mesh-list
20384260|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
20198239|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
20198240|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198241|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198242|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
20198243|NCT00240799|Acetaminophen|acetaminophen|mesh-list
20198244|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198245|NCT00240799|Analgesics|analgesics|mesh-ancestor
20198246|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
20198247|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338153|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19681992|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198248|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198249|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
20198250|NCT00240812|Ibuprofen|ibuprofen|mesh-list
19681993|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19681994|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20384261|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20384262|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
20384263|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384264|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384265|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384266|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20384267|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20384268|NCT01045928|Growth Substances|growth substances|mesh-ancestor
20384269|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
20384270|NCT01045941|Gemcitabine|gemcitabine|mesh-list
20384271|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384272|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
20384273|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384274|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384275|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
19681995|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19681996|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
19681997|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
19681998|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19681999|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19682000|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19682001|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19682002|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19682003|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20198251|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
20198252|NCT00240812|Ephedrine|ephedrine|mesh-list
20198253|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19338154|NCT03831984|Bromfenac|bromfenac|mesh-list
19338155|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
19338156|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19338157|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
19338158|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338159|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
19338160|NCT03831984|Protective Agents|protective agents|mesh-ancestor
19338161|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19338162|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338163|NCT03831984|Analgesics|analgesics|mesh-ancestor
19338164|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
19338165|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338166|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384276|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384277|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384278|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384279|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
20384280|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384281|NCT01045954|Insulin|insulin|mesh-list
20384282|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
20384283|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
20384284|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20384285|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384286|NCT01045980|Vitamin D|vitamin d|mesh-list
20384287|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
20384288|NCT01045980|Vitamins|vitamins|mesh-list
19338167|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19338168|NCT03831815|Rocuronium|rocuronium|mesh-list
19338169|NCT03831815|Cisatracurium|cisatracurium|mesh-list
19338170|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19338171|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19338172|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19338173|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198254|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198255|NCT00240812|Analgesics|analgesics|mesh-ancestor
20198256|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
20198257|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198258|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198259|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198260|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384289|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
20384290|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384291|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19338174|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198261|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19338175|NCT03831334|Minoxidil|minoxidil|mesh-list
19338176|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19338177|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
19338178|NCT03831321|Diclofenac|diclofenac|mesh-list
19338179|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20198262|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198263|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198264|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19338180|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338181|NCT03831321|Analgesics|analgesics|mesh-ancestor
19338182|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
19338183|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338184|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338185|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338186|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384292|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384293|NCT01046006|Dexamethasone|dexamethasone|mesh-list
20384294|NCT01046006|Rituximab|rituximab|mesh-list
20384295|NCT01046006|Bortezomib|bortezomib|mesh-list
20384296|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384297|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384298|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
20384299|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338187|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19338188|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338189|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338190|NCT03831464|Metformin|metformin|mesh-list
19338191|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19338192|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198265|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
20198266|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20198267|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198268|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
20198269|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20198270|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20198271|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
19338193|NCT03831269|Azithromycin|azithromycin|mesh-list
19338194|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338195|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338196|NCT03831113|Buprenorphine|buprenorphine|mesh-list
19338197|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19338198|NCT03831113|Narcotics|narcotics|mesh-ancestor
19338199|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338200|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338201|NCT03831113|Analgesics|analgesics|mesh-ancestor
19338202|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
19338203|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338204|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19338205|NCT03831126|Betamethasone|betamethasone|mesh-list
19338206|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
19338207|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19338208|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
20198272|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
20198273|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198274|NCT00240825|Acetaminophen|acetaminophen|mesh-list
20198275|NCT00240825|Ibuprofen|ibuprofen|mesh-list
20198276|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198277|NCT00240825|Analgesics|analgesics|mesh-ancestor
20198278|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
20198279|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338209|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19338210|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
19338211|NCT03831126|Hormones|hormones|mesh-ancestor
19338212|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338213|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338214|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338215|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19338216|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198280|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198281|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
20198282|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20198283|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198284|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19338217|NCT03831425|Ubiquinone|ubiquinone|mesh-list
20384300|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19338218|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
19338219|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
20198285|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20198286|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682004|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19338220|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338221|NCT03831425|Vitamins|vitamins|mesh-ancestor
19338222|NCT03831295|Antibodies|antibodies|mesh-list
19338223|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
19338224|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338225|NCT03830827|Vortioxetine|vortioxetine|mesh-list
19338226|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
19338227|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19338228|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19338229|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19338230|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338231|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338232|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20384301|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384302|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
20384303|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
20384304|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384305|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384306|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
20384307|NCT01046006|Hormones|hormones|mesh-ancestor
20384308|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384309|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19338233|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19338234|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19338235|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338236|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338237|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
19338238|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19682005|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19682006|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19682007|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
19682008|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19692592|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692593|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19692594|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198287|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198288|NCT00240838|Acetaminophen|acetaminophen|mesh-list
20198289|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198290|NCT00240838|Analgesics|analgesics|mesh-ancestor
20198291|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
20198292|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198293|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692595|NCT04989413|Analgesics|analgesics|mesh-ancestor
19692596|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
19692597|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692598|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19692599|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19692600|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692601|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692602|NCT04989413|Hormones|hormones|mesh-ancestor
20198294|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
20198295|NCT00240851|Acetaminophen|acetaminophen|mesh-list
20198296|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198297|NCT00240851|Analgesics|analgesics|mesh-ancestor
20198298|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
20198299|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198300|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198301|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
20198302|NCT00240864|Acetaminophen|acetaminophen|mesh-list
20198303|NCT00240864|Ibuprofen|ibuprofen|mesh-list
20198304|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198305|NCT00240864|Analgesics|analgesics|mesh-ancestor
20198306|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
20198307|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198308|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198309|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
20198310|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20198311|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198312|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198313|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20384310|NCT01046032|Metformin|metformin|mesh-list
20384311|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20384312|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384313|NCT01046045|Everolimus|everolimus|mesh-list
20384314|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384315|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384316|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
20384317|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384318|NCT01046058|Simeprevir|simeprevir|mesh-list
20384319|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
20384320|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384321|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
20384322|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384323|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384324|NCT01046162|Alprazolam|alprazolam|mesh-list
20384325|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20384326|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384327|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198314|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198315|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198316|NCT00240916|Vaccines|vaccines|mesh-list
20198317|NCT00240916|Immunoglobulins|immunoglobulins|mesh-list
20198318|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
20198319|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198320|NCT00240929|Palivizumab|palivizumab|mesh-list
20198321|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
20198322|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198323|NCT00240942|Letrozole|letrozole|mesh-list
20198324|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198325|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20198326|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20198327|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198328|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198329|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20198330|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
20198331|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198332|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384328|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20384329|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20384330|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20384331|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
20384332|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
20384333|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384334|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426347|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426348|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426349|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426350|NCT01280162|Piperaquine|piperaquine|mesh-list
20426351|NCT01280162|Artenimol|artenimol|mesh-list
20426352|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
20426353|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20426354|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20426355|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426356|NCT01280175|Charcoal|charcoal|mesh-list
20426357|NCT01280175|Antidotes|antidotes|mesh-ancestor
20426358|NCT01280175|Protective Agents|protective agents|mesh-ancestor
20426359|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426360|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20426361|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
20426362|NCT01280188|Coagulants|coagulants|mesh-ancestor
19338239|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19338240|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20198333|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
20198334|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20198335|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198336|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20198337|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
20426363|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19338241|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19338242|NCT03830957|Metoprolol|metoprolol|mesh-list
19338243|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19338244|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20426364|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
20426365|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426366|NCT01280214|Triamcinolone|triamcinolone|mesh-list
20426367|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426368|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
19842707|NCT00654381|Linagliptin|linagliptin|mesh-list
19842708|NCT00654381|Voglibose|voglibose|mesh-list
20198338|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20198339|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198340|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198341|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682009|NCT04943679|Interferons|interferons|mesh-list
19682010|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
20198342|NCT00241007|Valsartan|valsartan|mesh-list
20198343|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20198344|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198345|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198346|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198347|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198348|NCT00241007|Diuretics|diuretics|mesh-ancestor
20198349|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
20198350|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198351|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20198352|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198353|NCT00241020|Octreotide|octreotide|mesh-list
20198354|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198355|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20198356|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384335|NCT01046214|Bupropion|bupropion|mesh-list
20384336|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20384337|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
19338245|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
19338246|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
19338247|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338248|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338249|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19338250|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19338251|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19338252|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
19338253|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338254|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338255|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
19338256|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
19338257|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338258|NCT03830489|Protective Agents|protective agents|mesh-ancestor
19338259|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338260|NCT03830489|Vitamins|vitamins|mesh-ancestor
19338261|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
19338262|NCT03830684|Baicalein|baicalein|mesh-list
19338263|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
20384338|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20384339|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20384340|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20384341|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20384342|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384343|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
20384344|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384345|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384346|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20384347|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20384348|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384349|NCT01046227|Vaccines|vaccines|mesh-list
20384350|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
20384351|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384352|NCT01046240|Palonosetron|palonosetron|mesh-list
20384353|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
19338264|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338265|NCT03830684|Protective Agents|protective agents|mesh-ancestor
19338266|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338267|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338268|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
19338269|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
19338270|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338271|NCT03830606|Paclitaxel|paclitaxel|mesh-list
19338272|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19338273|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338274|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
19338275|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
19338276|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
19399853|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
19338277|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338278|NCT03830398|Acetaminophen|acetaminophen|mesh-list
19338279|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338280|NCT03830398|Analgesics|analgesics|mesh-ancestor
19338281|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
19338282|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338283|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338284|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
19338285|NCT03830164|Vitamins|vitamins|mesh-list
19338286|NCT03830164|Vitamin E|vitamin e|mesh-list
19338287|NCT03830164|Tocopherols|tocopherols|mesh-list
19338288|NCT03830164|Tocotrienols|tocotrienols|mesh-list
19338289|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
19338290|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
19338291|NCT03830164|Atorvastatin|atorvastatin|mesh-list
19338292|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
19338293|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842709|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19842710|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842711|NCT00654381|Incretins|incretins|mesh-ancestor
19842712|NCT00654381|Hormones|hormones|mesh-ancestor
19842713|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384354|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
19682011|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682012|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
19682013|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682014|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
20384355|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384356|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384357|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384358|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20384359|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20384360|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
20384361|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384362|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384363|NCT01046266|Cetuximab|cetuximab|mesh-list
20384364|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384365|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384366|NCT01046279|Bevacizumab|bevacizumab|mesh-list
20384367|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338294|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19338295|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19338296|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
19338297|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338298|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19338299|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19338300|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338301|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
19338302|NCT03830164|Protective Agents|protective agents|mesh-ancestor
19338303|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19338304|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19682015|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682016|NCT04939987|Acetaminophen|acetaminophen|mesh-list
19682017|NCT04939987|Ketorolac|ketorolac|mesh-list
19682018|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19682019|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19682020|NCT04939987|Ketamine|ketamine|mesh-list
19338305|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19338306|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
19338307|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19682021|NCT04939987|Oxycodone|oxycodone|mesh-list
19682022|NCT04939987|Gabapentin|gabapentin|mesh-list
19682023|NCT04939987|Tramadol|tramadol|mesh-list
19682024|NCT04939987|Hydrocodone|hydrocodone|mesh-list
19682025|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
19682026|NCT04939987|Analgesics|analgesics|mesh-ancestor
19682027|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
19682028|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682029|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682030|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19682031|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19682032|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
19682033|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
19842714|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19842715|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
19338308|NCT03830385|Carboplatin|carboplatin|mesh-list
19338309|NCT03830385|Bleomycin|bleomycin|mesh-list
19682034|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338310|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338311|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19338312|NCT03830086|Midazolam|midazolam|mesh-list
19338313|NCT03830086|Sufentanil|sufentanil|mesh-list
19338314|NCT03830086|Bupivacaine|bupivacaine|mesh-list
19338315|NCT03830086|Propofol|propofol|mesh-list
19338316|NCT03830086|Sevoflurane|sevoflurane|mesh-list
19338317|NCT03830086|Rocuronium|rocuronium|mesh-list
19338318|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
19338319|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
19682035|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19682036|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19682037|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682038|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682039|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682040|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
19682041|NCT04939987|Narcotics|narcotics|mesh-ancestor
19338320|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338321|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384368|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384369|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20384370|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20384371|NCT01046279|Growth Substances|growth substances|mesh-ancestor
20384372|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384373|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
20384374|NCT01046383|Caseins|caseins|mesh-list
20384375|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
20384376|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
20384377|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384378|NCT01046435|Amoxicillin|amoxicillin|mesh-list
20384379|NCT01046435|Metronidazole|metronidazole|mesh-list
20384380|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20384381|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384382|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20384383|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20384384|NCT01046461|Dexamethasone|dexamethasone|mesh-list
19338322|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
19338323|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338324|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20384385|NCT01046461|Aprepitant|aprepitant|mesh-list
20384386|NCT01046461|Ramosetron|ramosetron|mesh-list
20384387|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384388|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
20384389|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
20384390|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842716|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198357|NCT00241046|Letrozole|letrozole|mesh-list
20198358|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198359|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20198360|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20198361|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198362|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198363|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20198364|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
19842717|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842718|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19842719|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
20198365|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384391|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384392|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384393|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
19338325|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19338326|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
19338327|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19338328|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19338329|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19338330|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19338331|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
19682042|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
19682043|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19682044|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19682045|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682046|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
19842720|NCT00654381|Vitamins|vitamins|mesh-ancestor
20384394|NCT01046461|Hormones|hormones|mesh-ancestor
19338332|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
19338333|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384395|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384396|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20384397|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384398|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20384399|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384400|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384401|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20384402|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
20198366|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198367|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
20198368|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20198369|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198370|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20198371|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
20198372|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338334|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338335|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19338336|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19338337|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19338338|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19338339|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19842721|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
19842722|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19842723|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384403|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
20384404|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
20384405|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384406|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
20384407|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384408|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842724|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19842725|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842726|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842727|NCT00654498|Pramipexole|pramipexole|mesh-list
19842728|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
19842729|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842730|NCT00654498|Protective Agents|protective agents|mesh-ancestor
19842731|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842732|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19842733|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19842734|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
19842735|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
19842736|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842737|NCT00654511|Fentanyl|fentanyl|mesh-list
19842738|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
19842739|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19842740|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842741|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198373|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198374|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384409|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19338340|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19338341|NCT03830086|Narcotics|narcotics|mesh-ancestor
20384410|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
20384411|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384412|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338342|NCT03830086|Analgesics|analgesics|mesh-ancestor
19338343|NCT03830216|Insulin|insulin|mesh-list
19338344|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19338345|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20384413|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20384414|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20384415|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384416|NCT01046500|Inositol|inositol|mesh-list
20384417|NCT01046500|Metformin|metformin|mesh-list
20384418|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20384419|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384420|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
20384421|NCT01046500|Vitamins|vitamins|mesh-ancestor
20384422|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
20384423|NCT01046539|Buprenorphine|buprenorphine|mesh-list
19842742|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198375|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399854|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
20198376|NCT00241072|Valsartan|valsartan|mesh-list
20384424|NCT01046539|ALKS-33|alks-33|mesh-list
20384425|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20384426|NCT01046539|Narcotics|narcotics|mesh-ancestor
20384427|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384428|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384429|NCT01046539|Analgesics|analgesics|mesh-ancestor
20384430|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
20384431|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384432|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20384433|NCT01046578|Letrozole|letrozole|mesh-list
20384434|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384435|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20384436|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20384437|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384438|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384439|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20384440|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
20384441|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384442|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338346|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338347|NCT03830034|Iron|iron|mesh-list
19338348|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
19338349|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
19338350|NCT03830034|Trace Elements|trace elements|mesh-ancestor
19338351|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
19338352|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338353|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
19338354|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
19338355|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384443|NCT01046630|Ketamine|ketamine|mesh-list
20384444|NCT01046630|Analgesics|analgesics|mesh-ancestor
20384445|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
20384446|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384447|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384448|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20384449|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20384450|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
20384451|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
20384452|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384453|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20384454|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20384455|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384456|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384457|NCT01046708|Progesterone|progesterone|mesh-list
20384458|NCT01046708|Progestins|progestins|mesh-ancestor
20384459|NCT01046708|Hormones|hormones|mesh-ancestor
19338356|NCT03829696|Misoprostol|misoprostol|mesh-list
19338357|NCT03829696|Mifepristone|mifepristone|mesh-list
19338358|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
19338359|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19338360|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
19338361|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20198377|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198378|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198379|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198380|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198381|NCT00241085|Valsartan|valsartan|mesh-list
20198382|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19842743|NCT00654511|Analgesics|analgesics|mesh-ancestor
19842744|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
19842745|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198383|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198384|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198385|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198386|NCT00241098|Valsartan|valsartan|mesh-list
20198387|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198388|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198389|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198390|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198391|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
20384460|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426369|NCT01280214|Hormones|hormones|mesh-ancestor
19338362|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338363|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19338364|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338365|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
19338366|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19338367|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19338368|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19338369|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19338370|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
19338371|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19338372|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19338373|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
19338374|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338375|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
19338376|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19338377|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19338378|NCT03829839|Lorazepam|lorazepam|mesh-list
19338379|NCT03829839|Oxytocin|oxytocin|mesh-list
19338380|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
19338381|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19338382|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338383|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
19338384|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
19338385|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
19338386|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338387|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338388|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19338389|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338390|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19338391|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19338392|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19338393|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
19338394|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
19338395|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338396|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338397|NCT03829943|Vitamin D|vitamin d|mesh-list
19338398|NCT03829943|Vitamins|vitamins|mesh-ancestor
19338399|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
20384461|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384462|NCT01046721|Exenatide|exenatide|mesh-list
20384463|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20384464|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384465|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20384466|NCT01046721|Incretins|incretins|mesh-ancestor
20384467|NCT01046721|Hormones|hormones|mesh-ancestor
20384468|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384469|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
20384470|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384471|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384472|NCT01046773|Vitamins|vitamins|mesh-ancestor
20384473|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
20384474|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20384475|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
20384476|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20384477|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20384478|NCT01046786|Prednisolone|prednisolone|mesh-list
20384479|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
19338400|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338401|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19338402|NCT03829774|Acetaminophen|acetaminophen|mesh-list
19338403|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198392|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20198393|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198394|NCT00241124|Valsartan|valsartan|mesh-list
20198395|NCT00241124|Lisinopril|lisinopril|mesh-list
20198396|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198397|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198398|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198399|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198400|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20198401|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
20198402|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198403|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19338404|NCT03829774|Analgesics|analgesics|mesh-ancestor
19338405|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
19338406|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399855|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
19338407|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338408|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
19338409|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
19338410|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338411|NCT03829917|Paromomycin|paromomycin|mesh-list
19338412|NCT03829917|Miltefosine|miltefosine|mesh-list
19338413|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338414|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198404|NCT00241124|Protective Agents|protective agents|mesh-ancestor
20198405|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338415|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19338416|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19338417|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
19338418|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399856|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399857|NCT03631875|Ketamine|ketamine|mesh-list
19399858|NCT03631875|Propofol|propofol|mesh-list
19399859|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399860|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399861|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399862|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20198406|NCT00241137|Valsartan|valsartan|mesh-list
20198407|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198408|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198409|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19682047|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19682048|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384480|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20384481|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
20384482|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384483|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
20384484|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
20384485|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384486|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384487|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384488|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
20384489|NCT01046786|Hormones|hormones|mesh-ancestor
20384490|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384491|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20384492|NCT01046786|Protective Agents|protective agents|mesh-ancestor
20384493|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20384494|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384495|NCT01046799|Entecavir|entecavir|mesh-list
20384496|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
20384497|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384498|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
20384499|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
20384500|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20384501|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20384502|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384503|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399863|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
19399864|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
19399865|NCT03631875|Analgesics|analgesics|mesh-ancestor
19399866|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
19399867|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399868|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19399869|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19399870|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19399871|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399872|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399873|NCT03631862|Apatinib|apatinib|mesh-list
19399874|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399875|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19399876|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682049|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198410|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198411|NCT00241150|Valsartan|valsartan|mesh-list
20198412|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198413|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198414|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20384504|NCT01046838|Urological Agents|urological agents|mesh-ancestor
20384505|NCT01046864|Leucovorin|leucovorin|mesh-list
19399877|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384506|NCT01046864|Fluorouracil|fluorouracil|mesh-list
19338419|NCT03829930|Entinostat|entinostat|mesh-list
19338420|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338421|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19338422|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338423|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682050|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19682051|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682052|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
19682053|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
19682054|NCT04939792|Vitamin D|vitamin d|mesh-list
19682055|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
19682056|NCT04939792|Vitamins|vitamins|mesh-list
19682057|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
19682058|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682059|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19682060|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19682061|NCT04938557|Insulin|insulin|mesh-list
19682062|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19682063|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682064|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682065|NCT04933526|Dasatinib|dasatinib|mesh-list
19682066|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
19682067|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682068|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19682069|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682070|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682071|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
19682072|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682073|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
19682074|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682075|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682076|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19682077|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
19682078|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682079|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682080|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19682081|NCT04895280|Triamcinolone|triamcinolone|mesh-list
19682082|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19682083|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19682084|NCT04895280|Ketorolac|ketorolac|mesh-list
19682085|NCT04895280|Bupivacaine|bupivacaine|mesh-list
19682086|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19682087|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
19682088|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
19682089|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682090|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682091|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
19682092|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682093|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19682094|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
19682095|NCT04895280|Hormones|hormones|mesh-ancestor
19682096|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682097|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682098|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
20198415|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682099|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198416|NCT00241163|Thrombin|thrombin|mesh-list
20198417|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
20198418|NCT00241163|Coagulants|coagulants|mesh-ancestor
20198419|NCT00241189|Sirolimus|sirolimus|mesh-list
20198420|NCT00241189|Methotrexate|methotrexate|mesh-list
20198421|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20198422|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
19338451|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
19338452|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19338453|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19338454|NCT03829566|Prednisolone|prednisolone|mesh-list
19338455|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
19338456|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
19338457|NCT03829566|Rituximab|rituximab|mesh-list
19338458|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
19338459|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19338460|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19338461|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
19338462|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19338463|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
19338464|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338465|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19338466|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19338467|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
19338468|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338469|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338470|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19338471|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338472|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338473|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
19682100|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384507|NCT01046864|Irinotecan|irinotecan|mesh-list
20384508|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
20384509|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384510|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384511|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384512|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384513|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
20384514|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384515|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20384516|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20384517|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384518|NCT01046864|Antidotes|antidotes|mesh-ancestor
20384519|NCT01046864|Protective Agents|protective agents|mesh-ancestor
20384520|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
20384521|NCT01046864|Vitamins|vitamins|mesh-ancestor
20384522|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
20384523|NCT01046942|Aspirin|aspirin|mesh-list
20384524|NCT01046942|Clopidogrel|clopidogrel|mesh-list
20384525|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20384526|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20384527|NCT01046942|Analgesics|analgesics|mesh-ancestor
20384528|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
20384529|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384530|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384531|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384532|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384533|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20384534|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20384535|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384536|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20384537|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20384538|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384539|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
20384540|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19338474|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
19338475|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338476|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384541|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19338477|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
19338478|NCT03829566|Hormones|hormones|mesh-ancestor
19338479|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338480|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19338481|NCT03829566|Protective Agents|protective agents|mesh-ancestor
19338482|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19338483|NCT03829592|Misoprostol|misoprostol|mesh-list
19338484|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20384542|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20384543|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
20384544|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384545|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
20384546|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
20384547|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20384548|NCT01046955|Daclizumab|daclizumab|mesh-list
20384549|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
20384550|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682101|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19682102|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682103|NCT04895280|Analgesics|analgesics|mesh-ancestor
19338485|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
19338486|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19338487|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384551|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384552|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384553|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384554|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20384555|NCT01046981|Metronidazole|metronidazole|mesh-list
20384556|NCT01046981|Cefazolin|cefazolin|mesh-list
20384557|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20384558|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384559|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
19338488|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19338489|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338490|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
19338491|NCT03829345|Olaparib|olaparib|mesh-list
19338492|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19338493|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338494|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842746|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19842747|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19842748|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19842749|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
19842750|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842751|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842752|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19842753|NCT00654511|Narcotics|narcotics|mesh-ancestor
20384560|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19338495|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338496|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
19338497|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
19338498|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338499|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338500|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338501|NCT03829319|Carboplatin|carboplatin|mesh-list
19338502|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
19682104|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682105|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19682106|NCT04892459|Vaccines|vaccines|mesh-list
19682107|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
19682108|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338503|NCT03829319|Pemetrexed|pemetrexed|mesh-list
19338504|NCT03829319|Lenvatinib|lenvatinib|mesh-list
19842754|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19842755|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20384561|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20384562|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20384563|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384564|NCT01047059|Bevacizumab|bevacizumab|mesh-list
20384565|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20384566|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384567|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384568|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20384569|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20384570|NCT01047059|Growth Substances|growth substances|mesh-ancestor
20384571|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384572|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
20384573|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20384574|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384575|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384576|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
20384577|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
20384578|NCT01047072|Rituximab|rituximab|mesh-list
20384579|NCT01047072|Fludarabine|fludarabine|mesh-list
20384580|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
20384581|NCT01047072|Tacrolimus|tacrolimus|mesh-list
20384582|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384583|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
20384584|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384585|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384586|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20384587|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
20384588|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384589|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384590|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20384591|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682131|NCT04881539|Cannabidiol|cannabidiol|mesh-list
19682132|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
19682133|NCT04880278|Nabilone|nabilone|mesh-list
19682134|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
19682135|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
19682136|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384592|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384593|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
20384594|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20384595|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384596|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20384597|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20384598|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
20384599|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20384600|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384601|NCT01047098|Iron|iron|mesh-list
20384602|NCT01047098|Trace Elements|trace elements|mesh-ancestor
20384603|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
20384604|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384605|NCT01047202|Vaccines|vaccines|mesh-list
20384606|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
20384607|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384608|NCT01047215|Aripiprazole|aripiprazole|mesh-list
20384609|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20384610|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
20384611|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20384612|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20384613|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20384614|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384615|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384616|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
20384617|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
20384618|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338505|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842756|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
20428761|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682137|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682138|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19682139|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19682140|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19682141|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682142|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682143|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
19682144|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682145|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682146|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19682147|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19682148|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
19682149|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384619|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384620|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20384621|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19682150|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682151|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19682152|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
19682153|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682154|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338506|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384622|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
20384623|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20384624|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20384625|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20384626|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20384627|NCT01047423|Simvastatin|simvastatin|mesh-list
20384628|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19338507|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338508|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682155|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19682156|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19682157|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
20198423|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20198424|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198425|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198426|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
20198427|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198428|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338509|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19338510|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19338511|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19338512|NCT03829124|Ketamine|ketamine|mesh-list
19338513|NCT03829124|Propofol|propofol|mesh-list
19338514|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19338515|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338516|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338517|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19338518|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
19338519|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
19338520|NCT03829124|Analgesics|analgesics|mesh-ancestor
19338521|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
19338522|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338523|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20384629|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20384630|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
20384631|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384632|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20384633|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20384634|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384635|NCT01047488|Pregabalin|pregabalin|mesh-list
20384636|NCT01047488|Imipramine|imipramine|mesh-list
20384637|NCT01047488|Analgesics|analgesics|mesh-ancestor
20384638|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
19338524|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19842757|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
20198429|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
20198430|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198431|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20198432|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20198433|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
20198434|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384639|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384640|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198435|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20198436|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19682158|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682159|NCT04835506|Infliximab|infliximab|mesh-list
19338525|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19338526|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338527|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338528|NCT03829150|Amoxicillin|amoxicillin|mesh-list
19338529|NCT03829150|Metronidazole|metronidazole|mesh-list
19338530|NCT03829150|Clarithromycin|clarithromycin|mesh-list
19338531|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
19338532|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19682160|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
20384641|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
20384642|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20384643|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20384644|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384645|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384646|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20384647|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20384648|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384649|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20384650|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20384651|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
20384652|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20384653|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20384654|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
20384655|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384656|NCT01047566|Digoxin|digoxin|mesh-list
20384657|NCT01047566|Dronedarone|dronedarone|mesh-list
20384658|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
20384659|NCT01047566|Calcium|calcium|mesh-list
20384660|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20384661|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384662|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384663|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20384664|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20384665|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384666|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384667|NCT01047566|Protective Agents|protective agents|mesh-ancestor
20384668|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20384669|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
20384670|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384671|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20384672|NCT01047579|Rivastigmine|rivastigmine|mesh-list
20384673|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19682161|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19682162|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198437|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198438|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20198439|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
20198440|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
20198441|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20198442|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198443|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198444|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
20198445|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198446|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198447|NCT00241241|Interferons|interferons|mesh-list
20198448|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
20198449|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
20198450|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20198451|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198452|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
19682163|NCT04820686|Tenofovir|tenofovir|mesh-list
19682164|NCT04820686|Entecavir|entecavir|mesh-list
19682165|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
19682166|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198453|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338533|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682167|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19842758|NCT00654732|Rituximab|rituximab|mesh-list
20198454|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
19682168|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19682169|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682170|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682171|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19682172|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19682173|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19682174|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19842759|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19842760|NCT00654732|Doxorubicin|doxorubicin|mesh-list
19842761|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19842762|NCT00654732|Dacarbazine|dacarbazine|mesh-list
19842763|NCT00654732|Bleomycin|bleomycin|mesh-list
19338534|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19338535|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19338536|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19338537|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338538|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338539|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19338540|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19338541|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19338542|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338543|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19338544|NCT03829020|Metformin|metformin|mesh-list
19338545|NCT03829020|Nelfinavir|nelfinavir|mesh-list
19338546|NCT03829020|Bortezomib|bortezomib|mesh-list
19338547|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19338548|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338549|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842764|NCT00654732|Vinblastine|vinblastine|mesh-list
19842765|NCT00654732|Antibodies|antibodies|mesh-list
19842766|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
20198455|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198456|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
19338550|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19338551|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19338552|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
19338553|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338554|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338555|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20198457|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20198458|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20198459|NCT00241254|Prednisolone|prednisolone|mesh-list
20198460|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
19338556|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20198461|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
20198462|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20198463|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
20384674|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384675|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384676|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
20384677|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384678|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384679|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20384680|NCT01047579|Protective Agents|protective agents|mesh-ancestor
20384681|NCT01047657|Orlistat|orlistat|mesh-list
20384682|NCT01047657|Sibutramine|sibutramine|mesh-list
20384683|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384684|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384685|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19338557|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
19338558|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338559|NCT03829111|Nivolumab|nivolumab|mesh-list
19338560|NCT03829111|Ipilimumab|ipilimumab|mesh-list
19338561|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338562|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338563|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19338564|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338565|NCT03828929|Ascorbic Acid|ascorbic acid|mesh-list
19338566|NCT03828929|Thiamine|thiamine|mesh-list
19338567|NCT03828929|Vitamins|vitamins|mesh-ancestor
19338568|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
19338569|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338570|NCT03828929|Antioxidants|antioxidants|mesh-ancestor
19338571|NCT03828929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198464|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682175|NCT04813614|Lidocaine|lidocaine|mesh-list
20384686|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19338572|NCT03828929|Protective Agents|protective agents|mesh-ancestor
19338573|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
19338574|NCT03829046|Evolocumab|evolocumab|mesh-list
19338575|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19338576|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19338577|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
19338578|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338579|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19338580|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
19338581|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19338582|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338583|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19338584|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
19338585|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338586|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
19338587|NCT03828682|Prednisone|prednisone|mesh-list
19682176|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
19682177|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
19682178|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338588|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
19338589|NCT03828682|Tacrolimus|tacrolimus|mesh-list
19338590|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
19338591|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19338592|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19682179|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682180|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
19682181|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682182|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19682183|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19682184|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19682185|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19682186|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682187|NCT04813562|Vaccines|vaccines|mesh-list
19682188|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
19338593|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
19338594|NCT03828682|Hormones|hormones|mesh-ancestor
19338595|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338596|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338597|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19338598|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338599|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19338600|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
19338601|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19338602|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338603|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338604|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19338605|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19338606|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
19338607|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338608|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338609|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
19338610|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
19338611|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338612|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338613|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19338614|NCT03828682|Protective Agents|protective agents|mesh-ancestor
20384687|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
20384688|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20384689|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
20384690|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
20384691|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338615|NCT03828773|Fluconazole|fluconazole|mesh-list
19338616|NCT03828773|Posaconazole|posaconazole|mesh-list
19338617|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
19338618|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338619|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19338620|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19338621|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338622|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338623|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19338624|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
19338625|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384692|NCT01047722|Aspirin|aspirin|mesh-list
19338626|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399878|NCT03631836|Bevacizumab|bevacizumab|mesh-list
19338627|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19682189|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682190|NCT04800393|Propofol|propofol|mesh-list
19682191|NCT04800393|Sevoflurane|sevoflurane|mesh-list
19682192|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19682193|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338628|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19338629|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19338630|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19338631|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19338632|NCT03828474|Acetazolamide|acetazolamide|mesh-list
19338633|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
19682194|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682195|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19682196|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
19682197|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
19682198|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19682199|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19692603|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692604|NCT04989335|Fludarabine|fludarabine|mesh-list
20384693|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20384694|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20384695|NCT01047722|Analgesics|analgesics|mesh-ancestor
19338634|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19338635|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692605|NCT04989335|Clofarabine|clofarabine|mesh-list
19692606|NCT04989335|Bisantrene|bisantrene|mesh-list
19692607|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692608|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198465|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
20198466|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198467|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198468|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19692609|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
19692610|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692611|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19692612|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
19692613|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19692614|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
19692615|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692616|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
19842767|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19842768|NCT00654732|Imidazole|imidazole|mesh-list
19842769|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
19842770|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842771|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842772|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198469|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
20198470|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842773|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19842774|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19842775|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19842776|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842777|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842778|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20198471|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198472|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20198473|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198474|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
20198475|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
20198476|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198477|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198478|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
20198479|NCT00241254|Hormones|hormones|mesh-ancestor
20198480|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198481|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20198482|NCT00241254|Protective Agents|protective agents|mesh-ancestor
20198483|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20198484|NCT00241332|Fentanyl|fentanyl|mesh-list
20198485|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20198486|NCT00241332|Narcotics|narcotics|mesh-ancestor
20384696|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
19399879|NCT03631836|Antibodies|antibodies|mesh-list
19692617|NCT04989361|Protective Agents|protective agents|mesh-ancestor
19692618|NCT04989400|Misoprostol|misoprostol|mesh-list
19338636|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338637|NCT03828474|Diuretics|diuretics|mesh-ancestor
20198487|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338638|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
19682200|NCT04796012|Irinotecan|irinotecan|mesh-list
19682201|NCT04796012|Vincristine|vincristine|mesh-list
19682202|NCT04796012|Temozolomide|temozolomide|mesh-list
19682203|NCT04796012|Atezolizumab|atezolizumab|mesh-list
19682204|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19682205|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19682206|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682207|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682208|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682209|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19682210|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
19682211|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
19682212|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
19682213|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19682214|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
19682215|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
19682216|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19682217|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
19682218|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19682219|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682220|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19682221|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19682222|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19682223|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
19682224|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
19682225|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682226|NCT04783792|Protective Agents|protective agents|mesh-ancestor
19682227|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682228|NCT04783792|Vitamins|vitamins|mesh-ancestor
19682229|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
19682230|NCT04770532|Insulin|insulin|mesh-list
19682231|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19682232|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682233|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682234|NCT04750070|Dopamine|dopamine|mesh-list
19682235|NCT04750070|Epinephrine|epinephrine|mesh-list
19682236|NCT04750070|Racepinephrine|racepinephrine|mesh-list
19682237|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
19682238|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19682239|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20198488|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198489|NCT00241332|Analgesics|analgesics|mesh-ancestor
20198490|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
20198491|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198492|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20198493|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20198494|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
20198495|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
20198496|NCT00241345|Valganciclovir|valganciclovir|mesh-list
19682240|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
19682241|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682242|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682243|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198497|NCT00241345|Ganciclovir|ganciclovir|mesh-list
20198498|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20198499|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
20198500|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198501|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20198502|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198503|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198504|NCT00241371|Clofarabine|clofarabine|mesh-list
20198505|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198506|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
20198507|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198508|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198509|NCT00241423|Exenatide|exenatide|mesh-list
20198510|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20198511|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198512|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19682244|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20198513|NCT00241423|Incretins|incretins|mesh-ancestor
19682245|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19682246|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
19682247|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682248|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19338639|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338640|NCT03828175|Anesthetics|anesthetics|mesh-list
19338641|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338642|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338643|NCT03828227|Bevacizumab|bevacizumab|mesh-list
20384697|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384698|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384699|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384700|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384701|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20384702|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20384703|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384704|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20384705|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20384706|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384707|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
20384708|NCT01047748|Digoxin|digoxin|mesh-list
20384709|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20384710|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20384711|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384712|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384713|NCT01047748|Protective Agents|protective agents|mesh-ancestor
19338644|NCT03828227|Capecitabine|capecitabine|mesh-list
19682249|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
19682250|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
19682251|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
19682252|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19682253|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19682254|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
19682255|NCT04750070|Protective Agents|protective agents|mesh-ancestor
19682256|NCT04748523|Mirtazapine|mirtazapine|mesh-list
19682257|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
19682258|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682259|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19682260|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
19682261|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
19682262|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198514|NCT00241423|Hormones|hormones|mesh-ancestor
20198515|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198516|NCT00241436|Anastrozole|anastrozole|mesh-list
20198517|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20198518|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198519|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20198520|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20198521|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198522|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198523|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19338645|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338646|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338647|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19338648|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20198524|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
20198525|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198526|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198527|NCT00241449|Tamoxifen|tamoxifen|mesh-list
20198528|NCT00241449|Fulvestrant|fulvestrant|mesh-list
20198529|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20198530|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
20198531|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198532|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198533|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20198534|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198535|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20384714|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384715|NCT01047774|Caseins|caseins|mesh-list
20384716|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
20384717|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
19682263|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842779|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
19338649|NCT03828227|Growth Substances|growth substances|mesh-ancestor
19692619|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
20198536|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20198537|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20198538|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20198539|NCT00241475|Gefitinib|gefitinib|mesh-list
20198540|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198541|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19682264|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682265|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19682266|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19682267|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682268|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19682269|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19338650|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338651|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
19338652|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19338653|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
19338654|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338655|NCT03828006|Red yeast rice|red yeast rice|mesh-list
19338656|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19338657|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19338658|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19338659|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
19338660|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338661|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338662|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19338663|NCT03828032|Mannitol|mannitol|mesh-list
19338664|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19338665|NCT03828032|Diuretics|diuretics|mesh-ancestor
19682270|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19682271|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
19682272|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19682273|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19682274|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
19682275|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19682276|NCT04741334|Anticoagulants|anticoagulants|mesh-list
19682277|NCT04741334|Dicumarol|dicumarol|mesh-list
20198542|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198543|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198544|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20198545|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20198546|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20198547|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
20198548|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198549|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20198550|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19682278|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20198551|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198552|NCT00241501|Esomeprazole|esomeprazole|mesh-list
20198553|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20198554|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198555|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20198556|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198557|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217602|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217603|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19682279|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682280|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682281|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
20217604|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
20217605|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217606|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20217607|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
20217608|NCT00309920|Docetaxel|docetaxel|mesh-list
20217609|NCT00309920|Doxorubicin|doxorubicin|mesh-list
20217610|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20217611|NCT00309920|Fluorouracil|fluorouracil|mesh-list
20217612|NCT00309920|Epirubicin|epirubicin|mesh-list
20217613|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
20217614|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217615|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
20217616|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682282|NCT04734028|Aspirin|aspirin|mesh-list
19682283|NCT04734028|Clopidogrel|clopidogrel|mesh-list
19338666|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
19338667|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338668|NCT03828019|Cyclosporine|cyclosporine|mesh-list
19338669|NCT03828019|Adalimumab|adalimumab|mesh-list
20384718|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612890|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
20612891|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338670|NCT03828019|Methotrexate|methotrexate|mesh-list
19338671|NCT03828019|Azathioprine|azathioprine|mesh-list
19338672|NCT03828019|Tacrolimus|tacrolimus|mesh-list
19338673|NCT03828019|Cyclosporins|cyclosporins|mesh-list
19682284|NCT04734028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19682285|NCT04734028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198558|NCT00241514|Esomeprazole|esomeprazole|mesh-list
20198559|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20198560|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338674|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19338675|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
19338676|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19338677|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338678|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198561|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20198562|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198563|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198564|NCT00241527|Esomeprazole|esomeprazole|mesh-list
20198565|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20198566|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198567|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20198568|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198569|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198570|NCT00241540|Esomeprazole|esomeprazole|mesh-list
20198571|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20198572|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198573|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20198574|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198575|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198576|NCT00241553|Esomeprazole|esomeprazole|mesh-list
20198577|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19682286|NCT04734028|Analgesics|analgesics|mesh-ancestor
20198578|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198579|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19338679|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
19338680|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338681|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338682|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
19338683|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338684|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19338685|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19338686|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
19682287|NCT04734028|Sensory System Agents|sensory system agents|mesh-ancestor
20384719|NCT01047891|Sorafenib|sorafenib|mesh-list
20384720|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682288|NCT04734028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198580|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198581|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198582|NCT00241605|Metformin|metformin|mesh-list
20198583|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
20198584|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20198585|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198586|NCT00241618|Interferons|interferons|mesh-list
20198587|NCT00241618|Ribavirin|ribavirin|mesh-list
20198588|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
20198589|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
20198590|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198591|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
20198592|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384721|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20384722|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384723|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426370|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426371|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426372|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20426373|NCT01280240|Hematinics|hematinics|mesh-ancestor
19338687|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19399880|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20384724|NCT01047956|Methadone|methadone|mesh-list
20384725|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20384726|NCT01047956|Narcotics|narcotics|mesh-ancestor
20384727|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384728|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384729|NCT01047956|Analgesics|analgesics|mesh-ancestor
20384730|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
20384731|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384732|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
20384733|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
19338688|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19338689|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19338690|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
19338691|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338692|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338693|NCT03827876|Calcitriol|calcitriol|mesh-list
19338694|NCT03827876|Betamethasone|betamethasone|mesh-list
19338695|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19338696|NCT03827876|Calcipotriene|calcipotriene|mesh-list
19338697|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338698|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
19338699|NCT03827876|Hormones|hormones|mesh-ancestor
19682289|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682290|NCT04734028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19682291|NCT04734028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198593|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
20198594|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198595|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
20198596|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198597|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20198598|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20198599|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
20198600|NCT00241722|Alvimopan|alvimopan|mesh-list
20198601|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198602|NCT00241982|Prednisolone|prednisolone|mesh-list
20384734|NCT01047982|Folic Acid|folic acid|mesh-list
20384735|NCT01047982|Inositol|inositol|mesh-list
20384736|NCT01047982|Hematinics|hematinics|mesh-ancestor
20384737|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
20384738|NCT01047982|Vitamins|vitamins|mesh-ancestor
20384739|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
20384740|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384741|NCT01047995|Ritonavir|ritonavir|mesh-list
20384742|NCT01047995|Darunavir|darunavir|mesh-list
20384743|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
20384744|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20384745|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20384746|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
20384747|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384748|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384749|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20384750|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20384751|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
20384752|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384753|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20384754|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20384755|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20384756|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20384757|NCT01048034|Azacitidine|azacitidine|mesh-list
20384758|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
20384759|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384760|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
20384761|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384762|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384763|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384764|NCT01048034|Hematinics|hematinics|mesh-ancestor
20384765|NCT01048047|Amlodipine|amlodipine|mesh-list
20384766|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20384767|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20384768|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20384769|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682292|NCT04734028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19338700|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384770|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20198603|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384771|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384772|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
19682293|NCT04734028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19682294|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198604|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
20198605|NCT00241982|Hormones|hormones|mesh-ancestor
20198606|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198607|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198608|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19338701|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338702|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19338703|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
19338704|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19338705|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20198609|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198610|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
20198611|NCT00242008|Rotigotine|rotigotine|mesh-list
20384773|NCT01048086|Tretinoin|tretinoin|mesh-list
20384774|NCT01048086|Isotretinoin|isotretinoin|mesh-list
20384775|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384776|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
20384777|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
20384778|NCT01048138|Biperiden|biperiden|mesh-list
20198612|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
20198613|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
19682295|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19682296|NCT04734028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20384779|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
20384780|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20384781|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20384782|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
20384783|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
20384784|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384785|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384786|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20384787|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20384788|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
20384789|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384790|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338706|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19338707|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338708|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19338709|NCT03827876|Vitamins|vitamins|mesh-ancestor
19338710|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
19338711|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19682297|NCT04734028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682298|NCT04734028|Antipyretics|antipyretics|mesh-ancestor
19682299|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19682300|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19682301|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19682302|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
19682303|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682304|NCT04732195|Pilocarpine|pilocarpine|mesh-list
19682305|NCT04732195|Miotics|miotics|mesh-ancestor
19682306|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
19682307|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682308|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682309|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19682310|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19682311|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
19682312|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682313|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682314|NCT04719221|Evolocumab|evolocumab|mesh-list
19682315|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19682316|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20198614|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198615|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198616|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198617|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
20198618|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20198619|NCT00242177|Pioglitazone|pioglitazone|mesh-list
20198620|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20612892|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19338712|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
20198621|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682317|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
20384791|NCT01048177|Lidocaine|lidocaine|mesh-list
19682318|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682319|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19682320|NCT04712903|Carboplatin|carboplatin|mesh-list
19682321|NCT04712903|Etoposide|etoposide|mesh-list
19682322|NCT04712903|Durvalumab|durvalumab|mesh-list
19682323|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682324|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19682325|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20612893|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20612894|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20612895|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
20612896|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612897|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338713|NCT03828084|Decitabine|decitabine|mesh-list
19338714|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
20384792|NCT01048177|Heparin|heparin|mesh-list
20384793|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
19338715|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19338716|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
20198622|NCT00242190|Gemcitabine|gemcitabine|mesh-list
20198623|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
20198624|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198625|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
20198626|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198627|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198628|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
20198629|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198630|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198631|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682326|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19682327|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682328|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682329|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682330|NCT04710134|Reslizumab|reslizumab|mesh-list
19682331|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19682332|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198632|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
20198633|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198634|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
20198635|NCT00242203|Docetaxel|docetaxel|mesh-list
20198636|NCT00242203|Trastuzumab|trastuzumab|mesh-list
20384794|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
19682333|NCT04698057|Amoxicillin|amoxicillin|mesh-list
19682334|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
19682335|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
19682336|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
19682337|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19338717|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338718|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338719|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338720|NCT03828058|Tacrolimus|tacrolimus|mesh-list
19682338|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338721|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19338722|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
19338723|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338724|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19338725|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338726|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338727|NCT03827889|Fluorides|fluorides|mesh-list
19338728|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
19338729|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
19338730|NCT03827889|Protective Agents|protective agents|mesh-ancestor
19338731|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399881|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399882|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399883|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19399884|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19399885|NCT03631836|Growth Substances|growth substances|mesh-ancestor
19682339|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682340|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20384795|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384796|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384797|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
20384798|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384799|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20198637|NCT00242203|Epirubicin|epirubicin|mesh-list
19338732|NCT03827642|Naloxone|naloxone|mesh-list
19338733|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19338734|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338735|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
19338736|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338737|NCT03827629|Naloxone|naloxone|mesh-list
19338738|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19338739|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338740|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
20384800|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20384801|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20384802|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19338741|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338742|NCT03827408|Midazolam|midazolam|mesh-list
19338743|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
19338744|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19338745|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338746|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384803|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384804|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
20384805|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20384806|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20384807|NCT01048190|Vaccines|vaccines|mesh-list
20384808|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
19338747|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338748|NCT03827408|Analgesics|analgesics|mesh-ancestor
19338749|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
19338750|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338751|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19338752|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19338753|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19338754|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
19338755|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338756|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338757|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19338758|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19338759|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20384809|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384810|NCT01048229|Pramipexole|pramipexole|mesh-list
20384811|NCT01048229|Rasagiline|rasagiline|mesh-list
20384812|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
20384813|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384814|NCT01048229|Protective Agents|protective agents|mesh-ancestor
19338760|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682341|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19682342|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682343|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682344|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682345|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19682346|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19682347|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19682348|NCT04696757|Capecitabine|capecitabine|mesh-list
19682349|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682350|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
20198638|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198639|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
20198640|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
20198641|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
20198642|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198643|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20198644|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20198645|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19338761|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19338762|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
19682351|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682352|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682353|NCT04686799|Doxycycline|doxycycline|mesh-list
19682354|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19682355|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682356|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
19682357|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19682358|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20198646|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20612898|NCT02253212|Carboplatin|carboplatin|mesh-list
20384815|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384816|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20384817|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19338763|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
19338764|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
19338765|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
19338766|NCT03827070|Afatinib|afatinib|mesh-list
19338767|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338768|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19338769|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338770|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338771|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19338772|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19338773|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19338774|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338775|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338776|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19338777|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19338778|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338779|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
19338780|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338781|NCT03827044|Avelumab|avelumab|mesh-list
19338782|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338783|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338784|NCT03827200|Ambrisentan|ambrisentan|mesh-list
19338785|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19338786|NCT03827278|Itraconazole|itraconazole|mesh-list
19338787|NCT03827278|Voriconazole|voriconazole|mesh-list
19338788|NCT03827278|Amphotericin B|amphotericin b|mesh-list
19338789|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
19338790|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338791|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19338792|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19338793|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682359|NCT04684589|Tadalafil|tadalafil|mesh-list
19682360|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
19682361|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19682362|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19682363|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682364|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682365|NCT04684589|Urological Agents|urological agents|mesh-ancestor
19682366|NCT04682834|Probenecid|probenecid|mesh-list
19682367|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
19338794|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338795|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19338796|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
19338797|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338798|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338799|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19338800|NCT03827278|Amebicides|amebicides|mesh-ancestor
19338801|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19338802|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19338803|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19338804|NCT03826940|Lovastatin|lovastatin|mesh-list
19338805|NCT03826940|L 647318|l 647318|mesh-list
19338806|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
19338807|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19338808|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19338809|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
19338810|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338811|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19338812|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19338813|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338814|NCT03826875|Fluoxetine|fluoxetine|mesh-list
19338815|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19338816|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19338817|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19338818|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338819|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338820|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
19338821|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682368|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
19682369|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682370|NCT04682834|Renal Agents|renal agents|mesh-ancestor
20384818|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
19338822|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19338823|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
19338824|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19338825|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19338826|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19338827|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338828|NCT03826589|Avelumab|avelumab|mesh-list
19338829|NCT03826589|Axitinib|axitinib|mesh-list
19338830|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19338831|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338832|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19338833|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338834|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338835|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
19338836|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
19338837|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
19338838|NCT03826615|Gabapentin|gabapentin|mesh-list
19338839|NCT03826615|Analgesics|analgesics|mesh-ancestor
19338840|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
19338841|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338842|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338843|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
19338844|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19338845|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19338846|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338847|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19338848|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19338849|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19338850|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338851|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338852|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
19338853|NCT03826602|Metformin|metformin|mesh-list
19338854|NCT03826602|Tucatinib|tucatinib|mesh-list
19338855|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19338856|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338857|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338858|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19338859|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338860|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338861|NCT03826550|Diclofenac|diclofenac|mesh-list
19338862|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19338863|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338864|NCT03826550|Analgesics|analgesics|mesh-ancestor
19338865|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
19338866|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338867|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338868|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338869|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19338870|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19338871|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338872|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338873|NCT03826485|Pranlukast|pranlukast|mesh-list
19338874|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19338875|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
19338876|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19338877|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
19338878|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19338879|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338880|NCT03826524|Epinephrine|epinephrine|mesh-list
19338881|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19338882|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19338883|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
19338884|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338885|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338886|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338887|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19338888|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19338889|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
19338890|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338891|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19338892|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
19338893|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
19338894|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
19338895|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19338896|NCT03826368|Cannabidiol|cannabidiol|mesh-list
19338897|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
19338898|NCT03826316|Nalbuphine|nalbuphine|mesh-list
19338899|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19338900|NCT03826316|Narcotics|narcotics|mesh-ancestor
19338901|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338902|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338903|NCT03826316|Analgesics|analgesics|mesh-ancestor
19338904|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
19338905|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338906|NCT03825965|Cannabidiol|cannabidiol|mesh-list
19338907|NCT03825965|Anticonvulsants|anticonvulsants|mesh-ancestor
19338908|NCT03825887|Morphine|morphine|mesh-list
19338909|NCT03825887|Nalbuphine|nalbuphine|mesh-list
19338910|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19338911|NCT03825887|Narcotics|narcotics|mesh-ancestor
19338912|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338913|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338914|NCT03825887|Analgesics|analgesics|mesh-ancestor
19338915|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
19682371|NCT04682743|Acetaminophen|acetaminophen|mesh-list
19682372|NCT04682743|Ondansetron|ondansetron|mesh-list
19682373|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682374|NCT04682743|Analgesics|analgesics|mesh-ancestor
19682375|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
19682376|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682377|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682378|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
19682379|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
19682380|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
19682381|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19682382|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
19842780|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20198647|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198648|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20198649|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198650|NCT00242268|Simvastatin|simvastatin|mesh-list
20198651|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20198652|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20198653|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
20198654|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198655|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20198656|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20198657|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682383|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
20612899|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842781|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
20198658|NCT00242346|Candesartan|candesartan|mesh-list
20198659|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
20198660|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198661|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198662|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198663|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198664|NCT00242359|Omalizumab|omalizumab|mesh-list
19842782|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
19842783|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
19842784|NCT00654745|Amlodipine|amlodipine|mesh-list
19842785|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19842786|NCT00654745|Olmesartan|olmesartan|mesh-list
19842787|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19842788|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198665|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20612900|NCT02253264|Rituximab|rituximab|mesh-list
20612901|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20612902|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20612903|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
20612904|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612905|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20612906|NCT02253121|Insulin|insulin|mesh-list
20612907|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20612908|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
20612909|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19338916|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338917|NCT03826004|Clemastine|clemastine|mesh-list
19682384|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19338918|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
19682385|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
19842789|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20198666|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20198667|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198668|NCT00242372|Insulin|insulin|mesh-list
19338919|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
19338920|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19338921|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
19338922|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
19338923|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338924|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338925|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338926|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19338927|NCT03825861|Folfirinox|folfirinox|mesh-list
19338928|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338929|NCT03825809|Acetaminophen|acetaminophen|mesh-list
19338930|NCT03825809|Celecoxib|celecoxib|mesh-list
19338931|NCT03825809|Ketorolac|ketorolac|mesh-list
19338932|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19338933|NCT03825809|Diazepam|diazepam|mesh-list
19338934|NCT03825809|Gabapentin|gabapentin|mesh-list
19338935|NCT03825809|Hydrocodone|hydrocodone|mesh-list
19338936|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338937|NCT03825809|Analgesics|analgesics|mesh-ancestor
19338938|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
19338939|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338940|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338941|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
19338942|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19338943|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19338944|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19338945|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19338946|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19338947|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19338948|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338949|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
19338950|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19338951|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19338952|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338953|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20198669|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20198670|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198671|NCT00242411|Budesonide|budesonide|mesh-list
20198672|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
20198673|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198674|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20198675|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
20198676|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198677|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198678|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20198679|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198680|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
20198681|NCT00242411|Hormones|hormones|mesh-ancestor
20198682|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198683|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20198684|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20198685|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20198686|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
20198687|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198688|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198689|NCT00242437|Thrombin|thrombin|mesh-list
20198690|NCT00242437|Hemostatics|hemostatics|mesh-list
20198691|NCT00242437|Coagulants|coagulants|mesh-ancestor
20198692|NCT00242450|Metoclopramide|metoclopramide|mesh-list
20198693|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
20198694|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
20198695|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198696|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198697|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198698|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20198699|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20198700|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
20198701|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338954|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19338955|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19682386|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198702|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19338956|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338957|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
19338958|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19338959|NCT03825809|Narcotics|narcotics|mesh-ancestor
19338960|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
19338961|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
19338962|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19338963|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
19338964|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
20198703|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
20198704|NCT00242463|Nandrolone|nandrolone|mesh-list
19682387|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682388|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19682389|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19682390|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682391|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682392|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19682393|NCT04681677|Bevacizumab|bevacizumab|mesh-list
19682394|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20198705|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
20198706|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
20198707|NCT00242463|Androgens|androgens|mesh-ancestor
20198708|NCT00242463|Hormones|hormones|mesh-ancestor
20198709|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198710|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198711|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
20198712|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20198713|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
19682395|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19338965|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19338966|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19338967|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19338968|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19338969|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19338970|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
19682396|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19682397|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19682398|NCT04681677|Growth Substances|growth substances|mesh-ancestor
19682399|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338971|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
19338972|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
19338973|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
19338974|NCT03825601|Flumazenil|flumazenil|mesh-list
19338975|NCT03825601|Antidotes|antidotes|mesh-ancestor
20612910|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612911|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20612912|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198714|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20198715|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198716|NCT00242541|Octreotide|octreotide|mesh-list
20198717|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198718|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20612913|NCT02253420|Itraconazole|itraconazole|mesh-list
20612914|NCT02253420|Rifampin|rifampin|mesh-list
20612915|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
19338976|NCT03825601|Protective Agents|protective agents|mesh-ancestor
19338977|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19338978|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
19338979|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
19338980|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19338981|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384819|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
20384820|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399886|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399887|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
19399888|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
20198719|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198720|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
20217617|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384821|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20384822|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384823|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20384824|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20384825|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384826|NCT01048268|Incretins|incretins|mesh-ancestor
19399889|NCT03631823|Temozolomide|temozolomide|mesh-list
19399890|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19338982|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
19338983|NCT03825471|Anesthetics|anesthetics|mesh-list
19338984|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19338985|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198721|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20198722|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198723|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
20198724|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682400|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
19692620|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19692621|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
19692622|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19692623|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692624|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19692625|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384827|NCT01048268|Hormones|hormones|mesh-ancestor
20426374|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19338986|NCT03825471|Narcotics|narcotics|mesh-ancestor
19692626|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
19692627|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19692628|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
19692629|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19338987|NCT03825471|Analgesics|analgesics|mesh-ancestor
19338988|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
19338989|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19338990|NCT03825757|Aspirin|aspirin|mesh-list
19338991|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
19338992|NCT03825757|Salicylates|salicylates|mesh-list
19338993|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19338994|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
19338995|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
19338996|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
19338997|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19692630|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19692631|NCT04989127|Penicillins|penicillins|mesh-list
19692632|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19692633|NCT04989127|Analgesics|analgesics|mesh-list
19692634|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692635|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
19692636|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
19692637|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692638|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693136|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693137|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693138|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693139|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19338998|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19338999|NCT03825757|Analgesics|analgesics|mesh-ancestor
19339000|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
19339001|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339002|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339003|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339004|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339005|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339006|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339007|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693140|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
19693141|NCT04982900|Aflutinib|aflutinib|mesh-list
19693142|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19693143|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693144|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693145|NCT04982913|Oseltamivir|oseltamivir|mesh-list
19693146|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
19693147|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693148|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693149|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693150|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
20198725|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198726|NCT00242606|Lamotrigine|lamotrigine|mesh-list
20198727|NCT00242606|Levetiracetam|levetiracetam|mesh-list
20198728|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
20198729|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
20198730|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20198731|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198732|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682401|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
19682402|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19682403|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682404|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682405|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682406|NCT04656470|Analgesics|analgesics|mesh-ancestor
19682407|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
20198733|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384828|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384829|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384830|NCT01048307|Polihexanide|polihexanide|mesh-list
20384831|NCT01048307|Betaine|betaine|mesh-list
20384832|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20384833|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20384834|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
20384835|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20384836|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
20384837|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384838|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20384839|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
20384840|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384841|NCT01048320|Gemcitabine|gemcitabine|mesh-list
20384842|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
20384843|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
20384844|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384845|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
20384846|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339008|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19339009|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20384847|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384848|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
20384849|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384850|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384851|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384852|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
20612916|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339010|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19339011|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
19339012|NCT03825380|Bimatoprost|bimatoprost|mesh-list
19842790|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842791|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198734|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198735|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20198736|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20198737|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20198738|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20198739|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19339013|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19339014|NCT03825250|Valproic Acid|valproic acid|mesh-list
19339015|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
19339016|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339017|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339018|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
19339019|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339020|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339021|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
19339022|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19339023|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339024|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339025|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19682408|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198740|NCT00242697|Anesthetics|anesthetics|mesh-list
20198741|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20198742|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198743|NCT00242736|Esomeprazole|esomeprazole|mesh-list
20198744|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20198745|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198746|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20384853|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612917|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19682409|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19682410|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19682411|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19339026|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20384854|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20384855|NCT01048385|Ubiquinone|ubiquinone|mesh-list
20384856|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
20384857|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
20384858|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198747|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198748|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198749|NCT00242749|Gefitinib|gefitinib|mesh-list
20198750|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682412|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
19682413|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682414|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198751|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19339027|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339028|NCT03825198|Dexamethasone|dexamethasone|mesh-list
19339029|NCT03825198|Ketorolac|ketorolac|mesh-list
19339030|NCT03825198|Sufentanil|sufentanil|mesh-list
19339031|NCT03825198|Morphine|morphine|mesh-list
19339032|NCT03825198|Bromides|bromides|mesh-list
19339033|NCT03825198|Propofol|propofol|mesh-list
19339034|NCT03825198|Sevoflurane|sevoflurane|mesh-list
19339035|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
19339036|NCT03825198|Rocuronium|rocuronium|mesh-list
19339037|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339038|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
19339039|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
19339040|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339041|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339042|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339043|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
19339044|NCT03825198|Hormones|hormones|mesh-ancestor
19339045|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339046|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19339047|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339048|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
19339049|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339050|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19339051|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19339052|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
19339053|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19339054|NCT03825198|Narcotics|narcotics|mesh-ancestor
19339055|NCT03825198|Analgesics|analgesics|mesh-ancestor
19339056|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
19339057|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339058|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19339059|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19339060|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339061|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339062|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339063|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339064|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339065|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
19339066|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19339067|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19339068|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19339069|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
19339070|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19339071|NCT03825367|Nivolumab|nivolumab|mesh-list
19339072|NCT03825367|Azacitidine|azacitidine|mesh-list
19339073|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19339074|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339075|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19339076|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339077|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19339078|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
19339079|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339080|NCT03825328|Gemcitabine|gemcitabine|mesh-list
19339081|NCT03825328|Paclitaxel|paclitaxel|mesh-list
19339082|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
19339083|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20198752|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198753|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384859|NCT01048385|Vitamins|vitamins|mesh-ancestor
19339084|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20198754|NCT00242762|Docetaxel|docetaxel|mesh-list
19339085|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339086|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
20384860|NCT01048398|Acetaminophen|acetaminophen|mesh-list
20384861|NCT01048398|Remifentanil|remifentanil|mesh-list
20384862|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20384863|NCT01048398|Analgesics|analgesics|mesh-ancestor
19339087|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
19339088|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
19339089|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198755|NCT00242762|Gefitinib|gefitinib|mesh-list
20198756|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198757|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
20198758|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
20198759|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
19339090|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19339091|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
19339092|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
20198760|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198761|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20198762|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198763|NCT00242775|Fluticasone|fluticasone|mesh-list
19339093|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339094|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339095|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19339096|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
19339097|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339098|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
19339099|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19339100|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
19339101|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339102|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
19339103|NCT03825133|Protective Agents|protective agents|mesh-ancestor
19339104|NCT03824847|Clarithromycin|clarithromycin|mesh-list
19339105|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19339106|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339107|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19339108|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339109|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339110|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19339111|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19339112|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
19682415|NCT04647500|Methylphenidate|methylphenidate|mesh-list
19682416|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19682417|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682418|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19682419|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20384864|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
20384865|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384866|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384867|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
20384868|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20384869|NCT01048398|Narcotics|narcotics|mesh-ancestor
20384870|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20384871|NCT01048515|Caffeine|caffeine|mesh-list
20384872|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20384873|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384874|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19682420|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19682421|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682422|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
19682423|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682424|NCT04640402|Vaccines|vaccines|mesh-list
19682425|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
19682426|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682427|NCT04636333|Vaccines|vaccines|mesh-list
20384875|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384876|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384877|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20384878|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20384879|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
20384880|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20384881|NCT01048554|Bevacizumab|bevacizumab|mesh-list
20384882|NCT01048554|Temozolomide|temozolomide|mesh-list
19682428|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
19682429|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682430|NCT04623216|Azacitidine|azacitidine|mesh-list
19339113|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19682431|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682432|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
19682433|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682434|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682435|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682436|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
19682437|NCT04621526|Ketamine|ketamine|mesh-list
19682438|NCT04621526|Propofol|propofol|mesh-list
19339114|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19339115|NCT03824925|Zinc|zinc|mesh-list
19339116|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
19682439|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20198764|NCT00242775|Budesonide|budesonide|mesh-list
19339117|NCT03824925|Trace Elements|trace elements|mesh-ancestor
19339118|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
19339119|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198765|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
20198766|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20198767|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198768|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20198769|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
20198770|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198771|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198772|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20198773|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198774|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
20198775|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20198776|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
20198777|NCT00242775|Hormones|hormones|mesh-ancestor
20198778|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198779|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20198780|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20198781|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20198782|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
20198783|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198784|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198785|NCT00242788|Capecitabine|capecitabine|mesh-list
20198786|NCT00242788|Gefitinib|gefitinib|mesh-list
20198787|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198788|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
20198789|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198790|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198791|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20198792|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198793|NCT00242801|Gefitinib|gefitinib|mesh-list
20198794|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198795|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20198796|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198797|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198798|NCT00242814|Amlodipine|amlodipine|mesh-list
20198799|NCT00242814|Telmisartan|telmisartan|mesh-list
20198800|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20198801|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20198802|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198803|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198804|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20198805|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198806|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
20198807|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20198808|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20198809|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
20198810|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20198811|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
20198812|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198813|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198814|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20198815|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198816|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20198817|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
20198818|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198819|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339120|NCT03824925|Astringents|astringents|mesh-ancestor
19682440|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339121|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
20198820|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20198821|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
20198822|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
20198823|NCT00242853|Protective Agents|protective agents|mesh-ancestor
20198824|NCT00242879|Ritonavir|ritonavir|mesh-list
19339122|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19339123|NCT03825081|Pilocarpine|pilocarpine|mesh-list
19339124|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19339125|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19339126|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19339127|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19339128|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
19339129|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339130|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339131|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339132|NCT03825081|Miotics|miotics|mesh-ancestor
19339133|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
19339134|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339135|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19339136|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19339137|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
19339138|NCT03825068|Anesthetics|anesthetics|mesh-list
19682441|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682442|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19682443|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
19682444|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
19682445|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682446|NCT04621526|Analgesics|analgesics|mesh-ancestor
19339139|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
19339140|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339141|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339142|NCT03824665|Fentanyl|fentanyl|mesh-list
19339143|NCT03824665|Nalbuphine|nalbuphine|mesh-list
19339144|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19842792|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384883|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384884|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384885|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19842793|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842794|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
20384886|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20384887|NCT01048554|Growth Substances|growth substances|mesh-ancestor
19339145|NCT03824665|Narcotics|narcotics|mesh-ancestor
19339146|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339147|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842795|NCT00654745|Diuretics|diuretics|mesh-ancestor
19842796|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
19842797|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19842798|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19842799|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19842800|NCT00654784|Idebenone|idebenone|mesh-list
19842801|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
20198825|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19339148|NCT03824665|Analgesics|analgesics|mesh-ancestor
19339149|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
19682447|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
19682448|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682449|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20198826|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20198827|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
19339150|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339151|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19339152|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19339153|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
19339154|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
19339155|NCT03825016|Diclofenac|diclofenac|mesh-list
19339156|NCT03825016|Lidocaine|lidocaine|mesh-list
20198828|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198829|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198830|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20198831|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19339157|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
19339158|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
19682450|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19682451|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19682452|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19339159|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339160|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682453|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682454|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384888|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384889|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
20384890|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20384891|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
20384892|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384893|NCT01048580|Capecitabine|capecitabine|mesh-list
20384894|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20384895|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
20384896|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384897|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384898|NCT01048619|ON 01910|on 01910|mesh-list
19682455|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19682456|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19682457|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19682458|NCT04616014|Insulin|insulin|mesh-list
19682459|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19339161|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
19339162|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682460|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682461|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384899|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384900|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20384901|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384902|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384903|NCT01048632|Oxandrolone|oxandrolone|mesh-list
20384904|NCT01048632|Androgens|androgens|mesh-ancestor
20384905|NCT01048632|Hormones|hormones|mesh-ancestor
20384906|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20384907|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384908|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
20384909|NCT01048684|Mannitol|mannitol|mesh-list
20384910|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20384911|NCT01048684|Diuretics|diuretics|mesh-ancestor
20384912|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
20384913|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384914|NCT01048827|Busulfan|busulfan|mesh-list
20384915|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
19682462|NCT04609111|Aspirin|aspirin|mesh-list
19682463|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20198832|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
20198833|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198834|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20198835|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20198836|NCT00242918|Docetaxel|docetaxel|mesh-list
20198837|NCT00242918|Gefitinib|gefitinib|mesh-list
20198838|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198839|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
20198840|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
20198841|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
20198842|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682464|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20198843|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20198844|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198845|NCT00242944|Atorvastatin|atorvastatin|mesh-list
20198846|NCT00242944|Pitavastatin|pitavastatin|mesh-list
20198847|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20198848|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20198849|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
20198850|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198851|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20384916|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339163|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19339164|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19339165|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19339166|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19339167|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399891|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
19682465|NCT04609111|Analgesics|analgesics|mesh-ancestor
20198852|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19339168|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339169|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339170|NCT03825016|Analgesics|analgesics|mesh-ancestor
19339171|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339172|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339173|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339174|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339175|NCT03824717|Ropivacaine|ropivacaine|mesh-list
19339176|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
19339177|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
19339178|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339179|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339180|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
19339181|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20198853|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682466|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
19682467|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682468|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198854|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
20198855|NCT00242996|Carmustine|carmustine|mesh-list
20198856|NCT00242996|Rituximab|rituximab|mesh-list
19339182|NCT03824834|Morphine|morphine|mesh-list
19339183|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19339184|NCT03824834|Narcotics|narcotics|mesh-ancestor
19339185|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339186|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339187|NCT03824834|Analgesics|analgesics|mesh-ancestor
19339188|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
19339189|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339190|NCT03824691|Durvalumab|durvalumab|mesh-list
19682469|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198857|NCT00242996|Etoposide|etoposide|mesh-list
20198858|NCT00242996|Sargramostim|sargramostim|mesh-list
20198859|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20198860|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
20198861|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198862|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198863|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20198864|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
20198865|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682470|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682471|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19682472|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19682473|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384917|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384918|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
20384919|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384920|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20384921|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384922|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20384923|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
20198866|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198867|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20198868|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20198869|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20198870|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20198871|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20198872|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198873|NCT00243009|Cyclosporine|cyclosporine|mesh-list
20198874|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
20198875|NCT00243009|Fludarabine|fludarabine|mesh-list
20198876|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
20198877|NCT00243009|Cyclosporins|cyclosporins|mesh-list
20198878|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339191|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20384924|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20384925|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
20384926|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384927|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384928|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19339192|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339193|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20198879|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198880|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
19339194|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
20217618|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19339195|NCT03824379|Cathartics|cathartics|mesh-ancestor
19682474|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19682475|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19682476|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682477|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
19682478|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
19682479|NCT04601857|Futibatinib|futibatinib|mesh-list
19339196|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339197|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339198|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
19339199|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19339200|NCT03824535|Fluorides|fluorides|mesh-list
19339201|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20198881|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198882|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20198883|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
20198884|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198885|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198886|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
19682480|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682481|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682482|NCT04597437|Zanamivir|zanamivir|mesh-list
19682483|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
19682484|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682485|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682486|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682487|NCT04566991|Deferoxamine|deferoxamine|mesh-list
19682488|NCT04566991|Siderophores|siderophores|mesh-ancestor
19682489|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19339202|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339203|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
19339204|NCT03824535|Protective Agents|protective agents|mesh-ancestor
19339205|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339206|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
19339207|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
19339208|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339209|NCT03824327|Papaverine|papaverine|mesh-list
19339210|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19339211|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339212|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339213|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
19339214|NCT03824327|Urological Agents|urological agents|mesh-ancestor
19339215|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
19339216|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19339217|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19682490|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
20198887|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612918|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612919|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612920|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339218|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384929|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
19682491|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
19682492|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339219|NCT03824171|Vitamins|vitamins|mesh-ancestor
19339220|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
19339221|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19339222|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19339223|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339224|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339225|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19339226|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19339227|NCT03824314|Fentanyl|fentanyl|mesh-list
19682493|NCT04560595|Caffeine|caffeine|mesh-list
20384930|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384931|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384932|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20384933|NCT01048983|Minocycline|minocycline|mesh-list
20384934|NCT01048983|Curcumin|curcumin|mesh-list
20384935|NCT01048983|Modafinil|modafinil|mesh-list
20384936|NCT01048983|Bupropion|bupropion|mesh-list
20384937|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20384938|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
20198888|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20384939|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339228|NCT03824314|Midazolam|midazolam|mesh-list
19339229|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19339230|NCT03824314|Narcotics|narcotics|mesh-ancestor
19339231|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339232|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339233|NCT03824314|Analgesics|analgesics|mesh-ancestor
19339234|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
19339235|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842802|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842803|NCT00654784|Protective Agents|protective agents|mesh-ancestor
19682494|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20384940|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20384941|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20384942|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20384943|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384944|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
20384945|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842804|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842805|NCT00654836|Bevacizumab|bevacizumab|mesh-list
19842806|NCT00654836|Carboplatin|carboplatin|mesh-list
19842807|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19682495|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682496|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19682497|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682498|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682499|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19682500|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19682501|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
19682502|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682503|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
19682504|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
19682505|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682506|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682507|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19682508|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682509|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682510|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
19682511|NCT04545411|Volagidemab|volagidemab|mesh-list
19682512|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20384946|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384947|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20384948|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20612921|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20612922|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
20612923|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20612924|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612925|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19842808|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19842809|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842810|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19842811|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19339236|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19339237|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19339238|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
19339239|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
19339240|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19339241|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19339242|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19339243|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339244|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
19339245|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
19339246|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339247|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339248|NCT03824119|Ibuprofen|ibuprofen|mesh-list
19339249|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339250|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339251|NCT03824119|Analgesics|analgesics|mesh-ancestor
19339252|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
19339253|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339254|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339255|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339256|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384949|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384950|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20384951|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384952|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20384953|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20384954|NCT01048983|Analgesics|analgesics|mesh-ancestor
19339257|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339258|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339259|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339260|NCT03824340|Doxycycline|doxycycline|mesh-list
19339261|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19339262|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339263|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
20384955|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
20384956|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20384957|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20384958|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20384959|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384960|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19339264|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19339265|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19339266|NCT03824002|Insulin|insulin|mesh-list
19339267|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19339268|NCT03824002|Metformin|metformin|mesh-list
19339269|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
19339270|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
19339271|NCT03824002|Dulaglutide|dulaglutide|mesh-list
19339272|NCT03824002|Repaglinide|repaglinide|mesh-list
19339273|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
19339274|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19339275|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19339276|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384961|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20384962|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20384963|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20384964|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
20384965|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20384966|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20384967|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20384968|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19339277|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
19339278|NCT03823911|Grazoprevir|grazoprevir|mesh-list
19339279|NCT03823911|Ledipasvir|ledipasvir|mesh-list
19339280|NCT03823911|Velpatasvir|velpatasvir|mesh-list
19339281|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19339282|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19339283|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
19339284|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339285|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
19339286|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19339287|NCT03823846|Parecoxib|parecoxib|mesh-list
19339288|NCT03823846|Dezocine|dezocine|mesh-list
19339289|NCT03823846|Analgesics|analgesics|mesh-ancestor
19339290|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
19339291|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339292|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339293|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339294|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339295|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339296|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339297|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339298|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339299|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339300|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19339301|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19339302|NCT03823846|Narcotics|narcotics|mesh-ancestor
19339303|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339304|NCT03823703|Cortisone|cortisone|mesh-list
19339305|NCT03823703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19682513|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339306|NCT03823976|Anesthetics|anesthetics|mesh-list
19339307|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339308|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339309|NCT03823950|Sargramostim|sargramostim|mesh-list
19339310|NCT03823950|Lenograstim|lenograstim|mesh-list
19339311|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
19339312|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339313|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19682514|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682515|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842812|NCT00654836|Growth Substances|growth substances|mesh-ancestor
20612926|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20612927|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
20612928|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19339314|NCT03823612|Calcium|calcium|mesh-list
19339315|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19339316|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384969|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19399892|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399893|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399894|NCT03631641|Nivolumab|nivolumab|mesh-list
19399895|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399896|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399897|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19399898|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399899|NCT03631615|Antibodies|antibodies|mesh-list
19399900|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
19399901|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399902|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
19399903|NCT03631602|Clotrimazole|clotrimazole|mesh-list
19399904|NCT03631602|Miconazole|miconazole|mesh-list
19399905|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399906|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19399907|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19842813|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842814|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
20198889|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20198890|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20198891|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20198892|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20198893|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
19399908|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19399909|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19399910|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384970|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20384971|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384972|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384973|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19399911|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19399912|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
20198894|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20198895|NCT00243035|Bortezomib|bortezomib|mesh-list
20198896|NCT00243035|Tipifarnib|tipifarnib|mesh-list
20198897|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384974|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
20217619|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
19399913|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399914|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682516|NCT04530656|Vaccines|vaccines|mesh-list
19682517|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
19682518|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682519|NCT04529278|Liraglutide|liraglutide|mesh-list
19682520|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682521|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682522|NCT04529278|Incretins|incretins|mesh-ancestor
19682523|NCT04529278|Hormones|hormones|mesh-ancestor
19682524|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692639|NCT04989166|Curcumin|curcumin|mesh-list
19692640|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19692641|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20384975|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20384976|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384977|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20384978|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20384979|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20384980|NCT01049048|Vitamin D|vitamin d|mesh-list
20384981|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
20384982|NCT01049048|Vitamins|vitamins|mesh-ancestor
20384983|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
20426375|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19339317|NCT03823638|Mannitol|mannitol|mesh-list
19339318|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19339319|NCT03823638|Diuretics|diuretics|mesh-ancestor
19339320|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
19339321|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339322|NCT03823625|Nivolumab|nivolumab|mesh-list
19339323|NCT03823625|Ipilimumab|ipilimumab|mesh-list
20198898|NCT00243100|Gemcitabine|gemcitabine|mesh-list
20198899|NCT00243100|Vorinostat|vorinostat|mesh-list
20198900|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20198901|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
20198902|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198903|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198904|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
20198905|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20198906|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198907|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20198908|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
20198909|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198910|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20198911|NCT00243113|Docetaxel|docetaxel|mesh-list
20198912|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198913|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
19682525|NCT04518410|Gabexate|gabexate|mesh-list
19339324|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19339325|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339326|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20198914|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
20198915|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
19339327|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339328|NCT03823781|Milrinone|milrinone|mesh-list
19339329|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19339330|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19339331|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
19339332|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19339333|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19339334|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339335|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339336|NCT03823781|Protective Agents|protective agents|mesh-ancestor
19339337|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339338|NCT03823339|Liraglutide|liraglutide|mesh-list
19339339|NCT03823339|Xultophy|xultophy|mesh-list
19339340|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19339341|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339342|NCT03823339|Incretins|incretins|mesh-ancestor
19339343|NCT03823339|Hormones|hormones|mesh-ancestor
19339344|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682526|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
19682527|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20198916|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198917|NCT00243178|Clopidogrel|clopidogrel|mesh-list
20198918|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20198919|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20198920|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20198921|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20198922|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
20198923|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198924|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198925|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198926|NCT00243204|Docetaxel|docetaxel|mesh-list
20198927|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198928|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
20198929|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
20198930|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
20198931|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198932|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
20198933|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20198934|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198935|NCT00243256|Vitamins|vitamins|mesh-ancestor
20198936|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
20198937|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20198938|NCT00243399|Oxandrolone|oxandrolone|mesh-list
20198939|NCT00243399|Androgens|androgens|mesh-ancestor
19682528|NCT04518410|Antibodies|antibodies|mesh-list
19682529|NCT04518410|Camostat|camostat|mesh-list
20198940|NCT00243399|Hormones|hormones|mesh-ancestor
19339345|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
19339346|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19339347|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19339348|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339349|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
19339350|NCT03823417|Coagulants|coagulants|mesh-ancestor
19339351|NCT03823079|Irinotecan|irinotecan|mesh-list
19339352|NCT03823079|Raltitrexed|raltitrexed|mesh-list
19339353|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19339354|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19339355|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339356|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339357|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339358|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682530|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
19682531|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682532|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
20198941|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198942|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198943|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
20198944|NCT00243464|Betamethasone|betamethasone|mesh-list
20198945|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
20384984|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384985|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20384986|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20384987|NCT01049061|Farletuzumab|farletuzumab|mesh-list
20384988|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20384989|NCT01049178|Silymarin|silymarin|mesh-list
20384990|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
20384991|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384992|NCT01049178|Protective Agents|protective agents|mesh-ancestor
20384993|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20384994|NCT01049204|Maraviroc|maraviroc|mesh-list
20384995|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19339359|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
20198946|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20198947|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
20198948|NCT00243464|Calcipotriene|calcipotriene|mesh-list
20198949|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20198950|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20198951|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
20198952|NCT00243464|Hormones|hormones|mesh-ancestor
20198953|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198954|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198955|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19682533|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682534|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682535|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19682536|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19682537|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
19682538|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20384996|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19339360|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19339361|NCT03823274|Aspirin|aspirin|mesh-list
19339362|NCT03823274|Clopidogrel|clopidogrel|mesh-list
19339363|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339364|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339365|NCT03823274|Analgesics|analgesics|mesh-ancestor
19339366|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
19339367|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339368|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339369|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339370|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339371|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19339372|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19339373|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339374|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19339375|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339376|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339377|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
19339378|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20198956|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
20198957|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
19339379|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19682539|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682540|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
19682541|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682542|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
20384997|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20384998|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20384999|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20385000|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
20385001|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385002|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20385003|NCT01049347|Amitriptyline|amitriptyline|mesh-list
20385004|NCT01049347|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20385005|NCT01049347|Paroxetine|paroxetine|mesh-list
20385006|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20385007|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20385008|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20385009|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385010|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385011|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
20385012|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385013|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20385014|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
20385015|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20385016|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20385017|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20385018|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385019|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20198958|NCT00243477|Citalopram|citalopram|mesh-list
19682543|NCT04499196|Hormones|hormones|mesh-ancestor
19339380|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19339381|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
19339382|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339383|NCT03823482|Lidocaine|lidocaine|mesh-list
19339384|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
19339385|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
19339386|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339387|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682544|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682545|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682546|NCT04484337|Cabotegravir|cabotegravir|mesh-list
19682547|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19682548|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20198959|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20198960|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19339388|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
19339389|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682549|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20198961|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20198962|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198963|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20198964|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
20198965|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198966|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20198967|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
20198968|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20198969|NCT00243646|Bicalutamide|bicalutamide|mesh-list
20198970|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198971|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20198972|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
20198973|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
20198974|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20198975|NCT00243672|Atorvastatin|atorvastatin|mesh-list
20198976|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
20198977|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20198978|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20198979|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
20198980|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198981|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20198982|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20198983|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682550|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19682551|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682552|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682553|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19682554|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19339390|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19339391|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20198984|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20198985|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20198986|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20198987|NCT00243711|Glycerol|glycerol|mesh-list
20198988|NCT00243711|Laxatives|laxatives|mesh-ancestor
20198989|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198990|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20198991|NCT00243711|Protective Agents|protective agents|mesh-ancestor
20198992|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20198993|NCT00243724|Esomeprazole|esomeprazole|mesh-list
20198994|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20198995|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20198996|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20198997|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20198998|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20198999|NCT00243737|Artesunate|artesunate|mesh-list
20199000|NCT00243737|Mefloquine|mefloquine|mesh-list
20199001|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
20199002|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20199003|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20199004|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199005|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199006|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
20199007|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
20199008|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20199009|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
20199010|NCT00243750|Methotrexate|methotrexate|mesh-list
20199011|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20199012|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
20199013|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20199014|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199015|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682555|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
19682556|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682557|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199016|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
20199017|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199018|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199019|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20199020|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339392|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19339393|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19339394|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339395|NCT03823040|Oxiconazole|oxiconazole|mesh-list
19339396|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
19339397|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339398|NCT03823248|Folic Acid|folic acid|mesh-list
19339399|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
19339400|NCT03823248|Hematinics|hematinics|mesh-ancestor
19339401|NCT03823248|Vitamins|vitamins|mesh-ancestor
19339402|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
19339403|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339404|NCT03822975|Heparin|heparin|mesh-list
19339405|NCT03822975|Calcium heparin|calcium heparin|mesh-list
19339406|NCT03822975|Bivalirudin|bivalirudin|mesh-list
19339407|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
19339408|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19339409|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19339410|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339411|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
20199021|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20199022|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682558|NCT04484337|Analgesics|analgesics|mesh-ancestor
20199023|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
19339412|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19682559|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
20199024|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199025|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19339413|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
19339414|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339415|NCT03822936|Fluorouracil|fluorouracil|mesh-list
19682560|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682561|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682562|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682563|NCT04464174|Gemcitabine|gemcitabine|mesh-list
19682564|NCT04464174|Carboplatin|carboplatin|mesh-list
19682565|NCT04464174|Capecitabine|capecitabine|mesh-list
20385020|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385021|NCT01049347|Analgesics|analgesics|mesh-ancestor
20385022|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
20385023|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385024|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20385025|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
20385026|NCT01049347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20385027|NCT01049347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385028|NCT01049347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385029|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
20385030|NCT01049425|Docetaxel|docetaxel|mesh-list
20385031|NCT01049425|Epirubicin|epirubicin|mesh-list
20385032|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385033|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
20385034|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385035|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385036|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20385037|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
20385038|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385039|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385040|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20385041|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
20385042|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
20385043|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
20385044|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19682566|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682567|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682568|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
19682569|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682570|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
19682571|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682572|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339416|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
19339417|NCT03822936|Irinotecan|irinotecan|mesh-list
19339418|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
19682573|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682574|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
19682575|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682576|NCT04460352|Leucovorin|leucovorin|mesh-list
19682577|NCT04460352|Paclitaxel|paclitaxel|mesh-list
19682578|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19682579|NCT04460352|Carboplatin|carboplatin|mesh-list
20385045|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20385046|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20385047|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385048|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20385049|NCT01049438|Doxycycline|doxycycline|mesh-list
20385050|NCT01049438|Minocycline|minocycline|mesh-list
20385051|NCT01049438|Mupirocin|mupirocin|mesh-list
20385052|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20385053|NCT01049438|Trimethoprim|trimethoprim|mesh-list
19682580|NCT04460352|Fluorouracil|fluorouracil|mesh-list
19682581|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
19682582|NCT04460352|Calcium|calcium|mesh-list
19682583|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
19682584|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19682585|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682586|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
19682587|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
19682588|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
19682589|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682590|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20385054|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
20385055|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
19339419|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339420|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682591|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682592|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
19682593|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20385056|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385057|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
20385058|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20385059|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20385060|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20385061|NCT01049438|Renal Agents|renal agents|mesh-ancestor
20385062|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19339421|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339422|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19339423|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
19339424|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339425|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19339426|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19339427|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339428|NCT03822962|Acetaminophen|acetaminophen|mesh-list
19339429|NCT03822962|Ibuprofen|ibuprofen|mesh-list
19339430|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339431|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682594|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682595|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
19682596|NCT04460352|Antidotes|antidotes|mesh-ancestor
19682597|NCT04460352|Protective Agents|protective agents|mesh-ancestor
19682598|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
19682599|NCT04460352|Vitamins|vitamins|mesh-ancestor
20199026|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
20199027|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20199028|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199029|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199030|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20199031|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20199032|NCT00243789|Protective Agents|protective agents|mesh-ancestor
20199033|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199034|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
20199035|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20385063|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385064|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385065|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20385066|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20385067|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20385068|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20385069|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20385070|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
20385071|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20385072|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20385073|NCT01049451|Prednisolone|prednisolone|mesh-list
20385074|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
20385075|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20199036|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
20199037|NCT00243815|Ibuprofen|ibuprofen|mesh-list
20199038|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199039|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199040|NCT00243815|Analgesics|analgesics|mesh-ancestor
20199041|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
20199042|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339432|NCT03822962|Analgesics|analgesics|mesh-ancestor
19339433|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
19339434|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339435|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339436|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339437|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339438|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339439|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339440|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339441|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
19339442|NCT03822754|Vaccines|vaccines|mesh-list
19339443|NCT03822754|Immunologic Factors|immunologic factors|mesh-ancestor
19339444|NCT03822754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339445|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19339446|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19339447|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339448|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339449|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19339450|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339451|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199043|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682600|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
19682601|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19692642|NCT04989166|Analgesics|analgesics|mesh-ancestor
20385076|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
20385077|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20385078|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
20385079|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
20385080|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385081|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385082|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20385083|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
20385084|NCT01049451|Hormones|hormones|mesh-ancestor
20385085|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20385086|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20385087|NCT01049451|Protective Agents|protective agents|mesh-ancestor
19339452|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339453|NCT03822663|Caffeine|caffeine|mesh-list
19339454|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19339455|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339456|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19339457|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339458|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385088|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20385089|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385090|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
20385091|NCT01049464|Analgesics|analgesics|mesh-ancestor
20385092|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
20385093|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385094|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385095|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
20385096|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385097|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20385098|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
20385099|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20385100|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19339459|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19339460|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19339461|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
19339462|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339463|NCT03822767|Vaccines|vaccines|mesh-list
19339464|NCT03822767|Immunologic Factors|immunologic factors|mesh-ancestor
19339465|NCT03822767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339466|NCT03822559|Timolol|timolol|mesh-list
19339467|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19339468|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19339469|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19339470|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19339471|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
19339472|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339473|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339474|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385101|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385102|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20385103|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
20385104|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20385105|NCT01049542|Astressin|astressin|mesh-list
20385106|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20385107|NCT01049542|Protective Agents|protective agents|mesh-ancestor
20385108|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339475|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19842815|NCT00654901|Vaccines|vaccines|mesh-list
20199044|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199045|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199046|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20199047|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199048|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199049|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20199050|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199051|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199052|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199053|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199054|NCT00243880|Lovastatin|lovastatin|mesh-list
20199055|NCT00243880|L 647318|l 647318|mesh-list
20199056|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
20199057|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20385109|NCT01049620|Capecitabine|capecitabine|mesh-list
20385110|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
20385111|NCT01049620|Everolimus|everolimus|mesh-list
19339476|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20199058|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20199059|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
20199060|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199061|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20199062|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20199063|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385112|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20385113|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
20385114|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385115|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385116|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385117|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
20385118|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385119|NCT01049633|Aspirin|aspirin|mesh-list
20385120|NCT01049633|Sirolimus|sirolimus|mesh-list
20385121|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20385122|NCT01049633|Clotrimazole|clotrimazole|mesh-list
20385123|NCT01049633|Miconazole|miconazole|mesh-list
20385124|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
20385125|NCT01049633|Trimethoprim|trimethoprim|mesh-list
20385126|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
20385127|NCT01049633|Valganciclovir|valganciclovir|mesh-list
20385128|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
19339477|NCT03822845|Edetic Acid|edetic acid|mesh-list
19339478|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
20199064|NCT00243893|Doxycycline|doxycycline|mesh-list
20199065|NCT00243893|Minocycline|minocycline|mesh-list
20199066|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199067|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682602|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19339479|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
19339480|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682603|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842816|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
19339481|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
19339482|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19339483|NCT03822546|Nicotine|nicotine|mesh-list
19339484|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19339485|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
19339486|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339487|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339488|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19339489|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19339490|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
19339491|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339492|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339493|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
19339494|NCT03822520|Celecoxib|celecoxib|mesh-list
19339495|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19339496|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339497|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19339498|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19339499|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339500|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339501|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339502|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339503|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339504|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339505|NCT03822520|Analgesics|analgesics|mesh-ancestor
19339506|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
19339507|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339508|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339509|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339510|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19339511|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339512|NCT03822091|Terlipressin|terlipressin|mesh-list
19339513|NCT03822091|Norepinephrine|norepinephrine|mesh-list
19339514|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19339515|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19339516|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20385129|NCT01049633|Heparin|heparin|mesh-list
20385130|NCT01049633|Enoxaparin|enoxaparin|mesh-list
19339517|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20385131|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
20385132|NCT01049633|Tacrolimus|tacrolimus|mesh-list
20385133|NCT01049633|Basiliximab|basiliximab|mesh-list
19339518|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
19339519|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339520|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339521|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339522|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
19339523|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
19339524|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339525|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19339526|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19339527|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19339528|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19339529|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339530|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339531|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339532|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
19339533|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339534|NCT03822312|Tobramycin|tobramycin|mesh-list
19339535|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19339536|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339537|NCT03822169|Choline|choline|mesh-list
19339538|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
19339539|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19339540|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
19339541|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339542|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339543|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20385134|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20385135|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385136|NCT01049633|Analgesics|analgesics|mesh-ancestor
20385137|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
20385138|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385139|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385140|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20385141|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385142|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20385143|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20385144|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385145|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20385146|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20385147|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339544|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
20199068|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
20199069|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20199070|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20199071|NCT00243945|Rotigotine|rotigotine|mesh-list
19339545|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
19339546|NCT03821987|Busulfan|busulfan|mesh-list
19339547|NCT03821987|Fludarabine|fludarabine|mesh-list
19339548|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
19339549|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19339550|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
19339551|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339552|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682604|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19682605|NCT04451187|Zopiclone|zopiclone|mesh-list
19682606|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19682607|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682608|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682609|NCT04446117|Prednisone|prednisone|mesh-list
20199072|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
20199073|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
20199074|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199075|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199076|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385148|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
19339553|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19339554|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
19339555|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339556|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339557|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19339558|NCT03821792|Prednisone|prednisone|mesh-list
19339559|NCT03821792|Cortisone|cortisone|mesh-list
19682610|NCT04446117|Atezolizumab|atezolizumab|mesh-list
20199077|NCT00243984|Topiramate|topiramate|mesh-list
20199078|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
19339560|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
19339561|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339562|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
19339563|NCT03821792|Hormones|hormones|mesh-ancestor
19339564|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339565|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339566|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19339567|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842817|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842818|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
19842819|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19842820|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842821|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842822|NCT00654940|Pregabalin|pregabalin|mesh-list
19842823|NCT00654940|Analgesics|analgesics|mesh-ancestor
19842824|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
19842825|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842826|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842827|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
19842828|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19842829|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842830|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842831|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19842832|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19842833|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19842834|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842835|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19842836|NCT00654953|Gabapentin|gabapentin|mesh-list
19842837|NCT00654953|Sertraline|sertraline|mesh-list
19842838|NCT00654953|Analgesics|analgesics|mesh-ancestor
19842839|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
19842840|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842841|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339568|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19339569|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199079|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19842842|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
19842843|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19842844|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19842845|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199080|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199081|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
20199082|NCT00244023|Testosterone|testosterone|mesh-list
20199083|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
19682611|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
19682612|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19682613|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
19682614|NCT04446117|Hormones|hormones|mesh-ancestor
19682615|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842846|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339570|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339571|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339572|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19339573|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19339574|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19339575|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339576|NCT03821623|Niacinamide|niacinamide|mesh-list
19339577|NCT03821623|Niacin|niacin|mesh-list
19842847|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19842848|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19842849|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842850|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842851|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
19842852|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
19842853|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19842854|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19842855|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199084|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
19339578|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
19682616|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682617|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19682618|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199085|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19339579|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
19339580|NCT03821623|Vitamins|vitamins|mesh-ancestor
19339581|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
19339582|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199086|NCT00244023|Androgens|androgens|mesh-ancestor
20199087|NCT00244023|Hormones|hormones|mesh-ancestor
19339583|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19339584|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
19339585|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339586|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19339587|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
19339588|NCT03821714|Vitamins|vitamins|mesh-list
19339589|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
19339590|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19339591|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19339592|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19339593|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
19339594|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
19339595|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339596|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339597|NCT03821714|Hormones|hormones|mesh-ancestor
19339598|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339599|NCT03821480|Fluconazole|fluconazole|mesh-list
19339600|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
19339601|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339602|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19339603|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19339604|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339605|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339606|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19339607|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339608|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339609|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339610|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19339611|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19399915|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20385149|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385150|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
20385151|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20385152|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385153|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20385154|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385155|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
19399916|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19399917|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19399918|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
19399919|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399920|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
19399921|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399922|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399923|NCT03631316|Valganciclovir|valganciclovir|mesh-list
19399924|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
19399925|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399926|NCT03631277|Calcium|calcium|mesh-list
19399927|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19399928|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399929|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19399930|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19399931|NCT03631147|Rifaximin|rifaximin|mesh-list
19399932|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19399933|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199088|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199089|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199090|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20199091|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199092|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
20199093|NCT00244075|Hormones|hormones|mesh-list
20199094|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199095|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199096|NCT00244127|Prednisone|prednisone|mesh-list
20199097|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
20199098|NCT00244127|Rituximab|rituximab|mesh-list
20199099|NCT00244127|Vincristine|vincristine|mesh-list
20385156|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20385157|NCT01049633|Renal Agents|renal agents|mesh-ancestor
20385158|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
20385159|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20385160|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20385161|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20385162|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19339612|NCT03821415|Estradiol|estradiol|mesh-list
19339613|NCT03821415|Estrogens|estrogens|mesh-ancestor
19339614|NCT03821415|Hormones|hormones|mesh-ancestor
19339615|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339616|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339617|NCT03821454|Capecitabine|capecitabine|mesh-list
19339618|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19339619|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
19339620|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339621|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339622|NCT03821493|Itraconazole|itraconazole|mesh-list
19339623|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19339624|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
19339625|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339626|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19339627|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19339628|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339629|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339630|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19339631|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339632|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339633|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339634|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19339635|NCT03821168|Bevacizumab|bevacizumab|mesh-list
19339636|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
19339637|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682619|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20385163|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20385164|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20385165|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20385166|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20385167|NCT01049633|Protective Agents|protective agents|mesh-ancestor
20385168|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
20385169|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20385170|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
20385171|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20385172|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20385173|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20385174|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
20385175|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20385176|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19682620|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682621|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682622|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
19682623|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19339638|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339639|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19339640|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19339641|NCT03821168|Growth Substances|growth substances|mesh-ancestor
19339642|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339643|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
19339644|NCT03821168|Hematinics|hematinics|mesh-ancestor
19339645|NCT03820830|Palbociclib|palbociclib|mesh-list
19339646|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339647|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19682624|NCT04440735|Atezolizumab|atezolizumab|mesh-list
19682625|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682626|NCT04430452|Durvalumab|durvalumab|mesh-list
19682627|NCT04430452|Ipilimumab|ipilimumab|mesh-list
19682628|NCT04430452|Tremelimumab|tremelimumab|mesh-list
19682629|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
19682630|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19682631|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
19682632|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682633|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339648|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385177|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19339649|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339650|NCT03820622|Paclitaxel|paclitaxel|mesh-list
19339651|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19339652|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19339653|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339654|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
19339655|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
19339656|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
19339657|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339658|NCT03820531|Pancrelipase|pancrelipase|mesh-list
19339659|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339660|NCT03820518|Calcitriol|calcitriol|mesh-list
19339661|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19339662|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842856|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
19842857|NCT00655083|MEN 11420|men 11420|mesh-list
19339663|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19339664|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19339665|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339666|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19339667|NCT03820518|Vitamins|vitamins|mesh-ancestor
19339668|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
19339669|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19339670|NCT03820245|Lycopene|lycopene|mesh-list
19339671|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339672|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
19339673|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339674|NCT03820245|Protective Agents|protective agents|mesh-ancestor
19339675|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682634|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
19682635|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682636|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19682637|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682638|NCT04428008|Thymalfasin|thymalfasin|mesh-list
19682639|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19682640|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
19339676|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19339677|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19339678|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339679|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
19339680|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19339681|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19339682|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339683|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
19339684|NCT03820206|Coagulants|coagulants|mesh-ancestor
19339685|NCT03820193|Acetaminophen|acetaminophen|mesh-list
19682641|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682642|NCT04408560|Acetaminophen|acetaminophen|mesh-list
19682643|NCT04408560|Analgesics|analgesics|mesh-list
19682644|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682645|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
19682646|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682647|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682648|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
19842858|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20199100|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19339686|NCT03820193|Celecoxib|celecoxib|mesh-list
19339687|NCT03820193|Ketorolac|ketorolac|mesh-list
19339688|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19339689|NCT03820193|Diazepam|diazepam|mesh-list
19339690|NCT03820193|Gabapentin|gabapentin|mesh-list
19339691|NCT03820193|Hydrocodone|hydrocodone|mesh-list
19339692|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339693|NCT03820193|Analgesics|analgesics|mesh-ancestor
19339694|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
20199101|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
20199102|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199103|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199104|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20199105|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
20199106|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199107|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199108|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20385178|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
20385179|NCT01049646|Giapreza|giapreza|mesh-list
20199109|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20199110|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199111|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
20199112|NCT00244127|Hormones|hormones|mesh-ancestor
20199113|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682649|NCT04398914|Paclitaxel|paclitaxel|mesh-list
19682650|NCT04398914|Trastuzumab|trastuzumab|mesh-list
19682651|NCT04398914|Pertuzumab|pertuzumab|mesh-list
19682652|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19682653|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682654|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
19682655|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
19682656|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
19682657|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682658|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682659|NCT04398134|Entecavir|entecavir|mesh-list
19682660|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
19339695|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339696|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339697|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
19339698|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339699|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339700|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339701|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19339702|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339703|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339704|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339705|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
19339706|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19339707|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19339708|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339709|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339710|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19339711|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19339712|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682661|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682662|NCT04390399|Leucovorin|leucovorin|mesh-list
19682663|NCT04390399|Gemcitabine|gemcitabine|mesh-list
19682664|NCT04390399|Paclitaxel|paclitaxel|mesh-list
19682665|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
20199114|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20199115|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20199116|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
19339713|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
20385180|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
20385181|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20385182|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20385183|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
20385184|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385185|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426376|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339714|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19339715|NCT03820193|Narcotics|narcotics|mesh-ancestor
19339716|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
19339717|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19339718|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19339719|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
20199117|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
20199118|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
20199119|NCT00244153|Dexamethasone|dexamethasone|mesh-list
20199120|NCT00244153|Morphine|morphine|mesh-list
19339720|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
19339721|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339722|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19339723|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19339724|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19339725|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19339726|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
19842859|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
19842860|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199121|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426377|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339727|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
19682666|NCT04390399|Fluorouracil|fluorouracil|mesh-list
19682667|NCT04390399|Irinotecan|irinotecan|mesh-list
19682668|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19339728|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
19339729|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
19339730|NCT03820141|Trastuzumab|trastuzumab|mesh-list
19339731|NCT03820141|Durvalumab|durvalumab|mesh-list
19339732|NCT03820141|Pertuzumab|pertuzumab|mesh-list
19339733|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19339734|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339735|NCT03820180|Fluticasone|fluticasone|mesh-list
19339736|NCT03820180|Xhance|xhance|mesh-list
19339737|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19339738|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19339739|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339740|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20199122|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
20199123|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
20199124|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199125|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199126|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199127|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
20199128|NCT00244153|Hormones|hormones|mesh-ancestor
19339741|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
20199129|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199130|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20199131|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199132|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20199133|NCT00244153|Narcotics|narcotics|mesh-ancestor
20199134|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199135|NCT00244153|Analgesics|analgesics|mesh-ancestor
19682669|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682670|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
19682671|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
19682672|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
19682673|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682674|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682675|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
19682676|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682677|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682678|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19682679|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
19682680|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19682681|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682682|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
19682683|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
20199136|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
20199137|NCT00244166|Prednisolone|prednisolone|mesh-list
20199138|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199139|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
20199140|NCT00244166|Hormones|hormones|mesh-ancestor
19339742|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339743|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339744|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19339745|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
19339746|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
19339747|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20199141|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199142|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199143|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20199144|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199145|NCT00244179|Interferons|interferons|mesh-list
19339748|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19339749|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19339750|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19339751|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
19339752|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842861|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199146|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
19339753|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339754|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
19842862|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19842863|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
19842864|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
19842865|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19842866|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19842867|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
19842868|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199147|NCT00244179|Infliximab|infliximab|mesh-list
19339755|NCT03820180|Hormones|hormones|mesh-ancestor
19842869|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19842870|NCT00655486|Lacosamide|lacosamide|mesh-list
19842871|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
19842872|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19842873|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19339756|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339757|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
19339758|NCT03820037|Opicapone|opicapone|mesh-list
19339759|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19339760|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339761|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339762|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19339763|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19339764|NCT03819790|Insulin|insulin|mesh-list
19339765|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19339766|NCT03819790|Metformin|metformin|mesh-list
20199148|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199149|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
20199150|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199151|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
20199152|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339767|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
19339768|NCT03819790|Lixisenatide|lixisenatide|mesh-list
19339769|NCT03819790|Gliclazide|gliclazide|mesh-list
19339770|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19339771|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339772|NCT03819647|Stiripentol|stiripentol|mesh-list
19339773|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
19339774|NCT03819556|Caseins|caseins|mesh-list
19339775|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
19339776|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
19339777|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339778|NCT03819530|Micronutrients|micronutrients|mesh-list
19339779|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339780|NCT03819517|Resveratrol|resveratrol|mesh-list
19339781|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
19339782|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339783|NCT03819517|Protective Agents|protective agents|mesh-ancestor
19339784|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339785|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339786|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19399934|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399935|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19399936|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399937|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19399938|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399939|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
19399940|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19399941|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399942|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
19399943|NCT03630991|Edetic Acid|edetic acid|mesh-list
19399944|NCT03630991|Calcium|calcium|mesh-list
19399945|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
19399946|NCT03630991|Succimer|succimer|mesh-list
19682684|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682685|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682686|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19682687|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19682688|NCT04390399|Antidotes|antidotes|mesh-ancestor
19682689|NCT04390399|Protective Agents|protective agents|mesh-ancestor
19682690|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
19842874|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19842875|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842876|NCT00655499|Irinotecan|irinotecan|mesh-list
19842877|NCT00655499|Panitumumab|panitumumab|mesh-list
19842878|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19842879|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19842880|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842881|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842882|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842883|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19399947|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682691|NCT04390399|Vitamins|vitamins|mesh-ancestor
20199153|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199154|NCT00244192|Infliximab|infliximab|mesh-list
20199155|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
20385186|NCT01049672|Alfentanil|alfentanil|mesh-list
20385187|NCT01049672|Heroin|heroin|mesh-list
20385188|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20385189|NCT01049672|Narcotics|narcotics|mesh-ancestor
20385190|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385191|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385192|NCT01049672|Analgesics|analgesics|mesh-ancestor
20385193|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
20385194|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385195|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20385196|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
20385197|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
20385198|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20385199|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
20385200|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385201|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
20385202|NCT01049711|Hematinics|hematinics|mesh-ancestor
20385203|NCT01049763|Oseltamivir|oseltamivir|mesh-list
20385204|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
20385205|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385206|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385207|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385208|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
20385209|NCT01049815|Calcium|calcium|mesh-list
20385210|NCT01049815|Sevelamer|sevelamer|mesh-list
19682692|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
19682693|NCT04382664|Nivolumab|nivolumab|mesh-list
19682694|NCT04382664|Ipilimumab|ipilimumab|mesh-list
19682695|NCT04382664|Sargramostim|sargramostim|mesh-list
19682696|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682697|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682698|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19682699|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385211|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20385212|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385213|NCT01049815|Antacids|antacids|mesh-ancestor
20385214|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385215|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20385216|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
20385217|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
20385218|NCT01049841|Sirolimus|sirolimus|mesh-list
19682700|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
19682701|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682702|NCT04374578|Dulaglutide|dulaglutide|mesh-list
19682703|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682704|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339787|NCT03819296|Prednisone|prednisone|mesh-list
19339788|NCT03819296|Cortisone|cortisone|mesh-list
20385219|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20385220|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385221|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20385222|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385223|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
20385224|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385225|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
20385226|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385227|NCT01049854|Vidarabine|vidarabine|mesh-list
20385228|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
20385229|NCT01049854|Thiotepa|thiotepa|mesh-list
20385230|NCT01049854|Busulfan|busulfan|mesh-list
19339789|NCT03819296|Infliximab|infliximab|mesh-list
19339790|NCT03819296|Vedolizumab|vedolizumab|mesh-list
19339791|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
19339792|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
19339793|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339794|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
19339795|NCT03819296|Hormones|hormones|mesh-ancestor
19339796|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339797|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339798|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19339799|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339800|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
19339801|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
19682705|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
20385231|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
20385232|NCT01049854|Fludarabine|fludarabine|mesh-list
20385233|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19682706|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20385234|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385235|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
19339802|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339803|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19842884|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
19842885|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19842886|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19842887|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
19842888|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842889|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19842890|NCT00655551|Lacosamide|lacosamide|mesh-list
20199156|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199157|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199158|NCT00244283|Sevoflurane|sevoflurane|mesh-list
20199159|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20199160|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19339804|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
19339805|NCT03819348|Clotrimazole|clotrimazole|mesh-list
19339806|NCT03819348|Miconazole|miconazole|mesh-list
19339807|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339808|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19339809|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19339810|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19339811|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339812|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339813|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19339814|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339815|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339816|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339817|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19339818|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19339819|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
19339820|NCT03820986|Lenvatinib|lenvatinib|mesh-list
19339821|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19339822|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339823|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199161|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
20199162|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
19682707|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682708|NCT04351555|Carboplatin|carboplatin|mesh-list
19682709|NCT04351555|Pemetrexed|pemetrexed|mesh-list
19682710|NCT04351555|Osimertinib|osimertinib|mesh-list
19682711|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682712|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682713|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682714|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19682715|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19682716|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199163|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199164|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199165|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20199166|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20199167|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19682717|NCT04348032|Apatinib|apatinib|mesh-list
19339824|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682718|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682719|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19682720|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682721|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682722|NCT04332744|Talazoparib|talazoparib|mesh-list
19682723|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19682724|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682725|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682726|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692643|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
19692644|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692645|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692646|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842891|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
20199168|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199169|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199170|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199171|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199172|NCT00244296|Analgesics|analgesics|mesh-ancestor
20612929|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
19339825|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339826|NCT03819231|Oxytocin|oxytocin|mesh-list
19339827|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
19339828|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19339829|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339830|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
19339831|NCT03819322|Velpatasvir|velpatasvir|mesh-list
20199173|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
20199174|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199175|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
20199176|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199177|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
20199178|NCT00244309|Tamsulosin|tamsulosin|mesh-list
19339832|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
19339833|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339834|NCT03820908|Bisantrene|bisantrene|mesh-list
19339835|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19339836|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339837|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19339838|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19339839|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339840|NCT03819101|Aspirin|aspirin|mesh-list
20199179|NCT00244309|Dutasteride|dutasteride|mesh-list
20199180|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20199181|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20199182|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20199183|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
20199184|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199185|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199186|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199187|NCT00244309|Urological Agents|urological agents|mesh-ancestor
20199188|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20199189|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20199190|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339841|NCT03819101|Atorvastatin|atorvastatin|mesh-list
19339842|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19339843|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19339844|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
20385236|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339845|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339846|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19339847|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19339848|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339849|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339850|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385237|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385238|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20385239|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
20385240|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385241|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385242|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20385243|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20385244|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
20385245|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
20385246|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385247|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
20385248|NCT01049880|Gemcitabine|gemcitabine|mesh-list
20385249|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20385250|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
20385251|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385252|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385253|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
19339851|NCT03819101|Analgesics|analgesics|mesh-ancestor
19339852|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
19339853|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682727|NCT04301310|Rifampin|rifampin|mesh-list
19682728|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19682729|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
19682730|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19682731|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682732|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
19682733|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19682734|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682735|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199191|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
20199192|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199193|NCT00244348|Fluorouracil|fluorouracil|mesh-list
20199194|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
20199195|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
20199196|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199197|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20199198|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199199|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199200|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
20199201|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385254|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385255|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385256|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385257|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
20385258|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385259|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
20385260|NCT01049880|Protective Agents|protective agents|mesh-ancestor
20385261|NCT01049880|Vitamins|vitamins|mesh-ancestor
20199202|NCT00244361|Rituximab|rituximab|mesh-list
20199203|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20385262|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
20385263|NCT01049932|Rilpivirine|rilpivirine|mesh-list
20385264|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19339854|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339855|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339856|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339857|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19339858|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19339859|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19339860|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339861|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
19339862|NCT03819127|Metformin|metformin|mesh-list
19339863|NCT03819127|Vildagliptin|vildagliptin|mesh-list
19339864|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19339865|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339866|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19339867|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
19339868|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385265|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20385266|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385267|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385268|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
19339869|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339870|NCT03819010|Letrozole|letrozole|mesh-list
19339871|NCT03819010|Palbociclib|palbociclib|mesh-list
19339872|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339873|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19339874|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19339875|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339876|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339877|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19339878|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
19339879|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19339880|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339881|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19339882|NCT03818997|Paclitaxel|paclitaxel|mesh-list
19339883|NCT03818997|Atezolizumab|atezolizumab|mesh-list
19339884|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19339885|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339886|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
19339887|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
19339888|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
19339889|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339890|NCT03818945|Listerine|listerine|mesh-list
19339891|NCT03818945|Fluorides|fluorides|mesh-list
19339892|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
19339893|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
20385269|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385270|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19339894|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
20385271|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20385272|NCT01050036|Busulfan|busulfan|mesh-list
20385273|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
19339895|NCT03818945|Protective Agents|protective agents|mesh-ancestor
19339896|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385274|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385275|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19339897|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19339898|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19339899|NCT03818932|Acetaminophen|acetaminophen|mesh-list
19339900|NCT03818932|Celecoxib|celecoxib|mesh-list
19339901|NCT03818932|Ketorolac|ketorolac|mesh-list
19339902|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19339903|NCT03818932|Diazepam|diazepam|mesh-list
19339904|NCT03818932|Gabapentin|gabapentin|mesh-list
20199204|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199205|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
20199206|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199207|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199208|NCT00244426|Aspirin|aspirin|mesh-list
20199209|NCT00244426|Indobufen|indobufen|mesh-list
20199210|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199211|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199212|NCT00244426|Analgesics|analgesics|mesh-ancestor
20199213|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
20199214|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199215|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199216|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199217|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199218|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20199219|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20199220|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385276|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
20385277|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385278|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20385279|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385280|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20385281|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20385282|NCT01050114|Oxybutynin|oxybutynin|mesh-list
20385283|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20385284|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20385285|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385286|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385287|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19339905|NCT03818932|Hydrocodone|hydrocodone|mesh-list
19339906|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19339907|NCT03818932|Analgesics|analgesics|mesh-ancestor
19339908|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
19339909|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339910|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339911|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
19339912|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339913|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19339914|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339915|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19339916|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339917|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339918|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339919|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
20199221|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20199222|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20199223|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199224|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
20199225|NCT00244439|Permethrin|permethrin|mesh-list
20199226|NCT00244439|Malathion|malathion|mesh-list
20199227|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199228|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199229|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20199230|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
20199231|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199232|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199233|NCT00244452|Cetrorelix|cetrorelix|mesh-list
20199234|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20199235|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
20199236|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20199237|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199238|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
20385288|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19339920|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19339921|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199239|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199240|NCT00244504|Moxonidine|moxonidine|mesh-list
20199241|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20199242|NCT00244517|Remifentanil|remifentanil|mesh-list
20199243|NCT00244517|Sevoflurane|sevoflurane|mesh-list
20199244|NCT00244517|Desflurane|desflurane|mesh-list
20199245|NCT00244517|Isoflurane|isoflurane|mesh-list
20199246|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
20199247|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199248|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199249|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20199250|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20199251|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
20199252|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20199253|NCT00244517|Narcotics|narcotics|mesh-ancestor
20199254|NCT00244517|Analgesics|analgesics|mesh-ancestor
20199255|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
20199256|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199257|NCT00244530|Nifedipine|nifedipine|mesh-list
20199258|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20199259|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199260|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199261|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20199262|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339922|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682736|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19682737|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19682738|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20199263|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
20199264|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
20199265|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19842892|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20199266|NCT00244556|Etanercept|etanercept|mesh-list
20199267|NCT00244556|Methotrexate|methotrexate|mesh-list
20199268|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20199269|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
20385289|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385290|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
20385291|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385292|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
20385293|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
20385294|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20385295|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20199270|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20199271|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199272|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20199273|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
20199274|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199275|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682739|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19682740|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19682741|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19682742|NCT04288687|Niraparib|niraparib|mesh-list
19682743|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19682744|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842893|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19842894|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199276|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
20199277|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199278|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20385296|NCT01050114|Urological Agents|urological agents|mesh-ancestor
20385297|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
20385298|NCT01050270|Ondansetron|ondansetron|mesh-list
19842895|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842896|NCT00655564|Alefacept|alefacept|mesh-list
19842897|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842898|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
19842899|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842900|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19842901|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
19842902|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19842903|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19842904|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385299|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20385300|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
20385301|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
19339923|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339924|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19339925|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19339926|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339927|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
19339928|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19339929|NCT03818932|Narcotics|narcotics|mesh-ancestor
19339930|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
19339931|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
19339932|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20385302|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385303|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385304|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20385305|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
20385306|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
20385307|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20385308|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
20385309|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385310|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385311|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20385312|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385313|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385314|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20385315|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20385316|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
20385317|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385318|NCT01050270|Expectorants|expectorants|mesh-ancestor
20385319|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
20385320|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20199279|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199280|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
20199281|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199282|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20199283|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199284|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199285|NCT00244556|Analgesics|analgesics|mesh-ancestor
20199286|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
20199287|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385321|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
20385322|NCT01050270|Protective Agents|protective agents|mesh-ancestor
20385323|NCT01050270|Antidotes|antidotes|mesh-ancestor
20385324|NCT01050322|Gemcitabine|gemcitabine|mesh-list
20385325|NCT01050322|Capecitabine|capecitabine|mesh-list
20385326|NCT01050322|Vinorelbine|vinorelbine|mesh-list
20385327|NCT01050322|Lapatinib|lapatinib|mesh-list
20385328|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20385329|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
19339933|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
19842905|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199288|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199289|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19682745|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682746|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682747|NCT04285229|Ixekizumab|ixekizumab|mesh-list
19682748|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
19682749|NCT04282629|Milrinone|milrinone|mesh-list
19682750|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19682751|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19682752|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
19682753|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19682754|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19682755|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682756|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682757|NCT04282629|Protective Agents|protective agents|mesh-ancestor
19842906|NCT00655629|Urological Agents|urological agents|mesh-ancestor
19842907|NCT00655642|Promethazine|promethazine|mesh-list
20385330|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385331|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339934|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
20385332|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
20385333|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682758|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199290|NCT00244608|Budesonide|budesonide|mesh-list
19339935|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339936|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19339937|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19339938|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19339939|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19339940|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
19339941|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
19339942|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
19339943|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
20385334|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385335|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385336|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
20385337|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385338|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20385339|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
20385340|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
20385341|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
20385342|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20385343|NCT01050348|Atorvastatin|atorvastatin|mesh-list
20385344|NCT01050348|Calcium|calcium|mesh-list
20385345|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20385346|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385347|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19339944|NCT03818919|Acetaminophen|acetaminophen|mesh-list
19339945|NCT03818919|Celecoxib|celecoxib|mesh-list
19682759|NCT04280939|Anesthetics|anesthetics|mesh-list
19339946|NCT03818919|Ketorolac|ketorolac|mesh-list
19339947|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19339948|NCT03818919|Diazepam|diazepam|mesh-list
19682760|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682761|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682762|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
19682763|NCT04277975|Narcotics|narcotics|mesh-ancestor
19682764|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682765|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682766|NCT04277975|Analgesics|analgesics|mesh-ancestor
19682767|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
19682768|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682769|NCT04273165|Etravirine|etravirine|mesh-list
19682770|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19682771|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19682772|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682773|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199291|NCT00244608|Terbutaline|terbutaline|mesh-list
20199292|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
20199293|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199294|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20199295|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
20199296|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199297|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339949|NCT03818919|Gabapentin|gabapentin|mesh-list
19339950|NCT03818919|Hydrocodone|hydrocodone|mesh-list
19339951|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19682774|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
19682775|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682776|NCT04272801|Tamoxifen|tamoxifen|mesh-list
20199298|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20199299|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
20199300|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
20199301|NCT00244608|Hormones|hormones|mesh-ancestor
20199302|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199303|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20199304|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20199305|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20199306|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
20199307|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199308|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199309|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
20199310|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
20199311|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20217620|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217621|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217622|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20385348|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19339952|NCT03818919|Analgesics|analgesics|mesh-ancestor
19339953|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
19682777|NCT04272801|Letrozole|letrozole|mesh-list
19682778|NCT04272801|Anastrozole|anastrozole|mesh-list
20199312|NCT00244738|Castor Oil|castor oil|mesh-list
20199313|NCT00244738|Cathartics|cathartics|mesh-ancestor
20199314|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199315|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
20199316|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199317|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199318|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199319|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682779|NCT04272801|Exemestane|exemestane|mesh-list
19682780|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682781|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19682782|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19682783|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682784|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682785|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20199320|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
20199321|NCT00244907|Genistein|genistein|mesh-list
20199322|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20199323|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199324|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199325|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20199326|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199327|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20199328|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20199329|NCT00244907|Protective Agents|protective agents|mesh-ancestor
20199330|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199331|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199332|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199333|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
20199334|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20199335|NCT00244907|Estrogens|estrogens|mesh-ancestor
20199336|NCT00244907|Hormones|hormones|mesh-ancestor
20199337|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199338|NCT00244920|Squalamine|squalamine|mesh-list
20199339|NCT00244920|Leuprolide|leuprolide|mesh-list
20199340|NCT00244920|Bicalutamide|bicalutamide|mesh-list
20199341|NCT00244920|Hormones|hormones|mesh-list
20199342|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
20199343|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199344|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199345|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20199346|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
20199347|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20199348|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20199349|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199350|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
20199351|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199352|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199353|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20199354|NCT00244920|Protective Agents|protective agents|mesh-ancestor
20199355|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20199356|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20199357|NCT00244920|Growth Substances|growth substances|mesh-ancestor
20199358|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
20199359|NCT00244946|Cytarabine|cytarabine|mesh-list
20199360|NCT00244946|Etoposide|etoposide|mesh-list
20199361|NCT00244946|Melphalan|melphalan|mesh-list
20199362|NCT00244946|Carmustine|carmustine|mesh-list
20199363|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20199364|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199365|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20199366|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20199367|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199368|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199369|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20199370|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
20199371|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
19682786|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
19682787|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682788|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682789|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19682790|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20199372|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217623|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
19682791|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19339954|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19339955|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19339956|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
19682792|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19682793|NCT04259645|Bupivacaine|bupivacaine|mesh-list
19339957|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19339958|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19682794|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
19682795|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
19682796|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19682797|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682798|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
19682799|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682800|NCT04258150|Nivolumab|nivolumab|mesh-list
19682801|NCT04258150|Ipilimumab|ipilimumab|mesh-list
20199373|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199374|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
20199375|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199376|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20199377|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
20199378|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20199379|NCT00244959|Anastrozole|anastrozole|mesh-list
20199380|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20199381|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199382|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20199383|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20199384|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199385|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199386|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19339959|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19339960|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19339961|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19339962|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19339963|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19339964|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
19339965|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19339966|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19339967|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19339968|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19339969|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19339970|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19339971|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19339972|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
19339973|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19339974|NCT03818919|Narcotics|narcotics|mesh-ancestor
19339975|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
19339976|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
19339977|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19339978|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
19339979|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
19339980|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19339981|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19339982|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19339983|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19339984|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19339985|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
19339986|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
19339987|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
19339988|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
19339989|NCT03818685|Capecitabine|capecitabine|mesh-list
20199387|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
20199388|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199389|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199390|NCT00244972|Sorafenib|sorafenib|mesh-list
20199391|NCT00244972|Tipifarnib|tipifarnib|mesh-list
20199392|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199393|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199394|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199395|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199396|NCT00244998|Fulvestrant|fulvestrant|mesh-list
20199397|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20199398|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199399|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19339990|NCT03818685|Nivolumab|nivolumab|mesh-list
19339991|NCT03818685|Ipilimumab|ipilimumab|mesh-list
20385349|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
20385350|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385351|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20385352|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20385353|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385354|NCT01050374|Albendazole|albendazole|mesh-list
19339992|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19339993|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
19339994|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385355|NCT01050374|Praziquantel|praziquantel|mesh-list
20385356|NCT01050374|Mebendazole|mebendazole|mesh-list
20385357|NCT01050374|Piperazine|piperazine|mesh-list
20385358|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
20385359|NCT01050374|DMP 777|dmp 777|mesh-list
20199400|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19339995|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19339996|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19339997|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19339998|NCT03818581|Suvorexant|suvorexant|mesh-list
19339999|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19340000|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340001|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340002|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340003|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19340004|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340005|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340006|NCT03818672|Rifaximin|rifaximin|mesh-list
19340007|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19340008|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340009|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340010|NCT03818282|Paclitaxel|paclitaxel|mesh-list
19340011|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19340012|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340013|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
19340014|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
19340015|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
19340016|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385360|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
20385361|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20385362|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199401|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
20199402|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199403|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199404|NCT00245024|Sulindac|sulindac|mesh-list
19340017|NCT03818191|Acamprosate|acamprosate|mesh-list
19340018|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19340019|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
19340020|NCT03818308|Velpatasvir|velpatasvir|mesh-list
20199405|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199406|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199407|NCT00245024|Analgesics|analgesics|mesh-ancestor
20385363|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
20199408|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
20199409|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199410|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199411|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199412|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199413|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199414|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20199415|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199416|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199417|NCT00245089|Dactinomycin|dactinomycin|mesh-list
20199418|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
20199419|NCT00245089|Vincristine|vincristine|mesh-list
20199420|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199421|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
20199422|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199423|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199424|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20199425|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
20385364|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20385365|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20385366|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
20385367|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
19340021|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
19340022|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340023|NCT03817970|Ondansetron|ondansetron|mesh-list
19340024|NCT03817970|Palonosetron|palonosetron|mesh-list
19340025|NCT03817970|Granisetron|granisetron|mesh-list
19340026|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
19340027|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
19340028|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340029|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340030|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340031|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
19340032|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
19340033|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19340034|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
19340035|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340036|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842908|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
19842909|NCT00655642|Ondansetron|ondansetron|mesh-list
20385368|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
20385369|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385370|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385371|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
20385372|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340037|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19340038|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340039|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340040|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19340041|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19340042|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19340043|NCT03818295|Praliciguat|praliciguat|mesh-list
19340044|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19340045|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
19340046|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340047|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340048|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
19340049|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19340050|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
19340051|NCT03817931|Mirabegron|mirabegron|mesh-list
19340052|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19340053|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
20385373|NCT01050387|Vitamin D|vitamin d|mesh-list
20385374|NCT01050387|Vitamins|vitamins|mesh-ancestor
20385375|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
20385376|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385377|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20385378|NCT01050426|Leucovorin|leucovorin|mesh-list
20385379|NCT01050426|Cetuximab|cetuximab|mesh-list
19340054|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
19340055|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
19340056|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19340057|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
19340058|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340059|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340060|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340061|NCT03817931|Urological Agents|urological agents|mesh-ancestor
19340062|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19340063|NCT03818048|Propofol|propofol|mesh-list
19340064|NCT03818048|Sevoflurane|sevoflurane|mesh-list
20385380|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
20385381|NCT01050426|Antidotes|antidotes|mesh-ancestor
20385382|NCT01050426|Protective Agents|protective agents|mesh-ancestor
20385383|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385384|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
20385385|NCT01050426|Vitamins|vitamins|mesh-ancestor
20385386|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
20385387|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20385388|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385389|NCT01050452|Ivermectin|ivermectin|mesh-list
19340065|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340066|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340067|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340068|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340069|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
19340070|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
19340071|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20385390|NCT01050452|Albendazole|albendazole|mesh-list
19340072|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19842910|NCT00655642|Metoclopramide|metoclopramide|mesh-list
20385391|NCT01050452|Mebendazole|mebendazole|mesh-list
20385392|NCT01050452|Piperazine|piperazine|mesh-list
20385393|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
20385394|NCT01050452|DMP 777|dmp 777|mesh-list
20385395|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20385396|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385397|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
20385398|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
20385399|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20385400|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20385401|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
20385402|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
20385403|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
20385404|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385405|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385406|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
20385407|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385408|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20385409|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20385410|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385411|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385412|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385413|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20385414|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20385415|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20385416|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
20385417|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385418|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385419|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20385420|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20385421|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
20385422|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
20385423|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20385424|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385425|NCT01050517|Ivermectin|ivermectin|mesh-list
20385426|NCT01050517|Albendazole|albendazole|mesh-list
20385427|NCT01050517|Praziquantel|praziquantel|mesh-list
20385428|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20385429|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385430|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
20385431|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
20385432|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20385433|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19340073|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
19340074|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
19340075|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19340076|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
19340077|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340078|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19340079|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20385434|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
20199426|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199427|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199428|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20199429|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20199430|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
20199431|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
20199432|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
20199433|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199434|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199435|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20199436|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20199437|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199438|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20199439|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
20199440|NCT00245115|Busulfan|busulfan|mesh-list
20199441|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199442|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
20199443|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199444|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199445|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20199446|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
20199447|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385435|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
20385436|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
20385437|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385438|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385439|NCT01050556|Folic Acid|folic acid|mesh-list
20385440|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
20199448|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199449|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20199450|NCT00245141|Dactinomycin|dactinomycin|mesh-list
20199451|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
20199452|NCT00245141|Vincristine|vincristine|mesh-list
20199453|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199454|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
20199455|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199456|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199457|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19340080|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
19340081|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340082|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340083|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19340084|NCT03818321|Methenamine|methenamine|mesh-list
19340085|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
19340086|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
19340087|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20199458|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
20199459|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199460|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385441|NCT01050556|Hematinics|hematinics|mesh-ancestor
20385442|NCT01050556|Vitamins|vitamins|mesh-ancestor
20385443|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
20385444|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385445|NCT01050595|Naltrexone|naltrexone|mesh-list
20385446|NCT01050595|Bromides|bromides|mesh-list
19340088|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340089|NCT03818321|Renal Agents|renal agents|mesh-ancestor
19340090|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19340091|NCT03817541|Propofol|propofol|mesh-list
19340092|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340093|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340094|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340095|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340096|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
19340097|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
19340098|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19340099|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
19340100|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340101|NCT03817567|Cetuximab|cetuximab|mesh-list
19340102|NCT03817567|Antibodies|antibodies|mesh-list
19340103|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19340104|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
19340105|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340106|NCT03817567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19340107|NCT03817567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340108|NCT03817411|Capecitabine|capecitabine|mesh-list
19340109|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
19340110|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340111|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
19340112|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340113|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340114|NCT03817476|BI 425809|bi 425809|mesh-list
19340115|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
19399948|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19399949|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20199461|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20199462|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20199463|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
20199464|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
20199465|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
20199466|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199467|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199468|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20199469|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20199470|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199471|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20199472|NCT00245154|Paclitaxel|paclitaxel|mesh-list
20385447|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
20385448|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
19399950|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
19399951|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20385449|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20385450|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385451|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
20385452|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385453|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20385454|NCT01050608|Ethanol|ethanol|mesh-list
20385455|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20385456|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385457|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385458|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385459|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
20385460|NCT01050621|Vitamins|vitamins|mesh-ancestor
20385461|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
20385462|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385463|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
20199473|NCT00245154|Carboplatin|carboplatin|mesh-list
20385464|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385465|NCT01050621|Protective Agents|protective agents|mesh-ancestor
20385466|NCT01050699|Fentanyl|fentanyl|mesh-list
20385467|NCT01050699|Midazolam|midazolam|mesh-list
20199474|NCT00245154|Cediranib|cediranib|mesh-list
20199475|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20385468|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
20385469|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340116|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19340117|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385470|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385471|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385472|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19340118|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340119|NCT03817359|Remifentanil|remifentanil|mesh-list
19340120|NCT03817359|Propofol|propofol|mesh-list
19340121|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340122|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340123|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340124|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340125|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
20199476|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385473|NCT01050699|Analgesics|analgesics|mesh-ancestor
20385474|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
20385475|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385476|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20385477|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20385478|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20385479|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
20385480|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385481|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340126|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
19340127|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19340128|NCT03817359|Narcotics|narcotics|mesh-ancestor
19340129|NCT03817359|Analgesics|analgesics|mesh-ancestor
20385482|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20199477|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
20199478|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
20199479|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
20199480|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199481|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199482|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199483|NCT00245206|Olanzapine|olanzapine|mesh-list
20199484|NCT00245206|Risperidone|risperidone|mesh-list
20199485|NCT00245206|Aripiprazole|aripiprazole|mesh-list
20199486|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20199487|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
20199488|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199489|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199490|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199491|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20199492|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199493|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199494|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199495|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20199496|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
20385483|NCT01050699|Narcotics|narcotics|mesh-ancestor
20385484|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20385485|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340130|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
20199497|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
20385486|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
20385487|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
20385488|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20385489|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385490|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199498|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
20199499|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199500|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199501|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20199502|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20199503|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199504|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
19682802|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682803|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682804|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20199505|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
20199506|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20199507|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20199508|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19340131|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340132|NCT03816982|Bupivacaine|bupivacaine|mesh-list
19340133|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19340134|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
20385491|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
20385492|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
20385493|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
20199509|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20199510|NCT00245245|Factor VIII|factor viii|mesh-list
20199511|NCT00245245|Coagulants|coagulants|mesh-ancestor
20199512|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
20199513|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199514|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
20199515|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20385494|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
20385495|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385496|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
20385497|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385498|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340135|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340136|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340137|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
19340138|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340139|NCT03817320|Dexamethasone|dexamethasone|mesh-list
19340140|NCT03817320|Doxorubicin|doxorubicin|mesh-list
19340141|NCT03817320|Vincristine|vincristine|mesh-list
20385499|NCT01050777|Paromomycin|paromomycin|mesh-list
20385500|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20385501|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20385502|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385503|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20385504|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20385505|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20385506|NCT01050842|Bicalutamide|bicalutamide|mesh-list
20385507|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
20385508|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
20385509|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20385510|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385511|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385512|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20385513|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20385514|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20385515|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20385516|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
20385517|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
20385518|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385519|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
20385520|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385521|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385522|NCT01050985|Sirolimus|sirolimus|mesh-list
20385523|NCT01050985|Capecitabine|capecitabine|mesh-list
20199516|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19340142|NCT03817320|Asparaginase|asparaginase|mesh-list
19340143|NCT03817320|Ixazomib|ixazomib|mesh-list
19682805|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385524|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340144|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19340145|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
19340146|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
19340147|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199517|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199518|NCT00245258|Urological Agents|urological agents|mesh-ancestor
20199519|NCT00245297|Factor VIII|factor viii|mesh-list
20199520|NCT00245297|Coagulants|coagulants|mesh-ancestor
20199521|NCT00245336|Thrombin|thrombin|mesh-list
19340148|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340149|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340150|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
19340151|NCT03817320|Hormones|hormones|mesh-ancestor
19340152|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19340153|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19340154|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340155|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19340156|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19340157|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19340158|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340159|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340160|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19340161|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
19340162|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
19340163|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
19340164|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
19340165|NCT03817268|Capecitabine|capecitabine|mesh-list
20199522|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
20199523|NCT00245336|Coagulants|coagulants|mesh-ancestor
20199524|NCT00245375|Acetaminophen|acetaminophen|mesh-list
20199525|NCT00245375|Ibuprofen|ibuprofen|mesh-list
20199526|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199527|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199528|NCT00245375|Analgesics|analgesics|mesh-ancestor
20199529|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
20199530|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199531|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199532|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842911|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
19842912|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
19842913|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19842914|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199533|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199534|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20199535|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199536|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340166|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19842915|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19842916|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
19842917|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842918|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19842919|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
20199537|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
20199538|NCT00245401|Sirolimus|sirolimus|mesh-list
20199539|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199540|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199541|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20199542|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385525|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
20426378|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340167|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
19842920|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842921|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340168|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199543|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
19340169|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340170|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
19340171|NCT03817112|Propofol|propofol|mesh-list
19340172|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19399952|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
19842922|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20199544|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199545|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
20199546|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199547|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20199548|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
20199549|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
20199550|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199551|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
20385526|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385527|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385528|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20385529|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385530|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20385531|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
20199552|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340173|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340174|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340175|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340176|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
19340177|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
19340178|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19340179|NCT03817112|Analgesics|analgesics|mesh-ancestor
19340180|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
19842923|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199553|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20199554|NCT00245427|Lactams|lactams|mesh-list
20199555|NCT00245427|beta-Lactams|beta-lactams|mesh-list
20199556|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20199557|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199558|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
20199559|NCT00245440|Azithromycin|azithromycin|mesh-list
20199560|NCT00245440|Telithromycin|telithromycin|mesh-list
20199561|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199562|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385532|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385533|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
20385534|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385535|NCT01051011|Metformin|metformin|mesh-list
20385536|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
20385537|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20385538|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20385539|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385540|NCT01051011|Incretins|incretins|mesh-ancestor
20385541|NCT01051011|Hormones|hormones|mesh-ancestor
20385542|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20385543|NCT01051102|Insulin|insulin|mesh-list
20385544|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20385545|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
20385546|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
20385547|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20385548|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
20385549|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20385550|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20385551|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385552|NCT01051115|Dasatinib|dasatinib|mesh-list
19340181|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340182|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19340183|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19340184|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19340185|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
20385553|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385554|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20385555|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385556|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842924|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19842925|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19842926|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19842927|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19842928|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19842929|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
19842930|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19842931|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
20385557|NCT01051167|Cetuximab|cetuximab|mesh-list
20385558|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20385559|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385560|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
20385561|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
19340186|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199563|NCT00245453|Azithromycin|azithromycin|mesh-list
19842932|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
20385562|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20199564|NCT00245453|Clarithromycin|clarithromycin|mesh-list
19340187|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340188|NCT03816774|Simethicone|simethicone|mesh-list
19340189|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
19340190|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842933|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19842934|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19842935|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19842936|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
19842937|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
19842938|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
19842939|NCT00655668|Lenalidomide|lenalidomide|mesh-list
19842940|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
20199565|NCT00245453|Telithromycin|telithromycin|mesh-list
19340191|NCT03816774|Emollients|emollients|mesh-ancestor
19340192|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
19340193|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
19340194|NCT03816592|Anesthetics|anesthetics|mesh-list
19340195|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340196|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340197|NCT03816592|Narcotics|narcotics|mesh-ancestor
19340198|NCT03816592|Analgesics|analgesics|mesh-ancestor
19340199|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
19340200|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340201|NCT03816488|Metformin|metformin|mesh-list
20199566|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199567|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199568|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20199569|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199570|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199571|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20199572|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20199573|NCT00245505|Mesalamine|mesalamine|mesh-list
20199574|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199575|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385563|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19340202|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19340203|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19340204|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340205|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19340206|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19340207|NCT03816488|Analgesics|analgesics|mesh-ancestor
20385564|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340208|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
19340209|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340210|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19340211|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19340212|NCT03816553|Apatinib|apatinib|mesh-list
19340213|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340214|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19340215|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340216|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340217|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
19340218|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199576|NCT00245505|Analgesics|analgesics|mesh-ancestor
20199577|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
20199578|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199579|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842941|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842942|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19842943|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19842944|NCT00655668|Growth Substances|growth substances|mesh-ancestor
20199580|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199581|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199582|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
20199583|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
20199584|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20199585|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20199586|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199587|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199588|NCT00245596|Urological Agents|urological agents|mesh-ancestor
20199589|NCT00245609|Pregabalin|pregabalin|mesh-list
20199590|NCT00245609|Alprazolam|alprazolam|mesh-list
19340219|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842945|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
19340220|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19340221|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340222|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340223|NCT03816267|Albuterol|albuterol|mesh-list
19340224|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19340225|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
19340226|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340227|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340228|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19340229|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
19340230|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
19340231|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19340232|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19340233|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19340234|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19340235|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
20199591|NCT00245609|Analgesics|analgesics|mesh-ancestor
20199592|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
20199593|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340236|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340237|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199594|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199595|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
20199596|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20199597|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199598|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199599|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20199600|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20199601|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199602|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199603|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199604|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20199605|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
20199606|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
20199607|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199608|NCT00245661|Temazepam|temazepam|mesh-list
20199609|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20199610|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199611|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199612|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20199613|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199614|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199615|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
20199616|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
20199617|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199618|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199619|NCT00245674|Amisulpride|amisulpride|mesh-list
19340238|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19340239|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19340240|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340241|NCT03816020|Niacinamide|niacinamide|mesh-list
19340242|NCT03816020|Niacin|niacin|mesh-list
19340243|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
19340244|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
19340245|NCT03816020|Vitamins|vitamins|mesh-ancestor
19340246|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
19340247|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340248|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19340249|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
19340250|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340251|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19340252|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
19340253|NCT03816072|Phenylephrine|phenylephrine|mesh-list
19340254|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
20199620|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20199621|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199622|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199623|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199624|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199625|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19340255|NCT03816072|Propofol|propofol|mesh-list
19340256|NCT03816072|Sevoflurane|sevoflurane|mesh-list
19340257|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20199626|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
20385565|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385566|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20385567|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19340258|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340259|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340260|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340261|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
19340262|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
19340263|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19340264|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19340265|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19340266|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
19340267|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
20199627|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199628|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199629|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20199630|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
19682806|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
19682807|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385568|NCT01051219|Losartan|losartan|mesh-list
20385569|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20385570|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20385571|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20199631|NCT00245713|Levetiracetam|levetiracetam|mesh-list
20199632|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
20199633|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
20199634|NCT00245739|Darunavir|darunavir|mesh-list
19340268|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340269|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
19340270|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19340271|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
19340272|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
19340273|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19340274|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19340275|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19340276|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19340277|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340278|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340279|NCT03816072|Protective Agents|protective agents|mesh-ancestor
19340280|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
19340281|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20199635|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20385572|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20385573|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385574|NCT01051271|Midazolam|midazolam|mesh-list
20385575|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20385576|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20385577|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385578|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385579|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19340282|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19340283|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19340284|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340285|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340286|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
19340287|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340288|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340289|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19340290|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340291|NCT03815864|Antibodies|antibodies|mesh-list
19340292|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
19340293|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
19340294|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340295|NCT03815942|Nivolumab|nivolumab|mesh-list
19340296|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682808|NCT04250493|Insulin|insulin|mesh-list
19682809|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20199636|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19682810|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682811|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
20199637|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
20199638|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199639|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199640|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19842946|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842947|NCT00655746|Dasatinib|dasatinib|mesh-list
19842948|NCT00655746|Omeprazole|omeprazole|mesh-list
19842949|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20199641|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19340297|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340298|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19340299|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340300|NCT03815838|Fallypride|fallypride|mesh-list
19340301|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19340302|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19340303|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
19340304|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340305|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340306|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399953|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
19399954|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19399955|NCT03630991|Antidotes|antidotes|mesh-ancestor
19399956|NCT03630991|Protective Agents|protective agents|mesh-ancestor
19399957|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19399958|NCT03630952|Aflibercept|aflibercept|mesh-list
19399959|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19399960|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19399961|NCT03630952|Growth Substances|growth substances|mesh-ancestor
19399962|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399963|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
19399964|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399965|NCT03630796|Sevoflurane|sevoflurane|mesh-list
19399966|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19399967|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19399968|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
19399969|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
19399970|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19399971|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399972|NCT03630614|Nicotine|nicotine|mesh-list
19399973|NCT03630614|Varenicline|varenicline|mesh-list
19399974|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19399975|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
19399976|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399977|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399978|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19399979|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19399980|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
19399981|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19399982|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404489|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404490|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
19404491|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404492|NCT03594435|Ibudilast|ibudilast|mesh-list
20385580|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385581|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20385582|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404493|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404494|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
19404495|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404496|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404497|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19404498|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404499|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19404500|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842950|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19842951|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20199642|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
20199643|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199644|NCT00245791|Levofloxacin|levofloxacin|mesh-list
20199645|NCT00245791|Ofloxacin|ofloxacin|mesh-list
20199646|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20199647|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199648|NCT00245791|Renal Agents|renal agents|mesh-ancestor
20385583|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
19404824|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19842952|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199649|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199650|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20385584|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
20385585|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
19340307|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
20385586|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
20385587|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385588|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340308|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19340309|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
19340310|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340311|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
19340312|NCT03815539|Protective Agents|protective agents|mesh-ancestor
19340313|NCT03815487|Insulin|insulin|mesh-list
19340314|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19340315|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19340316|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340317|NCT03815474|Epirubicin|epirubicin|mesh-list
19340318|NCT03815474|Ifosfamide|ifosfamide|mesh-list
19340319|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19340320|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340321|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19340322|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20199651|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19682812|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19682813|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682814|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20199652|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199653|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199654|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199655|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20199656|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20199657|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
20385589|NCT01051284|Gemcitabine|gemcitabine|mesh-list
20385590|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20385591|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
20385592|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385593|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385594|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
20385595|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385596|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385597|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385598|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
20385599|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340323|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340324|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199658|NCT00245895|Hematinics|hematinics|mesh-ancestor
20199659|NCT00245908|Azithromycin|azithromycin|mesh-list
20199660|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20199661|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682815|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682816|NCT04227756|Psilocybin|psilocybin|mesh-list
19682817|NCT04227756|Mescaline|mescaline|mesh-list
19682818|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
19682819|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682820|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682821|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19682822|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
19340325|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19340326|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
19340327|NCT03815461|Paclitaxel|paclitaxel|mesh-list
19340328|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19340329|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340330|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
19340331|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
19340332|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
19340333|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340334|NCT03815448|Methotrexate|methotrexate|mesh-list
19340335|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19340336|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
19340337|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19340338|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340339|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340340|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
19340341|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682823|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385600|NCT01051362|Carboplatin|carboplatin|mesh-list
19682824|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340342|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340343|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19340344|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340345|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19340346|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19340347|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
19682825|NCT04224545|Colchicine|colchicine|mesh-list
19682826|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
19682827|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682828|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
19682829|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
19682830|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
19682831|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682832|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682833|NCT04208997|Amiodarone|amiodarone|mesh-list
19682834|NCT04208997|Sotalol|sotalol|mesh-list
19682835|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19682836|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
19682837|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19682838|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19682839|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682840|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19682841|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19682842|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20199662|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
20199663|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20199664|NCT00245921|Estradiol|estradiol|mesh-list
20199665|NCT00245921|Estrogens|estrogens|mesh-ancestor
20199666|NCT00245921|Hormones|hormones|mesh-ancestor
20199667|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199668|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199669|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20199670|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
20199671|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20385601|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426379|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20426380|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20426381|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20426382|NCT01280526|Romidepsin|romidepsin|mesh-list
20426383|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426384|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426385|NCT01280669|Sirolimus|sirolimus|mesh-list
20426386|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20426387|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426388|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426389|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426390|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
20426391|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426392|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
20426393|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199672|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20199673|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20199674|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20199675|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20199676|NCT00245934|Etanercept|etanercept|mesh-list
20199677|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199678|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199679|NCT00245934|Analgesics|analgesics|mesh-ancestor
20199680|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
20199681|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199682|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426394|NCT01280682|Rituximab|rituximab|mesh-list
20426395|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19340348|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19340349|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19340350|NCT03815344|Misoprostol|misoprostol|mesh-list
20426396|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340351|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19340352|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
19340353|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19340354|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426397|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
19340355|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19682843|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682844|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19340356|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340357|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
19340358|NCT03815305|Petrolatum|petrolatum|mesh-list
19340359|NCT03815305|Emollients|emollients|mesh-ancestor
19340360|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
20199683|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19340361|NCT03815435|Anesthetics|anesthetics|mesh-list
19340362|NCT03815435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340363|NCT03815435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340364|NCT03815279|Dexamethasone|dexamethasone|mesh-list
19340365|NCT03815279|Lenalidomide|lenalidomide|mesh-list
19340366|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19340367|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
19340368|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
20385602|NCT01051388|Rabeprazole|rabeprazole|mesh-list
20385603|NCT01051388|Gefarnate|gefarnate|mesh-list
20385604|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20385605|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20385606|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20385607|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385608|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340369|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340370|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340371|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340372|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
19340373|NCT03815279|Hormones|hormones|mesh-ancestor
19340374|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19340375|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19340376|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340377|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
19340378|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19340379|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19340380|NCT03815279|Growth Substances|growth substances|mesh-ancestor
19340381|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
19340382|NCT03814954|Epinephrine|epinephrine|mesh-list
19340383|NCT03814954|Albuterol|albuterol|mesh-list
19340384|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19340385|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19340386|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
19340387|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199684|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199685|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199686|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199687|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
20199688|NCT00246064|Infliximab|infliximab|mesh-list
20199689|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
20199690|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199691|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199692|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
20199693|NCT00246103|Fluorouracil|fluorouracil|mesh-list
19682845|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19682846|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19682847|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19682848|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19682849|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
20385609|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20385610|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20385611|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20385612|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
19340388|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340389|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340390|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19340391|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19340392|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
19340393|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340394|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19340395|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
19340396|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
19682850|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199694|NCT00246103|Epirubicin|epirubicin|mesh-list
20199695|NCT00246103|Valproic Acid|valproic acid|mesh-list
20385613|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340397|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
19340398|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19340399|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
20199696|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199697|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
20385614|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20385615|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20385616|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385617|NCT01051427|Hemostatics|hemostatics|mesh-list
20385618|NCT01051427|Surgiflo|surgiflo|mesh-list
20385619|NCT01051427|Coagulants|coagulants|mesh-ancestor
20385620|NCT01051479|Choline|choline|mesh-list
20385621|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
20385622|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20385623|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
20385624|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385625|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20385626|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20385627|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
20385628|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20385629|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20385630|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385631|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385632|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385633|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20385634|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20385635|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20385636|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
20385637|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385638|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385639|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20385640|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20385641|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
20385642|NCT01051544|Factor VIII|factor viii|mesh-list
20385643|NCT01051544|Coagulants|coagulants|mesh-ancestor
20385644|NCT01051583|Bevacizumab|bevacizumab|mesh-list
20385645|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20385646|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385647|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19682851|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682852|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
19682853|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
19682854|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682855|NCT04201873|Poly I-C|poly i-c|mesh-list
19682856|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
19682857|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20385648|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20385649|NCT01051583|Growth Substances|growth substances|mesh-ancestor
20385650|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385651|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
20385652|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
20385653|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20385654|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385655|NCT01051648|Triamcinolone|triamcinolone|mesh-list
19340400|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19340401|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19340402|NCT03814941|Anesthetics|anesthetics|mesh-list
19340403|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340404|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340405|NCT03814733|Ketamine|ketamine|mesh-list
19340406|NCT03814733|Alprazolam|alprazolam|mesh-list
20385656|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20385657|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20385658|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20385659|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20385660|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
20385661|NCT01051648|Hormones|hormones|mesh-ancestor
20385662|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682858|NCT04201873|Vaccines|vaccines|mesh-list
19682859|NCT04201873|Poly ICLC|poly iclc|mesh-list
19682860|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
19340407|NCT03814733|Analgesics|analgesics|mesh-ancestor
19340408|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
19340409|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340410|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340411|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19340412|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340413|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
19340414|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
19682861|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340415|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340416|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19340417|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19340418|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340419|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340420|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19682862|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20385663|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385664|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385665|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
20385666|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385667|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385668|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
20385669|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20385670|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20385671|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20385672|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20385673|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385674|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
19340421|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19340422|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340423|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19340424|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
19340425|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
19340426|NCT03814759|Cisplatin|cisplatin|mesh-list
19340427|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340428|NCT03814577|Antioxidants|antioxidants|mesh-list
19682863|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199698|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199699|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20199700|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19682864|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
19682865|NCT04201873|Laxatives|laxatives|mesh-ancestor
19682866|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19682867|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
19682868|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682869|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
19682870|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
19682871|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682872|NCT04165239|Protective Agents|protective agents|mesh-ancestor
19682873|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682874|NCT04163900|Gemcitabine|gemcitabine|mesh-list
19682875|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682876|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19682877|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
19682878|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682879|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
19682880|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682881|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682882|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19682883|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
19340429|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340430|NCT03814577|Protective Agents|protective agents|mesh-ancestor
19340431|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340432|NCT03814629|Vitamins|vitamins|mesh-list
19340433|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
19682884|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682885|NCT04153435|Calcium|calcium|mesh-list
19682886|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19340434|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340435|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
19340436|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19340437|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
19682887|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199701|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
20199702|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199703|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199704|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20199705|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
20199706|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20199707|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20199708|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19340438|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385675|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385676|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385677|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20385678|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340439|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
20199709|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20199710|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199711|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
20199712|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
20199713|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199714|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
20199715|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385679|NCT01051765|Irinotecan|irinotecan|mesh-list
20385680|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385681|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20385682|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20385683|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385684|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385685|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20385686|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
20385687|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20385688|NCT01051934|Paclitaxel|paclitaxel|mesh-list
20199716|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199717|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199718|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
20199719|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20199720|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20199721|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20199722|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199723|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199724|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
20385689|NCT01051934|Bevacizumab|bevacizumab|mesh-list
20385690|NCT01051934|Carboplatin|carboplatin|mesh-list
19340440|NCT03814707|Protective Agents|protective agents|mesh-ancestor
19340441|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
19340442|NCT03814447|Fludarabine|fludarabine|mesh-list
19340443|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19340444|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
19340445|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340446|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19340447|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19340448|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
19340449|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340450|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340451|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19340452|NCT03814616|Artesunate|artesunate|mesh-list
19340453|NCT03814616|Pyronaridine|pyronaridine|mesh-list
19340454|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
19340455|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19340456|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19340457|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340458|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340459|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
19340460|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
19340461|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19340462|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
19340463|NCT03814642|Esomeprazole|esomeprazole|mesh-list
19340464|NCT03814642|Clopidogrel|clopidogrel|mesh-list
19340465|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19340466|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19340467|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19340468|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19340469|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
19340470|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340471|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340472|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199725|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199726|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385691|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20385692|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199727|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20385693|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
19340473|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19340474|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340475|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20199728|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199729|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
20199730|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20199731|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20199732|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20199733|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340476|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340477|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20199734|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199735|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
20199736|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199737|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199738|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20199739|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340478|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
19340479|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385694|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
20385695|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
20385696|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385697|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20385698|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20385699|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20385700|NCT01051934|Growth Substances|growth substances|mesh-ancestor
20199740|NCT00246168|Acetaminophen|acetaminophen|mesh-list
20199741|NCT00246168|Tramadol|tramadol|mesh-list
20199742|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199743|NCT00246168|Analgesics|analgesics|mesh-ancestor
20199744|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
20199745|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199746|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199747|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
20199748|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20199749|NCT00246168|Narcotics|narcotics|mesh-ancestor
20199750|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385701|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340480|NCT03814343|Amphotericin B|amphotericin b|mesh-list
19340481|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19340482|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19340483|NCT03814343|Amebicides|amebicides|mesh-ancestor
19340484|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19340485|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19340486|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340487|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19340488|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
19340489|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19340490|NCT03814343|Protective Agents|protective agents|mesh-ancestor
19340491|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340492|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19340493|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
19340494|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340495|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
20385702|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
20385703|NCT01051947|Metoprolol|metoprolol|mesh-list
20385704|NCT01051947|Nebivolol|nebivolol|mesh-list
20385705|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20385706|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20385707|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
20385708|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
20385709|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385710|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385711|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20385712|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20385713|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20385714|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
20385715|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340496|NCT03814226|Growth Substances|growth substances|mesh-ancestor
19340497|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340498|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
19340499|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340500|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340501|NCT03813875|Fentanyl|fentanyl|mesh-list
19340502|NCT03813875|Midazolam|midazolam|mesh-list
19340503|NCT03813875|Alfentanil|alfentanil|mesh-list
20199751|NCT00246194|Risperidone|risperidone|mesh-list
19340504|NCT03813875|Propofol|propofol|mesh-list
20426398|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199752|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20199753|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
20199754|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199755|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199756|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199757|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20199758|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340505|NCT03813875|Sevoflurane|sevoflurane|mesh-list
19340506|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20199759|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199760|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199761|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20199762|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
20199763|NCT00246207|Methylphenidate|methylphenidate|mesh-list
20199764|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20199765|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199766|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20199767|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20199768|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199769|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199770|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
20199771|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199772|NCT00246220|Methylphenidate|methylphenidate|mesh-list
20199773|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20199774|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199775|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20199776|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20199777|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199778|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199779|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
20199780|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199781|NCT00246233|Methylphenidate|methylphenidate|mesh-list
20199782|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20199783|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199784|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20199785|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20199786|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199787|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199788|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
20385716|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682888|NCT04153188|Phenylephrine|phenylephrine|mesh-list
19682889|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
19842953|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842954|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842955|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20385717|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
19682890|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20385718|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20385719|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20385720|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20385721|NCT01052025|Curcumin|curcumin|mesh-list
19682891|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19682892|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
19340507|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340508|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340509|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340510|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
19340511|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
19340512|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19340513|NCT03813875|Narcotics|narcotics|mesh-ancestor
19340514|NCT03813875|Analgesics|analgesics|mesh-ancestor
19340515|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
19340516|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340517|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19340518|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19340519|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340520|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682893|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19682894|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842956|NCT00655811|Capsaicin|capsaicin|mesh-list
19340521|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
19682895|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340522|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
19340523|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199789|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199790|NCT00246246|Risperidone|risperidone|mesh-list
20199791|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20199792|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
20199793|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340524|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340525|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19340526|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19340527|NCT03813784|Capecitabine|capecitabine|mesh-list
19340528|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
19340529|NCT03813784|Apatinib|apatinib|mesh-list
19340530|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340531|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
19340532|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340533|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340534|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19340535|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340536|NCT03813979|Dolutegravir|dolutegravir|mesh-list
19340537|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19340538|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19340539|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340540|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340541|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19340542|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20199794|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199795|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385722|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20385723|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19340543|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
19340544|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340545|NCT03814148|Indapamide|indapamide|mesh-list
19340546|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19340547|NCT03814148|Diuretics|diuretics|mesh-ancestor
19340548|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
19340549|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340550|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19340551|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340552|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340553|NCT03814109|Niacin|niacin|mesh-list
19340554|NCT03814109|Indapamide|indapamide|mesh-list
19340555|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19340556|NCT03814109|Diuretics|diuretics|mesh-ancestor
20385724|NCT01052025|Analgesics|analgesics|mesh-ancestor
20385725|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
20385726|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385727|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385728|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20385729|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385730|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385731|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385732|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385733|NCT01052051|Vitamin D|vitamin d|mesh-list
20385734|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
20385735|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
20385736|NCT01052051|Calcium|calcium|mesh-list
20385737|NCT01052051|Vitamins|vitamins|mesh-ancestor
20385738|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
20385739|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385740|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20385741|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19340557|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
19340558|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340559|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19340560|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340561|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340562|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19340563|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
19340564|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19340565|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
19340566|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
19340567|NCT03814109|Vitamins|vitamins|mesh-ancestor
20199796|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20385742|NCT01052051|Antacids|antacids|mesh-ancestor
19340568|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
19340569|NCT03813927|Vitamin D|vitamin d|mesh-list
19340570|NCT03813927|Vitamins|vitamins|mesh-ancestor
19340571|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
19340572|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340573|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19340574|NCT03813940|Vaccines|vaccines|mesh-list
19340575|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
19340576|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399983|NCT03630367|Dexamethasone|dexamethasone|mesh-list
20199797|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19399984|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19399985|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
19399986|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
19399987|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19399988|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19399989|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19399990|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
19399991|NCT03630367|Hormones|hormones|mesh-ancestor
19399992|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19399993|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19399994|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19399995|NCT03630341|Clomiphene|clomiphene|mesh-list
19399996|NCT03630341|Enclomiphene|enclomiphene|mesh-list
19399997|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
19399998|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19399999|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
19400000|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400001|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199798|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199799|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400002|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19400003|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
19400004|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19400005|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19400006|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20199800|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20199801|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
20199802|NCT00246272|Risperidone|risperidone|mesh-list
20199803|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20199804|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
20199805|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199806|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400007|NCT03630315|Bevacizumab|bevacizumab|mesh-list
19400008|NCT03630315|Ranibizumab|ranibizumab|mesh-list
19400009|NCT03630315|Aflibercept|aflibercept|mesh-list
19400010|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19400011|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400012|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19400013|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19400014|NCT03630315|Growth Substances|growth substances|mesh-ancestor
19400015|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400016|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
19842957|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
19842958|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19842959|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
20199807|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199808|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20199809|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199810|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199811|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199812|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20199813|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
20199814|NCT00246285|Risperidone|risperidone|mesh-list
20199815|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20199816|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
20199817|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199818|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199819|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199820|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20199821|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20199822|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199823|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20199824|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20199825|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
20199826|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
19400017|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
20199827|NCT00246298|Hematinics|hematinics|mesh-ancestor
19340577|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
19340578|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
19340579|NCT03813771|Etanercept|etanercept|mesh-list
19340580|NCT03813771|Methotrexate|methotrexate|mesh-list
19340581|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19340582|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
19340583|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19340584|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340585|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340586|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
19340587|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340588|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340589|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
19340590|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340591|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19340592|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19340593|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
19340594|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19340595|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19340596|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
19340597|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19340598|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19340599|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340600|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19340601|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19340602|NCT03813771|Analgesics|analgesics|mesh-ancestor
19340603|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
19340604|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340605|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19340606|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340607|NCT03813641|Capecitabine|capecitabine|mesh-list
19340608|NCT03813641|Raltitrexed|raltitrexed|mesh-list
19340609|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340610|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
19340611|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340612|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340613|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19340614|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340615|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
19340616|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20199828|NCT00246363|Silymarin|silymarin|mesh-list
20199829|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
20199830|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199831|NCT00246363|Protective Agents|protective agents|mesh-ancestor
20199832|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199833|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
19340617|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19340618|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340619|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
19340620|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
19340621|NCT03813394|Bevacizumab|bevacizumab|mesh-list
20199834|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20199835|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
20199836|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19340622|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
19340623|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19340624|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340625|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19340626|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19340627|NCT03813394|Growth Substances|growth substances|mesh-ancestor
20385743|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385744|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340628|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340629|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
20199837|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20199838|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199839|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19842960|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199840|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199841|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340630|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
19340631|NCT03813329|Calcium|calcium|mesh-list
19340632|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19340633|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842961|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199842|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199843|NCT00246402|Acipimox|acipimox|mesh-list
20199844|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20199845|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
20199846|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199847|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20199848|NCT00246415|Memantine|memantine|mesh-list
20199849|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20199850|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19340634|NCT03813329|Antacids|antacids|mesh-ancestor
19340635|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340636|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199851|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
20199852|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19842962|NCT00655850|Gemcitabine|gemcitabine|mesh-list
19842963|NCT00655850|Paclitaxel|paclitaxel|mesh-list
19842964|NCT00655850|Bevacizumab|bevacizumab|mesh-list
19842965|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19842966|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842967|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
20199853|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199854|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199855|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20199856|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20217624|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
19340637|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
19340638|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340639|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340640|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340641|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19340642|NCT03813277|Analgesics|analgesics|mesh-ancestor
19340643|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
19340644|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340645|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19340646|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19340647|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20217625|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
20217626|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20217627|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20217628|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217629|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217630|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
20217631|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20217632|NCT00309920|Hematinics|hematinics|mesh-ancestor
20217633|NCT00309998|Bevacizumab|bevacizumab|mesh-list
20217634|NCT00309998|Vinorelbine|vinorelbine|mesh-list
20217635|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20217636|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217637|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20217638|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20217639|NCT00309998|Growth Substances|growth substances|mesh-ancestor
20217640|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340648|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
19340649|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340650|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340651|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19340652|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
19340653|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19340654|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19340655|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19340656|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340657|NCT03813316|Incretins|incretins|mesh-ancestor
19340658|NCT03813316|Hormones|hormones|mesh-ancestor
19340659|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19340660|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
19340661|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340662|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340663|NCT03813303|Fentanyl|fentanyl|mesh-list
19340664|NCT03813303|Midazolam|midazolam|mesh-list
19340665|NCT03813303|Propofol|propofol|mesh-list
19340666|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340667|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400018|NCT03630081|Meropenem|meropenem|mesh-list
19842968|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
20217641|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
19340668|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340669|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340670|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
19340671|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
19340672|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19340673|NCT03813303|Narcotics|narcotics|mesh-ancestor
19340674|NCT03813303|Analgesics|analgesics|mesh-ancestor
19340675|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
19340676|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340677|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19340678|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19340679|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340680|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19340681|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
19340682|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
19340683|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340684|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340685|NCT03813043|Midazolam|midazolam|mesh-list
19340686|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19340687|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340688|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340689|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340690|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19340691|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340692|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19340693|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340694|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
19340695|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
20199857|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20199858|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20199859|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
20199860|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199861|NCT00246467|Antacids|antacids|mesh-ancestor
20199862|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199863|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199864|NCT00246532|Morphine|morphine|mesh-list
20199865|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20199866|NCT00246532|Narcotics|narcotics|mesh-ancestor
20199867|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20199868|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199869|NCT00246532|Analgesics|analgesics|mesh-ancestor
20385745|NCT01052129|Naproxen|naproxen|mesh-list
20385746|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20385747|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385748|NCT01052129|Analgesics|analgesics|mesh-ancestor
20385749|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
20385750|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385751|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385752|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19340696|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
19340697|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
19340698|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340699|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199870|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
19340700|NCT03813069|Permethrin|permethrin|mesh-list
20199871|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199872|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
20199873|NCT00246597|Hematinics|hematinics|mesh-ancestor
20199874|NCT00246610|Nelfinavir|nelfinavir|mesh-list
20199875|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20199876|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20199877|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
20199878|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199879|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199880|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20199881|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20199882|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
20199883|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199884|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20199885|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199886|NCT00246636|Fenofibrate|fenofibrate|mesh-list
20199887|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20199888|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
19340701|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340702|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199889|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340703|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19340704|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
19340705|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19340706|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
19340707|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19340708|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19340709|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19340710|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340711|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340712|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
19340713|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340714|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340715|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19340716|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340717|NCT03813186|Decitabine|decitabine|mesh-list
20199890|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20199891|NCT00246675|Furosemide|furosemide|mesh-list
20199892|NCT00246675|Diuretics|diuretics|mesh-ancestor
19340718|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340719|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
19340720|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842969|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
19842970|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199893|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
19340721|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340722|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340723|NCT03812939|Octreotide|octreotide|mesh-list
19340724|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340725|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19340726|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385753|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385754|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
20385755|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20385756|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385757|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340727|NCT03813030|Lidocaine|lidocaine|mesh-list
19340728|NCT03813030|Prilocaine|prilocaine|mesh-list
20385758|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
20385759|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20385760|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385761|NCT01052181|Vitamins|vitamins|mesh-ancestor
20385762|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
20385763|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20385764|NCT01052246|Clindamycin|clindamycin|mesh-list
20385765|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
20385766|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
20385767|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20385768|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20385769|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340729|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
19842971|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20199894|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199895|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20199896|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20199897|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199898|NCT00246688|Sagopilone|sagopilone|mesh-list
20199899|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199900|NCT00246701|Simvastatin|simvastatin|mesh-list
20199901|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20199902|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20199903|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
20199904|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199905|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20199906|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20199907|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199908|NCT00246909|Pantoprazole|pantoprazole|mesh-list
20199909|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20199910|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199911|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20385770|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19842972|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
19842973|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
19842974|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199912|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385771|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340730|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
19340731|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340732|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340733|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
19340734|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340735|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19340736|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20199913|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842975|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19842976|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19842977|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
19842978|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385772|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385773|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
20385774|NCT01052259|Gusperimus|gusperimus|mesh-list
19842979|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19340737|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19340738|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340739|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340740|NCT03812783|Sorafenib|sorafenib|mesh-list
19340741|NCT03812783|Folfirinox|folfirinox|mesh-list
19340742|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340743|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19340744|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340745|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340746|NCT03812796|Avelumab|avelumab|mesh-list
20385775|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20385776|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385777|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20385778|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385779|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385780|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
20385781|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20385782|NCT01052259|Protective Agents|protective agents|mesh-ancestor
20385783|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
20385784|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20385785|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20385786|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20385787|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20385788|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385789|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385790|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385791|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20385792|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20385793|NCT01052311|Niacin|niacin|mesh-list
20385794|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20385795|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
20385796|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19842980|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19842981|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20199914|NCT00246974|Gemcitabine|gemcitabine|mesh-list
19842982|NCT00655850|Growth Substances|growth substances|mesh-ancestor
19842983|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
19842984|NCT00655863|Pioglitazone|pioglitazone|mesh-list
19842985|NCT00655863|Alogliptin|alogliptin|mesh-list
19842986|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19842987|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19842988|NCT00655863|Incretins|incretins|mesh-ancestor
19842989|NCT00655863|Hormones|hormones|mesh-ancestor
19842990|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19842991|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19842992|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
20199915|NCT00246974|Gefitinib|gefitinib|mesh-list
20199916|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199917|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20199918|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
20199919|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199920|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
20199921|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199922|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199923|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20199924|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
20385797|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20385798|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
20385799|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
20385800|NCT01052311|Vitamins|vitamins|mesh-ancestor
20385801|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
20199925|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199926|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20199927|NCT00247026|Ubiquinone|ubiquinone|mesh-list
20199928|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
20199929|NCT00247026|Curcumin|curcumin|mesh-list
20199930|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199931|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199932|NCT00247026|Analgesics|analgesics|mesh-ancestor
20199933|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
19340747|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19340748|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340749|NCT03812731|Fentanyl|fentanyl|mesh-list
19340750|NCT03812731|Ropivacaine|ropivacaine|mesh-list
20199934|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199935|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199936|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199937|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19340751|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
19340752|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
19340753|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340754|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385802|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340755|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
19340756|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340757|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19340758|NCT03812731|Narcotics|narcotics|mesh-ancestor
19340759|NCT03812731|Analgesics|analgesics|mesh-ancestor
19340760|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20385803|NCT01052324|Remifentanil|remifentanil|mesh-list
20385804|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20385805|NCT01052324|Narcotics|narcotics|mesh-ancestor
20385806|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385807|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385808|NCT01052324|Analgesics|analgesics|mesh-ancestor
20385809|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
20385810|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385811|NCT01052337|Anesthetics|anesthetics|mesh-list
20199938|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199939|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199940|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199941|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
20199942|NCT00247026|Vitamins|vitamins|mesh-ancestor
20199943|NCT00247052|Diclofenac|diclofenac|mesh-list
20199944|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20199945|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20199946|NCT00247052|Analgesics|analgesics|mesh-ancestor
20199947|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
20199948|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199949|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199950|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20199951|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385812|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340761|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340762|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
19340763|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
19340764|NCT03812380|Cathartics|cathartics|mesh-ancestor
19340765|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340766|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19682896|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
19682897|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
19682898|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682899|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
19682900|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20385813|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385814|NCT01052363|Bevacizumab|bevacizumab|mesh-list
20385815|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19340767|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19682901|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
20199952|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20385816|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385817|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404825|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
19682902|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20385818|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20385819|NCT01052363|Growth Substances|growth substances|mesh-ancestor
20385820|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385821|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
20385822|NCT01052389|Haloperidol|haloperidol|mesh-list
20385823|NCT01052389|Olanzapine|olanzapine|mesh-list
20385824|NCT01052389|Aripiprazole|aripiprazole|mesh-list
20385825|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
20385826|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
20385827|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
20385828|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385829|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385830|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19682903|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
19682904|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20199953|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199954|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199955|NCT00247078|Antivenins|antivenins|mesh-list
20199956|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
20199957|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199958|NCT00247117|Metformin|metformin|mesh-list
20385831|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20199959|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19682905|NCT04153188|Protective Agents|protective agents|mesh-ancestor
19682906|NCT04147221|Imipenem|imipenem|mesh-list
19682907|NCT04147221|Relebactam|relebactam|mesh-list
19682908|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19682909|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682910|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19682911|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682912|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199960|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199961|NCT00247130|Omeprazole|omeprazole|mesh-list
20199962|NCT00247130|Ranitidine|ranitidine|mesh-list
20199963|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20199964|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20199965|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199966|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20199967|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20199968|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199969|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19682913|NCT04140968|Progesterone|progesterone|mesh-list
19682914|NCT04140968|Progestins|progestins|mesh-ancestor
19682915|NCT04140968|Hormones|hormones|mesh-ancestor
19682916|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20385832|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385833|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385834|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682917|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682918|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
19682919|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682920|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692647|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692648|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692649|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692650|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692651|NCT04989140|Dexamethasone|dexamethasone|mesh-list
19692652|NCT04989140|Pomalidomide|pomalidomide|mesh-list
19692653|NCT04989140|Ixazomib|ixazomib|mesh-list
19692654|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692655|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
19692656|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
19692657|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692658|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692659|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20199970|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
20199971|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
20199972|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20199973|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199974|NCT00247143|Lopinavir|lopinavir|mesh-list
20199975|NCT00247143|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20199976|NCT00247143|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19404826|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
19692660|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
19692661|NCT04989140|Hormones|hormones|mesh-ancestor
20199977|NCT00247143|Protease Inhibitors|protease inhibitors|mesh-ancestor
20199978|NCT00247143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385835|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20199979|NCT00247143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199980|NCT00247143|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20199981|NCT00247143|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20199982|NCT00247143|Antiviral Agents|antiviral agents|mesh-ancestor
20199983|NCT00247143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20199984|NCT00247143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20199985|NCT00247143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20199986|NCT00247169|Progesterone|progesterone|mesh-list
20199987|NCT00247169|Progestins|progestins|mesh-ancestor
20199988|NCT00247169|Hormones|hormones|mesh-ancestor
20199989|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20199990|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20199991|NCT00247208|Paclitaxel|paclitaxel|mesh-list
20199992|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20199993|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20199994|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
20199995|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
20199996|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
20199997|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20199998|NCT00247247|Entacapone|entacapone|mesh-list
19340768|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19340769|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340770|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340771|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340772|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385836|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20385837|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20385838|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385839|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385840|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
20385841|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
20385842|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
20385843|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
20385844|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20385845|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20385846|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20385847|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20385848|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20385849|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20385850|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19340773|NCT03812523|Analgesics|analgesics|mesh-ancestor
19340774|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
19340775|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20199999|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19842993|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200000|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19340776|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
19340777|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19340778|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
20200001|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19842994|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385851|NCT01052584|Chloroquine|chloroquine|mesh-list
20385852|NCT01052584|Lumefantrine|lumefantrine|mesh-list
20385853|NCT01052584|Artemether|artemether|mesh-list
20385854|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20385855|NCT01052584|Amebicides|amebicides|mesh-ancestor
20385856|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20385857|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20385858|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19842995|NCT00655876|Paclitaxel|paclitaxel|mesh-list
19842996|NCT00655876|Cetuximab|cetuximab|mesh-list
19842997|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19842998|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19842999|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843000|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843001|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
19843002|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843003|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19843004|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
20200002|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385859|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
20200003|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385860|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200004|NCT00247364|Levetiracetam|levetiracetam|mesh-list
20200005|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
20200006|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
20200007|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
20200008|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
20385861|NCT01052597|Curcumin|curcumin|mesh-list
20385862|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20385863|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385864|NCT01052597|Analgesics|analgesics|mesh-ancestor
20385865|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
20385866|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200009|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200010|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
20200011|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200012|NCT00247481|Docetaxel|docetaxel|mesh-list
20200013|NCT00247481|Gefitinib|gefitinib|mesh-list
20200014|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340779|NCT03812562|Nivolumab|nivolumab|mesh-list
19340780|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19340781|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340782|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19340783|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340784|NCT03812419|Esomeprazole|esomeprazole|mesh-list
19340785|NCT03812419|Pantoprazole|pantoprazole|mesh-list
19340786|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19340787|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19340788|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20200015|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
20200016|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200017|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
20200018|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843005|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19843006|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
20200019|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20200020|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200021|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
20200022|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20200023|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843007|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843008|NCT00655928|Expectorants|expectorants|mesh-ancestor
19843009|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
19843010|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19843011|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
19843012|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200024|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20200025|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
20200026|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20200027|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200028|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200029|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200030|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
20200031|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20200032|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
20200033|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843013|NCT00655928|Protective Agents|protective agents|mesh-ancestor
19843014|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843015|NCT00655928|Antidotes|antidotes|mesh-ancestor
19843016|NCT00655980|Folic Acid|folic acid|mesh-list
20385867|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385868|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19340789|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340790|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843017|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
20385869|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385870|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385871|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200034|NCT00247507|Expectorants|expectorants|mesh-ancestor
20200035|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
20200036|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20200037|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
20200038|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200039|NCT00247507|Protective Agents|protective agents|mesh-ancestor
20200040|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200041|NCT00247507|Antidotes|antidotes|mesh-ancestor
19843018|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
20200042|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
20200043|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20200044|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20385872|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385873|NCT01052623|Clonidine|clonidine|mesh-list
20385874|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20385875|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20385876|NCT01052623|Estradiol|estradiol|mesh-list
20385877|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20385878|NCT01052623|Hormones|hormones|mesh-ancestor
20385879|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20385880|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385881|NCT01052623|Estrogens|estrogens|mesh-ancestor
19340791|NCT03812770|Leucovorin|leucovorin|mesh-list
19340792|NCT03812770|Fluorouracil|fluorouracil|mesh-list
19340793|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
19340794|NCT03812770|Sorafenib|sorafenib|mesh-list
19340795|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
19340796|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200045|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20200046|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200047|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200048|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
20200049|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200050|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340797|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19340798|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340799|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19340800|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
19340801|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340802|NCT03812770|Antidotes|antidotes|mesh-ancestor
19340803|NCT03812770|Protective Agents|protective agents|mesh-ancestor
19340804|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
19340805|NCT03812770|Vitamins|vitamins|mesh-ancestor
19340806|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
19340807|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19340808|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340809|NCT03812354|Nicotine|nicotine|mesh-list
19340810|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19340811|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
19340812|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340813|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340814|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19340815|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19340816|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
19340817|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340818|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340819|NCT03812315|Propolis|propolis|mesh-list
19340820|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19340821|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19340822|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
19340823|NCT03812120|Coagulants|coagulants|mesh-ancestor
19340824|NCT03812003|Remifentanil|remifentanil|mesh-list
19340825|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19340826|NCT03812003|Narcotics|narcotics|mesh-ancestor
19340827|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340828|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340829|NCT03812003|Analgesics|analgesics|mesh-ancestor
19340830|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
19682921|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
20200051|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20200052|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200053|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20200054|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20200055|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200056|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20200057|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200058|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200059|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200060|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
20200061|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426399|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19682922|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
19340831|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19682923|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19340832|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
19340833|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
19340834|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19682924|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19682925|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200062|NCT00247585|Ethanol|ethanol|mesh-list
20200063|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20200064|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200065|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200066|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200067|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
20200068|NCT00247650|Letrozole|letrozole|mesh-list
20200069|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200070|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19340835|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385882|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20385883|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
20385884|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20385885|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20385886|NCT01052623|Analgesics|analgesics|mesh-ancestor
20385887|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
20385888|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385889|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20385890|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
20385891|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
20385892|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20385893|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20385894|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20385895|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
20385896|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385897|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385898|NCT01052792|Naproxen|naproxen|mesh-list
20385899|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20385900|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385901|NCT01052792|Analgesics|analgesics|mesh-ancestor
20385902|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
20385903|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385904|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385905|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20385906|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385907|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
20385908|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20385909|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385910|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385911|NCT01052870|Finasteride|finasteride|mesh-list
20385912|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20385913|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20385914|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385915|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385916|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
20385917|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20200071|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20200072|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200073|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385918|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340836|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340837|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
19340838|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340839|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340840|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400019|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19400020|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400021|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20385919|NCT01052870|Urological Agents|urological agents|mesh-ancestor
19400022|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19400023|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400024|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400025|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20385920|NCT01052896|Gabapentin|gabapentin|mesh-list
20385921|NCT01052896|Analgesics|analgesics|mesh-ancestor
20385922|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
20385923|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385924|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400026|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19682926|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340841|NCT03811418|Docetaxel|docetaxel|mesh-list
19340842|NCT03811418|Trastuzumab|trastuzumab|mesh-list
19340843|NCT03811418|Vinorelbine|vinorelbine|mesh-list
19682927|NCT04110444|Urological Agents|urological agents|mesh-ancestor
19682928|NCT04108039|Cetrorelix|cetrorelix|mesh-list
19682929|NCT04108039|Progesterone|progesterone|mesh-list
20200074|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20200075|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
20200076|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20200077|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200078|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20200079|NCT00247663|Letrozole|letrozole|mesh-list
20200080|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200081|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19340844|NCT03811418|Pertuzumab|pertuzumab|mesh-list
19340845|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340846|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
20385925|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
20385926|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20385927|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20385928|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340847|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
19340848|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
19340849|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340850|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20200082|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20200083|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682930|NCT04108039|Ganirelix|ganirelix|mesh-list
19682931|NCT04108039|Progestins|progestins|mesh-ancestor
19682932|NCT04108039|Hormones|hormones|mesh-ancestor
19340851|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19340852|NCT03811509|Denosumab|denosumab|mesh-list
19340853|NCT03811509|Diphosphonates|diphosphonates|mesh-list
20200084|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200085|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19340854|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19340855|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340856|NCT03810872|Paclitaxel|paclitaxel|mesh-list
19340857|NCT03810872|Afatinib|afatinib|mesh-list
19340858|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19340859|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340860|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
19340861|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
19340862|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
19340863|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340864|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19340865|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385929|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20385930|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20385931|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20385932|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385933|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385934|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
20385935|NCT01052909|Glimepiride|glimepiride|mesh-list
19340866|NCT03811223|Evolocumab|evolocumab|mesh-list
19340867|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19340868|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19340869|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
19340870|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340871|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19340872|NCT03811054|Apatinib|apatinib|mesh-list
19340873|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340874|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20200086|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
20200087|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19340875|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200088|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200089|NCT00247702|Warfarin|warfarin|mesh-list
20200090|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
20200091|NCT00247715|Pantoprazole|pantoprazole|mesh-list
20200092|NCT00247715|Ranitidine|ranitidine|mesh-list
19682933|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682934|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340876|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682935|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
19843019|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
20200093|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20200094|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
20200095|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19682936|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19682937|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
19682938|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19682939|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
19682940|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19682941|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682942|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
19682943|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19682944|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19682945|NCT04090710|Nivolumab|nivolumab|mesh-list
19682946|NCT04090710|Ipilimumab|ipilimumab|mesh-list
19682947|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682948|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682949|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19682950|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682951|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
19682952|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19340877|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19340878|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340879|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385936|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20385937|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20385938|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385939|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20385940|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
20385941|NCT01052961|Oseltamivir|oseltamivir|mesh-list
20385942|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
20385943|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19682953|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19682954|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682955|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
19682956|NCT04089865|Coagulants|coagulants|mesh-ancestor
20200096|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20200097|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20385944|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385945|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385946|NCT01052974|Ropivacaine|ropivacaine|mesh-list
20385947|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
20385948|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
20385949|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385950|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385951|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
20200098|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20385952|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385953|NCT01052987|Tranilast|tranilast|mesh-list
20385954|NCT01052987|Allopurinol|allopurinol|mesh-list
20200099|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200100|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200101|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20200102|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
20200103|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
20200104|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200105|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200106|NCT00247715|Antacids|antacids|mesh-ancestor
20200107|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20200108|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
20200109|NCT00247741|Lidocaine|lidocaine|mesh-list
20200110|NCT00247741|Carticaine|carticaine|mesh-list
20200111|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
20385955|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
19682957|NCT04088500|Nivolumab|nivolumab|mesh-list
19682958|NCT04088500|Ipilimumab|ipilimumab|mesh-list
20200112|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
20200113|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385956|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340891|NCT03810703|Amphetamine|amphetamine|mesh-list
19340892|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
19340893|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19340894|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340895|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
19340896|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
19340897|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20385957|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20385958|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
20385959|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20385960|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20385961|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
19340898|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
19340899|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340900|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340901|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
19340902|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19340903|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19340904|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340905|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19340906|NCT03810742|Irinotecan|irinotecan|mesh-list
19340907|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19340908|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19340909|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340910|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340911|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340912|NCT03810547|Ketamine|ketamine|mesh-list
19340913|NCT03810547|Propofol|propofol|mesh-list
19340914|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19340915|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340916|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340917|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340918|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
19340919|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
19340920|NCT03810547|Analgesics|analgesics|mesh-ancestor
19340921|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
19340922|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340923|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19340924|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19340925|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19340926|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19340927|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340928|NCT03810391|Butorphanol|butorphanol|mesh-list
19340929|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19340930|NCT03810391|Narcotics|narcotics|mesh-ancestor
19340931|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340932|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340933|NCT03810391|Analgesics|analgesics|mesh-ancestor
19340934|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
19340935|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340936|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
19340937|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
19340938|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19340939|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
19340940|NCT03810209|Analgesics|analgesics|mesh-ancestor
19340941|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
19340942|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340943|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340944|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
19340945|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340946|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20385962|NCT01052987|Protective Agents|protective agents|mesh-ancestor
20385963|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385964|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20385965|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20385966|NCT01052987|Analgesics|analgesics|mesh-ancestor
20385967|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
20385968|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340947|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
20385969|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20385970|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19340948|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19340949|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340950|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340951|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19340952|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
19340953|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19340954|NCT03810066|Osimertinib|osimertinib|mesh-list
19340955|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19340956|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19340957|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19340958|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340959|NCT03809949|Fentanyl|fentanyl|mesh-list
19340960|NCT03809949|Anesthetics|anesthetics|mesh-list
19340961|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340962|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340963|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19340964|NCT03809949|Narcotics|narcotics|mesh-ancestor
19340965|NCT03809949|Analgesics|analgesics|mesh-ancestor
19340966|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
19340967|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340968|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19340969|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19340970|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
19340971|NCT03809793|Acipimox|acipimox|mesh-list
19340972|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19340973|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
19682959|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19682960|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200114|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200115|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
20200116|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200117|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20200118|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19340974|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340975|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19340976|NCT03809702|Pregabalin|pregabalin|mesh-list
19340977|NCT03809702|Analgesics|analgesics|mesh-ancestor
19340978|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
20385971|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20385972|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20385973|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20385974|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
20385975|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
20385976|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385977|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20385978|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20385979|NCT01053026|Olmesartan|olmesartan|mesh-list
20385980|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19340979|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19340980|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19340981|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
19340982|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19340983|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19340984|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19340985|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19340986|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19340987|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19340988|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19340989|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19340990|NCT03810261|Vitamin D|vitamin d|mesh-list
19340991|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
19340992|NCT03810261|Vitamins|vitamins|mesh-list
19340993|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
19340994|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200119|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20200120|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200121|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200122|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20200123|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20200124|NCT00247910|Diuretics|diuretics|mesh-ancestor
20200125|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
20385981|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19682961|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19340995|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19340996|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19340997|NCT03809897|Nicotine|nicotine|mesh-list
19340998|NCT03809897|Varenicline|varenicline|mesh-list
19340999|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19341000|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
19341001|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341002|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341003|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19341004|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19341005|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
19341006|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20385982|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20385983|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341007|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341008|NCT03809637|Pemetrexed|pemetrexed|mesh-list
19341009|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341010|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341011|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200126|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200127|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20200128|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200129|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200130|NCT00247988|Carboplatin|carboplatin|mesh-list
20200131|NCT00247988|Docetaxel|docetaxel|mesh-list
20200132|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200133|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
19341012|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19341013|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19341014|NCT03809650|Macitentan|macitentan|mesh-list
19341015|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19341016|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19341017|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385984|NCT01053039|Morphine|morphine|mesh-list
20385985|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20385986|NCT01053039|Narcotics|narcotics|mesh-ancestor
20385987|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20385988|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20385989|NCT01053039|Analgesics|analgesics|mesh-ancestor
20385990|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
20385991|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341018|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19341019|NCT03809546|Dronabinol|dronabinol|mesh-list
19341020|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
19341021|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341022|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341023|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341024|NCT03809546|Analgesics|analgesics|mesh-ancestor
19341025|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
19341026|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200134|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200135|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
20200136|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217642|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20217643|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
20217644|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
20217645|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
20217646|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217647|NCT00310011|Gemcitabine|gemcitabine|mesh-list
20217648|NCT00310011|Paclitaxel|paclitaxel|mesh-list
20217649|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20217650|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341027|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19341028|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19341029|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341030|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341031|NCT03809546|Hormones|hormones|mesh-ancestor
19341032|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341033|NCT03809312|Amoxicillin|amoxicillin|mesh-list
19341034|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
19682962|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682963|NCT04086147|Tenecteplase|tenecteplase|mesh-list
19682964|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20200137|NCT00248053|Curcumin|curcumin|mesh-list
20385992|NCT01053065|Atorvastatin|atorvastatin|mesh-list
19341035|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
19341036|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19341037|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341038|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341039|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341040|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20385993|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
20385994|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
20385995|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19400027|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19400028|NCT03630042|Rituximab|rituximab|mesh-list
19400029|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
20385996|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20385997|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
20385998|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20385999|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20386000|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20386001|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386002|NCT01053169|Thrombin|thrombin|mesh-list
20386003|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
20386004|NCT01053169|Coagulants|coagulants|mesh-ancestor
20386005|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
20386006|NCT01053208|Promethazine|promethazine|mesh-list
20386007|NCT01053208|Ibuprofen|ibuprofen|mesh-list
20386008|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386009|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20386010|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386011|NCT01053208|Analgesics|analgesics|mesh-ancestor
20386012|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
19400030|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19400031|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400032|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
19400033|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400034|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19400035|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19400036|NCT03630029|Hematinics|hematinics|mesh-ancestor
19400037|NCT03629847|Everolimus|everolimus|mesh-list
19400038|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400039|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400040|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
19400041|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400042|NCT03629717|Vitamin D|vitamin d|mesh-list
19400043|NCT03629717|Denosumab|denosumab|mesh-list
19400044|NCT03629717|Calcium|calcium|mesh-list
19400045|NCT03629717|Vitamins|vitamins|mesh-ancestor
19400046|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
19400047|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400048|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19400049|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19400050|NCT03629639|Metformin|metformin|mesh-list
19400051|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19400052|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400053|NCT03629613|Antioxidants|antioxidants|mesh-list
19400054|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400055|NCT03629613|Protective Agents|protective agents|mesh-ancestor
19400056|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400057|NCT03629600|Indomethacin|indomethacin|mesh-list
19400058|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19400059|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19400060|NCT03629600|Analgesics|analgesics|mesh-ancestor
19400061|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
20200138|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20200139|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20200140|NCT00248053|Analgesics|analgesics|mesh-ancestor
20200141|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
20200142|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200143|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400062|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386013|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400063|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400064|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400065|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20217651|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
20386014|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386015|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386016|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386017|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20386018|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341041|NCT03809442|Dexamethasone|dexamethasone|mesh-list
19341042|NCT03809442|Midazolam|midazolam|mesh-list
19341043|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
19341044|NCT03809442|Ketamine|ketamine|mesh-list
19341045|NCT03809442|Tramadol|tramadol|mesh-list
20386019|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20386020|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20386021|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386022|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
20386023|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
20386024|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
20386025|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
20386026|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341046|NCT03809442|Ropivacaine|ropivacaine|mesh-list
19843020|NCT00655980|Vitamins|vitamins|mesh-ancestor
19843021|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
19843022|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843023|NCT00655980|Hematinics|hematinics|mesh-ancestor
19843024|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
19843025|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20200144|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19341047|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19341048|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
19341049|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
19341050|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341051|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341052|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341053|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
20386027|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20386028|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
20386029|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
20386030|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386031|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20386032|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
20386033|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
19341054|NCT03809442|Hormones|hormones|mesh-ancestor
19341055|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341056|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19341057|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341058|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341059|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341060|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341061|NCT03809442|Analgesics|analgesics|mesh-ancestor
19341062|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
19341063|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19341064|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19341065|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19341066|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
19341067|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341068|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341069|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19341070|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341071|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
19341072|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
19341073|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19341074|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19341075|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
20200145|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200146|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200147|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200148|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200149|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20200150|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20200151|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200152|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20200153|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200154|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217652|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
20426400|NCT01280734|Melatonin|melatonin|mesh-list
20426401|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
19341076|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19843026|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
19341077|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19341078|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19341079|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341080|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
19341081|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
19341082|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341083|NCT03809442|Narcotics|narcotics|mesh-ancestor
19341084|NCT03809455|Fentanyl|fentanyl|mesh-list
19341085|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341086|NCT03809455|Narcotics|narcotics|mesh-ancestor
19341087|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341088|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341089|NCT03809455|Analgesics|analgesics|mesh-ancestor
19341090|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
19341091|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341092|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19341093|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341094|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
20386034|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20386035|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
20386036|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20386037|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20386038|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386039|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20386040|NCT01053325|Renal Agents|renal agents|mesh-ancestor
20386041|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386042|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
20386043|NCT01053338|Promethazine|promethazine|mesh-list
20386044|NCT01053338|Ibuprofen|ibuprofen|mesh-list
20386045|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386046|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20386047|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386048|NCT01053338|Analgesics|analgesics|mesh-ancestor
20386049|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
20386050|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341095|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
19341096|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19341097|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19341098|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19341099|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341100|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341101|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341102|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19341103|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19341104|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
19341105|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341106|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341107|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19341108|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19341109|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
19341110|NCT03809260|Metformin|metformin|mesh-list
19341111|NCT03809260|Vancomycin|vancomycin|mesh-list
19341112|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19341113|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341114|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19341115|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341116|NCT03809273|Trimetazidine|trimetazidine|mesh-list
20386051|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386052|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386053|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386054|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20386055|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386056|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20386057|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20386058|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386059|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
20386060|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
20386061|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
20386062|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
20386063|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341117|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
19341118|NCT03809065|Labetalol|labetalol|mesh-list
19341119|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
19341120|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
19341121|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19341122|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19341123|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
19341124|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341125|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341126|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341127|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19341128|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
19341129|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
19341130|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341131|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19341132|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19341133|NCT03809143|Buprenorphine|buprenorphine|mesh-list
19341134|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341135|NCT03809143|Narcotics|narcotics|mesh-ancestor
19341136|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341137|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341138|NCT03809143|Analgesics|analgesics|mesh-ancestor
19341139|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
19341140|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341141|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19341142|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19341143|NCT03809221|Hormones|hormones|mesh-list
19341144|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19341145|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341146|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341147|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
19341148|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19341149|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
19341150|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19341151|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19341152|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19341153|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341154|NCT03809156|Ambrisentan|ambrisentan|mesh-list
19341155|NCT03809156|Riociguat|riociguat|mesh-list
19341156|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
19341157|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341158|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19341159|NCT03808844|Propofol|propofol|mesh-list
19341160|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341161|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341162|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341163|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341164|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
19341165|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
19341166|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19341167|NCT03809078|Bombesin|bombesin|mesh-list
19341168|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19341169|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341170|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341171|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341172|NCT03808818|Nicotine|nicotine|mesh-list
19341173|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19341174|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
19341175|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341176|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341177|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19341178|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19341179|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
19341180|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341181|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341182|NCT03808805|Aprepitant|aprepitant|mesh-list
19341183|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
19341184|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
19341185|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
19341186|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
19682965|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20200155|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200156|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
20200157|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200158|NCT00248118|Bupropion|bupropion|mesh-list
20200159|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20200160|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200161|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200162|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20200163|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19341187|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341188|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200164|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200165|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200166|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
20200167|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200168|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200169|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20200170|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19341189|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341190|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19341191|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341192|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341193|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
19341194|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
19341195|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19341196|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
19341197|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
19341198|NCT03808649|Mannitol|mannitol|mesh-list
19341199|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19341200|NCT03808649|Diuretics|diuretics|mesh-ancestor
20386064|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20386065|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
20386066|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
20386067|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386068|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20386069|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
20386070|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
20386071|NCT01053377|Oseltamivir|oseltamivir|mesh-list
20200171|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200172|NCT00248131|Octreotide|octreotide|mesh-list
20200173|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20200174|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20200175|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200176|NCT00248144|Famciclovir|famciclovir|mesh-list
20200177|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
20200178|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200179|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20200180|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682966|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682967|NCT04084860|Ketamine|ketamine|mesh-list
19682968|NCT04084860|Analgesics|analgesics|mesh-ancestor
19682969|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
20200181|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200182|NCT00248157|Octreotide|octreotide|mesh-list
20200183|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341201|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
20386072|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
20386073|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386074|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386075|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341202|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341203|NCT03808168|Nivolumab|nivolumab|mesh-list
19341204|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19341205|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341206|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19341207|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341208|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
19341209|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19341210|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
19341211|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341212|NCT03808259|Ketamine|ketamine|mesh-list
19341213|NCT03808259|Esketamine|esketamine|mesh-list
19341214|NCT03808259|Analgesics|analgesics|mesh-ancestor
20200184|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20200185|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200186|NCT00248183|Naluzotan|naluzotan|mesh-list
20200187|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20200188|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20200189|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
20200190|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200191|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200192|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200193|NCT00248209|Bupropion|bupropion|mesh-list
20386076|NCT01053390|Leucovorin|leucovorin|mesh-list
19682970|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386077|NCT01053390|Fluorouracil|fluorouracil|mesh-list
20386078|NCT01053390|Epirubicin|epirubicin|mesh-list
20200194|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20200195|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200196|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200197|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20200198|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200199|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200200|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200201|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
20200202|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200203|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200204|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19682971|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19682972|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19682973|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19682974|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
19682975|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
19682976|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200205|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20200206|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200207|NCT00248248|Doxorubicin|doxorubicin|mesh-list
20200208|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19843027|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
19843028|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200209|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20200210|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200211|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19341215|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
19341216|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341217|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341218|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19341219|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341220|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
20386079|NCT01053390|Somatostatin|somatostatin|mesh-list
20200212|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200213|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200214|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200215|NCT00248261|Ziprasidone|ziprasidone|mesh-list
20200216|NCT00248261|Sertraline|sertraline|mesh-list
20200217|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200218|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200219|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20200220|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200221|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200222|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200223|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200224|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
20200225|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200226|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19341221|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
19341222|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341223|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19341224|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19341225|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341226|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341227|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
19341228|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341229|NCT03808129|Lidocaine|lidocaine|mesh-list
19341230|NCT03808129|Bupivacaine|bupivacaine|mesh-list
19341231|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
19341232|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
19341233|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341234|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341235|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
19341236|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200227|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200228|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200229|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200230|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19341237|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19341238|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19341239|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19682977|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20200231|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
20200232|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
20200233|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20200234|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200235|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
19341240|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19341241|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341242|NCT03808155|Tamsulosin|tamsulosin|mesh-list
19341243|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19341244|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19341245|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19341246|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
19341247|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341248|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341249|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341250|NCT03808155|Urological Agents|urological agents|mesh-ancestor
19843029|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19843030|NCT00655980|Analgesics|analgesics|mesh-ancestor
19341251|NCT03807999|Gemcitabine|gemcitabine|mesh-list
19341252|NCT03807999|Paclitaxel|paclitaxel|mesh-list
19341253|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19341254|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341255|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
19341256|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
19341257|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
19341258|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341259|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19341260|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
19341261|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
19341262|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341263|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341264|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19341265|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
19341266|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341267|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
19341268|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19341269|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
19341270|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341271|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
19341272|NCT03807596|Protective Agents|protective agents|mesh-ancestor
19341273|NCT03807882|Clozapine|clozapine|mesh-list
19341274|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19341275|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
19341276|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341277|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341278|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341279|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19341280|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19341281|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341282|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341283|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
19341284|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
19341285|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
19341286|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
19341287|NCT03807297|Propofol|propofol|mesh-list
19341288|NCT03807297|Sevoflurane|sevoflurane|mesh-list
19341289|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341290|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341291|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341292|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341293|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
19341294|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
19682978|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19682979|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341295|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341296|NCT03807297|Analgesics|analgesics|mesh-ancestor
19341297|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
19682980|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682981|NCT04079738|Ixazomib|ixazomib|mesh-list
19682982|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682983|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
19682984|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19682985|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682986|NCT04072822|Prednisone|prednisone|mesh-list
19843031|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
20200236|NCT00248313|Sirolimus|sirolimus|mesh-list
19843032|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843033|NCT00656019|Vitamin D|vitamin d|mesh-list
19843034|NCT00656019|Calcipotriene|calcipotriene|mesh-list
19843035|NCT00656019|Vitamins|vitamins|mesh-ancestor
19843036|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
19843037|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843038|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20200237|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20200238|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200239|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20200240|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200241|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
20200242|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20200243|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
19843039|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
19843040|NCT00656058|Montelukast|montelukast|mesh-list
19843041|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19843042|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
19843043|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20200244|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341298|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341299|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19341300|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19341301|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19341302|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
19341303|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341304|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341305|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19341306|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19400066|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
19400067|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
19400068|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19400069|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19400070|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400071|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400072|NCT03629522|Ondansetron|ondansetron|mesh-list
19400073|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
19400074|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
19400075|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400076|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400077|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400078|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
19400079|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
19400080|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19400081|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
19400082|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400083|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400084|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19400085|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200245|NCT00248339|Ribavirin|ribavirin|mesh-list
20200246|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20200247|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
20386080|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400086|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400087|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400088|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19400089|NCT03629418|Phenylephrine|phenylephrine|mesh-list
19400090|NCT03629418|Norepinephrine|norepinephrine|mesh-list
19400091|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19400092|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
19400093|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
19400094|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400095|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400096|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
20200248|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
20200249|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200250|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
20200251|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200252|NCT00248339|Hematinics|hematinics|mesh-ancestor
20200253|NCT00248430|Aldesleukin|aldesleukin|mesh-list
20200254|NCT00248430|Melphalan|melphalan|mesh-list
20200255|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20200256|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
20200257|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843044|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
20217653|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
19341307|NCT03807271|Anesthetics|anesthetics|mesh-list
19341308|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341309|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341310|NCT03807479|Ponatinib|ponatinib|mesh-list
19341311|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341312|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19341313|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341314|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341315|NCT03806985|Psilocybin|psilocybin|mesh-list
19341316|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
19341317|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341318|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341319|NCT03806816|Melatonin|melatonin|mesh-list
19341320|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
19341321|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341322|NCT03806816|Protective Agents|protective agents|mesh-ancestor
19341323|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341324|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341325|NCT03807011|Fentanyl|fentanyl|mesh-list
19341326|NCT03807011|Remifentanil|remifentanil|mesh-list
19341327|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341328|NCT03807011|Narcotics|narcotics|mesh-ancestor
19341329|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341330|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341331|NCT03807011|Analgesics|analgesics|mesh-ancestor
19341332|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
19682987|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19682988|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19682989|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
19682990|NCT04072822|Hormones|hormones|mesh-ancestor
19682991|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19682992|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200258|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200259|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20200260|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20200261|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
19341333|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341334|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20200262|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200263|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20200264|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20200265|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
19341335|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341336|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
19341337|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
19341338|NCT03806673|Bupivacaine|bupivacaine|mesh-list
19341339|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
19341340|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
19341341|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341342|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341343|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
19341344|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341345|NCT03806595|Lidocaine|lidocaine|mesh-list
19341346|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19341347|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
19341348|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
20200266|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200267|NCT00248456|Betamethasone|betamethasone|mesh-list
20200268|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
20200269|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20200270|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
20200271|NCT00248456|Calcipotriene|calcipotriene|mesh-list
19341349|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341350|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341351|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
19341352|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341353|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19341354|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19341355|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19341356|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200272|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20200273|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20200274|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
20200275|NCT00248456|Hormones|hormones|mesh-ancestor
20200276|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386081|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
20386082|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386083|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386084|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386085|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
20386086|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386087|NCT01053390|Antidotes|antidotes|mesh-ancestor
20386088|NCT01053390|Protective Agents|protective agents|mesh-ancestor
20386089|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
20386090|NCT01053390|Vitamins|vitamins|mesh-ancestor
20386091|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
20386092|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20386093|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20386094|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20386095|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386096|NCT01053390|Hormones|hormones|mesh-ancestor
20386097|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386098|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20386099|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
20386100|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386101|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386102|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
20386103|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386104|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386105|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19341357|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341358|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
20386106|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20386107|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20386108|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
20386109|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20386110|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20386111|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
19341359|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341360|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386112|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
20386113|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386114|NCT01053481|Vitamin D|vitamin d|mesh-list
20386115|NCT01053481|Vitamins|vitamins|mesh-ancestor
20386116|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
20386117|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386118|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20386119|NCT01053520|Navitoclax|navitoclax|mesh-list
20386120|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386121|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
20386122|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386123|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
19341361|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341362|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386124|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386125|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386126|NCT01053585|Baclofen|baclofen|mesh-list
20386127|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20386128|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386129|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20386130|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386131|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20386132|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
20386133|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
20386134|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386135|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386136|NCT01053611|Remifentanil|remifentanil|mesh-list
20386137|NCT01053611|Propofol|propofol|mesh-list
20386138|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20386139|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386140|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386141|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20386142|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
19341363|NCT03806777|Analgesics|analgesics|mesh-ancestor
19341364|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
19341365|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341366|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19341367|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20386143|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
20386144|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20386145|NCT01053611|Narcotics|narcotics|mesh-ancestor
20386146|NCT01053611|Analgesics|analgesics|mesh-ancestor
20386147|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
20386148|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386149|NCT01053637|Acetaminophen|acetaminophen|mesh-list
20386150|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20386151|NCT01053637|Hydrocodone|hydrocodone|mesh-list
20386152|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386153|NCT01053637|Analgesics|analgesics|mesh-ancestor
19341368|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19341369|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
19341370|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341371|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341372|NCT03807037|Tocotrienols|tocotrienols|mesh-list
19341373|NCT03807037|Vitamin E|vitamin e|mesh-list
19341374|NCT03807037|Tocopherols|tocopherols|mesh-list
19341375|NCT03807037|Tocovid|tocovid|mesh-list
19341376|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
19341377|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341378|NCT03807037|Protective Agents|protective agents|mesh-ancestor
19341379|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341380|NCT03807037|Vitamins|vitamins|mesh-ancestor
19341381|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
19341382|NCT03806582|Norepinephrine|norepinephrine|mesh-list
19341383|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19341384|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19341385|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
19341386|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341387|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19682993|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19682994|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19682995|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341388|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341389|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
19341390|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
19341391|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341392|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19341393|NCT03806530|Gabapentin|gabapentin|mesh-list
19682996|NCT04068194|Avelumab|avelumab|mesh-list
20200277|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200278|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19341394|NCT03806530|Ropinirole|ropinirole|mesh-list
19341395|NCT03806530|Analgesics|analgesics|mesh-ancestor
19341396|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
19682997|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20200279|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
20200280|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
20200281|NCT00248482|Cisplatin|cisplatin|mesh-list
20200282|NCT00248482|Irinotecan|irinotecan|mesh-list
20200283|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
20200284|NCT00248482|Camptothecin|camptothecin|mesh-list
20200285|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200286|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20200287|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200288|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341397|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341398|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200289|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200290|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20200291|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20200292|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
20200293|NCT00248716|Hematinics|hematinics|mesh-ancestor
20200294|NCT00248729|Midazolam|midazolam|mesh-list
20200295|NCT00248729|Etomidate|etomidate|mesh-list
20200296|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20200297|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20200298|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200299|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200300|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20200301|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200302|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200303|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341399|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
19682998|NCT04068194|Peposertib|peposertib|mesh-list
19682999|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683000|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200304|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
20386154|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
19341400|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19341401|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200305|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
19683001|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
19683002|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341402|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341403|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341404|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19341405|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19341406|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341407|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341408|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
19341409|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19341410|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19341411|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
19683003|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19683004|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683005|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683006|NCT04064918|Timolol|timolol|mesh-list
19683007|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19683008|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19683009|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
19683010|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683011|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683012|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683013|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19683014|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19683015|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
19683016|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19683017|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19683018|NCT04039347|Cyclosporine|cyclosporine|mesh-list
19683019|NCT04039347|Cyclosporins|cyclosporins|mesh-list
19683020|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341412|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
19341413|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
20386155|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386156|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386157|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
20386158|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20386159|NCT01053637|Narcotics|narcotics|mesh-ancestor
20386160|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386161|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
20386162|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
20386163|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20386164|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386165|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386166|NCT01053650|Acetaminophen|acetaminophen|mesh-list
20386167|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386168|NCT01053650|Analgesics|analgesics|mesh-ancestor
20386169|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
20386170|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341414|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19341415|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341416|NCT03806062|Domperidone|domperidone|mesh-list
19341417|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
19683021|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200306|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
20200307|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
20200308|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200309|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200310|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
20200311|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20200312|NCT00248963|Estradiol|estradiol|mesh-list
20200313|NCT00248963|Estrogens|estrogens|mesh-ancestor
20200314|NCT00248963|Hormones|hormones|mesh-ancestor
20200315|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20200316|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200317|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20200318|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
20200319|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20200320|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19341418|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
19341419|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341420|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341421|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341422|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19341423|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
20386171|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386172|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
20386173|NCT01053689|Glimepiride|glimepiride|mesh-list
20386174|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20386175|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20386176|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386177|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386178|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
20386179|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
20386180|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20386181|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386182|NCT01053806|Lenalidomide|lenalidomide|mesh-list
20386183|NCT01053806|Azacitidine|azacitidine|mesh-list
20386184|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
20386185|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386186|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19341424|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341425|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341426|NCT03806036|Vitamin D|vitamin d|mesh-list
19341427|NCT03806036|Clomiphene|clomiphene|mesh-list
19341428|NCT03806036|Enclomiphene|enclomiphene|mesh-list
19341429|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
19341430|NCT03806036|Vitamins|vitamins|mesh-ancestor
19341431|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
19341432|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341433|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19843045|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843046|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843047|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19843048|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19843049|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843050|NCT00656084|Gemcitabine|gemcitabine|mesh-list
19843051|NCT00656084|Rituximab|rituximab|mesh-list
19843052|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
19843053|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19843054|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843055|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
19843056|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200321|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19341434|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19341435|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
19341436|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341437|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19341438|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
19341439|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19341440|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19341441|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19341442|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
19341443|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341444|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341445|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341446|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341447|NCT03805945|Analgesics|analgesics|mesh-ancestor
19341448|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
19341449|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341450|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19341451|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19341452|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19341453|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
20200322|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20200323|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20200324|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20200325|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20200326|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
20200327|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200328|NCT00249041|Etanercept|etanercept|mesh-list
20200329|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20200330|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20200331|NCT00249041|Analgesics|analgesics|mesh-ancestor
20200332|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
20386187|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19341454|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341455|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341456|NCT03806374|Lidocaine|lidocaine|mesh-list
19341457|NCT03806374|Fentanyl|fentanyl|mesh-list
19341458|NCT03806374|Ketamine|ketamine|mesh-list
19341459|NCT03806374|Propofol|propofol|mesh-list
19341460|NCT03806374|Cisatracurium|cisatracurium|mesh-list
19341461|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
19341462|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
19341463|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341464|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341465|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
19341466|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341467|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19341468|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19341469|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19341470|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19341471|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341472|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341473|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341474|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
19341475|NCT03806374|Analgesics|analgesics|mesh-ancestor
19341476|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19341477|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19341478|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19341479|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341480|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341481|NCT03806374|Narcotics|narcotics|mesh-ancestor
19341482|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19341483|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19341484|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19341485|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20200333|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200334|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200335|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20200336|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200337|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20200338|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20200339|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
20200340|NCT00249106|Vaccines|vaccines|mesh-list
20200341|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
20200342|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200343|NCT00249119|Risperidone|risperidone|mesh-list
20200344|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200345|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
20200346|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200347|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200348|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200349|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200350|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200351|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200352|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200353|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200354|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
20200355|NCT00249132|Risperidone|risperidone|mesh-list
20200356|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200357|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
20200358|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200359|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200360|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200361|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200362|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200363|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200364|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200365|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200366|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
20200367|NCT00249145|Risperidone|risperidone|mesh-list
20200368|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200369|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
20200370|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200371|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341486|NCT03806101|Abrocitinib|abrocitinib|mesh-list
19843057|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386188|NCT01053806|Growth Substances|growth substances|mesh-ancestor
19341487|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20386189|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
20386190|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386191|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386192|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
20386193|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386194|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386195|NCT01053871|Fentanyl|fentanyl|mesh-list
20386196|NCT01053871|Midazolam|midazolam|mesh-list
20386197|NCT01053871|Propofol|propofol|mesh-list
20386198|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20386199|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386200|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386201|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20386202|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
20386203|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
20386204|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20386205|NCT01053871|Narcotics|narcotics|mesh-ancestor
20386206|NCT01053871|Analgesics|analgesics|mesh-ancestor
19341488|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19341489|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
19341490|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386207|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
20386208|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386209|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20386210|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20386211|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386212|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386213|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
20386214|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
20386215|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386216|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386217|NCT01053884|Anidulafungin|anidulafungin|mesh-list
20386218|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
20386219|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386220|NCT01053910|Ramipril|ramipril|mesh-list
20386221|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20386222|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
20386223|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386224|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386225|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20386226|NCT01053949|Thalidomide|thalidomide|mesh-list
20386227|NCT01053949|Pomalidomide|pomalidomide|mesh-list
20386228|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
20386229|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386230|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20386231|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20386232|NCT01053949|Growth Substances|growth substances|mesh-ancestor
20386233|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
20386234|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386235|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386236|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
20386237|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386238|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386239|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
20386240|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
20386241|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20386242|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19341491|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19341492|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19341493|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341494|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19341495|NCT03806049|Paclitaxel|paclitaxel|mesh-list
19341496|NCT03806049|Bevacizumab|bevacizumab|mesh-list
19341497|NCT03806049|Carboplatin|carboplatin|mesh-list
19341498|NCT03806049|Niraparib|niraparib|mesh-list
19341499|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19341500|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341501|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
19341502|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
20386243|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386244|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386245|NCT01054001|Urological Agents|urological agents|mesh-ancestor
20386246|NCT01054027|Phenylephrine|phenylephrine|mesh-list
19843058|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386247|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
19341503|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386248|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
19341504|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341505|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19341506|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19341507|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19341508|NCT03806049|Growth Substances|growth substances|mesh-ancestor
19341509|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341510|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
19341511|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19341512|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341513|NCT03805607|Ketorolac|ketorolac|mesh-list
19341514|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20386249|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20386250|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
19341515|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19341516|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341517|NCT03805607|Analgesics|analgesics|mesh-ancestor
19341518|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
19341519|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341520|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341521|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19341522|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341523|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19683022|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20200372|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200373|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20386251|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
20386252|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386253|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386254|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
20386255|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20386256|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
20386257|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
20386258|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20386259|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20386260|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20386261|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
20386262|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386263|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386264|NCT01054027|Protective Agents|protective agents|mesh-ancestor
20386265|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
20386266|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20386267|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20386268|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
20386269|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
20386270|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20386271|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341524|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341525|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341526|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
19341527|NCT03805568|Remifentanil|remifentanil|mesh-list
19341528|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341529|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341530|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341531|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341532|NCT03805568|Analgesics|analgesics|mesh-ancestor
19341533|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
19341534|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341535|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19341536|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19341537|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19341538|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
19341539|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200374|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200375|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200376|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19683023|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
19341540|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341541|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19683024|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200377|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200378|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
20200379|NCT00249158|Risperidone|risperidone|mesh-list
20386272|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19683025|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
19341542|NCT03805568|Narcotics|narcotics|mesh-ancestor
19341543|NCT03805633|Pancrelipase|pancrelipase|mesh-list
19341544|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341545|NCT03805282|Lidocaine|lidocaine|mesh-list
19341546|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
19341547|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
19341548|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341549|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341550|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
19341551|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341552|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19341553|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19683026|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683027|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
19683028|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683029|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19683030|NCT04001504|Vaccines|vaccines|mesh-list
19341554|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19341555|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19341556|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683031|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
19683032|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683033|NCT03999710|Durvalumab|durvalumab|mesh-list
19683034|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683035|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683036|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
19341557|NCT03805360|Ropivacaine|ropivacaine|mesh-list
19341558|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
19341559|NCT03805360|Anesthetics|anesthetics|mesh-list
19341560|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341561|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341562|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
19341563|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341564|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
19341565|NCT03805503|Procaine|procaine|mesh-list
19341566|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683037|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
19683038|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19683039|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
19683040|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19683041|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19683042|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683043|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19683044|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683045|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683046|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19683047|NCT03998839|Renal Agents|renal agents|mesh-ancestor
19683048|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19683049|NCT03995641|Bupivacaine|bupivacaine|mesh-list
20200380|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200381|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
20200382|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200383|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200384|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200385|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200386|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200387|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386273|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386274|NCT01054105|Iloprost|iloprost|mesh-list
20386275|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20386276|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
19341567|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
19341568|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386277|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20386278|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20386279|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386280|NCT01054118|Incretins|incretins|mesh-ancestor
20386281|NCT01054118|Hormones|hormones|mesh-ancestor
20386282|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341569|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341570|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
19683050|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683051|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
20200388|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200389|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20386283|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20386284|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
20386285|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386286|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386287|NCT01054313|Sirolimus|sirolimus|mesh-list
20386288|NCT01054313|Prednisone|prednisone|mesh-list
20386289|NCT01054313|Docetaxel|docetaxel|mesh-list
20386290|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386291|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
20386292|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
19341571|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341572|NCT03805178|Abatacept|abatacept|mesh-list
19341573|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19341574|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341575|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341576|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19341577|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
19341578|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341579|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19400097|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19400098|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
19400099|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
19400100|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19400101|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400102|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400103|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400104|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400105|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386293|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386294|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386295|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386296|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
20386297|NCT01054313|Hormones|hormones|mesh-ancestor
20386298|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386299|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386300|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20386301|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386302|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386303|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20386304|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
20386305|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386306|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
20386307|NCT01054469|Ropivacaine|ropivacaine|mesh-list
20386308|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
20386309|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
20386310|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386311|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400106|NCT03629418|Protective Agents|protective agents|mesh-ancestor
19400107|NCT03629379|Ustekinumab|ustekinumab|mesh-list
19400108|NCT03629379|Vedolizumab|vedolizumab|mesh-list
19400109|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
19400110|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400111|NCT03629288|Azithromycin|azithromycin|mesh-list
19400112|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19400113|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400114|NCT03629262|Sufentanil|sufentanil|mesh-list
19400115|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
19400116|NCT03629262|Dsuvia|dsuvia|mesh-list
19400117|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19400118|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400119|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400120|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20200390|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
20200391|NCT00249171|Risperidone|risperidone|mesh-list
20200392|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200393|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
20200394|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200395|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200396|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200397|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200398|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200399|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200400|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200401|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200402|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
19341580|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19341581|NCT03804931|Prednisone|prednisone|mesh-list
19341582|NCT03804931|Mesalamine|mesalamine|mesh-list
19341583|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19341584|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
19341585|NCT03804931|Hormones|hormones|mesh-ancestor
19341586|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341587|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341588|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19341589|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386312|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
20386313|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386314|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
20386315|NCT01054508|Niacin|niacin|mesh-list
20386316|NCT01054508|Niacinamide|niacinamide|mesh-list
20386317|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
20386318|NCT01054508|Vitamins|vitamins|mesh-ancestor
20386319|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
20386320|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386321|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20386322|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
20386323|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386324|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20386325|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
20386326|NCT01054547|Anesthetics|anesthetics|mesh-list
20386327|NCT01054547|Ropivacaine|ropivacaine|mesh-list
20386328|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386329|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386330|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
20386331|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
20386332|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386333|NCT01054651|Artesunate|artesunate|mesh-list
20386334|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
20386335|NCT01054651|Sulfalene|sulfalene|mesh-list
20386336|NCT01054651|Praziquantel|praziquantel|mesh-list
20386337|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
20386338|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20386339|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20386340|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386341|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386342|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
20386343|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
20386344|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20386345|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
20386346|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20386347|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386348|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386349|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20386350|NCT01054651|Renal Agents|renal agents|mesh-ancestor
20386351|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19341590|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19341591|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341592|NCT03804931|Analgesics|analgesics|mesh-ancestor
19341593|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
19341594|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341595|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341596|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
19341597|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19341598|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341599|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19341600|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19341601|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20386352|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386353|NCT01054781|Rituximab|rituximab|mesh-list
20386354|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20386355|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386356|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
19341602|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19341603|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341604|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
19341605|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341606|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843059|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
20386357|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386358|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386359|NCT01054872|Vaccines|vaccines|mesh-list
20386360|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
19341607|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19341608|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341609|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
19341610|NCT03805035|Maleic acid|maleic acid|mesh-list
20386361|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386362|NCT01055041|Budesonide|budesonide|mesh-list
20386363|NCT01055041|Doxofylline|doxofylline|mesh-list
20386364|NCT01055041|Montelukast|montelukast|mesh-list
20386365|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386366|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20386367|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
20386368|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341611|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
19341612|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
19341613|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19341614|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341615|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341616|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
19341617|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341618|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386369|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386370|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20386371|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
20386372|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
20386373|NCT01055041|Hormones|hormones|mesh-ancestor
20386374|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386375|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20386376|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
19341619|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
19341620|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
19341621|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19341622|NCT03804866|Doxorubicin|doxorubicin|mesh-list
19341623|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19341624|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19341625|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341626|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19341627|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19341628|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341629|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341630|NCT03804840|Dronabinol|dronabinol|mesh-list
20386377|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20386378|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20386379|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386380|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
20386381|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20386382|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386383|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
20386384|NCT01055145|Levofloxacin|levofloxacin|mesh-list
20386385|NCT01055145|Ofloxacin|ofloxacin|mesh-list
20386386|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386387|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386388|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20386389|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20386390|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386391|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386392|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386393|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20386394|NCT01055145|Renal Agents|renal agents|mesh-ancestor
20386395|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20386396|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20426402|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426403|NCT01280734|Protective Agents|protective agents|mesh-ancestor
20426404|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426405|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426406|NCT01280929|Ranibizumab|ranibizumab|mesh-list
20426407|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20426408|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20426409|NCT01280929|Growth Substances|growth substances|mesh-ancestor
20426410|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341631|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
19341632|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341633|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341634|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20426411|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
19341635|NCT03804840|Analgesics|analgesics|mesh-ancestor
19341636|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
19341637|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341638|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19341639|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19341640|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200403|NCT00249197|Levofloxacin|levofloxacin|mesh-list
20200404|NCT00249197|Ofloxacin|ofloxacin|mesh-list
20200405|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20200406|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200407|NCT00249197|Renal Agents|renal agents|mesh-ancestor
19341641|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341642|NCT03804840|Hormones|hormones|mesh-ancestor
19341643|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341644|NCT03804749|Suramin|suramin|mesh-list
19341645|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
20200408|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20200409|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20200410|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200411|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200412|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200413|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200414|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20200415|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20200416|NCT00249210|Levofloxacin|levofloxacin|mesh-list
20200417|NCT00249210|Ofloxacin|ofloxacin|mesh-list
20200418|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20200419|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200420|NCT00249210|Renal Agents|renal agents|mesh-ancestor
20200421|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20200422|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20200423|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200424|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200425|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200426|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200427|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20200428|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20200429|NCT00249223|Risperidone|risperidone|mesh-list
20200430|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200431|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
20200432|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200433|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200434|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200435|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200436|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200437|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200438|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200439|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200440|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
20200441|NCT00249236|Risperidone|risperidone|mesh-list
20200442|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19341646|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
19341647|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19341648|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341649|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341650|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19341651|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19341652|NCT03804372|Tenofovir|tenofovir|mesh-list
19341653|NCT03804372|Rituximab|rituximab|mesh-list
19341654|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19341655|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200443|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
20200444|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200445|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341656|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
19341657|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341658|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341659|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
20200446|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200447|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19341660|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341661|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20200448|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19341662|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19341663|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341664|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341665|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19341666|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19341667|NCT03804541|Ensartinib|ensartinib|mesh-list
19341668|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341669|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19341670|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341671|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341672|NCT03804723|Prednisone|prednisone|mesh-list
19341673|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19341674|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
20386397|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
20386398|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
20386399|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
20386400|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20386401|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
20386402|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
20386403|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386404|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386405|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386406|NCT01055249|Ibuprofen|ibuprofen|mesh-list
20386407|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
19341675|NCT03804723|Hormones|hormones|mesh-ancestor
19341676|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20200449|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200450|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200451|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200452|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
20200453|NCT00249353|Methylphenidate|methylphenidate|mesh-list
20200454|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20200455|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200456|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20200457|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19341677|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386408|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20386409|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20386410|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20386411|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20386412|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386413|NCT01055249|Analgesics|analgesics|mesh-ancestor
20386414|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
20386415|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386416|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386417|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386418|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341678|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19341679|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341680|NCT03804359|Rituximab|rituximab|mesh-list
19341681|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19341682|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386419|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20386420|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386421|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341683|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
19341684|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341685|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200458|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200459|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386422|NCT01055301|Thalidomide|thalidomide|mesh-list
19341686|NCT03804034|Molybdenum|molybdenum|mesh-list
20200460|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
20200461|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200462|NCT00249366|Lorazepam|lorazepam|mesh-list
20200463|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
20200464|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
20200465|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
20200466|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200467|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200468|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20200469|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20200470|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341687|NCT03804034|Trace Elements|trace elements|mesh-ancestor
19341688|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
19341689|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341690|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
19341691|NCT03804177|Melatonin|melatonin|mesh-list
19341692|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
19341693|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
19341694|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341695|NCT03804177|Protective Agents|protective agents|mesh-ancestor
19341696|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341697|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341698|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19341699|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
19341700|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
19341701|NCT03804177|Vitamins|vitamins|mesh-ancestor
19341702|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
19341703|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19341704|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19341705|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19341706|NCT03804229|Protective Agents|protective agents|mesh-ancestor
19341707|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341708|NCT03803553|Fluorouracil|fluorouracil|mesh-list
19341709|NCT03803553|Nivolumab|nivolumab|mesh-list
19341710|NCT03803553|Irinotecan|irinotecan|mesh-list
19341711|NCT03803553|Cetuximab|cetuximab|mesh-list
19341712|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
19341713|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341714|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19341715|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341716|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19341717|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
19341718|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341719|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19341720|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19341721|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19341722|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19341723|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341724|NCT03803787|Budesonide|budesonide|mesh-list
19341725|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19341726|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19341727|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
19843060|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843061|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
19843062|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843063|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843064|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843065|NCT00656084|Analgesics|analgesics|mesh-ancestor
19843066|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
19843067|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843068|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19843069|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19843070|NCT00656136|Afatinib|afatinib|mesh-list
19843071|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843072|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19843073|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843074|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843075|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
19341728|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341729|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341730|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19341731|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
19341732|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
19341733|NCT03803787|Hormones|hormones|mesh-ancestor
19341734|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19341735|NCT03803514|Epoetin Alfa|epoetin alfa|mesh-list
19341736|NCT03803514|Hematinics|hematinics|mesh-ancestor
19341737|NCT03803449|Fentanyl|fentanyl|mesh-list
19341738|NCT03803449|Midazolam|midazolam|mesh-list
19341739|NCT03803449|Propofol|propofol|mesh-list
19341740|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341741|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341742|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341743|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341744|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
19341745|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
19341746|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341747|NCT03803449|Narcotics|narcotics|mesh-ancestor
19341748|NCT03803449|Analgesics|analgesics|mesh-ancestor
19341749|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
19341750|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341751|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19341752|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19341753|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19341754|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341755|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
19341756|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
19341757|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341758|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341759|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
19341760|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19341761|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400121|NCT03629262|Analgesics|analgesics|mesh-ancestor
19400122|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
19400123|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400124|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19400125|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400126|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400127|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400128|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400129|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400130|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19400131|NCT03629262|Narcotics|narcotics|mesh-ancestor
19400132|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19400133|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19400134|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
19400135|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
19400136|NCT03629223|Tepotinib|tepotinib|mesh-list
19400137|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400138|NCT03629210|Dexamethasone|dexamethasone|mesh-list
19400139|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400140|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
19400141|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
20386423|NCT01055301|Dexamethasone|dexamethasone|mesh-list
20386424|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
20386425|NCT01055301|Melphalan|melphalan|mesh-list
20386426|NCT01055301|Doxorubicin|doxorubicin|mesh-list
20386427|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20386428|NCT01055301|Etoposide|etoposide|mesh-list
20386429|NCT01055301|Lenalidomide|lenalidomide|mesh-list
20386430|NCT01055301|Bortezomib|bortezomib|mesh-list
20386431|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400142|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400143|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400144|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400145|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
19400146|NCT03629210|Hormones|hormones|mesh-ancestor
19400147|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400148|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19400149|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400150|NCT03629093|Anesthetics|anesthetics|mesh-list
19400151|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
20200471|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20200472|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386432|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
20386433|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386434|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386435|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20386436|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
20386437|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386438|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386439|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20200473|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200474|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
20200475|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
20200476|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200477|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200478|NCT00249405|Citalopram|citalopram|mesh-list
20200479|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20200480|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200481|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200482|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386440|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400152|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200483|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200484|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
19341762|NCT03803371|Acetaminophen|acetaminophen|mesh-list
19341763|NCT03803371|Tramadol|tramadol|mesh-list
19341764|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341765|NCT03803371|Analgesics|analgesics|mesh-ancestor
19341766|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
19341767|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341768|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386441|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
20386442|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
20386443|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386444|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20386445|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
20386446|NCT01055301|Hormones|hormones|mesh-ancestor
20386447|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386448|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20386449|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20386450|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20386451|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20386452|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386453|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20386454|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20386455|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20386456|NCT01055301|Growth Substances|growth substances|mesh-ancestor
20386457|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
20386458|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
20386459|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386460|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386461|NCT01055327|Lamotrigine|lamotrigine|mesh-list
20386462|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
20386463|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20386464|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20386465|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386466|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20386467|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386468|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19341769|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
19341770|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341771|NCT03803371|Narcotics|narcotics|mesh-ancestor
19341772|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341773|NCT03803254|Lenvatinib|lenvatinib|mesh-list
19341774|NCT03803254|Antibodies|antibodies|mesh-list
19341775|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
20386469|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386470|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386471|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386472|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20386473|NCT01055379|Rasagiline|rasagiline|mesh-list
19341776|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341777|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341778|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20386474|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20386475|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386476|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386477|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20386478|NCT01055379|Protective Agents|protective agents|mesh-ancestor
19341779|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341780|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341781|NCT03803124|Tolvaptan|tolvaptan|mesh-list
19341782|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19341783|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341784|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
19341785|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341786|NCT03803267|Fentanyl|fentanyl|mesh-list
19341787|NCT03803267|Propofol|propofol|mesh-list
19341788|NCT03803267|Atracurium|atracurium|mesh-list
19341789|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
19341790|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341791|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341792|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19341793|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19341794|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
19341795|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341796|NCT03803267|Narcotics|narcotics|mesh-ancestor
19341797|NCT03803267|Analgesics|analgesics|mesh-ancestor
19341798|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
19341799|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341800|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19341801|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19341802|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19341803|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19341804|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19341805|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19341806|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
19341807|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341808|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341809|NCT03803007|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19341810|NCT03803007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19341811|NCT03803007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19341812|NCT03803007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341813|NCT03803215|Theophylline|theophylline|mesh-list
19341814|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19341815|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
19341816|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341817|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341818|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19341819|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
19341820|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19341821|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200485|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200486|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20200487|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200488|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200489|NCT00249431|Sertraline|sertraline|mesh-list
20200490|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
19341822|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341823|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
19341824|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19341825|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19341826|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
20200491|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341827|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341828|NCT03803163|Treprostinil|treprostinil|mesh-list
19341829|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19341830|NCT03802747|Durvalumab|durvalumab|mesh-list
19341831|NCT03802747|Tremelimumab|tremelimumab|mesh-list
19341832|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19341833|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19341834|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341835|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
19341836|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341837|NCT03802838|Amisulpride|amisulpride|mesh-list
19341838|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19341839|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19341840|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341841|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341842|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19341843|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19341844|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
19341845|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341846|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341847|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19341848|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
19341849|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
19341850|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19341851|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
19341852|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341853|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341854|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19341855|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
19341856|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341857|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341858|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19341859|NCT03802552|Cephalexin|cephalexin|mesh-list
19341860|NCT03802552|Cefadroxil|cefadroxil|mesh-list
19341861|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19341862|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341863|NCT03802318|Amoxicillin|amoxicillin|mesh-list
19341864|NCT03802318|Rabeprazole|rabeprazole|mesh-list
20200492|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20386479|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386480|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
20386481|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
20386482|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386483|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386484|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386485|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
20386486|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386487|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386488|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386489|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
20386490|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
20386491|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20386492|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20386493|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386494|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341865|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19341866|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341867|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19341868|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341869|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19341870|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341871|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341872|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
20386495|NCT01055405|Urological Agents|urological agents|mesh-ancestor
20386496|NCT01055418|Ascorbic Acid|ascorbic acid|mesh-list
20386497|NCT01055418|Vitamins|vitamins|mesh-ancestor
20386498|NCT01055418|Micronutrients|micronutrients|mesh-ancestor
20386499|NCT01055418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386500|NCT01055418|Antioxidants|antioxidants|mesh-ancestor
20386501|NCT01055418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386502|NCT01055418|Protective Agents|protective agents|mesh-ancestor
20386503|NCT01055431|Iron|iron|mesh-list
20386504|NCT01055431|Trace Elements|trace elements|mesh-ancestor
20386505|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
20386506|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386507|NCT01055470|Diclofenac|diclofenac|mesh-list
20386508|NCT01055470|Lornoxicam|lornoxicam|mesh-list
20386509|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20386510|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386511|NCT01055470|Analgesics|analgesics|mesh-ancestor
20386512|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
20386513|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386514|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386515|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386516|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386517|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20386518|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386519|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386520|NCT01055483|Panobinostat|panobinostat|mesh-list
20386521|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341873|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
20386522|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20386523|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341874|NCT03802422|Vitamins|vitamins|mesh-ancestor
19341875|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
19341876|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341877|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
19341878|NCT03802422|Hematinics|hematinics|mesh-ancestor
19341879|NCT03802071|Doxorubicin|doxorubicin|mesh-list
19341880|NCT03802071|Durvalumab|durvalumab|mesh-list
19341881|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19341882|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341883|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19341884|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19341885|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341886|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341887|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20386524|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341888|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
19341889|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19341890|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
19341891|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19341892|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386525|NCT01055522|Interleukin-2|interleukin-2|mesh-list
19341893|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19341894|NCT03802032|Lidocaine|lidocaine|mesh-list
20386526|NCT01055522|Dacarbazine|dacarbazine|mesh-list
20386527|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386528|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386529|NCT01055522|Analgesics|analgesics|mesh-ancestor
20386530|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
20386531|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386532|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386533|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20386534|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
20386535|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386536|NCT01055535|Plasminogen|plasminogen|mesh-list
20386537|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20386538|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20386539|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341895|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
19341896|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
19341897|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341898|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341899|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
19341900|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341901|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19341902|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19341903|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19341904|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19341905|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386540|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
20386541|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20386542|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386543|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20386544|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386545|NCT01055691|Metformin|metformin|mesh-list
20386546|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
20386547|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20386548|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200493|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200494|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20386549|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20386550|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386551|NCT01055743|Fluorouracil|fluorouracil|mesh-list
20386552|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
20386553|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386554|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386555|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386556|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386557|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
20386558|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386559|NCT01055756|Loratadine|loratadine|mesh-list
20386560|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
20386561|NCT01055756|Ephedrine|ephedrine|mesh-list
20386562|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
20386563|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
20386564|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20386565|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20386566|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20386567|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
19341906|NCT03802214|Vedolizumab|vedolizumab|mesh-list
19341907|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341908|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
19341909|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341910|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20200495|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200496|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200497|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
20200498|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200499|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20200500|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20200501|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200502|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200503|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386568|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
20386569|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386570|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386571|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386572|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19341911|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341912|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341913|NCT03802162|Memantine|memantine|mesh-list
19341914|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19341915|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19341916|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
19341917|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19341918|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341919|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341920|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19341921|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19341922|NCT03801603|Vaccines|vaccines|mesh-list
19341923|NCT03801603|Immunologic Factors|immunologic factors|mesh-ancestor
19341924|NCT03801603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341925|NCT03801746|Cyclosporine|cyclosporine|mesh-list
19341926|NCT03801746|Rifampin|rifampin|mesh-list
19341927|NCT03801746|Probenecid|probenecid|mesh-list
19341928|NCT03801746|Cyclosporins|cyclosporins|mesh-list
19341929|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341930|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341931|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386573|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
20386574|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386575|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20386576|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
20386577|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
20386578|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20386579|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20386580|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
20386581|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
20386582|NCT01055795|Bevacizumab|bevacizumab|mesh-list
20386583|NCT01055795|Everolimus|everolimus|mesh-list
20386584|NCT01055795|Panobinostat|panobinostat|mesh-list
20386585|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20386586|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386587|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20386588|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20386589|NCT01055795|Growth Substances|growth substances|mesh-ancestor
19341932|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
19341933|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341934|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
19341935|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341936|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
20200504|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200505|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200506|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20200507|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200508|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200509|NCT00249509|Bupropion|bupropion|mesh-list
20200510|NCT00249509|Nefazodone|nefazodone|mesh-list
20200511|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20200512|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200513|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200514|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20200515|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200516|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200517|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200518|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
20200519|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200520|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200521|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20200522|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20200523|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200524|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20200525|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19341937|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341938|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19843076|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20386590|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386591|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
20386592|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19341939|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19341940|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
19341941|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19341942|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
19341943|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19341944|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19341945|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19341946|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19341947|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19341948|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19341949|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19341950|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
19341951|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
19341952|NCT03801746|Renal Agents|renal agents|mesh-ancestor
19341953|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
19341954|NCT03801733|Atorvastatin|atorvastatin|mesh-list
19341955|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19341956|NCT03801733|Simvastatin|simvastatin|mesh-list
19341957|NCT03801733|Pravastatin|pravastatin|mesh-list
19341958|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19341959|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19341960|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
19341961|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341962|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19341963|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20200526|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200527|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
20200528|NCT00249574|Buprenorphine|buprenorphine|mesh-list
19341964|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19341965|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341966|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19341967|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19341968|NCT03801733|Analgesics|analgesics|mesh-ancestor
19341969|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
19683052|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683053|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683054|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
19683055|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683056|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19683057|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
20200529|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20200530|NCT00249574|Naloxone|naloxone|mesh-list
20200531|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20200532|NCT00249574|Narcotics|narcotics|mesh-ancestor
20200533|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200534|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200535|NCT00249574|Analgesics|analgesics|mesh-ancestor
20200536|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
20200537|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683058|NCT03995641|Hormones|hormones|mesh-ancestor
19683059|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683060|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683061|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
19683062|NCT03990766|Theophylline|theophylline|mesh-list
19683063|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19683064|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
20200538|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20200539|NCT00249587|Methadone|methadone|mesh-list
20612930|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19683065|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683066|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683067|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19683068|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
19843077|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20200540|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20200541|NCT00249587|Narcotics|narcotics|mesh-ancestor
20386593|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
20386594|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20386595|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386596|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386597|NCT01055808|Insulin|insulin|mesh-list
19341970|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341971|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341972|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19341973|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19341974|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19341975|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
20612931|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20200542|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200543|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200544|NCT00249587|Analgesics|analgesics|mesh-ancestor
20200545|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
20200546|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386598|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19341976|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19341977|NCT03801707|Velpatasvir|velpatasvir|mesh-list
19341978|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
19341979|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19341980|NCT03801668|Paclitaxel|paclitaxel|mesh-list
19341981|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
19341982|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19341983|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19341984|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19341985|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
19341986|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
19341987|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
19341988|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19341989|NCT03801629|Morphine|morphine|mesh-list
19341990|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19341991|NCT03801629|Narcotics|narcotics|mesh-ancestor
19341992|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19341993|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19341994|NCT03801629|Analgesics|analgesics|mesh-ancestor
19341995|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
19341996|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19341997|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
19341998|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19341999|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
20386599|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386600|NCT01055821|Interferons|interferons|mesh-list
19342000|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342001|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
19342002|NCT03801564|Protective Agents|protective agents|mesh-ancestor
19342003|NCT03801590|Riboflavin|riboflavin|mesh-list
19342004|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
19342005|NCT03801590|Vitamins|vitamins|mesh-ancestor
19342006|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
19342007|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342008|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19342009|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
19342010|NCT03801759|Adefovir|adefovir|mesh-list
19342011|NCT03801759|Digoxin|digoxin|mesh-list
19342012|NCT03801759|Furosemide|furosemide|mesh-list
19342013|NCT03801759|Diuretics|diuretics|mesh-ancestor
19342014|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
19342015|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342016|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19342017|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342018|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342019|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19342020|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19342021|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342022|NCT03801759|Protective Agents|protective agents|mesh-ancestor
19342023|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
19342024|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342025|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19342026|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19342027|NCT03801499|Lenvatinib|lenvatinib|mesh-list
19342028|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200547|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
20200548|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
20200549|NCT00249691|Topiramate|topiramate|mesh-list
20200550|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
20200551|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19342029|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20200552|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200553|NCT00249704|Vitamin D|vitamin d|mesh-list
19342030|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386601|NCT01055821|Ribavirin|ribavirin|mesh-list
19342031|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400153|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400154|NCT03628625|Letrozole|letrozole|mesh-list
19400155|NCT03628625|Misoprostol|misoprostol|mesh-list
19400156|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400157|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19400158|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19400159|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400160|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400161|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19400162|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
19400163|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400164|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400165|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19400166|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
19400167|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19400168|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19400169|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400170|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
19404501|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404502|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20200554|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
20200555|NCT00249704|Vitamins|vitamins|mesh-list
20200556|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
20200557|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200558|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20200559|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19404503|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
20217654|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217655|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19404504|NCT03594396|Durvalumab|durvalumab|mesh-list
19404505|NCT03594396|Olaparib|olaparib|mesh-list
19404506|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19404507|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404508|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20217656|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
20217657|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
20217658|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217659|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404509|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217660|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217661|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
20217662|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217663|NCT00310024|Bortezomib|bortezomib|mesh-list
20217664|NCT00310024|Vorinostat|vorinostat|mesh-list
20217665|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217666|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19404510|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404511|NCT03594240|Folic Acid|folic acid|mesh-list
19404512|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
19404513|NCT03594240|Vitamins|vitamins|mesh-ancestor
19404514|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
19404515|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404516|NCT03594240|Hematinics|hematinics|mesh-ancestor
19404517|NCT03594214|Vitamin D|vitamin d|mesh-list
19404518|NCT03594214|Vitamins|vitamins|mesh-ancestor
19404519|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
19404520|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404521|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19404522|NCT03594188|Anesthetics|anesthetics|mesh-list
19404523|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404524|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404525|NCT03594149|Levofloxacin|levofloxacin|mesh-list
19404526|NCT03594149|Ofloxacin|ofloxacin|mesh-list
19404527|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19404528|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404529|NCT03594149|Renal Agents|renal agents|mesh-ancestor
19404530|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19404531|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19404532|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19404533|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404534|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217667|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217668|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342032|NCT03801252|Azithromycin|azithromycin|mesh-list
19342033|NCT03801252|Cefazolin|cefazolin|mesh-list
19342034|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19342035|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386602|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386603|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
20386604|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386605|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
20200560|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
20200561|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
20200562|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20200563|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20200564|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200565|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200566|NCT00249730|Urological Agents|urological agents|mesh-ancestor
20200567|NCT00249782|Metronidazole|metronidazole|mesh-list
20386606|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386607|NCT01055847|Aztreonam|aztreonam|mesh-list
19342036|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
19342037|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19342038|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342039|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
19342040|NCT03801226|Calcium|calcium|mesh-list
20200568|NCT00249782|Dapsone|dapsone|mesh-list
20200569|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200570|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20200571|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20200572|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19683069|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19683070|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683071|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683072|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
20386608|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386609|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386610|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20386611|NCT01055925|Laxatives|laxatives|mesh-ancestor
20386612|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20386613|NCT01055938|Valproic Acid|valproic acid|mesh-list
20386614|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
20386615|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386616|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386617|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
19683073|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19683074|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20200573|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
20200574|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20386618|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386619|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386620|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
20386621|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386622|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386623|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386624|NCT01055964|Tacrolimus|tacrolimus|mesh-list
20386625|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386626|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
20386627|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386628|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20386629|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386630|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386631|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20386632|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20386633|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
20386634|NCT01056042|Gestodene|gestodene|mesh-list
20386635|NCT01056042|Estradiol|estradiol|mesh-list
20386636|NCT01056042|Estrogens|estrogens|mesh-ancestor
20386637|NCT01056042|Hormones|hormones|mesh-ancestor
20386638|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386639|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386640|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20386641|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
19342041|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19400171|NCT03628521|Gemcitabine|gemcitabine|mesh-list
19683075|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
19683076|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200575|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217669|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
20386642|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20386643|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20386644|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20386645|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19342042|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342043|NCT03801031|Lidocaine|lidocaine|mesh-list
19342044|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342045|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
19342046|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342047|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342048|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
19342049|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342050|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19342051|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19342052|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19342053|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342054|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342055|NCT03801317|Micronutrients|micronutrients|mesh-list
20386646|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20386647|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20386648|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20386649|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386650|NCT01056042|Progestins|progestins|mesh-ancestor
20386651|NCT01056172|Ribavirin|ribavirin|mesh-list
19342056|NCT03801317|Trace Elements|trace elements|mesh-list
19342057|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342058|NCT03800953|Avelumab|avelumab|mesh-list
19342059|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342060|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342061|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
19342062|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19342063|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
19342064|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342065|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
19342066|NCT03800810|Protective Agents|protective agents|mesh-ancestor
19342067|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
19342068|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
19342069|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342070|NCT03800667|Protective Agents|protective agents|mesh-ancestor
19342071|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342072|NCT03800667|Vitamins|vitamins|mesh-ancestor
19342073|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
19342074|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19342075|NCT03800745|Laxatives|laxatives|mesh-ancestor
19342076|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342077|NCT03800693|Leucovorin|leucovorin|mesh-list
19342078|NCT03800693|Fluorouracil|fluorouracil|mesh-list
19342079|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
19342080|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
19342081|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683077|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
19683078|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
19683079|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843078|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
19843079|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843080|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19843081|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19843082|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683080|NCT03965468|Paclitaxel|paclitaxel|mesh-list
19683081|NCT03965468|Carboplatin|carboplatin|mesh-list
19683082|NCT03965468|Durvalumab|durvalumab|mesh-list
19683083|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19683084|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683085|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
19683086|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
19683087|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683088|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386652|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19342082|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19342083|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342084|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342085|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
19342086|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342087|NCT03800693|Antidotes|antidotes|mesh-ancestor
19342088|NCT03800693|Protective Agents|protective agents|mesh-ancestor
19683089|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342089|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
19683090|NCT03954327|Tenofovir|tenofovir|mesh-list
19342090|NCT03800693|Vitamins|vitamins|mesh-ancestor
19342091|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
19342092|NCT03800550|Clarithromycin|clarithromycin|mesh-list
19342093|NCT03800550|Bedaquiline|bedaquiline|mesh-list
19342094|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19342095|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342096|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19342097|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342098|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342099|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19342100|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19342101|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
19342102|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
19342103|NCT03800264|Bisoprolol|bisoprolol|mesh-list
19342104|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342105|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19342106|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
19342107|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
19342108|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342109|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342110|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19342111|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19342112|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19342113|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
19843083|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843084|NCT00656201|Progesterone|progesterone|mesh-list
19843085|NCT00656201|Progestins|progestins|mesh-ancestor
20386653|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
20386654|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
20386655|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386656|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
19843086|NCT00656201|Hormones|hormones|mesh-ancestor
19843087|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843088|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843089|NCT00656292|Simvastatin|simvastatin|mesh-list
19843090|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19843091|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19843092|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
19843093|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843094|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20386657|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342114|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342115|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342116|NCT03800797|Loxoprofen|loxoprofen|mesh-list
19342117|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20386658|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
20386659|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386660|NCT01056224|Remifentanil|remifentanil|mesh-list
20386661|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20386662|NCT01056224|Narcotics|narcotics|mesh-ancestor
20386663|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386664|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386665|NCT01056224|Analgesics|analgesics|mesh-ancestor
20386666|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
20386667|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386668|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
20386669|NCT01056237|Azathioprine|azathioprine|mesh-list
20386670|NCT01056237|Tacrolimus|tacrolimus|mesh-list
19342118|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19342119|NCT03800797|Analgesics|analgesics|mesh-ancestor
19342120|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
19342121|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342122|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386671|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386672|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
20386673|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386674|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20386675|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342123|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342124|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342125|NCT03800290|Clenbuterol|clenbuterol|mesh-list
20386676|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342126|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19342127|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20386677|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19342128|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
19342129|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342130|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342131|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342132|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19342133|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
20386678|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386679|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20386680|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
20386681|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386682|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342134|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342135|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19342136|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
19342137|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
19342138|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19342139|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
19342140|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342141|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19342142|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342143|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
19342144|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19342145|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342146|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342147|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19342148|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19342149|NCT03800433|Protective Agents|protective agents|mesh-ancestor
19342150|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342151|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
19342152|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19342153|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
19342160|NCT03799809|Voriconazole|voriconazole|mesh-list
19342161|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
19342162|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342163|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19342164|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19342165|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342166|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342167|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19342168|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
19342169|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342170|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342171|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19342172|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
19342173|NCT03799536|Sotalol|sotalol|mesh-list
19342174|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19342175|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19342176|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
20200576|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200577|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
20200578|NCT00249847|Paroxetine|paroxetine|mesh-list
20200579|NCT00249847|Estrogens|estrogens|mesh-list
20200580|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20200581|NCT00249847|Hormones|hormones|mesh-ancestor
20200582|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20200583|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200584|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20200585|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200586|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200587|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200588|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200589|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
20200590|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20200591|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200592|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20217670|NCT00310089|Docetaxel|docetaxel|mesh-list
19342177|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683091|NCT03954327|Emtricitabine|emtricitabine|mesh-list
19683092|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
19683093|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
19683094|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683095|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19683096|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19342178|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342179|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342180|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19342181|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
19342182|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
19342183|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342184|NCT03799406|Vitamin D|vitamin d|mesh-list
19342185|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
19342186|NCT03799406|Vitamins|vitamins|mesh-ancestor
19342187|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
20386683|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
20386684|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386685|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386686|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
20386687|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
20386688|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386689|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
20386690|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
20386691|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342188|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342189|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19342190|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19342191|NCT03799224|Decitabine|decitabine|mesh-list
20200593|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20200594|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20200595|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200596|NCT00249860|Interferons|interferons|mesh-list
20386692|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386693|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
20386694|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
20386695|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386696|NCT01056497|Protective Agents|protective agents|mesh-ancestor
20386697|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386698|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
20386699|NCT01056497|Vitamins|vitamins|mesh-ancestor
20386700|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
20386701|NCT01056549|Exenatide|exenatide|mesh-list
20386702|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20386703|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386704|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20200597|NCT00249860|Ribavirin|ribavirin|mesh-list
20200598|NCT00249860|Interferon-beta|interferon-beta|mesh-list
20200599|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
20200600|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200601|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
20200602|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200603|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
20200604|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200605|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
20200606|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200607|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20200608|NCT00249886|Citalopram|citalopram|mesh-list
20200609|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20200610|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20200611|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200612|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200613|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200614|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
20200615|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200616|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20386705|NCT01056549|Incretins|incretins|mesh-ancestor
20386706|NCT01056549|Hormones|hormones|mesh-ancestor
20386707|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386708|NCT01056614|Methotrexate|methotrexate|mesh-list
20386709|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
19342192|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386710|NCT01056614|Fludarabine|fludarabine|mesh-list
20386711|NCT01056614|Busulfan|busulfan|mesh-list
20386712|NCT01056614|Tacrolimus|tacrolimus|mesh-list
20386713|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
20386714|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20386715|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
20386716|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20386717|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
20386718|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20386719|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386720|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386721|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
20386722|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386723|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386724|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
20386725|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386726|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20386727|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386728|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
20386729|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386730|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20386731|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20386732|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
20386733|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20386734|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20386735|NCT01056627|Valproic Acid|valproic acid|mesh-list
20386736|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
20386737|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386738|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386739|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
20386740|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386741|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386742|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
20386743|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386744|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386745|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386746|NCT01056679|Doxorubicin|doxorubicin|mesh-list
20386747|NCT01056679|Lenalidomide|lenalidomide|mesh-list
20386748|NCT01056679|Vinblastine|vinblastine|mesh-list
20386749|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20386750|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386751|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20386752|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20386753|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386754|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386755|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
20386756|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386757|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20200617|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200618|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200619|NCT00249899|Atorvastatin|atorvastatin|mesh-list
20200620|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20200621|NCT00249899|Simvastatin|simvastatin|mesh-list
20200622|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20200623|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20200624|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20200625|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
20200626|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200627|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19342193|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
19342194|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342195|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342196|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342197|NCT03799315|Nicotine|nicotine|mesh-list
19342198|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19342199|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
19342200|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342201|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342202|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20200628|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200629|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20200630|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20200631|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20200632|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
20386758|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20386759|NCT01056679|Growth Substances|growth substances|mesh-ancestor
19342203|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20200633|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683097|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683098|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683099|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19683100|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19342204|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
19342205|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342206|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342207|NCT03799172|Echinocandins|echinocandins|mesh-list
19342208|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
19683101|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19683102|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19683103|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
19683104|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19683105|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19683106|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683107|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
19683108|NCT03954314|Coagulants|coagulants|mesh-ancestor
19683109|NCT03942120|Ustekinumab|ustekinumab|mesh-list
19843095|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20200634|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20200635|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20200636|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200637|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19342209|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342210|NCT03799120|Tamsulosin|tamsulosin|mesh-list
20200638|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20200639|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20200640|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
20200641|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200642|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20200643|NCT00249964|Paclitaxel|paclitaxel|mesh-list
20200644|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20200645|NCT00249964|Carboplatin|carboplatin|mesh-list
20200646|NCT00249964|Temozolomide|temozolomide|mesh-list
20200647|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20200648|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200649|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
20200650|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200651|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
20200652|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200653|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20200654|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
20200655|NCT00249977|Capecitabine|capecitabine|mesh-list
19342211|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19342212|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19342213|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20200656|NCT00249977|Irinotecan|irinotecan|mesh-list
20200657|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342214|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
19342215|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342216|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342217|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342218|NCT03799120|Urological Agents|urological agents|mesh-ancestor
19342219|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
19342220|NCT03799094|Vitamins|vitamins|mesh-ancestor
19342221|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
19342222|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200658|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20200659|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
20200660|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200661|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20200662|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200663|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200664|NCT00250029|Capecitabine|capecitabine|mesh-list
20200665|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
20200666|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20200667|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
20200668|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200669|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200670|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
20200671|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
20200672|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342223|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
19400172|NCT03628521|Carboplatin|carboplatin|mesh-list
19683110|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
19342224|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342225|NCT03799094|Protective Agents|protective agents|mesh-ancestor
19342226|NCT03798912|Octreotide|octreotide|mesh-list
19342227|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342228|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20200673|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20200674|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200675|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342229|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342230|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
19342231|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19342232|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
19342233|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
19342234|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342235|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400173|NCT03628521|Pemetrexed|pemetrexed|mesh-list
19843096|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843097|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
20200676|NCT00250068|Rubitecan|rubitecan|mesh-list
20200677|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200678|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20200679|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200680|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200681|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200682|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
20200683|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20200684|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200685|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200686|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
19400174|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19400175|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386760|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
20386761|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20386762|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
20386763|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
20386764|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386765|NCT01056705|Vaccines|vaccines|mesh-list
20386766|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
20386767|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386768|NCT01056757|Ribavirin|ribavirin|mesh-list
20386769|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
19400176|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19400177|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
19400178|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400179|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
19400180|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400181|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400182|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400183|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
19400184|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400185|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20386770|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386771|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
20386772|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386773|NCT01056835|Epoprostenol|epoprostenol|mesh-list
20386774|NCT01056835|Tezosentan|tezosentan|mesh-list
20386775|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20386776|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20386777|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
20386778|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
20386779|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19400186|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19400187|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19400188|NCT03628443|Mitogens|mitogens|mesh-list
19400189|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
19400190|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200687|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200688|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200689|NCT00250094|Topotecan|topotecan|mesh-list
20200690|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20386780|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20386781|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19400191|NCT03628430|Lidocaine|lidocaine|mesh-list
19843098|NCT00656448|Hematinics|hematinics|mesh-ancestor
19843099|NCT00656487|Rimonabant|rimonabant|mesh-list
19342236|NCT03798834|Anesthetics|anesthetics|mesh-list
19342237|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342238|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342239|NCT03798821|Sulfalene|sulfalene|mesh-list
19342240|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342241|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20200691|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19683111|NCT03941093|Leucovorin|leucovorin|mesh-list
19683112|NCT03941093|Gemcitabine|gemcitabine|mesh-list
19683113|NCT03941093|Paclitaxel|paclitaxel|mesh-list
19683114|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19683115|NCT03941093|Irinotecan|irinotecan|mesh-list
19683116|NCT03941093|Fluorouracil|fluorouracil|mesh-list
19683117|NCT03941093|Folfirinox|folfirinox|mesh-list
19683118|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
19683119|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19683120|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683121|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
19683122|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
19683123|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683124|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683125|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20200692|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200693|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200694|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200695|NCT00250120|Camptothecin|camptothecin|mesh-list
20200696|NCT00250120|Rubitecan|rubitecan|mesh-list
20200697|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20200698|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200699|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20200700|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200701|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200702|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200703|NCT00250172|Rolipram|rolipram|mesh-list
20200704|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
20200705|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200706|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20200707|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19683126|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
19683127|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
20200708|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200709|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200710|NCT00250185|Acetylcholine|acetylcholine|mesh-list
20200711|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
20200712|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20200713|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
20200714|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200715|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342242|NCT03798821|Renal Agents|renal agents|mesh-ancestor
19342243|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
19342244|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19342245|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19843100|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19843101|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19843102|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19843103|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843104|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843105|NCT00656487|Hormones|hormones|mesh-ancestor
19843106|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843107|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843108|NCT00656513|Pilocarpine|pilocarpine|mesh-list
19843109|NCT00656513|Miotics|miotics|mesh-ancestor
19843110|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
19843111|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843112|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342246|NCT03798600|Caspofungin|caspofungin|mesh-list
20200716|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200717|NCT00250237|Haloperidol|haloperidol|mesh-list
20200718|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
20200719|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
20200720|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
20200721|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200722|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683128|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683129|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683130|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683131|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
19683132|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200723|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20200724|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200725|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200726|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200727|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200728|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200729|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
20200730|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200731|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200732|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20200733|NCT00250315|Dobutamine|dobutamine|mesh-list
20386782|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20386783|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386784|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
20386785|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386786|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386787|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20386788|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386789|NCT01056874|Maraviroc|maraviroc|mesh-list
20386790|NCT01056874|Digoxin|digoxin|mesh-list
20386791|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20386792|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20386793|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386794|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20386795|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20386796|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
20200734|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20200735|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
20200736|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
20200737|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386797|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386798|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20386799|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20200738|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200739|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20200740|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20200741|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20200742|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
20200743|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200744|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200745|NCT00250315|Protective Agents|protective agents|mesh-ancestor
20200746|NCT00250354|Risperidone|risperidone|mesh-list
20200747|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200748|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
20200749|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200750|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200751|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200752|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200753|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200754|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200755|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200756|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19342247|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
19342248|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342249|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200757|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
20386800|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20386801|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386802|NCT01056874|Protective Agents|protective agents|mesh-ancestor
20386803|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200758|NCT00250367|Risperidone|risperidone|mesh-list
20200759|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200760|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
20200761|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200762|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200763|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200764|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200765|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386804|NCT01056926|Nicotine|nicotine|mesh-list
20386805|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20200766|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400192|NCT03628430|Epinephrine|epinephrine|mesh-list
20386806|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
20200767|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19342250|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342251|NCT03798522|Nalbuphine|nalbuphine|mesh-list
20386807|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386808|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386809|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20386810|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20386811|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
20386812|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386813|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426412|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426413|NCT01280994|Xenon|xenon|mesh-list
19342252|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20200768|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20200769|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
20200770|NCT00250393|Istradefylline|istradefylline|mesh-list
20200771|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20200772|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20200773|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20200774|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
20200775|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200776|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426414|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20426415|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
19342253|NCT03798522|Narcotics|narcotics|mesh-ancestor
19342254|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426416|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
20426417|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426418|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426419|NCT01281111|Aspirin|aspirin|mesh-list
20426420|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20426421|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20426422|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20426423|NCT01281111|Analgesics|analgesics|mesh-ancestor
20426424|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
20426425|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426426|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426427|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20200777|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200778|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
20200779|NCT00250536|Nandrolone|nandrolone|mesh-list
20200780|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
20200781|NCT00250536|Androgens|androgens|mesh-ancestor
20200782|NCT00250536|Hormones|hormones|mesh-ancestor
20200783|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20200784|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426428|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426429|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20426430|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19342255|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342256|NCT03798522|Analgesics|analgesics|mesh-ancestor
19342257|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
19342258|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342259|NCT03798405|Analgesics|analgesics|mesh-list
19342260|NCT03798405|Narcotics|narcotics|mesh-list
19342261|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
19342262|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342263|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342264|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342265|NCT03798392|Anesthetics|anesthetics|mesh-list
19342266|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426431|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426432|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20426433|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20426434|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426435|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
20426436|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
20426437|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426438|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
20426439|NCT01281150|Paclitaxel|paclitaxel|mesh-list
20426440|NCT01281150|Carboplatin|carboplatin|mesh-list
20426441|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20426442|NCT01281150|Veliparib|veliparib|mesh-list
19342267|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426443|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20200785|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
20200786|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20200787|NCT00250562|Valsartan|valsartan|mesh-list
19683133|NCT03941093|Antidotes|antidotes|mesh-ancestor
19683134|NCT03941093|Protective Agents|protective agents|mesh-ancestor
19683135|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
19342268|NCT03798314|Nivolumab|nivolumab|mesh-list
19342269|NCT03798314|Pomalidomide|pomalidomide|mesh-list
19342270|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20200788|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20200789|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20200790|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20200791|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20200792|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342271|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342272|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19342273|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843113|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19843114|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20200793|NCT00250562|Diuretics|diuretics|mesh-ancestor
20386814|NCT01057069|Paclitaxel|paclitaxel|mesh-list
20386815|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20386816|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
20200794|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
20200795|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200796|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20200797|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200798|NCT00250575|Clozapine|clozapine|mesh-list
20200799|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20200800|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
20200801|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200802|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200803|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200804|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20200805|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200806|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200807|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386817|NCT01057069|Carboplatin|carboplatin|mesh-list
20386818|NCT01057069|Doxorubicin|doxorubicin|mesh-list
20386819|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19342274|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
19342275|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386820|NCT01057069|Thiotepa|thiotepa|mesh-list
20386821|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20386822|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386823|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
20386824|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
20386825|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386826|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386827|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342276|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19342277|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19342278|NCT03798314|Growth Substances|growth substances|mesh-ancestor
19342279|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
19342280|NCT03798106|Durvalumab|durvalumab|mesh-list
19342281|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342282|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342283|NCT03798119|Tenofovir|tenofovir|mesh-list
19342284|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
19342285|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342286|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19342287|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19342288|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342289|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342290|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19342291|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19683136|NCT03941093|Vitamins|vitamins|mesh-ancestor
19683137|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
19683138|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19683139|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19692662|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692663|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19692664|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692665|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
19843115|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
19342292|NCT03799822|Vitamin K|vitamin k|mesh-list
19342293|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
19342294|NCT03799822|Vitamins|vitamins|mesh-ancestor
19342295|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
19342296|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342297|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20200808|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
20200809|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
20200810|NCT00250640|Iloprost|iloprost|mesh-list
20200811|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20200812|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
19342298|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
20200813|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
20200814|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20200815|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
20200816|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
20200817|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342299|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19342300|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
19342301|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342302|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342303|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
19342304|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19342305|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19342306|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
19342307|NCT03799822|Coagulants|coagulants|mesh-ancestor
19342308|NCT03799900|Ketamine|ketamine|mesh-list
19342309|NCT03799900|Analgesics|analgesics|mesh-ancestor
19342310|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
20386828|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
20386829|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200818|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200819|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20200820|NCT00250692|Analgesics|analgesics|mesh-ancestor
20200821|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
20200822|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200823|NCT00250744|Gabapentin|gabapentin|mesh-list
19342311|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342312|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342313|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20612932|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20612933|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20386830|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20386831|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20386832|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
20386833|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20386834|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19342314|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19342315|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
19342316|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
20612934|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20612935|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19342317|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200824|NCT00250744|Aprepitant|aprepitant|mesh-list
20200825|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
20200826|NCT00250744|Analgesics|analgesics|mesh-ancestor
20200827|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
20200828|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200829|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200830|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
19342318|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19342319|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19342320|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200831|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20200832|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200833|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20200834|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200835|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20200836|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19342321|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683140|NCT03938831|Fentanyl|fentanyl|mesh-list
19683141|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
19683142|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19342322|NCT03799757|Bupivacaine|bupivacaine|mesh-list
19342323|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342324|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
20200837|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217671|NCT00310089|Doxorubicin|doxorubicin|mesh-list
19683143|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683144|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683145|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683146|NCT03938831|Analgesics|analgesics|mesh-ancestor
19683147|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
19683148|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683149|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19683150|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19683151|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19683152|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
19683153|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386835|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20386836|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20386837|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386838|NCT01057160|Rizatriptan|rizatriptan|mesh-list
20386839|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20386840|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
20386841|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386842|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386843|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386844|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
20386845|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20386846|NCT01057186|Sevelamer|sevelamer|mesh-list
19683154|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200838|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386847|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
20386848|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
20386849|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386850|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20386851|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386852|NCT01057186|Vitamins|vitamins|mesh-ancestor
20386853|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
20386854|NCT01057212|Bevacizumab|bevacizumab|mesh-list
20386855|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20386856|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386857|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20386858|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20386859|NCT01057212|Growth Substances|growth substances|mesh-ancestor
20386860|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386861|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
20386862|NCT01057264|Gemcitabine|gemcitabine|mesh-list
20386863|NCT01057264|Paclitaxel|paclitaxel|mesh-list
19342325|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342326|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342327|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
19342328|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342329|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
19342330|NCT03799913|Fludarabine|fludarabine|mesh-list
19342331|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386864|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20386865|NCT01057264|Bevacizumab|bevacizumab|mesh-list
20386866|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20386867|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386868|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
20386869|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200839|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
20200840|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
20200841|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
20200842|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20200843|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20200844|NCT00250796|Interferons|interferons|mesh-list
20200845|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
20200846|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20200847|NCT00250796|Thalidomide|thalidomide|mesh-list
20200848|NCT00250796|Octreotide|octreotide|mesh-list
20200849|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200850|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
20200851|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200852|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20200853|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
20200854|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200855|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
20200856|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20386870|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386871|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200857|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20200858|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20200859|NCT00250796|Growth Substances|growth substances|mesh-ancestor
20200860|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
20200861|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20200862|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20200863|NCT00250861|Aldesleukin|aldesleukin|mesh-list
20386872|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20386873|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20386874|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20200864|NCT00250861|Rituximab|rituximab|mesh-list
20200865|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20200866|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386875|NCT01057264|Growth Substances|growth substances|mesh-ancestor
20386876|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386877|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
20386878|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20386879|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
20386880|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
20386881|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386882|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386883|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20386884|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
20386885|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20386886|NCT01057329|Olanzapine|olanzapine|mesh-list
20386887|NCT01057329|Aripiprazole|aripiprazole|mesh-list
20386888|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20386889|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
20386890|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
20386891|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200867|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
20200868|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200869|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200870|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20200871|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20200872|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
19342332|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
20200873|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200874|NCT00250874|Docetaxel|docetaxel|mesh-list
20200875|NCT00250874|Doxorubicin|doxorubicin|mesh-list
20200876|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20200877|NCT00250874|Trastuzumab|trastuzumab|mesh-list
20200878|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200879|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
20200880|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200881|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
20200882|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200883|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20200884|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20200885|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20200886|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200887|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20200888|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19342333|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200889|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20200890|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19342334|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342335|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19342336|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
19342337|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683155|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20200891|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200892|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200893|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20200894|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20200895|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386892|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683156|NCT03938831|Narcotics|narcotics|mesh-ancestor
19683157|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20386893|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20386894|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20386895|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19683158|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19683159|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
19683160|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
20200896|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
19342338|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342339|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19342340|NCT03797833|Anesthetics|anesthetics|mesh-list
19342341|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342342|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342343|NCT03799601|Carboplatin|carboplatin|mesh-list
19342344|NCT03799601|Docetaxel|docetaxel|mesh-list
19342345|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843116|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843117|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843118|NCT00656617|Cytarabine|cytarabine|mesh-list
19843119|NCT00656617|Vorinostat|vorinostat|mesh-list
19843120|NCT00656617|Idarubicin|idarubicin|mesh-list
20386896|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386897|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386898|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20386899|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20386900|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20386901|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386902|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386903|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
19683161|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
19683162|NCT03930680|Razoxane|razoxane|mesh-list
19683163|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683164|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19683165|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19683166|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19683167|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843121|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19843122|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
20386904|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
20386905|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
20386906|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
19683168|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683169|NCT03930680|Protective Agents|protective agents|mesh-ancestor
19683170|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843123|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843124|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843125|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
19843126|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200897|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20200898|NCT00250978|Bevacizumab|bevacizumab|mesh-list
20200899|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20200900|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200901|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19843127|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843128|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
19342346|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843129|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843130|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19843131|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843132|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19843133|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19843134|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19843135|NCT00656630|Naltrexone|naltrexone|mesh-list
20200902|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20200903|NCT00250978|Growth Substances|growth substances|mesh-ancestor
20200904|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200905|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
20200906|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20200907|NCT00250991|Eptifibatide|eptifibatide|mesh-list
20200908|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20200909|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20200910|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200911|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20200912|NCT00251017|Vancomycin|vancomycin|mesh-list
20200913|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20200914|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200915|NCT00251030|Nelfinavir|nelfinavir|mesh-list
20200916|NCT00251030|Omeprazole|omeprazole|mesh-list
20200917|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20200918|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843136|NCT00656630|Acamprosate|acamprosate|mesh-list
19342347|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
19683171|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
19342348|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
19342349|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683172|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683173|NCT03919617|Volagidemab|volagidemab|mesh-list
19683174|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19683175|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683176|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19683177|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19683178|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683179|NCT03869944|Lamivudine|lamivudine|mesh-list
19683180|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19683181|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19683182|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683183|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683184|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
20386907|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20386908|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19683185|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683186|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19683187|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19683188|NCT03867357|Goserelin|goserelin|mesh-list
19683189|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19683190|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683191|NCT03864094|Phenylephrine|phenylephrine|mesh-list
19683192|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
19683193|NCT03864094|Norepinephrine|norepinephrine|mesh-list
20386909|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20386910|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19342350|NCT03797703|Lidocaine|lidocaine|mesh-list
19342351|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342352|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
19342353|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342354|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342355|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
19342356|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342357|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20386911|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20386912|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20386913|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20386914|NCT01057329|Analgesics|analgesics|mesh-ancestor
19342358|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19342359|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19342360|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342361|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342362|NCT03797729|Tirofiban|tirofiban|mesh-list
19342363|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19342364|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19342365|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342366|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19342367|NCT03797625|Cisplatin|cisplatin|mesh-list
20200919|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20386915|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
20386916|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20386917|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
20386918|NCT01057342|Paclitaxel|paclitaxel|mesh-list
20386919|NCT01057342|Carboplatin|carboplatin|mesh-list
20386920|NCT01057342|Vadimezan|vadimezan|mesh-list
20386921|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20386922|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386923|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
20386924|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
20386925|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386926|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683194|NCT03864094|Ephedrine|ephedrine|mesh-list
19683195|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
19683196|NCT03864094|Remifentanil|remifentanil|mesh-list
20200920|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20200921|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200922|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20200923|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20200924|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
20200925|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20200926|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20386927|NCT01057355|Ethanol|ethanol|mesh-list
20386928|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20200927|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
20200928|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200929|NCT00251056|Mannitol|mannitol|mesh-list
19342368|NCT03797625|Irinotecan|irinotecan|mesh-list
19342369|NCT03797625|Endostar protein|endostar protein|mesh-list
19342370|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342371|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19342372|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19342373|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342374|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342375|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19342376|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19342377|NCT03797625|Growth Substances|growth substances|mesh-ancestor
19342378|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342379|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
19342380|NCT03799445|Nivolumab|nivolumab|mesh-list
20200930|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20200931|NCT00251056|Diuretics|diuretics|mesh-ancestor
20200932|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
20200933|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200934|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20200935|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20200936|NCT00251082|Estradiol|estradiol|mesh-list
20200937|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20200938|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
19342381|NCT03799445|Ipilimumab|ipilimumab|mesh-list
19342382|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342383|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342384|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19342385|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342386|NCT03797508|Progesterone|progesterone|mesh-list
19342387|NCT03797508|Progestins|progestins|mesh-ancestor
19342388|NCT03797508|Hormones|hormones|mesh-ancestor
19342389|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342390|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400193|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400194|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
19400195|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400196|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400197|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
19400198|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400199|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19400200|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19400201|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19400202|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19400203|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400204|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400205|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400206|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400207|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400208|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19400209|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19400210|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
19400211|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19400212|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
19400213|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
19400214|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
19400215|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19400216|NCT03628339|Tepotinib|tepotinib|mesh-list
19400217|NCT03628339|Midazolam|midazolam|mesh-list
19400218|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19400219|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19400220|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400221|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200939|NCT00251082|Estrogens|estrogens|mesh-ancestor
20200940|NCT00251082|Hormones|hormones|mesh-ancestor
20200941|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20200942|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200943|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20200944|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
20200945|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20200946|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20200947|NCT00251082|Progestins|progestins|mesh-ancestor
19400222|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20200948|NCT00251095|Paclitaxel|paclitaxel|mesh-list
20217672|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20386929|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20386930|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386931|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386932|NCT01057407|Sevelamer|sevelamer|mesh-list
20386933|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
20386934|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
20386935|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386936|NCT01057498|RNS60|rns60|mesh-list
20386937|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20386938|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20386939|NCT01057498|Analgesics|analgesics|mesh-ancestor
20386940|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
20386941|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20386942|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386943|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20386944|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200949|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20200950|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200951|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843137|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20200952|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200953|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386945|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20386946|NCT01057511|Progesterone|progesterone|mesh-list
20386947|NCT01057511|Progestins|progestins|mesh-ancestor
19342391|NCT03797079|Bupivacaine|bupivacaine|mesh-list
19342392|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342393|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
19342394|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342395|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342396|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
19342397|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342398|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19342399|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
19342400|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342401|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
19342402|NCT03797443|Gemcitabine|gemcitabine|mesh-list
19342403|NCT03797443|Paclitaxel|paclitaxel|mesh-list
19342404|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20386948|NCT01057511|Hormones|hormones|mesh-ancestor
20386949|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20386950|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386951|NCT01057563|Paclitaxel|paclitaxel|mesh-list
20386952|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20386953|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20386954|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20386955|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
19342405|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342406|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
19342407|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
19342408|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
19342409|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200954|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200955|NCT00251186|Capecitabine|capecitabine|mesh-list
20200956|NCT00251186|Cetuximab|cetuximab|mesh-list
19342410|NCT03797443|Vitamins|vitamins|mesh-ancestor
19342411|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
19342412|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342413|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20200957|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20200958|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
19342414|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
19342415|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
19342416|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342417|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342418|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342419|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
19342420|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
19342421|NCT03797443|Protective Agents|protective agents|mesh-ancestor
19342422|NCT03796884|Linaclotide|linaclotide|mesh-list
19843138|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19843139|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843140|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
19843141|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843142|NCT00656656|Dexamethasone|dexamethasone|mesh-list
19843143|NCT00656656|Rituximab|rituximab|mesh-list
19843144|NCT00656656|Azathioprine|azathioprine|mesh-list
19342423|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19342424|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
20386956|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200959|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200960|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200961|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20200962|NCT00251277|Rituximab|rituximab|mesh-list
20200963|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20386957|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
20386958|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386959|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
20386960|NCT01057615|Vitamins|vitamins|mesh-ancestor
20386961|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
20386962|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386963|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
20386964|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386965|NCT01057615|Protective Agents|protective agents|mesh-ancestor
20386966|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
20386967|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20386968|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342425|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342426|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342427|NCT03797222|Vitamin E|vitamin e|mesh-list
19342428|NCT03797222|Tocopherols|tocopherols|mesh-list
19342429|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
19342430|NCT03797222|Vitamins|vitamins|mesh-ancestor
19342431|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
19342432|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342433|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
19342434|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342435|NCT03797222|Protective Agents|protective agents|mesh-ancestor
19342436|NCT03796975|Metformin|metformin|mesh-list
19342437|NCT03796975|Pioglitazone|pioglitazone|mesh-list
20200964|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200965|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
20200966|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200967|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200968|NCT00251355|Gemcitabine|gemcitabine|mesh-list
20200969|NCT00251355|Fluorouracil|fluorouracil|mesh-list
20200970|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20200971|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
20200972|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386969|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20386970|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843145|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342438|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19342439|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342440|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19342441|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342442|NCT03796572|Ropivacaine|ropivacaine|mesh-list
19342443|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342444|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
19342445|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342446|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342447|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
19342448|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342449|NCT03796585|Vaccines|vaccines|mesh-list
19342450|NCT03796585|Immunologic Factors|immunologic factors|mesh-ancestor
19843146|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843147|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
20386971|NCT01057654|Pravastatin|pravastatin|mesh-list
20386972|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20386973|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19342451|NCT03796585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342452|NCT03796533|Posaconazole|posaconazole|mesh-list
19342453|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
19342454|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843148|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843149|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19843150|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19843151|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
19843152|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
19843153|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20200973|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342455|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20386974|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
19342456|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19342457|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19342458|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19342459|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19342460|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342461|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386975|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386976|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20386977|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20386978|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386979|NCT01057758|Simvastatin|simvastatin|mesh-list
20386980|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19342462|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19342463|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
19342464|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342465|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342466|NCT03796403|Diclofenac|diclofenac|mesh-list
19342467|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19342468|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19342469|NCT03796403|Analgesics|analgesics|mesh-ancestor
19342470|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
19342471|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342472|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386981|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20386982|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
20386983|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20386984|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20386985|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20386986|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386987|NCT01057849|Olanzapine|olanzapine|mesh-list
20386988|NCT01057849|Risperidone|risperidone|mesh-list
20386989|NCT01057849|Aripiprazole|aripiprazole|mesh-list
20386990|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20386991|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
20386992|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20386993|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342473|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342474|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342475|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19342476|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342477|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342478|NCT03796507|Temozolomide|temozolomide|mesh-list
19342479|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19342480|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
19400223|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20200974|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
20200975|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20200976|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20386994|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20386995|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20386996|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20386997|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20386998|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20386999|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20387000|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
20387001|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
20387002|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
20387003|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387004|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20200977|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20200978|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
20200979|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217673|NCT00310089|Cediranib|cediranib|mesh-list
20217674|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217675|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
20217676|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217677|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20217678|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20217679|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
20217680|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217681|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387005|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20387006|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20387007|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387008|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
20387009|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
20387010|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20387011|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20387012|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20387013|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20387014|NCT01057875|Caffeine|caffeine|mesh-list
20387015|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20200980|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
20200981|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200982|NCT00251381|Cetuximab|cetuximab|mesh-list
20200983|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683197|NCT03864094|Propofol|propofol|mesh-list
19683198|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19683199|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683200|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683201|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19683202|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
19683203|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
19683204|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20200984|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342481|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342482|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342483|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
19342484|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19342485|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
20200985|NCT00251394|Rituximab|rituximab|mesh-list
20200986|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20200987|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200988|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
20200989|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20200990|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20200991|NCT00251407|Docetaxel|docetaxel|mesh-list
20200992|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20200993|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
20200994|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
20200995|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
20200996|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20200997|NCT00251433|Docetaxel|docetaxel|mesh-list
20387016|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387017|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20387018|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387019|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387020|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20387021|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20387022|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
20387023|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387024|NCT01057966|Vitamins|vitamins|mesh-list
20387025|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
20387026|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387027|NCT01058057|Atorvastatin|atorvastatin|mesh-list
20387028|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20387029|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20387030|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
20387031|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387032|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20387033|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19342486|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19342487|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
19342488|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387034|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387035|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
20387036|NCT01058109|Calcium|calcium|mesh-list
19342489|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342490|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
19342491|NCT03796364|Endostar protein|endostar protein|mesh-list
19342492|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683205|NCT03864094|Narcotics|narcotics|mesh-ancestor
20200998|NCT00251433|Trastuzumab|trastuzumab|mesh-list
19400224|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20200999|NCT00251433|Lapatinib|lapatinib|mesh-list
20201000|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342493|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19342494|NCT03796364|Growth Substances|growth substances|mesh-ancestor
19342495|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342496|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
19342497|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342498|NCT03795909|Dexamethasone|dexamethasone|mesh-list
19342499|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342500|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
19342501|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
19342502|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342503|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342504|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201001|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
20201002|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
20201003|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201004|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201005|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342505|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
19342506|NCT03795909|Hormones|hormones|mesh-ancestor
19342507|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201006|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201007|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201008|NCT00251459|Ranibizumab|ranibizumab|mesh-list
20201009|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20201010|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20201011|NCT00251459|Growth Substances|growth substances|mesh-ancestor
20201012|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201013|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
20201014|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201015|NCT00251472|Paclitaxel|paclitaxel|mesh-list
20201016|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20201017|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201018|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
20201019|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
20201020|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201021|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201022|NCT00251485|Cetuximab|cetuximab|mesh-list
20201023|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20201024|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201025|NCT00251498|Cetuximab|cetuximab|mesh-list
20201026|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20201027|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201028|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
20201029|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201030|NCT00251524|Bevacizumab|bevacizumab|mesh-list
20201031|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
19683206|NCT03864094|Analgesics|analgesics|mesh-ancestor
19683207|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
20201032|NCT00251524|Pemetrexed|pemetrexed|mesh-list
20201033|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20201034|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201035|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20201036|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20201037|NCT00251524|Growth Substances|growth substances|mesh-ancestor
20201038|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201039|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
20201040|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201041|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201042|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20201043|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20201044|NCT00251550|Pemetrexed|pemetrexed|mesh-list
20201045|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201046|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201047|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201048|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19683208|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683209|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19683210|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
19683211|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
20201049|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20201050|NCT00251602|Propranolol|propranolol|mesh-list
20201051|NCT00251602|Atropine|atropine|mesh-list
20201052|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19683212|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
19683213|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19342508|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19342509|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387037|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20387038|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387039|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20387040|NCT01058174|Fluconazole|fluconazole|mesh-list
20387041|NCT01058174|Amphotericin B|amphotericin b|mesh-list
20387042|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20387043|NCT01058174|Caspofungin|caspofungin|mesh-list
20387044|NCT01058174|Micafungin|micafungin|mesh-list
20387045|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
20387046|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387047|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20387048|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20387049|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387050|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387051|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20387052|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
20387053|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201053|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20201054|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201055|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201056|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201057|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201058|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20201059|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20201060|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
20201061|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20201062|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20201063|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
20201064|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201065|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20201066|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
20201067|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
20201068|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
20201069|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20201070|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20201071|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
20201072|NCT00251654|Anesthetics|anesthetics|mesh-list
20201073|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201074|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201075|NCT00251680|Atorvastatin|atorvastatin|mesh-list
20201076|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20201077|NCT00251680|Simvastatin|simvastatin|mesh-list
20201078|NCT00251680|Fenofibrate|fenofibrate|mesh-list
20387054|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387055|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20387056|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20387057|NCT01058174|Amebicides|amebicides|mesh-ancestor
20387058|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20387059|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20387060|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387061|NCT01058252|Indomethacin|indomethacin|mesh-list
20387062|NCT01058252|Letrozole|letrozole|mesh-list
19342510|NCT03795844|Liver Extracts|liver extracts|mesh-list
19342511|NCT03795844|Hematinics|hematinics|mesh-ancestor
19342512|NCT03795792|Curcumin|curcumin|mesh-list
19342513|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19342514|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19342515|NCT03795792|Analgesics|analgesics|mesh-ancestor
20387063|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387064|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20387065|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20387066|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387067|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387068|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20201079|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20201080|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20387069|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
20426444|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683214|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
19683215|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
19683216|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19683217|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19683218|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20201081|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
20201082|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201083|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20201084|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20201085|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201086|NCT00251706|Amiodarone|amiodarone|mesh-list
20201087|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20201088|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
19843154|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843155|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
19843156|NCT00656656|Hormones|hormones|mesh-ancestor
19843157|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201089|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19342516|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
19342517|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342518|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342519|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342520|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342521|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342522|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342523|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342524|NCT03795584|Hemostatics|hemostatics|mesh-list
19342525|NCT03795584|Coagulants|coagulants|mesh-ancestor
19342526|NCT03795571|Gemcitabine|gemcitabine|mesh-list
19342527|NCT03795571|Dexamethasone|dexamethasone|mesh-list
19342528|NCT03795571|Rituximab|rituximab|mesh-list
19342529|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
19342530|NCT03795571|Lenalidomide|lenalidomide|mesh-list
19342531|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342532|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342533|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
19342534|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342535|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342536|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342537|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
19342538|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
19342539|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342540|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342541|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
19342542|NCT03795571|Hormones|hormones|mesh-ancestor
19342543|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342544|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19342545|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19342546|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
19342547|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342548|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
19342549|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342550|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342551|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342552|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19342553|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19342554|NCT03795571|Growth Substances|growth substances|mesh-ancestor
19342555|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
19342556|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
19342557|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19342558|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19342559|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342560|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
19342561|NCT03795649|Coagulants|coagulants|mesh-ancestor
19342562|NCT03795597|Melphalan|melphalan|mesh-list
19342563|NCT03795597|Busulfan|busulfan|mesh-list
19342564|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19342565|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
19342566|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342567|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342568|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20387070|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387071|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387072|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19342569|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342570|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
19342571|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843158|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19342572|NCT03795805|Lidocaine|lidocaine|mesh-list
19342573|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342574|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
19342575|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342576|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201090|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201091|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201092|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20201093|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20201094|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20387073|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387074|NCT01058252|Analgesics|analgesics|mesh-ancestor
20387075|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
20201095|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201096|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20201097|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19342577|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
19342578|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342579|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19342580|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19342581|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19342582|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342583|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342584|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
19342585|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19342586|NCT03795259|Rocuronium|rocuronium|mesh-list
19342587|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19342588|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19342589|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19342590|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342591|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342592|NCT03795272|Rucaparib|rucaparib|mesh-list
19342593|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19342594|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843159|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
20201098|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20201099|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
20387076|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387077|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387078|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20387079|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
20387080|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
20387081|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20387082|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20387083|NCT01058291|Apomorphine|apomorphine|mesh-list
20387084|NCT01058291|Emetics|emetics|mesh-ancestor
20387085|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387086|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
20387087|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387088|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387089|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
20387090|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
20387091|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387092|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843160|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843161|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19843162|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843163|NCT00656669|Paclitaxel|paclitaxel|mesh-list
19843164|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
19843165|NCT00656669|Doxorubicin|doxorubicin|mesh-list
19843166|NCT00656669|Sunitinib|sunitinib|mesh-list
19843167|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19843168|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843169|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843170|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843171|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201100|NCT00251732|Nortriptyline|nortriptyline|mesh-list
20387093|NCT01058317|Propranolol|propranolol|mesh-list
19843172|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843173|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20387094|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20387095|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19843174|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
19843175|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201101|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
20201102|NCT00251732|Rabeprazole|rabeprazole|mesh-list
20201103|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20201104|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201105|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20201106|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201107|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201108|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201109|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20201110|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20201111|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201112|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201113|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387096|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
19342595|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342596|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342597|NCT03795311|Bevacizumab|bevacizumab|mesh-list
19342598|NCT03795311|Folfirinox|folfirinox|mesh-list
19342599|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342600|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342601|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19342602|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19342603|NCT03795311|Growth Substances|growth substances|mesh-ancestor
19342604|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387097|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342605|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
19342606|NCT03795207|Durvalumab|durvalumab|mesh-list
19342607|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342608|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400225|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19400226|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
20387098|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387099|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400227|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
19400228|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
19400229|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
19400230|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400231|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400232|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400233|NCT03628300|Piperacillin|piperacillin|mesh-list
19400234|NCT03628300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19400235|NCT03628300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400236|NCT03628131|Carboplatin|carboplatin|mesh-list
19400237|NCT03628131|Etoposide|etoposide|mesh-list
19400238|NCT03628131|Ifosfamide|ifosfamide|mesh-list
19400239|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400240|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19400241|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19400242|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19400243|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400244|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400245|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19400246|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
19400247|NCT03628079|Mebendazole|mebendazole|mesh-list
20387100|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20387101|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20387102|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387103|NCT01058382|Progesterone|progesterone|mesh-list
20387104|NCT01058382|Progestins|progestins|mesh-ancestor
20387105|NCT01058382|Hormones|hormones|mesh-ancestor
20387106|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387107|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387108|NCT01058408|Cisplatin|cisplatin|mesh-list
20387109|NCT01058408|Everolimus|everolimus|mesh-list
20387110|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400248|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
19400249|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
19400250|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19400251|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400252|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
19400253|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
20387111|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400254|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
19400255|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400256|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342609|NCT03794765|Metronidazole|metronidazole|mesh-list
19342610|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
19342611|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342612|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19342613|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19342614|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20387112|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
20387113|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387114|NCT01058577|Somatostatin|somatostatin|mesh-list
20387115|NCT01058577|Hormones|hormones|mesh-ancestor
20387116|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387117|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387118|NCT01058720|Vitamin D|vitamin d|mesh-list
19342615|NCT03794843|Nimodipine|nimodipine|mesh-list
19342616|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19342617|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19843176|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19843177|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19843178|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
19843179|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19843180|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20387119|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
20387120|NCT01058720|Vitamins|vitamins|mesh-ancestor
20387121|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
19342618|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342619|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342620|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20387122|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387123|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20387124|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20426445|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
20426446|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
20426447|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
20426448|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426449|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19843181|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19843182|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19843183|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843184|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19843185|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19843186|NCT00656669|Growth Substances|growth substances|mesh-ancestor
19843187|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
20426450|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342621|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342622|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
19342623|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
19342624|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19342625|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19342626|NCT03794505|Prednisolone|prednisolone|mesh-list
19342627|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
19342628|NCT03794505|Lidocaine|lidocaine|mesh-list
19342629|NCT03794505|Ropivacaine|ropivacaine|mesh-list
19342630|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19342631|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
19342632|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342633|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
19342634|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342635|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342636|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
19342637|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342638|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19342639|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19342640|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19342641|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342642|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342643|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342644|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
19342645|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
19342646|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342647|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
19342648|NCT03794505|Hormones|hormones|mesh-ancestor
19342649|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342650|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19342651|NCT03794505|Protective Agents|protective agents|mesh-ancestor
20426451|NCT01281163|Lapatinib|lapatinib|mesh-list
19342652|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19342653|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342654|NCT03794544|Durvalumab|durvalumab|mesh-list
19342655|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342656|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342657|NCT03794778|Paclitaxel|paclitaxel|mesh-list
19342658|NCT03794778|Carboplatin|carboplatin|mesh-list
19342659|NCT03794778|Doxorubicin|doxorubicin|mesh-list
19342660|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19342661|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19342662|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342663|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
19342664|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
19342665|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
19342666|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342667|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20387125|NCT01058759|Enoxaparin|enoxaparin|mesh-list
20387126|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
20387127|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
20387128|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20387129|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387130|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387131|NCT01058824|Lincomycin|lincomycin|mesh-list
20387132|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387133|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387134|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20387135|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387136|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387137|NCT01058850|Rindopepimut|rindopepimut|mesh-list
19342668|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19342669|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19342670|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342671|NCT03794518|Pioglitazone|pioglitazone|mesh-list
19342672|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20201114|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342673|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342674|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
19342675|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
19342676|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
19342677|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
20201115|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
20201116|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387138|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20387139|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387140|NCT01058876|Nicotine|nicotine|mesh-list
20387141|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20387142|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
20387143|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201117|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20201118|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20201119|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201120|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201121|NCT00251784|Urological Agents|urological agents|mesh-ancestor
20201122|NCT00251797|Thalidomide|thalidomide|mesh-list
20201123|NCT00251797|Irinotecan|irinotecan|mesh-list
20201124|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20201125|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20201126|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201127|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387144|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387145|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19342678|NCT03794492|Prednisolone|prednisolone|mesh-list
19342679|NCT03794492|Tacrolimus|tacrolimus|mesh-list
19342680|NCT03794492|Basiliximab|basiliximab|mesh-list
19342681|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342682|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
19342683|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342684|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19342685|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342686|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342687|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19342688|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201128|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387146|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19342689|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20387147|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
20387148|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387149|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387150|NCT01058902|Aspirin|aspirin|mesh-list
20387151|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20387152|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387153|NCT01058902|Analgesics|analgesics|mesh-ancestor
20387154|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
20387155|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387156|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387157|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387158|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20387159|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20387160|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387161|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387162|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19342690|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
19342691|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19342692|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342693|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342694|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
19342695|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
19342696|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342697|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342698|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
19342699|NCT03794492|Hormones|hormones|mesh-ancestor
19342700|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342701|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19843188|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201129|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20201130|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
19342702|NCT03794492|Protective Agents|protective agents|mesh-ancestor
19342703|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19342704|NCT03794596|Aspirin|aspirin|mesh-list
19342705|NCT03794596|Avelumab|avelumab|mesh-list
19342706|NCT03794596|Lansoprazole|lansoprazole|mesh-list
20387163|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20387164|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387165|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
20387166|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20387167|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20387168|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20387169|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
20387170|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387171|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20201131|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201132|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
20201133|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387172|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20387173|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342707|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
19342708|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20201134|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201135|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20201136|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20201137|NCT00251797|Growth Substances|growth substances|mesh-ancestor
20201138|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
20201139|NCT00251823|Eptifibatide|eptifibatide|mesh-list
20201140|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20201141|NCT00251849|KRM 1648|krm 1648|mesh-list
20201142|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20387174|NCT01059058|Fluorides|fluorides|mesh-list
20387175|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
20387176|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
20387177|NCT01059058|Protective Agents|protective agents|mesh-ancestor
20201143|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
20201144|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20201145|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201146|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
20201147|NCT00251888|Irinotecan|irinotecan|mesh-list
20201148|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201149|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20201150|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19342709|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19342710|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20201151|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387178|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387179|NCT01059084|Valacyclovir|valacyclovir|mesh-list
20387180|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
20387181|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387182|NCT01059110|Salicylates|salicylates|mesh-list
20201152|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201153|NCT00251901|Esomeprazole|esomeprazole|mesh-list
20201154|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20201155|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201156|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20201157|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201158|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843189|NCT00656799|Bromides|bromides|mesh-list
19342711|NCT03794596|Analgesics|analgesics|mesh-ancestor
19342712|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
19342713|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342714|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342715|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342716|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342717|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19342718|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19342719|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342720|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19342721|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19342722|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342723|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
19342724|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342725|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342726|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19843190|NCT00656799|Rocuronium|rocuronium|mesh-list
19843191|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
19843192|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19843193|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19843194|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19843195|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843196|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843197|NCT00656851|Pioglitazone|pioglitazone|mesh-list
19843198|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19843199|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843200|NCT00656968|Esomeprazole|esomeprazole|mesh-list
19843201|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19843202|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843203|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20201159|NCT00251914|Esomeprazole|esomeprazole|mesh-list
20201160|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20201161|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201162|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20201163|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201164|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342727|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342728|NCT03794219|Naproxen|naproxen|mesh-list
20387183|NCT01059110|Imiquimod|imiquimod|mesh-list
20387184|NCT01059110|Fluorouracil|fluorouracil|mesh-list
20387185|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20387186|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
20387187|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387188|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387189|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
20201165|NCT00251940|Glyburide|glyburide|mesh-list
20201166|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20201167|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201168|NCT00251953|Metformin|metformin|mesh-list
20201169|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20201170|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201171|NCT00251966|Esomeprazole|esomeprazole|mesh-list
20201172|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20201173|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342729|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19342730|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20201174|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20201175|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201176|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201177|NCT00251992|Esomeprazole|esomeprazole|mesh-list
20387190|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
19342731|NCT03794219|Analgesics|analgesics|mesh-ancestor
19843204|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387191|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342732|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
19342733|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342734|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342735|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19342736|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342737|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
19342738|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19342739|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843205|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201178|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20201179|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201180|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20201181|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201182|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201183|NCT00252044|Pergolide|pergolide|mesh-list
20201184|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
20201185|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
20201186|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201187|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387192|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20387193|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20387194|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20387195|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387196|NCT01059110|Analgesics|analgesics|mesh-ancestor
20387197|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
20387198|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342740|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342741|NCT03794440|Sorafenib|sorafenib|mesh-list
19342742|NCT03794440|Bevacizumab|bevacizumab|mesh-list
19342743|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342744|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19683219|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201188|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201189|NCT00252122|Ketamine|ketamine|mesh-list
20201190|NCT00252122|Analgesics|analgesics|mesh-ancestor
20201191|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
20201192|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201193|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201194|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20201195|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20201196|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
20201197|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
20201198|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201199|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20201200|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20201201|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201202|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201203|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20201204|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
20201205|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201206|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20201207|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
20201208|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19683220|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683221|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683222|NCT03864094|Protective Agents|protective agents|mesh-ancestor
20201209|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201210|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201211|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201212|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201213|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20201214|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20201215|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20201216|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201217|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387199|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19683223|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19683224|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19683225|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19683226|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
19683227|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19683228|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683229|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
19342745|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342746|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342747|NCT03794440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20387200|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20387201|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20387202|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387203|NCT01059123|Amoxicillin|amoxicillin|mesh-list
20387204|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387205|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387206|NCT01059136|Spironolactone|spironolactone|mesh-list
20387207|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20387208|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
20387209|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342748|NCT03794440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19342749|NCT03794440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19342750|NCT03794440|Growth Substances|growth substances|mesh-ancestor
19342751|NCT03794440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342752|NCT03794440|Growth Inhibitors|growth inhibitors|mesh-ancestor
19342753|NCT03794037|Montelukast|montelukast|mesh-list
19342754|NCT03794037|Progesterone|progesterone|mesh-list
19342755|NCT03794037|Progestins|progestins|mesh-ancestor
19342756|NCT03794037|Hormones|hormones|mesh-ancestor
19342757|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342758|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342759|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19342760|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
19342761|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19342762|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
19342763|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19342764|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19342765|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342766|NCT03794271|Anesthetics|anesthetics|mesh-list
19342767|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342768|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342769|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19342770|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19342771|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19342772|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342773|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342774|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342775|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342776|NCT03794154|Analgesics|analgesics|mesh-ancestor
19342777|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
19342778|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342779|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
19342780|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19342781|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
19683230|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
19683231|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201218|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201219|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201220|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201221|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
20201222|NCT00252291|Miotics|miotics|mesh-ancestor
20201223|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
20201224|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201225|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201226|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20201227|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20201228|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
20201229|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20201230|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20201231|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
20201232|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201233|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201234|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
20201235|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201236|NCT00252304|Astringents|astringents|mesh-ancestor
20201237|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
20387210|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387211|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20387212|NCT01059136|Diuretics|diuretics|mesh-ancestor
20387213|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
20387214|NCT01059331|Pregabalin|pregabalin|mesh-list
20387215|NCT01059331|Analgesics|analgesics|mesh-ancestor
20387216|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
20387217|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342782|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
19683232|NCT03845166|Atezolizumab|atezolizumab|mesh-list
19683233|NCT03845166|Avelumab|avelumab|mesh-list
19683234|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342783|NCT03794167|Melphalan|melphalan|mesh-list
19342784|NCT03794167|Busulfan|busulfan|mesh-list
19342785|NCT03794167|Etoposide|etoposide|mesh-list
19342786|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342787|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
19342788|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683235|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683236|NCT03843970|Bupivacaine|bupivacaine|mesh-list
19683237|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
19683238|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19683239|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683240|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
19683241|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683242|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683243|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
19683244|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683245|NCT03841201|Nivolumab|nivolumab|mesh-list
19683246|NCT03841201|Lenvatinib|lenvatinib|mesh-list
20201238|NCT00252317|Captopril|captopril|mesh-list
20201239|NCT00252317|Trandolapril|trandolapril|mesh-list
20201240|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20201241|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
20201242|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342789|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19342790|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19342791|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
19342792|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342793|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342794|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19342795|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19342796|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19342797|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19342798|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342799|NCT03794297|Trametinib|trametinib|mesh-list
19342800|NCT03794297|Dabrafenib|dabrafenib|mesh-list
19342801|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19342802|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342803|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19342804|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342805|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342806|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19342807|NCT03794297|Protective Agents|protective agents|mesh-ancestor
19342808|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342809|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19342810|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
19342811|NCT03793725|Apatinib|apatinib|mesh-list
19342812|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201243|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201244|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20201245|NCT00252330|Amibegron|amibegron|mesh-list
20201246|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20201247|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20387218|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387219|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
20387220|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20387221|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387222|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387223|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20387224|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19342813|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19342814|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683247|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20201248|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
19342815|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342816|NCT03793517|Decitabine|decitabine|mesh-list
20201249|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201250|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201251|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201252|NCT00252343|Amibegron|amibegron|mesh-list
20201253|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20201254|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20201255|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201256|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201257|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342817|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19342818|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
19342819|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342820|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342821|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342822|NCT03793309|Vitamin D|vitamin d|mesh-list
19342823|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
19342824|NCT03793309|Vitamins|vitamins|mesh-list
19342825|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
19342826|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387225|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20387226|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387227|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19342827|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19342828|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19342829|NCT03793283|Insulin|insulin|mesh-list
19342830|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19342831|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19342832|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400257|NCT03628053|Blinatumomab|blinatumomab|mesh-list
19400258|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19400259|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400260|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19400261|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19400262|NCT03628040|Ropivacaine|ropivacaine|mesh-list
19400263|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400264|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
19400265|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400266|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400267|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
19400268|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400269|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19400270|NCT03627715|Proxigermanium|proxigermanium|mesh-list
19400271|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400272|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
19400273|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
19400274|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400275|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
19400276|NCT03627546|Velpatasvir|velpatasvir|mesh-list
19400277|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
19400278|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400279|NCT03627468|Bromides|bromides|mesh-list
19400280|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
19400281|NCT03627390|Molybdenum|molybdenum|mesh-list
19400282|NCT03627390|Trace Elements|trace elements|mesh-ancestor
19400283|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
19400284|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400285|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
19400286|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19400287|NCT03627260|Protective Agents|protective agents|mesh-ancestor
19400288|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400289|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
19400290|NCT03627039|Metformin|metformin|mesh-list
19400291|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
19400292|NCT03627039|Empagliflozin|empagliflozin|mesh-list
19400293|NCT03627039|Canagliflozin|canagliflozin|mesh-list
19400294|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19400295|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387228|NCT01059383|Esomeprazole|esomeprazole|mesh-list
20387229|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20387230|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387231|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20387232|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387233|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400296|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20387234|NCT01059396|Propranolol|propranolol|mesh-list
19400297|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400298|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20387235|NCT01059396|Carvedilol|carvedilol|mesh-list
20387236|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19342833|NCT03793075|Ketamine|ketamine|mesh-list
19342834|NCT03793075|Propofol|propofol|mesh-list
19342835|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19342836|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342837|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342838|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19342839|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
19342840|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
19342841|NCT03793075|Analgesics|analgesics|mesh-ancestor
19342842|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
19342843|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342844|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19342845|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19342846|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19342847|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342848|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342849|NCT03793205|Lenograstim|lenograstim|mesh-list
19342850|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19342851|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
19342852|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342853|NCT03793114|Cosyntropin|cosyntropin|mesh-list
19342854|NCT03793114|Hormones|hormones|mesh-ancestor
19342855|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342856|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342857|NCT03792867|Doxorubicin|doxorubicin|mesh-list
19342858|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19342859|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342860|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19342861|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19342862|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342863|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342864|NCT03792776|Lidocaine|lidocaine|mesh-list
19342865|NCT03792776|Anesthetics|anesthetics|mesh-list
19342866|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
19342867|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342868|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342869|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
19342870|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342871|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19342872|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19342873|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19342874|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342875|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342876|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19342877|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19342878|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19342879|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342880|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342881|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342882|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342883|NCT03792828|Analgesics|analgesics|mesh-ancestor
19342884|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
19400299|NCT03626831|Evolocumab|evolocumab|mesh-list
20201258|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201259|NCT00252356|Amibegron|amibegron|mesh-list
20201260|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20201261|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20201262|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201263|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201264|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201265|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201266|NCT00252369|Infliximab|infliximab|mesh-list
20201267|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20201268|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
20201269|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201270|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20201271|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
20201272|NCT00252369|Coagulants|coagulants|mesh-ancestor
20201273|NCT00252408|Hormones|hormones|mesh-list
20201274|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387237|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20387238|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
20387239|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387240|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201275|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201276|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
20201277|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
20201278|NCT00252434|Methamphetamine|methamphetamine|mesh-list
20201279|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20201280|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342885|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342886|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
19342887|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19342888|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
19342889|NCT03792724|Nivolumab|nivolumab|mesh-list
19342890|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19342891|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342892|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19342893|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342894|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
19342895|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
19342896|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
19342897|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
19342898|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19342899|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19342900|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342901|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342902|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342903|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
19342904|NCT03792971|Protective Agents|protective agents|mesh-ancestor
19342905|NCT03792984|Vitamin D|vitamin d|mesh-list
19342906|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
19843206|NCT00657020|Nicotine|nicotine|mesh-list
19843207|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19843208|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
19843209|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843210|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843211|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19843212|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19843213|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
19342907|NCT03792984|Metformin|metformin|mesh-list
19342908|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
20387241|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342909|NCT03792984|Calcium|calcium|mesh-list
19342910|NCT03792984|Vitamins|vitamins|mesh-ancestor
19342911|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
19843214|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342912|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342913|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19342914|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19342915|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19342916|NCT03792984|Antacids|antacids|mesh-ancestor
19342917|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342918|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19342919|NCT03792815|Etoposide|etoposide|mesh-list
19342920|NCT03792815|Melphalan|melphalan|mesh-list
19342921|NCT03792815|Busulfan|busulfan|mesh-list
19342922|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19342923|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342924|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19342925|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19342926|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342927|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342928|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19342929|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
19342930|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19342931|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19342932|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
19342933|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342934|NCT03792906|Norepinephrine|norepinephrine|mesh-list
19342935|NCT03792906|Bupivacaine|bupivacaine|mesh-list
19342936|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
19843215|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201281|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
20201282|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
20201283|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342937|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
19342938|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19342939|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342940|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
20201284|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
20387242|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20387243|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20387244|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387245|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
20387246|NCT01059396|Protective Agents|protective agents|mesh-ancestor
19342941|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19342942|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19342943|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19342944|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
19342945|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19342946|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342947|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
19342948|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
19342949|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19342950|NCT03792763|Denosumab|denosumab|mesh-list
19342951|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19342952|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20387247|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20387248|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387249|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20387250|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20387251|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20387252|NCT01059422|Lamivudine|lamivudine|mesh-list
20387253|NCT01059422|Abacavir|abacavir|mesh-list
20387254|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
20387255|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20387256|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20387257|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387258|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387259|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
20387260|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387261|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20387262|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20387263|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20387264|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19342953|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342954|NCT03792620|Daratumumab|daratumumab|mesh-list
19342955|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342956|NCT03792503|Pemetrexed|pemetrexed|mesh-list
19342957|NCT03792503|Apatinib|apatinib|mesh-list
19342958|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342959|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342960|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342961|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20387265|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
20387266|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20387267|NCT01059461|Protective Agents|protective agents|mesh-ancestor
19342962|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19342963|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19342964|NCT03792490|Fasudil|fasudil|mesh-list
19342965|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19342966|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19342967|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342968|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19342969|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342970|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
19342971|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19342972|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342973|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20201285|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201286|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201287|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201288|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20201289|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20201290|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201291|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20201292|NCT00252603|Galantamine|galantamine|mesh-list
19342974|NCT03792217|Eusol|eusol|mesh-list
19342975|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
20201293|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20201294|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201295|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201296|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
20201297|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201298|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342976|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342977|NCT03792139|Itraconazole|itraconazole|mesh-list
19342978|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
19342979|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19342980|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19342981|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19342982|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342983|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342984|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19342985|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
19342986|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19342987|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342988|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19342989|NCT03792269|Capecitabine|capecitabine|mesh-list
19342990|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
20201299|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20201300|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
20201301|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201302|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
20201303|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20201304|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
20201305|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201306|NCT00252655|Sirolimus|sirolimus|mesh-list
20201307|NCT00252655|Tacrolimus|tacrolimus|mesh-list
20201308|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20201309|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
20201310|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201311|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20201312|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201313|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201314|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20201315|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201316|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20201317|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201318|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
20201319|NCT00252668|Etanercept|etanercept|mesh-list
20387268|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19342991|NCT03792269|Irinotecan|irinotecan|mesh-list
19342992|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19342993|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
19342994|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19342995|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19342996|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19342997|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19342998|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19342999|NCT03792295|Acetaminophen|acetaminophen|mesh-list
19343000|NCT03792295|Ibuprofen|ibuprofen|mesh-list
19343001|NCT03792295|Oxycodone|oxycodone|mesh-list
19343002|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20387269|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
20387270|NCT01059552|Vorinostat|vorinostat|mesh-list
19343003|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343004|NCT03792295|Analgesics|analgesics|mesh-ancestor
19343005|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
19343006|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343007|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343008|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343009|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343010|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343011|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343012|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343013|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20201320|NCT00252668|Methotrexate|methotrexate|mesh-list
20201321|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20201322|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
20201323|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20201324|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343014|NCT03792295|Narcotics|narcotics|mesh-ancestor
20387271|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343015|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343016|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
19343017|NCT03792152|Warfarin|warfarin|mesh-list
19343018|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
19343019|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
19343020|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19343021|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
19343022|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19343023|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
19343024|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343025|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343026|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
19343027|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19343028|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343029|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
19343030|NCT03792321|Testosterone|testosterone|mesh-list
19343031|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
19343032|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
19343033|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19343034|NCT03792321|Androgens|androgens|mesh-ancestor
19343035|NCT03792321|Hormones|hormones|mesh-ancestor
19343036|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343037|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343038|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19343039|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343040|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
19343041|NCT03792009|Bupivacaine|bupivacaine|mesh-list
19343042|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343043|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
19343044|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201325|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20201326|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
20201327|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683248|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683249|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19683250|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201328|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201329|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
20201330|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201331|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20201332|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20201333|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
20201334|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20201335|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20201336|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20201337|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20201338|NCT00252668|Analgesics|analgesics|mesh-ancestor
20201339|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
20201340|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201341|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20201342|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201343|NCT00252707|Docetaxel|docetaxel|mesh-list
19343045|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343046|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
19343047|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343048|NCT03792074|Paclitaxel|paclitaxel|mesh-list
19343049|NCT03792074|Bevacizumab|bevacizumab|mesh-list
19343050|NCT03792074|Carboplatin|carboplatin|mesh-list
20201344|NCT00252707|Gefitinib|gefitinib|mesh-list
19343051|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19343052|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683251|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19683252|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683253|NCT03841058|Abaloparatide|abaloparatide|mesh-list
19683254|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19683255|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683256|NCT03838042|Nivolumab|nivolumab|mesh-list
19343053|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
19343054|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
19343055|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
19343056|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343057|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19343058|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20201345|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343059|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19683257|NCT03838042|Entinostat|entinostat|mesh-list
19683258|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683259|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683260|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19683261|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683262|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19683263|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387272|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20387273|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387274|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387275|NCT01059604|Naproxen|naproxen|mesh-list
20387276|NCT01059604|Sumatriptan|sumatriptan|mesh-list
20387277|NCT01059604|Naratriptan|naratriptan|mesh-list
20387278|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20387279|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387280|NCT01059604|Analgesics|analgesics|mesh-ancestor
20387281|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
20387282|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387283|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387284|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387285|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19843216|NCT00657046|Droxidopa|droxidopa|mesh-list
19843217|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19843218|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19843219|NCT00657150|Enoxaparin|enoxaparin|mesh-list
19843220|NCT00657150|Dabigatran|dabigatran|mesh-list
19843221|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
19843222|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19843223|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19843224|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843225|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
19843226|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19843227|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
19843228|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843229|NCT00657267|Temozolomide|temozolomide|mesh-list
19843230|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19843231|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
19843232|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683264|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
19683265|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
19843233|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843234|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19343060|NCT03792074|Growth Substances|growth substances|mesh-ancestor
19343061|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343062|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
19343063|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19343064|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
19343065|NCT03792113|Coagulants|coagulants|mesh-ancestor
19343066|NCT03791905|Leucovorin|leucovorin|mesh-list
19343067|NCT03791905|Paclitaxel|paclitaxel|mesh-list
19343068|NCT03791905|Fluorouracil|fluorouracil|mesh-list
19343069|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
19343070|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19343071|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343072|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
19343073|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
19343074|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
19343075|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343076|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
19343077|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19343078|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19343079|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
19343080|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343081|NCT03791905|Antidotes|antidotes|mesh-ancestor
19343082|NCT03791905|Protective Agents|protective agents|mesh-ancestor
19343083|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
19343084|NCT03791905|Vitamins|vitamins|mesh-ancestor
19343085|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
19343086|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
19343087|NCT03791918|Lenvatinib|lenvatinib|mesh-list
19843235|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19843236|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343088|NCT03791918|Antibodies|antibodies|mesh-list
20387286|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
19343089|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
19343090|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
19343091|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343092|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19843237|NCT00657280|Incretins|incretins|mesh-ancestor
20387287|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343093|NCT03791918|Estrogens|estrogens|mesh-ancestor
19343094|NCT03791918|Hormones|hormones|mesh-ancestor
19343095|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343096|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19343097|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343098|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19343099|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343100|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343101|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19343102|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
19343103|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19343104|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
19343105|NCT03791801|Rocuronium|rocuronium|mesh-list
19343106|NCT03791801|Neostigmine|neostigmine|mesh-list
19343107|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19343108|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19343109|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19343110|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343111|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343112|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19343113|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343114|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343115|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
19343116|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343117|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19343118|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
19343119|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19343120|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20201346|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
19343121|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19343122|NCT03791775|Polidocanol|polidocanol|mesh-list
19343123|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19343124|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19343125|NCT03791827|Cyclosporine|cyclosporine|mesh-list
19343126|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
19343127|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
19343128|NCT03791827|Prednisone|prednisone|mesh-list
19343129|NCT03791827|Prednisolone|prednisolone|mesh-list
19343130|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
19343131|NCT03791827|Rituximab|rituximab|mesh-list
19343132|NCT03791827|Azathioprine|azathioprine|mesh-list
19343133|NCT03791827|Tacrolimus|tacrolimus|mesh-list
19343134|NCT03791827|Cyclosporins|cyclosporins|mesh-list
19343135|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19343136|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
19343137|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343138|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343139|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19343140|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
19343141|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343142|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343143|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19343144|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19343145|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343146|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
19343147|NCT03791827|Hormones|hormones|mesh-ancestor
20201347|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
20201348|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201349|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201350|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201351|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201352|NCT00252785|Budesonide|budesonide|mesh-list
20201353|NCT00252785|Theophylline|theophylline|mesh-list
20201354|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
20201355|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20201356|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20201357|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
20201358|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201359|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201360|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20201361|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
20201362|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
20201363|NCT00252785|Hormones|hormones|mesh-ancestor
19400300|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19843238|NCT00657280|Hormones|hormones|mesh-ancestor
20217682|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20387288|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387289|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387290|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20387291|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20387292|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20387293|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
19343148|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343149|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19343150|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19343151|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343152|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
20387294|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387295|NCT01059890|Metronidazole|metronidazole|mesh-list
20387296|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
19343153|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19343154|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19343155|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19343156|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19343157|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
19343158|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19343159|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
19343160|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19343161|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19343162|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
19343163|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19343164|NCT03791736|Octreotide|octreotide|mesh-list
19343165|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19343166|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19343167|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343168|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19343169|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
19343170|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19343171|NCT03791762|Protective Agents|protective agents|mesh-ancestor
19343172|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343173|NCT03791723|Valsartan|valsartan|mesh-list
19343174|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19343175|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19343176|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19343177|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19343178|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343179|NCT03791515|Calcitonin|calcitonin|mesh-list
20387297|NCT01059890|Cefotaxime|cefotaxime|mesh-list
20387298|NCT01059890|Cefoxitin|cefoxitin|mesh-list
20387299|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387300|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387301|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20387302|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20387303|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20387304|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20387305|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387306|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387307|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387308|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20387309|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20387310|NCT01059955|Dexamethasone|dexamethasone|mesh-list
20387311|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
20387312|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20387313|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20387314|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20387315|NCT01059955|BB 1101|bb 1101|mesh-list
20387316|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387317|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
20387318|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
20387319|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343180|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
19343181|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19343182|NCT03791515|Katacalcin|katacalcin|mesh-list
19343183|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19343184|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343185|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19343186|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387320|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387321|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387322|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
20387323|NCT01059955|Hormones|hormones|mesh-ancestor
20387324|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387325|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20387326|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387327|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
20387328|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387329|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387330|NCT01060137|Fentanyl|fentanyl|mesh-list
20387331|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20387332|NCT01060137|Narcotics|narcotics|mesh-ancestor
20387333|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387334|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387335|NCT01060137|Analgesics|analgesics|mesh-ancestor
20387336|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
20387337|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387338|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19343187|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
20201364|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201365|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20201366|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20201367|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20201368|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201369|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201370|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201371|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20201372|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201373|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
20201374|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20201375|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20201376|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
20201377|NCT00252798|Paclitaxel|paclitaxel|mesh-list
20201378|NCT00252798|Carboplatin|carboplatin|mesh-list
20201379|NCT00252798|Gefitinib|gefitinib|mesh-list
20201380|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20201381|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201382|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
20201383|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
20201384|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201385|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201386|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201387|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201388|NCT00252811|Gefitinib|gefitinib|mesh-list
20201389|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201390|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201391|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201392|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201393|NCT00252824|Budesonide|budesonide|mesh-list
20201394|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
19343188|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343189|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343190|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343191|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19343192|NCT03791424|Midazolam|midazolam|mesh-list
19343193|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19343194|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19343195|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343196|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343197|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19343198|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19343199|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19343200|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19343201|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
19343202|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
19343203|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
19343204|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
19343205|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343206|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343207|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
19343208|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
19343209|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19343210|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
19343211|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201395|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343212|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
19343213|NCT03791294|Protective Agents|protective agents|mesh-ancestor
19343214|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
19343215|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19343216|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
19343217|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19343218|NCT03791099|Metronidazole|metronidazole|mesh-list
19343219|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19343220|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19343221|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19343222|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19343223|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
19343224|NCT03791255|Calcium|calcium|mesh-list
19343225|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19343226|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343227|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19343228|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19343229|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20201396|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20201397|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
20201398|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201399|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201400|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20201401|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
19343230|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343231|NCT03790839|Incretins|incretins|mesh-ancestor
19343232|NCT03790839|Hormones|hormones|mesh-ancestor
20387339|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20387340|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
20387341|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
20387342|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
20387343|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20387344|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387345|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387346|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
20387347|NCT01060163|Coagulants|coagulants|mesh-ancestor
20387348|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
20387349|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20387350|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387351|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387352|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
20387353|NCT01060176|Coagulants|coagulants|mesh-ancestor
20387354|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
20387355|NCT01060189|Urinastatin|urinastatin|mesh-list
20387356|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20387357|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387358|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387359|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
20387360|NCT01060189|Coagulants|coagulants|mesh-ancestor
20387361|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19343233|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343234|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19343235|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
19343236|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201402|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
20201403|NCT00252824|Hormones|hormones|mesh-ancestor
20201404|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201405|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20201406|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20201407|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20201408|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201409|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201410|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201411|NCT00252863|Fluticasone|fluticasone|mesh-list
20201412|NCT00252863|Xhance|xhance|mesh-list
20201413|NCT00252863|Budesonide|budesonide|mesh-list
20201414|NCT00252863|Theophylline|theophylline|mesh-list
20201415|NCT00252863|Albuterol|albuterol|mesh-list
20201416|NCT00252863|Terbutaline|terbutaline|mesh-list
20201417|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
20201418|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20387362|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20387363|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
20387364|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343237|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387365|NCT01060228|Valproic Acid|valproic acid|mesh-list
19343238|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
20201419|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20387366|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20201420|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20201421|NCT00252863|Montelukast|montelukast|mesh-list
20201422|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20201423|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20201424|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
20201425|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387367|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20387368|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20387369|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201426|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201427|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20201428|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
20201429|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
20201430|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20201431|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
20201432|NCT00252863|Hormones|hormones|mesh-ancestor
20387370|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387371|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20387372|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20387373|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20387374|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
20387375|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387376|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387377|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20201433|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201434|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20387378|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20387379|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
20387380|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
20387381|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387382|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
20387383|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
20387384|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20387385|NCT01060267|Erythromycin|erythromycin|mesh-list
20387386|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
20201435|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20201436|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20201437|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
20201438|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201439|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201440|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
19343239|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343240|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201441|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20201442|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20201443|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
20201444|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20387387|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20387388|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
20387389|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387390|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387391|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20387392|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387393|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387394|NCT01060293|Dopamine|dopamine|mesh-list
20387395|NCT01060293|Furosemide|furosemide|mesh-list
20387396|NCT01060293|Diuretics|diuretics|mesh-ancestor
20387397|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
20387398|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387399|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20387400|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387401|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387402|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19343241|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343242|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20201445|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20201446|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20201447|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343243|NCT03790800|Urapidil|urapidil|mesh-list
19343244|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19343245|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387403|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
19343246|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19343247|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
20387404|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
20387405|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387406|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
20387407|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387408|NCT01060293|Protective Agents|protective agents|mesh-ancestor
20387409|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
20387410|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19343248|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343249|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343250|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343251|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19343252|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19343253|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19343254|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
19343255|NCT03790787|Empagliflozin|empagliflozin|mesh-list
19343256|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19343257|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343258|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19343259|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343260|NCT03790670|Sargramostim|sargramostim|mesh-list
19343261|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
19343262|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343263|NCT03790540|Benzocaine|benzocaine|mesh-list
19343264|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343265|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
20201448|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
19343266|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343267|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343268|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
19343269|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343270|NCT03790605|Curcumin|curcumin|mesh-list
19343271|NCT03790605|Iproplatin|iproplatin|mesh-list
19343272|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19343273|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343274|NCT03790605|Analgesics|analgesics|mesh-ancestor
19343275|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
19343276|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343277|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343278|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343279|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343280|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343281|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343282|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343283|NCT03790345|Vitamins|vitamins|mesh-list
19343284|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
19343285|NCT03790345|Pyridoxine|pyridoxine|mesh-list
19343286|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
19343287|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
20201449|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20201450|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20201451|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
20201452|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
20201453|NCT00252889|Doxorubicin|doxorubicin|mesh-list
20201454|NCT00252889|Topotecan|topotecan|mesh-list
20201455|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
20387411|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
19343288|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
19343289|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343290|NCT03790618|Methamphetamine|methamphetamine|mesh-list
19343291|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19343292|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
19343293|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343294|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19343295|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
19343296|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343297|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343298|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19343299|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19343300|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343301|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
19343302|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19343303|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
20201456|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20201457|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387412|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343304|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
19343305|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343306|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
19343307|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19343308|NCT03790566|Bupivacaine|bupivacaine|mesh-list
19343309|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343310|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
19343311|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343312|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343313|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
19343314|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343315|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
19343316|NCT03790215|Progestins|progestins|mesh-ancestor
19343317|NCT03790215|Hormones|hormones|mesh-ancestor
19343318|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343319|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343320|NCT03790228|Carboplatin|carboplatin|mesh-list
19343321|NCT03790228|Pemetrexed|pemetrexed|mesh-list
19343322|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343323|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343324|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343325|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19343326|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19343327|NCT03790371|Misoprostol|misoprostol|mesh-list
19343328|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19343329|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
19343330|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19343331|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343332|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19343333|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19343334|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
19343335|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
19343336|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343337|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
19343338|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387413|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20387414|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20387415|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
20387416|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387417|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387418|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20387419|NCT01060423|Irinotecan|irinotecan|mesh-list
20387420|NCT01060423|Cetuximab|cetuximab|mesh-list
19343339|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343340|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
19343341|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343342|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19343343|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
19343344|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343345|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19343346|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19343347|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
19343348|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343349|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343350|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19343351|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20201458|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20201459|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20201460|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201461|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201462|NCT00252928|Troclosene|troclosene|mesh-list
20201463|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
20201464|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201465|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
20201466|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
20201467|NCT00252954|Levetiracetam|levetiracetam|mesh-list
20201468|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
20201469|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
20217683|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
20217684|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
20217685|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
19343352|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343353|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343354|NCT03790384|Mitomycins|mitomycins|mesh-list
20217686|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19343355|NCT03790384|Mitomycin|mitomycin|mesh-list
19343356|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
19343357|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19343358|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343359|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
19343360|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343361|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19343362|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343363|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19343364|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
19343365|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343366|NCT03790397|Osimertinib|osimertinib|mesh-list
19343367|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343368|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19343369|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343370|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343371|NCT03790293|Rituximab|rituximab|mesh-list
19343372|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19343373|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343374|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
19843239|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843240|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19843241|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
19843242|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843243|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343375|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343376|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343377|NCT03790020|Bupivacaine|bupivacaine|mesh-list
19343378|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343379|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
19343380|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343381|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343382|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
19343383|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343384|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
19343385|NCT03790072|Fludarabine|fludarabine|mesh-list
19343386|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19343387|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
19343388|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343389|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343390|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19343391|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
19343392|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343393|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343394|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19343395|NCT03789890|Itraconazole|itraconazole|mesh-list
19343396|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
19343397|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19343398|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19343399|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19343400|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343401|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343402|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19343403|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
19343404|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343405|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343406|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19343407|NCT03790085|Olanzapine|olanzapine|mesh-list
19343408|NCT03790085|Risperidone|risperidone|mesh-list
19343409|NCT03790085|Aripiprazole|aripiprazole|mesh-list
19343410|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19343411|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
19343412|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343413|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343414|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343415|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19343416|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19343417|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343418|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19343419|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19343420|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
19343421|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
19343422|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
19343423|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343424|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19343425|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19343426|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19343427|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343428|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
19343429|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
19343430|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19343431|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19343432|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20201470|NCT00253058|Cetirizine|cetirizine|mesh-list
20201471|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20201472|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20201473|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20201474|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
20201475|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
20201476|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343433|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19343434|NCT03789916|Aspirin|aspirin|mesh-list
19343435|NCT03789916|Ticagrelor|ticagrelor|mesh-list
19343436|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19343437|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19343438|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19343439|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19343440|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
19343441|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343442|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343443|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343444|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19343445|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387421|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20387422|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20387423|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387424|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387425|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387426|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20387427|NCT01060475|Tacrolimus|tacrolimus|mesh-list
20387428|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20387429|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
20387430|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387431|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20387432|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387433|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387434|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20387435|NCT01060488|Hormones|hormones|mesh-ancestor
20201477|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201478|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201479|NCT00253110|Haloperidol|haloperidol|mesh-list
20201480|NCT00253110|Risperidone|risperidone|mesh-list
20201481|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
20201482|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19343446|NCT03789916|Analgesics|analgesics|mesh-ancestor
19343447|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
19343448|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343449|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343450|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343451|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19343452|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19343453|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343454|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343455|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
19343456|NCT03790137|Fenfluramine|fenfluramine|mesh-list
19343457|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19343458|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19343459|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343460|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343461|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343462|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
19343463|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201483|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
20201484|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201485|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343464|NCT03790007|Bupivacaine|bupivacaine|mesh-list
19343465|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343466|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
20201486|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201487|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201488|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201489|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201490|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201491|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20201492|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
20201493|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
20201494|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
20201495|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201496|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201497|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20201498|NCT00253123|Risperidone|risperidone|mesh-list
20201499|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20201500|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
19343467|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343468|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343469|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
19343470|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343471|NCT03789695|Dabigatran|dabigatran|mesh-list
19343472|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
19343473|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19343474|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
19343475|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343476|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343477|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
19343478|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
19343479|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
19343480|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19343481|NCT03789799|Protective Agents|protective agents|mesh-ancestor
19343482|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343483|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
19343484|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19400301|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19400302|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
19400303|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400304|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19400305|NCT03626753|Acetaminophen|acetaminophen|mesh-list
19400306|NCT03626753|Piroxicam|piroxicam|mesh-list
19400307|NCT03626753|Nefopam|nefopam|mesh-list
19400308|NCT03626753|Proroxan|proroxan|mesh-list
19400309|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19400310|NCT03626753|Analgesics|analgesics|mesh-ancestor
19400311|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
19400312|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400313|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400314|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
19400315|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19400316|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400317|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19400318|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19400319|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400320|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400321|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19400322|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20201501|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201502|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387436|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400323|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
20387437|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387438|NCT01060501|Leucovorin|leucovorin|mesh-list
20387439|NCT01060501|Folic Acid|folic acid|mesh-list
20387440|NCT01060501|Interferons|interferons|mesh-list
20387441|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
20387442|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
20387443|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387444|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
20387445|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400324|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400325|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400326|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
20201503|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400327|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20201504|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19343485|NCT03789370|Propofol|propofol|mesh-list
19343486|NCT03789370|Sevoflurane|sevoflurane|mesh-list
19343487|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19343488|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343489|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343490|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19343491|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
19343492|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
19343493|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19343494|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19343495|NCT03789539|Vaccines|vaccines|mesh-list
19343496|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
20387446|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
20387447|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387448|NCT01060501|Antidotes|antidotes|mesh-ancestor
20387449|NCT01060501|Protective Agents|protective agents|mesh-ancestor
20387450|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
20387451|NCT01060501|Vitamins|vitamins|mesh-ancestor
19343497|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343498|NCT03789422|Cetirizine|cetirizine|mesh-list
19343499|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
19343500|NCT03789422|Levocetirizine|levocetirizine|mesh-list
19343501|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19343502|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20201505|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201506|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201507|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19343503|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343504|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
20387452|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
20387453|NCT01060501|Hematinics|hematinics|mesh-ancestor
20387454|NCT01060514|Vinorelbine|vinorelbine|mesh-list
20387455|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20387456|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387457|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
20387458|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
20387459|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
20387460|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387461|NCT01060566|Ivacaftor|ivacaftor|mesh-list
20387462|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20387463|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387464|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387465|NCT01060605|Sirolimus|sirolimus|mesh-list
20387466|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387467|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387468|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20387469|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387470|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
19343505|NCT03789422|Coagulants|coagulants|mesh-ancestor
19343506|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19343507|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19343508|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
19343509|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
19343510|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343511|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343512|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19343513|NCT03789123|Dienogest|dienogest|mesh-list
19343514|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19343515|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19343516|NCT03789123|Estradiol|estradiol|mesh-list
19343517|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20201508|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20201509|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
20201510|NCT00253136|Risperidone|risperidone|mesh-list
20201511|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20201512|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
20201513|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201514|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201515|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201516|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201517|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201518|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343518|NCT03789123|Nandrolone|nandrolone|mesh-list
19343519|NCT03789123|Estrogens|estrogens|mesh-ancestor
19343520|NCT03789123|Hormones|hormones|mesh-ancestor
19343521|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387471|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19343522|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343523|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19343524|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
19343525|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19343526|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19343527|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19343528|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19343529|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19343530|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
19343531|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19343532|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343533|NCT03789123|Androgens|androgens|mesh-ancestor
19343534|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
19343535|NCT03789214|Suvorexant|suvorexant|mesh-list
20387472|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
20387473|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387474|NCT01060618|Maraviroc|maraviroc|mesh-list
20387475|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20387476|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20387477|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387478|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20387479|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20387480|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
20387481|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387482|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20387483|NCT01060631|Propofol|propofol|mesh-list
20387484|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20387485|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387486|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201519|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201520|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20201521|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
20201522|NCT00253149|Risperidone|risperidone|mesh-list
20201523|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20387487|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20387488|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
20387489|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
20387490|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
20387491|NCT01060696|Scopolamine|scopolamine|mesh-list
20387492|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20387493|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20387494|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
20387495|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
20387496|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387497|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387498|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19343536|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19343537|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19343538|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343539|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343540|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20201524|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
20201525|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201526|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201527|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201528|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201529|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201530|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201531|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201532|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19343541|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343542|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343543|NCT03789058|Ibuprofen|ibuprofen|mesh-list
19343544|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19343545|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343546|NCT03789058|Analgesics|analgesics|mesh-ancestor
19843244|NCT00657358|Lidocaine|lidocaine|mesh-list
19843245|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
19843246|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
19843247|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843248|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843249|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
19843250|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387499|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
20387500|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20387501|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
20387502|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387503|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387504|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20387505|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
20387506|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20387507|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387508|NCT01060696|Analgesics|analgesics|mesh-ancestor
20387509|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
20387510|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387511|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20387512|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20387513|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426452|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426453|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20426454|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343547|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
19343548|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343549|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343550|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343551|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20201533|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
20201534|NCT00253162|Risperidone|risperidone|mesh-list
20201535|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20201536|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
20201537|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201538|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201539|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201540|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201541|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201542|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201543|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201544|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19343552|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343553|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426455|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426456|NCT01281228|Exenatide|exenatide|mesh-list
20426457|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20426458|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426459|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19343554|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343555|NCT03788889|Ketamine|ketamine|mesh-list
19343556|NCT03788889|Lorazepam|lorazepam|mesh-list
19343557|NCT03788889|Phenobarbital|phenobarbital|mesh-list
19343558|NCT03788889|Analgesics|analgesics|mesh-ancestor
19343559|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
19343560|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343561|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343562|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19343563|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19343564|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
19343565|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
19343566|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343567|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19343568|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19343569|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343570|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343571|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
19343572|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
19343573|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
19343574|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19343575|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19343576|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19343577|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19343578|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19343579|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
19343580|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
19343581|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19343582|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19343583|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19343584|NCT03788902|Methylphenidate|methylphenidate|mesh-list
19343585|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20201545|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
19343586|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201546|NCT00253175|Topiramate|topiramate|mesh-list
20387514|NCT01060735|Vitamin D|vitamin d|mesh-list
20387515|NCT01060735|Vitamins|vitamins|mesh-ancestor
20387516|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
19343587|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19343588|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19343589|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343590|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343591|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
19343592|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343593|NCT03788863|Diflucortolone|diflucortolone|mesh-list
19343594|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
19343595|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343596|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
19343597|NCT03788863|Hormones|hormones|mesh-ancestor
19343598|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343599|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343600|NCT03789032|Rabeprazole|rabeprazole|mesh-list
19343601|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19343602|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19343603|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19343604|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387517|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387518|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20387519|NCT01060774|Lidocaine|lidocaine|mesh-list
19343605|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343606|NCT03788733|Melatonin|melatonin|mesh-list
19343607|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
19343608|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343609|NCT03788733|Protective Agents|protective agents|mesh-ancestor
19343610|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343611|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343612|NCT03788694|Ketamine|ketamine|mesh-list
19343613|NCT03788694|Analgesics|analgesics|mesh-ancestor
19343614|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
19343615|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343616|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343617|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19343618|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19343619|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
19343620|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
19343621|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343622|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19343623|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19343624|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343625|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343626|NCT03789006|Interleukin-2|interleukin-2|mesh-list
19343627|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
19343628|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19343629|NCT03789006|Antibodies|antibodies|mesh-list
19343630|NCT03789006|Basiliximab|basiliximab|mesh-list
19343631|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
19343632|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19343633|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
19343634|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343635|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201547|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
20201548|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20201549|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201550|NCT00253188|Galantamine|galantamine|mesh-list
20201551|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20201552|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201553|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201554|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
20201555|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201556|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201557|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20201558|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
20201559|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201560|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
20201561|NCT00253201|Galantamine|galantamine|mesh-list
20201562|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19343636|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343637|NCT03789006|Analgesics|analgesics|mesh-ancestor
20387520|NCT01060774|Bupivacaine|bupivacaine|mesh-list
20387521|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343638|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
19343639|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201563|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201564|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201565|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
20201566|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201567|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201568|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20201569|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
20201570|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201571|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
20201572|NCT00253214|Galantamine|galantamine|mesh-list
20201573|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20201574|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201575|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201576|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
19343640|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19343641|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
19343642|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
19343643|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387522|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
20387523|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387524|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387525|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
20387526|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387527|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20387528|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20387529|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20387530|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387531|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387532|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20387533|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387534|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
20387535|NCT01060787|Hormones|hormones|mesh-ancestor
19343644|NCT03788759|Protective Agents|protective agents|mesh-ancestor
19343645|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343646|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
19343647|NCT03788759|Vitamins|vitamins|mesh-ancestor
19343648|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
19343649|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19343650|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19343651|NCT03788681|Estradiol|estradiol|mesh-list
19343652|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19343653|NCT03788681|Estrogens|estrogens|mesh-ancestor
19343654|NCT03788681|Hormones|hormones|mesh-ancestor
19343655|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19343656|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343657|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19343658|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
19343659|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19343660|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19343661|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
19343662|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19343663|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343664|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343665|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343666|NCT03788538|Analgesics|analgesics|mesh-ancestor
19343667|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
19343668|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343669|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19343670|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19343671|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20387536|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387537|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387538|NCT01060826|Somatostatin|somatostatin|mesh-list
20387539|NCT01060826|Hormones|hormones|mesh-ancestor
20387540|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387541|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387542|NCT01060891|Colistin|colistin|mesh-list
19343672|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
19343673|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343674|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343675|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19343676|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19343677|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
19343678|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
19343679|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19343680|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19343681|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19343682|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343683|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343684|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
19343685|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343686|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343687|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19343688|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343689|NCT03787992|Gefitinib|gefitinib|mesh-list
19343690|NCT03787992|Aflutinib|aflutinib|mesh-list
19343691|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343692|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19343693|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343694|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343695|NCT03787940|Isoniazid|isoniazid|mesh-list
19343696|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
19343697|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19343698|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19343699|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19343700|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20387543|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387544|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387545|NCT01060904|Doxorubicin|doxorubicin|mesh-list
20387546|NCT01060904|Bleomycin|bleomycin|mesh-list
20387547|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20387548|NCT01060904|Dacarbazine|dacarbazine|mesh-list
20387549|NCT01060904|Vinblastine|vinblastine|mesh-list
20387550|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20387551|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20387552|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343701|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
19343702|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343703|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19343704|NCT03787953|Antibodies|antibodies|mesh-list
19343705|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
19343706|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343707|NCT03788018|Lidocaine|lidocaine|mesh-list
19343708|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
20201577|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201578|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201579|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20201580|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
20201581|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201582|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
20201583|NCT00253227|Galantamine|galantamine|mesh-list
20201584|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20201585|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201586|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201587|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
20201588|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343709|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343710|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
19343711|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343712|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343713|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
19343714|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343715|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19343716|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19343717|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19343718|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343719|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343720|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20201589|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201590|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20201591|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
20201592|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201593|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
20201594|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19343721|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343722|NCT03788018|Analgesics|analgesics|mesh-ancestor
20387553|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20387554|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20387555|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387556|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387557|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20387558|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
20387559|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387560|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20201595|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20201596|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
20201597|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201598|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201599|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201600|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201601|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201602|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20387561|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
20387562|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20387563|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
20387564|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
20387565|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
20387566|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20387567|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387568|NCT01060930|Epinephrine|epinephrine|mesh-list
20387569|NCT01060930|Norepinephrine|norepinephrine|mesh-list
20201603|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20201604|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201605|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201606|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201607|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20201608|NCT00253305|Terbinafine|terbinafine|mesh-list
20201609|NCT00253305|Naftifine|naftifine|mesh-list
20201610|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
20387570|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20387571|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19343723|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19343724|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19343725|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19343726|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
19343727|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343728|NCT03788174|Apatinib|apatinib|mesh-list
19343729|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343730|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19343731|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343732|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343733|NCT03787927|Aspirin|aspirin|mesh-list
19343734|NCT03787927|Clopidogrel|clopidogrel|mesh-list
19343735|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19343736|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343737|NCT03787927|Analgesics|analgesics|mesh-ancestor
19343738|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
19343739|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343740|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343741|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343742|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343743|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19343744|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19343745|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387572|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20387573|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
20387574|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387575|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387576|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343746|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19343747|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343748|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343749|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
19343750|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19343751|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19343752|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20201611|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387577|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20201612|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201613|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201614|NCT00253318|Dexamethasone|dexamethasone|mesh-list
20201615|NCT00253318|Docetaxel|docetaxel|mesh-list
20201616|NCT00253318|Everolimus|everolimus|mesh-list
20387578|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20387579|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
20387580|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387581|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20387582|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
20387583|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
20387584|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
20387585|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20387586|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387587|NCT01060969|Acetazolamide|acetazolamide|mesh-list
20387588|NCT01060969|Tadalafil|tadalafil|mesh-list
20387589|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387590|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19343753|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
19343754|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343755|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19343756|NCT03787550|Analgesics|analgesics|mesh-list
19343757|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19343758|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19343759|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
19343760|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343761|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343762|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387591|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20387592|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387593|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387594|NCT01060969|Urological Agents|urological agents|mesh-ancestor
20387595|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
20387596|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19400328|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19400329|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
19400330|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
19400331|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400332|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400333|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19400334|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19400335|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400336|NCT03626519|Menthol|menthol|mesh-list
19400337|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
19400338|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
19400339|NCT03626506|Amlodipine|amlodipine|mesh-list
19400340|NCT03626506|Indapamide|indapamide|mesh-list
19400341|NCT03626506|Spironolactone|spironolactone|mesh-list
19400342|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19400343|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19400344|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19400345|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400346|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19400347|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400348|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
19400349|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19400350|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
19843251|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19843252|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19843253|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19843254|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201617|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20201618|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
20201619|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
20201620|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201621|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201622|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201623|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
20201624|NCT00253318|Hormones|hormones|mesh-ancestor
20201625|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201626|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20201627|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387597|NCT01060969|Diuretics|diuretics|mesh-ancestor
19400351|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201628|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
19343763|NCT03787641|Protamines|protamines|mesh-list
19343764|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
19343765|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343766|NCT03787641|Coagulants|coagulants|mesh-ancestor
19343767|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19343768|NCT03787264|Venetoclax|venetoclax|mesh-list
19343769|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
19343770|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
19343771|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19343772|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
20201629|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
20201630|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201631|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387598|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
20387599|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387600|NCT01061060|Epoprostenol|epoprostenol|mesh-list
20387601|NCT01061060|Beraprost|beraprost|mesh-list
20387602|NCT01061060|Tezosentan|tezosentan|mesh-list
20201632|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20201633|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
20201634|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
20201635|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
20201636|NCT00253344|Docetaxel|docetaxel|mesh-list
20201637|NCT00253344|Lenalidomide|lenalidomide|mesh-list
20201638|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201639|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
20201640|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
20201641|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201642|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201643|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
20201644|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201645|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19343773|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343774|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343775|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20201646|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20201647|NCT00253344|Growth Substances|growth substances|mesh-ancestor
20201648|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
19343776|NCT03787147|Lidocaine|lidocaine|mesh-list
19343777|NCT03787147|Bupivacaine|bupivacaine|mesh-list
19343778|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
19343779|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
19343780|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343781|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343782|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
19343783|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343784|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19343785|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19343786|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19343787|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343788|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343789|NCT03786887|Nalbuphine|nalbuphine|mesh-list
19343790|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19343791|NCT03786887|Narcotics|narcotics|mesh-ancestor
19343792|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343793|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343794|NCT03786887|Analgesics|analgesics|mesh-ancestor
19343795|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
20201649|NCT00253396|Heparin|heparin|mesh-list
20201650|NCT00253396|Enoxaparin|enoxaparin|mesh-list
20201651|NCT00253396|Calcium heparin|calcium heparin|mesh-list
20201652|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
20201653|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20201654|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20201655|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387603|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20387604|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387605|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20387606|NCT01061112|Tolbutamide|tolbutamide|mesh-list
20387607|NCT01061112|Fluconazole|fluconazole|mesh-list
20387608|NCT01061112|Ketoprofen|ketoprofen|mesh-list
19343796|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343797|NCT03787043|Metformin|metformin|mesh-list
20201656|NCT00253422|Fulvestrant|fulvestrant|mesh-list
20387609|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
20387610|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
20387611|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387612|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20387613|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20201657|NCT00253422|Anastrozole|anastrozole|mesh-list
19683266|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683267|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
19683268|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683269|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683270|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19343798|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19343799|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343800|NCT03787017|Metformin|metformin|mesh-list
19343801|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19343802|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343803|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
19343804|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19343805|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
19343806|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19683271|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
19683272|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683273|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683274|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19683275|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683276|NCT03832049|Vaccines|vaccines|mesh-list
20201658|NCT00253422|Exemestane|exemestane|mesh-list
20201659|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20201660|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201661|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20201662|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20201663|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
19683277|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
19683278|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387614|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387615|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387616|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20387617|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
20387618|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387619|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683279|NCT03810105|Durvalumab|durvalumab|mesh-list
19683280|NCT03810105|Olaparib|olaparib|mesh-list
19683281|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683282|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683283|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19683284|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683285|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387620|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20387621|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20387622|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20387623|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387624|NCT01061112|Analgesics|analgesics|mesh-ancestor
20387625|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
20387626|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387627|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387628|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20387629|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20387630|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20387631|NCT01061190|Propranolol|propranolol|mesh-list
19343807|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
19343808|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343809|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343810|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
19343811|NCT03787030|Vitamin E|vitamin e|mesh-list
19343812|NCT03787030|Tocopherols|tocopherols|mesh-list
19343813|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
19683286|NCT03806751|Acetazolamide|acetazolamide|mesh-list
20387632|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19683287|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
20201664|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201665|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201666|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20201667|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20201668|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343814|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
19343815|NCT03787030|Vitamins|vitamins|mesh-ancestor
19343816|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
19343817|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343818|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
19343819|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343820|NCT03787030|Protective Agents|protective agents|mesh-ancestor
19343821|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
19343822|NCT03787069|Lidocaine|lidocaine|mesh-list
19343823|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683288|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19683289|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683290|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683291|NCT03806751|Diuretics|diuretics|mesh-ancestor
19683292|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
19343824|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
19343825|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343826|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343827|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
19343828|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343829|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19343830|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19343831|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19343832|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343833|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343834|NCT03786562|Morphine|morphine|mesh-list
19343835|NCT03786562|Nalbuphine|nalbuphine|mesh-list
19343836|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19343837|NCT03786562|Narcotics|narcotics|mesh-ancestor
19343838|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343839|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343840|NCT03786562|Analgesics|analgesics|mesh-ancestor
20387633|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20387634|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
20387635|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387636|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343841|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
19343842|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343843|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
19683293|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201669|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201670|NCT00253461|Topotecan|topotecan|mesh-list
20201671|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20201672|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20201673|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20201674|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201675|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387637|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343844|NCT03786289|Hematinics|hematinics|mesh-ancestor
19343845|NCT03786419|Atezolizumab|atezolizumab|mesh-list
20201676|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201677|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20201678|NCT00253474|Interferons|interferons|mesh-list
20201679|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
20201680|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
20201681|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20201682|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201683|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
20201684|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201685|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
20201686|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201687|NCT00253487|Temozolomide|temozolomide|mesh-list
20201688|NCT00253487|Busulfan|busulfan|mesh-list
20201689|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20201690|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20201691|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
20201692|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201693|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201694|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20201695|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
20201696|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201697|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20201698|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201699|NCT00253500|Epirubicin|epirubicin|mesh-list
20201700|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19683294|NCT03805399|Sirolimus|sirolimus|mesh-list
20201701|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201702|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20201703|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20201704|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201705|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201706|NCT00253526|Gemcitabine|gemcitabine|mesh-list
20201707|NCT00253526|Bevacizumab|bevacizumab|mesh-list
20201708|NCT00253526|Antibodies|antibodies|mesh-list
20201709|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
20201710|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20201711|NCT00253526|Mitogens|mitogens|mesh-list
20201712|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19343846|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343847|NCT03786120|Zolpidem|zolpidem|mesh-list
19343848|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19343849|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20387638|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20387639|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20387640|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387641|NCT01061216|Insulin|insulin|mesh-list
20387642|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20387643|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20387644|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387645|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20387646|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
20387647|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20387648|NCT01061320|Tocopherols|tocopherols|mesh-list
20387649|NCT01061320|Vitamin E|vitamin e|mesh-list
20387650|NCT01061320|Tocotrienols|tocotrienols|mesh-list
20387651|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
20387652|NCT01061320|Vitamins|vitamins|mesh-ancestor
20387653|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
20387654|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387655|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
20387656|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387657|NCT01061320|Protective Agents|protective agents|mesh-ancestor
19343850|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343851|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343852|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19343853|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
19343854|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
19343855|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343856|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343857|NCT03785873|Leucovorin|leucovorin|mesh-list
19343858|NCT03785873|Fluorouracil|fluorouracil|mesh-list
19343859|NCT03785873|Nivolumab|nivolumab|mesh-list
19343860|NCT03785873|Irinotecan|irinotecan|mesh-list
19343861|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
19343862|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343863|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19343864|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343865|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19343866|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
19343867|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343868|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19343869|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19343870|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20201713|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201714|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20201715|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20201716|NCT00253526|Growth Substances|growth substances|mesh-ancestor
20201717|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343871|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19343872|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343873|NCT03785873|Antidotes|antidotes|mesh-ancestor
19343874|NCT03785873|Protective Agents|protective agents|mesh-ancestor
19343875|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
19343876|NCT03785873|Vitamins|vitamins|mesh-ancestor
19343877|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
19343878|NCT03786237|ON 01910|on 01910|mesh-list
19343879|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201718|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
19343880|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19343881|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343882|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343883|NCT03786029|Acetaminophen|acetaminophen|mesh-list
20201719|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
20201720|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20387658|NCT01061372|Pregabalin|pregabalin|mesh-list
20387659|NCT01061372|Analgesics|analgesics|mesh-ancestor
20387660|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
19343884|NCT03786029|Ibuprofen|ibuprofen|mesh-list
19343885|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343886|NCT03786029|Analgesics|analgesics|mesh-ancestor
19343887|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
19343888|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343889|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343890|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
20201721|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
20201722|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201723|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
20201724|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201725|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683295|NCT03805399|Paclitaxel|paclitaxel|mesh-list
19683296|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20201726|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20201727|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
19343891|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19343892|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343893|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343894|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343895|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343896|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400352|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19400353|NCT03626506|Diuretics|diuretics|mesh-ancestor
19400354|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
19400355|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19400356|NCT03626454|Norepinephrine|norepinephrine|mesh-list
19400357|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19400358|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400359|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400360|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400361|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400362|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400363|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400364|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
19400365|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
19400366|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400367|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19400368|NCT03626298|Niacinamide|niacinamide|mesh-list
19400369|NCT03626298|Niacin|niacin|mesh-list
19400370|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
19400371|NCT03626298|Adapalene|adapalene|mesh-list
19400372|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
19400373|NCT03626298|Vitamins|vitamins|mesh-ancestor
19400374|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
19400375|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400376|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19400377|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
19400378|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400379|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19400380|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
19400381|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19400382|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19400383|NCT03626298|Analgesics|analgesics|mesh-ancestor
19400384|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
19400385|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400386|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400387|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19400388|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
19400389|NCT03626259|Losartan|losartan|mesh-list
19400390|NCT03626259|Amlodipine|amlodipine|mesh-list
19400391|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19400392|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19400393|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19400394|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400395|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19400396|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400397|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
19400398|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20201728|NCT00253539|Tamoxifen|tamoxifen|mesh-list
20201729|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20201730|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
20201731|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400399|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19400400|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19343897|NCT03785756|Ibuprofen|ibuprofen|mesh-list
19343898|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19343899|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343900|NCT03785756|Analgesics|analgesics|mesh-ancestor
19343901|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
19343902|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343903|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343904|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343905|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343906|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343907|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387661|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387662|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387663|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
20387664|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20387665|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343908|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343909|NCT03785496|Spartalizumab|spartalizumab|mesh-list
19343910|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19343911|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343912|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19343913|NCT03785587|Bromides|bromides|mesh-list
20201732|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387666|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387667|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20387668|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20387669|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20387670|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387671|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20387672|NCT01061411|Sunitinib|sunitinib|mesh-list
20387673|NCT01061411|Dalteparin|dalteparin|mesh-list
20387674|NCT01061411|Tinzaparin|tinzaparin|mesh-list
20387675|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20387676|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387677|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20387678|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19343914|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
19343915|NCT03785691|Ondansetron|ondansetron|mesh-list
19343916|NCT03785691|Mirtazapine|mirtazapine|mesh-list
19343917|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
19343918|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
20201733|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20201734|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201735|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20201736|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20201737|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20201738|NCT00253552|Cyclosporine|cyclosporine|mesh-list
20201739|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
20201740|NCT00253552|Busulfan|busulfan|mesh-list
20201741|NCT00253552|Methotrexate|methotrexate|mesh-list
20201742|NCT00253552|Etoposide|etoposide|mesh-list
19343919|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343920|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343921|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20201743|NCT00253552|Cyclosporins|cyclosporins|mesh-list
19343922|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
19343923|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
19343924|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19343925|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
19343926|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343927|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343928|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19343929|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201744|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20201745|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
20201746|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201747|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20201748|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20201749|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
20201750|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201751|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201752|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20201753|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19343930|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387679|NCT01061411|Growth Substances|growth substances|mesh-ancestor
20387680|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387681|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
20387682|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20387683|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387684|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387685|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
20387686|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20387687|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387688|NCT01061437|Lansoprazole|lansoprazole|mesh-list
20387689|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
20201754|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
20201755|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20201756|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20201757|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
20201758|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
20201759|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201760|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19343931|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19343932|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19343933|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
19343934|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19343935|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
19343936|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
19343937|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19343938|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19343939|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19343940|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
19343941|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19343942|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19343943|NCT03785613|Buprenorphine|buprenorphine|mesh-list
19343944|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19343945|NCT03785613|Narcotics|narcotics|mesh-ancestor
19343946|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343947|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343948|NCT03785613|Analgesics|analgesics|mesh-ancestor
20201761|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20201762|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20201763|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20201764|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20201765|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
20201766|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201767|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20201768|NCT00253565|Capecitabine|capecitabine|mesh-list
20201769|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
20201770|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19343949|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
19343950|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343951|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19343952|NCT03785522|Insulin|insulin|mesh-list
19343953|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19343954|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387690|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20387691|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387692|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20387693|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387694|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387695|NCT01061450|Simvastatin|simvastatin|mesh-list
20387696|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19343955|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19343956|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19343957|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19343958|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20201771|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
20201772|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201773|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201774|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201775|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201776|NCT00253578|Sorafenib|sorafenib|mesh-list
20201777|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387697|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20387698|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
20426460|NCT01281228|Incretins|incretins|mesh-ancestor
19343959|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20201778|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19343960|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
19343961|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19343962|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843255|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843256|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19843257|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19843258|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20387699|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343963|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343964|NCT03785158|Melatonin|melatonin|mesh-list
19343965|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
19343966|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343967|NCT03785158|Protective Agents|protective agents|mesh-ancestor
19343968|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343969|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19343970|NCT03785223|Methylphenidate|methylphenidate|mesh-list
19343971|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19343972|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343973|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19343974|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19343975|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19343976|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343977|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
19343978|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387700|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20387701|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20387702|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201779|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201780|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201781|NCT00253591|Vinorelbine|vinorelbine|mesh-list
20201782|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201783|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19343979|NCT03785015|Aspirin|aspirin|mesh-list
19343980|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19343981|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19343982|NCT03785015|Analgesics|analgesics|mesh-ancestor
19343983|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
19343984|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19343985|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19343986|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343987|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19343988|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19343989|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19343990|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19343991|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19343992|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19343993|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19343994|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
19343995|NCT03785184|Dexamethasone|dexamethasone|mesh-list
20201784|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
20201785|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
19343996|NCT03785184|Lenalidomide|lenalidomide|mesh-list
19343997|NCT03785184|Venetoclax|venetoclax|mesh-list
20387703|NCT01061658|Vaccines|vaccines|mesh-list
20387704|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
19343998|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19343999|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
19344000|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
19344001|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344002|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344003|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344004|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
19344005|NCT03785184|Hormones|hormones|mesh-ancestor
19344006|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344007|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19344008|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344009|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
19344010|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19344011|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19344012|NCT03785184|Growth Substances|growth substances|mesh-ancestor
20201786|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201787|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344013|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
19344014|NCT03785041|Tramadol|tramadol|mesh-list
19344015|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
19344016|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19344017|NCT03785041|Narcotics|narcotics|mesh-ancestor
19344018|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344019|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344020|NCT03785041|Analgesics|analgesics|mesh-ancestor
19344021|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
20201788|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20201789|NCT00253617|Trioxsalen|trioxsalen|mesh-list
20201790|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201791|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
20201792|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20201793|NCT00253721|Melphalan|melphalan|mesh-list
19344022|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344023|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
19344024|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
20387705|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387706|NCT01061697|Pregabalin|pregabalin|mesh-list
20387707|NCT01061697|Analgesics|analgesics|mesh-ancestor
20387708|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
20387709|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387710|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387711|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
19344025|NCT03784794|Thrombin|thrombin|mesh-list
19344026|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
19344027|NCT03784794|Coagulants|coagulants|mesh-ancestor
20387712|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20387713|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387714|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387715|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20387716|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20387717|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20387718|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387719|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20387720|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20387721|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
20387722|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387723|NCT01061788|Everolimus|everolimus|mesh-list
20387724|NCT01061788|Panitumumab|panitumumab|mesh-list
19344028|NCT03785067|Amlodipine|amlodipine|mesh-list
19344029|NCT03785067|Telmisartan|telmisartan|mesh-list
19344030|NCT03785067|Indapamide|indapamide|mesh-list
19344031|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19344032|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19344033|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344034|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344035|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19344036|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344037|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
19344038|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19344039|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19344040|NCT03785067|Diuretics|diuretics|mesh-ancestor
19344041|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
19344042|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19344043|NCT03784495|Melatonin|melatonin|mesh-list
19344044|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
20201794|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20201795|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
20201796|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344045|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344046|NCT03784495|Protective Agents|protective agents|mesh-ancestor
19344047|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344048|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344049|NCT03784599|Trastuzumab|trastuzumab|mesh-list
19344050|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19344051|NCT03784599|Osimertinib|osimertinib|mesh-list
19344052|NCT03784599|Maytansine|maytansine|mesh-list
19344053|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344054|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344055|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19344056|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387725|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344057|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344058|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19344059|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
19344060|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
19344061|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
19344062|NCT03784703|Atorvastatin|atorvastatin|mesh-list
19344063|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19344064|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19344065|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19344066|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
19344067|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344068|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19344069|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19344070|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344071|NCT03784677|SOR-C13|sor-c13|mesh-list
19344072|NCT03784677|Calcium|calcium|mesh-list
19344073|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19344074|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344075|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344076|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19344077|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344078|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344079|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19344080|NCT03784443|Ranibizumab|ranibizumab|mesh-list
19344081|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19344082|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19344083|NCT03784443|Growth Substances|growth substances|mesh-ancestor
19344084|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344085|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
19344086|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344087|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344088|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
19344089|NCT03784443|Hormones|hormones|mesh-ancestor
19344090|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344091|NCT03784378|Agerafenib|agerafenib|mesh-list
19344092|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19344093|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344094|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344095|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
19344096|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
19344097|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344098|NCT03784391|Nifurtimox|nifurtimox|mesh-list
19344099|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19344100|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19344101|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19344102|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344103|NCT03784105|Codeine|codeine|mesh-list
20201797|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201798|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20201799|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683297|NCT03805399|Capecitabine|capecitabine|mesh-list
20201800|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
20201801|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201802|NCT00253773|Acetaminophen|acetaminophen|mesh-list
20201803|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20201804|NCT00253773|Analgesics|analgesics|mesh-ancestor
20201805|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
20201806|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201807|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201808|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
20201809|NCT00253799|Hylan|hylan|mesh-list
20201810|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
20201811|NCT00253799|Protective Agents|protective agents|mesh-ancestor
20201812|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201813|NCT00253851|Heparin|heparin|mesh-list
20201814|NCT00253851|Calcium heparin|calcium heparin|mesh-list
20201815|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
20201816|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20201817|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20201818|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201819|NCT00253903|SR 46349B|sr 46349b|mesh-list
20201820|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20201821|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19344104|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19344105|NCT03784105|Narcotics|narcotics|mesh-ancestor
19344106|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683298|NCT03805399|Everolimus|everolimus|mesh-list
20201822|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426461|NCT01281228|Hormones|hormones|mesh-ancestor
19683299|NCT03805399|Apatinib|apatinib|mesh-list
20201823|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20201824|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20201825|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
19344107|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344108|NCT03784105|Analgesics|analgesics|mesh-ancestor
19344109|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
19344110|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344111|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
19344112|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
19344113|NCT03784014|Durvalumab|durvalumab|mesh-list
19344114|NCT03784014|Olaparib|olaparib|mesh-list
19344115|NCT03784014|Lapatinib|lapatinib|mesh-list
19344116|NCT03784014|Palbociclib|palbociclib|mesh-list
19344117|NCT03784014|Trametinib|trametinib|mesh-list
19344118|NCT03784014|Dabrafenib|dabrafenib|mesh-list
19344119|NCT03784014|Ceritinib|ceritinib|mesh-list
19344120|NCT03784014|Futibatinib|futibatinib|mesh-list
19344121|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344122|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344123|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19344124|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683300|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19683301|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19683302|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683303|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
19683304|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
19683305|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683306|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683307|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20201826|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201827|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201828|NCT00253929|Adenosine|adenosine|mesh-list
19344125|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344126|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19344127|NCT03784326|Fluorouracil|fluorouracil|mesh-list
19344128|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
19344129|NCT03784326|Atezolizumab|atezolizumab|mesh-list
19344130|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19344131|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
19344132|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344133|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19344134|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344135|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344136|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
19344137|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201829|NCT00253929|Nitroprusside|nitroprusside|mesh-list
20201830|NCT00253929|Acetylcholine|acetylcholine|mesh-list
20201831|NCT00253929|Caffeine|caffeine|mesh-list
19683308|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
19683309|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683310|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
19683311|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683312|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683313|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201832|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20201833|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201834|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20201835|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201836|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201837|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20201838|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20201839|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
20201840|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201841|NCT00253929|Analgesics|analgesics|mesh-ancestor
20201842|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
20201843|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20201844|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20201845|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
20201846|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20201847|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
19344138|NCT03784261|Abatacept|abatacept|mesh-list
19683314|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20201848|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19344139|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19400401|NCT03626064|Nicotine|nicotine|mesh-list
19344140|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344141|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344142|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344143|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
19344144|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344145|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19344146|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19344147|NCT03783897|Norgestimate|norgestimate|mesh-list
19344148|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
19344149|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
19344150|NCT03783897|Estradiol|estradiol|mesh-list
19344151|NCT03783897|Estrogens|estrogens|mesh-ancestor
19344152|NCT03783897|Hormones|hormones|mesh-ancestor
19344153|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344154|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344155|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19344156|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19344157|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19344158|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19344159|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19344160|NCT03783949|Gemcitabine|gemcitabine|mesh-list
19344161|NCT03783949|Paclitaxel|paclitaxel|mesh-list
19344162|NCT03783949|Carboplatin|carboplatin|mesh-list
19344163|NCT03783949|Niraparib|niraparib|mesh-list
19344164|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19344165|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344166|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19344167|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19344168|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19344169|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683315|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683316|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19683317|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
19683318|NCT03800979|Tofacitinib|tofacitinib|mesh-list
19683319|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19683320|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683321|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683322|NCT03780829|Cycloserine|cycloserine|mesh-list
20201849|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20201850|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20201851|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
20201852|NCT00253955|Levofloxacin|levofloxacin|mesh-list
20201853|NCT00253955|Ofloxacin|ofloxacin|mesh-list
20201854|NCT00253955|Tazobactam|tazobactam|mesh-list
20201855|NCT00253955|Piperacillin|piperacillin|mesh-list
20201856|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20201857|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20201858|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387726|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344170|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19344171|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
19344172|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
19344173|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344174|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344175|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344176|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
19344177|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344178|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19344179|NCT03783936|Leucovorin|leucovorin|mesh-list
19344180|NCT03783936|Fluorouracil|fluorouracil|mesh-list
19344181|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
19344182|NCT03783936|Trastuzumab|trastuzumab|mesh-list
19344183|NCT03783936|Avelumab|avelumab|mesh-list
19344184|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
19344185|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344186|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19344187|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387727|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
20387728|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387729|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344188|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344189|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
19344190|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344191|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683323|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19683324|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344192|NCT03783936|Antidotes|antidotes|mesh-ancestor
19344193|NCT03783936|Protective Agents|protective agents|mesh-ancestor
19344194|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
19344195|NCT03783936|Vitamins|vitamins|mesh-ancestor
19344196|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
19344197|NCT03784040|Nivolumab|nivolumab|mesh-list
19344198|NCT03784040|Ipilimumab|ipilimumab|mesh-list
19344199|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344200|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344201|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19344202|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344203|NCT03783845|Amoxicillin|amoxicillin|mesh-list
19344204|NCT03783845|Metronidazole|metronidazole|mesh-list
19344205|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344206|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344207|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19344208|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19344209|NCT03783728|Pyridoxine|pyridoxine|mesh-list
19344210|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
19344211|NCT03783728|Isoniazid|isoniazid|mesh-list
19344212|NCT03783728|Rifapentine|rifapentine|mesh-list
19344213|NCT03783728|Vitamins|vitamins|mesh-ancestor
19344214|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
19344215|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344216|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
20201859|NCT00253955|Renal Agents|renal agents|mesh-ancestor
20201860|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20201861|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20201862|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20201863|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201864|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201865|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344217|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
19344218|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20201866|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20201867|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20201868|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20201869|NCT00254007|Citalopram|citalopram|mesh-list
20201870|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20201871|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20201872|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344219|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344220|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19344221|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19344222|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
19344223|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344224|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19344225|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19344226|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
19344227|NCT03783754|Amlodipine|amlodipine|mesh-list
19344228|NCT03783754|Telmisartan|telmisartan|mesh-list
19344229|NCT03783754|Indapamide|indapamide|mesh-list
19344230|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19344231|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19344232|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344233|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344234|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19344235|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344236|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
19344237|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19344238|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19344239|NCT03783754|Diuretics|diuretics|mesh-ancestor
19344240|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
19344241|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19400402|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19400403|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
19400404|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400405|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400406|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19400407|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19400408|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
19400409|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201873|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400410|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400411|NCT03625960|Cantharidin|cantharidin|mesh-list
19344242|NCT03783715|Ketoprofen|ketoprofen|mesh-list
19344243|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19344244|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19344245|NCT03783715|Analgesics|analgesics|mesh-ancestor
19344246|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
19344247|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344248|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344249|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344250|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19344251|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19344252|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344253|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344254|NCT03783494|Propofol|propofol|mesh-list
19344255|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19344256|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344257|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344258|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19344259|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
19344260|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
19344261|NCT03783676|Remifentanil|remifentanil|mesh-list
19344262|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20201874|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201875|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
20201876|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201877|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20201878|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
20201879|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201880|NCT00254020|Citalopram|citalopram|mesh-list
20201881|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20201882|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19683325|NCT03780829|Renal Agents|renal agents|mesh-ancestor
19683326|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19683327|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
19683328|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19683329|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
19683330|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683331|NCT03770260|Ixazomib|ixazomib|mesh-list
19843259|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843260|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
19843261|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19843262|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
19843263|NCT00657709|Vaccines|vaccines|mesh-list
19843264|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19843265|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
19843266|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843267|NCT00657917|Gentamicins|gentamicins|mesh-list
19843268|NCT00657917|Paromomycin|paromomycin|mesh-list
19843269|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344263|NCT03783676|Narcotics|narcotics|mesh-ancestor
19344264|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843270|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201883|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201884|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201885|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344265|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344266|NCT03783676|Analgesics|analgesics|mesh-ancestor
19344267|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
20201886|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
20201887|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201888|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20201889|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
20201890|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201891|NCT00254033|Methylphenidate|methylphenidate|mesh-list
20201892|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
20201893|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20201894|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201895|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20387730|NCT01061814|Mipomersen|mipomersen|mesh-list
20387731|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19683332|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19683333|NCT03770260|Pevonedistat|pevonedistat|mesh-list
19843271|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19344268|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683334|NCT03770260|Glycine|glycine|mesh-list
19843272|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387732|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20387733|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
20387734|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387735|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20387736|NCT01061853|Sirolimus|sirolimus|mesh-list
20387737|NCT01061853|Betamethasone|betamethasone|mesh-list
20387738|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387739|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387740|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20387741|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387742|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
20387743|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20387744|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
20387745|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387746|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387747|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
20387748|NCT01061853|Hormones|hormones|mesh-ancestor
20387749|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387750|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20387751|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
20387752|NCT01061996|Basiliximab|basiliximab|mesh-list
20387753|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20387754|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
20387755|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344269|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
19344270|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19344271|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
19344272|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344273|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
19344274|NCT03783455|Protective Agents|protective agents|mesh-ancestor
19344275|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19344276|NCT03783520|Eusol|eusol|mesh-list
19344277|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
19344278|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344279|NCT03783338|Vitamin D|vitamin d|mesh-list
20387756|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20387757|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20387758|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387759|NCT01062048|Incretins|incretins|mesh-ancestor
20387760|NCT01062048|Hormones|hormones|mesh-ancestor
20387761|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387762|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20387763|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
20387764|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387765|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387766|NCT01062087|Lidocaine|lidocaine|mesh-list
20387767|NCT01062087|Bupivacaine|bupivacaine|mesh-list
20387768|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
20387769|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
20387770|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387771|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387772|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
20387773|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344280|NCT03783338|Vitamins|vitamins|mesh-ancestor
19344281|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
19344282|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344283|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19344284|NCT03783312|Acetaminophen|acetaminophen|mesh-list
19344285|NCT03783312|Ibuprofen|ibuprofen|mesh-list
19344286|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19344287|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19344288|NCT03783312|Analgesics|analgesics|mesh-ancestor
19344289|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
19344290|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344291|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344292|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344293|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19344294|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19344295|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344296|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344297|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
19344298|NCT03783429|Digoxin|digoxin|mesh-list
19344299|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19344300|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19344301|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344302|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344303|NCT03783429|Protective Agents|protective agents|mesh-ancestor
19344304|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344305|NCT03783182|Betamethasone|betamethasone|mesh-list
19683335|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683336|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387774|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20387775|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20387776|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20387777|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387778|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387779|NCT01062139|Cetirizine|cetirizine|mesh-list
20387780|NCT01062139|Levocetirizine|levocetirizine|mesh-list
20387781|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20387782|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20387783|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
20387784|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
20387785|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683337|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
19683338|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
19683339|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683340|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683341|NCT03762018|Bevacizumab|bevacizumab|mesh-list
19683342|NCT03762018|Carboplatin|carboplatin|mesh-list
19683343|NCT03762018|Pemetrexed|pemetrexed|mesh-list
19683344|NCT03762018|Atezolizumab|atezolizumab|mesh-list
19683345|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683346|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683347|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683348|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19683349|NCT03762018|Growth Substances|growth substances|mesh-ancestor
19683350|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201896|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20201897|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20201898|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201899|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
20201900|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201901|NCT00254046|Etravirine|etravirine|mesh-list
20201902|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20201903|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20201904|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201905|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201906|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
20201907|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20201908|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
20201909|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20201910|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201911|NCT00254137|Capecitabine|capecitabine|mesh-list
20201912|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
20387786|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387787|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387788|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20387789|NCT01062152|Lenalidomide|lenalidomide|mesh-list
20387790|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
20387791|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387792|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20387793|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20387794|NCT01062152|Growth Substances|growth substances|mesh-ancestor
20387795|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
20387796|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387797|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20387798|NCT01062191|Laxatives|laxatives|mesh-ancestor
19344306|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
19344307|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19344308|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
20387799|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344309|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19344310|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
19344311|NCT03783182|Hormones|hormones|mesh-ancestor
19344312|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344313|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344314|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344315|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20201913|NCT00254137|Irinotecan|irinotecan|mesh-list
20201914|NCT00254137|Cetuximab|cetuximab|mesh-list
20201915|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20201916|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
20201917|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201918|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201919|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19683351|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
19683352|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344316|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
19344317|NCT03783299|Lumefantrine|lumefantrine|mesh-list
19344318|NCT03783299|Artemether|artemether|mesh-list
19683353|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683354|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19683355|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19683356|NCT03750786|Leucovorin|leucovorin|mesh-list
19683357|NCT03750786|Antidotes|antidotes|mesh-ancestor
19683358|NCT03750786|Protective Agents|protective agents|mesh-ancestor
20201920|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20201921|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201922|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20201923|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
20201924|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20201925|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19683359|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683360|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
19683361|NCT03750786|Vitamins|vitamins|mesh-ancestor
19683362|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
20201926|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
20201927|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20201928|NCT00254189|Estradiol|estradiol|mesh-list
19344319|NCT03783299|Primaquine|primaquine|mesh-list
19344320|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19344321|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
19344322|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19344323|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19344324|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344325|NCT03783273|Vitamin D|vitamin d|mesh-list
19344326|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
19344327|NCT03783273|Vitamins|vitamins|mesh-ancestor
19344328|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
19344329|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344330|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19344331|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19344332|NCT03782987|Itraconazole|itraconazole|mesh-list
19344333|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
19344334|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344335|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20387800|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20387801|NCT01062204|Laxatives|laxatives|mesh-ancestor
20387802|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387803|NCT01062282|Iloprost|iloprost|mesh-list
20387804|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20387805|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
19344336|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19344337|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344338|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344339|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19344340|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
19344341|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344342|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344343|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19344344|NCT03783065|Propranolol|propranolol|mesh-list
19344345|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19344346|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19344347|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
19344348|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344349|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344350|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344351|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19344352|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19683363|NCT03748966|Calcitriol|calcitriol|mesh-list
19683364|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19683365|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19683366|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201929|NCT00254189|Estrogens|estrogens|mesh-ancestor
20387806|NCT01062360|Aspirin|aspirin|mesh-list
19344353|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
19344354|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
19344355|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344356|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344357|NCT03782935|Choline|choline|mesh-list
19344358|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
19344359|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19344360|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
19344361|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344362|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344363|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19683367|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19683368|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19683369|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683370|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19683371|NCT03748966|Vitamins|vitamins|mesh-ancestor
19683372|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
19683373|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19683374|NCT03748433|Insulin|insulin|mesh-list
19344364|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
19344365|NCT03783013|Lycopene|lycopene|mesh-list
19344366|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344367|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
19344368|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344369|NCT03783013|Protective Agents|protective agents|mesh-ancestor
19344370|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344371|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19683375|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20387807|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
20387808|NCT01062360|Ephedrine|ephedrine|mesh-list
20387809|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20387810|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20387811|NCT01062360|Analgesics|analgesics|mesh-ancestor
20387812|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
20387813|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387814|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387815|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387816|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20387817|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20387818|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387819|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387820|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19344372|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19344373|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344374|NCT03782831|Antibodies|antibodies|mesh-list
19344375|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
19344376|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344377|NCT03783000|BI 425809|bi 425809|mesh-list
19344378|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
19344379|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
19344380|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19344381|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683376|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683377|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
19683378|NCT03737955|Calicheamicins|calicheamicins|mesh-list
19683379|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683380|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683381|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19683382|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
20387821|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20387822|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387823|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
20387824|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20387825|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
20387826|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20387827|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
20387828|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
20387829|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20387830|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19344382|NCT03782805|Vitamins|vitamins|mesh-ancestor
19344383|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
19683383|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20387831|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
19344384|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19843273|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683384|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843274|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19843275|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19843276|NCT00658021|Exenatide|exenatide|mesh-list
20387832|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
20387833|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426462|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428619|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428620|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428621|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20428622|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
20428623|NCT01292993|Metformin|metformin|mesh-list
20428624|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20428625|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20428626|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344390|NCT03782662|Itraconazole|itraconazole|mesh-list
19344391|NCT03782662|Rifampin|rifampin|mesh-list
19344392|NCT03782662|Verapamil|verapamil|mesh-list
19344393|NCT03782662|Midazolam|midazolam|mesh-list
19344394|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19344395|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19344396|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344397|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344398|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19344399|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19843277|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19843278|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843279|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19843280|NCT00658021|Incretins|incretins|mesh-ancestor
20201930|NCT00254189|Hormones|hormones|mesh-ancestor
20428627|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20428628|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428629|NCT01293058|Naloxone|naloxone|mesh-list
20428630|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19344400|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19344401|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19344402|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
19344403|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
19344404|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
19344405|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
19344406|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344407|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344408|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
19344409|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344410|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19344411|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19344412|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344413|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19344414|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
20201931|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683385|NCT03698006|Ropivacaine|ropivacaine|mesh-list
19683386|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19683387|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683388|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
19683389|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201932|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201933|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20201934|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
20201935|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20201936|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20201937|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20201938|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20201939|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20201940|NCT00254202|Iloperidone|iloperidone|mesh-list
19400412|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683390|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683391|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
19683392|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683393|NCT03695237|Leuprolide|leuprolide|mesh-list
19683394|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19683395|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
19683396|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19843281|NCT00658021|Hormones|hormones|mesh-ancestor
19843282|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201941|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201942|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19344415|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344416|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19344417|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19344418|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
19683397|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683398|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19683399|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692666|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19692667|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19692668|NCT04989140|Growth Substances|growth substances|mesh-ancestor
19692669|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
19692670|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
19692671|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692672|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692673|NCT04988945|Durvalumab|durvalumab|mesh-list
19692674|NCT04988945|Tremelimumab|tremelimumab|mesh-list
19692675|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19843283|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20201943|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201944|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201945|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201946|NCT00254241|Risperidone|risperidone|mesh-list
19344419|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344420|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
19344421|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19344422|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19344423|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19344424|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19344425|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19344426|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19344427|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19344428|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19344429|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19344430|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344431|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19344432|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
19344433|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19344434|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19344435|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
19344436|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344437|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
19344438|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19344439|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19344440|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344441|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
19344442|NCT03782025|Coagulants|coagulants|mesh-ancestor
20201947|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20201948|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20201949|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
20201950|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20201951|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201952|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344443|NCT03782025|Vitamins|vitamins|mesh-ancestor
19344444|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
19344445|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344446|NCT03781947|Antarelix|antarelix|mesh-list
19344447|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
19344448|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344449|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201953|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20201954|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20201955|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20201956|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20201957|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20201958|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
20201959|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
20201960|NCT00254254|Exenatide|exenatide|mesh-list
20201961|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20201962|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201963|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20201964|NCT00254254|Incretins|incretins|mesh-ancestor
20387834|NCT01062477|Vaccines|vaccines|mesh-list
20387835|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
20387836|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387837|NCT01062490|Treosulfan|treosulfan|mesh-list
20387838|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20387839|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
20387840|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387841|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201965|NCT00254254|Hormones|hormones|mesh-ancestor
20201966|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201967|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
20201968|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201969|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20201970|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20201971|NCT00254319|Bevacizumab|bevacizumab|mesh-list
20201972|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20201973|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201974|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20201975|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20201976|NCT00254319|Growth Substances|growth substances|mesh-ancestor
20201977|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201978|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
20201979|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20201980|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
20201981|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20201982|NCT00254345|Protective Agents|protective agents|mesh-ancestor
20201983|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20201984|NCT00254371|Androgens|androgens|mesh-list
20201985|NCT00254371|Hormones|hormones|mesh-ancestor
20201986|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20201987|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387842|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
19683400|NCT03657342|Cyclosporine|cyclosporine|mesh-list
19683401|NCT03657342|Cyclosporins|cyclosporins|mesh-list
19683402|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683403|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683404|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683405|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
19683406|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683407|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
19843284|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
20201988|NCT00254384|Cisplatin|cisplatin|mesh-list
20201989|NCT00254384|Docetaxel|docetaxel|mesh-list
20201990|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20201991|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20201992|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
20201993|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
20201994|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
20201995|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387843|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20387844|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387845|NCT01062516|Esomeprazole|esomeprazole|mesh-list
20201996|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20201997|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344450|NCT03782064|Nivolumab|nivolumab|mesh-list
19344451|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344452|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344453|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19843285|NCT00658320|Cyclosporine|cyclosporine|mesh-list
19843286|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
20387846|NCT01062516|Famotidine|famotidine|mesh-list
20387847|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20387848|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387849|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20387850|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387851|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387852|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19843287|NCT00658320|Everolimus|everolimus|mesh-list
19843288|NCT00658320|Cyclosporins|cyclosporins|mesh-list
19344454|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843289|NCT00658320|Basiliximab|basiliximab|mesh-list
20387853|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
19683408|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843290|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843291|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843292|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843293|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
19843294|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843295|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
19843296|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344455|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
19344456|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19344457|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344458|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
19344459|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19344460|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344461|NCT03781895|Vitamins|vitamins|mesh-ancestor
19344462|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
19344463|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19344464|NCT03781843|Lidocaine|lidocaine|mesh-list
19344465|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
19344466|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
19344467|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344468|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344469|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
19344470|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344471|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19344472|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19843297|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
19843298|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19843299|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19344473|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19344474|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344475|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344476|NCT03781869|Cisplatin|cisplatin|mesh-list
19344477|NCT03781869|Etoposide|etoposide|mesh-list
19344478|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
19344479|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344480|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19344481|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19344482|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19344483|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344484|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344485|NCT03781687|Morphine|morphine|mesh-list
19344486|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19344487|NCT03781687|Narcotics|narcotics|mesh-ancestor
19344488|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344489|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344490|NCT03781687|Analgesics|analgesics|mesh-ancestor
19683409|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
19683410|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683411|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19683412|NCT03656926|Cyclosporine|cyclosporine|mesh-list
19683413|NCT03656926|Cyclosporins|cyclosporins|mesh-list
19683414|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683415|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683416|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20202003|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
19843300|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843301|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20202004|NCT00254436|Hematinics|hematinics|mesh-ancestor
20202005|NCT00254449|Capsaicin|capsaicin|mesh-list
20202006|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
19683417|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
19843302|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19843303|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
19843304|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19843305|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
19843306|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19843307|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843308|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19843309|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
19843310|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202007|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
20202008|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
19344491|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
20202009|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202010|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202011|NCT00254475|Valsartan|valsartan|mesh-list
20202012|NCT00254475|Simvastatin|simvastatin|mesh-list
20202013|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20202014|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20202015|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
20202016|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202017|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20202018|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20202019|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202020|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20202021|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20202022|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20202023|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
20202024|NCT00254553|Testosterone|testosterone|mesh-list
20202025|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
20202026|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
20202027|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20202028|NCT00254553|Androgens|androgens|mesh-ancestor
20202029|NCT00254553|Hormones|hormones|mesh-ancestor
20202030|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683418|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683419|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
19683420|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202031|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202032|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20202033|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202034|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
20202035|NCT00254618|Mesalamine|mesalamine|mesh-list
20202036|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20202037|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683421|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
19683422|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683423|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20387854|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
20387855|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387856|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387857|NCT01062529|Somatostatin|somatostatin|mesh-list
20387858|NCT01062529|Hormones|hormones|mesh-ancestor
20387859|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387860|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387861|NCT01062633|Erythritol|erythritol|mesh-list
20387862|NCT01062633|Sorbitol|sorbitol|mesh-list
20387863|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
20387864|NCT01062633|Cathartics|cathartics|mesh-ancestor
20387865|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20202038|NCT00254618|Analgesics|analgesics|mesh-ancestor
20202039|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
20387866|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19344492|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387867|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20387868|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20387869|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387870|NCT01062776|Furosemide|furosemide|mesh-list
19344493|NCT03781596|Fluticasone|fluticasone|mesh-list
19344494|NCT03781596|Omeprazole|omeprazole|mesh-list
19344495|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344496|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19344497|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
19344498|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344499|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344500|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19344501|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
19344502|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
19344503|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19344504|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19344505|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344506|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19344507|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344508|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683424|NCT03651895|Metformin|metformin|mesh-list
20387871|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19683425|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19683426|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344509|NCT03781674|Progesterone|progesterone|mesh-list
19344510|NCT03781674|Progestins|progestins|mesh-ancestor
19344511|NCT03781674|Hormones|hormones|mesh-ancestor
19344512|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344513|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344514|NCT03781635|Ketamine|ketamine|mesh-list
19344515|NCT03781635|Analgesics|analgesics|mesh-ancestor
19344516|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
19344517|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387872|NCT01062776|Diuretics|diuretics|mesh-ancestor
20387873|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
20387874|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387875|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20387876|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387877|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387878|NCT01062802|Atorvastatin|atorvastatin|mesh-list
19344518|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344519|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19344520|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19683427|NCT03646617|Nivolumab|nivolumab|mesh-list
19683428|NCT03646617|Ipilimumab|ipilimumab|mesh-list
19683429|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683430|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683431|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19683432|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683433|NCT03643744|Celecoxib|celecoxib|mesh-list
19683434|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19683435|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683436|NCT03643744|Analgesics|analgesics|mesh-ancestor
19683437|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
19683438|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683439|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202040|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202041|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202042|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202043|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20202044|NCT00254631|Oxycodone|oxycodone|mesh-list
19683440|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19683441|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683442|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19683443|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19683444|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202045|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20202046|NCT00254631|Narcotics|narcotics|mesh-ancestor
20202047|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202048|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202049|NCT00254631|Analgesics|analgesics|mesh-ancestor
20202050|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
20202051|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202052|NCT00254657|Levetiracetam|levetiracetam|mesh-list
20202053|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
20202054|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
20202055|NCT00254670|Naltrexone|naltrexone|mesh-list
20202056|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20202057|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20202058|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683445|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683446|NCT03639389|Morphine|morphine|mesh-list
19683447|NCT03639389|Analgesics|analgesics|mesh-list
19683448|NCT03639389|Bupivacaine|bupivacaine|mesh-list
19683449|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683450|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
19683451|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683452|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683453|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
19683454|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683455|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19683456|NCT03639389|Narcotics|narcotics|mesh-ancestor
19683457|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19683458|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19683459|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683460|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
20387879|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20202059|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
20387880|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19344521|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
19344522|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
19344523|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344524|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19344525|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19344526|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344527|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344528|NCT03781544|Acetaminophen|acetaminophen|mesh-list
19344529|NCT03781544|Diclofenac|diclofenac|mesh-list
19683461|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683462|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683463|NCT03600090|Paclitaxel|paclitaxel|mesh-list
19683464|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19683465|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683466|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
19344530|NCT03781544|Tramadol|tramadol|mesh-list
19344531|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19344532|NCT03781544|Analgesics|analgesics|mesh-ancestor
19344533|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
19344534|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344535|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344536|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
19683467|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
19683468|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683469|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683470|NCT03595150|Diclofenac|diclofenac|mesh-list
19683471|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19683472|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683473|NCT03595150|Analgesics|analgesics|mesh-ancestor
19683474|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
19683475|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683476|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683477|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344537|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19344538|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344539|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19344540|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19344541|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344542|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344543|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19344544|NCT03781544|Narcotics|narcotics|mesh-ancestor
19344545|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344546|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
19344547|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19344548|NCT03781505|Acetaminophen|acetaminophen|mesh-list
19344549|NCT03781505|Ropivacaine|ropivacaine|mesh-list
19344550|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
19344551|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
19344552|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344553|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344554|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
20387881|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
20387882|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344555|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344556|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19344557|NCT03781505|Analgesics|analgesics|mesh-ancestor
19344558|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
19344559|NCT03781700|Prednisolone|prednisolone|mesh-list
19344560|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344561|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
19344562|NCT03781700|Hormones|hormones|mesh-ancestor
19344563|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344564|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344565|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19683478|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683479|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19843311|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843312|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843313|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843314|NCT00658359|Cyclosporine|cyclosporine|mesh-list
19843315|NCT00658359|Cyclosporins|cyclosporins|mesh-list
19843316|NCT00658359|Tofacitinib|tofacitinib|mesh-list
19843317|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843318|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843319|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344566|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344567|NCT03781466|Progesterone|progesterone|mesh-list
19344568|NCT03781466|Progestins|progestins|mesh-ancestor
19344569|NCT03781466|Hormones|hormones|mesh-ancestor
19344570|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344571|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344572|NCT03781388|Bupivacaine|bupivacaine|mesh-list
19344573|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683480|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683481|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683482|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19683483|NCT03594175|Reteplase|reteplase|mesh-list
19683484|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19683485|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19683486|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683487|NCT03583333|Linezolid|linezolid|mesh-list
19843320|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
19843321|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344574|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
19344575|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344576|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202060|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217687|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20387883|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19344577|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
19843322|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
19843323|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843324|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
20217688|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217689|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217690|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20217691|NCT00310128|Cytarabine|cytarabine|mesh-list
19344578|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344579|NCT03781258|Warfarin|warfarin|mesh-list
19344580|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
20387884|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20387885|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387886|NCT01062906|Lidocaine|lidocaine|mesh-list
20387887|NCT01062906|Fentanyl|fentanyl|mesh-list
20387888|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
20387889|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
19344581|NCT03781063|Fulvestrant|fulvestrant|mesh-list
19344582|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19344583|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344584|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19344585|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19344586|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
19344587|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344588|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344589|NCT03781115|Olanzapine|olanzapine|mesh-list
19344590|NCT03781115|Ziprasidone|ziprasidone|mesh-list
19344591|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
19344592|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
19344593|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344594|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344595|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344596|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19344597|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19344598|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344599|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19344600|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19344601|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19344602|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19843325|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20217692|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
20217693|NCT00310128|Rituximab|rituximab|mesh-list
19843326|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19843327|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19843328|NCT00658411|Deferoxamine|deferoxamine|mesh-list
19843329|NCT00658411|Siderophores|siderophores|mesh-ancestor
20217694|NCT00310128|Etoposide|etoposide|mesh-list
19344603|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683488|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19683489|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217695|NCT00310128|Antibodies|antibodies|mesh-list
20217696|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
20387890|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20387891|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387892|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
20387893|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20387894|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20387895|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20387896|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20387897|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20387898|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387899|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19344604|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344605|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
19344606|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19344607|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19344608|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
19344609|NCT03781050|Sirolimus|sirolimus|mesh-list
19344610|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344611|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344612|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19344613|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344614|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
19344615|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344616|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
19683490|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19683491|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683492|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683493|NCT03582722|Orlistat|orlistat|mesh-list
19683494|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683495|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344617|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344618|NCT03781011|Choline|choline|mesh-list
19344619|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
19344620|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19344621|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
19344622|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344623|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344624|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19344625|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
19344626|NCT03780933|Ascorbic Acid|ascorbic acid|mesh-list
19344627|NCT03780933|Vitamins|vitamins|mesh-ancestor
19344628|NCT03780933|Micronutrients|micronutrients|mesh-ancestor
19344629|NCT03780933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344630|NCT03780933|Antioxidants|antioxidants|mesh-ancestor
19344631|NCT03780933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344632|NCT03780933|Protective Agents|protective agents|mesh-ancestor
19344633|NCT03780673|Rifaximin|rifaximin|mesh-list
19344634|NCT03780673|Simvastatin|simvastatin|mesh-list
19344635|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19344636|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20387900|NCT01062906|Narcotics|narcotics|mesh-ancestor
20387901|NCT01062906|Analgesics|analgesics|mesh-ancestor
20387902|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19344637|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
19344638|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344639|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19344640|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19344641|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344642|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344643|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344644|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344645|NCT03780686|Dopamine|dopamine|mesh-list
19344646|NCT03780686|Norepinephrine|norepinephrine|mesh-list
19344647|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19344648|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19344649|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
19344650|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344651|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344652|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344653|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
19344654|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
19344655|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344656|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19344657|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19683496|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19344658|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
19344659|NCT03780686|Protective Agents|protective agents|mesh-ancestor
19344660|NCT03780556|Lornoxicam|lornoxicam|mesh-list
19344661|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19344662|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19344663|NCT03780556|Analgesics|analgesics|mesh-ancestor
19344664|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
19344665|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344666|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344667|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344668|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19344669|NCT03780621|Andrographolide|andrographolide|mesh-list
19344670|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344671|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19344672|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19344673|NCT03780621|Analgesics|analgesics|mesh-ancestor
19344674|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
19344675|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344676|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344677|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19344678|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19344679|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19344680|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344681|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
19344682|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19344683|NCT03780634|Sorafenib|sorafenib|mesh-list
19344684|NCT03780634|Antibodies|antibodies|mesh-list
19344685|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
19344686|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
19344687|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344688|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344689|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19344690|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344691|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344692|NCT03780192|Sirolimus|sirolimus|mesh-list
19344693|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344694|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344695|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19683497|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19683498|NCT03581734|Vaccines|vaccines|mesh-list
19683499|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
19683500|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683501|NCT03576989|Mineral Oil|mineral oil|mesh-list
19683502|NCT03576989|Emollients|emollients|mesh-ancestor
19683503|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
19344696|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344697|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
19344698|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344699|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
19344700|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344701|NCT03780569|Temozolomide|temozolomide|mesh-list
19843330|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19843331|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
19843332|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
20202061|NCT00254709|Sirolimus|sirolimus|mesh-list
19344702|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19344703|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
19344704|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344705|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344706|NCT03780205|Methamphetamine|methamphetamine|mesh-list
19344707|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19344708|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344709|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
19344710|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
19344711|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843333|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843334|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
19843335|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20202062|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202063|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202064|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20202065|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202066|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
19344712|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
19344713|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683504|NCT03568318|Upadacitinib|upadacitinib|mesh-list
20202067|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20202068|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
19843336|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19843337|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
19344714|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387903|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20387904|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
20387905|NCT01062932|Cycloserine|cycloserine|mesh-list
20387906|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20387907|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387908|NCT01062932|Renal Agents|renal agents|mesh-ancestor
20387909|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20387910|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
20387911|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387912|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
20387913|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387914|NCT01062945|Doxazosin|doxazosin|mesh-list
20387915|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19344715|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19344716|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19344717|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19344718|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344719|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19344720|NCT03780361|Aflibercept|aflibercept|mesh-list
19344721|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20387916|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20387917|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20387918|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20387919|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
20387920|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20387921|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387922|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387923|NCT01062958|Vitamins|vitamins|mesh-list
20387924|NCT01062958|Folic Acid|folic acid|mesh-list
20387925|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
20387926|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
20387927|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
20387928|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387929|NCT01062958|Hematinics|hematinics|mesh-ancestor
20387930|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
20387931|NCT01063010|Bevacizumab|bevacizumab|mesh-list
20387932|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20387933|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387934|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20387935|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20387936|NCT01063010|Growth Substances|growth substances|mesh-ancestor
20387937|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387938|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
20387939|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
20387940|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20387941|NCT01063023|Asunaprevir|asunaprevir|mesh-list
20387942|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
20387943|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20387944|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387945|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20387946|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
20387947|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20387948|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387949|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20387950|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20387951|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20387952|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344722|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19344723|NCT03780361|Growth Substances|growth substances|mesh-ancestor
19344724|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344725|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
19344726|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344727|NCT03780270|Fluorides|fluorides|mesh-list
19344728|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
19344729|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
19344730|NCT03780270|Protective Agents|protective agents|mesh-ancestor
19344731|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344732|NCT03780127|Fenfluramine|fenfluramine|mesh-list
20387953|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387954|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20387955|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20387956|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344733|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19344734|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20387957|NCT01063101|Fucoidan|fucoidan|mesh-list
20387958|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20387959|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20387960|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
20202069|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202070|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20202071|NCT00254735|Clomipramine|clomipramine|mesh-list
19344735|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344736|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683505|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19683506|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19683507|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683508|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683509|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683510|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
19683511|NCT03565445|Nivolumab|nivolumab|mesh-list
19683512|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683513|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683514|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19843338|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202072|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
20202073|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19344737|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344738|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
19344739|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344740|NCT03779776|Vitamins|vitamins|mesh-list
19344741|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
19344742|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344743|NCT03780049|Leucovorin|leucovorin|mesh-list
19344744|NCT03780049|Fluorouracil|fluorouracil|mesh-list
19344745|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
19344746|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
19344747|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344748|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19344749|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344750|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344751|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
19344752|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344753|NCT03780049|Antidotes|antidotes|mesh-ancestor
19344754|NCT03780049|Protective Agents|protective agents|mesh-ancestor
19344755|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
19344756|NCT03780049|Vitamins|vitamins|mesh-ancestor
19344757|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
19344758|NCT03780608|Durvalumab|durvalumab|mesh-list
19344759|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344760|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202074|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202075|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202076|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344761|NCT03779789|Vortioxetine|vortioxetine|mesh-list
19344762|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
19344763|NCT03779789|Citalopram|citalopram|mesh-list
19344764|NCT03779789|Fluoxetine|fluoxetine|mesh-list
19344765|NCT03779789|Paroxetine|paroxetine|mesh-list
19344766|NCT03779789|Sertraline|sertraline|mesh-list
19344767|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19344768|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19344769|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202077|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202078|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20202079|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20202080|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20217697|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19344770|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843339|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19344771|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344772|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
19344773|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344774|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19843340|NCT00658528|Esomeprazole|esomeprazole|mesh-list
19843341|NCT00658528|Rabeprazole|rabeprazole|mesh-list
19843342|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19843343|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843344|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20387961|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387962|NCT01063127|Insulin|insulin|mesh-list
20387963|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20387964|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387965|NCT01063140|Vaccines|vaccines|mesh-list
20387966|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
20202081|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202082|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202083|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344775|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
19344776|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19344777|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19344778|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19344779|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344780|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19344781|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19344782|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344783|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19344784|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19344785|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19344786|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19344787|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19344788|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19400413|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400414|NCT03625830|Paclitaxel|paclitaxel|mesh-list
20202084|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
20202085|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20202086|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
20202087|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400415|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19400416|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400417|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
19400418|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
19400419|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
19400420|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400421|NCT03625739|Amoxicillin|amoxicillin|mesh-list
19400422|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
20202088|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202089|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202090|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202091|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387967|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400423|NCT03625739|Levofloxacin|levofloxacin|mesh-list
19400424|NCT03625739|Isoniazid|isoniazid|mesh-list
19400425|NCT03625739|Cycloserine|cycloserine|mesh-list
19400426|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
19400427|NCT03625739|Imipenem|imipenem|mesh-list
19400428|NCT03625739|Amikacin|amikacin|mesh-list
19400429|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
19400430|NCT03625739|Ethambutol|ethambutol|mesh-list
19400431|NCT03625739|Bedaquiline|bedaquiline|mesh-list
19400432|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19400433|NCT03625739|Clofazimine|clofazimine|mesh-list
19400434|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
19400435|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19400436|NCT03625739|Streptomycin|streptomycin|mesh-list
19400437|NCT03625739|Kanamycin|kanamycin|mesh-list
20202092|NCT00254774|Valproic Acid|valproic acid|mesh-list
20387968|NCT01063179|Thalidomide|thalidomide|mesh-list
20387969|NCT01063179|Prednisone|prednisone|mesh-list
20387970|NCT01063179|Bortezomib|bortezomib|mesh-list
20387971|NCT01063179|Melphalan|melphalan|mesh-list
20387972|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20387973|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
20387974|NCT01063179|Hormones|hormones|mesh-ancestor
20387975|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20387976|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20387977|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20387978|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20387979|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20387980|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
20387981|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387982|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20387983|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400438|NCT03625739|Ethionamide|ethionamide|mesh-list
19400439|NCT03625739|Capreomycin|capreomycin|mesh-list
19400440|NCT03625739|Thioacetazone|thioacetazone|mesh-list
20387984|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
20387985|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
20387986|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20387987|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20387988|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20387989|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20387990|NCT01063179|Growth Substances|growth substances|mesh-ancestor
20387991|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
20387992|NCT01063192|Leucovorin|leucovorin|mesh-list
20387993|NCT01063192|Gemcitabine|gemcitabine|mesh-list
20387994|NCT01063192|Fluorouracil|fluorouracil|mesh-list
20387995|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
20202093|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20202094|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
20387996|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20387997|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
20387998|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20387999|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388000|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
20388001|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388002|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388003|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388004|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
20388005|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388006|NCT01063192|Antidotes|antidotes|mesh-ancestor
19344789|NCT03779685|Anesthetics|anesthetics|mesh-list
19344790|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344791|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344792|NCT03779633|Estradiol|estradiol|mesh-list
19344793|NCT03779633|Estrogens|estrogens|mesh-ancestor
19344794|NCT03779633|Hormones|hormones|mesh-ancestor
19344795|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344796|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344797|NCT03779516|Lidocaine|lidocaine|mesh-list
19344798|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
19344799|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
19344800|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344801|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344802|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
19344803|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344804|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19344805|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19344806|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19344807|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19344808|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344809|NCT03779451|Progesterone|progesterone|mesh-list
19344810|NCT03779451|Progestins|progestins|mesh-ancestor
19344811|NCT03779451|Hormones|hormones|mesh-ancestor
19344812|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19344813|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344814|NCT03779594|Acetazolamide|acetazolamide|mesh-list
20202095|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202096|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202097|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202098|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202099|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202100|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
20202101|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202102|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202103|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
20202104|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202105|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
20202106|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20202107|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
20202108|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202109|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202110|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202111|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202112|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202113|NCT00254800|Exenatide|exenatide|mesh-list
20202114|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20202115|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20202116|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
20202117|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19344815|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
20388007|NCT01063192|Protective Agents|protective agents|mesh-ancestor
20202118|NCT00254800|Estradiol|estradiol|mesh-list
20202119|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20202120|NCT00254800|Estrogens|estrogens|mesh-ancestor
20202121|NCT00254800|Hormones|hormones|mesh-ancestor
20202122|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202123|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202124|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20202125|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
20202126|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19344816|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20388008|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
20388009|NCT01063192|Vitamins|vitamins|mesh-ancestor
20388010|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
20388011|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
19344817|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344818|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388012|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20388013|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
20388014|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388015|NCT01063205|Expectorants|expectorants|mesh-ancestor
20388016|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
20388017|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20388018|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
19344819|NCT03779594|Diuretics|diuretics|mesh-ancestor
19344820|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
19344821|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344822|NCT03779464|Gemcitabine|gemcitabine|mesh-list
19344823|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19344824|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
19344825|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344826|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388019|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388020|NCT01063205|Protective Agents|protective agents|mesh-ancestor
20388021|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388022|NCT01063205|Antidotes|antidotes|mesh-ancestor
20388023|NCT01063218|Emollients|emollients|mesh-list
20388024|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
20388025|NCT01063257|Clofarabine|clofarabine|mesh-list
20388026|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388027|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
20388028|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388029|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388030|NCT01063270|Rifampin|rifampin|mesh-list
20388031|NCT01063270|Clindamycin|clindamycin|mesh-list
20388032|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
20388033|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
20388034|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20388035|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
20388036|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20388037|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388038|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
20388039|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20388040|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388041|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388042|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20388043|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20388044|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20388045|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20388046|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20388047|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20388048|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20388049|NCT01063426|Enoxaparin|enoxaparin|mesh-list
20388050|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
20388051|NCT01063426|Atorvastatin|atorvastatin|mesh-list
20388052|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20388053|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20388054|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
20202127|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20202128|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20202129|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20202130|NCT00254800|Incretins|incretins|mesh-ancestor
20202131|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20388055|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388056|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20202132|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20388057|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20202133|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20202134|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20202135|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
20202136|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202137|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202138|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202139|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388058|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388059|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
20388060|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20388061|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20388062|NCT01063439|Cytarabine|cytarabine|mesh-list
20388063|NCT01063439|Etoposide|etoposide|mesh-list
20388064|NCT01063439|Melphalan|melphalan|mesh-list
20388065|NCT01063439|Busulfan|busulfan|mesh-list
20388066|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20388067|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388068|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20388069|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20388070|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344827|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
19344828|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344829|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344830|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344831|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
19344832|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344833|NCT03779568|Bupivacaine|bupivacaine|mesh-list
19344834|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
20202140|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202141|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20202142|NCT00254865|Norelgestromin|norelgestromin|mesh-list
20202143|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
20202144|NCT00254865|Estradiol|estradiol|mesh-list
20202145|NCT00254865|Estrogens|estrogens|mesh-ancestor
19344835|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
19344836|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388071|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344837|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344838|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
19344839|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344840|NCT03779659|Anesthetics|anesthetics|mesh-list
19344841|NCT03779659|Benzocaine|benzocaine|mesh-list
19344842|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
19344843|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344844|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344845|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
19344846|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344847|NCT03779646|Bisoprolol|bisoprolol|mesh-list
19344848|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19344849|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
19344850|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
19344851|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344852|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344853|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19344854|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19344855|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19344856|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
19344857|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344858|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344859|NCT03779672|Memantine|memantine|mesh-list
20202146|NCT00254865|Hormones|hormones|mesh-ancestor
20202147|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202148|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202149|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20202150|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20202151|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20202152|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20202153|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20202154|NCT00254878|Methylphenidate|methylphenidate|mesh-list
20202155|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20388072|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19344860|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19344861|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20217698|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
19344862|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
19344863|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344864|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344865|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344866|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19344867|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19344868|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
19344869|NCT03779282|Ketamine|ketamine|mesh-list
19344870|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19344871|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344872|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683515|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344873|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19344874|NCT03779282|Analgesics|analgesics|mesh-ancestor
19344875|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
19344876|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344877|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19344878|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19344879|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19344880|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
19344881|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344882|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344883|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19344884|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19344885|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
19344886|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
19344887|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19344888|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19344889|NCT03779360|Clindamycin|clindamycin|mesh-list
19344890|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
19344891|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
19344892|NCT03779360|Erythromycin|erythromycin|mesh-list
19344893|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
19344894|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19344895|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
19344896|NCT03779360|Prednisolone|prednisolone|mesh-list
19344897|NCT03779360|Clobetasol|clobetasol|mesh-list
19344898|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19344899|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
19344900|NCT03779360|Hormones|hormones|mesh-ancestor
19344901|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388073|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
19344902|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344903|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19344904|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344905|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344906|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19344907|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344908|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19344909|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344910|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344911|NCT03779347|Praziquantel|praziquantel|mesh-list
19344912|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
19344913|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20388074|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
20388075|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388076|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388077|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
20388078|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388079|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20388080|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
20388081|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20388082|NCT01063478|Everolimus|everolimus|mesh-list
20388083|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388084|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388085|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
20388086|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388087|NCT01063504|Teriparatide|teriparatide|mesh-list
20388088|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19683516|NCT03564340|Cemiplimab|cemiplimab|mesh-list
19683517|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20388089|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388090|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20388091|NCT01063530|Fluorides|fluorides|mesh-list
19344914|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344915|NCT03779178|Landiolol|landiolol|mesh-list
19344916|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19344917|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19344918|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
19344919|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344920|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344921|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344922|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19344923|NCT03779035|Gemcitabine|gemcitabine|mesh-list
19344924|NCT03779035|Capecitabine|capecitabine|mesh-list
19344925|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19344926|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
19344927|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344928|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344929|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
19344930|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344931|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344932|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19344933|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
19344934|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344935|NCT03779191|Bevacizumab|bevacizumab|mesh-list
19344936|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344937|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344938|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19344939|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19344940|NCT03779191|Growth Substances|growth substances|mesh-ancestor
19344941|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344942|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
19344943|NCT03779087|Amoxicillin|amoxicillin|mesh-list
19344944|NCT03779087|Levofloxacin|levofloxacin|mesh-list
19344945|NCT03779087|Ofloxacin|ofloxacin|mesh-list
19344946|NCT03779087|Tetracycline|tetracycline|mesh-list
19683518|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683519|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19683520|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19683521|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683522|NCT03493646|Azacitidine|azacitidine|mesh-list
19683523|NCT03493646|Cc-486|cc-486|mesh-list
19683524|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19683525|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
19683526|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683527|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683528|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683529|NCT03473340|Pirfenidone|pirfenidone|mesh-list
19683530|NCT03473340|Analgesics|analgesics|mesh-ancestor
20388092|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
20388093|NCT01063530|Protective Agents|protective agents|mesh-ancestor
20388094|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388095|NCT01063556|Donepezil|donepezil|mesh-list
20388096|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20388097|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388098|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388099|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
20388100|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388101|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388102|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
20388103|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
20388104|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20388105|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20388106|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20388107|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388108|NCT01063621|Apomorphine|apomorphine|mesh-list
20388109|NCT01063621|Emetics|emetics|mesh-ancestor
20388110|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388111|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
20388112|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388113|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20388114|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
20388115|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
20388116|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388117|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344947|NCT03779087|Esomeprazole|esomeprazole|mesh-list
19344948|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19683531|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
19683532|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388118|NCT01063647|Treosulfan|treosulfan|mesh-list
20388119|NCT01063647|Busulfan|busulfan|mesh-list
20388120|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20388121|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
20388122|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388123|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388124|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388125|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
19344949|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19344950|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19683533|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683534|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19683535|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683536|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19683537|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683538|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683539|NCT03457896|Trastuzumab|trastuzumab|mesh-list
19683540|NCT03457896|Cetuximab|cetuximab|mesh-list
19683541|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683542|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683543|NCT03451370|Bevacizumab|bevacizumab|mesh-list
19683544|NCT03451370|Capecitabine|capecitabine|mesh-list
19683545|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
19683546|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19344951|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19344952|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19344953|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388126|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388127|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20388128|NCT01063660|Treosulfan|treosulfan|mesh-list
20388129|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20388130|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
20388131|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388132|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388133|NCT01063816|Gemcitabine|gemcitabine|mesh-list
19683547|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683548|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683549|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19344954|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344955|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19344956|NCT03779087|Renal Agents|renal agents|mesh-ancestor
19843345|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202156|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843346|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843347|NCT00658541|Zolpidem|zolpidem|mesh-list
19843348|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19843349|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19843350|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843351|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843352|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19843353|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
19843354|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
19843355|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843356|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843357|NCT00658567|Pimavanserin|pimavanserin|mesh-list
19843358|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19843359|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19843360|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19843361|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202157|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20202158|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20202159|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202160|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202161|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
20202162|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202163|NCT00254917|Vaccines|vaccines|mesh-list
20202164|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
20202165|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388134|NCT01063816|Carboplatin|carboplatin|mesh-list
20388135|NCT01063816|Veliparib|veliparib|mesh-list
19344957|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19344958|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19683550|NCT03451370|Growth Substances|growth substances|mesh-ancestor
19683551|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843362|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388136|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388137|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388138|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
19344959|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344960|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19344961|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19344962|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19344963|NCT03779100|Lenvatinib|lenvatinib|mesh-list
19344964|NCT03779100|Antibodies|antibodies|mesh-list
19344965|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
19344966|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
19344967|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344968|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19344969|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19344970|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19344971|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344972|NCT03779048|Phentermine|phentermine|mesh-list
19344973|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19344974|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344975|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
19344976|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19344977|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
19344978|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
19344979|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344980|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
19344981|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19344982|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19344983|NCT03778723|Fentanyl|fentanyl|mesh-list
19344984|NCT03778723|Anesthetics|anesthetics|mesh-list
19344985|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344986|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344987|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19344988|NCT03778723|Narcotics|narcotics|mesh-ancestor
19344989|NCT03778723|Analgesics|analgesics|mesh-ancestor
19843363|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843364|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19843365|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20202166|NCT00254930|Risperidone|risperidone|mesh-list
20202167|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20202168|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
20202169|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202170|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202171|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202172|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202173|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202174|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202175|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202176|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20202177|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
20202178|NCT00254956|Ciclesonide|ciclesonide|mesh-list
20202179|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
20202180|NCT00254956|Hormones|hormones|mesh-ancestor
20202181|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202182|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202183|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20202184|NCT00255073|Baclofen|baclofen|mesh-list
20202185|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20202186|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202187|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20202188|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202189|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20202190|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
20202191|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
20202192|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202193|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202194|NCT00255242|Simvastatin|simvastatin|mesh-list
20202195|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20202196|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20202197|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
20202198|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202199|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20426463|NCT01281514|Carboplatin|carboplatin|mesh-list
19344990|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
19344991|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19344992|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19344993|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20612936|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20202200|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20202201|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202202|NCT00255255|Budesonide|budesonide|mesh-list
20202203|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
20202204|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202205|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20388139|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388140|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
20388141|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388142|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388143|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20612937|NCT02253446|Diclofenac|diclofenac|mesh-list
19344994|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
19344995|NCT03779061|Propofol|propofol|mesh-list
19344996|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19344997|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19344998|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19344999|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345000|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
19345001|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
19345002|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
19345003|NCT03778619|Rituximab|rituximab|mesh-list
19345004|NCT03778619|Fludarabine|fludarabine|mesh-list
20202206|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
20202207|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202208|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345005|NCT03778619|Interleukin-2|interleukin-2|mesh-list
19345006|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345007|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
19345008|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345009|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19345010|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19345011|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
19345012|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345013|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345014|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19345015|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345016|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19345017|NCT03778619|Analgesics|analgesics|mesh-ancestor
19345018|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
19345019|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345020|NCT03778645|Epinephrine|epinephrine|mesh-list
19345021|NCT03778645|Racepinephrine|racepinephrine|mesh-list
19345022|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
19345023|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19345024|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19345025|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
19345026|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345027|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202209|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20202210|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
20202211|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
20202212|NCT00255255|Hormones|hormones|mesh-ancestor
20202213|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202214|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20202215|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20202216|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20202217|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
20202218|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202219|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202220|NCT00255268|Goserelin|goserelin|mesh-list
20202221|NCT00255268|Bicalutamide|bicalutamide|mesh-list
20202222|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20202223|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388144|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
20612938|NCT02253446|Piroxicam|piroxicam|mesh-list
20612939|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20612940|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19345028|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345029|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19345030|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20388145|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388146|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20388147|NCT01063842|Acetaminophen|acetaminophen|mesh-list
20388148|NCT01063842|Tramadol|tramadol|mesh-list
20388149|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20388150|NCT01063842|Analgesics|analgesics|mesh-ancestor
19345031|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
20388151|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
20388152|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388153|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388154|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
20388155|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20388156|NCT01063842|Narcotics|narcotics|mesh-ancestor
20388157|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388158|NCT01063920|Naproxen|naproxen|mesh-list
20388159|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20388160|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20388161|NCT01063920|Analgesics|analgesics|mesh-ancestor
20388162|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
20388163|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388164|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388165|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388166|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388167|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
20388168|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20388169|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388170|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388171|NCT01063933|Peramivir|peramivir|mesh-list
20388172|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
20612941|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19345032|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345033|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19345034|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
19345035|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
19345036|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
19345037|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19345038|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
19345039|NCT03778450|Analgesics|analgesics|mesh-list
19345040|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19345041|NCT03778450|Narcotics|narcotics|mesh-ancestor
19345042|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345043|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345044|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
19345045|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345046|NCT03778359|Leuprolide|leuprolide|mesh-list
19345047|NCT03778359|Dienogest|dienogest|mesh-list
19345048|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
20612942|NCT02253446|Analgesics|analgesics|mesh-ancestor
19345049|NCT03778359|Progestins|progestins|mesh-list
19345050|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19345051|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
19345052|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345053|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345054|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19345055|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19345056|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19345057|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19345058|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
19345059|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19345060|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843366|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20612943|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
19843367|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
19843368|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20612944|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202224|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
20202225|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
20202226|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202227|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202228|NCT00255372|Lactulose|lactulose|mesh-list
20202229|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20202230|NCT00255385|Micronutrients|micronutrients|mesh-list
20202231|NCT00255385|Trace Elements|trace elements|mesh-list
20202232|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202233|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20202234|NCT00255424|Hematinics|hematinics|mesh-ancestor
20388173|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683552|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
19683553|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19683554|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
19683555|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843369|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345061|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19345062|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19345063|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
20388174|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388175|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388176|NCT01064102|Cetirizine|cetirizine|mesh-list
20388177|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19345064|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19345065|NCT03778359|Hormones|hormones|mesh-ancestor
19843370|NCT00658606|Alefacept|alefacept|mesh-list
19843371|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
19843372|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
19843373|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843374|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19843375|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19843376|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19843377|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19843378|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19843379|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
19843380|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843381|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345066|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
19345067|NCT03778502|Apixaban|apixaban|mesh-list
19345068|NCT03778502|Edoxaban|edoxaban|mesh-list
19345069|NCT03778502|Dabigatran|dabigatran|mesh-list
19345070|NCT03778502|Anticoagulants|anticoagulants|mesh-list
19345071|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19345072|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
19345073|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19345074|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
19345075|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345076|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345077|NCT03778281|Baclofen|baclofen|mesh-list
19345078|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19345079|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683556|NCT03444298|Vitamin E|vitamin e|mesh-list
19683557|NCT03444298|Tocopherols|tocopherols|mesh-list
19683558|NCT03444298|Tocotrienols|tocotrienols|mesh-list
19683559|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
19683560|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
19683561|NCT03444298|Vitamins|vitamins|mesh-ancestor
19683562|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
19683563|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683564|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
19683565|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683566|NCT03444298|Protective Agents|protective agents|mesh-ancestor
19683567|NCT03434379|Bevacizumab|bevacizumab|mesh-list
19683568|NCT03434379|Sorafenib|sorafenib|mesh-list
19683569|NCT03434379|Atezolizumab|atezolizumab|mesh-list
19683570|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683571|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683572|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683573|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19683574|NCT03434379|Growth Substances|growth substances|mesh-ancestor
19683575|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683576|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
19683577|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19843382|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388178|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20388179|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20388180|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
20388181|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
20388182|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388183|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388184|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388185|NCT01064115|Cetirizine|cetirizine|mesh-list
19683578|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388186|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19345080|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19400441|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
19683579|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388187|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20388188|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19345081|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683580|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
19683581|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
19683582|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
19683583|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683584|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683585|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19683586|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19683587|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
19683588|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683589|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692676|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692677|NCT04989270|Anesthetics|anesthetics|mesh-list
19692678|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345082|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19345083|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
19345084|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
19345085|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345086|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345087|NCT03778567|Lamivudine|lamivudine|mesh-list
19345088|NCT03778567|Telbivudine|telbivudine|mesh-list
19345089|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19345090|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19345091|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345092|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345093|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
19345094|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345095|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19345096|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19345097|NCT03778541|Temozolomide|temozolomide|mesh-list
19345098|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19345099|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
19345100|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345101|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345102|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
19345103|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
19345104|NCT03778580|Vitamins|vitamins|mesh-ancestor
19345105|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
19345106|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345107|NCT03778372|Methadone|methadone|mesh-list
19345108|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19345109|NCT03778372|Narcotics|narcotics|mesh-ancestor
19345110|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345111|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692679|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692680|NCT04989257|Clopidogrel|clopidogrel|mesh-list
19692681|NCT04989257|Ticagrelor|ticagrelor|mesh-list
19692682|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19692683|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19692684|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20202235|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20202236|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20202237|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20202238|NCT00255437|Hematinics|hematinics|mesh-ancestor
20202239|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20202240|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20202241|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20202242|NCT00255450|Hematinics|hematinics|mesh-ancestor
20202243|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20202244|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20202245|NCT00255463|Gefitinib|gefitinib|mesh-list
20202246|NCT00255463|Anastrozole|anastrozole|mesh-list
20202247|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202248|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20202249|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202250|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202251|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20202252|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20202253|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20202254|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20388189|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
19345112|NCT03778372|Analgesics|analgesics|mesh-ancestor
19692685|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19683590|NCT03414658|Trastuzumab|trastuzumab|mesh-list
19683591|NCT03414658|Avelumab|avelumab|mesh-list
19345113|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
19345114|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345115|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
19345116|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
19345117|NCT03778593|Leucovorin|leucovorin|mesh-list
19345118|NCT03778593|Fluorouracil|fluorouracil|mesh-list
19345119|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
19345120|NCT03778593|Irinotecan|irinotecan|mesh-list
19345121|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
19345122|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345123|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345124|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345125|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345126|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
19345127|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843383|NCT00658632|Esomeprazole|esomeprazole|mesh-list
20202255|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
20202256|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202257|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202258|NCT00255476|Gefitinib|gefitinib|mesh-list
19345128|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19345129|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19345130|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345131|NCT03778593|Antidotes|antidotes|mesh-ancestor
19345132|NCT03778593|Protective Agents|protective agents|mesh-ancestor
19345133|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
19345134|NCT03778593|Vitamins|vitamins|mesh-ancestor
19345135|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
19345136|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
19345137|NCT03778008|Hydroxocobalamin|hydroxocobalamin|mesh-list
19345138|NCT03778008|Gentamicins|gentamicins|mesh-list
19345139|NCT03778008|Dexamethasone|dexamethasone|mesh-list
19345140|NCT03778008|Lidocaine|lidocaine|mesh-list
19345141|NCT03778008|Mitogens|mitogens|mesh-list
19345142|NCT03778008|Vitamins|vitamins|mesh-ancestor
19345143|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
19345144|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345145|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19345146|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
19345147|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
19345148|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345149|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19345150|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
19345151|NCT03778008|Hormones|hormones|mesh-ancestor
19345152|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19345153|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19345154|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345155|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
19345156|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
19345157|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345158|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
19683592|NCT03414658|Vinorelbine|vinorelbine|mesh-list
19683593|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683594|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683595|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19683596|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
20202259|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202260|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20202261|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202262|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202263|NCT00255489|Gefitinib|gefitinib|mesh-list
20202264|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202265|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20202266|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202267|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202268|NCT00255502|Metoprolol|metoprolol|mesh-list
20202269|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20388190|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
19683597|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
19683598|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683599|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683600|NCT03376659|Bevacizumab|bevacizumab|mesh-list
19683601|NCT03376659|Durvalumab|durvalumab|mesh-list
19345159|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19345160|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19345161|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20202270|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20202271|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
19345162|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345163|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345164|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
19345165|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
19345166|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345167|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388191|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388192|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388193|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388194|NCT01064141|Vaccines|vaccines|mesh-list
20388195|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
20388196|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388197|NCT01064154|Carvedilol|carvedilol|mesh-list
20388198|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20388199|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20388200|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
20388201|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388202|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388203|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388204|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20388205|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
20388206|NCT01064154|Protective Agents|protective agents|mesh-ancestor
20388207|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20388208|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345168|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19345169|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345170|NCT03778008|Hematinics|hematinics|mesh-ancestor
19345171|NCT03778242|Oxytocin|oxytocin|mesh-list
19345172|NCT03778242|Oxytocics|oxytocics|mesh-ancestor
19345173|NCT03778242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345174|NCT03778242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345175|NCT03778138|Pemetrexed|pemetrexed|mesh-list
19345176|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345177|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345178|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388209|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20388210|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
20388211|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20388212|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20388213|NCT01064180|Carvedilol|carvedilol|mesh-list
20388214|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20388215|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20388216|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
20388217|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388218|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345179|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19345180|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19345181|NCT03777956|Lacosamide|lacosamide|mesh-list
19345182|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
19345183|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19345184|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19345185|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345186|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400442|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19400443|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400444|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19400445|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19400446|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400447|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202272|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
19400448|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202273|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202274|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202275|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20202276|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20202277|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20388219|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388220|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19400449|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19400450|NCT03625739|Renal Agents|renal agents|mesh-ancestor
20388221|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
20388222|NCT01064180|Protective Agents|protective agents|mesh-ancestor
20388223|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20388224|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345187|NCT03777878|Oxytocin|oxytocin|mesh-list
19345188|NCT03777878|Carbetocin|carbetocin|mesh-list
19345189|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
19345190|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345191|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202278|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
20388225|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20388226|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
20388227|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20202279|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202280|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202281|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20202282|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
19345192|NCT03777813|Leucovorin|leucovorin|mesh-list
19345193|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
19345194|NCT03777813|Durvalumab|durvalumab|mesh-list
19345195|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
19345196|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345197|NCT03777813|Antidotes|antidotes|mesh-ancestor
20202283|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202284|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202285|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202286|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202287|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202288|NCT00255528|Metoprolol|metoprolol|mesh-list
20202289|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20202290|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20202291|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
20202292|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
20202293|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202294|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202295|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20202296|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19683602|NCT03376659|Capecitabine|capecitabine|mesh-list
19683603|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20202297|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20202298|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
20202299|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202300|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202301|NCT00255541|Glyburide|glyburide|mesh-list
20202302|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20202303|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202304|NCT00255554|Citalopram|citalopram|mesh-list
20388228|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20426464|NCT01281514|Doxorubicin|doxorubicin|mesh-list
20426465|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20426466|NCT01281514|Everolimus|everolimus|mesh-list
20426467|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426468|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426469|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20426470|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20426471|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426472|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426473|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426474|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
20426475|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426476|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20426477|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20426478|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20426479|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426480|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426481|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20426482|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20426483|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20426484|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
20426485|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426486|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683604|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345198|NCT03777813|Protective Agents|protective agents|mesh-ancestor
19345199|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345200|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
19345201|NCT03777813|Vitamins|vitamins|mesh-ancestor
19345202|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
19345203|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345204|NCT03777930|Thalidomide|thalidomide|mesh-list
19345205|NCT03777930|Megestrol|megestrol|mesh-list
19345206|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
19345207|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683605|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683606|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19683607|NCT03376659|Growth Substances|growth substances|mesh-ancestor
19683608|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683609|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
19683610|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19683611|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
19683612|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388229|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20388230|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20388231|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388232|NCT01064232|Risperidone|risperidone|mesh-list
20388233|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20388234|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
20388235|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388236|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388237|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388238|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20388239|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20388240|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388241|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20388242|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20388243|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
19683613|NCT03345173|Ketamine|ketamine|mesh-list
19683614|NCT03345173|Analgesics|analgesics|mesh-ancestor
20388244|NCT01064271|Risperidone|risperidone|mesh-list
19345208|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
19345209|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345210|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
19345211|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345212|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345213|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19345214|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19345215|NCT03777930|Growth Substances|growth substances|mesh-ancestor
19345216|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
19345217|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345218|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19345219|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19345220|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19345221|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
19345222|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345223|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19345224|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19345225|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19345226|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
19345227|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19345228|NCT03777579|Paclitaxel|paclitaxel|mesh-list
19345229|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19345230|NCT03777579|Antibodies|antibodies|mesh-list
19345231|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
19345232|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19345233|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345234|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
19345235|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
19345236|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
20388245|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20388246|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
20388247|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388248|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388249|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388250|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20388251|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20388252|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388253|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20388254|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19345237|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345238|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
19345239|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388255|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
20388256|NCT01064349|Trastuzumab|trastuzumab|mesh-list
19345240|NCT03777696|Misoprostol|misoprostol|mesh-list
19345241|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19345242|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
19345243|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345244|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345245|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19345246|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19345247|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
19345248|NCT03777423|Cobalt|cobalt|mesh-list
19345249|NCT03777423|Chromium|chromium|mesh-list
19683615|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
19683616|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683617|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683618|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19683619|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19683620|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
19683621|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
19683622|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683623|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19683624|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19683625|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683626|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683627|NCT03344419|Ketamine|ketamine|mesh-list
19683628|NCT03344419|Analgesics|analgesics|mesh-ancestor
19683629|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
20202305|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20202306|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20202307|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202308|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683630|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683631|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683632|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19683633|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19683634|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
20202309|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388257|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20388258|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388259|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
20388260|NCT01064375|Molgramostim|molgramostim|mesh-list
20388261|NCT01064375|Sargramostim|sargramostim|mesh-list
20388262|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388263|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
20388264|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388265|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388266|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20388267|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
20388268|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388269|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388270|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20388271|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19345250|NCT03777423|Trace Elements|trace elements|mesh-ancestor
19345251|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
19345252|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345253|NCT03777787|Denatonium|denatonium|mesh-list
19345254|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
19345255|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345256|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
19345257|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345258|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
19345259|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345260|NCT03777644|Morphine|morphine|mesh-list
19345261|NCT03777644|Ropivacaine|ropivacaine|mesh-list
19345262|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19345263|NCT03777644|Narcotics|narcotics|mesh-ancestor
20202310|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
20202311|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202312|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19345264|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683635|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
19345265|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345266|NCT03777644|Analgesics|analgesics|mesh-ancestor
19345267|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
20202313|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
20202314|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19683636|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683637|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19683638|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19683639|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683640|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683641|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
19683642|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
19683643|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20202315|NCT00255567|Paromomycin|paromomycin|mesh-list
20202316|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20202317|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202318|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202319|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20202320|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20202321|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
20202322|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20202323|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
19345268|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345269|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
19345270|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
19345271|NCT03777657|Capecitabine|capecitabine|mesh-list
19345272|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
19345273|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202324|NCT00255593|Rituximab|rituximab|mesh-list
20202325|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20202326|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202327|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
20202328|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202329|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20202330|NCT00255606|Prednisone|prednisone|mesh-list
20202331|NCT00255606|Docetaxel|docetaxel|mesh-list
20202332|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202333|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
20202334|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
20202335|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
20202336|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202337|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202338|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
20202339|NCT00255606|Hormones|hormones|mesh-ancestor
20202340|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202341|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202342|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20202343|NCT00255658|Sirolimus|sirolimus|mesh-list
20202344|NCT00255658|Sorafenib|sorafenib|mesh-list
19345274|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345275|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
19345276|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345277|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
19345278|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
19345279|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
19345280|NCT03777761|Tucatinib|tucatinib|mesh-list
19345281|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345282|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345283|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19345284|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19345285|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345286|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345287|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345288|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345289|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
20202345|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202346|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20202347|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202348|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202349|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202350|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202351|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20202352|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
20202353|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20202354|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
20202355|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202356|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
20202357|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
19345290|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19345291|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19345292|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345293|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
19345294|NCT03777488|Coagulants|coagulants|mesh-ancestor
19345295|NCT03777514|Ascorbic Acid|ascorbic acid|mesh-list
19345296|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19345297|NCT03777514|Vitamins|vitamins|mesh-ancestor
19345298|NCT03777514|Micronutrients|micronutrients|mesh-ancestor
19345299|NCT03777514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345300|NCT03777514|Antioxidants|antioxidants|mesh-ancestor
19345301|NCT03777514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345302|NCT03777514|Protective Agents|protective agents|mesh-ancestor
19345303|NCT03777514|Hematinics|hematinics|mesh-ancestor
20388272|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20388273|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388274|NCT01064466|Etoposide|etoposide|mesh-list
20388275|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
20388276|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20388277|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388278|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20388279|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20388280|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388281|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388282|NCT01064557|Tretinoin|tretinoin|mesh-list
20388283|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388284|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
20388285|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
20388286|NCT01064570|Tretinoin|tretinoin|mesh-list
20388287|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388288|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
20388289|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
20388290|NCT01064726|Fluticasone|fluticasone|mesh-list
20388291|NCT01064726|Xhance|xhance|mesh-list
19345304|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19345305|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19345306|NCT03777085|Rituximab|rituximab|mesh-list
19345307|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20202358|NCT00255710|Fludarabine|fludarabine|mesh-list
20202359|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
20202360|NCT00255710|Tacrolimus|tacrolimus|mesh-list
20202361|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20202362|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
20202363|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202364|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388292|NCT01064726|Ibuprofen|ibuprofen|mesh-list
19345308|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345309|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
19345310|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345311|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19345312|NCT03777124|Carboplatin|carboplatin|mesh-list
19345313|NCT03777124|Pemetrexed|pemetrexed|mesh-list
19345314|NCT03777124|Apatinib|apatinib|mesh-list
19345315|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345316|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345317|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345318|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19345319|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19345320|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345321|NCT03777280|Cobalt|cobalt|mesh-list
20388293|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388294|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20388295|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
20388296|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388297|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388298|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20388299|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
20388300|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
20388301|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19345322|NCT03777280|Chromium|chromium|mesh-list
19345323|NCT03777280|Trace Elements|trace elements|mesh-ancestor
20202365|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19345324|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
19345325|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388302|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20388303|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20388304|NCT01064726|Analgesics|analgesics|mesh-ancestor
20612945|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345326|NCT03777163|Vaccines|vaccines|mesh-list
19345327|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
19345328|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345329|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
19345330|NCT03777033|Calcium|calcium|mesh-list
19345331|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19345332|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345333|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19345334|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
19345335|NCT03776851|Hematinics|hematinics|mesh-ancestor
19345336|NCT03776916|Simethicone|simethicone|mesh-list
19345337|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
19345338|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345339|NCT03776916|Emollients|emollients|mesh-ancestor
19345340|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
19345341|NCT03776838|Fentanyl|fentanyl|mesh-list
19683644|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683645|NCT03334409|Vitamins|vitamins|mesh-list
19683646|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
19683647|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
19683648|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683649|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
19683650|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683651|NCT03334409|Protective Agents|protective agents|mesh-ancestor
19683652|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
19683653|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19843384|NCT00658632|Rabeprazole|rabeprazole|mesh-list
19345342|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19345343|NCT03776838|Narcotics|narcotics|mesh-ancestor
19345344|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345345|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345346|NCT03776838|Analgesics|analgesics|mesh-ancestor
19345347|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
19683654|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683655|NCT03326921|Vidarabine|vidarabine|mesh-list
19683656|NCT03326921|Fludarabine|fludarabine|mesh-list
19683657|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
19843385|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20202366|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
20202367|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202368|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345348|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345349|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19345350|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345351|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
19345352|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
19345353|NCT03777345|Cobalt|cobalt|mesh-list
19345354|NCT03777345|Chromium|chromium|mesh-list
19345355|NCT03777345|Trace Elements|trace elements|mesh-ancestor
19345356|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
19345357|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345358|NCT03776955|Carvedilol|carvedilol|mesh-list
19345359|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19345360|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19345361|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
19345362|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345363|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345364|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345365|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19345366|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
19345367|NCT03776955|Protective Agents|protective agents|mesh-ancestor
19345368|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19345369|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345370|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19345371|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
19345372|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19345373|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19345374|NCT03776656|Allopurinol|allopurinol|mesh-list
20202369|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20202370|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20202371|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
20202372|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19683658|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683659|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20202373|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345375|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
19345376|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345377|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388305|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
20388306|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388307|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20388308|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388309|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388310|NCT01064752|Minocycline|minocycline|mesh-list
20388311|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20388312|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388313|NCT01064921|Vorinostat|vorinostat|mesh-list
20388314|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388315|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20388316|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388317|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388318|NCT01064973|Baclofen|baclofen|mesh-list
20388319|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20388320|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388321|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20388322|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388323|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20388324|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
20388325|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
20388326|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388327|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345378|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
19345379|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388328|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
20388329|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20388330|NCT01064986|Epinephrine|epinephrine|mesh-list
20388331|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20388332|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20388333|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
20388334|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388335|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388336|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388337|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20388338|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20388339|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
20388340|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388341|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20388342|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
20388343|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
20388344|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
20388345|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20388346|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388347|NCT01064999|Capecitabine|capecitabine|mesh-list
19345380|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19345381|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
19345382|NCT03776656|Protective Agents|protective agents|mesh-ancestor
19843386|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843387|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19843388|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843389|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843390|NCT00658658|Panitumumab|panitumumab|mesh-list
19345383|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345384|NCT03776994|Vaccines|vaccines|mesh-list
19345385|NCT03776994|Immunologic Factors|immunologic factors|mesh-ancestor
19345386|NCT03776994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345387|NCT03776409|Vancomycin|vancomycin|mesh-list
19345388|NCT03776409|Tazobactam|tazobactam|mesh-list
19345389|NCT03776409|Piperacillin|piperacillin|mesh-list
19345390|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19345391|NCT03776409|Lactams|lactams|mesh-list
19345392|NCT03776409|beta-Lactams|beta-lactams|mesh-list
19345393|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345394|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202374|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20202375|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20202376|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
20202377|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202378|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202379|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
20202380|NCT00255749|Hematinics|hematinics|mesh-ancestor
20202381|NCT00255762|Paclitaxel|paclitaxel|mesh-list
20202382|NCT00255762|Bevacizumab|bevacizumab|mesh-list
20388348|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
19345395|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19345396|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202383|NCT00255762|Carboplatin|carboplatin|mesh-list
20388349|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388350|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
20388351|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388352|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388353|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
20388354|NCT01065038|Anagrelide|anagrelide|mesh-list
20388355|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388356|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
19345397|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345398|NCT03776448|Charcoal|charcoal|mesh-list
19345399|NCT03776448|Antidotes|antidotes|mesh-ancestor
19345400|NCT03776448|Protective Agents|protective agents|mesh-ancestor
19345401|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345402|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19345403|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345404|NCT03776487|Fluorouracil|fluorouracil|mesh-list
19345405|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
19345406|NCT03776487|Nivolumab|nivolumab|mesh-list
19345407|NCT03776487|Ipilimumab|ipilimumab|mesh-list
19345408|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
20202384|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20202385|NCT00255762|Antibodies|antibodies|mesh-list
20202386|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
20202387|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20202388|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20388357|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388358|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345409|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345410|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345411|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345412|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345413|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
19345414|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345415|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345416|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19345417|NCT03776500|Macozinone|macozinone|mesh-list
19345418|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
19345419|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345420|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345421|NCT03776812|Paclitaxel|paclitaxel|mesh-list
19345422|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19345423|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19345424|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345425|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
19345426|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
19345427|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
19345428|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345429|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
19345430|NCT03776279|Analgesics|analgesics|mesh-ancestor
19345431|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
19345432|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345433|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345434|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345435|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19345436|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19345437|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345438|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345439|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
19843391|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20202389|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202390|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
20202391|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
20202392|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
20202393|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202394|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20202395|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20202396|NCT00255762|Growth Substances|growth substances|mesh-ancestor
19843392|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843393|NCT00658684|Fesoterodine|fesoterodine|mesh-list
19843394|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19843395|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19843396|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
20202397|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345440|NCT03776136|Lenvatinib|lenvatinib|mesh-list
19345441|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345442|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202398|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
20202399|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
20202400|NCT00255788|Everolimus|everolimus|mesh-list
20202401|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345443|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345444|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345445|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345446|NCT03776305|Imipenem|imipenem|mesh-list
19345447|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345448|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345449|NCT03776240|Trastuzumab|trastuzumab|mesh-list
19345450|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345451|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202402|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20202403|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
20202404|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202405|NCT00255879|Olanzapine|olanzapine|mesh-list
20202406|NCT00255879|Risperidone|risperidone|mesh-list
20202407|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20202408|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20202409|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
20202410|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202411|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202412|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202413|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202414|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202415|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202416|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202417|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20202418|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
20202419|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
20202420|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
20202421|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202422|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20202423|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20202424|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20202425|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202426|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
20202427|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
20202428|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20202429|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20388359|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19345452|NCT03776058|Cinacalcet|cinacalcet|mesh-list
19345453|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19345454|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345455|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19345456|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
19345457|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400451|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19400452|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19400453|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19400454|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
19400455|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20202430|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
20202431|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202432|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202433|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202434|NCT00255996|Linezolid|linezolid|mesh-list
20202435|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202436|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202437|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20202438|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202439|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202440|NCT00256009|Misoprostol|misoprostol|mesh-list
20202441|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20202442|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
20202443|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20202444|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202445|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20202446|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20388360|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19345458|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
19345459|NCT03776032|Hematinics|hematinics|mesh-ancestor
19345460|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
19345461|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345462|NCT03775993|Hormones|hormones|mesh-list
19345463|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19345464|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345465|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
19345466|NCT03775876|Propofol|propofol|mesh-list
19345467|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345468|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345469|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345470|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345471|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
19345472|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
19345473|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19345474|NCT03775876|Analgesics|analgesics|mesh-ancestor
20202447|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
20202448|NCT00256100|PENTA|penta|mesh-list
20202449|NCT00256100|Fondaparinux|fondaparinux|mesh-list
20202450|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20202451|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
20202452|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20202453|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
20202454|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202455|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202456|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
20202457|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20202458|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20202459|NCT00256178|Simvastatin|simvastatin|mesh-list
20202460|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19345475|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
19345476|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345477|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19345478|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19345479|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20388361|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20388362|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20388363|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20388364|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
20388365|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20388366|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19345480|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
19345481|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345482|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345483|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
19345484|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19345485|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345486|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202461|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20202462|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
20202463|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202464|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20202465|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20202466|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202467|NCT00256230|Disulfiram|disulfiram|mesh-list
20202468|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20388367|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345487|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345488|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345489|NCT03775863|Liver Extracts|liver extracts|mesh-list
20202469|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20202470|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345490|NCT03775863|Hematinics|hematinics|mesh-ancestor
19345491|NCT03775707|Lenvatinib|lenvatinib|mesh-list
20202471|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202472|NCT00256256|Glucagon|glucagon|mesh-list
20202473|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20202474|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20202475|NCT00256256|Hormones|hormones|mesh-ancestor
20202476|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202477|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388368|NCT01065129|Plerixafor|plerixafor|mesh-list
20388369|NCT01065129|Azacitidine|azacitidine|mesh-list
20388370|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388371|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
20388372|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388373|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388374|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345492|NCT03775707|Antibodies|antibodies|mesh-list
19345493|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
19345494|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345495|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202478|NCT00256256|Incretins|incretins|mesh-ancestor
20202479|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
20202480|NCT00256269|Irinotecan|irinotecan|mesh-list
20202481|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202482|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20202483|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202484|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388375|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20388376|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20388377|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
20388378|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388379|NCT01065194|Simendan|simendan|mesh-list
20388380|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20388381|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
20388382|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20388383|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20388384|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388385|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388386|NCT01065194|Protective Agents|protective agents|mesh-ancestor
20388387|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388388|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
20388389|NCT01065220|Testolactone|testolactone|mesh-list
20388390|NCT01065220|Lynestrenol|lynestrenol|mesh-list
20388391|NCT01065220|Estradiol|estradiol|mesh-list
20388392|NCT01065220|Cyproterone|cyproterone|mesh-list
20388393|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
20388394|NCT01065220|Estrogens|estrogens|mesh-ancestor
20388395|NCT01065220|Hormones|hormones|mesh-ancestor
20388396|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388397|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388398|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20388399|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
20388400|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20388401|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20388402|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
20388403|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
20202485|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202486|NCT00256321|Celecoxib|celecoxib|mesh-list
20202487|NCT00256321|Capecitabine|capecitabine|mesh-list
20202488|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
20202489|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388404|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388405|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20388406|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20388407|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388408|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388409|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20388410|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20388411|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20388412|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20388413|NCT01065246|Catumaxomab|catumaxomab|mesh-list
20388414|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20388415|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20388416|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20388417|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20388418|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20388419|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388420|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
20202490|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
20388421|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345496|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345497|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345498|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345499|NCT03775902|Nicorandil|nicorandil|mesh-list
20388422|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683660|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
19683661|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388423|NCT01065272|Dexamethasone|dexamethasone|mesh-list
20388424|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388425|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
20388426|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
20388427|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388428|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388429|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20388430|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
20388431|NCT01065272|Hormones|hormones|mesh-ancestor
20388432|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388433|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20388434|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388435|NCT01065285|Vaccines|vaccines|mesh-list
20388436|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
20388437|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388438|NCT01065376|Cabergoline|cabergoline|mesh-list
20388439|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20388440|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20388441|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
20388442|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
20388443|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388444|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388445|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388446|NCT01065467|Panobinostat|panobinostat|mesh-list
20388447|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388448|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20388449|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388450|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388451|NCT01065519|Umirolimus|umirolimus|mesh-list
20388452|NCT01065519|Everolimus|everolimus|mesh-list
20388453|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388454|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388455|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
20388456|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388457|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388458|NCT01065532|Paclitaxel|paclitaxel|mesh-list
20388459|NCT01065532|Everolimus|everolimus|mesh-list
20388460|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20388461|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388462|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
20388463|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
20388464|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
20388465|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388466|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388467|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
19345500|NCT03775902|Glimepiride|glimepiride|mesh-list
19345501|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19345502|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19345503|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345504|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345505|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
19345506|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19345507|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
19345508|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
19345509|NCT03775902|Vitamins|vitamins|mesh-ancestor
20388468|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388469|NCT01065545|Clofarabine|clofarabine|mesh-list
20388470|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388471|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
20388472|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202491|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202492|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202493|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20202494|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20388473|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388474|NCT01065610|Oxytocin|oxytocin|mesh-list
20388475|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
20388476|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20388477|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612946|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19345510|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
20202495|NCT00256321|Analgesics|analgesics|mesh-ancestor
20202496|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
20202497|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388478|NCT01065649|Nortriptyline|nortriptyline|mesh-list
20388479|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19345511|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
19345512|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345513|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345514|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345515|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19345516|NCT03775655|Analgesics|analgesics|mesh-ancestor
19345517|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
19345518|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202498|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202499|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202500|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20202501|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20202502|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20202503|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202504|NCT00256334|Resveratrol|resveratrol|mesh-list
20388480|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
20388481|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20388482|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19345519|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19345520|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19345521|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19345522|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
19345523|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345524|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345525|NCT03775590|Acetic Acid|acetic acid|mesh-list
20202505|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
20202506|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202507|NCT00256334|Protective Agents|protective agents|mesh-ancestor
20202508|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202509|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202510|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20202511|NCT00256347|Morphine|morphine|mesh-list
20202512|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20202513|NCT00256347|Narcotics|narcotics|mesh-ancestor
20202514|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202515|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202516|NCT00256347|Analgesics|analgesics|mesh-ancestor
20202517|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
20202518|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345526|NCT03775590|Retinol acetate|retinol acetate|mesh-list
19345527|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19345528|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202519|NCT00256399|Alfuzosin|alfuzosin|mesh-list
20202520|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20202521|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20202522|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20202523|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
20202524|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202525|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202526|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202527|NCT00256399|Urological Agents|urological agents|mesh-ancestor
20217699|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217700|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217701|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345529|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19345530|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
19345531|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345532|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19345533|NCT03775590|Protective Agents|protective agents|mesh-ancestor
19345534|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345535|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
19345536|NCT03775746|Clopidogrel|clopidogrel|mesh-list
20217702|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20217703|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20217704|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20217705|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217706|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217707|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217708|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388483|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20388484|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345537|NCT03775746|Ticagrelor|ticagrelor|mesh-list
19345538|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20202528|NCT00256542|Lidocaine|lidocaine|mesh-list
20202529|NCT00256542|Heparin|heparin|mesh-list
20202530|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20202531|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
20202532|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202533|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202534|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
20202535|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202536|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20202537|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20202538|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20202539|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202540|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388485|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388486|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20388487|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388488|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388489|NCT01065662|Sirolimus|sirolimus|mesh-list
20388490|NCT01065662|Cediranib|cediranib|mesh-list
20388491|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20388492|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388493|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20388494|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345539|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19345540|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19345541|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19345542|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
19345543|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202541|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
20202542|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20202543|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20388495|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
20388496|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388497|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
20388498|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388499|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20388500|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388501|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388502|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
20388503|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345544|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202544|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
20202545|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19345545|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345546|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19345547|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
19345548|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19683662|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20202546|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202547|NCT00256711|Vinorelbine|vinorelbine|mesh-list
20202548|NCT00256711|Gefitinib|gefitinib|mesh-list
20202549|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20202550|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202551|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
20202552|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
20202553|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683663|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
19683664|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683665|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
19683666|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683667|NCT03324932|Denosumab|denosumab|mesh-list
19683668|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19683669|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683670|NCT03322215|Capecitabine|capecitabine|mesh-list
19683671|NCT03322215|Fulvestrant|fulvestrant|mesh-list
19683672|NCT03322215|Palbociclib|palbociclib|mesh-list
19683673|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19683674|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
19683675|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202554|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388504|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388505|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345549|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
19683676|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683677|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19683678|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19683679|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19683680|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
19683681|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683682|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683683|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19683684|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683685|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19683686|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683687|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
19683688|NCT03311334|Nivolumab|nivolumab|mesh-list
19683689|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683690|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683691|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19683692|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388506|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683693|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
19683694|NCT03308448|Hematinics|hematinics|mesh-ancestor
19683695|NCT03298087|Leuprolide|leuprolide|mesh-list
19683696|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19683697|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
19683698|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19683699|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345550|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345551|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
19345552|NCT03775928|Capecitabine|capecitabine|mesh-list
19345553|NCT03775928|Apatinib|apatinib|mesh-list
19345554|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345555|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
19345556|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345557|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345558|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345559|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345560|NCT03775538|Dopamine|dopamine|mesh-list
19683700|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19683701|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683702|NCT03294694|Fulvestrant|fulvestrant|mesh-list
19683703|NCT03294694|Spartalizumab|spartalizumab|mesh-list
19683704|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19683705|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683706|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20202555|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20388507|NCT01065701|Analgesics|analgesics|mesh-ancestor
20388508|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
20388509|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388510|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20388511|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20388512|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20388513|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
20388514|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388515|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388516|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
20388517|NCT01065727|Natalizumab|natalizumab|mesh-list
20388518|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
20388519|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
20388520|NCT01065727|Analgesics|analgesics|mesh-ancestor
20388521|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
20388522|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388523|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388524|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388525|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19345561|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20202556|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202557|NCT00256737|Omeprazole|omeprazole|mesh-list
20202558|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20202559|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20202560|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20202561|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202562|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202563|NCT00256828|Lamivudine|lamivudine|mesh-list
20202564|NCT00256828|Efavirenz|efavirenz|mesh-list
20388526|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20388527|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345562|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
19345563|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
20388528|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388529|NCT01065805|Alovudine|alovudine|mesh-list
20388530|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
20388531|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388532|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
20388533|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
20388534|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
20388535|NCT01065857|Citric Acid|citric acid|mesh-list
20388536|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
20388537|NCT01065857|Cathartics|cathartics|mesh-ancestor
20388538|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20388539|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
20388540|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20388541|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
20388542|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
20388543|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388544|NCT01065857|Antacids|antacids|mesh-ancestor
20388545|NCT01065870|Gemcitabine|gemcitabine|mesh-list
20388546|NCT01065870|Capecitabine|capecitabine|mesh-list
20388547|NCT01065870|Docetaxel|docetaxel|mesh-list
20388548|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388549|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
19683707|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19683708|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
20202565|NCT00256828|Didanosine|didanosine|mesh-list
20202566|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19345564|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345565|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345566|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
19345567|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202567|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20202568|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202569|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683709|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683710|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202570|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
20202571|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202572|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20202573|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19345568|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345569|NCT03775538|Protective Agents|protective agents|mesh-ancestor
19345570|NCT03775460|Prednisolone|prednisolone|mesh-list
20388550|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388551|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388552|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
20388553|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388554|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388555|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388556|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
20388557|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388558|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
20388559|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
20388560|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
20388561|NCT01065961|Dexamethasone|dexamethasone|mesh-list
20388562|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
20388563|NCT01065961|BB 1101|bb 1101|mesh-list
20388564|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388565|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
19345571|NCT03775460|Methotrexate|methotrexate|mesh-list
19345572|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19345573|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
19345574|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345575|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400456|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20202574|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20202575|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202576|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20202577|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20202578|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20202579|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20202580|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
20388566|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
20388567|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388568|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388569|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20388570|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
19345576|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345577|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
19345578|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202581|NCT00256893|Ropinirole|ropinirole|mesh-list
20202582|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20202583|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20202584|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
20202585|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
19345579|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345580|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19345581|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345582|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19345583|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345584|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
19345585|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19345586|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19345587|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19345588|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
19345589|NCT03775460|Hormones|hormones|mesh-ancestor
19345590|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19345591|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19345592|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
19345593|NCT03775382|Vitamins|vitamins|mesh-ancestor
19345594|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
19345595|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345596|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
19345597|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345598|NCT03775382|Protective Agents|protective agents|mesh-ancestor
19345599|NCT03775096|Carvedilol|carvedilol|mesh-list
19345600|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19345601|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20388571|NCT01065961|Hormones|hormones|mesh-ancestor
20388572|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388573|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20388574|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388575|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
20388576|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345602|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
19345603|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345604|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345605|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345606|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19345607|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
19345608|NCT03775096|Protective Agents|protective agents|mesh-ancestor
19345609|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19345610|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345611|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19345612|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
19345613|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19345614|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19345615|NCT03775395|Sorafenib|sorafenib|mesh-list
20388577|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345616|NCT03775395|Lenvatinib|lenvatinib|mesh-list
19345617|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345618|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345619|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388578|NCT01065987|Tizanidine|tizanidine|mesh-list
20388579|NCT01065987|Analgesics|analgesics|mesh-ancestor
20388580|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
20388581|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388582|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388583|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
20388584|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20388585|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19345620|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202586|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202587|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202588|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202589|NCT00256932|Alvimopan|alvimopan|mesh-list
20202590|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843397|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843398|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345621|NCT03775356|Anesthetics|anesthetics|mesh-list
20202591|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20388586|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
20388587|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
20388588|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20388589|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20388590|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20388591|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
19843399|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843400|NCT00658684|Urological Agents|urological agents|mesh-ancestor
19843401|NCT00658697|Bevacizumab|bevacizumab|mesh-list
19843402|NCT00658697|Docetaxel|docetaxel|mesh-list
20202592|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202593|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202594|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202595|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202596|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19683711|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19683712|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683713|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
19683714|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19683715|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19683716|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
19345622|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345623|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345624|NCT03775070|Simvastatin|simvastatin|mesh-list
19345625|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19345626|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19345627|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
19345628|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345629|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19843403|NCT00658697|Bicalutamide|bicalutamide|mesh-list
19843404|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683717|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
20388592|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388593|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388594|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
19683718|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683719|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843405|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843406|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19843407|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19843408|NCT00658697|Growth Substances|growth substances|mesh-ancestor
19843409|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843410|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
19843411|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843412|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843413|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
19843414|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843415|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
19843416|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
19843417|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843418|NCT00658736|Triamcinolone|triamcinolone|mesh-list
19843419|NCT00658736|Bupivacaine|bupivacaine|mesh-list
19843420|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
19843421|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
20202597|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20202598|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20388595|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20426487|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19345630|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20202599|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
20202600|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202601|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202602|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20202603|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20202604|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
20202605|NCT00257036|Levofloxacin|levofloxacin|mesh-list
20202606|NCT00257036|Ofloxacin|ofloxacin|mesh-list
20202607|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20202608|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202609|NCT00257036|Renal Agents|renal agents|mesh-ancestor
20202610|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20217709|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
19683720|NCT03290560|Kallikreins|kallikreins|mesh-list
19843422|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843423|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843424|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
19843425|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843426|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202611|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20202612|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202613|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202614|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202615|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202616|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20202617|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202618|NCT00257049|Levofloxacin|levofloxacin|mesh-list
19345631|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345632|NCT03774901|Avelumab|avelumab|mesh-list
19345633|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683721|NCT03290560|Coagulants|coagulants|mesh-ancestor
19683722|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19683723|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
20202619|NCT00257049|Ofloxacin|ofloxacin|mesh-list
20202620|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20202621|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202622|NCT00257049|Renal Agents|renal agents|mesh-ancestor
19345634|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345635|NCT03774732|Paclitaxel|paclitaxel|mesh-list
19345636|NCT03774732|Cisplatin|cisplatin|mesh-list
19345637|NCT03774732|Carboplatin|carboplatin|mesh-list
19345638|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
19345639|NCT03774732|Pemetrexed|pemetrexed|mesh-list
19345640|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19345641|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345642|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
19345643|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
19345644|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
19345645|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345646|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345647|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345648|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19345649|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19345650|NCT03774654|Cyclophosphamide|cyclophosphamide|mesh-list
19345651|NCT03774654|Fludarabine|fludarabine|mesh-list
19345652|NCT03774654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345653|NCT03774654|Immunologic Factors|immunologic factors|mesh-ancestor
19345654|NCT03774654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345655|NCT03774654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19345656|NCT03774654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19345657|NCT03774654|Alkylating Agents|alkylating agents|mesh-ancestor
19345658|NCT03774654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345659|NCT03774654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345660|NCT03774654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19345661|NCT03774953|Vitamins|vitamins|mesh-list
19345662|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
19345663|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345664|NCT03774706|Misoprostol|misoprostol|mesh-list
19345665|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
19345666|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19345667|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19683724|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19683725|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683726|NCT03289910|Carboplatin|carboplatin|mesh-list
19683727|NCT03289910|Topotecan|topotecan|mesh-list
19683728|NCT03289910|Veliparib|veliparib|mesh-list
19683729|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683730|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19683731|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19683732|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683733|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683734|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19683735|NCT03269994|Tazobactam|tazobactam|mesh-list
19683736|NCT03269994|Piperacillin|piperacillin|mesh-list
19683737|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19683738|NCT03269994|Cefoxitin|cefoxitin|mesh-list
19683739|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19683740|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683741|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19345668|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345669|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
20202623|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202624|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20388596|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
20388597|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388598|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388599|NCT01066169|Lactitol|lactitol|mesh-list
20388600|NCT01066169|Cathartics|cathartics|mesh-ancestor
20388601|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20388602|NCT01066195|Pemetrexed|pemetrexed|mesh-list
20388603|NCT01066195|Gefitinib|gefitinib|mesh-list
20388604|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388605|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388606|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388607|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20388608|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20388609|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20388610|NCT01066247|Midazolam|midazolam|mesh-list
20388611|NCT01066247|Morphine|morphine|mesh-list
20388612|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20388613|NCT01066247|Narcotics|narcotics|mesh-ancestor
20388614|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388615|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202625|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202626|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202627|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202628|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202629|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19345670|NCT03774706|Coagulants|coagulants|mesh-ancestor
19683742|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683743|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683744|NCT03258281|Evolocumab|evolocumab|mesh-list
20388616|NCT01066247|Analgesics|analgesics|mesh-ancestor
20388617|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
20388618|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388619|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20388620|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20388621|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20202630|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202631|NCT00257062|Levofloxacin|levofloxacin|mesh-list
20202632|NCT00257062|Ofloxacin|ofloxacin|mesh-list
20202633|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20202634|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202635|NCT00257062|Renal Agents|renal agents|mesh-ancestor
20202636|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202637|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20202638|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20388622|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20388623|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20388624|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20202639|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202640|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202641|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202642|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20202643|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202644|NCT00257075|Risperidone|risperidone|mesh-list
20202645|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20202646|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
20202647|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202648|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202649|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202650|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20202651|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20388625|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
20388626|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
20388627|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
20388628|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
20388629|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388630|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388631|NCT01066299|Oxytocin|oxytocin|mesh-list
20388632|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
19683745|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20388633|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20388634|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388635|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
19345671|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20388636|NCT01066351|Hematinics|hematinics|mesh-ancestor
20388637|NCT01066377|Sulfalene|sulfalene|mesh-list
20388638|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388639|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20388640|NCT01066377|Renal Agents|renal agents|mesh-ancestor
20388641|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
20388642|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20388643|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20388644|NCT01066403|Pergolide|pergolide|mesh-list
20388645|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
20388646|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
20388647|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388648|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388649|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388650|NCT01066429|Dexamethasone|dexamethasone|mesh-list
20388651|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
20388652|NCT01066429|BB 1101|bb 1101|mesh-list
20388653|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388654|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388655|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202652|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202653|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202654|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20202655|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
20202656|NCT00257114|Bortezomib|bortezomib|mesh-list
20202657|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202658|NCT00257127|Vaccines|vaccines|mesh-list
20202659|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20202660|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
20388656|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
19345672|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
19345673|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345674|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345675|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19345676|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19345677|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
19683746|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19683747|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
19683748|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683749|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19683750|NCT03235986|Poractant alfa|poractant alfa|mesh-list
19683751|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19683752|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
19683753|NCT03199547|Azithromycin|azithromycin|mesh-list
19683754|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19683755|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683756|NCT03189641|Cilostazol|cilostazol|mesh-list
19683757|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19683758|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
19683759|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683760|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683761|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19683762|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
19683763|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19683764|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19683765|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683766|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19683767|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
19683768|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19683769|NCT03189641|Protective Agents|protective agents|mesh-ancestor
19683770|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19683771|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19683772|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345678|NCT03774771|Cinacalcet|cinacalcet|mesh-list
19345679|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19345680|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345681|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19345682|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
19345683|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19345684|NCT03774693|Fentanyl|fentanyl|mesh-list
19345685|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
19683773|NCT03168256|Apremilast|apremilast|mesh-list
20388657|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
19345686|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692686|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
20388658|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388659|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19345687|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345688|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19345689|NCT03774693|Narcotics|narcotics|mesh-ancestor
19345690|NCT03774693|Analgesics|analgesics|mesh-ancestor
19683774|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19683775|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683776|NCT03168256|Analgesics|analgesics|mesh-ancestor
19683777|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
19683778|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683779|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683780|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202661|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202662|NCT00257140|Levofloxacin|levofloxacin|mesh-list
20202663|NCT00257140|Ofloxacin|ofloxacin|mesh-list
20202664|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20202665|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202666|NCT00257140|Renal Agents|renal agents|mesh-ancestor
20202667|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202668|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20202669|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202670|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202671|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202672|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202673|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19683781|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683782|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19683783|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19683784|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683785|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683786|NCT03161223|Azacitidine|azacitidine|mesh-list
19683787|NCT03161223|Durvalumab|durvalumab|mesh-list
19683788|NCT03161223|Romidepsin|romidepsin|mesh-list
19683789|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19683790|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
19683791|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202674|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19345691|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
19345692|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345693|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19345694|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345695|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
19345696|NCT03774836|Morphine|morphine|mesh-list
20202675|NCT00257257|Rimonabant|rimonabant|mesh-list
20202676|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20202677|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20202678|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20202679|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388660|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
20388661|NCT01066429|Hormones|hormones|mesh-ancestor
19345697|NCT03774836|Tramadol|tramadol|mesh-list
19345698|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19345699|NCT03774836|Narcotics|narcotics|mesh-ancestor
19345700|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345701|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345702|NCT03774836|Analgesics|analgesics|mesh-ancestor
19345703|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
19345704|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345705|NCT03774680|Cetuximab|cetuximab|mesh-list
19345706|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345707|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345708|NCT03774615|Ferric maltol|ferric maltol|mesh-list
20202680|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202681|NCT00257257|Hormones|hormones|mesh-ancestor
20202682|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202683|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202684|NCT00257270|Gabapentin|gabapentin|mesh-list
20426488|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19345709|NCT03774615|Hematinics|hematinics|mesh-ancestor
19345710|NCT03774810|Zolpidem|zolpidem|mesh-list
19345711|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19345712|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345713|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345714|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345715|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19345716|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
19683792|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683793|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683794|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683795|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19683796|NCT03160846|Milrinone|milrinone|mesh-list
20388662|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388663|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20388664|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
20388665|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683797|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19345717|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
19345718|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345719|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843427|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
19843428|NCT00658736|Hormones|hormones|mesh-ancestor
19843429|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843430|NCT00658775|Esomeprazole|esomeprazole|mesh-list
19843431|NCT00658775|Rabeprazole|rabeprazole|mesh-list
19843432|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19843433|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843434|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19843435|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345720|NCT03774524|Misoprostol|misoprostol|mesh-list
19345721|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19345722|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
19345723|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345724|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345725|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19345726|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19345727|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
19345728|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
20388666|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388667|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
20388668|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345729|NCT03774472|Letrozole|letrozole|mesh-list
19345730|NCT03774472|Palbociclib|palbociclib|mesh-list
19345731|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683798|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19683799|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
19683800|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19683801|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19683802|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683803|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683804|NCT03160846|Protective Agents|protective agents|mesh-ancestor
19683805|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388669|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20388670|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388671|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388672|NCT01066494|Cytarabine|cytarabine|mesh-list
20388673|NCT01066494|Amonafide|amonafide|mesh-list
20388674|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388675|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
20388676|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388677|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388678|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
20388679|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388680|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388681|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
20388682|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388683|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388684|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20388685|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
20388686|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20388687|NCT01066559|Protective Agents|protective agents|mesh-ancestor
20388688|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388689|NCT01066572|Lisinopril|lisinopril|mesh-list
20388690|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20388691|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
20388692|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388693|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388694|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19843436|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345732|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19400457|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
20388695|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20388696|NCT01066572|Protective Agents|protective agents|mesh-ancestor
20388697|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345733|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19345734|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345735|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345736|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19345737|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
19345738|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19345739|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345740|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
19345741|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19345742|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19345743|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202685|NCT00257270|Analgesics|analgesics|mesh-ancestor
20202686|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
20202687|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202688|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202689|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
20202690|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20202691|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202692|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345744|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19345745|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345746|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
19345747|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19345748|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
19345749|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345750|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345751|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19345752|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
19345753|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19345754|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
19345755|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345756|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345757|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19345758|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
19345759|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
19345760|NCT03773991|Protective Agents|protective agents|mesh-ancestor
19400458|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19400459|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19400460|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400461|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20202693|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400462|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19843437|NCT00658788|Calcitriol|calcitriol|mesh-list
19400463|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19400464|NCT03625726|Thrombin|thrombin|mesh-list
19400465|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
19400466|NCT03625726|Coagulants|coagulants|mesh-ancestor
19400467|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
19400468|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19400469|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400470|NCT03625531|Letrozole|letrozole|mesh-list
19400471|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400472|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19400473|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19400474|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400475|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400476|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19400477|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
19400478|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400479|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400480|NCT03625518|Oxytocin|oxytocin|mesh-list
19400481|NCT03625518|Dinoprostone|dinoprostone|mesh-list
19400482|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
19400483|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19400484|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400485|NCT03625505|Venetoclax|venetoclax|mesh-list
19400486|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400487|NCT03625310|Listerine|listerine|mesh-list
19843438|NCT00658788|Clobetasol|clobetasol|mesh-list
19400488|NCT03625310|Fluorides|fluorides|mesh-list
19400489|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
20202694|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20217710|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
20388698|NCT01066598|Rituximab|rituximab|mesh-list
20388699|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20388700|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388701|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
20388702|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388703|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388704|NCT01066650|Everolimus|everolimus|mesh-list
20388705|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388706|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388707|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
20388708|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388709|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
20388710|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
20388711|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20388712|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20388713|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388714|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20388715|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388716|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388717|NCT01066676|Ibuprofen|ibuprofen|mesh-list
20388718|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20388719|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20388720|NCT01066676|Analgesics|analgesics|mesh-ancestor
19345761|NCT03774108|Metformin|metformin|mesh-list
19345762|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19345763|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345764|NCT03774446|Roscovitine|roscovitine|mesh-list
19345765|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345766|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
19345767|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345768|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19345769|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345770|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345771|NCT03774095|Pycnogenols|pycnogenols|mesh-list
19345772|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19345773|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
19345774|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202695|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20202696|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202697|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202698|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
20202699|NCT00257348|Docetaxel|docetaxel|mesh-list
20202700|NCT00257348|Capecitabine|capecitabine|mesh-list
20202701|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345775|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
19345776|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345777|NCT03774095|Protective Agents|protective agents|mesh-ancestor
19345778|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19345779|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
19345780|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388721|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
19345781|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
19345782|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
19345783|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345784|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
19345785|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345786|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19345787|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19345788|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
19345789|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345790|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345791|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19345792|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345793|NCT03773562|Erenumab|erenumab|mesh-list
19345794|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19345795|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345796|NCT03773562|Analgesics|analgesics|mesh-ancestor
19345797|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
19345798|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345799|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345800|NCT03773536|Artesunate|artesunate|mesh-list
19345801|NCT03773536|Primaquine|primaquine|mesh-list
20202702|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
20202703|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
20388722|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426489|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
19345802|NCT03773536|Amodiaquine|amodiaquine|mesh-list
20202704|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
20202705|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202706|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345803|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
19345804|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19345805|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19345806|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345807|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345808|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
19345809|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
20202707|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
20202708|NCT00257361|Cycloserine|cycloserine|mesh-list
20202709|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19345810|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19345811|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
19345812|NCT03773809|Vitamin D|vitamin d|mesh-list
19345813|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
19345814|NCT03773809|Vitamins|vitamins|mesh-list
19345815|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
19683806|NCT03113942|Thalidomide|thalidomide|mesh-list
19683807|NCT03113942|Pomalidomide|pomalidomide|mesh-list
19683808|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
19683809|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683810|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683811|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19683812|NCT03113942|Growth Substances|growth substances|mesh-ancestor
19683813|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
19683814|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683815|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19683816|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
19683817|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19683818|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683819|NCT03109093|Blinatumomab|blinatumomab|mesh-list
19683820|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683821|NCT03104270|Dexamethasone|dexamethasone|mesh-list
19683822|NCT03104270|Pomalidomide|pomalidomide|mesh-list
19683823|NCT03104270|Elotuzumab|elotuzumab|mesh-list
19683824|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19683825|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
20202710|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202711|NCT00257361|Renal Agents|renal agents|mesh-ancestor
20202712|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20202713|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
20202714|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202715|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
19345816|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345817|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19345818|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19345819|NCT03773588|Propofol|propofol|mesh-list
19345820|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345821|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345822|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345823|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345824|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
19345825|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
19345826|NCT03773510|Trabectedin|trabectedin|mesh-list
19345827|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19345828|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
19345829|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345830|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202716|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202717|NCT00257387|Cyclosporine|cyclosporine|mesh-list
20202718|NCT00257387|Cyclosporins|cyclosporins|mesh-list
20202719|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345831|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
19683826|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
19683827|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683828|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683829|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19683830|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
19683831|NCT03104270|Hormones|hormones|mesh-ancestor
20202720|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345832|NCT03773484|Narcotics|narcotics|mesh-ancestor
19345833|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683832|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683833|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19345834|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345835|NCT03773484|Analgesics|analgesics|mesh-ancestor
19345836|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
19345837|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19345838|NCT03773367|Fluorouracil|fluorouracil|mesh-list
19345839|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
19345840|NCT03773367|Irinotecan|irinotecan|mesh-list
19345841|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
19345842|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345843|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345844|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843439|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19843440|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843441|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19345845|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345846|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
19345847|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345848|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19345849|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19345850|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345851|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
19345852|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19345853|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19345854|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345855|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
19345856|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
19345857|NCT03773042|Propofol|propofol|mesh-list
19345858|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345859|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345860|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345861|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345862|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
19345863|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
19345864|NCT03772834|Methylphenidate|methylphenidate|mesh-list
19345865|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19345866|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345867|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19345868|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19345869|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345870|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345871|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
19345872|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345873|NCT03772613|Heparin|heparin|mesh-list
19345874|NCT03772613|Calcium heparin|calcium heparin|mesh-list
19345875|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
19345876|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19345877|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19345878|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345879|NCT03772990|Calcium|calcium|mesh-list
19345880|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19345881|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345882|NCT03772483|Anesthetics|anesthetics|mesh-list
19345883|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345884|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345885|NCT03772561|Durvalumab|durvalumab|mesh-list
19345886|NCT03772561|Olaparib|olaparib|mesh-list
19345887|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345888|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843442|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426490|NCT01281540|Cisapride|cisapride|mesh-list
19345889|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19345890|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345891|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345892|NCT03772314|Modafinil|modafinil|mesh-list
19345893|NCT03772314|Amphetamine|amphetamine|mesh-list
19345894|NCT03772314|Adderall|adderall|mesh-list
19345895|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
19345896|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19345897|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345898|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19345899|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19345900|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19345901|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345902|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
20388723|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388724|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19345903|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
19345904|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388725|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388726|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20388727|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388728|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388729|NCT01066689|Rituximab|rituximab|mesh-list
20388730|NCT01066689|Citric Acid|citric acid|mesh-list
20388731|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
20388732|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20388733|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388734|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
20388735|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388736|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388737|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
20388738|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20388739|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
20388740|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
20388741|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388742|NCT01066728|Theophylline|theophylline|mesh-list
20388743|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20388744|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
20388745|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388746|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388747|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20388748|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
20388749|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20388750|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388751|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388752|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
20388753|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20388754|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20388755|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
20388756|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388757|NCT01066754|Fexofenadine|fexofenadine|mesh-list
20388758|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20388759|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20388760|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20388761|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
20388762|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
20388763|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388764|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388765|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388766|NCT01066767|Fexofenadine|fexofenadine|mesh-list
20388767|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20388768|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20388769|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20388770|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
20388771|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
20388772|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388773|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612947|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20612948|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19345905|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
19345906|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345907|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
19345908|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19345909|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19345910|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345911|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19345912|NCT03772262|Metformin|metformin|mesh-list
19345913|NCT03772262|Furosemide|furosemide|mesh-list
19683834|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683835|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
19683836|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683837|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19683838|NCT03104270|Growth Substances|growth substances|mesh-ancestor
19683839|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
19683840|NCT03084536|Acetaminophen|acetaminophen|mesh-list
19683841|NCT03084536|Celecoxib|celecoxib|mesh-list
19345914|NCT03772262|Midazolam|midazolam|mesh-list
19683842|NCT03084536|Fentanyl|fentanyl|mesh-list
19683843|NCT03084536|Midazolam|midazolam|mesh-list
19683844|NCT03084536|Gabapentin|gabapentin|mesh-list
19345915|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19345916|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19345917|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345918|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19345919|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345920|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345921|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19345922|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19345923|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19345924|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345925|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
19345926|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
19345927|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
19345928|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
19345929|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345930|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345931|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19345932|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19345933|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
19345934|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19345935|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19345936|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345937|NCT03772262|Diuretics|diuretics|mesh-ancestor
19345938|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
19345939|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19345940|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19345941|NCT03772223|Budesonide|budesonide|mesh-list
19345942|NCT03772223|Albuterol|albuterol|mesh-list
19345943|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19345944|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19345945|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
19345946|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388774|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388775|NCT01066806|Calcium|calcium|mesh-list
20388776|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20388777|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388778|NCT01066832|Paclitaxel|paclitaxel|mesh-list
20388779|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20388780|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388781|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
20388782|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
20388783|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
20388784|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388785|NCT01066845|Tadalafil|tadalafil|mesh-list
20388786|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
20388787|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20388788|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20388789|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388790|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388791|NCT01066845|Urological Agents|urological agents|mesh-ancestor
20388792|NCT01066858|Tenofovir|tenofovir|mesh-list
20388793|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
20388794|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388795|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20388796|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20388797|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388798|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388799|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20388800|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20388801|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20388802|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388803|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20388804|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388805|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683845|NCT03084536|Bupivacaine|bupivacaine|mesh-list
19683846|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
19683847|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
19683848|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388806|NCT01066962|Ritonavir|ritonavir|mesh-list
20388807|NCT01066962|Darunavir|darunavir|mesh-list
20388808|NCT01066962|Tenofovir|tenofovir|mesh-list
19345947|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345948|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19683849|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683850|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
19345949|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
19345950|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
19345951|NCT03772223|Hormones|hormones|mesh-ancestor
19345952|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683851|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202721|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20202722|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
20202723|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202724|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
20202725|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19683852|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19683853|NCT03084536|Narcotics|narcotics|mesh-ancestor
20202726|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
20202727|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20202728|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20202729|NCT00257426|Octreotide|octreotide|mesh-list
20202730|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19683854|NCT03084536|Analgesics|analgesics|mesh-ancestor
19683855|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19683856|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345953|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
19345954|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19345955|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19683857|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
19683858|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19683859|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19683860|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19683861|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19683862|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
19683863|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
19683864|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683865|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683866|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683867|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
19683868|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19683869|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19683870|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683871|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19683872|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19683873|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683874|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
19683875|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19683876|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19683877|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
19683878|NCT03083067|Budesonide|budesonide|mesh-list
19683879|NCT03083067|Bromides|bromides|mesh-list
19683880|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
19683881|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
19683882|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19683883|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19683884|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
19683885|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683886|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683887|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19683888|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
19683889|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
19683890|NCT03083067|Hormones|hormones|mesh-ancestor
19683891|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683892|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19683893|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19683894|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19683895|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
19683896|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19683897|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683898|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
19683899|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19683900|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
19683901|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
20202731|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20202732|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388809|NCT01066962|Emtricitabine|emtricitabine|mesh-list
19683902|NCT03043807|Docetaxel|docetaxel|mesh-list
19843443|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683903|NCT03043807|Leuprolide|leuprolide|mesh-list
19683904|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
20202733|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
19683905|NCT03043807|Bicalutamide|bicalutamide|mesh-list
19683906|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683907|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
19683908|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
19683909|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
19683910|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683911|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19683912|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
19683913|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19683914|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683915|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19683916|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19683917|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683918|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
19683919|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683920|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19683921|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
19683922|NCT03020875|Acetaminophen|acetaminophen|mesh-list
19683923|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19683924|NCT03020875|Analgesics|analgesics|mesh-ancestor
20202734|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
20202735|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202736|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612949|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612950|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612951|NCT02253459|Capecitabine|capecitabine|mesh-list
20612952|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20612953|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
20612954|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612955|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683925|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
19683926|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612956|NCT02253485|Telbivudine|telbivudine|mesh-list
20612957|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
20612958|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345956|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19345957|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19345958|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
19345959|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345960|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400490|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
19400491|NCT03625310|Protective Agents|protective agents|mesh-ancestor
19400492|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400493|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20388810|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
20388811|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19400494|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400495|NCT03625219|Prednisone|prednisone|mesh-list
19400496|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400497|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
19400498|NCT03625219|Hormones|hormones|mesh-ancestor
19404535|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202737|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20202738|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202739|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202740|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202741|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202742|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202743|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20202744|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
20202745|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202746|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20202747|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
20202748|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
20202749|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20388812|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20388813|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
20388814|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388815|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388816|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20388817|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20388818|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
20388819|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388820|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20388821|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20388822|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20388823|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20388824|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19683927|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683928|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
20202750|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
20202751|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202752|NCT00257465|Vaccines|vaccines|mesh-list
20202753|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
20202754|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202755|NCT00257491|Telmisartan|telmisartan|mesh-list
20202756|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20202757|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20202758|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20202759|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202760|NCT00257530|Imiquimod|imiquimod|mesh-list
20202761|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20202762|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
20202763|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202764|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202765|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
20388825|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20388826|NCT01066988|Emollients|emollients|mesh-list
20388827|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20388828|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20388829|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
20388830|NCT01067053|Bevacizumab|bevacizumab|mesh-list
20388831|NCT01067053|Capecitabine|capecitabine|mesh-list
20388832|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
20388833|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20388834|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388835|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19345961|NCT03772106|Propofol|propofol|mesh-list
20202766|NCT00257569|Cetirizine|cetirizine|mesh-list
20202767|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20202768|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20202769|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20202770|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
20202771|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
20202772|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202773|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202774|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202775|NCT00257582|Cetirizine|cetirizine|mesh-list
20202776|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20202777|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19345962|NCT03772106|Sevoflurane|sevoflurane|mesh-list
19345963|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345964|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19345965|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345966|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345967|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
20202778|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20202779|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
20202780|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
20202781|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202782|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202783|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202784|NCT00257595|Cetirizine|cetirizine|mesh-list
20202785|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19345968|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
19345969|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19345970|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19345971|NCT03772054|Propofol|propofol|mesh-list
19345972|NCT03772054|Sevoflurane|sevoflurane|mesh-list
19345973|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19345974|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202786|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20202787|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20202788|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
20202789|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
20202790|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388836|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19345975|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692687|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19345976|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19345977|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
19345978|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
19345979|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19345980|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19345981|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
19345982|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19345983|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345984|NCT03771846|Leucovorin|leucovorin|mesh-list
19345985|NCT03771846|Gemcitabine|gemcitabine|mesh-list
19345986|NCT03771846|Fluorouracil|fluorouracil|mesh-list
19345987|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
19345988|NCT03771846|Irinotecan|irinotecan|mesh-list
19345989|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19345990|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
19345991|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19345992|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19345993|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
19345994|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19345995|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19345996|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19345997|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
19345998|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19345999|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19346000|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19346001|NCT03771846|Antidotes|antidotes|mesh-ancestor
19346002|NCT03771846|Protective Agents|protective agents|mesh-ancestor
19346003|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
19346004|NCT03771846|Vitamins|vitamins|mesh-ancestor
19346005|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
19346006|NCT03771755|Acetaminophen|acetaminophen|mesh-list
19346007|NCT03771755|Ibuprofen|ibuprofen|mesh-list
19346008|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19346009|NCT03771755|Analgesics|analgesics|mesh-ancestor
19346010|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
19346011|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346012|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346013|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
19346014|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19346015|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346016|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346017|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19346018|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346019|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346020|NCT03771729|Valsartan|valsartan|mesh-list
19346021|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19346022|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19346023|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19346024|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19346025|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346026|NCT03772067|Insulin|insulin|mesh-list
19346027|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19346028|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19346029|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346030|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346031|NCT03772067|Incretins|incretins|mesh-ancestor
19346032|NCT03772067|Hormones|hormones|mesh-ancestor
19346033|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346034|NCT03771677|Interferons|interferons|mesh-list
19346035|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
19346036|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
19346037|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346038|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
19346039|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346040|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
19346041|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202791|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202792|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202793|NCT00257621|Ritonavir|ritonavir|mesh-list
19843444|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20202794|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20202795|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19843445|NCT00658788|Vitamins|vitamins|mesh-ancestor
20202796|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
20202797|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202798|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202799|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20202800|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20202801|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
20202802|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346044|NCT03771781|Empagliflozin|empagliflozin|mesh-list
19346045|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19346046|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346047|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346048|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346049|NCT03771768|Triamcinolone|triamcinolone|mesh-list
19346050|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19346051|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19346052|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19346053|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346054|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
19346055|NCT03771768|Hormones|hormones|mesh-ancestor
19346056|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346057|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346058|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19346059|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
19346060|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346061|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346062|NCT03771638|Tenofovir|tenofovir|mesh-list
19346063|NCT03771638|Emtricitabine|emtricitabine|mesh-list
19346064|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
19346065|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346066|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19346067|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19346068|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346069|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346070|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19346071|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19346072|NCT03771222|Decitabine|decitabine|mesh-list
19346073|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19346074|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
19346075|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346076|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202803|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20202804|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202805|NCT00257634|Dexamethasone|dexamethasone|mesh-list
20202806|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202807|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
20202808|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
20202809|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202810|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202811|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20202812|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
20202813|NCT00257634|Hormones|hormones|mesh-ancestor
20202814|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202815|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20202816|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202817|NCT00257699|Metronidazole|metronidazole|mesh-list
19843446|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
19346077|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346078|NCT03771066|Bisphenol A|bisphenol a|mesh-list
19346079|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19346080|NCT03771066|Estrogens|estrogens|mesh-ancestor
19346081|NCT03771066|Hormones|hormones|mesh-ancestor
19346082|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346083|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346084|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19346085|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
19346086|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346087|NCT03771066|Protective Agents|protective agents|mesh-ancestor
19346088|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
19346089|NCT03771092|Hematinics|hematinics|mesh-ancestor
19346090|NCT03770923|Montelukast|montelukast|mesh-list
19346091|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19346092|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19346093|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20202818|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
20202819|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202820|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202821|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20202822|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20202823|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20202824|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202825|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202826|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202827|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202828|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20202829|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202830|NCT00257712|Hormones|hormones|mesh-list
20202831|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20202832|NCT00257712|Tesamorelin|tesamorelin|mesh-list
20202833|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388837|NCT01067053|Growth Substances|growth substances|mesh-ancestor
20388838|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388839|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
19346094|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
19346095|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388840|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388841|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
19346096|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202834|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202835|NCT00257712|Growth Substances|growth substances|mesh-ancestor
20202836|NCT00257790|Tobramycin|tobramycin|mesh-list
19346097|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19346098|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19346099|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346100|NCT03770936|Candesartan|candesartan|mesh-list
19346101|NCT03770936|Ramipril|ramipril|mesh-list
19346102|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19346103|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19346104|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19346105|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346106|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19346107|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
20202837|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202838|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202839|NCT00257803|Oxytocin|oxytocin|mesh-list
19346108|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346109|NCT03770806|Acetaminophen|acetaminophen|mesh-list
19346110|NCT03770806|Celecoxib|celecoxib|mesh-list
19346111|NCT03770806|Oxycodone|oxycodone|mesh-list
19346112|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19346113|NCT03770806|Analgesics|analgesics|mesh-ancestor
19346114|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
19346115|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346116|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346117|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
19346118|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19346119|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346120|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346121|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19346122|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19346123|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346124|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346125|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346126|NCT03770806|Narcotics|narcotics|mesh-ancestor
19346127|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346128|NCT03771053|Simvastatin|simvastatin|mesh-list
19346129|NCT03771053|Ezetimibe|ezetimibe|mesh-list
19346130|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19346131|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19346132|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
19346133|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346134|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20202840|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
20202841|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20202842|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202843|NCT00257816|Topotecan|topotecan|mesh-list
20202844|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202845|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20202846|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202847|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202848|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426491|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19346135|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19346136|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346137|NCT03770416|Nivolumab|nivolumab|mesh-list
19346138|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346139|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346140|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19346141|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346142|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19346143|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346144|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
19346145|NCT03770663|Azathioprine|azathioprine|mesh-list
19346146|NCT03770663|Tacrolimus|tacrolimus|mesh-list
19346147|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19346148|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
20202849|NCT00257829|Methazolamide|methazolamide|mesh-list
20388842|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388843|NCT01067066|Temozolomide|temozolomide|mesh-list
20388844|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20388845|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
20388846|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346149|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346150|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346151|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19346152|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
19346153|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346154|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346155|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20202850|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19683929|NCT02996305|Gaboxadol|gaboxadol|mesh-list
19683930|NCT02996305|Analgesics|analgesics|mesh-ancestor
19683931|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
19683932|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19683933|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683934|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
19683935|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
20388847|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388848|NCT01067118|Insulin|insulin|mesh-list
19683936|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
20202851|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202852|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202853|NCT00257829|Diuretics|diuretics|mesh-ancestor
20202854|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
20202855|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202856|NCT00257855|Lamotrigine|lamotrigine|mesh-list
20202857|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
20202858|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20202859|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202860|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202861|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20202862|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346156|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19346157|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346158|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
19346159|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19346160|NCT03770637|Glucagon|glucagon|mesh-list
20388849|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20388850|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
20388851|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20388852|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388853|NCT01067222|Modafinil|modafinil|mesh-list
19346161|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19346162|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346163|NCT03770637|Hormones|hormones|mesh-ancestor
20202863|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20388854|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20388855|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388856|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20388857|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20388858|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20426492|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346164|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683937|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693151|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388859|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202864|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20388860|NCT01067235|Modafinil|modafinil|mesh-list
20388861|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20388862|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388863|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19346165|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346166|NCT03770637|Incretins|incretins|mesh-ancestor
19346167|NCT03770767|Insulin|insulin|mesh-list
19346168|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19346169|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
19346170|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346171|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346172|NCT03770208|Lidocaine|lidocaine|mesh-list
19346173|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
19346174|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
19346175|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346176|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346177|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
19346178|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346179|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19346180|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19346181|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19346182|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19346183|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400499|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400500|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400501|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19400502|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400503|NCT03625167|Petrolatum|petrolatum|mesh-list
19400504|NCT03625167|Emollients|emollients|mesh-ancestor
19400505|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
19404536|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19404537|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19404538|NCT03593954|Ritonavir|ritonavir|mesh-list
19404539|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19404540|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19404541|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
19404542|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404543|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404544|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19404545|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19404546|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
19404547|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404548|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19404549|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19404550|NCT03593707|Metformin|metformin|mesh-list
19404551|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404552|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404553|NCT03593668|Metformin|metformin|mesh-list
19404554|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404555|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404556|NCT03593473|Oxytocin|oxytocin|mesh-list
19404557|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
19404558|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404559|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404560|NCT03593447|Ribavirin|ribavirin|mesh-list
19404561|NCT03593447|Yimitasvir|yimitasvir|mesh-list
19404562|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
19404563|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404564|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
19404565|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404566|NCT03593408|Fentanyl|fentanyl|mesh-list
19404567|NCT03593408|Midazolam|midazolam|mesh-list
20202865|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202866|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202867|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20202868|NCT00257868|Rivastigmine|rivastigmine|mesh-list
20202869|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20202870|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202871|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202872|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
20202873|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202874|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346184|NCT03770000|Romidepsin|romidepsin|mesh-list
19346185|NCT03770000|Tenalisib|tenalisib|mesh-list
19346186|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19346187|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346188|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
20388864|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20388865|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20202875|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20202876|NCT00257868|Protective Agents|protective agents|mesh-ancestor
20202877|NCT00257959|Amiodarone|amiodarone|mesh-list
20202878|NCT00257959|Sotalol|sotalol|mesh-list
20202879|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20388866|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388867|NCT01067274|Cytarabine|cytarabine|mesh-list
20388868|NCT01067274|Azacitidine|azacitidine|mesh-list
20388869|NCT01067274|Tretinoin|tretinoin|mesh-list
20388870|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20388871|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
20388872|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388873|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388874|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
20388875|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388876|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20388877|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
20388878|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388879|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388880|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
20388881|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
20388882|NCT01067287|Pidilizumab|pidilizumab|mesh-list
20388883|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20388884|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346189|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346190|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346191|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19346192|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19346193|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19346194|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
19346195|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346196|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346197|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19346198|NCT03770039|PF-06700841|pf-06700841|mesh-list
19346199|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19346200|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346201|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346202|NCT03770026|Clomiphene|clomiphene|mesh-list
19346203|NCT03770026|Enclomiphene|enclomiphene|mesh-list
19346204|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
19346205|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19346206|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
19346207|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346208|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346209|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19346210|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
19346211|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19346212|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19346213|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19346214|NCT03770013|Clonidine|clonidine|mesh-list
19346215|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
19346216|NCT03770013|Bupivacaine|bupivacaine|mesh-list
19346217|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
19346218|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
19346219|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346220|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346221|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
20202880|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20202881|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
20202882|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20202883|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20202884|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202885|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20202886|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20202887|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202888|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400506|NCT03625089|Atorvastatin|atorvastatin|mesh-list
20388885|NCT01067365|Citric Acid|citric acid|mesh-list
20388886|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
20388887|NCT01067365|Enclomiphene|enclomiphene|mesh-list
20388888|NCT01067365|Clomiphene|clomiphene|mesh-list
20388889|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
20388890|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
20388891|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20202889|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20388892|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
20388893|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
20388894|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388895|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20388896|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
20388897|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20388898|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388899|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20388900|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
20388901|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20388902|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20388903|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20388904|NCT01067391|Tadalafil|tadalafil|mesh-list
20202890|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20202891|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20202892|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20202893|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
20202894|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202895|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202896|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
19346222|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346223|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19346224|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19346225|NCT03770013|Analgesics|analgesics|mesh-ancestor
19346226|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19346227|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19346228|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19346229|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
19346230|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19346231|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202897|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
20202898|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202899|NCT00257972|Aripiprazole|aripiprazole|mesh-list
19683938|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683939|NCT02976753|Factor VIII|factor viii|mesh-list
19683940|NCT02976753|Coagulants|coagulants|mesh-ancestor
20202900|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
20202901|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202902|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19683941|NCT02955082|Carboplatin|carboplatin|mesh-list
19683942|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683943|NCT02951767|Atezolizumab|atezolizumab|mesh-list
20202903|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20388905|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
20388906|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19346232|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19346233|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
19346234|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
19346235|NCT03769935|Etoposide|etoposide|mesh-list
19346236|NCT03769935|Cisplatin|cisplatin|mesh-list
19346237|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19346238|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388907|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20388908|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388909|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388910|NCT01067391|Urological Agents|urological agents|mesh-ancestor
19346239|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19346240|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19346241|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346242|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346243|NCT03769870|Atorvastatin|atorvastatin|mesh-list
19683944|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202904|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202905|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388911|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
19346244|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19683945|NCT02946996|Metformin|metformin|mesh-list
20202906|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
20202907|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
20202908|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202909|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202910|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20202911|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20202912|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
20202913|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20202914|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20202915|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20202916|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20202917|NCT00258050|Lapatinib|lapatinib|mesh-list
19346245|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19346246|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
19346247|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346248|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19346249|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20202918|NCT00258050|Midazolam|midazolam|mesh-list
20202919|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20202920|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20202921|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202922|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202923|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20202924|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20202925|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20202926|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20202927|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
20202928|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
19843447|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19843448|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19843449|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
19843450|NCT00658788|Hormones|hormones|mesh-ancestor
20388912|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
20388913|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19843451|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843452|NCT00659165|Insulin|insulin|mesh-list
19843453|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19843454|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
19843455|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
19843456|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20388914|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19346250|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346251|NCT03769818|Dexamethasone|dexamethasone|mesh-list
19346252|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
19346253|NCT03769818|Bupivacaine|bupivacaine|mesh-list
19346254|NCT03769818|BB 1101|bb 1101|mesh-list
19346255|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346256|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
19346257|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
19346258|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346259|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346260|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346261|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
19346262|NCT03769818|Hormones|hormones|mesh-ancestor
19346263|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346264|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19346265|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346266|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19346267|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346268|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346269|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
19346270|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
19346271|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346272|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
19346273|NCT03769714|Bupivacaine|bupivacaine|mesh-list
19346274|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
19843457|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202929|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
20202930|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
20202931|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20202932|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202933|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202934|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19346275|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
19346276|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20388915|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388916|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20388917|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388918|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388919|NCT01067430|Diclofenac|diclofenac|mesh-list
20388920|NCT01067430|Etoricoxib|etoricoxib|mesh-list
20388921|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20388922|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20202935|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202936|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20202937|NCT00258063|Norelgestromin|norelgestromin|mesh-list
20202938|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
20202939|NCT00258063|Estradiol|estradiol|mesh-list
20202940|NCT00258063|Estrogens|estrogens|mesh-ancestor
20202941|NCT00258063|Hormones|hormones|mesh-ancestor
20202942|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20202943|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202944|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20388923|NCT01067430|Analgesics|analgesics|mesh-ancestor
20388924|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
20388925|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388926|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388927|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20388928|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20388929|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19346277|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346278|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
20202945|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20202946|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20202947|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20202948|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20217711|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217712|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217713|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217714|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
20217715|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
19346279|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346280|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
19346281|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346282|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346283|NCT03769402|Citric Acid|citric acid|mesh-list
19346284|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
19346285|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
19346286|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19346287|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
19346288|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
19346289|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346290|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
19346291|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346292|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346293|NCT03769103|Osimertinib|osimertinib|mesh-list
19346294|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346295|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19346296|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346297|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346298|NCT03769064|Methylphenidate|methylphenidate|mesh-list
19346299|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19346300|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346301|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19346302|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19346303|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19346304|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346305|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
19346306|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19346307|NCT03768908|Artesunate|artesunate|mesh-list
19346308|NCT03768908|Lumefantrine|lumefantrine|mesh-list
19346309|NCT03768908|Artemether|artemether|mesh-list
19346310|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19346311|NCT03768908|Amodiaquine|amodiaquine|mesh-list
19346312|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
19346313|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19346314|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20217716|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388930|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217717|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346315|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346316|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346317|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
19346318|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
19346319|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19346320|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
19346321|NCT03768882|Acetaminophen|acetaminophen|mesh-list
19346322|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19346323|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19346324|NCT03768882|Analgesics|analgesics|mesh-ancestor
19346325|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
19346326|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346327|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346328|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
19346329|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19346330|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346331|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346332|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19346333|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19346334|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346335|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
19346336|NCT03768713|Suvorexant|suvorexant|mesh-list
19346337|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19346338|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19346339|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346340|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346341|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19346342|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19346343|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346344|NCT03768609|Cyclosporine|cyclosporine|mesh-list
19346345|NCT03768609|Cyclosporins|cyclosporins|mesh-list
20202949|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
20202950|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20202951|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202952|NCT00258089|Levofloxacin|levofloxacin|mesh-list
20388931|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388932|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20388933|NCT01067443|Amphotericin B|amphotericin b|mesh-list
20388934|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20202953|NCT00258089|Ofloxacin|ofloxacin|mesh-list
20202954|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20202955|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202956|NCT00258089|Renal Agents|renal agents|mesh-ancestor
20202957|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202958|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20202959|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202960|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202961|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346346|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346347|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346348|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19346349|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
19346350|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346351|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
19346352|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346353|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
19346354|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346355|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19346356|NCT03768596|Vaccines|vaccines|mesh-list
19346357|NCT03768596|Immunologic Factors|immunologic factors|mesh-ancestor
19346358|NCT03768596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346359|NCT03768557|Minocycline|minocycline|mesh-list
19346360|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202962|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202963|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20202964|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202965|NCT00258102|Levofloxacin|levofloxacin|mesh-list
20202966|NCT00258102|Ofloxacin|ofloxacin|mesh-list
20388935|NCT01067443|Miltefosine|miltefosine|mesh-list
19346361|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346362|NCT03768531|Nivolumab|nivolumab|mesh-list
19346363|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346364|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346365|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20202967|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19843458|NCT00659230|Dopamine|dopamine|mesh-list
19346366|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388936|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19346367|NCT03768518|Exenatide|exenatide|mesh-list
19346368|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346369|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346370|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19346371|NCT03768518|Incretins|incretins|mesh-ancestor
19346372|NCT03768518|Hormones|hormones|mesh-ancestor
20388937|NCT01067443|Amebicides|amebicides|mesh-ancestor
20388938|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19346373|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346374|NCT03768427|Atorvastatin|atorvastatin|mesh-list
19346375|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19346376|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19346377|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
19346378|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346379|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19346380|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19346381|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346382|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
19346383|NCT03768258|Anastrozole|anastrozole|mesh-list
19843459|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19843460|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
19843461|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
19843462|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843463|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843464|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
19843465|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843466|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843467|NCT00659230|Protective Agents|protective agents|mesh-ancestor
19843468|NCT00659269|Vitamins|vitamins|mesh-list
19843469|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
19346384|NCT03768258|Testosterone|testosterone|mesh-list
19346385|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
19346386|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
19346387|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19346388|NCT03768258|Androgens|androgens|mesh-ancestor
19346389|NCT03768258|Hormones|hormones|mesh-ancestor
19346390|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346391|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202968|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20202969|NCT00258102|Renal Agents|renal agents|mesh-ancestor
20202970|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20202971|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20202972|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20202973|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20202974|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202975|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202976|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20202977|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20202978|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20202979|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20202980|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20202981|NCT00258115|Analgesics|analgesics|mesh-ancestor
20388939|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20388940|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20388941|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20388942|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
20388943|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388944|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
20388945|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20388946|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
20388947|NCT01067534|Albuterol|albuterol|mesh-list
20388948|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20388949|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
20388950|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388951|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388952|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20388953|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
20202982|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
19346392|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19843470|NCT00659269|Hydroxocobalamin|hydroxocobalamin|mesh-list
19843471|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
20217718|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
20388954|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
20388955|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20388956|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19346393|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346394|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
19346395|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20388957|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20388958|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20388959|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
20388960|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388961|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388962|NCT01067547|Iron|iron|mesh-list
20388963|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20388964|NCT01067547|Trace Elements|trace elements|mesh-ancestor
20388965|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
20388966|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388967|NCT01067547|Hematinics|hematinics|mesh-ancestor
20388968|NCT01067599|Nicotine|nicotine|mesh-list
20388969|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20388970|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
20388971|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388972|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388973|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19346396|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19346397|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346398|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346399|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19346400|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
19346401|NCT03768037|Pemetrexed|pemetrexed|mesh-list
19346402|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20388974|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20388975|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
20388976|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388977|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388978|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
20388979|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20388980|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20388981|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388982|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
20388983|NCT01067638|Coagulants|coagulants|mesh-ancestor
20388984|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
20388985|NCT01067677|Promethazine|promethazine|mesh-list
20388986|NCT01067677|Ondansetron|ondansetron|mesh-list
20388987|NCT01067677|Metoclopramide|metoclopramide|mesh-list
20388988|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
20388989|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
20388990|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20388991|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20388992|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346403|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346404|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346405|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19346406|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19400507|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19400508|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19400509|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
19400510|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400511|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19400512|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19400513|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400514|NCT03625076|Lidocaine|lidocaine|mesh-list
19400515|NCT03625076|Propofol|propofol|mesh-list
19400516|NCT03625076|Etomidate|etomidate|mesh-list
19400517|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400518|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
20388993|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
20388994|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
20388995|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20388996|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
20388997|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20388998|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20388999|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20389000|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19400519|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400520|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400521|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
20389001|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346407|NCT03768024|Hydromorphone|hydromorphone|mesh-list
19346408|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346409|NCT03768024|Narcotics|narcotics|mesh-ancestor
19346410|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346411|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346412|NCT03768024|Analgesics|analgesics|mesh-ancestor
19346413|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
19346414|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346415|NCT03767920|Dexamethasone|dexamethasone|mesh-list
19346416|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
19346417|NCT03767920|Bupivacaine|bupivacaine|mesh-list
19346418|NCT03767920|BB 1101|bb 1101|mesh-list
19346419|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346420|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
19346421|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
19346422|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346423|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346424|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346425|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
19346426|NCT03767920|Hormones|hormones|mesh-ancestor
19346427|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346428|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20202983|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20202984|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20202985|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20202986|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20202987|NCT00258193|Linaclotide|linaclotide|mesh-list
20202988|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20202989|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
20202990|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202991|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346429|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346430|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
19346431|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346432|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346433|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
19346434|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
19346435|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20202992|NCT00258232|Celecoxib|celecoxib|mesh-list
20202993|NCT00258232|Capecitabine|capecitabine|mesh-list
19346436|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
19346437|NCT03767660|Sirolimus|sirolimus|mesh-list
19346438|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19346439|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346440|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19346441|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346442|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
19346443|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19346444|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
19346445|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346446|NCT03767569|Folic Acid|folic acid|mesh-list
19346447|NCT03767569|Inositol|inositol|mesh-list
19346448|NCT03767569|Hematinics|hematinics|mesh-ancestor
19346449|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
19346450|NCT03767569|Vitamins|vitamins|mesh-ancestor
19346451|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
19346452|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346453|NCT03767504|Thymol|thymol|mesh-list
19346454|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346455|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19346456|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
19346457|NCT03767439|Nivolumab|nivolumab|mesh-list
19346458|NCT03767439|Ipilimumab|ipilimumab|mesh-list
20202994|NCT00258232|Irinotecan|irinotecan|mesh-list
20202995|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20202996|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
20202997|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20202998|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20202999|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20203000|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20203001|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203002|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20203003|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20203004|NCT00258232|Analgesics|analgesics|mesh-ancestor
19346459|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346460|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346461|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19404568|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
20389002|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20389003|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19346462|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346463|NCT03767335|Trastuzumab|trastuzumab|mesh-list
19346464|NCT03767335|Fulvestrant|fulvestrant|mesh-list
19346465|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346466|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346467|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19346468|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19346469|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20203005|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
20203006|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203007|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203008|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203009|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346470|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
19346471|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346472|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346473|NCT03767322|Allopurinol|allopurinol|mesh-list
19346474|NCT03767322|Febuxostat|febuxostat|mesh-list
19346475|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
19346476|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346477|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346478|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
19346479|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203010|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20203011|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20203012|NCT00258245|Aspirin|aspirin|mesh-list
20203013|NCT00258245|Vitamins|vitamins|mesh-list
20203014|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
20203015|NCT00258245|Thalidomide|thalidomide|mesh-list
20389004|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20389005|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20389006|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
20389007|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
20389008|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
20389009|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20389010|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
20389011|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
20389012|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20389013|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19346480|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19346481|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
19346482|NCT03767322|Protective Agents|protective agents|mesh-ancestor
19346483|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346484|NCT03767296|Phenylephrine|phenylephrine|mesh-list
20389014|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20389015|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
20389016|NCT01067690|Indinavir|indinavir|mesh-list
19346485|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
19346486|NCT03767296|Ephedrine|ephedrine|mesh-list
19346487|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
19346488|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19346489|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
19346490|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
19346491|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346492|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346493|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
19346494|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19346495|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
19346496|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
19346497|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19346498|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19346499|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19346500|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
19346501|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203016|NCT00258245|Dexamethasone|dexamethasone|mesh-list
20203017|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
20217719|NCT00310128|Hormones|hormones|mesh-ancestor
20389017|NCT01067690|Bleomycin|bleomycin|mesh-list
20389018|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20389019|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20389020|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
20389021|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346502|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389022|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346503|NCT03767296|Protective Agents|protective agents|mesh-ancestor
19346504|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19346505|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19346506|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19346507|NCT03767075|Atezolizumab|atezolizumab|mesh-list
19346508|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346509|NCT03767036|Ketorolac|ketorolac|mesh-list
19346510|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19346511|NCT03767036|Tramadol|tramadol|mesh-list
19346512|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19346513|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19346514|NCT03767036|Analgesics|analgesics|mesh-ancestor
19346515|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
19346516|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346517|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346518|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346519|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346520|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19346521|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346522|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346523|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346524|NCT03767036|Narcotics|narcotics|mesh-ancestor
19346525|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346526|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
19346527|NCT03766997|Betamethasone|betamethasone|mesh-list
19346528|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
19346529|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346530|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
19346531|NCT03766997|Hormones|hormones|mesh-ancestor
19346532|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346533|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346534|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19346535|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
19346536|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
19346537|NCT03766984|Diclofenac|diclofenac|mesh-list
19346538|NCT03766984|Tramadol|tramadol|mesh-list
19346539|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19346540|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19346541|NCT03766984|Analgesics|analgesics|mesh-ancestor
19346542|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
19346543|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346544|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346545|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346546|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346547|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19346548|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346549|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346550|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346551|NCT03766984|Narcotics|narcotics|mesh-ancestor
19346552|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346553|NCT03766893|Naltrexone|naltrexone|mesh-list
19346554|NCT03766893|Buprenorphine|buprenorphine|mesh-list
19346555|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19346556|NCT03766893|Naloxone|naloxone|mesh-list
19346557|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346558|NCT03766893|Narcotics|narcotics|mesh-ancestor
19346559|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346560|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346561|NCT03766893|Analgesics|analgesics|mesh-ancestor
19346562|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
19843472|NCT00659269|Pyridoxal|pyridoxal|mesh-list
19843473|NCT00659269|Pyridoxine|pyridoxine|mesh-list
19843474|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
19843475|NCT00659269|Paclitaxel|paclitaxel|mesh-list
19843476|NCT00659269|Vincristine|vincristine|mesh-list
19843477|NCT00659269|Vinorelbine|vinorelbine|mesh-list
19843478|NCT00659269|Docetaxel|docetaxel|mesh-list
19843479|NCT00659269|Cisplatin|cisplatin|mesh-list
19843480|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
19843481|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20203018|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
20203019|NCT00258245|Bortezomib|bortezomib|mesh-list
20203020|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
20203021|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20203022|NCT00258245|BB 1101|bb 1101|mesh-list
19346563|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346564|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19843482|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843483|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
20389023|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20389024|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20389025|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
20389026|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389027|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20389028|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426493|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20426494|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
20426495|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19346565|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19346566|NCT03766867|Vortioxetine|vortioxetine|mesh-list
19346567|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
19346568|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19346569|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19346570|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19346571|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346572|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346573|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19346574|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19346575|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19346576|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346577|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19346578|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
19346579|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19346580|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19346581|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19346582|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19346583|NCT03766854|Insulin|insulin|mesh-list
19346584|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19346585|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
19346586|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346587|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346588|NCT03766763|Venetoclax|venetoclax|mesh-list
19346589|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346590|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
19346591|NCT03766750|Linagliptin|linagliptin|mesh-list
19346592|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19346593|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346594|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346595|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346596|NCT03766750|Incretins|incretins|mesh-ancestor
19346597|NCT03766750|Hormones|hormones|mesh-ancestor
19346598|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346599|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19346600|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
19346601|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346602|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
19346603|NCT03766724|Empagliflozin|empagliflozin|mesh-list
19346604|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19346605|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346606|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346607|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426496|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426497|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426498|NCT01281553|Cisapride|cisapride|mesh-list
20426499|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20426500|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346608|NCT03766607|Paclitaxel|paclitaxel|mesh-list
19346609|NCT03766607|Trastuzumab|trastuzumab|mesh-list
19346610|NCT03766607|Ramucirumab|ramucirumab|mesh-list
19346611|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19346612|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346613|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
19346614|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
19346615|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
19346616|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346617|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346618|NCT03766594|Folic Acid|folic acid|mesh-list
20426501|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20426502|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
20426503|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426504|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426505|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346619|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
19346620|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346621|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
19346622|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19346623|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19346624|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346625|NCT03766594|Urological Agents|urological agents|mesh-ancestor
19346626|NCT03766594|Hematinics|hematinics|mesh-ancestor
19346627|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
19346628|NCT03766594|Vitamins|vitamins|mesh-ancestor
19346629|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
19346630|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346631|NCT03766490|Gefitinib|gefitinib|mesh-list
19346632|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346633|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19346634|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346635|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346636|NCT03766425|Aflibercept|aflibercept|mesh-list
19346637|NCT03766425|Mitomycins|mitomycins|mesh-list
19346638|NCT03766425|Mitomycin|mitomycin|mesh-list
19346639|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19346640|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19346641|NCT03766425|Growth Substances|growth substances|mesh-ancestor
19346642|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346643|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
19346644|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346645|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19346646|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
19346647|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346648|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19346649|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346650|NCT03766269|Dronabinol|dronabinol|mesh-list
19346651|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
20389029|NCT01067898|Vitamin D|vitamin d|mesh-list
20389030|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
20389031|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
20389032|NCT01067898|Vitamins|vitamins|mesh-list
20389033|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
20389034|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
20389035|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389036|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19346652|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346653|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19346654|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19346655|NCT03766269|Analgesics|analgesics|mesh-ancestor
19346656|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
19346657|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346658|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19346659|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20203023|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
20203024|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203025|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203026|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
20203027|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
20203028|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203029|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203030|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
20203031|NCT00258245|Hormones|hormones|mesh-ancestor
20203032|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203033|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20203034|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203035|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
20203036|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203037|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203038|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20203039|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20203040|NCT00258245|Analgesics|analgesics|mesh-ancestor
20203041|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
20203042|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203043|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20389037|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20389038|NCT01067898|Antacids|antacids|mesh-ancestor
19346660|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19346661|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389039|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389040|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346662|NCT03766269|Hormones|hormones|mesh-ancestor
19346663|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346664|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
19346665|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19346666|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400522|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400523|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19400524|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19400525|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19400526|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19400527|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400528|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19400529|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19400530|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
19400531|NCT03625050|Celecoxib|celecoxib|mesh-list
19400532|NCT03625050|Esomeprazole|esomeprazole|mesh-list
19400533|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19400534|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389041|NCT01067950|Pancrelipase|pancrelipase|mesh-list
20389042|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389043|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
20389044|NCT01067989|Pamidronate|pamidronate|mesh-list
20389045|NCT01067989|Celecoxib|celecoxib|mesh-list
20389046|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
20389047|NCT01067989|Capecitabine|capecitabine|mesh-list
20389048|NCT01067989|Methotrexate|methotrexate|mesh-list
20389049|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389050|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
19400535|NCT03625050|Analgesics|analgesics|mesh-ancestor
19400536|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
19400537|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400538|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400539|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400540|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19400541|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19400542|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19400543|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400544|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400545|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19400546|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400547|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19400548|NCT03625011|Gabapentin|gabapentin|mesh-list
19400549|NCT03625011|Analgesics|analgesics|mesh-ancestor
19400550|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
19400551|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400552|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400553|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
19400554|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19400555|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19400556|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400557|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203044|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19400558|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19400559|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19400560|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400561|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400562|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
19400563|NCT03624985|Lidocaine|lidocaine|mesh-list
19400564|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400565|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
19400566|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683946|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20203045|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20203046|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20203047|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
20203048|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
19683947|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683948|NCT02912988|Letrozole|letrozole|mesh-list
19683949|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683950|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20203049|NCT00258245|Protective Agents|protective agents|mesh-ancestor
20203050|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203051|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
20203052|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
20203053|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19683951|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19683952|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389051|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389052|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389053|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20389054|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
20389055|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683953|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203054|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203055|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20203056|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20203057|NCT00258245|Growth Substances|growth substances|mesh-ancestor
20203058|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
20203059|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
20203060|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20389056|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389057|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20389058|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389059|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
20389060|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20389061|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
20389062|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20203061|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203062|NCT00258271|Cytarabine|cytarabine|mesh-list
20203063|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
20203064|NCT00258271|Cladribine|cladribine|mesh-list
20203065|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20203066|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
20203067|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203068|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203069|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
19346667|NCT03766074|Vitamin D|vitamin d|mesh-list
19346668|NCT03766074|Vitamins|vitamins|mesh-ancestor
20203070|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203071|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203072|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
20203073|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203074|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20203075|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203076|NCT00258284|Docetaxel|docetaxel|mesh-list
20203077|NCT00258284|Capecitabine|capecitabine|mesh-list
20203078|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203079|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
20203080|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
20203081|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
20203082|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346669|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
19346670|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346671|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19346672|NCT03765944|Sirolimus|sirolimus|mesh-list
19346673|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19346674|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346675|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19346676|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203083|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19683954|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19683955|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
19683956|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19683957|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683958|NCT02898259|Rituximab|rituximab|mesh-list
19683959|NCT02898259|Lenalidomide|lenalidomide|mesh-list
19683960|NCT02898259|Ixazomib|ixazomib|mesh-list
19346677|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
19346678|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19346679|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
19346680|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346681|NCT03765931|Amoxicillin|amoxicillin|mesh-list
19346682|NCT03765931|Doxycycline|doxycycline|mesh-list
19346683|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19346684|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203084|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
19346685|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
19346686|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19346687|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20203085|NCT00258297|Gefitinib|gefitinib|mesh-list
20203086|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19346688|NCT03765827|Vitamins|vitamins|mesh-list
19346689|NCT03765827|Vitamin E|vitamin e|mesh-list
19346690|NCT03765827|Tocopherols|tocopherols|mesh-list
19346691|NCT03765827|Tocotrienols|tocotrienols|mesh-list
19346692|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
19346693|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
19346694|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346695|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
19346696|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346697|NCT03765827|Protective Agents|protective agents|mesh-ancestor
19346698|NCT03765697|Lidocaine|lidocaine|mesh-list
19346699|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
19346700|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
19843484|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843485|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
19843486|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843487|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
19843488|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683961|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683962|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683963|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
19683964|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683965|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19683966|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19683967|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19683968|NCT02898259|Growth Substances|growth substances|mesh-ancestor
20203087|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203088|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20203089|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203090|NCT00258323|Fluorouracil|fluorouracil|mesh-list
20203091|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203092|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
20203093|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389063|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
20389064|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389065|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20389066|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20389067|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20389068|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389069|NCT01067989|Analgesics|analgesics|mesh-ancestor
19346701|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346702|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346703|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
19346704|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346705|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19346706|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19346707|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19346708|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19346709|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346710|NCT03765645|Tazobactam|tazobactam|mesh-list
19346711|NCT03765645|Piperacillin|piperacillin|mesh-list
19346712|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19346713|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20389070|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
20389071|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389072|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389073|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20389074|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20389075|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20389076|NCT01068054|Cyclosporine|cyclosporine|mesh-list
20389077|NCT01068054|Tacrolimus|tacrolimus|mesh-list
20389078|NCT01068054|Cyclosporins|cyclosporins|mesh-list
19346714|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346715|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19346716|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346717|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346718|NCT03765554|PF-06700841|pf-06700841|mesh-list
19346719|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19346720|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346721|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346722|NCT03765541|Cytarabine|cytarabine|mesh-list
19346723|NCT03765541|Dexamethasone|dexamethasone|mesh-list
19346724|NCT03765541|Azacitidine|azacitidine|mesh-list
19843489|NCT00659269|Hematinics|hematinics|mesh-ancestor
20426506|NCT01281566|Cisapride|cisapride|mesh-list
19683969|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
19683970|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
19683971|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346725|NCT03765541|Amsacrine|amsacrine|mesh-list
19346726|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346727|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
19346728|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
19346729|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346730|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346731|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346732|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
19346733|NCT03765541|Hormones|hormones|mesh-ancestor
19346734|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346735|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19346736|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346737|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19346738|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
19346739|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346740|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
19346741|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346742|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19346743|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
19346744|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346745|NCT03765450|Infliximab|infliximab|mesh-list
19346746|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
19346747|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346748|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19346749|NCT03765346|Oxycodone|oxycodone|mesh-list
19346750|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346751|NCT03765346|Narcotics|narcotics|mesh-ancestor
19346752|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19683972|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683973|NCT02878798|Topiramate|topiramate|mesh-list
19683974|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
19683975|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19683976|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19683977|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19683978|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19683979|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19683980|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
19683981|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19683982|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683983|NCT02854488|Ipilimumab|ipilimumab|mesh-list
19683984|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19683985|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19683986|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19683987|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683988|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
19683989|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19683990|NCT02841280|Diuretics|diuretics|mesh-ancestor
19683991|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
19843490|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
20389079|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389080|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
20389081|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346753|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843491|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20389082|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20389083|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389084|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389085|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
20389086|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389087|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
20389088|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389089|NCT01068067|Tacrolimus|tacrolimus|mesh-list
20389090|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389091|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
20389092|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389093|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19843492|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843493|NCT00659360|Saracatinib|saracatinib|mesh-list
19843494|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389094|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346754|NCT03765346|Analgesics|analgesics|mesh-ancestor
19683992|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389095|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346755|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
19346756|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346757|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
19346758|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19346759|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19346760|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346761|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
19346762|NCT03765021|Coagulants|coagulants|mesh-ancestor
19346763|NCT03764722|Simendan|simendan|mesh-list
19346764|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19346765|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
19346766|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19346767|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19346768|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346769|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346770|NCT03764722|Protective Agents|protective agents|mesh-ancestor
19346771|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346772|NCT03764683|Suvorexant|suvorexant|mesh-list
19346773|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19346774|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19346775|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346776|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346777|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19346778|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19346779|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346780|NCT03764605|Metformin|metformin|mesh-list
19346781|NCT03764605|Tolvaptan|tolvaptan|mesh-list
19346782|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346783|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346784|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19346785|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346786|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
19346787|NCT03764553|Leucovorin|leucovorin|mesh-list
19346788|NCT03764553|Carboplatin|carboplatin|mesh-list
19346789|NCT03764553|Fluorouracil|fluorouracil|mesh-list
19346790|NCT03764553|Capecitabine|capecitabine|mesh-list
19346791|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
19346792|NCT03764553|Irinotecan|irinotecan|mesh-list
19346793|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346794|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
19346795|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346796|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19346797|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19346798|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
19346799|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346800|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19346801|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19346802|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346803|NCT03764553|Antidotes|antidotes|mesh-ancestor
19346804|NCT03764553|Protective Agents|protective agents|mesh-ancestor
19346805|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
19346806|NCT03764553|Vitamins|vitamins|mesh-ancestor
19346807|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
19346808|NCT03764540|Prednisone|prednisone|mesh-list
19346809|NCT03764540|Docetaxel|docetaxel|mesh-list
19346810|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346811|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
19346812|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
19346813|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
19346814|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346815|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346816|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
19346817|NCT03764540|Hormones|hormones|mesh-ancestor
19346818|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346819|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843495|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843496|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843497|NCT00659373|Tamoxifen|tamoxifen|mesh-list
19843498|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19843499|NCT00659373|Exemestane|exemestane|mesh-list
20203094|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389096|NCT01068093|Ezetimibe|ezetimibe|mesh-list
19346820|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19346821|NCT03764527|Artesunate|artesunate|mesh-list
19843500|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19346822|NCT03764527|Lumefantrine|lumefantrine|mesh-list
19843501|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
19843502|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843503|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843504|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19843505|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843506|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19843507|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19346823|NCT03764527|Artemether|artemether|mesh-list
19346824|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19346825|NCT03764527|Amodiaquine|amodiaquine|mesh-list
19346826|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
19683993|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19683994|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19683995|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19683996|NCT02838745|Pemetrexed|pemetrexed|mesh-list
19683997|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203095|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203096|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
20203097|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203098|NCT00258336|Rituximab|rituximab|mesh-list
20203099|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
20203100|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20203101|NCT00258336|Antibodies|antibodies|mesh-list
20203102|NCT00258336|Sargramostim|sargramostim|mesh-list
20203103|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20203104|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203105|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203106|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
20203107|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203108|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203109|NCT00258375|Docetaxel|docetaxel|mesh-list
20203110|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203111|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
20203112|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
20203113|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389097|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20389098|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20389099|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
19346827|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19346828|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19346829|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346830|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346831|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
19346832|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
19346833|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19346834|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
19346835|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
19346836|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19346837|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346838|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19346839|NCT03764462|AD 101|ad 101|mesh-list
19346840|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19346841|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
19346842|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346843|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346844|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19346845|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19346846|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19404569|NCT03593408|Morphine|morphine|mesh-list
19683998|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203114|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203115|NCT00258388|Prednisone|prednisone|mesh-list
20389100|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389101|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20389102|NCT01068132|Cetuximab|cetuximab|mesh-list
20389103|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389104|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389105|NCT01068223|Cetirizine|cetirizine|mesh-list
20389106|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20389107|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20389108|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19683999|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684000|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20203116|NCT00258388|Docetaxel|docetaxel|mesh-list
20203117|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389109|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
20203118|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
20203119|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
20203120|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
20203121|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203122|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203123|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
19684001|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19684002|NCT02809820|Metoprolol|metoprolol|mesh-list
19684003|NCT02809820|Carvedilol|carvedilol|mesh-list
19684004|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19684005|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20203124|NCT00258388|Hormones|hormones|mesh-ancestor
20203125|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203126|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203127|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20203128|NCT00258479|Modafinil|modafinil|mesh-list
20203129|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20203130|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203131|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20203132|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19684006|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19684007|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
19684008|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
19684009|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684010|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684011|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19684012|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19684013|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
19684014|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684015|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203133|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20203134|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203135|NCT00258557|Darunavir|darunavir|mesh-list
20203136|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20203137|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20203138|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
20203139|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203140|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203141|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20203142|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20389110|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
19346847|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19346848|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346849|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19346850|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19346851|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
19346852|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389111|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389112|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389113|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389114|NCT01068301|Plerixafor|plerixafor|mesh-list
19346853|NCT03764293|Sorafenib|sorafenib|mesh-list
19346854|NCT03764293|Apatinib|apatinib|mesh-list
19346855|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346856|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19346857|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346858|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346859|NCT03764280|Insulin|insulin|mesh-list
19346860|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
19346861|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19346862|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346863|NCT03764267|Lidocaine|lidocaine|mesh-list
19346864|NCT03764267|Remifentanil|remifentanil|mesh-list
19346865|NCT03764267|Anesthetics|anesthetics|mesh-list
19346866|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
19346867|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
19346868|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346869|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346870|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
19684016|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
19684017|NCT02809820|Protective Agents|protective agents|mesh-ancestor
19684018|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19684019|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19843508|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19346871|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346872|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19346873|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19346874|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19346875|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19346876|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346877|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346878|NCT03764267|Narcotics|narcotics|mesh-ancestor
19346879|NCT03764267|Analgesics|analgesics|mesh-ancestor
19346880|NCT03764241|Vitamin K|vitamin k|mesh-list
19346881|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
19346882|NCT03764241|Vitamins|vitamins|mesh-ancestor
19346883|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
19346884|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346885|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19346886|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
19346887|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19346888|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
20203143|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
20203144|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203145|NCT00258596|Sirolimus|sirolimus|mesh-list
20203146|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20203147|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346889|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346890|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346891|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
19346892|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19346893|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19346894|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
20203148|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20203149|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203150|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
20203151|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203152|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
20203153|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203154|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
20203155|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20203156|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20203157|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20203158|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203159|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203160|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
20203161|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203162|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203163|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20203164|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203165|NCT00258622|Lidocaine|lidocaine|mesh-list
20203166|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
20203167|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
20203168|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20203169|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203170|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
20203171|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203172|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20203173|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20203174|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20203175|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203176|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203177|NCT00258739|Gemcitabine|gemcitabine|mesh-list
20203178|NCT00258739|Carboplatin|carboplatin|mesh-list
20203179|NCT00258739|Docetaxel|docetaxel|mesh-list
20203180|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203181|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20203182|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
20203183|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203184|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
20203185|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203186|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203187|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203188|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
20203189|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346895|NCT03764241|Coagulants|coagulants|mesh-ancestor
19346896|NCT03764202|Sufentanil|sufentanil|mesh-list
19843509|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19346897|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19346898|NCT03764202|Narcotics|narcotics|mesh-ancestor
19346899|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346900|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346901|NCT03764202|Analgesics|analgesics|mesh-ancestor
19346902|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
19346903|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346904|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19346905|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19346906|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
19346907|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
19346908|NCT03764163|Xenon|xenon|mesh-list
19346909|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19346910|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
19346911|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
19346912|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346913|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389115|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20389116|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20389117|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
19400567|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400568|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
19400569|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400570|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19400571|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19400572|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20389118|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400573|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19400574|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400575|NCT03624959|Itraconazole|itraconazole|mesh-list
19400576|NCT03624959|Rifampin|rifampin|mesh-list
19400577|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
19400578|NCT03624959|Ozanimod|ozanimod|mesh-list
19400579|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
19400580|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400581|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19400582|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19400583|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400584|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400585|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19400586|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
19400587|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400588|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400589|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19400590|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19684020|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19400591|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
19400592|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19684021|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
20203190|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
20203191|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
20203192|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
19400593|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
19400594|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19400595|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19400596|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19400597|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19400598|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19400599|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19400600|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20203193|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
20203194|NCT00258765|Docetaxel|docetaxel|mesh-list
20203195|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203196|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
20203197|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
20203198|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
20203199|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203200|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20203201|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203202|NCT00258791|Ibuprofen|ibuprofen|mesh-list
20203203|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20203204|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389119|NCT01068327|Leucovorin|leucovorin|mesh-list
19346914|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
19346915|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19346916|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346917|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
19346918|NCT03764020|Melatonin|melatonin|mesh-list
19346919|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
19346920|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346921|NCT03764020|Protective Agents|protective agents|mesh-ancestor
19346922|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346923|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19346924|NCT03763786|Cetrorelix|cetrorelix|mesh-list
19843510|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19346925|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19346926|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
19346927|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389120|NCT01068327|Gemcitabine|gemcitabine|mesh-list
20389121|NCT01068327|Nelfinavir|nelfinavir|mesh-list
19346928|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346929|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
19346930|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346931|NCT03763760|Dexamethasone|dexamethasone|mesh-list
19346932|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346933|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
19346934|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
19346935|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346936|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346937|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346938|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
19346939|NCT03763760|Hormones|hormones|mesh-ancestor
19346940|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346941|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19346942|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346943|NCT03763734|Dexamethasone|dexamethasone|mesh-list
19346944|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19346945|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
19346946|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
19346947|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19346948|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346949|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346950|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
19346951|NCT03763734|Hormones|hormones|mesh-ancestor
19346952|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19346953|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19346954|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19346955|NCT03763669|Folic Acid|folic acid|mesh-list
19346956|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
19346957|NCT03763669|Inositol|inositol|mesh-list
19346958|NCT03763669|Hematinics|hematinics|mesh-ancestor
19684022|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20389122|NCT01068327|Fluorouracil|fluorouracil|mesh-list
19346959|NCT03763669|Vitamins|vitamins|mesh-ancestor
19684023|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19684024|NCT02804022|Morphine|morphine|mesh-list
19684025|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20203205|NCT00258791|Analgesics|analgesics|mesh-ancestor
20203206|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
20203207|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203208|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203209|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19684026|NCT02804022|Narcotics|narcotics|mesh-ancestor
19684027|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684028|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684029|NCT02804022|Analgesics|analgesics|mesh-ancestor
19684030|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
19684031|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203210|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203211|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20203212|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203213|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203214|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
20203215|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20203216|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346960|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
19684032|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
19684033|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389123|NCT01068327|Calcium|calcium|mesh-list
20389124|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
20389125|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389126|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
20389127|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389128|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389129|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
20389130|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389131|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389132|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389133|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
20389134|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346961|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346962|NCT03763409|Losartan|losartan|mesh-list
19346963|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19346964|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389135|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20389136|NCT01068327|Antidotes|antidotes|mesh-ancestor
20389137|NCT01068327|Protective Agents|protective agents|mesh-ancestor
20389138|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
20389139|NCT01068327|Vitamins|vitamins|mesh-ancestor
20389140|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
20389141|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20389142|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20389143|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
20389144|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20389145|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20203217|NCT00258843|Vaccines|vaccines|mesh-list
20203218|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
20203219|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203220|NCT00259051|Omeprazole|omeprazole|mesh-list
20203221|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20203222|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203223|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20389146|NCT01068353|Etanercept|etanercept|mesh-list
19346965|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19346966|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20389147|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20389148|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389149|NCT01068353|Analgesics|analgesics|mesh-ancestor
20389150|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
20389151|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389152|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389153|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389154|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389155|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19346967|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346968|NCT03763396|Ketoconazole|ketoconazole|mesh-list
19346969|NCT03763396|Posaconazole|posaconazole|mesh-list
20203224|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203225|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203226|NCT00259064|Gefitinib|gefitinib|mesh-list
20203227|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203228|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20203229|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203230|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203231|NCT00259077|Omeprazole|omeprazole|mesh-list
20203232|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20203233|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203234|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20203235|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203236|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389156|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389157|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
20389158|NCT01068392|Prednisolone|prednisolone|mesh-list
20389159|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
19346970|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
19684034|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684035|NCT02786498|Vitamin D|vitamin d|mesh-list
19684036|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
19684037|NCT02786498|Vitamins|vitamins|mesh-ancestor
19684038|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
19684039|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684040|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19684041|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20389160|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389161|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389162|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
20389163|NCT01068392|Hormones|hormones|mesh-ancestor
20389164|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389165|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389166|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19346971|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346972|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19346973|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19346974|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389167|NCT01068405|Methotrexate|methotrexate|mesh-list
20389168|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19684042|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
19684043|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
19684044|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684045|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
19684046|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346975|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346976|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19346977|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
19346978|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203237|NCT00259116|Methocarbamol|methocarbamol|mesh-list
20203238|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20203239|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203240|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20203241|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203242|NCT00259129|Sorafenib|sorafenib|mesh-list
19684047|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203243|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203244|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20203245|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203246|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203247|NCT00259142|Chloroquine|chloroquine|mesh-list
20203248|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
20203249|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
20203250|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19346979|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346980|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19346981|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19346982|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19346983|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20203251|NCT00259142|Amebicides|amebicides|mesh-ancestor
20203252|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20203253|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20203254|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203255|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
20203256|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203257|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20203258|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203259|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203260|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20203261|NCT00259142|Renal Agents|renal agents|mesh-ancestor
20203262|NCT00259155|Rifaximin|rifaximin|mesh-list
19684048|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20203263|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20203264|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203265|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203266|NCT00259168|Nateglinide|nateglinide|mesh-list
19346984|NCT03763279|Triclosan|triclosan|mesh-list
19346985|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19346986|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19346987|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19346988|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19346989|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
19346990|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19346991|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20203267|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20203268|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346992|NCT03763227|Ranibizumab|ranibizumab|mesh-list
19346993|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
19346994|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19684049|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
19693152|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20203269|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
20203270|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20203271|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20389169|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
20389170|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389171|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389172|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389173|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
20389174|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389175|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389176|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
20389177|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19346995|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20203272|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20203273|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203274|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
20203275|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
20203276|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
20203277|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20203278|NCT00259181|Protective Agents|protective agents|mesh-ancestor
20203279|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19346996|NCT03763227|Growth Substances|growth substances|mesh-ancestor
19346997|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203280|NCT00259220|Erythromycin|erythromycin|mesh-list
20203281|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
20203282|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20203283|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
20203284|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20203285|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203286|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203287|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20389178|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19346998|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
19346999|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347000|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347001|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684050|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203288|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347002|NCT03763123|Paclitaxel|paclitaxel|mesh-list
19347003|NCT03763123|Topotecan|topotecan|mesh-list
19347004|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19347005|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347006|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347007|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347008|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347009|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347010|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19347011|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19347012|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347013|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19347014|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19347015|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347016|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
19347017|NCT03763084|Acetaminophen|acetaminophen|mesh-list
19347018|NCT03763084|Sufentanil|sufentanil|mesh-list
19347019|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19347020|NCT03763084|Analgesics|analgesics|mesh-ancestor
19347021|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
19347022|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347023|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347024|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
19347025|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19347026|NCT03763084|Narcotics|narcotics|mesh-ancestor
19347027|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347028|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19347029|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19347030|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
19347031|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
19347032|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
19347033|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
19347034|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19347035|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19347036|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347037|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203289|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203290|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
19347038|NCT03763045|Urological Agents|urological agents|mesh-ancestor
19347039|NCT03762967|Hormones|hormones|mesh-list
20389179|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389180|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
20389181|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389182|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20389183|NCT01068444|Pioglitazone|pioglitazone|mesh-list
20389184|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20389185|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389186|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20389187|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389188|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389189|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389190|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389191|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
20389192|NCT01068756|Rifampin|rifampin|mesh-list
20389193|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20389194|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389195|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20389196|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389197|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20389198|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
20389199|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20389200|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389201|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
20389202|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20389203|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389204|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20389205|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20389206|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19347040|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347041|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347042|NCT03762928|Efavirenz|efavirenz|mesh-list
19347043|NCT03762928|Midazolam|midazolam|mesh-list
19347044|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19347045|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347046|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347047|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347048|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19347049|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19347050|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19347051|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19347052|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
19347053|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
19347054|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
19347055|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
19347056|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347057|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347058|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20389207|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20389208|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20389209|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20389210|NCT01068795|Enoxaparin|enoxaparin|mesh-list
20389211|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
20389212|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20389213|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20389214|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389215|NCT01068847|Cycloserine|cycloserine|mesh-list
20389216|NCT01068847|Verapamil|verapamil|mesh-list
20389217|NCT01068847|Nifedipine|nifedipine|mesh-list
20389218|NCT01068847|Tizanidine|tizanidine|mesh-list
20389219|NCT01068847|Naloxone|naloxone|mesh-list
20389220|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20389221|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389222|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
20389223|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389224|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20389225|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426507|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19347059|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19347060|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347061|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
19347062|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347063|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19347064|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19843511|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347065|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20389226|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389227|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20389228|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389229|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
20389230|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389231|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20389232|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389233|NCT01068847|Renal Agents|renal agents|mesh-ancestor
20389234|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20389235|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
20389236|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19684051|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684052|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19684053|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684054|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19347066|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19347067|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19347068|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19347069|NCT03762889|Anesthetics|anesthetics|mesh-list
19347070|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347071|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347072|NCT03762850|Irbesartan|irbesartan|mesh-list
19347073|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19684055|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20203291|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389237|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
20389238|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20389239|NCT01068847|Analgesics|analgesics|mesh-ancestor
20389240|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
20389241|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20389242|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20203292|NCT00259376|Dronedarone|dronedarone|mesh-list
20203293|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20203294|NCT00259402|Fluorouracil|fluorouracil|mesh-list
20203295|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
20203296|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203297|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
20203298|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203299|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20203300|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203301|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
20203302|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203303|NCT00259428|Dronedarone|dronedarone|mesh-list
20203304|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20203305|NCT00259441|Simvastatin|simvastatin|mesh-list
20203306|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20203307|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20203308|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
20203309|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203310|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20203311|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20203312|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203313|NCT00259636|Zonisamide|zonisamide|mesh-list
20203314|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
19347074|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19347075|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19347076|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347077|NCT03762824|Vaccines|vaccines|mesh-list
19347078|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19347079|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
19347080|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347081|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
19347082|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347083|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347084|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347085|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19347086|NCT03762785|Analgesics|analgesics|mesh-ancestor
19347087|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
19347088|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347089|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19347090|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20203315|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20203316|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19347091|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19347092|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
19347093|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347094|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347095|NCT03762759|Edetic Acid|edetic acid|mesh-list
19347096|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20203317|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389243|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
20389244|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
19347097|NCT03762759|Anticoagulants|anticoagulants|mesh-ancestor
19347098|NCT03762759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19347099|NCT03762759|Chelating Agents|chelating agents|mesh-ancestor
19347100|NCT03762759|Sequestering Agents|sequestering agents|mesh-ancestor
19347101|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347102|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19347103|NCT03762564|Paclitaxel|paclitaxel|mesh-list
19347104|NCT03762564|Ramucirumab|ramucirumab|mesh-list
19347105|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19347106|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203318|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20203319|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203320|NCT00259662|Atorvastatin|atorvastatin|mesh-list
20203321|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20203322|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20203323|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
20203324|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347107|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347108|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347109|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347110|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347111|NCT03762538|Propofol|propofol|mesh-list
19347112|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347113|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347114|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347115|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19347116|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
19347117|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
19347118|NCT03762395|CXA-10|cxa-10|mesh-list
19347119|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347120|NCT03762382|Tenofovir|tenofovir|mesh-list
19347121|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
19347122|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
19347123|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347124|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19347125|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19347126|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347127|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347128|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19347129|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19347130|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19347131|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
19347132|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19347133|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347134|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19347135|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19347136|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19347137|NCT03762369|Latanoprost|latanoprost|mesh-list
19347138|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19347139|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19347140|NCT03762317|Clonidine|clonidine|mesh-list
19347141|NCT03762317|Analgesics|analgesics|mesh-ancestor
19347142|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
20203325|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20203326|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20203327|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203328|NCT00259675|Gemcitabine|gemcitabine|mesh-list
20203329|NCT00259675|Carboplatin|carboplatin|mesh-list
20203330|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203331|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20203332|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
20203333|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203334|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
19347143|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684056|NCT02744612|Antibodies|antibodies|mesh-list
19347144|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347145|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19347146|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
19347147|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
19347148|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19347149|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19347150|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19347151|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
19347152|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347153|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400601|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20203335|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203336|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203337|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203338|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
20203339|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684057|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
19684058|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19684059|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
20203340|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
20203341|NCT00259701|Acetylcholine|acetylcholine|mesh-list
20203342|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
20203343|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20203344|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
20203345|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400602|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400603|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
19400604|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20203346|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400605|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
19400606|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19400607|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19400608|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
19400609|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19400610|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400611|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400612|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19400613|NCT03624595|Analgesics|analgesics|mesh-ancestor
19400614|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
19400615|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400616|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20203347|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203348|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
20203349|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20217720|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217721|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20217722|NCT00310128|Protective Agents|protective agents|mesh-ancestor
20217723|NCT00310141|Nicotine|nicotine|mesh-list
20217724|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20217725|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
20217726|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217727|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217728|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20217729|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19400617|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400618|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400619|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400620|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400621|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400622|NCT03624322|Olanzapine|olanzapine|mesh-list
19400623|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
19400624|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
19400625|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400626|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400627|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400628|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19400629|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19400630|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400631|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400632|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19400633|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19684060|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
20217730|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
20217731|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347154|NCT03762226|Bevacizumab|bevacizumab|mesh-list
19684061|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684062|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684063|NCT02729116|Ertapenem|ertapenem|mesh-list
19684064|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
19684065|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19684066|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684067|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19684068|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19684069|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347155|NCT03762226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389245|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20389246|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20389247|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20389248|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
20389249|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389250|NCT01068925|Dolutegravir|dolutegravir|mesh-list
20389251|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20389252|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20389253|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389254|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389255|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20389256|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20389257|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
20389258|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389259|NCT01068977|Bevacizumab|bevacizumab|mesh-list
20389260|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20389261|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389262|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389263|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20389264|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20389265|NCT01068977|Growth Substances|growth substances|mesh-ancestor
20389266|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684070|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347156|NCT03762226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347157|NCT03762226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19347158|NCT03762226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19347159|NCT03762226|Growth Substances|growth substances|mesh-ancestor
19347160|NCT03762226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347161|NCT03762226|Growth Inhibitors|growth inhibitors|mesh-ancestor
19347162|NCT03762148|Vitamins|vitamins|mesh-list
19347163|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
19347164|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
19347165|NCT03762148|Iron|iron|mesh-list
19347166|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
19347167|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347168|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
19347169|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347170|NCT03762148|Protective Agents|protective agents|mesh-ancestor
19347171|NCT03762148|Trace Elements|trace elements|mesh-ancestor
19684071|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203350|NCT00259766|Budesonide|budesonide|mesh-list
20389267|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
20389268|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
20389269|NCT01069042|Enalapril|enalapril|mesh-list
20203351|NCT00259766|Terbutaline|terbutaline|mesh-list
20203352|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
20203353|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203354|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20203355|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
20203356|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203357|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203358|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20203359|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
20203360|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
20203361|NCT00259766|Hormones|hormones|mesh-ancestor
20203362|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203363|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20203364|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20203365|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20389270|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20389271|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19347172|NCT03762096|Resveratrol|resveratrol|mesh-list
19684072|NCT02675959|Defibrotide|defibrotide|mesh-list
20203366|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
19347173|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
19843512|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843513|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
19843514|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20389272|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389273|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389274|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389275|NCT01069055|Acetaminophen|acetaminophen|mesh-list
20389276|NCT01069055|Lornoxicam|lornoxicam|mesh-list
20389277|NCT01069055|Piroxicam|piroxicam|mesh-list
20389278|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389279|NCT01069055|Analgesics|analgesics|mesh-ancestor
20389280|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
20389281|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389282|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389283|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
20389284|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20389285|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347174|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347175|NCT03762096|Protective Agents|protective agents|mesh-ancestor
19347176|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347177|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347178|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19347179|NCT03761511|Niacinamide|niacinamide|mesh-list
19347180|NCT03761511|Niacin|niacin|mesh-list
19347181|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
19347182|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
19347183|NCT03761511|Vitamins|vitamins|mesh-ancestor
19347184|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
19347185|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347186|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20389286|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389287|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20389288|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389289|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389290|NCT01069081|Cisplatin|cisplatin|mesh-list
20389291|NCT01069081|Docetaxel|docetaxel|mesh-list
19347187|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
19843515|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
19843516|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19843517|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20203367|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347188|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347189|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19347190|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
19347191|NCT03761485|Fluorides|fluorides|mesh-list
19347192|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
19347193|NCT03761485|Protective Agents|protective agents|mesh-ancestor
19347194|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347195|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
19347196|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19347197|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
19347198|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347199|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
19347200|NCT03761472|Protective Agents|protective agents|mesh-ancestor
19347201|NCT03761329|Lidocaine|lidocaine|mesh-list
19347202|NCT03761329|Anesthetics|anesthetics|mesh-list
19347203|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19347204|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347205|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347206|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
19347207|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203368|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203369|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
20203370|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
20203371|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20203372|NCT00259779|Prednisolone|prednisolone|mesh-list
20203373|NCT00259779|Budesonide|budesonide|mesh-list
20203374|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
20203375|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203376|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
20389292|NCT01069081|Esomeprazole|esomeprazole|mesh-list
20389293|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347208|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19843518|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
20389294|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347209|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20203377|NCT00259779|Hormones|hormones|mesh-ancestor
19347210|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19347211|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19347212|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347213|NCT03761264|Amoxicillin|amoxicillin|mesh-list
19347214|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
19347215|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684073|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19684074|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20203378|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203379|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684075|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684076|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19684077|NCT02675426|Upadacitinib|upadacitinib|mesh-list
19684078|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19684079|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19684080|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684081|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684082|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684083|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
19347216|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347217|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347218|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
19347219|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
19347220|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19347221|NCT03761264|Protective Agents|protective agents|mesh-ancestor
19347222|NCT03761004|Levodopa|levodopa|mesh-list
19347223|NCT03761004|Carbidopa|carbidopa|mesh-list
19347224|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19347225|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19347226|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19347227|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
19347228|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347229|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347230|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347231|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19347232|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347233|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19347234|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
19684084|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684085|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684086|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
19684087|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389295|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389296|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389297|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389298|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20389299|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389300|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20389301|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389302|NCT01069094|Leuprolide|leuprolide|mesh-list
19684088|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684089|NCT02632448|Gemcitabine|gemcitabine|mesh-list
19684090|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19684091|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
20203380|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20203381|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203382|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
20203383|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203384|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20203385|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20203386|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
20203387|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20203388|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20203389|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20203390|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
20203391|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203392|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203393|NCT00259792|Budesonide|budesonide|mesh-list
20203394|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
20203395|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389303|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20389304|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
19347235|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
20203396|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20203397|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
20203398|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203399|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203400|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20203401|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
20203402|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
20203403|NCT00259792|Hormones|hormones|mesh-ancestor
19684092|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684093|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684094|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
19684095|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347236|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
19347237|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347238|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347239|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347240|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19347241|NCT03760978|Analgesics|analgesics|mesh-ancestor
19347242|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
19347243|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684096|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684097|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684098|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
19684099|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684100|NCT02597660|Hormones|hormones|mesh-list
19843519|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843520|NCT00659438|Bicalutamide|bicalutamide|mesh-list
19684101|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684102|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843521|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
20203404|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347244|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19347245|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19347246|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19347247|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
19347248|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347249|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347250|NCT03760848|Midazolam|midazolam|mesh-list
19347251|NCT03760848|Atorvastatin|atorvastatin|mesh-list
19347252|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20203405|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20203406|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20203407|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20203408|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
20203409|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203410|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203411|NCT00259805|Rituximab|rituximab|mesh-list
19347253|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19347254|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
19347255|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347256|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19347257|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19347258|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347259|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19347260|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20389305|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19347261|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347262|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347263|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19347264|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19347265|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19347266|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19347267|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
19347268|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
19347269|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
19347270|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
20203412|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203413|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203414|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
20203415|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203416|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203417|NCT00259870|Olanzapine|olanzapine|mesh-list
20203418|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
20203419|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
20203420|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203421|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203422|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203423|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20203424|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20203425|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20203426|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203427|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20203428|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20203429|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19347271|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347272|NCT03760822|Paclitaxel|paclitaxel|mesh-list
19347273|NCT03760822|Ramucirumab|ramucirumab|mesh-list
19347274|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19347275|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347276|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347277|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389306|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389307|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20389308|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389309|NCT01069133|Rifaximin|rifaximin|mesh-list
19347278|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347279|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347280|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
19347281|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347282|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347283|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347284|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19347285|NCT03760809|Analgesics|analgesics|mesh-ancestor
19347286|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
19684103|NCT02592707|Dexamethasone|dexamethasone|mesh-list
19684104|NCT02592707|Ondansetron|ondansetron|mesh-list
20203430|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203431|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203432|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
20203433|NCT00259883|Paroxetine|paroxetine|mesh-list
20389310|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347287|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347288|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19347289|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19347290|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19347291|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
19347292|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347293|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347294|NCT03760770|Riboflavin|riboflavin|mesh-list
19347295|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
19347296|NCT03760770|Vitamins|vitamins|mesh-ancestor
19347297|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
19347298|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347299|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19347300|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
19347301|NCT03760666|Ribavirin|ribavirin|mesh-list
19347302|NCT03760666|Brequinar|brequinar|mesh-list
19347303|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
19347304|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347305|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
20389311|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389312|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389313|NCT01069159|Propranolol|propranolol|mesh-list
20389314|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20389315|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20389316|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
20389317|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203434|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20203435|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20203436|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203437|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389318|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389319|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347306|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389320|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19347307|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684105|NCT02592707|Antiemetics|antiemetics|mesh-list
20389321|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389322|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389323|NCT01069198|Vitamin A|vitamin a|mesh-list
20389324|NCT01069198|Albendazole|albendazole|mesh-list
20203438|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684106|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19684107|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19684108|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
19684109|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684110|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347308|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347309|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19347310|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
19347311|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347312|NCT03760614|Entinostat|entinostat|mesh-list
19347313|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347314|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19684111|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684112|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
19684113|NCT02592707|Hormones|hormones|mesh-ancestor
19684114|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684115|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20389325|NCT01069198|Vitamins|vitamins|mesh-ancestor
20389326|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
20389327|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389328|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389329|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389330|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
20389331|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20389332|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389333|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
19684116|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684117|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684118|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
20203439|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
20389334|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20389335|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20389336|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
20389337|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389338|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389339|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20389340|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20389341|NCT01069263|Protective Agents|protective agents|mesh-ancestor
20203440|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203441|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20203442|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
20203443|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203444|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20203445|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20203446|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203447|NCT00259896|Exenatide|exenatide|mesh-list
20203448|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20203449|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203450|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20203451|NCT00259896|Incretins|incretins|mesh-ancestor
20203452|NCT00259896|Hormones|hormones|mesh-ancestor
20203453|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203454|NCT00259922|Alvimopan|alvimopan|mesh-list
20203455|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203456|NCT00259935|Topotecan|topotecan|mesh-list
20203457|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20203458|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20203459|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203460|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203461|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203462|NCT00259974|Rituximab|rituximab|mesh-list
20203463|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203464|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203465|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
20389342|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389343|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19347315|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347316|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389344|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
20203466|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684119|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19684120|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19347317|NCT03760588|Valsartan|valsartan|mesh-list
19347318|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19347319|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19347320|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19347321|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347322|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
19347323|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347324|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347325|NCT03760445|Cytarabine|cytarabine|mesh-list
19347326|NCT03760445|Posaconazole|posaconazole|mesh-list
19347327|NCT03760445|Daunorubicin|daunorubicin|mesh-list
19347328|NCT03760445|Idarubicin|idarubicin|mesh-list
19684121|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
19684122|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843522|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
19843523|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843524|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843525|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843526|NCT00659490|Naproxen|naproxen|mesh-list
20203467|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203468|NCT00259987|Lapatinib|lapatinib|mesh-list
20203469|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203470|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20203471|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203472|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203473|NCT00260026|Docetaxel|docetaxel|mesh-list
20203474|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203475|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
20203476|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347329|NCT03760445|Midostaurin|midostaurin|mesh-list
19347330|NCT03760445|Midazolam|midazolam|mesh-list
19347331|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19347332|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
19347333|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347334|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347335|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
19347336|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347337|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19347338|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
19347339|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347340|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19347341|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347342|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347343|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19347344|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19347345|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19347346|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19347347|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
19347348|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
19684123|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20203477|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
20203478|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203479|NCT00260039|Vaccines|vaccines|mesh-list
20203480|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
20203481|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203482|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
20203483|NCT00260052|Hematinics|hematinics|mesh-ancestor
20203484|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
20203485|NCT00260143|Testosterone|testosterone|mesh-list
20203486|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
20203487|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
20203488|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20203489|NCT00260143|Androgens|androgens|mesh-ancestor
19347349|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
19347350|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
19347351|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684124|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19684125|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684126|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19684127|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19684128|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
19684129|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
19347352|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19684130|NCT02575339|Sorafenib|sorafenib|mesh-list
20203490|NCT00260143|Hormones|hormones|mesh-ancestor
19347353|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19347354|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19347355|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347356|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
20203491|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203492|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203493|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20203494|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203495|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
20203496|NCT00260247|Carbamazepine|carbamazepine|mesh-list
20203497|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
20203498|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
20203499|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
20203500|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20203501|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426508|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203502|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203503|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203504|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19347357|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19347358|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19347359|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19347360|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20203505|NCT00260247|Analgesics|analgesics|mesh-ancestor
20203506|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
20203507|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203508|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20203509|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203510|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203511|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19347361|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19347362|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19347363|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
19347364|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347365|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19347366|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
19347367|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19347368|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19347369|NCT03760354|Prednisolone|prednisolone|mesh-list
19347370|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
19347371|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19347372|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
19347373|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347374|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
19347375|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
19347376|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347377|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347378|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19347379|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
19347380|NCT03760354|Hormones|hormones|mesh-ancestor
19347381|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347382|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19347383|NCT03760354|Protective Agents|protective agents|mesh-ancestor
19347384|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19347385|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347386|NCT03760302|Analgesics|analgesics|mesh-list
19347387|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19347388|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
19347389|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347390|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347391|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347392|NCT03760276|Voriconazole|voriconazole|mesh-list
19347393|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
19347394|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347395|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19347396|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20203512|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20203513|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20203514|NCT00260260|Oxycodone|oxycodone|mesh-list
20203515|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20203516|NCT00260260|Narcotics|narcotics|mesh-ancestor
20203517|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20203518|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203519|NCT00260260|Analgesics|analgesics|mesh-ancestor
20203520|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
20203521|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203522|NCT00260325|Valdecoxib|valdecoxib|mesh-list
20203523|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20203524|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20389345|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389346|NCT01069302|Clopidogrel|clopidogrel|mesh-list
19843527|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19843528|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19843529|NCT00659490|Analgesics|analgesics|mesh-ancestor
19843530|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
19347397|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347398|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347399|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19347400|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
19347401|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347402|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347403|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20203525|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203526|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203527|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20203528|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20203529|NCT00260325|Analgesics|analgesics|mesh-ancestor
20203530|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
20203531|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347411|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19347412|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19347413|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347414|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347415|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19347416|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19347417|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347418|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
19347419|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400634|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19843531|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389347|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19400635|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400636|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400637|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
20203532|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203533|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203534|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203535|NCT00260351|Vaccines|vaccines|mesh-list
20203536|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
20203537|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203538|NCT00260364|Gemcitabine|gemcitabine|mesh-list
20203539|NCT00260364|Bevacizumab|bevacizumab|mesh-list
20389348|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19684131|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684132|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19684133|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684134|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684135|NCT02537314|Benzocaine|benzocaine|mesh-list
19684136|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
20389349|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20389350|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20389351|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
19400638|NCT03624309|Docetaxel|docetaxel|mesh-list
19400639|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400640|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
19400641|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
19400642|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
19400643|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684137|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
19400644|NCT03624283|Betahistine|betahistine|mesh-list
19400645|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
19400646|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
19684138|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20203540|NCT00260364|Capecitabine|capecitabine|mesh-list
20203541|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20389352|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347420|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
19347421|NCT03759938|Apixaban|apixaban|mesh-list
19347422|NCT03759938|Edoxaban|edoxaban|mesh-list
19347423|NCT03759938|Dabigatran|dabigatran|mesh-list
19684139|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684140|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
19684141|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684142|NCT02535078|Durvalumab|durvalumab|mesh-list
19684143|NCT02535078|Tremelimumab|tremelimumab|mesh-list
19684144|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684145|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684146|NCT02530034|Antibodies|antibodies|mesh-list
19684147|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19684148|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
19684149|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684150|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
20389353|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389354|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389355|NCT01069328|Paclitaxel|paclitaxel|mesh-list
20389356|NCT01069328|Bevacizumab|bevacizumab|mesh-list
20389357|NCT01069328|Carboplatin|carboplatin|mesh-list
20389358|NCT01069328|Sorafenib|sorafenib|mesh-list
20389359|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20389360|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389361|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
20389362|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389363|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389364|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389365|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389366|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20389367|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20389368|NCT01069328|Growth Substances|growth substances|mesh-ancestor
20389369|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389370|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
19684151|NCT02499003|Pixantrone|pixantrone|mesh-list
19684152|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684153|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684154|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19684155|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20203542|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203543|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203544|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20203545|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20203546|NCT00260364|Growth Substances|growth substances|mesh-ancestor
20203547|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203548|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
20203549|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20203550|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
19347424|NCT03759938|Anticoagulants|anticoagulants|mesh-list
19347425|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19347426|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
19347427|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19347428|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
19347429|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347430|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347431|NCT03759886|Metronidazole|metronidazole|mesh-list
19347432|NCT03759886|Paromomycin|paromomycin|mesh-list
19347433|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347434|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347435|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20203551|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203552|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
19684156|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684157|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684158|NCT02498444|Treprostinil|treprostinil|mesh-list
19684159|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19684160|NCT02487108|Acetaminophen|acetaminophen|mesh-list
19347436|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19347437|NCT03759860|Ranibizumab|ranibizumab|mesh-list
19684161|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19684162|NCT02487108|Hydrocodone|hydrocodone|mesh-list
19684163|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19684164|NCT02487108|Analgesics|analgesics|mesh-ancestor
19347438|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19347439|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19684165|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
19684166|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684167|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684168|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
19684169|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19347440|NCT03759860|Growth Substances|growth substances|mesh-ancestor
19347441|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347442|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
19347443|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347444|NCT03759782|Tenofovir|tenofovir|mesh-list
19347445|NCT03759782|Ribavirin|ribavirin|mesh-list
19684170|NCT02487108|Narcotics|narcotics|mesh-ancestor
20203553|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203554|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203555|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203556|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
20203557|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20203558|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
20203559|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20203560|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203561|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
20203562|NCT00260390|Hormones|hormones|mesh-ancestor
19684171|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684172|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
19684173|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
19684174|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19684175|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347446|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
19347447|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347448|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19347449|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19347450|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347451|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347452|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19347453|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19347454|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
19347455|NCT03759353|Lactoferrin|lactoferrin|mesh-list
19347456|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347457|NCT03759301|Cetrorelix|cetrorelix|mesh-list
19347458|NCT03759301|Hormones|hormones|mesh-list
19347459|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347460|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347461|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19347462|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
19347463|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389371|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389372|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684176|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684177|NCT02455557|Temozolomide|temozolomide|mesh-list
19684178|NCT02455557|Sargramostim|sargramostim|mesh-list
19684179|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20203563|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203564|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203565|NCT00260416|Abciximab|abciximab|mesh-list
20389373|NCT01069536|Metoclopramide|metoclopramide|mesh-list
20389374|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
19347464|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
19347465|NCT03759262|Vitamin D|vitamin d|mesh-list
19347466|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
19684180|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
20203566|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
20203567|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20203568|NCT00260520|Dalteparin|dalteparin|mesh-list
20203569|NCT00260520|Tinzaparin|tinzaparin|mesh-list
20203570|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20203571|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
20203572|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20203573|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20203574|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203575|NCT00260611|Docetaxel|docetaxel|mesh-list
20203576|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
20203577|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347467|NCT03759262|Vitamins|vitamins|mesh-ancestor
20203578|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
20203579|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347468|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
20203580|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389375|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
20389376|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389377|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347469|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347470|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19347471|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19347472|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
19347473|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19347474|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
19347475|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347476|NCT03759158|Expectorants|expectorants|mesh-ancestor
19347477|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
19347478|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19347479|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
19347480|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347481|NCT03759158|Protective Agents|protective agents|mesh-ancestor
19347482|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347483|NCT03759158|Antidotes|antidotes|mesh-ancestor
19347484|NCT03759093|Thalidomide|thalidomide|mesh-list
19347485|NCT03759093|Dexamethasone|dexamethasone|mesh-list
19347486|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
19347487|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
19347488|NCT03759093|Bortezomib|bortezomib|mesh-list
19347489|NCT03759093|BB 1101|bb 1101|mesh-list
19347490|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389378|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389379|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20389380|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20389381|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
19347491|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
19347492|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347493|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19347494|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19347495|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
20203581|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203582|NCT00260624|Citalopram|citalopram|mesh-list
20203583|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20203584|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20203585|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203586|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203587|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203588|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
20203589|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203590|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19843532|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843533|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19843534|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19843535|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
19843536|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19843537|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843538|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843539|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
19843540|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
20203591|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
20203592|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203593|NCT00260702|Omalizumab|omalizumab|mesh-list
20203594|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20203595|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20203596|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
20203597|NCT00260793|Ropinirole|ropinirole|mesh-list
20203598|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19843541|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19843542|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19843543|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843544|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843545|NCT00659529|Urological Agents|urological agents|mesh-ancestor
20203599|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20203600|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
19843546|NCT00659581|Telmisartan|telmisartan|mesh-list
20203601|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
20203602|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203603|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389382|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347496|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426509|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19347497|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347498|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19347499|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347500|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
19347501|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
19347502|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347503|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19347504|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
19347505|NCT03759093|Hormones|hormones|mesh-ancestor
19347506|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347507|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19347508|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
19347509|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347510|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
19347511|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347512|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347513|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19347514|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19347515|NCT03759093|Growth Substances|growth substances|mesh-ancestor
19347516|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
19347517|NCT03759067|Clopidogrel|clopidogrel|mesh-list
19347518|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19347519|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19347520|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19347521|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19347522|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
19347523|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347524|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347525|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347526|NCT03758989|Prednisone|prednisone|mesh-list
19347527|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
19347528|NCT03758989|Rituximab|rituximab|mesh-list
19347529|NCT03758989|Doxorubicin|doxorubicin|mesh-list
19347530|NCT03758989|Vincristine|vincristine|mesh-list
19347531|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19347532|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
19347533|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347534|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19347535|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19347536|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
19347537|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347538|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347539|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19347540|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19347541|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19347542|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19347543|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19347544|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347545|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347546|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
20203604|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203605|NCT00260819|Bosentan|bosentan|mesh-list
20203606|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20203607|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20203608|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203609|NCT00260988|Dalteparin|dalteparin|mesh-list
20203610|NCT00260988|Tinzaparin|tinzaparin|mesh-list
20203611|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20203612|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
20203613|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20203614|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20203615|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203616|NCT00261027|Exemestane|exemestane|mesh-list
20203617|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203618|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20203619|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20203620|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203621|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203622|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20203623|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
20203624|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347547|NCT03758989|Hormones|hormones|mesh-ancestor
19400647|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
19347548|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347549|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19347550|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19347551|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347552|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347553|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347554|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
19347555|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347556|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
19347557|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19347558|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19347559|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
19347560|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19347561|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
19347562|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347563|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
19347564|NCT03758859|Protective Agents|protective agents|mesh-ancestor
19347565|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19347566|NCT03758729|Nivolumab|nivolumab|mesh-list
19347567|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19347568|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347569|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19347570|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347571|NCT03758677|Gemcitabine|gemcitabine|mesh-list
19347572|NCT03758677|Docetaxel|docetaxel|mesh-list
19347573|NCT03758677|Pemetrexed|pemetrexed|mesh-list
19347574|NCT03758677|Apatinib|apatinib|mesh-list
19347575|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19347576|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
19347577|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347578|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347579|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
19347580|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347581|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347582|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19347583|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
20426510|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
19347584|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347585|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347586|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347587|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347588|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19347589|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19347590|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19347591|NCT03758469|Rifampin|rifampin|mesh-list
19347592|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19347593|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
19347594|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347595|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347596|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
19347597|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19347598|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347599|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347600|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19347601|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19347602|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19347603|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19347604|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19347605|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19347606|NCT03758339|Tucatinib|tucatinib|mesh-list
19347607|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347608|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19347609|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347610|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203625|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203626|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20203627|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20203628|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203629|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
20203630|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203631|NCT00261079|Fexofenadine|fexofenadine|mesh-list
20203632|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20203633|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19347611|NCT03758287|Gefitinib|gefitinib|mesh-list
19347612|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347613|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19347614|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347615|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347616|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19347617|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19347618|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19347619|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19347620|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347621|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347622|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20389383|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426511|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426512|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426513|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426514|NCT01281579|Canagliflozin|canagliflozin|mesh-list
20426515|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20426516|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347623|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19347624|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347625|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
19347626|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347627|NCT03758144|Rifaximin|rifaximin|mesh-list
19347628|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347629|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347630|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19347631|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19347632|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
19400648|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400649|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400650|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400651|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
19400652|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
19400653|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
19400654|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400655|NCT03624270|Protective Agents|protective agents|mesh-ancestor
19400656|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400657|NCT03624270|Vitamins|vitamins|mesh-ancestor
19400658|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
19400659|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400660|NCT03624244|Letrozole|letrozole|mesh-list
19400661|NCT03624244|Exemestane|exemestane|mesh-list
19400662|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19400663|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400664|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19400665|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400666|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400667|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19400668|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
20426517|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20426518|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400669|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400670|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400671|NCT03624231|Durvalumab|durvalumab|mesh-list
19400672|NCT03624231|Tremelimumab|tremelimumab|mesh-list
19400673|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19400674|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400675|NCT03624205|Paclitaxel|paclitaxel|mesh-list
19400676|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19400677|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400678|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
19400679|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
19400680|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
19400681|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400682|NCT03624166|Ketamine|ketamine|mesh-list
19400683|NCT03624166|Anesthetics|anesthetics|mesh-list
19400684|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
19400685|NCT03624166|Analgesics|analgesics|mesh-ancestor
19400686|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
19400687|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400688|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400689|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20203634|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20203635|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
20203636|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
20203637|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203638|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347633|NCT03758079|Gabapentin|gabapentin|mesh-list
19347634|NCT03758079|Doxepin|doxepin|mesh-list
19347635|NCT03758079|Analgesics|analgesics|mesh-ancestor
19347636|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
19347637|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347638|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347639|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
19347640|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19347641|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20203639|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203640|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
20203641|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203642|NCT00261105|Telithromycin|telithromycin|mesh-list
20203643|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20203644|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203645|NCT00261118|Rituximab|rituximab|mesh-list
19347642|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347643|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19347644|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19347645|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19347646|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347647|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347648|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
19347649|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19347650|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347651|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19347652|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
19347653|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
19347654|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
19347655|NCT03758014|Lomustine|lomustine|mesh-list
19347656|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19347657|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
19347658|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347659|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347660|NCT03757923|Metformin|metformin|mesh-list
19347661|NCT03757923|Pioglitazone|pioglitazone|mesh-list
19347662|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19347663|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347664|NCT03757910|Corticosterone|corticosterone|mesh-list
19347665|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347680|NCT03757858|Antibodies|antibodies|mesh-list
19347681|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
19347682|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203646|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203647|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203648|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
20203649|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203650|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203651|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
20203652|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20203653|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20203654|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20203655|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203656|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347683|NCT03757650|Amoxicillin|amoxicillin|mesh-list
20203657|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
19347684|NCT03757650|Clarithromycin|clarithromycin|mesh-list
19347685|NCT03757650|Omeprazole|omeprazole|mesh-list
19347686|NCT03757650|Bismuth|bismuth|mesh-list
19347687|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19347688|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347689|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347690|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19347691|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19347692|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19347693|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347694|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347695|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19347696|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19347697|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19347698|NCT03757650|Antacids|antacids|mesh-ancestor
19347699|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
19347700|NCT03757585|Inositol|inositol|mesh-list
19347701|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
19347702|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19347703|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
19347704|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347705|NCT03757585|Expectorants|expectorants|mesh-ancestor
19347706|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
19347707|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19347708|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
19347709|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347710|NCT03757585|Protective Agents|protective agents|mesh-ancestor
19347711|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347712|NCT03757585|Antidotes|antidotes|mesh-ancestor
19347713|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
19347714|NCT03757585|Vitamins|vitamins|mesh-ancestor
19347715|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
19347716|NCT03757559|Hydromorphone|hydromorphone|mesh-list
19347717|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19347718|NCT03757559|Narcotics|narcotics|mesh-ancestor
19347719|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347720|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347721|NCT03757559|Analgesics|analgesics|mesh-ancestor
19347722|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
19347723|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347724|NCT03757403|Mebendazole|mebendazole|mesh-list
19347725|NCT03757403|Piperazine|piperazine|mesh-list
19843547|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19347726|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
19347727|NCT03757403|DMP 777|dmp 777|mesh-list
19347728|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
19347729|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
19347730|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19347731|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347732|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347733|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347734|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347735|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347736|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347737|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843548|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19843549|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19843550|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843551|NCT00659633|Lidocaine|lidocaine|mesh-list
19843552|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
19843553|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
20203658|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203659|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203660|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20203661|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203662|NCT00261170|Bupropion|bupropion|mesh-list
20203663|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20203664|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
20203665|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203666|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20203667|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20203668|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203669|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426519|NCT01281605|Insulin|insulin|mesh-list
19347738|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19347739|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19347740|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20203670|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
19347741|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20203671|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203672|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203673|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20203674|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20203675|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203676|NCT00261183|Melatonin|melatonin|mesh-list
20203677|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
20203678|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203679|NCT00261183|Protective Agents|protective agents|mesh-ancestor
20203680|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203681|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389384|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20389385|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203682|NCT00261222|Amodiaquine|amodiaquine|mesh-list
20203683|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
20203684|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20203685|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20203686|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203687|NCT00261248|Vaccines|vaccines|mesh-list
19347742|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
19347743|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347744|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19347745|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19347746|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347747|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19347748|NCT03757364|Methotrexate|methotrexate|mesh-list
19347749|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19347750|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
19347751|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19347752|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347753|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19347754|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
19347755|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347756|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347757|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
19347758|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347759|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19347760|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19347761|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
19347762|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19347763|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19347764|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19347765|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19347766|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347767|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19347768|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
19347769|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347770|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
19347771|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19347772|NCT03757221|Daratumumab|daratumumab|mesh-list
19347773|NCT03757221|Ixazomib|ixazomib|mesh-list
19347774|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347775|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
19347776|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347777|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347778|NCT03757156|Aspirin|aspirin|mesh-list
19347779|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20203688|NCT00261248|Immunologic Factors|immunologic factors|mesh-ancestor
20203689|NCT00261248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203690|NCT00261261|Midazolam|midazolam|mesh-list
20203691|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20203692|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20203693|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20203694|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203695|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20203696|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20203697|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203698|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20203699|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
20203700|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
19684181|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389386|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389387|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389388|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389389|NCT01069770|Sunitinib|sunitinib|mesh-list
20389390|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389391|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20389392|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20389393|NCT01069770|Growth Substances|growth substances|mesh-ancestor
20389394|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389395|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
20203701|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
20203702|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
20203703|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203704|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217732|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217733|NCT00310154|Docetaxel|docetaxel|mesh-list
19347780|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19347781|NCT03757156|Analgesics|analgesics|mesh-ancestor
19347782|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
19347783|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347784|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347785|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19347786|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19347787|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19347788|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19347789|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347790|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19347791|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19347792|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347793|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
19347794|NCT03757143|Ethanol|ethanol|mesh-list
19347795|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
19347796|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
19347797|NCT03757143|Povidone|povidone|mesh-list
19347798|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19347799|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347800|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347801|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347802|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
19347803|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
19347804|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
19347805|NCT03757117|Hormones|hormones|mesh-list
19347806|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347807|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684182|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217734|NCT00310154|Gefitinib|gefitinib|mesh-list
20217735|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217736|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
20389396|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389397|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389398|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389399|NCT01069796|Paclitaxel|paclitaxel|mesh-list
20389400|NCT01069796|Bevacizumab|bevacizumab|mesh-list
20389401|NCT01069796|Capecitabine|capecitabine|mesh-list
20389402|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20389403|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389404|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
20389405|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389406|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347808|NCT03757052|Amoxicillin|amoxicillin|mesh-list
19347809|NCT03757052|Penicillins|penicillins|mesh-list
19684183|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
20217737|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
20217738|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
20217739|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217740|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20217741|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217742|NCT00310206|Vaccines|vaccines|mesh-list
20217743|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
20426520|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19347810|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347811|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684184|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684185|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
19684186|NCT02455141|Carboplatin|carboplatin|mesh-list
19684187|NCT02455141|Epirubicin|epirubicin|mesh-list
19684188|NCT02455141|Taxane|taxane|mesh-list
20389407|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389408|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389409|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19843554|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843555|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843556|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
19843557|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389410|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20389411|NCT01069796|Growth Substances|growth substances|mesh-ancestor
20389412|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389413|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
20389414|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389415|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
20389416|NCT01069822|Midazolam|midazolam|mesh-list
20389417|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20389418|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20389419|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843558|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19843559|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19843560|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19684189|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203705|NCT00261287|Ciclesonide|ciclesonide|mesh-list
20203706|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
20203707|NCT00261287|Hormones|hormones|mesh-ancestor
19843561|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19843562|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843563|NCT00659737|Scopolamine|scopolamine|mesh-list
19843564|NCT00659737|Aprepitant|aprepitant|mesh-list
20203708|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389420|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389421|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20203709|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203710|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20203711|NCT00261300|Pantoprazole|pantoprazole|mesh-list
20203712|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20203713|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389422|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20389423|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20389424|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20389425|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
20389426|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
19347812|NCT03756987|Ropivacaine|ropivacaine|mesh-list
19347813|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
19347814|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
20389427|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
20389428|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
20389429|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389430|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389431|NCT01069874|Vitamin D|vitamin d|mesh-list
20389432|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
20389433|NCT01069874|Vitamins|vitamins|mesh-ancestor
20389434|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
20389435|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389436|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20389437|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19347815|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347816|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347817|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
19347818|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347819|NCT03756896|Dexamethasone|dexamethasone|mesh-list
19347820|NCT03756896|Pomalidomide|pomalidomide|mesh-list
19684190|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
19684191|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684192|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684193|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19684194|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
19684195|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684196|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684197|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19684198|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19684199|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19684200|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19684201|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347821|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389438|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20389439|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
20389440|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389441|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
20389442|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389443|NCT01069965|BGP 15|bgp 15|mesh-list
20389444|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389445|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389446|NCT01070030|Amlodipine|amlodipine|mesh-list
20389447|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20389448|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389449|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20389450|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20389451|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389452|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20389453|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389454|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389455|NCT01070030|Diuretics|diuretics|mesh-ancestor
20389456|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
20389457|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20389458|NCT01070108|Ketamine|ketamine|mesh-list
20389459|NCT01070108|Analgesics|analgesics|mesh-ancestor
20389460|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
20389461|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389462|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389463|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20389464|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20389465|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
20389466|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
20389467|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389468|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20389469|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20426521|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
19347822|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
19347823|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
19347824|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347825|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347826|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19347827|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
19347828|NCT03756896|Hormones|hormones|mesh-ancestor
19347829|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347830|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19347831|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347832|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
19347833|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19347834|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19347835|NCT03756896|Growth Substances|growth substances|mesh-ancestor
19347836|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
19347837|NCT03756818|Paclitaxel|paclitaxel|mesh-list
19347838|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19347839|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19347840|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347841|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347842|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684202|NCT02439385|Curcumin|curcumin|mesh-list
20203714|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20203715|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203716|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203717|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
20203718|NCT00261313|Hematinics|hematinics|mesh-ancestor
20203719|NCT00261326|Simvastatin|simvastatin|mesh-list
20203720|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20203721|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20203722|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
20203723|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203724|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20203725|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20203726|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203727|NCT00261339|Pantoprazole|pantoprazole|mesh-list
20203728|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20203729|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203730|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20203731|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347843|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
20217744|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389470|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389471|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389472|NCT01070160|Metformin|metformin|mesh-list
20389473|NCT01070160|Progesterone|progesterone|mesh-list
20389474|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20389475|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389476|NCT01070160|Progestins|progestins|mesh-ancestor
20389477|NCT01070160|Hormones|hormones|mesh-ancestor
20389478|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389479|NCT01070186|Sunitinib|sunitinib|mesh-list
20389480|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389481|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20389482|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20203732|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203733|NCT00261352|Metformin|metformin|mesh-list
20203734|NCT00261352|Fenofibrate|fenofibrate|mesh-list
20203735|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20203736|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203737|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20203738|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
20203739|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203740|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20203741|NCT00261365|Ipilimumab|ipilimumab|mesh-list
20203742|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203743|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203744|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20203745|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347844|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347845|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
19347846|NCT03756727|Vitamins|vitamins|mesh-ancestor
19347847|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
19347848|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347849|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
19347850|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347851|NCT03756727|Protective Agents|protective agents|mesh-ancestor
19347852|NCT03756623|Metformin|metformin|mesh-list
19684203|NCT02439385|Bevacizumab|bevacizumab|mesh-list
19684204|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684205|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203746|NCT00261378|Doxorubicin|doxorubicin|mesh-list
19347853|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20203747|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20203748|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20203749|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203750|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20203751|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20203752|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203753|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203754|NCT00261391|Marimastat|marimastat|mesh-list
20203755|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347854|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347855|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19347856|NCT03756324|Cefdinir|cefdinir|mesh-list
19347857|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19347858|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347859|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
19347860|NCT03756298|Capecitabine|capecitabine|mesh-list
20203756|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203757|NCT00261469|Topiramate|topiramate|mesh-list
20203758|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
20203759|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20203760|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203761|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20203762|NCT00261482|Norelgestromin|norelgestromin|mesh-list
20203763|NCT00261482|Estradiol|estradiol|mesh-list
20203764|NCT00261482|Estrogens|estrogens|mesh-ancestor
20203765|NCT00261482|Hormones|hormones|mesh-ancestor
19347861|NCT03756298|Atezolizumab|atezolizumab|mesh-list
19347862|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19347863|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
19347864|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347865|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347866|NCT03756272|Bupivacaine|bupivacaine|mesh-list
19347867|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
19347868|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
19684206|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20389483|NCT01070186|Growth Substances|growth substances|mesh-ancestor
19347869|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347870|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347871|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
19347872|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347873|NCT03756246|Vaccines|vaccines|mesh-list
19347874|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
19347875|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400690|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19400691|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400692|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19400693|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19400694|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400695|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400696|NCT03624010|Simendan|simendan|mesh-list
19400697|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19400698|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
19400699|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19400700|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19400701|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400702|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400703|NCT03624010|Protective Agents|protective agents|mesh-ancestor
19400704|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400705|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
19400706|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
19400707|NCT03623789|Hemostatics|hemostatics|mesh-list
19400708|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19400709|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19400710|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400711|NCT03623789|Coagulants|coagulants|mesh-ancestor
19400712|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
19400713|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400714|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19400715|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400716|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19400717|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19400718|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400719|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400720|NCT03623776|Carboplatin|carboplatin|mesh-list
19400721|NCT03623776|Pemetrexed|pemetrexed|mesh-list
19400722|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400723|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400724|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400725|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19400726|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19400727|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
19400728|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400729|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
19400730|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400731|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684207|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19684208|NCT02439385|Growth Substances|growth substances|mesh-ancestor
20203766|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203767|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203768|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20203769|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
20203770|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20203771|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20203772|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20203773|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20203774|NCT00261508|Risperidone|risperidone|mesh-list
20203775|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20203776|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
20203777|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203778|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203779|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203780|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20203781|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20203782|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20203783|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203784|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19400732|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20389484|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389485|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
20389486|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389487|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389488|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389489|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
20389490|NCT01070225|Propranolol|propranolol|mesh-list
20389491|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389492|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20389493|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20389494|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
20389495|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203785|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
20203786|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
20203787|NCT00261521|Hematinics|hematinics|mesh-ancestor
20203788|NCT00261547|Rituximab|rituximab|mesh-list
20203789|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203790|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203791|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
20203792|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203793|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203794|NCT00261560|Acetaminophen|acetaminophen|mesh-list
19347876|NCT03756233|Remifentanil|remifentanil|mesh-list
19347877|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19347878|NCT03756233|Narcotics|narcotics|mesh-ancestor
19347879|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19347880|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203795|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389496|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389497|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389498|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20203796|NCT00261560|Analgesics|analgesics|mesh-ancestor
20203797|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
20203798|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203799|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203800|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
20203801|NCT00261573|Galantamine|galantamine|mesh-list
20203802|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20203803|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203804|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203805|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
20203806|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203807|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203808|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20203809|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
20203810|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203811|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
20203812|NCT00261586|Aspirin|aspirin|mesh-list
20203813|NCT00261586|Acetaminophen|acetaminophen|mesh-list
20203814|NCT00261586|Ibuprofen|ibuprofen|mesh-list
20203815|NCT00261586|Celecoxib|celecoxib|mesh-list
20203816|NCT00261586|Naproxen|naproxen|mesh-list
20203817|NCT00261586|Rofecoxib|rofecoxib|mesh-list
20203818|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20203819|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20203820|NCT00261586|Analgesics|analgesics|mesh-ancestor
20203821|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
20203822|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203823|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203824|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203825|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389499|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389500|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389501|NCT01070277|Albendazole|albendazole|mesh-list
20389502|NCT01070277|Tinidazole|tinidazole|mesh-list
20389503|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
20389504|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20389505|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389506|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
20389507|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20389508|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20389509|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347881|NCT03756233|Analgesics|analgesics|mesh-ancestor
20203826|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20203827|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20389510|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389511|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
20203828|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389512|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389513|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389514|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
20389515|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20389516|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20389517|NCT01070290|Capecitabine|capecitabine|mesh-list
20389518|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
20389519|NCT01070290|Irinotecan|irinotecan|mesh-list
20389520|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389521|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
20389522|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203829|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20203830|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20203831|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203832|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
20203833|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20389523|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389524|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20389525|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20389526|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389527|NCT01070407|Cloricromen|cloricromen|mesh-list
20389528|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20389529|NCT01070446|Choline|choline|mesh-list
20389530|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
20389531|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20389532|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
20389533|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389534|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203834|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
20203835|NCT00261599|Midazolam|midazolam|mesh-list
20203836|NCT00261599|Fospropofol|fospropofol|mesh-list
20203837|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20203838|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19347882|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
19347883|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347884|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
19347885|NCT03756220|Thiamine|thiamine|mesh-list
19347886|NCT03756220|Vitamins|vitamins|mesh-ancestor
19347887|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
19347888|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347889|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
19347890|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347891|NCT03756220|Protective Agents|protective agents|mesh-ancestor
19347892|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
19347893|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19347894|NCT03756116|Epinephrine|epinephrine|mesh-list
19347895|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19347896|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19347897|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
19347898|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347899|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347900|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347901|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19347902|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19347903|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
19347904|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19347905|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19347906|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
19347907|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
19347908|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
19347909|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19347910|NCT03756090|Paclitaxel|paclitaxel|mesh-list
20203839|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20203840|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203841|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20203842|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20203843|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203844|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20203845|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
20203846|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
20203847|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
20203848|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
20203849|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389535|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19347911|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
19347912|NCT03756090|Epirubicin|epirubicin|mesh-list
20203850|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347913|NCT03756090|Palbociclib|palbociclib|mesh-list
19347914|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19684209|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203851|NCT00261612|Dexamethasone|dexamethasone|mesh-list
20203852|NCT00261612|Rituximab|rituximab|mesh-list
20203853|NCT00261612|Bortezomib|bortezomib|mesh-list
20203854|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20203855|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203856|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
20203857|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203858|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203859|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203860|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
20203861|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
20203862|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684210|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
19684211|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19684212|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19684213|NCT02439385|Analgesics|analgesics|mesh-ancestor
19684214|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
19684215|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684216|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19684217|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684218|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843565|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
19843566|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19843567|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
20389536|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
20389537|NCT01070472|Misoprostol|misoprostol|mesh-list
20389538|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19843568|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
19843569|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843570|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843571|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843572|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19843573|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843574|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389539|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
20389540|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389541|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389542|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20389543|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389544|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
20389545|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20389546|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389547|NCT01070511|Tadalafil|tadalafil|mesh-list
20389548|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389549|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20389550|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20389551|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389552|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389553|NCT01070511|Urological Agents|urological agents|mesh-ancestor
20389554|NCT01070524|Budesonide|budesonide|mesh-list
20389555|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20389556|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389557|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20389558|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
20389559|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203863|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203864|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
20203865|NCT00261612|Hormones|hormones|mesh-ancestor
20203866|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203867|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20203868|NCT00261625|Alendronate|alendronate|mesh-list
20203869|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20203870|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203871|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
20203872|NCT00261677|Hematinics|hematinics|mesh-ancestor
20203873|NCT00261703|Cisplatin|cisplatin|mesh-list
20203874|NCT00261703|Docetaxel|docetaxel|mesh-list
20203875|NCT00261703|Fluorouracil|fluorouracil|mesh-list
20203876|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389560|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684219|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389561|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20203877|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
20389562|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
20389563|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
20389564|NCT01070524|Hormones|hormones|mesh-ancestor
20389565|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389566|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
20203878|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
20203879|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
20203880|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203881|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
20203882|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19347915|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347916|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347917|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
19347918|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347919|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347920|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19347921|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
19347922|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347923|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19347924|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19347925|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
19347926|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19347927|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19347928|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20203883|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203884|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
20203885|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347929|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19347930|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347931|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19347932|NCT03756064|Carboplatin|carboplatin|mesh-list
19347933|NCT03756064|Docetaxel|docetaxel|mesh-list
19347934|NCT03756064|Trastuzumab|trastuzumab|mesh-list
19347935|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347936|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
19347937|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389567|NCT01070615|Prucalopride|prucalopride|mesh-list
20389568|NCT01070615|Laxatives|laxatives|mesh-ancestor
20389569|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389570|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20389571|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20389572|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
20389573|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389574|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389575|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389576|NCT01070628|Levodopa|levodopa|mesh-list
20389577|NCT01070628|Carbidopa|carbidopa|mesh-list
20389578|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20389579|NCT01070628|Entacapone|entacapone|mesh-list
20389580|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20389581|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20389582|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
20389583|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347938|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
19347939|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347940|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19347941|NCT03755947|Venetoclax|venetoclax|mesh-list
19347942|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
19347943|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347944|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19347945|NCT03755778|Itraconazole|itraconazole|mesh-list
19347946|NCT03755778|Rifampin|rifampin|mesh-list
19347947|NCT03755778|Quinidine|quinidine|mesh-list
20389584|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389585|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389586|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19347948|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
19347949|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203886|NCT00261729|Prazosin|prazosin|mesh-list
20203887|NCT00261729|Paroxetine|paroxetine|mesh-list
20203888|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20217745|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
20389587|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347950|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19347951|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19347952|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19347953|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19347954|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19347955|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
19347956|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19347957|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347958|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19347959|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19347960|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
19347961|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19347962|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
19347963|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19347964|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19347965|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19347966|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19347967|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19347968|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19347969|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19347970|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19347971|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19347972|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
19347973|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19347974|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19347975|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
19347976|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19347977|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19347978|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19347979|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19347980|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
19347981|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19347982|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19347983|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19347984|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19347985|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
19347986|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20203889|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20203890|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203891|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203892|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203893|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
20203894|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203895|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20203896|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
20203897|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203898|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20203899|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20203900|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203901|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20203902|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20203903|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20203904|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20203905|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
20203906|NCT00261742|Penicillins|penicillins|mesh-list
20203907|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20203908|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203909|NCT00261755|Analgesics|analgesics|mesh-list
20203910|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
20203911|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203912|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203913|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
20203914|NCT00261820|Sirolimus|sirolimus|mesh-list
20203915|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
20203916|NCT00261820|Prednisolone|prednisolone|mesh-list
20203917|NCT00261820|Tacrolimus|tacrolimus|mesh-list
20203918|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203919|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
20203920|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203921|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20203922|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203923|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203924|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19347987|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19347988|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19347989|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19347990|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
19347991|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19347992|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19347993|NCT03755700|Vitamin E|vitamin e|mesh-list
19347994|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
19347995|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19347996|NCT03755700|Vitamins|vitamins|mesh-ancestor
19347997|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
19347998|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19347999|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
19348000|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348001|NCT03755700|Protective Agents|protective agents|mesh-ancestor
19348002|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
19348003|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348004|NCT03755700|Expectorants|expectorants|mesh-ancestor
19348005|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348006|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19348007|NCT03755700|Antidotes|antidotes|mesh-ancestor
19348008|NCT03755609|Fentanyl|fentanyl|mesh-list
19348009|NCT03755609|Oxycodone|oxycodone|mesh-list
19348010|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20203925|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203926|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20203927|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
20203928|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20203929|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203930|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
20203931|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20203932|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
20203933|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
20203934|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20203935|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203936|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
20203937|NCT00261820|Hormones|hormones|mesh-ancestor
20203938|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20203939|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20203940|NCT00261820|Protective Agents|protective agents|mesh-ancestor
20203941|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20203942|NCT00261872|Methylphenidate|methylphenidate|mesh-list
20203943|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20203944|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348011|NCT03755609|Narcotics|narcotics|mesh-ancestor
19348012|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348013|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348014|NCT03755609|Analgesics|analgesics|mesh-ancestor
19348015|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
19348016|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348017|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19348018|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19348019|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
19348020|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
19348021|NCT03755557|Budesonide|budesonide|mesh-list
19348022|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348023|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19348024|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
19348025|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348026|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348027|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19348028|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348029|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
19348030|NCT03755557|Hormones|hormones|mesh-ancestor
19348031|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348032|NCT03755531|Oxytocin|oxytocin|mesh-list
19348033|NCT03755531|Carbetocin|carbetocin|mesh-list
19348034|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
19348035|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19348036|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348037|NCT03755479|Insulin|insulin|mesh-list
20217746|NCT00310232|Hematinics|hematinics|mesh-ancestor
19348038|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19348039|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348040|NCT03755466|Tofacitinib|tofacitinib|mesh-list
19348041|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19348042|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400733|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
19348043|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348044|NCT03755440|Antibodies|antibodies|mesh-list
19348045|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
19348046|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348047|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19348048|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19348049|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
19348050|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348051|NCT03755427|Antacids|antacids|mesh-ancestor
19348052|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348053|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19348054|NCT03755310|Suvorexant|suvorexant|mesh-list
19348055|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19348056|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19348057|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348058|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348059|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19348060|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348061|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348062|NCT03755193|Diphosphonates|diphosphonates|mesh-list
19348063|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20389588|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20389589|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
20203945|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20203946|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20203947|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203948|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203949|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
19348064|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348065|NCT03755115|Epirubicin|epirubicin|mesh-list
20203950|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20203951|NCT00261911|Sibutramine|sibutramine|mesh-list
20203952|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
20203953|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20203954|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
20203955|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20203956|NCT00261937|Furosemide|furosemide|mesh-list
20203957|NCT00261937|Diuretics|diuretics|mesh-ancestor
20203958|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
19684220|NCT02419664|Edotreotide|edotreotide|mesh-list
20389590|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
20389591|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20389592|NCT01070641|Carvedilol|carvedilol|mesh-list
19348066|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19684221|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19684222|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684223|NCT02402439|Pancrelipase|pancrelipase|mesh-list
19684224|NCT02402439|Pancreatin|pancreatin|mesh-list
19348067|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348068|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19684225|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684226|NCT02393690|Iodine|iodine|mesh-list
19684227|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
19684228|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19684229|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684230|NCT02393690|Trace Elements|trace elements|mesh-ancestor
19684231|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
19684232|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203959|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203960|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20203961|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203962|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203963|NCT00261976|Infliximab|infliximab|mesh-list
20203964|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
20203965|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20203966|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684233|NCT02387996|Nivolumab|nivolumab|mesh-list
19684234|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684235|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684236|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19684237|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684238|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
20203967|NCT00262015|Vaccines|vaccines|mesh-list
20389593|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20203968|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
19348069|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19348070|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348071|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348072|NCT03755102|Osimertinib|osimertinib|mesh-list
19348073|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348074|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19348075|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348076|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348077|NCT03755089|Lidocaine|lidocaine|mesh-list
19348078|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
19348079|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
19348080|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348081|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348082|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
19348083|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348084|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19348085|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19348086|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19348087|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20203969|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203970|NCT00262054|Heparin|heparin|mesh-list
20203971|NCT00262054|Calcium heparin|calcium heparin|mesh-list
20203972|NCT00262054|Bivalirudin|bivalirudin|mesh-list
20203973|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
20203974|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20203975|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20203976|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203977|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
19348088|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348089|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19348090|NCT03755037|Estradiol|estradiol|mesh-list
19348091|NCT03755037|Estrogens|estrogens|mesh-ancestor
19348092|NCT03755037|Hormones|hormones|mesh-ancestor
19348093|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348094|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348095|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19348096|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
19348097|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19348098|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19348099|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19348100|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19348101|NCT03754959|Midazolam|midazolam|mesh-list
19348102|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19348103|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19348104|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348105|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348106|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20203978|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20203979|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
20203980|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203981|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
20203982|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20203983|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20203984|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20203985|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
20203986|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20203987|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20203988|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20203989|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20203990|NCT00262210|Prednisolone|prednisolone|mesh-list
20203991|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
20203992|NCT00262210|Etoposide|etoposide|mesh-list
20203993|NCT00262210|Epirubicin|epirubicin|mesh-list
20203994|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20203995|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
20203996|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20203997|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20203998|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20203999|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
20204000|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204001|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204002|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20204003|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20389594|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20389595|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
20389596|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389597|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389598|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389599|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389600|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
19348107|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348108|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19348109|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19348110|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
19348111|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
19348112|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
19348113|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
19348114|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348115|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348116|NCT03754933|Fludarabine|fludarabine|mesh-list
19348117|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
20389601|NCT01070641|Protective Agents|protective agents|mesh-ancestor
20389602|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20389603|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20389604|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20389605|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389606|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20389607|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20389608|NCT01070667|Dronedarone|dronedarone|mesh-list
20389609|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20389610|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
20389611|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20389612|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389613|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389614|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389615|NCT01070680|Analgesics|analgesics|mesh-ancestor
20389616|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
20389617|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389618|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20389619|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20389620|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20389621|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
20389622|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389623|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348118|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348119|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204004|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20204005|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204006|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204007|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204008|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
20204009|NCT00262210|Hormones|hormones|mesh-ancestor
19348120|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
19348121|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348122|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348123|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
19348124|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348125|NCT03754842|Niacinamide|niacinamide|mesh-list
19684239|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684240|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204010|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204011|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204012|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20389624|NCT01070706|Gemcitabine|gemcitabine|mesh-list
19684241|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19684242|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19684243|NCT02349386|Estradiol|estradiol|mesh-list
19684244|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19348126|NCT03754842|Niacin|niacin|mesh-list
19684245|NCT02349386|Estrogens|estrogens|mesh-ancestor
19684246|NCT02349386|Hormones|hormones|mesh-ancestor
19684247|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684248|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684249|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19684250|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
19684251|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684252|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19684253|NCT02337985|Prednisone|prednisone|mesh-list
19684254|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
19684255|NCT02337985|Rituximab|rituximab|mesh-list
19684256|NCT02337985|Doxorubicin|doxorubicin|mesh-list
20389625|NCT01070706|Paclitaxel|paclitaxel|mesh-list
20389626|NCT01070706|Sunitinib|sunitinib|mesh-list
20204013|NCT00262262|Levetiracetam|levetiracetam|mesh-list
20204014|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
20204015|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
20204016|NCT00262275|Aspirin|aspirin|mesh-list
20204017|NCT00262275|Clopidogrel|clopidogrel|mesh-list
20204018|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20389627|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20389628|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389629|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204019|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204020|NCT00262275|Analgesics|analgesics|mesh-ancestor
20389630|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
19348127|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
19348128|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
19348129|NCT03754842|Vitamins|vitamins|mesh-ancestor
19348130|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
19348131|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348132|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19348133|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
19348134|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348135|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19348136|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
19348137|NCT03754816|Anesthetics|anesthetics|mesh-list
19348138|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
19348139|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348140|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348141|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
19348142|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
19348143|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348144|NCT03754712|Vitamin D|vitamin d|mesh-list
19348145|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
19348146|NCT03754712|Vitamins|vitamins|mesh-ancestor
19348147|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
19348148|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348149|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19348150|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19348151|NCT03754686|Acetaminophen|acetaminophen|mesh-list
19348152|NCT03754686|Oseltamivir|oseltamivir|mesh-list
19348153|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19348154|NCT03754686|Analgesics|analgesics|mesh-ancestor
19348155|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
19348156|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348157|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348158|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
19348159|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
19348160|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348161|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348162|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348163|NCT03754647|Ascorbic Acid|ascorbic acid|mesh-list
19348164|NCT03754647|Vitamins|vitamins|mesh-ancestor
19348165|NCT03754647|Micronutrients|micronutrients|mesh-ancestor
19348166|NCT03754647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348167|NCT03754647|Antioxidants|antioxidants|mesh-ancestor
19348168|NCT03754647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348169|NCT03754647|Protective Agents|protective agents|mesh-ancestor
19348170|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
19348171|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348172|NCT03754543|Iron|iron|mesh-list
19348173|NCT03754543|Trace Elements|trace elements|mesh-ancestor
19348174|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
19348175|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684257|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20204021|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
20204022|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204023|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204024|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400734|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400735|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400736|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19400737|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19684258|NCT02337985|Etoposide|etoposide|mesh-list
20389631|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684259|NCT02337985|Vincristine|vincristine|mesh-list
20204025|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348176|NCT03754387|Ceftazidime|ceftazidime|mesh-list
19348177|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19348178|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348179|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
19348180|NCT03754179|Trametinib|trametinib|mesh-list
19348181|NCT03754179|Dabrafenib|dabrafenib|mesh-list
19348182|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
19348183|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19348184|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19348185|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348186|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348187|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348188|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348189|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348190|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19348191|NCT03754140|Polidocanol|polidocanol|mesh-list
20389632|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389633|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389634|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
20389635|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
20389636|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389637|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389638|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389639|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
19348192|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19348193|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19348194|NCT03754062|Haloperidol|haloperidol|mesh-list
19348195|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
19348196|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
19348197|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
19348198|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204026|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20204027|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20204028|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204029|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20204030|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19348199|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348200|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19348201|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19348202|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348203|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348204|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19348205|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19348206|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
19348207|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348208|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348209|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19348210|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
19348211|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19348212|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
19348213|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348214|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
19348215|NCT03754010|Protective Agents|protective agents|mesh-ancestor
19348216|NCT03753867|Acitretin|acitretin|mesh-list
19348217|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
20204031|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204032|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
20204033|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20204034|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20204035|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20204036|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
20204037|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204038|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20204039|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20204040|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204041|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
20204042|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204043|NCT00262327|Endostatins|endostatins|mesh-list
20204044|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204045|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20204046|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20389640|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348218|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
19348219|NCT03753685|Ensartinib|ensartinib|mesh-list
19348220|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348221|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389641|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20389642|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20389643|NCT01070706|Growth Substances|growth substances|mesh-ancestor
20204047|NCT00262327|Growth Substances|growth substances|mesh-ancestor
20204048|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204049|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
20204050|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
19348222|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348223|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348224|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
19348225|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19348226|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348227|NCT03753581|Cytarabine|cytarabine|mesh-list
20389644|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
20389645|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389646|NCT01070732|Acetaminophen|acetaminophen|mesh-list
19348228|NCT03753581|Methotrexate|methotrexate|mesh-list
19348229|NCT03753581|Etoposide|etoposide|mesh-list
19348230|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19684260|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684261|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
20204051|NCT00262379|Hematinics|hematinics|mesh-ancestor
20204052|NCT00262392|Pamidronate|pamidronate|mesh-list
20204053|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20204054|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204055|NCT00262405|Prednisone|prednisone|mesh-list
20204056|NCT00262405|Zileuton|zileuton|mesh-list
19684262|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684263|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684264|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19684265|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
19684266|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684267|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684268|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19684269|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684270|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19684271|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19684272|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204057|NCT00262405|Azathioprine|azathioprine|mesh-list
20204058|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204059|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
20204060|NCT00262405|Hormones|hormones|mesh-ancestor
20204061|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204062|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204063|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204064|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204065|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
20204066|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204067|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204068|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204069|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
20204070|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204071|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20204072|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204073|NCT00262405|Analgesics|analgesics|mesh-ancestor
20204074|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
20204075|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204076|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20204077|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204078|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20204079|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
20204080|NCT00262418|Ivermectin|ivermectin|mesh-list
20204081|NCT00262418|Permethrin|permethrin|mesh-list
20204082|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20204083|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204084|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204085|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204086|NCT00262470|Indomethacin|indomethacin|mesh-list
20204087|NCT00262470|Octreotide|octreotide|mesh-list
20204088|NCT00262470|Propranolol|propranolol|mesh-list
20204089|NCT00262470|Clonidine|clonidine|mesh-list
20204090|NCT00262470|Mecamylamine|mecamylamine|mesh-list
20204091|NCT00262470|Acetazolamide|acetazolamide|mesh-list
20204092|NCT00262470|Isosorbide|isosorbide|mesh-list
19348231|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
20204093|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20217747|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
20204094|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20204095|NCT00262470|Midodrine|midodrine|mesh-list
20204096|NCT00262470|Memantine|memantine|mesh-list
20204097|NCT00262470|Entacapone|entacapone|mesh-list
20204098|NCT00262470|Melatonin|melatonin|mesh-list
20204099|NCT00262470|Modafinil|modafinil|mesh-list
19684273|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684274|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348232|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348233|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348234|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
19348235|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348236|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348237|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
19348238|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389647|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389648|NCT01070732|Analgesics|analgesics|mesh-ancestor
20389649|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
20389650|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389651|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389652|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
20389653|NCT01070745|Ibuprofen|ibuprofen|mesh-list
20389654|NCT01070745|Indomethacin|indomethacin|mesh-list
20389655|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19348239|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20204100|NCT00262470|Sertraline|sertraline|mesh-list
20204101|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20204102|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
20204103|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204104|NCT00262470|Protective Agents|protective agents|mesh-ancestor
20389656|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389657|NCT01070745|Analgesics|analgesics|mesh-ancestor
20389658|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
20389659|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389660|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389661|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389662|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389663|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20389664|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389665|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204105|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348240|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19348241|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19348242|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348243|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19348244|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
19348245|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19348246|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
19348247|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20389666|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
20389667|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
20389668|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389669|NCT01070758|Lanreotide|lanreotide|mesh-list
20389670|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389671|NCT01070823|Natalizumab|natalizumab|mesh-list
20389672|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
20389673|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389674|NCT01070836|Natalizumab|natalizumab|mesh-list
20389675|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
20389676|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348248|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348249|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19348250|NCT03753477|Amlodipine|amlodipine|mesh-list
19348251|NCT03753477|Olmesartan|olmesartan|mesh-list
19348252|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19348253|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
19348254|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19348255|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19348256|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19348257|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348258|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348259|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19684275|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
20389677|NCT01070862|Thalidomide|thalidomide|mesh-list
20204106|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389678|NCT01070862|Dexamethasone|dexamethasone|mesh-list
20204107|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20204108|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20204109|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
20204110|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348260|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348261|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
19348262|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20389679|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
20389680|NCT01070862|Doxorubicin|doxorubicin|mesh-list
20389681|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20389682|NCT01070862|Melphalan|melphalan|mesh-list
20389683|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
20389684|NCT01070862|Vincristine|vincristine|mesh-list
20389685|NCT01070862|BB 1101|bb 1101|mesh-list
20389686|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389687|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
20389688|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
20389689|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389690|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389691|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389692|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
20389693|NCT01070862|Hormones|hormones|mesh-ancestor
20389694|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389695|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20389696|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389697|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
20389698|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348263|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19348264|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
19348265|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19348266|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19348267|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348268|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19348269|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20204111|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20204112|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20204113|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
20204114|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
20204115|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20204116|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20204117|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20204118|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204119|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
20204120|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20204121|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20204122|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
20204123|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20204124|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20204125|NCT00262470|Analgesics|analgesics|mesh-ancestor
20204126|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
19348270|NCT03753269|Fasudil|fasudil|mesh-list
19348271|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19348272|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348273|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348274|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19348275|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348276|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
19348277|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19348278|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348279|NCT03752931|Celiprolol|celiprolol|mesh-list
19348280|NCT03752931|Diltiazem|diltiazem|mesh-list
19348281|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19348282|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19348283|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348284|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348285|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19348286|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348287|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
19348288|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19348289|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
20204127|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389699|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389700|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20389701|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20204128|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
20204129|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
20204130|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19843575|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19843576|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
19843577|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19843578|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
19843579|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19843580|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
19848236|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848237|NCT00691704|Aspirin|aspirin|mesh-list
20204131|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20389702|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204132|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20204133|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20204134|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204135|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204136|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19684276|NCT02337985|Hormones|hormones|mesh-ancestor
19684277|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348290|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
19348291|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348292|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19348293|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19348294|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19348295|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
19348296|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348297|NCT03752749|Prednisolone|prednisolone|mesh-list
19348298|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348299|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
19348300|NCT03752749|Hormones|hormones|mesh-ancestor
19348301|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348302|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348303|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19348304|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348305|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
19348306|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19684278|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19684279|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19684280|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
19684281|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684282|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684283|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
19684284|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684285|NCT02308241|Ribavirin|ribavirin|mesh-list
19684286|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
19684287|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204137|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20204138|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20204139|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20204140|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20204141|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20204142|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204143|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204144|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204145|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
20204146|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
20204147|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684288|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
19684289|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684290|NCT02274155|Antibodies|antibodies|mesh-list
19684291|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
19684292|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848238|NCT00691704|Prednisone|prednisone|mesh-list
20389703|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20389704|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
20389705|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20389706|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389707|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
20389708|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
20389709|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20389710|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389711|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19348307|NCT03752736|Protective Agents|protective agents|mesh-ancestor
20389712|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20389713|NCT01070862|Growth Substances|growth substances|mesh-ancestor
20389714|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
20389715|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389716|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20389717|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
20389718|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389719|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389720|NCT01070875|Heparin|heparin|mesh-list
20389721|NCT01070875|Calcium heparin|calcium heparin|mesh-list
20389722|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
20389723|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20389724|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20389725|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389726|NCT01070927|R04929097|r04929097|mesh-list
20389727|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389728|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389729|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20389730|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389731|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389732|NCT01071005|Leuprolide|leuprolide|mesh-list
20389733|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19348308|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204148|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20204149|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204150|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
19348309|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
19348310|NCT03752658|Tenofovir|tenofovir|mesh-list
19348311|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
19348312|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348313|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19348314|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19348315|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348316|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348317|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19348318|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19400738|NCT03623711|Citalopram|citalopram|mesh-list
19400739|NCT03623711|Bupropion|bupropion|mesh-list
19400740|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19400741|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19843581|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19843582|NCT00659945|Ondansetron|ondansetron|mesh-list
19843583|NCT00659945|Aprepitant|aprepitant|mesh-list
19843584|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
20204151|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20204152|NCT00262470|Diuretics|diuretics|mesh-ancestor
20204153|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
20204154|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
20204155|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20204156|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20389734|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
20389735|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389736|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389737|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20389738|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389739|NCT01071057|Morphine|morphine|mesh-list
20389740|NCT01071057|Naloxone|naloxone|mesh-list
19684293|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
19684294|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19684295|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20204157|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20204158|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20204159|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20204160|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20204161|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20204162|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20204163|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
19400742|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19684296|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684297|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
19684298|NCT02257580|Coagulants|coagulants|mesh-ancestor
19684299|NCT02180711|Rituximab|rituximab|mesh-list
19684300|NCT02180711|Lenalidomide|lenalidomide|mesh-list
19684301|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
19843585|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
19843586|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389741|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20389742|NCT01071057|Narcotics|narcotics|mesh-ancestor
20204164|NCT00262483|Ribavirin|ribavirin|mesh-list
20204165|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20204166|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
20389743|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389744|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389745|NCT01071057|Analgesics|analgesics|mesh-ancestor
20389746|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
20389747|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389748|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20389749|NCT01071122|Valsartan|valsartan|mesh-list
20389750|NCT01071122|Nifedipine|nifedipine|mesh-list
20389751|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389752|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20389753|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20389754|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389755|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20389756|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20389757|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20389758|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389759|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389760|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
20389761|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389762|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19348319|NCT03752476|Lactams|lactams|mesh-list
20204167|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204168|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
20204169|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204170|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20204171|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20204172|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20204173|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
20204174|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684302|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684303|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684304|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
19684305|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684306|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684307|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19684308|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19684309|NCT02180711|Growth Substances|growth substances|mesh-ancestor
20204175|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20204176|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20204177|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204178|NCT00262561|Aspirin|aspirin|mesh-list
20204179|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20204180|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204181|NCT00262561|Analgesics|analgesics|mesh-ancestor
20204182|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
20204183|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204184|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204185|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204186|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204187|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20204188|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20204189|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204190|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20204191|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20204192|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204193|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
20389763|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
20389764|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20389765|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20389766|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20389767|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389768|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348320|NCT03752476|beta-Lactams|beta-lactams|mesh-list
19348321|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19348322|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348323|NCT03752437|Heparin|heparin|mesh-list
19348324|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
19684310|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
19684311|NCT02163356|Ketoconazole|ketoconazole|mesh-list
19348325|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19684312|NCT02163356|Vincristine|vincristine|mesh-list
20204194|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19684313|NCT02163356|Fenretinide|fenretinide|mesh-list
19348326|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20389769|NCT01071161|Azithromycin|azithromycin|mesh-list
20389770|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20389771|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389772|NCT01071174|Dapivirine|dapivirine|mesh-list
20389773|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20389774|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20389775|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
20204195|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
20204196|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204197|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20204198|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20204199|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
20204200|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204201|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204202|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20204203|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
20204204|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
20204205|NCT00262587|Hormones|hormones|mesh-ancestor
20204206|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204207|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
20204208|NCT00262769|Gemcitabine|gemcitabine|mesh-list
20204209|NCT00262769|Cisplatin|cisplatin|mesh-list
20204210|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204211|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204212|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
20204213|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204214|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
20204215|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204216|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389776|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389777|NCT01071187|Varenicline|varenicline|mesh-list
20389778|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20389779|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20389780|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
20389781|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389782|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348327|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348328|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
19348329|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19348330|NCT03752398|Ipilimumab|ipilimumab|mesh-list
19348331|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19348332|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348333|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19348334|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348335|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
19348336|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19348337|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348338|NCT03752294|Dabigatran|dabigatran|mesh-list
19348339|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
19348340|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19348341|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
19348342|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348343|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348344|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
19348345|NCT03752229|Diazepam|diazepam|mesh-list
19348346|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19348347|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
19348348|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
19348349|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
19348350|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348351|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348352|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19348353|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19348354|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348355|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19684314|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19684315|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684316|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
19684317|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684318|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684319|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389783|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389784|NCT01071291|Niacin|niacin|mesh-list
19348356|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19348357|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19348358|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348359|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19348360|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19348361|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
19348362|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
19348363|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
19348364|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
19348365|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348366|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348367|NCT03752190|Cosyntropin|cosyntropin|mesh-list
19348368|NCT03752190|Hormones|hormones|mesh-ancestor
19348369|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348370|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348371|NCT03752138|Decitabine|decitabine|mesh-list
19348372|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19348373|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
19348374|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348375|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348376|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348377|NCT03752125|Caffeine|caffeine|mesh-list
19348378|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19348379|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348380|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19348381|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348382|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348383|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19348384|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19348385|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
19348386|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348387|NCT03752112|Penicillins|penicillins|mesh-list
19348388|NCT03752112|Cefixime|cefixime|mesh-list
20204217|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204218|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
19348389|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19348390|NCT03752112|Penicillin G|penicillin g|mesh-list
19348391|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
19348392|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19348393|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389785|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
20389786|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20389787|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
20389788|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389789|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20389790|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
19348394|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
19348395|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204219|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204220|NCT00262782|Fludarabine|fludarabine|mesh-list
20204221|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204222|NCT00262795|Fludarabine|fludarabine|mesh-list
20204223|NCT00262795|Chlorambucil|chlorambucil|mesh-list
20204224|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348396|NCT03751761|Paclitaxel|paclitaxel|mesh-list
19348397|NCT03751761|Durvalumab|durvalumab|mesh-list
19348398|NCT03751761|Tremelimumab|tremelimumab|mesh-list
19348399|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19348400|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348401|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
19348402|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
19348403|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
19348404|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348405|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19348406|NCT03751514|Azithromycin|azithromycin|mesh-list
19348407|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19348408|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348409|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19348410|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19348411|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348412|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348413|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843587|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389791|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
19348414|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20217748|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20389792|NCT01071291|Vitamins|vitamins|mesh-ancestor
19348415|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19348416|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19348417|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
19348418|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348419|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348420|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20204225|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204226|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19348421|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19348422|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
19348423|NCT03751423|Fentanyl|fentanyl|mesh-list
19348424|NCT03751423|Ketamine|ketamine|mesh-list
19348425|NCT03751423|Morphine|morphine|mesh-list
19348426|NCT03751423|Analgesics|analgesics|mesh-ancestor
19348427|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
19348428|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348429|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348430|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19348431|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19348432|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
19348433|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
19348434|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348435|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19348436|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19348437|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348438|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348439|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19348440|NCT03751423|Narcotics|narcotics|mesh-ancestor
19348441|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19348442|NCT03751358|Anesthetics|anesthetics|mesh-list
19348443|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
19348444|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348445|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348446|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
19348447|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348448|NCT03751332|Tacrolimus|tacrolimus|mesh-list
19348449|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348450|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
19348451|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348452|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19348453|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348454|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348455|NCT03751228|BMS-986165|bms-986165|mesh-list
19348456|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
19348457|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19348458|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204227|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
20204228|NCT00262808|Leucovorin|leucovorin|mesh-list
20204229|NCT00262808|Fluorouracil|fluorouracil|mesh-list
20204230|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
19684320|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
19684321|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684322|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20389793|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
19348459|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348460|NCT03751202|Fluticasone|fluticasone|mesh-list
19348461|NCT03751202|Xhance|xhance|mesh-list
19348462|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19348463|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19348464|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348465|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19348466|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
19348467|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348468|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348469|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20204231|NCT00262808|Calcium|calcium|mesh-list
20204232|NCT00262808|Sargramostim|sargramostim|mesh-list
20204233|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
20389794|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389795|NCT01071304|Midazolam|midazolam|mesh-list
20389796|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20204234|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20204235|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389797|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20204236|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
20426522|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19348470|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348471|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19684323|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19684324|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684325|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19684326|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
19684327|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684328|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684329|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19684330|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19684331|NCT02163356|Protective Agents|protective agents|mesh-ancestor
19684332|NCT02108652|Atezolizumab|atezolizumab|mesh-list
19684333|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684334|NCT02102477|Androgens|androgens|mesh-list
19684335|NCT02102477|Hormones|hormones|mesh-ancestor
19684336|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684337|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684338|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
19684339|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19348472|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19348473|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19348474|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19348475|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19348476|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
19348477|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348478|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348479|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
19348480|NCT03751202|Hormones|hormones|mesh-ancestor
19348481|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348482|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
19348483|NCT03751176|Leucovorin|leucovorin|mesh-list
19348484|NCT03751176|Folic Acid|folic acid|mesh-list
19348485|NCT03751176|Fluorouracil|fluorouracil|mesh-list
19348486|NCT03751176|Irinotecan|irinotecan|mesh-list
19348487|NCT03751176|Panitumumab|panitumumab|mesh-list
19348488|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
19348489|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
19348490|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348491|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19348492|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348493|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348494|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
19348495|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348496|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19348497|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19348498|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348499|NCT03751176|Antidotes|antidotes|mesh-ancestor
19348500|NCT03751176|Protective Agents|protective agents|mesh-ancestor
19348501|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
19348502|NCT03751176|Vitamins|vitamins|mesh-ancestor
19348503|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
19348504|NCT03751176|Hematinics|hematinics|mesh-ancestor
20204237|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204238|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204239|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204240|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204241|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
19348505|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19348506|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
19348507|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
19348508|NCT03751163|Hydroquinone|hydroquinone|mesh-list
19348509|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19348510|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19348511|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348512|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
19348513|NCT03751163|Coagulants|coagulants|mesh-ancestor
19348514|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19348515|NCT03751163|Protective Agents|protective agents|mesh-ancestor
19684340|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684341|NCT02021006|Amoxicillin|amoxicillin|mesh-list
19684342|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
19348516|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348517|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
20204242|NCT00262808|Antidotes|antidotes|mesh-ancestor
19348518|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
19348519|NCT03751111|Naloxone|naloxone|mesh-list
19348520|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20204243|NCT00262808|Protective Agents|protective agents|mesh-ancestor
20204244|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
20204245|NCT00262808|Vitamins|vitamins|mesh-ancestor
20389798|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389799|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389800|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19684343|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
19684344|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19684345|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
19684346|NCT02021006|Cefixime|cefixime|mesh-list
19684347|NCT02021006|Trimethoprim|trimethoprim|mesh-list
19684348|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
19684349|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19684350|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389801|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20389802|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20389803|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19684351|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19684352|NCT02021006|Renal Agents|renal agents|mesh-ancestor
19843588|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843589|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
19843590|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
19843591|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19843592|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
19843593|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843594|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389804|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
19348521|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348522|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
19843595|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19843596|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19843597|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843598|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19843599|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19348523|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348524|NCT03751059|Dexamethasone|dexamethasone|mesh-list
19348525|NCT03751059|Bromfenac|bromfenac|mesh-list
20389805|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
20389806|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
19348526|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19843600|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20204246|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
20204247|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
19348527|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
19684353|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
19684354|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20204248|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
20204249|NCT00262886|Fludarabine|fludarabine|mesh-list
20204250|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
20204251|NCT00262886|Tacrolimus|tacrolimus|mesh-list
20204252|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20204253|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204254|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
19684355|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20204255|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204256|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204257|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20204258|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
20204259|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204260|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204261|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20204262|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204263|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
20204264|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20204265|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204266|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20204267|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20204268|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
20204269|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20204270|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204271|NCT00262977|Aspirin|aspirin|mesh-list
19348528|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
20204272|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20204273|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19684356|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20204274|NCT00262977|Analgesics|analgesics|mesh-ancestor
20389807|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
20389808|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684357|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348529|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348530|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348531|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19348532|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
19348533|NCT03751059|Hormones|hormones|mesh-ancestor
19684358|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684359|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20389809|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389810|NCT01071369|Betamethasone|betamethasone|mesh-list
20389811|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
20389812|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20389813|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
20389814|NCT01071369|Lidocaine|lidocaine|mesh-list
20389815|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20389816|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
20389817|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
20389818|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389819|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389820|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
20389821|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348534|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348535|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19348536|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348537|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19348538|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19348539|NCT03751059|Analgesics|analgesics|mesh-ancestor
19684360|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19684361|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19684362|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19684363|NCT02016924|Cobicistat|cobicistat|mesh-list
19684364|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684365|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684366|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19684367|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19684368|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
19684369|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684370|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19684371|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19348540|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
19348541|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348542|NCT03750916|Docetaxel|docetaxel|mesh-list
19348543|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348544|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
19348545|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
19348546|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
19348547|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348548|NCT03750773|Gabapentin|gabapentin|mesh-list
19348549|NCT03750773|Analgesics|analgesics|mesh-ancestor
19348550|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
19348551|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348552|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348553|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
19348554|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19348555|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348556|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348557|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19348558|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19348559|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19348560|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348561|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348562|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
19348563|NCT03750760|Atorvastatin|atorvastatin|mesh-list
19684372|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
19684373|NCT02013336|Irinotecan|irinotecan|mesh-list
19843601|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20204275|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
20204276|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204277|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204278|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204279|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204280|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20204281|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19684374|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684375|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
19684376|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684377|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389822|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20389823|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20389824|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20389825|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348564|NCT03750760|Ezetimibe|ezetimibe|mesh-list
19348565|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19348566|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19348567|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
19348568|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348569|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19348570|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19348571|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400743|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400744|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400745|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
19400746|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400747|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19400748|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
19400749|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19400750|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400751|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19400752|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
19400753|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19400754|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19400755|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400756|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19400757|NCT03623711|Analgesics|analgesics|mesh-ancestor
19400758|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
19400759|NCT03623633|Denosumab|denosumab|mesh-list
19400760|NCT03623633|Alendronate|alendronate|mesh-list
19400761|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19400762|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19400763|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400764|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19400765|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
19400766|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400767|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19400768|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19400769|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
19400770|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400771|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
19400772|NCT03623529|Giapreza|giapreza|mesh-list
19400773|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
19400774|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19400775|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19400776|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
19400777|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400778|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404570|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19404571|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404572|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404573|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19404574|NCT03593408|Analgesics|analgesics|mesh-ancestor
19404575|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
19404576|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404577|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19404578|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19404579|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20389826|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389827|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389828|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
20389829|NCT01071369|Hormones|hormones|mesh-ancestor
20389830|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389831|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20389832|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
20426523|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404580|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
19848239|NCT00691704|Lenalidomide|lenalidomide|mesh-list
19348572|NCT03750721|Rifampin|rifampin|mesh-list
19348573|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19348574|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
19348575|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19348576|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348577|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
19348578|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19348579|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348580|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348581|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19348582|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19348583|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20389833|NCT01071499|Morphine|morphine|mesh-list
19348584|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19348585|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19348586|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19348587|NCT03750669|Folic Acid|folic acid|mesh-list
19348588|NCT03750669|Gemcitabine|gemcitabine|mesh-list
19348589|NCT03750669|Paclitaxel|paclitaxel|mesh-list
19348590|NCT03750669|Fluorouracil|fluorouracil|mesh-list
19348591|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
19348592|NCT03750669|Irinotecan|irinotecan|mesh-list
19348593|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19348594|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348595|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
19348596|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19348597|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19348598|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348599|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19348600|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
19348601|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
19348602|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348603|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348604|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348605|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
19348606|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348607|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19348608|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19348609|NCT03750669|Hematinics|hematinics|mesh-ancestor
19348610|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
19348611|NCT03750669|Vitamins|vitamins|mesh-ancestor
19348612|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
19348613|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
19348614|NCT03750656|Tamsulosin|tamsulosin|mesh-list
19348615|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19348616|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19348617|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19348618|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
19348619|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389834|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20389835|NCT01071499|Narcotics|narcotics|mesh-ancestor
20389836|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389837|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389838|NCT01071499|Analgesics|analgesics|mesh-ancestor
20389839|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
20389840|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389841|NCT01071525|Niacin|niacin|mesh-list
20389842|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20389843|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
20389844|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389845|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20389846|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389847|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
20389848|NCT01071525|Vitamins|vitamins|mesh-ancestor
20389849|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
20389850|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389851|NCT01071564|R04929097|r04929097|mesh-list
20389852|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348620|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348621|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348622|NCT03750656|Urological Agents|urological agents|mesh-ancestor
19348623|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19348624|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20389853|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684378|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19348625|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20389854|NCT01071655|Fluorouracil|fluorouracil|mesh-list
20389855|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
19348626|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
19348627|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348628|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19348629|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348630|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
19348631|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
19348632|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19348633|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20389856|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389857|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20389858|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684379|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
19684380|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204282|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204283|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20204284|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20204285|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204286|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
19843602|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843603|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348634|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
19348635|NCT03750383|Cyclosporine|cyclosporine|mesh-list
19348636|NCT03750383|Prednisone|prednisone|mesh-list
19348637|NCT03750383|Cyclosporins|cyclosporins|mesh-list
19348638|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348639|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
19348640|NCT03750383|Hormones|hormones|mesh-ancestor
19348641|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348642|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348643|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19348644|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348645|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348646|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684381|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848240|NCT00691704|Bortezomib|bortezomib|mesh-list
20204287|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20204288|NCT00263003|Irbesartan|irbesartan|mesh-list
20204289|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20204290|NCT00263003|Diuretics|diuretics|mesh-ancestor
20204291|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
20389859|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389860|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
20389861|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389862|NCT01071681|Telmisartan|telmisartan|mesh-list
20389863|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389864|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20389865|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20389866|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389867|NCT01071694|Interferons|interferons|mesh-list
20389868|NCT01071694|Interferon-beta|interferon-beta|mesh-list
20389869|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
20389870|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389871|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
20389872|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20389873|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
20389874|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389875|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20389876|NCT01071772|Insulin|insulin|mesh-list
20389877|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20389878|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389879|NCT01071889|Flumazenil|flumazenil|mesh-list
20389880|NCT01071889|Antidotes|antidotes|mesh-ancestor
20389881|NCT01071889|Protective Agents|protective agents|mesh-ancestor
20389882|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389883|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
20389884|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
19348647|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684382|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19684383|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19684384|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19684385|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348648|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
19684386|NCT01921140|Olaparib|olaparib|mesh-list
20389885|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204292|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389886|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348649|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
19348650|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348651|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
19348652|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348653|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19348654|NCT03750136|Furosemide|furosemide|mesh-list
19348655|NCT03750136|Diuretics|diuretics|mesh-ancestor
19348656|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
20389887|NCT01071928|Docetaxel|docetaxel|mesh-list
20389888|NCT01071928|Vadimezan|vadimezan|mesh-list
20389889|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389890|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
19348657|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389891|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
20389892|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389893|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348658|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19348659|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348660|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348661|NCT03750071|Avelumab|avelumab|mesh-list
20389894|NCT01072045|Prednisone|prednisone|mesh-list
20389895|NCT01072045|Propranolol|propranolol|mesh-list
19348662|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19348663|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348664|NCT03749915|Tetracaine|tetracaine|mesh-list
19348665|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
19348666|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
20389896|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389897|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
20389898|NCT01072045|Hormones|hormones|mesh-ancestor
20389899|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389900|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389901|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20389902|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389903|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20389904|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20389905|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
20389906|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20389907|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389908|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20389909|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20389910|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
20389911|NCT01072058|Adalimumab|adalimumab|mesh-list
20389912|NCT01072058|Etanercept|etanercept|mesh-list
19348667|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204293|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20204294|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204295|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204296|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20204297|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20204298|NCT00263016|Docetaxel|docetaxel|mesh-list
19348668|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348669|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
19348670|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348671|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
19348672|NCT03749850|Doxorubicin|doxorubicin|mesh-list
19348673|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19348674|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348675|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
19348676|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348677|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348678|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19348679|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
19348680|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204299|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204300|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204301|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
20204302|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
20204303|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204304|NCT00263029|Capecitabine|capecitabine|mesh-list
20204305|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
20389913|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19348681|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348682|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19348683|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19348684|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19348685|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19348686|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348687|NCT03749733|Megestrol|megestrol|mesh-list
19348688|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19348689|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19348690|NCT03749733|Estradiol|estradiol|mesh-list
19348691|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19348692|NCT03749733|Estrogens|estrogens|mesh-ancestor
19348693|NCT03749733|Hormones|hormones|mesh-ancestor
19348694|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204306|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204307|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
20204308|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204309|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204310|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
20204311|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204312|NCT00263068|Rotigotine|rotigotine|mesh-list
19348695|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348696|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19348697|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
19348698|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19348699|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19348700|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19348701|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19348702|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19348703|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19348704|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348705|NCT03749642|Gabapentin|gabapentin|mesh-list
19348706|NCT03749642|Trazodone|trazodone|mesh-list
19348707|NCT03749642|Analgesics|analgesics|mesh-ancestor
19348708|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
19348709|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348710|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348711|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
19348712|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19348713|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348714|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348715|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19348716|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19348717|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19348718|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348719|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348720|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
19348721|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20389914|NCT01072058|Infliximab|infliximab|mesh-list
20389915|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389916|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389917|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
20389918|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20389919|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20389920|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20389921|NCT01072058|Analgesics|analgesics|mesh-ancestor
20389922|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
19348722|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19348723|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348724|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
19348725|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19348726|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
19348727|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
19348728|NCT03749590|Analgesics|analgesics|mesh-ancestor
19348729|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
19348730|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204313|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
20204314|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
20204315|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204316|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204317|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217749|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217750|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
20217751|NCT00310323|Caffeine|caffeine|mesh-list
19348731|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348732|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
19348733|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348734|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20204318|NCT00263094|Rofecoxib|rofecoxib|mesh-list
20204319|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20204320|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20204321|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204322|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348735|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
19348736|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19348737|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348738|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348739|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19348740|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
19348741|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19348742|NCT03749408|Mannitol|mannitol|mesh-list
19348743|NCT03749408|Bupivacaine|bupivacaine|mesh-list
19348744|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
19348745|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
19348746|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348747|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348748|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
19348749|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348750|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19348751|NCT03749408|Diuretics|diuretics|mesh-ancestor
19348752|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
19348753|NCT03749356|Tacrolimus|tacrolimus|mesh-list
19348754|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348755|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
19348756|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348757|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19348758|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348759|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348760|NCT03749226|Aztreonam|aztreonam|mesh-list
19348761|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19348762|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348763|NCT03749174|Anesthetics|anesthetics|mesh-list
19348764|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348765|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348766|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
19348767|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19348768|NCT03749096|Antibodies|antibodies|mesh-list
19348769|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
19348770|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19348771|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
19348772|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348773|NCT03749018|Prednisone|prednisone|mesh-list
19348774|NCT03749018|Cortisone|cortisone|mesh-list
19348775|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
19348776|NCT03749018|Rituximab|rituximab|mesh-list
19348777|NCT03749018|Doxorubicin|doxorubicin|mesh-list
19348778|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19348779|NCT03749018|Nivolumab|nivolumab|mesh-list
19348780|NCT03749018|Etoposide|etoposide|mesh-list
19348781|NCT03749018|Vincristine|vincristine|mesh-list
19348782|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
19348783|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
19348784|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20204323|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20204324|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204325|NCT00263094|Analgesics|analgesics|mesh-ancestor
20204326|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
20204327|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204328|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204329|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204330|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204331|NCT00263133|Sertraline|sertraline|mesh-list
20204332|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
20204333|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20204334|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20204335|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20204336|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348785|NCT03749018|Antibodies|antibodies|mesh-list
19348786|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
19348787|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19348788|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19348789|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
19348790|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348791|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348792|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19348793|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
19348794|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348795|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348796|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19348797|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19348798|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19348799|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19348800|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348801|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348802|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
19348803|NCT03749018|Hormones|hormones|mesh-ancestor
19348804|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348805|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19348806|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20204337|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204338|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204339|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
20204340|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204341|NCT00263185|Vitamin D|vitamin d|mesh-list
19348807|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19348808|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204342|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
20204343|NCT00263185|Vitamins|vitamins|mesh-list
20204344|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
20204345|NCT00263185|Calcium|calcium|mesh-list
20204346|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
20204347|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204348|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20204349|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20204350|NCT00263185|Antacids|antacids|mesh-ancestor
20204351|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204352|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20204353|NCT00263198|Letrozole|letrozole|mesh-list
20204354|NCT00263198|Vatalanib|vatalanib|mesh-list
20204355|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204356|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20204357|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20204358|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204359|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348809|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19348810|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19348811|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
19348812|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
19348813|NCT03748940|Mirikizumab|mirikizumab|mesh-list
19684387|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20204360|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20204361|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
20204362|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204363|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204364|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20204365|NCT00263263|Sirolimus|sirolimus|mesh-list
20204366|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20204367|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204368|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20204369|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204370|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
20204371|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204372|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
20204373|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204374|NCT00263276|Metformin|metformin|mesh-list
20204375|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
20204376|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20204377|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204378|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20204379|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204380|NCT00263302|Dexamethasone|dexamethasone|mesh-list
20204381|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348814|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19684388|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204382|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
20204383|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
19348815|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19348816|NCT03748940|Analgesics|analgesics|mesh-ancestor
19348817|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
19348818|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348819|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348820|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348821|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19348822|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19348823|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400779|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19400780|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19400781|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400782|NCT03623256|Fentanyl|fentanyl|mesh-list
19400783|NCT03623256|Bupivacaine|bupivacaine|mesh-list
19400784|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400785|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
19400786|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400787|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400788|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
19400789|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400790|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19400791|NCT03623256|Narcotics|narcotics|mesh-ancestor
19400792|NCT03623256|Analgesics|analgesics|mesh-ancestor
19400793|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19684389|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684390|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684391|NCT01904032|Vitamin D|vitamin d|mesh-list
19684392|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
19400794|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19400795|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
19400796|NCT03623230|Bupivacaine|bupivacaine|mesh-list
19400797|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19400798|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400799|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
19400800|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400801|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400802|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
20389923|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389924|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389925|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20389926|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
20389927|NCT01072071|Furosemide|furosemide|mesh-list
20389928|NCT01072071|Diuretics|diuretics|mesh-ancestor
20389929|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
20389930|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400803|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684393|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
19684394|NCT01904032|Vitamins|vitamins|mesh-list
20204384|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204385|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204386|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20204387|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
20204388|NCT00263302|Hormones|hormones|mesh-ancestor
20204389|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204390|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204391|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204392|NCT00263315|Amphotericin B|amphotericin b|mesh-list
20204393|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20204394|NCT00263315|Amebicides|amebicides|mesh-ancestor
20204395|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20204396|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20204397|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204398|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20204399|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
20204400|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
20204401|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204402|NCT00263393|Atenolol|atenolol|mesh-list
20204403|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20204404|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20204405|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20204406|NCT00263393|Diuretics|diuretics|mesh-ancestor
20204407|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
20204408|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426524|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19400804|NCT03623087|Gemcitabine|gemcitabine|mesh-list
19400805|NCT03623087|Dexamethasone|dexamethasone|mesh-list
19348824|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
19348825|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348826|NCT03748446|Xenon|xenon|mesh-list
19348827|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19348828|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
19348829|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
19348830|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348831|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348832|NCT03748303|Pregnanolone|pregnanolone|mesh-list
19348833|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
19348834|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348835|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348836|NCT03748290|Pregabalin|pregabalin|mesh-list
19348837|NCT03748290|Analgesics|analgesics|mesh-ancestor
19348838|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
19348839|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348840|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348841|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
19348842|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19348843|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348844|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348845|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19348846|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19348847|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348848|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348849|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19348850|NCT03748173|Calfactant|calfactant|mesh-list
19348851|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19348852|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348853|NCT03748147|Misoprostol|misoprostol|mesh-list
19348854|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19348855|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
19348856|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19348857|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348858|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19348859|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19348860|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
19348861|NCT03748108|Lidocaine|lidocaine|mesh-list
19684395|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
19684396|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684397|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19684398|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20204409|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20204410|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204411|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204412|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20204413|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
20204414|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
20204415|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204416|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20204417|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19684399|NCT01876953|Cytarabine|cytarabine|mesh-list
19684400|NCT01876953|Dasatinib|dasatinib|mesh-list
19684401|NCT01876953|Idarubicin|idarubicin|mesh-list
19684402|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19684403|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
19684404|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684405|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843604|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204418|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20204419|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
20204420|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204421|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
20204422|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348862|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
19684406|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
19843605|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19843606|NCT00660010|Leuprolide|leuprolide|mesh-list
19843607|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19843608|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
19843609|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19843610|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204423|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19848241|NCT00691704|Melphalan|melphalan|mesh-list
19348863|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
20204424|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
19348864|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348865|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348866|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
19348867|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348868|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19348869|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19348870|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20204425|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204426|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204427|NCT00263458|Buprenorphine|buprenorphine|mesh-list
20204428|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20204429|NCT00263458|Narcotics|narcotics|mesh-ancestor
20204430|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684407|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204431|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204432|NCT00263458|Analgesics|analgesics|mesh-ancestor
20204433|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
20204434|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204435|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20204436|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
19348871|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348872|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348873|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
19348874|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19348875|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
19348876|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348877|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204437|NCT00263484|Thalidomide|thalidomide|mesh-list
19684408|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684409|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
19684410|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204438|NCT00263484|Dexamethasone|dexamethasone|mesh-list
20204439|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
20204440|NCT00263484|BB 1101|bb 1101|mesh-list
20204441|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204442|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
19348878|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19348879|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348880|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19348881|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
19348882|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348883|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348884|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19348885|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
19348886|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
19348887|NCT03748082|Protective Agents|protective agents|mesh-ancestor
19348888|NCT03748043|Lactoferrin|lactoferrin|mesh-list
19348889|NCT03748043|Teferrol|teferrol|mesh-list
19348890|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19348891|NCT03748043|Hematinics|hematinics|mesh-ancestor
20204443|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
20204444|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204445|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204446|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20204447|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
20204448|NCT00263484|Hormones|hormones|mesh-ancestor
20204449|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348892|NCT03747978|Amlodipine|amlodipine|mesh-list
19348893|NCT03747978|Perindopril|perindopril|mesh-list
19348894|NCT03747978|Indapamide|indapamide|mesh-list
19348895|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
19348896|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20204450|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204451|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204452|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
20204453|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204454|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204455|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204456|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
20204457|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
20204458|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20204459|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204460|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20204461|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19348897|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19348898|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348899|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348900|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19348901|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348902|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
19348903|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19348904|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
19348905|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348906|NCT03747978|Diuretics|diuretics|mesh-ancestor
19348907|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
19348908|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19348909|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
19348910|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19348911|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19348912|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19348913|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19348914|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348915|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
19348916|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348917|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204462|NCT00263484|Growth Substances|growth substances|mesh-ancestor
20204463|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
20204464|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20204465|NCT00263705|Capecitabine|capecitabine|mesh-list
20204466|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204467|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
20204468|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204469|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204470|NCT00263718|Betamethasone|betamethasone|mesh-list
20204471|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
20204472|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20204473|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
20204474|NCT00263718|Calcipotriene|calcipotriene|mesh-list
20204475|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19348918|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19348919|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348920|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19348921|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389931|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20389932|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20389933|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389934|NCT01072097|Atorvastatin|atorvastatin|mesh-list
20389935|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19348922|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348923|NCT03747679|Mannitol|mannitol|mesh-list
19348924|NCT03747679|Sorbitol|sorbitol|mesh-list
19348925|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19348926|NCT03747679|Diuretics|diuretics|mesh-ancestor
19348927|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
19348928|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348929|NCT03747679|Cathartics|cathartics|mesh-ancestor
19348930|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19348931|NCT03747614|Fluorometholone|fluorometholone|mesh-list
19348932|NCT03747614|Tacrolimus|tacrolimus|mesh-list
20204476|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204477|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
20389936|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20389937|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
20389938|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389939|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20389940|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20389941|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389942|NCT01072175|Trametinib|trametinib|mesh-list
20389943|NCT01072175|Dabrafenib|dabrafenib|mesh-list
20389944|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19348933|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843611|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204478|NCT00263718|Hormones|hormones|mesh-ancestor
20204479|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204480|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204481|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20204482|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348934|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
19348935|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348936|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19348937|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19348938|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348939|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19348940|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
19348941|NCT03747614|Hormones|hormones|mesh-ancestor
19348942|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19348943|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19348944|NCT03747562|Gabapentin|gabapentin|mesh-list
19348945|NCT03747562|Analgesics|analgesics|mesh-ancestor
19348946|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
19348947|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843612|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843613|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
19843614|NCT00660023|Hematinics|hematinics|mesh-ancestor
19843615|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20389945|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389946|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389947|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389948|NCT01072240|Rituximab|rituximab|mesh-list
20389949|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20389950|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389951|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
20389952|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348948|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348949|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
19348950|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19348951|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19348952|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348953|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19348954|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19348955|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19348956|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348957|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348958|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
19348959|NCT03747536|Bromides|bromides|mesh-list
19348960|NCT03747536|Ipratropium|ipratropium|mesh-list
19348961|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
19348962|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19348963|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
19348964|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348965|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348966|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19348967|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
19348968|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19348969|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
19348970|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19348971|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348972|NCT03747523|Vitamin D|vitamin d|mesh-list
19348973|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
19348974|NCT03747523|Vitamins|vitamins|mesh-ancestor
19348975|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
20204483|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
20204484|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20204485|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20204486|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
20204487|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348976|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348977|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19348978|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19348979|NCT03747341|Fentanyl|fentanyl|mesh-list
19348980|NCT03747341|Oxycodone|oxycodone|mesh-list
19348981|NCT03747341|Buprenorphine|buprenorphine|mesh-list
19348982|NCT03747341|Ondansetron|ondansetron|mesh-list
19843616|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20204488|NCT00263744|Antacids|antacids|mesh-ancestor
20204489|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204490|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20204491|NCT00263796|Oxytocin|oxytocin|mesh-list
20204492|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
20204493|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20389953|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19843617|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843618|NCT00660075|Incretins|incretins|mesh-ancestor
20389954|NCT01072318|Letrozole|letrozole|mesh-list
20204494|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204495|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20204496|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204497|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20204498|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204499|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204500|NCT00263965|Metformin|metformin|mesh-list
20204501|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20204502|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204503|NCT00263978|Defibrotide|defibrotide|mesh-list
20204504|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20204505|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19348983|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19348984|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19348985|NCT03747341|Narcotics|narcotics|mesh-ancestor
20389955|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389956|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20389957|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20389958|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389959|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19348986|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19348987|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19348988|NCT03747341|Analgesics|analgesics|mesh-ancestor
19348989|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
19348990|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19348991|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19348992|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19348993|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
19348994|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
19348995|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19348996|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
19348997|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
19348998|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19348999|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
20204506|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204507|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20204508|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
20204509|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
19349000|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
19349001|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19349002|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
19349003|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349004|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349005|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19349006|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19349007|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19349008|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19349009|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
20389960|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20389961|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
20389962|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20389963|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389964|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
20389965|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20389966|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389967|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20389968|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389969|NCT01072604|Aspirin|aspirin|mesh-list
20389970|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20389971|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204510|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19349010|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204511|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20204512|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204513|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204514|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
20204515|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19684411|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19684412|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684413|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20204516|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349011|NCT03747094|Fentanyl|fentanyl|mesh-list
19349012|NCT03747094|Ketamine|ketamine|mesh-list
19349013|NCT03747094|Analgesics|analgesics|mesh-ancestor
19349014|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
19349015|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349016|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349017|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19349018|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19349019|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
19349020|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
19349021|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349022|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19349023|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19349024|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349025|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349026|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19349027|NCT03747094|Narcotics|narcotics|mesh-ancestor
19349028|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19349029|NCT03747081|Warfarin|warfarin|mesh-list
19349030|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
19684414|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19684415|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19684416|NCT01850355|Buspirone|buspirone|mesh-list
19684417|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19684418|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19684419|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684420|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684421|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19684422|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19684423|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
19684424|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684425|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684426|NCT01799629|Glycerol|glycerol|mesh-list
19684427|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19684428|NCT01799629|Protective Agents|protective agents|mesh-ancestor
19684429|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684430|NCT01772472|Trastuzumab|trastuzumab|mesh-list
19684431|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19843619|NCT00660075|Hormones|hormones|mesh-ancestor
19843620|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843621|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20389972|NCT01072604|Analgesics|analgesics|mesh-ancestor
20389973|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
20389974|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20389975|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389976|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20389977|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20389978|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20389979|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20389980|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349031|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
19349032|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19349033|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
19349034|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19349035|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
19349036|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349037|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400806|NCT03623087|Etoposide|etoposide|mesh-list
19400807|NCT03623087|Asparaginase|asparaginase|mesh-list
19400808|NCT03623087|Ifosfamide|ifosfamide|mesh-list
19843622|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
19843623|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843624|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843625|NCT00660179|Macitentan|macitentan|mesh-list
20204517|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
20204518|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
20204519|NCT00264108|Hematinics|hematinics|mesh-ancestor
20204520|NCT00264134|Carboplatin|carboplatin|mesh-list
20204521|NCT00264134|Docetaxel|docetaxel|mesh-list
20204522|NCT00264134|Irinotecan|irinotecan|mesh-list
20204523|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204524|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204525|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
20204526|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
20389981|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19400809|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684432|NCT01772472|Maytansine|maytansine|mesh-list
20204527|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204528|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19349038|NCT03746821|Biotin|biotin|mesh-list
19349039|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
19349040|NCT03746821|Vitamins|vitamins|mesh-ancestor
19349041|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
19349042|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349043|NCT03746782|Thrombin|thrombin|mesh-list
19349044|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
19349045|NCT03746782|Coagulants|coagulants|mesh-ancestor
19349046|NCT03746691|Citalopram|citalopram|mesh-list
19349047|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19349048|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19349049|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19349050|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349051|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349052|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
20389982|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20389983|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20389984|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
20389985|NCT01072695|Ribavirin|ribavirin|mesh-list
20389986|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20389987|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
20389988|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20389989|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
20389990|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349053|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349054|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19349055|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
19349056|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19349057|NCT03746652|Dexamethasone|dexamethasone|mesh-list
19349058|NCT03746652|Daratumumab|daratumumab|mesh-list
19349059|NCT03746652|Ixazomib|ixazomib|mesh-list
19349060|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349061|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
19349062|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
19349063|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349064|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349065|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349066|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
19349067|NCT03746652|Hormones|hormones|mesh-ancestor
19349068|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349069|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19349070|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349071|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
19349072|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349073|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349074|NCT03746444|Anesthetics|anesthetics|mesh-list
19349075|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349076|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684433|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684434|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684435|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19684436|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19684437|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684438|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684439|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684440|NCT01764711|Cosyntropin|cosyntropin|mesh-list
19684441|NCT01764711|Hormones|hormones|mesh-ancestor
19684442|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684443|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684444|NCT01553071|Fenretinide|fenretinide|mesh-list
19684445|NCT01553071|Safingol|safingol|mesh-list
19684446|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20389991|NCT01072734|Vaccines|vaccines|mesh-list
19349077|NCT03746366|Corticosterone|corticosterone|mesh-list
19349078|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349079|NCT03746340|Propofol|propofol|mesh-list
19349080|NCT03746340|Sevoflurane|sevoflurane|mesh-list
20389992|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
20389993|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20389994|NCT01072747|Heparin|heparin|mesh-list
20389995|NCT01072747|Calcium heparin|calcium heparin|mesh-list
20389996|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
19349081|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19349082|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20389997|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19349083|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349084|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19349085|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
19349086|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
19349087|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19349088|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19349089|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
19349090|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19349091|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349092|NCT03746249|Lenvatinib|lenvatinib|mesh-list
19349093|NCT03746249|Antibodies|antibodies|mesh-list
19349094|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
19349095|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
19349096|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349097|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349098|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20389998|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20389999|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390000|NCT01072786|Vaccines|vaccines|mesh-list
20390001|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
20390002|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390003|NCT01072812|Phenserine|phenserine|mesh-list
20390004|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20390005|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390006|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390007|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
20390008|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390009|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390010|NCT01072890|Sirolimus|sirolimus|mesh-list
20390011|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19349099|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349100|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349101|NCT03746223|Rituximab|rituximab|mesh-list
19349102|NCT03746223|Methotrexate|methotrexate|mesh-list
19349103|NCT03746223|Lenalidomide|lenalidomide|mesh-list
19349104|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349105|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349106|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
19349107|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349108|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349109|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19349110|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
19349111|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19349112|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19349113|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
19349114|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349115|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
19349116|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349117|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19349118|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19349119|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20204529|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204530|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204531|NCT00264173|Valproic Acid|valproic acid|mesh-list
20204532|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
20204533|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684447|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19684448|NCT01553071|Protective Agents|protective agents|mesh-ancestor
19684449|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684450|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684451|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684452|NCT01551472|Vitamin E|vitamin e|mesh-list
19349120|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20390012|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390013|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20390014|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390015|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
20390016|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20390017|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
20390018|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349121|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19684453|NCT01551472|Vitamins|vitamins|mesh-ancestor
20204534|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204535|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
20204536|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204537|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390019|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
20204538|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
20204539|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20204540|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204541|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20204542|NCT00264186|Norepinephrine|norepinephrine|mesh-list
20204543|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
20204544|NCT00264186|Acetylcholine|acetylcholine|mesh-list
19349122|NCT03746223|Growth Substances|growth substances|mesh-ancestor
19349123|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
19349124|NCT03746158|Curcumin|curcumin|mesh-list
19349125|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19349126|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349127|NCT03746158|Analgesics|analgesics|mesh-ancestor
19349128|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
19349129|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349130|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349131|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349132|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349133|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349134|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349135|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349136|NCT03746119|Nicotine|nicotine|mesh-list
19349137|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19349138|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
19349139|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349140|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349141|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19349142|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19349143|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
19349144|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349145|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349146|NCT03746106|Thiamine|thiamine|mesh-list
19349147|NCT03746106|Metformin|metformin|mesh-list
19349148|NCT03746106|Trimethoprim|trimethoprim|mesh-list
19349149|NCT03746106|Vitamins|vitamins|mesh-ancestor
19349150|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
19349151|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349152|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19349153|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
19349154|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19349155|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349156|NCT03746106|Renal Agents|renal agents|mesh-ancestor
20204545|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20204546|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20204547|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
20204548|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204549|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349157|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
19349158|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19349159|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19349160|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19349161|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349162|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349163|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19349164|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19349165|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19349166|NCT03745950|Olaparib|olaparib|mesh-list
19684454|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
19684455|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204550|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204551|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
20204552|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
19349167|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19349168|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349169|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349170|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204553|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204554|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19349171|NCT03745911|Paclitaxel|paclitaxel|mesh-list
19349172|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19349173|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349174|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
19349175|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684456|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
19693153|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20204555|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
19349176|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
19349177|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349178|NCT03745807|Nivolumab|nivolumab|mesh-list
19349179|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684457|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684458|NCT01551472|Protective Agents|protective agents|mesh-ancestor
19684459|NCT01506973|Gemcitabine|gemcitabine|mesh-list
19349180|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390020|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20390021|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390022|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20390023|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20390024|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390025|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390026|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390027|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20390028|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19684460|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
19684461|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19684462|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19684463|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
19684464|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684465|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684466|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
20204556|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20204557|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
19349181|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19349182|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349183|NCT03745716|Azacitidine|azacitidine|mesh-list
19349184|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19349185|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
19349186|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349187|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349188|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349189|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
19349190|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19349191|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19349192|NCT03745664|Prednisolone|prednisolone|mesh-list
19349193|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
20204558|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20204559|NCT00264212|Irbesartan|irbesartan|mesh-list
20204560|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20204561|NCT00264212|Diuretics|diuretics|mesh-ancestor
20204562|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
20204563|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204564|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20204565|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204566|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204567|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20204568|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20204569|NCT00264225|Codeine|codeine|mesh-list
19843626|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19349194|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19349195|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
19349196|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349197|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
19349198|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
19349199|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349200|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349201|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843627|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19843628|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843629|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19843630|NCT00660309|Irbesartan|irbesartan|mesh-list
19843631|NCT00660309|Captopril|captopril|mesh-list
19843632|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19843633|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19843634|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19843635|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204570|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20204571|NCT00264225|Narcotics|narcotics|mesh-ancestor
19349202|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
20204572|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204573|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204574|NCT00264225|Analgesics|analgesics|mesh-ancestor
19349203|NCT03745664|Hormones|hormones|mesh-ancestor
19349204|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390029|NCT01072955|Heparin|heparin|mesh-list
20390030|NCT01072955|Calcium heparin|calcium heparin|mesh-list
20204575|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
20204576|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204577|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
20204578|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
20204579|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
20204580|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20204581|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204582|NCT00264277|Vitamin K|vitamin k|mesh-list
20204583|NCT00264277|Anticoagulants|anticoagulants|mesh-list
20204584|NCT00264277|Vitamins|vitamins|mesh-ancestor
20390031|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
20390032|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20390033|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20390034|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390035|NCT01073007|Simvastatin|simvastatin|mesh-list
20390036|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20390037|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20390038|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
20390039|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390040|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20390041|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20390042|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390043|NCT01073059|Ertapenem|ertapenem|mesh-list
20390044|NCT01073059|Valproic Acid|valproic acid|mesh-list
19349205|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19349206|NCT03745664|Protective Agents|protective agents|mesh-ancestor
19349207|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19349208|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349209|NCT03745625|Propofol|propofol|mesh-list
20390045|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
20390046|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390047|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349210|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19349211|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349212|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349213|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19349214|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
19349215|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
19349216|NCT03745599|Diclofenac|diclofenac|mesh-list
19349217|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
19349218|NCT03745599|Benzydamine|benzydamine|mesh-list
19349219|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19349220|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349221|NCT03745599|Analgesics|analgesics|mesh-ancestor
19349222|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
19349223|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349224|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349225|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349226|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349227|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19349228|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349229|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349230|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
19349231|NCT03745586|Hormones|hormones|mesh-ancestor
19349232|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349233|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349234|NCT03745404|Lidocaine|lidocaine|mesh-list
19349235|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
19349236|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
19349237|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349238|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349239|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
19349240|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349241|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20390048|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
19349242|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19693154|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
19693155|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693156|NCT04982549|Paclitaxel|paclitaxel|mesh-list
19349243|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20204585|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
20204586|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204587|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20204588|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20204589|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204590|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
20204591|NCT00264277|Coagulants|coagulants|mesh-ancestor
20204592|NCT00264355|Cyclosporine|cyclosporine|mesh-list
20204593|NCT00264355|Cyclosporins|cyclosporins|mesh-list
19684467|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684468|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684469|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204594|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204595|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204596|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19349244|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19349245|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349246|NCT03745300|Atorvastatin|atorvastatin|mesh-list
19349247|NCT03745300|Simvastatin|simvastatin|mesh-list
19349248|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19349249|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19349250|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
19349251|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349252|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19349253|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19349254|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349255|NCT03745261|Fluticasone|fluticasone|mesh-list
19684470|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
20204597|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
20204598|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204599|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
20204600|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204601|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
20204602|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204603|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20204604|NCT00264368|Ganciclovir|ganciclovir|mesh-list
20204605|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20204606|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
20204607|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204608|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20204609|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204610|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204611|NCT00264407|Hormones|hormones|mesh-list
20204612|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204613|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204614|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
20204615|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20204616|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204617|NCT00264446|Eniluracil|eniluracil|mesh-list
20204618|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204619|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204620|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
20204621|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204622|NCT00264472|Eniluracil|eniluracil|mesh-list
20204623|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204624|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204625|NCT00264485|Fentanyl|fentanyl|mesh-list
20204626|NCT00264485|Morphine|morphine|mesh-list
20204627|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20204628|NCT00264485|Narcotics|narcotics|mesh-ancestor
20204629|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204630|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204631|NCT00264485|Analgesics|analgesics|mesh-ancestor
20204632|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
20204633|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204634|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20204635|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20204636|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
20204637|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
20204638|NCT00264615|Lamotrigine|lamotrigine|mesh-list
20204639|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
20204640|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19693157|NCT04982549|Carboplatin|carboplatin|mesh-list
20204641|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19349256|NCT03745261|Xhance|xhance|mesh-list
19349257|NCT03745261|Bromides|bromides|mesh-list
19349258|NCT03745261|Albuterol|albuterol|mesh-list
19349259|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
19349260|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20204642|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204643|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20204644|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204645|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20204646|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20204647|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204648|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20204649|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20204650|NCT00264628|Casopitant|casopitant|mesh-list
20204651|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
20204652|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
20204653|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204654|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204655|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20204656|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20204657|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204658|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204659|NCT00264654|Paroxetine|paroxetine|mesh-list
20204660|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19349261|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19349262|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349263|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20204661|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20204662|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19349264|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
19349265|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349266|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349267|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19349268|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
19349269|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
19349270|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19349271|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
19349272|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19349273|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
19349274|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349275|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349276|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19349277|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19349278|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19349279|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
19349280|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
19349281|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
19349282|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19349283|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
19349284|NCT03745261|Hormones|hormones|mesh-ancestor
19349285|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349286|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
19349287|NCT03745170|Capecitabine|capecitabine|mesh-list
19349288|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
19349289|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19349290|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
19349291|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349292|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349293|NCT03745157|Insulin|insulin|mesh-list
19349294|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
20204663|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204664|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204665|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
20204666|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349295|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19349296|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349297|NCT03745105|Dexamethasone|dexamethasone|mesh-list
19349298|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
19349299|NCT03745105|Piroxicam|piroxicam|mesh-list
19349300|NCT03745105|Mepivacaine|mepivacaine|mesh-list
19349301|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19349302|NCT03745105|BB 1101|bb 1101|mesh-list
19349303|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349304|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
19349305|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
19693158|NCT04982549|Pemetrexed|pemetrexed|mesh-list
19349306|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349307|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349308|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349309|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
19349310|NCT03745105|Hormones|hormones|mesh-ancestor
19349311|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349312|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19349313|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349314|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
19349315|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
19349316|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204667|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20204668|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
20204669|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20204670|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20204671|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19349317|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
19349318|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
19349319|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349320|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349321|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20390049|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390050|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390051|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
20390052|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20390053|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390054|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390055|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20390056|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390057|NCT01073111|Sirolimus|sirolimus|mesh-list
19349322|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349323|NCT03745105|Analgesics|analgesics|mesh-ancestor
19349324|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349325|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19349326|NCT03745040|Bupivacaine|bupivacaine|mesh-list
20204672|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204673|NCT00264680|Lamotrigine|lamotrigine|mesh-list
20204674|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
20204675|NCT00264680|Valproic Acid|valproic acid|mesh-list
20204676|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20204677|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204678|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204679|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20204680|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204681|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20204682|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20204683|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390058|NCT01073111|Everolimus|everolimus|mesh-list
20390059|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390060|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20390061|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
20390062|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390063|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20390064|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204684|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19684471|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684472|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
20204685|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20390065|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20390066|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
20390067|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
20204686|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204687|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
20204688|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204689|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
20217752|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20217753|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217754|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20217755|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390068|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20390069|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390070|NCT01073189|Fenoldopam|fenoldopam|mesh-list
19684473|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20390071|NCT01073189|Furosemide|furosemide|mesh-list
20390072|NCT01073189|Diuretics|diuretics|mesh-ancestor
19684474|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19684475|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684476|NCT01347970|Carvedilol|carvedilol|mesh-list
19684477|NCT01347970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19684478|NCT01347970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19684479|NCT01347970|Adrenergic Agents|adrenergic agents|mesh-ancestor
19684480|NCT01347970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684481|NCT01347970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684482|NCT01347970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684483|NCT01347970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390073|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
20390074|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390075|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20390076|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20390077|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390078|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390079|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
20390080|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
20390081|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
20390082|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390083|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20390084|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20390085|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426525|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20426526|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426527|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426528|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
20426529|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426530|NCT01281696|Bevacizumab|bevacizumab|mesh-list
20426531|NCT01281696|Methotrexate|methotrexate|mesh-list
20426532|NCT01281696|Etoposide|etoposide|mesh-list
20426533|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20204690|NCT00264719|Metoclopramide|metoclopramide|mesh-list
20204691|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
20204692|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
20204693|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204694|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204695|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426534|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426535|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20426536|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20426537|NCT01281696|Growth Substances|growth substances|mesh-ancestor
20426538|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426539|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
20426540|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20426541|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
20426542|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20426543|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20426544|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
20426545|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426546|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
20426547|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426548|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20426549|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426550|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
20426551|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426552|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20426553|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20426554|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20426555|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20426556|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
20426557|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19349327|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
19349328|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
20204696|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20204697|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20204698|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
20204699|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204700|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204701|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
19684484|NCT01347970|Antioxidants|antioxidants|mesh-ancestor
19684485|NCT01347970|Protective Agents|protective agents|mesh-ancestor
20204702|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20204703|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204704|NCT00264914|Satavaptan|satavaptan|mesh-list
20204705|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20204706|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204707|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
20390086|NCT01073319|Rivastigmine|rivastigmine|mesh-list
20390087|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20390088|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390089|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390090|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
20390091|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204708|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204709|NCT00264927|Satavaptan|satavaptan|mesh-list
20204710|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20204711|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204712|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
20204713|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204714|NCT00264953|Prednisone|prednisone|mesh-list
20204715|NCT00264953|Etoposide|etoposide|mesh-list
20204716|NCT00264953|Vincristine|vincristine|mesh-list
20204717|NCT00264953|Doxorubicin|doxorubicin|mesh-list
20204718|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20390092|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390093|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20390094|NCT01073319|Protective Agents|protective agents|mesh-ancestor
20390095|NCT01073332|Antioxidants|antioxidants|mesh-list
20390096|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390097|NCT01073332|Protective Agents|protective agents|mesh-ancestor
20390098|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390099|NCT01073371|Prilocaine|prilocaine|mesh-list
19349329|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349330|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843636|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19843637|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
19349331|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
19349332|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349333|NCT03744988|Androgens|androgens|mesh-list
19349334|NCT03744988|Hormones|hormones|mesh-ancestor
19349335|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349336|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349337|NCT03744949|Remifentanil|remifentanil|mesh-list
19349338|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19349339|NCT03744949|Narcotics|narcotics|mesh-ancestor
19349340|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349341|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349342|NCT03744949|Analgesics|analgesics|mesh-ancestor
19349343|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
19349344|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400810|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19400811|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
19843638|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843639|NCT00660387|Levodopa|levodopa|mesh-list
19843640|NCT00660387|Carbidopa|carbidopa|mesh-list
19843641|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19843642|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19843643|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19843644|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
19843645|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843646|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204719|NCT00264953|Bleomycin|bleomycin|mesh-list
20204720|NCT00264953|Vinblastine|vinblastine|mesh-list
20390100|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400812|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
19400813|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400814|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400815|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19400816|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
19400817|NCT03623087|Hormones|hormones|mesh-ancestor
19693159|NCT04982549|Durvalumab|durvalumab|mesh-list
19693160|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19693161|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693162|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
19693163|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
19693164|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
19693165|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349345|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19349346|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349347|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349348|NCT03744806|Bevacizumab|bevacizumab|mesh-list
19349349|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349350|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349351|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19349352|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19349353|NCT03744806|Growth Substances|growth substances|mesh-ancestor
19349354|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349355|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
19349356|NCT03744767|Spironolactone|spironolactone|mesh-list
19349357|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19349358|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
19349359|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349360|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390101|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
20390102|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349361|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19349362|NCT03744767|Diuretics|diuretics|mesh-ancestor
19349363|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
19349364|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
19349365|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
19349366|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349367|NCT03744702|Protective Agents|protective agents|mesh-ancestor
19349368|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349369|NCT03744702|Vitamins|vitamins|mesh-ancestor
19349370|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
19349371|NCT03744689|Bupivacaine|bupivacaine|mesh-list
19349372|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
19349373|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
19349374|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349375|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349376|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
19349377|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349378|NCT03744663|Buprenorphine|buprenorphine|mesh-list
19349379|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19349380|NCT03744663|Naloxone|naloxone|mesh-list
19349381|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19349382|NCT03744663|Narcotics|narcotics|mesh-ancestor
19349383|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349384|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349385|NCT03744663|Analgesics|analgesics|mesh-ancestor
19349386|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
20390103|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390104|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
20390105|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390106|NCT01073384|Beclomethasone|beclomethasone|mesh-list
20390107|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390108|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
20390109|NCT01073384|Hormones|hormones|mesh-ancestor
20390110|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390111|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390112|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20390113|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
20390114|NCT01073501|Pregabalin|pregabalin|mesh-list
20390115|NCT01073501|Analgesics|analgesics|mesh-ancestor
20390116|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
20390117|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390118|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390119|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
20390120|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20390121|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20390122|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390123|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20390124|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20390125|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20390126|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390127|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390128|NCT01073527|Adenosine|adenosine|mesh-list
20390129|NCT01073527|Albuterol|albuterol|mesh-list
20390130|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20390131|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
20390132|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349387|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349388|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19349389|NCT03744364|Misoprostol|misoprostol|mesh-list
19349390|NCT03744364|Dinoprostone|dinoprostone|mesh-list
19349391|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19349392|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
19349393|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19349394|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390133|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390134|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20390135|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
20390136|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
20390137|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390138|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20390139|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20390140|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19349395|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19349396|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349397|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
19349398|NCT03744247|Lenvatinib|lenvatinib|mesh-list
19349399|NCT03744247|Antibodies|antibodies|mesh-list
19349400|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
19349401|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
19349402|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349403|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349404|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19349405|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349406|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349407|NCT03744208|Cetuximab|cetuximab|mesh-list
19349408|NCT03744208|Antibodies|antibodies|mesh-list
19349409|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19349410|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
19349411|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349412|NCT03744208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349413|NCT03744208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349414|NCT03744104|Vaccines|vaccines|mesh-list
19349415|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
19349416|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349417|NCT03744091|Dronabinol|dronabinol|mesh-list
19349418|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
19349419|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349420|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19349421|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349422|NCT03744091|Analgesics|analgesics|mesh-ancestor
19843647|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843648|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19843649|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349423|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
19349424|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349425|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19349426|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19349427|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349428|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390141|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390142|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390143|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390144|NCT01073527|Analgesics|analgesics|mesh-ancestor
20390145|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
20390146|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20390147|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
20390148|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20390149|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
20390150|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
20390151|NCT01073540|Cephalexin|cephalexin|mesh-list
20390152|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19349429|NCT03744091|Hormones|hormones|mesh-ancestor
19349430|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349431|NCT03743987|Pemetrexed|pemetrexed|mesh-list
19349432|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349433|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349434|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390153|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390154|NCT01073553|Cephalexin|cephalexin|mesh-list
20390155|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19349435|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19349436|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19349437|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
19349438|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
19349439|NCT03743922|Vitamin D|vitamin d|mesh-list
19349440|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19349441|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349442|NCT03743922|Vitamins|vitamins|mesh-ancestor
19349443|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
19349444|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19349445|NCT03743896|Capsaicin|capsaicin|mesh-list
19349446|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
19349447|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
19349448|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
19349449|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349450|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349451|NCT03743883|Aspirin|aspirin|mesh-list
19349452|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19349453|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349454|NCT03743883|Analgesics|analgesics|mesh-ancestor
19349455|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
19349456|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349457|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349458|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349459|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349460|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19349461|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20390156|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390157|NCT01073579|Vigabatrin|vigabatrin|mesh-list
20390158|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
20390159|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390160|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390161|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
20390162|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349462|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349463|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19349464|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19349465|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349466|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
19349467|NCT03743870|Bupivacaine|bupivacaine|mesh-list
19349468|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
19349469|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
19349470|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
19349471|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349472|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349473|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
19349474|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349475|NCT03743805|Naloxone|naloxone|mesh-list
19349476|NCT03743805|Flumazenil|flumazenil|mesh-list
19349477|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19349478|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349479|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
19349480|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349481|NCT03743805|Antidotes|antidotes|mesh-ancestor
19349482|NCT03743805|Protective Agents|protective agents|mesh-ancestor
19349483|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
19349484|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
19349485|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349486|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349487|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
19349488|NCT03743727|Ledipasvir|ledipasvir|mesh-list
19349489|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19349490|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
19349491|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349492|NCT03743649|Lorazepam|lorazepam|mesh-list
19349493|NCT03743649|Haloperidol|haloperidol|mesh-list
19349494|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
19349495|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
19349496|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
19349497|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684486|NCT01347970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20390163|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349498|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349499|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349500|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19693166|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349501|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19349502|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390164|NCT01073644|Sunitinib|sunitinib|mesh-list
20390165|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390166|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20390167|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19349503|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390168|NCT01073644|Growth Substances|growth substances|mesh-ancestor
20390169|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390170|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
20390171|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20390172|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349504|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19349505|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
19349506|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349507|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349508|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19349509|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
19349510|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19349511|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19349512|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
19349513|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
19349514|NCT03743428|Bevacizumab|bevacizumab|mesh-list
19349515|NCT03743428|Apatinib|apatinib|mesh-list
19349516|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349517|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349518|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19349519|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19349520|NCT03743428|Growth Substances|growth substances|mesh-ancestor
19349521|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349522|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
19349523|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19349524|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349525|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390173|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390174|NCT01073670|Acetaminophen|acetaminophen|mesh-list
20390175|NCT01073670|Indomethacin|indomethacin|mesh-list
20390176|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349526|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
19349527|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19349528|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349529|NCT03743259|Charcoal|charcoal|mesh-list
19349530|NCT03743259|Antidotes|antidotes|mesh-ancestor
20204721|NCT00264953|Procarbazine|procarbazine|mesh-list
20390177|NCT01073670|Analgesics|analgesics|mesh-ancestor
20390178|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
20390179|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390180|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390181|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
20390182|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20390183|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390184|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349531|NCT03743259|Protective Agents|protective agents|mesh-ancestor
19349532|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204722|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204723|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
20204724|NCT00264953|Hormones|hormones|mesh-ancestor
20204725|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204726|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204727|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204728|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204729|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20204730|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20204731|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204732|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204733|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204734|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204735|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
20204736|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20204737|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20204738|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20204739|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20204740|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19349533|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
19349534|NCT03743246|Fludarabine|fludarabine|mesh-list
19349535|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204741|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349536|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
19349537|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349538|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349539|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19349540|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
19349541|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349542|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349543|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19349544|NCT03743103|Nitroprusside|nitroprusside|mesh-list
19349545|NCT03743103|Esmolol|esmolol|mesh-list
20390185|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
20390186|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
20390187|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390188|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20390189|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390190|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390191|NCT01073683|Docetaxel|docetaxel|mesh-list
20390192|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390193|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
20390194|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
20390195|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
20390196|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390197|NCT01073696|Granisetron|granisetron|mesh-list
19349546|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19349547|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
19349548|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19349549|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349550|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19349551|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19349552|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19349553|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
19349554|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349555|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349556|NCT03743025|Dulaglutide|dulaglutide|mesh-list
19349557|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20204742|NCT00265018|Doxorubicin|doxorubicin|mesh-list
20204743|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20204744|NCT00265018|Bleomycin|bleomycin|mesh-list
20204745|NCT00265018|Vinblastine|vinblastine|mesh-list
20204746|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20204747|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204748|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20204749|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204750|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204751|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204752|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20204753|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204754|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
20204755|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
20204756|NCT00265031|Prednisone|prednisone|mesh-list
20204757|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
20204758|NCT00265031|Etoposide|etoposide|mesh-list
20204759|NCT00265031|Vincristine|vincristine|mesh-list
20204760|NCT00265031|Doxorubicin|doxorubicin|mesh-list
20204761|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20204762|NCT00265031|Bleomycin|bleomycin|mesh-list
20204763|NCT00265031|Procarbazine|procarbazine|mesh-list
20204764|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204765|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
20204766|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204767|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204768|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20204769|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
20204770|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204771|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204772|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20204773|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204774|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
20204775|NCT00265031|Hormones|hormones|mesh-ancestor
20204776|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204777|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204778|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20204779|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20390198|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
20390199|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
20390200|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349558|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349559|NCT03742947|Hemostatics|hemostatics|mesh-list
19349560|NCT03742947|Coagulants|coagulants|mesh-ancestor
19400818|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400819|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19400820|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19400821|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
19400822|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400823|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
19400824|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400825|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400826|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19400827|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
19400828|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19400829|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19400830|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19400831|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19400832|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
19400833|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
19400834|NCT03623048|Propolis|propolis|mesh-list
19400835|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19400836|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400837|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
19400838|NCT03622918|Rifampin|rifampin|mesh-list
19400839|NCT03622918|Colistin|colistin|mesh-list
19400840|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19400841|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
19400842|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19400843|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400844|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
19400845|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19400846|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400847|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400848|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19400849|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19400850|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19400851|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19400852|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19400853|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19400854|NCT03622827|Endostar protein|endostar protein|mesh-list
19400855|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19400856|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19400857|NCT03622827|Growth Substances|growth substances|mesh-ancestor
19400858|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400859|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
19400860|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400861|NCT03622541|Sorafenib|sorafenib|mesh-list
19400862|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843650|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19843651|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
20204780|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204781|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204782|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204783|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20204784|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20204785|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20204786|NCT00265070|Gefitinib|gefitinib|mesh-list
20204787|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204788|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20204789|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400863|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19843652|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
19843653|NCT00660400|Azacitidine|azacitidine|mesh-list
19843654|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19843655|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
19843656|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843657|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843658|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843659|NCT00660504|Etoposide|etoposide|mesh-list
19843660|NCT00660504|Amrubicin|amrubicin|mesh-list
19843661|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843662|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19843663|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20204790|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349561|NCT03742921|Romidepsin|romidepsin|mesh-list
19349562|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19349563|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349564|NCT03742908|Clindamycin|clindamycin|mesh-list
19349565|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
19349566|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
19349567|NCT03742908|Cefazolin|cefazolin|mesh-list
19349568|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19349569|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349570|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19349571|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349572|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349573|NCT03742713|Docetaxel|docetaxel|mesh-list
19349574|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390201|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390202|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20390203|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20390204|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
20390205|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390206|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390207|NCT01073709|Acetaminophen|acetaminophen|mesh-list
20390208|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20390209|NCT01073709|Analgesics|analgesics|mesh-ancestor
20390210|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
20390211|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390212|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390213|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
20390214|NCT01073748|Acetaminophen|acetaminophen|mesh-list
20390215|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20390216|NCT01073748|Analgesics|analgesics|mesh-ancestor
20390217|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
20390218|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390219|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390220|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
20390221|NCT01073761|Ritonavir|ritonavir|mesh-list
20390222|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20390223|NCT01073761|Darunavir|darunavir|mesh-list
20390224|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20390225|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20390226|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
19349575|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
19349576|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
19349577|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
19349578|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349579|NCT03742557|Ketamine|ketamine|mesh-list
19349580|NCT03742557|Analgesics|analgesics|mesh-ancestor
19349581|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
19349582|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349583|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349584|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19349585|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19349586|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
19349587|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
19349588|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390227|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390228|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390229|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19349589|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19349590|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19349591|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349592|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349593|NCT03742531|Oxytocin|oxytocin|mesh-list
19349594|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
19349595|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19349596|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349597|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
19349598|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19349599|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19349600|NCT03742466|Prednisolone|prednisolone|mesh-list
19349601|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
19349602|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19349603|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
20390230|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20390231|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
19349604|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349605|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
20390232|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390233|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20390234|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20390235|NCT01073800|Atorvastatin|atorvastatin|mesh-list
20390236|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20390237|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20390238|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
20390239|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390240|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20390241|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20390242|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390243|NCT01073813|Minocycline|minocycline|mesh-list
20390244|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20390245|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390246|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20390247|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19349606|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
19349607|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349608|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349609|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349610|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
19349611|NCT03742466|Hormones|hormones|mesh-ancestor
19349612|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349613|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19349614|NCT03742466|Protective Agents|protective agents|mesh-ancestor
19349615|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19349616|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349617|NCT03742336|Dabigatran|dabigatran|mesh-list
19349618|NCT03742336|Abrocitinib|abrocitinib|mesh-list
19349619|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
19349620|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20390248|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390249|NCT01073826|Incretins|incretins|mesh-ancestor
20390250|NCT01073826|Hormones|hormones|mesh-ancestor
20390251|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390252|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20390253|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
20390254|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390255|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349621|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
19349622|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349623|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349624|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
19349625|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20390256|NCT01073839|Gemcitabine|gemcitabine|mesh-list
20390257|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390258|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20390259|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
20390260|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349626|NCT03742323|Idelalisib|idelalisib|mesh-list
19349627|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349628|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349629|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684487|NCT01347970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19684488|NCT01347970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19684489|NCT01347970|Vasodilator Agents|vasodilator agents|mesh-ancestor
19684490|NCT01347970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20204791|NCT00265135|Siltuximab|siltuximab|mesh-list
20204792|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204793|NCT00265252|Alendronate|alendronate|mesh-list
20204794|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20204795|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204796|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20204797|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20204798|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20204799|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204800|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204801|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
20204802|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204803|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204804|NCT00265278|Modafinil|modafinil|mesh-list
20204805|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20390261|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
20390262|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390263|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390264|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20390265|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
20390266|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390267|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
20390268|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
20390269|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20204806|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204807|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20204808|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20204809|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20204810|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684491|NCT01347970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19684492|NCT01187810|Cytarabine|cytarabine|mesh-list
19349630|NCT03742310|Vitamin D|vitamin d|mesh-list
19349631|NCT03742310|Calcitriol|calcitriol|mesh-list
19349632|NCT03742310|Vitamins|vitamins|mesh-ancestor
19349633|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
19349634|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349635|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19349636|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19349637|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19349638|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19349639|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390270|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19349640|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19349641|NCT03742297|Dexamethasone|dexamethasone|mesh-list
19349642|NCT03742297|Prednisone|prednisone|mesh-list
19349643|NCT03742297|Lenalidomide|lenalidomide|mesh-list
19349644|NCT03742297|Bortezomib|bortezomib|mesh-list
19349645|NCT03742297|Melphalan|melphalan|mesh-list
19349646|NCT03742297|Daratumumab|daratumumab|mesh-list
19349647|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349648|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
19349649|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
19349650|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349651|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349652|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349653|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
19349654|NCT03742297|Hormones|hormones|mesh-ancestor
19349655|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349656|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19349657|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349658|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
19349659|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19349660|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19349661|NCT03742297|Growth Substances|growth substances|mesh-ancestor
19349662|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
19843664|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20204811|NCT00265291|Fluoxetine|fluoxetine|mesh-list
20204812|NCT00265291|Desipramine|desipramine|mesh-list
20204813|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20204814|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20204815|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204816|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204817|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204818|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
19349663|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19349664|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
19349665|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349666|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19349667|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684493|NCT01187810|Methotrexate|methotrexate|mesh-list
19684494|NCT01187810|Fenretinide|fenretinide|mesh-list
19684495|NCT01187810|Retinamide|retinamide|mesh-list
19684496|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19684497|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
19684498|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684499|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684500|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19684501|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
19684502|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390271|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349668|NCT03742258|Prednisone|prednisone|mesh-list
19349669|NCT03742258|Cortisone|cortisone|mesh-list
19349670|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
19349671|NCT03742258|Rituximab|rituximab|mesh-list
20204819|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204820|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19349672|NCT03742258|Doxorubicin|doxorubicin|mesh-list
19349673|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19349674|NCT03742258|Vincristine|vincristine|mesh-list
19349675|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19349676|NCT03742258|Antibodies|antibodies|mesh-list
19349677|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
19349678|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19349679|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19349680|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
19349681|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349682|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349683|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19349684|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
19349685|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349686|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349687|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19349688|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19349689|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19349690|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19349691|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349692|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349693|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
19349694|NCT03742258|Hormones|hormones|mesh-ancestor
19349695|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349696|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19349697|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19349698|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
19349699|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
19349700|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
19349701|NCT03742245|Olaparib|olaparib|mesh-list
19349702|NCT03742245|Vorinostat|vorinostat|mesh-list
19349703|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19349704|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684503|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204821|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
20204822|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20204823|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20204824|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19684504|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
20204825|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204826|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20204827|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20204828|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
20204829|NCT00265304|Ketoprofen|ketoprofen|mesh-list
20204830|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20204831|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204832|NCT00265304|Analgesics|analgesics|mesh-ancestor
20204833|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
20204834|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204835|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204836|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204837|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204838|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20204839|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204840|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204841|NCT00265408|Aspirin|aspirin|mesh-list
20204842|NCT00265408|Warfarin|warfarin|mesh-list
20204843|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20204844|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20204845|NCT00265408|Analgesics|analgesics|mesh-ancestor
20204846|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
20204847|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204848|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204849|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204850|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204851|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20390272|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349705|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684505|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349706|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349707|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19349708|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19349709|NCT03742232|Laxatives|laxatives|mesh-ancestor
19349710|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349711|NCT03742180|Ketorolac|ketorolac|mesh-list
19349712|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
19349713|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19349714|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349715|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349716|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349717|NCT03742180|Analgesics|analgesics|mesh-ancestor
19349718|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
19349719|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349720|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19349721|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19349722|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19349723|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
19349724|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349725|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349726|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19349727|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390273|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390274|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20390275|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
20390276|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20390277|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20390278|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390279|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20390280|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20390281|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390282|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390283|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390284|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20390285|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
20390286|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390287|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390288|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20390289|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20390290|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19349728|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349729|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19349730|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349731|NCT03742115|Dexamethasone|dexamethasone|mesh-list
19349732|NCT03742115|Etoposide|etoposide|mesh-list
19349733|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
19349734|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349735|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
19349736|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
19349737|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349738|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349739|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349740|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
19349741|NCT03742115|Hormones|hormones|mesh-ancestor
19349742|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349743|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19349744|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349745|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19349746|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19349747|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19349748|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390291|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
20390292|NCT01073904|Norgestrel|norgestrel|mesh-list
20204852|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20204853|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204854|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20204855|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20204856|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204857|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
20204858|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
20204859|NCT00265460|Lobeline|lobeline|mesh-list
20390293|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19349749|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204860|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20204861|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
20204862|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204863|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390294|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
20204864|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20204865|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20204866|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
20204867|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204868|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204869|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
20204870|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
20204871|NCT00265486|Hematinics|hematinics|mesh-ancestor
20390295|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390296|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390297|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19349750|NCT03741933|Apremilast|apremilast|mesh-list
19349751|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19349752|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349753|NCT03741933|Analgesics|analgesics|mesh-ancestor
19349754|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
19349755|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349756|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349757|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349758|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349759|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20204872|NCT00265551|Olanzapine|olanzapine|mesh-list
20204873|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
20204874|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
20204875|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20204876|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204877|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20204878|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19349760|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19349761|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349762|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204879|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20204880|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20204881|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20204882|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20204883|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20204884|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20204885|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204886|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20204887|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
20204888|NCT00265642|Irbesartan|irbesartan|mesh-list
20204889|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20204890|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20204891|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20204892|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204893|NCT00265694|Gemcitabine|gemcitabine|mesh-list
20204894|NCT00265694|Carboplatin|carboplatin|mesh-list
20204895|NCT00265694|Vinorelbine|vinorelbine|mesh-list
20204896|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204897|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204898|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
20204899|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204900|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
20204901|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349763|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
19349764|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19349765|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349766|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
19349767|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
19349768|NCT03741686|Cathartics|cathartics|mesh-ancestor
19349769|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349770|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
19349771|NCT03741660|Cathartics|cathartics|mesh-ancestor
19349772|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349773|NCT03741621|Psyllium|psyllium|mesh-list
19349774|NCT03741621|Cathartics|cathartics|mesh-ancestor
19349775|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349776|NCT03741478|Insulin|insulin|mesh-list
19349777|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19349778|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
19349779|NCT03741478|Olanzapine|olanzapine|mesh-list
19349780|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19349781|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204902|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204903|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204904|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
20204905|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204906|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20204907|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204908|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
20204909|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684506|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19684507|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684508|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
19684509|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684510|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19684511|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
19684512|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204910|NCT00265733|Paclitaxel|paclitaxel|mesh-list
20204911|NCT00265733|Capecitabine|capecitabine|mesh-list
20204912|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19349782|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
19349783|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
19349784|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349785|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19349786|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19349787|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19349788|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349789|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19349790|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19349791|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19349792|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19349793|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349794|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349795|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
19349796|NCT03741426|Durvalumab|durvalumab|mesh-list
19349797|NCT03741426|Olaparib|olaparib|mesh-list
19349798|NCT03741426|Cediranib|cediranib|mesh-list
19349799|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349800|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349801|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20204913|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19349802|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349803|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349804|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19349805|NCT03741309|Calcium|calcium|mesh-list
19349806|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19349807|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349808|NCT03741244|Temozolomide|temozolomide|mesh-list
19349809|NCT03741244|Apatinib|apatinib|mesh-list
19349810|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19349811|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
20390298|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20390299|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20390300|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20390301|NCT01073995|Triamcinolone|triamcinolone|mesh-list
20390302|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20390303|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20390304|NCT01073995|Bupivacaine|bupivacaine|mesh-list
20390305|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20204914|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204915|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
20204916|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
20204917|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
20204918|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204919|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204920|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
20204921|NCT00265746|Metformin|metformin|mesh-list
20204922|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20204923|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390306|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
19684513|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20390307|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
19349812|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684514|NCT01187810|Protective Agents|protective agents|mesh-ancestor
19349813|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349814|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19349815|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400864|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400865|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400866|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
19400867|NCT03622502|Remifentanil|remifentanil|mesh-list
19400868|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19400869|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400870|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400871|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19400872|NCT03622502|Analgesics|analgesics|mesh-ancestor
19400873|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
19400874|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400875|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19400876|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400877|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400878|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400879|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400880|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400881|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19400882|NCT03622502|Narcotics|narcotics|mesh-ancestor
19400883|NCT03622489|Acetaminophen|acetaminophen|mesh-list
19400884|NCT03622489|Dipyrone|dipyrone|mesh-list
19400885|NCT03622489|Ibuprofen|ibuprofen|mesh-list
19400886|NCT03622489|Morphine|morphine|mesh-list
20390308|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390309|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390310|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
20390311|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390312|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390313|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
20390314|NCT01073995|Hormones|hormones|mesh-ancestor
20390315|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400887|NCT03622489|Tramadol|tramadol|mesh-list
19400888|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19400889|NCT03622489|Narcotics|narcotics|mesh-ancestor
20390316|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20390317|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
20390318|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390319|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390320|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
20390321|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20390322|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390323|NCT01074060|Plerixafor|plerixafor|mesh-list
20390324|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
20390325|NCT01074060|Lenograstim|lenograstim|mesh-list
20390326|NCT01074060|Sargramostim|sargramostim|mesh-list
20390327|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20390328|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
20390329|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204924|NCT00265772|Prednisolone|prednisolone|mesh-list
19400890|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19400891|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204925|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20204926|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
20204927|NCT00265772|Hormones|hormones|mesh-ancestor
20204928|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204929|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204930|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20204931|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204932|NCT00265811|Cetuximab|cetuximab|mesh-list
20204933|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20204934|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204935|NCT00265824|Bevacizumab|bevacizumab|mesh-list
20204936|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20204937|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20204938|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204939|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20390330|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20390331|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19684515|NCT01093612|Copper|copper|mesh-list
19400892|NCT03622489|Analgesics|analgesics|mesh-ancestor
19684516|NCT01093612|Trastuzumab|trastuzumab|mesh-list
19400893|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
19843665|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390332|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
19349816|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
19349817|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19349818|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19349819|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349820|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
19349821|NCT03741075|Coagulants|coagulants|mesh-ancestor
19349822|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19349823|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19349824|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
19349825|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349826|NCT03740893|Durvalumab|durvalumab|mesh-list
19349827|NCT03740893|Olaparib|olaparib|mesh-list
19349828|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349829|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349830|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19349831|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349832|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349833|NCT03740581|Insulin|insulin|mesh-list
19349834|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19349835|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349836|NCT03740568|Progesterone|progesterone|mesh-list
19349837|NCT03740568|Progestins|progestins|mesh-ancestor
20204940|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20204941|NCT00265824|Growth Substances|growth substances|mesh-ancestor
20204942|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204943|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
20204944|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20204945|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204946|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204947|NCT00265863|Mitomycins|mitomycins|mesh-list
20204948|NCT00265863|Mitomycin|mitomycin|mesh-list
20204949|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20204950|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204951|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
20204952|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204953|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20204954|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204955|NCT00265876|Gemcitabine|gemcitabine|mesh-list
20204956|NCT00265876|Saracatinib|saracatinib|mesh-list
20204957|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20204958|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
20204959|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204960|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204961|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
20204962|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20204963|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20204964|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20204965|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
20390333|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390334|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390335|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20390336|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20390337|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20390338|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20390339|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
20390340|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390341|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20390342|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19349838|NCT03740568|Hormones|hormones|mesh-ancestor
19349839|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20204966|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204967|NCT00265915|Rituximab|rituximab|mesh-list
20204968|NCT00265915|Sargramostim|sargramostim|mesh-list
20204969|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20204970|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204971|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
20204972|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204973|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204974|NCT00265928|Rituximab|rituximab|mesh-list
20204975|NCT00265928|Bortezomib|bortezomib|mesh-list
19349840|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204976|NCT00265928|Antibodies|antibodies|mesh-list
20204977|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
20204978|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20390343|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19349841|NCT03740516|Apremilast|apremilast|mesh-list
19349842|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19349843|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19349844|NCT03740516|Analgesics|analgesics|mesh-ancestor
19349845|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
19349846|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349847|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349848|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390344|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390345|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390346|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390347|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20390348|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20390349|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20390350|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390351|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390352|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390353|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20390354|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20390355|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
20390356|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20390357|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20390358|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
20390359|NCT01074086|Everolimus|everolimus|mesh-list
20390360|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390361|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20390362|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
20390363|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390364|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
20390365|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390366|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390367|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19349849|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19349850|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20204979|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20204980|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
20204981|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20204982|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20204983|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20204984|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20204985|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204986|NCT00265967|Irbesartan|irbesartan|mesh-list
20204987|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20204988|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20204989|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20204990|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204991|NCT00265993|Enoxaparin|enoxaparin|mesh-list
20204992|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
20204993|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20204994|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20204995|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20204996|NCT00266058|Ritonavir|ritonavir|mesh-list
20204997|NCT00266058|Lopinavir|lopinavir|mesh-list
20204998|NCT00266058|Efavirenz|efavirenz|mesh-list
20204999|NCT00266058|Lumefantrine|lumefantrine|mesh-list
20205000|NCT00266058|Artemether|artemether|mesh-list
20205001|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20205002|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19349851|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19349852|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349853|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349854|NCT03740464|Sargramostim|sargramostim|mesh-list
19349855|NCT03740464|Lenograstim|lenograstim|mesh-list
19349856|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
19349857|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349858|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19349859|NCT03740399|Anesthetics|anesthetics|mesh-list
19349860|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349861|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390368|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19349862|NCT03740386|Phentolamine|phentolamine|mesh-list
19349863|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20205003|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20390369|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20390370|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20390371|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390372|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390373|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390374|NCT01074151|Analgesics|analgesics|mesh-ancestor
19349864|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19349865|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
19349866|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349867|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349868|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349869|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19349870|NCT03740373|Budesonide|budesonide|mesh-list
19349871|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
20205004|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
20205005|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205006|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205007|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20205008|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20205009|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
19349872|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
19349873|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19349874|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19349875|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
19349876|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349877|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205010|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205011|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20205012|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20205013|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20205014|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20205015|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20205016|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20205017|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20205018|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20205019|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20205020|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
20205021|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20205022|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20205023|NCT00266097|Gemcitabine|gemcitabine|mesh-list
20205024|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
20205025|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20205026|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205027|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
20205028|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205029|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205030|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
20205031|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205032|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205033|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205034|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
20205035|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205036|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20205037|NCT00266123|Sirolimus|sirolimus|mesh-list
19349878|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19349879|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
19349880|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
19349881|NCT03740373|Hormones|hormones|mesh-ancestor
19349882|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19349883|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19349884|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19349885|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19349886|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
19349887|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349888|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349889|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19349890|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19349891|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19349892|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
19349893|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19349894|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
19400894|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349895|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349896|NCT03740295|Protective Agents|protective agents|mesh-ancestor
19349897|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349898|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19349899|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19349900|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349901|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19349902|NCT03740243|Buprenorphine|buprenorphine|mesh-list
19349903|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19349904|NCT03740243|Naloxone|naloxone|mesh-list
19349905|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19349906|NCT03740243|Narcotics|narcotics|mesh-ancestor
19349907|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349908|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349909|NCT03740243|Analgesics|analgesics|mesh-ancestor
19349910|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
19349911|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19349912|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19349913|NCT03740178|Donepezil|donepezil|mesh-list
19349914|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19349915|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349916|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349917|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
19349918|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19349919|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349920|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
19349921|NCT03740165|Paclitaxel|paclitaxel|mesh-list
19349922|NCT03740165|Docetaxel|docetaxel|mesh-list
19843666|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843667|NCT00660517|Fluticasone|fluticasone|mesh-list
19843668|NCT00660517|Xhance|xhance|mesh-list
19843669|NCT00660517|Azelastine|azelastine|mesh-list
20205038|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20205039|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205040|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20205041|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205042|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
20205043|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205044|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
20205045|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205046|NCT00266136|Cytarabine|cytarabine|mesh-list
20205047|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
20205048|NCT00266136|Daunorubicin|daunorubicin|mesh-list
20205049|NCT00266136|Thioguanine|thioguanine|mesh-list
19843670|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19843671|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19843672|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
19843673|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843674|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843675|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19843676|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
19843677|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
20205050|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205051|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
20205052|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205053|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205054|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20205055|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
20205056|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205057|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205058|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20205059|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205060|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
20205061|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
20205062|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205063|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20205064|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20205065|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20205066|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205067|NCT00266149|Lamotrigine|lamotrigine|mesh-list
20205068|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
19349923|NCT03740165|Bevacizumab|bevacizumab|mesh-list
19349924|NCT03740165|Carboplatin|carboplatin|mesh-list
19843678|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19843679|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19843680|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205069|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19349925|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
19349926|NCT03740165|Olaparib|olaparib|mesh-list
19349927|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19349928|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349929|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
19349930|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
20205070|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205071|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205072|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20205073|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205074|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20205075|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20205076|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205077|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205078|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20205079|NCT00266162|Bosentan|bosentan|mesh-list
20205080|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20205081|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20205082|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205083|NCT00266214|Lidocaine|lidocaine|mesh-list
20205084|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
20205085|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
20205086|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205087|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205088|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
20205089|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205090|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20205091|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20205092|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20205093|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205094|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205095|NCT00266253|Metformin|metformin|mesh-list
20205096|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20205097|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205098|NCT00266318|Interferons|interferons|mesh-list
20205099|NCT00266318|Ribavirin|ribavirin|mesh-list
20205100|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
20205101|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205102|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
20205103|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205104|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
20205105|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205106|NCT00266344|Gaboxadol|gaboxadol|mesh-list
20205107|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205108|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205109|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205110|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205111|NCT00266344|Analgesics|analgesics|mesh-ancestor
20390375|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
19349931|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
19349932|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349933|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349934|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19349935|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19349936|NCT03740165|Growth Substances|growth substances|mesh-ancestor
19843681|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843682|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19843683|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19843684|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
19843685|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
19843686|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843687|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19843688|NCT00660543|Hematinics|hematinics|mesh-ancestor
19843689|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19843690|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19843691|NCT00660660|Esomeprazole|esomeprazole|mesh-list
19843692|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19843693|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19843694|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19843695|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843696|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843697|NCT00660699|Gemcitabine|gemcitabine|mesh-list
19349937|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349938|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
19349939|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19349940|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349941|NCT03739801|Irinotecan|irinotecan|mesh-list
19349942|NCT03739801|Ramucirumab|ramucirumab|mesh-list
19349943|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19349944|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19349945|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349946|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349947|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349948|NCT03739788|BMS-986165|bms-986165|mesh-list
19349949|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
19349950|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19349951|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19349952|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349953|NCT03739671|Vitamin D|vitamin d|mesh-list
20205112|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
19349954|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
19349955|NCT03739671|Vitamins|vitamins|mesh-list
20205113|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
20205114|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
20205115|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
20205116|NCT00266357|Gaboxadol|gaboxadol|mesh-list
20205117|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205118|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205119|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205120|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205121|NCT00266357|Analgesics|analgesics|mesh-ancestor
20205122|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
20205123|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
20205124|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
20205125|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
20205126|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
20205127|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19349956|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
19349957|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205128|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205129|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
20205130|NCT00266487|Vitamins|vitamins|mesh-list
20205131|NCT00266487|Folic Acid|folic acid|mesh-list
20205132|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
20205133|NCT00266487|Hydroxocobalamin|hydroxocobalamin|mesh-list
20205134|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
20205135|NCT00266487|Pyridoxal|pyridoxal|mesh-list
20205136|NCT00266487|Pyridoxine|pyridoxine|mesh-list
20205137|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
20205138|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
20205139|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205140|NCT00266487|Hematinics|hematinics|mesh-ancestor
20217756|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217757|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20217758|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20217759|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
20217760|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217761|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
20217762|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
20217763|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20217764|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19349958|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20390376|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390377|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
20390378|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390379|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
20390380|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
20390381|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20390382|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390383|NCT01074281|Enalapril|enalapril|mesh-list
20390384|NCT01074281|Enalaprilat|enalaprilat|mesh-list
20390385|NCT01074281|Nitrendipine|nitrendipine|mesh-list
19349959|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19684517|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20217765|NCT00310336|Interferons|interferons|mesh-list
20217766|NCT00310336|Ribavirin|ribavirin|mesh-list
20217767|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
20217768|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
20390386|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390387|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390388|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19349960|NCT03739619|Gemcitabine|gemcitabine|mesh-list
19349961|NCT03739619|Nivolumab|nivolumab|mesh-list
19349962|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20390389|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
20390390|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390391|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20390392|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20390393|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20390394|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390395|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
20390396|NCT01074333|Cetuximab|cetuximab|mesh-list
20390397|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20390398|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390399|NCT01074346|Interferons|interferons|mesh-list
20390400|NCT01074346|Interferon-beta|interferon-beta|mesh-list
20390401|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
20390402|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390403|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
20390404|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390405|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
20390406|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390407|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19349963|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19349964|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
19349965|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19349966|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19349967|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
19349968|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349969|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205141|NCT00266539|Fentanyl|fentanyl|mesh-list
20205142|NCT00266539|Morphine|morphine|mesh-list
20205143|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20205144|NCT00266539|Narcotics|narcotics|mesh-ancestor
20205145|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205146|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205147|NCT00266539|Analgesics|analgesics|mesh-ancestor
20205148|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
20205149|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205150|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20205151|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20205152|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
20205153|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
20205154|NCT00266552|Risperidone|risperidone|mesh-list
20205155|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20205156|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
20205157|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205158|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205159|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205160|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20205161|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20205162|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205163|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205164|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20205165|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
20205166|NCT00266578|Fluticasone|fluticasone|mesh-list
20205167|NCT00266578|Xhance|xhance|mesh-list
20205168|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205169|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20205170|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
20205171|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205172|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205173|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20205174|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205175|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
20205176|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20205177|NCT00266591|Topiramate|topiramate|mesh-list
20205178|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
20205179|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20205180|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205181|NCT00266604|Topiramate|topiramate|mesh-list
20205182|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
20205183|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20205184|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684518|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205185|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
20205186|NCT00266617|Hematinics|hematinics|mesh-ancestor
20205187|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20217769|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19349970|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19349971|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
19349972|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349973|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19349974|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19349975|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19349976|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
19349977|NCT03739606|Antibodies|antibodies|mesh-list
19349978|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
19349979|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19349980|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19349981|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
19349982|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349983|NCT03739541|Benzonidazole|benzonidazole|mesh-list
19349984|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19349985|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
19349986|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19349987|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19349988|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19349989|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19349990|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19349991|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20205188|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20205189|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20205190|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19349992|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
19349993|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19349994|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19349995|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19349996|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19349997|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205191|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205192|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205193|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205194|NCT00266643|Analgesics|analgesics|mesh-ancestor
20205195|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
20205196|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205197|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
20205198|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205199|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
20205200|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
20205201|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
20205202|NCT00266721|Pancrelipase|pancrelipase|mesh-list
20205203|NCT00266721|Pancreatin|pancreatin|mesh-list
20205204|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20205205|NCT00266747|Amibegron|amibegron|mesh-list
20205206|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20205207|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20205208|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
20205209|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684519|NCT01093612|Trace Elements|trace elements|mesh-ancestor
19684520|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
19684521|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684522|NCT00931255|Sirolimus|sirolimus|mesh-list
19684523|NCT00931255|Tacrolimus|tacrolimus|mesh-list
19684524|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205210|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205211|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205212|NCT00266786|Ketorolac|ketorolac|mesh-list
20205213|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20205214|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20205215|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20205216|NCT00266786|Analgesics|analgesics|mesh-ancestor
20205217|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
20205218|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205219|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205220|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205221|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205222|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20205223|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205224|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205225|NCT00266838|Dexamethasone|dexamethasone|mesh-list
20205226|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205227|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
19684525|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
20205228|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
20205229|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205230|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350003|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
19350004|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19350005|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350006|NCT03739294|Fluticasone|fluticasone|mesh-list
19350007|NCT03739294|Xhance|xhance|mesh-list
19350008|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350009|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19350010|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
19350011|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350012|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350013|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19350014|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
19350015|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
19350016|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20205231|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20205232|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
20205233|NCT00266838|Hormones|hormones|mesh-ancestor
20205234|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205235|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20205236|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205237|NCT00267163|Donepezil|donepezil|mesh-list
20205238|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20205239|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205240|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205241|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
20205242|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205243|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205244|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
19684526|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684527|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19684528|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684529|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684530|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19684531|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684532|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20205245|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
20205246|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20205247|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20205248|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205249|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205250|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20205251|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20205252|NCT00267176|Analgesics|analgesics|mesh-ancestor
20205253|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
20205254|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205255|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205256|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205257|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205258|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
20205259|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20205260|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20205261|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205262|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205263|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20205264|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20205265|NCT00267215|Analgesics|analgesics|mesh-ancestor
20205266|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
20205267|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205268|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205269|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205270|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205271|NCT00267254|Atorvastatin|atorvastatin|mesh-list
20205272|NCT00267254|Simvastatin|simvastatin|mesh-list
20205273|NCT00267254|Torcetrapib|torcetrapib|mesh-list
20205274|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20205275|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20205276|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
20205277|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205278|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20205279|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20205280|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350017|NCT03739112|Vaccines|vaccines|mesh-list
19350018|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
19350019|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350020|NCT03739021|Ropivacaine|ropivacaine|mesh-list
19350021|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350022|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
19350023|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350024|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350025|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
19350026|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350027|NCT03738956|Tofacitinib|tofacitinib|mesh-list
19350028|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19350029|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350030|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350031|NCT03738943|Pyridoxine|pyridoxine|mesh-list
19350032|NCT03738943|Pyridoxal|pyridoxal|mesh-list
19350033|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
19350034|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
19350035|NCT03738943|Adenosine|adenosine|mesh-list
20205281|NCT00267267|Atorvastatin|atorvastatin|mesh-list
20205282|NCT00267267|Simvastatin|simvastatin|mesh-list
20205283|NCT00267267|Ezetimibe|ezetimibe|mesh-list
20205284|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20205285|NCT00267267|Torcetrapib|torcetrapib|mesh-list
20205286|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20205287|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20205288|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
20205289|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205290|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20205291|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20205292|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205293|NCT00267306|Visilizumab|visilizumab|mesh-list
20205294|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
20205295|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205296|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
20205297|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
20205298|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20205299|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
20205300|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205301|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205302|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205303|NCT00267332|Modafinil|modafinil|mesh-list
20205304|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20205305|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205306|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20205307|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20205308|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20205309|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205310|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
20205311|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20205312|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
20205313|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205314|NCT00267384|Expectorants|expectorants|mesh-ancestor
20205315|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205316|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20205317|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
20205318|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205319|NCT00267384|Protective Agents|protective agents|mesh-ancestor
20205320|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205321|NCT00267384|Antidotes|antidotes|mesh-ancestor
20205322|NCT00267514|Sevelamer|sevelamer|mesh-list
20205323|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
20205324|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
20205325|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205326|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
20205327|NCT00267540|Vitamins|vitamins|mesh-ancestor
20205328|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
20205329|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205330|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20205331|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20205332|NCT00267553|Toremifene|toremifene|mesh-list
19350036|NCT03738943|Nitroprusside|nitroprusside|mesh-list
19684533|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205333|NCT00267553|Letrozole|letrozole|mesh-list
19350037|NCT03738943|Acetylcholine|acetylcholine|mesh-list
19350038|NCT03738943|Vitamins|vitamins|mesh-ancestor
20205334|NCT00267553|Atamestane|atamestane|mesh-list
20205335|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350039|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
19350040|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350041|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
19350042|NCT03738943|Analgesics|analgesics|mesh-ancestor
19350043|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
19350044|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350045|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19350046|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
19350047|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19350048|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
19350049|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
19350050|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350051|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350052|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19350053|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19350054|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19350055|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
19350056|NCT03738917|Bromides|bromides|mesh-list
19350057|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
19350058|NCT03738917|Ipratropium|ipratropium|mesh-list
19350059|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19350060|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
19350061|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
19350062|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
19350063|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19350064|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19350065|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350066|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350067|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350068|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19350069|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
19350070|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350071|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19350072|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
19350073|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19350074|NCT03738878|Valsartan|valsartan|mesh-list
20390408|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
20390409|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
20390410|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390411|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
20390412|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390413|NCT01074359|Protective Agents|protective agents|mesh-ancestor
19684534|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
20205336|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20205337|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20205338|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205339|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205340|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20205341|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
20205342|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205343|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205344|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20205345|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20217770|NCT00310336|Betaine|betaine|mesh-list
20390414|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390415|NCT01074411|Carboplatin|carboplatin|mesh-list
19350075|NCT03738878|Bradykinin|bradykinin|mesh-list
19350076|NCT03738878|Kininogens|kininogens|mesh-list
19350077|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19350078|NCT03738878|Substance P|substance p|mesh-list
20390416|NCT01074411|Bortezomib|bortezomib|mesh-list
20390417|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390418|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20390419|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20390420|NCT01074567|Protective Agents|protective agents|mesh-ancestor
20390421|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390422|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20390423|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
20390424|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390425|NCT01074593|Interferons|interferons|mesh-list
20390426|NCT01074593|Interferon-beta|interferon-beta|mesh-list
20390427|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
19350079|NCT03738878|Neurokinin A|neurokinin a|mesh-list
19684535|NCT00540995|Etoposide|etoposide|mesh-list
19350080|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19350081|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684536|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
20390428|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390429|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
20205346|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20205347|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20205348|NCT00267657|Reserpine|reserpine|mesh-list
20205349|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20205350|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20205351|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20205352|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205353|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205354|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205355|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20205356|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20205357|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19843698|NCT00660699|Docetaxel|docetaxel|mesh-list
19843699|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19843700|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
19843701|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843702|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843703|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
20205358|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205359|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
20205360|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684537|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
19684538|NCT00540995|Busulfan|busulfan|mesh-list
19684539|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19684540|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684541|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19684542|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19684543|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684544|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684545|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
19684546|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684547|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
19684548|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684549|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19684550|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19684551|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
19684552|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
19684553|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
19684554|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684555|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684556|NCT00484471|Valproic Acid|valproic acid|mesh-list
19684557|NCT00484471|Aripiprazole|aripiprazole|mesh-list
19684558|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
19684559|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205361|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
20205362|NCT00267683|Glyburide|glyburide|mesh-list
20205363|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20205364|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205365|NCT00267709|Visilizumab|visilizumab|mesh-list
20205366|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
20205367|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205368|NCT00267722|Visilizumab|visilizumab|mesh-list
20205369|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
20205370|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205371|NCT00267813|Bupropion|bupropion|mesh-list
20205372|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20205373|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
20205374|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205375|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20205376|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20205377|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205378|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205379|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
20205380|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205381|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205382|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20205383|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19684560|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19684561|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20205384|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843704|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350082|NCT03738878|Incretins|incretins|mesh-ancestor
19350083|NCT03738878|Hormones|hormones|mesh-ancestor
19350084|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205385|NCT00267826|Rituximab|rituximab|mesh-list
20205386|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20205387|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205388|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
20205389|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205390|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205391|NCT00267917|Fenoterol|fenoterol|mesh-list
20205392|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
20205393|NCT00267917|Ipratropium|ipratropium|mesh-list
20205394|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20205395|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
20205396|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205397|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205398|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20205399|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205400|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
20205401|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
20205402|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20205403|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20205404|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20205405|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20205406|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
20205407|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205408|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205409|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20205410|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
20205411|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20205412|NCT00267943|Telmisartan|telmisartan|mesh-list
20205413|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20205414|NCT00267943|Diuretics|diuretics|mesh-ancestor
20205415|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
20205416|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205417|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20205418|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205419|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205420|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20205421|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20205422|NCT00268138|Fluorides|fluorides|mesh-list
20205423|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
20205424|NCT00268138|Protective Agents|protective agents|mesh-ancestor
20205425|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205426|NCT00268151|Capecitabine|capecitabine|mesh-list
20205427|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
20205428|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205429|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
20205430|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205431|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205432|NCT00268177|Fluticasone|fluticasone|mesh-list
20205433|NCT00268177|Xhance|xhance|mesh-list
20205434|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20205435|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205436|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20205437|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
20205438|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205439|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205440|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20205441|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205442|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
20205443|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20205444|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20205445|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20205446|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20205447|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
20205448|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205449|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205450|NCT00268216|Fluticasone|fluticasone|mesh-list
20205451|NCT00268216|Xhance|xhance|mesh-list
20205452|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20205453|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205454|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19350085|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19350086|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
20205455|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
20205456|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390430|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390431|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
20390432|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390433|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20390434|NCT01074619|Memantine|memantine|mesh-list
20390435|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20390436|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20390437|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
20390438|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684562|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205457|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205458|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20205459|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205460|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
20205461|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20205462|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20205463|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20205464|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20205465|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
20205466|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205467|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205468|NCT00268229|Cytarabine|cytarabine|mesh-list
20205469|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
20205470|NCT00268229|Daunorubicin|daunorubicin|mesh-list
20205471|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205472|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
20205473|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205474|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205475|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
20205476|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205477|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205478|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
20205479|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205480|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20205481|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205482|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20205483|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20205484|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20205485|NCT00268255|Gefitinib|gefitinib|mesh-list
20205486|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20205487|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205488|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20205489|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205490|NCT00268333|Leucovorin|leucovorin|mesh-list
20205491|NCT00268333|Fluorouracil|fluorouracil|mesh-list
20205492|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
20205493|NCT00268333|Calcium|calcium|mesh-list
20205494|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
20205495|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20205496|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205497|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
20205498|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205499|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205500|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205501|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205502|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
20205503|NCT00268333|Antidotes|antidotes|mesh-ancestor
20205504|NCT00268333|Protective Agents|protective agents|mesh-ancestor
20205505|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
20205506|NCT00268333|Vitamins|vitamins|mesh-ancestor
20205507|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
20205508|NCT00268359|Bevacizumab|bevacizumab|mesh-list
20205509|NCT00268359|Irinotecan|irinotecan|mesh-list
20205510|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20205511|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205512|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20205513|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20205514|NCT00268359|Growth Substances|growth substances|mesh-ancestor
20205515|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205516|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
20205517|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20205518|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20390439|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205519|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350087|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350088|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350089|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19350090|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19350091|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19350092|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
19350093|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19350094|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350095|NCT03738800|Trifarotene|trifarotene|mesh-list
19350096|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
19400895|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19400896|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
19400897|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20205520|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205521|NCT00268372|Docetaxel|docetaxel|mesh-list
20205522|NCT00268372|Fluorouracil|fluorouracil|mesh-list
20205523|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205524|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
20205525|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
20205526|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
20205527|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205528|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
20205529|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205530|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205531|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
20205532|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205533|NCT00268398|Leucovorin|leucovorin|mesh-list
20205534|NCT00268398|Folic Acid|folic acid|mesh-list
20205535|NCT00268398|Fluorouracil|fluorouracil|mesh-list
20205536|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
20205537|NCT00268398|Irinotecan|irinotecan|mesh-list
20205538|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
20205539|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
20205540|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205541|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205542|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205543|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205544|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
20205545|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205546|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20205547|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20205548|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205549|NCT00268398|Antidotes|antidotes|mesh-ancestor
20205550|NCT00268398|Protective Agents|protective agents|mesh-ancestor
20205551|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
20205552|NCT00268398|Vitamins|vitamins|mesh-ancestor
20205553|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
20205554|NCT00268398|Hematinics|hematinics|mesh-ancestor
20217771|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217772|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
20217773|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217774|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
20217775|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217776|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
20217777|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684563|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684564|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
19684565|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
19684566|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684567|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684568|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19684569|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19684570|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
19684571|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20217778|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217779|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
20217780|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20217781|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20217782|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20217783|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
20217784|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217785|NCT00310388|Ezogabine|ezogabine|mesh-list
19400898|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217786|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
20217787|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205555|NCT00268411|Gemcitabine|gemcitabine|mesh-list
20205556|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
20205557|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205558|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
20205559|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205560|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205561|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
20205562|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350097|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19350098|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350099|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
19350100|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19350101|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19350102|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350103|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
19350104|NCT03738527|Coagulants|coagulants|mesh-ancestor
19350105|NCT03738176|Triamcinolone|triamcinolone|mesh-list
19350106|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350107|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
19350108|NCT03738176|Hormones|hormones|mesh-ancestor
19350109|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350110|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350111|NCT03738137|Lidocaine|lidocaine|mesh-list
19350112|NCT03738137|Midazolam|midazolam|mesh-list
19350113|NCT03738137|Sufentanil|sufentanil|mesh-list
19350114|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350115|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
19350116|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350117|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350118|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
20390440|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390441|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20390442|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20390443|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20390444|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20390445|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20390446|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390447|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390448|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390449|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20390450|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20390451|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20390452|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390453|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350119|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205563|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205564|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205565|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
20205566|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205567|NCT00268489|Bevacizumab|bevacizumab|mesh-list
20205568|NCT00268489|Pemetrexed|pemetrexed|mesh-list
19350120|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19350121|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19350122|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19350123|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350124|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350125|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19350126|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19350127|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19350128|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19350129|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19350130|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19350131|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
19350132|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
19350133|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
19350134|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350135|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19350136|NCT03738137|Narcotics|narcotics|mesh-ancestor
19350137|NCT03738137|Analgesics|analgesics|mesh-ancestor
19350138|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
20205569|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20205570|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350139|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20205571|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19350140|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350141|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350142|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19350143|NCT03738059|Analgesics|analgesics|mesh-ancestor
19350144|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
19350145|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350146|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19350147|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19350148|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19350149|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350150|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350151|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350152|NCT03737968|Durvalumab|durvalumab|mesh-list
19350153|NCT03737968|Tremelimumab|tremelimumab|mesh-list
19350154|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19350155|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19350156|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205572|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20205573|NCT00268489|Growth Substances|growth substances|mesh-ancestor
20205574|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205575|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
20205576|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205577|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205578|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20205579|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20205580|NCT00268515|Cyclosporine|cyclosporine|mesh-list
20205581|NCT00268515|Prednisone|prednisone|mesh-list
20205582|NCT00268515|Azathioprine|azathioprine|mesh-list
20205583|NCT00268515|Tacrolimus|tacrolimus|mesh-list
20205584|NCT00268515|Cyclosporins|cyclosporins|mesh-list
20205585|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205586|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
20205587|NCT00268515|Hormones|hormones|mesh-ancestor
20205588|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205589|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205590|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20205591|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205592|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205593|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
20205594|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19350157|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
19350158|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350159|NCT03737773|Methamphetamine|methamphetamine|mesh-list
19350160|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19350161|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843705|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205595|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205596|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205597|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
20205598|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205599|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
20205600|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205601|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
20205602|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205603|NCT00268528|Methotrexate|methotrexate|mesh-list
19843706|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843707|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
19843708|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843709|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843710|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843711|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
19843712|NCT00660816|Docetaxel|docetaxel|mesh-list
20205604|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
20205605|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20205606|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
20205607|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20205608|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205609|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205610|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
20205611|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843713|NCT00660816|Pemetrexed|pemetrexed|mesh-list
20205612|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205613|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
20205614|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205615|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20205616|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843714|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19843715|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843716|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843717|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843718|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
19843719|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843720|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843721|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19843722|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19843723|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19843724|NCT00660829|Azelastine|azelastine|mesh-list
19843725|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19843726|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
19843727|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205617|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
20205618|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20205619|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20205620|NCT00268554|Dipyridamole|dipyridamole|mesh-list
20205621|NCT00268554|Caffeine|caffeine|mesh-list
20205622|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20205623|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205624|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20205625|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684572|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19684573|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19684574|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19684575|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
19684576|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684577|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
19684578|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
19684579|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19684580|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19684581|NCT00080756|Estradiol|estradiol|mesh-list
19684582|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19684583|NCT00080756|Testosterone|testosterone|mesh-list
19684584|NCT00080756|Deslorelin|deslorelin|mesh-list
19684585|NCT00080756|Estrogens|estrogens|mesh-ancestor
20205626|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205627|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19350162|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
19350163|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
19350164|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350165|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
20205628|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20205629|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
20205630|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205631|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20205632|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
20205633|NCT00268567|Prednisone|prednisone|mesh-list
20205634|NCT00268567|Leflunomide|leflunomide|mesh-list
20205635|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205636|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
20205637|NCT00268567|Hormones|hormones|mesh-ancestor
20205638|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205639|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205640|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20205641|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205642|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205643|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205644|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205645|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
20205646|NCT00268593|Prednisone|prednisone|mesh-list
20205647|NCT00268593|Docetaxel|docetaxel|mesh-list
20205648|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205649|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
20205650|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
19350166|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684586|NCT00080756|Hormones|hormones|mesh-ancestor
19843728|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843729|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19843730|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
19843731|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20205651|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
20205652|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426558|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19684587|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205653|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205654|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
20205655|NCT00268593|Hormones|hormones|mesh-ancestor
20205656|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205657|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205658|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20205659|NCT00268619|Ramipril|ramipril|mesh-list
19350167|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350168|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350169|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19350170|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20205660|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20205661|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
20205662|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205663|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205664|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20205665|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
20205666|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20205667|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205668|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205669|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20205670|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205671|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20205672|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
20205673|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19350171|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350172|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19350173|NCT03737721|Avelumab|avelumab|mesh-list
19350174|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19350175|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350176|NCT03737708|Adalimumab|adalimumab|mesh-list
19350177|NCT03737708|Methotrexate|methotrexate|mesh-list
19350178|NCT03737708|Abatacept|abatacept|mesh-list
19350179|NCT03737708|Tacrolimus|tacrolimus|mesh-list
19350180|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19350181|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
19350182|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19350183|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350184|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19350185|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
19350186|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350187|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350188|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
19350189|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350190|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19350191|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350192|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
19350193|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350194|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19350195|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19350196|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350197|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19350198|NCT03737656|Progesterone|progesterone|mesh-list
19350199|NCT03737656|Progestins|progestins|mesh-ancestor
19350200|NCT03737656|Hormones|hormones|mesh-ancestor
19350201|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350202|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350203|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
19350204|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
19350205|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350206|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350207|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350208|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
19350209|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
20205674|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205675|NCT00268671|Docetaxel|docetaxel|mesh-list
20205676|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205677|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
20205678|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
20205679|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
19350210|NCT03737448|Trimetazidine|trimetazidine|mesh-list
19350211|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
19350212|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19350213|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350214|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
19350215|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19350216|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19350217|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350218|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
19350219|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
19350220|NCT03736980|Psilocybin|psilocybin|mesh-list
19350221|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
19350222|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350223|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19350224|NCT03736616|Cytarabine|cytarabine|mesh-list
19350225|NCT03736616|Rituximab|rituximab|mesh-list
19350226|NCT03736616|Carboplatin|carboplatin|mesh-list
19350227|NCT03736616|Etoposide|etoposide|mesh-list
19350228|NCT03736616|Melphalan|melphalan|mesh-list
19350229|NCT03736616|Ifosfamide|ifosfamide|mesh-list
19350230|NCT03736616|Carmustine|carmustine|mesh-list
19350231|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
19350232|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19350233|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350234|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
19350235|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350236|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350237|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19350238|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19350239|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19350240|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350241|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350242|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19350243|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
19350244|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
19843732|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843733|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843734|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19843735|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19843736|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20205680|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205681|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20205682|NCT00268684|Temozolomide|temozolomide|mesh-list
20205683|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205684|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20205685|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205686|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205687|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20205688|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
20205689|NCT00268697|Ezetimibe|ezetimibe|mesh-list
20205690|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20205691|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20205692|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
20205693|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205694|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20205695|NCT00268710|Docetaxel|docetaxel|mesh-list
20205696|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205697|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
20205698|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
20205699|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
20205700|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205701|NCT00268723|Albuterol|albuterol|mesh-list
20205702|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20205703|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
20205704|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205705|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205706|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20205707|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205708|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
20205709|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20205710|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20205711|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20205712|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20205713|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350245|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350246|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350247|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19350248|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
19350249|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19400899|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19400900|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19400901|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400902|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400903|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
19400904|NCT03622450|Levofloxacin|levofloxacin|mesh-list
19400905|NCT03622450|Gentamicins|gentamicins|mesh-list
19400906|NCT03622450|Meropenem|meropenem|mesh-list
19400907|NCT03622450|Amikacin|amikacin|mesh-list
19400908|NCT03622450|Colistin|colistin|mesh-list
19400909|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19400910|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19400911|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19400912|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19400913|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19400914|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400915|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400916|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19400917|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19400918|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19400919|NCT03622450|Renal Agents|renal agents|mesh-ancestor
19400920|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19400921|NCT03622060|Nicardipine|nicardipine|mesh-list
19400922|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
19400923|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
20205714|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205715|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205716|NCT00268749|Glycine|glycine|mesh-list
19400924|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19400925|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19400926|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19400927|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400928|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19400929|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400930|NCT03622047|Sufentanil|sufentanil|mesh-list
19400931|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
19400932|NCT03622047|Ropivacaine|ropivacaine|mesh-list
19400933|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19684588|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684589|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19684590|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
19684591|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684592|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19684593|NCT00080756|Androgens|androgens|mesh-ancestor
19684594|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684595|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205717|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
20205718|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205719|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205720|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205721|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
19684596|NCT00015002|Betamethasone|betamethasone|mesh-list
19684597|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205722|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20205723|NCT00268788|Antibodies|antibodies|mesh-list
20205724|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
20205725|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20205726|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
20205727|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205728|NCT00268814|Methadone|methadone|mesh-list
20205729|NCT00268814|Heroin|heroin|mesh-list
20205730|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20205731|NCT00268814|Narcotics|narcotics|mesh-ancestor
20205732|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205733|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205734|NCT00268814|Analgesics|analgesics|mesh-ancestor
20205735|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
20205736|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205737|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
20205738|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205739|NCT00268827|Lopinavir|lopinavir|mesh-list
20426559|NCT01281748|Prednisolone|prednisolone|mesh-list
19400934|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684598|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
19684599|NCT00015002|Hormones|hormones|mesh-ancestor
20205740|NCT00268827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19350250|NCT03736369|Esomeprazole|esomeprazole|mesh-list
19350251|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19350252|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19350253|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19350254|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350255|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350256|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
19350257|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19350258|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350259|NCT03736187|Metronidazole|metronidazole|mesh-list
19350260|NCT03736187|Cephalexin|cephalexin|mesh-list
19350261|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350262|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19350263|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19350264|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19350265|NCT03736161|Methotrexate|methotrexate|mesh-list
19350266|NCT03736161|Tofacitinib|tofacitinib|mesh-list
19350267|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19350268|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
19350269|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19350270|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350271|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19350272|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
19350273|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350274|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350275|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
19350276|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350277|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19350278|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350279|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
19350280|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350281|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19350282|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19350283|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19350284|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350285|NCT03735979|Argatroban|argatroban|mesh-list
19350286|NCT03735979|Eptifibatide|eptifibatide|mesh-list
19350287|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
19350288|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19350289|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
19350290|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350291|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350292|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
19350293|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19350294|NCT03735966|Carboplatin|carboplatin|mesh-list
19350295|NCT03735966|Docetaxel|docetaxel|mesh-list
19350296|NCT03735966|Trastuzumab|trastuzumab|mesh-list
19350297|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350298|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
19350299|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
19350300|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
19350301|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350302|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19350303|NCT03735875|Venetoclax|venetoclax|mesh-list
19350304|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350305|NCT03735771|Bupivacaine|bupivacaine|mesh-list
19350306|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350307|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
19350308|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350309|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350310|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
19350311|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350312|NCT03735563|Fentanyl|fentanyl|mesh-list
19350313|NCT03735563|Ketamine|ketamine|mesh-list
20205741|NCT00268827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20205742|NCT00268827|Protease Inhibitors|protease inhibitors|mesh-ancestor
20205743|NCT00268827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205744|NCT00268827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205745|NCT00268827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20205746|NCT00268827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19350314|NCT03735563|Analgesics|analgesics|mesh-ancestor
19350315|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
19350316|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350317|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350318|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19350319|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19350320|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
19350321|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
19350322|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350323|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19350324|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19350325|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350326|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350327|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19350328|NCT03735563|Narcotics|narcotics|mesh-ancestor
19350329|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19350330|NCT03735446|Cytarabine|cytarabine|mesh-list
19350331|NCT03735446|Etoposide|etoposide|mesh-list
19350332|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
19350333|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20390454|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390455|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20390456|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20390457|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
19350334|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350335|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19350336|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19350337|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350338|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350339|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19350340|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
19350341|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
19350342|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350343|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350344|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
19350345|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350346|NCT03735446|Analgesics|analgesics|mesh-ancestor
19350347|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
19350348|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350349|NCT03735433|Aspirin|aspirin|mesh-list
19350350|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19350351|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19350352|NCT03735433|Analgesics|analgesics|mesh-ancestor
19684600|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684601|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684602|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19684603|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
19692688|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692689|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350353|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
19350354|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350355|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350356|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350357|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350358|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19350359|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19350360|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350361|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19350362|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19350363|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350364|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
19350365|NCT03735368|Pregabalin|pregabalin|mesh-list
19350366|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
19350367|NCT03735368|Benoxinate|benoxinate|mesh-list
19350368|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
19350369|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350370|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350371|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19350372|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19350373|NCT03735368|Analgesics|analgesics|mesh-ancestor
19350374|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
19350375|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350376|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19350377|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19350378|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19350379|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350380|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400935|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350381|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350382|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
19350383|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19350384|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350385|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19350386|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19350387|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19350388|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205747|NCT00268827|Antiviral Agents|antiviral agents|mesh-ancestor
20390458|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20390459|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20390460|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
20390461|NCT01074645|Tenofovir|tenofovir|mesh-list
20390462|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
20390463|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390464|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20390465|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20390466|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350389|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350390|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
19350391|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
19350392|NCT03735316|Vitamins|vitamins|mesh-ancestor
19350393|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
19350394|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350395|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
19350396|NCT03735316|Hematinics|hematinics|mesh-ancestor
20205748|NCT00268827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205749|NCT00268827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20205750|NCT00268827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19350397|NCT03735264|Docetaxel|docetaxel|mesh-list
19350398|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350399|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
19350400|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
19350401|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
19350402|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350403|NCT03735251|Metoprolol|metoprolol|mesh-list
19350404|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19350405|NCT03735251|Diuretics|diuretics|mesh-list
19350406|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
19350407|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350408|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19350409|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19350410|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
19350411|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
19350412|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350413|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19350414|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19350415|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19350416|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350417|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350418|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350419|NCT03735134|Colchicine|colchicine|mesh-list
19350420|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
19350421|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350422|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
19350423|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
20205751|NCT00268840|Gemcitabine|gemcitabine|mesh-list
19350424|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
19350425|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350426|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350427|NCT03735082|Paclitaxel|paclitaxel|mesh-list
19350428|NCT03735082|Carboplatin|carboplatin|mesh-list
19350429|NCT03735082|Apatinib|apatinib|mesh-list
19350430|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20205752|NCT00268840|Docetaxel|docetaxel|mesh-list
20205753|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20205754|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
20205755|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205756|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205757|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
20205758|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390467|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390468|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19350431|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205759|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350432|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
20390469|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20390470|NCT01074697|Dexamethasone|dexamethasone|mesh-list
20390471|NCT01074697|Palonosetron|palonosetron|mesh-list
20390472|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
20390473|NCT01074697|Aprepitant|aprepitant|mesh-list
19350433|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
19350434|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
19350435|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350436|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19350437|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350438|NCT03734627|Acetaminophen|acetaminophen|mesh-list
19350439|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
19350440|NCT03734627|Octreotide|octreotide|mesh-list
19350441|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19350442|NCT03734627|Analgesics|analgesics|mesh-ancestor
19350443|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
19350444|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350445|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350446|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
19350447|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19350448|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19350449|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350450|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390474|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390475|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
20390476|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
20390477|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390478|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390479|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20390480|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
20390481|NCT01074697|Hormones|hormones|mesh-ancestor
20390482|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390483|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20390484|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390485|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390486|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20390487|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19350451|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19350452|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350453|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350454|NCT03734614|Aspirin|aspirin|mesh-list
19350455|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19350456|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19350457|NCT03734614|Analgesics|analgesics|mesh-ancestor
19350458|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
19350459|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350460|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350461|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350462|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20390488|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
20390489|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390490|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20390491|NCT01074723|Carotenoids|carotenoids|mesh-list
20390492|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
20390493|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390494|NCT01074723|Protective Agents|protective agents|mesh-ancestor
20390495|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390496|NCT01074801|Insulin|insulin|mesh-list
19350463|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19350464|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19350465|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350466|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19350467|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19350468|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350469|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
19350470|NCT03734562|Amiodarone|amiodarone|mesh-list
19350471|NCT03734562|Sotalol|sotalol|mesh-list
19350472|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20390497|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19350473|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
19350474|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19350475|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350476|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390498|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19684604|NCT05108974|Choline|choline|mesh-list
20390499|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390500|NCT01074853|Propranolol|propranolol|mesh-list
20390501|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20390502|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20390503|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390504|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390505|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390506|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390507|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20390508|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390509|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
20205760|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20205761|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
20205762|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350477|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19350478|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19350479|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19350480|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350481|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19350482|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20390510|NCT01074879|Caseins|caseins|mesh-list
20390511|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
20390512|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
20390513|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390514|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20390515|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
20390516|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
20390517|NCT01074892|Progestins|progestins|mesh-list
20390518|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20390519|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
20390520|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390521|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390522|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20390523|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20390524|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20390525|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20390526|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20390527|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20390528|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390529|NCT01074892|Hormones|hormones|mesh-ancestor
19350483|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19350484|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19350485|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19350486|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350487|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350488|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350489|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
19350490|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
19350491|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684605|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
20390530|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390531|NCT01074905|Artesunate|artesunate|mesh-list
20390532|NCT01074905|Chloroquine|chloroquine|mesh-list
20390533|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20390534|NCT01074905|Primaquine|primaquine|mesh-list
20390535|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
20390536|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20390537|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19400936|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19400937|NCT03622047|Analgesics|analgesics|mesh-ancestor
19400938|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
19400939|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400940|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19400941|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400942|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400943|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400944|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684606|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20205763|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
20205764|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
20205765|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
20205766|NCT00268879|Renzapride|renzapride|mesh-list
20205767|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20205768|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
20205769|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390538|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350492|NCT03734445|Vitamins|vitamins|mesh-list
19350493|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
19350494|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390539|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205770|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205771|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205772|NCT00268918|Docetaxel|docetaxel|mesh-list
20205773|NCT00268918|Vatalanib|vatalanib|mesh-list
20205774|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205775|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
20205776|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
20390540|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
20390541|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
20390542|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20390543|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
20390544|NCT01074905|Amebicides|amebicides|mesh-ancestor
20390545|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350495|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
19350496|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
19350497|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350498|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350499|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350500|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
19350501|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
19350502|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
19350503|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
19350504|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350505|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350506|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350507|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
19350508|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
19350509|NCT03734198|Daratumumab|daratumumab|mesh-list
19350510|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19350511|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350512|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
19350513|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350514|NCT03734159|Ropivacaine|ropivacaine|mesh-list
19350515|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350516|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
19350517|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350518|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350519|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
19350520|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350521|NCT03734068|Doxorubicin|doxorubicin|mesh-list
19350522|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19350523|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350524|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19350525|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19350526|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350527|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350528|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19350529|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
19843737|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
20390546|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19350530|NCT03733873|Coagulants|coagulants|mesh-ancestor
19350531|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19350532|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
19684607|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
19684608|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390547|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19350533|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684609|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684610|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19684611|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
19684612|NCT05105139|Triclosan|triclosan|mesh-list
19684613|NCT05105139|Coal Tar|coal tar|mesh-list
19684614|NCT05105139|Allantoin|allantoin|mesh-list
19684615|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19684616|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684617|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19843738|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
19350534|NCT03733860|Alprostadil|alprostadil|mesh-list
20390548|NCT01074905|Analgesics|analgesics|mesh-ancestor
19350535|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19350536|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
20205777|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
20390549|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
19350537|NCT03733860|Urological Agents|urological agents|mesh-ancestor
19350538|NCT03733691|Lenalidomide|lenalidomide|mesh-list
19350539|NCT03733691|Ixazomib|ixazomib|mesh-list
19350540|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
19350541|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350542|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19350543|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19350544|NCT03733691|Growth Substances|growth substances|mesh-ancestor
19350545|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
19350546|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350547|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
19350548|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350549|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350550|NCT03733652|Interferons|interferons|mesh-list
19350551|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
19684618|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19684619|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
20205778|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205779|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20205780|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390550|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390551|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350552|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
19350553|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350554|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
19350555|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350556|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
19350557|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350558|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19350559|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
19350560|NCT03733639|Coagulants|coagulants|mesh-ancestor
19350561|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
19350562|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350563|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
19350564|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350565|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350566|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19350567|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
19350568|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350569|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350570|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19350571|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19350572|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19350573|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19350574|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350575|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350576|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205781|NCT00268957|Sevelamer|sevelamer|mesh-list
20205782|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
20205783|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
20205784|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205785|NCT00268970|Paclitaxel|paclitaxel|mesh-list
20205786|NCT00268970|Satraplatin|satraplatin|mesh-list
20205787|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20205788|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205789|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20205790|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
20205791|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20205792|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205793|NCT00269035|Risperidone|risperidone|mesh-list
20205794|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20205795|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
20205796|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350577|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350578|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
19350579|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205797|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205798|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205799|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20205800|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20205801|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205802|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19350580|NCT03733561|Rotigotine|rotigotine|mesh-list
19350581|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
19843739|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843740|NCT00660907|Metformin|metformin|mesh-list
19843741|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
20205803|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19350582|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
19350583|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350584|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350585|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350586|NCT03733535|Benralizumab|benralizumab|mesh-list
19350587|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19350588|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
19350589|NCT03733379|Amoxicillin|amoxicillin|mesh-list
19350590|NCT03733379|Metronidazole|metronidazole|mesh-list
19350591|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20205804|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
20205805|NCT00269061|Pioglitazone|pioglitazone|mesh-list
20205806|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20205807|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350592|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350593|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19350594|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19350595|NCT03733340|Imipenem|imipenem|mesh-list
19350596|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19350597|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350598|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
19350599|NCT03733327|Busulfan|busulfan|mesh-list
19350600|NCT03733327|Etoposide|etoposide|mesh-list
19350601|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350602|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
19350603|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350604|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19350605|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19350606|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
19350607|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350608|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350609|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19350610|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19350611|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19350612|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19350613|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350614|NCT03733275|Lidocaine|lidocaine|mesh-list
19350615|NCT03733275|Bupivacaine|bupivacaine|mesh-list
19350616|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350617|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
19350618|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350619|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350620|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
19350621|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350622|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20205808|NCT00269126|Fluticasone|fluticasone|mesh-list
20205809|NCT00269126|Xhance|xhance|mesh-list
20205810|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20205811|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19843742|NCT00660907|Glipizide|glipizide|mesh-list
19843743|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19843744|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843745|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20205812|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20205813|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20205814|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
20205815|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205816|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205817|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20205818|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
20205819|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
20205820|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20205821|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20205822|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19350623|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19350624|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19350625|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350626|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350627|NCT03733210|Panitumumab|panitumumab|mesh-list
19350628|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20205823|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20205824|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350629|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350630|NCT03733171|Epinephrine|epinephrine|mesh-list
19350631|NCT03733171|Hemostatics|hemostatics|mesh-list
19350632|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19350633|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19350634|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
19350635|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350636|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350637|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350638|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19350639|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19350640|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
19350641|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350642|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20390552|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390553|NCT01074905|Filaricides|filaricides|mesh-ancestor
19350643|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
19350644|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
19350645|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
19350646|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19350647|NCT03733171|Coagulants|coagulants|mesh-ancestor
19350648|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
19350649|NCT03733145|Giapreza|giapreza|mesh-list
19350650|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
20390554|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
20390555|NCT01074970|Cisplatin|cisplatin|mesh-list
20390556|NCT01074970|Rucaparib|rucaparib|mesh-list
20390557|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390558|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20390559|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390560|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390561|NCT01074996|Leucovorin|leucovorin|mesh-list
20390562|NCT01074996|Antidotes|antidotes|mesh-ancestor
20390563|NCT01074996|Protective Agents|protective agents|mesh-ancestor
20390564|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390565|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
19350651|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19350652|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19350653|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
20390566|NCT01074996|Vitamins|vitamins|mesh-ancestor
20390567|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
20390568|NCT01075022|Vitamin D|vitamin d|mesh-list
20390569|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
20390570|NCT01075022|Vitamins|vitamins|mesh-ancestor
20390571|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
20390572|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390573|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20390574|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20426560|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
20426561|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20426562|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
20426563|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426564|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
20426565|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
19350654|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350655|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350656|NCT03732963|Melatonin|melatonin|mesh-list
19350657|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
19350658|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350659|NCT03732963|Protective Agents|protective agents|mesh-ancestor
19350660|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350661|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350662|NCT03732703|Thalidomide|thalidomide|mesh-list
19350663|NCT03732703|Dexamethasone|dexamethasone|mesh-list
19692690|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
20205825|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205826|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205827|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
20205828|NCT00269126|Hormones|hormones|mesh-ancestor
20205829|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205830|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
20205831|NCT00269204|Niacin|niacin|mesh-list
20205832|NCT00269204|Niacinamide|niacinamide|mesh-list
19350664|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
19350665|NCT03732703|Venetoclax|venetoclax|mesh-list
20205833|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
20426566|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426567|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390575|NCT01075113|Sorafenib|sorafenib|mesh-list
20390576|NCT01075113|Vorinostat|vorinostat|mesh-list
20390577|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390578|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20390579|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350666|NCT03732703|Daratumumab|daratumumab|mesh-list
19350667|NCT03732703|Pomalidomide|pomalidomide|mesh-list
19350668|NCT03732703|Ixazomib|ixazomib|mesh-list
20390580|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390581|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20390582|NCT01075126|Valproic Acid|valproic acid|mesh-list
20390583|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390584|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390585|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390586|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
20390587|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20390588|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390589|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350669|NCT03732703|BB 1101|bb 1101|mesh-list
19350670|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19350671|NCT03732703|Glycine|glycine|mesh-list
19350672|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350673|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
19350674|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
19350675|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350676|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350677|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20390590|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
20390591|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
20390592|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390593|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20390594|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390595|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390596|NCT01075425|Bortezomib|bortezomib|mesh-list
20390597|NCT01075425|Belinostat|belinostat|mesh-list
20390598|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390599|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20205834|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20205835|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
20205836|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205837|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20205838|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
20205839|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
20205840|NCT00269204|Vitamins|vitamins|mesh-ancestor
20205841|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
20205842|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205843|NCT00269217|Niacin|niacin|mesh-list
20205844|NCT00269217|Niacinamide|niacinamide|mesh-list
20205845|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
19350678|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
19350679|NCT03732703|Hormones|hormones|mesh-ancestor
19350680|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350681|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19350682|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350683|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
19350684|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350685|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350686|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
19350687|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19350688|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19350689|NCT03732703|Growth Substances|growth substances|mesh-ancestor
19350690|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
19350691|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350692|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
19350693|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19350694|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350695|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
19350696|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350697|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
19350698|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19350699|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19350700|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
19350701|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390600|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350702|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20390601|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205846|NCT00269217|Simvastatin|simvastatin|mesh-list
20205847|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20205848|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20205849|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
20205850|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205851|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20205852|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20205853|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205854|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
20390602|NCT01075438|Vaccines|vaccines|mesh-list
20390603|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20390604|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
19350703|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19350704|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350705|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350706|NCT03732547|Poly I-C|poly i-c|mesh-list
19350707|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
19350708|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350709|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
19350710|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
19350711|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400945|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205855|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
20205856|NCT00269217|Vitamins|vitamins|mesh-ancestor
20205857|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
20390605|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390606|NCT01075464|Paclitaxel|paclitaxel|mesh-list
20390607|NCT01075464|Bevacizumab|bevacizumab|mesh-list
20390608|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20390609|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390610|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
20390611|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
20390612|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
20390613|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390614|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20390615|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20205858|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205859|NCT00269243|Quinapril|quinapril|mesh-list
20205860|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20205861|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
19684620|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684621|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19684622|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
19684623|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
19684624|NCT05103215|Lidocaine|lidocaine|mesh-list
19684625|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
19684626|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
20205862|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205863|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400946|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
19400947|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
19400948|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19400949|NCT03622047|Narcotics|narcotics|mesh-ancestor
19400950|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19400951|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19400952|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
20205864|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20205865|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
20205866|NCT00269334|Paroxetine|paroxetine|mesh-list
20205867|NCT00269334|Citalopram|citalopram|mesh-list
20205868|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20205869|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20390616|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20390617|NCT01075464|Growth Substances|growth substances|mesh-ancestor
20390618|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390619|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
20390620|NCT01075477|Rituximab|rituximab|mesh-list
20390621|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20390622|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390623|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
20390624|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390625|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20390626|NCT01075490|Clonidine|clonidine|mesh-list
19400953|NCT03621995|Catalase|catalase|mesh-list
20205870|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205871|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390627|NCT01075490|Analgesics|analgesics|mesh-ancestor
20390628|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
20390629|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390630|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350712|NCT03732508|Fluorouracil|fluorouracil|mesh-list
19350713|NCT03732508|Irinotecan|irinotecan|mesh-list
19350714|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
19843746|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205872|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20205873|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
20205874|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205875|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20205876|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
20205877|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205878|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19350715|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350716|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19350717|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350718|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350719|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
19350720|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350721|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20205879|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20390631|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390632|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
20390633|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
20390634|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20390635|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20390636|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20390637|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390638|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390639|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390640|NCT01075503|Ropivacaine|ropivacaine|mesh-list
20390641|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
20390642|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
20390643|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390644|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390645|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
20390646|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390647|NCT01075529|Fluoxetine|fluoxetine|mesh-list
20390648|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20390649|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19350722|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19350723|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350724|NCT03732482|Temozolomide|temozolomide|mesh-list
19350725|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19350726|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
20390650|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20390651|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390652|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390653|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
19350727|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350728|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350729|NCT03732469|Acetaminophen|acetaminophen|mesh-list
19350730|NCT03732469|Fentanyl|fentanyl|mesh-list
19350731|NCT03732469|Propofol|propofol|mesh-list
19350732|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19350733|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350734|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350735|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19350736|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
19350737|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
19350738|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19350739|NCT03732469|Narcotics|narcotics|mesh-ancestor
19350740|NCT03732469|Analgesics|analgesics|mesh-ancestor
19350741|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
19350742|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350743|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19350744|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19350745|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
19350746|NCT03732391|Carboplatin|carboplatin|mesh-list
19350747|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
19350748|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350749|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19350750|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19350751|NCT03732365|Cefazolin|cefazolin|mesh-list
19350752|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350753|NCT03732287|Anesthetics|anesthetics|mesh-list
19350754|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350755|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350756|NCT03732235|Bevacizumab|bevacizumab|mesh-list
19350757|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
19350758|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19350759|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350760|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19350761|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19350762|NCT03732235|Growth Substances|growth substances|mesh-ancestor
20390654|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390655|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20390656|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
20390657|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20390658|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20390659|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20390660|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390661|NCT01075555|Sorafenib|sorafenib|mesh-list
20390662|NCT01075555|Pravastatin|pravastatin|mesh-list
20390663|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390664|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20390665|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390666|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390667|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19350763|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350764|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
19350765|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19350766|NCT03732235|Estrogens|estrogens|mesh-ancestor
19350767|NCT03732235|Hormones|hormones|mesh-ancestor
19350768|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350769|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19350770|NCT03732105|Apatinib|apatinib|mesh-list
19350771|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19350772|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350773|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19350774|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350775|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350776|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19350777|NCT03732105|Growth Substances|growth substances|mesh-ancestor
19350778|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350779|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
19350780|NCT03732040|Fluorides|fluorides|mesh-list
19843747|NCT00660985|Adapalene|adapalene|mesh-list
20205880|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205881|NCT00269386|Clarithromycin|clarithromycin|mesh-list
20205882|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20205883|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205884|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20205885|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205886|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205887|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20390668|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20390669|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
19350781|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
19350782|NCT03732040|Protective Agents|protective agents|mesh-ancestor
19350783|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350784|NCT03732001|Docetaxel|docetaxel|mesh-list
19350785|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350786|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
19350787|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843748|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19843749|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19843750|NCT00660985|Analgesics|analgesics|mesh-ancestor
19843751|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
19843752|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843753|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843754|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19843755|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19843756|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
19843757|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
20205888|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20390670|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20390671|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20390672|NCT01075581|Epinephrine|epinephrine|mesh-list
20390673|NCT01075581|Racepinephrine|racepinephrine|mesh-list
20390674|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
20390675|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20390676|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20390677|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390678|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390679|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390680|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390681|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20390682|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20390683|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
20390684|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350788|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
19350789|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350790|NCT03731988|Lidocaine|lidocaine|mesh-list
19350791|NCT03731988|Prilocaine|prilocaine|mesh-list
19350792|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19350793|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350794|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
19350795|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350796|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350797|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
19350798|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350799|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19350800|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19350801|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19350802|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350803|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350804|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19684627|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684628|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205889|NCT00269412|Rifaximin|rifaximin|mesh-list
19684629|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
19684630|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684631|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19684632|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20205890|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20205891|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20205892|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20205893|NCT00269542|Iron|iron|mesh-list
20205894|NCT00269542|Folic Acid|folic acid|mesh-list
20205895|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
20205896|NCT00269542|Trace Elements|trace elements|mesh-ancestor
20205897|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
20205898|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205899|NCT00269542|Hematinics|hematinics|mesh-ancestor
20205900|NCT00269542|Vitamins|vitamins|mesh-ancestor
20205901|NCT00269555|Genistein|genistein|mesh-list
20205902|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20205903|NCT00269555|Protective Agents|protective agents|mesh-ancestor
20205904|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205905|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20205906|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20205907|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20205908|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205909|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
20205910|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20205911|NCT00269555|Estrogens|estrogens|mesh-ancestor
20205912|NCT00269555|Hormones|hormones|mesh-ancestor
20205913|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205914|NCT00269568|Misoprostol|misoprostol|mesh-list
20205915|NCT00269568|Mifepristone|mifepristone|mesh-list
20205916|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20205917|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
20205918|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20205919|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205920|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20390685|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20390686|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
19350805|NCT03731897|Lidocaine|lidocaine|mesh-list
20205921|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20205922|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
20205923|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20205924|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20205925|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20205926|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20205927|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
20205928|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20205929|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20205930|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
20205931|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20205932|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
20205933|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20205934|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20390687|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
20390688|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
20390689|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19350806|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350807|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
19350808|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350809|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350810|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
19350811|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350812|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19350813|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19350814|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19350815|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350816|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205935|NCT00269594|Lamotrigine|lamotrigine|mesh-list
20205936|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
19684633|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19684634|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19684635|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684636|NCT05042700|Melatonin|melatonin|mesh-list
19684637|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
19684638|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684639|NCT05042700|Protective Agents|protective agents|mesh-ancestor
20205937|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20390690|NCT01075659|Nicotine|nicotine|mesh-list
20390691|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20390692|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
20390693|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390694|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390695|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20390696|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20390697|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
20205938|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20205939|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205940|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20205941|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205942|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20205943|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20205944|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205945|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20205946|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20205947|NCT00269607|Naltrexone|naltrexone|mesh-list
20205948|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20205949|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20205950|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205951|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
20205952|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20205953|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20205954|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20205955|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20205956|NCT00269620|Etonogestrel|etonogestrel|mesh-list
20205957|NCT00269620|NuvaRing|nuvaring|mesh-list
19350817|NCT03731832|Dexamethasone|dexamethasone|mesh-list
20205958|NCT00269620|Norelgestromin|norelgestromin|mesh-list
20205959|NCT00269620|Ortho Evra|ortho evra|mesh-list
19350818|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
19350819|NCT03731832|Pomalidomide|pomalidomide|mesh-list
19350820|NCT03731832|Ixazomib|ixazomib|mesh-list
19350821|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19350822|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
19350823|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350824|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20390698|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350825|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19350826|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
19350827|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350828|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350829|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19350830|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350831|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
19350832|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
19350833|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350834|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19350835|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
19350836|NCT03731832|Hormones|hormones|mesh-ancestor
19350837|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350838|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19350839|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19350840|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19350841|NCT03731832|Growth Substances|growth substances|mesh-ancestor
19350842|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
19350843|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
19350844|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350845|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
19350846|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19350847|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350848|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
19350849|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
19350850|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20390699|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390700|NCT01075698|Telmisartan|telmisartan|mesh-list
20390701|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390702|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20390703|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20390704|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390705|NCT01075711|Prednisone|prednisone|mesh-list
20390706|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390707|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
19350851|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350852|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350853|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19350854|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19350855|NCT03731741|Protective Agents|protective agents|mesh-ancestor
19350856|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390708|NCT01075711|Hormones|hormones|mesh-ancestor
20390709|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390710|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390711|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20390712|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390713|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
19350857|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
19350858|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19350859|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
19350860|NCT03731494|Nickel|nickel|mesh-list
19350861|NCT03731494|Trace Elements|trace elements|mesh-ancestor
19350862|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
19350863|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350864|NCT03731468|Dexamethasone|dexamethasone|mesh-list
19350865|NCT03731468|Anesthetics|anesthetics|mesh-list
19350866|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
19350867|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350868|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
19350869|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
19350870|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350871|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350872|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19350873|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
19350874|NCT03731468|Hormones|hormones|mesh-ancestor
19350875|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350876|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19350877|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350878|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350879|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
19350880|NCT03731442|Paclitaxel|paclitaxel|mesh-list
19350881|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19350882|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19350883|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19350884|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19350885|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19350886|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205960|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
20205961|NCT00269620|Estradiol|estradiol|mesh-list
20205962|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20205963|NCT00269620|Estrogens|estrogens|mesh-ancestor
20205964|NCT00269620|Hormones|hormones|mesh-ancestor
20205965|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350887|NCT03731429|Lidocaine|lidocaine|mesh-list
19350888|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
19350889|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
19350890|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350891|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350892|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
19350893|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19350894|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19350895|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19350896|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19350897|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350898|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350899|NCT03731403|Fluorides|fluorides|mesh-list
19350900|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
19350901|NCT03731403|Protective Agents|protective agents|mesh-ancestor
19350902|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350903|NCT03731286|Caffeine|caffeine|mesh-list
19350904|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19350905|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350906|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19350907|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350908|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350909|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19350910|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19350911|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
19350912|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350913|NCT03731169|Voriconazole|voriconazole|mesh-list
19350914|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
19350915|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350916|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19350917|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19350918|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350919|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350920|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19350921|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
19350922|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350923|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350924|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19350925|NCT03731117|Furosemide|furosemide|mesh-list
19350926|NCT03731117|Diuretics|diuretics|mesh-ancestor
19350927|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
19350928|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400954|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
20205966|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390714|NCT01075776|Acetylcholine|acetylcholine|mesh-list
20390715|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
20390716|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20390717|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
20205967|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20205968|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20205969|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20205970|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20205971|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20205972|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20205973|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
20205974|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205975|NCT00269685|Vasopressins|vasopressins|mesh-list
20205976|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
20205977|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
20205978|NCT00269685|Coagulants|coagulants|mesh-ancestor
20205979|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20205980|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20205981|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
20390718|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390719|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20205982|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205983|NCT00269724|Oxybutynin|oxybutynin|mesh-list
20205984|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
20205985|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
20205986|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684640|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684641|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684642|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
19684643|NCT05033483|Trace Elements|trace elements|mesh-ancestor
20390720|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390721|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
20390722|NCT01075789|Lidocaine|lidocaine|mesh-list
20390723|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
19684644|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
19684645|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684646|NCT05015608|Carboplatin|carboplatin|mesh-list
19684647|NCT05015608|Pemetrexed|pemetrexed|mesh-list
20205987|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205988|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20205989|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20205990|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
20205991|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19350929|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19350930|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350931|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350932|NCT03731091|Calcitriol|calcitriol|mesh-list
19350933|NCT03731091|Betamethasone|betamethasone|mesh-list
19350934|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
19350935|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19350936|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
19350937|NCT03731091|Calcipotriene|calcipotriene|mesh-list
19350938|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19350939|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19350940|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
19350941|NCT03731091|Hormones|hormones|mesh-ancestor
19350942|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19350943|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350944|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19350945|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
19350946|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
19350947|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19350948|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19350949|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350950|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350951|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19350952|NCT03731091|Vitamins|vitamins|mesh-ancestor
20205992|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684648|NCT05015608|Osimertinib|osimertinib|mesh-list
19684649|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684650|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684651|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684652|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20390724|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
20390725|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390726|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390727|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
20390728|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390729|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20390730|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19350953|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
19350954|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19350955|NCT03730857|Olanzapine|olanzapine|mesh-list
19350956|NCT03730857|Risperidone|risperidone|mesh-list
19350957|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19350958|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
19350959|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19350960|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
19350961|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684653|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20205993|NCT00269724|Urological Agents|urological agents|mesh-ancestor
20390731|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19684654|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20205994|NCT00269737|Fentanyl|fentanyl|mesh-list
19350962|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350963|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350964|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19350965|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19350966|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19350967|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19350968|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
19350969|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
19350970|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
19350971|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390732|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19350972|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684655|NCT05001815|Insulin|insulin|mesh-list
19684656|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19684657|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19684658|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684659|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19684660|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684661|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19684662|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19684663|NCT05001555|Analgesics|analgesics|mesh-ancestor
19350973|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19350974|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19350975|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19684664|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
19684665|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684666|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19684667|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684668|NCT04975555|Siltuximab|siltuximab|mesh-list
19684669|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684670|NCT04968158|Acetaminophen|acetaminophen|mesh-list
19350976|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19350977|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19350978|NCT03730766|Amoxicillin|amoxicillin|mesh-list
19350979|NCT03730766|Metronidazole|metronidazole|mesh-list
19350980|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
19350981|NCT03730766|Esomeprazole|esomeprazole|mesh-list
19350982|NCT03730766|Bismuth|bismuth|mesh-list
19350983|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19350984|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19350985|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19350986|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19350987|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19350988|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19350989|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19350990|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19350991|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19350992|NCT03730766|Antacids|antacids|mesh-ancestor
19350993|NCT03730766|Diuretics|diuretics|mesh-ancestor
19350994|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
19350995|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19350996|NCT03730766|Expectorants|expectorants|mesh-ancestor
19350997|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
19350998|NCT03730740|Lenalidomide|lenalidomide|mesh-list
19350999|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
19351000|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351001|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20205995|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20205996|NCT00269737|Narcotics|narcotics|mesh-ancestor
20205997|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20205998|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20205999|NCT00269737|Analgesics|analgesics|mesh-ancestor
20206000|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
20206001|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206002|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20206003|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20206004|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
20206005|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
20206006|NCT00269750|Oxybutynin|oxybutynin|mesh-list
20206007|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
20206008|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
20206009|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351002|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19684671|NCT04968158|Etoricoxib|etoricoxib|mesh-list
20206010|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206011|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19684672|NCT04968158|Tramadol|tramadol|mesh-list
19351003|NCT03730740|Growth Substances|growth substances|mesh-ancestor
19351004|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
19351005|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684673|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19684674|NCT04968158|Analgesics|analgesics|mesh-ancestor
19684675|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
19684676|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684677|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684678|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
19684679|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19684680|NCT04968158|Narcotics|narcotics|mesh-ancestor
19684681|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684682|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19684683|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19684684|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684685|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19684686|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19684687|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684688|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684689|NCT04905251|Misoprostol|misoprostol|mesh-list
19684690|NCT04905251|Mifepristone|mifepristone|mesh-list
19684691|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19684692|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
19684693|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684694|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684695|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19684696|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684697|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
19351006|NCT03730714|Epinephrine|epinephrine|mesh-list
19351007|NCT03730714|Racepinephrine|racepinephrine|mesh-list
19351008|NCT03730714|Morphine|morphine|mesh-list
19351009|NCT03730714|Anesthetics|anesthetics|mesh-list
19351010|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
19351011|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
19684698|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19684699|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20206012|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20206013|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
19351012|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19351013|NCT03730714|Narcotics|narcotics|mesh-ancestor
19351014|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351015|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351016|NCT03730714|Analgesics|analgesics|mesh-ancestor
19351017|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
19351018|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351019|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19351020|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19351021|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
19351022|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351023|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351024|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19351025|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20206014|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206015|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206016|NCT00269750|Urological Agents|urological agents|mesh-ancestor
20206017|NCT00269763|Fentanyl|fentanyl|mesh-list
20206018|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20206019|NCT00269763|Narcotics|narcotics|mesh-ancestor
20206020|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206021|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206022|NCT00269763|Analgesics|analgesics|mesh-ancestor
20206023|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
20206024|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206025|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20206026|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20206027|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
20206028|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
20206029|NCT00269776|Methylphenidate|methylphenidate|mesh-list
20206030|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20206031|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351026|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
19351027|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19351028|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
19351029|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
19684700|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20206032|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20390733|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390734|NCT01075802|Tamoxifen|tamoxifen|mesh-list
20390735|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20390736|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
20390737|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19351030|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
19351031|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19400955|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400956|NCT03621995|Protective Agents|protective agents|mesh-ancestor
19400957|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400958|NCT03621904|Tamoxifen|tamoxifen|mesh-list
19400959|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
19400960|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
19400961|NCT03621904|Progesterone|progesterone|mesh-list
19400962|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19400963|NCT03621904|Progestins|progestins|mesh-ancestor
19400964|NCT03621904|Hormones|hormones|mesh-ancestor
19400965|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19400966|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400967|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19400968|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
19400969|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19400970|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19400971|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19400972|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19400973|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390738|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390739|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20390740|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390741|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20390742|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20206033|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20206034|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206035|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206036|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
20206037|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206038|NCT00269789|Methylphenidate|methylphenidate|mesh-list
20206039|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20206040|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206041|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20206042|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20206043|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206044|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400974|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404581|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404582|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404583|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404584|NCT03593408|Narcotics|narcotics|mesh-ancestor
19404585|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19404586|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404587|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
19404588|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
19404589|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19404590|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19404591|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20206045|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
20206046|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206047|NCT00269802|Methylphenidate|methylphenidate|mesh-list
20206048|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20206049|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206050|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20206051|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20206052|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206053|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206054|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
20206055|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206056|NCT00269815|Methylphenidate|methylphenidate|mesh-list
20206057|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20206058|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404592|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
20206059|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20390743|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20390744|NCT01075828|Cetuximab|cetuximab|mesh-list
20390745|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20390746|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390747|NCT01075841|Cetuximab|cetuximab|mesh-list
20390748|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20206060|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20206061|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206062|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206063|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
20206064|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206065|NCT00269828|Paclitaxel|paclitaxel|mesh-list
20206066|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20206067|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20206068|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20206069|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351032|NCT03730675|Sorafenib|sorafenib|mesh-list
20390749|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390750|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20390751|NCT01075854|Hormones|hormones|mesh-ancestor
20390752|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390753|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390754|NCT01075880|Interferons|interferons|mesh-list
20390755|NCT01075880|Interferon-beta|interferon-beta|mesh-list
20390756|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
20390757|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390758|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
20390759|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390760|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
20390761|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390762|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20390763|NCT01075906|Colchicine|colchicine|mesh-list
20390764|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
20390765|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20390766|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
20390767|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
20390768|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
19351033|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351034|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19351035|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351036|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351037|NCT03730649|Sulforaphane|sulforaphane|mesh-list
19351038|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19351039|NCT03730649|Protective Agents|protective agents|mesh-ancestor
19351040|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351041|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351042|NCT03730584|Ropivacaine|ropivacaine|mesh-list
19351043|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351044|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
19351045|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351046|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351047|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
19351048|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351049|NCT03730558|Aflibercept|aflibercept|mesh-list
19351050|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19351051|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19351052|NCT03730558|Growth Substances|growth substances|mesh-ancestor
19351053|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351054|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
19351055|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351056|NCT03730402|Bupivacaine|bupivacaine|mesh-list
19351057|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351058|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
19351059|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351060|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351061|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
19351062|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206070|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206071|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206072|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
20390769|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684701|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19684702|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
19351063|NCT03730363|Pentamidine|pentamidine|mesh-list
19351064|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
19351065|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351066|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19351067|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19351068|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19351069|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
19351070|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19351071|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19351072|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
20390770|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390771|NCT01075945|Lumefantrine|lumefantrine|mesh-list
20390772|NCT01075945|Artemether|artemether|mesh-list
20390773|NCT01075945|Piperaquine|piperaquine|mesh-list
20390774|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19351073|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351074|NCT03730272|Analgesics|analgesics|mesh-list
19351075|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
19351076|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351077|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351078|NCT03730181|Isoniazid|isoniazid|mesh-list
19351079|NCT03730181|Rifapentine|rifapentine|mesh-list
19351080|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
19351081|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19351082|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351083|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19351084|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19351085|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
19351086|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351087|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19351088|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19351089|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
19351090|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
19351091|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19351092|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
19351093|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351094|NCT03730064|Expectorants|expectorants|mesh-ancestor
19351095|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
19351096|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20390775|NCT01075945|Artenimol|artenimol|mesh-list
20390776|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
20390777|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20390778|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20390779|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351097|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
19351098|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351099|NCT03730064|Protective Agents|protective agents|mesh-ancestor
19351100|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351101|NCT03730064|Antidotes|antidotes|mesh-ancestor
19351102|NCT03730038|Pitavastatin|pitavastatin|mesh-list
19351103|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19351104|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19351105|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19351106|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
19351107|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684703|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19684704|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19684705|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
19684706|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390780|NCT01076062|Misoprostol|misoprostol|mesh-list
19351108|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351109|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19351110|NCT03730012|Atezolizumab|atezolizumab|mesh-list
19351111|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351112|NCT03729973|Lidocaine|lidocaine|mesh-list
20390781|NCT01076062|Oxytocin|oxytocin|mesh-list
20390782|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
20390783|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390784|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351113|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
19351114|NCT03729973|Ketamine|ketamine|mesh-list
20390785|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19351115|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19351116|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351117|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
19351118|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390786|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
20390787|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20390788|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20390789|NCT01076140|Lisinopril|lisinopril|mesh-list
20390790|NCT01076140|Nebivolol|nebivolol|mesh-list
19351119|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351120|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
19351121|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351122|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19351123|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19351124|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19351125|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351126|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843758|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19843759|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19843760|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19843761|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19843762|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843763|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
19843764|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843765|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843766|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19843767|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843768|NCT00661141|Ethanol|ethanol|mesh-list
19843769|NCT00661141|Fomepizole|fomepizole|mesh-list
19843770|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19351127|NCT03729973|Analgesics|analgesics|mesh-ancestor
19351128|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19351129|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20206073|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206074|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20206075|NCT00269841|Infliximab|infliximab|mesh-list
20206076|NCT00269841|Antibodies|antibodies|mesh-list
19351130|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
19351131|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19351132|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20206077|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
20206078|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20206079|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
20206080|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206081|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206082|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206083|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19351133|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351134|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
19351135|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19351136|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19351137|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
19351138|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19351139|NCT03729804|Dexamethasone|dexamethasone|mesh-list
19351140|NCT03729804|Lenalidomide|lenalidomide|mesh-list
19351141|NCT03729804|Bortezomib|bortezomib|mesh-list
19351142|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19351143|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
19351144|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
19351145|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843771|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843772|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843773|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206084|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206085|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20206086|NCT00269854|Infliximab|infliximab|mesh-list
20206087|NCT00269854|Antibodies|antibodies|mesh-list
20206088|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
20206089|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20206090|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
20206091|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206092|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206093|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206094|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206095|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206096|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20206097|NCT00269867|Infliximab|infliximab|mesh-list
20206098|NCT00269867|Antibodies|antibodies|mesh-list
20206099|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
20206100|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20206101|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
20426568|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206102|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206103|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206104|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206105|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206106|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206107|NCT00269880|Heparin|heparin|mesh-list
20206108|NCT00269880|Abciximab|abciximab|mesh-list
20206109|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
20206110|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20206111|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20206112|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843774|NCT00661141|Antidotes|antidotes|mesh-ancestor
20206113|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20206114|NCT00269893|Abciximab|abciximab|mesh-list
20206115|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
20206116|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20206117|NCT00269906|Abciximab|abciximab|mesh-list
20206118|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
20206119|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20390791|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20390792|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
20390793|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390794|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390795|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20390796|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20390797|NCT01076140|Protective Agents|protective agents|mesh-ancestor
20390798|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390799|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
20390800|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20206120|NCT00269932|Levofloxacin|levofloxacin|mesh-list
20206121|NCT00269932|Ofloxacin|ofloxacin|mesh-list
19351146|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351147|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19351148|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
19351149|NCT03729804|Hormones|hormones|mesh-ancestor
19351150|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19351151|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19351152|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351153|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
19351154|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19351155|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19351156|NCT03729804|Growth Substances|growth substances|mesh-ancestor
19351157|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
19351158|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19351159|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
19351160|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351161|NCT03729687|Capecitabine|capecitabine|mesh-list
19351162|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
20390801|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20390802|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20390803|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390804|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351163|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19351164|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
19351165|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351166|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351167|NCT03729674|Infliximab|infliximab|mesh-list
19351168|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
19351169|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19351170|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19351171|NCT03729505|Lidocaine|lidocaine|mesh-list
20206122|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20206123|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206124|NCT00269932|Renal Agents|renal agents|mesh-ancestor
20206125|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20206126|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20206127|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20206128|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206129|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206130|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206131|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20206132|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20206133|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
19351172|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
20206134|NCT00269945|Hematinics|hematinics|mesh-ancestor
20206135|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
20390805|NCT01076322|Albuterol|albuterol|mesh-list
20390806|NCT01076322|Procaterol|procaterol|mesh-list
20390807|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20390808|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
20390809|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390810|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390811|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20390812|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
20390813|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
20390814|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390815|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20390816|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20390817|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20390818|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390819|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390820|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390821|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
20390822|NCT01076439|Fluticasone|fluticasone|mesh-list
20390823|NCT01076439|Xhance|xhance|mesh-list
20390824|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20390825|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20390826|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20390827|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
20390828|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390829|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390830|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20390831|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
20390832|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20390833|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20390834|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20390835|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20390836|NCT01076439|Analgesics|analgesics|mesh-ancestor
20390837|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
20390838|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20390839|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20390840|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20390841|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
20390842|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
20390843|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390844|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390845|NCT01076478|Cilostazol|cilostazol|mesh-list
20390846|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20390847|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
20390848|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390849|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390850|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20390851|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
20390852|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20390853|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19843775|NCT00661141|Protective Agents|protective agents|mesh-ancestor
19843776|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843777|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843778|NCT00661193|Paclitaxel|paclitaxel|mesh-list
19843779|NCT00661193|Carboplatin|carboplatin|mesh-list
19843780|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19843781|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20206136|NCT00269958|Hematinics|hematinics|mesh-ancestor
20206137|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
20206138|NCT00269971|Hematinics|hematinics|mesh-ancestor
20206139|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
20206140|NCT00269984|Hematinics|hematinics|mesh-ancestor
20217788|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217789|NCT00310505|Amphotericin B|amphotericin b|mesh-list
20217790|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20217791|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20217792|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
20217793|NCT00310505|Amebicides|amebicides|mesh-ancestor
20217794|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20217795|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20217796|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217797|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20217798|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
20217799|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20217800|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217801|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
20426569|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
20390854|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390855|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20390856|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
20390857|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20390858|NCT01076478|Protective Agents|protective agents|mesh-ancestor
20390859|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20390860|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20390861|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390862|NCT01076491|Mannitol|mannitol|mesh-list
20390863|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20390864|NCT01076491|Diuretics|diuretics|mesh-ancestor
20390865|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
20390866|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390867|NCT01076530|Temozolomide|temozolomide|mesh-list
20390868|NCT01076530|Vorinostat|vorinostat|mesh-list
20390869|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20390870|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
20390871|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390872|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390873|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20390874|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390875|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
20390876|NCT01076556|Rituximab|rituximab|mesh-list
19351173|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351174|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
19351175|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351176|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351177|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
19351178|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351179|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19351180|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19351181|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19351182|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351183|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351184|NCT03729505|Analgesics|analgesics|mesh-ancestor
19351185|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
19351186|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19351187|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19351188|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
19351189|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19351190|NCT03729375|Bupivacaine|bupivacaine|mesh-list
19351191|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351192|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
19351193|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351194|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351195|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
19351196|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351197|NCT03729310|Triamcinolone|triamcinolone|mesh-list
19351198|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19351199|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
19351200|NCT03729310|Hormones|hormones|mesh-ancestor
19351201|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19351202|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351203|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19351204|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19351205|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19351206|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351207|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351208|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351209|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206141|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
20206142|NCT00269997|Hematinics|hematinics|mesh-ancestor
20206143|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
20206144|NCT00270010|Hematinics|hematinics|mesh-ancestor
20206145|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
20206146|NCT00270023|Hematinics|hematinics|mesh-ancestor
20206147|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
20206148|NCT00270036|Hematinics|hematinics|mesh-ancestor
20206149|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
20206150|NCT00270049|Hematinics|hematinics|mesh-ancestor
20206151|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
20206152|NCT00270062|Hematinics|hematinics|mesh-ancestor
20390877|NCT01076556|Alvocidib|alvocidib|mesh-list
20206153|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
20206154|NCT00270075|Hematinics|hematinics|mesh-ancestor
20390878|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20206155|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
20206156|NCT00270088|Hematinics|hematinics|mesh-ancestor
20206157|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
20206158|NCT00270101|Hematinics|hematinics|mesh-ancestor
19351210|NCT03729284|Analgesics|analgesics|mesh-ancestor
19351211|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
19351212|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351213|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
19351214|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19351215|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
19351216|NCT03729128|Memantine|memantine|mesh-list
19351217|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
19351218|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19351219|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19351220|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
19351221|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390879|NCT01076556|Antibodies|antibodies|mesh-list
20390880|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
20390881|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20390882|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20390883|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
20390884|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390885|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206159|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
20206160|NCT00270114|Hematinics|hematinics|mesh-ancestor
20206161|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
20390886|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20390887|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
20390888|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390889|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390890|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20390891|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
20390892|NCT01076556|Growth Substances|growth substances|mesh-ancestor
20390893|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20390894|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20390895|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20390896|NCT01076582|Desogestrel|desogestrel|mesh-list
20390897|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20390898|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20390899|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20390900|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
20390901|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390902|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351222|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351223|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351224|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19351225|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19351226|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
19351227|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
19351228|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
19351229|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
19351230|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351231|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
19351232|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351233|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351234|NCT03729011|Propofol|propofol|mesh-list
20206162|NCT00270127|Hematinics|hematinics|mesh-ancestor
20206163|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
20206164|NCT00270140|Hematinics|hematinics|mesh-ancestor
20206165|NCT00270153|Enalapril|enalapril|mesh-list
20206166|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20206167|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
20206168|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206169|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206170|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19351235|NCT03729011|Sevoflurane|sevoflurane|mesh-list
19351236|NCT03729011|Desflurane|desflurane|mesh-list
19351237|NCT03729011|Isoflurane|isoflurane|mesh-list
20206171|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
20206172|NCT00270166|Hematinics|hematinics|mesh-ancestor
19351238|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20206173|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
20206174|NCT00270179|Hematinics|hematinics|mesh-ancestor
20206175|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
20206176|NCT00270270|Hematinics|hematinics|mesh-ancestor
20206177|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
20206178|NCT00270283|Hematinics|hematinics|mesh-ancestor
19400975|NCT03621800|Menthol|menthol|mesh-list
20206179|NCT00270322|Fentanyl|fentanyl|mesh-list
20206180|NCT00270322|Morphine|morphine|mesh-list
20206181|NCT00270322|Bupivacaine|bupivacaine|mesh-list
20206182|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20206183|NCT00270322|Narcotics|narcotics|mesh-ancestor
19843782|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351239|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206184|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206185|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206186|NCT00270322|Analgesics|analgesics|mesh-ancestor
20206187|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
20206188|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206189|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20206190|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20206191|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
20206192|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
20206193|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
20206194|NCT00270335|Propofol|propofol|mesh-list
20206195|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20206196|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206197|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351240|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351241|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351242|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
19351243|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
19351244|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19843783|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843784|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206198|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351245|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19351246|NCT03728946|Bupivacaine|bupivacaine|mesh-list
19351247|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351248|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
19351249|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351250|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351251|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
19351252|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351253|NCT03728933|Rotigotine|rotigotine|mesh-list
19351254|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
19351255|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
19351256|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351257|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351258|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351259|NCT03728894|Midazolam|midazolam|mesh-list
19351260|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
19351261|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19351262|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19351263|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351264|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351265|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19351266|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19351267|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19351268|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351269|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
19351270|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
19351271|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
19351272|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
19351273|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351274|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351275|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
19684707|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
19684708|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19684709|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19684710|NCT04895098|Ezetimibe|ezetimibe|mesh-list
19684711|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19684712|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19684713|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20206199|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
20206200|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
20206201|NCT00270348|Ciclesonide|ciclesonide|mesh-list
20206202|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
20206203|NCT00270348|Hormones|hormones|mesh-ancestor
20206204|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206205|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206206|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20206207|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19684714|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
20206208|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
20206209|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206210|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20206211|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
20206212|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390903|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20390904|NCT01076582|Estrogens|estrogens|mesh-ancestor
20390905|NCT01076582|Hormones|hormones|mesh-ancestor
20390906|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390907|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20390908|NCT01076582|Progestins|progestins|mesh-ancestor
20390909|NCT01076595|Interferons|interferons|mesh-list
20390910|NCT01076595|Interferon-beta|interferon-beta|mesh-list
20390911|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
20390912|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351276|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
19351277|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19351278|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
19351279|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
19351280|NCT03728829|Carboplatin|carboplatin|mesh-list
19351281|NCT03728829|Docetaxel|docetaxel|mesh-list
19351282|NCT03728829|Trastuzumab|trastuzumab|mesh-list
20206213|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20206214|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
20206215|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206216|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20390913|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
20390914|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390915|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
20390916|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390917|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20390918|NCT01076621|Norethindrone|norethindrone|mesh-list
20390919|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
20390920|NCT01076621|Estradiol|estradiol|mesh-list
20390921|NCT01076621|Estrogens|estrogens|mesh-ancestor
20390922|NCT01076621|Hormones|hormones|mesh-ancestor
20390923|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390924|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390925|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19351283|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351284|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206217|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
20206218|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206219|NCT00270413|Sunitinib|sunitinib|mesh-list
20206220|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206221|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20206222|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19351285|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
19351286|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
19351287|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351288|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19351289|NCT03728777|Resveratrol|resveratrol|mesh-list
19351290|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
19351291|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351292|NCT03728777|Protective Agents|protective agents|mesh-ancestor
19351293|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351294|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351295|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20206223|NCT00270413|Growth Substances|growth substances|mesh-ancestor
19400976|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
19400977|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
19843785|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206224|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206225|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
20206226|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20206227|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206228|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206229|NCT00270426|Benazepril|benazepril|mesh-list
20206230|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20206231|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
20206232|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206233|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206234|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20206235|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
20206236|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
20390926|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
19400978|NCT03621683|Antioxidants|antioxidants|mesh-list
19404593|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
20390927|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20390928|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20390929|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20390930|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20390931|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20390932|NCT01076634|Insulin|insulin|mesh-list
20390933|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20390934|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
20390935|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20390936|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390937|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
20390938|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19351296|NCT03728673|Dexetimide|dexetimide|mesh-list
19351297|NCT03728673|Citalopram|citalopram|mesh-list
19351298|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19351299|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19351300|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351301|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351302|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351303|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
19351304|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390939|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
20390940|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351305|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19351306|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
19351307|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19351308|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19351309|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19351310|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
19351311|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
19351312|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351313|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19351314|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19351315|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
19351316|NCT03728465|Nivolumab|nivolumab|mesh-list
19351317|NCT03728465|Ipilimumab|ipilimumab|mesh-list
19351318|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19351319|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351320|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19351321|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351322|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
20390941|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
19351323|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19351324|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
19351325|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351326|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
19351327|NCT03728244|Protective Agents|protective agents|mesh-ancestor
19351328|NCT03728192|Camptothecin|camptothecin|mesh-list
19351329|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19351330|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351331|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19351332|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19351333|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351334|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206237|NCT00270478|Hematinics|hematinics|mesh-ancestor
19351335|NCT03728153|Fluoxetine|fluoxetine|mesh-list
19351336|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19351337|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19351338|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351339|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351340|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351341|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
20206238|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206239|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
20206240|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206241|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206242|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20206243|NCT00270491|Paclitaxel|paclitaxel|mesh-list
20206244|NCT00270491|Capecitabine|capecitabine|mesh-list
20206245|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20206246|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206247|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206248|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
20390942|NCT01076673|Protective Agents|protective agents|mesh-ancestor
19351342|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351343|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19351344|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
19351345|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20206249|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206250|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390943|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
20390944|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20390945|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390946|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390947|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20390948|NCT01076790|Analgesics|analgesics|mesh-ancestor
20390949|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
20390950|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390951|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20390952|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20390953|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20390954|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390955|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390956|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390957|NCT01076803|Lanreotide|lanreotide|mesh-list
20390958|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20390959|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
20390960|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20206251|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20206252|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
20206253|NCT00270517|Telithromycin|telithromycin|mesh-list
20206254|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20206255|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206256|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
20206257|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
20206258|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20206259|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
20206260|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20206261|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20206262|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351346|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19351347|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20206263|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20390961|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390962|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390963|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20390964|NCT01076816|Analgesics|analgesics|mesh-ancestor
20390965|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
20390966|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20390967|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20390968|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20390969|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20390970|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
20390971|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20390972|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20390973|NCT01076842|Insulin|insulin|mesh-list
20390974|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20390975|NCT01076842|Exenatide|exenatide|mesh-list
20390976|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
20390977|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20390978|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390979|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20390980|NCT01076842|Incretins|incretins|mesh-ancestor
20390981|NCT01076842|Hormones|hormones|mesh-ancestor
20390982|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20390983|NCT01076868|Primaquine|primaquine|mesh-list
20390984|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
20390985|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20390986|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20390987|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20390988|NCT01076894|Anesthetics|anesthetics|mesh-list
20390989|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20390990|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20390991|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20390992|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
20390993|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20390994|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20390995|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
20390996|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20390997|NCT01077206|Simvastatin|simvastatin|mesh-list
19351348|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351349|NCT03728101|Dabigatran|dabigatran|mesh-list
19351350|NCT03728101|Simvastatin|simvastatin|mesh-list
19351351|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19351352|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19351353|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
19351354|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351355|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19351356|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19351357|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351358|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
19351359|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19351360|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
19351361|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
19351362|NCT03727867|Mitogens|mitogens|mesh-list
19351363|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
19351364|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351365|NCT03727763|Cetuximab|cetuximab|mesh-list
19351366|NCT03727763|Vemurafenib|vemurafenib|mesh-list
19351367|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19351368|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351369|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19351370|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351371|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351372|NCT03727646|Niacinamide|niacinamide|mesh-list
19351373|NCT03727646|Niacin|niacin|mesh-list
19351374|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
19351375|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
19351376|NCT03727646|Vitamins|vitamins|mesh-ancestor
19351377|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
19843786|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843787|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19843788|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843789|NCT00661362|Metformin|metformin|mesh-list
19843790|NCT00661362|Saxagliptin|saxagliptin|mesh-list
19843791|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19843792|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843793|NCT00661362|Incretins|incretins|mesh-ancestor
19843794|NCT00661362|Hormones|hormones|mesh-ancestor
19843795|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843796|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19843797|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
19843798|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843799|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351378|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351379|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19351380|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
19351381|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351382|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19351383|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
19843800|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
19843801|NCT00661388|Hematinics|hematinics|mesh-ancestor
19843802|NCT00661427|Cetuximab|cetuximab|mesh-list
19843803|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19351384|NCT03727620|Amoxicillin|amoxicillin|mesh-list
19351385|NCT03727620|Metronidazole|metronidazole|mesh-list
19351386|NCT03727620|Doxycycline|doxycycline|mesh-list
19351387|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19351388|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351389|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19351390|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19351391|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
19351392|NCT03727607|Propofol|propofol|mesh-list
19351393|NCT03727607|Desflurane|desflurane|mesh-list
19351394|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19351395|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351396|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843804|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351397|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351398|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
20390998|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20390999|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20391000|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
19351399|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
19351400|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19351401|NCT03727464|Propofol|propofol|mesh-list
19351402|NCT03727464|Sevoflurane|sevoflurane|mesh-list
20426570|NCT01281748|Hormones|hormones|mesh-ancestor
20391001|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391002|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20391003|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19351403|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19351404|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351405|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351406|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351407|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
19351408|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
19351409|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19351410|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19351411|NCT03727412|Naproxen|naproxen|mesh-list
19351412|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19351413|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19351414|NCT03727412|Analgesics|analgesics|mesh-ancestor
19351415|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
19351416|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351417|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391004|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391005|NCT01077427|Gemcitabine|gemcitabine|mesh-list
20391006|NCT01077427|Capecitabine|capecitabine|mesh-list
20391007|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391008|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20391009|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
20391010|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391011|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
20391012|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391013|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391014|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391015|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
20391016|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391017|NCT01077453|Letrozole|letrozole|mesh-list
20391018|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391019|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20391020|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20391021|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391022|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391023|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19351418|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19351419|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19351420|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
19351421|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19351422|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351423|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351424|NCT03727295|Idebenone|idebenone|mesh-list
19351425|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
19351426|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351427|NCT03727295|Protective Agents|protective agents|mesh-ancestor
19351428|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351429|NCT03727282|Dobutamine|dobutamine|mesh-list
19351430|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19351431|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
19351432|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
19351433|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351434|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351435|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19351436|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19351437|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19351438|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
19351439|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351440|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351441|NCT03727282|Protective Agents|protective agents|mesh-ancestor
19351442|NCT03727100|Clonidine|clonidine|mesh-list
20206264|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206265|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206266|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20206267|NCT00270530|Renal Agents|renal agents|mesh-ancestor
20206268|NCT00270543|Leucovorin|leucovorin|mesh-list
20206269|NCT00270543|Fluorouracil|fluorouracil|mesh-list
20206270|NCT00270543|Docetaxel|docetaxel|mesh-list
20206271|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
20206272|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206273|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20206274|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351443|NCT03727100|Analgesics|analgesics|mesh-ancestor
19351444|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
19351445|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351446|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351447|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19351448|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
19351449|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
19351450|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19351451|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19351452|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19351453|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
19351454|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351455|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351456|NCT03727048|Ketorolac|ketorolac|mesh-list
19351457|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19351458|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19351459|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19351460|NCT03727048|Analgesics|analgesics|mesh-ancestor
19351461|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
19351462|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351463|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351464|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206275|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20206276|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
20391024|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
20391025|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391026|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351465|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19351466|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19351467|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351468|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351469|NCT03726788|Triamcinolone|triamcinolone|mesh-list
20391027|NCT01077466|Natalizumab|natalizumab|mesh-list
20391028|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
19351470|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19351471|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19351472|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
19351473|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19351474|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19351475|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19351476|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19351477|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351478|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351479|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
20206277|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206278|NCT00270543|Antidotes|antidotes|mesh-ancestor
20206279|NCT00270543|Protective Agents|protective agents|mesh-ancestor
20206280|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
20206281|NCT00270543|Vitamins|vitamins|mesh-ancestor
20206282|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
20206283|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206284|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206285|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206286|NCT00270556|Tenofovir|tenofovir|mesh-list
19351480|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351481|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351482|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19351483|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351484|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19351485|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
19351486|NCT03726788|Hormones|hormones|mesh-ancestor
19351487|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19351488|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19351489|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
19351490|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351491|NCT03726775|Durvalumab|durvalumab|mesh-list
19351492|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19351493|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351494|NCT03726749|Prednisone|prednisone|mesh-list
19351495|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
19351496|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19351497|NCT03726749|Hormones|hormones|mesh-ancestor
19351498|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404594|NCT03593317|Spironolactone|spironolactone|mesh-list
20206287|NCT00270556|Abacavir|abacavir|mesh-list
20206288|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
19351499|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351500|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19351501|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19400979|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400980|NCT03621683|Protective Agents|protective agents|mesh-ancestor
19400981|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400982|NCT03621618|Dobutamine|dobutamine|mesh-list
19400983|NCT03621618|Norepinephrine|norepinephrine|mesh-list
20391029|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391030|NCT01077479|Metformin|metformin|mesh-list
19400984|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19400985|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19400986|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
19400987|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19400988|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19400989|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19400990|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
19400991|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
19400992|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19400993|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19400994|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19400995|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19400996|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19400997|NCT03621618|Protective Agents|protective agents|mesh-ancestor
19400998|NCT03621553|Vitamin D|vitamin d|mesh-list
19400999|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
19401000|NCT03621553|Vitamins|vitamins|mesh-list
19401001|NCT03621553|Calcium|calcium|mesh-list
19401002|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
19401003|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401004|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19401005|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19401006|NCT03621527|Remifentanil|remifentanil|mesh-list
20391031|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20391032|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391033|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
20391034|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20391035|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
19401007|NCT03621527|Anesthetics|anesthetics|mesh-list
19401008|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401009|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401010|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19843805|NCT00661453|Valproic Acid|valproic acid|mesh-list
19843806|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
19401011|NCT03621527|Narcotics|narcotics|mesh-ancestor
19401012|NCT03621527|Analgesics|analgesics|mesh-ancestor
19401013|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
19401014|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401015|NCT03621514|Lidocaine|lidocaine|mesh-list
19401016|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
19401017|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
19401018|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401019|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401020|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
19401021|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401022|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401023|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19401024|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19401025|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401026|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401027|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
19401028|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
19401029|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19401030|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401031|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401032|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
19401033|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19401034|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401035|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401036|NCT03621072|Fluconazole|fluconazole|mesh-list
19401037|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
19401038|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401039|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19843807|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351502|NCT03726736|Docetaxel|docetaxel|mesh-list
19351503|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351504|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
19351505|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206289|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206290|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20206291|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20206292|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206293|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206294|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20206295|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20206296|NCT00270569|Cisplatin|cisplatin|mesh-list
20206297|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351506|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
19351507|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684715|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684716|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19684717|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206298|NCT00270582|Gemcitabine|gemcitabine|mesh-list
20206299|NCT00270582|Docetaxel|docetaxel|mesh-list
20206300|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391036|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
20391037|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20391038|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391039|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20391040|NCT01077505|Incretins|incretins|mesh-ancestor
20391041|NCT01077505|Hormones|hormones|mesh-ancestor
20391042|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391043|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20391044|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19684718|NCT04848454|Vinorelbine|vinorelbine|mesh-list
19684719|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684720|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19351508|NCT03726593|Artesunate|artesunate|mesh-list
19351509|NCT03726593|Mefloquine|mefloquine|mesh-list
19351510|NCT03726593|Atovaquone|atovaquone|mesh-list
19351511|NCT03726593|Proguanil|proguanil|mesh-list
19351512|NCT03726593|Pyronaridine|pyronaridine|mesh-list
19351513|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19351514|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
19351515|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19351516|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19351517|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351518|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351519|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
19351520|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
19351521|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19351522|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
19351523|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351524|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351525|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
19351526|NCT03726580|Propofol|propofol|mesh-list
19351527|NCT03726580|Sevoflurane|sevoflurane|mesh-list
19351528|NCT03726580|Isoflurane|isoflurane|mesh-list
19351529|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20391045|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20391046|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20391047|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20391048|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20391049|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
19351530|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351531|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351532|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351533|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
19351534|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
19351535|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19351536|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19684721|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
19684722|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
20391050|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391051|NCT01077570|Repaglinide|repaglinide|mesh-list
19351537|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
19351538|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19351539|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351540|NCT03726398|Macitentan|macitentan|mesh-list
19351541|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19684723|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206301|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20206302|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
20206303|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206304|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
20206305|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206306|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206307|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20206308|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
20391052|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19351542|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19351543|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351544|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19351545|NCT03726372|Bromides|bromides|mesh-list
19351546|NCT03726372|Rocuronium|rocuronium|mesh-list
20391053|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391054|NCT01077609|Fluticasone|fluticasone|mesh-list
20391055|NCT01077609|Xhance|xhance|mesh-list
20391056|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391057|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20391058|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
20391059|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391060|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351547|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
19351548|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19351549|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19351550|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19351551|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351552|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351553|NCT03726281|Nivolumab|nivolumab|mesh-list
19351554|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684724|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684725|NCT04810559|Antibodies|antibodies|mesh-list
20206309|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206310|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206311|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206312|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206313|NCT00270647|Vitamins|vitamins|mesh-list
20206314|NCT00270647|Ascorbic Acid|ascorbic acid|mesh-list
20206315|NCT00270647|Vitamin E|vitamin e|mesh-list
20206316|NCT00270647|Beta Carotene|beta carotene|mesh-list
20206317|NCT00270647|Carotenoids|carotenoids|mesh-list
20206318|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
19684726|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
19684727|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684728|NCT04799236|Amphotericin B|amphotericin b|mesh-list
19684729|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20206319|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206320|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
20206321|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206322|NCT00270647|Protective Agents|protective agents|mesh-ancestor
20206323|NCT00270647|Provitamins|provitamins|mesh-ancestor
20206324|NCT00270751|Minocycline|minocycline|mesh-list
19351555|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351556|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19351557|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351558|NCT03726268|Fentanyl|fentanyl|mesh-list
19351559|NCT03726268|Sufentanil|sufentanil|mesh-list
19351560|NCT03726268|Morphine|morphine|mesh-list
19351561|NCT03726268|Methadone|methadone|mesh-list
19351562|NCT03726268|Hydromorphone|hydromorphone|mesh-list
19351563|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19351564|NCT03726268|Narcotics|narcotics|mesh-ancestor
19351565|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351566|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351567|NCT03726268|Analgesics|analgesics|mesh-ancestor
19351568|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
19351569|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351570|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19351571|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351572|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
19351573|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
19351574|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
20206325|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19684730|NCT04799236|Miltefosine|miltefosine|mesh-list
20206326|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206327|NCT00270777|Promethazine|promethazine|mesh-list
20206328|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
20206329|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
19351575|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
19351576|NCT03726242|Cromakalim|cromakalim|mesh-list
19351577|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20391061|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20206330|NCT00270777|Epinephrine|epinephrine|mesh-list
20206331|NCT00270777|Racepinephrine|racepinephrine|mesh-list
20206332|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
20206333|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206334|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20391062|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
19351578|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19351579|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
19351580|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351581|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351582|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19351583|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
19351584|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
20206335|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20206336|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
20206337|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206338|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206339|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351585|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
19843808|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843809|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
19351586|NCT03726216|Dalbavancin|dalbavancin|mesh-list
19351587|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19351588|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351589|NCT03726177|Aspirin|aspirin|mesh-list
19351590|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19351591|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19351592|NCT03726177|Analgesics|analgesics|mesh-ancestor
19351593|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
19351594|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351595|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351596|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19351597|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19351598|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19351599|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19351600|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351601|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19351602|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19843810|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843811|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843812|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
19843813|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19843814|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843815|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19351603|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351604|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
19351605|NCT03726125|Insulin|insulin|mesh-list
19351606|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19351607|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
19351608|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19351609|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351610|NCT03726099|Amoxicillin|amoxicillin|mesh-list
19351611|NCT03726099|Tetracycline|tetracycline|mesh-list
19351612|NCT03726099|Furazolidone|furazolidone|mesh-list
19351613|NCT03726099|Esomeprazole|esomeprazole|mesh-list
19351614|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19351615|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351616|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19351617|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19351618|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19351619|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351620|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351621|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19351622|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19351623|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19351624|NCT03726099|Renal Agents|renal agents|mesh-ancestor
19351625|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19351626|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19351627|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19351628|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19351629|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
20206340|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19351630|NCT03726021|Irinotecan|irinotecan|mesh-list
19351631|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351632|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19351633|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19351634|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351635|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351636|NCT03725995|Lidocaine|lidocaine|mesh-list
19351637|NCT03725995|Midazolam|midazolam|mesh-list
19351638|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351639|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
19351640|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351641|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351642|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
20206341|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20206342|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
19351643|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351644|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19351645|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19351646|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19351647|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351648|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351649|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19351650|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19351651|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19351652|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19351653|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20206343|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206344|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20206345|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
20206346|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
20206347|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
20206348|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19351654|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20391063|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391064|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20391065|NCT01077648|Trastuzumab|trastuzumab|mesh-list
20391066|NCT01077648|Lapatinib|lapatinib|mesh-list
20391067|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391068|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391069|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20391070|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351655|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
19351656|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
19351657|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
19351658|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206349|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
20206350|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206351|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20206352|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
20206353|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
20206354|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20391071|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391072|NCT01077661|Nebivolol|nebivolol|mesh-list
19351659|NCT03725930|Clonidine|clonidine|mesh-list
19351660|NCT03725930|Analgesics|analgesics|mesh-ancestor
19351661|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
19351662|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351663|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351664|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19351665|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
20391073|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20391074|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
20391075|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20391076|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20391077|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20391078|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
19351666|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
19351667|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19351668|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19351669|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19351670|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
19351671|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206355|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20206356|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20391079|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401040|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19351672|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351673|NCT03725904|Progesterone|progesterone|mesh-list
19351674|NCT03725904|Progestins|progestins|mesh-ancestor
19351675|NCT03725904|Hormones|hormones|mesh-ancestor
19351676|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19351677|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351678|NCT03725891|Aspirin|aspirin|mesh-list
19351679|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19351680|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19351681|NCT03725891|Analgesics|analgesics|mesh-ancestor
19351682|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
19351683|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351684|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206357|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206358|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
20206359|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
20206360|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
20206361|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
20206362|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206363|NCT00270816|Interferons|interferons|mesh-list
20206364|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206365|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
20206366|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206367|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20206368|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
20206369|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206370|NCT00270881|Cytarabine|cytarabine|mesh-list
20206371|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
20206372|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20206373|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
20206374|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206375|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206376|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20206377|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
20206378|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206379|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206380|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20206381|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20206382|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
20206383|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
20206384|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206385|NCT00270907|Gemcitabine|gemcitabine|mesh-list
20391080|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391081|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391082|NCT01077726|Capecitabine|capecitabine|mesh-list
20391083|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20391084|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
20391085|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351685|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19351686|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206386|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19351687|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20206387|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20206388|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
20206389|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206390|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206391|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
20206392|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206393|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206394|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20206395|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
20206396|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206397|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20206398|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
20206399|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206400|NCT00271063|Annamycin|annamycin|mesh-list
20206401|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20206402|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206403|NCT00271206|Progesterone|progesterone|mesh-list
20206404|NCT00271206|Progestins|progestins|mesh-ancestor
20206405|NCT00271206|Hormones|hormones|mesh-ancestor
19351688|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20206406|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206407|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206408|NCT00271245|Selenium|selenium|mesh-list
19351689|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351690|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19351691|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19351692|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351693|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
19351694|NCT03725878|Folic Acid|folic acid|mesh-list
19351695|NCT03725878|Hematinics|hematinics|mesh-ancestor
19351696|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
19351697|NCT03725878|Vitamins|vitamins|mesh-ancestor
19351698|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
19351699|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351700|NCT03725709|Anesthetics|anesthetics|mesh-list
19351701|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351702|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351703|NCT03725553|Vasopressins|vasopressins|mesh-list
19351704|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
19351705|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
19351706|NCT03725553|Coagulants|coagulants|mesh-ancestor
19351707|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19351708|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19351709|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
19351710|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351711|NCT03725501|Ranibizumab|ranibizumab|mesh-list
19351712|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19351713|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19351714|NCT03725501|Growth Substances|growth substances|mesh-ancestor
19351715|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351716|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
20206409|NCT00271245|Selenic Acid|selenic acid|mesh-list
20206410|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
20206411|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684731|NCT04799236|Amebicides|amebicides|mesh-ancestor
19684732|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19351717|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351718|NCT03725423|Apatinib|apatinib|mesh-list
20612959|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19351719|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351720|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19351721|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351722|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351723|NCT03725267|Melatonin|melatonin|mesh-list
19351724|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
19351725|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351726|NCT03725267|Protective Agents|protective agents|mesh-ancestor
19351727|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351728|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351729|NCT03725228|Lidocaine|lidocaine|mesh-list
19351730|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
19351731|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
19684733|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19684734|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684735|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19684736|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
19684737|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351732|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
19351733|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351734|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843816|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19843817|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19843818|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19843819|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19351735|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
19351736|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351737|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19843820|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19843821|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
19843822|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843823|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206412|NCT00271245|Protective Agents|protective agents|mesh-ancestor
19351738|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19684738|NCT04785326|Ustekinumab|ustekinumab|mesh-list
20206413|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351739|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19684739|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206414|NCT00271245|Trace Elements|trace elements|mesh-ancestor
20391086|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391087|NCT01077752|Acetaminophen|acetaminophen|mesh-list
20391088|NCT01077752|Lidocaine|lidocaine|mesh-list
20391089|NCT01077752|Morphine|morphine|mesh-list
20391090|NCT01077752|Ropivacaine|ropivacaine|mesh-list
20391091|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
20391092|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
20391093|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351740|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19351741|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351742|NCT03725228|Analgesics|analgesics|mesh-ancestor
19351743|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
19351744|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19351745|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19351746|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
19351747|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19351748|NCT03725020|Fluorides|fluorides|mesh-list
19351749|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
19351750|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
19684740|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
19684741|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19684742|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684743|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684744|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19684745|NCT04771637|Analgesics|analgesics|mesh-ancestor
19684746|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
19684747|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684748|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19351751|NCT03725020|Protective Agents|protective agents|mesh-ancestor
19351752|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351753|NCT03724955|Estradiol|estradiol|mesh-list
19351754|NCT03724955|Estrogens|estrogens|mesh-ancestor
19351755|NCT03724955|Hormones|hormones|mesh-ancestor
19351756|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19351757|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351758|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
19351759|NCT03724838|Esomeprazole|esomeprazole|mesh-list
19351760|NCT03724838|Citric Acid|citric acid|mesh-list
19351761|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
19351762|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
19351763|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19351764|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
19351765|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
19684749|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19684750|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20612960|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612961|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612962|NCT02253524|Metoclopramide|metoclopramide|mesh-list
20612963|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
20612964|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
20612965|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
20612966|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206415|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
20206416|NCT00271271|Gemcitabine|gemcitabine|mesh-list
20206417|NCT00271271|Vinorelbine|vinorelbine|mesh-list
20206418|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
20206419|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20206420|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
20206421|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206422|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206423|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
20206424|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206425|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206426|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20206427|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
20206428|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206429|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20206430|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206431|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206432|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206433|NCT00271284|Insulin|insulin|mesh-list
20206434|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19351766|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351767|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
20206435|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
20206436|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
20391094|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20612967|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351768|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20391095|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
20391096|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391097|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20391098|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20391099|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20391100|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391101|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391102|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20391103|NCT01077752|Narcotics|narcotics|mesh-ancestor
20391104|NCT01077752|Analgesics|analgesics|mesh-ancestor
20391105|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20391106|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
20391107|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
20391108|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391109|NCT01077947|Anesthetics|anesthetics|mesh-list
20391110|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351769|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19351770|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351771|NCT03724838|Urological Agents|urological agents|mesh-ancestor
19351772|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19351773|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19351774|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19401041|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401042|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401043|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19401044|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
19401045|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206437|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
20206438|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20206439|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206440|NCT00271323|Docetaxel|docetaxel|mesh-list
19401046|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391111|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391112|NCT01077986|Capecitabine|capecitabine|mesh-list
20391113|NCT01077986|Cetuximab|cetuximab|mesh-list
20391114|NCT01077986|Everolimus|everolimus|mesh-list
20391115|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20391116|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
20206441|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206442|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206443|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206444|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206445|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206446|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
20206447|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20206448|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391117|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401047|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19401048|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19401049|NCT03621046|Zolpidem|zolpidem|mesh-list
19401050|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19843824|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843825|NCT00661492|Cetuximab|cetuximab|mesh-list
19843826|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
19843827|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19843828|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843829|NCT00661492|Analgesics|analgesics|mesh-ancestor
19843830|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
19843831|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843832|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843833|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19843834|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19843835|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843836|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843837|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
19843838|NCT00661505|Hematinics|hematinics|mesh-ancestor
19843839|NCT00661531|Anastrozole|anastrozole|mesh-list
19843840|NCT00661531|Estradiol|estradiol|mesh-list
19843841|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19843842|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843843|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19843844|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20612968|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206449|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206450|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20206451|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20206452|NCT00271336|Protective Agents|protective agents|mesh-ancestor
20206453|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206454|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
20206455|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20206456|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
20206457|NCT00271349|Budesonide|budesonide|mesh-list
20206458|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206459|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20206460|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
20206461|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206462|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206463|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19351775|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
19351776|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19351777|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
19351778|NCT03724578|Fluorides|fluorides|mesh-list
20206464|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
20206465|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
20206466|NCT00271349|Hormones|hormones|mesh-ancestor
20206467|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206468|NCT00271401|Heparin|heparin|mesh-list
20206469|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
20206470|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20206471|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19351779|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
19351780|NCT03724578|Protective Agents|protective agents|mesh-ancestor
19351781|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351782|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20206472|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206473|NCT00271414|Fentanyl|fentanyl|mesh-list
20206474|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19351783|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351784|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
19351785|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351786|NCT03724266|Chitosan|chitosan|mesh-list
19351787|NCT03724266|Calcium|calcium|mesh-list
19351788|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19351789|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351790|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19351791|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19351792|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
19351793|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351794|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19351795|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
19351796|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
19351797|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
19351798|NCT03724266|Coagulants|coagulants|mesh-ancestor
19351799|NCT03724071|Flucytosine|flucytosine|mesh-list
19351800|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
19351801|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351802|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
19351803|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351804|NCT03723941|Etoposide|etoposide|mesh-list
19351805|NCT03723941|Mitotane|mitotane|mesh-list
19351806|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351807|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19351808|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19351809|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19351810|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351811|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351812|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19351813|NCT03723824|Grazoprevir|grazoprevir|mesh-list
19351814|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19351815|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
19351816|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351817|NCT03723785|Insulin|insulin|mesh-list
19351818|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19351819|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19351820|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351821|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
19351822|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
19684751|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
20206475|NCT00271414|Narcotics|narcotics|mesh-ancestor
19351823|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19351824|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19351825|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351826|NCT03723395|Repaglinide|repaglinide|mesh-list
19351827|NCT03723395|Tolbutamide|tolbutamide|mesh-list
19351828|NCT03723395|Itraconazole|itraconazole|mesh-list
19351829|NCT03723395|Rifampin|rifampin|mesh-list
19351830|NCT03723395|Tucatinib|tucatinib|mesh-list
19351831|NCT03723395|Digoxin|digoxin|mesh-list
19351832|NCT03723395|Midazolam|midazolam|mesh-list
19351833|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
19351834|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19351835|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19351836|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351837|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351838|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19351839|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19351840|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19351841|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19351842|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
19351843|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
19351844|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
20206476|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206477|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206478|NCT00271414|Analgesics|analgesics|mesh-ancestor
19351845|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
19351846|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351847|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351848|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
19351849|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351850|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19351851|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19351852|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351853|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19351854|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
19351855|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19351856|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19351857|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19351858|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
19351859|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19351860|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
19351861|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19351862|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19351863|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19351864|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19351865|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19351866|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19351867|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19351868|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19351869|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19351870|NCT03723395|Protective Agents|protective agents|mesh-ancestor
19684752|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684753|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684754|NCT04737343|Azathioprine|azathioprine|mesh-list
19843845|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206479|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
20206480|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206481|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20206482|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20206483|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
20206484|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
19684755|NCT04737343|Leflunomide|leflunomide|mesh-list
19684756|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
19684757|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684758|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19684759|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684760|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684761|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
19684762|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684763|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684764|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684765|NCT04696445|Morphine|morphine|mesh-list
19684766|NCT04696445|Oxycodone|oxycodone|mesh-list
19684767|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19684768|NCT04696445|Narcotics|narcotics|mesh-ancestor
19684769|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684770|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684771|NCT04696445|Analgesics|analgesics|mesh-ancestor
20391118|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391119|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391120|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391121|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
19351871|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20391122|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391123|NCT01077999|Paclitaxel|paclitaxel|mesh-list
20391124|NCT01077999|Carboplatin|carboplatin|mesh-list
20391125|NCT01077999|Panitumumab|panitumumab|mesh-list
20391126|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20391127|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391128|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
20391129|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
20391130|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
20391131|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391132|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391133|NCT01078038|Sirolimus|sirolimus|mesh-list
20391134|NCT01078038|Everolimus|everolimus|mesh-list
20391135|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391136|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391137|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
20391138|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351872|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351873|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19351874|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19351875|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
19351876|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19351877|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19351878|NCT03723291|Tocopherols|tocopherols|mesh-list
19351879|NCT03723291|Vitamin E|vitamin e|mesh-list
19351880|NCT03723291|Tocotrienols|tocotrienols|mesh-list
19351881|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
19351882|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
19351883|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19351884|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351885|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351886|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19351887|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19351888|NCT03723291|Protective Agents|protective agents|mesh-ancestor
19351889|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351890|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
19351891|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19351892|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
19351893|NCT03723291|Vitamins|vitamins|mesh-ancestor
19351894|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
19351895|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
19351896|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19351897|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351898|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19351899|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351900|NCT03723187|Heparin|heparin|mesh-list
19351901|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
19351902|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19351903|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19351904|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351905|NCT03723135|Azacitidine|azacitidine|mesh-list
19684772|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
19351906|NCT03723135|Cc-486|cc-486|mesh-list
19684773|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684774|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
19684775|NCT04638881|Analgesics|analgesics|mesh-ancestor
19684776|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
19351907|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19351908|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
19351909|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351910|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351911|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684777|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684778|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684779|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
19684780|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684781|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19684782|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
19351912|NCT03723109|Anesthetics|anesthetics|mesh-list
19351913|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351914|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351915|NCT03723096|Pomalidomide|pomalidomide|mesh-list
19351916|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
20391139|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391140|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391141|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20391142|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
20391143|NCT01078142|Sirolimus|sirolimus|mesh-list
20391144|NCT01078142|Rituximab|rituximab|mesh-list
20391145|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20391146|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391147|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391148|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
20391149|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391150|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19351917|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351918|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20391151|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20391152|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
20391153|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391154|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391155|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391156|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19351919|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19351920|NCT03723096|Growth Substances|growth substances|mesh-ancestor
19351921|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
19351922|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351923|NCT03723083|Thalidomide|thalidomide|mesh-list
19351924|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19351925|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
19351926|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351927|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
19351928|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19351929|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19351930|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19351931|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19351932|NCT03723083|Growth Substances|growth substances|mesh-ancestor
19351933|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
19351934|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351935|NCT03723031|Misoprostol|misoprostol|mesh-list
20391157|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
20391158|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391159|NCT01078428|Petrolatum|petrolatum|mesh-list
20391160|NCT01078428|Emollients|emollients|mesh-ancestor
20391161|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391162|NCT01078519|Anesthetics|anesthetics|mesh-list
20391163|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
20391164|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391165|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391166|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
20391167|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351936|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19351937|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
19351938|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19351939|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351940|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19351941|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19351942|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
19351943|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
19351944|NCT03722940|Analgesics|analgesics|mesh-ancestor
19351945|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
19351946|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351947|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351948|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
19351949|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351950|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19351951|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
19351952|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19351953|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391168|NCT01078610|Adalimumab|adalimumab|mesh-list
20391169|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391170|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19351954|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391171|NCT01078714|Bumetanide|bumetanide|mesh-list
19351955|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19351956|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
19351957|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19351958|NCT03722927|Bupivacaine|bupivacaine|mesh-list
19684783|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19684784|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19684785|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684786|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19684787|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
19684788|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684789|NCT04563338|Bevacizumab|bevacizumab|mesh-list
19684790|NCT04563338|Atezolizumab|atezolizumab|mesh-list
19684791|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684792|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684793|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19684794|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19684795|NCT04563338|Growth Substances|growth substances|mesh-ancestor
19684796|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684797|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
19684798|NCT04498273|Aspirin|aspirin|mesh-list
19684799|NCT04498273|Apixaban|apixaban|mesh-list
19684800|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19684801|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20206485|NCT00271427|Selenium|selenium|mesh-list
20391172|NCT01078714|Diuretics|diuretics|mesh-ancestor
20391173|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
19351959|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
19351960|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
19351961|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19351962|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351963|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
19351964|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351965|NCT03722914|Benzonatate|benzonatate|mesh-list
19351966|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
19351967|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
19351968|NCT03722875|Apatinib|apatinib|mesh-list
19351969|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351970|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19351971|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351972|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351973|NCT03722849|Adenosine|adenosine|mesh-list
19351974|NCT03722849|Capsaicin|capsaicin|mesh-list
19351975|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
19351976|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
19351977|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
19351978|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19351979|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19351980|NCT03722849|Analgesics|analgesics|mesh-ancestor
19351981|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19351982|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
20391174|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391175|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20391176|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391177|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391178|NCT01078779|Chloroquine|chloroquine|mesh-list
20391179|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20391180|NCT01078779|Amebicides|amebicides|mesh-ancestor
20391181|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20391182|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20391183|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391184|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
19351983|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19351984|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
19351985|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
19684802|NCT04498273|Analgesics|analgesics|mesh-ancestor
19351986|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206486|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
19401051|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20206487|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206488|NCT00271427|Protective Agents|protective agents|mesh-ancestor
20206489|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206490|NCT00271427|Trace Elements|trace elements|mesh-ancestor
20206491|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
20206492|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
20206493|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20206494|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391185|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391186|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20391187|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20391188|NCT01078779|Analgesics|analgesics|mesh-ancestor
20391189|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
20391190|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391191|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391192|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391193|NCT01078779|Filaricides|filaricides|mesh-ancestor
20391194|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
20391195|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
20391196|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
20391197|NCT01078818|Trace Elements|trace elements|mesh-ancestor
20391198|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
20391199|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391200|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20391201|NCT01078870|Citalopram|citalopram|mesh-list
20391202|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20391203|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20391204|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391205|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391206|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391207|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
20391208|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391209|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20391210|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
19351987|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351988|NCT03722823|Tucatinib|tucatinib|mesh-list
19351989|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19351990|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19351991|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19351992|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351993|NCT03722680|Riluzole|riluzole|mesh-list
19351994|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
19351995|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19351996|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19351997|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19351998|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19351999|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352000|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19352001|NCT03722680|Protective Agents|protective agents|mesh-ancestor
19401052|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401053|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401054|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19401055|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
19401056|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
19401057|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401058|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401059|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19401060|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19401061|NCT03620929|Estradiol|estradiol|mesh-list
19401062|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20391211|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391212|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391213|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20391214|NCT01078870|Analgesics|analgesics|mesh-ancestor
20391215|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
20391216|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
20391217|NCT01078961|Bortezomib|bortezomib|mesh-list
20391218|NCT01078961|Sorafenib|sorafenib|mesh-list
20391219|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391220|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20391221|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391222|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401063|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
19401064|NCT03620929|Estrogens|estrogens|mesh-ancestor
19401065|NCT03620929|Hormones|hormones|mesh-ancestor
19401066|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401067|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401068|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19401069|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
19401070|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19401071|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19352002|NCT03722498|Leucovorin|leucovorin|mesh-list
19352003|NCT03722498|Fluorouracil|fluorouracil|mesh-list
19352004|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
19352005|NCT03722498|Sorafenib|sorafenib|mesh-list
19352006|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
19352007|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352008|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19352009|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352010|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352011|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
19352012|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352013|NCT03722498|Antidotes|antidotes|mesh-ancestor
19352014|NCT03722498|Protective Agents|protective agents|mesh-ancestor
19352015|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
19352016|NCT03722498|Vitamins|vitamins|mesh-ancestor
19352017|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
19352018|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19352019|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352020|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
20391223|NCT01079013|Treosulfan|treosulfan|mesh-list
20391224|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20391225|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
20391226|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391227|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391228|NCT01079052|Famotidine|famotidine|mesh-list
20391229|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20391230|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20391231|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20391232|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
20391233|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
20391234|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352021|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352022|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19352023|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352024|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352025|NCT03722381|Amlodipine|amlodipine|mesh-list
19352026|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19352027|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19352028|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19352029|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352030|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352031|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352032|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
19352033|NCT03722355|Carmustine|carmustine|mesh-list
19352034|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19352035|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
19684803|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
19684804|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684805|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684806|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19684807|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391235|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391236|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391237|NCT01079065|Famotidine|famotidine|mesh-list
20391238|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20391239|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20391240|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20391241|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
20391242|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
20391243|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352036|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684808|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19684809|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19684810|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206495|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
20206496|NCT00271453|Fentanyl|fentanyl|mesh-list
20206497|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20206498|NCT00271453|Narcotics|narcotics|mesh-ancestor
20206499|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206500|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206501|NCT00271453|Analgesics|analgesics|mesh-ancestor
20206502|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
20206503|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206504|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19352037|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352038|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
19352039|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19352040|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352041|NCT03722329|Eculizumab|eculizumab|mesh-list
19352042|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19352043|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391244|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391245|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391246|NCT01079078|Acetaminophen|acetaminophen|mesh-list
20391247|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20391248|NCT01079078|Analgesics|analgesics|mesh-ancestor
20391249|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
20391250|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391251|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391252|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
20391253|NCT01079117|Morphine|morphine|mesh-list
20391254|NCT01079117|Methadone|methadone|mesh-list
20391255|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20391256|NCT01079117|Narcotics|narcotics|mesh-ancestor
20391257|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391258|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391259|NCT01079117|Analgesics|analgesics|mesh-ancestor
20391260|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
20391261|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352044|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
19352045|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352046|NCT03722303|Cortisone|cortisone|mesh-list
19352047|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352048|NCT03722290|Metformin|metformin|mesh-list
20206505|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20206506|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
19352049|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19352050|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352051|NCT03722173|Itraconazole|itraconazole|mesh-list
19352052|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
19352053|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352054|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19352055|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19352056|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352057|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352058|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19352059|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
19352060|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352061|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352062|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19352063|NCT03721991|Butyric Acid|butyric acid|mesh-list
19352064|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352065|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352066|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352067|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
19352068|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
19352069|NCT03721900|Ketamine|ketamine|mesh-list
19352070|NCT03721900|Analgesics|analgesics|mesh-ancestor
19352071|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
19352072|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352073|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352074|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19352075|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19352076|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
19352077|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
20206507|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
20206508|NCT00271466|Fentanyl|fentanyl|mesh-list
20206509|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20206510|NCT00271466|Narcotics|narcotics|mesh-ancestor
20206511|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206512|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206513|NCT00271466|Analgesics|analgesics|mesh-ancestor
20206514|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
20206515|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206516|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20206517|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20206518|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
20206519|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
19352078|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206520|NCT00271492|Atrasentan|atrasentan|mesh-list
20391262|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
19352079|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19352080|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19352081|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352082|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352083|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
20391263|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
20426571|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426572|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20426573|NCT01281748|Protective Agents|protective agents|mesh-ancestor
20426574|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20426575|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426576|NCT01281761|Irinotecan|irinotecan|mesh-list
20426577|NCT01281761|Cetuximab|cetuximab|mesh-list
19352084|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19352085|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352086|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19352087|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352088|NCT03721757|Nivolumab|nivolumab|mesh-list
19352089|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19352090|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684811|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19352091|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19352092|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352093|NCT03721744|Gemcitabine|gemcitabine|mesh-list
19352094|NCT03721744|Paclitaxel|paclitaxel|mesh-list
19352095|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19352096|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352097|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
19352098|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
19352099|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
19352100|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352101|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19352102|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
19352103|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
19352104|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352105|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684812|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19684813|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684814|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
19684815|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19684816|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
19684817|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19684818|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
19684819|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
19684820|NCT04450953|Eplerenone|eplerenone|mesh-list
19684821|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19684822|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
19684823|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684824|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352106|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352107|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
19352108|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206521|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206522|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20206523|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20206524|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206525|NCT00271518|Hormones|hormones|mesh-list
20206526|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206527|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217802|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217803|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20217804|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20217805|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217806|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217807|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
20217808|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20217809|NCT00310531|Estradiol|estradiol|mesh-list
20217810|NCT00310531|Estrogens|estrogens|mesh-ancestor
20217811|NCT00310531|Hormones|hormones|mesh-ancestor
20217812|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217813|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206528|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20206529|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
20206530|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206531|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
19352109|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
19352110|NCT03721679|Nivolumab|nivolumab|mesh-list
19352111|NCT03721679|Durvalumab|durvalumab|mesh-list
20391264|NCT01079286|Sirolimus|sirolimus|mesh-list
19352112|NCT03721679|Atezolizumab|atezolizumab|mesh-list
19352113|NCT03721679|Poly ICLC|poly iclc|mesh-list
19352114|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19352115|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352116|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19352117|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352118|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
19352119|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
19352120|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352121|NCT03721653|Leucovorin|leucovorin|mesh-list
19352122|NCT03721653|Bevacizumab|bevacizumab|mesh-list
19352123|NCT03721653|Fluorouracil|fluorouracil|mesh-list
19352124|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
19352125|NCT03721653|Irinotecan|irinotecan|mesh-list
19352126|NCT03721653|Atezolizumab|atezolizumab|mesh-list
19352127|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
19352128|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19352129|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352130|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19352131|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19352132|NCT03721653|Growth Substances|growth substances|mesh-ancestor
19352133|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352134|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
19352135|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
19352136|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352137|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19352138|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352139|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
20206532|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20206533|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
20206534|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20206535|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206536|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20206537|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19843846|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206538|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20206539|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
20206540|NCT00271635|Vitamins|vitamins|mesh-ancestor
20206541|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
20206542|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206543|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
20206544|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206545|NCT00271635|Protective Agents|protective agents|mesh-ancestor
20206546|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
20206547|NCT00271713|Vitamin D|vitamin d|mesh-list
20206548|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
20206549|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
20206550|NCT00271713|Vitamins|vitamins|mesh-list
20206551|NCT00271713|Calcium|calcium|mesh-list
20206552|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
20206553|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206554|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20206555|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20206556|NCT00271791|Prednisone|prednisone|mesh-list
20206557|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206558|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
20206559|NCT00271791|Hormones|hormones|mesh-ancestor
20206560|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206561|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206562|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20206563|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206564|NCT00271804|Bortezomib|bortezomib|mesh-list
19352140|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19352141|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19352142|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352143|NCT03721653|Antidotes|antidotes|mesh-ancestor
19352144|NCT03721653|Protective Agents|protective agents|mesh-ancestor
20206565|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391265|NCT01079286|Nelfinavir|nelfinavir|mesh-list
19352145|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
19352146|NCT03721653|Vitamins|vitamins|mesh-ancestor
19352147|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
19352148|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
19352149|NCT03721627|Ledipasvir|ledipasvir|mesh-list
19352150|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19352151|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
19352152|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352153|NCT03721614|Sirolimus|sirolimus|mesh-list
19352154|NCT03721614|Everolimus|everolimus|mesh-list
19352155|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352156|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391266|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391267|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391268|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20391269|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391270|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
20391271|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391272|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
20391273|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391274|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20391275|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20391276|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
20391277|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391278|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391279|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20391280|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19352157|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
19352158|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352159|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19352160|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352161|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19352162|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
19352163|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
19352164|NCT03721497|Testosterone|testosterone|mesh-list
19352165|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
19352166|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
19352167|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19352168|NCT03721497|Androgens|androgens|mesh-ancestor
19352169|NCT03721497|Hormones|hormones|mesh-ancestor
19352170|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352171|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352172|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19352173|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352174|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
19352175|NCT03721432|Pregabalin|pregabalin|mesh-list
19352176|NCT03721432|Analgesics|analgesics|mesh-ancestor
19352177|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
19352178|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352179|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352180|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
19352181|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19352182|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19352183|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352184|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352185|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19352186|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19352187|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352188|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19352189|NCT03721380|Methadone|methadone|mesh-list
19352190|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19352191|NCT03721380|Narcotics|narcotics|mesh-ancestor
19352192|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206566|NCT00271973|Oxycodone|oxycodone|mesh-list
20206567|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20206568|NCT00271973|Narcotics|narcotics|mesh-ancestor
20206569|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206570|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206571|NCT00271973|Analgesics|analgesics|mesh-ancestor
20206572|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
20206573|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391281|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
20391282|NCT01079312|Fentanyl|fentanyl|mesh-list
20391283|NCT01079312|Remifentanil|remifentanil|mesh-list
19352193|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352194|NCT03721380|Analgesics|analgesics|mesh-ancestor
20206574|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
20391284|NCT01079312|Propofol|propofol|mesh-list
20206575|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20206576|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206577|NCT00272025|Citalopram|citalopram|mesh-list
20206578|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20206579|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20206580|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206581|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206582|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206583|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
20206584|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206585|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20206586|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
20206587|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20206588|NCT00272051|Xaliproden|xaliproden|mesh-list
20206589|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20206590|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19352195|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
19352196|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352197|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
19352198|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
19352199|NCT03721081|Lidocaine|lidocaine|mesh-list
19352200|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
19352201|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
19352202|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352203|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352204|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
19352205|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352206|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19352207|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19352208|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19352209|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19352210|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206591|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
19352211|NCT03720899|Nicotine|nicotine|mesh-list
19352212|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19352213|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
19352214|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352215|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352216|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19352217|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19352218|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
20206592|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352219|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352220|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352221|NCT03720886|Teriparatide|teriparatide|mesh-list
19352222|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352223|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352224|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19401072|NCT03620929|Progestins|progestins|mesh-ancestor
19401073|NCT03620916|Morphine|morphine|mesh-list
19401074|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19401075|NCT03620916|Narcotics|narcotics|mesh-ancestor
19401076|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401077|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206593|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206594|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206595|NCT00272064|Insulin|insulin|mesh-list
20206596|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20206597|NCT00272064|Metformin|metformin|mesh-list
20206598|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
20206599|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
20206600|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20206601|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206602|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
20206603|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20206604|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206605|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
20206606|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20206607|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206608|NCT00272116|Vitamins|vitamins|mesh-list
20206609|NCT00272116|Vitamin A|vitamin a|mesh-list
20206610|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
20206611|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
20206612|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843847|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20206613|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
20206614|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206615|NCT00272116|Protective Agents|protective agents|mesh-ancestor
20206616|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20206617|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206618|NCT00272207|Nabilone|nabilone|mesh-list
20206619|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
20206620|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
20206621|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684825|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19684826|NCT04450953|Diuretics|diuretics|mesh-ancestor
19684827|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
19684828|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20426578|NCT01281761|Simvastatin|simvastatin|mesh-list
19352225|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19352226|NCT03720873|Gefitinib|gefitinib|mesh-list
19352227|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352228|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19352229|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352230|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352231|NCT03720756|Nickel|nickel|mesh-list
19352232|NCT03720756|Trace Elements|trace elements|mesh-ancestor
19352233|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
19352234|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352235|NCT03720717|Baclofen|baclofen|mesh-list
19352236|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19352237|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352238|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19352239|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352240|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19352241|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
19352242|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
19352243|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692691|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19692692|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
19692693|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692694|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692695|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19692696|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
19692697|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19692698|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
19692699|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692700|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692701|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19843848|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
19843849|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19843850|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843851|NCT00661531|Estrogens|estrogens|mesh-ancestor
19692702|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
19692703|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
19843852|NCT00661531|Hormones|hormones|mesh-ancestor
20206622|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206623|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352244|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352245|NCT03720665|Caffeine|caffeine|mesh-list
19843853|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
19843854|NCT00661544|Melphalan|melphalan|mesh-list
20206624|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20206625|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20206626|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206627|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19692704|NCT04988932|Protective Agents|protective agents|mesh-ancestor
19843855|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
20206628|NCT00272285|Granisetron|granisetron|mesh-list
20206629|NCT00272285|Ramosetron|ramosetron|mesh-list
20206630|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
20206631|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
20206632|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206633|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206634|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352246|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20206635|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20206636|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
19352247|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401078|NCT03620916|Analgesics|analgesics|mesh-ancestor
19843856|NCT00661544|Vitamins|vitamins|mesh-ancestor
19352248|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19352249|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352250|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352251|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19352252|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19352253|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
19352254|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352255|NCT03720522|Adenosine|adenosine|mesh-list
20391285|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20391286|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391287|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352256|NCT03720522|Analgesics|analgesics|mesh-ancestor
19352257|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
19352258|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352259|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352260|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19352261|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
19352262|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19352263|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
19352264|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
19352265|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352266|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391288|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20391289|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
20391290|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
20391291|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20391292|NCT01079312|Narcotics|narcotics|mesh-ancestor
20391293|NCT01079312|Analgesics|analgesics|mesh-ancestor
20391294|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
20391295|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352267|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
19352268|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19352269|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
19352270|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352271|NCT03720483|Expectorants|expectorants|mesh-ancestor
20391296|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20391297|NCT01079338|Caffeine|caffeine|mesh-list
19352272|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
19352273|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19352274|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
19352275|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352276|NCT03720483|Protective Agents|protective agents|mesh-ancestor
19352277|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352278|NCT03720483|Antidotes|antidotes|mesh-ancestor
19352279|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
19352280|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19352281|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352282|NCT03720340|Oprelvekin|oprelvekin|mesh-list
19352283|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352284|NCT03720288|Acetazolamide|acetazolamide|mesh-list
19352285|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
19352286|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19352287|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352288|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352289|NCT03720288|Diuretics|diuretics|mesh-ancestor
19352290|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
19352291|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352292|NCT03720249|Vitamins|vitamins|mesh-list
19352293|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
19352294|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
19352295|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
19352296|NCT03720249|Betaine|betaine|mesh-list
19352297|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
19352298|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352299|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352300|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
19352301|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19352302|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
19352303|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352304|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19352305|NCT03720223|Bupivacaine|bupivacaine|mesh-list
19352306|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
19352307|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
19684829|NCT04268498|Acetaminophen|acetaminophen|mesh-list
20391298|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20391299|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352308|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352309|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352310|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
19352311|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352312|NCT03720067|Propranolol|propranolol|mesh-list
19352313|NCT03720067|Carvedilol|carvedilol|mesh-list
19352314|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19352315|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19352316|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19352317|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
19352318|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352319|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19352320|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19352321|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352322|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19352323|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19352324|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
19352325|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352326|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352327|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19352328|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19352329|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
19352330|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
19352331|NCT03720067|Protective Agents|protective agents|mesh-ancestor
19352332|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19352333|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19352334|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352335|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20391300|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20391301|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391302|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391303|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20391304|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20391305|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
20391306|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391307|NCT01079351|Carbamazepine|carbamazepine|mesh-list
20391308|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
20391309|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
20391310|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20391311|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391312|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391313|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391314|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20391315|NCT01079351|Analgesics|analgesics|mesh-ancestor
20391316|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
19352336|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19352337|NCT03720041|Dexamethasone|dexamethasone|mesh-list
19352338|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
19352339|NCT03720041|Lenalidomide|lenalidomide|mesh-list
19352340|NCT03720041|Ixazomib|ixazomib|mesh-list
20206637|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206638|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206639|NCT00272324|Aspirin|aspirin|mesh-list
20206640|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20206641|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20206642|NCT00272324|Analgesics|analgesics|mesh-ancestor
20206643|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
20206644|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206645|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206646|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206647|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206648|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20206649|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20206650|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206651|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20206652|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20206653|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206654|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
20206655|NCT00272415|Temozolomide|temozolomide|mesh-list
20206656|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19352341|NCT03720041|BB 1101|bb 1101|mesh-list
19684830|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
20206657|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
20391317|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352342|NCT03720041|Glycine|glycine|mesh-list
19684831|NCT04268498|Promethazine|promethazine|mesh-list
20391318|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20391319|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391320|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391321|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20391322|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20391323|NCT01079364|Insulin|insulin|mesh-list
19352343|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352344|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
19352345|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
19352346|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352347|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352348|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352349|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
19352350|NCT03720041|Hormones|hormones|mesh-ancestor
19352351|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352352|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19352353|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352354|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
19352355|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352356|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352357|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
19352358|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19352359|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19352360|NCT03720041|Growth Substances|growth substances|mesh-ancestor
19352361|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
19352362|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
19352363|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352364|NCT03719989|Azacitidine|azacitidine|mesh-list
19352365|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19352366|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
20391324|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20391325|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
20391326|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
20391327|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
20391328|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20391329|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20391330|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352367|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352368|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352369|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352370|NCT03719820|Aspirin|aspirin|mesh-list
19684832|NCT04268498|Dexamethasone|dexamethasone|mesh-list
20206658|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206659|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684833|NCT04268498|Lenalidomide|lenalidomide|mesh-list
19684834|NCT04268498|Bortezomib|bortezomib|mesh-list
19684835|NCT04268498|Daratumumab|daratumumab|mesh-list
19684836|NCT04268498|Montelukast|montelukast|mesh-list
20206660|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
20206661|NCT00272428|Vitamin E|vitamin e|mesh-list
20206662|NCT00272428|Beta Carotene|beta carotene|mesh-list
20206663|NCT00272428|Selenium|selenium|mesh-list
20206664|NCT00272428|Carotenoids|carotenoids|mesh-list
20391331|NCT01079455|Corticosterone|corticosterone|mesh-list
20391332|NCT01079455|Bupivacaine|bupivacaine|mesh-list
19352371|NCT03719820|Clopidogrel|clopidogrel|mesh-list
19352372|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19352373|NCT03719820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19352374|NCT03719820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19352375|NCT03719820|Analgesics|analgesics|mesh-ancestor
19352376|NCT03719820|Sensory System Agents|sensory system agents|mesh-ancestor
20206665|NCT00272428|Vitamins|vitamins|mesh-ancestor
20206666|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
20206667|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684837|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19684838|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
19684839|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
20206668|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
19352377|NCT03719820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352378|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352379|NCT03719820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206669|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206670|NCT00272428|Protective Agents|protective agents|mesh-ancestor
20391333|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
19684840|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684841|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206671|NCT00272428|Trace Elements|trace elements|mesh-ancestor
19352380|NCT03719820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19352381|NCT03719820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19352382|NCT03719820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20206672|NCT00272428|Provitamins|provitamins|mesh-ancestor
20206673|NCT00272454|Aspirin|aspirin|mesh-list
20206674|NCT00272454|Cilostazol|cilostazol|mesh-list
20206675|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20206676|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20206677|NCT00272454|Analgesics|analgesics|mesh-ancestor
20206678|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
20206679|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206680|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352383|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352384|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19352385|NCT03719820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19352386|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352387|NCT03719820|Antipyretics|antipyretics|mesh-ancestor
19352388|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19352389|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19352390|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19352391|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
19352392|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352393|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19352394|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19352395|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
19352396|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19352397|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19352398|NCT03719729|Rifaximin|rifaximin|mesh-list
19352399|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391334|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
20391335|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
20391336|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391337|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391338|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
20391339|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391340|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20391341|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
20391342|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
20391343|NCT01079455|Protective Agents|protective agents|mesh-ancestor
20391344|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391345|NCT01079481|Everolimus|everolimus|mesh-list
20391346|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391347|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391348|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
20391349|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391350|NCT01079559|Tobramycin|tobramycin|mesh-list
20391351|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391352|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391353|NCT01079624|Glucagon|glucagon|mesh-list
20391354|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20391355|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20391356|NCT01079624|Hormones|hormones|mesh-ancestor
20391357|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391358|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391359|NCT01079624|Incretins|incretins|mesh-ancestor
20391360|NCT01079676|Lenograstim|lenograstim|mesh-list
20391361|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20391362|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
20391363|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391364|NCT01079702|Capecitabine|capecitabine|mesh-list
20391365|NCT01079702|Everolimus|everolimus|mesh-list
20391366|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20391367|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
20391368|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391369|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352400|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352401|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352402|NCT03719690|Tipifarnib|tipifarnib|mesh-list
19352403|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352404|NCT03719625|Norepinephrine|norepinephrine|mesh-list
20206681|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206682|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391370|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352405|NCT03719625|Ephedrine|ephedrine|mesh-list
19352406|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19692705|NCT04989348|Hormones|hormones|mesh-list
20391371|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
20391372|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391373|NCT01079715|Propranolol|propranolol|mesh-list
20391374|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20391375|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20391376|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
20391377|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391378|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391379|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391380|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20391381|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20391382|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
20391383|NCT01079754|Morphine|morphine|mesh-list
20391384|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
20391385|NCT01079754|Narcotics|narcotics|mesh-ancestor
20391386|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391387|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391388|NCT01079754|Analgesics|analgesics|mesh-ancestor
20391389|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
20391390|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391391|NCT01079767|Sirolimus|sirolimus|mesh-list
20391392|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391393|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391394|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20391395|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391396|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
20391397|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391398|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
20391399|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391400|NCT01079780|Irinotecan|irinotecan|mesh-list
20391401|NCT01079780|Cetuximab|cetuximab|mesh-list
20391402|NCT01079780|Ramucirumab|ramucirumab|mesh-list
20391403|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20391404|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20391405|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352407|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19352408|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
19352409|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391406|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391407|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352410|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352411|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352412|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
19352413|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
19352414|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352415|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19352416|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19352417|NCT03719560|Cytarabine|cytarabine|mesh-list
19352418|NCT03719560|Methotrexate|methotrexate|mesh-list
19352419|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19352420|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
19352421|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19352422|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352423|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19352424|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
20391408|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391409|NCT01079884|Esomeprazole|esomeprazole|mesh-list
20391410|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20391411|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20391412|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20391413|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391414|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391415|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
19352425|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352426|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352427|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
19352428|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352429|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19352430|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352431|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
19352432|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19352433|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19352434|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
20391416|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391417|NCT01079910|Fluorides|fluorides|mesh-list
19352435|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391418|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
19352436|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
19352437|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19352438|NCT03719404|Eusol|eusol|mesh-list
20206683|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20206684|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20206685|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206686|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19352439|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19352440|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352441|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
19352442|NCT03719391|Nicotine|nicotine|mesh-list
19352443|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19352444|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
19352445|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352446|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352447|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19352448|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19352449|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
19352450|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352451|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352452|NCT03719313|Interferons|interferons|mesh-list
19352453|NCT03719313|Ritonavir|ritonavir|mesh-list
19352454|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
19352455|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19352456|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
19352457|NCT03719313|Lonafarnib|lonafarnib|mesh-list
19352458|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352459|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
20206687|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20206688|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206689|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
20206690|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20206691|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
19843857|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
19843858|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843859|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19843860|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
19843861|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206692|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20206693|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
20206694|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
20206695|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20206696|NCT00272454|Protective Agents|protective agents|mesh-ancestor
20206697|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20206698|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20206699|NCT00272467|Omeprazole|omeprazole|mesh-list
20206700|NCT00272467|Rebamipide|rebamipide|mesh-list
20206701|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20206702|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206703|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20206704|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206705|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206706|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
20206707|NCT00272467|Protective Agents|protective agents|mesh-ancestor
19352460|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352461|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19352462|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19352463|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
19352464|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352465|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352466|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19352467|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19352468|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19352469|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19352470|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
19352471|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352472|NCT03719274|Ascorbic Acid|ascorbic acid|mesh-list
19352473|NCT03719274|Vitamins|vitamins|mesh-ancestor
19352474|NCT03719274|Micronutrients|micronutrients|mesh-ancestor
19352475|NCT03719274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352476|NCT03719274|Antioxidants|antioxidants|mesh-ancestor
20206708|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206709|NCT00272480|Lamivudine|lamivudine|mesh-list
19352477|NCT03719274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352478|NCT03719274|Protective Agents|protective agents|mesh-ancestor
20391419|NCT01079910|Protective Agents|protective agents|mesh-ancestor
20391420|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391421|NCT01079923|Vitamin D|vitamin d|mesh-list
20391422|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
20391423|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
20391424|NCT01079923|Vitamins|vitamins|mesh-list
20391425|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
20391426|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391427|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20391428|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20391429|NCT01080027|Interferons|interferons|mesh-list
20391430|NCT01080027|Interferon-beta|interferon-beta|mesh-list
19352479|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19352480|NCT03719261|Eusol|eusol|mesh-list
19352481|NCT03719261|Chitosan|chitosan|mesh-list
19352482|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19352483|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19352484|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
19352485|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352486|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19352487|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
19352488|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
19352489|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
19352490|NCT03719261|Coagulants|coagulants|mesh-ancestor
19352491|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
19352492|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352493|NCT03719157|Anesthetics|anesthetics|mesh-list
20391431|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
20206710|NCT00272480|Zidovudine|zidovudine|mesh-list
20206711|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20206712|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20391432|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352494|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
19352495|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352496|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352497|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
19352498|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352499|NCT03719131|Rituximab|rituximab|mesh-list
19352500|NCT03719131|Nivolumab|nivolumab|mesh-list
19352501|NCT03719131|Ipilimumab|ipilimumab|mesh-list
19352502|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19352503|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352504|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
19352505|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352506|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19352507|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19352508|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352509|NCT03719105|Dexamethasone|dexamethasone|mesh-list
19352510|NCT03719105|Prednisone|prednisone|mesh-list
19352511|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
19352512|NCT03719105|Ifosfamide|ifosfamide|mesh-list
19352513|NCT03719105|Doxorubicin|doxorubicin|mesh-list
19352514|NCT03719105|Methotrexate|methotrexate|mesh-list
19352515|NCT03719105|Etoposide|etoposide|mesh-list
19352516|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19352517|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352518|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
19352519|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352520|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19352521|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19352522|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
19352523|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352524|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352525|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19352526|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352527|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
19352528|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
19352529|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206713|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206714|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206715|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
20206716|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206717|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20391433|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
19843862|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206718|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20391434|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391435|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
19352530|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352531|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
20206719|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
20206720|NCT00272493|Vaccines|vaccines|mesh-list
20206721|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
20206722|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206723|NCT00272558|Carboplatin|carboplatin|mesh-list
20206724|NCT00272558|Vinorelbine|vinorelbine|mesh-list
20206725|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206726|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20206727|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
19352532|NCT03719105|Hormones|hormones|mesh-ancestor
19352533|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352534|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19352535|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20206728|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206729|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206730|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206731|NCT00272584|Risperidone|risperidone|mesh-list
20206732|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20206733|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
20206734|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391436|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391437|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20391438|NCT01080066|Cetuximab|cetuximab|mesh-list
20391439|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391440|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391441|NCT01080079|Terbinafine|terbinafine|mesh-list
20391442|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
20391443|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391444|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391445|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391446|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
20391447|NCT01080352|Vitamins|vitamins|mesh-ancestor
20391448|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
20391449|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391450|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
20391451|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391452|NCT01080352|Protective Agents|protective agents|mesh-ancestor
20391453|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
20391454|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20391455|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206735|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352536|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19352537|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19352538|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352539|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19352540|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
19352541|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19352542|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19352543|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
19352544|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391456|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20391457|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
20391458|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391459|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391460|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391461|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391462|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
20391463|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19352545|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19352546|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20391464|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391465|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20391466|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
20391467|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391468|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391469|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391470|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391471|NCT01080456|Tacrolimus|tacrolimus|mesh-list
20391472|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19692706|NCT04989348|Progestins|progestins|mesh-list
20206736|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391473|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
20391474|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391475|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20391476|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391477|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391478|NCT01080469|Tacrolimus|tacrolimus|mesh-list
20391479|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352547|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19352548|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19352549|NCT03719053|Tenofovir|tenofovir|mesh-list
19352550|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
19352551|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352552|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19352553|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19352554|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352555|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352556|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19352557|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19401079|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
19401080|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206737|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20206738|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20206739|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20206740|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20206741|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20206742|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
20206743|NCT00272597|Risperidone|risperidone|mesh-list
20206744|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20206745|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
20206746|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206747|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206748|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206749|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20206750|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20206751|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391480|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
20391481|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391482|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20391483|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206752|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20206753|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20391484|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391485|NCT01080482|Tacrolimus|tacrolimus|mesh-list
20391486|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391487|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
20391488|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391489|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20391490|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391491|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391492|NCT01080534|Tacrolimus|tacrolimus|mesh-list
20391493|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391494|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
20391495|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391496|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20391497|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206754|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
20206755|NCT00272610|Vitamin A|vitamin a|mesh-list
20206756|NCT00272610|Vitamins|vitamins|mesh-ancestor
20206757|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
20206758|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206759|NCT00272636|Amiodarone|amiodarone|mesh-list
20206760|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20206761|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
20391498|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391499|NCT01080547|Capecitabine|capecitabine|mesh-list
20391500|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
19401081|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
19401082|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
19401083|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19401084|NCT03620838|Progesterone|progesterone|mesh-list
20206762|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20391501|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20206763|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391502|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
20206764|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401085|NCT03620838|Progestins|progestins|mesh-ancestor
19352558|NCT03719001|Clevidipine|clevidipine|mesh-list
19352559|NCT03719001|Phenylephrine|phenylephrine|mesh-list
19352560|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
19352561|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
19352562|NCT03719001|Calcium|calcium|mesh-list
19352563|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352564|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352565|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19352566|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352567|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19352568|NCT03719001|Analgesics|analgesics|mesh-ancestor
19352569|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
19352570|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352571|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19352572|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19352573|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19352574|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
19352575|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352576|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352577|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19352578|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
19352579|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
19352580|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
19352581|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19352582|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
19352583|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
19352584|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19352585|NCT03719001|Protective Agents|protective agents|mesh-ancestor
19352586|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19352587|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19352588|NCT03718884|Mirikizumab|mirikizumab|mesh-list
19352589|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19352590|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19352591|NCT03718884|Analgesics|analgesics|mesh-ancestor
19352592|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
19352593|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352594|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352595|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352596|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19352597|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19352598|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352599|NCT03718715|Metformin|metformin|mesh-list
19352600|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19352601|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352602|NCT03718676|Pemetrexed|pemetrexed|mesh-list
19352603|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352604|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352605|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352606|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19352607|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19352608|NCT03718624|Paclitaxel|paclitaxel|mesh-list
19352609|NCT03718624|Apatinib|apatinib|mesh-list
19352610|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19352611|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352612|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
19352613|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
19352614|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
19352615|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352616|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19352617|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352618|NCT03718559|Edoxaban|edoxaban|mesh-list
19352619|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19352620|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19352621|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
19352622|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19352623|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
19352624|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352625|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352626|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
19352627|NCT03718507|Atropine|atropine|mesh-list
20206765|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20206766|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20206767|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20206768|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206769|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19352628|NCT03718507|Fentanyl|fentanyl|mesh-list
19352629|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19352630|NCT03718507|Narcotics|narcotics|mesh-ancestor
19352631|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391503|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391504|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391505|NCT01080560|Cyclosporine|cyclosporine|mesh-list
20391506|NCT01080560|Cyclosporins|cyclosporins|mesh-list
20391507|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391508|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391509|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391510|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
20391511|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391512|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
20391513|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391514|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
19352632|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352633|NCT03718507|Analgesics|analgesics|mesh-ancestor
19352634|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
19352635|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352636|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19352637|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19352638|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
19352639|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
19352640|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19352641|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19352642|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
20391515|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391516|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20391517|NCT01080586|Cyclosporine|cyclosporine|mesh-list
20391518|NCT01080586|Cyclosporins|cyclosporins|mesh-list
20391519|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391520|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391521|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391522|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
20391523|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391524|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
20391525|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391526|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391527|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391528|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20391529|NCT01080612|Pregabalin|pregabalin|mesh-list
20391530|NCT01080612|Analgesics|analgesics|mesh-ancestor
20391531|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
20391532|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352643|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19352644|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
19352645|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
19352646|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
19352647|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20391533|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391534|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
20391535|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20391536|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391537|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391538|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20391539|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20391540|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20391541|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391542|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391543|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
20391544|NCT01080638|Abciximab|abciximab|mesh-list
20391545|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
20391546|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20391547|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20391548|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
20391549|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391550|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20391551|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391552|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
20391553|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352648|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19352649|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
19352650|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391554|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
20391555|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19352651|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352652|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
19352653|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19352654|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
20206770|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20206771|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20206772|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
20206773|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20206774|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20206775|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206776|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
20206777|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206778|NCT00272688|Levodopa|levodopa|mesh-list
19352655|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19352656|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
19352657|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352658|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206779|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20206780|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20206781|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
20206782|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206783|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206784|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206785|NCT00272701|Esomeprazole|esomeprazole|mesh-list
20206786|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19352659|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
19352660|NCT03718403|Theophylline|theophylline|mesh-list
19352661|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19352662|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
19352663|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206787|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206788|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20206789|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206790|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206791|NCT00272714|Afimoxifene|afimoxifene|mesh-list
20206792|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352664|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206793|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20206794|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
20206795|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206796|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352665|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19352666|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
19352667|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19352668|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352669|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352670|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
19352671|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19352672|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19352673|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
19352674|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352675|NCT03718377|Anesthetics|anesthetics|mesh-list
19352676|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352677|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352678|NCT03718273|Digoxin|digoxin|mesh-list
19352679|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19352680|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19352681|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352682|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352683|NCT03718273|Protective Agents|protective agents|mesh-ancestor
19352684|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352685|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
19352686|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19352687|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19352688|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19352689|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
19352690|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352691|NCT03718234|Hormones|hormones|mesh-ancestor
19352692|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352693|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206797|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20206798|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20206799|NCT00272740|Fulvestrant|fulvestrant|mesh-list
19352694|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
19352695|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352696|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352697|NCT03718182|Vitamins|vitamins|mesh-ancestor
19352698|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
19352699|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19352700|NCT03718039|Aprepitant|aprepitant|mesh-list
19352701|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
20391556|NCT01080638|Protective Agents|protective agents|mesh-ancestor
20391557|NCT01080651|Voriconazole|voriconazole|mesh-list
19352702|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
19352703|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352704|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391558|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
20391559|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391560|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19352705|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352706|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19352707|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352708|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352709|NCT03717909|Valproic Acid|valproic acid|mesh-list
20391561|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20391562|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391563|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352710|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
19352711|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352712|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352713|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
19352714|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352715|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352716|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
19352717|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19352718|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352719|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19352720|NCT03717740|Esomeprazole|esomeprazole|mesh-list
19352721|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19352722|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352723|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19352724|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352725|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352726|NCT03717701|Metformin|metformin|mesh-list
19352727|NCT03717701|Esomeprazole|esomeprazole|mesh-list
19352728|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19352729|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352730|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19352731|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352732|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19352733|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352734|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352735|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19352736|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19352737|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20391564|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20391565|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
20391566|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391567|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352738|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19352739|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352740|NCT03717688|Incretins|incretins|mesh-ancestor
19352741|NCT03717688|Hormones|hormones|mesh-ancestor
19352742|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352743|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
19843863|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19843864|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843865|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
19843866|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
19843867|NCT00661544|Protective Agents|protective agents|mesh-ancestor
19843868|NCT00661583|Ranibizumab|ranibizumab|mesh-list
19843869|NCT00661583|Mitomycins|mitomycins|mesh-list
19843870|NCT00661583|Mitomycin|mitomycin|mesh-list
20391568|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19843871|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20391569|NCT01080729|Hormones|hormones|mesh-list
19843872|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19352744|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352745|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352746|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19352747|NCT03717662|Nicotine|nicotine|mesh-list
19352748|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19352749|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
19352750|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352751|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352752|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19352753|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19352754|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
19352755|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352756|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352757|NCT03717558|Ivermectin|ivermectin|mesh-list
20391570|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20391571|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391572|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391573|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20391574|NCT01080742|Bisoprolol|bisoprolol|mesh-list
20391575|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20391576|NCT01080742|Diuretics|diuretics|mesh-ancestor
20391577|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
20391578|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391579|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20391580|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391581|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391582|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
20206800|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20206801|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352758|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19352759|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352760|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
19352761|NCT03717467|Analgesics|analgesics|mesh-ancestor
19352762|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
19352763|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352764|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352765|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
19352766|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352767|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19352768|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
19352769|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19352770|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19352771|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352772|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352773|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
19352774|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19352775|NCT03717415|Carboplatin|carboplatin|mesh-list
19352776|NCT03717415|Rebastinib|rebastinib|mesh-list
19352777|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352778|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19352779|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206802|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20206803|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20206804|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
20206805|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206806|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391583|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
20391584|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391585|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20391586|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19352780|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352781|NCT03717350|Meropenem|meropenem|mesh-list
19352782|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19352783|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352784|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
19352785|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20206807|NCT00272753|Budesonide|budesonide|mesh-list
20206808|NCT00272753|Albuterol|albuterol|mesh-list
20206809|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
20206810|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206811|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20206812|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
20217814|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19352786|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352787|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19352788|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352789|NCT03717168|Hormones|hormones|mesh-list
19352790|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352791|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352792|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
19352793|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19352794|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401086|NCT03620838|Hormones|hormones|mesh-ancestor
19401087|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401088|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401089|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19401090|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19401091|NCT03620825|Indomethacin|indomethacin|mesh-list
19401092|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19401093|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401094|NCT03620825|Analgesics|analgesics|mesh-ancestor
19401095|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
19401096|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401097|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401098|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401099|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401100|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
19401101|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
19401102|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19401103|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19401104|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401105|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401106|NCT03620760|Aspirin|aspirin|mesh-list
19401107|NCT03620760|Ticagrelor|ticagrelor|mesh-list
19401108|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19401109|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401110|NCT03620760|Analgesics|analgesics|mesh-ancestor
19401111|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
19401112|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401113|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401114|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401115|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401116|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19401117|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19401118|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401119|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19401120|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19401121|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401122|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
19401123|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19401124|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19401125|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19401126|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
19401127|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401128|NCT03620591|Lidocaine|lidocaine|mesh-list
19401129|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
19401130|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
19401131|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401132|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401133|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
19401134|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401135|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401136|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19401137|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19401138|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401139|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401140|NCT03620526|Iloprost|iloprost|mesh-list
19401141|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19401142|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
19401143|NCT03620513|Lidocaine|lidocaine|mesh-list
19401144|NCT03620513|Phenylephrine|phenylephrine|mesh-list
19401145|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
19401146|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
19401147|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
19401148|NCT03620513|Ephedrine|ephedrine|mesh-list
20206813|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352795|NCT03717038|Trifluridine|trifluridine|mesh-list
19352796|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
19352797|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352798|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
19352799|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352800|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
19352801|NCT03716856|Fludarabine|fludarabine|mesh-list
19352802|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352803|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
19352804|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352805|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20206814|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206815|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19352806|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19352807|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
19352808|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352809|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352810|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19352811|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
19352812|NCT03716804|Cefuroxime|cefuroxime|mesh-list
19352813|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
19352814|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
20206816|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
20206817|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
20206818|NCT00272753|Hormones|hormones|mesh-ancestor
20206819|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206820|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20206821|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20206822|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19352815|NCT03716804|Cefixime|cefixime|mesh-list
19352816|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19352817|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352818|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19352819|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19352820|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206823|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
20206824|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206825|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206826|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
20206827|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20206828|NCT00272805|Carvedilol|carvedilol|mesh-list
20206829|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20206830|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20206831|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
20206832|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206833|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206834|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206835|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20206836|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
20206837|NCT00272805|Protective Agents|protective agents|mesh-ancestor
20206838|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20206839|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206840|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20206841|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
20206842|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20206843|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20206844|NCT00272831|Cilostazol|cilostazol|mesh-list
20206845|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20206846|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
20206847|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206848|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206849|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20206850|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
20206851|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20206852|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20206853|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206854|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20206855|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
20206856|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20206857|NCT00272831|Protective Agents|protective agents|mesh-ancestor
19352821|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352822|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352823|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19352824|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19352825|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19352826|NCT03716804|Renal Agents|renal agents|mesh-ancestor
19352827|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
19352828|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352829|NCT03716765|Vitamin D|vitamin d|mesh-list
19352830|NCT03716765|Vitamins|vitamins|mesh-ancestor
19352831|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
19352832|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352833|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19352834|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
19352835|NCT03716739|Testosterone|testosterone|mesh-list
19352836|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
19352837|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
19352838|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19352839|NCT03716739|Androgens|androgens|mesh-ancestor
19352840|NCT03716739|Hormones|hormones|mesh-ancestor
19352841|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352842|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352843|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19352844|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352845|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
19352846|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
19352847|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
19352848|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19352849|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19352850|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
19352851|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352852|NCT03716622|Clarithromycin|clarithromycin|mesh-list
19352853|NCT03716622|Furazolidone|furazolidone|mesh-list
19352854|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19352855|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19352856|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19352857|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352858|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352859|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19352860|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19352861|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19352862|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19352863|NCT03716622|Renal Agents|renal agents|mesh-ancestor
19352864|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19352865|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19352866|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19352867|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19352868|NCT03716596|Antibodies|antibodies|mesh-list
19352869|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
19352870|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352871|NCT03716583|Melatonin|melatonin|mesh-list
19352872|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19352873|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
19352874|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352875|NCT03716583|Protective Agents|protective agents|mesh-ancestor
19352876|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352877|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352878|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19352879|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19352880|NCT03716427|Tolbutamide|tolbutamide|mesh-list
19352881|NCT03716427|Midazolam|midazolam|mesh-list
19352882|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
19352883|NCT03716427|Omeprazole|omeprazole|mesh-list
19352884|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20391587|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20391588|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
20391589|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352885|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19352886|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352887|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352888|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19352889|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19352890|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19352891|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19352892|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
20391590|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
19352893|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
19352894|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
19352895|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
19352896|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352897|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352898|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19352899|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19352900|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19352901|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352902|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
19352903|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
19352904|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19352905|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19352906|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19352907|NCT03716388|Mesalamine|mesalamine|mesh-list
19352908|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19352909|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19352910|NCT03716388|Analgesics|analgesics|mesh-ancestor
19352911|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
19352912|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352913|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352914|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352915|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19352916|NCT03716115|Budesonide|budesonide|mesh-list
19352917|NCT03716115|Teduglutide|teduglutide|mesh-list
19352918|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352919|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19352920|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
19352921|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352922|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352923|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19352924|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
19352925|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
19352926|NCT03716115|Hormones|hormones|mesh-ancestor
19352927|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352928|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206858|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20206859|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20206860|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206861|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20206862|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206863|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206864|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206865|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
20206866|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206867|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
20206868|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20206869|NCT00272896|Protective Agents|protective agents|mesh-ancestor
20206870|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206871|NCT00272909|Piclozotan|piclozotan|mesh-list
19352929|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19352930|NCT03716115|Protective Agents|protective agents|mesh-ancestor
19352931|NCT03715998|Ramipril|ramipril|mesh-list
20391591|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
19352932|NCT03715998|Firibastat|firibastat|mesh-list
19352933|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19352934|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
19352935|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352936|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352937|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19352938|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
19352939|NCT03715972|Acetazolamide|acetazolamide|mesh-list
19352940|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352941|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
19352942|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352943|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352944|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19352945|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
19352946|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19352947|NCT03715972|Diuretics|diuretics|mesh-ancestor
19352948|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
19352949|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352950|NCT03715881|Prednisolone|prednisolone|mesh-list
19352951|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
19352952|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206872|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19352953|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
19352954|NCT03715881|Hormones|hormones|mesh-ancestor
20206873|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19352955|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352956|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352957|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19352958|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352959|NCT03715881|Hematinics|hematinics|mesh-ancestor
19352960|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19352961|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19352962|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19352963|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352964|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19352965|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19352966|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352967|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
19352968|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19352969|NCT03715725|Warfarin|warfarin|mesh-list
19352970|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
20391592|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391593|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20391594|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20391595|NCT01080846|Misoprostol|misoprostol|mesh-list
19352971|NCT03715725|Dabigatran|dabigatran|mesh-list
19352972|NCT03715725|Apixaban|apixaban|mesh-list
19352973|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
19352974|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19352975|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
19352976|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19352977|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
19352978|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352979|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352980|NCT03715699|Prednisone|prednisone|mesh-list
19352981|NCT03715699|Leflunomide|leflunomide|mesh-list
19352982|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19352983|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
19352984|NCT03715699|Hormones|hormones|mesh-ancestor
19352985|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19352986|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352987|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19352988|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19352989|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19352990|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19352991|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19352992|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
19352993|NCT03715634|Buprenorphine|buprenorphine|mesh-list
19352994|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19352995|NCT03715634|Narcotics|narcotics|mesh-ancestor
19352996|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19352997|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19352998|NCT03715634|Analgesics|analgesics|mesh-ancestor
19352999|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
19353000|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353001|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19353002|NCT03715582|Trimetazidine|trimetazidine|mesh-list
19353003|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
19353004|NCT03715556|Amiodarone|amiodarone|mesh-list
19353005|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19353006|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
19353007|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19353008|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353009|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353010|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19843873|NCT00661583|Growth Substances|growth substances|mesh-ancestor
19843874|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843875|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
19843876|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843877|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19843878|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
19843879|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843880|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19843881|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843882|NCT00661622|Molgramostim|molgramostim|mesh-list
19843883|NCT00661622|Sargramostim|sargramostim|mesh-list
19843884|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
19353011|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19353012|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19353013|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353014|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19353015|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19353016|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19353017|NCT03715517|Morphine|morphine|mesh-list
20391596|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20391597|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
20391598|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20391599|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391600|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20391601|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20391602|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
20391603|NCT01080911|Morphine|morphine|mesh-list
20391604|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
20391605|NCT01080911|Narcotics|narcotics|mesh-ancestor
19353018|NCT03715517|Hydromorphone|hydromorphone|mesh-list
19353019|NCT03715517|Bupivacaine|bupivacaine|mesh-list
19353020|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19353021|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
19353022|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
19353023|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353024|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353025|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
19353026|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353027|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19353028|NCT03715517|Narcotics|narcotics|mesh-ancestor
19353029|NCT03715517|Analgesics|analgesics|mesh-ancestor
19353030|NCT03715478|Dexamethasone|dexamethasone|mesh-list
19353031|NCT03715478|Pomalidomide|pomalidomide|mesh-list
19353032|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19353033|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
19353034|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
19353035|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353036|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353037|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20391606|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391607|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353038|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
19353039|NCT03715478|Hormones|hormones|mesh-ancestor
19353040|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353041|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19353042|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353043|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
19353044|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353045|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353046|NCT03715478|Growth Substances|growth substances|mesh-ancestor
19353047|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353048|NCT03715413|Tamoxifen|tamoxifen|mesh-list
19353049|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19353050|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
20206874|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
20206875|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206876|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206877|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206878|NCT00272935|Estrogens|estrogens|mesh-list
20206879|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20206880|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
20206881|NCT00272935|Hormones|hormones|mesh-ancestor
20206882|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217815|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
20391608|NCT01080911|Analgesics|analgesics|mesh-ancestor
19353051|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353052|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353053|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19353054|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353055|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19353056|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19353057|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19353058|NCT03715387|Bacitracin|bacitracin|mesh-list
19353059|NCT03715387|Polymyxin B|polymyxin b|mesh-list
19353060|NCT03715387|Tacrolimus|tacrolimus|mesh-list
20391609|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
20391610|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353061|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19353062|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
19353063|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353064|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19353065|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353066|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353067|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19353068|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353069|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19401149|NCT03620513|Anesthetics|anesthetics|mesh-list
19401150|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
19401151|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401152|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401153|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
19401154|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401155|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401156|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20391611|NCT01080963|Daptomycin|daptomycin|mesh-list
20391612|NCT01080963|Cefuroxime|cefuroxime|mesh-list
20391613|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
20391614|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20391615|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391616|NCT01081002|Lidocaine|lidocaine|mesh-list
20391617|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
20391618|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
20391619|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391620|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391621|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
20391622|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391623|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20391624|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20391625|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20391626|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391627|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391628|NCT01081158|Ritonavir|ritonavir|mesh-list
20391629|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20391630|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
20391631|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20391632|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20391633|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
20391634|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391635|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391636|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20391637|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19401157|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19401158|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401159|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401160|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19401161|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19401162|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
19401163|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401164|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
19401165|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
19401166|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19401167|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
19401168|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19401169|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
19401170|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19401171|NCT03620513|Protective Agents|protective agents|mesh-ancestor
19401172|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19401173|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19401174|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19401175|NCT03620461|Gemcitabine|gemcitabine|mesh-list
19401176|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19401177|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19401178|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
19401179|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401180|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401181|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
19401182|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401183|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401184|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401185|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
19692707|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
20391638|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
20391639|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391640|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19353070|NCT03715348|Thrombin|thrombin|mesh-list
19353071|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
19353072|NCT03715348|Coagulants|coagulants|mesh-ancestor
19353073|NCT03715322|Tobramycin|tobramycin|mesh-list
19353074|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19353075|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353076|NCT03715309|Lenalidomide|lenalidomide|mesh-list
19353077|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
19353078|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353079|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353080|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353081|NCT03715309|Growth Substances|growth substances|mesh-ancestor
19353082|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353083|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353084|NCT03715296|Lenalidomide|lenalidomide|mesh-list
19353085|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
19353086|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353087|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353088|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353089|NCT03715296|Growth Substances|growth substances|mesh-ancestor
19353090|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353091|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353092|NCT03715244|Anesthetics|anesthetics|mesh-list
19353093|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
19353094|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353095|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353096|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
19353097|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353098|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
19353099|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19353100|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353101|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19353102|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19353103|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19353104|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
19353105|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353106|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19353107|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19353108|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391641|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20391642|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
20391643|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391644|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
20391645|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
20391646|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391647|NCT01081353|Aspirin|aspirin|mesh-list
19353109|NCT03715023|PC-786|pc-786|mesh-list
19353110|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
19353111|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353112|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353113|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353114|NCT03714958|Trametinib|trametinib|mesh-list
19353115|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353116|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19353117|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353118|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353119|NCT03714880|Mifepristone|mifepristone|mesh-list
19353120|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19353121|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
19353122|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353123|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353124|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19353125|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19353126|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19353127|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
19353128|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19353129|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19353130|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
19353131|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353132|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
19353133|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19353134|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19353135|NCT03714867|Pregabalin|pregabalin|mesh-list
19353136|NCT03714867|Analgesics|analgesics|mesh-ancestor
19353137|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
19353138|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353139|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353140|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
20391648|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20391649|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20391650|NCT01081353|Analgesics|analgesics|mesh-ancestor
20391651|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
20391652|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391653|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391654|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391655|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391656|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20391657|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20391658|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391659|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20391660|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20391661|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353141|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19353142|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353143|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353144|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19353145|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19353146|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19353147|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353148|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19353149|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
19353150|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19353151|NCT03714737|Vaccines|vaccines|mesh-list
19353152|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
19353153|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353154|NCT03714685|Firibastat|firibastat|mesh-list
19353155|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19353156|NCT03714620|Ketamine|ketamine|mesh-list
19353157|NCT03714620|Analgesics|analgesics|mesh-ancestor
19353158|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
19353159|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353160|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353161|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19353162|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19353163|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
19353164|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
20391662|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
20391663|NCT01081431|Lenalidomide|lenalidomide|mesh-list
20391664|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
20391665|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391666|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20391667|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20391668|NCT01081431|Growth Substances|growth substances|mesh-ancestor
20391669|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353165|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353166|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19353167|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19353168|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353169|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353170|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
19353171|NCT03714594|Saxagliptin|saxagliptin|mesh-list
19353172|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19353173|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353174|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19353175|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353176|NCT03714594|Incretins|incretins|mesh-ancestor
19353177|NCT03714594|Hormones|hormones|mesh-ancestor
19353178|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391670|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353179|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19353180|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
19353181|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353182|NCT03714555|Copper|copper|mesh-list
19353183|NCT03714555|Gemcitabine|gemcitabine|mesh-list
19353184|NCT03714555|Paclitaxel|paclitaxel|mesh-list
19353185|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19353186|NCT03714555|Folfirinox|folfirinox|mesh-list
20391671|NCT01081535|Ketorolac|ketorolac|mesh-list
19353187|NCT03714555|Disulfiram|disulfiram|mesh-list
19843885|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843886|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353188|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19353189|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353190|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
19353191|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
19353192|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
19353193|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353194|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19353195|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
19353196|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
19353197|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353198|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353199|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19353200|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
19353201|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353202|NCT03714555|Trace Elements|trace elements|mesh-ancestor
19353203|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
19353204|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19353205|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19353206|NCT03714490|Capecitabine|capecitabine|mesh-list
19353207|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
19353208|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19353209|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
19353210|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353211|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353212|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
19353213|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19353214|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19353215|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353216|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
19353217|NCT03714360|Coagulants|coagulants|mesh-ancestor
19353218|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19353219|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
19353220|NCT03714165|Defensins|defensins|mesh-list
19353221|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353222|NCT03714113|Antibodies|antibodies|mesh-list
19353223|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
19353224|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353225|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
19353226|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
19353227|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19353228|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353229|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353230|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
19353231|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19353232|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353233|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353234|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19353235|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353236|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353237|NCT03713879|Indomethacin|indomethacin|mesh-list
19353238|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19353239|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19353240|NCT03713879|Analgesics|analgesics|mesh-ancestor
19353241|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
19353242|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353243|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353244|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19353245|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19353246|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
19353247|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
19353248|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353249|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19353250|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353251|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353252|NCT03713762|Lidocaine|lidocaine|mesh-list
19353253|NCT03713762|Fentanyl|fentanyl|mesh-list
19353254|NCT03713762|Bupivacaine|bupivacaine|mesh-list
19353255|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
19353256|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
19843887|NCT00661661|Tofacitinib|tofacitinib|mesh-list
19843888|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19353257|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19843889|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353258|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353259|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
19353260|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353261|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19353262|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20391672|NCT01081535|Fentanyl|fentanyl|mesh-list
20391673|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19353263|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19353264|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353265|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353266|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19353267|NCT03713762|Narcotics|narcotics|mesh-ancestor
19353268|NCT03713762|Analgesics|analgesics|mesh-ancestor
19353269|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19353270|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19353271|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
19353272|NCT03713658|Risperidone|risperidone|mesh-list
19353273|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19353274|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19353275|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
19353276|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353277|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353278|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353279|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19353280|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19353281|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353282|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19353283|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19353284|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
19353285|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19353286|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19401186|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401187|NCT03620435|Atezolizumab|atezolizumab|mesh-list
19401188|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401189|NCT03620422|Mannitol|mannitol|mesh-list
19401190|NCT03620422|Albuterol|albuterol|mesh-list
19401191|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19401192|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
19401193|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401194|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401195|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19401196|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
19401197|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
19401198|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19401199|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19401200|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19401201|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19401202|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
19401203|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401204|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401205|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19401206|NCT03620422|Diuretics|diuretics|mesh-ancestor
19401207|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
20391674|NCT01081535|Narcotics|narcotics|mesh-ancestor
20391675|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391676|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391677|NCT01081535|Analgesics|analgesics|mesh-ancestor
20391678|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
19401208|NCT03620318|Crenolanib|crenolanib|mesh-list
19401209|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401210|NCT03620292|Bevacizumab|bevacizumab|mesh-list
19401211|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19401212|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401213|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19401214|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19401215|NCT03620292|Growth Substances|growth substances|mesh-ancestor
20391679|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391680|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20391681|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19401216|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401217|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
19401218|NCT03620253|Modafinil|modafinil|mesh-list
19401219|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19401220|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401221|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20206883|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206884|NCT00272948|Defibrotide|defibrotide|mesh-list
20206885|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20206886|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20206887|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206888|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20206889|NCT00273013|Montelukast|montelukast|mesh-list
19353287|NCT03713437|Insulin|insulin|mesh-list
19353288|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19353289|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353290|NCT03713372|Cetuximab|cetuximab|mesh-list
19353291|NCT03713372|Antibodies|antibodies|mesh-list
19353292|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19353293|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
19353294|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353295|NCT03713372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19353296|NCT03713372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353297|NCT03713346|Caseins|caseins|mesh-list
19353298|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
19353299|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
19353300|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353301|NCT03713216|Morphine|morphine|mesh-list
19353302|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19353303|NCT03713216|Narcotics|narcotics|mesh-ancestor
19353304|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353305|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843890|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843891|NCT00661674|Palonosetron|palonosetron|mesh-list
19843892|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
19843893|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
19843894|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
19843895|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843896|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353306|NCT03713216|Analgesics|analgesics|mesh-ancestor
19353307|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
20391682|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
20391683|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
20391684|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20391685|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20391686|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391687|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391688|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20391689|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353308|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353309|NCT03713190|Empagliflozin|empagliflozin|mesh-list
19353310|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19353311|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353312|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19353313|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353314|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19843897|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206890|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20391690|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391691|NCT01081548|Atorvastatin|atorvastatin|mesh-list
20391692|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20391693|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20391694|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
20391695|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391696|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20391697|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20391698|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391699|NCT01081561|Riboflavin|riboflavin|mesh-list
20391700|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
20391701|NCT01081561|Vitamins|vitamins|mesh-ancestor
20391702|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
20391703|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391704|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20391705|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
19353315|NCT03712956|Doxorubicin|doxorubicin|mesh-list
19843898|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20206891|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
20206892|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20206893|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
20391706|NCT01081600|Trastuzumab|trastuzumab|mesh-list
19353316|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20391707|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391708|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391709|NCT01081613|Bevacizumab|bevacizumab|mesh-list
20206894|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206895|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206896|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20391710|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20391711|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391712|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353317|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353318|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19353319|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19353320|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353321|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353322|NCT03712904|Aflibercept|aflibercept|mesh-list
19353323|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
19353324|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353325|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353326|NCT03712904|Growth Substances|growth substances|mesh-ancestor
19353327|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353328|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353329|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353330|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
19353331|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
19353332|NCT03712878|Tacrolimus|tacrolimus|mesh-list
19353333|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391713|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20391714|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20391715|NCT01081613|Growth Substances|growth substances|mesh-ancestor
20391716|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391717|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
20391718|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20391719|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353334|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
19353335|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353336|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19353337|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19353338|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
19353339|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353340|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353341|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19353342|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19353343|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206897|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20206898|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206899|NCT00273026|Fluticasone|fluticasone|mesh-list
20206900|NCT00273026|Xhance|xhance|mesh-list
20206901|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20206902|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391720|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20391721|NCT01081639|Hormones|hormones|mesh-ancestor
20391722|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391723|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391724|NCT01081652|Progesterone|progesterone|mesh-list
20391725|NCT01081652|Progestins|progestins|mesh-ancestor
20391726|NCT01081652|Hormones|hormones|mesh-ancestor
20391727|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391728|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391729|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20391730|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
20391731|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353344|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19353345|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19353346|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
19353347|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19353348|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353349|NCT03712826|Ustekinumab|ustekinumab|mesh-list
19353350|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
19353351|NCT03712735|Fentanyl|fentanyl|mesh-list
19353352|NCT03712735|Bupivacaine|bupivacaine|mesh-list
19353353|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
19353354|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
19353355|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391732|NCT01081704|Ustekinumab|ustekinumab|mesh-list
19353356|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206903|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20206904|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
20206905|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391733|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391734|NCT01081717|Golimumab|golimumab|mesh-list
20391735|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20391736|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391737|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391738|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
20391739|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391740|NCT01081730|Ustekinumab|ustekinumab|mesh-list
20391741|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391742|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20391743|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20391744|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391745|NCT01081847|Mannitol|mannitol|mesh-list
20391746|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
20391747|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20391748|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
20391749|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391750|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20391751|NCT01081847|Diuretics|diuretics|mesh-ancestor
20391752|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
20391753|NCT01081938|Insulin|insulin|mesh-list
20391754|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20391755|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
20391756|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
20391757|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20391758|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391759|NCT01081964|Levofloxacin|levofloxacin|mesh-list
20391760|NCT01081964|Ofloxacin|ofloxacin|mesh-list
20391761|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
20391762|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19353357|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
19353358|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353359|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19353360|NCT03712735|Narcotics|narcotics|mesh-ancestor
19353361|NCT03712735|Analgesics|analgesics|mesh-ancestor
19353362|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19353363|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19353364|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
19353365|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
19353366|NCT03712670|Aflibercept|aflibercept|mesh-list
19353367|NCT03712670|Carotenoids|carotenoids|mesh-list
19353368|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353369|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353370|NCT03712670|Growth Substances|growth substances|mesh-ancestor
19353371|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353372|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353373|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353374|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
19353375|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353376|NCT03712670|Protective Agents|protective agents|mesh-ancestor
19353377|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19353378|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19353379|NCT03712670|Analgesics|analgesics|mesh-ancestor
19353380|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
20206906|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206907|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20206908|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
20206909|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206910|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20206911|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20206912|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20206913|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20206914|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
20206915|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206916|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206917|NCT00273039|Paroxetine|paroxetine|mesh-list
20206918|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20206919|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19353381|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353382|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391763|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391764|NCT01081964|Renal Agents|renal agents|mesh-ancestor
20391765|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19353383|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19353384|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
19353385|NCT03712540|Rifampin|rifampin|mesh-list
19353386|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19353387|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
19353388|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19353389|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353390|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
19353391|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19353392|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353393|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353394|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19353395|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19353396|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19353397|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19353398|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19353399|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19353400|NCT03712475|Pregabalin|pregabalin|mesh-list
20206920|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353401|NCT03712475|Analgesics|analgesics|mesh-ancestor
19353402|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
19353403|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353404|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353405|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
19353406|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19353407|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353408|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353409|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19353410|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19353411|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19353412|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353413|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19353414|NCT03712423|Docetaxel|docetaxel|mesh-list
19353415|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353416|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
19353417|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
20391766|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20391767|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19353418|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
19353419|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353420|NCT03712397|Irinotecan|irinotecan|mesh-list
19353421|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19353422|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19353423|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353424|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353425|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843899|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19843900|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
19843901|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19843902|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206921|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206922|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20206923|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
20206924|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206925|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20206926|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
19843903|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
19353431|NCT03712241|Indomethacin|indomethacin|mesh-list
20206927|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20206928|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20206929|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20206930|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206931|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
20206932|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20206933|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20206934|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206935|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217816|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20217817|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20217818|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20391768|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843904|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
19843905|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19843906|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
19843907|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
19843908|NCT00661713|Vaccines|vaccines|mesh-list
19843909|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
19843910|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843911|NCT00661726|Decitabine|decitabine|mesh-list
19353432|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19353433|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19353434|NCT03712241|Analgesics|analgesics|mesh-ancestor
19353435|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
19353436|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353437|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843912|NCT00661726|Azacitidine|azacitidine|mesh-list
19843913|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19843914|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
19843915|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353438|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206936|NCT00273247|Interferons|interferons|mesh-list
20206937|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
20206938|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
19353439|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19353440|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
19843916|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843917|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843918|NCT00661778|Bevacizumab|bevacizumab|mesh-list
19843919|NCT00661778|Docetaxel|docetaxel|mesh-list
19843920|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19843921|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843922|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19843923|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19843924|NCT00661778|Growth Substances|growth substances|mesh-ancestor
20206939|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391769|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391770|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391771|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20391772|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20391773|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20391774|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
20391775|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20391776|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
20391777|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391778|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19353441|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
19353442|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353443|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19353444|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353445|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353446|NCT03712163|Ketotifen|ketotifen|mesh-list
19353447|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
19353448|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
19353449|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19353450|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
19353451|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
19353452|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353453|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353454|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353455|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19353456|NCT03712111|Norepinephrine|norepinephrine|mesh-list
19353457|NCT03712111|Bupivacaine|bupivacaine|mesh-list
19353458|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
19353459|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
19353460|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353461|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353462|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
19843925|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206940|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
20206941|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20206942|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
20206943|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206944|NCT00273299|Valsartan|valsartan|mesh-list
20206945|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19843926|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
20206946|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217819|NCT00310583|Pregabalin|pregabalin|mesh-list
19353463|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353464|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19353465|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19353466|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
19353467|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353468|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353469|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
19353470|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
19353471|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19353472|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19353473|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19353474|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353475|NCT03711708|Sertraline|sertraline|mesh-list
19353476|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
19353477|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19353478|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19353479|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19353480|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353481|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353482|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353483|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
19353484|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401222|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19401223|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19401224|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401225|NCT03620149|Denosumab|denosumab|mesh-list
19401226|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19401227|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401228|NCT03620032|Vinorelbine|vinorelbine|mesh-list
19401229|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
19401230|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19401231|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401232|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
19401233|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
19401234|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
19401235|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401236|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19401237|NCT03620019|Denosumab|denosumab|mesh-list
19401238|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
19401239|NCT03620019|Nivolumab|nivolumab|mesh-list
19401240|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684842|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206947|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20206948|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20206949|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206950|NCT00273299|Diuretics|diuretics|mesh-ancestor
20206951|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
20206952|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206953|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20206954|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206955|NCT00273312|Epothilone B|epothilone b|mesh-list
20206956|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206957|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206958|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206959|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
19843927|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
20206960|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206961|NCT00273338|Calcitriol|calcitriol|mesh-list
20206962|NCT00273338|Docetaxel|docetaxel|mesh-list
20206963|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684843|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
19843928|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
19843929|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
19843930|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843931|NCT00661830|Gemcitabine|gemcitabine|mesh-list
19843932|NCT00661830|Sorafenib|sorafenib|mesh-list
19684844|NCT04268498|Hormones|hormones|mesh-ancestor
19684845|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684846|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19684847|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684848|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
19684849|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19843933|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19353485|NCT03711474|Dexamethasone|dexamethasone|mesh-list
19353486|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19353487|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
19353488|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
19353489|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353490|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353491|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19353492|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
19353493|NCT03711474|Hormones|hormones|mesh-ancestor
19353494|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353495|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19353496|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353497|NCT03711422|Afatinib|afatinib|mesh-list
19353498|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353499|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19353500|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353501|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353502|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19353503|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353504|NCT03711279|Apatinib|apatinib|mesh-list
19353505|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353506|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20206964|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
19353507|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353508|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353509|NCT03711253|Tenofovir|tenofovir|mesh-list
19353510|NCT03711253|Emtricitabine|emtricitabine|mesh-list
19353511|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
20391779|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391780|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20391781|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391782|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20391783|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391784|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
20391785|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20391786|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391787|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391788|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20391789|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20391790|NCT01082003|Protective Agents|protective agents|mesh-ancestor
20391791|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353512|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353513|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19353514|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19353515|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353516|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353517|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19353518|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19353519|NCT03711240|Leucovorin|leucovorin|mesh-list
19353520|NCT03711240|Bevacizumab|bevacizumab|mesh-list
19353521|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
19353522|NCT03711240|Irinotecan|irinotecan|mesh-list
19353523|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19353524|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206965|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
20206966|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
20206967|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206968|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20206969|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20206970|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20206971|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20206972|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20206973|NCT00273338|Vitamins|vitamins|mesh-ancestor
20206974|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
20206975|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20206976|NCT00273377|Dexamethasone|dexamethasone|mesh-list
20206977|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20206978|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
20206979|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
20206980|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206981|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353525|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353526|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353527|NCT03711240|Growth Substances|growth substances|mesh-ancestor
20206982|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206983|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
19353528|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353529|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353530|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19353531|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19353532|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353533|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353534|NCT03711240|Antidotes|antidotes|mesh-ancestor
19353535|NCT03711240|Protective Agents|protective agents|mesh-ancestor
19353536|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
19353537|NCT03711240|Vitamins|vitamins|mesh-ancestor
19353538|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
19353539|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
19353540|NCT03710863|Vorolanib|vorolanib|mesh-list
19353541|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19353542|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353543|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353544|NCT03710811|Insulin|insulin|mesh-list
19353545|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19353546|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353547|NCT03710655|Histamine|histamine|mesh-list
19353548|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
19353549|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
19353550|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353551|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353552|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353553|NCT03710603|Dexamethasone|dexamethasone|mesh-list
19353554|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
19353555|NCT03710603|Lenalidomide|lenalidomide|mesh-list
19353556|NCT03710603|Bortezomib|bortezomib|mesh-list
19353557|NCT03710603|Daratumumab|daratumumab|mesh-list
19353558|NCT03710603|BB 1101|bb 1101|mesh-list
19353559|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19353560|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
19353561|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
20391792|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
20391793|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20391794|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
20391795|NCT01082029|Lansoprazole|lansoprazole|mesh-list
20391796|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
20391797|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20391798|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20391799|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19353562|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20206984|NCT00273377|Hormones|hormones|mesh-ancestor
20206985|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20206986|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20206987|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20206988|NCT00273390|Infliximab|infliximab|mesh-list
20206989|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
20206990|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20206991|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20391800|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353563|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353564|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19353565|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
19353566|NCT03710603|Hormones|hormones|mesh-ancestor
19353567|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353568|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19353569|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353570|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
19353571|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353572|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353573|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
19353574|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353575|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353576|NCT03710603|Growth Substances|growth substances|mesh-ancestor
19353577|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
20391801|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391802|NCT01082120|Pioglitazone|pioglitazone|mesh-list
19353578|NCT03710460|Metformin|metformin|mesh-list
19353579|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
19843934|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
19353580|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20206992|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
20206993|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
20217820|NCT00310583|Analgesics|analgesics|mesh-ancestor
19353581|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353582|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19353583|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353584|NCT03710434|Lansoprazole|lansoprazole|mesh-list
19353585|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
19353586|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19353587|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19353588|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19353589|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353590|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353591|NCT03710395|Nifedipine|nifedipine|mesh-list
19353592|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20391803|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20391804|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391805|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20391806|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20391807|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20391808|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391809|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391810|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391811|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20391812|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20391813|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20391814|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
20391815|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391816|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353593|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353594|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353595|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19353596|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353597|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
19353598|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
19353599|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353600|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
19353601|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
19353602|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19684850|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19684851|NCT04268498|Growth Substances|growth substances|mesh-ancestor
19843935|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843936|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19843937|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
19843938|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843939|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843940|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19843941|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
19843942|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843943|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19843944|NCT00661895|Metoprolol|metoprolol|mesh-list
19843945|NCT00661895|Atenolol|atenolol|mesh-list
19843946|NCT00661895|Amlodipine|amlodipine|mesh-list
19843947|NCT00661895|Valsartan|valsartan|mesh-list
19843948|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19843949|NCT00661895|Clonidine|clonidine|mesh-list
19843950|NCT00661895|Lisinopril|lisinopril|mesh-list
19843951|NCT00661895|Doxazosin|doxazosin|mesh-list
19843952|NCT00661895|Hydralazine|hydralazine|mesh-list
20206994|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20206995|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19684852|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
19684853|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19684854|NCT04268498|Analgesics|analgesics|mesh-ancestor
20206996|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20206997|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20206998|NCT00273416|Urological Agents|urological agents|mesh-ancestor
20206999|NCT00273429|Timolol|timolol|mesh-list
19684855|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
19684856|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
20207000|NCT00273429|Dorzolamide|dorzolamide|mesh-list
20207001|NCT00273429|Latanoprost|latanoprost|mesh-list
20207002|NCT00273429|Maleic acid|maleic acid|mesh-list
19684857|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19843953|NCT00661895|Nifedipine|nifedipine|mesh-list
19843954|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19843955|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20207003|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19353603|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19353604|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353605|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353606|NCT03710369|Urological Agents|urological agents|mesh-ancestor
19353607|NCT03710356|Danazol|danazol|mesh-list
19353608|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19353609|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
19353610|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353611|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353612|NCT03710343|Metformin|metformin|mesh-list
19353613|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19353614|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353615|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
19353616|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19353617|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19353618|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353619|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
19353620|NCT03710330|Coagulants|coagulants|mesh-ancestor
19353621|NCT03710317|Misoprostol|misoprostol|mesh-list
19353622|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
19353623|NCT03710317|Carbetocin|carbetocin|mesh-list
19353624|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19353625|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19353626|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353627|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
19353628|NCT03710317|Coagulants|coagulants|mesh-ancestor
19353629|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19353630|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
19353631|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353632|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353633|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19353634|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19353635|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
19353636|NCT03710304|Misoprostol|misoprostol|mesh-list
19353637|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
19353638|NCT03710304|Oxytocin|oxytocin|mesh-list
19353639|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
19353640|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353641|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353642|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19353643|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19353644|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353645|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
19353646|NCT03710304|Coagulants|coagulants|mesh-ancestor
19353647|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19353648|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
19353649|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19353650|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19353651|NCT03710252|Ritonavir|ritonavir|mesh-list
19353652|NCT03710252|Ribavirin|ribavirin|mesh-list
19353653|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19353654|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19353655|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
19353656|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353657|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353658|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19353659|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19353660|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
19684858|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
19684859|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19684860|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
19684861|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20207004|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20207005|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207006|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207007|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207008|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207009|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20207010|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207011|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207012|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20207013|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19353661|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684862|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19353662|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19353663|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19353664|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
19353665|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
19353666|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353667|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
19353668|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
19353669|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
19353670|NCT03710122|Vancomycin|vancomycin|mesh-list
19353671|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19353672|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353673|NCT03710044|Cyclosporine|cyclosporine|mesh-list
19353674|NCT03710044|Cyclosporins|cyclosporins|mesh-list
19353675|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353676|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612969|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20612970|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19353677|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19353678|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
19353679|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353680|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
19353681|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353682|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
19353683|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19353684|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19353685|NCT03709992|Tamsulosin|tamsulosin|mesh-list
19353686|NCT03709992|Trospium chloride|trospium chloride|mesh-list
19353687|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19353688|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19353689|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19353690|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
19353691|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353692|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353693|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353694|NCT03709992|Urological Agents|urological agents|mesh-ancestor
19353695|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
19353696|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
19353697|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353698|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19353699|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19353700|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
20391817|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20391818|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20391819|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
20391820|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20391821|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20391822|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
20391823|NCT01082198|Vaccines|vaccines|mesh-list
20391824|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20391825|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
20391826|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391827|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20391828|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
19353701|NCT03709953|Apatinib|apatinib|mesh-list
19353702|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353703|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19353704|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353705|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353706|NCT03709940|Methylphenidate|methylphenidate|mesh-list
19353707|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19353708|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391829|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391830|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20391831|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391832|NCT01082237|Citalopram|citalopram|mesh-list
20391833|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20391834|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19353709|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19353710|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19353711|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353712|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353713|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
19353714|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353715|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
20391835|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20612971|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
19353716|NCT03709927|Fosfomycin|fosfomycin|mesh-list
19353717|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19353718|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353719|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19353720|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19353721|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353722|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353723|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353724|NCT03709849|Citric Acid|citric acid|mesh-list
19353725|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
20391836|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391837|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391838|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
20391839|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391840|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20391841|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
19353726|NCT03709849|Clomiphene|clomiphene|mesh-list
19353727|NCT03709849|Enclomiphene|enclomiphene|mesh-list
19353728|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
19353729|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
20207014|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20207015|NCT00273442|Timolol|timolol|mesh-list
20207016|NCT00273442|Dorzolamide|dorzolamide|mesh-list
20207017|NCT00273442|Maleic acid|maleic acid|mesh-list
20207018|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19353730|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19353731|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
19353732|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
19353733|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353734|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19353735|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
19353736|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353737|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353738|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19353739|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
19353740|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353741|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19353742|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19401241|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401242|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19401243|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401244|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19401245|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404595|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19404596|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
20207019|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20207020|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207021|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207022|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207023|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207024|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20207025|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207026|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207027|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19684863|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207028|NCT00273455|Timolol|timolol|mesh-list
20207029|NCT00273455|Bimatoprost|bimatoprost|mesh-list
20207030|NCT00273455|Dorzolamide|dorzolamide|mesh-list
20207031|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20207032|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20207033|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207034|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207035|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207036|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207037|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19684864|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19684865|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19684866|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684867|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
19684868|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
19684869|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20207038|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207039|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353743|NCT03709745|Ranibizumab|ranibizumab|mesh-list
19353744|NCT03709745|Aflibercept|aflibercept|mesh-list
19353745|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353746|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353747|NCT03709745|Growth Substances|growth substances|mesh-ancestor
19353748|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353749|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353750|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353751|NCT03709719|Blinatumomab|blinatumomab|mesh-list
19353752|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353753|NCT03709550|Decitabine|decitabine|mesh-list
19353754|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19353755|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
20391842|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391843|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20391844|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19353756|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353757|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353758|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391845|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20391846|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391847|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391848|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391849|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20391850|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20391851|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20391852|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
19353759|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19353760|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19353761|NCT03709381|Cosyntropin|cosyntropin|mesh-list
19353762|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
19353763|NCT03709381|Hormones|hormones|mesh-ancestor
19353764|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353765|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353766|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353767|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353768|NCT03709160|Bumetanide|bumetanide|mesh-list
20391853|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391854|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353769|NCT03709160|Diuretics|diuretics|mesh-ancestor
19353770|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
19353771|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353772|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19353773|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19353774|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353775|NCT03709147|Metformin|metformin|mesh-list
19353776|NCT03709147|Carboplatin|carboplatin|mesh-list
19353777|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
19353778|NCT03709147|Pemetrexed|pemetrexed|mesh-list
19353779|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353780|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19353781|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353782|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19353783|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353784|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353785|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19353786|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19353787|NCT03709082|Trastuzumab|trastuzumab|mesh-list
19353788|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19353789|NCT03709082|Letrozole|letrozole|mesh-list
19353790|NCT03709082|Palbociclib|palbociclib|mesh-list
19353791|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19353792|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353793|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19353794|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19353795|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353796|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353797|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19353798|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
19353799|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353800|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353801|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19353802|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
19353803|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
19353804|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
19353805|NCT03709056|Propofol|propofol|mesh-list
19353806|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19353807|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19353808|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353809|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19353810|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
20391855|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20391856|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20391857|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
20391858|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20391859|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20391860|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
20391861|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20391862|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20391863|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19353811|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
19353812|NCT03709017|Ponatinib|ponatinib|mesh-list
19353813|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353814|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19353815|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353816|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353817|NCT03708926|Abaloparatide|abaloparatide|mesh-list
20391864|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391865|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391866|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391867|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20391868|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19353818|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19353819|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353820|NCT03708861|Ritonavir|ritonavir|mesh-list
19353821|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19353822|NCT03708861|Maraviroc|maraviroc|mesh-list
19353823|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19353824|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19353825|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
19353826|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207040|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20207041|NCT00273468|Granisetron|granisetron|mesh-list
20207042|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
20207043|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
20207044|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207045|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207046|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207047|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20207048|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
20207049|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207050|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207051|NCT00273481|Timolol|timolol|mesh-list
20207052|NCT00273481|Dorzolamide|dorzolamide|mesh-list
20207053|NCT00273481|Latanoprost|latanoprost|mesh-list
20207054|NCT00273481|Maleic acid|maleic acid|mesh-list
20207055|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20207056|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19353827|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353828|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19353829|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19353830|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
19353831|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353832|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20207057|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207058|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207059|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207060|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207061|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20207062|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207063|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207064|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20207065|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20391869|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19353833|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19353834|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19353835|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19401246|NCT03619876|Adalimumab|adalimumab|mesh-list
19353836|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19353837|NCT03708848|Metronidazole|metronidazole|mesh-list
19353838|NCT03708848|Clarithromycin|clarithromycin|mesh-list
19353839|NCT03708848|Levofloxacin|levofloxacin|mesh-list
19353840|NCT03708848|Ofloxacin|ofloxacin|mesh-list
19353841|NCT03708848|Tetracycline|tetracycline|mesh-list
19353842|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
19353843|NCT03708848|Esomeprazole|esomeprazole|mesh-list
19353844|NCT03708848|Bismuth|bismuth|mesh-list
19353845|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353846|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353847|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19353848|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19353849|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19353850|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19353851|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19353852|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19353853|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353854|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19353855|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19353856|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19353857|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19353858|NCT03708848|Renal Agents|renal agents|mesh-ancestor
19353859|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19353860|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19353861|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353862|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19353863|NCT03708848|Antacids|antacids|mesh-ancestor
19353864|NCT03708848|Diuretics|diuretics|mesh-ancestor
19353865|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
20391870|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
20391871|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391872|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391873|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20391874|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20391875|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
20391876|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20391877|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20391878|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
20391879|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20391880|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20391881|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20391882|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391883|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391884|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20391885|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20391886|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20391887|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19353866|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353867|NCT03708848|Expectorants|expectorants|mesh-ancestor
19353868|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
19353869|NCT03708822|Docetaxel|docetaxel|mesh-list
19353870|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
19353871|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353872|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
19353873|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
19353874|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
19353875|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353876|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19353877|NCT03708718|Prednisolone|prednisolone|mesh-list
19353878|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19353879|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
19353880|NCT03708718|Hormones|hormones|mesh-ancestor
19353881|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19353882|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353883|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19353884|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19353885|NCT03708588|Ticagrelor|ticagrelor|mesh-list
19353886|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19353887|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20391888|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
20391889|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353888|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19353889|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19353890|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
19353891|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19353892|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353893|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353894|NCT03708536|Bevacizumab|bevacizumab|mesh-list
19353895|NCT03708536|Capecitabine|capecitabine|mesh-list
19353896|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391890|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391891|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19353897|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207066|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20207067|NCT00273507|Paclitaxel|paclitaxel|mesh-list
20207068|NCT00273507|Carboplatin|carboplatin|mesh-list
20207069|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20207070|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207071|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
19353898|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19353899|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19353900|NCT03708536|Growth Substances|growth substances|mesh-ancestor
19353901|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207072|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207073|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
20207074|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207075|NCT00273520|Telithromycin|telithromycin|mesh-list
20207076|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20207077|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207078|NCT00273533|Ramipril|ramipril|mesh-list
20207079|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20207080|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
20207081|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207082|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207083|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207084|NCT00273546|Docetaxel|docetaxel|mesh-list
20207085|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207086|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
19843956|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20207087|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207088|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
20207089|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353902|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
19353903|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19353904|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
19353905|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353906|NCT03708497|Misoprostol|misoprostol|mesh-list
19353907|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
19353908|NCT03708497|Carbetocin|carbetocin|mesh-list
19353909|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19353910|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19353911|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353912|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
19353913|NCT03708497|Coagulants|coagulants|mesh-ancestor
19353914|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19353915|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
19353916|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353917|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353918|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19353919|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19353920|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
19353921|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
19353922|NCT03708458|Indomethacin|indomethacin|mesh-list
19353923|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19353924|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
19353925|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353926|NCT03708458|Expectorants|expectorants|mesh-ancestor
19353927|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207090|NCT00273559|Prednisone|prednisone|mesh-list
20207091|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207092|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
20207093|NCT00273559|Hormones|hormones|mesh-ancestor
20391892|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20391893|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
20391894|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20391895|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20391896|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
20391897|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19353928|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20207094|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207095|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207096|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20207097|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207098|NCT00273611|Vitamin D|vitamin d|mesh-list
20207099|NCT00273611|Vitamins|vitamins|mesh-ancestor
19353929|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
19353930|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353931|NCT03708458|Protective Agents|protective agents|mesh-ancestor
19353932|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353933|NCT03708458|Antidotes|antidotes|mesh-ancestor
19353934|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19353935|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19353936|NCT03708458|Analgesics|analgesics|mesh-ancestor
19353937|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
19353938|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19353939|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19353940|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19353941|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
19353942|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
19353943|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19353944|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19353945|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353946|NCT03708341|Melatonin|melatonin|mesh-list
19353947|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
19353948|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353949|NCT03708341|Protective Agents|protective agents|mesh-ancestor
19353950|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353951|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20207100|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
20207101|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207102|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20207103|NCT00273624|Olanzapine|olanzapine|mesh-list
20207104|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
20207105|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
20207106|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207107|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207108|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207109|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20207110|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20207111|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20207112|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20207113|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20207114|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20207115|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20207116|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207117|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391898|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20391899|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20391900|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391901|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391902|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20207118|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
20207119|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19353972|NCT03708146|Zamicastat|zamicastat|mesh-list
19353973|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19353974|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207120|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20207121|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207122|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
20207123|NCT00273689|Albuterol|albuterol|mesh-list
20207124|NCT00273689|Montelukast|montelukast|mesh-list
20207125|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207126|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207127|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20207128|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
20207129|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207130|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207131|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20207132|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19353975|NCT03708133|Nifurtimox|nifurtimox|mesh-list
19353976|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19353977|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20391903|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19353978|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19353979|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353980|NCT03708120|Insect Repellents|insect repellents|mesh-list
19353981|NCT03708120|Protective Agents|protective agents|mesh-ancestor
19684870|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
19684871|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
19684872|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684873|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19684874|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
20207133|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207134|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207135|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
20207136|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207137|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
20207138|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20207139|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20207140|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20207141|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20207142|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207143|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207144|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
19353982|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207145|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20207146|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
20207147|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353983|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
19353984|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19353985|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
19353986|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19353987|NCT03707951|Expectorants|expectorants|mesh-ancestor
19353988|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
19353989|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19353990|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
19353991|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19353992|NCT03707951|Protective Agents|protective agents|mesh-ancestor
19353993|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19353994|NCT03707951|Antidotes|antidotes|mesh-ancestor
19401247|NCT03619876|Abatacept|abatacept|mesh-list
19401248|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401249|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401250|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19401251|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401252|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401253|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401254|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
19401255|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391904|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20391905|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20391906|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
20391907|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391908|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391909|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20391910|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20391911|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
20391912|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20391913|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20391914|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
20391915|NCT01082315|Cetuximab|cetuximab|mesh-list
19401256|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20207148|NCT00273702|Expectorants|expectorants|mesh-ancestor
20207149|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
20391916|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20391917|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391918|NCT01082341|Vaccines|vaccines|mesh-list
20391919|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
19401257|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20207150|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20207151|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
20207152|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207153|NCT00273702|Protective Agents|protective agents|mesh-ancestor
19401258|NCT03619850|Hematinics|hematinics|mesh-ancestor
19684875|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
20207154|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207155|NCT00273702|Antidotes|antidotes|mesh-ancestor
20391920|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391921|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
20391922|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
19353995|NCT03707899|Amlodipine|amlodipine|mesh-list
19353996|NCT03707899|Telmisartan|telmisartan|mesh-list
19353997|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19353998|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19353999|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20391923|NCT01082393|Tacrolimus|tacrolimus|mesh-list
20391924|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20391925|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
20391926|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391927|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20391928|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20391929|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391930|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20391931|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
20391932|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20391933|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20391934|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20391935|NCT01082393|Analgesics|analgesics|mesh-ancestor
20391936|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
19354000|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19354001|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354002|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354003|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19354004|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354005|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
19354006|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19354007|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19354008|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
19354009|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19354010|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19354011|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354012|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19354013|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19354014|NCT03707847|Etoposide|etoposide|mesh-list
19354015|NCT03707847|Crizotinib|crizotinib|mesh-list
19354016|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19354017|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354018|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19354019|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19354020|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354021|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354022|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19354023|NCT03707808|Nivolumab|nivolumab|mesh-list
19354024|NCT03707808|Ipilimumab|ipilimumab|mesh-list
19354025|NCT03707808|Avelumab|avelumab|mesh-list
19354026|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207156|NCT00273741|Methylphenidate|methylphenidate|mesh-list
20207157|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20207158|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207159|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20207160|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20207161|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20207162|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207163|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
20207164|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207165|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
20207166|NCT00273767|Hematinics|hematinics|mesh-ancestor
20207167|NCT00273871|Cyclosporine|cyclosporine|mesh-list
19843957|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843958|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20207168|NCT00273871|Tacrolimus|tacrolimus|mesh-list
20207169|NCT00273871|Cyclosporins|cyclosporins|mesh-list
20207170|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207171|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
20207172|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207173|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20207174|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207175|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207176|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
20207177|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391937|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391938|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207178|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
20207179|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207180|NCT00273884|Cytarabine|cytarabine|mesh-list
20207181|NCT00273884|Amonafide|amonafide|mesh-list
20207182|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207183|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
20207184|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207185|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207186|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
20207187|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207188|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207189|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
20207190|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207191|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207192|NCT00273949|Lactulose|lactulose|mesh-list
20207193|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207194|NCT00273962|Albuterol|albuterol|mesh-list
20207195|NCT00273962|Ipratropium|ipratropium|mesh-list
20207196|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207197|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
20207198|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207199|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207200|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207201|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
19354027|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354028|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19354029|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354030|NCT03707795|Betamethasone|betamethasone|mesh-list
19354031|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
19354032|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19354033|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
19354034|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
19354035|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
19354036|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19354037|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207202|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
20207203|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20207204|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20207205|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20207206|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19843959|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19843960|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
19843961|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19843962|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19843963|NCT00661895|Diuretics|diuretics|mesh-ancestor
19843964|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
19843965|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19843966|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19843967|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
19843968|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
19843969|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19843970|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19843971|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19843972|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19843973|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
19843974|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207207|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207208|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20391939|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
19354038|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
19354039|NCT03707795|Hormones|hormones|mesh-ancestor
19354040|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19354041|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354042|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19684876|NCT04248465|Ravulizumab|ravulizumab|mesh-list
19684877|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19684878|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19684879|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
19684880|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684881|NCT05245227|Misoprostol|misoprostol|mesh-list
19684882|NCT05245227|Oxytocin|oxytocin|mesh-list
19684883|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
19684884|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684885|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354043|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
19354044|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19354045|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
19354046|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354047|NCT03707678|Albuterol|albuterol|mesh-list
19354048|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19843975|NCT00661895|Analgesics|analgesics|mesh-ancestor
19354049|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
19354050|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354051|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354052|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19354053|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
19354054|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
19354055|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19354056|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19354057|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20391940|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20391941|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
20391942|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20391943|NCT01082445|Expectorants|expectorants|mesh-ancestor
19354058|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19354059|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354060|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354061|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354062|NCT03707652|Vitamins|vitamins|mesh-list
19354063|NCT03707652|Niacinamide|niacinamide|mesh-list
19354064|NCT03707652|Niacin|niacin|mesh-list
19354065|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
19354066|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
19354067|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
19354068|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354069|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19354070|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
19354071|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354072|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19354073|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
19354074|NCT03707639|Apatinib|apatinib|mesh-list
19354075|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354076|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19354077|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354078|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354079|NCT03707535|Infliximab|infliximab|mesh-list
19354080|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
19354081|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19354082|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19354083|NCT03707509|Gemcitabine|gemcitabine|mesh-list
19354084|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354085|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20612972|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207209|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207210|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207211|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207212|NCT00273975|Lamivudine|lamivudine|mesh-list
20207213|NCT00273975|Zidovudine|zidovudine|mesh-list
20207214|NCT00273975|Nevirapine|nevirapine|mesh-list
20207215|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20207216|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20207217|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207218|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207219|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
20207220|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207221|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20207222|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20207223|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
20207224|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19354086|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
19843976|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
20391944|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
20391945|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20391946|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
20391947|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391948|NCT01082445|Protective Agents|protective agents|mesh-ancestor
20391949|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391950|NCT01082445|Antidotes|antidotes|mesh-ancestor
20391951|NCT01082458|Lidocaine|lidocaine|mesh-list
20391952|NCT01082458|Remifentanil|remifentanil|mesh-list
20391953|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
20391954|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
20391955|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391956|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391957|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
20391958|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391959|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20391960|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20391961|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20391962|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20391963|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391964|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20391965|NCT01082458|Narcotics|narcotics|mesh-ancestor
20391966|NCT01082458|Analgesics|analgesics|mesh-ancestor
20207225|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20207226|NCT00273988|Nevirapine|nevirapine|mesh-list
20207227|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20207228|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20207229|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20612973|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612974|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20612975|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
20612976|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
20612977|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
20612978|NCT02253550|Simeprevir|simeprevir|mesh-list
20207230|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207231|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
19354087|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354088|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
19354089|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354090|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354091|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19354092|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
19354093|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354094|NCT03707483|Ascorbic Acid|ascorbic acid|mesh-list
19354095|NCT03707483|Vitamins|vitamins|mesh-ancestor
19354096|NCT03707483|Micronutrients|micronutrients|mesh-ancestor
19354097|NCT03707483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354098|NCT03707483|Antioxidants|antioxidants|mesh-ancestor
19354099|NCT03707483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391967|NCT01082471|Morphine|morphine|mesh-list
20391968|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20391969|NCT01082471|Narcotics|narcotics|mesh-ancestor
20391970|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391971|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391972|NCT01082471|Analgesics|analgesics|mesh-ancestor
20391973|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
20391974|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391975|NCT01082484|Treprostinil|treprostinil|mesh-list
20391976|NCT01082484|Iloprost|iloprost|mesh-list
20391977|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20391978|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20391979|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
20391980|NCT01082510|Tegafur|tegafur|mesh-list
20391981|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19354100|NCT03707483|Protective Agents|protective agents|mesh-ancestor
19354101|NCT03707457|Nivolumab|nivolumab|mesh-list
20207232|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207233|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20207234|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20207235|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20207236|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19354102|NCT03707457|Ipilimumab|ipilimumab|mesh-list
19354103|NCT03707457|Antibodies|antibodies|mesh-list
19354104|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19354105|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
19354106|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354107|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207237|NCT00274001|Nevirapine|nevirapine|mesh-list
20207238|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20207239|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20207240|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207241|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20612979|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
19354108|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354109|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20207242|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
20207243|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207244|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20207245|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20207246|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20391982|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
20391983|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20391984|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20391985|NCT01082627|Somatostatin|somatostatin|mesh-list
20391986|NCT01082627|Hormones|hormones|mesh-ancestor
20207247|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20207248|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
19354110|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354111|NCT03707418|Heparin|heparin|mesh-list
19354112|NCT03707418|Calcium heparin|calcium heparin|mesh-list
19354113|NCT03707418|Bivalirudin|bivalirudin|mesh-list
19354114|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
19354115|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19354116|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19354117|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354118|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
19354119|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19354120|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
19354121|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354122|NCT03707353|Vaccines|vaccines|mesh-list
19354123|NCT03707353|Immunologic Factors|immunologic factors|mesh-ancestor
19354124|NCT03707353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354125|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
19354126|NCT03707249|Hematinics|hematinics|mesh-ancestor
19354127|NCT03707171|Liraglutide|liraglutide|mesh-list
19354128|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19354129|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354130|NCT03707171|Incretins|incretins|mesh-ancestor
19354131|NCT03707171|Hormones|hormones|mesh-ancestor
19354132|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19354133|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19354134|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
20391987|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20391988|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354135|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19354136|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19354137|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354138|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354139|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
19354140|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354141|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19354142|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19354143|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
19354144|NCT03706781|Benzydamine|benzydamine|mesh-list
19354145|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19354146|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354147|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19354148|NCT03706755|Norepinephrine|norepinephrine|mesh-list
19354149|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19354150|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19354151|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354152|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354153|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354154|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207249|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207250|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
20207251|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207252|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207253|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207254|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207255|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
20207256|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207257|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207258|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207259|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207260|NCT00274027|Bromides|bromides|mesh-list
20207261|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
20207262|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207263|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
20391989|NCT01082679|Buprenorphine|buprenorphine|mesh-list
20391990|NCT01082679|Methadone|methadone|mesh-list
20391991|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20391992|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20391993|NCT01082679|Narcotics|narcotics|mesh-ancestor
20391994|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20391995|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20391996|NCT01082679|Analgesics|analgesics|mesh-ancestor
20391997|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
20391998|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20391999|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20392000|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
20207264|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207265|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207266|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19354155|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
19354156|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
19354157|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354158|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19354159|NCT03706703|Carboplatin|carboplatin|mesh-list
19354160|NCT03706703|Docetaxel|docetaxel|mesh-list
19354161|NCT03706703|Pemetrexed|pemetrexed|mesh-list
19354162|NCT03706703|Endostar protein|endostar protein|mesh-list
19354163|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354164|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
19354165|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207267|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207268|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
19354166|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
19354167|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354168|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354169|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19354170|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19354171|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19354172|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19354173|NCT03706703|Growth Substances|growth substances|mesh-ancestor
19354174|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207269|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207270|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207271|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207272|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207273|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
20207274|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
20207275|NCT00274040|Ipratropium|ipratropium|mesh-list
20207276|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207277|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
20207278|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207279|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207280|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207281|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207282|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
20207283|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207284|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207285|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207286|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207287|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
20207288|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207289|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
20207290|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207291|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207292|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207293|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207294|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
20207295|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207296|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207297|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207298|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207299|NCT00274066|Fenoterol|fenoterol|mesh-list
20207300|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
20207301|NCT00274066|Ipratropium|ipratropium|mesh-list
20207302|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207303|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
19354175|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
20392001|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
20392002|NCT01082705|Lumefantrine|lumefantrine|mesh-list
19354176|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
19354177|NCT03706547|Fludarabine|fludarabine|mesh-list
19354178|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207304|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207305|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207306|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207307|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207308|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
20207309|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207310|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207311|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207312|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354179|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
19684886|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19684887|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
19684888|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19354180|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354181|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19354182|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19354183|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
19354184|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354185|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354186|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19354187|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
19354188|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19354189|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19354190|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354191|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
19354192|NCT03706339|Coagulants|coagulants|mesh-ancestor
19354193|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
19354194|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
19354195|NCT03706300|Ephedrine|ephedrine|mesh-list
19354196|NCT03706300|Guaifenesin|guaifenesin|mesh-list
19354197|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19354198|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19354199|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
19354200|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354201|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354202|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19354203|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
19354204|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
19354205|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19354206|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19354207|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
19354208|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354209|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354210|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354211|NCT03706300|Expectorants|expectorants|mesh-ancestor
19354212|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19354213|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19354214|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
19354215|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19354216|NCT03706287|Cisplatin|cisplatin|mesh-list
19354217|NCT03706287|Carboplatin|carboplatin|mesh-list
19354218|NCT03706287|Pemetrexed|pemetrexed|mesh-list
19354219|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684889|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684890|NCT05244954|Chloroquine|chloroquine|mesh-list
19684891|NCT05244954|Piperaquine|piperaquine|mesh-list
19684892|NCT05244954|Artenimol|artenimol|mesh-list
19684893|NCT05244954|Amebicides|amebicides|mesh-ancestor
19684894|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19684895|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19684896|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19684897|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
19684898|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19684899|NCT05244837|Paclitaxel|paclitaxel|mesh-list
19684900|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19684901|NCT05244837|Carboplatin|carboplatin|mesh-list
19684902|NCT05244837|Pemetrexed|pemetrexed|mesh-list
19684903|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19684904|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684905|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
19684906|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684907|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684908|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354220|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354221|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354222|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19354223|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19354224|NCT03706222|Grazoprevir|grazoprevir|mesh-list
19354225|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
19843977|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19843978|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19843979|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19843980|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
20207313|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
19684909|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19684910|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19684911|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19684912|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
19684913|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
19684914|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19684915|NCT05244811|Progestins|progestins|mesh-list
19684916|NCT05244811|Estradiol|estradiol|mesh-list
19354226|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354227|NCT03706157|Doxorubicin|doxorubicin|mesh-list
20207314|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
20207315|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20207316|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20207317|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20207318|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20207319|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207320|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
19354228|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19354229|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19354230|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354231|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19354232|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19354233|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354234|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401259|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19401260|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19401261|NCT03619824|Gemcitabine|gemcitabine|mesh-list
19401262|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401263|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19401264|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
19401265|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401266|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
19401267|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401268|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401269|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401270|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
19401271|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401272|NCT03619785|Acetaminophen|acetaminophen|mesh-list
19401273|NCT03619785|Ibuprofen|ibuprofen|mesh-list
19401274|NCT03619785|Ketorolac|ketorolac|mesh-list
19401275|NCT03619785|Fentanyl|fentanyl|mesh-list
19684917|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19684918|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684919|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19684920|NCT05244811|Hormones|hormones|mesh-ancestor
19684921|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19684922|NCT05244811|Estrogens|estrogens|mesh-ancestor
19684923|NCT05244798|Paclitaxel|paclitaxel|mesh-list
19684924|NCT05244798|Cisplatin|cisplatin|mesh-list
19684925|NCT05244798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19684926|NCT05244798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19684927|NCT05244798|Tubulin Modulators|tubulin modulators|mesh-ancestor
19684928|NCT05244798|Antimitotic Agents|antimitotic agents|mesh-ancestor
19684929|NCT05244798|Mitosis Modulators|mitosis modulators|mesh-ancestor
19684930|NCT05244798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684931|NCT05244694|Insulin|insulin|mesh-list
19684932|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19684933|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684934|NCT05244577|Olanzapine|olanzapine|mesh-list
19684935|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
19401276|NCT03619785|Ketamine|ketamine|mesh-list
19401277|NCT03619785|Morphine|morphine|mesh-list
19401278|NCT03619785|Gabapentin|gabapentin|mesh-list
19684936|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
19684937|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207321|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19354235|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
19354236|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
19354237|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19354238|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
19354239|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354240|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
19354241|NCT03705949|Protective Agents|protective agents|mesh-ancestor
19354242|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19354243|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19354244|NCT03705884|Prednisolone|prednisolone|mesh-list
19354245|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19354246|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
19354247|NCT03705884|Hormones|hormones|mesh-ancestor
19354248|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19354249|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354250|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19354251|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354252|NCT03705858|Lintuzumab|lintuzumab|mesh-list
19354253|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19684938|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684939|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684940|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19684941|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19684942|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354254|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354255|NCT03705780|Fentanyl|fentanyl|mesh-list
19354256|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19354257|NCT03705780|Narcotics|narcotics|mesh-ancestor
19354258|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354259|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354260|NCT03705780|Analgesics|analgesics|mesh-ancestor
19354261|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
19354262|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354263|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19354264|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19354265|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
19354266|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
19354267|NCT03705728|Remifentanil|remifentanil|mesh-list
19354268|NCT03705728|Propofol|propofol|mesh-list
19684943|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19684944|NCT05244577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19684945|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19684946|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19684947|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684948|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684949|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
19684950|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
19684951|NCT05244460|Promethazine|promethazine|mesh-list
19684952|NCT05244460|Droperidol|droperidol|mesh-list
19684953|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19684954|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19684955|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19684956|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684957|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
19684958|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
19684959|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
19684960|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19684961|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
20207322|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
20207323|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207324|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207325|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207326|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207327|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
20207328|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207329|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207330|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207331|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207332|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
20207333|NCT00274092|Ipratropium|ipratropium|mesh-list
20207334|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207335|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
20207336|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392003|NCT01082705|Artemether|artemether|mesh-list
19354269|NCT03705728|Sevoflurane|sevoflurane|mesh-list
19354270|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19354271|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354272|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354273|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19354274|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
19354275|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
19354276|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19354277|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19354278|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19354279|NCT03705728|Narcotics|narcotics|mesh-ancestor
19354280|NCT03705728|Analgesics|analgesics|mesh-ancestor
19354281|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
19354282|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354283|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
19354284|NCT03705559|Narcotics|narcotics|mesh-ancestor
19354285|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354286|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354287|NCT03705559|Analgesics|analgesics|mesh-ancestor
19354288|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
19354289|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354290|NCT03705533|Telmisartan|telmisartan|mesh-list
19354291|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19354292|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19354293|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19354294|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354295|NCT05177666|Trastuzumab|trastuzumab|mesh-list
19354296|NCT05177666|Pertuzumab|pertuzumab|mesh-list
19354297|NCT05177666|Vemurafenib|vemurafenib|mesh-list
19354298|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354299|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354300|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19684962|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
19684963|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19684964|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19684965|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
19684966|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
19684967|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19684968|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684969|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19684970|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
19843981|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19843982|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19843983|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
19843984|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843985|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19843986|NCT00661895|Protective Agents|protective agents|mesh-ancestor
19843987|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19843988|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19843989|NCT00661960|Efavirenz|efavirenz|mesh-list
19843990|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
19843991|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19843992|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19843993|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19843994|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19843995|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
19843996|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19843997|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19843998|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19843999|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19844000|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19844001|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19844002|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19844003|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20207337|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207338|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207339|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207340|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
20207341|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207342|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207343|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207344|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207345|NCT00274105|Telmisartan|telmisartan|mesh-list
20207346|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19354301|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844004|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19844005|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19354302|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354303|NCT05177601|Cycloserine|cycloserine|mesh-list
19354304|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19354305|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354306|NCT05177601|Renal Agents|renal agents|mesh-ancestor
19354307|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19354308|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
19354309|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19354310|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
19354311|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392004|NCT01082705|Piperaquine|piperaquine|mesh-list
20392005|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20392006|NCT01082705|Artenimol|artenimol|mesh-list
20392007|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
19354312|NCT05177588|Metformin|metformin|mesh-list
19354313|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19354314|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354315|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19354316|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
19354317|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354318|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19354319|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19354320|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
19354321|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354322|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354323|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19354324|NCT05177406|Erenumab|erenumab|mesh-list
19354325|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19354326|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354327|NCT05177406|Analgesics|analgesics|mesh-ancestor
19354328|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
19354329|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354330|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354331|NCT05177276|Irinotecan|irinotecan|mesh-list
19354332|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20207347|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20207348|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20207349|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207350|NCT00274118|Telmisartan|telmisartan|mesh-list
20207351|NCT00274118|Enalapril|enalapril|mesh-list
19354333|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19354334|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354335|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354336|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354337|NCT05177237|Endostar protein|endostar protein|mesh-list
19354338|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20207352|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19354339|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19354340|NCT05177237|Growth Substances|growth substances|mesh-ancestor
19844006|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20207353|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20207354|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20207355|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207356|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20207357|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
20207358|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207359|NCT00274131|Pramipexole|pramipexole|mesh-list
20207360|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
20207361|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207362|NCT00274131|Protective Agents|protective agents|mesh-ancestor
20207363|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207364|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20207365|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20207366|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
20207367|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
20207368|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207369|NCT00274144|Telmisartan|telmisartan|mesh-list
20207370|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207371|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20207372|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19354341|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354342|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
19354343|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354344|NCT05176821|Amoxicillin|amoxicillin|mesh-list
19354345|NCT05176821|Furazolidone|furazolidone|mesh-list
19844007|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
19844008|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
20392008|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19354346|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
19354347|NCT05176821|Esomeprazole|esomeprazole|mesh-list
19354348|NCT05176821|Bismuth|bismuth|mesh-list
19354349|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354350|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19354351|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354352|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19354353|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19354354|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19354355|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354356|NCT05176821|Antacids|antacids|mesh-ancestor
19354357|NCT05176821|Diuretics|diuretics|mesh-ancestor
19354358|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
19354359|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354360|NCT05176821|Expectorants|expectorants|mesh-ancestor
19354361|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
19354362|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19354363|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19354364|NCT05176821|Renal Agents|renal agents|mesh-ancestor
19354365|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19354366|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19354367|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19354368|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19354369|NCT05176626|Phentermine|phentermine|mesh-list
19354370|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19354371|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392009|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20392010|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354372|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
19354373|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19354374|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
19354375|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
19354376|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354377|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354378|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354379|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354380|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19354381|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
19354382|NCT05176548|Paraproteins|paraproteins|mesh-list
19354383|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
19354384|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354385|NCT05176288|Palbociclib|palbociclib|mesh-list
19354386|NCT05176288|Avelumab|avelumab|mesh-list
19354387|NCT05176288|Axitinib|axitinib|mesh-list
19354388|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354389|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19354390|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354391|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354392|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354393|NCT05176119|Ketamine|ketamine|mesh-list
20207373|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207374|NCT00274170|Octreotide|octreotide|mesh-list
20207375|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207376|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20207377|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207378|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
20207379|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
20207380|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20207381|NCT00274235|Mefloquine|mefloquine|mesh-list
20207382|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
20392011|NCT01082718|Artesunate|artesunate|mesh-list
19354394|NCT05176119|Nalbuphine|nalbuphine|mesh-list
19354395|NCT05176119|Analgesics|analgesics|mesh-ancestor
19354396|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
20392012|NCT01082718|Mefloquine|mefloquine|mesh-list
19354397|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354398|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354399|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19354400|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19844009|NCT00661999|Hematinics|hematinics|mesh-ancestor
20392013|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
19354401|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
19354402|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
19354403|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354404|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19354405|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19354406|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354407|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354408|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19354409|NCT05176119|Narcotics|narcotics|mesh-ancestor
19401279|NCT03619785|Hydromorphone|hydromorphone|mesh-list
19401280|NCT03619785|Hydrocodone|hydrocodone|mesh-list
19401281|NCT03619785|Bupivacaine|bupivacaine|mesh-list
19401282|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
19401283|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
19401284|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401285|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207383|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19401286|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
19401287|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401288|NCT03619785|Analgesics|analgesics|mesh-ancestor
19401289|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19401290|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19401291|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
19401292|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19401293|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19401294|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401295|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401296|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19401297|NCT03619785|Narcotics|narcotics|mesh-ancestor
19401298|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19401299|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401300|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
19401301|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20392014|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20392015|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20392016|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401302|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401303|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401304|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19401305|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401306|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
19401307|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20392017|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392018|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
20392019|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
20392020|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20392021|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
20207384|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20207385|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207386|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20207387|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207388|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207389|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20207390|NCT00274235|Renal Agents|renal agents|mesh-ancestor
20207391|NCT00274274|Insulin|insulin|mesh-list
20207392|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20207393|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
20207394|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
20207395|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20207396|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207397|NCT00274326|Satavaptan|satavaptan|mesh-list
20207398|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20207399|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207400|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
20207401|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207402|NCT00274339|Lansoprazole|lansoprazole|mesh-list
20207403|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20207404|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207405|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20207406|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392022|NCT01082731|Artesunate|artesunate|mesh-list
19401308|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19401309|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20207407|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207408|NCT00274352|Adalimumab|adalimumab|mesh-list
20392023|NCT01082731|Lumefantrine|lumefantrine|mesh-list
19354410|NCT05175703|Paclitaxel|paclitaxel|mesh-list
19354411|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19354412|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354413|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
19354414|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
19354415|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
19354416|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354417|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
19354418|NCT05175625|Paraproteins|paraproteins|mesh-list
19354419|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
19354420|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354421|NCT05175547|Clevidipine|clevidipine|mesh-list
19354422|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19354423|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354424|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354425|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19354426|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354427|NCT05175508|Azacitidine|azacitidine|mesh-list
19354428|NCT05175508|Tretinoin|tretinoin|mesh-list
19354429|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19354430|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
19354431|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354432|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354433|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354434|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
19354435|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
20392024|NCT01082731|Artemether|artemether|mesh-list
20392025|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20392026|NCT01082731|Mefloquine|mefloquine|mesh-list
20392027|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
20392028|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20392029|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20392030|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392031|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392032|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
20392033|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
20392034|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20392035|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
20392036|NCT01082744|Sufentanil|sufentanil|mesh-list
20392037|NCT01082744|Ropivacaine|ropivacaine|mesh-list
19354436|NCT05175430|Paroxetine|paroxetine|mesh-list
19354437|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19354438|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19354439|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19354440|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354441|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354442|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354443|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
19354444|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354445|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19354446|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
19354447|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19354448|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19354449|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19354450|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354451|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
19354452|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19354453|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19354454|NCT05175235|Nivolumab|nivolumab|mesh-list
19354455|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354456|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354457|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19354458|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354459|NCT05175131|Mebeverine|mebeverine|mesh-list
19354460|NCT05175131|Simethicone|simethicone|mesh-list
19354461|NCT05175131|Alverine|alverine|mesh-list
19354462|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
19354463|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354464|NCT05175131|Emollients|emollients|mesh-ancestor
19354465|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
19354466|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
19354467|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
19354468|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
20392038|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
19354469|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392039|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
19354470|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354471|NCT05175066|Bisoprolol|bisoprolol|mesh-list
19354472|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19354473|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
19354474|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
19354475|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354476|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354477|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19354478|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19354479|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19354480|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354481|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354482|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354483|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
19354484|NCT05175027|Povidone|povidone|mesh-list
19354485|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
19354486|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
19354487|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19354488|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354496|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
19354497|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
19354498|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354499|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
19354500|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19354501|NCT05173441|Antibodies|antibodies|mesh-list
19354502|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
19354503|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354504|NCT05170919|Olanzapine|olanzapine|mesh-list
19354505|NCT05170919|Mirtazapine|mirtazapine|mesh-list
19354506|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
19354507|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
19354508|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354509|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684971|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
19684972|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19684973|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19684974|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19684975|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19684976|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19684977|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19684978|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
19684979|NCT05244200|Insulin|insulin|mesh-list
19684980|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19684981|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19684982|NCT05244109|Antibodies|antibodies|mesh-list
19684983|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
19684984|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
19684985|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207409|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207410|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207411|NCT00274391|Amiloride|amiloride|mesh-list
20207412|NCT00274391|Diuretics|diuretics|mesh-ancestor
20207413|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
20207414|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207415|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20207416|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20207417|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20207418|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354510|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19354511|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19354512|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19354513|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354514|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19354515|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19354516|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19354517|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354518|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19684997|NCT05244057|Interferons|interferons|mesh-list
19684998|NCT05244057|Tenofovir|tenofovir|mesh-list
19684999|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
19685000|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
19685001|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19685002|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685003|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
19685004|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685005|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19685006|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19685007|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354519|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354520|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
19354521|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
19685008|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844010|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20392040|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392041|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844011|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19844012|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19844013|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844014|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
19844015|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19844016|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
19844017|NCT00662025|Capecitabine|capecitabine|mesh-list
20392042|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
20392043|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392044|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20392045|NCT01082744|Narcotics|narcotics|mesh-ancestor
19354522|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19354523|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
19354524|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
20392046|NCT01082744|Analgesics|analgesics|mesh-ancestor
20392047|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20392048|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20392049|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
20392050|NCT01082796|Glipizide|glipizide|mesh-list
20392051|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20392052|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392053|NCT01082809|Sunitinib|sunitinib|mesh-list
20392054|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354525|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19354526|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19354527|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19354528|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19354529|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354530|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19354531|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20392055|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20392056|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20392057|NCT01082809|Growth Substances|growth substances|mesh-ancestor
20392058|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392059|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
20392060|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20392061|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392062|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392063|NCT01082848|Aripiprazole|aripiprazole|mesh-list
20392064|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
20392065|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20392066|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19354532|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19354533|NCT05156684|Zinc|zinc|mesh-list
19354534|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
19354535|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
19354536|NCT05156684|Trace Elements|trace elements|mesh-ancestor
19354537|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
19354538|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354539|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19354540|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354541|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392067|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20392068|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354542|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20392069|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354543|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19685009|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19844018|NCT00662025|Sunitinib|sunitinib|mesh-list
20392070|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
19354544|NCT05156684|Protective Agents|protective agents|mesh-ancestor
19685010|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19685011|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
19685012|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844019|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844020|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
19354545|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
19354546|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19354547|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
20207419|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19354548|NCT05156684|Astringents|astringents|mesh-ancestor
19354549|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
19354550|NCT05155540|Plasminogen|plasminogen|mesh-list
19354551|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19354552|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19354553|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19354554|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354555|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
19354556|NCT05148637|Lidocaine|lidocaine|mesh-list
19354557|NCT05148637|Fentanyl|fentanyl|mesh-list
19354558|NCT05148637|Anesthetics|anesthetics|mesh-list
19354559|NCT05148637|Sevoflurane|sevoflurane|mesh-list
19354560|NCT05148637|Desflurane|desflurane|mesh-list
19354561|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
19354562|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354563|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354564|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
19354565|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354566|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19354567|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19354568|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19354569|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354570|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354571|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19354572|NCT05148637|Narcotics|narcotics|mesh-ancestor
19354573|NCT05148637|Analgesics|analgesics|mesh-ancestor
19354574|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19354575|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19354576|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
19354577|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19354578|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19354579|NCT05133310|Simvastatin|simvastatin|mesh-list
19354580|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19354581|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19685013|NCT05243862|Atezolizumab|atezolizumab|mesh-list
19685014|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685015|NCT05243797|Lenalidomide|lenalidomide|mesh-list
19354582|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
19354583|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354584|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19354585|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19354586|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354587|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
19354588|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19685016|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
19685017|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844021|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844022|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844023|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844024|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19844025|NCT00662025|Growth Substances|growth substances|mesh-ancestor
20207420|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20207421|NCT00274404|Valacyclovir|valacyclovir|mesh-list
20207422|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
20207423|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207424|NCT00274417|Dutasteride|dutasteride|mesh-list
20207425|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20207426|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19685018|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844026|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685019|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19354589|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
19354590|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685020|NCT05243797|Growth Substances|growth substances|mesh-ancestor
20207427|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354591|NCT05122559|Expectorants|expectorants|mesh-ancestor
19354592|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
19354593|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19354594|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
19354595|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392071|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
20392072|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392073|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392074|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20392075|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20392076|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
20392077|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20392078|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20392079|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20392080|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20392081|NCT01082926|Aldesleukin|aldesleukin|mesh-list
20392082|NCT01082926|Interleukin-2|interleukin-2|mesh-list
20392083|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354596|NCT05122559|Protective Agents|protective agents|mesh-ancestor
19354597|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354598|NCT05122559|Antidotes|antidotes|mesh-ancestor
19354599|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
19354600|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20392084|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19354601|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401310|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
19685021|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
19685022|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685023|NCT05243706|Loratadine|loratadine|mesh-list
19685024|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
19685025|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
19685026|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19685027|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19685028|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19685029|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
19685030|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
19685031|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392085|NCT01082926|Analgesics|analgesics|mesh-ancestor
20392086|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
20392087|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392088|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392089|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20392090|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20392091|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
20392092|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392093|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
20392094|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
20392095|NCT01083017|Diuretics|diuretics|mesh-ancestor
20392096|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
20392097|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392098|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20392099|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20392100|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392101|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
20392102|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392103|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
20392104|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392105|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20392106|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20392107|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20392108|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392109|NCT01083251|Vitamin D|vitamin d|mesh-list
20392110|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
20392111|NCT01083251|Vitamins|vitamins|mesh-list
20392112|NCT01083251|Entecavir|entecavir|mesh-list
20392113|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
20392114|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392115|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20392116|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20392117|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
20392118|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392119|NCT01083264|Gestodene|gestodene|mesh-list
20392120|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19401311|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
20392121|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20392122|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19844027|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
19685032|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685033|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685034|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19685035|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685036|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685037|NCT05243654|Metformin|metformin|mesh-list
19685038|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19685039|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685040|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
19685041|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685042|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
19685043|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685044|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19685045|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19685046|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
19685047|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685048|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392123|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
20392124|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19354602|NCT05095831|Pancrelipase|pancrelipase|mesh-list
19354603|NCT05095831|Pancreatin|pancreatin|mesh-list
19354604|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19354605|NCT05065801|Folfirinox|folfirinox|mesh-list
19354606|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354607|NCT05052307|Vaccines|vaccines|mesh-list
19354608|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
19354609|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354610|NCT05051436|Tadalafil|tadalafil|mesh-list
19354611|NCT05051436|Mirabegron|mirabegron|mesh-list
19354612|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
19354613|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20392125|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392126|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20392127|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20392128|NCT01083264|Progestins|progestins|mesh-ancestor
20392129|NCT01083264|Hormones|hormones|mesh-ancestor
20392130|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392131|NCT01083290|Spironolactone|spironolactone|mesh-list
20392132|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20392133|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
20392134|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392135|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392136|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20392137|NCT01083290|Diuretics|diuretics|mesh-ancestor
20392138|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
20392139|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
20392140|NCT01083329|Niacin|niacin|mesh-list
20392141|NCT01083329|Niacinamide|niacinamide|mesh-list
20392142|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
20392143|NCT01083329|Vitamins|vitamins|mesh-ancestor
20392144|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
20392145|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354614|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19354615|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354616|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354617|NCT05051436|Urological Agents|urological agents|mesh-ancestor
20392146|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19354618|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19354619|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19354620|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19354621|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354622|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354623|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354624|NCT05041842|Trastuzumab|trastuzumab|mesh-list
20392147|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
20392148|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354625|NCT05041842|Pertuzumab|pertuzumab|mesh-list
19354626|NCT05041842|Tucatinib|tucatinib|mesh-list
19354627|NCT05041842|Hormones|hormones|mesh-list
19354628|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354629|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354630|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19354631|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354632|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19685049|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19354633|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354634|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354635|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
19354636|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354637|NCT05035277|Aspirin|aspirin|mesh-list
19354638|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
19354639|NCT05035277|Apixaban|apixaban|mesh-list
19354640|NCT05035277|Edoxaban|edoxaban|mesh-list
19354641|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19354642|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
19354643|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19354644|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
19354645|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354646|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354647|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
20392149|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19354648|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19354649|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19354650|NCT05035277|Analgesics|analgesics|mesh-ancestor
19354651|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
20392150|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
20392151|NCT01083381|Risperidone|risperidone|mesh-list
20392152|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20392153|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
20392154|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392155|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354652|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354653|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354654|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19354655|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19354656|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19354657|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19354658|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19354659|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19354660|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
19354661|NCT05022147|Dopamine|dopamine|mesh-list
19354662|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
19354663|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19354664|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
19354665|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
19354666|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354667|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354668|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
19354669|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354670|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354671|NCT05022147|Protective Agents|protective agents|mesh-ancestor
19354672|NCT05003037|Carboplatin|carboplatin|mesh-list
19685050|NCT05243446|Losartan|losartan|mesh-list
19685051|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19685052|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19685053|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19685054|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19685055|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685056|NCT05243355|Endostatins|endostatins|mesh-list
19685057|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685058|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20207428|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207429|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
20207430|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207431|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207432|NCT00274430|Dexamethasone|dexamethasone|mesh-list
20207433|NCT00274430|Tadalafil|tadalafil|mesh-list
20207434|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207435|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
20207436|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
20207437|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685059|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19685060|NCT05243355|Growth Substances|growth substances|mesh-ancestor
19685061|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207438|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207439|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207440|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
20392156|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354673|NCT05003037|Pemetrexed|pemetrexed|mesh-list
20392157|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20392158|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20392159|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392160|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20392161|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20392162|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
19354674|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354675|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354676|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354677|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19354678|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19354679|NCT04996771|Cisplatin|cisplatin|mesh-list
19354680|NCT04996771|Etoposide|etoposide|mesh-list
19354681|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
19354682|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354683|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19354684|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19354685|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19354686|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354687|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354688|NCT04977232|Citalopram|citalopram|mesh-list
20392163|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
20392164|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19354689|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19354690|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19354691|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354692|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354693|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354694|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
19354695|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354696|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19354697|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
19354698|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19685062|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
19685063|NCT05243290|Niacinamide|niacinamide|mesh-list
19685064|NCT05243290|Niacin|niacin|mesh-list
19685065|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
19685066|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
19685067|NCT05243290|Vitamins|vitamins|mesh-ancestor
19685068|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
19844028|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19844029|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844030|NCT00662038|Pirfenidone|pirfenidone|mesh-list
19844031|NCT00662038|Analgesics|analgesics|mesh-ancestor
19844032|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
19844033|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844034|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354699|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
19354700|NCT04976790|Analgesics|analgesics|mesh-ancestor
19354701|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
19354702|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844035|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19844036|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844037|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20392165|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20392166|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392167|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
20392168|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
19354703|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354704|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19354705|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19354706|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19354707|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19354708|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19354709|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354710|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354711|NCT04973670|Sivelestat|sivelestat|mesh-list
19354712|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19354713|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
19354714|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354715|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685069|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685070|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392169|NCT01083420|Minocycline|minocycline|mesh-list
20392170|NCT01083420|Dexamethasone|dexamethasone|mesh-list
19685071|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
19685072|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354716|NCT04969198|Nicotine|nicotine|mesh-list
19354717|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20392171|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20392172|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
20392173|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
20392174|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392175|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392176|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20392177|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
20392178|NCT01083420|Hormones|hormones|mesh-ancestor
20392179|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392180|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20392181|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392182|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20207441|NCT00274430|Hormones|hormones|mesh-ancestor
20207442|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207443|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20207444|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207445|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
20207446|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20207447|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19354718|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
19354719|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354720|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354721|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19354722|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20392183|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392184|NCT01083537|Paclitaxel|paclitaxel|mesh-list
20392185|NCT01083537|Cisplatin|cisplatin|mesh-list
20392186|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20392187|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392188|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392189|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392190|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19354723|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
19354724|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354725|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354726|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19354727|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19354728|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19354729|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354730|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354731|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19354732|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354733|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354734|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
19354735|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354736|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
19354737|NCT04944368|Paraproteins|paraproteins|mesh-list
19354738|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
19354739|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354740|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
19354741|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19354742|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354743|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19354744|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
19354745|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19354746|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354747|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354748|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354749|NCT04911361|Dexamethasone|dexamethasone|mesh-list
19354750|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19354751|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
19354752|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
19354753|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354754|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354755|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207448|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207449|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207450|NCT00274430|Urological Agents|urological agents|mesh-ancestor
20207451|NCT00274443|Carboplatin|carboplatin|mesh-list
20207452|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19354756|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
19354757|NCT04911361|Hormones|hormones|mesh-ancestor
19354758|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19354759|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19354760|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354761|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19354762|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19354763|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392191|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392192|NCT01083589|Docetaxel|docetaxel|mesh-list
19354764|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
19354765|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
19354766|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354767|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354768|NCT04869371|Prednisone|prednisone|mesh-list
19354769|NCT04869371|Docetaxel|docetaxel|mesh-list
19354770|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20392193|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
20392194|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392195|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392196|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392197|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392198|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392199|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20392200|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392201|NCT01083784|Valproic Acid|valproic acid|mesh-list
20392202|NCT01083784|Clonazepam|clonazepam|mesh-list
20392203|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
20392204|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392205|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354771|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354772|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
19844038|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844039|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844040|NCT00662129|Gemcitabine|gemcitabine|mesh-list
19844041|NCT00662129|Paclitaxel|paclitaxel|mesh-list
19844042|NCT00662129|Bevacizumab|bevacizumab|mesh-list
19844043|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19844044|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19844045|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844046|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
19844047|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
19844048|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685073|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19685074|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
19685075|NCT05239533|Nivolumab|nivolumab|mesh-list
19685076|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19685077|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354773|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
19354774|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
19354775|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354776|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19354777|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
19354778|NCT04869371|Hormones|hormones|mesh-ancestor
19354779|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19685078|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685079|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19685080|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685081|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
19685082|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685083|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19685084|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685085|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685086|NCT05215691|Morphine|morphine|mesh-list
19685087|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19685088|NCT05215691|Narcotics|narcotics|mesh-ancestor
20392206|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
20392207|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392208|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392209|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
20392210|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19354780|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685089|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848242|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20392211|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612980|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20612981|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
19844049|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844050|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392212|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20392213|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
20392214|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
19844051|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19848243|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
20392215|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
19354781|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19354782|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
19354783|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19354784|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
19354785|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19354786|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19354787|NCT04763928|Decitabine|decitabine|mesh-list
19354788|NCT04763928|Venetoclax|venetoclax|mesh-list
19354789|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19354790|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
19354791|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354792|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354793|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401312|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
19401313|NCT03619538|Nefopam|nefopam|mesh-list
19401314|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401315|NCT03619538|Analgesics|analgesics|mesh-ancestor
19401316|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
19401317|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401318|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401319|NCT03619408|Antacids|antacids|mesh-list
19401320|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401321|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19401322|NCT03619330|Liraglutide|liraglutide|mesh-list
19401323|NCT03619330|Testosterone|testosterone|mesh-list
19401324|NCT03619330|Androgens|androgens|mesh-ancestor
19401325|NCT03619330|Hormones|hormones|mesh-ancestor
19401326|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401327|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401328|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19401329|NCT03619330|Incretins|incretins|mesh-ancestor
19685090|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685091|NCT05215691|Analgesics|analgesics|mesh-ancestor
19685092|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
19685093|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401330|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19401331|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19685094|NCT05213650|Methamphetamine|methamphetamine|mesh-list
19685095|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19685096|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685097|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
19685098|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
19685099|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685100|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
19685101|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207453|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207454|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
20207455|NCT00274495|Ribavirin|ribavirin|mesh-list
19685102|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685103|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19685104|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20207456|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20207457|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
20207458|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207459|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
20207460|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207461|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20207462|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207463|NCT00274508|Bromides|bromides|mesh-list
20207464|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
20207465|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207466|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
20392216|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19401332|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
20207467|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392217|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392218|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354794|NCT04749108|Folfirinox|folfirinox|mesh-list
19354795|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354796|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
19354797|NCT04748224|Bupivacaine|bupivacaine|mesh-list
19354798|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
19354799|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
19354800|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354801|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354802|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
19354803|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354804|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19354805|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19354806|NCT04748224|Analgesics|analgesics|mesh-ancestor
19354807|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20207468|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354808|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19354809|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19354810|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354811|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354812|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354813|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19354814|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19354815|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354816|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207469|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207470|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207471|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
20207472|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19354817|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
19354818|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354819|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19354820|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354821|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685105|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19685106|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19685107|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19685108|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
20207473|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19354822|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
19354823|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19354824|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354825|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19354826|NCT04724668|Melatonin|melatonin|mesh-list
19354827|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
19354828|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354829|NCT04724668|Protective Agents|protective agents|mesh-ancestor
19354830|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685109|NCT05201612|Olaparib|olaparib|mesh-list
19354831|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354832|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
19354833|NCT04722848|Blinatumomab|blinatumomab|mesh-list
19354834|NCT04722848|Ponatinib|ponatinib|mesh-list
19354835|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354836|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19685110|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685111|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685112|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19844052|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20207474|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207475|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207476|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
20207477|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
20207478|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207479|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
20207480|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207481|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207482|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207483|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
20392219|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19685113|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207484|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
20207485|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19354837|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354838|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354839|NCT04682860|Scopolamine|scopolamine|mesh-list
19354840|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19354841|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19354842|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
19354843|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
19354844|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354845|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354846|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19354847|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
19354848|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19354849|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
19354850|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354851|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354852|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20392220|NCT01083797|Analgesics|analgesics|mesh-ancestor
20392221|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
20392222|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392223|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20392224|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20392225|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20392226|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
20392227|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392228|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354853|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
20207486|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
19354855|NCT04666636|Mirabegron|mirabegron|mesh-list
19354856|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19354857|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19354858|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19354859|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
19354860|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354861|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354862|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354863|NCT04666636|Urological Agents|urological agents|mesh-ancestor
19354864|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
19354865|NCT04664946|Protective Agents|protective agents|mesh-ancestor
19354866|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354867|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
19354868|NCT04664933|Protective Agents|protective agents|mesh-ancestor
19354869|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354870|NCT04621500|Vitamin D|vitamin d|mesh-list
19354871|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
19354872|NCT04621500|Vitamins|vitamins|mesh-ancestor
19354873|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
19354874|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354875|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19354876|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19354877|NCT04613453|Midazolam|midazolam|mesh-list
19354878|NCT04613453|Ketamine|ketamine|mesh-list
19354879|NCT04613453|Analgesics|analgesics|mesh-ancestor
19354880|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
19354881|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19354882|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354883|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19354884|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19354885|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
19354886|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
19354887|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19354888|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19354889|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19685114|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685115|NCT05200052|Colchicine|colchicine|mesh-list
19685116|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
20207487|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207488|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207489|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
20207490|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20207491|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19354890|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19685117|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844053|NCT00662129|Growth Substances|growth substances|mesh-ancestor
19685118|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685119|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685120|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685121|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685122|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685123|NCT05196945|Amoxicillin|amoxicillin|mesh-list
19685124|NCT05196945|Clarithromycin|clarithromycin|mesh-list
19685125|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
19685126|NCT05196945|Esomeprazole|esomeprazole|mesh-list
19685127|NCT05196945|Bismuth|bismuth|mesh-list
19844054|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844055|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
19354891|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354892|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19354893|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19354894|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19354895|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19844056|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844057|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
19844058|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
19844059|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207492|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
20207493|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207494|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354896|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19354897|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
19354898|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
19354899|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
20207495|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19354900|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354901|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354902|NCT04602507|Ivermectin|ivermectin|mesh-list
19354903|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19354904|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19354905|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
19354906|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19354907|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19354908|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19354909|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354910|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354911|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
19354912|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354913|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354914|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19354915|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685128|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685129|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19685130|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685131|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19685132|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844060|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844061|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844062|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
19844063|NCT00662155|Zolpidem|zolpidem|mesh-list
19844064|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20207496|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
19354916|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19354917|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19354918|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685133|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19844065|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19844066|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844067|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844068|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19844069|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
19844070|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
19844071|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844072|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844073|NCT00662259|Alprazolam|alprazolam|mesh-list
19844074|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19844075|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844076|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844077|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20207497|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
19844078|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19685134|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685135|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19685136|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19685137|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19685138|NCT05196945|Antacids|antacids|mesh-ancestor
19685139|NCT05196945|Diuretics|diuretics|mesh-ancestor
19685140|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
19685141|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685142|NCT05196945|Expectorants|expectorants|mesh-ancestor
19685143|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
19685144|NCT05183126|Paclitaxel|paclitaxel|mesh-list
19685145|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19685146|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685147|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685148|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685149|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685150|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685151|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685152|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
19685153|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19685154|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
19685155|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
19685156|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685157|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685158|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19685159|NCT05167331|Analgesics|analgesics|mesh-ancestor
19685160|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
19685161|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685162|NCT05160597|Edetic Acid|edetic acid|mesh-list
19685163|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19685164|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
19685165|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
19685166|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685167|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
19685168|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19685169|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19685170|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
19844079|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844080|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
19844081|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
19844082|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392229|NCT01083875|Amlexanox|amlexanox|mesh-list
20392230|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19354919|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354920|NCT04552197|Tofacitinib|tofacitinib|mesh-list
19354921|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20392231|NCT01083953|Sevoflurane|sevoflurane|mesh-list
20392232|NCT01083953|Desflurane|desflurane|mesh-list
20392233|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20392234|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20392235|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
20392236|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
20392237|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392238|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685171|NCT05155007|Cyclosporine|cyclosporine|mesh-list
19685172|NCT05155007|Cyclosporins|cyclosporins|mesh-list
19685173|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685174|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685175|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844083|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844084|NCT00662298|Prednisolone|prednisolone|mesh-list
19844085|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207498|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207499|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207500|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207501|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207502|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20207503|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20207504|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20207505|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207506|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
19685176|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
19685177|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844086|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
19844087|NCT00662298|Hormones|hormones|mesh-ancestor
20392239|NCT01083966|Bevacizumab|bevacizumab|mesh-list
20392240|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392241|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392242|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20392243|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20392244|NCT01083966|Growth Substances|growth substances|mesh-ancestor
20392245|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354922|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354923|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354924|NCT04537793|Ivacaftor|ivacaftor|mesh-list
19354925|NCT04537793|Elexacaftor|elexacaftor|mesh-list
19354926|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19354927|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19354928|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354929|NCT04533568|Ibuprofen|ibuprofen|mesh-list
19354930|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19354931|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19354932|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19354933|NCT04533568|Analgesics|analgesics|mesh-ancestor
19354934|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
19354935|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392246|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
20392247|NCT01083992|Vitamin D|vitamin d|mesh-list
20392248|NCT01083992|Vildagliptin|vildagliptin|mesh-list
20392249|NCT01083992|Vitamins|vitamins|mesh-ancestor
20392250|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
20392251|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392252|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20392253|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20392254|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20392255|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
20392256|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392257|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392258|NCT01084031|Propofol|propofol|mesh-list
20392259|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20392260|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392261|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392262|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20392263|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
20392264|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
20392265|NCT01084044|Urinastatin|urinastatin|mesh-list
20392266|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20392267|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20392268|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
20392269|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392270|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392271|NCT01084057|Vorinostat|vorinostat|mesh-list
20392272|NCT01084057|Epothilone B|epothilone b|mesh-list
20392273|NCT01084057|Epothilones|epothilones|mesh-list
20392274|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392275|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20392276|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392277|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392278|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392279|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392280|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392281|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19354936|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685178|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
19685179|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685180|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
19685181|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19685182|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19685183|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19685184|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
19685185|NCT05129475|Ritonavir|ritonavir|mesh-list
19685186|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19685187|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19685188|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
19685189|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685190|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685191|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19685192|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19685193|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
19848244|NCT00691704|Hormones|hormones|mesh-ancestor
20392282|NCT01084122|Hematinics|hematinics|mesh-ancestor
20392283|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19844088|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844089|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844090|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19844091|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844092|NCT00662311|Paclitaxel|paclitaxel|mesh-list
19844093|NCT00662311|Vorinostat|vorinostat|mesh-list
19844094|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19844095|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392284|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
20392285|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20392286|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19844096|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
19844097|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
19844098|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
19844099|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844100|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19844101|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844102|NCT00662363|Lubiprostone|lubiprostone|mesh-list
19844103|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19844104|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844105|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844106|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19844107|NCT00662532|Minocycline|minocycline|mesh-list
19844108|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844109|NCT00662545|Tenofovir|tenofovir|mesh-list
20392287|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354937|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19354938|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19354939|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19354940|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354941|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354942|NCT04511078|Panitumumab|panitumumab|mesh-list
19354943|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354944|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354945|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
19354946|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19354947|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19354948|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354949|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19354950|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
19354951|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844110|NCT00662545|Lamivudine|lamivudine|mesh-list
19844111|NCT00662545|Emtricitabine|emtricitabine|mesh-list
20392288|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392289|NCT01084187|Urological Agents|urological agents|mesh-ancestor
20392290|NCT01084200|Propofol|propofol|mesh-list
20392291|NCT01084200|Sevoflurane|sevoflurane|mesh-list
20392292|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20392293|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844112|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19354955|NCT04507373|Simvastatin|simvastatin|mesh-list
19354956|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19354957|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19354958|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
19354959|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354960|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19354961|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19685194|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685195|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19685196|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19685197|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
19685198|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685199|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354962|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354963|NCT04501653|Methylphenidate|methylphenidate|mesh-list
19354964|NCT04501653|Psilocybin|psilocybin|mesh-list
19354965|NCT04501653|Psilocin|psilocin|mesh-list
19354966|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19685200|NCT05083845|Anesthetics|anesthetics|mesh-list
19685201|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
19844113|NCT00662545|Entecavir|entecavir|mesh-list
20392294|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392295|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20392296|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
20392297|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
19354967|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354968|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19354969|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19354970|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20392298|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20392299|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20392300|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20392301|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
20392302|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20392303|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19354971|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354972|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
19354973|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19354974|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
19354975|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19354976|NCT04481009|Gemcitabine|gemcitabine|mesh-list
19354977|NCT04481009|Paclitaxel|paclitaxel|mesh-list
19354978|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19354979|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354980|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
19844114|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19844115|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
19844116|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844117|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19844118|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19354981|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
19354982|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
19354983|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354984|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19354985|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
19354986|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
19354987|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685202|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685203|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685204|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
19685205|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685206|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
19685207|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685208|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685209|NCT04954287|Vaccines|vaccines|mesh-list
19685210|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
19685211|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685212|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
19685213|NCT04938765|Analgesics|analgesics|mesh-ancestor
19685214|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
19685215|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392304|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392305|NCT01084291|Vaccines|vaccines|mesh-list
20392306|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
20392307|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392308|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
20392309|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19685216|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685217|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
19844119|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207507|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207508|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
20207509|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207510|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207511|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207512|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207513|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
20207514|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207515|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207516|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207517|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207518|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
20207519|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19354988|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685218|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392310|NCT01084369|Testosterone|testosterone|mesh-list
20392311|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
20392312|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
20392313|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20392314|NCT01084369|Androgens|androgens|mesh-ancestor
19685219|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19685220|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
19685221|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19685222|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19685223|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685224|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19685225|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
19685226|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19685227|NCT04920344|Cisplatin|cisplatin|mesh-list
19685228|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685229|NCT04912115|Midazolam|midazolam|mesh-list
19685230|NCT04912115|Ketamine|ketamine|mesh-list
19685231|NCT04912115|Analgesics|analgesics|mesh-ancestor
19685232|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
19354989|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19354990|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
19354991|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19354992|NCT04475731|Ponatinib|ponatinib|mesh-list
19354993|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19354994|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19354995|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19354996|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19354997|NCT04469491|Interferons|interferons|mesh-list
19354998|NCT04469491|Interferon Type I|interferon type i|mesh-list
19354999|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355000|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
19355001|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355002|NCT04398524|Cemiplimab|cemiplimab|mesh-list
19355003|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355004|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355005|NCT04397354|Dexamethasone|dexamethasone|mesh-list
19355006|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
19355007|NCT04397354|BB 1101|bb 1101|mesh-list
19355008|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355009|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
19355010|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
19685233|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685234|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685235|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19685236|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19685237|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
19685238|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
19685239|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685240|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19685241|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19685242|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19685243|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355011|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355012|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685244|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20392315|NCT01084369|Hormones|hormones|mesh-ancestor
20392316|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392317|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392318|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20392319|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392320|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
20392321|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
20392322|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20392323|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20392324|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392325|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392326|NCT01084369|Urological Agents|urological agents|mesh-ancestor
20392327|NCT01084408|Paclitaxel|paclitaxel|mesh-list
20392328|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19685245|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19685246|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20392329|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355013|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20392330|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355014|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
19355015|NCT04397354|Hormones|hormones|mesh-ancestor
20392331|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392332|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392333|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392334|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392335|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
20392336|NCT01084473|Morphine|morphine|mesh-list
20392337|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20392338|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392339|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392340|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20392341|NCT01084473|Analgesics|analgesics|mesh-ancestor
20392342|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
20392343|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392344|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20392345|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20392346|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20392347|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
20392348|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392349|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392350|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20392351|NCT01084473|Narcotics|narcotics|mesh-ancestor
20392352|NCT01084486|Metformin|metformin|mesh-list
20392353|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20392354|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392355|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20392356|NCT01084577|Laxatives|laxatives|mesh-ancestor
20392357|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426579|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20426580|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20426581|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355016|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207520|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207521|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
20207522|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207523|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207524|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207525|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207526|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
19355017|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355018|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355019|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
19355020|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355021|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355022|NCT04394481|Dexamethasone|dexamethasone|mesh-list
20207527|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19355023|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
19355024|NCT04394481|Ropivacaine|ropivacaine|mesh-list
20426582|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426583|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426584|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20426585|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20426586|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20426587|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
20426588|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19355025|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355026|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
19355027|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
19355028|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355029|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355030|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355031|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
19355032|NCT04394481|Hormones|hormones|mesh-ancestor
19355033|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355034|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355035|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355036|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19355037|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355038|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19355039|NCT04394481|Analgesics|analgesics|mesh-ancestor
19355040|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
19355041|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19355042|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20207528|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
20612982|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355043|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19355044|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
19355045|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355046|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355047|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
19355048|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
19355049|NCT04370847|Ephedrine|ephedrine|mesh-list
19355050|NCT04370847|Fentanyl|fentanyl|mesh-list
19355051|NCT04370847|Bupivacaine|bupivacaine|mesh-list
19355052|NCT04370847|Oxytocin|oxytocin|mesh-list
19355053|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
19355054|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
19355055|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355056|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355057|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
19355058|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355059|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19355060|NCT04370847|Narcotics|narcotics|mesh-ancestor
19685247|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19685248|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19685249|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
19685250|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
19685251|NCT04905693|Treprostinil|treprostinil|mesh-list
19685252|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19355061|NCT04370847|Analgesics|analgesics|mesh-ancestor
19355062|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19355063|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19355064|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
19355065|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
19355066|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19355067|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19355068|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
19355069|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
19355070|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19355071|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
19355072|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355073|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401333|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401334|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401335|NCT03619057|Anesthetics|anesthetics|mesh-list
19401336|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401337|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401338|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19401339|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19401340|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
19401341|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392358|NCT01084720|V0034CR|v0034cr|mesh-list
20392359|NCT01084720|Emollients|emollients|mesh-ancestor
20392360|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
20392361|NCT01084824|Cantharidin|cantharidin|mesh-list
20392362|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401342|NCT03618953|Atezolizumab|atezolizumab|mesh-list
19401343|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401344|NCT03618797|Fenofibrate|fenofibrate|mesh-list
20392363|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392364|NCT01084837|Bortezomib|bortezomib|mesh-list
20392365|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392366|NCT01084863|Paclitaxel|paclitaxel|mesh-list
20392367|NCT01084863|Trastuzumab|trastuzumab|mesh-list
20392368|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20392369|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392370|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392371|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392372|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392373|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392374|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392375|NCT01084876|Paclitaxel|paclitaxel|mesh-list
20392376|NCT01084876|Trastuzumab|trastuzumab|mesh-list
20392377|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19401345|NCT03618797|Pitavastatin|pitavastatin|mesh-list
19401346|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392378|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401347|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
19404827|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685253|NCT04902625|Naltrexone|naltrexone|mesh-list
19685254|NCT04902625|Bupropion|bupropion|mesh-list
19685255|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19685256|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20392379|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
19844120|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844121|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19844122|NCT00662558|Celecoxib|celecoxib|mesh-list
19844123|NCT00662558|Tramadol|tramadol|mesh-list
19844124|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19844125|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844126|NCT00662558|Analgesics|analgesics|mesh-ancestor
19844127|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
19844128|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844129|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207529|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207530|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207531|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20207532|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20207533|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20207534|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
20207535|NCT00274573|Bromides|bromides|mesh-list
20207536|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
20392380|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392381|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392382|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392383|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392384|NCT01084902|Latanoprost|latanoprost|mesh-list
20392385|NCT01084902|Brinzolamide|brinzolamide|mesh-list
20392386|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20392387|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20392388|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20392389|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392390|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392391|NCT01084980|Tacrolimus|tacrolimus|mesh-list
20392392|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20392393|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
20392394|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392395|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20392396|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355074|NCT04356430|Prednisone|prednisone|mesh-list
19355075|NCT04356430|Goserelin|goserelin|mesh-list
19355076|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
19355077|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355078|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
19355079|NCT04356430|Hormones|hormones|mesh-ancestor
19355080|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355081|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355082|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355083|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355084|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19355085|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355086|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355087|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
19355088|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19355089|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
19355090|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
19355091|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19355092|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19355093|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355094|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355095|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355096|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355097|NCT05310344|Paclitaxel|paclitaxel|mesh-list
19355098|NCT05310344|Bevacizumab|bevacizumab|mesh-list
19355099|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19685257|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685258|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
19685259|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685260|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19685261|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
19685262|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19685263|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19685264|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19685265|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19685266|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685267|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
19685268|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355100|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355101|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355102|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355103|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
19355104|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355105|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355106|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355107|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19355108|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20392397|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392398|NCT01084993|Heparin|heparin|mesh-list
20392399|NCT01084993|Bivalirudin|bivalirudin|mesh-list
20392400|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
20392401|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20392402|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20392403|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392404|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
20392405|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20392406|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
20392407|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392408|NCT01085032|Nicotine|nicotine|mesh-list
20392409|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20392410|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
20392411|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392412|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392413|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20392414|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20392415|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
20392416|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392417|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392418|NCT01085058|Lenograstim|lenograstim|mesh-list
20392419|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20392420|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
20392421|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392422|NCT01085149|Simvastatin|simvastatin|mesh-list
20392423|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20392424|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392425|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
19355109|NCT05310344|Growth Substances|growth substances|mesh-ancestor
19355110|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355111|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
19355112|NCT05310331|Paclitaxel|paclitaxel|mesh-list
19355113|NCT05310331|Antibodies|antibodies|mesh-list
19355114|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355115|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355116|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355117|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
19355118|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355119|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355120|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
19355121|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355122|NCT05310305|Antibodies|antibodies|mesh-list
19355123|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
19355124|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355125|NCT05309928|Amoxicillin|amoxicillin|mesh-list
19355126|NCT05309928|Probenecid|probenecid|mesh-list
19355127|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19355128|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355129|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
19355130|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
19355131|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355132|NCT05309928|Renal Agents|renal agents|mesh-ancestor
19355133|NCT05309785|Canagliflozin|canagliflozin|mesh-list
19355134|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19355135|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355136|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19355137|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355138|NCT05309694|Copper|copper|mesh-list
19355139|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
19355140|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19355141|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355142|NCT05309694|Trace Elements|trace elements|mesh-ancestor
19355143|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
19355144|NCT05309629|Carboplatin|carboplatin|mesh-list
19685269|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19355145|NCT05309629|Etoposide|etoposide|mesh-list
19355146|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355147|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355148|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19355149|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19355150|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355151|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355152|NCT05309616|Ixekizumab|ixekizumab|mesh-list
19355153|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
19355154|NCT05309538|Betahistine|betahistine|mesh-list
19685270|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19685271|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685272|NCT04860713|Aspirin|aspirin|mesh-list
19685273|NCT04860713|Ketamine|ketamine|mesh-list
19355155|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
19355156|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
19355157|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
19355158|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355159|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355160|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355161|NCT05309460|Labetalol|labetalol|mesh-list
19355162|NCT05309460|Nifedipine|nifedipine|mesh-list
19355163|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19355164|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19355165|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355166|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19355167|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355168|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
19355169|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
20392426|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392427|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20392428|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20392429|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392430|NCT01085383|Aripiprazole|aripiprazole|mesh-list
20392431|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
20392432|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20392433|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20392434|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20392435|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392436|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392437|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
20392438|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
20392439|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844130|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844131|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844132|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19685274|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19685275|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19685276|NCT04860713|Analgesics|analgesics|mesh-ancestor
20392440|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392441|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20392442|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20392443|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
20392444|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20392445|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19355170|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19355171|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19355172|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19844133|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19844134|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844135|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844136|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19844137|NCT00662558|Narcotics|narcotics|mesh-ancestor
19355173|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
19355174|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355175|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19685277|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
19685278|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685279|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685280|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19685281|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19685282|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19844138|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392446|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19355176|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
19355177|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
19355178|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355179|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19355180|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19844139|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19355181|NCT05309304|Cefazolin|cefazolin|mesh-list
19355182|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19355183|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355184|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
19355185|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355186|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355187|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
19355188|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19355189|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
19355190|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355191|NCT05309070|Expectorants|expectorants|mesh-ancestor
19355192|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
19355193|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19355194|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
19355195|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355196|NCT05309070|Protective Agents|protective agents|mesh-ancestor
19355197|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355198|NCT05309070|Antidotes|antidotes|mesh-ancestor
19355199|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19355200|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19355201|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355202|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19355203|NCT05308849|beta-Lactams|beta-lactams|mesh-list
19355204|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401348|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401349|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19401350|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19401351|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19401352|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685283|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20207537|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20207538|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
20207539|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207540|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207541|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19685284|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685285|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19685286|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19685287|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685288|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
19685289|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19685290|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19685291|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
19844140|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19844141|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207542|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
20207543|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
20207544|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20207545|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
20207546|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207547|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207548|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
20207549|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20207550|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20207551|NCT00274599|Telmisartan|telmisartan|mesh-list
20207552|NCT00274599|Ramipril|ramipril|mesh-list
20207553|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207554|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20207555|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19844142|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844143|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
19844144|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844145|NCT00662675|Pancrelipase|pancrelipase|mesh-list
19844146|NCT00662675|Pancreatin|pancreatin|mesh-list
20392447|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20392448|NCT01085422|Temozolomide|temozolomide|mesh-list
20392449|NCT01085422|Veliparib|veliparib|mesh-list
20392450|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20392451|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
19355205|NCT05308628|Complement C3|complement c3|mesh-list
19355206|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
19355207|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355208|NCT05308602|Vaccines|vaccines|mesh-list
19355209|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
19355210|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355211|NCT05308576|Vaccines|vaccines|mesh-list
19844147|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844148|NCT00662818|Acetaminophen|acetaminophen|mesh-list
19844149|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844150|NCT00662818|Analgesics|analgesics|mesh-ancestor
20392452|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355212|NCT05308576|Immunologic Factors|immunologic factors|mesh-ancestor
19355213|NCT05308576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355214|NCT05308342|Hormones|hormones|mesh-list
19355215|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355216|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355217|NCT05308212|Vaccines|vaccines|mesh-list
19355218|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
19355219|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355220|NCT05306899|Ketamine|ketamine|mesh-list
19355221|NCT05306899|Analgesics|analgesics|mesh-ancestor
19355222|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
19355223|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355224|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355225|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19355226|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19355227|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
19355228|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
19355229|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355230|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19355231|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19685292|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
19685293|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685294|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19685295|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19685296|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692708|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692709|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692710|NCT04988776|Bupivacaine|bupivacaine|mesh-list
19692711|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
20392453|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355232|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355233|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355234|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19355235|NCT05303324|Choline|choline|mesh-list
19355236|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
19355237|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19355238|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
19355239|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355240|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355241|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19355242|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
19355243|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
19355244|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
19355245|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355246|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19355247|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19355248|NCT05303324|Growth Substances|growth substances|mesh-ancestor
19355249|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355250|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
19355251|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355252|NCT05294172|Gemcitabine|gemcitabine|mesh-list
19355253|NCT05294172|Cisplatin|cisplatin|mesh-list
19355254|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355255|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19355256|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
19355257|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355258|NCT05294172|Antiviral Agents|antiviral agents|mesh-ancestor
19692712|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
19692713|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844151|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
20428631|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355259|NCT05294172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355260|NCT05294172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355261|NCT05294172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19355262|NCT05294172|Immunologic Factors|immunologic factors|mesh-ancestor
19355263|NCT05294172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355264|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
19844152|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844153|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844154|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
19844155|NCT00662831|Dalteparin|dalteparin|mesh-list
19844156|NCT00662831|Tinzaparin|tinzaparin|mesh-list
19355265|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
19355266|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
19355267|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19355268|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
19355269|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355270|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
19355271|NCT05291650|Protective Agents|protective agents|mesh-ancestor
19355272|NCT05291650|Hormones|hormones|mesh-ancestor
19355273|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355274|NCT05288361|Acetylcholine|acetylcholine|mesh-list
19355275|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
19355276|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19844157|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19844158|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
19844159|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19355277|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
19355278|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355279|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355280|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355281|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
19355282|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19355283|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355284|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355285|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19355286|NCT05283083|Analgesics|analgesics|mesh-ancestor
19355287|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
19355288|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355289|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19355290|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19355291|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19355292|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
19355293|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355294|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685297|NCT04799015|Dexamethasone|dexamethasone|mesh-list
19685298|NCT04799015|Metoclopramide|metoclopramide|mesh-list
20207556|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207557|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20207558|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
20207559|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207560|NCT00274612|Telmisartan|telmisartan|mesh-list
19685299|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19685300|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
19685301|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
19685302|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685303|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685304|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19685305|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
19685306|NCT04799015|Hormones|hormones|mesh-ancestor
19685307|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19685308|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19685309|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685310|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19685311|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19685312|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
19844160|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19844161|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844162|NCT00662857|Insulin|insulin|mesh-list
20207561|NCT00274612|Ramipril|ramipril|mesh-list
20207562|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20207563|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20207564|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20207565|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217821|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
19355295|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
19355296|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19355297|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19355298|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19355299|NCT05282940|Estradiol|estradiol|mesh-list
19355300|NCT05282940|Estrogens|estrogens|mesh-ancestor
19355301|NCT05282940|Hormones|hormones|mesh-ancestor
19355302|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355303|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355304|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19355305|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
19355306|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19355307|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19355308|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19355309|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19355310|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19355311|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19355312|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19355313|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19355314|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19355315|NCT05278676|Dotinurad|dotinurad|mesh-list
19355316|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
19355317|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
19685313|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19685314|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685315|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
19685316|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
19685317|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19685318|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685319|NCT04713657|Propranolol|propranolol|mesh-list
19685320|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19685321|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19685322|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
19685323|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19685324|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685325|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685326|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19355318|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355319|NCT05278676|Renal Agents|renal agents|mesh-ancestor
19355320|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
19355321|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355322|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355323|NCT05275569|Antiemetics|antiemetics|mesh-list
19355324|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
19355325|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355326|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355327|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355328|NCT05255653|Paclitaxel|paclitaxel|mesh-list
19355329|NCT05255653|Cisplatin|cisplatin|mesh-list
19355330|NCT05255653|Carboplatin|carboplatin|mesh-list
19355331|NCT05255653|Durvalumab|durvalumab|mesh-list
19355332|NCT05255653|Olaparib|olaparib|mesh-list
19355333|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19355334|NCT05255653|Megestrol|megestrol|mesh-list
19355335|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
19355336|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
19355337|NCT05255653|Progestins|progestins|mesh-list
19355338|NCT05255653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355339|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355340|NCT05255653|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355341|NCT05255653|Antimitotic Agents|antimitotic agents|mesh-ancestor
19355342|NCT05255653|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355343|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685327|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19685328|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
19685329|NCT04701593|Triamcinolone|triamcinolone|mesh-list
19685330|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19685331|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19685332|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19685333|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19685334|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
20207566|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19355344|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355345|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19355346|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392454|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20392455|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392456|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
20392457|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
20392458|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20392459|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
20392460|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20392461|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392462|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20392463|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20392464|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20392465|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20392466|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392467|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
20392468|NCT01085487|Coagulants|coagulants|mesh-ancestor
20392469|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
20392470|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392471|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
20392472|NCT01085552|Hematinics|hematinics|mesh-ancestor
20392473|NCT01085617|Cytarabine|cytarabine|mesh-list
20392474|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
20392475|NCT01085617|Melphalan|melphalan|mesh-list
20392476|NCT01085617|Rituximab|rituximab|mesh-list
20392477|NCT01085617|Methotrexate|methotrexate|mesh-list
20392478|NCT01085617|Fludarabine|fludarabine|mesh-list
20392479|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
20392480|NCT01085617|Etoposide|etoposide|mesh-list
20392481|NCT01085617|Vincristine|vincristine|mesh-list
20392482|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
20392483|NCT01085617|Daunorubicin|daunorubicin|mesh-list
20392484|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
20392485|NCT01085617|Pegaspargase|pegaspargase|mesh-list
20392486|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20392487|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
20392488|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355347|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19685335|NCT04701593|Hormones|hormones|mesh-ancestor
19685336|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19685337|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685338|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685339|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
19685340|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685341|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685342|NCT04611529|Ibuprofen|ibuprofen|mesh-list
19685343|NCT04611529|Diclofenac|diclofenac|mesh-list
19685344|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19685345|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19685346|NCT04611529|Analgesics|analgesics|mesh-ancestor
19685347|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
19685348|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685349|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355348|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19355349|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19355350|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
19355351|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19355352|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355353|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19355354|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19355355|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19355356|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355357|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
19355358|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19355359|NCT05255653|Hormones|hormones|mesh-ancestor
19844163|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20207567|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
20207568|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207569|NCT00274638|Losartan|losartan|mesh-list
20207570|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20207571|NCT00274638|Telmisartan|telmisartan|mesh-list
20207572|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20207573|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20392489|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207574|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20392490|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20392491|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
20392492|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392493|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355360|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355361|NCT05254847|Capecitabine|capecitabine|mesh-list
19355362|NCT05254847|Lenvatinib|lenvatinib|mesh-list
19355363|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19355364|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
19355365|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355366|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355367|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19355368|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355369|NCT05249725|Irsogladine|irsogladine|mesh-list
19355370|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
19355371|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355372|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20392494|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20392495|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392496|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20392497|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
20392498|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19355373|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355374|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355375|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19355376|NCT05249725|Protective Agents|protective agents|mesh-ancestor
19355377|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355378|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19355379|NCT05249725|Antacids|antacids|mesh-ancestor
19355380|NCT05249699|Isoniazid|isoniazid|mesh-list
19355381|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
19685350|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19685351|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19685352|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19685353|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685354|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685355|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
19685356|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685357|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685358|NCT04552847|Octreotide|octreotide|mesh-list
19685359|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19685360|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19685361|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685362|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19685363|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
19685364|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
19685365|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19685366|NCT04537078|Cetrorelix|cetrorelix|mesh-list
19685367|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19685368|NCT04537078|Progesterone|progesterone|mesh-list
19685369|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
19685370|NCT04537078|Estradiol|estradiol|mesh-list
19685371|NCT04537078|Progestins|progestins|mesh-ancestor
19685372|NCT04537078|Hormones|hormones|mesh-ancestor
19685373|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19685374|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207575|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20207576|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207577|NCT00274638|Diuretics|diuretics|mesh-ancestor
20207578|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
20207579|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207580|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20207581|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217822|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217823|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217824|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
20217825|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20217826|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217827|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217828|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20217829|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20217830|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20217831|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217832|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19401353|NCT03618758|Paclitaxel|paclitaxel|mesh-list
19685375|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19685376|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19685377|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
19685378|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19685379|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19685380|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685381|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19685382|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
19685383|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
19685384|NCT04537078|Estrogens|estrogens|mesh-ancestor
19685385|NCT04509401|Vitamins|vitamins|mesh-list
19685386|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
19685387|NCT04509401|Pyridoxal|pyridoxal|mesh-list
19685388|NCT04509401|Pyridoxine|pyridoxine|mesh-list
19685389|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
19685390|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
19685391|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685392|NCT04460937|Adavosertib|adavosertib|mesh-list
19685393|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685394|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685395|NCT04457596|Trastuzumab|trastuzumab|mesh-list
19685396|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19685397|NCT04457596|Maytansine|maytansine|mesh-list
19685398|NCT04457596|Tucatinib|tucatinib|mesh-list
19685399|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685400|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685401|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685402|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685403|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685404|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685405|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685406|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19685407|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685408|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
20392499|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20392500|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
20392501|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
20392502|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392503|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20392504|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20392505|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20392506|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20392507|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20392508|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
20392509|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355382|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19355383|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355384|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19355385|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19355386|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
19685409|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19685410|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19685411|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207582|NCT00274677|Lamotrigine|lamotrigine|mesh-list
20207583|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
20207584|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20207585|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19685412|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
19685413|NCT04448184|Coagulants|coagulants|mesh-ancestor
19685414|NCT04440176|Vaccines|vaccines|mesh-list
19685415|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
19685416|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207586|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207587|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20207588|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207589|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20207590|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20207591|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20207592|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20207593|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20207594|NCT00274690|Casopitant|casopitant|mesh-list
20207595|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
20207596|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
20207597|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207598|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392510|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685417|NCT04430426|Glycolic acid|glycolic acid|mesh-list
19685418|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
19685419|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
19685420|NCT04425252|Brequinar|brequinar|mesh-list
19685421|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685422|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207599|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355387|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355388|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19355389|NCT05244213|Paclitaxel|paclitaxel|mesh-list
19355390|NCT05244213|Carboplatin|carboplatin|mesh-list
19355391|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355392|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355393|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355394|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
19355395|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355396|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355397|NCT05243745|Fluorides|fluorides|mesh-list
19355398|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
19355399|NCT05243745|Protective Agents|protective agents|mesh-ancestor
19355400|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355401|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
19355402|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19355403|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355404|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19355405|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19355406|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355407|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355408|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401354|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19401355|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401356|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
19401357|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
19401358|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
19401359|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401360|NCT03618654|Metformin|metformin|mesh-list
19401361|NCT03618654|Durvalumab|durvalumab|mesh-list
19401362|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
19401363|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19401364|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
19401365|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19401366|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401367|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19401368|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401369|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
19401370|NCT03618589|Pregabalin|pregabalin|mesh-list
19401371|NCT03618589|Analgesics|analgesics|mesh-ancestor
19401372|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
19401373|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401374|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401375|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
19401376|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19401377|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401378|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401379|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19401380|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19401381|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19401382|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401383|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19401384|NCT03618472|Metformin|metformin|mesh-list
19401385|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19401386|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401387|NCT03618355|Sirolimus|sirolimus|mesh-list
19401388|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19401389|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401390|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19401391|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401392|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
19401393|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401394|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
19401395|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401396|NCT03618316|Cimetidine|cimetidine|mesh-list
19685423|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685424|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685425|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
19685426|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685427|NCT04424862|Cyclosporine|cyclosporine|mesh-list
20207600|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19355409|NCT05207709|Paclitaxel|paclitaxel|mesh-list
20392511|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392512|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392513|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20392514|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20392515|NCT01085656|Combretastatin|combretastatin|mesh-list
20392516|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20392517|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392518|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392519|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392520|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392521|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392522|NCT01085695|Rabeprazole|rabeprazole|mesh-list
20392523|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20392524|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20392525|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20392526|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392527|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392528|NCT01085708|Rabeprazole|rabeprazole|mesh-list
20392529|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20392530|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20392531|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20392532|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392533|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392534|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
20392535|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
20392536|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
20392537|NCT01085721|Ephedrine|ephedrine|mesh-list
20392538|NCT01085721|Guaifenesin|guaifenesin|mesh-list
19355410|NCT05207709|Letrozole|letrozole|mesh-list
19355411|NCT05207709|Fulvestrant|fulvestrant|mesh-list
19355412|NCT05207709|Palbociclib|palbociclib|mesh-list
19355413|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355414|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355415|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355416|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
19355417|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355418|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355419|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19355420|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19355421|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355422|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19355423|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
19355424|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355425|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355426|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355427|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19355428|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19355429|NCT05194995|Cetuximab|cetuximab|mesh-list
19355430|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685428|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
19685429|NCT04424862|Prednisone|prednisone|mesh-list
19685430|NCT04424862|Cyclosporins|cyclosporins|mesh-list
19685431|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207601|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207602|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207603|NCT00274794|Rituximab|rituximab|mesh-list
20207604|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207605|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207606|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
20207607|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207608|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207609|NCT00274807|Cytarabine|cytarabine|mesh-list
20207610|NCT00274807|Etoposide|etoposide|mesh-list
20207611|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
20207612|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20207613|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207614|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20207615|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20207616|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207617|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355431|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355432|NCT05194735|Aldesleukin|aldesleukin|mesh-list
19685432|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
20207618|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207619|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
19685433|NCT04424862|Hormones|hormones|mesh-ancestor
19685434|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19685435|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685436|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19685437|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685438|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685439|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685440|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685441|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
19685442|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
19685443|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685444|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
19685445|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19685446|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19685447|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19685448|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19685449|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
19685450|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19685451|NCT04382898|Cemiplimab|cemiplimab|mesh-list
19685452|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685453|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685454|NCT04330040|Olaparib|olaparib|mesh-list
19685455|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19685456|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685457|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685458|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685459|NCT04313166|Copper|copper|mesh-list
19685460|NCT04313166|Trace Elements|trace elements|mesh-ancestor
19685461|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
19685462|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685463|NCT04302766|Remdesivir|remdesivir|mesh-list
19685464|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
19844164|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19355433|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355434|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19355435|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19355436|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
19355437|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355438|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
19355439|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19355440|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
19355441|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355442|NCT05177848|Nicotine|nicotine|mesh-list
19355443|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19355444|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
19355445|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355446|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844165|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844166|NCT00662909|Mirabegron|mirabegron|mesh-list
19844167|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19844168|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19844169|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20207620|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
20207621|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207622|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207623|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
20207624|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207625|NCT00274807|Analgesics|analgesics|mesh-ancestor
20207626|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
20207627|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207628|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
20207629|NCT00274820|Thalidomide|thalidomide|mesh-list
20207630|NCT00274820|Dexamethasone|dexamethasone|mesh-list
20207631|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
20207632|NCT00274820|Vitamins|vitamins|mesh-ancestor
20207633|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
20207634|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207635|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207636|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
20207637|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
20207638|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207639|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207640|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
19355447|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20207641|NCT00274820|Hormones|hormones|mesh-ancestor
19844170|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
20217833|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
20207642|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207643|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20207644|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207645|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
20207646|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207647|NCT00274820|Protective Agents|protective agents|mesh-ancestor
20207648|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207649|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
19355448|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20207650|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
20207651|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19355449|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
19355450|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355451|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355452|NCT05077969|Celecoxib|celecoxib|mesh-list
19355453|NCT05077969|Famotidine|famotidine|mesh-list
19355454|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19355455|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19355456|NCT05077969|Analgesics|analgesics|mesh-ancestor
19355457|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
19355458|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355459|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355460|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355461|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355462|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19355463|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19355464|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355465|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355466|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19355467|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355468|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19355469|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
19355470|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
19355471|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355472|NCT05055024|Mazindol|mazindol|mesh-list
19355473|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19355474|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355475|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19355476|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19355477|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19355478|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355479|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
19355480|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355481|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19355482|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
20392539|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19355483|NCT05031975|Irinotecan|irinotecan|mesh-list
19355484|NCT05031975|Temozolomide|temozolomide|mesh-list
20207652|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207653|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20207654|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20207655|NCT00274820|Growth Substances|growth substances|mesh-ancestor
20207656|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
20207657|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20207658|NCT00274833|Temozolomide|temozolomide|mesh-list
20207659|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207660|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20207661|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207662|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207663|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207664|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
20207665|NCT00274859|Gemcitabine|gemcitabine|mesh-list
19355485|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19355486|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19355487|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355488|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355489|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355490|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19355491|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
19355492|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
19355493|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
19355494|NCT05031897|Melphalan|melphalan|mesh-list
19692714|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355495|NCT05031897|Fludarabine|fludarabine|mesh-list
19355496|NCT05031897|Tacrolimus|tacrolimus|mesh-list
19355497|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19355498|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
19355499|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355500|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355501|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19355502|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
19355503|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355504|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355505|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19685465|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685466|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
19685467|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685468|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
19685469|NCT04298229|Diuretics|diuretics|mesh-list
19685470|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19685471|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685472|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20207666|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
20207667|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207668|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
20392540|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20392541|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20392542|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
20392543|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355506|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19355507|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355508|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19355509|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19355510|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
19355511|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19355512|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355513|NCT05023369|Dexamethasone|dexamethasone|mesh-list
19355514|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355515|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
19355516|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
19355517|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355518|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685473|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685474|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
19685475|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
19685476|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19685477|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
19685478|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685479|NCT04278898|Expectorants|expectorants|mesh-ancestor
19685480|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
19685481|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19685482|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
19685483|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685484|NCT04278898|Protective Agents|protective agents|mesh-ancestor
19685485|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844171|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844172|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844173|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844174|NCT00662909|Urological Agents|urological agents|mesh-ancestor
19844175|NCT00663039|Oxytocin|oxytocin|mesh-list
19844176|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
19844177|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19844178|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844179|NCT00663117|Naltrexone|naltrexone|mesh-list
19844180|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20207669|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207670|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207671|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
20207672|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207673|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207674|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207675|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
20207676|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207677|NCT00274872|Leucovorin|leucovorin|mesh-list
19355519|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19685486|NCT04278898|Antidotes|antidotes|mesh-ancestor
19685487|NCT04268849|Ascorbic Acid|ascorbic acid|mesh-list
19685488|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19355520|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
19355521|NCT05023369|Hormones|hormones|mesh-ancestor
19685489|NCT04268849|Vitamins|vitamins|mesh-ancestor
19685490|NCT04268849|Micronutrients|micronutrients|mesh-ancestor
19685491|NCT04268849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685492|NCT04268849|Antioxidants|antioxidants|mesh-ancestor
19685493|NCT04268849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685494|NCT04268849|Protective Agents|protective agents|mesh-ancestor
19685495|NCT04268849|Hematinics|hematinics|mesh-ancestor
19685496|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19355522|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355523|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355524|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355525|NCT05002127|Paclitaxel|paclitaxel|mesh-list
19355526|NCT05002127|Trastuzumab|trastuzumab|mesh-list
19355527|NCT05002127|Ramucirumab|ramucirumab|mesh-list
19355528|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355529|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355530|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355531|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685497|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19685498|NCT04229004|Gemcitabine|gemcitabine|mesh-list
19685499|NCT04229004|Paclitaxel|paclitaxel|mesh-list
19685500|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19685501|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685502|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685503|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685504|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685505|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685506|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207678|NCT00274872|Fluorouracil|fluorouracil|mesh-list
19844181|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19844182|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844183|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
20207679|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
19355532|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355533|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355534|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685507|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19685508|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
19685509|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
19685510|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685511|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685512|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685513|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
19685514|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685515|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19685516|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685517|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355535|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
19355536|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
19355537|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19355538|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19355539|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355540|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685518|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19685519|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19685520|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685521|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
19685522|NCT04133532|Metoprolol|metoprolol|mesh-list
19685523|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19685524|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19685525|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
19844184|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844185|NCT00663169|Dexamethasone|dexamethasone|mesh-list
19844186|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
19844187|NCT00663169|BB 1101|bb 1101|mesh-list
20207680|NCT00274872|Calcium|calcium|mesh-list
20207681|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
20207682|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20207683|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207684|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
20207685|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844188|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19401397|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19844189|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20392544|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392545|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20392546|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
20392547|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
20392548|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20392549|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20392550|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
20392551|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
20392552|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392553|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392554|NCT01085721|Expectorants|expectorants|mesh-ancestor
20207686|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207687|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207688|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207689|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
20207690|NCT00274872|Antidotes|antidotes|mesh-ancestor
19355541|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355542|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355543|NCT04959812|Sufentanil|sufentanil|mesh-list
19355544|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19355545|NCT04959812|Narcotics|narcotics|mesh-ancestor
19355546|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355547|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355548|NCT04959812|Analgesics|analgesics|mesh-ancestor
19355549|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
19355550|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355551|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19355552|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19355553|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
20392555|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20392556|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20392557|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
20392558|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20392559|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20392560|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
20392561|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
20392562|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
20392563|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
20392564|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20392565|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20392566|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392567|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19355554|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
19355555|NCT04952610|Etripamil|etripamil|mesh-list
19355556|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19685526|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
20207691|NCT00274872|Protective Agents|protective agents|mesh-ancestor
20207692|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
20392568|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392569|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392570|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
20392571|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20392572|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20392573|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
20392574|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
20392575|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392576|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392577|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392578|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
20392579|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
20207693|NCT00274872|Vitamins|vitamins|mesh-ancestor
20207694|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
20207695|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
20207696|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207697|NCT00274898|Celecoxib|celecoxib|mesh-list
20207698|NCT00274898|Docetaxel|docetaxel|mesh-list
20207699|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207700|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
20207701|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207702|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
20207703|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392580|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19355557|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19685527|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207704|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20392581|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19355558|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355559|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19355560|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355561|NCT04943848|Iodine|iodine|mesh-list
19355562|NCT04943848|Vaccines|vaccines|mesh-list
19355563|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
19355564|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355565|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19355566|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355567|NCT04943848|Trace Elements|trace elements|mesh-ancestor
19355568|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
19355569|NCT04928339|Bupivacaine|bupivacaine|mesh-list
19355570|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
19355571|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
19355572|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355573|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355574|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
19355575|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355576|NCT04923594|Mazindol|mazindol|mesh-list
19355577|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19355578|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355579|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19355580|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20392582|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20392583|NCT01085877|Estradiol|estradiol|mesh-list
20392584|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20392585|NCT01085877|Estrogens|estrogens|mesh-ancestor
20392586|NCT01085877|Hormones|hormones|mesh-ancestor
20392587|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392588|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392589|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20392590|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
20392591|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20392592|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20392593|NCT01085981|Niacin|niacin|mesh-list
20392594|NCT01085981|Niacinamide|niacinamide|mesh-list
19355581|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19355582|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355583|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
19355584|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355585|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19355586|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
19355587|NCT04909021|Vaccines|vaccines|mesh-list
19355588|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
19355589|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355590|NCT04892173|Cetuximab|cetuximab|mesh-list
19355591|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355592|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401398|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19401399|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19401400|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
19401401|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
19401402|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401403|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401404|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401405|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19401406|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19401407|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401408|NCT03618264|Dexamethasone|dexamethasone|mesh-list
19685528|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685529|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19685530|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19685531|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20207705|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20207706|NCT00274898|Analgesics|analgesics|mesh-ancestor
20207707|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
20207708|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207709|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207710|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207711|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207712|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20207713|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20392595|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
20392596|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19355593|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
19355594|NCT04862585|Promethazine|promethazine|mesh-list
19355595|NCT04862585|Dexamethasone|dexamethasone|mesh-list
19355596|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
19355597|NCT04862585|Paclitaxel|paclitaxel|mesh-list
19355598|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19355599|NCT04862585|Famotidine|famotidine|mesh-list
19355600|NCT04862585|Ranitidine|ranitidine|mesh-list
19355601|NCT04862585|Cimetidine|cimetidine|mesh-list
19355602|NCT04862585|BB 1101|bb 1101|mesh-list
19355603|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19355604|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355605|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355606|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
19355607|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355608|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355609|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355610|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
19355611|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
19355612|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392597|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
20392598|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355613|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355614|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355615|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
19355616|NCT04862585|Hormones|hormones|mesh-ancestor
19355617|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355618|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355619|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
19844190|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
19355620|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355621|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19355622|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19355623|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355624|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
19844191|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
19844192|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844193|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844194|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844195|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
20207714|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355625|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
19355626|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
19355627|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19355628|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
19355629|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
19355630|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355631|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19355632|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
19355633|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
19355634|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19355635|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19355636|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19355637|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19355638|NCT04847596|Ofatumumab|ofatumumab|mesh-list
19355639|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355640|NCT04844268|Vaccines|vaccines|mesh-list
19355641|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
19355642|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355643|NCT04818216|Niacinamide|niacinamide|mesh-list
19355644|NCT04818216|Niacin|niacin|mesh-list
19355645|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
19844196|NCT00663169|Hormones|hormones|mesh-ancestor
20207715|NCT00274911|Vincristine|vincristine|mesh-list
20207716|NCT00274911|Lomustine|lomustine|mesh-list
20207717|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207718|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20207719|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
20207720|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207721|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
20207722|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207723|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207724|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
20207725|NCT00274950|Carboplatin|carboplatin|mesh-list
20207726|NCT00274950|Etoposide|etoposide|mesh-list
20207727|NCT00274950|Ifosfamide|ifosfamide|mesh-list
20207728|NCT00274950|Bleomycin|bleomycin|mesh-list
20207729|NCT00274950|Vinblastine|vinblastine|mesh-list
19355646|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
19355647|NCT04818216|Vitamins|vitamins|mesh-ancestor
20392599|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20392600|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
20392601|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
20392602|NCT01085981|Vitamins|vitamins|mesh-ancestor
20392603|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
20392604|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392605|NCT01086020|Atorvastatin|atorvastatin|mesh-list
20392606|NCT01086020|Ezetimibe|ezetimibe|mesh-list
20392607|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20392608|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392609|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
19355648|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
19355649|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355650|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19685532|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
20392610|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392611|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20392612|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19355651|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
19355652|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355653|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19355654|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
19355655|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
19355656|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685533|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19685534|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685535|NCT04126135|Nicotine|nicotine|mesh-list
19685536|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19685537|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
19685538|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685539|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685540|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19685541|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19685542|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
19685543|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355657|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355658|NCT04788667|Erenumab|erenumab|mesh-list
19355659|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
19355660|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19355661|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19355662|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355663|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
19355664|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355665|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355666|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19355667|NCT04788667|Analgesics|analgesics|mesh-ancestor
19355668|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
19355669|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355670|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19355671|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19355672|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355673|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
19355674|NCT04776499|Perphenazine|perphenazine|mesh-list
19355675|NCT04776499|Riociguat|riociguat|mesh-list
19355676|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
19355677|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
19401409|NCT03618264|Ropivacaine|ropivacaine|mesh-list
19844197|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207730|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207731|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20207732|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20207733|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20207734|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207735|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207736|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207737|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
20207738|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20207739|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
20207740|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207741|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
20207742|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20207743|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
20207744|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20392613|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355678|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355679|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19355680|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19355681|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19355682|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355683|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19355684|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19355685|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
19355686|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355687|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
19355688|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
19355689|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
19685544|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692715|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
19692716|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692717|NCT04988789|Paclitaxel|paclitaxel|mesh-list
19692718|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19692719|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692720|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
19692721|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
19692722|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
19692723|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692724|NCT04988607|Bevacizumab|bevacizumab|mesh-list
19692725|NCT04988607|Osimertinib|osimertinib|mesh-list
19692726|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19692727|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692728|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19692729|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19692730|NCT04988607|Growth Substances|growth substances|mesh-ancestor
19692731|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692732|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
19692733|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19692734|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692735|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692736|NCT04988646|Acyclovir|acyclovir|mesh-list
19692737|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
19692738|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692739|NCT04988191|Bevacizumab|bevacizumab|mesh-list
19692740|NCT04988191|Irinotecan|irinotecan|mesh-list
19692741|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355690|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355691|NCT04767711|Prednisolone|prednisolone|mesh-list
19355692|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355693|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
19355694|NCT04767711|Hormones|hormones|mesh-ancestor
19355695|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19355696|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355697|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19355698|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355699|NCT04756427|Citric Acid|citric acid|mesh-list
19355700|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
19355701|NCT04756427|Anticoagulants|anticoagulants|mesh-list
19692742|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692743|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19692744|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20207745|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
19355702|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19355703|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
19355704|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
19355705|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355706|NCT04753749|Aspirin|aspirin|mesh-list
19355707|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19355708|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19355709|NCT04753749|Analgesics|analgesics|mesh-ancestor
19355710|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
20207746|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207747|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355711|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355712|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355713|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207748|NCT00274963|Analgesics|analgesics|mesh-ancestor
20207749|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
19355714|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692745|NCT04988191|Growth Substances|growth substances|mesh-ancestor
19355715|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19355716|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19685545|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19355717|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355718|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19355719|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19355720|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355721|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
19355722|NCT04753372|Aspirin|aspirin|mesh-list
19355723|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
19355724|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19355725|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
19355726|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19355727|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
19355728|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355729|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355730|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
19355731|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19355732|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19355733|NCT04753372|Analgesics|analgesics|mesh-ancestor
19355734|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
19355735|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355736|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355737|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355738|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355739|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19355740|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19355741|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19355742|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19355743|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
19355744|NCT04747496|Edoxaban|edoxaban|mesh-list
19355745|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19355746|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
19355747|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19355748|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
19355749|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355750|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355751|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
19355752|NCT04741386|Vaccines|vaccines|mesh-list
20392614|NCT01086046|Heparin|heparin|mesh-list
20392615|NCT01086046|Enoxaparin|enoxaparin|mesh-list
20392616|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19355753|NCT04741386|Immunologic Factors|immunologic factors|mesh-ancestor
19355754|NCT04741386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355755|NCT04733118|Trastuzumab|trastuzumab|mesh-list
20392617|NCT01086046|Tinzaparin|tinzaparin|mesh-list
20392618|NCT01086046|Dalteparin|dalteparin|mesh-list
19355756|NCT04733118|Pertuzumab|pertuzumab|mesh-list
19355757|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355758|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355759|NCT04732910|Ivacaftor|ivacaftor|mesh-list
19355760|NCT04732910|Elexacaftor|elexacaftor|mesh-list
19355761|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19355762|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19355763|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355764|NCT04703920|Talazoparib|talazoparib|mesh-list
19355765|NCT04703920|Belinostat|belinostat|mesh-list
19355766|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19355767|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355768|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355769|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355770|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19355771|NCT04698031|Aspirin|aspirin|mesh-list
19355772|NCT04698031|Clopidogrel|clopidogrel|mesh-list
19355773|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19355774|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19355775|NCT04698031|Analgesics|analgesics|mesh-ancestor
19355776|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
19355777|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355778|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355779|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19685546|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
20392619|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
20392620|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19355780|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20392621|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20428632|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
19355781|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19355782|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19355783|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355784|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19355785|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19355786|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355787|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
19355788|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19685547|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19355789|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19355790|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19355791|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
19355792|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355793|NCT04689347|Leucovorin|leucovorin|mesh-list
19355794|NCT04689347|Bevacizumab|bevacizumab|mesh-list
19355795|NCT04689347|Fluorouracil|fluorouracil|mesh-list
19355796|NCT04689347|Irinotecan|irinotecan|mesh-list
19685548|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19685549|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19355797|NCT04689347|Temozolomide|temozolomide|mesh-list
19355798|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355799|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355800|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19355801|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19355802|NCT04689347|Growth Substances|growth substances|mesh-ancestor
19355803|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355804|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
19355805|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
19355806|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355807|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19355808|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19355809|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
19355810|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19685550|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685551|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685552|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
19685553|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844198|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19844199|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844200|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
19844201|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844202|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844203|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
19844204|NCT00663234|Atorvastatin|atorvastatin|mesh-list
19844205|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19844206|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19844207|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
19844208|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685554|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685555|NCT03962855|Ifetroban|ifetroban|mesh-list
19685556|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19685557|NCT03940326|Levetiracetam|levetiracetam|mesh-list
19844209|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19844210|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19844211|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844212|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
19844213|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19844214|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844215|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20207750|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685558|NCT03940326|Valproic Acid|valproic acid|mesh-list
20207751|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207752|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20207753|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20207754|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207755|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
20207756|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207757|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207758|NCT00274989|Rituximab|rituximab|mesh-list
20207759|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20207760|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207761|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355811|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19685559|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
19355812|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355813|NCT04689347|Antidotes|antidotes|mesh-ancestor
20392622|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392623|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20392624|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
20392625|NCT01086085|Adefovir|adefovir|mesh-list
19685560|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
20207762|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
20207763|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207764|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207765|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207766|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
19355814|NCT04689347|Protective Agents|protective agents|mesh-ancestor
19355815|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
20392626|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
20392627|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392628|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
20392629|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392630|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20392631|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20392632|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392633|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207767|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207768|NCT00275015|Cytarabine|cytarabine|mesh-list
20207769|NCT00275015|Dexamethasone|dexamethasone|mesh-list
20207770|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
20207771|NCT00275015|Melphalan|melphalan|mesh-list
20207772|NCT00275015|Carmustine|carmustine|mesh-list
20207773|NCT00275015|Fludarabine|fludarabine|mesh-list
19355816|NCT04689347|Vitamins|vitamins|mesh-ancestor
19355817|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
19355818|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207774|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
20207775|NCT00275015|Etoposide|etoposide|mesh-list
20207776|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207777|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
20207778|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207779|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207780|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207781|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
20207782|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207783|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392634|NCT01086254|Gemcitabine|gemcitabine|mesh-list
20392635|NCT01086254|Iniparib|iniparib|mesh-list
20392636|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355819|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
19355820|NCT04678479|Ganaxolone|ganaxolone|mesh-list
19355821|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
19355822|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355823|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355824|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207784|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20207785|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207786|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
20207787|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
19355825|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
19355826|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
19355827|NCT04672291|Poly I-C|poly i-c|mesh-list
19355828|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19355829|NCT04672291|Poly ICLC|poly iclc|mesh-list
19355830|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
19355831|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
19355832|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355833|NCT04672291|Laxatives|laxatives|mesh-ancestor
19355834|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19685561|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685562|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355835|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
19355836|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685563|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
19685564|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19685565|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685566|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
19685567|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19685568|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685569|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20207788|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207789|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207790|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
19355837|NCT04623684|Phenylephrine|phenylephrine|mesh-list
19355838|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
19355839|NCT04623684|Tropicamide|tropicamide|mesh-list
19355840|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19355841|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
19355842|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
19355843|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392637|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20392638|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
20392639|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207791|NCT00275015|Hormones|hormones|mesh-ancestor
20207792|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207793|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20207794|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207795|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
20207796|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20207797|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20207798|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19685593|NCT03892018|Paclitaxel|paclitaxel|mesh-list
19685594|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685595|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392640|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
20392641|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392642|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392643|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20392644|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
20392645|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392646|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20392647|NCT01086332|Gemcitabine|gemcitabine|mesh-list
19355844|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355845|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
19355846|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19355847|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
19355848|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
19355849|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19355850|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19355851|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19685596|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685597|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685598|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685599|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685600|NCT03885921|Atorvastatin|atorvastatin|mesh-list
19685601|NCT03885921|Simvastatin|simvastatin|mesh-list
19685602|NCT03885921|Ezetimibe|ezetimibe|mesh-list
19685603|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19685604|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19685605|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
19685606|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355852|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
19355853|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355854|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685607|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19685608|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19685609|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685610|NCT03884452|Atorvastatin|atorvastatin|mesh-list
20207799|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207800|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
20207801|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207802|NCT00275041|Irinotecan|irinotecan|mesh-list
20207803|NCT00275041|Cetuximab|cetuximab|mesh-list
20207804|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20207805|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20207806|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207807|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207808|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207809|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207810|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
20207811|NCT00275054|Rituximab|rituximab|mesh-list
19355855|NCT04623684|Protective Agents|protective agents|mesh-ancestor
19355856|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19685611|NCT03884452|Simvastatin|simvastatin|mesh-list
19355857|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19685612|NCT03884452|Ezetimibe|ezetimibe|mesh-list
19685613|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19685614|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19844216|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844217|NCT00663403|Daptomycin|daptomycin|mesh-list
19844218|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19685615|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
19685616|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685617|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19685618|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19685619|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844219|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355858|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
19355859|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19355860|NCT04616196|Cetuximab|cetuximab|mesh-list
19355861|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355862|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355863|NCT04578652|Metformin|metformin|mesh-list
19355864|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19355865|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355866|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19355867|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19355868|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19355869|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
19355870|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355871|NCT04546581|Remdesivir|remdesivir|mesh-list
19355872|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
19355873|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19355874|NCT04546581|Antibodies|antibodies|mesh-list
19355875|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
19355876|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844220|NCT00663702|Abatacept|abatacept|mesh-list
19844221|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19844222|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844223|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844224|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19355877|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
19355878|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355879|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
19355880|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19355881|NCT04511702|Methotrexate|methotrexate|mesh-list
19355882|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19355883|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
19355884|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20392648|NCT01086332|Nelfinavir|nelfinavir|mesh-list
20392649|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20392650|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
19355885|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355886|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19355887|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
19355888|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355889|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355890|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
19355891|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355892|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19355893|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19355894|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
19355895|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355896|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19401410|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401411|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
19685620|NCT03882996|Atorvastatin|atorvastatin|mesh-list
20207812|NCT00275054|Fludarabine|fludarabine|mesh-list
20207813|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207814|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
20207815|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207816|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207817|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207818|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
20207819|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207820|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401412|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
19401413|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685621|NCT03882996|Ezetimibe|ezetimibe|mesh-list
20207821|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20392651|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392652|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392653|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
19355897|NCT04421378|Bevacizumab|bevacizumab|mesh-list
19355898|NCT04421378|Temozolomide|temozolomide|mesh-list
19355899|NCT04421378|Carmustine|carmustine|mesh-list
19355900|NCT04421378|Lomustine|lomustine|mesh-list
19355901|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355902|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355903|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19355904|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19355905|NCT04421378|Growth Substances|growth substances|mesh-ancestor
19355906|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355907|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
19355908|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19355909|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
19355910|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685622|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19685623|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19685624|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
19685625|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685626|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19685627|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19685628|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685629|NCT03882905|Ezetimibe|ezetimibe|mesh-list
19685630|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19685631|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392654|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392655|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685632|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
19685633|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685634|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19685635|NCT03882892|Ezetimibe|ezetimibe|mesh-list
19685636|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19685637|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19685638|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
19685639|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392656|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20392657|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
20392658|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355911|NCT04410445|Nivolumab|nivolumab|mesh-list
19355912|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355913|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355914|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19355915|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355916|NCT04401384|Pyridoxine|pyridoxine|mesh-list
19355917|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
20392659|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20392660|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20392661|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
20392662|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20392663|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19355918|NCT04401384|Doxylamine|doxylamine|mesh-list
19355919|NCT04401384|Dicyclomine|dicyclomine|mesh-list
19355920|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
19355921|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
19355922|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355923|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392664|NCT01086345|Bevacizumab|bevacizumab|mesh-list
20392665|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20392666|NCT01086345|Irinotecan|irinotecan|mesh-list
19355924|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19355925|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19355926|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
19355927|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
19355928|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355929|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355930|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
19355931|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19355932|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20392667|NCT01086345|Camptothecin|camptothecin|mesh-list
19355933|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
19355934|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
19355935|NCT04401384|Vitamins|vitamins|mesh-ancestor
19685640|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19355936|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
19355937|NCT04276493|Docetaxel|docetaxel|mesh-list
19355938|NCT04276493|Capecitabine|capecitabine|mesh-list
19355939|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
19355940|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355941|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
19355942|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
19355943|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
19355944|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355945|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19355946|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
19355947|NCT04239222|Ibuprofen|ibuprofen|mesh-list
19355948|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19355949|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19355950|NCT04239222|Analgesics|analgesics|mesh-ancestor
19355951|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
19355952|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355953|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355954|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19355955|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19355956|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19355957|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355958|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355959|NCT04147494|Edetic Acid|edetic acid|mesh-list
19355960|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19355961|NCT04147494|FAPI-46|fapi-46|mesh-list
19355962|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
19355963|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
19355964|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355965|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
19355966|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19355967|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19355968|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
19355969|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19355970|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355971|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19355972|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20612983|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355973|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19355974|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392668|NCT01086345|Antibodies|antibodies|mesh-list
20612984|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20612985|NCT02253602|Hematinics|hematinics|mesh-ancestor
20612986|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20612987|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20612988|NCT02253758|Propofol|propofol|mesh-list
20612989|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20612990|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20612991|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355975|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19355976|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355977|NCT04137107|Analgesics|analgesics|mesh-ancestor
19355978|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
20392669|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
20392670|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20392671|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392672|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20392673|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20392674|NCT01086345|Growth Substances|growth substances|mesh-ancestor
20392675|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392676|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
20392677|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
20392678|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20392679|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20392680|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19355979|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19355980|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
20392681|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392682|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20426589|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20426590|NCT01281787|Losartan|losartan|mesh-list
20426591|NCT01281787|Metoprolol|metoprolol|mesh-list
20426592|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19355981|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19355982|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
19355983|NCT04080804|Nivolumab|nivolumab|mesh-list
19355984|NCT04080804|Ipilimumab|ipilimumab|mesh-list
20392683|NCT01086527|Montelukast|montelukast|mesh-list
20392684|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20392685|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
20392686|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20392687|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
20392688|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392689|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392690|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20392691|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19355985|NCT04080804|Antibodies|antibodies|mesh-list
19355986|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
19355987|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
19355988|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19355989|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355990|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355991|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19355992|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19355993|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
19355994|NCT04042701|Trastuzumab|trastuzumab|mesh-list
19355995|NCT04042701|Camptothecin|camptothecin|mesh-list
20392692|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392693|NCT01086553|Budesonide|budesonide|mesh-list
20392694|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20392695|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20392696|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
19355996|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
19355997|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19355998|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19355999|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356000|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19356001|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19356002|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356003|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356004|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
19356005|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356006|NCT04005690|Olaparib|olaparib|mesh-list
19685641|NCT03878524|Vitamins|vitamins|mesh-list
19685642|NCT03878524|Leucovorin|leucovorin|mesh-list
19685643|NCT03878524|Vitamin A|vitamin a|mesh-list
19844225|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
19844226|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844227|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844228|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
19844229|NCT00663793|Finasteride|finasteride|mesh-list
19844230|NCT00663793|Testosterone|testosterone|mesh-list
19844231|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
19844232|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
19844233|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19844234|NCT00663793|Acyline|acyline|mesh-list
19844235|NCT00663793|Androgens|androgens|mesh-ancestor
19844236|NCT00663793|Hormones|hormones|mesh-ancestor
19685644|NCT03878524|Sirolimus|sirolimus|mesh-list
19685645|NCT03878524|Celecoxib|celecoxib|mesh-list
19685646|NCT03878524|Paclitaxel|paclitaxel|mesh-list
19685647|NCT03878524|Maytansine|maytansine|mesh-list
19685648|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19685649|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19685650|NCT03878524|Bevacizumab|bevacizumab|mesh-list
19685651|NCT03878524|Carboplatin|carboplatin|mesh-list
19685652|NCT03878524|Doxorubicin|doxorubicin|mesh-list
19685653|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19685654|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
19685655|NCT03878524|Fluorouracil|fluorouracil|mesh-list
19685656|NCT03878524|Capecitabine|capecitabine|mesh-list
19685657|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
19685658|NCT03878524|Nivolumab|nivolumab|mesh-list
19844237|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844238|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844239|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19356007|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19356008|NCT04005690|Onvansertib|onvansertib|mesh-list
19685659|NCT03878524|Trastuzumab|trastuzumab|mesh-list
19356009|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685660|NCT03878524|Everolimus|everolimus|mesh-list
19685661|NCT03878524|Bortezomib|bortezomib|mesh-list
19685662|NCT03878524|Sorafenib|sorafenib|mesh-list
19685663|NCT03878524|Ipilimumab|ipilimumab|mesh-list
19844240|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685664|NCT03878524|Durvalumab|durvalumab|mesh-list
19685665|NCT03878524|Sunitinib|sunitinib|mesh-list
19685666|NCT03878524|Daunorubicin|daunorubicin|mesh-list
19685667|NCT03878524|Dasatinib|dasatinib|mesh-list
19685668|NCT03878524|Venetoclax|venetoclax|mesh-list
19685669|NCT03878524|Olaparib|olaparib|mesh-list
19685670|NCT03878524|Lenvatinib|lenvatinib|mesh-list
19685671|NCT03878524|Palbociclib|palbociclib|mesh-list
19685672|NCT03878524|Vorinostat|vorinostat|mesh-list
19685673|NCT03878524|Pertuzumab|pertuzumab|mesh-list
19685674|NCT03878524|Trametinib|trametinib|mesh-list
19685675|NCT03878524|Tretinoin|tretinoin|mesh-list
19685676|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
19685677|NCT03878524|Bicalutamide|bicalutamide|mesh-list
19685678|NCT03878524|Afatinib|afatinib|mesh-list
19685679|NCT03878524|Panobinostat|panobinostat|mesh-list
19685680|NCT03878524|Vemurafenib|vemurafenib|mesh-list
19685681|NCT03878524|Dabrafenib|dabrafenib|mesh-list
19685682|NCT03878524|Ponatinib|ponatinib|mesh-list
19685683|NCT03878524|Idelalisib|idelalisib|mesh-list
19685684|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19685685|NCT03878524|Losartan|losartan|mesh-list
19844241|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
19844242|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19685686|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
19844243|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19844244|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844245|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392697|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392698|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392699|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20392700|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
20392701|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
20392702|NCT01086553|Hormones|hormones|mesh-ancestor
20392703|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392704|NCT01086579|Paclitaxel|paclitaxel|mesh-list
19356010|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844246|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
19844247|NCT00663793|Urological Agents|urological agents|mesh-ancestor
19844248|NCT00663858|Cetrorelix|cetrorelix|mesh-list
19844249|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19844250|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
19844251|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19844252|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356011|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844253|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
20207822|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207823|NCT00275067|Temozolomide|temozolomide|mesh-list
20207824|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
19844254|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844255|NCT00663962|Pregabalin|pregabalin|mesh-list
19844256|NCT00663962|Analgesics|analgesics|mesh-ancestor
19844257|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
19844258|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844259|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844260|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
19844261|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19844262|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844263|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844264|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19844265|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19844266|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19844267|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19356012|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19685687|NCT03878524|Antibodies|antibodies|mesh-list
19844268|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844269|NCT00664105|Carboplatin|carboplatin|mesh-list
20207825|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207826|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
20207827|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207828|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207829|NCT00275080|Decitabine|decitabine|mesh-list
20207830|NCT00275080|Azacitidine|azacitidine|mesh-list
19844270|NCT00664105|Docetaxel|docetaxel|mesh-list
20207831|NCT00275080|Vorinostat|vorinostat|mesh-list
19685688|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
19685689|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19685690|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19685691|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
19685692|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
19685693|NCT03878524|Entrectinib|entrectinib|mesh-list
19356013|NCT03968822|Lidocaine|lidocaine|mesh-list
19356014|NCT03968822|Bupivacaine|bupivacaine|mesh-list
19685694|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
19685695|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685696|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685697|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685698|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685699|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685700|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685701|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19685702|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19685703|NCT03878524|Growth Substances|growth substances|mesh-ancestor
19844271|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356015|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19356016|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
19356017|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
19844272|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
19844273|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
19844274|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
19844275|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844276|NCT00664209|Amoxicillin|amoxicillin|mesh-list
20392705|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20392706|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20392707|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392708|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392709|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392710|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392711|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392712|NCT01086631|Rituximab|rituximab|mesh-list
20392713|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392714|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392715|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
20392716|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392717|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20392718|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19356018|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844277|NCT00664209|Omeprazole|omeprazole|mesh-list
19844278|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19844279|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844280|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19844281|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844282|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19844283|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844284|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844285|NCT00664430|Calcitriol|calcitriol|mesh-list
19844286|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19844287|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844288|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19844289|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844290|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844291|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19844292|NCT00664430|Vitamins|vitamins|mesh-ancestor
19844293|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
19844294|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19356019|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356020|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
19356021|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844295|NCT00664521|Rituximab|rituximab|mesh-list
19356022|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19356023|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19356024|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19356025|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19356026|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356027|NCT03961971|Spartalizumab|spartalizumab|mesh-list
19356028|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19356029|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356030|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356031|NCT03915626|Rivastigmine|rivastigmine|mesh-list
19356032|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19356033|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401414|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844296|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392719|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
19356034|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356035|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
19356036|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392720|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20392721|NCT01086826|Cisplatin|cisplatin|mesh-list
20392722|NCT01086826|Docetaxel|docetaxel|mesh-list
20392723|NCT01086826|Fluorouracil|fluorouracil|mesh-list
20392724|NCT01086826|Cetuximab|cetuximab|mesh-list
20392725|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392726|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392727|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392728|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392729|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392730|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
20392731|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20392732|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356037|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356038|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19356039|NCT03915626|Protective Agents|protective agents|mesh-ancestor
19356040|NCT03907046|Aspirin|aspirin|mesh-list
19356041|NCT03907046|Apixaban|apixaban|mesh-list
19356042|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19356043|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19356044|NCT03907046|Analgesics|analgesics|mesh-ancestor
19356045|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
19685704|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356046|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356047|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356048|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19356049|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356050|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19356051|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19356052|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356053|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19356054|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19356055|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356056|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
19356057|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19356058|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
19356059|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19356060|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
19356061|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
19356062|NCT03822013|Miglustat|miglustat|mesh-list
19356063|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356064|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356065|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19356066|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19356067|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
19356068|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356069|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19356070|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19356071|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356072|NCT03785925|Nivolumab|nivolumab|mesh-list
19356073|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356074|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356075|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19356076|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356077|NCT03779334|Risdiplam|risdiplam|mesh-list
19356078|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19356079|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392733|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
20392734|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392735|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392736|NCT01086878|Trimethoprim|trimethoprim|mesh-list
20392737|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20392738|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
20392739|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20392740|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392741|NCT01086878|Renal Agents|renal agents|mesh-ancestor
20392742|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
20392743|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20392744|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19356080|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685705|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
20392745|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19356081|NCT03729245|Nivolumab|nivolumab|mesh-list
19356082|NCT03729245|Sunitinib|sunitinib|mesh-list
19356083|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392746|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392747|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392748|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20392749|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20392750|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20392751|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20392752|NCT01086956|Sufentanil|sufentanil|mesh-list
20392753|NCT01086956|Ropivacaine|ropivacaine|mesh-list
20392754|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
20392755|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
20392756|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392757|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392758|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
20392759|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392760|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20392761|NCT01086956|Narcotics|narcotics|mesh-ancestor
20392762|NCT01086956|Analgesics|analgesics|mesh-ancestor
20392763|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20392764|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20392765|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
20392766|NCT01086982|Octreotide|octreotide|mesh-list
19356084|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356085|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19356086|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356087|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19356088|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19356089|NCT03729245|Growth Substances|growth substances|mesh-ancestor
19356090|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356091|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
19356092|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356093|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356094|NCT03706690|Durvalumab|durvalumab|mesh-list
19356095|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356096|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356097|NCT03698279|Vaccines|vaccines|mesh-list
19356098|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
19356099|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356100|NCT03692403|Quinagolide|quinagolide|mesh-list
19356101|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
20392767|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20392768|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20392769|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392770|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
20392771|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20392772|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392773|NCT01087099|Albendazole|albendazole|mesh-list
20392774|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
20392775|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20392776|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392777|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
19356102|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
19356103|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356104|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356105|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356106|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
20392778|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20392779|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20392780|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356107|NCT03680274|Vitamins|vitamins|mesh-ancestor
19356108|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
19356109|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356110|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
19356111|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356112|NCT03680274|Protective Agents|protective agents|mesh-ancestor
19356113|NCT03653247|Plerixafor|plerixafor|mesh-list
19356114|NCT03653247|Busulfan|busulfan|mesh-list
19356115|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
19685706|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
19685707|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
19685708|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19685709|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19685710|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19685711|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685712|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
19356116|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356117|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356118|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
19356119|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356120|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19685713|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19685714|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685715|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19685716|NCT03878524|Antidotes|antidotes|mesh-ancestor
19685717|NCT03878524|Protective Agents|protective agents|mesh-ancestor
19685718|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
19685719|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19685720|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19844297|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844298|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
19356121|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356122|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19356123|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19356124|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19356125|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
19356126|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356127|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
19356128|NCT03593811|Ondansetron|ondansetron|mesh-list
19356129|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
19356130|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
19356131|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356132|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392781|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
20392782|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392783|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392784|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392785|NCT01087138|Calcium|calcium|mesh-list
20392786|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19356133|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19356134|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
19356135|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19356136|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19356137|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
19356138|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356139|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356140|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19356141|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19356142|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19356143|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19356144|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19356145|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19356146|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
19356147|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
19356148|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19356149|NCT03572764|Cytarabine|cytarabine|mesh-list
19356150|NCT03572764|Daunorubicin|daunorubicin|mesh-list
19356151|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356152|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
19844299|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356153|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356154|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356155|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
19356156|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356157|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356158|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
19356159|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356160|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19356161|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19356162|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19356163|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356164|NCT03559010|Norgestrel|norgestrel|mesh-list
19356165|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19356166|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19356167|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19356168|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
19356169|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19356170|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356171|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19356172|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19356173|NCT03520686|Paclitaxel|paclitaxel|mesh-list
19356174|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19356175|NCT03520686|Cisplatin|cisplatin|mesh-list
19356176|NCT03520686|Carboplatin|carboplatin|mesh-list
19356177|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
19356178|NCT03520686|Pemetrexed|pemetrexed|mesh-list
19356179|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356180|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356181|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356182|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356183|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356184|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356185|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392787|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392788|NCT01087190|Isoniazid|isoniazid|mesh-list
20392789|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
20392790|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20392791|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392792|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20392793|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392794|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
20392795|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392796|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20392797|NCT01087203|Tanezumab|tanezumab|mesh-list
20392798|NCT01087203|Analgesics|analgesics|mesh-ancestor
20392799|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
20392800|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392801|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392802|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
20392803|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19356186|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356187|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20207832|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207833|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
20207834|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207835|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207836|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207837|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20207838|NCT00275093|Sirolimus|sirolimus|mesh-list
20207839|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19356188|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19356189|NCT03509012|Paclitaxel|paclitaxel|mesh-list
19356190|NCT03509012|Etoposide|etoposide|mesh-list
19356191|NCT03509012|Cisplatin|cisplatin|mesh-list
19356192|NCT03509012|Carboplatin|carboplatin|mesh-list
19356193|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
19356194|NCT03509012|Pemetrexed|pemetrexed|mesh-list
19356195|NCT03509012|Durvalumab|durvalumab|mesh-list
19356196|NCT03509012|Tremelimumab|tremelimumab|mesh-list
19356197|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356198|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356199|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356200|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356201|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356202|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356203|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19356204|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19356205|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356206|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19356207|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19356208|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356209|NCT03478930|Omalizumab|omalizumab|mesh-list
19356210|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19356211|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19356212|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
19356213|NCT03477539|Lenalidomide|lenalidomide|mesh-list
19356214|NCT03477539|Daratumumab|daratumumab|mesh-list
19356215|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
19356216|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207840|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207841|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19356217|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19356218|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19356219|NCT03477539|Growth Substances|growth substances|mesh-ancestor
19356220|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
19356221|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356222|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
20207842|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207843|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
20207844|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207845|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
20207846|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356223|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356224|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356225|NCT03476603|Irbesartan|irbesartan|mesh-list
19356226|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19356227|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19356228|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19356229|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356230|NCT03476577|Ibuprofen|ibuprofen|mesh-list
19844300|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20207847|NCT00275106|Leucovorin|leucovorin|mesh-list
20207848|NCT00275106|Cytarabine|cytarabine|mesh-list
20207849|NCT00275106|Dexamethasone|dexamethasone|mesh-list
19356231|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19356232|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19356233|NCT03476577|Analgesics|analgesics|mesh-ancestor
19356234|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
20207850|NCT00275106|Prednisolone|prednisolone|mesh-list
20207851|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
19356235|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356236|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356237|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19356238|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356239|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19356240|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356241|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356242|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19356243|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19356244|NCT03476551|Diuretics|diuretics|mesh-ancestor
19356245|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
19356246|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844301|NCT00664534|Insulin|insulin|mesh-list
19844302|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20392804|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
20392805|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
20392806|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392807|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392808|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20392809|NCT01087229|Analgesics|analgesics|mesh-ancestor
20392810|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
20392811|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20392812|NCT01087359|Melatonin|melatonin|mesh-list
20392813|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
20392814|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392815|NCT01087359|Protective Agents|protective agents|mesh-ancestor
20392816|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392817|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20392818|NCT01087398|Cyclosporine|cyclosporine|mesh-list
20392819|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
20392820|NCT01087398|Busulfan|busulfan|mesh-list
20392821|NCT01087398|Methotrexate|methotrexate|mesh-list
20392822|NCT01087398|Fludarabine|fludarabine|mesh-list
20392823|NCT01087398|Cyclosporins|cyclosporins|mesh-list
20392824|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
20392825|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20392826|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
20392827|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392828|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20392829|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19844303|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
19844304|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
19844305|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19844306|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844307|NCT00664560|Celecoxib|celecoxib|mesh-list
19844308|NCT00664560|Antacids|antacids|mesh-list
19844309|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19844310|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844311|NCT00664560|Analgesics|analgesics|mesh-ancestor
19844312|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
19844313|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207852|NCT00275106|Doxorubicin|doxorubicin|mesh-list
20207853|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20207854|NCT00275106|Methotrexate|methotrexate|mesh-list
20392830|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
20426593|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19356247|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19356248|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19356249|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356250|NCT03476538|Gabapentin|gabapentin|mesh-list
19356251|NCT03476538|Analgesics|analgesics|mesh-ancestor
19356252|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
19356253|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356254|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356255|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
19356256|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19356257|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19356258|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19356259|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19356260|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19356261|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19356262|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392831|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392832|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392833|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20392834|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20392835|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
20392836|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20392837|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20392838|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
20392839|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
20392840|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392841|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20392842|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20392843|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
19356263|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356264|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
19356265|NCT03476525|Fluoxetine|fluoxetine|mesh-list
19356266|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19356267|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19356268|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19356269|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356270|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356271|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
19356272|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356273|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19356274|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
19356275|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19356276|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19356277|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19356278|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356279|NCT03440112|Clarithromycin|clarithromycin|mesh-list
19356280|NCT03440112|Flumazenil|flumazenil|mesh-list
19356281|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19356282|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356283|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19356284|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685721|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685722|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
19356285|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356286|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19356287|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19356288|NCT03440112|Antidotes|antidotes|mesh-ancestor
19356289|NCT03440112|Protective Agents|protective agents|mesh-ancestor
19356290|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356291|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
19356292|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
19356293|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356294|NCT03435640|Nivolumab|nivolumab|mesh-list
19356295|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20207855|NCT00275106|Vincristine|vincristine|mesh-list
20207856|NCT00275106|Daunorubicin|daunorubicin|mesh-list
20207857|NCT00275106|Asparaginase|asparaginase|mesh-list
20207858|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
20207859|NCT00275106|Thioguanine|thioguanine|mesh-list
20207860|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
20207861|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207862|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
20207863|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207864|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356296|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356297|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19356298|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356299|NCT03434262|Gemcitabine|gemcitabine|mesh-list
19356300|NCT03434262|Trametinib|trametinib|mesh-list
19356301|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356302|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
19356303|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356304|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356305|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
19356306|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356307|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356308|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356309|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
19356310|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356311|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356312|NCT03425838|Letrozole|letrozole|mesh-list
19356313|NCT03425838|Fulvestrant|fulvestrant|mesh-list
20392844|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392845|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20392846|NCT01087437|Calcium|calcium|mesh-list
19356314|NCT03425838|Palbociclib|palbociclib|mesh-list
19356315|NCT03425838|Anastrozole|anastrozole|mesh-list
19356316|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19356317|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356318|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19356319|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356320|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356321|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19356322|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
19356323|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356324|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356325|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19356326|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19356327|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356328|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
19356329|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
19356330|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356331|NCT03404960|Nivolumab|nivolumab|mesh-list
19356332|NCT03404960|Ipilimumab|ipilimumab|mesh-list
19356333|NCT03404960|Niraparib|niraparib|mesh-list
19356334|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356335|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356336|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19356337|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392847|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20392848|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392849|NCT01087476|Doxycycline|doxycycline|mesh-list
20392850|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20392851|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392852|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
20392853|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20392854|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20392855|NCT01087554|Sirolimus|sirolimus|mesh-list
20392856|NCT01087554|Everolimus|everolimus|mesh-list
20392857|NCT01087554|Vorinostat|vorinostat|mesh-list
20392858|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392859|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20392860|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
20392861|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392862|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20392863|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392864|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20392865|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
20392866|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20392867|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392868|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356338|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19356339|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356340|NCT03367689|Olaparib|olaparib|mesh-list
19356341|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19356342|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356343|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392869|NCT01087567|Insulin|insulin|mesh-list
20392870|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19356344|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356345|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
19356346|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
19356347|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19356348|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19356349|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356350|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356351|NCT03364244|Urological Agents|urological agents|mesh-ancestor
19356352|NCT03334617|Trastuzumab|trastuzumab|mesh-list
19356353|NCT03334617|Durvalumab|durvalumab|mesh-list
19356354|NCT03334617|Olaparib|olaparib|mesh-list
19356355|NCT03334617|Cediranib|cediranib|mesh-list
19685723|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19685724|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20392871|NCT01087567|Metformin|metformin|mesh-list
19356356|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356357|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356358|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19356359|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356360|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356361|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356362|NCT03323151|Ixazomib|ixazomib|mesh-list
20392872|NCT01087567|Pioglitazone|pioglitazone|mesh-list
20392873|NCT01087567|Glimepiride|glimepiride|mesh-list
20392874|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19356363|NCT03323151|Glycine|glycine|mesh-list
19356364|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356365|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
19356366|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356367|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356368|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
19356369|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356370|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401415|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19401416|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
19401417|NCT03618264|Hormones|hormones|mesh-ancestor
19401418|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401419|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20392875|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392876|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20392877|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401420|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401421|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
19401422|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
19401423|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401424|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
20392878|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
20392879|NCT01087580|Prednisone|prednisone|mesh-list
20392880|NCT01087580|Docetaxel|docetaxel|mesh-list
20392881|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392882|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
20392883|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
19404597|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404598|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404599|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19404600|NCT03593317|Diuretics|diuretics|mesh-ancestor
19404601|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
19404602|NCT03593304|Vitamins|vitamins|mesh-list
19404603|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
19404604|NCT03593304|Pyridoxine|pyridoxine|mesh-list
19404605|NCT03593304|Pyridoxal|pyridoxal|mesh-list
19404606|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
19404607|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
19404608|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
19404609|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404610|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19404611|NCT03593291|Dalteparin|dalteparin|mesh-list
20392884|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
20392885|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404612|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
19404613|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20612992|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404614|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19404615|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685725|NCT03878524|Analgesics|analgesics|mesh-ancestor
19685726|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
20392886|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20392887|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
20612993|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
19356371|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
19356372|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356373|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356374|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
19356375|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19356376|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
19356377|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
19356378|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19356379|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356380|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19356381|NCT03283670|Analgesics|analgesics|mesh-ancestor
19356382|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
19356383|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356384|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
19356385|NCT03239145|Trebananib|trebananib|mesh-list
19356386|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356387|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356388|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19356389|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19356390|NCT03239145|Growth Substances|growth substances|mesh-ancestor
19356391|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356392|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
19356393|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
19356394|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
19356395|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356396|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356397|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356398|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
19356399|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
19356400|NCT03233217|Vaccines|vaccines|mesh-list
19356401|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
19356402|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356403|NCT03206047|Poly I-C|poly i-c|mesh-list
19356404|NCT03206047|Atezolizumab|atezolizumab|mesh-list
19356405|NCT03206047|Guadecitabine|guadecitabine|mesh-list
19356406|NCT03206047|Azacitidine|azacitidine|mesh-list
19356407|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19356408|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19356409|NCT03206047|Poly ICLC|poly iclc|mesh-list
19356410|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356411|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
19356412|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356413|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
19356414|NCT03206047|Laxatives|laxatives|mesh-ancestor
19356415|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19356416|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
19356417|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356418|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356419|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
19356420|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356421|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356422|NCT03205358|Vaccines|vaccines|mesh-list
19356423|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
19356424|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356425|NCT03198078|Aripiprazole|aripiprazole|mesh-list
19356426|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
19356427|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
19356428|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19356429|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19356430|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19356431|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19356432|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356433|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
19356434|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
19356435|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356436|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356437|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19356438|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19356439|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
19356440|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19356441|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19356442|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19356443|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19356444|NCT03182426|Liraglutide|liraglutide|mesh-list
19356445|NCT03182426|Plerixafor|plerixafor|mesh-list
19356446|NCT03182426|Etanercept|etanercept|mesh-list
19356447|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
19356448|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19356449|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19356450|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356451|NCT03182426|Incretins|incretins|mesh-ancestor
19356452|NCT03182426|Hormones|hormones|mesh-ancestor
19356453|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356454|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19356455|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20392888|NCT01087580|Hormones|hormones|mesh-ancestor
20392889|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392890|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392891|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20392892|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20392893|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20392894|NCT01087593|Estradiol|estradiol|mesh-list
19356456|NCT03182426|Analgesics|analgesics|mesh-ancestor
19356457|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
19356458|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356459|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19356460|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356461|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19356462|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356463|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
19356464|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356465|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356466|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19356467|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19356468|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
19356469|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356470|NCT03153111|Macitentan|macitentan|mesh-list
19356471|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19356472|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19356473|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356474|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19356475|NCT03093064|Natalizumab|natalizumab|mesh-list
19356476|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
19356477|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356478|NCT03063749|Sirolimus|sirolimus|mesh-list
19356479|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19356480|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356481|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19356482|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356483|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
19356484|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356485|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
19356486|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356487|NCT03013998|Cytarabine|cytarabine|mesh-list
19356488|NCT03013998|Azacitidine|azacitidine|mesh-list
19356489|NCT03013998|Decitabine|decitabine|mesh-list
19356490|NCT03013998|Daunorubicin|daunorubicin|mesh-list
19356491|NCT03013998|Venetoclax|venetoclax|mesh-list
19356492|NCT03013998|AZD5991|azd5991|mesh-list
19356493|NCT03013998|Pevonedistat|pevonedistat|mesh-list
19356494|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356495|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
19356496|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356497|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356498|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
19356499|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356500|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356501|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
19356502|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356503|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356504|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19356505|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19356506|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20392895|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20392896|NCT01087593|Estrogens|estrogens|mesh-ancestor
20392897|NCT01087593|Hormones|hormones|mesh-ancestor
20392898|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356507|NCT03011671|Temozolomide|temozolomide|mesh-list
19356508|NCT03011671|Acetazolamide|acetazolamide|mesh-list
19356509|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19356510|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
19401425|NCT03618173|Dexamethasone|dexamethasone|mesh-list
19356511|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356512|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356513|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
19356514|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19356515|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356516|NCT03011671|Diuretics|diuretics|mesh-ancestor
19356517|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
20392899|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392900|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20207865|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207866|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
20207867|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207868|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207869|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20207870|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20207871|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
20207872|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
20207873|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207874|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207875|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
20207876|NCT00275106|Hormones|hormones|mesh-ancestor
20207877|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20207878|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20392901|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
19356518|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356519|NCT03008616|Digoxin|digoxin|mesh-list
19356520|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19356521|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19356522|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356523|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356524|NCT03008616|Protective Agents|protective agents|mesh-ancestor
19356525|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356526|NCT02989636|Nivolumab|nivolumab|mesh-list
19356527|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356528|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356529|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19356530|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356531|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19356532|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19356533|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19356534|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
19356535|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356536|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356537|NCT02931695|Hormones|hormones|mesh-list
19356538|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356539|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356540|NCT02922777|Docetaxel|docetaxel|mesh-list
19356541|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356542|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356543|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356544|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356545|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356546|NCT02921035|Interferons|interferons|mesh-list
19356547|NCT02921035|Interferon-beta|interferon-beta|mesh-list
19356548|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
19356549|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356550|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
19356551|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356552|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
19356553|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356554|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19356555|NCT02885753|Leucovorin|leucovorin|mesh-list
19356556|NCT02885753|Folic Acid|folic acid|mesh-list
19356557|NCT02885753|Bevacizumab|bevacizumab|mesh-list
19685727|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685728|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19685729|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19685730|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19685731|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19685732|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19685733|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19685734|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19356558|NCT02885753|Panitumumab|panitumumab|mesh-list
19356559|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
20207879|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20207880|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20207881|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20207882|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207883|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20207884|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
20207885|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20207886|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207887|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
20207888|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
20207889|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20207890|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20207891|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
20207892|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207893|NCT00275106|Antidotes|antidotes|mesh-ancestor
20207894|NCT00275106|Protective Agents|protective agents|mesh-ancestor
20207895|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
20392902|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20392903|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20392904|NCT01087632|Folic Acid|folic acid|mesh-list
20392905|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
20392906|NCT01087632|Policosanol|policosanol|mesh-list
20392907|NCT01087632|Red yeast rice|red yeast rice|mesh-list
19356560|NCT02885753|Irinotecan|irinotecan|mesh-list
19356561|NCT02885753|Fluorouracil|fluorouracil|mesh-list
19356562|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
19356563|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356564|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356565|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19356566|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19356567|NCT02885753|Growth Substances|growth substances|mesh-ancestor
19356568|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356569|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
19685735|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19685736|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19685737|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19685738|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
19685739|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
19685740|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
19356570|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19356571|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19356572|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356573|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356574|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
19356575|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356576|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356577|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
19356578|NCT02885753|Antidotes|antidotes|mesh-ancestor
19356579|NCT02885753|Protective Agents|protective agents|mesh-ancestor
19356580|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
19356581|NCT02885753|Vitamins|vitamins|mesh-ancestor
19356582|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
19356583|NCT02885753|Hematinics|hematinics|mesh-ancestor
19356584|NCT02881086|Cytarabine|cytarabine|mesh-list
19356585|NCT02881086|Dexamethasone|dexamethasone|mesh-list
19356586|NCT02881086|Prednisolone|prednisolone|mesh-list
19356587|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
19685741|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19685742|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
19685743|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
19685744|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19685745|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20207896|NCT00275106|Vitamins|vitamins|mesh-ancestor
20207897|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
20207898|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20207899|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
20207900|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207901|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
20207902|NCT00275119|Gemcitabine|gemcitabine|mesh-list
20207903|NCT00275119|Fluorouracil|fluorouracil|mesh-list
19356588|NCT02881086|Rituximab|rituximab|mesh-list
19356589|NCT02881086|Methotrexate|methotrexate|mesh-list
19356590|NCT02881086|Fludarabine|fludarabine|mesh-list
19685746|NCT03875313|Talazoparib|talazoparib|mesh-list
19356591|NCT02881086|Vincristine|vincristine|mesh-list
19356592|NCT02881086|Doxorubicin|doxorubicin|mesh-list
20207904|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
20207905|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20207906|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
20392908|NCT01087632|Hematinics|hematinics|mesh-ancestor
19356593|NCT02881086|Daunorubicin|daunorubicin|mesh-list
19356594|NCT02881086|Asparaginase|asparaginase|mesh-list
19356595|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
19356596|NCT02881086|Idarubicin|idarubicin|mesh-list
19356597|NCT02881086|Pegaspargase|pegaspargase|mesh-list
19356598|NCT02881086|Vindesine|vindesine|mesh-list
19356599|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356600|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
19356601|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356602|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356603|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19356604|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
19356605|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356606|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356607|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19356608|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356609|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19356610|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
19356611|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
19356612|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356613|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19356614|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
19356615|NCT02881086|Hormones|hormones|mesh-ancestor
19356616|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356617|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19356618|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19356619|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
19356620|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19356621|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356622|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
19356623|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
19356624|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356625|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19356626|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19356627|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
19356628|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356629|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356630|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356631|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356632|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356633|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19356634|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19356635|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19356636|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
19356637|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19844314|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844315|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844316|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844317|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19844318|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19844319|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207907|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356638|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
19356639|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356640|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356641|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19356642|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
19356643|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19685747|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19685748|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685749|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685750|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685751|NCT03867318|Atorvastatin|atorvastatin|mesh-list
19685752|NCT03867318|Ezetimibe|ezetimibe|mesh-list
19685753|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19685754|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19685755|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
20207908|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207909|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
20207910|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207911|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207912|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20207913|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
19356644|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
20207914|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356645|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685756|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356646|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356647|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19356648|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
19356649|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
19356650|NCT02836899|Protective Agents|protective agents|mesh-ancestor
19356651|NCT02824575|Paclitaxel|paclitaxel|mesh-list
19356652|NCT02824575|Rebastinib|rebastinib|mesh-list
19356653|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356654|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356655|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356656|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356657|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356658|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356659|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20392909|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
20392910|NCT01087632|Vitamins|vitamins|mesh-ancestor
20392911|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
20392912|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392913|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20392914|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20392915|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
20392916|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392917|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20392918|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20392919|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20392920|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392921|NCT01087658|Calcium|calcium|mesh-list
20392922|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20392923|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392924|NCT01087710|Vitamins|vitamins|mesh-list
20392925|NCT01087710|Antioxidants|antioxidants|mesh-list
20392926|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
20392927|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392928|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392929|NCT01087710|Protective Agents|protective agents|mesh-ancestor
20392930|NCT01087749|Losartan|losartan|mesh-list
20392931|NCT01087749|Propranolol|propranolol|mesh-list
20392932|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20392933|NCT01087749|Eprosartan|eprosartan|mesh-list
20392934|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20392935|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20392936|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20392937|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19356660|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356661|NCT02822378|Vitamin D|vitamin d|mesh-list
19356662|NCT02822378|Calcium|calcium|mesh-list
19356663|NCT02822378|Vitamins|vitamins|mesh-ancestor
19356664|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
19356665|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356666|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19356667|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19356668|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
19356669|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356670|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356671|NCT02807181|Gemcitabine|gemcitabine|mesh-list
19356672|NCT02807181|Cisplatin|cisplatin|mesh-list
19356673|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356674|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356675|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
19356676|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356677|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
19356678|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356679|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356680|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356681|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
19356682|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685757|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20392938|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392939|NCT01087749|Diuretics|diuretics|mesh-ancestor
20392940|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
20612994|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
19356683|NCT02749968|Bupivacaine|bupivacaine|mesh-list
19356684|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
20392941|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356685|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
19356686|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19356687|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356688|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
19356689|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356690|NCT02713776|Pasireotide|pasireotide|mesh-list
19356691|NCT02713776|Somatostatin|somatostatin|mesh-list
19356692|NCT02713776|Hormones|hormones|mesh-ancestor
19356693|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356694|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356695|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
19356696|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356697|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356698|NCT02637531|Nivolumab|nivolumab|mesh-list
20207915|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20207916|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207917|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20207918|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207919|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207920|NCT00275184|Metoclopramide|metoclopramide|mesh-list
19356699|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356700|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356701|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19356702|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356703|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
19356704|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19356705|NCT02573233|Fluticasone|fluticasone|mesh-list
19356706|NCT02573233|Xhance|xhance|mesh-list
19356707|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
19356708|NCT02573233|Budesonide|budesonide|mesh-list
19356709|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
19356710|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19356711|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19356712|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19356713|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
19356714|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356715|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356716|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19356717|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
19356718|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
19356719|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19356720|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
19356721|NCT02573233|Hormones|hormones|mesh-ancestor
19356722|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356723|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19356724|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19356725|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19356726|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
19356727|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356728|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356729|NCT02439658|Sotalol|sotalol|mesh-list
19356730|NCT02439658|Dofetilide|dofetilide|mesh-list
19685758|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19685759|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685760|NCT03867188|Bupivacaine|bupivacaine|mesh-list
19685761|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
19685762|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
19685763|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685764|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685765|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
19685766|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685767|NCT03867110|Atorvastatin|atorvastatin|mesh-list
19685768|NCT03867110|Ezetimibe|ezetimibe|mesh-list
19685769|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19685770|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19685771|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
19692746|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207921|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
20207922|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
20207923|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20612995|NCT02253784|Dexamethasone|dexamethasone|mesh-list
19356731|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19356732|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19356733|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
19401426|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
19356734|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356735|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356736|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356737|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19356738|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
19356739|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
19356740|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844320|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392942|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19356741|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19356742|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19356743|NCT02425904|Clofarabine|clofarabine|mesh-list
19356744|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356745|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
19356746|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356747|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356748|NCT02420795|TIC10 compound|tic10 compound|mesh-list
19356749|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356750|NCT02384759|Aflibercept|aflibercept|mesh-list
19356751|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19356752|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19356753|NCT02384759|Growth Substances|growth substances|mesh-ancestor
19356754|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356755|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
19356756|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356757|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
19356758|NCT02367846|NuvaRing|nuvaring|mesh-list
19356759|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
19356760|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19356761|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19356762|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356763|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19356764|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19356765|NCT02274662|Cyclosporine|cyclosporine|mesh-list
19356766|NCT02274662|Tacrolimus|tacrolimus|mesh-list
19356767|NCT02274662|Cyclosporins|cyclosporins|mesh-list
19356768|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19356769|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
19356770|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356771|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
19356772|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356773|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19356774|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356775|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356776|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
19685772|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685773|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19685774|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19685775|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685776|NCT03865082|Nivolumab|nivolumab|mesh-list
19685777|NCT03865082|Ipilimumab|ipilimumab|mesh-list
19685778|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685779|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356777|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356778|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
19356779|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356780|NCT02243878|Ranibizumab|ranibizumab|mesh-list
19356781|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19356782|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19356783|NCT02243878|Growth Substances|growth substances|mesh-ancestor
19356784|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356785|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
19356786|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356787|NCT02199691|Vaccines|vaccines|mesh-list
19356788|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
19356789|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356790|NCT02199665|Dexamethasone|dexamethasone|mesh-list
19401427|NCT03618173|BB 1101|bb 1101|mesh-list
19685780|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19685781|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685782|NCT03840915|Gemcitabine|gemcitabine|mesh-list
19685783|NCT03840915|Paclitaxel|paclitaxel|mesh-list
19685784|NCT03840915|Docetaxel|docetaxel|mesh-list
19685785|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19685786|NCT03840915|Carboplatin|carboplatin|mesh-list
19685787|NCT03840915|Pemetrexed|pemetrexed|mesh-list
19685788|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685789|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685790|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685791|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685792|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685793|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685794|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356791|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19356792|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
19356793|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
19356794|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356795|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356796|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19356797|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
19356798|NCT02199665|Hormones|hormones|mesh-ancestor
19356799|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356800|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19356801|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356802|NCT02163694|Paclitaxel|paclitaxel|mesh-list
19356803|NCT02163694|Carboplatin|carboplatin|mesh-list
19356804|NCT02163694|Veliparib|veliparib|mesh-list
19356805|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356806|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356807|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356808|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356809|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356810|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356811|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19356812|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356813|NCT02143726|Everolimus|everolimus|mesh-list
19685795|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
19844321|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844322|NCT00664755|Nicotine|nicotine|mesh-list
19356814|NCT02143726|Sorafenib|sorafenib|mesh-list
19356815|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356816|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356817|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
19356818|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356819|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356820|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356821|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356822|NCT02091141|Trastuzumab|trastuzumab|mesh-list
19356823|NCT02091141|Pertuzumab|pertuzumab|mesh-list
19356824|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19844323|NCT00664755|Varenicline|varenicline|mesh-list
19844324|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19844325|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
19844326|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844327|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844328|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19844329|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19844330|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
19844331|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844332|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844333|NCT00664859|Atorvastatin|atorvastatin|mesh-list
19844334|NCT00664859|Fenofibrate|fenofibrate|mesh-list
19844335|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19844336|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19844337|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
20207924|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207925|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20207926|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20207927|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20207928|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
20207929|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207930|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207931|NCT00275197|Sertraline|sertraline|mesh-list
20207932|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
20207933|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20207934|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19356825|NCT02091141|Atezolizumab|atezolizumab|mesh-list
19356826|NCT02091141|Vemurafenib|vemurafenib|mesh-list
19685796|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
19844338|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844339|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20612996|NCT02253784|Bupivacaine|bupivacaine|mesh-list
19356827|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356828|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356829|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356830|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356831|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356832|NCT02088112|Durvalumab|durvalumab|mesh-list
19685797|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685798|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685799|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685800|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
19685801|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685802|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19685803|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19685804|NCT03746080|Plerixafor|plerixafor|mesh-list
19685805|NCT03746080|Temozolomide|temozolomide|mesh-list
19685806|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19685807|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
19844340|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19844341|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844342|NCT00665002|Sargramostim|sargramostim|mesh-list
19844343|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
19844344|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848245|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848246|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848247|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848248|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356833|NCT02088112|Gefitinib|gefitinib|mesh-list
19356834|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356835|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356836|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356837|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356838|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356839|NCT02076620|Doxorubicin|doxorubicin|mesh-list
19356840|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19356841|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356842|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19356843|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19356844|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356845|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356846|NCT02010593|Dapivirine|dapivirine|mesh-list
19356847|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19356848|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19685808|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685809|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685810|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19356849|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
19356850|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356851|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19356852|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
19356853|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356854|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19356855|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
19356856|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356857|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356858|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19356859|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19356860|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19356861|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19356862|NCT01946074|Paclitaxel|paclitaxel|mesh-list
19356863|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356864|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356865|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356866|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356867|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356868|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356869|NCT01842035|Regadenoson|regadenoson|mesh-list
19685811|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19685812|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
19685813|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685814|NCT03715933|Carboplatin|carboplatin|mesh-list
19685815|NCT03715933|Fluorouracil|fluorouracil|mesh-list
19356870|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19685816|NCT03715933|Irinotecan|irinotecan|mesh-list
19685817|NCT03715933|Pemetrexed|pemetrexed|mesh-list
19685818|NCT03715933|Temozolomide|temozolomide|mesh-list
19685819|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685820|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
19685821|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685822|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19685823|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685824|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
19685825|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692747|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
20392943|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20392944|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20392945|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20392946|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
20392947|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20392948|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
20392949|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
20392950|NCT01087840|Tenofovir|tenofovir|mesh-list
19356871|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19356872|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
19356873|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
19356874|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19356875|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356876|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356877|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19356878|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19356879|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
19356880|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356881|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19356882|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356883|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19356884|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356885|NCT01732627|Vaccines|vaccines|mesh-list
19356886|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
19356887|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356888|NCT01702571|Trastuzumab|trastuzumab|mesh-list
19356889|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19356890|NCT01702571|Maytansine|maytansine|mesh-list
20392951|NCT01087840|Emtricitabine|emtricitabine|mesh-list
20392952|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
19356891|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356892|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356893|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356894|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
19356895|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
19356896|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
19356897|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401428|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401429|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
19401430|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
19401431|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401432|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401433|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19401434|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
19401435|NCT03618173|Hormones|hormones|mesh-ancestor
19401436|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401437|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19401438|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401439|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
19401440|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401441|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401442|NCT03618108|Azithromycin|azithromycin|mesh-list
19401443|NCT03618108|Doxycycline|doxycycline|mesh-list
19401444|NCT03618108|Rifabutin|rifabutin|mesh-list
19401445|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19401446|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401447|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
19401448|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19401449|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19401450|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19401451|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
19401452|NCT03618082|Desflurane|desflurane|mesh-list
19401453|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19401454|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
20392953|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
20392954|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356898|NCT01581840|Panitumumab|panitumumab|mesh-list
19356899|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356900|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356901|NCT01578239|Octreotide|octreotide|mesh-list
19356902|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19356903|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19356904|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19356905|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356906|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19356907|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356908|NCT01411267|Cytarabine|cytarabine|mesh-list
19356909|NCT01411267|Methotrexate|methotrexate|mesh-list
19356910|NCT01411267|Etoposide|etoposide|mesh-list
19356911|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
19356912|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19356913|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
19356914|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19356915|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356916|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19356917|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
19356918|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356919|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356920|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
19356921|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356922|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19356923|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356924|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
19356925|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356926|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19356927|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19356928|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19356929|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19356930|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
19356931|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356932|NCT01357772|Tamoxifen|tamoxifen|mesh-list
19356933|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19356934|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
19356935|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356936|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356937|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19356938|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356939|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19356940|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19356941|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19356942|NCT01336634|Trametinib|trametinib|mesh-list
19356943|NCT01336634|Dabrafenib|dabrafenib|mesh-list
19356944|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356945|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19356946|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356947|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356948|NCT01312857|Panitumumab|panitumumab|mesh-list
19356949|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19356950|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356951|NCT01220531|Cyclosporine|cyclosporine|mesh-list
19356952|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
19356953|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
19356954|NCT01220531|Prednisolone|prednisolone|mesh-list
19356955|NCT01220531|Tacrolimus|tacrolimus|mesh-list
19356956|NCT01220531|Cyclosporins|cyclosporins|mesh-list
19356957|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19356958|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
19356959|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19356960|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
19356961|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356962|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19356963|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19356964|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19356965|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
19356966|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356967|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
19356968|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19356969|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19356970|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19356971|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19356972|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
20612997|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20612998|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
19356973|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19356974|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19356975|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
19356976|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
19356977|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19356978|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19356979|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
19356980|NCT01220531|Hormones|hormones|mesh-ancestor
19356981|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19356982|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19356983|NCT01220531|Protective Agents|protective agents|mesh-ancestor
19356984|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19356985|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
19356986|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19356987|NCT01155375|Hematinics|hematinics|mesh-ancestor
19356988|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19356989|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19356990|NCT01155375|Trace Elements|trace elements|mesh-ancestor
19356991|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
19356992|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19356993|NCT00799058|Dapivirine|dapivirine|mesh-list
19356994|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19356995|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19356996|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
19356997|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19356998|NCT00788684|Rituximab|rituximab|mesh-list
19356999|NCT00788684|Navitoclax|navitoclax|mesh-list
19357000|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357001|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357002|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
19357003|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685826|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19685827|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19685828|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685829|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19685830|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19685831|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20207935|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20207936|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20207937|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207938|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207939|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
20207940|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207941|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
20207942|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357004|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357005|NCT00785798|Doxorubicin|doxorubicin|mesh-list
19357006|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19357007|NCT00785798|Vorinostat|vorinostat|mesh-list
19357008|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19357009|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357010|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357011|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357012|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357013|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357014|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19357015|NCT00673010|Iodine|iodine|mesh-list
19357016|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19357017|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357018|NCT00673010|Trace Elements|trace elements|mesh-ancestor
19357019|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
19685832|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
19685833|NCT03713944|Bevacizumab|bevacizumab|mesh-list
20207943|NCT00275236|Rotigotine|rotigotine|mesh-list
20207944|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
20207945|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
20207946|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207947|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207948|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357020|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357021|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
19357022|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20207949|NCT00275249|Levorphanol|levorphanol|mesh-list
20612999|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
19357023|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357024|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
19357025|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19357026|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19357027|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357028|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357029|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357030|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357031|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357032|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357033|NCT00360425|Hematinics|hematinics|mesh-ancestor
19357034|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19357035|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19357036|NCT00346125|Doxorubicin|doxorubicin|mesh-list
19357037|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19357038|NCT00346125|Ifosfamide|ifosfamide|mesh-list
19357039|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19357040|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19357041|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357042|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357043|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357044|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357045|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357046|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19357047|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
19357048|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19357049|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19357050|NCT00233597|Hematinics|hematinics|mesh-ancestor
19357051|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19357052|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19357053|NCT04335669|Paclitaxel|paclitaxel|mesh-list
19357054|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19357055|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
19357056|NCT04335669|Carboplatin|carboplatin|mesh-list
19357057|NCT04335669|Capecitabine|capecitabine|mesh-list
19357058|NCT04335669|Epirubicin|epirubicin|mesh-list
19357059|NCT04335669|Taxane|taxane|mesh-list
19357060|NCT04335669|Antimetabolites|antimetabolites|mesh-list
19685834|NCT03713944|Carboplatin|carboplatin|mesh-list
19685835|NCT03713944|Pemetrexed|pemetrexed|mesh-list
19685836|NCT03713944|Atezolizumab|atezolizumab|mesh-list
19685837|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685838|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685839|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19685840|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19685841|NCT03713944|Growth Substances|growth substances|mesh-ancestor
19685842|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685843|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
19685844|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685845|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685846|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19685847|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19685848|NCT03708224|Atezolizumab|atezolizumab|mesh-list
19685849|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685850|NCT03689855|Atezolizumab|atezolizumab|mesh-list
19685851|NCT03689855|Ramucirumab|ramucirumab|mesh-list
19685852|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685853|NCT03681561|Nivolumab|nivolumab|mesh-list
19685854|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20392955|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20392956|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20392957|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20392958|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392959|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19357061|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19357062|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685855|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685856|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19685857|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844345|NCT00665353|Pioglitazone|pioglitazone|mesh-list
19844346|NCT00665353|Ribavirin|ribavirin|mesh-list
19844347|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
19844348|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685858|NCT03639246|Paclitaxel|paclitaxel|mesh-list
19844349|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
19357063|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
19357064|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19844350|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844351|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19844352|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844353|NCT00665366|Valproic Acid|valproic acid|mesh-list
19844354|NCT00665366|Aripiprazole|aripiprazole|mesh-list
19357065|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19357066|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357067|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357068|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
19357069|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357070|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357071|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19357072|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
19357073|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19357074|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19357075|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19357076|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357077|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357078|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357079|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
20392960|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20392961|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20392962|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20392963|NCT01087866|Metformin|metformin|mesh-list
20392964|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20392965|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392966|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20392967|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19357080|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19357081|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19357082|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19357083|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19357084|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357085|NCT04323189|Incretins|incretins|mesh-ancestor
19357086|NCT04323189|Hormones|hormones|mesh-ancestor
19357087|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357088|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19357089|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
19357090|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357091|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357092|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
19357093|NCT04313153|Hematinics|hematinics|mesh-ancestor
19357094|NCT04282811|Venetoclax|venetoclax|mesh-list
19357095|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357096|NCT04279197|Ascorbic Acid|ascorbic acid|mesh-list
19357097|NCT04279197|Vitamins|vitamins|mesh-ancestor
19357098|NCT04279197|Micronutrients|micronutrients|mesh-ancestor
19357099|NCT04279197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357100|NCT04279197|Antioxidants|antioxidants|mesh-ancestor
19357101|NCT04279197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357102|NCT04279197|Protective Agents|protective agents|mesh-ancestor
19357103|NCT04245085|Paclitaxel|paclitaxel|mesh-list
19357104|NCT04245085|Bevacizumab|bevacizumab|mesh-list
19357105|NCT04245085|Carboplatin|carboplatin|mesh-list
19357106|NCT04245085|Pemetrexed|pemetrexed|mesh-list
19357107|NCT04245085|Atezolizumab|atezolizumab|mesh-list
19357108|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19357109|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685859|NCT03639246|Doxorubicin|doxorubicin|mesh-list
19685860|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19357110|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
19357111|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
19357112|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685861|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685862|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685863|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685864|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685865|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685866|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685867|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19685868|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19685869|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19685870|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844355|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
20392968|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19685871|NCT03498378|Cetuximab|cetuximab|mesh-list
19844356|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844357|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19844358|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19844359|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844360|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844361|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
19685872|NCT03498378|Avelumab|avelumab|mesh-list
19685873|NCT03498378|Palbociclib|palbociclib|mesh-list
19685874|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685875|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685876|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19685877|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685878|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357113|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357114|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357115|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357116|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19357117|NCT04245085|Growth Substances|growth substances|mesh-ancestor
19357118|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357119|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
19357120|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357121|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19685879|NCT03466801|Prednisone|prednisone|mesh-list
19844362|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
19844363|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844364|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844365|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19844366|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19357122|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19357123|NCT04235855|Liver Extracts|liver extracts|mesh-list
19357124|NCT04235855|Hematinics|hematinics|mesh-ancestor
19357125|NCT04234945|Doxycycline|doxycycline|mesh-list
19357126|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19357127|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357128|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
19357129|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19357130|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19357131|NCT04192370|Cannabidiol|cannabidiol|mesh-list
19357132|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
19357133|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
19357134|NCT04188028|Paroxetine|paroxetine|mesh-list
19357135|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19357136|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19357137|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19357138|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357139|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357140|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
19685880|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
19685881|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19685882|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357141|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357142|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19357143|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
19357144|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19357145|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19357146|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19357147|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357148|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
19357149|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
19685883|NCT03466801|Hormones|hormones|mesh-ancestor
19685884|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19685885|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685886|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19685887|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685888|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
19685889|NCT03466450|Temozolomide|temozolomide|mesh-list
19685890|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19685891|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
19685892|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685893|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685894|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
19844367|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
19357150|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19357151|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19685895|NCT03449888|Calcium|calcium|mesh-list
19685896|NCT03449888|Regadenoson|regadenoson|mesh-list
19685897|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19685898|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685899|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19685900|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19685901|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19685902|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
19685903|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
19685904|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19685905|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357152|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
19357153|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357154|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357155|NCT04154800|Itraconazole|itraconazole|mesh-list
19357156|NCT04154800|Diltiazem|diltiazem|mesh-list
19357157|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
19357158|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357159|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19357160|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19357161|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357162|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357163|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19357164|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
19357165|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357166|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357167|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19357168|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19357169|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19357170|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19357171|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19357172|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
19357173|NCT04127968|Vitamin A|vitamin a|mesh-list
19357174|NCT04127968|Vitamins|vitamins|mesh-ancestor
19357175|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
19357176|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685906|NCT03415854|Gemcitabine|gemcitabine|mesh-list
19685907|NCT03415854|Paclitaxel|paclitaxel|mesh-list
19685908|NCT03415854|Cisplatin|cisplatin|mesh-list
19685909|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19685910|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685911|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685912|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685913|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
19357177|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
20207950|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19357178|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19685914|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685915|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844368|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19844369|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19844370|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20207951|NCT00275249|Narcotics|narcotics|mesh-ancestor
20207952|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357179|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357180|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19357181|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357182|NCT04056962|Tacrolimus|tacrolimus|mesh-list
19357183|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357184|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
19357185|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357186|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19357187|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685916|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844371|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19844372|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844373|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
19844374|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
19844375|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
19844376|NCT00665392|Docetaxel|docetaxel|mesh-list
19844377|NCT00665392|Fluorouracil|fluorouracil|mesh-list
19844378|NCT00665392|Cetuximab|cetuximab|mesh-list
19844379|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844380|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685917|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
19685918|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
19685919|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19685920|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19685921|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357188|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357189|NCT04051268|Vaccines|vaccines|mesh-list
19357190|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
19357191|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357205|NCT04031508|SMOFlipid|smoflipid|mesh-list
19357206|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19357207|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19357208|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19357209|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19357210|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19357211|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357212|NCT04017832|Incretins|incretins|mesh-ancestor
19685922|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
19685923|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685924|NCT03408873|Aripiprazole|aripiprazole|mesh-list
19685925|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
19357213|NCT04017832|Hormones|hormones|mesh-ancestor
19357214|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357215|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19357216|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
19357217|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357218|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357219|NCT04006522|Atezolizumab|atezolizumab|mesh-list
19357220|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401455|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
19401456|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401457|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401458|NCT03617900|Acetaminophen|acetaminophen|mesh-list
20392969|NCT01087879|Etonogestrel|etonogestrel|mesh-list
20392970|NCT01087879|Desogestrel|desogestrel|mesh-list
20392971|NCT01087879|NuvaRing|nuvaring|mesh-list
20392972|NCT01087879|Norelgestromin|norelgestromin|mesh-list
20392973|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
19685926|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19685927|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19685928|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20392974|NCT01087879|Estradiol|estradiol|mesh-list
19401459|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401460|NCT03617900|Analgesics|analgesics|mesh-ancestor
19401461|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
19401462|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685929|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685930|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685931|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
19685932|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
19685933|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844381|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
20207953|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207954|NCT00275249|Analgesics|analgesics|mesh-ancestor
20207955|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
20207956|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20207957|NCT00275314|Valganciclovir|valganciclovir|mesh-list
20207958|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
20207959|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207960|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
20207961|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
20207962|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20392975|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20392976|NCT01087879|Estrogens|estrogens|mesh-ancestor
20392977|NCT01087879|Hormones|hormones|mesh-ancestor
19844382|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
19844383|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844384|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
19844385|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844386|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844387|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
19844388|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844389|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844390|NCT00665431|Celecoxib|celecoxib|mesh-list
19844391|NCT00665431|Antacids|antacids|mesh-list
19844392|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19357221|NCT03945825|Vaccines|vaccines|mesh-list
19357222|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
19357223|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844393|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844394|NCT00665431|Analgesics|analgesics|mesh-ancestor
19844395|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
19844396|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844397|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844398|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844399|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844400|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19844401|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19844402|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844403|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357224|NCT03942419|Atropine|atropine|mesh-list
19357225|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19357226|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19357227|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19357228|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19357229|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19357230|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
19357231|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357232|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357233|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20207963|NCT00275405|Protective Agents|protective agents|mesh-ancestor
19685934|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685935|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19685936|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19685937|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
19685938|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19685939|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19685940|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19685941|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19685942|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
19685943|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685944|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685945|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
19685946|NCT03375645|Narcotics|narcotics|mesh-ancestor
19685947|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19685948|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685949|NCT03375645|Analgesics|analgesics|mesh-ancestor
19357234|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
19685950|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
19685951|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19685952|NCT03363763|Sirolimus|sirolimus|mesh-list
19685953|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19844404|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357235|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
19357236|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
19357237|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19357238|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19357239|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
19357240|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357241|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844405|NCT00665457|Celecoxib|celecoxib|mesh-list
20207964|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207965|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20207966|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207967|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20207968|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20207969|NCT00275418|Beta Carotene|beta carotene|mesh-list
20207970|NCT00275418|Carotenoids|carotenoids|mesh-list
20207971|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
19357242|NCT03877354|Anesthetics|anesthetics|mesh-list
19357243|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357244|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357245|NCT03733925|Golimumab|golimumab|mesh-list
19357246|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19357247|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357248|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357249|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
19357250|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392978|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20392979|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392980|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20392981|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20392982|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20392983|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20392984|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20392985|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20392986|NCT01087879|Progestins|progestins|mesh-ancestor
20392987|NCT01087983|Metformin|metformin|mesh-list
20392988|NCT01087983|Sirolimus|sirolimus|mesh-list
20392989|NCT01087983|Lapatinib|lapatinib|mesh-list
20392990|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20392991|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20392992|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20392993|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20392994|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20392995|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20392996|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
20392997|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20392998|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
19357251|NCT03659578|Thymalfasin|thymalfasin|mesh-list
19357252|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19357253|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
19357254|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357255|NCT03629873|Cytarabine|cytarabine|mesh-list
19357256|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
19357257|NCT03629873|Carmustine|carmustine|mesh-list
19357258|NCT03629873|Etoposide|etoposide|mesh-list
19357259|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357260|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
19357261|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357262|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357263|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19357264|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
19357265|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357266|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357267|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19357268|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19357269|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357270|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357271|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357272|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19357273|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
19357274|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
19357275|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357276|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19357277|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357278|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357279|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19357280|NCT03608865|Durvalumab|durvalumab|mesh-list
19357281|NCT03608865|Tremelimumab|tremelimumab|mesh-list
20392999|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20393000|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393001|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393002|NCT01088009|Lamivudine|lamivudine|mesh-list
20393003|NCT01088009|Adefovir|adefovir|mesh-list
20393004|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20393005|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20393006|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393007|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393008|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
19357282|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357283|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357284|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
19357285|NCT03602235|Melphalan|melphalan|mesh-list
19357286|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20393009|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393010|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20393011|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20393012|NCT01088022|Dexamethasone|dexamethasone|mesh-list
20393013|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
20393014|NCT01088022|Aprepitant|aprepitant|mesh-list
20393015|NCT01088022|Palonosetron|palonosetron|mesh-list
20393016|NCT01088022|BB 1101|bb 1101|mesh-list
20393017|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357287|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
19357288|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357289|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357290|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19357291|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357292|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
19357293|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357294|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
19357295|NCT03602235|Protective Agents|protective agents|mesh-ancestor
19357296|NCT03602235|Vitamins|vitamins|mesh-ancestor
19357297|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
19357298|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
19357299|NCT03560193|Ethanol|ethanol|mesh-list
19357300|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
19357301|NCT03560193|Povidone|povidone|mesh-list
19357302|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19357303|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357304|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
19357305|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357306|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357307|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
19357308|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
19357309|NCT03557281|GSK656|gsk656|mesh-list
20207972|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207973|NCT00275418|Protective Agents|protective agents|mesh-ancestor
20207974|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207975|NCT00275418|Provitamins|provitamins|mesh-ancestor
20207976|NCT00275418|Vitamins|vitamins|mesh-ancestor
19357310|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19685954|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207977|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
20207978|NCT00275444|Tipranavir|tipranavir|mesh-list
20207979|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20207980|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20207981|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
20207982|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207983|NCT00275457|Pramipexole|pramipexole|mesh-list
19685955|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20207984|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
20207985|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20207986|NCT00275457|Protective Agents|protective agents|mesh-ancestor
20207987|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207988|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20207989|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20207990|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
20207991|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
20207992|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20207993|NCT00275522|Sirolimus|sirolimus|mesh-list
20207994|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20207995|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20207996|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20207997|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393018|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
19357311|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357312|NCT03557242|Aspirin|aspirin|mesh-list
19357313|NCT03557242|Warfarin|warfarin|mesh-list
19685956|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685957|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
19685958|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19685959|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
19685960|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685961|NCT03332667|Vorinostat|vorinostat|mesh-list
19685962|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19685963|NCT03332667|Dinutuximab|dinutuximab|mesh-list
19685964|NCT03332667|Sargramostim|sargramostim|mesh-list
19685965|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
19685966|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20207998|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
20393019|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
20393020|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357314|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19357315|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19357316|NCT03557242|Analgesics|analgesics|mesh-ancestor
19357317|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
19357318|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357319|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357320|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357321|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357322|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19357323|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19357324|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357325|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19357326|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19357327|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357328|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
19357329|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
19357330|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
19357331|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
19357332|NCT03516279|Dasatinib|dasatinib|mesh-list
19357333|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357334|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357335|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19357336|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357337|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357338|NCT03508739|Valsartan|valsartan|mesh-list
19357339|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19357340|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19357341|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19357342|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357343|NCT03473561|Racecadotril|racecadotril|mesh-list
20393021|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393022|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20393023|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
20393024|NCT01088022|Hormones|hormones|mesh-ancestor
20393025|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393026|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20393027|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393028|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
20393029|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393030|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393031|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20393032|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393033|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20393034|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20393035|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
20393036|NCT01088035|Carboplatin|carboplatin|mesh-list
20393037|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393038|NCT01088165|Adalimumab|adalimumab|mesh-list
19357344|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
19357345|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357346|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
19357347|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357348|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685967|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20207999|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208000|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
20208001|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393039|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393040|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393041|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
20393042|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20393043|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
20393044|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20393045|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357349|NCT03455517|Rituximab|rituximab|mesh-list
19685968|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19685969|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844406|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
20208002|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
20208003|NCT00275535|Sirolimus|sirolimus|mesh-list
20208004|NCT00275535|Prednisone|prednisone|mesh-list
20208005|NCT00275535|Tacrolimus|tacrolimus|mesh-list
20208006|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
20208007|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20393046|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20393047|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20393048|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20393049|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
20393050|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20393051|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
20393052|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357350|NCT03455517|Venetoclax|venetoclax|mesh-list
19357351|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357352|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357353|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
19357354|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357355|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357356|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
19357357|NCT03419234|Prednisone|prednisone|mesh-list
19357358|NCT03419234|Cortisone|cortisone|mesh-list
20208008|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20208009|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
19357359|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
19357360|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
19357361|NCT03419234|Hormones|hormones|mesh-list
19357362|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19357363|NCT03419234|Androgens|androgens|mesh-list
19357364|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
19357365|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357366|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
19357367|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357368|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357369|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19357370|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357371|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19357372|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357373|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357374|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
19357375|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19357376|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
19357377|NCT03419234|Protective Agents|protective agents|mesh-ancestor
20208010|NCT00275535|Hormones|hormones|mesh-ancestor
20208011|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208012|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208013|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20208014|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208015|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208016|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
20208017|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20393053|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
19357378|NCT03419234|Vitamins|vitamins|mesh-ancestor
19357379|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
19357380|NCT03419234|Estrogens|estrogens|mesh-ancestor
19357381|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
19357382|NCT03383679|Capecitabine|capecitabine|mesh-list
19357383|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19357384|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
19357385|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685970|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685971|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19685972|NCT03321045|Trastuzumab|trastuzumab|mesh-list
19685973|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685974|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357386|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357387|NCT03367299|Blinatumomab|blinatumomab|mesh-list
19357388|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357389|NCT03341806|Avelumab|avelumab|mesh-list
19357390|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357391|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357392|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
19357393|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357394|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357395|NCT03271047|Nivolumab|nivolumab|mesh-list
19357396|NCT03271047|Ipilimumab|ipilimumab|mesh-list
19357397|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357398|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357399|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19357400|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404616|NCT03593135|Metformin|metformin|mesh-list
19685975|NCT03308396|Durvalumab|durvalumab|mesh-list
20393054|NCT01088191|Protective Agents|protective agents|mesh-ancestor
19357401|NCT03171480|Isosorbide|isosorbide|mesh-list
19357402|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19357403|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19357404|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19357405|NCT03171480|Diuretics|diuretics|mesh-ancestor
19357406|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
19357407|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357408|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
19357409|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19357410|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357411|NCT03164655|Leucovorin|leucovorin|mesh-list
19357412|NCT03164655|Bevacizumab|bevacizumab|mesh-list
19357413|NCT03164655|Cetuximab|cetuximab|mesh-list
19685976|NCT03308396|Guadecitabine|guadecitabine|mesh-list
19685977|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685978|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685979|NCT03285321|Nivolumab|nivolumab|mesh-list
19357414|NCT03164655|Panitumumab|panitumumab|mesh-list
19357415|NCT03164655|Fluorouracil|fluorouracil|mesh-list
19357416|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
19357417|NCT03164655|Irinotecan|irinotecan|mesh-list
19357418|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357419|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357420|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357421|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19357422|NCT03164655|Growth Substances|growth substances|mesh-ancestor
20393055|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
20393056|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20393057|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393058|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393059|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
20393060|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393061|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393062|NCT01088256|Etoricoxib|etoricoxib|mesh-list
20393063|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20393064|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20393065|NCT01088256|Analgesics|analgesics|mesh-ancestor
20393066|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
20393067|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393068|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393069|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393070|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393071|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20393072|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20393073|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393074|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393075|NCT01088282|Dipivefrin|dipivefrin|mesh-list
20393076|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20393077|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
20393078|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393079|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393080|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357423|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357424|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
19357425|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
19357426|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357427|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19357428|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357429|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
19357430|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19357431|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357432|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357433|NCT03164655|Antidotes|antidotes|mesh-ancestor
19357434|NCT03164655|Protective Agents|protective agents|mesh-ancestor
19685980|NCT03285321|Ipilimumab|ipilimumab|mesh-list
19685981|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19685982|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685983|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19685984|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685985|NCT03284866|Vaccines|vaccines|mesh-list
19685986|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
19685987|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19685988|NCT03283761|Leucovorin|leucovorin|mesh-list
19357435|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
19357436|NCT03164655|Vitamins|vitamins|mesh-ancestor
19357437|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
19357438|NCT03162627|Olaparib|olaparib|mesh-list
19357439|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20393081|NCT01088347|Mapatumumab|mapatumumab|mesh-list
20393082|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393083|NCT01088373|Lenalidomide|lenalidomide|mesh-list
20393084|NCT01088373|Azacitidine|azacitidine|mesh-list
20393085|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
20393086|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393087|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20393088|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393089|NCT01088373|Growth Substances|growth substances|mesh-ancestor
20393090|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
20393091|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393092|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393093|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
20393094|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393095|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393096|NCT01088451|Insulin|insulin|mesh-list
20393097|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20393098|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357440|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357441|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357442|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357443|NCT03115424|Liraglutide|liraglutide|mesh-list
19357444|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19357445|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357446|NCT03115424|Incretins|incretins|mesh-ancestor
19357447|NCT03115424|Hormones|hormones|mesh-ancestor
19357448|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357449|NCT03074240|Anesthetics|anesthetics|mesh-list
19357450|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
19357451|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357452|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357453|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
19357454|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19357455|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357456|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357457|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19357458|NCT05276830|Analgesics|analgesics|mesh-ancestor
19357459|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
19357460|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357461|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19357462|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19357463|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19357464|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
19357465|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357466|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357467|NCT05276687|Vancomycin|vancomycin|mesh-list
19357468|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
19357469|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19357470|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357471|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19357472|NCT05276596|Norepinephrine|norepinephrine|mesh-list
20393099|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20393100|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20393101|NCT01088477|Estradiol|estradiol|mesh-list
20393102|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20393103|NCT01088477|Estrogens|estrogens|mesh-ancestor
20393104|NCT01088477|Hormones|hormones|mesh-ancestor
20393105|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393106|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393107|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20393108|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
20393109|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20393110|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19357473|NCT05276596|Ephedrine|ephedrine|mesh-list
19357474|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19357475|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19357476|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
19357477|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357478|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357479|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357480|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
19357481|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
20393111|NCT01088516|Ritonavir|ritonavir|mesh-list
20393112|NCT01088516|Lopinavir|lopinavir|mesh-list
20393113|NCT01088516|Zidovudine|zidovudine|mesh-list
20393114|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20393115|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20393116|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
20393117|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393118|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357482|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357483|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19357484|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19357485|NCT05276531|Progesterone|progesterone|mesh-list
19357486|NCT05276531|Progestins|progestins|mesh-ancestor
19357487|NCT05276531|Hormones|hormones|mesh-ancestor
19357488|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357489|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357490|NCT05276492|Prednisone|prednisone|mesh-list
19357491|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357492|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
19357493|NCT05276492|Hormones|hormones|mesh-ancestor
19357494|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357495|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357496|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19357497|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357498|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
19357499|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357500|NCT05276258|Bupivacaine|bupivacaine|mesh-list
19357501|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
19357502|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
19685989|NCT03283761|Paclitaxel|paclitaxel|mesh-list
19685990|NCT03283761|Fluorouracil|fluorouracil|mesh-list
19685991|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
19685992|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19685993|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19685994|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
19685995|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
19685996|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
19685997|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19685998|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
19685999|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686000|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686001|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
19357503|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357504|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357505|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
19357506|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357507|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19357508|NCT05275894|Metronidazole|metronidazole|mesh-list
19686002|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686003|NCT03283761|Antidotes|antidotes|mesh-ancestor
19686004|NCT03283761|Protective Agents|protective agents|mesh-ancestor
19686005|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
20208018|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357509|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357510|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19357511|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19357512|NCT05275777|Paclitaxel|paclitaxel|mesh-list
19357513|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
19357514|NCT05275777|Doxorubicin|doxorubicin|mesh-list
19357515|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19357516|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357517|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
19357518|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686006|NCT03283761|Vitamins|vitamins|mesh-ancestor
20208019|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208020|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20208021|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20208022|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
20208023|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20208024|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208025|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
20208026|NCT00275548|Ribavirin|ribavirin|mesh-list
20208027|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20393119|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20393120|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19357519|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
19357520|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686007|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
19357521|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357522|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
19357523|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393121|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
19357524|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357525|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19357526|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
19357527|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19357528|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19357529|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357530|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357531|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357532|NCT05275699|Glycine|glycine|mesh-list
19357533|NCT05275699|Glycine Agents|glycine agents|mesh-ancestor
19357534|NCT05275699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357535|NCT05275699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357536|NCT05275699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357537|NCT05275270|Oxytocin|oxytocin|mesh-list
19357538|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
19357539|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19357540|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393122|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393123|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20393124|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20393125|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
20393126|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20393127|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20393128|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
19357548|NCT05275179|Posaconazole|posaconazole|mesh-list
19357549|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
19357550|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357551|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19357552|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19357553|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19357554|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19357555|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19357556|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357557|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357558|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19357559|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
19357560|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357561|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357562|NCT05274984|Lidocaine|lidocaine|mesh-list
19357563|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
19357564|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
19357565|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357566|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393129|NCT01088555|Antidotes|antidotes|mesh-ancestor
20393130|NCT01088555|Protective Agents|protective agents|mesh-ancestor
20393131|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393132|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
20393133|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393134|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
20393135|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393136|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393137|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
20393138|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
19357567|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
19357568|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357569|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19357570|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19357571|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19357572|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19686008|NCT03251911|Ivacaftor|ivacaftor|mesh-list
19686009|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19401463|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686010|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19686011|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686012|NCT03221400|Leucovorin|leucovorin|mesh-list
19686013|NCT03221400|Folic Acid|folic acid|mesh-list
19686014|NCT03221400|Fluorouracil|fluorouracil|mesh-list
19686015|NCT03221400|Niraparib|niraparib|mesh-list
19686016|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
19686017|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
19686018|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686019|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686020|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686021|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686022|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
19686023|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686024|NCT03221400|Antidotes|antidotes|mesh-ancestor
19686025|NCT03221400|Protective Agents|protective agents|mesh-ancestor
19686026|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
19357573|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357574|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19357575|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686027|NCT03221400|Vitamins|vitamins|mesh-ancestor
19686028|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
19686029|NCT03221400|Hematinics|hematinics|mesh-ancestor
19686030|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19686031|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686032|NCT03197662|Oxytocin|oxytocin|mesh-list
19686033|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
19686034|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19686035|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686036|NCT03138720|Gemcitabine|gemcitabine|mesh-list
19401464|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
19401465|NCT03617705|Ethanol|ethanol|mesh-list
19401466|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19401467|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393139|NCT01088594|Pioglitazone|pioglitazone|mesh-list
20393140|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
20393141|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20393142|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393143|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20393144|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20393145|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20393146|NCT01088620|Pemetrexed|pemetrexed|mesh-list
20393147|NCT01088620|Panitumumab|panitumumab|mesh-list
20393148|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393149|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393150|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393151|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20393152|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20208028|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
20208029|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208030|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
20208031|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208032|NCT00275600|Vitamin E|vitamin e|mesh-list
20208033|NCT00275600|Vitamins|vitamins|mesh-ancestor
20393153|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686037|NCT03138720|Paclitaxel|paclitaxel|mesh-list
19686038|NCT03138720|Cisplatin|cisplatin|mesh-list
19686039|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19686040|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19686041|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686042|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
19686043|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686044|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
19686045|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686046|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686047|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
19686048|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
19686049|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686050|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686051|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686052|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
20208034|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
20393154|NCT01088659|Tenofovir|tenofovir|mesh-list
20393155|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20393156|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
20393157|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393158|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20208035|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208036|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
20208037|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208038|NCT00275600|Protective Agents|protective agents|mesh-ancestor
19686053|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686054|NCT03137888|Temozolomide|temozolomide|mesh-list
20393159|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19844407|NCT00665457|Docetaxel|docetaxel|mesh-list
20393160|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393161|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393162|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20393163|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20393164|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
20393165|NCT01088724|Rituximab|rituximab|mesh-list
20393166|NCT01088724|Doxorubicin|doxorubicin|mesh-list
20393167|NCT01088724|Fludarabine|fludarabine|mesh-list
20393168|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393169|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
19357576|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
19357577|NCT05274672|Cephalexin|cephalexin|mesh-list
19357578|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19357579|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
19357580|NCT05274672|Trimethoprim|trimethoprim|mesh-list
19357581|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
19357582|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19357583|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357584|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357585|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19686055|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19686056|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
19686057|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686058|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686059|NCT03136809|Copper|copper|mesh-list
19357586|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357587|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357588|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357589|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19357590|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19357591|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19357592|NCT05274672|Renal Agents|renal agents|mesh-ancestor
19357593|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
19357594|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19357595|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20393170|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393171|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393172|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20393173|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
20393174|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393175|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686060|NCT03136809|Trace Elements|trace elements|mesh-ancestor
19686061|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
19686062|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686063|NCT03132467|Durvalumab|durvalumab|mesh-list
19686064|NCT03132467|Ipilimumab|ipilimumab|mesh-list
19686065|NCT03132467|Tremelimumab|tremelimumab|mesh-list
19686066|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
19686067|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19686068|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
19686069|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686070|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393176|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20393177|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20393178|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20393179|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20393180|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20393181|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393182|NCT01088737|Imiquimod|imiquimod|mesh-list
20393183|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20393184|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
20393185|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393186|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393187|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
20393188|NCT01088750|Prednisolone|prednisolone|mesh-list
20393189|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
20393190|NCT01088750|Vinblastine|vinblastine|mesh-list
20393191|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357596|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19357597|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19357598|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19357599|NCT05255471|Olaparib|olaparib|mesh-list
19844408|NCT00665457|Doxorubicin|doxorubicin|mesh-list
19357600|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19357601|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686071|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
19844409|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19686072|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686073|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19686074|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692748|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19692749|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19692750|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692751|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692752|NCT04988048|Vaccines|vaccines|mesh-list
19692753|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
19692754|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692755|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
19692756|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19692757|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19692758|NCT04988282|Prednisolone|prednisolone|mesh-list
19692759|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
19692760|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19692761|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
19692762|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692763|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
19692764|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
19692765|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692766|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692767|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692768|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
19692769|NCT04988282|Hormones|hormones|mesh-ancestor
19692770|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692771|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19692772|NCT04988282|Protective Agents|protective agents|mesh-ancestor
19692773|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19692774|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692775|NCT04987632|Letrozole|letrozole|mesh-list
19357602|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357603|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357615|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19357616|NCT05232396|Antibodies|antibodies|mesh-list
19357617|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
19357618|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19357619|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
19357620|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357621|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357622|NCT05222724|Ibuprofen|ibuprofen|mesh-list
19357623|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19357624|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19357625|NCT05222724|Analgesics|analgesics|mesh-ancestor
19357626|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
19357627|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357628|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357629|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357630|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357631|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19357632|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357633|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357634|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19357635|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357636|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357637|NCT05218603|Bortezomib|bortezomib|mesh-list
19357638|NCT05218603|Daratumumab|daratumumab|mesh-list
19357639|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357640|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
19357641|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19357642|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19692776|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692777|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19357643|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357644|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357645|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19357646|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19357647|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19357648|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19357649|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357650|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393192|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
20393193|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393194|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393195|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20393196|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
20393197|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393198|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393199|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20393200|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393201|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
20393202|NCT01088750|Hormones|hormones|mesh-ancestor
20393203|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393204|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20393205|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20393206|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
20393207|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
20393208|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
20393209|NCT01088763|Dexamethasone|dexamethasone|mesh-list
20393210|NCT01088763|R04929097|r04929097|mesh-list
20393211|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393212|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
20393213|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
20393214|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393215|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393216|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20393217|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
20393218|NCT01088763|Hormones|hormones|mesh-ancestor
20393219|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393220|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20393221|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357651|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
19357652|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19357653|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
20393222|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393223|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393224|NCT01088802|Carboplatin|carboplatin|mesh-list
20393225|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393226|NCT01088815|Gemcitabine|gemcitabine|mesh-list
20393227|NCT01088815|Paclitaxel|paclitaxel|mesh-list
20393228|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20393229|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393230|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
20393231|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
20393232|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
20393233|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357654|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19357655|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19357656|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357657|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19357658|NCT05200884|Lidocaine|lidocaine|mesh-list
19357659|NCT05200884|Carticaine|carticaine|mesh-list
19357660|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
19357661|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
19357662|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19686075|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
19686076|NCT03107988|Topotecan|topotecan|mesh-list
19686077|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686078|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
19686079|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686080|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393234|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393235|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
20393236|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
20393237|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393238|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393239|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686081|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19686082|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
19686083|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686084|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686085|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19686086|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19686087|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19686088|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686089|NCT03096288|Evolocumab|evolocumab|mesh-list
19686090|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686091|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686092|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
19686093|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686094|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686095|NCT03090165|Bicalutamide|bicalutamide|mesh-list
19686096|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
19686097|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
19686098|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19686099|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686100|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357663|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357664|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
19357665|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357666|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19357667|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19357668|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19357669|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393240|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
19357670|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357671|NCT05200312|Prednisone|prednisone|mesh-list
19357672|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
20393241|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393242|NCT01088893|Everolimus|everolimus|mesh-list
20393243|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393244|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393245|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
20393246|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393247|NCT01088906|Pemetrexed|pemetrexed|mesh-list
20393248|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686101|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
19686102|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
19686103|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19357673|NCT05200312|Rituximab|rituximab|mesh-list
19357674|NCT05200312|Doxorubicin|doxorubicin|mesh-list
19357675|NCT05200312|Vincristine|vincristine|mesh-list
19686104|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
20393249|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393250|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393251|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20393252|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20393253|NCT01088919|Pioglitazone|pioglitazone|mesh-list
20393254|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
20393255|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20393256|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393257|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19686105|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686106|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686107|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19686108|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
19686109|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19686110|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20393258|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357676|NCT05200312|Lenalidomide|lenalidomide|mesh-list
20393259|NCT01088932|SRX246|srx246|mesh-list
20393260|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20393261|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393262|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
20393263|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393264|NCT01088958|Micronutrients|micronutrients|mesh-list
20393265|NCT01088958|Trace Elements|trace elements|mesh-list
20393266|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393267|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
19357677|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
20428633|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357678|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357679|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
19357680|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357681|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357682|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19357683|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
19357684|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357685|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357686|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19357687|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357688|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19357689|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19357690|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19357691|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357692|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393268|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20393269|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20393270|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20393271|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393272|NCT01089088|Gemcitabine|gemcitabine|mesh-list
20393273|NCT01089088|Sunitinib|sunitinib|mesh-list
20393274|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393275|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393276|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
20393277|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393278|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
20393279|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393280|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393281|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393282|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
20393283|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393284|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20393285|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393286|NCT01089088|Growth Substances|growth substances|mesh-ancestor
20393287|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
20393288|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20393289|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
20393290|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20393291|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20393292|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393293|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
19357693|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
19357694|NCT05200312|Hormones|hormones|mesh-ancestor
20393294|NCT01089140|Coagulants|coagulants|mesh-ancestor
20393295|NCT01089166|Metformin|metformin|mesh-list
20393296|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20393297|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393298|NCT01089179|Metformin|metformin|mesh-list
19357695|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208039|NCT00275613|Rituximab|rituximab|mesh-list
20208040|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20208041|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393299|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20393300|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393301|NCT01089192|Metformin|metformin|mesh-list
20393302|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20393303|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208042|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
20208043|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208044|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208045|NCT00275639|Losartan|losartan|mesh-list
20208046|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20208047|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20208048|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20208049|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20208050|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208051|NCT00275652|Lamivudine|lamivudine|mesh-list
20208052|NCT00275652|Telbivudine|telbivudine|mesh-list
20208053|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20393304|NCT01089205|Metformin|metformin|mesh-list
20393305|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20208054|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20393306|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393307|NCT01089218|Amoxicillin|amoxicillin|mesh-list
20393308|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
20393309|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
20393310|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20393311|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393312|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393313|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20393314|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393315|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393316|NCT01089309|Spironolactone|spironolactone|mesh-list
20393317|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19357696|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19357697|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19357698|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
19357699|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
19357700|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
19357701|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357702|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19357703|NCT05200312|Growth Substances|growth substances|mesh-ancestor
19357704|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
19357705|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19844410|NCT00665457|Capecitabine|capecitabine|mesh-list
19844411|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844412|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
20208055|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208056|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208057|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
20208058|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357709|NCT05197270|Aflibercept|aflibercept|mesh-list
20393318|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
20393319|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393320|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393321|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20393322|NCT01089309|Diuretics|diuretics|mesh-ancestor
20393323|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
20393324|NCT01089348|Metronidazole|metronidazole|mesh-list
19357710|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357711|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19357712|NCT05197270|Growth Substances|growth substances|mesh-ancestor
19357713|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357714|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
19357715|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357716|NCT05150587|Rifaximin|rifaximin|mesh-list
19357717|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19357718|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357719|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357720|NCT05116202|Nivolumab|nivolumab|mesh-list
19357721|NCT05116202|Ipilimumab|ipilimumab|mesh-list
19357722|NCT05116202|Atezolizumab|atezolizumab|mesh-list
19686111|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19686112|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
19686113|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686114|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686115|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19686116|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19686117|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686118|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686119|NCT03041688|Decitabine|decitabine|mesh-list
20208059|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20208060|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20208061|NCT00275665|Valganciclovir|valganciclovir|mesh-list
20208062|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
20208063|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208064|NCT00275730|Indomethacin|indomethacin|mesh-list
20208065|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20208066|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20208067|NCT00275730|Analgesics|analgesics|mesh-ancestor
20208068|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
20208069|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208070|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208071|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20208072|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208073|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
20208074|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
20208075|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19357723|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686120|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19357724|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686121|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
19686122|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686123|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686124|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686125|NCT02942290|Azacitidine|azacitidine|mesh-list
19686126|NCT02942290|Venetoclax|venetoclax|mesh-list
19686127|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686128|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
19686129|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686130|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686131|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686132|NCT02919436|Tamsulosin|tamsulosin|mesh-list
19686133|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19686134|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19686135|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20393325|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393326|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393327|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19686136|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
19686137|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686138|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686139|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686140|NCT02919436|Urological Agents|urological agents|mesh-ancestor
19686141|NCT02879136|Methylphenidate|methylphenidate|mesh-list
19686142|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19686143|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19686144|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686145|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19686146|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19686147|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19686148|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686149|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
19686150|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686151|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19686152|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
19686153|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
19686154|NCT02875314|Thiotepa|thiotepa|mesh-list
19686155|NCT02875314|Cisplatin|cisplatin|mesh-list
19686156|NCT02875314|Carboplatin|carboplatin|mesh-list
19686157|NCT02875314|Methotrexate|methotrexate|mesh-list
19686158|NCT02875314|Etoposide|etoposide|mesh-list
19686159|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
19686160|NCT02875314|Vincristine|vincristine|mesh-list
19686161|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686162|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
19686163|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686164|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19686165|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19686166|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
20393328|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20393329|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
20393330|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20393331|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
19686167|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686168|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686169|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20208076|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20208077|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208078|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208079|NCT00275756|Timolol|timolol|mesh-list
20208080|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20208081|NCT00275756|Dorzolamide|dorzolamide|mesh-list
20208082|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20208083|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20208084|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
20208085|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208086|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208087|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208088|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20208089|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20208090|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20208091|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20393332|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357725|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19357726|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357727|NCT05090566|Dexamethasone|dexamethasone|mesh-list
19357728|NCT05090566|Lenalidomide|lenalidomide|mesh-list
19357729|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357730|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
19357731|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
19357732|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357733|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357734|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357735|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
19357736|NCT05090566|Hormones|hormones|mesh-ancestor
19357737|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357738|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19357739|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357740|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
19357741|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357742|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19357743|NCT05090566|Growth Substances|growth substances|mesh-ancestor
19357744|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
19357745|NCT05051735|Acetaminophen|acetaminophen|mesh-list
19357746|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19357747|NCT05051735|Analgesics|analgesics|mesh-ancestor
19357748|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
19357749|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357750|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357751|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
19357752|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
19357753|NCT05040984|Mirabegron|mirabegron|mesh-list
19357754|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19357755|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19357756|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
19357757|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357758|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357759|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357760|NCT05040984|Urological Agents|urological agents|mesh-ancestor
19357761|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19357762|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19357763|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19357764|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
19357765|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
19357766|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19357767|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357768|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357769|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19357770|NCT05037500|Decitabine|decitabine|mesh-list
19357771|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19357772|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
19357773|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357774|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357775|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357776|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
19357777|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357778|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357779|NCT04973254|Rilpivirine|rilpivirine|mesh-list
19357780|NCT04973254|Cabotegravir|cabotegravir|mesh-list
19357781|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19357782|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19357783|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357784|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357785|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
19357786|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357787|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19357788|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19686170|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19686171|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
19686172|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19357789|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20208092|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20208093|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20208094|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208095|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
20208096|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
20208097|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20208098|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20393333|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393334|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20393335|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
20393336|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19357790|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19357791|NCT04949269|BMS-986165|bms-986165|mesh-list
19357792|NCT04949269|Famotidine|famotidine|mesh-list
19357793|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19357794|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357795|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19357796|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
19357797|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
19357798|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357799|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357800|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357801|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
19357802|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19357803|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357804|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19357805|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19357806|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
19357807|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357808|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357809|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
19357810|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357811|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357812|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
19357813|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19401468|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401469|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401470|NCT03617679|Rucaparib|rucaparib|mesh-list
19401471|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19401472|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401473|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401474|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401475|NCT03617575|Lactoferrin|lactoferrin|mesh-list
19401476|NCT03617575|Fesoterodine|fesoterodine|mesh-list
19401477|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401478|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19401479|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19401480|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
19401481|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401482|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401483|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401484|NCT03617575|Urological Agents|urological agents|mesh-ancestor
19401485|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
19401486|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19401487|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401488|NCT03617510|Analgesics|analgesics|mesh-ancestor
19401489|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
19686173|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686174|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
19686175|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686176|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686177|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19686178|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19686179|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19686180|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19686181|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19686182|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
19686183|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
20393337|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
20393338|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393339|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393340|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20393341|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393342|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
20393343|NCT01089439|Protective Agents|protective agents|mesh-ancestor
20393344|NCT01089452|Amlodipine|amlodipine|mesh-list
20393345|NCT01089452|Olmesartan|olmesartan|mesh-list
20393346|NCT01089452|Perindopril|perindopril|mesh-list
20393347|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20393348|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20393349|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19686184|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
19357814|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
19357815|NCT04893915|Fludarabine|fludarabine|mesh-list
19357816|NCT04893915|Interleukin-2|interleukin-2|mesh-list
19357817|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357818|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
19357819|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357820|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357821|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19357822|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
19357823|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357824|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357825|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19357826|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20393350|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393351|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20393352|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357827|NCT04893915|Analgesics|analgesics|mesh-ancestor
19357828|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
19357829|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357830|NCT04837716|Bevacizumab|bevacizumab|mesh-list
19357831|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19357832|NCT04837716|Carboplatin|carboplatin|mesh-list
19357833|NCT04837716|Pemetrexed|pemetrexed|mesh-list
19357834|NCT04837716|Ensartinib|ensartinib|mesh-list
19357835|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
20393353|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393354|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20393355|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20393356|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20393357|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
20393358|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393359|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
20393360|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20393361|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20393362|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20393363|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393364|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393365|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393366|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393367|NCT01089621|Analgesics|analgesics|mesh-ancestor
20393368|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
20393369|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393370|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
19357836|NCT04837716|Antibodies|antibodies|mesh-list
19357837|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
19357838|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19357839|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
19357840|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357841|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357842|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19357843|NCT04837716|Growth Substances|growth substances|mesh-ancestor
19357844|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357845|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
19357846|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
19357847|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686185|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
20393371|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20393372|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
19357848|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357849|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20208099|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208100|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208101|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20208102|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20208103|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
20208104|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
20208105|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20208106|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20208107|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208108|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357850|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20393373|NCT01089660|Vaccines|vaccines|mesh-list
20393374|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
20428634|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19357851|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19357852|NCT04817189|Dexamethasone|dexamethasone|mesh-list
19357853|NCT04817189|Ondansetron|ondansetron|mesh-list
19357854|NCT04817189|Palonosetron|palonosetron|mesh-list
19357855|NCT04817189|Granisetron|granisetron|mesh-list
19357856|NCT04817189|Tropisetron|tropisetron|mesh-list
19357857|NCT04817189|Dolasetron|dolasetron|mesh-list
19357858|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357859|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
19357860|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
19357861|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357862|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357863|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357864|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
19357865|NCT04817189|Hormones|hormones|mesh-ancestor
19357866|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357867|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19357868|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357869|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
19357870|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
19357871|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19357872|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
19357873|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357874|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357875|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19357876|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19357877|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357878|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19357879|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19357880|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19357881|NCT04782830|Midodrine|midodrine|mesh-list
19357882|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19357883|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19357884|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19357885|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19357886|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357887|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
19357888|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19357889|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357890|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
19357891|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
19357892|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357893|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19357894|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19357895|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19357896|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19357897|NCT04781426|Tenofovir|tenofovir|mesh-list
19357898|NCT04781426|Lamivudine|lamivudine|mesh-list
19357899|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
19357900|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357901|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19357902|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19357903|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686186|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686187|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686188|NCT02178436|Gemcitabine|gemcitabine|mesh-list
19686189|NCT02178436|Paclitaxel|paclitaxel|mesh-list
19686190|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19686191|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19686192|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686193|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
19686194|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208109|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20208110|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20208111|NCT00275938|Interferons|interferons|mesh-list
20208112|NCT00275938|Ribavirin|ribavirin|mesh-list
20208113|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
19357904|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686195|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208114|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
20208115|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208116|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
20208117|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208118|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
19357905|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19357906|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19357907|NCT04774666|Antibodies|antibodies|mesh-list
19357908|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
19357909|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357910|NCT04740931|Aflibercept|aflibercept|mesh-list
19357911|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357912|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19357913|NCT04740931|Growth Substances|growth substances|mesh-ancestor
19357914|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357915|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
19357916|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357917|NCT04730856|Tinzaparin|tinzaparin|mesh-list
19357918|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19357919|NCT04730856|Dalteparin|dalteparin|mesh-list
19357920|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
20393375|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393376|NCT01089855|Carbamazepine|carbamazepine|mesh-list
20393377|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
20393378|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
20393379|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20393380|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20393381|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393382|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20393383|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20208119|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208120|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
20208121|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208122|NCT00275951|Cetuximab|cetuximab|mesh-list
20208123|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20208124|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208125|NCT00276003|Gemcitabine|gemcitabine|mesh-list
20208126|NCT00276003|Irinotecan|irinotecan|mesh-list
19357921|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19357922|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19357923|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357924|NCT04707534|Dexamethasone|dexamethasone|mesh-list
19357925|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19686196|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686197|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686198|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
19686199|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
19686200|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686201|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686202|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686203|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
19686204|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686205|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20208127|NCT00276003|Allopurinol|allopurinol|mesh-list
20208128|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393384|NCT01089855|Analgesics|analgesics|mesh-ancestor
20393385|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
20393386|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393387|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20393388|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393389|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393390|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20393391|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20393392|NCT01089933|Anesthetics|anesthetics|mesh-list
20393393|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
20393394|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20393395|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393396|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
20393397|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393398|NCT01089959|Esomeprazole|esomeprazole|mesh-list
20393399|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20393400|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357926|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
20208129|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
20208130|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357927|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
19357928|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357929|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357930|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19357931|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
20393401|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20393402|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393403|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393404|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20393405|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20393406|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20393407|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20393408|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393409|NCT01090037|Epoprostenol|epoprostenol|mesh-list
20393410|NCT01090037|Beraprost|beraprost|mesh-list
19357932|NCT04707534|Hormones|hormones|mesh-ancestor
19357933|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357934|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19357935|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686206|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686207|NCT02086604|Lenalidomide|lenalidomide|mesh-list
19686208|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19686209|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
19686210|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357936|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
19357937|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19357938|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
19357939|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357940|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
19357941|NCT04697823|Protective Agents|protective agents|mesh-ancestor
19357942|NCT04691856|Acetaminophen|acetaminophen|mesh-list
19357943|NCT04691856|Ibuprofen|ibuprofen|mesh-list
19357944|NCT04691856|Morphine|morphine|mesh-list
19357945|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19357946|NCT04691856|Narcotics|narcotics|mesh-ancestor
19357947|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19357948|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357949|NCT04691856|Analgesics|analgesics|mesh-ancestor
19357950|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
19357951|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357952|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19357953|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19357954|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357955|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357956|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19357957|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357958|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357959|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
19357960|NCT04671966|Cetrorelix|cetrorelix|mesh-list
19357961|NCT04671966|Estradiol|estradiol|mesh-list
19357962|NCT04671966|Estrogens|estrogens|mesh-ancestor
19357963|NCT04671966|Hormones|hormones|mesh-ancestor
19357964|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19357965|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357966|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19357967|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19357968|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
19357969|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
19357970|NCT04666688|Gemcitabine|gemcitabine|mesh-list
19357971|NCT04666688|Paclitaxel|paclitaxel|mesh-list
19357972|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19357973|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357974|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
19357975|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
19357976|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
19357977|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19357978|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19357979|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
19357980|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
19357981|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19357982|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357983|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19357984|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
19357985|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357986|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
19357987|NCT04632459|Ramucirumab|ramucirumab|mesh-list
19686211|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19357988|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19357989|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19357990|NCT04528082|Apremilast|apremilast|mesh-list
19357991|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19357992|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19357993|NCT04528082|Analgesics|analgesics|mesh-ancestor
19686212|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19686213|NCT02086604|Growth Substances|growth substances|mesh-ancestor
19844413|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844414|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844415|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19844416|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
19844417|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844418|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844419|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19844420|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
19844421|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
19844422|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
19844423|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19844424|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19844425|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208131|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208132|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
20208133|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208134|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19357994|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
19357995|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19357996|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19357997|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19357998|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19357999|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19358000|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19358001|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358002|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358003|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
19358004|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19358005|NCT04509791|Antibodies|antibodies|mesh-list
19358006|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
19358007|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
19358008|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358009|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358010|NCT04401059|Gefitinib|gefitinib|mesh-list
19358011|NCT04401059|Osimertinib|osimertinib|mesh-list
19358012|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358013|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19358014|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686214|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
19686215|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686216|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686217|NCT01983774|Esomeprazole|esomeprazole|mesh-list
19686218|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19358015|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401490|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401491|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401492|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401493|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401494|NCT03617484|Bortezomib|bortezomib|mesh-list
19401495|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208135|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208136|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
20208137|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208138|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20208139|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19401496|NCT03617471|Acetaminophen|acetaminophen|mesh-list
19401497|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401498|NCT03617471|Analgesics|analgesics|mesh-ancestor
19401499|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
19401500|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401501|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401502|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
19401503|NCT03617458|Metformin|metformin|mesh-list
19401504|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19686219|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844426|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208140|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
19401505|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401506|NCT03617432|Prednisone|prednisone|mesh-list
19401507|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
19401508|NCT03617432|Doxorubicin|doxorubicin|mesh-list
19686220|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19686221|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686222|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686223|NCT01970865|Crizotinib|crizotinib|mesh-list
19686224|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686225|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19686226|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686227|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686228|NCT01554410|Gemcitabine|gemcitabine|mesh-list
19686229|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686230|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686231|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
19686232|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686233|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
19686234|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686235|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686236|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686237|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
19686238|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686239|NCT01499888|Sirolimus|sirolimus|mesh-list
19686240|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
19686241|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19686242|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686243|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19358016|NCT04301765|Testosterone|testosterone|mesh-list
19358017|NCT04301765|Androgens|androgens|mesh-ancestor
19358018|NCT04301765|Hormones|hormones|mesh-ancestor
19358019|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358020|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358021|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19358022|NCT04280328|Daratumumab|daratumumab|mesh-list
19358023|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358024|NCT04251884|Ropivacaine|ropivacaine|mesh-list
19358025|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
19358026|NCT04251884|Anesthetics|anesthetics|mesh-list
19358027|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19358028|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358029|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
19358030|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686244|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358031|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
19358032|NCT04209660|Lenvatinib|lenvatinib|mesh-list
19686245|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
19686246|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686247|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
19358033|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686248|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686249|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686250|NCT01204684|Vaccines|vaccines|mesh-list
19686251|NCT01204684|Poly ICLC|poly iclc|mesh-list
19686252|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
19686253|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686254|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
19686255|NCT00867191|Desloratadine|desloratadine|mesh-list
19686256|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686257|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686258|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686259|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686260|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686261|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686262|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686263|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686264|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
19686265|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
19358034|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358035|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19358036|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358037|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358038|NCT04196283|Paclitaxel|paclitaxel|mesh-list
19358039|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19358040|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358041|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
20393411|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19686266|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358042|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686267|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686268|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686269|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
19686270|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19686271|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
20393412|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393413|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20393414|NCT01090128|Paclitaxel|paclitaxel|mesh-list
20393415|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
20393416|NCT01090128|Doxorubicin|doxorubicin|mesh-list
20393417|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20393418|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20393419|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393420|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
20393421|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
20393422|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
20393423|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393424|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393425|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
20393426|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393427|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393428|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20393429|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
20393430|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19686272|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686273|NCT00805584|Desloratadine|desloratadine|mesh-list
19686274|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686275|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
20393431|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20393432|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20393433|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20393434|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426594|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19358043|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358044|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358045|NCT04188405|Decitabine|decitabine|mesh-list
19358046|NCT04188405|Venetoclax|venetoclax|mesh-list
19358047|NCT04188405|Ponatinib|ponatinib|mesh-list
20426595|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20426596|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426597|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
20426598|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
20426599|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358048|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358049|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
19358050|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358051|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358052|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358053|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20208141|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208142|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20208143|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
20208144|NCT00276003|Protective Agents|protective agents|mesh-ancestor
19686276|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686277|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686278|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686279|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20208145|NCT00276029|Etanercept|etanercept|mesh-list
20208146|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20208147|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20208148|NCT00276029|Analgesics|analgesics|mesh-ancestor
20208149|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
20208150|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208151|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208152|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20208153|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208154|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20208155|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208156|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
20208157|NCT00276055|Gemcitabine|gemcitabine|mesh-list
20208158|NCT00276055|Bevacizumab|bevacizumab|mesh-list
20208159|NCT00276055|Docetaxel|docetaxel|mesh-list
20208160|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20208161|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208162|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20426600|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393435|NCT01090167|Clofarabine|clofarabine|mesh-list
20393436|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393437|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
20393438|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393439|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393440|NCT01090206|Vitamin D|vitamin d|mesh-list
20393441|NCT01090206|Calcium|calcium|mesh-list
20393442|NCT01090206|Vitamins|vitamins|mesh-ancestor
20393443|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
20393444|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393445|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20393446|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20393447|NCT01090466|Gemcitabine|gemcitabine|mesh-list
20393448|NCT01090466|Sirolimus|sirolimus|mesh-list
19358058|NCT03800134|Gemcitabine|gemcitabine|mesh-list
19358059|NCT03800134|Paclitaxel|paclitaxel|mesh-list
19358060|NCT03800134|Cisplatin|cisplatin|mesh-list
19358061|NCT03800134|Carboplatin|carboplatin|mesh-list
19358062|NCT03800134|Pemetrexed|pemetrexed|mesh-list
19358063|NCT03800134|Durvalumab|durvalumab|mesh-list
19358064|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19358065|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358066|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358067|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358068|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358069|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358070|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358071|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
19358072|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
19358073|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686280|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686281|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686282|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
19686283|NCT00795522|Desloratadine|desloratadine|mesh-list
19686284|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686285|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686286|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686287|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686288|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686289|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686290|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686291|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686292|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
19686293|NCT00795158|Desloratadine|desloratadine|mesh-list
19686294|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20393449|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393450|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393451|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
20393452|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393453|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
20393454|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393455|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393456|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393457|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
20393458|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393459|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393460|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20393461|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
20393462|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
20393463|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393464|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
20393465|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393466|NCT01090596|Naproxen|naproxen|mesh-list
20393467|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20393468|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20393469|NCT01090596|Analgesics|analgesics|mesh-ancestor
20393470|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
20393471|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393472|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393473|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393474|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393475|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
20393476|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19358074|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358075|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358076|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
19358077|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393477|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393478|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686295|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686296|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686297|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686298|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686299|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686300|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20393479|NCT01090648|Etravirine|etravirine|mesh-list
20393480|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20393481|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20393482|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393483|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393484|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
20393485|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393486|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
20393487|NCT01090661|Mipomersen|mipomersen|mesh-list
20393488|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20393489|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393490|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393491|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20393492|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20393493|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393494|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393495|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393496|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20393497|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
20393498|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19358078|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19358079|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19358080|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358081|NCT03783286|Ivacaftor|ivacaftor|mesh-list
19358082|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19358083|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19358084|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358085|NCT03708003|Venetoclax|venetoclax|mesh-list
19358086|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358087|NCT03699865|Nicotine|nicotine|mesh-list
19358088|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19358089|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
19358090|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358091|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358092|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19358093|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19358094|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
19358095|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358096|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358097|NCT03678506|Apixaban|apixaban|mesh-list
19358098|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19358099|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
19358100|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19358101|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
19358102|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358103|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358104|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
19358105|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19358106|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358107|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393499|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393500|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20393501|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20393502|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19358108|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19358109|NCT03648489|Paclitaxel|paclitaxel|mesh-list
19686301|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686302|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
19686303|NCT00794846|Cetirizine|cetirizine|mesh-list
19686304|NCT00794846|Desloratadine|desloratadine|mesh-list
19686305|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19358110|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19358111|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358112|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358113|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358114|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358115|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358116|NCT03637660|Penicillins|penicillins|mesh-list
19358117|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19358118|NCT03637660|Penicillin G|penicillin g|mesh-list
19358119|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
19358120|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19358121|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358122|NCT03622073|Misoprostol|misoprostol|mesh-list
19358123|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19358124|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
19358125|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19358126|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358127|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19358128|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358129|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
19358130|NCT03541447|Octreotide|octreotide|mesh-list
19358131|NCT03541447|Tolvaptan|tolvaptan|mesh-list
19358132|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358133|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19358134|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358135|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19358136|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358137|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
19358138|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358139|NCT03469492|Insulin|insulin|mesh-list
19686306|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19358140|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19358141|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358142|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
19358143|NCT03448978|Fludarabine|fludarabine|mesh-list
19358144|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358145|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
19358146|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358147|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358148|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19358149|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
19358150|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358151|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358152|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19358153|NCT03439033|Edetic Acid|edetic acid|mesh-list
19358154|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
19358155|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
19358156|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
19358157|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358158|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
19358159|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19358160|NCT03396874|Edetic Acid|edetic acid|mesh-list
19358161|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19358162|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19358163|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358164|NCT03396874|Anticoagulants|anticoagulants|mesh-ancestor
19358165|NCT03396874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19358166|NCT03396874|Chelating Agents|chelating agents|mesh-ancestor
19358167|NCT03396874|Sequestering Agents|sequestering agents|mesh-ancestor
19358168|NCT03383575|Azacitidine|azacitidine|mesh-list
19358169|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358170|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
19358171|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358172|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358173|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358174|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
19358175|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
19358176|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358177|NCT03362099|Bupropion|bupropion|mesh-list
19358178|NCT03362099|Varenicline|varenicline|mesh-list
19358179|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19358180|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
19358181|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19358182|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19358183|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19358184|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19358185|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358186|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
19358187|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358188|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358189|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19358190|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19358191|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358192|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19358193|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19358194|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
19358195|NCT03340896|Docetaxel|docetaxel|mesh-list
19358196|NCT03340896|Fluorouracil|fluorouracil|mesh-list
19358197|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358198|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358199|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358200|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358201|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358202|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
19358203|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358204|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358205|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
19358206|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358207|NCT03340064|Levetiracetam|levetiracetam|mesh-list
19358208|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
19358209|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
19358210|NCT03330249|Cisplatin|cisplatin|mesh-list
19358211|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358212|NCT03316807|Vaccines|vaccines|mesh-list
19358213|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
19358214|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358215|NCT03304379|Celecoxib|celecoxib|mesh-list
19358216|NCT03304379|Diclofenac|diclofenac|mesh-list
19358217|NCT03304379|Fasinumab|fasinumab|mesh-list
19358218|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19358219|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19358220|NCT03304379|Analgesics|analgesics|mesh-ancestor
19358221|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
19358222|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358223|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358224|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358225|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358226|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19358227|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19358228|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358229|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358230|NCT03268499|Cisplatin|cisplatin|mesh-list
19358231|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358232|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
19358233|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
19358234|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358235|NCT03122522|Nivolumab|nivolumab|mesh-list
19358236|NCT03122522|Ipilimumab|ipilimumab|mesh-list
19358237|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358238|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358239|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358240|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358241|NCT03110978|Nivolumab|nivolumab|mesh-list
19358242|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358243|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358244|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358245|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358246|NCT03085056|Paclitaxel|paclitaxel|mesh-list
19358247|NCT03085056|Trametinib|trametinib|mesh-list
19358248|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19358249|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358250|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358251|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358252|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358253|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358254|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19358255|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358256|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
19358257|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358258|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358259|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
19358260|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19358261|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
19358262|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19358263|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
19358264|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358265|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358266|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
19358267|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
19358268|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
19358269|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358270|NCT02999087|Cetuximab|cetuximab|mesh-list
19358271|NCT02999087|Avelumab|avelumab|mesh-list
19686307|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686308|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686309|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
19686310|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686311|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686312|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686313|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686314|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686315|NCT00794768|Fexofenadine|fexofenadine|mesh-list
19686316|NCT00794768|Desloratadine|desloratadine|mesh-list
19686317|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686318|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686319|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686320|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686321|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686322|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686323|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686324|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
19358272|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358273|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358274|NCT02998385|Cisplatin|cisplatin|mesh-list
19358275|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393503|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20393504|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20393505|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
20393506|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20393507|NCT01090700|Simeprevir|simeprevir|mesh-list
20393508|NCT01090700|Dexetimide|dexetimide|mesh-list
20393509|NCT01090700|Citalopram|citalopram|mesh-list
19686325|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
19686326|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686327|NCT00794599|Cetirizine|cetirizine|mesh-list
19686328|NCT00794599|Desloratadine|desloratadine|mesh-list
19686329|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686330|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686331|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686332|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686333|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
19686334|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686335|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393510|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20393511|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20393512|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19358276|NCT02987543|Olaparib|olaparib|mesh-list
19358277|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
19358278|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19358279|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358280|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358281|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358282|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20393513|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393514|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393515|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
20393516|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393517|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20393518|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
20393519|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20393520|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20393521|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20393522|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
20393523|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
20393524|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393525|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19358283|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
20393526|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19358284|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393527|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
20393528|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
20393529|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393530|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
20393531|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393532|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20393533|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20393534|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393535|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20393536|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20393537|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393538|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393539|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
20393540|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393541|NCT01090778|Hormones|hormones|mesh-list
20393542|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393543|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393544|NCT01090830|Paclitaxel|paclitaxel|mesh-list
20393545|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20393546|NCT01090830|Bevacizumab|bevacizumab|mesh-list
20393547|NCT01090830|Carboplatin|carboplatin|mesh-list
20393548|NCT01090830|Belinostat|belinostat|mesh-list
20393549|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20393550|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393551|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
20393552|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
20393553|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208163|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393554|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393555|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20393556|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20393557|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393558|NCT01090830|Growth Substances|growth substances|mesh-ancestor
20393559|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393560|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
20393561|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20393562|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393563|NCT01090882|Bupivacaine|bupivacaine|mesh-list
19358285|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358286|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19358287|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
19358288|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19358289|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19358290|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358291|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19358292|NCT02958150|Analgesics|analgesics|mesh-ancestor
19358293|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
19358294|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208164|NCT00276055|Growth Substances|growth substances|mesh-ancestor
20208165|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208166|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
19358295|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19358296|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19358297|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19358298|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
19358299|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686336|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686337|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686338|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686339|NCT00794495|Cetirizine|cetirizine|mesh-list
19686340|NCT00794495|Desloratadine|desloratadine|mesh-list
19686341|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686342|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686343|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686344|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686345|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
19686346|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208167|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208168|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
20208169|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208170|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
20208171|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208172|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393564|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
20393565|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
20393566|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20393567|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393568|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
20393569|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686347|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686348|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686349|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686350|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686351|NCT00794248|Fexofenadine|fexofenadine|mesh-list
19686352|NCT00794248|Desloratadine|desloratadine|mesh-list
19686353|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686354|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686355|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686356|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393570|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
19358300|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358301|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
19358302|NCT02955290|Nivolumab|nivolumab|mesh-list
19358303|NCT02955290|Vaccines|vaccines|mesh-list
19358304|NCT02955290|Mitogens|mitogens|mesh-list
19358305|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
19358306|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358307|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358308|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358309|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358310|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358311|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358312|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
19358313|NCT02955134|Antacids|antacids|mesh-ancestor
19358314|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358315|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20208173|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208174|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
20208175|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
19401509|NCT03617432|Etoposide|etoposide|mesh-list
19401510|NCT03617432|Vincristine|vincristine|mesh-list
19401511|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401512|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
19401513|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401514|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401515|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20393571|NCT01090895|Vitamins|vitamins|mesh-ancestor
20393572|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
20393573|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401516|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
19401517|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401518|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401519|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19401520|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19401521|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19401522|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19401523|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401524|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401525|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
19401526|NCT03617432|Hormones|hormones|mesh-ancestor
19686357|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686358|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686359|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686360|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686361|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
19686362|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20208176|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208177|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208178|NCT00276068|Lidocaine|lidocaine|mesh-list
20208179|NCT00276068|Desipramine|desipramine|mesh-list
20208180|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
20208181|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
20208182|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208183|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208184|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
20208185|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208186|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20208187|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19358316|NCT02935205|Indomethacin|indomethacin|mesh-list
19358317|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19358318|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19358319|NCT02935205|Analgesics|analgesics|mesh-ancestor
19358320|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
20393574|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
20393575|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393576|NCT01090895|Protective Agents|protective agents|mesh-ancestor
20393577|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20393578|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393579|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
20393580|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393581|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20393582|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20393583|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393584|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393585|NCT01091012|Urological Agents|urological agents|mesh-ancestor
20393586|NCT01091051|Ustekinumab|ustekinumab|mesh-list
20393587|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
20393588|NCT01091077|Naringenin|naringenin|mesh-list
20393589|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19358321|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358322|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358323|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358324|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358325|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
19358326|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
19358327|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19358328|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19358329|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358330|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358331|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
20208188|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20208189|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208190|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208191|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20208192|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
20208193|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20393590|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358332|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19358333|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
19358334|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358335|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
19358336|NCT02861183|Protective Agents|protective agents|mesh-ancestor
19358337|NCT02807805|Niclosamide|niclosamide|mesh-list
19358338|NCT02807805|Prednisone|prednisone|mesh-list
20393591|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20393592|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
20393593|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393594|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393595|NCT01091207|Sorafenib|sorafenib|mesh-list
20393596|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393597|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19358339|NCT02807805|Cortisone|cortisone|mesh-list
19358340|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
19358341|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358342|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
19358343|NCT02807805|Hormones|hormones|mesh-ancestor
19358344|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19686363|NCT00783354|Loratadine|loratadine|mesh-list
19686364|NCT00783354|Desloratadine|desloratadine|mesh-list
19686365|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686366|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686367|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686368|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208194|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208195|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20208196|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20208197|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
20208198|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208199|NCT00276081|Gabapentin|gabapentin|mesh-list
20393598|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358345|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686369|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208200|NCT00276081|Estrogens|estrogens|mesh-list
20393599|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686370|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686371|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686372|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686373|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
19686374|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
19686375|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
19844427|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358346|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19358347|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358348|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19358349|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358350|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358351|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
20393600|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
20393601|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393602|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
20393603|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358352|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19358353|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
19358354|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19358355|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
19358356|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19358357|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358358|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
19358359|NCT02764268|Apatinib|apatinib|mesh-list
19358360|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358361|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19358362|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358363|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358364|NCT02714322|Adalimumab|adalimumab|mesh-list
19358365|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358366|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358367|NCT02607813|Spartalizumab|spartalizumab|mesh-list
19358368|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358369|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358370|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358371|NCT02553473|Doxycycline|doxycycline|mesh-list
19358372|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19358373|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358374|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
19358375|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19358376|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19358377|NCT02472912|Adalimumab|adalimumab|mesh-list
19358378|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358379|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358380|NCT02467582|Aspirin|aspirin|mesh-list
19358381|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19358382|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19358383|NCT02467582|Analgesics|analgesics|mesh-ancestor
19358384|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
19358385|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358386|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358387|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358388|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393604|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393605|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
20393606|NCT01091324|Silymarin|silymarin|mesh-list
20393607|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
20393608|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
20393609|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20393610|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20393611|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393612|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393613|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393614|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
20393615|NCT01091324|Protective Agents|protective agents|mesh-ancestor
20393616|NCT01091337|Albuterol|albuterol|mesh-list
20393617|NCT01091337|Procaterol|procaterol|mesh-list
20393618|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19358389|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19686376|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686377|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
19686378|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844428|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
19686379|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
20393619|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
19358390|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19358391|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358392|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19358393|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19358394|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358395|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
19358396|NCT02356458|Bortezomib|bortezomib|mesh-list
19358397|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358398|NCT02254278|Cisplatin|cisplatin|mesh-list
19358399|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358400|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19358401|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
19358402|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358403|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
19358404|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358405|NCT01974609|Acetaminophen|acetaminophen|mesh-list
19358406|NCT01974609|Ibuprofen|ibuprofen|mesh-list
19358407|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19358408|NCT01974609|Hydrocodone|hydrocodone|mesh-list
19358409|NCT01974609|Narcotics|narcotics|mesh-list
19358410|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19358411|NCT01974609|Analgesics|analgesics|mesh-ancestor
19358412|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
19358413|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358414|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358415|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
19358416|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19358417|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358418|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358419|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19358420|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358421|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358422|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19358423|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19358424|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
19686380|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686381|NCT00783133|Fexofenadine|fexofenadine|mesh-list
19686382|NCT00783133|Desloratadine|desloratadine|mesh-list
19686383|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686384|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686385|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686386|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686387|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208201|NCT00276081|Analgesics|analgesics|mesh-ancestor
20208202|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
20208203|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208204|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208205|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
20208206|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20208207|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208208|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208209|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208210|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20208211|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20208212|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208213|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208214|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
20208215|NCT00276081|Hormones|hormones|mesh-ancestor
20208216|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208217|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20208218|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
20208219|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208220|NCT00276133|Atorvastatin|atorvastatin|mesh-list
20208221|NCT00276133|Probucol|probucol|mesh-list
20208222|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20208223|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20208224|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
20208225|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208226|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20208227|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20208228|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358425|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
19358426|NCT01850524|Dexamethasone|dexamethasone|mesh-list
19358427|NCT01850524|Lenalidomide|lenalidomide|mesh-list
19358428|NCT01850524|Ixazomib|ixazomib|mesh-list
19358429|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358430|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
19358431|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
19358432|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358433|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358434|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358435|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
19358436|NCT01850524|Hormones|hormones|mesh-ancestor
19358437|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358438|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20393620|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393621|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393622|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20393623|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
20393624|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
20393625|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20393626|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20393627|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20393628|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19358439|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358440|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
19358441|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19358442|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19358443|NCT01850524|Growth Substances|growth substances|mesh-ancestor
19358444|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
19358445|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
19358446|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358447|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358448|NCT01758081|Vitamin D|vitamin d|mesh-list
19358449|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
19358450|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
19358451|NCT01758081|Vitamins|vitamins|mesh-list
19358452|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
19358453|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358454|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19358455|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19358456|NCT01673867|Docetaxel|docetaxel|mesh-list
19358457|NCT01673867|Nivolumab|nivolumab|mesh-list
19358458|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358459|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358460|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358461|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358462|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358463|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358464|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358465|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19358466|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19844429|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19844430|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844431|NCT00665457|Analgesics|analgesics|mesh-ancestor
19844432|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
19844433|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844434|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844435|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19844436|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20208229|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
20208230|NCT00276133|Protective Agents|protective agents|mesh-ancestor
20208231|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208232|NCT00276146|Dipyridamole|dipyridamole|mesh-list
20208233|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20208234|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208235|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208236|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20208237|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
20208238|NCT00276172|Natalizumab|natalizumab|mesh-list
20208239|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
19358467|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844437|NCT00665470|Aldesleukin|aldesleukin|mesh-list
19844438|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844439|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20208240|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208241|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
20393629|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
20393630|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358468|NCT01182727|Analgesics|analgesics|mesh-ancestor
19358469|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
19358470|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358471|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358472|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358473|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358474|NCT01059188|Docetaxel|docetaxel|mesh-list
19358475|NCT01059188|Cetuximab|cetuximab|mesh-list
19358476|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358477|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358478|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358479|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358480|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358481|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358482|NCT01033552|Cyclosporine|cyclosporine|mesh-list
19358483|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
19358484|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
19358485|NCT01033552|Fludarabine|fludarabine|mesh-list
19358486|NCT01033552|Cyclosporins|cyclosporins|mesh-list
19358487|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19358488|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393631|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393632|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
20393633|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20393634|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393635|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20393636|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393637|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393638|NCT01091415|Calcium|calcium|mesh-list
20393639|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19358489|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
19358490|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358491|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358492|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19358493|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
19358494|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358495|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358496|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19358497|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358498|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
19358499|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358500|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686388|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686389|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686390|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686391|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
19686392|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686393|NCT00779636|Desloratadine|desloratadine|mesh-list
19686394|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19686395|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686396|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686397|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686398|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208242|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20208243|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208244|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208245|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
20208246|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208247|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208248|NCT00276198|Vitamin D|vitamin d|mesh-list
20208249|NCT00276198|Vitamin A|vitamin a|mesh-list
20208250|NCT00276198|Vitamins|vitamins|mesh-ancestor
20208251|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
20208252|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208253|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20208254|NCT00276276|Topotecan|topotecan|mesh-list
20208255|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20208256|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19358501|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20208257|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208258|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358502|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19844440|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19844441|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
19844442|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844443|NCT00665561|Maraviroc|maraviroc|mesh-list
19844444|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19844445|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19844446|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19844447|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844448|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19844449|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
19844450|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393640|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393641|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
20393642|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393643|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393644|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20393645|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20393646|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393647|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393648|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393649|NCT01091571|Dipyridamole|dipyridamole|mesh-list
20393650|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20393651|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844451|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19844452|NCT00665652|Lenalidomide|lenalidomide|mesh-list
19844453|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
19844454|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358503|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19358504|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
19358505|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19358506|NCT00877500|Epothilones|epothilones|mesh-list
19358507|NCT00877500|Epothilone B|epothilone b|mesh-list
19358508|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358509|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358510|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358511|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358512|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358513|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
19358514|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19358515|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
19358516|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
19358517|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358518|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358519|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844455|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844456|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19844457|NCT00665652|Growth Substances|growth substances|mesh-ancestor
19844458|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
19844459|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844460|NCT00665847|Etravirine|etravirine|mesh-list
19844461|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19844462|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19844463|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844464|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844465|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
19844466|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844467|NCT00666029|Atorvastatin|atorvastatin|mesh-list
19844468|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19844469|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19844470|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
19844471|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844472|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19844473|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19844474|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393652|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393653|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20393654|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393655|NCT01091649|Ritonavir|ritonavir|mesh-list
20393656|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19358520|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19844475|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
19844476|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393657|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20393658|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
19358521|NCT00335777|Analgesics|analgesics|mesh-ancestor
20393659|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393660|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393661|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20393662|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20393663|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
20393664|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393665|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20393666|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20393667|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
20393668|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20393669|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20393670|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
20393671|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20393672|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20393673|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20393674|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393675|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393676|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
20393677|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393678|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393679|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20393680|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358522|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
19358523|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358524|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
19358525|NCT00159588|Gabapentin|gabapentin|mesh-list
19358526|NCT00159588|Valproic Acid|valproic acid|mesh-list
19358527|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
19358528|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
19358529|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19358530|NCT00159588|Analgesics|analgesics|mesh-ancestor
19358531|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
19358532|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358533|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393681|NCT01091753|Amlodipine|amlodipine|mesh-list
20393682|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20393683|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20393684|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393685|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358534|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
19358535|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19358536|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19358537|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19358538|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19358539|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19358540|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19358541|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358542|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844477|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19844478|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19844479|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208259|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208260|NCT00276289|Spironolactone|spironolactone|mesh-list
20208261|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20208262|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
20208263|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208264|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208265|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20208266|NCT00276289|Diuretics|diuretics|mesh-ancestor
20208267|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
20208268|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
20208269|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20208270|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20208271|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20208272|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208273|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208274|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
20208275|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208276|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208277|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20208278|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844480|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844481|NCT00666198|Urological Agents|urological agents|mesh-ancestor
20208279|NCT00276393|Insulin|insulin|mesh-list
20393686|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19358543|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
19358544|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358545|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
19358546|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19358547|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19358548|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
19358549|NCT03060473|Amoxicillin|amoxicillin|mesh-list
19358550|NCT03060473|Azithromycin|azithromycin|mesh-list
19358551|NCT03060473|Erythromycin|erythromycin|mesh-list
19358552|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
19358553|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19358554|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
19358555|NCT03060473|Ampicillin|ampicillin|mesh-list
19358556|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19358557|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358558|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358559|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19358560|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358561|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358562|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
19358563|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358564|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
19358565|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358566|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358567|NCT03008382|Metoprolol|metoprolol|mesh-list
19358568|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19358569|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19358570|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
19358571|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
19358572|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358573|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358574|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19358575|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19358576|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19358577|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
19358578|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358579|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358580|NCT02988401|Insulin|insulin|mesh-list
19358581|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19358582|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358583|NCT02987530|Tenofovir|tenofovir|mesh-list
19358584|NCT02987530|Emtricitabine|emtricitabine|mesh-list
19358585|NCT02987530|Darunavir|darunavir|mesh-list
19358586|NCT02987530|Dolutegravir|dolutegravir|mesh-list
19358587|NCT02987530|Cobicistat|cobicistat|mesh-list
19358588|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
19358589|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358590|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19358591|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19358592|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358593|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358594|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19686399|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686400|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686401|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686402|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
19686403|NCT00763529|Fluticasone|fluticasone|mesh-list
19686404|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
19686405|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19686406|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19686407|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
19686408|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208280|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20208281|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208282|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
20208283|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20208284|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
20208285|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208286|NCT00276497|Pioglitazone|pioglitazone|mesh-list
20208287|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20208288|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208289|NCT00276523|Interferons|interferons|mesh-list
20208290|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
20393687|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393688|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393689|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20426601|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20426602|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20426603|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20426604|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
20426605|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426606|NCT01281800|Gemcitabine|gemcitabine|mesh-list
20426607|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20426608|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
20426609|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426610|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426611|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
20426612|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426613|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426614|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358595|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19358596|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19358597|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19358598|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
19358599|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19358600|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19358601|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19358602|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19844482|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
20426615|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
20426616|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686409|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686410|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19686411|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
19686412|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686413|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686414|NCT00757562|Desloratadine|desloratadine|mesh-list
19686415|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19358603|NCT02965690|Cimetidine|cimetidine|mesh-list
19358604|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19358605|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358606|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20426617|NCT01281813|Ritonavir|ritonavir|mesh-list
20426618|NCT01281813|Darunavir|darunavir|mesh-list
20426619|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20426620|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20426621|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
20426622|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426623|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358607|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
19358608|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
19358609|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358610|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426624|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20426625|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20426626|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
20426627|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426628|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20426629|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20426630|NCT01281852|Paclitaxel|paclitaxel|mesh-list
19358611|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358612|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19358613|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19358614|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358615|NCT02964182|Nicotine|nicotine|mesh-list
19358616|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19358617|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
19358618|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358619|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358620|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19358621|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19358622|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
19358623|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686416|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
19686417|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426631|NCT01281852|Cisplatin|cisplatin|mesh-list
20426632|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20426633|NCT01281852|Veliparib|veliparib|mesh-list
19358624|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358625|NCT02889809|Fluticasone|fluticasone|mesh-list
19358626|NCT02889809|Xhance|xhance|mesh-list
19358627|NCT02889809|Montelukast|montelukast|mesh-list
19358628|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358629|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19358630|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
19358631|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686418|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686419|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686420|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19686421|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19686422|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686423|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
19686424|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
19358632|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358633|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19358634|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
19358635|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
19358636|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19358637|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19358638|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
19358639|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393690|NCT01091792|Bevacizumab|bevacizumab|mesh-list
20393691|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20393692|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393693|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20393694|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393695|NCT01091792|Growth Substances|growth substances|mesh-ancestor
20393696|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393697|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
20393698|NCT01091818|Midazolam|midazolam|mesh-list
20393699|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
20393700|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20393701|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20393702|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393703|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20393704|NCT01091818|Analgesics|analgesics|mesh-ancestor
20393705|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
19358640|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19686425|NCT00751075|Amoxicillin|amoxicillin|mesh-list
19686426|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19686427|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686428|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19686429|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686430|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686431|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
19686432|NCT00750750|Amoxicillin|amoxicillin|mesh-list
19358641|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19358642|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358643|NCT02884648|Bevacizumab|bevacizumab|mesh-list
19844483|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
19844484|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19844485|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
19844486|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844487|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844488|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358644|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358645|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358646|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19358647|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19358648|NCT02884648|Growth Substances|growth substances|mesh-ancestor
19358649|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358650|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
19358651|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
19358652|NCT02818023|Vemurafenib|vemurafenib|mesh-list
19686433|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19686434|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686435|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19686436|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686437|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19358653|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686438|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
19686439|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393706|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208291|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
20208292|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20208293|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208294|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
20208295|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208296|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
19844489|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20393707|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20393708|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20393709|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20393710|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
20208297|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208298|NCT00276536|Interferons|interferons|mesh-list
19358654|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358655|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19358656|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358657|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358658|NCT02815540|Cannabidiol|cannabidiol|mesh-list
19358659|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
19358660|NCT02808572|Mitogens|mitogens|mesh-list
19358661|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358662|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358663|NCT02785224|Vasopressins|vasopressins|mesh-list
19358664|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
19358665|NCT02785224|Epinephrine|epinephrine|mesh-list
19358666|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19358667|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19358668|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
19358669|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358670|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358671|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358672|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19358673|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19358674|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
19358675|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358676|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19358677|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
19358678|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
19358679|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
19358680|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19358681|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
19358682|NCT02785224|Coagulants|coagulants|mesh-ancestor
19358683|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19358684|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
19686440|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686441|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19686442|NCT00653835|Simvastatin|simvastatin|mesh-list
19686443|NCT00653835|Ezetimibe|ezetimibe|mesh-list
19686444|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686445|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686446|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
19686447|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393711|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393712|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393713|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20393714|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20393715|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20393716|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20393717|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20393718|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
20393719|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
20393720|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
20393721|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
20393722|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
20393723|NCT01091870|Citric Acid|citric acid|mesh-list
20393724|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
20393725|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
20393726|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20393727|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
19358685|NCT02781883|Decitabine|decitabine|mesh-list
19844490|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
19358686|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208299|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
19358687|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
19358688|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686448|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19844491|NCT00666263|Antibodies|antibodies|mesh-list
20208300|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20393728|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
19358689|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358690|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358691|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19686449|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686450|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686451|NCT00653796|Atorvastatin|atorvastatin|mesh-list
19686452|NCT00653796|Ezetimibe|ezetimibe|mesh-list
19686453|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686454|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686455|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
19686456|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358692|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358693|NCT02778204|Maraviroc|maraviroc|mesh-list
19358694|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19358695|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19358696|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358697|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20393729|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393730|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
20393731|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20393732|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20393733|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393734|NCT01091870|Urological Agents|urological agents|mesh-ancestor
20393735|NCT01091896|Bevacizumab|bevacizumab|mesh-list
20393736|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20393737|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393738|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20208301|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358698|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19358699|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
19358700|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358701|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19358702|NCT02743364|Simvastatin|simvastatin|mesh-list
19358703|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19358704|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19358705|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
19358706|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358707|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19358708|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19358709|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358710|NCT02670044|Venetoclax|venetoclax|mesh-list
19686457|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686458|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686459|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686460|NCT00651404|Ezetimibe|ezetimibe|mesh-list
19686461|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686462|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686463|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
19686464|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358711|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358712|NCT02648997|Nivolumab|nivolumab|mesh-list
19358713|NCT02648997|Ipilimumab|ipilimumab|mesh-list
19358714|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358715|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358716|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358717|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401527|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401528|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19686465|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686466|NCT00651391|Simvastatin|simvastatin|mesh-list
19686467|NCT00651391|Ezetimibe|ezetimibe|mesh-list
19686468|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686469|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20208302|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
20208303|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208304|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
20208305|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208306|NCT00276575|Bevacizumab|bevacizumab|mesh-list
20208307|NCT00276575|Everolimus|everolimus|mesh-list
20208308|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20208309|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20208310|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208311|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20208312|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19358718|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
19358719|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358720|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358721|NCT02560298|Paclitaxel|paclitaxel|mesh-list
19358722|NCT02560298|Cisplatin|cisplatin|mesh-list
19358723|NCT02560298|Carboplatin|carboplatin|mesh-list
19358724|NCT02560298|Fluorouracil|fluorouracil|mesh-list
19358725|NCT02560298|Capecitabine|capecitabine|mesh-list
19358726|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19358727|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19358728|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358729|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358730|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358731|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358732|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358733|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
20393739|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393740|NCT01091896|Growth Substances|growth substances|mesh-ancestor
20393741|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393742|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
20393743|NCT01092039|Lactoferrin|lactoferrin|mesh-list
19358734|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358735|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358736|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
19358737|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358738|NCT02547493|Abatacept|abatacept|mesh-list
19358739|NCT02547493|Vaccines|vaccines|mesh-list
19358740|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19358741|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
19358742|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358743|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358744|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686470|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
19686471|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686472|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686473|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686474|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686475|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19686476|NCT00651144|Ezetimibe|ezetimibe|mesh-list
19686477|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686478|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686479|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
19686480|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686481|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19358745|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358746|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358747|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358748|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
19358749|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358750|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686482|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686483|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686484|NCT00651014|Ezetimibe|ezetimibe|mesh-list
19686485|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19358751|NCT02496611|Exenatide|exenatide|mesh-list
19358752|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19358753|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358754|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19358755|NCT02496611|Incretins|incretins|mesh-ancestor
19358756|NCT02496611|Hormones|hormones|mesh-ancestor
19358757|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358758|NCT02476097|Esomeprazole|esomeprazole|mesh-list
19358759|NCT02476097|Omeprazole|omeprazole|mesh-list
19686486|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686487|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
20208313|NCT00276575|Growth Substances|growth substances|mesh-ancestor
20208314|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208315|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
20208316|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208317|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
20208318|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20208319|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208320|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358760|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19358761|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358762|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20393744|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393745|NCT01092091|BCT-100|bct-100|mesh-list
20393746|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393747|NCT01092130|Vitamin D|vitamin d|mesh-list
20393748|NCT01092130|Vitamins|vitamins|mesh-ancestor
20393749|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
20393750|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844492|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
19844493|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19844494|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19844495|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
19844496|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844497|NCT00666276|Linezolid|linezolid|mesh-list
19844498|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19844499|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358763|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358764|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358765|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19358766|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
19358767|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19358768|NCT02459392|Prednisolone|prednisolone|mesh-list
19358769|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
19358770|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
19358771|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19844500|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19844501|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844502|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844503|NCT00666328|Clevidipine|clevidipine|mesh-list
19844504|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19844505|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844506|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358772|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
19358773|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19358774|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
20393751|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20393752|NCT01092221|Allopurinol|allopurinol|mesh-list
20393753|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
20393754|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393755|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393756|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
20393757|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393758|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20393759|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
20393760|NCT01092221|Protective Agents|protective agents|mesh-ancestor
20393761|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393762|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
20393763|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20393764|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393765|NCT01092351|Renal Agents|renal agents|mesh-ancestor
20393766|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393767|NCT01092455|Heparin|heparin|mesh-list
20393768|NCT01092455|Calcium heparin|calcium heparin|mesh-list
20393769|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
20393770|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20393771|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20393772|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393773|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
20393774|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358775|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358776|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
19358777|NCT02459392|Protective Agents|protective agents|mesh-ancestor
19358778|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19358779|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
19358780|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
19358781|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358782|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19358783|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
19358784|NCT02459392|Hormones|hormones|mesh-ancestor
19358785|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358786|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19358787|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19358788|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358789|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
20393775|NCT01092520|Gabapentin|gabapentin|mesh-list
19358790|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393776|NCT01092520|Analgesics|analgesics|mesh-ancestor
20393777|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
19358791|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19358792|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358793|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358794|NCT02361125|Methylphenidate|methylphenidate|mesh-list
19358795|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19358796|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358797|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19358798|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19358799|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19358800|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358801|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
19358802|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358803|NCT02338921|Metformin|metformin|mesh-list
19358804|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19358805|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
19358806|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19358807|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358808|NCT02338921|Incretins|incretins|mesh-ancestor
19358809|NCT02338921|Hormones|hormones|mesh-ancestor
19358810|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358811|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19358812|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
19358813|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358814|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358815|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19358816|NCT02245308|Bupropion|bupropion|mesh-list
19358817|NCT02245308|Nicotine|nicotine|mesh-list
19844507|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19844508|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844509|NCT00666406|Factor VIII|factor viii|mesh-list
19844510|NCT00666406|Coagulants|coagulants|mesh-ancestor
19844511|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19844512|NCT00666458|Saxagliptin|saxagliptin|mesh-list
19844513|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19844514|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844515|NCT00666458|Incretins|incretins|mesh-ancestor
19844516|NCT00666458|Hormones|hormones|mesh-ancestor
19844517|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844518|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19844519|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
19844520|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844521|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844522|NCT00666536|Amlodipine|amlodipine|mesh-list
19844523|NCT00666536|Valsartan|valsartan|mesh-list
19844524|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19844525|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19844526|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19844527|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844528|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844529|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19844530|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844531|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
19844532|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19844533|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19844534|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20208321|NCT00276588|Gemcitabine|gemcitabine|mesh-list
20208322|NCT00276588|Paclitaxel|paclitaxel|mesh-list
19358818|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19358819|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
19358820|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358821|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358822|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19358823|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20208323|NCT00276588|Carboplatin|carboplatin|mesh-list
20208324|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208325|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208326|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208327|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208328|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208329|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208330|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208331|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
20393778|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393779|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393780|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
20393781|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20393782|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20393783|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20393784|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20393785|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19358824|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
19358825|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358826|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358827|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19358828|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
19358829|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19358830|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19358831|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19358832|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19358833|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
19358834|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19358835|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19358836|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358837|NCT02227199|Carboplatin|carboplatin|mesh-list
19358838|NCT02227199|Etoposide|etoposide|mesh-list
20393786|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20393787|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393788|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393789|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
20393790|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
20393791|NCT01092533|Prednisolone|prednisolone|mesh-list
20393792|NCT01092533|Prednisone|prednisone|mesh-list
20393793|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20393794|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393795|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20393796|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
19358839|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
19358840|NCT02227199|Ifosfamide|ifosfamide|mesh-list
19358841|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
19358842|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19358843|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
19358844|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19358845|NCT02227199|Antibodies|antibodies|mesh-list
19358846|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
19358847|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19358848|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
19358849|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
19358850|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358851|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358852|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19358853|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19358854|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19358855|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358856|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358857|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19358858|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
19358859|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
19358860|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
19358861|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358862|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358863|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358864|NCT02177695|Gemcitabine|gemcitabine|mesh-list
19358865|NCT02177695|Doxorubicin|doxorubicin|mesh-list
19358866|NCT02177695|Methotrexate|methotrexate|mesh-list
19358867|NCT02177695|Vinblastine|vinblastine|mesh-list
19358868|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686488|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686489|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686490|NCT00650689|Atorvastatin|atorvastatin|mesh-list
19686491|NCT00650689|Ezetimibe|ezetimibe|mesh-list
19358869|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358870|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
19358871|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358872|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
19686492|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686493|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686494|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
20393797|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19358873|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19358874|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393798|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393799|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393800|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393801|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393802|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
20393803|NCT01092533|Hormones|hormones|mesh-ancestor
20393804|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358875|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358876|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
19358877|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358878|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19358879|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19358880|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19358881|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19358882|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
19358883|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19686495|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686496|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686497|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686498|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686499|NCT00650663|Simvastatin|simvastatin|mesh-list
19686500|NCT00650663|Ezetimibe|ezetimibe|mesh-list
19686501|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686502|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686503|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
19686504|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686505|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686506|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686507|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686508|NCT00589420|Docetaxel|docetaxel|mesh-list
19686509|NCT00589420|Sorafenib|sorafenib|mesh-list
19686510|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686511|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19686512|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686513|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19686514|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686515|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19686516|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686517|NCT00552097|Simvastatin|simvastatin|mesh-list
19686518|NCT00552097|Ezetimibe|ezetimibe|mesh-list
19686519|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686520|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686521|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
19686522|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686523|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686524|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686525|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686526|NCT00398294|Simvastatin|simvastatin|mesh-list
19686527|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19686528|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19686529|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
19686530|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686531|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19686532|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19686533|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686534|NCT00396175|Finasteride|finasteride|mesh-list
19686535|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686536|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686537|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19844535|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
20208332|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
20208333|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208334|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208335|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208336|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
20208337|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208338|NCT00276601|Cytarabine|cytarabine|mesh-list
20208339|NCT00276601|Methotrexate|methotrexate|mesh-list
20208340|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
20208341|NCT00276601|Daunorubicin|daunorubicin|mesh-list
20208342|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
20208343|NCT00276601|Tretinoin|tretinoin|mesh-list
20393805|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393806|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20393807|NCT01092572|Simvastatin|simvastatin|mesh-list
20393808|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20393809|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20393810|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
20393811|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393812|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20393813|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20393814|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393815|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
20393816|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20393817|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20393818|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
20393819|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393820|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393821|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393822|NCT01092624|Urological Agents|urological agents|mesh-ancestor
20393823|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
20393824|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393825|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20393826|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393827|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393828|NCT01092806|Tacrolimus|tacrolimus|mesh-list
20393829|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393830|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
20393831|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393832|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20393833|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393834|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358884|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
19358885|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19358886|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19686538|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19686539|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686540|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
19686541|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358887|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19358888|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19358889|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358890|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
19358891|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358892|NCT02145403|Tacrolimus|tacrolimus|mesh-list
19358893|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358894|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
19358895|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358896|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19358897|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358898|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358899|NCT02105636|Docetaxel|docetaxel|mesh-list
19358900|NCT02105636|Methotrexate|methotrexate|mesh-list
19358901|NCT02105636|Nivolumab|nivolumab|mesh-list
19358902|NCT02105636|Cetuximab|cetuximab|mesh-list
19358903|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358904|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
19358905|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686542|NCT00396175|Urological Agents|urological agents|mesh-ancestor
19686543|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
19686544|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20208344|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20208345|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
20208346|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20208347|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208348|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208349|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
20208350|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208351|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208352|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
20208353|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208354|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20208355|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358906|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
19358907|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208356|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
20208357|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208358|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20208359|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
20208360|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393835|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
19358908|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19358909|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
19358910|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19358911|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358912|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358913|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
19358914|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
19358915|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358916|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19358917|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19358918|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
19358919|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19358920|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19358921|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358922|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358923|NCT02038946|Nivolumab|nivolumab|mesh-list
19358924|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19358925|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358926|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19358927|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358928|NCT01988571|Atorvastatin|atorvastatin|mesh-list
19358929|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19358930|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19358931|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
19358932|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358933|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19358934|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19358935|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358936|NCT01979367|Analgesics|analgesics|mesh-list
19358937|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
19358938|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358939|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358940|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
19358941|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19358942|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19358943|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358944|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19358945|NCT01973452|Analgesics|analgesics|mesh-ancestor
19358946|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
19358947|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358948|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19358949|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19358950|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19358951|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
19358952|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19358953|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358954|NCT01863550|Dexamethasone|dexamethasone|mesh-list
19358955|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
19358956|NCT01863550|Lenalidomide|lenalidomide|mesh-list
19358957|NCT01863550|Bortezomib|bortezomib|mesh-list
19358958|NCT01863550|Ichthammol|ichthammol|mesh-list
19358959|NCT01863550|BB 1101|bb 1101|mesh-list
19358960|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393836|NCT01092858|Testosterone|testosterone|mesh-list
19358961|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
19358962|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
19358963|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19358964|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358965|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20208361|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20208362|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208363|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208364|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
20208365|NCT00276640|Carboplatin|carboplatin|mesh-list
20208366|NCT00276640|Etoposide|etoposide|mesh-list
20208367|NCT00276640|Vincristine|vincristine|mesh-list
20208368|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686545|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20208369|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19844536|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844537|NCT00666562|Protective Agents|protective agents|mesh-ancestor
19844538|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844539|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19844540|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19844541|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686546|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19358966|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
19358967|NCT01863550|Hormones|hormones|mesh-ancestor
19358968|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19358969|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19358970|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358971|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
19358972|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19358973|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19358974|NCT01863550|Growth Substances|growth substances|mesh-ancestor
19358975|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
19358976|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
19358977|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19358978|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358979|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
19358980|NCT01824875|Capecitabine|capecitabine|mesh-list
19358981|NCT01824875|Temozolomide|temozolomide|mesh-list
19358982|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19358983|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
19358984|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358985|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19358986|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19358987|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
19358988|NCT01792583|Modafinil|modafinil|mesh-list
19358989|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19358990|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358991|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19358992|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19358993|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19358994|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19358995|NCT01755975|Lenalidomide|lenalidomide|mesh-list
19358996|NCT01755975|Romidepsin|romidepsin|mesh-list
19358997|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
19358998|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19358999|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19359000|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19359001|NCT01755975|Growth Substances|growth substances|mesh-ancestor
19359002|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
19359003|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359004|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19359005|NCT01670409|Cisplatin|cisplatin|mesh-list
19359006|NCT01670409|Fluorouracil|fluorouracil|mesh-list
19359007|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359008|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
19359009|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359010|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359011|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359012|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
19359013|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686547|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686548|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686549|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686550|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
19686551|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
19686552|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686553|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
19686554|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19844542|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20208370|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208371|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208372|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208373|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208374|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208375|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208376|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208377|NCT00276666|Vincristine|vincristine|mesh-list
20208378|NCT00276666|Lomustine|lomustine|mesh-list
20208379|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208380|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208381|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208382|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208383|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208384|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208385|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20208386|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
20208387|NCT00276679|Temozolomide|temozolomide|mesh-list
20208388|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20208389|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
20208390|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208391|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208392|NCT00276692|Irinotecan|irinotecan|mesh-list
20208393|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20208394|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208395|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208396|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208397|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208398|NCT00276705|Thalidomide|thalidomide|mesh-list
20208399|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
20208400|NCT00276705|Doxorubicin|doxorubicin|mesh-list
20208401|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20208402|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208403|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
20208404|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208405|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208406|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19359014|NCT01526135|Gemcitabine|gemcitabine|mesh-list
19686555|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
19686556|NCT00370890|Gemcitabine|gemcitabine|mesh-list
19686557|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686558|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686559|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
19686560|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686561|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
19686562|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686563|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686564|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686565|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
19686566|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686567|NCT04231565|Tenofovir|tenofovir|mesh-list
19686568|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
19686569|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686570|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19686571|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19686572|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686573|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686574|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19686575|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19686576|NCT04189445|Futibatinib|futibatinib|mesh-list
19686577|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686578|NCT04123444|Iloprost|iloprost|mesh-list
19359015|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359016|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
19359017|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359018|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359019|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
19359020|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359021|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359022|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359023|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
19686579|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19686580|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
19686581|NCT04116502|Interferons|interferons|mesh-list
19686582|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
19686583|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
19686584|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
19686585|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686586|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
19359024|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359025|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
19359026|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686587|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686588|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
19844543|NCT00666588|Cytarabine|cytarabine|mesh-list
19359027|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19359028|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359029|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359030|NCT01415752|Rituximab|rituximab|mesh-list
19359031|NCT01415752|Lenalidomide|lenalidomide|mesh-list
19359032|NCT01415752|Bortezomib|bortezomib|mesh-list
19359033|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19359034|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844544|NCT00666588|Etoposide|etoposide|mesh-list
19844545|NCT00666588|Idarubicin|idarubicin|mesh-list
19844546|NCT00666588|Bortezomib|bortezomib|mesh-list
19844547|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
20208407|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
19359035|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359036|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
19686589|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686590|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
19686591|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686592|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686593|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19686594|NCT04116047|Durvalumab|durvalumab|mesh-list
19686595|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686596|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844548|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19844549|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393837|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
20393838|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
20393839|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20393840|NCT01092858|Androgens|androgens|mesh-ancestor
20393841|NCT01092858|Hormones|hormones|mesh-ancestor
20393842|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393843|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393844|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20393845|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393846|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
20393847|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
20393848|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
20393849|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393850|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
20393851|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393852|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393853|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20393854|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
20393855|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359037|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359038|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359039|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844550|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19844551|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19844552|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844553|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844554|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844555|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
19844556|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
19844557|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844558|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844559|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
19844560|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844561|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19844562|NCT00666666|Acetic Acid|acetic acid|mesh-list
19844563|NCT00666666|Bicalutamide|bicalutamide|mesh-list
19844564|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
19844565|NCT00666666|Gossypol|gossypol|mesh-list
20208408|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208409|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208410|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20208411|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20208412|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208413|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208414|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208415|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
20208416|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20208417|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208418|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20393856|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393857|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20393858|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20393859|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20393860|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
20393861|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20393862|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393863|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393864|NCT01092975|Phenylephrine|phenylephrine|mesh-list
20393865|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
20393866|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20393867|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
20393868|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
20393869|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20393870|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393871|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
20393872|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20393873|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
20393874|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
20393875|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20393876|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20393877|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20393878|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
20393879|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393880|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393881|NCT01092975|Protective Agents|protective agents|mesh-ancestor
20393882|NCT01093040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20393883|NCT01093040|Immunologic Factors|immunologic factors|mesh-ancestor
20393884|NCT01093040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393885|NCT01093092|Calcitriol|calcitriol|mesh-list
20393886|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
20393887|NCT01093092|Gemcitabine|gemcitabine|mesh-list
20393888|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393889|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393890|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
20393891|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393892|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
20393893|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20393894|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393895|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393896|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
20393897|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393898|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20393899|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20393900|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393901|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19686597|NCT04095845|Tacrine|tacrine|mesh-list
19686598|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19686599|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686600|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686601|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
20208419|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393902|NCT01093092|Vitamins|vitamins|mesh-ancestor
20393903|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
20393904|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20393905|NCT01093157|Hormones|hormones|mesh-list
20208420|NCT00276705|Growth Substances|growth substances|mesh-ancestor
20208421|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
20208422|NCT00276718|Carboplatin|carboplatin|mesh-list
20208423|NCT00276718|Etoposide|etoposide|mesh-list
20208424|NCT00276718|Bleomycin|bleomycin|mesh-list
20208425|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208426|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208427|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208428|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208429|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208430|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208431|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20208432|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
20208433|NCT00276731|Carboplatin|carboplatin|mesh-list
20208434|NCT00276731|Etoposide|etoposide|mesh-list
20208435|NCT00276731|Vincristine|vincristine|mesh-list
20208436|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686602|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404617|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20208437|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
20208438|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393906|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20393907|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20393908|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393909|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
20393910|NCT01093235|Bevacizumab|bevacizumab|mesh-list
20393911|NCT01093235|Docetaxel|docetaxel|mesh-list
20393912|NCT01093235|Fluorouracil|fluorouracil|mesh-list
20208439|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208440|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20208441|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
20208442|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208443|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208444|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19686603|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686604|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19686605|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
19686606|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359040|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19359041|NCT01415752|Growth Substances|growth substances|mesh-ancestor
19359042|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
19359043|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19359044|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
19359045|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359046|NCT01398852|Riboflavin|riboflavin|mesh-list
19359047|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
19359048|NCT01398852|Vitamins|vitamins|mesh-ancestor
19359049|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
19359050|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359051|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19359052|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
19686607|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
19686608|NCT04092179|Venetoclax|venetoclax|mesh-list
19686609|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692778|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19692779|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692780|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692781|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19692782|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
19692783|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692784|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692785|NCT04987463|Sirolimus|sirolimus|mesh-list
19692786|NCT04987463|Vigabatrin|vigabatrin|mesh-list
19692787|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19692788|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208445|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20393913|NCT01093235|Epirubicin|epirubicin|mesh-list
20393914|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359053|NCT01332266|Cetuximab|cetuximab|mesh-list
19359054|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19692789|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19692790|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692791|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
19692792|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19692793|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
19692794|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359055|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359056|NCT01261728|Gemcitabine|gemcitabine|mesh-list
19359057|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359058|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359059|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
19359060|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359061|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
19359062|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359063|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359064|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359065|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
19692795|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
19692796|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844566|NCT00666666|Hormones|hormones|mesh-list
19844567|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844568|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844569|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
19844570|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
20393915|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
20393916|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393917|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393918|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20393919|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
20393920|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208446|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208447|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208448|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208449|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208450|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
20393921|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393922|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20393923|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20393924|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19359066|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359067|NCT01222754|Lenalidomide|lenalidomide|mesh-list
19359068|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
20393925|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20393926|NCT01093235|Growth Substances|growth substances|mesh-ancestor
20393927|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
20393928|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
20393929|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
20393930|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
20393931|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
20393932|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20393933|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20393934|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20393935|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20393936|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393937|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
20393938|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
20393939|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20393940|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
20393941|NCT01093274|Cathartics|cathartics|mesh-ancestor
20393942|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20393943|NCT01093300|Paclitaxel|paclitaxel|mesh-list
20393944|NCT01093300|Everolimus|everolimus|mesh-list
20393945|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20393946|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20393947|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
19686610|NCT04046900|Metronidazole|metronidazole|mesh-list
19686611|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686612|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19686613|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19686614|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19359069|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359070|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19359071|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19359072|NCT01222754|Growth Substances|growth substances|mesh-ancestor
19359073|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
19359074|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359075|NCT01150890|Brodalumab|brodalumab|mesh-list
19359076|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
19359077|NCT01143779|Telbivudine|telbivudine|mesh-list
19359078|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
19359079|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359080|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19359081|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359082|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359083|NCT01140867|Zonisamide|zonisamide|mesh-list
19359084|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
19359085|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19359086|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19686615|NCT04038099|Lidocaine|lidocaine|mesh-list
19686616|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
19686617|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
19686618|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19686619|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686620|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
19686621|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208451|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208452|NCT00276757|Leucovorin|leucovorin|mesh-list
20208453|NCT00276757|Prednisolone|prednisolone|mesh-list
20208454|NCT00276757|Methotrexate|methotrexate|mesh-list
20208455|NCT00276757|Vinblastine|vinblastine|mesh-list
20208456|NCT00276757|Calcium|calcium|mesh-list
20208457|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
20208458|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19686622|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19686623|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19686624|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19686625|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19686626|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686627|NCT03991832|Durvalumab|durvalumab|mesh-list
19686628|NCT03991832|Olaparib|olaparib|mesh-list
19844571|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844572|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19359087|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359088|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19359089|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359090|NCT01137773|Insulin|insulin|mesh-list
19359091|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19359092|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19359093|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359094|NCT01127256|Carbamazepine|carbamazepine|mesh-list
19359095|NCT01127256|Zonisamide|zonisamide|mesh-list
19359096|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
19359097|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
19359098|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19359099|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359100|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359101|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19359102|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19359103|NCT01127256|Analgesics|analgesics|mesh-ancestor
19359104|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
19359105|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359106|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19359107|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19359108|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359109|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19359110|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19359111|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19359112|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19359113|NCT00978458|Temozolomide|temozolomide|mesh-list
19359114|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19359115|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
19359116|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359117|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686629|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844573|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844574|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19844575|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19844576|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
19844577|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19844578|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19844579|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20208459|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208460|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20208461|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
20208462|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20208463|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208464|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
20208465|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208466|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208467|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
20208468|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208469|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19686630|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686631|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19686632|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686633|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686634|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
19686635|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19686636|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208470|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208471|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
20208472|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20393948|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
19359118|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
19359119|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359120|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19359121|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359122|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393949|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
20393950|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393951|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20393952|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
20393953|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393954|NCT01093365|Varenicline|varenicline|mesh-list
20393955|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19359123|NCT00482833|Methotrexate|methotrexate|mesh-list
20208473|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20208474|NCT00276757|Antidotes|antidotes|mesh-ancestor
20393956|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20393957|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
20393958|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393959|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393960|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393961|NCT01093638|Insulin|insulin|mesh-list
20393962|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20393963|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426634|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20426635|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426636|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
20426637|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
20426638|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
20426639|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426640|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20426641|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426642|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
20426643|NCT01281878|Pyridoxal|pyridoxal|mesh-list
20426644|NCT01281878|Pyridoxine|pyridoxine|mesh-list
20426645|NCT01281878|Vitamins|vitamins|mesh-ancestor
20426646|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
20426647|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426648|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
20426649|NCT01281891|Morphine|morphine|mesh-list
20426650|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20426651|NCT01281891|Narcotics|narcotics|mesh-ancestor
20426652|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426653|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426654|NCT01281891|Analgesics|analgesics|mesh-ancestor
20426655|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
20426656|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208475|NCT00276757|Protective Agents|protective agents|mesh-ancestor
20208476|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
20208477|NCT00276757|Vitamins|vitamins|mesh-ancestor
20208478|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
20208479|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20208480|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
20208481|NCT00276757|Hormones|hormones|mesh-ancestor
19359124|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
19359125|NCT00482833|Idarubicin|idarubicin|mesh-list
19844580|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19844581|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
20426657|NCT01281943|Sirolimus|sirolimus|mesh-list
20426658|NCT01281943|Doxorubicin|doxorubicin|mesh-list
20426659|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20426660|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426661|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426662|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19359126|NCT00482833|Tretinoin|tretinoin|mesh-list
19844582|NCT00666679|Montelukast|montelukast|mesh-list
19844583|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19844584|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
19844585|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19844586|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
19844587|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844588|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426663|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19359127|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
20208482|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208483|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19404618|NCT03593135|Acetic Acid|acetic acid|mesh-list
20426664|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393964|NCT01093768|Vasopressins|vasopressins|mesh-list
20393965|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
20393966|NCT01093768|Oxytocin|oxytocin|mesh-list
20393967|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
20393968|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20393969|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393970|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
20393971|NCT01093768|Coagulants|coagulants|mesh-ancestor
20393972|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20393973|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20393974|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
20393975|NCT01093807|Enalapril|enalapril|mesh-list
20393976|NCT01093807|Enalaprilat|enalaprilat|mesh-list
20393977|NCT01093807|Lercanidipine|lercanidipine|mesh-list
20393978|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20393979|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
19359128|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19359129|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
19359130|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19359131|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359132|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359133|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
19359134|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359135|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359136|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
19359137|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359138|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19359139|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359140|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
19359141|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359142|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19359143|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19359144|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20393980|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20393981|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393982|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20393983|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20393984|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20393985|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20393986|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393987|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
19359145|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19359146|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
19359147|NCT00381381|Donepezil|donepezil|mesh-list
19359148|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19359149|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359150|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359151|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
19359152|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359153|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393988|NCT01093820|Hematinics|hematinics|mesh-ancestor
20393989|NCT01093937|Varenicline|varenicline|mesh-list
20393990|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20393991|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20393992|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
20393993|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20393994|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20393995|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393996|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20393997|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20393998|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20393999|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20394000|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20394001|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394002|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394003|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
20394004|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394005|NCT01094015|Lidocaine|lidocaine|mesh-list
20394006|NCT01094015|Prilocaine|prilocaine|mesh-list
20394007|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20394008|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
20394009|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
20394010|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394011|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394012|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
20394013|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394014|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20394015|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20394016|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20394017|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394018|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394019|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20394020|NCT01094028|Oxytocin|oxytocin|mesh-list
20394021|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
20394022|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20394023|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394024|NCT01094158|Cholic Acids|cholic acids|mesh-list
20394025|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394026|NCT01094210|Fluorides|fluorides|mesh-list
20394027|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
20394028|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
20394029|NCT01094210|Protective Agents|protective agents|mesh-ancestor
20394030|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208484|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208485|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208486|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208487|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208488|NCT00276770|Fluorides|fluorides|mesh-list
20208489|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
20208490|NCT00276770|Protective Agents|protective agents|mesh-ancestor
19359154|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
19359155|NCT00102648|Temozolomide|temozolomide|mesh-list
19359156|NCT00102648|Lonafarnib|lonafarnib|mesh-list
19359157|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19844589|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19844590|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19844591|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844592|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844593|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
19844594|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19844595|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
19844596|NCT00666705|Maraviroc|maraviroc|mesh-list
19844597|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19844598|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19844599|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
19844600|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208491|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208492|NCT00276783|Pemetrexed|pemetrexed|mesh-list
20208493|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359158|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
19359159|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844601|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19844602|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19844603|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844604|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208494|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208495|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208496|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20208497|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20208498|NCT00276796|Paclitaxel|paclitaxel|mesh-list
20394031|NCT01094249|Valproic Acid|valproic acid|mesh-list
19686637|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
19686638|NCT03965741|Apixaban|apixaban|mesh-list
19686639|NCT03965741|Dabigatran|dabigatran|mesh-list
19686640|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19686641|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
19686642|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19686643|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
19686644|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686645|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686646|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
19686647|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
19686648|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19686649|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
19686650|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844605|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19359160|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686651|NCT03945812|Sargramostim|sargramostim|mesh-list
19686652|NCT03945812|Lenograstim|lenograstim|mesh-list
19686653|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
20208499|NCT00276796|Topotecan|topotecan|mesh-list
20208500|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208501|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208502|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208503|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208504|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208505|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208506|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20394032|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20394033|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20394034|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20394035|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394036|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394037|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20394038|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20394039|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20394040|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
20394041|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394042|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394043|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20394044|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20394045|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
20394046|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
20394047|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394048|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
20394049|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
20394050|NCT01094275|Omeprazole|omeprazole|mesh-list
20394051|NCT01094275|Clopidogrel|clopidogrel|mesh-list
20394052|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20394053|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20394054|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20394055|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20394056|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
19686654|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686655|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19686656|NCT03920007|Trimethoprim|trimethoprim|mesh-list
19359161|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359162|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
19359163|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359164|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19359165|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359166|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359167|NCT05179525|Risperidone|risperidone|mesh-list
19359168|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19359169|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
19359170|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359171|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686657|NCT03920007|Polymyxins|polymyxins|mesh-list
19686658|NCT03920007|Polymyxin B|polymyxin b|mesh-list
20394057|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394058|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394059|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394060|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20394061|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394062|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20394063|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686659|NCT03920007|Prednisone|prednisone|mesh-list
19686660|NCT03920007|Prednisolone|prednisolone|mesh-list
19686661|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19686662|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
20394064|NCT01094340|Thalidomide|thalidomide|mesh-list
20394065|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394066|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
20394067|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394068|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
20394069|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20394070|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394071|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20394072|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20394073|NCT01094340|Growth Substances|growth substances|mesh-ancestor
20394074|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
20394075|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394076|NCT01094444|Vitamin K|vitamin k|mesh-list
20394077|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
20394078|NCT01094444|Vitamins|vitamins|mesh-ancestor
20394079|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
19686663|NCT03920007|Hormones|hormones|mesh-ancestor
20394080|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394081|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20394082|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20394083|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394084|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
20394085|NCT01094444|Coagulants|coagulants|mesh-ancestor
20394086|NCT01094457|Aspirin|aspirin|mesh-list
20394087|NCT01094457|Cilostazol|cilostazol|mesh-list
20394088|NCT01094457|Clopidogrel|clopidogrel|mesh-list
20394089|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19686664|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19686665|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686666|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19686667|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686668|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19686669|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686670|NCT03920007|Renal Agents|renal agents|mesh-ancestor
19686671|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
19686672|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19686673|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19686674|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19686675|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686676|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686677|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19686678|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20394090|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20394091|NCT01094457|Analgesics|analgesics|mesh-ancestor
20394092|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
20394093|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394094|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394095|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394096|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394097|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20394098|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19686679|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20394099|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359172|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359173|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19359174|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19359175|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359176|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208507|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208508|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208509|NCT00276809|Cytarabine|cytarabine|mesh-list
20208510|NCT00276809|Dexamethasone|dexamethasone|mesh-list
20208511|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
20208512|NCT00276809|Melphalan|melphalan|mesh-list
19359177|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19359178|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
19359179|NCT05179512|Fluticasone|fluticasone|mesh-list
19359180|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
19359181|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19359182|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19359183|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359184|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19359185|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
19359186|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359187|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359188|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19686680|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20394100|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20394101|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20394102|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394103|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
20394104|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20394105|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20394106|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20394107|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
20208513|NCT00276809|Carmustine|carmustine|mesh-list
20208514|NCT00276809|Fludarabine|fludarabine|mesh-list
20208515|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
20208516|NCT00276809|Etoposide|etoposide|mesh-list
20208517|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
20208518|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208519|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
20394108|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359189|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
19359190|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
19359191|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19359192|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
20394109|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20394110|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
20394111|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20394112|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
20394113|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
20394114|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20394115|NCT01094457|Protective Agents|protective agents|mesh-ancestor
19359193|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19359194|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
19359195|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359196|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359197|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19359198|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19686681|NCT03913845|Lidocaine|lidocaine|mesh-list
19686682|NCT03913845|Epinephrine|epinephrine|mesh-list
19686683|NCT03913845|Racepinephrine|racepinephrine|mesh-list
19686684|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
19686685|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
19359199|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19359200|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
19359201|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
19359202|NCT05179512|Hormones|hormones|mesh-ancestor
19359203|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359204|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
19359205|NCT05179213|Azacitidine|azacitidine|mesh-list
19359206|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359207|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
19359208|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359209|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359210|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401529|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19401530|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
19401531|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
19401532|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
19401533|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
19401534|NCT03617289|Analgesics|analgesics|mesh-ancestor
19401535|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
19404619|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19686686|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
20208520|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208521|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208522|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20208523|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
20208524|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208525|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208526|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19686687|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19686688|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686689|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
19686690|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686691|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19686692|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19686693|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19686694|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19686695|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686696|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19686697|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19686698|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
19686699|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686700|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19686701|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19686702|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
19686703|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19686704|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
20208527|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20208528|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
20208529|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
20208530|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208531|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394116|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19359211|NCT05179070|Carvedilol|carvedilol|mesh-list
20394117|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20394118|NCT01094535|Secretin|secretin|mesh-list
20394119|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394120|NCT01094535|Hormones|hormones|mesh-ancestor
20394121|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394122|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394123|NCT01094600|Secretin|secretin|mesh-list
19359212|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19359213|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19359214|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
19359215|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686705|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
19686706|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
20394124|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394125|NCT01094600|Hormones|hormones|mesh-ancestor
20394126|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394127|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394128|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
20394129|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
20394130|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394131|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20394132|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208532|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
20208533|NCT00276809|Hormones|hormones|mesh-ancestor
20208534|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208535|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20208536|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208537|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
20208538|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208539|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20394133|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394134|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
20394135|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394136|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20394137|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394138|NCT01094626|Secretin|secretin|mesh-list
19686707|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19686708|NCT03903939|Iloprost|iloprost|mesh-list
19686709|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19686710|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
19686711|NCT03870438|Lamivudine|lamivudine|mesh-list
19686712|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19686713|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20394139|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359216|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359217|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359218|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19359219|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
19359220|NCT05179070|Protective Agents|protective agents|mesh-ancestor
19359221|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19359222|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394140|NCT01094626|Hormones|hormones|mesh-ancestor
20394141|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394142|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394143|NCT01094769|Moxonidine|moxonidine|mesh-list
20394144|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20394145|NCT01094821|ATI 7505|ati 7505|mesh-list
20394146|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20394147|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20394148|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
20394149|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394150|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394151|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394152|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
20394153|NCT01094912|Narcotics|narcotics|mesh-ancestor
20394154|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394155|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394156|NCT01094912|Analgesics|analgesics|mesh-ancestor
20394157|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
19359223|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19359224|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
19686714|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394158|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359225|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19359226|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19359227|NCT05179018|Autoantibodies|autoantibodies|mesh-list
19359228|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
19359229|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359230|NCT05179005|Imidacloprid|imidacloprid|mesh-list
19359231|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
19359232|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359233|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359234|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359235|NCT05178953|Zinc|zinc|mesh-list
19359236|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
19359237|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
19359238|NCT05178953|Trace Elements|trace elements|mesh-ancestor
19359239|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
19359240|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359241|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19359242|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359243|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359244|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19359245|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19359246|NCT05178953|Protective Agents|protective agents|mesh-ancestor
19359247|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
19359248|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19359249|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
19359250|NCT05178953|Astringents|astringents|mesh-ancestor
19359251|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
19359252|NCT05178745|Fluorouracil|fluorouracil|mesh-list
19359253|NCT05178745|Irinotecan|irinotecan|mesh-list
19359254|NCT05178745|Aflibercept|aflibercept|mesh-list
20394159|NCT01094925|Gabapentin|gabapentin|mesh-list
20394160|NCT01094925|Analgesics|analgesics|mesh-ancestor
20394161|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
20394162|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394163|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394164|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
20394165|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20394166|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20394167|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394168|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20394169|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20394170|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20394171|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394172|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394173|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
20394174|NCT01094964|Interferons|interferons|mesh-list
20394175|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
20394176|NCT01094964|Epirubicin|epirubicin|mesh-list
20394177|NCT01094964|Mitomycins|mitomycins|mesh-list
20394178|NCT01094964|Mitomycin|mitomycin|mesh-list
20394179|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394180|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
20394181|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394182|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
20394183|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394184|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20394185|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20394186|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20394187|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359255|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
19359256|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359257|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844606|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19844607|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19844608|NCT00666718|Insulin|insulin|mesh-list
19844609|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19844610|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
19844611|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
19844612|NCT00666718|Protamines|protamines|mesh-list
19844613|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19844614|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394188|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394189|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
19359258|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359259|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359260|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
20394190|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19359261|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686715|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686716|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
19686717|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686718|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19686719|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19686720|NCT03834363|Fentanyl|fentanyl|mesh-list
19686721|NCT03834363|Morphine|morphine|mesh-list
19686722|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19686723|NCT03834363|Narcotics|narcotics|mesh-ancestor
19686724|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19686725|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394191|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
19359262|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19359263|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19359264|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359265|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19359266|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20208540|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19844615|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
20394192|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20394193|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20394194|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394195|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
20394196|NCT01094977|Coagulants|coagulants|mesh-ancestor
20394197|NCT01094990|Dexamethasone|dexamethasone|mesh-list
20394198|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394199|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
20394200|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
20394201|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394202|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394203|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359267|NCT05178745|Growth Substances|growth substances|mesh-ancestor
19359268|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
19359269|NCT05178511|Ensartinib|ensartinib|mesh-list
19359270|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359271|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19359272|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359273|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359274|NCT05177926|Tenofovir|tenofovir|mesh-list
19359275|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
19359276|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359277|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19359278|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19359279|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359280|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359281|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19359282|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19359283|NCT05161468|Triamcinolone|triamcinolone|mesh-list
19359284|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19359285|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19844616|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844617|NCT00666718|Coagulants|coagulants|mesh-ancestor
19844618|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19844619|NCT00666757|Sertraline|sertraline|mesh-list
19844620|NCT00666757|Fluoxetine|fluoxetine|mesh-list
20208541|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844621|NCT00666757|Paroxetine|paroxetine|mesh-list
19844622|NCT00666757|Citalopram|citalopram|mesh-list
19844623|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19844624|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19844625|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844626|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844627|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844628|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844629|NCT00666757|Analgesics|analgesics|mesh-ancestor
20208542|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
20208543|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208544|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20208545|NCT00276835|Aldesleukin|aldesleukin|mesh-list
20208546|NCT00276835|Interleukin-2|interleukin-2|mesh-list
20208547|NCT00276835|Genistein|genistein|mesh-list
19686726|NCT03834363|Analgesics|analgesics|mesh-ancestor
20208548|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208549|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20208550|NCT00276835|Analgesics|analgesics|mesh-ancestor
19844630|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
19844631|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359286|NCT05161468|Lidocaine|lidocaine|mesh-list
19359287|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
19359288|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
19359289|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19359290|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
19686727|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
19686728|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686729|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19686730|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19686731|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
19686732|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
19686733|NCT03792958|Vorolanib|vorolanib|mesh-list
19686734|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19686735|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686736|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686737|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
19686738|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20208551|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
20208552|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208553|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844632|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
19359291|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
19359292|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359293|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359294|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
19359295|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359296|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19359297|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19359298|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19359299|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19359300|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359301|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
19359302|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359303|NCT05161468|Hormones|hormones|mesh-ancestor
19359304|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359305|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359306|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
19359307|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359308|NCT05158491|Irinotecan|irinotecan|mesh-list
19359309|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19359310|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19359311|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359312|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359313|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359314|NCT05157464|Losartan|losartan|mesh-list
19844633|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844634|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
19844635|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19844636|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
19844637|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19844638|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19844639|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19844640|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844641|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
19844642|NCT00666835|Hematinics|hematinics|mesh-ancestor
19844643|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19844644|NCT00666848|Enalapril|enalapril|mesh-list
20208554|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20208555|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19359315|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19686739|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19686740|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686741|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
19359316|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19359317|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19359318|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19359319|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359320|NCT05135910|Terbinafine|terbinafine|mesh-list
19844645|NCT00666848|Enalaprilat|enalaprilat|mesh-list
19844646|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20208556|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
20208557|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394204|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
20394205|NCT01094990|Hormones|hormones|mesh-ancestor
20394206|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394207|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20394208|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394209|NCT01095016|Fenoterol|fenoterol|mesh-list
20394210|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20394211|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
20208558|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20208559|NCT00276835|Protective Agents|protective agents|mesh-ancestor
20208560|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20208561|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208562|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394212|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394213|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394214|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19359321|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
19359322|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359323|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359324|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359325|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
19359326|NCT05121714|Caffeine|caffeine|mesh-list
19359327|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19844647|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844648|NCT00666848|Incretins|incretins|mesh-ancestor
19844649|NCT00666848|Hormones|hormones|mesh-ancestor
19844650|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844651|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19844652|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
19844653|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359328|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359329|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19359330|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359331|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359332|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19359333|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19359334|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
19359335|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359336|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19359337|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19359338|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359339|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19359340|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19359341|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19359342|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19359343|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
19359344|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19359345|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
19844654|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844655|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20208563|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
20208564|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20208565|NCT00276835|Estrogens|estrogens|mesh-ancestor
19359346|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19359347|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19359348|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19359349|NCT05117710|Ebselen|ebselen|mesh-list
19359350|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20208566|NCT00276835|Hormones|hormones|mesh-ancestor
20208567|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208568|NCT00276848|Vidarabine|vidarabine|mesh-list
20208569|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
20208570|NCT00276848|Fludarabine|fludarabine|mesh-list
20208571|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
20208572|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208573|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
20208574|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208575|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394215|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20394216|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
20394217|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
20394218|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19359351|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19359352|NCT05117710|Analgesics|analgesics|mesh-ancestor
19686742|NCT03782350|Coagulants|coagulants|mesh-ancestor
19686743|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
19686744|NCT03734731|Narcotics|narcotics|mesh-ancestor
19686745|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19686746|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686747|NCT03734731|Analgesics|analgesics|mesh-ancestor
19686748|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
19686749|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686750|NCT03691714|Cetuximab|cetuximab|mesh-list
19686751|NCT03691714|Durvalumab|durvalumab|mesh-list
19686752|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686753|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686754|NCT03636256|Docetaxel|docetaxel|mesh-list
19686755|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686756|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
19686757|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686758|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
19686759|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359353|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
19359354|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359355|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359356|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359357|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844656|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19844657|NCT00666965|Rotigotine|rotigotine|mesh-list
19844658|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
20394219|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19359358|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19686760|NCT03578965|Cefazolin|cefazolin|mesh-list
19686761|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19686762|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686763|NCT03559400|Gentamicins|gentamicins|mesh-list
19686764|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19686765|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686766|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19686767|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686768|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686769|NCT03558087|Gemcitabine|gemcitabine|mesh-list
19686770|NCT03558087|Nivolumab|nivolumab|mesh-list
19686771|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394220|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20394221|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20394222|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
20394223|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394224|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394225|NCT01095133|Amiloride|amiloride|mesh-list
20394226|NCT01095133|Diuretics|diuretics|mesh-ancestor
20394227|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
20394228|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394229|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20394230|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20394231|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394232|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686772|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686773|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
19686774|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686775|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
19686776|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19686777|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686778|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686779|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
19686780|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686781|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686782|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19686783|NCT03519984|Cytarabine|cytarabine|mesh-list
19686784|NCT03519984|Vincristine|vincristine|mesh-list
19686785|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686786|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
19686787|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844659|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
19686788|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686789|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
19686790|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359359|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359360|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
19359361|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359362|NCT05117710|Protective Agents|protective agents|mesh-ancestor
19359363|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19359364|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359365|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19359366|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19359367|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401536|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401537|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401538|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
19401539|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401540|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401541|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
19401542|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19401543|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208576|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20208577|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
20208578|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208579|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208580|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20208581|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208582|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
20208583|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
20208584|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208585|NCT00276874|Aripiprazole|aripiprazole|mesh-list
20208586|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
20208587|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208588|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20208589|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208590|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208591|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208592|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
20208593|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
20208594|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208595|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208596|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20208597|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20208598|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
20208599|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20208600|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20208601|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20394233|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20394234|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20394235|NCT01095172|Prednisolone|prednisolone|mesh-list
20394236|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20394237|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
20394238|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20394239|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
20394240|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
20394241|NCT01095172|Rituximab|rituximab|mesh-list
20394242|NCT01095172|Tacrolimus|tacrolimus|mesh-list
20394243|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20394244|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
20394245|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20394246|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394247|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
20394248|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394249|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394250|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394251|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20394252|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394253|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401544|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401545|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19401546|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
19401547|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19401548|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
19401549|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19401550|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208602|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20208603|NCT00276900|Sertraline|sertraline|mesh-list
20208604|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
19359368|NCT05060315|Treprostinil|treprostinil|mesh-list
19359369|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19359370|NCT05043870|Infliximab|infliximab|mesh-list
19359371|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20394254|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394255|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
20394256|NCT01095172|Hormones|hormones|mesh-ancestor
20394257|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394258|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20394259|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
20394260|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
20394261|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394262|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359372|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
19359373|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359374|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359375|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
19359376|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359377|NCT05035303|Epinephrine|epinephrine|mesh-list
19359378|NCT05035303|Norepinephrine|norepinephrine|mesh-list
19359379|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19359380|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19359381|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
19359382|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359383|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359384|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359385|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19359386|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19359387|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
19359388|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359389|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19844660|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844661|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844662|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844663|NCT00666978|Bupropion|bupropion|mesh-list
19844664|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19359390|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
19359391|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
19359392|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
19359393|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19359394|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
19359395|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19359396|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
19686791|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686792|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
19686793|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686794|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19686795|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
19686796|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686797|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
19686798|NCT03363893|Fulvestrant|fulvestrant|mesh-list
19686799|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19686800|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394263|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20394264|NCT01095172|Protective Agents|protective agents|mesh-ancestor
19359397|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359398|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
19359399|NCT05025865|Protective Agents|protective agents|mesh-ancestor
19359400|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
19359401|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19359402|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
19359403|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359404|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
19359405|NCT05018481|Protective Agents|protective agents|mesh-ancestor
19359406|NCT05011149|Ibuprofen|ibuprofen|mesh-list
19359407|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19359408|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19359409|NCT05011149|Analgesics|analgesics|mesh-ancestor
19359410|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
19359411|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359412|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359413|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359414|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359415|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19359416|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844665|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
19844666|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844667|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19844668|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19844669|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844670|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844671|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
19844672|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686801|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19686802|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19686803|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
19686804|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19686805|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686806|NCT03287778|Pyridoxine|pyridoxine|mesh-list
19686807|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
19686808|NCT03287778|Vitamins|vitamins|mesh-ancestor
19686809|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
19686810|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686811|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
19686812|NCT03277170|Montelukast|montelukast|mesh-list
19686813|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19686814|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
19686815|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19686816|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
19686817|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19686818|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686819|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19686820|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19686821|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394265|NCT01095185|Simvastatin|simvastatin|mesh-list
20394266|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20394267|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20394268|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
20394269|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394270|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20394271|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20394272|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394273|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
20394274|NCT01095211|Vitamins|vitamins|mesh-ancestor
20394275|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
20394276|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394277|NCT01095302|Docetaxel|docetaxel|mesh-list
19686834|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
19686835|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
19686836|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686837|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
19844673|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394278|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394279|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20394280|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
19844674|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19844675|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19844676|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844677|NCT00667004|Ecabet|ecabet|mesh-list
19844678|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19844679|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19844680|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844681|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19844682|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844683|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
19844684|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394281|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
19401551|NCT03617055|Cystatins|cystatins|mesh-list
19844685|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844686|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19844687|NCT00667004|Protective Agents|protective agents|mesh-ancestor
19844688|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844689|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844690|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19844691|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19844692|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19359417|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359418|NCT04995978|Pioglitazone|pioglitazone|mesh-list
19359419|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19359420|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359421|NCT04950426|Propranolol|propranolol|mesh-list
19359422|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19359423|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19359424|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
19359425|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359426|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359427|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686838|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686839|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19686840|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19686841|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
19359428|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19686842|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359429|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19359430|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
19359431|NCT04950322|Leucovorin|leucovorin|mesh-list
19359432|NCT04950322|Fluorouracil|fluorouracil|mesh-list
19359433|NCT04950322|Oxaliplatin|oxaliplatin|mesh-list
19359434|NCT04950322|Antimetabolites|antimetabolites|mesh-ancestor
19359435|NCT04950322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359436|NCT04950322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359437|NCT04950322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359438|NCT04950322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359439|NCT04950322|Immunologic Factors|immunologic factors|mesh-ancestor
19359440|NCT04950322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359441|NCT04950322|Antidotes|antidotes|mesh-ancestor
19686843|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686844|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19686845|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686846|NCT02762669|Oxytocin|oxytocin|mesh-list
19686847|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
19686848|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19844693|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844694|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844695|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19844696|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208605|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208606|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20208607|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20208608|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208609|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208610|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208611|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
20208612|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208613|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
20208614|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208615|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20208616|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208617|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208618|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
20208619|NCT00276965|Sertraline|sertraline|mesh-list
20208620|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
20208621|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208622|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20208623|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20208624|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208625|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208626|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208627|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
19844697|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844698|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
19844699|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844700|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19844701|NCT00667095|Protective Agents|protective agents|mesh-ancestor
19844702|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19844703|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
19844704|NCT00667225|Cantharidin|cantharidin|mesh-list
19844705|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844706|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844707|NCT00667277|Bevacizumab|bevacizumab|mesh-list
20394282|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426665|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426666|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19359442|NCT04950322|Protective Agents|protective agents|mesh-ancestor
19359443|NCT04950322|Vitamin B Complex|vitamin b complex|mesh-ancestor
19359444|NCT04950322|Vitamins|vitamins|mesh-ancestor
19359445|NCT04950322|Micronutrients|micronutrients|mesh-ancestor
19359446|NCT04939636|Vitamin D|vitamin d|mesh-list
19359447|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
19359448|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
19359449|NCT04939636|Vitamins|vitamins|mesh-list
19359450|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
19359451|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359452|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19359453|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19686849|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686850|NCT02716948|Nivolumab|nivolumab|mesh-list
19686851|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19686852|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686853|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19686854|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686855|NCT02431897|Estrogens|estrogens|mesh-list
19686856|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19686857|NCT02431897|Hormones|hormones|mesh-ancestor
19686858|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844708|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844709|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844710|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844711|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19844712|NCT00667277|Growth Substances|growth substances|mesh-ancestor
19844713|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208628|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208629|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208630|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
20208631|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208632|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208633|NCT00276978|Aripiprazole|aripiprazole|mesh-list
20208634|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
20208635|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208636|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20208637|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208638|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208639|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208640|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
20208641|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
20208642|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208643|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208644|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20208645|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20208646|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
20208647|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20208648|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20208649|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20208650|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20208651|NCT00277017|Interferons|interferons|mesh-list
20208652|NCT00277017|Thalidomide|thalidomide|mesh-list
20208653|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208654|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
20208655|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208656|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208657|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
19359454|NCT04929548|Maleic acid|maleic acid|mesh-list
19844714|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
19359455|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359456|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359457|NCT04921722|Sirolimus|sirolimus|mesh-list
19359458|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19359459|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359460|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19359461|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359462|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
19359463|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359464|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
19359465|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359466|NCT04745845|Norepinephrine|norepinephrine|mesh-list
19359467|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19359468|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19359469|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
19359470|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359471|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359472|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359473|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
19359474|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
19359475|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359476|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19359477|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
19359478|NCT04740294|Analgesics|analgesics|mesh-ancestor
19359479|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
19359480|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359481|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359482|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
19359483|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359484|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19359485|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
19359486|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19359487|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19359488|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359489|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19359490|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
19359491|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19359492|NCT04728646|Dexamethasone|dexamethasone|mesh-list
19359493|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359494|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
19359495|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
19359496|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359497|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359498|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359499|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
20208658|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208659|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
20208660|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19359500|NCT04728646|Hormones|hormones|mesh-ancestor
19359501|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359502|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19359503|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359504|NCT04708886|Alendronate|alendronate|mesh-list
19359505|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19359506|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359507|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19359508|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
19359509|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359510|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19359511|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
19359512|NCT04664738|Coagulants|coagulants|mesh-ancestor
19359513|NCT04594408|Epinephrine|epinephrine|mesh-list
19359514|NCT04594408|Racepinephrine|racepinephrine|mesh-list
19844715|NCT00667342|Bevacizumab|bevacizumab|mesh-list
19844716|NCT00667342|Doxorubicin|doxorubicin|mesh-list
19844717|NCT00667342|Methotrexate|methotrexate|mesh-list
19844718|NCT00667342|Etoposide|etoposide|mesh-list
19844719|NCT00667342|Ifosfamide|ifosfamide|mesh-list
19844720|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844721|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359515|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
19359516|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
19359517|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20208661|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844722|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19359518|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19359519|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
19359520|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359521|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359522|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359523|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19359524|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19359525|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
19844723|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19844724|NCT00667342|Growth Substances|growth substances|mesh-ancestor
19844725|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844726|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
20394283|NCT01095445|Ribavirin|ribavirin|mesh-list
20394284|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20394285|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
20394286|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394287|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
20394288|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394289|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19359526|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844727|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19844728|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19844729|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19844730|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844731|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844732|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19844733|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
19844734|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19844735|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844736|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
19844737|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
19844738|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19844739|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844740|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
19844741|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844742|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19844743|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19844744|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19844745|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
19844746|NCT00667355|Adalimumab|adalimumab|mesh-list
19844747|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844748|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844749|NCT00667368|Metronidazole|metronidazole|mesh-list
19844750|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844751|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19844752|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19844753|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19844754|NCT00667394|Bevacizumab|bevacizumab|mesh-list
19844755|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844756|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844757|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844758|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19844759|NCT00667394|Growth Substances|growth substances|mesh-ancestor
19844760|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844761|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
20394290|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
20394291|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394292|NCT01095484|Rotigotine|rotigotine|mesh-list
20394293|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
20394294|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
20394295|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359527|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19359528|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
19359529|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
19359530|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
19359531|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19359532|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20394296|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394297|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394298|NCT01095575|Morphine|morphine|mesh-list
20394299|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19359533|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19359534|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
19844762|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
19359535|NCT04594408|Coagulants|coagulants|mesh-ancestor
19844763|NCT00667420|Epirubicin|epirubicin|mesh-list
20394300|NCT01095575|Narcotics|narcotics|mesh-ancestor
20394301|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394302|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394303|NCT01095575|Analgesics|analgesics|mesh-ancestor
20394304|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
19844764|NCT00667420|Panitumumab|panitumumab|mesh-list
19844765|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844766|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359536|NCT04580134|Risperidone|risperidone|mesh-list
19359537|NCT04580134|Clozapine|clozapine|mesh-list
19359538|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19359539|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
19359540|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359541|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359542|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359543|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19359544|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19359545|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359546|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19359547|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19359548|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
19359549|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
19686859|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692797|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692798|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
19692799|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692800|NCT04987450|Prednisone|prednisone|mesh-list
19692801|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
19692802|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19692803|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19692804|NCT04987450|Prednisolone|prednisolone|mesh-list
19692805|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
19692806|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19692807|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
19692808|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692809|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
19692810|NCT04987450|Hormones|hormones|mesh-ancestor
19692811|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19692812|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692813|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19359550|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
19359551|NCT04567420|Fulvestrant|fulvestrant|mesh-list
19359552|NCT04567420|Palbociclib|palbociclib|mesh-list
19359553|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19359554|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359555|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19359556|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19359557|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
19359558|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359559|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359560|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19359561|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359562|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692814|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692815|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
19692816|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
20394305|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394306|NCT01095640|Adapalene|adapalene|mesh-list
20394307|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20394308|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20394309|NCT01095640|Analgesics|analgesics|mesh-ancestor
20394310|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
20394311|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394312|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394313|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394314|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394315|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
19359563|NCT04555811|Rituximab|rituximab|mesh-list
19359564|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19359565|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394316|NCT01095679|Baclofen|baclofen|mesh-list
19692817|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394317|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19359566|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
19359567|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359568|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359569|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19359570|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19359571|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359572|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394318|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686860|NCT01641107|Ponatinib|ponatinib|mesh-list
19686861|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686862|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19686863|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686864|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686865|NCT00843037|Sunitinib|sunitinib|mesh-list
20394319|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20394320|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394321|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20394322|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
20394323|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
20394324|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394325|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394326|NCT01095731|Acetic Acid|acetic acid|mesh-list
20394327|NCT01095731|Retinol acetate|retinol acetate|mesh-list
20394328|NCT01095731|Glycine|glycine|mesh-list
20394329|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
20394330|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394331|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394332|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394333|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20394334|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394335|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20394336|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
20394337|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20394338|NCT01095731|Protective Agents|protective agents|mesh-ancestor
19359573|NCT04543383|Thrombin|thrombin|mesh-list
19359574|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
19359575|NCT04543383|Coagulants|coagulants|mesh-ancestor
20394339|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394340|NCT01095809|Triamcinolone|triamcinolone|mesh-list
20394341|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20394342|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20394343|NCT01095809|Bevacizumab|bevacizumab|mesh-list
20394344|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20394345|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19359576|NCT04529720|Vaccines|vaccines|mesh-list
19359577|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
19359578|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359579|NCT04522284|Capecitabine|capecitabine|mesh-list
19359580|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359581|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
19359582|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359583|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401552|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19401553|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
19401554|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401555|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401556|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
19401557|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401558|NCT03617016|Domperidone|domperidone|mesh-list
19686866|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686867|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19686868|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20394346|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394347|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20394348|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19401559|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
19686869|NCT00843037|Growth Substances|growth substances|mesh-ancestor
19686870|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686871|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
19686872|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19686873|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686874|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401560|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
19401561|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686875|NCT00054964|Albuterol|albuterol|mesh-list
20394349|NCT01095809|Growth Substances|growth substances|mesh-ancestor
19359584|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
20394350|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394351|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
20394352|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394353|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
20394354|NCT01095809|Hormones|hormones|mesh-ancestor
20394355|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394356|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394357|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
19359585|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19359586|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19359587|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19359588|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359589|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19359590|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19359591|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19359592|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359593|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
19359594|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359595|NCT04423237|Deferasirox|deferasirox|mesh-list
19359596|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19359597|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
19359598|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
19359599|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359600|NCT04413266|Curcumin|curcumin|mesh-list
19686876|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20208662|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20208663|NCT00277017|Growth Substances|growth substances|mesh-ancestor
20208664|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
20208665|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20208666|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
20208667|NCT00277043|Paclitaxel|paclitaxel|mesh-list
20394358|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394359|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394360|NCT01095822|Valsartan|valsartan|mesh-list
20394361|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20394362|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20394363|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20394364|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394365|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
20394366|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20208668|NCT00277043|Docetaxel|docetaxel|mesh-list
20394367|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394368|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394369|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
20394370|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394371|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394372|NCT01095926|Doxorubicin|doxorubicin|mesh-list
20394373|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20394374|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394375|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20394376|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20394377|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394378|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394379|NCT01095939|Benazepril|benazepril|mesh-list
20394380|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20394381|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
20394382|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394383|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394384|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20208669|NCT00277043|Taxane|taxane|mesh-list
20208670|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208671|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208672|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208673|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
19686877|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
19686878|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686879|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686880|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19686881|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
20208674|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208675|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686882|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
19686883|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19686884|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19686885|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19686886|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19686887|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
19686888|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686889|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686890|NCT00045201|Irinotecan|irinotecan|mesh-list
19686891|NCT00045201|Camptothecin|camptothecin|mesh-list
19686892|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19686893|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19686894|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19686895|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686896|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686897|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686898|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19686899|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19686900|NCT05073692|Liraglutide|liraglutide|mesh-list
19686901|NCT05073692|Empagliflozin|empagliflozin|mesh-list
19686902|NCT05073692|Exenatide|exenatide|mesh-list
19686903|NCT05073692|Glimepiride|glimepiride|mesh-list
19686904|NCT05073692|Linagliptin|linagliptin|mesh-list
19686905|NCT05073692|Saxagliptin|saxagliptin|mesh-list
19686906|NCT05073692|Alogliptin|alogliptin|mesh-list
19686907|NCT05073692|Glipizide|glipizide|mesh-list
19686908|NCT05073692|Glucagon|glucagon|mesh-list
19686909|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19686910|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19686911|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686912|NCT05073692|Incretins|incretins|mesh-ancestor
19686913|NCT05073692|Hormones|hormones|mesh-ancestor
19686914|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19686915|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19686916|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686917|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19686918|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19686919|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19686920|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
19686921|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19686922|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19686923|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686924|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19686925|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
19686926|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19686927|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19686928|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686929|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19686930|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19686931|NCT05073640|Protective Agents|protective agents|mesh-ancestor
19686932|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686933|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
19686934|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19686935|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
19686936|NCT05073744|Morphine|morphine|mesh-list
19686937|NCT05073744|Nalbuphine|nalbuphine|mesh-list
19686938|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19686939|NCT05073744|Narcotics|narcotics|mesh-ancestor
19686940|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19686941|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686942|NCT05073744|Analgesics|analgesics|mesh-ancestor
19686943|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
19686944|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19686945|NCT05073094|Esmolol|esmolol|mesh-list
19686946|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19686947|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19686948|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19686949|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
19686950|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19686951|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686952|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686953|NCT05073055|Anesthetics|anesthetics|mesh-list
19686954|NCT05073055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19686955|NCT05073055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686956|NCT05073029|Vitamin D|vitamin d|mesh-list
19686957|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
20394385|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20394386|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20394387|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394388|NCT01095991|Incretins|incretins|mesh-ancestor
20394389|NCT01095991|Hormones|hormones|mesh-ancestor
20394390|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394391|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20394392|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
20394393|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394394|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686958|NCT05073029|Vitamins|vitamins|mesh-ancestor
19686959|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
19686960|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686961|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19686962|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19686963|NCT05072938|Nizatidine|nizatidine|mesh-list
19686964|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19686965|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19686966|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19686967|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
19686968|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
19686969|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844767|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19844768|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19686970|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686971|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686972|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
19686973|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19686974|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
19686975|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686976|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
19844769|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19844770|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844771|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844772|NCT00667446|Leuprolide|leuprolide|mesh-list
19844773|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19844774|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
19844775|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19844776|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394395|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
19844777|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19844778|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208676|NCT00277069|Carboplatin|carboplatin|mesh-list
20208677|NCT00277069|Capecitabine|capecitabine|mesh-list
20394396|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
20394397|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20394398|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394399|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394400|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
20394401|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20394402|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394403|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394404|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20394405|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394406|NCT01096121|Enalapril|enalapril|mesh-list
20394407|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20394408|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
20394409|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394410|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686977|NCT05072899|Protective Agents|protective agents|mesh-ancestor
19686978|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
19844779|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
20208678|NCT00277069|Vinorelbine|vinorelbine|mesh-list
20208679|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208680|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208681|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
20208682|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208683|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208684|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208685|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208686|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208687|NCT00277082|Camptothecin|camptothecin|mesh-list
20208688|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208689|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686979|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19686980|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19686981|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686982|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
19686983|NCT05072860|Coagulants|coagulants|mesh-ancestor
20394411|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20394412|NCT01096199|Cisplatin|cisplatin|mesh-list
20394413|NCT01096199|Everolimus|everolimus|mesh-list
20394414|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359601|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19359602|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19359603|NCT04413266|Analgesics|analgesics|mesh-ancestor
19359604|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
19359605|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359606|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359607|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359608|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359609|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359610|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359611|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359612|NCT04409795|Metformin|metformin|mesh-list
19359613|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19359614|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19359615|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359616|NCT04409795|Incretins|incretins|mesh-ancestor
19359617|NCT04409795|Hormones|hormones|mesh-ancestor
19359618|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359619|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20394415|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394416|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
20394417|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394418|NCT01096212|Sevoflurane|sevoflurane|mesh-list
19359620|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
19359621|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359622|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359623|NCT04375033|Buprenorphine|buprenorphine|mesh-list
19359624|NCT04375033|Naloxone|naloxone|mesh-list
19359625|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19359626|NCT04375033|Narcotics|narcotics|mesh-ancestor
19359627|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359628|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359629|NCT04375033|Analgesics|analgesics|mesh-ancestor
19359630|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
19359631|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359632|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19359633|NCT04367740|Antibodies|antibodies|mesh-list
19359634|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
19359635|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
19359636|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359637|NCT04297605|Paclitaxel|paclitaxel|mesh-list
19359638|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
19359639|NCT04297605|Pemetrexed|pemetrexed|mesh-list
19359640|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19359641|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359642|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
19359643|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
19359644|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
19359645|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359646|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19359647|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359648|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19359649|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19359650|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
19686984|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
19686985|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19686986|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19686987|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686988|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
19686989|NCT05072873|Coagulants|coagulants|mesh-ancestor
19686990|NCT05072782|Methotrexate|methotrexate|mesh-list
19686991|NCT05072782|Infliximab|infliximab|mesh-list
19359651|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19359652|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
19686992|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19359653|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20394419|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20208690|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20208691|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208692|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208693|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394420|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20394421|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
20394422|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
20394423|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394424|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394425|NCT01096225|Vaccines|vaccines|mesh-list
20394426|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
20394427|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394428|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20394429|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20394430|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394431|NCT01096277|Incretins|incretins|mesh-ancestor
20394432|NCT01096277|Hormones|hormones|mesh-ancestor
20394433|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394434|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20394435|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
19359654|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359655|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
19359656|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
19844780|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19686993|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
19686994|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19686995|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19686996|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19686997|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
19686998|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19686999|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687000|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687001|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687002|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19687003|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19687004|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
19687005|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687006|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19687007|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687008|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
19687009|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19687010|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19687011|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19687012|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687013|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687014|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
19687015|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844781|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
20208694|NCT00277108|Citalopram|citalopram|mesh-list
20208695|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19844782|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19844783|NCT00667576|Protective Agents|protective agents|mesh-ancestor
19844784|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844785|NCT00667589|Fluocinonide|fluocinonide|mesh-list
19844786|NCT00667589|Tazarotene|tazarotene|mesh-list
19844787|NCT00667589|Emollients|emollients|mesh-list
19844788|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
19359665|NCT04222426|Atezolizumab|atezolizumab|mesh-list
19359666|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359667|NCT04195204|Tropisetron|tropisetron|mesh-list
19359668|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
19359669|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
19359670|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359671|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359672|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359673|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19359674|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19359675|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
20208696|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20208697|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394436|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394437|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394438|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
19359676|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844789|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
19359677|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359678|NCT04183101|Enalapril|enalapril|mesh-list
19359679|NCT04183101|Enalaprilat|enalaprilat|mesh-list
19359680|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19359681|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
19359682|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359683|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359684|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19359685|NCT04084626|Lenalidomide|lenalidomide|mesh-list
19359686|NCT04084626|Antibodies|antibodies|mesh-list
19359687|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
19359688|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359689|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19359690|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19359691|NCT04084626|Growth Substances|growth substances|mesh-ancestor
19359692|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
19359693|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359694|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
19359695|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359696|NCT04081337|Tirzepatide|tirzepatide|mesh-list
19359697|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19359698|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359699|NCT04081337|Incretins|incretins|mesh-ancestor
19359700|NCT04081337|Hormones|hormones|mesh-ancestor
19359701|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687016|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687017|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19687018|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687019|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
19359702|NCT04078568|Aspirin|aspirin|mesh-list
19359703|NCT04078568|Prednisolone|prednisolone|mesh-list
19359704|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
19687020|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19687021|NCT05072691|Antibodies|antibodies|mesh-list
19687022|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
19687023|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687024|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19687025|NCT05072405|Simvastatin|simvastatin|mesh-list
19687026|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19687027|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20208698|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687028|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
19844790|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844791|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
19844792|NCT00667589|Hormones|hormones|mesh-ancestor
19844793|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844794|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844795|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19844796|NCT00667615|Prednisone|prednisone|mesh-list
19844797|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
19844798|NCT00667615|Rituximab|rituximab|mesh-list
19844799|NCT00667615|Etoposide|etoposide|mesh-list
19844800|NCT00667615|Vorinostat|vorinostat|mesh-list
19844801|NCT00667615|Lenograstim|lenograstim|mesh-list
19844802|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844803|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
19844804|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844805|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208699|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208700|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
20208701|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359705|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19359706|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
19359707|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19844806|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19844807|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
19844808|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844809|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844810|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19844811|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844812|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844813|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
19844814|NCT00667615|Hormones|hormones|mesh-ancestor
19844815|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208702|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19359708|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19844816|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20208703|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
20208704|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208705|NCT00277199|Abatacept|abatacept|mesh-list
20208706|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20208707|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208708|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208709|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208710|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
20208711|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208712|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208713|NCT00277225|Abatacept|abatacept|mesh-list
20208714|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20208715|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208716|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208717|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208718|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
20208719|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844817|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19844818|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19844819|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19844820|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844821|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19844822|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19844823|NCT00667719|Amlodipine|amlodipine|mesh-list
19844824|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19844825|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19844826|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19844827|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844828|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844829|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19844830|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844831|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
19844832|NCT00667719|Diuretics|diuretics|mesh-ancestor
19844833|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
19844834|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19844835|NCT00667732|Exenatide|exenatide|mesh-list
19844836|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20208720|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208721|NCT00277251|Alendronate|alendronate|mesh-list
20208722|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20208723|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208724|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
20208725|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20208726|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
20208727|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208728|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208729|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20394439|NCT01096329|Testosterone|testosterone|mesh-list
20394440|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
20394441|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
20394442|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20394443|NCT01096329|Androgens|androgens|mesh-ancestor
20394444|NCT01096329|Hormones|hormones|mesh-ancestor
19687029|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687030|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19687031|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19687032|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687033|NCT05072249|Naloxone|naloxone|mesh-list
19687034|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19687035|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687036|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
19687037|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687038|NCT05072314|Lidocaine|lidocaine|mesh-list
19687039|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
19687040|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
19687041|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687042|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687043|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
19687044|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687045|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19687046|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20426667|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394445|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20394446|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394447|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20394448|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359709|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19359710|NCT04078568|Analgesics|analgesics|mesh-ancestor
19359711|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
19359712|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359713|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359714|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359715|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359716|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19359717|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19359718|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359719|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19359720|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19359721|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359722|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
19359723|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
19359724|NCT04078568|Hormones|hormones|mesh-ancestor
19359725|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359726|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19359727|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394449|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
20394450|NCT01096355|R04929097|r04929097|mesh-list
20394451|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394452|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394453|NCT01096420|Topiramate|topiramate|mesh-list
20394454|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
20394455|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20394456|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394457|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
20394458|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20394459|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
20394460|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20394461|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394462|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20394463|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20394464|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20394465|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
20394466|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20394467|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
20394468|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20394469|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394470|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20394471|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20394472|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20394473|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
20394474|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20394475|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20394476|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394477|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20394478|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20394479|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394480|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394481|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394482|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20394483|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
20394484|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20394485|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394486|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20394487|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20394488|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20394489|NCT01096654|Epinephrine|epinephrine|mesh-list
20394490|NCT01096654|Racepinephrine|racepinephrine|mesh-list
20394491|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
20394492|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20394493|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20394494|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
20394495|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359728|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
19844837|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359729|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20394496|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394497|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394498|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20394499|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19359730|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19359731|NCT03979365|Tacrolimus|tacrolimus|mesh-list
19359732|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359733|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
19359734|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359735|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19359736|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359737|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687047|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19687048|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687049|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687050|NCT05072106|Bosentan|bosentan|mesh-list
19687051|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19687052|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19687053|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687054|NCT05071794|Propofol|propofol|mesh-list
19687055|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19687056|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687057|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687058|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19687059|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
19687060|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
19687061|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
19687062|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
20394500|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
20394501|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394502|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20394503|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
20394504|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
20394505|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
20394506|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20394507|NCT01096693|Substance P|substance p|mesh-list
20394508|NCT01096693|Neurokinin A|neurokinin a|mesh-list
20394509|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687063|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687064|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687065|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394510|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394511|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394512|NCT01096706|Aspirin|aspirin|mesh-list
20394513|NCT01096706|Fluconazole|fluconazole|mesh-list
20394514|NCT01096706|Substance P|substance p|mesh-list
20394515|NCT01096706|Neurokinin A|neurokinin a|mesh-list
20394516|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20394517|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20394518|NCT01096706|Analgesics|analgesics|mesh-ancestor
20394519|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
20394520|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426668|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
19687066|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687067|NCT05071703|Carboplatin|carboplatin|mesh-list
19687068|NCT05071703|Etoposide|etoposide|mesh-list
19687069|NCT05071703|Topotecan|topotecan|mesh-list
19687070|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394521|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394522|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394523|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394524|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20394525|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20394526|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394527|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20394528|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20394529|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394530|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
19687071|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19687072|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19687073|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19687074|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687075|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687076|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19687077|NCT05071781|Hormones|hormones|mesh-list
19687078|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19359775|NCT03948035|Dexamethasone|dexamethasone|mesh-list
19359776|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
19359777|NCT03948035|Lenalidomide|lenalidomide|mesh-list
19359778|NCT03948035|Elotuzumab|elotuzumab|mesh-list
19359779|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359780|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
19359781|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
19359782|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359783|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359784|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19359785|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
19359786|NCT03948035|Hormones|hormones|mesh-ancestor
19359787|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359788|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19359789|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687079|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687080|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394531|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
20394532|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394533|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20394534|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20394535|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20394536|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687081|NCT05071352|Nefopam|nefopam|mesh-list
19844838|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19844839|NCT00667732|Incretins|incretins|mesh-ancestor
19844840|NCT00667732|Hormones|hormones|mesh-ancestor
19844841|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844842|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
19844843|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
19844844|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844845|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844846|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844847|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
19844848|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20394537|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359790|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
19359791|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19359792|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19359793|NCT03948035|Growth Substances|growth substances|mesh-ancestor
19359794|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
19359795|NCT03861390|Prednisone|prednisone|mesh-list
19844849|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844850|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844851|NCT00667862|Panobinostat|panobinostat|mesh-list
19844852|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844853|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19359796|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359797|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
19359798|NCT03861390|Hormones|hormones|mesh-ancestor
19359799|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19359800|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359801|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19359802|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359803|NCT03861078|Nicotine|nicotine|mesh-list
19359804|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19359805|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
19359806|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359807|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359808|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19359809|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19359810|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
19359811|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359812|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359813|NCT03849443|Ascorbic Acid|ascorbic acid|mesh-list
19359814|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
19844854|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844855|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844856|NCT00667875|Naltrexone|naltrexone|mesh-list
19844857|NCT00667875|Aripiprazole|aripiprazole|mesh-list
19844858|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20394538|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20394539|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20394540|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394541|NCT01096745|Gemcitabine|gemcitabine|mesh-list
20394542|NCT01096745|Cisplatin|cisplatin|mesh-list
19687082|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19687083|NCT05071352|Analgesics|analgesics|mesh-ancestor
19687084|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
19687085|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687086|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394543|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394544|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844859|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19844860|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844861|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
19844862|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359815|NCT03849443|Vitamins|vitamins|mesh-ancestor
19359816|NCT03849443|Micronutrients|micronutrients|mesh-ancestor
19359817|NCT03849443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359818|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19359819|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19687087|NCT05071339|Ganirelix|ganirelix|mesh-list
19687088|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687089|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687090|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844863|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
19844864|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844865|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19844866|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19844867|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844868|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
19844869|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
20394545|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
20394546|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394547|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
19844870|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394548|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359820|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359821|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
19359822|NCT03849443|Coagulants|coagulants|mesh-ancestor
20394549|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394550|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394551|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
20394552|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394553|NCT01096797|Sevoflurane|sevoflurane|mesh-list
19359823|NCT03849443|Antioxidants|antioxidants|mesh-ancestor
19359824|NCT03849443|Protective Agents|protective agents|mesh-ancestor
19359825|NCT03810417|Digoxin|digoxin|mesh-list
19359826|NCT03810417|Antibodies|antibodies|mesh-list
19359827|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
19359828|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
19359829|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359830|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19359831|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19359832|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359833|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359834|NCT03810417|Protective Agents|protective agents|mesh-ancestor
19359835|NCT03781362|Capecitabine|capecitabine|mesh-list
19359836|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359837|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
19359838|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359839|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401562|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401563|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19401564|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19401565|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
19401566|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401567|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401568|NCT03616808|Hemostatics|hemostatics|mesh-list
19401569|NCT03616808|Coagulants|coagulants|mesh-ancestor
19401570|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
19401571|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19401572|NCT03616691|Bevacizumab|bevacizumab|mesh-list
19401573|NCT03616691|Atezolizumab|atezolizumab|mesh-list
19401574|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19401575|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19401576|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401577|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19401578|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19401579|NCT03616691|Growth Substances|growth substances|mesh-ancestor
19401580|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401581|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
19401582|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
19401583|NCT03616639|Morphine|morphine|mesh-list
19401584|NCT03616639|Oxycodone|oxycodone|mesh-list
19401585|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20394554|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20394555|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20394556|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
20394557|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
20394558|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394559|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394560|NCT01096927|Amoxicillin|amoxicillin|mesh-list
20394561|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
20394562|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
20394563|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20394564|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394565|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394566|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394567|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20394568|NCT01096940|Simvastatin|simvastatin|mesh-list
20394569|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20394570|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20394571|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
20394572|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394573|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20394574|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20394575|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394576|NCT01097148|Atracurium|atracurium|mesh-list
19401586|NCT03616639|Narcotics|narcotics|mesh-ancestor
19401587|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401588|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401589|NCT03616639|Analgesics|analgesics|mesh-ancestor
19401590|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
19687091|NCT05071118|Pregabalin|pregabalin|mesh-list
20394577|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19687092|NCT05071118|Analgesics|analgesics|mesh-ancestor
20208730|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
20208731|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
20208732|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20208733|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
20208734|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208735|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208736|NCT00277342|Insulin|insulin|mesh-list
20208737|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20208738|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208739|NCT00277472|Valsartan|valsartan|mesh-list
20208740|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20208741|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20208742|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20208743|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20208744|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208745|NCT00277472|Diuretics|diuretics|mesh-ancestor
20208746|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
20208747|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208748|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20394578|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20394579|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19359840|NCT03689582|Edetic Acid|edetic acid|mesh-list
19359841|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19359842|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19359843|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359844|NCT03689582|Anticoagulants|anticoagulants|mesh-ancestor
19359845|NCT03689582|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19359846|NCT03689582|Chelating Agents|chelating agents|mesh-ancestor
19359847|NCT03689582|Sequestering Agents|sequestering agents|mesh-ancestor
19359848|NCT03597568|Resveratrol|resveratrol|mesh-list
19359849|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
19359850|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359851|NCT03597568|Protective Agents|protective agents|mesh-ancestor
19687093|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
19687094|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687095|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208749|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394580|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394581|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394582|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20394583|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19359852|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359853|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394584|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
20394585|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394586|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426669|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426670|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
20426671|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426672|NCT01282047|Lenalidomide|lenalidomide|mesh-list
20426673|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
20426674|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426675|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20426676|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19359854|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19359855|NCT03591770|Vaccines|vaccines|mesh-list
19359856|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
19359857|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359858|NCT03532555|Zinc|zinc|mesh-list
20426677|NCT01282047|Growth Substances|growth substances|mesh-ancestor
20426678|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
20426679|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426680|NCT01282073|Cyclosporine|cyclosporine|mesh-list
20426681|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
20426682|NCT01282073|Cyclosporins|cyclosporins|mesh-list
20426683|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426684|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426685|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426686|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
20426687|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426688|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
19359859|NCT03532555|Trace Elements|trace elements|mesh-ancestor
20426689|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359860|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
20208750|NCT00277498|Timolol|timolol|mesh-list
19359861|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359862|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
19359863|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
19359864|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19359865|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359866|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359867|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19359868|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
19359869|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19359870|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359871|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
19359872|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
19359873|NCT03511599|Cycloserine|cycloserine|mesh-list
19687096|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
19687097|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19687098|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687099|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687100|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19687101|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19687102|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19687103|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687104|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19692818|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692819|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19692820|NCT04987450|Protective Agents|protective agents|mesh-ancestor
19692821|NCT04987567|Antioxidants|antioxidants|mesh-list
19692822|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692823|NCT04987567|Protective Agents|protective agents|mesh-ancestor
19692824|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692825|NCT04987554|Immunoferon|immunoferon|mesh-list
19692826|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19692827|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
19692828|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359874|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19359875|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359876|NCT03511599|Renal Agents|renal agents|mesh-ancestor
19359877|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19359878|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
19359879|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19692829|NCT04987242|Rasburicase|rasburicase|mesh-list
19692830|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
19692831|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692832|NCT04986982|Opicapone|opicapone|mesh-list
19692833|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19359880|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
19359881|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359882|NCT03441282|Fentanyl|fentanyl|mesh-list
19359883|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19359884|NCT03441282|Narcotics|narcotics|mesh-ancestor
19359885|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19359886|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359887|NCT03441282|Analgesics|analgesics|mesh-ancestor
19359888|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
19359889|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359890|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19359891|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19359892|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
19692834|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692835|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692836|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19692837|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19692838|NCT04986995|Opicapone|opicapone|mesh-list
19692839|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19692840|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692841|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692842|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19692843|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19693167|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19693168|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19693169|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693170|NCT04982016|Methamphetamine|methamphetamine|mesh-list
19693171|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20208751|NCT00277498|Latanoprost|latanoprost|mesh-list
20208752|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20394587|NCT01097213|Ethanol|ethanol|mesh-list
20394588|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20394589|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394590|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394591|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394592|NCT01097252|Cisplatin|cisplatin|mesh-list
20394593|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394594|NCT01097265|Capecitabine|capecitabine|mesh-list
20394595|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
20394596|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20394597|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
20394598|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687105|NCT05070520|Lumefantrine|lumefantrine|mesh-list
19687106|NCT05070520|Artemether|artemether|mesh-list
19687107|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19687108|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
19687109|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19687110|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19687111|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687112|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
19359893|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
19359894|NCT03432741|Gemcitabine|gemcitabine|mesh-list
19359895|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
19359896|NCT03432741|Rituximab|rituximab|mesh-list
19844871|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844872|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19844873|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19844874|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
19687113|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
19687114|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20394599|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394600|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
20394601|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20394602|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394603|NCT01097278|Vitamins|vitamins|mesh-ancestor
20394604|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
20394605|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20394606|NCT01097317|Carboplatin|carboplatin|mesh-list
20208753|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20208754|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
20208755|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394607|NCT01097317|Vinorelbine|vinorelbine|mesh-list
20394608|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208756|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208757|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208758|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20208759|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20208760|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20208761|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20208762|NCT00277511|Levofloxacin|levofloxacin|mesh-list
20208763|NCT00277511|Ofloxacin|ofloxacin|mesh-list
20208764|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19687115|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844875|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19844876|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19844877|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19844878|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19687116|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687117|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
19687118|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19687119|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687120|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687121|NCT05070468|Dexamethasone|dexamethasone|mesh-list
19687122|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687123|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
19687124|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
19687125|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844879|NCT00667992|Budesonide|budesonide|mesh-list
19844880|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844881|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20394609|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20394610|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
20394611|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
19359897|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19359898|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
19359899|NCT03432741|Nivolumab|nivolumab|mesh-list
19359900|NCT03432741|Trastuzumab|trastuzumab|mesh-list
19687126|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687127|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687128|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
19687129|NCT05070468|Hormones|hormones|mesh-ancestor
19687130|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687131|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19687132|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687133|NCT05070598|Paclitaxel|paclitaxel|mesh-list
19687134|NCT05070598|Tegafur|tegafur|mesh-list
19687135|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19687136|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687137|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
19687138|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
19687139|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
19687140|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687141|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19687142|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
20394612|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
20394613|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394614|NCT01097382|Zolpidem|zolpidem|mesh-list
20394615|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20394616|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20394617|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687143|NCT05070260|Glenzocimab|glenzocimab|mesh-list
19687144|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
19687145|NCT05070195|Midazolam|midazolam|mesh-list
19687146|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19687147|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19687148|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687149|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687150|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19687151|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19687152|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19687153|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19687154|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
19687155|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
19687156|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
19687157|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
19687158|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394618|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394619|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20394620|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
20394621|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
20394622|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394623|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394624|NCT01097512|Gemcitabine|gemcitabine|mesh-list
20394625|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20394626|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
20394627|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394628|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394629|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
20394630|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394631|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394632|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394633|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
20394634|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359901|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
19687159|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687160|NCT05070221|Axitinib|axitinib|mesh-list
19687161|NCT05070221|Antibodies|antibodies|mesh-list
19687162|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19687163|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
19687164|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687165|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687166|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687167|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844882|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
19844883|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844884|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844885|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19844886|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
19844887|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
19687168|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687169|NCT05069870|Itraconazole|itraconazole|mesh-list
20394635|NCT01097551|Phenylephrine|phenylephrine|mesh-list
20394636|NCT01097551|Acetylcholine|acetylcholine|mesh-list
19687170|NCT05069870|Rifampin|rifampin|mesh-list
19687171|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
19687172|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
19687173|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687174|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19687175|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19687176|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687177|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687178|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19687179|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687180|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687181|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687182|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19687183|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19687184|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
19687185|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687186|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
19687187|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19359902|NCT03432741|Daratumumab|daratumumab|mesh-list
19359903|NCT03432741|Romidepsin|romidepsin|mesh-list
19359904|NCT03432741|Belinostat|belinostat|mesh-list
19359905|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19359906|NCT03432741|Antibodies|antibodies|mesh-list
19359907|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
19359908|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19359909|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19359910|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
19359911|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359912|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359913|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359914|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359915|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
19359916|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359917|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
20394637|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
20394638|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
20394639|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20394640|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
20394641|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394642|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394643|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394644|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19359918|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359919|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359920|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359921|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19359922|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19359923|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19359924|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19359925|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
19687188|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19687189|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19687190|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19687191|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19687192|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19687193|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20208765|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208766|NCT00277511|Renal Agents|renal agents|mesh-ancestor
20208767|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20208768|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208769|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208770|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208771|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208772|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208773|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20208774|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20208775|NCT00277537|Mannitol|mannitol|mesh-list
20208776|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20208777|NCT00277537|Diuretics|diuretics|mesh-ancestor
20208778|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
20394645|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
19359926|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19359927|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
19359928|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19359929|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
19359930|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359931|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359932|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
19359933|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19359934|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
19359935|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394646|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
20394647|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394648|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
20394649|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20394650|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
20394651|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
20394652|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19359936|NCT03223883|Curcumin|curcumin|mesh-list
19359937|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19359938|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19359939|NCT03223883|Analgesics|analgesics|mesh-ancestor
19359940|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
19359941|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19359942|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359943|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19359944|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359945|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359946|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359947|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359948|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
19359949|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19359950|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359951|NCT03125642|Cytarabine|cytarabine|mesh-list
19359952|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
19359953|NCT03125642|Melphalan|melphalan|mesh-list
20394653|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20394654|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20394655|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
20394656|NCT01097551|Protective Agents|protective agents|mesh-ancestor
20394657|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
20394658|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20394659|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394660|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20394661|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394662|NCT01097811|Erythromycin|erythromycin|mesh-list
20394663|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
20394664|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20394665|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
20208779|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208780|NCT00277550|Tegaserod|tegaserod|mesh-list
20208781|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20208782|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
20208783|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208784|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208785|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208786|NCT00277589|Iodine|iodine|mesh-list
20394666|NCT01097811|Neomycin|neomycin|mesh-list
20394667|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20394668|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359954|NCT03125642|Carmustine|carmustine|mesh-list
19359955|NCT03125642|Etoposide|etoposide|mesh-list
19359956|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359957|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
19359958|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359959|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359960|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19359961|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
20208787|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20208788|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208789|NCT00277589|Trace Elements|trace elements|mesh-ancestor
20208790|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
20208791|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208792|NCT00277602|Riluzole|riluzole|mesh-list
20208793|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
20208794|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20208795|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19359962|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359963|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687194|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19687195|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
19687196|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19687197|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19687198|NCT05070104|Bevacizumab|bevacizumab|mesh-list
19687199|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19687200|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687201|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19687202|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19687203|NCT05070104|Growth Substances|growth substances|mesh-ancestor
19687204|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687205|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
19687206|NCT05069779|Diazepam|diazepam|mesh-list
19687207|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19687208|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
19687209|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
19687210|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
19687211|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687212|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687213|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687214|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19687215|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687216|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19687217|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19687218|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19687219|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19687220|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19687221|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19687222|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
19687223|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
19687224|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
19687225|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
19687226|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687227|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359964|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19359965|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19359966|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19359967|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19359968|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359969|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19359970|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
19359971|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
19359972|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19359973|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
19359974|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19359975|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359976|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
19359977|NCT03103971|Fludarabine|fludarabine|mesh-list
19359978|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19359979|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
19359980|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19359981|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19359982|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19359983|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
19359984|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359985|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359986|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19359987|NCT03086616|Irinotecan|irinotecan|mesh-list
19359988|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19359989|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19359990|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19359991|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19359992|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19359993|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19359994|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19359995|NCT03007030|Antibodies|antibodies|mesh-list
19359996|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
19359997|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19359998|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
19359999|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
19360000|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360001|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360002|NCT02995252|Tenofovir|tenofovir|mesh-list
19360003|NCT02995252|Liver Extracts|liver extracts|mesh-list
19687228|NCT05069454|Vaccines|vaccines|mesh-list
19687229|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
19692844|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
20394669|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394670|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20394671|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394672|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394673|NCT01097902|Ibuprofen|ibuprofen|mesh-list
20394674|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20394675|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20394676|NCT01097902|Analgesics|analgesics|mesh-ancestor
20394677|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
20394678|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394679|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394680|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394681|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394682|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20394683|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394684|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394685|NCT01097941|Vaccines|vaccines|mesh-list
20394686|NCT01097941|Immunoglobulins|immunoglobulins|mesh-list
19360004|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
19360005|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360006|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19360007|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19360008|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360009|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360010|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19360011|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19360012|NCT02995252|Hematinics|hematinics|mesh-ancestor
19687230|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687231|NCT05069688|Rifampin|rifampin|mesh-list
19687232|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19687233|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
19687234|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687235|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687236|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
19687237|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19687238|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687239|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687240|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19687241|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19687242|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19687243|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19687244|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19687245|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19687246|NCT05068960|Bupivacaine|bupivacaine|mesh-list
19687247|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
19687248|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
19687249|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687250|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687251|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
19687252|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394687|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
20394688|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394689|NCT01097980|Trazodone|trazodone|mesh-list
20394690|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20394691|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20394692|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394693|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394694|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20394695|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20394696|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19687253|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
19687254|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19687255|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687256|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
19687257|NCT05068453|Antibodies|antibodies|mesh-list
19687258|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20394697|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394698|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394699|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687259|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
19687260|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394700|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
20426690|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687261|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19687262|NCT05067699|Calcifediol|calcifediol|mesh-list
19687263|NCT05067699|Vitamins|vitamins|mesh-ancestor
19687264|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
19687265|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687266|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19687267|NCT05067530|Paclitaxel|paclitaxel|mesh-list
19687268|NCT05067530|Carboplatin|carboplatin|mesh-list
19687269|NCT05067530|Palbociclib|palbociclib|mesh-list
20394701|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20394702|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
20394703|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
20394704|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20394705|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20394706|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20208796|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687270|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19687271|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687272|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
19687273|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
19687274|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
19687275|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687276|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20208797|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208798|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360013|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
19360014|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360015|NCT02991144|Prednisone|prednisone|mesh-list
19360016|NCT02991144|Prednisolone|prednisolone|mesh-list
19360017|NCT02991144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360018|NCT02991144|Glucocorticoids|glucocorticoids|mesh-ancestor
19360019|NCT02991144|Hormones|hormones|mesh-ancestor
19360020|NCT02991144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360021|NCT02991144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360022|NCT02991144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19360023|NCT02991144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360024|NCT02953509|Gemcitabine|gemcitabine|mesh-list
19360025|NCT02953509|Rituximab|rituximab|mesh-list
19360026|NCT02953509|Magrolimab|magrolimab|mesh-list
19360027|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
19360028|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360029|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360030|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
19360031|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360032|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360033|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208799|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20208800|NCT00277602|Protective Agents|protective agents|mesh-ancestor
20208801|NCT00277641|Lamotrigine|lamotrigine|mesh-list
20208802|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
20208803|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20208804|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20208805|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208806|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20208807|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208808|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20208809|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208810|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208811|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208812|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20208813|NCT00277654|Risperidone|risperidone|mesh-list
20208814|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20208815|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
20394707|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394708|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394709|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
20394710|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394711|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394712|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20394713|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687277|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394714|NCT01098084|Decitabine|decitabine|mesh-list
19360034|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
19360035|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692845|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20394715|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20394716|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
20394717|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394718|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394719|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394720|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
19360036|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
19360037|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360038|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360039|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360040|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
19360041|NCT02921789|Prednisone|prednisone|mesh-list
19360042|NCT02921789|Tacrolimus|tacrolimus|mesh-list
19360043|NCT02921789|Basiliximab|basiliximab|mesh-list
19360044|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687278|NCT05067517|Nintedanib|nintedanib|mesh-list
19687279|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687280|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687281|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687282|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687283|NCT05067153|Heparin|heparin|mesh-list
19687284|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19687285|NCT05067153|Tinzaparin|tinzaparin|mesh-list
19687286|NCT05067153|Dalteparin|dalteparin|mesh-list
19687287|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
19687288|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19687289|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19687290|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687291|NCT05067309|Letrozole|letrozole|mesh-list
19687292|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394721|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394722|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
19687293|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19687294|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19687295|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687296|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687297|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19687298|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687299|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360045|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
19687300|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687301|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
19687302|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687303|NCT05066802|Folfirinox|folfirinox|mesh-list
19687304|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687305|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19687306|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687307|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687308|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
19687309|NCT05066516|Linagliptin|linagliptin|mesh-list
19687310|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19687311|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687312|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20394723|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394724|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394725|NCT01098344|Gemcitabine|gemcitabine|mesh-list
20394726|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20394727|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
20394728|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687313|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687314|NCT05066516|Incretins|incretins|mesh-ancestor
20208816|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208817|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208818|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208819|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20208820|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208821|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208822|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20208823|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20208824|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
20208825|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20208826|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
20208827|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360046|NCT02921789|Hormones|hormones|mesh-ancestor
19401591|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687315|NCT05066516|Hormones|hormones|mesh-ancestor
19687316|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687317|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19687318|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
19687319|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687320|NCT05066633|Metoprolol|metoprolol|mesh-list
19687321|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19360047|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360048|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360049|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19360050|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360051|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360052|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
19360053|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19360054|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360055|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360056|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19360057|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19360058|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
19360059|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19360060|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360061|NCT02918500|Nicotine|nicotine|mesh-list
19360062|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19360063|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
20208828|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20208829|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208830|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20208831|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208832|NCT00277693|Spironolactone|spironolactone|mesh-list
20394729|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394730|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
20394731|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394732|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394733|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394734|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
19360064|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360065|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360066|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19360067|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19360068|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
19360069|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360070|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687322|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19687323|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
19844888|NCT00667992|Hormones|hormones|mesh-ancestor
19844889|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208833|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20208834|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
20208835|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844890|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19844891|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
19844892|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844893|NCT00668200|Vitamin D|vitamin d|mesh-list
19844894|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
19844895|NCT00668200|Calcium|calcium|mesh-list
19844896|NCT00668200|Vitamins|vitamins|mesh-ancestor
19844897|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
19844898|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844899|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20208836|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208837|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20208838|NCT00277693|Diuretics|diuretics|mesh-ancestor
20208839|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
20394735|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360071|NCT02903381|Dexamethasone|dexamethasone|mesh-list
19360072|NCT02903381|Nivolumab|nivolumab|mesh-list
19360073|NCT02903381|Lenalidomide|lenalidomide|mesh-list
19360074|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360075|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
19844900|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19844901|NCT00668317|Omeprazole|omeprazole|mesh-list
19844902|NCT00668317|Ranitidine|ranitidine|mesh-list
19360076|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
19844903|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19844904|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19360077|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360078|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208840|NCT00277706|Vitamin D|vitamin d|mesh-list
20208841|NCT00277706|Calcium|calcium|mesh-list
20208842|NCT00277706|Vitamins|vitamins|mesh-ancestor
20208843|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
20208844|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208845|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20208846|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20394736|NCT01098357|Becaplermin|becaplermin|mesh-list
20394737|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
20394738|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20394739|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20394740|NCT01098357|Growth Substances|growth substances|mesh-ancestor
20394741|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394742|NCT01098383|Acetylcholine|acetylcholine|mesh-list
20394743|NCT01098383|Donepezil|donepezil|mesh-list
20394744|NCT01098383|Choline|choline|mesh-list
20394745|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20394746|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394747|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394748|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
20394749|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394750|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394751|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
20394752|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
20394753|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19360079|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19360080|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
19360081|NCT02903381|Hormones|hormones|mesh-ancestor
19360082|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360083|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19360084|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360085|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360086|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19360087|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360088|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
19360089|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19360090|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360091|NCT02903381|Growth Substances|growth substances|mesh-ancestor
19360092|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360093|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
19360094|NCT02866279|Etonogestrel|etonogestrel|mesh-list
19360095|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20394754|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
20394755|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394756|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20394757|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
20394758|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20394759|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20394760|NCT01098448|Amoxicillin|amoxicillin|mesh-list
20394761|NCT01098448|Metronidazole|metronidazole|mesh-list
20394762|NCT01098448|Tetracycline|tetracycline|mesh-list
20394763|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394764|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20394765|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20394766|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20394767|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394768|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208847|NCT00277758|Interferons|interferons|mesh-list
20208848|NCT00277758|Ribavirin|ribavirin|mesh-list
20208849|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
20208850|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20208851|NCT00277758|Interleukin-2|interleukin-2|mesh-list
20208852|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208853|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
20208854|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208855|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
20208856|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208857|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
20208858|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208859|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20208860|NCT00277758|Analgesics|analgesics|mesh-ancestor
20394769|NCT01098513|Dolutegravir|dolutegravir|mesh-list
20394770|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20394771|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20394772|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360096|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360097|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19844905|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19844906|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19844907|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844908|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844909|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19844910|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
19844911|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
19844912|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844913|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360098|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19360099|NCT02774265|Aspirin|aspirin|mesh-list
19360100|NCT02774265|Heparin|heparin|mesh-list
19687324|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
19687325|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844914|NCT00668395|Efavirenz|efavirenz|mesh-list
19844915|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19844916|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19687326|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687327|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19687328|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19687329|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19687330|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
19687331|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844917|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208861|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
20208862|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394773|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394774|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20394775|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20394776|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
20394777|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394778|NCT01098526|Efavirenz|efavirenz|mesh-list
20394779|NCT01098526|Dolutegravir|dolutegravir|mesh-list
20394780|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20394781|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20394782|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394783|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394784|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
20394785|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394786|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20394787|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20394788|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20394789|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20394790|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20394791|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20394792|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20394793|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19360101|NCT02774265|Enoxaparin|enoxaparin|mesh-list
19360102|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19360103|NCT02774265|Tinzaparin|tinzaparin|mesh-list
19360104|NCT02774265|Dalteparin|dalteparin|mesh-list
19360105|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19360106|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360107|NCT02774265|Analgesics|analgesics|mesh-ancestor
19360108|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
19360109|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360110|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360111|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360112|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360113|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19687332|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687333|NCT05066607|Dexamethasone|dexamethasone|mesh-list
20208863|NCT00277862|Ribavirin|ribavirin|mesh-list
20208864|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
20208865|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
20208866|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20208867|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20208868|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
20208869|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208870|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
20208871|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208872|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
19687334|NCT05066607|Pomalidomide|pomalidomide|mesh-list
19844918|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844919|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
19844920|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844921|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19844922|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20394794|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20394795|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20394796|NCT01098656|Lenalidomide|lenalidomide|mesh-list
19360114|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19360115|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360116|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19360117|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19360118|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360119|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
19687335|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687336|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
19687337|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
19687338|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687339|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687340|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20394797|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
20394798|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394799|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20394800|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20394801|NCT01098656|Growth Substances|growth substances|mesh-ancestor
20394802|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
20394803|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360120|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
19360121|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
19360122|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360123|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360124|NCT02695992|Metoprolol|metoprolol|mesh-list
19360125|NCT02695992|Diltiazem|diltiazem|mesh-list
19360126|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19360127|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19360128|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
19360129|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
19360130|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360131|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360132|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19360133|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19360134|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19360135|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
19360136|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360137|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360138|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19360139|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360140|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19360141|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
19360142|NCT02667418|Vancomycin|vancomycin|mesh-list
19360143|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
19360144|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19360145|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394804|NCT01098760|Sorafenib|sorafenib|mesh-list
20394805|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394806|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20394807|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394808|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394809|NCT01098890|Plasminogen|plasminogen|mesh-list
20394810|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20394811|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20394812|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20394813|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394814|NCT01098955|Varenicline|varenicline|mesh-list
20394815|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20394816|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20394817|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
20394818|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360146|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
19687341|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
19687342|NCT05066607|Hormones|hormones|mesh-ancestor
20394819|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394820|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360147|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
20208873|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360148|NCT02652468|Rituximab|rituximab|mesh-list
19360149|NCT02652468|Fludarabine|fludarabine|mesh-list
19360150|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
19360151|NCT02652468|Tacrolimus|tacrolimus|mesh-list
19360152|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360153|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
19360154|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360155|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360156|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20394821|NCT01098994|Vitamin E|vitamin e|mesh-list
20394822|NCT01098994|Tocopherols|tocopherols|mesh-list
20394823|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
20394824|NCT01098994|Vitamins|vitamins|mesh-ancestor
20394825|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
20394826|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394827|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
20394828|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394829|NCT01098994|Protective Agents|protective agents|mesh-ancestor
20426691|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426692|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20426693|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426694|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426695|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20426696|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
20426697|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20426698|NCT01282151|Cisplatin|cisplatin|mesh-list
19360157|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
19360158|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360159|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360160|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19360161|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360162|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360163|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
19360164|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19360165|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360166|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19360167|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19360168|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
19360169|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19360170|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360171|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19360172|NCT02579265|SMOFlipid|smoflipid|mesh-list
19360173|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19360174|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19360175|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19360176|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19360177|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19360178|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360179|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
19360180|NCT02484391|Cytarabine|cytarabine|mesh-list
19360181|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
19360182|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208874|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217834|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20217835|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20217836|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217837|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20217838|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20217839|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217840|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217841|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217842|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20217843|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
20217844|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20217845|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217846|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20426699|NCT01282151|Pemetrexed|pemetrexed|mesh-list
20426700|NCT01282151|Docetaxel|docetaxel|mesh-list
19687343|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687344|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19687345|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687346|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
19687347|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20426701|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360183|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
19360184|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360185|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360186|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
19360187|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360188|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360189|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
20394830|NCT01099059|Amantadine|amantadine|mesh-list
20394831|NCT01099059|Methylphenidate|methylphenidate|mesh-list
20394832|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20394833|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394834|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20394835|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20394836|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394837|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394838|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
20394839|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394840|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20394841|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20394842|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
20394843|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394844|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20394845|NCT01099059|Analgesics|analgesics|mesh-ancestor
20394846|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
20394847|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394848|NCT01099072|Methylphenidate|methylphenidate|mesh-list
19360190|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394849|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20394850|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394851|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19360191|NCT02484391|Analgesics|analgesics|mesh-ancestor
19360192|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
19360193|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360194|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19360195|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19360196|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360197|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
19360198|NCT02484391|Protective Agents|protective agents|mesh-ancestor
19360199|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
19360200|NCT02484391|Vitamins|vitamins|mesh-ancestor
19360201|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
19360202|NCT02448095|Ponatinib|ponatinib|mesh-list
19360203|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360204|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20208875|NCT00278070|Vinorelbine|vinorelbine|mesh-list
20208876|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208877|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208878|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208879|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208880|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208881|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208882|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
19360205|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360206|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360207|NCT02398825|Ponatinib|ponatinib|mesh-list
19360208|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360209|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19360210|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360211|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208883|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20208884|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
20208885|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208886|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208887|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19360212|NCT02393248|Gemcitabine|gemcitabine|mesh-list
19360213|NCT02393248|Docetaxel|docetaxel|mesh-list
19360214|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
19360215|NCT02393248|Trastuzumab|trastuzumab|mesh-list
19360216|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360217|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360218|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
20217847|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19360219|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360220|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
19360221|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394852|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20394853|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20394854|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360222|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360223|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360224|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
20394855|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
19360225|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360226|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19360227|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19360228|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19360229|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360230|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19360231|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
19360232|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
19360233|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19360234|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360235|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
19360236|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360237|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19360238|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19360239|NCT02307656|Cobicistat|cobicistat|mesh-list
19360240|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19360241|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19360242|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
19360243|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360244|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360245|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19360246|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19360247|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
19360248|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360249|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19360250|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19360251|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
19687348|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19687349|NCT05066607|Growth Substances|growth substances|mesh-ancestor
19687350|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
19687351|NCT05066360|Hormones|hormones|mesh-list
19687352|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687353|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687354|NCT05065658|Posaconazole|posaconazole|mesh-list
19687355|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
19687356|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687357|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19687358|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19687359|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19687360|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19687361|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19687362|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687363|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687364|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19687365|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687366|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687367|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687368|NCT05065905|Interferons|interferons|mesh-list
19687369|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
19687370|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687371|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
19687372|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208888|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
20208889|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20208890|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
20208891|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208892|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20208893|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20208894|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
20208895|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
20208896|NCT00278083|Protective Agents|protective agents|mesh-ancestor
20208897|NCT00278122|Paclitaxel|paclitaxel|mesh-list
20208898|NCT00278122|Sargramostim|sargramostim|mesh-list
20394856|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360252|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20208899|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19687373|NCT05066035|Neostigmine|neostigmine|mesh-list
19360253|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19360254|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19360255|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360256|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360257|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
19360258|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360259|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360260|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20208900|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208901|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
20208902|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
20208903|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
20208904|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360261|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401592|NCT03616561|Apremilast|apremilast|mesh-list
19401593|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19401594|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401595|NCT03616561|Analgesics|analgesics|mesh-ancestor
19401596|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
19401597|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401598|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401599|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401600|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401601|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19401602|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19401603|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401604|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401605|NCT03616509|Hormones|hormones|mesh-list
19401606|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401607|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394857|NCT01099085|Simvastatin|simvastatin|mesh-list
20394858|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20394859|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20394860|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
20394861|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394862|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20394863|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20394864|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394865|NCT01099137|Vildagliptin|vildagliptin|mesh-list
20394866|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20394867|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394868|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20394869|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
20394870|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394871|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394872|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
20394873|NCT01099150|Procyanidin|procyanidin|mesh-list
20394874|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
20394875|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394876|NCT01099150|Protective Agents|protective agents|mesh-ancestor
20394877|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394878|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20394879|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19401608|NCT03616405|Amoxicillin|amoxicillin|mesh-list
19401609|NCT03616405|Tetracycline|tetracycline|mesh-list
19401610|NCT03616405|Furazolidone|furazolidone|mesh-list
19401611|NCT03616405|Rabeprazole|rabeprazole|mesh-list
20394880|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394881|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20394882|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394883|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208905|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
19401612|NCT03616405|Bismuth|bismuth|mesh-list
19401613|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19401614|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401615|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19401616|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20208906|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208907|NCT00278174|Interferons|interferons|mesh-list
20208908|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
20208909|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20208910|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394884|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687374|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19687375|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687376|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687377|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
19687378|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687379|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687380|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19687381|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
19360262|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
19360263|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
19360264|NCT02090114|Testosterone|testosterone|mesh-list
19360265|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
19360266|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
19360267|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19687382|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687383|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19687384|NCT05065164|Denosumab|denosumab|mesh-list
19687385|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19687386|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687387|NCT05065177|Vaccines|vaccines|mesh-list
19687388|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
19687389|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692846|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19844923|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19844924|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19844925|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19692847|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692848|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
19692849|NCT04986813|Coagulants|coagulants|mesh-ancestor
19692850|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
19692851|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19692852|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
19692853|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692854|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
19692855|NCT04986644|Protective Agents|protective agents|mesh-ancestor
19692856|NCT04986735|Empagliflozin|empagliflozin|mesh-list
19692857|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19692858|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692859|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19692860|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692861|NCT04986371|Niraparib|niraparib|mesh-list
19692862|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19692863|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692864|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692865|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692866|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19692867|NCT04986254|Meropenem|meropenem|mesh-list
19692868|NCT04986254|Tazobactam|tazobactam|mesh-list
19692869|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
19692870|NCT04986254|Piperacillin|piperacillin|mesh-list
19692871|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19692872|NCT04986254|Penicillin G|penicillin g|mesh-list
19692873|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19692874|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
19692875|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692876|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19692877|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692878|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692879|NCT04986319|Vitamin D|vitamin d|mesh-list
19692880|NCT04986319|Vitamins|vitamins|mesh-ancestor
19844926|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19844927|NCT00668434|Prednisone|prednisone|mesh-list
20394885|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19844928|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19844929|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
20394886|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
20394887|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
20394888|NCT01099436|Docetaxel|docetaxel|mesh-list
20394889|NCT01099436|Doxorubicin|doxorubicin|mesh-list
20394890|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20394891|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394892|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
20394893|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394894|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692881|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
19844930|NCT00668434|Hormones|hormones|mesh-ancestor
20394895|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20394896|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
20394897|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394898|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394899|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20394900|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
19360268|NCT02090114|Androgens|androgens|mesh-ancestor
19360269|NCT02090114|Hormones|hormones|mesh-ancestor
19360270|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360271|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360272|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19360273|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360274|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
19360275|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20394901|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
20394902|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
20394903|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20394904|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20394905|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20394906|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394907|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20394908|NCT01099462|Ibuprofen|ibuprofen|mesh-list
20394909|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20394910|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20394911|NCT01099462|Analgesics|analgesics|mesh-ancestor
20394912|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
20394913|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394914|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394915|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20394916|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394917|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20394918|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394919|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394920|NCT01099527|Capecitabine|capecitabine|mesh-list
19360276|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360277|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360278|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
19360279|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19360280|NCT02031250|Carboplatin|carboplatin|mesh-list
19360281|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360282|NCT02015351|Bevacizumab|bevacizumab|mesh-list
19360283|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360284|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360285|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19360286|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360287|NCT02015351|Growth Substances|growth substances|mesh-ancestor
19360288|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360289|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360290|NCT02013167|Blinatumomab|blinatumomab|mesh-list
19360291|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360292|NCT02004522|Ofatumumab|ofatumumab|mesh-list
19360293|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360294|NCT02000427|Blinatumomab|blinatumomab|mesh-list
19360295|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360296|NCT01996436|Verapamil|verapamil|mesh-list
19687390|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
20208911|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
20208912|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208913|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
20208914|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208915|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20208916|NCT00278187|Volociximab|volociximab|mesh-list
20208917|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208918|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20208919|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208920|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208921|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20208922|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20208923|NCT00278187|Growth Substances|growth substances|mesh-ancestor
20208924|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208925|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
20208926|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
20208927|NCT00278213|Fludarabine|fludarabine|mesh-list
20208928|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
19360297|NCT01996436|Nicardipine|nicardipine|mesh-list
19360298|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
20394921|NCT01099527|Everolimus|everolimus|mesh-list
20394922|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20394923|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
20394924|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394925|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394926|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20394927|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
20394928|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687391|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19687392|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
19687393|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687394|NCT05064020|Tenofovir|tenofovir|mesh-list
19687395|NCT05064020|Emtricitabine|emtricitabine|mesh-list
20394929|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20394930|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19360299|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
19360300|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19360301|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19360302|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360303|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360304|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19360305|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360306|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19360307|NCT01957332|Trastuzumab|trastuzumab|mesh-list
19360308|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360309|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844931|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19844932|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844933|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19844934|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844935|NCT00668525|Dexetimide|dexetimide|mesh-list
19844936|NCT00668525|Citalopram|citalopram|mesh-list
19844937|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19844938|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20208929|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
19687396|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19687397|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
19687398|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687399|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19687400|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19687401|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687402|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394931|NCT01099592|Citalopram|citalopram|mesh-list
20394932|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20426702|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360310|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
19360311|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360312|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19360313|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360314|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360315|NCT01807182|Aldesleukin|aldesleukin|mesh-list
19360316|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
19360317|NCT01807182|Fludarabine|fludarabine|mesh-list
19360318|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
19360319|NCT01807182|Interleukin-2|interleukin-2|mesh-list
19360320|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360321|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
19687403|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19687404|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19687405|NCT05063838|Anesthetics|anesthetics|mesh-list
19687406|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687407|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687408|NCT05063578|Lidocaine|lidocaine|mesh-list
19687409|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
20208930|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
20208931|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208932|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
20208933|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208934|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208935|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20208936|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
20208937|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208938|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208939|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20208940|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208941|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
20394933|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20394934|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360322|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208942|NCT00278213|Analgesics|analgesics|mesh-ancestor
19360323|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360324|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19360325|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
19360326|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360327|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360328|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19360329|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360330|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
19360331|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360332|NCT01807182|Analgesics|analgesics|mesh-ancestor
19360333|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
19360334|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360335|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19360336|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19360337|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
19360338|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360339|NCT01765140|Amifampridine|amifampridine|mesh-list
19360340|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19360341|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360342|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360343|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19360344|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360345|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360346|NCT01761890|Dasatinib|dasatinib|mesh-list
19360347|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360348|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19360349|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360350|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360351|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19360352|NCT01703949|Nivolumab|nivolumab|mesh-list
19360353|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19360354|NCT01703949|Antibodies|antibodies|mesh-list
19360355|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
20208943|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
20208944|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20208945|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208946|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20208947|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208948|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20208949|NCT00278252|Etoposide|etoposide|mesh-list
20208950|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20208951|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208952|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20208953|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19360356|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19360357|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
19360358|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
19360359|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360360|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360361|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19360362|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360363|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
19360364|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19360365|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19360366|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19360367|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360368|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360369|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
19360370|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360371|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360372|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19360373|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687410|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
19687411|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687412|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687413|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
20208954|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394935|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394936|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394937|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
20394938|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394939|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20394940|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
20394941|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360374|NCT01556776|Lenalidomide|lenalidomide|mesh-list
19360375|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
19844939|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19844940|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844941|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844942|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
19844943|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844944|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19844945|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
19844946|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19844947|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20394942|NCT01099605|Bupivacaine|bupivacaine|mesh-list
19360376|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360377|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19360378|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360379|NCT01556776|Growth Substances|growth substances|mesh-ancestor
19360380|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360381|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360382|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19844948|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19844949|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
20394943|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
20394944|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
20394945|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394946|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394947|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
20394948|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394949|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20394950|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19844950|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
19844951|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19844952|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19844953|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19844954|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
19844955|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
19687414|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687415|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19687416|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19687417|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19687418|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687419|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687420|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
19844956|NCT00668564|Busulfan|busulfan|mesh-list
19844957|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
19844958|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844959|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
19844960|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844961|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19844962|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19844963|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
19844964|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844965|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844966|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19360383|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
19360384|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
19360385|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687421|NCT05063513|Rituximab|rituximab|mesh-list
20394951|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
20394952|NCT01099748|Methadone|methadone|mesh-list
20394953|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20394954|NCT01099748|Narcotics|narcotics|mesh-ancestor
19360386|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
19360387|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844967|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19844968|NCT00668707|Melatonin|melatonin|mesh-list
19844969|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
19360388|NCT01186640|Vidarabine|vidarabine|mesh-list
19360389|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
19360390|NCT01186640|Fludarabine|fludarabine|mesh-list
19360391|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
19360392|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
19360393|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
19360394|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360395|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
19360396|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360397|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360398|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19360399|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
19360400|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360401|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360402|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19360403|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360404|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
19360405|NCT01186640|Antiviral Agents|antiviral agents|mesh-ancestor
19360406|NCT01186640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360407|NCT01186640|Analgesics|analgesics|mesh-ancestor
19360408|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
19360409|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360410|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19360411|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19360412|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360413|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360414|NCT01112306|Selexipag|selexipag|mesh-list
19360415|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19360416|NCT00688376|Donepezil|donepezil|mesh-list
19360417|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19360418|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360419|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360420|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
19360421|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360422|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394955|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20394956|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394957|NCT01099748|Analgesics|analgesics|mesh-ancestor
19360423|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
19360424|NCT00492349|Varenicline|varenicline|mesh-list
19360425|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19360426|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19360427|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
19360428|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360429|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360430|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687422|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19687423|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687424|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
19687425|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687426|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687427|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19687428|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19687429|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
19687430|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687431|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687432|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687433|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687434|NCT05063422|Trimethoprim|trimethoprim|mesh-list
19687435|NCT05063422|Polymyxins|polymyxins|mesh-list
19687436|NCT05063422|Polymyxin B|polymyxin b|mesh-list
19687437|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19687438|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20217848|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19360431|NCT00003102|Antibodies|antibodies|mesh-list
19360432|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19360433|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
19360434|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687439|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687440|NCT05063422|Renal Agents|renal agents|mesh-ancestor
20217849|NCT00310765|Pregabalin|pregabalin|mesh-list
20217850|NCT00310765|Gabapentin|gabapentin|mesh-list
20217851|NCT00310765|Analgesics|analgesics|mesh-ancestor
20217852|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
20217853|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217854|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217855|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
19687441|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
20394958|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
20394959|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394960|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
20394961|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
20394962|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
20394963|NCT01099839|Miglitol|miglitol|mesh-list
20394964|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20394965|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394966|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20394967|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394968|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20394969|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20394970|NCT01100021|Doxazosin|doxazosin|mesh-list
20394971|NCT01100021|Tamsulosin|tamsulosin|mesh-list
20394972|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20394973|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20394974|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20394975|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
20394976|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20394977|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20394978|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20394979|NCT01100021|Urological Agents|urological agents|mesh-ancestor
20394980|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20394981|NCT01100060|Azithromycin|azithromycin|mesh-list
20208955|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208956|NCT00278265|Vidarabine|vidarabine|mesh-list
20208957|NCT00278265|Methotrexate|methotrexate|mesh-list
20208958|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
20208959|NCT00278265|Fludarabine|fludarabine|mesh-list
20208960|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20208961|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
20208962|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20208963|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208964|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208965|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
20208966|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208967|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20394982|NCT01100060|Chloroquine|chloroquine|mesh-list
19687442|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19687443|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19687444|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19687445|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687446|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687447|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19687448|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20394983|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20394984|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20394985|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20394986|NCT01100060|Amebicides|amebicides|mesh-ancestor
20394987|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20394988|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20394989|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
20394990|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20394991|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20394992|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20394993|NCT01100060|Analgesics|analgesics|mesh-ancestor
20394994|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
20394995|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20394996|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360435|NCT05181852|Pregabalin|pregabalin|mesh-list
19360436|NCT05181852|Analgesics|analgesics|mesh-ancestor
19360437|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
19360438|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360439|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360440|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
19360441|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19360442|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360443|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360444|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19360445|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19360446|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20208968|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
20394997|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687449|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19687450|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687451|NCT05063422|Laxatives|laxatives|mesh-ancestor
19687452|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687453|NCT05063318|Itraconazole|itraconazole|mesh-list
19687454|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
19687455|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687456|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19687457|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19687458|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687459|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687460|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19687461|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687462|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687463|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687464|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19687465|NCT05063071|Tenofovir|tenofovir|mesh-list
19687466|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
19360447|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19360448|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360449|NCT05181605|Folfirinox|folfirinox|mesh-list
19360450|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360451|NCT05181592|Luspatercept|luspatercept|mesh-list
19360452|NCT05181592|Hematinics|hematinics|mesh-ancestor
19360453|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19360454|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19360455|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19360456|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19360457|NCT05181150|Glucagon|glucagon|mesh-list
19360458|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19360459|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687467|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687468|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20394998|NCT01100060|Filaricides|filaricides|mesh-ancestor
20394999|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
20395000|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
19687469|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19687470|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687471|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687472|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19687473|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19687474|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
19687475|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19687476|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687477|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687478|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
19687479|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19844970|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844971|NCT00668707|Protective Agents|protective agents|mesh-ancestor
19360460|NCT05181150|Hormones|hormones|mesh-ancestor
19360461|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360462|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360463|NCT05181150|Incretins|incretins|mesh-ancestor
19360464|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19360465|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19360466|NCT05181033|Letrozole|letrozole|mesh-list
19360467|NCT05181033|Fulvestrant|fulvestrant|mesh-list
19360468|NCT05181033|Lenvatinib|lenvatinib|mesh-list
19360469|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360470|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19360471|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20395001|NCT01100125|Insulin|insulin|mesh-list
19360472|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360473|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360474|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19360475|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
19360476|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360477|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360478|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19360479|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19360480|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687480|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395002|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20395003|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20395004|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
20395005|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20395006|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395007|NCT01100125|Incretins|incretins|mesh-ancestor
20395008|NCT01100125|Hormones|hormones|mesh-ancestor
20395009|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395010|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20395011|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
20395012|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395013|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395014|NCT01100164|Eszopiclone|eszopiclone|mesh-list
20395015|NCT01100164|Zopiclone|zopiclone|mesh-list
20395016|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20395017|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395018|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395019|NCT01100177|Sunitinib|sunitinib|mesh-list
20395020|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395021|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20395022|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20395023|NCT01100177|Growth Substances|growth substances|mesh-ancestor
20395024|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395025|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
20395026|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20395027|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395028|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395029|NCT01100203|Eplerenone|eplerenone|mesh-list
20395030|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19360481|NCT05181007|Valproic Acid|valproic acid|mesh-list
19360482|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
19360483|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395031|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
20395032|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395033|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395034|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20395035|NCT01100203|Diuretics|diuretics|mesh-ancestor
20395036|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
20395037|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20395038|NCT01100216|Nicotine|nicotine|mesh-list
19360484|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360485|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
19360486|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360487|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360488|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
19360489|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19360490|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19360491|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360492|NCT05180994|Infliximab|infliximab|mesh-list
19360493|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
19360494|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19360495|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360496|NCT05180825|Trametinib|trametinib|mesh-list
20395039|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20395040|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
19360497|NCT05180825|Vinblastine|vinblastine|mesh-list
20395041|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395042|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395043|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20395044|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20395045|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
20395046|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395047|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395048|NCT01100294|Vaccines|vaccines|mesh-list
20395049|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
20395050|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395051|NCT01100333|Hormones|hormones|mesh-list
20395052|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20395053|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395054|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395055|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20395056|NCT01100346|Hormones|hormones|mesh-ancestor
19360498|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360499|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19360500|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687481|NCT05062681|Dexamethasone|dexamethasone|mesh-list
19360501|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360502|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19360503|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
19360504|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19360505|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
19360506|NCT05180799|Nivolumab|nivolumab|mesh-list
19360507|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360508|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360509|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19360510|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401617|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19401618|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401619|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401620|NCT03616405|Antacids|antacids|mesh-ancestor
19401621|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19401622|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19401623|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19401624|NCT03616405|Renal Agents|renal agents|mesh-ancestor
19401625|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19401626|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19401627|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19401628|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19401629|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19401630|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19401631|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401632|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19401633|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687482|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
19687483|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19687484|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19687485|NCT05062681|Prednisolone|prednisolone|mesh-list
19687486|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
19687487|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19687488|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
19687489|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687490|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
19687491|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
19687492|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687493|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687494|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687495|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
19687496|NCT05062681|Hormones|hormones|mesh-ancestor
19687497|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687498|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19687499|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687500|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19687501|NCT05062681|Protective Agents|protective agents|mesh-ancestor
19687502|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
19687503|NCT05062954|Procyanidin|procyanidin|mesh-list
19687504|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
19687505|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687506|NCT05062954|Protective Agents|protective agents|mesh-ancestor
19687507|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687508|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19401634|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401635|NCT03616288|Thiamine|thiamine|mesh-list
19401636|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
19401637|NCT03616288|Vitamins|vitamins|mesh-ancestor
19401638|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
19401639|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401640|NCT03616262|Lidocaine|lidocaine|mesh-list
19401641|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
19687509|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19401642|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
19687510|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208969|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208970|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20208971|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20208972|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
20208973|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20208974|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20208975|NCT00278265|Antiviral Agents|antiviral agents|mesh-ancestor
20208976|NCT00278265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20208977|NCT00278278|Prednisone|prednisone|mesh-list
20208978|NCT00278278|Methotrexate|methotrexate|mesh-list
20208979|NCT00278278|Etoposide|etoposide|mesh-list
19360511|NCT05180461|Ivermectin|ivermectin|mesh-list
19360512|NCT05180461|Emodepside|emodepside|mesh-list
19360513|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19360514|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395057|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395058|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395059|NCT01100359|Carboplatin|carboplatin|mesh-list
20395060|NCT01100359|Doxorubicin|doxorubicin|mesh-list
20395061|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20395062|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395063|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20395064|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20395065|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20395066|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395067|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360515|NCT05173298|Bevacizumab|bevacizumab|mesh-list
20208980|NCT00278278|Vincristine|vincristine|mesh-list
20395068|NCT01100372|Gemcitabine|gemcitabine|mesh-list
20395069|NCT01100372|Doxorubicin|doxorubicin|mesh-list
20395070|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20208981|NCT00278278|Ifosfamide|ifosfamide|mesh-list
20208982|NCT00278278|Lomustine|lomustine|mesh-list
20208983|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360516|NCT05173298|Atezolizumab|atezolizumab|mesh-list
19360517|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360518|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360519|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844972|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844973|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19844974|NCT00668746|Minocycline|minocycline|mesh-list
19844975|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19844976|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19844977|NCT00668811|Sunitinib|sunitinib|mesh-list
19844978|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20208984|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360520|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360521|NCT05173298|Growth Substances|growth substances|mesh-ancestor
19360522|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360523|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360524|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
19360525|NCT05156814|Progestins|progestins|mesh-ancestor
19360526|NCT05156814|Hormones|hormones|mesh-ancestor
19360527|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360528|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395071|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20395072|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
19360529|NCT05152888|Evolocumab|evolocumab|mesh-list
19360530|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19360531|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19360532|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
19360533|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360534|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19360535|NCT05152017|Vaccines|vaccines|mesh-list
19360536|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
19360537|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360538|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
19360539|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19360540|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
19360541|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360542|NCT05142735|Expectorants|expectorants|mesh-ancestor
19360543|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
19360544|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19360545|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
19360546|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360547|NCT05142735|Protective Agents|protective agents|mesh-ancestor
19360548|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360549|NCT05142735|Antidotes|antidotes|mesh-ancestor
19844979|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19844980|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20208985|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
20208986|NCT00278278|Hormones|hormones|mesh-ancestor
20208987|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20208988|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20208989|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20395073|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360550|NCT05140694|Empagliflozin|empagliflozin|mesh-list
19360551|NCT05140694|Dulaglutide|dulaglutide|mesh-list
19360552|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19360553|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19360554|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360555|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19360556|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360557|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
19360558|NCT05135312|Etanercept|etanercept|mesh-list
19360559|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19360560|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360561|NCT05135312|Analgesics|analgesics|mesh-ancestor
19360562|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
19360563|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395074|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395075|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
20395076|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395077|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395078|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20395079|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
20395080|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395081|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20395082|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20395083|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20395084|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
20395085|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20395086|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395087|NCT01100736|Bosentan|bosentan|mesh-list
20395088|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
20395089|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20395090|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20395091|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395092|NCT01100775|Galantamine|galantamine|mesh-list
19360564|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360565|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360566|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360567|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19360568|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360569|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
19360570|NCT05116774|Eculizumab|eculizumab|mesh-list
19360571|NCT05116774|Ravulizumab|ravulizumab|mesh-list
19360572|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19360573|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360574|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
19360575|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360576|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
19360577|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19360578|NCT05109104|Protective Agents|protective agents|mesh-ancestor
19360579|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360580|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
19360581|NCT05089123|Vaccines|vaccines|mesh-list
19360582|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
19360583|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360584|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19360585|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
19360586|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
19360587|NCT05064332|Estradiol|estradiol|mesh-list
19360588|NCT05064332|Estrogens|estrogens|mesh-ancestor
19360589|NCT05064332|Hormones|hormones|mesh-ancestor
19360590|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360591|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360592|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19360593|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19360594|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19360595|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19360596|NCT05034029|Metformin|metformin|mesh-list
19360597|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19360598|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360599|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
19360600|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19360601|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360602|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19360603|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19360604|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360605|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395093|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20395094|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360606|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360607|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
19360608|NCT04938024|Vitamins|vitamins|mesh-ancestor
19360609|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
19360610|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360611|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
19360612|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360613|NCT04938024|Protective Agents|protective agents|mesh-ancestor
19360614|NCT04936984|Abaloparatide|abaloparatide|mesh-list
19360615|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
19360616|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395095|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395096|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
20395097|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395098|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395099|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20395100|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
20395101|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395102|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
20395103|NCT01100801|Cisplatin|cisplatin|mesh-list
20395104|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
20395105|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426703|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426704|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20426705|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20426706|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
20426707|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
20426708|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
20426709|NCT01282333|Gemcitabine|gemcitabine|mesh-list
20426710|NCT01282333|Veliparib|veliparib|mesh-list
20426711|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426712|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20426713|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
20426714|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426715|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
20426716|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426717|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360617|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360618|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20208990|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20208991|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
20208992|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20426718|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426719|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
20426720|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426721|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20426722|NCT01282385|Simvastatin|simvastatin|mesh-list
20426723|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20426724|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20426725|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
19360619|NCT04855526|Dronabinol|dronabinol|mesh-list
19360620|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
19360621|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360622|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360623|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360624|NCT04855526|Analgesics|analgesics|mesh-ancestor
20208993|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20208994|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
19360625|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
19360626|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360627|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19360628|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19360629|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360630|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360631|NCT04855526|Hormones|hormones|mesh-ancestor
19360632|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360633|NCT04842552|Hydralazine|hydralazine|mesh-list
20208995|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20208996|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
20208997|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20208998|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19360634|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20426726|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395106|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
20395107|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20395108|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395109|NCT01101009|Amlodipine|amlodipine|mesh-list
20395110|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20395111|NCT01101009|Olmesartan|olmesartan|mesh-list
20395112|NCT01101009|Perindopril|perindopril|mesh-list
20395113|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20395114|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20395115|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395116|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395117|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20395118|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395119|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
20395120|NCT01101009|Diuretics|diuretics|mesh-ancestor
20395121|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
20395122|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20395123|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20395124|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20395125|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20395126|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
19360635|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
19360636|NCT04818944|Tirofiban|tirofiban|mesh-list
19360637|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19360638|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19360639|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360640|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19401643|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395127|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395128|NCT01101113|Cinacalcet|cinacalcet|mesh-list
20395129|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19401644|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401645|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
19401646|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401647|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401648|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19401649|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19401650|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401651|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401652|NCT03616236|Buprenorphine|buprenorphine|mesh-list
19401653|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19401654|NCT03616236|Naloxone|naloxone|mesh-list
19401655|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19401656|NCT03616236|Narcotics|narcotics|mesh-ancestor
19401657|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401658|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401659|NCT03616236|Analgesics|analgesics|mesh-ancestor
19401660|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
19401661|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401662|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19404620|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404621|NCT03593135|Incretins|incretins|mesh-ancestor
19404622|NCT03593135|Hormones|hormones|mesh-ancestor
19404623|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404624|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19404625|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
19404626|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687511|NCT05062486|Curcumin|curcumin|mesh-list
19687512|NCT05062486|Resveratrol|resveratrol|mesh-list
20395130|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687513|NCT05062486|Quercetin|quercetin|mesh-list
20395131|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20395132|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
20395133|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395134|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20395135|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20395136|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20395137|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395138|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395139|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395140|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395141|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
19844981|NCT00668811|Growth Substances|growth substances|mesh-ancestor
19844982|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844983|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
19844984|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19844985|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19844986|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844987|NCT00668863|Leucovorin|leucovorin|mesh-list
19844988|NCT00668863|Fluorouracil|fluorouracil|mesh-list
19844989|NCT00668863|Irinotecan|irinotecan|mesh-list
19844990|NCT00668863|Sunitinib|sunitinib|mesh-list
19844991|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
19844992|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
19844993|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19844994|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19844995|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19844996|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19844997|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
19844998|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19844999|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19845000|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19845001|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845002|NCT00668863|Antidotes|antidotes|mesh-ancestor
19845003|NCT00668863|Protective Agents|protective agents|mesh-ancestor
19845004|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
19845005|NCT00668863|Vitamins|vitamins|mesh-ancestor
19845006|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
20395142|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20395143|NCT01101204|Metformin|metformin|mesh-list
20395144|NCT01101204|Simvastatin|simvastatin|mesh-list
20395145|NCT01101204|Fenofibrate|fenofibrate|mesh-list
20395146|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20395147|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845007|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845008|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19845009|NCT00668863|Growth Substances|growth substances|mesh-ancestor
19845010|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845011|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687514|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19687515|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19687516|NCT05062486|Analgesics|analgesics|mesh-ancestor
19687517|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
19687518|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687519|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687520|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395148|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20395149|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20395150|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
20395151|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395152|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19360641|NCT04812951|Cyclosporine|cyclosporine|mesh-list
19360642|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19360643|NCT04812951|Cyclosporins|cyclosporins|mesh-list
19360644|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360645|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360646|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360647|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
19360648|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360649|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
19360650|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360651|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
19360652|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360653|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19360654|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19360655|NCT04772313|Methotrexate|methotrexate|mesh-list
19360656|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19360657|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
19360658|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19360659|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360660|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360661|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
19687521|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687522|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687523|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687524|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687525|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
19845012|NCT00668902|Pantoprazole|pantoprazole|mesh-list
19845013|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20395153|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20395154|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395155|NCT01101269|Lisinopril|lisinopril|mesh-list
19360662|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360663|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360664|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
19360665|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360666|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19360667|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360668|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
19360669|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360670|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19360671|NCT04756401|Dexamethasone|dexamethasone|mesh-list
19360672|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
19360673|NCT04756401|Daratumumab|daratumumab|mesh-list
19360674|NCT04756401|Ichthammol|ichthammol|mesh-list
19360675|NCT04756401|BB 1101|bb 1101|mesh-list
19360676|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20208999|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209000|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
19360677|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
19360678|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
19360679|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360680|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360681|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19360682|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
19360683|NCT04756401|Hormones|hormones|mesh-ancestor
19360684|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845014|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845015|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19845016|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845017|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845018|NCT00669019|Saracatinib|saracatinib|mesh-list
19845019|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845020|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845021|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360685|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19360686|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360687|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
19360688|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360689|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360690|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
19360691|NCT04707625|Aflibercept|aflibercept|mesh-list
19360692|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19360693|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360694|NCT04707625|Growth Substances|growth substances|mesh-ancestor
19360695|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360696|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360697|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360698|NCT04696146|Complement C1s|complement c1s|mesh-list
19360699|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19360700|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19360701|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
19360702|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360703|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19360704|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360705|NCT04663464|Abaloparatide|abaloparatide|mesh-list
19360706|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
19360707|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20209001|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209002|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20209003|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209004|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20209005|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20209006|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209007|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209008|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209009|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209010|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
20209011|NCT00278330|Vorinostat|vorinostat|mesh-list
20209012|NCT00278330|Alvocidib|alvocidib|mesh-list
20209013|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209014|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20395156|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20395157|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
20395158|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395159|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395160|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20395161|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20395162|NCT01101269|Protective Agents|protective agents|mesh-ancestor
20395163|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395164|NCT01101386|Voriconazole|voriconazole|mesh-list
20395165|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
20395166|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395167|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20395168|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20395169|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395170|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360708|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360709|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19360710|NCT04639466|Vaccines|vaccines|mesh-list
19360711|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
19360712|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360713|NCT04624945|Thromboplastin|thromboplastin|mesh-list
19360714|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
19360715|NCT04624945|Coagulants|coagulants|mesh-ancestor
19360716|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
19360717|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
19360718|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360719|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209015|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209016|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209017|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
20209018|NCT00278330|Growth Substances|growth substances|mesh-ancestor
19360720|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360721|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
19360722|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19360723|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19360724|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360725|NCT04596657|Vitamin D|vitamin d|mesh-list
19360726|NCT04596657|Vitamins|vitamins|mesh-ancestor
19360727|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
19360728|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360729|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19360730|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
19360731|NCT04540380|Rituximab|rituximab|mesh-list
19360732|NCT04540380|Fludarabine|fludarabine|mesh-list
19360733|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360734|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
19360735|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360736|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360737|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19360738|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
19360739|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360740|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395171|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20395172|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
20395173|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395174|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395175|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20395176|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
20395177|NCT01101412|Ethanol|ethanol|mesh-list
20395178|NCT01101412|Trimethoprim|trimethoprim|mesh-list
20395179|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
20395180|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20395181|NCT01101412|Edetic Acid|edetic acid|mesh-list
20395182|NCT01101412|Calcium|calcium|mesh-list
20395183|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
20395184|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20209019|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209020|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20209021|NCT00278343|Cediranib|cediranib|mesh-list
20209022|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209023|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360741|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19360742|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19360743|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19360744|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19360745|NCT04499131|Progesterone|progesterone|mesh-list
19360746|NCT04499131|Progestins|progestins|mesh-ancestor
19360747|NCT04499131|Hormones|hormones|mesh-ancestor
19360748|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360749|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360750|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19360751|NCT04469595|Aflibercept|aflibercept|mesh-list
19360752|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19360753|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360754|NCT04469595|Growth Substances|growth substances|mesh-ancestor
20209024|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360755|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360756|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360757|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360758|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360759|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
19360760|NCT04469595|Hormones|hormones|mesh-ancestor
19360761|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360762|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19360763|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
19360764|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360765|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360766|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
19360767|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360768|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360769|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19360770|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19360771|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19360772|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
19360773|NCT04454424|Midazolam|midazolam|mesh-list
19360774|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19360775|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19360776|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19360777|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360778|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19360779|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19360780|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19360781|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19360782|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
19360783|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
19360784|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
19360785|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
19360786|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360787|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360788|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
19360789|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19360790|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
19360791|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360792|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360793|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19360794|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
19360795|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19360796|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
19360797|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360798|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360799|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19360800|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
19360801|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
19360802|NCT04338828|Protective Agents|protective agents|mesh-ancestor
19360803|NCT04331288|Ethanol|ethanol|mesh-list
19360804|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19360805|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360806|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209025|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20209026|NCT00278369|Aldesleukin|aldesleukin|mesh-list
20209027|NCT00278369|Interleukin-2|interleukin-2|mesh-list
20209028|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
20209029|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209030|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20209031|NCT00278369|Analgesics|analgesics|mesh-ancestor
20209032|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
20209033|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209034|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209035|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20209036|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20395185|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395186|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19360807|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360808|NCT04283500|Buprenorphine|buprenorphine|mesh-list
19845022|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
19845023|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19845024|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
19360809|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19360810|NCT04283500|Naloxone|naloxone|mesh-list
19360811|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19360812|NCT04283500|Narcotics|narcotics|mesh-ancestor
19360813|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19360814|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360815|NCT04283500|Analgesics|analgesics|mesh-ancestor
19360816|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
19845025|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845026|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
19845027|NCT00669032|Protective Agents|protective agents|mesh-ancestor
19845028|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19360817|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360818|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19360819|NCT04241549|Azacitidine|azacitidine|mesh-list
19360820|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360821|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
19360822|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360823|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360824|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360825|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
19360826|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
19360827|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360828|NCT04225026|Protective Agents|protective agents|mesh-ancestor
19360829|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360830|NCT04217135|Hydralazine|hydralazine|mesh-list
19360831|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19360832|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
19360833|NCT04205838|Vidarabine|vidarabine|mesh-list
19360834|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
19360835|NCT04205838|Fludarabine|fludarabine|mesh-list
19360836|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
19360837|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19360838|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360839|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
19360840|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360841|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360842|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209037|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
20209038|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209039|NCT00278382|Sorafenib|sorafenib|mesh-list
20209040|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209041|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20209042|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209043|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209044|NCT00278408|Prednisone|prednisone|mesh-list
20209045|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
20209046|NCT00278408|Rituximab|rituximab|mesh-list
20209047|NCT00278408|Doxorubicin|doxorubicin|mesh-list
20209048|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20209049|NCT00278408|Vincristine|vincristine|mesh-list
20209050|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209051|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
20209052|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209053|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209054|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209055|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
20209056|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209057|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209058|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20209059|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20209060|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20209061|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20209062|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19360843|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
19845029|NCT00669071|Tretinoin|tretinoin|mesh-list
19845030|NCT00669071|Hydroquinone|hydroquinone|mesh-list
20209063|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360844|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360845|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360846|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19360847|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360848|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
19360849|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
19360850|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360851|NCT04178603|Insulin|insulin|mesh-list
19360852|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845031|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395187|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20395188|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395189|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395190|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20395191|NCT01101412|Renal Agents|renal agents|mesh-ancestor
19845032|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
20395192|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
20395193|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20395194|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20395195|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20395196|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395197|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395198|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19360853|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360854|NCT04170972|Insulin|insulin|mesh-list
19360855|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19360856|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360857|NCT04133623|Ibuprofen|ibuprofen|mesh-list
19360858|NCT04133623|Ketorolac|ketorolac|mesh-list
20395199|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20395200|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20395201|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20395202|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
20395203|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20395204|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
20395205|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
20395206|NCT01101412|Antidotes|antidotes|mesh-ancestor
20395207|NCT01101412|Protective Agents|protective agents|mesh-ancestor
19360859|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19360860|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360861|NCT04133623|Analgesics|analgesics|mesh-ancestor
19360862|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
19360863|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360864|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360865|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360866|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360867|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19360868|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360869|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360870|NCT04064411|Abaloparatide|abaloparatide|mesh-list
19360871|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
20395208|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19845033|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
20395209|NCT01101529|Aprepitant|aprepitant|mesh-list
20395210|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
20395211|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
20395212|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395213|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395214|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19360872|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19360873|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360874|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19360875|NCT04057937|Apremilast|apremilast|mesh-list
19687526|NCT05062486|Protective Agents|protective agents|mesh-ancestor
19687527|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19687528|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
19687529|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19687530|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19687531|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687532|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
19687533|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
19687534|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687535|NCT05062304|Fluticasone|fluticasone|mesh-list
19687536|NCT05062304|Xhance|xhance|mesh-list
19687537|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395215|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19360876|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19360877|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19845034|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845035|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
19845036|NCT00669071|Hormones|hormones|mesh-ancestor
19845037|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845038|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845039|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
19845040|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845041|NCT00669071|Protective Agents|protective agents|mesh-ancestor
19845042|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19360878|NCT04057937|Analgesics|analgesics|mesh-ancestor
19360879|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
19360880|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360881|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360882|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360883|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360884|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19360885|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19360886|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360887|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360888|NCT04042831|Olaparib|olaparib|mesh-list
19360889|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19360890|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360891|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845043|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19845044|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19845045|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19360892|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360893|NCT04017962|Letermovir|letermovir|mesh-list
19360894|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19360895|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360896|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360897|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360898|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
19360899|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401663|NCT03616132|Sirolimus|sirolimus|mesh-list
19401664|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19401665|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401666|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19401667|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401668|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
19401669|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401670|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
19401671|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401672|NCT03615950|Vitamin D|vitamin d|mesh-list
19401673|NCT03615950|Vitamins|vitamins|mesh-ancestor
19401674|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
19401675|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401676|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19401677|NCT03615833|Vitamin D|vitamin d|mesh-list
19401678|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
19401679|NCT03615833|Vitamins|vitamins|mesh-ancestor
19401680|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
19401681|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401682|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19401683|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19401684|NCT03615768|Clindamycin|clindamycin|mesh-list
19401685|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
19401686|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
19401687|NCT03615768|Adapalene|adapalene|mesh-list
19401688|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19401689|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401690|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19401691|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401692|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401693|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19401694|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401695|NCT03615768|Analgesics|analgesics|mesh-ancestor
19401696|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
19401697|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401698|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360900|NCT03907826|Antibodies|antibodies|mesh-list
19360901|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
20395216|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395217|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395218|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20395219|NCT01101568|Simvastatin|simvastatin|mesh-list
20395220|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20395221|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20395222|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
19360902|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
19360903|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360904|NCT03905889|Sunitinib|sunitinib|mesh-list
19360905|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360906|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19360907|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360908|NCT03905889|Growth Substances|growth substances|mesh-ancestor
19360909|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360910|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360911|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19360912|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360913|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360914|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
19360915|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360916|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19360917|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360918|NCT03847311|Analgesics|analgesics|mesh-ancestor
19360919|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
19360920|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360921|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360922|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360923|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395223|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395224|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20395225|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20395226|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395227|NCT01101581|Epratuzumab|epratuzumab|mesh-list
20395228|NCT01101581|Veltuzumab|veltuzumab|mesh-list
20395229|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
20395230|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20395231|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395232|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
20395233|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
20395234|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395235|NCT01101620|Simendan|simendan|mesh-list
19360924|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19360925|NCT03823989|Mitomycins|mitomycins|mesh-list
19360926|NCT03823989|Mitomycin|mitomycin|mesh-list
19360927|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19360928|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360929|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
19360930|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360931|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19360932|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360933|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
19360934|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19360935|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360936|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
19360937|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
19360938|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360939|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360940|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19360941|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
19360942|NCT03818737|Hormones|hormones|mesh-ancestor
19360943|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19360944|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19360945|NCT03818737|Protective Agents|protective agents|mesh-ancestor
19360946|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
19360947|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19360948|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19360949|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360950|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360951|NCT03770130|Analgesics|analgesics|mesh-ancestor
19360952|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
19360953|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360954|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20395236|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20395237|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
20395238|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20395239|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20395240|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360955|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19360956|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19360957|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
19360958|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19360959|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360960|NCT03747939|Thalidomide|thalidomide|mesh-list
19360961|NCT03747939|Apremilast|apremilast|mesh-list
19360962|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19360963|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19360964|NCT03747939|Analgesics|analgesics|mesh-ancestor
19360965|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
19360966|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19360967|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19360968|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360969|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19360970|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19360971|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19360972|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19360973|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360974|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19360975|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
19360976|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
20209064|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19360977|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19360978|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360979|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19360980|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19360981|NCT03747939|Growth Substances|growth substances|mesh-ancestor
19360982|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
19360983|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360984|NCT03727971|Omalizumab|omalizumab|mesh-list
19360985|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19360986|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19360987|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
19360988|NCT03593018|Gemcitabine|gemcitabine|mesh-list
19360989|NCT03593018|Azacitidine|azacitidine|mesh-list
19360990|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19360991|NCT03593018|Romidepsin|romidepsin|mesh-list
19360992|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19360993|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
19360994|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360995|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360996|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
20209065|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
20209066|NCT00278408|Hormones|hormones|mesh-ancestor
20209067|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20209068|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20209069|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209070|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209071|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209072|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209073|NCT00278421|Prednisone|prednisone|mesh-list
20209074|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
20209075|NCT00278421|Rituximab|rituximab|mesh-list
20209076|NCT00278421|Doxorubicin|doxorubicin|mesh-list
20209077|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20209078|NCT00278421|Vincristine|vincristine|mesh-list
20209079|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209080|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
20209081|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209082|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209083|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209084|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
20209085|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395241|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19360997|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19360998|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209086|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19360999|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361000|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
19361001|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361002|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19361003|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
19361004|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19361005|NCT03563742|Tenofovir|tenofovir|mesh-list
19361006|NCT03563742|Lamivudine|lamivudine|mesh-list
19361007|NCT03563742|Rilpivirine|rilpivirine|mesh-list
19361008|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
19361009|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361010|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19361011|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19361012|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361013|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361014|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19361015|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19361016|NCT03548428|Atezolizumab|atezolizumab|mesh-list
19361017|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361018|NCT03517969|Carboplatin|carboplatin|mesh-list
19361019|NCT03517969|Docetaxel|docetaxel|mesh-list
19361020|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361021|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
19361022|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
19361023|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
19361024|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361025|NCT03493425|Cisplatin|cisplatin|mesh-list
19361026|NCT03493425|Carboplatin|carboplatin|mesh-list
19361027|NCT03493425|Docetaxel|docetaxel|mesh-list
19361028|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361029|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
19361030|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
19361031|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
19361032|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361033|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
19361034|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19361035|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
19361036|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19361037|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
19361038|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361039|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361040|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
20209087|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20209088|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20209089|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20209090|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20209091|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20209092|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361047|NCT03386214|Pevonedistat|pevonedistat|mesh-list
19361048|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361049|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361050|NCT03373188|Nivolumab|nivolumab|mesh-list
19361051|NCT03373188|Ipilimumab|ipilimumab|mesh-list
19361052|NCT03373188|Antibodies|antibodies|mesh-list
19361053|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361054|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
19361055|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361056|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361057|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361058|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19361059|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361060|NCT03369665|Cladribine|cladribine|mesh-list
19361061|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361062|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361063|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
19361064|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361065|NCT03303339|Cytarabine|cytarabine|mesh-list
19361066|NCT03303339|Decitabine|decitabine|mesh-list
19361067|NCT03303339|Onvansertib|onvansertib|mesh-list
19361068|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19361069|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
20209093|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19361070|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361071|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209094|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
20209095|NCT00278421|Hormones|hormones|mesh-ancestor
20209096|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395242|NCT01101620|Protective Agents|protective agents|mesh-ancestor
20395243|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361072|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
19361073|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361074|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361075|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
19361076|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361077|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361078|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361079|NCT03220178|Letrozole|letrozole|mesh-list
19361080|NCT03220178|Fulvestrant|fulvestrant|mesh-list
19361081|NCT03220178|Palbociclib|palbociclib|mesh-list
19361082|NCT03220178|Anastrozole|anastrozole|mesh-list
19361083|NCT03220178|Exemestane|exemestane|mesh-list
19361084|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361085|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19361086|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19361087|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361088|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361089|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19361090|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
19361091|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361092|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361093|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19361094|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19361095|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361096|NCT03122301|Bupivacaine|bupivacaine|mesh-list
19361097|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
19361098|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
19361099|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361100|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361101|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
19361102|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361103|NCT03085147|Olaparib|olaparib|mesh-list
19361104|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19361105|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361106|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361107|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361108|NCT03034356|Levetiracetam|levetiracetam|mesh-list
19361109|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
19361110|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
19361111|NCT03032510|Levofloxacin|levofloxacin|mesh-list
19361112|NCT03032510|Ofloxacin|ofloxacin|mesh-list
19361113|NCT03032510|Ertapenem|ertapenem|mesh-list
19361114|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19361115|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361116|NCT03032510|Renal Agents|renal agents|mesh-ancestor
19361117|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19361118|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19361119|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19361120|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209097|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20209098|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209099|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209100|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209101|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209102|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
20209103|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20209104|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209105|NCT00278460|Gemcitabine|gemcitabine|mesh-list
20209106|NCT00278460|Docetaxel|docetaxel|mesh-list
20209107|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209108|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
20209109|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209110|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209111|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
20209112|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209113|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209114|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209115|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
20209116|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209117|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
19361121|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361122|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209118|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
20395244|NCT01101646|Rabeprazole|rabeprazole|mesh-list
19361123|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19361124|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19361125|NCT03029000|Lenograstim|lenograstim|mesh-list
19361126|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20395245|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20395246|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20395247|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20395248|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395249|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209119|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209120|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
20209121|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209122|NCT00278772|Valproic Acid|valproic acid|mesh-list
20209123|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
20395250|NCT01101659|Ketamine|ketamine|mesh-list
20395251|NCT01101659|Analgesics|analgesics|mesh-ancestor
20395252|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
20395253|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395254|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395255|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20395256|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20395257|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
20395258|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
20395259|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395260|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20395261|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20395262|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395263|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395264|NCT01101685|Citalopram|citalopram|mesh-list
20395265|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20395266|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20395267|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395268|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395269|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395270|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
20395271|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395272|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20395273|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
20395274|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20395275|NCT01101698|Vitamin D|vitamin d|mesh-list
20395276|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
20395277|NCT01101698|Vitamins|vitamins|mesh-list
20395278|NCT01101698|Vitamin K|vitamin k|mesh-list
19361127|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
19361128|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361129|NCT03022292|Aflibercept|aflibercept|mesh-list
19361130|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19361131|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19361132|NCT03022292|Growth Substances|growth substances|mesh-ancestor
19361133|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361134|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
19361135|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361136|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
19361137|NCT03012100|Vaccines|vaccines|mesh-list
19361138|NCT03012100|Sargramostim|sargramostim|mesh-list
19361139|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
19361140|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361141|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361142|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19361143|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19361144|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
19361145|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209124|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209125|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209126|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
20209127|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361146|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361147|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19361148|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
19361149|NCT02973997|Lenvatinib|lenvatinib|mesh-list
20209128|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209129|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
20209130|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20395279|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
19361150|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20395280|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
20395281|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395282|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395283|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19361151|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361152|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361153|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361154|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361155|NCT02968602|Minocycline|minocycline|mesh-list
19361156|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19361157|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361158|NCT02946047|Ixazomib|ixazomib|mesh-list
19361159|NCT02946047|Glycine|glycine|mesh-list
19361160|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361161|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
19361162|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361163|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361164|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
19361165|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361166|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361167|NCT02832648|Selenium|selenium|mesh-list
19361168|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
19361169|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361170|NCT02832648|Protective Agents|protective agents|mesh-ancestor
19361171|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361172|NCT02832648|Trace Elements|trace elements|mesh-ancestor
19361173|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
19361174|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19361175|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361176|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361177|NCT02784704|Meropenem|meropenem|mesh-list
19361178|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687538|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19687539|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
19687540|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687541|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687542|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19687543|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19687544|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687545|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19687546|NCT05061732|Amoxicillin|amoxicillin|mesh-list
19687547|NCT05061732|Metronidazole|metronidazole|mesh-list
19687548|NCT05061732|Clarithromycin|clarithromycin|mesh-list
19687549|NCT05061732|Doxycycline|doxycycline|mesh-list
19687550|NCT05061732|Levofloxacin|levofloxacin|mesh-list
19687551|NCT05061732|Tetracycline|tetracycline|mesh-list
19687552|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
19687553|NCT05061732|Rabeprazole|rabeprazole|mesh-list
19687554|NCT05061732|Bismuth|bismuth|mesh-list
19361179|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361180|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19361181|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361182|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19361183|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209131|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209132|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20209133|NCT00278824|Fentanyl|fentanyl|mesh-list
20209134|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20209135|NCT00278824|Narcotics|narcotics|mesh-ancestor
20209136|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209137|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209138|NCT00278824|Analgesics|analgesics|mesh-ancestor
20209139|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
20209140|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209141|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19687555|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687556|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687557|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687558|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19687559|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20209142|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19361196|NCT05241249|Gemcitabine|gemcitabine|mesh-list
19361197|NCT05241249|Paclitaxel|paclitaxel|mesh-list
19361198|NCT05241249|Bethanechol|bethanechol|mesh-list
19687560|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19687561|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361199|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19361200|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361201|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
19361202|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
19361203|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
19361204|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361205|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19361206|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
19361207|NCT05241249|Antiviral Agents|antiviral agents|mesh-ancestor
19361208|NCT05241249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361209|NCT05241249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361210|NCT05241249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361211|NCT05241249|Immunologic Factors|immunologic factors|mesh-ancestor
19687562|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19687563|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19687564|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
19687565|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19687566|NCT05061732|Renal Agents|renal agents|mesh-ancestor
19687567|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19687568|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19687569|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687570|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19687571|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19687572|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687573|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19687574|NCT05061732|Antacids|antacids|mesh-ancestor
19687575|NCT05061732|Diuretics|diuretics|mesh-ancestor
19687576|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
19687577|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687578|NCT05061732|Expectorants|expectorants|mesh-ancestor
19687579|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
19687580|NCT05061901|Lisinopril|lisinopril|mesh-list
19361212|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361213|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19361214|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
19361215|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361216|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19361217|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19361218|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
19361219|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401699|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401700|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401701|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
19401702|NCT03615677|Esomeprazole|esomeprazole|mesh-list
19401703|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19401704|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19401705|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19401706|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401707|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401708|NCT03615547|Clomiphene|clomiphene|mesh-list
19401709|NCT03615547|Enclomiphene|enclomiphene|mesh-list
19401710|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
19401711|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19401712|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
19401713|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401714|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401715|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19401716|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
19401717|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19692882|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401718|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19401719|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19401720|NCT03615430|Anesthetics|anesthetics|mesh-list
19401721|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
19401722|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401723|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401724|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
19401725|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401726|NCT03615417|Anesthetics|anesthetics|mesh-list
19401727|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401728|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401729|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
19401730|NCT03615326|Capecitabine|capecitabine|mesh-list
19401731|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
19401732|NCT03615326|Trastuzumab|trastuzumab|mesh-list
19401733|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361220|NCT05241132|Paclitaxel|paclitaxel|mesh-list
19361221|NCT05241132|Cisplatin|cisplatin|mesh-list
19361222|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19361223|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361224|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
19361225|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
19361226|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
19687581|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20209143|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
20395284|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20395285|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20395286|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395287|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
19361227|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209144|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
20209145|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20209146|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20209147|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20395288|NCT01101698|Coagulants|coagulants|mesh-ancestor
20395289|NCT01101776|Interferons|interferons|mesh-list
20395290|NCT01101776|Interferon-beta|interferon-beta|mesh-list
20395291|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
20395292|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395293|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
20395294|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395295|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
20395296|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395297|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20395298|NCT01101789|Triclosan|triclosan|mesh-list
20395299|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20395300|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395301|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20395302|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20395303|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
20395304|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395305|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20395306|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
20395307|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20395308|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395309|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20395310|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
19361228|NCT05241093|Cytarabine|cytarabine|mesh-list
19361229|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19361230|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
19361231|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361232|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361233|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
19361234|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361235|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361236|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
19361237|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361238|NCT05241054|Acetaminophen|acetaminophen|mesh-list
19361239|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
19361240|NCT05241054|Fentanyl|fentanyl|mesh-list
19361241|NCT05241054|Bupivacaine|bupivacaine|mesh-list
19361242|NCT05241054|Propofol|propofol|mesh-list
19361243|NCT05241054|Sevoflurane|sevoflurane|mesh-list
19361244|NCT05241054|Atracurium|atracurium|mesh-list
19361245|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
19361246|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
19361247|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361248|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361249|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
20209148|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19361250|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209149|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20209150|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
20209151|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361251|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19361252|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19361253|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
19361254|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20395311|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20395312|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361255|NCT05241054|Narcotics|narcotics|mesh-ancestor
19361256|NCT05241054|Analgesics|analgesics|mesh-ancestor
19361257|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19361258|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19361259|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
19361260|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19361261|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19361262|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
19361263|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19361264|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19361265|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19361266|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19361267|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19361268|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
19361269|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361270|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361271|NCT05241028|Ensartinib|ensartinib|mesh-list
19361272|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361273|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361274|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361275|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361276|NCT05240755|Cannabidiol|cannabidiol|mesh-list
20395313|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395314|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395315|NCT01101815|Naltrexone|naltrexone|mesh-list
20395316|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20395317|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20395318|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395319|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
20395320|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395321|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
20395322|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20395323|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20395324|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
20395325|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395326|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20395327|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20395328|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395329|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395330|NCT01101919|Tofacitinib|tofacitinib|mesh-list
19361277|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
19361278|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
19361279|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19361280|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
19361281|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
19361282|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
19361283|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19361284|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
19361285|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361286|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361287|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361288|NCT05240456|Urological Agents|urological agents|mesh-ancestor
19361289|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19361290|NCT05240274|Metformin|metformin|mesh-list
19361291|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19361292|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361293|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19361294|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
19361295|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361296|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19361297|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19361298|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361299|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361300|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19361301|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361302|NCT05240131|Atezolizumab|atezolizumab|mesh-list
19361303|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361304|NCT05239884|Nicotine|nicotine|mesh-list
19361305|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19361306|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
19361307|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361308|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361309|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19361310|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19361311|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
20395331|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361312|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395332|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361313|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687582|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
19687583|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687584|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687585|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19687586|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19687587|NCT05061901|Protective Agents|protective agents|mesh-ancestor
19687588|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361314|NCT05224895|Anesthetics|anesthetics|mesh-list
19361315|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361316|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361317|NCT05209867|Cannabidiol|cannabidiol|mesh-list
19361318|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
19361319|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
19361320|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19361321|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401734|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19401735|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19401736|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
19401737|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401738|NCT03615313|Antibodies|antibodies|mesh-list
19401739|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
19401740|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401741|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19401742|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19401743|NCT03614832|Clopidogrel|clopidogrel|mesh-list
19401744|NCT03614832|Ticagrelor|ticagrelor|mesh-list
19401745|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19401746|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19401747|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19401748|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19401749|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
20395333|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395334|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19401750|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401751|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401752|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401753|NCT03614741|Tinzaparin|tinzaparin|mesh-list
19401754|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19401755|NCT03614741|Dalteparin|dalteparin|mesh-list
19401756|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
19401757|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19401758|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19401759|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401760|NCT03614715|Interferons|interferons|mesh-list
19401761|NCT03614715|Interferon-beta|interferon-beta|mesh-list
19401762|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
19401763|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401764|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
19401765|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692883|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19692884|NCT04985890|UB-421|ub-421|mesh-list
19692885|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19692886|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
19692887|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401766|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
19401767|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401768|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19401769|NCT03614533|Vaccines|vaccines|mesh-list
19401770|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
19401771|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401772|NCT03614494|Piroxicam|piroxicam|mesh-list
19401773|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
19401774|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19401775|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
19401776|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19401777|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401778|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19401779|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19401780|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19401781|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19401782|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401783|NCT03614494|Analgesics|analgesics|mesh-ancestor
19401784|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
19401785|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692888|NCT04986098|Paclitaxel|paclitaxel|mesh-list
20395335|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20395336|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
20395337|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20395338|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
20395339|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395340|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
20395341|NCT01101984|Protective Agents|protective agents|mesh-ancestor
20395342|NCT01102101|Remifentanil|remifentanil|mesh-list
19361322|NCT05208619|Anesthetics|anesthetics|mesh-list
19361323|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361324|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361325|NCT05186623|Ustekinumab|ustekinumab|mesh-list
19361326|NCT05186623|Vedolizumab|vedolizumab|mesh-list
19361327|NCT05186623|Tofacitinib|tofacitinib|mesh-list
19361328|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
19361329|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361330|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361331|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361332|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19361333|NCT05168163|Atezolizumab|atezolizumab|mesh-list
19361334|NCT05168163|Lenvatinib|lenvatinib|mesh-list
19361335|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361336|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361337|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361338|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361339|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395343|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20395344|NCT01102101|Narcotics|narcotics|mesh-ancestor
20395345|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395346|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395347|NCT01102101|Analgesics|analgesics|mesh-ancestor
20395348|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
20395349|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395350|NCT01102114|Vaccines|vaccines|mesh-list
20395351|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
20395352|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395353|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
20395354|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395355|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20395356|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395357|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
20395358|NCT01102244|Hormones|hormones|mesh-ancestor
19361340|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
19361341|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361342|NCT05118724|Atezolizumab|atezolizumab|mesh-list
19361343|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361344|NCT05099666|Doxorubicin|doxorubicin|mesh-list
19361345|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20395359|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361346|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361347|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19361348|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19361349|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361350|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361351|NCT05095064|Irinotecan|irinotecan|mesh-list
19361352|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19361353|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19361354|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361355|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361356|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361357|NCT05093959|Metformin|metformin|mesh-list
19361358|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19361359|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361360|NCT05045794|Liver Extracts|liver extracts|mesh-list
19361361|NCT05045794|Hematinics|hematinics|mesh-ancestor
19361362|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19361363|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361364|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
19361365|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19361366|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395360|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395361|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19361367|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
19361368|NCT04984083|Vitamin K|vitamin k|mesh-list
19361369|NCT04984083|Vitamins|vitamins|mesh-ancestor
19361370|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
20395362|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19361371|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361372|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19361373|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19361374|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361375|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
19361376|NCT04984083|Coagulants|coagulants|mesh-ancestor
20395363|NCT01102335|Telbivudine|telbivudine|mesh-list
20395364|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
20395365|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395366|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20395367|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395368|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395369|NCT01102439|Aspirin|aspirin|mesh-list
20395370|NCT01102439|Clopidogrel|clopidogrel|mesh-list
20395371|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20395372|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19361377|NCT04976777|Dexamethasone|dexamethasone|mesh-list
19361378|NCT04976777|Dexamethasone acetate|dexamethasone acetate|mesh-list
19361379|NCT04976777|BB 1101|bb 1101|mesh-list
19361380|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19361381|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
19361382|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
19361383|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361384|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361385|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19361386|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
19361387|NCT04976777|Hormones|hormones|mesh-ancestor
19361388|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361389|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19361390|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361391|NCT04976777|Protease Inhibitors|protease inhibitors|mesh-ancestor
19361392|NCT04976777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361393|NCT04976777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361394|NCT04971954|Nicotine|nicotine|mesh-list
19361395|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19361396|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
19361397|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361398|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361399|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19361400|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19361401|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
19361402|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361403|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361404|NCT04965077|Antibodies|antibodies|mesh-list
19845046|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19845047|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845048|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845049|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845050|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
19845051|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19845052|NCT00669162|Docetaxel|docetaxel|mesh-list
19845053|NCT00669162|Leuprolide|leuprolide|mesh-list
19845054|NCT00669162|Goserelin|goserelin|mesh-list
20209152|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20209153|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20209154|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209155|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209156|NCT00278967|Bisacodyl|bisacodyl|mesh-list
20209157|NCT00278967|Cathartics|cathartics|mesh-ancestor
20209158|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20209159|NCT00278967|Laxatives|laxatives|mesh-ancestor
20209160|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
20209161|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20209162|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
20209163|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209164|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209165|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20209166|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209167|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
19361405|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361406|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
19361407|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845055|NCT00669162|Bicalutamide|bicalutamide|mesh-list
20209168|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20395373|NCT01102439|Analgesics|analgesics|mesh-ancestor
19361408|NCT04959006|Antioxidants|antioxidants|mesh-list
19361409|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395374|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
20395375|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361410|NCT04959006|Protective Agents|protective agents|mesh-ancestor
19361411|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361412|NCT04942470|Propolis|propolis|mesh-list
19361413|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361414|NCT04933383|Budesonide|budesonide|mesh-list
19361415|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19361416|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19361417|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
19361418|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361419|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361420|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19361421|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
19361422|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
20209169|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
20209170|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845056|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845057|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
19845058|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845059|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
19845060|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845061|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19845062|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
19845063|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845064|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209171|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209172|NCT00279045|Metformin|metformin|mesh-list
20209173|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
20209174|NCT00279045|Glyburide|glyburide|mesh-list
20209175|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20209176|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209177|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
20209178|NCT00279084|Hematinics|hematinics|mesh-ancestor
20209179|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20209180|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
20209181|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395376|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395377|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395378|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395379|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19361423|NCT04933383|Hormones|hormones|mesh-ancestor
19361424|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361425|NCT04926571|Dexamethasone|dexamethasone|mesh-list
19361426|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19361427|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
19361428|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
19361429|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361430|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361431|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19361432|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
19361433|NCT04926571|Hormones|hormones|mesh-ancestor
19361434|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361435|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19361436|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361437|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
19361438|NCT04904562|Giapreza|giapreza|mesh-list
19687589|NCT05061641|Progesterone|progesterone|mesh-list
19687590|NCT05061641|Progestins|progestins|mesh-ancestor
19687591|NCT05061641|Hormones|hormones|mesh-ancestor
19687592|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687593|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687594|NCT05061147|Azacitidine|azacitidine|mesh-list
19687595|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19687596|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
19687597|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687598|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687599|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687600|NCT05060822|Pirfenidone|pirfenidone|mesh-list
19687601|NCT05060822|Analgesics|analgesics|mesh-ancestor
19687602|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
19687603|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209182|NCT00279123|Pantoprazole|pantoprazole|mesh-list
20209183|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19361439|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
19361440|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19361441|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19361442|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
19361443|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361444|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401786|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401787|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19401788|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19401789|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401790|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401791|NCT03614455|Itraconazole|itraconazole|mesh-list
19401792|NCT03614455|Posaconazole|posaconazole|mesh-list
19401793|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
19687604|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687605|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19687606|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19687607|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401794|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
19401795|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401796|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19401797|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19401798|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401799|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401800|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19401801|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
19401802|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401803|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401804|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19401805|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19687608|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687609|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687610|NCT05060809|Vitamin K|vitamin k|mesh-list
19401806|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19401807|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
19401808|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19401809|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401810|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
19401811|NCT03614403|Vitamin D|vitamin d|mesh-list
19401812|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
19401813|NCT03614403|Vitamins|vitamins|mesh-ancestor
19401814|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
19401815|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401816|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19401817|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19404627|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404628|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19404629|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404630|NCT03593044|Atropine|atropine|mesh-list
19404631|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19404632|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19404633|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404634|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
19404635|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404636|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404637|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19404638|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404639|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
19404640|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
19404641|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19404642|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19404643|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
19404644|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404645|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404646|NCT03592992|Morphine|morphine|mesh-list
19404647|NCT03592992|Hydromorphone|hydromorphone|mesh-list
19404648|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404649|NCT03592992|Narcotics|narcotics|mesh-ancestor
19404650|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687611|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
19687612|NCT05060809|Vitamins|vitamins|mesh-ancestor
19687613|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
19687614|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404651|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361445|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19361446|NCT04851522|Eusol|eusol|mesh-list
19361447|NCT04851522|Petrolatum|petrolatum|mesh-list
19361448|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
19361449|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361450|NCT04851522|Emollients|emollients|mesh-ancestor
19361451|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
19361452|NCT04834024|Antibodies|antibodies|mesh-list
19361453|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361454|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
19361455|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845065|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20395380|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20395381|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395382|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20395383|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20395384|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395385|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
20395386|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20395387|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20395388|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20395389|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
20395390|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395391|NCT01102465|Losartan|losartan|mesh-list
20395392|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20395393|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20395394|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20395395|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20395396|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19361456|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
19361457|NCT04821141|Estrogens|estrogens|mesh-list
19361458|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19361459|NCT04821141|Hormones|hormones|mesh-ancestor
19361460|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361461|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361462|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19361463|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19361464|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
19361465|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19361466|NCT04788017|Ziresovir|ziresovir|mesh-list
19361467|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
19361468|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361469|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
19361470|NCT04767776|Charcoal|charcoal|mesh-list
19361471|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19361472|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
19361473|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19361474|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
19361475|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361476|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361477|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
19361478|NCT04767776|Antidotes|antidotes|mesh-ancestor
19361479|NCT04767776|Protective Agents|protective agents|mesh-ancestor
20395397|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395398|NCT01102465|Diuretics|diuretics|mesh-ancestor
20395399|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
20395400|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395401|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20395402|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395403|NCT01102478|Losartan|losartan|mesh-list
20395404|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20395405|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20395406|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19361480|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361481|NCT04756765|Talazoparib|talazoparib|mesh-list
19845066|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
19845067|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
20395407|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20395408|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20395409|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361482|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19361483|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361484|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361485|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361486|NCT04753970|Cilostazol|cilostazol|mesh-list
20395410|NCT01102478|Diuretics|diuretics|mesh-ancestor
20395411|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
19361487|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19361488|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
19361489|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361490|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361491|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19361492|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
19361493|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19361494|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19361495|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361496|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19361497|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
19361498|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19361499|NCT04753970|Protective Agents|protective agents|mesh-ancestor
19361500|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19361501|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19361502|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845068|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845069|NCT00669240|Varenicline|varenicline|mesh-list
19845070|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19845071|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19845072|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
19845073|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845074|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845075|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845076|NCT00669279|Atenolol|atenolol|mesh-list
19845077|NCT00669279|Carvedilol|carvedilol|mesh-list
19845078|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19845079|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19845080|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
19845081|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395412|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395413|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20395414|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395415|NCT01102595|Bevacizumab|bevacizumab|mesh-list
20395416|NCT01102595|Temozolomide|temozolomide|mesh-list
20395417|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20395418|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395419|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20395420|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20395421|NCT01102595|Growth Substances|growth substances|mesh-ancestor
19361517|NCT04724447|Valganciclovir|valganciclovir|mesh-list
19361518|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
19361519|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687615|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19845082|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845083|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845084|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19845085|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
19845086|NCT00669279|Protective Agents|protective agents|mesh-ancestor
19845087|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20395422|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395423|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
20395424|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19687616|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19687617|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687618|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
19687619|NCT05060809|Coagulants|coagulants|mesh-ancestor
19687620|NCT05060731|Iron|iron|mesh-list
19687621|NCT05060731|Trace Elements|trace elements|mesh-ancestor
19845088|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395425|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
20395426|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845089|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19845090|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
19845091|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19845092|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19845093|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19361520|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
19361521|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19687622|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
19687623|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687624|NCT05060588|Valsartan|valsartan|mesh-list
19845094|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
19845095|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
19845096|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845097|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19845098|NCT00669318|Rituximab|rituximab|mesh-list
19845099|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
19845100|NCT00669318|Pentostatin|pentostatin|mesh-list
19845101|NCT00669318|Sargramostim|sargramostim|mesh-list
19845102|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845103|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845104|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
19845105|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845106|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845107|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19845108|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845109|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361522|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19361523|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361524|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
19361525|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
19361526|NCT04710732|Enoxaparin|enoxaparin|mesh-list
19361527|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
19361528|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
19361529|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19361530|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19361531|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361532|NCT04688294|Valsartan|valsartan|mesh-list
19361533|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19361534|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19361535|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19361536|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19361537|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361538|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
19361539|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
20395427|NCT01102608|Ifosfamide|ifosfamide|mesh-list
20395428|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20395429|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
20395430|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395431|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426727|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19361540|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361541|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
19361542|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687625|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19687626|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19687627|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19687628|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687629|NCT05060419|Meropenem|meropenem|mesh-list
19687630|NCT05060419|Tazobactam|tazobactam|mesh-list
19687631|NCT05060419|Piperacillin|piperacillin|mesh-list
19687632|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19687633|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19361543|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845110|NCT00669331|Mannitol|mannitol|mesh-list
19361544|NCT04672460|Talazoparib|talazoparib|mesh-list
19687634|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845111|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19845112|NCT00669331|Diuretics|diuretics|mesh-ancestor
19845113|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
19845114|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845115|NCT00669383|Betamethasone|betamethasone|mesh-list
19845116|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845117|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
19845118|NCT00669383|Hormones|hormones|mesh-ancestor
19845119|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845120|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845121|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19845122|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
19845123|NCT00669396|Copper|copper|mesh-list
19845124|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
19845125|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19845126|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
19845127|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845128|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845129|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19845130|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19845131|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19845132|NCT00669396|Trace Elements|trace elements|mesh-ancestor
19845133|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
19361545|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19361546|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361547|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361548|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361549|NCT04671875|Antibodies|antibodies|mesh-list
19361550|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361551|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
19361552|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845134|NCT00669409|Tanezumab|tanezumab|mesh-list
19845135|NCT00669409|Analgesics|analgesics|mesh-ancestor
19687635|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19687636|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687637|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687638|NCT05060744|Antacids|antacids|mesh-list
19687639|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
19687640|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687641|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687642|NCT05060198|Lumefantrine|lumefantrine|mesh-list
19687643|NCT05060198|Artemether|artemether|mesh-list
19687644|NCT05060198|Piperaquine|piperaquine|mesh-list
19687645|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19687646|NCT05060198|Artenimol|artenimol|mesh-list
19687647|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
19687648|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19687649|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19687650|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687651|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19687652|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19687653|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687654|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687655|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19687656|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687657|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845136|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
19845137|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845138|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845139|NCT00669578|Pomalidomide|pomalidomide|mesh-list
19361553|NCT04651348|Antibodies|antibodies|mesh-list
19361554|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361555|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
19361556|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361557|NCT04623099|Citalopram|citalopram|mesh-list
19361558|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19361559|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19361560|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19361561|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361562|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361563|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
19361564|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361565|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19687658|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
19687659|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687660|NCT05059782|Coal Tar|coal tar|mesh-list
19687661|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
19687662|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687663|NCT05059418|Clonazepam|clonazepam|mesh-list
19687664|NCT05059418|Capsaicin|capsaicin|mesh-list
19687665|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
19687666|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687667|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
19687668|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687669|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687670|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
19687671|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
19687672|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
19687673|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845140|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
19687674|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687675|NCT05059028|Oxytocin|oxytocin|mesh-list
19845141|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845142|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19361566|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
19361567|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361568|NCT04563247|Antibodies|antibodies|mesh-list
19361569|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
19361570|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361571|NCT04552080|Amoxicillin|amoxicillin|mesh-list
19687676|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
19361572|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20395432|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
20395433|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395434|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395435|NCT01102686|Leucovorin|leucovorin|mesh-list
20395436|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
20395437|NCT01102686|Antidotes|antidotes|mesh-ancestor
20395438|NCT01102686|Protective Agents|protective agents|mesh-ancestor
20395439|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395440|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
20395441|NCT01102686|Vitamins|vitamins|mesh-ancestor
20395442|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
20395443|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
20395444|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20395445|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20395446|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395447|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19361573|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687677|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19687678|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687679|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
19687680|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19361574|NCT04508855|Heparin|heparin|mesh-list
19361575|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19361576|NCT04508855|Tinzaparin|tinzaparin|mesh-list
19361577|NCT04508855|Dalteparin|dalteparin|mesh-list
19361578|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
19361579|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19361580|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19361581|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361582|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
19361583|NCT04499950|Naltrexone|naltrexone|mesh-list
19361584|NCT04499950|Bupropion|bupropion|mesh-list
19361585|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19361586|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19845143|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19845144|NCT00669578|Growth Substances|growth substances|mesh-ancestor
19845145|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845146|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845147|NCT00669617|Fluticasone|fluticasone|mesh-list
19845148|NCT00669617|Xhance|xhance|mesh-list
19361587|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845149|NCT00669617|Albuterol|albuterol|mesh-list
19845150|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19845151|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845152|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19845153|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
19845154|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845155|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845156|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19845157|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
19361588|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
19361589|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361590|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19361591|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
19361592|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361593|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19361594|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19361595|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19361596|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361597|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
19361598|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687681|NCT05059145|Fluconazole|fluconazole|mesh-list
19687682|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19687683|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845158|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845159|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19845160|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20395448|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687684|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
19687685|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687686|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
19687687|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19687688|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19687689|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687690|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687691|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19687692|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687693|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687694|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687695|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19687696|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19687697|NCT05058976|Vitamin D|vitamin d|mesh-list
19687698|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
19687699|NCT05058976|Calcium|calcium|mesh-list
19687700|NCT05058976|Vitamins|vitamins|mesh-ancestor
19687701|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
19687702|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687703|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19845161|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20395449|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395450|NCT01102699|Lenograstim|lenograstim|mesh-list
20395451|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20395452|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
20395453|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395454|NCT01102946|Ranibizumab|ranibizumab|mesh-list
20395455|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20395456|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20395457|NCT01102946|Growth Substances|growth substances|mesh-ancestor
20395458|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395459|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
20395460|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395461|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20395462|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
20395463|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395464|NCT01103050|Cetirizine|cetirizine|mesh-list
20395465|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20395466|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20395467|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20395468|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
20395469|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
20395470|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395471|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395472|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395473|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
20395474|NCT01103115|Vitamin D|vitamin d|mesh-list
20395475|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
20395476|NCT01103115|Calcium|calcium|mesh-list
20395477|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20395478|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613000|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361599|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19361600|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19361601|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361602|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19361603|NCT04495621|Cetuximab|cetuximab|mesh-list
19361604|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361605|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361606|NCT04463394|Vasopressins|vasopressins|mesh-list
19361607|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
19361608|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
19361609|NCT04463394|Coagulants|coagulants|mesh-ancestor
20613001|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613002|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20613003|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
20613004|NCT02253784|Hormones|hormones|mesh-ancestor
20613005|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613006|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20613007|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613008|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
20613009|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
20613010|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361610|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19687704|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19687705|NCT05058677|Lidocaine|lidocaine|mesh-list
19687706|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
19687707|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
19687708|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687709|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687710|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
19687711|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687712|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19687713|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19361611|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19361612|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
19361613|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401818|NCT03614273|Epinephrine|epinephrine|mesh-list
19401819|NCT03614273|Racepinephrine|racepinephrine|mesh-list
19401820|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
19401821|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19401822|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19401823|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
19401824|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401825|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401826|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401827|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19401828|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19401829|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
19401830|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401831|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19401832|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
19401833|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
19401834|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
20395479|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395480|NCT01103115|Vitamins|vitamins|mesh-ancestor
20395481|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
20395482|NCT01103115|Antacids|antacids|mesh-ancestor
20395483|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395484|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687714|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19687715|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395485|NCT01103154|Nadolol|nadolol|mesh-list
20395486|NCT01103154|Carvedilol|carvedilol|mesh-list
20395487|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20395488|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20613011|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
19401835|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19401836|NCT03614221|Tacrolimus|tacrolimus|mesh-list
19401837|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19401838|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
19401839|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401840|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19401841|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401842|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401843|NCT03614065|Endostar protein|endostar protein|mesh-list
19687716|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692889|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19692890|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209184|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20209185|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20209186|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209187|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209188|NCT00279162|Betamethasone|betamethasone|mesh-list
20209189|NCT00279162|Calcipotriene|calcipotriene|mesh-list
20209190|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20209191|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
20209192|NCT00279162|Hormones|hormones|mesh-ancestor
20209193|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20209194|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209195|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20209196|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209197|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
20209198|NCT00279240|Metformin|metformin|mesh-list
20209199|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20209200|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209201|NCT00279253|Clonidine|clonidine|mesh-list
20395489|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
20395490|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687717|NCT05058612|Midodrine|midodrine|mesh-list
19687718|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
19687719|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
19687720|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687721|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687722|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19687723|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19361614|NCT04454476|Trametinib|trametinib|mesh-list
19361615|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361616|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361617|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845162|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19845163|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
19845164|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845165|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845166|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
19845167|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845168|NCT00669864|Metformin|metformin|mesh-list
19845169|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
19687724|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19687725|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19687726|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
19687727|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361618|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845170|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
19845171|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19845172|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845173|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845174|NCT00669877|Cytarabine|cytarabine|mesh-list
19845175|NCT00669877|Dexamethasone|dexamethasone|mesh-list
19361619|NCT04454411|Naltrexone|naltrexone|mesh-list
19361620|NCT04454411|Buprenorphine|buprenorphine|mesh-list
19361621|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19361622|NCT04454411|Narcotics|narcotics|mesh-ancestor
19361623|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361624|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361625|NCT04454411|Analgesics|analgesics|mesh-ancestor
19361626|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
19361627|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361628|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19361629|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19361630|NCT04447846|Cannabidiol|cannabidiol|mesh-list
19361631|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
19845176|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
19845177|NCT00669877|Rituximab|rituximab|mesh-list
19845178|NCT00669877|Doxorubicin|doxorubicin|mesh-list
19845179|NCT00669877|Methotrexate|methotrexate|mesh-list
19845180|NCT00669877|Vincristine|vincristine|mesh-list
19845181|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845182|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
19845183|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845184|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845185|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19361632|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
19361633|NCT04424602|Dimethoate|dimethoate|mesh-list
19361634|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687728|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687729|NCT05058443|Denosumab|denosumab|mesh-list
19687730|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19687731|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687732|NCT05058755|Etoposide|etoposide|mesh-list
19687733|NCT05058755|Lenalidomide|lenalidomide|mesh-list
19687734|NCT05058755|Azacitidine|azacitidine|mesh-list
19845186|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
19845187|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845188|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845189|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19845190|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845191|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845192|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
19687735|NCT05058755|Pegaspargase|pegaspargase|mesh-list
19361635|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845193|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
19687736|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19845194|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845195|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19361636|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845196|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
19845197|NCT00669877|Hormones|hormones|mesh-ancestor
19361637|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361638|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
19361639|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361640|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19361641|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19361642|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
19687737|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845198|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687738|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19687739|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19687740|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687741|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687742|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
19687743|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687744|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19687745|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19687746|NCT05058755|Growth Substances|growth substances|mesh-ancestor
19687747|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
19687748|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19687749|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
19687750|NCT05058209|Triamcinolone|triamcinolone|mesh-list
19687751|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19687752|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19361643|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19361644|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19361645|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
19361646|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361647|NCT04398329|Bupivacaine|bupivacaine|mesh-list
19361648|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19361649|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
19361650|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361651|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361652|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
19687753|NCT05058209|Betamethasone|betamethasone|mesh-list
20395491|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395492|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395493|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20395494|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
20395495|NCT01103154|Protective Agents|protective agents|mesh-ancestor
20395496|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20395497|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687754|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
20209202|NCT00279253|Analgesics|analgesics|mesh-ancestor
19361653|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361654|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
19361655|NCT04391855|Tramadol|tramadol|mesh-list
19361656|NCT04391855|Ropivacaine|ropivacaine|mesh-list
19361657|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19687755|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19687756|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
19687757|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
19687758|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19687759|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19687760|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687761|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
19687762|NCT05058209|Hormones|hormones|mesh-ancestor
19687763|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687764|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687765|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209203|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
20209204|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209205|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209206|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20209207|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
20209208|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
20209209|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20209210|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20209211|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20209212|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20209213|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613012|NCT02253797|Ritonavir|ritonavir|mesh-list
19361658|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209214|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209215|NCT00279266|Thiamine|thiamine|mesh-list
20209216|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
20209217|NCT00279266|Vitamins|vitamins|mesh-ancestor
19361659|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361660|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19361661|NCT04391855|Analgesics|analgesics|mesh-ancestor
19361662|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
19361663|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361664|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19361665|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19361666|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19845199|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19845200|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19845201|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19845202|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19845203|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361667|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
19361668|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361669|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361670|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
19361671|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
19361672|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19361673|NCT04391855|Narcotics|narcotics|mesh-ancestor
19361674|NCT04371380|Rilpivirine|rilpivirine|mesh-list
19361675|NCT04371380|Cabotegravir|cabotegravir|mesh-list
19361676|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19687766|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
19687767|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687768|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687769|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19687770|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
19687771|NCT05058105|Meropenem|meropenem|mesh-list
19361677|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19361678|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361679|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361680|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
19361681|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361682|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19361683|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19361684|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19361685|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19361686|NCT04297618|Lifitegrast|lifitegrast|mesh-list
19361687|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19361688|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19361689|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
19361690|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19361691|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209218|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
20209219|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209220|NCT00279344|Fentanyl|fentanyl|mesh-list
20209221|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19687772|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687773|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687774|NCT05057767|Midazolam|midazolam|mesh-list
19687775|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19687776|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20209222|NCT00279344|Narcotics|narcotics|mesh-ancestor
20209223|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209224|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687777|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687778|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209225|NCT00279344|Analgesics|analgesics|mesh-ancestor
20209226|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
20209227|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209228|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20209229|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19687779|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19687780|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20209230|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
20209231|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
19361692|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404652|NCT03592992|Analgesics|analgesics|mesh-ancestor
19845204|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20209232|NCT00279383|Thrombin|thrombin|mesh-list
19687781|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20209233|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
20209234|NCT00279383|Coagulants|coagulants|mesh-ancestor
20209235|NCT00279422|Visilizumab|visilizumab|mesh-list
20209236|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
20209237|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209238|NCT00279435|Visilizumab|visilizumab|mesh-list
20209239|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
20209240|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209241|NCT00279448|Tamoxifen|tamoxifen|mesh-list
20395498|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20395499|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
20395500|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20395501|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20395502|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20395503|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
20395504|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
20209242|NCT00279448|Exemestane|exemestane|mesh-list
20209243|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20209244|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
20209245|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20209246|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209247|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20209248|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209249|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20209250|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20209251|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395505|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209252|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20209253|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20209254|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209255|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395506|NCT01103193|Remifentanil|remifentanil|mesh-list
20395507|NCT01103193|Sevoflurane|sevoflurane|mesh-list
20209256|NCT00279461|Vitamin D|vitamin d|mesh-list
20395508|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20395509|NCT01103193|Narcotics|narcotics|mesh-ancestor
20395510|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395511|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395512|NCT01103193|Analgesics|analgesics|mesh-ancestor
20395513|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
20395514|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395515|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20395516|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20395517|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
20395518|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
20395519|NCT01103206|Cinacalcet|cinacalcet|mesh-list
20395520|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20395521|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395522|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20395523|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
20395524|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395525|NCT01103336|Nicorandil|nicorandil|mesh-list
20395526|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20395527|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20395528|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
20395529|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
19361693|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19687782|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19687783|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
19687784|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
19687785|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
19687786|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
19687787|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687788|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687789|NCT05057845|Lenvatinib|lenvatinib|mesh-list
19687790|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687791|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687792|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687793|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687794|NCT05057663|Fluorouracil|fluorouracil|mesh-list
19687795|NCT05057663|Bleomycin|bleomycin|mesh-list
19687796|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
19692891|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209257|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
20209258|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
20395530|NCT01103336|Vitamins|vitamins|mesh-ancestor
19361694|NCT04266665|Analgesics|analgesics|mesh-ancestor
19361695|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
19361696|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361697|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19361698|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19361699|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19361700|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
19361701|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361702|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361703|NCT04259749|Menthol|menthol|mesh-list
19361704|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
19361705|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19361706|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19361707|NCT04250636|Antibodies|antibodies|mesh-list
19361708|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
19361709|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361710|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
19361711|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361712|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361713|NCT04246996|Gentamicins|gentamicins|mesh-list
19361714|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19361715|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361716|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19361717|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361718|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845205|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
19845206|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845207|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19361719|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19361720|NCT04245748|Citalopram|citalopram|mesh-list
19361721|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19845208|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
19845209|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845210|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19845211|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19845212|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
20395531|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
20395532|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395533|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20395534|NCT01103375|Isotretinoin|isotretinoin|mesh-list
19845213|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845214|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19845215|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
19845216|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845217|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
19848249|NCT00691704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19848250|NCT00691704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19848251|NCT00691704|Analgesics|analgesics|mesh-ancestor
19848252|NCT00691704|Sensory System Agents|sensory system agents|mesh-ancestor
20395535|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395536|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20395537|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395538|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395539|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
20395540|NCT01103388|Rituximab|rituximab|mesh-list
20395541|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20395542|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395543|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
20395544|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395545|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395546|NCT01103401|Tobramycin|tobramycin|mesh-list
20395547|NCT01103401|Dexamethasone|dexamethasone|mesh-list
20395548|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
20395549|NCT01103401|Ketorolac|ketorolac|mesh-list
20395550|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20395551|NCT01103401|BB 1101|bb 1101|mesh-list
20395552|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395553|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
20395554|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
20395555|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395556|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395557|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19361722|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19848253|NCT00691704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848254|NCT00691704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395558|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
20395559|NCT01103401|Hormones|hormones|mesh-ancestor
20395560|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395561|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20395562|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395563|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
20209259|NCT00279461|Vitamins|vitamins|mesh-list
20209260|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
19845218|NCT00669955|Amoxicillin|amoxicillin|mesh-list
19845219|NCT00669955|Metronidazole|metronidazole|mesh-list
19845220|NCT00669955|Clarithromycin|clarithromycin|mesh-list
19845221|NCT00669955|Tetracycline|tetracycline|mesh-list
20209261|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209262|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20209263|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20209264|NCT00279487|Gabapentin|gabapentin|mesh-list
20209265|NCT00279487|Analgesics|analgesics|mesh-ancestor
20395564|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395565|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395566|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20395567|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20395568|NCT01103401|Analgesics|analgesics|mesh-ancestor
20395569|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
20395570|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395571|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20395572|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20395573|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845222|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19845223|NCT00669955|Omeprazole|omeprazole|mesh-list
19845224|NCT00669955|Bismuth|bismuth|mesh-list
19845225|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19845226|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845227|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19845228|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19845229|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20209266|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
20209267|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209268|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209269|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
19361723|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19361724|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361725|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361726|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
19361727|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361728|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19687797|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395574|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
19687798|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209270|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20209271|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20209272|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395575|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20395576|NCT01103518|Estradiol|estradiol|mesh-list
20395577|NCT01103518|Cyproterone|cyproterone|mesh-list
20395578|NCT01103518|Estrogens|estrogens|mesh-ancestor
20395579|NCT01103518|Hormones|hormones|mesh-ancestor
20395580|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361729|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
19361730|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361731|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361732|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19361733|NCT04245748|Analgesics|analgesics|mesh-ancestor
19687799|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687800|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361734|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
19361735|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
19361736|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19361737|NCT04245436|Citalopram|citalopram|mesh-list
19361738|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19361739|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19687801|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
19687802|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687803|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19687804|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
19687805|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19692892|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845230|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19361740|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19361741|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361742|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361743|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
20613013|NCT02253797|Tipranavir|tipranavir|mesh-list
20613014|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19361744|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361745|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19361746|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
19687806|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19687807|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19687808|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687809|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
19687810|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687811|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687812|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19687813|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687814|NCT05057351|Glycerol|glycerol|mesh-list
19845231|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19845232|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361747|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361748|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361749|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19361750|NCT04245436|Analgesics|analgesics|mesh-ancestor
19361751|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
19361752|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
19361753|NCT04221997|Sertraline|sertraline|mesh-list
19361754|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
19361755|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361756|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19361757|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20395581|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395582|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20395583|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
20395584|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20395585|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20395586|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19361758|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19361759|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361760|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361761|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
19361762|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361763|NCT04161989|Progesterone|progesterone|mesh-list
19361764|NCT04161989|Progestins|progestins|mesh-ancestor
19361765|NCT04161989|Hormones|hormones|mesh-ancestor
19361766|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19361767|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361768|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
19361769|NCT04130828|Trace Elements|trace elements|mesh-ancestor
19361770|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
19361771|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361772|NCT03881059|Ustekinumab|ustekinumab|mesh-list
20395587|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20395588|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
20395589|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
19361773|NCT03881059|BMS-986165|bms-986165|mesh-list
19361774|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
19361775|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687815|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19845233|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845234|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19845235|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19845236|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19845237|NCT00669955|Antacids|antacids|mesh-ancestor
19845238|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
19845239|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19845240|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845241|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845242|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20395590|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687816|NCT05057351|Protective Agents|protective agents|mesh-ancestor
20613015|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613016|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
19361776|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361777|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361778|NCT03837860|Oxycodone|oxycodone|mesh-list
19361779|NCT03837860|Risperidone|risperidone|mesh-list
19361780|NCT03837860|Ziprasidone|ziprasidone|mesh-list
19361781|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19361782|NCT03837860|Narcotics|narcotics|mesh-ancestor
19361783|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361784|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361785|NCT03837860|Analgesics|analgesics|mesh-ancestor
19361786|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
19361787|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361788|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19361789|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
19361790|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361791|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687817|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687818|NCT05056896|Aspirin|aspirin|mesh-list
19687819|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
19687820|NCT05056896|Salicylates|salicylates|mesh-list
19687821|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19687822|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19687823|NCT05056896|Analgesics|analgesics|mesh-ancestor
19687824|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
19687825|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687826|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687827|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687828|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687829|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19687830|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19687831|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687832|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19687833|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19687834|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687835|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
19687836|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845243|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20395591|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20395592|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
20395593|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395594|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
20395595|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361792|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19361793|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19361794|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19361795|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19361796|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
19361797|NCT03697629|Daratumumab|daratumumab|mesh-list
19361798|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361799|NCT03677830|Acetaminophen|acetaminophen|mesh-list
19361800|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19361801|NCT03677830|Analgesics|analgesics|mesh-ancestor
19361802|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
20395596|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395597|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20395598|NCT01103609|Warfarin|warfarin|mesh-list
19361803|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361804|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361805|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
19361806|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
19361807|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
19361808|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361809|NCT03582137|Cannabidiol|cannabidiol|mesh-list
19361810|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
19361811|NCT03547999|Nivolumab|nivolumab|mesh-list
19361812|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361813|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361814|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19361815|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361816|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19361817|NCT03526848|Antibodies|antibodies|mesh-list
19361818|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
19361819|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361820|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
19687837|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
19687838|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
19361821|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361822|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361823|NCT03501381|Aldesleukin|aldesleukin|mesh-list
19361824|NCT03501381|Interleukin-2|interleukin-2|mesh-list
19361825|NCT03501381|Entinostat|entinostat|mesh-list
19361826|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361827|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19361828|NCT03501381|Analgesics|analgesics|mesh-ancestor
19361829|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
19361830|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361831|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361832|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19361833|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19687839|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687840|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
19687841|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687842|NCT05056402|Vaccines|vaccines|mesh-list
19687843|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
19687844|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687845|NCT05056142|Anesthetics|anesthetics|mesh-list
19687846|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19361834|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
20395599|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
20395600|NCT01103622|Digoxin|digoxin|mesh-list
20395601|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20395602|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20395603|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395604|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395605|NCT01103622|Protective Agents|protective agents|mesh-ancestor
20395606|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395607|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20395608|NCT01103635|Ipilimumab|ipilimumab|mesh-list
20395609|NCT01103635|Tremelimumab|tremelimumab|mesh-list
20395610|NCT01103635|Antibodies|antibodies|mesh-list
20395611|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
20395612|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20395613|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
20395614|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845244|NCT00670046|Valproic Acid|valproic acid|mesh-list
19845245|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
19845246|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395615|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395616|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20395617|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395618|NCT01103648|Simvastatin|simvastatin|mesh-list
20395619|NCT01103648|Ezetimibe|ezetimibe|mesh-list
20395620|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
20395621|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20395622|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20395623|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
19361835|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361836|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19361837|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361838|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361839|NCT03495973|Ustekinumab|ustekinumab|mesh-list
20395624|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395625|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20395626|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395627|NCT01103739|Simvastatin|simvastatin|mesh-list
20395628|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20395629|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20395630|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
20395631|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395632|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20395633|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20395634|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395635|NCT01103791|Docetaxel|docetaxel|mesh-list
20395636|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395637|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
20395638|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
20395639|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
20395640|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361840|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
19361841|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19692893|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
20395641|NCT01103817|Vitamin D|vitamin d|mesh-list
19361842|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20209273|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20209274|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20209275|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20209276|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209277|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687847|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687848|NCT05056519|Vaccines|vaccines|mesh-list
19687849|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
19687850|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687851|NCT05056337|Lenvatinib|lenvatinib|mesh-list
19687852|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687853|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19687854|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687855|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687856|NCT05056025|Vitamins|vitamins|mesh-list
19687857|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
19687858|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687859|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19687860|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
19687861|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687862|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687863|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692894|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692895|NCT04985656|Decitabine|decitabine|mesh-list
19692896|NCT04985656|Pevonedistat|pevonedistat|mesh-list
19692897|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19692898|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
19692899|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395642|NCT01103817|Vitamins|vitamins|mesh-ancestor
20395643|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
20395644|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395645|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395646|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
20395647|NCT01103830|Lumefantrine|lumefantrine|mesh-list
19845247|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845248|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
19845249|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845250|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845251|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
19845252|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19692900|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692901|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692902|NCT04985435|Adalimumab|adalimumab|mesh-list
19692903|NCT04985435|Etanercept|etanercept|mesh-list
19692904|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692905|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19692906|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19692907|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19692908|NCT04985435|Analgesics|analgesics|mesh-ancestor
19692909|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
19845253|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395648|NCT01103830|Artemether|artemether|mesh-list
20395649|NCT01103830|Piperaquine|piperaquine|mesh-list
20395650|NCT01103830|Artenimol|artenimol|mesh-list
20395651|NCT01103830|Artemisinins|artemisinins|mesh-list
20395652|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20395653|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20395654|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20395655|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395656|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20395657|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20395658|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395659|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395660|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395661|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19692910|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845254|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19845255|NCT00670202|Fasudil|fasudil|mesh-list
20209278|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
20209279|NCT00279539|Mitogens|mitogens|mesh-list
20209280|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
19845256|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20209281|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209282|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209283|NCT00279539|Growth Substances|growth substances|mesh-ancestor
19687864|NCT05055544|Fosfomycin|fosfomycin|mesh-list
19687865|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19687866|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687867|NCT05054868|Ketorolac|ketorolac|mesh-list
20395662|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
20395663|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20395664|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395665|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20395666|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19687868|NCT05054868|Oxycodone|oxycodone|mesh-list
20209284|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209285|NCT00279565|Interferons|interferons|mesh-list
20209286|NCT00279565|Ribavirin|ribavirin|mesh-list
20209287|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
20209288|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
20209289|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20209290|NCT00279565|Buprenorphine|buprenorphine|mesh-list
20209291|NCT00279565|Methadone|methadone|mesh-list
20209292|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209293|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
19361843|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19361844|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19361845|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19361846|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19361847|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19687869|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19687870|NCT05054868|Narcotics|narcotics|mesh-ancestor
19687871|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687872|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687873|NCT05054868|Analgesics|analgesics|mesh-ancestor
19845257|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19845258|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209294|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361848|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
20395667|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20395668|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
20395669|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20395670|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20395671|NCT01103843|Clopidogrel|clopidogrel|mesh-list
20395672|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20395673|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19687874|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
19687875|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613017|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613018|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613019|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613020|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613021|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
20613022|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613023|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19361849|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361850|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361851|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361852|NCT03448718|Olaparib|olaparib|mesh-list
19361853|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19361854|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361855|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361856|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361857|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
19361858|NCT03445858|Decitabine|decitabine|mesh-list
19361859|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361860|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361861|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20613024|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613025|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
20613026|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20613027|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20613216|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361862|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
19361863|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687876|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19687877|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20209295|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
20217856|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20395674|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19687878|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687879|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687880|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19687881|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687882|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687883|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
19687884|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19687885|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19687886|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361864|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361865|NCT03442413|Nicotine|nicotine|mesh-list
19361866|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19687887|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
19687888|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
19687889|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687890|NCT05054842|Metformin|metformin|mesh-list
19687891|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19687892|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395675|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19361867|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
19361868|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19361869|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361870|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19361871|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19361872|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
19361873|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19361874|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361875|NCT03439462|Sirolimus|sirolimus|mesh-list
19361876|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19361877|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361878|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19361879|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361880|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
19361881|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20395676|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20395677|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
20395678|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395679|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395680|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395681|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
20395682|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20395683|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20395684|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395685|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
20395686|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
20395687|NCT01104259|Vinorelbine|vinorelbine|mesh-list
20395688|NCT01104259|Veliparib|veliparib|mesh-list
20395689|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361882|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
19361883|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395690|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20395691|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
20395692|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
20395693|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
20395694|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395695|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20395696|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395697|NCT01104298|Doxorubicin|doxorubicin|mesh-list
20395698|NCT01104298|Trabectedin|trabectedin|mesh-list
20395699|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20395700|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395701|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20395702|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20395703|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395704|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395705|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20395706|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
20395707|NCT01104337|Acetaminophen|acetaminophen|mesh-list
20395708|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20395709|NCT01104337|Analgesics|analgesics|mesh-ancestor
20395710|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
19361884|NCT03386500|Manganese|manganese|mesh-list
19361885|NCT03386500|Trace Elements|trace elements|mesh-ancestor
19361886|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
19687893|NCT05054465|Venetoclax|venetoclax|mesh-list
19687894|NCT05054465|Navitoclax|navitoclax|mesh-list
20395711|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395712|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395713|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
20395714|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
20395715|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20395716|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20395717|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395718|NCT01104519|Niacin|niacin|mesh-list
20395719|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
19361887|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361888|NCT03379727|Midostaurin|midostaurin|mesh-list
19361889|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361890|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361891|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361892|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361893|NCT03326492|Antivenins|antivenins|mesh-list
19361894|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
19361895|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361896|NCT03272217|Bevacizumab|bevacizumab|mesh-list
19361897|NCT03272217|Atezolizumab|atezolizumab|mesh-list
19361898|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361899|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361900|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19361901|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20395720|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20395721|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
20395722|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395723|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20395724|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
20395725|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
20395726|NCT01104519|Vitamins|vitamins|mesh-ancestor
20395727|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
20395728|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361902|NCT03272217|Growth Substances|growth substances|mesh-ancestor
19361903|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361904|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
19401844|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19401845|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19401846|NCT03614065|Growth Substances|growth substances|mesh-ancestor
19401847|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687895|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687896|NCT05054478|Daratumumab|daratumumab|mesh-list
19687897|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426728|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19687898|NCT05054426|Methotrexate|methotrexate|mesh-list
19687899|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19687900|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
20426729|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426730|NCT01282398|Simvastatin|simvastatin|mesh-list
20426731|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20426732|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20426733|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
20426734|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426735|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20426736|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20426737|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426738|NCT01282502|Midostaurin|midostaurin|mesh-list
20426739|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426740|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20426741|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426742|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426743|NCT01282515|Clobetasol|clobetasol|mesh-list
20426744|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426745|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
20426746|NCT01282515|Hormones|hormones|mesh-ancestor
20426747|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426748|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687901|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19687902|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426749|NCT01282528|Infliximab|infliximab|mesh-list
20426750|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
19401848|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
19401849|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401850|NCT03614052|Tamsulosin|tamsulosin|mesh-list
20395729|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20395730|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
20395731|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20395732|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395733|NCT01104532|Incretins|incretins|mesh-ancestor
20395734|NCT01104532|Hormones|hormones|mesh-ancestor
20395735|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395736|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20395737|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
20395738|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395739|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395740|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20395741|NCT01104571|Trastuzumab|trastuzumab|mesh-list
20395742|NCT01104571|Lapatinib|lapatinib|mesh-list
20395743|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361905|NCT03260023|Avelumab|avelumab|mesh-list
19361906|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361907|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361908|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19361909|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19361910|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
19361911|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361912|NCT03215524|Thalidomide|thalidomide|mesh-list
19361913|NCT03215524|Dexamethasone|dexamethasone|mesh-list
19361914|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
19361915|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
19361916|NCT03215524|Daratumumab|daratumumab|mesh-list
19361917|NCT03215524|Pomalidomide|pomalidomide|mesh-list
19361918|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19361919|NCT03215524|BB 1101|bb 1101|mesh-list
19361920|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361921|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
19687903|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19687904|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
19687905|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687906|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687907|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
20395744|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361922|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361923|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19361924|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19361925|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
19361926|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361927|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361928|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19361929|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19361930|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
19361931|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
19361932|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395745|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20395746|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395747|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361933|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19361934|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
19361935|NCT03215524|Hormones|hormones|mesh-ancestor
19361936|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395748|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
20395749|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
20395750|NCT01104649|Riluzole|riluzole|mesh-list
20395751|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
20395752|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20395753|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20395754|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395755|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395756|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361937|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19361938|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
19361939|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361940|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19361941|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19361942|NCT03215524|Growth Substances|growth substances|mesh-ancestor
19687908|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395757|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19361943|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
19687909|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19361944|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
19361945|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19361946|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19361947|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
19361948|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361949|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361950|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
19361951|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361952|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361953|NCT03117309|Nivolumab|nivolumab|mesh-list
20395758|NCT01104649|Protective Agents|protective agents|mesh-ancestor
20395759|NCT01104844|Acetaminophen|acetaminophen|mesh-list
20395760|NCT01104844|Ibuprofen|ibuprofen|mesh-list
20395761|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20395762|NCT01104844|Analgesics|analgesics|mesh-ancestor
20395763|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
20395764|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395765|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395766|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
20395767|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20395768|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395769|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395770|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20395771|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361954|NCT03117309|Ipilimumab|ipilimumab|mesh-list
19361955|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361956|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361957|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19361958|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361959|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
19361960|NCT03073785|Fluorouracil|fluorouracil|mesh-list
19361961|NCT03073785|Capecitabine|capecitabine|mesh-list
19361962|NCT03073785|Imidazole|imidazole|mesh-list
20395772|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395773|NCT01104883|Iodine|iodine|mesh-list
20395774|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20395775|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395776|NCT01104883|Trace Elements|trace elements|mesh-ancestor
19361963|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
19361964|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361965|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19361966|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361967|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19361968|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
19361969|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361970|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19361971|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361972|NCT03047135|Olaparib|olaparib|mesh-list
19361973|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19361974|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19361975|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361976|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361977|NCT03035630|Sunitinib|sunitinib|mesh-list
19361978|NCT03035630|Avelumab|avelumab|mesh-list
20209296|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209297|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
20209298|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209299|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20209300|NCT00279565|Narcotics|narcotics|mesh-ancestor
20209301|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209302|NCT00279565|Analgesics|analgesics|mesh-ancestor
20209303|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
20209304|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209305|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20209306|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
20209307|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209308|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
20209309|NCT00279578|Factor VIII|factor viii|mesh-list
20209310|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20209311|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20209312|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209313|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
20395777|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
20395778|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395779|NCT01104896|Nicotine|nicotine|mesh-list
19361979|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19361980|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19361981|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19361982|NCT03035630|Growth Substances|growth substances|mesh-ancestor
19361983|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361984|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845259|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19845260|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845261|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
19845262|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19845263|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845264|NCT00670228|Insulin|insulin|mesh-list
19845265|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20209314|NCT00279578|Coagulants|coagulants|mesh-ancestor
20209315|NCT00279617|Levetiracetam|levetiracetam|mesh-list
20209316|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
19361985|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19361986|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209317|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
20217857|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217858|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217859|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19361987|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361988|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19361989|NCT02962297|Vitamin E|vitamin e|mesh-list
19361990|NCT02962297|Vitamins|vitamins|mesh-ancestor
19361991|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
19361992|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361993|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
20395780|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20395781|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
20395782|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395783|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19361994|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19361995|NCT02962297|Protective Agents|protective agents|mesh-ancestor
19687910|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19687911|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
19687912|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687913|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19687914|NCT05054751|Fulvestrant|fulvestrant|mesh-list
19687915|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19361996|NCT02913664|Losartan|losartan|mesh-list
19361997|NCT02913664|Amlodipine|amlodipine|mesh-list
19361998|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
19361999|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
19362000|NCT02913664|Giapreza|giapreza|mesh-list
19362001|NCT02913664|Calcium|calcium|mesh-list
19362002|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19362003|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
19362004|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19362005|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362006|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362007|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362008|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362009|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
19362010|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362011|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362012|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19362013|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19362014|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
19362015|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362016|NCT02889133|Iron|iron|mesh-list
19362017|NCT02889133|Dextrans|dextrans|mesh-list
19362018|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
19687916|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687917|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19687918|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19687919|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
19687920|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687921|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687922|NCT05054322|Fluticasone|fluticasone|mesh-list
19687923|NCT05054322|Xhance|xhance|mesh-list
19687924|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687925|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19845266|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
19845267|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
19362019|NCT02889133|Trace Elements|trace elements|mesh-ancestor
19362020|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
19362021|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362022|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
19362023|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
19362024|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
19362025|NCT02889133|Hematinics|hematinics|mesh-ancestor
19362026|NCT02818582|Remdesivir|remdesivir|mesh-list
19362027|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
19362028|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362029|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
19687926|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
19687927|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687928|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687929|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19687930|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
19845268|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845269|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845270|NCT00670241|Betamethasone|betamethasone|mesh-list
19362030|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362031|NCT02703623|Prednisone|prednisone|mesh-list
19362032|NCT02703623|Cortisone|cortisone|mesh-list
19362033|NCT02703623|Carboplatin|carboplatin|mesh-list
19362034|NCT02703623|Ipilimumab|ipilimumab|mesh-list
19362035|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
19362036|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362037|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362038|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
19362039|NCT02703623|Hormones|hormones|mesh-ancestor
19362040|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362041|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845271|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
19845272|NCT00670241|Calcipotriene|calcipotriene|mesh-list
19845273|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845274|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
19845275|NCT00670241|Hormones|hormones|mesh-ancestor
19845276|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845277|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845278|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362042|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19362043|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362044|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19362045|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362046|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19362047|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362048|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
19362049|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19362050|NCT02684032|Letrozole|letrozole|mesh-list
19362051|NCT02684032|Fulvestrant|fulvestrant|mesh-list
19362052|NCT02684032|Palbociclib|palbociclib|mesh-list
19362053|NCT02684032|Gedatolisib|gedatolisib|mesh-list
19362054|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362055|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19362056|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19362057|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362058|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362059|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19362060|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
19362061|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19687931|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
19687932|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19687933|NCT05054361|Mannitol|mannitol|mesh-list
19362062|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362063|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19687934|NCT05054361|Lactulose|lactulose|mesh-list
20395784|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20395785|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20395786|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
20395787|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395788|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395789|NCT01104935|Trastuzumab|trastuzumab|mesh-list
19362064|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19362065|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20395790|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362066|NCT02668770|Ipilimumab|ipilimumab|mesh-list
19845279|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
19362067|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362068|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362069|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19362070|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362071|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
19362072|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19362073|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
19362074|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362075|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362076|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362077|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
19362078|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19362079|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
19362080|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362081|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362082|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19362083|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
19362084|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
19362085|NCT02652429|Protective Agents|protective agents|mesh-ancestor
19362086|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
19362087|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362088|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
19362089|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362090|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362091|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20613028|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613029|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
19362092|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
19362093|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362094|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362095|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19362096|NCT02649764|Cytarabine|cytarabine|mesh-list
19362097|NCT02649764|Fludarabine|fludarabine|mesh-list
19362098|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
19362099|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362100|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19362101|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
19362102|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362103|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362104|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
19362105|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362106|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
19362107|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362108|NCT02629419|Amphotericin B|amphotericin b|mesh-list
19362109|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19362110|NCT02629419|Amebicides|amebicides|mesh-ancestor
19362111|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19362112|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19362113|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362114|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19362115|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
19362116|NCT02596503|Cefixime|cefixime|mesh-list
19362117|NCT02596503|Irinotecan|irinotecan|mesh-list
19362118|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19362119|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19362120|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613030|NCT02253810|Coagulants|coagulants|mesh-ancestor
20613031|NCT02253836|Ritonavir|ritonavir|mesh-list
20613032|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20613033|NCT02253836|Tipranavir|tipranavir|mesh-list
20613034|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19362121|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395791|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395792|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20395793|NCT01104987|Alendronate|alendronate|mesh-list
20395794|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395795|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395796|NCT01105013|Clotrimazole|clotrimazole|mesh-list
20395797|NCT01105013|Miconazole|miconazole|mesh-list
20395798|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20395799|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845280|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362122|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395800|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
20613035|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613036|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
20395801|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20395802|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20395803|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395804|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395805|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20395806|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
20395807|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395808|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395809|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20395810|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20395811|NCT01105208|Cephalexin|cephalexin|mesh-list
20395812|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20395813|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395814|NCT01105234|Vitamin D|vitamin d|mesh-list
20395815|NCT01105234|Calcipotriene|calcipotriene|mesh-list
20395816|NCT01105234|Vitamins|vitamins|mesh-ancestor
20395817|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
20395818|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395819|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395820|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
20395821|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
20395822|NCT01105273|Fludarabine|fludarabine|mesh-list
20395823|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20395824|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20395825|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
20395826|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395827|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395828|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20395829|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
20395830|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395831|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395832|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20395833|NCT01105286|Vitamin D|vitamin d|mesh-list
20395834|NCT01105286|Calcipotriene|calcipotriene|mesh-list
20395835|NCT01105286|Vitamins|vitamins|mesh-ancestor
20395836|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
20395837|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395838|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395839|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
20395840|NCT01105299|Anastrozole|anastrozole|mesh-list
20395841|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20395842|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395843|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20395844|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20395845|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395846|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395847|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20395848|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
20395849|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395850|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395851|NCT01105338|Lycopene|lycopene|mesh-list
20395852|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395853|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
20395854|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395855|NCT01105338|Protective Agents|protective agents|mesh-ancestor
20395856|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687935|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19687936|NCT05054361|Diuretics|diuretics|mesh-ancestor
19687937|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
19687938|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687939|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19687940|NCT05054114|Interferons|interferons|mesh-list
19687941|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
19687942|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687943|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
19687944|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19687945|NCT05054023|Piroxicam|piroxicam|mesh-list
19687946|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19687947|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19687948|NCT05054023|Analgesics|analgesics|mesh-ancestor
19687949|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
19687950|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687951|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687952|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19687953|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19687954|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19687955|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687956|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687957|NCT05053854|Talazoparib|talazoparib|mesh-list
19687958|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19687959|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687960|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362123|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19362124|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362125|NCT02581215|Ramucirumab|ramucirumab|mesh-list
20395857|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20395858|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20395859|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845281|NCT00670267|Nadolol|nadolol|mesh-list
19845282|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19845283|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19845284|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
19845285|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845286|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845287|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845288|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20395860|NCT01105351|Folic Acid|folic acid|mesh-list
20395861|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
20395862|NCT01105351|Hematinics|hematinics|mesh-ancestor
19362126|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362127|NCT02554253|Ketamine|ketamine|mesh-list
19362128|NCT02554253|Propofol|propofol|mesh-list
19362129|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19362130|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845289|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19845290|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
20395863|NCT01105351|Vitamins|vitamins|mesh-ancestor
20395864|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
20395865|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209318|NCT00279734|Abatacept|abatacept|mesh-list
20209319|NCT00279734|Vaccines|vaccines|mesh-list
20395866|NCT01105390|Pemetrexed|pemetrexed|mesh-list
20395867|NCT01105390|Rilotumumab|rilotumumab|mesh-list
19845291|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
19845292|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362131|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362132|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19362133|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
19845293|NCT00670306|Cetrorelix|cetrorelix|mesh-list
19845294|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19845295|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
19845296|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845297|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845298|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
19845299|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845300|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19845301|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19845302|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845303|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845304|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
19845305|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845306|NCT00670748|Aldesleukin|aldesleukin|mesh-list
19845307|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
19845308|NCT00670748|Fludarabine|fludarabine|mesh-list
20209320|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
20209321|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209322|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20209323|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209324|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209325|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209326|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209327|NCT00279747|Naproxen|naproxen|mesh-list
20209328|NCT00279747|Meloxicam|meloxicam|mesh-list
20209329|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20209330|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20209331|NCT00279747|Analgesics|analgesics|mesh-ancestor
20209332|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
20209333|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395868|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20395869|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395870|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362134|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
19362135|NCT02554253|Analgesics|analgesics|mesh-ancestor
19362136|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
19362137|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362138|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19362139|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20395871|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395872|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20395873|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19362140|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19362141|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362142|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362143|NCT02535091|Cenobamate|cenobamate|mesh-list
19362144|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
19362145|NCT02513563|Paclitaxel|paclitaxel|mesh-list
19362146|NCT02513563|Carboplatin|carboplatin|mesh-list
19362147|NCT02513563|Adavosertib|adavosertib|mesh-list
19362148|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19362149|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687961|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687962|NCT05053633|Anesthetics|anesthetics|mesh-list
19687963|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19687964|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687965|NCT05053750|Paclitaxel|paclitaxel|mesh-list
19687966|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19687967|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19687968|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19687969|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
19687970|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
19687971|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19687972|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687973|NCT05053594|Neostigmine|neostigmine|mesh-list
19687974|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19687975|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19687976|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362150|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
19362151|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
19362152|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
19687977|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
19687978|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19687979|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19687980|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19687981|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
19687982|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687983|NCT05053893|Valsartan|valsartan|mesh-list
20395874|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845309|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
20395875|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
20395876|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395877|NCT01105481|Amisulpride|amisulpride|mesh-list
20395878|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20395879|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20395880|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395881|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395882|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19362153|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362154|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362155|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
19362156|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19362157|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362158|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362159|NCT02441686|Dexamethasone|dexamethasone|mesh-list
19362160|NCT02441686|Lenalidomide|lenalidomide|mesh-list
19362161|NCT02441686|Bortezomib|bortezomib|mesh-list
19362162|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19692911|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395883|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20395884|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
20395885|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395886|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362163|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
19362164|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
19362165|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362166|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613037|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362167|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19362168|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
19362169|NCT02441686|Hormones|hormones|mesh-ancestor
19362170|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20209334|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209335|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20209336|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209337|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
20209338|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20209339|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362171|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19362172|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362173|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
19362174|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19362175|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19362176|NCT02441686|Growth Substances|growth substances|mesh-ancestor
19362177|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
19362178|NCT02382406|Paclitaxel|paclitaxel|mesh-list
19362179|NCT02382406|Carboplatin|carboplatin|mesh-list
19362180|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
19845310|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845311|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
19362181|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19362182|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362183|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
19362184|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
19362185|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
19362186|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362187|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362188|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
19362189|NCT02308527|Temozolomide|temozolomide|mesh-list
19362190|NCT02308527|Bevacizumab|bevacizumab|mesh-list
19362191|NCT02308527|Irinotecan|irinotecan|mesh-list
19362192|NCT02308527|Topotecan|topotecan|mesh-list
19362193|NCT02308527|Dinutuximab|dinutuximab|mesh-list
19362194|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362195|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
19362196|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362197|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362198|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19362199|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
19362200|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687984|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19687985|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19687986|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19687987|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19687988|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362201|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362202|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19362203|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362204|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19362205|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19362206|NCT02308527|Growth Substances|growth substances|mesh-ancestor
19362207|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
19362208|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19362209|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19362210|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362211|NCT02121184|Oxytocin|oxytocin|mesh-list
19362212|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
19362213|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19362214|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362215|NCT01972919|Gemcitabine|gemcitabine|mesh-list
19362216|NCT01972919|Capecitabine|capecitabine|mesh-list
19362217|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19687989|NCT05053841|Metformin|metformin|mesh-list
19687990|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19687991|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845312|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845313|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209340|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209341|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20209342|NCT00279760|Abatacept|abatacept|mesh-list
19362218|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
19362219|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362220|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362221|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
19362222|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362223|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362224|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362225|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
19362226|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362227|NCT01524536|Prednisone|prednisone|mesh-list
19362228|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362229|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
19362230|NCT01524536|Hormones|hormones|mesh-ancestor
19362231|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362232|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362233|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19362234|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362235|NCT01485874|Doxorubicin|doxorubicin|mesh-list
19362236|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19362237|NCT01485874|Nintedanib|nintedanib|mesh-list
19362238|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19362239|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362240|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19362241|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19362242|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362243|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362244|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20209343|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20395887|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20395888|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
20395889|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
20395890|NCT01105494|Hematinics|hematinics|mesh-ancestor
20395891|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20395892|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20395893|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
19362245|NCT01424982|Cytarabine|cytarabine|mesh-list
19362246|NCT01424982|Dexamethasone|dexamethasone|mesh-list
19362247|NCT01424982|Prednisone|prednisone|mesh-list
19362248|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
19362249|NCT01424982|Cortisone|cortisone|mesh-list
19362250|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
19362251|NCT01424982|Rituximab|rituximab|mesh-list
19362252|NCT01424982|Doxorubicin|doxorubicin|mesh-list
19362253|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19362254|NCT01424982|Methotrexate|methotrexate|mesh-list
19362255|NCT01424982|Vincristine|vincristine|mesh-list
19362256|NCT01424982|Daunorubicin|daunorubicin|mesh-list
19362257|NCT01424982|Ponatinib|ponatinib|mesh-list
19362258|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19362259|NCT01424982|Antibodies|antibodies|mesh-list
19362260|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
19362261|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19362262|NCT01424982|BB 1101|bb 1101|mesh-list
19362263|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362264|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
19362265|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362266|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362267|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19362268|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
19362269|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362270|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362271|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19362272|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362273|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
19362274|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
20209344|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209345|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209346|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209347|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
20209348|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209349|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209350|NCT00279825|Levodopa|levodopa|mesh-list
20209351|NCT00279825|Carbidopa|carbidopa|mesh-list
19362275|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362276|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19362277|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
20209352|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20613217|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19362278|NCT01424982|Hormones|hormones|mesh-ancestor
19362279|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362280|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19362281|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19362282|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19362283|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19362284|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362285|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19362286|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
19362287|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19362288|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19362289|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
19362290|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362291|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20395894|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395895|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20395896|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395897|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20395898|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395899|NCT01105611|Ritonavir|ritonavir|mesh-list
20395900|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20395901|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
20395902|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20395903|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20395904|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
20209353|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20209354|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20209355|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
20209356|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209357|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687992|NCT05053503|Lofexidine|lofexidine|mesh-list
19687993|NCT05053503|Naltrexone|naltrexone|mesh-list
19687994|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20395905|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395906|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362292|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19362293|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
19362294|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362295|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19362296|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19362297|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
19362298|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
19362299|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
20395907|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20395908|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20395909|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
20395910|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20395911|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19362300|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19362301|NCT01307046|Losartan|losartan|mesh-list
19362302|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362303|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362304|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362305|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362306|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362307|NCT01307033|Losartan|losartan|mesh-list
19362308|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362309|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362310|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362311|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362312|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362313|NCT01041807|Losartan|losartan|mesh-list
19362314|NCT01041807|Amlodipine|amlodipine|mesh-list
19362315|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362316|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19362317|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362318|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19687995|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19687996|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209358|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209359|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20209360|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209361|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20395912|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20395913|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19362319|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19362320|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362321|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
19362322|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362323|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362324|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362325|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20395914|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20395915|NCT01105793|Danazol|danazol|mesh-list
20395916|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20395917|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
19362326|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362327|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19362328|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362329|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401851|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19401852|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19401853|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19401854|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
19401855|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401856|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395918|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20395919|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401857|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209362|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
20209363|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
19401858|NCT03614052|Urological Agents|urological agents|mesh-ancestor
19401859|NCT03613974|Lidocaine|lidocaine|mesh-list
19401860|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
19401861|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
19401862|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401863|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401864|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
19401865|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401866|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401867|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19401868|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19401869|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401870|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401871|NCT03613961|Anesthetics|anesthetics|mesh-list
19401872|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401873|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401874|NCT03613857|Clopidogrel|clopidogrel|mesh-list
19401875|NCT03613857|Ticagrelor|ticagrelor|mesh-list
19401876|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19687997|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
19687998|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19687999|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19688000|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19688001|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19688002|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19688003|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19688004|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688005|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692912|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692913|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19692914|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
19692915|NCT04985344|Propranolol|propranolol|mesh-list
20209364|NCT00279903|Cortisone|cortisone|mesh-list
20209365|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
20209366|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20209367|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20209368|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20209369|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20209370|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209371|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
20209372|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209373|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209374|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20209375|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209376|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395920|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
20395921|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20395922|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362330|NCT00739674|Losartan|losartan|mesh-list
19362331|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19362332|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
19362333|NCT00739674|Calcium|calcium|mesh-list
19362334|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19362335|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362336|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362337|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362338|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362339|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362340|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395923|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
20395924|NCT01105832|Teriparatide|teriparatide|mesh-list
20395925|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20395926|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395927|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20395928|NCT01105871|Naloxone|naloxone|mesh-list
20395929|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20395930|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395931|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
20395932|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395933|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20395934|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
20395935|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20395936|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
20395937|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
20395938|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
20395939|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20395940|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395941|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
20395942|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362341|NCT00739674|Diuretics|diuretics|mesh-ancestor
19362342|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362343|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19362344|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362345|NCT00731757|Adalimumab|adalimumab|mesh-list
19362346|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20395943|NCT01106053|Pramipexole|pramipexole|mesh-list
20395944|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
20395945|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395946|NCT01106053|Protective Agents|protective agents|mesh-ancestor
20395947|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395948|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20395949|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20395950|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
20395951|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
20395952|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20395953|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
20395954|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395955|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20395956|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
20395957|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20395958|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20395959|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362347|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362348|NCT00730717|Adalimumab|adalimumab|mesh-list
19362349|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362350|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362351|NCT00546754|Losartan|losartan|mesh-list
19362352|NCT00546754|Valsartan|valsartan|mesh-list
19362353|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19688006|NCT05053009|Ibuprofen|ibuprofen|mesh-list
20395960|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395961|NCT01106118|Urological Agents|urological agents|mesh-ancestor
20395962|NCT01106131|Pioglitazone|pioglitazone|mesh-list
20395963|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20395964|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362354|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362355|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19688007|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20395965|NCT01106235|Aldesleukin|aldesleukin|mesh-list
20395966|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
20395967|NCT01106235|Interleukin-2|interleukin-2|mesh-list
19688008|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19688009|NCT05053009|Analgesics|analgesics|mesh-ancestor
19688010|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
20395968|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20395969|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
20395970|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20395971|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20395972|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20395973|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
20395974|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395975|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395976|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20395977|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19362356|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362357|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362358|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362359|NCT00546754|Diuretics|diuretics|mesh-ancestor
19688011|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688012|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688013|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688014|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19688015|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19688016|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688017|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688018|NCT05053386|Epirubicin|epirubicin|mesh-list
19688019|NCT05053386|Idarubicin|idarubicin|mesh-list
19688020|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19362360|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362361|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688021|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688022|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19688023|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19688024|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688025|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688026|NCT05052879|Tadalafil|tadalafil|mesh-list
19688027|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
19688028|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19688029|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19688030|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688031|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688032|NCT05052879|Urological Agents|urological agents|mesh-ancestor
19688033|NCT05052515|Ascorbic Acid|ascorbic acid|mesh-list
19688034|NCT05052515|Choline|choline|mesh-list
19688035|NCT05052515|Vitamins|vitamins|mesh-ancestor
19688036|NCT05052515|Micronutrients|micronutrients|mesh-ancestor
19688037|NCT05052515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688038|NCT05052515|Antioxidants|antioxidants|mesh-ancestor
19688039|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688040|NCT05052515|Protective Agents|protective agents|mesh-ancestor
19688041|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
19688042|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19688043|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
19688044|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688045|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19688046|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
19688047|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19688048|NCT05052619|Cefmetazole|cefmetazole|mesh-list
19688049|NCT05052619|Sulperazone|sulperazone|mesh-list
19845314|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19845315|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
19845316|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845317|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845318|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19845319|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20395978|NCT01106235|Analgesics|analgesics|mesh-ancestor
20395979|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
19362362|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19362363|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20395980|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20395981|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20395982|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19688050|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688051|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19688052|NCT05052619|Renal Agents|renal agents|mesh-ancestor
20395983|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
20395984|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426751|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426752|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426753|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
20426754|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20426755|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20426756|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20426757|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426758|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426759|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
20426760|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426761|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426762|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20426763|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426764|NCT01282619|Huperzine A|huperzine a|mesh-list
20426765|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20426766|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426767|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426768|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
20426769|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426770|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426771|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20426772|NCT01282619|Protective Agents|protective agents|mesh-ancestor
20426773|NCT01282632|Olanzapine|olanzapine|mesh-list
20426774|NCT01282632|Risperidone|risperidone|mesh-list
20426775|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20426776|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
20426777|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426778|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426779|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426780|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20426781|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20426782|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426783|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20426784|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20426785|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
20426786|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
20426787|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
19362364|NCT00480805|Losartan|losartan|mesh-list
19362365|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19362366|NCT00480805|Ramipril|ramipril|mesh-list
19362367|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20426788|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426789|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426790|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20426791|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20426792|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426793|NCT01282697|Sirolimus|sirolimus|mesh-list
20426794|NCT01282697|Irinotecan|irinotecan|mesh-list
20426795|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19362368|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362369|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19688053|NCT05052931|Paclitaxel|paclitaxel|mesh-list
19688054|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
19688055|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209377|NCT00280007|Bevacizumab|bevacizumab|mesh-list
20209378|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20209379|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209380|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20209381|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20209382|NCT00280007|Growth Substances|growth substances|mesh-ancestor
20209383|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209384|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
20209385|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20209386|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20209387|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
20209388|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209389|NCT00280033|Antacids|antacids|mesh-ancestor
20209390|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209391|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20209392|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
20209393|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
20426796|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19688056|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20395985|NCT01106495|Simvastatin|simvastatin|mesh-list
20395986|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20395987|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20395988|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
20395989|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395990|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20395991|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362370|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362371|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362372|NCT00480805|Diuretics|diuretics|mesh-ancestor
19362373|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362374|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362375|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19362376|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19845320|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
19845321|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19845322|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19845323|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
19362377|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19362378|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
19362379|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362380|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19362381|NCT00479713|Simvastatin|simvastatin|mesh-list
19362382|NCT00479713|Ezetimibe|ezetimibe|mesh-list
19362383|NCT00479713|Calcium|calcium|mesh-list
19362384|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19362385|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362386|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20395992|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20395993|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
20395994|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20395995|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20395996|NCT01106547|Prednisolone|prednisolone|mesh-list
20395997|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
19362387|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362388|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
19362389|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362390|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362391|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362392|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362393|NCT00457275|Ezetimibe|ezetimibe|mesh-list
19362394|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362395|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362396|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
19362397|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362398|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362399|NCT00449111|Losartan|losartan|mesh-list
19362400|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362401|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362402|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362403|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362404|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20395998|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20395999|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
20396000|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396001|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
19362405|NCT00406783|Desloratadine|desloratadine|mesh-list
19362406|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19362407|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
19845324|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209394|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20209395|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209396|NCT00280098|Docetaxel|docetaxel|mesh-list
20209397|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209398|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209399|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209400|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209401|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209402|NCT00280176|Fluorouracil|fluorouracil|mesh-list
20209403|NCT00280176|Bortezomib|bortezomib|mesh-list
20209404|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
20209405|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209406|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20396002|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
20396003|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209407|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209408|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209409|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
20209410|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209411|NCT00280215|Losartan|losartan|mesh-list
20209412|NCT00280215|Lisinopril|lisinopril|mesh-list
19362408|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362409|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209413|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20209414|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20209415|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20209416|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20209417|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20209418|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362410|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362411|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20209419|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396004|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396005|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20396006|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
20396007|NCT01106547|Hormones|hormones|mesh-ancestor
20396008|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20396009|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20396010|NCT01106547|Protective Agents|protective agents|mesh-ancestor
20396011|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20396012|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396013|NCT01106716|Lidocaine|lidocaine|mesh-list
20396014|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
20396015|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
20396016|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396017|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396018|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
20396019|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362412|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19362413|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
19362414|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
19362415|NCT00405964|Desloratadine|desloratadine|mesh-list
19362416|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19362417|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
19362418|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362419|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362420|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362421|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19362422|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19362423|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
20209420|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
20209421|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20209422|NCT00280215|Protective Agents|protective agents|mesh-ancestor
20209423|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209424|NCT00280267|Testosterone|testosterone|mesh-list
19362424|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
19362425|NCT00400218|Losartan|losartan|mesh-list
19362426|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19362427|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362428|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362429|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20209425|NCT00280267|Androgens|androgens|mesh-ancestor
20209426|NCT00280267|Hormones|hormones|mesh-ancestor
20209427|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20209428|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209429|NCT00280280|Baclofen|baclofen|mesh-list
20209430|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20209431|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209432|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20209433|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209434|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20209435|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
20209436|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
20209437|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396020|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20426797|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209438|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209439|NCT00280358|Fluticasone|fluticasone|mesh-list
19362430|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362431|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362432|NCT00400218|Diuretics|diuretics|mesh-ancestor
19362433|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362434|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362435|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19362436|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362437|NCT00398541|Losartan|losartan|mesh-list
19362438|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19362439|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362440|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362441|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19688057|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
19688058|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
19362442|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362443|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362444|NCT00398541|Diuretics|diuretics|mesh-ancestor
19362445|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362446|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362447|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19362448|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362449|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
19362450|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
19362451|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19362452|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
19362453|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362454|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362455|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362456|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
19362457|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20209440|NCT00280358|Xhance|xhance|mesh-list
20613218|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
19362458|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19362459|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19362460|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
19362461|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362462|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362463|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362464|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362465|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19688059|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19688060|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688061|NCT05052437|Capecitabine|capecitabine|mesh-list
19688062|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19688063|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
19688064|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209441|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
20209442|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20209443|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20209444|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
20209445|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209446|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209447|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20209448|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209449|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
20209450|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20209451|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20209452|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20209453|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20209454|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
20209455|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209456|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209457|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
20209458|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20209459|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
20209460|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209461|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209462|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20209463|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209464|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20209465|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19362466|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
19362467|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
19362468|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20396021|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20396022|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20396023|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20396024|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396025|NCT01106872|Gemcitabine|gemcitabine|mesh-list
19362469|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
19362470|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362471|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688065|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688066|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
19688067|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19688068|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688069|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
20396026|NCT01106872|Bevacizumab|bevacizumab|mesh-list
20209466|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20209467|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
20209468|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209469|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209470|NCT00280423|Casopitant|casopitant|mesh-list
20209471|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
20209472|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
20209473|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688070|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
19688071|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19688072|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
19688073|NCT05052814|Calcium|calcium|mesh-list
19688074|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19845325|NCT00670774|Eculizumab|eculizumab|mesh-list
19845326|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19845327|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845328|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
19845329|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845330|NCT00670800|Metformin|metformin|mesh-list
19362472|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20209474|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396027|NCT01106872|Docetaxel|docetaxel|mesh-list
20396028|NCT01106872|Valproic Acid|valproic acid|mesh-list
20396029|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20396030|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362473|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
19362474|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19362475|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19362476|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20396031|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20396032|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20396033|NCT01106872|Growth Substances|growth substances|mesh-ancestor
20396034|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396035|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
20396036|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20396037|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
20396038|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396039|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
20396040|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396041|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688075|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845331|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20396042|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396043|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
20396044|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396045|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396046|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396047|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
20396048|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
20396049|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396050|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
20396051|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20396052|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396053|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19362477|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
19688076|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19845332|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362478|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396054|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
19362479|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362480|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362481|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362482|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19362483|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
19362484|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
19362485|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19362486|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
19362487|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362488|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362489|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362490|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
20396055|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396056|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396057|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20396058|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20396059|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396060|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396061|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396062|NCT01107067|Testosterone|testosterone|mesh-list
19362491|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19362492|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19362493|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19362494|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
19362495|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362496|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362497|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362498|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362499|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19362500|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
19362501|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
20396063|NCT01107067|Androgens|androgens|mesh-ancestor
19362502|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19362503|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
19362504|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362505|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396064|NCT01107067|Hormones|hormones|mesh-ancestor
20396065|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20396066|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362506|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362507|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
19362508|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19362509|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19362510|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19362511|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
19362512|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362513|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362514|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362515|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362516|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19362517|NCT00379288|Fluticasone|fluticasone|mesh-list
19362518|NCT00379288|Xhance|xhance|mesh-list
19362519|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
19362520|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19362521|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19362522|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362523|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19362524|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
19362525|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362526|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362527|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362528|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209475|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20209476|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20209477|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209478|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209479|NCT00280436|Casopitant|casopitant|mesh-list
20209480|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
20209481|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
20209482|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209483|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209484|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217860|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19362529|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
19688077|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688078|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
19688079|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
19688080|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
19688081|NCT05052008|Erenumab|erenumab|mesh-list
20396067|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
20396068|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20396069|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
20396070|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20396071|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396072|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20396073|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
20396074|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20396075|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
20396076|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20396077|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396078|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20396079|NCT01107145|Artesunate|artesunate|mesh-list
19688082|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20396080|NCT01107145|Chloroquine|chloroquine|mesh-list
19362530|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19362531|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19362532|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19362533|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19362534|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
19362535|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362536|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362537|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
19362538|NCT00379288|Hormones|hormones|mesh-ancestor
19362539|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362540|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
19362541|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
19362542|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362543|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362544|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19362545|NCT00338260|Atenolol|atenolol|mesh-list
19362546|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
19362547|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362548|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362549|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362550|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
19362551|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362552|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362553|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362554|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
19362555|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19362556|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19362557|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19362558|NCT00308347|Losartan|losartan|mesh-list
19362559|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362560|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362561|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362562|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362563|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362564|NCT00307060|Losartan|losartan|mesh-list
19362565|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19362566|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362567|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362568|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362569|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362570|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362571|NCT00307060|Diuretics|diuretics|mesh-ancestor
19362572|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362573|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362574|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19362575|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362576|NCT00157963|Losartan|losartan|mesh-list
19362577|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19362578|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19688083|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396081|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19688084|NCT05052008|Analgesics|analgesics|mesh-ancestor
20396082|NCT01107145|Lumefantrine|lumefantrine|mesh-list
19362579|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362580|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362581|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362582|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362583|NCT00157963|Diuretics|diuretics|mesh-ancestor
19362584|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362585|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362586|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19362587|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362588|NCT00151424|Olanzapine|olanzapine|mesh-list
19362589|NCT00151424|Asenapine|asenapine|mesh-list
19362590|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
19362591|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
19362592|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209485|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20209486|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209487|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209488|NCT00280462|Nifedipine|nifedipine|mesh-list
20209489|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20209490|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20209491|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209492|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20209493|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362593|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362594|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19362595|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19362596|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19362597|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19362598|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19845333|NCT00670930|Omalizumab|omalizumab|mesh-list
19845334|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19845335|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19845336|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
19845337|NCT00670956|Betamethasone|betamethasone|mesh-list
19845338|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845339|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
19845340|NCT00670956|Hormones|hormones|mesh-ancestor
19845341|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845342|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845343|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20209494|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
20209495|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
20209496|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20209497|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20209498|NCT00280501|Sulpiride|sulpiride|mesh-list
20209499|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
20209500|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20209501|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20209502|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20209503|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209504|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209505|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20209506|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
20209507|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209508|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209509|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20209510|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
20209511|NCT00280514|Cefpirome|cefpirome|mesh-list
20209512|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20209513|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209514|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20209515|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20209516|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209517|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209518|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209519|NCT00280540|Valsartan|valsartan|mesh-list
20209520|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20209521|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20209522|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20209523|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20217861|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19845344|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
19845345|NCT00670982|Bevacizumab|bevacizumab|mesh-list
20396083|NCT01107145|Artemether|artemether|mesh-list
19845346|NCT00670982|Trastuzumab|trastuzumab|mesh-list
20209524|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209525|NCT00280540|Diuretics|diuretics|mesh-ancestor
20209526|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
20209527|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209528|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20209529|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20209530|NCT00280553|Bupivacaine|bupivacaine|mesh-list
20209531|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
20209532|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
20209533|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845347|NCT00670982|Vinorelbine|vinorelbine|mesh-list
20209534|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362599|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19362600|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19362601|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362602|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362603|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396084|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20396085|NCT01107145|Mefloquine|mefloquine|mesh-list
20396086|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
20396087|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20396088|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20396089|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396090|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396091|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
20396092|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
20396093|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20396094|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
20396095|NCT01107145|Amebicides|amebicides|mesh-ancestor
20396096|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396097|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19362604|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
19362605|NCT00092690|Atorvastatin|atorvastatin|mesh-list
19362606|NCT00092690|Simvastatin|simvastatin|mesh-list
20396098|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20396099|NCT01107145|Analgesics|analgesics|mesh-ancestor
19688085|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
19688086|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362607|NCT00092690|Ezetimibe|ezetimibe|mesh-list
19362608|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362609|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362610|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
19362611|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362612|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362613|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362614|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362615|NCT00092664|Simvastatin|simvastatin|mesh-list
19362616|NCT00092664|Ezetimibe|ezetimibe|mesh-list
19362617|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362618|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19688087|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688088|NCT05052359|Lectins|lectins|mesh-list
19688089|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
19688090|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
19362619|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
19362620|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362621|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362622|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362623|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362624|NCT00092651|Simvastatin|simvastatin|mesh-list
19688091|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688092|NCT05052359|Coagulants|coagulants|mesh-ancestor
19688093|NCT05051956|Palbociclib|palbociclib|mesh-list
19688094|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688095|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19688096|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688097|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396100|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
19688098|NCT05051007|Lidocaine|lidocaine|mesh-list
19688099|NCT05051007|Fentanyl|fentanyl|mesh-list
19688100|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19362625|NCT00092651|Ezetimibe|ezetimibe|mesh-list
19688101|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
19688102|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396101|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396102|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362626|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19362627|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362628|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362629|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
19362630|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362631|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362632|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362633|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362634|NCT00092638|Ezetimibe|ezetimibe|mesh-list
19362635|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362636|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362637|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
19362638|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362639|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362640|NCT00092625|Ezetimibe|ezetimibe|mesh-list
19362641|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362642|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362643|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
19362644|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362645|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362646|NCT00092612|Ezetimibe|ezetimibe|mesh-list
19362647|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362648|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362649|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
19362650|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362651|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362652|NCT00092599|Ezetimibe|ezetimibe|mesh-list
19362653|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362654|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362655|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
19362656|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362657|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362658|NCT00092586|Ezetimibe|ezetimibe|mesh-list
19362659|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362660|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362661|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
19362662|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396103|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396104|NCT01107145|Filaricides|filaricides|mesh-ancestor
20396105|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
20396106|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20396107|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20396108|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396109|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
20396110|NCT01107236|Naproxen|naproxen|mesh-list
20396111|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20396112|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20396113|NCT01107236|Analgesics|analgesics|mesh-ancestor
20396114|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
20396115|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396116|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396117|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396118|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396119|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
20396120|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20396121|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396122|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396123|NCT01107431|Chromium|chromium|mesh-list
20396124|NCT01107431|Trace Elements|trace elements|mesh-ancestor
20396125|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
20396126|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396127|NCT01107509|Everolimus|everolimus|mesh-list
20396128|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396129|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396130|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
20396131|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396132|NCT01107522|Temozolomide|temozolomide|mesh-list
20396133|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20396134|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
20396135|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396136|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396137|NCT01107574|Gabapentin|gabapentin|mesh-list
20396138|NCT01107574|Analgesics|analgesics|mesh-ancestor
20396139|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
20396140|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396141|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396142|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
20396143|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20396144|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19845348|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845349|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396145|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396146|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20396147|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20396148|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20396149|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362663|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362664|NCT00092573|Ezetimibe|ezetimibe|mesh-list
19845350|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845351|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19845352|NCT00670982|Growth Substances|growth substances|mesh-ancestor
19845353|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845354|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845355|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19362665|NCT00092573|Fenofibrate|fenofibrate|mesh-list
19362666|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362667|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362668|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
19362669|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362670|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362671|NCT00092560|Ezetimibe|ezetimibe|mesh-list
19362672|NCT00092560|Fenofibrate|fenofibrate|mesh-list
19362673|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362674|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362675|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
19362676|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362677|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362678|NCT00092209|Losartan|losartan|mesh-list
19362679|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19362680|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362681|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362682|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19362683|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19688103|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688104|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
19688105|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688106|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19688107|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19688108|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19688109|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688110|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688111|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19688112|NCT05051007|Narcotics|narcotics|mesh-ancestor
19688113|NCT05051007|Analgesics|analgesics|mesh-ancestor
19688114|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19688115|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19688116|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
19688117|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
19688118|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
19688119|NCT05051137|Infliximab|infliximab|mesh-list
19688120|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
19688121|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19688122|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19688123|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688124|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688125|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688126|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209535|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
20209536|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209537|NCT00280605|Alfuzosin|alfuzosin|mesh-list
20209538|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20209539|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20209540|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20209541|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
20209542|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209543|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209544|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688127|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362684|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362685|NCT00092209|Diuretics|diuretics|mesh-ancestor
19362686|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
19362687|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362688|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20209545|NCT00280605|Urological Agents|urological agents|mesh-ancestor
20209546|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
20209547|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688128|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688129|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19688130|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19688131|NCT05051137|Analgesics|analgesics|mesh-ancestor
19688132|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
19688133|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613038|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613039|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20396150|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396151|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
20209548|NCT00280644|Leflunomide|leflunomide|mesh-list
20209549|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209550|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396152|NCT01107639|Docetaxel|docetaxel|mesh-list
20396153|NCT01107639|Cetuximab|cetuximab|mesh-list
20396154|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396155|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
20613040|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613041|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
20613042|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362689|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19362690|NCT00092157|Simvastatin|simvastatin|mesh-list
19362691|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19688134|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396156|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396157|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396158|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396159|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20396160|NCT01107756|Lenograstim|lenograstim|mesh-list
20396161|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20396162|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
20396163|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396164|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
20396165|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
20396166|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20396167|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20396168|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396169|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396170|NCT01107782|Urological Agents|urological agents|mesh-ancestor
20396171|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
20396172|NCT01107808|Vitamin D|vitamin d|mesh-list
20396173|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
20396174|NCT01107808|Metformin|metformin|mesh-list
20396175|NCT01107808|Calcium|calcium|mesh-list
20396176|NCT01107808|Vitamins|vitamins|mesh-ancestor
20396177|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
20396178|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396179|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20396180|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19688135|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20209551|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209552|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
20209553|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209554|NCT00280696|Levetiracetam|levetiracetam|mesh-list
20209555|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
20209556|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
20209557|NCT00280774|Memantine|memantine|mesh-list
20209558|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20209559|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20209560|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
20209561|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209562|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209563|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209564|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20209565|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20613043|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19688136|NCT05051163|Gentamicins|gentamicins|mesh-list
20396181|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20396182|NCT01107938|Esomeprazole|esomeprazole|mesh-list
20396183|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20396184|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20396185|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20396186|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396187|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362692|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362693|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
19362694|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362695|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362696|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362697|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362698|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19362699|NCT00090298|Simvastatin|simvastatin|mesh-list
19362700|NCT00090298|Ezetimibe|ezetimibe|mesh-list
19362701|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19362702|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362703|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
19362704|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362705|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362706|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362707|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362708|NCT00090181|Diclofenac|diclofenac|mesh-list
19362709|NCT00090181|Etoricoxib|etoricoxib|mesh-list
19362710|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19362711|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19362712|NCT00090181|Analgesics|analgesics|mesh-ancestor
19362713|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
19362714|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362715|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362716|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362717|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362718|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19362719|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362720|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362721|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19688137|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
20613044|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613045|NCT02253849|Ritonavir|ritonavir|mesh-list
20613046|NCT02253849|Tipranavir|tipranavir|mesh-list
20613047|NCT02253849|Carbamazepine|carbamazepine|mesh-list
20613048|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613049|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19688138|NCT05051163|Ampicillin|ampicillin|mesh-list
19688139|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19688140|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688141|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19688142|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688143|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396188|NCT01107951|Dexamethasone|dexamethasone|mesh-list
20396189|NCT01107951|Rituximab|rituximab|mesh-list
20396190|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19688144|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19688145|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19688146|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19688147|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20396191|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396192|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
20396193|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396194|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396195|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688148|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688149|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688150|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396196|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
20396197|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
20396198|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396199|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20396200|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
20396201|NCT01107951|Hormones|hormones|mesh-ancestor
20613050|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613051|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613219|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19362722|NCT00090168|Atorvastatin|atorvastatin|mesh-list
19688151|NCT05050656|Analgesics|analgesics|mesh-ancestor
19688152|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
19688153|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688154|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
19688155|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19688156|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
19688157|NCT05050604|Choline|choline|mesh-list
19688158|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
19362723|NCT00090168|Simvastatin|simvastatin|mesh-list
19362724|NCT00090168|Ezetimibe|ezetimibe|mesh-list
19362725|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19688159|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19688160|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
19688161|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688162|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688163|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19688164|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
19692916|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19692917|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19692918|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
19692919|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692920|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692921|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692922|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19692923|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362726|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19362727|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
19362728|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362729|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19362730|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19362731|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362732|NCT00089895|Eptifibatide|eptifibatide|mesh-list
19362733|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19362734|NCT02765854|Dexamethasone|dexamethasone|mesh-list
19362735|NCT02765854|Lenalidomide|lenalidomide|mesh-list
19362736|NCT02765854|Ixazomib|ixazomib|mesh-list
19362737|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362738|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
19362739|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
19362740|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362741|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362742|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19362743|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
19362744|NCT02765854|Hormones|hormones|mesh-ancestor
19362745|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362746|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19845356|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19845357|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396202|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362747|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362748|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
19362749|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19362750|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19362751|NCT02765854|Growth Substances|growth substances|mesh-ancestor
19362752|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
19362753|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362754|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
19362755|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362756|NCT02761057|Sunitinib|sunitinib|mesh-list
19362757|NCT02761057|Crizotinib|crizotinib|mesh-list
19362758|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362759|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19362760|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20396203|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20396204|NCT01108029|Memantine|memantine|mesh-list
19362761|NCT02761057|Growth Substances|growth substances|mesh-ancestor
19362762|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362763|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
19692924|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
19692925|NCT04985526|Octenidine|octenidine|mesh-list
19692926|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362764|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19362765|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692927|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19692928|NCT04985669|Prucalopride|prucalopride|mesh-list
19692929|NCT04985669|Laxatives|laxatives|mesh-ancestor
19362766|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688165|NCT05050357|Norethindrone|norethindrone|mesh-list
19688166|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
19688167|NCT05050357|Progestins|progestins|mesh-list
19688168|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19688169|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19688170|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19688171|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
19688172|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19688173|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688174|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19688175|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19688176|NCT05050357|Hormones|hormones|mesh-ancestor
19688177|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688178|NCT05050188|Lansoprazole|lansoprazole|mesh-list
19688179|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
19688180|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19688181|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688182|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19688183|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688184|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688185|NCT05050305|Dexamethasone|dexamethasone|mesh-list
19688186|NCT05050305|Pomalidomide|pomalidomide|mesh-list
19688187|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688188|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
19688189|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
19362767|NCT02750540|Tenofovir|tenofovir|mesh-list
19362768|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
19362769|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362770|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19362771|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19362772|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362773|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362774|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19362775|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19362776|NCT02520791|Antibodies|antibodies|mesh-list
19362777|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20396205|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20396206|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20396207|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
20396208|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396209|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362778|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
19362779|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362780|NCT02474173|Paclitaxel|paclitaxel|mesh-list
19362781|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19362782|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19362783|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362784|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
19362785|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
19362786|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
19362787|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362788|NCT02207504|Crizotinib|crizotinib|mesh-list
19362789|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362790|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19362791|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362792|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362793|NCT02196961|Nivolumab|nivolumab|mesh-list
19362794|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362795|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362796|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19362797|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362798|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
19362799|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19362800|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19362801|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19688190|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688191|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688192|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688193|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
19688194|NCT05050305|Hormones|hormones|mesh-ancestor
19845358|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
19688195|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848255|NCT00691704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19688196|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19688197|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688198|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
19688199|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19688200|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19688201|NCT05050305|Growth Substances|growth substances|mesh-ancestor
19688202|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
19688203|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
19688204|NCT05050071|Calcium|calcium|mesh-list
19688205|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19688206|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688207|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19688208|NCT05050448|Diclofenac|diclofenac|mesh-list
19688209|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19688210|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19688211|NCT05050448|Analgesics|analgesics|mesh-ancestor
19688212|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
19688213|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209566|NCT00280787|Paclitaxel|paclitaxel|mesh-list
20209567|NCT00280787|Carboplatin|carboplatin|mesh-list
20209568|NCT00280787|Irinotecan|irinotecan|mesh-list
20209569|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209570|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209571|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209572|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209573|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209574|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209575|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20209576|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20209577|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209578|NCT00280839|Topiramate|topiramate|mesh-list
20209579|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
20209580|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20209581|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209582|NCT00280865|Pioglitazone|pioglitazone|mesh-list
20209583|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20209584|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209585|NCT00280878|Gemcitabine|gemcitabine|mesh-list
20209586|NCT00280878|Rituximab|rituximab|mesh-list
20209587|NCT00280878|Vinorelbine|vinorelbine|mesh-list
20209588|NCT00280878|Ifosfamide|ifosfamide|mesh-list
20209589|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20209590|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209591|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
20209592|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209593|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209594|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209595|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
20209596|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209597|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
20209598|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209599|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209600|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209601|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209602|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209603|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209604|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209605|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209606|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
20209607|NCT00280930|Letrozole|letrozole|mesh-list
20209608|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209609|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20209610|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20209611|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209612|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209613|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20209614|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
20209615|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20209616|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209617|NCT00280956|Natalizumab|natalizumab|mesh-list
20209618|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
20209619|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209620|NCT00280969|Efavirenz|efavirenz|mesh-list
20209621|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20209622|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20396210|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209623|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20209624|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209625|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209626|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
20209627|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209628|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20209629|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20209630|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20209631|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20209632|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20209633|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20209634|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20209635|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20209636|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
20209637|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20209638|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20209639|NCT00280995|Mipomersen|mipomersen|mesh-list
20209640|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20209641|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20209642|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
20209643|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209644|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20209645|NCT00281008|Mipomersen|mipomersen|mesh-list
20396211|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20396212|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20396213|NCT01108042|Docetaxel|docetaxel|mesh-list
20396214|NCT01108042|Fluorouracil|fluorouracil|mesh-list
20396215|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396216|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396217|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396218|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396219|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396220|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
20396221|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20396222|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396223|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
20396224|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396225|NCT01108055|Paclitaxel|paclitaxel|mesh-list
20396226|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20396227|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396228|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396229|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396230|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396231|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396232|NCT01108107|Capecitabine|capecitabine|mesh-list
20396233|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
20396234|NCT01108107|Panitumumab|panitumumab|mesh-list
20396235|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20396236|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
20396237|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396238|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396239|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20396240|NCT01108133|Dexamethasone|dexamethasone|mesh-list
20396241|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396242|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
20396243|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
20396244|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396245|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396246|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20396247|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
20396248|NCT01108133|Hormones|hormones|mesh-ancestor
20396249|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20396250|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20396251|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396252|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
20396253|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20396254|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20396255|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20396256|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396257|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
20396258|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396259|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
20396260|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19362802|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20209646|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20209647|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20209648|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
19362803|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362804|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19362805|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362806|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19362807|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19362808|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19362809|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19362810|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19362811|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
19362812|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362813|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
19362814|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19362815|NCT02118610|Analgesics|analgesics|mesh-ancestor
19362816|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
19362817|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362818|NCT02083250|Fludarabine|fludarabine|mesh-list
19362819|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
19362820|NCT02083250|Busulfan|busulfan|mesh-list
19362821|NCT02083250|Vorinostat|vorinostat|mesh-list
19362822|NCT02083250|Clofarabine|clofarabine|mesh-list
19362823|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
19362824|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19362825|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362826|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19362827|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
19362828|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362829|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362830|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
19362831|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362832|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
19688214|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209649|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209650|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20209651|NCT00281125|Pemetrexed|pemetrexed|mesh-list
20209652|NCT00281125|Vatalanib|vatalanib|mesh-list
19688215|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845359|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845360|NCT00671034|Cytarabine|cytarabine|mesh-list
19845361|NCT00671034|Dexamethasone|dexamethasone|mesh-list
19845362|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
19845363|NCT00671034|Prednisone|prednisone|mesh-list
19845364|NCT00671034|Cortisone|cortisone|mesh-list
20209653|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209654|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209655|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845365|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
19845366|NCT00671034|Doxorubicin|doxorubicin|mesh-list
19845367|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19845368|NCT00671034|Methotrexate|methotrexate|mesh-list
20209656|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20209657|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20209658|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19688216|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19688217|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19688218|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688219|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688220|NCT05049603|Atorvastatin|atorvastatin|mesh-list
19688221|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19688222|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19688223|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
19688224|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688225|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19688226|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19688227|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688228|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
19688229|NCT05049707|Analgesics|analgesics|mesh-ancestor
20209659|NCT00281255|Allopurinol|allopurinol|mesh-list
19845369|NCT00671034|Vincristine|vincristine|mesh-list
19845370|NCT00671034|Daunorubicin|daunorubicin|mesh-list
19845371|NCT00671034|Asparaginase|asparaginase|mesh-list
19845372|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
20209660|NCT00281255|Dobutamine|dobutamine|mesh-list
20209661|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
20396261|NCT01108289|Oxytocin|oxytocin|mesh-list
20396262|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
20396263|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20396264|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396265|NCT01108302|Oxytocin|oxytocin|mesh-list
20396266|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
20396267|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20396268|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396269|NCT01108393|S 20098|s 20098|mesh-list
20396270|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20396271|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396272|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396273|NCT01108562|Lidocaine|lidocaine|mesh-list
20396274|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
20396275|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
20396276|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396277|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396278|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
20396279|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396280|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20396281|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20396282|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20396283|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20396284|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396285|NCT01108588|Aspirin|aspirin|mesh-list
20396286|NCT01108588|Clopidogrel|clopidogrel|mesh-list
20396287|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20396288|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19362833|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209662|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209663|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209664|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
20209665|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209666|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20209667|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
19362834|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19362835|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19362836|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362837|NCT01857934|Aldesleukin|aldesleukin|mesh-list
19362838|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
19362839|NCT01857934|Melphalan|melphalan|mesh-list
19362840|NCT01857934|Busulfan|busulfan|mesh-list
19362841|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
19362842|NCT01857934|Doxorubicin|doxorubicin|mesh-list
19362843|NCT01857934|Etoposide|etoposide|mesh-list
19362844|NCT01857934|Vincristine|vincristine|mesh-list
19362845|NCT01857934|Topotecan|topotecan|mesh-list
19362846|NCT01857934|Interleukin-2|interleukin-2|mesh-list
19362847|NCT01857934|Molgramostim|molgramostim|mesh-list
19362848|NCT01857934|Dinutuximab|dinutuximab|mesh-list
19362849|NCT01857934|Levetiracetam|levetiracetam|mesh-list
19362850|NCT01857934|Isotretinoin|isotretinoin|mesh-list
19362851|NCT01857934|Antibodies|antibodies|mesh-list
19362852|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
19362853|NCT01857934|Sargramostim|sargramostim|mesh-list
19362854|NCT01857934|Lenograstim|lenograstim|mesh-list
19362855|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362856|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
19362857|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362858|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362859|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19362860|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
19362861|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362862|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362863|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19362864|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19362865|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19362866|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19362867|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688230|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
20209668|NCT00281255|Protective Agents|protective agents|mesh-ancestor
20209669|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209670|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19362868|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209671|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
19362869|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
19362870|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
19362871|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
19845373|NCT00671034|Pegaspargase|pegaspargase|mesh-list
19362872|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19362873|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19362874|NCT01857934|Analgesics|analgesics|mesh-ancestor
19362875|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
20209672|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
20209673|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209674|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20209675|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19688231|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688232|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688233|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
19688234|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688235|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19688236|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
19688237|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19688238|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688239|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396289|NCT01108588|Analgesics|analgesics|mesh-ancestor
20396290|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
20396291|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396292|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396293|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362876|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362877|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19362878|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19688240|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19688241|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
19688242|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19688243|NCT05049473|Cytarabine|cytarabine|mesh-list
19688244|NCT05049473|Dexamethasone|dexamethasone|mesh-list
19688245|NCT05049473|Prednisone|prednisone|mesh-list
19688246|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
19688247|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
19688248|NCT05049473|Rituximab|rituximab|mesh-list
19688249|NCT05049473|Doxorubicin|doxorubicin|mesh-list
19688250|NCT05049473|Methotrexate|methotrexate|mesh-list
19688251|NCT05049473|Etoposide|etoposide|mesh-list
19688252|NCT05049473|Vincristine|vincristine|mesh-list
19688253|NCT05049473|Vindesine|vindesine|mesh-list
19688254|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19688255|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
19688256|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688257|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19688258|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19688259|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
20396294|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396295|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19362879|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
19362880|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362881|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19362882|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
19362883|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
19362884|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
19362885|NCT01841177|Milrinone|milrinone|mesh-list
19362886|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19362887|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19362888|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
19362889|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19362890|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20396296|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19362891|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209676|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20209677|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
20209678|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217862|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217863|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20217864|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20217865|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20217866|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217867|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
20217868|NCT00310778|Atenolol|atenolol|mesh-list
20217869|NCT00310778|Valsartan|valsartan|mesh-list
20217870|NCT00310778|Candesartan|candesartan|mesh-list
20217871|NCT00310778|Ramipril|ramipril|mesh-list
19688260|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688261|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688262|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20217872|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20209679|NCT00281281|Vancomycin|vancomycin|mesh-list
20209680|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396297|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396298|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20396299|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20396300|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396301|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
20396302|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20396303|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20396304|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20209681|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209682|NCT00281307|Tocopherols|tocopherols|mesh-list
20209683|NCT00281307|Vitamin E|vitamin e|mesh-list
20209684|NCT00281307|Tocotrienols|tocotrienols|mesh-list
20209685|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
20209686|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
20209687|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209688|NCT00281307|Protective Agents|protective agents|mesh-ancestor
20396305|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
20396306|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396307|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
20396308|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396309|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396310|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20396311|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20209689|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396312|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362892|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362893|NCT01841177|Protective Agents|protective agents|mesh-ancestor
19362894|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362895|NCT01697527|Aldesleukin|aldesleukin|mesh-list
19362896|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
19362897|NCT01697527|Fludarabine|fludarabine|mesh-list
19362898|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
19362899|NCT01697527|Interleukin-2|interleukin-2|mesh-list
19362900|NCT01697527|Vaccines|vaccines|mesh-list
19362901|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19362902|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362903|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
19362904|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362905|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362906|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19362907|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
19362908|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362909|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362910|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19362911|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19362912|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
20396313|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396314|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396315|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20396316|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19362913|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19362914|NCT01697527|Analgesics|analgesics|mesh-ancestor
19362915|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
19362916|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362917|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19362918|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19362919|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
19362920|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362921|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19362922|NCT01591577|Temozolomide|temozolomide|mesh-list
19362923|NCT01591577|Lapatinib|lapatinib|mesh-list
19362924|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19362925|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
19362926|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362927|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362928|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19362929|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362930|NCT01512888|Busulfan|busulfan|mesh-list
19845374|NCT00671034|Thioguanine|thioguanine|mesh-list
19362931|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
20209690|NCT00281307|Vitamins|vitamins|mesh-ancestor
19362932|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209691|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
19362933|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396317|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
20396318|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20396319|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
20396320|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396321|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396322|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20396323|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
20396324|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20396325|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20396326|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20396327|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396328|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396329|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396330|NCT01108744|Mannitol|mannitol|mesh-list
20396331|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20396332|NCT01108744|Diuretics|diuretics|mesh-ancestor
20396333|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
20396334|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396335|NCT01108783|Desloratadine|desloratadine|mesh-list
19362934|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
19362935|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362936|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19362937|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362938|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19362939|NCT01453946|Budesonide|budesonide|mesh-list
19362940|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362941|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19362942|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
19688263|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19688264|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688265|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
19688266|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
19688267|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688268|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688269|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
19688270|NCT05049473|Hormones|hormones|mesh-ancestor
19688271|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688272|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19688273|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19688274|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19688275|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19688276|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688277|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19688278|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
19688279|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20209692|NCT00281476|Simvastatin|simvastatin|mesh-list
20209693|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20209694|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20209695|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
20209696|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209697|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20209698|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20209699|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209700|NCT00281489|Anesthetics|anesthetics|mesh-list
20209701|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209702|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209703|NCT00281502|Rifaximin|rifaximin|mesh-list
20209704|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20209705|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209706|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20209707|NCT00281515|Lonafarnib|lonafarnib|mesh-list
20209708|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209709|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209710|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
20209711|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20209712|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
20209713|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209714|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209715|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20209716|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209717|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
20209718|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20396336|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20396337|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
20613052|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688280|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19688281|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
19688282|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
19688283|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19688284|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19688285|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19688286|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
19688287|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688288|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
19688289|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
19688290|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
19688291|NCT05049681|Apatinib|apatinib|mesh-list
19688292|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688293|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20613053|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613054|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613055|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
19362943|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362944|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688294|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688295|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688296|NCT05048914|Acetaminophen|acetaminophen|mesh-list
19688297|NCT05048914|Dipyrone|dipyrone|mesh-list
19688298|NCT05048914|Ibuprofen|ibuprofen|mesh-list
19688299|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19688300|NCT05048914|Analgesics|analgesics|mesh-ancestor
19688301|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
19688302|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362945|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362946|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
19362947|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
19362948|NCT01453946|Hormones|hormones|mesh-ancestor
19362949|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362950|NCT01444092|Budesonide|budesonide|mesh-list
19362951|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19362952|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20209719|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
19362953|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
19362954|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19362955|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362956|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19362957|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
19362958|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
19362959|NCT01444092|Hormones|hormones|mesh-ancestor
19362960|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362961|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19362962|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19362963|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362964|NCT01265784|Ertapenem|ertapenem|mesh-list
19362965|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19362966|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362967|NCT00719966|Letrozole|letrozole|mesh-list
19362968|NCT00719966|Anastrozole|anastrozole|mesh-list
19362969|NCT00719966|Exemestane|exemestane|mesh-list
19362970|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362971|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19362972|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19362973|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19362974|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362975|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19688303|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688304|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
19688305|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19688306|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688307|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209720|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209721|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209722|NCT00281593|Telmisartan|telmisartan|mesh-list
20209723|NCT00281593|Ramipril|ramipril|mesh-list
20209724|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20209725|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20613056|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19362976|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
19362977|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19362978|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362979|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19362980|NCT00637832|Prednisolone|prednisolone|mesh-list
19362981|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
19362982|NCT00637832|Rituximab|rituximab|mesh-list
19362983|NCT00637832|Doxorubicin|doxorubicin|mesh-list
19362984|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19362985|NCT00637832|Vincristine|vincristine|mesh-list
19362986|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19362987|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
19362988|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19362989|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19362990|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19362991|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
19362992|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19362993|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19362994|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19688308|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19688309|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209726|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19362995|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19362996|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19362997|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20209727|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209728|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20396338|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19362998|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19362999|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363000|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19363001|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363002|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363003|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363004|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363005|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
19363006|NCT00637832|Hormones|hormones|mesh-ancestor
19363007|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363008|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363009|NCT00392327|Vitamin A|vitamin a|mesh-list
19363010|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
19363011|NCT00392327|Cisplatin|cisplatin|mesh-list
19363012|NCT00392327|Carboplatin|carboplatin|mesh-list
19363013|NCT00392327|Vincristine|vincristine|mesh-list
19363014|NCT00392327|Tretinoin|tretinoin|mesh-list
19363015|NCT00392327|Isotretinoin|isotretinoin|mesh-list
19363016|NCT00392327|Lenograstim|lenograstim|mesh-list
19363017|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363018|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
19363019|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363020|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363021|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19363022|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
19363023|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363024|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363025|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19363026|NCT00392327|Vitamins|vitamins|mesh-ancestor
19363027|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
19363028|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19363029|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19363030|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363031|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363032|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363033|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
19363034|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
19363035|NCT00116220|Goserelin|goserelin|mesh-list
19363036|NCT00116220|Flutamide|flutamide|mesh-list
19363037|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363038|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363039|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363040|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
20209729|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
20209730|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209731|NCT00281606|Ritonavir|ritonavir|mesh-list
20209732|NCT00281606|Lopinavir|lopinavir|mesh-list
20209733|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20209734|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20209735|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
19363041|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
19363042|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363043|NCT00099086|Docetaxel|docetaxel|mesh-list
19363044|NCT00099086|Leuprolide|leuprolide|mesh-list
19363045|NCT00099086|Goserelin|goserelin|mesh-list
19363046|NCT00099086|Bicalutamide|bicalutamide|mesh-list
19363047|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363048|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363049|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363050|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363051|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688310|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688311|NCT05048940|Vaccines|vaccines|mesh-list
19688312|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
19688313|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688314|NCT05048901|Lanreotide|lanreotide|mesh-list
19688315|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688316|NCT05048615|Itraconazole|itraconazole|mesh-list
19688317|NCT05048615|Azacitidine|azacitidine|mesh-list
19688318|NCT05048615|Venetoclax|venetoclax|mesh-list
19688319|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19688320|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
19688321|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688322|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688323|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688324|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
19688325|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688326|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19688327|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19688328|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19688329|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
19688330|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688331|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688332|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19688333|NCT05048511|Vitamin D|vitamin d|mesh-list
19688334|NCT05048511|Vitamins|vitamins|mesh-ancestor
19845375|NCT00671034|BB 1101|bb 1101|mesh-list
19845376|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
19845377|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845378|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
19363052|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19363053|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
19363054|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19363055|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363056|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363057|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
19363058|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
19363059|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363060|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
19363061|NCT00085202|Vincristine|vincristine|mesh-list
19363062|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363063|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
19363064|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363065|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363066|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19845379|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845380|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845381|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19845382|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
19845383|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845384|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845385|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19845386|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845387|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
19845388|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
19845389|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845390|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845391|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
19845392|NCT00671034|Hormones|hormones|mesh-ancestor
19845393|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845394|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19845395|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
19363067|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
19363068|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363069|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845396|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845397|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20396339|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396340|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396341|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20396342|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20396343|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
20396344|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
20396345|NCT01108848|Complement C1s|complement c1s|mesh-list
20396346|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20396347|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20396348|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
19845398|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19845399|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19845400|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19845401|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
19845402|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845403|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845404|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
19845405|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845406|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19845407|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19845408|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
19845409|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845410|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19363070|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20396349|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396350|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20396351|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396352|NCT01108874|Metaraminol|metaraminol|mesh-list
20396353|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
20396354|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
19363071|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19363072|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363073|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363074|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363075|NCT05187507|Theobromine|theobromine|mesh-list
19363076|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19363077|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
19363078|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363079|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363080|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19363081|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
19363082|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
19363083|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19363084|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
19845411|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363085|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
19363086|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845412|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396355|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396356|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396357|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20396358|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20396359|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20396360|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20396361|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396362|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396363|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396364|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
20396365|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
20396366|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19363087|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363088|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
19363089|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363090|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19401877|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19401878|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19401879|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19401880|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
19401881|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845413|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
19845414|NCT00671060|Misoprostol|misoprostol|mesh-list
19845415|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19845416|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
19363091|NCT05186675|Epinephrine|epinephrine|mesh-list
19363092|NCT05186675|Racepinephrine|racepinephrine|mesh-list
19363093|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
19363094|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19363095|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19363096|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
19363097|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363098|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396367|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20396368|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396369|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396370|NCT01108900|Urological Agents|urological agents|mesh-ancestor
19363099|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363100|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19363101|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19363102|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
19363103|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363104|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19363105|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
19363106|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
19363107|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
19363108|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19363109|NCT05186649|Warfarin|warfarin|mesh-list
19363110|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
19363111|NCT05186545|Fulvestrant|fulvestrant|mesh-list
19363112|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363113|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363114|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19363115|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19363116|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
19363117|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363118|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363119|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
19363120|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
19363121|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19363122|NCT05186363|Amodiaquine|amodiaquine|mesh-list
19363123|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
19363124|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19363125|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19363126|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363127|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19363128|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363129|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845417|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845418|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845419|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19845420|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845421|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
19845422|NCT00671437|Cetuximab|cetuximab|mesh-list
19845423|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845424|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845425|NCT00671502|Carisoprodol|carisoprodol|mesh-list
19845426|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19845427|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845428|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20209736|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209737|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209738|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20209739|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20209740|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
20209741|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209742|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20209743|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20209744|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
20209745|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20209746|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209747|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20209748|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
20209749|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396371|NCT01108926|Tenofovir|tenofovir|mesh-list
19363130|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20209750|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396372|NCT01108926|Emtricitabine|emtricitabine|mesh-list
20396373|NCT01108926|Efavirenz|efavirenz|mesh-list
20396374|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20396375|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
20396376|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845429|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845430|NCT00671515|Pioglitazone|pioglitazone|mesh-list
19845431|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845432|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845433|NCT00671658|Cytarabine|cytarabine|mesh-list
19845434|NCT00671658|Dexamethasone|dexamethasone|mesh-list
19363131|NCT05186363|Renal Agents|renal agents|mesh-ancestor
19363132|NCT05186194|Vitamin D|vitamin d|mesh-list
19363133|NCT05186194|Calcium|calcium|mesh-list
19363134|NCT05186194|Vitamins|vitamins|mesh-ancestor
19363135|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
19363136|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363137|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19363138|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19363139|NCT05185869|Gemcitabine|gemcitabine|mesh-list
19363140|NCT05185869|Paclitaxel|paclitaxel|mesh-list
19363141|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20396377|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20396378|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20396379|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845435|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
19845436|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19845437|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19363142|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363143|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363144|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363145|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363146|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363147|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845438|NCT00671658|Prednisolone|prednisolone|mesh-list
19845439|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
19845440|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
19845441|NCT00671658|Rituximab|rituximab|mesh-list
20396380|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688335|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
19688336|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688337|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19688338|NCT05048589|Vaccines|vaccines|mesh-list
19688339|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
19688340|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688341|NCT05048524|Leucovorin|leucovorin|mesh-list
19688342|NCT05048524|Gemcitabine|gemcitabine|mesh-list
20396381|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20396382|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20396383|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20396384|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20396385|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20396386|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20396387|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20396388|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20396389|NCT01108939|Antimalarials|antimalarials|mesh-list
20396390|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19688343|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
19688344|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19688345|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
19688346|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396391|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20396392|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396393|NCT01109030|Pioglitazone|pioglitazone|mesh-list
20396394|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
19688347|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688348|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
19688349|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363148|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
19363149|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
19363150|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363151|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363152|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19688350|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688351|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845442|NCT00671658|Doxorubicin|doxorubicin|mesh-list
19845443|NCT00671658|Methotrexate|methotrexate|mesh-list
19688352|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
19688353|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688354|NCT05048524|Antidotes|antidotes|mesh-ancestor
19688355|NCT05048524|Protective Agents|protective agents|mesh-ancestor
19688356|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
19688357|NCT05048524|Vitamins|vitamins|mesh-ancestor
20396395|NCT01109030|Dexetimide|dexetimide|mesh-list
20396396|NCT01109030|Citalopram|citalopram|mesh-list
20396397|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20396398|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396399|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20396400|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20396401|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20396402|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396403|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688358|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
19363153|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
19363154|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363155|NCT05185804|Enoxaparin|enoxaparin|mesh-list
19363156|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
19363157|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
19363158|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19363159|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19363160|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363161|NCT05185544|Pemetrexed|pemetrexed|mesh-list
19363162|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363163|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363164|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363165|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19363166|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19363167|NCT05185518|Insulin|insulin|mesh-list
19363168|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19363169|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363170|NCT05185505|Bevacizumab|bevacizumab|mesh-list
19363171|NCT05185505|Atezolizumab|atezolizumab|mesh-list
19688359|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
20396404|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
20396405|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19363172|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363173|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363174|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19363175|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19363176|NCT05185505|Growth Substances|growth substances|mesh-ancestor
19363177|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363178|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
19363179|NCT05185284|Remdesivir|remdesivir|mesh-list
19363180|NCT05185284|Favipiravir|favipiravir|mesh-list
19363181|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
19363182|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363183|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
19363184|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363185|NCT05184816|Deferoxamine|deferoxamine|mesh-list
19363186|NCT05184816|Siderophores|siderophores|mesh-ancestor
19363187|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19363188|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
19363189|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
19363190|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363191|NCT05184803|Docetaxel|docetaxel|mesh-list
19363192|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
19363193|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363194|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363195|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363196|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363197|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401882|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401883|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401884|NCT03613792|Fentanyl|fentanyl|mesh-list
19401885|NCT03613792|Midazolam|midazolam|mesh-list
19401886|NCT03613792|Ketamine|ketamine|mesh-list
19401887|NCT03613792|Remifentanil|remifentanil|mesh-list
19401888|NCT03613792|Analgesics|analgesics|mesh-ancestor
19401889|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
19401890|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401891|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688360|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19688361|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20396406|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
20396407|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20396408|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20396409|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20396410|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
20396411|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
20396412|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396413|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20396414|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20396415|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
19363198|NCT05184530|Evolocumab|evolocumab|mesh-list
19363199|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19363200|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19363201|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
19688362|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688363|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688364|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
19363202|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363203|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19363204|NCT05184517|Cyclosporine|cyclosporine|mesh-list
19363205|NCT05184517|Cyclosporins|cyclosporins|mesh-list
19363206|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363207|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363208|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363209|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
19363210|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363211|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
19363212|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363213|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
19363214|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363215|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19363216|NCT05184465|Anesthetics|anesthetics|mesh-list
19363217|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363218|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363219|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19363220|NCT05184374|Hormones|hormones|mesh-ancestor
19363221|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363222|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688365|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19688366|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19688367|NCT05047874|Prednisolone|prednisolone|mesh-list
20396416|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20396417|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20396418|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396419|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20396420|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20396421|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
20396422|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
19363223|NCT05184179|Olmesartan|olmesartan|mesh-list
19363224|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19363225|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20396423|NCT01109043|Bisoprolol|bisoprolol|mesh-list
20396424|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20396425|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
20396426|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
20396427|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396428|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396429|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20396430|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20396431|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19363226|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19363227|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20396432|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396433|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396434|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363228|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
19363229|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363230|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19363231|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19363232|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688368|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
20396435|NCT01109121|Allopurinol|allopurinol|mesh-list
20396436|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
20396437|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363233|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19363234|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19363235|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19363236|NCT05184101|Heparin|heparin|mesh-list
19363237|NCT05184101|Calcium heparin|calcium heparin|mesh-list
19363238|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
19363239|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19363240|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19363241|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363242|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
19363243|NCT05184049|Epalrestat|epalrestat|mesh-list
20396438|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396439|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
20396440|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396441|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20396442|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
20396443|NCT01109121|Protective Agents|protective agents|mesh-ancestor
20396444|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396445|NCT01109134|Tirofiban|tirofiban|mesh-list
20396446|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20396447|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20396448|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396449|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20396450|NCT01109160|Azithromycin|azithromycin|mesh-list
20396451|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396452|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363244|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
19363245|NCT05184049|Vitamins|vitamins|mesh-ancestor
19363246|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
19363247|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363248|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363249|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363250|NCT05183997|Verapamil|verapamil|mesh-list
19363251|NCT05183997|Thrombin|thrombin|mesh-list
19363252|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20396453|NCT01109212|Bindarit|bindarit|mesh-list
20396454|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396455|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20396456|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396457|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396458|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20396459|NCT01109264|Chlorambucil|chlorambucil|mesh-list
20396460|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20396461|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
20396462|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396463|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396464|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20396465|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19363253|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19363254|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19363255|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363256|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19363257|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363258|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
19363259|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
19363260|NCT05183997|Coagulants|coagulants|mesh-ancestor
19363261|NCT05183880|Vitamins|vitamins|mesh-list
19363262|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
19363263|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
19363264|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363265|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
19363266|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363267|NCT05183880|Protective Agents|protective agents|mesh-ancestor
19363268|NCT05183841|Fenoterol|fenoterol|mesh-list
19363269|NCT05183841|Ipratropium|ipratropium|mesh-list
19363270|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
19363271|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
19363272|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363273|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363274|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19363275|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
20396466|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20396467|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20396468|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19363276|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19363277|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
19363278|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363279|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363280|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
19363281|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
19363282|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19363283|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20396469|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20396470|NCT01109485|Analgesics|analgesics|mesh-ancestor
20396471|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
20396472|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396473|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396474|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396475|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363284|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19363285|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19363286|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
19363287|NCT05183737|Propolis|propolis|mesh-list
19363288|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363289|NCT05183555|Edotreotide|edotreotide|mesh-list
19363290|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19363291|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363292|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
19363293|NCT05183334|Tramadol|tramadol|mesh-list
19363294|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
19363295|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19363296|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19363297|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363298|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363299|NCT05183334|Urological Agents|urological agents|mesh-ancestor
19363300|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19363301|NCT05183334|Narcotics|narcotics|mesh-ancestor
19363302|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363303|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363304|NCT05183334|Analgesics|analgesics|mesh-ancestor
19363305|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
19363306|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363307|NCT05183204|Metformin|metformin|mesh-list
19363308|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19363309|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363310|NCT05182970|Metformin|metformin|mesh-list
19363311|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19363312|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363313|NCT05182957|Lenalidomide|lenalidomide|mesh-list
19363314|NCT05182957|Azacitidine|azacitidine|mesh-list
19363315|NCT05182957|Antibodies|antibodies|mesh-list
19363316|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
19363317|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19363318|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
19363319|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363320|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845444|NCT00671658|Vincristine|vincristine|mesh-list
19845445|NCT00671658|Asparaginase|asparaginase|mesh-list
19845446|NCT00671658|Pegaspargase|pegaspargase|mesh-list
20396476|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20396477|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20396478|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20396479|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
20396480|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
20396481|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396482|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396483|NCT01109498|Cyclosporine|cyclosporine|mesh-list
20396484|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
20396485|NCT01109498|Cyclosporins|cyclosporins|mesh-list
20396486|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396487|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396488|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396489|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
20396490|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396491|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
19363321|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19363322|NCT05182957|Growth Substances|growth substances|mesh-ancestor
19363323|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
19363324|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845447|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20396492|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396493|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845448|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
19845449|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845450|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
19845451|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845452|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845453|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19845454|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
19845455|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688369|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19688370|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
19688371|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688372|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
19688373|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
19688374|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688375|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688376|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688377|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
19688378|NCT05047874|Hormones|hormones|mesh-ancestor
19688379|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688380|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19688381|NCT05047874|Protective Agents|protective agents|mesh-ancestor
19688382|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19688383|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692930|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19692931|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19692932|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19845456|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396494|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396495|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20396496|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20396497|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396498|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20396499|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
20396500|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396501|NCT01109511|Oxycodone|oxycodone|mesh-list
20396502|NCT01109511|Naloxone|naloxone|mesh-list
20396503|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20396504|NCT01109511|Narcotics|narcotics|mesh-ancestor
20396505|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396506|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363325|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19692933|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
19692934|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19692935|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692936|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692937|NCT04985500|Bupivacaine|bupivacaine|mesh-list
19692938|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
19692939|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
19692940|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19692941|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363326|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
19363327|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363328|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363329|NCT05182710|Vaccines|vaccines|mesh-list
19363330|NCT05182710|Immunologic Factors|immunologic factors|mesh-ancestor
19363331|NCT05182710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363332|NCT05182385|Venetoclax|venetoclax|mesh-list
19363333|NCT05182385|Blinatumomab|blinatumomab|mesh-list
19363334|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363335|NCT05182138|Zinc|zinc|mesh-list
19363336|NCT05182138|Trace Elements|trace elements|mesh-ancestor
19363337|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
19363338|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363339|NCT05182112|Gemcitabine|gemcitabine|mesh-list
19363340|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363341|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19363342|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
19363343|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363344|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
19363345|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363346|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363347|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363348|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
19845457|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20396507|NCT01109511|Analgesics|analgesics|mesh-ancestor
19363349|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363350|NCT05181969|Dextrans|dextrans|mesh-list
19363351|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
19363352|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
20209751|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209752|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209753|NCT00281645|Analgesics|analgesics|mesh-list
20209754|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
20209755|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209756|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209757|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
19363353|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
19363354|NCT05180292|Carvedilol|carvedilol|mesh-list
19363355|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19363356|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19363357|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
19363358|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363359|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363360|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363361|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19363362|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
19363363|NCT05180292|Protective Agents|protective agents|mesh-ancestor
19363364|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19363365|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19363366|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19363367|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
19363368|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19363369|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19363370|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
19363371|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19363372|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19363373|NCT05177939|Prednisolone|prednisolone|mesh-list
19363374|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
19363375|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19363376|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
19363377|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
19363378|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19363379|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
19363380|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19363381|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363382|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
19363383|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
19363384|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363385|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363386|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19363387|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
19363388|NCT05177939|Hormones|hormones|mesh-ancestor
19363389|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363390|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19363391|NCT05177939|Protective Agents|protective agents|mesh-ancestor
19363392|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363393|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363394|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
19363395|NCT05177718|Natalizumab|natalizumab|mesh-list
19363396|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
20209758|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20209759|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20209760|NCT00281710|Prednisolone|prednisolone|mesh-list
20209761|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
20209762|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19363397|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363398|NCT05171166|Leucovorin|leucovorin|mesh-list
19363399|NCT05171166|Fluorouracil|fluorouracil|mesh-list
19363400|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
19363401|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
19363402|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
19363403|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363404|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19363405|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363406|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363407|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
19363408|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363409|NCT05171166|Antidotes|antidotes|mesh-ancestor
19688384|NCT05047848|Fulvestrant|fulvestrant|mesh-list
20209763|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
19363410|NCT05171166|Protective Agents|protective agents|mesh-ancestor
20209764|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688385|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19688386|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363411|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
19363412|NCT05171166|Vitamins|vitamins|mesh-ancestor
19363413|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
19363414|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19363415|NCT05171166|Estrogens|estrogens|mesh-ancestor
19363416|NCT05171166|Hormones|hormones|mesh-ancestor
19363417|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363418|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363419|NCT05170139|Caffeine|caffeine|mesh-list
20209765|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
20396508|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
20396509|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396510|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20396511|NCT01109615|Gemcitabine|gemcitabine|mesh-list
20396512|NCT01109615|Pemetrexed|pemetrexed|mesh-list
20396513|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20396514|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
20396515|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396516|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396517|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
20396518|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396519|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396520|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363420|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19363421|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363422|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20209766|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
20209767|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209768|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209769|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20209770|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
20209771|NCT00281710|Hormones|hormones|mesh-ancestor
19363423|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363424|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363425|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19363426|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19363427|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
19363428|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363429|NCT05168423|Cyclophosphamide|cyclophosphamide|mesh-list
19363430|NCT05168423|Fludarabine|fludarabine|mesh-list
19363431|NCT05168423|Isotretinoin|isotretinoin|mesh-list
19363432|NCT05168423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363433|NCT05168423|Immunologic Factors|immunologic factors|mesh-ancestor
19363434|NCT05168423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363435|NCT05168423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363436|NCT05168423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19363437|NCT05168423|Alkylating Agents|alkylating agents|mesh-ancestor
19363438|NCT05168423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363439|NCT05168423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363440|NCT05168423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19363441|NCT05168423|Dermatologic Agents|dermatologic agents|mesh-ancestor
19363442|NCT05166291|Anesthetics|anesthetics|mesh-list
19363443|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363444|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363445|NCT05163561|Vaccines|vaccines|mesh-list
19363446|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
19363447|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363448|NCT05163496|Psilocybin|psilocybin|mesh-list
20209772|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20209773|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20209774|NCT00281710|Protective Agents|protective agents|mesh-ancestor
20209775|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20209776|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209777|NCT00281788|Paclitaxel|paclitaxel|mesh-list
20209778|NCT00281788|Carboplatin|carboplatin|mesh-list
20209779|NCT00281788|Capecitabine|capecitabine|mesh-list
20209780|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209781|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209782|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209783|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363449|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
19688387|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20209784|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363450|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363451|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19363452|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
19363453|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19363454|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363455|NCT05159752|Afamelanotide|afamelanotide|mesh-list
19363456|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
19363457|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
19688388|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20209785|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209786|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209787|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
20209788|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20209789|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209790|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20209791|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209792|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688389|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
19688390|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688391|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688392|NCT05047991|Leucovorin|leucovorin|mesh-list
19688393|NCT05047991|Gemcitabine|gemcitabine|mesh-list
19688394|NCT05047991|Paclitaxel|paclitaxel|mesh-list
19688395|NCT05047991|Fluorouracil|fluorouracil|mesh-list
19688396|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
19688397|NCT05047991|Irinotecan|irinotecan|mesh-list
20396521|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
20396522|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396523|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20396524|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20396525|NCT01109654|Cetrorelix|cetrorelix|mesh-list
20396526|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20396527|NCT01109654|Hormones|hormones|mesh-ancestor
20396528|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20396529|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396530|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20396531|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
20396532|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20396533|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
20396534|NCT01109693|Mirtazapine|mirtazapine|mesh-list
20396535|NCT01109693|Sertraline|sertraline|mesh-list
20396536|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
19688398|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19688399|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688400|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396537|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20396538|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20396539|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20396540|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20396541|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396542|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396543|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
20396544|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396545|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20396546|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
20396547|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
20396548|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20396549|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20396550|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396551|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20396552|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20396553|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20396554|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396555|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20396556|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20396557|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20396558|NCT01109758|Fenofibrate|fenofibrate|mesh-list
20396559|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20396560|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
20396561|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688401|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19688402|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19688403|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688404|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19688405|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
19363458|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19688406|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
19688407|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688408|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688409|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20613057|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613058|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613059|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
19688410|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
19688411|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688412|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19688413|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19688414|NCT05047991|Antidotes|antidotes|mesh-ancestor
19688415|NCT05047991|Protective Agents|protective agents|mesh-ancestor
19688416|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
19688417|NCT05047991|Vitamins|vitamins|mesh-ancestor
19688418|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
19688419|NCT05047978|Caseins|caseins|mesh-list
19688420|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
20396562|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20396563|NCT01109784|Clopidogrel|clopidogrel|mesh-list
20396564|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20396565|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20396566|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20396567|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20396568|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20396569|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
20396570|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396571|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396572|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396573|NCT01109823|Levofloxacin|levofloxacin|mesh-list
20396574|NCT01109823|Ofloxacin|ofloxacin|mesh-list
20396575|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20396576|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396577|NCT01109823|Renal Agents|renal agents|mesh-ancestor
20613060|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
19688421|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
19688422|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688423|NCT05047328|Inolimomab|inolimomab|mesh-list
19688424|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19688425|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
20209793|NCT00281892|Vidarabine|vidarabine|mesh-list
20209794|NCT00281892|Fludarabine|fludarabine|mesh-list
20209795|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
20209796|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209797|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209798|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
20209799|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209800|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19688426|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688427|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
19688428|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19688429|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19688430|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688431|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
19688432|NCT05047133|Coagulants|coagulants|mesh-ancestor
19688433|NCT05047393|Vitamin D|vitamin d|mesh-list
19688434|NCT05047393|Vitamins|vitamins|mesh-ancestor
19688435|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
19688436|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688437|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19688438|NCT05047211|Dextrans|dextrans|mesh-list
19688439|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
19688440|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
19688441|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
19688442|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
20209801|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
19688443|NCT05047211|Hematinics|hematinics|mesh-ancestor
19688444|NCT05046860|Dalbavancin|dalbavancin|mesh-list
19688445|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19688446|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688447|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
19688448|NCT05047055|Rifampin|rifampin|mesh-list
19688449|NCT05047055|Isoniazid|isoniazid|mesh-list
19688450|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
19688451|NCT05047055|Ethambutol|ethambutol|mesh-list
19688452|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19688453|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688454|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19688455|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19688456|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688457|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688458|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688459|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19688460|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
19688461|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
19688462|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19688463|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19688464|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19688465|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19688466|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19688467|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19688468|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19688469|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19688470|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19688471|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
19688472|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19363459|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
19363460|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363461|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363462|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209802|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209803|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
20209804|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209805|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
20209806|NCT00281905|Carboplatin|carboplatin|mesh-list
20209807|NCT00281905|Methotrexate|methotrexate|mesh-list
20209808|NCT00281905|Vincristine|vincristine|mesh-list
20209809|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363463|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
19688473|NCT05046431|Golimumab|golimumab|mesh-list
19688474|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19688475|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688476|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19688477|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
19688478|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688479|NCT05046262|Calcium|calcium|mesh-list
19688480|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19688481|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688482|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
19688483|NCT05046457|Provitamins|provitamins|mesh-ancestor
19688484|NCT05046457|Vitamins|vitamins|mesh-ancestor
19688485|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
19688486|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688487|NCT05046041|Misoprostol|misoprostol|mesh-list
20209810|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
20209811|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209812|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209813|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209814|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
20396578|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396579|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20396580|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20396581|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396582|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363464|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363465|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363466|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19363467|NCT05153772|Octreotide|octreotide|mesh-list
19363468|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19363469|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363470|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363471|NCT05152862|Bevacizumab|bevacizumab|mesh-list
19363472|NCT05152862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363473|NCT05152862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363474|NCT05152862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19363475|NCT05152862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19363476|NCT05152862|Growth Substances|growth substances|mesh-ancestor
19688488|NCT05046041|Mifepristone|mifepristone|mesh-list
20209815|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209816|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396583|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396584|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20396585|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20396586|NCT01109888|Cetrorelix|cetrorelix|mesh-list
20396587|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20396588|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
20396589|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20396590|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396591|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
20396592|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20396593|NCT01109927|Insulin|insulin|mesh-list
20396594|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20396595|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426798|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426799|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426800|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20426801|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426802|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426803|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
19363477|NCT05152862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363478|NCT05152862|Growth Inhibitors|growth inhibitors|mesh-ancestor
19363479|NCT05151159|Antibodies|antibodies|mesh-list
19363480|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
19363481|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363482|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
19363483|NCT05150782|Curcumin|curcumin|mesh-list
19363484|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
19363485|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363486|NCT05150782|Protective Agents|protective agents|mesh-ancestor
19363487|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363488|NCT05150782|Vitamins|vitamins|mesh-ancestor
19363489|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
19363490|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19363491|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19363492|NCT05150782|Analgesics|analgesics|mesh-ancestor
19363493|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
19363494|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363495|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363496|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363497|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363498|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363499|NCT05149560|Ticagrelor|ticagrelor|mesh-list
19363500|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19363501|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20426804|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426805|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
20426806|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426807|NCT01282762|Vaccines|vaccines|mesh-list
20426808|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
20426809|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426810|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20426811|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20426812|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20426813|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
20426814|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20426815|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426816|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426817|NCT01282840|Urological Agents|urological agents|mesh-ancestor
20426818|NCT01282879|Itraconazole|itraconazole|mesh-list
20426819|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
20426820|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426821|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20426822|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19363502|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19363503|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19363504|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
19363505|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363506|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363507|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363508|NCT05146674|Tadalafil|tadalafil|mesh-list
20426823|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363509|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
19363510|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19363511|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20396596|NCT01110031|Ofatumumab|ofatumumab|mesh-list
20396597|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396598|NCT01110226|Cisplatin|cisplatin|mesh-list
19363512|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363513|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363514|NCT05146674|Urological Agents|urological agents|mesh-ancestor
19363515|NCT05146635|Epirubicin|epirubicin|mesh-list
19363516|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19363517|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363518|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19363519|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19363520|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363521|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363522|NCT05145569|Paclitaxel|paclitaxel|mesh-list
19363523|NCT05145569|Carboplatin|carboplatin|mesh-list
19363524|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19363525|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363526|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363527|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845458|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20396599|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
20396600|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396601|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396602|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396603|NCT01110291|Docetaxel|docetaxel|mesh-list
20613061|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20209817|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20209818|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20209819|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
20209820|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20209821|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209822|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
20209823|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
20209824|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363528|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363529|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363530|NCT05133518|Midazolam|midazolam|mesh-list
19363531|NCT05133518|Ketamine|ketamine|mesh-list
19363532|NCT05133518|Analgesics|analgesics|mesh-ancestor
19363533|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
19688489|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19688490|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
19688491|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19688492|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688493|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19688494|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688495|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
20209825|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20209826|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20209827|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209828|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209829|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209830|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209831|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
20209832|NCT00281931|Rituximab|rituximab|mesh-list
20209833|NCT00281931|Fludarabine|fludarabine|mesh-list
20209834|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
20209835|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209836|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
20209837|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209838|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209839|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20209840|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
20209841|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209842|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209843|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20209844|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20209845|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209846|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
19363534|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688496|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19688497|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20209847|NCT00281944|Leucovorin|leucovorin|mesh-list
20209848|NCT00281944|Fluorouracil|fluorouracil|mesh-list
20396604|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396605|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396606|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396607|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396608|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396609|NCT01110304|Analgesics|analgesics|mesh-list
20396610|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
20396611|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396612|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396613|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20396614|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20396615|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20396616|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363535|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363536|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20396617|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396618|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20396619|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20396620|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19363537|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19363538|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
19363539|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
19363540|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363541|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19363542|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19363543|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363544|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363545|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19363546|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19363547|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19363548|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19363549|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19363550|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
19363551|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
19363552|NCT05130060|Trifluridine|trifluridine|mesh-list
19363553|NCT05130060|Vaccines|vaccines|mesh-list
19363554|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
19363555|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363556|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
19363557|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363558|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
19363559|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363560|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
19363561|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20396621|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
20396622|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396623|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396624|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20396625|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20396626|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
19363562|NCT05124899|Protective Agents|protective agents|mesh-ancestor
19363563|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363564|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
19363565|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
19363566|NCT05119140|Mesalamine|mesalamine|mesh-list
19363567|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
19363568|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19363569|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19363570|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363571|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363572|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363573|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19363574|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19363575|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19363576|NCT05119140|Analgesics|analgesics|mesh-ancestor
19363577|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
19363578|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363579|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363580|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363581|NCT05119075|Dopamine|dopamine|mesh-list
19363582|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
19363583|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19363584|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
19363585|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
19363586|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363587|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363588|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
19363589|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363590|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363591|NCT05119075|Protective Agents|protective agents|mesh-ancestor
19363592|NCT05111262|Budesonide|budesonide|mesh-list
20209849|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
20396627|NCT01110473|Azacitidine|azacitidine|mesh-list
20396628|NCT01110473|Ilorasertib|ilorasertib|mesh-list
20396629|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209850|NCT00281944|Calcium|calcium|mesh-list
20209851|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
20209852|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20209853|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209854|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
20209855|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209856|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209857|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209858|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209859|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
20209860|NCT00281944|Antidotes|antidotes|mesh-ancestor
20209861|NCT00281944|Protective Agents|protective agents|mesh-ancestor
19688498|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19688499|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19688500|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
19688501|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19688502|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19688503|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
19688504|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688505|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
19688506|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19688507|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20209862|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
20209863|NCT00281944|Vitamins|vitamins|mesh-ancestor
20209864|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
20396630|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
20396631|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396632|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688508|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
20209865|NCT00281970|Docetaxel|docetaxel|mesh-list
20209866|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396633|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396634|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20396635|NCT01110486|Carboplatin|carboplatin|mesh-list
20396636|NCT01110486|Docetaxel|docetaxel|mesh-list
20396637|NCT01110486|Ilorasertib|ilorasertib|mesh-list
20396638|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396639|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396640|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396641|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396642|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396643|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20396644|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396645|NCT01110551|Vaccines|vaccines|mesh-list
20396646|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
20396647|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396648|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20396649|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
20396650|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20396651|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20396652|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396653|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363593|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
19363594|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363595|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19363596|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
19363597|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363598|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363599|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19363600|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
19363601|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
19363602|NCT05111262|Hormones|hormones|mesh-ancestor
19363603|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363604|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20396654|NCT01110590|Urological Agents|urological agents|mesh-ancestor
20396655|NCT01110603|Paclitaxel|paclitaxel|mesh-list
20396656|NCT01110603|Carboplatin|carboplatin|mesh-list
20396657|NCT01110603|Doxorubicin|doxorubicin|mesh-list
20396658|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20396659|NCT01110603|Niraparib|niraparib|mesh-list
20396660|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20396661|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396662|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396663|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396664|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396665|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396666|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20396667|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20396668|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20396669|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396670|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20396671|NCT01110616|Lorazepam|lorazepam|mesh-list
20396672|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
20396673|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
20396674|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
20396675|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396676|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396677|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20396678|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20396679|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396680|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20396681|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20396682|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20396683|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
20396684|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
20396685|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396686|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396687|NCT01110642|Lovastatin|lovastatin|mesh-list
20396688|NCT01110642|L 647318|l 647318|mesh-list
20396689|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
19363605|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19363606|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19363607|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
19363608|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363609|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401892|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19401893|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19401894|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
19401895|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
19401896|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396690|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19401897|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19401898|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19401899|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401900|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401901|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19401902|NCT03613792|Narcotics|narcotics|mesh-ancestor
19401903|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19401904|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19401905|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19401906|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19401907|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19401908|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
19401909|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
19401910|NCT03613753|Irinotecan|irinotecan|mesh-list
19401911|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19401912|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19401913|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401914|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401915|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401916|NCT03613597|Etoposide|etoposide|mesh-list
19401917|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
19401918|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401919|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19401920|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19401921|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19401922|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19401923|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401924|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
20396691|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20396692|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
20396693|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363610|NCT05099107|Albuterol|albuterol|mesh-list
19363611|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19363612|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
19363613|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363614|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363615|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19363616|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
19363617|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
19363618|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19363619|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19363620|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19363621|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19363622|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
19363623|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363624|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363625|NCT05089643|Capecitabine|capecitabine|mesh-list
19363626|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19363627|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
19363628|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363629|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363630|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
19363631|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19363632|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363633|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363634|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363635|NCT05064488|Metformin|metformin|mesh-list
19363636|NCT05064488|Digoxin|digoxin|mesh-list
19363637|NCT05064488|Sumatriptan|sumatriptan|mesh-list
19363638|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19363639|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19363640|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363641|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19363642|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19363643|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
19363644|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363645|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19363646|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19363647|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363648|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19363649|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19363650|NCT05064488|Protective Agents|protective agents|mesh-ancestor
20396694|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20396695|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20396696|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396697|NCT01110785|Panitumumab|panitumumab|mesh-list
20396698|NCT01110785|Simvastatin|simvastatin|mesh-list
20396699|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20396700|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20396701|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
20396702|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396703|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20396704|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19363651|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19363652|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19363653|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19363654|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
19363655|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363656|NCT05061524|Omalizumab|omalizumab|mesh-list
19363657|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19363658|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19363659|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
19363660|NCT05060627|Dexamethasone|dexamethasone|mesh-list
19363661|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363662|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
19363663|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
19363664|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363665|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396705|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396706|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20396707|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396708|NCT01110824|Carvedilol|carvedilol|mesh-list
20396709|NCT01110824|Enalapril|enalapril|mesh-list
19363666|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20396710|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19363667|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
19363668|NCT05060627|Hormones|hormones|mesh-ancestor
19363669|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363670|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363671|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396711|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20396712|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396713|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396714|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396715|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396716|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20396717|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
20396718|NCT01110824|Protective Agents|protective agents|mesh-ancestor
20396719|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20396720|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19363672|NCT05031494|Gemcitabine|gemcitabine|mesh-list
19363673|NCT05031494|Paclitaxel|paclitaxel|mesh-list
20396721|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20396722|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
20396723|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20396724|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20396725|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20396726|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
20396727|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363674|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19363675|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363676|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363677|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363678|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363679|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396728|NCT01110941|Leucovorin|leucovorin|mesh-list
20396729|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
20396730|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396731|NCT01110941|Antidotes|antidotes|mesh-ancestor
20396732|NCT01110941|Protective Agents|protective agents|mesh-ancestor
19363680|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19363681|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
19363682|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
19363683|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363684|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363685|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363686|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
19363687|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363688|NCT05027633|Carboplatin|carboplatin|mesh-list
19363689|NCT05027633|Docetaxel|docetaxel|mesh-list
19363690|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
19688509|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19688510|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688511|NCT05045651|Cimetidine|cimetidine|mesh-list
19688512|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19688513|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688514|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19688515|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
19688516|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
19688517|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688518|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688519|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688520|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20396733|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396734|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
20396735|NCT01110941|Vitamins|vitamins|mesh-ancestor
20396736|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
19688521|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19688522|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688523|NCT05045508|Varenicline|varenicline|mesh-list
19688524|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19688525|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19688526|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19688527|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688528|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688529|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396737|NCT01111019|Hormones|hormones|mesh-list
19363691|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688530|NCT05045248|Apraclonidine|apraclonidine|mesh-list
20396738|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20396739|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396740|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20396741|NCT01111084|Hormones|hormones|mesh-ancestor
20396742|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20396743|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396744|NCT01111188|Bortezomib|bortezomib|mesh-list
20396745|NCT01111188|Palbociclib|palbociclib|mesh-list
20396746|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396747|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20396748|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396749|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396750|NCT01111227|Propofol|propofol|mesh-list
20396751|NCT01111227|Isoflurane|isoflurane|mesh-list
19688531|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19688532|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19363692|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363693|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363694|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363695|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363696|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363697|NCT05008484|Vitamin D|vitamin d|mesh-list
19363698|NCT05008484|Vitamins|vitamins|mesh-ancestor
19363699|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
19363700|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363701|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19363702|NCT05000710|Durvalumab|durvalumab|mesh-list
19363703|NCT05000710|Tremelimumab|tremelimumab|mesh-list
19363704|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363705|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363706|NCT04967248|Fulvestrant|fulvestrant|mesh-list
19363707|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19363708|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363709|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19363710|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19363711|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
19363712|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363713|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363714|NCT04965519|Trastuzumab|trastuzumab|mesh-list
19363715|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363716|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363717|NCT04952389|Budesonide|budesonide|mesh-list
19363718|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363719|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19363720|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
19363721|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396752|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20396753|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396754|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396755|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20396756|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
20396757|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
20396758|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20396759|NCT01111253|Amoxicillin|amoxicillin|mesh-list
20396760|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
20396761|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
20396762|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20396763|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396764|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396765|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20396766|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396767|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396768|NCT01111383|Tobramycin|tobramycin|mesh-list
20396769|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396770|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396771|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
20396772|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20396773|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
20396774|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396775|NCT01111422|Expectorants|expectorants|mesh-ancestor
20396776|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
20396777|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19363722|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363723|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19688533|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19688534|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396778|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
20396779|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396780|NCT01111422|Protective Agents|protective agents|mesh-ancestor
20396781|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396782|NCT01111422|Antidotes|antidotes|mesh-ancestor
20396783|NCT01111448|Sirolimus|sirolimus|mesh-list
20396784|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396785|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396786|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20396787|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396788|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
20396789|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396790|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
20396791|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396792|NCT01111513|Analgesics|analgesics|mesh-list
19688535|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688536|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688537|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688538|NCT05045274|Aspirin|aspirin|mesh-list
19688539|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
19688540|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
19688541|NCT05045274|Giapreza|giapreza|mesh-list
19688542|NCT05045274|Clopidogrel|clopidogrel|mesh-list
19688543|NCT05045274|Ticagrelor|ticagrelor|mesh-list
19688544|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19688545|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19688546|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
19688547|NCT05045274|Diuretics|diuretics|mesh-list
19688548|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19688549|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19688550|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19688551|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19688552|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
19363724|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
19363725|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
19363726|NCT04952389|Hormones|hormones|mesh-ancestor
19363727|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19363728|NCT04943549|Bupivacaine|bupivacaine|mesh-list
19363729|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
19363730|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
19363731|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363732|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688553|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19688554|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19688555|NCT05045274|Analgesics|analgesics|mesh-ancestor
19688556|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
19688557|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688558|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688559|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688560|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19688561|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19688562|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19688563|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688564|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19688565|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19688566|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
19688567|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19688568|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19688569|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20396793|NCT01111513|Ropivacaine|ropivacaine|mesh-list
20396794|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
19363733|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
19363734|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363735|NCT04931667|Lorecivivint|lorecivivint|mesh-list
19363736|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19363737|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
19363738|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
19401925|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19401926|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401927|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401928|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19401929|NCT03613558|Analgesics|analgesics|mesh-ancestor
19401930|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
19688570|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
20396795|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
20396796|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396797|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396798|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
20396799|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363739|NCT04893291|Sirolimus|sirolimus|mesh-list
19363740|NCT04893291|Everolimus|everolimus|mesh-list
19363741|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363742|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363743|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
19363744|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363745|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19363746|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363747|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19363748|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
19363749|NCT04889599|Docetaxel|docetaxel|mesh-list
19363750|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363751|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363752|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363753|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363754|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363755|NCT04877587|Gemcitabine|gemcitabine|mesh-list
19363756|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363757|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19363758|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
19363759|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363760|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363761|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
19363762|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363763|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363764|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19363765|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
19363766|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
19363767|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
19363768|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363769|NCT04842422|Imiquimod|imiquimod|mesh-list
19363770|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19363771|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
19363772|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363773|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363774|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
19363775|NCT04840641|Efavirenz|efavirenz|mesh-list
19363776|NCT04840641|Floxacillin|floxacillin|mesh-list
19363777|NCT04840641|Losartan|losartan|mesh-list
19363778|NCT04840641|Metoprolol|metoprolol|mesh-list
19363779|NCT04840641|Midazolam|midazolam|mesh-list
19363780|NCT04840641|Caffeine|caffeine|mesh-list
19363781|NCT04840641|Omeprazole|omeprazole|mesh-list
19363782|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19363783|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19688571|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688572|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19688573|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19688574|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19688575|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19363784|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363785|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363786|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19363787|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19363788|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19363789|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19363790|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
19363791|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
19363792|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
19363793|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
19363794|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363795|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363796|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19363797|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19363798|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19363799|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19363800|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19688576|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
19363801|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688577|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19363802|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19688578|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
19363803|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363804|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20396800|NCT01111591|Celecoxib|celecoxib|mesh-list
19363805|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19363806|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19363807|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19363808|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
19363809|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19363810|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19363811|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
19363812|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363813|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19363814|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19363815|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19363816|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19363817|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19363818|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19363819|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
19363820|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
19363821|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363822|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19363823|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19363824|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19363825|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
19363826|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19363827|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
19363828|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
19363829|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
19363830|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363831|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363832|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
19363833|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363834|NCT04802863|Imipenem|imipenem|mesh-list
19363835|NCT04802863|Cilastatin|cilastatin|mesh-list
19363836|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19363837|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363838|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
19363839|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688579|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19688580|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
19688581|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19688582|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19688583|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
19688584|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
19688585|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688586|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19363840|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363841|NCT04802746|Alprazolam|alprazolam|mesh-list
19363842|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19363843|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363844|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363845|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19363846|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19363847|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19363848|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
19688587|NCT05045274|Hormones|hormones|mesh-ancestor
19688588|NCT05045443|Curcumin|curcumin|mesh-list
19688589|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19688590|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19363849|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
19363850|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363851|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363852|NCT04801043|Imipenem|imipenem|mesh-list
19363853|NCT04801043|Cilastatin|cilastatin|mesh-list
19363854|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19363855|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363856|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
19363857|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363858|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363859|NCT04791176|Lenvatinib|lenvatinib|mesh-list
19363860|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363861|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19363862|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363863|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688591|NCT05045443|Analgesics|analgesics|mesh-ancestor
19688592|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
19363864|NCT04787562|Imipenem|imipenem|mesh-list
19363865|NCT04787562|Cilastatin|cilastatin|mesh-list
19363866|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19363867|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363868|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
20396801|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
20396802|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20396803|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20396804|NCT01111591|Analgesics|analgesics|mesh-ancestor
20396805|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
20396806|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396807|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396808|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396809|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396810|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20396811|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396812|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396813|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
20396814|NCT01111630|Hematinics|hematinics|mesh-ancestor
20396815|NCT01111656|Interferons|interferons|mesh-list
20396816|NCT01111656|Interferon-beta|interferon-beta|mesh-list
19363869|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363870|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363871|NCT04786756|Bupivacaine|bupivacaine|mesh-list
19363872|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
19363873|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
19363874|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363875|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363876|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
19363877|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363878|NCT04784715|Trastuzumab|trastuzumab|mesh-list
19363879|NCT04784715|Pertuzumab|pertuzumab|mesh-list
19363880|NCT04784715|Taxane|taxane|mesh-list
19363881|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363882|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363883|NCT04782791|Nivolumab|nivolumab|mesh-list
20396817|NCT01111656|Atorvastatin|atorvastatin|mesh-list
20396818|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
20396819|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363884|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363885|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363886|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19363887|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396820|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
20396821|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396822|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20396823|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20396824|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
20396825|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363891|NCT04777643|Cannabidiol|cannabidiol|mesh-list
19363892|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
19363893|NCT04776018|Daratumumab|daratumumab|mesh-list
19363894|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363895|NCT04768426|Capecitabine|capecitabine|mesh-list
19363896|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19363897|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
19363898|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363899|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396826|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19363900|NCT04766086|Vaccines|vaccines|mesh-list
19363901|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
19363902|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363903|NCT04762836|Cycloserine|cycloserine|mesh-list
19363904|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19363905|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19363906|NCT04762836|Renal Agents|renal agents|mesh-ancestor
19363907|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19363908|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
19363909|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19363910|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
19363911|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363912|NCT04758949|Nivolumab|nivolumab|mesh-list
19363913|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363914|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363915|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19363916|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363917|NCT04750395|Haloperidol|haloperidol|mesh-list
19363918|NCT04750395|Olanzapine|olanzapine|mesh-list
19363919|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
19363920|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
19363921|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
20396827|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20396828|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396829|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
20396830|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396831|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20396832|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
20396833|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20396834|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20396835|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396836|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
20396837|NCT01111669|Coagulants|coagulants|mesh-ancestor
20396838|NCT01111682|Mannitol|mannitol|mesh-list
20396839|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20396840|NCT01111682|Diuretics|diuretics|mesh-ancestor
20396841|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
20396842|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396843|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
20396844|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20396845|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396846|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
20396847|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396848|NCT01111734|Expectorants|expectorants|mesh-ancestor
19363922|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19363923|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363924|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19363925|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19688593|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688594|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688595|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688596|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19688597|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688598|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688599|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692942|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
19692943|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396849|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
20396850|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20396851|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
20396852|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396853|NCT01111734|Protective Agents|protective agents|mesh-ancestor
20396854|NCT01111734|Antidotes|antidotes|mesh-ancestor
19363926|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19363927|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363928|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19363929|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19363930|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19363931|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19363932|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363933|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363934|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
19363935|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19363936|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
19363937|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19363938|NCT04739735|Anesthetics|anesthetics|mesh-list
19363939|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363940|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363941|NCT04735965|Meperidine|meperidine|mesh-list
19363942|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
19363943|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19363944|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19363945|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363946|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19363947|NCT04735965|Analgesics|analgesics|mesh-ancestor
19363948|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
19363949|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692944|NCT04985201|Irinotecan|irinotecan|mesh-list
20396855|NCT01111747|Mitogens|mitogens|mesh-list
20396856|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396857|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396858|NCT01111864|Micronutrients|micronutrients|mesh-list
19363950|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19363951|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19363952|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19363953|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
19363954|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19363955|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363956|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19363957|NCT04735965|Narcotics|narcotics|mesh-ancestor
19363958|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19363959|NCT04734535|Thrombin|thrombin|mesh-list
19363960|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19363961|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
19363962|NCT04734535|Coagulants|coagulants|mesh-ancestor
19363963|NCT04734379|Fasudil|fasudil|mesh-list
19363964|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19363965|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19363966|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363967|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19363968|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363969|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
19363970|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19363971|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363972|NCT04731272|Dulaglutide|dulaglutide|mesh-list
19363973|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19363974|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19363975|NCT04730037|Warfarin|warfarin|mesh-list
19363976|NCT04730037|Edoxaban|edoxaban|mesh-list
19363977|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
19363978|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19363979|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
19363980|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19363981|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
19363982|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363983|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363984|NCT04714190|Paclitaxel|paclitaxel|mesh-list
19363985|NCT04714190|Irinotecan|irinotecan|mesh-list
19363986|NCT04714190|Apatinib|apatinib|mesh-list
19363987|NCT04714190|Trastuzumab|trastuzumab|mesh-list
19363988|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19363989|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19363990|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
19363991|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
19363992|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
19363993|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19363994|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19363995|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19363996|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19363997|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19363998|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19363999|NCT04704999|Chloroquine|chloroquine|mesh-list
19364000|NCT04704999|Lumefantrine|lumefantrine|mesh-list
19364001|NCT04704999|Artemether|artemether|mesh-list
19364002|NCT04704999|Tafenoquine|tafenoquine|mesh-list
19364003|NCT04704999|Amebicides|amebicides|mesh-ancestor
19364004|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19364005|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19364006|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364007|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
20209867|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20209868|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
20209869|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20209870|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209871|NCT00281983|Cyclosporine|cyclosporine|mesh-list
20209872|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
20209873|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
20209874|NCT00281983|Busulfan|busulfan|mesh-list
20209875|NCT00281983|Rituximab|rituximab|mesh-list
20209876|NCT00281983|Methotrexate|methotrexate|mesh-list
20209877|NCT00281983|Fludarabine|fludarabine|mesh-list
20209878|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
20209879|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
20209880|NCT00281983|Cyclosporins|cyclosporins|mesh-list
20209881|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20209882|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209883|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
20209884|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209885|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364008|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364009|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
19364010|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19364011|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
19364012|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364013|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
19364014|NCT04702802|Protective Agents|protective agents|mesh-ancestor
19364015|NCT04702789|Timolol|timolol|mesh-list
19364016|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19364017|NCT04702789|Dorzolamide|dorzolamide|mesh-list
19364018|NCT04702789|Latanoprost|latanoprost|mesh-list
19364019|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19364020|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19364021|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
19364022|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364023|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364024|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364025|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19364026|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19364027|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19364028|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19364029|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19364030|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19364031|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19688600|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19688601|NCT05045053|Lifitegrast|lifitegrast|mesh-list
19688602|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19688603|NCT05044819|Cannabidiol|cannabidiol|mesh-list
19688604|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
19688605|NCT05044728|Paclitaxel|paclitaxel|mesh-list
19688606|NCT05044728|Carboplatin|carboplatin|mesh-list
19688607|NCT05044728|Antibodies|antibodies|mesh-list
19688608|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19688609|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688610|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
19688611|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
19688612|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
19364032|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19364033|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364034|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
19364035|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19364036|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
19364037|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364038|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
19364039|NCT04702776|Protective Agents|protective agents|mesh-ancestor
19364040|NCT04699422|Pirinitramide|pirinitramide|mesh-list
19364041|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19364042|NCT04699422|Narcotics|narcotics|mesh-ancestor
19364043|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364044|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364045|NCT04699422|Analgesics|analgesics|mesh-ancestor
19364046|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
19364047|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364048|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
19364049|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19401931|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688613|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688614|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
19688615|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688616|NCT05044637|Primaquine|primaquine|mesh-list
19688617|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
19401932|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19401933|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19401934|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19688618|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19688619|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19688620|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688621|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
19688622|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19688623|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
20209886|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19401935|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
19688624|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688625|NCT05044429|Lidocaine|lidocaine|mesh-list
19688626|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
20209887|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
20209888|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396859|NCT01111864|Trace Elements|trace elements|mesh-list
19364050|NCT04686773|Vaccines|vaccines|mesh-list
19364051|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
19364052|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364053|NCT04684953|Hormones|hormones|mesh-list
19364054|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364055|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364056|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19364057|NCT04674020|Erenumab|erenumab|mesh-list
19364058|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19364059|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364060|NCT04674020|Analgesics|analgesics|mesh-ancestor
19364061|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
19364062|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364063|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364064|NCT04673786|Ustekinumab|ustekinumab|mesh-list
19364065|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364066|NCT04667637|Edaravone|edaravone|mesh-list
19364067|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20396860|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396861|NCT01111890|Timolol|timolol|mesh-list
20396862|NCT01111890|Dorzolamide|dorzolamide|mesh-list
20396863|NCT01111890|Brinzolamide|brinzolamide|mesh-list
20396864|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20396865|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20396866|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396867|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396868|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396869|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396870|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20396871|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20396872|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20396873|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396874|NCT01111903|Lenalidomide|lenalidomide|mesh-list
20396875|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
20396876|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396877|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20396878|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20396879|NCT01111903|Growth Substances|growth substances|mesh-ancestor
20396880|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
20396881|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426824|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426825|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20426826|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
20426827|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364068|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
19364069|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364070|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19364071|NCT04667637|Protective Agents|protective agents|mesh-ancestor
19364072|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364073|NCT04659317|Oxycodone|oxycodone|mesh-list
19364074|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20426828|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426829|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20426830|NCT01283048|Bevacizumab|bevacizumab|mesh-list
20426831|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20426832|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426833|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20426834|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20426835|NCT01283048|Growth Substances|growth substances|mesh-ancestor
20426836|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364075|NCT04659317|Narcotics|narcotics|mesh-ancestor
19364076|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364077|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364078|NCT04659317|Analgesics|analgesics|mesh-ancestor
19364079|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
19364080|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364081|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
19364082|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364083|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364084|NCT04641312|Dulaglutide|dulaglutide|mesh-list
19364085|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364086|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364087|NCT04635423|Vaccines|vaccines|mesh-list
20209889|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209890|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20209891|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845459|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845460|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
19845461|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
19845462|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396882|NCT01111942|Cisplatin|cisplatin|mesh-list
19364088|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
19364089|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396883|NCT01111942|Carboplatin|carboplatin|mesh-list
20396884|NCT01111942|Docetaxel|docetaxel|mesh-list
20396885|NCT01111942|Fluorouracil|fluorouracil|mesh-list
19364090|NCT04611802|Vaccines|vaccines|mesh-list
19688627|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
19364091|NCT04611802|Immunologic Factors|immunologic factors|mesh-ancestor
19364092|NCT04611802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364093|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
19364094|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19364095|NCT04611763|Analgesics|analgesics|mesh-ancestor
19364096|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
19364097|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364098|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364099|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19364100|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364101|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19364102|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364103|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19364104|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364105|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364106|NCT04608786|Capecitabine|capecitabine|mesh-list
19364107|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19364108|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
19364109|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364110|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688628|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688629|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688630|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
19688631|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688632|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19688633|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19688634|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19688635|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364111|NCT04603911|Dexamethasone|dexamethasone|mesh-list
19364112|NCT04603911|Clonidine|clonidine|mesh-list
19364113|NCT04603911|Epinephrine|epinephrine|mesh-list
19364114|NCT04603911|Bupivacaine|bupivacaine|mesh-list
19364115|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19364116|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
19364117|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
19364118|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364119|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364120|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19364121|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
19364122|NCT04603911|Hormones|hormones|mesh-ancestor
19688636|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688637|NCT05044468|Lidocaine|lidocaine|mesh-list
19364123|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364124|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19364125|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364126|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
19364127|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
19364128|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688638|NCT05044468|Bupivacaine|bupivacaine|mesh-list
19845463|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845464|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
20209892|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20209893|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
20209894|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20209895|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209896|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
19364129|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
19364130|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19688639|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
20396886|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396887|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
19364131|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19364132|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396888|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
20396889|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
20396890|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364133|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364134|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364135|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19364136|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19364137|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19364138|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
19364139|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
19364140|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
19364141|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19364142|NCT04603911|Analgesics|analgesics|mesh-ancestor
19364143|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19364144|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
19364145|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19364146|NCT04595266|Leucovorin|leucovorin|mesh-list
20396891|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
20396892|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20396893|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396894|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
20396895|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688640|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
20396896|NCT01111968|Vaccines|vaccines|mesh-list
20396897|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
19364147|NCT04595266|Bevacizumab|bevacizumab|mesh-list
19364148|NCT04595266|Fluorouracil|fluorouracil|mesh-list
19364149|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
19364150|NCT04595266|Irinotecan|irinotecan|mesh-list
19364151|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364152|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364153|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19364154|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19364155|NCT04595266|Growth Substances|growth substances|mesh-ancestor
19364156|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364157|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
19364158|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
19364159|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364160|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19364161|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19364162|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
19364163|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19364164|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19364165|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364166|NCT04595266|Antidotes|antidotes|mesh-ancestor
19364167|NCT04595266|Protective Agents|protective agents|mesh-ancestor
19364168|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
19364169|NCT04595266|Vitamins|vitamins|mesh-ancestor
19364170|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
19364171|NCT04594798|Prednisone|prednisone|mesh-list
19364172|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
19364173|NCT04594798|Rituximab|rituximab|mesh-list
19364174|NCT04594798|Doxorubicin|doxorubicin|mesh-list
19364175|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19364176|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
19364177|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364178|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396898|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396899|NCT01111981|Clobetasol|clobetasol|mesh-list
20613062|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364179|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19364180|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
19364181|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688641|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688642|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688643|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
20613063|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613064|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613065|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613066|NCT02253849|Analgesics|analgesics|mesh-ancestor
20613067|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
20613068|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364182|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364183|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20396900|NCT01111981|Emollients|emollients|mesh-list
20396901|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20396902|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
20396903|NCT01111981|Hormones|hormones|mesh-ancestor
20396904|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613069|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19688644|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688645|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20396905|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396906|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
20396907|NCT01111994|Clindamycin|clindamycin|mesh-list
20396908|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
20396909|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
20396910|NCT01111994|Tretinoin|tretinoin|mesh-list
20396911|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396912|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396913|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19364184|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364185|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19364186|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19364187|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19364188|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364189|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19364190|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
19364191|NCT04594798|Hormones|hormones|mesh-ancestor
19364192|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364193|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19364194|NCT04592536|Alprazolam|alprazolam|mesh-list
19364195|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19364196|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364197|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364198|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19364199|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19364200|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19364201|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
19364202|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
19364203|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364204|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364205|NCT04552535|Afatinib|afatinib|mesh-list
19364206|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364207|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19364208|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364209|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364210|NCT04541797|Empagliflozin|empagliflozin|mesh-list
19364211|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19364212|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364213|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364214|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364215|NCT04531553|Bupivacaine|bupivacaine|mesh-list
19364216|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
19364217|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
19364218|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364219|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364220|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
19364221|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364222|NCT04529265|Methylene Blue|methylene blue|mesh-list
19364223|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364224|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364225|NCT04528680|Paclitaxel|paclitaxel|mesh-list
19364226|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19692945|NCT04985201|Simvastatin|simvastatin|mesh-list
20209897|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
20209898|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209899|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20209900|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20209901|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
20209902|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209903|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20209904|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20209905|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20209906|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
20396914|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364227|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20209907|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19364228|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364229|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
20396915|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396916|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396917|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
20396918|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
20396919|NCT01112085|Ranibizumab|ranibizumab|mesh-list
20396920|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20396921|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20396922|NCT01112085|Growth Substances|growth substances|mesh-ancestor
20396923|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396924|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
20396925|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396926|NCT01112137|Clopidogrel|clopidogrel|mesh-list
20396927|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20396928|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20396929|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20396930|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20396931|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
20396932|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396933|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396934|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396935|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
20396936|NCT01112215|Azathioprine|azathioprine|mesh-list
20396937|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20396938|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20396939|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20396940|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
20396941|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20396942|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20396943|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20396944|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396945|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
19364230|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
19364231|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
19364232|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364233|NCT04520685|Cannabidiol|cannabidiol|mesh-list
19364234|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
19364235|NCT04515329|Cyclosporine|cyclosporine|mesh-list
19364236|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
19364237|NCT04515329|Cyclosporins|cyclosporins|mesh-list
19364238|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364239|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364240|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19364241|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
19364242|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364243|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
19364244|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364245|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364246|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364247|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19364248|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19364249|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19401936|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19401937|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396946|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20396947|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20396948|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
20396949|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396950|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20396951|NCT01112449|Selenium|selenium|mesh-list
20396952|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
20396953|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396954|NCT01112449|Protective Agents|protective agents|mesh-ancestor
20396955|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396956|NCT01112449|Trace Elements|trace elements|mesh-ancestor
20396957|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
19401938|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19401939|NCT03613545|Rifaximin|rifaximin|mesh-list
19401940|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
19401941|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401942|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20396958|NCT01112462|Acetaminophen|acetaminophen|mesh-list
20396959|NCT01112462|Phenylephrine|phenylephrine|mesh-list
20396960|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
19364250|NCT04508790|Dexamethasone|dexamethasone|mesh-list
19364251|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
19364252|NCT04508790|Pomalidomide|pomalidomide|mesh-list
19364253|NCT04508790|Ichthammol|ichthammol|mesh-list
19364254|NCT04508790|BB 1101|bb 1101|mesh-list
19364255|NCT04508790|Leflunomide|leflunomide|mesh-list
19364256|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19364257|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
19688646|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19688647|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19688648|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688649|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364258|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
20396961|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20396962|NCT01112462|Analgesics|analgesics|mesh-ancestor
20396963|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
20396964|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396965|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396966|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
20396967|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20396968|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
20396969|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
20396970|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
20396971|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20396972|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
19364259|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364260|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364261|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19364262|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
19364263|NCT04508790|Hormones|hormones|mesh-ancestor
19364264|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364265|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19364266|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364267|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
20396973|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
20396974|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20396975|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20396976|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20396977|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
20396978|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20396979|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20396980|NCT01112462|Protective Agents|protective agents|mesh-ancestor
20396981|NCT01112540|Morphine|morphine|mesh-list
19364268|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364269|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364270|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
19364271|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19364272|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19364273|NCT04508790|Growth Substances|growth substances|mesh-ancestor
19364274|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
19364275|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364276|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19364277|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19364278|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19364279|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364280|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
19364281|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19364282|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19364283|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19364284|NCT04503668|Dexamethasone|dexamethasone|mesh-list
19364285|NCT04503668|Ondansetron|ondansetron|mesh-list
19364286|NCT04503668|Olanzapine|olanzapine|mesh-list
20396982|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20396983|NCT01112540|Narcotics|narcotics|mesh-ancestor
20396984|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20396985|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396986|NCT01112540|Analgesics|analgesics|mesh-ancestor
20396987|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
20396988|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396989|NCT01112644|Oxycodone|oxycodone|mesh-list
20396990|NCT01112644|Naloxone|naloxone|mesh-list
20396991|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19364287|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
20396992|NCT01112644|Narcotics|narcotics|mesh-ancestor
20396993|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426837|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
19364288|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
19364289|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
19364290|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19364291|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
19364292|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
19364293|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364294|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364295|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19364296|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
19364297|NCT04503668|Hormones|hormones|mesh-ancestor
19364298|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364299|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19364300|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364301|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
19364302|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364303|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19364304|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
19364305|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364306|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364307|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19364308|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19364309|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364310|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19364311|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19364312|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19364313|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19364314|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364315|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19364316|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
19364317|NCT04502550|Propofol|propofol|mesh-list
20209908|NCT00281996|Gemcitabine|gemcitabine|mesh-list
20209909|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
20396994|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20396995|NCT01112644|Analgesics|analgesics|mesh-ancestor
20613070|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364318|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19364319|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364320|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364321|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19364322|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
19364323|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
19364324|NCT04502407|Cisplatin|cisplatin|mesh-list
19364325|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364326|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
19364327|NCT04481672|Analgesics|analgesics|mesh-ancestor
19364328|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
19364329|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364330|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364331|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
19688650|NCT05044364|Clevidipine|clevidipine|mesh-list
19688651|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19688652|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364332|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364333|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19364334|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
19364335|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19364336|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364337|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364338|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19364339|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
19364340|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19364341|NCT04470778|Famotidine|famotidine|mesh-list
19364342|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20209910|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20209911|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
20209912|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209913|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209914|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
20209915|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209916|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209917|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209918|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
20209919|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209920|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20209921|NCT00282061|Melatonin|melatonin|mesh-list
20209922|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
19364343|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19364344|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19364345|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
19364346|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
19364347|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364348|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364349|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364357|NCT04418427|Aflibercept|aflibercept|mesh-list
19364358|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19364359|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19364360|NCT04418427|Growth Substances|growth substances|mesh-ancestor
19364361|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364362|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
19364363|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364364|NCT04412863|Interferons|interferons|mesh-list
19364365|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
19364366|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
19364367|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19364368|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688653|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688654|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19688655|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688656|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
19688657|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19364369|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
19364370|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364371|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
19364372|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364373|NCT04412785|Cyclosporine|cyclosporine|mesh-list
19364374|NCT04412785|Cyclosporins|cyclosporins|mesh-list
19364375|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364376|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364377|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19364378|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
19364379|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364380|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
19364381|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364382|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364383|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364384|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19364385|NCT04385433|Pravastatin|pravastatin|mesh-list
19364386|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19364387|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19364388|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
19364389|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364390|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19364391|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19364392|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364393|NCT04377711|Ciclesonide|ciclesonide|mesh-list
19364394|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
19688658|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19688659|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688660|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688661|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688662|NCT05043766|Naltrexone|naltrexone|mesh-list
19688663|NCT05043766|Oxycodone|oxycodone|mesh-list
19688664|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19688665|NCT05043766|Narcotics|narcotics|mesh-ancestor
19688666|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688667|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688668|NCT05043766|Analgesics|analgesics|mesh-ancestor
19688669|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
20209923|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209924|NCT00282061|Protective Agents|protective agents|mesh-ancestor
20209925|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209926|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209927|NCT00282100|Gefitinib|gefitinib|mesh-list
19364395|NCT04377711|Hormones|hormones|mesh-ancestor
20396996|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
20396997|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20396998|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20396999|NCT01112722|Histamine|histamine|mesh-list
20397000|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
20397001|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
20397002|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397003|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397004|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397005|NCT01112748|Lidocaine|lidocaine|mesh-list
20397006|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
20397007|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
19688670|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688671|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19364396|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364397|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364398|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19364399|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19364400|NCT04369560|Hematinics|hematinics|mesh-ancestor
20397008|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397009|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397010|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
20397011|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397012|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20397013|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20397014|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20397015|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20397016|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397017|NCT01112787|Tazarotene|tazarotene|mesh-list
20397018|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397019|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
20397020|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
20397021|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
19688672|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19688673|NCT05043740|Evolocumab|evolocumab|mesh-list
19688674|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19688675|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19688676|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
19688677|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688678|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19688679|NCT05043896|Tadalafil|tadalafil|mesh-list
19688680|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
19688681|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19688682|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19688683|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688684|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688685|NCT05043896|Urological Agents|urological agents|mesh-ancestor
19688686|NCT05043506|Palbociclib|palbociclib|mesh-list
19688687|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19688688|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688689|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19688690|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688691|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688692|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19688693|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19688694|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
19688695|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688696|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688697|NCT05043688|Paclitaxel|paclitaxel|mesh-list
19688698|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19688699|NCT05043688|Carboplatin|carboplatin|mesh-list
20397022|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397023|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397024|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397025|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
20397026|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397027|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397028|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397029|NCT01112826|Capecitabine|capecitabine|mesh-list
20397030|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20397031|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
19364401|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19688700|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19688701|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688702|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
19688703|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
19688704|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
19688705|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397032|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397033|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397034|NCT01112852|Terlipressin|terlipressin|mesh-list
20397035|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20397036|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20397037|NCT01112852|Somatostatin|somatostatin|mesh-list
20397038|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397039|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397040|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209928|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209929|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20397041|NCT01112852|Hormones|hormones|mesh-ancestor
20397042|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397043|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397044|NCT01112878|Clonidine|clonidine|mesh-list
20397045|NCT01112878|Gabapentin|gabapentin|mesh-list
20397046|NCT01112878|Analgesics|analgesics|mesh-ancestor
20397047|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
20397048|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397049|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364402|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19364403|NCT04356690|Etoposide|etoposide|mesh-list
19688706|NCT05043350|Loratadine|loratadine|mesh-list
19688707|NCT05043350|Famotidine|famotidine|mesh-list
19688708|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20209930|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364404|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19364405|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364406|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19364407|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19364408|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364409|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364410|NCT04356209|Pravastatin|pravastatin|mesh-list
19364411|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19364412|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19364413|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
19364414|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364415|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19364416|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19364417|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364418|NCT04354025|Cytarabine|cytarabine|mesh-list
19364419|NCT04354025|Fludarabine|fludarabine|mesh-list
19364420|NCT04354025|Interleukin-2|interleukin-2|mesh-list
19364421|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364422|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19364423|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
19364424|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364425|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19364426|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
19364427|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364428|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
19364429|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364430|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364431|NCT04354025|Analgesics|analgesics|mesh-ancestor
19364432|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
19364433|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364434|NCT04352101|Citalopram|citalopram|mesh-list
19364435|NCT04352101|Bupropion|bupropion|mesh-list
19364436|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19364437|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20209931|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209932|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
20209933|NCT00282126|Diuretics|diuretics|mesh-ancestor
20209934|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
20209935|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397050|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
19364438|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688709|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20209936|NCT00282126|Expectorants|expectorants|mesh-ancestor
20397051|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20397052|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397053|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397054|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397055|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20397056|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20397057|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397058|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397059|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
19364439|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688710|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19688711|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
19688712|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
19688713|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688714|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364440|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364441|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
19364442|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364443|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19364444|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
19364445|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19364446|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19364447|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
19364448|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19364449|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19364450|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688715|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688716|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
19688717|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
19688718|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19688719|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19364451|NCT04347408|Antibodies|antibodies|mesh-list
19364452|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
19364453|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364454|NCT04336943|Durvalumab|durvalumab|mesh-list
19364455|NCT04336943|Olaparib|olaparib|mesh-list
19364456|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19364457|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
19364458|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19364459|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
19364460|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20397060|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397061|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
20397062|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
20397063|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20397064|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20397065|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20397066|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
20397067|NCT01112891|Vitamin D|vitamin d|mesh-list
20397068|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
20397069|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
20397070|NCT01112891|Vitamins|vitamins|mesh-list
20397071|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
20397072|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397073|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20397074|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20397075|NCT01113047|Amlodipine|amlodipine|mesh-list
20397076|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397077|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20397078|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364461|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364462|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
19364463|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364464|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364465|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364466|NCT04296942|Trastuzumab|trastuzumab|mesh-list
19364467|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19364468|NCT04296942|Maytansine|maytansine|mesh-list
20397079|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397080|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20397081|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397082|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
19364469|NCT04296942|Entinostat|entinostat|mesh-list
19364470|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364471|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688720|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19364472|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19364473|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
19364474|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
19364475|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
19364476|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364477|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19364478|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364479|NCT04291599|Ketorolac|ketorolac|mesh-list
19364480|NCT04291599|Morphine|morphine|mesh-list
19364481|NCT04291599|Hydromorphone|hydromorphone|mesh-list
19364482|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19364483|NCT04291599|Narcotics|narcotics|mesh-ancestor
19364484|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397083|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
20397084|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20397085|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397086|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20397087|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397088|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397089|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
20397090|NCT01113138|Analgesics|analgesics|mesh-ancestor
20397091|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
20397092|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397093|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397094|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
20397095|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397096|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20397097|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
20397098|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20397099|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20397100|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397101|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20397102|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
20397103|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20397104|NCT01113164|Ondansetron|ondansetron|mesh-list
20397105|NCT01113164|Sertraline|sertraline|mesh-list
19364485|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688721|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20397106|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
20397107|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
20397108|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397109|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397110|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397111|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
20397112|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397113|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20397114|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
20397115|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397116|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397117|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20397118|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397119|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397120|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397121|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20397122|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
20397123|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19688722|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19688723|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688724|NCT05043233|Methimazole|methimazole|mesh-list
19688725|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
19688726|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
19688727|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688728|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688729|NCT05043129|Vaccines|vaccines|mesh-list
19688730|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
19688731|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688732|NCT05043142|Antibodies|antibodies|mesh-list
19688733|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
19688734|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397124|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20397125|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688735|NCT05043116|Vitamin D|vitamin d|mesh-list
19364486|NCT04291599|Analgesics|analgesics|mesh-ancestor
19688736|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
20397126|NCT01113229|Misoprostol|misoprostol|mesh-list
20397127|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19364487|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
20397128|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
20397129|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20397130|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397131|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20397132|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397133|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
20397134|NCT01113281|Vaccines|vaccines|mesh-list
20397135|NCT01113281|Immunoglobulins|immunoglobulins|mesh-list
20397136|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
20397137|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397138|NCT01113372|Clopidogrel|clopidogrel|mesh-list
20397139|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20397140|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20397141|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20397142|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19364488|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364489|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19364490|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364491|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19364492|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364493|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19364494|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364495|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401943|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19401944|NCT03613428|Prednisone|prednisone|mesh-list
19401945|NCT03613428|Vincristine|vincristine|mesh-list
19401946|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19401947|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
19401948|NCT03613428|Hormones|hormones|mesh-ancestor
19401949|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19401950|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401951|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19401952|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688737|NCT05043116|Vitamins|vitamins|mesh-ancestor
19688738|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
19688739|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688740|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20397143|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
20397144|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397145|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397146|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397147|NCT01113424|Nicotine|nicotine|mesh-list
20397148|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20397149|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
20397150|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397151|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397152|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20397153|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20397154|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
20397155|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397156|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397157|NCT01113437|Omalizumab|omalizumab|mesh-list
20397158|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20397159|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20397160|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
20397161|NCT01113489|Beclomethasone|beclomethasone|mesh-list
20397162|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397163|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
20397164|NCT01113489|Hormones|hormones|mesh-ancestor
19688741|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19688742|NCT05042973|Empagliflozin|empagliflozin|mesh-list
19688743|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19688744|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688745|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19688746|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688747|NCT05042817|Sufentanil|sufentanil|mesh-list
19688748|NCT05042817|Morphine|morphine|mesh-list
19688749|NCT05042817|Prilocaine|prilocaine|mesh-list
19688750|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20613071|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20613072|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20426838|NCT01283061|Zafirlukast|zafirlukast|mesh-list
20397165|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397166|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397167|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20397168|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
20397169|NCT01113515|Esmolol|esmolol|mesh-list
19688751|NCT05042817|Narcotics|narcotics|mesh-ancestor
19688752|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688753|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688754|NCT05042817|Analgesics|analgesics|mesh-ancestor
19364496|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
19364497|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19364498|NCT04269356|Antacids|antacids|mesh-ancestor
19364499|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364500|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19364501|NCT04222504|Tenofovir|tenofovir|mesh-list
19364502|NCT04222504|Emtricitabine|emtricitabine|mesh-list
19364503|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
19364504|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364505|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19364506|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19364507|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364508|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364509|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19364510|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19364511|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
19364512|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19364513|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
19364514|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
20397170|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20397171|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20397172|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20397173|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
20397174|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397175|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397176|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397177|NCT01113528|Aspirin|aspirin|mesh-list
20397178|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20397179|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20397180|NCT01113528|Analgesics|analgesics|mesh-ancestor
19364515|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364516|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364517|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364518|NCT04177706|Ketamine|ketamine|mesh-list
19364519|NCT04177706|Analgesics|analgesics|mesh-ancestor
19364520|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
19364521|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688755|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
19688756|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688757|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19688758|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19688759|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
19688760|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
19688761|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
19692946|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19692947|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19692948|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692949|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692950|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692951|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19692952|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19692953|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
19692954|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19692955|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19692956|NCT04984759|Primaquine|primaquine|mesh-list
19692957|NCT04984759|Tafenoquine|tafenoquine|mesh-list
19692958|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
19692959|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19692960|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19692961|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692962|NCT04984980|Gemcitabine|gemcitabine|mesh-list
19692963|NCT04984980|Bevacizumab|bevacizumab|mesh-list
20397181|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
20613073|NCT02253862|Ritonavir|ritonavir|mesh-list
19692964|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
19692965|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20397182|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397183|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397184|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397185|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397186|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20397187|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19845465|NCT00671658|Hormones|hormones|mesh-ancestor
19845466|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845467|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20397188|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397189|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20397190|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20397191|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397192|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
20426839|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20426840|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
20426841|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19845468|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19845469|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19364522|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364523|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19364524|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19364525|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
19364526|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
19364527|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364528|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19364529|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19364530|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364531|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364532|NCT04173247|Mineral Oil|mineral oil|mesh-list
19364533|NCT04173247|Emollients|emollients|mesh-ancestor
19364534|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364535|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20426842|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
20428635|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19364536|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19364537|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19364538|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364539|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364540|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19364541|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364542|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364543|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
19364544|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364545|NCT04166331|Dobutamine|dobutamine|mesh-list
19364546|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19364547|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
19364548|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
19364549|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364550|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364551|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19364552|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19364553|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19364554|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
19364555|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209937|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
20209938|NCT00282139|Aripiprazole|aripiprazole|mesh-list
20209939|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
20209940|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20209941|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20209942|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20209943|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20209944|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209945|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
20209946|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
20209947|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209948|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209949|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20209950|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20209951|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
20209952|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19845470|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20397193|NCT01113671|Vitamin E|vitamin e|mesh-list
20397194|NCT01113671|Tocopherols|tocopherols|mesh-list
20397195|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
20397196|NCT01113671|Vitamins|vitamins|mesh-ancestor
20397197|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
20397198|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397199|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
20397200|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397201|NCT01113671|Protective Agents|protective agents|mesh-ancestor
20397202|NCT01113762|Cimetidine|cimetidine|mesh-list
20397203|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20397204|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397205|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20397206|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
20397207|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
20397208|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397209|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397210|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397211|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20397212|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20397213|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364556|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364557|NCT04166331|Protective Agents|protective agents|mesh-ancestor
19364558|NCT04163874|Pramlintide|pramlintide|mesh-list
19364559|NCT04163874|Pancrelipase|pancrelipase|mesh-list
19364560|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19364561|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364562|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364563|NCT04129996|Paclitaxel|paclitaxel|mesh-list
19364564|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20397214|NCT01114048|Thalidomide|thalidomide|mesh-list
20397215|NCT01114048|Dexamethasone|dexamethasone|mesh-list
20397216|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
20397217|NCT01114048|Bortezomib|bortezomib|mesh-list
20397218|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20397219|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
20397220|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397221|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397222|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19364565|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364566|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
19364567|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
19364568|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
19364569|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364570|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19364571|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
19364572|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19364573|NCT04120766|Nicorandil|nicorandil|mesh-list
19364574|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19364575|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19364576|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
19364577|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
19364578|NCT04120766|Vitamins|vitamins|mesh-ancestor
19364579|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
19364580|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364581|NCT04105998|Oxytocin|oxytocin|mesh-list
19364582|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
19364583|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19364584|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364585|NCT04074967|Nivolumab|nivolumab|mesh-list
19364586|NCT04074967|Ipilimumab|ipilimumab|mesh-list
19364587|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364588|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364589|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19364590|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364591|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
19364592|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364593|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364594|NCT04074174|Acetaminophen|acetaminophen|mesh-list
19364595|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
19688762|NCT05042674|Ergothioneine|ergothioneine|mesh-list
20397223|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
20397224|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397225|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364596|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
20613074|NCT02253862|Tipranavir|tipranavir|mesh-list
20613075|NCT02253862|Tadalafil|tadalafil|mesh-list
19688763|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
19364597|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364598|NCT04074174|Analgesics|analgesics|mesh-ancestor
19364599|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
19364600|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364601|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364602|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
19364603|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19364604|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19364605|NCT04068831|Avelumab|avelumab|mesh-list
19364606|NCT04068831|Talazoparib|talazoparib|mesh-list
19364607|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364608|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364609|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19364610|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364611|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364612|NCT04061421|Decitabine|decitabine|mesh-list
19364613|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19364614|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
19364615|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845471|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845472|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19845473|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
19845474|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19845475|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845476|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
19845477|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397226|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20397227|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397228|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
19364616|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364617|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364618|NCT04054713|Acetic Acid|acetic acid|mesh-list
19364619|NCT04054713|Retinol acetate|retinol acetate|mesh-list
19364620|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19364621|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364622|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20397229|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
20397230|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397231|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397232|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
20397233|NCT01114048|Hormones|hormones|mesh-ancestor
20397234|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397235|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20397236|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
20397237|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20397238|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397239|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20397240|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20397241|NCT01114048|Growth Substances|growth substances|mesh-ancestor
20397242|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
20397243|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
20397244|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364623|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
19364624|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364625|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19364626|NCT04054713|Protective Agents|protective agents|mesh-ancestor
19364627|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364628|NCT04044469|Vaccines|vaccines|mesh-list
19364629|NCT04044469|Immunologic Factors|immunologic factors|mesh-ancestor
20397245|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20397246|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397247|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397248|NCT01114100|Sertraline|sertraline|mesh-list
20397249|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
20397250|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397251|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20397252|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19364630|NCT04044469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364631|NCT04040959|Niacinamide|niacinamide|mesh-list
19364632|NCT04040959|Niacin|niacin|mesh-list
19364633|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
19364634|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
19364635|NCT04040959|Vitamins|vitamins|mesh-ancestor
19364636|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
19845478|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20397253|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364637|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364638|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19364639|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
19364640|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364641|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19364642|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
19401953|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19401954|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19401955|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19401956|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19401957|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401958|NCT03613389|Vitamin E|vitamin e|mesh-list
19401959|NCT03613389|Vitamins|vitamins|mesh-ancestor
19401960|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
19401961|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401962|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
19401963|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401964|NCT03613389|Protective Agents|protective agents|mesh-ancestor
19401965|NCT03613259|Alovudine|alovudine|mesh-list
19401966|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
19401967|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19401968|NCT03613207|Lidocaine|lidocaine|mesh-list
19401969|NCT03613207|Prilocaine|prilocaine|mesh-list
19401970|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
19401971|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
19401972|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401973|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19401974|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
19401975|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19401976|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401977|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20397254|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397255|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397256|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
20397257|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397258|NCT01114191|Ketoconazole|ketoconazole|mesh-list
20397259|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
20397260|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397261|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20397262|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20397263|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397264|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397265|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20397266|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
19401978|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19401979|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401980|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401981|NCT03613168|Trastuzumab|trastuzumab|mesh-list
19401982|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19401983|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19401984|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
19401985|NCT03612947|Bupivacaine|bupivacaine|mesh-list
19401986|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
19845479|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19845480|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
19845481|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845482|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19845483|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
19845484|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845485|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
19401987|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
19401988|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19401989|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209953|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20209954|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20209955|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19401990|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
19401991|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209956|NCT00282165|Naratriptan|naratriptan|mesh-list
20209957|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20209958|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20209959|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20209960|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
20397267|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397268|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397269|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20397270|NCT01114282|Bortezomib|bortezomib|mesh-list
20397271|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397272|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
20397273|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20397274|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20397275|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20397276|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
20397277|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397278|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20397279|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20397280|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397281|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397282|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20397283|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19364643|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
19364644|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20397284|NCT01114490|Anacetrapib|anacetrapib|mesh-list
20397285|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20397286|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20397287|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
20397288|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364645|NCT04023071|Rituximab|rituximab|mesh-list
19364646|NCT04023071|Fludarabine|fludarabine|mesh-list
19364647|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
19364648|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19364649|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
19364650|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364651|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364652|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19364653|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
19364654|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364655|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364656|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19364657|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364658|NCT04019262|Temozolomide|temozolomide|mesh-list
19364659|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19364660|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
19364661|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364662|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364663|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
19364664|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19364665|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
19364666|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
19364667|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364668|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364669|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364670|NCT04008628|Analgesics|analgesics|mesh-ancestor
19364671|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
19364672|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364673|NCT04001894|Clopidogrel|clopidogrel|mesh-list
19364674|NCT04001894|Ticagrelor|ticagrelor|mesh-list
19364675|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19364676|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19364677|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19364678|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19364679|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
19364680|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364681|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364682|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364683|NCT03988920|Sevelamer|sevelamer|mesh-list
19364684|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
19364685|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
19364686|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364687|NCT03982485|Paclitaxel|paclitaxel|mesh-list
19364688|NCT03982485|Apatinib|apatinib|mesh-list
19364689|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19364690|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364691|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
19364692|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
19364693|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
19401992|NCT03612947|Analgesics|analgesics|mesh-ancestor
19364694|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364695|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19364696|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364697|NCT03969121|Palbociclib|palbociclib|mesh-list
19688764|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688765|NCT05042674|Protective Agents|protective agents|mesh-ancestor
19688766|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688767|NCT05042635|Ixekizumab|ixekizumab|mesh-list
19688768|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
19688769|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
19688770|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19688771|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688772|NCT05042336|Lenvatinib|lenvatinib|mesh-list
19688773|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688774|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19688775|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688776|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688777|NCT05042271|Meropenem|meropenem|mesh-list
19688778|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19688779|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397289|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20397290|NCT01114542|Insulin|insulin|mesh-list
20397291|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20397292|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
20397293|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20397294|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397295|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
20397296|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20397297|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397298|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20397299|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688780|NCT05042245|Silymarin|silymarin|mesh-list
19688781|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
19688782|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
19688783|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688784|NCT05042245|Protective Agents|protective agents|mesh-ancestor
19688785|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397300|NCT01114750|Dextrans|dextrans|mesh-list
20397301|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
19364698|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364699|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19364700|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364701|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364702|NCT03966339|Hormones|hormones|mesh-list
19364703|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364704|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364705|NCT03948022|Progesterone|progesterone|mesh-list
19364706|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
19364707|NCT03948022|Progestins|progestins|mesh-ancestor
19364708|NCT03948022|Hormones|hormones|mesh-ancestor
19364709|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397302|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
20397303|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
20397304|NCT01114841|Tazarotene|tazarotene|mesh-list
20397305|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397306|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
20397307|NCT01114854|Topiramate|topiramate|mesh-list
19364710|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364711|NCT03946111|Naltrexone|naltrexone|mesh-list
19364712|NCT03946111|Bupropion|bupropion|mesh-list
19364713|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19364714|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19364715|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364716|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
19364717|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364718|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19364719|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
19364720|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19364721|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19364722|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19364723|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364724|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364725|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
20397308|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
20397309|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364726|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364727|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19364728|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19364729|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364730|NCT03937596|Cycloserine|cycloserine|mesh-list
19364731|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19364732|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364733|NCT03937596|Renal Agents|renal agents|mesh-ancestor
19364734|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19364735|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
19364736|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19364737|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
19364738|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364739|NCT03928158|Valsartan|valsartan|mesh-list
19364740|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19364741|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19364742|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19364743|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19364744|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364745|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19364746|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19364747|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364748|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19364749|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19364750|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364751|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364752|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
19364753|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364754|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19364755|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19845486|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19845487|NCT00671658|Protective Agents|protective agents|mesh-ancestor
19845488|NCT00671749|Clindamycin|clindamycin|mesh-list
19845489|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
19845490|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
19845491|NCT00671749|Adapalene|adapalene|mesh-list
19845492|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19845493|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19364756|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209961|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20209962|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209963|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364757|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19364758|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19364759|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364760|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364761|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
19364762|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364763|NCT03922880|Nivolumab|nivolumab|mesh-list
19364764|NCT03922880|Ipilimumab|ipilimumab|mesh-list
19364765|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364766|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364767|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19364768|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364769|NCT03920722|Rituximab|rituximab|mesh-list
19364770|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364771|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364772|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
19364773|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364774|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19364775|NCT03902314|Lidocaine|lidocaine|mesh-list
19364776|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
19364777|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
19364778|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845494|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845495|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19845496|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209964|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20209965|NCT00282178|Candesartan|candesartan|mesh-list
20209966|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20209967|NCT00282178|Diuretics|diuretics|mesh-ancestor
20209968|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
19364779|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397310|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397311|NCT01114958|Cisplatin|cisplatin|mesh-list
20397312|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397313|NCT01115036|Panobinostat|panobinostat|mesh-list
20397314|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397315|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19364780|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
20397316|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397317|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397318|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
20397319|NCT01115049|Hexetidine|hexetidine|mesh-list
20397320|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20397321|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397322|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
20397323|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
20397324|NCT01115062|Lidocaine|lidocaine|mesh-list
20397325|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
20397326|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
20397327|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397328|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397329|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
20397330|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397331|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20397332|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20397333|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20397334|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20397335|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397336|NCT01115127|Inositol|inositol|mesh-list
20397337|NCT01115127|Melatonin|melatonin|mesh-list
20397338|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
20397339|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397340|NCT01115127|Protective Agents|protective agents|mesh-ancestor
20397341|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397342|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397343|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
20397344|NCT01115127|Vitamins|vitamins|mesh-ancestor
20397345|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
20397346|NCT01115140|Folic Acid|folic acid|mesh-list
20397347|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
20397348|NCT01115140|Metformin|metformin|mesh-list
20397349|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364781|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364782|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19364783|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20397350|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397351|NCT01115140|Hematinics|hematinics|mesh-ancestor
20397352|NCT01115140|Vitamins|vitamins|mesh-ancestor
20397353|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
20397354|NCT01115179|Propofol|propofol|mesh-list
20397355|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20397356|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20397357|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397358|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397359|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20397360|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
20397361|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
20397362|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20397363|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20397364|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19364784|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19364785|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364786|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364787|NCT03900715|Luspatercept|luspatercept|mesh-list
19364788|NCT03900715|Hematinics|hematinics|mesh-ancestor
19364789|NCT03898037|Metformin|metformin|mesh-list
19364790|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364791|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364792|NCT03894501|Methadone|methadone|mesh-list
19364793|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19364794|NCT03894501|Narcotics|narcotics|mesh-ancestor
19364795|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364796|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364797|NCT03894501|Analgesics|analgesics|mesh-ancestor
20397365|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
20397366|NCT01115322|Tazarotene|tazarotene|mesh-list
20397367|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364798|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
20397368|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
20397369|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
20397370|NCT01115322|Vitamins|vitamins|mesh-ancestor
20397371|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
20397372|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397373|NCT01115426|Losartan|losartan|mesh-list
20397374|NCT01115426|Ramipril|ramipril|mesh-list
20397375|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20397376|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397377|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20397378|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19364799|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364800|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
20397379|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397380|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20397381|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
20397382|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397383|NCT01115439|Artesunate|artesunate|mesh-list
20397384|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
20397385|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
20397386|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20397387|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
20397388|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20397389|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20397390|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397391|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397392|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
20397393|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
20397394|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20397395|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
20397396|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20397397|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397398|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397399|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20397400|NCT01115439|Renal Agents|renal agents|mesh-ancestor
20397401|NCT01115478|Vitamin A|vitamin a|mesh-list
20397402|NCT01115478|Vitamins|vitamins|mesh-ancestor
20397403|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
20397404|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397405|NCT01115504|Thiamine|thiamine|mesh-list
20397406|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
20397407|NCT01115504|Vitamins|vitamins|mesh-ancestor
20397408|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
20397409|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426843|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426844|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426845|NCT01283100|Dolutegravir|dolutegravir|mesh-list
20426846|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20426847|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20426848|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426849|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426850|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20426851|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20426852|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
20426853|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426854|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20426855|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426856|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20426857|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20426858|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426859|NCT01283204|Leucovorin|leucovorin|mesh-list
20426860|NCT01283204|Paclitaxel|paclitaxel|mesh-list
20426861|NCT01283204|Docetaxel|docetaxel|mesh-list
20426862|NCT01283204|Cisplatin|cisplatin|mesh-list
20426863|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
19364801|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
19364802|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
19364803|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19364804|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
19364805|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
19364806|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426864|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
19364807|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426865|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20426866|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426867|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
20426868|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
19364808|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364809|NCT03879538|Analgesics|analgesics|mesh-ancestor
19364810|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
19364811|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397410|NCT01115543|Calcitriol|calcitriol|mesh-list
20397411|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
20397412|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20397413|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20397414|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397415|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20397416|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20397417|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397418|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20397419|NCT01115543|Vitamins|vitamins|mesh-ancestor
20397420|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
19364827|NCT03853317|Avelumab|avelumab|mesh-list
19364828|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364829|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845497|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845498|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845499|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19845500|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19845501|NCT00671749|Analgesics|analgesics|mesh-ancestor
19845502|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
20397421|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20397422|NCT01115712|Pioglitazone|pioglitazone|mesh-list
19845503|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845504|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845505|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845506|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845507|NCT00671788|Dasatinib|dasatinib|mesh-list
19845508|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397423|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20426869|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
19364830|NCT03831165|Acyclovir|acyclovir|mesh-list
19364831|NCT03831165|Melatonin|melatonin|mesh-list
19364832|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
19364833|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364834|NCT03831165|Protective Agents|protective agents|mesh-ancestor
19364835|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364836|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364837|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
19364838|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364839|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19364840|NCT03830723|Hormones|hormones|mesh-ancestor
19364841|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364842|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364843|NCT03829007|Durvalumab|durvalumab|mesh-list
19364844|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19364845|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19688786|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19688787|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19688788|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688789|NCT05041985|Diazepam|diazepam|mesh-list
19688790|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19688791|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
19688792|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
19688793|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
19688794|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688795|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397424|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397425|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20397426|NCT01115725|Hormones|hormones|mesh-ancestor
20397427|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397428|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397429|NCT01115842|Vitamin D|vitamin d|mesh-list
20397430|NCT01115842|Vitamins|vitamins|mesh-ancestor
19364846|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364847|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
19364848|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364849|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19364850|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364851|NCT03801863|Ropivacaine|ropivacaine|mesh-list
19364852|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
19364853|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
20397431|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
20397432|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397433|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20397434|NCT01115894|Naltrexone|naltrexone|mesh-list
20397435|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20397436|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20397437|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397438|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
20397439|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397440|NCT01115946|Enalapril|enalapril|mesh-list
20397441|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20397442|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
20397443|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397444|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397445|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397446|NCT01115959|Valproic Acid|valproic acid|mesh-list
20397447|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
20397448|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397449|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397450|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
19364854|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364855|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364856|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
19364857|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364858|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
19845509|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19845510|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845511|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845512|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19845513|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
19845514|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19845515|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19845516|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19845517|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845518|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845519|NCT00671879|Carisoprodol|carisoprodol|mesh-list
19845520|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19845521|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209969|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209970|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20209971|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20209972|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209973|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20209974|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20209975|NCT00282217|Sirolimus|sirolimus|mesh-list
20209976|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20209977|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20209978|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20209979|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209980|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
20209981|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20209982|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
20209983|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209984|NCT00282360|Trimetazidine|trimetazidine|mesh-list
20209985|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
20209986|NCT00282386|Rofecoxib|rofecoxib|mesh-list
20397451|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397452|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845522|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20397453|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
20397454|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397455|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397456|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397457|NCT01115972|Valsartan|valsartan|mesh-list
20397458|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397459|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20397460|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20397461|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397462|NCT01115985|Atorvastatin|atorvastatin|mesh-list
20397463|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19364859|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19364860|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364861|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364862|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364863|NCT03800641|Analgesics|analgesics|mesh-ancestor
19364864|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
19364865|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364866|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19364867|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19845523|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845524|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
19845525|NCT00671931|Propofol|propofol|mesh-list
19845526|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19845527|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845528|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845529|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19364868|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19364869|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
19364870|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364871|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364872|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
19364873|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20397464|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20397465|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
20397466|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397467|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20397468|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20397469|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397470|NCT01116050|Misoprostol|misoprostol|mesh-list
20397471|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20397472|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
20397473|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20397474|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397475|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20397476|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397477|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
19364874|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19364875|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364876|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
19364877|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
19364878|NCT03772951|Clozapine|clozapine|mesh-list
19364879|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19364880|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
19364881|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364882|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364883|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364884|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19364885|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19364886|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19364887|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19364888|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
19364889|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
19364890|NCT03753087|Empagliflozin|empagliflozin|mesh-list
19364891|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19364892|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364893|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19364894|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845530|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
20397478|NCT01116063|Iloprost|iloprost|mesh-list
19401993|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19401994|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
19845531|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
20397479|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19364895|NCT03735420|Xanthohumol|xanthohumol|mesh-list
19364896|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364897|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19364898|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19364899|NCT03735420|Growth Substances|growth substances|mesh-ancestor
19364900|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364901|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
19364902|NCT03734237|Vaccines|vaccines|mesh-list
19364903|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
19364904|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364905|NCT03730337|Nivolumab|nivolumab|mesh-list
19364906|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364907|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364908|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19364909|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364910|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19364911|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
19364912|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
19364913|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364914|NCT03727776|Hormones|hormones|mesh-list
19364915|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19364916|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19845532|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19364917|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
19845533|NCT00671931|Analgesics|analgesics|mesh-ancestor
19364918|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845534|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
19845535|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845536|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19845537|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19845538|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19845539|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
19845540|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845541|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845542|NCT00671970|Bevacizumab|bevacizumab|mesh-list
19845543|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19845544|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19364919|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364920|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19364921|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364922|NCT03721328|Vancomycin|vancomycin|mesh-list
19364923|NCT03721328|Tobramycin|tobramycin|mesh-list
19364924|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19364925|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364926|NCT03715153|Bumetanide|bumetanide|mesh-list
19364927|NCT03715153|Diuretics|diuretics|mesh-ancestor
19364928|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
19364929|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364930|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19364931|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19364932|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364933|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
19364934|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19364935|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
19364936|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364937|NCT03711838|Expectorants|expectorants|mesh-ancestor
19364938|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
19364939|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19364940|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
19364941|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364942|NCT03711838|Protective Agents|protective agents|mesh-ancestor
19364943|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364944|NCT03711838|Antidotes|antidotes|mesh-ancestor
19364945|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
19364946|NCT03706898|Dolutegravir|dolutegravir|mesh-list
19364947|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
19364948|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
19364949|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19364950|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19364951|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19364952|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19364953|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364954|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19845545|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364955|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19364956|NCT03694002|Paclitaxel|paclitaxel|mesh-list
19364957|NCT03694002|Carboplatin|carboplatin|mesh-list
19364958|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19364959|NCT03694002|Ramucirumab|ramucirumab|mesh-list
19364960|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19364961|NCT03694002|Antibodies|antibodies|mesh-list
19364962|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
19364963|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19364964|NCT03694002|Lexatumumab|lexatumumab|mesh-list
19364965|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19364966|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19364967|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
19364968|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
19364969|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
19364970|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364971|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
19364972|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364973|NCT03691727|Tirofiban|tirofiban|mesh-list
19364974|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19364975|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19364976|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364977|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19364978|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
19364979|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19364980|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19364981|NCT03647852|Prednisolone|prednisolone|mesh-list
19364982|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
19364983|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20397480|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
20397481|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
20397482|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397483|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397484|NCT01116128|Prednisone|prednisone|mesh-list
20397485|NCT01116128|Melphalan|melphalan|mesh-list
20397486|NCT01116128|Dasatinib|dasatinib|mesh-list
20397487|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397488|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
20397489|NCT01116128|Hormones|hormones|mesh-ancestor
20397490|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397491|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397492|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20397493|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397494|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20397495|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
20397496|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19364984|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
19364985|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19364986|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
19364987|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
19364988|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19364989|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19364990|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19364991|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
19364992|NCT03647852|Hormones|hormones|mesh-ancestor
19364993|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19364994|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19364995|NCT03647852|Protective Agents|protective agents|mesh-ancestor
19364996|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19364997|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20209987|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20209988|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20209989|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20209990|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20209991|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20209992|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20209993|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20209994|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20209995|NCT00282386|Analgesics|analgesics|mesh-ancestor
20209996|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
20209997|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397497|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19364998|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
19364999|NCT03630211|Thiotepa|thiotepa|mesh-list
19365000|NCT03630211|Rituximab|rituximab|mesh-list
20397498|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20397499|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
20397500|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20397501|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397502|NCT01116154|Lenalidomide|lenalidomide|mesh-list
20397503|NCT01116154|Vorinostat|vorinostat|mesh-list
20397504|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
20397505|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397506|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20397507|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20397508|NCT01116154|Growth Substances|growth substances|mesh-ancestor
20397509|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
20397510|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688796|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688797|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19688798|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688799|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19688800|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20397511|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20397512|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397513|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397514|NCT01116167|Letrozole|letrozole|mesh-list
20397515|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397516|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20397517|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20397518|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397519|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365001|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
19365002|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
19365003|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19365004|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
19365005|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19365006|NCT03630211|Antibodies|antibodies|mesh-list
19365007|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
19365008|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19365009|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365010|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
19365011|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688801|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19688802|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19688803|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19688804|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19688805|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
19688806|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
19688807|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
19688808|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
19688809|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688810|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688811|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
19688812|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19688813|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19688814|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688815|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688816|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688817|NCT05041582|Citalopram|citalopram|mesh-list
20397520|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20397521|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
20397522|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397523|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397524|NCT01116180|Candesartan|candesartan|mesh-list
20397525|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
20397526|NCT01116180|Giapreza|giapreza|mesh-list
20397527|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20397528|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
20397529|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397530|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20397531|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397532|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20397533|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20397534|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
20397535|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397536|NCT01116193|Dexamethasone|dexamethasone|mesh-list
20397537|NCT01116193|Lenalidomide|lenalidomide|mesh-list
19365012|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365013|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19365014|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
20397538|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688818|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19688819|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19688820|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688821|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688822|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688823|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
19688824|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688825|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19688826|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
19845546|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845547|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19845548|NCT00671970|Growth Substances|growth substances|mesh-ancestor
19845549|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365015|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365016|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365017|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19365018|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365019|NCT03629327|Aspirin|aspirin|mesh-list
19365020|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19365021|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19365022|NCT03629327|Analgesics|analgesics|mesh-ancestor
19845550|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845551|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19845552|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845553|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845554|NCT00672100|Ropivacaine|ropivacaine|mesh-list
19845555|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
19845556|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
19845557|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845558|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845559|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
19845560|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845561|NCT00672139|Bromides|bromides|mesh-list
19845562|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
20397539|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
20397540|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
20397541|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397542|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397543|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397544|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
20397545|NCT01116193|Hormones|hormones|mesh-ancestor
20397546|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397547|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20397548|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397549|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
20397550|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20397551|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20397552|NCT01116193|Growth Substances|growth substances|mesh-ancestor
20397553|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
20397554|NCT01116206|Prucalopride|prucalopride|mesh-list
20397555|NCT01116206|Laxatives|laxatives|mesh-ancestor
20397556|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397557|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20397558|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20397559|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
20397560|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397561|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397562|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397563|NCT01116219|Bevacizumab|bevacizumab|mesh-list
20397564|NCT01116219|Pemetrexed|pemetrexed|mesh-list
20397565|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20397566|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20397567|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397568|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20397569|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20397570|NCT01116219|Growth Substances|growth substances|mesh-ancestor
20397571|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397572|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
19365023|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
19845563|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
20397573|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397574|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365024|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397575|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20397576|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20397577|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20397578|NCT01116271|Irinotecan|irinotecan|mesh-list
20397579|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20397580|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20397581|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397582|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397583|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397584|NCT01116310|Glycine|glycine|mesh-list
20397585|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
20397586|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397587|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397588|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397589|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20397590|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397591|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20397592|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397593|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397594|NCT01116388|Caseins|caseins|mesh-list
20397595|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
20397596|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
20397597|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397598|NCT01116531|Pregabalin|pregabalin|mesh-list
20397599|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19365025|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365026|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365027|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365028|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19365029|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19365030|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365031|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19365032|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19365033|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365034|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
19365035|NCT03604159|Buprenorphine|buprenorphine|mesh-list
19365036|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19365037|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19365038|NCT03604159|Narcotics|narcotics|mesh-ancestor
19365039|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365040|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397600|NCT01116531|Tramadol|tramadol|mesh-list
20397601|NCT01116531|Analgesics|analgesics|mesh-ancestor
20397602|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
20397603|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397604|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397605|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
19365041|NCT03604159|Analgesics|analgesics|mesh-ancestor
19365042|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
19365043|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365044|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20397606|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20397607|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365048|NCT03592693|Vitamins|vitamins|mesh-list
19365049|NCT03592693|Ascorbic Acid|ascorbic acid|mesh-list
19365050|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
19365051|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
19365052|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365053|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365054|NCT03592693|Antioxidants|antioxidants|mesh-ancestor
19365055|NCT03592693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365056|NCT03592693|Protective Agents|protective agents|mesh-ancestor
19365057|NCT03591380|Belimumab|belimumab|mesh-list
19365058|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365059|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
19365060|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365061|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
19365062|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
19365063|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365064|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19688827|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19688828|NCT05041790|Choline|choline|mesh-list
19688829|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
19688830|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19365065|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365066|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365067|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
19365068|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845564|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19845565|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845566|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
19845567|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845568|NCT00672204|Sirolimus|sirolimus|mesh-list
19845569|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
19845570|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19845571|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19845572|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845573|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20397608|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397609|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20397610|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20397611|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397612|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397613|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397614|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20397615|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19845574|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845575|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
19845576|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845577|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
19845578|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845579|NCT00672243|Sirolimus|sirolimus|mesh-list
19845580|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19845581|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845582|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19845583|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845584|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845585|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19845586|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845587|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19365069|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
19365070|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365071|NCT03578172|Menotropins|menotropins|mesh-list
19365072|NCT03578172|Hormones|hormones|mesh-list
19365073|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365074|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365075|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19365076|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
19365077|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19365078|NCT03578081|Dexamethasone|dexamethasone|mesh-list
19365079|NCT03578081|Ondansetron|ondansetron|mesh-list
19365080|NCT03578081|Olanzapine|olanzapine|mesh-list
19365081|NCT03578081|Palonosetron|palonosetron|mesh-list
19365082|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
19365083|NCT03578081|Aprepitant|aprepitant|mesh-list
19365084|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365085|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
19365086|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
19688831|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
19688832|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688833|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688834|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19688835|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
19688836|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
19688837|NCT05041153|Lenvatinib|lenvatinib|mesh-list
19688838|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19688839|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688840|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19688841|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688842|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688843|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
19688844|NCT05041270|Nalbuphine|nalbuphine|mesh-list
19688845|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19688846|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688847|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688848|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19688849|NCT05041270|Analgesics|analgesics|mesh-ancestor
19688850|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
19845588|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
19688851|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688852|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19688853|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19688854|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19688855|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
19688856|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688857|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688858|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19688859|NCT05041270|Narcotics|narcotics|mesh-ancestor
19688860|NCT05040906|Rituximab|rituximab|mesh-list
19688861|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19688862|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688863|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
19688864|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688865|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397616|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397617|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
19365087|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365088|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365089|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365090|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
19365091|NCT03578081|Hormones|hormones|mesh-ancestor
19365092|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365093|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19365094|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365095|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
19365096|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397618|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
20397619|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20397620|NCT01116531|Narcotics|narcotics|mesh-ancestor
20397621|NCT01116583|Gabapentin|gabapentin|mesh-list
20397622|NCT01116583|Analgesics|analgesics|mesh-ancestor
20397623|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
20397624|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397625|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397626|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
20397627|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19365097|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19365098|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
19365099|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365100|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365101|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19365102|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19365103|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365104|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365105|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19365106|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19365107|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19365108|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365109|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19365110|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19365111|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19365112|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365113|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365114|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365115|NCT03561259|Vorinostat|vorinostat|mesh-list
19365116|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19365117|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365118|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19365119|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365120|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365121|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19365122|NCT03551522|Seladelpar|seladelpar|mesh-list
19365123|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19365124|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
19365125|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365126|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19365127|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
19365128|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
19365129|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
19365130|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365131|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20397628|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20209998|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20209999|NCT00282399|Decitabine|decitabine|mesh-list
20210000|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20210001|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
20210002|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210003|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210004|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210005|NCT00282451|Insulin|insulin|mesh-list
20210006|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20210007|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
20210008|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
20397629|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210009|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20210010|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
20210011|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210012|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210013|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
20210014|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20210015|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20210016|NCT00282503|Prednisolone|prednisolone|mesh-list
20210017|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
20397630|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397631|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20397632|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20397633|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397634|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397635|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
20397636|NCT01116596|Acetaminophen|acetaminophen|mesh-list
20397637|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20397638|NCT01116596|Analgesics|analgesics|mesh-ancestor
20397639|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
20397640|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397641|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397642|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
20397643|NCT01116609|Epinephrine|epinephrine|mesh-list
19365132|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20210018|NCT00282503|Methoxsalen|methoxsalen|mesh-list
20397644|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20397645|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20397646|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19365133|NCT03539601|Analgesics|analgesics|mesh-ancestor
19365134|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
19365135|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365136|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365137|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365138|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
19365139|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365140|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
19365141|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19365142|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365143|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365144|NCT03535688|Cycloserine|cycloserine|mesh-list
19365145|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19365146|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365147|NCT03535688|Renal Agents|renal agents|mesh-ancestor
19365148|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19365149|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
20397647|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397648|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397649|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397650|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20397651|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20397652|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
20397653|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397654|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20397655|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
20397656|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
20397657|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
20397658|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19365150|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19365151|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
20210019|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20210020|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
20210021|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397659|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20397660|NCT01116622|Bexarotene|bexarotene|mesh-list
19365152|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365153|NCT03535350|Temozolomide|temozolomide|mesh-list
19365154|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19365155|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
19365156|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365157|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365158|NCT03532451|Nivolumab|nivolumab|mesh-list
19365159|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365160|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365161|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365162|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365163|NCT03522844|Citalopram|citalopram|mesh-list
19365164|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19365165|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19365166|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365167|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365168|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365169|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
19365170|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365171|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19365172|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
19365173|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365174|NCT03514719|Avelumab|avelumab|mesh-list
19688866|NCT05040828|Montelukast|montelukast|mesh-list
19688867|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19688868|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
19688869|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19688870|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
19688871|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688872|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688873|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19688874|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19688875|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688876|NCT05040724|Ivermectin|ivermectin|mesh-list
19688877|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19365175|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19365176|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365177|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365178|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
19365179|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365180|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
19365181|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365182|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365183|NCT03513770|Ketorolac|ketorolac|mesh-list
19365184|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19365185|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19365186|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19365187|NCT03513770|Analgesics|analgesics|mesh-ancestor
19365188|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
19365189|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365190|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365191|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688878|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688879|NCT05040594|Lidocaine|lidocaine|mesh-list
20397661|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397662|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20397663|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397664|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397665|NCT01116635|Doxorubicin|doxorubicin|mesh-list
20397666|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20397667|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397668|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20397669|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20397670|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397671|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397672|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
20397673|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19365192|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365193|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19845589|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845590|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
19688880|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
19688881|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
19688882|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688883|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688884|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
20397674|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397675|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397676|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20397677|NCT01116700|Analgesics|analgesics|mesh-ancestor
20397678|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
20397679|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397680|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20397681|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20397682|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20397683|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
20397684|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397685|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397686|NCT01116713|Dexamethasone|dexamethasone|mesh-list
20397687|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397688|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
20397689|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
19688885|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688886|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19688887|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19688888|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19688889|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688890|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688891|NCT05040217|Mitogens|mitogens|mesh-list
19688892|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
19688893|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692966|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692967|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19692968|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19692969|NCT04984980|Growth Substances|growth substances|mesh-ancestor
19692970|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692971|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
19692972|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19692973|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
20397690|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397691|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365194|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365195|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401995|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19401996|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19401997|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19401998|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19401999|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
19402000|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19402001|NCT03612817|Timolol|timolol|mesh-list
19402002|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19402003|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19402004|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402005|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402006|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402007|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402008|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19402009|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19402010|NCT03612739|Azacitidine|azacitidine|mesh-list
19402011|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19402012|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
19402013|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402014|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402015|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404653|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
19404654|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404655|NCT03592901|Anesthetics|anesthetics|mesh-list
19404656|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404657|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404658|NCT03592836|Furosemide|furosemide|mesh-list
19404659|NCT03592836|Diuretics|diuretics|mesh-list
19404660|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20397692|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365196|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
19365197|NCT03492112|Velpatasvir|velpatasvir|mesh-list
19365198|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
19365199|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365200|NCT03484520|Venetoclax|venetoclax|mesh-list
19365201|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365202|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19365203|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19365204|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19365205|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19365206|NCT03476642|Epinephrine|epinephrine|mesh-list
19365207|NCT03476642|Ropivacaine|ropivacaine|mesh-list
19365208|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
19365209|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
19365210|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365211|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365212|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
20397693|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
20397694|NCT01116713|Hormones|hormones|mesh-ancestor
20397695|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397696|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20397697|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397698|NCT01116791|Cisplatin|cisplatin|mesh-list
20397699|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397700|NCT01116817|Ritonavir|ritonavir|mesh-list
19365213|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365214|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19365215|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19365216|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
19365217|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365218|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365219|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19365220|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19365221|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
19365222|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19365223|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
19845591|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845592|NCT00672438|Alfentanil|alfentanil|mesh-list
19845593|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19845594|NCT00672438|Narcotics|narcotics|mesh-ancestor
19845595|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845596|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845597|NCT00672438|Analgesics|analgesics|mesh-ancestor
19845598|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
19845599|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845600|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19845601|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
19845602|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
19845603|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
19845604|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19845605|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845606|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
19845607|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845608|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19845609|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
19845610|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19845611|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19845612|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19845613|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845614|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845615|NCT00672594|Sunitinib|sunitinib|mesh-list
19845616|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845617|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845618|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19845619|NCT00672594|Growth Substances|growth substances|mesh-ancestor
19845620|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845621|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845622|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19845623|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397701|NCT01116817|Lopinavir|lopinavir|mesh-list
20397702|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20397703|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19845624|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397704|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
19365224|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
19845625|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19845626|NCT00672620|Vortioxetine|vortioxetine|mesh-list
20397705|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365225|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
19365226|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19365227|NCT03465280|Interferons|interferons|mesh-list
19365228|NCT03465280|Acyclovir|acyclovir|mesh-list
19365229|NCT03465280|Cidofovir|cidofovir|mesh-list
19365230|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
19365231|NCT03465280|Artemisinins|artemisinins|mesh-list
19365232|NCT03465280|Artemisinin|artemisinin|mesh-list
19365233|NCT03465280|Celecoxib|celecoxib|mesh-list
20397706|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397707|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20397708|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20397709|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
20397710|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397711|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20397712|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20397713|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
20397714|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397715|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397716|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397717|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397718|NCT01117038|Amlodipine|amlodipine|mesh-list
20397719|NCT01117038|Enalapril|enalapril|mesh-list
20397720|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20397721|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20397722|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20397723|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397724|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20397725|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397726|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
20397727|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20397728|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
20397729|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397730|NCT01117116|Fluticasone|fluticasone|mesh-list
20397731|NCT01117116|Xhance|xhance|mesh-list
20397732|NCT01117116|Budesonide|budesonide|mesh-list
20397733|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
20397734|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20397735|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397736|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20397737|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
20397738|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397739|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397740|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20397741|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
20397742|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397743|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19365234|NCT03465280|Bevacizumab|bevacizumab|mesh-list
19365235|NCT03465280|Methotrexate|methotrexate|mesh-list
19365236|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
19365237|NCT03465280|Isotretinoin|isotretinoin|mesh-list
19365238|NCT03465280|Cimetidine|cimetidine|mesh-list
20397744|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
19365239|NCT03465280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365240|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365241|NCT03465280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19365242|NCT03465280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19365243|NCT03465280|Growth Substances|growth substances|mesh-ancestor
19365244|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365245|NCT03465280|Growth Inhibitors|growth inhibitors|mesh-ancestor
19365246|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19365247|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
19365248|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19365249|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365250|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
20397745|NCT01117116|Hormones|hormones|mesh-ancestor
20397746|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397747|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20397748|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20397749|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20397750|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
20397751|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365251|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365252|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
19365253|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397752|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397753|NCT01117129|Rituximab|rituximab|mesh-list
20397754|NCT01117129|Methotrexate|methotrexate|mesh-list
20397755|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20397756|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397757|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
20210022|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
20210023|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
20210024|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210025|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210026|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210027|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
20210028|NCT00282503|Hormones|hormones|mesh-ancestor
20210029|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210030|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20397758|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688894|NCT05039801|Pembrolizumab|pembrolizumab|mesh-list
19688895|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19688896|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688897|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19688898|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19688899|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688900|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688901|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19688902|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19688903|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688904|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
20210031|NCT00282503|Protective Agents|protective agents|mesh-ancestor
20397759|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397760|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20397761|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
20397762|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20397763|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20397764|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
19688905|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688906|NCT05039580|Dexamethasone|dexamethasone|mesh-list
19688907|NCT05039580|Antibodies|antibodies|mesh-list
20210032|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20397765|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397766|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397767|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397768|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20397769|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20397770|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20397771|NCT01117220|Ziprasidone|ziprasidone|mesh-list
20397772|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20397773|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
20397774|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397775|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397776|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397777|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20397778|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397779|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365254|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20397780|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397781|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20397782|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
20397783|NCT01117298|Tadalafil|tadalafil|mesh-list
20397784|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
19365255|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365256|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
19365257|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365258|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19365259|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
19365260|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365261|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19365262|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19365263|NCT03465280|Analgesics|analgesics|mesh-ancestor
19365264|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
19365265|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365266|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365267|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19688908|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19365268|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19365269|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19365270|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365271|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19365272|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
19365273|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
19365274|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365275|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19365276|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19365277|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
19365278|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19365279|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19365280|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19365281|NCT03465280|Protective Agents|protective agents|mesh-ancestor
19365282|NCT03464136|Adalimumab|adalimumab|mesh-list
19365283|NCT03464136|Ustekinumab|ustekinumab|mesh-list
19365284|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365285|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365286|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
19365287|NCT03454035|Palbociclib|palbociclib|mesh-list
19365288|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365289|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19365290|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365291|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365292|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19365293|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
19365294|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365295|NCT03421041|Dexamethasone|dexamethasone|mesh-list
19365296|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365297|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
19365298|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
19365299|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365300|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365301|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365302|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
19365303|NCT03421041|Hormones|hormones|mesh-ancestor
19365304|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365305|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19365306|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210033|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210034|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20210035|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
20210036|NCT00282594|Insulin|insulin|mesh-list
20210037|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210038|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365307|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19365308|NCT03377790|Cantharidin|cantharidin|mesh-list
19365309|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365310|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365311|NCT03376477|Lenalidomide|lenalidomide|mesh-list
19688909|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
19688910|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397785|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20397786|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20397787|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397788|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397789|NCT01117298|Urological Agents|urological agents|mesh-ancestor
20397790|NCT01117376|Erythromycin|erythromycin|mesh-list
20397791|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
20397792|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20397793|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
20397794|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
20397795|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20397796|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397797|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397798|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19688911|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688912|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
19688913|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
19688914|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688915|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210039|NCT00282607|Udenafil|udenafil|mesh-list
19365312|NCT03376477|Molgramostim|molgramostim|mesh-list
19365313|NCT03376477|Vaccines|vaccines|mesh-list
19688916|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
19688917|NCT05039580|Hormones|hormones|mesh-ancestor
20210040|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20397799|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397800|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397801|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20397802|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397803|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
20397804|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426870|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365314|NCT03376477|Sargramostim|sargramostim|mesh-list
19365315|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19365316|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
19365317|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365318|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19365319|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19365320|NCT03376477|Growth Substances|growth substances|mesh-ancestor
19365321|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
19365322|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365323|NCT03367871|Paclitaxel|paclitaxel|mesh-list
19365324|NCT03367871|Bevacizumab|bevacizumab|mesh-list
19365325|NCT03367871|Carboplatin|carboplatin|mesh-list
19365326|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
19365327|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19365328|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426871|NCT01283204|Antidotes|antidotes|mesh-ancestor
20426872|NCT01283204|Protective Agents|protective agents|mesh-ancestor
20426873|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426874|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
20426875|NCT01283204|Vitamins|vitamins|mesh-ancestor
20426876|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
20426877|NCT01283217|Cisplatin|cisplatin|mesh-list
20426878|NCT01283217|Docetaxel|docetaxel|mesh-list
19365329|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
19365330|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19365331|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19365332|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845627|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19845628|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19845629|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19845630|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845631|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845632|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845633|NCT00672620|Analgesics|analgesics|mesh-ancestor
19845634|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
20426879|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426880|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20426881|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20426882|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20426883|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428636|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428637|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
20428638|NCT01293097|Atorvastatin|atorvastatin|mesh-list
20428639|NCT01293097|Pravastatin|pravastatin|mesh-list
20428640|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20428641|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19365333|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365334|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19365335|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19365336|NCT03367871|Growth Substances|growth substances|mesh-ancestor
19365337|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365338|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
19365339|NCT03365609|Bismuth|bismuth|mesh-list
19365340|NCT03365609|Antacids|antacids|mesh-ancestor
19365341|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428642|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
20428643|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428644|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20428645|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20428646|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428647|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
20428648|NCT01293136|Narcotics|narcotics|mesh-ancestor
20428649|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428650|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428651|NCT01293136|Analgesics|analgesics|mesh-ancestor
19365342|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365343|NCT03353675|Nivolumab|nivolumab|mesh-list
20397805|NCT01117610|Ropivacaine|ropivacaine|mesh-list
20397806|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
20397807|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
20397808|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397809|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397810|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
20397811|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365344|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365345|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365346|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365347|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365348|NCT03341156|Thrombin|thrombin|mesh-list
19365349|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
19365350|NCT03341156|Coagulants|coagulants|mesh-ancestor
19365351|NCT03341078|Ibudilast|ibudilast|mesh-list
19365352|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19365353|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
19365354|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365355|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365356|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19365357|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
19365358|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19365359|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365360|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365361|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19365362|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
19365363|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19365364|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
19365365|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
19365366|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365367|NCT03319316|Durvalumab|durvalumab|mesh-list
19365368|NCT03319316|Tremelimumab|tremelimumab|mesh-list
19365369|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365370|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365371|NCT03317496|Gemcitabine|gemcitabine|mesh-list
19365372|NCT03317496|Cisplatin|cisplatin|mesh-list
19365373|NCT03317496|Carboplatin|carboplatin|mesh-list
19365374|NCT03317496|Pemetrexed|pemetrexed|mesh-list
19365375|NCT03317496|Avelumab|avelumab|mesh-list
19365376|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19365377|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365378|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365379|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
19365380|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397812|NCT01117636|Aspirin|aspirin|mesh-list
20397813|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20397814|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20397815|NCT01117636|Analgesics|analgesics|mesh-ancestor
20397816|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
20397817|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365381|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
19365382|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365383|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365384|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365385|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
19365386|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365387|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19365388|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19365389|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365390|NCT03315832|Valsartan|valsartan|mesh-list
19365391|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19365392|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19365393|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19365394|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365395|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19688918|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688919|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19688920|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688921|NCT05039606|Nedaplatin|nedaplatin|mesh-list
19688922|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688923|NCT05038969|Esomeprazole|esomeprazole|mesh-list
19688924|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20426884|NCT01283256|Zonisamide|zonisamide|mesh-list
19365396|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19365397|NCT03300518|Estradiol|estradiol|mesh-list
19365398|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19365399|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19365400|NCT03300518|Ganirelix|ganirelix|mesh-list
19365401|NCT03300518|Estrogens|estrogens|mesh-ancestor
19365402|NCT03300518|Hormones|hormones|mesh-ancestor
19365403|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365404|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365405|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19365406|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
19365407|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20397818|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365408|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19365409|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
20397819|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397820|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397821|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20397822|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20397823|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397824|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20397825|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20397826|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397827|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
20397828|NCT01117662|Rituximab|rituximab|mesh-list
20397829|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20397830|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397831|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
20397832|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397833|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397834|NCT01118039|Sunitinib|sunitinib|mesh-list
20397835|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397836|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20397837|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20397838|NCT01118039|Growth Substances|growth substances|mesh-ancestor
20397839|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397840|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
20397841|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20397842|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397843|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397844|NCT01118065|Everolimus|everolimus|mesh-list
20397845|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397846|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20397847|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
19688925|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19688926|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19365410|NCT03299309|Vaccines|vaccines|mesh-list
19365411|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
19365412|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365413|NCT03294109|Bupivacaine|bupivacaine|mesh-list
20210041|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20210042|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210043|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210044|NCT00282698|Insulin|insulin|mesh-list
20210045|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210046|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210047|NCT00282724|Liarozole|liarozole|mesh-list
20210048|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
20210049|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
20210050|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20397848|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688927|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397849|NCT01118234|Rituximab|rituximab|mesh-list
20397850|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20397851|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397852|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
20397853|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397854|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397855|NCT01118260|Anesthetics|anesthetics|mesh-list
20397856|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397857|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397858|NCT01118286|Nifedipine|nifedipine|mesh-list
20397859|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20397860|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426885|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
19693172|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365414|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
19365415|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
19365416|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365417|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365418|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
19365419|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365420|NCT03277196|Ivacaftor|ivacaftor|mesh-list
19365421|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19365422|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365423|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365424|NCT03273413|Pravastatin|pravastatin|mesh-list
19365425|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19365426|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19365427|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
19688928|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688929|NCT05038605|Metronidazole|metronidazole|mesh-list
19688930|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688931|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20397861|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397862|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20397863|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688932|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19688933|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19688934|NCT05038657|Atezolizumab|atezolizumab|mesh-list
20397864|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
19365428|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365429|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19365430|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19365431|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397865|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
19365432|NCT03269409|Coal Tar|coal tar|mesh-list
19365433|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
19365434|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
19365435|NCT03268005|Insulin|insulin|mesh-list
19365436|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19365437|NCT03268005|Metformin|metformin|mesh-list
19365438|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
19365439|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
19365440|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19365441|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19365442|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365443|NCT03257618|Temozolomide|temozolomide|mesh-list
19365444|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19365445|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
19365446|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365447|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365448|NCT03228186|Docetaxel|docetaxel|mesh-list
19365449|NCT03228186|Pevonedistat|pevonedistat|mesh-list
19365450|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365451|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
19365452|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
19365453|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
19365454|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365455|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365456|NCT03226756|Nivolumab|nivolumab|mesh-list
19365457|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365458|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365459|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365460|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365461|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19365462|NCT03220854|Antibodies|antibodies|mesh-list
19365463|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
19365464|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19365465|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
19365466|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365467|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365468|NCT03187769|Olanzapine|olanzapine|mesh-list
19365469|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
20397866|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20397867|NCT01118403|Ampicillin|ampicillin|mesh-list
20397868|NCT01118403|Sulbactam|sulbactam|mesh-list
20397869|NCT01118403|Sultamicillin|sultamicillin|mesh-list
20397870|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20397871|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688935|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20397872|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20397873|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397874|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397875|NCT01118429|Oxybutynin|oxybutynin|mesh-list
20397876|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
20397877|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
20397878|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397879|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397880|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20397881|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20397882|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
20397883|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397884|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397885|NCT01118429|Urological Agents|urological agents|mesh-ancestor
20397886|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
20397887|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
20397888|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397889|NCT01118559|Darexaban|darexaban|mesh-list
20397890|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20397891|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
20397892|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20397893|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
20397894|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397895|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397896|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
20397897|NCT01118572|Celecoxib|celecoxib|mesh-list
20397898|NCT01118572|Etodolac|etodolac|mesh-list
20397899|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19365470|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
19365471|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365472|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365473|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365474|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19845635|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845636|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
19845637|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19845638|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
19845639|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19845640|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19845641|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397900|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20397901|NCT01118572|Analgesics|analgesics|mesh-ancestor
19365475|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19365476|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365477|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365478|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19365479|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19365480|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365481|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365482|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365483|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
19365484|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
19365485|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
19365486|NCT03168438|Fludarabine|fludarabine|mesh-list
19365487|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365488|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
20397902|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
20397903|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397904|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397905|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20397906|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397907|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20397908|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20397909|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397910|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397911|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
20397912|NCT01118598|Niacin|niacin|mesh-list
20397913|NCT01118598|Niacinamide|niacinamide|mesh-list
20397914|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
20397915|NCT01118598|Vitamins|vitamins|mesh-ancestor
20397916|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
19365489|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365490|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20397917|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397918|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20397919|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
20397920|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365491|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19365492|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
19365493|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365494|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365495|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19365496|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365497|NCT03154996|Topotecan|topotecan|mesh-list
19365498|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19365499|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19365500|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365501|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365502|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365503|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
19365504|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365505|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365506|NCT03141034|Irinotecan|irinotecan|mesh-list
19365507|NCT03141034|Ramucirumab|ramucirumab|mesh-list
19365508|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19365509|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19365510|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365511|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365512|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365513|NCT03132038|Nivolumab|nivolumab|mesh-list
19365514|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365515|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365516|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365517|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365518|NCT03128021|Milnacipran|milnacipran|mesh-list
19365519|NCT03128021|Citalopram|citalopram|mesh-list
19365520|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
19365521|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19365522|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19365523|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365524|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365525|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210051|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210052|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
20210053|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210054|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210055|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20210056|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210057|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20210058|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20210059|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20210060|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
20210061|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365526|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
19365527|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365528|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19365529|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
19365530|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365531|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365532|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20210062|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210063|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210064|NCT00282932|Urological Agents|urological agents|mesh-ancestor
20210065|NCT00282945|Metformin|metformin|mesh-list
20210066|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
20210067|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210068|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210069|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
20210070|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20210071|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20397921|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20397922|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
20397923|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20397924|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20397925|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397926|NCT01118702|Methylphenidate|methylphenidate|mesh-list
20397927|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19365533|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19365534|NCT03128021|Analgesics|analgesics|mesh-ancestor
19365535|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
19402016|NCT03612557|Penicillins|penicillins|mesh-list
19402017|NCT03612557|Penicillin G|penicillin g|mesh-list
19402018|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19402019|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
19402020|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402021|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613076|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613077|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613078|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613079|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397928|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397929|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20397930|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20397931|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20397932|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397933|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
20397934|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397935|NCT01118793|Clopidogrel|clopidogrel|mesh-list
20397936|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20397937|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20397938|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20613080|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613081|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613082|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20397939|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20397940|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
20613083|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
19402022|NCT03612492|Lidocaine|lidocaine|mesh-list
19402023|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
19402024|NCT03612492|Anesthetics|anesthetics|mesh-list
19402025|NCT03612492|Esmolol|esmolol|mesh-list
19402026|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402027|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402028|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
19402029|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402030|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19402031|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19402032|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19402033|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402034|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402035|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19402036|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19402037|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402038|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402039|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19402040|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
19402041|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19402042|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402043|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402044|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19402045|NCT03612440|Analgesics|analgesics|mesh-ancestor
19402046|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
19402047|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402048|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19402049|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19402050|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19402051|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402052|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402053|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402054|NCT03612401|Mirabegron|mirabegron|mesh-list
19402055|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19402056|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19402057|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19402058|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402059|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402060|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404661|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
19688936|NCT05038072|Triamcinolone|triamcinolone|mesh-list
19688937|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19688938|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19845642|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19845643|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
20397941|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397942|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397943|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397944|NCT01118871|Ritonavir|ritonavir|mesh-list
20397945|NCT01118871|Darunavir|darunavir|mesh-list
20397946|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20397947|NCT01118871|Etravirine|etravirine|mesh-list
20397948|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20397949|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20397950|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
20397951|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20397952|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397953|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20397954|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20397955|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
20397956|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20397957|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20397958|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19845644|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19845645|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19845646|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20210072|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20210073|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210074|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210075|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
20210076|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210077|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210078|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20397959|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19845647|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19845648|NCT00672646|Naproxen|naproxen|mesh-list
20613084|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613085|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613086|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20397960|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20397961|NCT01118884|Promethazine|promethazine|mesh-list
20397962|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
20397963|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
20397964|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
20397965|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20397966|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
20397967|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
20397968|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20397969|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397970|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397971|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20397972|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20397973|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20397974|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397975|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
20397976|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
20397977|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
20397978|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20397979|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
20397980|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
20397981|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397982|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
20613087|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
20613088|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19365536|NCT03110380|Dolutegravir|dolutegravir|mesh-list
19365537|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19365538|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20397983|NCT01118923|Antacids|antacids|mesh-ancestor
20397984|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397985|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845649|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20210079|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210080|NCT00282997|Pregabalin|pregabalin|mesh-list
20210081|NCT00282997|Analgesics|analgesics|mesh-ancestor
20397986|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
20397987|NCT01118936|Antacids|antacids|mesh-ancestor
19365539|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19365540|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365541|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365542|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19365543|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19365544|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
19365545|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365546|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19365547|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19365548|NCT03078478|Insulin|insulin|mesh-list
19365549|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19365550|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
19365551|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19365552|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365553|NCT03061539|Nivolumab|nivolumab|mesh-list
19365554|NCT03061539|Ipilimumab|ipilimumab|mesh-list
19365555|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365556|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365557|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365558|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365559|NCT03046927|Vitamin D|vitamin d|mesh-list
19365560|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
19365561|NCT03046927|Vitamins|vitamins|mesh-ancestor
19365562|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
19365563|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365564|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19365565|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19365566|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
20397988|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20397989|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20397990|NCT01119014|Aripiprazole|aripiprazole|mesh-list
20397991|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20397992|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
20397993|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20397994|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20397995|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20397996|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20397997|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20397998|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
20397999|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
20398000|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398001|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398002|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20398003|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20398004|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
20398005|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20398006|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20398007|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19365567|NCT03016377|Fludarabine|fludarabine|mesh-list
19365568|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365569|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
19365570|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398008|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19365571|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365572|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19365573|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
19365574|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365575|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365576|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19365577|NCT03009487|Amlodipine|amlodipine|mesh-list
19365578|NCT03009487|Olmesartan|olmesartan|mesh-list
19365579|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20210082|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
20210083|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365580|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
20210084|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210085|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
20210086|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20210087|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210088|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210089|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19365581|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19365582|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20613089|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20613090|NCT02253862|Urological Agents|urological agents|mesh-ancestor
20613091|NCT02253875|Ritonavir|ritonavir|mesh-list
20210090|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20210091|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20210092|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210093|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210094|NCT00283036|Irbesartan|irbesartan|mesh-list
20398009|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
20398010|NCT01119066|Melphalan|melphalan|mesh-list
20398011|NCT01119066|Busulfan|busulfan|mesh-list
20398012|NCT01119066|Thiotepa|thiotepa|mesh-list
20398013|NCT01119066|Fludarabine|fludarabine|mesh-list
20398014|NCT01119066|Clofarabine|clofarabine|mesh-list
20210095|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20210096|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20210097|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20210098|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365583|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19365584|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365585|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365586|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19365587|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365588|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
19845650|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19845651|NCT00672646|Analgesics|analgesics|mesh-ancestor
19845652|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
19845653|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210099|NCT00283088|Plasminogen|plasminogen|mesh-list
20398015|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398016|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
20398017|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613092|NCT02253875|Tipranavir|tipranavir|mesh-list
20613093|NCT02253875|Omeprazole|omeprazole|mesh-list
20613094|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19365589|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19365590|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19365591|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
19365592|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19365593|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19365594|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365595|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19365596|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19365597|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
19365598|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
19365599|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365600|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365601|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365602|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
19365603|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19365604|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365605|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365606|NCT02966782|Azacitidine|azacitidine|mesh-list
19365607|NCT02966782|Venetoclax|venetoclax|mesh-list
20613095|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19365608|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365609|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
19365610|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365611|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365612|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365613|NCT02961881|Blinatumomab|blinatumomab|mesh-list
19365614|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688939|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19688940|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688941|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
19688942|NCT05038072|Hormones|hormones|mesh-ancestor
19688943|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19688944|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688945|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19688946|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
19688947|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688948|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688949|NCT05038007|Bupivacaine|bupivacaine|mesh-list
20398018|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613096|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
19845654|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365615|NCT02954523|Dasatinib|dasatinib|mesh-list
19365616|NCT02954523|Osimertinib|osimertinib|mesh-list
19365617|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365618|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19365619|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365620|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365621|NCT02927249|Aspirin|aspirin|mesh-list
19365622|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19365623|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20398019|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20398020|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
20398021|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398022|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398023|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20398024|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20398025|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
20398026|NCT01119079|Anesthetics|anesthetics|mesh-list
19365624|NCT02927249|Analgesics|analgesics|mesh-ancestor
19365625|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
19365626|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365627|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365628|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365629|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19365630|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19365631|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19365632|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365633|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19365634|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19365635|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365636|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
19845655|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845656|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845657|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
19845658|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19845659|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845660|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845661|NCT00672737|Remifentanil|remifentanil|mesh-list
20398027|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398028|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398029|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
20398030|NCT01119144|Calcium|calcium|mesh-list
20398031|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398032|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398033|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20398034|NCT01119157|Vaccines|vaccines|mesh-list
19688950|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19688951|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
19688952|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398035|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
20398036|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398037|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
20398038|NCT01119196|Icodextrin|icodextrin|mesh-list
20398039|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20398040|NCT01119209|Ropivacaine|ropivacaine|mesh-list
19365637|NCT02924272|Ixazomib|ixazomib|mesh-list
19688953|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688954|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
19688955|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688956|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
19688957|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19688958|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19688959|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688960|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19688961|NCT05038111|Analgesics|analgesics|mesh-ancestor
19688962|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
19688963|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19688964|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19688965|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19688966|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19845662|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19845663|NCT00672737|Narcotics|narcotics|mesh-ancestor
19365638|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365639|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
19365640|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365641|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365642|NCT02908087|Liraglutide|liraglutide|mesh-list
19365643|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19365644|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365645|NCT02908087|Incretins|incretins|mesh-ancestor
19365646|NCT02908087|Hormones|hormones|mesh-ancestor
19365647|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365648|NCT02901483|Cisplatin|cisplatin|mesh-list
19365649|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365650|NCT02874651|Apatinib|apatinib|mesh-list
19365651|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365652|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19365653|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365654|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365655|NCT02873195|Bevacizumab|bevacizumab|mesh-list
19365656|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19365657|NCT02873195|Capecitabine|capecitabine|mesh-list
19365658|NCT02873195|Atezolizumab|atezolizumab|mesh-list
19365659|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
19365660|NCT02873195|Antibodies|antibodies|mesh-list
19365661|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
19365662|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19365663|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
19365664|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365665|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19365666|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19365667|NCT02873195|Growth Substances|growth substances|mesh-ancestor
19365668|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365669|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845664|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845665|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845666|NCT00672737|Analgesics|analgesics|mesh-ancestor
19845667|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
19845668|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845669|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
19845670|NCT00672841|Clotrimazole|clotrimazole|mesh-list
19845671|NCT00672841|Miconazole|miconazole|mesh-list
19845672|NCT00672841|Anidulafungin|anidulafungin|mesh-list
19845673|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845674|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19845675|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19845676|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19365670|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
19365671|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365672|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
19365673|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365674|NCT02851056|Sargramostim|sargramostim|mesh-list
19365675|NCT02851056|Lenograstim|lenograstim|mesh-list
19365676|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
19365677|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398041|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
20398042|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
20398043|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398044|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398045|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
20398046|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845677|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845678|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845679|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19845680|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
20426886|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20426887|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20426888|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426889|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20426890|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426891|NCT01283360|Tenofovir|tenofovir|mesh-list
20426892|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
20426893|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426894|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20426895|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20426896|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428652|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
19365678|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19365679|NCT02834975|Paclitaxel|paclitaxel|mesh-list
19845681|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845682|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845683|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19845684|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20210100|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20210101|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20398047|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20398048|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19365680|NCT02834975|Carboplatin|carboplatin|mesh-list
19365681|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
20398049|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20398050|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398051|NCT01119430|Fluoxetine|fluoxetine|mesh-list
20398052|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20398053|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20398054|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398055|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398056|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398057|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
20398058|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398059|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20398060|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
20398061|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20398062|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20398063|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19365682|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19365683|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365684|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
19365685|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
19365686|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
19365687|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365688|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365689|NCT02818868|Apixaban|apixaban|mesh-list
19365690|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19365691|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
19365692|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19365693|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
20210102|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20210103|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210104|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
20210105|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20210106|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210107|NCT00283114|Lintuzumab|lintuzumab|mesh-list
20210108|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20210109|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365694|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365695|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365696|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
19365697|NCT02809131|Levofloxacin|levofloxacin|mesh-list
19365698|NCT02809131|Ofloxacin|ofloxacin|mesh-list
19365699|NCT02809131|Clindamycin|clindamycin|mesh-list
19365700|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
19365701|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
19365702|NCT02809131|Cephalexin|cephalexin|mesh-list
19365703|NCT02809131|Polymyxins|polymyxins|mesh-list
19365704|NCT02809131|Bacitracin|bacitracin|mesh-list
19365705|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19365706|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365707|NCT02809131|Renal Agents|renal agents|mesh-ancestor
19365708|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19365709|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19365710|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19365711|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365712|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365713|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845685|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19845686|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19845687|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19845688|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19845689|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
19845690|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19845691|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19845692|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
20398064|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398065|NCT01119482|Vaccines|vaccines|mesh-list
20398066|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
19365714|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19365715|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19365716|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19365717|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19365718|NCT02785952|Nivolumab|nivolumab|mesh-list
19365719|NCT02785952|Ipilimumab|ipilimumab|mesh-list
19365720|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365721|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365722|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365723|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365724|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
19365725|NCT02784171|Pemetrexed|pemetrexed|mesh-list
19365726|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365727|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365728|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365729|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365730|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19365731|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19365732|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19365733|NCT02758717|Nivolumab|nivolumab|mesh-list
19365734|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19365735|NCT02758717|Antibodies|antibodies|mesh-list
19365736|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
19365737|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19365738|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
19365739|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
19365740|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365741|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365742|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365743|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365744|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19365745|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19365746|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365747|NCT02738866|Fulvestrant|fulvestrant|mesh-list
19365748|NCT02738866|Palbociclib|palbociclib|mesh-list
19365749|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19365750|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365751|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19365752|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19365753|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
19365754|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365755|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365756|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20398067|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398068|NCT01119521|Isoniazid|isoniazid|mesh-list
20398069|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
20398070|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20398071|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398072|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20398073|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20398074|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
20398075|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398076|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20398077|NCT01119534|Camphor|camphor|mesh-list
19365757|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365758|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365759|NCT02730429|Letrozole|letrozole|mesh-list
19365760|NCT02730429|Palbociclib|palbociclib|mesh-list
19365761|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365762|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19365763|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19365764|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365765|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365766|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19365767|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
19845693|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845694|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19845695|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20398078|NCT01119534|Eucalyptol|eucalyptol|mesh-list
20398079|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
20398080|NCT01119534|Menthol|menthol|mesh-list
20398081|NCT01119534|Guaifenesin|guaifenesin|mesh-list
20398082|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20398083|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
20398084|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
19365768|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365769|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365770|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19365771|NCT02730416|Paclitaxel|paclitaxel|mesh-list
19365772|NCT02730416|Carboplatin|carboplatin|mesh-list
19365773|NCT02730416|Nintedanib|nintedanib|mesh-list
19365774|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19365775|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365776|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
19365777|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
19365778|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
19365779|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365780|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19365781|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365782|NCT02693821|Gabapentin|gabapentin|mesh-list
19365783|NCT02693821|Analgesics|analgesics|mesh-ancestor
19365784|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
19845696|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398085|NCT01119534|Expectorants|expectorants|mesh-ancestor
20398086|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
20398087|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20398088|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20398089|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
20398090|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365785|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365786|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365787|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
19365788|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19845697|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845698|NCT00672958|Vortioxetine|vortioxetine|mesh-list
19845699|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
19845700|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19845701|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19845702|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19845703|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845704|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365789|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19365790|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365791|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365792|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19365793|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19365794|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365795|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845705|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19845706|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20210110|NCT00283179|Risperidone|risperidone|mesh-list
19365796|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
20210111|NCT00283179|Aripiprazole|aripiprazole|mesh-list
19365797|NCT02671890|Gemcitabine|gemcitabine|mesh-list
19365798|NCT02671890|Disulfiram|disulfiram|mesh-list
19365799|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365800|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
19365801|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365802|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365803|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
19365804|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210112|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20210113|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
20210114|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210115|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210116|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210117|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20210118|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20210119|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210120|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210121|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20210122|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
20428653|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365805|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365806|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365807|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
20398091|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398092|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398093|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
20398094|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20398095|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
20398096|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
20398097|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398098|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
20398099|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20398100|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20398101|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398102|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
19365808|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365809|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19365810|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19365811|NCT02664181|Nivolumab|nivolumab|mesh-list
19365812|NCT02664181|Decitabine|decitabine|mesh-list
20398103|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
20398104|NCT01119534|Protective Agents|protective agents|mesh-ancestor
20398105|NCT01119599|Temozolomide|temozolomide|mesh-list
20398106|NCT01119599|R04929097|r04929097|mesh-list
20398107|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20398108|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
20398109|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398110|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365813|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
19365814|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365815|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365816|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365817|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365818|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365819|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
19365820|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365821|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20398111|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398112|NCT01119638|Risperidone|risperidone|mesh-list
20398113|NCT01119638|Citalopram|citalopram|mesh-list
20398114|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20398115|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
20398116|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398117|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398118|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398119|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20398120|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20398121|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398122|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365822|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365823|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365824|NCT02633397|Riociguat|riociguat|mesh-list
19365825|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
19845707|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19845708|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845709|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845710|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
19845711|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19845712|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19845713|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19845714|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19845715|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
19845716|NCT00672984|Guanfacine|guanfacine|mesh-list
19845717|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19845718|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845719|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19845720|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19845721|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845722|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845723|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845724|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845725|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19845726|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20398123|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20398124|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
19402061|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845727|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19845728|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19845729|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
19365826|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365827|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
19365828|NCT02633241|Propofol|propofol|mesh-list
19365829|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19365830|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365831|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365832|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19365833|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
19365834|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
19365835|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19365836|NCT02633241|Analgesics|analgesics|mesh-ancestor
19365837|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
19365838|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365839|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19365840|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19365841|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19365842|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
20398125|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20398126|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20398127|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365843|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365844|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365845|NCT02626715|Vidarabine|vidarabine|mesh-list
19365846|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
19365847|NCT02626715|Fludarabine|fludarabine|mesh-list
19365848|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
19365849|NCT02626715|Thiotepa|thiotepa|mesh-list
19365850|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365851|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
19365852|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365853|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365854|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365855|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
19365856|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365857|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
19365858|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365859|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365860|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19365861|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
19365862|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19365863|NCT02589860|Melphalan|melphalan|mesh-list
19365864|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19365865|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
19365866|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365867|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365868|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19365869|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365870|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
19365871|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365872|NCT02583789|Treprostinil|treprostinil|mesh-list
19365873|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19402062|NCT03612401|Urological Agents|urological agents|mesh-ancestor
19402063|NCT03612349|Menthol|menthol|mesh-list
19402064|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
19402065|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
19402066|NCT03612323|Piroxicam|piroxicam|mesh-list
19402067|NCT03612323|Carticaine|carticaine|mesh-list
19402068|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402069|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
19402070|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402071|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402072|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
19402073|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402074|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19402075|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19402076|NCT03612323|Analgesics|analgesics|mesh-ancestor
19402077|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402078|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398128|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19402079|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19402080|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402081|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365874|NCT02556606|Midazolam|midazolam|mesh-list
19365875|NCT02556606|Ketamine|ketamine|mesh-list
19365876|NCT02556606|Analgesics|analgesics|mesh-ancestor
19365877|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
19365878|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365879|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365880|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19365881|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19365882|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
19365883|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
19365884|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365885|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19365886|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19365887|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365888|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365889|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19365890|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19365891|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19365892|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19365893|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19365894|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
19365895|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
19365896|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
19365897|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19365898|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19365899|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19365900|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365901|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
19365902|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365903|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365904|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19365905|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365906|NCT02545283|Cytarabine|cytarabine|mesh-list
19365907|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365908|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
19365909|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365910|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365911|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
19365912|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365913|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365914|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
19365915|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365916|NCT02532231|Nivolumab|nivolumab|mesh-list
19365917|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19365918|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365919|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19365920|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365921|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
19365922|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19365923|NCT02510300|Ledipasvir|ledipasvir|mesh-list
19365924|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19365925|NCT02510300|Velpatasvir|velpatasvir|mesh-list
19365926|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
19365927|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365928|NCT02507505|Anesthetics|anesthetics|mesh-list
19365929|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19365930|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365931|NCT02476968|Olaparib|olaparib|mesh-list
19365932|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19365933|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365934|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365935|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365936|NCT02465593|Fluorouracil|fluorouracil|mesh-list
19365937|NCT02465593|Capecitabine|capecitabine|mesh-list
20210123|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
20210124|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
20210125|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20210126|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20210127|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20210128|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20210129|NCT00283192|Sertraline|sertraline|mesh-list
20210130|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
20210131|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210132|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19365938|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
19845730|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845731|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19845732|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365939|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365940|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365941|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365942|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365943|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
19365944|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365945|NCT02465268|Molgramostim|molgramostim|mesh-list
20398129|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
20398130|NCT01119651|Tazarotene|tazarotene|mesh-list
20398131|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
20398132|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
19365946|NCT02465268|Sargramostim|sargramostim|mesh-list
19365947|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
19365948|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365949|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365950|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19365951|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365952|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
19365953|NCT02424019|Hormones|hormones|mesh-ancestor
19365954|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365955|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365956|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
19365957|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19365958|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19365959|NCT02422368|Prednisolone|prednisolone|mesh-list
19365960|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
19365961|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19365962|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
19365963|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19365964|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
19365965|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
19365966|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19365967|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365968|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19365969|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
19365970|NCT02422368|Hormones|hormones|mesh-ancestor
19365971|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19365972|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19365973|NCT02422368|Protective Agents|protective agents|mesh-ancestor
19365974|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19365975|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365976|NCT02420847|Gemcitabine|gemcitabine|mesh-list
19365977|NCT02420847|Doxorubicin|doxorubicin|mesh-list
19365978|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19365979|NCT02420847|Ixazomib|ixazomib|mesh-list
19365980|NCT02420847|Glycine|glycine|mesh-list
19365981|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19365982|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
19365983|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19365984|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19365985|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
19365986|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19365987|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19365988|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19365989|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
19365990|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845733|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19845734|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845735|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210133|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20210134|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210135|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210136|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210137|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
20210138|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210139|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
20210140|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20398133|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
19365991|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19845736|NCT00673075|Carvedilol|carvedilol|mesh-list
20398134|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20398135|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
20398136|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210141|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210142|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19365992|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19365993|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19365994|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
19365995|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
19365996|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19365997|NCT02400242|Dexamethasone|dexamethasone|mesh-list
19365998|NCT02400242|Pomalidomide|pomalidomide|mesh-list
19365999|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19366000|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366001|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
19366002|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
19366003|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366004|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366005|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19366006|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
19366007|NCT02400242|Hormones|hormones|mesh-ancestor
19366008|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366009|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366010|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366011|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
19366012|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20398137|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398138|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
19366013|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366014|NCT02400242|Growth Substances|growth substances|mesh-ancestor
19366015|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366016|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366017|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366018|NCT02393183|Selenium|selenium|mesh-list
19366019|NCT02393183|Antioxidants|antioxidants|mesh-list
19366020|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366021|NCT02393183|Protective Agents|protective agents|mesh-ancestor
19366022|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366023|NCT02393183|Trace Elements|trace elements|mesh-ancestor
19366024|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
19366025|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
19366026|NCT02379520|Nivolumab|nivolumab|mesh-list
19366027|NCT02379520|Fludarabine|fludarabine|mesh-list
19366028|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366029|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
19366030|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366031|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366032|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366033|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
19366034|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366035|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366036|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19366037|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366038|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19366039|NCT02354131|Bevacizumab|bevacizumab|mesh-list
19366040|NCT02354131|Niraparib|niraparib|mesh-list
19366041|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366042|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366043|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366044|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366045|NCT02354131|Growth Substances|growth substances|mesh-ancestor
19366046|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210143|NCT00283309|Riluzole|riluzole|mesh-list
20210144|NCT00283309|Memantine|memantine|mesh-list
20210145|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20210146|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20210147|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
20210148|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210149|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210150|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210151|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20210152|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20210153|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
20210154|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20210155|NCT00283309|Protective Agents|protective agents|mesh-ancestor
20210156|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
20210157|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20210158|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
20210159|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366047|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366048|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20398139|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398140|NCT01119742|Butenafine|butenafine|mesh-list
20398141|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
20398142|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398143|NCT01119885|Fentanyl|fentanyl|mesh-list
20398144|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20398145|NCT01119885|Narcotics|narcotics|mesh-ancestor
20398146|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398147|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398148|NCT01119885|Analgesics|analgesics|mesh-ancestor
20398149|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
20398150|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398151|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20398152|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20398153|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
20398154|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
19366049|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366050|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366051|NCT02335944|Nazartinib|nazartinib|mesh-list
19366052|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366053|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
19366054|NCT02333162|Fludarabine|fludarabine|mesh-list
19366055|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
19366056|NCT02333162|Melphalan|melphalan|mesh-list
19366057|NCT02333162|Tacrolimus|tacrolimus|mesh-list
19366058|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366059|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19366060|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
19366061|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366062|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366063|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
19366064|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366065|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19366066|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366067|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19366068|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19366069|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
19366070|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19366071|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366072|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366073|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
19366074|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19366075|NCT02318342|Warfarin|warfarin|mesh-list
19366076|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
19366077|NCT02304991|Glycerol|glycerol|mesh-list
19366078|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19366079|NCT02304991|Protective Agents|protective agents|mesh-ancestor
19366080|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210160|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20210161|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20210162|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20210163|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210164|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
20210165|NCT00283465|Hematinics|hematinics|mesh-ancestor
20210166|NCT00283478|Gemcitabine|gemcitabine|mesh-list
20210167|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20210168|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
20210169|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210170|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210171|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
20210172|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210173|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210174|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210175|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
20210176|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210177|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
20210178|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19366081|NCT02303821|Cytarabine|cytarabine|mesh-list
20210179|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210180|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398155|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
19845737|NCT00673075|Nebivolol|nebivolol|mesh-list
19845738|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19845739|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19845740|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
19845741|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845742|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845743|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845744|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19845745|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
19366082|NCT02303821|Dexamethasone|dexamethasone|mesh-list
19366083|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
19366084|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
19366085|NCT02303821|Methotrexate|methotrexate|mesh-list
19366086|NCT02303821|Vincristine|vincristine|mesh-list
19366087|NCT02303821|Daunorubicin|daunorubicin|mesh-list
19366088|NCT02303821|Asparaginase|asparaginase|mesh-list
19366089|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
20398156|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20398157|NCT01120106|Simendan|simendan|mesh-list
20398158|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20398159|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
20398160|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20398161|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20398162|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366090|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
19366091|NCT02303821|Pegaspargase|pegaspargase|mesh-list
19366092|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366093|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
20398163|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398164|NCT01120106|Protective Agents|protective agents|mesh-ancestor
20398165|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366094|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366095|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366096|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366097|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
19366098|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366099|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366100|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19366101|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366102|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
20398166|NCT01120119|Calcitriol|calcitriol|mesh-list
20398167|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398168|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398169|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20398170|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398171|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398172|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20398173|NCT01120119|Vitamins|vitamins|mesh-ancestor
19366103|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
19366104|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366105|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845746|NCT00673075|Protective Agents|protective agents|mesh-ancestor
19845747|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19845748|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19845749|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398174|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
20398175|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20398176|NCT01120158|Paclitaxel|paclitaxel|mesh-list
20398177|NCT01120158|Bevacizumab|bevacizumab|mesh-list
20398178|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20398179|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398180|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
20398181|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
20398182|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
20398183|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366106|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
19366107|NCT02303821|Hormones|hormones|mesh-ancestor
19366108|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366109|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366110|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19366111|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
19366112|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19366113|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845750|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
19366114|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
19366115|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
19366116|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366117|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19366118|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19366119|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
19366120|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398184|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20398185|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20398186|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398187|NCT01120158|Growth Substances|growth substances|mesh-ancestor
20398188|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398189|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366121|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19366122|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366123|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366124|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366125|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19366126|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366127|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366128|NCT02303821|Analgesics|analgesics|mesh-ancestor
19366129|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
19366130|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
19366131|NCT02287311|Fludarabine|fludarabine|mesh-list
19366132|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366133|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
19366134|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366135|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366136|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366137|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
19366138|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366139|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366140|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19366141|NCT02271919|Nicotine|nicotine|mesh-list
19366142|NCT02271919|Varenicline|varenicline|mesh-list
19366143|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19366144|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
19366145|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366146|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366147|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19366148|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19366149|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
19366150|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366151|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366152|NCT02263729|Losartan|losartan|mesh-list
19366153|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19366154|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19366155|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19366156|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20398190|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
20398191|NCT01120171|Doxorubicin|doxorubicin|mesh-list
20398192|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20398193|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398194|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
20398195|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398196|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398197|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20398198|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
20398199|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398200|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398201|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20398202|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20210181|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210182|NCT00283543|Temozolomide|temozolomide|mesh-list
20210183|NCT00283543|Carmustine|carmustine|mesh-list
20210184|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20210185|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
20210186|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210187|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210188|NCT00283556|Irinotecan|irinotecan|mesh-list
20398203|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20398204|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366157|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210189|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19366158|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
19366159|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19366160|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19366161|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366162|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
19366163|NCT02261415|Coagulants|coagulants|mesh-ancestor
19366164|NCT02225600|Oxytocin|oxytocin|mesh-list
19366165|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
19366166|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19366167|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366168|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
19366169|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19366170|NCT02223520|Mupirocin|mupirocin|mesh-list
19366171|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19366172|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366173|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
19366174|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
19366175|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19845751|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19366176|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19366177|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366178|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366179|NCT02220309|Pramipexole|pramipexole|mesh-list
19366180|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
19366181|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366182|NCT02220309|Protective Agents|protective agents|mesh-ancestor
19366183|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366184|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19366185|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19366186|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
19366187|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
19366188|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366195|NCT02141282|Venetoclax|venetoclax|mesh-list
19366196|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366197|NCT02126553|Lenalidomide|lenalidomide|mesh-list
19366198|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
19366199|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366200|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366201|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20210190|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366202|NCT02126553|Growth Substances|growth substances|mesh-ancestor
19366203|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366204|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366205|NCT02122198|Leuprolide|leuprolide|mesh-list
19366206|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19366207|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
19366208|NCT02122198|Estradiol|estradiol|mesh-list
19366209|NCT02122198|Estrogens|estrogens|mesh-ancestor
19366210|NCT02122198|Hormones|hormones|mesh-ancestor
19366211|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366212|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366213|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19366214|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
19366215|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19366216|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19366217|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19366218|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
19366219|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20210191|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210192|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210193|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210194|NCT00283621|Doxorubicin|doxorubicin|mesh-list
20210195|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20210196|NCT00283621|Ifosfamide|ifosfamide|mesh-list
20210197|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
20210198|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20210199|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210200|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366220|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366221|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19366222|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20398205|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19688967|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
19688968|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19688969|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210201|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20210202|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210203|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210204|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20210205|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
20210206|NCT00283621|Hematinics|hematinics|mesh-ancestor
20210207|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20210208|NCT00283634|Bortezomib|bortezomib|mesh-list
20210209|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210210|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20398206|NCT01120314|Otamixaban|otamixaban|mesh-list
19688970|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
19688971|NCT05038202|Bromides|bromides|mesh-list
19688972|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
19688973|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688974|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19688975|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19688976|NCT05038449|Colchicine|colchicine|mesh-list
19688977|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
19688978|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19688979|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
19688980|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
19688981|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
19688982|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688983|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688984|NCT05038059|Acetic Acid|acetic acid|mesh-list
19688985|NCT05038059|Retinol acetate|retinol acetate|mesh-list
19688986|NCT05038059|Ethylene|ethylene|mesh-list
19688987|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19688988|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19688989|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20398207|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20398208|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
19366223|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19366224|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19366225|NCT02079948|Folic Acid|folic acid|mesh-list
19366226|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
19366227|NCT02079948|Methotrexate|methotrexate|mesh-list
19366228|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19366229|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
19366230|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19366231|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366232|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19366233|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
19366234|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366235|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366236|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
19366237|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366238|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19366239|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366240|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
19366241|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366242|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19366243|NCT02079948|Hematinics|hematinics|mesh-ancestor
19366244|NCT02079948|Vitamins|vitamins|mesh-ancestor
19366245|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
19366246|NCT02060188|Nivolumab|nivolumab|mesh-list
19366247|NCT02060188|Ipilimumab|ipilimumab|mesh-list
19366248|NCT02060188|Daratumumab|daratumumab|mesh-list
19366249|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366250|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366251|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19366252|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19688990|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
20398209|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19688991|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19688992|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20210211|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366253|NCT02055053|Bupivacaine|bupivacaine|mesh-list
19366254|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
19366255|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
19688993|NCT05038059|Protective Agents|protective agents|mesh-ancestor
20398210|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
19366256|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19366257|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398211|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398212|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398213|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
20398214|NCT01120327|Amlodipine|amlodipine|mesh-list
20398215|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19688994|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19688995|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19688996|NCT05038059|Growth Substances|growth substances|mesh-ancestor
19366258|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
19366259|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366260|NCT02034110|Trametinib|trametinib|mesh-list
19366261|NCT02034110|Dabrafenib|dabrafenib|mesh-list
19366262|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366263|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19366264|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366265|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366266|NCT02004275|Dexamethasone|dexamethasone|mesh-list
19366267|NCT02004275|Pomalidomide|pomalidomide|mesh-list
19366268|NCT02004275|Ixazomib|ixazomib|mesh-list
19366269|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20210212|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210213|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
20210214|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
20210215|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
20210216|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20210217|NCT00283660|Protective Agents|protective agents|mesh-ancestor
20210218|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210219|NCT00283699|Albendazole|albendazole|mesh-list
20210220|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
20210221|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19366270|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
20398216|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20398217|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398218|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398219|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398220|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398221|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
20398222|NCT01120340|Mesalamine|mesalamine|mesh-list
20398223|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20398224|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20398225|NCT01120340|Analgesics|analgesics|mesh-ancestor
20398226|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
20398227|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398228|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398229|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20398230|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398231|NCT01120366|Methotrexate|methotrexate|mesh-list
20398232|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20398233|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
20398234|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19692974|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692975|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
20398235|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398236|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20398237|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
20398238|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398239|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398240|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
20398241|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398242|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20398243|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398244|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
19366271|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
19366272|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692976|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692977|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19692978|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19692979|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
19366273|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398245|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366274|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19366275|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
19366276|NCT02004275|Hormones|hormones|mesh-ancestor
20398246|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20398247|NCT01120418|Besifloxacin|besifloxacin|mesh-list
19845752|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19845753|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19845754|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20398248|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19366277|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366278|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366279|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366280|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
19366281|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366282|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366283|NCT02004275|Growth Substances|growth substances|mesh-ancestor
19366284|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366285|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
19366286|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366287|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366288|NCT01978938|Levofloxacin|levofloxacin|mesh-list
19366289|NCT01978938|Ofloxacin|ofloxacin|mesh-list
19366290|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19366291|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366292|NCT01978938|Renal Agents|renal agents|mesh-ancestor
19366293|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19366294|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366295|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366296|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398249|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398250|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366297|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366298|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366299|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20398251|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20398252|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398253|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398254|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398255|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20398256|NCT01120444|Insulin|insulin|mesh-list
20398257|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398258|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398259|NCT01120561|Trastuzumab|trastuzumab|mesh-list
20398260|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20398261|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20398262|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398263|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
20398264|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
20398265|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366300|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19366301|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19366302|NCT01976065|Metronidazole|metronidazole|mesh-list
19366303|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
19366304|NCT01976065|Minocycline|minocycline|mesh-list
19366305|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398266|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398267|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20398268|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20398269|NCT01120665|Estradiol|estradiol|mesh-list
20398270|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20398271|NCT01120665|Hormones|hormones|mesh-ancestor
20398272|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20398273|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398274|NCT01120665|Estrogens|estrogens|mesh-ancestor
20398275|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20398276|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
20398277|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20398278|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20398279|NCT01120769|Acetaminophen|acetaminophen|mesh-list
20398280|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20398281|NCT01120769|Analgesics|analgesics|mesh-ancestor
20398282|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
20398283|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398284|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845755|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20398285|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
20398286|NCT01120795|Interferons|interferons|mesh-list
20398287|NCT01120795|Ribavirin|ribavirin|mesh-list
19366306|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19366307|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19366308|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366309|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366310|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366311|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366312|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366313|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19366314|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19366315|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
19366316|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19366317|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
19366318|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366319|NCT01878669|Expectorants|expectorants|mesh-ancestor
19366320|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
19366321|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19366322|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
19366323|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845756|NCT00673127|Ketoconazole|ketoconazole|mesh-list
19845757|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
19845758|NCT00673127|Dutasteride|dutasteride|mesh-list
19845759|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19688997|NCT05037695|Empagliflozin|empagliflozin|mesh-list
19688998|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19688999|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689000|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19689001|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689002|NCT05037539|Fentanyl|fentanyl|mesh-list
19845760|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
19845761|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845762|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19845763|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19845764|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845765|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845766|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19845767|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
20210222|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210223|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
19366324|NCT01878669|Protective Agents|protective agents|mesh-ancestor
19366325|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689003|NCT05037539|Morphine|morphine|mesh-list
19689004|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20210224|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20210225|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19689005|NCT05037539|Narcotics|narcotics|mesh-ancestor
19689006|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689007|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689008|NCT05037539|Analgesics|analgesics|mesh-ancestor
19689009|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
19689010|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689011|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19689012|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19689013|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
19689014|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
19689015|NCT05037253|Vitamin D|vitamin d|mesh-list
19689016|NCT05037253|Vitamins|vitamins|mesh-ancestor
19689017|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
19689018|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689019|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19689020|NCT05037240|Quercetin|quercetin|mesh-list
19689021|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
19689022|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689023|NCT05037240|Protective Agents|protective agents|mesh-ancestor
19689024|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689025|NCT05037006|Anesthetics|anesthetics|mesh-list
19689026|NCT05037006|Sevoflurane|sevoflurane|mesh-list
19689027|NCT05037006|Neostigmine|neostigmine|mesh-list
19845768|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210226|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
20210227|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
20210228|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366326|NCT01878669|Antidotes|antidotes|mesh-ancestor
19366327|NCT01854385|Sumatriptan|sumatriptan|mesh-list
19689028|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689029|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398288|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19689030|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19689031|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19689032|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
19689033|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19689034|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689035|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689036|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
19689037|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689038|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19689039|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
19689040|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689041|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
19689042|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19689043|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19689044|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366328|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19366329|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19366330|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19366331|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
19366332|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366333|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366334|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689045|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
19689046|NCT05037162|Coagulants|coagulants|mesh-ancestor
19689047|NCT05036824|Tinzaparin|tinzaparin|mesh-list
19689048|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19689049|NCT05036824|Dalteparin|dalteparin|mesh-list
19689050|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
19689051|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20398289|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
20398290|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398291|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
20398292|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398293|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
20398294|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398295|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
20398296|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398297|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
20398298|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398299|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20398300|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398301|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845769|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366335|NCT01844856|Ertapenem|ertapenem|mesh-list
19366336|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19366337|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366338|NCT01817166|Vitamin D|vitamin d|mesh-list
19366339|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
19366340|NCT01817166|Vitamins|vitamins|mesh-ancestor
19689052|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19845770|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20398302|NCT01120912|Insulin|insulin|mesh-list
20398303|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398304|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398305|NCT01121016|Montelukast|montelukast|mesh-list
20398306|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20398307|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20398308|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20398309|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
20398310|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20398311|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398312|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20398313|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20398314|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398315|NCT01121042|Ondansetron|ondansetron|mesh-list
20398316|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
20398317|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
20398318|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398319|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398320|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20398321|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
19845771|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19693173|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
19366341|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
19845772|NCT00673153|Vorinostat|vorinostat|mesh-list
19845773|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
20398322|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
19366342|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366343|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19366344|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19366345|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
19366346|NCT01783535|Carboplatin|carboplatin|mesh-list
19845774|NCT00673153|Calicheamicins|calicheamicins|mesh-list
19845775|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845776|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19845777|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845778|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845779|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845780|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19845781|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
19366347|NCT01783535|Doxorubicin|doxorubicin|mesh-list
19366348|NCT01783535|Etoposide|etoposide|mesh-list
19366349|NCT01783535|Vincristine|vincristine|mesh-list
19366350|NCT01783535|Topotecan|topotecan|mesh-list
19366351|NCT01783535|Lenograstim|lenograstim|mesh-list
19845782|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19845783|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845784|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845785|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845786|NCT00673244|Furosemide|furosemide|mesh-list
19845787|NCT00673244|Diuretics|diuretics|mesh-ancestor
19845788|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
19845789|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845790|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19366352|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366353|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
19366354|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366355|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366356|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366357|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
19366358|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366359|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366360|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19366361|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19689053|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689054|NCT05036798|Lenvatinib|lenvatinib|mesh-list
19689055|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689056|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19689057|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366362|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366363|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366364|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689058|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689059|NCT05036005|Pertuzumab|pertuzumab|mesh-list
19689060|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689061|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689062|NCT05035953|Edaravone|edaravone|mesh-list
19689063|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19689064|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
19689065|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689066|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20210229|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210230|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210231|NCT00283751|Insulin|insulin|mesh-list
20210232|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20210233|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
20210234|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
20210235|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210236|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210237|NCT00283764|Latanoprost|latanoprost|mesh-list
20210238|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20210239|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20210240|NCT00283777|Chromium|chromium|mesh-list
20210241|NCT00283777|Picolinic acid|picolinic acid|mesh-list
20210242|NCT00283777|Trace Elements|trace elements|mesh-ancestor
20210243|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
20210244|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366365|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19366366|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19366367|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
20398323|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20398324|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
19366368|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845791|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398325|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398326|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398327|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20398328|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20398329|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398330|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20398331|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20398332|NCT01121055|Lorazepam|lorazepam|mesh-list
20398333|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
20398334|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
20398335|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
20398336|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398337|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398338|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20398339|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20398340|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398341|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20398342|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20398343|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20398344|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
20398345|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
20398346|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398347|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398348|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20398349|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20398350|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
20398351|NCT01121133|Rifampin|rifampin|mesh-list
20398352|NCT01121133|Navitoclax|navitoclax|mesh-list
20398353|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20398354|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
20398355|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19845792|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845793|NCT00673387|Pramlintide|pramlintide|mesh-list
19845794|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20398356|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398357|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
20398358|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20398359|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398360|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398361|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20398362|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20398363|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20398364|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20398365|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20398366|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19845795|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845796|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398367|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398368|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
20398369|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20398370|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366369|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366370|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19689067|NCT05035953|Protective Agents|protective agents|mesh-ancestor
19689068|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689069|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
19689070|NCT05036174|Promethazine|promethazine|mesh-list
19689071|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19689072|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19689073|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845797|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
19845798|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19845799|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
19848256|NCT00691704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19689074|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689075|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
19689076|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
20398371|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19366371|NCT01726452|Leucovorin|leucovorin|mesh-list
19689077|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
19689078|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689079|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
19366372|NCT01726452|Paclitaxel|paclitaxel|mesh-list
19366373|NCT01726452|Docetaxel|docetaxel|mesh-list
19366374|NCT01726452|Carboplatin|carboplatin|mesh-list
19366375|NCT01726452|Fluorouracil|fluorouracil|mesh-list
19366376|NCT01726452|Capecitabine|capecitabine|mesh-list
19366377|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
19366378|NCT01726452|Epirubicin|epirubicin|mesh-list
19366379|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689080|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
19689081|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19689082|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19689083|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
19689084|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
19689085|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689086|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689087|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19689088|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
19689089|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
20210245|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20210246|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
20210247|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
20210248|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210249|NCT00283790|Zolpidem|zolpidem|mesh-list
20210250|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20210251|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20210252|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210253|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689090|NCT05035888|Phenylephrine|phenylephrine|mesh-list
19689091|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
19689092|NCT05035888|Norepinephrine|norepinephrine|mesh-list
19689093|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19689094|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19689095|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
19689096|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
19689097|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689098|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366380|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366381|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366382|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366383|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366384|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366385|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
19366386|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19366387|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366388|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
19366389|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366390|NCT01726452|Antidotes|antidotes|mesh-ancestor
19366391|NCT01726452|Protective Agents|protective agents|mesh-ancestor
19366392|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
19366393|NCT01726452|Vitamins|vitamins|mesh-ancestor
20398372|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398373|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
20398374|NCT01121237|Hematinics|hematinics|mesh-ancestor
20398375|NCT01121276|Insulin|insulin|mesh-list
19366394|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
19366395|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19366396|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366397|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366398|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402082|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19689099|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
19689100|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
19689101|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
19689102|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19689103|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19689104|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19689105|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689106|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210254|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19402083|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402084|NCT03612219|Apatinib|apatinib|mesh-list
19402085|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402086|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19402087|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689107|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689108|NCT05035888|Protective Agents|protective agents|mesh-ancestor
20398376|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19366399|NCT01712789|Dexamethasone|dexamethasone|mesh-list
19366400|NCT01712789|Pomalidomide|pomalidomide|mesh-list
19366401|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366402|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
19366403|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
19366404|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366405|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366406|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19366407|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
19366408|NCT01712789|Hormones|hormones|mesh-ancestor
19366409|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366410|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366411|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366412|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
19366413|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366414|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366415|NCT01712789|Growth Substances|growth substances|mesh-ancestor
19689109|NCT05035745|Talazoparib|talazoparib|mesh-list
19689110|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19689111|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689112|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689113|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689114|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19689115|NCT05035849|Acarbose|acarbose|mesh-list
19689116|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398377|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
20398378|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
20398379|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20398380|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398381|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398382|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
19366416|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
20398383|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398384|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426897|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426898|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20426899|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20426900|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
20426901|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20426902|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20426903|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426904|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20426905|NCT01283412|Analgesics|analgesics|mesh-ancestor
20426906|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
20426907|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20426908|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19366417|NCT01665794|Dexamethasone|dexamethasone|mesh-list
19366418|NCT01665794|Daratumumab|daratumumab|mesh-list
19366419|NCT01665794|Pomalidomide|pomalidomide|mesh-list
19366420|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366421|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
19366422|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
19366423|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366424|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366425|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19366426|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
19366427|NCT01665794|Hormones|hormones|mesh-ancestor
19366428|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366429|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366430|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366431|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
19366432|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366433|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366434|NCT01665794|Growth Substances|growth substances|mesh-ancestor
19366435|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366436|NCT01651403|Tenofovir|tenofovir|mesh-list
19366437|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
19689117|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689118|NCT05035849|Incretins|incretins|mesh-ancestor
20426909|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20426910|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20426911|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
20426912|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366438|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366439|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19689119|NCT05035849|Hormones|hormones|mesh-ancestor
20398385|NCT01121354|Cefazolin|cefazolin|mesh-list
20398386|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20398387|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398388|NCT01121458|Clevidipine|clevidipine|mesh-list
20398389|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20398390|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398391|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398392|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398393|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398394|NCT01121497|Physostigmine|physostigmine|mesh-list
20398395|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20398396|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398397|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398398|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
20398399|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398400|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398401|NCT01121497|Miotics|miotics|mesh-ancestor
20398402|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
20398403|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398404|NCT01121588|Crizotinib|crizotinib|mesh-list
20398405|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398406|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20398407|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398408|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689120|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689121|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19689122|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
19689123|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689124|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689125|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19689126|NCT05035381|Leucovorin|leucovorin|mesh-list
19689127|NCT05035381|Bevacizumab|bevacizumab|mesh-list
19689128|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
19689129|NCT05035381|Fluorouracil|fluorouracil|mesh-list
19689130|NCT05035381|Irinotecan|irinotecan|mesh-list
19689131|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19689132|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689133|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689134|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19689135|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398409|NCT01121705|Interferons|interferons|mesh-list
20398410|NCT01121705|Ribavirin|ribavirin|mesh-list
20398411|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
20398412|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
20398413|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20398414|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398415|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
20398416|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398417|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
20398418|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398419|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
20398420|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398421|NCT01121731|Interferons|interferons|mesh-list
20398422|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
20398423|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398424|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
20398425|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398426|NCT01121744|Sirolimus|sirolimus|mesh-list
20398427|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19366440|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19366441|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845800|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845801|NCT00673439|PENTA|penta|mesh-list
19845802|NCT00673439|Warfarin|warfarin|mesh-list
19845803|NCT00673439|Fondaparinux|fondaparinux|mesh-list
19845804|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
19366442|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366443|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19366444|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19366445|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
19366446|NCT01560572|Prednisolone|prednisolone|mesh-list
19366447|NCT01560572|Tacrolimus|tacrolimus|mesh-list
19366448|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845805|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19845806|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
20398428|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428654|NCT01293149|Clonidine|clonidine|mesh-list
20398429|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20398430|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398431|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
20398432|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398433|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
20398434|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398435|NCT01121770|PENTA|penta|mesh-list
20398436|NCT01121770|Fondaparinux|fondaparinux|mesh-list
20398437|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20398438|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
20398439|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20398440|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
20398441|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398442|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398443|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
20398444|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20398445|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20398446|NCT01121796|Vitamin D|vitamin d|mesh-list
20398447|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
19845807|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19845808|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
19845809|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845810|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398448|NCT01121796|Vitamins|vitamins|mesh-list
20398449|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
20398450|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398451|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20398452|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398453|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
20398454|NCT01121809|Etravirine|etravirine|mesh-list
20398455|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20398456|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20398457|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
20398458|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398459|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20398460|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20398461|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398462|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398463|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20398464|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20398465|NCT01121822|Vaccines|vaccines|mesh-list
20398466|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
20398467|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398468|NCT01121835|Insulin|insulin|mesh-list
20398469|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20398470|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
20398471|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
20398472|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398473|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398474|NCT01121848|Leucovorin|leucovorin|mesh-list
19366449|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
19366450|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366451|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20398475|NCT01121848|Fluorouracil|fluorouracil|mesh-list
20398476|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
20398477|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
20398478|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398479|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20398480|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398481|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398482|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
20398483|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398484|NCT01121848|Antidotes|antidotes|mesh-ancestor
20398485|NCT01121848|Protective Agents|protective agents|mesh-ancestor
20398486|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
20398487|NCT01121848|Vitamins|vitamins|mesh-ancestor
20398488|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
19366452|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366453|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845811|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19366454|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366455|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
19845812|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20398489|NCT01122004|Pregabalin|pregabalin|mesh-list
20398490|NCT01122004|Analgesics|analgesics|mesh-ancestor
20398491|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
19366456|NCT01560572|Hormones|hormones|mesh-ancestor
20398492|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366457|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366458|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366459|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366460|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19366461|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19366462|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
19366463|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19366464|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366465|NCT01543633|Propofol|propofol|mesh-list
20398493|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398494|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
20398495|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20398496|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398497|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398498|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398499|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20398500|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20398501|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398502|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20398503|NCT01122056|Interferons|interferons|mesh-list
20398504|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
20398505|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398506|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
20398507|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398508|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20398509|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
19366466|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19366467|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398510|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398511|NCT01122121|Leuprolide|leuprolide|mesh-list
20398512|NCT01122121|Flutamide|flutamide|mesh-list
20398513|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20398514|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
19366468|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366469|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20398515|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20398516|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398517|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20398518|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398519|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
20398520|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
20398521|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20398522|NCT01122134|Artesunate|artesunate|mesh-list
20398523|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
20398524|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20398525|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20398526|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398527|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398528|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
20398529|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
20398530|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20398531|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
20398532|NCT01122199|Everolimus|everolimus|mesh-list
20398533|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398534|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398535|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
20398536|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366470|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
19366471|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
19366472|NCT01542736|Carboplatin|carboplatin|mesh-list
19366473|NCT01542736|Vincristine|vincristine|mesh-list
19366474|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366475|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19366476|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366477|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366478|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
20398537|NCT01122251|Valsartan|valsartan|mesh-list
20398538|NCT01122251|Lercanidipine|lercanidipine|mesh-list
20398539|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20398540|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19366479|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366480|NCT01481974|Treprostinil|treprostinil|mesh-list
19366481|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20398541|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20398542|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366482|NCT01465100|Liver Extracts|liver extracts|mesh-list
19366483|NCT01465100|Hematinics|hematinics|mesh-ancestor
19366484|NCT01442649|Leucovorin|leucovorin|mesh-list
19366485|NCT01442649|Folic Acid|folic acid|mesh-list
19366486|NCT01442649|Bevacizumab|bevacizumab|mesh-list
19366487|NCT01442649|Cetuximab|cetuximab|mesh-list
19366488|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
19366489|NCT01442649|Irinotecan|irinotecan|mesh-list
19366490|NCT01442649|Fluorouracil|fluorouracil|mesh-list
19366491|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
20210255|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
20398543|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20398544|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398545|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20398546|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398547|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
20398548|NCT01122342|Testosterone|testosterone|mesh-list
20398549|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
20398550|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
20398551|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20398552|NCT01122342|Androgens|androgens|mesh-ancestor
20398553|NCT01122342|Hormones|hormones|mesh-ancestor
20398554|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210256|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
20210257|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366492|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366493|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366494|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366495|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366496|NCT01442649|Growth Substances|growth substances|mesh-ancestor
19366497|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366498|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366499|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19366500|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366501|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366502|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689136|NCT05035381|Growth Substances|growth substances|mesh-ancestor
19689137|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689138|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
19689139|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
20210258|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398555|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398556|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20398557|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398558|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
20398559|NCT01122368|Micafungin|micafungin|mesh-list
20398560|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
20398561|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366503|NCT01442649|Antidotes|antidotes|mesh-ancestor
19366504|NCT01442649|Protective Agents|protective agents|mesh-ancestor
19366505|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
19366506|NCT01442649|Vitamins|vitamins|mesh-ancestor
19366507|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
19366508|NCT01442649|Hematinics|hematinics|mesh-ancestor
19366509|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
19366510|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19366511|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366512|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
19366513|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
19366514|NCT01147666|Hematinics|hematinics|mesh-ancestor
19366515|NCT00982111|Pemetrexed|pemetrexed|mesh-list
19366516|NCT00982111|Necitumumab|necitumumab|mesh-list
19366517|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366518|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366519|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210259|NCT00283829|Docetaxel|docetaxel|mesh-list
20210260|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210261|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20210262|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
20210263|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20210264|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210265|NCT00283946|Zolpidem|zolpidem|mesh-list
20210266|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20210267|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20210268|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398562|NCT01122407|Trimethaphan|trimethaphan|mesh-list
20398563|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
19689140|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366520|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19366521|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19366522|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366523|NCT00670358|Prednisone|prednisone|mesh-list
19366524|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
19366525|NCT00670358|Rituximab|rituximab|mesh-list
19366526|NCT00670358|Doxorubicin|doxorubicin|mesh-list
19366527|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19366528|NCT00670358|Vincristine|vincristine|mesh-list
19366529|NCT00670358|Lenalidomide|lenalidomide|mesh-list
19366530|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366531|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
19366532|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366533|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366534|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366535|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
19366536|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366537|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366538|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19689141|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19689142|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689143|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
19689144|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19689145|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19689146|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689147|NCT05035381|Antidotes|antidotes|mesh-ancestor
19689148|NCT05035381|Protective Agents|protective agents|mesh-ancestor
19689149|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
19689150|NCT05035381|Vitamins|vitamins|mesh-ancestor
19689151|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
19689152|NCT05035498|Phenylephrine|phenylephrine|mesh-list
19366539|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366540|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19689153|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
19689154|NCT05035498|Norepinephrine|norepinephrine|mesh-list
19366541|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366542|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20210269|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210270|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20210271|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
20210272|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
20210273|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210274|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210275|NCT00283985|Dexamethasone|dexamethasone|mesh-list
19689155|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19689156|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19689157|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
19689158|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
19689159|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689160|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689161|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
19689162|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
19689163|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
19689164|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19689165|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19689166|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19689167|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689168|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689169|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689170|NCT05035498|Protective Agents|protective agents|mesh-ancestor
19689171|NCT05035485|Phenylephrine|phenylephrine|mesh-list
19689172|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
19689173|NCT05035485|Norepinephrine|norepinephrine|mesh-list
19689174|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19689175|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19689176|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
19689177|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
19689178|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689179|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689180|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
19689181|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
20210276|NCT00283985|Methotrexate|methotrexate|mesh-list
19366543|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689182|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
19689183|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20210277|NCT00283985|Asparaginase|asparaginase|mesh-list
19366544|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689184|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20398564|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398565|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20398566|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20398567|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20398568|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
19366545|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
19366546|NCT00670358|Hormones|hormones|mesh-ancestor
19689185|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19689186|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689187|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210278|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366547|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366548|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366549|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19366550|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366551|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366552|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366553|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366554|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366555|NCT00670358|Growth Substances|growth substances|mesh-ancestor
19366556|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366557|NCT00193219|Leucovorin|leucovorin|mesh-list
19366558|NCT00193219|Bevacizumab|bevacizumab|mesh-list
19366559|NCT00193219|Cetuximab|cetuximab|mesh-list
19366560|NCT00193219|Fluorouracil|fluorouracil|mesh-list
19366561|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
19366562|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366563|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366564|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366565|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366566|NCT00193219|Growth Substances|growth substances|mesh-ancestor
19366567|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366568|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366569|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
19366570|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366571|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19366572|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366573|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
19366574|NCT00193219|Antidotes|antidotes|mesh-ancestor
19366575|NCT00193219|Protective Agents|protective agents|mesh-ancestor
19366576|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
19366577|NCT00193219|Vitamins|vitamins|mesh-ancestor
19366578|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
19366579|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
19366580|NCT00116142|Docetaxel|docetaxel|mesh-list
19366581|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
19366582|NCT00116142|Androgens|androgens|mesh-list
19366583|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19366584|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366585|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366586|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366587|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366588|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366589|NCT00116142|Hormones|hormones|mesh-ancestor
19366590|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366591|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366592|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
19689188|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210279|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
20210280|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
20210281|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210282|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210283|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210284|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
20210285|NCT00283985|Hormones|hormones|mesh-ancestor
20210286|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210287|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20210288|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210289|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20210290|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
20210291|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20210292|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19366593|NCT00116142|Protective Agents|protective agents|mesh-ancestor
19366594|NCT00116142|Vitamins|vitamins|mesh-ancestor
19366595|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
19366596|NCT00116142|Estrogens|estrogens|mesh-ancestor
19366597|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366598|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
19366599|NCT00070018|Prednisone|prednisone|mesh-list
19366600|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
19366601|NCT00070018|Rituximab|rituximab|mesh-list
20398569|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398570|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398571|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20398572|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20398573|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
19366602|NCT00070018|Doxorubicin|doxorubicin|mesh-list
19366603|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19366604|NCT00070018|Vincristine|vincristine|mesh-list
19366605|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19366606|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366607|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
19366608|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398574|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398575|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
20398576|NCT01122472|Lenalidomide|lenalidomide|mesh-list
20398577|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
20398578|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398579|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20398580|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398581|NCT01122472|Growth Substances|growth substances|mesh-ancestor
20398582|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
20398583|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398584|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
20398585|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20398586|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20398587|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
19366609|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366610|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366611|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
19366612|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366613|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366614|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19689189|NCT05035485|Protective Agents|protective agents|mesh-ancestor
19689190|NCT05035472|Phenylephrine|phenylephrine|mesh-list
20398588|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398589|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398590|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398591|NCT01122563|Urological Agents|urological agents|mesh-ancestor
20398592|NCT01122602|Aspirin|aspirin|mesh-list
19689191|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
19689192|NCT05035472|Norepinephrine|norepinephrine|mesh-list
19689193|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19689194|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19689195|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
20398593|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20398594|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20398595|NCT01122602|Analgesics|analgesics|mesh-ancestor
20398596|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
20398597|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398598|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398599|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845813|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19845814|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19845815|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19845816|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398600|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398601|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20398602|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20398603|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398604|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20398605|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19689196|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
19689197|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689198|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689199|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
19366615|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689200|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
19366616|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19689201|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
19693174|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
20398606|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398607|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
20398608|NCT01122615|Sirolimus|sirolimus|mesh-list
20398609|NCT01122615|Sunitinib|sunitinib|mesh-list
20398610|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398611|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20398612|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398613|NCT01122615|Growth Substances|growth substances|mesh-ancestor
20398614|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398615|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
20398616|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20398617|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366617|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366618|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366619|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366620|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366621|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
19845817|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845818|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845819|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845820|NCT00673452|Analgesics|analgesics|mesh-ancestor
19845821|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
19845822|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845823|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
19366622|NCT00070018|Hormones|hormones|mesh-ancestor
19366623|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689202|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19689203|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19689204|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19689205|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689206|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689207|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689208|NCT05035472|Protective Agents|protective agents|mesh-ancestor
19689209|NCT05035238|Vaccines|vaccines|mesh-list
19689210|NCT05035238|Immunologic Factors|immunologic factors|mesh-ancestor
19689211|NCT05035238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689212|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
19689213|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19689214|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
19689215|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689216|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
19689217|NCT05034965|Protective Agents|protective agents|mesh-ancestor
19692980|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19692981|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20210293|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
20398618|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398619|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20398620|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398621|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20210294|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210295|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
20210296|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210297|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20210298|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210299|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
20210300|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20210301|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20210302|NCT00284024|Domperidone|domperidone|mesh-list
20210303|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
20210304|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
20210305|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210306|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210307|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210308|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20210309|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
20210310|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210311|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210312|NCT00284193|Thrombin|thrombin|mesh-list
20210313|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
20210314|NCT00284193|Factor VIII|factor viii|mesh-list
20210315|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
20210316|NCT00284193|Coagulants|coagulants|mesh-ancestor
20210317|NCT00284206|Risperidone|risperidone|mesh-list
19366624|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20398622|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
20398623|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398624|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
20398625|NCT01122641|Vildagliptin|vildagliptin|mesh-list
20398626|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398627|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398628|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20398629|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
20398630|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398631|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398632|NCT01122667|Anacetrapib|anacetrapib|mesh-list
20398633|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20398634|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20398635|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
20398636|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398637|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20398638|NCT01122771|Amphotericin B|amphotericin b|mesh-list
20398639|NCT01122771|Paromomycin|paromomycin|mesh-list
20398640|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20398641|NCT01122771|Miltefosine|miltefosine|mesh-list
20398642|NCT01122771|Amebicides|amebicides|mesh-ancestor
20398643|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20398644|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20398645|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398646|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20398647|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
20398648|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398649|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20398650|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398651|NCT01122940|Phenytoin|phenytoin|mesh-list
20398652|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
20398653|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20398654|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20398655|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398656|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398657|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20398658|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20398659|NCT01122953|Phenytoin|phenytoin|mesh-list
20398660|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
20398661|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20398662|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20398663|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398664|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398665|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20398666|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20398667|NCT01122966|Bevacizumab|bevacizumab|mesh-list
20398668|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20398669|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398670|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20398671|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398672|NCT01122966|Growth Substances|growth substances|mesh-ancestor
20398673|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398674|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
20398675|NCT01122979|Insulin|insulin|mesh-list
20398676|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19366625|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20210318|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20210319|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
20210320|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210321|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210322|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210323|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20210324|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20210325|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210326|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210327|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20210328|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
20210329|NCT00284232|Insulin|insulin|mesh-list
20398677|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
19366626|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366627|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366628|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366629|NCT05189535|Paclitaxel|paclitaxel|mesh-list
19366630|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
20210330|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19366631|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19366632|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366633|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366634|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366635|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366636|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366637|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19366638|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366639|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19366640|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19366641|NCT05189535|Protective Agents|protective agents|mesh-ancestor
19366642|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366643|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
19366644|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19366645|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
19366646|NCT05189223|Buprenorphine|buprenorphine|mesh-list
19366647|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19366648|NCT05189223|Narcotics|narcotics|mesh-ancestor
19366649|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19366650|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366651|NCT05189223|Analgesics|analgesics|mesh-ancestor
19366652|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
19366653|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366654|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19366655|NCT05189184|Paclitaxel|paclitaxel|mesh-list
19366656|NCT05189184|Apatinib|apatinib|mesh-list
19366657|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19366658|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20398678|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
20398679|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
20398680|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
20398681|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
20398682|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398683|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398684|NCT01123031|Esomeprazole|esomeprazole|mesh-list
20398685|NCT01123031|Lansoprazole|lansoprazole|mesh-list
20398686|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
20398687|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20398688|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20398689|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20398690|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398691|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426913|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426914|NCT01283646|Vitamins|vitamins|mesh-list
20426915|NCT01283646|Ascorbic Acid|ascorbic acid|mesh-list
19366659|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366660|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366661|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366662|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366663|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366664|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19366665|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366666|NCT05189093|Antibodies|antibodies|mesh-list
19366667|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19366668|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
19366669|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426916|NCT01283646|Folic Acid|folic acid|mesh-list
20426917|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
20426918|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
20426919|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210331|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210332|NCT00284258|Irinotecan|irinotecan|mesh-list
20210333|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20210334|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20210335|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210336|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210337|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426920|NCT01283646|Antioxidants|antioxidants|mesh-ancestor
20426921|NCT01283646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426922|NCT01283646|Protective Agents|protective agents|mesh-ancestor
19366670|NCT05189067|Paclitaxel|paclitaxel|mesh-list
19366671|NCT05189067|Docetaxel|docetaxel|mesh-list
19845824|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210338|NCT00284271|Prednisone|prednisone|mesh-list
20426923|NCT01283646|Hematinics|hematinics|mesh-ancestor
19366672|NCT05189067|Trastuzumab|trastuzumab|mesh-list
20426924|NCT01283724|Dienogest|dienogest|mesh-list
20426925|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19366673|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19366674|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366675|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366676|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366677|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366678|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366679|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366680|NCT05189015|Olmesartan|olmesartan|mesh-list
19366681|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19366682|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19366683|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19366684|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19366685|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366686|NCT05188911|Prednisone|prednisone|mesh-list
19366687|NCT05188911|Androgens|androgens|mesh-list
19366688|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366689|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
19366690|NCT05188911|Hormones|hormones|mesh-ancestor
19366691|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366692|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366693|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366694|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366695|NCT05188859|Pemetrexed|pemetrexed|mesh-list
19366696|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366697|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366698|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366699|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19366700|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19366701|NCT05188833|Paroxetine|paroxetine|mesh-list
19366702|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19366703|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19366704|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19366705|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366706|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366707|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
19366708|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366709|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19366710|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
19366711|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19366712|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19366713|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19366714|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366715|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
19366716|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366717|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366718|NCT05188768|Mitogens|mitogens|mesh-list
19366719|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366720|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366721|NCT05188742|Mirabegron|mirabegron|mesh-list
19366722|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19366723|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19366724|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19366725|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689218|NCT05035069|Propofol|propofol|mesh-list
20210339|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
20210340|NCT00284271|Vincristine|vincristine|mesh-list
20210341|NCT00284271|Bleomycin|bleomycin|mesh-list
20210342|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
20210343|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210344|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
20210345|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210346|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20210347|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20210348|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
20210349|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210350|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210351|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20210352|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20210353|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
20210354|NCT00284271|Hormones|hormones|mesh-ancestor
20210355|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20398692|NCT01123057|Riboflavin|riboflavin|mesh-list
20210356|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20398693|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
20398694|NCT01123057|Vitamins|vitamins|mesh-ancestor
20398695|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
20398696|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398697|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19366726|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366727|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366728|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366729|NCT05188742|Urological Agents|urological agents|mesh-ancestor
19366730|NCT05188495|Trastuzumab|trastuzumab|mesh-list
19366731|NCT05188495|Pertuzumab|pertuzumab|mesh-list
19689219|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20398698|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
20398699|NCT01123265|Methotrexate|methotrexate|mesh-list
20398700|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20398701|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
20398702|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20398703|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398704|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20398705|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
20398706|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398707|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398708|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
20398709|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398710|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20398711|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398712|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
20398713|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398714|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20398715|NCT01123278|Testosterone|testosterone|mesh-list
20398716|NCT01123278|Androgens|androgens|mesh-ancestor
20398717|NCT01123278|Hormones|hormones|mesh-ancestor
20398718|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20398719|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398720|NCT01123317|Oxytocin|oxytocin|mesh-list
20398721|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
20398722|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20398723|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398724|NCT01123408|Haloperidol|haloperidol|mesh-list
20398725|NCT01123408|Olanzapine|olanzapine|mesh-list
20398726|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
20398727|NCT01123408|Clozapine|clozapine|mesh-list
19689220|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19366732|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366733|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366734|NCT05188339|Citric Acid|citric acid|mesh-list
19366735|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
19366736|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
19366737|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19366738|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
19366739|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
19366740|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366741|NCT05188313|Paclitaxel|paclitaxel|mesh-list
19366742|NCT05188313|Carboplatin|carboplatin|mesh-list
19366743|NCT05188313|Trastuzumab|trastuzumab|mesh-list
19366744|NCT05188313|Pertuzumab|pertuzumab|mesh-list
19366745|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19366746|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366747|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366748|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366749|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366750|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366751|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402088|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402089|NCT03612180|Metoprolol|metoprolol|mesh-list
19402090|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19402091|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19402092|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
19402093|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
19402094|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689221|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689222|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19689223|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
19689224|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
19689225|NCT05035147|Gemcitabine|gemcitabine|mesh-list
19689226|NCT05035147|Paclitaxel|paclitaxel|mesh-list
19689227|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19366752|NCT05188131|Diclofenac|diclofenac|mesh-list
19366753|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19366754|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19366755|NCT05188131|Analgesics|analgesics|mesh-ancestor
19366756|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
19366757|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366758|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398728|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
20398729|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
20398730|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398731|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398732|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20398733|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20398734|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20398735|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398736|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20398737|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20398738|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20398739|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398740|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398741|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398742|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
20398743|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20398744|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
20398745|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20398746|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20398747|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
20398748|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
20398749|NCT01123473|Fluorouracil|fluorouracil|mesh-list
20398750|NCT01123473|Capecitabine|capecitabine|mesh-list
20398751|NCT01123473|Epirubicin|epirubicin|mesh-list
20398752|NCT01123473|Lapatinib|lapatinib|mesh-list
19366759|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845825|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
19366760|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366761|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19366762|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366763|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366764|NCT05188118|Nivolumab|nivolumab|mesh-list
19366765|NCT05188118|Ipilimumab|ipilimumab|mesh-list
19366766|NCT05188118|Everolimus|everolimus|mesh-list
19366767|NCT05188118|Lenvatinib|lenvatinib|mesh-list
19366768|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366769|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366770|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19366771|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366772|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845826|NCT00673465|Metformin|metformin|mesh-list
19845827|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845828|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366773|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
19366774|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366775|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19366776|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366777|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
19366778|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19689228|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689229|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689230|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
19689231|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
19689232|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
19689233|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689234|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20398753|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398754|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
20398755|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398756|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20398757|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398758|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
20398759|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398760|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19366779|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398761|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20398762|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366780|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
19845829|NCT00673673|Bevacizumab|bevacizumab|mesh-list
19689235|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
19689236|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
20210357|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20210358|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
20210359|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
20210360|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
19689237|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689238|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398763|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398764|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20398765|NCT01123486|Hydromorphone|hydromorphone|mesh-list
19366781|NCT05169424|Fluticasone|fluticasone|mesh-list
19366782|NCT05169424|Xhance|xhance|mesh-list
19366783|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
19366784|NCT05169424|Olodaterol|olodaterol|mesh-list
19366785|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366786|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19366787|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
19689239|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689240|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
19366788|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366789|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366790|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19366791|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
19366792|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
19366793|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19366794|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
19366795|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19366796|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
19689241|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689242|NCT05034783|Exenatide|exenatide|mesh-list
19689243|NCT05034783|Edetic Acid|edetic acid|mesh-list
19689244|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
20210361|NCT00284271|Hematinics|hematinics|mesh-ancestor
19366797|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366798|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366799|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
19366800|NCT05165225|Docetaxel|docetaxel|mesh-list
19366801|NCT05165225|Epirubicin|epirubicin|mesh-list
19366802|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19366803|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
19366804|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366805|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366806|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366807|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
19366808|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366809|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366810|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19366811|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
19366812|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
19366813|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
19366814|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19366815|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19366816|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366817|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366818|NCT05162222|Itraconazole|itraconazole|mesh-list
19366819|NCT05162222|Diltiazem|diltiazem|mesh-list
19366820|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
19366821|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366822|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19366823|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19366824|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366825|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366826|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19366827|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
19366828|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689245|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
19689246|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210362|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20210363|NCT00284323|Adenosine|adenosine|mesh-list
20210364|NCT00284323|Analgesics|analgesics|mesh-ancestor
20210365|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
20210366|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398766|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20398767|NCT01123486|Narcotics|narcotics|mesh-ancestor
19689247|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
19689248|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19689249|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19689250|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689251|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19689252|NCT05034783|Incretins|incretins|mesh-ancestor
19689253|NCT05034783|Hormones|hormones|mesh-ancestor
19845830|NCT00673673|Fluorouracil|fluorouracil|mesh-list
19845831|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845832|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845833|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845834|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398768|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19366829|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366830|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19366831|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19366832|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19366833|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19366834|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19366835|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
19366836|NCT05160896|Bevacizumab|bevacizumab|mesh-list
19366837|NCT05160896|Cetuximab|cetuximab|mesh-list
19366838|NCT05160896|Irinotecan|irinotecan|mesh-list
19689254|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689255|NCT05034887|Trastuzumab|trastuzumab|mesh-list
19689256|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689257|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689258|NCT05034406|Lidocaine|lidocaine|mesh-list
19689259|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
19689260|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
19689261|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
19689262|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689263|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689264|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
19689265|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689266|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20398769|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398770|NCT01123486|Analgesics|analgesics|mesh-ancestor
20398771|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
20398772|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398773|NCT01123525|Adenosine|adenosine|mesh-list
20398774|NCT01123525|Analgesics|analgesics|mesh-ancestor
20398775|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
20398776|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398777|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398778|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20398779|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
20398780|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20398781|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
20398782|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
19366839|NCT05160896|Raltitrexed|raltitrexed|mesh-list
19366840|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366841|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366842|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366843|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398783|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398784|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366844|NCT05160896|Growth Substances|growth substances|mesh-ancestor
19366845|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366846|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
19366847|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19366848|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19366849|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366850|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366851|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19366852|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
19366853|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19366854|NCT05152004|Amoxicillin|amoxicillin|mesh-list
19366855|NCT05152004|Metronidazole|metronidazole|mesh-list
19366856|NCT05152004|Clarithromycin|clarithromycin|mesh-list
19366857|NCT05152004|Rabeprazole|rabeprazole|mesh-list
19366858|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19689267|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19689268|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19366859|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20398785|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
19366860|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20398786|NCT01123538|Progesterone|progesterone|mesh-list
20398787|NCT01123538|Progestins|progestins|mesh-ancestor
20398788|NCT01123538|Hormones|hormones|mesh-ancestor
20398789|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20398790|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398791|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
20398792|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
20398793|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20398794|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20398795|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20398796|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
20398797|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20398798|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20398799|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20398800|NCT01123551|Morphine|morphine|mesh-list
20398801|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20398802|NCT01123551|Narcotics|narcotics|mesh-ancestor
20398803|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398804|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398805|NCT01123551|Analgesics|analgesics|mesh-ancestor
20398806|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
20398807|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398808|NCT01123564|Ranibizumab|ranibizumab|mesh-list
20398809|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20398810|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366861|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19366862|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19366863|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366864|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366865|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19366866|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19689269|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398811|NCT01123564|Growth Substances|growth substances|mesh-ancestor
20398812|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398813|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
20398814|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398815|NCT01123811|Cetuximab|cetuximab|mesh-list
20398816|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20398817|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398818|NCT01123824|Clopidogrel|clopidogrel|mesh-list
20398819|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20398820|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20398821|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20398822|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20398823|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
20398824|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398825|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398826|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398827|NCT01123876|Veliparib|veliparib|mesh-list
20398828|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20398829|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398830|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398831|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398832|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20398833|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20398834|NCT01123915|Protective Agents|protective agents|mesh-ancestor
20398835|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398836|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20398837|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
20398838|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398839|NCT01123967|Nicotine|nicotine|mesh-list
20398840|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20398841|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
19366867|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19366868|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19366869|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19366870|NCT05124509|Vaccines|vaccines|mesh-list
19366871|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
19366872|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366873|NCT05076409|Fluconazole|fluconazole|mesh-list
20398842|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398843|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366874|NCT05076409|BI 425809|bi 425809|mesh-list
20398844|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20398845|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20398846|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
20398847|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398848|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689270|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689271|NCT05034055|Atezolizumab|atezolizumab|mesh-list
19689272|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689273|NCT05033665|Benzocaine|benzocaine|mesh-list
19689274|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
19689275|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
19689276|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689277|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689278|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
20398849|NCT01124032|Methylphenidate|methylphenidate|mesh-list
20398850|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20398851|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398852|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20398853|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19689279|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689280|NCT05033769|Paclitaxel|paclitaxel|mesh-list
19689281|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19689282|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689283|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689284|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
19689285|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
19689286|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
19689287|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366875|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
19366876|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19366877|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19366878|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19366879|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366880|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366881|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19366882|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
19366883|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366884|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366885|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19689288|NCT05034133|Cisplatin|cisplatin|mesh-list
19689289|NCT05034133|Etoposide|etoposide|mesh-list
19689290|NCT05034133|Durvalumab|durvalumab|mesh-list
19689291|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689292|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689293|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20398854|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19366886|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19366887|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
19366888|NCT05060068|Ketamine|ketamine|mesh-list
19366889|NCT05060068|Esketamine|esketamine|mesh-list
19366890|NCT05060068|Analgesics|analgesics|mesh-ancestor
19366891|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
19366892|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366893|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398855|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398856|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
20398857|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398858|NCT01124058|Heparin|heparin|mesh-list
20398859|NCT01124058|Calcium heparin|calcium heparin|mesh-list
20398860|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20398861|NCT01124058|Tinzaparin|tinzaparin|mesh-list
20398862|NCT01124058|Dalteparin|dalteparin|mesh-list
20398863|NCT01124058|Warfarin|warfarin|mesh-list
20398864|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
20398865|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20398866|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20398867|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398868|NCT01124227|Icodextrin|icodextrin|mesh-list
20398869|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
20398870|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20398871|NCT01124240|Temozolomide|temozolomide|mesh-list
20398872|NCT01124240|Procarbazine|procarbazine|mesh-list
20398873|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20398874|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
20426926|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
20398875|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366894|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19366895|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19366896|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
19366897|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
19366898|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19366899|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19366900|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19366901|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366902|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366903|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
19366904|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19366905|NCT05038982|Abrocitinib|abrocitinib|mesh-list
19366906|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19366907|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19366908|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366909|NCT05028062|Naltrexone|naltrexone|mesh-list
19366910|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19366911|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19366912|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689294|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19689295|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689296|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689297|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689298|NCT05033860|Vaccines|vaccines|mesh-list
19689299|NCT05033860|Immunologic Factors|immunologic factors|mesh-ancestor
19689300|NCT05033860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689301|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
19689302|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19689303|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
19689304|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19689305|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
19689306|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689307|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689308|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
19689309|NCT05033574|Hormones|hormones|mesh-list
20398876|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398877|NCT01124253|Endostatins|endostatins|mesh-list
19366913|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
19689310|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689311|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689312|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
19689313|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
19689314|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
19689315|NCT05033535|Olmesartan|olmesartan|mesh-list
19689316|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19689317|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19689318|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20210367|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366914|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366915|NCT05022342|Fulvestrant|fulvestrant|mesh-list
19366916|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366917|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366918|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19366919|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19366920|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
19689319|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20210368|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20210369|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
20210370|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20210371|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
20210372|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
20210373|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210374|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210375|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
20210376|NCT00284336|Doxorubicin|doxorubicin|mesh-list
20210377|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20210378|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210379|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
20210380|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210381|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20210382|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20210383|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
19366921|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366922|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366923|NCT05017545|Abatacept|abatacept|mesh-list
19366924|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19366925|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366926|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366927|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689320|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689321|NCT05033106|Bevacizumab|bevacizumab|mesh-list
19689322|NCT05033106|Ranibizumab|ranibizumab|mesh-list
19689323|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689324|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689325|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19689326|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19689327|NCT05033106|Growth Substances|growth substances|mesh-ancestor
19689328|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689329|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
19689330|NCT05032781|Minocycline|minocycline|mesh-list
19366928|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
19366929|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366930|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366931|NCT05008575|Fludarabine|fludarabine|mesh-list
19366932|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
19366933|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689331|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19689332|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692982|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19692983|NCT04985110|Renal Agents|renal agents|mesh-ancestor
20398878|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20398879|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20398880|NCT01124253|Growth Substances|growth substances|mesh-ancestor
20398881|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398882|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
20398883|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19692984|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19692985|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
19692986|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19692987|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19693175|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693176|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
19693177|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693178|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693179|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
19693180|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19693181|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20398884|NCT01124318|Lactulose|lactulose|mesh-list
20398885|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20398886|NCT01124383|Lidocaine|lidocaine|mesh-list
19366934|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366935|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210384|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210385|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210386|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20210387|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20210388|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20210389|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20210390|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210391|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
19366936|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
19366937|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398887|NCT01124383|Ephedrine|ephedrine|mesh-list
20398888|NCT01124383|Midazolam|midazolam|mesh-list
20398889|NCT01124383|Sufentanil|sufentanil|mesh-list
20398890|NCT01124383|Dsuvia|dsuvia|mesh-list
20398891|NCT01124383|Anesthetics|anesthetics|mesh-list
20398892|NCT01124383|Propofol|propofol|mesh-list
20398893|NCT01124383|Sevoflurane|sevoflurane|mesh-list
19366938|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19366939|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19366940|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
19366941|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19693182|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693183|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20398894|NCT01124383|Rocuronium|rocuronium|mesh-list
20398895|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
20398896|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20398897|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398898|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
20398899|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398900|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20398901|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20398902|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20398903|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398904|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398905|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20398906|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20398907|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
20398908|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20398909|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20398910|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20398911|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20398912|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
20398913|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
20398914|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398915|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20398916|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20398917|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20398918|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20398919|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20398920|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20398921|NCT01124383|Narcotics|narcotics|mesh-ancestor
20398922|NCT01124383|Analgesics|analgesics|mesh-ancestor
20210392|NCT00284427|Vitamins|vitamins|mesh-ancestor
20210393|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
20210394|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689333|NCT05032261|Norepinephrine|norepinephrine|mesh-list
19689334|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19689335|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19689336|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689337|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689338|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689339|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689340|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
19689341|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
19689342|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689343|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19689344|NCT05032287|Tamsulosin|tamsulosin|mesh-list
19689345|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20428655|NCT01293149|Ropivacaine|ropivacaine|mesh-list
19366942|NCT04988074|Cemiplimab|cemiplimab|mesh-list
19366943|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366944|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366945|NCT04984369|Cetuximab|cetuximab|mesh-list
19366946|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19366947|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366948|NCT04971473|Hormones|hormones|mesh-list
19366949|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366950|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366951|NCT04964284|Hormones|hormones|mesh-list
19366952|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366953|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689346|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19689347|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19689348|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689349|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689350|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689351|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689352|NCT05032287|Urological Agents|urological agents|mesh-ancestor
19689353|NCT05032248|Tacrolimus|tacrolimus|mesh-list
19689354|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689355|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
19689356|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689357|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20210395|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
20210396|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210397|NCT00284427|Protective Agents|protective agents|mesh-ancestor
20210398|NCT00284505|Thalidomide|thalidomide|mesh-list
20210399|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210400|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
20210401|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689358|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689359|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689360|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
20398923|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20398924|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
19689361|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19689362|NCT05031936|Ropivacaine|ropivacaine|mesh-list
19689363|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
19689364|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
19689365|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689366|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689367|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
19689368|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689369|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19689370|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19689371|NCT05032001|Biguanides|biguanides|mesh-list
19689372|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689373|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19366954|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
19366955|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19366956|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19366957|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366958|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19366959|NCT04946396|Analgesics|analgesics|mesh-ancestor
19366960|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
19366961|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366962|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19366963|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19689374|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689375|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
19689376|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689377|NCT05032118|Ketamine|ketamine|mesh-list
20210402|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
19366964|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19366965|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
19366966|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19366967|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19366968|NCT04925193|Dexamethasone|dexamethasone|mesh-list
19366969|NCT04925193|Daratumumab|daratumumab|mesh-list
19366970|NCT04925193|Pomalidomide|pomalidomide|mesh-list
19366971|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19366972|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
19366973|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
19366974|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19366975|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366976|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19366977|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
19366978|NCT04925193|Hormones|hormones|mesh-ancestor
20398925|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
20398926|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19366979|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366980|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19366981|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366982|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
19366983|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19366984|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19366985|NCT04925193|Growth Substances|growth substances|mesh-ancestor
19366986|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
20210403|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20210404|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210405|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20210406|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20210407|NCT00284505|Growth Substances|growth substances|mesh-ancestor
20210408|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
20210409|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210410|NCT00284531|Daclizumab|daclizumab|mesh-list
20210411|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210412|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
20210413|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210414|NCT00284583|Lidocaine|lidocaine|mesh-list
20210415|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
20210416|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
20210417|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19366987|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
20398927|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
20398928|NCT01124435|Celecoxib|celecoxib|mesh-list
20398929|NCT01124435|Carboplatin|carboplatin|mesh-list
20398930|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398931|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20210418|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210419|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
20210420|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210421|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20210422|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19366988|NCT04925180|Cyproterone|cyproterone|mesh-list
19366989|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
19689378|NCT05032118|Propofol|propofol|mesh-list
19689379|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19689380|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689381|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689382|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19689383|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
19689384|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
19689385|NCT05032118|Analgesics|analgesics|mesh-ancestor
19689386|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
20398932|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20398933|NCT01124435|Analgesics|analgesics|mesh-ancestor
20398934|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
20398935|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20398936|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398937|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20398938|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398939|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20398940|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20398941|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398942|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398943|NCT01124487|Insulin|insulin|mesh-list
19689387|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689388|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19689389|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19689390|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19689391|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689392|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689393|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
20398944|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398945|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398946|NCT01124500|Methylphenidate|methylphenidate|mesh-list
20398947|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20398948|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398949|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20398950|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20398951|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20398952|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398953|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
19366990|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
19366991|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19366992|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19366993|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19366994|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19366995|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
19366996|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19366997|NCT04886531|Trastuzumab|trastuzumab|mesh-list
19366998|NCT04886531|Letrozole|letrozole|mesh-list
19366999|NCT04886531|Anastrozole|anastrozole|mesh-list
19367000|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367001|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367002|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19367003|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20210423|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20210424|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210425|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210426|NCT00284687|Artesunate|artesunate|mesh-list
20210427|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
20210428|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20210429|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19367004|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689394|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19689395|NCT05031689|Protective Agents|protective agents|mesh-ancestor
19845835|NCT00673673|Growth Substances|growth substances|mesh-ancestor
20398954|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20398955|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
20398956|NCT01124526|Rituximab|rituximab|mesh-list
20398957|NCT01124526|Fludarabine|fludarabine|mesh-list
20398958|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398959|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
20398960|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398961|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20398962|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20398963|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
20398964|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398965|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398966|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20398967|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20398968|NCT01124539|Camptothecin|camptothecin|mesh-list
20398969|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
19845836|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845837|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845838|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
19845839|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845840|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845841|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845842|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
19845843|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
19845844|NCT00673712|Narcotics|narcotics|mesh-ancestor
19845845|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19845846|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845847|NCT00673712|Analgesics|analgesics|mesh-ancestor
20398970|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20398971|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398972|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20398973|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20398974|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398975|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398976|NCT01124630|Leucovorin|leucovorin|mesh-list
20398977|NCT01124630|Fluorouracil|fluorouracil|mesh-list
20398978|NCT01124630|Irinotecan|irinotecan|mesh-list
20398979|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
20398980|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20398981|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845848|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
19845849|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19845850|NCT00673738|Docetaxel|docetaxel|mesh-list
19845851|NCT00673738|Cetuximab|cetuximab|mesh-list
19845852|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845853|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
19845854|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845855|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
19845856|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845857|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19845858|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19845859|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
19845860|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19845861|NCT00673790|Losartan|losartan|mesh-list
19845862|NCT00673790|Lisinopril|lisinopril|mesh-list
19845863|NCT00673790|Nebivolol|nebivolol|mesh-list
19845864|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19845865|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19845866|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19845867|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19845868|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845869|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19845870|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
19845871|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845872|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19845873|NCT00673790|Protective Agents|protective agents|mesh-ancestor
19845874|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398982|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20398983|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20398984|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
19367005|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845875|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
19845876|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20210430|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689396|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689397|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
19689398|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
20398985|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398986|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20398987|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20398988|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20398989|NCT01124630|Antidotes|antidotes|mesh-ancestor
20398990|NCT01124630|Protective Agents|protective agents|mesh-ancestor
20398991|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
20398992|NCT01124630|Vitamins|vitamins|mesh-ancestor
20398993|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
20398994|NCT01124656|Pioglitazone|pioglitazone|mesh-list
19689399|NCT05031676|Anesthetics|anesthetics|mesh-list
19689400|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689401|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689402|NCT05031676|Narcotics|narcotics|mesh-ancestor
19689403|NCT05031676|Analgesics|analgesics|mesh-ancestor
19689404|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
19689405|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689406|NCT05031481|Butoconazole|butoconazole|mesh-list
19689407|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
19689408|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689409|NCT05031520|Metoprolol|metoprolol|mesh-list
19689410|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
19689411|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19689412|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19689413|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
19689414|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
19689415|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689416|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689417|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19689418|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19689419|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19367006|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19367007|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
19367008|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367009|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367010|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402095|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402096|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19402097|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19402098|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19402099|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402100|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402101|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402102|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
19402103|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
19402104|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402105|NCT03612037|Protective Agents|protective agents|mesh-ancestor
19402106|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402107|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
19402108|NCT03612037|Vitamins|vitamins|mesh-ancestor
19402109|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
19402110|NCT03611985|Taxane|taxane|mesh-list
19402111|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402112|NCT03611920|Tetracycline|tetracycline|mesh-list
19402113|NCT03611920|Dexamethasone|dexamethasone|mesh-list
20210431|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210432|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
20210433|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
20210434|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20210435|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
20210436|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20210437|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210438|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20210439|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20210440|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20210441|NCT00284765|Analgesics|analgesics|mesh-ancestor
20210442|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
20210443|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402114|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20398995|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19689420|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689421|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689422|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689423|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
20398996|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20398997|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20398998|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20398999|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20399000|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399001|NCT01124695|Tamoxifen|tamoxifen|mesh-list
20399002|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20399003|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
19689424|NCT05031234|Morphine|morphine|mesh-list
19689425|NCT05031234|Anesthetics|anesthetics|mesh-list
19689426|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689427|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689428|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19689429|NCT05031234|Narcotics|narcotics|mesh-ancestor
19689430|NCT05031234|Analgesics|analgesics|mesh-ancestor
19689431|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
19689432|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689433|NCT05031143|Triamcinolone|triamcinolone|mesh-list
19689434|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19689435|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20399004|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20399005|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399006|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20399007|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399008|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19689436|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19689437|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689438|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
19689439|NCT05031143|Hormones|hormones|mesh-ancestor
19689440|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689441|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689442|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689443|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
19367011|NCT04786067|Abatacept|abatacept|mesh-list
19367012|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19367013|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210444|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210445|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20210446|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20399009|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19367014|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367015|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367016|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
19367017|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367018|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367019|NCT04775680|Antibodies|antibodies|mesh-list
19367020|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
19367021|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367022|NCT04760613|Cannabidiol|cannabidiol|mesh-list
19367023|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
19367024|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
19367025|NCT04757363|Nivolumab|nivolumab|mesh-list
19367026|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210447|NCT00284778|Docetaxel|docetaxel|mesh-list
20210448|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210449|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
20210450|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
20210451|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
20210452|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217873|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19367027|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367028|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19367029|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367030|NCT04738292|Fulvestrant|fulvestrant|mesh-list
19367031|NCT04738292|Onapristone|onapristone|mesh-list
19367032|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367033|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217874|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20217875|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402115|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
19689444|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367034|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19367035|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19367036|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
19367037|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367038|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689445|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399010|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20399011|NCT01124760|Ketoconazole|ketoconazole|mesh-list
20399012|NCT01124760|Diltiazem|diltiazem|mesh-list
20399013|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
20399014|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399015|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20399016|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20399017|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399018|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399019|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20399020|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
19367039|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19367040|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
19367041|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19367042|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
19367043|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367044|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689446|NCT05030623|Tadalafil|tadalafil|mesh-list
19689447|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
19689448|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19689449|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19689450|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689451|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689452|NCT05030623|Urological Agents|urological agents|mesh-ancestor
19689453|NCT05030545|Eplerenone|eplerenone|mesh-list
19689454|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19367045|NCT04681417|Carboplatin|carboplatin|mesh-list
19367046|NCT04681417|Etoposide|etoposide|mesh-list
19367047|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
19689455|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
19689456|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
19689457|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689458|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689459|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19689460|NCT05030545|Diuretics|diuretics|mesh-ancestor
19689461|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
19689462|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19689463|NCT05030545|Hormones|hormones|mesh-ancestor
19692988|NCT04984408|Vaccines|vaccines|mesh-list
19692989|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
19692990|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692991|NCT04984200|Mydriatics|mydriatics|mesh-list
19692992|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
19367048|NCT04681417|Vincristine|vincristine|mesh-list
19367049|NCT04681417|Melphalan|melphalan|mesh-list
19367050|NCT04681417|Topotecan|topotecan|mesh-list
19367051|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367052|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19692993|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19692994|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19692995|NCT04984577|Edaravone|edaravone|mesh-list
19692996|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19692997|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
19692998|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19692999|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20210453|NCT00284791|Lamotrigine|lamotrigine|mesh-list
20210454|NCT00284791|Sertraline|sertraline|mesh-list
20210455|NCT00284791|Fluoxetine|fluoxetine|mesh-list
20210456|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
20210457|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210458|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20210459|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20210460|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210461|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210462|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210463|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
20210464|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428656|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
19367053|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19689464|NCT05030493|Bevacizumab|bevacizumab|mesh-list
20399021|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20399022|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399023|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20399024|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20399025|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20399026|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399027|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399028|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
20399029|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
20399030|NCT01124799|Simeprevir|simeprevir|mesh-list
19689465|NCT05030493|Panitumumab|panitumumab|mesh-list
19689466|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689467|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689468|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19689469|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19689470|NCT05030493|Growth Substances|growth substances|mesh-ancestor
19689471|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399031|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20399032|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399033|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20399034|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20399035|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399036|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399037|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399038|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20399039|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20399040|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
20399041|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399042|NCT01124877|Ziprasidone|ziprasidone|mesh-list
19689472|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
19689473|NCT05030116|Domperidone|domperidone|mesh-list
20210465|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19367054|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19367055|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367056|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367057|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367058|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
19367059|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367060|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19367061|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
20399043|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20399044|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
20399045|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399046|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399047|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399048|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20399049|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20399050|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399051|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20399052|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20399053|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
20426927|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20426928|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426929|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20613097|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613098|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367062|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19367063|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367064|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
19367065|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367066|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19689474|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
20210466|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20210467|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20210468|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210469|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
20210470|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20210471|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20210472|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20210473|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20426930|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20399054|NCT01125020|Gemcitabine|gemcitabine|mesh-list
19367067|NCT04657640|Iron|iron|mesh-list
19367068|NCT04657640|Trace Elements|trace elements|mesh-list
19367069|NCT04657640|Folic Acid|folic acid|mesh-list
19367070|NCT04657640|Micronutrients|micronutrients|mesh-list
19367071|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
19367072|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367073|NCT04657640|Hematinics|hematinics|mesh-ancestor
19367074|NCT04657640|Vitamins|vitamins|mesh-ancestor
19367075|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
19367076|NCT04651088|Diuretics|diuretics|mesh-ancestor
19367077|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
19367078|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367079|NCT04651088|Expectorants|expectorants|mesh-ancestor
19367080|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
19367081|NCT04595513|Sirolimus|sirolimus|mesh-list
19367082|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19367083|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367084|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19367085|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367086|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
19367087|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367088|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
19367089|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367090|NCT04589832|Entrectinib|entrectinib|mesh-list
19367091|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367092|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367093|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367094|NCT04575181|Insulin|insulin|mesh-list
19367095|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19367096|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
19367097|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19367098|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367099|NCT04560881|Vaccines|vaccines|mesh-list
19367100|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
19367101|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399055|NCT01125020|Doxorubicin|doxorubicin|mesh-list
20399056|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
20399057|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399058|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20399059|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
20399060|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399061|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
20399062|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399063|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399064|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20399065|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
20399066|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399067|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20399068|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19367102|NCT04501120|Azacitidine|azacitidine|mesh-list
19367103|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367104|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
20399069|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20399070|NCT01125033|Vitamins|vitamins|mesh-list
20399071|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
20399072|NCT01125033|Vitamin E|vitamin e|mesh-list
20399073|NCT01125033|Tocopherols|tocopherols|mesh-list
20399074|NCT01125033|Tocotrienols|tocotrienols|mesh-list
20399075|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
20399076|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
20399077|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367105|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367106|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367107|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367108|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
19367109|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19367110|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367111|NCT04497961|Lenalidomide|lenalidomide|mesh-list
19367112|NCT04497961|Daratumumab|daratumumab|mesh-list
19367113|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
20399078|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
19367114|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367115|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19367116|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19367117|NCT04497961|Growth Substances|growth substances|mesh-ancestor
19367118|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
19367119|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399079|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367120|NCT04483583|Clopidogrel|clopidogrel|mesh-list
19367121|NCT04483583|Ticagrelor|ticagrelor|mesh-list
19367122|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19367123|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19367124|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19689475|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
19689476|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689477|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689478|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19689479|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19689480|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
19689481|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689482|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689483|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
19689484|NCT05030155|Azathioprine|azathioprine|mesh-list
19689485|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689486|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
19689487|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689488|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19689489|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19689490|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
19689491|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689492|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689493|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19689494|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
19689495|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19689496|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
19689497|NCT05030129|Pyridoxal|pyridoxal|mesh-list
19845877|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19367125|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19367126|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
19367127|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367128|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367129|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367130|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
19367131|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19367132|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
19367133|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367134|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367135|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19367136|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
19367137|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19367138|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
19367139|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367140|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367141|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19367142|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
19845878|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19367143|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
19367144|NCT04460183|Protective Agents|protective agents|mesh-ancestor
19367145|NCT04447287|Buprenorphine|buprenorphine|mesh-list
19367146|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19367147|NCT04447287|Naloxone|naloxone|mesh-list
19367148|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19367149|NCT04447287|Narcotics|narcotics|mesh-ancestor
19367150|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367151|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367152|NCT04447287|Analgesics|analgesics|mesh-ancestor
19367153|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
19367154|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367155|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19367156|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
19367157|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19367158|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
19367159|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19845879|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
19845880|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845881|NCT00673816|Sunitinib|sunitinib|mesh-list
19845882|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845883|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845884|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19845885|NCT00673816|Growth Substances|growth substances|mesh-ancestor
19845886|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845887|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
20399080|NCT01125033|Protective Agents|protective agents|mesh-ancestor
20399081|NCT01125059|Methadone|methadone|mesh-list
20399082|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20399083|NCT01125059|Narcotics|narcotics|mesh-ancestor
20399084|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399085|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399086|NCT01125059|Analgesics|analgesics|mesh-ancestor
20399087|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
20399088|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399089|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
20399090|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
20399091|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
20399092|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20399093|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399094|NCT01125150|Metformin|metformin|mesh-list
20399095|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20399096|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399097|NCT01125215|Capsaicin|capsaicin|mesh-list
20399098|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
20399099|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
20399100|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
20399101|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399102|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210474|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210475|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20210476|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
20399103|NCT01125254|Amlodipine|amlodipine|mesh-list
20399104|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20399105|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20399106|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399107|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399108|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399109|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399110|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
20399111|NCT01125371|Ethanol|ethanol|mesh-list
20399112|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20399113|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399114|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399115|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399116|NCT01125410|Clindamycin|clindamycin|mesh-list
20399117|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
20399118|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
20399119|NCT01125410|Dequalinium|dequalinium|mesh-list
20399120|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20399121|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210477|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19367160|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
19367161|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367162|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367163|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
19367164|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
20399122|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20399123|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399124|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399125|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20399126|NCT01125423|Milnacipran|milnacipran|mesh-list
20399127|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
20399128|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20399129|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20399130|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613099|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19367165|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
19367166|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19367167|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19367168|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367169|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210478|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210479|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20210480|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
20210481|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20210482|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210483|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210484|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399131|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613100|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20399132|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399133|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399134|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20399135|NCT01125423|Analgesics|analgesics|mesh-ancestor
20399136|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
20399137|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399138|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
20399139|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20399140|NCT01125436|Vitamin D|vitamin d|mesh-list
20399141|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
20399142|NCT01125436|Vitamins|vitamins|mesh-ancestor
19367170|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367171|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19689498|NCT05030129|Pyridoxine|pyridoxine|mesh-list
19689499|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
19689500|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
19689501|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
19689502|NCT05030129|Vitamins|vitamins|mesh-ancestor
19689503|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
19689504|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689505|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
19689506|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19689507|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
19689508|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19689509|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19689510|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19689511|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
20399143|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
20399144|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399145|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20399146|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399147|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
20399148|NCT01125449|Vitamins|vitamins|mesh-ancestor
20399149|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
20399150|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399151|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
19367172|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
19367173|NCT04393350|Lenvatinib|lenvatinib|mesh-list
19367174|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367175|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367176|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367177|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367178|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367179|NCT04336735|Vaccines|vaccines|mesh-list
19367180|NCT04336735|Immunologic Factors|immunologic factors|mesh-ancestor
20399152|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399153|NCT01125449|Protective Agents|protective agents|mesh-ancestor
20210485|NCT00284947|Prednisone|prednisone|mesh-list
20210486|NCT00284947|Prednisolone|prednisolone|mesh-list
20399154|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20399155|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
20399156|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20399157|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
19367181|NCT04336735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367182|NCT04283669|Crizotinib|crizotinib|mesh-list
19367183|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367184|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367185|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367186|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367187|NCT04262154|Prednisone|prednisone|mesh-list
19367188|NCT04262154|Atezolizumab|atezolizumab|mesh-list
19367189|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367190|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
20210487|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
20210488|NCT00284947|Basiliximab|basiliximab|mesh-list
20210489|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20210490|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
20210491|NCT00284947|Hormones|hormones|mesh-ancestor
20210492|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210493|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210494|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367191|NCT04262154|Hormones|hormones|mesh-ancestor
19402116|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
19689512|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693000|NCT04984577|Protective Agents|protective agents|mesh-ancestor
20210495|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210496|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
20399158|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19367192|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367193|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367194|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367195|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367196|NCT04175964|Metformin|metformin|mesh-list
20399159|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399160|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20399161|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20399162|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399163|NCT01125527|Vaccines|vaccines|mesh-list
20399164|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
20399165|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399166|NCT01125553|Insulin|insulin|mesh-list
20399167|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
20399168|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20399169|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399170|NCT01125657|Darexaban|darexaban|mesh-list
20399171|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20399172|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
20399173|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20399174|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399175|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399176|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399177|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
20399178|NCT01125670|Darexaban|darexaban|mesh-list
20399179|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20399180|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
20399181|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20399182|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399183|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399184|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399185|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
20399186|NCT01125683|Donepezil|donepezil|mesh-list
20399187|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20399188|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367197|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19367198|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367199|NCT04175834|Cetirizine|cetirizine|mesh-list
19367200|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
19367201|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19367202|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19367203|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19367204|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
19367205|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367206|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367207|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399189|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399190|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
20399191|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399192|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399193|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
20399194|NCT01125696|Ritonavir|ritonavir|mesh-list
20399195|NCT01125696|Lopinavir|lopinavir|mesh-list
20399196|NCT01125696|Tenofovir|tenofovir|mesh-list
20399197|NCT01125696|Lamivudine|lamivudine|mesh-list
20399198|NCT01125696|Zidovudine|zidovudine|mesh-list
20399199|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20399200|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20399201|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399202|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399203|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399204|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20399205|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20399206|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
20399207|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399208|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20399209|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20399210|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20399211|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20399212|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
20399213|NCT01125761|Clemastine|clemastine|mesh-list
20399214|NCT01125761|Dexamethasone|dexamethasone|mesh-list
20399215|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
20399216|NCT01125761|BB 1101|bb 1101|mesh-list
20399217|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20399218|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
20399219|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
20399220|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399221|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399222|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399223|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
19367208|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
19367209|NCT04157985|Nivolumab|nivolumab|mesh-list
19367210|NCT04157985|Ipilimumab|ipilimumab|mesh-list
19367211|NCT04157985|Cemiplimab|cemiplimab|mesh-list
19367212|NCT04157985|Atezolizumab|atezolizumab|mesh-list
19367213|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19367214|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367215|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367216|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367217|NCT04125745|CXA-10|cxa-10|mesh-list
19367218|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402117|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402118|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402119|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402120|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
19402121|NCT03611920|Hormones|hormones|mesh-ancestor
19402122|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402123|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402124|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402125|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402126|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402127|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19402128|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402129|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402130|NCT03611595|Tretinoin|tretinoin|mesh-list
19402131|NCT03611595|Isotretinoin|isotretinoin|mesh-list
19402132|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402133|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
19402134|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
19402135|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19402136|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19402137|NCT03611504|Hemostatics|hemostatics|mesh-list
19402138|NCT03611504|Coagulants|coagulants|mesh-ancestor
19402139|NCT03611491|Lidocaine|lidocaine|mesh-list
19402140|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402141|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
19402142|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402143|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402144|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
19402145|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402146|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19402147|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19402148|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19402149|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402150|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402151|NCT03611426|Thrombin|thrombin|mesh-list
19402152|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
19402153|NCT03611426|Coagulants|coagulants|mesh-ancestor
19402154|NCT03611348|Latanoprost|latanoprost|mesh-list
19402155|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19402156|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19402157|NCT03611244|Benzocaine|benzocaine|mesh-list
19402158|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
20210497|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
20210498|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210499|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210500|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20210501|NCT00284947|Protective Agents|protective agents|mesh-ancestor
20210502|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20399224|NCT01125761|Hormones|hormones|mesh-ancestor
20399225|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20399226|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20399227|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399228|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399229|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399230|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399231|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
19402159|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
20210503|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
20210504|NCT00285051|Ondansetron|ondansetron|mesh-list
20210505|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
19402160|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210506|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
20399232|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
20399233|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20399234|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
20399235|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
20399236|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399237|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20399238|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19367219|NCT04070768|Venetoclax|venetoclax|mesh-list
19367220|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
19367221|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367222|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367223|NCT04058366|Ivacaftor|ivacaftor|mesh-list
19367224|NCT04058366|Elexacaftor|elexacaftor|mesh-list
19367225|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20399239|NCT01125787|Ofatumumab|ofatumumab|mesh-list
20399240|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20399241|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20399242|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
20399243|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399244|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399245|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
20399246|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399247|NCT01125891|Gemcitabine|gemcitabine|mesh-list
20399248|NCT01125891|ON 01910|on 01910|mesh-list
20399249|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20399250|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
20399251|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399252|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399253|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
20399254|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399255|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399256|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689513|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689514|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
19689515|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
19689516|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
19689517|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
19689518|NCT05030077|Gemcitabine|gemcitabine|mesh-list
19689519|NCT05030077|Carboplatin|carboplatin|mesh-list
19689520|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399257|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
20399258|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399259|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20399260|NCT01125904|Crizotinib|crizotinib|mesh-list
19689521|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19689522|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
19689523|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367226|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19367227|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367228|NCT04042740|Ribavirin|ribavirin|mesh-list
20399261|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399262|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20399263|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399264|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367229|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
19367230|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367231|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
19367232|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367233|NCT04039503|Tirzepatide|tirzepatide|mesh-list
19367234|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19367235|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367236|NCT04039503|Incretins|incretins|mesh-ancestor
19367237|NCT04039503|Hormones|hormones|mesh-ancestor
19367238|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367239|NCT03913195|Ibalizumab|ibalizumab|mesh-list
19367240|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19367241|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19367242|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
19367243|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367244|NCT03695172|Ropivacaine|ropivacaine|mesh-list
19367245|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
19367246|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
20399265|NCT01125943|Bevacizumab|bevacizumab|mesh-list
20399266|NCT01125943|Nitroprusside|nitroprusside|mesh-list
20399267|NCT01125943|Acetylcholine|acetylcholine|mesh-list
19367247|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367248|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367249|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
19367250|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367251|NCT03554044|Tamoxifen|tamoxifen|mesh-list
19367252|NCT03554044|Gemcitabine|gemcitabine|mesh-list
19367253|NCT03554044|Paclitaxel|paclitaxel|mesh-list
19367254|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19367255|NCT03554044|Carboplatin|carboplatin|mesh-list
19689524|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
19689525|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689526|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689527|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689528|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
19689529|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689530|NCT05029453|Apatinib|apatinib|mesh-list
19689531|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689532|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20210507|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210508|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399268|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367256|NCT03554044|Letrozole|letrozole|mesh-list
19367257|NCT03554044|Fulvestrant|fulvestrant|mesh-list
19367258|NCT03554044|Anastrozole|anastrozole|mesh-list
19367259|NCT03554044|Exemestane|exemestane|mesh-list
19367260|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19367261|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19367262|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367263|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367264|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
19367265|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367266|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367267|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367268|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
19367269|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
19367270|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367271|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367272|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367273|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
19367274|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367275|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19367276|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19367277|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19367278|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
19367279|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367280|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367281|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19367282|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19367283|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19367284|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19367285|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367286|NCT03552380|Nivolumab|nivolumab|mesh-list
20210509|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210510|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
20210511|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
20210512|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20210513|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
20210514|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367287|NCT03552380|Ipilimumab|ipilimumab|mesh-list
20210515|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210516|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20210517|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20210518|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210519|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210520|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20210521|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
20210522|NCT00285090|Vitamin D|vitamin d|mesh-list
20210523|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
20210524|NCT00285090|Vitamins|vitamins|mesh-list
20210525|NCT00285090|Calcium|calcium|mesh-list
20210526|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
20210527|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210528|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20210529|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19689533|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689534|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367288|NCT03552380|Entinostat|entinostat|mesh-list
19689535|NCT05029596|Heparin|heparin|mesh-list
19367289|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367290|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367291|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19367292|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399269|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399270|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20399271|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20399272|NCT01125943|Growth Substances|growth substances|mesh-ancestor
20399273|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399274|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
20399275|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20399276|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
19367293|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19367294|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367295|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
19367296|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367297|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399277|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20399278|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399279|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20399280|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
20399281|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399282|NCT01125982|Propofol|propofol|mesh-list
20399283|NCT01125982|Desflurane|desflurane|mesh-list
20399284|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20399285|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399286|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399287|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20399288|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
20399289|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
20399290|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20399291|NCT01126008|Docetaxel|docetaxel|mesh-list
20399292|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367298|NCT03491267|Tretinoin|tretinoin|mesh-list
19367299|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367300|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
20399293|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20399294|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20399295|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20399296|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399297|NCT01126073|Niacin|niacin|mesh-list
20399298|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20399299|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
20399300|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399301|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20399302|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
20399303|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
20399304|NCT01126073|Vitamins|vitamins|mesh-ancestor
20399305|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
20399306|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399307|NCT01126086|Otamixaban|otamixaban|mesh-list
20399308|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20399309|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
20399310|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20399311|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399312|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399313|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399314|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
20399315|NCT01126112|Panitumumab|panitumumab|mesh-list
19367301|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
19689536|NCT05029596|Calcium heparin|calcium heparin|mesh-list
19845888|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20399316|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689537|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
19689538|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19689539|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19689540|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689541|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19689542|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689543|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19689544|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689545|NCT05029076|Liraglutide|liraglutide|mesh-list
20399317|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367302|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20399318|NCT01126138|Docetaxel|docetaxel|mesh-list
19845889|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845890|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845891|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19845892|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
19845893|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19845894|NCT00673881|Choline|choline|mesh-list
19845895|NCT00673881|Fenofibrate|fenofibrate|mesh-list
19845896|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19845897|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
19845898|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845899|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19845900|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
19367303|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
19367304|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367305|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19367306|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
19367307|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367308|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367309|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19367310|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19367311|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19367312|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
19367313|NCT03470675|Ketamine|ketamine|mesh-list
19367314|NCT03470675|Morphine|morphine|mesh-list
19367315|NCT03470675|Analgesics|analgesics|mesh-ancestor
20399319|NCT01126138|Capecitabine|capecitabine|mesh-list
20399320|NCT01126138|Vinorelbine|vinorelbine|mesh-list
20399321|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399322|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
20399323|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
20399324|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
20399325|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399326|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20399327|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
19689546|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19689547|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689548|NCT05029076|Incretins|incretins|mesh-ancestor
19689549|NCT05029076|Hormones|hormones|mesh-ancestor
20399328|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20399329|NCT01126177|Interferons|interferons|mesh-list
20399330|NCT01126177|Interferon-beta|interferon-beta|mesh-list
20399331|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
20399332|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399333|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
20399334|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399335|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
20399336|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367316|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
19367317|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367318|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367319|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19367320|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19367321|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
19367322|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
19367323|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367324|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19367325|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19367326|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367327|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367328|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19367329|NCT03470675|Narcotics|narcotics|mesh-ancestor
19367330|NCT03467360|Etoposide|etoposide|mesh-list
19367331|NCT03467360|Acetazolamide|acetazolamide|mesh-list
19367332|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689550|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689551|NCT05029297|Capsaicin|capsaicin|mesh-list
19689552|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
19689553|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845901|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845902|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
19845903|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19845904|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19845905|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845906|NCT00673894|Incretins|incretins|mesh-ancestor
19845907|NCT00673894|Hormones|hormones|mesh-ancestor
20399337|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20399338|NCT01126216|Paclitaxel|paclitaxel|mesh-list
20399339|NCT01126216|Cisplatin|cisplatin|mesh-list
20399340|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20399341|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399342|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
20399343|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
19845908|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19845909|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19845910|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399344|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
20399345|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367333|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367334|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20399346|NCT01126229|Resveratrol|resveratrol|mesh-list
20399347|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
20399348|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399349|NCT01126229|Protective Agents|protective agents|mesh-ancestor
20399350|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399351|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399352|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20399353|NCT01126294|Melatonin|melatonin|mesh-list
20399354|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
20399355|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399356|NCT01126294|Protective Agents|protective agents|mesh-ancestor
20399357|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399358|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399359|NCT01126307|Verapamil|verapamil|mesh-list
20399360|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20399361|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20399362|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399363|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399364|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399365|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399366|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
20399367|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20399368|NCT01126450|Cetuximab|cetuximab|mesh-list
20399369|NCT01126450|Lenalidomide|lenalidomide|mesh-list
20399370|NCT01126450|Antibodies|antibodies|mesh-list
20399371|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
20399372|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20399373|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
20399374|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399375|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399376|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20399377|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20399378|NCT01126450|Growth Substances|growth substances|mesh-ancestor
20399379|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20399380|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
20399381|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399382|NCT01126528|Vitamin D|vitamin d|mesh-list
20399383|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
20399384|NCT01126528|Vitamins|vitamins|mesh-ancestor
20399385|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
20399386|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399387|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20399388|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399389|NCT01126606|Glycerol|glycerol|mesh-list
19367335|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19367336|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367337|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367338|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
20210530|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
20210531|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210532|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210533|NCT00285155|Bupropion|bupropion|mesh-list
20210534|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20210535|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
20210536|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210537|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20210538|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20210539|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210540|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210541|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
20210542|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399390|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20399391|NCT01126606|Protective Agents|protective agents|mesh-ancestor
20399392|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399393|NCT01126645|Sorafenib|sorafenib|mesh-list
20399394|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399395|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20399396|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367339|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19367340|NCT03467360|Diuretics|diuretics|mesh-ancestor
19367341|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
19367342|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689554|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
19689555|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689556|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399397|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399398|NCT01126684|Atorvastatin|atorvastatin|mesh-list
20399399|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20399400|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20399401|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
20399402|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399403|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20399404|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20399405|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399406|NCT01126697|Ubiquinone|ubiquinone|mesh-list
20399407|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
20399408|NCT01126697|Lisinopril|lisinopril|mesh-list
20399409|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20399410|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
20399411|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845911|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845912|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689557|NCT05029037|Ascorbic Acid|ascorbic acid|mesh-list
19689558|NCT05029037|Vitamins|vitamins|mesh-ancestor
19689559|NCT05029037|Micronutrients|micronutrients|mesh-ancestor
19689560|NCT05029037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689561|NCT05029037|Antioxidants|antioxidants|mesh-ancestor
19689562|NCT05029037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689563|NCT05029037|Protective Agents|protective agents|mesh-ancestor
19689564|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
19689565|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19689566|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
19689567|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19689568|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
19689569|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689570|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689571|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
19689572|NCT05028907|Tocopherols|tocopherols|mesh-list
19845913|NCT00673920|Methotrexate|methotrexate|mesh-list
20399412|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399413|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20399414|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20399415|NCT01126697|Protective Agents|protective agents|mesh-ancestor
20399416|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399417|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
20399418|NCT01126697|Vitamins|vitamins|mesh-ancestor
20426931|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20426932|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20426933|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
20426934|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20426935|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367343|NCT03452072|Timolol|timolol|mesh-list
19367344|NCT03452072|Petrolatum|petrolatum|mesh-list
19689573|NCT05028907|Vitamin E|vitamin e|mesh-list
19845914|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
20210543|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210544|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20210545|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20210546|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210547|NCT00285181|Simvastatin|simvastatin|mesh-list
20210548|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20210549|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20210550|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
20210551|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210552|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20210553|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19689574|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
19689575|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
19689576|NCT05028907|Dexamethasone|dexamethasone|mesh-list
19689577|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
19367345|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19367346|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19367347|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19367348|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367349|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367350|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367351|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19367352|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19367353|NCT03452072|Emollients|emollients|mesh-ancestor
19367354|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
19367355|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19367356|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20399419|NCT01126736|Pemetrexed|pemetrexed|mesh-list
20399420|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399421|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399422|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399423|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20399424|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20399425|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
20399426|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399427|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20399428|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399429|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399430|NCT01126866|Bevacizumab|bevacizumab|mesh-list
20210554|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210555|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
20210556|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20210557|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367357|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19367358|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
19689578|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
19689579|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19689580|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
19689581|NCT05028907|BB 1101|bb 1101|mesh-list
20210558|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367359|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367360|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367361|NCT03433040|Progestins|progestins|mesh-ancestor
19367362|NCT03433040|Hormones|hormones|mesh-ancestor
19367363|NCT03432065|Buspirone|buspirone|mesh-list
19367364|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19367365|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19367366|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367367|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367368|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19367369|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19367370|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
19367371|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367372|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367373|NCT03412799|Gemcitabine|gemcitabine|mesh-list
19367374|NCT03412799|Paclitaxel|paclitaxel|mesh-list
19367375|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19367376|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19367377|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367378|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367379|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
19367380|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367381|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210559|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20210560|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20210561|NCT00285298|Protective Agents|protective agents|mesh-ancestor
20210562|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210563|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
20210564|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20210565|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
20210566|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
20210567|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20399431|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689582|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689583|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
20210568|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399432|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399433|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20399434|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20399435|NCT01126866|Growth Substances|growth substances|mesh-ancestor
20399436|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399437|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
20399438|NCT01127009|Cytarabine|cytarabine|mesh-list
20399439|NCT01127009|Etoposide|etoposide|mesh-list
20399440|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
20399441|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
20399442|NCT01127009|Bortezomib|bortezomib|mesh-list
20399443|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
19367382|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367383|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
19367384|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
19367385|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367386|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367387|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367388|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
19367389|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367390|NCT03405870|SMOFlipid|smoflipid|mesh-list
19367391|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19367392|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20399444|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20399445|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399446|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20399447|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20399448|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399449|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399450|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20399451|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
20399452|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
20399453|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399454|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20399455|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
20399456|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399457|NCT01127009|Analgesics|analgesics|mesh-ancestor
20399458|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
20399459|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399460|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
20399461|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20399462|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
20399463|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
20399464|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
20399465|NCT01127022|Choline|choline|mesh-list
20399466|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
19367393|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19367394|NCT03394027|TIC10 compound|tic10 compound|mesh-list
19367395|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367396|NCT03391882|Apomorphine|apomorphine|mesh-list
19367397|NCT03391882|Emetics|emetics|mesh-ancestor
19367398|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367399|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
19367400|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367401|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399467|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20399468|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
20399469|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399470|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399471|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20399472|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
19367402|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
19367403|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
19367404|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367405|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367406|NCT03382574|Denosumab|denosumab|mesh-list
19367407|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19367408|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367409|NCT03357952|Daratumumab|daratumumab|mesh-list
19367410|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367411|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19367412|NCT03286556|Autoantibodies|autoantibodies|mesh-list
19367413|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367414|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
19845915|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20399473|NCT01127100|Fentanyl|fentanyl|mesh-list
20399474|NCT01127100|Gabapentin|gabapentin|mesh-list
20399475|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19367415|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367416|NCT03241186|Nivolumab|nivolumab|mesh-list
19367417|NCT03241186|Ipilimumab|ipilimumab|mesh-list
19367418|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367419|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367420|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19367421|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367422|NCT03113422|Venetoclax|venetoclax|mesh-list
19367423|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367424|NCT03066622|Olanzapine|olanzapine|mesh-list
19367425|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
19367426|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
19367427|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367428|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367429|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19367430|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19367431|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19367432|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367433|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19367434|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19367435|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19367436|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19367437|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367438|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367439|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
19367440|NCT03029598|Carboplatin|carboplatin|mesh-list
19367441|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
19367442|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367443|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367444|NCT03020030|Leucovorin|leucovorin|mesh-list
19367445|NCT03020030|Cytarabine|cytarabine|mesh-list
19367446|NCT03020030|Dexamethasone|dexamethasone|mesh-list
19367447|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
19367448|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
19367449|NCT03020030|Doxorubicin|doxorubicin|mesh-list
19367450|NCT03020030|Methotrexate|methotrexate|mesh-list
19367451|NCT03020030|Etoposide|etoposide|mesh-list
19367452|NCT03020030|Vincristine|vincristine|mesh-list
19367453|NCT03020030|Asparaginase|asparaginase|mesh-list
19367454|NCT03020030|Dasatinib|dasatinib|mesh-list
19689584|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
19689585|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689586|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689587|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19689588|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
19689589|NCT05028907|Hormones|hormones|mesh-ancestor
19689590|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689591|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19689592|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689593|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19689594|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
19689595|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
19689596|NCT05028907|Protective Agents|protective agents|mesh-ancestor
19689597|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
19689598|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689599|NCT05028907|Vitamins|vitamins|mesh-ancestor
19689600|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
20210569|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20210570|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
20210571|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20210572|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210573|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210574|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210575|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20210576|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
20210577|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210578|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20210579|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20210580|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210581|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210582|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210583|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
19367455|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
19367456|NCT03020030|Pegaspargase|pegaspargase|mesh-list
19367457|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
19367458|NCT03020030|Razoxane|razoxane|mesh-list
19367459|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
19689601|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19689602|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689603|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19689604|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689605|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19689606|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19689607|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19689608|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
19689609|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
19689610|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19689611|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
19689612|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19689613|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689614|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
19689615|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19689616|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689617|NCT05028322|Imiquimod|imiquimod|mesh-list
19689618|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19689619|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
19689620|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689621|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689622|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
19689623|NCT05028348|Dexamethasone|dexamethasone|mesh-list
19689624|NCT05028348|Pomalidomide|pomalidomide|mesh-list
19689625|NCT05028348|Elotuzumab|elotuzumab|mesh-list
19689626|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689627|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
19689628|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
19689629|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689630|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689631|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19689632|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
19689633|NCT05028348|Hormones|hormones|mesh-ancestor
19689634|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689635|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19689636|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689637|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
20210584|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367460|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367461|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
19367462|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367463|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367464|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19367465|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
19367466|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367467|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367468|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19367469|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367470|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
19367471|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
19367472|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367473|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19367474|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
19367475|NCT03020030|Hormones|hormones|mesh-ancestor
19367476|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367477|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367478|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19367479|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19367480|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19367481|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367482|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19367483|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
19367484|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19367485|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367486|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
19367487|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
19367488|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19367489|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19689638|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20210585|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20210586|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20210587|NCT00285389|Dexamethasone|dexamethasone|mesh-list
20210588|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
19689639|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20210589|NCT00285389|Melphalan|melphalan|mesh-list
20210590|NCT00285389|Chlorambucil|chlorambucil|mesh-list
20399476|NCT01127100|Narcotics|narcotics|mesh-ancestor
20399477|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399478|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399479|NCT01127100|Analgesics|analgesics|mesh-ancestor
20399480|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
20399481|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399482|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20399483|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20399484|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
20399485|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
20399486|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
20399487|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20399488|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19367490|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19367491|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
19367492|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367493|NCT03020030|Antidotes|antidotes|mesh-ancestor
19367494|NCT03020030|Protective Agents|protective agents|mesh-ancestor
19367495|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
19367496|NCT03020030|Vitamins|vitamins|mesh-ancestor
19367497|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
19367498|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
20399489|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20399490|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20399491|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19367499|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
19367500|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367501|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367502|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19367503|NCT03016312|Atezolizumab|atezolizumab|mesh-list
19367504|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367505|NCT02799212|Somatostatin|somatostatin|mesh-list
19367506|NCT02799212|Hormones|hormones|mesh-ancestor
19367507|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367508|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402161|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402162|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
19402163|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402164|NCT03611179|Bevacizumab|bevacizumab|mesh-list
19402165|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402166|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402167|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19402168|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19402169|NCT03611179|Growth Substances|growth substances|mesh-ancestor
19402170|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402171|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
19402172|NCT03611049|Vitamin D|vitamin d|mesh-list
19402173|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
19402174|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
19402175|NCT03611049|Vitamins|vitamins|mesh-list
19689640|NCT05028348|Growth Substances|growth substances|mesh-ancestor
19689641|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
19689642|NCT05028049|Sufentanil|sufentanil|mesh-list
19689643|NCT05028049|Remifentanil|remifentanil|mesh-list
19689644|NCT05028049|Dsuvia|dsuvia|mesh-list
19689645|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19689646|NCT05028049|Narcotics|narcotics|mesh-ancestor
19689647|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689648|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689649|NCT05028049|Analgesics|analgesics|mesh-ancestor
19689650|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
20210591|NCT00285389|Rituximab|rituximab|mesh-list
20210592|NCT00285389|Vincristine|vincristine|mesh-list
20210593|NCT00285389|Doxorubicin|doxorubicin|mesh-list
20210594|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210595|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
20210596|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210597|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20210598|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20210599|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
20210600|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210601|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210602|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20399492|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399493|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689651|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689652|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19367509|NCT02553941|Azacitidine|azacitidine|mesh-list
19367510|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367511|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
19367512|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367513|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367514|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367515|NCT02482753|Exemestane|exemestane|mesh-list
19367516|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367517|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19367518|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19367519|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367520|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367521|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19367522|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
19367523|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367524|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367525|NCT02420574|Albendazole|albendazole|mesh-list
19367526|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
19367527|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19367528|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367529|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
19367530|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19367531|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19367532|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367533|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
19367534|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367535|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367536|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367537|NCT02403193|Spartalizumab|spartalizumab|mesh-list
19367538|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19367539|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367540|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399494|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
20399495|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
20399496|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20399497|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399498|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399499|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399500|NCT01127204|Lamivudine|lamivudine|mesh-list
20399501|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20399502|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20399503|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399504|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399505|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
19367541|NCT02358681|Ketorolac|ketorolac|mesh-list
19367542|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19367543|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19367544|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19367545|NCT02358681|Analgesics|analgesics|mesh-ancestor
19367546|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
19367547|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367548|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367549|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367550|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367551|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19367552|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367553|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367554|NCT02339168|Metformin|metformin|mesh-list
19367555|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19367556|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367557|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
19367558|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
19367559|NCT02269267|Protective Agents|protective agents|mesh-ancestor
19367560|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367561|NCT02101788|Tamoxifen|tamoxifen|mesh-list
19367562|NCT02101788|Paclitaxel|paclitaxel|mesh-list
19367563|NCT02101788|Doxorubicin|doxorubicin|mesh-list
19367564|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19367565|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19367566|NCT02101788|Letrozole|letrozole|mesh-list
19367567|NCT02101788|Topotecan|topotecan|mesh-list
19367568|NCT02101788|Trametinib|trametinib|mesh-list
19367569|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19367570|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20399506|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399507|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20399508|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20399509|NCT01127217|Losartan|losartan|mesh-list
20399510|NCT01127217|Amlodipine|amlodipine|mesh-list
20399511|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20399512|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19367571|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367572|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367573|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
19367574|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367575|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367576|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19367577|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20399513|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399514|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399515|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19367578|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19367579|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367580|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19367581|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19367582|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19367583|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
19367584|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367585|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367586|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19367587|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367588|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19367589|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19367590|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19367591|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367592|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19367593|NCT02101788|Protective Agents|protective agents|mesh-ancestor
19367594|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19367595|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
19367596|NCT02081378|Niacinamide|niacinamide|mesh-list
19367597|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
19367598|NCT02081378|Dasatinib|dasatinib|mesh-list
19367599|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367600|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20210603|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20399516|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399517|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
20399518|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20399519|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20399520|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20399521|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
20399522|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20399523|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399524|NCT01127282|Vitamins|vitamins|mesh-list
20399525|NCT01127282|Vitamin A|vitamin a|mesh-list
20399526|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
20399527|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399528|NCT01127295|Tamoxifen|tamoxifen|mesh-list
20399529|NCT01127295|Letrozole|letrozole|mesh-list
20399530|NCT01127295|Anastrozole|anastrozole|mesh-list
20399531|NCT01127295|Exemestane|exemestane|mesh-list
20399532|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399533|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20399534|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20399535|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399536|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399537|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20399538|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
20399539|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20399540|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210604|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20210605|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
20210606|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
20210607|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210608|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210609|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
20210610|NCT00285389|Hormones|hormones|mesh-ancestor
20399541|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20428657|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
20399542|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20399543|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20399544|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20399545|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
20399546|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20399547|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399548|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20399549|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399550|NCT01127360|Bevacizumab|bevacizumab|mesh-list
20399551|NCT01127360|Ranibizumab|ranibizumab|mesh-list
20399552|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367601|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367602|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689653|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19689654|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
19689655|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
19689656|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
19689657|NCT05027893|Cefixime|cefixime|mesh-list
19689658|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19689659|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689660|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19689661|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19689662|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399553|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399554|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20399555|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20399556|NCT01127360|Growth Substances|growth substances|mesh-ancestor
20399557|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399558|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
20399559|NCT01127386|Lenalidomide|lenalidomide|mesh-list
20399560|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
20399561|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399562|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20399563|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20399564|NCT01127386|Growth Substances|growth substances|mesh-ancestor
20399565|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
20399566|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399567|NCT01127464|Poly ICLC|poly iclc|mesh-list
20399568|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
20399569|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
20399570|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399571|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20399572|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
20399573|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
20399574|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20399575|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20399576|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20399577|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399578|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399579|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399580|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399581|NCT01127490|Analgesics|analgesics|mesh-ancestor
20399582|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
20399583|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399584|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
20399585|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20399586|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
20399587|NCT01127529|Protein C|protein c|mesh-list
20399588|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
19367603|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
19367604|NCT02081378|Vitamins|vitamins|mesh-ancestor
19367605|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
19367606|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367607|NCT01970410|Teriflunomide|teriflunomide|mesh-list
19367608|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19367609|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19367610|NCT01970410|Analgesics|analgesics|mesh-ancestor
19367611|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
19367612|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367613|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367614|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689663|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399589|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20399590|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19845916|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
19845917|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19367615|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367616|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367617|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
19367618|NCT01963728|Insulin|insulin|mesh-list
19367619|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19367620|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
19367621|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
19367622|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
19367623|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
19367624|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19367625|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367626|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
19367627|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19367628|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367629|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19367630|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19367631|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367632|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367633|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367634|NCT01880567|Rituximab|rituximab|mesh-list
19367635|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19367636|NCT01880567|Antibodies|antibodies|mesh-list
19367637|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
20217876|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19367638|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19367639|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
19367640|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367641|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367642|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367643|NCT01842282|Amlexanox|amlexanox|mesh-list
19367644|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19367645|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
19367646|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
19367647|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367648|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367649|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19367650|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
19367651|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19367652|NCT01622335|Analgesics|analgesics|mesh-ancestor
19367653|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
19367654|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689664|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693001|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845918|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845919|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845920|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
19845921|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845922|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845923|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845924|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845925|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19845926|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845927|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
19845928|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845929|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19845930|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19845931|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19845932|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19845933|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845934|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19845935|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
19845936|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19693002|NCT04984278|Nabiximols|nabiximols|mesh-list
19693003|NCT04984278|Analgesics|analgesics|mesh-ancestor
19693004|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
19693005|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693006|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693007|NCT04983836|Anesthetics|anesthetics|mesh-list
19693008|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693009|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845937|NCT00674115|Omeprazole|omeprazole|mesh-list
19367655|NCT01509339|Vancomycin|vancomycin|mesh-list
19367656|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19367657|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210611|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210612|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20210613|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20210614|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367658|NCT01362374|Leucovorin|leucovorin|mesh-list
19367659|NCT01362374|Paclitaxel|paclitaxel|mesh-list
19367660|NCT01362374|Docetaxel|docetaxel|mesh-list
19367661|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
19367662|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19367663|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367664|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367665|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
19367666|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367667|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367668|NCT01362374|Antidotes|antidotes|mesh-ancestor
19367669|NCT01362374|Protective Agents|protective agents|mesh-ancestor
19367670|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367671|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
19367672|NCT01362374|Vitamins|vitamins|mesh-ancestor
19367673|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
19689665|NCT05028153|Azithromycin|azithromycin|mesh-list
19689666|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19689667|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689668|NCT05028140|Pioglitazone|pioglitazone|mesh-list
19689669|NCT05028140|Empagliflozin|empagliflozin|mesh-list
19689670|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19689671|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689672|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19689673|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399591|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399592|NCT01127542|Lenalidomide|lenalidomide|mesh-list
20399593|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
20399594|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367674|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19367675|NCT01248247|Sorafenib|sorafenib|mesh-list
19367676|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367677|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367678|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367679|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367680|NCT01164228|Gemcitabine|gemcitabine|mesh-list
19367681|NCT01164228|Sunitinib|sunitinib|mesh-list
19367682|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367683|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
19367684|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399595|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20399596|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20399597|NCT01127542|Growth Substances|growth substances|mesh-ancestor
19367685|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367686|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
19367687|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367688|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367689|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367690|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
19367691|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367692|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19367693|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19367694|NCT01164228|Growth Substances|growth substances|mesh-ancestor
19367695|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
19367696|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367697|NCT01012167|Galantamine|galantamine|mesh-list
19367698|NCT01012167|Oxytocin|oxytocin|mesh-list
19367699|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
19367700|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19689674|NCT05027594|Dexamethasone|dexamethasone|mesh-list
20210615|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
20210616|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
20210617|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20210618|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20210619|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20210620|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210621|NCT00285415|Carboplatin|carboplatin|mesh-list
20399598|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
19367701|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689675|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367702|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19367703|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399599|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399600|NCT01127555|Leucovorin|leucovorin|mesh-list
20399601|NCT01127555|Fluorouracil|fluorouracil|mesh-list
20399602|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
20399603|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
20399604|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399605|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20399606|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399607|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20399608|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
20399609|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399610|NCT01127555|Antidotes|antidotes|mesh-ancestor
20399611|NCT01127555|Protective Agents|protective agents|mesh-ancestor
20399612|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
20399613|NCT01127555|Vitamins|vitamins|mesh-ancestor
20399614|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
20399615|NCT01127568|Propranolol|propranolol|mesh-list
20399616|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20399617|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20399618|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
20399619|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399620|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399621|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399622|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20399623|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20399624|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
20399625|NCT01127594|Temozolomide|temozolomide|mesh-list
20399626|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20399627|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
20399628|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399629|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399630|NCT01127620|Cetirizine|cetirizine|mesh-list
20399631|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20399632|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20399633|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20399634|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
19367704|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367705|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
19367706|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367707|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19367708|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
19367709|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367710|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
19367711|NCT00924326|Vidarabine|vidarabine|mesh-list
19367712|NCT00924326|Aldesleukin|aldesleukin|mesh-list
19367713|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
19367714|NCT00924326|Fludarabine|fludarabine|mesh-list
19367715|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
19367716|NCT00924326|Interleukin-2|interleukin-2|mesh-list
19367717|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367718|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
19367719|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367720|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367721|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19367722|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
19367723|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367724|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367725|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19689676|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
19689677|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
19689678|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689679|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689680|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19689681|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
19689682|NCT05027594|Hormones|hormones|mesh-ancestor
19689683|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689684|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19689685|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689686|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
19689687|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19689688|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
19367726|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367727|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
19689689|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689690|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
19367728|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
19367729|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367730|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20399635|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
20399636|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399637|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399638|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399639|NCT01127672|Betamethasone|betamethasone|mesh-list
20399640|NCT01127672|Lidocaine|lidocaine|mesh-list
20399641|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20399642|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
20399643|NCT01127672|Hormones|hormones|mesh-ancestor
20399644|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20399645|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399646|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20399647|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
20399648|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
19367731|NCT00924326|Analgesics|analgesics|mesh-ancestor
19367732|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
19367733|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367734|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19367735|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19367736|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
19367737|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20399649|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
20399650|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399651|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
20399652|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399653|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20399654|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20399655|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20399656|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399657|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399658|NCT01127724|Vitamins|vitamins|mesh-list
20399659|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
20399660|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
20399661|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
20399662|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
20399663|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399664|NCT01127724|Hematinics|hematinics|mesh-ancestor
20399665|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20399666|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20399667|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399668|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367738|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19367739|NCT00321100|Bevacizumab|bevacizumab|mesh-list
19367740|NCT00321100|Cetuximab|cetuximab|mesh-list
19367741|NCT00321100|Capecitabine|capecitabine|mesh-list
19367742|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
19367743|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367744|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367745|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19367746|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19367747|NCT00321100|Growth Substances|growth substances|mesh-ancestor
19367748|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367749|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
19367750|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367751|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
19367752|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367753|NCT05191784|Bevacizumab|bevacizumab|mesh-list
19367754|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19367755|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367756|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19367757|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19367758|NCT05191784|Growth Substances|growth substances|mesh-ancestor
19367759|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367760|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
19367761|NCT05191706|Dexamethasone|dexamethasone|mesh-list
19367762|NCT05191706|Prednisolone|prednisolone|mesh-list
19367763|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19367764|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
19367765|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19367766|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
20399669|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
19367767|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19367768|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
19367769|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367770|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
19367771|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
19367772|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367773|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367774|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19367775|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
19689691|NCT05027581|Protective Agents|protective agents|mesh-ancestor
19689692|NCT05027295|Riboflavin|riboflavin|mesh-list
19689693|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19689694|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19689695|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
19689696|NCT05027295|Vitamins|vitamins|mesh-ancestor
19689697|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
19689698|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845938|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19367776|NCT05191706|Hormones|hormones|mesh-ancestor
19367777|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367778|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367779|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367780|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19367781|NCT05191706|Protective Agents|protective agents|mesh-ancestor
19367782|NCT05191394|Antibodies|antibodies|mesh-list
19367783|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
20399670|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399671|NCT01127841|Rituximab|rituximab|mesh-list
20399672|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20399673|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20399674|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399675|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
20399676|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399677|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20399678|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20399679|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
20399680|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399681|NCT01127880|Clindamycin|clindamycin|mesh-list
20399682|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
20399683|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
20399684|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20399685|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399686|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20399687|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399688|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367784|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367785|NCT05190952|Dexamethasone|dexamethasone|mesh-list
19367786|NCT05190952|Ketamine|ketamine|mesh-list
19367787|NCT05190952|Bupivacaine|bupivacaine|mesh-list
19367788|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367789|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
19367790|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
19367791|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367792|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845939|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19845940|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19845941|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845942|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845943|NCT00674154|Vitamin D|vitamin d|mesh-list
19845944|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
19845945|NCT00674154|Vitamins|vitamins|mesh-ancestor
19845946|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
19845947|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845948|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19845949|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19845950|NCT00674206|Gemcitabine|gemcitabine|mesh-list
19845951|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
19845952|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19845953|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
20399689|NCT01127906|Oxycodone|oxycodone|mesh-list
19367793|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19367794|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
19367795|NCT05190952|Hormones|hormones|mesh-ancestor
19367796|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367797|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402176|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
19689699|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19845954|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399690|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19367798|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367799|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
19367800|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
19367801|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367802|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
19367803|NCT05190952|Analgesics|analgesics|mesh-ancestor
19367804|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19367805|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19367806|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
19367807|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19367808|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19367809|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367810|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367811|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
19367812|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399691|NCT01127906|Narcotics|narcotics|mesh-ancestor
20399692|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399693|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399694|NCT01127906|Analgesics|analgesics|mesh-ancestor
20399695|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
20399696|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399697|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20399698|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
20399699|NCT01127984|Coagulants|coagulants|mesh-ancestor
19367813|NCT05190562|Astringents|astringents|mesh-ancestor
19367814|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
19367815|NCT05190341|Ibuprofen|ibuprofen|mesh-list
19367816|NCT05190341|Ketorolac|ketorolac|mesh-list
19367817|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19367818|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19367819|NCT05190341|Analgesics|analgesics|mesh-ancestor
19367820|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
19367821|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367822|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367823|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367824|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367825|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19367826|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367827|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402177|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402178|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19402179|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19404662|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404663|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19404664|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404665|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
19404666|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
19404667|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19404668|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19404669|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404670|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404671|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404672|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404673|NCT03592680|Ascorbic Acid|ascorbic acid|mesh-list
19404674|NCT03592680|Vitamins|vitamins|mesh-ancestor
19404675|NCT03592680|Micronutrients|micronutrients|mesh-ancestor
19404676|NCT03592680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404677|NCT03592680|Antioxidants|antioxidants|mesh-ancestor
19404678|NCT03592680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404679|NCT03592680|Protective Agents|protective agents|mesh-ancestor
19404680|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
19404681|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19404682|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404683|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404684|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404685|NCT03592576|Venetoclax|venetoclax|mesh-list
19404686|NCT03592576|Navitoclax|navitoclax|mesh-list
19404687|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404688|NCT03592537|Fentanyl|fentanyl|mesh-list
19404689|NCT03592537|Midazolam|midazolam|mesh-list
19404690|NCT03592537|Bupivacaine|bupivacaine|mesh-list
19404691|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
19404692|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
20399700|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
20399701|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20399702|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
20399703|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399704|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399705|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
20399706|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399707|NCT01128101|Spironolactone|spironolactone|mesh-list
20399708|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20399709|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
20399710|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20399711|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399712|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20399713|NCT01128101|Diuretics|diuretics|mesh-ancestor
20399714|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
20399715|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20399716|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20399717|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
20399718|NCT01128257|Alendronate|alendronate|mesh-list
20399719|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
20399720|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20399721|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399722|NCT01128322|Niacin|niacin|mesh-list
20399723|NCT01128322|Amlodipine|amlodipine|mesh-list
20399724|NCT01128322|Telmisartan|telmisartan|mesh-list
20399725|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20399726|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20399727|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399728|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399729|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399730|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399731|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
20399732|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20399733|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20399734|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20399735|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
20399736|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20399737|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
20399738|NCT01128322|Vitamins|vitamins|mesh-ancestor
20399739|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
20399740|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
20399741|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20426936|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426937|NCT01283763|Imiquimod|imiquimod|mesh-list
20426938|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20426939|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
20426940|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426941|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367828|NCT05190120|Ropivacaine|ropivacaine|mesh-list
19367829|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
19367830|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
19367831|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367832|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367833|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
19367834|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367835|NCT05190094|Letrozole|letrozole|mesh-list
20426942|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
19367836|NCT05190094|Palbociclib|palbociclib|mesh-list
19367837|NCT05190094|Anastrozole|anastrozole|mesh-list
19367838|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19367839|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367840|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19367841|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367842|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367843|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20210622|NCT00285415|Docetaxel|docetaxel|mesh-list
20210623|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210624|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
20210625|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
20210626|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
20210627|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210628|NCT00285428|Veltuzumab|veltuzumab|mesh-list
20210629|NCT00285428|Antibodies|antibodies|mesh-list
20210630|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
20210631|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210632|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210633|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20426943|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
20613101|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
20399742|NCT01128699|Bevacizumab|bevacizumab|mesh-list
20399743|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20399744|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399745|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20399746|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20399747|NCT01128699|Growth Substances|growth substances|mesh-ancestor
20399748|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367844|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
19367845|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367846|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367847|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19367848|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19367849|NCT05189977|Propranolol|propranolol|mesh-list
19367850|NCT05189977|Prazosin|prazosin|mesh-list
19367851|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19367852|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19367853|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
19367854|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367855|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367856|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367857|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19367858|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19367859|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
19367860|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19367861|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19367862|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
19367863|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19367864|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
19367865|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19367866|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367867|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19367868|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19367869|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19367870|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
19367871|NCT05189704|Narcotics|narcotics|mesh-ancestor
19367872|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367873|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367874|NCT05189704|Analgesics|analgesics|mesh-ancestor
19367875|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
19367876|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367877|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
19367878|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19367879|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367880|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
19845955|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19845956|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
19845957|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845958|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19845959|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845960|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
19845961|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845962|NCT00674219|Memantine|memantine|mesh-list
19845963|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19845964|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19845965|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
19845966|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19845967|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19845968|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845969|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19845970|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19845971|NCT00674323|Ranibizumab|ranibizumab|mesh-list
19845972|NCT00674323|Verteporfin|verteporfin|mesh-list
19845973|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19845974|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19845975|NCT00674323|Growth Substances|growth substances|mesh-ancestor
19845976|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845977|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
19845978|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399749|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
19367881|NCT05167084|Metyrapone|metyrapone|mesh-list
19367882|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367883|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
19845979|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20399750|NCT01128712|Pregabalin|pregabalin|mesh-list
20399751|NCT01128712|Analgesics|analgesics|mesh-ancestor
20399752|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
20399753|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399754|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399755|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
20399756|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20399757|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20399758|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399759|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399760|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20399761|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20399762|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399763|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20399764|NCT01128985|Canagliflozin|canagliflozin|mesh-list
20399765|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20399766|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399767|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20399768|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399769|NCT01128998|Sorafenib|sorafenib|mesh-list
20399770|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399771|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20399772|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399773|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399774|NCT01129063|Clopidogrel|clopidogrel|mesh-list
20399775|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20399776|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20399777|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20399778|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20399779|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
20399780|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399781|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399782|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399783|NCT01129089|Micronutrients|micronutrients|mesh-list
20399784|NCT01129089|Trace Elements|trace elements|mesh-list
20399785|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399786|NCT01129154|Panitumumab|panitumumab|mesh-list
20399787|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689700|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
19689701|NCT05027126|Folic Acid|folic acid|mesh-list
19689702|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
19367884|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367885|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367886|NCT05165992|Fentanyl|fentanyl|mesh-list
19367887|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19367888|NCT05165992|Narcotics|narcotics|mesh-ancestor
19367889|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367890|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367891|NCT05165992|Analgesics|analgesics|mesh-ancestor
19367892|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
19367893|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367894|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19367895|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19367896|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
19367897|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
19367898|NCT05154968|Mannitol|mannitol|mesh-list
19367899|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19367900|NCT05154968|Diuretics|diuretics|mesh-ancestor
19367901|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
19367902|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367903|NCT05118256|Pirfenidone|pirfenidone|mesh-list
19367904|NCT05118256|Analgesics|analgesics|mesh-ancestor
19367905|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
19367906|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367907|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367908|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19367909|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19367910|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19367911|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367912|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367913|NCT05106335|Docetaxel|docetaxel|mesh-list
19367914|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367915|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
19367916|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
19689703|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19689704|NCT05027126|Vitamins|vitamins|mesh-ancestor
19689705|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
19367917|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
19367918|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367919|NCT05096845|Vaccines|vaccines|mesh-list
19367920|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
19367921|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367922|NCT05096832|Vaccines|vaccines|mesh-list
19367923|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
19367924|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367925|NCT05060965|Nicotine|nicotine|mesh-list
19367926|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19367927|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
19367928|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19367929|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367930|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19367931|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19367932|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
19367933|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367934|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367935|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19367936|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19367937|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
19367938|NCT05042947|Hormones|hormones|mesh-ancestor
19367939|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19367940|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367941|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367942|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367943|NCT05033847|Vaccines|vaccines|mesh-list
19367944|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
19367945|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367946|NCT05019560|Sevoflurane|sevoflurane|mesh-list
19367947|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19367948|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19367949|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
20399788|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399789|NCT01129180|Bortezomib|bortezomib|mesh-list
20399790|NCT01129180|Azacitidine|azacitidine|mesh-list
20399791|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399792|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20399793|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
19367950|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
19367951|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19367952|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367953|NCT04990323|Vidarabine|vidarabine|mesh-list
19367954|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
19367955|NCT04990323|Busulfan|busulfan|mesh-list
19367956|NCT04990323|Thiotepa|thiotepa|mesh-list
19367957|NCT04990323|Fludarabine|fludarabine|mesh-list
19367958|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
19367959|NCT04990323|Clofarabine|clofarabine|mesh-list
19367960|NCT04990323|Tacrolimus|tacrolimus|mesh-list
19367961|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19367962|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
19367963|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367964|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19367965|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19367966|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
19367967|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367968|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19367969|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19367970|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19367971|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
19689706|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367972|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
19367973|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689707|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19689708|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19689709|NCT05027126|Analgesics|analgesics|mesh-ancestor
19689710|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
19689711|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689712|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689713|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19689714|NCT05027126|Hematinics|hematinics|mesh-ancestor
19689715|NCT05027386|Irinotecan|irinotecan|mesh-list
19689716|NCT05027386|Temozolomide|temozolomide|mesh-list
19689717|NCT05027386|Apatinib|apatinib|mesh-list
19845980|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
19845981|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
19845982|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19845983|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
20399794|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399795|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399796|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
20399797|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399798|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399799|NCT01129271|Clopidogrel|clopidogrel|mesh-list
20399800|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20399801|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20399802|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20399803|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20399804|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
20399805|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399806|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399807|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399808|NCT01129310|Capecitabine|capecitabine|mesh-list
20399809|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
20399810|NCT01129310|Irinotecan|irinotecan|mesh-list
20399811|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20399812|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
20399813|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399814|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399815|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20399816|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20399817|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399818|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
20399819|NCT01129323|Fludarabine|fludarabine|mesh-list
20399820|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
20399821|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20399822|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
20399823|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399824|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20399825|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20399826|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
20399827|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399828|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399829|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20399830|NCT01129375|Omeprazole|omeprazole|mesh-list
20399831|NCT01129375|Clopidogrel|clopidogrel|mesh-list
20399832|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20399833|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20399834|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20399835|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19845984|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845985|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19845986|NCT00674570|Cycloserine|cycloserine|mesh-list
19845987|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
19845988|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19845989|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19845990|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19845991|NCT00674570|Renal Agents|renal agents|mesh-ancestor
19845992|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19845993|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
19367974|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19367975|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367976|NCT04989829|Omeprazole|omeprazole|mesh-list
19367977|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19367978|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19367979|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19367980|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367981|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367982|NCT04947332|Vaccines|vaccines|mesh-list
19367983|NCT04947332|Immunologic Factors|immunologic factors|mesh-ancestor
19367984|NCT04947332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19845994|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19845995|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
19367985|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19367986|NCT04944290|Brinzolamide|brinzolamide|mesh-list
19845996|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367987|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19367988|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19367989|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19367990|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19367991|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
19367992|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19367993|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19367994|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19367995|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19367996|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19367997|NCT04939090|Megestrol|megestrol|mesh-list
19367998|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
19367999|NCT04939090|Olanzapine|olanzapine|mesh-list
19368000|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
19368001|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
19368002|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368003|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368004|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368005|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19368006|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19368007|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368008|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19368009|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19368010|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19368011|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19368012|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368013|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368014|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
19368015|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19368016|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19368017|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19368018|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
20399836|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
20399837|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399838|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399839|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368019|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19368020|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19368021|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19368022|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368023|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399840|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20399841|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399842|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20399843|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368024|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
19368025|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19368026|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
19368027|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368028|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
19368029|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
19368030|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368031|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
19368032|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368033|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368034|NCT04865497|Vaccines|vaccines|mesh-list
19368035|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
19368036|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402180|NCT03610945|Fluconazole|fluconazole|mesh-list
19402181|NCT03610945|Quinidine|quinidine|mesh-list
19402182|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
19402183|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402184|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19402185|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19402186|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402187|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402188|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19402189|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
19402190|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402191|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402192|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20399844|NCT01129388|Omeprazole|omeprazole|mesh-list
20399845|NCT01129388|Clopidogrel|clopidogrel|mesh-list
20399846|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19368037|NCT04823247|Interleukin-23|interleukin-23|mesh-list
19368038|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19368039|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19368040|NCT04823247|Growth Substances|growth substances|mesh-ancestor
19368041|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368042|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
19368043|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368044|NCT04817787|Metformin|metformin|mesh-list
20399847|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20399848|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20399849|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20399850|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
20399851|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368045|NCT04817787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19368046|NCT04817787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368047|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
19368048|NCT04816162|Ketamine|ketamine|mesh-list
19368049|NCT04816162|Propofol|propofol|mesh-list
19368050|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19368051|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368052|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368053|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20399852|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399853|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399854|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20399855|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399856|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20399857|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399858|NCT01129414|Omeprazole|omeprazole|mesh-list
20399859|NCT01129414|Clopidogrel|clopidogrel|mesh-list
20399860|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20399861|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20399862|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19368054|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
19368055|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
19368056|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19368057|NCT04816162|Analgesics|analgesics|mesh-ancestor
19368058|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
19368059|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368060|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19368061|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19368062|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19368063|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
19368064|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368065|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368066|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19368067|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19368068|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19368069|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
19368070|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19368071|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399863|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20399864|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
20399865|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399866|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399867|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399868|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20399869|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399870|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20399871|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399872|NCT01129427|Pantoprazole|pantoprazole|mesh-list
20399873|NCT01129427|Clopidogrel|clopidogrel|mesh-list
20399874|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20399875|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20399876|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20399877|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20399878|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
20399879|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399880|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399881|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399882|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20399883|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368072|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
19368073|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
19368074|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19368075|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368076|NCT04787965|Opicapone|opicapone|mesh-list
19368077|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19368078|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368079|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368080|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19368081|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20399884|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20399885|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399886|NCT01129479|Galantamine|galantamine|mesh-list
20399887|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19368082|NCT04770272|Paclitaxel|paclitaxel|mesh-list
19368083|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
19368084|NCT04770272|Carboplatin|carboplatin|mesh-list
19368085|NCT04770272|Atezolizumab|atezolizumab|mesh-list
19368086|NCT04770272|Epirubicin|epirubicin|mesh-list
19368087|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19368088|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19368089|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368090|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
19368091|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
19368092|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
19368093|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368094|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368095|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
19689718|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19689719|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19689720|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689721|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689722|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689723|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19689724|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
19689725|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19689726|NCT05027191|Sevoflurane|sevoflurane|mesh-list
19689727|NCT05027191|Desflurane|desflurane|mesh-list
19689728|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19689729|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19689730|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
19689731|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
19689732|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689733|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689734|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19689735|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19689736|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689737|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368096|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368097|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368098|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368099|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
19368100|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19368101|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19368102|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19368103|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20210634|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210635|NCT00285519|Doxazosin|doxazosin|mesh-list
20210636|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20210637|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20210638|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20210639|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20210640|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
20210641|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210642|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210643|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210644|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20210645|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20210646|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210647|NCT00285623|Thrombin|thrombin|mesh-list
20210648|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
20210649|NCT00285623|Coagulants|coagulants|mesh-ancestor
20210650|NCT00285662|Artesunate|artesunate|mesh-list
20210651|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
20210652|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
19368104|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210653|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20399888|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399889|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399890|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
20399891|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399892|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399893|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20399894|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
20399895|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399896|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
20399897|NCT01129518|Vaccines|vaccines|mesh-list
20399898|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
20399899|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399900|NCT01129570|Silybin|silybin|mesh-list
20399901|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20399902|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399903|NCT01129570|Protective Agents|protective agents|mesh-ancestor
20399904|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399905|NCT01129596|Donepezil|donepezil|mesh-list
20399906|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19368105|NCT04716946|Durvalumab|durvalumab|mesh-list
19368106|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368107|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368108|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
19368109|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368110|NCT04713358|Nalmefene|nalmefene|mesh-list
19368111|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19368112|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368113|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
19368114|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368115|NCT04696952|Zopiclone|zopiclone|mesh-list
19368116|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19368117|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368118|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368119|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
19689738|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19689739|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19689740|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689741|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
19689742|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689743|NCT05026398|Fenfluramine|fenfluramine|mesh-list
19368120|NCT04676802|Narcotics|narcotics|mesh-ancestor
19368121|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368122|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368123|NCT04676802|Analgesics|analgesics|mesh-ancestor
19368124|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
19368125|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368126|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
19368127|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19368128|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19368129|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368130|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368131|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19368132|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19368133|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19368134|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19368135|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368136|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368137|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
19368138|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19368139|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
19689744|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19689745|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20210654|NCT00285662|Amodiaquine|amodiaquine|mesh-list
20210655|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
20210656|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20210657|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20210658|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210659|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210660|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
20210661|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
20210662|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20210663|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
20399907|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399908|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399909|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
20210664|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20210665|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210666|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210667|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20210668|NCT00285662|Renal Agents|renal agents|mesh-ancestor
20210669|NCT00285675|Calcitriol|calcitriol|mesh-list
20210670|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20210671|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210672|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20210673|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210674|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210675|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20210676|NCT00285675|Vitamins|vitamins|mesh-ancestor
20210677|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
20210678|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20210679|NCT00285727|Ropinirole|ropinirole|mesh-list
20210680|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20210681|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20210682|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
19689746|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19689747|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689748|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689749|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
19689750|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689751|NCT05026593|Carboplatin|carboplatin|mesh-list
19689752|NCT05026593|Etoposide|etoposide|mesh-list
19689753|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689754|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19845997|NCT00674583|Vaccines|vaccines|mesh-list
19845998|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
20399910|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399911|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399912|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
20399913|NCT01129713|Esomeprazole|esomeprazole|mesh-list
20399914|NCT01129713|Omeprazole|omeprazole|mesh-list
20399915|NCT01129713|Lansoprazole|lansoprazole|mesh-list
20399916|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20399917|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399918|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20399919|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399920|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399921|NCT01129739|Cyclosporine|cyclosporine|mesh-list
20399922|NCT01129739|Cyclosporins|cyclosporins|mesh-list
20399923|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399924|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399925|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20399926|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
20399927|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399928|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
20399929|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399930|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
20399931|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20399932|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20399933|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20399934|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20399935|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
20399936|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399937|NCT01129856|Dexamethasone|dexamethasone|mesh-list
20399938|NCT01129856|Citric Acid|citric acid|mesh-list
20210683|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
20399939|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
19368140|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19689755|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19845999|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846000|NCT00674609|Nabiximols|nabiximols|mesh-list
19846001|NCT00674609|Analgesics|analgesics|mesh-ancestor
19846002|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
19846003|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846004|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846005|NCT00674661|Riboflavin|riboflavin|mesh-list
19846006|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19846007|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19846008|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
19846009|NCT00674661|Vitamins|vitamins|mesh-ancestor
20210684|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399940|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20399941|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19846010|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
19846011|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689756|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19689757|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689758|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689759|NCT05026125|Remifentanil|remifentanil|mesh-list
19689760|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19689761|NCT05026125|Narcotics|narcotics|mesh-ancestor
19689762|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689763|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368141|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19368142|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368143|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19368144|NCT04631471|Ibudilast|ibudilast|mesh-list
19368145|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19368146|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
19368147|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368148|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368149|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19368150|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
19368151|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19368152|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368153|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368154|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19368155|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
19368156|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
19368157|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368158|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19368159|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368160|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689764|NCT05026125|Analgesics|analgesics|mesh-ancestor
19689765|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
19689766|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689767|NCT05026229|Cytarabine|cytarabine|mesh-list
20399942|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20399943|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20399944|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
19689768|NCT05026229|Prednisone|prednisone|mesh-list
19689769|NCT05026229|Methotrexate|methotrexate|mesh-list
19689770|NCT05026229|Vincristine|vincristine|mesh-list
19689771|NCT05026229|Dasatinib|dasatinib|mesh-list
20399945|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
20399946|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399947|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399948|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399949|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
20399950|NCT01129856|Hormones|hormones|mesh-ancestor
20399951|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846012|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19846013|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848257|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689772|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689773|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
19689774|NCT05026229|Hormones|hormones|mesh-ancestor
19689775|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689776|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848258|NCT00691704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19368161|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
19368162|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19368163|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368164|NCT04558502|Amoxicillin|amoxicillin|mesh-list
19368165|NCT04558502|Clarithromycin|clarithromycin|mesh-list
19368166|NCT04558502|Minocycline|minocycline|mesh-list
19368167|NCT04558502|Esomeprazole|esomeprazole|mesh-list
19368168|NCT04558502|Bismuth|bismuth|mesh-list
19689777|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848259|NCT00691704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19848260|NCT00691704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399952|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20399953|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20399954|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
20399955|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20399956|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
19368169|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19689778|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368170|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20399957|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
20399958|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399959|NCT01129934|Promethazine|promethazine|mesh-list
20399960|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
19368171|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19368172|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368173|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19368174|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368175|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368176|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20399961|NCT01129934|Morphine|morphine|mesh-list
20399962|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20399963|NCT01129934|Narcotics|narcotics|mesh-ancestor
20399964|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20399965|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399966|NCT01129934|Analgesics|analgesics|mesh-ancestor
20399967|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
20399968|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20399969|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
20399970|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
20399971|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20399972|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
20399973|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
20399974|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20399975|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399976|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20399977|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20399978|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20399979|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
20399980|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
20399981|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
20399982|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
20399983|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20399984|NCT01130025|Tinzaparin|tinzaparin|mesh-list
19368177|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19368178|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19368179|NCT04558502|Antacids|antacids|mesh-ancestor
19368180|NCT04550455|Cladribine|cladribine|mesh-list
19368181|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368182|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368183|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
19368184|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368185|NCT04505735|Corticosterone|corticosterone|mesh-list
19368186|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368187|NCT04485104|Cannabidiol|cannabidiol|mesh-list
19368188|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
19368189|NCT04479267|Prednisone|prednisone|mesh-list
19368190|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
20399985|NCT01130025|Warfarin|warfarin|mesh-list
20399986|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
20399987|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20399988|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19368191|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19368192|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19368193|NCT04479267|Prednisolone|prednisolone|mesh-list
19368194|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
19368195|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
19368196|NCT04479267|Cortisone|cortisone|mesh-list
19368197|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
19368198|NCT04479267|Rituximab|rituximab|mesh-list
19368199|NCT04479267|Doxorubicin|doxorubicin|mesh-list
19368200|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19368201|NCT04479267|Antibodies|antibodies|mesh-list
19368202|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
19368203|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19368204|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
19368205|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19368206|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
19368207|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368208|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
19368209|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368210|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368211|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368212|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
19693010|NCT04984070|Metformin|metformin|mesh-list
19693011|NCT04984070|Drospirenone|drospirenone|mesh-list
19693012|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
19693013|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19693014|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
19693015|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19368213|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368214|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368215|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19368216|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368217|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19368218|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19368219|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19368220|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20399989|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20399990|NCT01130077|Poly ICLC|poly iclc|mesh-list
20399991|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
20399992|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
19689779|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19689780|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
19689781|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20399993|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399994|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
20399995|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20399996|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20399997|NCT01130181|Vitamins|vitamins|mesh-ancestor
20399998|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
20399999|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20400000|NCT01130194|Procarbazine|procarbazine|mesh-list
20400001|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400002|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
20400003|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20400004|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400005|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400006|NCT01130259|Iniparib|iniparib|mesh-list
20400007|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20400008|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400009|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400010|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400011|NCT01130298|Testosterone|testosterone|mesh-list
20400012|NCT01130298|Androgens|androgens|mesh-ancestor
20400013|NCT01130298|Hormones|hormones|mesh-ancestor
20400014|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400015|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400016|NCT01130311|Vitamin D|vitamin d|mesh-list
20400017|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
20400018|NCT01130311|Vitamins|vitamins|mesh-ancestor
20400019|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
20400020|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400021|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20400022|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20400023|NCT01130324|Telavancin|telavancin|mesh-list
20400024|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400025|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400026|NCT01130376|Aldesleukin|aldesleukin|mesh-list
19368221|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368222|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
19689782|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400027|NCT01130376|Interleukin-2|interleukin-2|mesh-list
20400028|NCT01130376|Hormones|hormones|mesh-list
20400029|NCT01130376|Sargramostim|sargramostim|mesh-list
20400030|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400031|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400032|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400033|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400034|NCT01130376|Analgesics|analgesics|mesh-ancestor
20400035|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
20400036|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400037|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
20400038|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20400039|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20400040|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
20400041|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400042|NCT01130467|Methylphenidate|methylphenidate|mesh-list
20400043|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20400044|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400045|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400046|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20400047|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20400048|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19689783|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
19368223|NCT04479267|Hormones|hormones|mesh-ancestor
19368224|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368225|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368226|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
19368227|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
19368228|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368229|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368230|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19368231|NCT04479267|Protective Agents|protective agents|mesh-ancestor
19368232|NCT04471597|Bupivacaine|bupivacaine|mesh-list
19368233|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
19368234|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
19368235|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368236|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368237|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
19368238|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368239|NCT04420455|Enoximone|enoximone|mesh-list
19368240|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19368241|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
19368242|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19368243|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19368244|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368245|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368246|NCT04420455|Protective Agents|protective agents|mesh-ancestor
19368247|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368248|NCT04419337|Metformin|metformin|mesh-list
19368249|NCT04419337|Pioglitazone|pioglitazone|mesh-list
19368250|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19368251|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19368252|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368253|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368254|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
19368255|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368256|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368257|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
19368258|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19368259|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368260|NCT04297592|Doxycycline|doxycycline|mesh-list
19368261|NCT04297592|Cephalexin|cephalexin|mesh-list
19368262|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19368263|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368264|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
19368265|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19368266|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19368267|NCT04251715|Leucovorin|leucovorin|mesh-list
19368268|NCT04251715|Dexamethasone|dexamethasone|mesh-list
19368269|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
19368270|NCT04251715|Fluorouracil|fluorouracil|mesh-list
19368271|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
19368272|NCT04251715|Irinotecan|irinotecan|mesh-list
19368273|NCT04251715|Floxuridine|floxuridine|mesh-list
20210685|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210686|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210687|NCT00285766|Selegiline|selegiline|mesh-list
20210688|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
20210689|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210690|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19368274|NCT04251715|BB 1101|bb 1101|mesh-list
19368275|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
19368276|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368277|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
19368278|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
19368279|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368280|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368281|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368282|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
19368283|NCT04251715|Hormones|hormones|mesh-ancestor
19689784|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689785|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
19689786|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689787|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20210691|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20210692|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19368284|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368285|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368286|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400049|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400050|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
20400051|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400052|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20400053|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400054|NCT01130506|Cytarabine|cytarabine|mesh-list
20400055|NCT01130506|Decitabine|decitabine|mesh-list
20400056|NCT01130506|Vorinostat|vorinostat|mesh-list
20400057|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400058|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
20400059|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400060|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400061|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
20400062|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400063|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400064|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
20400065|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400066|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400067|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20426944|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20426945|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
20426946|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426947|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426948|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20426949|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
20426950|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426951|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426952|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20426953|NCT01283789|Everolimus|everolimus|mesh-list
20426954|NCT01283789|Lapatinib|lapatinib|mesh-list
19368287|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
19368288|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368289|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368290|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
19368291|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19368292|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368293|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
19368294|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19368295|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19368296|NCT04251715|Antidotes|antidotes|mesh-ancestor
19368297|NCT04251715|Protective Agents|protective agents|mesh-ancestor
19368298|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
19368299|NCT04251715|Vitamins|vitamins|mesh-ancestor
19689788|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689789|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
19689790|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20426955|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426956|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368300|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
19368301|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
19368302|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368303|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368304|NCT04234464|Budesonide|budesonide|mesh-list
19368305|NCT04234464|Albuterol|albuterol|mesh-list
19368306|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20426957|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
20426958|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20426959|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20426960|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426961|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426962|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
20426963|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426964|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20426965|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20426966|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
20426967|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20426968|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426969|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426970|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426971|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
20426972|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20426973|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368307|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19368308|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
19368309|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689791|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19689792|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
19689793|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19689794|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689795|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
19689796|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
19689797|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
19689798|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19689799|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
19689800|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689801|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689802|NCT05025644|Dobutamine|dobutamine|mesh-list
19689803|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20400068|NCT01130636|Oseltamivir|oseltamivir|mesh-list
20400069|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
20400070|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400071|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400072|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400073|NCT01130662|Decitabine|decitabine|mesh-list
20400074|NCT01130662|Midostaurin|midostaurin|mesh-list
20400075|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400076|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
20400077|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689804|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
19689805|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
19368310|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368311|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19368312|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
19368313|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
19368314|NCT04234464|Hormones|hormones|mesh-ancestor
19368315|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368316|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
19368317|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19368318|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19368319|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19368320|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19368321|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689806|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689807|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689808|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19689809|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19689810|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19689811|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400078|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400079|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400080|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19689812|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689813|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689814|NCT05025644|Protective Agents|protective agents|mesh-ancestor
19689815|NCT05025488|Poly ICLC|poly iclc|mesh-list
19689816|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
19689817|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
19689818|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693016|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19693017|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19693018|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693019|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19693020|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19693021|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19693022|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19693023|NCT04984070|Estrogens|estrogens|mesh-ancestor
19693024|NCT04984070|Hormones|hormones|mesh-ancestor
19693025|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693026|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19693027|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
19693028|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20400081|NCT01130688|Zileuton|zileuton|mesh-list
20400082|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20400083|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400084|NCT01130688|Analgesics|analgesics|mesh-ancestor
20400085|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
19693029|NCT04984070|Diuretics|diuretics|mesh-ancestor
19693030|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
20400086|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689819|NCT05025228|Acetaminophen|acetaminophen|mesh-list
19689820|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19689821|NCT05025228|Analgesics|analgesics|mesh-ancestor
19689822|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
19368322|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368323|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368324|NCT04228965|Varenicline|varenicline|mesh-list
20400087|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400088|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400089|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400090|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20400091|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689823|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689824|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689825|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
20400092|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400093|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20400094|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
20400095|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400096|NCT01130701|Capecitabine|capecitabine|mesh-list
20400097|NCT01130701|Panitumumab|panitumumab|mesh-list
20400098|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400099|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
20400100|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400101|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400102|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20400103|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20400104|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400105|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20400106|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400107|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400108|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20400109|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368325|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19368326|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19368327|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
19368328|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368329|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368330|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368331|NCT04211675|Irinotecan|irinotecan|mesh-list
19368332|NCT04211675|Temozolomide|temozolomide|mesh-list
19368333|NCT04211675|Dinutuximab|dinutuximab|mesh-list
19368334|NCT04211675|Sargramostim|sargramostim|mesh-list
20400110|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19689826|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
19689827|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689828|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
19368335|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19368336|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19368337|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368338|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368339|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368340|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368341|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
19689829|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689830|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689831|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19689832|NCT05025033|Paclitaxel|paclitaxel|mesh-list
19689833|NCT05025033|Irinotecan|irinotecan|mesh-list
19689834|NCT05025033|Apatinib|apatinib|mesh-list
19846014|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
19846015|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846016|NCT00674739|Imiquimod|imiquimod|mesh-list
19846017|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19846018|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
19846019|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846020|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846021|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
19846022|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19846023|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
19846024|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19846025|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19846026|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19689835|NCT05025033|Antibodies|antibodies|mesh-list
19689836|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
19689837|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689838|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210693|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210694|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210695|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20210696|NCT00285766|Protective Agents|protective agents|mesh-ancestor
20210697|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210698|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
20210699|NCT00285805|Amiloride|amiloride|mesh-list
20210700|NCT00285805|Furosemide|furosemide|mesh-list
20210701|NCT00285805|Diuretics|diuretics|mesh-ancestor
20210702|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
20210703|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368342|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
19368343|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368344|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
19368345|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19368346|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368347|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19689839|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
19689840|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
20400111|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400112|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400113|NCT01130805|Capecitabine|capecitabine|mesh-list
20400114|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
19368348|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19368349|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368350|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368351|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368352|NCT04198805|Vitamins|vitamins|mesh-list
19368353|NCT04198805|Vitamin E|vitamin e|mesh-list
19368354|NCT04198805|Tocopherols|tocopherols|mesh-list
19368355|NCT04198805|Tocotrienols|tocotrienols|mesh-list
19368356|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
19368357|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
19368358|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368359|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
19368360|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368361|NCT04198805|Protective Agents|protective agents|mesh-ancestor
19368362|NCT04183868|Empagliflozin|empagliflozin|mesh-list
19368363|NCT04183868|Glimepiride|glimepiride|mesh-list
19368364|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19368365|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689841|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19689842|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689843|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
19689844|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689845|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19689846|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19689847|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689848|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19689849|NCT05025098|Azacitidine|azacitidine|mesh-list
19689850|NCT05025098|Venetoclax|venetoclax|mesh-list
19689851|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20210704|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20210705|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400115|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400116|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
20400117|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400118|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400119|NCT01130909|Ketamine|ketamine|mesh-list
20400120|NCT01130909|Analgesics|analgesics|mesh-ancestor
20400121|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
20400122|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400123|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400124|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20400125|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20400126|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
20400127|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
20400128|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400129|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19689852|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
20217877|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
19368366|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19693031|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
20210706|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210707|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210708|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20210709|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20210710|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20210711|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20210712|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19368367|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368368|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19368369|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368370|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
19368371|NCT04161755|Atezolizumab|atezolizumab|mesh-list
19368372|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368373|NCT04118387|Acetazolamide|acetazolamide|mesh-list
19368374|NCT04118387|Zolpidem|zolpidem|mesh-list
19368375|NCT04118387|Buspirone|buspirone|mesh-list
19368376|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19368377|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19368378|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210713|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19689853|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689854|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689855|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210714|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210715|NCT00285883|Saquinavir|saquinavir|mesh-list
20210716|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20210717|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20210718|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
20210719|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210720|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210721|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20210722|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19368379|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368380|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19368381|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
19368382|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
19368383|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368384|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368385|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
19368386|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19368387|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368388|NCT04118387|Diuretics|diuretics|mesh-ancestor
19368389|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
19368390|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19368391|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19368392|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19368393|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19368394|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
19368395|NCT04089514|Adalimumab|adalimumab|mesh-list
19368396|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368397|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19402193|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19402194|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19402195|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19402196|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402197|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402198|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19402199|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
19402200|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19402201|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19402202|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19402203|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19402204|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
19402205|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19402206|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19402207|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402208|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19689856|NCT05024799|Fentanyl|fentanyl|mesh-list
20210723|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
20210724|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210725|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20210726|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20210727|NCT00285896|Glucagon|glucagon|mesh-list
19402209|NCT03610932|Ascorbic Acid|ascorbic acid|mesh-list
19402210|NCT03610932|Vitamins|vitamins|mesh-ancestor
19402211|NCT03610932|Micronutrients|micronutrients|mesh-ancestor
19689857|NCT05024799|Butorphanol|butorphanol|mesh-list
19689858|NCT05024799|Propofol|propofol|mesh-list
19689859|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19368398|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
19368399|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19689860|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689861|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689862|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19368400|NCT03845114|Insulin|insulin|mesh-list
19368401|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19368402|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19368403|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368404|NCT03789318|Acetaminophen|acetaminophen|mesh-list
19368405|NCT03789318|Fentanyl|fentanyl|mesh-list
19368406|NCT03789318|Oxycodone|oxycodone|mesh-list
19368407|NCT03789318|Hydromorphone|hydromorphone|mesh-list
19368408|NCT03789318|Bupivacaine|bupivacaine|mesh-list
19368409|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
19368410|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
19368411|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368412|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368413|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
19368414|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368415|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19368416|NCT03789318|Narcotics|narcotics|mesh-ancestor
19368417|NCT03789318|Analgesics|analgesics|mesh-ancestor
19368418|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19368419|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19368420|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
19368421|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19368422|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
19368423|NCT03781414|Tacrolimus|tacrolimus|mesh-list
20400130|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20400131|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400132|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400133|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
20400134|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20400135|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400136|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400137|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20400138|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20400139|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400140|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400141|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400142|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20400143|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
19368424|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368425|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
19368426|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368427|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19368428|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368429|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368430|NCT03774875|Apremilast|apremilast|mesh-list
19368431|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19368432|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19368433|NCT03774875|Analgesics|analgesics|mesh-ancestor
19368434|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
19368435|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368436|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368437|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368438|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368439|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19689863|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
19689864|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
20400144|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20400145|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400146|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20400147|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20400148|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19368440|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19689865|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19689866|NCT05024799|Narcotics|narcotics|mesh-ancestor
19368441|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368442|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689867|NCT05024799|Analgesics|analgesics|mesh-ancestor
19689868|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
19689869|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689870|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19689871|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
19689872|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
19689873|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19689874|NCT05024825|Acetaminophen|acetaminophen|mesh-list
19689875|NCT05024825|Ibuprofen|ibuprofen|mesh-list
19689876|NCT05024825|Gabapentin|gabapentin|mesh-list
19689877|NCT05024825|Hydrocodone|hydrocodone|mesh-list
19689878|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19689879|NCT05024825|Analgesics|analgesics|mesh-ancestor
19689880|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
19689881|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689882|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689883|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
19689884|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19689885|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689886|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19689887|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19689888|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689889|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689890|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
19689891|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19689892|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19689893|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689894|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19689895|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19689896|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20400149|NCT01131000|Ibuprofen|ibuprofen|mesh-list
20400150|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20400151|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400152|NCT01131000|Analgesics|analgesics|mesh-ancestor
20400153|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
20400154|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689897|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689898|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
19368443|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
19368444|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
19368445|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368446|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368447|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368448|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
19368449|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
20400155|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400156|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400157|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400158|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20400159|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368450|NCT03646461|Nivolumab|nivolumab|mesh-list
19368451|NCT03646461|Cetuximab|cetuximab|mesh-list
19368452|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368453|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368454|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19368455|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368456|NCT03631004|Olanzapine|olanzapine|mesh-list
19368457|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
19368458|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
19368459|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689899|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20210728|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20210729|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210730|NCT00285896|Hormones|hormones|mesh-ancestor
20210731|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210732|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210733|NCT00285896|Incretins|incretins|mesh-ancestor
20210734|NCT00286013|Gemcitabine|gemcitabine|mesh-list
19689900|NCT05024825|Narcotics|narcotics|mesh-ancestor
19689901|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
20210735|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
20210736|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20210737|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
20210738|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210739|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210740|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
20426974|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19689902|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
19368460|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368461|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368462|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19368463|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19368464|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368465|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19368466|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20400160|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400161|NCT01131026|Amoxicillin|amoxicillin|mesh-list
20400162|NCT01131026|Levofloxacin|levofloxacin|mesh-list
20400163|NCT01131026|Ofloxacin|ofloxacin|mesh-list
20400164|NCT01131026|Lansoprazole|lansoprazole|mesh-list
20400165|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
20400166|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400167|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400168|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20400169|NCT01131026|Renal Agents|renal agents|mesh-ancestor
20400170|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20400171|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19368467|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19368468|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19368469|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368470|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368471|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
19368472|NCT03615664|Gemcitabine|gemcitabine|mesh-list
19689903|NCT05024604|Progesterone|progesterone|mesh-list
19689904|NCT05024604|Progestins|progestins|mesh-ancestor
19689905|NCT05024604|Hormones|hormones|mesh-ancestor
19689906|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689907|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368473|NCT03615664|Dexamethasone|dexamethasone|mesh-list
19368474|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19368475|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368476|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
19368477|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
19689908|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19689909|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
19689910|NCT05024448|Prednisone|prednisone|mesh-list
19689911|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689912|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
19689913|NCT05024448|Hormones|hormones|mesh-ancestor
19689914|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689915|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689916|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19689917|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368478|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368479|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368480|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368481|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
19368482|NCT03615664|Hormones|hormones|mesh-ancestor
19368483|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368484|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368485|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368486|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19368487|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
19368488|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368489|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
19368490|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368491|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368492|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368493|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
19368494|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368495|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
19368496|NCT03556345|Trastuzumab|trastuzumab|mesh-list
19368497|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368498|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689918|NCT05024877|Stanozolol|stanozolol|mesh-list
20400172|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400173|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400174|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400175|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19368499|NCT03513250|Scopolamine|scopolamine|mesh-list
19689919|NCT05024877|Androgens|androgens|mesh-ancestor
20400176|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19689920|NCT05024877|Hormones|hormones|mesh-ancestor
19368500|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19846027|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846028|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846029|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19846030|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400177|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20400178|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400179|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20400180|NCT01131039|Gemcitabine|gemcitabine|mesh-list
20400181|NCT01131039|Bevacizumab|bevacizumab|mesh-list
20400182|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20400183|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400184|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846031|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19846032|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846033|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689921|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689922|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689923|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
19689924|NCT05024526|Edaravone|edaravone|mesh-list
19689925|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20400185|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20400186|NCT01131039|Growth Substances|growth substances|mesh-ancestor
20400187|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400188|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
20400189|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400190|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
20400191|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368501|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19368502|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
19368503|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
19846034|NCT00675025|Donepezil|donepezil|mesh-list
19846035|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19846036|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846037|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846038|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
19368504|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368505|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846039|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846040|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368506|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368507|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
19368508|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19368509|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
19368510|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368511|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368512|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19368513|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
19368514|NCT03436563|Atezolizumab|atezolizumab|mesh-list
19368515|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368516|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19368517|NCT03406156|Venetoclax|venetoclax|mesh-list
19368518|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
19368519|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368520|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
19368521|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368522|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368523|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368524|NCT03368963|Trifluridine|trifluridine|mesh-list
19368525|NCT03368963|Irinotecan|irinotecan|mesh-list
19689926|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
19689927|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689928|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19846041|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
19846042|NCT00675259|Paclitaxel|paclitaxel|mesh-list
19368526|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19368527|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19368528|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368529|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368530|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846043|NCT00675259|Bevacizumab|bevacizumab|mesh-list
19368531|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
19368532|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
19846044|NCT00675259|Carboplatin|carboplatin|mesh-list
19368533|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846045|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19846046|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846047|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
19846048|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
19846049|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
19846050|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846051|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846052|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846053|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846054|NCT00675259|Growth Substances|growth substances|mesh-ancestor
20400192|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
20400193|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368534|NCT03345823|Upadacitinib|upadacitinib|mesh-list
19368535|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19368536|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20400194|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400195|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400196|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
20400197|NCT01131195|Paclitaxel|paclitaxel|mesh-list
20400198|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
20400199|NCT01131195|Bevacizumab|bevacizumab|mesh-list
20400200|NCT01131195|Capecitabine|capecitabine|mesh-list
19846055|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846056|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
19846057|NCT00675428|Natalizumab|natalizumab|mesh-list
20400201|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20400202|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368537|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368538|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368539|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368540|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
19368541|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368542|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368543|NCT03158688|Dexamethasone|dexamethasone|mesh-list
19368544|NCT03158688|Daratumumab|daratumumab|mesh-list
19368545|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368546|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
19368547|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
19368548|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368549|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368550|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368551|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
19368552|NCT03158688|Hormones|hormones|mesh-ancestor
20400203|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
20400204|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
20400205|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
20400206|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400207|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400208|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
20400209|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400210|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400211|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368553|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368554|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368555|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368556|NCT03152786|Propranolol|propranolol|mesh-list
19368557|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19368558|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19368559|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
19368560|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368561|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368562|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368563|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19368564|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19368565|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
19368566|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20400212|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
20400213|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20400214|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368567|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19368568|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400215|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19368569|NCT03127215|Olaparib|olaparib|mesh-list
20400216|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20400217|NCT01131195|Growth Substances|growth substances|mesh-ancestor
20400218|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
20400219|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400220|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
20400221|NCT01131234|Cediranib|cediranib|mesh-list
19368570|NCT03127215|Trabectedin|trabectedin|mesh-list
19368571|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19368572|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368573|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368574|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368575|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368576|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
19368577|NCT02983071|Fulvestrant|fulvestrant|mesh-list
19368578|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368579|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368580|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20400222|NCT01131234|R04929097|r04929097|mesh-list
20400223|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400224|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400225|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400226|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20400227|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20400228|NCT01131247|Ofatumumab|ofatumumab|mesh-list
20400229|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20400230|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20400231|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
19368581|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19368582|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
19368583|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368584|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368585|NCT02935595|Ketamine|ketamine|mesh-list
19368586|NCT02935595|Analgesics|analgesics|mesh-ancestor
19368587|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
19368588|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368589|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368590|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20400232|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400233|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400234|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
20400235|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400236|NCT01131273|Buprenorphine|buprenorphine|mesh-list
20400237|NCT01131273|Methadone|methadone|mesh-list
20400238|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20400239|NCT01131273|Naloxone|naloxone|mesh-list
20400240|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20400241|NCT01131273|Narcotics|narcotics|mesh-ancestor
19368591|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19368592|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
19368593|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
19368594|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368595|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19368596|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19368597|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368598|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368599|NCT02887248|Gemcitabine|gemcitabine|mesh-list
19368600|NCT02887248|Paclitaxel|paclitaxel|mesh-list
19368601|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19368602|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368603|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
20400242|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400243|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400244|NCT01131273|Analgesics|analgesics|mesh-ancestor
20400245|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
20400246|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400247|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20400248|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
20400249|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
19689929|NCT05024526|Protective Agents|protective agents|mesh-ancestor
19689930|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689931|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19689932|NCT05024565|Lactams|lactams|mesh-list
19689933|NCT05024565|beta-Lactams|beta-lactams|mesh-list
19689934|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400250|NCT01131364|Doxorubicin|doxorubicin|mesh-list
19368604|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19368605|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19846058|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
19846059|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846060|NCT00675441|Lenalidomide|lenalidomide|mesh-list
19689935|NCT05024422|Pyridoxine|pyridoxine|mesh-list
19368606|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368607|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19368608|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
19368609|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
19368610|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368611|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368612|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19689936|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
19689937|NCT05024422|Cabergoline|cabergoline|mesh-list
19689938|NCT05024422|Vitamins|vitamins|mesh-ancestor
19368613|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
19368614|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368615|NCT02849990|Prednisone|prednisone|mesh-list
19368616|NCT02849990|Cortisone|cortisone|mesh-list
19368617|NCT02849990|Indomethacin|indomethacin|mesh-list
19368618|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
19368619|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368620|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
19368621|NCT02849990|Hormones|hormones|mesh-ancestor
19368622|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368623|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368624|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368625|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368626|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19368627|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368628|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368629|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
19368630|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19368631|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19368632|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19368633|NCT02849990|Analgesics|analgesics|mesh-ancestor
19368634|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
19368635|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368636|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368637|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
19368638|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
19368639|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19368640|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19846061|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
19846062|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689939|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
19689940|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689941|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
19689942|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19689943|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19689944|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
19689945|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
19689946|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19689947|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689948|NCT05024357|Dasatinib|dasatinib|mesh-list
20400251|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20400252|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400253|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20400254|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20400255|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400256|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400257|NCT01131377|Acetazolamide|acetazolamide|mesh-list
19368641|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
19846063|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846064|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846065|NCT00675441|Growth Substances|growth substances|mesh-ancestor
19368642|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368643|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368644|NCT02817347|Tazobactam|tazobactam|mesh-list
19689949|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400258|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
19368645|NCT02817347|Piperacillin|piperacillin|mesh-list
19368646|NCT02817347|Dexamethasone|dexamethasone|mesh-list
19368647|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
19689950|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19846066|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
20400259|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20400260|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400261|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400262|NCT01131377|Diuretics|diuretics|mesh-ancestor
20400263|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
20400264|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368648|NCT02817347|BB 1101|bb 1101|mesh-list
20400265|NCT01131429|Cisplatin|cisplatin|mesh-list
19368649|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368650|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
19368651|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
19368652|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368653|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368654|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210741|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210742|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368655|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
19368656|NCT02817347|Hormones|hormones|mesh-ancestor
19368657|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368658|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368659|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368660|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
19368661|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368662|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368663|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19368664|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368665|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19368666|NCT02800824|Budesonide|budesonide|mesh-list
19368667|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368668|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19368669|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
19368670|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368671|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368672|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19368673|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
19368674|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
19368675|NCT02800824|Hormones|hormones|mesh-ancestor
19368676|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368677|NCT02780401|Vaccines|vaccines|mesh-list
19368678|NCT02780401|Sargramostim|sargramostim|mesh-list
19368679|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
19368680|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689951|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368681|NCT02760498|Cemiplimab|cemiplimab|mesh-list
19368682|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368683|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368684|NCT02673151|Edetic Acid|edetic acid|mesh-list
19368685|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19368686|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
19368687|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
19368688|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368689|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
19368690|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19368691|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19368692|NCT02653092|Heparin|heparin|mesh-list
19368693|NCT02653092|Anticoagulants|anticoagulants|mesh-list
19368694|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19368695|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19368696|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19368697|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368698|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19368699|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19368700|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20210743|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210744|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
20210745|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210746|NCT00286026|Azithromycin|azithromycin|mesh-list
20210747|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20210748|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210749|NCT00286052|Naloxone|naloxone|mesh-list
20210750|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19368701|NCT02593175|Paclitaxel|paclitaxel|mesh-list
19368702|NCT02593175|Carboplatin|carboplatin|mesh-list
19368703|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19368704|NCT02593175|Panitumumab|panitumumab|mesh-list
20210751|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400266|NCT01131429|Docetaxel|docetaxel|mesh-list
20400267|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20400268|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400269|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
20400270|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
20400271|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
20400272|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400273|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20400274|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689952|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689953|NCT05024344|Dexamethasone|dexamethasone|mesh-list
19689954|NCT05024344|Ropivacaine|ropivacaine|mesh-list
19689955|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689956|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
19689957|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
19689958|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689959|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689960|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19689961|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
19689962|NCT05024344|Hormones|hormones|mesh-ancestor
19689963|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689964|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19689965|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689966|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
19689967|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
19689968|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19689969|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
19689970|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
19689971|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19689972|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689973|NCT05023915|Dexamethasone|dexamethasone|mesh-list
19689974|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
19689975|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19689976|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
19368705|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19368706|NCT02593175|Antibodies|antibodies|mesh-list
19368707|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
19846067|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846068|NCT00675506|Hormones|hormones|mesh-list
20210752|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
19368708|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19368709|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19368710|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368711|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
19368712|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
19368713|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
19368714|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368715|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
19368716|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368717|NCT02589600|Vitamin D|vitamin d|mesh-list
19368718|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
19368719|NCT02589600|Calcium|calcium|mesh-list
19368720|NCT02589600|Vitamins|vitamins|mesh-ancestor
19368721|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
19368722|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368723|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19368724|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19368725|NCT02567578|YH12852|yh12852|mesh-list
19368726|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19689977|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
19689978|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19689979|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846069|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19846070|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210753|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210754|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20210755|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210756|NCT00286117|Tamoxifen|tamoxifen|mesh-list
20210757|NCT00286117|Anastrozole|anastrozole|mesh-list
20210758|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20210759|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
20210760|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368727|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19368728|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
20210761|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689980|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368729|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368730|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368731|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368732|NCT02523274|Resveratrol|resveratrol|mesh-list
19368733|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
19368734|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400275|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
20400276|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20400277|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
20400278|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368735|NCT02523274|Protective Agents|protective agents|mesh-ancestor
19368736|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368737|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368738|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19402212|NCT03610932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402213|NCT03610932|Antioxidants|antioxidants|mesh-ancestor
19402214|NCT03610932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402215|NCT03610932|Protective Agents|protective agents|mesh-ancestor
19402216|NCT03610893|Dexamethasone|dexamethasone|mesh-list
19402217|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
19402218|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846071|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846072|NCT00675584|Budesonide|budesonide|mesh-list
19846073|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400279|NCT01131468|Expectorants|expectorants|mesh-ancestor
20400280|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400281|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19402219|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
19402220|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
19402221|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402222|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402223|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402224|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
19402225|NCT03610893|Hormones|hormones|mesh-ancestor
19402226|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402227|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402228|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400282|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
20400283|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400284|NCT01131468|Protective Agents|protective agents|mesh-ancestor
20400285|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400286|NCT01131468|Antidotes|antidotes|mesh-ancestor
20400287|NCT01131546|Amlodipine|amlodipine|mesh-list
20400288|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20400289|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20400290|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400291|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400292|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20400293|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400294|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
20400295|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19402229|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19402230|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402231|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19402232|NCT03610893|Analgesics|analgesics|mesh-ancestor
19402233|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
19402234|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19402235|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19402236|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19402237|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402238|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402239|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400296|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400297|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400298|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20400299|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19402240|NCT03610880|Yimitasvir|yimitasvir|mesh-list
19402241|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
19402242|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402243|NCT03610685|Prednisolone|prednisolone|mesh-list
19402244|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846074|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400300|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400301|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400302|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
20400303|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400304|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
20400305|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20400306|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
20400307|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400308|NCT01131572|Expectorants|expectorants|mesh-ancestor
20400309|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400310|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20400311|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
20400312|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400313|NCT01131572|Protective Agents|protective agents|mesh-ancestor
20400314|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400315|NCT01131572|Antidotes|antidotes|mesh-ancestor
20400316|NCT01131689|Sorafenib|sorafenib|mesh-list
20400317|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400318|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20400319|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400320|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400321|NCT01131702|Ranitidine|ranitidine|mesh-list
20400322|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20400323|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20400324|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400325|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20400326|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
20400327|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
20400328|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400329|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400330|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400331|NCT01131728|Naproxen|naproxen|mesh-list
20400332|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
20400333|NCT01131728|Ephedrine|ephedrine|mesh-list
20400334|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20400335|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400336|NCT01131728|Analgesics|analgesics|mesh-ancestor
20400337|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
20400338|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400339|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400340|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400341|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400342|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
20400343|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20400344|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400345|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400346|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400347|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
20400348|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20400349|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400350|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
20400351|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20400352|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400353|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
20400354|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
19689981|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
19689982|NCT05023915|Hormones|hormones|mesh-ancestor
19689983|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19689984|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19689985|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689986|NCT05023941|Acetazolamide|acetazolamide|mesh-list
19689987|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
19689988|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19689989|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19689990|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19689991|NCT05023941|Diuretics|diuretics|mesh-ancestor
19689992|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
20400355|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400356|NCT01131741|Epinephrine|epinephrine|mesh-list
20400357|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20400358|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20400359|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400360|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400361|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400362|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693184|NCT04981899|Carboplatin|carboplatin|mesh-list
19689993|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19689994|NCT05024266|Paclitaxel|paclitaxel|mesh-list
19368739|NCT02467270|Ponatinib|ponatinib|mesh-list
19368740|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368741|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19368742|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368743|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368744|NCT02452554|Maytansine|maytansine|mesh-list
19689995|NCT05024266|Carboplatin|carboplatin|mesh-list
19689996|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19689997|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19689998|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
19689999|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690000|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
19690001|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690002|NCT05024084|Anesthetics|anesthetics|mesh-list
19690003|NCT05024084|Sevoflurane|sevoflurane|mesh-list
19690004|NCT05024084|Desflurane|desflurane|mesh-list
19690005|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690006|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690007|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19690008|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19690009|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
19690010|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
19690011|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19690012|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690013|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19690014|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19690015|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
19690016|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690017|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400363|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20400364|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400365|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
20400366|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400367|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19368745|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
19368746|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19368747|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19368748|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368749|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
19368750|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
19368751|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
19368752|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368753|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368754|NCT02432560|Sirolimus|sirolimus|mesh-list
19368755|NCT02432560|Everolimus|everolimus|mesh-list
19690018|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210762|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20210763|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368756|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368757|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368758|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
19368759|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368760|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19368761|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368762|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19368763|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
19368764|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19368765|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
19368766|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368767|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19368768|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
19368769|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690019|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
20400368|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
20210764|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20210765|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20210766|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20210767|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20210768|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20400369|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
20400370|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
20400371|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19368770|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368771|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19368772|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19368773|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19368774|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
19368775|NCT02359175|Acetaminophen|acetaminophen|mesh-list
19368776|NCT02359175|Fentanyl|fentanyl|mesh-list
19368777|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
19368778|NCT02359175|Bupivacaine|bupivacaine|mesh-list
19368779|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
19368780|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
19368781|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368782|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368783|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
19368784|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368785|NCT02359175|Narcotics|narcotics|mesh-ancestor
19368786|NCT02359175|Analgesics|analgesics|mesh-ancestor
19368787|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19368788|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19368789|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
19368790|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19368791|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
19368792|NCT02323698|Caffeine|caffeine|mesh-list
19368793|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19368794|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368795|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19368796|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368797|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368798|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19368799|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19368800|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
19368801|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368802|NCT02323659|Interferons|interferons|mesh-list
19368803|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
19368804|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
19368805|NCT02323659|Methotrexate|methotrexate|mesh-list
19368806|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19368807|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
19368808|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19368809|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368810|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19368811|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
19368812|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368813|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368814|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
19368815|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368816|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19368817|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368818|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
19846075|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
19846076|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846077|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846078|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19846079|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
19846080|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
19846081|NCT00675584|Hormones|hormones|mesh-ancestor
19846082|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846083|NCT00675597|Bevacizumab|bevacizumab|mesh-list
20210769|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210770|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210771|NCT00286130|Leucovorin|leucovorin|mesh-list
20210772|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
20210773|NCT00286130|Irinotecan|irinotecan|mesh-list
20210774|NCT00286130|Cetuximab|cetuximab|mesh-list
20210775|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210776|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19368819|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19402245|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
20210777|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20210778|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210779|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210780|NCT00286130|Antidotes|antidotes|mesh-ancestor
20210781|NCT00286130|Protective Agents|protective agents|mesh-ancestor
20210782|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210783|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
20210784|NCT00286130|Vitamins|vitamins|mesh-ancestor
19368820|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19368821|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
19368822|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846084|NCT00675597|Docetaxel|docetaxel|mesh-list
19846085|NCT00675597|Vinorelbine|vinorelbine|mesh-list
19846086|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846087|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846088|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846089|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846090|NCT00675597|Growth Substances|growth substances|mesh-ancestor
19846091|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846092|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
19846093|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
19846094|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
19368823|NCT02318277|Durvalumab|durvalumab|mesh-list
19368824|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368825|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368826|NCT02296801|Letrozole|letrozole|mesh-list
19368827|NCT02296801|Palbociclib|palbociclib|mesh-list
19368828|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368829|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19368830|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19368831|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368832|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368833|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19368834|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
19368835|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368836|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368837|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19368838|NCT02283853|Interferons|interferons|mesh-list
19368839|NCT02283853|Interferon-beta|interferon-beta|mesh-list
19368840|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
19368841|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19368842|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368843|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
19368844|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368845|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
19368846|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690020|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
19690021|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690022|NCT05023863|Protective Agents|protective agents|mesh-ancestor
19690023|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690024|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
19690025|NCT05023863|Vitamins|vitamins|mesh-ancestor
19690026|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
19690027|NCT05023382|Teduglutide|teduglutide|mesh-list
19690028|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19690029|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19846095|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
19846096|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846097|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19846098|NCT00675792|Bromides|bromides|mesh-list
19846099|NCT00675792|Rocuronium|rocuronium|mesh-list
19846100|NCT00675792|Neostigmine|neostigmine|mesh-list
19846101|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
19690030|NCT05023382|Protective Agents|protective agents|mesh-ancestor
19690031|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690032|NCT05023408|Bleomycin|bleomycin|mesh-list
19690033|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19690034|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690035|NCT05023304|Prednisolone|prednisolone|mesh-list
20210785|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
20210786|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20210787|NCT00286143|Fentanyl|fentanyl|mesh-list
20210788|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20210789|NCT00286143|Narcotics|narcotics|mesh-ancestor
20210790|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210791|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368847|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
19368848|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368849|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19368850|NCT02176668|Esomeprazole|esomeprazole|mesh-list
19690036|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19690037|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
19846102|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20210792|NCT00286143|Analgesics|analgesics|mesh-ancestor
20210793|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
20400372|NCT01131754|Heparin|heparin|mesh-list
20400373|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
20400374|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20400375|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20400376|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400377|NCT01131767|Naproxen|naproxen|mesh-list
20400378|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
19368851|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19368852|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368853|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19368854|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368855|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368856|NCT02143063|Cocaine|cocaine|mesh-list
19368857|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
19368858|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
19368859|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19368860|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368861|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
19368862|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368863|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19368864|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19368865|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19368866|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19368867|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368868|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
19368869|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368870|NCT02073097|Acyclovir|acyclovir|mesh-list
19368871|NCT02073097|Prednisone|prednisone|mesh-list
19368872|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
19368873|NCT02073097|Rituximab|rituximab|mesh-list
19368874|NCT02073097|Doxorubicin|doxorubicin|mesh-list
19368875|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19368876|NCT02073097|Vincristine|vincristine|mesh-list
19368877|NCT02073097|Sargramostim|sargramostim|mesh-list
19368878|NCT02073097|Lenograstim|lenograstim|mesh-list
19368879|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368880|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
19368881|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400379|NCT01131767|Ephedrine|ephedrine|mesh-list
20400380|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20400381|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400382|NCT01131767|Analgesics|analgesics|mesh-ancestor
20400383|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
20400384|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400385|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400386|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400387|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400388|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
20400389|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20400390|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368882|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368883|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368884|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
19368885|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368886|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368887|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19846103|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19846104|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19846105|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368888|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19368889|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19368890|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19368891|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690038|NCT05023304|Hormones|hormones|mesh-ancestor
19690039|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690040|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690041|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19690042|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690043|NCT05023759|Cannabidiol|cannabidiol|mesh-list
19690044|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
19690045|NCT05023577|Metronidazole|metronidazole|mesh-list
19690046|NCT05023577|Clarithromycin|clarithromycin|mesh-list
19368892|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368893|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368894|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
20426975|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
19368895|NCT02073097|Hormones|hormones|mesh-ancestor
19368896|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368897|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368898|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19368899|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
19368900|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
19368901|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
20210794|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210795|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20210796|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20210797|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
20210798|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
20210799|NCT00286208|Misoprostol|misoprostol|mesh-list
20210800|NCT00286208|Mifepristone|mifepristone|mesh-list
20210801|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20210802|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
20210803|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20210804|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368902|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19368903|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
19368904|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368905|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
19368906|NCT02017964|Carboplatin|carboplatin|mesh-list
19368907|NCT02017964|Methotrexate|methotrexate|mesh-list
19368908|NCT02017964|Etoposide|etoposide|mesh-list
19368909|NCT02017964|Vincristine|vincristine|mesh-list
19368910|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
19368911|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
19368912|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368913|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
19368914|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368915|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368916|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368917|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
19368918|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368919|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368920|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19368921|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19368922|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
19368923|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19368924|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19368925|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
19368926|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
19690047|NCT05023577|Levofloxacin|levofloxacin|mesh-list
19690048|NCT05023577|Ofloxacin|ofloxacin|mesh-list
19690049|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
20210805|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20210806|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20210807|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
20210808|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20210809|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20210810|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20210811|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20210812|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
20210813|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20210814|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20210815|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
20210816|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210817|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
20210818|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20210819|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20210820|NCT00286260|Levetiracetam|levetiracetam|mesh-list
20210821|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
20210822|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
20210823|NCT00286273|Heparin|heparin|mesh-list
20210824|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20210825|NCT00286273|Tinzaparin|tinzaparin|mesh-list
20210826|NCT00286273|Dalteparin|dalteparin|mesh-list
20210827|NCT00286273|Nadroparin|nadroparin|mesh-list
20210828|NCT00286273|Citric Acid|citric acid|mesh-list
20210829|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
20210830|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
20210831|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20210832|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
19368927|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690050|NCT05023577|Rabeprazole|rabeprazole|mesh-list
19690051|NCT05023577|Bismuth|bismuth|mesh-list
20210833|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
19690052|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690053|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690054|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19690055|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19690056|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19690057|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19690058|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690059|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19690060|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19690061|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19690062|NCT05023577|Renal Agents|renal agents|mesh-ancestor
19690063|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19368928|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19368929|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19368930|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19368931|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19368932|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19368933|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
19368934|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
19368935|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
19368936|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
19690064|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690065|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690066|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19690067|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19690068|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368937|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19368938|NCT01956110|Hormones|hormones|mesh-ancestor
19368939|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368940|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210834|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210835|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20210836|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20210837|NCT00286312|Atorvastatin|atorvastatin|mesh-list
20210838|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20210839|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20210840|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
20210841|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210842|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20210843|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20210844|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210845|NCT00286351|Goserelin|goserelin|mesh-list
20210846|NCT00286351|Anastrozole|anastrozole|mesh-list
20210847|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20210848|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400391|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210849|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20210850|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20210851|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210852|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210853|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20210854|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
20210855|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210856|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400392|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400393|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
20400394|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20400395|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400396|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
20400397|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20400398|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400399|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
20400400|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400401|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19368941|NCT01335581|Tretinoin|tretinoin|mesh-list
20210857|NCT00286364|Androgens|androgens|mesh-list
20210858|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20210859|NCT00286364|Hormones|hormones|mesh-ancestor
20210860|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368942|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690069|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20400402|NCT01131780|Ibuprofen|ibuprofen|mesh-list
20400403|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
20400404|NCT01131780|Ephedrine|ephedrine|mesh-list
20400405|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20400406|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400407|NCT01131780|Analgesics|analgesics|mesh-ancestor
20400408|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
20400409|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400410|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400411|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368943|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
19368944|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
19368945|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
19368946|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
19690070|NCT05023577|Antacids|antacids|mesh-ancestor
19690071|NCT05023577|Diuretics|diuretics|mesh-ancestor
19690072|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
19690073|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400412|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400413|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20400414|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690074|NCT05023577|Expectorants|expectorants|mesh-ancestor
19690075|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
19690076|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20400415|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400416|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400417|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
20400418|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20400419|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400420|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
19690077|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19690078|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19690079|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19690080|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400421|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20400422|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400423|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
20400424|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400425|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400426|NCT01131806|Fluticasone|fluticasone|mesh-list
20400427|NCT01131806|Xhance|xhance|mesh-list
20400428|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20400429|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20400430|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400431|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400432|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
20400433|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400434|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400435|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20400436|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400437|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
20400438|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20400439|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20400440|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20400441|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20400442|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400443|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400444|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400445|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
20400446|NCT01131806|Hormones|hormones|mesh-ancestor
20400447|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400448|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
20400449|NCT01131845|Treprostinil|treprostinil|mesh-list
20400450|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20400451|NCT01131897|Levetiracetam|levetiracetam|mesh-list
20400452|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
20400453|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
20400454|NCT01131910|Vaccines|vaccines|mesh-list
20400455|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
20400456|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400457|NCT01131923|Amlodipine|amlodipine|mesh-list
19368947|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19690081|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690082|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400458|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20400459|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19690083|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19690084|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
20400460|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400461|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400462|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690085|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19693032|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19693033|NCT04983940|Testosterone|testosterone|mesh-list
19693034|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
19693035|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
20400463|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400464|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
20400465|NCT01131936|Amlodipine|amlodipine|mesh-list
20400466|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20400467|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20400468|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400469|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400470|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20400471|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400472|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
19693036|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693037|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693038|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
19368948|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19368949|NCT00882895|Prednisolone|prednisolone|mesh-list
19368950|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
19368951|NCT00882895|Tacrolimus|tacrolimus|mesh-list
19368952|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
19368953|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19368954|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19368955|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
19368956|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693039|NCT04983940|Hormones|hormones|mesh-ancestor
19693040|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400473|NCT01131949|Lamotrigine|lamotrigine|mesh-list
20400474|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
20400475|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20400476|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400477|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400478|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20400479|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400480|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20400481|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20400482|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400483|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20400484|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20400485|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
20400486|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20400487|NCT01131975|Lamotrigine|lamotrigine|mesh-list
20400488|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
20400489|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20400490|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400491|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400492|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20400493|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400494|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20400495|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20400496|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400497|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20400498|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20400499|NCT01131988|Tacrolimus|tacrolimus|mesh-list
20400500|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400501|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
20400502|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400503|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20400504|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400505|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400506|NCT01132027|Tacrolimus|tacrolimus|mesh-list
20400507|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400508|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
19368957|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
19402246|NCT03610685|Hormones|hormones|mesh-ancestor
19693041|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368958|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368959|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19368960|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19368961|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368962|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19368963|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368964|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19368965|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
19368966|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19368967|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19368968|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19368969|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
19368970|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
19368971|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19368972|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19368973|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
19368974|NCT00882895|Hormones|hormones|mesh-ancestor
19368975|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19368976|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19368977|NCT00882895|Protective Agents|protective agents|mesh-ancestor
19368978|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19368979|NCT00867178|Vitamin A|vitamin a|mesh-list
19368980|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
19368981|NCT00867178|Thiotepa|thiotepa|mesh-list
19368982|NCT00867178|Cisplatin|cisplatin|mesh-list
19368983|NCT00867178|Carboplatin|carboplatin|mesh-list
19368984|NCT00867178|Etoposide|etoposide|mesh-list
19368985|NCT00867178|Vincristine|vincristine|mesh-list
19368986|NCT00867178|Vorinostat|vorinostat|mesh-list
19368987|NCT00867178|Tretinoin|tretinoin|mesh-list
20400509|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400510|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20400511|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400512|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400513|NCT01132040|Primidone|primidone|mesh-list
20400514|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
20400515|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
20400516|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
19368988|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
19368989|NCT00867178|Isotretinoin|isotretinoin|mesh-list
19368990|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19368991|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
19368992|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19368993|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19368994|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19368995|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
19368996|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19368997|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19368998|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19368999|NCT00867178|Vitamins|vitamins|mesh-ancestor
19369000|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
19369001|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19369002|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19369003|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19369004|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369005|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369006|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
20400517|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400518|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400519|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400520|NCT01132157|Propofol|propofol|mesh-list
20400521|NCT01132157|Desflurane|desflurane|mesh-list
20400522|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20400523|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400524|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400525|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20400526|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
20400527|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
19369007|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369008|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19369009|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
19369010|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
19369011|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20400528|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20400529|NCT01132170|Valproic Acid|valproic acid|mesh-list
20400530|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
19369012|NCT00787176|Oxytocin|oxytocin|mesh-list
19369013|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
20400531|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400532|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400533|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
19369014|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19369015|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369016|NCT00352534|Dactinomycin|dactinomycin|mesh-list
19369017|NCT00352534|Cactinomycin|cactinomycin|mesh-list
19369018|NCT00352534|Doxorubicin|doxorubicin|mesh-list
19369019|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19369020|NCT00352534|Vincristine|vincristine|mesh-list
19369021|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19369022|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369023|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19369024|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19369025|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369026|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210861|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210862|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20210863|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210864|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210865|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20210866|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
20210867|NCT00286403|Fenoldopam|fenoldopam|mesh-list
20400534|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400535|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400536|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
20400537|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20400538|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400539|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20400540|NCT01132183|Valproic Acid|valproic acid|mesh-list
20400541|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
20400542|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400543|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400544|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
20400545|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400546|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400547|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
20400548|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20400549|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400550|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20400551|NCT01132196|Valproic Acid|valproic acid|mesh-list
20400552|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
20400553|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400554|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400555|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
20400556|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400557|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400558|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
20400559|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20400560|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400561|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20400562|NCT01132222|Ibuprofen|ibuprofen|mesh-list
20400563|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
20400564|NCT01132222|Ephedrine|ephedrine|mesh-list
20400565|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20400566|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400567|NCT01132222|Analgesics|analgesics|mesh-ancestor
20400568|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
20400569|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400570|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400571|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400572|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400573|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20400574|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400575|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400576|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400577|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
20400578|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20400579|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400580|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
20400581|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19369027|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19690086|NCT05023122|Vitamin D|vitamin d|mesh-list
19369028|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690087|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
20400582|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400583|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
20400584|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400585|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369029|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369030|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369031|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19369032|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369033|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19369034|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19369035|NCT00033293|Prednisone|prednisone|mesh-list
19369036|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
19369037|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
19369038|NCT00033293|Antibodies|antibodies|mesh-list
19369039|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
19369040|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19369041|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19369042|NCT00033293|Hormones|hormones|mesh-list
19369043|NCT00033293|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19369044|NCT00033293|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19369045|NCT00033293|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20400586|NCT01132235|Etanercept|etanercept|mesh-list
20400587|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20400588|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19369046|NCT00033293|beta-Endorphin|beta-endorphin|mesh-list
19369047|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369048|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
19369049|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369050|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19369051|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19369052|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
19369053|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369054|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369055|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20400589|NCT01132235|Analgesics|analgesics|mesh-ancestor
19369056|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19369057|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
19369058|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369059|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19369060|NCT00033293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369061|NCT05193370|Vasopressins|vasopressins|mesh-list
19369062|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
19369063|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
19369064|NCT05193370|Giapreza|giapreza|mesh-list
19369065|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
19369066|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
19369067|NCT05193370|Coagulants|coagulants|mesh-ancestor
19369068|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19369069|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19369070|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
19369071|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369072|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19369073|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
19369074|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210868|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210869|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20210870|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
20210871|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
20400590|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
20400591|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400592|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400593|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400594|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20400595|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400596|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400597|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
20400598|NCT01132248|Mefloquine|mefloquine|mesh-list
20400599|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
20210872|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
20210873|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210874|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400600|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19369075|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369076|NCT05193318|Ketamine|ketamine|mesh-list
19369077|NCT05193318|Analgesics|analgesics|mesh-ancestor
19369078|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
20210875|NCT00286416|Omalizumab|omalizumab|mesh-list
20400601|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20400602|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426976|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20426977|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20426978|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426979|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426980|NCT01283919|Pantoprazole|pantoprazole|mesh-list
20426981|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20426982|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426983|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20426984|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20426985|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426986|NCT01283932|Pantoprazole|pantoprazole|mesh-list
20426987|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20426988|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20426989|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20426990|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210876|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19369079|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369080|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369081|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19369082|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19369083|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
19369084|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
19369085|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369086|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19369087|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19369088|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369089|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369090|NCT05193292|Trastuzumab|trastuzumab|mesh-list
19369091|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369092|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369093|NCT05193227|Lidocaine|lidocaine|mesh-list
19369094|NCT05193227|Bupivacaine|bupivacaine|mesh-list
19369095|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
19369096|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
19369097|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369098|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369099|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
19369100|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369101|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19369102|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19369103|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19369104|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19369105|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369106|NCT05193214|Antibodies|antibodies|mesh-list
19369107|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19369108|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
19369109|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369110|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19369111|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369112|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369113|NCT05192902|Anesthetics|anesthetics|mesh-list
19369114|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369115|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369116|NCT05192681|Docetaxel|docetaxel|mesh-list
19369117|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369118|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369119|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369120|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369121|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369122|NCT05192304|Maleic acid|maleic acid|mesh-list
20210877|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20210878|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
20217878|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217879|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20217880|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
20217881|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
20217882|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217883|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217884|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20217885|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20400603|NCT01132352|Levetiracetam|levetiracetam|mesh-list
20400604|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
20400605|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
20400606|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
20400607|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
20400608|NCT01132404|Leuprolide|leuprolide|mesh-list
20400609|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20400610|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
20400611|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20400612|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400613|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19369123|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369124|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369125|NCT05192213|Ascorbic Acid|ascorbic acid|mesh-list
19369126|NCT05192213|Thiamine|thiamine|mesh-list
19369127|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
19369128|NCT05192213|Vitamins|vitamins|mesh-ancestor
19369129|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
19369130|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369131|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19369132|NCT05192213|Antioxidants|antioxidants|mesh-ancestor
19369133|NCT05192213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400614|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400615|NCT01132417|Tigecycline|tigecycline|mesh-list
20400616|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400617|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400618|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20400619|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400620|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400621|NCT01132443|Clindamycin|clindamycin|mesh-list
20400622|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
20400623|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
20400624|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20400625|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400626|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400627|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20400628|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400629|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400630|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
20400631|NCT01132521|Urinastatin|urinastatin|mesh-list
20400632|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
20400633|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20400634|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
20400635|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400636|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400637|NCT01132573|Clofarabine|clofarabine|mesh-list
20400638|NCT01132573|Entinostat|entinostat|mesh-list
20400639|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19369134|NCT05192213|Protective Agents|protective agents|mesh-ancestor
19369135|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
19369136|NCT05191914|Fulvestrant|fulvestrant|mesh-list
19369137|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20400640|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400641|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
20400642|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400643|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369138|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369139|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19369140|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19369141|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
19369142|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369143|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369144|NCT05191888|Amoxicillin|amoxicillin|mesh-list
19369145|NCT05191888|Metronidazole|metronidazole|mesh-list
19369146|NCT05191888|Clarithromycin|clarithromycin|mesh-list
19369147|NCT05191888|Rabeprazole|rabeprazole|mesh-list
19369148|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19369149|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369150|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19369151|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19369152|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19369153|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369154|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400644|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369155|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19369156|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19369157|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19369158|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19369159|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19690088|NCT05023122|Calcium|calcium|mesh-list
19690089|NCT05023122|Vitamins|vitamins|mesh-ancestor
19690090|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
19690091|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690092|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19402247|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690093|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20210879|NCT00286481|Simvastatin|simvastatin|mesh-list
20210880|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20210881|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20210882|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
20210883|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690099|NCT05022030|Cetuximab|cetuximab|mesh-list
19690100|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19690101|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690102|NCT05021887|Fluticasone|fluticasone|mesh-list
19690103|NCT05021887|Xhance|xhance|mesh-list
19690104|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19690105|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19690106|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
19690107|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690108|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690109|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19690110|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400645|NCT01132586|Cytarabine|cytarabine|mesh-list
19402248|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400646|NCT01132586|Lenalidomide|lenalidomide|mesh-list
20400647|NCT01132586|Idarubicin|idarubicin|mesh-list
20400648|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400649|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
20400650|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400651|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400652|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
20400653|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400654|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400655|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
20400656|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400657|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19402249|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402250|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402251|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
19402252|NCT03610412|Antacids|antacids|mesh-ancestor
19402253|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402254|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402255|NCT03610347|Paclitaxel|paclitaxel|mesh-list
19402256|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19402257|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402258|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
19402259|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
19402260|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
19402261|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402262|NCT03610321|Gefarnate|gefarnate|mesh-list
19402263|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19402264|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402265|NCT03610282|Propofol|propofol|mesh-list
19402266|NCT03610282|Methylphenidate|methylphenidate|mesh-list
19402267|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19402268|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402269|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402270|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19402271|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
19402272|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
19402273|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19402274|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19690111|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
19690112|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20210884|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20210885|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20210886|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210887|NCT00286585|Propofol|propofol|mesh-list
20210888|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
20210889|NCT00286585|Anesthetics|anesthetics|mesh-list
20210890|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19369160|NCT05189483|Paclitaxel|paclitaxel|mesh-list
19369161|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20210891|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210892|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210893|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
19369162|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19369163|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369164|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369165|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369166|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369167|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369168|NCT05173857|Paclitaxel|paclitaxel|mesh-list
19369169|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19369170|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369171|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369172|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369173|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369174|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369175|NCT05169008|Vaccines|vaccines|mesh-list
19690113|NCT05022186|Cannabidiol|cannabidiol|mesh-list
19690114|NCT05022186|Tramiprosate|tramiprosate|mesh-list
19690115|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
20210894|NCT00286611|Amifostine|amifostine|mesh-list
20210895|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20210896|NCT00286611|Protective Agents|protective agents|mesh-ancestor
20210897|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210898|NCT00286624|Cyclosporine|cyclosporine|mesh-list
20210899|NCT00286624|Everolimus|everolimus|mesh-list
20210900|NCT00286624|Cyclosporins|cyclosporins|mesh-list
20210901|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20210902|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210903|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690116|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
19690117|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
19690118|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690119|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690120|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690121|NCT05021770|Thiotepa|thiotepa|mesh-list
19846106|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846107|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19846108|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846109|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210904|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20210905|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
19846110|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
20210906|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210907|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
20210908|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20210909|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
20210910|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20210911|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20210912|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210913|NCT00286689|Hormones|hormones|mesh-list
20210914|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20210915|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210916|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
20210917|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20210918|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210919|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20210920|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
20210921|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20210922|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210923|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20210924|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20210925|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20210926|NCT00286871|Tacrolimus|tacrolimus|mesh-list
20210927|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369176|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
19369177|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846111|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846112|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20210928|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
20210929|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210930|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19369178|NCT05168527|Gemcitabine|gemcitabine|mesh-list
19369179|NCT05168527|Paclitaxel|paclitaxel|mesh-list
19369180|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19369181|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369182|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369183|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369184|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369185|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369186|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19846113|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
19846114|NCT00675909|Midazolam|midazolam|mesh-list
19846115|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19846116|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19846117|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846118|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846119|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19846120|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20400658|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20400659|NCT01132586|Growth Substances|growth substances|mesh-ancestor
19369187|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
19369188|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
19369189|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369190|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369191|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369192|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
19369193|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369194|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
19369195|NCT05166811|Analgesics|analgesics|mesh-ancestor
19369196|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
19369197|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369198|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369199|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
19369200|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369201|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19369202|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
19369203|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19369204|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19369205|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369206|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19369207|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
19369208|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19369209|NCT05159245|Trastuzumab|trastuzumab|mesh-list
19369210|NCT05159245|Pertuzumab|pertuzumab|mesh-list
19369211|NCT05159245|Atezolizumab|atezolizumab|mesh-list
19369212|NCT05159245|Vemurafenib|vemurafenib|mesh-list
19369213|NCT05159245|Entrectinib|entrectinib|mesh-list
19369214|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369215|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369216|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19369217|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400660|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
20400661|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20400662|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20400663|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20400664|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400665|NCT01132599|Choline|choline|mesh-list
20400666|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
20400667|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20400668|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
20400669|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400670|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400671|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19369218|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369219|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19369220|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19369221|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369222|NCT05149365|Incretins|incretins|mesh-ancestor
19369223|NCT05149365|Hormones|hormones|mesh-ancestor
19369224|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369225|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19369226|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
19369227|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369228|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369229|NCT05133297|Tofacitinib|tofacitinib|mesh-list
19846121|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20400672|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
20400673|NCT01132638|Esomeprazole|esomeprazole|mesh-list
20400674|NCT01132638|Pantoprazole|pantoprazole|mesh-list
20400675|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20400676|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400677|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20400678|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400679|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400680|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
19369230|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19369231|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369232|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369233|NCT05123820|Midazolam|midazolam|mesh-list
19369234|NCT05123820|Omeprazole|omeprazole|mesh-list
19369235|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19369236|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19369237|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369238|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369239|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19690122|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19690123|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
19690124|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690125|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690126|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19690127|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690128|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
19690129|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690130|NCT05021588|Anticoagulants|anticoagulants|mesh-list
19690131|NCT05021406|Carvedilol|carvedilol|mesh-list
19690132|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19690133|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19690134|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400681|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20400682|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19369240|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19369241|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19369242|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20400683|NCT01132677|Prednisolone|prednisolone|mesh-list
20400684|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
20400685|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20400686|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
20400687|NCT01132677|Hylan|hylan|mesh-list
20400688|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400689|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
20400690|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
20400691|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400692|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400693|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19369243|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
19369244|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
19369245|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
19369246|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
19369247|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369248|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369249|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19690135|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400694|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
20613102|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613103|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613104|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613105|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20613106|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400695|NCT01132677|Hormones|hormones|mesh-ancestor
20400696|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400697|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20400698|NCT01132677|Protective Agents|protective agents|mesh-ancestor
20400699|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20400700|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400701|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
20400702|NCT01132703|Glyburide|glyburide|mesh-list
20400703|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20400704|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613107|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19369250|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400705|NCT01132716|Valacyclovir|valacyclovir|mesh-list
20400706|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
20613108|NCT02253888|Ritonavir|ritonavir|mesh-list
20400707|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400708|NCT01132729|Valacyclovir|valacyclovir|mesh-list
20613109|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613110|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613111|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613112|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613113|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613114|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19369251|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19369252|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369253|NCT05103631|Cyclophosphamide|cyclophosphamide|mesh-list
19369254|NCT05103631|Fludarabine|fludarabine|mesh-list
19369255|NCT05103631|Fludarabine phosphate|fludarabine phosphate|mesh-list
19369256|NCT05103631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369257|NCT05103631|Immunologic Factors|immunologic factors|mesh-ancestor
19369258|NCT05103631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400709|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
20400710|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400711|NCT01132768|Atenolol|atenolol|mesh-list
20400712|NCT01132768|Olmesartan|olmesartan|mesh-list
20400713|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19369259|NCT05103631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19369260|NCT05103631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19369261|NCT05103631|Alkylating Agents|alkylating agents|mesh-ancestor
19369262|NCT05103631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369263|NCT05103631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369264|NCT05103631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19369265|NCT05103631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19369266|NCT05103631|Antimetabolites|antimetabolites|mesh-ancestor
19369267|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
19369268|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
19369269|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19369270|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
20400714|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20400715|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20400716|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20400717|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400718|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20400719|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
20400720|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
20400721|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400722|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400723|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20400724|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20400725|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19369271|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19369272|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19369273|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369274|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19369275|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369276|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369277|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19369278|NCT05085340|Renal Agents|renal agents|mesh-ancestor
19369279|NCT05078671|Cobicistat|cobicistat|mesh-list
19369280|NCT05078671|Olaparib|olaparib|mesh-list
19369281|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19369282|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369283|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369284|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369285|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19369286|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19369287|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
19369288|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369289|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19369290|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19369291|NCT05077800|Losartan|losartan|mesh-list
19369292|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19369293|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19369294|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19369295|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19690136|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690137|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400726|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613115|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20400727|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400728|NCT01132781|Theophylline|theophylline|mesh-list
20400729|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400730|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
19369296|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369297|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
19369298|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369299|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369300|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19369301|NCT05070585|Protective Agents|protective agents|mesh-ancestor
19369302|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369303|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369304|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19369305|NCT05026736|Antibodies|antibodies|mesh-list
19369306|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
19369307|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19369308|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
19369309|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369310|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369311|NCT05011812|Ritonavir|ritonavir|mesh-list
19369312|NCT05011812|Midazolam|midazolam|mesh-list
19369313|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19369314|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19369315|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369316|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369317|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19369318|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19369319|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19369320|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19369321|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
19369322|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
19369323|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
19369324|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
19369325|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369326|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369327|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19369328|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19369329|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
19369330|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369331|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19369332|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19369333|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
19369334|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369335|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19369336|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19369337|NCT05007873|Decitabine|decitabine|mesh-list
19369338|NCT05007873|Dasatinib|dasatinib|mesh-list
19369339|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19369340|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
19369341|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369342|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369343|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369344|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19369345|NCT04933149|Ketamine|ketamine|mesh-list
19369346|NCT04933149|Analgesics|analgesics|mesh-ancestor
19369347|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
19369348|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369349|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369350|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19369351|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19369352|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
19369353|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
19369354|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369355|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19369356|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19369357|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369358|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369359|NCT04893161|Belimumab|belimumab|mesh-list
19369360|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369361|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
19369362|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369363|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
19369364|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19369365|NCT04871165|Antibodies|antibodies|mesh-list
20400731|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400732|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400733|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20400734|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400735|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20400736|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400737|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400738|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
20400739|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20400740|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20400741|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
20400742|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400743|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
20400744|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20400745|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400746|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400747|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20400748|NCT01132794|Analgesics|analgesics|mesh-ancestor
20400749|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
19369366|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
19369367|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369368|NCT04857385|Hemostatics|hemostatics|mesh-list
19369369|NCT04857385|Coagulants|coagulants|mesh-ancestor
19402275|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19402276|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402277|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402278|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
19402279|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210931|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210932|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210933|NCT00286923|Topiramate|topiramate|mesh-list
20210934|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
20210935|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19402280|NCT03610230|Iron|iron|mesh-list
19690138|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19690139|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
19690140|NCT05021406|Protective Agents|protective agents|mesh-ancestor
19690141|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19690142|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402281|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19402282|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19402283|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
19402284|NCT03610230|Trace Elements|trace elements|mesh-ancestor
19402285|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
19402286|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402287|NCT03610230|Hematinics|hematinics|mesh-ancestor
19402288|NCT03610178|Insulin|insulin|mesh-list
19402289|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19402290|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19402291|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402292|NCT03610139|Vitamin D|vitamin d|mesh-list
19402293|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
19402294|NCT03610139|Vitamins|vitamins|mesh-ancestor
19402295|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
19402296|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400750|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400751|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20400752|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20400753|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19402297|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19402298|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19402299|NCT03610100|Gemcitabine|gemcitabine|mesh-list
19402300|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19690143|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690144|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
20210936|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210937|NCT00286936|Zolpidem|zolpidem|mesh-list
20210938|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20210939|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20210940|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210941|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210942|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19402301|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
19402302|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402303|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210943|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
19369370|NCT04735185|Anesthetics|anesthetics|mesh-list
19369371|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
19369372|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369373|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369374|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
19369375|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400754|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400755|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400756|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400757|NCT01132911|Bortezomib|bortezomib|mesh-list
20400758|NCT01132911|Vorinostat|vorinostat|mesh-list
20400759|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400760|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20400761|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369376|NCT04666389|Atorvastatin|atorvastatin|mesh-list
19369377|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19369378|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19369379|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
19369380|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369381|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19369382|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19369383|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369384|NCT04635631|Talazoparib|talazoparib|mesh-list
19369385|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20400762|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400763|NCT01132989|Lenalidomide|lenalidomide|mesh-list
20400764|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
20400765|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400766|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20400767|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20400768|NCT01132989|Growth Substances|growth substances|mesh-ancestor
20400769|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
20400770|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400771|NCT01133080|Minocycline|minocycline|mesh-list
19369386|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369387|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369388|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369389|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19690145|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19690146|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19690147|NCT05021484|Felzartamab|felzartamab|mesh-list
19690148|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690149|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
19690150|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210944|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
20210945|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210946|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210947|NCT00286962|Insulin|insulin|mesh-list
20210948|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20210949|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210950|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400772|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400773|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400774|NCT01133119|Bupivacaine|bupivacaine|mesh-list
20400775|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
20400776|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
20400777|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400778|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400779|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
20400780|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400781|NCT01133210|Maraviroc|maraviroc|mesh-list
20400782|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20400783|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20400784|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400785|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20400786|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20400787|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
20400788|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690151|NCT05021731|Rifampin|rifampin|mesh-list
19369390|NCT04614168|Glycerol|glycerol|mesh-list
20210951|NCT00286988|Topiramate|topiramate|mesh-list
20210952|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
20210953|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210954|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210955|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
19690152|NCT05021731|Rifapentine|rifapentine|mesh-list
19690153|NCT05021731|Isoniazid|isoniazid|mesh-list
19846122|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19846123|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
19846124|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
20400789|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20400790|NCT01133223|Plasminogen|plasminogen|mesh-list
19846125|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
19846126|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
19846127|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369391|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369392|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19369393|NCT04614168|Protective Agents|protective agents|mesh-ancestor
19369394|NCT04559139|Gemcitabine|gemcitabine|mesh-list
19369395|NCT04559139|Cisplatin|cisplatin|mesh-list
19369396|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690154|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19690155|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
19690156|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19690157|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690158|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
19369397|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19369398|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
19369399|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369400|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
19369401|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369402|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369403|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369404|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
19369405|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369406|NCT04553419|Cephalexin|cephalexin|mesh-list
19369407|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19369408|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369409|NCT04528108|Hemostatics|hemostatics|mesh-list
19369410|NCT04528108|Coagulants|coagulants|mesh-ancestor
19369411|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
19690159|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19690160|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690161|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369412|NCT04527549|Trametinib|trametinib|mesh-list
19369413|NCT04527549|Dabrafenib|dabrafenib|mesh-list
19369414|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19369415|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
19369416|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19369417|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19369418|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369419|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369420|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369421|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19369422|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369423|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19369424|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19369425|NCT04527549|Protective Agents|protective agents|mesh-ancestor
19369426|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369427|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20400791|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20400792|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20400793|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20400794|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369428|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
19369429|NCT04521114|Leronlimab|leronlimab|mesh-list
19369430|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19369431|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19690162|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20210956|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210957|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20210958|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20210959|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20210960|NCT00287066|Insulin|insulin|mesh-list
20210961|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20210962|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20210963|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210964|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
19369432|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369433|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19693042|NCT04983940|Androgens|androgens|mesh-ancestor
19848261|NCT00691704|Antipyretics|antipyretics|mesh-ancestor
20400795|NCT01133301|Naltrexone|naltrexone|mesh-list
20400796|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20400797|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20400798|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400799|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
20400800|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400801|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
19846128|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846129|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
19846130|NCT00675922|Mafenide|mafenide|mesh-list
19846131|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20400802|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20400803|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20400804|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20400805|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400806|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400807|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400808|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400809|NCT01133366|Warfarin|warfarin|mesh-list
20400810|NCT01133366|Mipomersen|mipomersen|mesh-list
20400811|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
20400812|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20400813|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20400814|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
20400815|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400816|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19369434|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19369435|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
20400817|NCT01133431|Glimepiride|glimepiride|mesh-list
20400818|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20400819|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20400820|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400821|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400822|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
20400823|NCT01133444|Finasteride|finasteride|mesh-list
20400824|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20400825|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20400826|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400827|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400828|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
20400829|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400830|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400831|NCT01133444|Urological Agents|urological agents|mesh-ancestor
20400832|NCT01133457|Finasteride|finasteride|mesh-list
20400833|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20400834|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20400835|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400836|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400837|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
20400838|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369436|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369437|NCT04504942|Leronlimab|leronlimab|mesh-list
19369438|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19369439|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19369440|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400839|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400840|NCT01133457|Urological Agents|urological agents|mesh-ancestor
20400841|NCT01133470|Fexofenadine|fexofenadine|mesh-list
20400842|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
20400843|NCT01133470|Ephedrine|ephedrine|mesh-list
20400844|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400845|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
20400846|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400847|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400848|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19369441|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19369442|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19369443|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
19369444|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369445|NCT04485039|Sevelamer|sevelamer|mesh-list
19369446|NCT04485039|Calcium acetate|calcium acetate|mesh-list
20400849|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400850|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
20400851|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19369447|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
20400852|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400853|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
20400854|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400855|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400856|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400857|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20400858|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20400859|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20400860|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
20400861|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
20400862|NCT01133483|Fexofenadine|fexofenadine|mesh-list
20400863|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
19846132|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369448|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
19369449|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369450|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
19369451|NCT04477837|Apixaban|apixaban|mesh-list
19369452|NCT04477837|Edoxaban|edoxaban|mesh-list
19369453|NCT04477837|Dabigatran|dabigatran|mesh-list
19369454|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19369455|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
19369456|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19369457|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
19369458|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369459|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369460|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
19369461|NCT04473807|Sotalol|sotalol|mesh-list
19369462|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20400864|NCT01133483|Ephedrine|ephedrine|mesh-list
20400865|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20400866|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
19369463|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19369464|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
19369465|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369466|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369467|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369468|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19369469|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
19369470|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
19369471|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369472|NCT04452344|Analgesics|analgesics|mesh-list
19369473|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369474|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
19369475|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369476|NCT04436744|Palbociclib|palbociclib|mesh-list
19369477|NCT04436744|Anastrozole|anastrozole|mesh-list
20400867|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400868|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400869|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20400870|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400871|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
19369478|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369479|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19369480|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369481|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369482|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19369483|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19369484|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19369485|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20400872|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20400873|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20400874|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
20400875|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400876|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400877|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400878|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20400879|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20400880|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20400881|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
20400882|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
20400883|NCT01133496|Alendronate|alendronate|mesh-list
19369486|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
19402304|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
20400884|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20400885|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400886|NCT01133509|Vaccines|vaccines|mesh-list
19369487|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369488|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369489|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
19369490|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19369491|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369492|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
19369493|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19369494|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
19369495|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
19369496|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369497|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369498|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369499|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19369500|NCT04406649|Analgesics|analgesics|mesh-ancestor
20210965|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210966|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20210967|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20210968|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210969|NCT00287157|Tizanidine|tizanidine|mesh-list
20210970|NCT00287157|Analgesics|analgesics|mesh-ancestor
20210971|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
20210972|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210973|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846133|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19846134|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19846135|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846136|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846137|NCT00675948|Nabiximols|nabiximols|mesh-list
19846138|NCT00675948|Analgesics|analgesics|mesh-ancestor
19369501|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
19369502|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369503|NCT04388475|Temozolomide|temozolomide|mesh-list
19369504|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19369505|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
19369506|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369507|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369508|NCT04347239|Leronlimab|leronlimab|mesh-list
19369509|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19369510|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19369511|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846139|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
19846140|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846141|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846142|NCT00675987|Losartan|losartan|mesh-list
19846143|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19846144|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19846145|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19846146|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19846147|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846148|NCT00676091|Vaccines|vaccines|mesh-list
19846149|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19846150|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
19846151|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846152|NCT00676130|Trimethoprim|trimethoprim|mesh-list
19848262|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
20210974|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
20210975|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20210976|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20210977|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
20210978|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
20210979|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20210980|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20210981|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20210982|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
20210983|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20210984|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210985|NCT00287170|Calcitriol|calcitriol|mesh-list
20210986|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
20210987|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20210988|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20210989|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20400887|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
19369512|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19369513|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20400888|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400889|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
20400890|NCT01133548|Testosterone|testosterone|mesh-list
20400891|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
20400892|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
20400893|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20400894|NCT01133548|Androgens|androgens|mesh-ancestor
20400895|NCT01133548|Hormones|hormones|mesh-ancestor
20400896|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400897|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400898|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19369514|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
19369515|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369516|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19369517|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369518|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369519|NCT04285086|Anagrelide|anagrelide|mesh-list
19369520|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19369521|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19369522|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369523|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19369524|NCT04249167|Paclitaxel|paclitaxel|mesh-list
19369525|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19369526|NCT04249167|Atezolizumab|atezolizumab|mesh-list
19369527|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19369528|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19369529|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369530|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369531|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369532|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369533|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369534|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
19369535|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369536|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
19369537|NCT04245423|Narcotics|narcotics|mesh-ancestor
19369538|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369539|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369540|NCT04245423|Analgesics|analgesics|mesh-ancestor
19369541|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
19369542|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20210990|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20210991|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20210992|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19369543|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
19369544|NCT04230265|Fludarabine|fludarabine|mesh-list
19369545|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369546|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
19369547|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369548|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19369549|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19369550|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
19369551|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369552|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369553|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20210993|NCT00287170|Vitamins|vitamins|mesh-ancestor
20210994|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
20210995|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20210996|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
20210997|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20210998|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20210999|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211000|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
20211001|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20211002|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211003|NCT00287209|Amiodarone|amiodarone|mesh-list
20211004|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20211005|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
20211006|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20211007|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20211008|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211009|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20400899|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400900|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
20400901|NCT01133600|Vancomycin|vancomycin|mesh-list
20400902|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400903|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400904|NCT01133743|Thalidomide|thalidomide|mesh-list
20400905|NCT01133743|Dexamethasone|dexamethasone|mesh-list
20400906|NCT01133743|Lenalidomide|lenalidomide|mesh-list
20400907|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20400908|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
20400909|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
20400910|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400911|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400912|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400913|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
20400914|NCT01133743|Hormones|hormones|mesh-ancestor
20400915|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20400916|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20400917|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400918|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
20400919|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19369554|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
19369555|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19369556|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
19369557|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19369558|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
19369559|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369560|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369561|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
20400920|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20400921|NCT01133743|Growth Substances|growth substances|mesh-ancestor
20400922|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
20400923|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400924|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
20400925|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19369562|NCT04198363|Amoxicillin|amoxicillin|mesh-list
19369563|NCT04198363|Clarithromycin|clarithromycin|mesh-list
19369564|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
19369565|NCT04198363|Esomeprazole|esomeprazole|mesh-list
19369566|NCT04198363|Bismuth|bismuth|mesh-list
19369567|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369568|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19369569|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369570|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19369571|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19369572|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19369573|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369574|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19369575|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19369576|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19369577|NCT04198363|Antacids|antacids|mesh-ancestor
19369578|NCT04198363|Diuretics|diuretics|mesh-ancestor
20400926|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400927|NCT01133795|Midodrine|midodrine|mesh-list
19369579|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
19369580|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369581|NCT04198363|Expectorants|expectorants|mesh-ancestor
19369582|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
19402305|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402306|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402307|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19402308|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
19402309|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402310|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
19402311|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
19402312|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
19402313|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402314|NCT03609996|Ranibizumab|ranibizumab|mesh-list
19402315|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846153|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19846154|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
20400928|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
20400929|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
20400930|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400931|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402316|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19402317|NCT03609996|Growth Substances|growth substances|mesh-ancestor
20400932|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19369583|NCT05366933|Folic Acid|folic acid|mesh-list
19369584|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
19369585|NCT05366933|Vitamins|vitamins|mesh-ancestor
19369586|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
19369587|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369588|NCT05366933|Hematinics|hematinics|mesh-ancestor
19369589|NCT05366868|Metformin|metformin|mesh-list
19369590|NCT05366868|Vildagliptin|vildagliptin|mesh-list
19369591|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19369592|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369593|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19369594|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
19369595|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369596|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369597|NCT05366816|Sunitinib|sunitinib|mesh-list
19369598|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369599|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19369600|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19369601|NCT05366816|Growth Substances|growth substances|mesh-ancestor
20400933|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20400934|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20400935|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20400936|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
20400937|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400938|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400939|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
20400940|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
20400941|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20400942|NCT01133873|Narcotics|narcotics|mesh-ancestor
20400943|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20400944|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400945|NCT01133873|Analgesics|analgesics|mesh-ancestor
20400946|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
20400947|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20400948|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
20400949|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
20400950|NCT01133886|Decitabine|decitabine|mesh-list
20400951|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400952|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
20400953|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400954|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400955|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400956|NCT01133912|Gemcitabine|gemcitabine|mesh-list
20400957|NCT01133912|Paclitaxel|paclitaxel|mesh-list
19369602|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369603|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
19369604|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19369605|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369606|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369607|NCT05366725|Avelumab|avelumab|mesh-list
19369608|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369609|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369610|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
19369611|NCT05366595|Astringents|astringents|mesh-ancestor
19369612|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369613|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
19846155|NCT00676130|Cephalexin|cephalexin|mesh-list
19846156|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19846157|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846158|NCT00676130|Renal Agents|renal agents|mesh-ancestor
19846159|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
19846160|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19846161|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19846162|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19369622|NCT05366101|Valsartan|valsartan|mesh-list
19369623|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19369624|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19369625|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19369626|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400958|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20400959|NCT01133912|Lapatinib|lapatinib|mesh-list
19369627|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
19369628|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
19369629|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846163|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20400960|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19369630|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
19369631|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369632|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369633|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
19369634|NCT05365893|Losartan|losartan|mesh-list
20400961|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400962|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
20400963|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
20400964|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
20400965|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400966|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20400967|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
20400968|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
20400969|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400970|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369635|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
19369636|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19369637|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19369638|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19369639|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369640|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369641|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19369642|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19369643|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19369644|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19369645|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19369646|NCT05365555|Anesthetics|anesthetics|mesh-list
19369647|NCT05365555|Ropivacaine|ropivacaine|mesh-list
19369648|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
19369649|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369650|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369651|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
19369652|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369653|NCT05365464|Progesterone|progesterone|mesh-list
19369654|NCT05365464|Progestins|progestins|mesh-ancestor
20400971|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400972|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
20400973|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400974|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20400975|NCT01133925|Sirolimus|sirolimus|mesh-list
20400976|NCT01133925|Paclitaxel|paclitaxel|mesh-list
20400977|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20400978|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20400979|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
20400980|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
20400981|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
20400982|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400983|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20400984|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20400985|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20400986|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
20400987|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20400988|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
20400989|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369655|NCT05365464|Hormones|hormones|mesh-ancestor
19369656|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369657|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369658|NCT05365451|Metformin|metformin|mesh-list
19369659|NCT05365451|Probenecid|probenecid|mesh-list
19369660|NCT05365451|Furosemide|furosemide|mesh-list
19369661|NCT05365451|Cimetidine|cimetidine|mesh-list
19369662|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19369663|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369664|NCT05365451|Diuretics|diuretics|mesh-ancestor
19369665|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
19369666|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19369667|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19369668|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369669|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
19369670|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
19369671|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19690163|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20613116|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
19690164|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19369672|NCT05365451|Renal Agents|renal agents|mesh-ancestor
19369673|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20400990|NCT01134185|Prucalopride|prucalopride|mesh-list
20400991|NCT01134185|Laxatives|laxatives|mesh-ancestor
19369674|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19369675|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19369676|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
19369677|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
19369678|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369679|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19369680|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19369681|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369682|NCT05365438|Atorvastatin|atorvastatin|mesh-list
19369683|NCT05365438|Ezetimibe|ezetimibe|mesh-list
19369684|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19369685|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19369686|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
19369687|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369688|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19369689|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19369690|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369691|NCT05365425|Choline|choline|mesh-list
19369692|NCT05365425|Policosanol|policosanol|mesh-list
19369693|NCT05365425|Fenofibrate|fenofibrate|mesh-list
19369694|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19369695|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
19369696|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369697|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19369698|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
19369699|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19369700|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
20400992|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20400993|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20400994|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20400995|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
20400996|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20400997|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20400998|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20400999|NCT01134224|Insulin|insulin|mesh-list
20401000|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20401001|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
20401002|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
20401003|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20401004|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
20401005|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20401006|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
20401007|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401008|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401009|NCT01134289|Bupivacaine|bupivacaine|mesh-list
20401010|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
20401011|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
19690165|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19690166|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19690167|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20401012|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
20211010|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20211011|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20211012|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211013|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20211014|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20211015|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20211016|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
20211017|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20211018|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211019|NCT00287300|Azithromycin|azithromycin|mesh-list
20211020|NCT00287300|Artesunate|artesunate|mesh-list
20211021|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
20211022|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
20211023|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20211024|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401013|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613117|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690168|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19690169|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19690170|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
19369701|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20401014|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401015|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
20401016|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401017|NCT01134341|Vitamins|vitamins|mesh-list
20401018|NCT01134341|Folic Acid|folic acid|mesh-list
20401019|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
20401020|NCT01134341|Hydroxocobalamin|hydroxocobalamin|mesh-list
20401021|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
20401022|NCT01134341|Bexarotene|bexarotene|mesh-list
20401023|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
20401024|NCT01134341|Aminopterin|aminopterin|mesh-list
20401025|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
20401026|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401027|NCT01134341|Hematinics|hematinics|mesh-ancestor
20401028|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401029|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20401030|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401031|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401032|NCT01134406|Hylan|hylan|mesh-list
20401033|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
20401034|NCT01134406|Protective Agents|protective agents|mesh-ancestor
20401035|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401036|NCT01134432|Prednisolone|prednisolone|mesh-list
20401037|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19369702|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19402318|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402319|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
19402320|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402321|NCT03609970|Vitamin D|vitamin d|mesh-list
19402322|NCT03609970|Vitamins|vitamins|mesh-ancestor
19402323|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
19402324|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402325|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19402326|NCT03609892|Amoxicillin|amoxicillin|mesh-list
19402327|NCT03609892|Tetracycline|tetracycline|mesh-list
19402328|NCT03609892|Furazolidone|furazolidone|mesh-list
20401038|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
20401039|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20401040|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
20401041|NCT01134432|Rituximab|rituximab|mesh-list
20401042|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20401043|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
20401044|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401045|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401046|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
19402329|NCT03609892|Esomeprazole|esomeprazole|mesh-list
19402330|NCT03609892|Bismuth|bismuth|mesh-list
19402331|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402332|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402333|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19402334|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402335|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19402336|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402337|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402338|NCT03609892|Antacids|antacids|mesh-ancestor
19402339|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19402340|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19402341|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20401047|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401048|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20401049|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401050|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
20401051|NCT01134432|Hormones|hormones|mesh-ancestor
20401052|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401053|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20401054|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
20401055|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
20401056|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401057|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401058|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20401059|NCT01134432|Protective Agents|protective agents|mesh-ancestor
20401060|NCT01134484|Thalidomide|thalidomide|mesh-list
20401061|NCT01134484|Dexamethasone|dexamethasone|mesh-list
19402342|NCT03609892|Renal Agents|renal agents|mesh-ancestor
19402343|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20401062|NCT01134484|Bortezomib|bortezomib|mesh-list
20401063|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401064|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
20401065|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
20401066|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369703|NCT05365178|Fulvestrant|fulvestrant|mesh-list
20401067|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401068|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401069|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
20401070|NCT01134484|Hormones|hormones|mesh-ancestor
20401071|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401072|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20401073|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401074|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20401075|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
19369704|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19369705|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369706|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19369707|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19369708|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
19369709|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369710|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369711|NCT05365165|Sevoflurane|sevoflurane|mesh-list
19369712|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19369713|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19369714|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
19369715|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
19369716|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369717|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369718|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
19846164|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846165|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19846166|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19846167|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19846168|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19846169|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
19846170|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19846171|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
19369719|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
19369720|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
19369721|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369722|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369723|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
19369724|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369725|NCT05359224|Clopidogrel|clopidogrel|mesh-list
19369726|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19369727|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19369728|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19369729|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19369730|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19369731|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
19369732|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369733|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369734|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369735|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
19369736|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
19369737|NCT05352178|Androgens|androgens|mesh-list
19369738|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19369739|NCT05352178|Hormones|hormones|mesh-ancestor
19690171|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19690172|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19690173|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19690174|NCT05021094|Estradiol|estradiol|mesh-list
19690175|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19690176|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
19690177|NCT05021094|Estrogens|estrogens|mesh-ancestor
19690178|NCT05021094|Hormones|hormones|mesh-ancestor
19690179|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846172|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211025|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211026|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
20211027|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20211028|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20211029|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211030|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
20211031|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
20211032|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19690180|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211033|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
19369740|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369741|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369742|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
19369743|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401076|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
20401077|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401078|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401079|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20401080|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20401081|NCT01134484|Growth Substances|growth substances|mesh-ancestor
20401082|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
19369744|NCT05352178|Protective Agents|protective agents|mesh-ancestor
19369745|NCT05352178|Vitamins|vitamins|mesh-ancestor
19369746|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
19369747|NCT05352178|Estrogens|estrogens|mesh-ancestor
19369748|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19369749|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369750|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
19369751|NCT05347316|Colchicine|colchicine|mesh-list
19369752|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
19369753|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19369754|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369755|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369756|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369757|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369758|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369759|NCT05335018|Lenalidomide|lenalidomide|mesh-list
19369760|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
19369761|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369762|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19369763|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19369764|NCT05335018|Growth Substances|growth substances|mesh-ancestor
19369765|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
19369766|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369767|NCT05324423|Colchicine|colchicine|mesh-list
19369768|NCT05324423|Febuxostat|febuxostat|mesh-list
19369769|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
19369770|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19369771|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
19369772|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369773|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
19369774|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369775|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369776|NCT05322707|Budesonide|budesonide|mesh-list
19369777|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
19369778|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19369779|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19369780|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19369781|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
19369782|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401083|NCT01134523|Paclitaxel|paclitaxel|mesh-list
20401084|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20401085|NCT01134523|Epirubicin|epirubicin|mesh-list
20401086|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20401087|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369783|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369784|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19369785|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
19369786|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
19369787|NCT05322707|Hormones|hormones|mesh-ancestor
19369788|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369789|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19369790|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19369791|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19369792|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
19369793|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369794|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369795|NCT05310643|Nivolumab|nivolumab|mesh-list
19369796|NCT05310643|Ipilimumab|ipilimumab|mesh-list
19369797|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369798|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369799|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20401088|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
20401089|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
19369800|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846173|NCT00676195|Expectorants|expectorants|mesh-ancestor
19846174|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
19846175|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19846176|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
19846177|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846178|NCT00676195|Protective Agents|protective agents|mesh-ancestor
19846179|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369801|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
19369802|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19369803|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20401090|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
20401091|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401092|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20401093|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20401094|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20401095|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401096|NCT01134536|Tapentadol|tapentadol|mesh-list
20401097|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20401098|NCT01134536|Narcotics|narcotics|mesh-ancestor
20401099|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20401100|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401101|NCT01134536|Analgesics|analgesics|mesh-ancestor
20401102|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
20401103|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401104|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20401105|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19369804|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369805|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19369806|NCT05305248|Analgesics|analgesics|mesh-ancestor
19369807|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
20211034|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20401106|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20401107|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401108|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
20401109|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401110|NCT01134666|Cetuximab|cetuximab|mesh-list
20401111|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401112|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401113|NCT01134692|Norfloxacin|norfloxacin|mesh-list
20401114|NCT01134692|Propranolol|propranolol|mesh-list
20401115|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20401116|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20401117|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
20401118|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401119|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401120|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401121|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20401122|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20401123|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
20401124|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401125|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401126|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20401127|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20401128|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401129|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401130|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20401131|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20401132|NCT01134718|Simeprevir|simeprevir|mesh-list
20401133|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
20401134|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401135|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
20401136|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401137|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401138|NCT01134848|Morphine|morphine|mesh-list
19369808|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211035|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211036|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211037|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20211038|NCT00287300|Renal Agents|renal agents|mesh-ancestor
20211039|NCT00287313|Vitamin K|vitamin k|mesh-list
20211040|NCT00287313|Vitamins|vitamins|mesh-ancestor
20211041|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
20211042|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211043|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20401139|NCT01134848|Secretin|secretin|mesh-list
20401140|NCT01134848|Neostigmine|neostigmine|mesh-list
20401141|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20401142|NCT01134848|Narcotics|narcotics|mesh-ancestor
20401143|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369809|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19369810|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19369811|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19369812|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
19369813|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369814|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369815|NCT05280769|Lobeline|lobeline|mesh-list
19369816|NCT05280769|Nicotine|nicotine|mesh-list
19369817|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19369818|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
19369819|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369820|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369821|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19369822|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19369823|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
19369824|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369825|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369826|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
19369827|NCT05262855|FAPI-46|fapi-46|mesh-list
19369828|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19369829|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369830|NCT05262777|Lidocaine|lidocaine|mesh-list
19369831|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
19369832|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
19369833|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369834|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369835|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
19369836|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369837|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19369838|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19369839|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19690181|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20401144|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401145|NCT01134848|Analgesics|analgesics|mesh-ancestor
20401146|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
20401147|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401148|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20401149|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690182|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
19690183|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19690184|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20401150|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401151|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
20401152|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401153|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20401154|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
20401155|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401156|NCT01134848|Hormones|hormones|mesh-ancestor
20401157|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401158|NCT01134861|Cisplatin|cisplatin|mesh-list
20401159|NCT01134861|Etoposide|etoposide|mesh-list
19369840|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19690185|NCT05021094|Progestins|progestins|mesh-ancestor
19690186|NCT05021263|GABA Agonists|gaba agonists|mesh-list
19690187|NCT05021263|GABA Agents|gaba agents|mesh-ancestor
19369841|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369842|NCT05261321|Dronabinol|dronabinol|mesh-list
19369843|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
19369844|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369845|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19369846|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19369847|NCT05261321|Analgesics|analgesics|mesh-ancestor
19369848|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
19369849|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369850|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19369851|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19369852|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402344|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19690188|NCT05021263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401160|NCT01134861|Vinblastine|vinblastine|mesh-list
20401161|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401162|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20401163|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20401164|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20401165|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401166|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401167|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
20401168|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
20401169|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
20401170|NCT01134926|Misoprostol|misoprostol|mesh-list
20401171|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20401172|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
20401173|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20401174|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401175|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20401176|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401177|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
20401178|NCT01134965|Digoxin|digoxin|mesh-list
20401179|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20401180|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20401181|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401182|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401183|NCT01134965|Protective Agents|protective agents|mesh-ancestor
19369853|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369854|NCT05261321|Hormones|hormones|mesh-ancestor
19369855|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369856|NCT05251948|Capecitabine|capecitabine|mesh-list
19369857|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
19369858|NCT05251948|Atezolizumab|atezolizumab|mesh-list
19369859|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19369860|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
19369861|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369862|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369863|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
19369864|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19369865|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369866|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19369867|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369868|NCT05224050|Nicotine|nicotine|mesh-list
19369869|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19369870|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
19369871|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369872|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369873|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19369874|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19369875|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
19369876|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369877|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402345|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19402346|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19402347|NCT03609827|Melphalan|melphalan|mesh-list
19402348|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19402349|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
19402350|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402351|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402352|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19402353|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846180|NCT00676195|Antidotes|antidotes|mesh-ancestor
19846181|NCT00676338|Metformin|metformin|mesh-list
19846182|NCT00676338|Pioglitazone|pioglitazone|mesh-list
19846183|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19846184|NCT00676338|Exenatide|exenatide|mesh-list
19846185|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846186|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846187|NCT00676338|Incretins|incretins|mesh-ancestor
19846188|NCT00676338|Hormones|hormones|mesh-ancestor
19846189|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846190|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19846191|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
19846192|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846193|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846194|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19846195|NCT00676364|Lidocaine|lidocaine|mesh-list
19846196|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
19369878|NCT05200143|Nivolumab|nivolumab|mesh-list
19369879|NCT05200143|Ipilimumab|ipilimumab|mesh-list
19369880|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369881|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369882|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19369883|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369884|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
20211044|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20211045|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401184|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401185|NCT01134991|Minocycline|minocycline|mesh-list
20401186|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401187|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401188|NCT01135056|Sorafenib|sorafenib|mesh-list
19369885|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369886|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369887|NCT05179421|Oxytocin|oxytocin|mesh-list
19369888|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
19369889|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19369890|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369891|NCT05160090|Bupropion|bupropion|mesh-list
19369892|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19369893|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
19369894|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19369895|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19369896|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19369897|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19369898|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369899|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
19369900|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369901|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369902|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19369903|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19690189|NCT05021263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690190|NCT05021263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690191|NCT05021276|Basiliximab|basiliximab|mesh-list
19369904|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369905|NCT05157841|Bupivacaine|bupivacaine|mesh-list
19369906|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
19369907|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
19690192|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19369908|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369909|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369910|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
19369911|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369912|NCT05154994|Durvalumab|durvalumab|mesh-list
19369913|NCT05154994|Ipilimumab|ipilimumab|mesh-list
19369914|NCT05154994|Tremelimumab|tremelimumab|mesh-list
19369915|NCT05154994|Belinostat|belinostat|mesh-list
19369916|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
19369917|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19369918|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
19369919|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369920|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369921|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
19369922|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369923|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19369924|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369925|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19369926|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19369927|NCT05148546|Nivolumab|nivolumab|mesh-list
19369928|NCT05148546|Ipilimumab|ipilimumab|mesh-list
19690193|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
20211046|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
20211047|NCT00287313|Coagulants|coagulants|mesh-ancestor
20211048|NCT00287326|Clonidine|clonidine|mesh-list
20211049|NCT00287326|Morphine|morphine|mesh-list
20211050|NCT00287326|Bupivacaine|bupivacaine|mesh-list
20211051|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
20211052|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
20211053|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211054|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211055|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
20211056|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211057|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20211058|NCT00287326|Narcotics|narcotics|mesh-ancestor
19369929|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369930|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401189|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401190|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401191|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401192|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401193|NCT01135199|Pomalidomide|pomalidomide|mesh-list
20401194|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
20401195|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401196|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20401197|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20401198|NCT01135199|Growth Substances|growth substances|mesh-ancestor
20401199|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
20401200|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401201|NCT01135212|Candesartan|candesartan|mesh-list
20401202|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
20401203|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20401204|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19369931|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19369932|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369933|NCT05147662|Factor VIII|factor viii|mesh-list
19369934|NCT05147662|Coagulants|coagulants|mesh-ancestor
19369935|NCT05143762|Acetaminophen|acetaminophen|mesh-list
19369936|NCT05143762|Dexamethasone|dexamethasone|mesh-list
19369937|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401205|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20401206|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401207|NCT01135290|Petrolatum|petrolatum|mesh-list
20401208|NCT01135290|Emollients|emollients|mesh-ancestor
20401209|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
20401210|NCT01135433|Metformin|metformin|mesh-list
20401211|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
20401212|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401213|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401214|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20401215|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401216|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
20401217|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20401218|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401219|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401220|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401221|NCT01135472|Esomeprazole|esomeprazole|mesh-list
20401222|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20401223|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401224|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20401225|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401226|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401227|NCT01135550|Dexamethasone|dexamethasone|mesh-list
19369938|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
19369939|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
19369940|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369941|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369942|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401228|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
20401229|NCT01135550|BB 1101|bb 1101|mesh-list
20401230|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401231|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
20401232|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
20401233|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401234|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401235|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401236|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
20401237|NCT01135550|Hormones|hormones|mesh-ancestor
20401238|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401239|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20401240|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369943|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
19369944|NCT05143762|Hormones|hormones|mesh-ancestor
19369945|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401241|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
20401242|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401243|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401244|NCT01135563|Sirolimus|sirolimus|mesh-list
20613118|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20401245|NCT01135563|Vinblastine|vinblastine|mesh-list
20401246|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401247|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401248|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20401249|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401250|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
20401251|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20401252|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
20401253|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401254|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20401255|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
20401256|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
20401257|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
20401258|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401259|NCT01135589|Micafungin|micafungin|mesh-list
19369946|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19369947|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369948|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19369949|NCT05143762|Analgesics|analgesics|mesh-ancestor
19369950|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
19369951|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
19369952|NCT05139030|Bupivacaine|bupivacaine|mesh-list
19369953|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
19369954|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
19369955|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19369956|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369957|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
19369958|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369959|NCT05133531|Ravulizumab|ravulizumab|mesh-list
20401260|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
20401261|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401262|NCT01135602|Topiramate|topiramate|mesh-list
20401263|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
20401264|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401265|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401266|NCT01135615|Calcium|calcium|mesh-list
20401267|NCT01135615|Sevelamer|sevelamer|mesh-list
20401268|NCT01135615|Calcium acetate|calcium acetate|mesh-list
20401269|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20401270|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401271|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
20401272|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
20401273|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401274|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
20401275|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20401276|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401277|NCT01135641|Cyclosporine|cyclosporine|mesh-list
20401278|NCT01135641|Rituximab|rituximab|mesh-list
20401279|NCT01135641|Cyclosporins|cyclosporins|mesh-list
20401280|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401281|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401282|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
20401283|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401284|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20401285|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401286|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401287|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20401288|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
20401289|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401290|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
20401291|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20401292|NCT01135667|Clopidogrel|clopidogrel|mesh-list
20401293|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20401294|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20401295|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20401296|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20401297|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20401298|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
20401299|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369960|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19369961|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690194|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690195|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
19690196|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401300|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401301|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690197|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
19690198|NCT05021315|Povidone|povidone|mesh-list
19690199|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
19690200|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
19690201|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19690202|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690203|NCT05020964|Trastuzumab|trastuzumab|mesh-list
19690204|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19690205|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690206|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
19690207|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19369962|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
19369963|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369964|NCT05132699|Cannabidiol|cannabidiol|mesh-list
19690208|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690209|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690210|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19690211|NCT05020821|Analgesics|analgesics|mesh-ancestor
19690212|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
19690213|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369965|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19369966|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
19369967|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
19369968|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369969|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369970|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
19369971|NCT05114590|Lixisenatide|lixisenatide|mesh-list
19369972|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19369973|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369974|NCT05114486|Pilocarpine|pilocarpine|mesh-list
19369975|NCT05114486|Miotics|miotics|mesh-ancestor
19369976|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
19369977|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19369978|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369979|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19369980|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19369981|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
19369982|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19369983|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19369984|NCT05103228|Menotropins|menotropins|mesh-list
19369985|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19369986|NCT05103228|Hormones|hormones|mesh-ancestor
19369987|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19369988|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19369989|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19369990|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
19369991|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19369992|NCT05098210|Poly I-C|poly i-c|mesh-list
19369993|NCT05098210|Nivolumab|nivolumab|mesh-list
19369994|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19369995|NCT05098210|Poly ICLC|poly iclc|mesh-list
19369996|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19369997|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19369998|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19369999|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370000|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
19370001|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
19370002|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370003|NCT05098210|Laxatives|laxatives|mesh-ancestor
19370004|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370005|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
19370006|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690214|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19690215|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19690216|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20401302|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
20401303|NCT01135680|Glycerol|glycerol|mesh-list
20401304|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401305|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401306|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20401307|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20401308|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401309|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690217|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
19370007|NCT05087212|Plerixafor|plerixafor|mesh-list
20401310|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370008|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19370009|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19370010|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
19370011|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401311|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401312|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20401313|NCT01135680|Protective Agents|protective agents|mesh-ancestor
20401314|NCT01135758|Ketamine|ketamine|mesh-list
20401315|NCT01135758|Analgesics|analgesics|mesh-ancestor
20401316|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
20401317|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401318|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401319|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20401320|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20401321|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
20401322|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
20401323|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20401324|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20401325|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19370012|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
19370013|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19370014|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
19370015|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370016|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
19370017|NCT05082480|Protective Agents|protective agents|mesh-ancestor
20211059|NCT00287326|Analgesics|analgesics|mesh-ancestor
20211060|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211061|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
20211062|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
20211063|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20211064|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20211065|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19690218|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690219|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690220|NCT05020704|Empagliflozin|empagliflozin|mesh-list
19690221|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19690222|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690223|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19690224|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690225|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
19690226|NCT05020483|Coagulants|coagulants|mesh-ancestor
19690227|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19690228|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19690229|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19690230|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19690231|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690232|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690233|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690234|NCT05020600|Analgesics|analgesics|mesh-ancestor
19690235|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
19690236|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690237|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
19690238|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690239|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
19693043|NCT04983849|Metronidazole|metronidazole|mesh-list
19693044|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846197|NCT00676364|Anesthetics|anesthetics|mesh-list
20401326|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401327|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211066|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
20211067|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211068|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211069|NCT00287352|Amantadine|amantadine|mesh-list
20211070|NCT00287352|Olanzapine|olanzapine|mesh-list
20211071|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
20211072|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
20211073|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211074|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370034|NCT05061550|Durvalumab|durvalumab|mesh-list
19370035|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846198|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370036|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211075|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401328|NCT01135771|Insulin|insulin|mesh-list
20401329|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401330|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401331|NCT01135927|Insulin|insulin|mesh-list
20401332|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20401333|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
20401334|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401335|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401336|NCT01135953|Cycloserine|cycloserine|mesh-list
20401337|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20401338|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401339|NCT01135953|Renal Agents|renal agents|mesh-ancestor
20401340|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20401341|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
20401342|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401343|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
20401344|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426991|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20426992|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20426993|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20426994|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20426995|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20426996|NCT01284166|Timolol|timolol|mesh-list
20426997|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20426998|NCT01284166|Dorzolamide|dorzolamide|mesh-list
20426999|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20427000|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20427001|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20427002|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20427003|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
20427004|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427005|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427006|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427007|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20427008|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19370049|NCT05047640|Vaccines|vaccines|mesh-list
19370050|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
19370051|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370052|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19370053|NCT05041127|Cetuximab|cetuximab|mesh-list
19370054|NCT05041127|Antibodies|antibodies|mesh-list
19370055|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
19370056|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19370057|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
19370058|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370059|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427009|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20427010|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20427011|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20427012|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20427013|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370060|NCT05021991|Pramoxine|pramoxine|mesh-list
19370061|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
19370062|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
19370063|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370064|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370065|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
19370066|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846199|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846200|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
19846201|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427014|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
19846202|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20427015|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19846203|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19846204|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20401345|NCT01136005|Provitamins|provitamins|mesh-list
19846205|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19846206|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846207|NCT00676403|Pregabalin|pregabalin|mesh-list
19846208|NCT00676403|Analgesics|analgesics|mesh-ancestor
19846209|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
19846210|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846211|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846212|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
19846213|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19846214|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19846215|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846216|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19846217|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19846218|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19846219|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846220|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19846221|NCT00676520|Everolimus|everolimus|mesh-list
20401346|NCT01136005|Vitamins|vitamins|mesh-ancestor
20401347|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
19370086|NCT05008887|Fluorouracil|fluorouracil|mesh-list
19370087|NCT05008887|Methotrexate|methotrexate|mesh-list
19370088|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
19370089|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370090|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370091|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370092|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370093|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
19370094|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370095|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19370096|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
19370097|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19370098|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
19370099|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370100|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19370101|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370102|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20401348|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401349|NCT01136031|Paclitaxel|paclitaxel|mesh-list
20401350|NCT01136031|Irinotecan|irinotecan|mesh-list
20401351|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20401352|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401353|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20401354|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20401355|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20401356|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401357|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19370103|NCT05007522|Ketotifen|ketotifen|mesh-list
19370104|NCT05007522|Indomethacin|indomethacin|mesh-list
19370105|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19370106|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19370107|NCT05007522|Analgesics|analgesics|mesh-ancestor
19370108|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
19370109|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370110|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370111|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370112|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370113|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
19370114|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
19370115|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19370116|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19370117|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370118|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370119|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
19370120|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
19370121|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19370122|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
19370123|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
19370124|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401358|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19370125|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19370126|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
19370127|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19370128|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402354|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
19402355|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402356|NCT03609814|Fludarabine|fludarabine|mesh-list
19846222|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846223|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690240|NCT05020028|Cannabidiol|cannabidiol|mesh-list
19690241|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
19690242|NCT05020210|Sivelestat|sivelestat|mesh-list
20401359|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401360|NCT01136213|Fluoxetine|fluoxetine|mesh-list
20211076|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19402357|NCT03609814|Clofarabine|clofarabine|mesh-list
20401361|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20401362|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20401363|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402358|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402359|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19402360|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
19402361|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402362|NCT03609775|Ethanol|ethanol|mesh-list
19402363|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19402364|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402365|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402366|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402367|NCT03609593|Rituximab|rituximab|mesh-list
19402368|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19402369|NCT03609593|Venetoclax|venetoclax|mesh-list
19402370|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402371|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402372|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
19402373|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402374|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19402375|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19402376|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
19402377|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402378|NCT03609580|Tamsulosin|tamsulosin|mesh-list
20401364|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401365|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401366|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
20401367|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401368|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20401369|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
20401370|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20401371|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20401372|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20401373|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401374|NCT01136252|Adalimumab|adalimumab|mesh-list
20401375|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401376|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20401377|NCT01136278|Clonidine|clonidine|mesh-list
20401378|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20401379|NCT01136278|Analgesics|analgesics|mesh-ancestor
20401380|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
20401381|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690243|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19690244|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
19690245|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402379|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19402380|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19690246|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690247|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
19690248|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19690249|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211077|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211078|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211079|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20211080|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20211081|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20211082|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20217886|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20427016|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
19402381|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19846224|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
20401382|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370129|NCT04995653|Vancomycin|vancomycin|mesh-list
19370130|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19370131|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370132|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
19370133|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19370134|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19370135|NCT04988425|Prednisolone|prednisolone|mesh-list
19370136|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
19370137|NCT04988425|Antibodies|antibodies|mesh-list
19370138|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19370139|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19370140|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
19370141|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
19370142|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370143|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370144|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
19370145|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
19370146|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401383|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20401384|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
20401385|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
20401386|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20401387|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20401388|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20401389|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
20401390|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401391|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401392|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
20401393|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20401394|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
20401395|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19370147|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370148|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
19370149|NCT04988425|Hormones|hormones|mesh-ancestor
19370150|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370151|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19370152|NCT04988425|Protective Agents|protective agents|mesh-ancestor
19370153|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19370154|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370155|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
19370156|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370157|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370158|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
19370159|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19370160|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19370161|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19370162|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19370163|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370164|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
19370165|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19370166|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401396|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20401397|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20401398|NCT01136317|Omeprazole|omeprazole|mesh-list
20401399|NCT01136317|Rabeprazole|rabeprazole|mesh-list
20401400|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20401401|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401402|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20401403|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401404|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401405|NCT01136395|Rituximab|rituximab|mesh-list
20401406|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401407|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401408|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
20401409|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370167|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19370168|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370169|NCT04977986|Cannabidiol|cannabidiol|mesh-list
19370170|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
19370171|NCT04969276|Vaccines|vaccines|mesh-list
19370172|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
20401410|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370173|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370174|NCT04959760|Antibodies|antibodies|mesh-list
19370175|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
19370176|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
19370177|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
19370178|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370179|NCT04951492|Olaparib|olaparib|mesh-list
19370180|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19370181|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370182|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370183|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370184|NCT04944771|Rabeprazole|rabeprazole|mesh-list
19370185|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19370186|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370187|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19370188|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370189|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370190|NCT04941287|Atezolizumab|atezolizumab|mesh-list
19370191|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
19370192|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19370193|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
19370194|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370195|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
19370196|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370197|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
19370198|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370199|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
19370200|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
19370201|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
19370202|NCT04933227|Capecitabine|capecitabine|mesh-list
19370203|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
19370204|NCT04933227|Atezolizumab|atezolizumab|mesh-list
19370205|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370206|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
19370207|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370208|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370209|NCT04930887|Bupivacaine|bupivacaine|mesh-list
19370210|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
19370211|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
19370212|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370213|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370214|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
19370215|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846225|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846226|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
20211083|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401411|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
20401412|NCT01136421|Bromides|bromides|mesh-list
20401413|NCT01136421|Ipratropium|ipratropium|mesh-list
20401414|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
20401415|NCT01136421|Analgesics|analgesics|mesh-ancestor
20401416|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
20401417|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401418|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401419|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
20401420|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20401421|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20401422|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20401423|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20401424|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401425|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20401426|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
20401427|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20401428|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20401429|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
20401430|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19846227|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846228|NCT00676650|Prednisone|prednisone|mesh-list
20211084|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211085|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
20211086|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20211087|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20211088|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
20211089|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211090|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
20211091|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20211092|NCT00287352|Analgesics|analgesics|mesh-ancestor
20401431|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
20401432|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19846229|NCT00676650|Sunitinib|sunitinib|mesh-list
20401433|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
20401434|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401435|NCT01136499|Panobinostat|panobinostat|mesh-list
20401436|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401437|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20401438|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401439|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401440|NCT01136525|Valacyclovir|valacyclovir|mesh-list
20401441|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
20401442|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846230|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846231|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
19846232|NCT00676650|Hormones|hormones|mesh-ancestor
19846233|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846234|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211093|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
20401443|NCT01136538|Valacyclovir|valacyclovir|mesh-list
20401444|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
20401445|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401446|NCT01136551|Huperzine A|huperzine a|mesh-list
20401447|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20401448|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401449|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401450|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
20401451|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401452|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401453|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20401454|NCT01136551|Protective Agents|protective agents|mesh-ancestor
20401455|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
20401456|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20401457|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20427017|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211094|NCT00287378|Omalizumab|omalizumab|mesh-list
20211095|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19370229|NCT04891809|Dexamethasone|dexamethasone|mesh-list
19370230|NCT04891809|Lenalidomide|lenalidomide|mesh-list
19370231|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370232|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
19370233|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
19370234|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370235|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370236|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370237|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
19370238|NCT04891809|Hormones|hormones|mesh-ancestor
19370239|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370240|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19370241|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370242|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
19370243|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19370244|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19370245|NCT04891809|Growth Substances|growth substances|mesh-ancestor
19370246|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
19370247|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
19370248|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19370249|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370250|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370251|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19370252|NCT04878510|Analgesics|analgesics|mesh-ancestor
19370253|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
19370254|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370255|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19370256|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19370257|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19370258|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
19370259|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211096|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20211097|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
20211098|NCT00287391|Rabeprazole|rabeprazole|mesh-list
20211099|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20211100|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20211101|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20211102|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211103|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211104|NCT00287430|Hormones|hormones|mesh-list
20211105|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401458|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401459|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
20401460|NCT01136590|Coagulants|coagulants|mesh-ancestor
20401461|NCT01136642|Nicotine|nicotine|mesh-list
20401462|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20401463|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
20401464|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401465|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401466|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19370260|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370261|NCT04876781|Tofacitinib|tofacitinib|mesh-list
19370262|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19370263|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370264|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370265|NCT04872218|Abatacept|abatacept|mesh-list
19370266|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19370267|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370268|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370269|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370270|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
19370271|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370272|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370273|NCT04865289|Paclitaxel|paclitaxel|mesh-list
20211106|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211107|NCT00287443|Hormones|hormones|mesh-list
20211108|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211109|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211110|NCT00287456|Insulin|insulin|mesh-list
20211111|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20211112|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20211113|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690250|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690251|NCT05019794|Infigratinib|infigratinib|mesh-list
20401467|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20401468|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
20401469|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401470|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370274|NCT04865289|Carboplatin|carboplatin|mesh-list
19690252|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690253|NCT05019586|Amoxicillin|amoxicillin|mesh-list
19690254|NCT05019586|Clarithromycin|clarithromycin|mesh-list
19690255|NCT05019586|Levofloxacin|levofloxacin|mesh-list
19690256|NCT05019586|Ofloxacin|ofloxacin|mesh-list
19690257|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19690258|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690259|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19690260|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690261|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211114|NCT00287495|Sorafenib|sorafenib|mesh-list
20211115|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211116|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20211117|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211118|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211119|NCT00287521|Timolol|timolol|mesh-list
20211120|NCT00287521|Latanoprost|latanoprost|mesh-list
20211121|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20211122|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20211123|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
20211124|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211125|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211126|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211127|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20211128|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211129|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20211130|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20211131|NCT00287534|Tamoxifen|tamoxifen|mesh-list
20211132|NCT00287534|Anastrozole|anastrozole|mesh-list
20211133|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20211134|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
20211135|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690262|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20211136|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401471|NCT01136759|Tenofovir|tenofovir|mesh-list
19370275|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
19370276|NCT04865289|Lenvatinib|lenvatinib|mesh-list
19370277|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370278|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370279|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
19370280|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
19370281|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
19370282|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370283|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370284|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19370285|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370286|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19370287|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
19690263|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19690264|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19690265|NCT05019586|Renal Agents|renal agents|mesh-ancestor
19690266|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19690267|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690268|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690269|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19690270|NCT05019690|Paclitaxel|paclitaxel|mesh-list
19690271|NCT05019690|Apatinib|apatinib|mesh-list
19690272|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19690273|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370288|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
19370289|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401472|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
20401473|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401474|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20401475|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20401476|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401477|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401478|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20401479|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20401480|NCT01136850|Azithromycin|azithromycin|mesh-list
20401481|NCT01136850|Chloroquine|chloroquine|mesh-list
20401482|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
20401483|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
20401484|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20401485|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401486|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401487|NCT01136850|Amebicides|amebicides|mesh-ancestor
20401488|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20401489|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19370290|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370291|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20401490|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
20401491|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20401492|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20401493|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401494|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401495|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20401496|NCT01136850|Renal Agents|renal agents|mesh-ancestor
20401497|NCT01136863|Felodipine|felodipine|mesh-list
20401498|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20401499|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20401500|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20401501|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20401502|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401503|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19370292|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19370293|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19370294|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
20401504|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401505|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
20401506|NCT01136941|Zileuton|zileuton|mesh-list
20401507|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19370295|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370296|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19370297|NCT04843111|Vaccines|vaccines|mesh-list
19370298|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
19370299|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370300|NCT04832854|Gemcitabine|gemcitabine|mesh-list
19370301|NCT04832854|Paclitaxel|paclitaxel|mesh-list
19370302|NCT04832854|Carboplatin|carboplatin|mesh-list
19370303|NCT04832854|Pemetrexed|pemetrexed|mesh-list
19370304|NCT04832854|Atezolizumab|atezolizumab|mesh-list
19370305|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370306|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370307|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
19370308|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
19370309|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
19370310|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401508|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20401509|NCT01136941|Analgesics|analgesics|mesh-ancestor
20401510|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
20401511|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401512|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401513|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401514|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20401515|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20401516|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401517|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401518|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20401519|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
20401520|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370311|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370312|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
19370313|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
19370314|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370315|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370316|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370317|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
19370318|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401521|NCT01136967|Lenvatinib|lenvatinib|mesh-list
20401522|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370319|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19370320|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19370321|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
19370322|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19370323|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19370324|NCT04826588|Prednisolone|prednisolone|mesh-list
19370325|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
19370326|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19370327|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
19370328|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
19370329|NCT04826588|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20401523|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401524|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401525|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401526|NCT01137019|Everolimus|everolimus|mesh-list
20401527|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401528|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20401529|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
20401530|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401531|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
20401532|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20401533|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20401534|NCT01137084|Prednisolone|prednisolone|mesh-list
20401535|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
20401536|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20401537|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
19370330|NCT04826588|Antibodies|antibodies|mesh-list
19370331|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370332|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
19370333|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
19370334|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370335|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370336|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370337|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
19370338|NCT04826588|Hormones|hormones|mesh-ancestor
19370339|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370340|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19370341|NCT04826588|Protective Agents|protective agents|mesh-ancestor
19370342|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19370343|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370344|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
20401538|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370345|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
20401539|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
19370346|NCT04820205|Ketamine|ketamine|mesh-list
19370347|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
20401540|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
20401541|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401542|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370348|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19370349|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370350|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370351|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19370352|NCT04820205|Analgesics|analgesics|mesh-ancestor
19370353|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
19370354|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370355|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19370356|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19370357|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19370358|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19370359|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19370360|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370361|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19370362|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19370363|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
19370364|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
19370365|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19370366|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19370367|NCT04809233|Tipifarnib|tipifarnib|mesh-list
19370368|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370369|NCT04796584|Antibodies|antibodies|mesh-list
19370370|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
19370371|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370372|NCT04785638|Bupivacaine|bupivacaine|mesh-list
19370373|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
19370374|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
19370375|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370376|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370377|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
19370378|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370379|NCT04784559|Remdesivir|remdesivir|mesh-list
19370380|NCT04784559|Favipiravir|favipiravir|mesh-list
19370381|NCT04784559|Dexamethasone|dexamethasone|mesh-list
19370382|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370383|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
19370384|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
19370385|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370386|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370387|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370388|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
19370389|NCT04784559|Hormones|hormones|mesh-ancestor
19370390|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370391|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19370392|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370393|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
19370394|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370395|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
19370396|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370397|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
19370398|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19370399|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
19370400|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370401|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370402|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19370403|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
19370404|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19370405|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
19370406|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370407|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846235|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20211137|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20211138|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211139|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20211140|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20211141|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20211142|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20211143|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20211144|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401543|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401544|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
20401545|NCT01137084|Hormones|hormones|mesh-ancestor
20401546|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401547|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20401548|NCT01137084|Protective Agents|protective agents|mesh-ancestor
20401549|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20401550|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370408|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19370409|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
19370410|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
19370411|NCT04776408|Protective Agents|protective agents|mesh-ancestor
19370412|NCT04775225|Lidocaine|lidocaine|mesh-list
19370413|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
19370414|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
19370415|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370416|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370417|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
19370418|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370419|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19370420|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19370421|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19370422|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19370423|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370424|NCT04757662|Tadalafil|tadalafil|mesh-list
19370425|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
19370426|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19370427|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19370428|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370429|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370430|NCT04757662|Urological Agents|urological agents|mesh-ancestor
19370431|NCT04739995|Naltrexone|naltrexone|mesh-list
19370432|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19370433|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19370434|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370435|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
19370436|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846236|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846237|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846238|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846239|NCT00676650|Growth Substances|growth substances|mesh-ancestor
19846240|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
19846241|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401551|NCT01137253|Trimethaphan|trimethaphan|mesh-list
20401552|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
20401553|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20401554|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20401555|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20401556|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
20401557|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401558|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401559|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20401560|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19846242|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846243|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846244|NCT00676676|Testosterone|testosterone|mesh-list
19846245|NCT00676676|Androgens|androgens|mesh-ancestor
19846246|NCT00676676|Hormones|hormones|mesh-ancestor
19846247|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846248|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846249|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
20401561|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
19846250|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846251|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
19846252|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690274|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690275|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690276|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690277|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
19690278|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690279|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19690280|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690281|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19690282|NCT05019417|Glycerol|glycerol|mesh-list
19370447|NCT04712643|Atezolizumab|atezolizumab|mesh-list
19690283|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19846253|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846254|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19846255|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
19846256|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846257|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846258|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19846259|NCT00676897|Simvastatin|simvastatin|mesh-list
19846260|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19846261|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19846262|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
19846263|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401562|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401563|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401564|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
20401565|NCT01137383|Interferons|interferons|mesh-list
20401566|NCT01137383|Ribavirin|ribavirin|mesh-list
20401567|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
20401568|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
20401569|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20401570|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401571|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
20401572|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401573|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
20401574|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401575|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
19370448|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370449|NCT04709471|Nicotine|nicotine|mesh-list
19370450|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19370451|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
19370452|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370453|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370454|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19370455|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19370456|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
19370457|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19370458|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370459|NCT04703257|Dipyrone|dipyrone|mesh-list
19370460|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19370461|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19370462|NCT04703257|Analgesics|analgesics|mesh-ancestor
19370463|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
19370464|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370465|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370466|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370467|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370468|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
19402382|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402383|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402384|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402385|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402386|NCT03609580|Urological Agents|urological agents|mesh-ancestor
19402387|NCT03609489|Capecitabine|capecitabine|mesh-list
19402388|NCT03609489|Apatinib|apatinib|mesh-list
19402389|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20613119|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613120|NCT02253901|Ritonavir|ritonavir|mesh-list
20401576|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613121|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20613122|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613123|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613124|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
19402390|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
19402391|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402392|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402393|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19846264|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20217887|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
20217888|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217889|NCT00310843|Nevirapine|nevirapine|mesh-list
20217890|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20217891|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20217892|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217893|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217894|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
20401577|NCT01137591|Acetaminophen|acetaminophen|mesh-list
20401578|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
20401579|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20401580|NCT01137591|Analgesics|analgesics|mesh-ancestor
20401581|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
20401582|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401583|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401584|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
20401585|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
20401586|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401587|NCT01137591|Expectorants|expectorants|mesh-ancestor
20401588|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
20401589|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19370469|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
19370470|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19370471|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
19370472|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
19370473|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19370474|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370475|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370476|NCT04677959|Fluticasone|fluticasone|mesh-list
19370477|NCT04677959|Xhance|xhance|mesh-list
20401590|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
20401591|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401592|NCT01137591|Protective Agents|protective agents|mesh-ancestor
20401593|NCT01137656|Acetylcholine|acetylcholine|mesh-list
20401594|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
20401595|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20401596|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
20401597|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401598|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370478|NCT04677959|Albuterol|albuterol|mesh-list
19370479|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19370480|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370481|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19370482|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
19370483|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370484|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370485|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19370486|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
19370487|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
19370488|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19370489|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19370490|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19370491|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19370492|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
19370493|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19370494|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370495|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
19370496|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19370497|NCT04661150|Capecitabine|capecitabine|mesh-list
19370498|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
19370499|NCT04661150|Trastuzumab|trastuzumab|mesh-list
20211145|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211146|NCT00287560|Propofol|propofol|mesh-list
20211147|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20211148|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211149|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211150|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20211151|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
20211152|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
20211153|NCT00287651|Insulin|insulin|mesh-list
20211154|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20211155|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20211156|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370500|NCT04661150|Atezolizumab|atezolizumab|mesh-list
19370501|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370502|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
19370503|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370504|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370505|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20211157|NCT00287664|Terlipressin|terlipressin|mesh-list
20211158|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211159|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20211160|NCT00287677|Hormones|hormones|mesh-list
20401599|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401600|NCT01137695|Pramlintide|pramlintide|mesh-list
19370506|NCT04624984|Gemcitabine|gemcitabine|mesh-list
19370507|NCT04624984|Doxorubicin|doxorubicin|mesh-list
19370508|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19370509|NCT04624984|Vinorelbine|vinorelbine|mesh-list
19370510|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19370511|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370512|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
19370513|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370514|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370515|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
19370516|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370517|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370518|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370519|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
19370520|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370521|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19370522|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19370523|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19370524|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370525|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
19370526|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
19370527|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
19370528|NCT04624958|Rituximab|rituximab|mesh-list
19370529|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
19370530|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370531|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370532|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
19370533|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370534|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370535|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19370536|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370537|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370538|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
19370539|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
19370540|NCT04620252|Citric Acid|citric acid|mesh-list
19370541|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
19370542|NCT04620252|Calcium|calcium|mesh-list
19370543|NCT04620252|Fluorides|fluorides|mesh-list
19370544|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19370545|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370546|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19370547|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
19370548|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19370549|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
19370550|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
19370551|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370552|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
19370553|NCT04620252|Protective Agents|protective agents|mesh-ancestor
19370554|NCT04620252|Antacids|antacids|mesh-ancestor
19370555|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370556|NCT04613024|Topiramate|topiramate|mesh-list
20211161|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211162|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370557|NCT04613024|Gabapentin|gabapentin|mesh-list
19370558|NCT04613024|Analgesics|analgesics|mesh-ancestor
19370559|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
19370560|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370561|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370562|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
19370563|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19370564|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19370565|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370566|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19370567|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19370568|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19370569|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19370570|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370571|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
19370572|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19370573|NCT04594759|Isotretinoin|isotretinoin|mesh-list
19370574|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
19370575|NCT04588688|Mifepristone|mifepristone|mesh-list
19370576|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20211163|NCT00287742|Risperidone|risperidone|mesh-list
20211164|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19370577|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
20401601|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20401602|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401603|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401604|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
20401605|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20613125|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370578|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19370579|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370580|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19370581|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19370582|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19370583|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
19370584|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19370585|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19370586|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
19370587|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370588|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
19370589|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19370590|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19370591|NCT04585893|Rituximab|rituximab|mesh-list
19370592|NCT04585893|Etoposide|etoposide|mesh-list
19370593|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370594|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370595|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
19370596|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370597|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370598|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370599|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19370600|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19370601|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370602|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370603|NCT04585815|Axitinib|axitinib|mesh-list
19370604|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370605|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19370606|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370607|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370608|NCT04583618|Vaccines|vaccines|mesh-list
19370609|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19370610|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
19370611|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370612|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
19370613|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370614|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
19370615|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370616|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370617|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19370618|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
19370619|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370620|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370621|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19370622|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19370623|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19370624|NCT04567303|Ranibizumab|ranibizumab|mesh-list
19846265|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19846266|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846267|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
19370625|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19370626|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846268|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211165|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
20211166|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211167|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211168|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211169|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20211170|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211171|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211172|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20211173|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20211174|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
20211175|NCT00287768|Docetaxel|docetaxel|mesh-list
20211176|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211177|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211178|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
20401606|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
20401607|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401608|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
20401609|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20401610|NCT01137708|Tofacitinib|tofacitinib|mesh-list
19370627|NCT04567303|Growth Substances|growth substances|mesh-ancestor
19370628|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370629|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
19370630|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370631|NCT04544267|Vaccines|vaccines|mesh-list
19370632|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
19370633|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370634|NCT04538742|Paclitaxel|paclitaxel|mesh-list
19370635|NCT04538742|Trastuzumab|trastuzumab|mesh-list
20401611|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20401612|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
20401613|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20401614|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401615|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20401616|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20401617|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20401618|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401619|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401620|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401621|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20401622|NCT01137708|Estrogens|estrogens|mesh-ancestor
20401623|NCT01137708|Hormones|hormones|mesh-ancestor
20401624|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427018|NCT01284309|Mirabegron|mirabegron|mesh-list
20427019|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20427020|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20427021|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19370636|NCT04538742|Durvalumab|durvalumab|mesh-list
19370637|NCT04538742|Pertuzumab|pertuzumab|mesh-list
19370638|NCT04538742|Tucatinib|tucatinib|mesh-list
19370639|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370640|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370641|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
19370642|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
19370643|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
19370644|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370645|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370646|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19370647|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370648|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
19370649|NCT04535401|Leucovorin|leucovorin|mesh-list
19370650|NCT04535401|Folic Acid|folic acid|mesh-list
19370651|NCT04535401|Fluorouracil|fluorouracil|mesh-list
19370652|NCT04535401|Irinotecan|irinotecan|mesh-list
19370653|NCT04535401|Camptothecin|camptothecin|mesh-list
19370654|NCT04535401|Calcium|calcium|mesh-list
19370655|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
19370656|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20211179|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211180|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211181|NCT00287781|Lidocaine|lidocaine|mesh-list
20211182|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
20211183|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
20211184|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211185|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211186|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
19370657|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370658|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20427022|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
19370659|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
19370660|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370661|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370662|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370663|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370664|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
19370665|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19370666|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19370667|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370668|NCT04535401|Antidotes|antidotes|mesh-ancestor
19370669|NCT04535401|Protective Agents|protective agents|mesh-ancestor
19370670|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
20401625|NCT01137903|Amoxicillin|amoxicillin|mesh-list
20401626|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
20401627|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
20401628|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
20401629|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20401630|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20401631|NCT01137903|Trimethoprim|trimethoprim|mesh-list
19370671|NCT04535401|Vitamins|vitamins|mesh-ancestor
19370672|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
19370673|NCT04535401|Hematinics|hematinics|mesh-ancestor
19370674|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370675|NCT04513925|Atezolizumab|atezolizumab|mesh-list
19370676|NCT04513925|Durvalumab|durvalumab|mesh-list
19370677|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370678|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370679|NCT04502602|Niraparib|niraparib|mesh-list
19370680|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20401632|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
20401633|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401634|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401635|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20401636|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20401637|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401638|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401639|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401640|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20401641|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20401642|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20401643|NCT01137903|Renal Agents|renal agents|mesh-ancestor
20401644|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
20401645|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20401646|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20401647|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20401648|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20401649|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20401650|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20401651|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
20401652|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401653|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401654|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401655|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401656|NCT01137942|Metronidazole|metronidazole|mesh-list
20401657|NCT01137942|Clarithromycin|clarithromycin|mesh-list
20401658|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20401659|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401660|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401661|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20401662|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20401663|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20401664|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401665|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401666|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20401667|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20401668|NCT01137955|Rifaximin|rifaximin|mesh-list
20401669|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401670|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401671|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401672|NCT01137994|Paclitaxel|paclitaxel|mesh-list
20401673|NCT01137994|Vinorelbine|vinorelbine|mesh-list
20401674|NCT01137994|Docetaxel|docetaxel|mesh-list
20401675|NCT01137994|Trastuzumab|trastuzumab|mesh-list
20401676|NCT01137994|Lapatinib|lapatinib|mesh-list
20401677|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20401678|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401679|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
20401680|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
20401681|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
20401682|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401683|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401684|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401685|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401686|NCT01138072|Atorvastatin|atorvastatin|mesh-list
20401687|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19370681|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370682|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401688|NCT01138072|Simvastatin|simvastatin|mesh-list
19370683|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211187|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401689|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20401690|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20401691|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
20401692|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401693|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20401694|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20401695|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211188|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20211189|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20211190|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20211191|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20211192|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211193|NCT00287794|Diazepam|diazepam|mesh-list
20211194|NCT00287794|Melatonin|melatonin|mesh-list
20211195|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
20401696|NCT01138085|Trametinib|trametinib|mesh-list
19370694|NCT04490018|Vaccines|vaccines|mesh-list
19370695|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
19370696|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370697|NCT04454658|Navitoclax|navitoclax|mesh-list
19370698|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370699|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
19370700|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19370701|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370702|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370703|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19370704|NCT04454515|Analgesics|analgesics|mesh-ancestor
19370705|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
19370706|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370707|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19370708|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19370709|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19370710|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
19370711|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19370712|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370713|NCT04442022|Gemcitabine|gemcitabine|mesh-list
19370714|NCT04442022|Dexamethasone|dexamethasone|mesh-list
19370715|NCT04442022|Rituximab|rituximab|mesh-list
19370716|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370717|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370718|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
19370719|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370720|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370721|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370722|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
20401697|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401698|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401699|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401700|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370723|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
19370724|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370725|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370726|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
19370727|NCT04442022|Hormones|hormones|mesh-ancestor
19370728|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370729|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19370730|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370731|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
19370732|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370733|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
19370734|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370735|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370736|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370737|NCT04429880|Oxytocin|oxytocin|mesh-list
19370738|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
19370739|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19370740|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370741|NCT04398706|Vaccines|vaccines|mesh-list
19370742|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19370743|NCT04398706|Immunoglobulins|immunoglobulins|mesh-list
19370744|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
19370745|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370746|NCT04398368|Gemcitabine|gemcitabine|mesh-list
20401701|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
20401702|NCT01138137|Paclitaxel|paclitaxel|mesh-list
20401703|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20401704|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20401705|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401706|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
20401707|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
20401708|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
20401709|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401710|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
20401711|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401712|NCT01138137|Expectorants|expectorants|mesh-ancestor
20401713|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
20401714|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20401715|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
20401716|NCT01138137|Protective Agents|protective agents|mesh-ancestor
20401717|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401718|NCT01138137|Antidotes|antidotes|mesh-ancestor
20401719|NCT01138215|Vaccines|vaccines|mesh-list
20401720|NCT01138215|Immunologic Factors|immunologic factors|mesh-ancestor
20401721|NCT01138215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401722|NCT01138384|Lapatinib|lapatinib|mesh-list
19370747|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370748|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
19370749|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370750|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370751|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
19370752|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370753|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370754|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370755|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
19370756|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370757|NCT04342715|Paromomycin|paromomycin|mesh-list
19370758|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19370759|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19370760|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370761|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19370762|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19370763|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
19370764|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19370765|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
19370766|NCT04308785|Atezolizumab|atezolizumab|mesh-list
19370767|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370768|NCT04269213|Cytarabine|cytarabine|mesh-list
19370769|NCT04269213|Daunorubicin|daunorubicin|mesh-list
19370770|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370771|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
19370772|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370773|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370774|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
19370775|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370776|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370777|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
19370778|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370779|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19690284|NCT05019417|Protective Agents|protective agents|mesh-ancestor
19690285|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690286|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690287|NCT05018923|Metronidazole|metronidazole|mesh-list
19690288|NCT05018923|Doxycycline|doxycycline|mesh-list
19690289|NCT05018923|Tetracycline|tetracycline|mesh-list
19690290|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
19690291|NCT05018923|Rabeprazole|rabeprazole|mesh-list
19690292|NCT05018923|Bismuth|bismuth|mesh-list
19690293|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690294|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690295|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19690296|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19690297|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19690298|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
20401723|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401724|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19370780|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19370781|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690299|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19690300|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693185|NCT04981899|Nivolumab|nivolumab|mesh-list
20401725|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690301|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19690302|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690303|NCT05018923|Antacids|antacids|mesh-ancestor
19370782|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370783|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19370784|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
19370785|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370786|NCT04182204|Gemcitabine|gemcitabine|mesh-list
19370787|NCT04182204|Rituximab|rituximab|mesh-list
19370788|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
19370789|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370790|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370791|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
19370792|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370793|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370794|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370795|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
19370796|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370797|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
19370798|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370799|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370800|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370801|NCT04175600|Selexipag|selexipag|mesh-list
19370802|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19370803|NCT04164082|Gemcitabine|gemcitabine|mesh-list
19370804|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
19370805|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20401726|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401727|NCT01138397|Vaccines|vaccines|mesh-list
20401728|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
20401729|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401730|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20401731|NCT01138423|Moxonidine|moxonidine|mesh-list
20401732|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20401733|NCT01138423|Diuretics|diuretics|mesh-ancestor
19370806|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
19370807|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370808|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370809|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
19370810|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370811|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370812|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370813|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
19370814|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370815|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402394|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402395|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
19402396|NCT03609424|Spartalizumab|spartalizumab|mesh-list
20401734|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
20401735|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401736|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20401737|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402397|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402398|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19402399|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402400|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402401|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19402402|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
19402403|NCT03609359|Lenvatinib|lenvatinib|mesh-list
19402404|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402405|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402406|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19402407|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402408|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402409|NCT03609307|Bevacizumab|bevacizumab|mesh-list
19402410|NCT03609307|Propranolol|propranolol|mesh-list
19402411|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402412|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402413|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19402414|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19402415|NCT03609307|Growth Substances|growth substances|mesh-ancestor
19690304|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19690305|NCT05018923|Diuretics|diuretics|mesh-ancestor
19690306|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
19402416|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402417|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
19370816|NCT04126733|Nivolumab|nivolumab|mesh-list
19370817|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370818|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370819|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19370820|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846269|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19846270|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846271|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846272|NCT00677352|Sertraline|sertraline|mesh-list
19846273|NCT00677352|Paroxetine|paroxetine|mesh-list
19846274|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
19846275|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19846276|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19370829|NCT04113616|Cytarabine|cytarabine|mesh-list
19370830|NCT04113616|Decitabine|decitabine|mesh-list
19370831|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19370832|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
19370833|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370834|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370835|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
19370836|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370837|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690307|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690308|NCT05018923|Expectorants|expectorants|mesh-ancestor
19690309|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19690310|NCT05019326|Andrographolide|andrographolide|mesh-list
19690311|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19690312|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19690313|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19370838|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
19370839|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370840|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690314|NCT05019326|Analgesics|analgesics|mesh-ancestor
19370841|NCT04055116|Lidocaine|lidocaine|mesh-list
19370842|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
19370843|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
19370844|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19370845|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370846|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
19370847|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370848|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19370849|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19370850|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19370851|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19370852|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370853|NCT04045795|Dexamethasone|dexamethasone|mesh-list
19370854|NCT04045795|Pomalidomide|pomalidomide|mesh-list
19370855|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19370856|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370857|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
19370858|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
19370859|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370860|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370861|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370862|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
19370863|NCT04045795|Hormones|hormones|mesh-ancestor
19370864|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370865|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19370866|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370867|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
19370868|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19370869|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19370870|NCT04045795|Growth Substances|growth substances|mesh-ancestor
19370871|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19370872|NCT04045028|Rituximab|rituximab|mesh-list
19370873|NCT04045028|Atezolizumab|atezolizumab|mesh-list
19370874|NCT04045028|Daratumumab|daratumumab|mesh-list
19370875|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370876|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370877|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
19370878|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370879|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370880|NCT04041973|Lumefantrine|lumefantrine|mesh-list
19370881|NCT04041973|Artemether|artemether|mesh-list
19370882|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19370883|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
19370884|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19370885|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19370886|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370887|NCT04040946|Choline|choline|mesh-list
19370888|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
19370889|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19370890|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
19370891|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370892|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401738|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401739|NCT01138449|Vitamin A|vitamin a|mesh-list
20401740|NCT01138449|Vitamins|vitamins|mesh-ancestor
20401741|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
20401742|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401743|NCT01138488|Insulin|insulin|mesh-list
20401744|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
20401745|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401746|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401747|NCT01138553|Mifepristone|mifepristone|mesh-list
20401748|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20401749|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
20401750|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20401751|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401752|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20401753|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20401754|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20401755|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
20401756|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20401757|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20401758|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
20401759|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401760|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
20401761|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20401762|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20401763|NCT01138605|Ritonavir|ritonavir|mesh-list
20401764|NCT01138605|Darunavir|darunavir|mesh-list
20401765|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20401766|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20401767|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
20401768|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401769|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401770|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20401771|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20401772|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
20401773|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401774|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20401775|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20401776|NCT01138683|Diuretics|diuretics|mesh-list
20401777|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
20401778|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370893|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19370894|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
19370895|NCT03992456|Trifluridine|trifluridine|mesh-list
19370896|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19370897|NCT03992456|Panitumumab|panitumumab|mesh-list
19370898|NCT03992456|Antibodies|antibodies|mesh-list
19370899|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
19370900|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19370901|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
19370902|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401779|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
20401780|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
20401781|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401782|NCT01138774|Protective Agents|protective agents|mesh-ancestor
20401783|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401784|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
20401785|NCT01138774|Vitamins|vitamins|mesh-ancestor
20401786|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
20401787|NCT01138839|Dexamethasone|dexamethasone|mesh-list
20401788|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401789|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
20401790|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
20401791|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401792|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370903|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370904|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
20401793|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401794|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
20401795|NCT01138839|Hormones|hormones|mesh-ancestor
20401796|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20401797|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20401798|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401799|NCT01138852|Ampicillin|ampicillin|mesh-list
20401800|NCT01138852|Cefuroxime|cefuroxime|mesh-list
20401801|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
20401802|NCT01138852|Sulbactam|sulbactam|mesh-list
20401803|NCT01138852|Sultamicillin|sultamicillin|mesh-list
20401804|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401805|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401806|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20401807|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401808|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401809|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
20401810|NCT01138904|Irinotecan|irinotecan|mesh-list
20401811|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401812|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20401813|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20401814|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690315|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
19690316|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690317|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370905|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370906|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
19370907|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19370908|NCT03981796|Paclitaxel|paclitaxel|mesh-list
19370909|NCT03981796|Carboplatin|carboplatin|mesh-list
19370910|NCT03981796|Niraparib|niraparib|mesh-list
19370911|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19370912|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370913|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
19370914|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
19370915|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
19370916|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370917|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19370918|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370919|NCT03965091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19370920|NCT03965091|Immunologic Factors|immunologic factors|mesh-ancestor
19370921|NCT03965091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370922|NCT03919071|Trametinib|trametinib|mesh-list
19370923|NCT03919071|Dabrafenib|dabrafenib|mesh-list
19370924|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19370925|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370926|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401815|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401816|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
20401817|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20401818|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
19370927|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370928|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19370929|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19370930|NCT03919071|Protective Agents|protective agents|mesh-ancestor
19370931|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370932|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19370933|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
19370934|NCT03875378|Estrogens|estrogens|mesh-list
19370935|NCT03875378|Hormones|hormones|mesh-ancestor
19370936|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370937|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370938|NCT03871348|Cemiplimab|cemiplimab|mesh-list
19370939|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19370940|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690318|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19690319|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19690320|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20401819|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401820|NCT01138956|Expectorants|expectorants|mesh-ancestor
19370941|NCT03869866|Vaccines|vaccines|mesh-list
19690321|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690322|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
19690323|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19690324|NCT05018988|Vitamin D|vitamin d|mesh-list
19690325|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
20401821|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
19370942|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
19370943|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211196|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211197|NCT00287794|Protective Agents|protective agents|mesh-ancestor
20211198|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401822|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20401823|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
20401824|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211199|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211200|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20211201|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
20211202|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
20211203|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
20211204|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690326|NCT05018988|Vitamins|vitamins|mesh-list
19690327|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
19690328|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690329|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19690330|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690331|NCT05018962|Paclitaxel|paclitaxel|mesh-list
19690332|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19690333|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211205|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20211206|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20211207|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20211208|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20211209|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20211210|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211211|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20401825|NCT01138956|Protective Agents|protective agents|mesh-ancestor
20401826|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401827|NCT01138956|Antidotes|antidotes|mesh-ancestor
20401828|NCT01139138|Irinotecan|irinotecan|mesh-list
20401829|NCT01139138|Everolimus|everolimus|mesh-list
20401830|NCT01139138|Panitumumab|panitumumab|mesh-list
19370960|NCT03860844|Cytarabine|cytarabine|mesh-list
20211212|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19370961|NCT03860844|Dexamethasone|dexamethasone|mesh-list
19370962|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
19370963|NCT03860844|Doxorubicin|doxorubicin|mesh-list
19370964|NCT03860844|Methotrexate|methotrexate|mesh-list
20211213|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
19370965|NCT03860844|Fludarabine|fludarabine|mesh-list
19370966|NCT03860844|Etoposide|etoposide|mesh-list
19370967|NCT03860844|Vincristine|vincristine|mesh-list
19370968|NCT03860844|Daunorubicin|daunorubicin|mesh-list
19370969|NCT03860844|Asparaginase|asparaginase|mesh-list
19370970|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
19370971|NCT03860844|Idarubicin|idarubicin|mesh-list
19370972|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
19370973|NCT03860844|Pegaspargase|pegaspargase|mesh-list
19690334|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690335|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690336|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
19690337|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211214|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
20211215|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
19370974|NCT03860844|Montelukast|montelukast|mesh-list
19370975|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19370976|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
20211216|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
20211217|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211218|NCT00287820|Olanzapine|olanzapine|mesh-list
20211219|NCT00287820|Risperidone|risperidone|mesh-list
20211220|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19370977|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370978|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19370979|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19690338|NCT05018637|Teriparatide|teriparatide|mesh-list
20211221|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
20211222|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211223|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211224|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19370980|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
19370981|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401831|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19370982|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19370983|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19370984|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19370985|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
19370986|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
19370987|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19370988|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19370989|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
19370990|NCT03860844|Hormones|hormones|mesh-ancestor
19370991|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19370992|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19370993|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19370994|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19370995|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19370996|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19370997|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19370998|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
19370999|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19371000|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371001|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
19371002|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
19371003|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19371004|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19371005|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19371006|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
19371007|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211225|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20211226|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211227|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211228|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20211229|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20211230|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
19371008|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
19371009|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
19371010|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
19371011|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19371012|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
19371013|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19371014|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
19371015|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19371016|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19371017|NCT03860844|Analgesics|analgesics|mesh-ancestor
19371018|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
19371019|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
20211231|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
20211232|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
20211233|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211234|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20211235|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20211236|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20211237|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20211238|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
20211239|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211240|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20211241|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211242|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211243|NCT00287859|Topotecan|topotecan|mesh-list
20211244|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20211245|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211246|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690339|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690340|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690341|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19690342|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
20211247|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211248|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211249|NCT00287885|Docetaxel|docetaxel|mesh-list
20211250|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211251|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211252|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211253|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211254|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211255|NCT00287911|Topotecan|topotecan|mesh-list
19371044|NCT03816345|Nivolumab|nivolumab|mesh-list
19371045|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401832|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20401833|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401834|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401835|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401836|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371046|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371047|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371048|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371049|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
19371050|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371051|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371052|NCT03782207|Atezolizumab|atezolizumab|mesh-list
19371053|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371054|NCT03768063|Atezolizumab|atezolizumab|mesh-list
19371055|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371056|NCT03703050|Nivolumab|nivolumab|mesh-list
19371057|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371058|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371059|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371060|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371061|NCT03700476|Gemcitabine|gemcitabine|mesh-list
19371062|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371063|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371064|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
19371065|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371066|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
19371067|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371068|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371069|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371070|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
19371071|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371072|NCT03694249|Ifetroban|ifetroban|mesh-list
19371073|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19371074|NCT03693300|Durvalumab|durvalumab|mesh-list
19371075|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371076|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371077|NCT03678883|Gemcitabine|gemcitabine|mesh-list
19371078|NCT03678883|Paclitaxel|paclitaxel|mesh-list
19371079|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19371080|NCT03678883|Carboplatin|carboplatin|mesh-list
19371081|NCT03678883|Doxorubicin|doxorubicin|mesh-list
19371082|NCT03678883|Irinotecan|irinotecan|mesh-list
19371083|NCT03678883|Lomustine|lomustine|mesh-list
19371084|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19371085|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211256|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211257|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20211258|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211259|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211260|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211261|NCT00287924|Methotrexate|methotrexate|mesh-list
20211262|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20401837|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
20401838|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401839|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401840|NCT01139151|Cytarabine|cytarabine|mesh-list
20401841|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20401842|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
20401843|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401844|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401845|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
20401846|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401847|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20401848|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
20401849|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401850|NCT01139203|Lamivudine|lamivudine|mesh-list
20401851|NCT01139203|Adefovir|adefovir|mesh-list
20613126|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371086|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690343|NCT05018364|Hematinics|hematinics|mesh-ancestor
20211263|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
20401852|NCT01139203|Entecavir|entecavir|mesh-list
19371087|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690344|NCT05018182|Leucovorin|leucovorin|mesh-list
19371088|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
19371089|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371090|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371091|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
19371092|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
19371093|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371094|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371095|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371096|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
19371097|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371098|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19371099|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19371100|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19371101|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19371102|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19371103|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
19371104|NCT03662659|Nivolumab|nivolumab|mesh-list
20401853|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20401854|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20401855|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401856|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401857|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
20401858|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401859|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20401860|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20401861|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20401862|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
20401863|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20401864|NCT01139437|Vaccines|vaccines|mesh-list
20401865|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
20401866|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401867|NCT01139463|Haloperidol|haloperidol|mesh-list
20401868|NCT01139463|Olanzapine|olanzapine|mesh-list
20401869|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
20401870|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
20401871|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
20401872|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401873|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371105|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371106|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371107|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371108|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371109|NCT03656718|Nivolumab|nivolumab|mesh-list
20401874|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401875|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19371110|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371111|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371112|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371113|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371114|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
19371115|NCT03654768|Dasatinib|dasatinib|mesh-list
19371116|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19371117|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371118|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19371119|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371120|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371121|NCT03610711|Nivolumab|nivolumab|mesh-list
19371122|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371123|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371124|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371125|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371126|NCT03604874|Oxytocin|oxytocin|mesh-list
19371127|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
19371128|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19371129|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371130|NCT03595124|Nivolumab|nivolumab|mesh-list
19371131|NCT03595124|Axitinib|axitinib|mesh-list
19371132|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371133|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371134|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371135|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371136|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20401876|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20401877|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19371137|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371138|NCT03584152|Acetaminophen|acetaminophen|mesh-list
19371139|NCT03584152|Ibuprofen|ibuprofen|mesh-list
19371140|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19371141|NCT03584152|Analgesics|analgesics|mesh-ancestor
20401878|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20401879|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20401880|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20401881|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20401882|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401883|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401884|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
20401885|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20401886|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
20401887|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19371142|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
19371143|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371144|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371145|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
19371146|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371147|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371148|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371149|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19371150|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371151|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371152|NCT03575572|Colchicine|colchicine|mesh-list
19371153|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
19371154|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371155|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
19371156|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
19371157|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
19371158|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371159|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371160|NCT03565991|Avelumab|avelumab|mesh-list
19371161|NCT03565991|Talazoparib|talazoparib|mesh-list
19371162|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371163|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371164|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19371165|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371166|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371167|NCT03557359|Nivolumab|nivolumab|mesh-list
19371168|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371169|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371170|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371171|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371172|NCT03555149|Bevacizumab|bevacizumab|mesh-list
19371173|NCT03555149|Atezolizumab|atezolizumab|mesh-list
19371174|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371175|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371176|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19371177|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19371178|NCT03555149|Growth Substances|growth substances|mesh-ancestor
19371179|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371180|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
19371181|NCT03532295|Bevacizumab|bevacizumab|mesh-list
19371182|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371183|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371184|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19371185|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20211264|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20211265|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211266|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20211267|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
20211268|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211269|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211270|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
20211271|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211272|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20211273|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211274|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
20211275|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211276|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20211277|NCT00287937|Paclitaxel|paclitaxel|mesh-list
20613127|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20401888|NCT01139645|Esomeprazole|esomeprazole|mesh-list
20401889|NCT01139645|Rabeprazole|rabeprazole|mesh-list
20401890|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20401891|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20401892|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20401893|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371186|NCT03532295|Growth Substances|growth substances|mesh-ancestor
19371187|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371188|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
19371189|NCT03531645|Fulvestrant|fulvestrant|mesh-list
19371190|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371191|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371192|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20401894|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401895|NCT01139671|Remifentanil|remifentanil|mesh-list
20401896|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20401897|NCT01139671|Narcotics|narcotics|mesh-ancestor
20401898|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20401899|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401900|NCT01139671|Analgesics|analgesics|mesh-ancestor
20401901|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
20401902|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401903|NCT01139723|Bevacizumab|bevacizumab|mesh-list
20401904|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20401905|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401906|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20401907|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20401908|NCT01139723|Growth Substances|growth substances|mesh-ancestor
19371193|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19371194|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
19371195|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371196|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371197|NCT03522415|Methotrexate|methotrexate|mesh-list
19371198|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19371199|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
19371200|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19371201|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371202|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371203|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
19371204|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371205|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371206|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
19371207|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371208|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19371209|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371210|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
19371211|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371212|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19371213|NCT03521687|Apremilast|apremilast|mesh-list
19371214|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371215|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19371216|NCT03521687|Analgesics|analgesics|mesh-ancestor
19371217|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
19371218|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371219|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371220|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371221|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371222|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19371223|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19371224|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371225|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371226|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
19371227|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19371228|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402418|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19402419|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19402420|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
20401909|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401910|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
20401911|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
20401912|NCT01139749|Ciclopirox|ciclopirox|mesh-list
20401913|NCT01139749|Salicylates|salicylates|mesh-list
20401914|NCT01139749|Isotretinoin|isotretinoin|mesh-list
20401915|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19371229|NCT03501368|Trametinib|trametinib|mesh-list
19371230|NCT03501368|Ceritinib|ceritinib|mesh-list
19371231|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371232|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19371233|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371234|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846277|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19846278|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19846279|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846280|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846281|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
19846282|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846283|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19846284|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19846285|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19846286|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846287|NCT00677365|Levofloxacin|levofloxacin|mesh-list
19846288|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19846289|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846290|NCT00677365|Renal Agents|renal agents|mesh-ancestor
19846291|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20401916|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401917|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
20401918|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
20401919|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20401920|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20401921|NCT01139749|Analgesics|analgesics|mesh-ancestor
20401922|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
20401923|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20401924|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401925|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20401926|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20401927|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20401928|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846292|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19846293|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19846294|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846295|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846296|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401929|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401930|NCT01139840|Vitamin D|vitamin d|mesh-list
20401931|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
20401932|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
20401933|NCT01139840|Vitamins|vitamins|mesh-list
20401934|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
20401935|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401936|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20401937|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20401938|NCT01139905|Ritonavir|ritonavir|mesh-list
20401939|NCT01139905|Lopinavir|lopinavir|mesh-list
20401940|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20401941|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20401942|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
20401943|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20401944|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401945|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20401946|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20401947|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
20401948|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401949|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20401950|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20401951|NCT01140009|Vaccines|vaccines|mesh-list
20401952|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
20401953|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401954|NCT01140035|Insulin|insulin|mesh-list
19690345|NCT05018182|Folic Acid|folic acid|mesh-list
19690346|NCT05018182|Fluorouracil|fluorouracil|mesh-list
19690347|NCT05018182|Capecitabine|capecitabine|mesh-list
19690348|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
19690349|NCT05018182|Irinotecan|irinotecan|mesh-list
19690350|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
19690351|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
19690352|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371257|NCT03498131|Melatonin|melatonin|mesh-list
19371258|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
19690353|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20401955|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20401956|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401957|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
20401958|NCT01140074|Astringents|astringents|mesh-ancestor
20401959|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401960|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
20401961|NCT01140100|Thiopental|thiopental|mesh-list
20401962|NCT01140100|Propofol|propofol|mesh-list
20401963|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20401964|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20401965|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401966|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19690354|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690355|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690356|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
19690357|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690358|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20613128|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613129|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
20613130|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613131|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19371259|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371260|NCT03498131|Protective Agents|protective agents|mesh-ancestor
19371261|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690359|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690360|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690361|NCT05018182|Antidotes|antidotes|mesh-ancestor
20211278|NCT00287937|Carboplatin|carboplatin|mesh-list
20211279|NCT00287937|Vorinostat|vorinostat|mesh-list
20211280|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20211281|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211282|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690362|NCT05018182|Protective Agents|protective agents|mesh-ancestor
19690363|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
19690364|NCT05018182|Vitamins|vitamins|mesh-ancestor
19690365|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
19690366|NCT05018182|Hematinics|hematinics|mesh-ancestor
19690367|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19690368|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690369|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19690370|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19690371|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19846297|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19846298|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19846299|NCT00677534|Vitamin D|vitamin d|mesh-list
19846300|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
19846301|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
19846302|NCT00677534|Vitamins|vitamins|mesh-ancestor
20401967|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
20401968|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
19371262|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19371263|NCT03490344|Lenalidomide|lenalidomide|mesh-list
19371264|NCT03490344|Daratumumab|daratumumab|mesh-list
19371265|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
19371266|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371267|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19371268|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19371269|NCT03490344|Growth Substances|growth substances|mesh-ancestor
19371270|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
19371271|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371272|NCT03410901|Antibodies|antibodies|mesh-list
19371273|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
19371274|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371275|NCT03406507|Ravulizumab|ravulizumab|mesh-list
19371276|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19371277|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371278|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
19371279|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693045|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211283|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211284|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211285|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211286|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20211287|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846303|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
20401969|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
20401970|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
20401971|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
20401972|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20401973|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401974|NCT01140126|UB-421|ub-421|mesh-list
20401975|NCT01140126|Antibodies|antibodies|mesh-list
20401976|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
20401977|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401978|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20401979|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
19371280|NCT03403205|Choline|choline|mesh-list
19371281|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
19371282|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19371283|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
19371284|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371285|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371286|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19371287|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
19690372|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
19690373|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20211288|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
19371292|NCT03387423|Tofacitinib|tofacitinib|mesh-list
19371293|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19371294|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371295|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371296|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
19371297|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19371298|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19371299|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371300|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
19371301|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
19371302|NCT03371017|Gemcitabine|gemcitabine|mesh-list
19371303|NCT03371017|Carboplatin|carboplatin|mesh-list
19371304|NCT03371017|Capecitabine|capecitabine|mesh-list
19371305|NCT03371017|Atezolizumab|atezolizumab|mesh-list
19371306|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371307|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371308|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
19371309|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371310|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
19371311|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371312|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371313|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20401980|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20401981|NCT01140308|Ubiquinone|ubiquinone|mesh-list
19371314|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
19371315|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371316|NCT03357939|Adalimumab|adalimumab|mesh-list
19371317|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371318|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371319|NCT03337724|Paclitaxel|paclitaxel|mesh-list
19371320|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19371321|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371322|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
19371323|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
19371324|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211289|NCT00287950|Carboplatin|carboplatin|mesh-list
20211290|NCT00287950|Etoposide|etoposide|mesh-list
20211291|NCT00287950|Vincristine|vincristine|mesh-list
20211292|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211293|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
20211294|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211295|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211296|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20211297|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
20211298|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211299|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211300|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19371325|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371326|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
19371327|NCT03337087|Leucovorin|leucovorin|mesh-list
19690374|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
20211301|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20401982|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
20401983|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
19371328|NCT03337087|Folic Acid|folic acid|mesh-list
19371329|NCT03337087|Fluorouracil|fluorouracil|mesh-list
19371330|NCT03337087|Irinotecan|irinotecan|mesh-list
19371331|NCT03337087|Rucaparib|rucaparib|mesh-list
19371332|NCT03337087|Calcium|calcium|mesh-list
19371333|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
19371334|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19371335|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371336|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19371337|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
19371338|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371339|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371340|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371341|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371342|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
19371343|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19371344|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19371345|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371346|NCT03337087|Antidotes|antidotes|mesh-ancestor
19371347|NCT03337087|Protective Agents|protective agents|mesh-ancestor
19371348|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
19371349|NCT03337087|Vitamins|vitamins|mesh-ancestor
19371350|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
19371351|NCT03337087|Hematinics|hematinics|mesh-ancestor
19371352|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19371353|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
19371354|NCT03324113|Promethazine|promethazine|mesh-list
19371355|NCT03324113|Dexamethasone|dexamethasone|mesh-list
19371356|NCT03324113|Naphazoline|naphazoline|mesh-list
19371357|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19371358|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371359|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
19371360|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
19371361|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371362|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371363|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371364|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
19371365|NCT03324113|Hormones|hormones|mesh-ancestor
19371366|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211302|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20211303|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211304|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211305|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211306|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211307|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211308|NCT00287963|Topotecan|topotecan|mesh-list
20211309|NCT00287963|Vinorelbine|vinorelbine|mesh-list
20211310|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20211311|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211312|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211313|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211314|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211315|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20211316|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211317|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211318|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211319|NCT00287976|Irinotecan|irinotecan|mesh-list
20211320|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20211321|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211322|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211323|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211324|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211325|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
20211326|NCT00288002|Docetaxel|docetaxel|mesh-list
20211327|NCT00288002|Capecitabine|capecitabine|mesh-list
20211328|NCT00288002|Trastuzumab|trastuzumab|mesh-list
20211329|NCT00288002|Epirubicin|epirubicin|mesh-list
20211330|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211331|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
20211332|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211333|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211334|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19371367|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371368|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211335|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
20211336|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401984|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371369|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19371370|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19371371|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19371372|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19371373|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
20401985|NCT01140308|Vitamins|vitamins|mesh-ancestor
20401986|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
20401987|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20401988|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
20401989|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20401990|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20401991|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20401992|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
20401993|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20401994|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20401995|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20401996|NCT01140399|Dopamine|dopamine|mesh-list
20401997|NCT01140399|Furosemide|furosemide|mesh-list
19371374|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
19371375|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
19371376|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19371377|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
19371378|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
19371379|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19371380|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371381|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19371382|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
19371383|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
19371384|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19371385|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19371386|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19371387|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
19371388|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19846304|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846305|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19846306|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19846307|NCT00677833|Azithromycin|azithromycin|mesh-list
19846308|NCT00677833|Chloroquine|chloroquine|mesh-list
19846309|NCT00677833|Lumefantrine|lumefantrine|mesh-list
19846310|NCT00677833|Artemether|artemether|mesh-list
20401998|NCT01140399|Diuretics|diuretics|mesh-ancestor
20401999|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
20402000|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402001|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20402002|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20402003|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402004|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20402005|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
20402006|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
20402007|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402008|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
20402009|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402010|NCT01140399|Protective Agents|protective agents|mesh-ancestor
20402011|NCT01140412|Ritonavir|ritonavir|mesh-list
20402012|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
20402013|NCT01140412|Maraviroc|maraviroc|mesh-list
20402014|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20402015|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20402016|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
20402017|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402018|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402019|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20402020|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19371389|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
19371390|NCT03321643|Gemcitabine|gemcitabine|mesh-list
19371391|NCT03321643|Rituximab|rituximab|mesh-list
19371392|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19371393|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
19371394|NCT03321643|Atezolizumab|atezolizumab|mesh-list
19371395|NCT03321643|Antibodies|antibodies|mesh-list
20402021|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
20402022|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402023|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20402024|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19371396|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
19371397|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19371398|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
19371399|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371400|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371401|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371402|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371403|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
19371404|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371405|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
19371406|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371407|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371408|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371409|NCT03316781|Adalimumab|adalimumab|mesh-list
19371410|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371411|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371412|NCT03306901|Fluorouracil|fluorouracil|mesh-list
19371413|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371414|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
19371415|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371416|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371417|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371418|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
19371419|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371420|NCT03256045|Dexamethasone|dexamethasone|mesh-list
19371421|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
19371422|NCT03256045|Panobinostat|panobinostat|mesh-list
19371423|NCT03256045|Ichthammol|ichthammol|mesh-list
19371424|NCT03256045|BB 1101|bb 1101|mesh-list
19371425|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371426|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
19371427|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
19371428|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371429|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371430|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371431|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
19371432|NCT03256045|Hormones|hormones|mesh-ancestor
19371433|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371434|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371435|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371436|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
19371437|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371438|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371439|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19371440|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
19371441|NCT03232593|Atezolizumab|atezolizumab|mesh-list
19371442|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371443|NCT03228693|Triamcinolone|triamcinolone|mesh-list
19371444|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371445|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
19371446|NCT03228693|Hormones|hormones|mesh-ancestor
19371447|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371448|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371449|NCT03194867|Cemiplimab|cemiplimab|mesh-list
19371450|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371451|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371452|NCT03190915|Trametinib|trametinib|mesh-list
19371453|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371454|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19371455|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371456|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371457|NCT03186456|Aspirin|aspirin|mesh-list
19371458|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371459|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19371460|NCT03186456|Analgesics|analgesics|mesh-ancestor
19371461|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
19371462|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371463|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371464|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371465|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371466|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19371467|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19371468|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371469|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19371470|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19371471|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371472|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
20402025|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20402026|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20402027|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20402028|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
20402029|NCT01140425|PF 232798|pf 232798|mesh-list
20402030|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20402031|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402032|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20402033|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19846311|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19846312|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20402034|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402035|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402036|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402037|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20402038|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20402039|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20402040|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
20402041|NCT01140438|Metformin|metformin|mesh-list
20402042|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20402043|NCT01140438|Repaglinide|repaglinide|mesh-list
20402044|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
20402045|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
20402046|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
20402047|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20402048|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402049|NCT01140438|Incretins|incretins|mesh-ancestor
20402050|NCT01140438|Hormones|hormones|mesh-ancestor
20402051|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402052|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20402053|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
20402054|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402055|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402056|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
20402057|NCT01140529|Haloperidol|haloperidol|mesh-list
20402058|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
20402059|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20402060|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402061|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402062|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20402063|NCT01140529|Analgesics|analgesics|mesh-ancestor
19846313|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846314|NCT00677833|Amebicides|amebicides|mesh-ancestor
19371473|NCT03184935|Decitabine|decitabine|mesh-list
19371474|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371475|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
19371476|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371477|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371478|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371479|NCT03176498|Aspirin|aspirin|mesh-list
19371480|NCT03176498|Atorvastatin|atorvastatin|mesh-list
19371481|NCT03176498|Calcium|calcium|mesh-list
19371482|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19371483|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371484|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371485|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19371486|NCT03176498|Analgesics|analgesics|mesh-ancestor
19371487|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
19371488|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371489|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371490|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371491|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19371492|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19371493|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690375|NCT05017454|Valproic Acid|valproic acid|mesh-list
19690376|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19690377|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
19690378|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19690379|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
19690380|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690381|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846315|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20402064|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
19690382|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
19690383|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402065|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690384|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690385|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
19690386|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19690387|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690388|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690389|NCT05017311|Citalopram|citalopram|mesh-list
19690390|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
19690391|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19690392|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19690393|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19690394|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371494|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19371495|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19371496|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371497|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
19371498|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19371499|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19371500|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
19371501|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19371502|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19371503|NCT03155620|Olaparib|olaparib|mesh-list
19371504|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19371505|NCT03155620|Palbociclib|palbociclib|mesh-list
19371506|NCT03155620|Vemurafenib|vemurafenib|mesh-list
19371507|NCT03155620|Tipifarnib|tipifarnib|mesh-list
19371508|NCT03155620|Ensartinib|ensartinib|mesh-list
19371509|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402066|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20402067|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20402068|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20402069|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20402070|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402071|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402072|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
20402073|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
20402074|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402075|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19371510|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371511|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371512|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19371513|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
19371514|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19371515|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
19371516|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371517|NCT03149107|Expectorants|expectorants|mesh-ancestor
19371518|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
19371519|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19371520|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
19371521|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371522|NCT03149107|Protective Agents|protective agents|mesh-ancestor
19371523|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371524|NCT03149107|Antidotes|antidotes|mesh-ancestor
19371525|NCT03135301|Metformin|metformin|mesh-list
19371526|NCT03135301|Letrozole|letrozole|mesh-list
19371527|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19371528|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371529|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371530|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19371531|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19371532|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371533|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371534|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19371535|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
19371536|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371537|NCT03117010|Dexamethasone|dexamethasone|mesh-list
19371538|NCT03117010|Etoposide|etoposide|mesh-list
19371539|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371540|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
19371541|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
19371542|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371543|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371544|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371545|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
19690395|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402076|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19371546|NCT03117010|Hormones|hormones|mesh-ancestor
19690396|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
19690397|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402077|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20402078|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20402079|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
20402080|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20402081|NCT01140581|Dronedarone|dronedarone|mesh-list
20402082|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20402083|NCT01140620|Ketamine|ketamine|mesh-list
20402084|NCT01140620|Risperidone|risperidone|mesh-list
20402085|NCT01140620|Analgesics|analgesics|mesh-ancestor
20402086|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
20402087|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402088|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402089|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20402090|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19690398|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19690399|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
19690400|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690401|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
19690402|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
20402091|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
20402092|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
20402093|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402094|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20402095|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20402096|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402097|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402098|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20402099|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
19371547|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371548|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371549|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690403|NCT05017428|Niacinamide|niacinamide|mesh-list
19371550|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371551|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371552|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19371553|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19371554|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19371555|NCT03066648|Azacitidine|azacitidine|mesh-list
19371556|NCT03066648|Decitabine|decitabine|mesh-list
19371557|NCT03066648|Spartalizumab|spartalizumab|mesh-list
19371558|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371559|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
19371560|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371561|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371562|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371563|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371564|NCT03046836|Oxytocin|oxytocin|mesh-list
19371565|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
19371566|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19371567|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371568|NCT03038594|Hormones|hormones|mesh-list
19371569|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211337|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211338|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20211339|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211340|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211341|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211342|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20211343|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
20211344|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20211345|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20211346|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20211347|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211348|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371570|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371571|NCT03036098|Gemcitabine|gemcitabine|mesh-list
19371572|NCT03036098|Carboplatin|carboplatin|mesh-list
19371573|NCT03036098|Nivolumab|nivolumab|mesh-list
19371574|NCT03036098|Ipilimumab|ipilimumab|mesh-list
19690404|NCT05017428|Niacin|niacin|mesh-list
19690405|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
19846316|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20211349|NCT00288028|Bortezomib|bortezomib|mesh-list
20402100|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20402101|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20402102|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20402103|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20402104|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
20402105|NCT01140737|Axitinib|axitinib|mesh-list
20402106|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402107|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20402108|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402109|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402110|NCT01140828|Rabeprazole|rabeprazole|mesh-list
20402111|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20402112|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402113|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20402114|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402115|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402116|NCT01140893|Exenatide|exenatide|mesh-list
20402117|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20402118|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402119|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19371575|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371576|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371577|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
19371578|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371579|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
19371580|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371581|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371582|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371583|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
19690406|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
19690407|NCT05017428|Vitamins|vitamins|mesh-ancestor
19690408|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
19690409|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690410|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19690411|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
19690412|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211350|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371584|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371585|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371586|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371587|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
19371588|NCT03030378|Interleukin-12|interleukin-12|mesh-list
19371589|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371590|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371591|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19371592|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
19371593|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371594|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20211351|NCT00288041|Paclitaxel|paclitaxel|mesh-list
20211352|NCT00288041|Carboplatin|carboplatin|mesh-list
20211353|NCT00288041|Bortezomib|bortezomib|mesh-list
20211354|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20211355|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211356|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211357|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211358|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211359|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217895|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217896|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20402120|NCT01140893|Incretins|incretins|mesh-ancestor
19371595|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19690413|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19690414|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
19690415|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
19690416|NCT05017272|Narcotics|narcotics|mesh-ancestor
19690417|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690418|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690419|NCT05017272|Analgesics|analgesics|mesh-ancestor
19690420|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
19690421|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690422|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19690423|NCT05017103|Antibodies|antibodies|mesh-list
19690424|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
19690425|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20217897|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20402121|NCT01140893|Hormones|hormones|mesh-ancestor
20427023|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846317|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
19846318|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846319|NCT00677924|Zalutumumab|zalutumumab|mesh-list
19846320|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846321|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846322|NCT00678015|Masoprocol|masoprocol|mesh-list
20402122|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402123|NCT01140932|Prednisolone|prednisolone|mesh-list
20402124|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20402125|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
20402126|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20402127|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
20402128|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19690426|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
19690427|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690428|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690429|NCT05017155|Mexiletine|mexiletine|mesh-list
19690430|NCT05017155|Lamotrigine|lamotrigine|mesh-list
20402129|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
20402130|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402131|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
20402132|NCT01140932|Hormones|hormones|mesh-ancestor
20402133|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402134|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402135|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20402136|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402137|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
20402138|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
20402139|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402140|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402141|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20402142|NCT01140932|Protective Agents|protective agents|mesh-ancestor
20402143|NCT01140971|Misoprostol|misoprostol|mesh-list
20402144|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20402145|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
20402146|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20402147|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402148|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20402149|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402150|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
20402151|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
20402152|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20402153|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20402154|NCT01140984|Prednisolone|prednisolone|mesh-list
20402155|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
20402156|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19371596|NCT03030378|Growth Substances|growth substances|mesh-ancestor
19371597|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
19371598|NCT03009838|Letrozole|letrozole|mesh-list
20402157|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
20402158|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19690431|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
19690432|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19371599|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371600|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19371601|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19371602|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371603|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371604|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19371605|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
19371606|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371607|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371608|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
19846323|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
20402159|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
20402160|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
20402161|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402162|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402163|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371609|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
19371610|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
19846324|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402164|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
20402165|NCT01140984|Hormones|hormones|mesh-ancestor
19690433|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19846325|NCT00678015|Protective Agents|protective agents|mesh-ancestor
20402166|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371611|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371612|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371613|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371614|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19371615|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
19371616|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371617|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371618|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20402167|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20402168|NCT01140984|Protective Agents|protective agents|mesh-ancestor
20402169|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20402170|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402171|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19371619|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371620|NCT02983747|Loxoprofen|loxoprofen|mesh-list
19371621|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371622|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19371623|NCT02983747|Analgesics|analgesics|mesh-ancestor
19690434|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690435|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690436|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690437|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19690438|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19371624|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
19371625|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371626|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371627|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371628|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371629|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
19371630|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371631|NCT02966119|Aspirin|aspirin|mesh-list
19371632|NCT02966119|Clopidogrel|clopidogrel|mesh-list
19371633|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371634|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19371635|NCT02966119|Analgesics|analgesics|mesh-ancestor
19371636|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
19371637|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371638|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371639|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371640|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371641|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19371642|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19371643|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371644|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19371645|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19371646|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371647|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
19371648|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19371649|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19371650|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19371651|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
19371652|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19371653|NCT02947386|Nivolumab|nivolumab|mesh-list
19371654|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
19371655|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371656|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371657|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371658|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371659|NCT02941926|Letrozole|letrozole|mesh-list
19371660|NCT02941926|Leuprolide|leuprolide|mesh-list
19371661|NCT02941926|Goserelin|goserelin|mesh-list
19690439|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690440|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690441|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19690442|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19690443|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19690444|NCT05017116|Entecavir|entecavir|mesh-list
19690445|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
19690446|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690447|NCT05016869|Capecitabine|capecitabine|mesh-list
20402172|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20402173|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
19371662|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371663|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19371664|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19371665|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371666|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371667|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19371668|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
19371669|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371670|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402174|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402175|NCT01141036|Midazolam|midazolam|mesh-list
20402176|NCT01141036|Propofol|propofol|mesh-list
20402177|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20402178|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402179|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402180|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20402181|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
20402182|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
20402183|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20402184|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20402185|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19371671|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19371672|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
19371673|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19371674|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371675|NCT02870738|Triamcinolone|triamcinolone|mesh-list
19371676|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371677|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
19371678|NCT02870738|Hormones|hormones|mesh-ancestor
19371679|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371680|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371681|NCT02859896|Calcitriol|calcitriol|mesh-list
19371682|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
19371683|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19371684|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371685|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19371686|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19371687|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371688|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19371689|NCT02859896|Vitamins|vitamins|mesh-ancestor
19371690|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
19371691|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19371692|NCT02832167|Nivolumab|nivolumab|mesh-list
19371693|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371694|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371695|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19371696|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371697|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
19371698|NCT02821026|Sirolimus|sirolimus|mesh-list
19690448|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20402186|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20402187|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
20402188|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
20402189|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402190|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402191|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
20402192|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20402193|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20402194|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402195|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
20402196|NCT01141127|Coagulants|coagulants|mesh-ancestor
20402197|NCT01141153|Aspirin|aspirin|mesh-list
20402198|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
20402199|NCT01141153|Clopidogrel|clopidogrel|mesh-list
20402200|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20402201|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20402202|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20402203|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20402204|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
20402205|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402206|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402207|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402208|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20402209|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20402210|NCT01141153|Analgesics|analgesics|mesh-ancestor
20402211|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
20402212|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402213|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402214|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402215|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19371699|NCT02821026|Etanercept|etanercept|mesh-list
19371700|NCT02821026|Tacrolimus|tacrolimus|mesh-list
19371701|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
19371702|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19371703|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371704|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
19371705|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371706|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19371707|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371708|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371709|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19371710|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371711|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19371712|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
19371713|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19371714|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371715|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
19690449|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
19690450|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690451|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690452|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
20402216|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19371716|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371717|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19371718|NCT02821026|Analgesics|analgesics|mesh-ancestor
19371719|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
19371720|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402217|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20402218|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402219|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
20402220|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
20402221|NCT01141192|Vitamin D|vitamin d|mesh-list
20402222|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
20402223|NCT01141192|Vitamins|vitamins|mesh-ancestor
20402224|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
20402225|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402226|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20402227|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19371721|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371722|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371723|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371724|NCT02787239|Rituximab|rituximab|mesh-list
19371725|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371726|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402228|NCT01141244|Sirolimus|sirolimus|mesh-list
20402229|NCT01141244|Irinotecan|irinotecan|mesh-list
20402230|NCT01141244|Temozolomide|temozolomide|mesh-list
20402231|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20402232|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20402233|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402234|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402235|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402236|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20402237|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
20402238|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20402239|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402240|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20402241|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
20402242|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402243|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
20402244|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427024|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427025|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427026|NCT01284309|Urological Agents|urological agents|mesh-ancestor
20427027|NCT01284413|Gemcitabine|gemcitabine|mesh-list
20427028|NCT01284413|Cisplatin|cisplatin|mesh-list
20427029|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371727|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
19371728|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690453|NCT05016713|Fluorides|fluorides|mesh-list
20427030|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371729|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371730|NCT02772081|Poractant alfa|poractant alfa|mesh-list
19371731|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19371732|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
19371733|NCT02754154|Warfarin|warfarin|mesh-list
19371734|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
20402245|NCT01141296|Fenofibrate|fenofibrate|mesh-list
20402246|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20402247|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
20402248|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402249|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20402250|NCT01141309|Everolimus|everolimus|mesh-list
20402251|NCT01141309|Sorafenib|sorafenib|mesh-list
20402252|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371735|NCT02754154|Dabigatran|dabigatran|mesh-list
19371736|NCT02754154|Apixaban|apixaban|mesh-list
19371737|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
20402253|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690454|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
19690455|NCT05016713|Protective Agents|protective agents|mesh-ancestor
19690456|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690457|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19690458|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690459|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
19690460|NCT05016128|Ketamine|ketamine|mesh-list
20211360|NCT00288158|Allopurinol|allopurinol|mesh-list
20211361|NCT00288158|Probenecid|probenecid|mesh-list
20402254|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
20402255|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402256|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19371738|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19371739|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
19371740|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19371741|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
19371742|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371743|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371744|NCT02740179|Eplerenone|eplerenone|mesh-list
19371745|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19371746|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
19371747|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371748|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371749|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19371750|NCT02740179|Diuretics|diuretics|mesh-ancestor
19371751|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
19371752|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19402421|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402422|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402423|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19402424|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20402257|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402258|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402259|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20402260|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20402261|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402262|NCT01141439|Fluticasone|fluticasone|mesh-list
20402263|NCT01141439|Xhance|xhance|mesh-list
19402425|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
20402264|NCT01141439|Beclomethasone|beclomethasone|mesh-list
20402265|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402266|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20402267|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
20402268|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402426|NCT03609294|Linagliptin|linagliptin|mesh-list
19402427|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20211362|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
20211363|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211364|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211365|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
20211366|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211367|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20211368|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
20211369|NCT00288158|Protective Agents|protective agents|mesh-ancestor
20402269|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402270|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19402428|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402429|NCT03609294|Incretins|incretins|mesh-ancestor
19402430|NCT03609294|Hormones|hormones|mesh-ancestor
19690461|NCT05016128|Esketamine|esketamine|mesh-list
19371753|NCT02681237|Olaparib|olaparib|mesh-list
19371754|NCT02681237|Cediranib|cediranib|mesh-list
19371755|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19371756|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371757|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371758|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371759|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19371760|NCT02674529|Citalopram|citalopram|mesh-list
19371761|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20402271|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
20402272|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20402273|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19846326|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846327|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19846328|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846329|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20402274|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
20402275|NCT01141439|Hormones|hormones|mesh-ancestor
20402276|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402277|NCT01141452|Fluticasone|fluticasone|mesh-list
20402278|NCT01141452|Xhance|xhance|mesh-list
20402279|NCT01141452|Beclomethasone|beclomethasone|mesh-list
20402280|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402281|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20402282|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
20402283|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402284|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402285|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20402286|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
20402287|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
20402288|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20402289|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
20402290|NCT01141452|Hormones|hormones|mesh-ancestor
20402291|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402292|NCT01141465|Fluticasone|fluticasone|mesh-list
20402293|NCT01141465|Xhance|xhance|mesh-list
20402294|NCT01141465|Budesonide|budesonide|mesh-list
20402295|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
19371762|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19371763|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19371764|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371765|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19371766|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
19371767|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371768|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19371769|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
19371770|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19371771|NCT02669953|Aflibercept|aflibercept|mesh-list
19371772|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19371773|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19371774|NCT02669953|Growth Substances|growth substances|mesh-ancestor
19371775|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371776|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
19371777|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371778|NCT02659020|Gemcitabine|gemcitabine|mesh-list
19371779|NCT02659020|Docetaxel|docetaxel|mesh-list
19371780|NCT02659020|Olaratumab|olaratumab|mesh-list
19371781|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371782|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
19371783|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371784|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371785|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
19371786|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371787|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371788|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402296|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20402297|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20402298|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20402299|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402300|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20402301|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
19371789|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
20402302|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371790|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371791|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
19846330|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20402303|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402304|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20402305|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
20402306|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
20402307|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20402308|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
20402309|NCT01141465|Hormones|hormones|mesh-ancestor
20402310|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402311|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20402312|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20402313|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20402314|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
20402315|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19371792|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
19371793|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
19371794|NCT02584920|Rituximab|rituximab|mesh-list
19846331|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19846332|NCT00678015|Analgesics|analgesics|mesh-ancestor
19846333|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
19846334|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846335|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846336|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846337|NCT00678080|Metformin|metformin|mesh-list
19846338|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846339|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846340|NCT00678210|Tofacitinib|tofacitinib|mesh-list
19846341|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19846342|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846343|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846344|NCT00678301|Vaccines|vaccines|mesh-list
19846345|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
19846346|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846347|NCT00678379|Lidocaine|lidocaine|mesh-list
19846348|NCT00678379|Clonidine|clonidine|mesh-list
19846349|NCT00678379|Bupivacaine|bupivacaine|mesh-list
19846350|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
19846351|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
19846352|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402316|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402317|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
20402318|NCT01141543|Plerixafor|plerixafor|mesh-list
20402319|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20402320|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20402321|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
20402322|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402323|NCT01141556|Selenium|selenium|mesh-list
20402324|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
19846353|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846354|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
19846355|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846356|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20402325|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402326|NCT01141556|Protective Agents|protective agents|mesh-ancestor
20402327|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846357|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19846358|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19846359|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19846360|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846361|NCT00678379|Analgesics|analgesics|mesh-ancestor
19846362|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19846363|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
19846364|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
20402328|NCT01141556|Trace Elements|trace elements|mesh-ancestor
20402329|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
19371795|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371796|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371797|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
20402330|NCT01141855|Varenicline|varenicline|mesh-list
20402331|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20402332|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19371798|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846365|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20402333|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
20402334|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402335|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371799|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371800|NCT02565914|Ivacaftor|ivacaftor|mesh-list
19371801|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19371802|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19371803|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371804|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
19371805|NCT02550652|Prednisone|prednisone|mesh-list
19371806|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
19371807|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
19371808|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371809|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
19371810|NCT02550652|Hormones|hormones|mesh-ancestor
19371811|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371812|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846366|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19846367|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19846368|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
19371813|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371814|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371815|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19371816|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19371817|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
19371818|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19371819|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371820|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371821|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371822|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
19371823|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
19371824|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371825|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371826|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19371827|NCT02550652|Protective Agents|protective agents|mesh-ancestor
19371828|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19371829|NCT02535832|Pioglitazone|pioglitazone|mesh-list
19371830|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19371831|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371832|NCT02513186|Dexamethasone|dexamethasone|mesh-list
19846369|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846370|NCT00678392|Sorafenib|sorafenib|mesh-list
19846371|NCT00678392|Axitinib|axitinib|mesh-list
19846372|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846373|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19846374|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846375|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846376|NCT00678418|Naltrexone|naltrexone|mesh-list
19846377|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19846378|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19846379|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846380|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
19846381|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846382|NCT00678470|Alefacept|alefacept|mesh-list
19846383|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
19846384|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
20211370|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211371|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
20211372|NCT00288158|Renal Agents|renal agents|mesh-ancestor
20211373|NCT00288171|Allopurinol|allopurinol|mesh-list
20402336|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402337|NCT01141881|Bevacizumab|bevacizumab|mesh-list
20402338|NCT01141881|Plasminogen|plasminogen|mesh-list
20402339|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20402340|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20402341|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402342|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20402343|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20211374|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
20211375|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211376|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211377|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
20402344|NCT01141881|Growth Substances|growth substances|mesh-ancestor
20402345|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371833|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
19846385|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371834|NCT02513186|Lenalidomide|lenalidomide|mesh-list
19371835|NCT02513186|Bortezomib|bortezomib|mesh-list
20211378|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402346|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
20402347|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20402348|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20402349|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402350|NCT01141894|Phenylephrine|phenylephrine|mesh-list
20402351|NCT01141894|Dobutamine|dobutamine|mesh-list
20402352|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
20402353|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20402354|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20402355|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
20402356|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
20402357|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402358|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402359|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
20402360|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20402361|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
20402362|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
20402363|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20402364|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20402365|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20402366|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
20402367|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402368|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690462|NCT05016128|Analgesics|analgesics|mesh-ancestor
19690463|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
19690464|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690465|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690466|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19690467|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19690468|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
19690469|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
19690470|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690471|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19690472|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19690473|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690474|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690475|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
19690476|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690477|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
19690478|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19690479|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19690480|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690481|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19690482|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690483|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690484|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690485|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690486|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20211379|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20211380|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
20211381|NCT00288171|Protective Agents|protective agents|mesh-ancestor
20211382|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211383|NCT00288184|Allopurinol|allopurinol|mesh-list
20211384|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
20211385|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211386|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211387|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
20211388|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211389|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19690487|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
19690488|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19690489|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690490|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19690491|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19690492|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19690493|NCT05016440|Lisinopril|lisinopril|mesh-list
19690494|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19690495|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
19690496|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690497|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690498|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211390|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
20402369|NCT01141894|Protective Agents|protective agents|mesh-ancestor
20402370|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20402371|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20402372|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
20402373|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
20402374|NCT01141972|Vitamin D|vitamin d|mesh-list
20402375|NCT01141972|Vitamins|vitamins|mesh-ancestor
20402376|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
20402377|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402378|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20402379|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
20402380|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
20402381|NCT01141998|Calcium|calcium|mesh-list
20402382|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20402383|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402384|NCT01141998|Vitamins|vitamins|mesh-ancestor
20402385|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
20402386|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20402387|NCT01142011|Belimumab|belimumab|mesh-list
19690499|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19690500|NCT05016440|Protective Agents|protective agents|mesh-ancestor
19690501|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690502|NCT05016349|Tamoxifen|tamoxifen|mesh-list
19371836|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371837|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
20402388|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402389|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
20402390|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402391|NCT01142245|Esomeprazole|esomeprazole|mesh-list
20402392|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20402393|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402394|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20402395|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402396|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402397|NCT01142258|Trazodone|trazodone|mesh-list
20402398|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20402399|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20402400|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402401|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371838|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371839|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371840|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19371841|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
19371842|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371843|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371844|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19371845|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371846|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
19371847|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
19371848|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371849|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371850|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
19371851|NCT02513186|Hormones|hormones|mesh-ancestor
19371852|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371853|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20402402|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20402403|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20402404|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20402405|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20402406|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402407|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402408|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
20402409|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20402410|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
19371854|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19371855|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19371856|NCT02513186|Growth Substances|growth substances|mesh-ancestor
19371857|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
19371858|NCT02373241|Losartan|losartan|mesh-list
19371859|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19371860|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19371861|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19690503|NCT05016349|Tocopherols|tocopherols|mesh-list
19690504|NCT05016349|Tretinoin|tretinoin|mesh-list
20402411|NCT01142284|Cilostazol|cilostazol|mesh-list
20402412|NCT01142284|Probucol|probucol|mesh-list
20402413|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20402414|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
20402415|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402416|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402417|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20402418|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
20402419|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20402420|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20402421|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402422|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20402423|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
20402424|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20402425|NCT01142284|Protective Agents|protective agents|mesh-ancestor
20402426|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20402427|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20402428|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402429|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20402430|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20402431|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
20402432|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19371862|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19371863|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371864|NCT02005471|Rituximab|rituximab|mesh-list
19371865|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19371866|NCT02005471|Venetoclax|venetoclax|mesh-list
19371867|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20211391|NCT00288184|Protective Agents|protective agents|mesh-ancestor
20211392|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211393|NCT00288197|Voriconazole|voriconazole|mesh-list
20211394|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
20613132|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613133|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20613134|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20211395|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211396|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19371868|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371869|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
19371870|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371871|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371872|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19371873|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
19371874|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371875|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
20402433|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
20402434|NCT01142401|Bortezomib|bortezomib|mesh-list
20402435|NCT01142401|Fulvestrant|fulvestrant|mesh-list
20402436|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402437|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371876|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19371877|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19371878|NCT01941589|Prednisolone|prednisolone|mesh-list
19371879|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
19371880|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
19371881|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19371882|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19371883|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19371884|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19371885|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
19371886|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19371887|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
19371888|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
19371889|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19371890|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371891|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19371892|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
19371893|NCT01941589|Hormones|hormones|mesh-ancestor
19371894|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371895|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19371896|NCT01941589|Protective Agents|protective agents|mesh-ancestor
19690505|NCT05016349|Alitretinoin|alitretinoin|mesh-list
20211397|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20211398|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211399|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211400|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20211401|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
19371897|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19371898|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371899|NCT01845649|Estradiol|estradiol|mesh-list
19371900|NCT01845649|Estrogens|estrogens|mesh-ancestor
19371901|NCT01845649|Hormones|hormones|mesh-ancestor
20402438|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20402439|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20402440|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
20402441|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402442|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402443|NCT01142414|Fluorouracil|fluorouracil|mesh-list
20402444|NCT01142414|Panitumumab|panitumumab|mesh-list
20402445|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402446|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
20402447|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402448|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20402449|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402450|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
20402451|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402452|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20402453|NCT01142453|Interferons|interferons|mesh-list
20402454|NCT01142453|Interferon-beta|interferon-beta|mesh-list
20402455|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
20402456|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402457|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
20402458|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371902|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371903|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371904|NCT01844986|Olaparib|olaparib|mesh-list
19371905|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19371906|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371907|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371908|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371909|NCT01816139|Estradiol|estradiol|mesh-list
19371910|NCT01816139|Estrogens|estrogens|mesh-ancestor
19371911|NCT01816139|Hormones|hormones|mesh-ancestor
19371912|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371913|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371914|NCT01684397|Bevacizumab|bevacizumab|mesh-list
19371915|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19371916|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
20402459|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
20402460|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402461|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20402462|NCT01142492|Interferons|interferons|mesh-list
20402463|NCT01142492|Interferon-beta|interferon-beta|mesh-list
20402464|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
20402465|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402466|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
20402467|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402468|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
20402469|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402470|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20402471|NCT01142505|Mannitol|mannitol|mesh-list
20402472|NCT01142505|Montelukast|montelukast|mesh-list
20402473|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20402474|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
20402475|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20402476|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
20402477|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402478|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402479|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19371917|NCT01684397|Antibodies|antibodies|mesh-list
19371918|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
19371919|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19371920|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
19371921|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371922|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19371923|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19371924|NCT01684397|Growth Substances|growth substances|mesh-ancestor
19371925|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371926|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
19371927|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
19371928|NCT01455597|Estradiol|estradiol|mesh-list
20427031|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
19371929|NCT01455597|Estrogens|estrogens|mesh-ancestor
19371930|NCT01455597|Hormones|hormones|mesh-ancestor
19371931|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371932|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371933|NCT01453088|Bortezomib|bortezomib|mesh-list
19371934|NCT01453088|Melphalan|melphalan|mesh-list
19371935|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371936|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19371937|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
19371938|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371939|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19846386|NCT00678535|Capecitabine|capecitabine|mesh-list
19846387|NCT00678535|Cetuximab|cetuximab|mesh-list
19846388|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402480|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20402481|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402482|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20402483|NCT01142505|Diuretics|diuretics|mesh-ancestor
20402484|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
20402485|NCT01142518|Interferons|interferons|mesh-list
20402486|NCT01142518|Interferon-beta|interferon-beta|mesh-list
20402487|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
20402488|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402489|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
20402490|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402491|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
20402492|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402493|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20402494|NCT01142557|Interferons|interferons|mesh-list
20402495|NCT01142557|Interferon-beta|interferon-beta|mesh-list
20402496|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
20402497|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402498|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
20402499|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402500|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
20402501|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402502|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19371940|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371941|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
19371942|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371943|NCT01400776|Estradiol|estradiol|mesh-list
19371944|NCT01400776|Estrogens|estrogens|mesh-ancestor
19371945|NCT01400776|Hormones|hormones|mesh-ancestor
19371946|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19371947|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371948|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
19371949|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
19371950|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371951|NCT01182766|Topiramate|topiramate|mesh-list
19371952|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
19371953|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19690506|NCT05016349|Cannabidiol|cannabidiol|mesh-list
19690507|NCT05016349|Isotretinoin|isotretinoin|mesh-list
19690508|NCT05016349|Mifepristone|mifepristone|mesh-list
19690509|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19690510|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
19690511|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690512|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690513|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19690514|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690515|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20211402|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846389|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19846390|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
20211403|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211404|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20211405|NCT00288223|Telithromycin|telithromycin|mesh-list
20211406|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211407|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211408|NCT00288236|Rimonabant|rimonabant|mesh-list
20211409|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20211410|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20211411|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20211412|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402503|NCT01142622|Ropivacaine|ropivacaine|mesh-list
19371954|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402504|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
19371955|NCT00936936|Gemcitabine|gemcitabine|mesh-list
19371956|NCT00936936|Carboplatin|carboplatin|mesh-list
19371957|NCT00936936|Docetaxel|docetaxel|mesh-list
19371958|NCT00936936|Etoposide|etoposide|mesh-list
19371959|NCT00936936|Melphalan|melphalan|mesh-list
19371960|NCT00936936|Ifosfamide|ifosfamide|mesh-list
19371961|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371962|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371963|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
19371964|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371965|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
19371966|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19371967|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371968|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371969|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
19371970|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371971|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
19371972|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
19371973|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
19371974|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19371975|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19371976|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19371977|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19371978|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
20402505|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
20402506|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402507|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402508|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
20402509|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402510|NCT01142635|Bromides|bromides|mesh-list
20402511|NCT01142635|Rocuronium|rocuronium|mesh-list
20402512|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
20402513|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19371979|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19371980|NCT00783536|Etanercept|etanercept|mesh-list
19371981|NCT00783536|Methotrexate|methotrexate|mesh-list
19371982|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19371983|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
19371984|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19371985|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19371986|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19371987|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
19371988|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19371989|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19371990|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
19371991|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19371992|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19371993|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19371994|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
19371995|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19371996|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19371997|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19371998|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19690516|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19690517|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19690518|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
20211413|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211414|NCT00288236|Hormones|hormones|mesh-ancestor
20211415|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211416|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211417|NCT00288249|Sagopilone|sagopilone|mesh-list
20211418|NCT00288249|Epothilones|epothilones|mesh-list
20211419|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211420|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211421|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211422|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211423|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211424|NCT00288262|Melatonin|melatonin|mesh-list
20211425|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
20211426|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211427|NCT00288262|Protective Agents|protective agents|mesh-ancestor
20211428|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211429|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19371999|NCT00783536|Analgesics|analgesics|mesh-ancestor
19372000|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
20211430|NCT00288353|Aripiprazole|aripiprazole|mesh-list
19372001|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372002|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372003|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402514|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20402515|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20402516|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402517|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402518|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
20402519|NCT01142648|Neostigmine|neostigmine|mesh-list
20402520|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20402521|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402522|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402523|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
20402524|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402525|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402526|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20402527|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
20402528|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402529|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20402530|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20402531|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20402532|NCT01142700|Ribavirin|ribavirin|mesh-list
20402533|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20402534|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
20402535|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402536|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
20402537|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402538|NCT01142778|Bevacizumab|bevacizumab|mesh-list
20402539|NCT01142778|Trastuzumab|trastuzumab|mesh-list
20402540|NCT01142778|Docetaxel|docetaxel|mesh-list
19372004|NCT00695214|Propofol|propofol|mesh-list
19372005|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19372006|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372007|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372008|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19372009|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
20402541|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20402542|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402543|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20402544|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20402545|NCT01142778|Growth Substances|growth substances|mesh-ancestor
20402546|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402547|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
20402548|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
20402549|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
20402550|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
20402551|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402552|NCT01142843|Propolis|propolis|mesh-list
20402553|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402554|NCT01142869|Cetuximab|cetuximab|mesh-list
20402555|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372010|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
19372011|NCT00511134|Eszopiclone|eszopiclone|mesh-list
19372012|NCT00511134|Bupropion|bupropion|mesh-list
19372013|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19372014|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
19372015|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19372016|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19372017|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19372018|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19372019|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372020|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
20211431|NCT00288353|Ziprasidone|ziprasidone|mesh-list
20211432|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
20211433|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20211434|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20211435|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211436|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211437|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211438|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
20211439|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
20402556|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402557|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
19372021|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402558|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19372022|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372023|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19372024|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19372025|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372026|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19372027|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372028|NCT04057469|Tulobuterol|tulobuterol|mesh-list
19372029|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19372030|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19372031|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
19690519|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
19690520|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
19690521|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19690522|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
19690523|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19690524|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19690525|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19690526|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19690527|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
19690528|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20402559|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20402560|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372032|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372033|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372034|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372035|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19372036|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
19372037|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372038|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19372039|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
19372040|NCT04020809|Atezolizumab|atezolizumab|mesh-list
19372041|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372042|NCT04005209|Ketamine|ketamine|mesh-list
19372043|NCT04005209|Analgesics|analgesics|mesh-ancestor
19372044|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
19372045|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372046|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372047|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19372048|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19372049|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
19372050|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
19372051|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372052|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19372053|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19372054|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372055|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372056|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
19372057|NCT03961789|Narcotics|narcotics|mesh-ancestor
19372058|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372059|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372060|NCT03961789|Analgesics|analgesics|mesh-ancestor
19372061|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
20402561|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
20402562|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
20427032|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427033|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
20427034|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427035|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427036|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427037|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
20427038|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427039|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
20427040|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20427041|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
20427042|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427043|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
20427044|NCT01284439|Protective Agents|protective agents|mesh-ancestor
20427045|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
20427046|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427047|NCT01284478|Dexamethasone|dexamethasone|mesh-list
19372062|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372063|NCT03951870|Vaccines|vaccines|mesh-list
19372064|NCT03951870|Immunologic Factors|immunologic factors|mesh-ancestor
19372065|NCT03951870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372066|NCT03912064|Ipilimumab|ipilimumab|mesh-list
20402563|NCT01143025|Ropivacaine|ropivacaine|mesh-list
20402564|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
20402565|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
20402566|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402567|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402568|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
20402569|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402570|NCT01143129|Dexamethasone|dexamethasone|mesh-list
20402571|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402572|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
20402573|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
20402574|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402575|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402576|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402577|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
20402578|NCT01143129|Hormones|hormones|mesh-ancestor
20402579|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402580|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20402581|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402582|NCT01143545|Celecoxib|celecoxib|mesh-list
20402583|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
20402584|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402585|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
20402586|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402587|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402588|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20402589|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
20402590|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402591|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402592|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20402593|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20402594|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20402595|NCT01143545|Analgesics|analgesics|mesh-ancestor
20402596|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
20402597|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402598|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402599|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20402600|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20402601|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402602|NCT01143584|Dopamine|dopamine|mesh-list
20402603|NCT01143584|Cabergoline|cabergoline|mesh-list
20402604|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
20402605|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20402606|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
20402607|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
20402608|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402609|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402610|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
20402611|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402612|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402613|NCT01143584|Protective Agents|protective agents|mesh-ancestor
20402614|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20402615|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20402616|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20402617|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
20402618|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402619|NCT01143805|Tofacitinib|tofacitinib|mesh-list
20402620|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20402621|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402622|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402623|NCT01143831|Vitamins|vitamins|mesh-list
20402624|NCT01143831|Vitamin K|vitamin k|mesh-list
20402625|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
20402626|NCT01143831|Menatetrenone|menatetrenone|mesh-list
19372067|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372068|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402627|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
20402628|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402629|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20402630|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20402631|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402632|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
20402633|NCT01143831|Coagulants|coagulants|mesh-ancestor
19693046|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19693047|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19693048|NCT04983966|Desflurane|desflurane|mesh-list
19846391|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402634|NCT01143857|Varenicline|varenicline|mesh-list
20402635|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20402636|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20402637|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
20402638|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402639|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402640|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402641|NCT01143948|Insulin|insulin|mesh-list
20402642|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20402643|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20402644|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402645|NCT01143974|Pemetrexed|pemetrexed|mesh-list
20402646|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402647|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402648|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402649|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20402650|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19846392|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846393|NCT00678561|Tofacitinib|tofacitinib|mesh-list
19846394|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20402651|NCT01143987|Cinacalcet|cinacalcet|mesh-list
20402652|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20402653|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402654|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20402655|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
20402656|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402657|NCT01144000|Daptomycin|daptomycin|mesh-list
20402658|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20402659|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402660|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
20402661|NCT01144065|Testosterone|testosterone|mesh-list
20402662|NCT01144065|Androgens|androgens|mesh-ancestor
20402663|NCT01144065|Hormones|hormones|mesh-ancestor
20402664|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20402665|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402666|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402667|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
20402668|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20402669|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402670|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402671|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20402672|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19372069|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19372070|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690529|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19690530|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
19690531|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19372071|NCT03894540|Paclitaxel|paclitaxel|mesh-list
19372072|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
19372073|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372074|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372075|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690532|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19690533|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
19690534|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690535|NCT05016349|Protective Agents|protective agents|mesh-ancestor
19372076|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372077|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372078|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372079|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372080|NCT03873675|Hormones|hormones|mesh-list
19372081|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
19372082|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372083|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372084|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19402431|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402432|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19402433|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
19690536|NCT05016349|Vitamins|vitamins|mesh-ancestor
19690537|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
19690538|NCT05016180|Ropivacaine|ropivacaine|mesh-list
19372085|NCT03826992|Cytarabine|cytarabine|mesh-list
19372086|NCT03826992|Daunorubicin|daunorubicin|mesh-list
19372087|NCT03826992|Venetoclax|venetoclax|mesh-list
19372088|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19372089|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
19372090|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372091|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372092|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
19372093|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372094|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372095|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
19372096|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372097|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19372098|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19372099|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19372100|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372101|NCT03740529|Rituximab|rituximab|mesh-list
19372102|NCT03740529|Venetoclax|venetoclax|mesh-list
19372103|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372104|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372105|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
19372106|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372107|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372108|NCT03728179|Aspirin|aspirin|mesh-list
19372109|NCT03728179|Celecoxib|celecoxib|mesh-list
19372110|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
19372111|NCT03728179|Nivolumab|nivolumab|mesh-list
19372112|NCT03728179|Ipilimumab|ipilimumab|mesh-list
19372113|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372114|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
19372115|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372116|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372117|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19372118|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
19372119|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372120|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372121|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19372122|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372123|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19372124|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19372125|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19372126|NCT03728179|Analgesics|analgesics|mesh-ancestor
20402673|NCT01144091|Protective Agents|protective agents|mesh-ancestor
20402674|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402675|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
20402676|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20402677|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
20402678|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
20402679|NCT01144117|Hematinics|hematinics|mesh-ancestor
20402680|NCT01144156|Adalimumab|adalimumab|mesh-list
20402681|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402682|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402683|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
20402684|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
20402685|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20402686|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20402687|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402688|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402689|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402690|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402691|NCT01144195|Panitumumab|panitumumab|mesh-list
20402692|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20402693|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402694|NCT01144260|Bafetinib|bafetinib|mesh-list
20402695|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20402696|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402697|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402698|NCT01144312|Fentanyl|fentanyl|mesh-list
20402699|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20402700|NCT01144312|Narcotics|narcotics|mesh-ancestor
20402701|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372127|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
19372128|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372129|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372130|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20402702|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402703|NCT01144312|Analgesics|analgesics|mesh-ancestor
20402704|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
19372131|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19372132|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19372133|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19372134|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372135|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
19372136|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20402705|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402706|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20402707|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19690539|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
19690540|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
19690541|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690542|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690543|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
19690544|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690545|NCT05016063|Fludarabine|fludarabine|mesh-list
19690546|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
19690547|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690548|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402708|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
20402709|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
20402710|NCT01144390|Methadone|methadone|mesh-list
20402711|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20402712|NCT01144390|Narcotics|narcotics|mesh-ancestor
20402713|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402714|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402715|NCT01144390|Analgesics|analgesics|mesh-ancestor
20402716|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
20402717|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402718|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
19372137|NCT03626376|Valacyclovir|valacyclovir|mesh-list
19372138|NCT03626376|Acyclovir|acyclovir|mesh-list
19372139|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19372140|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19372141|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
19372142|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372143|NCT03556358|Paclitaxel|paclitaxel|mesh-list
19372144|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
19372145|NCT03556358|Trastuzumab|trastuzumab|mesh-list
19372146|NCT03556358|Epirubicin|epirubicin|mesh-list
19372147|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372148|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372149|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372150|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372151|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372152|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372153|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372154|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
19372155|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372156|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372157|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19372158|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
19690549|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690550|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
19693186|NCT04981899|Etoposide|etoposide|mesh-list
20211440|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211441|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211442|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20211443|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20211444|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
20211445|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20211446|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20211447|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20211448|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20211449|NCT00288379|Budesonide|budesonide|mesh-list
20211450|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
20211451|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20211452|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20211453|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
20211454|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211455|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211456|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20402719|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
19846395|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372159|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20402720|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
20211457|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
20211458|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
20211459|NCT00288379|Hormones|hormones|mesh-ancestor
20211460|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211461|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20211462|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19372160|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372161|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19372162|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19372163|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19372164|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372165|NCT03555578|Leuprolide|leuprolide|mesh-list
19372166|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19372167|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
19372168|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20402721|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20402722|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
20402723|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372169|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372170|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19372171|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372172|NCT03539302|Flecainide|flecainide|mesh-list
19372173|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19372174|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19372175|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19372176|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19372177|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372178|NCT03520790|Gemcitabine|gemcitabine|mesh-list
19372179|NCT03520790|Paclitaxel|paclitaxel|mesh-list
19372180|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372181|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372182|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372183|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372184|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372185|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372186|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19372187|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
19372188|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
20402724|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
20402725|NCT01144533|Protective Agents|protective agents|mesh-ancestor
20402726|NCT01144650|Dapsone|dapsone|mesh-list
20402727|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402728|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
19372189|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372190|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372191|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372192|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
19372193|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372194|NCT03490760|Durvalumab|durvalumab|mesh-list
19372195|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372196|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372197|NCT03436108|Bisphenol A|bisphenol a|mesh-list
19372198|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19372199|NCT03436108|Estrogens|estrogens|mesh-ancestor
19372200|NCT03436108|Hormones|hormones|mesh-ancestor
19372201|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372202|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372203|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19372204|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
19402434|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211463|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20211464|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
20211465|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211466|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211467|NCT00288431|Sirolimus|sirolimus|mesh-list
20211468|NCT00288431|Doxorubicin|doxorubicin|mesh-list
20211469|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20211470|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211471|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20211472|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211473|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211474|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211475|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211476|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372205|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372206|NCT03436108|Protective Agents|protective agents|mesh-ancestor
19372207|NCT03433248|Empagliflozin|empagliflozin|mesh-list
19372208|NCT03433248|Gliclazide|gliclazide|mesh-list
19372209|NCT03433248|Linagliptin|linagliptin|mesh-list
19372210|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19372211|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372212|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19372213|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372214|NCT03433248|Incretins|incretins|mesh-ancestor
19372215|NCT03433248|Hormones|hormones|mesh-ancestor
19372216|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372217|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19372218|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
19372219|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372220|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
19372221|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19372222|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372223|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372224|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19372225|NCT03417999|Analgesics|analgesics|mesh-ancestor
19372226|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
19372227|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372228|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19372229|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19372230|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19372231|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372232|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372233|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372234|NCT03348670|BCG Vaccine|bcg vaccine|mesh-list
19372235|NCT03348670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19372236|NCT03348670|Immunologic Factors|immunologic factors|mesh-ancestor
19372237|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372238|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
19372239|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372240|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372241|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
19372242|NCT03263559|Thiotepa|thiotepa|mesh-list
19372243|NCT03263559|Fludarabine|fludarabine|mesh-list
19372244|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
19372245|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
19372246|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372247|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
19372248|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372249|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372250|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19372251|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
20402729|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20402730|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20402731|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20402732|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402733|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402734|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
20402735|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20402736|NCT01144676|Dapivirine|dapivirine|mesh-list
20402737|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20402738|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20402739|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
19372252|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372253|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372254|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19372255|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
19372256|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372257|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19372258|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19372259|NCT03228680|Hormones|hormones|mesh-ancestor
19372260|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372261|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372262|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
19372263|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
19372264|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19372265|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
19372266|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402740|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402741|NCT01144702|Artesunate|artesunate|mesh-list
20402742|NCT01144702|Mefloquine|mefloquine|mesh-list
20402743|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
20402744|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20402745|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20402746|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402747|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402748|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
20402749|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
20402750|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20402751|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
20402752|NCT01144728|Metformin|metformin|mesh-list
20402753|NCT01144728|Glimepiride|glimepiride|mesh-list
20402754|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20402755|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402756|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20402757|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402758|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
20402759|NCT01144754|Rituximab|rituximab|mesh-list
20402760|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20402761|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402762|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
20402763|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402764|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402765|NCT01144832|Ebastine|ebastine|mesh-list
19372267|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372268|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372269|NCT03112174|Venetoclax|venetoclax|mesh-list
19372270|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372271|NCT03082729|Apremilast|apremilast|mesh-list
19372272|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19372273|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19372274|NCT03082729|Analgesics|analgesics|mesh-ancestor
19372275|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
19372276|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372277|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372278|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372279|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372280|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19372281|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19372282|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372283|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372284|NCT03062826|Aspirin|aspirin|mesh-list
19372285|NCT03062826|Clopidogrel|clopidogrel|mesh-list
20211477|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
20211478|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211479|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
20211480|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211481|NCT00288444|Docetaxel|docetaxel|mesh-list
20211482|NCT00288444|Lonafarnib|lonafarnib|mesh-list
20211483|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402766|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19372286|NCT03062826|Ticagrelor|ticagrelor|mesh-list
19372287|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19372288|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19372289|NCT03062826|Analgesics|analgesics|mesh-ancestor
19372290|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
19372291|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402767|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
20402768|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
20402769|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402770|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402771|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402772|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
20402773|NCT01144910|Miotics|miotics|mesh-ancestor
20402774|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
20402775|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402776|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402777|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20402778|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20402779|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
19372292|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211484|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372293|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372294|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402780|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20402781|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20402782|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
20402783|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402784|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402785|NCT01144923|Gabapentin|gabapentin|mesh-list
20402786|NCT01144923|Nortriptyline|nortriptyline|mesh-list
20402787|NCT01144923|Analgesics|analgesics|mesh-ancestor
20402788|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
20402789|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402790|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402791|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
20402792|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19372295|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19372296|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19372297|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372298|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19372299|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19372300|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372301|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
19372302|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19372303|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19372304|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19372305|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
19372306|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372307|NCT03029611|Paclitaxel|paclitaxel|mesh-list
19372308|NCT03029611|Carboplatin|carboplatin|mesh-list
19372309|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19372310|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372311|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372312|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372313|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372314|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372315|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211485|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211486|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211487|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211488|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211489|NCT00288470|Hylan|hylan|mesh-list
20211490|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
20211491|NCT00288470|Protective Agents|protective agents|mesh-ancestor
20211492|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402793|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20402794|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372316|NCT03024996|Atezolizumab|atezolizumab|mesh-list
19372317|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372318|NCT02914977|Daunorubicin|daunorubicin|mesh-list
19372319|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19372320|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372321|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19372322|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19372323|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372324|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372325|NCT02891798|Dexamethasone|dexamethasone|mesh-list
19372326|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
19372327|NCT02891798|Clonidine|clonidine|mesh-list
19372328|NCT02891798|Buprenorphine|buprenorphine|mesh-list
19372329|NCT02891798|Bupivacaine|bupivacaine|mesh-list
19372330|NCT02891798|BB 1101|bb 1101|mesh-list
19372331|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372332|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
19372333|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
19372334|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372335|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372336|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19372337|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
19372338|NCT02891798|Hormones|hormones|mesh-ancestor
19372339|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372340|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19372341|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372342|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
19372343|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372344|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372345|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
19372346|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
19372347|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372348|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
19372349|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19372350|NCT02891798|Narcotics|narcotics|mesh-ancestor
20211493|NCT00288483|Policosanol|policosanol|mesh-list
19372351|NCT02891798|Analgesics|analgesics|mesh-ancestor
19372352|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19372353|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19372354|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
19372355|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20402795|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20402796|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20402797|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20402798|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402799|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402800|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
20402801|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20402802|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
20402803|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20402804|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20402805|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19372356|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19372357|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19372358|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372359|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372360|NCT02870218|Nicotine|nicotine|mesh-list
19372361|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19372362|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
19372363|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372364|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372365|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19372366|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19372367|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
19372368|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372369|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372370|NCT02864992|Tepotinib|tepotinib|mesh-list
19372371|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372372|NCT02859961|Leronlimab|leronlimab|mesh-list
19372373|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
20402806|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
20402807|NCT01144988|Bevacizumab|bevacizumab|mesh-list
20402808|NCT01144988|Irinotecan|irinotecan|mesh-list
20402809|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20402810|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402811|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20402812|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20402813|NCT01144988|Growth Substances|growth substances|mesh-ancestor
20402814|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402815|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
19372374|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19690551|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690552|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19690553|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19690554|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
20402816|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19372375|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19372376|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372377|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20402817|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20402818|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402819|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402820|NCT01145079|Sirolimus|sirolimus|mesh-list
20402821|NCT01145079|Everolimus|everolimus|mesh-list
20402822|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402823|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402824|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
19372378|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19372379|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
19372380|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372381|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
19372382|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372383|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
19372384|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372385|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372386|NCT02679781|Midazolam|midazolam|mesh-list
19372387|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19372388|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19690555|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19372389|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372390|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372391|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19372392|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19372393|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19372394|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19372395|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
19372396|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
19372397|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
19372398|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
19372399|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372400|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372401|NCT02624869|Evolocumab|evolocumab|mesh-list
19372402|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19372403|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19372404|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
19372405|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372406|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19372407|NCT02614690|Calpastatin|calpastatin|mesh-list
19372408|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19372409|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
19372410|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372411|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372412|NCT02595424|Carboplatin|carboplatin|mesh-list
19372413|NCT02595424|Capecitabine|capecitabine|mesh-list
19372414|NCT02595424|Etoposide|etoposide|mesh-list
19372415|NCT02595424|Temozolomide|temozolomide|mesh-list
19372416|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372417|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19372418|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
19372419|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372420|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372421|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19372422|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20402825|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402826|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20402827|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402828|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20402829|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
20427048|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427049|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
20427050|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
20427051|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427052|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427053|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427054|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
20427055|NCT01284478|Hormones|hormones|mesh-ancestor
20427056|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427057|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20427058|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427059|NCT01284556|Phenobarbital|phenobarbital|mesh-list
20427060|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
20427061|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20427062|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20427063|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427064|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20427065|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19372423|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372424|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19372425|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
19372426|NCT02569242|Paclitaxel|paclitaxel|mesh-list
19372427|NCT02569242|Docetaxel|docetaxel|mesh-list
19372428|NCT02569242|Nivolumab|nivolumab|mesh-list
19372429|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372430|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427066|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427067|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427068|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
20427069|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
19372431|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372432|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372433|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372434|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372435|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19372436|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19846396|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846397|NCT00678652|Vaccines|vaccines|mesh-list
20402830|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20402831|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20402832|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
20402833|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402834|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
20402835|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20402836|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402837|NCT01145326|Lidocaine|lidocaine|mesh-list
20402838|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
20402839|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
19846398|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
19846399|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846400|NCT00678691|Modafinil|modafinil|mesh-list
20402840|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402841|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402842|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
20402843|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402844|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20402845|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20402846|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20402847|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20402848|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402849|NCT01145365|Anesthetics|anesthetics|mesh-list
20402850|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402851|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402852|NCT01145404|Capecitabine|capecitabine|mesh-list
20402853|NCT01145404|Lapatinib|lapatinib|mesh-list
20402854|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20402855|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
20402856|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402857|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402858|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20402859|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402860|NCT01145430|Doxorubicin|doxorubicin|mesh-list
20402861|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20402862|NCT01145430|Veliparib|veliparib|mesh-list
20402863|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20402864|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402865|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20402866|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20402867|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402868|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402869|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20402870|NCT01145456|Gemcitabine|gemcitabine|mesh-list
20402871|NCT01145456|R04929097|r04929097|mesh-list
20402872|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19846401|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19846402|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372437|NCT02435433|Ramucirumab|ramucirumab|mesh-list
19372438|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372439|NCT02426125|Docetaxel|docetaxel|mesh-list
19372440|NCT02426125|Ramucirumab|ramucirumab|mesh-list
19372441|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372442|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372443|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211494|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20211495|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20211496|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
20211497|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211498|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20402873|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
20402874|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402875|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402876|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
20402877|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372444|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372445|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372446|NCT02417142|Exenatide|exenatide|mesh-list
19846403|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20211499|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20211500|NCT00288522|Lanreotide|lanreotide|mesh-list
20211501|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211502|NCT00288535|Sirolimus|sirolimus|mesh-list
20402878|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372447|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19372448|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372449|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19372450|NCT02417142|Incretins|incretins|mesh-ancestor
19372451|NCT02417142|Hormones|hormones|mesh-ancestor
19690556|NCT05015907|Ropivacaine|ropivacaine|mesh-list
19690557|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
19690558|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
19690559|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690560|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846404|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19846405|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19846406|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846407|NCT00678795|Nabiximols|nabiximols|mesh-list
19846408|NCT00678795|Analgesics|analgesics|mesh-ancestor
19846409|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
19846410|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372452|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372453|NCT02368886|Clobetasol|clobetasol|mesh-list
19372454|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372455|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
19372456|NCT02368886|Hormones|hormones|mesh-ancestor
19690561|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
19690562|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690563|NCT05015595|Memantine|memantine|mesh-list
19690564|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19690565|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19690566|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
19690567|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690568|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846411|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372457|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372458|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372459|NCT02354703|Ondansetron|ondansetron|mesh-list
19372460|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
19372461|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
19372462|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402879|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402880|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
20402881|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402882|NCT01145534|Glyburide|glyburide|mesh-list
20402883|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20402884|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402885|NCT01145573|Calcium|calcium|mesh-list
20402886|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20402887|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402888|NCT01145612|Losartan|losartan|mesh-list
20402889|NCT01145612|Atenolol|atenolol|mesh-list
20402890|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20402891|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20402892|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20402893|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20402894|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402895|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
20402896|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
20402897|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402898|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402899|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20402900|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20402901|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19372463|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372464|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19846412|NCT00678834|Tocopherols|tocopherols|mesh-list
19372465|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
20211503|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211504|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211505|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20211506|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211507|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
20211508|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211509|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
20211510|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211511|NCT00288548|Metoprolol|metoprolol|mesh-list
20211512|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20211513|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211514|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
19846413|NCT00678834|Vitamin E|vitamin e|mesh-list
19846414|NCT00678834|Tocotrienols|tocotrienols|mesh-list
19846415|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
19846416|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
19846417|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846418|NCT00678834|Protective Agents|protective agents|mesh-ancestor
19846419|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846420|NCT00678834|Vitamins|vitamins|mesh-ancestor
19846421|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
19846422|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
19846423|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
19846424|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846425|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846426|NCT00679029|Gemcitabine|gemcitabine|mesh-list
19846427|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
19846428|NCT00679029|Bevacizumab|bevacizumab|mesh-list
19846429|NCT00679029|Doxorubicin|doxorubicin|mesh-list
19846430|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19846431|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19846432|NCT00679029|Antibodies|antibodies|mesh-list
19846433|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
19846434|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19846435|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846436|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846437|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846438|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
20402902|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
20402903|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402904|NCT01145677|Topiramate|topiramate|mesh-list
19372466|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
19372467|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19372468|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
19372469|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372470|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372471|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19846439|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846440|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846441|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19846442|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
20402905|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
20402906|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20402907|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402908|NCT01145703|Vitamin D|vitamin d|mesh-list
20402909|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
20402910|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
20402911|NCT01145703|Vitamins|vitamins|mesh-list
20402912|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
20402913|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402914|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20402915|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20402916|NCT01145807|Terbinafine|terbinafine|mesh-list
20402917|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
20402918|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846443|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19372472|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19846444|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20402919|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402920|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402921|NCT01145846|Cytarabine|cytarabine|mesh-list
20402922|NCT01145846|Daunorubicin|daunorubicin|mesh-list
20402923|NCT01145846|Idarubicin|idarubicin|mesh-list
20402924|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20402925|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
20402926|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402927|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20402928|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
20402929|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20402930|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402931|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
20402932|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372473|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20402933|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19846445|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846446|NCT00679029|Growth Substances|growth substances|mesh-ancestor
19846447|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
20402934|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20402935|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20402936|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402937|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
19690569|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690570|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19690571|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19693049|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19693050|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
19693051|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
19693052|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693053|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693054|NCT04983550|Doxorubicin|doxorubicin|mesh-list
19693055|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19693056|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19693057|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372474|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19372475|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19402435|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404693|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404694|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404695|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
19404696|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404697|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404698|NCT03592537|Narcotics|narcotics|mesh-ancestor
19404699|NCT03592537|Analgesics|analgesics|mesh-ancestor
19404700|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19404701|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19404702|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
19404703|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19404704|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19404705|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19404706|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20402938|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20402939|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
20402940|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20402941|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
20402942|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402943|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402944|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
20402945|NCT01145950|Etanercept|etanercept|mesh-list
20402946|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20402947|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20402948|NCT01145950|Analgesics|analgesics|mesh-ancestor
20402949|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
20402950|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402951|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402952|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20402953|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402954|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20402955|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402956|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
20402957|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
20402958|NCT01145976|Fludarabine|fludarabine|mesh-list
20402959|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
20402960|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19404707|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
19404708|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
19404709|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404710|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404711|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
19846448|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19846449|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
19846450|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
19846451|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846452|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404712|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19404713|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19404714|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404715|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19404716|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19693187|NCT04981899|Ifosfamide|ifosfamide|mesh-list
20211515|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
20211516|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211517|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211518|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20211519|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20211520|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20211521|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
20402961|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20402962|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
20402963|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402964|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20402965|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19846453|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19372476|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19372477|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19372478|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372479|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372480|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
19372481|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372482|NCT00796068|Cyclosporine|cyclosporine|mesh-list
19372483|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
19372484|NCT00796068|Fludarabine|fludarabine|mesh-list
19372485|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
19372486|NCT00796068|Treosulfan|treosulfan|mesh-list
19372487|NCT00796068|Busulfan|busulfan|mesh-list
19372488|NCT00796068|Cyclosporins|cyclosporins|mesh-list
19372489|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372490|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19372491|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
19372492|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372493|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372494|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
19372495|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372496|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402966|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
20402967|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402968|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372497|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
19372498|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372499|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
19372500|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372501|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19372502|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19372503|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19372504|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
19372505|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19372506|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20402969|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20402970|NCT01146002|Guanfacine|guanfacine|mesh-list
20402971|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20402972|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20402973|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20402974|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20402975|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372507|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
19372508|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19372509|NCT00468130|Aripiprazole|aripiprazole|mesh-list
19372510|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
19372511|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19372512|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19372513|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19372514|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372515|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372516|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
19372517|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
19372518|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846454|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19846455|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19846456|NCT00679042|Exenatide|exenatide|mesh-list
19846457|NCT00679042|Sirolimus|sirolimus|mesh-list
19846458|NCT00679042|Etanercept|etanercept|mesh-list
19846459|NCT00679042|Tacrolimus|tacrolimus|mesh-list
19846460|NCT00679042|Basiliximab|basiliximab|mesh-list
19846461|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846462|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
19846463|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846464|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19846465|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846466|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402976|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372519|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372520|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20402977|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402978|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402979|NCT01146028|Tizanidine|tizanidine|mesh-list
20402980|NCT01146028|Analgesics|analgesics|mesh-ancestor
19846467|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19846468|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846469|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19846470|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846471|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
20211522|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211523|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402981|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
20402982|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20402983|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20402984|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
20402985|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19372521|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19372522|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
19372523|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20402986|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20402987|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
20402988|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
20402989|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20402990|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20402991|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20402992|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372524|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19372525|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19372526|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19690572|NCT05015621|Leucovorin|leucovorin|mesh-list
19690573|NCT05015621|Fluorouracil|fluorouracil|mesh-list
19690574|NCT05015621|Irinotecan|irinotecan|mesh-list
20402993|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20402994|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402995|NCT01146041|Rivastigmine|rivastigmine|mesh-list
20402996|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20402997|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20402998|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20402999|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
20403000|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403001|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403002|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20403003|NCT01146041|Protective Agents|protective agents|mesh-ancestor
20403004|NCT01146067|Rivastigmine|rivastigmine|mesh-list
19372527|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19372528|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19690575|NCT05015621|Calcium|calcium|mesh-list
19690576|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
19690577|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690578|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690579|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
19690580|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690581|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19690582|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690583|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690584|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
19846472|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19846473|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20211524|NCT00288561|Ranibizumab|ranibizumab|mesh-list
20211525|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20211526|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20211527|NCT00288561|Growth Substances|growth substances|mesh-ancestor
20211528|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211529|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
20211530|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211531|NCT00288652|Reboxetine|reboxetine|mesh-list
20211532|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
20211533|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19846474|NCT00679042|Analgesics|analgesics|mesh-ancestor
19846475|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
19846476|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211534|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20211535|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403005|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20403006|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403007|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403008|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
20403009|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403010|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372529|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
19372530|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372531|NCT05197751|Antacids|antacids|mesh-ancestor
19372532|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403011|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20403012|NCT01146067|Protective Agents|protective agents|mesh-ancestor
20403013|NCT01146093|Pravastatin|pravastatin|mesh-list
20403014|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20403015|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403016|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
20403017|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403018|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20403019|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20403020|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403021|NCT01146106|Pravastatin|pravastatin|mesh-list
20403022|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20403023|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403024|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
20403025|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403026|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20403027|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20403028|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403029|NCT01146145|Ketamine|ketamine|mesh-list
20403030|NCT01146145|Morphine|morphine|mesh-list
20403031|NCT01146145|Analgesics|analgesics|mesh-ancestor
20403032|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
20403033|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403034|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403035|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20403036|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20403037|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
20403038|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
20403039|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403040|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20403041|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20211536|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20211537|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211538|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
20211539|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211540|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211541|NCT00288717|Telmisartan|telmisartan|mesh-list
20211542|NCT00288717|Candesartan|candesartan|mesh-list
20211543|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211544|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20211545|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20211546|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211547|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20211548|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
20211549|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211550|NCT00288743|Insulin|insulin|mesh-list
20403042|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403043|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403044|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20403045|NCT01146145|Narcotics|narcotics|mesh-ancestor
20403046|NCT01146301|Clopidogrel|clopidogrel|mesh-list
20403047|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20403048|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20403049|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20403050|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20403051|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
20403052|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403053|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403054|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403055|NCT01146431|Anesthetics|anesthetics|mesh-list
20403056|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372533|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19372534|NCT05197621|Vaccines|vaccines|mesh-list
19372535|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
19372536|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372537|NCT05197504|Bevacizumab|bevacizumab|mesh-list
19372538|NCT05197504|Atezolizumab|atezolizumab|mesh-list
19372539|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20403057|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403058|NCT01146483|Pantoprazole|pantoprazole|mesh-list
20403059|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20403060|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20403061|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403062|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
20403063|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403064|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20403065|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20403066|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403067|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19372540|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372541|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19372542|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19372543|NCT05197504|Growth Substances|growth substances|mesh-ancestor
19372544|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372545|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
19372546|NCT05197101|Oxytocin|oxytocin|mesh-list
19372547|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
19372548|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19372549|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372550|NCT05197088|Tamsulosin|tamsulosin|mesh-list
19372551|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19372552|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19372553|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19372554|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372555|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372556|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372557|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403068|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20403069|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20403070|NCT01146509|Donepezil|donepezil|mesh-list
20403071|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20403072|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403073|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403074|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
19372558|NCT05197088|Urological Agents|urological agents|mesh-ancestor
19372559|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
19372560|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19372561|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372562|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20403075|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403076|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403077|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
20403078|NCT01146535|Interferons|interferons|mesh-list
20403079|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
20403080|NCT01146535|Oseltamivir|oseltamivir|mesh-list
20403081|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403082|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
20403083|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403084|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
20403085|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403086|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403087|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403088|NCT01146548|Fluoxetine|fluoxetine|mesh-list
20403089|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20403090|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403091|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19372563|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372564|NCT05196256|Sufentanil|sufentanil|mesh-list
19372565|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
19372566|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
19372567|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
19372568|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372569|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690585|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19690586|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690587|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690588|NCT05015621|Antidotes|antidotes|mesh-ancestor
19690589|NCT05015621|Protective Agents|protective agents|mesh-ancestor
20403092|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403093|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403094|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
20403095|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403096|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20403097|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
20403098|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403099|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20403100|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19372570|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
19372571|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372572|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19372573|NCT05196256|Narcotics|narcotics|mesh-ancestor
19372574|NCT05196256|Analgesics|analgesics|mesh-ancestor
19372575|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20211551|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19372576|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19372577|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
19372578|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19372579|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19372580|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372581|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19846477|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846478|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846479|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19846480|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19372582|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19372583|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19372584|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372585|NCT05195944|Incretins|incretins|mesh-ancestor
19372586|NCT05195944|Hormones|hormones|mesh-ancestor
19372587|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372588|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19372589|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
19372590|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372591|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402436|NCT03609190|Ketamine|ketamine|mesh-list
19402437|NCT03609190|Analgesics|analgesics|mesh-ancestor
19402438|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
19402439|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402440|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402441|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19402442|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19402443|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
19402444|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
19402445|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402446|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19402447|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19402448|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402449|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402450|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19846481|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19846482|NCT00679042|Incretins|incretins|mesh-ancestor
19846483|NCT00679042|Hormones|hormones|mesh-ancestor
19846484|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846485|NCT00679211|Trastuzumab|trastuzumab|mesh-list
19846486|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19846487|NCT00679211|Maytansine|maytansine|mesh-list
20211552|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211553|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
20211554|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
20211555|NCT00288769|Vitamins|vitamins|mesh-ancestor
20211556|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
20211557|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211558|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
20211559|NCT00288769|Hematinics|hematinics|mesh-ancestor
20211560|NCT00288782|Mirtazapine|mirtazapine|mesh-list
20211561|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
20211562|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20211563|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20211564|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
19846488|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20403101|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211565|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
20211566|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403102|NCT01146626|Vitamin D|vitamin d|mesh-list
20403103|NCT01146626|Ribavirin|ribavirin|mesh-list
20403104|NCT01146626|Vitamins|vitamins|mesh-ancestor
20403105|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
20403106|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403107|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20403108|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
20403109|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403110|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
20403111|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403112|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
20403113|NCT01146678|Lixisenatide|lixisenatide|mesh-list
19372592|NCT05195645|Abatacept|abatacept|mesh-list
19372593|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19372594|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372595|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372596|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372597|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
20211567|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211568|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211569|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19372598|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372599|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372600|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
19372601|NCT05195619|Vaccines|vaccines|mesh-list
19372602|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
19372603|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372604|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372605|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846489|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372606|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19372607|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
19372608|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372609|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372610|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19372611|NCT05195294|Lenvatinib|lenvatinib|mesh-list
19372612|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372613|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19372614|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372615|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372616|NCT05195177|Anesthetics|anesthetics|mesh-list
19372617|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
19372618|NCT05195177|Histamine|histamine|mesh-list
19372619|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
19372620|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19372621|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372622|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372623|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
19372624|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372625|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
19372626|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
19372627|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372628|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372629|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
19372630|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
19372631|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372632|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
19846490|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19846491|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
19846492|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
19846493|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
19846494|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846495|NCT00679289|Interferons|interferons|mesh-list
19846496|NCT00679289|Ecromeximab|ecromeximab|mesh-list
19846497|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846498|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
19846499|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211570|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211571|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211572|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20211573|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20211574|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20211575|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
20403114|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404717|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
19372633|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372634|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372635|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19372636|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
19372637|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372638|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846500|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846501|NCT00679302|Trimethoprim|trimethoprim|mesh-list
19846502|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19846503|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
19846504|NCT00679302|Simethicone|simethicone|mesh-list
20211576|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20211577|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20211578|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
20211579|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20211580|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
20211581|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
20211582|NCT00288873|Vitamin D|vitamin d|mesh-list
20211583|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20403115|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403116|NCT01146925|Deferiprone|deferiprone|mesh-list
20403117|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20403118|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
20403119|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
20403120|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427070|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20427071|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20427072|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20427073|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
20427074|NCT01284647|Sucralfate|sucralfate|mesh-list
20427075|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20427076|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427077|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427078|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
20427079|NCT01284725|Azathioprine|azathioprine|mesh-list
20427080|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20427081|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20427082|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427083|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19372639|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19372640|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19372641|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19372642|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
19372643|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19372644|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372645|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372646|NCT05194904|Ketorolac|ketorolac|mesh-list
19372647|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
19372648|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19372649|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372650|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372651|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19372652|NCT05194904|Analgesics|analgesics|mesh-ancestor
19372653|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
19372654|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372655|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19372656|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19372657|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19372658|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372659|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372660|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372661|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19372662|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19690590|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
19690591|NCT05015621|Vitamins|vitamins|mesh-ancestor
19690592|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
19690593|NCT05015829|Dobutamine|dobutamine|mesh-list
19690594|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19690595|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
19690596|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
19690597|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690598|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690599|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19690600|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19372663|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372664|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19372665|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372666|NCT05194852|Anesthetics|anesthetics|mesh-list
19372667|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
19372668|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372669|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372670|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
19372671|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372672|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19372673|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372674|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690601|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19690602|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372675|NCT05194046|Amoxicillin|amoxicillin|mesh-list
19372676|NCT05194046|Clarithromycin|clarithromycin|mesh-list
19372677|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19372678|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372679|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19372680|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372681|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372682|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19372683|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19372684|NCT05193838|Allopurinol|allopurinol|mesh-list
19372685|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
19372686|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372687|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403121|NCT01146977|Cytarabine|cytarabine|mesh-list
20403122|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20403123|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
20403124|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403125|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403126|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
20403127|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403128|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372688|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
19372689|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372690|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19372691|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
19372692|NCT05193838|Protective Agents|protective agents|mesh-ancestor
19372693|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372694|NCT05193747|Anesthetics|anesthetics|mesh-list
19372695|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372696|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372697|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
19372698|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
19372699|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
19372700|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372701|NCT05193604|Gemcitabine|gemcitabine|mesh-list
19690603|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690604|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690605|NCT05015829|Protective Agents|protective agents|mesh-ancestor
19690606|NCT05015361|Propofol|propofol|mesh-list
19690607|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19690608|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690609|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690610|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19690611|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
19690612|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
19690613|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
19690614|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19372702|NCT05193604|Paclitaxel|paclitaxel|mesh-list
19372703|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372704|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372705|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372706|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372707|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372708|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372709|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19372710|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
19372711|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
19690615|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19690616|NCT05015322|Prednisolone|prednisolone|mesh-list
20403129|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
20403130|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372712|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846505|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19846506|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846507|NCT00679302|Renal Agents|renal agents|mesh-ancestor
19846508|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
19846509|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19846510|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19846511|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19846512|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846513|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846514|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19846515|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19846516|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19372713|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372714|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372715|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
19372716|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372717|NCT05193253|Liver Extracts|liver extracts|mesh-list
19372718|NCT05193253|Hematinics|hematinics|mesh-ancestor
19372719|NCT05190445|Paclitaxel|paclitaxel|mesh-list
19372720|NCT05190445|Ramucirumab|ramucirumab|mesh-list
19372721|NCT05190445|Tucatinib|tucatinib|mesh-list
19372722|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372723|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372724|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372725|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372726|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372727|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846517|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
19846518|NCT00679302|Emollients|emollients|mesh-ancestor
19846519|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
19846520|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19846521|NCT00679341|Docetaxel|docetaxel|mesh-list
19846522|NCT00679341|Trastuzumab|trastuzumab|mesh-list
19846523|NCT00679341|Maytansine|maytansine|mesh-list
19846524|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19846525|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846526|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
19846527|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
19846528|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
19846529|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846530|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846531|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372728|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19372729|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402451|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19402452|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
19402453|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402454|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402455|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19402456|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19402457|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402458|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402459|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402460|NCT03609086|Melatonin|melatonin|mesh-list
19402461|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
19402462|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402463|NCT03609086|Protective Agents|protective agents|mesh-ancestor
19402464|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690617|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
19690618|NCT05015322|Bupivacaine|bupivacaine|mesh-list
19690619|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19690620|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
19690621|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402465|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402466|NCT03609060|Dexamethasone|dexamethasone|mesh-list
19690622|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
19690623|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690624|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690625|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
19690626|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690627|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846532|NCT00679367|Dexamethasone|dexamethasone|mesh-list
20403131|NCT01147016|Paclitaxel|paclitaxel|mesh-list
19402467|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846533|NCT00679367|Lenalidomide|lenalidomide|mesh-list
19846534|NCT00679367|Melphalan|melphalan|mesh-list
20403132|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
20403133|NCT01147016|Doxorubicin|doxorubicin|mesh-list
20403134|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19690628|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
19690629|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
19690630|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19690631|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
20403135|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20403136|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372730|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19372731|NCT05173597|Hormones|hormones|mesh-ancestor
19372732|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403137|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372733|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372734|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
19372735|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19372736|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
19372737|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19372738|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372739|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19372740|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19372741|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19372742|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19372743|NCT05170464|Caffeine|caffeine|mesh-list
19372744|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19372745|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372746|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19372747|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372748|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372749|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19372750|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19372751|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
19372752|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372753|NCT05170438|Paclitaxel|paclitaxel|mesh-list
19372754|NCT05170438|Lenvatinib|lenvatinib|mesh-list
19372755|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19372756|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372757|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
19372758|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372759|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
19372760|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372761|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19372762|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372763|NCT05165251|Amlodipine|amlodipine|mesh-list
19372764|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19690632|NCT05015322|Hormones|hormones|mesh-ancestor
19690633|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690634|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19372765|NCT05165251|Atorvastatin|atorvastatin|mesh-list
19372766|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19372767|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19372768|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
19372769|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372770|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19372771|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19372772|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372773|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19372774|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19372775|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19372776|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19372777|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846535|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846536|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
19846537|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
20403138|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
19372778|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
19372779|NCT05154669|Nicotine|nicotine|mesh-list
19372780|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19372781|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
19372782|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372783|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690635|NCT05015322|Protective Agents|protective agents|mesh-ancestor
19690636|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20403139|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
20403140|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403141|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403142|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
20403143|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403144|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403145|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20403146|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
20403147|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20403148|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20403149|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20403150|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20403151|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403152|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
20403153|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20403154|NCT01147029|Growth Substances|growth substances|mesh-ancestor
20403155|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372784|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19372785|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19372786|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
19372787|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372788|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372789|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19372790|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19372791|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19372792|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
19372793|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19372794|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372795|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19372796|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19372797|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19372798|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19372799|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19372800|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19372801|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19372802|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19372803|NCT05151146|Metformin|metformin|mesh-list
19372804|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19372805|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372806|NCT05150652|Tamoxifen|tamoxifen|mesh-list
19372807|NCT05150652|Letrozole|letrozole|mesh-list
19372808|NCT05150652|Anastrozole|anastrozole|mesh-list
19372809|NCT05150652|Exemestane|exemestane|mesh-list
19372810|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403156|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
20403157|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403158|NCT01147133|Clopidogrel|clopidogrel|mesh-list
20403159|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20403160|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20403161|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20403162|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20403163|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
20403164|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403165|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403166|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403167|NCT01147146|Fentanyl|fentanyl|mesh-list
20403168|NCT01147146|Midazolam|midazolam|mesh-list
20403169|NCT01147146|Bupivacaine|bupivacaine|mesh-list
20403170|NCT01147146|Propofol|propofol|mesh-list
20403171|NCT01147146|Atracurium|atracurium|mesh-list
20403172|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
20403173|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
20403174|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403175|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403176|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
20403177|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403178|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20403179|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19372811|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19372812|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19372813|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690637|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690638|NCT05014711|Fentanyl|fentanyl|mesh-list
19690639|NCT05014711|Remifentanil|remifentanil|mesh-list
19690640|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20403180|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
20403181|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20403182|NCT01147146|Narcotics|narcotics|mesh-ancestor
20403183|NCT01147146|Analgesics|analgesics|mesh-ancestor
20403184|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20403185|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19372814|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372815|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19372816|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
19372817|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372818|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372819|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19372820|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19372821|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19372822|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19372823|NCT05143489|Lidocaine|lidocaine|mesh-list
19372824|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
19372825|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
19372826|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372827|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372828|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
19372829|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372830|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19372831|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19372832|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19372833|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19372834|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372835|NCT05143073|Ethanol|ethanol|mesh-list
19372836|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19372837|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372838|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372839|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211584|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211585|NCT00288873|Vitamins|vitamins|mesh-ancestor
20211586|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
19372840|NCT05139875|Triamcinolone|triamcinolone|mesh-list
19372841|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19372842|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19372843|NCT05139875|Betamethasone|betamethasone|mesh-list
19372844|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
19372845|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19372846|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
19372847|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19372848|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19372849|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372850|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
19372851|NCT05139875|Hormones|hormones|mesh-ancestor
19372852|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372853|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372854|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19372855|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
19372856|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690641|NCT05014711|Narcotics|narcotics|mesh-ancestor
19690642|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690643|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690644|NCT05014711|Analgesics|analgesics|mesh-ancestor
19690645|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
19690646|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690647|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19690648|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19690649|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
19690650|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
19690651|NCT05014685|Amoxicillin|amoxicillin|mesh-list
19690652|NCT05014685|Metronidazole|metronidazole|mesh-list
19690653|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
19690654|NCT05014685|Rabeprazole|rabeprazole|mesh-list
19690655|NCT05014685|Bismuth|bismuth|mesh-list
20211587|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20211588|NCT00288951|Travoprost|travoprost|mesh-list
20211589|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211590|NCT00289042|Enoxaparin|enoxaparin|mesh-list
19690656|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211591|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
20403186|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20403187|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690657|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19690658|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690659|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20403188|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
20403189|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
20403190|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403191|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403192|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20403193|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20403194|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20403195|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19690660|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19690661|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19690662|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19690663|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19690664|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690665|NCT05014685|Antacids|antacids|mesh-ancestor
19690666|NCT05014685|Diuretics|diuretics|mesh-ancestor
19690667|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
20403196|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20403197|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
20403198|NCT01147224|Ciclesonide|ciclesonide|mesh-list
20403199|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
20403200|NCT01147224|Hormones|hormones|mesh-ancestor
20403201|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403202|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403203|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20403204|NCT01147276|Vildagliptin|vildagliptin|mesh-list
19690668|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690669|NCT05014685|Expectorants|expectorants|mesh-ancestor
19690670|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
19690671|NCT05014906|Minocycline|minocycline|mesh-list
19690672|NCT05014906|Azelaic acid|azelaic acid|mesh-list
20211592|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20403205|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19372857|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372858|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19372859|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
19372860|NCT05137860|Bortezomib|bortezomib|mesh-list
19372861|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372862|NCT05136898|Mitomycins|mitomycins|mesh-list
19372863|NCT05136898|Mitomycin|mitomycin|mesh-list
19372864|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19372865|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372866|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
19372867|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372868|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19372869|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372870|NCT05131997|Atorvastatin|atorvastatin|mesh-list
19372871|NCT05131997|Ezetimibe|ezetimibe|mesh-list
19690673|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211593|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20211594|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211595|NCT00289250|Artesunate|artesunate|mesh-list
20211596|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
20211597|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
20211598|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20211599|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
20211600|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20211601|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20211602|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211603|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211604|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
20211605|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
20211606|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20211607|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
20211608|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20211609|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211610|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211611|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20211612|NCT00289250|Renal Agents|renal agents|mesh-ancestor
20211613|NCT00289263|Paclitaxel|paclitaxel|mesh-list
20403206|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211614|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20211615|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402468|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
19690674|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372872|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19372873|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19372874|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
19372875|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372876|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19372877|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20403207|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20403208|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
20403209|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403210|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403211|NCT01147289|Meloxicam|meloxicam|mesh-list
19372878|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372879|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19372880|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
19372881|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372882|NCT05123170|Lidocaine|lidocaine|mesh-list
19372883|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
19372884|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
19372885|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
19372886|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372887|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372888|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
19372889|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690675|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690676|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19690677|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
19690678|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403212|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19690679|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
19690680|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690681|NCT05014828|Lenvatinib|lenvatinib|mesh-list
19690682|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690683|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19690684|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690685|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690686|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
19690687|NCT05015387|Procyanidin|procyanidin|mesh-list
20403213|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20403214|NCT01147289|Analgesics|analgesics|mesh-ancestor
20403215|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
20403216|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403217|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403218|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403219|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403220|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20403221|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20403222|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403223|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403224|NCT01147354|Selenium|selenium|mesh-list
20403225|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
19690688|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
19690689|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690690|NCT05015387|Protective Agents|protective agents|mesh-ancestor
19690691|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690692|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19690693|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19690694|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690695|NCT05014464|Crizotinib|crizotinib|mesh-list
19690696|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690697|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19690698|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690699|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690700|NCT05014490|Etoricoxib|etoricoxib|mesh-list
19690701|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19690702|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19690703|NCT05014490|Analgesics|analgesics|mesh-ancestor
19690704|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
19690705|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690706|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690707|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403226|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372890|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19690708|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19402469|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
19690709|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19690710|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20403227|NCT01147354|Protective Agents|protective agents|mesh-ancestor
20403228|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403229|NCT01147354|Trace Elements|trace elements|mesh-ancestor
20403230|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
20403231|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
20403232|NCT01147432|Capsaicin|capsaicin|mesh-list
20403233|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
20403234|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
20403235|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
20403236|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403237|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403238|NCT01147510|Montelukast|montelukast|mesh-list
20403239|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20403240|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
20403241|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20403242|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
20403243|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403244|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403245|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20403246|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20403247|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372891|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19372892|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19372893|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19372894|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372895|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19372896|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19372897|NCT05123170|Analgesics|analgesics|mesh-ancestor
19372898|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19372899|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19372900|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19372901|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
19372902|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372903|NCT05123131|Dexamethasone|dexamethasone|mesh-list
19372904|NCT05123131|Lenalidomide|lenalidomide|mesh-list
19372905|NCT05123131|Bortezomib|bortezomib|mesh-list
19372906|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372907|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
19372908|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
19372909|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372910|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372911|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19372912|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
19372913|NCT05123131|Hormones|hormones|mesh-ancestor
19372914|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372915|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19372916|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19372917|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
19372918|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19372919|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19372920|NCT05123131|Growth Substances|growth substances|mesh-ancestor
19372921|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
19372922|NCT05116241|Vaccines|vaccines|mesh-list
19372923|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
19372924|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372925|NCT05105750|Aspirin|aspirin|mesh-list
19372926|NCT05105750|Indobufen|indobufen|mesh-list
19372927|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19372928|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19372929|NCT05105750|Analgesics|analgesics|mesh-ancestor
19372930|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
19372931|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372932|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372933|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19372934|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19372935|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19372936|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19372937|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372938|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19690711|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403248|NCT01147523|Vitamin E|vitamin e|mesh-list
19690712|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690713|NCT05014516|Xenon|xenon|mesh-list
19690714|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19690715|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
19690716|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
19690717|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690718|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372939|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19372940|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372941|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
19372942|NCT05081089|Lumefantrine|lumefantrine|mesh-list
19372943|NCT05081089|Artemether|artemether|mesh-list
19372944|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
19372945|NCT05081089|Primaquine|primaquine|mesh-list
19372946|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
19372947|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19372948|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19372949|NCT05081089|Amodiaquine|amodiaquine|mesh-list
19372950|NCT05081089|Tafenoquine|tafenoquine|mesh-list
19372951|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
19372952|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19372953|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20403249|NCT01147523|Spironolactone|spironolactone|mesh-list
20403250|NCT01147523|Vitamins|vitamins|mesh-ancestor
20403251|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
19690719|NCT05014581|Norepinephrine|norepinephrine|mesh-list
19690720|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19690721|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20211616|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
20403252|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403253|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
20403254|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403255|NCT01147523|Protective Agents|protective agents|mesh-ancestor
20403256|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20403257|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
19372954|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372955|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19372956|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403258|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403259|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20403260|NCT01147523|Diuretics|diuretics|mesh-ancestor
20403261|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
20403262|NCT01147588|Esomeprazole|esomeprazole|mesh-list
19372957|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19372958|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19372959|NCT05081089|Renal Agents|renal agents|mesh-ancestor
19372960|NCT05068661|Fentanyl|fentanyl|mesh-list
19372961|NCT05068661|Bupivacaine|bupivacaine|mesh-list
19372962|NCT05068661|Ropivacaine|ropivacaine|mesh-list
19372963|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19372964|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
19372965|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
20403263|NCT01147588|Omeprazole|omeprazole|mesh-list
20403264|NCT01147588|Lansoprazole|lansoprazole|mesh-list
20403265|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
20403266|NCT01147588|Clopidogrel|clopidogrel|mesh-list
20403267|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20403268|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20403269|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20403270|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20403271|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
20403272|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19372966|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19372967|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211617|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211618|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211619|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211620|NCT00289354|Chromium|chromium|mesh-list
20211621|NCT00289354|Biotin|biotin|mesh-list
20211622|NCT00289354|Picolinic acid|picolinic acid|mesh-list
20211623|NCT00289354|Trace Elements|trace elements|mesh-ancestor
20211624|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
20211625|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403273|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613135|NCT02253914|Ritonavir|ritonavir|mesh-list
19372968|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
19372969|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19372970|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19372971|NCT05068661|Narcotics|narcotics|mesh-ancestor
20403274|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403275|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20403276|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20403277|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20403278|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403279|NCT01147692|Simvastatin|simvastatin|mesh-list
20403280|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
20403281|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20403282|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403283|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
20403284|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403285|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19372972|NCT05068661|Analgesics|analgesics|mesh-ancestor
19690722|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19690723|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690724|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690725|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690726|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
19690727|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
20211626|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
20211627|NCT00289354|Vitamins|vitamins|mesh-ancestor
20211628|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20403286|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20403287|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403288|NCT01147692|Incretins|incretins|mesh-ancestor
20403289|NCT01147692|Hormones|hormones|mesh-ancestor
19690728|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211629|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
20211630|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
20211631|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211632|NCT00289406|Amlodipine|amlodipine|mesh-list
20211633|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20211634|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20211635|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20211636|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211637|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20211638|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211639|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
20211640|NCT00289419|Ketorolac|ketorolac|mesh-list
19372973|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19372974|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19372975|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
19372976|NCT05064800|Ritonavir|ritonavir|mesh-list
19372977|NCT05064800|Dabigatran|dabigatran|mesh-list
19372978|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19372979|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20211641|NCT00289419|Epinephrine|epinephrine|mesh-list
20211642|NCT00289419|Racepinephrine|racepinephrine|mesh-list
19372980|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
19372981|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372982|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690729|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19690730|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
19690731|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19690732|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690733|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20211643|NCT00289419|Morphine|morphine|mesh-list
20211644|NCT00289419|Ropivacaine|ropivacaine|mesh-list
20211645|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
20211646|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20211647|NCT00289419|Narcotics|narcotics|mesh-ancestor
20211648|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211649|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211650|NCT00289419|Analgesics|analgesics|mesh-ancestor
20211651|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
20211652|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211653|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
20211654|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
20211655|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20211656|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20211657|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403290|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19372983|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19372984|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20403291|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19372985|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
19846538|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846539|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211658|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211659|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20211660|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19372986|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19372987|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19372988|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19372989|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
19372990|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19846540|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19846541|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
19846542|NCT00679367|Hormones|hormones|mesh-ancestor
19846543|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846544|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19372991|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
19372992|NCT05062889|Leucovorin|leucovorin|mesh-list
19372993|NCT05062889|Trifluridine|trifluridine|mesh-list
19372994|NCT05062889|Fluorouracil|fluorouracil|mesh-list
19372995|NCT05062889|Capecitabine|capecitabine|mesh-list
19372996|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
19372997|NCT05062889|Irinotecan|irinotecan|mesh-list
19372998|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
19372999|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
19373000|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373001|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373002|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373003|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373004|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
19373005|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373006|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19373007|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19373008|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373009|NCT05062889|Antidotes|antidotes|mesh-ancestor
19373010|NCT05062889|Protective Agents|protective agents|mesh-ancestor
19373011|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
19373012|NCT05062889|Vitamins|vitamins|mesh-ancestor
19373013|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
19373014|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
19373015|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373016|NCT05057806|Empagliflozin|empagliflozin|mesh-list
19373017|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19373018|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373019|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19373020|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373021|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19373022|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
19373023|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846545|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846546|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
19846547|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20211661|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211662|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20211663|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20211664|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
20211665|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211666|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20211667|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20211668|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
20211669|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20211670|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
20211671|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
20211672|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
20211673|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20211674|NCT00289445|Leucovorin|leucovorin|mesh-list
20211675|NCT00289445|Folic Acid|folic acid|mesh-list
20211676|NCT00289445|Mitomycins|mitomycins|mesh-list
20211677|NCT00289445|Mitomycin|mitomycin|mesh-list
20211678|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
19373024|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846548|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20211679|NCT00289445|Antidotes|antidotes|mesh-ancestor
20403292|NCT01147705|Allopurinol|allopurinol|mesh-list
19373025|NCT05042505|Incretins|incretins|mesh-ancestor
19373026|NCT05042505|Hormones|hormones|mesh-ancestor
20211680|NCT00289445|Protective Agents|protective agents|mesh-ancestor
20403293|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
20403294|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403295|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403296|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
20403297|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403298|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20403299|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
20403300|NCT01147705|Protective Agents|protective agents|mesh-ancestor
19846549|NCT00679367|Growth Substances|growth substances|mesh-ancestor
19846550|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
19846551|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19846552|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
19846553|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373027|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373028|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19373029|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
19373030|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373031|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373032|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19373033|NCT05041673|Metformin|metformin|mesh-list
19373034|NCT05041673|Liraglutide|liraglutide|mesh-list
19373035|NCT05041673|Empagliflozin|empagliflozin|mesh-list
19373036|NCT05041673|Vildagliptin|vildagliptin|mesh-list
19373037|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19373038|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373039|NCT05041673|Incretins|incretins|mesh-ancestor
19373040|NCT05041673|Hormones|hormones|mesh-ancestor
19373041|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373042|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20211681|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211682|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
20211683|NCT00289445|Vitamins|vitamins|mesh-ancestor
20211684|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
19373043|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373044|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19373045|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
19373046|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373047|NCT05032950|Ritonavir|ritonavir|mesh-list
19373048|NCT05032950|Midazolam|midazolam|mesh-list
19373049|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20211685|NCT00289445|Hematinics|hematinics|mesh-ancestor
20211686|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20211687|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211688|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
20211689|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403301|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403302|NCT01147718|Digoxin|digoxin|mesh-list
20403303|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
20403304|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20403305|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20403306|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403307|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403308|NCT01147718|Protective Agents|protective agents|mesh-ancestor
20403309|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373050|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19373051|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373052|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373053|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19373054|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19373055|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19373056|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20403310|NCT01147718|Incretins|incretins|mesh-ancestor
20403311|NCT01147718|Hormones|hormones|mesh-ancestor
20403312|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373057|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
19373058|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
19373059|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
19846554|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19846555|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211690|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20211691|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211692|NCT00289510|Vaccines|vaccines|mesh-list
19373060|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
19846556|NCT00679380|Budesonide|budesonide|mesh-list
19846557|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373061|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373062|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373063|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19373064|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19373065|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
19373066|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373067|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19373068|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19373069|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
19373070|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211693|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
20211694|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211695|NCT00289588|Mupirocin|mupirocin|mesh-list
20211696|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211697|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211698|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20211699|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211700|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211701|NCT00289601|Eptifibatide|eptifibatide|mesh-list
20211702|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20211703|NCT00289627|Ipilimumab|ipilimumab|mesh-list
20211704|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20211705|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211706|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20211707|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211708|NCT00289809|Ifosfamide|ifosfamide|mesh-list
20403313|NCT01147731|Warfarin|warfarin|mesh-list
19373071|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19373072|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19373073|NCT05026320|Diclofenac|diclofenac|mesh-list
19373074|NCT05026320|Naproxen|naproxen|mesh-list
19373075|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20403314|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
20403315|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
20403316|NCT01147731|Incretins|incretins|mesh-ancestor
20403317|NCT01147731|Hormones|hormones|mesh-ancestor
20403318|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403319|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403320|NCT01147757|Remifentanil|remifentanil|mesh-list
19373076|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19373077|NCT05026320|Analgesics|analgesics|mesh-ancestor
19373078|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
19373079|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373080|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373081|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373082|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403321|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20403322|NCT01147757|Narcotics|narcotics|mesh-ancestor
20403323|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403324|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403325|NCT01147757|Analgesics|analgesics|mesh-ancestor
20403326|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
20403327|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403328|NCT01147770|Progesterone|progesterone|mesh-list
20403329|NCT01147770|Progestins|progestins|mesh-ancestor
20403330|NCT01147770|Hormones|hormones|mesh-ancestor
20403331|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403332|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403333|NCT01148004|Ritonavir|ritonavir|mesh-list
20403334|NCT01148004|Lopinavir|lopinavir|mesh-list
20403335|NCT01148004|Fenofibrate|fenofibrate|mesh-list
20403336|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20403337|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20403338|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
20403339|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403340|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403341|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20403342|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20403343|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
20403344|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403345|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20403346|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19690734|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373083|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19373084|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403347|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403348|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
20403349|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20403350|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20403351|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403352|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
19373085|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373086|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
19373087|NCT05022927|Bevacizumab|bevacizumab|mesh-list
19373088|NCT05022927|Atezolizumab|atezolizumab|mesh-list
19373089|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373090|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373091|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19373092|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19373093|NCT05022927|Growth Substances|growth substances|mesh-ancestor
19373094|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373095|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
19402470|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402471|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402472|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402473|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
19402474|NCT03609060|Hormones|hormones|mesh-ancestor
20403353|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
20403354|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20403355|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20403356|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402475|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402476|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402477|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402478|NCT03609008|Cromakalim|cromakalim|mesh-list
19402479|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19402480|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19402481|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
19402482|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402483|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402484|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19402485|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
19402486|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
19402487|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
19402488|NCT03608761|Rebamipide|rebamipide|mesh-list
19402489|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19402490|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19690735|NCT05014373|Favipiravir|favipiravir|mesh-list
19690736|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
19690737|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402491|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
19402492|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690738|NCT05014100|Lenalidomide|lenalidomide|mesh-list
20403357|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402493|NCT03608761|Protective Agents|protective agents|mesh-ancestor
19402494|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402495|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402496|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
19402497|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19402498|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
19402499|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402500|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19402501|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19402502|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
19402503|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402504|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402505|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19402506|NCT03608514|Terlipressin|terlipressin|mesh-list
19402507|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19402508|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19402509|NCT03608501|Thalidomide|thalidomide|mesh-list
19402510|NCT03608501|Dexamethasone|dexamethasone|mesh-list
19402511|NCT03608501|Ixazomib|ixazomib|mesh-list
19402512|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402513|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
19402514|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
19402515|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402516|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402517|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402518|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
19690739|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
20403358|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403359|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19690740|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690741|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20613136|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613137|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613138|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613139|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211709|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20211710|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
20211711|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211712|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211713|NCT00289835|Paclitaxel|paclitaxel|mesh-list
20211714|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20211715|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20211716|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211717|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211718|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211719|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211720|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211721|NCT00289861|Risperidone|risperidone|mesh-list
20211722|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20211723|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
20403360|NCT01148147|Adenosine|adenosine|mesh-list
20403361|NCT01148147|Analgesics|analgesics|mesh-ancestor
20403362|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
20403363|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403364|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403365|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20403366|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
20403367|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20613140|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373096|NCT05008276|Dextrans|dextrans|mesh-list
19373097|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
19373098|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
19373099|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
19373100|NCT05005312|Ritonavir|ritonavir|mesh-list
20211724|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373101|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19373102|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19373103|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
19373104|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373105|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373106|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19373107|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19373108|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
19373109|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373110|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19373111|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19373112|NCT04995120|Paclitaxel|paclitaxel|mesh-list
19373113|NCT04995120|Cisplatin|cisplatin|mesh-list
19373114|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19373115|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373116|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
19373117|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
19373118|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
19373119|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373120|NCT04989946|Nivolumab|nivolumab|mesh-list
19373121|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373122|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373123|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19373124|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373125|NCT04971837|Cannabidiol|cannabidiol|mesh-list
19373126|NCT04971837|Sorbitol|sorbitol|mesh-list
19373127|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
19373128|NCT04971837|Cathartics|cathartics|mesh-ancestor
19373129|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373130|NCT04964960|Paclitaxel|paclitaxel|mesh-list
19373131|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20211725|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373132|NCT04964960|Carboplatin|carboplatin|mesh-list
19373133|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
20403368|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
19373134|NCT04964960|Pemetrexed|pemetrexed|mesh-list
19373135|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19373136|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373137|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
19373138|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
19846558|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19846559|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
19846560|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373139|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
19373140|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373141|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373142|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373143|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19373144|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19373145|NCT04958044|Calcium|calcium|mesh-list
19373146|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19373147|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690742|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19690743|NCT05014100|Growth Substances|growth substances|mesh-ancestor
19690744|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
19690745|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690746|NCT05014048|Vitamin D|vitamin d|mesh-list
19690747|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
19690748|NCT05014048|Vitamins|vitamins|mesh-ancestor
19690749|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
20211726|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211727|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20211728|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211729|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211730|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19373156|NCT04890106|Bimatoprost|bimatoprost|mesh-list
19373157|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19373158|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19373159|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19373160|NCT04885881|Lidocaine|lidocaine|mesh-list
19373161|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
19373162|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
19373163|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373164|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690750|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690751|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19690752|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690753|NCT05013697|Paclitaxel|paclitaxel|mesh-list
19690754|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19690755|NCT05013697|Cisplatin|cisplatin|mesh-list
19690756|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19690757|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690758|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690759|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690760|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211731|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20211732|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
20211733|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20211734|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20211735|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
20211736|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211737|NCT00289952|Valproic Acid|valproic acid|mesh-list
20211738|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
20211739|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211740|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211741|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
20211742|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211743|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211744|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
20211745|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211746|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211747|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690761|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373165|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
19373166|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373167|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20403369|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
20403370|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403371|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403372|NCT01148160|Voriconazole|voriconazole|mesh-list
20403373|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
19373168|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19373169|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19373170|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373171|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373172|NCT04885257|Methylphenidate|methylphenidate|mesh-list
19373173|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19373174|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373175|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19373176|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19373177|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373178|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373179|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
19373180|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373181|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
19373182|NCT04872595|Melphalan|melphalan|mesh-list
19373183|NCT04872595|Busulfan|busulfan|mesh-list
19373184|NCT04872595|Thiotepa|thiotepa|mesh-list
19373185|NCT04872595|Fludarabine|fludarabine|mesh-list
19373186|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373187|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
19373188|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373189|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19373190|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19373191|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
20403374|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403375|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20403376|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20403377|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403378|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403379|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20403380|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
20403381|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403382|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403383|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20403384|NCT01148173|Ifosfamide|ifosfamide|mesh-list
20403385|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20403386|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
19373192|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373193|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373194|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19373195|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19373196|NCT04871360|Laxatives|laxatives|mesh-ancestor
19373197|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373198|NCT04860804|Aspirin|aspirin|mesh-list
19690762|NCT05013060|Butyric Acid|butyric acid|mesh-list
20403387|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403388|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403389|NCT01148264|Olanzapine|olanzapine|mesh-list
20403390|NCT01148264|Metoclopramide|metoclopramide|mesh-list
20211748|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
20211749|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211750|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20211751|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
20211752|NCT00290017|Pemetrexed|pemetrexed|mesh-list
20211753|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211754|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211755|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211756|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20211757|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20403391|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
20403392|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
20403393|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403394|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403395|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20211758|NCT00290030|Alfuzosin|alfuzosin|mesh-list
20403396|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20403397|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20403398|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403399|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403400|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20403401|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403402|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20403403|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403404|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403405|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
20403406|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20403407|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20403408|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
20403409|NCT01148277|Fentanyl|fentanyl|mesh-list
20403410|NCT01148277|Midazolam|midazolam|mesh-list
20403411|NCT01148277|Propofol|propofol|mesh-list
20403412|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20403413|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403414|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403415|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20403416|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
20403417|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
20403418|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20403419|NCT01148277|Narcotics|narcotics|mesh-ancestor
20403420|NCT01148277|Analgesics|analgesics|mesh-ancestor
20403421|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
20403422|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403423|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20403424|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20211759|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20211760|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20211761|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20211762|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
20211763|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211764|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211765|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211766|NCT00290030|Urological Agents|urological agents|mesh-ancestor
20403425|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20403426|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403427|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
20403428|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
20403429|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211767|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
20211768|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20211769|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211770|NCT00290069|Sirolimus|sirolimus|mesh-list
20211771|NCT00290069|Tacrolimus|tacrolimus|mesh-list
19373199|NCT04860804|Ketamine|ketamine|mesh-list
19373200|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19373201|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19373202|NCT04860804|Analgesics|analgesics|mesh-ancestor
19373203|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
19373204|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373205|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373206|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373207|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19373208|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19373209|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19373210|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211772|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211773|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
20211774|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211775|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20211776|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211777|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403430|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846561|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403431|NCT01148303|Etoricoxib|etoricoxib|mesh-list
20403432|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20403433|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20403434|NCT01148303|Analgesics|analgesics|mesh-ancestor
20403435|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
20403436|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373211|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20613141|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20403437|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403438|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373212|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19373213|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373214|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
19373215|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19373216|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19373217|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
19373218|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
19373219|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373220|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19373221|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19373222|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373223|NCT04856488|Lugol's solution|lugol's solution|mesh-list
19373224|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19373225|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
19373226|NCT04856488|Coagulants|coagulants|mesh-ancestor
19373227|NCT04796948|Leucovorin|leucovorin|mesh-list
19373228|NCT04796948|Fluorouracil|fluorouracil|mesh-list
19373229|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
19373230|NCT04796948|Irinotecan|irinotecan|mesh-list
19373231|NCT04796948|Calcium|calcium|mesh-list
19373232|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
19373233|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19373234|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373235|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
19373236|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373237|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373238|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373239|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373240|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
19373241|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19373242|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19373243|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373244|NCT04796948|Antidotes|antidotes|mesh-ancestor
19373245|NCT04796948|Protective Agents|protective agents|mesh-ancestor
20403439|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403440|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20403441|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20403442|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403443|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403444|NCT01148316|Fluoxetine|fluoxetine|mesh-list
20403445|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20403446|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403447|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20403448|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403449|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403450|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
20403451|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403452|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20403453|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
20403454|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19373246|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
19373247|NCT04796948|Vitamins|vitamins|mesh-ancestor
19690763|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
19690764|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
19690765|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690766|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690767|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211778|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211779|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211780|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20211781|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211782|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
20211783|NCT00290082|Midazolam|midazolam|mesh-list
20211784|NCT00290082|Loxapine|loxapine|mesh-list
20211785|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20211786|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20211787|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211788|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211789|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20211790|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19373248|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
19373249|NCT04792567|Siponimod|siponimod|mesh-list
19373250|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20403455|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20403456|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20403457|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403458|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19373251|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373252|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373253|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
19373254|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373255|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
19373256|NCT04774107|Ribavirin|ribavirin|mesh-list
19373257|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
19373258|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373259|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
19373260|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373261|NCT04763577|Bradykinin|bradykinin|mesh-list
19846562|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19373262|NCT04763577|Kininogens|kininogens|mesh-list
19373263|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
19373264|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19373265|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
19373266|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373267|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402519|NCT03608501|Hormones|hormones|mesh-ancestor
19402520|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402521|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19690768|NCT05013112|Metformin|metformin|mesh-list
19690769|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19690770|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19690771|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690772|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402522|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402523|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402524|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19402525|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
19402526|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
19402527|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402528|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402529|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19402530|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19402531|NCT03608501|Growth Substances|growth substances|mesh-ancestor
19402532|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
19402533|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
19402534|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211791|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20211792|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20211793|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
20211794|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
20211795|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
20211796|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
19690773|NCT05013164|Leucovorin|leucovorin|mesh-list
19690774|NCT05013164|Folic Acid|folic acid|mesh-list
19846563|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
20211797|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211798|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211799|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20211800|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20211801|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
20211802|NCT00290108|Propofol|propofol|mesh-list
20211803|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20211804|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690775|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
20211805|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373268|NCT04750824|Afatinib|afatinib|mesh-list
19373269|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373270|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19373271|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373272|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373273|NCT04731233|Triamcinolone|triamcinolone|mesh-list
19373274|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19373275|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19373276|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19373277|NCT04731233|Mitogens|mitogens|mesh-list
19373278|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373279|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
19373280|NCT04731233|Hormones|hormones|mesh-ancestor
19373281|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373282|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373283|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373284|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
19373285|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403459|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
20403460|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403461|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403462|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
20403463|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403464|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403465|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20403466|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403467|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373286|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373287|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
19373288|NCT04726475|Cannabidiol|cannabidiol|mesh-list
19373289|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
19373290|NCT04721613|Melatonin|melatonin|mesh-list
19373291|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
19373292|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373293|NCT04721613|Protective Agents|protective agents|mesh-ancestor
19373294|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373295|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373296|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
19373297|NCT04720976|Osimertinib|osimertinib|mesh-list
20403468|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
20403469|NCT01148446|Prednisone|prednisone|mesh-list
20403470|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
20403471|NCT01148446|Rituximab|rituximab|mesh-list
20403472|NCT01148446|Doxorubicin|doxorubicin|mesh-list
19373298|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373299|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373300|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19690776|NCT05013164|Antidotes|antidotes|mesh-ancestor
19690777|NCT05013164|Protective Agents|protective agents|mesh-ancestor
20403473|NCT01148446|Vincristine|vincristine|mesh-list
20403474|NCT01148446|Epirubicin|epirubicin|mesh-list
20403475|NCT01148446|Vinblastine|vinblastine|mesh-list
20403476|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403477|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
19373301|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690778|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690779|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
19690780|NCT05013164|Vitamins|vitamins|mesh-ancestor
20403478|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613142|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613143|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
20613144|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613145|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613146|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613147|NCT02253927|Ritonavir|ritonavir|mesh-list
20613148|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613149|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613150|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613151|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613152|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613153|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613154|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613155|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
20403479|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613156|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690781|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
20403480|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20403481|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
20403482|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403483|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403484|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20403485|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20403486|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20403487|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20403488|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20403489|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403490|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403491|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
20403492|NCT01148446|Hormones|hormones|mesh-ancestor
20403493|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403494|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20403495|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20613157|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19373302|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373303|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
19373304|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19373305|NCT04717362|Testosterone|testosterone|mesh-list
19373306|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
19373307|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
19373308|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19373309|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373310|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
19373311|NCT04717362|Hormones|hormones|mesh-ancestor
19373312|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373313|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373314|NCT04717362|Androgens|androgens|mesh-ancestor
19373315|NCT04707326|Lamivudine|lamivudine|mesh-list
19373316|NCT04707326|Dolutegravir|dolutegravir|mesh-list
19373317|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19373318|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19373319|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373320|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373321|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
19373322|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373323|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19373324|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19373325|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19373326|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19373327|NCT04703101|Leucovorin|leucovorin|mesh-list
19373328|NCT04703101|Fluorouracil|fluorouracil|mesh-list
19373329|NCT04703101|Capecitabine|capecitabine|mesh-list
19373330|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
19373331|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
19373332|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373333|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373334|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373335|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373336|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
19373337|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373338|NCT04703101|Antidotes|antidotes|mesh-ancestor
19373339|NCT04703101|Protective Agents|protective agents|mesh-ancestor
19373340|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
19373341|NCT04703101|Vitamins|vitamins|mesh-ancestor
19373342|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
20211806|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20211807|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
20211808|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
20211809|NCT00290121|Olanzapine|olanzapine|mesh-list
20211810|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
20211811|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
20211812|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211813|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211814|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20211815|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20211816|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20211817|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211818|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20211819|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19373343|NCT04690023|Ropivacaine|ropivacaine|mesh-list
19373344|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
20211820|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19373345|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
19373346|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373347|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373348|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
19373349|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373350|NCT04678895|Naltrexone|naltrexone|mesh-list
19373351|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19373352|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19373353|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373354|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
19373355|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373356|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
19373357|NCT04653818|Velpatasvir|velpatasvir|mesh-list
19373358|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
19373359|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373360|NCT04646590|Vaccines|vaccines|mesh-list
19373361|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
19373362|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373363|NCT04645667|Tacrolimus|tacrolimus|mesh-list
19373364|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373365|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
19373366|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373367|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19373368|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373369|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373370|NCT04638309|Azacitidine|azacitidine|mesh-list
19373371|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373372|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
19373373|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373374|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373375|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373376|NCT04635254|Histamine|histamine|mesh-list
19373377|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
19373378|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
19373379|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373380|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373381|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373382|NCT04625946|Metformin|metformin|mesh-list
19373383|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19373384|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373385|NCT04608344|Atorvastatin|atorvastatin|mesh-list
19373386|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19373387|NCT04608344|Pravastatin|pravastatin|mesh-list
19373388|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19373389|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19373390|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
19373391|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373392|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19373393|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19373394|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373395|NCT04591002|Osimertinib|osimertinib|mesh-list
19373396|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373397|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19373398|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373399|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373400|NCT04589351|Ezetimibe|ezetimibe|mesh-list
19373401|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19373402|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19373403|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
19373404|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373405|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19373406|NCT04583592|Gabexate|gabexate|mesh-list
19373407|NCT04583592|Camostat|camostat|mesh-list
19373408|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
19373409|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373410|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373411|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19690782|NCT05013164|Hematinics|hematinics|mesh-ancestor
19693058|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19373412|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19693059|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20403496|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
20403497|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
19373413|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
20403498|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
19693060|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373414|NCT04570904|Vaccines|vaccines|mesh-list
19373415|NCT04570904|Immunologic Factors|immunologic factors|mesh-ancestor
19373416|NCT04570904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373417|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
19373418|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
19373419|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373420|NCT04529850|Protective Agents|protective agents|mesh-ancestor
19373421|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373422|NCT04523961|Lidocaine|lidocaine|mesh-list
19373423|NCT04523961|Tetracaine|tetracaine|mesh-list
19373424|NCT04523961|Prilocaine|prilocaine|mesh-list
19373425|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19373426|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
19373427|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
19373428|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373429|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373430|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
19373431|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373432|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20403499|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20403500|NCT01148472|Citalopram|citalopram|mesh-list
20403501|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20403502|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403503|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20403504|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403505|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403506|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
20403507|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403508|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20403509|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
19373433|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19373434|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19373435|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373436|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373437|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19373438|NCT04500509|Diclofenac|diclofenac|mesh-list
19373439|NCT04500509|Dinoprostone|dinoprostone|mesh-list
19373440|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20403510|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403511|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403512|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20403513|NCT01148472|Analgesics|analgesics|mesh-ancestor
20403514|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
19690783|NCT05013034|Basiliximab|basiliximab|mesh-list
19690784|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690785|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
19690786|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211821|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20211822|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211823|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211824|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
20211825|NCT00290173|Ritodrine|ritodrine|mesh-list
20211826|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
20211827|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
20211828|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211829|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211830|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
20211831|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20211832|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20211833|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20211834|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19373441|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19373442|NCT04500509|Analgesics|analgesics|mesh-ancestor
19690787|NCT05013151|Castor Oil|castor oil|mesh-list
19690788|NCT05013151|Cathartics|cathartics|mesh-ancestor
19690789|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19690790|NCT05013268|Paclitaxel|paclitaxel|mesh-list
19690791|NCT05013268|Docetaxel|docetaxel|mesh-list
19690792|NCT05013268|Carboplatin|carboplatin|mesh-list
19690793|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19690794|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690795|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690796|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690797|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211835|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19846564|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
19846565|NCT00679380|Hormones|hormones|mesh-ancestor
19846566|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846567|NCT00679432|Budesonide|budesonide|mesh-list
19846568|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403515|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
20403516|NCT01148576|Vitamin E|vitamin e|mesh-list
20403517|NCT01148576|Entecavir|entecavir|mesh-list
20403518|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
20403519|NCT01148576|Vitamins|vitamins|mesh-ancestor
20403520|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
20403521|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403522|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
20403523|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403524|NCT01148576|Protective Agents|protective agents|mesh-ancestor
20403525|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
20403526|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403527|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20403528|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
20403529|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20403530|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403531|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
20403532|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19846569|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19846570|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
19846571|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846572|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403533|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20403534|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
20403535|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20403536|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19373443|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
19373444|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373445|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373446|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373447|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19373448|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19846573|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19846574|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
19846575|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
19846576|NCT00679432|Hormones|hormones|mesh-ancestor
19846577|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846578|NCT00679627|Galantamine|galantamine|mesh-list
19846579|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19373449|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373450|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373451|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
19373452|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19373453|NCT04500470|Ketoprofen|ketoprofen|mesh-list
19373454|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19373455|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20211836|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211837|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211838|NCT00290264|Budesonide|budesonide|mesh-list
20211839|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
19373456|NCT04500470|Analgesics|analgesics|mesh-ancestor
19373457|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
19373458|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373459|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373460|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373461|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19373462|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19373463|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373464|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402548|NCT03608306|Methamphetamine|methamphetamine|mesh-list
19402549|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19402550|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402551|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
19402552|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
20211840|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20211841|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20211842|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
20211843|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403537|NCT01148615|Docetaxel|docetaxel|mesh-list
20403538|NCT01148615|Aflibercept|aflibercept|mesh-list
20403539|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373465|NCT04461015|Insulin|insulin|mesh-list
19373466|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19373467|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19373468|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373469|NCT04457297|Trifluridine|trifluridine|mesh-list
20403540|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
20403541|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
20403542|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
20403543|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403544|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20403545|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20403546|NCT01148615|Growth Substances|growth substances|mesh-ancestor
20403547|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403548|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
20403549|NCT01148628|Everolimus|everolimus|mesh-list
20403550|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403551|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403552|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
20403553|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403554|NCT01148667|Caseins|caseins|mesh-list
20403555|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
20403556|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
20403557|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427084|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
20427085|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20427086|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373470|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
19373471|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373472|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
19373473|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373474|NCT04441073|Lidocaine|lidocaine|mesh-list
19373475|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
19373476|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
19373477|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373478|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373479|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
19373480|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373481|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19373482|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19373483|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19373484|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373485|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373486|NCT04409665|Ketamine|ketamine|mesh-list
19373487|NCT04409665|Analgesics|analgesics|mesh-ancestor
19373488|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
19373489|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373490|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373491|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19373492|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19373493|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
19373494|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
19373495|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373496|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19373497|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19373498|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211844|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211845|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20211846|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
20211847|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
20211848|NCT00290264|Hormones|hormones|mesh-ancestor
20211849|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373499|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690798|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690799|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
19690800|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
19690801|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19690802|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211850|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20211851|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20211852|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20211853|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
19373500|NCT04382937|Ribavirin|ribavirin|mesh-list
19373501|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19373502|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
19373503|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373504|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
19373505|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373506|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19373507|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373508|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
19373509|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19373510|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20403558|NCT01148901|Infliximab|infliximab|mesh-list
20403559|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
20403560|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20403561|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19373511|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373512|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373513|NCT04351698|Montelukast|montelukast|mesh-list
19373514|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19373515|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
19373516|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19373517|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
19373518|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373519|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373520|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19373521|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19373522|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373523|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19373524|NCT04319627|Calcium|calcium|mesh-list
19373525|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19373526|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373527|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19690803|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690804|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19373528|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19373529|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
19373530|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690805|NCT05013320|Analgesics|analgesics|mesh-ancestor
19690806|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
19690807|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690808|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19690809|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19690810|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19690811|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
19846580|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373531|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19373532|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19373533|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373534|NCT04233879|Tenofovir|tenofovir|mesh-list
19373535|NCT04233879|Emtricitabine|emtricitabine|mesh-list
19373536|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19373537|NCT04233879|Islatravir|islatravir|mesh-list
19373538|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
19373539|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373540|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19373541|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19373542|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846581|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846582|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
19846583|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846584|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846585|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20211854|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211855|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211856|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
20211857|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20211858|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211859|NCT00290420|Chloroquine|chloroquine|mesh-list
20211860|NCT00290420|Amebicides|amebicides|mesh-ancestor
20211861|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20403562|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19846586|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
19846587|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846588|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
19846589|NCT00679939|Metformin|metformin|mesh-list
19846590|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
19373543|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373544|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19373545|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19373546|NCT04226833|Entrectinib|entrectinib|mesh-list
19373547|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19373548|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373549|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373550|NCT04214860|Azacitidine|azacitidine|mesh-list
19373551|NCT04214860|Venetoclax|venetoclax|mesh-list
19373552|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373553|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
19373554|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373555|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373556|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373557|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19373558|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19373559|NCT04205994|Tolcapone|tolcapone|mesh-list
19373560|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19373561|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19373562|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19373563|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373564|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373565|NCT04200313|Pancrelipase|pancrelipase|mesh-list
19373566|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373567|NCT04197310|Nivolumab|nivolumab|mesh-list
19373568|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373569|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373570|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19373571|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373572|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
19373573|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373574|NCT04176848|Durvalumab|durvalumab|mesh-list
19373575|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373576|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373577|NCT04168112|Dexamethasone|dexamethasone|mesh-list
19373578|NCT04168112|Prednisolone|prednisolone|mesh-list
19373579|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19373580|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
19373581|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19373582|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
19373583|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19373584|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
19373585|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373586|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
19373587|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
19373588|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373589|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373590|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373591|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
19373592|NCT04168112|Hormones|hormones|mesh-ancestor
19373593|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373594|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19373595|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373596|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19373597|NCT04168112|Protective Agents|protective agents|mesh-ancestor
19373598|NCT04165122|Valacyclovir|valacyclovir|mesh-list
19373599|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
19373600|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373601|NCT04103554|Valsartan|valsartan|mesh-list
19373602|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19373603|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19373604|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19373605|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19690812|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690813|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690814|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19690815|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19690816|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19690817|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
19690818|NCT05012137|Ropivacaine|ropivacaine|mesh-list
19690819|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
19690820|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
19690821|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402553|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373606|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402554|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
19402555|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402556|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402557|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402558|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19402559|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19402560|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402561|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19402562|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19402563|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
19402564|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
19402565|NCT03608241|Estradiol|estradiol|mesh-list
19402566|NCT03608241|Estrogens|estrogens|mesh-ancestor
19402567|NCT03608241|Hormones|hormones|mesh-ancestor
19402568|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402569|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402570|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19402571|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19402572|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19402573|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19402574|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
19402575|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19402576|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19402577|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402578|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402579|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402580|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402581|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
19402582|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
19402583|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402584|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
19402585|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19402586|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
19402587|NCT03608046|Irinotecan|irinotecan|mesh-list
19402588|NCT03608046|Cetuximab|cetuximab|mesh-list
19402589|NCT03608046|Avelumab|avelumab|mesh-list
19402590|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19402591|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19402592|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402593|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402594|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402595|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402596|NCT03608007|Ensartinib|ensartinib|mesh-list
19402597|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402598|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20403563|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20403564|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
20403565|NCT01148992|Lofexidine|lofexidine|mesh-list
20403566|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20403567|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20403568|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403569|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
20403570|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403571|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19402599|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402600|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402601|NCT03607955|Paclitaxel|paclitaxel|mesh-list
19402602|NCT03607955|Carboplatin|carboplatin|mesh-list
19402603|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19402604|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402605|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
20403572|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20403573|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20403574|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
20403575|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403576|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403577|NCT01149005|Insulin|insulin|mesh-list
20403578|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20403579|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
20403580|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
20403581|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
20403582|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20403583|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403584|NCT01149018|Dronabinol|dronabinol|mesh-list
20403585|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
19373607|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
19373608|NCT04088890|Fludarabine|fludarabine|mesh-list
19373609|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19373610|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
19373611|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211862|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20211863|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211864|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
20403586|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403587|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403588|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20403589|NCT01149018|Analgesics|analgesics|mesh-ancestor
20403590|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
20403591|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403592|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20403593|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20403594|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403595|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403596|NCT01149018|Hormones|hormones|mesh-ancestor
20403597|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211865|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211866|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
19373612|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19373613|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19373614|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
19373615|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373616|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373617|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19373618|NCT04080843|Capecitabine|capecitabine|mesh-list
20211867|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211868|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20211869|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211870|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211871|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
20211872|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20211873|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20403598|NCT01149109|Temozolomide|temozolomide|mesh-list
19373619|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
19373620|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373621|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
19373622|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373623|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373624|NCT04073147|Venetoclax|venetoclax|mesh-list
19373625|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
19373626|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373627|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373628|NCT04054375|Prednisone|prednisone|mesh-list
19373629|NCT04054375|Prednisolone|prednisolone|mesh-list
19373630|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373631|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
19373632|NCT04054375|Hormones|hormones|mesh-ancestor
19373633|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373634|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373635|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19373636|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373637|NCT04052139|Naltrexone|naltrexone|mesh-list
19373638|NCT04052139|Gabapentin|gabapentin|mesh-list
19373639|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19373640|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19373641|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373642|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
19373643|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373644|NCT04052139|Analgesics|analgesics|mesh-ancestor
19373645|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
19373646|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19690822|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403599|NCT01149109|Lomustine|lomustine|mesh-list
20403600|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20403601|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
20403602|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373647|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19373648|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20211874|NCT00290602|Prednisolone|prednisolone|mesh-list
20211875|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
20403603|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403604|NCT01149122|Gemcitabine|gemcitabine|mesh-list
19373649|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19373650|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19373651|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19373652|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211876|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20211877|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
20211878|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20211879|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
20211880|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
20211881|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211882|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211883|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20211884|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
20211885|NCT00290602|Hormones|hormones|mesh-ancestor
19373653|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373654|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
19373655|NCT04032301|Ketamine|ketamine|mesh-list
19373656|NCT04032301|Analgesics|analgesics|mesh-ancestor
19373657|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
19373658|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373659|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373660|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19373661|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19373662|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
19373663|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
19373664|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373665|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19373666|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19373667|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373668|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373669|NCT03998319|Tenecteplase|tenecteplase|mesh-list
19373670|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19373671|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19373672|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373673|NCT03984214|Dronabinol|dronabinol|mesh-list
19373674|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
19373675|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373676|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19373677|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19373678|NCT03984214|Analgesics|analgesics|mesh-ancestor
19373679|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
19373680|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373681|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19846591|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846592|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846593|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19846594|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
19846595|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19846596|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19846597|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
19846598|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846599|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19846600|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19846601|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846602|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
19846603|NCT00680043|Hematinics|hematinics|mesh-ancestor
19846604|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
19846605|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
19846606|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19846607|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
19846608|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846609|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846610|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19846611|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
19846612|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20211886|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211887|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20211888|NCT00290602|Protective Agents|protective agents|mesh-ancestor
20211889|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20403605|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
19846613|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20403606|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19846614|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20403607|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373682|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19373683|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20211890|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211891|NCT00290628|Cyclosporine|cyclosporine|mesh-list
20211892|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
20211893|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
20211894|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
20211895|NCT00290628|Melphalan|melphalan|mesh-list
20403608|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
20403609|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403610|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403611|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
20403612|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403613|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403614|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403615|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
20403616|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403617|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20403618|NCT01149174|Mitomycins|mitomycins|mesh-list
20403619|NCT01149174|Mitomycin|mitomycin|mesh-list
20403620|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20403621|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403622|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
20403623|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403624|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20403625|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403626|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
20403627|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20211896|NCT00290628|Busulfan|busulfan|mesh-list
20211897|NCT00290628|Cyclosporins|cyclosporins|mesh-list
20211898|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20403628|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373684|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373685|NCT03984214|Hormones|hormones|mesh-ancestor
19373686|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373687|NCT03976323|Cisplatin|cisplatin|mesh-list
19373688|NCT03976323|Carboplatin|carboplatin|mesh-list
19373689|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
19373690|NCT03976323|Pemetrexed|pemetrexed|mesh-list
19373691|NCT03976323|Olaparib|olaparib|mesh-list
19373692|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373693|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373694|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211899|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403629|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403630|NCT01149278|Benzocaine|benzocaine|mesh-list
20403631|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
20403632|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
20403633|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403634|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403635|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
20403636|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403637|NCT01149304|Enoxaparin|enoxaparin|mesh-list
20403638|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
20403639|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20403640|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
20403641|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20403642|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20403643|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403644|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20403645|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403646|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20403647|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20403648|NCT01149304|Protective Agents|protective agents|mesh-ancestor
20403649|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403650|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
20403651|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20403652|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
20403653|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20403654|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373695|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373696|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20211900|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
20403655|NCT01149330|Adapalene|adapalene|mesh-list
20211901|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373697|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19373698|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19373699|NCT03965130|Glucagon|glucagon|mesh-list
19373700|NCT03965130|Hormones|hormones|mesh-ancestor
19373701|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373702|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373703|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373704|NCT03958383|Nivolumab|nivolumab|mesh-list
19373705|NCT03958383|Ipilimumab|ipilimumab|mesh-list
19373706|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373707|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373708|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19373709|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373710|NCT03953079|Sunitinib|sunitinib|mesh-list
19373711|NCT03953079|Aflibercept|aflibercept|mesh-list
19373712|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373713|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19373714|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19373715|NCT03953079|Growth Substances|growth substances|mesh-ancestor
19373716|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373717|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
19373718|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19373719|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373720|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373721|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
19373722|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19373723|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19373724|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19373725|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373726|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373727|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
19373728|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373729|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373730|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19373731|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373732|NCT03944577|Evolocumab|evolocumab|mesh-list
19373733|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19373734|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403656|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19373735|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
19373736|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373737|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19373738|NCT03931291|Azacitidine|azacitidine|mesh-list
19373739|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373740|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
19373741|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373742|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373743|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373744|NCT03922750|Insulin|insulin|mesh-list
19373745|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19373746|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
19373747|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19373748|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373749|NCT03910673|Fosfomycin|fosfomycin|mesh-list
19373750|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19373751|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373752|NCT03882970|Tirzepatide|tirzepatide|mesh-list
19373753|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20211902|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211903|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19373754|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211904|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
20211905|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211906|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211907|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20211908|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211909|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
20211910|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211911|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
20211912|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20211913|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20211914|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19373755|NCT03882970|Incretins|incretins|mesh-ancestor
19373756|NCT03882970|Hormones|hormones|mesh-ancestor
19373757|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373758|NCT03867734|Aztreonam|aztreonam|mesh-list
19373759|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19373760|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373761|NCT03854903|Fulvestrant|fulvestrant|mesh-list
19373762|NCT03854903|Palbociclib|palbociclib|mesh-list
19373763|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19373764|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373765|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19373766|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19373767|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
19373768|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19373769|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373770|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19373771|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373772|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373773|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
19373774|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19373775|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690823|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
19690824|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690825|NCT05012033|Prednisolone|prednisolone|mesh-list
19690826|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19690827|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
19690828|NCT05012033|Hormones|hormones|mesh-ancestor
19690829|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690830|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690831|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19690832|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690833|NCT05012189|Oseltamivir|oseltamivir|mesh-list
20403657|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20403658|NCT01149330|Analgesics|analgesics|mesh-ancestor
20403659|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
20403660|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403661|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403662|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403663|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403664|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
20403665|NCT01149356|Exemestane|exemestane|mesh-list
20403666|NCT01149356|Goserelin|goserelin|mesh-list
20403667|NCT01149356|R04929097|r04929097|mesh-list
20403668|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403669|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19373776|NCT03829410|Bevacizumab|bevacizumab|mesh-list
19373777|NCT03829410|Onvansertib|onvansertib|mesh-list
19373778|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20403670|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20403671|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403672|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403673|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19373779|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373780|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19373781|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19373782|NCT03829410|Growth Substances|growth substances|mesh-ancestor
19373783|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373784|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
19373785|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20403674|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
20403675|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20403676|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403677|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19373786|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373787|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373788|NCT03818802|Niacinamide|niacinamide|mesh-list
19373789|NCT03818802|Niacin|niacin|mesh-list
19373790|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
19373791|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
19373792|NCT03818802|Vitamins|vitamins|mesh-ancestor
19373793|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
19373794|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373795|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19373796|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
19373797|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690834|NCT05012189|Baloxavir|baloxavir|mesh-list
19373798|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19373799|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
19373800|NCT03810313|Aflibercept|aflibercept|mesh-list
19373801|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19373802|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19373803|NCT03810313|Growth Substances|growth substances|mesh-ancestor
19373804|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373805|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
19373806|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373807|NCT03806335|Anesthetics|anesthetics|mesh-list
19373808|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373809|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373810|NCT03802630|Aflibercept|aflibercept|mesh-list
19373811|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19373812|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19373813|NCT03802630|Growth Substances|growth substances|mesh-ancestor
19373814|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373815|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
19373816|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373817|NCT03796156|Aspirin|aspirin|mesh-list
19373818|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19373819|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19373820|NCT03796156|Analgesics|analgesics|mesh-ancestor
19373821|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
19373822|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373823|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373824|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19373825|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403678|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
20403679|NCT01149395|Lansoprazole|lansoprazole|mesh-list
20403680|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20403681|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373826|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19373827|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19373828|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373829|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19373830|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19373831|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373832|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
19373833|NCT03794427|Anesthetics|anesthetics|mesh-list
19373834|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373835|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373836|NCT03770676|Selenium|selenium|mesh-list
19373837|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
19373838|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373839|NCT03770676|Protective Agents|protective agents|mesh-ancestor
19373840|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373841|NCT03770676|Trace Elements|trace elements|mesh-ancestor
19373842|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
19373843|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19373844|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19373845|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402606|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
19402607|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
20403682|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20403683|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403684|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403685|NCT01149408|Decitabine|decitabine|mesh-list
19402608|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402609|NCT03607916|Morphine|morphine|mesh-list
19402610|NCT03607916|Prilocaine|prilocaine|mesh-list
19402611|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19402612|NCT03607916|Narcotics|narcotics|mesh-ancestor
19402613|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402614|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402615|NCT03607916|Analgesics|analgesics|mesh-ancestor
19402616|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
19402617|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402618|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402619|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
19402620|NCT03607903|Adalimumab|adalimumab|mesh-list
19402621|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402622|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403686|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19402623|NCT03607851|Lacosamide|lacosamide|mesh-list
19402624|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
19404718|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20403687|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
20403688|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403689|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403690|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403691|NCT01149499|Valacyclovir|valacyclovir|mesh-list
20403692|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
20403693|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403694|NCT01149564|Ibuprofen|ibuprofen|mesh-list
20403695|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20403696|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20403697|NCT01149564|Analgesics|analgesics|mesh-ancestor
20403698|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
20403699|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403700|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403701|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403702|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403703|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20403704|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403705|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403706|NCT01149577|Olanzapine|olanzapine|mesh-list
20403707|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
20403708|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
20403709|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211915|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
20211916|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211917|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846615|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
19846616|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846617|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846618|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
19846619|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19846620|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
19848263|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19848264|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19690835|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
19690836|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690837|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690838|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690839|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19690840|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19690841|NCT05011760|Amphetamine|amphetamine|mesh-list
20211918|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
20211919|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
20211920|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211921|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373846|NCT03760458|Lamivudine|lamivudine|mesh-list
19373847|NCT03760458|Abacavir|abacavir|mesh-list
19373848|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
19373849|NCT03760458|Dolutegravir|dolutegravir|mesh-list
19373850|NCT03760458|Triumeq|triumeq|mesh-list
19690842|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
19690843|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19690844|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403710|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373851|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19373852|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19373853|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373854|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373855|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
19373856|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403711|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20403712|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20403713|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20403714|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403715|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403716|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20403717|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403718|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373857|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19690845|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
19690846|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
19848265|NCT00691704|Growth Substances|growth substances|mesh-ancestor
20211922|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
20427087|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848266|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
19373858|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19373859|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
19373860|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19373861|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19373862|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
20403719|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403720|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403721|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
20403722|NCT01149629|Droxidopa|droxidopa|mesh-list
20403723|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20403724|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20403725|NCT01149668|Abexinostat|abexinostat|mesh-list
20403726|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20403727|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403728|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403729|NCT01149746|Tamsulosin|tamsulosin|mesh-list
19373863|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
19373864|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373865|NCT03689712|Protective Agents|protective agents|mesh-ancestor
19373866|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373867|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
19373868|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
19373869|NCT03631446|Citric Acid|citric acid|mesh-list
19373870|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
19373871|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
19373872|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19373873|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
19373874|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
19373875|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373876|NCT03631446|Cathartics|cathartics|mesh-ancestor
19373877|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19373878|NCT03631446|Antacids|antacids|mesh-ancestor
19373879|NCT03630640|Nivolumab|nivolumab|mesh-list
19373880|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373881|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373882|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19373883|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373884|NCT03625388|Dasatinib|dasatinib|mesh-list
19373885|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373886|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19373887|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373888|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373889|NCT03567057|Amantadine|amantadine|mesh-list
19373890|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19373891|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19373892|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
19373893|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19373894|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
19373895|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373896|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373897|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373898|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19373899|NCT03567057|Analgesics|analgesics|mesh-ancestor
19373900|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
19373901|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373902|NCT03566511|Diazoxide|diazoxide|mesh-list
19373903|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19373904|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
19373905|NCT03552068|Clonidine|clonidine|mesh-list
19373906|NCT03552068|Analgesics|analgesics|mesh-ancestor
19373907|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
19373908|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373909|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373910|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19373911|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
19373912|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
19373913|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19373914|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19373915|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20403730|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20403731|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20403732|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20403733|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
19373916|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
19373917|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373918|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403734|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403735|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403736|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403737|NCT01149746|Urological Agents|urological agents|mesh-ancestor
20403738|NCT01149798|Cisplatin|cisplatin|mesh-list
20403739|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20403740|NCT01149798|Paclitaxel|paclitaxel|mesh-list
20403741|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403742|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20403743|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
20403744|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
20403745|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
20403746|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403747|NCT01149824|Salvinorin A|salvinorin a|mesh-list
20403748|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
19373919|NCT03548064|Vaccines|vaccines|mesh-list
19373920|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
19373921|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373922|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
19373923|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19373924|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373925|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19373926|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
19373927|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373928|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19373929|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
19373930|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19373931|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373932|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19373933|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19373934|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19373935|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
19373936|NCT03526679|Lenvatinib|lenvatinib|mesh-list
19373937|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373938|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19373939|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373940|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373941|NCT03502785|Atezolizumab|atezolizumab|mesh-list
19373942|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373943|NCT03502668|Decitabine|decitabine|mesh-list
19373944|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373945|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
19373946|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19373947|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373948|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373949|NCT03496610|Bupivacaine|bupivacaine|mesh-list
19373950|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
19373951|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
19373952|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373953|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373954|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
19373955|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211923|NCT00290628|Hormones|hormones|mesh-ancestor
20211924|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211925|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19373959|NCT03446456|Vasopressins|vasopressins|mesh-list
19373960|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
19373961|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
19373962|NCT03446456|Coagulants|coagulants|mesh-ancestor
19373963|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19373964|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19373965|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
19373966|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373967|NCT03396692|Morphine|morphine|mesh-list
19373968|NCT03396692|Ropivacaine|ropivacaine|mesh-list
20211926|NCT00290628|Protective Agents|protective agents|mesh-ancestor
20211927|NCT00290641|Cyclosporine|cyclosporine|mesh-list
20211928|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
20211929|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
20211930|NCT00290641|Fludarabine|fludarabine|mesh-list
20211931|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
20211932|NCT00290641|Cyclosporins|cyclosporins|mesh-list
20211933|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211934|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
20211935|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211936|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211937|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20403749|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403750|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403751|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
20403752|NCT01149902|Docetaxel|docetaxel|mesh-list
20403753|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403754|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
20403755|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403756|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403757|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20403758|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
20403759|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403760|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403761|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20403762|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
20403763|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
20403764|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
20403765|NCT01149941|Ibuprofen|ibuprofen|mesh-list
20403766|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20403767|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20403768|NCT01149941|Analgesics|analgesics|mesh-ancestor
20403769|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
20403770|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403771|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403772|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403773|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403774|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20403775|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403776|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403777|NCT01149954|Ibuprofen|ibuprofen|mesh-list
20403778|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20403779|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20403780|NCT01149954|Analgesics|analgesics|mesh-ancestor
20403781|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
20403782|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403783|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403784|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403785|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20403786|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20403787|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403788|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403789|NCT01149967|Dexetimide|dexetimide|mesh-list
20403790|NCT01149967|Citalopram|citalopram|mesh-list
20403791|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20403792|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403793|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20403794|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403795|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403796|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
20403797|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403798|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20403799|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
20403800|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403801|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20403802|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20403803|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
20403804|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
20403805|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403806|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20403807|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20403808|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
20403809|NCT01149980|Dexetimide|dexetimide|mesh-list
20403810|NCT01149980|Citalopram|citalopram|mesh-list
20403811|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20403812|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20403813|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20403814|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403815|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403816|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
19373969|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19373970|NCT03396692|Narcotics|narcotics|mesh-ancestor
19373971|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19373972|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19373973|NCT03396692|Analgesics|analgesics|mesh-ancestor
19373974|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
19373975|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19373976|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
19373977|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
19373978|NCT03395639|Heparin|heparin|mesh-list
19373979|NCT03395639|Enoxaparin|enoxaparin|mesh-list
19373980|NCT03395639|Warfarin|warfarin|mesh-list
19373981|NCT03395639|Edoxaban|edoxaban|mesh-list
19373982|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
19373983|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19373984|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19373985|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211938|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
20211939|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211940|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211941|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20211942|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20211943|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
19373986|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19373987|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
19373988|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19373989|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
19373990|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19373991|NCT03388190|Leucovorin|leucovorin|mesh-list
19373992|NCT03388190|Fluorouracil|fluorouracil|mesh-list
19690847|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690848|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
20403817|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403818|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20403819|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
20403820|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403821|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20403822|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20403823|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
20403824|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
20403825|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690849|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690850|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690851|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
19690852|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19690853|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19690854|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19690855|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19690856|NCT05011487|Pemetrexed|pemetrexed|mesh-list
19690857|NCT05011487|Osimertinib|osimertinib|mesh-list
20211944|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211945|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
20403826|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20403827|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20403828|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
20403829|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
20403830|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
20403831|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20403832|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
20403833|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403834|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403835|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20403836|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19373993|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
19373994|NCT03388190|Nivolumab|nivolumab|mesh-list
19373995|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
19373996|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
19373997|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211946|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20211947|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
20211948|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20211949|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20211950|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20211951|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
20211952|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20211953|NCT00290667|Prednisone|prednisone|mesh-list
20211954|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
20211955|NCT00290667|Rituximab|rituximab|mesh-list
19373998|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19373999|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374000|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374001|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
20211956|NCT00290667|Doxorubicin|doxorubicin|mesh-list
20211957|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19690858|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690859|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690860|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690861|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19690862|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19690863|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19690864|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19690865|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19846621|NCT00680121|Benphothiamine|benphothiamine|mesh-list
19846622|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19374002|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374003|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19374004|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19374005|NCT03388190|Antidotes|antidotes|mesh-ancestor
19374006|NCT03388190|Protective Agents|protective agents|mesh-ancestor
20403837|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20403838|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
20403839|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20403840|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403841|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403842|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403843|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
20403844|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403845|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
19374007|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
19374008|NCT03388190|Vitamins|vitamins|mesh-ancestor
19374009|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
19374010|NCT03382834|Tamoxifen|tamoxifen|mesh-list
19374011|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19374012|NCT03382834|Vorinostat|vorinostat|mesh-list
19374013|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19374014|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
19374015|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374016|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374017|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19374018|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374019|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19374020|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19374021|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19374022|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19374023|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374024|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374025|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
19374026|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374027|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
19374028|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19374029|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374030|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
19374031|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19374032|NCT03326193|Bevacizumab|bevacizumab|mesh-list
19374033|NCT03326193|Niraparib|niraparib|mesh-list
19374034|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19374035|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403846|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
19374036|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19374037|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19374038|NCT03326193|Growth Substances|growth substances|mesh-ancestor
19374039|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374040|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
19374041|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19374042|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374043|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374044|NCT03310905|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19374045|NCT03310905|Immunologic Factors|immunologic factors|mesh-ancestor
19374046|NCT03310905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690866|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19846623|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
19846624|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846625|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
19846626|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
19846627|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846628|NCT00680186|Warfarin|warfarin|mesh-list
20403847|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
20403848|NCT01150162|Omeprazole|omeprazole|mesh-list
19846629|NCT00680186|Dabigatran|dabigatran|mesh-list
19846630|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
19846631|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
19846632|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20211958|NCT00290667|Vincristine|vincristine|mesh-list
20211959|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20211960|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
20211961|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211962|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211963|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20211964|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
20211965|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403849|NCT01150162|Rebamipide|rebamipide|mesh-list
19374047|NCT03302286|Mannitol|mannitol|mesh-list
19374048|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19374049|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20211966|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211967|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20211968|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20211969|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19374050|NCT03302286|Diuretics|diuretics|mesh-ancestor
19374051|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
20211970|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20211971|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20211972|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211973|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20211974|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
20211975|NCT00290667|Hormones|hormones|mesh-ancestor
20211976|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20211977|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20211978|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20403850|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20403851|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20403852|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20403853|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403854|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403855|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
20403856|NCT01150162|Protective Agents|protective agents|mesh-ancestor
20403857|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403858|NCT01150201|Losartan|losartan|mesh-list
20403859|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20403860|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20403861|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20403862|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20403863|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403864|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20403865|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20403866|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20403867|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403868|NCT01150318|Iodine|iodine|mesh-list
20403869|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20403870|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403871|NCT01150318|Trace Elements|trace elements|mesh-ancestor
20403872|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
20403873|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403874|NCT01150331|Levetiracetam|levetiracetam|mesh-list
20403875|NCT01150331|Clonazepam|clonazepam|mesh-list
20403876|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
20403877|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
20211979|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
20211980|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
20211981|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
20211982|NCT00290680|Celecoxib|celecoxib|mesh-list
20211983|NCT00290680|Bortezomib|bortezomib|mesh-list
20403878|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
20403879|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
20403880|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19690867|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690868|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690869|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690870|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19690871|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19690872|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19690873|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
19690874|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846633|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
20403881|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403882|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211984|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20211985|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20211986|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20211987|NCT00290680|Analgesics|analgesics|mesh-ancestor
20211988|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
20211989|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20211990|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20211991|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20211992|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20211993|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20211994|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20211995|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20211996|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20211997|NCT00290719|Irinotecan|irinotecan|mesh-list
20211998|NCT00290719|Gefitinib|gefitinib|mesh-list
20211999|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212000|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20212001|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20212002|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212003|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212004|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20212005|NCT00290758|Genistein|genistein|mesh-list
20212006|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20212007|NCT00290758|Protective Agents|protective agents|mesh-ancestor
20212008|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212009|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403883|NCT01150344|Artemether|artemether|mesh-list
20403884|NCT01150344|Atovaquone|atovaquone|mesh-list
20403885|NCT01150344|Proguanil|proguanil|mesh-list
20403886|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20403887|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
20403888|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20403889|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20403890|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403891|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403892|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403893|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
20403894|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20403895|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20403896|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20403897|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403898|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212010|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20212011|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403899|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20403900|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20403901|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20403902|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
20403903|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20403904|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403905|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20403906|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20403907|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
20403908|NCT01150617|Insulin|insulin|mesh-list
20403909|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20403910|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
20403911|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20403912|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
20403913|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403914|NCT01150630|Gemcitabine|gemcitabine|mesh-list
20212012|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212013|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
20212014|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20212015|NCT00290758|Estrogens|estrogens|mesh-ancestor
20212016|NCT00290758|Hormones|hormones|mesh-ancestor
20212017|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212018|NCT00290823|Albendazole|albendazole|mesh-list
20212019|NCT00290823|Dexamethasone|dexamethasone|mesh-list
20212020|NCT00290823|Omeprazole|omeprazole|mesh-list
20212021|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20403915|NCT01150630|Capecitabine|capecitabine|mesh-list
20403916|NCT01150630|Epirubicin|epirubicin|mesh-list
20403917|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403918|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212022|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
20212023|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
20212024|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212025|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403919|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
20403920|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403921|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
20403922|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403923|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403924|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20403925|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
20403926|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403927|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20403928|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20403929|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20427088|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427089|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
20427090|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20427091|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
20427092|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427093|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212026|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20212027|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
20212028|NCT00290823|Hormones|hormones|mesh-ancestor
19374052|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374053|NCT03271021|Minocycline|minocycline|mesh-list
19374054|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374055|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374056|NCT03264352|Amlodipine|amlodipine|mesh-list
20427094|NCT01284764|Mosapride|mosapride|mesh-list
20427095|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427096|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20427097|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
20427098|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427099|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374057|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212029|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427100|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374058|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19374059|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19374060|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374061|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19374062|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374063|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
19374064|NCT03255083|Osimertinib|osimertinib|mesh-list
19374065|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374066|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374067|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374068|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374069|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
19374070|NCT03253172|Diuretics|diuretics|mesh-ancestor
19374071|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
19374072|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374073|NCT03253172|Expectorants|expectorants|mesh-ancestor
19374074|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
19374075|NCT03227471|Ivacaftor|ivacaftor|mesh-list
19374076|NCT03227471|Elexacaftor|elexacaftor|mesh-list
19374077|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19374078|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19374079|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402625|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19402626|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19402627|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402628|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402629|NCT03607734|Amoxicillin|amoxicillin|mesh-list
19402630|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402631|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427101|NCT01284855|Antivenins|antivenins|mesh-list
20427102|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
20427103|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427104|NCT01284868|Propranolol|propranolol|mesh-list
19402632|NCT03607643|Leucovorin|leucovorin|mesh-list
19402633|NCT03607643|Gemcitabine|gemcitabine|mesh-list
20212030|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19374080|NCT03221842|Complement C1s|complement c1s|mesh-list
19374081|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19374082|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19374083|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
19374084|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374085|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19374086|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374087|NCT03194321|Tacrolimus|tacrolimus|mesh-list
20403930|NCT01150747|Azithromycin|azithromycin|mesh-list
20403931|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
20403932|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20403933|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20403934|NCT01150786|Selenium|selenium|mesh-list
20403935|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
20403936|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374088|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374089|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
19374090|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374091|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19374092|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374093|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374094|NCT03189693|Anesthetics|anesthetics|mesh-list
19374095|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374096|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374097|NCT03170206|Palbociclib|palbociclib|mesh-list
19374098|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403937|NCT01150786|Protective Agents|protective agents|mesh-ancestor
20403938|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403939|NCT01150786|Trace Elements|trace elements|mesh-ancestor
20403940|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
20403941|NCT01150877|Vitamin D|vitamin d|mesh-list
19374099|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374100|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374101|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374102|NCT03150173|Buprenorphine|buprenorphine|mesh-list
19374103|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19374104|NCT03150173|Narcotics|narcotics|mesh-ancestor
19374105|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374106|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374107|NCT03150173|Analgesics|analgesics|mesh-ancestor
19374108|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
19374109|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374110|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20403942|NCT01150877|Vitamins|vitamins|mesh-ancestor
20403943|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
20403944|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690875|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690876|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19690877|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19690878|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
19690879|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19690880|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19374111|NCT03093922|Gemcitabine|gemcitabine|mesh-list
19374112|NCT03093922|Atezolizumab|atezolizumab|mesh-list
19374113|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374114|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19374115|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
19374116|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374117|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
19374118|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374119|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374120|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374121|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
19374122|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374123|NCT03085095|Leuprolide|leuprolide|mesh-list
19374124|NCT03085095|Relugolix|relugolix|mesh-list
19374125|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19374126|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
19374127|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19374128|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690881|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
19374129|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20403945|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20403946|NCT01150955|Resveratrol|resveratrol|mesh-list
19374130|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403947|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
20403948|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403949|NCT01150955|Protective Agents|protective agents|mesh-ancestor
20403950|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403951|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403952|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20403953|NCT01151072|Insulin|insulin|mesh-list
20403954|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20403955|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403956|NCT01151176|Insulin|insulin|mesh-list
20403957|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20403958|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20403959|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403960|NCT01151241|Anesthetics|anesthetics|mesh-list
20403961|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
20403962|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403963|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403964|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
20403965|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20403966|NCT01151254|Propofol|propofol|mesh-list
20403967|NCT01151254|Sevoflurane|sevoflurane|mesh-list
20403968|NCT01151254|Isoflurane|isoflurane|mesh-list
20403969|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20403970|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403971|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374131|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
19374132|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
19374133|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374134|NCT03065062|Palbociclib|palbociclib|mesh-list
19374135|NCT03065062|Gedatolisib|gedatolisib|mesh-list
19374136|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374137|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374138|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374139|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374140|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19374141|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19374142|NCT03057431|Diuretics|diuretics|mesh-ancestor
19374143|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
19374144|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374145|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19374146|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19374147|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374148|NCT03048422|Tenofovir|tenofovir|mesh-list
19374149|NCT03048422|Emtricitabine|emtricitabine|mesh-list
19374150|NCT03048422|Efavirenz|efavirenz|mesh-list
19374151|NCT03048422|Dolutegravir|dolutegravir|mesh-list
19374152|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19374153|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19374154|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19374155|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
19374156|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374157|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19374158|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374159|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212031|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212032|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20212033|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20212034|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212035|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212036|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
20212037|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20212038|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212039|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
20212040|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20212041|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20212042|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
20212043|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
20212044|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212045|NCT00290836|Thrombin|thrombin|mesh-list
20212046|NCT00290836|Aprotinin|aprotinin|mesh-list
20212047|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
20212048|NCT00290836|Coagulants|coagulants|mesh-ancestor
20212049|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20403972|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20212050|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19374160|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846634|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846635|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690882|NCT05011383|Testosterone|testosterone|mesh-list
19690883|NCT05011383|Androgens|androgens|mesh-list
19690884|NCT05011383|Hormones|hormones|mesh-ancestor
19690885|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690886|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690887|NCT05010876|Icatibant|icatibant|mesh-list
19690888|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19690889|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19690890|NCT05010876|Analgesics|analgesics|mesh-ancestor
19690891|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
20403973|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
20403974|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
20403975|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20403976|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20403977|NCT01151267|Anesthetics|anesthetics|mesh-list
19690892|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690893|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212051|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
20212052|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212053|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212054|NCT00290849|Bivalirudin|bivalirudin|mesh-list
20212055|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
20212056|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20212057|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
19846636|NCT00680225|Ranibizumab|ranibizumab|mesh-list
19846637|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846638|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846639|NCT00680225|Growth Substances|growth substances|mesh-ancestor
19846640|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846641|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
19846642|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846643|NCT00680407|Silymarin|silymarin|mesh-list
19846644|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
19846645|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846646|NCT00680407|Protective Agents|protective agents|mesh-ancestor
19846647|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846648|NCT00680459|Ethanol|ethanol|mesh-list
20212058|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212059|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374161|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19374162|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19374163|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19374164|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19374165|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19374166|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19374167|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19374168|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19374169|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19374170|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19374171|NCT03022279|Ropivacaine|ropivacaine|mesh-list
19374172|NCT03022279|Anesthetics, Local|anesthetics, local|mesh-ancestor
19374173|NCT03022279|Anesthetics|anesthetics|mesh-ancestor
19374174|NCT03022279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374175|NCT03022279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374176|NCT03022279|Sensory System Agents|sensory system agents|mesh-ancestor
19374177|NCT03022279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374178|NCT02984800|Anesthetics|anesthetics|mesh-list
19374179|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374180|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374181|NCT02964884|Lovastatin|lovastatin|mesh-list
19374182|NCT02964884|L 647318|l 647318|mesh-list
19374183|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
19374184|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19374185|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19374186|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
19374187|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374188|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19374189|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19690894|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846649|NCT00680459|Heparin|heparin|mesh-list
19846650|NCT00680459|Anticoagulants|anticoagulants|mesh-list
19374190|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374191|NCT02910843|Capecitabine|capecitabine|mesh-list
19374192|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19374193|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
19374194|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374195|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374196|NCT02891811|Thalidomide|thalidomide|mesh-list
19374197|NCT02891811|Dexamethasone|dexamethasone|mesh-list
20403978|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20403979|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403980|NCT01151306|Simvastatin|simvastatin|mesh-list
20403981|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20403982|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20403983|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
20403984|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403985|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20403986|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20403987|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20403988|NCT01151384|Docetaxel|docetaxel|mesh-list
20403989|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20403990|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
20403991|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
20403992|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
20403993|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20403994|NCT01151397|Vitamin D|vitamin d|mesh-list
19374198|NCT02891811|Lenalidomide|lenalidomide|mesh-list
19374199|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19374200|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
19374201|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
19374202|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374203|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374204|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19374205|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
19374206|NCT02891811|Hormones|hormones|mesh-ancestor
19374207|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212060|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
20212061|NCT00290901|Celecoxib|celecoxib|mesh-list
20403995|NCT01151397|Ribavirin|ribavirin|mesh-list
20403996|NCT01151397|Vitamins|vitamins|mesh-ancestor
20403997|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
20403998|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20403999|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20404000|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
20404001|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404002|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
20404003|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404004|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20404005|NCT01151592|Hematinics|hematinics|mesh-ancestor
20404006|NCT01151605|Insulin|insulin|mesh-list
20404007|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20404008|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404009|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404010|NCT01151670|Pioglitazone|pioglitazone|mesh-list
20404011|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404012|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212062|NCT00290901|Tramadol|tramadol|mesh-list
20212063|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20404013|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
20404014|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
20212064|NCT00290901|Narcotics|narcotics|mesh-ancestor
20212065|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212066|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212067|NCT00290901|Analgesics|analgesics|mesh-ancestor
20212068|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
20212069|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212070|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212071|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212072|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212073|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212074|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20212075|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212076|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212077|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374208|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20404015|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
20404016|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20404017|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
20404018|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
20404019|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404020|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404021|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404022|NCT01151722|Bevacizumab|bevacizumab|mesh-list
20404023|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20404024|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404025|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20404026|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20404027|NCT01151722|Growth Substances|growth substances|mesh-ancestor
20404028|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404029|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
20404030|NCT01151735|Complement C1s|complement c1s|mesh-list
20404031|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
20404032|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212078|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19690895|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19690896|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19690897|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19690898|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690899|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19690900|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690901|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
20404033|NCT01151787|Amitriptyline|amitriptyline|mesh-list
20404034|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
20404035|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20404036|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
20404037|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19690902|NCT05010707|Spironolactone|spironolactone|mesh-list
19690903|NCT05010707|Hormones|hormones|mesh-list
19690904|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19690905|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690906|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19690907|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
19690908|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19690909|NCT05010707|Diuretics|diuretics|mesh-ancestor
19690910|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
19690911|NCT05010668|Lenvatinib|lenvatinib|mesh-list
20404038|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20404039|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404040|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20404041|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404042|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20404043|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404044|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19374209|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374210|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
19374211|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19374212|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19374213|NCT02891811|Growth Substances|growth substances|mesh-ancestor
19374214|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
19374215|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374216|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
19374217|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374218|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374219|NCT02876510|Vidarabine|vidarabine|mesh-list
19374220|NCT02876510|Aldesleukin|aldesleukin|mesh-list
19374221|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
19374222|NCT02876510|Fludarabine|fludarabine|mesh-list
19374223|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
19690912|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690913|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20212079|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
20212080|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20212081|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20212082|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20212083|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20212084|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212085|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212086|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
19374224|NCT02876510|Atezolizumab|atezolizumab|mesh-list
19374225|NCT02876510|Interleukin-2|interleukin-2|mesh-list
19374226|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374227|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
19374228|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374229|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374230|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19374231|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
20404045|NCT01151787|Analgesics|analgesics|mesh-ancestor
20404046|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
20404047|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20404048|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20404049|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404050|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404051|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
20404052|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404053|NCT01151800|Benzocaine|benzocaine|mesh-list
20404054|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
20404055|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
20404056|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374232|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374233|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374234|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19374235|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19374236|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
19374237|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
19374238|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374239|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19374240|NCT02876510|Analgesics|analgesics|mesh-ancestor
19374241|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
19374242|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374243|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19374244|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19374245|NCT02839915|Leucovorin|leucovorin|mesh-list
19374246|NCT02839915|Folic Acid|folic acid|mesh-list
19374247|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
19374248|NCT02839915|Antidotes|antidotes|mesh-ancestor
19374249|NCT02839915|Protective Agents|protective agents|mesh-ancestor
19374250|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374251|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
19374252|NCT02839915|Vitamins|vitamins|mesh-ancestor
19374253|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
19374254|NCT02839915|Hematinics|hematinics|mesh-ancestor
19374255|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
19374256|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19374257|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374258|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
19374259|NCT02828761|Calcium|calcium|mesh-list
19374260|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404057|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404058|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
20404059|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404060|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
20404061|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20404062|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404063|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404064|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20404065|NCT01151865|Analgesics|analgesics|mesh-ancestor
20404066|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
20404067|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404068|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20404069|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20404070|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20404071|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
20404072|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404073|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404074|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
19374261|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374262|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19374263|NCT02815280|Minocycline|minocycline|mesh-list
19374264|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374265|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374266|NCT02815267|Minocycline|minocycline|mesh-list
20404075|NCT01151878|Cathartics|cathartics|mesh-ancestor
19374267|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374268|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374269|NCT02811783|Naloxone|naloxone|mesh-list
19374270|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19374271|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374272|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
19374273|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374274|NCT02802228|Ifetroban|ifetroban|mesh-list
19374275|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19374276|NCT02801448|Sulforaphane|sulforaphane|mesh-list
19374277|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19374278|NCT02801448|Protective Agents|protective agents|mesh-ancestor
19374279|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374280|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212087|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212088|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20212089|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20212090|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
20212091|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20212092|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212093|NCT00290940|Metformin|metformin|mesh-list
20212094|NCT00290940|Pioglitazone|pioglitazone|mesh-list
20212095|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20212096|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212097|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
20212098|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20212099|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404076|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20404077|NCT01151943|Anesthetics|anesthetics|mesh-list
20404078|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
20404079|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404080|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404081|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
20404082|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404083|NCT01152047|Oxytocin|oxytocin|mesh-list
20404084|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
20404085|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404086|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404087|NCT01152203|Bevacizumab|bevacizumab|mesh-list
20404088|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20404089|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212100|NCT00290992|Rasburicase|rasburicase|mesh-list
19374281|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
19374282|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404090|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374283|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
19374284|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374285|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374286|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374287|NCT02661022|Dexamethasone|dexamethasone|mesh-list
19374288|NCT02661022|Pomalidomide|pomalidomide|mesh-list
19374289|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19374290|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
19374291|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
19374292|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374293|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374294|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19374295|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
19374296|NCT02661022|Hormones|hormones|mesh-ancestor
19374297|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374298|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19374299|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374300|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
19374301|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19374302|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19374303|NCT02661022|Growth Substances|growth substances|mesh-ancestor
20212101|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
20212102|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212103|NCT00291005|Docetaxel|docetaxel|mesh-list
20212104|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212105|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
20212106|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20212107|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212108|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212109|NCT00291109|Letrozole|letrozole|mesh-list
20212110|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212111|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20212112|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20212113|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374304|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
19374305|NCT02655016|Niraparib|niraparib|mesh-list
20404091|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20404092|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20404093|NCT01152203|Growth Substances|growth substances|mesh-ancestor
19374306|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19374307|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374308|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404094|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404095|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
20404096|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20404097|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
20404098|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404099|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
20404100|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404101|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404102|NCT01152346|Azacitidine|azacitidine|mesh-list
20404103|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20404104|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
20404105|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404106|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404107|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404108|NCT01152372|Insulin|insulin|mesh-list
20404109|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404110|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404111|NCT01152476|Remifentanil|remifentanil|mesh-list
20404112|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20404113|NCT01152476|Narcotics|narcotics|mesh-ancestor
20404114|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404115|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404116|NCT01152476|Analgesics|analgesics|mesh-ancestor
20404117|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
20404118|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427105|NCT01284868|Bisoprolol|bisoprolol|mesh-list
20427106|NCT01284868|Mirabegron|mirabegron|mesh-list
20427107|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20427108|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20427109|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
20427110|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19374309|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374310|NCT02652195|Oxytocin|oxytocin|mesh-list
19374311|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
20427111|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427112|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427113|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20427114|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20427115|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
20427116|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20427117|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20427118|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20427119|NCT01284868|Urological Agents|urological agents|mesh-ancestor
20427120|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
20427121|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
20427122|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427123|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20427124|NCT01284907|Vitamin D|vitamin d|mesh-list
20427125|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
20427126|NCT01284907|Vitamins|vitamins|mesh-ancestor
19374312|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19374313|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374314|NCT02650271|Tenofovir|tenofovir|mesh-list
19374315|NCT02650271|Entecavir|entecavir|mesh-list
19374316|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
19374317|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374318|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19374319|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374320|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374321|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374322|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19374323|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19374324|NCT02649855|Docetaxel|docetaxel|mesh-list
19374325|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374326|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
19374327|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
19374328|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
19374329|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846651|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19374330|NCT02570984|Omalizumab|omalizumab|mesh-list
19374331|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19374332|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19374333|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
19374334|NCT02539693|Lidocaine|lidocaine|mesh-list
19846652|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20404119|NCT01152593|Mupirocin|mupirocin|mesh-list
20404120|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404121|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404122|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20404123|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404124|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404125|NCT01152606|Trastuzumab|trastuzumab|mesh-list
20404126|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20404127|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404128|NCT01152710|Capecitabine|capecitabine|mesh-list
20404129|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20404130|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
20404131|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404132|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404133|NCT01152723|Nicotine|nicotine|mesh-list
20404134|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19846653|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846654|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19846655|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846656|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846657|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846658|NCT00680628|Enoxaparin|enoxaparin|mesh-list
19846659|NCT00680628|Tenecteplase|tenecteplase|mesh-list
19846660|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
19846661|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
19846662|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19846663|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20404135|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
20404136|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404137|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404138|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20404139|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20404140|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
20404141|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404142|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404143|NCT01152736|Nicotine|nicotine|mesh-list
20404144|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20404145|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
20404146|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427127|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
19374335|NCT02539693|Clonidine|clonidine|mesh-list
19374336|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
19374337|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
19374338|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374339|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374340|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
19374341|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374342|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19374343|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19374344|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19374345|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19374346|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374347|NCT02539693|Analgesics|analgesics|mesh-ancestor
19374348|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19690914|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690915|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690916|NCT05010681|Lenvatinib|lenvatinib|mesh-list
19690917|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690918|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19690919|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690920|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690921|NCT05010538|Sarecycline|sarecycline|mesh-list
19690922|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19690923|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690924|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
19693061|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846664|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374349|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
19374350|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
19374351|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19374352|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19374353|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19374354|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
19374355|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19374356|NCT02534012|Anesthetics|anesthetics|mesh-list
19374357|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374358|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374359|NCT02505204|Clonidine|clonidine|mesh-list
19374360|NCT02505204|Analgesics|analgesics|mesh-ancestor
19374361|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
19374362|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374363|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374364|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19374365|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
19374366|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
19374367|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19374368|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19374369|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19374370|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
20404147|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404148|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20404149|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20404150|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
20404151|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404152|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404153|NCT01152749|Nicotine|nicotine|mesh-list
20404154|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20404155|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
20404156|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404157|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404158|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19374371|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19374372|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846665|NCT00680706|Thiamine|thiamine|mesh-list
19846666|NCT00680706|Vitamins|vitamins|mesh-ancestor
19846667|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
19846668|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846669|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
19846670|NCT00680745|Metformin|metformin|mesh-list
19846671|NCT00680745|Pioglitazone|pioglitazone|mesh-list
19846672|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
19846673|NCT00680745|Glimepiride|glimepiride|mesh-list
19846674|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
20404159|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19374373|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
19374374|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
19374375|NCT02487979|Immunotoxins|immunotoxins|mesh-list
19374376|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19374377|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
19374378|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374379|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19374380|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374381|NCT02310867|Abatacept|abatacept|mesh-list
19374382|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19374383|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374384|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374385|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374386|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
19374387|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374388|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374389|NCT02303431|Edoxaban|edoxaban|mesh-list
19374390|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20404160|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
20404161|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404162|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404163|NCT01152801|Everolimus|everolimus|mesh-list
20404164|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374391|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
19374392|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19374393|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
19374394|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374395|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374396|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
19846675|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846676|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374397|NCT02288897|Temozolomide|temozolomide|mesh-list
19374398|NCT02288897|Dacarbazine|dacarbazine|mesh-list
19374399|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19374400|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20404165|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404166|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
20404167|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404168|NCT01152827|Everolimus|everolimus|mesh-list
20404169|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404170|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404171|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
20404172|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404173|NCT01152840|Everolimus|everolimus|mesh-list
20404174|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404175|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404176|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
20404177|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404178|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20404179|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404180|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404181|NCT01152931|Vitamins|vitamins|mesh-list
20404182|NCT01152931|Vitamin E|vitamin e|mesh-list
20404183|NCT01152931|Tocopherols|tocopherols|mesh-list
20404184|NCT01152931|Tocotrienols|tocotrienols|mesh-list
20404185|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
20404186|NCT01152931|Vitamin A|vitamin a|mesh-list
20404187|NCT01152931|Zinc|zinc|mesh-list
20404188|NCT01152931|Selenium|selenium|mesh-list
20404189|NCT01152931|Artesunate|artesunate|mesh-list
20404190|NCT01152931|Lumefantrine|lumefantrine|mesh-list
20404191|NCT01152931|Artemether|artemether|mesh-list
20404192|NCT01152931|Amodiaquine|amodiaquine|mesh-list
20404193|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
20404194|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
20404195|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404196|NCT01152931|Trace Elements|trace elements|mesh-ancestor
20404197|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
20404198|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404199|NCT01152931|Protective Agents|protective agents|mesh-ancestor
20404200|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
20404201|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20404202|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20404203|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404204|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404205|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
19374401|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
19374402|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374403|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374404|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19374405|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
19374406|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402634|NCT03607643|Bevacizumab|bevacizumab|mesh-list
19402635|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
19402636|NCT03607643|Irinotecan|irinotecan|mesh-list
19402637|NCT03607643|Temozolomide|temozolomide|mesh-list
19402638|NCT03607643|Bortezomib|bortezomib|mesh-list
19402639|NCT03607643|Cannabidiol|cannabidiol|mesh-list
19402640|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402641|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402642|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19402643|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19402644|NCT03607643|Growth Substances|growth substances|mesh-ancestor
19402645|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402646|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
19402647|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19402648|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
19402649|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402650|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
20404206|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
20404207|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19402651|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404208|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
19402652|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402653|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404209|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20404210|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
20404211|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404212|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404213|NCT01153165|Citalopram|citalopram|mesh-list
20404214|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20404215|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20404216|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404217|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374407|NCT02022982|Palbociclib|palbociclib|mesh-list
19374408|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374409|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374410|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374411|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374412|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19374413|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
19374414|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374415|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19374416|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
19374417|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19374418|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374419|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19374420|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20404218|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404219|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
20404220|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404221|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20404222|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
20404223|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20404224|NCT01153191|Gentamicins|gentamicins|mesh-list
20404225|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404226|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404227|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20404228|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404229|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404230|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
20404231|NCT01153204|Citric Acid|citric acid|mesh-list
20404232|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
20404233|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
20404234|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20404235|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
19374421|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19374422|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
19374423|NCT01898312|Mifepristone|mifepristone|mesh-list
19374424|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19374425|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
19374426|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404236|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
20404237|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404238|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
20404239|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20404240|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20404241|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404242|NCT01153204|Urological Agents|urological agents|mesh-ancestor
20404243|NCT01153217|Tenofovir|tenofovir|mesh-list
20404244|NCT01153217|Abacavir|abacavir|mesh-list
20404245|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
20404246|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404247|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20404248|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20404249|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404250|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404251|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20404252|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20404253|NCT01153243|Vitamin D|vitamin d|mesh-list
20404254|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
20404255|NCT01153243|Vitamins|vitamins|mesh-ancestor
19374427|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374428|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19374429|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19374430|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19374431|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
19374432|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19374433|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19374434|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
19374435|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374436|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
19848267|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20404256|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
19374437|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19374438|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19374439|NCT01883804|Methyldopa|methyldopa|mesh-list
19374440|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19374441|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
19374442|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
19374443|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212114|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212115|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20212116|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
19374444|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374445|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19374446|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19374447|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19374448|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
19374449|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19374450|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374451|NCT01881048|Celecoxib|celecoxib|mesh-list
19374452|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19374453|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19374454|NCT01881048|Analgesics|analgesics|mesh-ancestor
19374455|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
19374456|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374457|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374458|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19374459|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374460|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19374461|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19374462|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374463|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374464|NCT01838187|Vorinostat|vorinostat|mesh-list
19374465|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19374466|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374467|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19374468|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374469|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374470|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19374471|NCT01720147|Quercetin|quercetin|mesh-list
19374472|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
19374473|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374474|NCT01720147|Protective Agents|protective agents|mesh-ancestor
19374475|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374476|NCT01694004|Benzocaine|benzocaine|mesh-list
19374477|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
19374478|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
19374479|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374480|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374481|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
19374482|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374483|NCT01566695|Azacitidine|azacitidine|mesh-list
19374484|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19846677|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19846678|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846679|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19846680|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846681|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
19846682|NCT00680797|Testosterone|testosterone|mesh-list
19846683|NCT00680797|Estrogens|estrogens|mesh-list
19846684|NCT00680797|Androgens|androgens|mesh-ancestor
19846685|NCT00680797|Hormones|hormones|mesh-ancestor
19374485|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
19374486|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374487|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374488|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374489|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
19846686|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846687|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846688|NCT00680823|Ropivacaine|ropivacaine|mesh-list
19846689|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
19846690|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
20212117|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212118|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212119|NCT00291122|Celecoxib|celecoxib|mesh-list
20404257|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404258|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20404259|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404260|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
20404261|NCT01153256|Analgesics|analgesics|mesh-ancestor
20404262|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
20404263|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404264|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404265|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
20404266|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404267|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20404268|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
20404269|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19374490|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374491|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374492|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374493|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374494|NCT01376427|Dexamethasone|dexamethasone|mesh-list
19374495|NCT01376427|Methotrexate|methotrexate|mesh-list
19374496|NCT01376427|Vincristine|vincristine|mesh-list
19374497|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19374498|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
19374499|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
20212120|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212121|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212122|NCT00291122|Analgesics|analgesics|mesh-ancestor
20212123|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
20212124|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212125|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212126|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19374500|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374501|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374502|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20404270|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404271|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404272|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404273|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
20404274|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404275|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20404276|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20404277|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20404278|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
20404279|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404280|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20404281|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20404282|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404283|NCT01153373|Ethanol|ethanol|mesh-list
20404284|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20404285|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404286|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404287|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404288|NCT01153386|Treprostinil|treprostinil|mesh-list
20404289|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20404290|NCT01153542|Ivacaftor|ivacaftor|mesh-list
20404291|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20404292|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404293|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404294|NCT01153568|Vitamin D|vitamin d|mesh-list
20404295|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
20404296|NCT01153568|Vitamins|vitamins|mesh-ancestor
20404297|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
20404298|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404299|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20404300|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20212127|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212128|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20212129|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212130|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212131|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212132|NCT00291148|Pregabalin|pregabalin|mesh-list
19374503|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
19374504|NCT01376427|Hormones|hormones|mesh-ancestor
19374505|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404301|NCT01153659|Esomeprazole|esomeprazole|mesh-list
20404302|NCT01153659|Rabeprazole|rabeprazole|mesh-list
20404303|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20404304|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20212133|NCT00291148|Paroxetine|paroxetine|mesh-list
20212134|NCT00291148|Analgesics|analgesics|mesh-ancestor
20212135|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
20212136|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212137|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212138|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
20212139|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20212140|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20212141|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212142|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20212143|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20212144|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20212145|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212146|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20212147|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20212148|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20212149|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212150|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
20212151|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20212152|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
20212153|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20212154|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20404305|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20404306|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404307|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404308|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
20404309|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404310|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20404311|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404312|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404313|NCT01153802|Dopamine|dopamine|mesh-list
20404314|NCT01153802|Norepinephrine|norepinephrine|mesh-list
20404315|NCT01153802|Serotonin|serotonin|mesh-list
20404316|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
20404317|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20212155|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212156|NCT00291213|Levetiracetam|levetiracetam|mesh-list
20212157|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
20212158|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
20212159|NCT00291369|Interferons|interferons|mesh-list
20212160|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
20212161|NCT00291369|Interleukin-2|interleukin-2|mesh-list
20212162|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20404318|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20404319|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
20404320|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404321|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404322|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
20404323|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
20404324|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404325|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20404326|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19374506|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19374507|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212163|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
20212164|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212165|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
20212166|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212167|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
20212168|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212169|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212170|NCT00291369|Analgesics|analgesics|mesh-ancestor
20404327|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
19374508|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19374509|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
19374510|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19374511|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19374512|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
19374513|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374514|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
20404328|NCT01153802|Protective Agents|protective agents|mesh-ancestor
20404329|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20404330|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
20404331|NCT01153828|Mupirocin|mupirocin|mesh-list
20404332|NCT01153828|Retapamulin|retapamulin|mesh-list
20404333|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
20404334|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404335|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404336|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20404337|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404338|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404339|NCT01153854|Racecadotril|racecadotril|mesh-list
20404340|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
20404341|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19374515|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374516|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19374517|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212171|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
20212172|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212173|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20212174|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20404342|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
20404343|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404344|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404345|NCT01153880|Mupirocin|mupirocin|mesh-list
20404346|NCT01153880|Retapamulin|retapamulin|mesh-list
20212175|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20212176|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
20212177|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20212178|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19374518|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
19374519|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19690925|NCT05010499|Bupivacaine|bupivacaine|mesh-list
19690926|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
19690927|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
19690928|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
19690929|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19690930|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374520|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374521|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19374522|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
19374523|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
19374524|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
19374525|NCT01366898|Methotrexate|methotrexate|mesh-list
19374526|NCT01366898|Idarubicin|idarubicin|mesh-list
19374527|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19374528|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
19374529|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19374530|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374531|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19690931|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
19690932|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19690933|NCT05010434|Bevacizumab|bevacizumab|mesh-list
19690934|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19690935|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690936|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19690937|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19690938|NCT05010434|Growth Substances|growth substances|mesh-ancestor
19690939|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690940|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
19690941|NCT05010356|Insulin|insulin|mesh-list
19690942|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19690943|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690944|NCT05010200|Poly ICLC|poly iclc|mesh-list
19690945|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
19690946|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
19690947|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690948|NCT05009953|Leucovorin|leucovorin|mesh-list
19690949|NCT05009953|Fluorouracil|fluorouracil|mesh-list
19690950|NCT05009953|Irinotecan|irinotecan|mesh-list
19690951|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
19690952|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690953|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212179|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20404347|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374532|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
19690954|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374533|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374534|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374535|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
19374536|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374537|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19374538|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374539|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
19374540|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374541|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374542|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19374543|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19374544|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19374545|NCT01358201|Cytarabine|cytarabine|mesh-list
19374546|NCT01358201|Dexamethasone|dexamethasone|mesh-list
19374547|NCT01358201|Methotrexate|methotrexate|mesh-list
19374548|NCT01358201|Vincristine|vincristine|mesh-list
19374549|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19374550|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
19374551|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
19374552|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374553|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374554|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19374555|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
19374556|NCT01358201|Hormones|hormones|mesh-ancestor
19374557|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374558|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19374559|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374560|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19374561|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
19374562|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19374563|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19374564|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
19374565|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374566|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
19374567|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690955|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19690956|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
19690957|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374568|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19374569|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374570|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
19374571|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374572|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374573|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19374574|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
19374575|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
19374576|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
19690958|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19690959|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19690960|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690961|NCT05009953|Antidotes|antidotes|mesh-ancestor
19690962|NCT05009953|Protective Agents|protective agents|mesh-ancestor
19690963|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
19690964|NCT05009953|Vitamins|vitamins|mesh-ancestor
19690965|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
19690966|NCT05009342|Calpastatin|calpastatin|mesh-list
19690967|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19690968|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
19690969|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19690970|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212180|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20212181|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20212182|NCT00291382|Fluticasone|fluticasone|mesh-list
20212183|NCT00291382|Xhance|xhance|mesh-list
20212184|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20212185|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212186|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20212187|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
20212188|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212189|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212190|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19374577|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
19690971|NCT05009498|Vitamin D|vitamin d|mesh-list
19374578|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374579|NCT01338636|Ambrisentan|ambrisentan|mesh-list
20212191|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
20404348|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404349|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20404350|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404351|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404352|NCT01153919|Interferons|interferons|mesh-list
20404353|NCT01153919|Ribavirin|ribavirin|mesh-list
20404354|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
20404355|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
20404356|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20404357|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404358|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
20404359|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404360|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
20404361|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374580|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19374581|NCT01308034|Sunitinib|sunitinib|mesh-list
19374582|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374583|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19374584|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19374585|NCT01308034|Growth Substances|growth substances|mesh-ancestor
19374586|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374587|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
19374588|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374589|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374590|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374591|NCT01149083|Carboplatin|carboplatin|mesh-list
19374592|NCT01149083|Veliparib|veliparib|mesh-list
19374593|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374594|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19374595|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374596|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404362|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
20404363|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404364|NCT01154114|Darapladib|darapladib|mesh-list
20404365|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20404366|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404367|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404368|NCT01154348|Metformin|metformin|mesh-list
20404369|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404370|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404371|NCT01154361|Cortisone|cortisone|mesh-list
20404372|NCT01154361|Icatibant|icatibant|mesh-list
20404373|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20404374|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20404375|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20404376|NCT01154361|Analgesics|analgesics|mesh-ancestor
20404377|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
20404378|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404379|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404380|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20404381|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20404382|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20404383|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404384|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20404385|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404386|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
20404387|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
20404388|NCT01154387|Tacrolimus|tacrolimus|mesh-list
20404389|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
20404390|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20404391|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404392|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
20404393|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404394|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20404395|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404396|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404397|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20404398|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404399|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20404400|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
20404401|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404402|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19690972|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
19374597|NCT00938912|Lacosamide|lacosamide|mesh-list
20404403|NCT01154400|Caseins|caseins|mesh-list
19374598|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
19374599|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19374600|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19374601|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19374602|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404404|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
20404405|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
20404406|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404407|NCT01154426|Gemcitabine|gemcitabine|mesh-list
20404408|NCT01154426|Veliparib|veliparib|mesh-list
20404409|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20404410|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
20404411|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404412|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374603|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
19374604|NCT00925652|Bevacizumab|bevacizumab|mesh-list
19374605|NCT00925652|Methotrexate|methotrexate|mesh-list
19374606|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374607|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
19374608|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374609|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374610|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19374611|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
19374612|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374613|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374614|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19374615|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20404413|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
20404414|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404415|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404416|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404417|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
20404418|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404419|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19374616|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19374617|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20404420|NCT01154439|Cytarabine|cytarabine|mesh-list
20404421|NCT01154439|Etoposide|etoposide|mesh-list
20404422|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
20404423|NCT01154439|Idarubicin|idarubicin|mesh-list
20404424|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
20404425|NCT01154439|Everolimus|everolimus|mesh-list
19374618|NCT00925652|Growth Substances|growth substances|mesh-ancestor
19374619|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
19374620|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19374621|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
19374622|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19374623|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19374624|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
19374625|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
19374626|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374627|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19374628|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374629|NCT00700258|Sirolimus|sirolimus|mesh-list
19374630|NCT00700258|Sunitinib|sunitinib|mesh-list
19374631|NCT00700258|Axitinib|axitinib|mesh-list
19374632|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374633|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19374634|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19374635|NCT00700258|Growth Substances|growth substances|mesh-ancestor
19374636|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404426|NCT01154439|Ifosfamide|ifosfamide|mesh-list
20404427|NCT01154439|Carboplatin|carboplatin|mesh-list
20404428|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20404429|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404430|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20404431|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20404432|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404433|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374637|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
19374638|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20404434|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20404435|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
20404436|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
20404437|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404438|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374639|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374640|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374641|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374642|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374643|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19374644|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
19374645|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374646|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
19374647|NCT00676715|Interferons|interferons|mesh-list
19374648|NCT00676715|Interferon-beta|interferon-beta|mesh-list
19374649|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
19374650|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404439|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
20404440|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404441|NCT01154439|Analgesics|analgesics|mesh-ancestor
20404442|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
20404443|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404444|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20404445|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20404446|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
20427128|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427129|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20427130|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20428658|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428659|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428660|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
20428661|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428662|NCT01293149|Analgesics|analgesics|mesh-ancestor
20428663|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20428664|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
20428665|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
20428666|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20428667|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20428668|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20428669|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
20428670|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428671|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428672|NCT01293162|Folic Acid|folic acid|mesh-list
20428673|NCT01293162|Policosanol|policosanol|mesh-list
20428674|NCT01293162|Hematinics|hematinics|mesh-ancestor
20428675|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
20428676|NCT01293162|Vitamins|vitamins|mesh-ancestor
20428677|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
20428678|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428679|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20428680|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20428681|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
20428682|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428683|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19374651|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
19374652|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374653|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
19374654|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374655|NCT00604617|Interferons|interferons|mesh-list
19374656|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
19374657|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374658|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
19374659|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374660|NCT00579826|Letrozole|letrozole|mesh-list
19374661|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374662|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19374663|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19374664|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374665|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374666|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19374667|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
19374668|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374669|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374670|NCT00365157|Halichondrin B|halichondrin b|mesh-list
19374671|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
19374672|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
19374673|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19374674|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374675|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374676|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
19846691|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846692|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846693|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
19846694|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846695|NCT00680836|Rifaximin|rifaximin|mesh-list
19846696|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19846697|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846698|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19846699|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19846700|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
19374677|NCT00186888|Carboplatin|carboplatin|mesh-list
19374678|NCT00186888|Doxorubicin|doxorubicin|mesh-list
19374679|NCT00186888|Etoposide|etoposide|mesh-list
19374680|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
19374681|NCT00186888|Vincristine|vincristine|mesh-list
19374682|NCT00186888|Topotecan|topotecan|mesh-list
19374683|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374684|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
19374685|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374686|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374687|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19374688|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
19374689|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374690|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374691|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19374692|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19374693|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19846701|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846702|NCT00680953|Denosumab|denosumab|mesh-list
19846703|NCT00680953|Alendronate|alendronate|mesh-list
19846704|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19846705|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846706|NCT00680992|Denosumab|denosumab|mesh-list
19846707|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
19846708|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
19846709|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
19846710|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846711|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19846712|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19846713|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
19846714|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846715|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20404447|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
20404448|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20404449|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404450|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
20404451|NCT01154491|Hematinics|hematinics|mesh-ancestor
20404452|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
20404453|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20404454|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19374694|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19374695|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374696|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19374697|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
19374698|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
19374699|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
19374700|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19690973|NCT05009498|Vitamins|vitamins|mesh-ancestor
20404455|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
20404456|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404457|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404458|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20404459|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
20404460|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20404461|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
20404462|NCT01154504|Protective Agents|protective agents|mesh-ancestor
19374701|NCT00001563|Rituximab|rituximab|mesh-list
19690974|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
19690975|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690976|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19690977|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19690978|NCT05009017|Bevacizumab|bevacizumab|mesh-list
19690979|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19690980|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374702|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848268|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
20404463|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
20404464|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19374703|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374704|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
19374705|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374706|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374707|NCT05200442|Cetuximab|cetuximab|mesh-list
19374708|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19374709|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374710|NCT05200429|Ivacaftor|ivacaftor|mesh-list
19374711|NCT05200429|Elexacaftor|elexacaftor|mesh-list
19374712|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19374713|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19374714|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374715|NCT05200299|Leucovorin|leucovorin|mesh-list
19374716|NCT05200299|Fluorouracil|fluorouracil|mesh-list
19374717|NCT05200299|Capecitabine|capecitabine|mesh-list
19374718|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
19374719|NCT05200299|Irinotecan|irinotecan|mesh-list
19374720|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
19374721|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
19374722|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374723|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19374724|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374725|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374726|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
19374727|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374728|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19374729|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19374730|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374731|NCT05200299|Antidotes|antidotes|mesh-ancestor
19374732|NCT05200299|Protective Agents|protective agents|mesh-ancestor
19374733|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
19374734|NCT05200299|Vitamins|vitamins|mesh-ancestor
19374735|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
19374736|NCT05200260|Niraparib|niraparib|mesh-list
19374737|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19374738|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374739|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374740|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374741|NCT05200156|Choline|choline|mesh-list
19374742|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
19374743|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19374744|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
19374745|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374746|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19374747|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19374748|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
20212192|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
20212193|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20212194|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20212195|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20212196|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20212197|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
20212198|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212199|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212200|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
20212201|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20212202|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
20212203|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212204|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212205|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20212206|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
20212207|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20212208|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
20212209|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212210|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212211|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20212212|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
20212213|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
20212214|NCT00291408|Protective Agents|protective agents|mesh-ancestor
20212215|NCT00291538|Bortezomib|bortezomib|mesh-list
20212216|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212217|NCT00291616|Interferons|interferons|mesh-list
20212218|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
20212219|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
20212220|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20212221|NCT00291616|Thymalfasin|thymalfasin|mesh-list
20212222|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212223|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
19374754|NCT05199727|Tadalafil|tadalafil|mesh-list
20404465|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404466|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
20404467|NCT01154569|Azithromycin|azithromycin|mesh-list
20404468|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404469|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404470|NCT01154647|Citalopram|citalopram|mesh-list
20404471|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20404472|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20404473|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404474|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404475|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404476|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
20404477|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404478|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20404479|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
20404480|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20404481|NCT01154738|Lidocaine|lidocaine|mesh-list
20404482|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
20404483|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
20404484|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404485|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374755|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
19374756|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19374757|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19374758|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374759|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374760|NCT05199727|Urological Agents|urological agents|mesh-ancestor
19846716|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19846717|NCT00681187|Lanreotide|lanreotide|mesh-list
19846718|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846719|NCT00681265|Glycerol|glycerol|mesh-list
19846720|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19846721|NCT00681265|Protective Agents|protective agents|mesh-ancestor
19846722|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846723|NCT00681538|Nabiximols|nabiximols|mesh-list
19846724|NCT00681538|Analgesics|analgesics|mesh-ancestor
19846725|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
19846726|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846727|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846728|NCT00681590|Vitamin D|vitamin d|mesh-list
19846729|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
19846730|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
19846731|NCT00681590|Vitamins|vitamins|mesh-list
19374777|NCT05199571|Ofatumumab|ofatumumab|mesh-list
19374778|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374779|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19374780|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
20212224|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212225|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
20212226|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212227|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20212228|NCT00291707|Pemetrexed|pemetrexed|mesh-list
20212229|NCT00291707|Cetuximab|cetuximab|mesh-list
20212230|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212231|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212232|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212233|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20212234|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20212235|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212236|NCT00291720|Spironolactone|spironolactone|mesh-list
20212237|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20212238|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
20212239|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212240|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212241|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20212242|NCT00291720|Diuretics|diuretics|mesh-ancestor
20212243|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
19374781|NCT05199324|Cefazolin|cefazolin|mesh-list
19374782|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
19846732|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
19846733|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212244|NCT00291733|Levetiracetam|levetiracetam|mesh-list
20404486|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
20404487|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374783|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19374784|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
19374785|NCT05199324|Trimethoprim|trimethoprim|mesh-list
19374786|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
19374787|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374788|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19374789|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19374790|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404488|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20404489|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20404490|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20404491|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404492|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404493|NCT01154764|Ketoconazole|ketoconazole|mesh-list
20404494|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
20404495|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404496|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20404497|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20404498|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404499|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404500|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19374791|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374792|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374793|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19374794|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19374795|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19374796|NCT05199324|Renal Agents|renal agents|mesh-ancestor
19374797|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
19374798|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19374799|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19374800|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19374801|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19374802|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19374803|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19402654|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
19402655|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19402656|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19402657|NCT03607643|Antidotes|antidotes|mesh-ancestor
19402658|NCT03607643|Protective Agents|protective agents|mesh-ancestor
19402659|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
19402660|NCT03607643|Vitamins|vitamins|mesh-ancestor
19402661|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
19402662|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19402663|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
19402664|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
19402665|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
19402666|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19402667|NCT03607578|Protective Agents|protective agents|mesh-ancestor
19402668|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402669|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
19404719|NCT03592485|Acetaminophen|acetaminophen|mesh-list
19404720|NCT03592485|Oxycodone|oxycodone|mesh-list
19404721|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404722|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404723|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19404724|NCT03592485|Analgesics|analgesics|mesh-ancestor
19404725|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
19404726|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404727|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
19404728|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19404729|NCT03592485|Narcotics|narcotics|mesh-ancestor
19404730|NCT03592472|Abexinostat|abexinostat|mesh-list
19404731|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19404732|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404733|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404734|NCT03592342|Clobetasol|clobetasol|mesh-list
19404735|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404736|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
19404737|NCT03592342|Hormones|hormones|mesh-ancestor
19690981|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20404501|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
19404738|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374804|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19374805|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
19374806|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
19374807|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374808|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374809|NCT05198960|Aspirin|aspirin|mesh-list
19374810|NCT05198960|Anticoagulants|anticoagulants|mesh-list
19374811|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19374812|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19374813|NCT05198960|Analgesics|analgesics|mesh-ancestor
19374814|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
19374815|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374816|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374817|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19374818|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374819|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19374820|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19374821|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374822|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19374823|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19374824|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374825|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
19374826|NCT05198947|Ivermectin|ivermectin|mesh-list
20404502|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404503|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404504|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20404505|NCT01154790|Naproxen|naproxen|mesh-list
20404506|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20404507|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20404508|NCT01154790|Analgesics|analgesics|mesh-ancestor
20404509|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
20404510|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404511|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404512|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20404513|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20404514|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
19374827|NCT05198947|Permethrin|permethrin|mesh-list
19374828|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19374829|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374830|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374831|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404515|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20404516|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404517|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404518|NCT01154803|Micronutrients|micronutrients|mesh-list
20404519|NCT01154803|Trace Elements|trace elements|mesh-list
19374832|NCT05198856|Thalidomide|thalidomide|mesh-list
19374833|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19374834|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
19374835|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374836|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
19374837|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374838|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374839|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19374840|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19374841|NCT05198856|Growth Substances|growth substances|mesh-ancestor
19374842|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
19374843|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374844|NCT05198609|Apatinib|apatinib|mesh-list
19374845|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374846|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374847|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374848|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374849|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19374850|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19374851|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20404520|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404521|NCT01154829|Aripiprazole|aripiprazole|mesh-list
20404522|NCT01154829|Amisulpride|amisulpride|mesh-list
20404523|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
20404524|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20404525|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19374852|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374853|NCT05198141|Letrozole|letrozole|mesh-list
20404526|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19374854|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374855|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19374856|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19374857|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374858|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374859|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19374860|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
20404527|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404528|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404529|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
20404530|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
19374861|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374862|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374863|NCT05198050|Letrozole|letrozole|mesh-list
19374864|NCT05198050|Alprostadil|alprostadil|mesh-list
19374865|NCT05198050|Misoprostol|misoprostol|mesh-list
19374866|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846734|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19846735|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19846736|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19846737|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
19846738|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19846739|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19846740|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19846741|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846742|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846743|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19846744|NCT00681824|Thrombin|thrombin|mesh-list
19846745|NCT00681824|Aprotinin|aprotinin|mesh-list
19846746|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
20212245|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
20212246|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
20212247|NCT00291746|Esomeprazole|esomeprazole|mesh-list
20212248|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20212249|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20212250|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20212251|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374867|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19374868|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19374869|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374870|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374871|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20404531|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404532|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404533|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19374872|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
19374873|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374874|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374875|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19374876|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
19374877|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19374878|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19374879|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19374880|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
19374881|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19374882|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
19846747|NCT00681824|Coagulants|coagulants|mesh-ancestor
19374883|NCT05198050|Urological Agents|urological agents|mesh-ancestor
19374884|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19374885|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20212252|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374886|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19374887|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
19374888|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374889|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19374890|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19846748|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20212253|NCT00291759|Tamoxifen|tamoxifen|mesh-list
20212254|NCT00291759|Anastrozole|anastrozole|mesh-list
20212255|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20212256|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
20212257|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212258|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212259|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19374891|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374892|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
19374893|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19374894|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
19374895|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374896|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
19374897|NCT05188898|Protective Agents|protective agents|mesh-ancestor
19374898|NCT05184920|Nicotine|nicotine|mesh-list
19374899|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19374900|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
19374901|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374902|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404534|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20404535|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
20404536|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20404537|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20404538|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20404539|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20404540|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20404541|NCT01154881|Insulin|insulin|mesh-list
20404542|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404543|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404544|NCT01154907|Praziquantel|praziquantel|mesh-list
20404545|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
20404546|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20404547|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404548|NCT01154933|Exenatide|exenatide|mesh-list
20404549|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404550|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404551|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20404552|NCT01154933|Incretins|incretins|mesh-ancestor
20404553|NCT01154933|Hormones|hormones|mesh-ancestor
20404554|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404555|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
20404556|NCT01154959|Rifampin|rifampin|mesh-list
20404557|NCT01154959|Isoniazid|isoniazid|mesh-list
20404558|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
20404559|NCT01154959|Ethambutol|ethambutol|mesh-list
20404560|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404561|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404562|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19374903|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19374904|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19374905|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
19374906|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19374907|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374908|NCT05178225|Ubiquinone|ubiquinone|mesh-list
19374909|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
19374910|NCT05178225|Anticoagulants|anticoagulants|mesh-list
19374911|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
19374912|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374913|NCT05178225|Vitamins|vitamins|mesh-ancestor
19374914|NCT05178173|Ethanol|ethanol|mesh-list
19374915|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
19374916|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19374917|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404563|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20404564|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404565|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404566|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404567|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19374918|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19374919|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374920|NCT05162443|Adagrasib|adagrasib|mesh-list
19374921|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374922|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
19374923|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
19690982|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19690983|NCT05009017|Growth Substances|growth substances|mesh-ancestor
20404568|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
20404569|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
20404570|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20404571|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20404572|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19374924|NCT05139849|Vasopressins|vasopressins|mesh-list
19374925|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
19374926|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20404573|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20404574|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20404575|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20404576|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20404577|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20404578|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20404579|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
20404580|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20404581|NCT01155037|Vaccines|vaccines|mesh-list
20404582|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
20404583|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404584|NCT01155089|Anastrozole|anastrozole|mesh-list
20404585|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20404586|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374927|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
19374928|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
19374929|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19374930|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374931|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19374932|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
19374933|NCT05139849|Hormones|hormones|mesh-ancestor
19374934|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374935|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19374936|NCT05139849|Protective Agents|protective agents|mesh-ancestor
19374937|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
19374938|NCT05139849|Coagulants|coagulants|mesh-ancestor
19374939|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19374940|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19374941|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
19374942|NCT05131698|Lenvatinib|lenvatinib|mesh-list
19374943|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374944|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19374945|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374946|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374947|NCT05110781|Atezolizumab|atezolizumab|mesh-list
19374948|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19374949|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374950|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
19374951|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374952|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
20404587|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20404588|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20404589|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404590|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404591|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20404592|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
20404593|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404594|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404595|NCT01155102|Anastrozole|anastrozole|mesh-list
20404596|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20404597|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404598|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20404599|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20404600|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404601|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404602|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20404603|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
20404604|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404605|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404606|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
20404607|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20404608|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
20404609|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404610|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404611|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20404612|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
20404613|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20404614|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
20404615|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404616|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404617|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19374953|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19374954|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19374955|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404618|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
20404619|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
19374956|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
19374957|NCT05099276|Coagulants|coagulants|mesh-ancestor
19374958|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
19374959|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19374960|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
19374961|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374962|NCT05081479|Expectorants|expectorants|mesh-ancestor
19374963|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
19374964|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19374965|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
19374966|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374967|NCT05081479|Protective Agents|protective agents|mesh-ancestor
19374968|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374969|NCT05081479|Antidotes|antidotes|mesh-ancestor
19402670|NCT03607383|Red yeast rice|red yeast rice|mesh-list
20404620|NCT01155115|Protective Agents|protective agents|mesh-ancestor
20404621|NCT01155206|Glucagon|glucagon|mesh-list
20404622|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20404623|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402671|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19402672|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19402673|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19402674|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
19402675|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402676|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402677|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19402678|NCT03607331|Citalopram|citalopram|mesh-list
20404624|NCT01155206|Hormones|hormones|mesh-ancestor
20404625|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404626|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404627|NCT01155206|Incretins|incretins|mesh-ancestor
20404628|NCT01155232|Teriparatide|teriparatide|mesh-list
20404629|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
20404630|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404631|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404632|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20404633|NCT01155245|Teriparatide|teriparatide|mesh-list
20404634|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404635|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404636|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20404637|NCT01155258|Sirolimus|sirolimus|mesh-list
20404638|NCT01155258|Vinorelbine|vinorelbine|mesh-list
20404639|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404640|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404641|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20404642|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404643|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
20404644|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404645|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
20404646|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404647|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20404648|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
20404649|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
20404650|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
20404651|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690984|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212260|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212261|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20212262|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20212263|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20212264|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20212265|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20212266|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212267|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212268|NCT00291772|Pramlintide|pramlintide|mesh-list
20212269|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20212270|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212271|NCT00291785|Leucovorin|leucovorin|mesh-list
20212272|NCT00291785|Folic Acid|folic acid|mesh-list
20404652|NCT01155440|Lidocaine|lidocaine|mesh-list
20404653|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402679|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20212273|NCT00291785|Fluorouracil|fluorouracil|mesh-list
20212274|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
20404654|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
20404655|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404656|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404657|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
20404658|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404659|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20404660|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20404661|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20404662|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404663|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404664|NCT01155453|Trametinib|trametinib|mesh-list
20404665|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404666|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20404667|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404668|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404669|NCT01155505|Lenalidomide|lenalidomide|mesh-list
20404670|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
20404671|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404672|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20404673|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20404674|NCT01155505|Growth Substances|growth substances|mesh-ancestor
20404675|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
20404676|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404677|NCT01155635|Carvedilol|carvedilol|mesh-list
20404678|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20404679|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20404680|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
20404681|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404682|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404683|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374970|NCT05077449|Fulvestrant|fulvestrant|mesh-list
19374971|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19374972|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19374973|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19374974|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19374975|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
19374976|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19374977|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374978|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19374979|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19374980|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
19374981|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19374982|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
19374983|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19374984|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
19374985|NCT05073575|Protective Agents|protective agents|mesh-ancestor
19374986|NCT05072093|Tenofovir|tenofovir|mesh-list
19374987|NCT05072093|Emtricitabine|emtricitabine|mesh-list
19374988|NCT05072093|Doxycycline|doxycycline|mesh-list
19374989|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
19374990|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19374991|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19374992|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19374993|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19374994|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19374995|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19374996|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19374997|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19374998|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
19374999|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19375000|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19375001|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
19375002|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19375003|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19375004|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19375005|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375006|NCT05062135|Progesterone|progesterone|mesh-list
19375007|NCT05062135|Progestins|progestins|mesh-ancestor
19375008|NCT05062135|Hormones|hormones|mesh-ancestor
19375009|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375010|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375011|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
19375012|NCT05005182|Luspatercept|luspatercept|mesh-list
19375013|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20404684|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19375014|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375015|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
19375016|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375017|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375018|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19375019|NCT05005182|Hematinics|hematinics|mesh-ancestor
20404685|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
20404686|NCT01155635|Protective Agents|protective agents|mesh-ancestor
20404687|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20404688|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404689|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404690|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
20404691|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20404692|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20404693|NCT01155700|Omalizumab|omalizumab|mesh-list
20404694|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20404695|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20404696|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
20404697|NCT01155765|Clopidogrel|clopidogrel|mesh-list
20404698|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20404699|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19375020|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
19375021|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375022|NCT04997902|Tipifarnib|tipifarnib|mesh-list
19375023|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375024|NCT04996823|Ipilimumab|ipilimumab|mesh-list
19375025|NCT04996823|Axitinib|axitinib|mesh-list
19375026|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375027|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375028|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19375029|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375030|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375031|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375032|NCT04945148|Metformin|metformin|mesh-list
19375033|NCT04945148|Temozolomide|temozolomide|mesh-list
19375034|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19375035|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375036|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19375037|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
19375038|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375039|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375040|NCT04937816|Empagliflozin|empagliflozin|mesh-list
19375041|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19375042|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375043|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19375044|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375045|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
19375046|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375047|NCT04878211|Interferons|interferons|mesh-list
20404700|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20404701|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20404702|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20404703|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
20404704|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427131|NCT01284946|Deferasirox|deferasirox|mesh-list
19375048|NCT04878211|Ofatumumab|ofatumumab|mesh-list
19375049|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
19375050|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
20212275|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
20212276|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212277|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212278|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212279|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212280|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
20212281|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212282|NCT00291785|Antidotes|antidotes|mesh-ancestor
20212283|NCT00291785|Protective Agents|protective agents|mesh-ancestor
20212284|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
20212285|NCT00291785|Vitamins|vitamins|mesh-ancestor
20212286|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
20212287|NCT00291785|Hematinics|hematinics|mesh-ancestor
20212288|NCT00291811|Plerixafor|plerixafor|mesh-list
20212289|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20212290|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20212291|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
19375051|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375052|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
19375053|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375054|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19375055|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
19375056|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375057|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375058|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375059|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
19375060|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20404705|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404706|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404707|NCT01155791|Prednisone|prednisone|mesh-list
20404708|NCT01155791|Docetaxel|docetaxel|mesh-list
20404709|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404710|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
20404711|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
20404712|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
20404713|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404714|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20404715|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
20404716|NCT01155791|Hormones|hormones|mesh-ancestor
20404717|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404718|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404719|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20404720|NCT01155895|Amlodipine|amlodipine|mesh-list
20404721|NCT01155895|Benazepril|benazepril|mesh-list
20404722|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20404723|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20404724|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404725|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404726|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404727|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375061|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375062|NCT04865731|Esomeprazole|esomeprazole|mesh-list
19375063|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19375064|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375065|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19375066|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375067|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375068|NCT04856293|Crizotinib|crizotinib|mesh-list
19375069|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375070|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375071|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375072|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375073|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19375074|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19375075|NCT04783233|Chitosan|chitosan|mesh-list
19375076|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19375077|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19375078|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19375079|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
19375080|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375081|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20404728|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
20404729|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20404730|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375082|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
19375083|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
19375084|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
19375085|NCT04783233|Coagulants|coagulants|mesh-ancestor
19375086|NCT04742036|Paclitaxel|paclitaxel|mesh-list
19375087|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19690985|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
19690986|NCT05009082|Paclitaxel|paclitaxel|mesh-list
20404731|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404732|NCT01155908|Amlodipine|amlodipine|mesh-list
20404733|NCT01155908|Benazepril|benazepril|mesh-list
20404734|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20404735|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20404736|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375088|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375089|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375090|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690987|NCT05009082|Bevacizumab|bevacizumab|mesh-list
19690988|NCT05009082|Carboplatin|carboplatin|mesh-list
20404737|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404738|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20404739|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404740|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
19375091|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375092|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404741|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20404742|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
20404743|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404744|NCT01155921|Risperidone|risperidone|mesh-list
20404745|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19375093|NCT04707183|Lidocaine|lidocaine|mesh-list
19375094|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
19375095|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
19375096|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375097|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375098|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
19375099|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212292|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212293|NCT00291850|Paclitaxel|paclitaxel|mesh-list
20212294|NCT00291850|Cisplatin|cisplatin|mesh-list
20212295|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20212296|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375100|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19375101|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19375102|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19375103|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375104|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212297|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
20212298|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
20404746|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
19375105|NCT04703205|Ivermectin|ivermectin|mesh-list
19375106|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19375107|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404747|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404748|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404749|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404750|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20404751|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20404752|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404753|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20404754|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20404755|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
20404756|NCT01155934|Risperidone|risperidone|mesh-list
20404757|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20404758|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
20404759|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20404760|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404761|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404762|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20404763|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20404764|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404765|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20404766|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20404767|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
20404768|NCT01155947|Anastrozole|anastrozole|mesh-list
20404769|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20404770|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404771|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20404772|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20404773|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404774|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404775|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20404776|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
19375108|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
19375109|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375110|NCT04676334|Rucaparib|rucaparib|mesh-list
19375111|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20212299|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212300|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212301|NCT00291863|Simvastatin|simvastatin|mesh-list
20212302|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20212303|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20212304|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
20404777|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404778|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404779|NCT01155960|Anastrozole|anastrozole|mesh-list
20404780|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20404781|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404782|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20404783|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20404784|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404785|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404786|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20404787|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
20404788|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375112|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375113|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375114|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375115|NCT04639414|Empagliflozin|empagliflozin|mesh-list
19375116|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19375117|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375118|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19375119|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375120|NCT04608903|Sulforaphane|sulforaphane|mesh-list
19375121|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19375122|NCT04608903|Protective Agents|protective agents|mesh-ancestor
19375123|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375124|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375125|NCT04560127|Apatinib|apatinib|mesh-list
20404789|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404790|NCT01155986|Lidocaine|lidocaine|mesh-list
20404791|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
20404792|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
19375126|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375127|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375128|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375129|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375130|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19375131|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19375132|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404793|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404794|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404795|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
20404796|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404797|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20404798|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20404799|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20404800|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404801|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404802|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
20404803|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20404804|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404805|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20404806|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
20404807|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20404808|NCT01156220|Furosemide|furosemide|mesh-list
20404809|NCT01156220|Diuretics|diuretics|mesh-ancestor
20404810|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
20404811|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404812|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20404813|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20404814|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404815|NCT01156233|Anesthetics|anesthetics|mesh-list
20404816|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20404817|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404818|NCT01156246|Metformin|metformin|mesh-list
20404819|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
20404820|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404821|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404822|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19375133|NCT04518345|Azacitidine|azacitidine|mesh-list
19375134|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19375135|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
19375136|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375137|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375138|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402680|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19402681|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19402682|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402683|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402684|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
20404823|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427132|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20427133|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
20427134|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
20427135|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427136|NCT01285037|Gemcitabine|gemcitabine|mesh-list
20427137|NCT01285037|Cetuximab|cetuximab|mesh-list
19402685|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402686|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19402687|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
19402688|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19402689|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
19402690|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402691|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
20427138|NCT01285037|Ramucirumab|ramucirumab|mesh-list
20427139|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427140|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20427141|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
20427142|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427143|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
20427144|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427145|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427146|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427147|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
20427148|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427149|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20427150|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
20427151|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20427152|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
20427153|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427154|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20427155|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402692|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402693|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402694|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
19402695|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402696|NCT03607175|Triamcinolone|triamcinolone|mesh-list
19402697|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19402698|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402699|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
20427156|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
20427157|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427158|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
20427159|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20427160|NCT01285141|Protective Agents|protective agents|mesh-ancestor
20427161|NCT01285219|Lenograstim|lenograstim|mesh-list
20427162|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20427163|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
19402700|NCT03607175|Hormones|hormones|mesh-ancestor
19402701|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427164|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427165|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20427166|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427167|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20427168|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427169|NCT01285271|Sevoflurane|sevoflurane|mesh-list
20427170|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20427171|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20427172|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
20427173|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
20427174|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20427175|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427176|NCT01285375|Curcumin|curcumin|mesh-list
20427177|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20427178|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20427179|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427180|NCT01285375|Analgesics|analgesics|mesh-ancestor
20404824|NCT01156350|Fludarabine|fludarabine|mesh-list
20404825|NCT01156350|Busulfan|busulfan|mesh-list
20404826|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404827|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404828|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404829|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
20404830|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404831|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
20404832|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20404833|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20404834|NCT01156389|Ritonavir|ritonavir|mesh-list
20404835|NCT01156389|Artesunate|artesunate|mesh-list
20404836|NCT01156389|Pyronaridine|pyronaridine|mesh-list
20404837|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20404838|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20404839|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
20404840|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404841|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404842|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20404843|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19375139|NCT04515472|Hormones|hormones|mesh-list
19375140|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375141|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375142|NCT04512079|Enoxaparin|enoxaparin|mesh-list
19375143|NCT04512079|Apixaban|apixaban|mesh-list
19375144|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
19375145|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19375146|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20404844|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
20404845|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404846|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20404847|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20404848|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
20404849|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20404850|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20404851|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404852|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
19375147|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375148|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19375149|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
19375150|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19375151|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375152|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375153|NCT04511247|Sirolimus|sirolimus|mesh-list
19375154|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19375155|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375156|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19375157|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375158|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
19375159|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375160|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
19375161|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375162|NCT04511234|Sirolimus|sirolimus|mesh-list
19375163|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19375164|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375165|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19375166|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375167|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
19375168|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375169|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
19375170|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375171|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
19375172|NCT04491617|Narcotics|narcotics|mesh-ancestor
19375173|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375174|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375175|NCT04491617|Analgesics|analgesics|mesh-ancestor
19375176|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
19375177|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375178|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19375179|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
19375180|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19690989|NCT05009082|Niraparib|niraparib|mesh-list
19375181|NCT04437485|Norepinephrine|norepinephrine|mesh-list
19375182|NCT04437485|Bupropion|bupropion|mesh-list
19375183|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
20404853|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19375184|NCT04437485|Serotonin|serotonin|mesh-list
20404854|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
19375185|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19375186|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19375187|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19375188|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19375189|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19375190|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375191|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375192|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
19375193|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19375194|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375195|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19375196|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20404855|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
20404856|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375197|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375198|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19375199|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19375200|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
19375201|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
19375202|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
19375203|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375204|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19375205|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19375206|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
19375207|NCT04436224|Fentanyl|fentanyl|mesh-list
19375208|NCT04436224|Hydromorphone|hydromorphone|mesh-list
19375209|NCT04436224|Butorphanol|butorphanol|mesh-list
19375210|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19375211|NCT04436224|Narcotics|narcotics|mesh-ancestor
19375212|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375213|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375214|NCT04436224|Analgesics|analgesics|mesh-ancestor
19375215|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
19375216|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375217|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19375218|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19375219|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
19375220|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
19375221|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
19375222|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
19375223|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19375224|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
19375225|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19375226|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375227|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375228|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19375229|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19375230|NCT04433988|Protective Agents|protective agents|mesh-ancestor
19375231|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375232|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
19375233|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19375234|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
19375235|NCT04414722|Amoxicillin|amoxicillin|mesh-list
19375236|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
19375237|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
19375238|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19375239|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19375240|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375241|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19375242|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375243|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846749|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19846750|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
19846751|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846752|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846753|NCT00681863|Pramipexole|pramipexole|mesh-list
19846754|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
19846755|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846756|NCT00681863|Protective Agents|protective agents|mesh-ancestor
19846757|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846758|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19846759|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19846760|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
19846761|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
20404857|NCT01156584|Flucytosine|flucytosine|mesh-list
20404858|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
20404859|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404860|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
20404861|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404862|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
20404863|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
20404864|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20404865|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20404866|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404867|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404868|NCT01156636|Urological Agents|urological agents|mesh-ancestor
20404869|NCT01156649|Acetaminophen|acetaminophen|mesh-list
20404870|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20404871|NCT01156649|Analgesics|analgesics|mesh-ancestor
20404872|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
20404873|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404874|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212305|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212306|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20404875|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
19846762|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846763|NCT00681889|Ranibizumab|ranibizumab|mesh-list
19846764|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19375260|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
19375261|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375262|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375263|NCT04374019|Artesunate|artesunate|mesh-list
19375264|NCT04374019|Ivermectin|ivermectin|mesh-list
19375265|NCT04374019|Camostat|camostat|mesh-list
19375266|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
19375267|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19375268|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19375269|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212307|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20212308|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212309|NCT00291915|Adalimumab|adalimumab|mesh-list
20212310|NCT00291915|Methotrexate|methotrexate|mesh-list
20212311|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20212312|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
20212313|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20212314|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375270|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375271|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
19375272|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
19375273|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19375274|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
19375275|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375276|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375277|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375278|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19375279|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19375280|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19375281|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19375282|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19375283|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375284|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
19375285|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375286|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
20212315|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212316|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
20212317|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212318|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212319|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
20212320|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212321|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20212322|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212323|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
20212324|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212325|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20212326|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20404876|NCT01156688|Misoprostol|misoprostol|mesh-list
20404877|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20404878|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
19375287|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19375288|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19375289|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375290|NCT04344678|Urological Agents|urological agents|mesh-ancestor
19375291|NCT04338399|Paclitaxel|paclitaxel|mesh-list
19375292|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20404879|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404880|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404881|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20404882|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20404883|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
20404884|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20404885|NCT01156740|Amoxicillin|amoxicillin|mesh-list
20404886|NCT01156740|Penicillins|penicillins|mesh-list
20404887|NCT01156740|beta-Lactams|beta-lactams|mesh-list
20404888|NCT01156740|Penicillin G|penicillin g|mesh-list
20404889|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20404890|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
20404891|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404892|NCT01156779|Exenatide|exenatide|mesh-list
20404893|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19375293|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375294|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375295|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375296|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375297|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375298|NCT04311463|Paroxetine|paroxetine|mesh-list
19375299|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19375300|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19375301|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375302|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375303|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19375304|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
19375305|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375306|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19375307|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
19375308|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19375309|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19846765|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19846766|NCT00681889|Growth Substances|growth substances|mesh-ancestor
19846767|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846768|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19846769|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846770|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
19846771|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19846772|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19846773|NCT00682357|Prednisolone|prednisolone|mesh-list
19846774|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
20404894|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375310|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19375311|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375312|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19375313|NCT04295005|Empagliflozin|empagliflozin|mesh-list
20404895|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20404896|NCT01156779|Incretins|incretins|mesh-ancestor
20404897|NCT01156779|Hormones|hormones|mesh-ancestor
20404898|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404899|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
20404900|NCT01156857|Progestins|progestins|mesh-list
20404901|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20404902|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
19375314|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19375315|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375316|NCT04295005|Incretins|incretins|mesh-ancestor
19375317|NCT04295005|Hormones|hormones|mesh-ancestor
19375318|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375319|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19375320|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375321|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375322|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375323|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19375324|NCT04225988|Tacrolimus|tacrolimus|mesh-list
19846775|NCT00682357|Lidocaine|lidocaine|mesh-list
20404903|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404904|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404905|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20404906|NCT01156857|Hormones|hormones|mesh-ancestor
19375325|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375326|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
19375327|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375328|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19375329|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375330|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375331|NCT04212364|Naloxone|naloxone|mesh-list
19375332|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19375333|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375334|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
19375335|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375336|NCT04195750|Everolimus|everolimus|mesh-list
20404907|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404908|NCT01156883|Cytarabine|cytarabine|mesh-list
20404909|NCT01156883|Dexamethasone|dexamethasone|mesh-list
20404910|NCT01156883|Prednisone|prednisone|mesh-list
19375337|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375338|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375339|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
19375340|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375341|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
19375342|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19846776|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19846777|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
19846778|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
19846779|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
19846780|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375343|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
19375344|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19375345|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375346|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375347|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375348|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
19375349|NCT04179890|Afatinib|afatinib|mesh-list
19375350|NCT04179890|Mitogens|mitogens|mesh-list
19375351|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375352|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375353|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375354|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375355|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375356|NCT04175509|Acetaminophen|acetaminophen|mesh-list
19375357|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19375358|NCT04175509|Analgesics|analgesics|mesh-ancestor
19375359|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
19375360|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375361|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375362|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
19375363|NCT04148105|Cilostazol|cilostazol|mesh-list
19375364|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19375365|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
19375366|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375367|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375368|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19375369|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
19375370|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19375371|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19375372|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375373|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19375374|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
19375375|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19375376|NCT04148105|Protective Agents|protective agents|mesh-ancestor
19375377|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19375378|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19375379|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846781|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846782|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
19846783|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846784|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19846785|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19846786|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19846787|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19846788|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375380|NCT04147351|Bevacizumab|bevacizumab|mesh-list
19375381|NCT04147351|Atezolizumab|atezolizumab|mesh-list
20404911|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
19375382|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375383|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404912|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
20404913|NCT01156883|Ifosfamide|ifosfamide|mesh-list
20404914|NCT01156883|Doxorubicin|doxorubicin|mesh-list
20404915|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20404916|NCT01156883|Methotrexate|methotrexate|mesh-list
20404917|NCT01156883|Vincristine|vincristine|mesh-list
20404918|NCT01156883|Daunorubicin|daunorubicin|mesh-list
20404919|NCT01156883|Asparaginase|asparaginase|mesh-list
20404920|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
20404921|NCT01156883|Thioguanine|thioguanine|mesh-list
20404922|NCT01156883|Vindesine|vindesine|mesh-list
20404923|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20404924|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
20404925|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404926|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20404927|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20404928|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
20404929|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404930|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404931|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20404932|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20404933|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
20404934|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
20404935|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20404936|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375384|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19375385|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19375386|NCT04147351|Growth Substances|growth substances|mesh-ancestor
19375387|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375388|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
19375389|NCT04140396|Lidocaine|lidocaine|mesh-list
19375390|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
19375391|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
19375392|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375393|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375394|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
20404937|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
20404938|NCT01156883|Hormones|hormones|mesh-ancestor
20404939|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20404940|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20404941|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20404942|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20404943|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20404944|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375395|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375396|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19375397|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19375398|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19375399|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375400|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375401|NCT04075110|Montelukast|montelukast|mesh-list
19375402|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19375403|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19375404|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19375405|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
19375406|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375407|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375408|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19375409|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19375410|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375411|NCT04059003|Taxane|taxane|mesh-list
19375412|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375413|NCT04050410|Moxonidine|moxonidine|mesh-list
19375414|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19375415|NCT04046575|Paclitaxel|paclitaxel|mesh-list
19375416|NCT04046575|Carboplatin|carboplatin|mesh-list
19375417|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19375418|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375419|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375420|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375421|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
20404945|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20404946|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
19375422|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375423|NCT04044209|Nivolumab|nivolumab|mesh-list
19375424|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20404947|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404948|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20404949|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
20404950|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
20404951|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20404952|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20404953|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
20404954|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20404955|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20404956|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
20404957|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
20404958|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375425|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375426|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19375427|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375428|NCT03998813|Ropivacaine|ropivacaine|mesh-list
19375429|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
19375430|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
19375431|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375432|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375433|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
19375434|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375435|NCT03990363|Allopurinol|allopurinol|mesh-list
19375436|NCT03990363|Verinurad|verinurad|mesh-list
19375437|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
19375438|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375439|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375440|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
19375441|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375442|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19375443|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
19375444|NCT03990363|Protective Agents|protective agents|mesh-ancestor
19375445|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375446|NCT03930186|Apremilast|apremilast|mesh-list
19375447|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19375448|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19375449|NCT03930186|Analgesics|analgesics|mesh-ancestor
19375450|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
19375451|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375452|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375453|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375454|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375455|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19375456|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19375457|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375458|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375459|NCT03911973|Talazoparib|talazoparib|mesh-list
19375460|NCT03911973|Gedatolisib|gedatolisib|mesh-list
19375461|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19375462|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375463|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375464|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375465|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375466|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19375467|NCT03910972|Vaccines|vaccines|mesh-list
19375468|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
19375469|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375470|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19375471|NCT03910972|Antacids|antacids|mesh-ancestor
19375472|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375473|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375474|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
19375475|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19375476|NCT03883828|Mupirocin|mupirocin|mesh-list
19375477|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19375478|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375479|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
19375480|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
19375481|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19375482|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19375483|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404959|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20404960|NCT01156883|Protective Agents|protective agents|mesh-ancestor
20404961|NCT01156909|Rituximab|rituximab|mesh-list
20404962|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20404963|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404964|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
20404965|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404966|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20404967|NCT01156922|Rituximab|rituximab|mesh-list
20404968|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20404969|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404970|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
20404971|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404972|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20404973|NCT01156948|Misoprostol|misoprostol|mesh-list
20404974|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20404975|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
20404976|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20404977|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404978|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20404979|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20404980|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
20404981|NCT01156961|Paclitaxel|paclitaxel|mesh-list
20404982|NCT01156961|Bevacizumab|bevacizumab|mesh-list
20404983|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20404984|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20404985|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
20404986|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
20404987|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375484|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375491|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
19375492|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375493|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375494|NCT03817463|Empagliflozin|empagliflozin|mesh-list
19375495|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19375496|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19375497|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375498|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19375499|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375500|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375501|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402702|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402703|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19402704|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
19402705|NCT03607149|Pemetrexed|pemetrexed|mesh-list
19402706|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402707|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20404988|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404989|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20404990|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20404991|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20404992|NCT01156961|Growth Substances|growth substances|mesh-ancestor
20404993|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20404994|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
20404995|NCT01157000|Canagliflozin|canagliflozin|mesh-list
20404996|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20404997|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20404998|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20404999|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405000|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20405001|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20405002|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405003|NCT01157026|Tamoxifen|tamoxifen|mesh-list
20405004|NCT01157026|Tocotrienols|tocotrienols|mesh-list
20405005|NCT01157026|Vitamin E|vitamin e|mesh-list
20405006|NCT01157026|Tocopherols|tocopherols|mesh-list
20405007|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20405008|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
19402708|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375502|NCT03787849|Anesthetics|anesthetics|mesh-list
19375503|NCT03787849|Propofol|propofol|mesh-list
19375504|NCT03787849|Sevoflurane|sevoflurane|mesh-list
19375505|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375506|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375507|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19375508|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19375509|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
19375510|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19375511|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20405009|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405010|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405011|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405012|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405013|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20405014|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20405015|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20405016|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
20405017|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405018|NCT01157026|Protective Agents|protective agents|mesh-ancestor
20405019|NCT01157026|Vitamins|vitamins|mesh-ancestor
20405020|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
20405021|NCT01157052|Capecitabine|capecitabine|mesh-list
19375512|NCT03781440|Lidocaine|lidocaine|mesh-list
19375513|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
19375514|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
19375515|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375516|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212327|NCT00291980|Vaccines|vaccines|mesh-list
20212328|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
19846789|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846790|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
19846791|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
19846792|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19846793|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
19846794|NCT00682357|Hormones|hormones|mesh-ancestor
19846795|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846796|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19846797|NCT00682357|Protective Agents|protective agents|mesh-ancestor
19846798|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19846799|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846800|NCT00682435|Hydromorphone|hydromorphone|mesh-list
19846801|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19846802|NCT00682435|Narcotics|narcotics|mesh-ancestor
19846803|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846804|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846805|NCT00682435|Analgesics|analgesics|mesh-ancestor
19846806|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
19846807|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846808|NCT00682448|Metformin|metformin|mesh-list
19846809|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846810|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846811|NCT00682539|Triamcinolone|triamcinolone|mesh-list
19846812|NCT00682539|Bevacizumab|bevacizumab|mesh-list
19846813|NCT00682539|Ranibizumab|ranibizumab|mesh-list
19846814|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846815|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846816|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20212329|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212330|NCT00292071|Caspofungin|caspofungin|mesh-list
20212331|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
20212332|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212333|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212334|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212335|NCT00292110|Methadone|methadone|mesh-list
20212336|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20212337|NCT00292110|Narcotics|narcotics|mesh-ancestor
20212338|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212339|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212340|NCT00292110|Analgesics|analgesics|mesh-ancestor
20212341|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
20212342|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405022|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
19375517|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
19846817|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20212343|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
20405023|NCT01157052|Calcium|calcium|mesh-list
20405024|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20405025|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405026|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20405027|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
20405028|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405029|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405030|NCT01157247|Fentanyl|fentanyl|mesh-list
20405031|NCT01157247|Anesthetics|anesthetics|mesh-list
20405032|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
20405033|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20405034|NCT01157247|Narcotics|narcotics|mesh-ancestor
20405035|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405036|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405037|NCT01157247|Analgesics|analgesics|mesh-ancestor
20405038|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
20212344|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
20212345|NCT00292123|Methadone|methadone|mesh-list
20212346|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19375518|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375519|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19375520|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19375521|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19375522|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375523|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405039|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846818|NCT00682539|Growth Substances|growth substances|mesh-ancestor
19846819|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846820|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
19846821|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846822|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
20212347|NCT00292123|Narcotics|narcotics|mesh-ancestor
19375524|NCT03777319|Prednisolone|prednisolone|mesh-list
19375525|NCT03777319|Spironolactone|spironolactone|mesh-list
19375526|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375527|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
19375528|NCT03777319|Hormones|hormones|mesh-ancestor
19375529|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375530|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375531|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19375532|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375533|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19375534|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
19375535|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19375536|NCT03777319|Diuretics|diuretics|mesh-ancestor
19375537|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
19375538|NCT03740100|Sirolimus|sirolimus|mesh-list
19375539|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19375540|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375541|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19375542|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375543|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
19375544|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375545|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
19846823|NCT00682539|Hormones|hormones|mesh-ancestor
19846824|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212348|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212349|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212350|NCT00292123|Analgesics|analgesics|mesh-ancestor
20212351|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
20212352|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212353|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
20212354|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
20212355|NCT00292201|Atorvastatin|atorvastatin|mesh-list
20212356|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20212357|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20405040|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19846825|NCT00682461|Nicotine|nicotine|mesh-list
19846826|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19846827|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
19846828|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846829|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212358|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
20405041|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19846830|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20405042|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
20405043|NCT01157312|Citric Acid|citric acid|mesh-list
20405044|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
20405045|NCT01157312|Clomiphene|clomiphene|mesh-list
20405046|NCT01157312|Enclomiphene|enclomiphene|mesh-list
20405047|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
20405048|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
20405049|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20405050|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
20405051|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
20405052|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405053|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19375546|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375547|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19375548|NCT03687814|Laxatives|laxatives|mesh-ancestor
19375549|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375550|NCT03635983|Nivolumab|nivolumab|mesh-list
19375551|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375552|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375553|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19375554|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375555|NCT03626337|Thiamine|thiamine|mesh-list
19375556|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
19375557|NCT03626337|Vitamins|vitamins|mesh-ancestor
19375558|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
19375559|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375560|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
19375561|NCT03600649|Topotecan|topotecan|mesh-list
19375562|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375563|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
19375564|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375565|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375566|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19375567|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
19375568|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375569|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375570|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19375571|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19375572|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19375573|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375574|NCT03547115|Voruciclib|voruciclib|mesh-list
19375575|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375576|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375577|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405054|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
20405055|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405056|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405057|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20405058|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
20405059|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20405060|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20405061|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20405062|NCT01157455|Aspirin|aspirin|mesh-list
20405063|NCT01157455|Everolimus|everolimus|mesh-list
20405064|NCT01157455|Heparin|heparin|mesh-list
20405065|NCT01157455|Bivalirudin|bivalirudin|mesh-list
20405066|NCT01157455|Clopidogrel|clopidogrel|mesh-list
20405067|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20405068|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20405069|NCT01157455|Analgesics|analgesics|mesh-ancestor
20405070|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
20405071|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405072|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405073|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20405074|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405075|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20405076|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20405077|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405078|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20405079|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20405080|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405081|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
20405082|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405083|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375578|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375579|NCT03515304|Evolocumab|evolocumab|mesh-list
19375580|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19375581|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19375582|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
20405084|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
20405085|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20405086|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20405087|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20405088|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
20405089|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405090|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
20405091|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
20405092|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20405093|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
20405094|NCT01157481|Nifedipine|nifedipine|mesh-list
20405095|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20405096|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405097|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405098|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20405099|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405100|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
20405101|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
20405102|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20405103|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20405104|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19375583|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375584|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19375585|NCT03490513|Anastrozole|anastrozole|mesh-list
19375586|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19375587|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375588|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19375589|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19375590|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375591|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375592|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19375593|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
20405105|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20405106|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846831|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20212359|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212360|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20212361|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20212362|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212363|NCT00292214|Acetaminophen|acetaminophen|mesh-list
20405107|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405108|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20405109|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405110|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405111|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
20405112|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405113|NCT01157546|Lidocaine|lidocaine|mesh-list
20405114|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
19375594|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375595|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375596|NCT03471728|Linaclotide|linaclotide|mesh-list
20212364|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212365|NCT00292214|Analgesics|analgesics|mesh-ancestor
20212366|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
20212367|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212368|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405115|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
19375597|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19375598|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
19402709|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19690990|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19690991|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19690992|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
19690993|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
19690994|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
19690995|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19690996|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19690997|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19846832|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
20405116|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405117|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405118|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
20405119|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405120|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20405121|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20405122|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20405123|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405124|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405125|NCT01157559|Ziprasidone|ziprasidone|mesh-list
20405126|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20405127|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
20405128|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405129|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405130|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405131|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20405132|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20405133|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405134|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20405135|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20405136|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
20405137|NCT01157572|Metoprolol|metoprolol|mesh-list
20405138|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20405139|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20405140|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
20405141|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
20405142|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405143|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405144|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20405145|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20405146|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20405147|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
20405148|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405149|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405150|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20405151|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20405152|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20405153|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405154|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405155|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20405156|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20405157|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20405158|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
20405159|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405160|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405161|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19375599|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375600|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375601|NCT03463057|Atezolizumab|atezolizumab|mesh-list
19375602|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375603|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
19375604|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19375605|NCT03404596|Nicotine|nicotine|mesh-list
19375606|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19375607|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
19375608|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375609|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375610|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19375611|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19375612|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
19375613|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19375614|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375615|NCT03342027|Bupropion|bupropion|mesh-list
19375616|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19690998|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19690999|NCT05009082|Growth Substances|growth substances|mesh-ancestor
19691000|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691001|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
19691002|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19691003|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691004|NCT05008939|Sevoflurane|sevoflurane|mesh-list
19691005|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19375617|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
19375618|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19375619|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19375620|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19375621|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375622|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375623|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
19375624|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19375625|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375626|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19375627|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19375628|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375629|NCT03321513|Bevacizumab|bevacizumab|mesh-list
19375630|NCT03321513|Aflibercept|aflibercept|mesh-list
19375631|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20405162|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20405163|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
20405164|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
20405165|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20405166|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
20405167|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20405168|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405169|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20405170|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19375632|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375633|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19375634|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19375635|NCT03321513|Growth Substances|growth substances|mesh-ancestor
19375636|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375637|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
19375638|NCT03273023|Chromium|chromium|mesh-list
19375639|NCT03273023|Everolimus|everolimus|mesh-list
19375640|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375641|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375642|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
19375643|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375644|NCT03273023|Trace Elements|trace elements|mesh-ancestor
20405171|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20405172|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
20405173|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20405174|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405175|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20405176|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20405177|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375645|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
19375646|NCT03125928|Paclitaxel|paclitaxel|mesh-list
19375647|NCT03125928|Trastuzumab|trastuzumab|mesh-list
19375648|NCT03125928|Atezolizumab|atezolizumab|mesh-list
19375649|NCT03125928|Pertuzumab|pertuzumab|mesh-list
19375650|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19375651|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375652|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
19846833|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846834|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846835|NCT00682643|Fluticasone|fluticasone|mesh-list
19846836|NCT00682643|Xhance|xhance|mesh-list
19846837|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846838|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20212369|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
20212370|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
20212371|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20212372|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
20212373|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212374|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212375|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
20212376|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212377|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
20212378|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20212379|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
20212380|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405178|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375653|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375654|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
19846839|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
19375655|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405179|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405180|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20405181|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20405182|NCT01157858|Everolimus|everolimus|mesh-list
20405183|NCT01157858|Octreotide|octreotide|mesh-list
20405184|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405185|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405186|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
20405187|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405188|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405189|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405190|NCT01157936|Allopurinol|allopurinol|mesh-list
20405191|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
20405192|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405193|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405194|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
20405195|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405196|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20405197|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
20405198|NCT01157936|Protective Agents|protective agents|mesh-ancestor
19846840|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846841|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846842|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19846843|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
19846844|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
20405199|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375656|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375657|NCT03086369|Gemcitabine|gemcitabine|mesh-list
19375658|NCT03086369|Paclitaxel|paclitaxel|mesh-list
19375659|NCT03086369|Olaratumab|olaratumab|mesh-list
19375660|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19375661|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375662|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375663|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375664|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375665|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375666|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19375667|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
19375668|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
19375669|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375670|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375671|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375672|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
19375673|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375674|NCT03081910|Cyclophosphamide|cyclophosphamide|mesh-list
19375675|NCT03081910|Fludarabine|fludarabine|mesh-list
19375676|NCT03081910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375677|NCT03081910|Immunologic Factors|immunologic factors|mesh-ancestor
19375678|NCT03081910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375679|NCT03081910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375680|NCT03081910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19375681|NCT03081910|Alkylating Agents|alkylating agents|mesh-ancestor
19375682|NCT03081910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375683|NCT03081910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375684|NCT03081910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19375685|NCT03081858|Paclitaxel|paclitaxel|mesh-list
19375686|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19375687|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405200|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
20405201|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
20405202|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405203|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405204|NCT01157975|Pioglitazone|pioglitazone|mesh-list
19375688|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375689|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375690|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375691|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375692|NCT03053362|Vortioxetine|vortioxetine|mesh-list
19375693|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
19375694|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19375695|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20405205|NCT01157975|Prednisone|prednisone|mesh-list
19375696|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19375697|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375698|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405206|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375699|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19375700|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19375701|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375702|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375703|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19375704|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
19375705|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19375706|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19375707|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19375708|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19375709|NCT02906332|Dexamethasone|dexamethasone|mesh-list
19375710|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
19375711|NCT02906332|Lenalidomide|lenalidomide|mesh-list
19375712|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375713|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
19375714|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
19375715|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375716|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375717|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375718|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
19846845|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19846846|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
19846847|NCT00682734|Promethazine|promethazine|mesh-list
19846848|NCT00682734|Metoclopramide|metoclopramide|mesh-list
19846849|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19846850|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19846851|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19846852|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405207|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
20405208|NCT01157975|Hormones|hormones|mesh-ancestor
20405209|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405210|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405211|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405212|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405213|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846853|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
19846854|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
19846855|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
19846856|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846857|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
19846858|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
20405214|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20405215|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
20405216|NCT01158014|Coagulants|coagulants|mesh-ancestor
20427181|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
19375719|NCT02906332|Hormones|hormones|mesh-ancestor
19375720|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375721|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19375722|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375723|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375724|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
19375725|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19375726|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19375727|NCT02906332|Growth Substances|growth substances|mesh-ancestor
19375728|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
19375729|NCT02795988|Fluorouracil|fluorouracil|mesh-list
19375730|NCT02795988|Capecitabine|capecitabine|mesh-list
19375731|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
19375732|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427182|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427183|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427184|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375733|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
19375734|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375735|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19375736|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375737|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
19375738|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375739|NCT02786329|Lidocaine|lidocaine|mesh-list
19375740|NCT02786329|Sevoflurane|sevoflurane|mesh-list
19375741|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19375742|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
19375743|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19375744|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846859|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375745|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
19375746|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375747|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19375748|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19375749|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19375750|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19375751|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375752|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20405217|NCT01158105|Bortezomib|bortezomib|mesh-list
20405218|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405219|NCT01158144|Paclitaxel|paclitaxel|mesh-list
19691006|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19691007|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
20405220|NCT01158144|Carboplatin|carboplatin|mesh-list
20405221|NCT01158144|Endostar protein|endostar protein|mesh-list
20405222|NCT01158144|Endostatins|endostatins|mesh-list
20405223|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405224|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405225|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405226|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375753|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19375754|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
19375755|NCT02779855|Paclitaxel|paclitaxel|mesh-list
19375756|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19375757|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19375758|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375759|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375760|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375761|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375762|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375763|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375764|NCT02731352|Apatinib|apatinib|mesh-list
19375765|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375766|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405227|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405228|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405229|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19375767|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375768|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375769|NCT02726659|Celecoxib|celecoxib|mesh-list
19375770|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19375771|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19375772|NCT02726659|Analgesics|analgesics|mesh-ancestor
19375773|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
20405230|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20405231|NCT01158144|Growth Substances|growth substances|mesh-ancestor
20405232|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405233|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
20405234|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19375774|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375775|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375776|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375777|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375778|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19375779|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19375780|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375781|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405235|NCT01158170|Gefitinib|gefitinib|mesh-list
20405236|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405237|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405238|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405239|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405240|NCT01158183|Interferons|interferons|mesh-list
20405241|NCT01158183|Interferon-beta|interferon-beta|mesh-list
20405242|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
20405243|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405244|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
20405245|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405246|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
20405247|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405248|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20405249|NCT01158248|Panitumumab|panitumumab|mesh-list
20405250|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405251|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20405252|NCT01158274|Capecitabine|capecitabine|mesh-list
20405253|NCT01158274|R04929097|r04929097|mesh-list
20405254|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20405255|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
20405256|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405257|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405258|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405259|NCT01158287|Sorafenib|sorafenib|mesh-list
20405260|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405261|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405262|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405263|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405264|NCT01158365|Glycerol|glycerol|mesh-list
20405265|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20405266|NCT01158365|Protective Agents|protective agents|mesh-ancestor
20405267|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405268|NCT01158560|Vitamin D|vitamin d|mesh-list
20405269|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
20405270|NCT01158560|Vitamins|vitamins|mesh-ancestor
20405271|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
20405272|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405273|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20405274|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20405275|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
20405276|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
20405277|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
20405278|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405279|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405280|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
20405281|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375782|NCT02654132|Dexamethasone|dexamethasone|mesh-list
19375783|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
19375784|NCT02654132|Pomalidomide|pomalidomide|mesh-list
19375785|NCT02654132|Elotuzumab|elotuzumab|mesh-list
19375786|NCT02654132|BB 1101|bb 1101|mesh-list
19375787|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375788|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
19846860|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19846861|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
19846862|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
19846863|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846864|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212381|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375789|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
19375790|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691008|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
20212382|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
20212383|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212384|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19691009|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691010|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691011|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
19691012|NCT05008861|Nivolumab|nivolumab|mesh-list
19691013|NCT05008861|Durvalumab|durvalumab|mesh-list
19691014|NCT05008861|Antibodies|antibodies|mesh-list
19691015|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19691016|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
19691017|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691018|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691019|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691020|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19691021|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846865|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20212385|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20212386|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20212387|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20212388|NCT00292344|Rifaximin|rifaximin|mesh-list
20212389|NCT00292344|Loperamide|loperamide|mesh-list
20212390|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
20212391|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20212392|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405282|NCT01158612|Hormones|hormones|mesh-list
20405283|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375791|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375792|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691022|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
20212393|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405284|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405285|NCT01158729|Antithrombins|antithrombins|mesh-list
20405286|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
20405287|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20405288|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
20405289|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405290|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405291|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
20405292|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
20405293|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19375793|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
19375794|NCT02654132|Hormones|hormones|mesh-ancestor
19375795|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375796|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19846866|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
19846867|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
19846868|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19846869|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19846870|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
19846871|NCT00682786|Fluorouracil|fluorouracil|mesh-list
19846872|NCT00682786|Irinotecan|irinotecan|mesh-list
19846873|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
19846874|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846875|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19846876|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846877|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846878|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
19375797|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375798|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375799|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212394|NCT00292409|Aripiprazole|aripiprazole|mesh-list
20212395|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
20212396|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19375800|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375801|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
19375802|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19375803|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19375804|NCT02654132|Growth Substances|growth substances|mesh-ancestor
19375805|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
19375806|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19375807|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
19375808|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
19375809|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19375810|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
19375811|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19375812|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19846879|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212397|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20212398|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20212399|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212400|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212401|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
20212402|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
20212403|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212404|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212405|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20212406|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20212407|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
20212408|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20212409|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20212410|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20212411|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20212412|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
20212413|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20212414|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
20212415|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212416|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212417|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20212418|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
20212419|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
20212420|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20212421|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
19375813|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
20212422|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405294|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405295|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20405296|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20405297|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405298|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405299|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405300|NCT01158846|Bivalirudin|bivalirudin|mesh-list
19375814|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375815|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375816|NCT02603432|Avelumab|avelumab|mesh-list
19375817|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19375818|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19375819|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375820|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
19375821|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375822|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
19375823|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375824|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405301|NCT01158846|Abciximab|abciximab|mesh-list
20405302|NCT01158846|Clopidogrel|clopidogrel|mesh-list
20405303|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20405304|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20405305|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20405306|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20405307|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20405308|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
20405309|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405310|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405311|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405312|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
20405313|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20405314|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
20405315|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405316|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
20405317|NCT01158859|Pregabalin|pregabalin|mesh-list
20405318|NCT01158859|Analgesics|analgesics|mesh-ancestor
20405319|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
20405320|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405321|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405322|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
20405323|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20405324|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405325|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405326|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20405327|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20405328|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20405329|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405330|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20405331|NCT01158937|Meropenem|meropenem|mesh-list
20405332|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20405333|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405334|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
20405335|NCT01159080|Tacrolimus|tacrolimus|mesh-list
20405336|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405337|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
20405338|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405339|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20405340|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405341|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405342|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20405343|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375825|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375826|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375827|NCT02600923|Letrozole|letrozole|mesh-list
19375828|NCT02600923|Palbociclib|palbociclib|mesh-list
19375829|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375830|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19375831|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19375832|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375833|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375834|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19375835|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
19375836|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375837|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375838|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375839|NCT02484664|Celecoxib|celecoxib|mesh-list
19375840|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19375841|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19375842|NCT02484664|Analgesics|analgesics|mesh-ancestor
19375843|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
19375844|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375845|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375846|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375847|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375848|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20405344|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20405345|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
20405346|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20405347|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405348|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
20405349|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20405350|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20405351|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
20405352|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405353|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20405354|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20405355|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405356|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405357|NCT01159145|Omeprazole|omeprazole|mesh-list
20405358|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19375849|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19375850|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375851|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375852|NCT02460900|Varenicline|varenicline|mesh-list
19375853|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19375854|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19375855|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
19375856|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846880|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19846881|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19846882|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846883|NCT00682890|Metformin|metformin|mesh-list
19846884|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846885|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846886|NCT00682929|Dronabinol|dronabinol|mesh-list
19846887|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
19846888|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846889|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19846890|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19846891|NCT00682929|Analgesics|analgesics|mesh-ancestor
19846892|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
19846893|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846894|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19846895|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19846896|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846897|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846898|NCT00682929|Hormones|hormones|mesh-ancestor
19846899|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846900|NCT00683046|Fludarabine|fludarabine|mesh-list
19846901|NCT00683046|Melphalan|melphalan|mesh-list
19846902|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
19846903|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846904|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846905|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846906|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
19846907|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846908|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19846909|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
19846910|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19846911|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19846912|NCT00683085|Vaccines|vaccines|mesh-list
19846913|NCT00683085|Immunologic Factors|immunologic factors|mesh-ancestor
19846914|NCT00683085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846915|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
19846916|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
20405359|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405360|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19375857|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846917|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19846918|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846919|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19846920|NCT00683332|Tigecycline|tigecycline|mesh-list
19846921|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19846922|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19846923|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19846924|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846925|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846926|NCT00683384|Etanercept|etanercept|mesh-list
19846927|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19846928|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19846929|NCT00683384|Analgesics|analgesics|mesh-ancestor
19846930|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
19846931|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846932|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846933|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846934|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846935|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405361|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405362|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405363|NCT01159158|Nateglinide|nateglinide|mesh-list
20405364|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20405365|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405366|NCT01159210|Thrombin|thrombin|mesh-list
20405367|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
20405368|NCT01159210|Coagulants|coagulants|mesh-ancestor
20405369|NCT01159236|Paclitaxel|paclitaxel|mesh-list
20405370|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
20405371|NCT01159236|Bevacizumab|bevacizumab|mesh-list
20405372|NCT01159236|Doxorubicin|doxorubicin|mesh-list
20405373|NCT01159236|Fluorouracil|fluorouracil|mesh-list
20405374|NCT01159236|Epirubicin|epirubicin|mesh-list
20405375|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405376|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405377|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405378|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405379|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405380|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405381|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375858|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375859|NCT02428647|Zinc|zinc|mesh-list
19375860|NCT02428647|Trace Elements|trace elements|mesh-ancestor
19375861|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
19375862|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375863|NCT02371889|Topiramate|topiramate|mesh-list
19375864|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
19375865|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19375866|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375867|NCT02272803|Dexamethasone|dexamethasone|mesh-list
19691023|NCT05008523|Narcotics|narcotics|mesh-ancestor
19691024|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691025|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691026|NCT05008523|Analgesics|analgesics|mesh-ancestor
19691027|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
19691028|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691029|NCT05008679|Oseltamivir|oseltamivir|mesh-list
19691030|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
19691031|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691032|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691033|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691034|NCT05008666|Azacitidine|azacitidine|mesh-list
19691035|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19691036|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
19691037|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691038|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691039|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691040|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
19691041|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
19691042|NCT05008458|Coagulants|coagulants|mesh-ancestor
19846936|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19846937|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
20405382|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
20405383|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375868|NCT02272803|Lenalidomide|lenalidomide|mesh-list
19375869|NCT02272803|Elotuzumab|elotuzumab|mesh-list
20405384|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19846938|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19846939|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
19846940|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846941|NCT00683475|Prednisone|prednisone|mesh-list
19846942|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
19375870|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375871|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
19375872|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
19375873|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375874|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375875|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375876|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
19375877|NCT02272803|Hormones|hormones|mesh-ancestor
19375878|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375879|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19375880|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375881|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
19375882|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19375883|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19375884|NCT02272803|Growth Substances|growth substances|mesh-ancestor
19375885|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
19402710|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19402711|NCT03607110|Fentanyl|fentanyl|mesh-list
19402712|NCT03607110|Ketamine|ketamine|mesh-list
19846943|NCT00683475|Ramucirumab|ramucirumab|mesh-list
20405385|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20405386|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
20405387|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20405388|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20405389|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20405390|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20405391|NCT01159236|Growth Substances|growth substances|mesh-ancestor
20405392|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
20405393|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19402713|NCT03607110|Analgesics|analgesics|mesh-ancestor
19402714|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
19402715|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405394|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19402716|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402717|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19402718|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19402719|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
19402720|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
19402721|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402722|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19402723|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19402724|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402725|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402726|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19402727|NCT03607110|Narcotics|narcotics|mesh-ancestor
19402728|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19402729|NCT03607071|Prednisolone|prednisolone|mesh-list
19402730|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402731|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
19402732|NCT03607071|Hormones|hormones|mesh-ancestor
19691043|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19691044|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19691045|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
19691046|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691047|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
19691048|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19691049|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19691050|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691051|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
19691052|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691053|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691054|NCT05008367|Dexamethasone|dexamethasone|mesh-list
19691055|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691056|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
19691057|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
19691058|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846944|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19402733|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691059|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375886|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
19375887|NCT02257424|Trametinib|trametinib|mesh-list
19375888|NCT02257424|Dabrafenib|dabrafenib|mesh-list
20405395|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20405396|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405397|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
20405398|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20405399|NCT01159275|Lopinavir|lopinavir|mesh-list
20405400|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20405401|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20405402|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
20405403|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375889|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
19375890|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19375891|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19375892|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375893|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375894|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375895|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375896|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375897|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19375898|NCT02186834|Dexamethasone|dexamethasone|mesh-list
19375899|NCT02186834|Doxorubicin|doxorubicin|mesh-list
19375900|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19375901|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19375902|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
19375903|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
19375904|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375905|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375906|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375907|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
19375908|NCT02186834|Hormones|hormones|mesh-ancestor
19375909|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19375910|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19375911|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375912|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19375913|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19375914|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19375915|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375916|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375917|NCT02034422|Antioxidants|antioxidants|mesh-list
19375918|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375919|NCT02034422|Protective Agents|protective agents|mesh-ancestor
19375920|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375921|NCT01988883|Propranolol|propranolol|mesh-list
19375922|NCT01988883|Modafinil|modafinil|mesh-list
19375923|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19375924|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19375925|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
19375926|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19375927|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375928|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375929|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19375930|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19375931|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
19375932|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19375933|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19375934|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19375935|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19375936|NCT01945775|Talazoparib|talazoparib|mesh-list
19375937|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19375938|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19375939|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375940|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375941|NCT01858922|Cytarabine|cytarabine|mesh-list
19375942|NCT01858922|Dexamethasone|dexamethasone|mesh-list
19375943|NCT01858922|Prednisone|prednisone|mesh-list
19375944|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
19375945|NCT01858922|Cisplatin|cisplatin|mesh-list
19375946|NCT01858922|Doxorubicin|doxorubicin|mesh-list
19691060|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691061|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
20405404|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375947|NCT01858922|Etoposide|etoposide|mesh-list
19375948|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
19375949|NCT01858922|Vincristine|vincristine|mesh-list
19691062|NCT05008367|Hormones|hormones|mesh-ancestor
19375950|NCT01858922|Bleomycin|bleomycin|mesh-list
19846945|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19846946|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
19846947|NCT00683475|Hormones|hormones|mesh-ancestor
19846948|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846949|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846950|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19846951|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19846952|NCT00683475|Analgesics|analgesics|mesh-ancestor
19846953|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
19846954|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19846955|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19846956|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19846957|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846958|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846959|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
19846960|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19846961|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
19846962|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19846963|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19846964|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19846965|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405405|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20405406|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20405407|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
20405408|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405409|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20405410|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20405411|NCT01159301|Sorafenib|sorafenib|mesh-list
20405412|NCT01159301|Entinostat|entinostat|mesh-list
20405413|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20405414|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405415|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405416|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405417|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405418|NCT01159327|Sorafenib|sorafenib|mesh-list
20405419|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405420|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405421|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405422|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846966|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375951|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19375952|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
19375953|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375954|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19375955|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19375956|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
19375957|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375958|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375959|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19375960|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20405423|NCT01159353|Insulin|insulin|mesh-list
20405424|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20405425|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
20405426|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
20405427|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20405428|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405429|NCT01159379|Ertapenem|ertapenem|mesh-list
20405430|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20405431|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375961|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
19375962|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
19375963|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19375964|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19375965|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
19375966|NCT01858922|Hormones|hormones|mesh-ancestor
19375967|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846967|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19846968|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
19846969|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375968|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19375969|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405432|NCT01159418|Paclitaxel|paclitaxel|mesh-list
20405433|NCT01159418|Carboplatin|carboplatin|mesh-list
20405434|NCT01159418|Panobinostat|panobinostat|mesh-list
19846970|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19846971|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19846972|NCT00683618|Atorvastatin|atorvastatin|mesh-list
19846973|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19846974|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19846975|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19846976|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
19846977|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846978|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19846979|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19846980|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846981|NCT00683644|Zinc|zinc|mesh-list
19846982|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
19846983|NCT00683644|Trace Elements|trace elements|mesh-ancestor
19846984|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
19846985|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846986|NCT00683644|Astringents|astringents|mesh-ancestor
19846987|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
19846988|NCT00683657|Saxagliptin|saxagliptin|mesh-list
19846989|NCT00683657|Incretins|incretins|mesh-ancestor
19846990|NCT00683657|Hormones|hormones|mesh-ancestor
20405435|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405436|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405437|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405438|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405439|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
19691063|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691064|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691065|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691066|NCT05008029|Anesthetics|anesthetics|mesh-list
19691067|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691068|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691069|NCT05008068|Simvastatin|simvastatin|mesh-list
19691070|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19691071|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19691072|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
19691073|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846991|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19846992|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19846993|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19846994|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
20405440|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405441|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20405442|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405443|NCT01159457|Vaccines|vaccines|mesh-list
20405444|NCT01159457|Immunologic Factors|immunologic factors|mesh-ancestor
20405445|NCT01159457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405446|NCT01159548|Promethazine|promethazine|mesh-list
20405447|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
20405448|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
20405449|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
20405450|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20405451|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
20405452|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
20405453|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405454|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405455|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405456|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20405457|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20405458|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20405459|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405460|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
20405461|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
20405462|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
20405463|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405464|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
20405465|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
20405466|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19846995|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19846996|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19846997|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19846998|NCT00683774|Diazoxide|diazoxide|mesh-list
20405467|NCT01159587|Factor VIII|factor viii|mesh-list
20405468|NCT01159587|Coagulants|coagulants|mesh-ancestor
20405469|NCT01159639|Clopidogrel|clopidogrel|mesh-list
19846999|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19847000|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
19847001|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19847002|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19847003|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19847004|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847005|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405470|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20405471|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20405472|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20405473|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20405474|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
20405475|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405476|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405477|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405478|NCT01159652|Zaleplon|zaleplon|mesh-list
20405479|NCT01159652|Zolpidem|zolpidem|mesh-list
20405480|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20405481|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20405482|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405483|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405484|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20405485|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
20405486|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
20405487|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405488|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405489|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
20405490|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
20427185|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427186|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427187|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427188|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427189|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
20427190|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427191|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20427192|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20427193|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427194|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427195|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
20427196|NCT01285414|Temozolomide|temozolomide|mesh-list
20427197|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20427198|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
20427199|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427200|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427201|NCT01285453|Vadimezan|vadimezan|mesh-list
20427202|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427203|NCT01285466|Paclitaxel|paclitaxel|mesh-list
20427204|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20427205|NCT01285466|Trastuzumab|trastuzumab|mesh-list
20427206|NCT01285466|Dactolisib|dactolisib|mesh-list
20427207|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20427208|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427209|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
20427210|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
20427211|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
20427212|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427213|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20427214|NCT01285505|Alprazolam|alprazolam|mesh-list
20427215|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20427216|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20427217|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427218|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19691074|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19691075|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19691076|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691077|NCT05008263|Liver Extracts|liver extracts|mesh-list
19691078|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
19691079|NCT05008263|Hematinics|hematinics|mesh-ancestor
19691080|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19691081|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691082|NCT05008237|Docetaxel|docetaxel|mesh-list
19691083|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405491|NCT01159821|Paroxetine|paroxetine|mesh-list
20212423|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212424|NCT00292526|Enalapril|enalapril|mesh-list
20212425|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20212426|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
19375970|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19375971|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19375972|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19375973|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19375974|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19375975|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
19375976|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
19375977|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19375978|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375979|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
19375980|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
19375981|NCT01781637|Omalizumab|omalizumab|mesh-list
19375982|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20405492|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20405493|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20405494|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405495|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405496|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405497|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
20405498|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405499|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19375983|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19375984|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
19375985|NCT01773278|Antioxidants|antioxidants|mesh-list
19375986|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19375987|NCT01773278|Protective Agents|protective agents|mesh-ancestor
19375988|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19375989|NCT01711541|Paclitaxel|paclitaxel|mesh-list
19375990|NCT01711541|Cisplatin|cisplatin|mesh-list
20212427|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212428|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691084|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
19691085|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
19691086|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212429|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212430|NCT00292695|Ifosfamide|ifosfamide|mesh-list
20212431|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375991|NCT01711541|Carboplatin|carboplatin|mesh-list
19375992|NCT01711541|Fluorouracil|fluorouracil|mesh-list
19375993|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19375994|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
19375995|NCT01711541|Veliparib|veliparib|mesh-list
19375996|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19375997|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19375998|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
19375999|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
19376000|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
19376001|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376002|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
19376003|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19376004|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376005|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
19691087|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691088|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
19691089|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19691090|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19691091|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19691092|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693062|NCT04983524|Propolis|propolis|mesh-list
19693063|NCT04983524|Calcium|calcium|mesh-list
19693064|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20212432|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20212433|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
20212434|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405500|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
19376006|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376007|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
19376008|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693065|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376009|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19376010|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19376011|NCT01670539|Triamcinolone|triamcinolone|mesh-list
19376012|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376013|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
19376014|NCT01670539|Hormones|hormones|mesh-ancestor
19376015|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376016|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376017|NCT01552434|Sirolimus|sirolimus|mesh-list
19376018|NCT01552434|Bevacizumab|bevacizumab|mesh-list
19376019|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19376020|NCT01552434|Cetuximab|cetuximab|mesh-list
19376021|NCT01552434|Valproic Acid|valproic acid|mesh-list
19376022|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
20405501|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20405502|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20405503|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20405504|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405505|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20405506|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20405507|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405508|NCT01159847|Incretins|incretins|mesh-ancestor
20405509|NCT01159847|Hormones|hormones|mesh-ancestor
20405510|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405511|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20405512|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
20405513|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405514|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405515|NCT01160029|Nateglinide|nateglinide|mesh-list
20405516|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20405517|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405518|NCT01160042|Metformin|metformin|mesh-list
20405519|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20405520|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405521|NCT01160068|Metformin|metformin|mesh-list
20405522|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20405523|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405524|NCT01160172|Vaccines|vaccines|mesh-list
20405525|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
19376023|NCT01552434|Antibodies|antibodies|mesh-list
19376024|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
19376025|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19376026|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
19376027|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376028|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19376029|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19376030|NCT01552434|Growth Substances|growth substances|mesh-ancestor
19376031|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376032|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
19376033|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
19376034|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19376035|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376036|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19376037|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
19376038|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376039|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405526|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405527|NCT01160185|Paclitaxel|paclitaxel|mesh-list
20405528|NCT01160185|Topotecan|topotecan|mesh-list
20405529|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405530|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405531|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405532|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405533|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405534|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405535|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20405536|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20405537|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405538|NCT01160276|Cyclosporine|cyclosporine|mesh-list
20405539|NCT01160276|Colchicine|colchicine|mesh-list
20405540|NCT01160276|Tacrolimus|tacrolimus|mesh-list
19376040|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
19691093|NCT05008250|Metoprolol|metoprolol|mesh-list
19691094|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20405541|NCT01160276|Cyclosporins|cyclosporins|mesh-list
19691095|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19691096|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
20405542|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405543|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
20405544|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405545|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20405546|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212435|NCT00292708|Cefmetazole|cefmetazole|mesh-list
20212436|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20212437|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212438|NCT00292721|Celecoxib|celecoxib|mesh-list
20212439|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212440|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212441|NCT00292721|Analgesics|analgesics|mesh-ancestor
19376041|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376042|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
19376043|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376044|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
19376045|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20405547|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376046|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376047|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376048|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
19376049|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
19376050|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19376051|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19376052|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376053|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376054|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376055|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19376056|NCT01416935|Amiodarone|amiodarone|mesh-list
19376057|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19376058|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
19376059|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19376060|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376061|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376062|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19376063|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19376064|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19376065|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376066|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19376067|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19376068|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19376069|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
19376070|NCT01351909|Veliparib|veliparib|mesh-list
19376071|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376072|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
19376073|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691097|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
19691098|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691099|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212442|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
20212443|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212444|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212445|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212446|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212447|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20212448|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212449|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212450|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212451|NCT00292734|Zolpidem|zolpidem|mesh-list
20212452|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20212453|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19691100|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19691101|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19691102|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19691103|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
19691104|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691105|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691106|NCT05007678|Leflunomide|leflunomide|mesh-list
19691107|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691108|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212454|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376074|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212455|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212456|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19847006|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847007|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847008|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
19376075|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19376076|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
19376077|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376078|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376079|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20212457|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
20212458|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
20212459|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212460|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212461|NCT00292747|Ibuprofen|ibuprofen|mesh-list
20212462|NCT00292747|Drotaverin|drotaverin|mesh-list
20212463|NCT00292747|Papaverine|papaverine|mesh-list
20212464|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212465|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20405548|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
19376080|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19376081|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376082|NCT01351896|Lenalidomide|lenalidomide|mesh-list
19376083|NCT01351896|Vaccines|vaccines|mesh-list
19376084|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19376085|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
19376086|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376087|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19376088|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19376089|NCT01351896|Growth Substances|growth substances|mesh-ancestor
19376090|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
20405549|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405550|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
20405551|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405552|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
20405553|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405554|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
19376091|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376092|NCT01046825|Leucovorin|leucovorin|mesh-list
19376093|NCT01046825|Folic Acid|folic acid|mesh-list
19376094|NCT01046825|Cytarabine|cytarabine|mesh-list
19376095|NCT01046825|Prednisone|prednisone|mesh-list
19376096|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
19376097|NCT01046825|Doxorubicin|doxorubicin|mesh-list
19376098|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19376099|NCT01046825|Rituximab|rituximab|mesh-list
19376100|NCT01046825|Rasburicase|rasburicase|mesh-list
19376101|NCT01046825|Lenograstim|lenograstim|mesh-list
19376102|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
19376103|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376104|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
19376105|NCT01046825|Hormones|hormones|mesh-ancestor
19376106|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376107|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376108|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19376109|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376110|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19376111|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
19376112|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691109|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691110|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
19691111|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691112|NCT05007587|Leucovorin|leucovorin|mesh-list
19691113|NCT05007587|Fluorouracil|fluorouracil|mesh-list
19691114|NCT05007587|Raltitrexed|raltitrexed|mesh-list
19691115|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
19691116|NCT05007587|Lenvatinib|lenvatinib|mesh-list
19691117|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
19691118|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847009|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19847010|NCT00683852|Aripiprazole|aripiprazole|mesh-list
19847011|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
19847012|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19847013|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20405555|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
19376113|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691119|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19847014|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20212466|NCT00292747|Analgesics|analgesics|mesh-ancestor
20212467|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
20405556|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405557|NCT01160302|Curcumin|curcumin|mesh-list
20405558|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20405559|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20405560|NCT01160302|Analgesics|analgesics|mesh-ancestor
20405561|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
20405562|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405563|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405564|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20405565|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405566|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405567|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376114|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19376115|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
19376116|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376117|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19376118|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19376119|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19376120|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20212468|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212469|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212470|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212471|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212472|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212473|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212474|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212475|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
20212476|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
20405568|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405569|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20405570|NCT01160315|Norethindrone|norethindrone|mesh-list
20405571|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
20405572|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
20405573|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19376121|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376122|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376123|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20405574|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
20405575|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20405576|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405577|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20405578|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405579|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405580|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20212477|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
20212478|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20405581|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20405582|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20405583|NCT01160328|Leuprolide|leuprolide|mesh-list
20405584|NCT01160328|Testosterone|testosterone|mesh-list
20405585|NCT01160328|Androgens|androgens|mesh-ancestor
20405586|NCT01160328|Hormones|hormones|mesh-ancestor
20405587|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405588|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405589|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405590|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405591|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20405592|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
20405593|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20212479|NCT00292747|Urological Agents|urological agents|mesh-ancestor
20212480|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
20212481|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212482|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212483|NCT00292799|Metformin|metformin|mesh-list
20212484|NCT00292799|Orlistat|orlistat|mesh-list
19691120|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691121|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691122|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
20212485|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20212486|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405594|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
20405595|NCT01160341|Testosterone|testosterone|mesh-list
20405596|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
20405597|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
20405598|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20405599|NCT01160341|Androgens|androgens|mesh-ancestor
20405600|NCT01160341|Hormones|hormones|mesh-ancestor
20405601|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405602|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405603|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405604|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212487|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376124|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
19376125|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
19376126|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376127|NCT01046825|Antidotes|antidotes|mesh-ancestor
20405605|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
20405606|NCT01160419|Leucovorin|leucovorin|mesh-list
20405607|NCT01160419|Folic Acid|folic acid|mesh-list
20405608|NCT01160419|Docetaxel|docetaxel|mesh-list
20405609|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
20405610|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
20405611|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847015|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847016|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847017|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
20405612|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405613|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405614|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405615|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405616|NCT01160419|Antidotes|antidotes|mesh-ancestor
20405617|NCT01160419|Protective Agents|protective agents|mesh-ancestor
20405618|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376128|NCT01046825|Protective Agents|protective agents|mesh-ancestor
19376129|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
19376130|NCT01046825|Vitamins|vitamins|mesh-ancestor
19376131|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
19376132|NCT01046825|Hematinics|hematinics|mesh-ancestor
19376133|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
19376134|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
19376135|NCT01019356|Acarbose|acarbose|mesh-list
19376136|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19376137|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376138|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19376139|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376140|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847018|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
19847019|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847020|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847021|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19847022|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20212488|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376141|NCT00576654|Irinotecan|irinotecan|mesh-list
19376142|NCT00576654|Camptothecin|camptothecin|mesh-list
19376143|NCT00576654|Veliparib|veliparib|mesh-list
19376144|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19376145|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20212489|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20212490|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20405619|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
20405620|NCT01160419|Vitamins|vitamins|mesh-ancestor
20405621|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
20405622|NCT01160419|Hematinics|hematinics|mesh-ancestor
19376146|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212491|NCT00292838|Fluticasone|fluticasone|mesh-list
20212492|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212493|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20212494|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
20212495|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212496|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212497|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20212498|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
20212499|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
20212500|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20212501|NCT00292890|Insulin|insulin|mesh-list
20405623|NCT01160432|Methadone|methadone|mesh-list
20405624|NCT01160432|Naloxone|naloxone|mesh-list
20405625|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20405626|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405627|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
19376147|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376148|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376149|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19376150|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19376151|NCT05202730|Anesthetics|anesthetics|mesh-list
20405628|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405629|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20405630|NCT01160432|Narcotics|narcotics|mesh-ancestor
19376152|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
19376153|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376154|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376155|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
19376156|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376157|NCT05202665|Fluorides|fluorides|mesh-list
19376158|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
19376159|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
19376160|NCT05202665|Protective Agents|protective agents|mesh-ancestor
19376161|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376162|NCT05202496|Calcitriol|calcitriol|mesh-list
19376163|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19376164|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376165|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19376166|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376167|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376168|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19376169|NCT05202496|Vitamins|vitamins|mesh-ancestor
19376170|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
19376171|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19376172|NCT05202288|Vaccines|vaccines|mesh-list
19376173|NCT05202288|Immunologic Factors|immunologic factors|mesh-ancestor
19376174|NCT05202288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376175|NCT05202275|Olanzapine|olanzapine|mesh-list
19376176|NCT05202275|Aprepitant|aprepitant|mesh-list
19376177|NCT05202275|Palonosetron|palonosetron|mesh-list
19376178|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
19376179|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
19376180|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376181|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376182|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19376183|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19376184|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19376185|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376186|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376187|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19376188|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19376189|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376190|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376191|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376192|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
19376193|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19376194|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19376195|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19376196|NCT05201560|Fentanyl|fentanyl|mesh-list
19376197|NCT05201560|Butorphanol|butorphanol|mesh-list
19376198|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20212502|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20212503|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212504|NCT00292929|Artesunate|artesunate|mesh-list
20212505|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
20212506|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20212507|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20212508|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212509|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212510|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
20212511|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
20212512|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20212513|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
20212514|NCT00292955|Cetuximab|cetuximab|mesh-list
20212515|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212516|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212517|NCT00293072|Rituximab|rituximab|mesh-list
20212518|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212519|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212520|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
20212521|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376199|NCT05201560|Narcotics|narcotics|mesh-ancestor
20427219|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19376200|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376201|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376202|NCT05201560|Analgesics|analgesics|mesh-ancestor
19376203|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
19376204|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376205|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19376206|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19376207|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
19376208|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
19376209|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
19376210|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
19376211|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19376212|NCT05201352|Trifluridine|trifluridine|mesh-list
19376213|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
19376214|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376215|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
19376216|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376217|NCT05201326|Bevacizumab|bevacizumab|mesh-list
19376218|NCT05201326|Irinotecan|irinotecan|mesh-list
19376219|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376220|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376221|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19376222|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19376223|NCT05201326|Growth Substances|growth substances|mesh-ancestor
19376224|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376225|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
19376226|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19376227|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19376228|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376229|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376230|NCT05201313|Lidocaine|lidocaine|mesh-list
19376231|NCT05201313|Mepivacaine|mepivacaine|mesh-list
19376232|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
19376233|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
19376234|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376235|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376236|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
19376237|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847023|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
19847024|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19847025|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19847026|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19847027|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19847028|NCT00683878|Pioglitazone|pioglitazone|mesh-list
20212522|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212523|NCT00293085|Docetaxel|docetaxel|mesh-list
20212524|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212525|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
19376238|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19376239|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19847029|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
20212526|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
20212527|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212528|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212529|NCT00293098|Deferiprone|deferiprone|mesh-list
20212530|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20212531|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
20212532|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
20212533|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212534|NCT00293111|Etodolac|etodolac|mesh-list
20212535|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212536|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212537|NCT00293111|Analgesics|analgesics|mesh-ancestor
20212538|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
20212539|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212540|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212541|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212542|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212543|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20212544|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212545|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376240|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19847030|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19376241|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405631|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405632|NCT01160432|Analgesics|analgesics|mesh-ancestor
20405633|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
20405634|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
20405635|NCT01160588|Sertraline|sertraline|mesh-list
20405636|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
19847031|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19847032|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847033|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19847034|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847035|NCT00683904|Carboplatin|carboplatin|mesh-list
19847036|NCT00683904|Epothilones|epothilones|mesh-list
19847037|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847038|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
19847039|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405637|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20405638|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20405639|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20405640|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405641|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405642|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405643|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
20405644|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405645|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
19847040|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
19847041|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847042|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
19847043|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19847044|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847045|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19847046|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
19847047|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19847048|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847049|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405646|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20405647|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
19376242|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376243|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
19376244|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19376245|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376246|NCT05200793|Metformin|metformin|mesh-list
19376247|NCT05200793|Empagliflozin|empagliflozin|mesh-list
19376248|NCT05200793|Linagliptin|linagliptin|mesh-list
19376249|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19376250|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376251|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19376252|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847050|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847051|NCT00684073|Buprenorphine|buprenorphine|mesh-list
19847052|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19847053|NCT00684073|Naloxone|naloxone|mesh-list
19847054|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19847055|NCT00684073|Narcotics|narcotics|mesh-ancestor
20212546|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376253|NCT05200793|Incretins|incretins|mesh-ancestor
19376254|NCT05200793|Hormones|hormones|mesh-ancestor
19376255|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376256|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19376257|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
19376258|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212547|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
20212548|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212549|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20212550|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212551|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212552|NCT00293150|Eplerenone|eplerenone|mesh-list
20212553|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20212554|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
20212555|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212556|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405648|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402734|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405649|NCT01160627|Expectorants|expectorants|mesh-ancestor
20405650|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
20405651|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20405652|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
20405653|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405654|NCT01160627|Protective Agents|protective agents|mesh-ancestor
20405655|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405656|NCT01160627|Antidotes|antidotes|mesh-ancestor
20405657|NCT01160666|Belimumab|belimumab|mesh-list
20405658|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405659|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
20405660|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376259|NCT05200663|Tamoxifen|tamoxifen|mesh-list
19376260|NCT05200663|Vitamin E|vitamin e|mesh-list
19376261|NCT05200663|Vitamins|vitamins|mesh-ancestor
19376262|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
19376263|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376264|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19376265|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
19376266|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376267|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19376268|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376269|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20212557|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20212558|NCT00293150|Diuretics|diuretics|mesh-ancestor
20212559|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
19376270|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19376271|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19376272|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
19376273|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376274|NCT05200663|Protective Agents|protective agents|mesh-ancestor
19847056|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847057|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847058|NCT00684073|Analgesics|analgesics|mesh-ancestor
19847059|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
19847060|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212560|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212561|NCT00293163|Hylan|hylan|mesh-list
20212562|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
20212563|NCT00293163|Protective Agents|protective agents|mesh-ancestor
20212564|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212565|NCT00293176|Donepezil|donepezil|mesh-list
20212566|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20212567|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212568|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376275|NCT05198531|Gemcitabine|gemcitabine|mesh-list
19376276|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376277|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19376278|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
19376279|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376280|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
19376281|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376282|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376283|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376284|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
19376285|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376286|NCT05184192|Gabapentin|gabapentin|mesh-list
19376287|NCT05184192|Analgesics|analgesics|mesh-ancestor
19376288|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
19376289|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376290|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691123|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691124|NCT05007587|Antidotes|antidotes|mesh-ancestor
19691125|NCT05007587|Protective Agents|protective agents|mesh-ancestor
20212569|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
20405661|NCT01160705|Docetaxel|docetaxel|mesh-list
20405662|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376291|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
19691126|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
19691127|NCT05007587|Vitamins|vitamins|mesh-ancestor
19691128|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
19691129|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19691130|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691131|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19691132|NCT05007860|Vaccines|vaccines|mesh-list
19691133|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
19691134|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847061|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19847062|NCT00684177|Retapamulin|retapamulin|mesh-list
20405663|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405664|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405665|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405666|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405667|NCT01160718|Fulvestrant|fulvestrant|mesh-list
20405668|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405669|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405670|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20405671|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20405672|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
20405673|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212570|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376292|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19376293|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19376294|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376295|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376296|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19376297|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19376298|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376299|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376300|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
19376301|NCT05180214|Ketorolac|ketorolac|mesh-list
19847063|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19847064|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847065|NCT00684203|Aspirin|aspirin|mesh-list
19847066|NCT00684203|Clopidogrel|clopidogrel|mesh-list
19847067|NCT00684203|Vorapaxar|vorapaxar|mesh-list
19847068|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19847069|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19847070|NCT00684203|Analgesics|analgesics|mesh-ancestor
19847071|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
19376302|NCT05180214|Bupivacaine|bupivacaine|mesh-list
19376303|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
19376304|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
19376305|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376306|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376307|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
20405674|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405675|NCT01160731|Etoposide|etoposide|mesh-list
20405676|NCT01160731|Panobinostat|panobinostat|mesh-list
19376308|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376309|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19376310|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376311|NCT05180214|Analgesics|analgesics|mesh-ancestor
19376312|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376313|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405677|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
20405678|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405679|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405680|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19376314|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19376315|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376316|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376317|NCT05170893|Ubiquinone|ubiquinone|mesh-list
19376318|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
19376319|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
19376320|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376321|NCT05170893|Vitamins|vitamins|mesh-ancestor
19376322|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
19376323|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19376324|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
19376325|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847072|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847073|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847074|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212571|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212572|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
20212573|NCT00293228|Isoniazid|isoniazid|mesh-list
20212574|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
20212575|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20212576|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212577|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19376326|NCT05074121|Expectorants|expectorants|mesh-ancestor
19376327|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
20405681|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20405682|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405683|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405684|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20405685|NCT01160900|Bivalirudin|bivalirudin|mesh-list
20405686|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20405687|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20405688|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
20405689|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20405690|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
20405691|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405692|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405693|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
20405694|NCT01160926|Cediranib|cediranib|mesh-list
20405695|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405696|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405697|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405698|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405699|NCT01160952|Itraconazole|itraconazole|mesh-list
20405700|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
20405701|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405702|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20405703|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20405704|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405705|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405706|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20405707|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
20405708|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405709|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405710|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20405711|NCT01160965|Ropivacaine|ropivacaine|mesh-list
20405712|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
20405713|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
20405714|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
20405715|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405716|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405717|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
20405718|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405719|NCT01160978|Simvastatin|simvastatin|mesh-list
20405720|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20405721|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20405722|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
20405723|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405724|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20405725|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20405726|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405727|NCT01160991|Olanzapine|olanzapine|mesh-list
20405728|NCT01160991|Amisulpride|amisulpride|mesh-list
20405729|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
20405730|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
20405731|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405732|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405733|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405734|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20405735|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20405736|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405737|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20405738|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20405739|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20405740|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405741|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376328|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19376329|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
19376330|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376331|NCT05074121|Protective Agents|protective agents|mesh-ancestor
19376332|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376333|NCT05074121|Antidotes|antidotes|mesh-ancestor
19376334|NCT05069012|Morphine|morphine|mesh-list
19691135|NCT05007613|Atezolizumab|atezolizumab|mesh-list
19691136|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376335|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20405742|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376336|NCT05069012|Narcotics|narcotics|mesh-ancestor
19847075|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405743|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
20405744|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20405745|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
20405746|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20405747|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
20405748|NCT01161017|Topiramate|topiramate|mesh-list
20405749|NCT01161017|Amitriptyline|amitriptyline|mesh-list
20405750|NCT01161017|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20405751|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
20405752|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20405753|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405754|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20405755|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
20405756|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20405757|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20405758|NCT01161017|Analgesics|analgesics|mesh-ancestor
20405759|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
19376337|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376338|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376339|NCT05069012|Analgesics|analgesics|mesh-ancestor
19376340|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
19376341|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376342|NCT05049343|Ketamine|ketamine|mesh-list
19376343|NCT05049343|Analgesics|analgesics|mesh-ancestor
19376344|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
19376345|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376346|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376347|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19376348|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19376349|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
19376350|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
19376351|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376352|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19376353|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19376354|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376355|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376356|NCT05041322|Buspirone|buspirone|mesh-list
19376357|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19376358|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19376359|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405760|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405761|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20405762|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19376360|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376361|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376362|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19376363|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
19376364|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376365|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405763|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405764|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691137|NCT05006911|Bromfenac|bromfenac|mesh-list
19691138|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19691139|NCT05006911|Phenylephrine|phenylephrine|mesh-list
19691140|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
19691141|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
19691142|NCT05006911|Pilocarpine|pilocarpine|mesh-list
19691143|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19691144|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
19691145|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691146|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
19691147|NCT05006911|Protective Agents|protective agents|mesh-ancestor
19691148|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19691149|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19691150|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19691151|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19691152|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
19691153|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691154|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691155|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
19691156|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
19691157|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847076|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19376366|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19376367|NCT05028673|Antacids|antacids|mesh-list
19376368|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19376369|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19376370|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
19376371|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376372|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376373|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847077|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19847078|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847079|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19847080|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19847081|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376374|NCT05023512|Vaccines|vaccines|mesh-list
19376375|NCT05023512|Immunologic Factors|immunologic factors|mesh-ancestor
19376376|NCT05023512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376377|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
19376378|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19376379|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19376380|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376381|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
19376382|NCT04996368|Coagulants|coagulants|mesh-ancestor
19376383|NCT04941755|Famotidine|famotidine|mesh-list
19376384|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19376385|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19376386|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19376387|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
19376388|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
19376389|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376390|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376391|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376392|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
19376393|NCT04931641|Trace Elements|trace elements|mesh-ancestor
19376394|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
19376395|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376396|NCT04878627|Cannabidiol|cannabidiol|mesh-list
19376397|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
19376398|NCT04872426|Insulin|insulin|mesh-list
19847082|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
19847083|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19847084|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19847085|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19847086|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
19847087|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847088|NCT00684242|Lenalidomide|lenalidomide|mesh-list
19847089|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
19847090|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847091|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19847092|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19847093|NCT00684242|Growth Substances|growth substances|mesh-ancestor
19847094|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
19847095|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847096|NCT00684307|Vitamin K|vitamin k|mesh-list
19847097|NCT00684307|Warfarin|warfarin|mesh-list
19847098|NCT00684307|Vitamins|vitamins|mesh-ancestor
19847099|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
19847100|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847101|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
19847102|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19847103|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19847104|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847105|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
19847106|NCT00684307|Coagulants|coagulants|mesh-ancestor
19847107|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
19847108|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847109|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19847110|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376399|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19376400|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376401|NCT04856176|Paclitaxel|paclitaxel|mesh-list
19847111|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847112|NCT00684515|Aspirin|aspirin|mesh-list
19847113|NCT00684515|Vorapaxar|vorapaxar|mesh-list
19847114|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19376402|NCT04856176|Carboplatin|carboplatin|mesh-list
19376403|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
19376404|NCT04856176|Pemetrexed|pemetrexed|mesh-list
19376405|NCT04856176|Molgramostim|molgramostim|mesh-list
20405765|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
19847115|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19847116|NCT00684515|Analgesics|analgesics|mesh-ancestor
19847117|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
19847118|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847119|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847120|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847121|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847122|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19847123|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19847124|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376406|NCT04856176|Sargramostim|sargramostim|mesh-list
19376407|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19376408|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376409|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
19376410|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
19376411|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
19376412|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376413|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376414|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376415|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19376416|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19376417|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
19376418|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402735|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402736|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402737|NCT03606928|Leucovorin|leucovorin|mesh-list
19402738|NCT03606928|Docetaxel|docetaxel|mesh-list
19402739|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
19402740|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212578|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20212579|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
20212580|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212581|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20212582|NCT00293280|Lomustine|lomustine|mesh-list
20212583|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20212584|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
20212585|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212586|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212587|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20212588|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212589|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212590|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212591|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20212592|NCT00293332|Bevacizumab|bevacizumab|mesh-list
20212593|NCT00293332|Carboplatin|carboplatin|mesh-list
20212594|NCT00293332|Docetaxel|docetaxel|mesh-list
20212595|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19847125|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19847126|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19847127|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212596|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405766|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405767|NCT01161017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20212597|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20405768|NCT01161017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20405769|NCT01161017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405770|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
20405771|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20405772|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20405773|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405774|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405775|NCT01161108|Melatonin|melatonin|mesh-list
20405776|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
20405777|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405778|NCT01161108|Protective Agents|protective agents|mesh-ancestor
20405779|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405780|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405781|NCT01161134|Meloxicam|meloxicam|mesh-list
19402741|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
19402742|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
19402743|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212598|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20212599|NCT00293332|Growth Substances|growth substances|mesh-ancestor
20212600|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212601|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
20212602|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
20212603|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
20212604|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212605|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212606|NCT00293345|Gemcitabine|gemcitabine|mesh-list
20212607|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212608|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
20212609|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212610|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212611|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
20212612|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212613|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405782|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20405783|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20405784|NCT01161134|Analgesics|analgesics|mesh-ancestor
20405785|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
20405786|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405787|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405788|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20405789|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405790|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20405791|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212614|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212615|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
20405792|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405793|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405794|NCT01161147|Meloxicam|meloxicam|mesh-list
20405795|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20405796|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20405797|NCT01161147|Analgesics|analgesics|mesh-ancestor
20405798|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
20405799|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405800|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405801|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20405802|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20405803|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20405804|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20405805|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212616|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212617|NCT00293358|Carboplatin|carboplatin|mesh-list
20212618|NCT00293358|Etoposide|etoposide|mesh-list
20212619|NCT00293358|Ifosfamide|ifosfamide|mesh-list
20212620|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
20212621|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405806|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405807|NCT01161186|Gemcitabine|gemcitabine|mesh-list
20405808|NCT01161186|Paclitaxel|paclitaxel|mesh-list
20405809|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20405810|NCT01161186|Capecitabine|capecitabine|mesh-list
20405811|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405812|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405813|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405814|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405815|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405816|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405817|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20405818|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
20405819|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
20405820|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405821|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405822|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405823|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
20405824|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405825|NCT01161277|Haloperidol|haloperidol|mesh-list
20212622|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405826|NCT01161277|Aripiprazole|aripiprazole|mesh-list
20405827|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
20405828|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
20212623|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20405829|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20212624|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20405830|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20405831|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20405832|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20405833|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405834|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
20405835|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
20405836|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405837|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405838|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20405839|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20405840|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
20405841|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20405842|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20405843|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20405844|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20212625|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212626|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212627|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20212628|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
20212629|NCT00293371|Prednisone|prednisone|mesh-list
20212630|NCT00293371|Docetaxel|docetaxel|mesh-list
20212631|NCT00293371|Vatalanib|vatalanib|mesh-list
20212632|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212633|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
20212634|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
20212635|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405845|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
20405846|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
20405847|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405848|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405849|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20405850|NCT01161316|Cetuximab|cetuximab|mesh-list
20405851|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20405852|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212636|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212637|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212638|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
20212639|NCT00293371|Hormones|hormones|mesh-ancestor
20212640|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212641|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212642|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20212643|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20212644|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212645|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
20212646|NCT00293410|Clofarabine|clofarabine|mesh-list
20212647|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212648|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
20212649|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405853|NCT01161368|Vinorelbine|vinorelbine|mesh-list
20405854|NCT01161368|Lapatinib|lapatinib|mesh-list
19376419|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
19691158|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
20405855|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20405856|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405857|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20405858|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20405859|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20405860|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405861|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405862|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405863|NCT01161459|Prednisone|prednisone|mesh-list
20405864|NCT01161459|Tacrolimus|tacrolimus|mesh-list
20405865|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376420|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19376421|NCT04800627|Pevonedistat|pevonedistat|mesh-list
19376422|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376423|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691159|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19691160|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
19691161|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19691162|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
19691163|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19691164|NCT05006911|Miotics|miotics|mesh-ancestor
19691165|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20405866|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
19691166|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20405867|NCT01161459|Hormones|hormones|mesh-ancestor
20405868|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405869|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405870|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405871|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405872|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405873|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
19847128|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
19847129|NCT00684554|Buprenorphine|buprenorphine|mesh-list
19847130|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19847131|NCT00684554|Narcotics|narcotics|mesh-ancestor
19847132|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847133|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847134|NCT00684554|Analgesics|analgesics|mesh-ancestor
19847135|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
19847136|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847137|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19847138|NCT00684567|Temozolomide|temozolomide|mesh-list
19847139|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19847140|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
19847141|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847142|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847143|NCT00684645|Sunitinib|sunitinib|mesh-list
19847144|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376424|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376425|NCT04792073|Avelumab|avelumab|mesh-list
19376426|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376427|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376428|NCT04782687|Dexamethasone|dexamethasone|mesh-list
19376429|NCT04782687|Lenalidomide|lenalidomide|mesh-list
19376430|NCT04782687|Daratumumab|daratumumab|mesh-list
19376431|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376432|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
19376433|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
19376434|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376435|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376436|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19376437|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
19847145|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19847146|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19847147|NCT00684645|Growth Substances|growth substances|mesh-ancestor
19847148|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847149|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
19847150|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19847151|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847152|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847153|NCT00684723|Lovastatin|lovastatin|mesh-list
19847154|NCT00684723|L 647318|l 647318|mesh-list
19847155|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
19847156|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19847157|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19847158|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
19847159|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847160|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19847161|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19847162|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405874|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19376438|NCT04782687|Hormones|hormones|mesh-ancestor
19376439|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376440|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19376441|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376442|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
19376443|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19376444|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20405875|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405876|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427220|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20427221|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
20427222|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
19376445|NCT04782687|Growth Substances|growth substances|mesh-ancestor
19847163|NCT00684762|Cilostazol|cilostazol|mesh-list
19847164|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19847165|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
19847166|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427223|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376446|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
19376447|NCT04742673|Guanfacine|guanfacine|mesh-list
19376448|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19376449|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19376450|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19376451|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19376452|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
19376453|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405877|NCT01161550|Cytarabine|cytarabine|mesh-list
20405878|NCT01161550|Tretinoin|tretinoin|mesh-list
20405879|NCT01161550|Cladribine|cladribine|mesh-list
20405880|NCT01161550|Midostaurin|midostaurin|mesh-list
20405881|NCT01161550|Sargramostim|sargramostim|mesh-list
20405882|NCT01161550|Lenograstim|lenograstim|mesh-list
20405883|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20405884|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
20405885|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405886|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405887|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
20405888|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20405889|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20405890|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
20405891|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405892|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20405893|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
20405894|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
20405895|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20405896|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405897|NCT01161654|Naratriptan|naratriptan|mesh-list
20405898|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20405899|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20405900|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20405901|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
20405902|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405903|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405904|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405905|NCT01161667|Naratriptan|naratriptan|mesh-list
20405906|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20405907|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20405908|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20405909|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
20405910|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405911|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405912|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405913|NCT01161836|Iniparib|iniparib|mesh-list
20405914|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20405915|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20405916|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405917|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405918|NCT01161888|Imiquimod|imiquimod|mesh-list
20405919|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20405920|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
20405921|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405922|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405923|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
20405924|NCT01161927|Nizatidine|nizatidine|mesh-list
20405925|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20405926|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19376454|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376455|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376456|NCT04734990|Azacitidine|azacitidine|mesh-list
19691167|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
19691168|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19691169|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19691170|NCT05006911|Analgesics|analgesics|mesh-ancestor
19691171|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
19691172|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691173|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691174|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19691175|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
19691176|NCT05006898|Pilocarpine|pilocarpine|mesh-list
19691177|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19691178|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20405927|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20405928|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
20405929|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
19376457|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19376458|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
19376459|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376460|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376461|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376462|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
19376463|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376464|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376465|NCT04704271|Dronabinol|dronabinol|mesh-list
19376466|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
19376467|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376468|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376469|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376470|NCT04704271|Analgesics|analgesics|mesh-ancestor
19376471|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
19376472|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376473|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19376474|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19376475|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376476|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376477|NCT04704271|Hormones|hormones|mesh-ancestor
20405930|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405931|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405932|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405933|NCT01161940|Nizatidine|nizatidine|mesh-list
20405934|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19376478|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376479|NCT04604782|Regadenoson|regadenoson|mesh-list
19376480|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20405935|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405936|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20405937|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
20405938|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
20405939|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405940|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405941|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405942|NCT01161966|Zonisamide|zonisamide|mesh-list
20405943|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
20405944|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20405945|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405946|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405947|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19376481|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19376482|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
20405948|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405949|NCT01161979|Zonisamide|zonisamide|mesh-list
20405950|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
20405951|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19376483|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
19376484|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376485|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405952|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405953|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405954|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19376486|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376487|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
19376488|NCT04596033|Fludarabine|fludarabine|mesh-list
19376489|NCT04596033|Interleukin-2|interleukin-2|mesh-list
19376490|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376491|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
19376492|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376493|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847167|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847168|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19847169|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
19847170|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19847171|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19376494|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19376495|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
19376496|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376497|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848269|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19376498|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19376499|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376500|NCT04596033|Analgesics|analgesics|mesh-ancestor
19376501|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
19376502|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376503|NCT04537806|Pregnanolone|pregnanolone|mesh-list
19376504|NCT04537806|Brexanolone|brexanolone|mesh-list
19376505|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
19376506|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376507|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847172|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847173|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19847174|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
19847175|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19847176|NCT00684762|Protective Agents|protective agents|mesh-ancestor
19847177|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19847178|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19847179|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847180|NCT00684775|Naltrexone|naltrexone|mesh-list
19847181|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19847182|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20405955|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405956|NCT01162031|Bortezomib|bortezomib|mesh-list
20405957|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405958|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20405959|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
20405960|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20405961|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20405962|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20405963|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405964|NCT01162603|Latanoprost|latanoprost|mesh-list
20405965|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20405966|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20405967|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
20405968|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20405969|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20405970|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
20405971|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20405972|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20405973|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405974|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
20405975|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
20405976|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405977|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
20405978|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20405979|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
20405980|NCT01162746|Dexamethasone|dexamethasone|mesh-list
20405981|NCT01162746|Ranibizumab|ranibizumab|mesh-list
20405982|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20405983|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
20405984|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
20405985|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20405986|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20405987|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20405988|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
20405989|NCT01162746|Hormones|hormones|mesh-ancestor
20405990|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20405991|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20405992|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20405993|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20405994|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20405995|NCT01162746|Growth Substances|growth substances|mesh-ancestor
20405996|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
20405997|NCT01162824|Adenosine|adenosine|mesh-list
20405998|NCT01162824|Acetylcholine|acetylcholine|mesh-list
20405999|NCT01162824|Analgesics|analgesics|mesh-ancestor
20406000|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
20406001|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406002|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406003|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19376508|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
19847183|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406004|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
20406005|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19376509|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406006|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
20406007|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
20406008|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406009|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406010|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20406011|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
20406012|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20406013|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
19376510|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376511|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
19376512|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
19376513|NCT04467723|Pirfenidone|pirfenidone|mesh-list
19376514|NCT04467723|Atezolizumab|atezolizumab|mesh-list
19376515|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376516|NCT04467723|Analgesics|analgesics|mesh-ancestor
19376517|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
19376518|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376519|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376520|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19376521|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376522|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376523|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19376524|NCT04400838|Vaccines|vaccines|mesh-list
19376525|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
19376526|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376527|NCT04378933|Methamphetamine|methamphetamine|mesh-list
19376528|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19376529|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376530|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
19376531|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
19376532|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376533|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
19376534|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376535|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376536|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
19376537|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19376538|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19376539|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376540|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19376541|NCT04368559|Fluconazole|fluconazole|mesh-list
19376542|NCT04368559|Posaconazole|posaconazole|mesh-list
19376543|NCT04368559|Rezafungin|rezafungin|mesh-list
19376544|NCT04368559|Trimethoprim|trimethoprim|mesh-list
19376545|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
19847184|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
19847185|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847186|NCT00684814|Zolpidem|zolpidem|mesh-list
19847187|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19847188|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19847189|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847190|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847191|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19847192|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
20212650|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212651|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20212652|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
20212653|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212654|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212655|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20212656|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212657|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
20212658|NCT00293436|Celecoxib|celecoxib|mesh-list
20212659|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20212660|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212661|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20212662|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212663|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212664|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212665|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212666|NCT00293436|Analgesics|analgesics|mesh-ancestor
20212667|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
20406014|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406015|NCT01162902|Candesartan|candesartan|mesh-list
20406016|NCT01162902|Diltiazem|diltiazem|mesh-list
20406017|NCT01162902|Bisoprolol|bisoprolol|mesh-list
20406018|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20406019|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20406020|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20406021|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406022|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20406023|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406024|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20406025|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406026|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
20406027|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
20406028|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
20406029|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406030|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20406031|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20406032|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20406033|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
20406034|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406035|NCT01162941|Prednisolone|prednisolone|mesh-list
20406036|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847193|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
19847194|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847195|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847196|NCT00684983|Capecitabine|capecitabine|mesh-list
19847197|NCT00684983|Lapatinib|lapatinib|mesh-list
19847198|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19847199|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19847200|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
19847201|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847202|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406037|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
20406038|NCT01162941|Hormones|hormones|mesh-ancestor
20406039|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406040|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406041|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20406042|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406043|NCT01162967|Posaconazole|posaconazole|mesh-list
19847203|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19847204|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847205|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
19847206|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847207|NCT00684996|Bevacizumab|bevacizumab|mesh-list
19847208|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19847209|NCT00684996|Antibodies|antibodies|mesh-list
19847210|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
19847211|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19847212|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847213|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19847214|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19847215|NCT00684996|Growth Substances|growth substances|mesh-ancestor
20406044|NCT01162967|Benzonidazole|benzonidazole|mesh-list
20406045|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
20406046|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406047|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20406048|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20406049|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20406050|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20406051|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406052|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406053|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406054|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20406055|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
20406056|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19847216|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847217|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
19847218|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
19847219|NCT00685139|Zonisamide|zonisamide|mesh-list
19847220|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
19847221|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19847222|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847223|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406057|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847224|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20406058|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406059|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
20406060|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
20406061|NCT01163201|Fludarabine|fludarabine|mesh-list
20406062|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406063|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
20406064|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406065|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20406066|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20406067|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
20406068|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406069|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406070|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20427224|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427225|NCT01285544|Atorvastatin|atorvastatin|mesh-list
20427226|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20427227|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20427228|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
20427229|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427230|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20427231|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20427232|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427233|NCT01285596|Mirabegron|mirabegron|mesh-list
20427234|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20427235|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20427236|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20427237|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
20427238|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427239|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427240|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427241|NCT01285596|Urological Agents|urological agents|mesh-ancestor
20427242|NCT01285661|Vitamin K|vitamin k|mesh-list
20427243|NCT01285661|Warfarin|warfarin|mesh-list
20427244|NCT01285661|Anticoagulants|anticoagulants|mesh-list
20427245|NCT01285661|Vitamins|vitamins|mesh-ancestor
19847225|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847226|NCT00685165|Primidone|primidone|mesh-list
19847227|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
19847228|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
19847229|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
19847230|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847231|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427246|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
20427247|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427248|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20427249|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20427250|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427251|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
20427252|NCT01285661|Coagulants|coagulants|mesh-ancestor
20427253|NCT01285674|Cisplatin|cisplatin|mesh-list
20427254|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427255|NCT01285765|Rituximab|rituximab|mesh-list
20427256|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19847232|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847233|NCT00685178|Topiramate|topiramate|mesh-list
19847234|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
19847235|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427257|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427258|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
20427259|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427260|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427261|NCT01285778|Panitumumab|panitumumab|mesh-list
20427262|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20427263|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427264|NCT01285817|Celecoxib|celecoxib|mesh-list
20427265|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
20427266|NCT01285817|Methotrexate|methotrexate|mesh-list
20427267|NCT01285817|Vinblastine|vinblastine|mesh-list
20427268|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427269|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
20427270|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427271|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427272|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19847236|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848270|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427273|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
19848271|NCT00691938|Decitabine|decitabine|mesh-list
19847237|NCT00685295|Fentanyl|fentanyl|mesh-list
19847238|NCT00685295|Oxycodone|oxycodone|mesh-list
19847239|NCT00685295|Lansoprazole|lansoprazole|mesh-list
19847240|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
19847241|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19847242|NCT00685295|Narcotics|narcotics|mesh-ancestor
19847243|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847244|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847245|NCT00685295|Analgesics|analgesics|mesh-ancestor
19847246|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
19847247|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847248|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19847249|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19847250|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
19847251|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
19847252|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19847253|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847254|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19847255|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847256|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847257|NCT00685334|Olanzapine|olanzapine|mesh-list
19847258|NCT00685334|Aripiprazole|aripiprazole|mesh-list
19847259|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
19847260|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
19847261|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847262|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847263|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847264|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19847265|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19847266|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847267|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19847268|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19847269|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19847270|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847271|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847272|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847273|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
19847274|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
19847275|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
19847276|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
19847277|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19847278|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19847279|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19847280|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19847281|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19847282|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20406071|NCT01163396|Leucovorin|leucovorin|mesh-list
20406072|NCT01163396|Bevacizumab|bevacizumab|mesh-list
20406073|NCT01163396|Fluorouracil|fluorouracil|mesh-list
20406074|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
20406075|NCT01163396|Irinotecan|irinotecan|mesh-list
20406076|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20406077|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406078|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20406079|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20406080|NCT01163396|Growth Substances|growth substances|mesh-ancestor
19847283|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19847284|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
19847285|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847286|NCT00685685|Lovastatin|lovastatin|mesh-list
19847287|NCT00685685|L 647318|l 647318|mesh-list
19847288|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
19847289|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19847290|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19847291|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
19847292|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847293|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19847294|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20406081|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406082|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
20406083|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
20406084|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847295|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406085|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20406086|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406087|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
20406088|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20406089|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406090|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406091|NCT01163396|Antidotes|antidotes|mesh-ancestor
20406092|NCT01163396|Protective Agents|protective agents|mesh-ancestor
20406093|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
20406094|NCT01163396|Vitamins|vitamins|mesh-ancestor
20406095|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
20406096|NCT01163435|Clarithromycin|clarithromycin|mesh-list
20406097|NCT01163435|Levofloxacin|levofloxacin|mesh-list
20406098|NCT01163435|Ofloxacin|ofloxacin|mesh-list
20406099|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20406100|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406101|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20406102|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406103|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406104|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20406105|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406106|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20406107|NCT01163435|Renal Agents|renal agents|mesh-ancestor
20406108|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20406109|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406110|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376546|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19376547|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
19376548|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376549|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19376550|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19376551|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376552|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376553|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20406111|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20406112|NCT01163500|Ubiquinone|ubiquinone|mesh-list
20406113|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
20406114|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
20406115|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406116|NCT01163500|Vitamins|vitamins|mesh-ancestor
20406117|NCT01163630|Esomeprazole|esomeprazole|mesh-list
20406118|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20406119|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406120|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20406121|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406122|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406123|NCT01163734|Ranolazine|ranolazine|mesh-list
20406124|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20406125|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406126|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406127|NCT01163799|Alefacept|alefacept|mesh-list
20406128|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
20406129|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
20406130|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406131|NCT01163825|Mitogens|mitogens|mesh-list
20406132|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20406133|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406134|NCT01163903|Doxorubicin|doxorubicin|mesh-list
20406135|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20406136|NCT01163903|Pantoprazole|pantoprazole|mesh-list
20406137|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20406138|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406139|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20406140|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406141|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406142|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406143|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20406144|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406145|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20406146|NCT01163929|Paclitaxel|paclitaxel|mesh-list
20406147|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20406148|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376554|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
19404739|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406149|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
20406150|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
20406151|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
20406152|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406153|NCT01163994|Doxycycline|doxycycline|mesh-list
20406154|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
20406155|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20406156|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376555|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376556|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376557|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19376558|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19376559|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19376560|NCT04368559|Renal Agents|renal agents|mesh-ancestor
20406157|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
20406158|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20406159|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20406160|NCT01164046|Vitamin K|vitamin k|mesh-list
20406161|NCT01164046|Heparin|heparin|mesh-list
20406162|NCT01164046|Enoxaparin|enoxaparin|mesh-list
20406163|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20406164|NCT01164046|Tinzaparin|tinzaparin|mesh-list
20406165|NCT01164046|Dalteparin|dalteparin|mesh-list
20406166|NCT01164046|Nadroparin|nadroparin|mesh-list
20406167|NCT01164046|Reviparin|reviparin|mesh-list
20406168|NCT01164046|Warfarin|warfarin|mesh-list
20406169|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
20406170|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
20406171|NCT01164046|Bemiparin|bemiparin|mesh-list
20212668|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212669|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212670|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212671|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212672|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20212673|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212674|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
20212675|NCT00293475|Rituximab|rituximab|mesh-list
20406172|NCT01164046|Certoparin|certoparin|mesh-list
19376561|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
19376562|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19376563|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19376564|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19376565|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19376566|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20406173|NCT01164046|Vitamins|vitamins|mesh-ancestor
20406174|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
19376567|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19376568|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19376569|NCT04364048|Cisplatin|cisplatin|mesh-list
19376570|NCT04364048|Carboplatin|carboplatin|mesh-list
20212676|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20406175|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406176|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
20406177|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20406178|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20406179|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406180|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20406181|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
20406182|NCT01164046|Coagulants|coagulants|mesh-ancestor
20406183|NCT01164059|Haloperidol|haloperidol|mesh-list
20406184|NCT01164059|Olanzapine|olanzapine|mesh-list
20212677|NCT00293475|Carboplatin|carboplatin|mesh-list
20406185|NCT01164059|Aripiprazole|aripiprazole|mesh-list
20406186|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20406187|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
20406188|NCT01164059|Flupenthixol|flupenthixol|mesh-list
20406189|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20406190|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
20406191|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
20406192|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406193|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406194|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406195|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20212678|NCT00293475|Methotrexate|methotrexate|mesh-list
20212679|NCT00293475|Mannitol|mannitol|mesh-list
20212680|NCT00293475|Antibodies|antibodies|mesh-list
20212681|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
20212682|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20212683|NCT00293475|Antidotes|antidotes|mesh-list
20406196|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20406197|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406198|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406199|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20406200|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20406201|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406202|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406203|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406204|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
20406205|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
20406206|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
20212684|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
20212685|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212686|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212687|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19376571|NCT04364048|Etoposide|etoposide|mesh-list
20406207|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
20406208|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20406209|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20406210|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20406211|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20406212|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20406213|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20406214|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20406215|NCT01164085|Ketorolac|ketorolac|mesh-list
20406216|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20406217|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20406218|NCT01164085|Analgesics|analgesics|mesh-ancestor
20406219|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
19376572|NCT04364048|Pemetrexed|pemetrexed|mesh-list
19376573|NCT04364048|Durvalumab|durvalumab|mesh-list
19376574|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19376575|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376576|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19376577|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20212688|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20212689|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
20212690|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20212691|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212692|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
20212693|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212694|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
20212695|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212696|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20212697|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212698|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20212699|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20212700|NCT00293475|Diuretics|diuretics|mesh-ancestor
20212701|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
20212702|NCT00293475|Protective Agents|protective agents|mesh-ancestor
20212703|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
20212704|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
20212705|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20212706|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376578|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406220|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376579|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691179|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19691180|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19691181|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
19691182|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691183|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691184|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691185|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
19691186|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
19691187|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847296|NCT00685763|Gemcitabine|gemcitabine|mesh-list
19847297|NCT00685763|Capecitabine|capecitabine|mesh-list
19847298|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19847299|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
20212707|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
20212708|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
20212709|NCT00293501|Tinzaparin|tinzaparin|mesh-list
20212710|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20212711|NCT00293501|Dalteparin|dalteparin|mesh-list
20212712|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
20212713|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20212714|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20212715|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212716|NCT00293514|Thrombin|thrombin|mesh-list
19376580|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406221|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406222|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691188|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
19691189|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19691190|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
19847300|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847301|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847302|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
19847303|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847304|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847305|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19847306|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
19847307|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847308|NCT00685802|Cilostazol|cilostazol|mesh-list
19847309|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19847310|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
19847311|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847312|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847313|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19847314|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
19847315|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19847316|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19847317|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212717|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
20212718|NCT00293514|Coagulants|coagulants|mesh-ancestor
20212719|NCT00293527|Interferons|interferons|mesh-list
20212720|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
20212721|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
20212722|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212723|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
20212724|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212725|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
19847318|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19847319|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
19847320|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19847321|NCT00685802|Protective Agents|protective agents|mesh-ancestor
20212726|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212727|NCT00293592|Dexamethasone|dexamethasone|mesh-list
19691191|NCT05006898|Miotics|miotics|mesh-ancestor
19691192|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19691193|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20406223|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20406224|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20406225|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406226|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691194|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
19691195|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
19376581|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19376582|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19376583|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376584|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
19376585|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376586|NCT04344444|Azithromycin|azithromycin|mesh-list
19376587|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
19376588|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20212728|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212729|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
20212730|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
20212731|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212732|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212733|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20212734|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
20212735|NCT00293592|Hormones|hormones|mesh-ancestor
20406227|NCT01164176|Everolimus|everolimus|mesh-list
19691196|NCT05007262|Calcium|calcium|mesh-list
19691197|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19691198|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691199|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
19691200|NCT05007262|Coagulants|coagulants|mesh-ancestor
19376589|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376590|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
19691201|NCT05007041|Vaccines|vaccines|mesh-list
20212736|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212737|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20212738|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691202|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
20406228|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406229|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406230|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
20406231|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212739|NCT00293631|Ketorolac|ketorolac|mesh-list
20212740|NCT00293631|Lornoxicam|lornoxicam|mesh-list
20212741|NCT00293631|Piroxicam|piroxicam|mesh-list
20212742|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212743|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212744|NCT00293631|Analgesics|analgesics|mesh-ancestor
20212745|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
20212746|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212747|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376591|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19376592|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19376593|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376594|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376595|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19376596|NCT04324606|Acetaminophen|acetaminophen|mesh-list
19376597|NCT04324606|Vaccines|vaccines|mesh-list
19376598|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
19376599|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376600|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376601|NCT04324606|Analgesics|analgesics|mesh-ancestor
19376602|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
19376603|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847322|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19847323|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19847324|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847325|NCT00685945|Isosorbide|isosorbide|mesh-list
19847326|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20406232|NCT01164189|Bevacizumab|bevacizumab|mesh-list
20406233|NCT01164189|Temozolomide|temozolomide|mesh-list
20406234|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20406235|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406236|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20406237|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19376604|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
20212748|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212749|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212750|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212751|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376605|NCT04320940|Phenobarbital|phenobarbital|mesh-list
19376606|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
19847327|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19847328|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
19847329|NCT00685945|Bradykinin|bradykinin|mesh-list
19847330|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19847331|NCT00685945|Kininogens|kininogens|mesh-list
19847332|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
19847333|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19847334|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19847335|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847336|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847337|NCT00685945|Urological Agents|urological agents|mesh-ancestor
19847338|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19376607|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19376608|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376609|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847339|NCT00685945|Diuretics|diuretics|mesh-ancestor
19847340|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
20212752|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376610|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19376611|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19376612|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376613|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376614|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
19376615|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
19376616|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19376617|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19376618|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19376619|NCT04295577|Niraparib|niraparib|mesh-list
19376620|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19376621|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406238|NCT01164189|Growth Substances|growth substances|mesh-ancestor
19404740|NCT03592277|Vitamins|vitamins|mesh-list
19847341|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376622|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406239|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406240|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
20406241|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20406242|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
20406243|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406244|NCT01164215|Leucovorin|leucovorin|mesh-list
20406245|NCT01164215|Fluorouracil|fluorouracil|mesh-list
20406246|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
20406247|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
20406248|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406249|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
20406250|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376623|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376624|NCT04261218|Paclitaxel|paclitaxel|mesh-list
19376625|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19376626|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406251|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20406252|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406253|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376627|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
19376628|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
19376629|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
19376630|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376631|NCT04251689|Mannitol|mannitol|mesh-list
19376632|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19376633|NCT04251689|Diuretics|diuretics|mesh-ancestor
19376634|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
19376635|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376636|NCT04232423|Olanzapine|olanzapine|mesh-list
19376637|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
19376638|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
19376639|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376640|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376641|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19376642|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20406254|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
20406255|NCT01164215|Antidotes|antidotes|mesh-ancestor
20406256|NCT01164215|Protective Agents|protective agents|mesh-ancestor
20406257|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
20406258|NCT01164215|Vitamins|vitamins|mesh-ancestor
20406259|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
20406260|NCT01164267|Everolimus|everolimus|mesh-list
20406261|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406262|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406263|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
20406264|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406265|NCT01164306|Nicotine|nicotine|mesh-list
20406266|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20406267|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
19376643|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19376644|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376645|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376646|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19376647|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19691203|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691204|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
19691205|NCT05006846|Narcotics|narcotics|mesh-ancestor
19691206|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691207|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691208|NCT05006846|Analgesics|analgesics|mesh-ancestor
19691209|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
19691210|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691211|NCT05007223|Doxycycline|doxycycline|mesh-list
19691212|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19691213|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691214|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
19691215|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19691216|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19691217|NCT05007132|Trifluridine|trifluridine|mesh-list
19691218|NCT05007132|Bevacizumab|bevacizumab|mesh-list
19691219|NCT05007132|Panitumumab|panitumumab|mesh-list
19691220|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691221|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691222|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20406268|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406269|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406270|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20406271|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20406272|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
20406273|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406274|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376648|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376649|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376650|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376651|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
19376652|NCT04196010|Cytarabine|cytarabine|mesh-list
19376653|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19376654|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
19376655|NCT04196010|Cladribine|cladribine|mesh-list
19376656|NCT04196010|Sargramostim|sargramostim|mesh-list
19376657|NCT04196010|Lenograstim|lenograstim|mesh-list
19376658|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19376659|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
20212753|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
20212754|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
20212755|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
20212756|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212757|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376660|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376661|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376662|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
19376663|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376664|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376665|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
19376666|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376667|NCT04196010|Analgesics|analgesics|mesh-ancestor
19376668|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
19376669|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376670|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19376671|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19376672|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376673|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19376674|NCT04190433|Carvedilol|carvedilol|mesh-list
19376675|NCT04190433|Lisinopril|lisinopril|mesh-list
19376676|NCT04190433|Spironolactone|spironolactone|mesh-list
19376677|NCT04190433|Pravastatin|pravastatin|mesh-list
19376678|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19376679|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
19376680|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691223|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19691224|NCT05007132|Growth Substances|growth substances|mesh-ancestor
20212758|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691225|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691226|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
19691227|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
19691228|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691229|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
19691230|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691231|NCT05006469|Dexamethasone|dexamethasone|mesh-list
19691232|NCT05006469|Doxorubicin|doxorubicin|mesh-list
19847342|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20212759|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20212760|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
20212761|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
20212762|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212763|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212764|NCT00293657|Lornoxicam|lornoxicam|mesh-list
20212765|NCT00293657|Piroxicam|piroxicam|mesh-list
20212766|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20212767|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20212768|NCT00293657|Analgesics|analgesics|mesh-ancestor
20212769|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
20212770|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212771|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212772|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212773|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212774|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20212775|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376681|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691233|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20406275|NCT01164345|Plerixafor|plerixafor|mesh-list
19847343|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19847344|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
19847345|NCT00686127|Lidocaine|lidocaine|mesh-list
19847346|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
20406276|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20406277|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20406278|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
20406279|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406280|NCT01164488|Ritonavir|ritonavir|mesh-list
20406281|NCT01164488|Ketoconazole|ketoconazole|mesh-list
20406282|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20406283|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20406284|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406285|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406286|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406287|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20406288|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20406289|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
20406290|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406291|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20406292|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406293|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
20406294|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20406295|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20406296|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
20406297|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406298|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406299|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20406300|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20406301|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20406302|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
20406303|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406304|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19376682|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19376683|NCT04190433|Diuretics|diuretics|mesh-ancestor
19376684|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
19376685|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19376686|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19376687|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19376688|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376689|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376690|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19376691|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
19376692|NCT04190433|Protective Agents|protective agents|mesh-ancestor
19376693|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19376694|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376695|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19376696|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
19376697|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19376698|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19691234|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19691235|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691236|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
19691237|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
19691238|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691239|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691240|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691241|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
19691242|NCT05006469|Hormones|hormones|mesh-ancestor
19691243|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212776|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212777|NCT00293670|Goserelin|goserelin|mesh-list
20212778|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20212779|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212780|NCT00293696|Goserelin|goserelin|mesh-list
20212781|NCT00293696|Bicalutamide|bicalutamide|mesh-list
20212782|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20212783|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212784|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
20212785|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
20212786|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212787|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212788|NCT00293735|Labetalol|labetalol|mesh-list
20406305|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20406306|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406307|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
20406308|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20406309|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20406310|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
20406311|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406312|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20406313|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20406314|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406315|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406316|NCT01164709|Nelfinavir|nelfinavir|mesh-list
20406317|NCT01164709|Bortezomib|bortezomib|mesh-list
20406318|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406319|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20406320|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20406321|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406322|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406323|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406324|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20406325|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20406326|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
20406327|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406328|NCT01164761|Ramipril|ramipril|mesh-list
20406329|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20406330|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
19376699|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19376700|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19376701|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
19376702|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19376703|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19376704|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406331|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406332|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406333|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20406334|NCT01164774|Ramipril|ramipril|mesh-list
20406335|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20406336|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406337|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406338|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406339|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20406340|NCT01164787|Trandolapril|trandolapril|mesh-list
20406341|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20406342|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406343|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406344|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406345|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20406346|NCT01164800|Trandolapril|trandolapril|mesh-list
20406347|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20406348|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406349|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406350|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406351|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20406352|NCT01164813|Nabumetone|nabumetone|mesh-list
20406353|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20406354|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376705|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19376706|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
19376707|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19376708|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19376709|NCT04178993|Methylphenidate|methylphenidate|mesh-list
19376710|NCT04178993|Methamphetamine|methamphetamine|mesh-list
19376711|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19376712|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376713|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19376714|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19376715|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376716|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376717|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
19376718|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404741|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
20406355|NCT01164813|Analgesics|analgesics|mesh-ancestor
20406356|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
19376719|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19376720|NCT04178993|Analgesics|analgesics|mesh-ancestor
19376721|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
19376722|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376723|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
19376724|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376725|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
19376726|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
19376727|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
19376728|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20406357|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406358|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406359|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20406360|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20406361|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20406362|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20406363|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406364|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406365|NCT01164826|Nabumetone|nabumetone|mesh-list
20406366|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20406367|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376729|NCT04156828|Gemcitabine|gemcitabine|mesh-list
19376730|NCT04156828|Dexamethasone|dexamethasone|mesh-list
19376731|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
19376732|NCT04156828|Rituximab|rituximab|mesh-list
19376733|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19376734|NCT04156828|Carboplatin|carboplatin|mesh-list
19376735|NCT04156828|Antibodies|antibodies|mesh-list
19376736|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
19376737|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19376738|NCT04156828|Lenograstim|lenograstim|mesh-list
19376739|NCT04156828|BB 1101|bb 1101|mesh-list
19376740|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
19376741|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376742|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376743|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19376744|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376745|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
19376746|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
19376747|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376748|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19376749|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
19376750|NCT04156828|Hormones|hormones|mesh-ancestor
19376751|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376752|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19376753|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19376754|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
19376755|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376756|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
19376757|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376758|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376759|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376760|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20212789|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20212790|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20212791|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
20212792|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212793|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212794|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212795|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212796|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
20212797|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
20212798|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212799|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20212800|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20217898|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20217899|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20217900|NCT00310895|Imetelstat|imetelstat|mesh-list
20217901|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
20217902|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217903|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406368|NCT01164826|Analgesics|analgesics|mesh-ancestor
20406369|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
19376761|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
19376762|NCT04107727|Cytarabine|cytarabine|mesh-list
19376763|NCT04107727|Idarubicin|idarubicin|mesh-list
19376764|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19376765|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
19376766|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376767|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376768|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
19376769|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376770|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376771|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
19376772|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376773|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19376774|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19376775|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19376776|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376777|NCT04107077|Mitomycins|mitomycins|mesh-list
19376778|NCT04107077|Mitomycin|mitomycin|mesh-list
19376779|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376780|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19376781|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
19376782|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376783|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19376784|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376785|NCT04065074|FX006|fx006|mesh-list
20406370|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406371|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406372|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20406373|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20406374|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20406375|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20406376|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406377|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406378|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20406379|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
20406380|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406381|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20406382|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406383|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20406384|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20406385|NCT01165060|Bezafibrate|bezafibrate|mesh-list
20406386|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20406387|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
20406388|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406389|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20427274|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427275|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427276|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20427277|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20427278|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
20427279|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19376786|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376787|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
19376788|NCT04065074|Hormones|hormones|mesh-ancestor
19376789|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376790|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376791|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376792|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
19376793|NCT04042116|Nivolumab|nivolumab|mesh-list
19376794|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212801|NCT00293761|Travoprost|travoprost|mesh-list
20212802|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212803|NCT00293787|Timolol|timolol|mesh-list
19376795|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376796|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19376797|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402744|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212804|NCT00293787|Travoprost|travoprost|mesh-list
20212805|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20212806|NCT00293787|Latanoprost|latanoprost|mesh-list
20212807|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20212808|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20212809|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20212810|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
20212811|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402745|NCT03606928|Antidotes|antidotes|mesh-ancestor
19376798|NCT04017390|Allantoin|allantoin|mesh-list
19376799|NCT04017390|Dermatologic Agents|dermatologic agents|mesh-ancestor
19376800|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
19376801|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
19376802|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19376803|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19376804|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376805|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406390|NCT01165125|Ketoconazole|ketoconazole|mesh-list
20406391|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
20406392|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376806|NCT03997097|Urological Agents|urological agents|mesh-ancestor
19376807|NCT03979885|Nicotine|nicotine|mesh-list
19376808|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19376809|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
19376810|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376811|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376812|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19376813|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19376814|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
19376815|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376816|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376817|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19376818|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376819|NCT03951961|Midostaurin|midostaurin|mesh-list
19376820|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376821|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19376822|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376823|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376824|NCT03947216|Pimavanserin|pimavanserin|mesh-list
19376825|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19847347|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
20212812|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212813|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212814|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20212815|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212816|NCT00293800|Timolol|timolol|mesh-list
20212817|NCT00293800|Travoprost|travoprost|mesh-list
20212818|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20212819|NCT00293800|Latanoprost|latanoprost|mesh-list
20212820|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20212821|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20212822|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20212823|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
20212824|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212825|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212826|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212827|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20212828|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212829|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20212830|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
20212831|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212832|NCT00293839|Oxybutynin|oxybutynin|mesh-list
20212833|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
20212834|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
20212835|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212836|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212837|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20212838|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20212839|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
20212840|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212841|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212842|NCT00293839|Urological Agents|urological agents|mesh-ancestor
20212843|NCT00293891|Tacrolimus|tacrolimus|mesh-list
20212844|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212845|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
20212846|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212847|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20212848|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212849|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212850|NCT00293917|Tacrolimus|tacrolimus|mesh-list
20212851|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212852|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
20406393|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20406394|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406395|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406396|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406397|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19376826|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19376827|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19376828|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19376829|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376830|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376831|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376832|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19376833|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19376834|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
19376835|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376836|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376837|NCT03939520|Pirfenidone|pirfenidone|mesh-list
19376838|NCT03939520|Nintedanib|nintedanib|mesh-list
19376839|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376840|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19376841|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847348|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847349|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847350|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
19847351|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847352|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19847353|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19847354|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19847355|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847356|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376842|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376843|NCT03939520|Analgesics|analgesics|mesh-ancestor
19376844|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
19376845|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376846|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376847|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19376848|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19376849|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376850|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19376851|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
19376852|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19376853|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376854|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
19376855|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
19376856|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376857|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
19376858|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19376859|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376860|NCT03906292|Niacinamide|niacinamide|mesh-list
19847357|NCT00686166|Capecitabine|capecitabine|mesh-list
19847358|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
19847359|NCT00686166|Cetuximab|cetuximab|mesh-list
19847360|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19847361|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
19847362|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847363|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847364|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19847365|NCT00686231|Lidocaine|lidocaine|mesh-list
19847366|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
19847367|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
19847368|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
19847369|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847370|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847371|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
20406398|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
20406399|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406400|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406401|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20406402|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20406403|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
20406404|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20406405|NCT01165255|Bupropion|bupropion|mesh-list
20406406|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
19848272|NCT00691938|Panobinostat|panobinostat|mesh-list
19847372|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847373|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19847374|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19847375|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19847376|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847377|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847378|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
19376861|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
19376862|NCT03906292|Dasatinib|dasatinib|mesh-list
19376863|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376864|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19376865|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376866|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376867|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
19847379|NCT00686335|Prednisone|prednisone|mesh-list
19847380|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847381|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
19847382|NCT00686335|Hormones|hormones|mesh-ancestor
19847383|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19847384|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376868|NCT03906292|Vitamins|vitamins|mesh-ancestor
19376869|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
19376870|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376871|NCT03891901|Isoniazid|isoniazid|mesh-list
19376872|NCT03891901|Rifabutin|rifabutin|mesh-list
19376873|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
19376874|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376875|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19376876|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376877|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376878|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
19376879|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19376880|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376881|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19376882|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19376883|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
19376884|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19376885|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19376886|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
19376887|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376888|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376889|NCT03793010|FX006|fx006|mesh-list
19376890|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376891|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
19376892|NCT03793010|Hormones|hormones|mesh-ancestor
19847385|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19376893|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19847386|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212853|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212854|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20212855|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212856|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212857|NCT00293930|Tacrolimus|tacrolimus|mesh-list
20212858|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212859|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
20212860|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212861|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20212862|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212863|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212864|NCT00293969|Morphine|morphine|mesh-list
20212865|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20212866|NCT00293969|Narcotics|narcotics|mesh-ancestor
20212867|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212868|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212869|NCT00293969|Analgesics|analgesics|mesh-ancestor
20212870|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
20212871|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20212872|NCT00294008|Risperidone|risperidone|mesh-list
20212873|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20212874|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
20427280|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19376894|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376895|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376896|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
19376897|NCT03781219|Vemurafenib|vemurafenib|mesh-list
19376898|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376899|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19376900|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376901|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376902|NCT03728556|Antibodies|antibodies|mesh-list
19376903|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19376904|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
19376905|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376906|NCT03684980|Leucovorin|leucovorin|mesh-list
19376907|NCT03684980|Rituximab|rituximab|mesh-list
19376908|NCT03684980|Methotrexate|methotrexate|mesh-list
19376909|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20406407|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20406408|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406409|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19376910|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376911|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
19376912|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376913|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19376914|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19376915|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
19376916|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19376917|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20406410|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20406411|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406412|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406413|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
20406414|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406415|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376918|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
19376919|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376920|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
19376921|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376922|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19376923|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376924|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19376925|NCT03684980|Antidotes|antidotes|mesh-ancestor
19376926|NCT03684980|Protective Agents|protective agents|mesh-ancestor
19376927|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
19376928|NCT03684980|Vitamins|vitamins|mesh-ancestor
19376929|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
19376930|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
19376931|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376932|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376933|NCT03596905|Plecanatide|plecanatide|mesh-list
19376934|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19376935|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
19376936|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376937|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19376938|NCT03529942|FX006|fx006|mesh-list
19376939|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19376940|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
19376941|NCT03529942|Hormones|hormones|mesh-ancestor
19376942|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376943|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847387|NCT00686517|Interferons|interferons|mesh-list
19847388|NCT00686517|Ribavirin|ribavirin|mesh-list
19847389|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
19847390|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
19847391|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19847392|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847393|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
19847394|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847395|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
19847396|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847397|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
19847398|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847399|NCT00686543|Posaconazole|posaconazole|mesh-list
19376944|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19376945|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
19847400|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
19376946|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
19376947|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19847401|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847402|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19376948|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19376949|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
19376950|NCT03501940|Fluorides|fluorides|mesh-list
19376951|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
19376952|NCT03501940|Protective Agents|protective agents|mesh-ancestor
19847403|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19847404|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19847405|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19847406|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19847407|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847408|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847409|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19847410|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
19847411|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19847412|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847413|NCT00686595|Infliximab|infliximab|mesh-list
19376953|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376954|NCT03349775|Metformin|metformin|mesh-list
19376955|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20406416|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20406417|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406418|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406419|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
20406420|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20406421|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406422|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19376956|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376957|NCT03263078|Propofol|propofol|mesh-list
19376958|NCT03263078|Sevoflurane|sevoflurane|mesh-list
20406423|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406424|NCT01165294|Ketamine|ketamine|mesh-list
20406425|NCT01165294|Analgesics|analgesics|mesh-ancestor
20406426|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
20406427|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406428|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406429|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20406430|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19376959|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19376960|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376961|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376962|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19376963|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
19376964|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
19376965|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19376966|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19376967|NCT03256344|Atezolizumab|atezolizumab|mesh-list
19376968|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19376969|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376970|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19376971|NCT03216187|Pregabalin|pregabalin|mesh-list
19376972|NCT03216187|Analgesics|analgesics|mesh-ancestor
19376973|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
19376974|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19376975|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406431|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
20406432|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
19376976|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
19376977|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19376978|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19376979|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691244|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691245|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691246|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691247|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691248|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19691249|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19691250|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19691251|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19691252|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
19691253|NCT05006664|Prednisone|prednisone|mesh-list
19691254|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
19847414|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847415|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406433|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406434|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20406435|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20406436|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406437|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406438|NCT01165372|Artesunate|artesunate|mesh-list
20406439|NCT01165372|Piperaquine|piperaquine|mesh-list
20406440|NCT01165372|Artenimol|artenimol|mesh-list
20406441|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
20406442|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20406443|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20406444|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406445|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406446|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
20406447|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
20406448|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20406449|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
19376980|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19847416|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212875|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212876|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847417|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19847418|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19847419|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847420|NCT00686634|Incretins|incretins|mesh-ancestor
19847421|NCT00686634|Hormones|hormones|mesh-ancestor
19847422|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19847423|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19847424|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
19847425|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847426|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847427|NCT00686686|Infliximab|infliximab|mesh-list
19847428|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847429|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847430|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20212877|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212878|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20212879|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20406450|NCT01165385|Cisplatin|cisplatin|mesh-list
20406451|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406452|NCT01165476|Treprostinil|treprostinil|mesh-list
20406453|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20406454|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
20406455|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20406456|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20406457|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406458|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20212880|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212881|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20212882|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20212883|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
20212884|NCT00294086|Valsartan|valsartan|mesh-list
20212885|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212886|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20212887|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20212888|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212889|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20212890|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20212891|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
20212892|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212893|NCT00294099|Antacids|antacids|mesh-ancestor
20212894|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212895|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20212896|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
20212897|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20212898|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
20212899|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212900|NCT00294164|Hormones|hormones|mesh-list
20212901|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212902|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212903|NCT00294190|Topotecan|topotecan|mesh-list
20406459|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20406460|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
20427281|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
19847431|NCT00686712|Insulin|insulin|mesh-list
20212904|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20212905|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20212906|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212907|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406461|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406462|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406463|NCT01165580|Valganciclovir|valganciclovir|mesh-list
20406464|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
20406465|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406466|NCT01165645|Ritonavir|ritonavir|mesh-list
20406467|NCT01165645|Lopinavir|lopinavir|mesh-list
20406468|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19376981|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19376982|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19376983|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19376984|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19376985|NCT03207815|Prednisone|prednisone|mesh-list
19376986|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20406469|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20406470|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406471|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406472|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406473|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19376987|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
19376988|NCT03207815|Hormones|hormones|mesh-ancestor
19376989|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19376990|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19376991|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19376992|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19376993|NCT03159936|Tofacitinib|tofacitinib|mesh-list
19376994|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19376995|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19376996|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19376997|NCT03156816|Colchicine|colchicine|mesh-list
19376998|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
19376999|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377000|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377001|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377002|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377003|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377004|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377005|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19377006|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377007|NCT03019640|Cytarabine|cytarabine|mesh-list
19377008|NCT03019640|Rituximab|rituximab|mesh-list
19377009|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19377010|NCT03019640|Etoposide|etoposide|mesh-list
19377011|NCT03019640|Lenalidomide|lenalidomide|mesh-list
19377012|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
19377013|NCT03019640|Melphalan|melphalan|mesh-list
19377014|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
19377015|NCT03019640|Carmustine|carmustine|mesh-list
19377016|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
19377017|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19377018|NCT03019640|Antibodies|antibodies|mesh-list
19377019|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
19377020|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19377021|NCT03019640|Lenograstim|lenograstim|mesh-list
19377022|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
19377023|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377024|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377025|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377026|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19377027|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19377028|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20212908|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212909|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
20212910|NCT00294203|Hematinics|hematinics|mesh-ancestor
20212911|NCT00294255|Risperidone|risperidone|mesh-list
20212912|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19377029|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377030|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377031|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19377032|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
19377033|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
20406474|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19377034|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406475|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
19377035|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377036|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19377037|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19377038|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19377039|NCT03019640|Growth Substances|growth substances|mesh-ancestor
19377040|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
19377041|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19377042|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
19377043|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19377044|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
19377045|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
19377046|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377047|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377048|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377049|NCT02991937|Tazobactam|tazobactam|mesh-list
19377050|NCT02991937|Piperacillin|piperacillin|mesh-list
20406476|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212913|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
20212914|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377051|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19377052|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19377053|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377054|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19377055|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377056|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377057|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
19377058|NCT02968563|Idelalisib|idelalisib|mesh-list
19377059|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19377060|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377061|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377062|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377063|NCT02931890|Paclitaxel|paclitaxel|mesh-list
19377064|NCT02931890|Docetaxel|docetaxel|mesh-list
19377065|NCT02931890|Carboplatin|carboplatin|mesh-list
19377066|NCT02931890|Capecitabine|capecitabine|mesh-list
20406477|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20406478|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406479|NCT01165814|Naproxen|naproxen|mesh-list
20406480|NCT01165814|Tramadol|tramadol|mesh-list
20406481|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20406482|NCT01165814|Narcotics|narcotics|mesh-ancestor
20406483|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406484|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406485|NCT01165814|Analgesics|analgesics|mesh-ancestor
19377067|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
19377068|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19377069|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377070|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377071|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377072|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377073|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377074|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19377075|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
19377076|NCT02915783|Everolimus|everolimus|mesh-list
19377077|NCT02915783|Lenvatinib|lenvatinib|mesh-list
19377078|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377079|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20212915|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212916|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212917|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20212918|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20212919|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20212920|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20212921|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20212922|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
20212923|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20212924|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
20212925|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212926|NCT00294359|Bevacizumab|bevacizumab|mesh-list
20212927|NCT00294359|Capecitabine|capecitabine|mesh-list
20212928|NCT00294359|Mitomycins|mitomycins|mesh-list
20212929|NCT00294359|Mitomycin|mitomycin|mesh-list
19377080|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
20406486|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
20406487|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377081|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377082|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20406488|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20406489|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20406490|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20406491|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20406492|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
20406493|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20406494|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406495|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406496|NCT01165866|Ondansetron|ondansetron|mesh-list
20406497|NCT01165866|Metoclopramide|metoclopramide|mesh-list
20406498|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
20406499|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
19377083|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377084|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402746|NCT03606928|Protective Agents|protective agents|mesh-ancestor
19402747|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402748|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
19402749|NCT03606928|Vitamins|vitamins|mesh-ancestor
19402750|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
19402751|NCT03606902|Fentanyl|fentanyl|mesh-list
19402752|NCT03606902|Bupivacaine|bupivacaine|mesh-list
19402753|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402754|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
19402755|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402756|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402757|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
19402758|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406500|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406501|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406502|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406503|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
20406504|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
20406505|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20406506|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
20406507|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406508|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402759|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19402760|NCT03606902|Narcotics|narcotics|mesh-ancestor
19402761|NCT03606902|Analgesics|analgesics|mesh-ancestor
19402762|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19402763|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20406509|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20406510|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19847432|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19847433|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
19847434|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
19847435|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
19847436|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
19847437|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19847438|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847439|NCT00686725|Temozolomide|temozolomide|mesh-list
20406511|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406512|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406513|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20406514|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20406515|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20406516|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
20406517|NCT01165905|Gemcitabine|gemcitabine|mesh-list
19402764|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
19402765|NCT03606889|Bupivacaine|bupivacaine|mesh-list
19402766|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19402767|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
19402768|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402769|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402770|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
19402771|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402772|NCT03606824|Pitavastatin|pitavastatin|mesh-list
19402773|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19402774|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19402775|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19402776|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
19402777|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402778|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402779|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20406518|NCT01165905|ON 01910|on 01910|mesh-list
19847440|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19847441|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
20212930|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212931|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212932|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20212933|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20212934|NCT00294359|Growth Substances|growth substances|mesh-ancestor
20212935|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212936|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
19377085|NCT02913482|Risdiplam|risdiplam|mesh-list
19377086|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19377087|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377088|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377089|NCT02897648|Lactams|lactams|mesh-list
19377090|NCT02897648|beta-Lactams|beta-lactams|mesh-list
19377091|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19377092|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377093|NCT02817659|Glucagon|glucagon|mesh-list
19377094|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377095|NCT02817659|Hormones|hormones|mesh-ancestor
19377096|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377097|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377098|NCT02811510|Dronabinol|dronabinol|mesh-list
19377099|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
20406519|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20406520|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
20406521|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406522|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406523|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
20406524|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406525|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406526|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406527|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
20406528|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406529|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20406530|NCT01165931|Riociguat|riociguat|mesh-list
20406531|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
20406532|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406533|NCT01165944|Pramlintide|pramlintide|mesh-list
20406534|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20406535|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406536|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20406537|NCT01165970|Laxatives|laxatives|mesh-ancestor
20406538|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406539|NCT01166035|Lenalidomide|lenalidomide|mesh-list
20406540|NCT01166035|Cetuximab|cetuximab|mesh-list
20406541|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
20406542|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406543|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20406544|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20406545|NCT01166035|Growth Substances|growth substances|mesh-ancestor
20406546|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
20406547|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406548|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20406549|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20406550|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20406551|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20406552|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406553|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406554|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377100|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377101|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19377102|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19377103|NCT02811510|Analgesics|analgesics|mesh-ancestor
19377104|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
19377105|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377106|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19377107|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19377108|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377109|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377110|NCT02811510|Hormones|hormones|mesh-ancestor
20212937|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212938|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
20212939|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402780|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
19377111|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377112|NCT02796261|Eflornithine|eflornithine|mesh-list
19377113|NCT02796261|Lomustine|lomustine|mesh-list
19377114|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19377115|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
19377116|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406555|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406556|NCT01166048|Analgesics|analgesics|mesh-ancestor
20406557|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
20406558|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406559|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
20406560|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406561|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
20406562|NCT01166087|Fluoxetine|fluoxetine|mesh-list
20406563|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19377117|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377118|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19377119|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19377120|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19377121|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377122|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19377123|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377124|NCT02787044|Vaccines|vaccines|mesh-list
19377125|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
19377126|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377127|NCT02781519|Dronabinol|dronabinol|mesh-list
19377128|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
19377129|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377130|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19377131|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19377132|NCT02781519|Analgesics|analgesics|mesh-ancestor
19377133|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
19377134|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377135|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19377136|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19377137|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377138|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377139|NCT02781519|Hormones|hormones|mesh-ancestor
19377140|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377141|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
19377142|NCT02773732|Etoposide|etoposide|mesh-list
19377143|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19377144|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377145|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19377146|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406564|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20406565|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406566|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377147|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377148|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377149|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20406567|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406568|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
20406569|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406570|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20406571|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
20406572|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406573|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20406574|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406575|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377150|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377151|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19377152|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19377153|NCT02764489|Thrombin|thrombin|mesh-list
19377154|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
19377155|NCT02764489|Coagulants|coagulants|mesh-list
20406576|NCT01166100|Fluoxetine|fluoxetine|mesh-list
20406577|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20406578|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20406579|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20427282|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
19377156|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
19377157|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19377158|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19377159|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406580|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406581|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20212940|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20212941|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
20212942|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20406582|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
20406583|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406584|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20406585|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
20406586|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406587|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20406588|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406589|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406590|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
20406591|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20406592|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377160|NCT02586675|Tamoxifen|tamoxifen|mesh-list
19377161|NCT02586675|Goserelin|goserelin|mesh-list
19377162|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19377163|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
19377164|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377165|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377166|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377167|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377168|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19377169|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19377170|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19377171|NCT02582905|Choline|choline|mesh-list
19377172|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19377173|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
19377174|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19377175|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
19377176|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377177|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377178|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19377179|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
19377180|NCT02572843|Durvalumab|durvalumab|mesh-list
19377181|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20212943|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212944|NCT00294385|Gemcitabine|gemcitabine|mesh-list
20212945|NCT00294385|Docetaxel|docetaxel|mesh-list
20212946|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20212947|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
20212948|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377182|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377183|NCT02560805|Losartan|losartan|mesh-list
19377184|NCT02560805|Atenolol|atenolol|mesh-list
19377185|NCT02560805|Nitroprusside|nitroprusside|mesh-list
19377186|NCT02560805|Phenylephrine|phenylephrine|mesh-list
19377187|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
19377188|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19377189|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19847442|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847443|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847444|NCT00686777|Interferons|interferons|mesh-list
19847445|NCT00686777|Ribavirin|ribavirin|mesh-list
19847446|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
19847447|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
19847448|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19847449|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847450|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
19847451|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847452|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
19847453|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212949|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406593|NCT01166165|Vitamins|vitamins|mesh-ancestor
20212950|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
20212951|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212952|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212953|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377190|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19377191|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19404742|NCT03592277|Thiamine|thiamine|mesh-list
19847454|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
20212954|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
19377192|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377193|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20406594|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
19377194|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
19377195|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
19377196|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377197|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377198|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
19377199|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19377200|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
19377201|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
19377202|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19377203|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19377204|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19377205|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
20406595|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20406596|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
20406597|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
20406598|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406599|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406600|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406601|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
20406602|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20406603|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406604|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406605|NCT01166451|Iron|iron|mesh-list
20406606|NCT01166451|Trace Elements|trace elements|mesh-ancestor
20406607|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
20406608|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406609|NCT01166477|Ritonavir|ritonavir|mesh-list
20406610|NCT01166477|Lopinavir|lopinavir|mesh-list
20406611|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20406612|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20406613|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406614|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406615|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406616|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20406617|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20406618|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
20406619|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406620|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20406621|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406622|NCT01166542|Paclitaxel|paclitaxel|mesh-list
20406623|NCT01166542|Carboplatin|carboplatin|mesh-list
20406624|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20406625|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406626|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377206|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377207|NCT02560805|Protective Agents|protective agents|mesh-ancestor
19377208|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
19377209|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19377210|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19377211|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19377212|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
19377213|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19377214|NCT02557672|Thrombin|thrombin|mesh-list
19377215|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
19377216|NCT02557672|Coagulants|coagulants|mesh-ancestor
19377217|NCT02529930|Vaccines|vaccines|mesh-list
19377218|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
19377219|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377220|NCT02504151|Cannabidiol|cannabidiol|mesh-list
19377221|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
19377222|NCT02485418|Propofol|propofol|mesh-list
20212955|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212956|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
20212957|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
20212958|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
20212959|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
20212960|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20212961|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212962|NCT00294463|Tibolone|tibolone|mesh-list
20212963|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20406627|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
20406628|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377223|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19377224|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19377225|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212964|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20212965|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20212966|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
20212967|NCT00294463|Estradiol|estradiol|mesh-list
20212968|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20212969|NCT00294463|Progesterone|progesterone|mesh-list
20212970|NCT00294463|Estrogens|estrogens|mesh-ancestor
20212971|NCT00294463|Hormones|hormones|mesh-ancestor
20406629|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406630|NCT01166594|Bevacizumab|bevacizumab|mesh-list
20406631|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20406632|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406633|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20406634|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20406635|NCT01166594|Growth Substances|growth substances|mesh-ancestor
20406636|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406637|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
20406638|NCT01166685|Everolimus|everolimus|mesh-list
20406639|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406640|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406641|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
20406642|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406643|NCT01166711|Chromium|chromium|mesh-list
20406644|NCT01166711|Paclitaxel|paclitaxel|mesh-list
20406645|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20406646|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20406647|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406648|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
20406649|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
20406650|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
20406651|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406652|NCT01166711|Trace Elements|trace elements|mesh-ancestor
20406653|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
20406654|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406655|NCT01166789|Lubiprostone|lubiprostone|mesh-list
20406656|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20406657|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406658|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406659|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
20406660|NCT01166815|Astringents|astringents|mesh-ancestor
20406661|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406662|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
20427283|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427284|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20427285|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20427286|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20427287|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427288|NCT01285817|Analgesics|analgesics|mesh-ancestor
20427289|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
20212972|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20212973|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20212974|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20212975|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
20212976|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20212977|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20212978|NCT00294463|Progestins|progestins|mesh-ancestor
20212979|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
20212980|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
20212981|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20212982|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20212983|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20212984|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20212985|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
20212986|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20212987|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20212988|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20212989|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20212990|NCT00294502|Minocycline|minocycline|mesh-list
20212991|NCT00294502|Gentamicins|gentamicins|mesh-list
20212992|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20212993|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20212994|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20212995|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19377226|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19377227|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
19377228|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
19377229|NCT02367105|Testosterone|testosterone|mesh-list
19377230|NCT02367105|Androgens|androgens|mesh-ancestor
19377231|NCT02367105|Hormones|hormones|mesh-ancestor
20406663|NCT01166932|Amoxicillin|amoxicillin|mesh-list
20406664|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
20406665|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
20406666|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
20406667|NCT01166932|Oxacillin|oxacillin|mesh-list
20406668|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20406669|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406670|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406671|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406672|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20406673|NCT01167010|Budesonide|budesonide|mesh-list
20406674|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
19377232|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377233|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377234|NCT02274571|Estrogens|estrogens|mesh-list
19377235|NCT02274571|Hormones|hormones|mesh-ancestor
19377236|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377237|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406675|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20406676|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20406677|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
20406678|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406679|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406680|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19377238|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
19377239|NCT02162420|Fludarabine|fludarabine|mesh-list
19377240|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
19377241|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19377242|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377243|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
19377244|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377245|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377246|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19377247|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
19377248|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377249|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377250|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19377251|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19377252|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
19377253|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
19377254|NCT01822652|Fludarabine|fludarabine|mesh-list
19377255|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
19377256|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377257|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
19377258|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377259|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377260|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19377261|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
19377262|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377263|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377264|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19377265|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19377266|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19377267|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
20212996|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20212997|NCT00294567|Amlodipine|amlodipine|mesh-list
20212998|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
20212999|NCT00294567|Calcium|calcium|mesh-list
20213000|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20213001|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213002|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20213003|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213004|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213005|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
20213006|NCT00294580|Maloprim|maloprim|mesh-list
20213007|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
20213008|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20406681|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
20406682|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
20406683|NCT01167010|Hormones|hormones|mesh-ancestor
20406684|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406685|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20406686|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20406687|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20406688|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
20406689|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406690|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406691|NCT01167049|Capecitabine|capecitabine|mesh-list
20406692|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20406693|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
20406694|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406695|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406696|NCT01167062|Tamsulosin|tamsulosin|mesh-list
20406697|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20406698|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20406699|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20406700|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
20406701|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406702|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377268|NCT01821690|Buspirone|buspirone|mesh-list
19377269|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19377270|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20406703|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847455|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847456|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19847457|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
19847458|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
19847459|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847460|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
19847461|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847462|NCT00686829|Maleic acid|maleic acid|mesh-list
19847463|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847464|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847465|NCT00686855|Dexamethasone|dexamethasone|mesh-list
19847466|NCT00686855|Tacrolimus|tacrolimus|mesh-list
20406704|NCT01167062|Urological Agents|urological agents|mesh-ancestor
20406705|NCT01167101|Pantoprazole|pantoprazole|mesh-list
20406706|NCT01167101|Rebamipide|rebamipide|mesh-list
20406707|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20406708|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406709|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20406710|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406711|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406712|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
20406713|NCT01167101|Protective Agents|protective agents|mesh-ancestor
20406714|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406715|NCT01167127|Oxycodone|oxycodone|mesh-list
19847467|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847468|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
19847469|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
19847470|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847471|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847472|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847473|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
19847474|NCT00686855|Hormones|hormones|mesh-ancestor
19847475|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406716|NCT01167127|Naloxone|naloxone|mesh-list
20406717|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20406718|NCT01167127|Narcotics|narcotics|mesh-ancestor
20406719|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406720|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406721|NCT01167127|Analgesics|analgesics|mesh-ancestor
20406722|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
20406723|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406724|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20406725|NCT01167231|Acarbose|acarbose|mesh-list
20406726|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20406727|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406728|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406729|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19847476|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847477|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847478|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19847479|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
19847480|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19847481|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377271|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19377272|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377273|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19377274|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20406730|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406731|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
20406732|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
20406733|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
20406734|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20406735|NCT01167465|Protective Agents|protective agents|mesh-ancestor
20406736|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406737|NCT01167478|Caffeine|caffeine|mesh-list
20406738|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20406739|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406740|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20406741|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406742|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406743|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20406744|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20406745|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
20406746|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406747|NCT01167530|Everolimus|everolimus|mesh-list
20406748|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377275|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
19377276|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377277|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377278|NCT01816165|Acipimox|acipimox|mesh-list
19377279|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20406749|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406750|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
20406751|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406752|NCT01167699|Oxycodone|oxycodone|mesh-list
20406753|NCT01167699|Naloxone|naloxone|mesh-list
20406754|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20406755|NCT01167699|Narcotics|narcotics|mesh-ancestor
20406756|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406757|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406758|NCT01167699|Analgesics|analgesics|mesh-ancestor
20406759|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
20406760|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406761|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20406762|NCT01167725|Leucovorin|leucovorin|mesh-list
20406763|NCT01167725|Bevacizumab|bevacizumab|mesh-list
20406764|NCT01167725|Cetuximab|cetuximab|mesh-list
20406765|NCT01167725|Fluorouracil|fluorouracil|mesh-list
20406766|NCT01167725|Capecitabine|capecitabine|mesh-list
20406767|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
20406768|NCT01167725|Irinotecan|irinotecan|mesh-list
20406769|NCT01167725|Mitomycins|mitomycins|mesh-list
20406770|NCT01167725|Mitomycin|mitomycin|mesh-list
20406771|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
19377280|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
19377281|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377282|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19377283|NCT01813929|Metformin|metformin|mesh-list
19377284|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19377285|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377286|NCT01693783|Ipilimumab|ipilimumab|mesh-list
19377287|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20213009|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20213010|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213011|NCT00294593|Leucovorin|leucovorin|mesh-list
20213012|NCT00294593|Folic Acid|folic acid|mesh-list
20213013|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
20213014|NCT00294593|Antidotes|antidotes|mesh-ancestor
20213015|NCT00294593|Protective Agents|protective agents|mesh-ancestor
20213016|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213017|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
20406772|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19847482|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213018|NCT00294593|Vitamins|vitamins|mesh-ancestor
20213019|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
20406773|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406774|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19377288|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377289|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19377290|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377291|NCT01555281|Nelfinavir|nelfinavir|mesh-list
19377292|NCT01555281|Dexamethasone|dexamethasone|mesh-list
19377293|NCT01555281|Lenalidomide|lenalidomide|mesh-list
19377294|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377295|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
19377296|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
19377297|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377298|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377299|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377300|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
19377301|NCT01555281|Hormones|hormones|mesh-ancestor
19377302|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377303|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847483|NCT00686881|Interferons|interferons|mesh-list
19847484|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
19847485|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
19377304|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377305|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
19377306|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19377307|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19377308|NCT01555281|Growth Substances|growth substances|mesh-ancestor
19377309|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
19377310|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19377311|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19377312|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
19377313|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377314|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377315|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19377316|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20406775|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20406776|NCT01167725|Growth Substances|growth substances|mesh-ancestor
20406777|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406778|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
20406779|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
20406780|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406781|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20406782|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406783|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
20213020|NCT00294593|Hematinics|hematinics|mesh-ancestor
20213021|NCT00294606|Phenylephrine|phenylephrine|mesh-list
20213022|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
20213023|NCT00294606|Norepinephrine|norepinephrine|mesh-list
20213024|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20213025|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
20213026|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
20213027|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406784|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20406785|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406786|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406787|NCT01167725|Antidotes|antidotes|mesh-ancestor
20406788|NCT01167725|Protective Agents|protective agents|mesh-ancestor
20406789|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
20406790|NCT01167725|Vitamins|vitamins|mesh-ancestor
20406791|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
20406792|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20406793|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
20406794|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20406795|NCT01167738|Metformin|metformin|mesh-list
20406796|NCT01167738|Gemcitabine|gemcitabine|mesh-list
20406797|NCT01167738|Capecitabine|capecitabine|mesh-list
20406798|NCT01167738|Epirubicin|epirubicin|mesh-list
20406799|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406800|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19377317|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
19377318|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377319|NCT01502085|Dexamethasone|dexamethasone|mesh-list
19847486|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20213028|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213029|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
20213030|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20213031|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
20406801|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
19377320|NCT01502085|Vorinostat|vorinostat|mesh-list
20213032|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
20406802|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377321|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377322|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
19377323|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
19377324|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377325|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377326|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377327|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
19377328|NCT01502085|Hormones|hormones|mesh-ancestor
19377329|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377330|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377331|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377332|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19377333|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377334|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377335|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
19377336|NCT01413100|Plerixafor|plerixafor|mesh-list
19377337|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
19377338|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
19377339|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20406803|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
20406804|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406805|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406806|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20406807|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
20406808|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406809|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20406810|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20406811|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20406812|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406813|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
20406814|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20406815|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20406816|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406817|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
20406818|NCT01167764|Coagulants|coagulants|mesh-ancestor
19377340|NCT01413100|Lenograstim|lenograstim|mesh-list
19377341|NCT01413100|Sargramostim|sargramostim|mesh-list
19377342|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377343|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
19377344|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377345|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377346|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20406819|NCT01167803|Desflurane|desflurane|mesh-list
20406820|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20406821|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
20406822|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
20406823|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406824|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406825|NCT01167816|Azacitidine|azacitidine|mesh-list
20406826|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20406827|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
20406828|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406829|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377347|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
19377348|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377349|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377350|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19377351|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19377352|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19377353|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20213033|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20213034|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19377354|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
19377355|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19377356|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213035|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20213036|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
20213037|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213038|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213039|NCT00294606|Protective Agents|protective agents|mesh-ancestor
20213040|NCT00294619|Hormones|hormones|mesh-list
20213041|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213042|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406830|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377357|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377358|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20406831|NCT01167894|Simvastatin|simvastatin|mesh-list
20406832|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20406833|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20406834|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
20406835|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406836|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20406837|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20406838|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406839|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
20406840|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
20406841|NCT01167920|Diuretics|diuretics|mesh-list
20406842|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19377359|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19377360|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
19377361|NCT01178814|Lenalidomide|lenalidomide|mesh-list
19377362|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
19377363|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377364|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19377365|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19377366|NCT01178814|Growth Substances|growth substances|mesh-ancestor
19377367|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
19377368|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377369|NCT01125176|Thalidomide|thalidomide|mesh-list
19377370|NCT01125176|Rituximab|rituximab|mesh-list
19377371|NCT01125176|Lenalidomide|lenalidomide|mesh-list
19377372|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19377373|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377374|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
19377375|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377376|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377377|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19377378|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19377379|NCT01125176|Growth Substances|growth substances|mesh-ancestor
19377380|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
19377381|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377382|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
19377383|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19377384|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377385|NCT00882050|Exenatide|exenatide|mesh-list
19377386|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19377387|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377388|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19377389|NCT00882050|Incretins|incretins|mesh-ancestor
19377390|NCT00882050|Hormones|hormones|mesh-ancestor
19377391|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377392|NCT00790829|Nicotine|nicotine|mesh-list
19377393|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19377394|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
19377395|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377396|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377397|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19377398|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19377399|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
19377400|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377401|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213043|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20213044|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377402|NCT00070564|Paclitaxel|paclitaxel|mesh-list
19847487|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213045|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20213046|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213047|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213048|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
20213049|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20213050|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213051|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20213052|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20213053|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213054|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213055|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213056|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20213057|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20213058|NCT00294775|Candesartan|candesartan|mesh-list
19377403|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
19377404|NCT00070564|Doxorubicin|doxorubicin|mesh-list
19377405|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19377406|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19377407|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377408|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377409|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377410|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377411|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377412|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377413|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
19377414|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377415|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377416|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19377417|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
19377418|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19377419|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19377420|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19377421|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19377422|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377423|NCT05206747|Methamphetamine|methamphetamine|mesh-list
19377424|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19377425|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377426|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
19377427|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
19377428|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377429|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
19377430|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377431|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377432|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
19377433|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19377434|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19377435|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19377436|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19377437|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
20213059|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20213060|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20213061|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20213062|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213063|NCT00294853|Calcium|calcium|mesh-list
20213064|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20213065|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213066|NCT00294892|Nevirapine|nevirapine|mesh-list
20213067|NCT00294892|Carbamazepine|carbamazepine|mesh-list
20406843|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19377438|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19377439|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377440|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
19377441|NCT05206682|Goserelin|goserelin|mesh-list
19377442|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377443|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377444|NCT05206448|Letrozole|letrozole|mesh-list
19377445|NCT05206448|Clomiphene|clomiphene|mesh-list
19377446|NCT05206448|Enclomiphene|enclomiphene|mesh-list
19377447|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
19377448|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377449|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377450|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19377451|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20213068|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20213069|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20213070|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213071|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213072|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
20213073|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406844|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377452|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691255|NCT05006664|Doxorubicin|doxorubicin|mesh-list
19691256|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20406845|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
20406846|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
20406847|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406848|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691257|NCT05006664|Etoposide|etoposide|mesh-list
20406849|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20406850|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20406851|NCT01167933|Simvastatin|simvastatin|mesh-list
20406852|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20213074|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20213075|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20406853|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20406854|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
20406855|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406856|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20406857|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20406858|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406859|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
20406860|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20406861|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20406862|NCT01167946|Prednisolone|prednisolone|mesh-list
20406863|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
20406864|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20406865|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
20406866|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377453|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19377454|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
19377455|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377456|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377457|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19377458|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
19377459|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19377460|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19377461|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19377462|NCT05206318|Cysteamine|cysteamine|mesh-list
19377463|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19377464|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402781|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19402782|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19402783|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402784|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
19402785|NCT03606785|Coagulants|coagulants|mesh-ancestor
19402786|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
19402787|NCT03606681|Calcium|calcium|mesh-list
19402788|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19402789|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402790|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19402791|NCT03606590|Sorafenib|sorafenib|mesh-list
19402792|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402793|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19402794|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402795|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402796|NCT03606577|Dexamethasone|dexamethasone|mesh-list
19402797|NCT03606577|Lenalidomide|lenalidomide|mesh-list
19402798|NCT03606577|Daratumumab|daratumumab|mesh-list
19402799|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402800|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
19402801|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
19402802|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402803|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402804|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402805|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
19402806|NCT03606577|Hormones|hormones|mesh-ancestor
19402807|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402808|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402809|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402810|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
19402811|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19402812|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19402813|NCT03606577|Growth Substances|growth substances|mesh-ancestor
19402814|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
20213076|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20213077|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19402815|NCT03606473|Amphetamine|amphetamine|mesh-list
20213078|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
20213079|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
20213080|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20213081|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213082|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213083|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213084|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20213085|NCT00294892|Analgesics|analgesics|mesh-ancestor
20213086|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
20213087|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213088|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19377465|NCT05206175|Methamphetamine|methamphetamine|mesh-list
19377466|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19377467|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377468|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
19377469|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
19377470|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377471|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
19377472|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377473|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406867|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
20406868|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
20406869|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406870|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406871|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406872|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
20406873|NCT01167946|Hormones|hormones|mesh-ancestor
19377474|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
19377475|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19377476|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19377477|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19377478|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19377479|NCT05205837|Letrozole|letrozole|mesh-list
19377480|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377481|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19377482|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19377483|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377484|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377485|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19377486|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
19377487|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377488|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377489|NCT05205811|Zonisamide|zonisamide|mesh-list
19377490|NCT05205811|Bupropion|bupropion|mesh-list
19377491|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19377492|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
19377493|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19377494|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19377495|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19377496|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19377497|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377498|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
19377499|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377500|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377501|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19377502|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19377503|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377504|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
19377505|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19377506|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19377507|NCT05205720|Ropivacaine|ropivacaine|mesh-list
19377508|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
19377509|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
19377510|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19377511|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377512|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
19377513|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377514|NCT05205603|Mesalamine|mesalamine|mesh-list
19377515|NCT05205603|Infliximab|infliximab|mesh-list
19377516|NCT05205603|Vedolizumab|vedolizumab|mesh-list
19377517|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
20213089|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213090|NCT00294918|Hormones|hormones|mesh-list
20213091|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213092|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213093|NCT00294931|Bevacizumab|bevacizumab|mesh-list
20406874|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406875|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19377518|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377519|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377520|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19377521|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19377522|NCT05205603|Analgesics|analgesics|mesh-ancestor
19377523|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
19377524|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377525|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377526|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377527|NCT05205577|Iodine|iodine|mesh-list
19377528|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19377529|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377530|NCT05205577|Trace Elements|trace elements|mesh-ancestor
19377531|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
19377532|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377533|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19377534|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19377535|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377536|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
19377537|NCT05205317|Metformin|metformin|mesh-list
19377538|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19377539|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377540|NCT05205200|Paclitaxel|paclitaxel|mesh-list
19377541|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19377542|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377543|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377544|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377545|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377546|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377547|NCT05205122|Mitomycins|mitomycins|mesh-list
19377548|NCT05205122|Mitomycin|mitomycin|mesh-list
19377549|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19377550|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377551|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
19377552|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377553|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19377554|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377555|NCT05204979|Misoprostol|misoprostol|mesh-list
19377556|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19377557|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
19377558|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19377559|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377560|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19377561|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377562|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
19377563|NCT05204862|Antibodies|antibodies|mesh-list
20406876|NCT01167946|Protective Agents|protective agents|mesh-ancestor
20406877|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20406878|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406879|NCT01168011|ON 01910|on 01910|mesh-list
20406880|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406881|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20406882|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406883|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406884|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20406885|NCT01168063|Amoxicillin|amoxicillin|mesh-list
20406886|NCT01168063|Metronidazole|metronidazole|mesh-list
20406887|NCT01168063|Clarithromycin|clarithromycin|mesh-list
20406888|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20406889|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20406890|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
20406891|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20406892|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20406893|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20406894|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406895|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406896|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20406897|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20406898|NCT01168336|Betahistine|betahistine|mesh-list
20406899|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
20406900|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
20406901|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
19377564|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
19377565|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847488|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
20406902|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847489|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847490|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
19377569|NCT05204667|Acetaminophen|acetaminophen|mesh-list
19377570|NCT05204667|Aspirin|aspirin|mesh-list
19377571|NCT05204667|Methocarbamol|methocarbamol|mesh-list
20406903|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406904|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406905|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20406906|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20406907|NCT01168440|Sunitinib|sunitinib|mesh-list
20406908|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406909|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20406910|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20406911|NCT01168440|Growth Substances|growth substances|mesh-ancestor
20406912|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406913|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
20406914|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20406915|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406916|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406917|NCT01168492|Ketamine|ketamine|mesh-list
20406918|NCT01168492|Analgesics|analgesics|mesh-ancestor
20406919|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
20406920|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406921|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406922|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20406923|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20406924|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
20406925|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
20406926|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406927|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20406928|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20406929|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20406930|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406931|NCT01168505|Teferrol|teferrol|mesh-list
20406932|NCT01168505|Hematinics|hematinics|mesh-ancestor
20406933|NCT01168531|Dexamethasone|dexamethasone|mesh-list
20406934|NCT01168531|Pregabalin|pregabalin|mesh-list
20406935|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20406936|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
20406937|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
20406938|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377572|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19377573|NCT05204667|Analgesics|analgesics|mesh-ancestor
19377574|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
19377575|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377576|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377577|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
19377578|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19377579|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377580|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377581|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19377582|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19377583|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377584|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19377585|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19377586|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377587|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19377588|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19377589|NCT05204641|Rifaximin|rifaximin|mesh-list
19377590|NCT05204641|Levodopa|levodopa|mesh-list
19377591|NCT05204641|Benserazide|benserazide|mesh-list
19377592|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20406939|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406940|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406941|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
20406942|NCT01168531|Hormones|hormones|mesh-ancestor
20406943|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406944|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20406945|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406946|NCT01168531|Analgesics|analgesics|mesh-ancestor
20406947|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
20406948|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
20406949|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20406950|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19377593|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19377594|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
20406951|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406952|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20406953|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20406954|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20213094|NCT00294931|Carboplatin|carboplatin|mesh-list
20213095|NCT00294931|Irinotecan|irinotecan|mesh-list
19377595|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377596|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377597|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377598|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19377599|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377600|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377601|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377602|NCT05204628|Crizotinib|crizotinib|mesh-list
19377603|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377604|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19377605|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377606|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377607|NCT05204550|Heparin|heparin|mesh-list
19377608|NCT05204550|Calcium heparin|calcium heparin|mesh-list
19377609|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
19377610|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19377611|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19377612|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377613|NCT05204524|Temozolomide|temozolomide|mesh-list
19377614|NCT05204524|Epirubicin|epirubicin|mesh-list
19377615|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19377616|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
19691258|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
20406955|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20406956|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20406957|NCT01168544|Vitamin D|vitamin d|mesh-list
20406958|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
20406959|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
20406960|NCT01168544|Vitamins|vitamins|mesh-list
20406961|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
20406962|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406963|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20406964|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20427290|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427291|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427292|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20427293|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20427294|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20427295|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
20427296|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377617|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377618|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377619|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19377620|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19377621|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19377622|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377623|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19377624|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19377625|NCT05204173|Paclitaxel|paclitaxel|mesh-list
19402816|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
19691259|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20213096|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20213097|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213098|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20213099|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20213100|NCT00294931|Growth Substances|growth substances|mesh-ancestor
20213101|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213102|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
20213103|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20213104|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20213105|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213106|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213107|NCT00294944|Idazoxan|idazoxan|mesh-list
20213108|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20213109|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20213110|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20213111|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
20427297|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377626|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19377627|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377628|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377629|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377630|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377631|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377632|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
19377633|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19377634|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19377635|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
19377636|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377637|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
19377638|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
19377639|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
19377640|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377641|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377642|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
19847491|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847492|NCT00686894|Infliximab|infliximab|mesh-list
19847493|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847494|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847495|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20406965|NCT01168739|Quercetin|quercetin|mesh-list
19377643|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19377644|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19377645|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
19377646|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377647|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377648|NCT05204056|Epinephrine|epinephrine|mesh-list
19377649|NCT05204056|Morphine|morphine|mesh-list
19377650|NCT05204056|Ropivacaine|ropivacaine|mesh-list
19377651|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
20406966|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
20406967|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406968|NCT01168739|Protective Agents|protective agents|mesh-ancestor
20406969|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406970|NCT01168791|Doxorubicin|doxorubicin|mesh-list
19377652|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19377653|NCT05204056|Narcotics|narcotics|mesh-ancestor
19377654|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19377655|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377656|NCT05204056|Analgesics|analgesics|mesh-ancestor
19377657|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
19377658|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377659|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
19377660|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
19377661|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19377662|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19377663|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
19377664|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377665|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377666|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19377667|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19377668|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
19377669|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19377670|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
19377671|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
19377672|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
20406971|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20406972|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
20406973|NCT01168791|Ifosfamide|ifosfamide|mesh-list
20406974|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20406975|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406976|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20406977|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406978|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20406979|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20406980|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20406981|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
20406982|NCT01168804|Dexamethasone|dexamethasone|mesh-list
20406983|NCT01168804|Bortezomib|bortezomib|mesh-list
20406984|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19377673|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20406985|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847496|NCT00686920|Rifaximin|rifaximin|mesh-list
20406986|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
19377674|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19847497|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20213112|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213113|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213114|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213115|NCT00294996|Doxorubicin|doxorubicin|mesh-list
20213116|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20213117|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213118|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20213119|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20406987|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
20406988|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20406989|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20406990|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20406991|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
20406992|NCT01168804|Hormones|hormones|mesh-ancestor
20406993|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20406994|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20406995|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20406996|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20406997|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
20406998|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377675|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19377676|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
19377677|NCT05204056|Coagulants|coagulants|mesh-ancestor
20406999|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20407000|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
20407001|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20407002|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20407003|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407004|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407005|NCT01168817|Urological Agents|urological agents|mesh-ancestor
19377678|NCT05203913|Paclitaxel|paclitaxel|mesh-list
19377679|NCT05203913|Nivolumab|nivolumab|mesh-list
19377680|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19377681|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377682|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
19377683|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
19377684|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
19377685|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213120|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213121|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213122|NCT00295035|Celecoxib|celecoxib|mesh-list
20213123|NCT00295035|Curcumin|curcumin|mesh-list
20213124|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20213125|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20213126|NCT00295035|Analgesics|analgesics|mesh-ancestor
20213127|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
20213128|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213129|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213130|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377686|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19377687|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19377688|NCT05203744|Tafenoquine|tafenoquine|mesh-list
19377689|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
19377690|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19377691|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19377692|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402817|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19402818|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402819|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
19402820|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
20407006|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
20407007|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20407008|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407009|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19402821|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402822|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
19402823|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402824|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402825|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
19402826|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19402827|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19402828|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19404743|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
19377693|NCT05203588|Vitamin D|vitamin d|mesh-list
19377694|NCT05203588|Denosumab|denosumab|mesh-list
19377695|NCT05203588|Calcium|calcium|mesh-list
19377696|NCT05203588|Vitamins|vitamins|mesh-ancestor
19377697|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
19377698|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377699|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19377700|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19377701|NCT05203562|Letrozole|letrozole|mesh-list
19377702|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377703|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19377704|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19377705|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377706|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377707|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19377708|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
20407010|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20407011|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407012|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407013|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407014|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20407015|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20407016|NCT01169012|Clofarabine|clofarabine|mesh-list
20407017|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20407018|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
20407019|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407020|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213131|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377709|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377710|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377711|NCT05203432|Atropine|atropine|mesh-list
19377712|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19377713|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19377714|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19377715|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
19377716|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377717|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213132|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20213133|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20213134|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213135|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213136|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213137|NCT00295100|Tamoxifen|tamoxifen|mesh-list
20213138|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20407021|NCT01169025|Fentanyl|fentanyl|mesh-list
20407022|NCT01169025|Ketamine|ketamine|mesh-list
20407023|NCT01169025|Analgesics|analgesics|mesh-ancestor
20407024|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
20407025|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407026|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407027|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20407028|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20407029|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
20407030|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
20407031|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407032|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19377718|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19377719|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
19377720|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
19377721|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
20213139|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
20407033|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20407034|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407035|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407036|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20407037|NCT01169025|Narcotics|narcotics|mesh-ancestor
20407038|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20407039|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20407040|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20407041|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407042|NCT01169090|Incretins|incretins|mesh-ancestor
20407043|NCT01169090|Hormones|hormones|mesh-ancestor
20427298|NCT01285934|Insulin|insulin|mesh-list
19377722|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19377723|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20407044|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407045|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20407046|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
19377724|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
19847498|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847499|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847500|NCT00686959|Paclitaxel|paclitaxel|mesh-list
19847501|NCT00686959|Etoposide|etoposide|mesh-list
19847502|NCT00686959|Vinorelbine|vinorelbine|mesh-list
20407047|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407048|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407049|NCT01169142|Vitamin D|vitamin d|mesh-list
20407050|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
20407051|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
20407052|NCT01169142|Vitamins|vitamins|mesh-list
20407053|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
20407054|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407055|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20407056|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20407057|NCT01169298|Lenalidomide|lenalidomide|mesh-list
20407058|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
19377725|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377726|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377727|NCT05203354|Acitretin|acitretin|mesh-list
19377728|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
19377729|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
20213140|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213141|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213142|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377733|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19377734|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
19377735|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
19377736|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377737|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
19377738|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377739|NCT05202821|Fluorides|fluorides|mesh-list
19377740|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
19377741|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
19377742|NCT05202821|Protective Agents|protective agents|mesh-ancestor
19377743|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377744|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
19377745|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377746|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19377747|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377748|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377749|NCT05198388|Endorphins|endorphins|mesh-list
19377750|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377751|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377752|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377753|NCT05180032|Denosumab|denosumab|mesh-list
19377754|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19377755|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377756|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19377757|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19377758|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
19847503|NCT00686959|Carboplatin|carboplatin|mesh-list
19847504|NCT00686959|Pemetrexed|pemetrexed|mesh-list
20213143|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213144|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20213145|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20213146|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20213147|NCT00295165|Sargramostim|sargramostim|mesh-list
20213148|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
20213149|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213150|NCT00295178|Vancomycin|vancomycin|mesh-list
20213151|NCT00295178|Daptomycin|daptomycin|mesh-list
20213152|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20213153|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213154|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
20213155|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20213156|NCT00295243|Topotecan|topotecan|mesh-list
20213157|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20213158|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20213159|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213160|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377759|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377760|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377761|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19377762|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19377763|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19377764|NCT05167370|Amifostine|amifostine|mesh-list
19377765|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19377766|NCT05167370|Protective Agents|protective agents|mesh-ancestor
19377767|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377768|NCT05156879|Aspirin|aspirin|mesh-list
19377769|NCT05156879|Drospirenone|drospirenone|mesh-list
19377770|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19377771|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19377772|NCT05156879|Estradiol|estradiol|mesh-list
19377773|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19377774|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19377775|NCT05156879|Analgesics|analgesics|mesh-ancestor
19377776|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
19377777|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377778|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377779|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377780|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377781|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19377782|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19377783|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377784|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19377785|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19377786|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377787|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
19377788|NCT05156879|Estrogens|estrogens|mesh-ancestor
19377789|NCT05156879|Hormones|hormones|mesh-ancestor
19377790|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377791|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19377792|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
19377793|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19377794|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19377795|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19377796|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19377797|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19377798|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
19377799|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19377800|NCT05156879|Diuretics|diuretics|mesh-ancestor
19377801|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
19377802|NCT05136560|Dexamethasone|dexamethasone|mesh-list
19377803|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
19377804|NCT05136560|BB 1101|bb 1101|mesh-list
20407059|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407060|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20407061|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20407062|NCT01169298|Growth Substances|growth substances|mesh-ancestor
20407063|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
20407064|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407065|NCT01169389|Bupivacaine|bupivacaine|mesh-list
19377805|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377806|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
19377807|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
19377808|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377809|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377810|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377811|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
19377812|NCT05136560|Hormones|hormones|mesh-ancestor
19377813|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377814|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377815|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377816|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
19377817|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377818|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377819|NCT05125523|Sirolimus|sirolimus|mesh-list
19377820|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19377821|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377822|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20407066|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
19377823|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377824|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
20407067|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
20407068|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407069|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407070|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
19377825|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377826|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
19377827|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377828|NCT05124678|Isoniazid|isoniazid|mesh-list
19377829|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
19377830|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19377831|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377832|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19377833|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19377834|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
19377835|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377836|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19377837|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
19377838|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19377839|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
19377840|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377841|NCT05123365|Expectorants|expectorants|mesh-ancestor
19377842|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
19377843|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19377844|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
20407071|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407072|NCT01169402|Fluconazole|fluconazole|mesh-list
20407073|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
20407074|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407075|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20407076|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20407077|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407078|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407079|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20407080|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
20407081|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407082|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407083|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20407084|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19377845|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377846|NCT05123365|Protective Agents|protective agents|mesh-ancestor
19377847|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377848|NCT05123365|Antidotes|antidotes|mesh-ancestor
19402829|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19402830|NCT03606369|Ondansetron|ondansetron|mesh-list
19402831|NCT03606369|Palonosetron|palonosetron|mesh-list
19402832|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
19402833|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
19402834|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402835|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402836|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402837|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
19402838|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
19402839|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20407085|NCT01169415|Dexamethasone|dexamethasone|mesh-list
20407086|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
20407087|NCT01169415|BB 1101|bb 1101|mesh-list
20407088|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407089|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
20407090|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
19402840|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
19402841|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19402842|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402843|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19402844|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19402845|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19402846|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19402847|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19402848|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19402849|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
19402850|NCT03606174|Nivolumab|nivolumab|mesh-list
19402851|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402852|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402853|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19402854|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407091|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407092|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407093|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407094|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
20407095|NCT01169415|Hormones|hormones|mesh-ancestor
20407096|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407097|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377849|NCT05106192|Triamcinolone|triamcinolone|mesh-list
19377850|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19377851|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19377852|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
19377853|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19377854|NCT05106192|Bexarotene|bexarotene|mesh-list
19377855|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19377856|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377857|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
19377858|NCT05106192|Hormones|hormones|mesh-ancestor
19377859|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377860|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377861|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407098|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407099|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
20407100|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407101|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407102|NCT01169506|Silicon|silicon|mesh-list
19377862|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
19377863|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377864|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377865|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
19377866|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20407103|NCT01169506|Trace Elements|trace elements|mesh-ancestor
20407104|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
20407105|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407106|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
20407107|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20407108|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407109|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407110|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20407111|NCT01169571|Analgesics|analgesics|mesh-ancestor
20407112|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
20407113|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407114|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20407115|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20407116|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20407117|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
20407118|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407119|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407120|NCT01169584|Molgramostim|molgramostim|mesh-list
20407121|NCT01169584|Sargramostim|sargramostim|mesh-list
20407122|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
20407123|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407124|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407125|NCT01169597|Prednisone|prednisone|mesh-list
20407126|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407127|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
20407128|NCT01169597|Hormones|hormones|mesh-ancestor
20407129|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407130|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377867|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377868|NCT05101564|Tamoxifen|tamoxifen|mesh-list
19377869|NCT05101564|Letrozole|letrozole|mesh-list
19377870|NCT05101564|Infigratinib|infigratinib|mesh-list
19377871|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377872|NCT05101564|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19377873|NCT05101564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20407131|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20407132|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407133|NCT01169688|Phenylephrine|phenylephrine|mesh-list
20407134|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
19377874|NCT05101564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377875|NCT05101564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377876|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19377877|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
19377878|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402855|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
19377879|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377880|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377881|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20407135|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
20407136|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20407137|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
20407138|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
20407139|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407140|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407141|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
19377882|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19377883|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19377884|NCT05083910|Misoprostol|misoprostol|mesh-list
19377885|NCT05083910|Oxytocin|oxytocin|mesh-list
19377886|NCT05083910|Carbetocin|carbetocin|mesh-list
19377887|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
19377888|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19377889|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377890|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19377891|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
19377892|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19377893|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377894|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
19377895|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
19377896|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
19377897|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19377898|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19377899|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19377900|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377901|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377902|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19377903|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19377904|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377905|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19377906|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377907|NCT05079841|Oxytocin|oxytocin|mesh-list
19377908|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
19377909|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19377910|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377911|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
19377912|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20407142|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20407143|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
20407144|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
20407145|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20407146|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20407147|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20407148|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
20407149|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407150|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407151|NCT01169688|Protective Agents|protective agents|mesh-ancestor
19377913|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
19377914|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377915|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19377916|NCT05055999|Atezolizumab|atezolizumab|mesh-list
19377917|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377918|NCT05055947|Atezolizumab|atezolizumab|mesh-list
19377919|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377920|NCT05055908|Atezolizumab|atezolizumab|mesh-list
19377921|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377922|NCT05050981|Hormones|hormones|mesh-list
19377923|NCT05050981|Serotonin|serotonin|mesh-list
19377924|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19377925|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377926|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377927|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19377928|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
19377929|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377930|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377931|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19377932|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19377938|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
19377939|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19377940|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377941|NCT05017246|Lidocaine|lidocaine|mesh-list
19377942|NCT05017246|Morphine|morphine|mesh-list
19377943|NCT05017246|Bupivacaine|bupivacaine|mesh-list
19377944|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
19377945|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
19377946|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19377947|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377948|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
19377949|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377950|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19377951|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19377952|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20407152|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
20407153|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20407154|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20407155|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
20407156|NCT01169740|Bilirubin|bilirubin|mesh-list
20407157|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
20407158|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407159|NCT01169740|Protective Agents|protective agents|mesh-ancestor
19377953|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19377954|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377955|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19377956|NCT05017246|Narcotics|narcotics|mesh-ancestor
19377957|NCT05017246|Analgesics|analgesics|mesh-ancestor
20407160|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407161|NCT01169792|Tamoxifen|tamoxifen|mesh-list
20407162|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20407163|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
20407164|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407165|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407166|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20427299|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19377958|NCT05013255|Pioglitazone|pioglitazone|mesh-list
19377959|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19377960|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377961|NCT05003076|Methamphetamine|methamphetamine|mesh-list
19377962|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19377963|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377964|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
19377965|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
19377966|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377967|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
19377968|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19377969|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377970|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
19377971|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19377972|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19377973|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19377974|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19377975|NCT04984330|Dexamethasone|dexamethasone|mesh-list
19377976|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19377977|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
19377978|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
19377979|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19377980|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19377981|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19377982|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
19377983|NCT04984330|Hormones|hormones|mesh-ancestor
19377984|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19377985|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19377986|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377987|NCT04953910|Decitabine|decitabine|mesh-list
19377988|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19377989|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
19377990|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377991|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377992|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691260|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19377993|NCT04953897|Decitabine|decitabine|mesh-list
20407167|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377994|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19377995|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
19377996|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19377997|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19377998|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19377999|NCT04949022|Insulin|insulin|mesh-list
19378000|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19378001|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378002|NCT04929379|Fenofibrate|fenofibrate|mesh-list
19378003|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19378004|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
19378005|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378006|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19378007|NCT04920292|Oxfendazole|oxfendazole|mesh-list
19378008|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
19378009|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19378010|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378011|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
19378012|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
19378013|NCT04917029|Bupivacaine|bupivacaine|mesh-list
19378014|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378015|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
19378016|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407168|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20407169|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20407170|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20407171|NCT01169805|Ondansetron|ondansetron|mesh-list
20407172|NCT01169805|Palonosetron|palonosetron|mesh-list
19378017|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378018|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
19378019|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378020|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19378021|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19378022|NCT04917029|Analgesics|analgesics|mesh-ancestor
19378023|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19378024|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19378025|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19378026|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
19378027|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378028|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378029|NCT04914195|Leuprolide|leuprolide|mesh-list
19378030|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19378031|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
19378032|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19378033|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378034|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378035|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378036|NCT04903119|Trametinib|trametinib|mesh-list
19378037|NCT04903119|Dabrafenib|dabrafenib|mesh-list
19378038|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378039|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378040|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378041|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378042|NCT04892420|Dexamethasone|dexamethasone|mesh-list
19378043|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
19378044|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
19378045|NCT04892420|Bupivacaine|bupivacaine|mesh-list
19378046|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378047|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
19378048|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
19378049|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378050|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407173|NCT01169805|Ramosetron|ramosetron|mesh-list
20407174|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
19378051|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19378052|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
19378053|NCT04892420|Hormones|hormones|mesh-ancestor
19378054|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378055|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378056|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407175|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
20407176|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378057|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378058|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
19378059|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213161|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213162|NCT00295282|Antibodies|antibodies|mesh-list
20213163|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20213164|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
20213165|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213166|NCT00295308|Clonidine|clonidine|mesh-list
20213167|NCT00295308|Analgesics|analgesics|mesh-ancestor
20213168|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
20213169|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213170|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213171|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20213172|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
19378060|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
19378061|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19378062|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19378063|NCT04892420|Analgesics|analgesics|mesh-ancestor
19378064|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19378065|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19378066|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19378067|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
19378068|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378069|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378070|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19378071|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
19378072|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19378073|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378074|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19378075|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
19378076|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19378077|NCT04876677|Beclomethasone|beclomethasone|mesh-list
19378078|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
19378079|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
19378080|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19378081|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
19378082|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378083|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378084|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19378085|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
19378086|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19378087|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19378088|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19378089|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
19378090|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378091|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378092|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378093|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
19378094|NCT04876677|Hormones|hormones|mesh-ancestor
19378095|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378096|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19378097|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19378098|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19378099|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
19402856|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19402857|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19402858|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402859|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
19402860|NCT03606109|Coagulants|coagulants|mesh-ancestor
19402861|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
19402862|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19402863|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402864|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691261|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
19691262|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691263|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213173|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
20213174|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19691264|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19691265|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
19691266|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691267|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213175|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20213176|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20213177|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
20407177|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407178|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407179|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
20407180|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
20407181|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20407182|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
20407183|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407184|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407185|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20407186|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20407187|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407188|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20407189|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19378100|NCT04874194|Venetoclax|venetoclax|mesh-list
19378101|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
19378102|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378103|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19378104|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19378105|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378106|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378107|NCT04857398|Insulin|insulin|mesh-list
19378108|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19378109|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378110|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19378111|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19378112|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
19378113|NCT04843579|Clarithromycin|clarithromycin|mesh-list
19378114|NCT04843579|Dexamethasone|dexamethasone|mesh-list
19378115|NCT04843579|Pomalidomide|pomalidomide|mesh-list
19378116|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378117|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
19378118|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
19378119|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378120|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407190|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20407191|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
20407192|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20407193|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407194|NCT01169857|Bortezomib|bortezomib|mesh-list
19378121|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19378122|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
19378123|NCT04843579|Hormones|hormones|mesh-ancestor
19378124|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378125|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378126|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378127|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378128|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378129|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19378130|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378131|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378132|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19378133|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19378134|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
20407195|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
20407196|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407197|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
20407198|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407199|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407200|NCT01169870|Paclitaxel|paclitaxel|mesh-list
20407201|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20407202|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407203|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
20407204|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
20407205|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
20407206|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378135|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19378136|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19378137|NCT04843579|Growth Substances|growth substances|mesh-ancestor
19378138|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
19378139|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
19378140|NCT04821375|Estrogens|estrogens|mesh-list
19378141|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19378142|NCT04821375|Hormones|hormones|mesh-ancestor
20407207|NCT01169909|Ranibizumab|ranibizumab|mesh-list
20407208|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19378143|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378144|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378145|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19378146|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19378147|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
19378148|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19378149|NCT04808505|Miglustat|miglustat|mesh-list
19378150|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378151|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378152|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19378153|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19378154|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
19378155|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378156|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19378157|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19378158|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378159|NCT04801797|Cytarabine|cytarabine|mesh-list
19378160|NCT04801797|Azacitidine|azacitidine|mesh-list
19378161|NCT04801797|Daunorubicin|daunorubicin|mesh-list
19378162|NCT04801797|Venetoclax|venetoclax|mesh-list
19378163|NCT04801797|Idarubicin|idarubicin|mesh-list
19378164|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19378165|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
19378166|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378167|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378168|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
19378169|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378170|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19378171|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
19378172|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378173|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378174|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19378175|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19378176|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19378177|NCT04785625|Bupivacaine|bupivacaine|mesh-list
19378178|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378179|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
19378180|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378181|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378182|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
19378183|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378184|NCT04739371|Insulin|insulin|mesh-list
19378185|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19378186|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19378187|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378188|NCT04725994|Irinotecan|irinotecan|mesh-list
20407209|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20407210|NCT01169909|Growth Substances|growth substances|mesh-ancestor
19378189|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20213178|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213179|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217904|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20217905|NCT00310908|Tramadol|tramadol|mesh-list
20217906|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20217907|NCT00310908|Narcotics|narcotics|mesh-ancestor
20407211|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378190|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19378191|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378192|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378193|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378194|NCT04716699|Lidocaine|lidocaine|mesh-list
19378195|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378196|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
19691268|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19691269|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19691270|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19691271|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19691272|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691273|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691274|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
19691275|NCT05006664|Hormones|hormones|mesh-ancestor
19691276|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691277|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217908|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407212|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
19378197|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378198|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378199|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
19378200|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378201|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19378202|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19378203|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19378204|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378205|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378206|NCT04712942|Azacitidine|azacitidine|mesh-list
19378207|NCT04712942|Pevonedistat|pevonedistat|mesh-list
20407213|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407214|NCT01169922|Ethanol|ethanol|mesh-list
20407215|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20407216|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407217|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407218|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407219|NCT01169935|Dextrans|dextrans|mesh-list
19378208|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19378209|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
19378210|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378211|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378212|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378213|NCT04708145|Aflibercept|aflibercept|mesh-list
19378214|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19378215|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19378216|NCT04708145|Growth Substances|growth substances|mesh-ancestor
19378217|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378218|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
19378219|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378220|NCT04688177|Nicotine|nicotine|mesh-list
19378221|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
19378222|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19378223|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
19378224|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378225|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378226|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19378227|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19378228|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
19378229|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378230|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378231|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
19378232|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
19378233|NCT04685590|Dasatinib|dasatinib|mesh-list
19378234|NCT04685590|Quercetin|quercetin|mesh-list
19378235|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378236|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378237|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378238|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378239|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
19378240|NCT04685590|Protective Agents|protective agents|mesh-ancestor
19378241|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378242|NCT04680910|Propofol|propofol|mesh-list
19378243|NCT04680910|Anesthetics|anesthetics|mesh-list
19378244|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19378245|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378246|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378247|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19378248|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
19378249|NCT04671810|Eculizumab|eculizumab|mesh-list
19378250|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19378251|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19378252|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
19378253|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378254|NCT04671615|Palbociclib|palbociclib|mesh-list
19378255|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378256|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378257|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378258|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378259|NCT04668365|Prednisone|prednisone|mesh-list
19378260|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
19378261|NCT04668365|Rituximab|rituximab|mesh-list
20407220|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
19378262|NCT04668365|Vincristine|vincristine|mesh-list
19378263|NCT04668365|Epirubicin|epirubicin|mesh-list
20407221|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
20407222|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
20407223|NCT01170052|Sirolimus|sirolimus|mesh-list
20407224|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20407225|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20407226|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
20407227|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407228|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407229|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20407230|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407231|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20407232|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
20407233|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407234|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
20407235|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407236|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
20407237|NCT01170078|Hematinics|hematinics|mesh-ancestor
20407238|NCT01170104|Sorafenib|sorafenib|mesh-list
20407239|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407240|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20407241|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378264|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
19378265|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19378266|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
19378267|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378268|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378269|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19378270|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
19378271|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378272|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378273|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19378274|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378275|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378276|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
19378277|NCT04668365|Hormones|hormones|mesh-ancestor
20407242|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407243|NCT01170130|Lidocaine|lidocaine|mesh-list
20407244|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
20407245|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
20407246|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407247|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407248|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
19378278|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378279|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378280|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19378281|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
19378282|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
19378283|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
19378284|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19378285|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19378286|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19378287|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378288|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378289|NCT04667039|Ranibizumab|ranibizumab|mesh-list
19378290|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19378291|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19378292|NCT04667039|Growth Substances|growth substances|mesh-ancestor
19378293|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378294|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
19378295|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407249|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407250|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20407251|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20407252|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20407253|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20407254|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407255|NCT01170143|Trastuzumab|trastuzumab|mesh-list
19378296|NCT04635735|Ipilimumab|ipilimumab|mesh-list
19378297|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378298|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378299|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19378300|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378301|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
20407256|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20407257|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407258|NCT01170169|Omeprazole|omeprazole|mesh-list
20407259|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19378302|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19378303|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
19378304|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378305|NCT04632069|Expectorants|expectorants|mesh-ancestor
19378306|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
19378307|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19378308|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
19378309|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378310|NCT04632069|Protective Agents|protective agents|mesh-ancestor
19378311|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378312|NCT04632069|Antidotes|antidotes|mesh-ancestor
19378313|NCT04629378|Amoxicillin|amoxicillin|mesh-list
19378314|NCT04629378|Meropenem|meropenem|mesh-list
20213180|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
20213181|NCT00295347|Spironolactone|spironolactone|mesh-list
20213182|NCT00295347|Citalopram|citalopram|mesh-list
19378315|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
19378316|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
19378317|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
19378318|NCT04629378|Bedaquiline|bedaquiline|mesh-list
19378319|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19378320|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378321|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378322|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19378323|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213183|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20213184|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20213185|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213186|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213187|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213188|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
20213189|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213190|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20213191|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
20213192|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213193|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20213194|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
20213195|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213196|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20213197|NCT00295347|Diuretics|diuretics|mesh-ancestor
20213198|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
20213199|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213200|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20213201|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20213202|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20213203|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
20213204|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213205|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20213206|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20213207|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213208|NCT00295386|Zopiclone|zopiclone|mesh-list
20213209|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20407260|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407261|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20407262|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407263|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407264|NCT01170182|Omeprazole|omeprazole|mesh-list
20407265|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20407266|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407267|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20407268|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407269|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407270|NCT01170260|Ethanol|ethanol|mesh-list
20407271|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20407272|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407273|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407274|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407275|NCT01170325|Valproic Acid|valproic acid|mesh-list
19378324|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378325|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
19378326|NCT04628572|Ceftazidime|ceftazidime|mesh-list
19378327|NCT04628572|Avibactam|avibactam|mesh-list
19378328|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19378329|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378330|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378331|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19378332|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378333|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213210|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213211|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213212|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20213213|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
20213214|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213215|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20213216|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20213217|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213218|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213219|NCT00295425|Cyclosporine|cyclosporine|mesh-list
20213220|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
20213221|NCT00295425|Cyclosporins|cyclosporins|mesh-list
19378334|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19378335|NCT04616183|Cetuximab|cetuximab|mesh-list
19378336|NCT04616183|Antibodies|antibodies|mesh-list
19378337|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
19378338|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19378339|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
19378340|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407276|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
20407277|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407278|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407279|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
20407280|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407281|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407282|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
20407283|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20407284|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407285|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20407286|NCT01170338|Varenicline|varenicline|mesh-list
20407287|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20407288|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20407289|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
19378341|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378342|NCT04608318|Venetoclax|venetoclax|mesh-list
19378343|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
19378344|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378345|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402865|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19402866|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19402867|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402868|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402869|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407290|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407291|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407292|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407293|NCT01170351|Cyclosporine|cyclosporine|mesh-list
19402870|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19402871|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
19402872|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19402873|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402874|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19402875|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19402876|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19402877|NCT03606018|Insulin|insulin|mesh-list
19402878|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19402879|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
19402880|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19402881|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402882|NCT03605940|Methoxsalen|methoxsalen|mesh-list
19402883|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19402884|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
19402885|NCT03605901|Methadone|methadone|mesh-list
19402886|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19402887|NCT03605901|Narcotics|narcotics|mesh-ancestor
20213222|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407294|NCT01170351|Cyclosporins|cyclosporins|mesh-list
19402888|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213223|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378346|NCT04606446|Letrozole|letrozole|mesh-list
19378347|NCT04606446|Fulvestrant|fulvestrant|mesh-list
19378348|NCT04606446|Palbociclib|palbociclib|mesh-list
19378349|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378350|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19378351|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19378352|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378353|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407295|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407296|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407297|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407298|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
20407299|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407300|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
20407301|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407302|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
20407303|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20407304|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20407305|NCT01170429|Procaterol|procaterol|mesh-list
20407306|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20407307|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
20407308|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407309|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407310|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20407311|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
20407312|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
20407313|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20407314|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20407315|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20407316|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
20407317|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407318|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407319|NCT01170442|Vitamin D|vitamin d|mesh-list
20407320|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
19378354|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19378355|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
19378356|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378357|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378358|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378359|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19378360|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378361|NCT04606069|Regadenoson|regadenoson|mesh-list
19378362|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19378363|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19378364|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
19378365|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
19378366|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378367|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378368|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378369|NCT04603846|Paclitaxel|paclitaxel|mesh-list
19378370|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19378371|NCT04603846|Antibodies|antibodies|mesh-list
19378372|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19378373|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378374|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19378375|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19378376|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19378377|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378378|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
19378379|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378380|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19378381|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378382|NCT04591353|Lidocaine|lidocaine|mesh-list
19378383|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378384|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
19378385|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378386|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378387|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
19378388|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378389|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20407321|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
19378390|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19378391|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20407322|NCT01170442|Vitamins|vitamins|mesh-list
20407323|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
20407324|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407325|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20407326|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20407327|NCT01170468|Vitamin D|vitamin d|mesh-list
19378392|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378393|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378394|NCT04581395|Rocuronium|rocuronium|mesh-list
19378395|NCT04581395|Succinylcholine|succinylcholine|mesh-list
19378396|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19378397|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19378398|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19378399|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378400|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378401|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19378402|NCT04578106|Trastuzumab|trastuzumab|mesh-list
19378403|NCT04578106|Pertuzumab|pertuzumab|mesh-list
20407328|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
20407329|NCT01170468|Vitamins|vitamins|mesh-ancestor
20407330|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
20407331|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407332|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20407333|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20407334|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
20407335|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
19378404|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378405|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378406|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
20407336|NCT01170494|Vitamin D|vitamin d|mesh-list
20407337|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19378407|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19378408|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
19378409|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378410|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378411|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378412|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
19378413|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
19378414|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19378415|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19378416|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
19378417|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378418|NCT04549376|Iodine|iodine|mesh-list
19378419|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
19378420|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
19378421|NCT04549376|Povidone|povidone|mesh-list
19378422|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19378423|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407338|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407339|NCT01170494|Vitamins|vitamins|mesh-ancestor
20407340|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
20407341|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20407342|NCT01170507|Vitamin D|vitamin d|mesh-list
20407343|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
20407344|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
20407345|NCT01170507|Vitamins|vitamins|mesh-list
20407346|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
20407347|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407348|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20407349|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20427300|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427301|NCT01286051|Ganirelix|ganirelix|mesh-list
20427302|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
20427303|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427304|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427305|NCT01286090|Cisapride|cisapride|mesh-list
20427306|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19378424|NCT04549376|Trace Elements|trace elements|mesh-ancestor
19378425|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
19378426|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378427|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
19378428|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
19378429|NCT04545151|Verapamil|verapamil|mesh-list
19378430|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20427307|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19378431|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20427308|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20407350|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20407351|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20407352|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20407353|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
20407354|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407355|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20407356|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20407357|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407358|NCT01170637|Ibuprofen|ibuprofen|mesh-list
20407359|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
20407360|NCT01170637|Ephedrine|ephedrine|mesh-list
20407361|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20407362|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20407363|NCT01170637|Analgesics|analgesics|mesh-ancestor
20407364|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
20407365|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407366|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407367|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407368|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20407369|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20407370|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407371|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407372|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19378432|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378433|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378434|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19378435|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378436|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
19378437|NCT04537598|Morphine|morphine|mesh-list
19378438|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19378439|NCT04537598|Narcotics|narcotics|mesh-ancestor
19378440|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378441|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378442|NCT04537598|Analgesics|analgesics|mesh-ancestor
19378443|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
19378444|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378445|NCT04528134|Listerine|listerine|mesh-list
19378446|NCT04528134|Fluorides|fluorides|mesh-list
19378447|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
19378448|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
19378449|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
19378450|NCT04528134|Protective Agents|protective agents|mesh-ancestor
19378451|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378452|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19378453|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378454|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
19378455|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378456|NCT04518046|Nivolumab|nivolumab|mesh-list
19378457|NCT04518046|Ipilimumab|ipilimumab|mesh-list
19378458|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378459|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378460|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19378461|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378462|NCT04502381|Amphotericin B|amphotericin b|mesh-list
19378463|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19378464|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
19378465|NCT04502381|Amebicides|amebicides|mesh-ancestor
19378466|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19378467|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19378468|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378469|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378470|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
19378471|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19378472|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19378473|NCT04472182|Calcium|calcium|mesh-list
19378474|NCT04472182|Fluorides|fluorides|mesh-list
19378475|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
19378476|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19378477|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378478|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
20407373|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
20407374|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20407375|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
19378479|NCT04472182|Protective Agents|protective agents|mesh-ancestor
19378480|NCT04467905|Etripamil|etripamil|mesh-list
19691278|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20407376|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
19378481|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19378482|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378483|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378484|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19378485|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378486|NCT04462965|Temozolomide|temozolomide|mesh-list
19378487|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19378488|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
19378489|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378490|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378491|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
19378492|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378493|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378494|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19378495|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19378496|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378497|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378498|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378499|NCT04413123|Nivolumab|nivolumab|mesh-list
19378500|NCT04413123|Ipilimumab|ipilimumab|mesh-list
19378501|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378502|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378503|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19378504|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378505|NCT04409509|Antibodies|antibodies|mesh-list
19378506|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19378507|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
19378508|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378509|NCT04401865|Riboflavin|riboflavin|mesh-list
19378510|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
19378511|NCT04401865|Vitamins|vitamins|mesh-ancestor
19378512|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
19378513|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378514|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19378515|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
19378516|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
19378517|NCT04401150|Vitamins|vitamins|mesh-ancestor
19378518|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
20213224|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213225|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
20213226|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213227|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
20213228|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213229|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
20213230|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213231|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20213232|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20213233|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213234|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20213235|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
20213236|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20213237|NCT00295464|Betamethasone|betamethasone|mesh-list
20213238|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213239|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
20213240|NCT00295464|Hormones|hormones|mesh-ancestor
20213241|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213242|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213243|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20407377|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20407378|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20407379|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
20407380|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
20407381|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407382|NCT01170767|Bevacizumab|bevacizumab|mesh-list
20407383|NCT01170767|Ranibizumab|ranibizumab|mesh-list
20407384|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20407385|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378519|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378520|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
19378521|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378522|NCT04401150|Protective Agents|protective agents|mesh-ancestor
19378523|NCT04388852|Ipilimumab|ipilimumab|mesh-list
20213244|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
20407386|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20407387|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20407388|NCT01170767|Growth Substances|growth substances|mesh-ancestor
20407389|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407390|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
20407391|NCT01170780|Dexamethasone|dexamethasone|mesh-list
19378524|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378525|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378526|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19378527|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378528|NCT04386811|Calcitriol|calcitriol|mesh-list
19378529|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19378530|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378531|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19378532|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378533|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378534|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19378535|NCT04386811|Vitamins|vitamins|mesh-ancestor
19378536|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
19378537|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19378538|NCT04381143|Aspirin|aspirin|mesh-list
19378539|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19378540|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19378541|NCT04381143|Analgesics|analgesics|mesh-ancestor
19378542|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
19378543|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378544|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378545|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378546|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378547|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19378548|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19378549|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378550|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19378551|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19378552|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378553|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
19378562|NCT04358133|Morphine|morphine|mesh-list
20407392|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407393|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
20407394|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
20407395|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407396|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378563|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19378564|NCT04358133|Narcotics|narcotics|mesh-ancestor
19378565|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378566|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378567|NCT04358133|Analgesics|analgesics|mesh-ancestor
19378568|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
19378569|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378570|NCT04349371|Chloroquine|chloroquine|mesh-list
19378571|NCT04349371|Amebicides|amebicides|mesh-ancestor
19378572|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19378573|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19378574|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378575|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
19378576|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378577|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
19378578|NCT04332211|Ephedrine|ephedrine|mesh-list
19378579|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19378580|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
19378581|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378582|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378583|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19378584|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
19378585|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
19378586|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19378587|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19378588|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
19378589|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
19378590|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378591|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402889|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402890|NCT03605901|Analgesics|analgesics|mesh-ancestor
19402891|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
19402892|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402893|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
19402894|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
19402895|NCT03605758|Ivermectin|ivermectin|mesh-list
19402896|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19402897|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402898|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
19402899|NCT03605654|Tacrolimus|tacrolimus|mesh-list
19402900|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19402901|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
19402902|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402903|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19402904|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402905|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402906|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19402907|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402908|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19402909|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
19402910|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19402911|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19402912|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
19402913|NCT03605589|Blinatumomab|blinatumomab|mesh-list
19402914|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19402915|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402916|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
19402917|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402918|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
19402919|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19402920|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
19402921|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
19402922|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404744|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404745|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
19404746|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404747|NCT03592277|Protective Agents|protective agents|mesh-ancestor
19404748|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
19404749|NCT03592199|Sunitinib|sunitinib|mesh-list
19404750|NCT03592199|Axitinib|axitinib|mesh-list
19404751|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404752|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404753|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19404754|NCT03592199|Growth Substances|growth substances|mesh-ancestor
19404755|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407397|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407398|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
20407399|NCT01170780|Hormones|hormones|mesh-ancestor
20407400|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407401|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20407402|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407403|NCT01170806|Orlistat|orlistat|mesh-list
20407404|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407405|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407406|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20407407|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19404756|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
19404757|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19404758|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404759|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404760|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19404761|NCT03592082|Bismuth|bismuth|mesh-list
19404762|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19404763|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404764|NCT03592082|Antacids|antacids|mesh-ancestor
19404765|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404766|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404767|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
19404768|NCT03592069|Amoxicillin|amoxicillin|mesh-list
19404769|NCT03592069|Metronidazole|metronidazole|mesh-list
19404770|NCT03592069|Clarithromycin|clarithromycin|mesh-list
19404771|NCT03592069|Esomeprazole|esomeprazole|mesh-list
19404772|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378592|NCT04299867|Metronidazole|metronidazole|mesh-list
19378593|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378594|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378595|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19378596|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19378597|NCT04294628|Trastuzumab|trastuzumab|mesh-list
19378598|NCT04294628|Camptothecin|camptothecin|mesh-list
19378599|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
19378600|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378601|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378602|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19378603|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19378604|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19378605|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378606|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378607|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
19378608|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378609|NCT04289779|Atezolizumab|atezolizumab|mesh-list
19378610|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378611|NCT04284657|Citric Acid|citric acid|mesh-list
19378612|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
19378613|NCT04284657|Pravastatin|pravastatin|mesh-list
19378614|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
19378615|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19378616|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
19378617|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
19378618|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378619|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19378620|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19378621|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
19378622|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19378623|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19378624|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378625|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
19378626|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
19378627|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
19378628|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20213245|NCT00295542|Atenolol|atenolol|mesh-list
20213246|NCT00295542|Valsartan|valsartan|mesh-list
20213247|NCT00295542|Telmisartan|telmisartan|mesh-list
20213248|NCT00295542|Carvedilol|carvedilol|mesh-list
20213249|NCT00295542|Olmesartan|olmesartan|mesh-list
20213250|NCT00295542|Enalapril|enalapril|mesh-list
19378629|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19378630|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378631|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378632|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378633|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
19378634|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
19378635|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19378636|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378637|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407408|NCT01170819|Dinoprostone|dinoprostone|mesh-list
20407409|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
20407410|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19378638|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
19378639|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19378640|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378641|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378642|NCT04185311|Nivolumab|nivolumab|mesh-list
19378643|NCT04185311|Ipilimumab|ipilimumab|mesh-list
19378644|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19378645|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378646|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378647|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19378648|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847505|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20213251|NCT00295542|Lisinopril|lisinopril|mesh-list
20213252|NCT00295542|Nebivolol|nebivolol|mesh-list
20213253|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
20213254|NCT00295542|Doxazosin|doxazosin|mesh-list
20213255|NCT00295542|Indapamide|indapamide|mesh-list
20213256|NCT00295542|Quinapril|quinapril|mesh-list
20213257|NCT00295542|Torsemide|torsemide|mesh-list
20213258|NCT00295542|Spirapril|spirapril|mesh-list
20213259|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20213260|NCT00295542|Diuretics|diuretics|mesh-list
20217909|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427309|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
20407411|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407412|NCT01170845|Sivelestat|sivelestat|mesh-list
20407413|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20407414|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
20407415|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407416|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407417|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20407418|NCT01170858|Icodextrin|icodextrin|mesh-list
20407419|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
19847506|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847507|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
19847508|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
19378654|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19378655|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19378656|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378657|NCT04161248|Gemcitabine|gemcitabine|mesh-list
19378658|NCT04161248|Dexamethasone|dexamethasone|mesh-list
19378659|NCT04161248|Rituximab|rituximab|mesh-list
19378660|NCT04161248|Venetoclax|venetoclax|mesh-list
19378661|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378662|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378663|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
19378664|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378665|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378666|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378667|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
19378668|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
19378669|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378670|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19378671|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
19378672|NCT04161248|Hormones|hormones|mesh-ancestor
19378673|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378674|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378675|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19378676|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
19378677|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378678|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
19378679|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378680|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378681|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19378682|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
19378683|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19378684|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
19378685|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19378686|NCT04155580|Decitabine|decitabine|mesh-list
19378687|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19378688|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
19378689|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378690|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378691|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378692|NCT04149145|Niraparib|niraparib|mesh-list
19378693|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19378694|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378695|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378696|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407420|NCT01170871|Pemetrexed|pemetrexed|mesh-list
20407421|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407422|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407423|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407424|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20407425|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19378697|NCT04136548|Fentanyl|fentanyl|mesh-list
19378698|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19378699|NCT04136548|Narcotics|narcotics|mesh-ancestor
19378700|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378701|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378702|NCT04136548|Analgesics|analgesics|mesh-ancestor
19378703|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
19378704|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378705|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19378706|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19378707|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
19378708|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
19847509|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
19847510|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407426|NCT01171092|Bortezomib|bortezomib|mesh-list
20407427|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407428|NCT01171170|Paclitaxel|paclitaxel|mesh-list
20407429|NCT01171170|Bevacizumab|bevacizumab|mesh-list
20407430|NCT01171170|Carboplatin|carboplatin|mesh-list
20407431|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19378709|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19378710|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19378711|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19378712|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378713|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378714|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378715|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378716|NCT04111627|Analgesics|analgesics|mesh-ancestor
19378717|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
19378718|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378719|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
19378720|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19378721|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
19378722|NCT04087395|Lidocaine|lidocaine|mesh-list
19378723|NCT04087395|Anesthetics|anesthetics|mesh-list
19378724|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378725|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378726|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378727|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
19378728|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378729|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19378730|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19378731|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19378732|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378733|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378734|NCT04085887|Panitumumab|panitumumab|mesh-list
19378735|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378736|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378737|NCT04074785|Bevacizumab|bevacizumab|mesh-list
19378738|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378739|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378740|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19378741|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19378742|NCT04074785|Growth Substances|growth substances|mesh-ancestor
19378743|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407432|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
20407433|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20407434|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407435|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
20407436|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
20407437|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
20407438|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407439|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20407440|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20407441|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20407442|NCT01171170|Growth Substances|growth substances|mesh-ancestor
19378744|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
19378745|NCT04069585|Lidocaine|lidocaine|mesh-list
19378746|NCT04069585|Anesthetics|anesthetics|mesh-list
19378747|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378748|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378749|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407443|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407444|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
20407445|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
20407446|NCT01171209|Interferons|interferons|mesh-list
20407447|NCT01171209|Interferon-beta|interferon-beta|mesh-list
20407448|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
20407449|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
20407450|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407451|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
20407452|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378750|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
19378751|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378752|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19378753|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19378754|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20407453|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
20407454|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407455|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20407456|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20407457|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20407458|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407459|NCT01171326|Minocycline|minocycline|mesh-list
20407460|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20407461|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378755|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378756|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407462|NCT01171365|Ciclesonide|ciclesonide|mesh-list
20407463|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
20407464|NCT01171365|Hormones|hormones|mesh-ancestor
20407465|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407466|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378757|NCT04055753|Doxorubicin|doxorubicin|mesh-list
19378758|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19378759|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378760|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19378761|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19378762|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378763|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378764|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
19378765|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19378766|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
19378767|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
19378768|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378769|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402923|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
19402924|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19402925|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
19402926|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19402927|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
19402928|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402929|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407467|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20407468|NCT01171378|Ofatumumab|ofatumumab|mesh-list
20407469|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407470|NCT01171456|Metformin|metformin|mesh-list
20407471|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20407472|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407473|NCT01171469|Imiquimod|imiquimod|mesh-list
20407474|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19402930|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
19402931|NCT03605199|Denosumab|denosumab|mesh-list
19402932|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19402933|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402934|NCT03605173|Vitamin D|vitamin d|mesh-list
19402935|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
19402936|NCT03605173|Vitamins|vitamins|mesh-list
19402937|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
19402938|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402939|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19402940|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19402941|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
19402942|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
20407475|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
20407476|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407477|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407478|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
20407479|NCT01171482|Fluorouracil|fluorouracil|mesh-list
20407480|NCT01171482|Sorafenib|sorafenib|mesh-list
20407481|NCT01171482|Mitomycins|mitomycins|mesh-list
20407482|NCT01171482|Mitomycin|mitomycin|mesh-list
20407483|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
20407484|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407485|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20407486|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407487|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407488|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
19402943|NCT03605056|Dexamethasone|dexamethasone|mesh-list
19691279|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691280|NCT05006677|Vitamin K|vitamin k|mesh-list
19402944|NCT03605056|Lenalidomide|lenalidomide|mesh-list
20407489|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407490|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20407491|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213261|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20213262|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19691281|NCT05006677|Anticoagulants|anticoagulants|mesh-list
19691282|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19691283|NCT05006677|Vitamins|vitamins|mesh-ancestor
19691284|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
19691285|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691286|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19691287|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19691288|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691289|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
19691290|NCT05006677|Coagulants|coagulants|mesh-ancestor
19691291|NCT05006287|Warfarin|warfarin|mesh-list
19691292|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
19691293|NCT05006287|Dabigatran|dabigatran|mesh-list
19691294|NCT05006287|Apixaban|apixaban|mesh-list
19691295|NCT05006287|Edoxaban|edoxaban|mesh-list
19691296|NCT05006287|Anticoagulants|anticoagulants|mesh-list
19691297|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19691298|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
19691299|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19691300|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
19691301|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691302|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407492|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20407493|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
20407494|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20407495|NCT01171547|Daptomycin|daptomycin|mesh-list
20407496|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378772|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
19378773|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19378774|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
19378775|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19378776|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
19378777|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378778|NCT03911713|Ivacaftor|ivacaftor|mesh-list
20407497|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407498|NCT01171651|Sorafenib|sorafenib|mesh-list
20407499|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407500|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20407501|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407502|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407503|NCT01171755|Gemcitabine|gemcitabine|mesh-list
20407504|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20407505|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
20407506|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407507|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407508|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
20407509|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407510|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407511|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407512|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
20407513|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407514|NCT01171781|Cisplatin|cisplatin|mesh-list
20407515|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407516|NCT01171807|Dexamethasone|dexamethasone|mesh-list
20407517|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20407518|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378779|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19691303|NCT05006638|Atropine|atropine|mesh-list
19378780|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19691304|NCT05006638|Ondansetron|ondansetron|mesh-list
19691305|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
20213263|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213264|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20213265|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
20213266|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213267|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213268|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
20213269|NCT00295542|Protective Agents|protective agents|mesh-ancestor
20213270|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20213271|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213272|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20213273|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
20213274|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20213275|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20407519|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
20407520|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
19378781|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378782|NCT03852459|Ibuprofen|ibuprofen|mesh-list
19378783|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19378784|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19378785|NCT03852459|Analgesics|analgesics|mesh-ancestor
19378786|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
19378787|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378788|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407521|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407522|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407523|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407524|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
20407525|NCT01171807|Hormones|hormones|mesh-ancestor
20407526|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407527|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20407528|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407529|NCT01171833|Sevoflurane|sevoflurane|mesh-list
20407530|NCT01171833|Desflurane|desflurane|mesh-list
20407531|NCT01171833|Isoflurane|isoflurane|mesh-list
20407532|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20407533|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20407534|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
20407535|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
20407536|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407537|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407538|NCT01171859|Doxycycline|doxycycline|mesh-list
20407539|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19378789|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378790|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378791|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19378792|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378793|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378794|NCT03849768|Gefitinib|gefitinib|mesh-list
19378795|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378796|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378797|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378798|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378799|NCT03828799|Folfirinox|folfirinox|mesh-list
19378800|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378801|NCT03824808|Lidocaine|lidocaine|mesh-list
19378802|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378803|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
19378804|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378805|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378806|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
19378807|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378808|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19378809|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19378810|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19378811|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378812|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378813|NCT03808610|Cytarabine|cytarabine|mesh-list
19378814|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
19378815|NCT03808610|Dexamethasone|dexamethasone|mesh-list
19378816|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
19378817|NCT03808610|Prednisone|prednisone|mesh-list
19378818|NCT03808610|Cortisone|cortisone|mesh-list
19378819|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
19378820|NCT03808610|Rituximab|rituximab|mesh-list
19378821|NCT03808610|Methotrexate|methotrexate|mesh-list
19378822|NCT03808610|Vincristine|vincristine|mesh-list
19378823|NCT03808610|Asparaginase|asparaginase|mesh-list
19378824|NCT03808610|Venetoclax|venetoclax|mesh-list
19378825|NCT03808610|Pegaspargase|pegaspargase|mesh-list
19378826|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19378827|NCT03808610|Antibodies|antibodies|mesh-list
19378828|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
19378829|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20407540|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19378830|NCT03808610|BB 1101|bb 1101|mesh-list
19378831|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19378832|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
20407541|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407542|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
20407543|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19378833|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407544|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20407545|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
20407546|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20407547|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407548|NCT01171885|Ropivacaine|ropivacaine|mesh-list
20407549|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
20407550|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
20407551|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407552|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407553|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
20407554|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407555|NCT01171911|Nicardipine|nicardipine|mesh-list
20407556|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
19378834|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378835|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19378836|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
19378837|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378838|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378839|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19378840|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378841|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
19378842|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
19378843|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378844|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19378845|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
19378846|NCT03808610|Hormones|hormones|mesh-ancestor
19378847|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378848|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378849|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
19378850|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378851|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20407557|NCT01171911|Esmolol|esmolol|mesh-list
20407558|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20407559|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407560|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20407561|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20407562|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20407563|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
20407564|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407565|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407566|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19378852|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
19378853|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19378854|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19378855|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
19378856|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
19378857|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19378858|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19378859|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
19378860|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378861|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19378862|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19378863|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
19378864|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
19378865|NCT03797560|Pregabalin|pregabalin|mesh-list
19378866|NCT03797560|Analgesics|analgesics|mesh-ancestor
19378867|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
19378868|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378869|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378870|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
19378871|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19378872|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19378873|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378874|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19378875|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19378876|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19378877|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378878|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19378879|NCT03740919|Insulin|insulin|mesh-list
19378880|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19378881|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
19378882|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
19378883|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19378884|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407567|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20407568|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
19378885|NCT03737565|Tryptophan|tryptophan|mesh-list
19378886|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19378887|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
19378888|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19378889|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
19378890|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19378891|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378892|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378893|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19378894|NCT03708315|Analgesics|analgesics|mesh-ancestor
19378895|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
19378896|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378897|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19378898|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19378899|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19378900|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
19378901|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19378902|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378903|NCT03700970|Bupivacaine|bupivacaine|mesh-list
19378904|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
19378905|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
19378906|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19378907|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378908|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
19378909|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378910|NCT03686345|Midostaurin|midostaurin|mesh-list
19378911|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378912|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378913|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378914|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378915|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
19378916|NCT03684590|Narcotics|narcotics|mesh-ancestor
19378917|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407569|NCT01172002|Azathioprine|azathioprine|mesh-list
20407570|NCT01172002|Leflunomide|leflunomide|mesh-list
20407571|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
20407572|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407573|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20407574|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407575|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407576|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
20407577|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378918|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378919|NCT03684590|Analgesics|analgesics|mesh-ancestor
19378920|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
19378921|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378922|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
20407578|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20407579|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407580|NCT01172028|Docetaxel|docetaxel|mesh-list
20407581|NCT01172028|Pemetrexed|pemetrexed|mesh-list
20407582|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407583|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
20407584|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20407585|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
20407586|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407587|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407588|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20407589|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20407590|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20407591|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20407592|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378923|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20407593|NCT01172171|Melatonin|melatonin|mesh-list
20407594|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
20407595|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407596|NCT01172171|Protective Agents|protective agents|mesh-ancestor
20407597|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407598|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407599|NCT01172223|Paclitaxel|paclitaxel|mesh-list
20407600|NCT01172223|Doxorubicin|doxorubicin|mesh-list
19378924|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847511|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19847512|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19847513|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847514|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19847515|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19847516|NCT00686998|Olanzapine|olanzapine|mesh-list
19847517|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
19847518|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
19378925|NCT03672643|Crizotinib|crizotinib|mesh-list
19378926|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378927|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19378928|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378929|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378930|NCT03647488|Docetaxel|docetaxel|mesh-list
19378931|NCT03647488|Spartalizumab|spartalizumab|mesh-list
19378932|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378933|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
19378934|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
19378935|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
19378936|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378937|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19378938|NCT03632759|Liraglutide|liraglutide|mesh-list
19378939|NCT03632759|Golimumab|golimumab|mesh-list
19378940|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19378941|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378942|NCT03632759|Incretins|incretins|mesh-ancestor
19378943|NCT03632759|Hormones|hormones|mesh-ancestor
19378944|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378945|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19378946|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378947|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19378948|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
19378949|NCT03618537|Dexamethasone|dexamethasone|mesh-list
19378950|NCT03618537|Ixazomib|ixazomib|mesh-list
20407601|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20407602|NCT01172223|Lapatinib|lapatinib|mesh-list
20407603|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20407604|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407605|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
19378951|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378952|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
19378953|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
19378954|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19378955|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378956|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19378957|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
19378958|NCT03618537|Hormones|hormones|mesh-ancestor
19378959|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19378960|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19378961|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378962|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
19378963|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19378964|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378965|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
19378966|NCT03615105|Melphalan|melphalan|mesh-list
19378967|NCT03615105|Busulfan|busulfan|mesh-list
19847519|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847520|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847521|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847522|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19847523|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19378968|NCT03615105|Thiotepa|thiotepa|mesh-list
19378969|NCT03615105|Rituximab|rituximab|mesh-list
19378970|NCT03615105|Fludarabine|fludarabine|mesh-list
20217910|NCT00310908|Analgesics|analgesics|mesh-ancestor
19378971|NCT03615105|Clofarabine|clofarabine|mesh-list
19378972|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19378973|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
20217911|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
20217912|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217913|NCT00310921|Misoprostol|misoprostol|mesh-list
20217914|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20217915|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
20217916|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20217917|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217918|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20217919|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217920|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
19378974|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19378975|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
19378976|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19378977|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19378978|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19378979|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
19378980|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378981|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378982|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19378983|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19378984|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19378985|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
19378986|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
19378987|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19378988|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
19378989|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19378990|NCT03613532|Fludarabine|fludarabine|mesh-list
19378991|NCT03613532|Azacitidine|azacitidine|mesh-list
19378992|NCT03613532|Busulfan|busulfan|mesh-list
20407606|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
20407607|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
20407608|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407609|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20407610|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20407611|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20407612|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407613|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20407614|NCT01172236|Lactoferrin|lactoferrin|mesh-list
20407615|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19378993|NCT03613532|Decitabine|decitabine|mesh-list
19378994|NCT03613532|Venetoclax|venetoclax|mesh-list
19378995|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19378996|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19378997|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
19378998|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19378999|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379000|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
19379001|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379002|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379003|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
19379004|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379005|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379006|NCT03579160|Timolol|timolol|mesh-list
19379007|NCT03579160|Petrolatum|petrolatum|mesh-list
19379008|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19379009|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19379010|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
19379011|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379012|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379013|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379014|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19379015|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19379016|NCT03579160|Emollients|emollients|mesh-ancestor
19379017|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
19379018|NCT03556696|Remifentanil|remifentanil|mesh-list
20427310|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427311|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427312|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427313|NCT01286103|Canagliflozin|canagliflozin|mesh-list
20427314|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20427315|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427316|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427317|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427318|NCT01286194|Rabeprazole|rabeprazole|mesh-list
20427319|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20427320|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19379019|NCT03556696|Propofol|propofol|mesh-list
19379020|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19379021|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19379022|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379023|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19379024|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
19379025|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
19379026|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19379027|NCT03556696|Narcotics|narcotics|mesh-ancestor
19379028|NCT03556696|Analgesics|analgesics|mesh-ancestor
19379029|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
19379030|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379031|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
19379032|NCT03531736|Fludarabine|fludarabine|mesh-list
20407616|NCT01172392|Interferons|interferons|mesh-list
20407617|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
20407618|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
20407619|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20407620|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407621|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
20407622|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407623|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
20407624|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407625|NCT01172405|Ibuprofen|ibuprofen|mesh-list
20407626|NCT01172405|Caffeine|caffeine|mesh-list
20407627|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20407628|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20407629|NCT01172405|Analgesics|analgesics|mesh-ancestor
20407630|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
20407631|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407632|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407633|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407634|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20407635|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20407636|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379033|NCT03531736|Rituximab|rituximab|mesh-list
19379034|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19379035|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
19379036|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379037|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
19379038|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379039|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379040|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379041|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
19379042|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379043|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379044|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379045|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379046|NCT03514069|Temozolomide|temozolomide|mesh-list
19379047|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379048|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
19379049|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379050|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407637|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407638|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20407639|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19379051|NCT03513445|Epinephrine|epinephrine|mesh-list
19379052|NCT03513445|Morphine|morphine|mesh-list
19379053|NCT03513445|Ropivacaine|ropivacaine|mesh-list
19379054|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19379055|NCT03513445|Narcotics|narcotics|mesh-ancestor
19379056|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19379057|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379058|NCT03513445|Analgesics|analgesics|mesh-ancestor
19379059|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
19379060|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379061|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19379062|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19379063|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
19379064|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379065|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379066|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19379067|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19379068|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
19379069|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19379070|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
19379071|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
19379072|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
19379073|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19379074|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
19379075|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
19379076|NCT03511118|Metformin|metformin|mesh-list
19379077|NCT03511118|Topiramate|topiramate|mesh-list
19379078|NCT03511118|Azithromycin|azithromycin|mesh-list
19379079|NCT03511118|Doxycycline|doxycycline|mesh-list
19379080|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
19379081|NCT03511118|Levofloxacin|levofloxacin|mesh-list
19379082|NCT03511118|Clindamycin|clindamycin|mesh-list
19379083|NCT03511118|Valganciclovir|valganciclovir|mesh-list
19379084|NCT03511118|Remdesivir|remdesivir|mesh-list
19379085|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
19379086|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19379087|NCT03511118|Verapamil|verapamil|mesh-list
19379088|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19379089|NCT03511118|Labetalol|labetalol|mesh-list
19379090|NCT03511118|Nifedipine|nifedipine|mesh-list
19379091|NCT03511118|Furosemide|furosemide|mesh-list
19379092|NCT03511118|Sumatriptan|sumatriptan|mesh-list
20407640|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20407641|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20407642|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
20407643|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407644|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20407645|NCT01172431|Indapamide|indapamide|mesh-list
20407646|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20407647|NCT01172431|Diuretics|diuretics|mesh-ancestor
20407648|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
20407649|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407650|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19379093|NCT03511118|Oxycodone|oxycodone|mesh-list
19379094|NCT03511118|Gabapentin|gabapentin|mesh-list
19379095|NCT03511118|Ondansetron|ondansetron|mesh-list
19379096|NCT03511118|Trazodone|trazodone|mesh-list
19379097|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
19379098|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
19379099|NCT03511118|Methylphenidate|methylphenidate|mesh-list
19379100|NCT03511118|Citalopram|citalopram|mesh-list
19379101|NCT03511118|Sertraline|sertraline|mesh-list
19379102|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19379103|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
19379104|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19379105|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19379106|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379107|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19379108|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19379109|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
19379110|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379111|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19379112|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19379113|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379114|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19379115|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379116|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19379117|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19379118|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
19379119|NCT03511118|Coagulants|coagulants|mesh-ancestor
19379120|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19379121|NCT03511118|Narcotics|narcotics|mesh-ancestor
19379122|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19379123|NCT03511118|Analgesics|analgesics|mesh-ancestor
19379124|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
20407651|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20407652|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407653|NCT01172444|Mesalamine|mesalamine|mesh-list
20407654|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19379125|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379126|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
19379127|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19379128|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19379129|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19379130|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19379131|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19379132|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379133|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
19379134|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19379135|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19379136|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19379137|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
19379138|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19379139|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
19379140|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
19379141|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19379142|NCT03511118|Diuretics|diuretics|mesh-ancestor
19379143|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
19379144|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19379145|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19379146|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20407655|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20407656|NCT01172444|Analgesics|analgesics|mesh-ancestor
20407657|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
20407658|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407659|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407660|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407661|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20407662|NCT01172470|Gemcitabine|gemcitabine|mesh-list
20407663|NCT01172470|Carboplatin|carboplatin|mesh-list
20407664|NCT01172470|Pemetrexed|pemetrexed|mesh-list
20407665|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407666|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20407667|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
20407668|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407669|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
20407670|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407671|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407672|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407673|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
20407674|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407675|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20407676|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20407677|NCT01172496|Treprostinil|treprostinil|mesh-list
20407678|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19379147|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
19379148|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
19379149|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19379150|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
19379151|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
19379152|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19379153|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19379154|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
19379155|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19379156|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19379157|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19379158|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19379159|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379160|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19379161|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19379162|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19379163|NCT03511118|Renal Agents|renal agents|mesh-ancestor
19379164|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19379165|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19379166|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20407679|NCT01172509|Baclofen|baclofen|mesh-list
20407680|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20407681|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407682|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20407683|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407684|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20407685|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
20407686|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
20407687|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379167|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
19379168|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19379169|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19379170|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19379171|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
19379172|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
19379173|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19379174|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379175|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19379176|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19379177|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19379178|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
19379179|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19379180|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19379181|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19379182|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19847524|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407688|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407689|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
19379183|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
19379184|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
19379185|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19379186|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19379187|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19379188|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19379189|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19379190|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
19379191|NCT03498014|Narcotics|narcotics|mesh-ancestor
19379192|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19379193|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379194|NCT03498014|Analgesics|analgesics|mesh-ancestor
19379195|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
19379196|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379197|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
19379198|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379199|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19379200|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379201|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379202|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
19379203|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379204|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379205|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19379206|NCT03447262|Ivacaftor|ivacaftor|mesh-list
19379207|NCT03447262|VX-659|vx-659|mesh-list
19379208|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19379209|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19379210|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379211|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20213276|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20213277|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
20213278|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213279|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20213280|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
20213281|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19379212|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379213|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379214|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19402945|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19402946|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
19402947|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
19402948|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402949|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402950|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19402951|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
19402952|NCT03605056|Hormones|hormones|mesh-ancestor
19402953|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19402954|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19402955|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402956|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
19402957|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19402958|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19402959|NCT03605056|Growth Substances|growth substances|mesh-ancestor
19402960|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
19402961|NCT03604796|Acetaminophen|acetaminophen|mesh-list
19402962|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19402963|NCT03604796|Analgesics|analgesics|mesh-ancestor
19402964|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
19402965|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19402966|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402967|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
19402968|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19402969|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19402970|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402971|NCT03604744|Psilocybin|psilocybin|mesh-list
20407690|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402972|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
20213282|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
20213283|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
20213284|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213285|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20213286|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20407691|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379215|NCT03417180|Remifentanil|remifentanil|mesh-list
19379216|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19379217|NCT03417180|Narcotics|narcotics|mesh-ancestor
19379218|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19379219|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379220|NCT03417180|Analgesics|analgesics|mesh-ancestor
19379221|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
19379222|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213287|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20213288|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20213289|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20213290|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19379227|NCT03342196|Fludarabine|fludarabine|mesh-list
19379228|NCT03342196|Melphalan|melphalan|mesh-list
19379229|NCT03342196|Thiotepa|thiotepa|mesh-list
19379230|NCT03342196|Mitogens|mitogens|mesh-list
19379231|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379232|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379233|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407692|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407693|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407694|NCT01172626|Valproic Acid|valproic acid|mesh-list
20407695|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
20407696|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407697|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407698|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
20407699|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407700|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407701|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
19379234|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
19379235|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379236|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379237|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
19379238|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379239|NCT03342196|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379240|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
19379241|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379242|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379243|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
19379244|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379245|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379246|NCT03321188|Paclitaxel|paclitaxel|mesh-list
19379247|NCT03321188|Carboplatin|carboplatin|mesh-list
19379248|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19379249|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379250|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379251|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
19379252|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379253|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379254|NCT03315026|Siltuximab|siltuximab|mesh-list
19379255|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379256|NCT03311308|Metformin|metformin|mesh-list
19379257|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
19379258|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19379259|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379260|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379261|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379262|NCT03292133|Gefitinib|gefitinib|mesh-list
19379263|NCT03292133|Nazartinib|nazartinib|mesh-list
19379264|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379265|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379266|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379267|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379268|NCT03267589|Durvalumab|durvalumab|mesh-list
19379269|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379270|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379271|NCT03255096|Rituximab|rituximab|mesh-list
19379272|NCT03255096|Venetoclax|venetoclax|mesh-list
19379273|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20213291|NCT00295555|Doxazosin|doxazosin|mesh-list
20213292|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20213293|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20213294|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20213295|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20213296|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
20213297|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379274|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379275|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
19379276|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379277|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379278|NCT03233139|Ipilimumab|ipilimumab|mesh-list
19379279|NCT03233139|Cemiplimab|cemiplimab|mesh-list
19379280|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379281|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379282|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19379283|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379284|NCT03221751|Prazosin|prazosin|mesh-list
19379285|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19379286|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19379287|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19379288|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20407702|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20407703|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407704|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20407705|NCT01172652|Ziprasidone|ziprasidone|mesh-list
20407706|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20407707|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
20407708|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407709|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379289|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
19379290|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379291|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379292|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379293|NCT03191084|Dronabinol|dronabinol|mesh-list
19379294|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
19379295|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379296|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19379297|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19379298|NCT03191084|Analgesics|analgesics|mesh-ancestor
19379299|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
19379300|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379301|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19379302|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19379303|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379304|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379305|NCT03191084|Hormones|hormones|mesh-ancestor
19379306|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379307|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
19379308|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379309|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379310|NCT03184155|Nicardipine|nicardipine|mesh-list
19379311|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19379312|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19379313|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19379314|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379315|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19379316|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379317|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
19379318|NCT03161912|Aflibercept|aflibercept|mesh-list
19379319|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19379320|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19379321|NCT03161912|Growth Substances|growth substances|mesh-ancestor
19379322|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379323|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
19379324|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379325|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
19379326|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19379327|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19379328|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
19379329|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379330|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379331|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379332|NCT03149809|Urological Agents|urological agents|mesh-ancestor
19379333|NCT03104400|Adalimumab|adalimumab|mesh-list
19379334|NCT03104400|Upadacitinib|upadacitinib|mesh-list
19379335|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379336|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379337|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19691306|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
19379338|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379339|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379340|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379341|NCT03104374|Upadacitinib|upadacitinib|mesh-list
19379342|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19379343|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379344|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379345|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379346|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379347|NCT03098654|Metformin|metformin|mesh-list
19379348|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19379349|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379350|NCT03072043|Azacitidine|azacitidine|mesh-list
19379351|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379352|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
19379353|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379354|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379355|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379356|NCT03016013|Methotrexate|methotrexate|mesh-list
19379357|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19379358|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
19379359|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19379360|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379361|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379362|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
19379363|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379364|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379365|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
19379366|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379367|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19379368|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379369|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
19379370|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379371|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19379372|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
19379373|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
19379374|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19379375|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19379376|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379377|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379378|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379379|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379380|NCT03011307|Oxytocin|oxytocin|mesh-list
19379381|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
19379382|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19379383|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379384|NCT02970981|Nivolumab|nivolumab|mesh-list
19379385|NCT02970981|Ipilimumab|ipilimumab|mesh-list
19379386|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379387|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379388|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19379389|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379390|NCT02911935|Azithromycin|azithromycin|mesh-list
19379391|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19379392|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379393|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
19379394|NCT02909452|Entinostat|entinostat|mesh-list
19379395|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379396|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379397|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19379398|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379399|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379400|NCT02909036|Melphalan|melphalan|mesh-list
19379401|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379402|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
19379403|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379404|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379405|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379406|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379407|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
19379408|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379409|NCT02898506|Liraglutide|liraglutide|mesh-list
19379410|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19379411|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379412|NCT02898506|Incretins|incretins|mesh-ancestor
20407710|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407711|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20407712|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20407713|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407714|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20407715|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20407716|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
20407717|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
20407718|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20407719|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
19379413|NCT02898506|Hormones|hormones|mesh-ancestor
19379414|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379415|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
19379416|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
19379417|NCT02880293|Melphalan|melphalan|mesh-list
19379418|NCT02880293|Thiotepa|thiotepa|mesh-list
19379419|NCT02880293|Fludarabine|fludarabine|mesh-list
19379420|NCT02880293|Tacrolimus|tacrolimus|mesh-list
19379421|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407720|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407721|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407722|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20407723|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
20407724|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20407725|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
19379422|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
19379423|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379424|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379425|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379426|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
19379427|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379428|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379429|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379430|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19379431|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379432|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19379433|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19379434|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
19379435|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19379436|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379437|NCT02853500|Doxorubicin|doxorubicin|mesh-list
19379438|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19379439|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379440|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19379441|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19379442|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379443|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379444|NCT02842827|Tretinoin|tretinoin|mesh-list
19379445|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379446|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
19379447|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19379448|NCT02837029|Nivolumab|nivolumab|mesh-list
19379449|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379450|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379451|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19379452|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379453|NCT02819635|Upadacitinib|upadacitinib|mesh-list
19379454|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19379455|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379456|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379457|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379458|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379459|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
19379460|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19379461|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19379462|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
19379463|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19379464|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379465|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
19379466|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
19379467|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379468|NCT02740127|Dexamethasone|dexamethasone|mesh-list
20407726|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379469|NCT02740127|Clonidine|clonidine|mesh-list
19379470|NCT02740127|Epinephrine|epinephrine|mesh-list
19379471|NCT02740127|Propofol|propofol|mesh-list
19379472|NCT02740127|Ropivacaine|ropivacaine|mesh-list
19379473|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379474|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
19379475|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
19379476|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379477|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379478|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19379479|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
19379480|NCT02740127|Hormones|hormones|mesh-ancestor
19379481|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379482|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19379483|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379484|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379485|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19379486|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19379487|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19379488|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
19379489|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
19379490|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
19379491|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
20407727|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407728|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20407729|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
19379492|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19379493|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19379494|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
19379495|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379496|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19379497|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19379498|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19379499|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
19379500|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
19379501|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
19379502|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19379503|NCT02740127|Analgesics|analgesics|mesh-ancestor
19379504|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19379505|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
19379506|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20407730|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
20407731|NCT01172691|Protective Agents|protective agents|mesh-ancestor
20407732|NCT01172717|Panitumumab|panitumumab|mesh-list
20407733|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20407734|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407735|NCT01172756|Riociguat|riociguat|mesh-list
20213298|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213299|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213300|NCT00295594|Tacrolimus|tacrolimus|mesh-list
20213301|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213302|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
20213303|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213304|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20213305|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213306|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213307|NCT00295607|Antibodies|antibodies|mesh-list
20213308|NCT00295607|Tacrolimus|tacrolimus|mesh-list
20213309|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
20407736|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
20407737|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407738|NCT01172769|Sirolimus|sirolimus|mesh-list
20407739|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
20407740|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20407741|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379507|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
19379508|NCT02737475|Nivolumab|nivolumab|mesh-list
19379509|NCT02737475|Ipilimumab|ipilimumab|mesh-list
19379510|NCT02737475|Vaccines|vaccines|mesh-list
19379511|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
19379512|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379513|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379514|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691307|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
20407742|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20407743|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379515|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379516|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
20407744|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
20407745|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407746|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
20407747|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407748|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379517|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379518|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379519|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379520|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379521|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19379522|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
20407749|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407750|NCT01172782|Hydromorphone|hydromorphone|mesh-list
20407751|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20407752|NCT01172782|Narcotics|narcotics|mesh-ancestor
20407753|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407754|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407755|NCT01172782|Analgesics|analgesics|mesh-ancestor
20407756|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
20407757|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407758|NCT01172912|Dexamethasone|dexamethasone|mesh-list
20407759|NCT01172912|Carboplatin|carboplatin|mesh-list
20407760|NCT01172912|Etoposide|etoposide|mesh-list
20407761|NCT01172912|Ifosfamide|ifosfamide|mesh-list
20407762|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407763|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407764|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
20407765|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
20407766|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379523|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379524|NCT02709512|Cisplatin|cisplatin|mesh-list
19379525|NCT02709512|Pemetrexed|pemetrexed|mesh-list
19379526|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379527|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379528|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379529|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19379530|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19379531|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
19379532|NCT02703714|Sargramostim|sargramostim|mesh-list
19379533|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379534|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379535|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
19379536|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407767|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407768|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407769|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
20407770|NCT01172912|Hormones|hormones|mesh-ancestor
20407771|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407772|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20407773|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20407774|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20407775|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20407776|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379537|NCT02689440|Dasatinib|dasatinib|mesh-list
19379538|NCT02689440|Venetoclax|venetoclax|mesh-list
19379539|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379540|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379541|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379542|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379543|NCT02684006|Sunitinib|sunitinib|mesh-list
19379544|NCT02684006|Avelumab|avelumab|mesh-list
19379545|NCT02684006|Axitinib|axitinib|mesh-list
19379546|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379547|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19379548|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19379549|NCT02684006|Growth Substances|growth substances|mesh-ancestor
19379550|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379551|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
19379552|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379553|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379554|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691308|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
20407777|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407778|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20407779|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
19379555|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379556|NCT02642965|Cytarabine|cytarabine|mesh-list
19379557|NCT02642965|Fludarabine|fludarabine|mesh-list
19379558|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
19379559|NCT02642965|Daunorubicin|daunorubicin|mesh-list
19379560|NCT02642965|Lenograstim|lenograstim|mesh-list
19379561|NCT02642965|Sargramostim|sargramostim|mesh-list
19379562|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379563|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379564|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
19379565|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379566|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379567|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
19379568|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379569|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
19379570|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379571|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19379572|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19379573|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19379574|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19379575|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402973|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402974|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19402975|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19402976|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19402977|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
19402978|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402979|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402980|NCT03604653|Cisplatin|cisplatin|mesh-list
19402981|NCT03604653|Doxorubicin|doxorubicin|mesh-list
19402982|NCT03604653|Mitomycins|mitomycins|mesh-list
19402983|NCT03604653|Mitomycin|mitomycin|mesh-list
19402984|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19402985|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19402986|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19402987|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19402988|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19402989|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19402990|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
19402991|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19402992|NCT03604627|Calcium|calcium|mesh-list
19402993|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19402994|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19402995|NCT03604575|Insulin|insulin|mesh-list
19402996|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19402997|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
19402998|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19402999|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403000|NCT03604471|Atorvastatin|atorvastatin|mesh-list
19403001|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19403002|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19403003|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
19403004|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403005|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19403006|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19403007|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403008|NCT03604419|Metformin|metformin|mesh-list
19403009|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19403010|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403011|NCT03604354|Pregabalin|pregabalin|mesh-list
19403012|NCT03604354|Tapentadol|tapentadol|mesh-list
19403013|NCT03604354|Analgesics|analgesics|mesh-ancestor
19403014|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
19403015|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403016|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403017|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
19403018|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19403019|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403020|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403021|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19403022|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19403023|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19403024|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403025|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19403026|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19403027|NCT03604354|Narcotics|narcotics|mesh-ancestor
20407780|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
20407781|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20407782|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
20407783|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407784|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407785|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20407786|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
20407787|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
20407788|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20407789|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
20407790|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407791|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407792|NCT01172964|Flucytosine|flucytosine|mesh-list
20407793|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
20407794|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407795|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
20407796|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407797|NCT01173003|Misoprostol|misoprostol|mesh-list
20407798|NCT01173003|Mifepristone|mifepristone|mesh-list
20407799|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20407800|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
20407801|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20407802|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407803|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19379576|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
19379577|NCT02638090|Vorinostat|vorinostat|mesh-list
19379578|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379579|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379580|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19379581|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379582|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379583|NCT02632175|Adalimumab|adalimumab|mesh-list
19379584|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379585|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379586|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
19379587|NCT02629809|Fludarabine|fludarabine|mesh-list
19379588|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
19379589|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
19379590|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379591|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
19379592|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379593|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379594|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379595|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
19379596|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379597|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379598|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379599|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379600|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
19379601|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379602|NCT02629159|Adalimumab|adalimumab|mesh-list
19379603|NCT02629159|Upadacitinib|upadacitinib|mesh-list
19379604|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379605|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379606|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19379607|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379608|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379609|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379610|NCT02611232|Liraglutide|liraglutide|mesh-list
19379611|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19379612|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379613|NCT02611232|Incretins|incretins|mesh-ancestor
20213310|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213311|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213312|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20213313|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213314|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379614|NCT02611232|Hormones|hormones|mesh-ancestor
20217921|NCT00310934|Buprenorphine|buprenorphine|mesh-list
19379615|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379616|NCT02604433|Luspatercept|luspatercept|mesh-list
19379617|NCT02604433|Hematinics|hematinics|mesh-ancestor
19379618|NCT02598895|Carboplatin|carboplatin|mesh-list
19379619|NCT02598895|Docetaxel|docetaxel|mesh-list
19379620|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379621|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379622|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
19379623|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379624|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379625|NCT02582775|Vidarabine|vidarabine|mesh-list
19379626|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
19379627|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
19379628|NCT02582775|Busulfan|busulfan|mesh-list
19379629|NCT02582775|Fludarabine|fludarabine|mesh-list
19379630|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
19379631|NCT02582775|Tacrolimus|tacrolimus|mesh-list
19379632|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
19379633|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19379634|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379635|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
19379636|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379637|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379638|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379639|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
19379640|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379641|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379642|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379643|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379644|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
19379645|NCT02582775|Antiviral Agents|antiviral agents|mesh-ancestor
19379646|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379647|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19379648|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379649|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19379650|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19379651|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
19379652|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19379653|NCT02570542|Cytarabine|cytarabine|mesh-list
19379654|NCT02570542|Plerixafor|plerixafor|mesh-list
19379655|NCT02570542|Etoposide|etoposide|mesh-list
19379656|NCT02570542|Melphalan|melphalan|mesh-list
19379657|NCT02570542|Carmustine|carmustine|mesh-list
19379658|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19379659|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379660|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19379661|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19379662|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379663|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379664|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379665|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
19379666|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
19379667|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379668|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379669|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
19379670|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379671|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379672|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
20213331|NCT00295672|Vinorelbine|vinorelbine|mesh-list
20213332|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20213333|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213334|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379673|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379674|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19379675|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19379676|NCT02537418|Durvalumab|durvalumab|mesh-list
19379677|NCT02537418|Tremelimumab|tremelimumab|mesh-list
19379678|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379679|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379680|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
19379681|NCT02519738|Triamcinolone|triamcinolone|mesh-list
19379682|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19379683|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379684|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
19379685|NCT02519738|Hormones|hormones|mesh-ancestor
20407804|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20407805|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
20407806|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20407807|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20407808|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20407809|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20407810|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
20407811|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20407812|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20407813|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
20407814|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407815|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
20407816|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20407817|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20407818|NCT01173068|Ertapenem|ertapenem|mesh-list
20407819|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20407820|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379686|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379687|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379688|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379689|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
19379690|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19379691|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379692|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19379693|NCT02430077|Cathartics|cathartics|mesh-ancestor
19379694|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19379695|NCT02420821|Bevacizumab|bevacizumab|mesh-list
19379696|NCT02420821|Sunitinib|sunitinib|mesh-list
19379697|NCT02420821|Atezolizumab|atezolizumab|mesh-list
20407821|NCT01173081|Teriparatide|teriparatide|mesh-list
20407822|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20407823|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379698|NCT02420821|Antibodies|antibodies|mesh-list
19379699|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19379700|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379701|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379702|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19379703|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19379704|NCT02420821|Growth Substances|growth substances|mesh-ancestor
19379705|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379706|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
19379707|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
19379708|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379709|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379710|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407824|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20407825|NCT01173107|Colchicine|colchicine|mesh-list
20407826|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
20407827|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20407828|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379711|NCT02412670|Gemcitabine|gemcitabine|mesh-list
19379712|NCT02412670|Cisplatin|cisplatin|mesh-list
19379713|NCT02412670|Carboplatin|carboplatin|mesh-list
19379714|NCT02412670|Doxorubicin|doxorubicin|mesh-list
19379715|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19379716|NCT02412670|Methotrexate|methotrexate|mesh-list
19379717|NCT02412670|Vinblastine|vinblastine|mesh-list
19379718|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407829|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
20407830|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379719|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379720|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
19379721|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379722|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
19379723|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379724|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379725|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379726|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
19379727|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379728|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20407831|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407832|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407833|NCT01173172|Boron|boron|mesh-list
20407834|NCT01173172|Trace Elements|trace elements|mesh-ancestor
20407835|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
20407836|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407837|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20407838|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
20407839|NCT01173263|Propofol|propofol|mesh-list
20407840|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20407841|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407842|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407843|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20407844|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
20407845|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
20407846|NCT01173315|Vitamins|vitamins|mesh-list
20407847|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
19379729|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19379730|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19379731|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19379732|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
19379733|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19379734|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19379735|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19379736|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379737|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19379738|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19379739|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379740|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
19379741|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379742|NCT02410343|Hormones|hormones|mesh-list
19379743|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379744|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379745|NCT02370329|Interferons|interferons|mesh-list
19379746|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
19379747|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
20407848|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407849|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
20407850|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20407851|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20407852|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20407853|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20407854|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
20407855|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407856|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19379748|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19379749|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19379750|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379751|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
19379752|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379753|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
19379754|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379755|NCT02343224|Interferons|interferons|mesh-list
19379756|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
19379757|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
19847525|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19847526|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20407857|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20407858|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407859|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847527|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19847528|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847529|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847530|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847531|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
19847532|NCT00687076|Aspirin|aspirin|mesh-list
19847533|NCT00687076|Niacin|niacin|mesh-list
19847534|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
19847535|NCT00687076|Clopidogrel|clopidogrel|mesh-list
19847536|NCT00687076|Ezetimibe|ezetimibe|mesh-list
19379758|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19847537|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20407860|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20407861|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20407862|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
20407863|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20407864|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407865|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20407866|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20407867|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407868|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407869|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407870|NCT01173549|Canagliflozin|canagliflozin|mesh-list
20407871|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20407872|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407873|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19379759|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379760|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
19379761|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379762|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
19379763|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379764|NCT02339740|Vitamins|vitamins|mesh-list
19379765|NCT02339740|Vitamin A|vitamin a|mesh-list
19379766|NCT02339740|Cytarabine|cytarabine|mesh-list
19379767|NCT02339740|Dexamethasone|dexamethasone|mesh-list
19379768|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
19379769|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
19379770|NCT02339740|Idarubicin|idarubicin|mesh-list
19379771|NCT02339740|Tretinoin|tretinoin|mesh-list
19379772|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
19379773|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
19379774|NCT02339740|BB 1101|bb 1101|mesh-list
19379775|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
19379776|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379777|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379778|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
19379779|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
19379780|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379781|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19379782|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
19379783|NCT02339740|Hormones|hormones|mesh-ancestor
19379784|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379785|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19379786|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379787|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
19379788|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379789|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379790|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379791|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
19379792|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
19379793|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379794|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379795|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
19379796|NCT02339740|Analgesics|analgesics|mesh-ancestor
19379797|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
19379798|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20407874|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407875|NCT01173562|Mebendazole|mebendazole|mesh-list
20407876|NCT01173562|Piperazine|piperazine|mesh-list
20407877|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
20407878|NCT01173562|DMP 777|dmp 777|mesh-list
20407879|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
20407880|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
20407881|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20407882|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407883|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
20407884|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
20407885|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
20407886|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407887|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407888|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379799|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19379800|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19379801|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
19379802|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
20407889|NCT01173627|Fentanyl|fentanyl|mesh-list
19379803|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
19379804|NCT02339740|Protective Agents|protective agents|mesh-ancestor
19379805|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20407890|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19379806|NCT02291445|Peppermint oil|peppermint oil|mesh-list
20407891|NCT01173627|Narcotics|narcotics|mesh-ancestor
20407892|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407893|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407894|NCT01173627|Analgesics|analgesics|mesh-ancestor
20407895|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
20407896|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407897|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20407898|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20407899|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
20407900|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
20407901|NCT01173640|Midazolam|midazolam|mesh-list
20407902|NCT01173640|Resveratrol|resveratrol|mesh-list
20407903|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20407904|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20407905|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20407906|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407907|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20407908|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20407909|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20407910|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20407911|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
20407912|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
20407913|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
20407914|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
20407915|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20407916|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407917|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
20407918|NCT01173640|Protective Agents|protective agents|mesh-ancestor
20407919|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407920|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20407921|NCT01173809|Amiodarone|amiodarone|mesh-list
20407922|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20407923|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
20407924|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20407925|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20407926|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407927|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20407928|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20407929|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20407930|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407931|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20407932|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20407933|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20407934|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
20407935|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407936|NCT01173926|Insulin|insulin|mesh-list
20407937|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20407938|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
20407939|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
20407940|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20407941|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20407942|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407943|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20407944|NCT01173939|Pravastatin|pravastatin|mesh-list
20407945|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20407946|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20407947|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
20407948|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407949|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20407950|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20407951|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407952|NCT01173978|Prednisolone|prednisolone|mesh-list
20407953|NCT01173978|Hormones|hormones|mesh-list
19379807|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
19379808|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
19379809|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379810|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379811|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19379812|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
19379813|NCT02262026|Saracatinib|saracatinib|mesh-list
20407954|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407955|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407956|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379814|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379815|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379816|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379817|NCT02159989|Aflibercept|aflibercept|mesh-list
19379818|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
20407957|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
20407958|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20407959|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427321|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20427322|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427323|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427324|NCT01286233|Metformin|metformin|mesh-list
20427325|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427326|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427327|NCT01286246|Progesterone|progesterone|mesh-list
20427328|NCT01286246|Progestins|progestins|mesh-ancestor
20427329|NCT01286246|Hormones|hormones|mesh-ancestor
20427330|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427331|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427332|NCT01286584|Varenicline|varenicline|mesh-list
20427333|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20427334|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20427335|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
20427336|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427337|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427338|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427339|NCT01286688|Terbinafine|terbinafine|mesh-list
20427340|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
20427341|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427342|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427343|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427344|NCT01286701|Terbinafine|terbinafine|mesh-list
20427345|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
20427346|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427347|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427348|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427349|NCT01286766|Cisplatin|cisplatin|mesh-list
20427350|NCT01286766|Docetaxel|docetaxel|mesh-list
20427351|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427352|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379819|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19379820|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19379821|NCT02159989|Growth Substances|growth substances|mesh-ancestor
19379822|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379823|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
19379824|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379825|NCT02124902|Carboplatin|carboplatin|mesh-list
19379826|NCT02124902|Docetaxel|docetaxel|mesh-list
19379827|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379828|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379829|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
19379830|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379831|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379832|NCT02113878|Cisplatin|cisplatin|mesh-list
19379833|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379834|NCT02097680|Letrozole|letrozole|mesh-list
19379835|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379836|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19379837|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20427353|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
20427354|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
20427355|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428684|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20428685|NCT01293266|Propofol|propofol|mesh-list
20428686|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20428687|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428688|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428689|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20428690|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
20428691|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
20428692|NCT01293292|Teriparatide|teriparatide|mesh-list
20428693|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19379838|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379839|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379840|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20428694|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379841|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
19379842|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379843|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379844|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19379845|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
19379846|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379847|NCT01995578|Azacitidine|azacitidine|mesh-list
19379848|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19379849|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
19379850|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379851|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379852|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379853|NCT01986075|Amphetamine|amphetamine|mesh-list
19379854|NCT01986075|Adderall|adderall|mesh-list
19379855|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19379856|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379857|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
19379858|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
20407960|NCT01174017|Iodine|iodine|mesh-list
20407961|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
20407962|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19379859|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379860|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
20213335|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
20213336|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
20213337|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213338|NCT00295685|Antacids|antacids|mesh-list
20213339|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407963|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407964|NCT01174017|Trace Elements|trace elements|mesh-ancestor
20407965|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
20407966|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407967|NCT01174056|Pioglitazone|pioglitazone|mesh-list
20407968|NCT01174056|Zileuton|zileuton|mesh-list
20213340|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20213341|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
20213342|NCT00295698|Filaricides|filaricides|mesh-ancestor
20213343|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
20213344|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
20213345|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20213346|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213347|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20213348|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213349|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213350|NCT00295776|Lamotrigine|lamotrigine|mesh-list
20213351|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
20213352|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20213353|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213354|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213355|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20213356|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213357|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20213358|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20213359|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213360|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213361|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20213362|NCT00295789|Paclitaxel|paclitaxel|mesh-list
20213363|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20213364|NCT00295789|Carboplatin|carboplatin|mesh-list
20213365|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19379861|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379862|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379863|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
19379864|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19379865|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19379866|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19379867|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19379868|NCT01935466|Pioglitazone|pioglitazone|mesh-list
19379869|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19379870|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379871|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19379872|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19379873|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379874|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407969|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
20407970|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20407971|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407972|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20407973|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20407974|NCT01174056|Analgesics|analgesics|mesh-ancestor
20407975|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
20407976|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20407977|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20407978|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20407979|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20407980|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20407981|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20407982|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19379875|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379876|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19379877|NCT01759836|Atorvastatin|atorvastatin|mesh-list
19379878|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19379879|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19379880|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
19379881|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379882|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19379883|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19379884|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379885|NCT01758328|Fludarabine|fludarabine|mesh-list
19379886|NCT01758328|Melphalan|melphalan|mesh-list
20407983|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
20407984|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20407985|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407986|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
20407987|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20407988|NCT01174199|Sirolimus|sirolimus|mesh-list
20407989|NCT01174199|Vorinostat|vorinostat|mesh-list
20407990|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19379887|NCT01758328|Busulfan|busulfan|mesh-list
19379888|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19379889|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379890|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213366|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213367|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
20213368|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
19379891|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379892|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
19379893|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379894|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379895|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
19379896|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379897|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
19379898|NCT01746849|Thiotepa|thiotepa|mesh-list
19379899|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379900|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
19379901|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379902|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379903|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379904|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
19379905|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379906|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847538|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20213369|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
20213370|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213371|NCT00295815|Lomustine|lomustine|mesh-list
20213372|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20213373|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
20213374|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213375|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213376|NCT00295841|Cytarabine|cytarabine|mesh-list
20213377|NCT00295841|Clofarabine|clofarabine|mesh-list
20213378|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213379|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
20213380|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213381|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213382|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
20213383|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213384|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379907|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379908|NCT01745588|Clarithromycin|clarithromycin|mesh-list
19379909|NCT01745588|Dexamethasone|dexamethasone|mesh-list
19379910|NCT01745588|Pomalidomide|pomalidomide|mesh-list
19379911|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19379912|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
19379913|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
19379914|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379915|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379916|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19379917|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
19379918|NCT01745588|Hormones|hormones|mesh-ancestor
19379919|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19379920|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19379921|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379922|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19379923|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19379924|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19379925|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379926|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379927|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19379928|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19379929|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
19379930|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19379931|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19379932|NCT01745588|Growth Substances|growth substances|mesh-ancestor
19379933|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
19379934|NCT01701674|Aldesleukin|aldesleukin|mesh-list
19379935|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
19379936|NCT01701674|Fludarabine|fludarabine|mesh-list
19379937|NCT01701674|Ipilimumab|ipilimumab|mesh-list
20407991|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20407992|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20407993|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20407994|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
20407995|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20407996|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
20407997|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20407998|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19379938|NCT01701674|Interleukin-2|interleukin-2|mesh-list
19379939|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19379940|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
19379941|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379942|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19379943|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19379944|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
19379945|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379946|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379947|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19379948|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19379949|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19379950|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19379951|NCT01701674|Analgesics|analgesics|mesh-ancestor
19379952|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
19379953|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19379954|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19379955|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19379956|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
19379957|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213385|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
20213386|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213387|NCT00295893|Paclitaxel|paclitaxel|mesh-list
20213388|NCT00295893|Docetaxel|docetaxel|mesh-list
20213389|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
20213390|NCT00295893|Carboplatin|carboplatin|mesh-list
20213391|NCT00295893|Doxorubicin|doxorubicin|mesh-list
20213392|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20213393|NCT00295893|Trastuzumab|trastuzumab|mesh-list
20213394|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20213395|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213396|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
20213397|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
20213398|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
20407999|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408000|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408001|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20408002|NCT01174212|Vancomycin|vancomycin|mesh-list
19379958|NCT01318486|Heparin|heparin|mesh-list
20408003|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20408004|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408005|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
20408006|NCT01174290|Haloperidol|haloperidol|mesh-list
19379959|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
20408007|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
20408008|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
20408009|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
20408010|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408011|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408012|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408013|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20408014|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20408015|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408016|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20408017|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20408018|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
20408019|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408020|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408021|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20408022|NCT01174303|Insulin|insulin|mesh-list
20408023|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20408024|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
20408025|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
20408026|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20408027|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
20408028|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19379960|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19379961|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19379962|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379963|NCT01064479|Cisplatin|cisplatin|mesh-list
19379964|NCT01064479|Carboplatin|carboplatin|mesh-list
19379965|NCT01064479|Docetaxel|docetaxel|mesh-list
19379966|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20408029|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20408030|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408031|NCT01174394|Fluoxetine|fluoxetine|mesh-list
20408032|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20408033|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20408034|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19379967|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379968|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379969|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
19379970|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379971|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379972|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19379973|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379974|NCT01042522|Paclitaxel|paclitaxel|mesh-list
19379975|NCT01042522|Etoposide|etoposide|mesh-list
19379976|NCT01042522|Cisplatin|cisplatin|mesh-list
19379977|NCT01042522|Carboplatin|carboplatin|mesh-list
19379978|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19379979|NCT01042522|Bleomycin|bleomycin|mesh-list
19379980|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
19379981|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19379982|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19379983|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
19379984|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
19379985|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
19379986|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19379987|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19379988|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19379989|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19379990|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19691309|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691310|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691311|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691312|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
19691313|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
19691314|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19691315|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
19379991|NCT00958737|Leucovorin|leucovorin|mesh-list
19691316|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19379992|NCT00958737|Fluorouracil|fluorouracil|mesh-list
19379993|NCT00958737|Capecitabine|capecitabine|mesh-list
19379994|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
19379995|NCT00958737|Calcium|calcium|mesh-list
19379996|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
19379997|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19379998|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19379999|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
19380000|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380001|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380002|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380003|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380004|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
19380005|NCT00958737|Antidotes|antidotes|mesh-ancestor
19380006|NCT00958737|Protective Agents|protective agents|mesh-ancestor
19380007|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
19380008|NCT00958737|Vitamins|vitamins|mesh-ancestor
19380009|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
19380010|NCT00826462|Triamcinolone|triamcinolone|mesh-list
19380011|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19380012|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19380013|NCT00826462|Naproxen|naproxen|mesh-list
20408035|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408036|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408037|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
20408038|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408039|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20408040|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
20408041|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20408042|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20408043|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20408044|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408045|NCT01174420|Mitomycins|mitomycins|mesh-list
20408046|NCT01174420|Mitomycin|mitomycin|mesh-list
20408047|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20408048|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408049|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
20408050|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408051|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20408052|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408053|NCT01174472|Paclitaxel|paclitaxel|mesh-list
20408054|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20408055|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408056|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
20408057|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
20408058|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20408059|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408060|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20408061|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19380014|NCT00826462|Lidocaine|lidocaine|mesh-list
19380015|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19380016|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
19380017|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
19380018|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380019|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380020|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
19380021|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380022|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19380023|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19380024|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19380025|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19380026|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380027|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380028|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
19380029|NCT00826462|Hormones|hormones|mesh-ancestor
19380030|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19380031|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408062|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20408063|NCT01174524|Gestodene|gestodene|mesh-list
20408064|NCT01174524|Femovan|femovan|mesh-list
20408065|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
20408066|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
20408067|NCT01174524|Estradiol|estradiol|mesh-list
20408068|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20408069|NCT01174524|Estrogens|estrogens|mesh-ancestor
19380032|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
19380033|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408070|NCT01174524|Hormones|hormones|mesh-ancestor
20427356|NCT01286857|Silicon|silicon|mesh-list
20408071|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408072|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408073|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20408074|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20408075|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20408076|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20408077|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19380034|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19380035|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19380036|NCT00826462|Analgesics|analgesics|mesh-ancestor
19380037|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380038|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
19380039|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19380040|NCT00710970|Tamoxifen|tamoxifen|mesh-list
20408078|NCT01174524|Progestins|progestins|mesh-ancestor
20408079|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20408080|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20408081|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408082|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20408083|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408084|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213399|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213400|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213401|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
20213402|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213403|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213404|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20213405|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
20213406|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20213407|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20213408|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20408085|NCT01174693|Clopidogrel|clopidogrel|mesh-list
20408086|NCT01174693|Triflusal|triflusal|mesh-list
20408087|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20408088|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20408089|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19380041|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19380042|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19380043|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
19380044|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19380045|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380046|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19380047|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380048|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19380049|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19380050|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20408090|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20408091|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
20408092|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408093|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408094|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380051|NCT00685919|Carbidopa|carbidopa|mesh-list
19380052|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19380053|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19380054|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
19380055|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380056|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380057|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408095|NCT01174810|Exenatide|exenatide|mesh-list
20408096|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20408097|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408098|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20408099|NCT01174810|Incretins|incretins|mesh-ancestor
20408100|NCT01174810|Hormones|hormones|mesh-ancestor
20408101|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408102|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20408103|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
20408104|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408105|NCT01174888|Cytarabine|cytarabine|mesh-list
20408106|NCT01174888|Etoposide|etoposide|mesh-list
20408107|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
19847539|NCT00687076|Analgesics|analgesics|mesh-ancestor
19380058|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19380059|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380060|NCT00574496|Gemcitabine|gemcitabine|mesh-list
19380061|NCT00574496|Cyclosporine|cyclosporine|mesh-list
19380062|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
19380063|NCT00574496|Prednisone|prednisone|mesh-list
19380064|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
20408108|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
20408109|NCT01174888|Bortezomib|bortezomib|mesh-list
20408110|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
20408111|NCT01174888|Midostaurin|midostaurin|mesh-list
20408112|NCT01174888|Staurosporine|staurosporine|mesh-list
19380065|NCT00574496|Melphalan|melphalan|mesh-list
19380066|NCT00574496|Ifosfamide|ifosfamide|mesh-list
19380067|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
19380068|NCT00574496|Methotrexate|methotrexate|mesh-list
19380069|NCT00574496|Fludarabine|fludarabine|mesh-list
19380070|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
19380071|NCT00574496|Vincristine|vincristine|mesh-list
19380072|NCT00574496|Vinorelbine|vinorelbine|mesh-list
19380073|NCT00574496|Procarbazine|procarbazine|mesh-list
19380074|NCT00574496|Cyclosporins|cyclosporins|mesh-list
19380075|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380076|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
19380077|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380078|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20408113|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20408114|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408115|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20408116|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20408117|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380079|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19380080|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
19380081|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380082|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380083|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19380084|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380085|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
19380086|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
19380087|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380088|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380089|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380090|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
19380091|NCT00574496|Hormones|hormones|mesh-ancestor
19380092|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19380093|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19380094|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19380095|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
19380096|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19380097|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
19380098|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19380099|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19380100|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19380101|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
20408118|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380102|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380103|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380104|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
19380105|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19380106|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19380107|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19380108|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
19380109|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19380110|NCT00344487|Ritonavir|ritonavir|mesh-list
19380111|NCT00344487|Lopinavir|lopinavir|mesh-list
19380112|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19380113|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19380114|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
19380115|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380116|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380117|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19380118|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19380119|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
19380120|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380121|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19380122|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19380123|NCT00281658|Paclitaxel|paclitaxel|mesh-list
20408119|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380124|NCT00281658|Lapatinib|lapatinib|mesh-list
19380125|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19380126|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380127|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380128|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380129|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380130|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380131|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19380132|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403028|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19403029|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19403030|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403031|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403032|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
19403033|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19403034|NCT03604315|Fluorides|fluorides|mesh-list
19403035|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19403036|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403037|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
19403038|NCT03604315|Protective Agents|protective agents|mesh-ancestor
19403039|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403040|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
19403041|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
19403042|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403043|NCT03604224|Canagliflozin|canagliflozin|mesh-list
19403044|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19403045|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403046|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19403047|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403048|NCT03604016|Tenofovir|tenofovir|mesh-list
19403049|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
19403050|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403051|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19403052|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19403053|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403054|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403055|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19403056|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19403057|NCT03604003|Losartan|losartan|mesh-list
19403058|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19403059|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19403060|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19403061|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19403062|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403063|NCT03603938|Losartan|losartan|mesh-list
19403064|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19403065|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20408120|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
20408121|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
20408122|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408123|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408124|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
20408125|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408126|NCT01174888|Analgesics|analgesics|mesh-ancestor
20408127|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
19403066|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19403067|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20408128|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408129|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
20408130|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
20408131|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
20408132|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
20408133|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
20408134|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20408135|NCT01174914|Tenofovir|tenofovir|mesh-list
19403068|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403069|NCT03603899|Xenon|xenon|mesh-list
19403070|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19403071|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
19403072|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
19403073|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403074|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403075|NCT03603834|Leucovorin|leucovorin|mesh-list
19403076|NCT03603834|Fluorouracil|fluorouracil|mesh-list
20408136|NCT01174914|Lamivudine|lamivudine|mesh-list
19380133|NCT05209529|Durvalumab|durvalumab|mesh-list
19380134|NCT05209529|Olaparib|olaparib|mesh-list
19380135|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380136|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408137|NCT01174914|Emtricitabine|emtricitabine|mesh-list
20408138|NCT01174914|Efavirenz|efavirenz|mesh-list
20408139|NCT01174914|Lopinavir|lopinavir|mesh-list
20408140|NCT01174914|Nevirapine|nevirapine|mesh-list
20408141|NCT01174914|Stavudine|stavudine|mesh-list
20408142|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
20408143|NCT01174914|Naltrexone|naltrexone|mesh-list
20408144|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
20408145|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408146|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20408147|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20408148|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408149|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408150|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20408151|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20408152|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20408153|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20408154|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408155|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
20408156|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408157|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20408158|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20408159|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20408160|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20408161|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20408162|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20408163|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20408164|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20408165|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
20408166|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20408167|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
20408168|NCT01174927|Heroin|heroin|mesh-list
20408169|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20408170|NCT01174927|Narcotics|narcotics|mesh-ancestor
19380137|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19380138|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380139|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380140|NCT05209412|Aspirin|aspirin|mesh-list
19380141|NCT05209412|Paclitaxel|paclitaxel|mesh-list
19380142|NCT05209412|Clopidogrel|clopidogrel|mesh-list
19380143|NCT05209412|Ticagrelor|ticagrelor|mesh-list
19380144|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19380145|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380146|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380147|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380148|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380149|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380150|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19380151|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19380152|NCT05209412|Analgesics|analgesics|mesh-ancestor
19380153|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
19380154|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380155|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380156|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380157|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380158|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19380159|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19380160|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19380161|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19380162|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380163|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
19380164|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19380165|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19380166|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19380167|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
19380168|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408171|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408172|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380172|NCT05209295|Azacitidine|azacitidine|mesh-list
19380173|NCT05209295|Cc-486|cc-486|mesh-list
19380174|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380175|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
19380176|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408173|NCT01174927|Analgesics|analgesics|mesh-ancestor
20408174|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
20408175|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408176|NCT01174953|Finasteride|finasteride|mesh-list
20408177|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20408178|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20408179|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408180|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408181|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
20408182|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408183|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408184|NCT01174953|Urological Agents|urological agents|mesh-ancestor
20408185|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
20408186|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20408187|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408188|NCT01175096|Everolimus|everolimus|mesh-list
20408189|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408190|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408191|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
20408192|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408193|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
20408194|NCT01175109|Panobinostat|panobinostat|mesh-list
20408195|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408196|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20408197|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408198|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408199|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20408200|NCT01175161|Copper|copper|mesh-list
20408201|NCT01175161|Trace Elements|trace elements|mesh-ancestor
20408202|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
20408203|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408204|NCT01175200|Lansoprazole|lansoprazole|mesh-list
20408205|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
20408206|NCT01175200|Clopidogrel|clopidogrel|mesh-list
20408207|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20408208|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20408209|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20408210|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20408211|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20408212|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
20408213|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380177|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380178|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380179|NCT05209256|Pemetrexed|pemetrexed|mesh-list
19380180|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380181|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380182|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380183|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19380184|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19380185|NCT05209152|Azacitidine|azacitidine|mesh-list
19380186|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20408214|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408215|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408216|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20408217|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408218|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20408219|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380187|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
19380188|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380189|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380190|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847540|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
19847541|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408220|NCT01175291|Leucovorin|leucovorin|mesh-list
19380194|NCT05208944|Cemiplimab|cemiplimab|mesh-list
19380195|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380196|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380197|NCT05208931|Mitogens|mitogens|mesh-list
19380198|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
19380199|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380200|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380201|NCT05208931|Growth Substances|growth substances|mesh-ancestor
19380202|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380203|NCT05208879|Carotenoids|carotenoids|mesh-list
19380204|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
19380205|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380206|NCT05208879|Protective Agents|protective agents|mesh-ancestor
19380207|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408221|NCT01175291|Bevacizumab|bevacizumab|mesh-list
20408222|NCT01175291|Fluorouracil|fluorouracil|mesh-list
20408223|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
20408224|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
20408225|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20408226|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408227|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20408228|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20408229|NCT01175291|Growth Substances|growth substances|mesh-ancestor
20408230|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408231|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
20408232|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
20408233|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380208|NCT05208827|Vitamin D|vitamin d|mesh-list
19380209|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
19380210|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
19380211|NCT05208827|Vitamins|vitamins|mesh-list
19380212|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
19380213|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380214|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19380215|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19380216|NCT05208801|Morphine|morphine|mesh-list
19380217|NCT05208801|Bupivacaine|bupivacaine|mesh-list
19380218|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
19380219|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
19380220|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380221|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380222|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
19380223|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380224|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19380225|NCT05208801|Narcotics|narcotics|mesh-ancestor
19380226|NCT05208801|Analgesics|analgesics|mesh-ancestor
19380227|NCT05208398|Warfarin|warfarin|mesh-list
19380228|NCT05208398|Apixaban|apixaban|mesh-list
19380229|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
19380230|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19380231|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
19380232|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19380233|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
19380234|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380235|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380236|NCT05208294|Sulpiride|sulpiride|mesh-list
19380237|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19380238|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19380239|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380240|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380241|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19380242|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19380243|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
19380244|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380245|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408234|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20408235|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408236|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
20408237|NCT01175291|Antidotes|antidotes|mesh-ancestor
20408238|NCT01175291|Protective Agents|protective agents|mesh-ancestor
20408239|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
20408240|NCT01175291|Vitamins|vitamins|mesh-ancestor
20408241|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
20408242|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20408243|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20408244|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19380246|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20408245|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20408246|NCT01175460|Nedaplatin|nedaplatin|mesh-list
20408247|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380247|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
19380248|NCT05208268|Rabeprazole|rabeprazole|mesh-list
20408248|NCT01175486|Pioglitazone|pioglitazone|mesh-list
20408249|NCT01175486|Acarbose|acarbose|mesh-list
19380249|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19380250|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19380251|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19380252|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380253|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380254|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19380255|NCT05207904|Paclitaxel|paclitaxel|mesh-list
19380256|NCT05207904|Carboplatin|carboplatin|mesh-list
20408250|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20408251|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408252|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20408253|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408254|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408255|NCT01175512|Naltrexone|naltrexone|mesh-list
20408256|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20408257|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20408258|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408259|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
20408260|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408261|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
20408262|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
20408263|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
20408264|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408265|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408266|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20408267|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
20408268|NCT01175538|Lactulose|lactulose|mesh-list
20408269|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408270|NCT01175577|Carotenoids|carotenoids|mesh-list
20408271|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
20408272|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408273|NCT01175577|Protective Agents|protective agents|mesh-ancestor
20408274|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408275|NCT01175733|Panitumumab|panitumumab|mesh-list
20408276|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20408277|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408278|NCT01175746|Nicardipine|nicardipine|mesh-list
20408279|NCT01175746|Remifentanil|remifentanil|mesh-list
20408280|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20408281|NCT01175746|Narcotics|narcotics|mesh-ancestor
20408282|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408283|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408284|NCT01175746|Analgesics|analgesics|mesh-ancestor
20408285|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
20408286|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408287|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20408288|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20408289|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20408290|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408291|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20408292|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
20408293|NCT01175772|Celecoxib|celecoxib|mesh-list
20408294|NCT01175772|Methotrexate|methotrexate|mesh-list
20408295|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
20408296|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20408297|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
20408298|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20408299|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408300|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20408301|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
20408302|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408303|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408304|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
20408305|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408306|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19380257|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20217922|NCT00310934|Methadone|methadone|mesh-list
19380258|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217923|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20217924|NCT00310934|Narcotics|narcotics|mesh-ancestor
20217925|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217926|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217927|NCT00310934|Analgesics|analgesics|mesh-ancestor
20217928|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
20217929|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408307|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408308|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
20408309|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380259|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380260|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380261|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380262|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380263|NCT05207774|Oxytocin|oxytocin|mesh-list
19380264|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
19380265|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19380266|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408310|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20408311|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20408312|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20408313|NCT01175772|Analgesics|analgesics|mesh-ancestor
20408314|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
20408315|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408316|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408317|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20408318|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20408319|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20408320|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
20408321|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20427357|NCT01286857|Trace Elements|trace elements|mesh-ancestor
20427358|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
20427359|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427360|NCT01286896|Sunitinib|sunitinib|mesh-list
20427361|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427362|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20427363|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20427364|NCT01286896|Growth Substances|growth substances|mesh-ancestor
19380267|NCT05207735|Capecitabine|capecitabine|mesh-list
19380268|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380269|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
19380270|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380271|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380272|NCT05207683|Antibodies|antibodies|mesh-list
19380273|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
19380274|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
19380275|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380276|NCT05207514|Ethanol|ethanol|mesh-list
19380277|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
19380278|NCT05207514|Docetaxel|docetaxel|mesh-list
19380279|NCT05207514|Doxorubicin|doxorubicin|mesh-list
19380280|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380281|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
19380282|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380283|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380284|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19380285|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
20427365|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427366|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
20427367|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20427368|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427369|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427370|NCT01286909|Lycopene|lycopene|mesh-list
20427371|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427372|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
20427373|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427374|NCT01286909|Protective Agents|protective agents|mesh-ancestor
20427375|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427376|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20427377|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20427378|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427379|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
20427380|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20427381|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
20427382|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19380286|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380287|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380288|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19380289|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380290|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380291|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380292|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19380293|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19380294|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19380295|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380296|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19380297|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380298|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380299|NCT05207436|Oxytocin|oxytocin|mesh-list
19380300|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
19380301|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19380302|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403077|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
19403078|NCT03603834|Irinotecan|irinotecan|mesh-list
19403079|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
19403080|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403081|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19403082|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403083|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213409|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20408322|NCT01175954|Lacosamide|lacosamide|mesh-list
20408323|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
19403084|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
20213410|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213411|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403085|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403086|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19403087|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19403088|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403089|NCT03603834|Antidotes|antidotes|mesh-ancestor
19403090|NCT03603834|Protective Agents|protective agents|mesh-ancestor
19403091|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
19403092|NCT03603834|Vitamins|vitamins|mesh-ancestor
19403093|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
19403094|NCT03603756|Paclitaxel|paclitaxel|mesh-list
19403095|NCT03603756|Irinotecan|irinotecan|mesh-list
19403096|NCT03603756|Apatinib|apatinib|mesh-list
19403097|NCT03603756|Nedaplatin|nedaplatin|mesh-list
19403098|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19403099|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403100|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
19403101|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
19403102|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
19403103|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403104|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19403105|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19403106|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403107|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19404773|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404774|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19404775|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19404776|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20213412|NCT00295919|Ketoconazole|ketoconazole|mesh-list
20213413|NCT00295919|Fenretinide|fenretinide|mesh-list
20213414|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
20213415|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213416|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20213417|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20213418|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213419|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213420|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20213421|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
20213422|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213423|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213424|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20213425|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213426|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20213427|NCT00295919|Protective Agents|protective agents|mesh-ancestor
20213428|NCT00295945|Fentanyl|fentanyl|mesh-list
20213429|NCT00295945|Hydromorphone|hydromorphone|mesh-list
20213430|NCT00295945|Ropivacaine|ropivacaine|mesh-list
20213431|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
20213432|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
20213433|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408324|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20408325|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19404777|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404778|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19404779|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380303|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
19380304|NCT05187338|Ipilimumab|ipilimumab|mesh-list
19380305|NCT05187338|Durvalumab|durvalumab|mesh-list
19380306|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380307|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380308|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19380309|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380310|NCT05187208|Niraparib|niraparib|mesh-list
19380311|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19380312|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380313|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380314|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380315|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
19380316|NCT05186467|Analgesics|analgesics|mesh-ancestor
19380317|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
19380318|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380319|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380320|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
19380321|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380322|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19380323|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
19380324|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19380325|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19380326|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380327|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19380328|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
19380329|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19380330|NCT05182892|Dopamine|dopamine|mesh-list
19380331|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
19380332|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19380333|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
19847542|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847543|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847544|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847545|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19847546|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19847547|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213434|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213435|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
20213436|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380334|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
19380335|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380336|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380337|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
19380338|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380339|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380340|NCT05182892|Protective Agents|protective agents|mesh-ancestor
19380341|NCT05171673|Diclofenac|diclofenac|mesh-list
19380342|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
19380343|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19380344|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19380345|NCT05171673|Analgesics|analgesics|mesh-ancestor
19380346|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
19380347|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380348|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380349|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213437|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20213438|NCT00295945|Narcotics|narcotics|mesh-ancestor
20213439|NCT00295945|Analgesics|analgesics|mesh-ancestor
20213440|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20213441|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20213442|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
20213443|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
20213444|NCT00295958|Immunotoxins|immunotoxins|mesh-list
20213445|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20213446|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
20213447|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213448|NCT00295971|Fludarabine|fludarabine|mesh-list
20213449|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
20213450|NCT00295971|Thiotepa|thiotepa|mesh-list
20213451|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20213452|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847548|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20213453|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213454|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
20213455|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213456|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213457|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
20213458|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213459|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20213460|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
20213461|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20213462|NCT00295984|Nicotine|nicotine|mesh-list
20213463|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20213464|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
20213465|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213466|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213467|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20213468|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20213469|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
20213470|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408326|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20408327|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408328|NCT01176175|Progesterone|progesterone|mesh-list
19380350|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380351|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19380352|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380353|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380354|NCT05166239|Lenvatinib|lenvatinib|mesh-list
19380355|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380356|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19380357|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380358|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380359|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
20408329|NCT01176175|Progestins|progestins|mesh-ancestor
20408330|NCT01176175|Hormones|hormones|mesh-ancestor
20408331|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408332|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408333|NCT01176318|Erdosteine|erdosteine|mesh-list
20408334|NCT01176318|Expectorants|expectorants|mesh-ancestor
20408335|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
20408336|NCT01176344|Vitamin D|vitamin d|mesh-list
20408337|NCT01176344|Vitamins|vitamins|mesh-ancestor
20408338|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
20408339|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408340|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20408341|NCT01176409|Valacyclovir|valacyclovir|mesh-list
20408342|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
20408343|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408344|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
20408345|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
20408346|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20408347|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
19380360|NCT05149287|Lidocaine|lidocaine|mesh-list
19380361|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
19380362|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
19380363|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408348|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408349|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
20408350|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408351|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408352|NCT01176669|Apatinib|apatinib|mesh-list
20408353|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408354|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20408355|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408356|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408357|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20408358|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
20408359|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408360|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408361|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20408362|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408363|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
20408364|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20408365|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
19380364|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380365|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
19380366|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408366|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380367|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19380368|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19380369|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20408367|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408368|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20408369|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
20408370|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20408371|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20408372|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20408373|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
20408374|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408375|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408376|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20408377|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
20408378|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408379|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408380|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20408381|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408382|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
20408383|NCT01176799|Doxorubicin|doxorubicin|mesh-list
20408384|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20408385|NCT01176799|Sunitinib|sunitinib|mesh-list
19380370|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19380371|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380372|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19380373|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408386|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408387|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
20408388|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408389|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20408390|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20408391|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
20408392|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408393|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408394|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20408395|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20408396|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20408397|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20408398|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408399|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20408400|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20408401|NCT01176799|Growth Substances|growth substances|mesh-ancestor
20408402|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
20408403|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20408404|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
20408405|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20408406|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20408407|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20408408|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
20408409|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408410|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408411|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408412|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
20408413|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
20408414|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20408415|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
19380374|NCT05122130|Melatonin|melatonin|mesh-list
19380375|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
19380376|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380377|NCT05122130|Protective Agents|protective agents|mesh-ancestor
19380378|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380379|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380383|NCT05081206|Propofol|propofol|mesh-list
19380384|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19380385|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380386|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380387|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19380388|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
19380389|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
19380390|NCT05047939|Propofol|propofol|mesh-list
19380391|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19380392|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408416|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408417|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408418|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19380393|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380394|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19380395|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
19380396|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
19380397|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19380398|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19380399|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380400|NCT05022329|Vaccines|vaccines|mesh-list
19380401|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
19380402|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380403|NCT05012254|Paclitaxel|paclitaxel|mesh-list
20408419|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
20408420|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
20408421|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20408422|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
20408423|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408424|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408425|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20408426|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20408427|NCT01177176|Bupropion|bupropion|mesh-list
20408428|NCT01177176|Nicotine|nicotine|mesh-list
20408429|NCT01177176|Varenicline|varenicline|mesh-list
20408430|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20408431|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
20408432|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408433|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408434|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20408435|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20408436|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
20408437|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408438|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408439|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19380404|NCT05012254|Cisplatin|cisplatin|mesh-list
19380405|NCT05012254|Carboplatin|carboplatin|mesh-list
19380406|NCT05012254|Nivolumab|nivolumab|mesh-list
19380407|NCT05012254|Pemetrexed|pemetrexed|mesh-list
19380408|NCT05012254|Ipilimumab|ipilimumab|mesh-list
19380409|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20408440|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
20408441|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20408442|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20408443|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20408444|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20408445|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
20408446|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20408447|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20408448|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408449|NCT01177306|Guanfacine|guanfacine|mesh-list
20408450|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20408451|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20408452|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20408453|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20408454|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
19380410|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380411|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380412|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380413|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
19847549|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19847550|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847551|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
19847552|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19847553|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19847554|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19847555|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
19847556|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847557|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19380414|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847558|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19380415|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380416|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20408455|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408456|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408457|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408458|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
20408459|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20408460|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20408461|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20408462|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20408463|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408464|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
20408465|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380417|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380418|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19380419|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19380420|NCT04973800|Simvastatin|simvastatin|mesh-list
19380421|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19380422|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19380423|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
19380424|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380425|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19380426|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19380427|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380428|NCT04947059|Gemcitabine|gemcitabine|mesh-list
19380429|NCT04947059|Epirubicin|epirubicin|mesh-list
19380430|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380431|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
19380432|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380433|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380434|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
19380435|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380436|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380437|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380438|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
19380439|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380440|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19380441|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19380442|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19380443|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
19380444|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380445|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380446|NCT04921735|Cisatracurium|cisatracurium|mesh-list
19380447|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19380448|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19380449|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380450|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691317|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691318|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19691319|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20213471|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213472|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
20213473|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
19691320|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691321|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19691322|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19691323|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19691324|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19691325|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19691326|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20213474|NCT00295997|Busulfan|busulfan|mesh-list
20213475|NCT00295997|Methotrexate|methotrexate|mesh-list
20213476|NCT00295997|Fludarabine|fludarabine|mesh-list
20213477|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
20213478|NCT00295997|Tacrolimus|tacrolimus|mesh-list
20213479|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20213480|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213481|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
20213482|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213483|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213484|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20213485|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
20213486|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213487|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380451|NCT04908475|Apremilast|apremilast|mesh-list
19380452|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19380453|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19380454|NCT04908475|Analgesics|analgesics|mesh-ancestor
19380455|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
19380456|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380457|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408466|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408467|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20408468|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408469|NCT01177371|Cyclosporine|cyclosporine|mesh-list
20408470|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
20408471|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20408472|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20408473|NCT01177371|Prednisolone|prednisolone|mesh-list
19380458|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380459|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380460|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19380461|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19380462|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380463|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380464|NCT04879368|Trifluridine|trifluridine|mesh-list
19380465|NCT04879368|Paclitaxel|paclitaxel|mesh-list
19380466|NCT04879368|Docetaxel|docetaxel|mesh-list
19380467|NCT04879368|Nivolumab|nivolumab|mesh-list
19380468|NCT04879368|Irinotecan|irinotecan|mesh-list
19380469|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19380470|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380471|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380472|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20408474|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
20408475|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
20408476|NCT01177371|Busulfan|busulfan|mesh-list
20408477|NCT01177371|Methotrexate|methotrexate|mesh-list
20408478|NCT01177371|Cyclosporins|cyclosporins|mesh-list
20408479|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20408480|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
20408481|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408482|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
20408483|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408484|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20408485|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20408486|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
19380473|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380474|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380475|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380476|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19380477|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19380478|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19380479|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380480|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
19380481|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
19380482|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847559|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
19847560|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19847561|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
20408487|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408488|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408489|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20408490|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20408491|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
20408492|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20408493|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20408494|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
20408495|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
20408496|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408497|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20408498|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20408499|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
20408500|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408501|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20408502|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403108|NCT03603626|Pregabalin|pregabalin|mesh-list
19847562|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
20408503|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
19403109|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408504|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
19847563|NCT00687076|Vitamins|vitamins|mesh-ancestor
19847564|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
19847565|NCT00687102|Tamoxifen|tamoxifen|mesh-list
19847566|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19847567|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19847568|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
19847569|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408505|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408506|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408507|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
20408508|NCT01177371|Hormones|hormones|mesh-ancestor
20408509|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408510|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20408511|NCT01177371|Protective Agents|protective agents|mesh-ancestor
20408512|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20408513|NCT01177423|Anesthetics|anesthetics|mesh-list
19380483|NCT04808245|Atezolizumab|atezolizumab|mesh-list
19380484|NCT04808245|Imiquimod|imiquimod|mesh-list
19380485|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380486|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19380487|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
20408514|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380488|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380489|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
19380490|NCT04776447|Carboplatin|carboplatin|mesh-list
19380491|NCT04776447|Atezolizumab|atezolizumab|mesh-list
19380492|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380493|NCT04739865|Psilocybin|psilocybin|mesh-list
19380494|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
19380495|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380496|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19380497|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
19380498|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19380499|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380500|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380501|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19380502|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19380503|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
19380504|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19380505|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380506|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380507|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19380508|NCT04720963|Analgesics|analgesics|mesh-ancestor
19380509|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
19380510|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380511|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19380512|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19380513|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19380514|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
19380515|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380516|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380517|NCT04699357|Atropine|atropine|mesh-list
19380518|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19380519|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19380520|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19380521|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
19380522|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380523|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380524|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19380525|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
19380526|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
19380527|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
19380528|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19691327|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
19691328|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
19691329|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
19691330|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19691331|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19691332|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
19691333|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19691334|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19691335|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
19691336|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
19847570|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380529|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19691337|NCT05006001|Colchicine|colchicine|mesh-list
20408515|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408516|NCT01177501|Topotecan|topotecan|mesh-list
20408517|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20408518|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20408519|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408520|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408521|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408522|NCT01177514|Gabapentin|gabapentin|mesh-list
20408523|NCT01177514|Analgesics|analgesics|mesh-ancestor
19380530|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
19380531|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380532|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380533|NCT04690192|Gemcitabine|gemcitabine|mesh-list
19380534|NCT04690192|Melphalan|melphalan|mesh-list
19380535|NCT04690192|Busulfan|busulfan|mesh-list
19380536|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380537|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
19380538|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380539|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380540|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
19380541|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380542|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380543|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380544|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
20408524|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
20408525|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408526|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408527|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
20408528|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20408529|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20408530|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408531|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20408532|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20408533|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20408534|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408535|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408536|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
19380545|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380546|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19380547|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
19380548|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19380549|NCT04661007|Lenalidomide|lenalidomide|mesh-list
19380550|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
19380551|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380552|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19380553|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19380554|NCT04661007|Growth Substances|growth substances|mesh-ancestor
19380555|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
19380556|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380557|NCT04629651|Captopril|captopril|mesh-list
19380558|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19380559|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
19380560|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380561|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380562|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19380563|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
19380564|NCT04626024|Dasatinib|dasatinib|mesh-list
19380565|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380566|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19380567|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380568|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380569|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
19380570|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20408537|NCT01177540|Decitabine|decitabine|mesh-list
20408538|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20408539|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
20408540|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408541|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408542|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408543|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
20408544|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20408545|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20408546|NCT01177566|Analgesics|analgesics|mesh-ancestor
20408547|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
19380571|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380572|NCT04589208|Ketamine|ketamine|mesh-list
19380573|NCT04589208|Analgesics|analgesics|mesh-ancestor
19380574|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
19380575|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380576|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380577|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19380578|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19380579|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
19380580|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
19380581|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380582|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19380583|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19380584|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380585|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380586|NCT04577638|Nivolumab|nivolumab|mesh-list
19380587|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380588|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380589|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19380590|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847571|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847572|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847573|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19847574|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19847575|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19847576|NCT00687167|Zonisamide|zonisamide|mesh-list
19847577|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
19847578|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19847579|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847580|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847581|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19380602|NCT04540120|Dapansutrile|dapansutrile|mesh-list
19380603|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380604|NCT04513860|Cenobamate|cenobamate|mesh-list
19380605|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
19380606|NCT04503148|Propofol|propofol|mesh-list
19380607|NCT04503148|Anesthetics|anesthetics|mesh-list
19380608|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
19380609|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
19380610|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19380611|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380612|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380613|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19380614|NCT04498468|Dexamethasone|dexamethasone|mesh-list
19380615|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380616|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
19380617|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
20408548|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408549|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408550|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408551|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20408552|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
20408553|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408554|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
19380618|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380619|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380620|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408555|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20408556|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408557|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408558|NCT01177579|Copper|copper|mesh-list
19380621|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
19380622|NCT04498468|Hormones|hormones|mesh-ancestor
19380623|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19380624|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19380625|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380626|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
19380627|NCT04477200|Temozolomide|temozolomide|mesh-list
19380628|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19380629|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380630|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19380631|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
19380632|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19380633|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380634|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408559|NCT01177579|Trace Elements|trace elements|mesh-ancestor
20408560|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
20408561|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408562|NCT01177683|Doxorubicin|doxorubicin|mesh-list
20408563|NCT01177683|Bortezomib|bortezomib|mesh-list
20408564|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20408565|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20408566|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408567|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19380635|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380636|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19380637|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
19380638|NCT04474223|Dexamethasone|dexamethasone|mesh-list
19380639|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380640|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
19380641|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
19380642|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380643|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380644|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19380645|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
19380646|NCT04474223|Hormones|hormones|mesh-ancestor
19380647|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19380648|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19380649|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380650|NCT04400799|Enoxaparin|enoxaparin|mesh-list
19380651|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
19380652|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19380653|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19380654|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380655|NCT04368910|Artesunate|artesunate|mesh-list
19380656|NCT04368910|Chloroquine|chloroquine|mesh-list
20408568|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20408569|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408570|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408571|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20408572|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
20408573|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
20427383|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427384|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20427385|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20427386|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20427387|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
20427388|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20427389|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
20427390|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
20427391|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20427392|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427393|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427394|NCT01287052|Analgesics|analgesics|mesh-ancestor
20427395|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
19380657|NCT04368910|Pyronaridine|pyronaridine|mesh-list
19380658|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
19380659|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19380660|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19380661|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380662|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380663|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
19380664|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
19380665|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19380666|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
19380667|NCT04368910|Amebicides|amebicides|mesh-ancestor
19380668|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380669|NCT04365985|Naltrexone|naltrexone|mesh-list
19380670|NCT04365985|Ketamine|ketamine|mesh-list
19380671|NCT04365985|Analgesics|analgesics|mesh-ancestor
19380672|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
19380673|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380674|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427396|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427397|NCT01287091|Rabeprazole|rabeprazole|mesh-list
20427398|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20427399|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19380675|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20427400|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19380676|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19380677|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
19380678|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
19380679|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380680|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19380681|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19380682|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380683|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380684|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20408574|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
20408575|NCT01177852|Promethazine|promethazine|mesh-list
20408576|NCT01177852|Brompheniramine|brompheniramine|mesh-list
20408577|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
20408578|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
20408579|NCT01177852|Ephedrine|ephedrine|mesh-list
20408580|NCT01177852|Dipropizine|dipropizine|mesh-list
20408581|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408582|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20408583|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20408584|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408585|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380685|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19380686|NCT04249258|Dobutamine|dobutamine|mesh-list
19380687|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19380688|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
19380689|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
19380690|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380691|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380692|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19380693|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19380694|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19380695|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
19380696|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380697|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380698|NCT04249258|Protective Agents|protective agents|mesh-ancestor
19380699|NCT04235608|Propofol|propofol|mesh-list
19380700|NCT04235608|Sevoflurane|sevoflurane|mesh-list
19380701|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19380702|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380703|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380704|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19380705|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
19380706|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
19380707|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19380708|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19380709|NCT04231838|Nicotine|nicotine|mesh-list
19380710|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19380711|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
19380712|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380713|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380714|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19380715|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20408586|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
20408587|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
20408588|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
20408589|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408590|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
20408591|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
20408592|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408593|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20408594|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
20408595|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
20408596|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408597|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20213488|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20213489|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20213490|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
20213491|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20213492|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213493|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
20213494|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
20213495|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213496|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20213497|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20408598|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
20408599|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
20408600|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19380716|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
19380717|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380718|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380719|NCT04146324|Nivolumab|nivolumab|mesh-list
20408601|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20408602|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
20408603|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
20408604|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20408605|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20408606|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
20408607|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
19380720|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380721|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380722|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19380723|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380724|NCT04141579|Evolocumab|evolocumab|mesh-list
19380725|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19380726|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19380727|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
19380728|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380729|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19380730|NCT04094519|Digoxin|digoxin|mesh-list
19380731|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19380732|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19380733|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19380734|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
19380735|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380736|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19380737|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19380738|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380739|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19380740|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19380741|NCT04094519|Protective Agents|protective agents|mesh-ancestor
19380742|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380743|NCT04080531|Vaccines|vaccines|mesh-list
19380744|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
19380745|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380746|NCT04064359|Antibodies|antibodies|mesh-list
19380747|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
19380748|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
19380749|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380750|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
19380751|NCT03938584|Vitamins|vitamins|mesh-ancestor
19380752|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
19380753|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380754|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
19380755|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380756|NCT03938584|Protective Agents|protective agents|mesh-ancestor
19380757|NCT03917381|Docetaxel|docetaxel|mesh-list
19380758|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
19380759|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380760|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380761|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380762|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
20408608|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
20408609|NCT01177904|Progesterone|progesterone|mesh-list
20408610|NCT01177904|Progestins|progestins|mesh-ancestor
20408611|NCT01177904|Hormones|hormones|mesh-ancestor
20408612|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408613|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380763|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380764|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403110|NCT03603626|Analgesics|analgesics|mesh-ancestor
19403111|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
19403112|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403113|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
19403114|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19403115|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403116|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403117|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19403118|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20408614|NCT01178021|Chloroquine|chloroquine|mesh-list
19691338|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
20408615|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20408616|NCT01178021|Primaquine|primaquine|mesh-list
19380765|NCT03837873|Cytarabine|cytarabine|mesh-list
19380766|NCT03837873|Dexamethasone|dexamethasone|mesh-list
19380767|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
19380768|NCT03837873|Rituximab|rituximab|mesh-list
19380769|NCT03837873|Doxorubicin|doxorubicin|mesh-list
19380770|NCT03837873|Etoposide|etoposide|mesh-list
19380771|NCT03837873|Vincristine|vincristine|mesh-list
19380772|NCT03837873|Lenalidomide|lenalidomide|mesh-list
19380773|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380774|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
19380775|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380776|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380777|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19380778|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
19380779|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408617|NCT01178021|Amebicides|amebicides|mesh-ancestor
20408618|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20408619|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19380780|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380781|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19380782|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380783|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380784|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
19380785|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
19380786|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380787|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19380788|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
19380789|NCT03837873|Hormones|hormones|mesh-ancestor
19380790|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19380791|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19380792|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19380793|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19380794|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19380795|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380796|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19380797|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380798|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
19380799|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
19380800|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380801|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380802|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
19380803|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380804|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19380805|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19380806|NCT03837873|Growth Substances|growth substances|mesh-ancestor
20408620|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408621|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
20408622|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20408623|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20408624|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20408625|NCT01178021|Analgesics|analgesics|mesh-ancestor
20408626|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
20408627|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408628|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408629|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408630|NCT01178021|Filaricides|filaricides|mesh-ancestor
20408631|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
19380807|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
19380808|NCT03810495|Naltrexone|naltrexone|mesh-list
19380809|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19380810|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19380811|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380812|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
19380813|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380814|NCT03775200|Psilocybin|psilocybin|mesh-list
19380815|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
20408632|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
20408633|NCT01178034|Warfarin|warfarin|mesh-list
20408634|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
20408635|NCT01178047|Rasagiline|rasagiline|mesh-list
19380816|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380817|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19691339|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691340|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
19691341|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
19691342|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
19691343|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408636|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19847582|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847583|NCT00687193|Tofacitinib|tofacitinib|mesh-list
19847584|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19847585|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380818|NCT03769766|Curcumin|curcumin|mesh-list
19380819|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19380820|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19380821|NCT03769766|Analgesics|analgesics|mesh-ancestor
19380822|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
19380823|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380824|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380825|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19380826|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19380827|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380828|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380829|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380830|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
19380831|NCT03753555|Atorvastatin|atorvastatin|mesh-list
19380832|NCT03753555|Probucol|probucol|mesh-list
19380833|NCT03753555|Calcium|calcium|mesh-list
19380834|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19380835|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380836|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19380837|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19380838|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19380839|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
19380840|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380841|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19380842|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19380843|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380844|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
19380845|NCT03753555|Protective Agents|protective agents|mesh-ancestor
19380846|NCT03734029|Gemcitabine|gemcitabine|mesh-list
19380847|NCT03734029|Paclitaxel|paclitaxel|mesh-list
19380848|NCT03734029|Camptothecin|camptothecin|mesh-list
19380849|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19380850|NCT03734029|Capecitabine|capecitabine|mesh-list
19380851|NCT03734029|Trastuzumab|trastuzumab|mesh-list
19380852|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
19847586|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847587|NCT00687219|Ribavirin|ribavirin|mesh-list
19847588|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19847589|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
19847590|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847591|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
19847592|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408637|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408638|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408639|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20408640|NCT01178047|Protective Agents|protective agents|mesh-ancestor
20408641|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408642|NCT01178112|Carboplatin|carboplatin|mesh-list
20408643|NCT01178112|Trientine|trientine|mesh-list
19847593|NCT00687271|Atorvastatin|atorvastatin|mesh-list
19847594|NCT00687271|Calcium|calcium|mesh-list
19847595|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19847596|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847597|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19847598|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19847599|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
19847600|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847601|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20213498|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20213499|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20213500|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20213501|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
20213502|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20213503|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213504|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
20213505|NCT00296010|Doxorubicin|doxorubicin|mesh-list
20213506|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19380853|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19380854|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380855|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
19380856|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
20213507|NCT00296010|Methotrexate|methotrexate|mesh-list
19380857|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
19380858|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380859|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19380860|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
19380861|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
19380862|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380863|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380864|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380865|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
19380866|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380867|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380868|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19380869|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19380870|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
19380871|NCT03716609|Citric Acid|citric acid|mesh-list
19380872|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
19380873|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
19380874|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19380875|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
19380876|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
19380877|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380878|NCT03716609|Cathartics|cathartics|mesh-ancestor
19380879|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19380880|NCT03709355|Clarithromycin|clarithromycin|mesh-list
19380881|NCT03709355|Rifampin|rifampin|mesh-list
19380882|NCT03709355|Rifabutin|rifabutin|mesh-list
19380883|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
19380884|NCT03709355|Omeprazole|omeprazole|mesh-list
19380885|NCT03709355|Atorvastatin|atorvastatin|mesh-list
19380886|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
19380887|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19380888|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19380889|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19380890|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19380891|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
19380892|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380893|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19380894|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19380895|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380896|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19380897|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19380898|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19380899|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19380900|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380901|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19380902|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19380903|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19380904|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19847602|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19847603|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847604|NCT00687297|Carboplatin|carboplatin|mesh-list
19847605|NCT00687297|Docetaxel|docetaxel|mesh-list
19847606|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847607|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
19847608|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
19847609|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
19847610|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847611|NCT00687323|Temozolomide|temozolomide|mesh-list
19847612|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19847613|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
19847614|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380905|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
19380906|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19380907|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380908|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19380909|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19380910|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19380911|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19380912|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
19847615|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213508|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19380913|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
20213509|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
20217930|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19380914|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19380915|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19380916|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19380917|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19380918|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19380919|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19380920|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20408644|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408645|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
20408646|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
20408647|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408648|NCT01178151|Everolimus|everolimus|mesh-list
20408649|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408650|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408651|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
20408652|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408653|NCT01178203|Naproxen|naproxen|mesh-list
20408654|NCT01178203|Tramadol|tramadol|mesh-list
20408655|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20408656|NCT01178203|Narcotics|narcotics|mesh-ancestor
20408657|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408658|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408659|NCT01178203|Analgesics|analgesics|mesh-ancestor
20408660|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
20408661|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408662|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20408663|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19380921|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19380922|NCT03709355|Estrogens|estrogens|mesh-ancestor
19380923|NCT03709355|Hormones|hormones|mesh-ancestor
19380924|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19380925|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19380926|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19380927|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
19380928|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19380929|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19380930|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
19380931|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19380932|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19380933|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19380934|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
19380935|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19380936|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380937|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19380938|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19380939|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19380940|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19380941|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380942|NCT03698552|Epratuzumab|epratuzumab|mesh-list
19380943|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380944|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380945|NCT03669133|Vitamin E|vitamin e|mesh-list
19380946|NCT03669133|Vitamins|vitamins|mesh-ancestor
19380947|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
19380948|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380949|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
19380950|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380951|NCT03669133|Protective Agents|protective agents|mesh-ancestor
19380952|NCT03637491|Avelumab|avelumab|mesh-list
19380953|NCT03637491|Talazoparib|talazoparib|mesh-list
19380954|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380955|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380956|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19380957|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380958|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380959|NCT03582618|Sorafenib|sorafenib|mesh-list
19380960|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380961|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19380962|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380963|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847616|NCT00687362|Infliximab|infliximab|mesh-list
20408664|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408665|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20408666|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
20408667|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20408668|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408669|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380964|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
19380965|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380966|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380967|NCT03498391|Ketamine|ketamine|mesh-list
19380968|NCT03498391|Propofol|propofol|mesh-list
19380969|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19380970|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19380971|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380972|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19380973|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
19380974|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
19380975|NCT03498391|Analgesics|analgesics|mesh-ancestor
19380976|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
19380977|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19380978|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19380979|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19380980|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20408670|NCT01178320|Niacin|niacin|mesh-list
20408671|NCT01178320|Niacinamide|niacinamide|mesh-list
20408672|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
20408673|NCT01178320|Simvastatin|simvastatin|mesh-list
20408674|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20408675|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20408676|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
20408677|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408678|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20408679|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20408680|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408681|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
20408682|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
20408683|NCT01178320|Vitamins|vitamins|mesh-ancestor
20408684|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
20408685|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408686|NCT01178372|Lactulose|lactulose|mesh-list
20408687|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408688|NCT01178450|Cinacalcet|cinacalcet|mesh-list
20408689|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20408690|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408691|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20408692|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
20408693|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408694|NCT01178645|Cytarabine|cytarabine|mesh-list
20408695|NCT01178645|Etoposide|etoposide|mesh-list
20408696|NCT01178645|Melphalan|melphalan|mesh-list
20408697|NCT01178645|Busulfan|busulfan|mesh-list
20408698|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20408699|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408700|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20408701|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20408702|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380981|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19380982|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380983|NCT03477162|Metformin|metformin|mesh-list
19380984|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19380985|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19380986|NCT03461952|Nivolumab|nivolumab|mesh-list
20213510|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213511|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213512|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19380987|NCT03461952|Ipilimumab|ipilimumab|mesh-list
20213513|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
20213514|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213515|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213516|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20213517|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20213518|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20213519|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20213520|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213521|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20408703|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408704|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20408705|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
19403119|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20408706|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
20408707|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19380988|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19380989|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380990|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19380991|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380992|NCT03420508|Ensartinib|ensartinib|mesh-list
19380993|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19380994|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19380995|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19380996|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19380997|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19380998|NCT03390296|Avelumab|avelumab|mesh-list
19380999|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
19381000|NCT03390296|Azacitidine|azacitidine|mesh-list
19381001|NCT03390296|Venetoclax|venetoclax|mesh-list
19381002|NCT03390296|Calicheamicins|calicheamicins|mesh-list
19381003|NCT03390296|Antibodies|antibodies|mesh-list
19381004|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
19381005|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19381006|NCT03390296|Maleic acid|maleic acid|mesh-list
19381007|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
19381008|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381009|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381010|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381011|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
19381012|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381013|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381014|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20408708|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408709|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
20408710|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408711|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20408712|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
20408713|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20408714|NCT01178658|Cytarabine|cytarabine|mesh-list
20408715|NCT01178658|Etoposide|etoposide|mesh-list
20408716|NCT01178658|Melphalan|melphalan|mesh-list
20408717|NCT01178658|Busulfan|busulfan|mesh-list
20408718|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20408719|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408720|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20408721|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20408722|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408723|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408724|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20408725|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
20408726|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
20408727|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408728|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408729|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
20408730|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408731|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20408732|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
20408733|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20408734|NCT01178697|Triamcinolone|triamcinolone|mesh-list
19381015|NCT03340727|Caffeine|caffeine|mesh-list
19381016|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
19381017|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381018|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19381019|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381020|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19381021|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381022|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19381023|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19381024|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
19381025|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381026|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19381027|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19381028|NCT03269344|Gabapentin|gabapentin|mesh-list
19381029|NCT03269344|Analgesics|analgesics|mesh-ancestor
19381030|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
19381031|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381032|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408735|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20408736|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20408737|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19381033|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
19381034|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19381035|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19381036|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381037|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381038|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19381039|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19381040|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381041|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381042|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
19381043|NCT03215095|Durvalumab|durvalumab|mesh-list
19381044|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381045|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381046|NCT03201458|Atezolizumab|atezolizumab|mesh-list
20408738|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408739|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
20408740|NCT01178697|Hormones|hormones|mesh-ancestor
20408741|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408742|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381047|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19381048|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381049|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
19381050|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381051|NCT03151746|Gabapentin|gabapentin|mesh-list
19381052|NCT03151746|Analgesics|analgesics|mesh-ancestor
19381053|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
19381054|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381055|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381056|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
19381057|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19381058|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19381059|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381060|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381061|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19381062|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19381063|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381064|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381065|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
19381066|NCT03071406|Nivolumab|nivolumab|mesh-list
19381067|NCT03071406|Ipilimumab|ipilimumab|mesh-list
19381068|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381069|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381070|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19381071|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381072|NCT03028857|Choline|choline|mesh-list
19381073|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
19381074|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19381075|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
19381076|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381077|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19381078|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19381079|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
19381080|NCT02971501|Bevacizumab|bevacizumab|mesh-list
19381081|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19381082|NCT02971501|Osimertinib|osimertinib|mesh-list
19381083|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
19381084|NCT02971501|Antibodies|antibodies|mesh-list
20408743|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20408744|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
20408745|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408746|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408747|NCT01178710|Simvastatin|simvastatin|mesh-list
19381085|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
19381086|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19381087|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
19381088|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381089|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19381090|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19381091|NCT02971501|Growth Substances|growth substances|mesh-ancestor
19381092|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381093|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
20408748|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19381094|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
19381095|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381096|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19381097|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381098|NCT02970448|Temozolomide|temozolomide|mesh-list
19381099|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19381100|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
19381101|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381102|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381103|NCT02966093|Lenvatinib|lenvatinib|mesh-list
19381104|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408749|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20408750|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
20408751|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408752|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20408753|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20408754|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408755|NCT01178788|Progesterone|progesterone|mesh-list
20408756|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20408757|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20408758|NCT01178788|Progestins|progestins|mesh-ancestor
20408759|NCT01178788|Hormones|hormones|mesh-ancestor
20408760|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381105|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19381106|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381107|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381108|NCT02953093|Acarbose|acarbose|mesh-list
19381109|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19381110|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381111|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381112|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20408761|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408762|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20408763|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
20408764|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
19381113|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381114|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
19381115|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381116|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381117|NCT02921997|Vaccines|vaccines|mesh-list
20408765|NCT01178931|Progesterone|progesterone|mesh-list
20408766|NCT01178931|Progestins|progestins|mesh-ancestor
20408767|NCT01178931|Hormones|hormones|mesh-ancestor
20408768|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408769|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408770|NCT01178996|Ribavirin|ribavirin|mesh-list
20408771|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20408772|NCT01178996|Thymalfasin|thymalfasin|mesh-list
20408773|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
20408774|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408775|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
20408776|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408777|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20408778|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
20408779|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381118|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
19381119|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381120|NCT02879162|Durvalumab|durvalumab|mesh-list
19381121|NCT02879162|Tremelimumab|tremelimumab|mesh-list
19381122|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381123|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381124|NCT02822092|Risperidone|risperidone|mesh-list
19381125|NCT02822092|Aripiprazole|aripiprazole|mesh-list
19381126|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19381127|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
19381128|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381129|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381130|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381131|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19381132|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19381133|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381134|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381135|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19381136|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
19381137|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
19381138|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
19847617|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
20408780|NCT01179009|Clonidine|clonidine|mesh-list
20408781|NCT01179009|Scopolamine|scopolamine|mesh-list
20408782|NCT01179009|Ketamine|ketamine|mesh-list
20408783|NCT01179009|Lorazepam|lorazepam|mesh-list
20408784|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20408785|NCT01179009|Analgesics|analgesics|mesh-ancestor
20408786|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
20408787|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381139|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19381140|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19381141|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19381142|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19381143|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
19381144|NCT02717416|Hemostatics|hemostatics|mesh-list
19381145|NCT02717416|Coagulants|coagulants|mesh-ancestor
19381146|NCT02712905|Nivolumab|nivolumab|mesh-list
19381147|NCT02712905|Azacitidine|azacitidine|mesh-list
19381148|NCT02712905|Tretinoin|tretinoin|mesh-list
19381149|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381150|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381151|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19381152|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381153|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381154|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
19381155|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381156|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
19381157|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
19403120|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408788|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408789|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20408790|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20408791|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
20408792|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
20408793|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403121|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19403122|NCT03603548|Tacrolimus|tacrolimus|mesh-list
19403123|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403124|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
19403125|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403126|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19403127|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403128|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403129|NCT03603418|Dexamethasone|dexamethasone|mesh-list
19403130|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
19403131|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19403132|NCT03603418|BB 1101|bb 1101|mesh-list
19403133|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403134|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
19403135|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
19403136|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403137|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403138|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403139|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
19403140|NCT03603418|Hormones|hormones|mesh-ancestor
19403141|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403142|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19403143|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403144|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
19403145|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403146|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403147|NCT03603366|Aspirin|aspirin|mesh-list
19403148|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19403149|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19403150|NCT03603366|Analgesics|analgesics|mesh-ancestor
19403151|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
19403152|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403153|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403154|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403155|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19403156|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19403157|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19403158|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403159|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19691344|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403160|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20408794|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19381158|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
19381159|NCT02675946|Cetuximab|cetuximab|mesh-list
19381160|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381161|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381162|NCT02660827|Insulin|insulin|mesh-list
19381163|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19381164|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381165|NCT02627963|Sorafenib|sorafenib|mesh-list
19381166|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381167|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19381168|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381169|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381170|NCT02520063|Everolimus|everolimus|mesh-list
19381171|NCT02520063|Letrozole|letrozole|mesh-list
19381172|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381173|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381174|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
19381175|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381176|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19381177|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19381178|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381179|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381180|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19381181|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
19381182|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381183|NCT02496663|Osimertinib|osimertinib|mesh-list
19381184|NCT02496663|Necitumumab|necitumumab|mesh-list
19381185|NCT02496663|Cetuximab|cetuximab|mesh-list
19381186|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19381187|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381188|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381189|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20408795|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20408796|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408797|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408798|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20408799|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
20408800|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
20408801|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20408802|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20408803|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20408804|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
20408805|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
20408806|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
20408807|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19381190|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381191|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381192|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
19381193|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381194|NCT02437370|Gemcitabine|gemcitabine|mesh-list
19381195|NCT02437370|Docetaxel|docetaxel|mesh-list
19381196|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
19381197|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381198|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
19381199|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381200|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381201|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
19381202|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381203|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381204|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381205|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
19381206|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381207|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
19381208|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
19381209|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
19381210|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381211|NCT02425644|Teriflunomide|teriflunomide|mesh-list
19381212|NCT02425644|Ponesimod|ponesimod|mesh-list
19381213|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19381214|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19381215|NCT02425644|Analgesics|analgesics|mesh-ancestor
20408808|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19381216|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
19381217|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408809|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20408810|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20408811|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20408812|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
20408813|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
20408814|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20408815|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
20408816|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20408817|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
20408818|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20408819|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
20408820|NCT01179100|Lidocaine|lidocaine|mesh-list
20408821|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
20408822|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
20408823|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408824|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408825|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
20408826|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408827|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20408828|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20408829|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20408830|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20408831|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408832|NCT01179152|Budesonide|budesonide|mesh-list
20408833|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
20408834|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408835|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20408836|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
20408837|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381218|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381219|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19381220|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19381221|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381222|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
19381223|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19381224|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381225|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19381226|NCT02395614|Gentamicins|gentamicins|mesh-list
19381227|NCT02395614|Cefazolin|cefazolin|mesh-list
19381228|NCT02395614|Bacitracin|bacitracin|mesh-list
19381229|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
19381230|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381231|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19381232|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
19381233|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19381234|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381235|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381236|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
19381237|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408838|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408839|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20408840|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
20408841|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
20408842|NCT01179152|Hormones|hormones|mesh-ancestor
20408843|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408844|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20408845|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20408846|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20408847|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
20408848|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408849|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408850|NCT01179230|Dipyridamole|dipyridamole|mesh-list
20408851|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20408852|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381238|NCT02340221|Fulvestrant|fulvestrant|mesh-list
19381239|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19381240|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408853|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408854|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20408855|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
20408856|NCT01179256|Curcumin|curcumin|mesh-list
20408857|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20408858|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20408859|NCT01179256|Analgesics|analgesics|mesh-ancestor
20408860|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
19403161|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381241|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19381242|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20408861|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408862|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408863|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408864|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20408865|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408866|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408867|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408868|NCT01179269|Paclitaxel|paclitaxel|mesh-list
20408869|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19381243|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
19381244|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381245|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381246|NCT02270957|Abatacept|abatacept|mesh-list
19381247|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19381248|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381249|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381250|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381251|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
19381252|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381253|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19381254|NCT02237183|Iloprost|iloprost|mesh-list
19381255|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19381256|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
19381257|NCT02204085|Decitabine|decitabine|mesh-list
19381258|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381259|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
19381260|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381261|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381262|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381263|NCT02134925|Poly ICLC|poly iclc|mesh-list
19381264|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
19381265|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
19381266|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381267|NCT02133573|Progesterone|progesterone|mesh-list
19381268|NCT02133573|Progestins|progestins|mesh-ancestor
20408870|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408871|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
20408872|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
19381269|NCT02133573|Hormones|hormones|mesh-ancestor
19381270|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381271|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381272|NCT02054104|Celecoxib|celecoxib|mesh-list
19381273|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
19381274|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381275|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
19381276|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381277|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19381278|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19381279|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
19381280|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381281|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408873|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
20408874|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408875|NCT01179308|Anesthetics|anesthetics|mesh-list
20408876|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408877|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408878|NCT01179412|Iodine|iodine|mesh-list
20408879|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
20408880|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
20408881|NCT01179412|Povidone|povidone|mesh-list
20408882|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20408883|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408884|NCT01179412|Trace Elements|trace elements|mesh-ancestor
20408885|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
20408886|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408887|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
19381282|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19381283|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19381284|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19381285|NCT02054104|Analgesics|analgesics|mesh-ancestor
20408888|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
20408889|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
20408890|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19381286|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
19381287|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381288|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408891|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408892|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408893|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20408894|NCT01179438|Analgesics|analgesics|mesh-ancestor
20408895|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
20408896|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408897|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20408898|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19381289|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19381290|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19381291|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381292|NCT01954979|Abatacept|abatacept|mesh-list
19381293|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19381294|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381295|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381296|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381297|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
20408899|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20408900|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
20408901|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408902|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408903|NCT01179464|Simvastatin|simvastatin|mesh-list
20408904|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19381298|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381299|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19381300|NCT01899144|Albuterol|albuterol|mesh-list
19381301|NCT01899144|Procaterol|procaterol|mesh-list
20408905|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20408906|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
20408907|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408908|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20408909|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19381302|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19381303|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
19381304|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381305|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381306|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19381307|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
19381308|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
19381309|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19381310|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19381311|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19381312|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19381313|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
19381314|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381315|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381316|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
19381317|NCT01853631|Cyclophosphamide|cyclophosphamide|mesh-list
19381318|NCT01853631|Fludarabine|fludarabine|mesh-list
19381319|NCT01853631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381320|NCT01853631|Immunologic Factors|immunologic factors|mesh-ancestor
19381321|NCT01853631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381322|NCT01853631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19381323|NCT01853631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19381324|NCT01853631|Alkylating Agents|alkylating agents|mesh-ancestor
19381325|NCT01853631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381326|NCT01853631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381327|NCT01853631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19381328|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20213522|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
20213523|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20213524|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213525|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
20213526|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
20213527|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20213528|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20213529|NCT00296023|Methotrexate|methotrexate|mesh-list
20213530|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
20213531|NCT00296023|Fludarabine|fludarabine|mesh-list
20213532|NCT00296023|Busulfan|busulfan|mesh-list
20213533|NCT00296023|Tacrolimus|tacrolimus|mesh-list
19381329|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
19381330|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381331|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381332|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
20408910|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408911|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
19381333|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381334|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381335|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19381336|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19381337|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381338|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
19381339|NCT01724879|Dasatinib|dasatinib|mesh-list
19381340|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381341|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19381342|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408912|NCT01179503|Vitamin D|vitamin d|mesh-list
20408913|NCT01179503|Calcium|calcium|mesh-list
20408914|NCT01179503|Vitamins|vitamins|mesh-ancestor
20408915|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
20408916|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408917|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20408918|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20427401|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427402|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381343|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381344|NCT01468831|Minocycline|minocycline|mesh-list
19381345|NCT01468831|Bevacizumab|bevacizumab|mesh-list
19381346|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381347|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381348|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19381349|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19381350|NCT01468831|Growth Substances|growth substances|mesh-ancestor
19381351|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381352|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
19381353|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19381354|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381355|NCT01383109|Pyronaridine|pyronaridine|mesh-list
19381356|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
19381357|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19381358|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19381359|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381360|NCT00822120|Prednisone|prednisone|mesh-list
19381361|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
19381362|NCT00822120|Dacarbazine|dacarbazine|mesh-list
19381363|NCT00822120|Doxorubicin|doxorubicin|mesh-list
19381364|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19381365|NCT00822120|Etoposide|etoposide|mesh-list
19381366|NCT00822120|Vincristine|vincristine|mesh-list
19381367|NCT00822120|Bleomycin|bleomycin|mesh-list
20427403|NCT01287130|Cetuximab|cetuximab|mesh-list
20427404|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20427405|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427406|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
20427407|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20427408|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19381368|NCT00822120|Vinblastine|vinblastine|mesh-list
19381369|NCT00822120|Procarbazine|procarbazine|mesh-list
19381370|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381371|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
19381372|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381373|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19381374|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19381375|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
19381376|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381377|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381378|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19381379|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19381380|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19381381|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19381382|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427409|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381383|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19381384|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
19381385|NCT00822120|Hormones|hormones|mesh-ancestor
19381386|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20408919|NCT01179529|Omalizumab|omalizumab|mesh-list
20408920|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20408921|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20408922|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
20408923|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20408924|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
20408925|NCT01179594|Entecavir|entecavir|mesh-list
20408926|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
20408927|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20408928|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
20408929|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408930|NCT01179620|Certoparin|certoparin|mesh-list
20408931|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
20408932|NCT01179646|Pantoprazole|pantoprazole|mesh-list
20408933|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20408934|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408935|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20408936|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408937|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408938|NCT01179659|Pantoprazole|pantoprazole|mesh-list
19381387|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19381388|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19381389|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
19381390|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
19381391|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
19381392|NCT00799110|Imiquimod|imiquimod|mesh-list
19381393|NCT00799110|Vaccines|vaccines|mesh-list
19381394|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
19381395|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381396|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19381397|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20408939|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20408940|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408941|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20408942|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408943|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408944|NCT01179724|Pantoprazole|pantoprazole|mesh-list
20408945|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20408946|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20408947|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20408948|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408949|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408950|NCT01179776|Iloprost|iloprost|mesh-list
19381398|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
19381399|NCT00697684|Clofarabine|clofarabine|mesh-list
19381400|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19381401|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381402|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
19381403|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381404|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381405|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
19381406|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381407|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381408|NCT00603954|Vidarabine|vidarabine|mesh-list
19381409|NCT00603954|Fludarabine|fludarabine|mesh-list
19381410|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
19381411|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19381412|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381413|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381414|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
19381415|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381416|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381417|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
20408951|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20408952|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
20408953|NCT01179828|Oxycodone|oxycodone|mesh-list
20408954|NCT01179828|Clobazam|clobazam|mesh-list
20408955|NCT01179828|Imipramine|imipramine|mesh-list
20408956|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20408957|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20408958|NCT01179828|Narcotics|narcotics|mesh-ancestor
19381418|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381419|NCT00603954|Antiviral Agents|antiviral agents|mesh-ancestor
19381420|NCT00603954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381421|NCT00392353|Azacitidine|azacitidine|mesh-list
20408959|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20408960|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408961|NCT01179828|Analgesics|analgesics|mesh-ancestor
20408962|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
20408963|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408964|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19381422|NCT00392353|Vorinostat|vorinostat|mesh-list
19381423|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381424|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
19381425|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381426|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381427|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20408965|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20408966|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
20408967|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20408968|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408969|NCT01179828|Urological Agents|urological agents|mesh-ancestor
20408970|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20408971|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
20408972|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20408973|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20408974|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20408975|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20408976|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
20408977|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
20408978|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20408979|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19381428|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19381429|NCT00003777|Fluorouracil|fluorouracil|mesh-list
19381430|NCT00003777|Amifostine|amifostine|mesh-list
19381431|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381432|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
19381433|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381434|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381435|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381436|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
19381437|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381438|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19381439|NCT00003777|Protective Agents|protective agents|mesh-ancestor
19381440|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19381441|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19381442|NCT05214573|Glucagon|glucagon|mesh-list
19381443|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19381444|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19381445|NCT05214573|Hormones|hormones|mesh-ancestor
19381446|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381447|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381448|NCT05214573|Incretins|incretins|mesh-ancestor
19381449|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
19381450|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381451|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381452|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19381453|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
19381454|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381455|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19381456|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381457|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381458|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19381459|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381460|NCT05214222|Paclitaxel|paclitaxel|mesh-list
19381461|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19381462|NCT05214222|Cisplatin|cisplatin|mesh-list
19381463|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19381464|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381465|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
19381466|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
19381467|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
19381468|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381469|NCT05214157|Bupivacaine|bupivacaine|mesh-list
19381470|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
19381471|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
19381472|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381473|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381474|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
19381475|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381476|NCT05214001|Almotriptan|almotriptan|mesh-list
19381477|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19381478|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
19381479|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381480|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381481|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381482|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
19381483|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19381484|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19381485|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
19381486|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381487|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19381488|NCT05213884|Cisplatin|cisplatin|mesh-list
19381489|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381490|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
19381491|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19381492|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
19381493|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381494|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381495|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19381496|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
19381497|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19381498|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
19381499|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381500|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381501|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20408980|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20408981|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
20408982|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
19381502|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
19381503|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
19381504|NCT05213676|Protective Agents|protective agents|mesh-ancestor
19381505|NCT05213585|Ivermectin|ivermectin|mesh-list
19381506|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19381507|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381508|NCT05213312|Paclitaxel|paclitaxel|mesh-list
19381509|NCT05213312|Fluorouracil|fluorouracil|mesh-list
19381510|NCT05213312|Nivolumab|nivolumab|mesh-list
19381511|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19381512|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381513|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
19381514|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
19381515|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
19381516|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381517|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
19381518|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381519|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381520|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
19381521|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381522|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381523|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19403162|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
19403163|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
19403164|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403165|NCT03603249|Trimetazidine|trimetazidine|mesh-list
19403166|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
19403167|NCT03603119|Dexamethasone|dexamethasone|mesh-list
19403168|NCT03603119|Midazolam|midazolam|mesh-list
19403169|NCT03603119|Ondansetron|ondansetron|mesh-list
19403170|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403171|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
19403172|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
19403173|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403174|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408983|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
20408984|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20408985|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20408986|NCT01179971|Analgesics|analgesics|mesh-ancestor
20408987|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
20408988|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20408989|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408990|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20408991|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19403175|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403176|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
19403177|NCT03603119|Hormones|hormones|mesh-ancestor
19403178|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403179|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19381524|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19381525|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19381526|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19381527|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381528|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381529|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381530|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19381531|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19381532|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19381533|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
19381534|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381535|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381536|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19381537|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19381538|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
19381539|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19381540|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19381541|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
19381542|NCT05213065|Bupivacaine|bupivacaine|mesh-list
19381543|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
19381544|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
19381545|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381546|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20408992|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20408993|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
20408994|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20408995|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20408996|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
20408997|NCT01180062|Latanoprost|latanoprost|mesh-list
20408998|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20408999|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20409000|NCT01180075|Ritonavir|ritonavir|mesh-list
20409001|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20409002|NCT01180075|Tenofovir|tenofovir|mesh-list
20409003|NCT01180075|Emtricitabine|emtricitabine|mesh-list
20409004|NCT01180075|Efavirenz|efavirenz|mesh-list
20409005|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20409006|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20409007|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
20409008|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409009|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409010|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20409011|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20409012|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
20409013|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409014|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20409015|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20409016|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20409017|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20409018|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19381547|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
19381548|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381549|NCT05212766|Vaccines|vaccines|mesh-list
19381550|NCT05212766|Immunologic Factors|immunologic factors|mesh-ancestor
20409019|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19381551|NCT05212766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381552|NCT05212662|Cysteamine|cysteamine|mesh-list
19381553|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19381554|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381555|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
19381556|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381557|NCT05212597|Losartan|losartan|mesh-list
19381558|NCT05212597|Amlodipine|amlodipine|mesh-list
19381559|NCT05212597|Valsartan|valsartan|mesh-list
19381560|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19381561|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19381562|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19381563|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381564|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381565|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19381566|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381567|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
19691345|NCT05006209|Calcium|calcium|mesh-list
20409020|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20409021|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20409022|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20409023|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
20409024|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409025|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
20409026|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409027|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847618|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847619|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847620|NCT00687401|Infliximab|infliximab|mesh-list
19847621|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847622|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847623|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847624|NCT00687440|Docetaxel|docetaxel|mesh-list
19847625|NCT00687440|Doxorubicin|doxorubicin|mesh-list
19381568|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19381569|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19381570|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19381571|NCT05212337|Denosumab|denosumab|mesh-list
19381572|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19381573|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381574|NCT05212246|Imiquimod|imiquimod|mesh-list
19847626|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19847627|NCT00687440|Trastuzumab|trastuzumab|mesh-list
19847628|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847629|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
19847630|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
19847631|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
19381575|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19381576|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
19847632|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847633|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19847634|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19847635|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19847636|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847637|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19847638|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
20409028|NCT01180179|Lansoprazole|lansoprazole|mesh-list
20409029|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
20409030|NCT01180179|Famotidine|famotidine|mesh-list
20409031|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20409032|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409033|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20409034|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381577|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381578|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381579|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
19381580|NCT05212025|Gemcitabine|gemcitabine|mesh-list
19381581|NCT05212025|Adavosertib|adavosertib|mesh-list
19381582|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381583|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
19381584|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381585|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381586|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
19381587|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847639|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20213534|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20213535|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20213536|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
20213537|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20213538|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213539|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213540|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
20213541|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213542|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213543|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
20213544|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213545|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20213546|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213547|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
20213548|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213549|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20213550|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20213551|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
19381588|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381589|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409035|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409036|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20409037|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
20409038|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
20409039|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409040|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409041|NCT01180205|Amlodipine|amlodipine|mesh-list
20409042|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20409043|NCT01180205|Telmisartan|telmisartan|mesh-list
20409044|NCT01180205|Olmesartan|olmesartan|mesh-list
20409045|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20409046|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20409047|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20409048|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20409049|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409050|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409051|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409052|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
20409053|NCT01180205|Diuretics|diuretics|mesh-ancestor
20409054|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
20409055|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20409056|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20409057|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20409058|NCT01180231|Moxonidine|moxonidine|mesh-list
20409059|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20409060|NCT01180322|Cytarabine|cytarabine|mesh-list
20409061|NCT01180322|Etoposide|etoposide|mesh-list
20409062|NCT01180322|Idarubicin|idarubicin|mesh-list
20409063|NCT01180322|Azacitidine|azacitidine|mesh-list
20409064|NCT01180322|Lenograstim|lenograstim|mesh-list
20409065|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20409066|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409067|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20409068|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20409069|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409070|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409071|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381590|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
19381591|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381592|NCT05211791|Anesthetics|anesthetics|mesh-list
19381593|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381594|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381595|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
20409072|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
20409073|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
20409074|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409075|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409076|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
20409077|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409078|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20409079|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20409080|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
20409081|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20409082|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20409083|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19381596|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
19381597|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19381598|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20409084|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20409085|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409086|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
20409087|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409088|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409089|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19381599|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19381600|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381601|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
19381602|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
19381603|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
20409090|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409091|NCT01180413|Losartan|losartan|mesh-list
19381604|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381605|NCT05211622|Protective Agents|protective agents|mesh-ancestor
20409092|NCT01180413|Amlodipine|amlodipine|mesh-list
20409093|NCT01180413|Ramipril|ramipril|mesh-list
20409094|NCT01180413|Lercanidipine|lercanidipine|mesh-list
20409095|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20409096|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20409097|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20409098|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409099|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409100|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409101|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
19381606|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381607|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
19381608|NCT05211622|Vitamins|vitamins|mesh-ancestor
19381609|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
19381610|NCT05211583|Progesterone|progesterone|mesh-list
19381611|NCT05211583|Progestins|progestins|mesh-ancestor
19381612|NCT05211583|Hormones|hormones|mesh-ancestor
19381613|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381614|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381615|NCT05211050|Cromakalim|cromakalim|mesh-list
19381616|NCT05211050|Sumatriptan|sumatriptan|mesh-list
19381617|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19381618|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19381619|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19381620|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
19381621|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381622|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381623|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381624|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19381625|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19381626|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
19381627|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381628|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19381629|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
19381630|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
19381631|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
19381632|NCT05211011|Fosfomycin|fosfomycin|mesh-list
19381633|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19381634|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381635|NCT05210595|Clopidogrel|clopidogrel|mesh-list
19381636|NCT05210595|Ticagrelor|ticagrelor|mesh-list
19381637|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19381638|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19381639|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19381640|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19381641|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
19381642|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381643|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381644|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403180|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403181|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19403182|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19403183|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403184|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19403185|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19403186|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19403187|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19403188|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
19403189|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
19403190|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
19403191|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
19403192|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403193|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403194|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
19403195|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
19403196|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19403197|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
19403198|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20409102|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19403199|NCT03603080|Metformin|metformin|mesh-list
19403200|NCT03603080|Topiramate|topiramate|mesh-list
19403201|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
19403202|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19403203|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409103|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20409104|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19381647|NCT05210517|Empagliflozin|empagliflozin|mesh-list
19381648|NCT05210517|Benzbromarone|benzbromarone|mesh-list
19381649|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19381650|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409105|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20409106|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
20409107|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409108|NCT01180426|Tosedostat|tosedostat|mesh-list
20409109|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409110|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409111|NCT01180569|Lenalidomide|lenalidomide|mesh-list
20409112|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
19381651|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19381652|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381653|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
19381654|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
19381655|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19381656|NCT05210517|Renal Agents|renal agents|mesh-ancestor
19381657|NCT05210465|Dobutamine|dobutamine|mesh-list
19381658|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19381659|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
19381660|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
19381661|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381662|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381663|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19381664|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20409113|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409114|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20409115|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20409116|NCT01180569|Growth Substances|growth substances|mesh-ancestor
20409117|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
20409118|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409119|NCT01180621|Vaccines|vaccines|mesh-list
20409120|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
19381665|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19381666|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
19381667|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381668|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381669|NCT05210465|Protective Agents|protective agents|mesh-ancestor
19381670|NCT05210192|Lidocaine|lidocaine|mesh-list
20409121|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409122|NCT01180725|Psyllium|psyllium|mesh-list
20409123|NCT01180725|Cathartics|cathartics|mesh-ancestor
19381671|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
19381672|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
19381673|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381674|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381675|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
19381676|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381677|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19381678|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19381679|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20409124|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409125|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20409126|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20409127|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409128|NCT01180816|Temozolomide|temozolomide|mesh-list
20409129|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20409130|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
20409131|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409132|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409133|NCT01180933|Folic Acid|folic acid|mesh-list
20409134|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
19381680|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381681|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381682|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
19381683|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
19381684|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381685|NCT05210166|Protective Agents|protective agents|mesh-ancestor
19381686|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381687|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20409135|NCT01180933|Hematinics|hematinics|mesh-ancestor
19381688|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381689|NCT05210153|Sertraline|sertraline|mesh-list
19381690|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
19381691|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381692|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19381693|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19381694|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381695|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381696|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381697|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
19381698|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381699|NCT05210140|Citalopram|citalopram|mesh-list
19381700|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19381701|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19381702|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381703|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381704|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381705|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
19381706|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381707|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19381708|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
19381709|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381710|NCT05209984|Topiramate|topiramate|mesh-list
19381711|NCT05209984|Sibutramine|sibutramine|mesh-list
19381712|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
19381713|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19381714|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381715|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
19381716|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381717|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
19381718|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19381719|NCT05209906|Fentanyl|fentanyl|mesh-list
19381720|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19381721|NCT05209906|Narcotics|narcotics|mesh-ancestor
19381722|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381723|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381724|NCT05209906|Analgesics|analgesics|mesh-ancestor
19381725|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
19381726|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381727|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19381728|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19381729|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
19381730|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
19381731|NCT05209217|Ketamine|ketamine|mesh-list
19381732|NCT05209217|Analgesics|analgesics|mesh-ancestor
19381733|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
19381734|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381735|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381736|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19381737|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19381738|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
19381739|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
19381740|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381741|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19381742|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19381743|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381744|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847640|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409136|NCT01180933|Vitamins|vitamins|mesh-ancestor
20409137|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
20409138|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409139|NCT01180946|Vitamin D|vitamin d|mesh-list
20409140|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
20409141|NCT01180946|Vitamins|vitamins|mesh-ancestor
20409142|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
20409143|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409144|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20409145|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409146|NCT01180959|Bevacizumab|bevacizumab|mesh-list
20409147|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19847641|NCT00687544|Ribavirin|ribavirin|mesh-list
19847642|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19381748|NCT05191264|Analgesics|analgesics|mesh-list
20409148|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19381749|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
19847643|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
19381750|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381751|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381752|NCT05190627|Loratadine|loratadine|mesh-list
20409149|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409150|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20409151|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20409152|NCT01180959|Growth Substances|growth substances|mesh-ancestor
20409153|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409154|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
20409155|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20409156|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409157|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409158|NCT01181063|Budesonide|budesonide|mesh-list
20409159|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
20409160|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20409161|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20409162|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
20409163|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409164|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409165|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20409166|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
20409167|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
20409168|NCT01181063|Hormones|hormones|mesh-ancestor
19381753|NCT05190627|Sirolimus|sirolimus|mesh-list
19381754|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19381755|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381756|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19381757|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381758|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
19381759|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19381760|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
19381761|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381762|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
20409169|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409170|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20409171|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20409172|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20409173|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
20409174|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409175|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409176|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
20409177|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20409178|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
20409179|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409180|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409181|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
20409182|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409183|NCT01181154|Rituximab|rituximab|mesh-list
20409184|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409185|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409186|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
20409187|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409188|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409189|NCT01181193|Vitamin D|vitamin d|mesh-list
19381763|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
19381764|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19381765|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19381766|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19381767|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
19381768|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
19381769|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381770|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381771|NCT05188820|Cortisone|cortisone|mesh-list
19381772|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19381773|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19381774|NCT05188417|Tirofiban|tirofiban|mesh-list
19381775|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19381776|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19381777|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381778|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19381779|NCT05188326|Azacitidine|azacitidine|mesh-list
19381780|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381781|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
19381782|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381783|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381784|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381785|NCT05187039|Anesthetics|anesthetics|mesh-list
19381786|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381787|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381788|NCT05186454|Dexamethasone|dexamethasone|mesh-list
19381789|NCT05186454|Midazolam|midazolam|mesh-list
19381790|NCT05186454|Morphine|morphine|mesh-list
19381791|NCT05186454|Bupivacaine|bupivacaine|mesh-list
19381792|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19381793|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
19381794|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
19381795|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381796|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381797|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19381798|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
19381799|NCT05186454|Hormones|hormones|mesh-ancestor
19381800|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381801|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19381802|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381803|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
19381804|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
19381805|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381806|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
19381807|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19381808|NCT05186454|Narcotics|narcotics|mesh-ancestor
19381809|NCT05186454|Analgesics|analgesics|mesh-ancestor
19381810|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19381811|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19381812|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19381813|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19381814|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381815|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19381816|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
19381817|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
19381818|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
19381819|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381820|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381821|NCT05176080|Fulvestrant|fulvestrant|mesh-list
19381822|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19381823|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381824|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19381825|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19381826|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
19381827|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381828|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381829|NCT05162898|Lenvatinib|lenvatinib|mesh-list
19381830|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381831|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19381832|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381833|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403204|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
19403205|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19403206|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19403207|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403208|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19403209|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19403210|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403211|NCT03602898|Cyclosporine|cyclosporine|mesh-list
19403212|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
19403213|NCT03602898|Busulfan|busulfan|mesh-list
19403214|NCT03602898|Methotrexate|methotrexate|mesh-list
19403215|NCT03602898|Fludarabine|fludarabine|mesh-list
19403216|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
19403217|NCT03602898|Tacrolimus|tacrolimus|mesh-list
19403218|NCT03602898|Cyclosporins|cyclosporins|mesh-list
19403219|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19403220|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403221|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
19403222|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403223|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409190|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
20409191|NCT01181193|Temozolomide|temozolomide|mesh-list
19403224|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19403225|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
19403226|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403227|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409192|NCT01181193|Vitamins|vitamins|mesh-ancestor
20409193|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
20409194|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409195|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20409196|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20409197|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
20409198|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409199|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409200|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409201|NCT01181232|Zolpidem|zolpidem|mesh-list
20409202|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20409203|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20409204|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409205|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409206|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20409207|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
20409208|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
19381834|NCT05155137|Amlodipine|amlodipine|mesh-list
19381835|NCT05155137|Valsartan|valsartan|mesh-list
19381836|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19381837|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19381838|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19381839|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381840|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381841|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19381842|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381843|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
19381844|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19381845|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19381846|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
19381847|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19381848|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19381849|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381850|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19381851|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19381852|NCT05153525|Cisatracurium|cisatracurium|mesh-list
19381853|NCT05153525|Atracurium|atracurium|mesh-list
19381854|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20409209|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381855|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19381856|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381857|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381858|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19381859|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19381860|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19381861|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
19847644|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847645|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
19847646|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847647|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19847648|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19847649|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19847650|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847651|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847652|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19847653|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847654|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847655|NCT00687674|Dexamethasone|dexamethasone|mesh-list
19381862|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381863|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381864|NCT05144295|Lactulose|lactulose|mesh-list
19381865|NCT05144295|Bisacodyl|bisacodyl|mesh-list
19381866|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
19381867|NCT05144295|Lubiprostone|lubiprostone|mesh-list
19381868|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19381869|NCT05144295|Cathartics|cathartics|mesh-ancestor
19381870|NCT05144295|Laxatives|laxatives|mesh-ancestor
19381871|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19381872|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381873|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381874|NCT05134857|Zonisamide|zonisamide|mesh-list
19381875|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
19847656|NCT00687674|Lenalidomide|lenalidomide|mesh-list
19847657|NCT00687674|Sorafenib|sorafenib|mesh-list
19381876|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19381877|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19381878|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381879|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19381880|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381881|NCT05113290|Sorafenib|sorafenib|mesh-list
19381882|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409210|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427410|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427411|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
20427412|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427413|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427414|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20427415|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427416|NCT01287260|Nifedipine|nifedipine|mesh-list
20427417|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20427418|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20427419|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427420|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20427421|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427422|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
20427423|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
20427424|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20427425|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20427426|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20427427|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427428|NCT01287338|Analgesics|analgesics|mesh-ancestor
20427429|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
20427430|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427431|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427432|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427433|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427434|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20427435|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20427436|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20427437|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
20427438|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
19381883|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19381884|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381885|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381886|NCT05107778|Entecavir|entecavir|mesh-list
19381887|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
20427439|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427440|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427441|NCT01287351|Fluticasone|fluticasone|mesh-list
20427442|NCT01287351|Xhance|xhance|mesh-list
20427443|NCT01287351|Beclomethasone|beclomethasone|mesh-list
20427444|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427445|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20427446|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
20427447|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427448|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427449|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19381888|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19381889|NCT05097716|Tolbutamide|tolbutamide|mesh-list
19381890|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19381891|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381892|NCT05095857|Ketamine|ketamine|mesh-list
19381893|NCT05095857|Esketamine|esketamine|mesh-list
19381894|NCT05095857|Analgesics|analgesics|mesh-ancestor
19381895|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
19381896|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381897|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381898|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19381899|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19381900|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
19381901|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
19381902|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381903|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19381904|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20427450|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
20427451|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
19381905|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381906|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381907|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
19381908|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381909|NCT05076877|Metformin|metformin|mesh-list
19381910|NCT05076877|Midazolam|midazolam|mesh-list
19381911|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19381912|NCT05076877|Lazertinib|lazertinib|mesh-list
19381913|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19381914|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381915|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19381916|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19381917|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381918|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19381919|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19381920|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19381921|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19381922|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
19381923|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
19381924|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
19381925|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
19381926|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381927|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381928|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19381929|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19381930|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
19381931|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19381932|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19381933|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19381934|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19847658|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847659|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
19847660|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
19847661|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847662|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847663|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847664|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
19847665|NCT00687674|Hormones|hormones|mesh-ancestor
19847666|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19847667|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847668|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847669|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
19847670|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19847671|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19847672|NCT00687674|Growth Substances|growth substances|mesh-ancestor
19847673|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
19847674|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19847675|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847676|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847677|NCT00687713|Bupropion|bupropion|mesh-list
19847678|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19847679|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
19847680|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19847681|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19847682|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20213552|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19381957|NCT05070039|Antibodies|antibodies|mesh-list
20213553|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20213554|NCT00296049|Vancomycin|vancomycin|mesh-list
20213555|NCT00296049|Daptomycin|daptomycin|mesh-list
20213556|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20213557|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213558|NCT00296062|Bevacizumab|bevacizumab|mesh-list
20213559|NCT00296062|Capecitabine|capecitabine|mesh-list
20213560|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
20213561|NCT00296062|Irinotecan|irinotecan|mesh-list
20213562|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20213563|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213564|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20213565|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20213566|NCT00296062|Growth Substances|growth substances|mesh-ancestor
20213567|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213568|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
20213569|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19381958|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
19381959|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381960|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
19381961|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19381962|NCT05058872|Estradiol|estradiol|mesh-list
19381963|NCT05058872|Estrogens|estrogens|mesh-ancestor
19381964|NCT05058872|Hormones|hormones|mesh-ancestor
19381965|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19381966|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381967|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19381968|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
20409211|NCT01181310|Scopolamine|scopolamine|mesh-list
20409212|NCT01181310|Donepezil|donepezil|mesh-list
20409213|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19381969|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19381970|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19381971|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19381972|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19381973|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19381974|NCT05041049|Anesthetics|anesthetics|mesh-list
19381975|NCT05041049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19381976|NCT05041049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381977|NCT05020145|Vaccines|vaccines|mesh-list
19381978|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
19381979|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381980|NCT05004662|Nicotine|nicotine|mesh-list
19381981|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19381982|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
19381983|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19381984|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19381985|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19381986|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19381987|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
19381988|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19381989|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381990|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19381991|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19381992|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
19381993|NCT04968366|Temozolomide|temozolomide|mesh-list
19381994|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19381995|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
19381996|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19381997|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19381998|NCT04964128|Insulin|insulin|mesh-list
19381999|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19382000|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403228|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20409214|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20409215|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409216|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409217|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
20409218|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409219|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409220|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
20409221|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19403229|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19403230|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
19403231|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19403232|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19403233|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
19403234|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
19403235|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403236|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19403237|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19403238|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19403239|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
19403240|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403241|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19403242|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403243|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
19403244|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20409222|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
20409223|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
20409224|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409225|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409226|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
19403245|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
20409227|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19382001|NCT04901715|Albuterol|albuterol|mesh-list
19382002|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19382003|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
19382004|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382005|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382006|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19382007|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
19382008|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
19382009|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19382010|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19382011|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19382012|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19382013|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
19382014|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382015|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382016|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
19382017|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19382018|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
19382019|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382020|NCT04880707|Anesthetics|anesthetics|mesh-list
19382021|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
19382022|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382023|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382024|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
19382025|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382026|NCT04864678|Vaccines|vaccines|mesh-list
19382027|NCT04864678|Immunologic Factors|immunologic factors|mesh-ancestor
19382028|NCT04864678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382036|NCT04827979|Daratumumab|daratumumab|mesh-list
19382037|NCT04827979|Abatacept|abatacept|mesh-list
19382038|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
19382039|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
19382040|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
19382041|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382042|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382043|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382044|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382045|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382046|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382047|NCT04824092|Prednisone|prednisone|mesh-list
19382048|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
19382049|NCT04824092|Rituximab|rituximab|mesh-list
19382050|NCT04824092|Doxorubicin|doxorubicin|mesh-list
19382051|NCT04824092|Vincristine|vincristine|mesh-list
19382052|NCT04824092|Lenalidomide|lenalidomide|mesh-list
19382053|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382054|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
20213570|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
20213571|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213572|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20213573|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20213574|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213575|NCT00296127|Celecoxib|celecoxib|mesh-list
20213576|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20213577|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20213578|NCT00296127|Analgesics|analgesics|mesh-ancestor
20213579|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
20213580|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213581|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213582|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213583|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213584|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20213585|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20213586|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213587|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213588|NCT00296179|Zolpidem|zolpidem|mesh-list
20213589|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20213590|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20217931|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
20409228|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20409229|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
20409230|NCT01181388|Tirofiban|tirofiban|mesh-list
20409231|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20409232|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20409233|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409234|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20409235|NCT01181401|Cisplatin|cisplatin|mesh-list
20409236|NCT01181401|Docetaxel|docetaxel|mesh-list
20409237|NCT01181401|Cetuximab|cetuximab|mesh-list
20409238|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409239|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
20409240|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
20409241|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
20409242|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409243|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409244|NCT01181414|Amiodarone|amiodarone|mesh-list
20409245|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20409246|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20409247|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
20409248|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20409249|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20409250|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409251|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20409252|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20409253|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20409254|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409255|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20409256|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20409257|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20409258|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20409259|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
20409260|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409261|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409262|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
20409263|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409264|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409265|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20409266|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20409267|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20409268|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
20409269|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409270|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409271|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409272|NCT01181505|Urological Agents|urological agents|mesh-ancestor
20409273|NCT01181544|Heparin|heparin|mesh-list
20409274|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
20213591|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213592|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409275|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20409276|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20409277|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409278|NCT01181570|Adalimumab|adalimumab|mesh-list
20409279|NCT01181570|Mannitol|mannitol|mesh-list
20409280|NCT01181570|Citric Acid|citric acid|mesh-list
20409281|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
20409282|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
20409283|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20409284|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
20409285|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
20409286|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409287|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20409288|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409289|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20409290|NCT01181570|Diuretics|diuretics|mesh-ancestor
20409291|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
20213593|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20213594|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
20213595|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
20213596|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213597|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213598|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
20213599|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213600|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
19382055|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382056|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382057|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19382058|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
19382059|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382060|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382061|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19382062|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382063|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19382064|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19382065|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19382066|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382067|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20409292|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409293|NCT01181765|Infliximab|infliximab|mesh-list
20409294|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
20409295|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409296|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409297|NCT01181882|Aspirin|aspirin|mesh-list
19382068|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
19382069|NCT04824092|Hormones|hormones|mesh-ancestor
20213601|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213602|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213603|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20213604|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
20213605|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382070|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382071|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382072|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19382073|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
19382074|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19382075|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382076|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19382077|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20213606|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409298|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20409299|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20409300|NCT01181882|Analgesics|analgesics|mesh-ancestor
20409301|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
20409302|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409303|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409304|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20409305|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409306|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20409307|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20409308|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409309|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20409310|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20409311|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409312|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
20409313|NCT01181934|Nicotine|nicotine|mesh-list
20409314|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20409315|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
20409316|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409317|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409318|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20409319|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20409320|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
20409321|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409322|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409323|NCT01181960|Risperidone|risperidone|mesh-list
20409324|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20409325|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
20409326|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20409327|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
20409328|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409329|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409330|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409331|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409332|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409333|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213607|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20409334|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19382078|NCT04824092|Growth Substances|growth substances|mesh-ancestor
19382079|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
19382080|NCT04814355|Celecoxib|celecoxib|mesh-list
19382081|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19382082|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19382083|NCT04814355|Analgesics|analgesics|mesh-ancestor
19382084|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
19382085|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382086|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382087|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382088|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382089|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19382090|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19382091|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382092|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382093|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
20409335|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
20409336|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20409337|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20409338|NCT01181999|Rituximab|rituximab|mesh-list
20409339|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409340|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409341|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
20409342|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409343|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409344|NCT01182077|Midazolam|midazolam|mesh-list
20409345|NCT01182077|Peficitinib|peficitinib|mesh-list
20409346|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20409347|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20409348|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409349|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409350|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20409351|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409352|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20409353|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20409354|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
20409355|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
20409356|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
20409357|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
20409358|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409359|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409360|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409361|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409362|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
20409363|NCT01182129|Nicotine|nicotine|mesh-list
19382094|NCT04798339|Hematinics|hematinics|mesh-ancestor
19382095|NCT04789304|Midazolam|midazolam|mesh-list
19382096|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19382097|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19382098|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382099|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382100|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19382101|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19382102|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382103|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19382104|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
19382105|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
19382106|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
19382107|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
19382108|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382109|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382110|NCT04784637|Insulin|insulin|mesh-list
19382111|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19382112|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382113|NCT04780724|Nitrox|nitrox|mesh-list
19382114|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19382115|NCT04780724|Protective Agents|protective agents|mesh-ancestor
19382116|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382117|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
19382118|NCT04774965|Promethazine|promethazine|mesh-list
19382119|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19382120|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20409364|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20409365|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
19382121|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382122|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409366|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382123|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
19382124|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
19382125|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
19382126|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382127|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
19382128|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
19382129|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382130|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19382131|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
19382132|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
19382133|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382134|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382135|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19382136|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
19382137|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
19382138|NCT04742959|Paclitaxel|paclitaxel|mesh-list
19382139|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19382140|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382141|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
19382142|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
19382143|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382144|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382145|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
19382146|NCT04700007|Promethazine|promethazine|mesh-list
20409367|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409368|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20409369|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19382147|NCT04700007|Morphine|morphine|mesh-list
19382148|NCT04700007|Capsaicin|capsaicin|mesh-list
19382149|NCT04700007|Histamine|histamine|mesh-list
19382150|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19382151|NCT04700007|Narcotics|narcotics|mesh-ancestor
19382152|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382153|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382154|NCT04700007|Analgesics|analgesics|mesh-ancestor
19382155|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
19382156|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382157|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
19382158|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847683|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847684|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847685|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
19847686|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213608|NCT00296218|Irbesartan|irbesartan|mesh-list
19382159|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19382160|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19382161|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19382162|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
19382163|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
19382164|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
19382165|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382166|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19382167|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-ancestor
19382168|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
19382169|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382170|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213609|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20213610|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20213611|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20213612|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213613|NCT00296257|Rimacalib|rimacalib|mesh-list
20213614|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20213615|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213616|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213617|NCT00296309|Tacrolimus|tacrolimus|mesh-list
20213618|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213619|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
20213620|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213621|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20213622|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213623|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213624|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
20213625|NCT00296348|Tacrolimus|tacrolimus|mesh-list
20213626|NCT00296348|Daclizumab|daclizumab|mesh-list
20213627|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213628|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
19382171|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19382172|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
19382173|NCT04681079|Albuterol|albuterol|mesh-list
19382174|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19382175|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
19382176|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382177|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382178|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20409370|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
20409371|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409372|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409373|NCT01182142|Capecitabine|capecitabine|mesh-list
20409374|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20409375|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
20409376|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409377|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382179|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
19847687|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847688|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19847689|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19847690|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847691|NCT00687739|Leuprolide|leuprolide|mesh-list
19382180|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
19382181|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20213629|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213630|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20213631|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213632|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213633|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19847692|NCT00687739|Estradiol|estradiol|mesh-list
20213634|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213635|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20213636|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
20213637|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20213638|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213639|NCT00296361|Tacrolimus|tacrolimus|mesh-list
20213640|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213641|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
20213642|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213643|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19382182|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19382183|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19382184|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19382185|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
19382186|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382187|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382188|NCT04672382|Morphine|morphine|mesh-list
19382189|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19382190|NCT04672382|Narcotics|narcotics|mesh-ancestor
19382191|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382192|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382193|NCT04672382|Analgesics|analgesics|mesh-ancestor
19382194|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
19382195|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403246|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213644|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213645|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213646|NCT00296387|Atorvastatin|atorvastatin|mesh-list
20213647|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20213648|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20213649|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20213650|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
19403247|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847693|NCT00687739|Estrogens|estrogens|mesh-ancestor
19847694|NCT00687739|Hormones|hormones|mesh-ancestor
20213651|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213652|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20213653|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20213654|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213655|NCT00296465|Citric Acid|citric acid|mesh-list
20213656|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
20213657|NCT00296465|Clomiphene|clomiphene|mesh-list
20409378|NCT01182168|Gemcitabine|gemcitabine|mesh-list
19848273|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213658|NCT00296465|Enclomiphene|enclomiphene|mesh-list
19382196|NCT04663282|Insulin|insulin|mesh-list
19382197|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19382198|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382199|NCT04654689|Curcumin|curcumin|mesh-list
19382200|NCT04654689|Resveratrol|resveratrol|mesh-list
19382201|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19382202|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19382203|NCT04654689|Analgesics|analgesics|mesh-ancestor
19382204|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
19382205|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382206|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382207|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382208|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382209|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382210|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382211|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382212|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
19847695|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409379|NCT01182168|Everolimus|everolimus|mesh-list
20409380|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409381|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20409382|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
20409383|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409384|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
20409385|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409386|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409387|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409388|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
20409389|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409390|NCT01182246|Genistein|genistein|mesh-list
20409391|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20409392|NCT01182246|Protective Agents|protective agents|mesh-ancestor
20409393|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409394|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409395|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20409396|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409397|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409398|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
20409399|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19847696|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409400|NCT01182246|Estrogens|estrogens|mesh-ancestor
20409401|NCT01182246|Hormones|hormones|mesh-ancestor
19382213|NCT04654689|Protective Agents|protective agents|mesh-ancestor
19382214|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19382215|NCT04643405|Gemcitabine|gemcitabine|mesh-list
19382216|NCT04643405|Paclitaxel|paclitaxel|mesh-list
19382217|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19382218|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382219|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
19382220|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
19382221|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382222|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382223|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19382224|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
19382225|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
19382226|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382227|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382228|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382229|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
19382230|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382231|NCT04625803|Apatinib|apatinib|mesh-list
19382232|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382233|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19382234|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382235|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382236|NCT04623567|Metformin|metformin|mesh-list
19382237|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19382238|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382239|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
19382240|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19382241|NCT04617821|Gemcitabine|gemcitabine|mesh-list
20409402|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409403|NCT01182272|Sorafenib|sorafenib|mesh-list
19382242|NCT04617821|Paclitaxel|paclitaxel|mesh-list
19382243|NCT04617821|Folfirinox|folfirinox|mesh-list
19382244|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20409404|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409405|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20409406|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409407|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409408|NCT01182597|Pantoprazole|pantoprazole|mesh-list
19382245|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382246|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
19382247|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
19382248|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382249|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382250|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19382251|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
19382252|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
19382253|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382254|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382255|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382256|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
19382257|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382258|NCT04607980|Ustekinumab|ustekinumab|mesh-list
19382259|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
19382260|NCT04601350|Anesthetics|anesthetics|mesh-list
19382261|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382262|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382263|NCT04581148|Antibodies|antibodies|mesh-list
19382264|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
19382265|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
19382266|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382267|NCT04574232|Triamcinolone|triamcinolone|mesh-list
19382268|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19382269|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19382270|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19382271|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382272|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
19382273|NCT04574232|Hormones|hormones|mesh-ancestor
19382274|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382275|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382276|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382277|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
19382278|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382279|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382280|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19382281|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
19382282|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382283|NCT04554888|Doxepin|doxepin|mesh-list
19382284|NCT04554888|Histamine|histamine|mesh-list
19382285|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
19382286|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
19382287|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382288|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382289|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382290|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19382291|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19382292|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382293|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19382294|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
19382295|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382296|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
19382297|NCT04548973|Esketamine|esketamine|mesh-list
19382298|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
19382299|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382300|NCT04547985|Naltrexone|naltrexone|mesh-list
19382301|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19382302|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19382303|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382304|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
19382305|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382306|NCT04544189|Fulvestrant|fulvestrant|mesh-list
19382307|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382308|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382309|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19382310|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19382311|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
19382312|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382313|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409409|NCT01182597|Lansoprazole|lansoprazole|mesh-list
19382314|NCT04539548|Prednisolone|prednisolone|mesh-list
19382315|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382316|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
19382317|NCT04539548|Hormones|hormones|mesh-ancestor
19382318|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382319|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382320|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382321|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382322|NCT04538040|Tenofovir|tenofovir|mesh-list
19382323|NCT04538040|Emtricitabine|emtricitabine|mesh-list
20409410|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
20409411|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20409412|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409413|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20409414|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409415|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409416|NCT01182636|Adapalene|adapalene|mesh-list
20409417|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19382324|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19382325|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
19382326|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382327|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19382328|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19382329|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382330|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382331|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20409418|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20409419|NCT01182636|Analgesics|analgesics|mesh-ancestor
20409420|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
20409421|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409422|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409423|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20409424|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409425|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
20409426|NCT01182662|Cyclosporine|cyclosporine|mesh-list
19382332|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19382333|NCT04530305|Upadacitinib|upadacitinib|mesh-list
19382334|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19382335|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19382336|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382337|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382338|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382339|NCT04522804|Psilocybin|psilocybin|mesh-list
19382340|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
19382341|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382342|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382343|NCT04519645|Lacosamide|lacosamide|mesh-list
20409427|NCT01182662|Cyclosporins|cyclosporins|mesh-list
20409428|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409429|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409430|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409431|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
20409432|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409433|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
20409434|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409435|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20409436|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409437|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20409438|NCT01182792|Ascorbic Acid|ascorbic acid|mesh-list
19382344|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
19382345|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19382346|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19382347|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19382348|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382349|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
19382350|NCT04512261|Trastuzumab|trastuzumab|mesh-list
19382351|NCT04512261|Tucatinib|tucatinib|mesh-list
19382352|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382353|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382354|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19382355|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382356|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409439|NCT01182792|Vitamins|vitamins|mesh-ancestor
20409440|NCT01182792|Micronutrients|micronutrients|mesh-ancestor
20409441|NCT01182792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409442|NCT01182792|Antioxidants|antioxidants|mesh-ancestor
20409443|NCT01182792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409444|NCT01182792|Protective Agents|protective agents|mesh-ancestor
20409445|NCT01182883|Sirolimus|sirolimus|mesh-list
20409446|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19382357|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
19382358|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19382359|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19382360|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
19382361|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382362|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382363|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382364|NCT04477265|Urological Agents|urological agents|mesh-ancestor
19382365|NCT04474847|Abatacept|abatacept|mesh-list
19382366|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382367|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382368|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382369|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382370|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
19382371|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382372|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382373|NCT04464070|Aspirin|aspirin|mesh-list
19382374|NCT04464070|Niacin|niacin|mesh-list
19382375|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19382376|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19382377|NCT04464070|Analgesics|analgesics|mesh-ancestor
19382378|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
19382379|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382380|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382381|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382382|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382383|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19382384|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19382385|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382386|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19382387|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19382388|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382389|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
19382390|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19382391|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
19382392|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20213659|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
20409447|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409448|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20409449|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409450|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
20409451|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409452|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
20409453|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409454|NCT01182974|Acetaminophen|acetaminophen|mesh-list
20213660|NCT00296465|Hormones|hormones|mesh-list
20213661|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20213662|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
20213663|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20213664|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
20213665|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
20213666|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213667|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213668|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213669|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20213670|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
20409455|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20409456|NCT01182974|Analgesics|analgesics|mesh-ancestor
20409457|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
20409458|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409459|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409460|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
20427452|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20427453|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
20427454|NCT01287351|Hormones|hormones|mesh-ancestor
20427455|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427456|NCT01287455|Vitamin D|vitamin d|mesh-list
20427457|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
20427458|NCT01287455|Vitamins|vitamins|mesh-ancestor
20427459|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
19382393|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
20409461|NCT01183247|Sirolimus|sirolimus|mesh-list
20409462|NCT01183247|Prednisone|prednisone|mesh-list
20409463|NCT01183247|Everolimus|everolimus|mesh-list
20409464|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20409465|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
19382394|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
19382395|NCT04464070|Vitamins|vitamins|mesh-ancestor
19382396|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
20213671|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20213672|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
20213673|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20213674|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19403248|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20409466|NCT01183247|Hormones|hormones|mesh-ancestor
20409467|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409468|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409469|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20409470|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409471|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409472|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
20409473|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20409474|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409475|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20409476|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
20409477|NCT01183364|Docetaxel|docetaxel|mesh-list
20409478|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403249|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
19847697|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19847698|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19847699|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
19847700|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847701|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847702|NCT00687804|Ranibizumab|ranibizumab|mesh-list
20213675|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20213676|NCT00296478|Progesterone|progesterone|mesh-list
20213677|NCT00296478|Progestins|progestins|mesh-ancestor
20213678|NCT00296478|Hormones|hormones|mesh-ancestor
20213679|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213680|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213681|NCT00296530|Fluticasone|fluticasone|mesh-list
20213682|NCT00296530|Xhance|xhance|mesh-list
20409479|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
19403250|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19403251|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
19403252|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403253|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403254|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19403255|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
19403256|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
19403257|NCT03602781|Protective Agents|protective agents|mesh-ancestor
19403258|NCT03602690|Ritonavir|ritonavir|mesh-list
19403259|NCT03602690|Darunavir|darunavir|mesh-list
19403260|NCT03602690|Dolutegravir|dolutegravir|mesh-list
19403261|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19403262|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19403263|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
19403264|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403265|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403266|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19403267|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19403268|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
19403269|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403270|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19403271|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19403272|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19403273|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19403274|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19403275|NCT03602638|Acarbose|acarbose|mesh-list
19403276|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19403277|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403278|NCT03602638|Incretins|incretins|mesh-ancestor
20213683|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20409480|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
19403279|NCT03602638|Hormones|hormones|mesh-ancestor
20213684|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19403280|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409481|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382401|NCT04370054|Factor VIII|factor viii|mesh-list
19382402|NCT04370054|Coagulants|coagulants|mesh-ancestor
20409482|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409483|NCT01183442|Vitamin D|vitamin d|mesh-list
20409484|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
20409485|NCT01183442|Vitamins|vitamins|mesh-list
20409486|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
20409487|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409488|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20409489|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409490|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
20409491|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20409492|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409493|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409494|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20409495|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20409496|NCT01183494|Irinotecan|irinotecan|mesh-list
20409497|NCT01183494|Bevacizumab|bevacizumab|mesh-list
20409498|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20409499|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20409500|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409501|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409502|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409503|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409504|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20409505|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20409506|NCT01183494|Growth Substances|growth substances|mesh-ancestor
20409507|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409508|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
20409509|NCT01183572|Iron|iron|mesh-list
20409510|NCT01183572|Folic Acid|folic acid|mesh-list
20409511|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
19382403|NCT04360980|Colchicine|colchicine|mesh-list
19382404|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
19382405|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382406|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
19382407|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
19382408|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382409|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382410|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382411|NCT04331704|Tenofovir|tenofovir|mesh-list
19382412|NCT04331704|Emtricitabine|emtricitabine|mesh-list
19382413|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
19382414|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847703|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19847704|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19847705|NCT00687804|Growth Substances|growth substances|mesh-ancestor
19847706|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847707|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
20409512|NCT01183572|Trace Elements|trace elements|mesh-ancestor
20409513|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
20409514|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409515|NCT01183572|Hematinics|hematinics|mesh-ancestor
19382415|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19382416|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19382417|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382418|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382419|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19382420|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19382421|NCT04313075|Leronlimab|leronlimab|mesh-list
19382422|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19382423|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19382424|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382425|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19382426|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19382427|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
19382428|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382429|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
19382430|NCT04305795|Cemiplimab|cemiplimab|mesh-list
19382431|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19847708|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382432|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382433|NCT04305756|Enoxaparin|enoxaparin|mesh-list
19847709|NCT00687908|Adapalene|adapalene|mesh-list
19847710|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20409516|NCT01183572|Vitamins|vitamins|mesh-ancestor
20409517|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19382434|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
19382435|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19382436|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19382437|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382438|NCT04301934|Estradiol|estradiol|mesh-list
20409518|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20409519|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20409520|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
20409521|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409522|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20409523|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20409524|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409525|NCT01183611|Vaccines|vaccines|mesh-list
20409526|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
20409527|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409528|NCT01183624|Analgesics|analgesics|mesh-list
20409529|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
20409530|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409531|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409532|NCT01183663|Leucovorin|leucovorin|mesh-list
20409533|NCT01183663|Sirolimus|sirolimus|mesh-list
20409534|NCT01183663|Bevacizumab|bevacizumab|mesh-list
20409535|NCT01183663|Lenalidomide|lenalidomide|mesh-list
20409536|NCT01183663|Fluorouracil|fluorouracil|mesh-list
20409537|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
20409538|NCT01183663|Sorafenib|sorafenib|mesh-list
20409539|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409540|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409541|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20409542|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20409543|NCT01183663|Growth Substances|growth substances|mesh-ancestor
20409544|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409545|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
20409546|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
20409547|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409548|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20409549|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409550|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
20409551|NCT01183663|Antidotes|antidotes|mesh-ancestor
20409552|NCT01183663|Protective Agents|protective agents|mesh-ancestor
20409553|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
20409554|NCT01183663|Vitamins|vitamins|mesh-ancestor
20409555|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
20409556|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20409557|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382439|NCT04301934|Estrogens|estrogens|mesh-list
19382440|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19382441|NCT04301934|Hormones|hormones|mesh-ancestor
19382442|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382443|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409558|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20409559|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409560|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20409561|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
20409562|NCT01183676|Valproic Acid|valproic acid|mesh-list
20409563|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
20409564|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382444|NCT04296305|Hydromorphone|hydromorphone|mesh-list
19382445|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19382446|NCT04296305|Narcotics|narcotics|mesh-ancestor
19382447|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382448|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382449|NCT04296305|Analgesics|analgesics|mesh-ancestor
19382450|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
19382451|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382452|NCT04278144|Nivolumab|nivolumab|mesh-list
19382453|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382454|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382455|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382456|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382457|NCT04233840|Nivolumab|nivolumab|mesh-list
19382458|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693066|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409565|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409566|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
20409567|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409568|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409569|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
20409570|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409571|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409572|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20409573|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20409574|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
20409575|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409576|NCT01183767|Protective Agents|protective agents|mesh-ancestor
20409577|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409578|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20409579|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20409580|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409581|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20409582|NCT01183806|Rivastigmine|rivastigmine|mesh-list
20409583|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20409584|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409585|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409586|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
20409587|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409588|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409589|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20409590|NCT01183806|Protective Agents|protective agents|mesh-ancestor
20409591|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
20409592|NCT01183910|Calcium|calcium|mesh-list
20409593|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409594|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409595|NCT01183910|Antacids|antacids|mesh-ancestor
20409596|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409597|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382459|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382460|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382461|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382462|NCT04229290|Dolutegravir|dolutegravir|mesh-list
19382463|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19382464|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19382465|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382466|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409598|NCT01183962|Vitamin D|vitamin d|mesh-list
20409599|NCT01183962|Vitamins|vitamins|mesh-ancestor
20409600|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
19382467|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19382468|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19382469|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
20409601|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409602|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20409603|NCT01184144|Pioglitazone|pioglitazone|mesh-list
20409604|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20409605|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409606|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
20409607|NCT01184196|Povidone|povidone|mesh-list
20409608|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
20409609|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
20409610|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20409611|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409612|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
20409613|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
20409614|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382470|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382471|NCT04223661|Dexamethasone|dexamethasone|mesh-list
19382472|NCT04223661|Lenalidomide|lenalidomide|mesh-list
19382473|NCT04223661|Daratumumab|daratumumab|mesh-list
19382474|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382475|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
19382476|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
19382477|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409615|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409616|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409617|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409618|NCT01184287|Ranpirnase|ranpirnase|mesh-list
20409619|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409620|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20409621|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382478|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427460|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693067|NCT04983615|Fentanyl|fentanyl|mesh-list
19693068|NCT04983615|Midazolam|midazolam|mesh-list
20213685|NCT00296530|Montelukast|montelukast|mesh-list
20213686|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213687|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20213688|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
20213689|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213690|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213691|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20409622|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409623|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20409624|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20409625|NCT01184378|Caseins|caseins|mesh-list
20409626|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
20409627|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
20213692|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
20213693|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
20213694|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20213695|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20409628|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382479|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382480|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
19382481|NCT04223661|Hormones|hormones|mesh-ancestor
19382482|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382483|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382484|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213696|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20213697|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20213698|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
20213699|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213700|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213701|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20213702|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
20213703|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213704|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20213705|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20213706|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
19382485|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
19382486|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19382487|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19382488|NCT04223661|Growth Substances|growth substances|mesh-ancestor
19382489|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
19382490|NCT04218240|Lofexidine|lofexidine|mesh-list
19382491|NCT04218240|Pregabalin|pregabalin|mesh-list
19382492|NCT04218240|Analgesics|analgesics|mesh-ancestor
19382493|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
19382494|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382495|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382496|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
19382497|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19382498|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19382499|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382500|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19382501|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19382502|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19382503|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382504|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382505|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19382506|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19382507|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19382508|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19382509|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19382510|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19382511|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382512|NCT04207931|Fluocinonide|fluocinonide|mesh-list
19382513|NCT04207931|Triamcinolone|triamcinolone|mesh-list
19382514|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19382515|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19382516|NCT04207931|Betamethasone|betamethasone|mesh-list
19382517|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
19382518|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19382519|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
19382520|NCT04207931|Clobetasol|clobetasol|mesh-list
19382521|NCT04207931|Minoxidil|minoxidil|mesh-list
19382522|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19382523|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19382524|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382525|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
19382526|NCT04207931|Hormones|hormones|mesh-ancestor
19382527|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382528|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382529|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213707|NCT00296530|Hormones|hormones|mesh-ancestor
20213708|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
20213709|NCT00296608|Leucovorin|leucovorin|mesh-list
20213710|NCT00296608|Fluorouracil|fluorouracil|mesh-list
20213711|NCT00296608|Calcium|calcium|mesh-list
20213712|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
20213713|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409629|NCT01184391|Valproic Acid|valproic acid|mesh-list
20409630|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
20409631|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409632|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409633|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
20409634|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409635|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382530|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
19382531|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382532|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382533|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19382534|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
19382535|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19382536|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
19382537|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19382538|NCT04199468|Ketamine|ketamine|mesh-list
19382539|NCT04199468|Dronabinol|dronabinol|mesh-list
19382540|NCT04199468|Analgesics|analgesics|mesh-ancestor
19382541|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
19382542|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382543|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382544|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19382545|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19382546|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
19382547|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
19382548|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382549|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19382550|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19382551|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382552|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382553|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
19382554|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382555|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19382556|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19382557|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19382558|NCT04199468|Hormones|hormones|mesh-ancestor
19382559|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382560|NCT04191187|Fludarabine|fludarabine|mesh-list
19382561|NCT04191187|Melphalan|melphalan|mesh-list
19382562|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382563|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382564|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382565|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
19382566|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382567|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19382568|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
19382569|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19382570|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
20409636|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
20409637|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409638|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409639|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382571|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19382572|NCT04181476|Protective Agents|protective agents|mesh-ancestor
19382573|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382574|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
19382575|NCT04162015|Carboplatin|carboplatin|mesh-list
20213714|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382576|NCT04162015|Nivolumab|nivolumab|mesh-list
20213715|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
20213716|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213717|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19382577|NCT04162015|Pemetrexed|pemetrexed|mesh-list
19382578|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382579|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382580|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382581|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382582|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382583|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19382584|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19382585|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
19382586|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
19382587|NCT04129723|Protective Agents|protective agents|mesh-ancestor
19382588|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213718|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213719|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20213720|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
20213721|NCT00296608|Antidotes|antidotes|mesh-ancestor
20213722|NCT00296608|Protective Agents|protective agents|mesh-ancestor
20213723|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
20213724|NCT00296608|Vitamins|vitamins|mesh-ancestor
20213725|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
20213726|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19382598|NCT04111978|Letrozole|letrozole|mesh-list
19382599|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409640|NCT01184404|Bosentan|bosentan|mesh-list
20409641|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20409642|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20409643|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409644|NCT01184443|Olanzapine|olanzapine|mesh-list
20409645|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
20409646|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
20409647|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409648|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409649|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409650|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20409651|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409652|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382600|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19382601|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19382602|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382603|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382604|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19382605|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
19382606|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382607|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382608|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
19382609|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
19382610|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409653|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20409654|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20409655|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19382611|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382612|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382613|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
19382614|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
19382615|NCT04066751|Ivacaftor|ivacaftor|mesh-list
19382616|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19382617|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19382618|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382619|NCT04065789|Dexamethasone|dexamethasone|mesh-list
19382620|NCT04065789|Lenalidomide|lenalidomide|mesh-list
19382621|NCT04065789|Daratumumab|daratumumab|mesh-list
19382622|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382623|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
19382624|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
20409656|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20409657|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409658|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409659|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
20409660|NCT01184482|Cetuximab|cetuximab|mesh-list
20409661|NCT01184482|Lapatinib|lapatinib|mesh-list
19382625|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382626|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382627|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382628|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
20213727|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20409662|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409663|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409664|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20409665|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409666|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382629|NCT04065789|Hormones|hormones|mesh-ancestor
19382630|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382631|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382632|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382633|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
19382634|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19382635|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19382636|NCT04065789|Growth Substances|growth substances|mesh-ancestor
19382637|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
19382638|NCT04047953|Paclitaxel|paclitaxel|mesh-list
19382639|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19382640|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
19382641|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19382642|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382643|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19382644|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19382645|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382646|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382647|NCT04031599|Hormones|hormones|mesh-list
19382648|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382649|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382650|NCT04030559|Niraparib|niraparib|mesh-list
19382651|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19382652|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382653|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382654|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382655|NCT04025658|Oxytocin|oxytocin|mesh-list
19382656|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
19382657|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19382658|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409667|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
20409668|NCT01184495|Hematinics|hematinics|mesh-ancestor
20409669|NCT01184560|Orlistat|orlistat|mesh-list
20409670|NCT01184560|Sibutramine|sibutramine|mesh-list
20409671|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409672|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409673|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20409674|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20409675|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
20409676|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19382659|NCT04019821|Insulin|insulin|mesh-list
19382660|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19382661|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
19382662|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
19382663|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
19382664|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19382665|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409677|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
20409678|NCT01184638|Propofol|propofol|mesh-list
20213728|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
20213729|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213730|NCT00296634|Antacids|antacids|mesh-ancestor
20213731|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213732|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403281|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19403282|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
19403283|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403284|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403285|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19403286|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
19403287|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403288|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213733|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
20213734|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
20213735|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20409679|NCT01184638|Sevoflurane|sevoflurane|mesh-list
20213736|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409680|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20409681|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213737|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20409682|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409683|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20409684|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
20409685|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
20409686|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20409687|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20409688|NCT01184664|Nicotine|nicotine|mesh-list
20409689|NCT01184664|Varenicline|varenicline|mesh-list
20409690|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20409691|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
20409692|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409693|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409694|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20409695|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20409696|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
20409697|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409698|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409699|NCT01184716|Vitamin D|vitamin d|mesh-list
20409700|NCT01184716|Vitamins|vitamins|mesh-ancestor
20409701|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
20409702|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409703|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20409704|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
20409705|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
20409706|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
20409707|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409708|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409709|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
20409710|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409711|NCT01184820|Factor VIII|factor viii|mesh-list
20409712|NCT01184820|Coagulants|coagulants|mesh-ancestor
20213738|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20213739|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213740|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213741|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
20213742|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213743|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
20213744|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213745|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20213746|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213747|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20213748|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20213749|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213750|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20213751|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20213752|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20213753|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213754|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409713|NCT01184833|Interferons|interferons|mesh-list
20409714|NCT01184833|Interferon-beta|interferon-beta|mesh-list
20409715|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
20409716|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409717|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
20409718|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409719|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
20409720|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409721|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20409722|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
20409723|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
20409724|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20409725|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
20409726|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20409727|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19382666|NCT04006288|Aspirin|aspirin|mesh-list
19382667|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
19382668|NCT04006288|Clopidogrel|clopidogrel|mesh-list
19382669|NCT04006288|Ticagrelor|ticagrelor|mesh-list
19382670|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19382671|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19382672|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19382673|NCT04006288|Analgesics|analgesics|mesh-ancestor
20409728|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409729|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19382674|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
20409730|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409731|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409732|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20409733|NCT01184911|Renal Agents|renal agents|mesh-ancestor
20427461|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20427462|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20427463|NCT01287494|Sertraline|sertraline|mesh-list
20427464|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
20427465|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20427466|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20427467|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19382675|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382676|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382677|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382678|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382679|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19382680|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19382681|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382682|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19382683|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19382684|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382685|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
19382686|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20427468|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20427469|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427470|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427471|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
20427472|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427473|NCT01287507|Lactoferrin|lactoferrin|mesh-list
20427474|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427475|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
20427476|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20427477|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427478|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20427479|NCT01287546|Trametinib|trametinib|mesh-list
20427480|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427481|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20427482|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427483|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427484|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
20427485|NCT01287598|Midazolam|midazolam|mesh-list
20427486|NCT01287598|Omeprazole|omeprazole|mesh-list
20427487|NCT01287598|Warfarin|warfarin|mesh-list
19382687|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19382688|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19382689|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
19382690|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382691|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19382692|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
19382693|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19382694|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
19382695|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
19382696|NCT03936933|Goserelin|goserelin|mesh-list
19382697|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382698|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382699|NCT03936218|Goserelin|goserelin|mesh-list
20427488|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20427489|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20427490|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382700|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847711|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
20427491|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427492|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20427493|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20427494|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20427495|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20427496|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
20427497|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
20427498|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
20427499|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
20427500|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427501|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427502|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
19382701|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382702|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20409734|NCT01185015|Nicorandil|nicorandil|mesh-list
20409735|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20409736|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19382703|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19382704|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409737|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
20409738|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
20409739|NCT01185015|Vitamins|vitamins|mesh-ancestor
20409740|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
20409741|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382705|NCT03923699|Anesthetics|anesthetics|mesh-list
19382706|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19382707|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382708|NCT03911661|Warfarin|warfarin|mesh-list
19382709|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
19382710|NCT03908255|Vitamins|vitamins|mesh-list
19382711|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
19382712|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382713|NCT03900754|Oxytocin|oxytocin|mesh-list
19382714|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
19382715|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19382716|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382717|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19382718|NCT03897244|Amoxicillin|amoxicillin|mesh-list
19382719|NCT03897244|Metronidazole|metronidazole|mesh-list
19382720|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19382721|NCT03897244|Rabeprazole|rabeprazole|mesh-list
19382722|NCT03897244|Bismuth|bismuth|mesh-list
19382723|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19382724|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382725|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
19382726|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19382727|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19382728|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19382729|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382730|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382731|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409742|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
20409743|NCT01185067|Resveratrol|resveratrol|mesh-list
19382732|NCT03897244|Antacids|antacids|mesh-ancestor
19382733|NCT03878316|Oxytocin|oxytocin|mesh-list
19382734|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
19382735|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19382736|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213755|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213756|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213757|NCT00296699|Analgesics|analgesics|mesh-ancestor
20213758|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
20213759|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213760|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
20213761|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20409744|NCT01185067|Antioxidants|antioxidants|mesh-list
20409745|NCT01185067|Quercetin|quercetin|mesh-list
19382737|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19382738|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19382739|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382740|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382741|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19382742|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19382743|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382744|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
19382745|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382746|NCT03854110|Gemcitabine|gemcitabine|mesh-list
19382747|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19382748|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
19382749|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382750|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382751|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
19382752|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382753|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382754|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382755|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
19382756|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382757|NCT03851081|Vincristine|vincristine|mesh-list
19382758|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19382759|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20213762|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
20409746|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409747|NCT01185067|Protective Agents|protective agents|mesh-ancestor
20409748|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409749|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409750|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20409751|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20409752|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409753|NCT01185119|Glucagon|glucagon|mesh-list
20409754|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20409755|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409756|NCT01185119|Hormones|hormones|mesh-ancestor
20409757|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409758|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409759|NCT01185119|Incretins|incretins|mesh-ancestor
20409760|NCT01185158|Gefitinib|gefitinib|mesh-list
19382760|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382761|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
19382762|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
19382763|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
19382764|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382765|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382766|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19382767|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
19382768|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382769|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409761|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409762|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20409763|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409764|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409765|NCT01185184|Tofacitinib|tofacitinib|mesh-list
20409766|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20409767|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409768|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409769|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
20409770|NCT01185197|Prednisolone|prednisolone|mesh-list
20409771|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20409772|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409773|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20409774|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
20409775|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20409776|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409777|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409778|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409779|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20409780|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
20409781|NCT01185197|Hormones|hormones|mesh-ancestor
20409782|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409783|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409784|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20409785|NCT01185223|Valganciclovir|valganciclovir|mesh-list
20409786|NCT01185223|Ganciclovir|ganciclovir|mesh-list
20409787|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20409788|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
20409789|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409790|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20409791|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409792|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409793|NCT01185236|Atorvastatin|atorvastatin|mesh-list
20409794|NCT01185236|Simvastatin|simvastatin|mesh-list
20409795|NCT01185236|Ezetimibe|ezetimibe|mesh-list
19382770|NCT03797014|Tenofovir|tenofovir|mesh-list
19382771|NCT03797014|Emtricitabine|emtricitabine|mesh-list
19382772|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19382773|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
19382774|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382775|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19382776|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19382777|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382778|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382779|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19382780|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19382781|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
19382782|NCT03766126|Fludarabine|fludarabine|mesh-list
20409796|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20409797|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19382783|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382784|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
19382785|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382786|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382787|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19382788|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
19382789|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382790|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382791|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19382792|NCT03758781|Nivolumab|nivolumab|mesh-list
19382793|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382794|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382795|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382796|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382797|NCT03742349|Spartalizumab|spartalizumab|mesh-list
19382798|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382799|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382800|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382801|NCT03737136|Bortezomib|bortezomib|mesh-list
19382802|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382803|NCT03736265|Carvedilol|carvedilol|mesh-list
19382804|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19382805|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19382806|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
19382807|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19382808|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382809|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382810|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19382811|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
19382812|NCT03736265|Protective Agents|protective agents|mesh-ancestor
19382813|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19382814|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19382815|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19382816|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
19382817|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19382818|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19382819|NCT03705507|Dexamethasone|dexamethasone|mesh-list
19382820|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382821|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
19382822|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
19382823|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382824|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382825|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382826|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
19382827|NCT03705507|Hormones|hormones|mesh-ancestor
19382828|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382829|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382830|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382831|NCT03667716|Nivolumab|nivolumab|mesh-list
19382832|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382833|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382834|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382835|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382836|NCT03665129|Avdoralimab|avdoralimab|mesh-list
19382837|NCT03665129|Durvalumab|durvalumab|mesh-list
19382838|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382839|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382840|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382841|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
19382842|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382843|NCT03648021|Acetaminophen|acetaminophen|mesh-list
19382844|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19382845|NCT03648021|Analgesics|analgesics|mesh-ancestor
19382846|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
19382847|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382848|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382849|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
19382850|NCT03617731|Dexamethasone|dexamethasone|mesh-list
19382851|NCT03617731|Lenalidomide|lenalidomide|mesh-list
19382852|NCT03617731|Bortezomib|bortezomib|mesh-list
19382853|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19382854|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
19382855|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
19382856|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213763|NCT00296712|Dexetimide|dexetimide|mesh-list
20213764|NCT00296712|Citalopram|citalopram|mesh-list
20213765|NCT00296712|Bupropion|bupropion|mesh-list
20213766|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20213767|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20213768|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213769|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213770|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213771|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
20213772|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213773|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20213774|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
20213775|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213776|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20409798|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
20409799|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409800|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20409801|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20409802|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409803|NCT01185262|Rituximab|rituximab|mesh-list
20409804|NCT01185262|Lenalidomide|lenalidomide|mesh-list
20409805|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20409806|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409807|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
20409808|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409809|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20409810|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20409811|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20409812|NCT01185262|Growth Substances|growth substances|mesh-ancestor
20409813|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
20409814|NCT01185405|Voriconazole|voriconazole|mesh-list
20409815|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
20409816|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409817|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20409818|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20409819|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409820|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409821|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20409822|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
20409823|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409824|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409825|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20409826|NCT01185418|Haloperidol|haloperidol|mesh-list
20409827|NCT01185418|Risperidone|risperidone|mesh-list
20409828|NCT01185418|Aripiprazole|aripiprazole|mesh-list
19382857|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382858|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382859|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
19382860|NCT03617731|Hormones|hormones|mesh-ancestor
19382861|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382862|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19382863|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382864|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
19382865|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19382866|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19382867|NCT03617731|Growth Substances|growth substances|mesh-ancestor
19382868|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
19382869|NCT03614949|Atezolizumab|atezolizumab|mesh-list
19382870|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382871|NCT03596164|Teduglutide|teduglutide|mesh-list
19382872|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19382873|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19382874|NCT03596164|Protective Agents|protective agents|mesh-ancestor
19382875|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382876|NCT03590821|Aspirin|aspirin|mesh-list
19382877|NCT03590821|Celecoxib|celecoxib|mesh-list
19382878|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19382879|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19382880|NCT03590821|Analgesics|analgesics|mesh-ancestor
19382881|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
19382882|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382883|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382884|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213777|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19382885|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382886|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19382887|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19382888|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382889|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19382890|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19382891|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382892|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
19382893|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19382894|NCT03557307|Benralizumab|benralizumab|mesh-list
20409829|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
20409830|NCT01185418|Amisulpride|amisulpride|mesh-list
20409831|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20409832|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
20409833|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409834|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409835|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409836|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20409837|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409838|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409839|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20409840|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20409841|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
20409842|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
20409843|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
20409844|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20409845|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20409846|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20409847|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20409848|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
20409849|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
20409850|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409851|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409852|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20409853|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19382895|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19382896|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
19403294|NCT03602547|Vorolanib|vorolanib|mesh-list
19403295|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403296|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403297|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403298|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
19403299|NCT03602508|Mirabegron|mirabegron|mesh-list
19403300|NCT03602508|Fesoterodine|fesoterodine|mesh-list
19403301|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19403302|NCT03602508|Oxybutynin|oxybutynin|mesh-list
19403303|NCT03602508|Darifenacin|darifenacin|mesh-list
19403304|NCT03602508|Propiverine|propiverine|mesh-list
19403305|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20409854|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
20409855|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20409856|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
20409857|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403306|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20409858|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
20409859|NCT01185444|Protective Agents|protective agents|mesh-ancestor
20409860|NCT01185470|Morphine|morphine|mesh-list
20409861|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20409862|NCT01185470|Narcotics|narcotics|mesh-ancestor
20409863|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409864|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409865|NCT01185470|Analgesics|analgesics|mesh-ancestor
20409866|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
20409867|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409868|NCT01185535|Anesthetics|anesthetics|mesh-list
20409869|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409870|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409871|NCT01185574|Vitamin D|vitamin d|mesh-list
20409872|NCT01185574|Vitamins|vitamins|mesh-ancestor
19403307|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19403308|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409873|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
20409874|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409875|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19382897|NCT03543189|Nivolumab|nivolumab|mesh-list
19382898|NCT03543189|Androgens|androgens|mesh-list
19382899|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382900|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382901|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19382902|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382903|NCT03543189|Hormones|hormones|mesh-ancestor
19382904|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19382905|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382906|NCT03505710|Trastuzumab|trastuzumab|mesh-list
19382907|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382908|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213778|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
20213779|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
20213780|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213781|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20213782|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19382909|NCT03482479|Naltrexone|naltrexone|mesh-list
19382910|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19382911|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19382912|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382913|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
19382914|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19382915|NCT03455829|Osimertinib|osimertinib|mesh-list
19382916|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382917|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19382918|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382919|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382920|NCT03446157|Cetuximab|cetuximab|mesh-list
19382921|NCT03446157|Palbociclib|palbociclib|mesh-list
19382922|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382923|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409876|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
20409877|NCT01185678|Desogestrel|desogestrel|mesh-list
20409878|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
20409879|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20409880|NCT01185678|Progestins|progestins|mesh-list
20409881|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20409882|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409883|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20409884|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20409885|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20409886|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20409887|NCT01185678|Hormones|hormones|mesh-ancestor
20409888|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20409889|NCT01185743|Olanzapine|olanzapine|mesh-list
20409890|NCT01185743|Ziprasidone|ziprasidone|mesh-list
20409891|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
20409892|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
20409893|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409894|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409895|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20409896|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20409897|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20409898|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20409899|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20409900|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20409901|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20409902|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20409903|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409904|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409905|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
19382924|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20213783|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
20213784|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20213785|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
20213786|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20213787|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20213788|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213789|NCT00296751|Fentanyl|fentanyl|mesh-list
20213790|NCT00296751|Meperidine|meperidine|mesh-list
20213791|NCT00296751|Bupivacaine|bupivacaine|mesh-list
20213792|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
19382925|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213793|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
19382926|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382927|NCT03428958|Leucovorin|leucovorin|mesh-list
19382928|NCT03428958|Bevacizumab|bevacizumab|mesh-list
19382929|NCT03428958|Cetuximab|cetuximab|mesh-list
19382930|NCT03428958|Panitumumab|panitumumab|mesh-list
19382931|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
19382932|NCT03428958|Irinotecan|irinotecan|mesh-list
19382933|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
19382934|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19382935|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382936|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19382937|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19382938|NCT03428958|Growth Substances|growth substances|mesh-ancestor
19382939|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382940|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
19382941|NCT03428958|Antidotes|antidotes|mesh-ancestor
19382942|NCT03428958|Protective Agents|protective agents|mesh-ancestor
19382943|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
19382944|NCT03428958|Vitamins|vitamins|mesh-ancestor
20409906|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20409907|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20409908|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
20409909|NCT01185769|Tocotrienols|tocotrienols|mesh-list
20409910|NCT01185769|Vitamin E|vitamin e|mesh-list
20409911|NCT01185769|Tocopherols|tocopherols|mesh-list
20409912|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
20409913|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409914|NCT01185769|Protective Agents|protective agents|mesh-ancestor
20409915|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409916|NCT01185769|Vitamins|vitamins|mesh-ancestor
20409917|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
20409918|NCT01185808|Vitamin D|vitamin d|mesh-list
20409919|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
20409920|NCT01185808|Vitamins|vitamins|mesh-list
20409921|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
20409922|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409923|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19382945|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
19382946|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19382947|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19382948|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382949|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382950|NCT03393611|Cytarabine|cytarabine|mesh-list
19382951|NCT03393611|Fludarabine|fludarabine|mesh-list
19382952|NCT03393611|Melphalan|melphalan|mesh-list
19382953|NCT03393611|Daunorubicin|daunorubicin|mesh-list
19382954|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
19382955|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382956|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19382957|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
19382958|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382959|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382960|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
19382961|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382962|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
19382963|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409924|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20409925|NCT01185847|Gemcitabine|gemcitabine|mesh-list
20409926|NCT01185847|Pemetrexed|pemetrexed|mesh-list
20409927|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20409928|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20409929|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
19382964|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19382965|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
19382966|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19382967|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19382968|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19382969|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19382970|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382971|NCT03382301|Cyclosporine|cyclosporine|mesh-list
19382972|NCT03382301|Cyclosporins|cyclosporins|mesh-list
20409930|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382973|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382974|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409931|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
20409932|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382975|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20409933|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409934|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19382976|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
19382977|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19382978|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
19382979|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382980|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
19382981|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19382982|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19382983|NCT03340506|Trametinib|trametinib|mesh-list
19382984|NCT03340506|Dabrafenib|dabrafenib|mesh-list
19382985|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382986|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19382987|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19382988|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382989|NCT03331198|Venetoclax|venetoclax|mesh-list
19382990|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382991|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19382992|NCT03296553|Valganciclovir|valganciclovir|mesh-list
20409935|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
20409936|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409937|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20409938|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20409939|NCT01185860|Ritonavir|ritonavir|mesh-list
20409940|NCT01185860|Ribavirin|ribavirin|mesh-list
20409941|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20409942|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20409943|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19382993|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
19382994|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19382995|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19382996|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19382997|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19382998|NCT03205423|Gabapentin|gabapentin|mesh-list
19382999|NCT03205423|Analgesics|analgesics|mesh-ancestor
19383000|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
19383001|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383002|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383003|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
19383004|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19383005|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19383006|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383007|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19383008|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19383009|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19383010|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383011|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383012|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
19383013|NCT03187379|Bupivacaine|bupivacaine|mesh-list
19383014|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
19383015|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
19383016|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383017|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383018|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
19383019|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20409944|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
20409945|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409946|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409947|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20409948|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20409949|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
20409950|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409951|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20409952|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20409953|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
20409954|NCT01185873|Ritonavir|ritonavir|mesh-list
20409955|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19383020|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
19383021|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383022|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383023|NCT03150914|Sirolimus|sirolimus|mesh-list
19383024|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383025|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383026|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20409956|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20409957|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
20409958|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383027|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383028|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
19383029|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383030|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
19383031|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383032|NCT03148795|Talazoparib|talazoparib|mesh-list
19383033|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19383034|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213794|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213795|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213796|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
20213797|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213798|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19383035|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383036|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383037|NCT03098485|Azithromycin|azithromycin|mesh-list
19383038|NCT03098485|Levofloxacin|levofloxacin|mesh-list
19383039|NCT03098485|Ofloxacin|ofloxacin|mesh-list
19383040|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
19383041|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
19383042|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383043|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383044|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19383045|NCT03098485|Renal Agents|renal agents|mesh-ancestor
19383046|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19383047|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19383048|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383049|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383050|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383051|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19383052|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19383053|NCT03086486|Linezolid|linezolid|mesh-list
19383054|NCT03086486|Bedaquiline|bedaquiline|mesh-list
19383055|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383056|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383057|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19383058|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383059|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383060|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
19383061|NCT03077243|Cisplatin|cisplatin|mesh-list
19383062|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383063|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
19383064|NCT03049449|Fludarabine|fludarabine|mesh-list
19383065|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383066|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
19383067|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383068|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383069|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19383070|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
19383071|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383072|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383073|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19383074|NCT03000569|Levodopa|levodopa|mesh-list
19383075|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
19383076|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19383077|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
19383078|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383079|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409959|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409960|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19383080|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383081|NCT02994784|Melphalan|melphalan|mesh-list
19383082|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19383083|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
19383084|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383085|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383086|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19383087|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383088|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
19383089|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383090|NCT02964507|Fulvestrant|fulvestrant|mesh-list
19383091|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20213799|NCT00296751|Narcotics|narcotics|mesh-ancestor
20213800|NCT00296751|Analgesics|analgesics|mesh-ancestor
20213801|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20409961|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19383092|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383093|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19383094|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19383095|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
19383096|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383097|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383098|NCT02955394|Fulvestrant|fulvestrant|mesh-list
19383099|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19383100|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383101|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19383102|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19383103|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
19383104|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383105|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383106|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19383107|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
19383108|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19383109|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19383110|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383111|NCT02942017|Brexanolone|brexanolone|mesh-list
19383112|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
19383113|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383114|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383115|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383116|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
19383117|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
19383118|NCT02942004|Pregnanolone|pregnanolone|mesh-list
19383119|NCT02942004|Brexanolone|brexanolone|mesh-list
20409962|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
20409963|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20409964|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20409965|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20409966|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
19383120|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
19383121|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383122|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383123|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383124|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
19383125|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
19383126|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
19383127|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383128|NCT02939573|Dapsone|dapsone|mesh-list
19383129|NCT02939573|Colchicine|colchicine|mesh-list
19383130|NCT02939573|Azathioprine|azathioprine|mesh-list
19383131|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
19383132|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383133|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383134|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
19383135|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
19383136|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383137|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383138|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
19383139|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383140|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383141|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
19383142|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383143|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383144|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
19383145|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19383146|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19383147|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19383148|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383149|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
19383150|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383151|NCT02929589|Ibuprofen|ibuprofen|mesh-list
19383152|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
19383153|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19383154|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20409967|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
20409968|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20409969|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20409970|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383155|NCT02929589|Analgesics|analgesics|mesh-ancestor
19383156|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
19383157|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383158|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383159|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383160|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383161|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20409971|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409972|NCT01185925|Urological Agents|urological agents|mesh-ancestor
20409973|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20409974|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20409975|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20409976|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
20409977|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409978|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20409979|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20409980|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409981|NCT01185951|Polidocanol|polidocanol|mesh-list
20409982|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20409983|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19383162|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383163|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383164|NCT02929589|Narcotics|narcotics|mesh-ancestor
20409984|NCT01185977|Fluoxetine|fluoxetine|mesh-list
20409985|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20409986|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20409987|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20427503|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19383165|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383166|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
19383167|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383168|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383169|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19383170|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19383171|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383172|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383173|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383174|NCT02861300|Capecitabine|capecitabine|mesh-list
19383175|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383176|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
19383177|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383178|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383179|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
19383180|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
19383181|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383182|NCT02840227|Anesthetics|anesthetics|mesh-list
19383183|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383184|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383185|NCT02820857|Bevacizumab|bevacizumab|mesh-list
19383186|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383187|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383188|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19383189|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19383190|NCT02820857|Growth Substances|growth substances|mesh-ancestor
19383191|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383192|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
19383193|NCT02796391|Nicotine|nicotine|mesh-list
19383194|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19383195|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
19383196|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383197|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383198|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19383199|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19383200|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
19383201|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383202|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383203|NCT02775435|Paclitaxel|paclitaxel|mesh-list
19383204|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19383205|NCT02775435|Carboplatin|carboplatin|mesh-list
19383206|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
19383207|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19383208|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383209|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383210|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
19383211|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
19693069|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19383212|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383213|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383214|NCT02767531|Orlistat|orlistat|mesh-list
19383215|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383216|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383217|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19383218|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19383219|NCT02757898|Biotin|biotin|mesh-list
20213802|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20213803|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
20213804|NCT00296777|Citalopram|citalopram|mesh-list
20409988|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20409989|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20409990|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
20409991|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20409992|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20409993|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
20409994|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20409995|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20409996|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20409997|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20409998|NCT01186029|Aprepitant|aprepitant|mesh-list
20409999|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
20410000|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
20213805|NCT00296777|Bupropion|bupropion|mesh-list
20213806|NCT00296777|Imipramine|imipramine|mesh-list
20213807|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20213808|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20213809|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20213810|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213811|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410001|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383220|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
19383221|NCT02757898|Vitamins|vitamins|mesh-ancestor
19383222|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
19383223|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383224|NCT02737306|Leronlimab|leronlimab|mesh-list
19383225|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19383226|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19383227|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383228|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19383229|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19383230|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
19383231|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383232|NCT02728648|Oxycodone|oxycodone|mesh-list
19383233|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19383234|NCT02728648|Narcotics|narcotics|mesh-ancestor
19383235|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383236|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383237|NCT02728648|Analgesics|analgesics|mesh-ancestor
19383238|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
19383239|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403309|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403310|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403311|NCT03602508|Urological Agents|urological agents|mesh-ancestor
19403312|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19403313|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19403314|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19403315|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403316|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
19403317|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
19403318|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403319|NCT03602469|Bupivacaine|bupivacaine|mesh-list
19403320|NCT03602469|Propofol|propofol|mesh-list
19403321|NCT03602469|Sevoflurane|sevoflurane|mesh-list
19403322|NCT03602469|Rocuronium|rocuronium|mesh-list
19403323|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
19403324|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
19403325|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410002|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410003|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20410004|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19403326|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403327|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
19403328|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410005|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410006|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410007|NCT01186094|Sirolimus|sirolimus|mesh-list
20410008|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383240|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
19383241|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
19383242|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383243|NCT02679170|Crizotinib|crizotinib|mesh-list
19383244|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383245|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383246|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383247|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383248|NCT02614547|Brexanolone|brexanolone|mesh-list
19383249|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
19383250|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383251|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383252|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383253|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
19383254|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
19383255|NCT02599454|Atezolizumab|atezolizumab|mesh-list
19383256|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383257|NCT02595905|Cisplatin|cisplatin|mesh-list
19383258|NCT02595905|Veliparib|veliparib|mesh-list
19383259|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383260|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19383261|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383262|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383263|NCT02592551|Durvalumab|durvalumab|mesh-list
19383264|NCT02592551|Tremelimumab|tremelimumab|mesh-list
19383265|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383266|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383267|NCT02589691|Rocuronium|rocuronium|mesh-list
19383268|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19383269|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19383270|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19383271|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383272|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383273|NCT02583048|Dolutegravir|dolutegravir|mesh-list
19383274|NCT02583048|Bedaquiline|bedaquiline|mesh-list
19383275|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19383276|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19383277|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383278|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383279|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19383280|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19383281|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
19383282|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383283|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
19383284|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383285|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
19383286|NCT02546986|Azacitidine|azacitidine|mesh-list
19383287|NCT02546986|Cc-486|cc-486|mesh-list
19383288|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383289|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383290|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383291|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
19383292|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383293|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410009|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410010|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20410011|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410012|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
20410013|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20410014|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
20410015|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383294|NCT02539160|Ticagrelor|ticagrelor|mesh-list
19383295|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19383296|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19383297|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19383298|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19383299|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
19383300|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383301|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383302|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410016|NCT01186120|Umirolimus|umirolimus|mesh-list
19383303|NCT02536300|Idelalisib|idelalisib|mesh-list
19383304|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383305|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383306|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383307|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
19383308|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410017|NCT01186120|Everolimus|everolimus|mesh-list
20410018|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410019|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20410020|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
20410021|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410022|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383309|NCT02477618|Brexanolone|brexanolone|mesh-list
19383310|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
19383311|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383312|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383313|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383314|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
19383315|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
19383316|NCT02473497|Crizotinib|crizotinib|mesh-list
20410023|NCT01186146|Aspirin|aspirin|mesh-list
20410024|NCT01186146|Clopidogrel|clopidogrel|mesh-list
20410025|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20410026|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410027|NCT01186146|Analgesics|analgesics|mesh-ancestor
19383317|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383318|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383319|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383320|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383321|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
19383322|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383323|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383324|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
19383325|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19383326|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19383327|NCT02444429|Prednisolone|prednisolone|mesh-list
19383328|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
19383329|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19383330|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
19383331|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383332|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
19383333|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
19383334|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383335|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383336|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19383337|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
19383338|NCT02444429|Hormones|hormones|mesh-ancestor
19383339|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383340|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19383341|NCT02444429|Protective Agents|protective agents|mesh-ancestor
19383342|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19383343|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383344|NCT02424851|Thalidomide|thalidomide|mesh-list
19383345|NCT02424851|Dexamethasone|dexamethasone|mesh-list
19383346|NCT02424851|Bortezomib|bortezomib|mesh-list
19383347|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19383348|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383349|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
19383350|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
19383351|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383352|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383353|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19383354|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
19383355|NCT02424851|Hormones|hormones|mesh-ancestor
19383356|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383357|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19383358|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383359|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19383360|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
19383361|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691346|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20410028|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
19383362|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691347|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691348|NCT05006235|Epinephrine|epinephrine|mesh-list
20410029|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383363|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
19383364|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
19383365|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383366|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383367|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20410030|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410031|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410032|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20410033|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20410034|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20410035|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410036|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20410037|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20410038|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383368|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19383369|NCT02424851|Growth Substances|growth substances|mesh-ancestor
19383370|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
19383371|NCT02423876|Hydromorphone|hydromorphone|mesh-list
19383372|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383373|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383374|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
19383375|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410039|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
20410040|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20410041|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19383376|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19383377|NCT02423876|Narcotics|narcotics|mesh-ancestor
19383378|NCT02423876|Analgesics|analgesics|mesh-ancestor
19383379|NCT02400814|Atezolizumab|atezolizumab|mesh-list
19383380|NCT02400814|Antibodies|antibodies|mesh-list
19383381|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19383382|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
19383383|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383384|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383385|NCT02285504|Brexanolone|brexanolone|mesh-list
19383386|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
19383387|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383388|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383389|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383390|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
19383391|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
19383392|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19383393|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19383394|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
19383395|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
19383396|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19383397|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
19383398|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19383399|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
19383400|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383401|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
19383402|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
19383403|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19383404|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19383405|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
19383406|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383407|NCT02073968|Paclitaxel|paclitaxel|mesh-list
19383408|NCT02073968|Carboplatin|carboplatin|mesh-list
19383409|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19383410|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19383411|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383412|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383413|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
19383414|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
19383415|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383416|NCT01971970|Adalimumab|adalimumab|mesh-list
19383417|NCT01971970|Infliximab|infliximab|mesh-list
19383418|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383419|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383420|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
19383421|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19383422|NCT01969409|Rituximab|rituximab|mesh-list
19847712|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19383423|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383424|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383425|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
20410042|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20410043|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
20410044|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410045|NCT01186159|Parecoxib|parecoxib|mesh-list
20410046|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20410047|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20410048|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410049|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410050|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20410051|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410052|NCT01186159|Analgesics|analgesics|mesh-ancestor
20410053|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
20410054|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410055|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410056|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410057|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213812|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
20213813|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213814|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20213815|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
20213816|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213817|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20213818|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
20213819|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20213820|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20410058|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19383426|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383427|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383428|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
19383429|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19383430|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19383431|NCT01942122|Analgesics|analgesics|mesh-ancestor
19383432|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
19383433|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383434|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383435|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410059|NCT01186172|Ethanol|ethanol|mesh-list
20410060|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410061|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20410062|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410063|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410064|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
20410065|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410066|NCT01186224|Plerixafor|plerixafor|mesh-list
20410067|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20410068|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20410069|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
20410070|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410071|NCT01186289|Atorvastatin|atorvastatin|mesh-list
20410072|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20410073|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20410074|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
19383436|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383437|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19383438|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383439|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383440|NCT01940094|Prednisone|prednisone|mesh-list
19383441|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
19383442|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383443|NCT01940094|Hormones|hormones|mesh-ancestor
19383444|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383445|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383446|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19383447|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383448|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
19383449|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383450|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
19383451|NCT01869829|Clotrimazole|clotrimazole|mesh-list
19383452|NCT01869829|Miconazole|miconazole|mesh-list
19383453|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410075|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383454|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19383455|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20410076|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20410077|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20410078|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410079|NCT01186445|Morphine|morphine|mesh-list
20410080|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20410081|NCT01186445|Narcotics|narcotics|mesh-ancestor
20410082|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410083|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410084|NCT01186445|Analgesics|analgesics|mesh-ancestor
20410085|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
20410086|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410087|NCT01186471|Nicotine|nicotine|mesh-list
20410088|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20410089|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
20410090|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410091|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410092|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20410093|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20410094|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
20410095|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383456|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19383457|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383458|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383459|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19383460|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
19383461|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383462|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383463|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19383464|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19383465|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
19383466|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383467|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
19383468|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383469|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383470|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19383471|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
19383472|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383473|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383474|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20410096|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410097|NCT01186497|Rabeprazole|rabeprazole|mesh-list
20410098|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20410099|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20410100|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20410101|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410102|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410103|NCT01186549|Lidocaine|lidocaine|mesh-list
20410104|NCT01186549|Ephedrine|ephedrine|mesh-list
20410105|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
20410106|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
20410107|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
20410108|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410109|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410110|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
20410111|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410112|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20410113|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20410114|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20410115|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19383475|NCT01754779|Indapamide|indapamide|mesh-list
19383476|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
19383477|NCT01754779|Citric Acid|citric acid|mesh-list
19383478|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
19383479|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
19383480|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19383481|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
19383482|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
19383483|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383484|NCT01754779|Diuretics|diuretics|mesh-ancestor
19383485|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
19383486|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383487|NCT01754779|Expectorants|expectorants|mesh-ancestor
19383488|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
19383489|NCT01754779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20427504|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19383490|NCT01754779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19383491|NCT01754779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19383492|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
19383493|NCT01752491|Temozolomide|temozolomide|mesh-list
19383494|NCT01752491|Vitamins|vitamins|mesh-ancestor
19383495|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
19383496|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383497|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19383498|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
19383499|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383500|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383501|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
19383502|NCT01752491|Protective Agents|protective agents|mesh-ancestor
19383503|NCT01578954|Lenalidomide|lenalidomide|mesh-list
19383504|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
19383505|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383506|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19383507|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19383508|NCT01578954|Growth Substances|growth substances|mesh-ancestor
19383509|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
19383510|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383511|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20410116|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410117|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20410118|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
20410119|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
20410120|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20410121|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
20410122|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410123|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20410124|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19383512|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383513|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383514|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383515|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19383516|NCT01218555|Lenalidomide|lenalidomide|mesh-list
19383517|NCT01218555|Everolimus|everolimus|mesh-list
19383518|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
19383519|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383520|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19383521|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19383522|NCT01218555|Growth Substances|growth substances|mesh-ancestor
19383523|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
19383524|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383525|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383526|NCT01161394|Pioglitazone|pioglitazone|mesh-list
19383527|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19383528|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383529|NCT01141712|Cytarabine|cytarabine|mesh-list
19383530|NCT01141712|Etoposide|etoposide|mesh-list
19383531|NCT01141712|Melphalan|melphalan|mesh-list
19383532|NCT01141712|Carmustine|carmustine|mesh-list
19383533|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19383534|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383535|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19383536|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19383537|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383538|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383539|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383540|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
19383541|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
19383542|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383543|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383544|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
19383545|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383546|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19383547|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
19383548|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19847713|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410125|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410126|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
20410127|NCT01186588|Canagliflozin|canagliflozin|mesh-list
20410128|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19383549|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
19383550|NCT01111305|Reslizumab|reslizumab|mesh-list
19383551|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20410129|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410130|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20213821|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213822|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20213823|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20213824|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
20213825|NCT00296790|Zolpidem|zolpidem|mesh-list
20213826|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19383552|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
19383553|NCT01111305|Filaricides|filaricides|mesh-ancestor
19383554|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
19383555|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
19383556|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19383557|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383558|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19383559|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383560|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383561|NCT00921856|Acetylcholine|acetylcholine|mesh-list
19383562|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
19383563|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19383564|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
19383565|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383566|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383567|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383568|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
20410131|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427505|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20427506|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427507|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427508|NCT01287624|Gemcitabine|gemcitabine|mesh-list
20427509|NCT01287624|Paclitaxel|paclitaxel|mesh-list
19383569|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19383570|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383571|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383572|NCT00659646|Levofloxacin|levofloxacin|mesh-list
19383573|NCT00659646|Ofloxacin|ofloxacin|mesh-list
19383574|NCT00659646|Gentamicins|gentamicins|mesh-list
19383575|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19383576|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383577|NCT00659646|Renal Agents|renal agents|mesh-ancestor
19383578|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383579|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19383580|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19383581|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383582|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383583|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383584|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19383585|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19383586|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19383587|NCT00567580|Leuprolide|leuprolide|mesh-list
19383588|NCT00567580|Goserelin|goserelin|mesh-list
19383589|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19383590|NCT00567580|Flutamide|flutamide|mesh-list
20427510|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20427511|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427512|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383591|NCT00567580|Bicalutamide|bicalutamide|mesh-list
19383592|NCT00567580|Buserelin|buserelin|mesh-list
19383593|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19383594|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
19383595|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19383596|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383597|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19383598|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383599|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
19383600|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
19383601|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383602|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
20427513|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
20427514|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
20427515|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427516|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383603|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20213827|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20213828|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383604|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
19383605|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19403329|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19403330|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20410132|NCT01186653|Fluticasone|fluticasone|mesh-list
20410133|NCT01186653|Budesonide|budesonide|mesh-list
20410134|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
20410135|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20410136|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20410137|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410138|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20410139|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
20410140|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410141|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410142|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20410143|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410144|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
20410145|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20213829|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213830|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20213831|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
20213832|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
20213833|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403331|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
19403332|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19403333|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19403334|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19403335|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19403336|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19403337|NCT03602430|Vitamin D|vitamin d|mesh-list
19403338|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
19403339|NCT03602430|Vitamins|vitamins|mesh-ancestor
19403340|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
19403341|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403342|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20213834|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213835|NCT00296803|Clopidogrel|clopidogrel|mesh-list
20213836|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20213837|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20213838|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20213839|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20213840|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
19403343|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19403344|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
19403345|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403346|NCT03602287|Lidocaine|lidocaine|mesh-list
19403347|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
20410146|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
20410147|NCT01186653|Hormones|hormones|mesh-ancestor
20410148|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403348|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
19403349|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403350|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403351|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
19403352|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403353|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19403354|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19847714|NCT00687908|Analgesics|analgesics|mesh-ancestor
19847715|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
19847716|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213841|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213842|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213843|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847717|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847718|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847719|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847720|NCT00687973|Atenolol|atenolol|mesh-list
19847721|NCT00687973|Amlodipine|amlodipine|mesh-list
19847722|NCT00687973|Valsartan|valsartan|mesh-list
19847723|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19847724|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20213844|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
20410149|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20410150|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20213845|NCT00296868|Vitamins|vitamins|mesh-ancestor
20213846|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
20213847|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691349|NCT05006235|Albuterol|albuterol|mesh-list
19691350|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19691351|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19691352|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
19691353|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691354|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691355|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847725|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20410151|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20410152|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
20410153|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213848|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
20213849|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213850|NCT00296868|Protective Agents|protective agents|mesh-ancestor
20213851|NCT00296894|Adalimumab|adalimumab|mesh-list
20213852|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213853|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20213854|NCT00296933|Citalopram|citalopram|mesh-list
20213855|NCT00296933|Bupropion|bupropion|mesh-list
19847726|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213856|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20213857|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20213858|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20410154|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410155|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
20410156|NCT01186731|Docetaxel|docetaxel|mesh-list
20410157|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410158|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
20410159|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
20410160|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
20410161|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213859|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213860|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213861|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
20213862|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213863|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20410162|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
20410163|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20410164|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20410165|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
20410166|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20410167|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20410168|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410169|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
20410170|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410171|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410172|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20410173|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
20213864|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
20213865|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19383606|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19383607|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19383608|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383609|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383610|NCT00477412|Cytarabine|cytarabine|mesh-list
19383611|NCT00477412|Dexamethasone|dexamethasone|mesh-list
19383612|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
19383613|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
19383614|NCT00477412|Rituximab|rituximab|mesh-list
19383615|NCT00477412|Doxorubicin|doxorubicin|mesh-list
20410174|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
20213866|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19383616|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19691356|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19691357|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19691358|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
19691359|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691360|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19691361|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
19691362|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
19691363|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
19383617|NCT00477412|Methotrexate|methotrexate|mesh-list
19383618|NCT00477412|Vincristine|vincristine|mesh-list
20213867|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
20213868|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20213869|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20213870|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213871|NCT00296946|Bromides|bromides|mesh-list
20213872|NCT00296946|Ipratropium|ipratropium|mesh-list
20213873|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
20213874|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20213875|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
20213876|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213877|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213878|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20213879|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
20213880|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20213881|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
20410175|NCT01186835|Protective Agents|protective agents|mesh-ancestor
20410176|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20410177|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410178|NCT01186887|Celecoxib|celecoxib|mesh-list
20410179|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20213882|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213883|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410180|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410181|NCT01186887|Analgesics|analgesics|mesh-ancestor
20410182|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
20213884|NCT00296959|Topiramate|topiramate|mesh-list
20213885|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
20213886|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20213887|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383619|NCT00477412|Bortezomib|bortezomib|mesh-list
19383620|NCT00477412|Daunorubicin|daunorubicin|mesh-list
19383621|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19383622|NCT00477412|Antibodies|antibodies|mesh-list
19383623|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
19383624|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19383625|NCT00477412|BB 1101|bb 1101|mesh-list
19383626|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383627|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
19383628|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383629|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19383630|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19383631|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
19383632|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383633|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383634|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19383635|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383636|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
19383637|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
20410183|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410184|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410185|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410186|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20410187|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20410188|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20410189|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410190|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410191|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
20410192|NCT01187108|Acetazolamide|acetazolamide|mesh-list
20410193|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20410194|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
20410195|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410196|NCT01187108|Expectorants|expectorants|mesh-ancestor
20410197|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410198|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20410199|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
20410200|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410201|NCT01187108|Protective Agents|protective agents|mesh-ancestor
20410202|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410203|NCT01187108|Antidotes|antidotes|mesh-ancestor
20410204|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
20410205|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20410206|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383638|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383639|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20213888|NCT00296972|Interferons|interferons|mesh-list
20213889|NCT00296972|Ribavirin|ribavirin|mesh-list
20410207|NCT01187108|Diuretics|diuretics|mesh-ancestor
20410208|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
20410209|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
20410210|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20410211|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410212|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20410213|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410214|NCT01187212|Cisplatin|cisplatin|mesh-list
20410215|NCT01187212|Capecitabine|capecitabine|mesh-list
20410216|NCT01187212|Sorafenib|sorafenib|mesh-list
20410217|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410218|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20410219|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
20410220|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410221|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20410222|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410223|NCT01187238|Cisplatin|cisplatin|mesh-list
20410224|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383640|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
19383641|NCT00477412|Hormones|hormones|mesh-ancestor
19383642|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383643|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19383644|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19383645|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19383646|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19383647|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410225|NCT01187264|Methotrexate|methotrexate|mesh-list
20410226|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20410227|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
20410228|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20410229|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410230|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20410231|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
20410232|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410233|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410234|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
20410235|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410236|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19383648|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19383649|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
19383650|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19383651|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383652|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
19383653|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
19383654|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19383655|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19383656|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
19383657|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383658|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19383659|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383660|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
19383661|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
19383662|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
19383663|NCT00369317|Cytarabine|cytarabine|mesh-list
19383664|NCT00369317|Etoposide|etoposide|mesh-list
19383665|NCT00369317|Daunorubicin|daunorubicin|mesh-list
19383666|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
19383667|NCT00369317|Asparaginase|asparaginase|mesh-list
19383668|NCT00369317|Thioguanine|thioguanine|mesh-list
19383669|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19383670|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383671|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19383672|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19383673|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383674|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383675|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383676|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
19383677|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
19383678|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383679|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383680|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
20410237|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383681|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383682|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19383683|NCT00261807|Daptomycin|daptomycin|mesh-list
19383684|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19383685|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383686|NCT05216653|Capecitabine|capecitabine|mesh-list
19383687|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
19383688|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383689|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
20410238|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
20410239|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20410240|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20410241|NCT01187303|Ofatumumab|ofatumumab|mesh-list
20410242|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410243|NCT01187459|Vitamin D|vitamin d|mesh-list
20410244|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
20410245|NCT01187459|Vitamins|vitamins|mesh-list
20410246|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
20410247|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410248|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20410249|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20410250|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
20410251|NCT01187485|Testosterone|testosterone|mesh-list
20410252|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
20410253|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
20410254|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19383690|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383691|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383692|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
19383693|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19383694|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383695|NCT05216419|Vitamins|vitamins|mesh-ancestor
19383696|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
19383697|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19383698|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
19383699|NCT05216237|Apatinib|apatinib|mesh-list
19383700|NCT05216237|Tegafur|tegafur|mesh-list
19383701|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383702|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383703|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383704|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383705|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19383706|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
19383707|NCT05215873|Misoprostol|misoprostol|mesh-list
19383708|NCT05215873|Oxytocin|oxytocin|mesh-list
19383709|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
19383710|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19383711|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383712|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19383713|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
19383714|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19383715|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19383716|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
19383717|NCT05215743|Antioxidants|antioxidants|mesh-list
19383718|NCT05215743|Deferoxamine|deferoxamine|mesh-list
19383719|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
19383720|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383721|NCT05215743|Expectorants|expectorants|mesh-ancestor
19383722|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
19383723|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19383724|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383725|NCT05215743|Protective Agents|protective agents|mesh-ancestor
19383726|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383727|NCT05215743|Siderophores|siderophores|mesh-ancestor
19383728|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19383729|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
19383730|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
19383731|NCT05215730|Copper|copper|mesh-list
19383732|NCT05215730|Trace Elements|trace elements|mesh-ancestor
19383733|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
19383734|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383735|NCT05215665|Lenvatinib|lenvatinib|mesh-list
19383736|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383737|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383738|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691364|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19383739|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383740|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
19383741|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
19383742|NCT05215366|Coagulants|coagulants|mesh-ancestor
19383743|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20410255|NCT01187485|Androgens|androgens|mesh-ancestor
20410256|NCT01187485|Hormones|hormones|mesh-ancestor
19383744|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19383745|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
19383746|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383747|NCT05215106|Durvalumab|durvalumab|mesh-list
19383748|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383749|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410257|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20410258|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410259|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20410260|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410261|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
20410262|NCT01187537|Bupivacaine|bupivacaine|mesh-list
20410263|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
20410264|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
20410265|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410266|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410267|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
20410268|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410269|NCT01187589|Albuterol|albuterol|mesh-list
20410270|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20410271|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
20410272|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410273|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410274|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20410275|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410276|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
20410277|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19383750|NCT05214911|Loratadine|loratadine|mesh-list
19383751|NCT05214911|Prednisolone|prednisolone|mesh-list
19383752|NCT05214911|Desloratadine|desloratadine|mesh-list
19383753|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19383754|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
19383755|NCT05214911|Hormones|hormones|mesh-ancestor
19383756|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383757|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383758|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19383759|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410278|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20410279|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20410280|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20410281|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
20410282|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410283|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410284|NCT01187615|Cisplatin|cisplatin|mesh-list
20410285|NCT01187615|Pemetrexed|pemetrexed|mesh-list
19383760|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19383761|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
19383762|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383763|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383764|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19383765|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19383766|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
19383767|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
19383768|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
19383769|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
19383770|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19383771|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20213890|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410286|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410287|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410288|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213891|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
20213892|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213893|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
20213894|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217932|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
20217933|NCT00311038|Landiolol|landiolol|mesh-list
20217934|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20217935|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20217936|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
20217937|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383772|NCT05214872|Calcium|calcium|mesh-list
19383773|NCT05214872|Mitogens|mitogens|mesh-list
20217938|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383774|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19383775|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383776|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
19383777|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383778|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
19383779|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19383780|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19383781|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383782|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20410289|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20410290|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20410291|NCT01187719|Phenytoin|phenytoin|mesh-list
20410292|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
20410293|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20410294|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20410295|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20410296|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410297|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20410298|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20410299|NCT01187849|Metformin|metformin|mesh-list
19691365|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
19691366|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19691367|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19691368|NCT05005689|Fluorides|fluorides|mesh-list
19691369|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
19691370|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691371|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
19691372|NCT05005689|Protective Agents|protective agents|mesh-ancestor
20410300|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20410301|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410302|NCT01187862|Efavirenz|efavirenz|mesh-list
20410303|NCT01187862|Losartan|losartan|mesh-list
20410304|NCT01187862|Metoprolol|metoprolol|mesh-list
20410305|NCT01187862|Midazolam|midazolam|mesh-list
20410306|NCT01187862|Caffeine|caffeine|mesh-list
19383783|NCT05193487|Anesthetics|anesthetics|mesh-list
19383784|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383785|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383786|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19383787|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19383788|NCT05189145|Hormones|hormones|mesh-list
19383789|NCT05189145|Estradiol|estradiol|mesh-list
19383790|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19383791|NCT05189145|Progesterone|progesterone|mesh-list
19383792|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
19383793|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383794|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383795|NCT05189145|Estrogens|estrogens|mesh-ancestor
19383796|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19383797|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
19383798|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19383799|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19383800|NCT05189145|Progestins|progestins|mesh-ancestor
19383801|NCT05186571|Vaccines|vaccines|mesh-list
19383802|NCT05186571|Immunologic Factors|immunologic factors|mesh-ancestor
19383803|NCT05186571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383804|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19383805|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
19383806|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383807|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19383808|NCT05160922|Crizotinib|crizotinib|mesh-list
20213895|NCT00297011|Valacyclovir|valacyclovir|mesh-list
20213896|NCT00297011|Clobetasol|clobetasol|mesh-list
20213897|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
20213898|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213899|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20213900|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
20213901|NCT00297011|Hormones|hormones|mesh-ancestor
20213902|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20213903|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213904|NCT00297050|Peramivir|peramivir|mesh-list
20213905|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
20410307|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
20410308|NCT01187862|Omeprazole|omeprazole|mesh-list
19691373|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
20213906|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213907|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410309|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19383809|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383810|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383811|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383812|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403355|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19403356|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403357|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403358|NCT03602248|Methamphetamine|methamphetamine|mesh-list
19403359|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19403360|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403361|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
19403362|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
19403363|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403364|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
19403365|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403366|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403367|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403368|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19403369|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19403370|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403371|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19403372|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19403373|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403374|NCT03602131|Gemcitabine|gemcitabine|mesh-list
19403375|NCT03602131|Busulfan|busulfan|mesh-list
19403376|NCT03602131|Cladribine|cladribine|mesh-list
19403377|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19403378|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
19403379|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403380|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403381|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
19403382|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403383|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403384|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20410310|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20410311|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410312|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410313|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20410314|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20410315|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19403385|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
19403386|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403387|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
19403388|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19403389|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19403390|NCT03602118|Phenobarbital|phenobarbital|mesh-list
19403391|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
19403392|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19403393|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403394|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403395|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19403396|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19403397|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403398|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403399|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
19403400|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
19403401|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19403402|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19403403|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19403404|NCT03602027|Gefitinib|gefitinib|mesh-list
19403405|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403406|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403407|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403408|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403409|NCT03602014|Droxidopa|droxidopa|mesh-list
19847727|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20410316|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20410317|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
20410318|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
20410319|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
20410320|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
20410321|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410322|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383813|NCT05130788|Nicotine|nicotine|mesh-list
19383814|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19383815|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
19383816|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383817|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383818|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19383819|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19383820|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
19383821|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383822|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410323|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20410324|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20410325|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20410326|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20410327|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20410328|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20410329|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20410330|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410331|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20410332|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20410333|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20410334|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20410335|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
20410336|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20410337|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20410338|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
20410339|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410340|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20410341|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20410342|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20410343|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20410344|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20410345|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20410346|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
20410347|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
20410348|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410349|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20410350|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19383823|NCT05114915|Docetaxel|docetaxel|mesh-list
19383824|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383825|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383826|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
19383827|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
19383828|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383829|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
19383830|NCT05064280|Lenvatinib|lenvatinib|mesh-list
19383831|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383832|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383833|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383834|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213908|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213909|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
20213910|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20213911|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213912|NCT00297076|Aplaviroc|aplaviroc|mesh-list
20213913|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19691374|NCT05005494|Analgesics|analgesics|mesh-ancestor
20213914|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20213915|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213916|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20213917|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20213918|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
20213919|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213920|NCT00297128|Capecitabine|capecitabine|mesh-list
20213921|NCT00297128|Cetuximab|cetuximab|mesh-list
20213922|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213923|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
20213924|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213925|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213926|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20213927|NCT00297141|Capecitabine|capecitabine|mesh-list
20410351|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19403410|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20410352|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
20410353|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20410354|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20410355|NCT01187888|Rasagiline|rasagiline|mesh-list
20410356|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20410357|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410358|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410359|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20410360|NCT01187888|Protective Agents|protective agents|mesh-ancestor
20410361|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383835|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383836|NCT05048849|Somatomedin B|somatomedin b|mesh-list
19383837|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20213928|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
19383838|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19383839|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
19383840|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383841|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383842|NCT05038618|Somatomedin B|somatomedin b|mesh-list
19383843|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19383844|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19383845|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
19383846|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383847|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383848|NCT04992013|Niraparib|niraparib|mesh-list
19383849|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19383850|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383851|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383852|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383853|NCT04967079|Trametinib|trametinib|mesh-list
19383854|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383855|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383856|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383857|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383858|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
19383859|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19383860|NCT04964193|Cyproterone|cyproterone|mesh-list
19383861|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
19383862|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19383863|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19383864|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19383865|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
19383866|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19383867|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383868|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19383869|NCT04964193|Estrogens|estrogens|mesh-ancestor
19383870|NCT04964193|Hormones|hormones|mesh-ancestor
19383871|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19383872|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
19383873|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
19383874|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383875|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19383876|NCT04958876|Naltrexone|naltrexone|mesh-list
19383877|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19383878|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19383879|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383880|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
19383881|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383882|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19383883|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19383884|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383885|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
20213929|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20213930|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
20213931|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213932|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213933|NCT00297206|Valacyclovir|valacyclovir|mesh-list
20213934|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
20213935|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20213936|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
20213937|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
20213938|NCT00297219|Calcium|calcium|mesh-list
20213939|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19383886|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19383887|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383888|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
19383889|NCT04896320|Tucatinib|tucatinib|mesh-list
19383890|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383891|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19383892|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383893|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383894|NCT04865796|Lactoferrin|lactoferrin|mesh-list
19383895|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383896|NCT04858269|Paclitaxel|paclitaxel|mesh-list
20410362|NCT01187992|Atorvastatin|atorvastatin|mesh-list
20410363|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20410364|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20410365|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
20410366|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410367|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20410368|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20410369|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410370|NCT01188005|Vitamins|vitamins|mesh-list
20410371|NCT01188005|Vitamin E|vitamin e|mesh-list
20410372|NCT01188005|Vitamin A|vitamin a|mesh-list
20410373|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
20410374|NCT01188005|Allopurinol|allopurinol|mesh-list
20410375|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20410376|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
20410377|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410378|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
20410379|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410380|NCT01188005|Protective Agents|protective agents|mesh-ancestor
20410381|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
19383897|NCT04858269|Carboplatin|carboplatin|mesh-list
19383898|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
19383899|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19383900|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383901|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383902|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
19383903|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
19383904|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383905|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19383906|NCT04844528|Niacinamide|niacinamide|mesh-list
19383907|NCT04844528|Niacin|niacin|mesh-list
19383908|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
19383909|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
19383910|NCT04844528|Vitamins|vitamins|mesh-ancestor
19383911|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
19383912|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383913|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19383914|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
19383915|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383916|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19383917|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
19383918|NCT04818086|Buprenorphine|buprenorphine|mesh-list
19383919|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19383920|NCT04818086|Lemborexant|lemborexant|mesh-list
19383921|NCT04818086|Naloxone|naloxone|mesh-list
19383922|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19383923|NCT04818086|Narcotics|narcotics|mesh-ancestor
19383924|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383925|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383926|NCT04818086|Analgesics|analgesics|mesh-ancestor
19383927|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
19383928|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383929|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19383930|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19383931|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213940|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213941|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20213942|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20213943|NCT00297284|Modafinil|modafinil|mesh-list
20213944|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20213945|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213946|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20410382|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383932|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410383|NCT01188005|Expectorants|expectorants|mesh-ancestor
20410384|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
19383933|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19383934|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19383935|NCT04811118|Docetaxel|docetaxel|mesh-list
19383936|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20213947|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20213948|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20410385|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20410386|NCT01188005|Antidotes|antidotes|mesh-ancestor
20410387|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
20410388|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410389|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
20410390|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20410391|NCT01188031|Alprazolam|alprazolam|mesh-list
20410392|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20410393|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410394|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410395|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20410396|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20410397|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20410398|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
20410399|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
20410400|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410401|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410402|NCT01188057|Alprazolam|alprazolam|mesh-list
20410403|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20410404|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410405|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410406|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20410407|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20410408|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20410409|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
20410410|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
20410411|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410412|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410413|NCT01188148|Memantine|memantine|mesh-list
20410414|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20410415|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20410416|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
20410417|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410418|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410419|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410420|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20410421|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20410422|NCT01188174|Clofarabine|clofarabine|mesh-list
20410423|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20410424|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
20410425|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410426|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410427|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
20410428|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410429|NCT01188265|Valproic Acid|valproic acid|mesh-list
20410430|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
20410431|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
20410432|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410433|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20410434|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20213949|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213950|NCT00297323|Topiramate|topiramate|mesh-list
20213951|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
20213952|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20213953|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213954|NCT00297336|Topiramate|topiramate|mesh-list
20213955|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
20213956|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20213957|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213958|NCT00297349|Topiramate|topiramate|mesh-list
20213959|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
20213960|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20213961|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213962|NCT00297362|Galantamine|galantamine|mesh-list
20213963|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20213964|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20213965|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213966|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
20213967|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213968|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213969|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20213970|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
19383937|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19383938|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19383939|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19383940|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383941|NCT04793685|Prazosin|prazosin|mesh-list
19383942|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19383943|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19383944|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19383945|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19383946|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
19383947|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383948|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383949|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383950|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19383951|NCT04785287|Nivolumab|nivolumab|mesh-list
19383952|NCT04785287|Antibodies|antibodies|mesh-list
19383953|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
19383954|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19383955|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
19383956|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383957|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19383958|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19383959|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383960|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
19383961|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19383962|NCT04703036|Glycine|glycine|mesh-list
19383963|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
19383964|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19383965|NCT04703036|Expectorants|expectorants|mesh-ancestor
19383966|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
19383967|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19383968|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
19383969|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383970|NCT04703036|Protective Agents|protective agents|mesh-ancestor
19383971|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383972|NCT04703036|Antidotes|antidotes|mesh-ancestor
19383973|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
19383974|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19383975|NCT04695652|Somatomedin B|somatomedin b|mesh-list
19383976|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19383977|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19383978|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
19383979|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19383980|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383981|NCT04647084|Lidocaine|lidocaine|mesh-list
19383982|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
19383983|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
19383984|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19383985|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19383986|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
19383987|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19383988|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19383989|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19383990|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19383991|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19383992|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19383993|NCT04632927|Ustekinumab|ustekinumab|mesh-list
20410435|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410436|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410437|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410438|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
19383994|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
19383995|NCT04620798|Antibodies|antibodies|mesh-list
19383996|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
19383997|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213971|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213972|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
20213973|NCT00297375|Acetaminophen|acetaminophen|mesh-list
20213974|NCT00297375|Tramadol|tramadol|mesh-list
20213975|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20213976|NCT00297375|Analgesics|analgesics|mesh-ancestor
20213977|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
20410439|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410440|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
20410441|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
20410442|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20410443|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410444|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20410445|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
20410446|NCT01188278|Dasatinib|dasatinib|mesh-list
20410447|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410448|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20410449|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410450|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410451|NCT01188304|Aspirin|aspirin|mesh-list
20410452|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20410453|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410454|NCT01188304|Analgesics|analgesics|mesh-ancestor
20410455|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
20410456|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410457|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410458|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410459|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20410460|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20410461|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20410462|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410463|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20410464|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20213978|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20213979|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213980|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
20213981|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20213982|NCT00297375|Narcotics|narcotics|mesh-ancestor
20213983|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213984|NCT00297388|Risperidone|risperidone|mesh-list
20213985|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20213986|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
20213987|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20213988|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20213989|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20213990|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20213991|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20213992|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20213993|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20213994|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20213995|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
20213996|NCT00297466|Nicotine|nicotine|mesh-list
20213997|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20213998|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
20213999|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214000|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214001|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20214002|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20214003|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
20214004|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214005|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214006|NCT00297505|Citalopram|citalopram|mesh-list
20214007|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20214008|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20214009|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214010|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214011|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214012|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
20214013|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214014|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20214015|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
20214016|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20214017|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
20214018|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
20214019|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20214020|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20214021|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214022|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214023|NCT00297544|Urological Agents|urological agents|mesh-ancestor
20214024|NCT00297570|Interferons|interferons|mesh-list
20214025|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
20410465|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214026|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214027|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
20214028|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214029|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20214030|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214031|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214032|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
20214033|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19384012|NCT04576078|Nefopam|nefopam|mesh-list
19384013|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384014|NCT04576078|Analgesics|analgesics|mesh-ancestor
19384015|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
19384016|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384017|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384018|NCT04557449|Letrozole|letrozole|mesh-list
19384019|NCT04557449|Fulvestrant|fulvestrant|mesh-list
19384020|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384021|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19384022|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19384023|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384024|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384025|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19384026|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
19384027|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384028|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384029|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19384030|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19384031|NCT04530409|Dexamethasone|dexamethasone|mesh-list
19384032|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
19384033|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384034|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
19384035|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
19384036|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384037|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384038|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384039|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
19384040|NCT04530409|Hormones|hormones|mesh-ancestor
19384041|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384042|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19384043|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410466|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
20410467|NCT01188317|Ibuprofen|ibuprofen|mesh-list
20410468|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20410469|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410470|NCT01188317|Analgesics|analgesics|mesh-ancestor
20410471|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
20410472|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410473|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410474|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410475|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384044|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19384045|NCT04530409|Protective Agents|protective agents|mesh-ancestor
19403411|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19403412|NCT03601975|Gemcitabine|gemcitabine|mesh-list
19403413|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403414|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19403415|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
19403416|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214034|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214035|NCT00297661|Sirolimus|sirolimus|mesh-list
20214036|NCT00297661|Paclitaxel|paclitaxel|mesh-list
20214037|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20214038|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214039|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
20214040|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
20214041|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
20214042|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410476|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20410477|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410478|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410479|NCT01188408|Docetaxel|docetaxel|mesh-list
19403417|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
19403418|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214043|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20410480|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410481|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
20410482|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
20410483|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
20410484|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427517|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
19384046|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
19384047|NCT04505774|Empagliflozin|empagliflozin|mesh-list
19384048|NCT04505774|Canagliflozin|canagliflozin|mesh-list
19384049|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
19384050|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19384051|NCT04505774|Heparin|heparin|mesh-list
19384052|NCT04505774|Calcium heparin|calcium heparin|mesh-list
19384053|NCT04505774|Enoxaparin|enoxaparin|mesh-list
19384054|NCT04505774|Dalteparin|dalteparin|mesh-list
19384055|NCT04505774|Tinzaparin|tinzaparin|mesh-list
19384056|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19384057|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
19384058|NCT04505774|Clopidogrel|clopidogrel|mesh-list
20427518|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
19691375|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
20214044|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214045|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20214046|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
20214047|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214048|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
20214049|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214050|NCT00297674|Clarithromycin|clarithromycin|mesh-list
20214051|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214052|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214053|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20214054|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214055|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214056|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20214057|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20214058|NCT00297739|Risperidone|risperidone|mesh-list
20214059|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20214060|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
20214061|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214062|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214063|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214064|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20214065|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20214066|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214067|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20214068|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20214069|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
20214070|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20214071|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20214072|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214073|NCT00297765|Tacrolimus|tacrolimus|mesh-list
20214074|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214075|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
20214076|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214077|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20214078|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214079|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214080|NCT00297804|Paclitaxel|paclitaxel|mesh-list
20214081|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20214082|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214083|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
20214084|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
20214085|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
20427519|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691376|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691377|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691378|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
19691379|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691380|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19691381|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
19691382|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20214086|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384059|NCT04505774|Ticagrelor|ticagrelor|mesh-list
19384060|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19384061|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19693070|NCT04983615|Narcotics|narcotics|mesh-ancestor
19384062|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19384063|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19384064|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
19384065|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384066|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384067|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384068|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
19384069|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19384070|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19384071|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19384072|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19384073|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19384074|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19384075|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19384076|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384077|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384078|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384079|NCT04504812|Analgesics|analgesics|mesh-ancestor
19384080|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
19384081|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384082|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
19384083|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384084|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
19384085|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
19384086|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19384087|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19384088|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847728|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847729|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
20410485|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20410486|NCT01188707|Belinostat|belinostat|mesh-list
20410487|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410488|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20410489|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410490|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410491|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20410492|NCT01188733|Octreotide|octreotide|mesh-list
20410493|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691383|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19691384|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691385|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19691386|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
19691387|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20410494|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20410495|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384089|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
19384090|NCT04489108|Coagulants|coagulants|mesh-ancestor
19384091|NCT04471675|Docetaxel|docetaxel|mesh-list
19384092|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384093|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
19384094|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
19384095|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
19384096|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384097|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
19384098|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384099|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
19384100|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19384101|NCT04453839|Protective Agents|protective agents|mesh-ancestor
19384102|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384103|NCT04439513|Hemostatics|hemostatics|mesh-list
20410496|NCT01188759|Voriconazole|voriconazole|mesh-list
19384104|NCT04439513|Coagulants|coagulants|mesh-ancestor
19691388|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
19691389|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19691390|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691391|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691392|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19691393|NCT05005715|Analgesics|analgesics|mesh-ancestor
19691394|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
19691395|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691396|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20410497|NCT01188759|Anidulafungin|anidulafungin|mesh-list
19384105|NCT04431375|Tenofovir|tenofovir|mesh-list
20410498|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
20410499|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410500|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20410501|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19691397|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19384106|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
19384107|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384108|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19384109|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19384110|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384111|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384112|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19384113|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19384114|NCT04410913|Psilocybin|psilocybin|mesh-list
19384115|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
19384116|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384117|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384118|NCT04369664|Atorvastatin|atorvastatin|mesh-list
19384119|NCT04369664|Ezetimibe|ezetimibe|mesh-list
19384120|NCT04369664|Evolocumab|evolocumab|mesh-list
19384121|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19384122|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19384123|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
19384124|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384125|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19384126|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19384127|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384128|NCT04315038|Anesthetics|anesthetics|mesh-list
19384129|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384130|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384131|NCT04304144|Dexamethasone|dexamethasone|mesh-list
19384132|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
19384133|NCT04304144|Bortezomib|bortezomib|mesh-list
19384134|NCT04304144|Daratumumab|daratumumab|mesh-list
19384135|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384136|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
19691398|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20214087|NCT00297817|Vaccines|vaccines|mesh-list
20214088|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
20214089|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214090|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19384137|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384138|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214091|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
20214092|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20214093|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20214094|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20214095|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214096|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214097|NCT00297960|Olanzapine|olanzapine|mesh-list
20214098|NCT00297960|Ziprasidone|ziprasidone|mesh-list
19691399|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
19691400|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691401|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691402|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
20410502|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410503|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410504|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20410505|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
19384139|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19384140|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
19384141|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384142|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384143|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19384144|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384145|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
19384146|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
19384147|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384148|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384149|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
19384150|NCT04304144|Hormones|hormones|mesh-ancestor
20427520|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384151|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384152|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20214099|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
20410506|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20410507|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384153|NCT04256629|Allopurinol|allopurinol|mesh-list
19384154|NCT04256629|Verinurad|verinurad|mesh-list
19384155|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
19384156|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384157|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384158|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
19384159|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384160|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19384161|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
19384162|NCT04256629|Protective Agents|protective agents|mesh-ancestor
19384163|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384164|NCT04231084|Epoprostenol|epoprostenol|mesh-list
19384165|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
19384166|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
19384167|NCT04231084|Tezosentan|tezosentan|mesh-list
19384168|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19384169|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
19384170|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384171|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384172|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19384173|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
19384174|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19384175|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
20214100|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
20214101|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214102|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214103|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214104|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20214105|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20214106|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384176|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384177|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384178|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19384179|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
19384180|NCT04231084|Protective Agents|protective agents|mesh-ancestor
19384181|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19384182|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19384183|NCT04186494|Liraglutide|liraglutide|mesh-list
19384184|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19384185|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384186|NCT04186494|Incretins|incretins|mesh-ancestor
19384187|NCT04186494|Hormones|hormones|mesh-ancestor
19384188|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20410508|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20410509|NCT01188824|Cilostazol|cilostazol|mesh-list
20410510|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19384189|NCT04180995|Axitinib|axitinib|mesh-list
19384190|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384191|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19384192|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384193|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384194|NCT04112199|Terlipressin|terlipressin|mesh-list
20214107|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20214108|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20214109|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20214110|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214111|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214112|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214113|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
20214114|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20214115|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20214116|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
20214117|NCT00298012|Methotrexate|methotrexate|mesh-list
20214118|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20214119|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
20214120|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20214121|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410511|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
19384195|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19847730|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19384196|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19847731|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19384197|NCT04083963|Paclitaxel|paclitaxel|mesh-list
20410512|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410513|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410514|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20410515|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410516|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20410517|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20410518|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410519|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20410520|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
20410521|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20410522|NCT01188824|Protective Agents|protective agents|mesh-ancestor
20410523|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20410524|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20410525|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410526|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20410527|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20410528|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410529|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20410530|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410531|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
20410532|NCT01188889|Everolimus|everolimus|mesh-list
20410533|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410534|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20410535|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410536|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410537|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20410538|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
20410539|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410540|NCT01188954|Doxycycline|doxycycline|mesh-list
20410541|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20410542|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410543|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
20410544|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20410545|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19384198|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
19384199|NCT04083963|Carboplatin|carboplatin|mesh-list
19384200|NCT04083963|Doxorubicin|doxorubicin|mesh-list
19384201|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19384202|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384203|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
19384204|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
19384205|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
19384206|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410546|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
20410547|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
20410548|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410549|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20410550|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19384207|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384208|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
19384209|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384210|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384211|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19384212|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
19384213|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19384214|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19384215|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19384216|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19384217|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384218|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19384219|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
20214122|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20214123|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
20214124|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214125|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214126|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
20214127|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214128|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20214129|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214130|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
19384220|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384221|NCT04014075|Trastuzumab|trastuzumab|mesh-list
19384222|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384223|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384224|NCT04003285|Pregnanolone|pregnanolone|mesh-list
19384225|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
19384226|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384227|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384228|NCT03925532|Denosumab|denosumab|mesh-list
19384229|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19384230|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384231|NCT03790111|Gemcitabine|gemcitabine|mesh-list
19384232|NCT03790111|Cisplatin|cisplatin|mesh-list
19384233|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384234|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19384235|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
19384236|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384237|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
19384238|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384239|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384240|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384241|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
19384242|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384243|NCT03771586|Ketamine|ketamine|mesh-list
19384244|NCT03771586|Analgesics|analgesics|mesh-ancestor
19384245|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
19384246|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384247|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384248|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19384249|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19384250|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
19384251|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
19384252|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384253|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19384254|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19384255|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384256|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384257|NCT03767582|Nivolumab|nivolumab|mesh-list
19384258|NCT03767582|Vaccines|vaccines|mesh-list
19384259|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
19384260|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384261|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384262|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384263|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19384264|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384265|NCT03706885|Efavirenz|efavirenz|mesh-list
20410551|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410552|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410553|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410554|NCT01189019|Ranibizumab|ranibizumab|mesh-list
20410555|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20410556|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20410557|NCT01189019|Growth Substances|growth substances|mesh-ancestor
19384266|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19384267|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19384268|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384269|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384270|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
19384271|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384272|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19384273|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19384274|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19384275|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19384276|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19384277|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19384278|NCT03560960|Pramlintide|pramlintide|mesh-list
19384279|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19384280|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403419|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403420|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403421|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
19403422|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410558|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410559|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
19384281|NCT03518606|Durvalumab|durvalumab|mesh-list
19384282|NCT03518606|Vinorelbine|vinorelbine|mesh-list
19384283|NCT03518606|Tremelimumab|tremelimumab|mesh-list
19384284|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384285|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384286|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19384287|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
19384288|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
19384289|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
19384290|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384291|NCT03504423|Leucovorin|leucovorin|mesh-list
19384292|NCT03504423|Folic Acid|folic acid|mesh-list
19384293|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
19384294|NCT03504423|Irinotecan|irinotecan|mesh-list
19384295|NCT03504423|Folfirinox|folfirinox|mesh-list
20214131|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214132|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20214133|NCT00298025|Cetrorelix|cetrorelix|mesh-list
20214134|NCT00298025|Menotropins|menotropins|mesh-list
20214135|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20214136|NCT00298025|Hormones|hormones|mesh-list
20214137|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20214138|NCT00298025|Ganirelix|ganirelix|mesh-list
20214139|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214140|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214141|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
20214142|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20214143|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
20214144|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20214145|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
20214146|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20214147|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
19384296|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
19384297|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384298|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19384299|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19384300|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384301|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384302|NCT03504423|Antidotes|antidotes|mesh-ancestor
19384303|NCT03504423|Protective Agents|protective agents|mesh-ancestor
19384304|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384305|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
19384306|NCT03504423|Vitamins|vitamins|mesh-ancestor
19384307|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
19384308|NCT03504423|Hematinics|hematinics|mesh-ancestor
19384309|NCT03424525|Trimethoprim|trimethoprim|mesh-list
19384310|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19384311|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384312|NCT03424525|Renal Agents|renal agents|mesh-ancestor
19384313|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
19384314|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19384315|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19691403|NCT05005637|Prednisone|prednisone|mesh-list
20214148|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214149|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20214150|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214151|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
20214152|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214153|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
20214154|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20214155|NCT00298168|Protective Agents|protective agents|mesh-ancestor
20214156|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
20214157|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20214158|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
20214159|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214160|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20214161|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214162|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
20214163|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214164|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
20214165|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20214166|NCT00298181|Protective Agents|protective agents|mesh-ancestor
20214167|NCT00298194|Z 338|z 338|mesh-list
19384316|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20214168|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20214169|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384317|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384318|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410560|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410561|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
20410562|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
20410563|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410564|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20410565|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20410566|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410567|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214170|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214171|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
20410568|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410569|NCT01189214|Memantine|memantine|mesh-list
20214172|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214173|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214174|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214175|NCT00298285|Enoxaparin|enoxaparin|mesh-list
20214176|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
20214177|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20214178|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20214179|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214180|NCT00298324|Cyclosporine|cyclosporine|mesh-list
20214181|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
20214182|NCT00298324|Prednisone|prednisone|mesh-list
20214183|NCT00298324|Cyclosporins|cyclosporins|mesh-list
19384319|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19384320|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19384321|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19384322|NCT03284853|Latanoprost|latanoprost|mesh-list
19384323|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20410570|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20410571|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20410572|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
20410573|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410574|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410575|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410576|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20410577|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20410578|NCT01189253|Doxorubicin|doxorubicin|mesh-list
20410579|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20410580|NCT01189253|Trabectedin|trabectedin|mesh-list
20410581|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20410582|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410583|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20410584|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20410585|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410586|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410587|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20410588|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
20410589|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19384324|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19384325|NCT03206463|Dronabinol|dronabinol|mesh-list
19384326|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
19384327|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384328|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384329|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384330|NCT03206463|Analgesics|analgesics|mesh-ancestor
19384331|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
19384332|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384333|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20214184|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410590|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
19384334|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19384335|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214185|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
20214186|NCT00298324|Hormones|hormones|mesh-ancestor
20214187|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214188|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214189|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20214190|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214191|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214192|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214193|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20410591|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20410592|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19384336|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384337|NCT03206463|Hormones|hormones|mesh-ancestor
19384338|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384339|NCT03166761|Dexamethasone|dexamethasone|mesh-list
19384340|NCT03166761|Triamcinolone|triamcinolone|mesh-list
19384341|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19384342|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19384343|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19384344|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384345|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
19384346|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
19384347|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384348|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384349|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384350|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
19384351|NCT03166761|Hormones|hormones|mesh-ancestor
19384352|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384353|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19384354|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384355|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384356|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
19384357|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384358|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384359|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
19384360|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
19384361|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384362|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
19384363|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384364|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384365|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19384366|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
19384367|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384368|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384369|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19384370|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384371|NCT03072147|Teriparatide|teriparatide|mesh-list
19384372|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19384373|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384374|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20214194|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
20214195|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
20214196|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214197|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
20214198|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214199|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20214200|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20214201|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20214202|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
20214203|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214204|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
20214205|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
19691404|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691405|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
20214206|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214207|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214208|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20214209|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20214210|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
20214211|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214212|NCT00298415|Gemcitabine|gemcitabine|mesh-list
20214213|NCT00298415|Paclitaxel|paclitaxel|mesh-list
20214214|NCT00298415|Vinorelbine|vinorelbine|mesh-list
20214215|NCT00298415|Carboplatin|carboplatin|mesh-list
20214216|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20214217|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20214218|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214219|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
20214220|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
20214221|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
20214222|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214223|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20214224|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
20214225|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
20214226|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410593|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20410594|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410595|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410596|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
20410597|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
20410598|NCT01189448|Spiramycin|spiramycin|mesh-list
19384375|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
19384376|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384377|NCT03016533|Lamivudine|lamivudine|mesh-list
19384378|NCT03016533|Dolutegravir|dolutegravir|mesh-list
19384379|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19384380|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19384381|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384382|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384383|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
19384384|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384385|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19384386|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19384387|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19384388|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19384389|NCT03011814|Lenalidomide|lenalidomide|mesh-list
19384390|NCT03011814|Durvalumab|durvalumab|mesh-list
19384391|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
19384392|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19384393|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
19384394|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
19384395|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384396|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19384397|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19384398|NCT03011814|Growth Substances|growth substances|mesh-ancestor
20410599|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
20410600|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20410601|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20410602|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410603|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20410604|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410605|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410606|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20410607|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
20410608|NCT01189526|Ranibizumab|ranibizumab|mesh-list
20410609|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20410610|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20410611|NCT01189526|Growth Substances|growth substances|mesh-ancestor
20410612|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410613|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
20410614|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410615|NCT01189643|Bevacizumab|bevacizumab|mesh-list
20410616|NCT01189643|Irinotecan|irinotecan|mesh-list
20410617|NCT01189643|Temozolomide|temozolomide|mesh-list
20410618|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384399|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
19384400|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214227|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691406|NCT05005637|Hormones|hormones|mesh-ancestor
19691407|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691408|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691409|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691410|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691411|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19691412|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693071|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214228|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214229|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
20214230|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214231|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20214232|NCT00298454|Furosemide|furosemide|mesh-list
20214233|NCT00298454|Diuretics|diuretics|mesh-ancestor
20214234|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
20214235|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214236|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20214237|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693072|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410619|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384401|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384402|NCT02962414|Everolimus|everolimus|mesh-list
20410620|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20410621|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20214238|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214239|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
20214240|NCT00298506|Tacrolimus|tacrolimus|mesh-list
20214241|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214242|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
19384403|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384404|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384405|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
19384406|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384407|NCT02947165|Spartalizumab|spartalizumab|mesh-list
19384408|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19384409|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384410|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384411|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20410622|NCT01189643|Growth Substances|growth substances|mesh-ancestor
20410623|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410624|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
20410625|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20410626|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20410627|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410628|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410629|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20410630|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
20410631|NCT01189656|Vaccines|vaccines|mesh-list
20410632|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
19384412|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384413|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384414|NCT02905318|Palbociclib|palbociclib|mesh-list
19384415|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384416|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19384417|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384418|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384419|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
20410633|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410634|NCT01189695|Ritonavir|ritonavir|mesh-list
20410635|NCT01189695|Lopinavir|lopinavir|mesh-list
19384420|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384421|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214243|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214244|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20214245|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214246|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214247|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20214248|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214249|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20214250|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
20214251|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214252|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214253|NCT00298545|Calcitriol|calcitriol|mesh-list
20214254|NCT00298545|Calcium|calcium|mesh-list
20214255|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20214256|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214257|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20214258|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214259|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214260|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20214261|NCT00298545|Vitamins|vitamins|mesh-ancestor
20214262|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
20214263|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20214264|NCT00298571|Epinephrine|epinephrine|mesh-list
20214265|NCT00298571|Bupivacaine|bupivacaine|mesh-list
20214266|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
20214267|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
20214268|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214269|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214270|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
20214271|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214272|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20214273|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20410636|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20410637|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20410638|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
20410639|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384422|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
19384423|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19384424|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19384425|NCT02767804|Crizotinib|crizotinib|mesh-list
19384426|NCT02767804|Ensartinib|ensartinib|mesh-list
19384427|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384428|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19384429|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384430|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384431|NCT02721069|Diazepam|diazepam|mesh-list
19384432|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19384433|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
19384434|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
19384435|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
19384436|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384437|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384438|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384439|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19384440|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384441|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19384442|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19384443|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19384444|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19384445|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384446|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19384447|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
19384448|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
19384449|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
19384450|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
19384451|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384452|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384453|NCT02719613|Dexamethasone|dexamethasone|mesh-list
19384454|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
19384455|NCT02719613|Nivolumab|nivolumab|mesh-list
19384456|NCT02719613|Lenalidomide|lenalidomide|mesh-list
19384457|NCT02719613|Bortezomib|bortezomib|mesh-list
20410640|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410641|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20410642|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20410643|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
20410644|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410645|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20410646|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19384458|NCT02719613|Pomalidomide|pomalidomide|mesh-list
20410647|NCT01189721|Propofol|propofol|mesh-list
20410648|NCT01189721|Sevoflurane|sevoflurane|mesh-list
20410649|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20410650|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410651|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410652|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20410653|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
20410654|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
20410655|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20410656|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20410657|NCT01189773|Ibuprofen|ibuprofen|mesh-list
20410658|NCT01189773|Codeine|codeine|mesh-list
20410659|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20410660|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410661|NCT01189773|Analgesics|analgesics|mesh-ancestor
20410662|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
20410663|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410664|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410665|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410666|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20410667|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20410668|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410669|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410670|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20410671|NCT01189773|Narcotics|narcotics|mesh-ancestor
20410672|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410673|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
20410674|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410675|NCT01189864|Diclofenac|diclofenac|mesh-list
19384459|NCT02719613|Elotuzumab|elotuzumab|mesh-list
19384460|NCT02719613|BB 1101|bb 1101|mesh-list
19384461|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384462|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
20410676|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
20410677|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20410678|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
20410679|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20410680|NCT01189864|Prednisolone|prednisolone|mesh-list
20410681|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20410682|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
19384463|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
19384464|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384465|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384466|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384467|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
19384468|NCT02719613|Hormones|hormones|mesh-ancestor
19384469|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384470|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19384471|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384472|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
19384473|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384474|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384475|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384476|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19384477|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
19384478|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19384479|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19384480|NCT02719613|Growth Substances|growth substances|mesh-ancestor
19384481|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
19384482|NCT02717507|Carvedilol|carvedilol|mesh-list
19384483|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19384484|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19384485|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
19384486|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384487|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384488|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384489|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19384490|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
19384491|NCT02717507|Protective Agents|protective agents|mesh-ancestor
19384492|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19384493|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19384494|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19384495|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
19384496|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19384497|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19384498|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
19384499|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384500|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19384501|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384502|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214274|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
20410683|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20410684|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410685|NCT01189864|Analgesics|analgesics|mesh-ancestor
20410686|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
20410687|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410688|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214275|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214276|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214277|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20214278|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20214279|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
20214280|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20214281|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
20214282|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
20214283|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
20214284|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20214285|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
20214286|NCT00298597|Sargramostim|sargramostim|mesh-list
20214287|NCT00298597|Immunologic Factors|immunologic factors|mesh-ancestor
20214288|NCT00298597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214289|NCT00298597|Hematinics|hematinics|mesh-ancestor
20214290|NCT00298636|Adenosine|adenosine|mesh-list
20214291|NCT00298636|Analgesics|analgesics|mesh-ancestor
20214292|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
20214293|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410689|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410690|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384503|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
20410691|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20410692|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410693|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410694|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
19384504|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214294|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214295|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20214296|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
20214297|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20214298|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
20214299|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
20214300|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214301|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214302|NCT00298662|Interferons|interferons|mesh-list
20214303|NCT00298662|Interferon-beta|interferon-beta|mesh-list
20214304|NCT00298662|Tacrolimus|tacrolimus|mesh-list
20214305|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
20214306|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214307|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
20214308|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214309|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214310|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
20214311|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214312|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20214313|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214314|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214315|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20217939|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217940|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20217941|NCT00311051|Ramatroban|ramatroban|mesh-list
20217942|NCT00311051|Montelukast|montelukast|mesh-list
20217943|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20217944|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
20217945|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20217946|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
20217947|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217948|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217949|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20217950|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20217951|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217952|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20217953|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
20217954|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20217955|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217956|NCT00311116|Vitamin E|vitamin e|mesh-list
20217957|NCT00311116|Vitamins|vitamins|mesh-ancestor
20217958|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
20217959|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217960|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
20217961|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217962|NCT00311116|Protective Agents|protective agents|mesh-ancestor
20217963|NCT00311129|Rituximab|rituximab|mesh-list
20217964|NCT00311129|Fludarabine|fludarabine|mesh-list
20217965|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
20217966|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20217967|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217968|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
20217969|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217970|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20217971|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20217972|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
20217973|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217974|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217975|NCT00311259|Melatonin|melatonin|mesh-list
20217976|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
20217977|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217978|NCT00311259|Protective Agents|protective agents|mesh-ancestor
20217979|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217980|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217981|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
20217982|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403423|NCT03601897|Paclitaxel|paclitaxel|mesh-list
20217983|NCT00311337|Bortezomib|bortezomib|mesh-list
19384505|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384506|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19384507|NCT02389465|Celecoxib|celecoxib|mesh-list
19384508|NCT02389465|Dexetimide|dexetimide|mesh-list
19384509|NCT02389465|Citalopram|citalopram|mesh-list
19384510|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19384511|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384512|NCT02389465|Analgesics|analgesics|mesh-ancestor
19384513|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
19384514|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384515|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384516|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384517|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384518|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20214316|NCT00298675|Irinotecan|irinotecan|mesh-list
20214317|NCT00298675|Iniparib|iniparib|mesh-list
20214318|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20214319|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20214320|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384519|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19384520|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384521|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384522|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19384523|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19384524|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19384525|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384526|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
19384527|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20214321|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410695|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
20410696|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20410697|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
20410698|NCT01189864|Hormones|hormones|mesh-ancestor
20410699|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20410700|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20410701|NCT01189864|Protective Agents|protective agents|mesh-ancestor
20410702|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20410703|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410704|NCT01189929|Gemcitabine|gemcitabine|mesh-list
20410705|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20410706|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20214322|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214323|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20214324|NCT00298688|Gefitinib|gefitinib|mesh-list
20214325|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214326|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20214327|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214328|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214329|NCT00298714|Losartan|losartan|mesh-list
20214330|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20214331|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20214332|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20214333|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20214334|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214335|NCT00298779|Bortezomib|bortezomib|mesh-list
20214336|NCT00298779|Omeprazole|omeprazole|mesh-list
20214337|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214338|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20214339|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214340|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20214341|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214342|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214343|NCT00298857|Valproic Acid|valproic acid|mesh-list
20214344|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
20214345|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214346|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214347|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
20214348|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214349|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214350|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
20214351|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19384528|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
19691413|NCT05005455|Bevacizumab|bevacizumab|mesh-list
20410707|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
19384529|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384530|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19384531|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19384532|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
19384533|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
19384534|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19384535|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19384536|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
19384537|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
19384538|NCT02335060|Dronabinol|dronabinol|mesh-list
19384539|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19384540|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
19384541|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384542|NCT02335060|Expectorants|expectorants|mesh-ancestor
19384543|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
19384544|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19384545|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
19384546|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384547|NCT02335060|Protective Agents|protective agents|mesh-ancestor
19384548|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384549|NCT02335060|Antidotes|antidotes|mesh-ancestor
19384550|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
20410708|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410709|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410710|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
20410711|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410712|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410713|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20410714|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
20410715|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410716|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
20410717|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
19384551|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384552|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384553|NCT02335060|Analgesics|analgesics|mesh-ancestor
19384554|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
19384555|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384556|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19384557|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19384558|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384559|NCT02335060|Hormones|hormones|mesh-ancestor
19384560|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384561|NCT02297438|Letrozole|letrozole|mesh-list
20214352|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410718|NCT01190137|Vitamin D|vitamin d|mesh-list
20410719|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20410720|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410721|NCT01190137|Vitamins|vitamins|mesh-ancestor
20410722|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
20410723|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20410724|NCT01190163|Oxytocin|oxytocin|mesh-list
20410725|NCT01190163|Dinoprostone|dinoprostone|mesh-list
20410726|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
20410727|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20410728|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410729|NCT01190241|Everolimus|everolimus|mesh-list
20410730|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20410731|NCT01190241|Sorafenib|sorafenib|mesh-list
20410732|NCT01190241|Sunitinib|sunitinib|mesh-list
20410733|NCT01190241|Lapatinib|lapatinib|mesh-list
19691414|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20214353|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20214354|NCT00298870|Isoniazid|isoniazid|mesh-list
20214355|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
20214356|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214357|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214358|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20214359|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20214360|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
20410734|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691415|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691416|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19384562|NCT02297438|Palbociclib|palbociclib|mesh-list
19384563|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384564|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19384565|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20217984|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410735|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20410736|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
19384566|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384567|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384568|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19384569|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
19384570|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384571|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384572|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19384573|NCT02297412|Minocycline|minocycline|mesh-list
19384574|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19384575|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384576|NCT02292758|Bevacizumab|bevacizumab|mesh-list
19384577|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19384578|NCT02292758|Cetuximab|cetuximab|mesh-list
19384579|NCT02292758|Irinotecan|irinotecan|mesh-list
19384580|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
19384581|NCT02292758|Antibodies|antibodies|mesh-list
19384582|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
19384583|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19384584|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
19384585|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384586|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19384587|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19384588|NCT02292758|Growth Substances|growth substances|mesh-ancestor
19384589|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384590|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
19384591|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
19384592|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19384593|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19384594|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384595|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214361|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410737|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410738|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20410739|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410740|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410741|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20410742|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20410743|NCT01190241|Growth Substances|growth substances|mesh-ancestor
20214362|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20214363|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
20214364|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20214365|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214366|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20214367|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
20214368|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214369|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214370|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214371|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214372|NCT00298909|Niacin|niacin|mesh-list
20214373|NCT00298909|Niacinamide|niacinamide|mesh-list
20214374|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
20214375|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20214376|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
20214377|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214378|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20214379|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
20214380|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
20214381|NCT00298909|Vitamins|vitamins|mesh-ancestor
20214382|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
20214383|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214384|NCT00298922|Azithromycin|azithromycin|mesh-list
20214385|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214386|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214387|NCT00298974|Acetaminophen|acetaminophen|mesh-list
20214388|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20214389|NCT00298974|Hydrocodone|hydrocodone|mesh-list
20214390|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214391|NCT00298974|Analgesics|analgesics|mesh-ancestor
20214392|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
20410744|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
19384596|NCT02250326|Paclitaxel|paclitaxel|mesh-list
19384597|NCT02250326|Azacitidine|azacitidine|mesh-list
19384598|NCT02250326|Cc-486|cc-486|mesh-list
20214393|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214394|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384599|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19384600|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384601|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
19384602|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
19384603|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
19384604|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384605|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19384606|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
19384607|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384608|NCT02102113|Dronabinol|dronabinol|mesh-list
19384609|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
19384610|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384611|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384612|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384613|NCT02102113|Analgesics|analgesics|mesh-ancestor
19384614|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
19384615|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214395|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
20214396|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20214397|NCT00298974|Narcotics|narcotics|mesh-ancestor
20214398|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214399|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
20214400|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
20214401|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20214402|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214403|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214404|NCT00299013|Prednisolone|prednisolone|mesh-list
20214405|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20214406|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
20214407|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20214408|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
20214409|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20214410|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
20214411|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214412|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
19384616|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19384617|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19384618|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847732|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19847733|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
19847734|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
19847735|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847736|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19847737|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20214413|NCT00299013|Hormones|hormones|mesh-ancestor
20214414|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214415|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410745|NCT01190293|Efavirenz|efavirenz|mesh-list
20410746|NCT01190293|Maraviroc|maraviroc|mesh-list
20410747|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20410748|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20410749|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410750|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410751|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
20410752|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214416|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20214417|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214418|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
20214419|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
20214420|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214421|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214422|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20214423|NCT00299013|Protective Agents|protective agents|mesh-ancestor
20214424|NCT00299026|Paclitaxel|paclitaxel|mesh-list
20214425|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20214426|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214427|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
20214428|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
19384619|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384620|NCT02102113|Hormones|hormones|mesh-ancestor
19384621|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214429|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
20214430|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214431|NCT00299039|Acetaminophen|acetaminophen|mesh-list
19384622|NCT01922076|Adavosertib|adavosertib|mesh-list
19384623|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384624|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384625|NCT01864018|Dexamethasone|dexamethasone|mesh-list
20214432|NCT00299039|Ibuprofen|ibuprofen|mesh-list
20214433|NCT00299039|Codeine|codeine|mesh-list
20214434|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214435|NCT00299039|Analgesics|analgesics|mesh-ancestor
20214436|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
20214437|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214438|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214439|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
20214440|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20214441|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214442|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214443|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20214444|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214445|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214446|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20214447|NCT00299039|Narcotics|narcotics|mesh-ancestor
20214448|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214449|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
20214450|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
20214451|NCT00299065|Zileuton|zileuton|mesh-list
20214452|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20214453|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214454|NCT00299065|Analgesics|analgesics|mesh-ancestor
20214455|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
20214456|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214457|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214458|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214459|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214460|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20214461|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214462|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214463|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20214464|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
20214465|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214466|NCT00299091|Efavirenz|efavirenz|mesh-list
20214467|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20214468|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20214469|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214470|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214471|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
20214472|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214473|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20214474|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20217985|NCT00311389|Timolol|timolol|mesh-list
19384626|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
19384627|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
19384628|NCT01864018|Ixazomib|ixazomib|mesh-list
19384629|NCT01864018|Ichthammol|ichthammol|mesh-list
19384630|NCT01864018|BB 1101|bb 1101|mesh-list
19384631|NCT01864018|Glycine|glycine|mesh-list
19384632|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384633|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
19384634|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384635|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384636|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19384637|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
19384638|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384639|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384640|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19384641|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384642|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
19384643|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
19384644|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384645|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384646|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
19384647|NCT01864018|Hormones|hormones|mesh-ancestor
19384648|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384649|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19384650|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
19384651|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384652|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
19384653|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
19384654|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384655|NCT01856270|Amitriptyline|amitriptyline|mesh-list
19384656|NCT01856270|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19384657|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19384658|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
19384659|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384660|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384661|NCT01856270|Analgesics|analgesics|mesh-ancestor
19384662|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
19384663|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384664|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847738|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20410753|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20410754|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20410755|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20410756|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20410757|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20410758|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20410759|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20214475|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20214476|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20214477|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20214478|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20214479|NCT00299208|Azithromycin|azithromycin|mesh-list
20214480|NCT00299208|Artesunate|artesunate|mesh-list
20214481|NCT00299208|Quinine|quinine|mesh-list
20214482|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214483|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214484|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
20214485|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20214486|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20214487|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214488|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
20214489|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
20214490|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20214491|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
20214492|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20214493|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214494|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20214495|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214496|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214497|NCT00299208|Analgesics|analgesics|mesh-ancestor
20214498|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
20214499|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20214500|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20214501|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20214502|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214503|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214504|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
20214505|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214506|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214507|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
20214508|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
20214509|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
20214510|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20214511|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20214512|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214513|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20214514|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214515|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214516|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20214517|NCT00299247|Renal Agents|renal agents|mesh-ancestor
20214518|NCT00299286|Lapatinib|lapatinib|mesh-list
20214519|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214520|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20214521|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214522|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214523|NCT00299351|Romidepsin|romidepsin|mesh-list
20214524|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20410760|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20214525|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214526|NCT00299364|Tibolone|tibolone|mesh-list
20214527|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
20214528|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
20214529|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214530|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214531|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20214532|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20214533|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214534|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20214535|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
19384665|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19384666|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19384667|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19384668|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384669|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
19384670|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384671|NCT01856270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19384672|NCT01856270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19384673|NCT01856270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384674|NCT01503515|Fluconazole|fluconazole|mesh-list
20214536|NCT00299364|Hormones|hormones|mesh-ancestor
20410761|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20410762|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20410763|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20410764|NCT01190345|Bevacizumab|bevacizumab|mesh-list
20410765|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20410766|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410767|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20410768|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20410769|NCT01190345|Growth Substances|growth substances|mesh-ancestor
20410770|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410771|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
20410772|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
20410773|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20214537|NCT00299377|Abciximab|abciximab|mesh-list
20214538|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
20214539|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20214540|NCT00299390|Sagopilone|sagopilone|mesh-list
20214541|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214542|NCT00299455|Amoxicillin|amoxicillin|mesh-list
20214543|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
20214544|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
20214545|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20214546|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214547|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214548|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20214549|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214550|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214551|NCT00299520|Linezolid|linezolid|mesh-list
20214552|NCT00299520|Iclaprim|iclaprim|mesh-list
20214553|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214554|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214555|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20214556|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214557|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214558|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20214559|NCT00299559|Camphor|camphor|mesh-list
20214560|NCT00299559|Menthol|menthol|mesh-list
20214561|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
20214562|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
20214563|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20214564|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214565|NCT00299572|Alendronate|alendronate|mesh-list
20214566|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20214567|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214568|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20214569|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214570|NCT00299611|Levetiracetam|levetiracetam|mesh-list
20214571|NCT00299611|Sertraline|sertraline|mesh-list
20214572|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
20214573|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20410774|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384675|NCT01503515|Voriconazole|voriconazole|mesh-list
19384676|NCT01503515|Caspofungin|caspofungin|mesh-list
20214574|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20214575|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20410775|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
20410776|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410777|NCT01190358|Protective Agents|protective agents|mesh-ancestor
20410778|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410779|NCT01190371|Artesunate|artesunate|mesh-list
20410780|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
20410781|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20410782|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20410783|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20410784|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410785|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
20410786|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
20410787|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20410788|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
20410789|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
20410790|NCT01190384|Antioxidants|antioxidants|mesh-list
20410791|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384677|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
19384678|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384679|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19384680|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19384681|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384682|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384683|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19384684|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
20410792|NCT01190384|Protective Agents|protective agents|mesh-ancestor
20214576|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214577|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214578|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214579|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
20214580|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214581|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
20214582|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
20214583|NCT00299650|Cisatracurium|cisatracurium|mesh-list
20214584|NCT00299650|Atracurium|atracurium|mesh-list
20214585|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20410793|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410794|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20410795|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410796|NCT01190462|Cetuximab|cetuximab|mesh-list
20214586|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20214587|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214588|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214589|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20214590|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20214591|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20214592|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
20214593|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214594|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214595|NCT00299676|Galantamine|galantamine|mesh-list
20214596|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20214597|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214598|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214599|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
20214600|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214601|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214602|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20214603|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
20214604|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214605|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
20214606|NCT00299754|Misoprostol|misoprostol|mesh-list
20214607|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20410797|NCT01190462|Simvastatin|simvastatin|mesh-list
20410798|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20214608|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
20214609|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19691417|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19691418|NCT05005455|Growth Substances|growth substances|mesh-ancestor
20410799|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410800|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19384685|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384686|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384687|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20214610|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384688|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19384689|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19384690|NCT01491893|Vaccines|vaccines|mesh-list
19384691|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
19384692|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384693|NCT01180374|Dronabinol|dronabinol|mesh-list
19384694|NCT01180374|Cannabidiol|cannabidiol|mesh-list
19384695|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
19384696|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
19384697|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384698|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19384699|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384700|NCT01180374|Analgesics|analgesics|mesh-ancestor
19384701|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
19384702|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384703|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19384704|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19384705|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384706|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384707|NCT01180374|Hormones|hormones|mesh-ancestor
19384708|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384709|NCT00357565|Cyclosporine|cyclosporine|mesh-list
19384710|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
19384711|NCT00357565|Fludarabine|fludarabine|mesh-list
19384712|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
19384713|NCT00357565|Melphalan|melphalan|mesh-list
19384714|NCT00357565|Busulfan|busulfan|mesh-list
19384715|NCT00357565|Cyclosporins|cyclosporins|mesh-list
19384716|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384717|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19384718|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
19384719|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384720|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384721|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
19384722|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384723|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384724|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
19384725|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384726|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
19384727|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384728|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19384729|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19384730|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19384731|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
19691419|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691420|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
20214611|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20214612|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214613|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
20214614|NCT00299819|Sifalimumab|sifalimumab|mesh-list
20214615|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20214616|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
20214617|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214618|NCT00299845|Lansoprazole|lansoprazole|mesh-list
20214619|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
20214620|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20214621|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214622|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20214623|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214624|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214625|NCT00299858|Theophylline|theophylline|mesh-list
20214626|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20214627|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
20214628|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214629|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214630|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20214631|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
20214632|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20214633|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214634|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214635|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
20214636|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20214637|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19384732|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19384733|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19691421|NCT05005741|Dulaglutide|dulaglutide|mesh-list
19384734|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
19384735|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19384736|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
19384737|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384738|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
19384739|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384740|NCT00245960|Etanercept|etanercept|mesh-list
19384741|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19384742|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384743|NCT00245960|Analgesics|analgesics|mesh-ancestor
19384744|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
19384745|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384746|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384747|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384748|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384749|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214638|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
20214639|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214640|NCT00299871|Lixisenatide|lixisenatide|mesh-list
20214641|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20214642|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214643|NCT00299884|Atorvastatin|atorvastatin|mesh-list
20214644|NCT00299884|Ezetimibe|ezetimibe|mesh-list
19384750|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384751|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
19384752|NCT00136903|Cyclosporine|cyclosporine|mesh-list
19384753|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
19384754|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
19384755|NCT00136903|Prednisone|prednisone|mesh-list
19384756|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
20410801|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20410802|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
20410803|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410804|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20410805|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19384757|NCT00136903|Tacrolimus|tacrolimus|mesh-list
19384758|NCT00136903|Cyclosporins|cyclosporins|mesh-list
19691422|NCT05005741|Glucagon|glucagon|mesh-list
20214645|NCT00299884|Fenofibrate|fenofibrate|mesh-list
20214646|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20214647|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20214648|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
20214649|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214650|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20214651|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20214652|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214653|NCT00299910|Montelukast|montelukast|mesh-list
20214654|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20214655|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
20214656|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20214657|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
20214658|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214659|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214660|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20214661|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19691423|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19691424|NCT05005741|Incretins|incretins|mesh-ancestor
19691425|NCT05005741|Hormones|hormones|mesh-ancestor
19691426|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691427|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214662|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214663|NCT00299923|Ribavirin|ribavirin|mesh-list
20214664|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20214665|NCT00299923|Amantadine|amantadine|mesh-list
20214666|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
20214667|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214668|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
20214669|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384759|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384760|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
19384761|NCT00136903|Hormones|hormones|mesh-ancestor
19691428|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214670|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20214671|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20214672|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
19403424|NCT03601897|Rebastinib|rebastinib|mesh-list
19691429|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19384762|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384763|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384764|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19384765|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384766|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384767|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
19384768|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19384769|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384770|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214673|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214674|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214675|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214676|NCT00299923|Analgesics|analgesics|mesh-ancestor
20214677|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
20214678|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214679|NCT00299936|Ribavirin|ribavirin|mesh-list
20214680|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20214681|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
20214682|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214683|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
20214684|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214685|NCT00299962|Interferons|interferons|mesh-list
20214686|NCT00299962|Interferon-beta|interferon-beta|mesh-list
20214687|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214688|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
20214689|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214690|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
20214691|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214692|NCT00300014|Triamcinolone|triamcinolone|mesh-list
20214693|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214694|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
20214695|NCT00300014|Hormones|hormones|mesh-ancestor
20214696|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214697|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214698|NCT00300040|HBOC 201|hboc 201|mesh-list
20214699|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
20214700|NCT00300079|Brinzolamide|brinzolamide|mesh-list
20214701|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20214702|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214703|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214704|NCT00300118|Budesonide|budesonide|mesh-list
20214705|NCT00300118|Mesalamine|mesalamine|mesh-list
20214706|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214707|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20214708|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
20613158|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613159|NCT02253940|Ritonavir|ritonavir|mesh-list
19384771|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
19384772|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384773|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
19384774|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384775|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19384776|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19384777|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
19384778|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19384779|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
19384780|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
19384781|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384782|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384783|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19384784|NCT00136903|Protective Agents|protective agents|mesh-ancestor
19384785|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
19384786|NCT05218915|Dulaglutide|dulaglutide|mesh-list
20613160|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613161|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613162|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613163|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613164|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613165|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613166|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19384787|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20214709|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214710|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214711|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19384788|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613167|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
19384789|NCT05218889|Gemcitabine|gemcitabine|mesh-list
19384790|NCT05218889|Paclitaxel|paclitaxel|mesh-list
19384791|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19384792|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19384793|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384794|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
19384795|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
19384796|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
19384797|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384798|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20214712|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
20214713|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
20214714|NCT00300118|Hormones|hormones|mesh-ancestor
20214715|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214716|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20214717|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214718|NCT00300118|Analgesics|analgesics|mesh-ancestor
20214719|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
20214720|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214721|NCT00300131|Everolimus|everolimus|mesh-list
20214722|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214723|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384799|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
19384800|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
19384801|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384802|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384803|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384804|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
19384805|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384806|NCT05218616|Sunitinib|sunitinib|mesh-list
19384807|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384808|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20214724|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
20214725|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214726|NCT00300196|Ancrod|ancrod|mesh-list
20214727|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
20214728|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20214729|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20214730|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214731|NCT00300222|Capsaicin|capsaicin|mesh-list
20214732|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
20214733|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
20214734|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
20214735|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214736|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214737|NCT00300287|Vildagliptin|vildagliptin|mesh-list
20214738|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20214739|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214740|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20214741|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
20214742|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214743|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384809|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19384810|NCT05218616|Growth Substances|growth substances|mesh-ancestor
19384811|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384812|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
20410806|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410807|NCT01190553|Amantadine|amantadine|mesh-list
20410808|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20410809|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20214744|NCT00300313|Citalopram|citalopram|mesh-list
20214745|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20214746|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20214747|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214748|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384813|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19384814|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384815|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384816|NCT05218577|Selenium|selenium|mesh-list
19384817|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
19384818|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214749|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410810|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
20410811|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384819|NCT05218577|Protective Agents|protective agents|mesh-ancestor
19847739|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
19847740|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384820|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384821|NCT05218577|Trace Elements|trace elements|mesh-ancestor
19384822|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
19384823|NCT05218486|Isotretinoin|isotretinoin|mesh-list
19384824|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
19403425|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19403426|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403427|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
19403428|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
19403429|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
19403430|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403431|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403432|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403433|NCT03601871|Thalidomide|thalidomide|mesh-list
19403434|NCT03601871|Dexamethasone|dexamethasone|mesh-list
19403435|NCT03601871|Palonosetron|palonosetron|mesh-list
19403436|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
19403437|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403438|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
19403439|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
19403440|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403441|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403442|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403443|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
19403444|NCT03601871|Hormones|hormones|mesh-ancestor
19403445|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403446|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847741|NCT00688064|Doxycycline|doxycycline|mesh-list
19847742|NCT00688064|Adapalene|adapalene|mesh-list
19847743|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19403447|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403448|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214750|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
20214751|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214752|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19403449|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
19403450|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
19403451|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19403452|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403453|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20214753|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
20214754|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20214755|NCT00300339|Clopidogrel|clopidogrel|mesh-list
20214756|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20214757|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20214758|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20214759|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20214760|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
20214761|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214762|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214763|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214764|NCT00300352|Folic Acid|folic acid|mesh-list
20214765|NCT00300352|Hematinics|hematinics|mesh-ancestor
20214766|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
20214767|NCT00300352|Vitamins|vitamins|mesh-ancestor
20214768|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
20214769|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214770|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20214771|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20214772|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20214773|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214774|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403454|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19847744|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847745|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
19847746|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19847747|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19847748|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19847749|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19847750|NCT00688064|Analgesics|analgesics|mesh-ancestor
19847751|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
19847752|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384825|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
19384826|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19384827|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384828|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384829|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384830|NCT05218161|Analgesics|analgesics|mesh-ancestor
19384831|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
19384832|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384833|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19384834|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19384835|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19384836|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
19384837|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384838|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691430|NCT05004909|Tretinoin|tretinoin|mesh-list
20214775|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214776|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214777|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
20214778|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20217986|NCT00311389|Travoprost|travoprost|mesh-list
20217987|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20217988|NCT00311389|Latanoprost|latanoprost|mesh-list
20217989|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20217990|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19691431|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691432|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
19691433|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
19691434|NCT05005000|Triamcinolone|triamcinolone|mesh-list
19691435|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19691436|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19691437|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19691438|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691439|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
19691440|NCT05005000|Hormones|hormones|mesh-ancestor
20217991|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19691441|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691442|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691443|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217992|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
20217993|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217994|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217995|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217996|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20217997|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20217998|NCT00311467|Interferons|interferons|mesh-list
20217999|NCT00311467|Capecitabine|capecitabine|mesh-list
20218000|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218001|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
20218002|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218003|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218004|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
20218005|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218006|NCT00311545|Siltuximab|siltuximab|mesh-list
20218007|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218008|NCT00311558|Interferons|interferons|mesh-list
20218009|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
20218010|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
20218011|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20218012|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218013|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
20218014|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218015|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
20218016|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218017|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20218018|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20218019|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
20218020|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20218021|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
20218022|NCT00311636|Paclitaxel|paclitaxel|mesh-list
20218023|NCT00311636|Docetaxel|docetaxel|mesh-list
19847753|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218024|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
20218025|NCT00311636|Doxorubicin|doxorubicin|mesh-list
19691444|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
20218026|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20218027|NCT00311636|Fluorouracil|fluorouracil|mesh-list
20218028|NCT00311636|Methotrexate|methotrexate|mesh-list
20218029|NCT00311636|Epirubicin|epirubicin|mesh-list
19384839|NCT05217836|Hepcidins|hepcidins|mesh-list
19384840|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384841|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
20410812|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
20410813|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410814|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410815|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214779|NCT00300404|Leucovorin|leucovorin|mesh-list
20214780|NCT00300404|Folic Acid|folic acid|mesh-list
20214781|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
20214782|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
20214783|NCT00300404|Antidotes|antidotes|mesh-ancestor
20214784|NCT00300404|Protective Agents|protective agents|mesh-ancestor
20214785|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214786|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
20410816|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410817|NCT01190553|Analgesics|analgesics|mesh-ancestor
19384842|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19384843|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20214787|NCT00300404|Vitamins|vitamins|mesh-ancestor
20214788|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
20214789|NCT00300404|Hematinics|hematinics|mesh-ancestor
20214790|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
20214791|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20214792|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20214793|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214794|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20214795|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214796|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214797|NCT00300443|Bimatoprost|bimatoprost|mesh-list
20214798|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20214799|NCT00300508|Anastrozole|anastrozole|mesh-list
20214800|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20214801|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214802|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20214803|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20214804|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214805|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214806|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20214807|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
20214808|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214809|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214810|NCT00300560|Colistin|colistin|mesh-list
20214811|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20214812|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214813|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
20214814|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20214815|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20214816|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214817|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214818|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
20214819|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214820|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20214821|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20214822|NCT00300586|Gemcitabine|gemcitabine|mesh-list
20214823|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20214824|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20214825|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
20214826|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214827|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214828|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
20214829|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214830|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410818|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
20410819|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384844|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19384845|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19384846|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384847|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
19384848|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384849|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691445|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693073|NCT04983615|Analgesics|analgesics|mesh-ancestor
20214831|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214832|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
20214833|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384850|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19691446|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691447|NCT05004753|Artemisinins|artemisinins|mesh-list
19691448|NCT05004753|Artemisinin|artemisinin|mesh-list
19691449|NCT05004753|Dexamethasone|dexamethasone|mesh-list
20214834|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20214835|NCT00300664|Hormones|hormones|mesh-list
20214836|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214837|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214838|NCT00300716|Memantine|memantine|mesh-list
20214839|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20214840|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20214841|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
20214842|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214843|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214844|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214845|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20214846|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19691450|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691451|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
19691452|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
19691453|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691454|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847754|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847755|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214847|NCT00300729|Celecoxib|celecoxib|mesh-list
20214848|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20214849|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214850|NCT00300729|Analgesics|analgesics|mesh-ancestor
20214851|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
20214852|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214853|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214854|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214855|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214856|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20214857|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20214858|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214859|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214860|NCT00300768|Ivermectin|ivermectin|mesh-list
20214861|NCT00300768|Moxidectin|moxidectin|mesh-list
20214862|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20214863|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214864|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
20214865|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
20214866|NCT00300794|Ketamine|ketamine|mesh-list
20214867|NCT00300794|Analgesics|analgesics|mesh-ancestor
20214868|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
20214869|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214870|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691455|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691456|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
20214871|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20214872|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20214873|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
20214874|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
20214875|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214876|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20214877|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19384851|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384852|NCT05217342|Diuretics|diuretics|mesh-list
19384853|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
19384854|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384855|NCT05217238|Remifentanil|remifentanil|mesh-list
19384856|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19384857|NCT05217238|Narcotics|narcotics|mesh-ancestor
19384858|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691457|NCT05004753|Hormones|hormones|mesh-ancestor
19847756|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847757|NCT00688103|Etanercept|etanercept|mesh-list
19847758|NCT00688103|Methotrexate|methotrexate|mesh-list
19847759|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19847760|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
19847761|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19691458|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20214878|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410820|NCT01190670|Tacrolimus|tacrolimus|mesh-list
20410821|NCT01190670|Peficitinib|peficitinib|mesh-list
20214879|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214880|NCT00300833|Tirofiban|tirofiban|mesh-list
20214881|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20214882|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20214883|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214884|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20214885|NCT00300846|Aripiprazole|aripiprazole|mesh-list
20214886|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
20214887|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20214888|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20214889|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20214890|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214891|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214892|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
20214893|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
20214894|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214895|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214896|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20214897|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20214898|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
20214899|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20214900|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20214901|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20214902|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20214903|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
20214904|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20214905|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214906|NCT00300924|Acetaminophen|acetaminophen|mesh-list
20214907|NCT00300924|Rizatriptan|rizatriptan|mesh-list
20214908|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20214909|NCT00300924|Analgesics|analgesics|mesh-ancestor
20214910|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
20214911|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214912|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214913|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
20214914|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20214915|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
20214916|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214917|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214918|NCT00300937|Ubiquinone|ubiquinone|mesh-list
20214919|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
20214920|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
20214921|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214922|NCT00300937|Vitamins|vitamins|mesh-ancestor
20214923|NCT00300950|Gemcitabine|gemcitabine|mesh-list
20214924|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20214925|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
20214926|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214927|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214928|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
20214929|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214930|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214931|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20214932|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
20214933|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214934|NCT00301002|Alefacept|alefacept|mesh-list
20214935|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
20214936|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
20214937|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214938|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
20214939|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
20214940|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20214941|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
20214942|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20214943|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20214944|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20214945|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20214946|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214947|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214948|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20214949|NCT00301054|Renal Agents|renal agents|mesh-ancestor
20214950|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
20214951|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410822|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384859|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384860|NCT05217238|Analgesics|analgesics|mesh-ancestor
19384861|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
19384862|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384863|NCT05217160|Morphine|morphine|mesh-list
19384864|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19384865|NCT05217160|Narcotics|narcotics|mesh-ancestor
19384866|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384867|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384868|NCT05217160|Analgesics|analgesics|mesh-ancestor
19384869|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
19384870|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384871|NCT05217069|Leucovorin|leucovorin|mesh-list
19384872|NCT05217069|Folic Acid|folic acid|mesh-list
19384873|NCT05217069|Irinotecan|irinotecan|mesh-list
19384874|NCT05217069|Cetuximab|cetuximab|mesh-list
19384875|NCT05217069|Avelumab|avelumab|mesh-list
19384876|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
19384877|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19384878|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19384879|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384880|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384881|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384882|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384883|NCT05217069|Antidotes|antidotes|mesh-ancestor
19384884|NCT05217069|Protective Agents|protective agents|mesh-ancestor
19384885|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384886|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
19384887|NCT05217069|Vitamins|vitamins|mesh-ancestor
19384888|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
19384889|NCT05217069|Hematinics|hematinics|mesh-ancestor
19384890|NCT05216822|Racecadotril|racecadotril|mesh-list
19384891|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
19384892|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384893|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
19384894|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384895|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384896|NCT05215470|Nivolumab|nivolumab|mesh-list
19384897|NCT05215470|Ipilimumab|ipilimumab|mesh-list
19384898|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19384899|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384900|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19384901|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384902|NCT05195242|Dexamethasone|dexamethasone|mesh-list
19384903|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384904|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
19384905|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
19384906|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410823|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
20410824|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410825|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20410826|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410827|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410828|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
20410829|NCT01190683|Vitamin D|vitamin d|mesh-list
20410830|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
20410831|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
20410832|NCT01190683|Vitamins|vitamins|mesh-list
20410833|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
20410834|NCT01190683|Calcium|calcium|mesh-list
19384907|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384908|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19384909|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
19384910|NCT05195242|Hormones|hormones|mesh-ancestor
19384911|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384912|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19384913|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384914|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
19384915|NCT05193565|Sirolimus|sirolimus|mesh-list
19384916|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19384917|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384918|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19847762|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410835|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
19384919|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
19384920|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19384921|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384922|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384923|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384924|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
19384925|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19384926|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
19384927|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384928|NCT05192460|Vaccines|vaccines|mesh-list
19384929|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
19384930|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384931|NCT05186779|Progestins|progestins|mesh-list
19384932|NCT05186779|Hormones|hormones|mesh-ancestor
20214952|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20214953|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20214954|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410836|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410837|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20410838|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20410839|NCT01190683|Antacids|antacids|mesh-ancestor
20410840|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410841|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20214955|NCT00301106|Interleukin-12|interleukin-12|mesh-list
20214956|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20214957|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
19384933|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19384934|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384935|NCT05177133|Capecitabine|capecitabine|mesh-list
19384936|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
19384937|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19384938|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
19384939|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384940|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19384941|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
19384942|NCT05175781|Ketamine|ketamine|mesh-list
20410842|NCT01190722|Diclofenac|diclofenac|mesh-list
20410843|NCT01190722|Etoricoxib|etoricoxib|mesh-list
20410844|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20410845|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20410846|NCT01190722|Analgesics|analgesics|mesh-ancestor
20410847|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
20410848|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410849|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410850|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20410851|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20410852|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20410853|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410854|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410855|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20410856|NCT01190735|Caffeine|caffeine|mesh-list
20410857|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20410858|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384943|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19384944|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384945|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384946|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384947|NCT05175781|Analgesics|analgesics|mesh-ancestor
19384948|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
19384949|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384950|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19384951|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19384952|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19384953|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
19384954|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20214958|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214959|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20214960|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20214961|NCT00301106|Growth Substances|growth substances|mesh-ancestor
20214962|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
20214963|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214964|NCT00301145|Varenicline|varenicline|mesh-list
20214965|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20214966|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20214967|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
20214968|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218030|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19384955|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410859|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20410860|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410861|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410862|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20410863|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20410864|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
20410865|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410866|NCT01190748|Galantamine|galantamine|mesh-list
20410867|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20410868|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410869|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410870|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
20410871|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410872|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410873|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20410874|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
20410875|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410876|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
20410877|NCT01190761|Galantamine|galantamine|mesh-list
20410878|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20410879|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410880|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410881|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
20410882|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613168|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19384956|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19384957|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19384958|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
19384959|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
19384960|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19384961|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19384962|NCT05160428|Vaccines|vaccines|mesh-list
19384963|NCT05160428|Immunologic Factors|immunologic factors|mesh-ancestor
19384964|NCT05160428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384965|NCT05146232|Anesthetics|anesthetics|mesh-list
19384966|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384967|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403455|NCT03601871|Growth Substances|growth substances|mesh-ancestor
19403456|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
19403457|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20214969|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214970|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214971|NCT00301171|Fluticasone|fluticasone|mesh-list
20214972|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20214973|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20214974|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
20214975|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214976|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214977|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20214978|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
20214979|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
20214980|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20214981|NCT00301210|Tramadol|tramadol|mesh-list
19403458|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
19403459|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403460|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403461|NCT03601806|Thalidomide|thalidomide|mesh-list
19403462|NCT03601806|Pomalidomide|pomalidomide|mesh-list
19403463|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403464|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
19403465|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403466|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
19403467|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19403468|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403469|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19403470|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19403471|NCT03601806|Growth Substances|growth substances|mesh-ancestor
19403472|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
19403473|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403474|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
19403475|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19691459|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20214982|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19384968|NCT05141305|Aspirin|aspirin|mesh-list
19384969|NCT05141305|Clopidogrel|clopidogrel|mesh-list
19384970|NCT05141305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19384971|NCT05141305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19384972|NCT05141305|Analgesics|analgesics|mesh-ancestor
19384973|NCT05141305|Sensory System Agents|sensory system agents|mesh-ancestor
19384974|NCT05141305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19384975|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384976|NCT05141305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19384977|NCT05141305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19384978|NCT05141305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19384979|NCT05141305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19384980|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19384981|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19384982|NCT05141305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19384983|NCT05141305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19384984|NCT05141305|Antipyretics|antipyretics|mesh-ancestor
19384985|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20214983|NCT00301210|Narcotics|narcotics|mesh-ancestor
20214984|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20214985|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214986|NCT00301210|Analgesics|analgesics|mesh-ancestor
20214987|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
20214988|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20214989|NCT00301223|Pregabalin|pregabalin|mesh-list
19384986|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19384987|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19384988|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
19384989|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19384990|NCT05089708|Trifarotene|trifarotene|mesh-list
19384991|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
19384992|NCT05072184|Anesthetics|anesthetics|mesh-list
19384993|NCT05072184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19384994|NCT05072184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384995|NCT05065294|Psilocybin|psilocybin|mesh-list
19384996|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19384997|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
19384998|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19384999|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385000|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19385001|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
19385002|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385003|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385004|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19385005|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19385006|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19385007|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
19385008|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19385009|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19385010|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385011|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
19385012|NCT05053867|Coagulants|coagulants|mesh-ancestor
19385013|NCT05052970|Dexamethasone|dexamethasone|mesh-list
19385014|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
19691460|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20214990|NCT00301223|Analgesics|analgesics|mesh-ancestor
20214991|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
20410883|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410884|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20410885|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
20410886|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410887|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
20410888|NCT01190982|Paclitaxel|paclitaxel|mesh-list
20410889|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20410890|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410891|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
20410892|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
20410893|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
20410894|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410895|NCT01191021|Propofol|propofol|mesh-list
19385015|NCT05052970|Bortezomib|bortezomib|mesh-list
19691461|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
20214992|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410896|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
19385016|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
19385017|NCT05052970|BB 1101|bb 1101|mesh-list
19385018|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385019|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
19385020|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
19385021|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385022|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385023|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385024|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
19385025|NCT05052970|Hormones|hormones|mesh-ancestor
19385026|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385027|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19385028|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385029|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
19385030|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385031|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410897|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385032|NCT05052970|Analgesics|analgesics|mesh-ancestor
19385033|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
19385034|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19385035|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20410898|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410899|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20410900|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20410901|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
19385036|NCT05029973|Bevacizumab|bevacizumab|mesh-list
19385037|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385038|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385039|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19385040|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19385041|NCT05029973|Growth Substances|growth substances|mesh-ancestor
19385042|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385043|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
19385044|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19385045|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385046|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385047|NCT05008783|Capecitabine|capecitabine|mesh-list
19385048|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
19385049|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19385050|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
19385051|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385052|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847763|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20410902|NCT01191034|Imiquimod|imiquimod|mesh-list
20410903|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20410904|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
20410905|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410906|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410907|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
20410908|NCT01191060|Lenalidomide|lenalidomide|mesh-list
20410909|NCT01191060|Bortezomib|bortezomib|mesh-list
20410910|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
20410911|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410912|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20410913|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20410914|NCT01191060|Growth Substances|growth substances|mesh-ancestor
20410915|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
20410916|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410917|NCT01191203|Copper|copper|mesh-list
20410918|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20410919|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
20410920|NCT01191203|Trace Elements|trace elements|mesh-ancestor
20410921|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
20410922|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847764|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
19847765|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847766|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847767|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847768|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20410923|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20410924|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19385059|NCT04986579|Trastuzumab|trastuzumab|mesh-list
19385060|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385061|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385062|NCT04969250|Vaccines|vaccines|mesh-list
20410925|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20410926|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
20410927|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19385063|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
19385064|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385065|NCT04930315|Apatinib|apatinib|mesh-list
19385066|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385067|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19385068|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385069|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385070|NCT04921007|Bupivacaine|bupivacaine|mesh-list
19385071|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19385072|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
19385073|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385074|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385075|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
19385076|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385077|NCT04920994|Bupivacaine|bupivacaine|mesh-list
19385078|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
19385079|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
19385080|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385081|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385082|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
19385083|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385084|NCT04909515|Isotretinoin|isotretinoin|mesh-list
19385085|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
19385086|NCT04908579|Ketamine|ketamine|mesh-list
19385087|NCT04908579|Bupivacaine|bupivacaine|mesh-list
19385088|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
19385089|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
19385090|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385091|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385092|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
19385093|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385094|NCT04908579|Analgesics|analgesics|mesh-ancestor
19385095|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20410928|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20410929|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20410930|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20410931|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20410932|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410933|NCT01191216|Docetaxel|docetaxel|mesh-list
20410934|NCT01191216|Tryptophan|tryptophan|mesh-list
20410935|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20410936|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
20410937|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
20410938|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
20410939|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410940|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20410941|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
19385096|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19385097|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
19385098|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19385099|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19385100|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385101|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385102|NCT04903210|Niacinamide|niacinamide|mesh-list
19385103|NCT04903210|Niacin|niacin|mesh-list
19385104|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
19385105|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
19385106|NCT04903210|Vitamins|vitamins|mesh-ancestor
19385107|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
19385108|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385109|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19385110|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
19385111|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385112|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19385113|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
19385114|NCT04896658|Dexamethasone|dexamethasone|mesh-list
19385115|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
19385116|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19385117|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
19385118|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385119|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385120|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19385121|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
19385122|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385123|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385124|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19385125|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385126|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
19385127|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
19385128|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385129|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385130|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
19385131|NCT04896658|Hormones|hormones|mesh-ancestor
19385132|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385133|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19385134|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19385135|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385136|NCT04802837|Vancomycin|vancomycin|mesh-list
19385137|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19385138|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403476|NCT03601624|Dexamethasone|dexamethasone|mesh-list
20410942|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20410943|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
20410944|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20410945|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
20410946|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403477|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
19403478|NCT03601624|Pomalidomide|pomalidomide|mesh-list
19403479|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403480|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
19403481|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403482|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19403483|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19403484|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
19403485|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403486|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403487|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19403488|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403489|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
19403490|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
19403491|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403492|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403493|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
19403494|NCT03601624|Hormones|hormones|mesh-ancestor
19403495|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403496|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19403497|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19403498|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19403499|NCT03601624|Growth Substances|growth substances|mesh-ancestor
19403500|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
19403501|NCT03601611|Prednisolone|prednisolone|mesh-list
19403502|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403503|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
19403504|NCT03601611|Hormones|hormones|mesh-ancestor
19403505|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403506|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403507|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19403508|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403509|NCT03601533|Phenol|phenol|mesh-list
19403510|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19403511|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403512|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
19403513|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19403514|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19403515|NCT03601338|Bemiparin|bemiparin|mesh-list
19403516|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
19403517|NCT03601260|Allopurinol|allopurinol|mesh-list
19403518|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
19403519|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403520|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403521|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
19403522|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20214993|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20214994|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
20214995|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20214996|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20214997|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20214998|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20214999|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20215000|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20215001|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20215002|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385139|NCT04779138|Vaccines|vaccines|mesh-list
19385140|NCT04779138|Immunologic Factors|immunologic factors|mesh-ancestor
19385141|NCT04779138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385142|NCT04769401|Progesterone|progesterone|mesh-list
19385143|NCT04769401|Progestins|progestins|mesh-ancestor
19385144|NCT04769401|Hormones|hormones|mesh-ancestor
19385145|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385146|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385147|NCT04742023|Insulin|insulin|mesh-list
19385148|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19385149|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385150|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
19385151|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19385152|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19385153|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385154|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
19385155|NCT04733157|Coagulants|coagulants|mesh-ancestor
19385156|NCT04727424|Budesonide|budesonide|mesh-list
19385157|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
19385158|NCT04727424|Maleic acid|maleic acid|mesh-list
19385159|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385160|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19385161|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
19385162|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385163|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385164|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19385165|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
19385166|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
19385167|NCT04727424|Hormones|hormones|mesh-ancestor
19385168|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385169|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385170|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385171|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19385172|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19385173|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385174|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385175|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19385176|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19385177|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19385178|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385179|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
19385180|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19385181|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
19385182|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19385183|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20410947|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410948|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19385184|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19385185|NCT04724252|Gabapentin|gabapentin|mesh-list
19385186|NCT04724252|Analgesics|analgesics|mesh-ancestor
19385187|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
19385188|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385189|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385190|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
19385191|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19385192|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19385193|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385194|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385195|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19385196|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19385197|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385198|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385199|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
20215003|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
20215004|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20215005|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215006|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20215007|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20215008|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20215009|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385200|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
19385201|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19385202|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19385203|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
19385204|NCT04719208|Listerine|listerine|mesh-list
19385205|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19385206|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19385207|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385208|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
19385209|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
19385210|NCT04718116|Tramadol|tramadol|mesh-list
19385211|NCT04718116|Tapentadol|tapentadol|mesh-list
19385212|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19385213|NCT04718116|Narcotics|narcotics|mesh-ancestor
19385214|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385215|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385216|NCT04718116|Analgesics|analgesics|mesh-ancestor
19385217|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
19385218|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385219|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19385220|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19385221|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19385222|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385223|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
19385224|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385225|NCT04707872|Antibodies|antibodies|mesh-list
19385226|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
19385227|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385228|NCT04706715|Cemiplimab|cemiplimab|mesh-list
19385229|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385230|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385231|NCT04701190|Norepinephrine|norepinephrine|mesh-list
19385232|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385233|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19385234|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19385235|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
19385236|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847769|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19847770|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19847771|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
19385237|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385238|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
19385239|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
19385240|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385241|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19385242|NCT04700423|Ivermectin|ivermectin|mesh-list
19385243|NCT04700423|Albendazole|albendazole|mesh-list
19385244|NCT04700423|Moxidectin|moxidectin|mesh-list
19385245|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19385246|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385247|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
19385248|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
19385249|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19847772|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847773|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19847774|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19847775|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19847776|NCT00688103|Analgesics|analgesics|mesh-ancestor
19847777|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
19847778|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847779|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847780|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847781|NCT00688324|Acamprosate|acamprosate|mesh-list
19847782|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19847783|NCT00688545|Celecoxib|celecoxib|mesh-list
19847784|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19847785|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19847786|NCT00688545|Analgesics|analgesics|mesh-ancestor
20215010|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
20215011|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215012|NCT00301301|Gemcitabine|gemcitabine|mesh-list
20215013|NCT00301301|Rituximab|rituximab|mesh-list
20215014|NCT00301301|Cisplatin|cisplatin|mesh-list
20215015|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215016|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385250|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19385251|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
20215017|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
20410949|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
20410950|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20410951|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20410952|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20410953|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
20410954|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20410955|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410956|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
20410957|NCT01191450|Amiloride|amiloride|mesh-list
20410958|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20410959|NCT01191450|Diuretics|diuretics|mesh-ancestor
20410960|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
20410961|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410962|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20410963|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19385252|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
19385253|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
19385254|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385255|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385256|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
19385257|NCT04666454|Adenosine|adenosine|mesh-list
19385258|NCT04666454|Dipyridamole|dipyridamole|mesh-list
19385259|NCT04666454|Apixaban|apixaban|mesh-list
19385260|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19385261|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
19385262|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19385263|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
19385264|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385265|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385266|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
19385267|NCT04666454|Analgesics|analgesics|mesh-ancestor
19385268|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
19385269|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385270|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385271|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20410964|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410965|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20410966|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20410967|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20410968|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20410969|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
20410970|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20410971|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20410972|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20410973|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
19385272|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
19385273|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19385274|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
19385275|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
19385276|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385277|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19385278|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19385279|NCT04606316|Nivolumab|nivolumab|mesh-list
19385280|NCT04606316|Ipilimumab|ipilimumab|mesh-list
19385281|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385282|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385283|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19385284|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385285|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
19385286|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19385287|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385288|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19385289|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385290|NCT04573777|Evolocumab|evolocumab|mesh-list
19385291|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19385292|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19385293|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
19385294|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385295|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19385296|NCT04560166|Irinotecan|irinotecan|mesh-list
19385297|NCT04560166|Temozolomide|temozolomide|mesh-list
19385298|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19385299|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20410974|NCT01191554|Coagulants|coagulants|mesh-ancestor
19385300|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385301|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385302|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385303|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19385304|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
19385305|NCT04559646|Hemostatics|hemostatics|mesh-list
19385306|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19385307|NCT04559646|Coagulants|coagulants|mesh-ancestor
19385308|NCT04546126|Dexamethasone|dexamethasone|mesh-list
19385309|NCT04546126|Cosyntropin|cosyntropin|mesh-list
19385310|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385311|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
19385312|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
19385313|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385314|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385315|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385316|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
20215018|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215019|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215020|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215021|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
20215022|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215023|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
20215024|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215025|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385317|NCT04546126|Hormones|hormones|mesh-ancestor
19385318|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385319|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19385320|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385321|NCT04538352|Insulin|insulin|mesh-list
19385322|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19385323|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
19385324|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19385325|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385326|NCT04531176|Liraglutide|liraglutide|mesh-list
19385327|NCT04531176|Topiramate|topiramate|mesh-list
19385328|NCT04531176|Orlistat|orlistat|mesh-list
19385329|NCT04531176|Phentermine|phentermine|mesh-list
19385330|NCT04531176|Naltrexone|naltrexone|mesh-list
19385331|NCT04531176|Bupropion|bupropion|mesh-list
19385332|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19385333|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19385334|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385335|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
19385336|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385337|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19385338|NCT04531176|Incretins|incretins|mesh-ancestor
19385339|NCT04531176|Hormones|hormones|mesh-ancestor
19385340|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20410975|NCT01191593|Ropivacaine|ropivacaine|mesh-list
20410976|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
20410977|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
19385341|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19385342|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
19385343|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385344|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19385345|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19385346|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19385347|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385348|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
19385349|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385350|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19385351|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19385352|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385353|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
20410978|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410979|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410980|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
20410981|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410982|NCT01191645|Remifentanil|remifentanil|mesh-list
20410983|NCT01191645|Metoclopramide|metoclopramide|mesh-list
20410984|NCT01191645|Naloxone|naloxone|mesh-list
19385354|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19385355|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19385356|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20410985|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20410986|NCT01191645|Narcotics|narcotics|mesh-ancestor
20410987|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20410988|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20410989|NCT01191645|Analgesics|analgesics|mesh-ancestor
20410990|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
20410991|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20410992|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20410993|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
20410994|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
20410995|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20410996|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20410997|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20410998|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
20410999|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411000|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411001|NCT01191684|Vaccines|vaccines|mesh-list
20411002|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
20411003|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411004|NCT01191697|Bevacizumab|bevacizumab|mesh-list
20411005|NCT01191697|Trastuzumab|trastuzumab|mesh-list
19385357|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
19385358|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
19385359|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
19385360|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19385361|NCT04496362|Heparin|heparin|mesh-list
19385362|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
19385363|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19385364|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19385365|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385366|NCT04465266|Tolperisone|tolperisone|mesh-list
20411006|NCT01191697|Capecitabine|capecitabine|mesh-list
20411007|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
20411008|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20411009|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411010|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20411011|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411012|NCT01191697|Growth Substances|growth substances|mesh-ancestor
20411013|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215026|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215027|NCT00301392|Pitavastatin|pitavastatin|mesh-list
20215028|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19385367|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19385368|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385369|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19385370|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385371|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
19385372|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19385373|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19385374|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
19385375|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385376|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385377|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385378|NCT04437108|Urological Agents|urological agents|mesh-ancestor
19385379|NCT04434300|Daptomycin|daptomycin|mesh-list
19385380|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19385381|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385382|NCT04433767|Nicotine|nicotine|mesh-list
19385383|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19385384|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
19385385|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385386|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385387|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19385388|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19385389|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
19385390|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385391|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385392|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
20215029|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20215030|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20215031|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
20215032|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215033|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385393|NCT04423588|Lansoprazole|lansoprazole|mesh-list
19385394|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19385395|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20411014|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
20411015|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19385396|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19385397|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385398|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385399|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
19385400|NCT04407377|Tolperisone|tolperisone|mesh-list
20215034|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20215035|NCT00301405|Thalidomide|thalidomide|mesh-list
20215036|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215037|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
20215038|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215039|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
20215040|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215041|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385401|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19385402|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
19385403|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385404|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19385405|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385406|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19385407|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385408|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19385409|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403523|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19403524|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
19403525|NCT03601260|Protective Agents|protective agents|mesh-ancestor
19403526|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403527|NCT03601091|Midazolam|midazolam|mesh-list
19403528|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
19403529|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19403530|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403531|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403532|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19403533|NCT03601091|Analgesics|analgesics|mesh-ancestor
20215042|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20215043|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411016|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
20411017|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411018|NCT01191710|Progesterone|progesterone|mesh-list
20411019|NCT01191710|Progestins|progestins|mesh-ancestor
20411020|NCT01191710|Hormones|hormones|mesh-ancestor
20411021|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411022|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411023|NCT01191892|Gemcitabine|gemcitabine|mesh-list
20411024|NCT01191892|Carboplatin|carboplatin|mesh-list
19403534|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
19403535|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403536|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19403537|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19403538|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19403539|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403540|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403541|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403542|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19403543|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19403544|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19403545|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19403546|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19403547|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
19403548|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
19403549|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
19403550|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
19403551|NCT03600974|Domperidone|domperidone|mesh-list
19403552|NCT03600974|Citalopram|citalopram|mesh-list
19403553|NCT03600974|Esomeprazole|esomeprazole|mesh-list
20215044|NCT00301405|Growth Substances|growth substances|mesh-ancestor
20215045|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
20215046|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215047|NCT00301457|Anastrozole|anastrozole|mesh-list
20215048|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20215049|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215050|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20215051|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20215052|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403554|NCT03600974|Omeprazole|omeprazole|mesh-list
19403555|NCT03600974|Rabeprazole|rabeprazole|mesh-list
20215053|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385410|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
19385411|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
19385412|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19385413|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19385414|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385415|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385416|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385417|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411025|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411026|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411027|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
20411028|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411029|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
20411030|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411031|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411032|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411033|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
20411034|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411035|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
20411036|NCT01191918|Donepezil|donepezil|mesh-list
20411037|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20411038|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411039|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411040|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
19385418|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
19385419|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
19385420|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19385421|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19385422|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385423|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385424|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385425|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385426|NCT04307797|Exenatide|exenatide|mesh-list
19385427|NCT04307797|Glucagon|glucagon|mesh-list
19385428|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19385429|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19385430|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385431|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19385432|NCT04307797|Incretins|incretins|mesh-ancestor
19385433|NCT04307797|Hormones|hormones|mesh-ancestor
19385434|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385435|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385436|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
19385437|NCT04297150|Apixaban|apixaban|mesh-list
19385438|NCT04297150|Edoxaban|edoxaban|mesh-list
19385439|NCT04297150|Dabigatran|dabigatran|mesh-list
19385440|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19385441|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
20411041|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411042|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411043|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
20411044|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
20411045|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20411046|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
20411047|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19385442|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19385443|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
19385444|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385445|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385446|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
19385447|NCT04249323|Prednisone|prednisone|mesh-list
19385448|NCT04249323|Cortisone|cortisone|mesh-list
19385449|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385450|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
19385451|NCT04249323|Hormones|hormones|mesh-ancestor
19385452|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385453|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385454|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847787|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
19847788|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847789|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847790|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385455|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385456|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19847791|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385457|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19385458|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20411048|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411049|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
20411050|NCT01191957|Busulfan|busulfan|mesh-list
20411051|NCT01191957|Fludarabine|fludarabine|mesh-list
20411052|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215054|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20215055|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
20215056|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385459|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385460|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385461|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19385462|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
19385463|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385464|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385465|NCT04218357|Probenecid|probenecid|mesh-list
19385466|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
19385467|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
19385468|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385469|NCT04218357|Renal Agents|renal agents|mesh-ancestor
19385470|NCT04190056|Tamoxifen|tamoxifen|mesh-list
19385471|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
19385472|NCT04190056|Vorinostat|vorinostat|mesh-list
19385473|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385474|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385475|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19385476|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
19385477|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385478|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385479|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19385480|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19385481|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19385482|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19385483|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19385484|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385485|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385486|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
19385487|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385488|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
19385489|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
19385490|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19385491|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
19385492|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19385493|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385494|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19385495|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20215057|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215058|NCT00301483|HBOC 201|hboc 201|mesh-list
20215059|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
20215060|NCT00301509|Ribavirin|ribavirin|mesh-list
20215061|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
20215062|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385496|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19385497|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19385498|NCT04136366|Methotrexate|methotrexate|mesh-list
19385499|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19385500|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
20411053|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
20411054|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411055|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411056|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19385501|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19385502|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385503|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19691462|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19691463|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20215063|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
20215064|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215065|NCT00301522|Paclitaxel|paclitaxel|mesh-list
20215066|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20215067|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215068|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
20215069|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
20411057|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
20411058|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411059|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411060|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20411061|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
20411062|NCT01191983|Hematinics|hematinics|mesh-ancestor
20411063|NCT01192087|Cetuximab|cetuximab|mesh-list
20411064|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385504|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
19385505|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385506|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385507|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
19385508|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385509|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19385510|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19385511|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
19385512|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385513|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19385514|NCT04112641|Niacinamide|niacinamide|mesh-list
19385515|NCT04112641|Niacin|niacin|mesh-list
19385516|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
19385517|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
19385518|NCT04112641|Vitamins|vitamins|mesh-ancestor
19385519|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
19385520|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385521|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19385522|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
19385523|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385524|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19385525|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
19385526|NCT04108962|Benralizumab|benralizumab|mesh-list
19385527|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19385528|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
19385529|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
19385530|NCT04090684|Celecoxib|celecoxib|mesh-list
19385531|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19385532|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19385533|NCT04090684|Analgesics|analgesics|mesh-ancestor
19385534|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
19385535|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385536|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385537|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385538|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385539|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19385540|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19385541|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385542|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385543|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19385544|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385545|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19385546|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19385547|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385548|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19385549|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19385550|NCT04051619|Oxytocin|oxytocin|mesh-list
19385551|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
19385552|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19385553|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385554|NCT04045301|Omalizumab|omalizumab|mesh-list
19385555|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19385556|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19385557|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19385558|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
19385559|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
19385560|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385561|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
19385562|NCT04033107|Metformin|metformin|mesh-list
19385563|NCT04033107|Vitamins|vitamins|mesh-ancestor
20411065|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411066|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
20411067|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
20411068|NCT01192113|Vitamins|vitamins|mesh-ancestor
20411069|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
20411070|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411071|NCT01192165|Paclitaxel|paclitaxel|mesh-list
19385564|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
19385565|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411072|NCT01192165|Docetaxel|docetaxel|mesh-list
20411073|NCT01192165|Carboplatin|carboplatin|mesh-list
19385566|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19385567|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
19385568|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385569|NCT04033107|Protective Agents|protective agents|mesh-ancestor
19385570|NCT04006457|Vaccines|vaccines|mesh-list
20215070|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
20411074|NCT01192165|Pemetrexed|pemetrexed|mesh-list
20411075|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20411076|NCT01192165|Trametinib|trametinib|mesh-list
20411077|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20411078|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411079|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
20411080|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
20411081|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
20411082|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411083|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411084|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20411085|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20411086|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20411087|NCT01192230|Docetaxel|docetaxel|mesh-list
20411088|NCT01192230|Endostatins|endostatins|mesh-list
20411089|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411090|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
20411091|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
20411092|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
20411093|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411094|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20411095|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411096|NCT01192230|Growth Substances|growth substances|mesh-ancestor
20411097|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215071|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215072|NCT00301535|HBOC 201|hboc 201|mesh-list
20215073|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
20215074|NCT00301574|Galantamine|galantamine|mesh-list
20215075|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19385571|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
19385572|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385573|NCT03950245|Glucagon|glucagon|mesh-list
19385574|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19385575|NCT03950245|Incretins|incretins|mesh-ancestor
19385576|NCT03950245|Hormones|hormones|mesh-ancestor
19385577|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385578|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385579|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385580|NCT03939104|Artesunate|artesunate|mesh-list
19385581|NCT03939104|Lumefantrine|lumefantrine|mesh-list
19385582|NCT03939104|Artemether|artemether|mesh-list
19385583|NCT03939104|Piperaquine|piperaquine|mesh-list
19385584|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19385585|NCT03939104|Amodiaquine|amodiaquine|mesh-list
19385586|NCT03939104|Mefloquine|mefloquine|mesh-list
19385587|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
19385588|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19385589|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19385590|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385591|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215076|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215077|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215078|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
20215079|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215080|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215081|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20215082|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
19385592|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
19385593|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
19691464|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215083|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215084|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
20215085|NCT00301587|Folic Acid|folic acid|mesh-list
20215086|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
20215087|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20215088|NCT00301587|Norgestimate|norgestimate|mesh-list
20411098|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
20411099|NCT01192243|Carboplatin|carboplatin|mesh-list
19385594|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19385595|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
20215089|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20215090|NCT00301587|Estradiol|estradiol|mesh-list
19385596|NCT03913091|Bupivacaine|bupivacaine|mesh-list
19385597|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
19385598|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
19385599|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385600|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385601|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
19385602|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385603|NCT03906136|Adalimumab|adalimumab|mesh-list
19385604|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385605|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385606|NCT03893955|Paclitaxel|paclitaxel|mesh-list
19385607|NCT03893955|Carboplatin|carboplatin|mesh-list
19385608|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19385609|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385610|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
19385611|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
19385612|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
19385613|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385614|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19385615|NCT03889249|Tenecteplase|tenecteplase|mesh-list
19385616|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19385617|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19385618|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385619|NCT03858322|Paclitaxel|paclitaxel|mesh-list
19385620|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
19385621|NCT03858322|Carboplatin|carboplatin|mesh-list
19385622|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19385623|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385624|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
19385625|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
20411100|NCT01192243|Pemetrexed|pemetrexed|mesh-list
20411101|NCT01192243|Gefitinib|gefitinib|mesh-list
20411102|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411103|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411104|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411105|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20411106|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20411107|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20411108|NCT01192308|Tamoxifen|tamoxifen|mesh-list
20411109|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20411110|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
20411111|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385626|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
19385627|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385628|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19385629|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
19385630|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385631|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385632|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19385633|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
19385634|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19385635|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
19385636|NCT03822637|Albuterol|albuterol|mesh-list
19385637|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20411112|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411113|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411114|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411115|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20411116|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20411117|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20411118|NCT01192490|Lidocaine|lidocaine|mesh-list
20411119|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
20411120|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
20411121|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411122|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411123|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
20411124|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411125|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20411126|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20411127|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20411128|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411129|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411130|NCT01192503|Rasagiline|rasagiline|mesh-list
19385638|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19385639|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
20411131|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20411132|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411133|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411134|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19385640|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385641|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385642|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19385643|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
19385644|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
19385645|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19385646|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19385647|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19385648|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19385649|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
19385650|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385651|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385652|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
19385653|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385654|NCT03822637|Expectorants|expectorants|mesh-ancestor
20411135|NCT01192503|Protective Agents|protective agents|mesh-ancestor
20411136|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411137|NCT01192529|Phentermine|phentermine|mesh-list
20411138|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20411139|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411140|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
20411141|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20411142|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
20411143|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
20411144|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411145|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20411146|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411147|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411148|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19385655|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19385656|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
19385657|NCT03822637|Protective Agents|protective agents|mesh-ancestor
19385658|NCT03822637|Antidotes|antidotes|mesh-ancestor
19385659|NCT03802591|Capecitabine|capecitabine|mesh-list
19385660|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
19385661|NCT03802591|Antibodies|antibodies|mesh-list
19385662|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19385663|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
19385664|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385665|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19385666|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
19385667|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385668|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385669|NCT03802565|Tolperisone|tolperisone|mesh-list
19385670|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19385671|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385672|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19385673|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385674|NCT03763422|Temozolomide|temozolomide|mesh-list
19385675|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19385676|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
19385677|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385678|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385679|NCT03752307|Prednisone|prednisone|mesh-list
19385680|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
19385681|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
19385682|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385683|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
19385684|NCT03752307|Hormones|hormones|mesh-ancestor
19385685|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385686|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385687|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411149|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
20411150|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
20427521|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427522|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
20427523|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427524|NCT01287663|Permethrin|permethrin|mesh-list
19385688|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385689|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
19385690|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
19385691|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385692|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385693|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20411151|NCT01192724|Aspirin|aspirin|mesh-list
20411152|NCT01192724|Cilostazol|cilostazol|mesh-list
20411153|NCT01192724|Clopidogrel|clopidogrel|mesh-list
20411154|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20411155|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20411156|NCT01192724|Analgesics|analgesics|mesh-ancestor
20411157|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
20411158|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411159|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411160|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20411161|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411162|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20411163|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20411164|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385694|NCT03752307|Protective Agents|protective agents|mesh-ancestor
19385695|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19385696|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19385697|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
19385698|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385699|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385700|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
19385701|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
19385702|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
19385703|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19385704|NCT03740334|Dexamethasone|dexamethasone|mesh-list
19385705|NCT03740334|Everolimus|everolimus|mesh-list
19385706|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385707|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
19385708|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
19385709|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385710|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385711|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385712|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
19385713|NCT03740334|Hormones|hormones|mesh-ancestor
19385714|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385715|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19385716|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385717|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19385718|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
19385719|NCT03637556|Deferasirox|deferasirox|mesh-list
19385720|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19385721|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
19385722|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
19385723|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385724|NCT03627897|Bupivacaine|bupivacaine|mesh-list
19385725|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
19385726|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
20411165|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20411166|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20411167|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411168|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
19385727|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385728|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385729|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
19385730|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385731|NCT03603184|Paclitaxel|paclitaxel|mesh-list
19385732|NCT03603184|Carboplatin|carboplatin|mesh-list
19385733|NCT03603184|Atezolizumab|atezolizumab|mesh-list
19385734|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19385735|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385736|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
19385737|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
19385738|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
19385739|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403556|NCT03600974|Pantoprazole|pantoprazole|mesh-list
19403557|NCT03600974|Lansoprazole|lansoprazole|mesh-list
19403558|NCT03600974|Mosapride|mosapride|mesh-list
19403559|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
20411169|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20427525|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403560|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19403561|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403562|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19403563|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385740|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
19385741|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
19385742|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385743|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385744|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385745|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
19385746|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
19385747|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
19385748|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
19385749|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385750|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411170|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20411171|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20411172|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
20411173|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411174|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20411175|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
20411176|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19385751|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385752|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
19385753|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
19385754|NCT03502031|Losartan|losartan|mesh-list
19385755|NCT03502031|Valsartan|valsartan|mesh-list
19385756|NCT03502031|Enalapril|enalapril|mesh-list
19385757|NCT03502031|Enalaprilat|enalaprilat|mesh-list
19385758|NCT03502031|Lisinopril|lisinopril|mesh-list
19385759|NCT03502031|Perindopril|perindopril|mesh-list
19385760|NCT03502031|Spironolactone|spironolactone|mesh-list
20411177|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
20411178|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411179|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20411180|NCT01192724|Protective Agents|protective agents|mesh-ancestor
20411181|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20411182|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20411183|NCT01192763|R04929097|r04929097|mesh-list
20411184|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411185|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411186|NCT01192789|Amoxicillin|amoxicillin|mesh-list
20411187|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20411188|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411189|NCT01192802|Albendazole|albendazole|mesh-list
20411190|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
20411191|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20411192|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411193|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
20411194|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20411195|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20411196|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
20411197|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
20411198|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
20411199|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385761|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19385762|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19385763|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19385764|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385765|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19385766|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19385767|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
19385768|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385769|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385770|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19385771|NCT03502031|Diuretics|diuretics|mesh-ancestor
19385772|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
19385773|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19385774|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
19385775|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385776|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19385777|NCT03502031|Protective Agents|protective agents|mesh-ancestor
19385778|NCT03452111|ST 1435|st 1435|mesh-list
19385779|NCT03452111|Testosterone|testosterone|mesh-list
19385780|NCT03452111|Androgens|androgens|mesh-ancestor
19385781|NCT03452111|Hormones|hormones|mesh-ancestor
19385782|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385783|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411200|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411201|NCT01192854|Adefovir|adefovir|mesh-list
19385784|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19385785|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
19385786|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19385787|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19385788|NCT03441555|Venetoclax|venetoclax|mesh-list
19385789|NCT03441555|Alvocidib|alvocidib|mesh-list
19385790|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411202|NCT01192854|Clevudine|clevudine|mesh-list
20411203|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
20411204|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411205|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20411206|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20411207|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411208|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411209|NCT01192971|Apatinib|apatinib|mesh-list
20411210|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411211|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20411212|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411213|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411214|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
20411215|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411216|NCT01193166|Olanzapine|olanzapine|mesh-list
20411217|NCT01193166|Risperidone|risperidone|mesh-list
20411218|NCT01193166|Aripiprazole|aripiprazole|mesh-list
20411219|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20411220|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20411221|NCT01193166|Perphenazine|perphenazine|mesh-list
20411222|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20411223|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
20411224|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411225|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411226|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411227|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20411228|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20411229|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411230|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385791|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
19385792|NCT03441555|Growth Substances|growth substances|mesh-ancestor
19385793|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385794|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19385795|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385796|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385797|NCT03439293|Dexamethasone|dexamethasone|mesh-list
19385798|NCT03439293|Daratumumab|daratumumab|mesh-list
19385799|NCT03439293|Ixazomib|ixazomib|mesh-list
19385800|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385801|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
19385802|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
19385803|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385804|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385805|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19385806|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
19385807|NCT03439293|Hormones|hormones|mesh-ancestor
19385808|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385809|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19385810|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385811|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
19385812|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385813|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385814|NCT03438526|Melatonin|melatonin|mesh-list
19385815|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
19385816|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385817|NCT03438526|Protective Agents|protective agents|mesh-ancestor
20411231|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20411232|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
20411233|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
20411234|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
20411235|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411236|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20411237|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20411238|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19385818|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411239|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411240|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
20411241|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
20411242|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20411243|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20411244|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20411245|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20411246|NCT01193192|Vitamins|vitamins|mesh-list
20411247|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
20411248|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411249|NCT01193270|Vitamin E|vitamin e|mesh-list
20411250|NCT01193270|Vitamins|vitamins|mesh-ancestor
20411251|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
20411252|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411253|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
20411254|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411255|NCT01193270|Protective Agents|protective agents|mesh-ancestor
20411256|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20411257|NCT01193296|Vildagliptin|vildagliptin|mesh-list
20411258|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20411259|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411260|NCT01193296|Incretins|incretins|mesh-ancestor
20411261|NCT01193296|Hormones|hormones|mesh-ancestor
20411262|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411263|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20411264|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
20411265|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411266|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411267|NCT01193387|Insulin|insulin|mesh-list
20411268|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20411269|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
20411270|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20411271|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385819|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385820|NCT03416179|Cytarabine|cytarabine|mesh-list
19385821|NCT03416179|Azacitidine|azacitidine|mesh-list
19385822|NCT03416179|Daunorubicin|daunorubicin|mesh-list
19385823|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19385824|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
19385825|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385826|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385827|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
19385828|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385829|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19385830|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
19385831|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385832|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385833|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19385834|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19385835|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19385836|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
19385837|NCT03409198|Doxorubicin|doxorubicin|mesh-list
19385838|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19385839|NCT03409198|Nivolumab|nivolumab|mesh-list
19385840|NCT03409198|Ipilimumab|ipilimumab|mesh-list
19385841|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19385842|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
19385843|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385844|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385845|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19385846|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
19385847|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385848|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385849|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19385850|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20411272|NCT01193400|Cytarabine|cytarabine|mesh-list
20411273|NCT01193400|Clofarabine|clofarabine|mesh-list
20411274|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411275|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
20411276|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385851|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19385852|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20411277|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411278|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
19385853|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385854|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20411279|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385855|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19385856|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
20411280|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411281|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
20411282|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411283|NCT01193452|Leucovorin|leucovorin|mesh-list
20411284|NCT01193452|Fluorouracil|fluorouracil|mesh-list
20411285|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
20411286|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
20411287|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385857|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
19385858|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19385859|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19385860|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385861|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385862|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385863|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385864|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
19385865|NCT03353922|Tolperisone|tolperisone|mesh-list
19385866|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19385867|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
19385868|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19385869|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19385870|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385871|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19385872|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385873|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19385874|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411288|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411289|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411290|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411291|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
20411292|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411293|NCT01193452|Antidotes|antidotes|mesh-ancestor
20411294|NCT01193452|Protective Agents|protective agents|mesh-ancestor
19385875|NCT03346239|Citalopram|citalopram|mesh-list
19385876|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19385877|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19385878|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19385879|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385880|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385881|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
19385882|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385883|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19385884|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
19385885|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20411295|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
20411296|NCT01193452|Vitamins|vitamins|mesh-ancestor
20411297|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
20411298|NCT01193465|Anesthetics|anesthetics|mesh-list
20411299|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411300|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411301|NCT01193478|Ledipasvir|ledipasvir|mesh-list
20411302|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
20411303|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385886|NCT03259074|Adalimumab|adalimumab|mesh-list
19385887|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385888|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385889|NCT03236857|Venetoclax|venetoclax|mesh-list
19385890|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385891|NCT03188705|Aspirin|aspirin|mesh-list
19385892|NCT03188705|Clopidogrel|clopidogrel|mesh-list
19385893|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20613169|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613170|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613171|NCT02253953|Ritonavir|ritonavir|mesh-list
20613172|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613173|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19847792|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20411304|NCT01193491|Geldanamycin|geldanamycin|mesh-list
20411305|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20411306|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411307|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
20411308|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411309|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848274|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
20411310|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411311|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20411312|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
19385894|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19385895|NCT03188705|Analgesics|analgesics|mesh-ancestor
19385896|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
19385897|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385898|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385899|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385900|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385901|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19385902|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19385903|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385904|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19385905|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19385906|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385907|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
19385908|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19385909|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19385910|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19385911|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
20411313|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20411314|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
20411315|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20411316|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
20411317|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20411318|NCT01193504|Prednisolone|prednisolone|mesh-list
20411319|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20613174|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613175|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385912|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385913|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
19385914|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385915|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385916|NCT03173456|Acetaminophen|acetaminophen|mesh-list
19691465|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
19691466|NCT05004519|Remifentanil|remifentanil|mesh-list
19691467|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19691468|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691469|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691470|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19691471|NCT05004519|Analgesics|analgesics|mesh-ancestor
19691472|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
19691473|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691474|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19691475|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19691476|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19691477|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
20215091|NCT00301587|Estrogens|estrogens|mesh-ancestor
19385917|NCT03173456|Ibuprofen|ibuprofen|mesh-list
19385918|NCT03173456|Oxycodone|oxycodone|mesh-list
19385919|NCT03173456|Hydrocodone|hydrocodone|mesh-list
19385920|NCT03173456|Codeine|codeine|mesh-list
19385921|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19385922|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19385923|NCT03173456|Analgesics|analgesics|mesh-ancestor
19385924|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
19385925|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19385926|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385927|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385928|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385929|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19385930|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385931|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385932|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19385933|NCT03173456|Narcotics|narcotics|mesh-ancestor
19385934|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19385935|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
19385936|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
20215092|NCT00301587|Hormones|hormones|mesh-ancestor
20215093|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215094|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215095|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20215096|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
20215097|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20215098|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20215099|NCT00301587|Hematinics|hematinics|mesh-ancestor
20411320|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
19385937|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
19385938|NCT03161678|Clopidogrel|clopidogrel|mesh-list
19385939|NCT03161678|Ticagrelor|ticagrelor|mesh-list
19385940|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19385941|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19385942|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19385943|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19385944|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
19385945|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19385946|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385947|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385948|NCT03136055|Paclitaxel|paclitaxel|mesh-list
19385949|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
19385950|NCT03136055|Irinotecan|irinotecan|mesh-list
19385951|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19385952|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385953|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
19385954|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
19691478|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691479|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691480|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20215100|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
20411321|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20411322|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
20411323|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
20411324|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411325|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411326|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20411327|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
20411328|NCT01193504|Hormones|hormones|mesh-ancestor
20411329|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411330|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20411331|NCT01193504|Protective Agents|protective agents|mesh-ancestor
20411332|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411333|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411334|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20411335|NCT01193595|Bevacizumab|bevacizumab|mesh-list
20411336|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385955|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
19385956|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385957|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19385958|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19385959|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19385960|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385961|NCT03101566|Gemcitabine|gemcitabine|mesh-list
19385962|NCT03101566|Nivolumab|nivolumab|mesh-list
19385963|NCT03101566|Ipilimumab|ipilimumab|mesh-list
19385964|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385965|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19385966|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
19385967|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385968|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
19385969|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19385970|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385971|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19385972|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
19385973|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385974|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215101|NCT00301587|Vitamins|vitamins|mesh-ancestor
20215102|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
19691481|NCT05004519|Narcotics|narcotics|mesh-ancestor
20215103|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20215104|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20215105|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20215106|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215107|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215108|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20215109|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215110|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215111|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215112|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215113|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19385975|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19691482|NCT05004545|Propofol|propofol|mesh-list
19385976|NCT03020199|Betamethasone|betamethasone|mesh-list
19385977|NCT03020199|Calcipotriene|calcipotriene|mesh-list
19385978|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19385979|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19385980|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
19385981|NCT03020199|Hormones|hormones|mesh-ancestor
19385982|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19385983|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19385984|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19385985|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
19385986|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
20411337|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411338|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20411339|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411340|NCT01193595|Growth Substances|growth substances|mesh-ancestor
20411341|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411342|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
20411343|NCT01193621|Haloperidol|haloperidol|mesh-list
20411344|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
19385987|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
19385988|NCT03006068|Upadacitinib|upadacitinib|mesh-list
19385989|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19385990|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19385991|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19385992|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19385993|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19385994|NCT03003520|Prednisone|prednisone|mesh-list
20411345|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
20411346|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
20411347|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411348|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411349|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20411350|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20411351|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20411352|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411353|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20411354|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20411355|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
20411356|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411357|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411358|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20411359|NCT01193816|Loxapine|loxapine|mesh-list
20411360|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20411361|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20411362|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411363|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411364|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20411365|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20411366|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
20411367|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411368|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411369|NCT01193855|Dutasteride|dutasteride|mesh-list
20411370|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20411371|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20411372|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411373|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411374|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
20411375|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411376|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411377|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20411378|NCT01193881|R04929097|r04929097|mesh-list
20411379|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411380|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20411381|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411382|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411383|NCT01194037|Interferons|interferons|mesh-list
20411384|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
20411385|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
20411386|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19385995|NCT03003520|Prednisolone|prednisolone|mesh-list
19385996|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
19385997|NCT03003520|Rituximab|rituximab|mesh-list
19385998|NCT03003520|Doxorubicin|doxorubicin|mesh-list
20411387|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19385999|NCT03003520|Vincristine|vincristine|mesh-list
19386000|NCT03003520|Lenalidomide|lenalidomide|mesh-list
19386001|NCT03003520|Durvalumab|durvalumab|mesh-list
20411388|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
20411389|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411390|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
20411391|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411392|NCT01194115|Metronidazole|metronidazole|mesh-list
20411393|NCT01194115|Cephalexin|cephalexin|mesh-list
20411394|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411395|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20411396|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20411397|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20411398|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
20411399|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411400|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20411401|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20411402|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411403|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386002|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386003|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
19386004|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386005|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386006|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386007|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
19386008|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386009|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386010|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19386011|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386012|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19386013|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19386014|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19386015|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386016|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20411404|NCT01194232|Urological Agents|urological agents|mesh-ancestor
20411405|NCT01194284|Mifamurtide|mifamurtide|mesh-list
20411406|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19386017|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
19386018|NCT03003520|Hormones|hormones|mesh-ancestor
19386019|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386020|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19386021|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19386022|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
19386023|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
19386024|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
19386025|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19386026|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19386027|NCT03003520|Growth Substances|growth substances|mesh-ancestor
19386028|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
19386029|NCT02992015|Gemcitabine|gemcitabine|mesh-list
19386030|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19386031|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
19386032|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386033|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386034|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
19386035|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411407|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
20411408|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411409|NCT01194336|Huperzine A|huperzine a|mesh-list
20411410|NCT01194336|Donepezil|donepezil|mesh-list
20411411|NCT01194336|Galantamine|galantamine|mesh-list
20411412|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20411413|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411414|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411415|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
20411416|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411417|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411418|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
20411419|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20411420|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
20411421|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411422|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20411423|NCT01194336|Protective Agents|protective agents|mesh-ancestor
19386036|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427526|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427527|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
20427528|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20427529|NCT01287689|Antibodies|antibodies|mesh-list
19386037|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386038|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
19386039|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386040|NCT02991495|Vaccines|vaccines|mesh-list
19386041|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
19386042|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386043|NCT02918370|Aripiprazole|aripiprazole|mesh-list
19386044|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
19386045|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19386046|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19386047|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19386048|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386049|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386050|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
19386051|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
19386052|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386053|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386054|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19386055|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19386056|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
20411424|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20411425|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20411426|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
20411427|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411428|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411429|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20411430|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
20411431|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
20411432|NCT01194700|Hormones|hormones|mesh-ancestor
20411433|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411434|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
20411435|NCT01194778|Vitamins|vitamins|mesh-list
20411436|NCT01194778|Vitamin K|vitamin k|mesh-list
20411437|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
20411438|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
20411439|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
20411440|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386057|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19386058|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19386059|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19386060|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19386061|NCT02891824|Bevacizumab|bevacizumab|mesh-list
19386062|NCT02891824|Atezolizumab|atezolizumab|mesh-list
19386063|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386064|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386065|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19386066|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19386067|NCT02891824|Growth Substances|growth substances|mesh-ancestor
19386068|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386069|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
19386070|NCT02862457|Paclitaxel|paclitaxel|mesh-list
19386071|NCT02862457|Cisplatin|cisplatin|mesh-list
19386072|NCT02862457|Carboplatin|carboplatin|mesh-list
19386073|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
19386074|NCT02862457|Pemetrexed|pemetrexed|mesh-list
19386075|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19386076|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386077|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
19386078|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
19386079|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
19386080|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386081|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386082|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386083|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19386084|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19386085|NCT02845323|Nivolumab|nivolumab|mesh-list
19386086|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386087|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386088|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19386089|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386090|NCT02790515|Sirolimus|sirolimus|mesh-list
19386091|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
19386092|NCT02790515|Melphalan|melphalan|mesh-list
20411441|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19386093|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
19386094|NCT02790515|Thiotepa|thiotepa|mesh-list
20411442|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20411443|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411444|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
20411445|NCT01194778|Coagulants|coagulants|mesh-ancestor
20411446|NCT01194791|Dexamethasone|dexamethasone|mesh-list
20411447|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
20411448|NCT01194791|Lenalidomide|lenalidomide|mesh-list
20411449|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411450|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
20411451|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411452|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411453|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20411454|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
19386095|NCT02790515|Rituximab|rituximab|mesh-list
19386096|NCT02790515|Fludarabine|fludarabine|mesh-list
19386097|NCT02790515|Blinatumomab|blinatumomab|mesh-list
19386098|NCT02790515|Tacrolimus|tacrolimus|mesh-list
19386099|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
19386100|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19386101|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386102|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
19386103|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386104|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386105|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386106|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
19847793|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19847794|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847795|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411455|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411456|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411457|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20411458|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20411459|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
20411460|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
19847796|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
19847797|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
20411461|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411462|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20411463|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
20411464|NCT01194791|Hormones|hormones|mesh-ancestor
20411465|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411466|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411467|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20411468|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411469|NCT01194791|Growth Substances|growth substances|mesh-ancestor
20411470|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
20411471|NCT01194843|Ropivacaine|ropivacaine|mesh-list
20411472|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
20411473|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
20411474|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411475|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411476|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
20411477|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411478|NCT01194882|Insulin|insulin|mesh-list
20411479|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20411480|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20411481|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411482|NCT01194934|Lenograstim|lenograstim|mesh-list
19386107|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386108|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386109|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19386110|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386111|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19386112|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386113|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19386114|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386115|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19386116|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
19386117|NCT02733042|Rituximab|rituximab|mesh-list
19386118|NCT02733042|Durvalumab|durvalumab|mesh-list
19386119|NCT02733042|Lenalidomide|lenalidomide|mesh-list
19386120|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19386121|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386122|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847798|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411483|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20411484|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
20411485|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411486|NCT01195181|Ribavirin|ribavirin|mesh-list
20411487|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
20411488|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411489|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
19847799|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847800|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847801|NCT00688623|Everolimus|everolimus|mesh-list
19847802|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386123|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
19386124|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386125|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386126|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19386127|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19386128|NCT02733042|Growth Substances|growth substances|mesh-ancestor
20411490|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411491|NCT01195246|Vaccines|vaccines|mesh-list
20411492|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
20411493|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411494|NCT01195259|Metformin|metformin|mesh-list
20411495|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
20411496|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20411497|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411498|NCT01195298|Bevacizumab|bevacizumab|mesh-list
20411499|NCT01195298|Capecitabine|capecitabine|mesh-list
20411500|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20411501|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411502|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20411503|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411504|NCT01195298|Growth Substances|growth substances|mesh-ancestor
20411505|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411506|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
20411507|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411508|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
20411509|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411510|NCT01195324|Canagliflozin|canagliflozin|mesh-list
19386129|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
19386130|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386131|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
19386132|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386133|NCT02663518|Rituximab|rituximab|mesh-list
19386134|NCT02663518|Nivolumab|nivolumab|mesh-list
19386135|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
19386136|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386137|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386138|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
19386139|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386140|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386141|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19386142|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386143|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19386144|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
19386145|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
19386146|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386147|NCT02575144|Clarithromycin|clarithromycin|mesh-list
19386148|NCT02575144|Dexamethasone|dexamethasone|mesh-list
19386149|NCT02575144|Lenalidomide|lenalidomide|mesh-list
19386150|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386151|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
19386152|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
19386153|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386154|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386155|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19386156|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
19386157|NCT02575144|Hormones|hormones|mesh-ancestor
19386158|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386159|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19386160|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847803|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19847804|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
20411511|NCT01195324|Warfarin|warfarin|mesh-list
20411512|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
20411513|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19386161|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
19847805|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847806|NCT00688636|Infliximab|infliximab|mesh-list
19847807|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847808|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847809|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847810|NCT00688688|Mirabegron|mirabegron|mesh-list
19847811|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19847812|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19847813|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19847814|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19847815|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19847816|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847817|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847818|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847819|NCT00688688|Urological Agents|urological agents|mesh-ancestor
19386162|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19386163|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19386164|NCT02575144|Growth Substances|growth substances|mesh-ancestor
19386165|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
19386166|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19386167|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386168|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19386169|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386170|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386171|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19386172|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19386173|NCT02574286|Vitamin D|vitamin d|mesh-list
19386174|NCT02574286|Vitamins|vitamins|mesh-ancestor
19386175|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
19386176|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386177|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19386178|NCT02542956|Bupivacaine|bupivacaine|mesh-list
19386179|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
19386180|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
19386181|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386182|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386183|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
19386184|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386185|NCT02471144|Etanercept|etanercept|mesh-list
19386186|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19386187|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19386188|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19386189|NCT02471144|Analgesics|analgesics|mesh-ancestor
19386190|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
19386191|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386192|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386193|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386194|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386195|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19386196|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386197|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
19386198|NCT02440464|Fludarabine|fludarabine|mesh-list
19386199|NCT02440464|Bortezomib|bortezomib|mesh-list
19386200|NCT02440464|Melphalan|melphalan|mesh-list
19386201|NCT02440464|Ixazomib|ixazomib|mesh-list
19386202|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386203|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386204|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386205|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
19386206|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386207|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386208|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
19386209|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19386210|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
19386211|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386212|NCT02366728|Temozolomide|temozolomide|mesh-list
19386213|NCT02366728|Basiliximab|basiliximab|mesh-list
19847820|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19847821|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19847822|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
19847823|NCT00688701|Lixisenatide|lixisenatide|mesh-list
19847824|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19847825|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847826|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
19386214|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
19386215|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847827|NCT00688740|Docetaxel|docetaxel|mesh-list
20411514|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411515|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20411516|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386216|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386217|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
19386218|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386219|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386220|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386221|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
20411517|NCT01195376|Dactolisib|dactolisib|mesh-list
20411518|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411519|NCT01195428|Simvastatin|simvastatin|mesh-list
20411520|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20411521|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20411522|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
20411523|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411524|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20411525|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20411526|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411527|NCT01195454|Insulin|insulin|mesh-list
20411528|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20411529|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
20411530|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20411531|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411532|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20411533|NCT01195571|Vaccines|vaccines|mesh-list
20411534|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
20411535|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411536|NCT01195649|Sorafenib|sorafenib|mesh-list
20411537|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411538|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19386222|NCT02344355|Temozolomide|temozolomide|mesh-list
19386223|NCT02344355|Vitamins|vitamins|mesh-ancestor
19386224|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
19386225|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386226|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386227|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
19386228|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386229|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215114|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
20215115|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20215116|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215117|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20215118|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
19386230|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
19386231|NCT02344355|Protective Agents|protective agents|mesh-ancestor
20411539|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411540|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411541|NCT01195714|Ofatumumab|ofatumumab|mesh-list
20411542|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411543|NCT01195727|Apixaban|apixaban|mesh-list
20411544|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20411545|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
20411546|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20411547|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
20411548|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411549|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386232|NCT02332850|Dexamethasone|dexamethasone|mesh-list
19386233|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386234|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
19386235|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
19386236|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386237|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386238|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19386239|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
20215119|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215120|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215121|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215122|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215123|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
20215124|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20215125|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215126|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20215127|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
20215128|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19386240|NCT02332850|Hormones|hormones|mesh-ancestor
19386241|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386242|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411550|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
20411551|NCT01195766|Ofatumumab|ofatumumab|mesh-list
20411552|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411553|NCT01195805|Amiloride|amiloride|mesh-list
20411554|NCT01195805|Spironolactone|spironolactone|mesh-list
20411555|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20411556|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
20411557|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411558|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411559|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20411560|NCT01195805|Diuretics|diuretics|mesh-ancestor
20411561|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
20411562|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20411563|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20411564|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411565|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411566|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20411567|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20411568|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20411569|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411570|NCT01196013|Clofarabine|clofarabine|mesh-list
20411571|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411572|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
20411573|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411574|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411575|NCT01196065|Memantine|memantine|mesh-list
20411576|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20411577|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20411578|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
20411579|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411580|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411581|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411582|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20411583|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20411584|NCT01196169|Vancomycin|vancomycin|mesh-list
20411585|NCT01196169|Daptomycin|daptomycin|mesh-list
20411586|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20411587|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411588|NCT01196195|Lopinavir|lopinavir|mesh-list
20411589|NCT01196195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20411590|NCT01196195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20411591|NCT01196195|Protease Inhibitors|protease inhibitors|mesh-ancestor
20411592|NCT01196195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386243|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386244|NCT02313870|Clobetasol|clobetasol|mesh-list
19386245|NCT02313870|Methotrexate|methotrexate|mesh-list
19386246|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19386247|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
19386248|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19386249|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386250|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19386251|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
19386252|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386253|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386254|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
19386255|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386256|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19386257|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386258|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
19386259|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386260|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19386261|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386262|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
19386263|NCT02313870|Hormones|hormones|mesh-ancestor
19386264|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386265|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19386266|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386267|NCT02243709|Mifepristone|mifepristone|mesh-list
19386268|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19386269|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
19386270|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19386271|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386272|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19386273|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19386274|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19386275|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
19386276|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19386277|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19386278|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
19386279|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386280|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
19386281|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19386282|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19386283|NCT02236806|Ramipril|ramipril|mesh-list
19386284|NCT02236806|Bisoprolol|bisoprolol|mesh-list
19386285|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19386286|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
19386287|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386288|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386289|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19386290|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
19386291|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
19386292|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386293|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386294|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19386295|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19386296|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19386297|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
19386298|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386299|NCT02236572|Everolimus|everolimus|mesh-list
19386300|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386301|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386302|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
19386303|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386304|NCT02220452|Anesthetics|anesthetics|mesh-list
19386305|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386306|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386307|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19386308|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403564|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403565|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19403566|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19403567|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403568|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
19403569|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403570|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19403571|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
19403572|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19403573|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
19403574|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403575|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
20215129|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215130|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215131|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215132|NCT00301639|Methylphenidate|methylphenidate|mesh-list
20215133|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20215134|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215135|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20215136|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20215137|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20215138|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215139|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
20215140|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215141|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
20215142|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20215143|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215144|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20215145|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
20215146|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20411593|NCT01196195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386309|NCT02083354|Trametinib|trametinib|mesh-list
19386310|NCT02083354|Dabrafenib|dabrafenib|mesh-list
19386311|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386312|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19386313|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386314|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386315|NCT02065635|Propofol|propofol|mesh-list
19386316|NCT02065635|Sevoflurane|sevoflurane|mesh-list
20613176|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613177|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613178|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613179|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
20613180|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613181|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613182|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613183|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20613184|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
20613185|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20613186|NCT02253966|Prednisolone|prednisolone|mesh-list
20613187|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
20613188|NCT02253966|Lidocaine|lidocaine|mesh-list
20613189|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20613190|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
20613191|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
20613192|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
19386317|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19386318|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411594|NCT01196195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20411595|NCT01196195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20411596|NCT01196195|Antiviral Agents|antiviral agents|mesh-ancestor
20411597|NCT01196195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411598|NCT01196195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19386319|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386320|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19386321|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
19386322|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
19386323|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19386324|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20411599|NCT01196195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20411600|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20411601|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20411602|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411603|NCT01196234|Paclitaxel|paclitaxel|mesh-list
20411604|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20411605|NCT01196234|Carboplatin|carboplatin|mesh-list
20411606|NCT01196234|Gefitinib|gefitinib|mesh-list
20411607|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20411608|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411609|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
20411610|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
20411611|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
20411612|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386325|NCT02061514|Propofol|propofol|mesh-list
19386326|NCT02061514|Desflurane|desflurane|mesh-list
19386327|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19386328|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386329|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386330|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19386331|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
19386332|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
19386333|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19386334|NCT01937468|Interleukin-2|interleukin-2|mesh-list
19386335|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386336|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19386337|NCT01937468|Analgesics|analgesics|mesh-ancestor
19386338|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
19386339|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386340|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411613|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20411614|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411615|NCT01196260|Capecitabine|capecitabine|mesh-list
20411616|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
20411617|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411618|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
19386341|NCT01775813|Metformin|metformin|mesh-list
19386342|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427530|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
20411619|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411620|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411621|NCT01196455|Capecitabine|capecitabine|mesh-list
20411622|NCT01196455|Mitomycins|mitomycins|mesh-list
20411623|NCT01196455|Mitomycin|mitomycin|mesh-list
20411624|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19386343|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386344|NCT01694069|Tazobactam|tazobactam|mesh-list
19386345|NCT01694069|Piperacillin|piperacillin|mesh-list
20411625|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
20411626|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411627|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411628|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20411629|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
20411630|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20411631|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386346|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19386347|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19386348|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386349|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19386350|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386351|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386352|NCT01446016|Paclitaxel|paclitaxel|mesh-list
19386353|NCT01446016|Docetaxel|docetaxel|mesh-list
19386354|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19386355|NCT01446016|Taxane|taxane|mesh-list
19386356|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19386357|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386358|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
19386359|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
19386360|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
19386361|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386362|NCT01434602|Everolimus|everolimus|mesh-list
19386363|NCT01434602|Sorafenib|sorafenib|mesh-list
19386364|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386365|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386366|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
19386367|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386368|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19386369|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386370|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386371|NCT01399918|Bevacizumab|bevacizumab|mesh-list
19386372|NCT01399918|Everolimus|everolimus|mesh-list
19386373|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386374|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386375|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19386376|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411632|NCT01196481|Carvedilol|carvedilol|mesh-list
20411633|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20411634|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20411635|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
20411636|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411637|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411638|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411639|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20411640|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
20411641|NCT01196481|Protective Agents|protective agents|mesh-ancestor
20411642|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20215147|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215148|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215149|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215150|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
20215151|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20411643|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411644|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20411645|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
19386377|NCT01399918|Growth Substances|growth substances|mesh-ancestor
20215152|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20215153|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20215154|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20215155|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411646|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20411647|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20215156|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
19386378|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386379|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
19386380|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386381|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
19386382|NCT01078454|Dexamethasone|dexamethasone|mesh-list
19386383|NCT01078454|Bortezomib|bortezomib|mesh-list
19386384|NCT01078454|Melphalan|melphalan|mesh-list
19386385|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386386|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
19386387|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
19386388|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386389|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386390|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19386391|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
19386392|NCT01078454|Hormones|hormones|mesh-ancestor
19386393|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386394|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411648|NCT01196507|Carvedilol|carvedilol|mesh-list
20411649|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20411650|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20411651|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
20411652|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411653|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411654|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411655|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20411656|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
20411657|NCT01196507|Protective Agents|protective agents|mesh-ancestor
20411658|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20411659|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411660|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20411661|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
19386395|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847828|NCT00688740|Doxorubicin|doxorubicin|mesh-list
20411662|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20411663|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20427531|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
20427532|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427533|NCT01287715|Etanercept|etanercept|mesh-list
19847829|NCT00688740|Fluorouracil|fluorouracil|mesh-list
19847830|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19847831|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
19847832|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386396|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386397|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
19386398|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386399|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19386400|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386401|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
19386402|NCT00472654|Vitamin D|vitamin d|mesh-list
19386403|NCT00472654|Vitamins|vitamins|mesh-ancestor
19386404|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
19386405|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386406|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19386407|NCT00458536|Molgramostim|molgramostim|mesh-list
19386408|NCT00458536|Sargramostim|sargramostim|mesh-list
19386409|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
19386410|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386411|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386412|NCT00112840|Bevacizumab|bevacizumab|mesh-list
19386413|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386414|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427534|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20427535|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427536|NCT01287715|Analgesics|analgesics|mesh-ancestor
20427537|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
20427538|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427539|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427540|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427541|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427542|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427543|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386415|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19386416|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19847833|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847834|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20411664|NCT01196546|Metformin|metformin|mesh-list
20411665|NCT01196546|Vildagliptin|vildagliptin|mesh-list
20411666|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20411667|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411668|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20411669|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
20411670|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411671|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411672|NCT01196559|Gemcitabine|gemcitabine|mesh-list
20411673|NCT01196559|Vinorelbine|vinorelbine|mesh-list
20411674|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411675|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
20411676|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386417|NCT00112840|Growth Substances|growth substances|mesh-ancestor
19386418|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386419|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
19386420|NCT05223244|Triamcinolone|triamcinolone|mesh-list
19386421|NCT05223244|Heparin|heparin|mesh-list
19386422|NCT05223244|Bupivacaine|bupivacaine|mesh-list
19386423|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19386424|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
19386425|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
19386426|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386427|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386428|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
19386429|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386430|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
19386431|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19386432|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19386433|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386434|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386435|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
19386436|NCT05223244|Hormones|hormones|mesh-ancestor
19386437|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386438|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19386439|NCT05223244|Protective Agents|protective agents|mesh-ancestor
19386440|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19386441|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
19386442|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
19386443|NCT05223088|Apatinib|apatinib|mesh-list
19386444|NCT05223088|Tegafur|tegafur|mesh-list
19386445|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386446|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19386447|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386448|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386449|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19386450|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
20411677|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411678|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
20411679|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411680|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411681|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411682|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
20411683|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411684|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20411685|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
20411686|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
20411687|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
20411688|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
20411689|NCT01196715|Hematinics|hematinics|mesh-ancestor
20411690|NCT01196754|Sevoflurane|sevoflurane|mesh-list
20411691|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20411692|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20411693|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
20411694|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
20411695|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411696|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411697|NCT01196767|Ropivacaine|ropivacaine|mesh-list
20411698|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
20411699|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
20411700|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411701|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386451|NCT05223075|Lidocaine|lidocaine|mesh-list
19386452|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19386453|NCT05223075|Carticaine|carticaine|mesh-list
19386454|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
20411702|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
20427544|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
20411703|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411704|NCT01197001|Losartan|losartan|mesh-list
20411705|NCT01197001|Amlodipine|amlodipine|mesh-list
20411706|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20411707|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20411708|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411709|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411710|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20411711|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411712|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411713|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20411714|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20411715|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20411716|NCT01197014|Losartan|losartan|mesh-list
20411717|NCT01197014|Amlodipine|amlodipine|mesh-list
20411718|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20411719|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20411720|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411721|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411722|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20411723|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411724|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411725|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20411726|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20411727|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20411728|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
20411729|NCT01197040|Prednisone|prednisone|mesh-list
19386455|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
19386456|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386457|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386458|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
19386459|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386460|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19386461|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19386462|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19386463|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19386464|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386465|NCT05223010|Sevoflurane|sevoflurane|mesh-list
19386466|NCT05223010|Melatonin|melatonin|mesh-list
19386467|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19386468|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19386469|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19386470|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
19386471|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
19386472|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386473|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386474|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
19386475|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386476|NCT05223010|Protective Agents|protective agents|mesh-ancestor
19386477|NCT05222932|Avelumab|avelumab|mesh-list
19386478|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386479|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386480|NCT05222828|Mepivacaine|mepivacaine|mesh-list
19386481|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
19386482|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
19386483|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386484|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386485|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
19386486|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386487|NCT05222646|Metoclopramide|metoclopramide|mesh-list
19386488|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
19386489|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
19386490|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386491|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386492|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19386493|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19386494|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19386495|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
19386496|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386497|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386498|NCT05222633|Ranibizumab|ranibizumab|mesh-list
19386499|NCT05222633|Aflibercept|aflibercept|mesh-list
20411730|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386500|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19386501|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19386502|NCT05222633|Growth Substances|growth substances|mesh-ancestor
19386503|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386504|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
19386505|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386506|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19386507|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19386508|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386509|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386510|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19386511|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19386512|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386513|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
19386514|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386515|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19386516|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386517|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386518|NCT05222334|Bupivacaine|bupivacaine|mesh-list
19386519|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
19386520|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
19386521|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386522|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386523|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
19386524|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386525|NCT05222243|Calcium|calcium|mesh-list
19386526|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19386527|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386528|NCT05222204|Gemcitabine|gemcitabine|mesh-list
19386529|NCT05222204|Paclitaxel|paclitaxel|mesh-list
19386530|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19386531|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386532|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
19386533|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
19386534|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
19386535|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386536|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19386537|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
19386538|NCT05222204|Antiviral Agents|antiviral agents|mesh-ancestor
19386539|NCT05222204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386540|NCT05222204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386541|NCT05222204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386542|NCT05222204|Immunologic Factors|immunologic factors|mesh-ancestor
19386543|NCT05222204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386544|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
19386545|NCT05222191|Spironolactone|spironolactone|mesh-list
19386546|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19386547|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
19386548|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386549|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386550|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19386551|NCT05222191|Diuretics|diuretics|mesh-ancestor
19386552|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
19386553|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19386554|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19386555|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19386556|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386557|NCT05222165|Infigratinib|infigratinib|mesh-list
19386558|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215157|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215158|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215159|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20215160|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215161|NCT00301730|Aldesleukin|aldesleukin|mesh-list
19386564|NCT05222113|Remdesivir|remdesivir|mesh-list
19386565|NCT05222113|Favipiravir|favipiravir|mesh-list
19386566|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
19386567|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386568|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
19386569|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403576|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19403577|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
19403578|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19847835|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
19386570|NCT05221892|Thiamine|thiamine|mesh-list
19386571|NCT05221892|Pyridoxine|pyridoxine|mesh-list
19386572|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
19386573|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
19386574|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
19386575|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386576|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
19386577|NCT05221892|Vitamins|vitamins|mesh-ancestor
19386578|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
19386579|NCT05221892|Hematinics|hematinics|mesh-ancestor
19386580|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
19386581|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386582|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386583|NCT05221879|Enoxaparin|enoxaparin|mesh-list
19386584|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
19386585|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19386586|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19386587|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386588|NCT05221775|Lenvatinib|lenvatinib|mesh-list
19386589|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386590|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19386591|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386592|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411731|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
20411732|NCT01197040|Hormones|hormones|mesh-ancestor
20411733|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411734|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411735|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411736|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411737|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20411738|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20411739|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
20411740|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20411741|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411742|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411743|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411744|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
20411745|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411746|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
20411747|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411748|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411749|NCT01197144|Adalimumab|adalimumab|mesh-list
20411750|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20411751|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411752|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
20411753|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20411754|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411755|NCT01197170|Bevacizumab|bevacizumab|mesh-list
20411756|NCT01197170|Everolimus|everolimus|mesh-list
20411757|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20411758|NCT01197170|Sorafenib|sorafenib|mesh-list
19386593|NCT05221749|Fluorides|fluorides|mesh-list
19386594|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
19386595|NCT05221749|Protective Agents|protective agents|mesh-ancestor
19386596|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386597|NCT05221736|Ethanol|ethanol|mesh-list
19386598|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19386599|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386600|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386601|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386602|NCT05221645|Rituximab|rituximab|mesh-list
19386603|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
19386604|NCT05221645|Carboplatin|carboplatin|mesh-list
19386605|NCT05221645|Etoposide|etoposide|mesh-list
19386606|NCT05221645|Ifosfamide|ifosfamide|mesh-list
19386607|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386608|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386609|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
19386610|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386611|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386612|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19386613|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20411759|NCT01197170|Anastrozole|anastrozole|mesh-list
19386614|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19386615|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403579|NCT03600961|Sirolimus|sirolimus|mesh-list
20411760|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20411761|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411762|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20411763|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411764|NCT01197170|Growth Substances|growth substances|mesh-ancestor
19386616|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386617|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19386618|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
19386619|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
19386620|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
19386621|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19386622|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386623|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386624|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
19386625|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19386626|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386627|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386628|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19386629|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19386630|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386631|NCT05221554|Tacrine|tacrine|mesh-list
19386632|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19386633|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386634|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215162|NCT00301730|Paclitaxel|paclitaxel|mesh-list
20215163|NCT00301730|Trastuzumab|trastuzumab|mesh-list
20215164|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19386635|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
19386636|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386637|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386638|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19386639|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
19386640|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386641|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
19386642|NCT05221502|Bedaquiline|bedaquiline|mesh-list
19386643|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
19386644|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
19386645|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19386646|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386647|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20411765|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411766|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
20411767|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411768|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
20411769|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20411770|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411771|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411772|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411773|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20411774|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20411775|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20411776|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
20411777|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411778|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
20411779|NCT01197235|Hematinics|hematinics|mesh-ancestor
20411780|NCT01197261|Oxycodone|oxycodone|mesh-list
20411781|NCT01197261|Naloxone|naloxone|mesh-list
20411782|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20411783|NCT01197261|Narcotics|narcotics|mesh-ancestor
20411784|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411785|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386648|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386649|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
19386650|NCT05221411|Tacrolimus|tacrolimus|mesh-list
19386651|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386652|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
20215165|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215166|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
20215167|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
20215168|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
20215169|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215170|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215171|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20215172|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20215173|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
20215174|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386653|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386654|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19386655|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386656|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386657|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19386658|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386659|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19386660|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
19386661|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19386662|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386663|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
19386664|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19386665|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386666|NCT05221190|Lidocaine|lidocaine|mesh-list
19386667|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
19386668|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
19386669|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386670|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386671|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
19386672|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386673|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19386674|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19386675|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19386676|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19386677|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386678|NCT05221164|Aspirin|aspirin|mesh-list
19386679|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19386680|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19386681|NCT05221164|Analgesics|analgesics|mesh-ancestor
19386682|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
19386683|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386684|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386685|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386686|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386687|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19386688|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19386689|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386690|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19386691|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19386692|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386693|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
19386694|NCT05220527|Triamcinolone|triamcinolone|mesh-list
19386695|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
19386696|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386697|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
19386698|NCT05220527|Hormones|hormones|mesh-ancestor
19386699|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386700|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386701|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
19386702|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19386703|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
19386704|NCT05220527|Protective Agents|protective agents|mesh-ancestor
19386705|NCT05220228|Prucalopride|prucalopride|mesh-list
19386706|NCT05220228|Laxatives|laxatives|mesh-ancestor
19386707|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19386708|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19386709|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19386710|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
19386711|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386712|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386713|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386714|NCT05219669|Nalmefene|nalmefene|mesh-list
20215175|NCT00301782|Carboplatin|carboplatin|mesh-list
20215176|NCT00301782|Etoposide|etoposide|mesh-list
20215177|NCT00301782|Vincristine|vincristine|mesh-list
20215178|NCT00301782|Bleomycin|bleomycin|mesh-list
20215179|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
20215180|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215181|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20215182|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20215183|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215184|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215185|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215186|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
20411786|NCT01197261|Analgesics|analgesics|mesh-ancestor
20411787|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
20411788|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411789|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20411790|NCT01197469|Tadalafil|tadalafil|mesh-list
20411791|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411792|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20411793|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20411794|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411795|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386715|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20215187|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
20215188|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
19386716|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386717|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
19386718|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386719|NCT05219656|Cyclosporine|cyclosporine|mesh-list
19386720|NCT05219656|Cyclosporins|cyclosporins|mesh-list
19386721|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386722|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386723|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386724|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
19386725|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386726|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
19386727|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386728|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
19386729|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386730|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19403580|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19403581|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403582|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19403583|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403584|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
19403585|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403586|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
19403587|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403588|NCT03600948|Sirolimus|sirolimus|mesh-list
19403589|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19403590|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403591|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19403592|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403593|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
19403594|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403595|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
19403596|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403597|NCT03600870|Midodrine|midodrine|mesh-list
19403598|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
19403599|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
19403600|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403601|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403602|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19403603|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19403604|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19403605|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19403606|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403607|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403608|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403609|NCT03600857|Misoprostol|misoprostol|mesh-list
19403610|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19403611|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
19403612|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19403613|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403614|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19403615|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20215189|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20215190|NCT00301795|Rituximab|rituximab|mesh-list
20215191|NCT00301795|Oblimersen|oblimersen|mesh-list
20215192|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215193|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215194|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
20215195|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215196|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215197|NCT00301847|Sorafenib|sorafenib|mesh-list
20215198|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215199|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19386731|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20411796|NCT01197469|Urological Agents|urological agents|mesh-ancestor
20411797|NCT01197664|Fluorouracil|fluorouracil|mesh-list
20411798|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
20411799|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411800|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411801|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411802|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411803|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
20411804|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411805|NCT01197781|Verapamil|verapamil|mesh-list
19847836|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411806|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20411807|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20411808|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411809|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411810|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20411811|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411812|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411813|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20411814|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
20411815|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20411816|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20411817|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20411818|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411819|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411820|NCT01198054|Lenalidomide|lenalidomide|mesh-list
20411821|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
20411822|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411823|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20411824|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20411825|NCT01198054|Growth Substances|growth substances|mesh-ancestor
20411826|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
20411827|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411828|NCT01198106|Cinnarizine|cinnarizine|mesh-list
20411829|NCT01198106|Scopolamine|scopolamine|mesh-list
20411830|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20411831|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20411832|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
20411833|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
20411834|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386732|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19386733|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386734|NCT05219409|Incretins|incretins|mesh-ancestor
19386735|NCT05219409|Hormones|hormones|mesh-ancestor
19386736|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386737|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19386738|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
19386739|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386740|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386741|NCT05219266|Midostaurin|midostaurin|mesh-list
19386742|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386743|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19386744|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386745|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386746|NCT05198453|Vaccines|vaccines|mesh-list
19386747|NCT05198453|Immunologic Factors|immunologic factors|mesh-ancestor
19386748|NCT05198453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386749|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19386750|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19386751|NCT05197374|Estradiol|estradiol|mesh-list
19386752|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19386753|NCT05197374|Estrogens|estrogens|mesh-ancestor
19386754|NCT05197374|Hormones|hormones|mesh-ancestor
19386755|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386756|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386757|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19386758|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
19386759|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19386760|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19847837|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411835|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411836|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20411837|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
19386761|NCT05191290|Heparin|heparin|mesh-list
19386762|NCT05191290|Calcium heparin|calcium heparin|mesh-list
19386763|NCT05191290|Citric Acid|citric acid|mesh-list
19386764|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
19386765|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
19386766|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19386767|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
20427545|NCT01287741|Prednisone|prednisone|mesh-list
19386768|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
19386769|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386770|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19386771|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20215200|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215201|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215202|NCT00301860|Cyclosporine|cyclosporine|mesh-list
20215203|NCT00301860|Methotrexate|methotrexate|mesh-list
20215204|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
19386772|NCT05189028|Gemcitabine|gemcitabine|mesh-list
19386773|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386774|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19386775|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
19386776|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386777|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
19386778|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386779|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386780|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386781|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
19386782|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386783|NCT05187377|Hormones|hormones|mesh-list
19386784|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386785|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386786|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
19386787|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19386788|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386789|NCT05181124|Naproxen|naproxen|mesh-list
19386790|NCT05181124|Meloxicam|meloxicam|mesh-list
19386791|NCT05181124|Aceclofenac|aceclofenac|mesh-list
19386792|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19386793|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19386794|NCT05181124|Analgesics|analgesics|mesh-ancestor
19386795|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
19386796|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386797|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386798|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386799|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19847838|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19847839|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
20215205|NCT00301860|Fludarabine|fludarabine|mesh-list
19386800|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
19847840|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
19847841|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
19847842|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19847843|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19847844|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19847845|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847846|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
19847847|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19847848|NCT00688753|Everolimus|everolimus|mesh-list
19847849|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847850|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19847851|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
19847852|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847853|NCT00688870|Vaccines|vaccines|mesh-list
19847854|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19847855|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
19847856|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847857|NCT00688909|Letrozole|letrozole|mesh-list
19847858|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847859|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19847860|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19847861|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847862|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847863|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20215206|NCT00301860|Melphalan|melphalan|mesh-list
20215207|NCT00301860|Cyclosporins|cyclosporins|mesh-list
20215208|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20215209|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19386801|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19386802|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386803|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386804|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19386805|NCT05179499|Norepinephrine|norepinephrine|mesh-list
19386806|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19386807|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19386808|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
20411838|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20411839|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
20411840|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411841|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411842|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20411843|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
20411844|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20411845|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411846|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20411847|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20411848|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
20411849|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
20411850|NCT01198184|Sirolimus|sirolimus|mesh-list
20411851|NCT01198184|R04929097|r04929097|mesh-list
20411852|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20411853|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411854|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20411855|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411856|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
20411857|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20411858|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
20411859|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411860|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411861|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411862|NCT01198210|Dexamethasone|dexamethasone|mesh-list
20411863|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
20411864|NCT01198210|Ketamine|ketamine|mesh-list
20411865|NCT01198210|BB 1101|bb 1101|mesh-list
20411866|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386809|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386810|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386811|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411867|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
20411868|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
20411869|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411870|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411871|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20411872|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
20411873|NCT01198210|Hormones|hormones|mesh-ancestor
20411874|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411875|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20411876|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20411877|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
20411878|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411879|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411880|NCT01198210|Analgesics|analgesics|mesh-ancestor
20411881|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
20411882|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20411883|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20411884|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
20411885|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
20411886|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411887|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20411888|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20411889|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411890|NCT01198223|Nystatin|nystatin|mesh-list
20411891|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20411892|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411893|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
19386812|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
19847864|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
19848275|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386813|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
19386814|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386815|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20411894|NCT01198223|Ionophores|ionophores|mesh-ancestor
20411895|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411896|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411897|NCT01198236|Itraconazole|itraconazole|mesh-list
20411898|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
20411899|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20411900|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20411901|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20411902|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411903|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411904|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20411905|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
20411906|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411907|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411908|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20411909|NCT01198249|Losartan|losartan|mesh-list
20411910|NCT01198249|Amlodipine|amlodipine|mesh-list
20411911|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19386816|NCT05168644|Niclosamide|niclosamide|mesh-list
19386817|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
19386818|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19386819|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
19386820|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19386821|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19386822|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
19386823|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
19386824|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19386825|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386826|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386827|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19386828|NCT05165836|Analgesics|analgesics|mesh-ancestor
19386829|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
19386830|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386831|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19386832|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19386833|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19386834|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
19386835|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386836|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386837|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
19386838|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386839|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386840|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
19386841|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386842|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386843|NCT05126264|Ibuprofen|ibuprofen|mesh-list
19386844|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19386845|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19386846|NCT05126264|Analgesics|analgesics|mesh-ancestor
19386847|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
19386848|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386849|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386850|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386851|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691483|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19691484|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691485|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691486|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19691487|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
19691488|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
19691489|NCT05004064|Rituximab|rituximab|mesh-list
19691490|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
19691491|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691492|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691493|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
19691494|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691495|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691496|NCT05004207|Lactulose|lactulose|mesh-list
19691497|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691498|NCT05004142|Letrozole|letrozole|mesh-list
19691499|NCT05004142|Fulvestrant|fulvestrant|mesh-list
19691500|NCT05004142|Goserelin|goserelin|mesh-list
19691501|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691502|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19691503|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20215210|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
20215211|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20215212|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215213|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215214|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
20215215|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215216|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215217|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
20215218|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215219|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19386852|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19386853|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386854|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386855|NCT05095311|Cetirizine|cetirizine|mesh-list
19386856|NCT05095311|Nedocromil|nedocromil|mesh-list
19386857|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19386858|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19386859|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19386860|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
19386861|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
19386862|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386863|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386864|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386865|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19386866|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
19386867|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386868|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19386869|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
19386870|NCT05085873|Midazolam|midazolam|mesh-list
19386871|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
19386872|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19386873|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19386874|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19386875|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386876|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19386877|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19386878|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19386879|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19386880|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
19386881|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
19386882|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
19386883|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
19386884|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386885|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386886|NCT05081375|Enoxaparin|enoxaparin|mesh-list
19386887|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
19386888|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19386889|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19386890|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403616|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
19403617|NCT03600831|Docetaxel|docetaxel|mesh-list
19403618|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403619|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
19403620|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
19403621|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
19403622|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403623|NCT03600818|Prednisone|prednisone|mesh-list
19403624|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403625|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
19403626|NCT03600818|Hormones|hormones|mesh-ancestor
19403627|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403628|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403629|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19403630|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403631|NCT03600766|Mirabegron|mirabegron|mesh-list
19403632|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19403633|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19691504|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691505|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691506|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19691507|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
19691508|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215220|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403634|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19847865|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19847866|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847867|NCT00689026|Lubiprostone|lubiprostone|mesh-list
19847868|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19847869|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847870|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847871|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19847872|NCT00689078|Prednisolone|prednisolone|mesh-list
19847873|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19847874|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
20411912|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20411913|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20411914|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411915|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411916|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19847875|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20411917|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411918|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411919|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20411920|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20411921|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20411922|NCT01198249|Diuretics|diuretics|mesh-ancestor
20411923|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
20411924|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20427546|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
20427547|NCT01287741|Rituximab|rituximab|mesh-list
20427548|NCT01287741|Doxorubicin|doxorubicin|mesh-list
19847876|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
19847877|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
19847878|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19847879|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
19847880|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847881|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
19847882|NCT00689078|Hormones|hormones|mesh-ancestor
19847883|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215221|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
20215222|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215223|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20215224|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
20215225|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427549|NCT01287741|Vincristine|vincristine|mesh-list
20427550|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
20427551|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427552|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
20427553|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427554|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427555|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20427556|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
20427557|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427558|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427559|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20427560|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215226|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20215227|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215228|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
20215229|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20215230|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
20215231|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
20215232|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20215233|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215234|NCT00301899|Trastuzumab|trastuzumab|mesh-list
20215235|NCT00301899|Pertuzumab|pertuzumab|mesh-list
20215236|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215237|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215238|NCT00301912|Methotrexate|methotrexate|mesh-list
20215239|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
20215240|NCT00301912|Fludarabine|fludarabine|mesh-list
20215241|NCT00301912|Busulfan|busulfan|mesh-list
20215242|NCT00301912|Tacrolimus|tacrolimus|mesh-list
20215243|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20215244|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
20215245|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20411925|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20411926|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
20411927|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411928|NCT01198340|Ropivacaine|ropivacaine|mesh-list
20411929|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
20411930|NCT01198340|Anesthetics|anesthetics|mesh-list
20411931|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411932|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411933|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
20411934|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411935|NCT01198353|Ziprasidone|ziprasidone|mesh-list
20411936|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20411937|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
20411938|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20411939|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411940|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411941|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20411942|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20411943|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20411944|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20411945|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20215246|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215247|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215248|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
20215249|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215250|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215251|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
20215252|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215253|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20411946|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
20411947|NCT01198379|Aspirin|aspirin|mesh-list
20411948|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20411949|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20411950|NCT01198379|Analgesics|analgesics|mesh-ancestor
20411951|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
20411952|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20411953|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411954|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20411955|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411956|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20411957|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20411958|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411959|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20411960|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20411961|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20411962|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
20411963|NCT01198392|Cisplatin|cisplatin|mesh-list
20411964|NCT01198392|Tegafur|tegafur|mesh-list
20411965|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386907|NCT05053152|Relugolix|relugolix|mesh-list
19386908|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
19386909|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
19386910|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386911|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386912|NCT05052827|Caseins|caseins|mesh-list
19386913|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
19386914|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
19403635|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
19847884|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411966|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20411967|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
20411968|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411969|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20411970|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20411971|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411972|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
19386915|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386916|NCT05049278|Phenylephrine|phenylephrine|mesh-list
19386917|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
19386918|NCT05049278|Norepinephrine|norepinephrine|mesh-list
19386919|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19386920|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
19386921|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
19386922|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386923|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386924|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
19386925|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20411973|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20411974|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411975|NCT01198496|Losartan|losartan|mesh-list
20411976|NCT01198496|Amlodipine|amlodipine|mesh-list
20411977|NCT01198496|Valsartan|valsartan|mesh-list
20411978|NCT01198496|Telmisartan|telmisartan|mesh-list
19386926|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
19386927|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
19386928|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19386929|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19386930|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19386931|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
20411979|NCT01198496|Candesartan|candesartan|mesh-list
20411980|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
20411981|NCT01198496|Olmesartan|olmesartan|mesh-list
20411982|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19386932|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386933|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386934|NCT05049278|Protective Agents|protective agents|mesh-ancestor
19386935|NCT05039632|Nivolumab|nivolumab|mesh-list
19386936|NCT05039632|Ipilimumab|ipilimumab|mesh-list
19386937|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19386938|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386939|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19386940|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215254|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215255|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
20215256|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20411983|NCT01198496|Spironolactone|spironolactone|mesh-list
20411984|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20411985|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20411986|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20411987|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20411988|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20411989|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411990|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
20411991|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20411992|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20411993|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20411994|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19386941|NCT05011357|Phenylephrine|phenylephrine|mesh-list
19386942|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
19386943|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19386944|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
19386945|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
20215257|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20215258|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20215259|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
20215260|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215261|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20215262|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
20215263|NCT00301925|Fluorouracil|fluorouracil|mesh-list
20215264|NCT00301925|Capecitabine|capecitabine|mesh-list
20215265|NCT00301925|Methotrexate|methotrexate|mesh-list
20215266|NCT00301925|Epirubicin|epirubicin|mesh-list
20215267|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215268|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
20215269|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215270|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19386946|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386947|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386948|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
19386949|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19386950|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
19386951|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
19386952|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19386953|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19386954|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19386955|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
19386956|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19386957|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386958|NCT05011357|Protective Agents|protective agents|mesh-ancestor
19386959|NCT05011188|Antibodies|antibodies|mesh-list
19386960|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
19386961|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
19386962|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
19386963|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20411995|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
20411996|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20411997|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20411998|NCT01198496|Diuretics|diuretics|mesh-ancestor
20411999|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
20412000|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20412001|NCT01198535|Cetuximab|cetuximab|mesh-list
20412002|NCT01198535|Antibodies|antibodies|mesh-list
20412003|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
20412004|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20412005|NCT01198535|R04929097|r04929097|mesh-list
19386964|NCT05008809|Leucovorin|leucovorin|mesh-list
19386965|NCT05008809|Fluorouracil|fluorouracil|mesh-list
19386966|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
19386967|NCT05008809|Irinotecan|irinotecan|mesh-list
19386968|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
19386969|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
19386970|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19386971|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19386972|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19386973|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19386974|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
19386975|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386976|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19386977|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19386978|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19386979|NCT05008809|Antidotes|antidotes|mesh-ancestor
20412006|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
20412007|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412008|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412009|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412010|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412011|NCT01198639|Remifentanil|remifentanil|mesh-list
20412012|NCT01198639|Propofol|propofol|mesh-list
20412013|NCT01198639|Anesthetics|anesthetics|mesh-list
19386980|NCT05008809|Protective Agents|protective agents|mesh-ancestor
19386981|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
19386982|NCT05008809|Vitamins|vitamins|mesh-ancestor
19386983|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
19386984|NCT04963816|Dexamethasone|dexamethasone|mesh-list
19386985|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
19386986|NCT04963816|Bupivacaine|bupivacaine|mesh-list
19386987|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19386988|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19386989|NCT04963816|BB 1101|bb 1101|mesh-list
19386990|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19386991|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
19386992|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
19386993|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19386994|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19386995|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19386996|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
19386997|NCT04963816|Hormones|hormones|mesh-ancestor
20412014|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19386998|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19386999|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387000|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412015|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387001|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
20412016|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387002|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387003|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387004|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
19387005|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
19387006|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387007|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
19387008|NCT04933552|Siponimod|siponimod|mesh-list
19387009|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19847885|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847886|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847887|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
19847888|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
20412017|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19387010|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387011|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387012|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
20412018|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
20412019|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20412020|NCT01198639|Narcotics|narcotics|mesh-ancestor
20412021|NCT01198639|Analgesics|analgesics|mesh-ancestor
20412022|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
20412023|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412024|NCT01198665|Prednisolone|prednisolone|mesh-list
20412025|NCT01198665|Doxorubicin|doxorubicin|mesh-list
20412026|NCT01198665|Vincristine|vincristine|mesh-list
20412027|NCT01198665|Everolimus|everolimus|mesh-list
20412028|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20412029|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412030|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20412031|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20412032|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412033|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412034|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20412035|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
20412036|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
20412037|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
20412038|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387013|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387014|NCT04933240|Tamoxifen|tamoxifen|mesh-list
19387015|NCT04933240|Estradiol|estradiol|mesh-list
19387016|NCT04933240|Estrogens|estrogens|mesh-ancestor
20412039|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
20412040|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412041|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412042|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
20412043|NCT01198665|Hormones|hormones|mesh-ancestor
20412044|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412045|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20412046|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20412047|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
20412048|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20412049|NCT01198821|Gemcitabine|gemcitabine|mesh-list
20412050|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20412051|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
20412052|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412053|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412054|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
20412055|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412056|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412057|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412058|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
20412059|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387017|NCT04933240|Hormones|hormones|mesh-ancestor
19387018|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387019|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387020|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19387021|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
19387022|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387023|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387024|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19387025|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20412060|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
19387026|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20412061|NCT01198860|Tenofovir|tenofovir|mesh-list
20412062|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
20412063|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412064|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20412065|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20412066|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412067|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412068|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20412069|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20412070|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
20412071|NCT01198860|Protective Agents|protective agents|mesh-ancestor
20412072|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412073|NCT01198860|Vitamins|vitamins|mesh-ancestor
20412074|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
20412075|NCT01198912|Doxycycline|doxycycline|mesh-list
20412076|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412077|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412078|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
20412079|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20412080|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20412081|NCT01198925|Piperacillin|piperacillin|mesh-list
20412082|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412083|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387027|NCT04917861|Vaccines|vaccines|mesh-list
19387028|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
19387029|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387030|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19387031|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19387032|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
19387033|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387034|NCT04915768|Antacids|antacids|mesh-ancestor
19387035|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387036|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19387037|NCT04891289|Gemcitabine|gemcitabine|mesh-list
19387038|NCT04891289|Dexamethasone|dexamethasone|mesh-list
19387039|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
19387040|NCT04891289|Floxuridine|floxuridine|mesh-list
19387041|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387042|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
19387043|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
19387044|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387045|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387046|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19387047|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
19387048|NCT04891289|Hormones|hormones|mesh-ancestor
20215271|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20412084|NCT01198938|Melatonin|melatonin|mesh-list
20412085|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
20412086|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412087|NCT01198938|Protective Agents|protective agents|mesh-ancestor
20412088|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412089|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412090|NCT01199029|Prednisone|prednisone|mesh-list
20412091|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412092|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
20412093|NCT01199029|Hormones|hormones|mesh-ancestor
20215272|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
19691509|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691510|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691511|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19691512|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
19691513|NCT05003765|Buprenorphine|buprenorphine|mesh-list
19691514|NCT05003765|Bupivacaine|bupivacaine|mesh-list
19691515|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20215273|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215274|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215275|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20215276|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
20215277|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215278|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20215279|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
20215280|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20215281|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
20412094|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412095|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387049|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387050|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387051|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387052|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19387053|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
19387054|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387055|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
19387056|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387057|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387058|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387059|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
19387060|NCT04891250|Ivermectin|ivermectin|mesh-list
19387061|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19387062|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387063|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
19387064|NCT04889703|Salicylates|salicylates|mesh-list
19387065|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387066|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
20215282|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215283|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20215284|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19387067|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
19387068|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
19387069|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19387070|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19387071|NCT04889703|Analgesics|analgesics|mesh-ancestor
19387072|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
19387073|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387074|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387075|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387076|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387077|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19387078|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387079|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387080|NCT04887792|Acetazolamide|acetazolamide|mesh-list
19387081|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
19387082|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19387083|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387084|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387085|NCT04887792|Diuretics|diuretics|mesh-ancestor
19387086|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
19387087|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387088|NCT04875715|Hydroquinone|hydroquinone|mesh-list
19387089|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
19387090|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387091|NCT04875715|Protective Agents|protective agents|mesh-ancestor
19387092|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387093|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19387094|NCT04873375|Cemiplimab|cemiplimab|mesh-list
19387095|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20412096|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20412097|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412098|NCT01199081|Dronedarone|dronedarone|mesh-list
20412099|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20412100|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
20412101|NCT01199159|Pyridoxal|pyridoxal|mesh-list
20412102|NCT01199159|Pyridoxine|pyridoxine|mesh-list
20412103|NCT01199159|Misoprostol|misoprostol|mesh-list
19387096|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403636|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403637|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403638|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403639|NCT03600766|Urological Agents|urological agents|mesh-ancestor
19691516|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
19691517|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
20215285|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20215286|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20215287|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215288|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
20215289|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215290|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20215291|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215292|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215293|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
20215294|NCT00301951|Fludarabine|fludarabine|mesh-list
20215295|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
20215296|NCT00301951|Busulfan|busulfan|mesh-list
20215297|NCT00301951|Tacrolimus|tacrolimus|mesh-list
20412104|NCT01199159|Vitamins|vitamins|mesh-ancestor
19387097|NCT04814433|Lidocaine|lidocaine|mesh-list
19387098|NCT04814433|Epinephrine|epinephrine|mesh-list
19387099|NCT04814433|Racepinephrine|racepinephrine|mesh-list
19387100|NCT04814433|Bupivacaine|bupivacaine|mesh-list
19387101|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
19387102|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
19387103|NCT04814433|Thrombin|thrombin|mesh-list
19387104|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
19387105|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
19387106|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
19387107|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387108|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387109|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
19387110|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387111|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19387112|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19387113|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19387114|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19387115|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387116|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19387117|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19387118|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387119|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387120|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19387121|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19387122|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
19387123|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20412105|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
20412106|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412107|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20412108|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
20412109|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20412110|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20412111|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19387124|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
19387125|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
19387126|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
19387127|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19387128|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19387129|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19387130|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
19387131|NCT04814433|Coagulants|coagulants|mesh-ancestor
19387132|NCT04805125|Vaccines|vaccines|mesh-list
19387133|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
19387134|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412112|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
20412113|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
19387135|NCT04789499|Theophylline|theophylline|mesh-list
19387136|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19387137|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
19387138|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387139|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387140|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19387141|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
19387142|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19387143|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387144|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387145|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
19387146|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19387147|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19387148|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
19691518|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412114|NCT01199224|Veliparib|veliparib|mesh-list
20412115|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20412116|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412117|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412118|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412119|NCT01199276|Sevoflurane|sevoflurane|mesh-list
20412120|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20412121|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20412122|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
20412123|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
20412124|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412125|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412126|NCT01199328|Aspirin|aspirin|mesh-list
19387149|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387150|NCT04765644|Celecoxib|celecoxib|mesh-list
19387151|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19387152|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19387153|NCT04765644|Analgesics|analgesics|mesh-ancestor
19387154|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
19387155|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387156|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387157|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387158|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387159|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19387160|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19387161|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387162|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387163|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19387164|NCT04747314|Aripiprazole|aripiprazole|mesh-list
19387165|NCT04747314|Mirtazapine|mirtazapine|mesh-list
19387166|NCT04747314|Citalopram|citalopram|mesh-list
19387167|NCT04747314|Bupropion|bupropion|mesh-list
19387168|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19387169|NCT04747314|Sertraline|sertraline|mesh-list
19387170|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
19387171|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20412127|NCT01199328|Esomeprazole|esomeprazole|mesh-list
20412128|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412129|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412130|NCT01199328|Analgesics|analgesics|mesh-ancestor
20412131|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
20412132|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412133|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412134|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412135|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387172|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19387173|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19387174|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387175|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387176|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
19387177|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387178|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19387179|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19387180|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387181|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19387182|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
19387183|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19387184|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19387185|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387186|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19387187|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19387188|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387189|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
19387190|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19387191|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19387192|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19387193|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19387194|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19387195|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19387196|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19387197|NCT04747314|Analgesics|analgesics|mesh-ancestor
19387198|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
19387199|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19387200|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
20412136|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20412137|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20412138|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412139|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20412140|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20412141|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412142|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
20412143|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20412144|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20412145|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20412146|NCT01199341|Warfarin|warfarin|mesh-list
19387201|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
19691519|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412147|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
19387202|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19387203|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19387204|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19387205|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19387206|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387207|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19387208|NCT04730193|Caffeine|caffeine|mesh-list
19387209|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19387210|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387211|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19387212|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387213|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387214|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19387215|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19387216|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
19387217|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387218|NCT04717765|Vitamin E|vitamin e|mesh-list
19387219|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
19387220|NCT04717765|Tocopherols|tocopherols|mesh-list
19387221|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
19387222|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387223|NCT04717765|Protective Agents|protective agents|mesh-ancestor
20412148|NCT01199367|Letrozole|letrozole|mesh-list
20412149|NCT01199367|Lapatinib|lapatinib|mesh-list
20412150|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412151|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20412152|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20412153|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412154|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387224|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387225|NCT04717765|Vitamins|vitamins|mesh-ancestor
19387226|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
19387227|NCT04705818|Durvalumab|durvalumab|mesh-list
19387228|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387229|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387230|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
19387231|NCT04704219|Lenvatinib|lenvatinib|mesh-list
19387232|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387233|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387234|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19387235|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387236|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387237|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19387238|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19387239|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387240|NCT04671355|Fluticasone|fluticasone|mesh-list
19387241|NCT04671355|Xhance|xhance|mesh-list
20215298|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20215299|NCT00301951|Sargramostim|sargramostim|mesh-list
20215300|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215301|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19387242|NCT04671355|Beclomethasone|beclomethasone|mesh-list
19387243|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
19387244|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
19387245|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387246|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19387247|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
19387248|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387249|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387250|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19387251|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
19387252|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
19387253|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19387254|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20215302|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
20215303|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215304|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215305|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
20215306|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215307|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20215308|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215309|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20215310|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20215311|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
20412155|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19387255|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20412156|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
20412157|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412158|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412159|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20412160|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
20412161|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
20412162|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
19387256|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19387257|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387258|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387259|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387260|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19387261|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19387262|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19387263|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
19387264|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
19387265|NCT04671355|Hormones|hormones|mesh-ancestor
19387266|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387267|NCT04627246|Vaccines|vaccines|mesh-list
19387268|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
19387269|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387270|NCT04625088|Atropine|atropine|mesh-list
19387271|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20412163|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412164|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412165|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
20412166|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412167|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
20412168|NCT01199432|Fluorouracil|fluorouracil|mesh-list
19387272|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19387273|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19387274|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
19387275|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387276|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387277|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19387278|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
19387279|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
19387280|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
19387281|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19387282|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19387283|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
19387284|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387285|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387286|NCT04614545|Phentermine|phentermine|mesh-list
19387287|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19387288|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387289|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
19387290|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19387291|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
19387292|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
19387293|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387294|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387295|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387296|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387297|NCT04610671|Nivolumab|nivolumab|mesh-list
19387298|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387299|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387300|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19387301|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387302|NCT04597671|Durvalumab|durvalumab|mesh-list
19387303|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387304|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387305|NCT04564898|Trifluridine|trifluridine|mesh-list
19387306|NCT04564898|Bevacizumab|bevacizumab|mesh-list
19387307|NCT04564898|Capecitabine|capecitabine|mesh-list
19387308|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387309|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387310|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19387311|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19387312|NCT04564898|Growth Substances|growth substances|mesh-ancestor
19387313|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387314|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
19691520|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
19387315|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19387316|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
19387317|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387318|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
19387319|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387320|NCT04562779|Naltrexone|naltrexone|mesh-list
19387321|NCT04562779|Ketamine|ketamine|mesh-list
19387322|NCT04562779|Analgesics|analgesics|mesh-ancestor
19387323|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
19387324|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387325|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387326|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19387327|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19387328|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
19387329|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
19387330|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387331|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19387332|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19387333|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387334|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387335|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19387336|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19387337|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19387338|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19387339|NCT04547790|Psyllium|psyllium|mesh-list
19387340|NCT04547790|Cathartics|cathartics|mesh-ancestor
20412169|NCT01199432|Epirubicin|epirubicin|mesh-list
20412170|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412171|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
20412172|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412173|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412174|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20412175|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
20412176|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412177|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412178|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20412179|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
20412180|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20412181|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20412182|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20412183|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20412184|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412185|NCT01199445|Vitamin A|vitamin a|mesh-list
20412186|NCT01199445|Vitamins|vitamins|mesh-ancestor
20412187|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
20412188|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412189|NCT01199458|Alfentanil|alfentanil|mesh-list
20412190|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20412191|NCT01199458|Narcotics|narcotics|mesh-ancestor
20412192|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412193|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412194|NCT01199458|Analgesics|analgesics|mesh-ancestor
20412195|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
20412196|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412197|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19387341|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403640|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
19403641|NCT03600727|Propofol|propofol|mesh-list
19403642|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19403643|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403644|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403645|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19403646|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
19403647|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
19403648|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412198|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
20412199|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
20412200|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20412201|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
20412202|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20412203|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
20412204|NCT01199523|Mirabegron|mirabegron|mesh-list
20412205|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412206|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412207|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19403649|NCT03600727|Analgesics|analgesics|mesh-ancestor
19403650|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
19387342|NCT04523363|Metformin|metformin|mesh-list
19387343|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19387344|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387345|NCT04517435|Prednisone|prednisone|mesh-list
19387346|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
19387347|NCT04517435|Rituximab|rituximab|mesh-list
19387348|NCT04517435|Doxorubicin|doxorubicin|mesh-list
19387349|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19387350|NCT04517435|Vincristine|vincristine|mesh-list
19387351|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387352|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
19387353|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387354|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412208|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20412209|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412210|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412211|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412212|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412213|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20412214|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20412215|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20412216|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387355|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19387356|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
19387357|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387358|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387359|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19387360|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387361|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19387362|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19387363|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215312|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215313|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215314|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
20215315|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215316|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20215317|NCT00301990|Aldesleukin|aldesleukin|mesh-list
20215318|NCT00301990|Bevacizumab|bevacizumab|mesh-list
20215319|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215320|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215321|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20215322|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20215323|NCT00301990|Growth Substances|growth substances|mesh-ancestor
20215324|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215325|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
20215326|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20215327|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20215328|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
20215329|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691521|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691522|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20218031|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20218032|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218033|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218034|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218035|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218036|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218037|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218038|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
20218039|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218040|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387364|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387365|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387366|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
19387367|NCT04517435|Hormones|hormones|mesh-ancestor
19387368|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387369|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387370|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19387371|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
19387372|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
19691523|NCT05003765|Narcotics|narcotics|mesh-ancestor
19691524|NCT05003765|Analgesics|analgesics|mesh-ancestor
20412217|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412218|NCT01199523|Urological Agents|urological agents|mesh-ancestor
19691525|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19387373|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
19387374|NCT04509050|Ivacaftor|ivacaftor|mesh-list
19387375|NCT04509050|Elexacaftor|elexacaftor|mesh-list
19387376|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19387377|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19387378|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387379|NCT04503993|Antibodies|antibodies|mesh-list
19387380|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
20412219|NCT01199562|Valganciclovir|valganciclovir|mesh-list
20412220|NCT01199562|Ganciclovir|ganciclovir|mesh-list
20412221|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20412222|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
20412223|NCT01199562|Foscarnet|foscarnet|mesh-list
20412224|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
20412225|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412226|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20412227|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412228|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412229|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20412230|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
20412231|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412232|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20412233|NCT01199757|Fluticasone|fluticasone|mesh-list
20412234|NCT01199757|Xhance|xhance|mesh-list
20412235|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
20412236|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412237|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20412238|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
20412239|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412240|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412241|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20412242|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
20412243|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
20412244|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20412245|NCT01199783|Vancomycin|vancomycin|mesh-list
20412246|NCT01199783|Daptomycin|daptomycin|mesh-list
20412247|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412248|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412249|NCT01199835|Calcium|calcium|mesh-list
20412250|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20412251|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412252|NCT01199900|Prednisone|prednisone|mesh-list
20412253|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412254|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
19387381|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
19387382|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387383|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
19387384|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19387385|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387386|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387387|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19387388|NCT04484922|Analgesics|analgesics|mesh-ancestor
20412255|NCT01199900|Hormones|hormones|mesh-ancestor
20412256|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412257|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412258|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20412259|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412260|NCT01200004|Lenalidomide|lenalidomide|mesh-list
20412261|NCT01200004|Azacitidine|azacitidine|mesh-list
20412262|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
20412263|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412264|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20412265|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20412266|NCT01200004|Growth Substances|growth substances|mesh-ancestor
20412267|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
20412268|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412269|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20412270|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
20412271|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412272|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412273|NCT01200056|Atorvastatin|atorvastatin|mesh-list
19387389|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
19387390|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387391|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20412274|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19387392|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20412275|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20412276|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
20412277|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412278|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20412279|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20412280|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412281|NCT01200108|Budesonide|budesonide|mesh-list
20412282|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412283|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20412284|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
20412285|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412286|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412287|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20412288|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
20412289|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
20412290|NCT01200108|Hormones|hormones|mesh-ancestor
19387393|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19387394|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387395|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387396|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412291|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412292|NCT01200121|Bevacizumab|bevacizumab|mesh-list
20412293|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20412294|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412295|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20412296|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20412297|NCT01200121|Growth Substances|growth substances|mesh-ancestor
20412298|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412299|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
20412300|NCT01200186|Progestins|progestins|mesh-list
20412301|NCT01200186|Hormones|hormones|mesh-ancestor
20412302|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412303|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427561|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20427562|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20427563|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20427564|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427565|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427566|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
20427567|NCT01287741|Hormones|hormones|mesh-ancestor
20427568|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20427569|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20427570|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19387397|NCT04446390|Listerine|listerine|mesh-list
19387398|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
19387399|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
19387400|NCT04446390|Protective Agents|protective agents|mesh-ancestor
19387401|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387402|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19387403|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387404|NCT04436913|Fluorides|fluorides|mesh-list
19387405|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
19387406|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
19387407|NCT04436913|Protective Agents|protective agents|mesh-ancestor
19387408|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387409|NCT04412707|Dexamethasone|dexamethasone|mesh-list
19387410|NCT04412707|Melphalan|melphalan|mesh-list
19387411|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387412|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
19387413|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
19387414|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387415|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387416|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19387417|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
19387418|NCT04412707|Hormones|hormones|mesh-ancestor
19387419|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387420|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387421|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387422|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19387423|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
19387424|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387425|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19691526|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19691527|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
19387426|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387427|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
19387428|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
19387429|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19387430|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19387431|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
19387432|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387433|NCT04390945|Capecitabine|capecitabine|mesh-list
19387434|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19387435|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
19387436|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387437|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387438|NCT04381364|Ciclesonide|ciclesonide|mesh-list
19387439|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
19387440|NCT04381364|Hormones|hormones|mesh-ancestor
19387441|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387442|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387443|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19387444|NCT04375384|Cetuximab|cetuximab|mesh-list
19387445|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387446|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387447|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
20412304|NCT01200212|Bevacizumab|bevacizumab|mesh-list
20412305|NCT01200212|Taxane|taxane|mesh-list
20412306|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20412307|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412308|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20412309|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19387448|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387449|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387450|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
19387451|NCT04363164|Testosterone|testosterone|mesh-list
19387452|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
19387453|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
19387454|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19387455|NCT04363164|Androgens|androgens|mesh-ancestor
19387456|NCT04363164|Hormones|hormones|mesh-ancestor
19387457|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387458|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387459|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387460|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387461|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
19387462|NCT04337827|Rituximab|rituximab|mesh-list
19387463|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
19387464|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387465|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387466|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
19387467|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387468|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387469|NCT04332068|Ivermectin|ivermectin|mesh-list
19387470|NCT04332068|Permethrin|permethrin|mesh-list
19387471|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19387472|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387473|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387474|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387475|NCT04327024|Allopurinol|allopurinol|mesh-list
19387476|NCT04327024|Verinurad|verinurad|mesh-list
19387477|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
19387478|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387479|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387480|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
19691528|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20215330|NCT00302224|Ketoconazole|ketoconazole|mesh-list
19387481|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387482|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20215331|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
20215332|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215333|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20215334|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20215335|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215336|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215337|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20215338|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
20215339|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215340|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387483|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
19387484|NCT04327024|Protective Agents|protective agents|mesh-ancestor
19387485|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387486|NCT04322669|Pidotimod|pidotimod|mesh-list
19387487|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19387488|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
19387489|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387490|NCT04296396|Oxycodone|oxycodone|mesh-list
19387491|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19387492|NCT04296396|Narcotics|narcotics|mesh-ancestor
19387493|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847889|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847890|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19847891|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19847892|NCT00689078|Protective Agents|protective agents|mesh-ancestor
19847893|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19847894|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20412310|NCT01200212|Growth Substances|growth substances|mesh-ancestor
20412311|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412312|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
20412313|NCT01200251|Bimatoprost|bimatoprost|mesh-list
20412314|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20412315|NCT01200264|Apremilast|apremilast|mesh-list
20412316|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412317|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412318|NCT01200264|Analgesics|analgesics|mesh-ancestor
20412319|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
20412320|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412321|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412322|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412323|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412324|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20412325|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20412326|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412327|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412328|NCT01200472|Apremilast|apremilast|mesh-list
20412329|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412330|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412331|NCT01200472|Analgesics|analgesics|mesh-ancestor
20412332|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
20412333|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412334|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412335|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412336|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412337|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20412338|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20412339|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412340|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412341|NCT01200537|Norinyl|norinyl|mesh-list
20412342|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
19387494|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387495|NCT04296396|Analgesics|analgesics|mesh-ancestor
19387496|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
19387497|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387498|NCT04291521|Ketamine|ketamine|mesh-list
19387499|NCT04291521|Propofol|propofol|mesh-list
19387500|NCT04291521|Etomidate|etomidate|mesh-list
19387501|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19387502|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412343|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
20412344|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20412345|NCT01200537|Estradiol|estradiol|mesh-list
20412346|NCT01200537|Estrogens|estrogens|mesh-ancestor
20412347|NCT01200537|Hormones|hormones|mesh-ancestor
20412348|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412349|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412350|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20412351|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20412352|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20412353|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20412354|NCT01200641|Gabapentin|gabapentin|mesh-list
20412355|NCT01200641|Melatonin|melatonin|mesh-list
20412356|NCT01200641|Analgesics|analgesics|mesh-ancestor
19387503|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387504|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20412357|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
20412358|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412359|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412360|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
20412361|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20412362|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20412363|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387505|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
19387506|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
19387507|NCT04291521|Analgesics|analgesics|mesh-ancestor
19387508|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
19387509|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387510|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19387511|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19387512|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19387513|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387514|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387515|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
19387516|NCT04240171|Glimepiride|glimepiride|mesh-list
19387517|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19387518|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387519|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19387520|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387521|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19387522|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387523|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
19387524|NCT04235101|Trastuzumab|trastuzumab|mesh-list
19387525|NCT04235101|Niraparib|niraparib|mesh-list
19387526|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387527|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412364|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20412365|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20412366|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20412367|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412368|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412369|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
20412370|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
20412371|NCT01200641|Protective Agents|protective agents|mesh-ancestor
20412372|NCT01200654|Linezolid|linezolid|mesh-list
20412373|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412374|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387528|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19387529|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387530|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387531|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
19387532|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387533|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387534|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
19387535|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
19387536|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19387537|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387538|NCT04214691|Acetaminophen|acetaminophen|mesh-list
19387539|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19387540|NCT04214691|Analgesics|analgesics|mesh-ancestor
19387541|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
19387542|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387543|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387544|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
19387545|NCT04205630|Trastuzumab|trastuzumab|mesh-list
19847895|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19847896|NCT00689104|Mirabegron|mirabegron|mesh-list
19847897|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19847898|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19847899|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19847900|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19847901|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
19847902|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847903|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847904|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847905|NCT00689104|Urological Agents|urological agents|mesh-ancestor
19847906|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20412375|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19387546|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387547|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387548|NCT04204941|Doxorubicin|doxorubicin|mesh-list
19847907|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20412376|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412377|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412378|NCT01200693|Sirolimus|sirolimus|mesh-list
20412379|NCT01200693|Everolimus|everolimus|mesh-list
20412380|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412381|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412382|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
20412383|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412384|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412385|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412386|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19387549|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19387550|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19387551|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387552|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19387553|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19387554|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387555|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387556|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
19387557|NCT04198766|Antibodies|antibodies|mesh-list
19387558|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
19387559|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387560|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387561|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387562|NCT04198116|Guanfacine|guanfacine|mesh-list
19387563|NCT04198116|Varenicline|varenicline|mesh-list
19387564|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19387565|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19387566|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
19387567|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387568|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387569|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387570|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19387571|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19387572|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19387573|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19387574|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403651|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403652|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19403653|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19403654|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19403655|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403656|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403657|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403658|NCT03600623|Gemcitabine|gemcitabine|mesh-list
19403659|NCT03600623|Paclitaxel|paclitaxel|mesh-list
19403660|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19403661|NCT03600623|Fluorouracil|fluorouracil|mesh-list
19403662|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
19403663|NCT03600623|Irinotecan|irinotecan|mesh-list
19403664|NCT03600623|Folfirinox|folfirinox|mesh-list
20412387|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
20412388|NCT01200706|Amoxicillin|amoxicillin|mesh-list
20412389|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412390|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412391|NCT01200732|Tadalafil|tadalafil|mesh-list
20412392|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
20412393|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20412394|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20412395|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412396|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412397|NCT01200732|Urological Agents|urological agents|mesh-ancestor
20412398|NCT01200745|Capsaicin|capsaicin|mesh-list
20412399|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
20412400|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
20412401|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
20412402|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412403|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412404|NCT01200784|Niacinamide|niacinamide|mesh-list
20412405|NCT01200784|Niacin|niacin|mesh-list
20412406|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
19403665|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20412407|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
19403666|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403667|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
20412408|NCT01200784|Vitamins|vitamins|mesh-ancestor
20412409|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
20412410|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412411|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20412412|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
20412413|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412414|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19387575|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19387576|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19387577|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19387578|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
19387579|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387580|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387581|NCT04183452|Progestins|progestins|mesh-ancestor
19387582|NCT04183452|Hormones|hormones|mesh-ancestor
19387583|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
19387584|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
20412415|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
20412416|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20412417|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
20412418|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20412419|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20412420|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19387585|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19387586|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387587|NCT04155710|Interleukin-2|interleukin-2|mesh-list
19387588|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387589|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19387590|NCT04155710|Analgesics|analgesics|mesh-ancestor
19387591|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
19387592|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387593|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387594|NCT04126096|Lactams|lactams|mesh-list
19387595|NCT04126096|beta-Lactams|beta-lactams|mesh-list
19387596|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19387597|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387598|NCT04113187|Propranolol|propranolol|mesh-list
19387599|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19387600|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19387601|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387602|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387603|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387604|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387605|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19387606|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19387607|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
19847908|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
19847909|NCT00689117|Clindamycin|clindamycin|mesh-list
19847910|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
19387611|NCT04095208|Nivolumab|nivolumab|mesh-list
19387612|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387613|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387614|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19387615|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387616|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
20412421|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412422|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412423|NCT01200914|Heparin|heparin|mesh-list
20412424|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
20412425|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19387617|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
19387618|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387619|NCT04088591|Protective Agents|protective agents|mesh-ancestor
19387620|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387621|NCT04088591|Vitamins|vitamins|mesh-ancestor
19387622|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
19387623|NCT04067609|Dexamethasone|dexamethasone|mesh-list
19387624|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387625|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
19387626|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
19387627|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387628|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387629|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19387630|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
19387631|NCT04067609|Hormones|hormones|mesh-ancestor
19387632|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387633|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20412426|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19387634|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387635|NCT04061980|Nivolumab|nivolumab|mesh-list
19387636|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387637|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387638|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19387639|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387640|NCT04042077|Vancomycin|vancomycin|mesh-list
19387641|NCT04042077|Tazobactam|tazobactam|mesh-list
19387642|NCT04042077|Linezolid|linezolid|mesh-list
19387643|NCT04042077|Piperacillin|piperacillin|mesh-list
19387644|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19387645|NCT04042077|Tigecycline|tigecycline|mesh-list
19387646|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19387647|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387648|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19387649|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387650|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387651|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19387652|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
19387653|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
19387654|NCT04022239|Melphalan|melphalan|mesh-list
19387655|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19387656|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
19387657|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19387658|NCT04022239|Rituximab|rituximab|mesh-list
19387659|NCT04022239|Fludarabine|fludarabine|mesh-list
19387660|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19387661|NCT04022239|Tacrolimus|tacrolimus|mesh-list
19387662|NCT04022239|Antibodies|antibodies|mesh-list
19387663|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
19387664|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20215341|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20215342|NCT00302289|Caffeine|caffeine|mesh-list
19847911|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
19847912|NCT00689117|Tretinoin|tretinoin|mesh-list
19847913|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19847914|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847915|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19847916|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19847917|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847918|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847919|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
19387665|NCT04022239|Lenograstim|lenograstim|mesh-list
19387666|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387667|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
19387668|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387669|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387670|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19387671|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
19387672|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387673|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387674|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19387675|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19387676|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19387677|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691529|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847920|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
19691530|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691531|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19691532|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
19691533|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19691534|NCT05003570|Fentanyl|fentanyl|mesh-list
19691535|NCT05003570|Remifentanil|remifentanil|mesh-list
19691536|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19691537|NCT05003570|Narcotics|narcotics|mesh-ancestor
19691538|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691539|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691540|NCT05003570|Analgesics|analgesics|mesh-ancestor
19691541|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
19691542|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691543|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20215343|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19387678|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19387679|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19403668|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
19847921|NCT00689221|Temozolomide|temozolomide|mesh-list
19387680|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
20412427|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412428|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
20412429|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
20412430|NCT01201005|Hematinics|hematinics|mesh-ancestor
20412431|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
19387681|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19387682|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387683|NCT04010539|Azithromycin|azithromycin|mesh-list
19387684|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
19387685|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19387686|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387687|NCT04009668|Adalimumab|adalimumab|mesh-list
19387688|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387689|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387690|NCT04008238|Trabectedin|trabectedin|mesh-list
19387691|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19387692|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
19387693|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387694|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387695|NCT03995017|Nivolumab|nivolumab|mesh-list
19387696|NCT03995017|Ramucirumab|ramucirumab|mesh-list
19387697|NCT03995017|Rucaparib|rucaparib|mesh-list
19387698|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387699|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387700|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19387701|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387702|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19387703|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387704|NCT03980314|Nivolumab|nivolumab|mesh-list
19387705|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387706|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412432|NCT01201005|Vitamins|vitamins|mesh-ancestor
20412433|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
20412434|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412435|NCT01201044|Gemcitabine|gemcitabine|mesh-list
20412436|NCT01201044|Nedaplatin|nedaplatin|mesh-list
20412437|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20412438|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
20412439|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412440|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412441|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
20412442|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412443|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412444|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412445|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
20412446|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412447|NCT01201070|Antithrombins|antithrombins|mesh-list
20412448|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
20412449|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20412450|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20412451|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412452|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412453|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
20412454|NCT01201122|Mesalamine|mesalamine|mesh-list
20412455|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412456|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412457|NCT01201122|Analgesics|analgesics|mesh-ancestor
20412458|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
20412459|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412460|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412461|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412462|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412463|NCT01201161|Ranibizumab|ranibizumab|mesh-list
20412464|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20412465|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20412466|NCT01201161|Growth Substances|growth substances|mesh-ancestor
20412467|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412468|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
20412469|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387707|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19387708|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387709|NCT03972527|Analgesics|analgesics|mesh-list
20412470|NCT01201213|Anesthetics|anesthetics|mesh-list
20412471|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
20412472|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387710|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
19387711|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387712|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387713|NCT03926299|Clobetasol|clobetasol|mesh-list
19387714|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387715|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
19387716|NCT03926299|Hormones|hormones|mesh-ancestor
19387717|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387718|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387719|NCT03923374|Buprenorphine|buprenorphine|mesh-list
19387720|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19387721|NCT03923374|Narcotics|narcotics|mesh-ancestor
19387722|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19847922|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19847923|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
19847924|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847925|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847926|NCT00689338|Fluconazole|fluconazole|mesh-list
19847927|NCT00689338|Voriconazole|voriconazole|mesh-list
19847928|NCT00689338|Anidulafungin|anidulafungin|mesh-list
19847929|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
19847930|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847931|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19847932|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19847933|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387723|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387724|NCT03923374|Analgesics|analgesics|mesh-ancestor
19387725|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
19387726|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387727|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19387728|NCT03915678|Atezolizumab|atezolizumab|mesh-list
19387729|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19387730|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387731|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
19387732|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387733|NCT03913104|Mifepristone|mifepristone|mesh-list
19387734|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19387735|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
19387736|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19387737|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387738|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19387739|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19387740|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19387741|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
19387742|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19387743|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19387744|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
19387745|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387746|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
19387747|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19387748|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19387749|NCT03905135|Avelumab|avelumab|mesh-list
19387750|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387751|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387752|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19387753|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19387754|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
19387755|NCT03893903|Avelumab|avelumab|mesh-list
19387756|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387757|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387758|NCT03875092|Paclitaxel|paclitaxel|mesh-list
19387759|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19387760|NCT03875092|Carboplatin|carboplatin|mesh-list
19387761|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
19387762|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19387763|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387764|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
19387765|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
19387766|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
19387767|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387768|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19847934|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387769|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
19847935|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19387770|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19387771|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19387772|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387773|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
19387774|NCT03868956|Coagulants|coagulants|mesh-ancestor
20215344|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215345|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20215346|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215347|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215348|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20215349|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20215350|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
20215351|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215352|NCT00302341|Trimethoprim|trimethoprim|mesh-list
20215353|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20215354|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
20215355|NCT00302341|Pafuramidine|pafuramidine|mesh-list
20412473|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412474|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
20412475|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412476|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
20412477|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20215356|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215357|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412478|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20412479|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
20412480|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412481|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20412482|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20412483|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412484|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412485|NCT01201278|Insulin|insulin|mesh-list
20412486|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20412487|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
20412488|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20412489|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412490|NCT01201499|Morphine|morphine|mesh-list
20412491|NCT01201499|Remifentanil|remifentanil|mesh-list
20412492|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20412493|NCT01201499|Narcotics|narcotics|mesh-ancestor
20412494|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412495|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412496|NCT01201499|Analgesics|analgesics|mesh-ancestor
20412497|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
20412498|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412499|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20412500|NCT01201551|Latanoprost|latanoprost|mesh-list
20412501|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20412502|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20412503|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20412504|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20412505|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20412506|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20412507|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
20412508|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412509|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412510|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412511|NCT01201577|Azithromycin|azithromycin|mesh-list
20412512|NCT01201577|Sulfalene|sulfalene|mesh-list
20412513|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412514|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412515|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20412516|NCT01201577|Renal Agents|renal agents|mesh-ancestor
20412517|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
20412518|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20412519|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20412520|NCT01201642|Prednisolone|prednisolone|mesh-list
20412521|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412522|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
20412523|NCT01201642|Hormones|hormones|mesh-ancestor
20412524|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412525|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412526|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691544|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19691545|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
20215358|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20215359|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215360|NCT00302341|Renal Agents|renal agents|mesh-ancestor
20215361|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
20215362|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20215363|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20215364|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20215365|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20215366|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20215367|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20215368|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215369|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19387775|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
19387776|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387777|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387778|NCT03841097|Tacrolimus|tacrolimus|mesh-list
19387779|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387780|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
19387781|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387782|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19387783|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387784|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387785|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
19387786|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387787|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387788|NCT03814356|Methylphenidate|methylphenidate|mesh-list
19387789|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19387790|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387791|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19387792|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19387793|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19387794|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387795|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
19387796|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387797|NCT03814200|Rifampin|rifampin|mesh-list
19387798|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19387799|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
19387800|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19387801|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387802|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
19387803|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19387804|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387805|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387806|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19387807|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19387808|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19387809|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19387810|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19387811|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19387812|NCT03811847|Methylphenidate|methylphenidate|mesh-list
19387813|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19387814|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387815|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19387816|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19387817|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19387818|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387819|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
19387820|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387821|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
19387822|NCT03809624|Antibodies|antibodies|mesh-list
19387823|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
19387824|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691546|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
19691547|NCT05003752|Goserelin|goserelin|mesh-list
19691548|NCT05003752|Androgens|androgens|mesh-list
19691549|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20215370|NCT00302354|Methylphenidate|methylphenidate|mesh-list
20613193|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613194|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215371|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20427571|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
20427572|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
20412527|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412528|NCT01201694|Curcumin|curcumin|mesh-list
20412529|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412530|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412531|NCT01201694|Analgesics|analgesics|mesh-ancestor
20412532|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
20412533|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412534|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387825|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387826|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387827|NCT03805022|Doxorubicin|doxorubicin|mesh-list
19387828|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19387829|NCT03805022|Ifosfamide|ifosfamide|mesh-list
19387830|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
19387831|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19387832|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387833|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20412535|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412536|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412537|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412538|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412539|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412540|NCT01201902|Vaccines|vaccines|mesh-list
20412541|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
20412542|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412543|NCT01201928|Insulin|insulin|mesh-list
20412544|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20412545|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427573|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
20427574|NCT01287780|Gentamicins|gentamicins|mesh-list
20427575|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20427576|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427577|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19387834|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19387835|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387836|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215372|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215373|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20215374|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20215375|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20215376|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215377|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
20215378|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215379|NCT00302367|Methylphenidate|methylphenidate|mesh-list
20215380|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20215381|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215382|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20215383|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20215384|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20215385|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427578|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427579|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427580|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
20427581|NCT01287793|Tigecycline|tigecycline|mesh-list
19387837|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19387838|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
19387839|NCT03802240|Pemetrexed|pemetrexed|mesh-list
20427582|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20427583|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427584|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19387840|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387841|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387842|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387843|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19387844|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19387845|NCT03798678|Dexamethasone|dexamethasone|mesh-list
19387846|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
19387847|NCT03798678|Ichthammol|ichthammol|mesh-list
19387848|NCT03798678|BB 1101|bb 1101|mesh-list
19387849|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387850|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
19387851|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
19387852|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387853|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387854|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19387855|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
19387856|NCT03798678|Hormones|hormones|mesh-ancestor
19387857|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387858|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387859|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387860|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
19387861|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387862|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387863|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
19403669|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
19403670|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403671|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19403672|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
19403673|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
19403674|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403675|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403676|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403677|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
19403678|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412546|NCT01202032|Bevacizumab|bevacizumab|mesh-list
20412547|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20412548|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412549|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20412550|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20412551|NCT01202032|Growth Substances|growth substances|mesh-ancestor
20412552|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412553|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
20412554|NCT01202058|Sirolimus|sirolimus|mesh-list
20412555|NCT01202058|Everolimus|everolimus|mesh-list
20412556|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412557|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412558|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
20412559|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403679|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19403680|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19403681|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
19403682|NCT03600506|Sympatholytics|sympatholytics|mesh-list
19403683|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19403684|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403685|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403686|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19403687|NCT03600506|Analgesics|analgesics|mesh-ancestor
19403688|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
19403689|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403690|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19403691|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19403692|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19403693|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403694|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403695|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403696|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
19403697|NCT03600493|Lidocaine|lidocaine|mesh-list
19403698|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
19403699|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
19403700|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
19403701|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412560|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412561|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412562|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20412563|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
20412564|NCT01202084|Fluticasone|fluticasone|mesh-list
20412565|NCT01202084|Xhance|xhance|mesh-list
20412566|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
20412567|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412568|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20412569|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
20412570|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412571|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412572|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20412573|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
19403702|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403703|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
20412574|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
20412575|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19387864|NCT03784066|Durvalumab|durvalumab|mesh-list
19387865|NCT03784066|Tremelimumab|tremelimumab|mesh-list
19387866|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19387867|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387868|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387869|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
19387870|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387871|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
19387872|NCT03740009|Estrogens|estrogens|mesh-list
19387873|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19387874|NCT03740009|Hormones|hormones|mesh-ancestor
20412576|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20412577|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20412578|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20412579|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
20412580|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412581|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412582|NCT01202097|Fluticasone|fluticasone|mesh-list
20412583|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20412584|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20412585|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387875|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387876|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387877|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19387878|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19387879|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
19387880|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19387881|NCT03738852|Insulin|insulin|mesh-list
19387882|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19387883|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387884|NCT03738397|Upadacitinib|upadacitinib|mesh-list
19387885|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19387886|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
20412586|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20412587|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
20412588|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412589|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412590|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20412591|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
20412592|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
20412593|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20412594|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20412595|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20412596|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20412597|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
20412598|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412599|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412600|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
19387887|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387888|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19387889|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19387890|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387891|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387892|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19387893|NCT03705845|Tocotrienols|tocotrienols|mesh-list
19387894|NCT03705845|Vitamin E|vitamin e|mesh-list
19387895|NCT03705845|Tocopherols|tocopherols|mesh-list
19387896|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
19387897|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387898|NCT03705845|Protective Agents|protective agents|mesh-ancestor
19387899|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412601|NCT01202097|Hormones|hormones|mesh-ancestor
20412602|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412603|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
19387900|NCT03705845|Vitamins|vitamins|mesh-ancestor
19387901|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
19387902|NCT03689244|Selexipag|selexipag|mesh-list
19387903|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19387904|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
20412604|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
19387905|NCT03674320|Testosterone|testosterone|mesh-list
19387906|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
19387907|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
19387908|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19387909|NCT03674320|Androgens|androgens|mesh-ancestor
19387910|NCT03674320|Hormones|hormones|mesh-ancestor
20412605|NCT01202149|Emollients|emollients|mesh-list
20412606|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412607|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412608|NCT01202149|Analgesics|analgesics|mesh-ancestor
20412609|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
20412610|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412611|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412612|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19387911|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387912|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387913|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387914|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387915|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
19387916|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
19387917|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19387918|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387919|NCT03650894|Nivolumab|nivolumab|mesh-list
19387920|NCT03650894|Ipilimumab|ipilimumab|mesh-list
19387921|NCT03650894|Bicalutamide|bicalutamide|mesh-list
19387922|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387923|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387924|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19387925|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387926|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
19387927|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
19387928|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387929|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387930|NCT03639610|Dexamethasone|dexamethasone|mesh-list
19387931|NCT03639610|Melphalan|melphalan|mesh-list
19387932|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412613|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412614|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
20412615|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412616|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
20412617|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20412618|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412619|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412620|NCT01202240|Ketoconazole|ketoconazole|mesh-list
20412621|NCT01202240|Tofacitinib|tofacitinib|mesh-list
20412622|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
20412623|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412624|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20412625|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20412626|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412627|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412628|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20412629|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
20412630|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412631|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412632|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20412633|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20412634|NCT01202331|Azithromycin|azithromycin|mesh-list
20412635|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412636|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412637|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
19387933|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
19387934|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
19387935|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19387936|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387937|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19387938|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
19387939|NCT03639610|Hormones|hormones|mesh-ancestor
19387940|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19387941|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19387942|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387943|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19387944|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
19387945|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387946|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19387947|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412638|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19387948|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
19387949|NCT03635892|Nivolumab|nivolumab|mesh-list
19387950|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387951|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387952|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19387953|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387954|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
19387955|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387956|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387957|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
19387958|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19387959|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19387960|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412639|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412640|NCT01202422|Pregabalin|pregabalin|mesh-list
19387961|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19387962|NCT03589729|Cytarabine|cytarabine|mesh-list
20412641|NCT01202422|Analgesics|analgesics|mesh-ancestor
20412642|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
19847936|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
19387963|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19387964|NCT03589729|Idarubicin|idarubicin|mesh-list
19387965|NCT03589729|Cladribine|cladribine|mesh-list
19387966|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
19387967|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
19387968|NCT03589729|Razoxane|razoxane|mesh-list
19387969|NCT03589729|Calicheamicins|calicheamicins|mesh-list
19387970|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19387971|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
19387972|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387973|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19387974|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
19387975|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19387976|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19387977|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
19387978|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387979|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19387980|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19387981|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19387982|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19387983|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19387984|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19387985|NCT03589729|Protective Agents|protective agents|mesh-ancestor
19387986|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
19387987|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
19387988|NCT03588754|Propranolol|propranolol|mesh-list
19387989|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19387990|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19387991|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
19387992|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19387993|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19387994|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19387995|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20412643|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412644|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412645|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
20412646|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20412647|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20412648|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412649|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20412650|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20412651|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20412652|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412653|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20412654|NCT01202435|Pregabalin|pregabalin|mesh-list
19387996|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19387997|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
19387998|NCT03569293|Upadacitinib|upadacitinib|mesh-list
19387999|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19388000|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388001|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388002|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412655|NCT01202435|Analgesics|analgesics|mesh-ancestor
19388003|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388004|NCT03564678|Folic Acid|folic acid|mesh-list
19388005|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
19388006|NCT03564678|Vitamins|vitamins|mesh-ancestor
19388007|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
19388008|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388009|NCT03564678|Hematinics|hematinics|mesh-ancestor
19388010|NCT03520491|Nivolumab|nivolumab|mesh-list
19388011|NCT03520491|Ipilimumab|ipilimumab|mesh-list
20412656|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
19388012|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388013|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388014|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19388015|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388016|NCT03495388|Oxycodone|oxycodone|mesh-list
19388017|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19388018|NCT03495388|Narcotics|narcotics|mesh-ancestor
19388019|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19388020|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388021|NCT03495388|Analgesics|analgesics|mesh-ancestor
19388022|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
19388023|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388024|NCT03488420|Edoxaban|edoxaban|mesh-list
19388025|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19388026|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
19388027|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19388028|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
19388029|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388030|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388031|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
19388032|NCT03476330|Quercetin|quercetin|mesh-list
19388033|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
19388034|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388035|NCT03476330|Protective Agents|protective agents|mesh-ancestor
19388036|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388037|NCT03473977|Benralizumab|benralizumab|mesh-list
19388038|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388039|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388040|NCT03461445|Tacrolimus|tacrolimus|mesh-list
19388041|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388042|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
19388043|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388044|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19388045|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388046|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388047|NCT03451006|Metformin|metformin|mesh-list
19388048|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19388049|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388050|NCT03437421|Vitamin D|vitamin d|mesh-list
19388051|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
19388052|NCT03437421|Vitamins|vitamins|mesh-ancestor
20412657|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412658|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412659|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
20412660|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20412661|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20412662|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412663|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20412664|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20412665|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20412666|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19388053|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
19388054|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388055|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19388056|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19388057|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19388058|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19388059|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388060|NCT03396211|Nivolumab|nivolumab|mesh-list
19388061|NCT03396211|Apatinib|apatinib|mesh-list
19388062|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388063|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388064|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19388065|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412667|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20412668|NCT01202474|Insulin|insulin|mesh-list
19388066|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388067|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412669|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19388068|NCT03392441|Insulin|insulin|mesh-list
19388069|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19388070|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388071|NCT03389243|Acetaminophen|acetaminophen|mesh-list
19388072|NCT03389243|Dipyrone|dipyrone|mesh-list
19388073|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412670|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
20412671|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
20412672|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20412673|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388074|NCT03389243|Analgesics|analgesics|mesh-ancestor
19388075|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
19388076|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388077|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388078|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
19388079|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19388080|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388081|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388082|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
19388083|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19388084|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19388085|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388086|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
19388087|NCT03364491|Coagulants|coagulants|mesh-ancestor
19403704|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403705|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19403706|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19403707|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19403708|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403709|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403710|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19403711|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19403712|NCT03600493|Analgesics|analgesics|mesh-ancestor
19403713|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19403714|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19403715|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19403716|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403717|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403718|NCT03600467|Seviteronel|seviteronel|mesh-list
19403719|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403720|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19403721|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403722|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403723|NCT03600454|Anesthetics|anesthetics|mesh-list
19403724|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403725|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403726|NCT03600441|Abexinostat|abexinostat|mesh-list
19403727|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19403728|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403729|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403730|NCT03600363|Metformin|metformin|mesh-list
19403731|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19403732|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403733|NCT03600311|Vitamin D|vitamin d|mesh-list
19403734|NCT03600311|Calcium|calcium|mesh-list
20412674|NCT01202487|Lidocaine|lidocaine|mesh-list
20412675|NCT01202487|Epinephrine|epinephrine|mesh-list
20412676|NCT01202487|Tetracaine|tetracaine|mesh-list
20412677|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
20412678|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
20412679|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412680|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412681|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
20412682|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403735|NCT03600311|Vitamins|vitamins|mesh-ancestor
19403736|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
20215386|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
20215387|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215388|NCT00302393|Methylphenidate|methylphenidate|mesh-list
20215389|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20215390|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215391|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20215392|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20215393|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388088|NCT03338920|Sumatriptan|sumatriptan|mesh-list
19388089|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20215394|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215395|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
20215396|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215397|NCT00302406|Methylphenidate|methylphenidate|mesh-list
20215398|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20215399|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215400|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20215401|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20215402|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388090|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19388091|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19388092|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
19388093|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388094|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388095|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388096|NCT03243838|Apatinib|apatinib|mesh-list
19388097|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388098|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388099|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388100|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388101|NCT03237780|Atezolizumab|atezolizumab|mesh-list
19388102|NCT03237780|Halichondrin B|halichondrin b|mesh-list
19388103|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19388104|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388105|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
19388106|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388107|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388108|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388109|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
19388110|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388111|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
19388112|NCT03221309|Narcotics|narcotics|mesh-ancestor
19388113|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19388114|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388115|NCT03221309|Analgesics|analgesics|mesh-ancestor
19388116|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
19388117|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388118|NCT03205761|Olaparib|olaparib|mesh-list
19388119|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19388120|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388121|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412683|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20412684|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20412685|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20412686|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20412687|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388122|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388123|NCT03151811|Dexamethasone|dexamethasone|mesh-list
19388124|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
19388125|NCT03151811|Melphalan|melphalan|mesh-list
19388126|NCT03151811|Pomalidomide|pomalidomide|mesh-list
19388127|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388128|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
19388129|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
19388130|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388131|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388132|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388133|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
19388134|NCT03151811|Hormones|hormones|mesh-ancestor
19388135|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388136|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19388137|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388138|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19388139|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
19848276|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412688|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20412689|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20412690|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
20412691|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412692|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20412693|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20215403|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215404|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
20215405|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215406|NCT00302419|Streptokinase|streptokinase|mesh-list
20215407|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20215408|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19388140|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388141|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19388142|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691550|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691551|NCT05003752|Hormones|hormones|mesh-ancestor
19847937|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388143|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
19388144|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19388145|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19388146|NCT03151811|Growth Substances|growth substances|mesh-ancestor
19388147|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
19388148|NCT03126968|Epinephrine|epinephrine|mesh-list
19388149|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19388150|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19388151|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
19388152|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388153|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388154|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388155|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19388156|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19388157|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
19388158|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388159|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388160|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388161|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
19388162|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
19388163|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19388164|NCT03086096|Irinotecan|irinotecan|mesh-list
19388165|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19388166|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19388167|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388168|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847938|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847939|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19847940|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19847941|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19388169|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388170|NCT03085680|Curcumin|curcumin|mesh-list
19388171|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19388172|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19388173|NCT03085680|Analgesics|analgesics|mesh-ancestor
19388174|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
19388175|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388176|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388177|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388178|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388179|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691552|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691553|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691554|NCT05003648|Pramipexole|pramipexole|mesh-list
19691555|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
19691556|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691557|NCT05003648|Protective Agents|protective agents|mesh-ancestor
19691558|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691559|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19691560|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19691561|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
19691562|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
19847942|NCT00689351|Vaccines|vaccines|mesh-list
19847943|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19847944|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
19847945|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847946|NCT00689390|Ribavirin|ribavirin|mesh-list
19847947|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19847948|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
20218041|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19388180|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412694|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
20412695|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388181|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388182|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
19388183|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19388184|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388185|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19388186|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19388187|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
19388188|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388189|NCT03051282|Enalapril|enalapril|mesh-list
19847949|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847950|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
19847951|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19847952|NCT00689572|Ondansetron|ondansetron|mesh-list
19847953|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
19847954|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
19847955|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847956|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215409|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412696|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388190|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19388191|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
19388192|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388193|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388194|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19388195|NCT03039673|Interleukin-2|interleukin-2|mesh-list
19388196|NCT03039673|Riluzole|riluzole|mesh-list
19388197|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388198|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19388199|NCT03039673|Analgesics|analgesics|mesh-ancestor
19388200|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
19388201|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388202|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847957|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20412697|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
20412698|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
20412699|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20412700|NCT01202513|Bimatoprost|bimatoprost|mesh-list
20412701|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20412702|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20412703|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20412704|NCT01202552|Vaccines|vaccines|mesh-list
20412705|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
20412706|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412707|NCT01202734|Methylphenidate|methylphenidate|mesh-list
20412708|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20412709|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412710|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20412711|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20412712|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20412713|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412714|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
20412715|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412716|NCT01202799|Diclofenac|diclofenac|mesh-list
20412717|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412718|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412719|NCT01202799|Analgesics|analgesics|mesh-ancestor
20412720|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
20412721|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215410|NCT00302432|Menthol|menthol|mesh-list
20215411|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
20215412|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
20215413|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
20215414|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20215415|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215416|NCT00302497|Basiliximab|basiliximab|mesh-list
20215417|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215418|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
20215419|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215420|NCT00302523|Tacrolimus|tacrolimus|mesh-list
20215421|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412722|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412723|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847958|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
19388203|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
19388204|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19388205|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20412724|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412725|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20412726|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412727|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412728|NCT01202825|Simeprevir|simeprevir|mesh-list
20412729|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
20412730|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388206|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388207|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388208|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19388209|NCT03039673|Protective Agents|protective agents|mesh-ancestor
20412731|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
20412732|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412733|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412734|NCT01202890|Bevacizumab|bevacizumab|mesh-list
20412735|NCT01202890|Lenalidomide|lenalidomide|mesh-list
20412736|NCT01202890|Doxorubicin|doxorubicin|mesh-list
20412737|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20412738|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20412739|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412740|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20412741|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20412742|NCT01202890|Growth Substances|growth substances|mesh-ancestor
20412743|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412744|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
20412745|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20412746|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20412747|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20412748|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388210|NCT03033225|Verteporfin|verteporfin|mesh-list
19388211|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19388212|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
19388213|NCT03011034|Daratumumab|daratumumab|mesh-list
19388214|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388215|NCT02999477|Paclitaxel|paclitaxel|mesh-list
19388216|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
19388217|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19388218|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388219|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388220|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388221|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
19388222|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388223|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388224|NCT02980666|Teduglutide|teduglutide|mesh-list
19388225|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388226|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19388227|NCT02980666|Protective Agents|protective agents|mesh-ancestor
19388228|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388229|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
19388230|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388231|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388232|NCT02962102|Calcitriol|calcitriol|mesh-list
19388233|NCT02962102|Calcifediol|calcifediol|mesh-list
19388234|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19388235|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388236|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19388237|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388238|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388239|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19388240|NCT02962102|Vitamins|vitamins|mesh-ancestor
19847959|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
20215422|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
20215423|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215424|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20215425|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215426|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215427|NCT00302536|Tacrolimus|tacrolimus|mesh-list
20215428|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215429|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
20215430|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215431|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19388241|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
19388242|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19388243|NCT02950259|Indomethacin|indomethacin|mesh-list
19388244|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
19388245|NCT02950259|Omeprazole|omeprazole|mesh-list
19388246|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388247|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
19388248|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388249|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388250|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19388251|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
19388252|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388253|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388254|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19388255|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19388256|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388257|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19388258|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388259|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19388260|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19388261|NCT02950259|Analgesics|analgesics|mesh-ancestor
19388262|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
19388263|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388264|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388265|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
19388266|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
19388267|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19388268|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19388269|NCT02947750|Folic Acid|folic acid|mesh-list
19388270|NCT02947750|Hematinics|hematinics|mesh-ancestor
19388271|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
20412749|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412750|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
20412751|NCT01203020|Vidarabine|vidarabine|mesh-list
20412752|NCT01203020|Fludarabine|fludarabine|mesh-list
20412753|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
20412754|NCT01203020|Busulfan|busulfan|mesh-list
20412755|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412756|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20412757|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
19388272|NCT02947750|Vitamins|vitamins|mesh-ancestor
19388273|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
19388274|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388275|NCT02880020|Nivolumab|nivolumab|mesh-list
19388276|NCT02880020|Ipilimumab|ipilimumab|mesh-list
19388277|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388278|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388279|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19388280|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388281|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
20412758|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412759|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412760|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
20412761|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412762|NCT01203020|Antiviral Agents|antiviral agents|mesh-ancestor
20412763|NCT01203020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412764|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
20412765|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20412766|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20412767|NCT01203111|Insulin|insulin|mesh-list
20412768|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20412769|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
20412770|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
20412771|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20412772|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412773|NCT01203202|Clomipramine|clomipramine|mesh-list
20412774|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20412775|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
20412776|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20412777|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20412778|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20412779|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388282|NCT02853331|Sunitinib|sunitinib|mesh-list
19388283|NCT02853331|Axitinib|axitinib|mesh-list
19388284|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388285|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412780|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412781|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412782|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
20412783|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215432|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215433|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215434|NCT00302549|Tacrolimus|tacrolimus|mesh-list
20412784|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
20412785|NCT01203228|Busulfan|busulfan|mesh-list
20412786|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
20412787|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412788|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
20412789|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412790|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412791|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20412792|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
19388286|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19388287|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19388288|NCT02853331|Growth Substances|growth substances|mesh-ancestor
19388289|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388290|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
19388291|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388292|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388293|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388294|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19388295|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19388296|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19388297|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
20412793|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412794|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412795|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20412796|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20412797|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
20412798|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20412799|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20412800|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20412801|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
20412802|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412803|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20412804|NCT01203267|Paclitaxel|paclitaxel|mesh-list
20412805|NCT01203267|Carboplatin|carboplatin|mesh-list
20412806|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20412807|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412808|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
20412809|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
20412810|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
20412811|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412812|NCT01203306|Bevacizumab|bevacizumab|mesh-list
20412813|NCT01203306|Capecitabine|capecitabine|mesh-list
20412814|NCT01203306|Octreotide|octreotide|mesh-list
20412815|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20412816|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412817|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20412818|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20412819|NCT01203306|Growth Substances|growth substances|mesh-ancestor
20412820|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412821|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
20412822|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20412823|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
20412824|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412825|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20412826|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20412827|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19388298|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215435|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215436|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
20215437|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215438|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20215439|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215440|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215441|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
20215442|NCT00302627|Vitamin D|vitamin d|mesh-list
20412828|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
20412829|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412830|NCT01203358|Beractant|beractant|mesh-list
20412831|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20412832|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
20412833|NCT01203371|Naftopidil|naftopidil|mesh-list
20412834|NCT01203371|Tamsulosin|tamsulosin|mesh-list
20412835|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19388299|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388300|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388301|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
19388302|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388303|NCT02812524|Ipilimumab|ipilimumab|mesh-list
19388304|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388305|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388306|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19388307|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388308|NCT02777424|Thrombin|thrombin|mesh-list
19388309|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
19388310|NCT02777424|Coagulants|coagulants|mesh-ancestor
19388311|NCT02748369|Glucagon|glucagon|mesh-list
19388312|NCT02748369|Hormones|hormones|mesh-list
19388313|NCT02748369|Somatostatin|somatostatin|mesh-list
19388314|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388315|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388316|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388317|NCT02734290|Paclitaxel|paclitaxel|mesh-list
19388318|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
19388319|NCT02734290|Capecitabine|capecitabine|mesh-list
19388320|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19388321|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388322|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388323|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388324|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
19388325|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388326|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388327|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19388328|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
19388329|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
19388330|NCT02630368|Avelumab|avelumab|mesh-list
19388331|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388332|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
19388333|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388334|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388335|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19388336|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
19388337|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388338|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388339|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19388340|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388341|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19388342|NCT02616965|Romidepsin|romidepsin|mesh-list
19388343|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388344|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388345|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19388346|NCT02613416|Denosumab|denosumab|mesh-list
19388347|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20412836|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20412837|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20412838|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
20412839|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412840|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412841|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412842|NCT01203371|Urological Agents|urological agents|mesh-ancestor
20412843|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20412844|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20412845|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20412846|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20412847|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20412848|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
20412849|NCT01203384|Analgesics|analgesics|mesh-ancestor
20412850|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
20613195|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
19388348|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388349|NCT02601014|Nivolumab|nivolumab|mesh-list
19388350|NCT02601014|Ipilimumab|ipilimumab|mesh-list
19388351|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388352|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388353|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19388354|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388355|NCT02598999|Lactoferrin|lactoferrin|mesh-list
19388356|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
19388357|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388358|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19388359|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388360|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388361|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19388362|NCT02581787|Antibodies|antibodies|mesh-list
19388363|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
19388364|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19388365|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
19388366|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
20412851|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412852|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388367|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388368|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388369|NCT02581085|Tocotrienols|tocotrienols|mesh-list
19388370|NCT02581085|Vitamin E|vitamin e|mesh-list
19388371|NCT02581085|Tocopherols|tocopherols|mesh-list
19388372|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
19388373|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388374|NCT02581085|Protective Agents|protective agents|mesh-ancestor
19388375|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388376|NCT02581085|Vitamins|vitamins|mesh-ancestor
19388377|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
19388378|NCT02579096|Allopurinol|allopurinol|mesh-list
19388379|NCT02579096|Febuxostat|febuxostat|mesh-list
19388380|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
19388381|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388382|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388383|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
19388384|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388385|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19388386|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
19388387|NCT02579096|Protective Agents|protective agents|mesh-ancestor
19388388|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388389|NCT02577406|Cytarabine|cytarabine|mesh-list
19388390|NCT02577406|Azacitidine|azacitidine|mesh-list
19388391|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19388392|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
19388393|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388394|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215443|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
20215444|NCT00302627|Pamidronate|pamidronate|mesh-list
20215445|NCT00302627|Vitamins|vitamins|mesh-list
19388395|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
19388396|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388397|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388398|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
19388399|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388400|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388401|NCT02538666|Nivolumab|nivolumab|mesh-list
19388402|NCT02538666|Ipilimumab|ipilimumab|mesh-list
19388403|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388404|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388405|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19388406|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388407|NCT02527200|Liraglutide|liraglutide|mesh-list
19388408|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20215446|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
20215447|NCT00302627|Calcium|calcium|mesh-list
20215448|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
20215449|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215450|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20215451|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20215452|NCT00302627|Antacids|antacids|mesh-ancestor
20215453|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215454|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20215455|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
19388409|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388410|NCT02527200|Incretins|incretins|mesh-ancestor
19388411|NCT02527200|Hormones|hormones|mesh-ancestor
19403737|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412853|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20412854|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20412855|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412856|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412857|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20412858|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412859|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412860|NCT01203488|Vitamin A|vitamin a|mesh-list
20412861|NCT01203488|Vitamins|vitamins|mesh-ancestor
20412862|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
20412863|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412864|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
20412865|NCT01203514|Hematinics|hematinics|mesh-ancestor
20412866|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20412867|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20412868|NCT01203592|Albuterol|albuterol|mesh-list
20412869|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20412870|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
20412871|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412872|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412873|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20412874|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
20412875|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
20412876|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20412877|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20412878|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20412879|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20412880|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
20412881|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412882|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412883|NCT01203618|Farletuzumab|farletuzumab|mesh-list
20412884|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412885|NCT01203696|Amlodipine|amlodipine|mesh-list
20412886|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19388412|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403738|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19403739|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19404780|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404781|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19404782|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19404783|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19404784|NCT03591991|Empagliflozin|empagliflozin|mesh-list
20412887|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20412888|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20412889|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412890|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20412891|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412892|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
20412893|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
20412894|NCT01203709|Tacrolimus|tacrolimus|mesh-list
20412895|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20412896|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
20412897|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412898|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20412899|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412900|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412901|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20412902|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412903|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20412904|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
20412905|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412906|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412907|NCT01203735|Valproic Acid|valproic acid|mesh-list
20412908|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
20412909|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412910|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412911|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
20412912|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412913|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412914|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
20412915|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20412916|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20412917|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19388413|NCT02516696|Clarithromycin|clarithromycin|mesh-list
19388414|NCT02516696|Dexamethasone|dexamethasone|mesh-list
19388415|NCT02516696|Lenalidomide|lenalidomide|mesh-list
19388416|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388417|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
19388418|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
19388419|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388420|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388421|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388422|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
19388423|NCT02516696|Hormones|hormones|mesh-ancestor
19388424|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388425|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19388426|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388427|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
19388428|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19388429|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19388430|NCT02516696|Growth Substances|growth substances|mesh-ancestor
19388431|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
19388432|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19388433|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388434|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19388435|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388436|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388437|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19388438|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19388439|NCT02511106|Osimertinib|osimertinib|mesh-list
19388440|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388441|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388442|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388443|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388444|NCT02491099|Afatinib|afatinib|mesh-list
19388445|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388446|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388447|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388448|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388449|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
19388450|NCT02476058|Promethazine|promethazine|mesh-list
20412918|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20412919|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19388451|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19388452|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19388453|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19388454|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691563|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412920|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20412921|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
20412922|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412923|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20412924|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20412925|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412926|NCT01204086|Fluoxetine|fluoxetine|mesh-list
20412927|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20412928|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20412929|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20412930|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20412931|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412932|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20412933|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
20412934|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412935|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20412936|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
20412937|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20412938|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20412939|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20412940|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412941|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20412942|NCT01204112|Rifampin|rifampin|mesh-list
20412943|NCT01204112|Tofacitinib|tofacitinib|mesh-list
20412944|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20412945|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
19388455|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
19388456|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
19388457|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
19388458|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388459|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
19388460|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
19388461|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388462|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19388463|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
19388464|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
19388465|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388466|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388467|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19388468|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
19388469|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
20412946|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20412947|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412948|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
20412949|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20412950|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412951|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412952|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20412953|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20412954|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20412955|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20412956|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20412957|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20412958|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20412959|NCT01204125|Paclitaxel|paclitaxel|mesh-list
20412960|NCT01204125|Iniparib|iniparib|mesh-list
19388470|NCT02451553|Capecitabine|capecitabine|mesh-list
20412961|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20412962|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412963|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
20412964|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
20412965|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
20412966|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388471|NCT02451553|Afatinib|afatinib|mesh-list
19388472|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19388473|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
19388474|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388475|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388476|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388477|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388478|NCT02432209|Orlistat|orlistat|mesh-list
19388479|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388480|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388481|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19388482|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19388483|NCT02422381|Gemcitabine|gemcitabine|mesh-list
19388484|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
19388485|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19388486|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
19388487|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388488|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388489|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
19388490|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388491|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388492|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388493|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
19388494|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388495|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388496|NCT02418195|Ketamine|ketamine|mesh-list
19388497|NCT02418195|Analgesics|analgesics|mesh-ancestor
19388498|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
19388499|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388500|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388501|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19388502|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19388503|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
19388504|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
19388505|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19388506|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19388507|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19388508|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388509|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388510|NCT02392637|Gemcitabine|gemcitabine|mesh-list
19388511|NCT02392637|Paclitaxel|paclitaxel|mesh-list
19388512|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19388513|NCT02392637|Cisplatin|cisplatin|mesh-list
19388514|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19388515|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388516|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388517|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388518|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
19388519|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388520|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19388521|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
19388522|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
19388523|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20412967|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20412968|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412969|NCT01204138|Apremilast|apremilast|mesh-list
20412970|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19388524|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388525|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388526|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
20412971|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19388527|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388528|NCT02372630|Linagliptin|linagliptin|mesh-list
19388529|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19388530|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388531|NCT02372630|Incretins|incretins|mesh-ancestor
19388532|NCT02372630|Hormones|hormones|mesh-ancestor
19388533|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388534|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19388535|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
19388536|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388537|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388538|NCT02341014|Lenalidomide|lenalidomide|mesh-list
19388539|NCT02341014|Romidepsin|romidepsin|mesh-list
19388540|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
20412972|NCT01204138|Analgesics|analgesics|mesh-ancestor
20412973|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
20412974|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412975|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412976|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412977|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20412978|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20412979|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20412980|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412981|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412982|NCT01204164|Dexamethasone|dexamethasone|mesh-list
20412983|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20412984|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
20412985|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
20412986|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20412987|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20412988|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20412989|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
20412990|NCT01204164|Hormones|hormones|mesh-ancestor
20412991|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20412992|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19388541|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388542|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19388543|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19388544|NCT02341014|Growth Substances|growth substances|mesh-ancestor
19388545|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
20215456|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20215457|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215458|NCT00302653|Rasburicase|rasburicase|mesh-list
20215459|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
20215460|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215461|NCT00302666|Dienogest|dienogest|mesh-list
19388546|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215462|NCT00302666|Nandrolone|nandrolone|mesh-list
20215463|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19847960|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19847961|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
20215464|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
20412993|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20412994|NCT01204177|Sorafenib|sorafenib|mesh-list
20412995|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388547|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19388548|NCT02270814|Paclitaxel|paclitaxel|mesh-list
19388549|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19388550|NCT02270814|Cisplatin|cisplatin|mesh-list
19388551|NCT02270814|Carboplatin|carboplatin|mesh-list
19388552|NCT02270814|Cetuximab|cetuximab|mesh-list
19388553|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19388554|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388555|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388556|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388557|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
19388558|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412996|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20412997|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20412998|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20412999|NCT01204190|Gestodene|gestodene|mesh-list
20413000|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20413001|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20413002|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20413003|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
20413004|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20413005|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413006|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20413007|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20413008|NCT01204190|Progestins|progestins|mesh-ancestor
19388559|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388560|NCT02253316|Dexamethasone|dexamethasone|mesh-list
19388561|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
19388562|NCT02253316|Lenalidomide|lenalidomide|mesh-list
19388563|NCT02253316|Ixazomib|ixazomib|mesh-list
19388564|NCT02253316|BB 1101|bb 1101|mesh-list
19388565|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388566|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
19388567|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
19388568|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388569|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388570|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388571|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
19388572|NCT02253316|Hormones|hormones|mesh-ancestor
19388573|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388574|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19388575|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388576|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
19388577|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388578|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388579|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
19388580|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19388581|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19388582|NCT02253316|Growth Substances|growth substances|mesh-ancestor
19388583|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
19388584|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19388585|NCT02245230|Trimethaphan|trimethaphan|mesh-list
19388586|NCT02245230|Phenylephrine|phenylephrine|mesh-list
19388587|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
19388588|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
19388589|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19388590|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
19388591|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
19388592|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388593|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388594|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
19388595|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19388596|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
19388597|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388598|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19388599|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19388600|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19388601|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
20413009|NCT01204190|Hormones|hormones|mesh-ancestor
19388602|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388603|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388604|NCT02245230|Protective Agents|protective agents|mesh-ancestor
19388605|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20413010|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413011|NCT01204216|Biotin|biotin|mesh-list
20413012|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
20413013|NCT01204216|Vitamins|vitamins|mesh-ancestor
20413014|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
20413015|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413016|NCT01204268|Sevoflurane|sevoflurane|mesh-list
20413017|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20413018|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19388606|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
19388607|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19388608|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19388609|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20413019|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
20413020|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
20413021|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413022|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413023|NCT01204307|Cisplatin|cisplatin|mesh-list
20413024|NCT01204307|Docetaxel|docetaxel|mesh-list
20413025|NCT01204307|Pemetrexed|pemetrexed|mesh-list
20413026|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413027|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388610|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19388611|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
19388612|NCT02224573|Cannabidiol|cannabidiol|mesh-list
19388613|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
19388614|NCT02164643|Flutemetamol|flutemetamol|mesh-list
19388615|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19388616|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388617|NCT02155920|Everolimus|everolimus|mesh-list
19388618|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388619|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388620|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
19388621|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388622|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19388623|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19388624|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388625|NCT02123823|Everolimus|everolimus|mesh-list
19388626|NCT02123823|Exemestane|exemestane|mesh-list
19388627|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388628|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388629|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
19388630|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388631|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19388632|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19388633|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388634|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388635|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19388636|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388637|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388638|NCT01966471|Maytansine|maytansine|mesh-list
19388639|NCT01966471|Docetaxel|docetaxel|mesh-list
19388640|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19388641|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
19388642|NCT01966471|Doxorubicin|doxorubicin|mesh-list
19388643|NCT01966471|Fluorouracil|fluorouracil|mesh-list
19388644|NCT01966471|Trastuzumab|trastuzumab|mesh-list
19388645|NCT01966471|Epirubicin|epirubicin|mesh-list
19388646|NCT01966471|Pertuzumab|pertuzumab|mesh-list
19388647|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19388648|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388649|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388650|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388651|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
19403740|NCT03600155|Nivolumab|nivolumab|mesh-list
20215465|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20215466|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215467|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20215468|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20215469|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20215470|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20215471|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
20215472|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215473|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20215474|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413028|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
19403741|NCT03600155|Ipilimumab|ipilimumab|mesh-list
20413029|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
20413030|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413031|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413032|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20413033|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20413034|NCT01204320|Paclitaxel|paclitaxel|mesh-list
20413035|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20413036|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20413037|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413038|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
20413039|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
20413040|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
20413041|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413042|NCT01204333|Heparin|heparin|mesh-list
20413043|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
20413044|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20413045|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20413046|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413047|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
20413048|NCT01204372|Gemcitabine|gemcitabine|mesh-list
20413049|NCT01204372|Trastuzumab|trastuzumab|mesh-list
20413050|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20413051|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20413052|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
19388652|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388653|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388654|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
19388655|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388656|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388657|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19388658|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
19388659|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19388660|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19388661|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19388662|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413053|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413054|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413055|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
20413056|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413057|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413058|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413059|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
20413060|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413061|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20413062|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20413063|NCT01204411|Artesunate|artesunate|mesh-list
20413064|NCT01204411|Amodiaquine|amodiaquine|mesh-list
20413065|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
19388663|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388664|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
19388665|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19388666|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19388667|NCT01927744|Docetaxel|docetaxel|mesh-list
19388668|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20413066|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20413067|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20413068|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413069|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413070|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
20413071|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
20413072|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20413073|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
20413074|NCT01204437|Paclitaxel|paclitaxel|mesh-list
20413075|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
20413076|NCT01204437|Capecitabine|capecitabine|mesh-list
20413077|NCT01204437|Methotrexate|methotrexate|mesh-list
19388669|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388670|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388671|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388672|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
19388673|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388674|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388675|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388676|NCT01774721|Gefitinib|gefitinib|mesh-list
19388677|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691564|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
20413078|NCT01204437|Epirubicin|epirubicin|mesh-list
20413079|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19388678|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388679|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388680|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388681|NCT01747447|Vitamin D|vitamin d|mesh-list
19388682|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
19388683|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
19388684|NCT01747447|Vitamins|vitamins|mesh-list
19388685|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
20413080|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413081|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
20413082|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388686|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388687|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19388688|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20413083|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
20413084|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413085|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413086|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
20413087|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413088|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413089|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20413090|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
20413091|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20413092|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20413093|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
20413094|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20413095|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
20413096|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20413097|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20413098|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413099|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20413100|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20413101|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20413102|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19388689|NCT01746836|Ponatinib|ponatinib|mesh-list
19388690|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388691|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388692|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388693|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388694|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19388695|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
19388696|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388697|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19388698|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
19388699|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388700|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388701|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19388702|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19388703|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388704|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19388705|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
19388706|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19388707|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19388708|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19388709|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19388710|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
19388711|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19388712|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388713|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19388714|NCT01656434|Estrogens|estrogens|mesh-ancestor
19388715|NCT01656434|Hormones|hormones|mesh-ancestor
19388716|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388717|NCT01656434|Trace Elements|trace elements|mesh-ancestor
19388718|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
19388719|NCT01601522|Ranitidine|ranitidine|mesh-list
20413103|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413104|NCT01204450|Sirolimus|sirolimus|mesh-list
20413105|NCT01204450|Valproic Acid|valproic acid|mesh-list
20413106|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20413107|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413108|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20413109|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388720|NCT01601522|Desloratadine|desloratadine|mesh-list
19388721|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
19388722|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19388723|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19388724|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
19388725|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388726|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388727|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388728|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20413110|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
20413111|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413112|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
20413113|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413114|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
20413115|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413116|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413117|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
20413118|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413119|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
20413120|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20413121|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413122|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20413123|NCT01204476|Everolimus|everolimus|mesh-list
19388729|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
19388730|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19388731|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19388732|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19388733|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19388734|NCT01599494|Progesterone|progesterone|mesh-list
19388735|NCT01599494|Ganirelix|ganirelix|mesh-list
19388736|NCT01599494|Progestins|progestins|mesh-ancestor
19388737|NCT01599494|Hormones|hormones|mesh-ancestor
19388738|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388739|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388740|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19388741|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388742|NCT01518517|Asparaginase|asparaginase|mesh-list
19388743|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388744|NCT01496118|Panobinostat|panobinostat|mesh-list
20413124|NCT01204476|Octreotide|octreotide|mesh-list
20413125|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20413126|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413127|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413128|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
20413129|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413130|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413131|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20413132|NCT01204580|Metformin|metformin|mesh-list
20413133|NCT01204580|Glimepiride|glimepiride|mesh-list
20413134|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413135|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388745|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388746|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19388747|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388748|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388749|NCT01415674|Afatinib|afatinib|mesh-list
19847962|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215475|NCT00302666|Androgens|androgens|mesh-ancestor
20215476|NCT00302666|Hormones|hormones|mesh-ancestor
20215477|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
20215478|NCT00302692|Metoprolol|metoprolol|mesh-list
20215479|NCT00302692|Esmolol|esmolol|mesh-list
20215480|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20215481|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20215482|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
20215483|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
20215484|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215485|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215486|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20215487|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20215488|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20413136|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20413137|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413138|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
20413139|NCT01204593|Insulin|insulin|mesh-list
20413140|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20215489|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
20215490|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413141|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
20215491|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388750|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388751|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388752|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388753|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388754|NCT01371630|Cytarabine|cytarabine|mesh-list
19388755|NCT01371630|Prednisone|prednisone|mesh-list
19388756|NCT01371630|Cortisone|cortisone|mesh-list
19388757|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
19388758|NCT01371630|Rituximab|rituximab|mesh-list
19388759|NCT01371630|Methotrexate|methotrexate|mesh-list
19388760|NCT01371630|Vincristine|vincristine|mesh-list
19388761|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
19388762|NCT01371630|Blinatumomab|blinatumomab|mesh-list
19388763|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19388764|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19388765|NCT01371630|Muromonab-CD3|muromonab-cd3|mesh-list
19388766|NCT01371630|Antibodies|antibodies|mesh-list
19388767|NCT01371630|Immunoglobulins|immunoglobulins|mesh-list
19388768|NCT01371630|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19388769|NCT01371630|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19388770|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388771|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
19388772|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388773|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19388774|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19388775|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
19388776|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388777|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388778|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19388779|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388780|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
19388781|NCT01371630|Hormones|hormones|mesh-ancestor
19388782|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388783|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19388784|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19388785|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
19388786|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19388787|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19388788|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
19388789|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
19388790|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388791|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20215492|NCT00302705|Valsartan|valsartan|mesh-list
20215493|NCT00302705|Enalapril|enalapril|mesh-list
20215494|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20215495|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20215496|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20215497|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215498|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20215499|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
20215500|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215501|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20215502|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
20215503|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20215504|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20215505|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20215506|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20215507|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215508|NCT00302822|Tenofovir|tenofovir|mesh-list
20215509|NCT00302822|Emtricitabine|emtricitabine|mesh-list
20215510|NCT00302822|Efavirenz|efavirenz|mesh-list
20215511|NCT00302822|Lopinavir|lopinavir|mesh-list
20215512|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
20215513|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
20215514|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215515|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20215516|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20215517|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215518|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215519|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19388792|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19388793|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
20215520|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19388794|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388795|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19388796|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388797|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
19388798|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
19388799|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19388800|NCT01358669|Denosumab|denosumab|mesh-list
19388801|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19388802|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388803|NCT01350934|Vitamin D|vitamin d|mesh-list
20413142|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
20413143|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413144|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413145|NCT01204723|Aprepitant|aprepitant|mesh-list
20413146|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
20413147|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
20413148|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
20413149|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413150|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413151|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413152|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20413153|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388804|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
19388805|NCT01350934|Alendronate|alendronate|mesh-list
19388806|NCT01350934|Calcitriol|calcitriol|mesh-list
19388807|NCT01350934|Calcium|calcium|mesh-list
19388808|NCT01350934|Vitamins|vitamins|mesh-ancestor
19388809|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
19388810|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388811|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19388812|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19388813|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19388814|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388815|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388816|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19388817|NCT01304511|Ganirelix|ganirelix|mesh-list
19388818|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388819|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388820|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388821|NCT01286207|Rizatriptan|rizatriptan|mesh-list
19388822|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19388823|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
19388824|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388825|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388826|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388827|NCT01263769|Axitinib|axitinib|mesh-list
19388828|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19388829|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19388830|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388831|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388832|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19388833|NCT01227187|Protein C|protein c|mesh-list
19388834|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19388835|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
19388836|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19388837|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19388838|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388839|NCT01222247|Betamethasone|betamethasone|mesh-list
19388840|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19388841|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
19388842|NCT01222247|Hormones|hormones|mesh-ancestor
19388843|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388844|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388845|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20413154|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413155|NCT01204801|Doxorubicin|doxorubicin|mesh-list
20413156|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20413157|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20413158|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413159|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20413160|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413161|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388846|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388847|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19388848|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
20427585|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413162|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413163|NCT01204840|Hormones|hormones|mesh-list
20413164|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413165|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413166|NCT01204996|Gemcitabine|gemcitabine|mesh-list
20413167|NCT01204996|Paclitaxel|paclitaxel|mesh-list
20413168|NCT01204996|Docetaxel|docetaxel|mesh-list
20413169|NCT01204996|Carboplatin|carboplatin|mesh-list
19388849|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388850|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19388851|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
19388852|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388853|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388854|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19388855|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19388856|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388857|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
19388858|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19388859|NCT01146418|Hormones|hormones|mesh-ancestor
19388860|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413170|NCT01204996|Doxorubicin|doxorubicin|mesh-list
20413171|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20413172|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20413173|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413174|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
19388861|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388862|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19388863|NCT01144416|Hormones|hormones|mesh-ancestor
19388864|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388865|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388866|NCT01077817|Alendronate|alendronate|mesh-list
19388867|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
19388868|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
19388869|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19388870|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
19388871|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19388872|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388873|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19388874|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19388875|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388876|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19388877|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19388878|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388879|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413175|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
20413176|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
20413177|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413178|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20413179|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
20413180|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
20413181|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413182|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413183|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388880|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19388881|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19388882|NCT01065779|Alendronate|alendronate|mesh-list
19388883|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19388884|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388885|NCT01056159|Albuterol|albuterol|mesh-list
19388886|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19388887|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
19388888|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388889|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388890|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388891|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388892|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
19388893|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19388894|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19388895|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20413184|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
20413185|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413186|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19388896|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19388897|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
19388898|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388899|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388900|NCT00988260|Ganirelix|ganirelix|mesh-list
19388901|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388902|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388903|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413187|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20413188|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413189|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19388904|NCT00974571|Cetirizine|cetirizine|mesh-list
19388905|NCT00974571|Montelukast|montelukast|mesh-list
20413190|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20413191|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413192|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
20413193|NCT01205022|Leucovorin|leucovorin|mesh-list
20413194|NCT01205022|Bevacizumab|bevacizumab|mesh-list
20413195|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20413196|NCT01205022|Fluorouracil|fluorouracil|mesh-list
19388906|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388907|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388908|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19388909|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388910|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388911|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413197|NCT01205022|Irinotecan|irinotecan|mesh-list
20413198|NCT01205022|Camptothecin|camptothecin|mesh-list
20413199|NCT01205022|Antibodies|antibodies|mesh-list
20413200|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
20413201|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20413202|NCT01205022|Calcium|calcium|mesh-list
20413203|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
20413204|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413205|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20413206|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20413207|NCT01205022|Growth Substances|growth substances|mesh-ancestor
20413208|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388912|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19388913|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19388914|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388915|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19388916|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19388917|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19388918|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
20215521|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20215522|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20215523|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20215524|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20215525|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20215526|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20215527|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20413209|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
20413210|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
20613196|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19388919|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
20215528|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20215529|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
20215530|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20215531|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20215532|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20215533|NCT00302835|Analgesics|analgesics|mesh-list
20215534|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
20215535|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215536|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215537|NCT00302913|Clopidogrel|clopidogrel|mesh-list
19388920|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388921|NCT00972738|Loratadine|loratadine|mesh-list
19388922|NCT00972738|Montelukast|montelukast|mesh-list
19388923|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388924|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388925|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20413211|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20413212|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20413213|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
20413214|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413215|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20413216|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413217|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19388926|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388927|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388928|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388929|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19388930|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19388931|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388932|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
20413218|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413219|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413220|NCT01205022|Antidotes|antidotes|mesh-ancestor
20413221|NCT01205022|Protective Agents|protective agents|mesh-ancestor
20413222|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
19388933|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
19388934|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19388935|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19388936|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20413223|NCT01205022|Vitamins|vitamins|mesh-ancestor
20413224|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
20413225|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20413226|NCT01205074|Ethanol|ethanol|mesh-list
20413227|NCT01205074|Propranolol|propranolol|mesh-list
20413228|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20413229|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20413230|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
20413231|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413232|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388937|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
19388938|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
19388939|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388940|NCT00968201|Montelukast|montelukast|mesh-list
19388941|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388942|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388943|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19388944|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388945|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388946|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388947|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19388948|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19388949|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215538|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20215539|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20215540|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19388950|NCT00968149|Montelukast|montelukast|mesh-list
19388951|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388952|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388953|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20215541|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20215542|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
20413233|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413234|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20413235|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20413236|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
20413237|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20413238|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413239|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413240|NCT01205087|Omeprazole|omeprazole|mesh-list
20413241|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20413242|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413243|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20413244|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413245|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215543|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215544|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215545|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215546|NCT00303004|Bosentan|bosentan|mesh-list
20215547|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
20215548|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
19388954|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388955|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388956|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388957|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19388958|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19388959|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403742|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403743|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403744|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19403745|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403746|NCT03600129|Ropivacaine|ropivacaine|mesh-list
20413246|NCT01205139|Simeprevir|simeprevir|mesh-list
20413247|NCT01205139|Rilpivirine|rilpivirine|mesh-list
20413248|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
20413249|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413250|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
20413251|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413252|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413253|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20413254|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20413255|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20413256|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20413257|NCT01205178|Chloroquine|chloroquine|mesh-list
20413258|NCT01205178|Primaquine|primaquine|mesh-list
20413259|NCT01205178|Tafenoquine|tafenoquine|mesh-list
20413260|NCT01205178|Amebicides|amebicides|mesh-ancestor
20413261|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20413262|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20413263|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413264|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
20413265|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413266|NCT01205204|Clonidine|clonidine|mesh-list
20413267|NCT01205204|Fentanyl|fentanyl|mesh-list
20413268|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20413269|NCT01205204|Narcotics|narcotics|mesh-ancestor
19403747|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
19403748|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
19403749|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403750|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403751|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
20215549|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20215550|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20215551|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215552|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215553|NCT00303004|Urological Agents|urological agents|mesh-ancestor
20215554|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20215555|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20215556|NCT00303017|Naproxen|naproxen|mesh-list
20215557|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20215558|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20215559|NCT00303017|Analgesics|analgesics|mesh-ancestor
20215560|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
20215561|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215562|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215563|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20215564|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215565|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
20215566|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20413270|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413271|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413272|NCT01205204|Analgesics|analgesics|mesh-ancestor
20413273|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
20413274|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413275|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20413276|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20215567|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218042|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
20413277|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
20413278|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
20413279|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20413280|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
20413281|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
20413282|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20413283|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20413284|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19388960|NCT00963469|Loratadine|loratadine|mesh-list
19388961|NCT00963469|Montelukast|montelukast|mesh-list
19388962|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388963|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388964|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19388965|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
20413285|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
20413286|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413287|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413288|NCT01205217|Paclitaxel|paclitaxel|mesh-list
20413289|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
20413290|NCT01205217|Trastuzumab|trastuzumab|mesh-list
20413291|NCT01205217|Epirubicin|epirubicin|mesh-list
20413292|NCT01205217|Lapatinib|lapatinib|mesh-list
20413293|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20413294|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413295|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20413296|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20413297|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20413298|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413299|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19388966|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388967|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388968|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19388969|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19388970|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19388971|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
19388972|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
20413300|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
20413301|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413302|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413303|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20413304|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
20413305|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19388973|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19388974|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19388975|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19388976|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
19388977|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
19388978|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388979|NCT00960141|Loratadine|loratadine|mesh-list
19388980|NCT00960141|Montelukast|montelukast|mesh-list
20215568|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215569|NCT00303056|Icatibant|icatibant|mesh-list
20215570|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20215571|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20215572|NCT00303056|Analgesics|analgesics|mesh-ancestor
20215573|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
20215574|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413306|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20413307|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20413308|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20413309|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413310|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413311|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20413312|NCT01205243|Abacavir|abacavir|mesh-list
20413313|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20413314|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20215575|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215576|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413315|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19388981|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19388982|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
19388983|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19388984|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
19388985|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19388986|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19388987|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19388988|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19388989|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413316|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413317|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
19388990|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
19388991|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
19388992|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19388993|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19388994|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19388995|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
19388996|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
19388997|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19388998|NCT00943683|Montelukast|montelukast|mesh-list
19388999|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389000|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389001|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389002|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389003|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389004|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389005|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19847963|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847964|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19847965|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19847966|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389006|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389007|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389008|NCT00943397|Montelukast|montelukast|mesh-list
19389009|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389010|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389011|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389012|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389013|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389014|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389015|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389016|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389017|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413318|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413319|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20413320|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20413321|NCT01205256|Methadone|methadone|mesh-list
20413322|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20413323|NCT01205256|Narcotics|narcotics|mesh-ancestor
20413324|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413325|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413326|NCT01205256|Analgesics|analgesics|mesh-ancestor
19389018|NCT00911547|Beclomethasone|beclomethasone|mesh-list
19389019|NCT00911547|Montelukast|montelukast|mesh-list
19389020|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389021|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389022|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389023|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389024|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389025|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389026|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389027|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389028|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389029|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19389030|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
19389031|NCT00911547|Hormones|hormones|mesh-ancestor
19389032|NCT00899379|Rizatriptan|rizatriptan|mesh-list
19389033|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389034|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
19389035|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389036|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389037|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413327|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
20413328|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413329|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
20413330|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389038|NCT00898677|Sumatriptan|sumatriptan|mesh-list
19389039|NCT00898677|Rizatriptan|rizatriptan|mesh-list
19389040|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20413331|NCT01205282|Pioglitazone|pioglitazone|mesh-list
20413332|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413333|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413334|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
20413335|NCT01205321|Bombesin|bombesin|mesh-list
20413336|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413337|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413338|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413339|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413340|NCT01205347|Simvastatin|simvastatin|mesh-list
20413341|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19847967|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19847968|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19847969|NCT00689611|Bupropion|bupropion|mesh-list
20215577|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19389041|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19389042|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389043|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
20413342|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20413343|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
20413344|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413345|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20413346|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20413347|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413348|NCT01205360|Fentanyl|fentanyl|mesh-list
20413349|NCT01205360|Bupivacaine|bupivacaine|mesh-list
20413350|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
20413351|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
20413352|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413353|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413354|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
20413355|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413356|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20413357|NCT01205360|Narcotics|narcotics|mesh-ancestor
20413358|NCT01205360|Analgesics|analgesics|mesh-ancestor
20413359|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19389044|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389045|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389046|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389047|NCT00897949|Rizatriptan|rizatriptan|mesh-list
19389048|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389049|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
19389050|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389051|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389052|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389053|NCT00897104|Sumatriptan|sumatriptan|mesh-list
19389054|NCT00897104|Rizatriptan|rizatriptan|mesh-list
19389055|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19389056|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19389057|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20413360|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20413361|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
20413362|NCT01205464|Doxycycline|doxycycline|mesh-list
20413363|NCT01205464|Tetracycline|tetracycline|mesh-list
20413364|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19389058|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
19389059|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389060|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389061|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389062|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
19389063|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19389064|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
19847970|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20215578|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20215579|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20215580|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215581|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20215582|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215583|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
20215584|NCT00303160|Ascorbic Acid|ascorbic acid|mesh-list
20215585|NCT00303160|Vitamins|vitamins|mesh-ancestor
20215586|NCT00303160|Micronutrients|micronutrients|mesh-ancestor
20215587|NCT00303160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215588|NCT00303160|Antioxidants|antioxidants|mesh-ancestor
20215589|NCT00303160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215590|NCT00303160|Protective Agents|protective agents|mesh-ancestor
20215591|NCT00303264|Esomeprazole|esomeprazole|mesh-list
19847971|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
20413365|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413366|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
20413367|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20413368|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20413369|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20413370|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413371|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413372|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20413373|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19389065|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19389066|NCT00803790|Vitamin D|vitamin d|mesh-list
19389067|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
19389068|NCT00803790|Alendronate|alendronate|mesh-list
19389069|NCT00803790|Vitamins|vitamins|mesh-list
19389070|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
19389071|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389072|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389073|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389074|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19389075|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19389076|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389077|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389078|NCT00773357|Carvedilol|carvedilol|mesh-list
19389079|NCT00773357|Guanfacine|guanfacine|mesh-list
19389080|NCT00773357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19389081|NCT00773357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19389082|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
19389083|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389084|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389085|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413374|NCT01205516|Morphine|morphine|mesh-list
20413375|NCT01205516|Methadone|methadone|mesh-list
20413376|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20413377|NCT01205516|Narcotics|narcotics|mesh-ancestor
19389086|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19389087|NCT00773357|Antioxidants|antioxidants|mesh-ancestor
19389088|NCT00773357|Protective Agents|protective agents|mesh-ancestor
19389089|NCT00773357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19389090|NCT00773357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19389091|NCT00773357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389092|NCT00773357|Vasodilator Agents|vasodilator agents|mesh-ancestor
19389093|NCT00773357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19389094|NCT00773357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19389095|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19389096|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19389097|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19389098|NCT00745108|Tibolone|tibolone|mesh-list
19389099|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389100|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19389101|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389102|NCT00745108|Hormones|hormones|mesh-ancestor
19389103|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389104|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
19389105|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389106|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19389107|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20413378|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413379|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413380|NCT01205516|Analgesics|analgesics|mesh-ancestor
20413381|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
20413382|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413383|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
20413384|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
20427586|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427587|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427588|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427589|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20427590|NCT01287806|Urinastatin|urinastatin|mesh-list
19389108|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
19389109|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19389110|NCT00725491|Ganirelix|ganirelix|mesh-list
19389111|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
19389112|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19389113|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
19389114|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20427591|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19389115|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389116|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19389117|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19389118|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389119|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389120|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389121|NCT00725374|Tibolone|tibolone|mesh-list
19389122|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
19389123|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389124|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389125|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389126|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19389127|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19389128|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389129|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19389130|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
19389131|NCT00725374|Hormones|hormones|mesh-ancestor
19389132|NCT00724789|Ganirelix|ganirelix|mesh-list
19389133|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389134|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389135|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389136|NCT00711607|Estradiol|estradiol|mesh-list
19389137|NCT00711607|Estrogens|estrogens|mesh-ancestor
19389138|NCT00711607|Hormones|hormones|mesh-ancestor
19389139|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389140|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389141|NCT00703014|Progesterone|progesterone|mesh-list
19389142|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389143|NCT00703014|Ganirelix|ganirelix|mesh-list
19389144|NCT00703014|Progestins|progestins|mesh-ancestor
19389145|NCT00703014|Hormones|hormones|mesh-ancestor
19389146|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389147|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389148|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389149|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389150|NCT00702988|Hormones|hormones|mesh-ancestor
19389151|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389152|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389153|NCT00702845|Hormones|hormones|mesh-list
19389154|NCT00702845|Progesterone|progesterone|mesh-list
19389155|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389156|NCT00702845|Ganirelix|ganirelix|mesh-list
19389157|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413385|NCT01205672|Metformin|metformin|mesh-list
20413386|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413387|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413388|NCT01205711|Leucovorin|leucovorin|mesh-list
20413389|NCT01205711|Fluorouracil|fluorouracil|mesh-list
20413390|NCT01205711|Irinotecan|irinotecan|mesh-list
20413391|NCT01205711|Calcium|calcium|mesh-list
20413392|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
20413393|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20413394|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413395|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
19389158|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389159|NCT00702845|Progestins|progestins|mesh-ancestor
19389160|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389161|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19389162|NCT00702806|Ganirelix|ganirelix|mesh-list
19389163|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389164|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389165|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389166|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19389167|NCT00702624|Hormones|hormones|mesh-list
19389168|NCT00702624|Progesterone|progesterone|mesh-list
19389169|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389170|NCT00702624|Ganirelix|ganirelix|mesh-list
19389171|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389172|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389173|NCT00702624|Progestins|progestins|mesh-ancestor
20413396|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389174|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389175|NCT00702546|Hormones|hormones|mesh-list
20413397|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20413398|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413399|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413400|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
20413401|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20413402|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413403|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413404|NCT01205711|Antidotes|antidotes|mesh-ancestor
20413405|NCT01205711|Protective Agents|protective agents|mesh-ancestor
19389176|NCT00702546|Progesterone|progesterone|mesh-list
19389177|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389178|NCT00702546|Ganirelix|ganirelix|mesh-list
19389179|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389180|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389181|NCT00702546|Progestins|progestins|mesh-ancestor
19389182|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389183|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19389184|NCT00702520|Hormones|hormones|mesh-list
19389185|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20215592|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20215593|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20215594|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19389186|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389187|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389188|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
19389189|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19389190|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
19389191|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19389192|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19389193|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19389194|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389195|NCT00702338|Hormones|hormones|mesh-list
19389196|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389197|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389198|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389199|NCT00702273|Progesterone|progesterone|mesh-list
19389200|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389201|NCT00702273|Ganirelix|ganirelix|mesh-list
19389202|NCT00702273|Progestins|progestins|mesh-ancestor
19389203|NCT00702273|Hormones|hormones|mesh-ancestor
19389204|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389205|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389206|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389207|NCT00702234|Progesterone|progesterone|mesh-list
19389208|NCT00702234|Progestins|progestins|mesh-ancestor
19389209|NCT00702234|Hormones|hormones|mesh-ancestor
19389210|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389211|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389212|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389213|NCT00702195|Hormones|hormones|mesh-ancestor
19389214|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389215|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389216|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19389217|NCT00697255|Hormones|hormones|mesh-list
19389218|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389219|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389220|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389221|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20413406|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
20413407|NCT01205711|Vitamins|vitamins|mesh-ancestor
20413408|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
20413409|NCT01205724|Factor VIII|factor viii|mesh-list
20413410|NCT01205724|Coagulants|coagulants|mesh-ancestor
20413411|NCT01205737|Rituximab|rituximab|mesh-list
19847972|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20215595|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215596|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215597|NCT00303277|Simvastatin|simvastatin|mesh-list
20215598|NCT00303277|Pravastatin|pravastatin|mesh-list
20215599|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20215600|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20215601|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
20215602|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413412|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20613197|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19389222|NCT00696878|Progesterone|progesterone|mesh-list
19389223|NCT00696878|Progestins|progestins|mesh-ancestor
19389224|NCT00696878|Hormones|hormones|mesh-ancestor
19389225|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389226|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389227|NCT00696800|Progesterone|progesterone|mesh-list
19389228|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389229|NCT00696800|Ganirelix|ganirelix|mesh-list
19389230|NCT00696800|Progestins|progestins|mesh-ancestor
19389231|NCT00696800|Hormones|hormones|mesh-ancestor
19389232|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389233|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389234|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389235|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19389236|NCT00647933|Lynestrenol|lynestrenol|mesh-list
19389237|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19389238|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19389239|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19389240|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
19389241|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19389242|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389243|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19389244|NCT00647933|Estrogens|estrogens|mesh-ancestor
19389245|NCT00647933|Hormones|hormones|mesh-ancestor
19389246|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389247|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19389248|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
19389249|NCT00641771|Alendronate|alendronate|mesh-list
19389250|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389251|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389252|NCT00641771|Vitamins|vitamins|mesh-ancestor
19389253|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
19389254|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20413413|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413414|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
20413415|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413416|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413417|NCT01205750|Insulin|insulin|mesh-list
20413418|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20413419|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413420|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413421|NCT01205880|Calcitriol|calcitriol|mesh-list
20413422|NCT01205880|Clobetasol|clobetasol|mesh-list
20413423|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20413424|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413425|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20413426|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20413427|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413428|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20413429|NCT01205880|Vitamins|vitamins|mesh-ancestor
19389255|NCT00616967|Paclitaxel|paclitaxel|mesh-list
19389256|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19389257|NCT00616967|Carboplatin|carboplatin|mesh-list
19389258|NCT00616967|Vorinostat|vorinostat|mesh-list
19389259|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19389260|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389261|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
19389262|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
19389263|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
19389264|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389265|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19389266|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389267|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19389268|NCT00598208|Hormones|hormones|mesh-ancestor
19389269|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389270|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413430|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
20413431|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20413432|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413433|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
20413434|NCT01205880|Hormones|hormones|mesh-ancestor
20413435|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413436|NCT01205932|Enoxaparin|enoxaparin|mesh-list
19389271|NCT00519857|Tibolone|tibolone|mesh-list
19389272|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
20413437|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
20413438|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20413439|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
20413440|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20413441|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
19389273|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389274|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389275|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389276|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19389277|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19389278|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389279|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19389280|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
19389281|NCT00519857|Hormones|hormones|mesh-ancestor
19389282|NCT00480662|Alendronate|alendronate|mesh-list
19389283|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389284|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389285|NCT00461032|Montelukast|montelukast|mesh-list
19389286|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389287|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389288|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389289|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389290|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389291|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389292|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389293|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389294|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389295|NCT00446056|Ketotifen|ketotifen|mesh-list
19389296|NCT00446056|Montelukast|montelukast|mesh-list
19389297|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389298|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389299|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389300|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389301|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389302|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389303|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389304|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389305|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389306|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389307|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
19389308|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
19389309|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19389310|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
19389311|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
19389312|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19389313|NCT00442338|Aminophylline|aminophylline|mesh-list
19389314|NCT00442338|Theophylline|theophylline|mesh-list
19389315|NCT00442338|Montelukast|montelukast|mesh-list
19389316|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389317|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389318|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389319|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389320|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389321|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389322|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389323|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389324|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389325|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19389326|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
19389327|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389328|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19389329|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19389330|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389331|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20215603|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20215604|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20215605|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215606|NCT00303290|Interferons|interferons|mesh-list
20215607|NCT00303290|Cytarabine|cytarabine|mesh-list
20215608|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
20215609|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
20215610|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20215611|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389332|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19389333|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
19389334|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389335|NCT00442338|Protective Agents|protective agents|mesh-ancestor
19389336|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
19389337|NCT00431093|Tibolone|tibolone|mesh-list
20413442|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413443|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413444|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
20413445|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20413446|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20413447|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
20413448|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20413449|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20413450|NCT01205958|Analgesics|analgesics|mesh-ancestor
20413451|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
19389338|NCT00431093|Estradiol|estradiol|mesh-list
19389339|NCT00431093|Estrogens|estrogens|mesh-ancestor
19389340|NCT00431093|Hormones|hormones|mesh-ancestor
19389341|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389342|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389343|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
19389344|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389345|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19389346|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19389347|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389348|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19389349|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
19389350|NCT00398931|Alendronate|alendronate|mesh-list
19389351|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389352|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389353|NCT00398606|Alendronate|alendronate|mesh-list
19389354|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
19389355|NCT00398606|Calcium|calcium|mesh-list
19389356|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389357|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389358|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389359|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389360|NCT00398606|Antacids|antacids|mesh-ancestor
19389361|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19389362|NCT00395408|Beclomethasone|beclomethasone|mesh-list
19389363|NCT00395408|Montelukast|montelukast|mesh-list
19389364|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389365|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389366|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389367|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389368|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389369|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389370|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389371|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389372|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389373|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19389374|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
19389375|NCT00395408|Hormones|hormones|mesh-ancestor
19389376|NCT00394069|Montelukast|montelukast|mesh-list
19389377|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389378|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389379|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389380|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389381|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389382|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215612|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
20215613|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215614|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215615|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
20215616|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215617|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215618|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
20215619|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215620|NCT00303381|Interferons|interferons|mesh-list
20215621|NCT00303381|Interferon-beta|interferon-beta|mesh-list
20413452|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389383|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20215622|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
19389384|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389385|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389386|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19389387|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389388|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19389389|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389390|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389391|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19389392|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19389393|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389394|NCT00289874|Montelukast|montelukast|mesh-list
19389395|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389396|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389397|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389398|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389399|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389400|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389401|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389402|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20413453|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413454|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413455|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413456|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
20413457|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20413458|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
20413459|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19389403|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389404|NCT00250458|Rizatriptan|rizatriptan|mesh-list
19389405|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389406|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
19389407|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389408|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389409|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389410|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19389411|NCT00245570|Montelukast|montelukast|mesh-list
19389412|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19389413|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
19389414|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389415|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389416|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389417|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389418|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19389419|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19389420|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19389421|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
19389422|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389423|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389424|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389425|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389426|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389427|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389428|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389429|NCT00229970|Montelukast|montelukast|mesh-list
19389430|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389431|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389432|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389433|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389434|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389435|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389436|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389437|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389438|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389439|NCT00140946|Montelukast|montelukast|mesh-list
19389440|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389441|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389442|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389443|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389444|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389445|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389446|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389447|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20413460|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20413461|NCT01205984|Prednisolone|prednisolone|mesh-list
20413462|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
20413463|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20413464|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
20413465|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413466|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
20413467|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
20413468|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413469|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413470|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413471|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
20413472|NCT01205984|Hormones|hormones|mesh-ancestor
20413473|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413474|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20413475|NCT01205984|Protective Agents|protective agents|mesh-ancestor
20413476|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20413477|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413478|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20413479|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413480|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20413481|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413482|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413483|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
20413484|NCT01205997|Fentanyl|fentanyl|mesh-list
20413485|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20413486|NCT01205997|Narcotics|narcotics|mesh-ancestor
20413487|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413488|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413489|NCT01205997|Analgesics|analgesics|mesh-ancestor
20413490|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
20413491|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413492|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20413493|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20413494|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
20413495|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
20413496|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20413497|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
20413498|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20413499|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20413500|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413501|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20413502|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
20413503|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20413504|NCT01206010|Varenicline|varenicline|mesh-list
20413505|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19389448|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389449|NCT00140881|Montelukast|montelukast|mesh-list
19389450|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389451|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389452|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389453|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389454|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389455|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389456|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389457|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389458|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389459|NCT00111722|Rizatriptan|rizatriptan|mesh-list
19389460|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389461|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389462|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389463|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389464|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
19389465|NCT00111709|Rizatriptan|rizatriptan|mesh-list
20413506|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20413507|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
20413508|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413509|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413510|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413511|NCT01206036|Sirolimus|sirolimus|mesh-list
19389466|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389467|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389468|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389469|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389470|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
19389471|NCT00095004|Rizatriptan|rizatriptan|mesh-list
19389472|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413512|NCT01206036|Docetaxel|docetaxel|mesh-list
20413513|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413514|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
20413515|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
20413516|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
19389473|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389474|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389475|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389476|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
19389477|NCT00092963|Rizatriptan|rizatriptan|mesh-list
19389478|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389479|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389480|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389481|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19389482|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
19389483|NCT00092885|Montelukast|montelukast|mesh-list
19389484|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389485|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389486|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389487|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389488|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389489|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389490|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389491|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389492|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389493|NCT00092131|Montelukast|montelukast|mesh-list
19389494|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389495|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389496|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389497|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389498|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389499|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389500|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389501|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389502|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389503|NCT00092118|Montelukast|montelukast|mesh-list
19389504|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389505|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389506|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389507|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389508|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389509|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389510|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389511|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389512|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389513|NCT00092105|Montelukast|montelukast|mesh-list
19389514|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389515|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389516|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389517|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389518|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389519|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389520|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389521|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389522|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389523|NCT00092092|Budesonide|budesonide|mesh-list
19389524|NCT00092092|Montelukast|montelukast|mesh-list
19389525|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19389526|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19389527|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
19847973|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19847974|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19389528|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389529|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389530|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389531|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389532|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
19389533|NCT00092092|Hormones|hormones|mesh-ancestor
19389534|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389535|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389536|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389537|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389538|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389539|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389540|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
19389541|NCT00092066|Alendronate|alendronate|mesh-list
19389542|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389543|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389544|NCT00092066|Vitamins|vitamins|mesh-ancestor
19389545|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
19389546|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389547|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
19389548|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389549|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389550|NCT00092040|Alendronate|alendronate|mesh-list
19389551|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
19389552|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389553|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389554|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389555|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19389556|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19389557|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389558|NCT00092027|Alendronate|alendronate|mesh-list
19389559|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427592|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19389560|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389561|NCT00092014|Vitamin D|vitamin d|mesh-list
19389562|NCT00092014|Alendronate|alendronate|mesh-list
19389563|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
19389564|NCT00092014|Calcium|calcium|mesh-list
19389565|NCT00092014|Vitamins|vitamins|mesh-ancestor
19389566|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
19389567|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389568|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389569|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389570|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19389571|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19389572|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389573|NCT00090142|Montelukast|montelukast|mesh-list
19389574|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389575|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389576|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389577|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389578|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389579|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389580|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389581|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389582|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389583|NCT00076973|Montelukast|montelukast|mesh-list
19389584|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389585|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
20215623|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215624|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
20215625|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215626|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
20215627|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215628|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20215629|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20215630|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215631|NCT00303407|Nadroparin|nadroparin|mesh-list
20215632|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
20215633|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20215634|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20215635|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413517|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413518|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20413519|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413520|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20413521|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
20413522|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413523|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
20413524|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389586|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19389587|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
19389588|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389589|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389590|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19389591|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19389592|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389593|NCT00043108|Paclitaxel|paclitaxel|mesh-list
19389594|NCT00043108|Carboplatin|carboplatin|mesh-list
19389595|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19389596|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389597|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
19389598|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
19389599|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
19389600|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389601|NCT05225597|Carbachol|carbachol|mesh-list
19389602|NCT05225597|Epinephrine|epinephrine|mesh-list
19389603|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19389604|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19389605|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
20413525|NCT01206049|Gemcitabine|gemcitabine|mesh-list
20413526|NCT01206049|Bevacizumab|bevacizumab|mesh-list
20413527|NCT01206049|Panitumumab|panitumumab|mesh-list
20413528|NCT01206049|Capecitabine|capecitabine|mesh-list
20413529|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
19389606|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389607|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389608|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389609|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19389610|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19389611|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
19389612|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389613|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389614|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389615|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
19389616|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
19389617|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19389618|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19389619|NCT05225597|Miotics|miotics|mesh-ancestor
19389620|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19389621|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
19389622|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19389623|NCT05225597|Analgesics|analgesics|mesh-ancestor
19389624|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
19389625|NCT05225597|Protective Agents|protective agents|mesh-ancestor
19403752|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403753|NCT03600064|Misoprostol|misoprostol|mesh-list
19403754|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19403755|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
19403756|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19403757|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403758|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19403759|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403760|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
19403761|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
19403762|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19403763|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19403764|NCT03599778|Apatinib|apatinib|mesh-list
19403765|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403766|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403767|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403768|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403769|NCT03599726|Donepezil|donepezil|mesh-list
19403770|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19403771|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403772|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403773|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
20427593|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
20413530|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20413531|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413532|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20413533|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20413534|NCT01206049|Growth Substances|growth substances|mesh-ancestor
20413535|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413536|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
20413537|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19389626|NCT05225155|Enoxaparin|enoxaparin|mesh-list
19389627|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
19389628|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19389629|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20413538|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
20413539|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413540|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
20413541|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413542|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413543|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413544|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
20413545|NCT01206075|Plerixafor|plerixafor|mesh-list
20413546|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20413547|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20413548|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
20413549|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413550|NCT01206153|Metformin|metformin|mesh-list
20413551|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413552|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413553|NCT01206205|Lenalidomide|lenalidomide|mesh-list
20413554|NCT01206205|Bortezomib|bortezomib|mesh-list
20413555|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
20413556|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413557|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20413558|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20413559|NCT01206205|Growth Substances|growth substances|mesh-ancestor
19389630|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389631|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
19389632|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19389633|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389634|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413560|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
20413561|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413562|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
20413563|NCT01206270|Castor Oil|castor oil|mesh-list
20413564|NCT01206270|Testosterone|testosterone|mesh-list
20413565|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
20413566|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
20413567|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20413568|NCT01206270|Androgens|androgens|mesh-ancestor
20413569|NCT01206270|Hormones|hormones|mesh-ancestor
20413570|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389635|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389636|NCT05224999|Nivolumab|nivolumab|mesh-list
19389637|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19389638|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389639|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19389640|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389641|NCT05224687|Daptomycin|daptomycin|mesh-list
19389642|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19389643|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389644|NCT05224388|Heparin|heparin|mesh-list
19389645|NCT05224388|Enoxaparin|enoxaparin|mesh-list
19389646|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
19389647|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19389648|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19389649|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389650|NCT05224336|Niacin|niacin|mesh-list
19389651|NCT05224336|Psilocybin|psilocybin|mesh-list
19389652|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19389653|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
19389654|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389655|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20413571|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413572|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20413573|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389656|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
20413574|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
20413575|NCT01206270|Cathartics|cathartics|mesh-ancestor
20413576|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413577|NCT01206348|Minocycline|minocycline|mesh-list
20413578|NCT01206348|Clindamycin|clindamycin|mesh-list
20413579|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
20413580|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
20413581|NCT01206348|Tretinoin|tretinoin|mesh-list
20413582|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20413583|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20413584|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413585|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20413586|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413587|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413588|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
20413589|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413590|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
20413591|NCT01206530|Leucovorin|leucovorin|mesh-list
20413592|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
20413593|NCT01206530|Bevacizumab|bevacizumab|mesh-list
20413594|NCT01206530|Fluorouracil|fluorouracil|mesh-list
20413595|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
19389657|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
19389658|NCT05224336|Vitamins|vitamins|mesh-ancestor
19389659|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
19389660|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389661|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
19389662|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19389663|NCT05224167|Melatonin|melatonin|mesh-list
19389664|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
19389665|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
19389666|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389667|NCT05224167|Protective Agents|protective agents|mesh-ancestor
19389668|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389669|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389670|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
19389671|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
19389672|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19389673|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
19389674|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
19389675|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389676|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
19389677|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389678|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19389679|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389680|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215636|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20215637|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20215638|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20215639|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215640|NCT00303433|Memantine|memantine|mesh-list
20215641|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20215642|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20215643|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
20413596|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20413597|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389681|NCT05224089|Dexamethasone|dexamethasone|mesh-list
19389682|NCT05224089|Epinephrine|epinephrine|mesh-list
19389683|NCT05224089|Bupivacaine|bupivacaine|mesh-list
19389684|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19389685|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
19389686|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
19389687|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389688|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389689|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19389690|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
20413598|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20413599|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20413600|NCT01206530|Growth Substances|growth substances|mesh-ancestor
20413601|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413602|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
19389691|NCT05224089|Hormones|hormones|mesh-ancestor
19389692|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389693|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19389694|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215644|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215645|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215646|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215647|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20413603|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
20413604|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413605|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20413606|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413607|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
20413608|NCT01206530|Antidotes|antidotes|mesh-ancestor
20413609|NCT01206530|Protective Agents|protective agents|mesh-ancestor
20413610|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
20413611|NCT01206530|Vitamins|vitamins|mesh-ancestor
20413612|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
20413613|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
20413614|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20413615|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20413616|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413617|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413618|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413619|NCT01206569|Tacrolimus|tacrolimus|mesh-list
20413620|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413621|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
19389695|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389696|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
19389697|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
19389698|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389699|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
19389700|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19389701|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19389702|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
19389703|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389704|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19389705|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19389706|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389707|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
19389708|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
19389709|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
19389710|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19389711|NCT05223907|Propofol|propofol|mesh-list
19389712|NCT05223907|Etomidate|etomidate|mesh-list
19389713|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19389714|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389715|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389716|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19389717|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
19389718|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
19847975|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19847976|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847977|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
19847978|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19847979|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847980|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20413622|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389726|NCT05223647|Carboplatin|carboplatin|mesh-list
19389727|NCT05223647|Etoposide|etoposide|mesh-list
19389728|NCT05223647|Durvalumab|durvalumab|mesh-list
19389729|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389730|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19389731|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19389732|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19389733|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389734|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389735|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19389736|NCT05223400|Clindamycin|clindamycin|mesh-list
19389737|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
19389738|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
19389739|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19389740|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389741|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19389742|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389743|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389744|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19389745|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19389746|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
19389747|NCT05202002|Hormones|hormones|mesh-ancestor
19389748|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413623|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20413624|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427594|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413625|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413626|NCT01206647|Metformin|metformin|mesh-list
20413627|NCT01206647|Saxagliptin|saxagliptin|mesh-list
20413628|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413629|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413630|NCT01206647|Incretins|incretins|mesh-ancestor
20413631|NCT01206647|Hormones|hormones|mesh-ancestor
20413632|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413633|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20413634|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
20413635|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413636|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413637|NCT01206803|Ganirelix|ganirelix|mesh-list
20413638|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
20413639|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413640|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413641|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
20413642|NCT01206881|Docetaxel|docetaxel|mesh-list
20413643|NCT01206881|Doxorubicin|doxorubicin|mesh-list
19389749|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389750|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389751|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389752|NCT05194124|alpha-MSH|alpha-msh|mesh-list
19389753|NCT05194124|Hormones|hormones|mesh-ancestor
20413644|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20413645|NCT01206881|Trastuzumab|trastuzumab|mesh-list
20413646|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413647|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
20413648|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413649|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413650|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19389754|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389755|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389756|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
19389757|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19389758|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403774|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403775|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403776|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
19403777|NCT03599609|Simvastatin|simvastatin|mesh-list
19403778|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19403779|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19403780|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
19403781|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403782|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19403783|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19403784|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403785|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
19403786|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
19403787|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19403788|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
19403789|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19403790|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19403791|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403792|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19403793|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403794|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403795|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19403796|NCT03599596|Renal Agents|renal agents|mesh-ancestor
19403797|NCT03599518|Gefitinib|gefitinib|mesh-list
19403798|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403799|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403800|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403801|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403802|NCT03599466|Lisinopril|lisinopril|mesh-list
19403803|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19403804|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
19403805|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403806|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403807|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19403808|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19403809|NCT03599466|Protective Agents|protective agents|mesh-ancestor
19848277|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413651|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
20413652|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413653|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413654|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20413655|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
20413656|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
20413657|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
20413658|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20413659|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20413660|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413661|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413662|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19389759|NCT05169866|Amiodarone|amiodarone|mesh-list
19389760|NCT05169866|Nifekalant|nifekalant|mesh-list
19389761|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19389762|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
19389763|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19389764|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19389765|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389766|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19389767|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19389768|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19389769|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413663|NCT01206907|Oxymorphone|oxymorphone|mesh-list
20413664|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20413665|NCT01206907|Narcotics|narcotics|mesh-ancestor
19389770|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19389771|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19389772|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19389773|NCT05153395|Insulin|insulin|mesh-list
19389774|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19389775|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19389776|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413666|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413667|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413668|NCT01206907|Analgesics|analgesics|mesh-ancestor
20413669|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
20413670|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413671|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20413672|NCT01206946|Betamethasone|betamethasone|mesh-list
20413673|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413674|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
20413675|NCT01206946|Hormones|hormones|mesh-ancestor
20413676|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389777|NCT05137600|Clarithromycin|clarithromycin|mesh-list
19389778|NCT05137600|Midazolam|midazolam|mesh-list
19389779|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19389780|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19389781|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20215648|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20215649|NCT00303524|Goserelin|goserelin|mesh-list
20215650|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20215651|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215652|NCT00303537|Metformin|metformin|mesh-list
20215653|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20215654|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215655|NCT00303550|Linezolid|linezolid|mesh-list
20215656|NCT00303550|Iclaprim|iclaprim|mesh-list
20215657|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215658|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389782|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389783|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19389784|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19389785|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19389786|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19389787|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
19389788|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
19389789|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
19389790|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
19389791|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389792|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389793|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19389794|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389795|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20215659|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20413677|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389796|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389797|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19389798|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19389799|NCT05137548|Tenofovir|tenofovir|mesh-list
19389800|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
19389801|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389802|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19389803|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19389804|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389805|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389806|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19389807|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19389808|NCT05091294|Anesthetics|anesthetics|mesh-list
19389809|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
19389810|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389811|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389812|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
19389813|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389814|NCT05082285|Vaccines|vaccines|mesh-list
19389815|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
19389816|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389817|NCT05072704|Sufentanil|sufentanil|mesh-list
19389818|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
19389819|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19389820|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389821|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389822|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19389823|NCT05072704|Analgesics|analgesics|mesh-ancestor
19389824|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
19389825|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389826|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19389827|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19389828|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19389829|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
20215660|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215661|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215662|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20215663|NCT00303576|Dapivirine|dapivirine|mesh-list
20215664|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20215665|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20215666|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
20215667|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215668|NCT00303589|Lactams|lactams|mesh-list
20215669|NCT00303589|beta-Lactams|beta-lactams|mesh-list
20215670|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215671|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215672|NCT00303615|Anastrozole|anastrozole|mesh-list
20215673|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
20215674|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20215675|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215676|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20413678|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20413679|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
20413680|NCT01206972|Enoxaparin|enoxaparin|mesh-list
20413681|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
20413682|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20413683|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
20413684|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20413685|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
20413686|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215677|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20215678|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215679|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215680|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20215681|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
20215682|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215683|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215684|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
20215685|NCT00303615|Hormones|hormones|mesh-ancestor
20215686|NCT00303732|Everolimus|everolimus|mesh-list
20215687|NCT00303732|Vatalanib|vatalanib|mesh-list
20215688|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413687|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215689|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215690|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
20413688|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
20413689|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20413690|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20413691|NCT01206998|Progesterone|progesterone|mesh-list
20413692|NCT01206998|Progestins|progestins|mesh-ancestor
20413693|NCT01206998|Hormones|hormones|mesh-ancestor
20413694|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413695|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413696|NCT01207128|Voriconazole|voriconazole|mesh-list
20413697|NCT01207128|Micafungin|micafungin|mesh-list
20413698|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
20413699|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413700|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20413701|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20413702|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413703|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413704|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20215691|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215692|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20215693|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215694|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215695|NCT00303745|Capecitabine|capecitabine|mesh-list
20215696|NCT00303745|Irinotecan|irinotecan|mesh-list
19389830|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389831|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389832|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19389833|NCT05072704|Narcotics|narcotics|mesh-ancestor
19389834|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19389835|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19389836|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
19389837|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
19389838|NCT05041426|Valganciclovir|valganciclovir|mesh-list
19389839|NCT05041426|Letermovir|letermovir|mesh-list
19389840|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
19389841|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389842|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19389843|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389844|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389845|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389846|NCT04987372|Lidocaine|lidocaine|mesh-list
19389847|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
19389848|NCT04987372|Pregabalin|pregabalin|mesh-list
19389849|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
19389850|NCT04987372|Ketamine|ketamine|mesh-list
19389851|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
19389852|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
19389853|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389854|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413705|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
20413706|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413707|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413708|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20413709|NCT01207206|Ketamine|ketamine|mesh-list
20413710|NCT01207206|Analgesics|analgesics|mesh-ancestor
20413711|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
20413712|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413713|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413714|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20413715|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20413716|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
20413717|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
20413718|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20413719|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20413720|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20413721|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389855|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
19389856|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389857|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19389858|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19389859|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19389860|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19389861|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389862|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20215697|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215698|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
19389863|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19389864|NCT04987372|Analgesics|analgesics|mesh-ancestor
19389865|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19389866|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19389867|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20413722|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413723|NCT01207245|Tobramycin|tobramycin|mesh-list
20413724|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20413725|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413726|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
20413727|NCT01207297|Tacrolimus|tacrolimus|mesh-list
20413728|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413729|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
20413730|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413731|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413732|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20413733|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
20413734|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413735|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389868|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
19389869|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19389870|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19389871|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19389872|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
19389873|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19389874|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19389875|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
19389876|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19389877|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19389878|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20413736|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20413737|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20413738|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413739|NCT01207310|Nicotine|nicotine|mesh-list
20413740|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20413741|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
20413742|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413743|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413744|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20413745|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20413746|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
20413747|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413748|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427595|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427596|NCT01287949|Vaccines|vaccines|mesh-list
20427597|NCT01287949|Immunologic Factors|immunologic factors|mesh-ancestor
20427598|NCT01287949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427599|NCT01287962|Apatinib|apatinib|mesh-list
20427600|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389879|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19389880|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19389881|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
19389882|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19389883|NCT04981067|Ropivacaine|ropivacaine|mesh-list
20427601|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20427602|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427603|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427604|NCT01288092|Dactolisib|dactolisib|mesh-list
20427605|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427606|NCT01288131|Cyclosporine|cyclosporine|mesh-list
20427607|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
20427608|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
20427609|NCT01288131|Cyclosporins|cyclosporins|mesh-list
19389884|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
19389885|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
19389886|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389887|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427610|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427611|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
20427612|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427613|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427614|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19389888|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
19389889|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427615|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
20413749|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20413750|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20413751|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20413752|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20413753|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413754|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
20413755|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413756|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413757|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
20413758|NCT01207739|Doxycycline|doxycycline|mesh-list
19389890|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
19389891|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19389892|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
19389893|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389894|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389895|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19389896|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19389897|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19389898|NCT04964050|Diuretics|diuretics|mesh-ancestor
20413759|NCT01207739|Clarithromycin|clarithromycin|mesh-list
20413760|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
20413761|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20413762|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20413763|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413764|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413765|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413766|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413767|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20413768|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19389899|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
19389900|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389901|NCT04905862|Antipyretics|antipyretics|mesh-list
19389902|NCT04905862|Analgesics|analgesics|mesh-list
19389903|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413769|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20413770|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20413771|NCT01207921|Lenalidomide|lenalidomide|mesh-list
20413772|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
20413773|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413774|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20413775|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20413776|NCT01207921|Growth Substances|growth substances|mesh-ancestor
20413777|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
20413778|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389904|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
19389905|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389906|NCT04898309|Complement C1s|complement c1s|mesh-list
19389907|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19389908|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19389909|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
19389910|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389911|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20413779|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20413780|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
20413781|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20413782|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20413783|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413784|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413785|NCT01207947|Urological Agents|urological agents|mesh-ancestor
20413786|NCT01208012|Liraglutide|liraglutide|mesh-list
20413787|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413788|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413789|NCT01208012|Incretins|incretins|mesh-ancestor
20413790|NCT01208012|Hormones|hormones|mesh-ancestor
20413791|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19389912|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19389913|NCT04895202|Siponimod|siponimod|mesh-list
19389914|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19389915|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389916|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19389917|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
19389918|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389919|NCT04840264|Docetaxel|docetaxel|mesh-list
19389920|NCT04840264|Fluorouracil|fluorouracil|mesh-list
19389921|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
19389922|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389923|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
19389924|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
19389925|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
19389926|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389927|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
19389928|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19389929|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19389930|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
19389931|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389932|NCT04822467|Ethanol|ethanol|mesh-list
19389933|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20413792|NCT01208090|Ponesimod|ponesimod|mesh-list
20413793|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20413794|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413795|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413796|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
20413797|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413798|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
20413799|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389934|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389935|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389936|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389937|NCT04808973|Lamivudine|lamivudine|mesh-list
19389938|NCT04808973|Dolutegravir|dolutegravir|mesh-list
20413800|NCT01208285|Ivacaftor|ivacaftor|mesh-list
20413801|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20413802|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20413803|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413804|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20413805|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20413806|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
20413807|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
19389939|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19389940|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19389941|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413808|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413809|NCT01208441|Letrozole|letrozole|mesh-list
20413810|NCT01208441|R04929097|r04929097|mesh-list
20413811|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413812|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20413813|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20413814|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413815|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413816|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20413817|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
20413818|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413819|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413820|NCT01208454|Vitamin A|vitamin a|mesh-list
20413821|NCT01208454|Vorinostat|vorinostat|mesh-list
20413822|NCT01208454|Tretinoin|tretinoin|mesh-list
19389942|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389943|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
19389944|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19389945|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19389946|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19389947|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19389948|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19389949|NCT04804007|Etoposide|etoposide|mesh-list
19389950|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19389951|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389952|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19389953|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19389954|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389955|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389956|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
19389957|NCT04787692|Narcotics|narcotics|mesh-ancestor
19389958|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19389959|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389960|NCT04787692|Analgesics|analgesics|mesh-ancestor
19389961|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
20413823|NCT01208454|Isotretinoin|isotretinoin|mesh-list
19389962|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413824|NCT01208454|Vitamins|vitamins|mesh-ancestor
20413825|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
20413826|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413827|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413828|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20413829|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413830|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413831|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
20413832|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
20413833|NCT01208480|Carboplatin|carboplatin|mesh-list
20413834|NCT01208480|Docetaxel|docetaxel|mesh-list
20413835|NCT01208480|Bevacizumab|bevacizumab|mesh-list
20413836|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413837|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
20413838|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
20413839|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
20413840|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413841|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20413842|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20413843|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20413844|NCT01208480|Growth Substances|growth substances|mesh-ancestor
20413845|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413846|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
20413847|NCT01208649|Exenatide|exenatide|mesh-list
20413848|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413849|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413850|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20413851|NCT01208649|Incretins|incretins|mesh-ancestor
20413852|NCT01208649|Hormones|hormones|mesh-ancestor
19389963|NCT04755244|Azacitidine|azacitidine|mesh-list
19389964|NCT04755244|Venetoclax|venetoclax|mesh-list
19389965|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19389966|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
19389967|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389968|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19389969|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19389970|NCT04741945|Metformin|metformin|mesh-list
19389971|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19389972|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389973|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19389974|NCT04720612|Omalizumab|omalizumab|mesh-list
19389975|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19389976|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19389977|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
20413853|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413854|NCT01208701|Atorvastatin|atorvastatin|mesh-list
20413855|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20413856|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20413857|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
20413858|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413859|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20413860|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20413861|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413862|NCT01208740|Metformin|metformin|mesh-list
20413863|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20413864|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389978|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19389979|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19389980|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19389981|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389982|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19389983|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19389984|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19389985|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413865|NCT01208766|Dexamethasone|dexamethasone|mesh-list
20413866|NCT01208766|Prednisone|prednisone|mesh-list
20413867|NCT01208766|Lenalidomide|lenalidomide|mesh-list
20413868|NCT01208766|Bortezomib|bortezomib|mesh-list
20413869|NCT01208766|Melphalan|melphalan|mesh-list
20413870|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413871|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
19389986|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
20413872|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
20413873|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413874|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413875|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413876|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
20413877|NCT01208766|Hormones|hormones|mesh-ancestor
20413878|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413879|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20413880|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413881|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
20413882|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20413883|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20413884|NCT01208766|Growth Substances|growth substances|mesh-ancestor
20413885|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
20413886|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20413887|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
20413888|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413889|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20413890|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413891|NCT01208818|Dexamethasone|dexamethasone|mesh-list
20413892|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
20413893|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
20413894|NCT01208818|Bortezomib|bortezomib|mesh-list
20413895|NCT01208818|BB 1101|bb 1101|mesh-list
20413896|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20413897|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
19389987|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389988|NCT04661137|Dexamethasone|dexamethasone|mesh-list
19389989|NCT04661137|Daratumumab|daratumumab|mesh-list
19389990|NCT04661137|Pomalidomide|pomalidomide|mesh-list
19389991|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19389992|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
19389993|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
19389994|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19389995|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19389996|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19389997|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
19389998|NCT04661137|Hormones|hormones|mesh-ancestor
19389999|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390000|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390001|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390002|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
19390003|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19390004|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19390005|NCT04661137|Growth Substances|growth substances|mesh-ancestor
19390006|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
19390007|NCT04657666|Nabiximols|nabiximols|mesh-list
19390008|NCT04657666|Analgesics|analgesics|mesh-ancestor
19390009|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
19390010|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390011|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390012|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
19390013|NCT04643574|Fludarabine|fludarabine|mesh-list
19390014|NCT04643574|Interleukin-2|interleukin-2|mesh-list
19390015|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390016|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
19390017|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413898|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413899|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413900|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19390018|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390019|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19390020|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
19390021|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390022|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390023|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19390024|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19390025|NCT04643574|Analgesics|analgesics|mesh-ancestor
19390026|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
19390027|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390028|NCT04633889|Deferoxamine|deferoxamine|mesh-list
19390029|NCT04633889|Siderophores|siderophores|mesh-ancestor
19390030|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19390031|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
19390032|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
20413901|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
19390033|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403810|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428695|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19390034|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19390035|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19390036|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390037|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390038|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19390039|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19390040|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390041|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
19390042|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390043|NCT04544007|Poly ICLC|poly iclc|mesh-list
19390044|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
19390045|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
19390046|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390047|NCT04510207|Vaccines|vaccines|mesh-list
19390048|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
19390049|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413902|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413903|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413904|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20413905|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413906|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
20413907|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
20413908|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413909|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413910|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
20413911|NCT01208818|Hormones|hormones|mesh-ancestor
19390050|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
19390051|NCT04509115|Narcotics|narcotics|mesh-ancestor
19390052|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390053|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390054|NCT04509115|Analgesics|analgesics|mesh-ancestor
20413912|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413913|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20413914|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
20413915|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413916|NCT01208935|Nicotine|nicotine|mesh-list
20413917|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20413918|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
20413919|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413920|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413921|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19390055|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
19390056|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847981|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19847982|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848278|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19848279|NCT00692185|Olanzapine|olanzapine|mesh-list
19848280|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
19848281|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
19848282|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848283|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848284|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848285|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19848286|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19848287|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848288|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390070|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19390071|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19390072|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390073|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
19390074|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
19390075|NCT04479566|Calcium|calcium|mesh-list
19390076|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19390077|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390078|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
19390079|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390080|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390081|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390082|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
19390083|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19390084|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390085|NCT04479566|Antacids|antacids|mesh-ancestor
19390086|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390087|NCT04428307|Artemisinins|artemisinins|mesh-list
19390088|NCT04428307|Artemisinin|artemisinin|mesh-list
20413922|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20413923|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
20413924|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20413925|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413926|NCT01209026|Fluticasone|fluticasone|mesh-list
20413927|NCT01209026|Xhance|xhance|mesh-list
20413928|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
20413929|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20413930|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413931|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20413932|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
20413933|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20413934|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413935|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20413936|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
20413937|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
20413938|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20413939|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20413940|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413941|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20413942|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20413943|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390089|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
19390090|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19390091|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19390092|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390093|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
19390094|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390095|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390096|NCT04356495|Ciclesonide|ciclesonide|mesh-list
19390097|NCT04356495|Interferons|interferons|mesh-list
19390098|NCT04356495|Interferon-beta|interferon-beta|mesh-list
19390099|NCT04356495|Telmisartan|telmisartan|mesh-list
20215699|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215700|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215701|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20215702|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215703|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215704|NCT00303758|Leucovorin|leucovorin|mesh-list
20215705|NCT00303758|Gemcitabine|gemcitabine|mesh-list
20215706|NCT00303758|Fluorouracil|fluorouracil|mesh-list
19390100|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
19390101|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390102|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390103|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
19390104|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390105|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19390106|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19390107|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19390108|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390109|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
19390110|NCT04356495|Hormones|hormones|mesh-ancestor
19390111|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390112|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19390113|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
19390114|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19390115|NCT04355572|Vitamin D|vitamin d|mesh-list
19390116|NCT04355572|Vitamins|vitamins|mesh-ancestor
19390117|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
19390118|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390119|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19390120|NCT04200963|Nivolumab|nivolumab|mesh-list
19390121|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390122|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390123|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19390124|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390125|NCT04200911|Sirolimus|sirolimus|mesh-list
19390126|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19390127|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390128|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19390129|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390130|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
19390131|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215707|NCT00303758|Calcium|calcium|mesh-list
20413944|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413945|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413946|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20413947|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390132|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
19390133|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390134|NCT04140162|Dexamethasone|dexamethasone|mesh-list
19390135|NCT04140162|Lenalidomide|lenalidomide|mesh-list
19390136|NCT04140162|Bortezomib|bortezomib|mesh-list
19390137|NCT04140162|Daratumumab|daratumumab|mesh-list
19390138|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390139|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
19390140|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
19390141|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390142|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390143|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390144|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
19390145|NCT04140162|Hormones|hormones|mesh-ancestor
19390146|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390147|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390148|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390149|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
19390150|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19390151|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19390152|NCT04140162|Growth Substances|growth substances|mesh-ancestor
19390153|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
19390154|NCT04104178|Clindamycin|clindamycin|mesh-list
19390155|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
19390156|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
19390157|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19390158|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390159|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19390160|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390161|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413948|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20413949|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20413950|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20413951|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20413952|NCT01209065|Ritonavir|ritonavir|mesh-list
20413953|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
20413954|NCT01209065|Dolutegravir|dolutegravir|mesh-list
20413955|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20413956|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20413957|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
20413958|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20413959|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20413960|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20413961|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20413962|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
20413963|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20413964|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20413965|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20413966|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20413967|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20413968|NCT01209130|Rituximab|rituximab|mesh-list
20413969|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20413970|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20413971|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
20413972|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413973|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427616|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427617|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427618|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20427619|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427620|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
20427621|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427622|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
20427623|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20427624|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20427625|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20427626|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
20427627|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20427628|NCT01288157|Golimumab|golimumab|mesh-list
20427629|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19390162|NCT03999268|Insulin|insulin|mesh-list
20427630|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19390163|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19390164|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413974|NCT01209208|Budesonide|budesonide|mesh-list
20413975|NCT01209208|Mesalamine|mesalamine|mesh-list
20413976|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20413977|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20413978|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
20413979|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390165|NCT03974828|Anesthetics|anesthetics|mesh-list
19390166|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390167|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390168|NCT03971643|Vilobelimab|vilobelimab|mesh-list
19390169|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19390170|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390171|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
19390172|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390173|NCT03929718|Spironolactone|spironolactone|mesh-list
19390174|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19390175|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
19390176|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390177|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390178|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19390179|NCT03929718|Diuretics|diuretics|mesh-ancestor
19390180|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
19390181|NCT03918915|Atropine|atropine|mesh-list
20413980|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413981|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20413982|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
20413983|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
20413984|NCT01209208|Hormones|hormones|mesh-ancestor
20413985|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20413986|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20413987|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20413988|NCT01209208|Analgesics|analgesics|mesh-ancestor
20413989|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
20413990|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20413991|NCT01209351|Teduglutide|teduglutide|mesh-list
20413992|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20413993|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20413994|NCT01209351|Protective Agents|protective agents|mesh-ancestor
20413995|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20413996|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
20413997|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19390182|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19390183|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19390184|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19390185|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
19390186|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390187|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390188|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19390189|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
19390190|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
19390191|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
19390192|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20413998|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20413999|NCT01209364|Prednisolone|prednisolone|mesh-list
20414000|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
20414001|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20414002|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
20414003|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414004|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
20414005|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
20414006|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414007|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414008|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414009|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
20414010|NCT01209364|Hormones|hormones|mesh-ancestor
20414011|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390193|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19390194|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
19390195|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390196|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390197|NCT03882918|Gaboxadol|gaboxadol|mesh-list
19390198|NCT03882918|Analgesics|analgesics|mesh-ancestor
19390199|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
20414012|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20414013|NCT01209364|Protective Agents|protective agents|mesh-ancestor
20428696|NCT01293422|Rifampin|rifampin|mesh-list
20414014|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20414015|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414016|NCT01209403|Insulin|insulin|mesh-list
19390200|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390201|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390202|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
19390203|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
19390204|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
19390205|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414017|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
20414018|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20414019|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414020|NCT01209416|Acipimox|acipimox|mesh-list
20414021|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20414022|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
20414023|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414024|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20414025|NCT01209429|Hormones|hormones|mesh-list
20414026|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414027|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414028|NCT01209455|Acetaminophen|acetaminophen|mesh-list
20414029|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
20414030|NCT01209455|Ranitidine|ranitidine|mesh-list
20414031|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20414032|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20414033|NCT01209455|Analgesics|analgesics|mesh-ancestor
20414034|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
20414035|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414036|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414037|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
20414038|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20414039|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414040|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20414041|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
20414042|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
20414043|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414044|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414045|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
19390206|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390207|NCT03878459|Pioglitazone|pioglitazone|mesh-list
19390208|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19390209|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390210|NCT03843008|Melatonin|melatonin|mesh-list
19390211|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
20414046|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414047|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20414048|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20414049|NCT01209533|Iloprost|iloprost|mesh-list
20414050|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20414051|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414052|NCT01209650|Afatinib|afatinib|mesh-list
19390212|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390213|NCT03843008|Protective Agents|protective agents|mesh-ancestor
19390214|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390215|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390216|NCT03840616|Fluconazole|fluconazole|mesh-list
19390217|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
19390218|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390219|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19390220|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19390221|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390222|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390223|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19390224|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
19390225|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390226|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390227|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19390228|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19390229|NCT03837977|Leucovorin|leucovorin|mesh-list
19390230|NCT03837977|Folic Acid|folic acid|mesh-list
19390231|NCT03837977|Docetaxel|docetaxel|mesh-list
20414053|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19847983|NCT00689793|Iron|iron|mesh-list
20414054|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20414055|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390232|NCT03837977|Fluorouracil|fluorouracil|mesh-list
19390233|NCT03837977|Irinotecan|irinotecan|mesh-list
19390234|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
19390235|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390236|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
19390237|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
19390238|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
19390239|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390240|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
19390241|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19390242|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390243|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
19390244|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390245|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19390246|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19390247|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390248|NCT03837977|Antidotes|antidotes|mesh-ancestor
20414056|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414057|NCT01209715|Fluticasone|fluticasone|mesh-list
20414058|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20414059|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20414060|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414061|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20414062|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
20414063|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414064|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414065|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20414066|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
20414067|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414068|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20414069|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20414070|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20414071|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20414072|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
20414073|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414074|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414075|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
20414076|NCT01209715|Hormones|hormones|mesh-ancestor
20414077|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414078|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
20414079|NCT01209728|Ethanol|ethanol|mesh-list
20414080|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20414081|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414082|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414083|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390249|NCT03837977|Protective Agents|protective agents|mesh-ancestor
19390250|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
19390251|NCT03837977|Vitamins|vitamins|mesh-ancestor
19390252|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
19390253|NCT03837977|Hematinics|hematinics|mesh-ancestor
19390254|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
19390255|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19390256|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19390257|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
19390258|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390259|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390260|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390261|NCT03787654|Urological Agents|urological agents|mesh-ancestor
19390262|NCT03772353|Letrozole|letrozole|mesh-list
19390263|NCT03772353|Fulvestrant|fulvestrant|mesh-list
19390264|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19390265|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215708|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
20215709|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215710|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215711|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
20215712|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215713|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
20215714|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215715|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215716|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390266|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19390267|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390268|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390269|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19390270|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
19390271|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390272|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390273|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390274|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19390275|NCT03697720|Naproxen|naproxen|mesh-list
19390276|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19390277|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19390278|NCT03697720|Analgesics|analgesics|mesh-ancestor
20414084|NCT01209806|Simethicone|simethicone|mesh-list
20414085|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
20414086|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19390279|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
19390280|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390281|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390282|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19847984|NCT00689793|Trace Elements|trace elements|mesh-ancestor
19847985|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
19847986|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847987|NCT00689936|Thalidomide|thalidomide|mesh-list
19847988|NCT00689936|Dexamethasone|dexamethasone|mesh-list
19847989|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
19847990|NCT00689936|Prednisone|prednisone|mesh-list
19847991|NCT00689936|Lenalidomide|lenalidomide|mesh-list
20414087|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19390283|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390284|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
19390285|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19390286|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390287|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390288|NCT03649633|Vitamins|vitamins|mesh-list
19390289|NCT03649633|Ascorbic Acid|ascorbic acid|mesh-list
19390290|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
19390291|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
19390292|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390293|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390294|NCT03649633|Antioxidants|antioxidants|mesh-ancestor
19390295|NCT03649633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390296|NCT03649633|Protective Agents|protective agents|mesh-ancestor
19390297|NCT03623373|Cytarabine|cytarabine|mesh-list
19390298|NCT03623373|Rituximab|rituximab|mesh-list
19390299|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19390300|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
19390301|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390302|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390303|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
19390304|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390305|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390306|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19390307|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
19390308|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390309|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
19390310|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390311|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390312|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20414088|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
20414089|NCT01209806|TEMPO|tempo|mesh-list
20414090|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
20414091|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414092|NCT01209806|Emollients|emollients|mesh-ancestor
19390313|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
19390314|NCT03603964|Guadecitabine|guadecitabine|mesh-list
19390315|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390316|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19390317|NCT03583528|Edotreotide|edotreotide|mesh-list
19390318|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19390319|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390320|NCT03582774|Edetic Acid|edetic acid|mesh-list
19390321|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19390322|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
19390323|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
19390324|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390325|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
19847992|NCT00689936|Melphalan|melphalan|mesh-list
19847993|NCT00689936|BB 1101|bb 1101|mesh-list
19847994|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20215717|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
20215718|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215719|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20215720|NCT00303758|Antidotes|antidotes|mesh-ancestor
20215721|NCT00303758|Protective Agents|protective agents|mesh-ancestor
20215722|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
20215723|NCT00303758|Vitamins|vitamins|mesh-ancestor
20215724|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
20215725|NCT00303771|Leucovorin|leucovorin|mesh-list
20215726|NCT00303771|Fluorouracil|fluorouracil|mesh-list
20215727|NCT00303771|Irinotecan|irinotecan|mesh-list
20215728|NCT00303771|Calcium|calcium|mesh-list
20215729|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
20215730|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20215731|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414093|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414094|NCT01209806|Antacids|antacids|mesh-ancestor
20414095|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390326|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19390327|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19390328|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
19390329|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390330|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390331|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
19390332|NCT03512210|Velpatasvir|velpatasvir|mesh-list
19390333|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
19390334|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390335|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19390336|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19390337|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390338|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
19390339|NCT03502577|Fludarabine|fludarabine|mesh-list
19390340|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390341|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
19390342|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390343|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390344|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19390345|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
19390346|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390347|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390348|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19403811|NCT03599453|Interferons|interferons|mesh-list
19403812|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
19403813|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
19403814|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19403815|NCT03599453|Poly I-C|poly i-c|mesh-list
19403816|NCT03599453|Celecoxib|celecoxib|mesh-list
19403817|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
19403818|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
19403819|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
19403820|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
19403821|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403822|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403823|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
19403824|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403825|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
20414096|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20414097|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
20414098|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414099|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
20414100|NCT01209806|Protective Agents|protective agents|mesh-ancestor
20414101|NCT01209845|Ketamine|ketamine|mesh-list
20414102|NCT01209845|Analgesics|analgesics|mesh-ancestor
20414103|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
20414104|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414105|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403826|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403827|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19403828|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19403829|NCT03599453|Analgesics|analgesics|mesh-ancestor
19403830|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
19403831|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403832|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414106|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20414107|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19403833|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215732|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
20414108|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
20414109|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
19390349|NCT03383770|Anesthetics|anesthetics|mesh-list
20414110|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414111|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20414112|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20414113|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414114|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414115|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20414116|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20414117|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20414118|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
20414119|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20414120|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414121|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20414122|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20414123|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20414124|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390350|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390351|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390352|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
19390353|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390354|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390355|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19390356|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390357|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390358|NCT03073941|Cimetidine|cimetidine|mesh-list
19390359|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19390360|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390361|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19390362|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
19390363|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
19390364|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390365|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390366|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390367|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20414125|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20414126|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20414127|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20414128|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20414129|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
20414130|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20414131|NCT01209871|Antibodies|antibodies|mesh-list
20414132|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
20414133|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390368|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19390369|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390370|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
19390371|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19390372|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19390373|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390374|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
19390375|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
19390376|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390377|NCT02668822|Ibuprofen|ibuprofen|mesh-list
19390378|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19390379|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19390380|NCT02668822|Analgesics|analgesics|mesh-ancestor
19390381|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
20215733|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215734|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215735|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215736|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215737|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
20215738|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20215739|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215740|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215741|NCT00303771|Antidotes|antidotes|mesh-ancestor
20215742|NCT00303771|Protective Agents|protective agents|mesh-ancestor
20215743|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
20215744|NCT00303771|Vitamins|vitamins|mesh-ancestor
20215745|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
20215746|NCT00303784|Goserelin|goserelin|mesh-list
20215747|NCT00303784|Estradiol|estradiol|mesh-list
20215748|NCT00303784|Estrogens|estrogens|mesh-ancestor
20414134|NCT01209988|Tamsulosin|tamsulosin|mesh-list
20414135|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20414136|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20414137|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20414138|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
20414139|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414140|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414141|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414142|NCT01209988|Urological Agents|urological agents|mesh-ancestor
20215749|NCT00303784|Hormones|hormones|mesh-ancestor
19390382|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390383|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390384|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390385|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390386|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19390387|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390388|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390389|NCT02668783|Ibuprofen|ibuprofen|mesh-list
19390390|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20414143|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
20414144|NCT01210014|Astringents|astringents|mesh-ancestor
20414145|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414146|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414147|NCT01210040|Folic Acid|folic acid|mesh-list
20414148|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
20414149|NCT01210040|Hematinics|hematinics|mesh-ancestor
20414150|NCT01210040|Vitamins|vitamins|mesh-ancestor
20414151|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
20414152|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414153|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19390391|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19390392|NCT02668783|Etonogestrel|etonogestrel|mesh-list
19390393|NCT02668783|Estradiol|estradiol|mesh-list
19390394|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19390395|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19390396|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19390397|NCT02668783|Analgesics|analgesics|mesh-ancestor
19390398|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
19390399|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390400|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390401|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390402|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390403|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19390404|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390405|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390406|NCT02668783|Estrogens|estrogens|mesh-ancestor
19390407|NCT02668783|Hormones|hormones|mesh-ancestor
19390408|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390409|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390410|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390411|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390412|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390413|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19390414|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19390415|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
20215750|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215751|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215752|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20215753|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215754|NCT00303797|Bortezomib|bortezomib|mesh-list
20215755|NCT00303797|Sorafenib|sorafenib|mesh-list
20215756|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215757|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19390416|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19390417|NCT02616146|Etonogestrel|etonogestrel|mesh-list
19403834|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20215758|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215759|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215760|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
20215761|NCT00303810|Thiotepa|thiotepa|mesh-list
20215762|NCT00303810|Lomustine|lomustine|mesh-list
20215763|NCT00303810|Carboplatin|carboplatin|mesh-list
20414154|NCT01210066|Fentanyl|fentanyl|mesh-list
20414155|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
20414156|NCT01210066|Narcotics|narcotics|mesh-ancestor
20215764|NCT00303810|Methotrexate|methotrexate|mesh-list
20414157|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390418|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19390419|NCT02616146|Estradiol|estradiol|mesh-list
19390420|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19390421|NCT02616146|Estrogens|estrogens|mesh-ancestor
19390422|NCT02616146|Hormones|hormones|mesh-ancestor
19390423|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390424|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390425|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390426|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390427|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390428|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390429|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390430|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19390431|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390432|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19390433|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
19390434|NCT02538510|Vorinostat|vorinostat|mesh-list
19390435|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390436|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390437|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19390438|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390439|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390440|NCT02489942|Empagliflozin|empagliflozin|mesh-list
19390441|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19390442|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390443|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19390444|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390445|NCT02477644|Olaparib|olaparib|mesh-list
19390446|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19390447|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390448|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390449|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390450|NCT02420860|Lenalidomide|lenalidomide|mesh-list
19390451|NCT02420860|Elotuzumab|elotuzumab|mesh-list
19390452|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
19390453|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390454|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19390455|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19390456|NCT02420860|Growth Substances|growth substances|mesh-ancestor
19390457|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
19390458|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414158|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414159|NCT01210066|Analgesics|analgesics|mesh-ancestor
20414160|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
20414161|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414162|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20414163|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19390459|NCT02420613|Sirolimus|sirolimus|mesh-list
19390460|NCT02420613|Vorinostat|vorinostat|mesh-list
19390461|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19390462|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390463|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19390464|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390465|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
19390466|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390467|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
19390468|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390469|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19390470|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390471|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390472|NCT02409342|Gemcitabine|gemcitabine|mesh-list
19390473|NCT02409342|Carboplatin|carboplatin|mesh-list
19390474|NCT02409342|Pemetrexed|pemetrexed|mesh-list
19390475|NCT02409342|Atezolizumab|atezolizumab|mesh-list
19390476|NCT02409342|Antibodies|antibodies|mesh-list
19390477|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19390478|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
19390479|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390480|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390481|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19390482|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
19390483|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390484|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
19390485|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414164|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
20414165|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
20414166|NCT01210287|Lamivudine|lamivudine|mesh-list
20414167|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20414168|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20414169|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390486|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390487|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390488|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19390489|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19390490|NCT02394535|Paclitaxel|paclitaxel|mesh-list
19390491|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19390492|NCT02394535|Capecitabine|capecitabine|mesh-list
19390493|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19390494|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390495|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
19390496|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
19390497|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
19390498|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390499|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19390500|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
19390501|NCT02385110|Dexamethasone|dexamethasone|mesh-list
19390502|NCT02385110|Methotrexate|methotrexate|mesh-list
19390503|NCT02385110|Etoposide|etoposide|mesh-list
19390504|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
19390505|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390506|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
19390507|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
19390508|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390509|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390510|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390511|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
19390512|NCT02385110|Hormones|hormones|mesh-ancestor
19390513|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390514|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390515|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390516|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19390517|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
19390518|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390519|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19390520|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
19390521|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390522|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
19390523|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390524|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19390525|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390526|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
19390527|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215765|NCT00303810|Etoposide|etoposide|mesh-list
20414170|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414171|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
20414172|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414173|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19390528|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19390529|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19390530|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19691565|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20215766|NCT00303810|Vincristine|vincristine|mesh-list
19390531|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19390532|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390533|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
19390534|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691566|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19691567|NCT05003596|Prednisolone|prednisolone|mesh-list
19691568|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
19691569|NCT05003596|Narcotics|narcotics|mesh-list
19691570|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19691571|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
20215767|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
20215768|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215769|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
20215770|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215771|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215772|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215773|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
19390535|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390536|NCT02316834|Talazoparib|talazoparib|mesh-list
19390537|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20414174|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20414175|NCT01210339|Esomeprazole|esomeprazole|mesh-list
20414176|NCT01210339|Clopidogrel|clopidogrel|mesh-list
20414177|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20414178|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20414179|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20414180|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20414181|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
20414182|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414183|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414184|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414185|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20414186|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414187|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20414188|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414189|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
20414190|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414191|NCT01210391|Caseins|caseins|mesh-list
20414192|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
20414193|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
20414194|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414195|NCT01210430|Vitamins|vitamins|mesh-list
20414196|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
19390538|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390539|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390540|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390541|NCT02293655|Methylphenidate|methylphenidate|mesh-list
20215774|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215775|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215776|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20215777|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20215778|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
20215779|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390542|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19390543|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390544|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19390545|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19390546|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19390547|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390548|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
19390549|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390550|NCT02275546|NuvaRing|nuvaring|mesh-list
19390551|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19390552|NCT02275546|Desogestrel|desogestrel|mesh-list
19390553|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390554|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390555|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390556|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390557|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390558|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19390559|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390560|NCT02275546|Estrogens|estrogens|mesh-ancestor
19390561|NCT02275546|Hormones|hormones|mesh-ancestor
19390562|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390563|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390564|NCT02275546|Progestins|progestins|mesh-ancestor
19390565|NCT02131597|Guadecitabine|guadecitabine|mesh-list
19390566|NCT02131597|Azacitidine|azacitidine|mesh-list
19390567|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390568|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19390569|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
19390570|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390571|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215780|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215781|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
20215782|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
20215783|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215784|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20414197|NCT01210430|Losartan|losartan|mesh-list
20414198|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
20414199|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414200|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20414201|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20215785|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20215786|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20215787|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20414202|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20414203|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20414204|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414205|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
20414206|NCT01210430|Protective Agents|protective agents|mesh-ancestor
20414207|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
20414208|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20414209|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
20414210|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414211|NCT01210456|Expectorants|expectorants|mesh-ancestor
20414212|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
20414213|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20414214|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
20414215|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414216|NCT01210456|Protective Agents|protective agents|mesh-ancestor
20414217|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414218|NCT01210456|Antidotes|antidotes|mesh-ancestor
20414219|NCT01210482|Sirolimus|sirolimus|mesh-list
20414220|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20414221|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390572|NCT02077166|Rituximab|rituximab|mesh-list
19390573|NCT02077166|Lenalidomide|lenalidomide|mesh-list
19390574|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390575|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390576|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
19390577|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390578|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390579|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19390580|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19390581|NCT02077166|Growth Substances|growth substances|mesh-ancestor
19390582|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
19390583|NCT02027935|Aldesleukin|aldesleukin|mesh-list
19390584|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
19390585|NCT02027935|Ipilimumab|ipilimumab|mesh-list
19390586|NCT02027935|Interleukin-2|interleukin-2|mesh-list
19390587|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390588|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
19390589|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390590|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390591|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19390592|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
19390593|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390594|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390595|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19390596|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390597|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19390598|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19390599|NCT02027935|Analgesics|analgesics|mesh-ancestor
19390600|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
19390601|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390602|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19390603|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19390604|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
19390605|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390606|NCT01965132|Adalimumab|adalimumab|mesh-list
19390607|NCT01965132|Etanercept|etanercept|mesh-list
19390608|NCT01965132|Golimumab|golimumab|mesh-list
19390609|NCT01965132|Abatacept|abatacept|mesh-list
19390610|NCT01965132|Infliximab|infliximab|mesh-list
19390611|NCT01965132|Upadacitinib|upadacitinib|mesh-list
19390612|NCT01965132|Ustekinumab|ustekinumab|mesh-list
20215788|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215789|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20215790|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20215791|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20215792|NCT00303836|Aldesleukin|aldesleukin|mesh-list
20215793|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
20215794|NCT00303836|Fludarabine|fludarabine|mesh-list
20215795|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
20215796|NCT00303836|Interleukin-2|interleukin-2|mesh-list
19390613|NCT01965132|Ixekizumab|ixekizumab|mesh-list
19390614|NCT01965132|Tofacitinib|tofacitinib|mesh-list
20414222|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20414223|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390615|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390616|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
19390617|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390618|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390619|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390620|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
19390621|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390622|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19390623|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19390624|NCT01965132|Analgesics|analgesics|mesh-ancestor
20414224|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
20414225|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414226|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
20414227|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414228|NCT01210521|Vitamin D|vitamin d|mesh-list
20414229|NCT01210521|Vitamins|vitamins|mesh-ancestor
19390625|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
19390626|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390627|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390628|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19390629|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390630|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20414230|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
20414231|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414232|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20414233|NCT01210599|Pamidronate|pamidronate|mesh-list
20414234|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20414235|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414236|NCT01210625|Psyllium|psyllium|mesh-list
20414237|NCT01210625|Cathartics|cathartics|mesh-ancestor
20414238|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414239|NCT01210638|Oxymorphone|oxymorphone|mesh-list
20414240|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20414241|NCT01210638|Narcotics|narcotics|mesh-ancestor
20414242|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414243|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414244|NCT01210638|Analgesics|analgesics|mesh-ancestor
19390631|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390632|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19390633|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19390634|NCT01891344|Rucaparib|rucaparib|mesh-list
19390635|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20414245|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
20414246|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414247|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20414248|NCT01210677|Prednisone|prednisone|mesh-list
19390636|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390637|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390638|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390639|NCT01847274|Niraparib|niraparib|mesh-list
19390640|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19390641|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390642|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390643|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390644|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19390645|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19390646|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414249|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414250|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
20414251|NCT01210677|Hormones|hormones|mesh-ancestor
20414252|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414253|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414254|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20414255|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414256|NCT01210742|Hylan|hylan|mesh-list
20414257|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
20414258|NCT01210742|Protective Agents|protective agents|mesh-ancestor
20414259|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390647|NCT01670656|Ibuprofen|ibuprofen|mesh-list
19390648|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
20414260|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
20414261|NCT01210755|Dabigatran|dabigatran|mesh-list
20414262|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20414263|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
20414264|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20414265|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
19390649|NCT01670656|Etonogestrel|etonogestrel|mesh-list
19390650|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19390651|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19390652|NCT01670656|Analgesics|analgesics|mesh-ancestor
19390653|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
19390654|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390655|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390656|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390657|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390658|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19390659|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390660|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390661|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390662|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390663|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390664|NCT01648751|Estrogens|estrogens|mesh-list
19390665|NCT01648751|Hormones|hormones|mesh-ancestor
19390666|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390667|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390668|NCT01498770|Olanzapine|olanzapine|mesh-list
19390669|NCT01498770|Risperidone|risperidone|mesh-list
19390670|NCT01498770|Aripiprazole|aripiprazole|mesh-list
19390671|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19390672|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19390673|NCT01498770|Ziprasidone|ziprasidone|mesh-list
19390674|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19390675|NCT01498770|Clozapine|clozapine|mesh-list
19390676|NCT01498770|Asenapine|asenapine|mesh-list
19390677|NCT01498770|Amisulpride|amisulpride|mesh-list
19390678|NCT01498770|Iloperidone|iloperidone|mesh-list
19390679|NCT01498770|Sertindole|sertindole|mesh-list
19390680|NCT01498770|Zotepine|zotepine|mesh-list
19390681|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19390682|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
19390683|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390684|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390685|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414266|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414267|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414268|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
20414269|NCT01210911|Metformin|metformin|mesh-list
20414270|NCT01210911|Gemcitabine|gemcitabine|mesh-list
20414271|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20414272|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20414273|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
20414274|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414275|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414276|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
20414277|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414278|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414279|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414280|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
20414281|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414282|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20414283|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20427631|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427632|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390686|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19390687|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19390688|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390689|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390690|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19390691|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
19390692|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
19390693|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
20427633|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
20427634|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427635|NCT01288170|Tobramycin|tobramycin|mesh-list
20427636|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19390694|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390695|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390696|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19390697|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19390698|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19390699|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
20427637|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427638|NCT01288261|Paclitaxel|paclitaxel|mesh-list
20414284|NCT01210976|Simendan|simendan|mesh-list
20414285|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20414286|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414287|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20414288|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20414289|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414290|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414291|NCT01210976|Protective Agents|protective agents|mesh-ancestor
19390700|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
19390701|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19390702|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19390703|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19390704|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19390705|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19390706|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19390707|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19390708|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
19390709|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
19390710|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
19390711|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19390712|NCT01335399|Dexamethasone|dexamethasone|mesh-list
19390713|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
19390714|NCT01335399|Lenalidomide|lenalidomide|mesh-list
19390715|NCT01335399|Elotuzumab|elotuzumab|mesh-list
19390716|NCT01335399|BB 1101|bb 1101|mesh-list
19390717|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19390718|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
19390719|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
19390720|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390721|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390722|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390723|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
19390724|NCT01335399|Hormones|hormones|mesh-ancestor
19390725|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390726|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390727|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390728|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
19390729|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390730|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390731|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
19390732|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19390733|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19390734|NCT01335399|Growth Substances|growth substances|mesh-ancestor
19390735|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
19390736|NCT01277211|NuvaRing|nuvaring|mesh-list
20414292|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414293|NCT01211002|Endostatins|endostatins|mesh-list
20414294|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414295|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20414296|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20414297|NCT01211002|Growth Substances|growth substances|mesh-ancestor
20414298|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414299|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
20414300|NCT01211080|Propranolol|propranolol|mesh-list
20414301|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20414302|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20414303|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
20414304|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414305|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414306|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414307|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19390737|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390738|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390739|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390740|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390741|NCT01267812|Rituximab|rituximab|mesh-list
19390742|NCT01267812|Bortezomib|bortezomib|mesh-list
19390743|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19390744|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390745|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
19390746|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390747|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19390748|NCT01244828|Asenapine|asenapine|mesh-list
20414308|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414309|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
19390749|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19390750|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19390751|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390752|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390753|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390754|NCT01047540|Pritelivir|pritelivir|mesh-list
19390755|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
20414310|NCT01211158|Ketamine|ketamine|mesh-list
20414311|NCT01211158|Propofol|propofol|mesh-list
20414312|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20414313|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414314|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414315|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20414316|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
20414317|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
19390756|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19390757|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19390758|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390759|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
19390760|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
19390761|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20414318|NCT01211158|Analgesics|analgesics|mesh-ancestor
20414319|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
20414320|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414321|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20414322|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20414323|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20414324|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414325|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414326|NCT01211171|Telmisartan|telmisartan|mesh-list
20414327|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414328|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20414329|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20414330|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414331|NCT01211210|Fluorouracil|fluorouracil|mesh-list
20414332|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
20414333|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
20414334|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414335|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19390762|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19390763|NCT01044056|NuvaRing|nuvaring|mesh-list
19390764|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
19390765|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390766|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390767|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390768|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390769|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390770|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390771|NCT01044056|Estrogens|estrogens|mesh-ancestor
19390772|NCT01044056|Hormones|hormones|mesh-ancestor
19390773|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390774|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19390775|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19390776|NCT01005056|Desogestrel|desogestrel|mesh-list
19390777|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390778|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19390779|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390780|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390781|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390782|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390783|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390784|NCT01005056|Estrogens|estrogens|mesh-ancestor
19390785|NCT01005056|Hormones|hormones|mesh-ancestor
19390786|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390787|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390788|NCT01005056|Progestins|progestins|mesh-ancestor
19390789|NCT00967746|Etonogestrel|etonogestrel|mesh-list
19390790|NCT00967746|Desogestrel|desogestrel|mesh-list
19390791|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390792|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390793|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390794|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414336|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414337|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390795|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390796|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390797|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19390798|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390799|NCT00967746|Progestins|progestins|mesh-ancestor
19390800|NCT00967746|Hormones|hormones|mesh-ancestor
19390801|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390802|NCT00944216|Emollients|emollients|mesh-list
19390803|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
19403835|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19403836|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403837|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403838|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
19403839|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19403840|NCT03599427|Lidocaine|lidocaine|mesh-list
19403841|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
19403842|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
19403843|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19403844|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403845|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
19403846|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19403847|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19403848|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19403849|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19403850|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403851|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403852|NCT03599323|Clotrimazole|clotrimazole|mesh-list
19403853|NCT03599323|Miconazole|miconazole|mesh-list
19403854|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19403855|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403856|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
19403857|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19403858|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19403859|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403860|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414338|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
20414339|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414340|NCT01211223|Amoxicillin|amoxicillin|mesh-list
20414341|NCT01211223|Metronidazole|metronidazole|mesh-list
20414342|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20414343|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414344|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20414345|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20414346|NCT01211275|Cisplatin|cisplatin|mesh-list
20414347|NCT01211275|Pemetrexed|pemetrexed|mesh-list
20414348|NCT01211275|Axitinib|axitinib|mesh-list
20414349|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414350|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414351|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414352|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20414353|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20414354|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403861|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19403862|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
19403863|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403864|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403865|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19403866|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19403867|NCT03599284|Clopidogrel|clopidogrel|mesh-list
19403868|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19403869|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19403870|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19403871|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19403872|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
19403873|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403874|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403875|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403876|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
20414355|NCT01211314|Enalapril|enalapril|mesh-list
20414356|NCT01211314|Lercanidipine|lercanidipine|mesh-list
20414357|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20414358|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
19403877|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19390804|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19390805|NCT00920634|Hormones|hormones|mesh-ancestor
19390806|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414359|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414360|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414361|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414362|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20414363|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20414364|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20414365|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414366|NCT01211327|Cyclosporine|cyclosporine|mesh-list
20414367|NCT01211327|Dexamethasone|dexamethasone|mesh-list
20414368|NCT01211327|Cyclosporins|cyclosporins|mesh-list
20414369|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414370|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
20414371|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
20414372|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414373|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414374|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414375|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
20414376|NCT01211327|Hormones|hormones|mesh-ancestor
20414377|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414378|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20414379|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414380|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414381|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414382|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414383|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
20414384|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
20414385|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414386|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414387|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414388|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19390807|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390808|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19390809|NCT00920361|Hormones|hormones|mesh-ancestor
19390810|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390811|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390812|NCT00886691|Bevacizumab|bevacizumab|mesh-list
19390813|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19390814|NCT00886691|Everolimus|everolimus|mesh-list
20215797|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
19390815|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
19390816|NCT00886691|Antibodies|antibodies|mesh-list
19390817|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
19390818|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19390819|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
19390820|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390821|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19390822|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19390823|NCT00886691|Growth Substances|growth substances|mesh-ancestor
19390824|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390825|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
19390826|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
19390827|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19390828|NCT00878462|Asenapine|asenapine|mesh-list
19390829|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19390830|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19390831|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390832|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390833|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390834|NCT00778999|Desogestrel|desogestrel|mesh-list
19390835|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390836|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19390837|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20215798|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215799|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
20215800|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215801|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215802|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215803|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
20215804|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215805|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414389|NCT01211457|Decitabine|decitabine|mesh-list
20414390|NCT01211457|Venetoclax|venetoclax|mesh-list
19390838|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390839|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390840|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390841|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390842|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390843|NCT00778999|Progestins|progestins|mesh-ancestor
19390844|NCT00778999|Hormones|hormones|mesh-ancestor
19390845|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390846|NCT00725413|Etonogestrel|etonogestrel|mesh-list
19390847|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390848|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390849|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390850|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390851|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390852|NCT00651807|Etonogestrel|etonogestrel|mesh-list
19390853|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390854|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390855|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390856|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390857|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390858|NCT00620464|Etonogestrel|etonogestrel|mesh-list
19390859|NCT00620464|Desogestrel|desogestrel|mesh-list
19390860|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390861|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390862|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390863|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390864|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390865|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19390866|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19390867|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390868|NCT00620464|Progestins|progestins|mesh-ancestor
19390869|NCT00620464|Hormones|hormones|mesh-ancestor
19390870|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390871|NCT00620035|Etonogestrel|etonogestrel|mesh-list
19390872|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390873|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390874|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390875|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390876|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390877|NCT00541684|Atenolol|atenolol|mesh-list
20215806|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20215807|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215808|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
20215809|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20215810|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20215811|NCT00303836|Analgesics|analgesics|mesh-ancestor
20215812|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
20215813|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390878|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
19390879|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390880|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390881|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390882|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
19390883|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390884|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19390885|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19390886|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
19390887|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19390888|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19390889|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19390890|NCT00431431|Tibolone|tibolone|mesh-list
19390891|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
19390892|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
19390893|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390894|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390895|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19390896|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390897|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390898|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19390899|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
19390900|NCT00431431|Hormones|hormones|mesh-ancestor
19390901|NCT00413764|Tibolone|tibolone|mesh-list
19390902|NCT00413764|Norethindrone|norethindrone|mesh-list
20215814|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19390903|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
19390904|NCT00413764|Estradiol|estradiol|mesh-list
19390905|NCT00413764|Estrogens|estrogens|mesh-ancestor
19390906|NCT00413764|Hormones|hormones|mesh-ancestor
19390907|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390908|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390909|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390910|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390911|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390912|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390913|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20215815|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20215816|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
20215817|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218043|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20218044|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20218045|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20218046|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20218047|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218048|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
20218049|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218050|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20218051|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
20218052|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390914|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19390915|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19390916|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
19390917|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
19390918|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19390919|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390920|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390921|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19390922|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
19390923|NCT00408863|Tibolone|tibolone|mesh-list
19390924|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
19390925|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
19390926|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390927|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390928|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19390929|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390930|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218053|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
20218054|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20218055|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20218056|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
20414391|NCT01211457|Sapacitabine|sapacitabine|mesh-list
20414392|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20414393|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
20414394|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414395|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414396|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414397|NCT01211470|Daptomycin|daptomycin|mesh-list
20414398|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20414399|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414400|NCT01211496|Methamphetamine|methamphetamine|mesh-list
20414401|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20414402|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414403|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
20414404|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
20414405|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414406|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
19390931|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19390932|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
19390933|NCT00408863|Hormones|hormones|mesh-ancestor
20414407|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414408|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19847995|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
19847996|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
20414409|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
20414410|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19390934|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
19390935|NCT00403793|Etonogestrel|etonogestrel|mesh-list
19390936|NCT00403793|Testosterone|testosterone|mesh-list
19390937|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
20218057|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390938|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
19390939|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19390940|NCT00403793|Androgens|androgens|mesh-ancestor
19390941|NCT00403793|Hormones|hormones|mesh-ancestor
19390942|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19390943|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390944|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19390945|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19390946|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
19390947|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19390948|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
19390949|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19390950|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19390951|NCT00159796|Olanzapine|olanzapine|mesh-list
20414411|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19390952|NCT00159796|Asenapine|asenapine|mesh-list
19390953|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
19390954|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
19390955|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390956|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390957|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390958|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19390959|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19390960|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390961|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390962|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19390963|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19390964|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19390965|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390966|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390967|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
19390968|NCT00159744|Olanzapine|olanzapine|mesh-list
19390969|NCT00159744|Asenapine|asenapine|mesh-list
19390970|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
19390971|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
19390972|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390973|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390974|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390975|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19390976|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19390977|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390978|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390979|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19390980|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20414412|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20414413|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20414414|NCT01211509|Montelukast|montelukast|mesh-list
20414415|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20414416|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
20414417|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20414418|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
20414419|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414420|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414421|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20414422|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20414423|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414424|NCT01211561|Selenium|selenium|mesh-list
20414425|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
20414426|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414427|NCT01211561|Protective Agents|protective agents|mesh-ancestor
20414428|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414429|NCT01211561|Trace Elements|trace elements|mesh-ancestor
20414430|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
20414431|NCT01211691|Antibodies|antibodies|mesh-list
19390981|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19390982|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19390983|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19390984|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
19390985|NCT00143182|Olanzapine|olanzapine|mesh-list
19390986|NCT00143182|Asenapine|asenapine|mesh-list
19390987|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
19390988|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
19390989|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19390990|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19390991|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19390992|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19390993|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19390994|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19390995|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19390996|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19390997|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19390998|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19390999|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391000|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391001|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
19391002|NCT03705442|Loperamide|loperamide|mesh-list
19391003|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
19391004|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19391005|NCT03705429|Paclitaxel|paclitaxel|mesh-list
19391006|NCT03705429|Docetaxel|docetaxel|mesh-list
19391007|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19391008|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
19391009|NCT03705429|Trastuzumab|trastuzumab|mesh-list
19391010|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391011|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391012|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391013|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391014|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391015|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391016|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391017|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
19391018|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391019|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391020|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19391021|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
19391022|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19391023|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391024|NCT03705351|Temozolomide|temozolomide|mesh-list
19391025|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19391026|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
19391027|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391028|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391029|NCT03705195|Gliclazide|gliclazide|mesh-list
19391030|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19391031|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391032|NCT03705065|Bupivacaine|bupivacaine|mesh-list
19391033|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
19391034|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
19391035|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391036|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391037|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
19391038|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391039|NCT03704909|Epinephrine|epinephrine|mesh-list
19391040|NCT03704909|Racepinephrine|racepinephrine|mesh-list
19391041|NCT03704909|Ephedrine|ephedrine|mesh-list
19391042|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
19391043|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19391044|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19391045|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
19391046|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391047|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391048|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391049|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19391050|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19391051|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
19391052|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391053|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19391054|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
19391055|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
19391056|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
19391057|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19391058|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19391059|NCT03704831|Anesthetics|anesthetics|mesh-list
19391060|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
19391061|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391062|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391063|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
20414432|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19391064|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391065|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
19391066|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19391067|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391068|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19391069|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391070|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
19391071|NCT03704766|Defensins|defensins|mesh-list
20414433|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
20414434|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414435|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20414436|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20414437|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20414438|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414439|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391072|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391073|NCT03704753|Ropivacaine|ropivacaine|mesh-list
19391074|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
19391075|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
19391076|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391077|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391078|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
19391079|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391080|NCT03704714|Prednisone|prednisone|mesh-list
19391081|NCT03704714|Cortisone|cortisone|mesh-list
19391082|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
19391083|NCT03704714|Rituximab|rituximab|mesh-list
19391084|NCT03704714|Doxorubicin|doxorubicin|mesh-list
20414440|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20414441|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20414442|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20414443|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
20414444|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414445|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414446|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20414447|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20414448|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
20414449|NCT01211795|Ketoprofen|ketoprofen|mesh-list
20414450|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20414451|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20414452|NCT01211795|Analgesics|analgesics|mesh-ancestor
20414453|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
20414454|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414455|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391085|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19391086|NCT03704714|Nivolumab|nivolumab|mesh-list
19391087|NCT03704714|Vincristine|vincristine|mesh-list
19391088|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19391089|NCT03704714|Antibodies|antibodies|mesh-list
19391090|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
19391091|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19391092|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391093|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
19391094|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391095|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391096|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19391097|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
19391098|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391099|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391100|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19391101|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19391102|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19391103|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19391104|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391105|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391106|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
19391107|NCT03704714|Hormones|hormones|mesh-ancestor
19391108|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391109|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19847997|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19847998|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19847999|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848000|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
19848001|NCT00689936|Hormones|hormones|mesh-ancestor
19391110|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19391111|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20414456|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414457|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414458|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20414459|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414460|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414461|NCT01211808|Diltiazem|diltiazem|mesh-list
20414462|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414463|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20414464|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20414465|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414466|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20414467|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414468|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414469|NCT01211821|Metoprolol|metoprolol|mesh-list
20414470|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20414471|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414472|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
20414473|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
20414474|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414475|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414476|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20414477|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20414478|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20414479|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
20414480|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414481|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414482|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
20414483|NCT01211847|Diazoxide|diazoxide|mesh-list
20414484|NCT01211847|Choline|choline|mesh-list
20414485|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
20414486|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20414487|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
20414488|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414489|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414490|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20414491|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
20414492|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19391112|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391113|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391114|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391115|NCT03704623|Acetaminophen|acetaminophen|mesh-list
19391116|NCT03704623|Parecoxib|parecoxib|mesh-list
19391117|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19391118|NCT03704623|Analgesics|analgesics|mesh-ancestor
19391119|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
19391120|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391121|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391122|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
19391123|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19391124|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19391125|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391126|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391127|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19391128|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391129|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391130|NCT03704506|Amoxicillin|amoxicillin|mesh-list
19391131|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19391132|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414493|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414494|NCT01211860|Diazoxide|diazoxide|mesh-list
20414495|NCT01211860|Choline|choline|mesh-list
19391133|NCT03704480|Durvalumab|durvalumab|mesh-list
19391134|NCT03704480|Tremelimumab|tremelimumab|mesh-list
19391135|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391136|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391137|NCT03704363|Infliximab|infliximab|mesh-list
19391138|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
19391139|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19391140|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391141|NCT03704246|Antibodies|antibodies|mesh-list
19391142|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19391143|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
20414496|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
19391144|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414497|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20414498|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
19391145|NCT03704220|Warfarin|warfarin|mesh-list
19391146|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
19391147|NCT03704181|Colchicine|colchicine|mesh-list
19391148|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
19391149|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391150|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391151|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391152|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391153|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391154|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391155|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
19391156|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19391157|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19391158|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19391159|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19391160|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391161|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
19391162|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391163|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391164|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19391165|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391166|NCT03704077|Paclitaxel|paclitaxel|mesh-list
20215818|NCT00303888|Docetaxel|docetaxel|mesh-list
20215819|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215820|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
20215821|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
20215822|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391167|NCT03704077|Nivolumab|nivolumab|mesh-list
19391168|NCT03704077|Ramucirumab|ramucirumab|mesh-list
19391169|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391170|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391171|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391172|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391173|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391174|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391175|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391176|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19403878|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403879|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403880|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19403881|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403882|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403883|NCT03598959|Tofacitinib|tofacitinib|mesh-list
19403884|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19403885|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403886|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403887|NCT03598868|Vortioxetine|vortioxetine|mesh-list
19403888|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
19403889|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19403890|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19403891|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19403892|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414499|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414500|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414501|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20414502|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
20414503|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414504|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414505|NCT01211912|Acetaminophen|acetaminophen|mesh-list
20414506|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19403893|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403894|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19403895|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19403896|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19403897|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215823|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215824|NCT00303927|Capecitabine|capecitabine|mesh-list
20215825|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215826|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
20215827|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215828|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215829|NCT00303940|Carboplatin|carboplatin|mesh-list
20215830|NCT00303940|Temozolomide|temozolomide|mesh-list
20215831|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414507|NCT01211912|Analgesics|analgesics|mesh-ancestor
19391177|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19391178|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391179|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391180|NCT03703596|Docetaxel|docetaxel|mesh-list
19391181|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391182|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
20414508|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
20414509|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414510|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391183|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391184|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391185|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391186|NCT03703427|Capecitabine|capecitabine|mesh-list
19391187|NCT03703427|Vinorelbine|vinorelbine|mesh-list
19391188|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391189|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
19391190|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391191|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391192|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391193|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391194|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391195|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391196|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
19391197|NCT03703349|Analgesics|analgesics|mesh-ancestor
19391198|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
20414511|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
20414512|NCT01211925|Aspirin|aspirin|mesh-list
20414513|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20414514|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20414515|NCT01211925|Analgesics|analgesics|mesh-ancestor
20414516|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
20414517|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391199|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391200|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391201|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
19391202|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391203|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19391204|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
19391205|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19391206|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19391207|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391208|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19391209|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
19391210|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19391211|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
19691572|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691573|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
19691574|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
19691575|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691576|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691577|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691578|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
19691579|NCT05003596|Hormones|hormones|mesh-ancestor
20215832|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215833|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
20215834|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215835|NCT00303992|Trastuzumab|trastuzumab|mesh-list
20215836|NCT00303992|Irinotecan|irinotecan|mesh-list
20215837|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215838|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215839|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20215840|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215841|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215842|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215843|NCT00304018|Prednisone|prednisone|mesh-list
20215844|NCT00304018|Fludarabine|fludarabine|mesh-list
20215845|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
20215846|NCT00304018|Etoposide|etoposide|mesh-list
20215847|NCT00304018|Busulfan|busulfan|mesh-list
20215848|NCT00304018|Tacrolimus|tacrolimus|mesh-list
20215849|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20414518|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414519|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391212|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20215850|NCT00304018|Sargramostim|sargramostim|mesh-list
19848002|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414520|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414521|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20414522|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20414523|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414524|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20414525|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20414526|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848003|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848004|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848005|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
19848006|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848007|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848008|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
20414527|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
20414528|NCT01211938|Cetuximab|cetuximab|mesh-list
20414529|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20414530|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848009|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19848010|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19848011|NCT00689936|Growth Substances|growth substances|mesh-ancestor
19848012|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
19848013|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19848014|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
20215851|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20215852|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
19391213|NCT03703271|Methotrexate|methotrexate|mesh-list
19391214|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19391215|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
19391216|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19391217|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391218|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391219|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
19391220|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391221|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391222|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
19391223|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215853|NCT00304018|Hormones|hormones|mesh-ancestor
20215854|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414531|NCT01212133|Liraglutide|liraglutide|mesh-list
20414532|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20414533|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414534|NCT01212133|Incretins|incretins|mesh-ancestor
20414535|NCT01212133|Hormones|hormones|mesh-ancestor
20414536|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414537|NCT01212250|Carvedilol|carvedilol|mesh-list
20414538|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20414539|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20414540|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
20414541|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414542|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414543|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414544|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414545|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
20414546|NCT01212250|Protective Agents|protective agents|mesh-ancestor
20414547|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20414548|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20414549|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20414550|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414551|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20414552|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20414553|NCT01212315|Triclosan|triclosan|mesh-list
20414554|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20414555|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215855|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215856|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20215857|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215858|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215859|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
19848015|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20218058|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
19391224|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19391225|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391226|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
19391227|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391228|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19391229|NCT03703206|Anesthetics|anesthetics|mesh-list
19391230|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
19391231|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391232|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391233|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
19391234|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391235|NCT03703167|Rituximab|rituximab|mesh-list
19391236|NCT03703167|Lenalidomide|lenalidomide|mesh-list
19391237|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391238|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391239|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
19391240|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391241|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414556|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20414557|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20414558|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
20414559|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414560|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20414561|NCT01212367|Interferons|interferons|mesh-list
19391242|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19391243|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19391244|NCT03703167|Growth Substances|growth substances|mesh-ancestor
19391245|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
19391246|NCT03703154|Tacrolimus|tacrolimus|mesh-list
19391247|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391248|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
19391249|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391250|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19391251|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391252|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391253|NCT03703089|Gemcitabine|gemcitabine|mesh-list
19391254|NCT03703089|Paclitaxel|paclitaxel|mesh-list
20414562|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
20414563|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
20414564|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20414565|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414566|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
20414567|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414568|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
20414569|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414570|NCT01212406|Vitamin D|vitamin d|mesh-list
19391255|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391256|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391257|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391258|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391259|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391260|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391261|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391262|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
19391263|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
19391264|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391265|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391266|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414571|NCT01212406|Vitamins|vitamins|mesh-ancestor
20414572|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
20414573|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414574|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20414575|NCT01212432|Daptomycin|daptomycin|mesh-list
20414576|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20414577|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414578|NCT01212523|Propofol|propofol|mesh-list
20414579|NCT01212523|Isoflurane|isoflurane|mesh-list
19391267|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
19391268|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391269|NCT03703063|Leucovorin|leucovorin|mesh-list
19391270|NCT03703063|Gemcitabine|gemcitabine|mesh-list
19391271|NCT03703063|Paclitaxel|paclitaxel|mesh-list
19391272|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20414580|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19391273|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848016|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848017|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
20414581|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391274|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391275|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391276|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391277|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391278|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391279|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
19391280|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
19391281|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391282|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391283|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391284|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
19391285|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391286|NCT03703063|Antidotes|antidotes|mesh-ancestor
19391287|NCT03703063|Protective Agents|protective agents|mesh-ancestor
19391288|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
19391289|NCT03703063|Vitamins|vitamins|mesh-ancestor
19391290|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
19391291|NCT03702985|Capecitabine|capecitabine|mesh-list
19391292|NCT03702985|Irinotecan|irinotecan|mesh-list
19391293|NCT03702985|Amifostine|amifostine|mesh-list
20414582|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414583|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20414584|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
20414585|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
20414586|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20414587|NCT01212653|Golimumab|golimumab|mesh-list
20414588|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20414589|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414590|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414591|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
20414592|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414593|NCT01212666|Ropivacaine|ropivacaine|mesh-list
20414594|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
20414595|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
20414596|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414597|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414598|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
20414599|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427639|NCT01288261|Bavituximab|bavituximab|mesh-list
20427640|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20427641|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391294|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391295|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
19391296|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391297|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391298|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19391299|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19391300|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391301|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19391302|NCT03702985|Protective Agents|protective agents|mesh-ancestor
20613198|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20613199|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20613200|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613201|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613202|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20215860|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215861|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215862|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
20215863|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20215864|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20215865|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215866|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215867|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20215868|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
20215869|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215870|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20215871|NCT00304135|Gemcitabine|gemcitabine|mesh-list
20215872|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
20215873|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215874|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20215875|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
20215876|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215877|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
19391303|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391304|NCT03702959|Betamethasone|betamethasone|mesh-list
20414600|NCT01212679|Mitogens|mitogens|mesh-list
20414601|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
20414602|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414603|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
20414604|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19391305|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391306|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
19391307|NCT03702959|Hormones|hormones|mesh-ancestor
19391308|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391309|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391310|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19391311|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
19391312|NCT03702946|Oxytocin|oxytocin|mesh-list
20414605|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
20414606|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414607|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
20414608|NCT01212809|Protective Agents|protective agents|mesh-ancestor
20414609|NCT01212822|Leucovorin|leucovorin|mesh-list
20414610|NCT01212822|Bevacizumab|bevacizumab|mesh-list
20414611|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20414612|NCT01212822|Fluorouracil|fluorouracil|mesh-list
20414613|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
20414614|NCT01212822|Antibodies|antibodies|mesh-list
19391313|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
19391314|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19391315|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391316|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19391317|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19391318|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391319|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19391320|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391321|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391322|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
19391323|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19391324|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19391325|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20414615|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
20414616|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20414617|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
20414618|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414619|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20414620|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20414621|NCT01212822|Growth Substances|growth substances|mesh-ancestor
20414622|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414623|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
19391326|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391327|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
19391328|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391329|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391330|NCT03702803|Alprazolam|alprazolam|mesh-list
20414624|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
20414625|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
20414626|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414627|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20414628|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414629|NCT01212822|Antidotes|antidotes|mesh-ancestor
20414630|NCT01212822|Protective Agents|protective agents|mesh-ancestor
20414631|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
20414632|NCT01212822|Vitamins|vitamins|mesh-ancestor
20414633|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
20414634|NCT01212887|Aldesleukin|aldesleukin|mesh-list
20414635|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
20414636|NCT01212887|Fludarabine|fludarabine|mesh-list
20414637|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
20414638|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414639|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
20414640|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414641|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414642|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20414643|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
20414644|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414645|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414646|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20414647|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20414648|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
20414649|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20414650|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20414651|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
20414652|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414653|NCT01212913|Insulin|insulin|mesh-list
20414654|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20414655|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
19391331|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19391332|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391333|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391334|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19391335|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19391336|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19391337|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
19391338|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
20414656|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
20414657|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
20414658|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20414659|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20414660|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414661|NCT01212965|Selenium|selenium|mesh-list
20414662|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
20414663|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414664|NCT01212965|Protective Agents|protective agents|mesh-ancestor
20414665|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414666|NCT01212965|Trace Elements|trace elements|mesh-ancestor
20414667|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
20414668|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
20414669|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20414670|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
20414671|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414672|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414673|NCT01213095|Rituximab|rituximab|mesh-list
19391339|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391340|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391341|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
19391342|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19391343|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
19391344|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391345|NCT03702738|Expectorants|expectorants|mesh-ancestor
20414674|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20414675|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414676|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
20414677|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414678|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414679|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20414680|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
20414681|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20414682|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19391346|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
19391347|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19391348|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
19391349|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391350|NCT03702738|Protective Agents|protective agents|mesh-ancestor
20414683|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20414684|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414685|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414686|NCT01213147|Clomiphene|clomiphene|mesh-list
20414687|NCT01213147|Enclomiphene|enclomiphene|mesh-list
20414688|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
20414689|NCT01213147|Buserelin|buserelin|mesh-list
20414690|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20414691|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
20414692|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414693|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414694|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20414695|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
20414696|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20414697|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20414698|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20414699|NCT01213238|Bevacizumab|bevacizumab|mesh-list
20414700|NCT01213238|Capecitabine|capecitabine|mesh-list
20414701|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
19391351|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391352|NCT03702738|Antidotes|antidotes|mesh-ancestor
20414702|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20414703|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391353|NCT03702647|Ropivacaine|ropivacaine|mesh-list
19391354|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
19391355|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
19391356|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391357|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391358|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
19391359|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391360|NCT03702621|Bupivacaine|bupivacaine|mesh-list
19391361|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
19391362|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
19391363|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391364|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391365|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
19391366|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391367|NCT03702582|Warfarin|warfarin|mesh-list
19391368|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
20414704|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20414705|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20414706|NCT01213238|Growth Substances|growth substances|mesh-ancestor
20414707|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414708|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
20414709|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20414710|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
20414711|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414712|NCT01213355|Scopolamine|scopolamine|mesh-list
20414713|NCT01213355|Donepezil|donepezil|mesh-list
20414714|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20414715|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20414716|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414717|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414718|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
20414719|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414720|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414721|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
20414722|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20414723|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
20414724|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
20414725|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414726|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414727|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
20414728|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20414729|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20414730|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
20414731|NCT01213368|Dronedarone|dronedarone|mesh-list
20414732|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20414733|NCT01213381|Gemcitabine|gemcitabine|mesh-list
20414734|NCT01213381|Carboplatin|carboplatin|mesh-list
20414735|NCT01213381|Iniparib|iniparib|mesh-list
20414736|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613203|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
19391369|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
19391370|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19391371|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
19391372|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19391373|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
19391374|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391375|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391376|NCT03702530|Albendazole|albendazole|mesh-list
19391377|NCT03702530|Vaccines|vaccines|mesh-list
19391378|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
19391379|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19391380|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391381|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
19391382|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19391383|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19391384|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391385|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391386|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391387|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391388|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391389|NCT03702530|Immunologic Factors|immunologic factors|mesh-ancestor
19391390|NCT03702530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391391|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
19391392|NCT03702491|Apatinib|apatinib|mesh-list
19391393|NCT03702491|Tegafur|tegafur|mesh-list
20414737|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20414738|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
20414739|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414740|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
20414741|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414742|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414743|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391394|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391395|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19391396|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391397|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391398|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391399|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
19391400|NCT03702426|Norfloxacin|norfloxacin|mesh-list
19391401|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19391402|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391403|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19391404|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19391405|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391406|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391407|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391408|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19391409|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19391410|NCT03702400|Phenylephrine|phenylephrine|mesh-list
19391411|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
19391412|NCT03702400|Norepinephrine|norepinephrine|mesh-list
19391413|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19391414|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
19691580|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691581|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19691582|NCT05003596|Protective Agents|protective agents|mesh-ancestor
19691583|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20414744|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
19391415|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
19391416|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391417|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391418|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
19391419|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19391420|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
19391421|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
19391422|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19391423|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19391424|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19391425|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
19391426|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391427|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391428|NCT03702400|Protective Agents|protective agents|mesh-ancestor
19391429|NCT03702387|Anesthetics|anesthetics|mesh-list
19391430|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391431|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403898|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403899|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
19403900|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19403901|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19403902|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19403903|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19403904|NCT03598816|Durvalumab|durvalumab|mesh-list
19403905|NCT03598816|Tremelimumab|tremelimumab|mesh-list
19403906|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403907|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403908|NCT03598738|Esomeprazole|esomeprazole|mesh-list
19403909|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19403910|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19403911|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19403912|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403913|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403914|NCT03598725|Prednisone|prednisone|mesh-list
19403915|NCT03598725|Rituximab|rituximab|mesh-list
19403916|NCT03598725|Factor VIII|factor viii|mesh-list
19403917|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19403918|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403919|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
20414745|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414746|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20414747|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
20414748|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19691584|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414749|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414750|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20414751|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
20414752|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19391432|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
19391433|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391434|NCT03702205|Betaine|betaine|mesh-list
19391435|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19391436|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
19391437|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19391438|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
19391439|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391440|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19391441|NCT03702140|Teriparatide|teriparatide|mesh-list
19391442|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19391443|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391444|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19391445|NCT03702023|Acetaminophen|acetaminophen|mesh-list
19391446|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19391447|NCT03702023|Analgesics|analgesics|mesh-ancestor
19391448|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
19391449|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391450|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391451|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
19391452|NCT03701984|Lidocaine|lidocaine|mesh-list
19391453|NCT03701984|Tramadol|tramadol|mesh-list
19391454|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
19391455|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
19391456|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391457|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391458|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
19391459|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391460|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19391461|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19391462|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20414753|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414754|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414755|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414756|NCT01213407|Temozolomide|temozolomide|mesh-list
20414757|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20414758|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
20414759|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414760|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414761|NCT01213433|Artesunate|artesunate|mesh-list
20414762|NCT01213433|Amodiaquine|amodiaquine|mesh-list
20414763|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
20414764|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20414765|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20414766|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414767|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391463|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19391464|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391465|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19391466|NCT03701984|Narcotics|narcotics|mesh-ancestor
19391467|NCT03701984|Analgesics|analgesics|mesh-ancestor
19391468|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
19391469|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19391470|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19391471|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19391472|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391473|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
19391474|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391475|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414768|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
20414769|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
20414770|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20414771|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
20414772|NCT01213498|Atorvastatin|atorvastatin|mesh-list
20414773|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20414774|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20414775|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
20414776|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391476|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20414777|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20414778|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19391477|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391478|NCT03701880|Bisoprolol|bisoprolol|mesh-list
19391479|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20414779|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414780|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
20414781|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20414782|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20414783|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414784|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
20414785|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414786|NCT01213563|Insulin|insulin|mesh-list
20414787|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20414788|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
20414789|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
20414790|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20414791|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414792|NCT01213667|Ranibizumab|ranibizumab|mesh-list
20414793|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20414794|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20414795|NCT01213667|Growth Substances|growth substances|mesh-ancestor
20414796|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414797|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
20414798|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414799|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20414800|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
20414801|NCT01213680|Hematinics|hematinics|mesh-ancestor
20414802|NCT01213693|Fluticasone|fluticasone|mesh-list
20414803|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20414804|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414805|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20414806|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
20414807|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414808|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414809|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20414810|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
20414811|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414812|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20414813|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20414814|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20414815|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20414816|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20414817|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391480|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
19391481|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
19391482|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391483|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391484|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19391485|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19391486|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19391487|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19391488|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391489|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391490|NCT03701750|Heparin|heparin|mesh-list
19391491|NCT03701750|Enoxaparin|enoxaparin|mesh-list
19391492|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19391493|NCT03701750|Tinzaparin|tinzaparin|mesh-list
19391494|NCT03701750|Dalteparin|dalteparin|mesh-list
19391495|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
19391496|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
19391497|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19391498|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19391499|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391500|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
19391501|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19391502|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19391503|NCT03701698|Prednisolone|prednisolone|mesh-list
19391504|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
19391505|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19391506|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
19391507|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391508|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
19391509|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
20414818|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391510|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414819|NCT01213719|Betaine|betaine|mesh-list
19391511|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414820|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414821|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
19391512|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19391513|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
19391514|NCT03701698|Hormones|hormones|mesh-ancestor
19391515|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391516|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19391517|NCT03701698|Protective Agents|protective agents|mesh-ancestor
19391518|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19391519|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391520|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
19391521|NCT03701672|Analgesics|analgesics|mesh-list
19391522|NCT03701672|Narcotics|narcotics|mesh-ancestor
19391523|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391524|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391525|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
19391526|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391527|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
19391528|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19391529|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19391530|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391531|NCT03701529|Anesthetics|anesthetics|mesh-list
19391532|NCT03701529|Propofol|propofol|mesh-list
19391533|NCT03701529|Sevoflurane|sevoflurane|mesh-list
19391534|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391535|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391536|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19391537|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19391538|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
19391539|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19391540|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19391541|NCT03701503|Hormones|hormones|mesh-list
19391542|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391543|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391544|NCT03701490|Progesterone|progesterone|mesh-list
19391545|NCT03701490|Progestins|progestins|mesh-ancestor
19391546|NCT03701490|Hormones|hormones|mesh-ancestor
19391547|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391548|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391549|NCT03701451|Decitabine|decitabine|mesh-list
19391550|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391551|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
19391552|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391553|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391554|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391555|NCT03701321|Dexamethasone|dexamethasone|mesh-list
19391556|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
19391557|NCT03701321|Bortezomib|bortezomib|mesh-list
19391558|NCT03701321|Venetoclax|venetoclax|mesh-list
19391559|NCT03701321|Daratumumab|daratumumab|mesh-list
19391560|NCT03701321|Ichthammol|ichthammol|mesh-list
20414822|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20414823|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
20414824|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414825|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20414826|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20414827|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414828|NCT01213849|Fluticasone|fluticasone|mesh-list
20414829|NCT01213849|Xhance|xhance|mesh-list
20414830|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20414831|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20414832|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
20414833|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20414834|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414835|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20414836|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
20414837|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414838|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20414839|NCT01213888|Trientine|trientine|mesh-list
20414840|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
20414841|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
20414842|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414843|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
20414844|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19391561|NCT03701321|BB 1101|bb 1101|mesh-list
20414845|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414846|NCT01213979|Iron|iron|mesh-list
19391562|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391563|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
19391564|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
19391565|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391566|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391567|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19391568|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
19391569|NCT03701321|Hormones|hormones|mesh-ancestor
19391570|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391571|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19391572|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391573|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
19391574|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391575|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391576|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
19391577|NCT03701256|Atracurium|atracurium|mesh-list
19391578|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19391579|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19391580|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19391581|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391582|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391583|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19391584|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19391585|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
19391586|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391587|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391588|NCT03701126|Bupivacaine|bupivacaine|mesh-list
19391589|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
19391590|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
19391591|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391592|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391593|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
19391594|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391595|NCT03701087|Vitamin D|vitamin d|mesh-list
19391596|NCT03701087|Vitamins|vitamins|mesh-ancestor
19391597|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
19391598|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391599|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19391600|NCT03701022|Apatinib|apatinib|mesh-list
19391601|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391602|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19391603|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391604|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391605|NCT03700905|Nivolumab|nivolumab|mesh-list
19391606|NCT03700905|Ipilimumab|ipilimumab|mesh-list
19391607|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391608|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391609|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19391610|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391611|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19391612|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19391613|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391614|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19391615|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391616|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391617|NCT03700801|Insulin|insulin|mesh-list
19391618|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19391619|NCT03700801|Metformin|metformin|mesh-list
19391620|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
19391621|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
19391622|NCT03700801|Saxagliptin|saxagliptin|mesh-list
19391623|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19391624|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391625|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19391626|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391627|NCT03700801|Incretins|incretins|mesh-ancestor
19391628|NCT03700801|Hormones|hormones|mesh-ancestor
19391629|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391630|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19391631|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
19391632|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391633|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
19391634|NCT03700788|Calcium|calcium|mesh-list
19391635|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19391636|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414847|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20414848|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
20414849|NCT01213979|Trace Elements|trace elements|mesh-ancestor
20414850|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
19391637|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19391638|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391639|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
20414851|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414852|NCT01213979|Hematinics|hematinics|mesh-ancestor
20414853|NCT01213992|Iron|iron|mesh-list
20414854|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20414855|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
20414856|NCT01213992|Trace Elements|trace elements|mesh-ancestor
20414857|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
20414858|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414859|NCT01213992|Hematinics|hematinics|mesh-ancestor
20414860|NCT01214122|Warfarin|warfarin|mesh-list
20414861|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
20414862|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
20414863|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20414864|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414865|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414866|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20414867|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20414868|NCT01214226|Protective Agents|protective agents|mesh-ancestor
20414869|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414870|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
20414871|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20414872|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
20414873|NCT01214291|Toremifene|toremifene|mesh-list
20414874|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20414875|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414876|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20414877|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20414878|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
20414879|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414880|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414881|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20414882|NCT01214343|Sorafenib|sorafenib|mesh-list
20414883|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414884|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20414885|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414886|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414887|NCT01214382|Sertraline|sertraline|mesh-list
20414888|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
20414889|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20414890|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20414891|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20414892|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20414893|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414894|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391640|NCT03700749|Iodine|iodine|mesh-list
19391641|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
19391642|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19391643|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
19391644|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
19391645|NCT03700749|Povidone|povidone|mesh-list
19391646|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19391647|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391648|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
19391649|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19391650|NCT03700749|Trace Elements|trace elements|mesh-ancestor
19391651|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
19391652|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391653|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
19391654|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
20414895|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
20414896|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414897|NCT01214408|Pantoprazole|pantoprazole|mesh-list
20414898|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20414899|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20414900|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20414901|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414902|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414903|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
19391655|NCT03700645|Allopurinol|allopurinol|mesh-list
19391656|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
19391657|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391658|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391659|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
20215878|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391660|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391661|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19391662|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
19391663|NCT03700645|Protective Agents|protective agents|mesh-ancestor
19391664|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403920|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403921|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19403922|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19403923|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
19403924|NCT03598725|Hormones|hormones|mesh-ancestor
19403925|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19403926|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19403927|NCT03598725|Coagulants|coagulants|mesh-ancestor
19403928|NCT03598673|Nebivolol|nebivolol|mesh-list
19403929|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19403930|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
19403931|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19403932|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19403933|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19403934|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
19403935|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403936|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403937|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403938|NCT03598634|Riboflavin|riboflavin|mesh-list
19403939|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
19403940|NCT03598634|Vitamins|vitamins|mesh-ancestor
19403941|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
19403942|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403943|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19403944|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
20414904|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20414905|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20414906|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
20414907|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414908|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20414909|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20414910|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414911|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427642|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
19404785|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19404786|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404787|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19404788|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404789|NCT03591913|Misoprostol|misoprostol|mesh-list
19404790|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19404791|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
19404792|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20427643|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
20427644|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
20427645|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427646|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20427647|NCT01288326|Liraglutide|liraglutide|mesh-list
19404793|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404794|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20215879|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215880|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20215881|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
20215882|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215883|NCT00304200|Temozolomide|temozolomide|mesh-list
20215884|NCT00304200|Sunitinib|sunitinib|mesh-list
20215885|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20215886|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
20215887|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215888|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215889|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20215890|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20215891|NCT00304200|Growth Substances|growth substances|mesh-ancestor
20215892|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215893|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
19391665|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
19391666|NCT03700515|Hematinics|hematinics|mesh-ancestor
19391667|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
19391668|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
19391669|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19391670|NCT03700489|Protective Agents|protective agents|mesh-ancestor
19391671|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391672|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
19391673|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19391674|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
19391675|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391676|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
19391677|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391678|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391679|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19391680|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
19391681|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391682|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391683|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19391684|NCT03700359|Etoposide|etoposide|mesh-list
19391685|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391686|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391687|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19391688|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19391689|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391690|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391691|NCT03700333|Pemetrexed|pemetrexed|mesh-list
19391692|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391693|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391694|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391695|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19391696|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19391697|NCT03700229|Rituximab|rituximab|mesh-list
19391698|NCT03700229|Bortezomib|bortezomib|mesh-list
19391699|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391700|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391701|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
19391702|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391703|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391704|NCT03700177|Dexamethasone|dexamethasone|mesh-list
19391705|NCT03700177|Ropivacaine|ropivacaine|mesh-list
19391706|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391707|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
19391708|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
19391709|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391710|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391711|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19391712|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
19391713|NCT03700177|Hormones|hormones|mesh-ancestor
19691585|NCT05003596|Analgesics|analgesics|mesh-ancestor
19691586|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
19691587|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414912|NCT01214746|Atorvastatin|atorvastatin|mesh-list
20414913|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20414914|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20414915|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
20414916|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414917|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20414918|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20414919|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414920|NCT01214772|Heparin|heparin|mesh-list
20414921|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
20414922|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20414923|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20414924|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414925|NCT01214889|Vaccines|vaccines|mesh-list
20414926|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
20414927|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414928|NCT01214928|Vitamin D|vitamin d|mesh-list
20414929|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
19691588|NCT05003700|Lenvatinib|lenvatinib|mesh-list
19691589|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391714|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391715|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691590|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19691591|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691592|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693074|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
19693075|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693076|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19693077|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19693078|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
19693079|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
19693080|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19693081|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19693082|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19693083|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19848018|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19848019|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848020|NCT00690235|Pramlintide|pramlintide|mesh-list
19848021|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19848022|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848023|NCT00690378|Imipenem|imipenem|mesh-list
19848024|NCT00690378|Ceftazidime|ceftazidime|mesh-list
19848025|NCT00690378|Avibactam|avibactam|mesh-list
19848026|NCT00690378|Cilastatin|cilastatin|mesh-list
19848027|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19848028|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848029|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
19848030|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848031|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391716|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391717|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
19848032|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19848033|NCT00690430|Octreotide|octreotide|mesh-list
19848034|NCT00690430|Pasireotide|pasireotide|mesh-list
19848035|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848036|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848037|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848038|NCT00690430|Hormones|hormones|mesh-ancestor
20414930|NCT01214928|Vitamins|vitamins|mesh-ancestor
20414931|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
20414932|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414933|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20414934|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20414935|NCT01214941|Itraconazole|itraconazole|mesh-list
20414936|NCT01214941|Ticlopidine|ticlopidine|mesh-list
20414937|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
20414938|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414939|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19391718|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
19391719|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391720|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
19391721|NCT03700099|Docetaxel|docetaxel|mesh-list
19391722|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391723|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391724|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391725|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391726|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391727|NCT03699956|Carboplatin|carboplatin|mesh-list
19391728|NCT03699956|Etoposide|etoposide|mesh-list
20414940|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20414941|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414942|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414943|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20414944|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
20414945|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20414946|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414947|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20414948|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20414949|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20414950|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20414951|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19391729|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391730|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391731|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19693084|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
19848039|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693085|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
19848040|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848041|NCT00690443|Atorvastatin|atorvastatin|mesh-list
20414952|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20414953|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20414954|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
19848042|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19848043|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19848044|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
19848045|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848046|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19848047|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19848048|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848049|NCT00690495|Propofol|propofol|mesh-list
19848050|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19848051|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848052|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848053|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19391732|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19391733|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391734|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391735|NCT03699904|Valacyclovir|valacyclovir|mesh-list
19391736|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
19391737|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391738|NCT03699839|Vaccines|vaccines|mesh-list
19391739|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
19391740|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391741|NCT03699774|Firuglipel|firuglipel|mesh-list
19391742|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19391743|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19391744|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19391745|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
19391746|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391747|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19391748|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19391749|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391750|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19391751|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848054|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
19848055|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
19848056|NCT00690573|Adalimumab|adalimumab|mesh-list
19848057|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848058|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20414955|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20414956|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20414957|NCT01214993|Dolutegravir|dolutegravir|mesh-list
20414958|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20414959|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20414960|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20414961|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414962|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20414963|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20414964|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
20414965|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20414966|NCT01215019|Mannitol|mannitol|mesh-list
20414967|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20414968|NCT01215019|Diuretics|diuretics|mesh-ancestor
20414969|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
20414970|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414971|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
20414972|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20414973|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20414974|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414975|NCT01215136|Paclitaxel|paclitaxel|mesh-list
20414976|NCT01215136|Everolimus|everolimus|mesh-list
20414977|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20414978|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20414979|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
20414980|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
20414981|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
20414982|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20414983|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19391752|NCT03699696|Propofol|propofol|mesh-list
19391753|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20414984|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
20414985|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848059|NCT00690612|Candesartan|candesartan|mesh-list
19848060|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
19391754|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391755|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391756|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19391757|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
19391758|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
19391759|NCT03699618|Bevacizumab|bevacizumab|mesh-list
19391760|NCT03699618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391761|NCT03699618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391762|NCT03699618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19391763|NCT03699618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19391764|NCT03699618|Growth Substances|growth substances|mesh-ancestor
19391765|NCT03699618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391766|NCT03699618|Growth Inhibitors|growth inhibitors|mesh-ancestor
19391767|NCT03699449|Paclitaxel|paclitaxel|mesh-list
19391768|NCT03699449|Durvalumab|durvalumab|mesh-list
20414986|NCT01215149|Vaccines|vaccines|mesh-list
20414987|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
20414988|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414989|NCT01215214|Midazolam|midazolam|mesh-list
20414990|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20414991|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20414992|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20414993|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20414994|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20414995|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20414996|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20414997|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20414998|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
20414999|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
20415000|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
20415001|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
20415002|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415003|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415004|NCT01215266|Sorafenib|sorafenib|mesh-list
20415005|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415006|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415007|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415008|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415009|NCT01215331|Insulin|insulin|mesh-list
20415010|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20415011|NCT01215331|Metformin|metformin|mesh-list
20415012|NCT01215331|Glyburide|glyburide|mesh-list
20415013|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20415014|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415015|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20415016|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
20415017|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20415018|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20415019|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391769|NCT03699449|Olaparib|olaparib|mesh-list
19391770|NCT03699449|Tremelimumab|tremelimumab|mesh-list
19391771|NCT03699449|Cediranib|cediranib|mesh-list
19391772|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19391773|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391774|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391775|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391776|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391777|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391778|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391779|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391780|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
19391781|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391782|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19391783|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391784|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19391785|NCT03699423|Atropine|atropine|mesh-list
19391786|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20415020|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415021|NCT01215409|Urological Agents|urological agents|mesh-ancestor
20415022|NCT01215539|Panitumumab|panitumumab|mesh-list
20415023|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391787|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19391788|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20415024|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415025|NCT01215565|Sunitinib|sunitinib|mesh-list
20415026|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403945|NCT03598595|Gemcitabine|gemcitabine|mesh-list
19391789|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19391790|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19391791|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
19391792|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391793|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415027|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415028|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415029|NCT01215565|Growth Substances|growth substances|mesh-ancestor
20415030|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415031|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415032|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415033|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415034|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415035|NCT01215578|Sunitinib|sunitinib|mesh-list
20415036|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415037|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415038|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415039|NCT01215578|Growth Substances|growth substances|mesh-ancestor
20415040|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415041|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415042|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415043|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415044|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415045|NCT01215669|Vaccines|vaccines|mesh-list
20415046|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
20415047|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415048|NCT01215682|Vitamin D|vitamin d|mesh-list
20415049|NCT01215682|Vitamins|vitamins|mesh-ancestor
20415050|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
20415051|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415052|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20415053|NCT01215708|Tamsulosin|tamsulosin|mesh-list
20415054|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20415055|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20415056|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20415057|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
20415058|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415059|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415060|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415061|NCT01215708|Urological Agents|urological agents|mesh-ancestor
20415062|NCT01215799|Bafetinib|bafetinib|mesh-list
20415063|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415064|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415065|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415066|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
19391794|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19391795|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
19391796|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
19391797|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
19391798|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19391799|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19391800|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
19391801|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391802|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391803|NCT03699384|Azacitidine|azacitidine|mesh-list
20415067|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20415068|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415069|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391804|NCT03699384|Avelumab|avelumab|mesh-list
20215894|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20215895|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215896|NCT00304213|Testosterone|testosterone|mesh-list
20215897|NCT00304213|Androgens|androgens|mesh-ancestor
20215898|NCT00304213|Hormones|hormones|mesh-ancestor
20215899|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215900|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215901|NCT00304226|Amlodipine|amlodipine|mesh-list
20215902|NCT00304226|Valsartan|valsartan|mesh-list
20215903|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20215904|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20215905|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415070|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20415071|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391805|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19391806|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
20415072|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20415073|NCT01216007|Propofol|propofol|mesh-list
20415074|NCT01216007|Sevoflurane|sevoflurane|mesh-list
20415075|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20415076|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415077|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415078|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20415079|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
20415080|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
20415081|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20415082|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20415083|NCT01216020|Cisplatin|cisplatin|mesh-list
20415084|NCT01216020|Cetuximab|cetuximab|mesh-list
20415085|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415086|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415087|NCT01216046|Ivacaftor|ivacaftor|mesh-list
20415088|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20415089|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415090|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415091|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
20415092|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415093|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415094|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415095|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415096|NCT01216111|Paclitaxel|paclitaxel|mesh-list
20415097|NCT01216111|Docetaxel|docetaxel|mesh-list
20415098|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
20415099|NCT01216111|Fluorouracil|fluorouracil|mesh-list
20415100|NCT01216111|Epirubicin|epirubicin|mesh-list
20415101|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20415102|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415103|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
20415104|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391807|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391808|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391809|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391810|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391811|NCT03699332|Labetuzumab|labetuzumab|mesh-list
19391812|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19391813|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391814|NCT03699293|Aspirin|aspirin|mesh-list
19391815|NCT03699293|Celecoxib|celecoxib|mesh-list
20415105|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
20415106|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415107|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415108|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
20415109|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415110|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20415111|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20415112|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
20415113|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20415114|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
20415115|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20415116|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20415117|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20415118|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20415119|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415120|NCT01216124|Docetaxel|docetaxel|mesh-list
20415121|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
20415122|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415123|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
20415124|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
20415125|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
20415126|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415127|NCT01216267|Lansoprazole|lansoprazole|mesh-list
20415128|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
20415129|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20415130|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415131|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20415132|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391816|NCT03699293|Naproxen|naproxen|mesh-list
20415133|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415134|NCT01216293|Esomeprazole|esomeprazole|mesh-list
19403946|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
20415135|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
19391817|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19391818|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20415136|NCT01216293|Lansoprazole|lansoprazole|mesh-list
20415137|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20415138|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415139|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20415140|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391819|NCT03699293|Analgesics|analgesics|mesh-ancestor
19391820|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
19391821|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391822|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391823|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391824|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391825|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19391826|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19391827|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391828|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19391829|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19391830|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391831|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
19391832|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19391833|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
19391834|NCT03699254|Valganciclovir|valganciclovir|mesh-list
19391835|NCT03699254|Ganciclovir|ganciclovir|mesh-list
19391836|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19391837|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
19391838|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391839|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19391840|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391841|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391842|NCT03699215|Simendan|simendan|mesh-list
19391843|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19391844|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
20415141|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415142|NCT01216345|Gemcitabine|gemcitabine|mesh-list
20415143|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
20415144|NCT01216345|Cetuximab|cetuximab|mesh-list
20415145|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20415146|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
20415147|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415148|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415149|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
20415150|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415151|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415152|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415153|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
20415154|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415155|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415156|NCT01216371|Sunitinib|sunitinib|mesh-list
20415157|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415158|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415159|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415160|NCT01216371|Growth Substances|growth substances|mesh-ancestor
20415161|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415162|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415163|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415164|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415165|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415166|NCT01216436|Vaccines|vaccines|mesh-list
20415167|NCT01216436|Immunologic Factors|immunologic factors|mesh-ancestor
20415168|NCT01216436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415169|NCT01216449|Citalopram|citalopram|mesh-list
20415170|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20415171|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20415172|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415173|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415174|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415175|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
20415176|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415177|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20415178|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
20415179|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20415180|NCT01216488|Lidocaine|lidocaine|mesh-list
19391845|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19391846|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19391847|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391848|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391849|NCT03699215|Protective Agents|protective agents|mesh-ancestor
19391850|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391851|NCT03699202|Ziresovir|ziresovir|mesh-list
19391852|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
19391853|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391854|NCT03699033|Paclitaxel|paclitaxel|mesh-list
19391855|NCT03699033|Carboplatin|carboplatin|mesh-list
19391856|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19391857|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391858|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
19391859|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
19391860|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19391861|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391862|NCT03698916|Celecoxib|celecoxib|mesh-list
20415181|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
20415182|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
20415183|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391863|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19391864|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19391865|NCT03698916|Analgesics|analgesics|mesh-ancestor
19391866|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
19391867|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391868|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391869|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20215906|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215907|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20215908|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415184|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415185|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
20415186|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415187|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20415188|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20415189|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20415190|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415191|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427648|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427649|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427650|NCT01288326|Incretins|incretins|mesh-ancestor
20427651|NCT01288326|Hormones|hormones|mesh-ancestor
20427652|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20215909|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
20215910|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20215911|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20215912|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20215913|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20215914|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20215915|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
20215916|NCT00304252|Interferons|interferons|mesh-list
20215917|NCT00304252|Interferon-beta|interferon-beta|mesh-list
20427653|NCT01288339|Leucovorin|leucovorin|mesh-list
20427654|NCT01288339|Fluorouracil|fluorouracil|mesh-list
20427655|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
20427656|NCT01288339|Panitumumab|panitumumab|mesh-list
20427657|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
20427658|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427659|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20427660|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427661|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427662|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
20427663|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427664|NCT01288339|Antidotes|antidotes|mesh-ancestor
20427665|NCT01288339|Protective Agents|protective agents|mesh-ancestor
20427666|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
20427667|NCT01288339|Vitamins|vitamins|mesh-ancestor
20427668|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
20427669|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20427670|NCT01288378|Caspofungin|caspofungin|mesh-list
20427671|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
20427672|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427673|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428697|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20215918|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
20215919|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215920|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
20215921|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391870|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691593|NCT05002725|Lidocaine|lidocaine|mesh-list
20415192|NCT01216579|Mannitol|mannitol|mesh-list
20415193|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19691594|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
20215922|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
20415194|NCT01216579|Diuretics|diuretics|mesh-ancestor
20415195|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
20415196|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415197|NCT01216605|Oxytocin|oxytocin|mesh-list
20415198|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
20415199|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20415200|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415201|NCT01216644|Leucovorin|leucovorin|mesh-list
20415202|NCT01216644|Docetaxel|docetaxel|mesh-list
20415203|NCT01216644|Fluorouracil|fluorouracil|mesh-list
20415204|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
20415205|NCT01216644|Epirubicin|epirubicin|mesh-list
20415206|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415207|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
20415208|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
20415209|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
20415210|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415211|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
20415212|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20415213|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415214|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
20415215|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415216|NCT01216644|Antidotes|antidotes|mesh-ancestor
20415217|NCT01216644|Protective Agents|protective agents|mesh-ancestor
20415218|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
20415219|NCT01216644|Vitamins|vitamins|mesh-ancestor
20415220|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
20415221|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20415222|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20415223|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20415224|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415225|NCT01216657|Sunitinib|sunitinib|mesh-list
20415226|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415227|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415228|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415229|NCT01216657|Growth Substances|growth substances|mesh-ancestor
20415230|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415231|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415232|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20215923|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215924|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20215925|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
20215926|NCT00304291|Analgesics|analgesics|mesh-ancestor
20215927|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
20215928|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215929|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215930|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215931|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20215932|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20215933|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215934|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215935|NCT00304317|Celecoxib|celecoxib|mesh-list
20215936|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20215937|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20215938|NCT00304317|Analgesics|analgesics|mesh-ancestor
20215939|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
20215940|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215941|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215942|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20215943|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20215944|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20215945|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20215946|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691595|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
20415233|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415234|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415235|NCT01216696|Ipilimumab|ipilimumab|mesh-list
19391871|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19391872|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19391873|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391874|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415236|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415237|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415238|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20415239|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415240|NCT01216709|Iron|iron|mesh-list
20415241|NCT01216709|Trace Elements|trace elements|mesh-ancestor
20415242|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
20415243|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415244|NCT01216787|R04929097|r04929097|mesh-list
20415245|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415246|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415247|NCT01216826|Everolimus|everolimus|mesh-list
20415248|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415249|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415250|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
20415251|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415252|NCT01216839|Everolimus|everolimus|mesh-list
20415253|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415254|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19403947|NCT03598595|Docetaxel|docetaxel|mesh-list
19403948|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19403949|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
19403950|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403951|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19403952|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
19403953|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415255|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
20415256|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415257|NCT01216852|Losartan|losartan|mesh-list
20415258|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20415259|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415260|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415261|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415262|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415263|NCT01216878|Losartan|losartan|mesh-list
20415264|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20415265|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415266|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415267|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415268|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415269|NCT01216904|Nicotine|nicotine|mesh-list
20415270|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20415271|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
20415272|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415273|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415274|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20415275|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20415276|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
20415277|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415278|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415279|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
20415280|NCT01216956|Niacin|niacin|mesh-list
20415281|NCT01216956|Niacinamide|niacinamide|mesh-list
20415282|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
20415283|NCT01216956|Vitamins|vitamins|mesh-ancestor
20415284|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
20415285|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415286|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20415287|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
20415288|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415289|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20415290|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
20415291|NCT01217034|Sorafenib|sorafenib|mesh-list
20415292|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
20415293|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415294|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415295|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415296|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415297|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20415298|NCT01217034|Estrogens|estrogens|mesh-ancestor
20415299|NCT01217034|Hormones|hormones|mesh-ancestor
19391875|NCT03698851|Methamphetamine|methamphetamine|mesh-list
19391876|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19391877|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391878|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
19391879|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
19391880|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391881|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
19391882|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391883|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391884|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
19391885|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19391886|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19391887|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19391888|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20415300|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415301|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415302|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20415303|NCT01217086|Infliximab|infliximab|mesh-list
20415304|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
19391889|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
19391890|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19391891|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19391892|NCT03698734|Analgesics|analgesics|mesh-ancestor
19391893|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
19391894|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391895|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391896|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391897|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391898|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19391899|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
19391900|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391901|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19391902|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
19391903|NCT03698695|Mefloquine|mefloquine|mesh-list
19391904|NCT03698695|Donepezil|donepezil|mesh-list
19391905|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19391906|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391907|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391908|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
19391909|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391910|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391911|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
19391912|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
19391913|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19391914|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19391915|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391916|NCT03698682|Levofloxacin|levofloxacin|mesh-list
19391917|NCT03698682|Ofloxacin|ofloxacin|mesh-list
19391918|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19391919|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19391920|NCT03698682|Renal Agents|renal agents|mesh-ancestor
19391921|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19391922|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19391923|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19391924|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415305|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415306|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20415307|NCT01217099|Azithromycin|azithromycin|mesh-list
20415308|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
20415309|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20415310|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20415311|NCT01217099|Prednisolone|prednisolone|mesh-list
20415312|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
20415313|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20415314|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
20415315|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20415316|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
20415317|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
20415318|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415319|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415320|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415321|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
20415322|NCT01217099|Hormones|hormones|mesh-ancestor
19391925|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391926|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391927|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19391928|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19391929|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
19391930|NCT03698669|Narcotics|narcotics|mesh-ancestor
19391931|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391932|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391933|NCT03698669|Analgesics|analgesics|mesh-ancestor
19391934|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
19391935|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391936|NCT03698630|Dexamethasone|dexamethasone|mesh-list
19391937|NCT03698630|Prednisolone|prednisolone|mesh-list
19391938|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19391939|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
19391940|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19391941|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
19391942|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19391943|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
19391944|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391945|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
19391946|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
19391947|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391948|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391949|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19391950|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
19391951|NCT03698630|Hormones|hormones|mesh-ancestor
19391952|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19391953|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19391954|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19391955|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19391956|NCT03698630|Protective Agents|protective agents|mesh-ancestor
19391957|NCT03698617|Propofol|propofol|mesh-list
19391958|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19391959|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20215947|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215948|NCT00304369|Metronidazole|metronidazole|mesh-list
20215949|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215950|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20215951|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20215952|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20215953|NCT00304382|Vaccines|vaccines|mesh-list
20215954|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19391960|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391961|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19391962|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
19391963|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
19391964|NCT03698513|Aspirin|aspirin|mesh-list
19391965|NCT03698513|Clopidogrel|clopidogrel|mesh-list
19391966|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19391967|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19391968|NCT03698513|Analgesics|analgesics|mesh-ancestor
19391969|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
19391970|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391971|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415323|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415324|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20415325|NCT01217099|Protective Agents|protective agents|mesh-ancestor
20415326|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20415327|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415328|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20415329|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415330|NCT01217125|Sirolimus|sirolimus|mesh-list
20415331|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20415332|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415333|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20415334|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415335|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
20415336|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415337|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
20415338|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415339|NCT01217138|Epinephrine|epinephrine|mesh-list
20415340|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20415341|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20215955|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
20415342|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
19391972|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19391973|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19391974|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19391975|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19391976|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391977|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19391978|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19391979|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19391980|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
19391981|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19391982|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19391983|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19391984|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
19391985|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19391986|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
19391987|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
19391988|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
19391989|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
19391990|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19391991|NCT03698474|Analgesics|analgesics|mesh-ancestor
19391992|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
19391993|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19391994|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19391995|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
19391996|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19391997|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19391998|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
19391999|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19392000|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19392001|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392002|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
19392003|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19392004|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
19392005|NCT03698474|Protective Agents|protective agents|mesh-ancestor
19392006|NCT03698474|Vitamins|vitamins|mesh-ancestor
19392007|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
19392008|NCT03698474|Cathartics|cathartics|mesh-ancestor
19392009|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20215956|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215957|NCT00304421|Rabeprazole|rabeprazole|mesh-list
20215958|NCT00304421|Pantoprazole|pantoprazole|mesh-list
20215959|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20215960|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20215961|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20215962|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215963|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392010|NCT03698461|Leucovorin|leucovorin|mesh-list
19392011|NCT03698461|Bevacizumab|bevacizumab|mesh-list
19392012|NCT03698461|Fluorouracil|fluorouracil|mesh-list
19392013|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
19392014|NCT03698461|Atezolizumab|atezolizumab|mesh-list
19392015|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
19392016|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392017|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392018|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19392019|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19392020|NCT03698461|Growth Substances|growth substances|mesh-ancestor
20215964|NCT00304434|Oseltamivir|oseltamivir|mesh-list
20215965|NCT00304434|Probenecid|probenecid|mesh-list
19392021|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392022|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
19392023|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
19392024|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392025|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19392026|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392027|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
20215966|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
20215967|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215968|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20215969|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215970|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
20215971|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
20215972|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392028|NCT03698461|Antidotes|antidotes|mesh-ancestor
19392029|NCT03698461|Protective Agents|protective agents|mesh-ancestor
20215973|NCT00304434|Renal Agents|renal agents|mesh-ancestor
20215974|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
19392030|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
19392031|NCT03698461|Vitamins|vitamins|mesh-ancestor
19392032|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
19392033|NCT03698435|Valganciclovir|valganciclovir|mesh-list
19392034|NCT03698435|Ganciclovir|ganciclovir|mesh-list
19392035|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19392036|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
19392037|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392038|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19392039|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392040|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392041|NCT03698383|Trastuzumab|trastuzumab|mesh-list
19392042|NCT03698383|Gedatolisib|gedatolisib|mesh-list
19392043|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392044|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392045|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19392046|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392047|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20215975|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20215976|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215977|NCT00304460|Aldesleukin|aldesleukin|mesh-list
20215978|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20215979|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20215980|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20215981|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
20415343|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415344|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415345|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415346|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20415347|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20415348|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
20415349|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415350|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20415351|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
20415352|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
20415353|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
20415354|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20415355|NCT01217177|Everolimus|everolimus|mesh-list
20415356|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415357|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415358|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
20415359|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415360|NCT01217203|Lenalidomide|lenalidomide|mesh-list
20415361|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
20415362|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415363|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415364|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415365|NCT01217203|Growth Substances|growth substances|mesh-ancestor
20415366|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415367|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392048|NCT03698292|Metoclopramide|metoclopramide|mesh-list
19392049|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
19392050|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
19392051|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392052|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392053|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19392054|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19848061|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848062|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19848063|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19848064|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392055|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19848065|NCT00690794|Travoprost|travoprost|mesh-list
19848066|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19848067|NCT00690794|Latanoprost|latanoprost|mesh-list
19848068|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19848069|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848070|NCT00690820|Pancrelipase|pancrelipase|mesh-list
19848071|NCT00690820|Pancreatin|pancreatin|mesh-list
20215982|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20215983|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20215984|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
20215985|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20215986|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20215987|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20215988|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20215989|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215990|NCT00304499|Oxybutynin|oxybutynin|mesh-list
19392056|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
19392057|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392058|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415368|NCT01217294|Morphine|morphine|mesh-list
20415369|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20415370|NCT01217294|Narcotics|narcotics|mesh-ancestor
20415371|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415372|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415373|NCT01217294|Analgesics|analgesics|mesh-ancestor
20415374|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
20415375|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415376|NCT01217359|Interferons|interferons|mesh-list
20415377|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
20415378|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
20415379|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415380|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
20415381|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415382|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
20415383|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415384|NCT01217398|Bevacizumab|bevacizumab|mesh-list
20415385|NCT01217398|Temozolomide|temozolomide|mesh-list
20415386|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415387|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415388|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415389|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415390|NCT01217398|Growth Substances|growth substances|mesh-ancestor
20415391|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415392|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415393|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20415394|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
20415395|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415396|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20415397|NCT01217450|Cetuximab|cetuximab|mesh-list
20415398|NCT01217450|Antibodies|antibodies|mesh-list
20415399|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
20415400|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20415401|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
20415402|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415403|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415404|NCT01217580|Ropivacaine|ropivacaine|mesh-list
20415405|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
20415406|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
20415407|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415408|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415409|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
20415410|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415411|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20415412|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415413|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415414|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415415|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415416|NCT01217632|Entecavir|entecavir|mesh-list
20415417|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
20415418|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415419|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
20415420|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20415421|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415422|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415423|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20415424|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20415425|NCT01217697|Prednisone|prednisone|mesh-list
20415426|NCT01217697|Prednisolone|prednisolone|mesh-list
20415427|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
20415428|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20415429|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
20415430|NCT01217697|Hormones|hormones|mesh-ancestor
20415431|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415432|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415433|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20415434|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415435|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20415436|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415437|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415438|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
20415439|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19392059|NCT03698227|Doxorubicin|doxorubicin|mesh-list
19392060|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
19392061|NCT03698227|Razoxane|razoxane|mesh-list
20415440|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
20415441|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20415442|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
20415443|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415444|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415445|NCT01217879|Telmisartan|telmisartan|mesh-list
20415446|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19392062|NCT03698227|Olaratumab|olaratumab|mesh-list
19392063|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19392064|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392065|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19392066|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19392067|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392068|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392069|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19392070|NCT03698227|Protective Agents|protective agents|mesh-ancestor
19392071|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392072|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19392073|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392074|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19392075|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19392076|NCT03697889|Naproxen|naproxen|mesh-list
19392077|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392078|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20415447|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415448|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415449|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415450|NCT01217970|Ibudilast|ibudilast|mesh-list
20415451|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20415452|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
20415453|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415454|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415455|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20415456|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
20415457|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20415458|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415459|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415460|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20415461|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
20415462|NCT01218022|Losartan|losartan|mesh-list
20415463|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20415464|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415465|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415466|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415467|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415468|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
20415469|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20415470|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415471|NCT01218217|Rifampin|rifampin|mesh-list
20415472|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20415473|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
20415474|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20415475|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392079|NCT03697889|Analgesics|analgesics|mesh-ancestor
19691596|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20215991|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
20215992|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
20215993|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20215994|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20215995|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20215996|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20215997|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
20215998|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20215999|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216000|NCT00304499|Urological Agents|urological agents|mesh-ancestor
20216001|NCT00304538|Glucagon|glucagon|mesh-list
20216002|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216003|NCT00304538|Hormones|hormones|mesh-ancestor
20216004|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216005|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415476|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
20415477|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20415478|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415479|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415480|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20415481|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20415482|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20415483|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20415484|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20415485|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20415486|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
20427674|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427675|NCT01288404|Fluorometholone|fluorometholone|mesh-list
20427676|NCT01288404|Bevacizumab|bevacizumab|mesh-list
20427677|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20427678|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427679|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20427680|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20427681|NCT01288404|Growth Substances|growth substances|mesh-ancestor
20427682|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427683|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
20427684|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427685|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
20427686|NCT01288404|Hormones|hormones|mesh-ancestor
20427687|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216006|NCT00304551|Ribavirin|ribavirin|mesh-list
20216007|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20216008|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
20216009|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
20216010|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216011|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
20216012|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216013|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
20427688|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20427689|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
20427690|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20427691|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20427692|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
20427693|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427694|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20427695|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20427696|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427697|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427698|NCT01288495|Psyllium|psyllium|mesh-list
20427699|NCT01288495|Cathartics|cathartics|mesh-ancestor
20427700|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427701|NCT01288508|Psyllium|psyllium|mesh-list
20427702|NCT01288508|Cathartics|cathartics|mesh-ancestor
20427703|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427704|NCT01288547|Theobromine|theobromine|mesh-list
20427705|NCT01288547|Caffeine|caffeine|mesh-list
20427706|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20427707|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427708|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20427709|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427710|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427711|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20427712|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20427713|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
20427714|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427715|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20427716|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
20427717|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427718|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20427719|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
20427720|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
20427721|NCT01288573|Plerixafor|plerixafor|mesh-list
20427722|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20427723|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20427724|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
20427725|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392080|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
19392081|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216014|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216015|NCT00304616|Olanzapine|olanzapine|mesh-list
20415487|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20415488|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20415489|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20415490|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
20415491|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415492|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20415493|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20415494|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415495|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20415496|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20415497|NCT01218386|Estradiol|estradiol|mesh-list
20415498|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20415499|NCT01218386|Estrogens|estrogens|mesh-ancestor
20415500|NCT01218386|Hormones|hormones|mesh-ancestor
20415501|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415502|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415503|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20415504|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
20415505|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20415506|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20415507|NCT01218425|Levodopa|levodopa|mesh-list
20415508|NCT01218425|Carbidopa|carbidopa|mesh-list
20415509|NCT01218425|Domperidone|domperidone|mesh-list
20216016|NCT00304616|Risperidone|risperidone|mesh-list
20216017|NCT00304616|Aripiprazole|aripiprazole|mesh-list
20216018|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20216019|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20216020|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
20216021|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216022|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216023|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415510|NCT01218425|Methylphenidate|methylphenidate|mesh-list
20415511|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20415512|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415513|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20415514|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20415515|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415516|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415517|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
20415518|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415519|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20415520|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20415521|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20415522|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415523|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
20415524|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
20415525|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415526|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415527|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20415528|NCT01218451|Vaccines|vaccines|mesh-list
20415529|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
20415530|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415531|NCT01218529|Lapatinib|lapatinib|mesh-list
20415532|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415533|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415534|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415535|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415536|NCT01218568|Rifaximin|rifaximin|mesh-list
20415537|NCT01218568|Lactulose|lactulose|mesh-list
20415538|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20415539|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415540|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415541|NCT01218581|Letrozole|letrozole|mesh-list
20415542|NCT01218581|Goserelin|goserelin|mesh-list
20415543|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415544|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20415545|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20415546|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415547|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415548|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20415549|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
20415550|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19392082|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216024|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20415551|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392083|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392084|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392085|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
19392086|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19392087|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392088|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392089|NCT03697850|Atezolizumab|atezolizumab|mesh-list
19392090|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392091|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
19392092|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
19392093|NCT03697824|Fludarabine|fludarabine|mesh-list
19392094|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392095|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
20415552|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20415553|NCT01218607|Bosentan|bosentan|mesh-list
20415554|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415555|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20415556|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415557|NCT01218620|Tolbutamide|tolbutamide|mesh-list
20415558|NCT01218620|Rifampin|rifampin|mesh-list
20415559|NCT01218620|Ketoconazole|ketoconazole|mesh-list
20415560|NCT01218620|Midazolam|midazolam|mesh-list
20415561|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
20415562|NCT01218620|Omeprazole|omeprazole|mesh-list
20415563|NCT01218620|R04929097|r04929097|mesh-list
20415564|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20415565|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20415566|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415567|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415568|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20415569|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20415570|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20415571|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20415572|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
20415573|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
20415574|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
20415575|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
20415576|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415577|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415578|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20415579|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415580|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20415581|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415582|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20415583|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
20415584|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20415585|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415586|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
20415587|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20415588|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20415589|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20415590|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20415591|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20415592|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20415593|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20415594|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
20415595|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20415596|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20415597|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20415598|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
20415599|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415600|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20415601|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
20415602|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
20415603|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20415604|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20415605|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20415606|NCT01218698|Losartan|losartan|mesh-list
20415607|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20415608|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415609|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415610|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415611|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392096|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415612|NCT01218711|Losartan|losartan|mesh-list
20415613|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20415614|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20415615|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19691597|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691598|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
19392097|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392098|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19392099|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
19392100|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392101|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392102|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19691599|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691600|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19691601|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19691602|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19691603|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19691604|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691605|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19691606|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19691607|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691608|NCT05002673|Anesthetics|anesthetics|mesh-list
19691609|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19691610|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691611|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
19691612|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19691613|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19691614|NCT05002517|Prednisolone|prednisolone|mesh-list
19691615|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
19691616|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19691617|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
19691618|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691619|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
19691620|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
19691621|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691622|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691623|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691624|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
19691625|NCT05002517|Hormones|hormones|mesh-ancestor
19691626|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691627|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19691628|NCT05002517|Protective Agents|protective agents|mesh-ancestor
19691629|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691630|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691631|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
19691632|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19691633|NCT05002270|Cetuximab|cetuximab|mesh-list
19691634|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691635|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415616|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415617|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415618|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415619|NCT01218711|Diuretics|diuretics|mesh-ancestor
20415620|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
20415621|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415622|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20415623|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415624|NCT01218724|Losartan|losartan|mesh-list
20415625|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20415626|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20415627|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415628|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415629|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415630|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415631|NCT01218724|Diuretics|diuretics|mesh-ancestor
20415632|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
20415633|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415634|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20415635|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415636|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
20415637|NCT01218737|Prednisolone|prednisolone|mesh-list
19403954|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392103|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392104|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19392105|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19392106|NCT03697746|Acetaminophen|acetaminophen|mesh-list
19392107|NCT03697746|Ibuprofen|ibuprofen|mesh-list
19392108|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19392109|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392110|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392111|NCT03697746|Analgesics|analgesics|mesh-ancestor
19392112|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
19392113|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392114|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392115|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392116|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392117|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19848072|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415638|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20415639|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
20415640|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20415641|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
20415642|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20415643|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
20415644|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20415645|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
20415646|NCT01218737|Hormones|hormones|mesh-ancestor
20415647|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415648|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415649|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20415650|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415651|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
20415652|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
20415653|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415654|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415655|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20415656|NCT01218737|Protective Agents|protective agents|mesh-ancestor
20415657|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20415658|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415659|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20415660|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19848073|NCT00690833|Desonide|desonide|mesh-list
19848074|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848075|NCT00690898|Lanreotide|lanreotide|mesh-list
19848076|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848077|NCT00690924|Calcitriol|calcitriol|mesh-list
19848078|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19848079|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848080|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19848081|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848082|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848083|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19848084|NCT00690924|Vitamins|vitamins|mesh-ancestor
19848085|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
19848086|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19848087|NCT00691002|Calcitriol|calcitriol|mesh-list
19848088|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
19848089|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19848090|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19848091|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19848092|NCT00691002|Calcipotriene|calcipotriene|mesh-list
19848093|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848094|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848095|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20415661|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20415662|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19848096|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848097|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19848098|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848099|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848100|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19848101|NCT00691002|Vitamins|vitamins|mesh-ancestor
19848102|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
19848103|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19848104|NCT00691015|Cytarabine|cytarabine|mesh-list
19392118|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848105|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
20415663|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392119|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848106|NCT00691015|Melphalan|melphalan|mesh-list
19848107|NCT00691015|Busulfan|busulfan|mesh-list
19848108|NCT00691015|Carmustine|carmustine|mesh-list
19848109|NCT00691015|Rituximab|rituximab|mesh-list
19848110|NCT00691015|Fludarabine|fludarabine|mesh-list
19848111|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
19848112|NCT00691015|Etoposide|etoposide|mesh-list
19848113|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
20415664|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415665|NCT01218750|Bevacizumab|bevacizumab|mesh-list
20415666|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415667|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415668|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415669|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415670|NCT01218750|Growth Substances|growth substances|mesh-ancestor
20415671|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415672|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415673|NCT01218893|Chloroquine|chloroquine|mesh-list
20415674|NCT01218893|Proguanil|proguanil|mesh-list
20415675|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20415676|NCT01218893|Vaccines|vaccines|mesh-list
20415677|NCT01218893|Amebicides|amebicides|mesh-ancestor
20415678|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20415679|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20415680|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415681|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
20415682|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20415683|NCT01218893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415684|NCT01218893|Immunologic Factors|immunologic factors|mesh-ancestor
20415685|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
20415686|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415687|NCT01219010|Siltuximab|siltuximab|mesh-list
19848114|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19848115|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848116|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
19848117|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848118|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848119|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20415688|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415689|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
20415690|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415691|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
20415692|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20415693|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20415694|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415695|NCT01219023|Urological Agents|urological agents|mesh-ancestor
20415696|NCT01219036|Budesonide|budesonide|mesh-list
20415697|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20415698|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20415699|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
20415700|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415701|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415702|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20415703|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
20415704|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
20415705|NCT01219036|Hormones|hormones|mesh-ancestor
20427726|NCT01288664|Tacrolimus|tacrolimus|mesh-list
19848120|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
19848121|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216025|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20216026|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216027|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216028|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20216029|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
20216030|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
20216031|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
20216032|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216033|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216034|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20216035|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20216036|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20216037|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
20216038|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
20216039|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20216040|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19392120|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
19392121|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
19392122|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19392123|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19392124|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392125|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
19392126|NCT03697681|Coagulants|coagulants|mesh-ancestor
19392127|NCT03697668|Piperaquine|piperaquine|mesh-list
19392128|NCT03697668|Artenimol|artenimol|mesh-list
20415706|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415707|NCT01219062|Morphine|morphine|mesh-list
20415708|NCT01219062|Bupivacaine|bupivacaine|mesh-list
20415709|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
20415710|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
20415711|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415712|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415713|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
20415714|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415715|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20415716|NCT01219062|Narcotics|narcotics|mesh-ancestor
20415717|NCT01219062|Analgesics|analgesics|mesh-ancestor
20415718|NCT01219088|Morphine|morphine|mesh-list
20415719|NCT01219088|Bupivacaine|bupivacaine|mesh-list
20415720|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
20415721|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
20415722|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415723|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415724|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
20415725|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415726|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20415727|NCT01219088|Narcotics|narcotics|mesh-ancestor
20415728|NCT01219088|Analgesics|analgesics|mesh-ancestor
20415729|NCT01219101|Citric Acid|citric acid|mesh-list
20415730|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
20415731|NCT01219101|Clomiphene|clomiphene|mesh-list
20415732|NCT01219101|Enclomiphene|enclomiphene|mesh-list
20415733|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
20415734|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
20415735|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20415736|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
20415737|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
20415738|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415739|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20415740|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
20415741|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415742|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415743|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20415744|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
20415745|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20415746|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20415747|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20415748|NCT01219153|Letrozole|letrozole|mesh-list
20415749|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
20415750|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20415751|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415752|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20415753|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20415754|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415755|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415756|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20415757|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
20415758|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415759|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415760|NCT01219153|Hormones|hormones|mesh-ancestor
20415761|NCT01219205|Bevacizumab|bevacizumab|mesh-list
20415762|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415763|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415764|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415765|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415766|NCT01219205|Growth Substances|growth substances|mesh-ancestor
20415767|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415768|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
19691636|NCT05002361|Dexamethasone|dexamethasone|mesh-list
20415769|NCT01219244|Resveratrol|resveratrol|mesh-list
19392129|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
19691637|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392130|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392131|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19392132|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415770|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
20415771|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415772|NCT01219244|Protective Agents|protective agents|mesh-ancestor
20415773|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415774|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415775|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20415776|NCT01219257|Adalimumab|adalimumab|mesh-list
20415777|NCT01219257|Etanercept|etanercept|mesh-list
20415778|NCT01219257|Golimumab|golimumab|mesh-list
20415779|NCT01219257|Infliximab|infliximab|mesh-list
20415780|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20415781|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20415782|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
20415783|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415784|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20415785|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20415786|NCT01219257|Analgesics|analgesics|mesh-ancestor
20415787|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
20415788|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415789|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415790|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415791|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
20415792|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20415793|NCT01219348|Vaccines|vaccines|mesh-list
20415794|NCT01219348|Immunologic Factors|immunologic factors|mesh-ancestor
20415795|NCT01219348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415796|NCT01219400|Vildagliptin|vildagliptin|mesh-list
20415797|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20415798|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415799|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20415800|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
20415801|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415802|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415803|NCT01219413|Perindopril|perindopril|mesh-list
20415804|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20415805|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
20415806|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415807|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415808|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415809|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20415810|NCT01219556|Olmesartan|olmesartan|mesh-list
20415811|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415812|NCT01219556|Diuretics|diuretics|mesh-ancestor
20415813|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
20415814|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415815|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20415816|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415817|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415818|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20415819|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20415820|NCT01219569|Propofol|propofol|mesh-list
20415821|NCT01219569|Sevoflurane|sevoflurane|mesh-list
20415822|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20415823|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415824|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415825|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20415826|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
20415827|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
20415828|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20415829|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20415830|NCT01219582|Metformin|metformin|mesh-list
20415831|NCT01219582|Acarbose|acarbose|mesh-list
20415832|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20415833|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415834|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20415835|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415836|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415837|NCT01219686|Pindolol|pindolol|mesh-list
20415838|NCT01219686|Dexetimide|dexetimide|mesh-list
20415839|NCT01219686|Citalopram|citalopram|mesh-list
20415840|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20415841|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20415842|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415843|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415844|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20415845|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
20415846|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415847|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20415848|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
20415849|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20415850|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20415851|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20415852|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
20415853|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
20415854|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415855|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20415856|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20415857|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
20415858|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20415859|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20415860|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
20415861|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20415862|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20415863|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
20415864|NCT01219699|Fulvestrant|fulvestrant|mesh-list
20415865|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20415866|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415867|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20415868|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20415869|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
20415870|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415871|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415872|NCT01219712|Simendan|simendan|mesh-list
20415873|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20415874|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
20415875|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20415876|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20415877|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415878|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415879|NCT01219712|Protective Agents|protective agents|mesh-ancestor
20415880|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415881|NCT01219751|Sunitinib|sunitinib|mesh-list
20415882|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415883|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415884|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415885|NCT01219751|Growth Substances|growth substances|mesh-ancestor
20415886|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415887|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415888|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20415889|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415890|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415891|NCT01219764|Amoxicillin|amoxicillin|mesh-list
20415892|NCT01219764|Metronidazole|metronidazole|mesh-list
20415893|NCT01219764|Clarithromycin|clarithromycin|mesh-list
20415894|NCT01219764|Rabeprazole|rabeprazole|mesh-list
20415895|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20415896|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415897|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20415898|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20415899|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20415900|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415901|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415902|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20415903|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20415904|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20415905|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20415906|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20415907|NCT01219816|Epratuzumab|epratuzumab|mesh-list
20415908|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415909|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415910|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
20415911|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20415912|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
20415913|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415914|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613204|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
19392133|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392134|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
19392135|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19392136|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19392137|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392138|NCT03697655|Daratumumab|daratumumab|mesh-list
19392139|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392140|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
19392141|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
20415915|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20415916|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
20415917|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415918|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415919|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20415920|NCT01219920|Leucovorin|leucovorin|mesh-list
20415921|NCT01219920|Irinotecan|irinotecan|mesh-list
20415922|NCT01219920|Antidotes|antidotes|mesh-ancestor
20415923|NCT01219920|Protective Agents|protective agents|mesh-ancestor
20415924|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415925|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
20415926|NCT01219920|Vitamins|vitamins|mesh-ancestor
20415927|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
20415928|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415929|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415930|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20415931|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20415932|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427727|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427728|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
20427729|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427730|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20427731|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427732|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427733|NCT01288716|Baclofen|baclofen|mesh-list
20427734|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20427735|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427736|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20427737|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427738|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20427739|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
20427740|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
20427741|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427742|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427743|NCT01288742|Simeprevir|simeprevir|mesh-list
20427744|NCT01288742|Digoxin|digoxin|mesh-list
20427745|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20427746|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20427747|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20427748|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
20427749|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392142|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216041|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20216042|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20216043|NCT00304629|Galantamine|galantamine|mesh-list
20216044|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20216045|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216046|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216047|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
20216048|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216049|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216050|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20216051|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
20216052|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216053|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
20216054|NCT00304642|Dapivirine|dapivirine|mesh-list
20216055|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20216056|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20216057|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
20216058|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216059|NCT00304655|Aripiprazole|aripiprazole|mesh-list
20216060|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
20216061|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216062|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20216063|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20427750|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20415933|NCT01220063|Irinotecan|irinotecan|mesh-list
20415934|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19691638|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
19691639|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
19691640|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691641|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691642|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691643|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
19691644|NCT05002361|Hormones|hormones|mesh-ancestor
19691645|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691646|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19691647|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691648|NCT05002686|Paclitaxel|paclitaxel|mesh-list
19691649|NCT05002686|Capecitabine|capecitabine|mesh-list
19691650|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
19691651|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19691652|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691653|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
19691654|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
19691655|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
19691656|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415935|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20415936|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415937|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415938|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415939|NCT01220076|Tamoxifen|tamoxifen|mesh-list
20415940|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20415941|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
20415942|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20415943|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415944|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20415945|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415946|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20415947|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20415948|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20415949|NCT01220102|Adapalene|adapalene|mesh-list
20415950|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20415951|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
20415952|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20415953|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20415954|NCT01220102|Analgesics|analgesics|mesh-ancestor
20415955|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
20415956|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415957|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415958|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20415959|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20415960|NCT01220154|Paclitaxel|paclitaxel|mesh-list
20415961|NCT01220154|Bevacizumab|bevacizumab|mesh-list
20415962|NCT01220154|Carboplatin|carboplatin|mesh-list
20415963|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20415964|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20415965|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
20415966|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
20415967|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
20415968|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415969|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20415970|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20415971|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20415972|NCT01220154|Growth Substances|growth substances|mesh-ancestor
20415973|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415974|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
20415975|NCT01220219|Pregabalin|pregabalin|mesh-list
20415976|NCT01220219|Analgesics|analgesics|mesh-ancestor
20415977|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
20415978|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20415979|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20415980|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
20415981|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20415982|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20415983|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415984|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20415985|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20415986|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19691657|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19392143|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392144|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392145|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
19392146|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
19691658|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
20415987|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20415988|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20415989|NCT01220232|Lamivudine|lamivudine|mesh-list
20415990|NCT01220232|Abacavir|abacavir|mesh-list
20415991|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
20415992|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20415993|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20415994|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20415995|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20415996|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
20415997|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20415998|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19392147|NCT03697564|Gemcitabine|gemcitabine|mesh-list
19392148|NCT03697564|Nivolumab|nivolumab|mesh-list
19392149|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19392150|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
19392151|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392152|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392153|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
19392154|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392155|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392156|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392157|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
20415999|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20416000|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
20416001|NCT01220245|Heparin|heparin|mesh-list
20416002|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
20416003|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20416004|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20416005|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416006|NCT01220258|Azithromycin|azithromycin|mesh-list
20416007|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20416008|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20416009|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416010|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416011|NCT01220284|Vinorelbine|vinorelbine|mesh-list
20416012|NCT01220284|Satraplatin|satraplatin|mesh-list
20416013|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416014|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416015|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416016|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416017|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416018|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416019|NCT01220362|Fentanyl|fentanyl|mesh-list
20416020|NCT01220362|Bupivacaine|bupivacaine|mesh-list
20416021|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
20416022|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
20416023|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416024|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416025|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
20416026|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416027|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20416028|NCT01220362|Narcotics|narcotics|mesh-ancestor
20416029|NCT01220362|Analgesics|analgesics|mesh-ancestor
20416030|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20416031|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20416032|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
20416033|NCT01220375|Plerixafor|plerixafor|mesh-list
20416034|NCT01220375|Vinorelbine|vinorelbine|mesh-list
20416035|NCT01220375|Lenograstim|lenograstim|mesh-list
20416036|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20416037|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
20416038|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416039|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416040|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416041|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416042|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416043|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416044|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691659|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20416045|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20416046|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20416047|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
20416048|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416049|NCT01220440|Methylphenidate|methylphenidate|mesh-list
20416050|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
20416051|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20416052|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416053|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20416054|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20416055|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416056|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416057|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
20416058|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416059|NCT01220518|Infliximab|infliximab|mesh-list
20416060|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
20416061|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20416062|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416063|NCT01220570|Sirolimus|sirolimus|mesh-list
20416064|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20416065|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416066|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416067|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20416068|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416069|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
20416070|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416071|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
20416072|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416073|NCT01220596|Interferons|interferons|mesh-list
20416074|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20416075|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
20416076|NCT01220596|Entecavir|entecavir|mesh-list
20416077|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416078|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
20416079|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416080|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
20416081|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416082|NCT01220622|Nimodipine|nimodipine|mesh-list
20416083|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20416084|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20416085|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416086|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416087|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20416088|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416089|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
20416090|NCT01220648|Interferons|interferons|mesh-list
20416091|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
20416092|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416093|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
20416094|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416095|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
20416096|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416097|NCT01220661|Cefotetan|cefotetan|mesh-list
20416098|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416099|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416100|NCT01220791|Progesterone|progesterone|mesh-list
20416101|NCT01220791|Progestins|progestins|mesh-ancestor
20416102|NCT01220791|Hormones|hormones|mesh-ancestor
20416103|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416104|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416105|NCT01220843|Sevelamer|sevelamer|mesh-list
20416106|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
20416107|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
20416108|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416109|NCT01221025|Parecoxib|parecoxib|mesh-list
20416110|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20416111|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20416112|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416113|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416114|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20416115|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20416116|NCT01221025|Analgesics|analgesics|mesh-ancestor
20416117|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
20416118|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416119|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416120|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416121|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416122|NCT01221103|Dexamethasone|dexamethasone|mesh-list
20416123|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20416124|NCT01221103|Ofatumumab|ofatumumab|mesh-list
20416125|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20416126|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416127|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
20416128|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
20416129|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416130|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416131|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20416132|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
20416133|NCT01221103|Hormones|hormones|mesh-ancestor
20416134|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416135|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20416136|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416137|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20416138|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
20416139|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416140|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
20416141|NCT01221116|Simendan|simendan|mesh-list
20416142|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20416143|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
20416144|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20416145|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20416146|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416147|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416148|NCT01221116|Protective Agents|protective agents|mesh-ancestor
20416149|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416150|NCT01221129|Zinc|zinc|mesh-list
20416151|NCT01221129|Trace Elements|trace elements|mesh-ancestor
20416152|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
20416153|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416154|NCT01221337|Heparin|heparin|mesh-list
20416155|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
20416156|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20416157|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19392158|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392159|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392160|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20216064|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216065|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416158|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416159|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
20416160|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416161|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20416162|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416163|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416164|NCT01221402|Niacin|niacin|mesh-list
20416165|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20416166|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
20416167|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416168|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20416169|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
20416170|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
20416171|NCT01221402|Vitamins|vitamins|mesh-ancestor
20416172|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
20416173|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416174|NCT01221558|Lycopene|lycopene|mesh-list
20416175|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416176|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
20416177|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392161|NCT03697408|Everolimus|everolimus|mesh-list
20216066|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
20216067|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
20216068|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216069|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216070|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20216071|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20216072|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
20216073|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20216074|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20216075|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20216076|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20216077|NCT00304668|Dapivirine|dapivirine|mesh-list
20216078|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20416178|NCT01221558|Protective Agents|protective agents|mesh-ancestor
20416179|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416180|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20416181|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20416182|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416183|NCT01221636|Abatacept|abatacept|mesh-list
20416184|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20416185|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416186|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416187|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416188|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
20416189|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416190|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416191|NCT01221675|Antibodies|antibodies|mesh-list
20416192|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
20416193|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416194|NCT01221740|Milnacipran|milnacipran|mesh-list
20416195|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
20416196|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20416197|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20416198|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416199|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416200|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416201|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416202|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20416203|NCT01221740|Analgesics|analgesics|mesh-ancestor
20416204|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
20416205|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416206|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
20416207|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20416208|NCT01221792|Carvedilol|carvedilol|mesh-list
20416209|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20416210|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20416211|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
20416212|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416213|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416214|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416215|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20416216|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
20416217|NCT01221792|Protective Agents|protective agents|mesh-ancestor
20416218|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20416219|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416220|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20416221|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
20416222|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20416223|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20416224|NCT01221831|Dienogest|dienogest|mesh-list
20416225|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20416226|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20416227|NCT01221831|Estradiol|estradiol|mesh-list
20416228|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20416229|NCT01221831|Estrogens|estrogens|mesh-ancestor
20416230|NCT01221831|Hormones|hormones|mesh-ancestor
20416231|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416232|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416233|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20416234|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
20416235|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20416236|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20416237|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20416238|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20416239|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20416240|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
20416241|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20416242|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427751|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20427752|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427753|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20427754|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20427755|NCT01288742|Protective Agents|protective agents|mesh-ancestor
20427756|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427757|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
20427758|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416243|NCT01221883|Diazepam|diazepam|mesh-list
20416244|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20416245|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
20416246|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
20416247|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
20416248|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416249|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416250|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20416251|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20416252|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416253|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20416254|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20416255|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20416256|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20416257|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20416258|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20416259|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
20416260|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
20416261|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
20416262|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
20416263|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416264|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416265|NCT01221896|Choline|choline|mesh-list
20416266|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
20416267|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20416268|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
20416269|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416270|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20416271|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20416272|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
20416273|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
20416274|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20416275|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20416276|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416277|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
20416278|NCT01221909|Coagulants|coagulants|mesh-ancestor
20416279|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20416280|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
20416281|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20416282|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416283|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416284|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416285|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416286|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
20416287|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20416288|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
20416289|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416290|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20416291|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416292|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416293|NCT01222026|Vitamin D|vitamin d|mesh-list
20416294|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
20416295|NCT01222026|Vitamins|vitamins|mesh-ancestor
20416296|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
20416297|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416298|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20416299|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
20416300|NCT01222052|Docetaxel|docetaxel|mesh-list
20416301|NCT01222052|Fluorouracil|fluorouracil|mesh-list
20416302|NCT01222052|Epirubicin|epirubicin|mesh-list
20416303|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416304|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
20416305|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416306|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416307|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20416308|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
20416309|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416310|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416311|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20416312|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416313|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416314|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416315|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
20416316|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20416317|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20416318|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20416319|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20416320|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416321|NCT01222169|Propofol|propofol|mesh-list
20416322|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20416323|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416324|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416325|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20416326|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
20416327|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
20416328|NCT01222182|Atorvastatin|atorvastatin|mesh-list
20416329|NCT01222182|Simvastatin|simvastatin|mesh-list
20416330|NCT01222182|Pravastatin|pravastatin|mesh-list
20416331|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20416332|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20416333|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
20416334|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416335|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20416336|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20416337|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416338|NCT01222221|Temozolomide|temozolomide|mesh-list
20416339|NCT01222221|Sargramostim|sargramostim|mesh-list
20416340|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20416341|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
20416342|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416343|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416344|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
20416345|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416346|NCT01222312|Docetaxel|docetaxel|mesh-list
20416347|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
20416348|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416349|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416350|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416351|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416352|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416353|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
20416354|NCT01222442|AZD-3199|azd-3199|mesh-list
20416355|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416356|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416357|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20416358|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20416359|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416360|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416361|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416362|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416363|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20416364|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20416365|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20416366|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
20416367|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416368|NCT01222468|Nabilone|nabilone|mesh-list
20416369|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
20416370|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
20416371|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416372|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416373|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20416374|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20416375|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20416376|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416377|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20416378|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
19392162|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392163|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392164|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
19392165|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216079|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20216080|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
20216081|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216082|NCT00304681|Methylphenidate|methylphenidate|mesh-list
20216083|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20216084|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216085|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20216086|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19392166|NCT03697265|Pregnanolone|pregnanolone|mesh-list
20416379|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20416380|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20416381|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
20416382|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416383|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416384|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20416385|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20416386|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
20416387|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416388|NCT01222650|Silodosin|silodosin|mesh-list
20416389|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20416390|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20416391|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20416392|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
20416393|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416394|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416395|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416396|NCT01222650|Urological Agents|urological agents|mesh-ancestor
20416397|NCT01222676|Gemcitabine|gemcitabine|mesh-list
20416398|NCT01222676|Sorafenib|sorafenib|mesh-list
20416399|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20416400|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416401|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20416402|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
20416403|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416404|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
20416405|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416406|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416407|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416408|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
20416409|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416410|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20416411|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20416412|NCT01222780|Vincristine|vincristine|mesh-list
20416413|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416414|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416415|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416416|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416417|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416418|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416419|NCT01222819|Lenograstim|lenograstim|mesh-list
20416420|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20416421|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
20416422|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416423|NCT01222897|Valacyclovir|valacyclovir|mesh-list
20416424|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
20416425|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416426|NCT01222910|Valacyclovir|valacyclovir|mesh-list
20416427|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
20416428|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416429|NCT01222923|Risperidone|risperidone|mesh-list
20416430|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20416431|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
19848122|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848123|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19848124|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848125|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19848126|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
20216087|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20216088|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216089|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
20216090|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216091|NCT00304720|Tacrolimus|tacrolimus|mesh-list
20216092|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216093|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
20216094|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216095|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20216096|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216097|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216098|NCT00304772|Fluconazole|fluconazole|mesh-list
20216099|NCT00304772|Micafungin|micafungin|mesh-list
20216100|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
20216101|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216102|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20416432|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416433|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416434|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416435|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20416436|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20416437|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416438|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20416439|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20416440|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
20416441|NCT01222936|Panobinostat|panobinostat|mesh-list
20416442|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416443|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20416444|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416445|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416446|NCT01222975|Risperidone|risperidone|mesh-list
20416447|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20416448|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
20416449|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416450|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416451|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416452|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20416453|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20416454|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416455|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20416456|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20416457|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
20416458|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20416459|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
20416460|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20416461|NCT01223053|Ketoprofen|ketoprofen|mesh-list
20416462|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20416463|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392167|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
19392168|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392169|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392170|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
20416464|NCT01223053|Analgesics|analgesics|mesh-ancestor
20416465|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
20416466|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416467|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416468|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416469|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416470|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20416471|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416472|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416473|NCT01223131|Insulin|insulin|mesh-list
20416474|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20416475|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
20416476|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
20416477|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
20416478|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
20216103|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20216104|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216105|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216106|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20216107|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
20216108|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216109|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216110|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20216111|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20216112|NCT00304785|Latanoprost|latanoprost|mesh-list
20216113|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20216114|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20216115|NCT00304811|Vancomycin|vancomycin|mesh-list
20216116|NCT00304811|Rifampin|rifampin|mesh-list
20216117|NCT00304811|Gentamicins|gentamicins|mesh-list
20216118|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20216119|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216120|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20216121|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
20216122|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
20216123|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20216124|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216125|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416479|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20416480|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416481|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
20416482|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20416483|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
20416484|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416485|NCT01223326|Expectorants|expectorants|mesh-ancestor
20416486|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
20416487|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20416488|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
20416489|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416490|NCT01223326|Protective Agents|protective agents|mesh-ancestor
20416491|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416492|NCT01223326|Antidotes|antidotes|mesh-ancestor
20416493|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
20416494|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20416495|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416496|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20416497|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416498|NCT01223443|Paclitaxel|paclitaxel|mesh-list
20416499|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416500|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416501|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416502|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416503|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416504|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416505|NCT01223534|Isoniazid|isoniazid|mesh-list
20416506|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
20416507|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416508|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416509|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20416510|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20416511|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
20416512|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416513|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20416514|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
20416515|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20416516|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416517|NCT01223612|Ranibizumab|ranibizumab|mesh-list
20416518|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20416519|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20416520|NCT01223612|Growth Substances|growth substances|mesh-ancestor
20416521|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416522|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
20416523|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416524|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20416525|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20416526|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20416527|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
20416528|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416529|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20416530|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20416531|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416532|NCT01223690|Clarithromycin|clarithromycin|mesh-list
20416533|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416534|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416535|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20416536|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416537|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416538|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20416539|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20416540|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
20416541|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
20416542|NCT01223729|Vitamins|vitamins|mesh-ancestor
20416543|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
20416544|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416545|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
20416546|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
20416547|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
20416548|NCT01223742|Vitamins|vitamins|mesh-ancestor
20416549|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
20416550|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416551|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
20416552|NCT01223755|Sirolimus|sirolimus|mesh-list
20416553|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416554|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416555|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20416556|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416557|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
20416558|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416559|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
20416560|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416561|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
20416562|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
20416563|NCT01223768|Vitamins|vitamins|mesh-ancestor
20416564|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
20416565|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416566|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
20427759|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
20427760|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
20427761|NCT01288755|Rilpivirine|rilpivirine|mesh-list
20427762|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20427763|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20427764|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
20427765|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427766|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20427767|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20427768|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427769|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427770|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20427771|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20427772|NCT01288794|Furosemide|furosemide|mesh-list
20427773|NCT01288794|Diuretics|diuretics|mesh-list
20427774|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
20427775|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427776|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20427777|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20427778|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427779|NCT01288820|Artesunate|artesunate|mesh-list
20427780|NCT01288820|Piperaquine|piperaquine|mesh-list
20427781|NCT01288820|Primaquine|primaquine|mesh-list
20427782|NCT01288820|Amodiaquine|amodiaquine|mesh-list
20427783|NCT01288820|Artenimol|artenimol|mesh-list
20427784|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
20427785|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20427786|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20427787|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427788|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427789|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
20427790|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
20427791|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20427792|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
20427793|NCT01288872|Praziquantel|praziquantel|mesh-list
20427794|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
20427795|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20427796|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427797|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
20427798|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20427799|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427800|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427801|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427802|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
20427803|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20427804|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427805|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20427806|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427807|NCT01288924|Parecoxib|parecoxib|mesh-list
20427808|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20427809|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20427810|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427811|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427812|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20427813|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427814|NCT01288924|Analgesics|analgesics|mesh-ancestor
20427815|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
20427816|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427817|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427818|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427819|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427820|NCT01288950|Vitamin D|vitamin d|mesh-list
20427821|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
20427822|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
20427823|NCT01288950|Vitamins|vitamins|mesh-list
20427824|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
20416567|NCT01223820|Capsaicin|capsaicin|mesh-list
20416568|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
20416569|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
20416570|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
20416571|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416572|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416573|NCT01224028|Tacrolimus|tacrolimus|mesh-list
20416574|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416575|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
20416576|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416577|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20416578|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416579|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416580|NCT01224041|Tacrolimus|tacrolimus|mesh-list
20416581|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416582|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
20416583|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416584|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20416585|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416586|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416587|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20416588|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
20416589|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20416590|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20416591|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20416592|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416593|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416594|NCT01224093|Rituximab|rituximab|mesh-list
20416595|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20416596|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416597|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
20416598|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416599|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416600|NCT01224197|Simeprevir|simeprevir|mesh-list
20416601|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
20416602|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416603|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
20416604|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416605|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416606|NCT01224301|Vaccines|vaccines|mesh-list
20416607|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
20416608|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416609|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
20416610|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20416611|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
20416612|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
20416613|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416614|NCT01224353|Protective Agents|protective agents|mesh-ancestor
20416615|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416616|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
20416617|NCT01224353|Vitamins|vitamins|mesh-ancestor
20416618|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
20416619|NCT01224366|Vildagliptin|vildagliptin|mesh-list
20416620|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20416621|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416622|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20416623|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
20416624|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416625|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392171|NCT03697239|Gemcitabine|gemcitabine|mesh-list
19392172|NCT03697239|Paclitaxel|paclitaxel|mesh-list
20216126|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20216127|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20216128|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20216129|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20216130|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20216131|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20216132|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20216133|NCT00304850|Ketamine|ketamine|mesh-list
20216134|NCT00304850|Analgesics|analgesics|mesh-ancestor
20216135|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
20416626|NCT01224392|Capecitabine|capecitabine|mesh-list
19392173|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20416627|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20416628|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
20416629|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416630|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416631|NCT01224405|Docetaxel|docetaxel|mesh-list
20416632|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416633|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416634|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416635|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416636|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416637|NCT01224418|Tacrolimus|tacrolimus|mesh-list
20416638|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416639|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
20416640|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392174|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19392175|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392176|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
19392177|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
19392178|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392179|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392180|NCT03697239|Vitamins|vitamins|mesh-ancestor
19392181|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
19392182|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392183|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19392184|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
19392185|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
19392186|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392187|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416641|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20416642|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416643|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416644|NCT01224457|Phenobarbital|phenobarbital|mesh-list
20416645|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
20416646|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20416647|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416648|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416649|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20416650|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20416651|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416652|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416653|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
20416654|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
20416655|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20416656|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20416657|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20416658|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
20416659|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20416660|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416661|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416662|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20416663|NCT01224470|Analgesics|analgesics|mesh-ancestor
20416664|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
20416665|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416666|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20416667|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20416668|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20416669|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
20416670|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416671|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416672|NCT01224509|Mifepristone|mifepristone|mesh-list
20416673|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20416674|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
20416675|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20416676|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416677|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20416678|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20416679|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20416680|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
20416681|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20416682|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20416683|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
20427825|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392188|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19392189|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
19392190|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
20416684|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416685|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
20416686|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20416687|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20416688|NCT01224535|Micronutrients|micronutrients|mesh-list
20416689|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416690|NCT01224613|Vaccines|vaccines|mesh-list
20416691|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
20416692|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416693|NCT01224652|Paclitaxel|paclitaxel|mesh-list
20416694|NCT01224652|Irinotecan|irinotecan|mesh-list
20416695|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416696|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416697|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416698|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416699|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416700|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416701|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20416702|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20416703|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416704|NCT01224717|Teriparatide|teriparatide|mesh-list
20416705|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20416706|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416707|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20416708|NCT01224756|Tinoridine|tinoridine|mesh-list
20416709|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20416710|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20416711|NCT01224756|Analgesics|analgesics|mesh-ancestor
20416712|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
20416713|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416714|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416715|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416716|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416717|NCT01224769|Rituximab|rituximab|mesh-list
20416718|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20416719|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20416720|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416721|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
20416722|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416723|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416724|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20416725|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
20416726|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416727|NCT01224847|Lidocaine|lidocaine|mesh-list
20416728|NCT01224847|Cocaine|cocaine|mesh-list
20416729|NCT01224847|Tetracaine|tetracaine|mesh-list
20416730|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
20416731|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
20416732|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416733|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416734|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
20416735|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416736|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20416737|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20416738|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20416739|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416740|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416741|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20416742|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20416743|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20416744|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
20416745|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416746|NCT01224860|Losartan|losartan|mesh-list
20416747|NCT01224860|Telmisartan|telmisartan|mesh-list
20416748|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20416749|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20416750|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20416751|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20416752|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416753|NCT01224951|Beclomethasone|beclomethasone|mesh-list
20416754|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416755|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
20416756|NCT01224951|Hormones|hormones|mesh-ancestor
20427826|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20416757|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416758|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416759|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20416760|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
20416761|NCT01224964|Montelukast|montelukast|mesh-list
20416762|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20416763|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
20416764|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20416765|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
20416766|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416767|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416768|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20416769|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20216136|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216137|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216138|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20216139|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20216140|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
20216141|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
20216142|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216143|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20216144|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20216145|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216146|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216147|NCT00304980|Lumefantrine|lumefantrine|mesh-list
20216148|NCT00304980|Artemether|artemether|mesh-list
20216149|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
20416770|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416771|NCT01224977|Azithromycin|azithromycin|mesh-list
20416772|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20416773|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416774|NCT01225081|Pioglitazone|pioglitazone|mesh-list
20416775|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
20416776|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20416777|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416778|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20416779|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416780|NCT01225094|Curcumin|curcumin|mesh-list
20416781|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20416782|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20416783|NCT01225094|Analgesics|analgesics|mesh-ancestor
20416784|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
20416785|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416786|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416787|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416788|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416789|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416790|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416791|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416792|NCT01225198|Vitamins|vitamins|mesh-list
20416793|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
20416794|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416795|NCT01225224|Peficitinib|peficitinib|mesh-list
20416796|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416797|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416798|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416799|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
20416800|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416801|NCT01225237|Ramosetron|ramosetron|mesh-list
20416802|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
20416803|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
20416804|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416805|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416806|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20416807|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20416808|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
20416809|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416810|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416811|NCT01225302|Paclitaxel|paclitaxel|mesh-list
20416812|NCT01225302|Carboplatin|carboplatin|mesh-list
20416813|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416814|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416815|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20216150|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
20216151|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20216152|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20216153|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
20416816|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416817|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416818|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416819|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20416820|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20416821|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20416822|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416823|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416824|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20416825|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416826|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416827|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
20416828|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416829|NCT01225406|Tenofovir|tenofovir|mesh-list
20416830|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
20416831|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416832|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20416833|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20416834|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416835|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416836|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20416837|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20416838|NCT01225419|Plerixafor|plerixafor|mesh-list
20416839|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20416840|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20416841|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
20416842|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416843|NCT01225445|Ramipril|ramipril|mesh-list
20416844|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20416845|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
20416846|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416847|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416848|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20416849|NCT01225484|Ropivacaine|ropivacaine|mesh-list
20216154|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20216155|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20216156|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216157|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20216158|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416850|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
20416851|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
20416852|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416853|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416854|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
20416855|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416856|NCT01225523|Paclitaxel|paclitaxel|mesh-list
20416857|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20416858|NCT01225523|Cisplatin|cisplatin|mesh-list
20416859|NCT01225523|Fluorouracil|fluorouracil|mesh-list
20416860|NCT01225523|Capecitabine|capecitabine|mesh-list
20416861|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416862|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416863|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416864|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416865|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416866|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416867|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
20416868|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20416869|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416870|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
20216159|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216160|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20216161|NCT00304980|Renal Agents|renal agents|mesh-ancestor
20216162|NCT00304993|Niacin|niacin|mesh-list
20216163|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
20216164|NCT00304993|Fenofibrate|fenofibrate|mesh-list
20216165|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20416871|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427827|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20427828|NCT01288963|Aldesleukin|aldesleukin|mesh-list
20216166|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416872|NCT01225653|Latanoprost|latanoprost|mesh-list
20416873|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20416874|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20416875|NCT01225705|Ritonavir|ritonavir|mesh-list
20416876|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20416877|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
20416878|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20416879|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20416880|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
20416881|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416882|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416883|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20416884|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20416885|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
20416886|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416887|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20416888|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20416889|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20416890|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20416891|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
20416892|NCT01225744|Irinotecan|irinotecan|mesh-list
20416893|NCT01225744|Cetuximab|cetuximab|mesh-list
20416894|NCT01225744|Tegafur|tegafur|mesh-list
20416895|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416896|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20416897|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20416898|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416899|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416900|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20416901|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20416902|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
20416903|NCT01225874|Cytarabine|cytarabine|mesh-list
20416904|NCT01225874|Dexamethasone|dexamethasone|mesh-list
20216167|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20216168|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
20216169|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216170|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20216171|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
20216172|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
20416905|NCT01225874|Prednisone|prednisone|mesh-list
20416906|NCT01225874|Methotrexate|methotrexate|mesh-list
20416907|NCT01225874|Vincristine|vincristine|mesh-list
20416908|NCT01225874|Daunorubicin|daunorubicin|mesh-list
20416909|NCT01225874|Asparaginase|asparaginase|mesh-list
20416910|NCT01225874|Pegaspargase|pegaspargase|mesh-list
20416911|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416912|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
20416913|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
20416914|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416915|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416916|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20416917|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
20416918|NCT01225874|Hormones|hormones|mesh-ancestor
20416919|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416920|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20416921|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416922|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20216173|NCT00304993|Vitamins|vitamins|mesh-ancestor
20216174|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
20216175|NCT00305019|Clevudine|clevudine|mesh-list
20216176|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
20216177|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216178|NCT00305201|Pravastatin|pravastatin|mesh-list
20216179|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20216180|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20216181|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
20216182|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216183|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20216184|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20216185|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216186|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
20216187|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
20216188|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216189|NCT00305292|Modafinil|modafinil|mesh-list
20216190|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20216191|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216192|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20416923|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
20416924|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20416925|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20416926|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
20416927|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416928|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
20416929|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416930|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20416931|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416932|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
20416933|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20416934|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20416935|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
20416936|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20416937|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20416938|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
20416939|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
20416940|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
20416941|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20416942|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20416943|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20416944|NCT01225913|Fluticasone|fluticasone|mesh-list
20416945|NCT01225913|Xhance|xhance|mesh-list
20416946|NCT01225913|Budesonide|budesonide|mesh-list
20416947|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
20416948|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20416949|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20416950|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20416951|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20416952|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20416953|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
20416954|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416955|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416956|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20416957|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
20416958|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
20416959|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20416960|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
20416961|NCT01225913|Hormones|hormones|mesh-ancestor
20416962|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20416963|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20416964|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20416965|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20416966|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
20416967|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20416968|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416969|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
20416970|NCT01226017|Oxytocin|oxytocin|mesh-list
20416971|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
20416972|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20416973|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416974|NCT01226056|Everolimus|everolimus|mesh-list
20416975|NCT01226056|Sorafenib|sorafenib|mesh-list
20416976|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20416977|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20416978|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
20416979|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416980|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20416981|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20416982|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416983|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
20216193|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20216194|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20216195|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216196|NCT00305331|Domperidone|domperidone|mesh-list
20216197|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
20216198|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
20216199|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216200|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216201|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216202|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20416984|NCT01226069|Glycerol|glycerol|mesh-list
20416985|NCT01226069|Analgesics|analgesics|mesh-ancestor
20416986|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
20416987|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20416988|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20416989|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
20416990|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20416991|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20416992|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
20416993|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20416994|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20416995|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20416996|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20416997|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
20416998|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20416999|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20417000|NCT01226069|Protective Agents|protective agents|mesh-ancestor
20417001|NCT01226186|Morphine|morphine|mesh-list
20417002|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20417003|NCT01226186|Narcotics|narcotics|mesh-ancestor
20417004|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417005|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417006|NCT01226186|Analgesics|analgesics|mesh-ancestor
20417007|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
20417008|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417009|NCT01226212|Sulfalene|sulfalene|mesh-list
20417010|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417011|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20417012|NCT01226212|Renal Agents|renal agents|mesh-ancestor
20417013|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
20417014|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20417015|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20417016|NCT01226303|Tretinoin|tretinoin|mesh-list
20417017|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417018|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
20417019|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417020|NCT01226355|Sirolimus|sirolimus|mesh-list
20417021|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417022|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417023|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20417024|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417025|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
20417026|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417027|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
20417028|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417029|NCT01226446|Vitamin D|vitamin d|mesh-list
20417030|NCT01226446|Vitamins|vitamins|mesh-ancestor
20417031|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
20417032|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417033|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20417034|NCT01226602|Ticagrelor|ticagrelor|mesh-list
20417035|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20417036|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20417037|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20417038|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20417039|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
20417040|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417041|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417042|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417043|NCT01226667|Pregabalin|pregabalin|mesh-list
20417044|NCT01226667|Analgesics|analgesics|mesh-ancestor
20417045|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
20417046|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216203|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
20216204|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216205|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216206|NCT00305370|Aripiprazole|aripiprazole|mesh-list
20216207|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
20216208|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216209|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20216210|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20216211|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216212|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216213|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
20216214|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
20216215|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216216|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216217|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20417047|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691660|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19691661|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19691662|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691663|NCT05002101|Zinc|zinc|mesh-list
20417048|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
20417049|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20417050|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20417051|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417052|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20417053|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20417054|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20417055|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417056|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20417057|NCT01226680|Tofacitinib|tofacitinib|mesh-list
20417058|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20417059|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417060|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417061|NCT01226771|Ribavirin|ribavirin|mesh-list
20417062|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
20417063|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216218|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20216219|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
20216220|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20417064|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
20417065|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417066|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20417067|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20417068|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20417069|NCT01226849|Rituximab|rituximab|mesh-list
20417070|NCT01226849|Carboplatin|carboplatin|mesh-list
20417071|NCT01226849|Etoposide|etoposide|mesh-list
20417072|NCT01226849|Bortezomib|bortezomib|mesh-list
20417073|NCT01226849|Ifosfamide|ifosfamide|mesh-list
20417074|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20417075|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417076|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
20417077|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417078|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417079|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20417080|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20417081|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20417082|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417083|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417084|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20417085|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
20417086|NCT01226901|Niraparib|niraparib|mesh-list
20417087|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20417088|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417089|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216221|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20216222|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20216223|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20216224|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20216225|NCT00305383|Taribavirin|taribavirin|mesh-list
20216226|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
20216227|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216228|NCT00305396|Sirolimus|sirolimus|mesh-list
20216229|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20216230|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216231|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20216232|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417090|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417091|NCT01226966|Liraglutide|liraglutide|mesh-list
20417092|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20417093|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216233|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
20216234|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216235|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
20216236|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216237|NCT00305409|Sulfalene|sulfalene|mesh-list
20216238|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216239|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20417094|NCT01226966|Incretins|incretins|mesh-ancestor
20417095|NCT01226966|Hormones|hormones|mesh-ancestor
19691664|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
20216240|NCT00305409|Renal Agents|renal agents|mesh-ancestor
20417096|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20417097|NCT01226992|Vancomycin|vancomycin|mesh-list
20417098|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417099|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417100|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
20417101|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
20417102|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417103|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20417104|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417105|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417106|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
20417107|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20417108|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20417109|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417110|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417111|NCT01227148|Insulin|insulin|mesh-list
20417112|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20417113|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417114|NCT01227174|Propofol|propofol|mesh-list
20417115|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20417116|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417117|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417118|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20417119|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
20417120|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
20417121|NCT01227200|Tramadol|tramadol|mesh-list
20417122|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20417123|NCT01227200|Narcotics|narcotics|mesh-ancestor
20417124|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417125|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417126|NCT01227200|Analgesics|analgesics|mesh-ancestor
20417127|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
20417128|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417129|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
19392191|NCT03697239|Protective Agents|protective agents|mesh-ancestor
19392192|NCT03697161|Gaboxadol|gaboxadol|mesh-list
19392193|NCT03697161|Analgesics|analgesics|mesh-ancestor
19392194|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
19392195|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392196|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392197|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
19392198|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
19392199|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
19392200|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392201|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19403955|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417130|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20417131|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20417132|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
19691665|NCT05002101|Trace Elements|trace elements|mesh-ancestor
19691666|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
19691667|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691668|NCT05002101|Astringents|astringents|mesh-ancestor
19691669|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
19691670|NCT05001919|Mitogens|mitogens|mesh-list
19691671|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
19691672|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691673|NCT05001763|Prucalopride|prucalopride|mesh-list
19691674|NCT05001763|Laxatives|laxatives|mesh-ancestor
19691675|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20417133|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417134|NCT01227356|Interferons|interferons|mesh-list
20417135|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
20417136|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417137|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
19403956|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
19403957|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403958|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
19403959|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
20216241|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
20216242|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20216243|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20216244|NCT00305422|Risperidone|risperidone|mesh-list
20216245|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20216246|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20216247|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
20216248|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216249|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417138|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417139|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20417140|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417141|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417142|NCT01227408|Paclitaxel|paclitaxel|mesh-list
20417143|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
20417144|NCT01227408|Doxorubicin|doxorubicin|mesh-list
20417145|NCT01227408|Capecitabine|capecitabine|mesh-list
20417146|NCT01227408|Methotrexate|methotrexate|mesh-list
20417147|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20417148|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20417149|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417150|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
20417151|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
20417152|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
20417153|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417154|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417155|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
20417156|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417157|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417158|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20417159|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
20417160|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20417161|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20417162|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20417163|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20417164|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417165|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20417166|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
20417167|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20417168|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
20417169|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20417170|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417171|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20417172|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20427829|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427830|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20427831|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20427832|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
20427833|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427834|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
20427835|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427836|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20427837|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427838|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691676|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19691677|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19691678|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
19691679|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691680|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691681|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691682|NCT05002114|Cannabidiol|cannabidiol|mesh-list
19691683|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
19691684|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
19691685|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427839|NCT01289132|Candesartan|candesartan|mesh-list
20427840|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
20216250|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216251|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20216252|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20216253|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216254|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216255|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20216256|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
20216257|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
20216258|NCT00305461|Ciclesonide|ciclesonide|mesh-list
20216259|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
20216260|NCT00305461|Hormones|hormones|mesh-ancestor
20216261|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216262|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427841|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20216263|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20216264|NCT00305474|Risperidone|risperidone|mesh-list
20427842|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20417173|NCT01227590|Ritonavir|ritonavir|mesh-list
20417174|NCT01227590|Lopinavir|lopinavir|mesh-list
20417175|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20417176|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20417177|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20417178|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417179|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417180|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20417181|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20417182|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
20417183|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417184|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20417185|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20417186|NCT01227603|Candesartan|candesartan|mesh-list
20417187|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
20417188|NCT01227603|Nifedipine|nifedipine|mesh-list
20417189|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20417190|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20417191|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20417192|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417193|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20417194|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20417195|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20417196|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417197|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
20417198|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
20417199|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20216265|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20216266|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
20216267|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216268|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216269|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216270|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20216271|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20216272|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216273|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216274|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20216275|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
20216276|NCT00305487|Ciclesonide|ciclesonide|mesh-list
20216277|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
20216278|NCT00305487|Hormones|hormones|mesh-ancestor
20216279|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216280|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216281|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20417200|NCT01227720|Nicotine|nicotine|mesh-list
20417201|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20417202|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
20417203|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417204|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417205|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20417206|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20417207|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
20417208|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417209|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417210|NCT01227759|Tyrothricin|tyrothricin|mesh-list
20417211|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20417212|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691686|NCT05001672|Tenofovir|tenofovir|mesh-list
19691687|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
19691688|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417213|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417214|NCT01227798|Interferons|interferons|mesh-list
20417215|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
20417216|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417217|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
20417218|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417219|NCT01227811|Darifenacin|darifenacin|mesh-list
20417220|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20417221|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
20417222|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20417223|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417224|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216282|NCT00305500|Citalopram|citalopram|mesh-list
20417225|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417226|NCT01227811|Urological Agents|urological agents|mesh-ancestor
20417227|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
20417228|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417229|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417230|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20417231|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
20417232|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20417233|NCT01227876|Prednisolone|prednisolone|mesh-list
20417234|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
20417235|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20417236|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
20417237|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417238|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
20417239|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
20417240|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417241|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417242|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20417243|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
20417244|NCT01227876|Hormones|hormones|mesh-ancestor
20417245|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20417246|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20417247|NCT01227876|Protective Agents|protective agents|mesh-ancestor
20417248|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20417249|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417250|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
20417251|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417252|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417253|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417254|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
20417255|NCT01227915|Hormones|hormones|mesh-ancestor
20417256|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20417257|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417258|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20417259|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20417260|NCT01227941|Doxorubicin|doxorubicin|mesh-list
20417261|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20417262|NCT01227941|Niraparib|niraparib|mesh-list
20417263|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20417264|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417265|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20417266|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20417267|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417268|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417269|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20417270|NCT01228045|Trastuzumab|trastuzumab|mesh-list
20417271|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417272|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20417273|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
20417274|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417275|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
20417276|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20417277|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20417278|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417279|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
20417280|NCT01228136|Coagulants|coagulants|mesh-ancestor
20417281|NCT01228214|Aspirin|aspirin|mesh-list
20417282|NCT01228214|Amiloride|amiloride|mesh-list
20417283|NCT01228214|Clopidogrel|clopidogrel|mesh-list
20417284|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417285|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417286|NCT01228214|Analgesics|analgesics|mesh-ancestor
20417287|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
20417288|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417289|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417290|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417291|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417292|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20417293|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20417294|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417295|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20417296|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417297|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417298|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
20417299|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19392202|NCT03697057|Anesthetics|anesthetics|mesh-list
20417300|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20417301|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20417302|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
20417303|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417304|NCT01228214|Diuretics|diuretics|mesh-ancestor
20417305|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
20417306|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20417307|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20417308|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20417309|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20417310|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20417311|NCT01228227|Atorvastatin|atorvastatin|mesh-list
20417312|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20417313|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20417314|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20417315|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
20417316|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417317|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20417318|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20417319|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417320|NCT01228240|Metformin|metformin|mesh-list
20417321|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20417322|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417323|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20417324|NCT01228279|Icodextrin|icodextrin|mesh-list
20417325|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
20417326|NCT01228292|Heparin|heparin|mesh-list
20417327|NCT01228292|Calcium heparin|calcium heparin|mesh-list
20417328|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
20417329|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20417330|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20417331|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417332|NCT01228305|Acetaminophen|acetaminophen|mesh-list
20417333|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417334|NCT01228305|Analgesics|analgesics|mesh-ancestor
20417335|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
20417336|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417337|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417338|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
20417339|NCT01228344|Lumefantrine|lumefantrine|mesh-list
20417340|NCT01228344|Artemether|artemether|mesh-list
20417341|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20417342|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
20417343|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20417344|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20417345|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417346|NCT01228357|Milnacipran|milnacipran|mesh-list
20417347|NCT01228357|Mirtazapine|mirtazapine|mesh-list
20417348|NCT01228357|Sertraline|sertraline|mesh-list
20417349|NCT01228357|Fluoxetine|fluoxetine|mesh-list
20417350|NCT01228357|Paroxetine|paroxetine|mesh-list
20417351|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20417352|NCT01228357|Nortriptyline|nortriptyline|mesh-list
20417353|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
20417354|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20417355|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20417356|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20417357|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20417358|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417359|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417360|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
20417361|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417362|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20216283|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20216284|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20216285|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20216286|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216287|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216288|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
20216289|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417363|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20417364|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20417365|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392203|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392204|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417366|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20417367|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20417368|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
20417369|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
20417370|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20417371|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20417372|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417373|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20417374|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20417375|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20417376|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
20417377|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20417378|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20417379|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20417380|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417381|NCT01228357|Analgesics|analgesics|mesh-ancestor
20417382|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
20417383|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417384|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20417385|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20417386|NCT01228370|Silodosin|silodosin|mesh-list
20417387|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20417388|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20417389|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20417390|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
20417391|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417392|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417393|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417394|NCT01228370|Urological Agents|urological agents|mesh-ancestor
20417395|NCT01228409|Acitretin|acitretin|mesh-list
20417396|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
20417397|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417398|NCT01228422|Interferons|interferons|mesh-list
20417399|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
20417400|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
20417401|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417402|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
20417403|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417404|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
20417405|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417406|NCT01228552|Ketoprofen|ketoprofen|mesh-list
20417407|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417408|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417409|NCT01228552|Analgesics|analgesics|mesh-ancestor
20417410|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
20417411|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417412|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417413|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417414|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417415|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417416|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417417|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417418|NCT01228565|Cetuximab|cetuximab|mesh-list
20417419|NCT01228565|OTD70DERM|otd70derm|mesh-list
20417420|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20417421|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417422|NCT01228565|Protective Agents|protective agents|mesh-ancestor
20417423|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417424|NCT01228604|Methylphenidate|methylphenidate|mesh-list
20417425|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20417426|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417427|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20417428|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20417429|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20417430|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417431|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
20417432|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417433|NCT01228617|Nicotine|nicotine|mesh-list
20417434|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20417435|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
20417436|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417437|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417438|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20417439|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20417440|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
20417441|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417442|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417443|NCT01228630|Loratadine|loratadine|mesh-list
20417444|NCT01228630|Fexofenadine|fexofenadine|mesh-list
20417445|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
20417446|NCT01228630|Ephedrine|ephedrine|mesh-list
20417447|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
20417448|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417449|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20417450|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20417451|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20417452|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
20417453|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
20417454|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417455|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417456|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417457|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20417458|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
20417459|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417460|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20417461|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
20417462|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
20417463|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20417464|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20417465|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
20417466|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
20417467|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
20417468|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
20417469|NCT01228656|Salicylates|salicylates|mesh-list
20417470|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417471|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417472|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20417473|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417474|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
20417475|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
20417476|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417477|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417478|NCT01228656|Analgesics|analgesics|mesh-ancestor
20417479|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
20417480|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417481|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417482|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417483|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417484|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417485|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417486|NCT01228682|Tolvaptan|tolvaptan|mesh-list
20417487|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19392205|NCT03697044|Irinotecan|irinotecan|mesh-list
19392206|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19392207|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20417488|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417489|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
20417490|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417491|NCT01228994|Baclofen|baclofen|mesh-list
20417492|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20417493|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417494|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20417495|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417496|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20417497|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
19392208|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392209|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392210|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216290|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20216291|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
20216292|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216293|NCT00305513|Caffeine|caffeine|mesh-list
20216294|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20216295|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216296|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20216297|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216298|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417498|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
20417499|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417500|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417501|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
20417502|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
20417503|NCT01229046|Ticarcillin|ticarcillin|mesh-list
20417504|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
20417505|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417506|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417507|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417508|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417509|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20417510|NCT01229072|Heparin|heparin|mesh-list
20417511|NCT01229072|Calcium heparin|calcium heparin|mesh-list
20417512|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
20417513|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20417514|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20417515|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417516|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
20417517|NCT01229085|Salicylates|salicylates|mesh-list
20417518|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417519|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
20417520|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
20417521|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417522|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417523|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417524|NCT01229085|Analgesics|analgesics|mesh-ancestor
20417525|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
20417526|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417527|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417528|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417529|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417530|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417531|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417532|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417533|NCT01229189|Vitamin D|vitamin d|mesh-list
20417534|NCT01229189|Vitamins|vitamins|mesh-ancestor
20417535|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
20417536|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417537|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20417538|NCT01229202|Bevacizumab|bevacizumab|mesh-list
20417539|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20417540|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417541|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20417542|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20417543|NCT01229202|Growth Substances|growth substances|mesh-ancestor
20417544|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417545|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
20417546|NCT01229241|Anesthetics|anesthetics|mesh-list
20417547|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
20417548|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417549|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417550|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
20417551|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417552|NCT01229280|Darifenacin|darifenacin|mesh-list
20417553|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20417554|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
20417555|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20417556|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417557|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417558|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417559|NCT01229280|Urological Agents|urological agents|mesh-ancestor
20417560|NCT01229319|Imiquimod|imiquimod|mesh-list
20417561|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20417562|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
20417563|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417564|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417565|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
20417566|NCT01229332|Carbidopa|carbidopa|mesh-list
20417567|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20417568|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20417569|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
20417570|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417571|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417572|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417573|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20417574|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427843|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20427844|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20216299|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20216300|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20216301|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
20216302|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216303|NCT00305539|Adalimumab|adalimumab|mesh-list
20216304|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20216305|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20216306|NCT00305552|Thalidomide|thalidomide|mesh-list
20216307|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216308|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
20216309|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216310|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
20216311|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20216312|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216313|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20216314|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20216315|NCT00305552|Growth Substances|growth substances|mesh-ancestor
20216316|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
20427845|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427846|NCT01289171|Glycolic acid|glycolic acid|mesh-list
20427847|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
20427848|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
20427849|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20427850|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20427851|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
20427852|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427853|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427854|NCT01289236|Milnacipran|milnacipran|mesh-list
20427855|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
20427856|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20427857|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20427858|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20427859|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427860|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427861|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427862|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427863|NCT01289236|Analgesics|analgesics|mesh-ancestor
20427864|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
20427865|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427866|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
20427867|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20427868|NCT01289301|Cyclosporine|cyclosporine|mesh-list
20427869|NCT01289301|Sirolimus|sirolimus|mesh-list
20427870|NCT01289301|Everolimus|everolimus|mesh-list
20427871|NCT01289301|Tacrolimus|tacrolimus|mesh-list
20427872|NCT01289301|Cyclosporins|cyclosporins|mesh-list
20427873|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20427874|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427875|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
20427876|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427877|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427878|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427879|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
20427880|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427881|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
20427882|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427883|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427884|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20427885|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20427886|NCT01289327|Midazolam|midazolam|mesh-list
20427887|NCT01289327|Alfentanil|alfentanil|mesh-list
20427888|NCT01289327|Propofol|propofol|mesh-list
20427889|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20427890|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20427891|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427892|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19392211|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
20427893|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
20427894|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
20216317|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427895|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20417575|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
20417576|NCT01229579|Astringents|astringents|mesh-ancestor
20417577|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417578|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417579|NCT01229592|Ethanol|ethanol|mesh-list
20417580|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20417581|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417582|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417583|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417584|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
20417585|NCT01229605|Docetaxel|docetaxel|mesh-list
20417586|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417587|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
20417588|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417589|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417590|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20417591|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
20417592|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417593|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417594|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20417595|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
20417596|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
20417597|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
20417598|NCT01229761|Trimethoprim|trimethoprim|mesh-list
20417599|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20417600|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
20417601|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20417602|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417603|NCT01229761|Renal Agents|renal agents|mesh-ancestor
20417604|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
20417605|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20417606|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20417607|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20417608|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417609|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417610|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20417611|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20417612|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20417613|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417614|NCT01229774|Diclofenac|diclofenac|mesh-list
20417615|NCT01229774|Etoricoxib|etoricoxib|mesh-list
20417616|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417617|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417618|NCT01229774|Analgesics|analgesics|mesh-ancestor
20417619|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
20417620|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417621|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417622|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417623|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417624|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417625|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417626|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417627|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20417628|NCT01229813|Bevacizumab|bevacizumab|mesh-list
20417629|NCT01229813|Capecitabine|capecitabine|mesh-list
20417630|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20417631|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20417632|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417633|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20417634|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20417635|NCT01229813|Growth Substances|growth substances|mesh-ancestor
20417636|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216318|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
20216319|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20216320|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20216321|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216322|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216323|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216324|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
20216325|NCT00305630|Triamcinolone|triamcinolone|mesh-list
20216326|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20216327|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20216328|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20216329|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417637|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
20417638|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20417639|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
20417640|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417641|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20417642|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417643|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
20417644|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
20417645|NCT01229930|Paclitaxel|paclitaxel|mesh-list
20417646|NCT01229930|Carboplatin|carboplatin|mesh-list
20417647|NCT01229930|Cediranib|cediranib|mesh-list
20417648|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20417649|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417650|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
20417651|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
20417652|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
20417653|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417654|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417655|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20417656|NCT01230034|Ramipril|ramipril|mesh-list
20417657|NCT01230034|Imidapril|imidapril|mesh-list
20417658|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20417659|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
20417660|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417661|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417662|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20417663|NCT01230359|Pyridoxine|pyridoxine|mesh-list
20417664|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
20417665|NCT01230359|Vitamins|vitamins|mesh-ancestor
20417666|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
20417667|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417668|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
20417669|NCT01230411|Ibuprofen|ibuprofen|mesh-list
20417670|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417671|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417672|NCT01230411|Analgesics|analgesics|mesh-ancestor
20417673|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
20417674|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417675|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417676|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417677|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417678|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417679|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417680|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417681|NCT01230463|Ketorolac|ketorolac|mesh-list
20417682|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20417683|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417684|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417685|NCT01230463|Analgesics|analgesics|mesh-ancestor
20417686|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
20417687|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392212|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
19392213|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19392214|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392215|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392216|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
19392217|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19392218|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392219|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392220|NCT03696940|Atorvastatin|atorvastatin|mesh-list
19392221|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19392222|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19691689|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19691690|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19691691|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691692|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691693|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19691694|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19691695|NCT05001412|Carboplatin|carboplatin|mesh-list
19691696|NCT05001412|Etoposide|etoposide|mesh-list
19691697|NCT05001412|Apatinib|apatinib|mesh-list
20417688|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417689|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417690|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691698|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417691|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19392223|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
19392224|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392225|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19392226|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19392227|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392228|NCT03696901|Dalbavancin|dalbavancin|mesh-list
19392229|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417692|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417693|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417694|NCT01230476|Cetuximab|cetuximab|mesh-list
20417695|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20417696|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417697|NCT01230541|Udenafil|udenafil|mesh-list
20417698|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20417699|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20417700|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417701|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417702|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20417703|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20417704|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
20417705|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
20417706|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417707|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417708|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417709|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20417710|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20417711|NCT01230697|Sorafenib|sorafenib|mesh-list
20417712|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417713|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20216330|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
20417714|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417715|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417716|NCT01230723|Everolimus|everolimus|mesh-list
20417717|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417718|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417719|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
20417720|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417721|NCT01230736|Timolol|timolol|mesh-list
20417722|NCT01230736|Travoprost|travoprost|mesh-list
20417723|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20417724|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20417725|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20417726|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20417727|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
20417728|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417729|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417730|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417731|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20417732|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20417733|NCT01230775|Anagrelide|anagrelide|mesh-list
20417734|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20417735|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20417736|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417737|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20417738|NCT01230983|Leucovorin|leucovorin|mesh-list
20417739|NCT01230983|Cytarabine|cytarabine|mesh-list
20417740|NCT01230983|Prednisone|prednisone|mesh-list
20417741|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
20417742|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20417743|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20417744|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20417745|NCT01230983|Doxorubicin|doxorubicin|mesh-list
20417746|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20417747|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
20417748|NCT01230983|Methotrexate|methotrexate|mesh-list
19403960|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
20216331|NCT00305630|Hormones|hormones|mesh-ancestor
20216332|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216333|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216334|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216335|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
20216336|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216337|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216338|NCT00305669|Sargramostim|sargramostim|mesh-list
20216339|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
20417749|NCT01230983|Vincristine|vincristine|mesh-list
20417750|NCT01230983|Asparaginase|asparaginase|mesh-list
20417751|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
20417752|NCT01230983|Razoxane|razoxane|mesh-list
20417753|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
20417754|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20417755|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417756|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20417757|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20417758|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417759|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417760|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417761|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417762|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
20417763|NCT01230983|Hormones|hormones|mesh-ancestor
20417764|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20417765|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20417766|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20417767|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
20417768|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20417769|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20417770|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
20417771|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417772|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20417773|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417774|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
20417775|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417776|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20417777|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
20417778|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417779|NCT01230983|Antidotes|antidotes|mesh-ancestor
20417780|NCT01230983|Protective Agents|protective agents|mesh-ancestor
20417781|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
20417782|NCT01230983|Vitamins|vitamins|mesh-ancestor
20417783|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
20417784|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20417785|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
20417786|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
20417787|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
20417788|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20417789|NCT01230996|Cisplatin|cisplatin|mesh-list
20417790|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417791|NCT01231074|Metformin|metformin|mesh-list
20417792|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20417793|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417794|NCT01231113|Artesunate|artesunate|mesh-list
20417795|NCT01231113|Piperaquine|piperaquine|mesh-list
20417796|NCT01231113|Amodiaquine|amodiaquine|mesh-list
20417797|NCT01231113|Artenimol|artenimol|mesh-list
20417798|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
20417799|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20417800|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20417801|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417802|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417803|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
20417804|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
20417805|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20417806|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
20417807|NCT01231126|Misoprostol|misoprostol|mesh-list
20417808|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20417809|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
20417810|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20417811|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417812|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20417813|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20417814|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
20417815|NCT01231139|Acetaminophen|acetaminophen|mesh-list
20417816|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417817|NCT01231139|Analgesics|analgesics|mesh-ancestor
20417818|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
20417819|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417820|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417821|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
20427896|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20427897|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20427898|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20427899|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
20427900|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
20427901|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417822|NCT01231165|Aspirin|aspirin|mesh-list
20417823|NCT01231165|Amiloride|amiloride|mesh-list
20417824|NCT01231165|Clopidogrel|clopidogrel|mesh-list
20417825|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20417826|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417827|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417828|NCT01231165|Analgesics|analgesics|mesh-ancestor
20417829|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
20417830|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417831|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417832|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417833|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417834|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19691699|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19691700|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19691701|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19691702|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691703|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691704|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19691705|NCT05001776|PENTA|penta|mesh-list
19691706|NCT05001776|Fondaparinux|fondaparinux|mesh-list
20417835|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20417836|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417837|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20417838|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417839|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417840|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
20417841|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20417842|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20417843|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20417844|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
20417845|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417846|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20417847|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20417848|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
20417849|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20417850|NCT01231165|Diuretics|diuretics|mesh-ancestor
20417851|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
20417852|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20417853|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20417854|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20417855|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20417856|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20417857|NCT01231191|Acetaminophen|acetaminophen|mesh-list
20417858|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417859|NCT01231191|Analgesics|analgesics|mesh-ancestor
20417860|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
20417861|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417862|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417863|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
20417864|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20417865|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20417866|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417867|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
20417868|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20417869|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417870|NCT01231490|Naproxen|naproxen|mesh-list
20417871|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20417872|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20417873|NCT01231490|Analgesics|analgesics|mesh-ancestor
20417874|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
20417875|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20417876|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417877|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20417878|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417879|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
20417880|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20417881|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417882|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417883|NCT01231529|Dolutegravir|dolutegravir|mesh-list
20417884|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20417885|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20417886|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417887|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417888|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20417889|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20417890|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
20417891|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417892|NCT01231542|Rifampin|rifampin|mesh-list
20417893|NCT01231542|Rifabutin|rifabutin|mesh-list
20417894|NCT01231542|Dolutegravir|dolutegravir|mesh-list
20417895|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20417896|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
20417897|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417898|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417899|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
20417900|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20417901|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417902|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417903|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20417904|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20417905|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20417906|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20417907|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20417908|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20417909|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20417910|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20417911|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20417912|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20417913|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
20417914|NCT01231594|Trametinib|trametinib|mesh-list
20417915|NCT01231594|Dabrafenib|dabrafenib|mesh-list
20417916|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
20417917|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20417918|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417919|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417920|NCT01231685|Ritonavir|ritonavir|mesh-list
20417921|NCT01231685|Lopinavir|lopinavir|mesh-list
20417922|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20417923|NCT01231685|Darunavir|darunavir|mesh-list
20417924|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20417925|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
20417926|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
20417927|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20417928|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417929|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417930|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20417931|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20417932|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
20417933|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417934|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20417935|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20417936|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20417937|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20417938|NCT01231698|Esmolol|esmolol|mesh-list
20417939|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20417940|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20417941|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20417942|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
20417943|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20417944|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417945|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417946|NCT01231711|Ethanol|ethanol|mesh-list
20417947|NCT01231711|Povidone-Iodine|povidone-iodine|mesh-list
20417948|NCT01231711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20417949|NCT01231711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417950|NCT01231711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20417951|NCT01231711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417952|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
20417953|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20417954|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417955|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20417956|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20417957|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417958|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417959|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417960|NCT01231802|Leucovorin|leucovorin|mesh-list
20417961|NCT01231802|Fluorouracil|fluorouracil|mesh-list
20417962|NCT01231802|Capecitabine|capecitabine|mesh-list
20417963|NCT01231802|Eniluracil|eniluracil|mesh-list
20417964|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
20417965|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417966|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20417967|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417968|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417969|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
20417970|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417971|NCT01231802|Antidotes|antidotes|mesh-ancestor
20417972|NCT01231802|Protective Agents|protective agents|mesh-ancestor
20417973|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
20417974|NCT01231802|Vitamins|vitamins|mesh-ancestor
20417975|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
20417976|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417977|NCT01231828|Lactulose|lactulose|mesh-list
20417978|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20417979|NCT01231854|Cyclosporine|cyclosporine|mesh-list
20417980|NCT01231854|Alitretinoin|alitretinoin|mesh-list
20417981|NCT01231854|Cyclosporins|cyclosporins|mesh-list
20417982|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20417983|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20417984|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20417985|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
20417986|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20417987|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
20417988|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417989|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
20417990|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20417991|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20417992|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20417993|NCT01231880|Piperaquine|piperaquine|mesh-list
20417994|NCT01231880|Artenimol|artenimol|mesh-list
20417995|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
20417996|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20417997|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20417998|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20417999|NCT01231997|Udenafil|udenafil|mesh-list
20418000|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20418001|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20418002|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418003|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418004|NCT01232010|Mirodenafil|mirodenafil|mesh-list
20418005|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20418006|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20418007|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418008|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418009|NCT01232023|Indobufen|indobufen|mesh-list
20418010|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20418011|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20418012|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418013|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418014|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20418015|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20418016|NCT01232023|Analgesics|analgesics|mesh-ancestor
20418017|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
20418018|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418019|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418020|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20418021|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418022|NCT01232036|Metformin|metformin|mesh-list
20418023|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418024|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418025|NCT01232075|Letrozole|letrozole|mesh-list
20418026|NCT01232075|Citric Acid|citric acid|mesh-list
20418027|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
20418028|NCT01232075|Clomiphene|clomiphene|mesh-list
20418029|NCT01232075|Enclomiphene|enclomiphene|mesh-list
20418030|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
20418031|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
20418032|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20418033|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
20418034|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
20418035|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418036|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418037|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20418038|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20418039|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418040|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20418041|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
20418042|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418043|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418044|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20418045|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
20418046|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20418047|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20418048|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20418049|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20418050|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418051|NCT01232244|Glucagon|glucagon|mesh-list
20418052|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20418053|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20418054|NCT01232244|Hormones|hormones|mesh-ancestor
20418055|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418056|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418057|NCT01232244|Incretins|incretins|mesh-ancestor
20418058|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
20418059|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20418060|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
20418061|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418062|NCT01232257|Expectorants|expectorants|mesh-ancestor
20418063|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
20418064|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20418065|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
20418066|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418067|NCT01232257|Protective Agents|protective agents|mesh-ancestor
20418068|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418069|NCT01232257|Antidotes|antidotes|mesh-ancestor
20418070|NCT01232270|Propofol|propofol|mesh-list
20418071|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20418072|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418073|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418074|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20418075|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
20418076|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
20418077|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
20418078|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418079|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20418080|NCT01232400|Esmolol|esmolol|mesh-list
20418081|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20418082|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20418083|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20418084|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
20418085|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418086|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418087|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418088|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
20418089|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
20418090|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20418091|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418092|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20418093|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20418094|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418095|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418096|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418097|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418098|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20418099|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418100|NCT01232439|Aticaprant|aticaprant|mesh-list
20418101|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418102|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
20418103|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418104|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20418105|NCT01232647|Vitamins|vitamins|mesh-list
20418106|NCT01232647|Vitamin K|vitamin k|mesh-list
20418107|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
20418108|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
20418109|NCT01232647|Menatetrenone|menatetrenone|mesh-list
20418110|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
20418111|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418112|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20418113|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20418114|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418115|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
19392230|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216340|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216341|NCT00305708|Fludarabine|fludarabine|mesh-list
20216342|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
20216343|NCT00305708|Busulfan|busulfan|mesh-list
20216344|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20418116|NCT01232647|Coagulants|coagulants|mesh-ancestor
20418117|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
20418118|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
20418119|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20418120|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20418121|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418122|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418123|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418124|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418125|NCT01232777|Bevacizumab|bevacizumab|mesh-list
20418126|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20418127|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418128|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20418129|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20418130|NCT01232777|Growth Substances|growth substances|mesh-ancestor
20418131|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418132|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
20418133|NCT01232803|Tenofovir|tenofovir|mesh-list
20418134|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
20418135|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418136|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20418137|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20418138|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418139|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418140|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20418141|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20427902|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427903|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20427904|NCT01289327|Narcotics|narcotics|mesh-ancestor
20427905|NCT01289327|Analgesics|analgesics|mesh-ancestor
20427906|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
20427907|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427908|NCT01289483|Fospropofol|fospropofol|mesh-list
20427909|NCT01289483|Propofol|propofol|mesh-list
20427910|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20427911|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20427912|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427913|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20427914|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
20427915|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
20427916|NCT01289496|Interferons|interferons|mesh-list
20427917|NCT01289496|Ribavirin|ribavirin|mesh-list
20427918|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
20427919|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
20427920|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20427921|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20427922|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
20427923|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427924|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
20427925|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427926|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
20427927|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427928|NCT01289561|Ethanol|ethanol|mesh-list
20427929|NCT01289561|Quinine|quinine|mesh-list
20427930|NCT01289561|Caffeine|caffeine|mesh-list
20427931|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20427932|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216345|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216346|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20216347|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
20216348|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216349|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216350|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
20216351|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216352|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
20216353|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20216354|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20216355|NCT00305734|Gemcitabine|gemcitabine|mesh-list
20427933|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216356|NCT00305734|Bortezomib|bortezomib|mesh-list
20427934|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418142|NCT01233167|Clopidogrel|clopidogrel|mesh-list
20418143|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20418144|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20418145|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20418146|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20418147|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
20418148|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418149|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418150|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418151|NCT01233206|Metformin|metformin|mesh-list
20418152|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418153|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418154|NCT01233219|Morphine|morphine|mesh-list
20418155|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20418156|NCT01233219|Narcotics|narcotics|mesh-ancestor
20418157|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418158|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418159|NCT01233219|Analgesics|analgesics|mesh-ancestor
20418160|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
20418161|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418162|NCT01233245|Interferons|interferons|mesh-list
20418163|NCT01233245|Interferon-beta|interferon-beta|mesh-list
20418164|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
20418165|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418166|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
20418167|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418168|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
20418169|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418170|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20418171|NCT01233362|Vaccines|vaccines|mesh-list
20418172|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
20418173|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418174|NCT01233453|Umirolimus|umirolimus|mesh-list
20418175|NCT01233453|Everolimus|everolimus|mesh-list
20418176|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418177|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418178|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
20418179|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418180|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20418181|NCT01233492|Mannitol|mannitol|mesh-list
20418182|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20418183|NCT01233492|Diuretics|diuretics|mesh-ancestor
20418184|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
20418185|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418186|NCT01233505|Capecitabine|capecitabine|mesh-list
20418187|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
20418188|NCT01233505|Veliparib|veliparib|mesh-list
20418189|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418190|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
20418191|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418192|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418193|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20418194|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418195|NCT01233570|Tacrolimus|tacrolimus|mesh-list
20418196|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418197|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
20418198|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418199|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20418200|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418201|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418202|NCT01233583|Adalimumab|adalimumab|mesh-list
20418203|NCT01233583|Etanercept|etanercept|mesh-list
20418204|NCT01233583|Infliximab|infliximab|mesh-list
20418205|NCT01233583|Acitretin|acitretin|mesh-list
20418206|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20418207|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418208|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
20418209|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20418210|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20418211|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20418212|NCT01233583|Analgesics|analgesics|mesh-ancestor
20418213|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
20418214|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418215|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418216|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418217|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
20418218|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
20418219|NCT01233622|Vildagliptin|vildagliptin|mesh-list
20418220|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418221|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418222|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20418223|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
20418224|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418225|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418226|NCT01233635|Losartan|losartan|mesh-list
20418227|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20418228|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20418229|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20418230|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20418231|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418232|NCT01233752|Morphine|morphine|mesh-list
20418233|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20418234|NCT01233752|Narcotics|narcotics|mesh-ancestor
20418235|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418236|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418237|NCT01233752|Analgesics|analgesics|mesh-ancestor
20418238|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
20418239|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418240|NCT01233791|Diazepam|diazepam|mesh-list
20418241|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20418242|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
20418243|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
20418244|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
20418245|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418246|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418247|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20418248|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20418249|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418250|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20418251|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20418252|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20418253|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20418254|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20418255|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20418256|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
20418257|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
20418258|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
20418259|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
20418260|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418261|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418262|NCT01233843|Carboplatin|carboplatin|mesh-list
20418263|NCT01233843|Fluorouracil|fluorouracil|mesh-list
20418264|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418265|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
20418266|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418267|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418268|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418269|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
20418270|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418271|NCT01233895|Bortezomib|bortezomib|mesh-list
20418272|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418273|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
20418274|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20418275|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20418276|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
20418277|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
20418278|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418279|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418280|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418281|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
20418282|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
20418283|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20418284|NCT01233947|Fulvestrant|fulvestrant|mesh-list
20418285|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20418286|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418287|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20418288|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20418289|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
20418290|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418291|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392231|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
20418292|NCT01234051|Docetaxel|docetaxel|mesh-list
20418293|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
20418294|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418295|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
20418296|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
20418297|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
20418298|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418299|NCT01234116|Tenofovir|tenofovir|mesh-list
20418300|NCT01234116|Emtricitabine|emtricitabine|mesh-list
20418301|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20418302|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
20418303|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418304|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20418305|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20418306|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418307|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418308|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20418309|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20418310|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
20418311|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20418312|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418313|NCT01234142|Varenicline|varenicline|mesh-list
20418314|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20418315|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20418316|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
20418317|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418318|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418319|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418320|NCT01234194|Remifentanil|remifentanil|mesh-list
20418321|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20418322|NCT01234194|Narcotics|narcotics|mesh-ancestor
20418323|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418324|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418325|NCT01234194|Analgesics|analgesics|mesh-ancestor
20418326|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
20418327|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418328|NCT01234272|Morphine|morphine|mesh-list
20418329|NCT01234272|Ropivacaine|ropivacaine|mesh-list
20418330|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20418331|NCT01234272|Narcotics|narcotics|mesh-ancestor
20418332|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418333|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418334|NCT01234272|Analgesics|analgesics|mesh-ancestor
20418335|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
20418336|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418337|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
20418338|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
20418339|NCT01234285|Heparin|heparin|mesh-list
20418340|NCT01234285|Calcium heparin|calcium heparin|mesh-list
20418341|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
20418342|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20418343|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20418344|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418345|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20418346|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20418347|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418348|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20418349|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20418350|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20418351|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418352|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
20418353|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19403961|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
20216357|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20216358|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
20216359|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216360|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216361|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
20216362|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216363|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216364|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216365|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
20216366|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216367|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20418354|NCT01234324|Cisplatin|cisplatin|mesh-list
20216368|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20418355|NCT01234324|Capecitabine|capecitabine|mesh-list
20418356|NCT01234324|Epirubicin|epirubicin|mesh-list
20418357|NCT01234324|Panitumumab|panitumumab|mesh-list
20418358|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418359|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418360|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
20418361|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418362|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20418363|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20418364|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20418365|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418366|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20418367|NCT01234454|Olanzapine|olanzapine|mesh-list
20418368|NCT01234454|Risperidone|risperidone|mesh-list
20418369|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20418370|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
20418371|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418372|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418373|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418374|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20418375|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20418376|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418377|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20418378|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20418379|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
20418380|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
20418381|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
20418382|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418383|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20418384|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20418385|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20418386|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20418387|NCT01234506|Vitamin D|vitamin d|mesh-list
20418388|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
20418389|NCT01234506|Vitamins|vitamins|mesh-ancestor
20418390|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
20418391|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418392|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20418393|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
20418394|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20418395|NCT01234506|Estrogens|estrogens|mesh-ancestor
20418396|NCT01234506|Hormones|hormones|mesh-ancestor
20418397|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418398|NCT01234597|Insulin|insulin|mesh-list
20418399|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20418400|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
20418401|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
20418402|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418403|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418404|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20418405|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20418406|NCT01234701|Liver Extracts|liver extracts|mesh-list
20418407|NCT01234701|Hematinics|hematinics|mesh-ancestor
20216369|NCT00305747|Protective Agents|protective agents|mesh-ancestor
20216370|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216371|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216372|NCT00305786|Gemcitabine|gemcitabine|mesh-list
20216373|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
20216374|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20216375|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
20418408|NCT01234740|Bafetinib|bafetinib|mesh-list
20418409|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20418410|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418411|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427935|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20427936|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20427937|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427938|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427939|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20216376|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216377|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216378|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
20216379|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216380|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427940|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20427941|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
20418412|NCT01234792|Nicotine|nicotine|mesh-list
20418413|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20418414|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
20418415|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418416|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418417|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20418418|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20418419|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
20418420|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418421|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418422|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
20418423|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20418424|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
20418425|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20418426|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418427|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20418428|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20418429|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20418430|NCT01234857|Sirolimus|sirolimus|mesh-list
20418431|NCT01234857|Exemestane|exemestane|mesh-list
20418432|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20418433|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418434|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20418435|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20418436|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418437|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418438|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20418439|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
20418440|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418441|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418442|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20418443|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418444|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20418445|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
20418446|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418447|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
20418448|NCT01234896|Nicotine|nicotine|mesh-list
20418449|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20418450|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
20418451|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418452|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418453|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20418454|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20418455|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
20418456|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418457|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418458|NCT01234935|Gemcitabine|gemcitabine|mesh-list
20418459|NCT01234935|Dasatinib|dasatinib|mesh-list
20418460|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418461|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
20418462|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418463|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418464|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
20418465|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418466|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418467|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418468|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
20418469|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418470|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20418471|NCT01234974|Everolimus|everolimus|mesh-list
20418472|NCT01234974|Pasireotide|pasireotide|mesh-list
20418473|NCT01234974|Somatostatin|somatostatin|mesh-list
20418474|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418475|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418476|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
20418477|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418478|NCT01234974|Hormones|hormones|mesh-ancestor
20418479|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418480|NCT01235013|Maraviroc|maraviroc|mesh-list
20418481|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20418482|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20418483|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418484|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20418485|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20418486|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
20418487|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418488|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20418489|NCT01235117|Azacitidine|azacitidine|mesh-list
20418490|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418491|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
20418492|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418493|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418494|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418495|NCT01235143|Sevoflurane|sevoflurane|mesh-list
20418496|NCT01235143|Desflurane|desflurane|mesh-list
20418497|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20418498|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20418499|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
20418500|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
20418501|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418502|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418503|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
20418504|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20418505|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20418506|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418507|NCT01235260|Becaplermin|becaplermin|mesh-list
20418508|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
20418509|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20418510|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20418511|NCT01235260|Growth Substances|growth substances|mesh-ancestor
20418512|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418513|NCT01235273|Hormones|hormones|mesh-list
20418514|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418515|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418516|NCT01235325|Vitamin K|vitamin k|mesh-list
20418517|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
20418518|NCT01235325|Vitamins|vitamins|mesh-ancestor
20418519|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
20418520|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418521|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20418522|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20418523|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418524|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
20418525|NCT01235325|Coagulants|coagulants|mesh-ancestor
20418526|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
20418527|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20418528|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418529|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418530|NCT01235455|Interferons|interferons|mesh-list
20418531|NCT01235455|Interferon-beta|interferon-beta|mesh-list
20418532|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
20418533|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418534|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
20418535|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418536|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
20418537|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418538|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20418539|NCT01235637|Sufentanil|sufentanil|mesh-list
20418540|NCT01235637|Alfentanil|alfentanil|mesh-list
20418541|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20418542|NCT01235637|Narcotics|narcotics|mesh-ancestor
20418543|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418544|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418545|NCT01235637|Analgesics|analgesics|mesh-ancestor
20418546|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
20418547|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418548|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20418549|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20418550|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
20418551|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
20418552|NCT01235819|Insulin|insulin|mesh-list
20418553|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20418554|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20418555|NCT01235819|Exenatide|exenatide|mesh-list
20418556|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20418557|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418558|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418559|NCT01235819|Incretins|incretins|mesh-ancestor
20418560|NCT01235819|Hormones|hormones|mesh-ancestor
20418561|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418562|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
20418563|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418564|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418565|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20418566|NCT01236040|Vaccines|vaccines|mesh-list
20418567|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
20418568|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418569|NCT01236144|Plerixafor|plerixafor|mesh-list
20418570|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20418571|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20418572|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
20418573|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418574|NCT01236482|Oxytocin|oxytocin|mesh-list
20418575|NCT01236482|Ergonovine|ergonovine|mesh-list
20418576|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
20418577|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20418578|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418579|NCT01236495|Morphine|morphine|mesh-list
20418580|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20418581|NCT01236495|Narcotics|narcotics|mesh-ancestor
20418582|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418583|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418584|NCT01236495|Analgesics|analgesics|mesh-ancestor
20418585|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
20418586|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418587|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20418588|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20418589|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418590|NCT01236586|Dexamethasone|dexamethasone|mesh-list
20418591|NCT01236586|R04929097|r04929097|mesh-list
20418592|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20418593|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
20418594|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
20418595|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418596|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418597|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20418598|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
20418599|NCT01236586|Hormones|hormones|mesh-ancestor
20418600|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418601|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20418602|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418603|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418604|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418605|NCT01236612|Chloroquine|chloroquine|mesh-list
20418606|NCT01236612|Proguanil|proguanil|mesh-list
20418607|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20216381|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216382|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
20216383|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218059|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20218060|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218061|NCT00311688|Interleukin-2|interleukin-2|mesh-list
20218062|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218063|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20218064|NCT00311688|Analgesics|analgesics|mesh-ancestor
20418608|NCT01236612|Vaccines|vaccines|mesh-list
20418609|NCT01236612|Amebicides|amebicides|mesh-ancestor
20418610|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20418611|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20418612|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418613|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
20418614|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418615|NCT01236612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418616|NCT01236612|Immunologic Factors|immunologic factors|mesh-ancestor
20418617|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
20418618|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418619|NCT01236651|Drotaverin|drotaverin|mesh-list
20418620|NCT01236651|Meperidine|meperidine|mesh-list
20418621|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20418622|NCT01236651|Narcotics|narcotics|mesh-ancestor
20418623|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418624|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418625|NCT01236651|Analgesics|analgesics|mesh-ancestor
20418626|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
20218065|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
20218066|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418627|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418628|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20418629|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
20418630|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
20418631|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
20418632|NCT01236716|Gemcitabine|gemcitabine|mesh-list
20418633|NCT01236716|Paclitaxel|paclitaxel|mesh-list
20418634|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20418635|NCT01236716|Carboplatin|carboplatin|mesh-list
20418636|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20418637|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418638|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
20418639|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
20418640|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
20418641|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418642|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418643|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
20418644|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
20418645|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418646|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418647|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418648|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
20418649|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427942|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427943|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
20427944|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20427945|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20427946|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20427947|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20427948|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427949|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427950|NCT01289561|Analgesics|analgesics|mesh-ancestor
20427951|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
20427952|NCT01289730|Etanercept|etanercept|mesh-list
20427953|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20427954|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427955|NCT01289730|Analgesics|analgesics|mesh-ancestor
20427956|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
20427957|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427958|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427959|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427960|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427961|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427962|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427963|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
20427964|NCT01289743|Etanercept|etanercept|mesh-list
20427965|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20427966|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20427967|NCT01289743|Analgesics|analgesics|mesh-ancestor
20427968|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
20427969|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20427970|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427971|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20427972|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20427973|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20427974|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20427975|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
20427976|NCT01289756|Clarithromycin|clarithromycin|mesh-list
20427977|NCT01289756|Paroxetine|paroxetine|mesh-list
20427978|NCT01289756|Clomiphene|clomiphene|mesh-list
20427979|NCT01289756|Enclomiphene|enclomiphene|mesh-list
20427980|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
20427981|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20427982|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20427983|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20427984|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20427985|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20427986|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20427987|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20427988|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20427989|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20427990|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20427991|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20427992|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
20427993|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20427994|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20427995|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
20427996|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20427997|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20427998|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20418650|NCT01236859|Gabapentin|gabapentin|mesh-list
20418651|NCT01236859|Analgesics|analgesics|mesh-ancestor
20418652|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
20418653|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418654|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418655|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
20418656|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20418657|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20418658|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418659|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20418660|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20418661|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20418662|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418663|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418664|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
20418665|NCT01236911|Calcium|calcium|mesh-list
20418666|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20418667|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418668|NCT01236950|Listerine|listerine|mesh-list
20418669|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20418670|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418671|NCT01236963|Listerine|listerine|mesh-list
20418672|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20418673|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418674|NCT01236989|Liver Extracts|liver extracts|mesh-list
20418675|NCT01236989|Hematinics|hematinics|mesh-ancestor
20418676|NCT01237028|Calcitriol|calcitriol|mesh-list
20418677|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20418678|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418679|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20418680|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20418681|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418682|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20418683|NCT01237028|Vitamins|vitamins|mesh-ancestor
20418684|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
20418685|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20418686|NCT01237067|Carboplatin|carboplatin|mesh-list
20418687|NCT01237067|Olaparib|olaparib|mesh-list
20418688|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418689|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20418690|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418691|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418692|NCT01237119|Liraglutide|liraglutide|mesh-list
20418693|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418694|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418695|NCT01237119|Incretins|incretins|mesh-ancestor
20418696|NCT01237119|Hormones|hormones|mesh-ancestor
20418697|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418698|NCT01237249|Dexamethasone|dexamethasone|mesh-list
20418699|NCT01237249|Prednisone|prednisone|mesh-list
20418700|NCT01237249|Melphalan|melphalan|mesh-list
20418701|NCT01237249|Lenalidomide|lenalidomide|mesh-list
20418702|NCT01237249|Bortezomib|bortezomib|mesh-list
20418703|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20418704|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
20418705|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
20418706|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418707|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418708|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216384|NCT00305812|Dexamethasone|dexamethasone|mesh-list
20216385|NCT00305812|Lenalidomide|lenalidomide|mesh-list
20216386|NCT00305812|Melphalan|melphalan|mesh-list
20216387|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20216388|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
20216389|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
20216390|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216391|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216392|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216393|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
20216394|NCT00305812|Hormones|hormones|mesh-ancestor
20216395|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216396|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20216397|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418709|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
20418710|NCT01237249|Hormones|hormones|mesh-ancestor
20418711|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216398|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
20418712|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20418713|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418714|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20418715|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
20418716|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418717|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20418718|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418719|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
20418720|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20418721|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20418722|NCT01237249|Growth Substances|growth substances|mesh-ancestor
20418723|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
20418724|NCT01237262|Adalimumab|adalimumab|mesh-list
20418725|NCT01237262|Etanercept|etanercept|mesh-list
20418726|NCT01237262|Infliximab|infliximab|mesh-list
20418727|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20418728|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418729|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
20418730|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20418731|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20418732|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20418733|NCT01237262|Analgesics|analgesics|mesh-ancestor
20418734|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
20418735|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418736|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418737|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418738|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
20418739|NCT01237275|Sertraline|sertraline|mesh-list
20418740|NCT01237275|Fluoxetine|fluoxetine|mesh-list
20418741|NCT01237275|Paroxetine|paroxetine|mesh-list
20418742|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
20418743|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20418744|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20418745|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20418746|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20418747|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418748|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418749|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
20418750|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418751|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20418752|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20418753|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20418754|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418755|NCT01237444|Ritonavir|ritonavir|mesh-list
20418756|NCT01237444|Lopinavir|lopinavir|mesh-list
20418757|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20418758|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20418759|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
20418760|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418761|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418762|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20418763|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20418764|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
20418765|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418766|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20418767|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20418768|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20418769|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20418770|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418771|NCT01237483|Cetuximab|cetuximab|mesh-list
20418772|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20418773|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418774|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20418775|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
20418776|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418777|NCT01237522|Metformin|metformin|mesh-list
20418778|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20418779|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418780|NCT01237535|Progesterone|progesterone|mesh-list
20418781|NCT01237535|Estrogens|estrogens|mesh-list
20418782|NCT01237535|Progestins|progestins|mesh-ancestor
20418783|NCT01237535|Hormones|hormones|mesh-ancestor
20418784|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20418785|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418786|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20418787|NCT01237730|Cefuroxime|cefuroxime|mesh-list
20418788|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
20418789|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418790|NCT01237769|Vitamin D|vitamin d|mesh-list
20418791|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
20418792|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
20418793|NCT01237769|Vitamins|vitamins|mesh-list
20418794|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
20418795|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418796|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20418797|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20418798|NCT01237782|Propolis|propolis|mesh-list
20418799|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20418800|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418801|NCT01237808|Cytarabine|cytarabine|mesh-list
20418802|NCT01237808|Etoposide|etoposide|mesh-list
20418803|NCT01237808|Tretinoin|tretinoin|mesh-list
20418804|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20418805|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418806|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20418807|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20418808|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418809|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418810|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418811|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
20418812|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
20418813|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418814|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418815|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
20418816|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418817|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
20418818|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
20418819|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
20418820|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20418821|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20418822|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
20418823|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
20418824|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418825|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418826|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418827|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
20418828|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
20418829|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20418830|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
20418831|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20418832|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20418833|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20418834|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20418835|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418836|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
20418837|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216399|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20216400|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20216401|NCT00305812|Growth Substances|growth substances|mesh-ancestor
20216402|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
20216403|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20216404|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
20216405|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216406|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20216407|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216408|NCT00305825|Bevacizumab|bevacizumab|mesh-list
20418838|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418839|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20418840|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418841|NCT01238029|Capecitabine|capecitabine|mesh-list
20418842|NCT01238029|Vinorelbine|vinorelbine|mesh-list
20418843|NCT01238029|Lapatinib|lapatinib|mesh-list
20418844|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20418845|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
20418846|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418847|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418848|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20216409|NCT00305825|Letrozole|letrozole|mesh-list
20418849|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
20418850|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
20418851|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
20427999|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
20418852|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20418853|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418854|NCT01238055|Docetaxel|docetaxel|mesh-list
19691707|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20418855|NCT01238055|Sunitinib|sunitinib|mesh-list
20418856|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418857|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
20418858|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
20418859|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
20418860|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418861|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20418862|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20418863|NCT01238055|Growth Substances|growth substances|mesh-ancestor
20418864|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418865|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
20418866|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20418867|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418868|NCT01238094|Simvastatin|simvastatin|mesh-list
20418869|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20418870|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20418871|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
20418872|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418873|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20418874|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20418875|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418876|NCT01238133|Paclitaxel|paclitaxel|mesh-list
20418877|NCT01238133|Carboplatin|carboplatin|mesh-list
20418878|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20418879|NCT01238133|R04929097|r04929097|mesh-list
20418880|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20418881|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418882|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
20418883|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
20418884|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
20418885|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418886|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418887|NCT01238146|Rituximab|rituximab|mesh-list
20418888|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20418889|NCT01238146|Obatoclax|obatoclax|mesh-list
20418890|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20418891|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418892|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
20418893|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418894|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418895|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20418896|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
20418897|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418898|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418899|NCT01238185|Aspirin|aspirin|mesh-list
20418900|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20418901|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20418902|NCT01238185|Analgesics|analgesics|mesh-ancestor
20418903|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
20418904|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418905|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418906|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20418907|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418908|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20418909|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20418910|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418911|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20418912|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20418913|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418914|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
20418915|NCT01238224|Tadalafil|tadalafil|mesh-list
20418916|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
20418917|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20418918|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20418919|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418920|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418921|NCT01238224|Urological Agents|urological agents|mesh-ancestor
20418922|NCT01238237|Cetuximab|cetuximab|mesh-list
20418923|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20418924|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418925|NCT01238276|Cefazolin|cefazolin|mesh-list
20418926|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20418927|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20418928|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
20418929|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20418930|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20418931|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
20418932|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418933|NCT01238367|Factor VIII|factor viii|mesh-list
20418934|NCT01238367|Coagulants|coagulants|mesh-ancestor
20418935|NCT01238393|Ranibizumab|ranibizumab|mesh-list
20418936|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20418937|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20418938|NCT01238393|Growth Substances|growth substances|mesh-ancestor
20418939|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418940|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
20418941|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428000|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428001|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20428002|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
20428003|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20428004|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20428005|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20428006|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
20428007|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20428008|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428009|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428010|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20428011|NCT01289769|Analgesics|analgesics|mesh-ancestor
20428012|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
20428013|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428014|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20428015|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20428016|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20428017|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
20428018|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428019|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428020|NCT01289925|Selenium|selenium|mesh-list
20428021|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
20428022|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428023|NCT01289925|Protective Agents|protective agents|mesh-ancestor
20428024|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428025|NCT01289925|Trace Elements|trace elements|mesh-ancestor
20428026|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
20428027|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
20428028|NCT01289938|Promethazine|promethazine|mesh-list
20428029|NCT01289938|Metoclopramide|metoclopramide|mesh-list
20428030|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20428031|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20428032|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428033|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428034|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
20428035|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
20428036|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
20428037|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428038|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
20428039|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
20428040|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20428041|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20428042|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
20428043|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
20428044|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428045|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428046|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20428047|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
20428048|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
20428049|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20428050|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20428051|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
20428052|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
20428053|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20428054|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20428055|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
20428056|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19403962|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20428057|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20428058|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20418942|NCT01238406|Pancrelipase|pancrelipase|mesh-list
20418943|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20418944|NCT01238523|Calpastatin|calpastatin|mesh-list
20418945|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20418946|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
20418947|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418948|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418949|NCT01238562|Lenograstim|lenograstim|mesh-list
20418950|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20418951|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
20418952|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418953|NCT01238627|Nicotine|nicotine|mesh-list
20418954|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20418955|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
20418956|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418957|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418958|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20418959|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20418960|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
20418961|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418962|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418963|NCT01238692|Rituximab|rituximab|mesh-list
20418964|NCT01238692|Panobinostat|panobinostat|mesh-list
20418965|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20418966|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20418967|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
20418968|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418969|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20418970|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20418971|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20418972|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418973|NCT01238705|Metoprolol|metoprolol|mesh-list
20418974|NCT01238705|Felodipine|felodipine|mesh-list
20418975|NCT01238705|Irbesartan|irbesartan|mesh-list
20418976|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20418977|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20418978|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
20418979|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
20418980|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20418981|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418982|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20418983|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20418984|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20418985|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
20418986|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20418987|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20418988|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20418989|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20418990|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20418991|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20418992|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20418993|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
20418994|NCT01238718|Lidocaine|lidocaine|mesh-list
20418995|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
20418996|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
20418997|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20418998|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20418999|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
20419000|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419001|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20419002|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20419003|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20419004|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419005|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419006|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
20419007|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419008|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
20419009|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419010|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20419011|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20419012|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
20419013|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419014|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419015|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20419016|NCT01238796|Telavancin|telavancin|mesh-list
20419017|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20419018|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419019|NCT01238926|Vitamins|vitamins|mesh-list
20419020|NCT01238926|Folic Acid|folic acid|mesh-list
20419021|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
20419022|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
20419023|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
20419024|NCT01238926|Pyridoxal|pyridoxal|mesh-list
20419025|NCT01238926|Pyridoxine|pyridoxine|mesh-list
20419026|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
20419027|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
20419028|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419029|NCT01238926|Hematinics|hematinics|mesh-ancestor
20419030|NCT01238952|Carboplatin|carboplatin|mesh-list
20419031|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419032|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
20419033|NCT01238965|Leucovorin|leucovorin|mesh-list
20419034|NCT01238965|Fluorouracil|fluorouracil|mesh-list
20419035|NCT01238965|Panobinostat|panobinostat|mesh-list
20419036|NCT01238965|Calcium|calcium|mesh-list
20419037|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
20419038|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20419039|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20419040|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419041|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20419042|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
20419043|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419044|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20419045|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419046|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419047|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
20419048|NCT01238965|Antidotes|antidotes|mesh-ancestor
20419049|NCT01238965|Protective Agents|protective agents|mesh-ancestor
20419050|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
20419051|NCT01238965|Vitamins|vitamins|mesh-ancestor
20419052|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
20419053|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419054|NCT01238978|Vildagliptin|vildagliptin|mesh-list
20419055|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419056|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419057|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20419058|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
20419059|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419060|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419061|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20419062|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20419063|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20419064|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
20419065|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419066|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20419067|NCT01239017|Fasinumab|fasinumab|mesh-list
20419068|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20419069|NCT01239017|Analgesics|analgesics|mesh-ancestor
20419070|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
20419071|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419072|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419073|NCT01239030|Methylphenidate|methylphenidate|mesh-list
20419074|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20419075|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419076|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20419077|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20419078|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419079|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419080|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
20419081|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419082|NCT01239173|Propranolol|propranolol|mesh-list
20419083|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20419084|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20419085|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392232|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
19392233|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19392234|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419086|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419087|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419088|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428059|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419089|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20419090|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20419091|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
20419092|NCT01239368|Sirolimus|sirolimus|mesh-list
20419093|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20419094|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419095|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20419096|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419097|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
20419098|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419099|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
20419100|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419101|NCT01239459|Teriflunomide|teriflunomide|mesh-list
20419102|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
20419103|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20419104|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20419105|NCT01239459|Analgesics|analgesics|mesh-ancestor
20419106|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
20419107|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419108|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419109|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419110|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20419111|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419112|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
20419113|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20419114|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20419115|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
20419116|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419117|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20419118|NCT01239485|Irinotecan|irinotecan|mesh-list
20419119|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20419120|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20419121|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419122|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419123|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419124|NCT01239498|Lidocaine|lidocaine|mesh-list
20419125|NCT01239498|Epinephrine|epinephrine|mesh-list
20419126|NCT01239498|Racepinephrine|racepinephrine|mesh-list
20419127|NCT01239498|Anesthetics|anesthetics|mesh-list
20419128|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
20419129|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
20419130|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419131|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419132|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
20419133|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419134|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20419135|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20419136|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20419137|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419138|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419139|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20419140|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20419141|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
20419142|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419143|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20419144|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20419145|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
20419146|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20419147|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419148|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
20419149|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
20419150|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20419151|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
20419152|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419153|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419154|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
20419155|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20419156|NCT01239563|Basiliximab|basiliximab|mesh-list
20419157|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
20419158|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419159|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419160|NCT01239719|Clemastine|clemastine|mesh-list
20419161|NCT01239719|Dexamethasone|dexamethasone|mesh-list
20419162|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
20419163|NCT01239719|BB 1101|bb 1101|mesh-list
20419164|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419165|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
20419166|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
20419167|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419168|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419169|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20419170|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
20419171|NCT01239719|Hormones|hormones|mesh-ancestor
20419172|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419173|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20419174|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419175|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
20419176|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419177|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419178|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
20419179|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
20419180|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20419181|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
20419182|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
20419183|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419184|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20419185|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
20419186|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20419187|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
20419188|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419189|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
20419190|NCT01239810|Protective Agents|protective agents|mesh-ancestor
20419191|NCT01239849|Atorvastatin|atorvastatin|mesh-list
20419192|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20419193|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20419194|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
20419195|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419196|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20419197|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20419198|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419199|NCT01239875|Vaccines|vaccines|mesh-list
20419200|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20419201|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
20419202|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419203|NCT01239888|Tibolone|tibolone|mesh-list
20419204|NCT01239888|Oxytocin|oxytocin|mesh-list
20419205|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
20419206|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20419207|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419208|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
20419209|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
20419210|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419211|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20419212|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20419213|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419214|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20419215|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
20419216|NCT01239888|Hormones|hormones|mesh-ancestor
20419217|NCT01239940|Paclitaxel|paclitaxel|mesh-list
20419218|NCT01239940|Everolimus|everolimus|mesh-list
20419219|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20419220|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419221|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
20419222|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
20419223|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
20419224|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419225|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419226|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
20419227|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419228|NCT01239953|Paclitaxel|paclitaxel|mesh-list
20419229|NCT01239953|Everolimus|everolimus|mesh-list
20419230|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20419231|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419232|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
20419233|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
20419234|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20419235|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419236|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419237|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
20419238|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419239|NCT01240096|Mirtazapine|mirtazapine|mesh-list
20419240|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
20419241|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20419242|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20419243|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
20419244|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
20419245|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419246|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419247|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419248|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20419249|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20419250|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419251|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20419252|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20419253|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20419254|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
20419255|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20419256|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20419257|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
20419258|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20419259|NCT01240109|Remifentanil|remifentanil|mesh-list
20419260|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20419261|NCT01240109|Narcotics|narcotics|mesh-ancestor
20419262|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419263|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419264|NCT01240109|Analgesics|analgesics|mesh-ancestor
20419265|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
20419266|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419267|NCT01240148|Lidocaine|lidocaine|mesh-list
20419268|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
20419269|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
20419270|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419271|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419272|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
20419273|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419274|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20419275|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20419276|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20419277|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419278|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428060|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428061|NCT01290003|Tazobactam|tazobactam|mesh-list
20428062|NCT01290003|Piperacillin|piperacillin|mesh-list
20428063|NCT01290003|Amikacin|amikacin|mesh-list
20428064|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20428065|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428066|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428067|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20428068|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428069|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428070|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20428071|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
20428072|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428073|NCT01290120|Rituximab|rituximab|mesh-list
20428074|NCT01290120|Doxorubicin|doxorubicin|mesh-list
20428075|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428076|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428077|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
20428078|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428079|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20428080|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20428081|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20428082|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20428083|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428084|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428085|NCT01290133|Vestipitant|vestipitant|mesh-list
20428086|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20428087|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428088|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428089|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428090|NCT01290146|Simendan|simendan|mesh-list
20428091|NCT01290146|Diuretics|diuretics|mesh-list
20428092|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
20428093|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428094|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20419279|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20419280|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419281|NCT01240213|Vitamin D|vitamin d|mesh-list
20419282|NCT01240213|Vitamins|vitamins|mesh-ancestor
20419283|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
20419284|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419285|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20419286|NCT01240226|Ketoconazole|ketoconazole|mesh-list
20419287|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
20419288|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419289|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20419290|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20419291|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419292|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419293|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20419294|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
20419295|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419296|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419297|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20419298|NCT01240252|Insulin|insulin|mesh-list
20419299|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20419300|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419301|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419302|NCT01240265|Vitamin D|vitamin d|mesh-list
20419303|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
20419304|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
20419305|NCT01240265|Vitamins|vitamins|mesh-list
20419306|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
20419307|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419308|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20419309|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20419310|NCT01240408|Lenvatinib|lenvatinib|mesh-list
20419311|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419312|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20419313|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419314|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419315|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
20419316|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419317|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
20419318|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419319|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20419320|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20419321|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
20419322|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419323|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419324|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20419325|NCT01240629|Doxorubicin|doxorubicin|mesh-list
20419326|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20419327|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20419328|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419329|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20419330|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20419331|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419332|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419333|NCT01240642|Vadimezan|vadimezan|mesh-list
20419334|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419335|NCT01240655|Paclitaxel|paclitaxel|mesh-list
20419336|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20419337|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419338|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
20419339|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
20419340|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
19691708|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
20216410|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20216411|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216412|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20216413|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20216414|NCT00305825|Growth Substances|growth substances|mesh-ancestor
20216415|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216416|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
20216417|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20419341|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419342|NCT01240824|Aminophylline|aminophylline|mesh-list
20216418|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20419343|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20419344|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
20419345|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419346|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419347|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20419348|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419349|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20419350|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20419351|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419352|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419353|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20419354|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20419355|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
20419356|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419357|NCT01240824|Protective Agents|protective agents|mesh-ancestor
20419358|NCT01240850|Prednisone|prednisone|mesh-list
20419359|NCT01240850|Methotrexate|methotrexate|mesh-list
20419360|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419361|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
20419362|NCT01240850|Hormones|hormones|mesh-ancestor
20419363|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419364|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419365|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20419366|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419367|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20419368|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
20419369|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20419370|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20419371|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
20419372|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419373|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
20419374|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419375|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20419376|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419377|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
20419378|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20419379|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20419380|NCT01240889|Fluticasone|fluticasone|mesh-list
20419381|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419382|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20419383|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
20419384|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419385|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419386|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20419387|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419388|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
20419389|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20419390|NCT01240928|Exemestane|exemestane|mesh-list
20419391|NCT01240928|Goserelin|goserelin|mesh-list
20419392|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392235|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392236|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
19392237|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19392238|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392239|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392240|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
19392241|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19392242|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19392243|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392244|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19392245|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19392246|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392247|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392248|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392249|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19392250|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
19392251|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19392252|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392253|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19392254|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19392255|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19392256|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
20419393|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19392257|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20419394|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20419395|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419396|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419397|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20419398|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
20419399|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419400|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419401|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20419402|NCT01240941|Exemestane|exemestane|mesh-list
20419403|NCT01240941|Goserelin|goserelin|mesh-list
20419404|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419405|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20419406|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20419407|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419408|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419409|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20419410|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
20419411|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419412|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419413|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20419414|NCT01241006|Dexamethasone|dexamethasone|mesh-list
20419415|NCT01241006|Prednisone|prednisone|mesh-list
20419416|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
20419417|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419418|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
20419419|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
20419420|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419421|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419422|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20419423|NCT01241006|Hormones|hormones|mesh-ancestor
20419424|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419425|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20419426|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419427|NCT01241019|Topiramate|topiramate|mesh-list
20419428|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
20419429|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419430|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419431|NCT01241032|Udenafil|udenafil|mesh-list
20419432|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20419433|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20419434|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419435|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419436|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
20419437|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
20419438|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419439|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419440|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20419441|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419442|NCT01241097|Simvastatin|simvastatin|mesh-list
20419443|NCT01241097|Ezetimibe|ezetimibe|mesh-list
20419444|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20419445|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20419446|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
20419447|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419448|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19392258|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19392259|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19392260|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392261|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392262|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392263|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392264|NCT03696290|Aztreonam|aztreonam|mesh-list
19392265|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19392266|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392267|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
19392268|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19392269|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392270|NCT03696186|Phenobarbital|phenobarbital|mesh-list
19392271|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
19392272|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19392273|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392274|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392275|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19392276|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19392277|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392278|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392279|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
19392280|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
19392281|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19392282|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19392283|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19392284|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19392285|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
19392286|NCT03696121|Coagulants|coagulants|mesh-ancestor
19392287|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19392288|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
19392289|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392290|NCT03696095|Ropivacaine|ropivacaine|mesh-list
20419449|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20419450|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419451|NCT01241110|Ofloxacin|ofloxacin|mesh-list
20419452|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20419453|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419454|NCT01241110|Renal Agents|renal agents|mesh-ancestor
20419455|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20419456|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20419457|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20419458|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419459|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419460|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419461|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20419462|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20419463|NCT01241162|Decitabine|decitabine|mesh-list
20419464|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20419465|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
20419466|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419467|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419468|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419469|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
20419470|NCT01241175|Analgesics|analgesics|mesh-ancestor
20419471|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
20419472|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419473|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419474|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
20419475|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419476|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20419477|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
20419478|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20419479|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419480|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419481|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20419482|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
20419483|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20419484|NCT01241383|Bosentan|bosentan|mesh-list
20419485|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20419486|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20419487|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419488|NCT01241409|Rabeprazole|rabeprazole|mesh-list
20419489|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20419490|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20419491|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20419492|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419493|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419494|NCT01241422|Montelukast|montelukast|mesh-list
20419495|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20419496|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419497|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20419498|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
20419499|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419500|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419501|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20419502|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19392291|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
19392292|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
20419503|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419504|NCT01241487|Amlodipine|amlodipine|mesh-list
20419505|NCT01241487|Valsartan|valsartan|mesh-list
20419506|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20419507|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20419508|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419509|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419510|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20419511|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419512|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
20419513|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20419514|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20419515|NCT01241500|ON 01910|on 01910|mesh-list
20419516|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419517|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20419518|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419519|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419520|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
20419521|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419522|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
20419523|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419524|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20419525|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20419526|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
20419527|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419528|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419529|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20419530|NCT01241708|Bortezomib|bortezomib|mesh-list
20419531|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419532|NCT01241734|Lenalidomide|lenalidomide|mesh-list
20419533|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
20419534|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419535|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20419536|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20419537|NCT01241734|Growth Substances|growth substances|mesh-ancestor
20419538|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
20419539|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419540|NCT01241773|Efavirenz|efavirenz|mesh-list
20419541|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
20419542|NCT01241773|Simeprevir|simeprevir|mesh-list
20419543|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20419544|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20419545|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419546|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419547|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
20419548|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419549|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20419550|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20419551|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20419552|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20419553|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20419554|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20419555|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20419556|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20419557|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20419558|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20419559|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
20419560|NCT01241786|Lenalidomide|lenalidomide|mesh-list
20419561|NCT01241786|Azacitidine|azacitidine|mesh-list
20419562|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
20216419|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216420|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216421|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20216422|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
20216423|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216424|NCT00305838|Tamoxifen|tamoxifen|mesh-list
20216425|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20216426|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
20216427|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216428|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216429|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20216430|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216431|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20216432|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20216433|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20216434|NCT00305903|Memantine|memantine|mesh-list
20216435|NCT00305903|Rivastigmine|rivastigmine|mesh-list
20216436|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20216437|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20216438|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
20216439|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216440|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216441|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216442|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20216443|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20216444|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20216445|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216446|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
20216447|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20216448|NCT00305903|Protective Agents|protective agents|mesh-ancestor
20216449|NCT00306020|Morphine|morphine|mesh-list
20216450|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20216451|NCT00306020|Narcotics|narcotics|mesh-ancestor
20216452|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216453|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216454|NCT00306020|Analgesics|analgesics|mesh-ancestor
20419563|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419564|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20419565|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20419566|NCT01241786|Growth Substances|growth substances|mesh-ancestor
20419567|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
20419568|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419569|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20419570|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
20419571|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419572|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428095|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
20428096|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20428097|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20428098|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428099|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428100|NCT01290146|Protective Agents|protective agents|mesh-ancestor
20428101|NCT01290172|Somatostatin|somatostatin|mesh-list
20428102|NCT01290172|Hormones|hormones|mesh-ancestor
20428103|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428104|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428105|NCT01290198|Fluconazole|fluconazole|mesh-list
20428106|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
20428107|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
20428108|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428109|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20428110|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20428111|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428112|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428113|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20428114|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
20428115|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428116|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428117|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20428118|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20428119|NCT01290211|Ritonavir|ritonavir|mesh-list
19691709|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19691710|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
19691711|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691712|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691713|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
19691714|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19691715|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19691716|NCT05001529|Antibodies|antibodies|mesh-list
19691717|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
19691718|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428120|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
20428121|NCT01290211|Maraviroc|maraviroc|mesh-list
20428122|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19691719|NCT05001243|Bromfenac|bromfenac|mesh-list
20419573|NCT01242046|Caffeine|caffeine|mesh-list
20419574|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20419575|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419576|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20419577|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419578|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419579|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20419580|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20419581|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
20419582|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419583|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
20419584|NCT01242072|Ifosfamide|ifosfamide|mesh-list
20419585|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20419586|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
20419587|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419588|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419589|NCT01242098|Fluticasone|fluticasone|mesh-list
20419590|NCT01242098|Beclomethasone|beclomethasone|mesh-list
20419591|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
20419592|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20419593|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419594|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20419595|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
20419596|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419597|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419598|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20419599|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419600|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
20419601|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20419602|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20419603|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20419604|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20419605|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
20419606|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419607|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419608|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
20419609|NCT01242098|Hormones|hormones|mesh-ancestor
20419610|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419611|NCT01242202|Acarbose|acarbose|mesh-list
20419612|NCT01242202|Voglibose|voglibose|mesh-list
20419613|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
20419614|NCT01242202|Miglitol|miglitol|mesh-list
20419615|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
20419616|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419617|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419618|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419619|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419620|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20419621|NCT01242215|Glimepiride|glimepiride|mesh-list
20419622|NCT01242215|Gliclazide|gliclazide|mesh-list
20419623|NCT01242215|Glyburide|glyburide|mesh-list
20419624|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
20419625|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20419626|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419627|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419628|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419629|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
20419630|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20419631|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419632|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20419633|NCT01242228|Vildagliptin|vildagliptin|mesh-list
20419634|NCT01242228|Saxagliptin|saxagliptin|mesh-list
20419635|NCT01242228|Alogliptin|alogliptin|mesh-list
20419636|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
20419637|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20419638|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419639|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419640|NCT01242228|Incretins|incretins|mesh-ancestor
20419641|NCT01242228|Hormones|hormones|mesh-ancestor
20419642|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419643|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
20419644|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419645|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419646|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20419647|NCT01242267|Thalidomide|thalidomide|mesh-list
20216455|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
20216456|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216457|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20216458|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
20216459|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20216460|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
20216461|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
20216462|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216463|NCT00306046|Diphosphonates|diphosphonates|mesh-list
20216464|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20216465|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216466|NCT00306124|Levodopa|levodopa|mesh-list
20216467|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20419648|NCT01242267|Bortezomib|bortezomib|mesh-list
20419649|NCT01242267|Melphalan|melphalan|mesh-list
20419650|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419651|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20419652|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
20419653|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419654|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20419655|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419656|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
20419657|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419658|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
20419659|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20419660|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419661|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20419662|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20419663|NCT01242267|Growth Substances|growth substances|mesh-ancestor
20419664|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
20419665|NCT01242306|Acetylcholine|acetylcholine|mesh-list
20419666|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
20419667|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20419668|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
20419669|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419670|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419671|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419672|NCT01242332|Pregabalin|pregabalin|mesh-list
20419673|NCT01242332|Analgesics|analgesics|mesh-ancestor
20419674|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
20419675|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419676|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419677|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
20419678|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20419679|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419680|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419681|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20419682|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20419683|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20419684|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419685|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20419686|NCT01242384|Silicon|silicon|mesh-list
20419687|NCT01242384|Trace Elements|trace elements|mesh-ancestor
20419688|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
20419689|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419690|NCT01242410|Silicon|silicon|mesh-list
20419691|NCT01242410|Trace Elements|trace elements|mesh-ancestor
20419692|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
20419693|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419694|NCT01242449|Trastuzumab|trastuzumab|mesh-list
20419695|NCT01242449|Vinorelbine|vinorelbine|mesh-list
20419696|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20419697|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419698|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20419699|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
20419700|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
20419701|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
20419702|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419703|NCT01242566|Temozolomide|temozolomide|mesh-list
20419704|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20419705|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
20419706|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392293|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419707|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216468|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20419708|NCT01242579|Maraviroc|maraviroc|mesh-list
20419709|NCT01242579|Dapivirine|dapivirine|mesh-list
20419710|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20419711|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20419712|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419713|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20419714|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20419715|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
20419716|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419717|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20419718|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
20419719|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20419720|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419721|NCT01242605|Gemcitabine|gemcitabine|mesh-list
20419722|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419723|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20419724|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
20419725|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419726|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
20419727|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419728|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419729|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419730|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
20419731|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419732|NCT01242631|Everolimus|everolimus|mesh-list
20419733|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419734|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419735|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
20419736|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419737|NCT01242774|Panobinostat|panobinostat|mesh-list
20419738|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419739|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20419740|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419741|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419742|NCT01242787|Entecavir|entecavir|mesh-list
20419743|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
20419744|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419745|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
20419746|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
20419747|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419748|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419749|NCT01242904|Icodextrin|icodextrin|mesh-list
20419750|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
20419751|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20419752|NCT01243060|Zolpidem|zolpidem|mesh-list
20419753|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20419754|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20419755|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419756|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419757|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20419758|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
20419759|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
20419760|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419761|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419762|NCT01243086|Dexamethasone|dexamethasone|mesh-list
20419763|NCT01243086|Ranibizumab|ranibizumab|mesh-list
20419764|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419765|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
20419766|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
20419767|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419768|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419769|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20419770|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
20419771|NCT01243086|Hormones|hormones|mesh-ancestor
20419772|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216469|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
20216470|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216471|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216472|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216473|NCT00306137|Aprotinin|aprotinin|mesh-list
20216474|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
20216475|NCT00306137|Coagulants|coagulants|mesh-ancestor
20216476|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20216477|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20216478|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
20419773|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20216479|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216480|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216481|NCT00306150|Aprotinin|aprotinin|mesh-list
20216482|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
20419774|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419775|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20419776|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20419777|NCT01243086|Growth Substances|growth substances|mesh-ancestor
20419778|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
20419779|NCT01243203|Varenicline|varenicline|mesh-list
20419780|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20419781|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20419782|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
20419783|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419784|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419785|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419786|NCT01243281|Entecavir|entecavir|mesh-list
20419787|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
20419788|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419789|NCT01243359|Bevacizumab|bevacizumab|mesh-list
20419790|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20419791|NCT01243359|Sunitinib|sunitinib|mesh-list
20419792|NCT01243359|Antibodies|antibodies|mesh-list
20419793|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
20419794|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20419795|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419796|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20419797|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20419798|NCT01243359|Growth Substances|growth substances|mesh-ancestor
20419799|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419800|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
20419801|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
20419802|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20419803|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419804|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419805|NCT01243385|Metformin|metformin|mesh-list
20419806|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419807|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419808|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
20419809|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20419810|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419811|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20419812|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20419813|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419814|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691720|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19691721|NCT05001243|Phenylephrine|phenylephrine|mesh-list
19691722|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
19691723|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
19691724|NCT05001243|Pilocarpine|pilocarpine|mesh-list
19691725|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19691726|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
19691727|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691728|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
19691729|NCT05001243|Protective Agents|protective agents|mesh-ancestor
19691730|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19691731|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19691732|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19691733|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19691734|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
19691735|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691736|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691737|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
19691738|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
20216483|NCT00306150|Coagulants|coagulants|mesh-ancestor
20216484|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20216485|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20216486|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
20216487|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216488|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216489|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
20216490|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20216491|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419815|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419816|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19691739|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691740|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
20419817|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20419818|NCT01243476|Lenalidomide|lenalidomide|mesh-list
20419819|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
20419820|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419821|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20419822|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20419823|NCT01243476|Growth Substances|growth substances|mesh-ancestor
20419824|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
20419825|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419826|NCT01243528|Vitamin D|vitamin d|mesh-list
20419827|NCT01243528|Vitamins|vitamins|mesh-ancestor
20419828|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
20419829|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419830|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20419831|NCT01243632|Gemcitabine|gemcitabine|mesh-list
20419832|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20419833|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
20419834|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419835|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419836|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
20419837|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419838|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419839|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419840|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
20419841|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419842|NCT01243658|Oxytocin|oxytocin|mesh-list
20419843|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
20419844|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20419845|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419846|NCT01243697|Desogestrel|desogestrel|mesh-list
20419847|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20419848|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20419849|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20419850|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
20419851|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20419852|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419853|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20419854|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20419855|NCT01243697|Progestins|progestins|mesh-ancestor
20419856|NCT01243697|Hormones|hormones|mesh-ancestor
20419857|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20419858|NCT01243710|Taurolidine|taurolidine|mesh-list
20419859|NCT01243710|Heparin|heparin|mesh-list
20419860|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
20419861|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20419862|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20419863|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419864|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20419865|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20419866|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428123|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20428124|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
20428125|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428126|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428127|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20428128|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20428129|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
20428130|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216492|NCT00306254|Enoxaparin|enoxaparin|mesh-list
20216493|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
20216494|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
20216495|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20216496|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20216497|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216498|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20216499|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
20216500|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20216501|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
20216502|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216503|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
20216504|NCT00306267|Hematinics|hematinics|mesh-ancestor
20216505|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
20216506|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428131|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20419867|NCT01243736|Metoclopramide|metoclopramide|mesh-list
20419868|NCT01243736|Simethicone|simethicone|mesh-list
20419869|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
20419870|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
20419871|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419872|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419873|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20419874|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20419875|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20419876|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
20419877|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419878|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419879|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
20419880|NCT01243736|Emollients|emollients|mesh-ancestor
20419881|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
20419882|NCT01243788|Fluticasone|fluticasone|mesh-list
20419883|NCT01243788|Xhance|xhance|mesh-list
20419884|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20419885|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419886|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20419887|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
20419888|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419889|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419890|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20419891|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419892|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
20419893|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20419894|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20419895|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20419896|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20419897|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
20216507|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216508|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20216509|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20216510|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216511|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419898|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419899|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419900|NCT01243801|Ketamine|ketamine|mesh-list
20419901|NCT01243801|Analgesics|analgesics|mesh-ancestor
20419902|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
20419903|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419904|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419905|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20419906|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20419907|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
20419908|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
20419909|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216512|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216513|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
20216514|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
20216515|NCT00306358|Vitamins|vitamins|mesh-ancestor
20216516|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
20216517|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392294|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392295|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
19392296|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392297|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
20419910|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20419911|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20419912|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20419913|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419914|NCT01243827|Carvedilol|carvedilol|mesh-list
20419915|NCT01243827|Bisoprolol|bisoprolol|mesh-list
20419916|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20419917|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19392298|NCT03695952|Nivolumab|nivolumab|mesh-list
19691741|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20216518|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
20216519|NCT00306358|Hematinics|hematinics|mesh-ancestor
20216520|NCT00306397|Sirolimus|sirolimus|mesh-list
20419918|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
20419919|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392299|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20216521|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20419920|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419921|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419922|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20419923|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
20419924|NCT01243827|Protective Agents|protective agents|mesh-ancestor
20419925|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20419926|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20419927|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20216522|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216523|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20216524|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216525|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
20216526|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20419928|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
20419929|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20419930|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20419931|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
20419932|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
20419933|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419934|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20419935|NCT01243970|Phenylephrine|phenylephrine|mesh-list
20419936|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
20419937|NCT01243970|Ephedrine|ephedrine|mesh-list
20419938|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20419939|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
20419940|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
20419941|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419942|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419943|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
20419944|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20419945|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
20419946|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
20419947|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20419948|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19392300|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20216527|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
20216528|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216529|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
20216530|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20216531|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216532|NCT00306410|Vitamins|vitamins|mesh-ancestor
20216533|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
20216534|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20216535|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
20216536|NCT00306462|Nifedipine|nifedipine|mesh-list
20216537|NCT00306462|Analgesics|analgesics|mesh-ancestor
20216538|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
20419949|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20419950|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
20419951|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216539|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216540|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216541|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
20216542|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216543|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20216544|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
20216545|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20216546|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20216547|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216548|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20216549|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
20419952|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419953|NCT01243970|Protective Agents|protective agents|mesh-ancestor
20419954|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20419955|NCT01243996|Ibuprofen|ibuprofen|mesh-list
20419956|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392301|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392302|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392303|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
19392304|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19392305|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
19392306|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
20419957|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19403963|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20419958|NCT01243996|Analgesics|analgesics|mesh-ancestor
20419959|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
20419960|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419961|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419962|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419963|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20419964|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20419965|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419966|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419967|NCT01244009|Niraparib|niraparib|mesh-list
20419968|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19691742|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
19691743|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19691744|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
20419969|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419970|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419971|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20419972|NCT01244100|Aspirin|aspirin|mesh-list
20419973|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20419974|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20419975|NCT01244100|Analgesics|analgesics|mesh-ancestor
20419976|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
20419977|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20419978|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419979|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20419980|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20419981|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20419982|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20419983|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20419984|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20419985|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20419986|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20419987|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
20419988|NCT01244113|Propofol|propofol|mesh-list
20419989|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20419990|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20419991|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419992|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20419993|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
20419994|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
20419995|NCT01244178|Insulin|insulin|mesh-list
20419996|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20419997|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20419998|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20419999|NCT01244204|Vitamin D|vitamin d|mesh-list
20420000|NCT01244204|Vitamins|vitamins|mesh-ancestor
20420001|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
20420002|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420003|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20420004|NCT01244217|Fexofenadine|fexofenadine|mesh-list
20420005|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20420006|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20420007|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20420008|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
20420009|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
20420010|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420011|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420012|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420013|NCT01244230|Fexofenadine|fexofenadine|mesh-list
20420014|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20420015|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20420016|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20420017|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
20420018|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
20420019|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420020|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420021|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420022|NCT01244256|Gentamicins|gentamicins|mesh-list
20420023|NCT01244256|Clotrimazole|clotrimazole|mesh-list
20420024|NCT01244256|Miconazole|miconazole|mesh-list
20420025|NCT01244256|Beclomethasone|beclomethasone|mesh-list
20420026|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420027|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691745|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20420028|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20420029|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216550|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20420030|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420031|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420032|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
20420033|NCT01244256|Hormones|hormones|mesh-ancestor
20420034|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420035|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420036|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20420037|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
20420038|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20420039|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
20420040|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20420041|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20420042|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20420043|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
20420044|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20420045|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20420046|NCT01244269|Methylphenidate|methylphenidate|mesh-list
20420047|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20420048|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420049|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20420050|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20420051|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20420052|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420053|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
20420054|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420055|NCT01244334|Prednisolone|prednisolone|mesh-list
20420056|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20420057|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
20420058|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20420059|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
20420060|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20420061|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
20420062|NCT01244334|Difluprednate|difluprednate|mesh-list
20420063|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420064|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
20420065|NCT01244334|Hormones|hormones|mesh-ancestor
20420066|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420067|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420068|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20420069|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420070|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
20420071|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
20420072|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420073|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420074|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20420075|NCT01244334|Protective Agents|protective agents|mesh-ancestor
20420076|NCT01244347|Folic Acid|folic acid|mesh-list
20420077|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
20420078|NCT01244347|Hematinics|hematinics|mesh-ancestor
20420079|NCT01244347|Vitamins|vitamins|mesh-ancestor
20420080|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
20420081|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420082|NCT01244360|Resveratrol|resveratrol|mesh-list
20420083|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
20420084|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420085|NCT01244360|Protective Agents|protective agents|mesh-ancestor
20420086|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420087|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420088|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20420089|NCT01244399|Inositol|inositol|mesh-list
20216551|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
20216552|NCT00306475|Valproic Acid|valproic acid|mesh-list
20216553|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
20216554|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216555|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216556|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
20216557|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216558|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216559|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
20216560|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20216561|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216562|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20420090|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
20420091|NCT01244399|Vitamins|vitamins|mesh-ancestor
20420092|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
20420093|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420094|NCT01244581|Amoxicillin|amoxicillin|mesh-list
20420095|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
20420096|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
20420097|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20420098|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420099|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420100|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20420101|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420102|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420103|NCT01244659|Tacrolimus|tacrolimus|mesh-list
20420104|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420105|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
20420106|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420107|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20420108|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420109|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420110|NCT01244698|Clindamycin|clindamycin|mesh-list
20420111|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
20420112|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
20420113|NCT01244698|Cefazolin|cefazolin|mesh-list
20420114|NCT01244698|Cefadroxil|cefadroxil|mesh-list
20420115|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420116|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420117|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20420118|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420119|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420120|NCT01244789|Paclitaxel|paclitaxel|mesh-list
20420121|NCT01244789|Carboplatin|carboplatin|mesh-list
20420122|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20420123|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420124|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
20420125|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420126|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
20420127|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420128|NCT01244880|Ketamine|ketamine|mesh-list
20420129|NCT01244880|Analgesics|analgesics|mesh-ancestor
20420130|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
20420131|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420132|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420133|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20420134|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20420135|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
20420136|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
20420137|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420138|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20420139|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20420140|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420141|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420142|NCT01244932|Bupivacaine|bupivacaine|mesh-list
20420143|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
20420144|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
20420145|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420146|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420147|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
20420148|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420149|NCT01244958|Rituximab|rituximab|mesh-list
20420150|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20216563|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20216564|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
20216565|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216566|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20216567|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20216568|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216569|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216570|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
20216571|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216572|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
20216573|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420151|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420152|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
20420153|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420154|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420155|NCT01244971|Acarbose|acarbose|mesh-list
20420156|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20420157|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420158|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420159|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20420160|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420161|NCT01245166|Metformin|metformin|mesh-list
20420162|NCT01245166|Acarbose|acarbose|mesh-list
20420163|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20420164|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420165|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20420166|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420167|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420168|NCT01245179|Panobinostat|panobinostat|mesh-list
20420169|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420170|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20420171|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420172|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420173|NCT01245205|Lapatinib|lapatinib|mesh-list
20420174|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420175|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20420176|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420177|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420178|NCT01245244|Morphine|morphine|mesh-list
20420179|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20420180|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20420181|NCT01245244|Narcotics|narcotics|mesh-ancestor
20420182|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420183|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420184|NCT01245244|Analgesics|analgesics|mesh-ancestor
20420185|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
20420186|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420187|NCT01245361|Infliximab|infliximab|mesh-list
20420188|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
20420189|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420190|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420191|NCT01245452|Methotrexate|methotrexate|mesh-list
20420192|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20420193|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
20420194|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20420195|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420196|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420197|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
20420198|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420199|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420200|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
20420201|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420202|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20420203|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420204|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
20420205|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420206|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20420207|NCT01245530|Donepezil|donepezil|mesh-list
20420208|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20420209|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420210|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420211|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
20420212|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420213|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420214|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
20420215|NCT01245543|Docetaxel|docetaxel|mesh-list
20420216|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420217|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
20420218|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420219|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
20420220|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420221|NCT01245556|Ipilimumab|ipilimumab|mesh-list
20420222|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20420223|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420224|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20420225|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420226|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20420227|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20420228|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
20420229|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420230|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420231|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20420232|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
20420233|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
20420234|NCT01245569|Hormones|hormones|mesh-ancestor
20420235|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420236|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
20428132|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20428133|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20428134|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20216574|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
20216575|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216576|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
20216577|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20216578|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216579|NCT00306683|Diazoxide|diazoxide|mesh-list
20216580|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20216581|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
20216582|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
20428135|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20428136|NCT01290276|Ondansetron|ondansetron|mesh-list
20428137|NCT01290276|Methylphenidate|methylphenidate|mesh-list
20428138|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20428139|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428140|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20428141|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20428142|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20428143|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428144|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
20428145|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428146|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
20428147|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
20428148|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428149|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20428150|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
20428151|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
20428152|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20428153|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
20428154|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20428155|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20428156|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428157|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20428158|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20428159|NCT01290302|Azacitidine|azacitidine|mesh-list
20428160|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20428161|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
20428162|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428163|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428164|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428165|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
20428166|NCT01290328|Hematinics|hematinics|mesh-ancestor
20428167|NCT01290354|Lapatinib|lapatinib|mesh-list
20428168|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428169|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20428170|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428171|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428172|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
20428173|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20428174|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
20428175|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428176|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
20428177|NCT01290367|Protective Agents|protective agents|mesh-ancestor
20428178|NCT01290380|Vadimezan|vadimezan|mesh-list
20428179|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428180|NCT01290406|Dactolisib|dactolisib|mesh-list
20428181|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428182|NCT01290419|Vaccines|vaccines|mesh-list
20428183|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
20428184|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428185|NCT01290432|Folic Acid|folic acid|mesh-list
20428186|NCT01290432|Melatonin|melatonin|mesh-list
19392307|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428187|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
20428188|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428189|NCT01290432|Protective Agents|protective agents|mesh-ancestor
20420237|NCT01245582|Capecitabine|capecitabine|mesh-list
20420238|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
20420239|NCT01245582|Sorafenib|sorafenib|mesh-list
20420240|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420241|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
20420242|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420243|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420244|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20420245|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420246|NCT01245660|Lapatinib|lapatinib|mesh-list
20420247|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420248|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20420249|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420250|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420251|NCT01245725|Tirofiban|tirofiban|mesh-list
20420252|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20420253|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20420254|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420255|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20420256|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20420257|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20420258|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20420259|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
20420260|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420261|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20420262|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20420263|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420264|NCT01245816|Eflornithine|eflornithine|mesh-list
20420265|NCT01245816|Sulindac|sulindac|mesh-list
20420266|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420267|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20420268|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20420269|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20420270|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420271|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20420272|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216583|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20216584|NCT00306696|Spironolactone|spironolactone|mesh-list
20216585|NCT00306696|Furosemide|furosemide|mesh-list
20216586|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20216587|NCT00306696|Diuretics|diuretics|mesh-ancestor
20216588|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
20216589|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216590|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20216591|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20216592|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420273|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420274|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20420275|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20420276|NCT01245816|Analgesics|analgesics|mesh-ancestor
20420277|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
20420278|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420279|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420280|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420281|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420282|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20420283|NCT01245855|Alprostadil|alprostadil|mesh-list
20420284|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20420285|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
20420286|NCT01245855|Urological Agents|urological agents|mesh-ancestor
20420287|NCT01245868|Lidocaine|lidocaine|mesh-list
20420288|NCT01245868|Bupivacaine|bupivacaine|mesh-list
20420289|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
20420290|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
20420291|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420292|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420293|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
20420294|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420295|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20420296|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20420297|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20420298|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20420299|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420300|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
20420301|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20420302|NCT01245881|Protective Agents|protective agents|mesh-ancestor
20420303|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420304|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
20420305|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20420306|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20420307|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20420308|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
20420309|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420310|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20420311|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20420312|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420313|NCT01245946|Doxycycline|doxycycline|mesh-list
19392308|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392309|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20420314|NCT01245946|Adapalene|adapalene|mesh-list
20420315|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420316|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420317|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
20420318|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20420319|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20420320|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20420321|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20420322|NCT01245946|Analgesics|analgesics|mesh-ancestor
20420323|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
20420324|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420325|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420326|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420327|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420328|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
20420329|NCT01245959|Cisplatin|cisplatin|mesh-list
20420330|NCT01245959|Docetaxel|docetaxel|mesh-list
20420331|NCT01245959|Fluorouracil|fluorouracil|mesh-list
20420332|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420333|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
20420334|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420335|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
20420336|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420337|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
20420338|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420339|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420340|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
20420341|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420342|NCT01245998|Dalteparin|dalteparin|mesh-list
20420343|NCT01245998|Tinzaparin|tinzaparin|mesh-list
20420344|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20420345|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
20420346|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20420347|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20420348|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420349|NCT01246037|Bisoprolol|bisoprolol|mesh-list
20420350|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20420351|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
20420352|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
20420353|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420354|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420355|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20420356|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20420357|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20420358|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
20420359|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420360|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420361|NCT01246089|Ranibizumab|ranibizumab|mesh-list
20420362|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420363|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420364|NCT01246089|Growth Substances|growth substances|mesh-ancestor
20420365|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420366|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420367|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420368|NCT01246180|Diclofenac|diclofenac|mesh-list
20420369|NCT01246180|Amiloride|amiloride|mesh-list
20420370|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392310|NCT03695887|Analgesics|analgesics|mesh-ancestor
19392311|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
20420371|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20420372|NCT01246180|Analgesics|analgesics|mesh-ancestor
20420373|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
20420374|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420375|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420376|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420377|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420378|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20420379|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420380|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420381|NCT01246180|Diuretics|diuretics|mesh-ancestor
20420382|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
20420383|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20420384|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20420385|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20420386|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20420387|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20420388|NCT01246232|Amisulpride|amisulpride|mesh-list
20420389|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20420390|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20420391|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420392|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420393|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20420394|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20420395|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
20420396|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420397|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420398|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20420399|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
20420400|NCT01246284|Triamcinolone|triamcinolone|mesh-list
20420401|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20420402|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20420403|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20420404|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420405|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
20420406|NCT01246284|Hormones|hormones|mesh-ancestor
20420407|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420408|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420409|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420410|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
20420411|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420412|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420413|NCT01246323|Fentanyl|fentanyl|mesh-list
20420414|NCT01246323|Morphine|morphine|mesh-list
20420415|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
20420416|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420417|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420418|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20420419|NCT01246323|Narcotics|narcotics|mesh-ancestor
20420420|NCT01246323|Analgesics|analgesics|mesh-ancestor
20420421|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
20420422|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420423|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20420424|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20420425|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
20420426|NCT01246362|Etoricoxib|etoricoxib|mesh-list
20420427|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20420428|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20420429|NCT01246362|Analgesics|analgesics|mesh-ancestor
20420430|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
20420431|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420432|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420433|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420434|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420435|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20420436|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20420437|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420438|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420439|NCT01246440|Catumaxomab|catumaxomab|mesh-list
20420440|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420441|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20420442|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20420443|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19392312|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420444|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392313|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19392314|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19392315|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392316|NCT03695835|Sargramostim|sargramostim|mesh-list
19392317|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
19392318|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392319|NCT03695822|Mirabegron|mirabegron|mesh-list
20420445|NCT01246557|Dexamethasone|dexamethasone|mesh-list
20420446|NCT01246557|Lenalidomide|lenalidomide|mesh-list
20420447|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420448|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
20420449|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
20420450|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420451|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420452|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420453|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
20420454|NCT01246557|Hormones|hormones|mesh-ancestor
20420455|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420456|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20420457|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420458|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
20420459|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420460|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420461|NCT01246557|Growth Substances|growth substances|mesh-ancestor
20420462|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420463|NCT01246622|Cytarabine|cytarabine|mesh-list
20420464|NCT01246622|Lenalidomide|lenalidomide|mesh-list
20420465|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420466|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
20420467|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420468|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420469|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
20420470|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420471|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420472|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
20420473|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420474|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420475|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420476|NCT01246622|Growth Substances|growth substances|mesh-ancestor
20420477|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420478|NCT01246752|Cytarabine|cytarabine|mesh-list
20420479|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420480|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
20420481|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420482|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420483|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
20420484|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420485|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420486|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
20420487|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420488|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
20420489|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20420490|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20420491|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
20420492|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420493|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20420494|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20420495|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420496|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420497|NCT01246817|Sirolimus|sirolimus|mesh-list
20420498|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420499|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420500|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20420501|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420502|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
20420503|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420504|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
20420505|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420506|NCT01246921|Fluticasone|fluticasone|mesh-list
20420507|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420508|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20420509|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
20420510|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392320|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20420511|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420512|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20420513|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
20420514|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
20420515|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20420516|NCT01247077|Selenium|selenium|mesh-list
20420517|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
20420518|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420519|NCT01247077|Protective Agents|protective agents|mesh-ancestor
20420520|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420521|NCT01247077|Trace Elements|trace elements|mesh-ancestor
20420522|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
20420523|NCT01247311|Vitamin D|vitamin d|mesh-list
20420524|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
20420525|NCT01247311|Vitamins|vitamins|mesh-list
20420526|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
20420527|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420528|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20420529|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20420530|NCT01247337|Gemcitabine|gemcitabine|mesh-list
20420531|NCT01247337|Capecitabine|capecitabine|mesh-list
20420532|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
20420533|NCT01247337|Cetuximab|cetuximab|mesh-list
20420534|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420535|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
20420536|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420537|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420538|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
20420539|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420540|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420541|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420542|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
20420543|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420544|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428190|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428191|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428192|NCT01290432|Hematinics|hematinics|mesh-ancestor
20428193|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
20428194|NCT01290432|Vitamins|vitamins|mesh-ancestor
20428195|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
20428196|NCT01290458|Vitamins|vitamins|mesh-list
20428197|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
20428198|NCT01290458|Vitamin E|vitamin e|mesh-list
20428199|NCT01290458|Tocopherols|tocopherols|mesh-list
19691746|NCT05001243|Miotics|miotics|mesh-ancestor
19691747|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19691748|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19691749|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
19691750|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19691751|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19691752|NCT05001243|Analgesics|analgesics|mesh-ancestor
19691753|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
20216593|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20216594|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
20216595|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216596|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20216597|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20216598|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20216599|NCT00306722|Fospropofol|fospropofol|mesh-list
20216600|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20216601|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216602|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216603|NCT00306735|Palonosetron|palonosetron|mesh-list
20216604|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
20216605|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
20216606|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216607|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216608|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216609|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20216610|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20216611|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
20216612|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216613|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216614|NCT00306748|Linaclotide|linaclotide|mesh-list
20216615|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20428200|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
20428201|NCT01290458|Antioxidants|antioxidants|mesh-list
20428202|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
20420545|NCT01247493|Cytarabine|cytarabine|mesh-list
20420546|NCT01247493|Fludarabine|fludarabine|mesh-list
20420547|NCT01247493|Idarubicin|idarubicin|mesh-list
20420548|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420549|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420550|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
20420551|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420552|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420553|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
20420554|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420555|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
20420556|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420557|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20420558|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20420559|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20420560|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420561|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
20420562|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
20420563|NCT01247558|Vitamins|vitamins|mesh-ancestor
20420564|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
20420565|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420566|NCT01247688|Fludarabine|fludarabine|mesh-list
20420567|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
20420568|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420569|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420570|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420571|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
20420572|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420573|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420574|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20420575|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
20420576|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20420577|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
20420578|NCT01247701|Busulfan|busulfan|mesh-list
20420579|NCT01247701|Fludarabine|fludarabine|mesh-list
20420580|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420581|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
20420582|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420583|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20420584|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20420585|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
20420586|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420587|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420588|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20420589|NCT01247714|Phentermine|phentermine|mesh-list
20420590|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20420591|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420592|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
20420593|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20420594|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
20420595|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
20420596|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420597|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
20420598|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420599|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420600|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
20420601|NCT01247805|Citric Acid|citric acid|mesh-list
20420602|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
20420603|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
20420604|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20420605|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
20420606|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
20420607|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420608|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
20420609|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20420610|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20420611|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420612|NCT01247805|Urological Agents|urological agents|mesh-ancestor
20420613|NCT01247857|Ropivacaine|ropivacaine|mesh-list
20420614|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
20420615|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
20420616|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420617|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420618|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
20420619|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420620|NCT01247870|Metformin|metformin|mesh-list
20420621|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20420622|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420623|NCT01247909|Gentamicins|gentamicins|mesh-list
20420624|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
20420625|NCT01247909|Penicillins|penicillins|mesh-list
20420626|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420627|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420628|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20420629|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420630|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420631|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20420632|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420633|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420634|NCT01247961|Dexamethasone|dexamethasone|mesh-list
20420635|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
20420636|NCT01247961|BB 1101|bb 1101|mesh-list
20420637|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420638|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
20420639|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
20420640|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420641|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420642|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420643|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
20420644|NCT01247961|Hormones|hormones|mesh-ancestor
20420645|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420646|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20420647|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420648|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
20420649|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420650|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420651|NCT01248078|Cephalexin|cephalexin|mesh-list
20420652|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420653|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420654|NCT01248091|Nitroprusside|nitroprusside|mesh-list
20420655|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20420656|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
20420657|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20420658|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420659|NCT01248117|Ranibizumab|ranibizumab|mesh-list
20420660|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420661|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420662|NCT01248117|Growth Substances|growth substances|mesh-ancestor
20420663|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420664|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420665|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420666|NCT01248195|Olanzapine|olanzapine|mesh-list
20420667|NCT01248195|Clozapine|clozapine|mesh-list
20420668|NCT01248195|Amisulpride|amisulpride|mesh-list
20420669|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
20420670|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
20420671|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420672|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420673|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420674|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20420675|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20420676|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420677|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20420678|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20420679|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20420680|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20216616|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
20216617|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216618|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216619|NCT00306774|Vitamin D|vitamin d|mesh-list
20216620|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
20216621|NCT00306774|Vitamins|vitamins|mesh-ancestor
20216622|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
20216623|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216624|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20216625|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20216626|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20216627|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20216628|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20216629|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
20216630|NCT00306813|Lenalidomide|lenalidomide|mesh-list
20216631|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
20420681|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420682|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420683|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
20420684|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20420685|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
20420686|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
20420687|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20420688|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
20420689|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20420690|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
20420691|NCT01248234|Propofol|propofol|mesh-list
20420692|NCT01248234|Etomidate|etomidate|mesh-list
20420693|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20420694|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420695|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420696|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20420697|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
20420698|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
20420699|NCT01248260|Folic Acid|folic acid|mesh-list
20420700|NCT01248260|Hematinics|hematinics|mesh-ancestor
20420701|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
20420702|NCT01248260|Vitamins|vitamins|mesh-ancestor
20420703|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
20420704|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420705|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
20420706|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
20420707|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420708|NCT01248299|Cisplatin|cisplatin|mesh-list
20420709|NCT01248299|Docetaxel|docetaxel|mesh-list
20420710|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
20420711|NCT01248299|Fluorouracil|fluorouracil|mesh-list
20420712|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420713|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
20420714|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420715|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
20420716|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420717|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
20420718|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420719|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420720|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
20420721|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420722|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20420723|NCT01248338|Metoprolol|metoprolol|mesh-list
20420724|NCT01248338|Nebivolol|nebivolol|mesh-list
20420725|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20420726|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20420727|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
20420728|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
20420729|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420730|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420731|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20420732|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20420733|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20420734|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
20420735|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420736|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420737|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
20420738|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20420739|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20420740|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20420741|NCT01248403|Paclitaxel|paclitaxel|mesh-list
20420742|NCT01248403|Everolimus|everolimus|mesh-list
20420743|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20420744|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420745|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
20420746|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420747|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
20420748|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420749|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420750|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
20420751|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420752|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
20420753|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20420754|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420755|NCT01248442|Vitamins|vitamins|mesh-ancestor
20420756|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
20420757|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20420758|NCT01248481|Acarbose|acarbose|mesh-list
20420759|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20420760|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420761|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216632|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216633|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20216634|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420762|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20420763|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420764|NCT01248494|Letrozole|letrozole|mesh-list
20420765|NCT01248494|Dactolisib|dactolisib|mesh-list
20420766|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420767|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20420768|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20420769|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420770|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420771|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20420772|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
20420773|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420774|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420775|NCT01248611|Fentanyl|fentanyl|mesh-list
20420776|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20420777|NCT01248611|Narcotics|narcotics|mesh-ancestor
20420778|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420779|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420780|NCT01248611|Analgesics|analgesics|mesh-ancestor
20420781|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
20420782|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420783|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20420784|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20420785|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
20420786|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
20420787|NCT01248819|Ropivacaine|ropivacaine|mesh-list
20420788|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
20420789|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
20420790|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420791|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420792|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
20420793|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420794|NCT01248858|Trametinib|trametinib|mesh-list
20216635|NCT00306813|Growth Substances|growth substances|mesh-ancestor
20420795|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420796|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20420797|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420798|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420799|NCT01248871|Sufentanil|sufentanil|mesh-list
20420800|NCT01248871|Remifentanil|remifentanil|mesh-list
20420801|NCT01248871|Dsuvia|dsuvia|mesh-list
20420802|NCT01248871|Propofol|propofol|mesh-list
20216636|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
20216637|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216638|NCT00306826|Pioglitazone|pioglitazone|mesh-list
20216639|NCT00306826|Simvastatin|simvastatin|mesh-list
20216640|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20216641|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20216642|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
20216643|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216644|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20216645|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20216646|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216647|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20216648|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216649|NCT00306878|Abatacept|abatacept|mesh-list
20216650|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20216651|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216652|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216653|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216654|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
20216655|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216656|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20216657|NCT00306969|Bexarotene|bexarotene|mesh-list
20420803|NCT01248871|Sevoflurane|sevoflurane|mesh-list
20216658|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420804|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20420805|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20420806|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420807|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20420808|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
20420809|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
20420810|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20420811|NCT01248871|Narcotics|narcotics|mesh-ancestor
20420812|NCT01248871|Analgesics|analgesics|mesh-ancestor
20420813|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
19691754|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691755|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691756|NCT05001061|Misoprostol|misoprostol|mesh-list
19691757|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19691758|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
19691759|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19691760|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691761|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19691762|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691763|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
19691764|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
19691765|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19691766|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691767|NCT05001074|Tacrolimus|tacrolimus|mesh-list
19691768|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691769|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
19691770|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216659|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20216660|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
20216661|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216662|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20216663|NCT00307099|Meropenem|meropenem|mesh-list
19691771|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19691772|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691773|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691774|NCT05001048|Phenylephrine|phenylephrine|mesh-list
19691775|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
19691776|NCT05001048|Synephrine|synephrine|mesh-list
19691777|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19691778|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
19691779|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
20216664|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420814|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420815|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20420816|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20420817|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20420818|NCT01248923|Dexamethasone|dexamethasone|mesh-list
20420819|NCT01248923|Bortezomib|bortezomib|mesh-list
20420820|NCT01248923|Filanesib|filanesib|mesh-list
20420821|NCT01248923|Lenograstim|lenograstim|mesh-list
20420822|NCT01248923|Sargramostim|sargramostim|mesh-list
20420823|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
20420824|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420825|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
20420826|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
20420827|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420828|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420829|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420830|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
20420831|NCT01248923|Hormones|hormones|mesh-ancestor
19691780|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691781|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216665|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20216666|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
20216667|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
20216668|NCT00307177|Vaccines|vaccines|mesh-list
20216669|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
20216670|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216671|NCT00307203|Bupropion|bupropion|mesh-list
20216672|NCT00307203|Nicotine|nicotine|mesh-list
20420832|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420833|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20420834|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420835|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20420836|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
20420837|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
20420838|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420839|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420840|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420841|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
20216673|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20216674|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
20216675|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216676|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216677|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20216678|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20216679|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
20216680|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216681|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216682|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20216683|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
20216684|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20216685|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20216686|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20216687|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20216688|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
20216689|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20216690|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20216691|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216692|NCT00307255|Gemcitabine|gemcitabine|mesh-list
20216693|NCT00307255|Paclitaxel|paclitaxel|mesh-list
20216694|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20216695|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20216696|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216697|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
20216698|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
20216699|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
20216700|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216701|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20216702|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
20216703|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
20216704|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216705|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216706|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216707|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
20216708|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216709|NCT00307307|Niacin|niacin|mesh-list
20216710|NCT00307307|Simvastatin|simvastatin|mesh-list
20216711|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20216712|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20216713|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
20216714|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216715|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20216716|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20216717|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216718|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
20216719|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
20216720|NCT00307307|Vitamins|vitamins|mesh-ancestor
20216721|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
20216722|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216723|NCT00307411|Hormones|hormones|mesh-list
20216724|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216725|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216726|NCT00307450|Levetiracetam|levetiracetam|mesh-list
20216727|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
20216728|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
20216729|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
20216730|NCT00307502|Ritonavir|ritonavir|mesh-list
20216731|NCT00307502|Lopinavir|lopinavir|mesh-list
20216732|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20216733|NCT00307502|Darunavir|darunavir|mesh-list
20216734|NCT00307502|Nelfinavir|nelfinavir|mesh-list
20216735|NCT00307502|Indinavir|indinavir|mesh-list
20216736|NCT00307502|Saquinavir|saquinavir|mesh-list
20216737|NCT00307502|Amprenavir|amprenavir|mesh-list
20216738|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
20216739|NCT00307502|Nevirapine|nevirapine|mesh-list
20216740|NCT00307502|Tipranavir|tipranavir|mesh-list
20216741|NCT00307502|Efavirenz|efavirenz|mesh-list
20216742|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20216743|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20216744|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
20420842|NCT01249001|Aprepitant|aprepitant|mesh-list
20216745|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216746|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216747|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20420843|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
20420844|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
20420845|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
20420846|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420847|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420848|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420849|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20420850|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420851|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428203|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428204|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428205|NCT01290458|Protective Agents|protective agents|mesh-ancestor
20428206|NCT01290471|U3-1565|u3-1565|mesh-list
20428207|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428208|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428209|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
20428210|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20428211|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
20428212|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428213|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
20428214|NCT01290497|Protective Agents|protective agents|mesh-ancestor
20428698|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
20428699|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428700|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428701|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
20428702|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20428703|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428704|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428705|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20428706|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20428707|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20428708|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20428709|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20428710|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20428711|NCT01293630|Paclitaxel|paclitaxel|mesh-list
20428712|NCT01293630|Carboplatin|carboplatin|mesh-list
20428713|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20428714|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428715|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
20428716|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
20428717|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
20428718|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428719|NCT01293643|Clindamycin|clindamycin|mesh-list
20428720|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
20428721|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
20428722|NCT01293643|Amphotericin B|amphotericin b|mesh-list
20428723|NCT01293643|Tetracycline|tetracycline|mesh-list
20428724|NCT01293643|Ketoconazole|ketoconazole|mesh-list
20428725|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20428726|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428727|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428728|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20428729|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428730|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428731|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
20428732|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20428733|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20428734|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20428735|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
20428736|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428737|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428738|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20428739|NCT01293643|Amebicides|amebicides|mesh-ancestor
20428740|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20428741|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20428742|NCT01293734|Budesonide|budesonide|mesh-list
20428743|NCT01293734|Theophylline|theophylline|mesh-list
20428744|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20428745|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20428746|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
20428747|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392321|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19392322|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20420852|NCT01249339|Lobeline|lobeline|mesh-list
20420853|NCT01249339|Nicotine|nicotine|mesh-list
20420854|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20420855|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
20420856|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420857|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420858|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20420859|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20420860|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
20420861|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20420862|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420863|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
20216748|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20216749|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
20216750|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216751|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20216752|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20216753|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20216754|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20216755|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20420864|NCT01249352|Fluorouracil|fluorouracil|mesh-list
20420865|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
20420866|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420867|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
20420868|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420869|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420870|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420871|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
20420872|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420873|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20420874|NCT01249430|Cytarabine|cytarabine|mesh-list
20420875|NCT01249430|Etoposide|etoposide|mesh-list
20420876|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
20420877|NCT01249430|Azacitidine|azacitidine|mesh-list
20420878|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
20420879|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20420880|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420881|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20420882|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20420883|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420884|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420885|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420886|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
20420887|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
20420888|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420889|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420890|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
20420891|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420892|NCT01249430|Analgesics|analgesics|mesh-ancestor
20420893|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
20420894|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420895|NCT01249443|Paclitaxel|paclitaxel|mesh-list
20420896|NCT01249443|Carboplatin|carboplatin|mesh-list
20420897|NCT01249443|Vorinostat|vorinostat|mesh-list
20420898|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20420899|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420900|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
20420901|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
20420902|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
20420903|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420904|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20420905|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420906|NCT01249521|Bevacizumab|bevacizumab|mesh-list
20420907|NCT01249521|Trebananib|trebananib|mesh-list
20420908|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20420909|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420910|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420911|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420912|NCT01249521|Growth Substances|growth substances|mesh-ancestor
20420913|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420914|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420915|NCT01249547|Axitinib|axitinib|mesh-list
20420916|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420917|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20420918|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420919|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420920|NCT01249638|Bevacizumab|bevacizumab|mesh-list
20420921|NCT01249638|Capecitabine|capecitabine|mesh-list
20420922|NCT01249638|Irinotecan|irinotecan|mesh-list
20420923|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20420924|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420925|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420926|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420927|NCT01249638|Growth Substances|growth substances|mesh-ancestor
20420928|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420929|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420930|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20420931|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
20420932|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420933|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20420934|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20420935|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420936|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
20420937|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20420938|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420939|NCT01249690|Thalidomide|thalidomide|mesh-list
20420940|NCT01249690|Dexamethasone|dexamethasone|mesh-list
20420941|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
20420942|NCT01249690|Bortezomib|bortezomib|mesh-list
20420943|NCT01249690|Pirarubicin|pirarubicin|mesh-list
20420944|NCT01249690|Doxorubicin|doxorubicin|mesh-list
20420945|NCT01249690|BB 1101|bb 1101|mesh-list
20420946|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420947|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
20420948|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
20420949|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20420950|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420951|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20420952|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
20420953|NCT01249690|Hormones|hormones|mesh-ancestor
20420954|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420955|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20420956|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420957|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
20420958|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420959|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20420960|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420961|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
20420962|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
20420963|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20420964|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420965|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420966|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420967|NCT01249690|Growth Substances|growth substances|mesh-ancestor
20420968|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420969|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20420970|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20420971|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20420972|NCT01249820|Anidulafungin|anidulafungin|mesh-list
20420973|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
20420974|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420975|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
20420976|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20420977|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20420978|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20420979|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
20420980|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
20420981|NCT01249937|Triamcinolone|triamcinolone|mesh-list
20420982|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20420983|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20420984|NCT01249937|Ranibizumab|ranibizumab|mesh-list
20420985|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20420986|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20420987|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20420988|NCT01249937|Growth Substances|growth substances|mesh-ancestor
20420989|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20420990|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
20420991|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20420992|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20420993|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
20420994|NCT01249937|Hormones|hormones|mesh-ancestor
20428215|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
20420995|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20420996|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20420997|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
20420998|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20420999|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421000|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20421001|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20421002|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20421003|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20421004|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20421005|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421006|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421007|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421008|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421009|NCT01250249|Vaccines|vaccines|mesh-list
20421010|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
20421011|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
20421012|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421013|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20421014|NCT01250340|Aspirin|aspirin|mesh-list
20421015|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20421016|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20421017|NCT01250340|Analgesics|analgesics|mesh-ancestor
20421018|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
20421019|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421020|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421021|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421022|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20421023|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20421024|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20421025|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421026|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20421027|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20421028|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421029|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
20421030|NCT01250366|Ribavirin|ribavirin|mesh-list
20421031|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
20421032|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421033|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
20421034|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421035|NCT01250405|Cinacalcet|cinacalcet|mesh-list
20421036|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20421037|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421038|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19392323|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392324|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392325|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392326|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392327|NCT03695822|Urological Agents|urological agents|mesh-ancestor
19392328|NCT03695744|Dexamethasone|dexamethasone|mesh-list
19392329|NCT03695744|Bortezomib|bortezomib|mesh-list
19392330|NCT03695744|Daratumumab|daratumumab|mesh-list
19392331|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392332|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
19392333|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
19392334|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392335|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392336|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19392337|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
19392338|NCT03695744|Hormones|hormones|mesh-ancestor
19392339|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19392340|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19392341|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421039|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
19392342|NCT03695705|Rifaximin|rifaximin|mesh-list
19392343|NCT03695705|Norfloxacin|norfloxacin|mesh-list
19392344|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19392345|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19392346|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19392347|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20421040|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421041|NCT01250457|Timolol|timolol|mesh-list
19392348|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19392349|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421042|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20421043|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20421044|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421045|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421046|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421047|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421048|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20421049|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20421050|NCT01250470|Sargramostim|sargramostim|mesh-list
20421051|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
20421052|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421053|NCT01250496|Aminophylline|aminophylline|mesh-list
20421054|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20421055|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
20421056|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421057|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421058|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20421059|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421060|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20421061|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20421062|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421063|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421064|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20421065|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20421066|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
20421067|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421068|NCT01250496|Protective Agents|protective agents|mesh-ancestor
20421069|NCT01250535|Warfarin|warfarin|mesh-list
20421070|NCT01250535|Lovastatin|lovastatin|mesh-list
20421071|NCT01250535|L 647318|l 647318|mesh-list
20421072|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
20421073|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
20421074|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20421075|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20421076|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
20421077|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421078|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20421079|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20421080|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421081|NCT01250548|Apremilast|apremilast|mesh-list
20421082|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20421083|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20421084|NCT01250548|Analgesics|analgesics|mesh-ancestor
20421085|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
20421086|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421087|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421088|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421089|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20421090|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20421091|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20421092|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421093|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421094|NCT01250561|Valacyclovir|valacyclovir|mesh-list
20421095|NCT01250561|Gabapentin|gabapentin|mesh-list
20421096|NCT01250561|Analgesics|analgesics|mesh-ancestor
20421097|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
20421098|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421099|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421100|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
20421101|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20421102|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20421103|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20421104|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20421105|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20421106|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20421107|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421108|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421109|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
20421110|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
20421111|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421112|NCT01250652|Cetirizine|cetirizine|mesh-list
20421113|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
20421114|NCT01250652|Levocetirizine|levocetirizine|mesh-list
20421115|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20421116|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20421117|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
20421118|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
20421119|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421120|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421121|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421122|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20421123|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
20421124|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
20421125|NCT01250743|Vitamins|vitamins|mesh-list
20421126|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
20421127|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
20421128|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421129|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
20421130|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421131|NCT01250743|Protective Agents|protective agents|mesh-ancestor
20428216|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20428217|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
20428218|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428219|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
20428220|NCT01290510|Protective Agents|protective agents|mesh-ancestor
20428221|NCT01290549|Rituximab|rituximab|mesh-list
20428222|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428223|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428224|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
20428225|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428226|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20428227|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
20428228|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
20428229|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428230|NCT01290744|Clofazimine|clofazimine|mesh-list
20428231|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20428232|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
20428233|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428234|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428235|NCT01290783|Irinotecan|irinotecan|mesh-list
20428236|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20428237|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20428238|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392350|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392351|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392352|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19392353|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19392354|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
19392355|NCT03695640|Analgesics|analgesics|mesh-ancestor
19392356|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
19392357|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392358|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392359|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
19392360|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19392361|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19392362|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
19392363|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19392364|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19392365|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392366|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392367|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
19392368|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20428239|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428240|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428241|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
20428242|NCT01290900|Ceftazidime|ceftazidime|mesh-list
20428243|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20428244|NCT01290900|Avibactam|avibactam|mesh-list
20428245|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428246|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428247|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20428248|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20428249|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428250|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428251|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428252|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19392369|NCT03695445|Norepinephrine|norepinephrine|mesh-list
20428253|NCT01290926|Sorafenib|sorafenib|mesh-list
20428254|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428255|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20421132|NCT01250808|Dexamethasone|dexamethasone|mesh-list
20421133|NCT01250808|Bortezomib|bortezomib|mesh-list
20421134|NCT01250808|Melphalan|melphalan|mesh-list
20421135|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421136|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
20421137|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
20421138|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421139|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421140|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421141|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
20421142|NCT01250808|Hormones|hormones|mesh-ancestor
20421143|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421144|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20421145|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421146|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20421147|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
20421148|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421149|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20421150|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20421151|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
20421152|NCT01250821|Menotropins|menotropins|mesh-list
20421153|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20421154|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
20421155|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20421156|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421157|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20421158|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
20421159|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20421160|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20421161|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20421162|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20421163|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421164|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20421165|NCT01250951|Deferasirox|deferasirox|mesh-list
20421166|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20421167|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
20421168|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
20421169|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421170|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
20421171|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20421172|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
20421173|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421174|NCT01251029|Expectorants|expectorants|mesh-ancestor
20421175|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421176|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20421177|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
20421178|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421179|NCT01251029|Protective Agents|protective agents|mesh-ancestor
20421180|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421181|NCT01251029|Antidotes|antidotes|mesh-ancestor
20421182|NCT01251107|Prednisone|prednisone|mesh-list
20421183|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
20421184|NCT01251107|Dacarbazine|dacarbazine|mesh-list
20421185|NCT01251107|Doxorubicin|doxorubicin|mesh-list
20421186|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20421187|NCT01251107|Etoposide|etoposide|mesh-list
20421188|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
20421189|NCT01251107|Vincristine|vincristine|mesh-list
20421190|NCT01251107|Bleomycin|bleomycin|mesh-list
20421191|NCT01251107|Vinblastine|vinblastine|mesh-list
20421192|NCT01251107|Procarbazine|procarbazine|mesh-list
20421193|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20421194|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
20421195|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421196|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20421197|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20421198|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
20421199|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421200|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421201|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20421202|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20421203|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20421204|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20421205|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421206|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421207|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
20421208|NCT01251107|Hormones|hormones|mesh-ancestor
20428256|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421209|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421210|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20421211|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20421212|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421213|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421214|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421215|NCT01251133|Vaccines|vaccines|mesh-list
20421216|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
20421217|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421218|NCT01251172|Melphalan|melphalan|mesh-list
20421219|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
20421220|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20421221|NCT01251172|R04929097|r04929097|mesh-list
20421222|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20421223|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
20421224|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421225|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421226|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20421227|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20421228|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
20421229|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421230|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421231|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
20421232|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20421233|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20421234|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20421235|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20421236|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421237|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
20421238|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421239|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421240|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20421241|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421242|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20421243|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20421244|NCT01251263|Estradiol|estradiol|mesh-list
20421245|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20421246|NCT01251263|Estrogens|estrogens|mesh-ancestor
20421247|NCT01251263|Hormones|hormones|mesh-ancestor
20421248|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421249|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421250|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20421251|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
20421252|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20421253|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20421254|NCT01251328|Anesthetics|anesthetics|mesh-list
20421255|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20421256|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421257|NCT01251458|Sirolimus|sirolimus|mesh-list
20421258|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20421259|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421260|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20421261|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421262|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
20421263|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20421264|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
20421265|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421266|NCT01251471|Citalopram|citalopram|mesh-list
20421267|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20216756|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20216757|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20216758|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20216759|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20216760|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20216761|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
20216762|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20216763|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20216764|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
20216765|NCT00307515|Coagulants|coagulants|mesh-ancestor
20216766|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20216767|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
20216768|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218067|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421268|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20421269|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20421270|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421271|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421272|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
20421273|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421274|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20421275|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
20421276|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20421277|NCT01251484|Nintedanib|nintedanib|mesh-list
20216769|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20216770|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20216771|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20216772|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216773|NCT00307593|Rituximab|rituximab|mesh-list
20216774|NCT00307593|Infliximab|infliximab|mesh-list
20216775|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20216776|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216777|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
20216778|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216779|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20216780|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
20421278|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421279|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20421280|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421281|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421282|NCT01251627|Decitabine|decitabine|mesh-list
20421283|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20421284|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
20421285|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421286|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421287|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421288|NCT01251640|Gemcitabine|gemcitabine|mesh-list
20421289|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20421290|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
20421291|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421292|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421293|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
20421294|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421295|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421296|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20421297|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
20421298|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421299|NCT01251718|Donepezil|donepezil|mesh-list
20421300|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20421301|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421302|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421303|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
20421304|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421305|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421306|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
20421307|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20421308|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421309|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20421310|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421311|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421312|NCT01251809|Pegaspargase|pegaspargase|mesh-list
20421313|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421314|NCT01251822|Prucalopride|prucalopride|mesh-list
20421315|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20421316|NCT01251822|Laxatives|laxatives|mesh-ancestor
20421317|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421318|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20421319|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20421320|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
20421321|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421322|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421323|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421324|NCT01251835|Rifampin|rifampin|mesh-list
20421325|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
20421326|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20421327|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
19403964|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20216781|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421328|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20421329|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421330|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
20421331|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20421332|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421333|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421334|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20421335|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20421336|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20421337|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20421338|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20421339|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20421340|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20421341|NCT01251848|Ritonavir|ritonavir|mesh-list
20421342|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
20421343|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20421344|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20421345|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
20421346|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421347|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421348|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20421349|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20421350|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
20421351|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421352|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20421353|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20421354|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20421355|NCT01251874|Alovudine|alovudine|mesh-list
20421356|NCT01251874|Carboplatin|carboplatin|mesh-list
20421357|NCT01251874|Veliparib|veliparib|mesh-list
20421358|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421359|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20421360|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421361|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421362|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
20421363|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421364|NCT01251926|Bevacizumab|bevacizumab|mesh-list
20421365|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20421366|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421367|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421368|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421369|NCT01251926|Growth Substances|growth substances|mesh-ancestor
20421370|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421371|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421372|NCT01251991|Psyllium|psyllium|mesh-list
20421373|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
20421374|NCT01251991|Cathartics|cathartics|mesh-ancestor
20421375|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421376|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
20421377|NCT01252056|Cilostazol|cilostazol|mesh-list
20421378|NCT01252056|Probucol|probucol|mesh-list
20421379|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20421380|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
20421381|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421382|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421383|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20421384|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421385|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20421386|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20421387|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421388|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20421389|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
20421390|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20421391|NCT01252056|Protective Agents|protective agents|mesh-ancestor
20421392|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20421393|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20421394|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421395|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20421396|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20421397|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
20421398|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20421399|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
20421400|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
20421401|NCT01252069|Progestins|progestins|mesh-list
19403965|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
20216782|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
20216783|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20216784|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20216785|NCT00307606|Prednisolone|prednisolone|mesh-list
20216786|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
20216787|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20216788|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
20216789|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20216790|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
20421402|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20421403|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
20421404|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20421405|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421406|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20421407|NCT01252069|Hormones|hormones|mesh-ancestor
20421408|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421409|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20421410|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
20421411|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20421412|NCT01252160|Capsaicin|capsaicin|mesh-list
20421413|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
20421414|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
20421415|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
20421416|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421417|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691782|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
19691783|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19691784|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
19691785|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421418|NCT01252225|Lidocaine|lidocaine|mesh-list
20421419|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
20421420|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
20421421|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20421422|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421423|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
20421424|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421425|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20421426|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20421427|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20421428|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20421429|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421430|NCT01252342|Oxytocin|oxytocin|mesh-list
20421431|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
20421432|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20421433|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421434|NCT01252420|Enoxaparin|enoxaparin|mesh-list
20421435|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
20421436|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20421437|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20421438|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421439|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
20421440|NCT01252524|Psyllium|psyllium|mesh-list
20421441|NCT01252524|Calcium|calcium|mesh-list
20421442|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20421443|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421444|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
20421445|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421446|NCT01252524|Cathartics|cathartics|mesh-ancestor
20428257|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428258|NCT01290939|Bevacizumab|bevacizumab|mesh-list
20428259|NCT01290939|Lomustine|lomustine|mesh-list
20428260|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428261|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428262|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20428263|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20428264|NCT01290939|Growth Substances|growth substances|mesh-ancestor
20428265|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428266|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
20428267|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20428268|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
20428269|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428270|NCT01291069|Tadalafil|tadalafil|mesh-list
20216791|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
20218068|NCT00311740|Valsartan|valsartan|mesh-list
20428271|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421447|NCT01252680|Vaccines|vaccines|mesh-list
20421448|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
20421449|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421450|NCT01252719|Vancomycin|vancomycin|mesh-list
20421451|NCT01252719|Oritavancin|oritavancin|mesh-list
20421452|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20421453|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421454|NCT01252758|Albuterol|albuterol|mesh-list
20421455|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20421456|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
20421457|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421458|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421459|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20421460|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421461|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
20421462|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20421463|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20421464|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20421465|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20421466|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421467|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421468|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421469|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20421470|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20421471|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421472|NCT01253382|Ecallantide|ecallantide|mesh-list
19392370|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19392371|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19392372|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
19392373|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392374|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421473|NCT01253382|Analgesics|analgesics|mesh-ancestor
20421474|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
20421475|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421476|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421477|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20421478|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20421479|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421480|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20421481|NCT01253473|Budesonide|budesonide|mesh-list
20421482|NCT01253473|Albuterol|albuterol|mesh-list
20421483|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
20421484|NCT01253473|Ipratropium|ipratropium|mesh-list
20421485|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421486|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20421487|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
20421488|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421489|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421490|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20421491|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421492|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
20421493|NCT01253473|Hormones|hormones|mesh-ancestor
20421494|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421495|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20421496|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20421497|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20421498|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421499|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421500|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421501|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
20421502|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20421503|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20421504|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
20421505|NCT01253681|Paclitaxel|paclitaxel|mesh-list
20421506|NCT01253681|Carboplatin|carboplatin|mesh-list
20421507|NCT01253681|Trebananib|trebananib|mesh-list
20421508|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20421509|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421510|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421511|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421512|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421513|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421514|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421515|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421516|NCT01253681|Growth Substances|growth substances|mesh-ancestor
20421517|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421518|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421519|NCT01253694|Ranibizumab|ranibizumab|mesh-list
20421520|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421521|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421522|NCT01253694|Growth Substances|growth substances|mesh-ancestor
20421523|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421524|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421525|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421526|NCT01253928|Pioglitazone|pioglitazone|mesh-list
20421527|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20421528|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421529|NCT01254006|Thiamine|thiamine|mesh-list
20421530|NCT01254006|Vitamins|vitamins|mesh-ancestor
20421531|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
20421532|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421533|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
20421534|NCT01254071|Tamsulosin|tamsulosin|mesh-list
20421535|NCT01254071|Dutasteride|dutasteride|mesh-list
20421536|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20421537|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20421538|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20421539|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421540|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421541|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421542|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421543|NCT01254071|Urological Agents|urological agents|mesh-ancestor
20421544|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20421545|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20421546|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421547|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
20421548|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421549|NCT01254123|Exenatide|exenatide|mesh-list
20421550|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20421551|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421552|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20421553|NCT01254123|Incretins|incretins|mesh-ancestor
20421554|NCT01254123|Hormones|hormones|mesh-ancestor
20421555|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421556|NCT01254175|Vaccines|vaccines|mesh-list
20421557|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
20421558|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421559|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
20421560|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
20421561|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20421562|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20421563|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421564|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421565|NCT01254383|Urological Agents|urological agents|mesh-ancestor
20421566|NCT01254461|Pravastatin|pravastatin|mesh-list
20421567|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20421568|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20421569|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
20421570|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421571|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20421572|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20421573|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421574|NCT00701207|Nicotine|nicotine|mesh-list
20421575|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20421576|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
20421577|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421578|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421579|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20421580|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20421581|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
20421582|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421583|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421584|NCT01254513|Prednisone|prednisone|mesh-list
20421585|NCT01254513|Docetaxel|docetaxel|mesh-list
20421586|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421587|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421588|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421589|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421590|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421591|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421592|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
20421593|NCT01254513|Hormones|hormones|mesh-ancestor
20421594|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421595|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421596|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20421597|NCT01254526|Paclitaxel|paclitaxel|mesh-list
20421598|NCT01254526|Bevacizumab|bevacizumab|mesh-list
20421599|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20421600|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421601|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421602|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421603|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421604|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421605|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20421606|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421607|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421608|NCT01254526|Growth Substances|growth substances|mesh-ancestor
20421609|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421610|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421611|NCT01254578|Lenalidomide|lenalidomide|mesh-list
20421612|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
20421613|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421614|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421615|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421616|NCT01254578|Growth Substances|growth substances|mesh-ancestor
20421617|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421618|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421619|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20421620|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20421621|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421622|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20421623|NCT01254617|Cetuximab|cetuximab|mesh-list
20421624|NCT01254617|Lenalidomide|lenalidomide|mesh-list
20421625|NCT01254617|Antibodies|antibodies|mesh-list
20421626|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
20421627|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20421628|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
20421629|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421630|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421631|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421632|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421633|NCT01254617|Growth Substances|growth substances|mesh-ancestor
20421634|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421635|NCT00660673|Levodopa|levodopa|mesh-list
20421636|NCT00660673|Carbidopa|carbidopa|mesh-list
20421637|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20421638|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20421639|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20421640|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
20421641|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421642|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421643|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421644|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20421645|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421646|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20421647|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
20421648|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
20428272|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
20428273|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20428274|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20428275|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428276|NCT01291069|Urological Agents|urological agents|mesh-ancestor
20428277|NCT01291095|Cisplatin|cisplatin|mesh-list
20428278|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428279|NCT01291121|Ranibizumab|ranibizumab|mesh-list
20428280|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20428281|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20428282|NCT01291121|Growth Substances|growth substances|mesh-ancestor
20428283|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428284|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
20428285|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428286|NCT01291186|Epinephrine|epinephrine|mesh-list
20428287|NCT01291186|Racepinephrine|racepinephrine|mesh-list
20428288|NCT01291186|Bupivacaine|bupivacaine|mesh-list
20428289|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
20428290|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
20421649|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20421650|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
20421651|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421652|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20421653|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20421654|NCT01254799|Doxycycline|doxycycline|mesh-list
20421655|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20421656|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421657|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
20421658|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20421659|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20421660|NCT01254825|Ropivacaine|ropivacaine|mesh-list
20421661|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
20421662|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
20421663|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20421664|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421665|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
20421666|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421667|NCT00660218|Paclitaxel|paclitaxel|mesh-list
20421668|NCT00660218|Cetuximab|cetuximab|mesh-list
20421669|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20421670|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20421671|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421672|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421673|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421674|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421675|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421676|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20421677|NCT01254929|Frovatriptan|frovatriptan|mesh-list
20421678|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20421679|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
20421680|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421681|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421682|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421683|NCT01254994|Entecavir|entecavir|mesh-list
20421684|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
20421685|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421686|NCT01255046|Donepezil|donepezil|mesh-list
20421687|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20421688|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421689|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421690|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
20421691|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421692|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421693|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
20421694|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
20421695|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20421696|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
20421697|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421698|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421699|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20421700|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421701|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20421702|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
20421703|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421704|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421705|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20421706|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
20421707|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
20421708|NCT01255215|Protective Agents|protective agents|mesh-ancestor
20421709|NCT01255358|Dexamethasone|dexamethasone|mesh-list
20421710|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
20421711|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20421712|NCT01255358|BB 1101|bb 1101|mesh-list
20421713|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392375|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216792|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216793|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216794|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216795|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
20216796|NCT00307606|Hormones|hormones|mesh-ancestor
20216797|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216798|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20216799|NCT00307606|Protective Agents|protective agents|mesh-ancestor
20421714|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
20421715|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
20421716|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421717|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421718|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421719|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
20421720|NCT01255358|Hormones|hormones|mesh-ancestor
20421721|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421722|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20421723|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421724|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
20421725|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421726|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421727|NCT01255371|Lopinavir|lopinavir|mesh-list
20421728|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20421729|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20421730|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20421731|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
20421732|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421733|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421734|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20421735|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20421736|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
20421737|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421738|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20421739|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20421740|NCT01255410|Vaccines|vaccines|mesh-list
20421741|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
20421742|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421743|NCT01255475|Amlodipine|amlodipine|mesh-list
20421744|NCT01255475|Hydralazine|hydralazine|mesh-list
20421745|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20421746|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20421747|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20421748|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421749|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20421750|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421751|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
20421752|NCT01255527|Bortezomib|bortezomib|mesh-list
20421753|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421754|NCT01255579|Fluticasone|fluticasone|mesh-list
20421755|NCT01255579|Beclomethasone|beclomethasone|mesh-list
20421756|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
20421757|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20421758|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20421759|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421760|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20421761|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
20421762|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421763|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421764|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20421765|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421766|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
20421767|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20421768|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20421769|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20421770|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20421771|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421772|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421773|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421774|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
20421775|NCT01255579|Hormones|hormones|mesh-ancestor
20421776|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421777|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
20421778|NCT01255644|Valganciclovir|valganciclovir|mesh-list
20421779|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
20421780|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421781|NCT01255774|Ranibizumab|ranibizumab|mesh-list
20421782|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421783|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421784|NCT01255774|Growth Substances|growth substances|mesh-ancestor
20421785|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421786|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421787|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421788|NCT01255800|Cetuximab|cetuximab|mesh-list
20421789|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20216800|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20216801|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216802|NCT00307619|Topiramate|topiramate|mesh-list
20421790|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421791|NCT01255852|Atorvastatin|atorvastatin|mesh-list
20421792|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20421793|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20216803|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
20216804|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20216805|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216806|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20216807|NCT00307632|Estradiol|estradiol|mesh-list
20216808|NCT00307632|Estrogens|estrogens|mesh-ancestor
20421794|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
20421795|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421796|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20421797|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20421798|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421799|NCT01255878|Gabapentin|gabapentin|mesh-list
20421800|NCT01255878|Analgesics|analgesics|mesh-ancestor
20421801|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
20421802|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421803|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421804|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
20421805|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20421806|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20421807|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20421808|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20421809|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20421810|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20421811|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421812|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421813|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
20421814|NCT01255891|Androgens|androgens|mesh-list
20421815|NCT01255891|Hormones|hormones|mesh-ancestor
20421816|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421817|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421818|NCT01255956|Sirolimus|sirolimus|mesh-list
20421819|NCT01255956|Paclitaxel|paclitaxel|mesh-list
20421820|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20421821|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421822|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421823|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421824|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421825|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421826|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20421827|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20421828|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20421829|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
20421830|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20421831|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
20421832|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421833|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
20421834|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20421835|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20421836|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20421837|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20421838|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421839|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
20421840|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421841|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216809|NCT00307632|Hormones|hormones|mesh-ancestor
20216810|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216811|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216812|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20216813|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
20216814|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20216815|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20216816|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20216817|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20421842|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20421843|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216818|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
20216819|NCT00307645|Prednisone|prednisone|mesh-list
20421844|NCT01256151|Alprazolam|alprazolam|mesh-list
20421845|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20421846|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20421847|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421848|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20421849|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20421850|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20421851|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
20421852|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
20421853|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421854|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421855|NCT01256268|Paclitaxel|paclitaxel|mesh-list
20421856|NCT01256268|Carboplatin|carboplatin|mesh-list
20421857|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20421858|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421859|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421860|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421861|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421862|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421863|NCT01256359|Docetaxel|docetaxel|mesh-list
20421864|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421865|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
20421866|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
20421867|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
20421868|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428291|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
20428292|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428293|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428294|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
20428295|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428296|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20428297|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20428298|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
20428299|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428300|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428301|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20428302|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20428303|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
20428304|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20428305|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
20428306|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
20428307|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
20428308|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20428309|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20428310|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
20428311|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20428312|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20428313|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428314|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428315|NCT01291199|Urological Agents|urological agents|mesh-ancestor
20428316|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
20428317|NCT01291212|Testosterone|testosterone|mesh-list
20428318|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
20428319|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
20428320|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20428321|NCT01291212|Androgens|androgens|mesh-ancestor
20428322|NCT01291212|Hormones|hormones|mesh-ancestor
20428323|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428324|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428325|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20428326|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428327|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
20428328|NCT01291316|Clonazepam|clonazepam|mesh-list
20428329|NCT01291316|Clobazam|clobazam|mesh-list
20428330|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20428331|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20428332|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20428333|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
20428334|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428335|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428336|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428337|NCT01291316|Urological Agents|urological agents|mesh-ancestor
20428338|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
20428339|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
20428340|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
20421869|NCT01256489|Infliximab|infliximab|mesh-list
20421870|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
20421871|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421872|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20421873|NCT01256541|Lactulose|lactulose|mesh-list
20421874|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421875|NCT01256580|Dexamethasone|dexamethasone|mesh-list
20421876|NCT01256580|Bevacizumab|bevacizumab|mesh-list
20421877|NCT01256580|Verteporfin|verteporfin|mesh-list
20421878|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20421879|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421880|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421881|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421882|NCT01256580|Growth Substances|growth substances|mesh-ancestor
20421883|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421884|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421885|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421886|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
20421887|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
20421888|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421889|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20421890|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
20421891|NCT01256580|Hormones|hormones|mesh-ancestor
20421892|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421893|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20421894|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20421895|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
20421896|NCT01256619|Desogestrel|desogestrel|mesh-list
20421897|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20421898|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20421899|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20421900|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
20421901|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20421902|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421903|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20421904|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20421905|NCT01256619|Progestins|progestins|mesh-ancestor
20421906|NCT01256619|Hormones|hormones|mesh-ancestor
20421907|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421908|NCT01256632|Ranibizumab|ranibizumab|mesh-list
20421909|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20421910|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20421911|NCT01256632|Growth Substances|growth substances|mesh-ancestor
20421912|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421913|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
20421914|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421915|NCT01256775|Aspirin|aspirin|mesh-list
20421916|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
20421917|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20421918|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20421919|NCT01256775|Analgesics|analgesics|mesh-ancestor
20421920|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
20421921|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421922|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421923|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421924|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20421925|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20421926|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20421927|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421928|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20421929|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20421930|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
20421931|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421932|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20421933|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
20421934|NCT01256801|Interleukin-2|interleukin-2|mesh-list
20421935|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20421936|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20421937|NCT01256801|Analgesics|analgesics|mesh-ancestor
20421938|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
20421939|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421940|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421941|NCT01256866|Midazolam|midazolam|mesh-list
20421942|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
20421943|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20421944|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20216820|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
20216821|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
20216822|NCT00307645|Azathioprine|azathioprine|mesh-list
20216823|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216824|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
20216825|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216826|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20216827|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20216828|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
20216829|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216830|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216831|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20216832|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20216833|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
20216834|NCT00307645|Hormones|hormones|mesh-ancestor
20216835|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216836|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20216837|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20216838|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20216839|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
20216840|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20216841|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216842|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216843|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
20216844|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
20216845|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216846|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216847|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20216848|NCT00307645|Protective Agents|protective agents|mesh-ancestor
20216849|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
20216850|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20216851|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
20216852|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20216853|NCT00307658|Antibodies|antibodies|mesh-list
20216854|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
20216855|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
20216856|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20216857|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
20216858|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216859|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
20216860|NCT00307671|Prednisone|prednisone|mesh-list
20216861|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
20216862|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20216863|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20216864|NCT00307671|Prednisolone|prednisolone|mesh-list
20216865|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
20216866|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
20216867|NCT00307671|Methotrexate|methotrexate|mesh-list
20216868|NCT00307671|Azathioprine|azathioprine|mesh-list
20216869|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20216870|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
20216871|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216872|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
20216873|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216874|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20216875|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20216876|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
20216877|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216878|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216879|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20216880|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20216881|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
20216882|NCT00307671|Hormones|hormones|mesh-ancestor
20216883|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216884|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20216885|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20216886|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
20216887|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20216888|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20216889|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
20216890|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
20216891|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216892|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20216893|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20421945|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421946|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20421947|NCT01256866|Analgesics|analgesics|mesh-ancestor
20421948|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
20421949|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421950|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20421951|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20421952|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20421953|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421954|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20421955|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421956|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20421957|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20421958|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20421959|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20421960|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20421961|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
20421962|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
20421963|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
20421964|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
20421965|NCT01256905|Modafinil|modafinil|mesh-list
20421966|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20421967|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421968|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20421969|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20421970|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20421971|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421972|NCT01257009|Atorvastatin|atorvastatin|mesh-list
20421973|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20421974|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20421975|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
20421976|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421977|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20421978|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20421979|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20421980|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20421981|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20421982|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20421983|NCT01257048|Budesonide|budesonide|mesh-list
20421984|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
20421985|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20421986|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20421987|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
20421988|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20421989|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20421990|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20421991|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
20421992|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
20421993|NCT01257048|Hormones|hormones|mesh-ancestor
20421994|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20421995|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20421996|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20421997|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20421998|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20421999|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422000|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422001|NCT01257074|Acyclovir|acyclovir|mesh-list
20422002|NCT01257074|Penciclovir|penciclovir|mesh-list
20422003|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
20422004|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422005|NCT01257126|Diclofenac|diclofenac|mesh-list
20422006|NCT01257126|Nimesulide|nimesulide|mesh-list
20422007|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422008|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422009|NCT01257126|Analgesics|analgesics|mesh-ancestor
20422010|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
20422011|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422012|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422013|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422014|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422015|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20422016|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392376|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
19392377|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
20422017|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422018|NCT01257139|Docetaxel|docetaxel|mesh-list
20422019|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422020|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
20422021|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
20422022|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
19392378|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392379|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19403966|NCT03598582|Hematinics|hematinics|mesh-ancestor
19403967|NCT03598556|Vitamin D|vitamin d|mesh-list
19403968|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
19403969|NCT03598556|Vitamins|vitamins|mesh-ancestor
19403970|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
20216894|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20216895|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20216896|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
20422023|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422024|NCT01257165|Ethanol|ethanol|mesh-list
20422025|NCT01257165|Zopiclone|zopiclone|mesh-list
20422026|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20422027|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422028|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422029|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422030|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20422031|NCT01257243|Potassium iodate|potassium iodate|mesh-list
20422032|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
20422033|NCT01257243|Guaifenesin|guaifenesin|mesh-list
20422034|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20422035|NCT01257243|Expectorants|expectorants|mesh-ancestor
20422036|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
20422037|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20422038|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20422039|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
20422040|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422041|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422042|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422043|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
20422044|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20422045|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
20422046|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
20422047|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422048|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
20422049|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20422050|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
20422051|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422052|NCT01257334|Empagliflozin|empagliflozin|mesh-list
20422053|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20422054|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422055|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20422056|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403971|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19403972|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19403973|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19403974|NCT03598452|Ganciclovir|ganciclovir|mesh-list
20216897|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20216898|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216899|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
20216900|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
20216901|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216902|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216903|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20216904|NCT00307671|Protective Agents|protective agents|mesh-ancestor
20216905|NCT00307723|Gemcitabine|gemcitabine|mesh-list
20216906|NCT00307723|Bevacizumab|bevacizumab|mesh-list
20216907|NCT00307723|Fluorouracil|fluorouracil|mesh-list
20216908|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
20216909|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20216910|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216911|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20216912|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20216913|NCT00307723|Growth Substances|growth substances|mesh-ancestor
20216914|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216915|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
19403975|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20422057|NCT01257360|Panitumumab|panitumumab|mesh-list
20422058|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20422059|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422060|NCT01257373|Cobalt|cobalt|mesh-list
20422061|NCT01257373|Chromium|chromium|mesh-list
20422062|NCT01257373|Sirolimus|sirolimus|mesh-list
20422063|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20422064|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422065|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20422066|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422067|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
20422068|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20422069|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
20422070|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422071|NCT01257373|Trace Elements|trace elements|mesh-ancestor
20422072|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
20422073|NCT01257386|Mesalamine|mesalamine|mesh-list
20422074|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422075|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422076|NCT01257386|Analgesics|analgesics|mesh-ancestor
20422077|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
20422078|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422079|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422080|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422081|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422082|NCT01257399|Mesalamine|mesalamine|mesh-list
20422083|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422084|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422085|NCT01257399|Analgesics|analgesics|mesh-ancestor
20422086|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
20422087|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422088|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422089|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422090|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422091|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
20422092|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20422093|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422094|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20422095|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422096|NCT01257451|Vildagliptin|vildagliptin|mesh-list
20422097|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20422098|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422099|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20422100|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
20422101|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422102|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422103|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20422104|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20422105|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20422106|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422107|NCT01257464|Incretins|incretins|mesh-ancestor
20422108|NCT01257464|Hormones|hormones|mesh-ancestor
20422109|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20422110|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
20422111|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422112|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422113|NCT01257490|Bupropion|bupropion|mesh-list
20422114|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20422115|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
20422116|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20422117|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20422118|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20422119|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422120|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422121|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
20422122|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422123|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422124|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20422125|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20422126|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422127|NCT01257516|Pregabalin|pregabalin|mesh-list
20422128|NCT01257516|Analgesics|analgesics|mesh-ancestor
20422129|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
20428341|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19691786|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20422130|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422131|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422132|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
20422133|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20422134|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422135|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422136|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20422137|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20422138|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20422139|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422140|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20422141|NCT01257529|Pregabalin|pregabalin|mesh-list
20422142|NCT01257529|Analgesics|analgesics|mesh-ancestor
20422143|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
20422144|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422145|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422146|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
20422147|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20422148|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422149|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422150|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20422151|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20422152|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20422153|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422154|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20422155|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20422156|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422157|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20422158|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422159|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422160|NCT01257672|Ondansetron|ondansetron|mesh-list
20422161|NCT01257672|Domperidone|domperidone|mesh-list
20422162|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
20422163|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
20422164|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422165|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422166|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20422167|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
20422168|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422169|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20422170|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
20422171|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422172|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422173|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20422174|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20422175|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422176|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20422177|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20422178|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20422179|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
20422180|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
20422181|NCT00077285|Ifosfamide|ifosfamide|mesh-list
20422182|NCT00077285|Carboplatin|carboplatin|mesh-list
20422183|NCT00077285|Doxorubicin|doxorubicin|mesh-list
20422184|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20422185|NCT00077285|Irinotecan|irinotecan|mesh-list
20422186|NCT00077285|Etoposide|etoposide|mesh-list
20422187|NCT00077285|Vincristine|vincristine|mesh-list
20422188|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
20422189|NCT00077285|Razoxane|razoxane|mesh-list
20422190|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20422191|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
20422192|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422193|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422194|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20422195|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
20422196|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422197|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422198|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20422199|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20422200|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20422201|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20422202|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422203|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20422204|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20422205|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
20422206|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
20422207|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
20422208|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20422209|NCT00077285|Protective Agents|protective agents|mesh-ancestor
20422210|NCT01257815|Ranibizumab|ranibizumab|mesh-list
20422211|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20422212|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20422213|NCT01257815|Growth Substances|growth substances|mesh-ancestor
20422214|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422215|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
20422216|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422217|NCT01257828|Riluzole|riluzole|mesh-list
20422218|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
20422219|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20422220|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20422221|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422222|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422223|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422224|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20422225|NCT01257828|Protective Agents|protective agents|mesh-ancestor
20422226|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
20422227|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
20422228|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20422229|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422230|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422231|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
20422232|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20422233|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422234|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422235|NCT01257893|Aspirin|aspirin|mesh-list
20422236|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422237|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422238|NCT01257893|Analgesics|analgesics|mesh-ancestor
20422239|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
20422240|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422241|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422242|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422243|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422244|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20422245|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20422246|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422247|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20422248|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20422249|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422250|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
20422251|NCT01257906|Tretinoin|tretinoin|mesh-list
20422252|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422253|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
20422254|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422255|NCT01257919|Azelaic acid|azelaic acid|mesh-list
20422256|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422257|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422258|NCT01257958|Vitamin D|vitamin d|mesh-list
20422259|NCT01257958|Vitamins|vitamins|mesh-ancestor
20422260|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
20422261|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422262|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20422263|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
20422264|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20422265|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20422266|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422267|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
20422268|NCT01258010|Coagulants|coagulants|mesh-ancestor
20422269|NCT01258036|Hormones|hormones|mesh-list
20422270|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20422271|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422272|NCT01258192|Paclitaxel|paclitaxel|mesh-list
20422273|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20422274|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20422275|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422276|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
20422277|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
20422278|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
20422279|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392380|NCT03695107|Nifedipine|nifedipine|mesh-list
19392381|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20422280|NCT01258296|Fentanyl|fentanyl|mesh-list
20422281|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20422282|NCT01258296|Narcotics|narcotics|mesh-ancestor
20422283|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422284|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422285|NCT01258296|Analgesics|analgesics|mesh-ancestor
20422286|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
20422287|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422288|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20422289|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20422290|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
20422291|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
20422292|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20422293|NCT01258309|Ketorolac|ketorolac|mesh-list
20422294|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20422295|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20422296|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20422297|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422298|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422299|NCT01258309|Analgesics|analgesics|mesh-ancestor
20422300|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
20422301|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422302|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422303|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422304|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422305|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20422306|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422307|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422308|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20422309|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20422310|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20422311|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
20422312|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
20422313|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422314|NCT01258322|Pioglitazone|pioglitazone|mesh-list
20422315|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20422316|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422317|NCT01258439|Ritonavir|ritonavir|mesh-list
20422318|NCT01258439|Darunavir|darunavir|mesh-list
20422319|NCT01258439|Tenofovir|tenofovir|mesh-list
20422320|NCT01258439|Emtricitabine|emtricitabine|mesh-list
20422321|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
20422322|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20422323|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20422324|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20422325|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
20422326|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422327|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422328|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20422329|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20422330|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
20422331|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422332|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20422333|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20422334|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20422335|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20422336|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20422337|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20422338|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
20422339|NCT01258491|Niacin|niacin|mesh-list
20422340|NCT01258491|Niacinamide|niacinamide|mesh-list
20422341|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
20422342|NCT01258491|Vitamins|vitamins|mesh-ancestor
20422343|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
20422344|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422345|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20422346|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
20422347|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422348|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20422349|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
20422350|NCT01258530|Oseltamivir|oseltamivir|mesh-list
20422351|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
20422352|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422353|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19403976|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
20422354|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422355|NCT01258569|Alvimopan|alvimopan|mesh-list
20422356|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20422357|NCT01258634|Leucovorin|leucovorin|mesh-list
20422358|NCT01258634|Doxorubicin|doxorubicin|mesh-list
20422359|NCT01258634|Etoposide|etoposide|mesh-list
20422360|NCT01258634|Ifosfamide|ifosfamide|mesh-list
20422361|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
20422362|NCT01258634|Razoxane|razoxane|mesh-list
20422363|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422364|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20422365|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20422366|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20422367|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422368|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422369|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20422370|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422371|NCT01258634|Antidotes|antidotes|mesh-ancestor
20422372|NCT01258634|Protective Agents|protective agents|mesh-ancestor
20422373|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
20422374|NCT01258634|Vitamins|vitamins|mesh-ancestor
20422375|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
20422376|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20422377|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
20422378|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20422379|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20422380|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20422381|NCT01258686|Silymarin|silymarin|mesh-list
20422382|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
20422383|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422384|NCT01258686|Protective Agents|protective agents|mesh-ancestor
20422385|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422386|NCT01258712|Methotrexate|methotrexate|mesh-list
20422387|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20422388|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
20422389|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20422390|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422391|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20422392|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
20422393|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422394|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422395|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422396|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422397|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20422398|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20422399|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
20422400|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422401|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20422402|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20422403|NCT01258764|Lisinopril|lisinopril|mesh-list
20422404|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20422405|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20422406|NCT01258764|Diuretics|diuretics|mesh-ancestor
20422407|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
20422408|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422409|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20422410|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422411|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422412|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
20422413|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422414|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20422415|NCT01258764|Protective Agents|protective agents|mesh-ancestor
20422416|NCT01258777|Golimumab|golimumab|mesh-list
20422417|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20422418|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20422419|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422420|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20422421|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
20422422|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422423|NCT01258868|Celecoxib|celecoxib|mesh-list
20422424|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422425|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422426|NCT01258868|Analgesics|analgesics|mesh-ancestor
20422427|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
20422428|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422429|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422430|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422431|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422432|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20422433|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20422434|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422435|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422436|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20422437|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20422438|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20422439|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422440|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422441|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20422442|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20422443|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20422444|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
20422445|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422446|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422447|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20422448|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20422449|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
20422450|NCT01258933|Ofatumumab|ofatumumab|mesh-list
20422451|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422452|NCT01258959|Anesthetics|anesthetics|mesh-list
20422453|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
20422454|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422455|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422456|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
20422457|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422458|NCT01259050|Copper|copper|mesh-list
20422459|NCT01259050|Trace Elements|trace elements|mesh-ancestor
20422460|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
20422461|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422462|NCT01259141|Azithromycin|azithromycin|mesh-list
20422463|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
20422464|NCT01259141|Cephalosporins|cephalosporins|mesh-list
20422465|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20422466|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422467|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20422468|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20422469|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422470|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422471|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422472|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
20422473|NCT01259193|Sorafenib|sorafenib|mesh-list
20422474|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422475|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20422476|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422477|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422478|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20422479|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422480|NCT01259219|Rifabutin|rifabutin|mesh-list
20422481|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20422482|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422483|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20422484|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
20422485|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20422486|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
20422487|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422488|NCT01259336|Itraconazole|itraconazole|mesh-list
20422489|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
20422490|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422491|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20422492|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20422493|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422494|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422495|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20422496|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
20422497|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20422498|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422499|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20422500|NCT01259362|Cocaine|cocaine|mesh-list
20422501|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
20422502|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
20422503|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422504|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422505|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
20422506|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392382|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20218069|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20422507|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20422508|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20422509|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20422510|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422511|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422512|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
20422513|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422514|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
20422515|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422516|NCT01259453|Vaccines|vaccines|mesh-list
20422517|NCT01259453|Immunologic Factors|immunologic factors|mesh-ancestor
20422518|NCT01259453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422519|NCT01259479|Satraplatin|satraplatin|mesh-list
20422520|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422521|NCT01259531|Silodosin|silodosin|mesh-list
20422522|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20422523|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20422524|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20422525|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
20422526|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422527|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422528|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422529|NCT01259531|Urological Agents|urological agents|mesh-ancestor
20422530|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
20422531|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20422532|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20422533|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20422534|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422535|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422536|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
20422537|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422538|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422539|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20422540|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422541|NCT01259817|Aspirin|aspirin|mesh-list
20422542|NCT01259817|Interferons|interferons|mesh-list
20422543|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
20422544|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
20422545|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20422546|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422547|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
20422548|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422549|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422550|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422551|NCT01259817|Analgesics|analgesics|mesh-ancestor
20422552|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
20422553|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422554|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422555|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422556|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422557|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20422558|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20422559|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422560|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20422561|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20422562|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422563|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
20422564|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
20422565|NCT01259830|Etoricoxib|etoricoxib|mesh-list
20218070|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218071|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20218072|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20218073|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218074|NCT00311740|Diuretics|diuretics|mesh-ancestor
20218075|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
20218076|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218077|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20218078|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422566|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422567|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422568|NCT01259830|Analgesics|analgesics|mesh-ancestor
20422569|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
20422570|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422571|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422572|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422573|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422574|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20422575|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20422576|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422577|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422578|NCT01259934|Interferons|interferons|mesh-list
20422579|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
20422580|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
20422581|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422582|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
20422583|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422584|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
20422585|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422586|NCT01259973|Haloperidol|haloperidol|mesh-list
20422587|NCT01259973|Risperidone|risperidone|mesh-list
20422588|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
20422589|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20422590|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
20422591|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422592|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422593|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422594|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20422595|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20422596|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422597|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20422598|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20422599|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
20422600|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
20422601|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
20422602|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422603|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20422604|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20428342|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20428343|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428344|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20428345|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20428346|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
20428347|NCT01291420|Vaccines|vaccines|mesh-list
20428348|NCT01291420|Immunologic Factors|immunologic factors|mesh-ancestor
20428349|NCT01291420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428350|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
20428351|NCT01291433|Tocopherols|tocopherols|mesh-list
20428352|NCT01291433|Vitamin E|vitamin e|mesh-list
20428353|NCT01291433|Tocotrienols|tocotrienols|mesh-list
20428354|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
20428355|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
20428356|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20428357|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428358|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428359|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20428360|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20428361|NCT01291433|Protective Agents|protective agents|mesh-ancestor
20428362|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428363|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
20428364|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20428365|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
20428366|NCT01291433|Vitamins|vitamins|mesh-ancestor
20428367|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
20428368|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20428369|NCT01291459|Tenofovir|tenofovir|mesh-list
20428370|NCT01291459|Emtricitabine|emtricitabine|mesh-list
20428371|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
20428372|NCT01291459|Maraviroc|maraviroc|mesh-list
20428373|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
20428374|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428375|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20428376|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20428377|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428378|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428379|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20422605|NCT01260012|Praziquantel|praziquantel|mesh-list
20422606|NCT01260012|Antioxidants|antioxidants|mesh-list
20422607|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422608|NCT01260012|Protective Agents|protective agents|mesh-ancestor
20422609|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422610|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
20422611|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20422612|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422613|NCT01260025|Endostatins|endostatins|mesh-list
20422614|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422615|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20422616|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20422617|NCT01260025|Growth Substances|growth substances|mesh-ancestor
20422618|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422619|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
20422620|NCT01260103|Temozolomide|temozolomide|mesh-list
20422621|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20216916|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20216917|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
20216918|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422622|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
20422623|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422624|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422625|NCT01260129|Silodosin|silodosin|mesh-list
20422626|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20422627|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20422628|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20422629|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
20422630|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422631|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422632|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422633|NCT01260129|Urological Agents|urological agents|mesh-ancestor
20422634|NCT01260233|Nicotine|nicotine|mesh-list
20216919|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
20422635|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20422636|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
20422637|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422638|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422639|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20422640|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20422641|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
20422642|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422643|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422644|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20422645|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20422646|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422647|NCT01260246|Incretins|incretins|mesh-ancestor
20422648|NCT01260246|Hormones|hormones|mesh-ancestor
20422649|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20422650|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20422651|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
20422652|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422653|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422654|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20422655|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
20422656|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20422657|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20422658|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422659|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422660|NCT01260285|Urological Agents|urological agents|mesh-ancestor
20422661|NCT01260376|Acipimox|acipimox|mesh-list
20216920|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216921|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216922|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20216923|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
20216924|NCT00307775|Estradiol|estradiol|mesh-list
20216925|NCT00307775|Estrogens|estrogens|mesh-ancestor
20216926|NCT00307775|Hormones|hormones|mesh-ancestor
20216927|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20216928|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216929|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
20216930|NCT00307814|Hematinics|hematinics|mesh-ancestor
20422662|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20216931|NCT00307827|Visilizumab|visilizumab|mesh-list
20422663|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
20422664|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422665|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20422666|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
20422667|NCT01260415|Panitumumab|panitumumab|mesh-list
20422668|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422669|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20422670|NCT01260506|Bevacizumab|bevacizumab|mesh-list
20422671|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20422672|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422673|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20422674|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20422675|NCT01260506|Growth Substances|growth substances|mesh-ancestor
20422676|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422677|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
20422678|NCT01260519|Heparin|heparin|mesh-list
20422679|NCT01260519|Calcium heparin|calcium heparin|mesh-list
20422680|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
20422681|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20422682|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20422683|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422684|NCT01260558|Sirolimus|sirolimus|mesh-list
20422685|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20422686|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422687|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20422688|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422689|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
20422690|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20422691|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
20422692|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422693|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20422694|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422695|NCT01260610|Tenofovir|tenofovir|mesh-list
20422696|NCT01260610|Telbivudine|telbivudine|mesh-list
20422697|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
20422698|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422699|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20422700|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20422701|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422702|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422703|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20422704|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20422705|NCT01260623|Prednisone|prednisone|mesh-list
20422706|NCT01260623|Prednisolone|prednisolone|mesh-list
20422707|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422708|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
20422709|NCT01260623|Hormones|hormones|mesh-ancestor
20422710|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20422711|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422712|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20422713|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422714|NCT01260675|Buprenorphine|buprenorphine|mesh-list
20422715|NCT01260675|Naloxone|naloxone|mesh-list
20422716|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20422717|NCT01260675|Narcotics|narcotics|mesh-ancestor
20422718|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422719|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422720|NCT01260675|Analgesics|analgesics|mesh-ancestor
20422721|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
20422722|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422723|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20422724|NCT01260714|Etoposide|etoposide|mesh-list
20422725|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
20422726|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
20422727|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
20422728|NCT01260714|Azacitidine|azacitidine|mesh-list
20422729|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20422730|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422731|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20422732|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20422733|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422734|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422735|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20422736|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
20422737|NCT01260714|Analgesics|analgesics|mesh-ancestor
20422738|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
20422739|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422740|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422741|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
20422742|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422743|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
20422744|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
20422745|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
20422746|NCT01260727|Vaccines|vaccines|mesh-list
20422747|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
20422748|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422749|NCT01260753|Fluticasone|fluticasone|mesh-list
20422750|NCT01260753|Xhance|xhance|mesh-list
20422751|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422752|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20422753|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
20422754|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422755|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422756|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20422757|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
20422758|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422759|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20422760|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
20422761|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20422762|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20422763|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422764|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
20422765|NCT01260818|Coagulants|coagulants|mesh-ancestor
20422766|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20422767|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
20422768|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422769|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
20422770|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20422771|NCT01260857|Diuretics|diuretics|mesh-ancestor
20422772|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
20422773|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422774|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20422775|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422776|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422777|NCT01260974|Caspofungin|caspofungin|mesh-list
20422778|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
20422779|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422780|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422781|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422782|NCT01261065|Carvedilol|carvedilol|mesh-list
20422783|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20422784|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20422785|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
20422786|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422787|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422788|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422789|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20422790|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
20422791|NCT01261065|Protective Agents|protective agents|mesh-ancestor
20422792|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20422793|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422794|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20216932|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
20216933|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216934|NCT00307944|Pantoprazole|pantoprazole|mesh-list
20216935|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20216936|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20216937|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20216938|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216939|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216940|NCT00307996|Ubiquinone|ubiquinone|mesh-list
20216941|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
20216942|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
20216943|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216944|NCT00307996|Vitamins|vitamins|mesh-ancestor
20216945|NCT00308048|Interferons|interferons|mesh-list
20216946|NCT00308048|Ribavirin|ribavirin|mesh-list
20216947|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
20216948|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
20216949|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20218079|NCT00311753|Heparin|heparin|mesh-list
20422795|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
20422796|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20422797|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20422798|NCT01261078|Epinephrine|epinephrine|mesh-list
20422799|NCT01261078|Racepinephrine|racepinephrine|mesh-list
20422800|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
20422801|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20422802|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20422803|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
20422804|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422805|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422806|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422807|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20422808|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20422809|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
20422810|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422811|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20422812|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
20422813|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
20422814|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
20422815|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20422816|NCT01261117|Ibuprofen|ibuprofen|mesh-list
20422817|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20422818|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20422819|NCT01261117|Analgesics|analgesics|mesh-ancestor
20422820|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
20422821|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422822|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422823|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422824|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20422825|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20422826|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422827|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422828|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20422829|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20422830|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
20422831|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422832|NCT01261130|Antacids|antacids|mesh-ancestor
20422833|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422834|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20422835|NCT01261156|Diltiazem|diltiazem|mesh-list
20422836|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20422837|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20422838|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422839|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422840|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20422841|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422842|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
20422843|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
20422844|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20422845|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422846|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20422847|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
20422848|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20422849|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422850|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422851|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422852|NCT01261234|Cilostazol|cilostazol|mesh-list
20422853|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20422854|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
20422855|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422856|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422857|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20422858|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
20422859|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20422860|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20422861|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422862|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20422863|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
20422864|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20422865|NCT01261234|Protective Agents|protective agents|mesh-ancestor
19403977|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20422866|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20422867|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20422868|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422869|NCT01261286|Verapamil|verapamil|mesh-list
20422870|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20422871|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20422872|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422873|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422874|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20422875|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422876|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
20422877|NCT01261299|Carboplatin|carboplatin|mesh-list
20422878|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422879|NCT01261416|Levetiracetam|levetiracetam|mesh-list
20422880|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
20422881|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
20422882|NCT01261481|Tolvaptan|tolvaptan|mesh-list
20422883|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20422884|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422885|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
20422886|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422887|NCT01261546|Dexamethasone|dexamethasone|mesh-list
20422888|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20422889|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
20422890|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
20422891|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422892|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422893|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20422894|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
20422895|NCT01261546|Hormones|hormones|mesh-ancestor
20422896|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20422897|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20422898|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422899|NCT01261637|Ropivacaine|ropivacaine|mesh-list
20422900|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
20422901|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
20422902|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422903|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422904|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
20422905|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422906|NCT01261689|Sufentanil|sufentanil|mesh-list
20422907|NCT01261689|Dsuvia|dsuvia|mesh-list
20422908|NCT01261689|Ropivacaine|ropivacaine|mesh-list
20422909|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
20422910|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
20422911|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422912|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422913|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
20422914|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422915|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20422916|NCT01261689|Narcotics|narcotics|mesh-ancestor
20422917|NCT01261689|Analgesics|analgesics|mesh-ancestor
20422918|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20422919|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20422920|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
20422921|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
20422922|NCT01261702|Analgesics|analgesics|mesh-ancestor
20422923|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
20422924|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422925|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422926|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
20422927|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422928|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20422929|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
20216950|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216951|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
20216952|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20216953|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
20216954|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216955|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
20216956|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216957|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20216958|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
20216959|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
20422930|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20422931|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20422932|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422933|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20422934|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
20422935|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20422936|NCT01261741|Memantine|memantine|mesh-list
20422937|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20422938|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20422939|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
20422940|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422941|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422942|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422943|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20422944|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20428380|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20428381|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20428382|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20428383|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20428384|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20428385|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20428386|NCT01291472|Ketorolac|ketorolac|mesh-list
20428387|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20428388|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20428389|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20428390|NCT01291472|Analgesics|analgesics|mesh-ancestor
20428391|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
20428392|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428393|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428394|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20428395|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20428396|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20428397|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428398|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428399|NCT01291511|Iloperidone|iloperidone|mesh-list
20428400|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20428401|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20428402|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428403|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428404|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20428405|NCT01291524|Pregabalin|pregabalin|mesh-list
20428406|NCT01291524|Analgesics|analgesics|mesh-ancestor
20428407|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
20428408|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428409|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428410|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
20428411|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20428412|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20428413|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428414|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20428415|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20428416|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20428417|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428418|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20428419|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20428420|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20428421|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
20428422|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428423|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20428424|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20428425|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
20428426|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
20428427|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428428|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428429|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
20428430|NCT01291563|Bedaquiline|bedaquiline|mesh-list
20428431|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
20428432|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20428433|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428434|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428435|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20428436|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20428437|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428438|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422945|NCT01261832|Cilostazol|cilostazol|mesh-list
20422946|NCT01261832|Clopidogrel|clopidogrel|mesh-list
20422947|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20422948|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20422949|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20422950|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20422951|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
20422952|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20422953|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422954|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422955|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20422956|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
20422957|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422958|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20422959|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
20422960|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20422961|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20422962|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
20422963|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20422964|NCT01261832|Protective Agents|protective agents|mesh-ancestor
20422965|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20422966|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20422967|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422968|NCT01261897|Ropivacaine|ropivacaine|mesh-list
20422969|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
20422970|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
20422971|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20422972|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422973|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
20422974|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20422975|NCT01261923|Alitretinoin|alitretinoin|mesh-list
20422976|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422977|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
20422978|NCT01262183|Panitumumab|panitumumab|mesh-list
20422979|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20422980|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422981|NCT01262274|Anastrozole|anastrozole|mesh-list
20422982|NCT01262274|Tegafur|tegafur|mesh-list
20422983|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20422984|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20422985|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20422986|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20422987|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20422988|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20422989|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20422990|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
20422991|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20422992|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20422993|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20422994|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
20422995|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
20422996|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20422997|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20422998|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
20422999|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423000|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423001|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423002|NCT01262391|Urological Agents|urological agents|mesh-ancestor
20423003|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
20423004|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20423005|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
20423006|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423007|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
20423008|NCT01262417|Protective Agents|protective agents|mesh-ancestor
20423009|NCT01262469|Capecitabine|capecitabine|mesh-list
20423010|NCT01262469|Lapatinib|lapatinib|mesh-list
20423011|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20423012|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
20423013|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423014|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423015|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20423016|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423017|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
20423018|NCT01262482|Sorafenib|sorafenib|mesh-list
20423019|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423020|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20423021|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423022|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423023|NCT01262586|Glimepiride|glimepiride|mesh-list
20423024|NCT01262586|Vildagliptin|vildagliptin|mesh-list
20423025|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20423026|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20423027|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423028|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423029|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
20423030|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20423031|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
20423032|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423033|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423034|NCT01262612|Cediranib|cediranib|mesh-list
20423035|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423036|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20423037|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423038|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423039|NCT01262729|Xenon|xenon|mesh-list
20423040|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20423041|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
20423042|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
20423043|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20423044|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423045|NCT01262742|Carbetocin|carbetocin|mesh-list
20423046|NCT01262742|Oxytocin|oxytocin|mesh-list
20423047|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
20423048|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20423049|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423050|NCT01262859|Bevacizumab|bevacizumab|mesh-list
20423051|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423052|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423053|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20423054|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20423055|NCT01262859|Growth Substances|growth substances|mesh-ancestor
20423056|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423057|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
20423058|NCT01262924|Vaccines|vaccines|mesh-list
20423059|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
20423060|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423061|NCT01262963|Dabrafenib|dabrafenib|mesh-list
20423062|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423063|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20423064|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423065|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423066|NCT01263002|Adefovir|adefovir|mesh-list
20423067|NCT01263002|Clevudine|clevudine|mesh-list
20423068|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
20423069|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423070|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20423071|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20423072|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423073|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423074|NCT01263080|Folic Acid|folic acid|mesh-list
20423075|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
20423076|NCT01263080|Mirtazapine|mirtazapine|mesh-list
20423077|NCT01263080|Vitamins|vitamins|mesh-ancestor
20423078|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
20423079|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423080|NCT01263080|Hematinics|hematinics|mesh-ancestor
20423081|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
20423082|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20423083|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20423084|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
20423085|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
20423086|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423087|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423088|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20423089|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20423090|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20423091|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20423092|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20423093|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20423094|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
20423095|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20423096|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20423097|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
20423098|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20423099|NCT01263145|Paclitaxel|paclitaxel|mesh-list
20423100|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20423101|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423102|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
20423103|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
20423104|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
20423105|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423106|NCT01263158|Oxytocin|oxytocin|mesh-list
20423107|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
20423108|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20423109|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423110|NCT01263171|Leucovorin|leucovorin|mesh-list
20423111|NCT01263171|Fluorouracil|fluorouracil|mesh-list
20423112|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
20423113|NCT01263171|Calcium|calcium|mesh-list
20423114|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
20423115|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20423116|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423117|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
20423118|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423119|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20423120|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423121|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423122|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
20423123|NCT01263171|Antidotes|antidotes|mesh-ancestor
20423124|NCT01263171|Protective Agents|protective agents|mesh-ancestor
20423125|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
20423126|NCT01263171|Vitamins|vitamins|mesh-ancestor
20423127|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
20423128|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20423129|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
20423130|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423131|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
20423132|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20423133|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423134|NCT01263288|Vitamins|vitamins|mesh-ancestor
20423135|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
20423136|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20423137|NCT01263353|Everolimus|everolimus|mesh-list
20423138|NCT01263353|Pasireotide|pasireotide|mesh-list
20423139|NCT01263353|Somatostatin|somatostatin|mesh-list
20423140|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423141|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423142|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
20423143|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423144|NCT01263353|Hormones|hormones|mesh-ancestor
20423145|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423146|NCT01263366|Norepinephrine|norepinephrine|mesh-list
20423147|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20423148|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20423149|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
20423150|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423151|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423152|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423153|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
20423154|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
20423155|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423156|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20423157|NCT01263418|Ofatumumab|ofatumumab|mesh-list
20423158|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423159|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20423160|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20423161|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423162|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20423163|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20423164|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19392383|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423165|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423166|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
20423167|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423168|NCT01263574|Ethanol|ethanol|mesh-list
20423169|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20423170|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423171|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20423172|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423173|NCT01263652|Dipyrone|dipyrone|mesh-list
20423174|NCT01263652|Diclofenac|diclofenac|mesh-list
20423175|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20423176|NCT01263652|Tramadol|tramadol|mesh-list
20423177|NCT01263652|Orphenadrine|orphenadrine|mesh-list
20423178|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20423179|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20423180|NCT01263652|Analgesics|analgesics|mesh-ancestor
20423181|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
20423182|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423183|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423184|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423185|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423186|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20423187|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423188|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423189|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20423190|NCT01263652|Narcotics|narcotics|mesh-ancestor
20423191|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20423192|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
20423193|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20423194|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20423195|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20423196|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20423197|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
20423198|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
19691787|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20423199|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20423200|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20423201|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
20423202|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423203|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
20423204|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20428439|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428440|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20428441|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
20428442|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20428443|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392384|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19392385|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428444|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20428445|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20428446|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20428447|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
20428448|NCT01291602|Avibactam|avibactam|mesh-list
20428449|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20428450|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428451|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428452|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428453|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428454|NCT01291615|Gemcitabine|gemcitabine|mesh-list
20428455|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20428456|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
20428457|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428458|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428459|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
20428460|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428461|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428462|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20428463|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
20428464|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428465|NCT01291628|Copper|copper|mesh-list
20428466|NCT01291628|Trace Elements|trace elements|mesh-ancestor
20428467|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
20428468|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428469|NCT01291641|Cilostazol|cilostazol|mesh-list
20428470|NCT01291641|Probucol|probucol|mesh-list
20428471|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20428472|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20428473|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
19392386|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
20423205|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
20423206|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20423207|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423208|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20423209|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20423210|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423211|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423212|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423213|NCT01263834|Bevacizumab|bevacizumab|mesh-list
20423214|NCT01263834|Mitomycins|mitomycins|mesh-list
20423215|NCT01263834|Mitomycin|mitomycin|mesh-list
20423216|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423217|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423218|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20423219|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20423220|NCT01263834|Growth Substances|growth substances|mesh-ancestor
20423221|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423222|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
20423223|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20423224|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
20423225|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423226|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20423227|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423228|NCT01263860|Ribavirin|ribavirin|mesh-list
20423229|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20423230|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
20423231|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
20423232|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423233|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
20423234|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423235|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
20423236|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423237|NCT01263951|Everolimus|everolimus|mesh-list
20423238|NCT01263951|Sorafenib|sorafenib|mesh-list
20423239|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423240|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423241|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
20423242|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423243|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20423244|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423245|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423246|NCT01264094|Clevudine|clevudine|mesh-list
20423247|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
20423248|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423249|NCT01264133|Adefovir|adefovir|mesh-list
20423250|NCT01264133|Clevudine|clevudine|mesh-list
20423251|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
20423252|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423253|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20423254|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20423255|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423256|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423257|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
20423258|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423259|NCT01264237|Etoricoxib|etoricoxib|mesh-list
20423260|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20423261|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20423262|NCT01264237|Analgesics|analgesics|mesh-ancestor
20423263|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
20423264|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423265|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423266|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423267|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423268|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20423269|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20423270|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423271|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423272|NCT01264289|Finasteride|finasteride|mesh-list
20423273|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20423274|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20423275|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423276|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423277|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
20423278|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423279|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423280|NCT01264289|Urological Agents|urological agents|mesh-ancestor
20423281|NCT01264302|Finasteride|finasteride|mesh-list
20423282|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20423283|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20423284|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423285|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423286|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
20423287|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423288|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423289|NCT01264302|Urological Agents|urological agents|mesh-ancestor
20423290|NCT01264315|Lenalidomide|lenalidomide|mesh-list
20423291|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
20423292|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423293|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20423294|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20423295|NCT01264315|Growth Substances|growth substances|mesh-ancestor
20423296|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
20423297|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423298|NCT01264328|Paclitaxel|paclitaxel|mesh-list
20423299|NCT01264328|Panitumumab|panitumumab|mesh-list
20423300|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20423301|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423302|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
20423303|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
20423304|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
20423305|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423306|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423307|NCT01264341|Sirolimus|sirolimus|mesh-list
20423308|NCT01264341|Bevacizumab|bevacizumab|mesh-list
20423309|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423310|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423311|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20423312|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20423313|NCT01264341|Growth Substances|growth substances|mesh-ancestor
20423314|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423315|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
20423316|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19691788|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19691789|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
19691790|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19691791|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691792|NCT05001048|Protective Agents|protective agents|mesh-ancestor
19691793|NCT05000892|Paclitaxel|paclitaxel|mesh-list
19691794|NCT05000892|Carboplatin|carboplatin|mesh-list
19691795|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19691796|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691797|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
19691798|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
19691799|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
19691800|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691801|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
20423317|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423318|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20423319|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
20423320|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423321|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
20423322|NCT01264354|Adefovir|adefovir|mesh-list
20423323|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20423324|NCT01264354|Clevudine|clevudine|mesh-list
20216960|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20216961|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
20216962|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
20216963|NCT00308165|Topotecan|topotecan|mesh-list
20216964|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20423325|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
20423326|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423327|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20423328|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20216965|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20216966|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20216967|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691802|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216968|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218080|NCT00311753|Certoparin|certoparin|mesh-list
20423329|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392387|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
19392388|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19392389|NCT03695029|Tenofovir|tenofovir|mesh-list
19392390|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
20423330|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423331|NCT01264367|Interferons|interferons|mesh-list
20423332|NCT01264367|Clevudine|clevudine|mesh-list
20423333|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423334|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
20423335|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423336|NCT01264432|Veliparib|veliparib|mesh-list
20423337|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20423338|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423339|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423340|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423341|NCT01264445|Vaccines|vaccines|mesh-list
20423342|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
20423343|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423344|NCT01264484|Imidacloprid|imidacloprid|mesh-list
20423345|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
20423346|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423347|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423348|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423349|NCT01264497|Tesamorelin|tesamorelin|mesh-list
20423350|NCT01264497|Growth Substances|growth substances|mesh-ancestor
20423351|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423352|NCT01264536|Lactoferrin|lactoferrin|mesh-list
20423353|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423354|NCT01264575|Epinephrine|epinephrine|mesh-list
20423355|NCT01264575|Racepinephrine|racepinephrine|mesh-list
20423356|NCT01264575|Bupivacaine|bupivacaine|mesh-list
20423357|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
20423358|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
20423359|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
20423360|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20423361|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423362|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
20423363|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423364|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20423365|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20423366|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
20423367|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423368|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423369|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20423370|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20423371|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
20423372|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20423373|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
20423374|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
20423375|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
20423376|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20423377|NCT01264588|Calcium|calcium|mesh-list
20423378|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20423379|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423380|NCT01264640|Aspirin|aspirin|mesh-list
20423381|NCT01264640|Clopidogrel|clopidogrel|mesh-list
20423382|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20423383|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20423384|NCT01264640|Analgesics|analgesics|mesh-ancestor
20423385|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
20423386|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423387|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423388|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423389|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423390|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20423391|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20423392|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423393|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20423394|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20423395|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423396|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
20423397|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19392391|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423398|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20423399|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20423400|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
20423401|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423402|NCT01264653|Epinephrine|epinephrine|mesh-list
20423403|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20423404|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20423405|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
20423406|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423407|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423408|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423409|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20423410|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20423411|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
20423412|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423413|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20423414|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
20423415|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
20423416|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
20423417|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20423418|NCT01264692|Amlodipine|amlodipine|mesh-list
20423419|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20423420|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20423421|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20423422|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423423|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20423424|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423425|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
20423426|NCT01264731|Imiquimod|imiquimod|mesh-list
20423427|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20423428|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
20423429|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423430|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423431|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
20423432|NCT01264783|RNS60|rns60|mesh-list
20423433|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20423434|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20423435|NCT01264783|Analgesics|analgesics|mesh-ancestor
20423436|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
20423437|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423438|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423439|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423440|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691803|NCT05000086|Diphosphonates|diphosphonates|mesh-list
19691804|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
19691805|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19691806|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691807|NCT05000281|Ibuprofen|ibuprofen|mesh-list
19691808|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19691809|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19691810|NCT05000281|Analgesics|analgesics|mesh-ancestor
19691811|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
19691812|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19691813|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691814|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691815|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19691816|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19691817|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19691818|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691819|NCT05000047|Silicon|silicon|mesh-list
19691820|NCT05000047|Trace Elements|trace elements|mesh-ancestor
19691821|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
19691822|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691823|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19691824|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19691825|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
20218081|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
20218082|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20218083|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20218084|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218085|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
20218086|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218087|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218088|NCT00311857|Cetuximab|cetuximab|mesh-list
20218089|NCT00311857|Temozolomide|temozolomide|mesh-list
20218090|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20218091|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423441|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20423442|NCT01264822|Rabeprazole|rabeprazole|mesh-list
20423443|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20423444|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20423445|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20423446|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423447|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423448|NCT01264874|Vitamin D|vitamin d|mesh-list
20423449|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
20423450|NCT01264874|Vitamins|vitamins|mesh-ancestor
20423451|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
20423452|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423453|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20423454|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20423455|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20423456|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
20423457|NCT01265004|Coagulants|coagulants|mesh-ancestor
20423458|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
20423459|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20423460|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20423461|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20423462|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20423463|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20423464|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20423465|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
20423466|NCT01265017|Estradiol|estradiol|mesh-list
20423467|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20423468|NCT01265017|Hormones|hormones|mesh-ancestor
20423469|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423470|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423471|NCT01265017|Estrogens|estrogens|mesh-ancestor
20423472|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20423473|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
20423474|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20423475|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20423476|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423477|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20423478|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20423479|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19392392|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19392393|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19392394|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19392395|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392396|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19392397|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19392398|NCT03694977|Spartalizumab|spartalizumab|mesh-list
19392399|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19392400|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392401|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19392402|NCT03694886|Caffeine|caffeine|mesh-list
19392403|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19392404|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392405|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19848127|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20423480|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20423481|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20423482|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423483|NCT01265030|Sirolimus|sirolimus|mesh-list
20423484|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20423485|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423486|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20423487|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423488|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
20423489|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423490|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
20423491|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423492|NCT01265108|Iron|iron|mesh-list
20423493|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20423494|NCT01265108|Trace Elements|trace elements|mesh-ancestor
20423495|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
20423496|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423497|NCT01265108|Hematinics|hematinics|mesh-ancestor
20423498|NCT01265147|Nedaplatin|nedaplatin|mesh-list
20423499|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423500|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
20423501|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
20423502|NCT01265173|Cefotaxime|cefotaxime|mesh-list
20423503|NCT01265173|Cefoxitin|cefoxitin|mesh-list
20423504|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20423505|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423506|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20423507|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20423508|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423509|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423510|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423511|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20423512|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20423513|NCT01265199|Cytarabine|cytarabine|mesh-list
20423514|NCT01265199|Daunorubicin|daunorubicin|mesh-list
20423515|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20423516|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
20423517|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423518|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423519|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
20423520|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423521|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423522|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
20423523|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423524|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20423525|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20423526|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20423527|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423528|NCT01265342|Beclomethasone|beclomethasone|mesh-list
20423529|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423530|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
20423531|NCT01265342|Hormones|hormones|mesh-ancestor
19848128|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19848129|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19848130|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848131|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
19848132|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848133|NCT00691028|Infliximab|infliximab|mesh-list
19848134|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848135|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848136|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848137|NCT00691054|Paclitaxel|paclitaxel|mesh-list
19848138|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19848139|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19848140|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848141|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
19848142|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
19848143|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
19848144|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848145|NCT00691093|Fesoterodine|fesoterodine|mesh-list
19848146|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19848147|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20423532|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423533|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423534|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20423535|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
20423536|NCT01265433|Molgramostim|molgramostim|mesh-list
20423537|NCT01265433|Sargramostim|sargramostim|mesh-list
20423538|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
20423539|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423540|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428474|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428475|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428476|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20428477|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
20428478|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20428479|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20428480|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428481|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20428482|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
20428483|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20428484|NCT01291641|Protective Agents|protective agents|mesh-ancestor
20428485|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20428486|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20428487|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428488|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20428489|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20423541|NCT01265576|Etodolac|etodolac|mesh-list
20423542|NCT01265576|Sorafenib|sorafenib|mesh-list
20423543|NCT01265576|Propranolol|propranolol|mesh-list
20423544|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423545|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20423546|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423547|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423548|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20423549|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20423550|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
20423551|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423552|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423553|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20423554|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20423555|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
20423556|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20423557|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20423558|NCT01265576|Analgesics|analgesics|mesh-ancestor
20423559|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
20423560|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423561|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423562|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423563|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20423564|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20423565|NCT01265589|Vitamin A|vitamin a|mesh-list
20423566|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20423567|NCT01265589|Vitamins|vitamins|mesh-ancestor
20423568|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
20423569|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423570|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
20423571|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
20423572|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20423573|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423574|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20423575|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20423576|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423577|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423578|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423579|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
20423580|NCT01265680|Hematinics|hematinics|mesh-ancestor
20423581|NCT01265810|Calcium|calcium|mesh-list
20423582|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20423583|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423584|NCT01265849|Indomethacin|indomethacin|mesh-list
20423585|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
20423586|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423587|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
20423588|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423589|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423590|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20423591|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
20423592|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423593|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423594|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20423595|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20423596|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20423597|NCT01265849|Analgesics|analgesics|mesh-ancestor
20423598|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
20423599|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423600|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423601|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
20423602|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
20423603|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20423604|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20423605|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423606|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
20216969|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20216970|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216971|NCT00308191|Bromides|bromides|mesh-list
20216972|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
20216973|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
20216974|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20216975|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
20216976|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20216977|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216978|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20423607|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20423608|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
20423609|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423610|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423611|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20423612|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
20423613|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20423614|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
20423615|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423616|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423617|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20423618|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
20423619|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
20423620|NCT01265888|Protective Agents|protective agents|mesh-ancestor
20423621|NCT01265927|Trastuzumab|trastuzumab|mesh-list
20423622|NCT01265927|Imetelstat|imetelstat|mesh-list
20216979|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
20216980|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20216981|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20216982|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20216983|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
20216984|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20216985|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216986|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
20216987|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20216988|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
20216989|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
20216990|NCT00308269|Folic Acid|folic acid|mesh-list
20216991|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
20216992|NCT00308269|Hematinics|hematinics|mesh-ancestor
20216993|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
20423623|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423624|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423625|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423626|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423627|NCT01265940|Vinblastine|vinblastine|mesh-list
20423628|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20423629|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423630|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
20423631|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
20423632|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
20423633|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423634|NCT01266005|Entecavir|entecavir|mesh-list
20423635|NCT01266005|Clevudine|clevudine|mesh-list
20423636|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
20423637|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423638|NCT01266031|Bevacizumab|bevacizumab|mesh-list
20423639|NCT01266031|Vorinostat|vorinostat|mesh-list
20423640|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423641|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423642|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20423643|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20423644|NCT01266031|Growth Substances|growth substances|mesh-ancestor
20423645|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423646|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
20423647|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20423648|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423649|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423650|NCT01266057|Sirolimus|sirolimus|mesh-list
20423651|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
20423652|NCT01266057|Vorinostat|vorinostat|mesh-list
20423653|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20423654|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423655|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20423656|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423657|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
20423658|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423659|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
20423660|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423661|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
20423662|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20423663|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20423664|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423665|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20216994|NCT00308269|Vitamins|vitamins|mesh-ancestor
20423666|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423667|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20423668|NCT01266174|Eltoprazine|eltoprazine|mesh-list
20423669|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20423670|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
20423671|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423672|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423673|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423674|NCT01266187|Leucovorin|leucovorin|mesh-list
20423675|NCT01266187|Cetuximab|cetuximab|mesh-list
20216995|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
20216996|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20216997|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20216998|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
20216999|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
20217000|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
20217001|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217002|NCT00308321|Prednisolone|prednisolone|mesh-list
20217003|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20423676|NCT01266187|Fluorouracil|fluorouracil|mesh-list
20423677|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
20423678|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423679|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423680|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
20423681|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423682|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20423683|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423684|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
20423685|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423686|NCT01266187|Antidotes|antidotes|mesh-ancestor
20423687|NCT01266187|Protective Agents|protective agents|mesh-ancestor
20423688|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
20423689|NCT01266187|Vitamins|vitamins|mesh-ancestor
20423690|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
20423691|NCT01266213|Fulvestrant|fulvestrant|mesh-list
20423692|NCT01266213|Anastrozole|anastrozole|mesh-list
20423693|NCT01266213|Goserelin|goserelin|mesh-list
20423694|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20423695|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423696|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20423697|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20423698|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
20423699|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423700|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423701|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20423702|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20423703|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423704|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423705|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
20423706|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20423707|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20423708|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423709|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20423710|NCT01266252|Analgesics|analgesics|mesh-ancestor
20423711|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
20423712|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423713|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20423714|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20423715|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20423716|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
20423717|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423718|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423719|NCT01266434|Simvastatin|simvastatin|mesh-list
20423720|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20423721|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20423722|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
20423723|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423724|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20423725|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20423726|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423727|NCT01266486|Metformin|metformin|mesh-list
20423728|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20423729|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423730|NCT01266499|Colistin|colistin|mesh-list
20423731|NCT01266499|Polymyxins|polymyxins|mesh-list
20423732|NCT01266499|Gentamicins|gentamicins|mesh-list
20423733|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20423734|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423735|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20423736|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423737|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423738|NCT01266512|Docetaxel|docetaxel|mesh-list
20423739|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423740|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
20423741|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
20423742|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
20423743|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423744|NCT01266655|Baclofen|baclofen|mesh-list
20423745|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20423746|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423747|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20423748|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423749|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20423750|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
20423751|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
20423752|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423753|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423754|NCT01266681|Amiodarone|amiodarone|mesh-list
20423755|NCT01266681|Dronedarone|dronedarone|mesh-list
20423756|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20423757|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
20423758|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20423759|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20423760|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423761|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20423762|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20423763|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20423764|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423765|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20423766|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20423767|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20423768|NCT01266694|Colchicine|colchicine|mesh-list
20423769|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
20423770|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423771|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
20423772|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
20423773|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
20423774|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423775|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423776|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
20423777|NCT01266707|Vaccines|vaccines|mesh-list
20423778|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
20423779|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423780|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20423781|NCT01266707|Growth Substances|growth substances|mesh-ancestor
20423782|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
20423783|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423784|NCT01266720|Gemcitabine|gemcitabine|mesh-list
20423785|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
20423786|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423787|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20423788|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
20423789|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423790|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423791|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
20423792|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423793|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423794|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19691826|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19691827|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19691828|NCT04999878|Gemcitabine|gemcitabine|mesh-list
19691829|NCT04999878|Dexamethasone|dexamethasone|mesh-list
19691830|NCT04999878|Etoposide|etoposide|mesh-list
19691831|NCT04999878|Cisplatin|cisplatin|mesh-list
19691832|NCT04999878|Pegaspargase|pegaspargase|mesh-list
20423795|NCT01266759|NuvaRing|nuvaring|mesh-list
20423796|NCT01266759|Norethindrone|norethindrone|mesh-list
20423797|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
20423798|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20423799|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
19691833|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19691834|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
20423800|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20423801|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423802|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20423803|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20423804|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20423805|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20423806|NCT01266772|Budesonide|budesonide|mesh-list
20423807|NCT01266772|Montelukast|montelukast|mesh-list
20423808|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423809|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20423810|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
20423811|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423812|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423813|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20423814|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
20423815|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
20423816|NCT01266772|Hormones|hormones|mesh-ancestor
20423817|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423818|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20423819|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
20423820|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20423821|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20423822|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423823|NCT01266785|Infliximab|infliximab|mesh-list
20423824|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
20423825|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20423826|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20423827|NCT01266811|Dexamethasone|dexamethasone|mesh-list
20423828|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
20423829|NCT01266811|Bortezomib|bortezomib|mesh-list
20423830|NCT01266811|Siltuximab|siltuximab|mesh-list
20423831|NCT01266811|BB 1101|bb 1101|mesh-list
20423832|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423833|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
20423834|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
20423835|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423836|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423837|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20423838|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
20423839|NCT01266811|Hormones|hormones|mesh-ancestor
20423840|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423841|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20423842|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423843|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
20423844|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423845|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423846|NCT01266837|Everolimus|everolimus|mesh-list
20423847|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423848|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423849|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
20423850|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423851|NCT01266928|Ascorbic Acid|ascorbic acid|mesh-list
20423852|NCT01266928|Vitamins|vitamins|mesh-ancestor
20423853|NCT01266928|Micronutrients|micronutrients|mesh-ancestor
20423854|NCT01266928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423855|NCT01266928|Antioxidants|antioxidants|mesh-ancestor
20423856|NCT01266928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423857|NCT01266928|Protective Agents|protective agents|mesh-ancestor
20423858|NCT01267058|Vaccines|vaccines|mesh-list
20423859|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
20423860|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423861|NCT01267084|Ketoconazole|ketoconazole|mesh-list
20423862|NCT01267084|Dexamethasone|dexamethasone|mesh-list
20423863|NCT01267084|Trabectedin|trabectedin|mesh-list
20423864|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20423865|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
20423866|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
20423867|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20423868|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423869|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20423870|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
20423871|NCT01267084|Hormones|hormones|mesh-ancestor
20423872|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423873|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19392406|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423874|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423875|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
20423876|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423877|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20423878|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20423879|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423880|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423881|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20423882|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
20423883|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20423884|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20423885|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
20423886|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
20423887|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20423888|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
20423889|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423890|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
20423891|NCT01267214|Protective Agents|protective agents|mesh-ancestor
20423892|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
20423893|NCT01267305|PENTA|penta|mesh-list
20423894|NCT01267305|Nadroparin|nadroparin|mesh-list
20217004|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
20217005|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20217006|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
20217007|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20217008|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
20423895|NCT01267305|Fondaparinux|fondaparinux|mesh-list
20423896|NCT01267305|Calcium|calcium|mesh-list
20423897|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20423898|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423899|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20423900|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20423901|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
20423902|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20423903|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
20423904|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423905|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423906|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
20423907|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20423908|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20423909|NCT01267344|Gemcitabine|gemcitabine|mesh-list
20423910|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
20423911|NCT01267344|Cetuximab|cetuximab|mesh-list
20423912|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20423913|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
20423914|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423915|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423916|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
20423917|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20423918|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423919|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423920|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
20423921|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423922|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20423923|NCT01267383|Sertraline|sertraline|mesh-list
20423924|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
20423925|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20423926|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20423927|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20423928|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20423929|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423930|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20423931|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
20423932|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423933|NCT01267396|Sertraline|sertraline|mesh-list
20423934|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
20423935|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20423936|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20423937|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20423938|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20423939|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423940|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217009|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20217010|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
20217011|NCT00308321|Hormones|hormones|mesh-ancestor
20423941|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
20423942|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423943|NCT01267448|Metformin|metformin|mesh-list
20423944|NCT01267448|Saxagliptin|saxagliptin|mesh-list
20423945|NCT01267448|Glipizide|glipizide|mesh-list
20423946|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20423947|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423948|NCT01267448|Incretins|incretins|mesh-ancestor
20423949|NCT01267448|Hormones|hormones|mesh-ancestor
20423950|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423951|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20423952|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
20423953|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423954|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423955|NCT01267487|Heparin|heparin|mesh-list
20423956|NCT01267487|Calcium heparin|calcium heparin|mesh-list
20423957|NCT01267487|Protamines|protamines|mesh-list
20423958|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
20423959|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20423960|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20423961|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423962|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
20423963|NCT01267487|Coagulants|coagulants|mesh-ancestor
20423964|NCT01267578|Vaccines|vaccines|mesh-list
20423965|NCT01267578|Immunologic Factors|immunologic factors|mesh-ancestor
20423966|NCT01267578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423967|NCT01267604|Inositol|inositol|mesh-list
20423968|NCT01267604|Melatonin|melatonin|mesh-list
20423969|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
20423970|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423971|NCT01267604|Protective Agents|protective agents|mesh-ancestor
20423972|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423973|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20423974|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
20423975|NCT01267604|Vitamins|vitamins|mesh-ancestor
20423976|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
20423977|NCT01267643|Alefacept|alefacept|mesh-list
20423978|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
20423979|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
20423980|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423981|NCT01267669|Somatostatin|somatostatin|mesh-list
20423982|NCT01267669|Hormones|hormones|mesh-ancestor
20423983|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20423984|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423985|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
20423986|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423987|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20423988|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20423989|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20423990|NCT01267734|Everolimus|everolimus|mesh-list
20423991|NCT01267734|Clopidogrel|clopidogrel|mesh-list
20423992|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20423993|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20423994|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
20423995|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20423996|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20423997|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20423998|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20423999|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20424000|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
19691835|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
20424001|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424002|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424003|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
20424004|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20424005|NCT01267903|Vaccines|vaccines|mesh-list
20424006|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
20424007|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424008|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20424009|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20424010|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424011|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20424012|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424013|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424014|NCT01268033|Rituximab|rituximab|mesh-list
20424015|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20424016|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424017|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
20424018|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424019|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424020|NCT01268163|Docetaxel|docetaxel|mesh-list
20424021|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424022|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
20424023|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
20424024|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
20424025|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424026|NCT01268176|Vitamin D|vitamin d|mesh-list
20424027|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
20424028|NCT01268176|Vitamins|vitamins|mesh-ancestor
20424029|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
20424030|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424031|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20424032|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20424033|NCT01268202|Pravastatin|pravastatin|mesh-list
20424034|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20424035|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20424036|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
20424037|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424038|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20424039|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20424040|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424041|NCT01268215|Budesonide|budesonide|mesh-list
20424042|NCT01268215|Calfactant|calfactant|mesh-list
20424043|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424044|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20424045|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
20424046|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424047|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424048|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20424049|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
20424050|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
20424051|NCT01268215|Hormones|hormones|mesh-ancestor
20424052|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424053|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20424054|NCT01268371|Everolimus|everolimus|mesh-list
20424055|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424056|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20424057|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
20424058|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424059|NCT01268384|Gemcitabine|gemcitabine|mesh-list
20424060|NCT01268384|Capecitabine|capecitabine|mesh-list
20424061|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20424062|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
20424063|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424064|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424065|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
20424066|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424067|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424068|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20424069|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
20424070|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424071|NCT01268579|Ribavirin|ribavirin|mesh-list
20424072|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
20424073|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424074|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
20424075|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424076|NCT01268631|Pregabalin|pregabalin|mesh-list
20424077|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20424078|NCT01268631|Analgesics|analgesics|mesh-ancestor
20424079|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
19691836|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217012|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20217013|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217014|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20217015|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217016|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
20217017|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
20217018|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217019|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424080|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424081|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424082|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
20424083|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20424084|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424085|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424086|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20424087|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20424088|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20424089|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424090|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424091|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20424092|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20424093|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424094|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
20424095|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
20424096|NCT01268670|Ibuprofen|ibuprofen|mesh-list
20424097|NCT01268670|Oxycodone|oxycodone|mesh-list
20424098|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20424099|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20424100|NCT01268670|Analgesics|analgesics|mesh-ancestor
20424101|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
20424102|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424103|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424104|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424105|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424106|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20424107|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424108|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424109|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20424110|NCT01268670|Narcotics|narcotics|mesh-ancestor
20424111|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424112|NCT01268709|Doxepin|doxepin|mesh-list
20424113|NCT01268709|Nortriptyline|nortriptyline|mesh-list
20424114|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20424115|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
20424116|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424117|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20424118|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20424119|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424120|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424121|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
20424122|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424123|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424124|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20424125|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20424126|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424127|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
20424128|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
20424129|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20424130|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
20424131|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20424132|NCT01268761|Cetrorelix|cetrorelix|mesh-list
20424133|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20424134|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
20424135|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20424136|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424137|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
20424138|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424139|NCT01268839|Efavirenz|efavirenz|mesh-list
20424140|NCT01268839|Rilpivirine|rilpivirine|mesh-list
20424141|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20424142|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20424143|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424144|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424145|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
20424146|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424147|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20424148|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20424149|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20424150|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20424151|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20424152|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20424153|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20424154|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20424155|NCT01268904|Valproic Acid|valproic acid|mesh-list
20424156|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
20424157|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424158|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424159|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
20424160|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424161|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424162|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
20424163|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20424164|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424165|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424166|NCT01268917|Aspirin|aspirin|mesh-list
20424167|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20424168|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20424169|NCT01268917|Analgesics|analgesics|mesh-ancestor
20424170|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
20424171|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424172|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424173|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424174|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424175|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20424176|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20424177|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424178|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20424179|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20424180|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424181|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
20424182|NCT01268930|Hemostatics|hemostatics|mesh-list
20424183|NCT01268930|Coagulants|coagulants|mesh-ancestor
20424184|NCT01268995|Cyclosporine|cyclosporine|mesh-list
20424185|NCT01268995|Tacrolimus|tacrolimus|mesh-list
20424186|NCT01268995|Cyclosporins|cyclosporins|mesh-list
20424187|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20424188|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
20424189|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424190|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20424191|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424192|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424193|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
20424194|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424195|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
20424196|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424197|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
20424198|NCT01269021|Prednisone|prednisone|mesh-list
20424199|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424200|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
20424201|NCT01269021|Hormones|hormones|mesh-ancestor
20424202|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424203|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424204|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20424205|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424206|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20424207|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20424208|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
20424209|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20424210|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424211|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424212|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424213|NCT01269099|Fentanyl|fentanyl|mesh-list
20424214|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20424215|NCT01269099|Narcotics|narcotics|mesh-ancestor
20424216|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424217|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424218|NCT01269099|Analgesics|analgesics|mesh-ancestor
20424219|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
20424220|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424221|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20424222|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20424223|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
20424224|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
20424225|NCT01269112|Citric Acid|citric acid|mesh-list
20424226|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
20424227|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
20424228|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20424229|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
20424230|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
19848148|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
20428490|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
20424231|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428491|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20428492|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
20428493|NCT01291654|Acetaminophen|acetaminophen|mesh-list
20428494|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20428495|NCT01291654|Analgesics|analgesics|mesh-ancestor
20428496|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
20428497|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428498|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428499|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
20428500|NCT01291719|Insulin|insulin|mesh-list
20428501|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20428502|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428503|NCT01291823|Gefitinib|gefitinib|mesh-list
20428504|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428505|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20428506|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428507|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428508|NCT01291927|Pancrelipase|pancrelipase|mesh-list
20428509|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20428510|NCT01291940|Petrolatum|petrolatum|mesh-list
20428511|NCT01291940|Emollients|emollients|mesh-ancestor
20428512|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
20428513|NCT01291979|Lidocaine|lidocaine|mesh-list
20428514|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
20428515|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
20428516|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20428517|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428518|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
20428519|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428520|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20428521|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20428522|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20428523|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20428524|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428525|NCT01292031|Meropenem|meropenem|mesh-list
20428526|NCT01292031|Colistin|colistin|mesh-list
20428527|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20428528|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428529|NCT01292083|Azacitidine|azacitidine|mesh-list
20428530|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20428531|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
20428532|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428533|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428534|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428535|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
20428536|NCT01292109|Cathartics|cathartics|mesh-ancestor
20428537|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20428538|NCT01292161|Silymarin|silymarin|mesh-list
20428539|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
20428540|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428541|NCT01292161|Protective Agents|protective agents|mesh-ancestor
20428542|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428543|NCT01292174|Ibalizumab|ibalizumab|mesh-list
20428544|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20428545|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20428546|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20428547|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
20428548|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428549|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
20428550|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428551|NCT01292343|Listerine|listerine|mesh-list
20428552|NCT01292343|Triclosan|triclosan|mesh-list
20428553|NCT01292343|Fluorides|fluorides|mesh-list
20428554|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
20428555|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
20428556|NCT01292343|Protective Agents|protective agents|mesh-ancestor
20428557|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428558|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19691837|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19691838|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19691839|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
19691840|NCT04999878|Hormones|hormones|mesh-ancestor
20428559|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428560|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20428561|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20428562|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
20428563|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424232|NCT01269138|Thrombin|thrombin|mesh-list
20424233|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
20424234|NCT01269138|Coagulants|coagulants|mesh-ancestor
20424235|NCT01269151|Ranibizumab|ranibizumab|mesh-list
20424236|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20424237|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20424238|NCT01269151|Growth Substances|growth substances|mesh-ancestor
20424239|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424240|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
20424241|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424242|NCT01269203|Curcumin|curcumin|mesh-list
20424243|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20424244|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20424245|NCT01269203|Analgesics|analgesics|mesh-ancestor
20424246|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
20424247|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424248|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424249|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424250|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424251|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424252|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424253|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424254|NCT01269216|Leucovorin|leucovorin|mesh-list
20424255|NCT01269216|Irinotecan|irinotecan|mesh-list
20424256|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20424257|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20424258|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424259|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424260|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424261|NCT01269216|Antidotes|antidotes|mesh-ancestor
20424262|NCT01269216|Protective Agents|protective agents|mesh-ancestor
20424263|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424264|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
20424265|NCT01269216|Vitamins|vitamins|mesh-ancestor
20424266|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
20424267|NCT01269242|Bindarit|bindarit|mesh-list
20424268|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424269|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20424270|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424271|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424272|NCT01269255|Cisplatin|cisplatin|mesh-list
20424273|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424274|NCT01269281|Sumatriptan|sumatriptan|mesh-list
20424275|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20424276|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20424277|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20424278|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
20424279|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424280|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424281|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424282|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
20424283|NCT01269294|Simeprevir|simeprevir|mesh-list
20424284|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20424285|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20424286|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424287|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20424288|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20424289|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424290|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424291|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424292|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20424293|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
20424294|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20424295|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424296|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20424297|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20424298|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20424299|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
20424300|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
20424301|NCT01269307|Ketamine|ketamine|mesh-list
20424302|NCT01269307|Propofol|propofol|mesh-list
20424303|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20424304|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424305|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424306|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20424307|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
20424308|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
20424309|NCT01269307|Analgesics|analgesics|mesh-ancestor
20424310|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
20424311|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424312|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20424313|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20424314|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20424315|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424316|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424317|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
20424318|NCT01269333|Omeprazole|omeprazole|mesh-list
20424319|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20424320|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424321|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20424322|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424323|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424324|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20424325|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20424326|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424327|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424328|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424329|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20424330|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20424331|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424332|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424333|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
20424334|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20424335|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
20424336|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20424337|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20424338|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20424339|NCT01269411|R04929097|r04929097|mesh-list
19691841|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19691842|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20424340|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424341|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424342|NCT01269437|Budesonide|budesonide|mesh-list
20424343|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424344|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20424345|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
20424346|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424347|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424348|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20424349|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
20424350|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
20424351|NCT01269437|Hormones|hormones|mesh-ancestor
20424352|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424353|NCT01269450|Progesterone|progesterone|mesh-list
20424354|NCT01269450|Progestins|progestins|mesh-ancestor
20424355|NCT01269450|Hormones|hormones|mesh-ancestor
20424356|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424357|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424358|NCT01269463|Methylphenidate|methylphenidate|mesh-list
20424359|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20424360|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424361|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20424362|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20424363|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424364|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424365|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
20424366|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424367|NCT01269476|Fluorides|fluorides|mesh-list
20424368|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
20424369|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
20424370|NCT01269476|Protective Agents|protective agents|mesh-ancestor
20424371|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424372|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20424373|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424374|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424375|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
20424376|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424377|NCT01269515|Etoricoxib|etoricoxib|mesh-list
20424378|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20424379|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20424380|NCT01269515|Analgesics|analgesics|mesh-ancestor
20424381|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
20424382|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424383|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424384|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424385|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424386|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20424387|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20424388|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424389|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424390|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
20424391|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
20424392|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20424393|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
20424394|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424395|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424396|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20424397|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
20424398|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20424399|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
20424400|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424401|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424402|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20424403|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
20424404|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
20424405|NCT01269528|Protective Agents|protective agents|mesh-ancestor
20424406|NCT01269528|Miotics|miotics|mesh-ancestor
20424407|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20424408|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20424409|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20424410|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20424411|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
20424412|NCT01269541|Rifampin|rifampin|mesh-list
20424413|NCT01269541|Mupirocin|mupirocin|mesh-list
20424414|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20424415|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
20424416|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20424417|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424418|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
20424419|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20424420|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424421|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424422|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20424423|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20424424|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20424425|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20424426|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20424427|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20424428|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20424429|NCT01269606|Insulin|insulin|mesh-list
20424430|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20424431|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
20424432|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
20424433|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20424434|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20424435|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424436|NCT01269671|Peppermint oil|peppermint oil|mesh-list
20424437|NCT01269671|Melatonin|melatonin|mesh-list
20424438|NCT01269671|Simethicone|simethicone|mesh-list
20424439|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
20424440|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424441|NCT01269671|Protective Agents|protective agents|mesh-ancestor
20424442|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424443|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424444|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
20424445|NCT01269671|Emollients|emollients|mesh-ancestor
20424446|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
20424447|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
20424448|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
20424449|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424450|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424451|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
20424452|NCT01269684|Everolimus|everolimus|mesh-list
20424453|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424454|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20424455|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
20424456|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424457|NCT01269788|Fluoxetine|fluoxetine|mesh-list
20424458|NCT01269788|Omeprazole|omeprazole|mesh-list
20424459|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20424460|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424461|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20424462|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424463|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424464|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20424465|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20424466|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424467|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424468|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
20424469|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424470|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20424471|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
20424472|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424473|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20424474|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20424475|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
20424476|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20424477|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424478|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424479|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20424480|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20424481|NCT01269827|Protective Agents|protective agents|mesh-ancestor
20424482|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424483|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
20424484|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20424485|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
20424486|NCT01269853|Bevacizumab|bevacizumab|mesh-list
20424487|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20424488|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424489|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20424490|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20424491|NCT01269853|Growth Substances|growth substances|mesh-ancestor
20424492|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424493|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
20424494|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20424495|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20424496|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20424497|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424498|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424499|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424500|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424501|NCT01269866|Analgesics|analgesics|mesh-ancestor
20424502|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
20424503|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424504|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
20424505|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424506|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
20424507|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20424508|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20424509|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424510|NCT01269996|Metformin|metformin|mesh-list
20424511|NCT01269996|Gliclazide|gliclazide|mesh-list
20424512|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20424513|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424514|NCT01270035|Adalimumab|adalimumab|mesh-list
20424515|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424516|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424517|NCT01270074|Azithromycin|azithromycin|mesh-list
20424518|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20424519|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424520|NCT01270087|Adalimumab|adalimumab|mesh-list
20424521|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424522|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424523|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
20424524|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
20424525|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19691843|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424526|NCT01270152|Protective Agents|protective agents|mesh-ancestor
20424527|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424528|NCT01270152|Vitamins|vitamins|mesh-ancestor
20424529|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
20424530|NCT01270165|Telbivudine|telbivudine|mesh-list
20424531|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
20424532|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424533|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20424534|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424535|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424536|NCT01270178|Entecavir|entecavir|mesh-list
20424537|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
20424538|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424539|NCT01270191|Exenatide|exenatide|mesh-list
20424540|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
20424541|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20424542|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424543|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20424544|NCT01270191|Incretins|incretins|mesh-ancestor
20424545|NCT01270191|Hormones|hormones|mesh-ancestor
20424546|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424547|NCT01270308|Lansoprazole|lansoprazole|mesh-list
20424548|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
20424549|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20424550|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424551|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20424552|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424553|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424554|NCT01270373|Docetaxel|docetaxel|mesh-list
20424555|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424556|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
20424557|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
20424558|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
20424559|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424560|NCT01270386|Apatinib|apatinib|mesh-list
20424561|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217020|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20217021|NCT00308321|Protective Agents|protective agents|mesh-ancestor
20217022|NCT00308334|Domperidone|domperidone|mesh-list
20217023|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
20217024|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
20424562|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20424563|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424564|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424565|NCT01270412|Mitogens|mitogens|mesh-list
20424566|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
20424567|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
20424568|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424569|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20424570|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
20424571|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424572|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
20424573|NCT01270412|Protective Agents|protective agents|mesh-ancestor
20424574|NCT01270438|Leucovorin|leucovorin|mesh-list
20424575|NCT01270438|Bevacizumab|bevacizumab|mesh-list
20424576|NCT01270438|Fluorouracil|fluorouracil|mesh-list
20424577|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
20424578|NCT01270438|Calcium|calcium|mesh-list
20424579|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
20424580|NCT01270438|R04929097|r04929097|mesh-list
20424581|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20424582|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424583|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20424584|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20424585|NCT01270438|Growth Substances|growth substances|mesh-ancestor
20424586|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424587|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
20424588|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20424589|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
20424590|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217025|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20217026|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217027|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20217028|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20217029|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
20424591|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20424592|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20424593|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
20424594|NCT01270438|Antidotes|antidotes|mesh-ancestor
20424595|NCT01270438|Protective Agents|protective agents|mesh-ancestor
20424596|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
20424597|NCT01270438|Vitamins|vitamins|mesh-ancestor
20424598|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
20424599|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424600|NCT01270451|Insulin|insulin|mesh-list
20424601|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20424602|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424603|NCT01270490|Interferons|interferons|mesh-list
20424604|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
20424605|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424606|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
20424607|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424608|NCT01270672|Carvedilol|carvedilol|mesh-list
20424609|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20424610|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20424611|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20424612|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
20424613|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424614|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424615|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424616|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20424617|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
20424618|NCT01270672|Protective Agents|protective agents|mesh-ancestor
20424619|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20424620|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424621|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20424622|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
20424623|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20424624|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20424625|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
20424626|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424627|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
20424628|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20424629|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20424630|NCT01270724|Gemcitabine|gemcitabine|mesh-list
20424631|NCT01270724|Paclitaxel|paclitaxel|mesh-list
20424632|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
20424633|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20424634|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424635|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
20424636|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
20424637|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
20424638|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424639|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20424640|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
20424641|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
20424642|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424643|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424644|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20424645|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
20424646|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424647|NCT01270737|Daidzein|daidzein|mesh-list
20424648|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
20424649|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20424650|NCT01270737|Estrogens|estrogens|mesh-ancestor
20424651|NCT01270737|Hormones|hormones|mesh-ancestor
20424652|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424653|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424654|NCT01270750|Bosentan|bosentan|mesh-list
20424655|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20424656|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20424657|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424658|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
20424659|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20424660|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20424661|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424662|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
20424663|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
20424664|NCT01270789|Liraglutide|liraglutide|mesh-list
20424665|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20424666|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424667|NCT01270789|Incretins|incretins|mesh-ancestor
20424668|NCT01270789|Hormones|hormones|mesh-ancestor
20424669|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424670|NCT01270815|Pregabalin|pregabalin|mesh-list
20424671|NCT01270815|Analgesics|analgesics|mesh-ancestor
20424672|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
20424673|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424674|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424675|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
20424676|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20424677|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20424678|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424679|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20424680|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20424681|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20424682|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20424683|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20424684|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
20424685|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20424686|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20424687|NCT01270932|Dexamethasone|dexamethasone|mesh-list
20424688|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
20424689|NCT01270932|Lenalidomide|lenalidomide|mesh-list
20424690|NCT01270932|BB 1101|bb 1101|mesh-list
20424691|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424692|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
20424693|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
20424694|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424695|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424696|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424697|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
20424698|NCT01270932|Hormones|hormones|mesh-ancestor
20424699|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20424700|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20424701|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424702|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
20424703|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424704|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424705|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
20424706|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20424707|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20424708|NCT01270932|Growth Substances|growth substances|mesh-ancestor
20424709|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
20424710|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
20424711|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20424712|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20424713|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424714|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424715|NCT01270997|Etanercept|etanercept|mesh-list
20424716|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20217030|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217031|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217032|NCT00308360|Valproic Acid|valproic acid|mesh-list
20217033|NCT00308360|Risperidone|risperidone|mesh-list
20217034|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20217035|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
20424717|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20424718|NCT01270997|Analgesics|analgesics|mesh-ancestor
20424719|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
20424720|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424721|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424722|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20424723|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20424724|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20424725|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20217036|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20217037|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20217038|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217039|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20217040|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20217041|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20217042|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20217043|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20424726|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
20424727|NCT01271023|Insulin|insulin|mesh-list
20217044|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
20424728|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20424729|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217045|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
20217046|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20217047|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
20217048|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
20424730|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
20424731|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20424732|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
20424733|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20424734|NCT01271088|Expectorants|expectorants|mesh-ancestor
20424735|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
20424736|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20424737|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
20424738|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424739|NCT01271088|Protective Agents|protective agents|mesh-ancestor
20424740|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424741|NCT01271088|Antidotes|antidotes|mesh-ancestor
20424742|NCT01271114|Terlipressin|terlipressin|mesh-list
20424743|NCT01271114|Norepinephrine|norepinephrine|mesh-list
20424744|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20424745|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20424746|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
20424747|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20424748|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20424749|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424750|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
20424751|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
20424752|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424753|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20424754|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20424755|NCT01271140|Insulin|insulin|mesh-list
20424756|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20424757|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424758|NCT01271153|Dobutamine|dobutamine|mesh-list
20424759|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20424760|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
20424761|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
20424762|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20424763|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20424764|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20424765|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20424766|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19392407|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19392408|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19392409|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19392410|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
19392411|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19392412|NCT03694873|Celecoxib|celecoxib|mesh-list
19392413|NCT03694873|Tramadol|tramadol|mesh-list
19392414|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19392415|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19392416|NCT03694873|Analgesics|analgesics|mesh-ancestor
19392417|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
19392418|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19392419|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19392420|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19392421|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19392422|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19392423|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19691844|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19691845|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
20217049|NCT00308373|Metformin|metformin|mesh-list
20217050|NCT00308373|Pioglitazone|pioglitazone|mesh-list
20217051|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20217052|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20217053|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20217054|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
20217055|NCT00308425|Valsartan|valsartan|mesh-list
20217056|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20217057|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20217058|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20217059|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
20217060|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20217061|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20217062|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20424767|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
20424768|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428564|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20428762|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20428763|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20428764|NCT01293747|Estradiol|estradiol|mesh-list
20428765|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20428766|NCT01293747|Progesterone|progesterone|mesh-list
20428767|NCT01293747|Estrogens|estrogens|mesh-ancestor
20428768|NCT01293747|Hormones|hormones|mesh-ancestor
20428769|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428770|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428771|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20428772|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
20428773|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20428774|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20428775|NCT01293747|Progestins|progestins|mesh-ancestor
20428776|NCT01293838|Citalopram|citalopram|mesh-list
20428777|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20428778|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20428779|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20428780|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428781|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428782|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
20428783|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428784|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20428785|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
20428786|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20428787|NCT01293942|Bevacizumab|bevacizumab|mesh-list
20428788|NCT01293942|Capecitabine|capecitabine|mesh-list
20428789|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
20428790|NCT01293942|Irinotecan|irinotecan|mesh-list
20428791|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428792|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428793|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20428794|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20428795|NCT01293942|Growth Substances|growth substances|mesh-ancestor
20428796|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428797|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
20428798|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20428799|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
20428800|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428801|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20428802|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20428803|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523232|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20523233|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20523234|NCT01744756|Growth Substances|growth substances|mesh-ancestor
20523235|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523236|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
20523237|NCT01744873|Bisoprolol|bisoprolol|mesh-list
20523238|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20523239|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
20523240|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
20523241|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523242|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523243|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20523244|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20523245|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20523246|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523247|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523248|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530288|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20530289|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
20530290|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530291|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530292|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530293|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
20530294|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20530295|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
20530296|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530297|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
20530298|NCT01787630|Protective Agents|protective agents|mesh-ancestor
20530299|NCT01787669|Dexamethasone|dexamethasone|mesh-list
20530300|NCT01787669|Bevacizumab|bevacizumab|mesh-list
20530301|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20530302|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428804|NCT01294059|Milnacipran|milnacipran|mesh-list
20428805|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
20428806|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20428807|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20428808|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20428809|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428810|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428811|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428812|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20428813|NCT01294059|Analgesics|analgesics|mesh-ancestor
20428814|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
20428815|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428816|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
20428817|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20428818|NCT01294072|Curcumin|curcumin|mesh-list
20428819|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20428820|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20428821|NCT01294072|Analgesics|analgesics|mesh-ancestor
20428822|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
20428823|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428824|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428825|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20428826|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20428827|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428828|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428829|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428830|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
20428831|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
20428832|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428833|NCT01294176|Protective Agents|protective agents|mesh-ancestor
20428834|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428835|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
20428836|NCT01294176|Vitamins|vitamins|mesh-ancestor
20428837|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
20428838|NCT01294215|Nifedipine|nifedipine|mesh-list
20428839|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20428840|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20428841|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428842|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20428843|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428844|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
20428845|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
20428846|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20428847|NCT01294293|Paclitaxel|paclitaxel|mesh-list
20428848|NCT01294293|Doxorubicin|doxorubicin|mesh-list
20428849|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20428850|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20428851|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428852|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
20428853|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
20428854|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
20428855|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428856|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20428857|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20428858|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20428859|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428860|NCT01294410|Antibodies|antibodies|mesh-list
20428861|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
20428862|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
20428863|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428864|NCT01294605|Edetic Acid|edetic acid|mesh-list
20428865|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
20428866|NCT01294605|Antidotes|antidotes|mesh-ancestor
20428867|NCT01294605|Protective Agents|protective agents|mesh-ancestor
20428868|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428869|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
20428870|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
20428871|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428872|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20428873|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
20428874|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20428875|NCT01294618|Interferons|interferons|mesh-list
20428876|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428877|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
20428878|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428879|NCT01294631|Canagliflozin|canagliflozin|mesh-list
20428880|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20428881|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428882|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20428883|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428884|NCT01294735|Temozolomide|temozolomide|mesh-list
20428885|NCT01294735|Niraparib|niraparib|mesh-list
20428886|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20428887|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
20428888|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428889|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428890|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20428891|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428892|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
20218107|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20218108|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
19404829|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404830|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
19404831|NCT03591744|Hormones|hormones|mesh-ancestor
19404832|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404833|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19404834|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404835|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20218109|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
20428893|NCT01294761|Darunavir|darunavir|mesh-list
20428894|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20428895|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20428896|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
20428897|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20428898|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20428899|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20428900|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428901|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428902|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20428903|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20428904|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
20428905|NCT01294826|Cetuximab|cetuximab|mesh-list
20428906|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428907|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428908|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20428909|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
20428910|NCT01294878|Omalizumab|omalizumab|mesh-list
20428911|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20428912|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20428913|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
20428914|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20218110|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
20218111|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20218112|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20218113|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218114|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218115|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218116|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20218117|NCT00311896|Bemiparin|bemiparin|mesh-list
20218118|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
20218119|NCT00311961|Prednisolone|prednisolone|mesh-list
20218120|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20218121|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
20428915|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20428916|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
20428917|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20428918|NCT01294956|Laxatives|laxatives|mesh-ancestor
20428919|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19404836|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19404837|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19404838|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404839|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404840|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
19404841|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404842|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19404843|NCT03591744|Growth Substances|growth substances|mesh-ancestor
19404844|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
20218122|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20428920|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20428921|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20428922|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20428923|NCT01294969|Analgesics|analgesics|mesh-ancestor
20428924|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
20428925|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428926|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428927|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20428928|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20428929|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20428930|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20428931|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20428932|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
20428933|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
20428934|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428935|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428936|NCT01295047|Atenolol|atenolol|mesh-list
20428937|NCT01295047|Verapamil|verapamil|mesh-list
20428938|NCT01295047|Perindopril|perindopril|mesh-list
20428939|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20428940|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20428941|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
20428942|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
20428943|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20428944|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428945|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20428946|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20428947|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20428948|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
20428949|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20428950|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428951|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20428952|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20428953|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20428954|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
20428955|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20428956|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
20428957|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20428958|NCT01295073|Trientine|trientine|mesh-list
20428959|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
20428960|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
20428961|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428962|NCT01295086|Docetaxel|docetaxel|mesh-list
20428963|NCT01295086|Capecitabine|capecitabine|mesh-list
20428964|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
20428965|NCT01295086|Trastuzumab|trastuzumab|mesh-list
20428966|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428967|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
20428968|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
20428969|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
20428970|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404845|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
19404846|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
20428971|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20428972|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
20428973|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428974|NCT01295099|Triamcinolone|triamcinolone|mesh-list
20428975|NCT01295099|Fluorouracil|fluorouracil|mesh-list
20428976|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
20428977|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20428978|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20428979|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428980|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20428981|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
20428982|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20428983|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20428984|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
20428985|NCT01295099|Hormones|hormones|mesh-ancestor
20428986|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20428987|NCT01295138|Lactulose|lactulose|mesh-list
20428988|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20428989|NCT01295151|Adalimumab|adalimumab|mesh-list
20428990|NCT01295151|Etanercept|etanercept|mesh-list
19404847|NCT03591679|Oxytocin|oxytocin|mesh-list
20428991|NCT01295151|Golimumab|golimumab|mesh-list
19404848|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
20428992|NCT01295151|Rituximab|rituximab|mesh-list
20428993|NCT01295151|Abatacept|abatacept|mesh-list
20428994|NCT01295151|Infliximab|infliximab|mesh-list
20428995|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
20428996|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20428997|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20428998|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
20428999|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429000|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429001|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429002|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
20429003|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429004|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20429005|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20429006|NCT01295151|Analgesics|analgesics|mesh-ancestor
20429007|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
20429008|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429009|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429010|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20429011|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429012|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20429013|NCT01295177|Insulin|insulin|mesh-list
20429014|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20429015|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20429016|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429017|NCT01295268|Emu Oil|emu oil|mesh-list
20429018|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429019|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
20429020|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
20429021|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
20429022|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
20429023|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20429024|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20429025|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429026|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
20429027|NCT01295294|Coagulants|coagulants|mesh-ancestor
20429028|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20429029|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
20429030|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20429031|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429032|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20429033|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20429034|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20429035|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20429036|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20429037|NCT01295294|Analgesics|analgesics|mesh-ancestor
20429038|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
20429039|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429040|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429041|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429042|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20429043|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429044|NCT01295307|Clofarabine|clofarabine|mesh-list
20429045|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20429046|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
20429047|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429048|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429049|NCT01295372|Risperidone|risperidone|mesh-list
20429050|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20429051|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
20429052|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429053|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429054|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404849|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19404850|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416468|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
19416469|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416470|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416471|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
19693191|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429055|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20429056|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20429057|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429058|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20429059|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20429060|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
20429061|NCT01295450|Vitamins|vitamins|mesh-list
20429062|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
20429063|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429064|NCT01295502|Paclitaxel|paclitaxel|mesh-list
20429065|NCT01295502|Cisplatin|cisplatin|mesh-list
20429066|NCT01295502|Carboplatin|carboplatin|mesh-list
20429067|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20429068|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20429069|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429070|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
19404851|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19404852|NCT03591575|Deferiprone|deferiprone|mesh-list
19404853|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19404854|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
19404855|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
19404856|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404857|NCT03591549|Fulvestrant|fulvestrant|mesh-list
19404858|NCT03591549|Goserelin|goserelin|mesh-list
19404859|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19404860|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404861|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20429071|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
20429072|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
20429073|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429074|NCT01295567|Dipyridamole|dipyridamole|mesh-list
20429075|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20429076|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429077|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429078|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20429079|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
20429080|NCT01295593|Cladribine|cladribine|mesh-list
20429081|NCT01295593|Valproic Acid|valproic acid|mesh-list
20429082|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
20429083|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429084|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429085|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
20429086|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429087|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429088|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
20429089|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20429090|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429091|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20429092|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429093|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429094|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
20429095|NCT01295606|Cefazolin|cefazolin|mesh-list
20429096|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429097|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429098|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
20429099|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
20429100|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20429101|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20429102|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429103|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429104|NCT01295736|Urological Agents|urological agents|mesh-ancestor
20429105|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
20429106|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
20429107|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20429108|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
20429109|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429110|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20429111|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20429112|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20429113|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20429114|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429115|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
20429116|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20429117|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
20429118|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429119|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404862|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20429120|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20429121|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
20429122|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20429123|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
20429124|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429125|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429126|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20429127|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
20429128|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
20429129|NCT01295866|Protective Agents|protective agents|mesh-ancestor
20429130|NCT01295892|Estrogens|estrogens|mesh-list
20429131|NCT01295892|Hormones|hormones|mesh-ancestor
20429132|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429133|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429134|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20429135|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523249|NCT01744886|Benzocaine|benzocaine|mesh-list
20523250|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
20523251|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
20523252|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523253|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523254|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
20523255|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523256|NCT01744964|Apomorphine|apomorphine|mesh-list
20523257|NCT01744964|Emetics|emetics|mesh-ancestor
20523258|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523259|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
20523260|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523261|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523262|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
20523263|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
20523264|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523265|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523266|NCT01745081|Mannitol|mannitol|mesh-list
20523267|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20523268|NCT01745081|Diuretics|diuretics|mesh-ancestor
20523269|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
20523270|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523271|NCT01745159|Tacrolimus|tacrolimus|mesh-list
20523272|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20523273|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
20523274|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523275|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20523276|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523277|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523278|NCT01745263|Vitamin D|vitamin d|mesh-list
20523279|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
20523280|NCT01745263|Vitamins|vitamins|mesh-ancestor
20523281|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
20523282|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523283|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20523284|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20523285|NCT01745302|Gefitinib|gefitinib|mesh-list
20523286|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523287|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20523288|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523289|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523290|NCT01745328|Amoxicillin|amoxicillin|mesh-list
20523291|NCT01745328|Levofloxacin|levofloxacin|mesh-list
20523292|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20523293|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523294|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20523295|NCT01745328|Renal Agents|renal agents|mesh-ancestor
20523296|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20523297|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20523298|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523299|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523300|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523301|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20523302|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20523303|NCT01745549|Insulin|insulin|mesh-list
20523304|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20523305|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20523306|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523307|NCT01745562|Alprazolam|alprazolam|mesh-list
20523308|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20523309|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523310|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429136|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20429137|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429138|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
20429139|NCT01296074|Hormones|hormones|mesh-ancestor
20429140|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429141|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429142|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20429143|NCT01296074|Protective Agents|protective agents|mesh-ancestor
20429144|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429145|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429146|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20429147|NCT01296139|Hematinics|hematinics|mesh-ancestor
20429148|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20429149|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20429150|NCT01296178|Idarubicin|idarubicin|mesh-list
20429151|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20429152|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429153|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20429154|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20429155|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429156|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429157|NCT01296204|Antibodies|antibodies|mesh-list
20429158|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
20429159|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429160|NCT01296230|Hormones|hormones|mesh-list
20429161|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429162|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429163|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20429164|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20429165|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
20429166|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429167|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429168|NCT01296269|Vasopressins|vasopressins|mesh-list
20429169|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
20429170|NCT01296269|Oxytocin|oxytocin|mesh-list
20429171|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
20429172|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20429173|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429174|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
20429175|NCT01296269|Coagulants|coagulants|mesh-ancestor
20429176|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20429177|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20429178|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
20429179|NCT01296334|Morphine|morphine|mesh-list
20429180|NCT01296334|Buprenorphine|buprenorphine|mesh-list
20429181|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20429182|NCT01296334|Narcotics|narcotics|mesh-ancestor
20429183|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429184|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429185|NCT01296334|Analgesics|analgesics|mesh-ancestor
20429186|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
20429187|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429188|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20429189|NCT01296438|Insulin|insulin|mesh-list
20429190|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20429191|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
20429192|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
20429193|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20429194|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20429195|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429196|NCT01296464|Carbidopa|carbidopa|mesh-list
20429197|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20429198|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20429199|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
20429200|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429201|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429202|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429203|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20429204|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429205|NCT01296503|Thalidomide|thalidomide|mesh-list
19404863|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
19416472|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20429206|NCT01296503|Dexamethasone|dexamethasone|mesh-list
20429207|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
20429208|NCT01296503|BB 1101|bb 1101|mesh-list
20429209|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429210|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
20429211|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
20429212|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429213|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429214|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429215|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
20429216|NCT01296503|Hormones|hormones|mesh-ancestor
20429217|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429218|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429219|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429220|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
20429221|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429222|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429223|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429224|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
20429225|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
20429226|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429227|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429228|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20429229|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20429230|NCT01296503|Growth Substances|growth substances|mesh-ancestor
20429231|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
20429232|NCT01296555|Letrozole|letrozole|mesh-list
20429233|NCT01296555|Fulvestrant|fulvestrant|mesh-list
20429234|NCT01296555|Midazolam|midazolam|mesh-list
20429235|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20429236|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20429237|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429238|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429239|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20429240|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20429241|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20429242|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20429243|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
20429244|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
20429245|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
20429246|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
20429247|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429248|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429249|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429250|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20429251|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20429252|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429253|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20429254|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
20429255|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429256|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429257|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20429258|NCT01296802|Fenfluramine|fenfluramine|mesh-list
20429259|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
20429260|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20429261|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20429262|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429263|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429264|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429265|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
20429266|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429267|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20429268|NCT01296958|Niclosamide|niclosamide|mesh-list
20429269|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
19404864|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404865|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404866|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
19404867|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19404868|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855576|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
20218123|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
20218124|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20218125|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
20218126|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20218127|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
20218128|NCT00311961|Hormones|hormones|mesh-ancestor
20218129|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218130|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429270|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20429271|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
20429272|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20429273|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429274|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
20429275|NCT01296971|Ribavirin|ribavirin|mesh-list
20429276|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20429277|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
20429278|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429279|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
20429280|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429281|NCT01296997|Calcium|calcium|mesh-list
20429282|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20429283|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429284|NCT01297010|Dexamethasone|dexamethasone|mesh-list
20429285|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
20429286|NCT01297010|BB 1101|bb 1101|mesh-list
20429287|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429288|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
20429289|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
20429290|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429291|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429292|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429293|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
20429294|NCT01297010|Hormones|hormones|mesh-ancestor
20429295|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429296|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429297|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429298|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
20429299|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429300|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429301|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
20429302|NCT01297023|Vitamin D|vitamin d|mesh-list
20429303|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
20429304|NCT01297023|Vitamins|vitamins|mesh-list
20429305|NCT01297023|Calcium|calcium|mesh-list
20429306|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
20429307|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429308|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20429309|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20429310|NCT01297036|Donepezil|donepezil|mesh-list
20429311|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20429312|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429313|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429314|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
20429315|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429316|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429317|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
20429318|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20429319|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429320|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20429321|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429322|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429323|NCT01297166|Calcitriol|calcitriol|mesh-list
20429324|NCT01297166|Calcipotriene|calcipotriene|mesh-list
20429325|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
20429326|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20429327|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429328|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20429329|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429330|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429331|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20429332|NCT01297166|Vitamins|vitamins|mesh-ancestor
20429333|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
20429334|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20429335|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
20429336|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20429337|NCT01297179|Mirabegron|mirabegron|mesh-list
20429338|NCT01297179|Estradiol|estradiol|mesh-list
20429339|NCT01297179|Estrogens|estrogens|mesh-ancestor
20429340|NCT01297179|Hormones|hormones|mesh-ancestor
20429341|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429342|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429343|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20429344|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
20429345|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20429346|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20429347|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20429348|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20429349|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20429350|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20429351|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20429352|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20429353|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
20429354|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429355|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429356|NCT01297179|Urological Agents|urological agents|mesh-ancestor
20429357|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
20429358|NCT01297192|Mirabegron|mirabegron|mesh-list
20429359|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20429360|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20429361|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
20429362|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429363|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429364|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429365|NCT01297192|Urological Agents|urological agents|mesh-ancestor
20429366|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20429367|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20429368|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20429369|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
20429370|NCT01297452|Paclitaxel|paclitaxel|mesh-list
20429371|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20429372|NCT01297452|Carboplatin|carboplatin|mesh-list
20429373|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20429374|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429375|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
20429376|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
20429377|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
20429378|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429379|NCT01297569|Ranibizumab|ranibizumab|mesh-list
20429380|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20429381|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20429382|NCT01297569|Growth Substances|growth substances|mesh-ancestor
20429383|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429384|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
20429385|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429386|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
20429387|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20429388|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20429389|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20429390|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429391|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429392|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
20429393|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429394|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429395|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20429396|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429397|NCT01297686|Dexamethasone|dexamethasone|mesh-list
20429398|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429399|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
20429400|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
20429401|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429402|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429403|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429404|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
20429405|NCT01297686|Hormones|hormones|mesh-ancestor
20429406|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429407|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429408|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429409|NCT01297764|Dexamethasone|dexamethasone|mesh-list
20429410|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
20429411|NCT01297764|Lenalidomide|lenalidomide|mesh-list
20429412|NCT01297764|Vorinostat|vorinostat|mesh-list
20429413|NCT01297764|BB 1101|bb 1101|mesh-list
20429414|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429415|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
20429416|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
20429417|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429418|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429419|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429420|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
20429421|NCT01297764|Hormones|hormones|mesh-ancestor
20429422|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429423|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429424|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429425|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
20429426|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429427|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429428|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
20429429|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20429430|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20429431|NCT01297764|Growth Substances|growth substances|mesh-ancestor
20429432|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
20429433|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20429434|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
20429435|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429436|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20429437|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429438|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523311|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20523312|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20523313|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523314|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
20523315|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
20523316|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523317|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523318|NCT01745575|Alprazolam|alprazolam|mesh-list
20523319|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20523320|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523321|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523322|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20523323|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20523324|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523325|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
20523326|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
20523327|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523328|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523329|NCT01745601|Dexetimide|dexetimide|mesh-list
20523330|NCT01745601|Citalopram|citalopram|mesh-list
20523331|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20523332|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20523333|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523334|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523335|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523336|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
20523337|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523338|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20523339|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
20523340|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523341|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20523342|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20523343|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
20523344|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
20523345|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523346|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20523347|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20523348|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
20523349|NCT01745614|Nimesulide|nimesulide|mesh-list
20523350|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20523351|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523352|NCT01745614|Analgesics|analgesics|mesh-ancestor
20523353|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
20523354|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523355|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523356|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523357|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523358|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20523359|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523360|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523361|NCT01745640|Dexamethasone|dexamethasone|mesh-list
20523362|NCT01745640|Pomalidomide|pomalidomide|mesh-list
20523363|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523364|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
20523365|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
20523366|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429439|NCT01297803|Mitomycins|mitomycins|mesh-list
20429440|NCT01297803|Mitomycin|mitomycin|mesh-list
20429441|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20429442|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429443|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
20429444|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429445|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20429446|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404869|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404870|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19404871|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19404872|NCT03591536|Protective Agents|protective agents|mesh-ancestor
19404873|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404874|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
19404875|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19404876|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
19404877|NCT03591471|Prednisone|prednisone|mesh-list
19404878|NCT03591471|Benazepril|benazepril|mesh-list
20429447|NCT01297816|Minocycline|minocycline|mesh-list
20429448|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429449|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429450|NCT01297829|Ibuprofen|ibuprofen|mesh-list
20429451|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20429452|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20429453|NCT01297829|Analgesics|analgesics|mesh-ancestor
20429454|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
20429455|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429456|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429457|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429458|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429459|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20429460|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429461|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429462|NCT01297842|Meropenem|meropenem|mesh-list
20429463|NCT01297842|Imipenem|imipenem|mesh-list
20429464|NCT01297842|Ertapenem|ertapenem|mesh-list
20429465|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429466|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429467|NCT01297855|Rifampin|rifampin|mesh-list
20429468|NCT01297855|Colistin|colistin|mesh-list
20429469|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20429470|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
20429471|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429472|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404879|NCT03591471|Heparin|heparin|mesh-list
19693192|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19693193|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19693194|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19693195|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693196|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20218131|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218132|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693197|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
19707704|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707705|NCT04824911|Aspirin|aspirin|mesh-list
19707706|NCT04824911|Clopidogrel|clopidogrel|mesh-list
19707707|NCT04824911|Atorvastatin|atorvastatin|mesh-list
19707708|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19707709|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19707710|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19707711|NCT04824911|Analgesics|analgesics|mesh-ancestor
20218133|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
20218134|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
20218135|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218136|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20218137|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20218138|NCT00311961|Protective Agents|protective agents|mesh-ancestor
20218139|NCT00311974|Dihydralazine|dihydralazine|mesh-list
20218140|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218141|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
20218142|NCT00311987|Hormones|hormones|mesh-ancestor
20218143|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218144|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218145|NCT00312000|Capecitabine|capecitabine|mesh-list
20429473|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
20429474|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20429475|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429476|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429477|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20429478|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20429479|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20429480|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20429481|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20429482|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20429483|NCT01297894|Colistin|colistin|mesh-list
20429484|NCT01297894|Fosfomycin|fosfomycin|mesh-list
20429485|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429486|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429487|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
20429488|NCT01297907|Miotics|miotics|mesh-ancestor
20429489|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
20429490|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429491|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429492|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20429493|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20429494|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
20429495|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20429496|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20429497|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
20429498|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429499|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429500|NCT01297946|Hormones|hormones|mesh-list
20429501|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429502|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429503|NCT01297998|Gemcitabine|gemcitabine|mesh-list
20429504|NCT01297998|Cisplatin|cisplatin|mesh-list
20429505|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429506|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20429507|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
20429508|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429509|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
20429510|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429511|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429512|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429513|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
20429514|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429515|NCT01298011|Gemcitabine|gemcitabine|mesh-list
20429516|NCT01298011|Paclitaxel|paclitaxel|mesh-list
20429517|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20429518|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20429519|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429520|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
20429521|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
20429522|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
20429523|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429524|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20429525|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
20429526|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
20429527|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429528|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429529|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429530|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
20429531|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429532|NCT01298076|Dexamethasone|dexamethasone|mesh-list
20429533|NCT01298076|Bevacizumab|bevacizumab|mesh-list
20429534|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20429535|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429536|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20429537|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20429538|NCT01298076|Growth Substances|growth substances|mesh-ancestor
20429539|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429540|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
20429541|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429542|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
20429543|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
20429544|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429545|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429546|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
20429547|NCT01298076|Hormones|hormones|mesh-ancestor
20429548|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429549|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429550|NCT01298180|Hormones|hormones|mesh-list
20429551|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429552|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429553|NCT01298271|Propranolol|propranolol|mesh-list
20429554|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20429555|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20429556|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
20429557|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429558|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429559|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429560|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20429561|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20429562|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
20429563|NCT01298284|Propranolol|propranolol|mesh-list
20429564|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20429565|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20429566|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
20429567|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429568|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429569|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429570|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20429571|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20429572|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
20429573|NCT01298297|Morphine|morphine|mesh-list
20429574|NCT01298297|Buprenorphine|buprenorphine|mesh-list
20429575|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20429576|NCT01298297|Narcotics|narcotics|mesh-ancestor
20429577|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429578|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429579|NCT01298297|Analgesics|analgesics|mesh-ancestor
20429580|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
20429581|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429582|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20429583|NCT01298310|Lidocaine|lidocaine|mesh-list
20429584|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
20429585|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
20429586|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429587|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429588|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
20429589|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429590|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20429591|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20429592|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20429593|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429594|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429595|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
20429596|NCT01298336|Clarithromycin|clarithromycin|mesh-list
20429597|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429598|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429599|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20429600|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20429601|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429602|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429603|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429604|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20429605|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20429606|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20429607|NCT01298401|Gemcitabine|gemcitabine|mesh-list
20429608|NCT01298401|Capecitabine|capecitabine|mesh-list
20429609|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20429610|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
20429611|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429612|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429613|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
20429614|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429615|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429616|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429617|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
20429618|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429619|NCT01298466|Pregabalin|pregabalin|mesh-list
20429620|NCT01298466|Analgesics|analgesics|mesh-ancestor
20429621|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
20429622|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429623|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429624|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
20429625|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20429626|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429627|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429628|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20429629|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20429630|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20429631|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429632|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20429633|NCT01298505|Fexofenadine|fexofenadine|mesh-list
20429634|NCT01298505|Terfenadine|terfenadine|mesh-list
20218146|NCT00312000|Irinotecan|irinotecan|mesh-list
20218147|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218148|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
20218149|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218150|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218151|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20218152|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20218153|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218154|NCT00312013|Nadroparin|nadroparin|mesh-list
20218155|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
20218156|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20218157|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20218158|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218159|NCT00312039|Lamivudine|lamivudine|mesh-list
20218160|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
20218161|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20218162|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20218163|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218164|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218165|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
19693198|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
20218166|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218167|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20218168|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20429635|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20429636|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19693199|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19693200|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613220|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613221|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20613222|NCT02254018|Maytansine|maytansine|mesh-list
20613223|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
20613224|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20613225|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613226|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
20613227|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
20613228|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19693201|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693202|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19693203|NCT04981951|Analgesics|analgesics|mesh-ancestor
19693204|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
19693205|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429637|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20429638|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
20429639|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
20429640|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429641|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429642|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429643|NCT01298713|Tamoxifen|tamoxifen|mesh-list
20429644|NCT01298713|Everolimus|everolimus|mesh-list
20429645|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429646|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429647|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
20429648|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429649|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20429650|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
20429651|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429652|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429653|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20218169|NCT00312104|Insulin|insulin|mesh-list
20218170|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20429654|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20429655|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20429656|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20429657|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429658|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429659|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
20429660|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429661|NCT01298934|Panobinostat|panobinostat|mesh-list
20429662|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429663|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20429664|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429665|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429666|NCT01299012|Liraglutide|liraglutide|mesh-list
20429667|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20429668|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429669|NCT01299012|Incretins|incretins|mesh-ancestor
20429670|NCT01299012|Hormones|hormones|mesh-ancestor
20429671|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429672|NCT01299181|Atorvastatin|atorvastatin|mesh-list
20429673|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20429674|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20429675|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
20429676|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429677|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20429678|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20429679|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429680|NCT01299194|Atorvastatin|atorvastatin|mesh-list
20429681|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20429682|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20429683|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
20429684|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429685|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20429686|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20429687|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429688|NCT01299220|Acitretin|acitretin|mesh-list
20429689|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
20429690|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
20429691|NCT01299298|Mipomersen|mipomersen|mesh-list
20429692|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20429693|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20429694|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
20429695|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429696|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20429697|NCT01299415|Vadimezan|vadimezan|mesh-list
20429698|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429699|NCT01299558|Fluticasone|fluticasone|mesh-list
20429700|NCT01299558|Xhance|xhance|mesh-list
20429701|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429702|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20429703|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
20429704|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429705|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429706|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20429707|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
20429708|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
20429709|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20429710|NCT01299597|Atorvastatin|atorvastatin|mesh-list
20429711|NCT01299597|Simvastatin|simvastatin|mesh-list
20429712|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20429713|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20429714|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
20429715|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429716|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20429717|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20429718|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523367|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523368|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523369|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
20523370|NCT01745640|Hormones|hormones|mesh-ancestor
20523371|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20523372|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20523373|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523374|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
20523375|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20523376|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20429719|NCT01299662|Poly ICLC|poly iclc|mesh-list
20429720|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
20429721|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
20429722|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429723|NCT01299701|Vadimezan|vadimezan|mesh-list
20429724|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429725|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20429726|NCT01299779|Laxatives|laxatives|mesh-ancestor
20429727|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429728|NCT01299831|Hormones|hormones|mesh-list
20429729|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429730|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429731|NCT01299857|Rituximab|rituximab|mesh-list
20429732|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20429733|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429734|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
20429735|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429736|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429737|NCT01299922|Cyclosporine|cyclosporine|mesh-list
20429738|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
20429739|NCT01299922|Cyclosporins|cyclosporins|mesh-list
20429740|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429741|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429742|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429743|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
20429744|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429745|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
20429746|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429747|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
20429748|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429749|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20429750|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20429751|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429752|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20429753|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
20429754|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429755|NCT01299948|Prednisolone|prednisolone|mesh-list
20429756|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429757|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
20429758|NCT01299948|Hormones|hormones|mesh-ancestor
20429759|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429760|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429761|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429762|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429763|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
20218171|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
20429764|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429765|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429766|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
20429767|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404880|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19404881|NCT03591471|Tinzaparin|tinzaparin|mesh-list
19404882|NCT03591471|Dalteparin|dalteparin|mesh-list
19404883|NCT03591471|Calcium heparin|calcium heparin|mesh-list
20218172|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
20218173|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
20218174|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218175|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218176|NCT00312130|Vildagliptin|vildagliptin|mesh-list
20218177|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20429768|NCT01300312|Diclofenac|diclofenac|mesh-list
20429769|NCT01300312|Eperisone|eperisone|mesh-list
20429770|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20429771|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20429772|NCT01300312|Analgesics|analgesics|mesh-ancestor
20429773|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
20429774|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429775|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429776|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429777|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429778|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19404884|NCT03591471|Dipyridamole|dipyridamole|mesh-list
20218178|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218179|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20429779|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218180|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
20429780|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429781|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
20429782|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20429783|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429784|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20429785|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20429786|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20429787|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
20429788|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
20429789|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
20429790|NCT01300364|Citalopram|citalopram|mesh-list
20429791|NCT01300364|Reboxetine|reboxetine|mesh-list
20429792|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20429793|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20429794|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429795|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429796|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429797|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
20429798|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429799|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20429800|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
20429801|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20429802|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20429803|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
20429804|NCT01300377|Lidocaine|lidocaine|mesh-list
20429805|NCT01300377|Bupivacaine|bupivacaine|mesh-list
20429806|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
20429807|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
20429808|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429809|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429810|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
20429811|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429812|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20429813|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20429814|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20429815|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429816|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429817|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20429818|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20429819|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
20429820|NCT01300637|Metformin|metformin|mesh-list
20429821|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20429822|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429823|NCT01300676|Estradiol|estradiol|mesh-list
20429824|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
20429825|NCT01300676|Estrogens|estrogens|mesh-ancestor
20429826|NCT01300676|Hormones|hormones|mesh-ancestor
20429827|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429828|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429829|NCT01300676|Progestins|progestins|mesh-ancestor
20429830|NCT01300754|Lidocaine|lidocaine|mesh-list
20429831|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
20429832|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
20429833|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20429834|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429835|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
20429836|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429837|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20429838|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20429839|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20429840|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20429841|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429842|NCT01300780|Etoricoxib|etoricoxib|mesh-list
20429843|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20429844|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20429845|NCT01300780|Analgesics|analgesics|mesh-ancestor
20429846|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
20429847|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429848|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429849|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429850|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613229|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404885|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429851|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20429852|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20429853|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429854|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429855|NCT01300793|Rituximab|rituximab|mesh-list
20429856|NCT01300793|Carboplatin|carboplatin|mesh-list
20429857|NCT01300793|Etoposide|etoposide|mesh-list
20429858|NCT01300793|Bortezomib|bortezomib|mesh-list
20429859|NCT01300793|Ifosfamide|ifosfamide|mesh-list
20429860|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
20429861|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20429862|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429863|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
20429864|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429865|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429866|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20429867|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20429868|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20429869|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429870|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429871|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20429872|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
20429873|NCT01300962|Capecitabine|capecitabine|mesh-list
20429874|NCT01300962|Trastuzumab|trastuzumab|mesh-list
20429875|NCT01300962|Lapatinib|lapatinib|mesh-list
20429876|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20429877|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
20429878|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429879|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429880|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20429881|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20429882|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429883|NCT01300988|Aprepitant|aprepitant|mesh-list
20429884|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
20429885|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
20429886|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
20429887|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20429888|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429889|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429890|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20429891|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429892|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429893|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
20429894|NCT01301040|Docetaxel|docetaxel|mesh-list
20429895|NCT01301040|Epirubicin|epirubicin|mesh-list
20429896|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20429897|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
20429898|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429899|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20429900|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20429901|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
20429902|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429903|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429904|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20429905|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
20429906|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
20429907|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
20429908|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20429909|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20429910|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20429911|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429912|NCT01301053|Insulin|insulin|mesh-list
20429913|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20429914|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20429915|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429916|NCT01301222|Octreotide|octreotide|mesh-list
20429917|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20429918|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20429919|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429920|NCT01301248|Cisplatin|cisplatin|mesh-list
20429921|NCT01301248|Cetuximab|cetuximab|mesh-list
20429922|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429923|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20429924|NCT01301313|Simendan|simendan|mesh-list
20429925|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20429926|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
20523377|NCT01745640|Growth Substances|growth substances|mesh-ancestor
20429927|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20429928|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20429929|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429930|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429931|NCT01301313|Protective Agents|protective agents|mesh-ancestor
20429932|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429933|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20523378|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
20523379|NCT01745666|Epinephrine|epinephrine|mesh-list
20523380|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20523381|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20523382|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523383|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523384|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523385|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523386|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20523387|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20523388|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
20523389|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523390|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20523391|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
20523392|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
20523393|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
20523394|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20523395|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
20523396|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20523397|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523398|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20523399|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20523400|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20523401|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523402|NCT01745770|Mesalamine|mesalamine|mesh-list
20523403|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20523404|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523405|NCT01745770|Analgesics|analgesics|mesh-ancestor
20523406|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
20523407|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523408|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523409|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523410|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523411|NCT01745835|Bisacodyl|bisacodyl|mesh-list
20523412|NCT01745835|Cathartics|cathartics|mesh-ancestor
20523413|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523414|NCT01745835|Laxatives|laxatives|mesh-ancestor
20523415|NCT01745965|Trastuzumab|trastuzumab|mesh-list
20523416|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20523417|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523418|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
20523419|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
20523420|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20523421|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20523422|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
20523423|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
20523424|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20523425|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20523426|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523427|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20523428|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523429|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523430|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20523431|NCT01746199|Renal Agents|renal agents|mesh-ancestor
20523432|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20523433|NCT01746251|Afatinib|afatinib|mesh-list
20523434|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523435|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20523436|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523437|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523438|NCT01746277|Docetaxel|docetaxel|mesh-list
20523439|NCT01746277|Pemetrexed|pemetrexed|mesh-list
20523440|NCT01746277|Gefitinib|gefitinib|mesh-list
20523441|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523442|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
20523443|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
20523444|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
20523445|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429934|NCT01301586|Doxycycline|doxycycline|mesh-list
20429935|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20429936|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429937|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
20429938|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20429939|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20429940|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
20429941|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
20429942|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20429943|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
20429944|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20429945|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429946|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429947|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20429948|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429949|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
20429950|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20429951|NCT01301612|Cisplatin|cisplatin|mesh-list
20429952|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
20429953|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429954|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20429955|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
20429956|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20429957|NCT01301716|Paclitaxel|paclitaxel|mesh-list
20429958|NCT01301716|Bevacizumab|bevacizumab|mesh-list
20429959|NCT01301716|Carboplatin|carboplatin|mesh-list
20429960|NCT01301716|Pemetrexed|pemetrexed|mesh-list
20429961|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20429962|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429963|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
20429964|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
20429965|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
20429966|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429967|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20429968|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20429969|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20429970|NCT01301716|Growth Substances|growth substances|mesh-ancestor
20429971|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429972|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
20429973|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429974|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20218181|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693206|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20429975|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20429976|NCT01301807|Panobinostat|panobinostat|mesh-list
20429977|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429978|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20429979|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429980|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429981|NCT01301820|Lenalidomide|lenalidomide|mesh-list
20429982|NCT01301820|Azacitidine|azacitidine|mesh-list
19404886|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404887|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
19404888|NCT03591471|Hormones|hormones|mesh-ancestor
19404889|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404890|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19404891|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404892|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
19693207|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19693208|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20218182|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218183|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
20218184|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20218185|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218186|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20218187|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
20218188|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20218189|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218190|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429983|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
20429984|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20429985|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20429986|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20429987|NCT01301820|Growth Substances|growth substances|mesh-ancestor
20429988|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
20429989|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20429990|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20429991|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
20429992|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20429993|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20429994|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20429995|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20429996|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20429997|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20429998|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20429999|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20430000|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20430001|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430002|NCT01302002|Metformin|metformin|mesh-list
20430003|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430004|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430005|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
20430006|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20430007|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430008|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430009|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430010|NCT01302093|Racecadotril|racecadotril|mesh-list
20430011|NCT01302093|Thiorphan|thiorphan|mesh-list
20430012|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
20430013|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20430014|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
20430015|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430016|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430017|NCT01302106|Clofarabine|clofarabine|mesh-list
20430018|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20430019|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
20430020|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430021|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430022|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
20430023|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20430024|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430025|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430026|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430027|NCT01302145|Metformin|metformin|mesh-list
20430028|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
20430029|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430030|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430031|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20430032|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430033|NCT01302158|Glimepiride|glimepiride|mesh-list
20430034|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
20430035|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20430036|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430037|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430038|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430039|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
20430040|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20430041|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430042|NCT01302171|Sargramostim|sargramostim|mesh-list
20430043|NCT01302171|Lenograstim|lenograstim|mesh-list
20430044|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
20430045|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430046|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20430047|NCT01302210|Mupirocin|mupirocin|mesh-list
20430048|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20430049|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430050|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20430051|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430052|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430053|NCT01302236|Eplerenone|eplerenone|mesh-list
20430054|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20430055|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
20430056|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430057|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430058|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20430059|NCT01302236|Diuretics|diuretics|mesh-ancestor
20430060|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
20430061|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20430062|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
20430063|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
20430064|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20430065|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20430066|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20430067|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430068|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20430069|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20430070|NCT01302340|Dronabinol|dronabinol|mesh-list
20430071|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
20430072|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430073|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20430074|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20430075|NCT01302340|Analgesics|analgesics|mesh-ancestor
20430076|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
20430077|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430078|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20430079|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20430080|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430081|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430082|NCT01302340|Hormones|hormones|mesh-ancestor
20430083|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430084|NCT01302353|Isoflurane|isoflurane|mesh-list
20430085|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20430086|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
20430087|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
20430088|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430089|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430090|NCT01302496|Ipilimumab|ipilimumab|mesh-list
20430091|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430092|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430093|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20430094|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430095|NCT01302587|Albuterol|albuterol|mesh-list
20430096|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20430097|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
20430098|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430099|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430100|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20430101|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
20430102|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
20430103|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20430104|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20430105|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20430106|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20430107|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430108|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430109|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430110|NCT01302613|Leucovorin|leucovorin|mesh-list
20430111|NCT01302613|Capecitabine|capecitabine|mesh-list
20430112|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
20430113|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20613230|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20613231|NCT02254031|Maytansine|maytansine|mesh-list
20613232|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
20613233|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20613234|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613235|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20613236|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20613237|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20613238|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613239|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20613240|NCT02254044|Maytansine|maytansine|mesh-list
20613241|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
20613242|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20613243|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613244|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
20613245|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
20613246|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
20613247|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613248|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430114|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
20430115|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430116|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430117|NCT01302613|Antidotes|antidotes|mesh-ancestor
20430118|NCT01302613|Protective Agents|protective agents|mesh-ancestor
20430119|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430120|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
20430121|NCT01302613|Vitamins|vitamins|mesh-ancestor
20430122|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
20430123|NCT01302756|Folic Acid|folic acid|mesh-list
20430124|NCT01302756|Hematinics|hematinics|mesh-ancestor
20430125|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
20430126|NCT01302756|Vitamins|vitamins|mesh-ancestor
20430127|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
20430128|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430129|NCT01302821|Tryptophan|tryptophan|mesh-list
20430130|NCT01302821|Vaccines|vaccines|mesh-list
20430131|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
20430132|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430133|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20430134|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
20430135|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20430136|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
20430137|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20430138|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430139|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20430140|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20430141|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430142|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430143|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430144|NCT01303029|Gemcitabine|gemcitabine|mesh-list
20430145|NCT01303029|Capecitabine|capecitabine|mesh-list
20430146|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20430147|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20430148|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
20430149|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430150|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430151|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
20430152|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430153|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430154|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430155|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
20430156|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430157|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848292|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848293|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848294|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
19848295|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
19848296|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
19848297|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19848298|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19848299|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848300|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848301|NCT00692237|Urological Agents|urological agents|mesh-ancestor
20218191|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430158|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
20430159|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
20430160|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430161|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430162|NCT01303055|Metformin|metformin|mesh-list
20430163|NCT01303055|Alogliptin|alogliptin|mesh-list
20430164|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430165|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430166|NCT01303055|Incretins|incretins|mesh-ancestor
20430167|NCT01303055|Hormones|hormones|mesh-ancestor
20218192|NCT00312156|Insulin|insulin|mesh-list
20218193|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20218194|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
20218195|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
20218196|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
20218197|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
20218198|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
20218199|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218200|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218201|NCT00312182|Nelfinavir|nelfinavir|mesh-list
20218202|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20430168|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247158|NCT00431236|Dexamethasone|dexamethasone|mesh-list
20430169|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20430170|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
20430171|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430172|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430173|NCT01303094|Trabectedin|trabectedin|mesh-list
20430174|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20430175|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
20430176|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430177|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430178|NCT01303107|Bupivacaine|bupivacaine|mesh-list
20430179|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
20430180|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
20430181|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430182|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430183|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
20430184|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430185|NCT01303237|Cetuximab|cetuximab|mesh-list
20430186|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430187|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430188|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20430189|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
20430190|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
20523446|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523447|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20523448|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20523449|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20523450|NCT01746485|Treprostinil|treprostinil|mesh-list
20523451|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20523452|NCT01746563|Ranibizumab|ranibizumab|mesh-list
20523453|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20523454|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20523455|NCT01746563|Growth Substances|growth substances|mesh-ancestor
20523456|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523457|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
20523458|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523459|NCT01746602|Timolol|timolol|mesh-list
20523460|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20523461|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20523462|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523463|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523464|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523465|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523466|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20523467|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20523468|NCT01746641|Remifentanil|remifentanil|mesh-list
20523469|NCT01746641|Propofol|propofol|mesh-list
20523470|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20523471|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523472|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523473|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20523474|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
20523475|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
20523476|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20523477|NCT01746641|Narcotics|narcotics|mesh-ancestor
20523478|NCT01746641|Analgesics|analgesics|mesh-ancestor
20523479|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
20523480|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530303|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20530304|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20530305|NCT01787669|Growth Substances|growth substances|mesh-ancestor
20530306|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218203|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20218204|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
20218205|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218206|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218207|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20218208|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20218209|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
20218210|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218211|NCT00312260|Gabapentin|gabapentin|mesh-list
20218212|NCT00312260|Amitriptyline|amitriptyline|mesh-list
20218213|NCT00312260|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20218214|NCT00312260|Analgesics|analgesics|mesh-ancestor
20530307|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
20530308|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430191|NCT01303471|Remifentanil|remifentanil|mesh-list
20430192|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20430193|NCT01303471|Narcotics|narcotics|mesh-ancestor
20430194|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430195|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430196|NCT01303471|Analgesics|analgesics|mesh-ancestor
20430197|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
20430198|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430199|NCT01303497|Paclitaxel|paclitaxel|mesh-list
20430200|NCT01303497|Bevacizumab|bevacizumab|mesh-list
20430201|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20430202|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430203|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
20430204|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
20430205|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
20430206|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430207|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430208|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20430209|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20430210|NCT01303497|Growth Substances|growth substances|mesh-ancestor
20430211|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430212|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
20430213|NCT01303536|Ondansetron|ondansetron|mesh-list
20430214|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
20430215|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
20430216|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430217|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430218|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20430219|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
20430220|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
20430221|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20430222|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
20430223|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430224|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430225|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20430226|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20430227|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430228|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20430229|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20430230|NCT01303549|Amphotericin B|amphotericin b|mesh-list
20430231|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20430232|NCT01303549|Anidulafungin|anidulafungin|mesh-list
20430233|NCT01303549|Amebicides|amebicides|mesh-ancestor
20430234|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20430235|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20430236|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430237|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20430238|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
20430239|NCT01303601|Olanzapine|olanzapine|mesh-list
20430240|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
20430241|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
20430242|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430243|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430244|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20430245|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20430246|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20430247|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430248|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20430249|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20430250|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20430251|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20430252|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430253|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430254|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
20430255|NCT01303614|Lidocaine|lidocaine|mesh-list
20430256|NCT01303614|Prilocaine|prilocaine|mesh-list
20430257|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20430258|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
20430259|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
20430260|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430261|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430262|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
20430263|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430264|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20430265|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19693209|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430266|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20430267|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20430268|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430269|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20430270|NCT01303640|Everolimus|everolimus|mesh-list
20430271|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430272|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430273|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
20430274|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430275|NCT01303679|Paclitaxel|paclitaxel|mesh-list
20430276|NCT01303679|Bevacizumab|bevacizumab|mesh-list
20430277|NCT01303679|Exemestane|exemestane|mesh-list
20430278|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20430279|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430280|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
20430281|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
20430282|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
20430283|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430284|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430285|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20430286|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20430287|NCT01303679|Growth Substances|growth substances|mesh-ancestor
20430288|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430289|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
20430290|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20430291|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20430292|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430293|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20430294|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
20430295|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430296|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
20430297|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430298|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
20430299|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430300|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430301|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20430302|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
20430303|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430304|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430305|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20430306|NCT01303731|Fentanyl|fentanyl|mesh-list
20430307|NCT01303731|Bupivacaine|bupivacaine|mesh-list
20430308|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
20430309|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
20430310|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430311|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430312|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
20430313|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430314|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20430315|NCT01303731|Narcotics|narcotics|mesh-ancestor
20430316|NCT01303731|Analgesics|analgesics|mesh-ancestor
20430317|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20430318|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20430319|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
20430320|NCT01303796|Decitabine|decitabine|mesh-list
20430321|NCT01303796|Sapacitabine|sapacitabine|mesh-list
20430322|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20430323|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
20430324|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430325|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430326|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430327|NCT01303874|Etanercept|etanercept|mesh-list
20430328|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20430329|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20430330|NCT01303874|Analgesics|analgesics|mesh-ancestor
20430331|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
20430332|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430333|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430334|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430335|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430336|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20430337|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430338|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
20430339|NCT01303887|Prednisolone|prednisolone|mesh-list
20430340|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
20430341|NCT01303887|Rituximab|rituximab|mesh-list
20430342|NCT01303887|Fludarabine|fludarabine|mesh-list
20430343|NCT01303887|Vincristine|vincristine|mesh-list
20430344|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430345|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
20430346|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430347|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430348|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20430349|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
20430350|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430351|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430352|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20430353|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430354|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20430355|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
20430356|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
20430357|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
20430358|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430359|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
20430360|NCT01303887|Hormones|hormones|mesh-ancestor
20430361|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430362|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20430363|NCT01303926|Paclitaxel|paclitaxel|mesh-list
20430364|NCT01303926|Bevacizumab|bevacizumab|mesh-list
20430365|NCT01303926|Carboplatin|carboplatin|mesh-list
20430366|NCT01303926|Pemetrexed|pemetrexed|mesh-list
20430367|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20430368|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430369|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
20430370|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
20430371|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
20430372|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430373|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430374|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20430375|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20430376|NCT01303926|Growth Substances|growth substances|mesh-ancestor
20430377|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430378|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
20430379|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430380|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20430381|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20430382|NCT01303952|Eculizumab|eculizumab|mesh-list
20430383|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20430384|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430385|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
20430386|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430387|NCT01304069|Etoricoxib|etoricoxib|mesh-list
20218215|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
20218216|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218217|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218218|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
20218219|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20218220|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20218221|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430388|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20430389|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20430390|NCT01304069|Analgesics|analgesics|mesh-ancestor
20430391|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
20430392|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430393|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430394|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430395|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430396|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20430397|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20430398|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430399|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430400|NCT01304095|Ranolazine|ranolazine|mesh-list
20430401|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20430402|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20430403|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430404|NCT01304134|Morphine|morphine|mesh-list
20430405|NCT01304134|Oxycodone|oxycodone|mesh-list
20430406|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20430407|NCT01304134|Narcotics|narcotics|mesh-ancestor
20523481|NCT01746680|Methotrexate|methotrexate|mesh-list
20430408|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430409|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430410|NCT01304134|Analgesics|analgesics|mesh-ancestor
20430411|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
20430412|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430413|NCT01304212|Ketorolac|ketorolac|mesh-list
20430414|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20430415|NCT01304212|Epinephrine|epinephrine|mesh-list
20430416|NCT01304212|Racepinephrine|racepinephrine|mesh-list
20430417|NCT01304212|Morphine|morphine|mesh-list
20430418|NCT01304212|Ropivacaine|ropivacaine|mesh-list
20430419|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
20430420|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20430421|NCT01304212|Narcotics|narcotics|mesh-ancestor
20430422|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430423|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430424|NCT01304212|Analgesics|analgesics|mesh-ancestor
20430425|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
20430426|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430427|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
20430428|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
20430429|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20430430|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20430431|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430432|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430433|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430434|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20430435|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20430436|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
20430437|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20430438|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
20430439|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
20430440|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
20430441|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20430442|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20430443|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20430444|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430445|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430446|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20430447|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430448|NCT01304264|Maleic acid|maleic acid|mesh-list
20430449|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430450|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430451|NCT01304316|Phenylephrine|phenylephrine|mesh-list
20430452|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
20430453|NCT01304316|Tetracaine|tetracaine|mesh-list
20430454|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
20430455|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
20430456|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430457|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430458|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
20430459|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430460|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20430461|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20430462|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430463|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430464|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430465|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
20430466|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
20430467|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
20430468|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20430469|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
20430470|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20430471|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
20430472|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20430473|NCT01304316|Protective Agents|protective agents|mesh-ancestor
20430474|NCT01304342|Fentanyl|fentanyl|mesh-list
20430475|NCT01304342|Remifentanil|remifentanil|mesh-list
20430476|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20430477|NCT01304342|Narcotics|narcotics|mesh-ancestor
20430478|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430479|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430480|NCT01304342|Analgesics|analgesics|mesh-ancestor
20430481|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
20430482|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693210|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430483|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20430484|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20430485|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
20430486|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
20430487|NCT01304472|Clopidogrel|clopidogrel|mesh-list
20430488|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20430489|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20430490|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20430491|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20430492|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20430493|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
20430494|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430495|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430496|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430497|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20430498|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
20430499|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20430500|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20430501|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
20430502|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430503|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430504|NCT01304563|Vaccines|vaccines|mesh-list
20430505|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
20430506|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430507|NCT01304602|Irinotecan|irinotecan|mesh-list
20430508|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20430509|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20430510|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430511|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430512|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404893|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19404894|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19404895|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404896|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19404897|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404898|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19404899|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
19404900|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19404901|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
19404902|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19404903|NCT03591341|Melatonin|melatonin|mesh-list
19404904|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
19404905|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404906|NCT03591341|Protective Agents|protective agents|mesh-ancestor
19404907|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404908|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19404909|NCT03591289|Bromides|bromides|mesh-list
19404910|NCT03591289|Rocuronium|rocuronium|mesh-list
19404911|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
19404912|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19404913|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19404914|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19404915|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848302|NCT00692341|Axitinib|axitinib|mesh-list
20218222|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20430513|NCT01304784|Paclitaxel|paclitaxel|mesh-list
20430514|NCT01304784|Docetaxel|docetaxel|mesh-list
20430515|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20430516|NCT01304784|Capecitabine|capecitabine|mesh-list
20430517|NCT01304784|Trastuzumab|trastuzumab|mesh-list
20430518|NCT01304784|Lapatinib|lapatinib|mesh-list
20430519|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20430520|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20430521|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430522|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
20430523|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
20430524|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218223|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20218224|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20218225|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218226|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218227|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
20218228|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20218229|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
20218230|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523482|NCT01746680|Tacrolimus|tacrolimus|mesh-list
20430525|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430526|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20430527|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
20430528|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430529|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20430530|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430531|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
20430532|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430533|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
20430534|NCT01304797|Trastuzumab|trastuzumab|mesh-list
20430535|NCT01304797|Doxorubicin|doxorubicin|mesh-list
20430536|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
20430537|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430538|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
20430539|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430540|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430541|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20430542|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
20430543|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430544|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430545|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20430546|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430547|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20430548|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20430549|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20430550|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430551|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
20430552|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
20430553|NCT01304836|Prednisolone|prednisolone|mesh-list
20430554|NCT01304836|Tacrolimus|tacrolimus|mesh-list
20430555|NCT01304836|Basiliximab|basiliximab|mesh-list
20430556|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430557|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
20430558|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430559|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20430560|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430561|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430562|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20430563|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430564|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20430565|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
20430566|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20430567|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430568|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430569|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
20430570|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
20430571|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430572|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20430573|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
20430574|NCT01304836|Hormones|hormones|mesh-ancestor
20430575|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430576|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20430577|NCT01304836|Protective Agents|protective agents|mesh-ancestor
20430578|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20430579|NCT01304901|Montelukast|montelukast|mesh-list
20430580|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20430581|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
20430582|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20430583|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
20430584|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430585|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430586|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20430587|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20430588|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430589|NCT01304927|Vitamin D|vitamin d|mesh-list
20430590|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
20430591|NCT01304927|Calcium|calcium|mesh-list
20430592|NCT01304927|Vitamins|vitamins|mesh-ancestor
20430593|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
20430594|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430595|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20430596|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20523483|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20523484|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
20430597|NCT01305057|Pyridoxine|pyridoxine|mesh-list
20430598|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
20430599|NCT01305057|Vitamins|vitamins|mesh-ancestor
20430600|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
20430601|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430602|NCT01305083|Udenafil|udenafil|mesh-list
20430603|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20430604|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20430605|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430606|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430607|NCT01305135|Azacitidine|azacitidine|mesh-list
20430608|NCT01305135|Idarubicin|idarubicin|mesh-list
20430609|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20430610|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
20430611|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430612|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430613|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430614|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20430615|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20430616|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20430617|NCT01305148|Warfarin|warfarin|mesh-list
20430618|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
20430619|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
20430620|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20430621|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
20430622|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430623|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
20430624|NCT01305187|Protective Agents|protective agents|mesh-ancestor
20430625|NCT01305226|Streptokinase|streptokinase|mesh-list
20430626|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20430627|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20430628|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430629|NCT01305317|Atorvastatin|atorvastatin|mesh-list
20430630|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20430631|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20430632|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
20430633|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430634|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20430635|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20430636|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430637|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20430638|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20430639|NCT01305395|Sirolimus|sirolimus|mesh-list
20430640|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20430641|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430642|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20430643|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430644|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
20430645|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20430646|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
20430647|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430648|NCT01305551|Metformin|metformin|mesh-list
20430649|NCT01305551|Saxagliptin|saxagliptin|mesh-list
20430650|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20430651|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430652|NCT01305551|Incretins|incretins|mesh-ancestor
20430653|NCT01305551|Hormones|hormones|mesh-ancestor
20430654|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430655|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20430656|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
20430657|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430658|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430659|NCT01305603|Bupivacaine|bupivacaine|mesh-list
20430660|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
20430661|NCT01305603|Anesthetics|anesthetics|mesh-list
20430662|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430663|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404916|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404917|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
19404918|NCT03591172|Propolis|propolis|mesh-list
20430664|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
20430665|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430666|NCT01305707|Diazepam|diazepam|mesh-list
20430667|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20430668|NCT01305707|Lorazepam|lorazepam|mesh-list
20430669|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
20430670|NCT01305707|Dexetimide|dexetimide|mesh-list
20430671|NCT01305707|Olanzapine|olanzapine|mesh-list
20430672|NCT01305707|Risperidone|risperidone|mesh-list
20430673|NCT01305707|Aripiprazole|aripiprazole|mesh-list
20430674|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20430675|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
20430676|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
20430677|NCT01305707|Mirtazapine|mirtazapine|mesh-list
20430678|NCT01305707|Citalopram|citalopram|mesh-list
20430679|NCT01305707|Sertraline|sertraline|mesh-list
20430680|NCT01305707|Fluoxetine|fluoxetine|mesh-list
20430681|NCT01305707|Paroxetine|paroxetine|mesh-list
20430682|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20430683|NCT01305707|Nortriptyline|nortriptyline|mesh-list
20430684|NCT01305707|Imipramine|imipramine|mesh-list
20430685|NCT01305707|Clomipramine|clomipramine|mesh-list
20430686|NCT01305707|Mianserin|mianserin|mesh-list
20430687|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
19404919|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404920|NCT03591003|Antibodies|antibodies|mesh-list
19404921|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
19404922|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
19404923|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404924|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
19404925|NCT03590912|Cetirizine|cetirizine|mesh-list
19404926|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19404927|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
20430688|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20430689|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
20430690|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430691|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430692|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430693|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20430694|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430695|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20430696|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20430697|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
20430698|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20430699|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20430700|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20430701|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20430702|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20430703|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20430704|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
20430705|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
20430706|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613249|NCT02254148|Metoprolol|metoprolol|mesh-list
20613250|NCT02254148|Digoxin|digoxin|mesh-list
20613251|NCT02254148|Midazolam|midazolam|mesh-list
20613252|NCT02254148|Caffeine|caffeine|mesh-list
20613253|NCT02254148|Omeprazole|omeprazole|mesh-list
20613254|NCT02254148|Warfarin|warfarin|mesh-list
20613255|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20613256|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20613257|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613258|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613259|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20613260|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20613261|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613262|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20613263|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
20613264|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
20613265|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
20613266|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
20613267|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613268|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613269|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
20613270|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20613271|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20613272|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20613273|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613274|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20613275|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20430707|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19404928|NCT03590912|Prednisolone|prednisolone|mesh-list
20430708|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20430709|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
20613276|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20613277|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19404929|NCT03590912|Phenylephrine|phenylephrine|mesh-list
20430710|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
20430711|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20430712|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
20430713|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20430714|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20430715|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20430716|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20430717|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20430718|NCT01305707|Analgesics|analgesics|mesh-ancestor
20430719|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
20430720|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20430721|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20430722|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430723|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
20430724|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
20430725|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20430726|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20430727|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
20430728|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
20430729|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20430730|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
20430731|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
20430732|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20430733|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20430734|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20430735|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430736|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20430737|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20430738|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20430739|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20430740|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20430741|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
20430742|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
20430743|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20430744|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20430745|NCT01305733|Ketorolac|ketorolac|mesh-list
20430746|NCT01305733|Epinephrine|epinephrine|mesh-list
20430747|NCT01305733|Racepinephrine|racepinephrine|mesh-list
20430748|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
20430749|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
20430750|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20430751|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20430752|NCT01305733|Analgesics|analgesics|mesh-ancestor
20430753|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
20430754|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430755|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430756|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430757|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430758|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20430759|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430760|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430761|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
20430762|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
20430763|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430764|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20430765|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20430766|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430767|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430768|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20430769|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20430770|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
20430771|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20430772|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
20430773|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
20430774|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
20430775|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20430776|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
20430777|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20430778|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20430779|NCT01305837|Prednisolone|prednisolone|mesh-list
20430780|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
20430781|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20430782|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
20430783|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430784|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
20430785|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
20430786|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430787|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430788|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20430789|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
20430790|NCT01305837|Hormones|hormones|mesh-ancestor
20430791|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430792|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20430793|NCT01305837|Protective Agents|protective agents|mesh-ancestor
20430794|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20430795|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430796|NCT01305850|Losartan|losartan|mesh-list
20430797|NCT01305850|Enalapril|enalapril|mesh-list
20430798|NCT01305850|Enalaprilat|enalaprilat|mesh-list
20430799|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20430800|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20430801|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20430802|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20430803|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430804|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20430805|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
20430806|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430807|NCT01306006|Vaccines|vaccines|mesh-list
20430808|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
20430809|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430810|NCT01306097|Zinc|zinc|mesh-list
20430811|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
20430812|NCT01306097|Trace Elements|trace elements|mesh-ancestor
20430813|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
20430814|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430815|NCT01306097|Astringents|astringents|mesh-ancestor
20430816|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
20430817|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
20430818|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
20430819|NCT01306123|Vitamins|vitamins|mesh-ancestor
20430820|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
20430821|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430822|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
20430823|NCT01306123|Hematinics|hematinics|mesh-ancestor
20430824|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20430825|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
20430826|NCT01306266|Rizatriptan|rizatriptan|mesh-list
20430827|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20430828|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
20430829|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430830|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430831|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430832|NCT01306318|Diclofenac|diclofenac|mesh-list
20430833|NCT01306318|Eperisone|eperisone|mesh-list
20430834|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20430835|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20430836|NCT01306318|Analgesics|analgesics|mesh-ancestor
20430837|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
20430838|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430839|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430840|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20430841|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20430842|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20430843|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430844|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430845|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
20430846|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20430847|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20430848|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20430849|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20430850|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20430851|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
20430852|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
20430853|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
20430854|NCT01306357|Hormones|hormones|mesh-list
20430855|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20430856|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430857|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
20430858|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20430859|NCT01306370|Hemostatics|hemostatics|mesh-list
20430860|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20430861|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20613278|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
20430862|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430863|NCT01306370|Coagulants|coagulants|mesh-ancestor
20430864|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
20430865|NCT01306409|Hematinics|hematinics|mesh-ancestor
20430866|NCT01306461|Timolol|timolol|mesh-list
20430867|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20430868|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20430869|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430870|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430871|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430872|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430873|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20430874|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20430875|NCT01306565|Atorvastatin|atorvastatin|mesh-list
20430876|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20430877|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20430878|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
20430879|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430880|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20430881|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20430882|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430883|NCT01306591|Bevacizumab|bevacizumab|mesh-list
20430884|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20430885|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430886|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20430887|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20430888|NCT01306591|Growth Substances|growth substances|mesh-ancestor
20430889|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430890|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
20430891|NCT01306630|Capecitabine|capecitabine|mesh-list
20430892|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20430893|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
20430894|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430895|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430896|NCT01306708|Amitriptyline|amitriptyline|mesh-list
19848303|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848304|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848305|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848306|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848307|NCT00692770|Sorafenib|sorafenib|mesh-list
19848308|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848309|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848310|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848311|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848312|NCT00692978|Fluticasone|fluticasone|mesh-list
19848313|NCT00692978|Xhance|xhance|mesh-list
19848314|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848315|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19848316|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
19848317|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218231|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20218232|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20218233|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20218234|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
20218235|NCT00312260|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20218236|NCT00312273|Aminophylline|aminophylline|mesh-list
20218237|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20218238|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
20218239|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218240|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218241|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20218242|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
20218243|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20218244|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20218245|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218246|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218247|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20218248|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20218249|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
20218250|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530309|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
19848318|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218251|NCT00312273|Protective Agents|protective agents|mesh-ancestor
20218252|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20218253|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
20218254|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20430897|NCT01306708|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20430898|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20430899|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
20430900|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20430901|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20430902|NCT01306708|Analgesics|analgesics|mesh-ancestor
20430903|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
20430904|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430905|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430906|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20430907|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20430908|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20430909|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430910|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430911|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430912|NCT01306708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20430913|NCT01306708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20430914|NCT01306708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430915|NCT01306721|Fexofenadine|fexofenadine|mesh-list
20430916|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
19404930|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
19404931|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
19404932|NCT03590912|Levocetirizine|levocetirizine|mesh-list
19404933|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
19404934|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19404935|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404936|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404937|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
20430917|NCT01306721|Ephedrine|ephedrine|mesh-list
20430918|NCT01306721|Terfenadine|terfenadine|mesh-list
20430919|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404938|NCT03590912|Hormones|hormones|mesh-ancestor
19404939|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404940|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404941|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19404942|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404943|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
19404944|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19404945|NCT03590912|Protective Agents|protective agents|mesh-ancestor
19404946|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19693211|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693212|NCT04981886|Bimatoprost|bimatoprost|mesh-list
19693213|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218255|NCT00312299|Protective Agents|protective agents|mesh-ancestor
20218256|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218257|NCT00312325|Prednisolone|prednisolone|mesh-list
20218258|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20218259|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
20218260|NCT00312325|Hormones|hormones|mesh-ancestor
20218261|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218262|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430920|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
20430921|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430922|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430923|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20430924|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
20430925|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
20430926|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20430927|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20430928|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
20430929|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
20430930|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430931|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430932|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20430933|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20430934|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19693214|NCT04982055|Nadroparin|nadroparin|mesh-list
19404947|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19693215|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
20247159|NCT00431236|Ondansetron|ondansetron|mesh-list
20430935|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
20430936|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
20430937|NCT01306760|Ketamine|ketamine|mesh-list
20430938|NCT01306760|Propofol|propofol|mesh-list
20430939|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20430940|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20430941|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218263|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218264|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218265|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20218266|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218267|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20430942|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20430943|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
20430944|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
20430945|NCT01306760|Analgesics|analgesics|mesh-ancestor
20430946|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
20430947|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430948|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20430949|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20430950|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20430951|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430952|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430953|NCT01306773|Oseltamivir|oseltamivir|mesh-list
20430954|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
20430955|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430956|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430957|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523485|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20523486|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218268|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20218269|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20218270|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
20218271|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523487|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20523488|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
20523489|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523490|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523491|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20523492|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523493|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20523494|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20523495|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
20523496|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523497|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20523498|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20523499|NCT01746719|Etodolac|etodolac|mesh-list
20523500|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20523501|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523502|NCT01746719|Analgesics|analgesics|mesh-ancestor
20523503|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
20523504|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523505|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523506|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523507|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523508|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19693216|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20218272|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218273|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218274|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
20218275|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
20218276|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
20523509|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20523510|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523511|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693217|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19693218|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693219|NCT04981743|Vitamin D|vitamin d|mesh-list
19693220|NCT04981743|Vitamins|vitamins|mesh-ancestor
19693221|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
19693222|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218277|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20218278|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430958|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20430959|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
20430960|NCT01306851|Coagulants|coagulants|mesh-ancestor
20430961|NCT01306864|Hemostatics|hemostatics|mesh-list
20430962|NCT01306864|Coagulants|coagulants|mesh-ancestor
20430963|NCT01306981|Ranibizumab|ranibizumab|mesh-list
20430964|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20430965|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20430966|NCT01306981|Growth Substances|growth substances|mesh-ancestor
20430967|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430968|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
20430969|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20430970|NCT01306994|Adenosine|adenosine|mesh-list
20430971|NCT01306994|Analgesics|analgesics|mesh-ancestor
20430972|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
20430973|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430974|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430975|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20430976|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
20430977|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20430978|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
20430979|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
20430980|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20430981|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430982|NCT01307124|Lopinavir|lopinavir|mesh-list
20430983|NCT01307124|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20430984|NCT01307124|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20430985|NCT01307124|Protease Inhibitors|protease inhibitors|mesh-ancestor
20430986|NCT01307124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20430987|NCT01307124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20430988|NCT01307124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20430989|NCT01307124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20430990|NCT01307124|Antiviral Agents|antiviral agents|mesh-ancestor
20430991|NCT01307124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20430992|NCT01307124|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20430993|NCT01307124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20430994|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
20430995|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20430996|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
20430997|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20430998|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20430999|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20431000|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
20431001|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
20431002|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20431003|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
20431004|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431005|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431006|NCT01307202|Gabapentin|gabapentin|mesh-list
20431007|NCT01307202|Analgesics|analgesics|mesh-ancestor
20431008|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
20431009|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431010|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431011|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
20431012|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19693223|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20431013|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20431014|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431015|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20431016|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20431017|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20431018|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431019|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431020|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
20431021|NCT01307215|Ropivacaine|ropivacaine|mesh-list
20431022|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
20431023|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
20431024|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431025|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431026|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
19693224|NCT04981457|Misoprostol|misoprostol|mesh-list
19693225|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20431027|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431028|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
20431029|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431030|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431031|NCT01307475|Adenosine|adenosine|mesh-list
20431032|NCT01307475|Analgesics|analgesics|mesh-ancestor
20431033|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
20431034|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431035|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431036|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20431037|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
20431038|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20431039|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
20431040|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
20431041|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431042|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431043|NCT01307488|Ritonavir|ritonavir|mesh-list
20431044|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20431045|NCT01307488|Lamivudine|lamivudine|mesh-list
20431046|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20431047|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20431048|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
20431049|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431050|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431051|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20431052|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20431053|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
20431054|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431055|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20431056|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20431057|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20431058|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20431059|NCT01307527|Riboflavin|riboflavin|mesh-list
20431060|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
20431061|NCT01307527|Vitamins|vitamins|mesh-ancestor
20431062|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
20431063|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431064|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20431065|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
20431066|NCT01307592|Gemcitabine|gemcitabine|mesh-list
20431067|NCT01307592|Rituximab|rituximab|mesh-list
20431068|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
20431069|NCT01307592|Lenalidomide|lenalidomide|mesh-list
20431070|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431071|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431072|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
20431073|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431074|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20431075|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20431076|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
20431077|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431078|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
20431079|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431080|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431081|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431082|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431083|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20431084|NCT01307592|Growth Substances|growth substances|mesh-ancestor
20431085|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
20431086|NCT01307605|Rituximab|rituximab|mesh-list
20431087|NCT01307605|Lenalidomide|lenalidomide|mesh-list
20431088|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431089|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431090|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
20431091|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431092|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20431093|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431094|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20431095|NCT01307605|Growth Substances|growth substances|mesh-ancestor
20431096|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
20431097|NCT01307839|Lidocaine|lidocaine|mesh-list
20431098|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
20431099|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
20431100|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431101|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431102|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
19693226|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
20431103|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431104|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20523512|NCT01746771|Paclitaxel|paclitaxel|mesh-list
20431105|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20431106|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20431107|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431108|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431109|NCT01307865|Mannitol|mannitol|mesh-list
20431110|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20431111|NCT01307865|Diuretics|diuretics|mesh-ancestor
20431112|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
20431113|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431114|NCT01307969|Lidocaine|lidocaine|mesh-list
20431115|NCT01307969|Epinephrine|epinephrine|mesh-list
20431116|NCT01307969|Racepinephrine|racepinephrine|mesh-list
20431117|NCT01307969|Ropivacaine|ropivacaine|mesh-list
20431118|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
20431119|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
20431120|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
20431121|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431122|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431123|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
20431124|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431125|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20431126|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20431127|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20431128|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431129|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431130|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20431131|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20431132|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431133|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431134|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20431135|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20431136|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
20431137|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20431138|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
20431139|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
20431140|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
20431141|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20431142|NCT01308047|Bupivacaine|bupivacaine|mesh-list
20431143|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
20431144|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
20431145|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431146|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431147|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
20431148|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431149|NCT01308086|Leucovorin|leucovorin|mesh-list
20431150|NCT01308086|Fluorouracil|fluorouracil|mesh-list
20431151|NCT01308086|Capecitabine|capecitabine|mesh-list
20431152|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
20431153|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
20613279|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20218279|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
20218280|NCT00312481|Protective Agents|protective agents|mesh-ancestor
20218281|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218282|NCT00312481|Vitamins|vitamins|mesh-ancestor
20218283|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
20218284|NCT00312481|Cathartics|cathartics|mesh-ancestor
20613280|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20613281|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
20613282|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
20613283|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613284|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20613285|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20613286|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19404948|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19404949|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
19404950|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19404951|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404952|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19404953|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19404954|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
19404955|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
20218285|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431154|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
20218286|NCT00312481|Laxatives|laxatives|mesh-ancestor
20218287|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20431155|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613287|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431156|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20431157|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431158|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431159|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
20431160|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431161|NCT01308086|Antidotes|antidotes|mesh-ancestor
20431162|NCT01308086|Protective Agents|protective agents|mesh-ancestor
19693227|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19693228|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693229|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20431163|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
20431164|NCT01308086|Vitamins|vitamins|mesh-ancestor
20431165|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
20431166|NCT01308177|Ecabet|ecabet|mesh-list
20431167|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431168|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20431169|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431170|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
20431171|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431172|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431173|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20431174|NCT01308177|Protective Agents|protective agents|mesh-ancestor
20431175|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431176|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431177|NCT01308203|Niacin|niacin|mesh-list
20431178|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20431179|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
20431180|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431181|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20431182|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
20431183|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
20431184|NCT01308203|Vitamins|vitamins|mesh-ancestor
20431185|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
20431186|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431187|NCT01308229|Paclitaxel|paclitaxel|mesh-list
20431188|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20431189|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431190|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431191|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431192|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431193|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431194|NCT01308242|Sevelamer|sevelamer|mesh-list
20431195|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
20431196|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
20431197|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431198|NCT01308255|Vitamins|vitamins|mesh-list
20431199|NCT01308255|Folic Acid|folic acid|mesh-list
20431200|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
20431201|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20431202|NCT01308255|Methotrexate|methotrexate|mesh-list
20431203|NCT01308255|Infliximab|infliximab|mesh-list
20431204|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
20431205|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431206|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20431207|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
20431208|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20431209|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20431210|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
20431211|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431212|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431213|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
20431214|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431215|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20431216|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431217|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
20431218|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20431219|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20431220|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20431221|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
20431222|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
20431223|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693230|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693231|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
20431224|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431225|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
20431226|NCT01308255|Hormones|hormones|mesh-ancestor
20431227|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20431228|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20431229|NCT01308255|Protective Agents|protective agents|mesh-ancestor
20431230|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20431231|NCT01308255|Hematinics|hematinics|mesh-ancestor
20431232|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
20431233|NCT01308268|Ivermectin|ivermectin|mesh-list
20431234|NCT01308268|Albendazole|albendazole|mesh-list
20431235|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20431236|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431237|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
20431238|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
20431239|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20431240|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20431241|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431242|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431243|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431244|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431245|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431246|NCT01308320|Fentanyl|fentanyl|mesh-list
20431247|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20431248|NCT01308320|Narcotics|narcotics|mesh-ancestor
20431249|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431250|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431251|NCT01308320|Analgesics|analgesics|mesh-ancestor
20431252|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
20431253|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431254|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20431255|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20431256|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
20431257|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
20431258|NCT01308346|Everolimus|everolimus|mesh-list
20431259|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431260|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431261|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
20431262|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431263|NCT01308437|Insulin|insulin|mesh-list
20431264|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20431265|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
20431266|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20431267|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431268|NCT01308528|Enoxaparin|enoxaparin|mesh-list
20431269|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
20431270|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
20431271|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20431272|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20431273|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431274|NCT01308541|Propofol|propofol|mesh-list
20431275|NCT01308541|Fospropofol|fospropofol|mesh-list
20431276|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20431277|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431278|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431279|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20431280|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
20431281|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
20431282|NCT01308554|Bupivacaine|bupivacaine|mesh-list
20431283|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
20431284|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
20431285|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431286|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431287|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
20431288|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431289|NCT01308606|Simeprevir|simeprevir|mesh-list
20431290|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
20431291|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431292|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
20431293|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431294|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431295|NCT01308632|Irinotecan|irinotecan|mesh-list
20431296|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20431297|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20431298|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431299|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431300|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523513|NCT01746771|Trastuzumab|trastuzumab|mesh-list
20523514|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20523515|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523516|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
20523517|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431301|NCT01308658|Ritonavir|ritonavir|mesh-list
20431302|NCT01308658|Darunavir|darunavir|mesh-list
20431303|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20431304|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20431305|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
20431306|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431307|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431308|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20431309|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19404956|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19404957|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
19404958|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19404959|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
20613288|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20613289|NCT02254148|Protective Agents|protective agents|mesh-ancestor
20613290|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
20613291|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20613292|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19404960|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19404961|NCT03590873|Vasopressins|vasopressins|mesh-list
20431310|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
20431311|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431312|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20431313|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20431314|NCT01308671|Varenicline|varenicline|mesh-list
20431315|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20431316|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20431317|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
20431318|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431319|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431320|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431321|NCT01308684|Bevacizumab|bevacizumab|mesh-list
20431322|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431323|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431324|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431325|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20431326|NCT01308684|Growth Substances|growth substances|mesh-ancestor
20431327|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431328|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
20431329|NCT01308723|Sorafenib|sorafenib|mesh-list
20431330|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20431331|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431332|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20431333|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431334|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431335|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
20431336|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523518|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
20523519|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523520|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20523521|NCT01746823|Cyclosporine|cyclosporine|mesh-list
20523522|NCT01746823|Cyclosporins|cyclosporins|mesh-list
20523523|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523524|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523525|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20523526|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
20523527|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523528|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
20523529|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523530|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
20523531|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523532|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20523533|NCT01746875|Aflibercept|aflibercept|mesh-list
20523534|NCT01746875|Verteporfin|verteporfin|mesh-list
20523535|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20523536|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20523537|NCT01746875|Growth Substances|growth substances|mesh-ancestor
20523538|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523539|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
20523540|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523541|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20523542|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
20523543|NCT01746992|Prednisone|prednisone|mesh-list
20523544|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
20523545|NCT01746992|Ifosfamide|ifosfamide|mesh-list
20523546|NCT01746992|Doxorubicin|doxorubicin|mesh-list
20431337|NCT01308944|Propranolol|propranolol|mesh-list
20431338|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20431339|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20431340|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431341|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431342|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431343|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431344|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20431345|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20431346|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
20431347|NCT01308983|Amiloride|amiloride|mesh-list
20431348|NCT01308983|Diuretics|diuretics|mesh-ancestor
20431349|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
20431350|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431351|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20431352|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20431353|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431354|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431355|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20431356|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20431357|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20431358|NCT01309009|MEN 11420|men 11420|mesh-list
20431359|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20431360|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
20431361|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431362|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431363|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20431364|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
20431365|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
20431366|NCT01309022|Sirolimus|sirolimus|mesh-list
20431367|NCT01309022|Tacrolimus|tacrolimus|mesh-list
20431368|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431369|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
20431370|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431371|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20431372|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431373|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431374|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20431375|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431376|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20431377|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
20431378|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20431379|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431380|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
20431381|NCT01309074|Pregabalin|pregabalin|mesh-list
20431382|NCT01309074|Sertraline|sertraline|mesh-list
20431383|NCT01309074|Analgesics|analgesics|mesh-ancestor
20431384|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
20431385|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431386|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431387|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
20431388|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20431389|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431390|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431391|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20431392|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20431393|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20431394|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431395|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20431396|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
20431397|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20431398|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20431399|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431400|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
20431401|NCT01309126|Cetuximab|cetuximab|mesh-list
20431402|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431403|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431404|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
20431405|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20431406|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
20431407|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431408|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431409|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20431410|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
20431411|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
20431412|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20431413|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
20431414|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431415|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431416|NCT01309178|Mannitol|mannitol|mesh-list
20431417|NCT01309178|Amitriptyline|amitriptyline|mesh-list
20431418|NCT01309178|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20218288|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
20218289|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
20431419|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20431420|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
20431421|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20431422|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20431423|NCT01309178|Analgesics|analgesics|mesh-ancestor
20431424|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
20431425|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431426|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431427|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20431428|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20431429|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431430|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431431|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431432|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431433|NCT01309178|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20431434|NCT01309178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20431435|NCT01309178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431436|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20431437|NCT01309178|Diuretics|diuretics|mesh-ancestor
20431438|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
20431439|NCT01309399|Teriparatide|teriparatide|mesh-list
20431440|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20431441|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431442|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20431443|NCT01309412|Siltuximab|siltuximab|mesh-list
20431444|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431445|NCT01309425|Tapentadol|tapentadol|mesh-list
20431446|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20431447|NCT01309425|Narcotics|narcotics|mesh-ancestor
20431448|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693232|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
19693233|NCT04981860|Povidone|povidone|mesh-list
19693234|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
19693235|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
19693236|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19693237|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693238|NCT04981327|Apixaban|apixaban|mesh-list
19693239|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19693240|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
19693241|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19693242|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
20218290|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20218291|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20218292|NCT00312520|Prednisolone|prednisolone|mesh-list
20218293|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
20218294|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20218295|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
20218296|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20218297|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
20218298|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
20218299|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218300|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218301|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20218302|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
20218303|NCT00312520|Hormones|hormones|mesh-ancestor
20218304|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218305|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20218306|NCT00312520|Protective Agents|protective agents|mesh-ancestor
20218307|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218308|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218309|NCT00312533|Hylan|hylan|mesh-list
20218310|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
20218311|NCT00312533|Protective Agents|protective agents|mesh-ancestor
20218312|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247160|NCT00431236|Casopitant|casopitant|mesh-list
20431449|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431450|NCT01309425|Analgesics|analgesics|mesh-ancestor
20431451|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
20431452|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431453|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20431454|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20431455|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431456|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431457|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431458|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431459|NCT01309438|Erythromycin|erythromycin|mesh-list
20431460|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
20431461|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20431462|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
20431463|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
20431464|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20431465|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
20431466|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20431467|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
20431468|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431469|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431470|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
20431471|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20431472|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431473|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431474|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20431475|NCT01309477|Tacrolimus|tacrolimus|mesh-list
20431476|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431477|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
20431478|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431479|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20431480|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431481|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431482|NCT01309490|Ribavirin|ribavirin|mesh-list
20431483|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
20431484|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431485|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
20431486|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431487|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20431488|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20431489|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20431490|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431491|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431492|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431493|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431494|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
20431495|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20431496|NCT01309607|Paclitaxel|paclitaxel|mesh-list
20431497|NCT01309607|Carboplatin|carboplatin|mesh-list
20431498|NCT01309607|Lapatinib|lapatinib|mesh-list
20431499|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20431500|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431501|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431502|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431503|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431504|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431505|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20431506|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431507|NCT01309620|Zinc|zinc|mesh-list
20431508|NCT01309620|Trace Elements|trace elements|mesh-ancestor
20431509|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
20431510|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431511|NCT01309633|Gemcitabine|gemcitabine|mesh-list
20431512|NCT01309633|Bevacizumab|bevacizumab|mesh-list
20431513|NCT01309633|Sunitinib|sunitinib|mesh-list
20431514|NCT01309633|Cisplatin|cisplatin|mesh-list
20431515|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431516|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431517|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431518|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20431519|NCT01309633|Growth Substances|growth substances|mesh-ancestor
20431520|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431521|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
19404962|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
20431522|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20431523|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
20431524|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431525|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
20431526|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431527|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431528|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431529|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
20431530|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20431531|NCT01309685|Varenicline|varenicline|mesh-list
20431532|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20431533|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20431534|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
20431535|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431536|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431537|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431538|NCT01309698|Inositol|inositol|mesh-list
20431539|NCT01309698|Vildagliptin|vildagliptin|mesh-list
20431540|NCT01309698|Voglibose|voglibose|mesh-list
20431541|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20431542|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431543|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20431544|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
20431545|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431546|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431547|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20431548|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
20431549|NCT01309698|Vitamins|vitamins|mesh-ancestor
20431550|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
20431551|NCT01309776|Citalopram|citalopram|mesh-list
20431552|NCT01309776|Tianeptine|tianeptine|mesh-list
20431553|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20431554|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20431555|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20431556|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431557|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431558|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
20431559|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431560|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20431561|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
20431562|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20431563|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20431564|NCT01309789|Prednisone|prednisone|mesh-list
20431565|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
20431566|NCT01309789|Doxorubicin|doxorubicin|mesh-list
20431567|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20431568|NCT01309789|Vincristine|vincristine|mesh-list
20431569|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20431570|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20431571|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431572|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
20431573|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431574|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20431575|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20431576|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
20431577|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431578|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431579|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20431580|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20431581|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20431582|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20431583|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19404963|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404964|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
19404965|NCT03590873|Coagulants|coagulants|mesh-ancestor
19404966|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19404967|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19404968|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
19404969|NCT03590808|Vaccines|vaccines|mesh-list
19404970|NCT03590808|Immunologic Factors|immunologic factors|mesh-ancestor
19404971|NCT03590808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404972|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19404973|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19404974|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19404975|NCT03590626|Dulaglutide|dulaglutide|mesh-list
19404976|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20431584|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404977|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431585|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
20431586|NCT01309789|Hormones|hormones|mesh-ancestor
20431587|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20431588|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20431589|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20431590|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431591|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431592|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431593|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431594|NCT01309854|Pioglitazone|pioglitazone|mesh-list
20431595|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20431596|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431597|NCT01309984|Propofol|propofol|mesh-list
20431598|NCT01309984|Fospropofol|fospropofol|mesh-list
20431599|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20431600|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431601|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431602|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20431603|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
20431604|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
20431605|NCT01310101|Dexamethasone|dexamethasone|mesh-list
20431606|NCT01310101|Ofatumumab|ofatumumab|mesh-list
20431607|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20431608|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
20431609|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
20431610|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431611|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431612|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431613|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
20431614|NCT01310101|Hormones|hormones|mesh-ancestor
20431615|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20431616|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20431617|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431618|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20431619|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20431620|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431621|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431622|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
20431623|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431624|NCT01310192|Choline|choline|mesh-list
20431625|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
20431626|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20431627|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
20431628|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431629|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431630|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20431631|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
20431632|NCT01310244|Paclitaxel|paclitaxel|mesh-list
20431633|NCT01310244|Carboplatin|carboplatin|mesh-list
20431634|NCT01310244|Belinostat|belinostat|mesh-list
20431635|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20431636|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431637|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431638|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431639|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431640|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431641|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20431642|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431643|NCT01310283|Fluorides|fluorides|mesh-list
20431644|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
20431645|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
20431646|NCT01310283|Protective Agents|protective agents|mesh-ancestor
20431647|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431648|NCT01310296|Lofexidine|lofexidine|mesh-list
20431649|NCT01310296|Clonidine|clonidine|mesh-list
20431650|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20431651|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20431652|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431653|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
20431654|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431655|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20431656|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20431657|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20431658|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431659|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523547|NCT01746992|Methotrexate|methotrexate|mesh-list
20431660|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431661|NCT01310296|Analgesics|analgesics|mesh-ancestor
20431662|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
20431663|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
20431664|NCT01310361|Amoxicillin|amoxicillin|mesh-list
20431665|NCT01310361|Penicillins|penicillins|mesh-list
20431666|NCT01310361|Penicillin G|penicillin g|mesh-list
20431667|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20431668|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
20431669|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20431670|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431671|NCT01310452|Insulin|insulin|mesh-list
20431672|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20431673|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
20431674|NCT01310452|Protamines|protamines|mesh-list
20431675|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20431676|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431677|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
20431678|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431679|NCT01310452|Coagulants|coagulants|mesh-ancestor
20431680|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
20431681|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20431682|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431683|NCT01310478|Endostatins|endostatins|mesh-list
20431684|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431685|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20431686|NCT01310478|Growth Substances|growth substances|mesh-ancestor
20431687|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431688|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
20431689|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523548|NCT01746992|Etoposide|etoposide|mesh-list
20523549|NCT01746992|Vincristine|vincristine|mesh-list
20523550|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
20523551|NCT01746992|Pirarubicin|pirarubicin|mesh-list
20523552|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20523553|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
20523554|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523555|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523556|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20523557|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
20523558|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523559|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523560|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20523561|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20523562|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20523563|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20523564|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523565|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523566|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
20523567|NCT01746992|Hormones|hormones|mesh-ancestor
20523568|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404978|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19404979|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404980|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
19404981|NCT03590587|Hormones|hormones|mesh-ancestor
19404982|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19404983|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404984|NCT03590496|Calcium|calcium|mesh-list
20523569|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20523570|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20523571|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
20523572|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20523573|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20523574|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
20523575|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
20523576|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20523577|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20523578|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20523579|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
20523580|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
20523581|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
20523582|NCT01747044|Milnacipran|milnacipran|mesh-list
20523583|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
20523584|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20523585|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20530310|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
20431690|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20431691|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
20431692|NCT01310647|Estradiol|estradiol|mesh-list
20431693|NCT01310647|Testosterone|testosterone|mesh-list
20431694|NCT01310647|Estrogens|estrogens|mesh-ancestor
20431695|NCT01310647|Hormones|hormones|mesh-ancestor
20431696|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20431697|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431698|NCT01310647|Androgens|androgens|mesh-ancestor
20431699|NCT01310673|Allopurinol|allopurinol|mesh-list
20431700|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
20431701|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431702|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431703|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
20431704|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19404985|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19404986|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404987|NCT03590444|Ranibizumab|ranibizumab|mesh-list
19404988|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19404989|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19404990|NCT03590444|Growth Substances|growth substances|mesh-ancestor
19404991|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19404992|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
19404993|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19404994|NCT03590431|Iodine|iodine|mesh-list
20431705|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20431706|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
20431707|NCT01310673|Protective Agents|protective agents|mesh-ancestor
20431708|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431709|NCT01310712|Oxybutynin|oxybutynin|mesh-list
20431710|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
20431711|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
20431712|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431713|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431714|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20431715|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20431716|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
20431717|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431718|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431719|NCT01310712|Urological Agents|urological agents|mesh-ancestor
20431720|NCT01310738|Amphotericin B|amphotericin b|mesh-list
20431721|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20431722|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20431723|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20431724|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
20431725|NCT01310738|Amebicides|amebicides|mesh-ancestor
20431726|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20431727|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20431728|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431729|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20431730|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
20431731|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20431732|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431733|NCT01310751|Iloprost|iloprost|mesh-list
20431734|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20431735|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
20431736|NCT01310842|Nicotine|nicotine|mesh-list
20431737|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20431738|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
20431739|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431740|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431741|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20431742|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20431743|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
20431744|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431745|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431746|NCT01310985|Capecitabine|capecitabine|mesh-list
20431747|NCT01310985|Cetuximab|cetuximab|mesh-list
20431748|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20431749|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
20431750|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431751|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431752|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431753|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19404995|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
20431754|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20431755|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431756|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431757|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20431758|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
20431759|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20431760|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431761|NCT01311050|Bevacizumab|bevacizumab|mesh-list
20431762|NCT01311050|Capecitabine|capecitabine|mesh-list
20431763|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
20431764|NCT01311050|Irinotecan|irinotecan|mesh-list
20431765|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431766|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431767|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431768|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20431769|NCT01311050|Growth Substances|growth substances|mesh-ancestor
20431770|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431771|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
20431772|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20431773|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
20431774|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431775|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20431776|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20431777|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431778|NCT01311076|Insulin|insulin|mesh-list
20431779|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20431780|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
20431781|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20431782|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431783|NCT01311141|Doripenem|doripenem|mesh-list
20431784|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20431785|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431786|NCT01311167|Dexamethasone|dexamethasone|mesh-list
20431787|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19404996|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19404997|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19404998|NCT03590431|Trace Elements|trace elements|mesh-ancestor
19404999|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
19405000|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405001|NCT03590275|Folfirinox|folfirinox|mesh-list
19405002|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405003|NCT03590262|Metformin|metformin|mesh-list
19405004|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19405005|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405006|NCT03590210|Nivolumab|nivolumab|mesh-list
19405007|NCT03590210|Trabectedin|trabectedin|mesh-list
19405008|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405009|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405010|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19405011|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405012|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19405013|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
19405014|NCT03590197|Melatonin|melatonin|mesh-list
19405015|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
19405016|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405017|NCT03590197|Protective Agents|protective agents|mesh-ancestor
19405018|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405019|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405020|NCT03590171|Bortezomib|bortezomib|mesh-list
20431788|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
20431789|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
20431790|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431791|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431792|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20431793|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
20431794|NCT01311167|Hormones|hormones|mesh-ancestor
20431795|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20431796|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20431797|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431798|NCT01311336|Loratadine|loratadine|mesh-list
20431799|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
20431800|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
20431801|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20431802|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20431803|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19405021|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405022|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20431804|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
20431805|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
20431806|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431807|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431808|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431809|NCT01311414|Urapidil|urapidil|mesh-list
20431810|NCT01311414|Theodrenaline|theodrenaline|mesh-list
20431811|NCT01311414|Cafedrine|cafedrine|mesh-list
20431812|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20431813|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
20431814|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20431815|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
20431816|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431817|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431818|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431819|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20431820|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20431821|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20431822|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431823|NCT01311570|Buprenorphine|buprenorphine|mesh-list
20431824|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20431825|NCT01311570|Narcotics|narcotics|mesh-ancestor
20431826|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431827|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431828|NCT01311570|Analgesics|analgesics|mesh-ancestor
20431829|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
20431830|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431831|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20431832|NCT01311622|Warfarin|warfarin|mesh-list
20431833|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
20431834|NCT01311700|Metoprolol|metoprolol|mesh-list
20431835|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20431836|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20431837|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
20431838|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
20431839|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431840|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431841|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20431842|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20431843|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20431844|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
20431845|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431846|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431847|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
20431848|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
20431849|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
20431850|NCT01311739|Vitamins|vitamins|mesh-ancestor
20431851|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
20431852|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431853|NCT01311739|Hematinics|hematinics|mesh-ancestor
20431854|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20431855|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431856|NCT01311778|Fentanyl|fentanyl|mesh-list
20431857|NCT01311778|Cannabidiol|cannabidiol|mesh-list
20431858|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20431859|NCT01311778|Narcotics|narcotics|mesh-ancestor
20431860|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431861|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431862|NCT01311778|Analgesics|analgesics|mesh-ancestor
20431863|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
20431864|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431865|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20431866|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20431867|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
20431868|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
20431869|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
20431870|NCT01311804|Parecoxib|parecoxib|mesh-list
20431871|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20431872|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20431873|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431874|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431875|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20431876|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20431877|NCT01311804|Analgesics|analgesics|mesh-ancestor
20431878|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
20431879|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431880|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431881|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20431882|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20431883|NCT01311882|Zopiclone|zopiclone|mesh-list
20431884|NCT01311882|Suvorexant|suvorexant|mesh-list
20431885|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20431886|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431887|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431888|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20431889|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20431890|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431891|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431892|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20431893|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
20431894|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431895|NCT01311960|Bevacizumab|bevacizumab|mesh-list
20431896|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20431897|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431898|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693243|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693244|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693245|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
20431899|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431900|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20431901|NCT01311960|Growth Substances|growth substances|mesh-ancestor
20431902|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431903|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
20431904|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20431905|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
20431906|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20431907|NCT01312064|Rituximab|rituximab|mesh-list
20431908|NCT01312064|Everolimus|everolimus|mesh-list
20431909|NCT01312064|Tacrolimus|tacrolimus|mesh-list
20431910|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
20431911|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431912|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431913|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
20431914|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431915|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20431916|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431917|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20431918|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431919|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431920|NCT01312077|Morphine|morphine|mesh-list
20431921|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
20431922|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20431923|NCT01312077|Narcotics|narcotics|mesh-ancestor
20431924|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431925|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431926|NCT01312077|Analgesics|analgesics|mesh-ancestor
20431927|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
20431928|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431929|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
20431930|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
20523586|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523587|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523588|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523589|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523590|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523591|NCT01747044|Analgesics|analgesics|mesh-ancestor
20523592|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
20523593|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523594|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
20523595|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523596|NCT01747083|Metformin|metformin|mesh-list
20523597|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20523598|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523599|NCT01747135|Betadex|betadex|mesh-list
20523600|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
20523601|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523602|NCT01747148|Radavirsen|radavirsen|mesh-list
20523603|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
20523604|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613293|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
20523605|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
20523606|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20431931|NCT01312298|Bupivacaine|bupivacaine|mesh-list
20431932|NCT01312298|Anesthetics|anesthetics|mesh-list
20431933|NCT01312298|Propofol|propofol|mesh-list
20431934|NCT01312298|Succinylcholine|succinylcholine|mesh-list
20431935|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
20431936|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20431937|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431938|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
20431939|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20431940|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20431941|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20431942|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
20431943|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20431944|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20431945|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20431946|NCT01312311|Docetaxel|docetaxel|mesh-list
20431947|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431948|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431949|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431950|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431951|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431952|NCT01312324|Docetaxel|docetaxel|mesh-list
20431953|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431954|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431955|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431956|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431957|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431958|NCT01312337|Gefitinib|gefitinib|mesh-list
20431959|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431960|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20431961|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431962|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431963|NCT01312350|Docetaxel|docetaxel|mesh-list
20431964|NCT01312350|Fluorouracil|fluorouracil|mesh-list
20431965|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431966|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
20431967|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
20431968|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
20431969|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431970|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
20431971|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20431972|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431973|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
20431974|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431975|NCT01312363|Rivastigmine|rivastigmine|mesh-list
20431976|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20431977|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20431978|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431979|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
20431980|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20431981|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431982|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20431983|NCT01312363|Protective Agents|protective agents|mesh-ancestor
20431984|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
20431985|NCT01312376|Bevacizumab|bevacizumab|mesh-list
20431986|NCT01312376|Fludarabine|fludarabine|mesh-list
20431987|NCT01312376|Vaccines|vaccines|mesh-list
20431988|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
20431989|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20431990|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20431991|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20431992|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20431993|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
20431994|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20431995|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20431996|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20431997|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20431998|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20431999|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20432000|NCT01312376|Growth Substances|growth substances|mesh-ancestor
20432001|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
20432002|NCT01312402|Brinzolamide|brinzolamide|mesh-list
19848319|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20432003|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20432004|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432005|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432006|NCT01312415|Morphine|morphine|mesh-list
20432007|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
20432008|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20432009|NCT01312415|Narcotics|narcotics|mesh-ancestor
20432010|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432011|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432012|NCT01312415|Analgesics|analgesics|mesh-ancestor
20432013|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
20432014|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432015|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
20432016|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
20432017|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
20432018|NCT01312441|Vitamin D|vitamin d|mesh-list
20432019|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20432020|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432021|NCT01312441|Vitamins|vitamins|mesh-ancestor
20432022|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
20432023|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20432024|NCT01312493|Panitumumab|panitumumab|mesh-list
20432025|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20432026|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432027|NCT01312714|Vitamin D|vitamin d|mesh-list
20432028|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
20432029|NCT01312714|Vitamins|vitamins|mesh-ancestor
20432030|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
20432031|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432032|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20432033|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20432034|NCT01312792|Ampicillin|ampicillin|mesh-list
20432035|NCT01312792|Cephradine|cephradine|mesh-list
20432036|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20432037|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432038|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
20432039|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
20432040|NCT01312831|Vitamins|vitamins|mesh-ancestor
20432041|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
20432042|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432043|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
20432044|NCT01312831|Hematinics|hematinics|mesh-ancestor
20432045|NCT01313143|Esmolol|esmolol|mesh-list
20432046|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20432047|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20432048|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20432049|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
20432050|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218313|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
20218314|NCT00312546|Valproic Acid|valproic acid|mesh-list
20432051|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432052|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432053|NCT01313247|Acetaminophen|acetaminophen|mesh-list
20432054|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432055|NCT01313247|Analgesics|analgesics|mesh-ancestor
20432056|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
20613294|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613295|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613296|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19405023|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19405024|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405025|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
19405026|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19405027|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19405028|NCT03590080|Prednisolone|prednisolone|mesh-list
20218315|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
20218316|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218317|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218318|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
20218319|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218320|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218321|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
20432057|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432058|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432059|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
20432060|NCT01313377|Gemcitabine|gemcitabine|mesh-list
20432061|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
20432062|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20432063|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
20613297|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
20432064|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432065|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432066|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
20432067|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432068|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432069|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432070|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
20432071|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432072|NCT01313390|Docetaxel|docetaxel|mesh-list
20432073|NCT01313390|Everolimus|everolimus|mesh-list
20432074|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432075|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
20432076|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
20432077|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
20432078|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432079|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432080|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
20432081|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432082|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
20432083|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20432084|NCT01313429|Celecoxib|celecoxib|mesh-list
20432085|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
20432086|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432087|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
20432088|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432089|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432090|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20432091|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
20432092|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432093|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432094|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20432095|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20432096|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432097|NCT01313429|Analgesics|analgesics|mesh-ancestor
20432098|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
20432099|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432100|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20432101|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20432102|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20432103|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218322|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19693246|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
19693247|NCT04981379|Favipiravir|favipiravir|mesh-list
19693248|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
19693249|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19693250|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19693251|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693252|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218323|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218324|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218325|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20218326|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20218327|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20218328|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20218329|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
20218330|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218331|NCT00312598|Aripiprazole|aripiprazole|mesh-list
20218332|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
20218333|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218334|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20218335|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20218336|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218337|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218338|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
20218339|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
20218340|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218341|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218342|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20218343|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20218344|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
20218345|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20218346|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20218347|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20218348|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20432104|NCT01313585|Beclomethasone|beclomethasone|mesh-list
20432105|NCT01313585|Albuterol|albuterol|mesh-list
20432106|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20432107|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
20432108|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432109|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432110|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20432111|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
20432112|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
20432113|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20432114|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20432115|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20432116|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20432117|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
20432118|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432119|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432120|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20432121|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
20432122|NCT01313585|Hormones|hormones|mesh-ancestor
20432123|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432124|NCT01313611|Rituximab|rituximab|mesh-list
20432125|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20432126|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20432127|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432128|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
20432129|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432130|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432131|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20432132|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
20432133|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432134|NCT01313689|Ofatumumab|ofatumumab|mesh-list
20432135|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432136|NCT01313702|Atenolol|atenolol|mesh-list
20432137|NCT01313702|Lisinopril|lisinopril|mesh-list
20432138|NCT01313702|Simvastatin|simvastatin|mesh-list
20432139|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20432140|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20432141|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
20432142|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432143|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20432144|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20432145|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432146|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20432147|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
20432148|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20432149|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20432150|NCT01313702|Protective Agents|protective agents|mesh-ancestor
20432151|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432152|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20432153|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
20432154|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
20432155|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432156|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20432157|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20432158|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20432159|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
20432160|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432161|NCT01313819|Amantadine|amantadine|mesh-list
20432162|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20432163|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20432164|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
20432165|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432166|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
20432167|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432168|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432169|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693253|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693254|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693255|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
20613298|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
20613299|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19405029|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
19405030|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20432170|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19693256|NCT04981392|Vaccines|vaccines|mesh-list
20432171|NCT01313819|Analgesics|analgesics|mesh-ancestor
19405031|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
19693257|NCT04981392|Immunologic Factors|immunologic factors|mesh-ancestor
19693258|NCT04981392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693259|NCT04981704|Itraconazole|itraconazole|mesh-list
19693260|NCT04981704|Phenytoin|phenytoin|mesh-list
20432172|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
20432173|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432174|NCT01313845|Amantadine|amantadine|mesh-list
20432175|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20432176|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20432177|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
20432178|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432179|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
20432180|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432181|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432182|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432183|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432184|NCT01313845|Analgesics|analgesics|mesh-ancestor
20432185|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
20432186|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432187|NCT01314027|Gemcitabine|gemcitabine|mesh-list
20432188|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
20432189|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20432190|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
20432191|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432192|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432193|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
20432194|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432195|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432196|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432197|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
20432198|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432199|NCT01314066|Bevacizumab|bevacizumab|mesh-list
20432200|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20432201|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432202|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20432203|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19405032|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405033|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
19405034|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
19405035|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405036|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432204|NCT01314066|Growth Substances|growth substances|mesh-ancestor
20432205|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432206|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
20432207|NCT01314144|Bupivacaine|bupivacaine|mesh-list
20432208|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
20432209|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
20432210|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432211|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432212|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
20432213|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523607|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523608|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523609|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
19405037|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405038|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
19405039|NCT03590080|Hormones|hormones|mesh-ancestor
19405040|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20523610|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523611|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523612|NCT01747174|Adenosine|adenosine|mesh-list
20523613|NCT01747174|Nitroprusside|nitroprusside|mesh-list
20523614|NCT01747174|Analgesics|analgesics|mesh-ancestor
20523615|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
20523616|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523617|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523618|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20523619|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
20523620|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19405041|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20523621|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
20523622|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
19405042|NCT03590080|Protective Agents|protective agents|mesh-ancestor
19693261|NCT04981704|Paroxetine|paroxetine|mesh-list
19693262|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
20432214|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
20432215|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20432216|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432217|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432218|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432219|NCT01314209|Analgesics|analgesics|mesh-ancestor
20432220|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
20432221|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432222|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20432223|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20432224|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20432225|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
20432226|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432227|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432228|NCT01314274|Bevacizumab|bevacizumab|mesh-list
20432229|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20432230|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432231|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20432232|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20432233|NCT01314274|Growth Substances|growth substances|mesh-ancestor
20432234|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432235|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
20432236|NCT01314300|Lidocaine|lidocaine|mesh-list
20432237|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
20432238|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
20432239|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432240|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432241|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
20432242|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432243|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20432244|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20432245|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20432246|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20432247|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432248|NCT01314339|Desloratadine|desloratadine|mesh-list
20432249|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20432250|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
20432251|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432252|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432253|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432254|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20432255|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20432256|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
20432257|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
20432258|NCT01314352|Desloratadine|desloratadine|mesh-list
20432259|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20432260|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
20432261|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432262|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432263|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432264|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20432265|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20432266|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
20432267|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
20432268|NCT01314482|Minocycline|minocycline|mesh-list
20432269|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20432270|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432271|NCT01314495|Abatacept|abatacept|mesh-list
20432272|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20432273|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432274|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432275|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432276|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
20432277|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432278|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432279|NCT01314508|Mecasermin|mecasermin|mesh-list
20432280|NCT01314508|Growth Substances|growth substances|mesh-ancestor
20432281|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432282|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
20432283|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
20432284|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20432285|NCT01314586|Estrogens|estrogens|mesh-ancestor
20432286|NCT01314586|Hormones|hormones|mesh-ancestor
20432287|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432288|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432289|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20432290|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20432291|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20432292|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432293|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
20432294|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20432295|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20432296|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
20432297|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432298|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432299|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432300|NCT01314781|Urological Agents|urological agents|mesh-ancestor
19693263|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693264|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19693265|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19693266|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693267|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432301|NCT01314833|Paclitaxel|paclitaxel|mesh-list
20432302|NCT01314833|Docetaxel|docetaxel|mesh-list
20432303|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
20432304|NCT01314833|Fluorouracil|fluorouracil|mesh-list
20432305|NCT01314833|Epirubicin|epirubicin|mesh-list
20432306|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20432307|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432308|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
20432309|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
20432310|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
20432311|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432312|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432313|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
20432314|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432315|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432316|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20432317|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
20432318|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20432319|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
20432320|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20432321|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20432322|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20432323|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20432324|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432325|NCT01314859|Nifedipine|nifedipine|mesh-list
20432326|NCT01314859|Atosiban|atosiban|mesh-list
20432327|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20432328|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20432329|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432330|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20432331|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432332|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
20432333|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
20432334|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20432335|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
20432336|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432337|NCT01314898|Spironolactone|spironolactone|mesh-list
20432338|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20432339|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
20432340|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432341|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432342|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20432343|NCT01314898|Diuretics|diuretics|mesh-ancestor
20432344|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
20432345|NCT01314937|Mebendazole|mebendazole|mesh-list
20432346|NCT01314937|Piperazine|piperazine|mesh-list
20432347|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
20432348|NCT01314937|DMP 777|dmp 777|mesh-list
20432349|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
20432350|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
20432351|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20432352|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432353|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
20432354|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20432355|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20432356|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432357|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432358|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432359|NCT01314976|Metronidazole|metronidazole|mesh-list
20432360|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432361|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20432362|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20432363|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20432364|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
20432365|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
20432366|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
20432367|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20432368|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20432369|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
20432370|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
20432371|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432372|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432373|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432374|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20432375|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
20432376|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20432377|NCT01315093|Heparin|heparin|mesh-list
20432378|NCT01315093|Calcium heparin|calcium heparin|mesh-list
20432379|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20432380|NCT01315093|Tinzaparin|tinzaparin|mesh-list
20432381|NCT01315093|Dalteparin|dalteparin|mesh-list
20432382|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
20432383|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20432384|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20432385|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432386|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
20432387|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
20432388|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20432389|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20432390|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432391|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432392|NCT01315262|Urological Agents|urological agents|mesh-ancestor
20432393|NCT01315275|Ranibizumab|ranibizumab|mesh-list
20432394|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20432395|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20218349|NCT00312650|Gemcitabine|gemcitabine|mesh-list
20218350|NCT00312650|Doxorubicin|doxorubicin|mesh-list
20218351|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20218352|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218353|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
20218354|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218355|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218356|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
20218357|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218358|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218359|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218360|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
20432396|NCT01315275|Growth Substances|growth substances|mesh-ancestor
20432397|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432398|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
20432399|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432400|NCT01315431|Capecitabine|capecitabine|mesh-list
20432401|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20432402|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
20432403|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432404|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432405|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
20432406|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20432407|NCT01315496|Antibodies|antibodies|mesh-list
20432408|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
20432409|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
20432410|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432411|NCT01315691|Amikacin|amikacin|mesh-list
20432412|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20432413|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432414|NCT01315704|Vitamin D|vitamin d|mesh-list
20613300|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
20432415|NCT01315704|Vitamins|vitamins|mesh-ancestor
20432416|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
20432417|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432418|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20432419|NCT01315795|Lanreotide|lanreotide|mesh-list
20432420|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432421|NCT01315886|Fentanyl|fentanyl|mesh-list
20432422|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20432423|NCT01315886|Narcotics|narcotics|mesh-ancestor
20432424|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432425|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432426|NCT01315886|Analgesics|analgesics|mesh-ancestor
20432427|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
20432428|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432429|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20432430|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20432431|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
20432432|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
20523623|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523624|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523625|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20523626|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20523627|NCT01747226|Fluorides|fluorides|mesh-list
20523628|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
20523629|NCT01747226|Protective Agents|protective agents|mesh-ancestor
20523630|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523631|NCT01747252|Resveratrol|resveratrol|mesh-list
20523632|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
20523633|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523634|NCT01747252|Protective Agents|protective agents|mesh-ancestor
20523635|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523636|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523637|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20523638|NCT01747278|Trimethoprim|trimethoprim|mesh-list
20523639|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
20523640|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20523641|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523642|NCT01747278|Renal Agents|renal agents|mesh-ancestor
20523643|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
20523644|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20523645|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20523646|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20523647|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523648|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523649|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20523650|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20523651|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20523652|NCT01747564|Mirabegron|mirabegron|mesh-list
20523653|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20523654|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20523655|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20523656|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523657|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523658|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523659|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523660|NCT01747564|Urological Agents|urological agents|mesh-ancestor
20523661|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
20523662|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20523663|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20523664|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
20523665|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523666|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523667|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523668|NCT01747577|Urological Agents|urological agents|mesh-ancestor
20523669|NCT01747590|Zolpidem|zolpidem|mesh-list
20523670|NCT01747590|Alprazolam|alprazolam|mesh-list
20523671|NCT01747590|Caffeine|caffeine|mesh-list
20523672|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20523673|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523674|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20523675|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523676|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523677|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20523678|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20523679|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
20523680|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523681|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20523682|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19405043|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20523683|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432433|NCT01315912|Letrozole|letrozole|mesh-list
20432434|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432435|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20432436|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20432437|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432438|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432439|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20432440|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
20432441|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432442|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432443|NCT01315938|Abatacept|abatacept|mesh-list
20432444|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20432445|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432446|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432447|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432448|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
20432449|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432450|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432451|NCT01315951|Petrolatum|petrolatum|mesh-list
20432452|NCT01315951|Emollients|emollients|mesh-ancestor
20432453|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
20613301|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613302|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613303|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20613304|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20613305|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20613306|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613307|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20613308|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20613309|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
20613310|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613311|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613312|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20613313|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
20613314|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20613315|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20613316|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20613317|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613318|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613319|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613320|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20613321|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20613322|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
20613323|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613324|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613325|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20613326|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
20613327|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20613328|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20613329|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20613330|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613331|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613332|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613333|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20613334|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20613335|NCT02254239|Everolimus|everolimus|mesh-list
20613336|NCT02254239|Antibodies|antibodies|mesh-list
20613337|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
20613338|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20613339|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
20613340|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
20613341|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613342|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613343|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20613344|NCT02254447|Candesartan|candesartan|mesh-list
20613345|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
20613346|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20613347|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20613348|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20613349|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613350|NCT02254525|Ibuprofen|ibuprofen|mesh-list
20613351|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20432454|NCT01315990|Cetuximab|cetuximab|mesh-list
20432455|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20432456|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432457|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
20432458|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
20432459|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20432460|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
20432461|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432462|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20432463|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20432464|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20432465|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20432466|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432467|NCT01316081|Vitamins|vitamins|mesh-list
20432468|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
20432469|NCT01316081|Vitamin E|vitamin e|mesh-list
20432470|NCT01316081|Tocopherols|tocopherols|mesh-list
20432471|NCT01316081|Tocotrienols|tocotrienols|mesh-list
20432472|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
20432473|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
20432474|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432475|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
20432476|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432477|NCT01316081|Protective Agents|protective agents|mesh-ancestor
20432478|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
20432479|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20432480|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432481|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20432482|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432483|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
20432484|NCT01316107|Nateglinide|nateglinide|mesh-list
20432485|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20432486|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432487|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20432488|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432489|NCT01316133|Tacrolimus|tacrolimus|mesh-list
20432490|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432491|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
20432492|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432493|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20432494|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432495|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432496|NCT01316445|Midazolam|midazolam|mesh-list
20432497|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20432498|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20432499|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432500|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432501|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20432502|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20432503|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20432504|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20432505|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
20432506|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
20432507|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
20432508|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
20432509|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432510|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432511|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
20432512|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432513|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20432514|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432515|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432516|NCT01316549|Fludarabine|fludarabine|mesh-list
20432517|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432518|NCT01316718|Mesalamine|mesalamine|mesh-list
20432519|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20432520|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432521|NCT01316718|Analgesics|analgesics|mesh-ancestor
20432522|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
20432523|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432524|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432525|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20432526|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432527|NCT01316744|Ketamine|ketamine|mesh-list
20432528|NCT01316744|Analgesics|analgesics|mesh-ancestor
20432529|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
20432530|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432531|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432532|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20432533|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20432534|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
20432535|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
20432536|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432537|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20432538|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20432539|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432540|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432541|NCT01316757|Paclitaxel|paclitaxel|mesh-list
20432542|NCT01316757|Carboplatin|carboplatin|mesh-list
20432543|NCT01316757|Cetuximab|cetuximab|mesh-list
20432544|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20432545|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20432546|NCT01316757|Antibodies|antibodies|mesh-list
20432547|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
20432548|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20432549|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20432550|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432551|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
20432552|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
20432553|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
19848320|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
19848321|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848322|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19848323|NCT00693160|Ketorolac|ketorolac|mesh-list
19848324|NCT00693160|Remifentanil|remifentanil|mesh-list
19848325|NCT00693160|Capsaicin|capsaicin|mesh-list
20432554|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432555|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
20432556|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432557|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20432558|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432559|NCT01316861|Acarbose|acarbose|mesh-list
20432560|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20432561|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432562|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432563|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20432564|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432565|NCT01316874|Valrubicin|valrubicin|mesh-list
20432566|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432567|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20432568|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20432569|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432570|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432571|NCT01316952|Carvedilol|carvedilol|mesh-list
19848326|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19848327|NCT00693160|Narcotics|narcotics|mesh-ancestor
19848328|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218361|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218362|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20218363|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20218364|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20218365|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20218366|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20218367|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20218368|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
20218369|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218370|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218371|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20218372|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20218373|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
20218374|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218375|NCT00312806|Pantoprazole|pantoprazole|mesh-list
20218376|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20218377|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20218378|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20218379|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218380|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218381|NCT00312819|Disulfiram|disulfiram|mesh-list
20218382|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20218383|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20432572|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20432573|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
20432574|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
20432575|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432576|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432577|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432578|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20432579|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
19405044|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432580|NCT01316952|Protective Agents|protective agents|mesh-ancestor
20432581|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20432582|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20432583|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20432584|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
20432585|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20432586|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20432587|NCT01316978|Ibuprofen|ibuprofen|mesh-list
20432588|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20432589|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432590|NCT01316978|Analgesics|analgesics|mesh-ancestor
20432591|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
20432592|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432593|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432594|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20432595|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432596|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20432597|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432598|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432599|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
20432600|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
20432601|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432602|NCT01317069|Fluorouracil|fluorouracil|mesh-list
20432603|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
20432604|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432605|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20432606|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432607|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432608|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
20432609|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432610|NCT01317212|Carboplatin|carboplatin|mesh-list
20432611|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432612|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20432613|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20432614|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20432615|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
20432616|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432617|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432618|NCT01317225|Progestins|progestins|mesh-ancestor
20432619|NCT01317225|Hormones|hormones|mesh-ancestor
20432620|NCT01317368|Ropivacaine|ropivacaine|mesh-list
20432621|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
20432622|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
20432623|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432624|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432625|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
20432626|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432627|NCT01317433|Doxycycline|doxycycline|mesh-list
20432628|NCT01317433|Cetuximab|cetuximab|mesh-list
20432629|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20432630|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432631|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20432632|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432633|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
20432634|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20432635|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20432636|NCT01317446|Fluorides|fluorides|mesh-list
20432637|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
20432638|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
20432639|NCT01317446|Protective Agents|protective agents|mesh-ancestor
20432640|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432641|NCT01317511|Caseins|caseins|mesh-list
20432642|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
20432643|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
20432644|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432645|NCT01317563|Vitamin A|vitamin a|mesh-list
20432646|NCT01317563|Selenium|selenium|mesh-list
20432647|NCT01317563|Vitamins|vitamins|mesh-ancestor
20432648|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
20432649|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432650|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
20432651|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432652|NCT01317563|Protective Agents|protective agents|mesh-ancestor
20432653|NCT01317563|Trace Elements|trace elements|mesh-ancestor
20432654|NCT01317589|Fentanyl|fentanyl|mesh-list
20432655|NCT01317589|Methadone|methadone|mesh-list
20432656|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20432657|NCT01317589|Narcotics|narcotics|mesh-ancestor
20432658|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432659|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432660|NCT01317589|Analgesics|analgesics|mesh-ancestor
20432661|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
20432662|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432663|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20432664|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20432665|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
20432666|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
20432667|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
20432668|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
20523684|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20523685|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
20523686|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
20523687|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20523688|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20523689|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523690|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
20523691|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
20523692|NCT01747616|Chitosan|chitosan|mesh-list
20523693|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20523694|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20523695|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20523696|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
20523697|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523698|NCT01747616|Expectorants|expectorants|mesh-ancestor
20523699|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
20523700|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20523701|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
20523702|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523703|NCT01747616|Protective Agents|protective agents|mesh-ancestor
20523704|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523705|NCT01747616|Antidotes|antidotes|mesh-ancestor
20523706|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20523707|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20523708|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
20523709|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20523710|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
20523711|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
20523712|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
20523713|NCT01747616|Coagulants|coagulants|mesh-ancestor
20523714|NCT01747642|Sorafenib|sorafenib|mesh-list
20523715|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523716|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20523717|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523718|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523719|NCT01747668|Tocopherols|tocopherols|mesh-list
20523720|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
20523721|NCT01747668|Vitamin E|vitamin e|mesh-list
20523722|NCT01747668|Vitamins|vitamins|mesh-ancestor
20523723|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
20523724|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523725|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
20523726|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523727|NCT01747668|Protective Agents|protective agents|mesh-ancestor
20523728|NCT01747707|Docetaxel|docetaxel|mesh-list
20523729|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523730|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
20523731|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
20523732|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
20523733|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523734|NCT01747720|Vitamin D|vitamin d|mesh-list
20523735|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
20523736|NCT01747720|Vitamins|vitamins|mesh-ancestor
20523737|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
20523738|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432669|NCT01317784|Antibodies|antibodies|mesh-list
20432670|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
20432671|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
20432672|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
20432673|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432674|NCT01317849|Vitamins|vitamins|mesh-list
20432675|NCT01317849|Folic Acid|folic acid|mesh-list
20432676|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
20432677|NCT01317849|Hydroxocobalamin|hydroxocobalamin|mesh-list
20432678|NCT01317849|Pyridoxine|pyridoxine|mesh-list
20432679|NCT01317849|Pyridoxal|pyridoxal|mesh-list
20432680|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
20432681|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
20432682|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
20432683|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432684|NCT01317849|Hematinics|hematinics|mesh-ancestor
20432685|NCT01317927|Belinostat|belinostat|mesh-list
20432686|NCT01317927|Warfarin|warfarin|mesh-list
20432687|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
20432688|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432689|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20432690|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432691|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432692|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20432693|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
20432694|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432695|NCT01317953|Protective Agents|protective agents|mesh-ancestor
20432696|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432697|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20432698|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20432699|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432700|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20432701|NCT01317966|Rituximab|rituximab|mesh-list
20432702|NCT01317966|Oprelvekin|oprelvekin|mesh-list
20432703|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20432704|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432705|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
20432706|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432707|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20432708|NCT01317992|Ibudilast|ibudilast|mesh-list
20432709|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20432710|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
20432711|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432712|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432713|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20218384|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218385|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218386|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
20218387|NCT00312871|Hematinics|hematinics|mesh-ancestor
20432714|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
20432715|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20432716|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432717|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432718|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20432719|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
20432720|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
20432721|NCT01318005|Norinyl|norinyl|mesh-list
20432722|NCT01318005|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20432723|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
20432724|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20432725|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432726|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20432727|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20432728|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20432729|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20432730|NCT01318005|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20218388|NCT00312988|Gemcitabine|gemcitabine|mesh-list
20218389|NCT00312988|Topotecan|topotecan|mesh-list
20218390|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218391|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
20218392|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218393|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218394|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
20218395|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432731|NCT01318005|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20432732|NCT01318044|Thiopental|thiopental|mesh-list
20432733|NCT01318044|Propofol|propofol|mesh-list
20432734|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20432735|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432736|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432737|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20432738|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
20432739|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
20432740|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
20432741|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
20432742|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
20432743|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432744|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432745|NCT01318096|Tenofovir|tenofovir|mesh-list
20432746|NCT01318096|Lamivudine|lamivudine|mesh-list
20432747|NCT01318096|Efavirenz|efavirenz|mesh-list
20432748|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
20432749|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
20432750|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432751|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20432752|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20432753|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432754|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432755|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20432756|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20432757|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20432758|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20432759|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20432760|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20432761|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20432762|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20432763|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20432764|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20432765|NCT01318148|Caspofungin|caspofungin|mesh-list
20432766|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
20432767|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432768|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432769|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432770|NCT01318161|Morphine|morphine|mesh-list
20432771|NCT01318161|Ropivacaine|ropivacaine|mesh-list
20432772|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20432773|NCT01318161|Narcotics|narcotics|mesh-ancestor
20432774|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432775|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432776|NCT01318161|Analgesics|analgesics|mesh-ancestor
20432777|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
20432778|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432779|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
20432780|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
20432781|NCT01318187|Acetaminophen|acetaminophen|mesh-list
20432782|NCT01318187|Morphine|morphine|mesh-list
20432783|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20432784|NCT01318187|Narcotics|narcotics|mesh-ancestor
20432785|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432786|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432787|NCT01318187|Analgesics|analgesics|mesh-ancestor
20432788|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
20432789|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432790|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432791|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
20432792|NCT01318265|Ketoconazole|ketoconazole|mesh-list
20432793|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
20432794|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432795|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20432796|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20432797|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432798|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432799|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20432800|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
20432801|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432802|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432803|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20432804|NCT01318369|Diazepam|diazepam|mesh-list
20432805|NCT01318369|Dronabinol|dronabinol|mesh-list
20432806|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
20432807|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432808|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20432809|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20432810|NCT01318369|Analgesics|analgesics|mesh-ancestor
20432811|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
20432812|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432813|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20432814|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20432815|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432816|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432817|NCT01318369|Hormones|hormones|mesh-ancestor
20432818|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432819|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20432820|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
20432821|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
20432822|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
20432823|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20432824|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20432825|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432826|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20432827|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20432828|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20432829|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20432830|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20432831|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
20432832|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
20432833|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
20432834|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
20432835|NCT01318460|Simendan|simendan|mesh-list
20432836|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20432837|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
20432838|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20432839|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20432840|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432841|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432842|NCT01318460|Protective Agents|protective agents|mesh-ancestor
20432843|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432844|NCT01318564|Metformin|metformin|mesh-list
20432845|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20613352|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613353|NCT02254525|Analgesics|analgesics|mesh-ancestor
20613354|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
20613355|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613356|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613357|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20613358|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416473|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
19416474|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19416475|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19416476|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416477|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19416478|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416479|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19416480|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416481|NCT02434744|Metformin|metformin|mesh-list
19416482|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19416483|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416484|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
20218396|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218397|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218398|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
20218399|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218400|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20218401|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20218402|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
20218403|NCT00313001|Exenatide|exenatide|mesh-list
20218404|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
20218405|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218406|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218407|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20218408|NCT00313001|Incretins|incretins|mesh-ancestor
20218409|NCT00313001|Hormones|hormones|mesh-ancestor
20218410|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218411|NCT00313053|Vincristine|vincristine|mesh-list
20432846|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432847|NCT01318590|Triamcinolone|triamcinolone|mesh-list
20432848|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20432849|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20432850|NCT01318590|Bupivacaine|bupivacaine|mesh-list
20432851|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20432852|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
20432853|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
20432854|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432855|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432856|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
20432857|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432858|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20432859|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
20432860|NCT01318590|Hormones|hormones|mesh-ancestor
20432861|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432862|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20432863|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
20432864|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432865|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432866|NCT01318655|Naloxegol|naloxegol|mesh-list
20432867|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20432868|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432869|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
20432870|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405052|NCT03589898|Gabapentin|gabapentin|mesh-list
19405053|NCT03589898|Analgesics|analgesics|mesh-ancestor
20432871|NCT01318668|Vaccines|vaccines|mesh-list
20432872|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
20432873|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432874|NCT01318681|Fluticasone|fluticasone|mesh-list
20432875|NCT01318681|Xhance|xhance|mesh-list
20432876|NCT01318681|Cetirizine|cetirizine|mesh-list
20432877|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20432878|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20432879|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
20432880|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432881|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432882|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20432883|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
20432884|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
20432885|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19405054|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
19405055|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405056|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218412|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20613359|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20613360|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613361|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432886|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20432887|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20432888|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
20613362|NCT02254577|Progesterone|progesterone|mesh-list
20613363|NCT02254577|Progestins|progestins|mesh-ancestor
20613364|NCT02254577|Hormones|hormones|mesh-ancestor
20613365|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613366|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613367|NCT02254629|Laxatives|laxatives|mesh-list
20613368|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20613369|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
20218413|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432889|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
20432890|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432891|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432892|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
20432893|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20432894|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20432895|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
20432896|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848329|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218414|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218415|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218416|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218417|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218418|NCT00313079|Vincristine|vincristine|mesh-list
20432897|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432898|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432899|NCT01318837|Urological Agents|urological agents|mesh-ancestor
20432900|NCT01318928|Metronidazole|metronidazole|mesh-list
20432901|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20432902|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20432903|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20432904|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20432905|NCT01318941|Ranibizumab|ranibizumab|mesh-list
20432906|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20432907|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20432908|NCT01318941|Growth Substances|growth substances|mesh-ancestor
20432909|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432910|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
20432911|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432912|NCT01319006|Glycine|glycine|mesh-list
20432913|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
20432914|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432915|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432916|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432917|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20432918|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20432919|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
20432920|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432921|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432922|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20432923|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
20432924|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20432925|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20432926|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20432927|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
20432928|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432929|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432930|NCT01319188|Ranibizumab|ranibizumab|mesh-list
20432931|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20432932|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20432933|NCT01319188|Growth Substances|growth substances|mesh-ancestor
20432934|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432935|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
20432936|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20432937|NCT01319214|Propranolol|propranolol|mesh-list
20432938|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20432939|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20432940|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
20432941|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20432942|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432943|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432944|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20432945|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20432946|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
20432947|NCT01319240|Insulin|insulin|mesh-list
20432948|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20432949|NCT01319240|Liraglutide|liraglutide|mesh-list
20432950|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
20432951|NCT01319240|Xultophy|xultophy|mesh-list
20432952|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20432953|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432954|NCT01319240|Incretins|incretins|mesh-ancestor
20432955|NCT01319240|Hormones|hormones|mesh-ancestor
20432956|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432957|NCT01319266|Hydrocodone|hydrocodone|mesh-list
20432958|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20432959|NCT01319266|Narcotics|narcotics|mesh-ancestor
20432960|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432961|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432962|NCT01319266|Analgesics|analgesics|mesh-ancestor
20432963|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
20432964|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20432965|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
20432966|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
20432967|NCT01319279|Hydrocodone|hydrocodone|mesh-list
20432968|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20432969|NCT01319279|Narcotics|narcotics|mesh-ancestor
20432970|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20432971|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432972|NCT01319279|Analgesics|analgesics|mesh-ancestor
20432973|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
20432974|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405057|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
19405058|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19405059|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20432975|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
20432976|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
20432977|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20432978|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
20432979|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20432980|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20432981|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
20432982|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20432983|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20432984|NCT01319344|Eplerenone|eplerenone|mesh-list
20432985|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20432986|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
20432987|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432988|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432989|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20432990|NCT01319344|Diuretics|diuretics|mesh-ancestor
20432991|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
19405060|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405061|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19405062|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19405063|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19848330|NCT00693160|Analgesics|analgesics|mesh-ancestor
20432992|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20432993|NCT01319357|Saxagliptin|saxagliptin|mesh-list
20432994|NCT01319357|Incretins|incretins|mesh-ancestor
20432995|NCT01319357|Hormones|hormones|mesh-ancestor
20432996|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20432997|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20432998|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20432999|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
20433000|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433001|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433002|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20433003|NCT01319370|Minoxidil|minoxidil|mesh-list
20433004|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20433005|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
20433006|NCT01319448|Artesunate|artesunate|mesh-list
20433007|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
20433008|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
20433009|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20433010|NCT01319448|Amodiaquine|amodiaquine|mesh-list
20433011|NCT01319448|Mefloquine|mefloquine|mesh-list
20433012|NCT01319448|Proguanil|proguanil|mesh-list
20433013|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
20433014|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20433015|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20433016|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433017|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433018|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
20433019|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
20433020|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20433021|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
20433022|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20433023|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433024|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433025|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20433026|NCT01319448|Renal Agents|renal agents|mesh-ancestor
20433027|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
20433028|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
20433029|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20433030|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
20433031|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433032|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
20433033|NCT01319461|Protective Agents|protective agents|mesh-ancestor
20523739|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20523740|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20523741|NCT01747746|Enoxaparin|enoxaparin|mesh-list
20523742|NCT01747746|Warfarin|warfarin|mesh-list
20523743|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
20523744|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
20523745|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20433034|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20433035|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20433036|NCT01319682|Lidocaine|lidocaine|mesh-list
20433037|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
20433038|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
20433039|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433040|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433041|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
20433042|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433043|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20433044|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20433045|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20433046|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20433047|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433048|NCT01319695|Hormones|hormones|mesh-list
20433049|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20433050|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20433051|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405064|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405065|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405066|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
19405067|NCT03589833|Methotrexate|methotrexate|mesh-list
19405068|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20433052|NCT01319734|Ascorbic Acid|ascorbic acid|mesh-list
20433053|NCT01319734|Glyburide|glyburide|mesh-list
20433054|NCT01319734|Vitamins|vitamins|mesh-ancestor
20433055|NCT01319734|Micronutrients|micronutrients|mesh-ancestor
20433056|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433057|NCT01319734|Antioxidants|antioxidants|mesh-ancestor
20433058|NCT01319734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433059|NCT01319734|Protective Agents|protective agents|mesh-ancestor
20433060|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20433061|NCT01319825|Milnacipran|milnacipran|mesh-list
20433062|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
20433063|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20433064|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20433065|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20433066|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433067|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433068|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433069|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20433070|NCT01319825|Analgesics|analgesics|mesh-ancestor
20433071|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
20433072|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433073|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
20433074|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20433075|NCT01319838|Isotretinoin|isotretinoin|mesh-list
20433076|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
20433077|NCT01319864|Plerixafor|plerixafor|mesh-list
20433078|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20433079|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20433080|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
20433081|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433082|NCT01319903|Antibodies|antibodies|mesh-list
20433083|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20433084|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
20433085|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433086|NCT01319942|Sorafenib|sorafenib|mesh-list
20433087|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433088|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433089|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433090|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433091|NCT01319981|Cytarabine|cytarabine|mesh-list
20433092|NCT01319981|Dexamethasone|dexamethasone|mesh-list
20433093|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
20433094|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20433095|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20433096|NCT01319981|Prednisolone|prednisolone|mesh-list
20433097|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
20433098|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
20433099|NCT01319981|Rituximab|rituximab|mesh-list
20433100|NCT01319981|Doxorubicin|doxorubicin|mesh-list
20433101|NCT01319981|Methotrexate|methotrexate|mesh-list
19405069|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
20433102|NCT01319981|Vincristine|vincristine|mesh-list
20433103|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
20433104|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20433105|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
20433106|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433107|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
20433108|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433109|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433110|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20433111|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
20433112|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433113|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433114|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20433115|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20433116|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433117|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
20433118|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
20433119|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433120|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433121|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
20433122|NCT01319981|Hormones|hormones|mesh-ancestor
20433123|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20433124|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20433125|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20433126|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20433127|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20433128|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433129|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20433130|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
20433131|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20433132|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20433133|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
20433134|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
20433135|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20433136|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20433137|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
20433138|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433139|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20433140|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
20433141|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
20433142|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
20433143|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20433144|NCT01319981|Protective Agents|protective agents|mesh-ancestor
20433145|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433146|NCT01320007|Furosemide|furosemide|mesh-list
20433147|NCT01320007|Diuretics|diuretics|mesh-ancestor
20433148|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
19848331|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
19848332|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848333|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19848334|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20433149|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433150|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20433151|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20433152|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433153|NCT01320020|Catumaxomab|catumaxomab|mesh-list
20433154|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433155|NCT01320111|Paclitaxel|paclitaxel|mesh-list
20433156|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20433157|NCT01320111|Sorafenib|sorafenib|mesh-list
20433158|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20433159|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433160|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
20433161|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
20433162|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
20433163|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433164|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433165|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433166|NCT01320176|Vaccines|vaccines|mesh-list
20433167|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
20433168|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433169|NCT01320254|Gemcitabine|gemcitabine|mesh-list
20433170|NCT01320254|Cisplatin|cisplatin|mesh-list
20433171|NCT01320254|Panitumumab|panitumumab|mesh-list
20433172|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20433173|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433174|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20433175|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
20433176|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433177|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
20433178|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433179|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433180|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433181|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
20433182|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433183|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20433184|NCT01320280|Afatinib|afatinib|mesh-list
20433185|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848335|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848336|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848337|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20433186|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433187|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433188|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433189|NCT01320345|Fenofibrate|fenofibrate|mesh-list
20433190|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20433191|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
20433192|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433193|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20433194|NCT01320397|Losartan|losartan|mesh-list
20433195|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20433196|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20433197|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20433198|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20433199|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433200|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20433201|NCT01320436|Curcumin|curcumin|mesh-list
20433202|NCT01320436|Mesalamine|mesalamine|mesh-list
20433203|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20433204|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20433205|NCT01320436|Analgesics|analgesics|mesh-ancestor
20433206|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
20433207|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433208|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433209|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433210|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433211|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433212|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433213|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433214|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
20433215|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20433216|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433217|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
20433218|NCT01320449|Hematinics|hematinics|mesh-ancestor
20433219|NCT01320475|Sufentanil|sufentanil|mesh-list
20433220|NCT01320475|Ketamine|ketamine|mesh-list
20433221|NCT01320475|Analgesics|analgesics|mesh-ancestor
20433222|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
20433223|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433224|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433225|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20433226|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20433227|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
20433228|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
20433229|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433230|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20433231|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20433232|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433233|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433234|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20433235|NCT01320475|Narcotics|narcotics|mesh-ancestor
20433236|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20433237|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20433238|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433239|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433240|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433241|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433242|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20433243|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
20433244|NCT01320514|Coagulants|coagulants|mesh-ancestor
20433245|NCT01320579|Tacrolimus|tacrolimus|mesh-list
20433246|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433247|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
20433248|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433249|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20433250|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433251|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433252|NCT01320592|Paclitaxel|paclitaxel|mesh-list
20433253|NCT01320592|Palbociclib|palbociclib|mesh-list
20433254|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20433255|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433256|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
19848338|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848339|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848340|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
19848341|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848342|NCT00693225|Omeprazole|omeprazole|mesh-list
19848343|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19848344|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848345|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19848346|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433257|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
20433258|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
20433259|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433260|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433261|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433262|NCT01320709|Piroxicam|piroxicam|mesh-list
20433263|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20433264|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20433265|NCT01320709|Analgesics|analgesics|mesh-ancestor
20433266|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
20433267|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433268|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433269|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433270|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433271|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20433272|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433273|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433274|NCT01320878|Iloprost|iloprost|mesh-list
20433275|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20433276|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20433277|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
20433278|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
20433279|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20433280|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
20433281|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20433282|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433283|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20433284|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20433285|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20433286|NCT01320982|Aspirin|aspirin|mesh-list
20433287|NCT01320982|Minocycline|minocycline|mesh-list
20433288|NCT01320982|Pramipexole|pramipexole|mesh-list
20433289|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20433290|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20433291|NCT01320982|Analgesics|analgesics|mesh-ancestor
20433292|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
20433293|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433294|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433295|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433296|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433297|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20433298|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20433299|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433300|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20433301|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20433302|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433303|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
20433304|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20433305|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433306|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
20433307|NCT01320982|Protective Agents|protective agents|mesh-ancestor
20433308|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20433309|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20433310|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
20433311|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
20433312|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433313|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
20433314|NCT01321021|Promethazine|promethazine|mesh-list
20433315|NCT01321021|Losartan|losartan|mesh-list
20433316|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20433317|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20433318|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20433319|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20433320|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433321|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20433322|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20433323|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433324|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433325|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
20433326|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
20433327|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
20433328|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433329|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
20433330|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
20433331|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433332|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20433333|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
20433334|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
20433335|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433336|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20433337|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
20433338|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
20433339|NCT01321034|Niacin|niacin|mesh-list
20433340|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20433341|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
20433342|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433343|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20433344|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
20433345|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
20433346|NCT01321034|Vitamins|vitamins|mesh-ancestor
20433347|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
20433348|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433349|NCT01321047|Propofol|propofol|mesh-list
20433350|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20433351|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433352|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433353|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20433354|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
20433355|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
20433356|NCT01321099|Ascorbic Acid|ascorbic acid|mesh-list
20433357|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20433358|NCT01321099|Vitamins|vitamins|mesh-ancestor
20433359|NCT01321099|Micronutrients|micronutrients|mesh-ancestor
20433360|NCT01321099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433361|NCT01321099|Antioxidants|antioxidants|mesh-ancestor
20433362|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433363|NCT01321099|Protective Agents|protective agents|mesh-ancestor
20433364|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20433365|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
20433366|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
20433367|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
19848347|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848348|NCT00693420|Bimatoprost|bimatoprost|mesh-list
20218419|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20218420|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218421|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218422|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218423|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218424|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218425|NCT00313105|Lobeline|lobeline|mesh-list
20218426|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20218427|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
20218428|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218429|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218430|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20218431|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20218432|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
20218433|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218434|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433368|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20433369|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
20433370|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20433371|NCT01321125|Povidone|povidone|mesh-list
20433372|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433373|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
20433374|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
20433375|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
20433376|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
20433377|NCT01321138|Morphine|morphine|mesh-list
20433378|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20433379|NCT01321138|Narcotics|narcotics|mesh-ancestor
20433380|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433381|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433382|NCT01321138|Analgesics|analgesics|mesh-ancestor
20433383|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
20433384|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523746|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
20523747|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20523748|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
20523749|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523750|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523751|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20523752|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20523753|NCT01747798|Auranofin|auranofin|mesh-list
20523754|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523755|NCT01747993|Tamsulosin|tamsulosin|mesh-list
20523756|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20523757|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20523758|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20523759|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523760|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523761|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523762|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523763|NCT01747993|Urological Agents|urological agents|mesh-ancestor
20523764|NCT01748019|Namitecan|namitecan|mesh-list
20523765|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20523766|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523767|NCT01748084|Rituximab|rituximab|mesh-list
20523768|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20523769|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523770|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
20523771|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523772|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523773|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20523774|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
20523775|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20523776|NCT01748123|Diuretics|diuretics|mesh-ancestor
20523777|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
20523778|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523779|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20523780|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523781|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523782|NCT01748253|Amlodipine|amlodipine|mesh-list
20523783|NCT01748253|Telmisartan|telmisartan|mesh-list
20523784|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20523785|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20523786|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20523787|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523788|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523789|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20523790|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523791|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
20523792|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20523793|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20523794|NCT01748279|Atorvastatin|atorvastatin|mesh-list
20523795|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
20523796|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20523797|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20523798|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
20523799|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523800|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20523801|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20523802|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523803|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20523804|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
20523805|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523806|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433385|NCT01321255|Aspirin|aspirin|mesh-list
20433386|NCT01321255|Ramipril|ramipril|mesh-list
20433387|NCT01321255|Simvastatin|simvastatin|mesh-list
20433388|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20433389|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20433390|NCT01321255|Analgesics|analgesics|mesh-ancestor
20433391|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
20433392|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433393|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433394|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433395|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433396|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20433397|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20433398|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433399|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20433400|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20433401|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433402|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
20433403|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20433404|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20433405|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
20433406|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20433407|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20433408|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20433409|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
20433410|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20433411|NCT01321268|Beta Carotene|beta carotene|mesh-list
20433412|NCT01321268|Lycopene|lycopene|mesh-list
20433413|NCT01321268|Resveratrol|resveratrol|mesh-list
20433414|NCT01321268|Carotenoids|carotenoids|mesh-list
20433415|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
20433416|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433417|NCT01321268|Protective Agents|protective agents|mesh-ancestor
20433418|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693268|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19693269|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
19693270|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693271|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693272|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20433419|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433420|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20433421|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433422|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20433423|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20433424|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433425|NCT01321268|Provitamins|provitamins|mesh-ancestor
20433426|NCT01321268|Vitamins|vitamins|mesh-ancestor
20433427|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
20433428|NCT01321346|Cytarabine|cytarabine|mesh-list
20433429|NCT01321346|Panobinostat|panobinostat|mesh-list
20433430|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20433431|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
20433432|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433433|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433434|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
20433435|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433436|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433437|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
20433438|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433439|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20433440|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433441|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
20433442|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433443|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
20433444|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20433445|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20433446|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433447|NCT01321489|Urological Agents|urological agents|mesh-ancestor
20433448|NCT01321502|Famciclovir|famciclovir|mesh-list
20433449|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
19405070|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19405071|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433450|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433451|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20433452|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433453|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433454|NCT01321515|Famciclovir|famciclovir|mesh-list
20433455|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
20433456|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433457|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20433458|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433459|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433460|NCT01321567|Rabeprazole|rabeprazole|mesh-list
20433461|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20433462|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433463|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20433464|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433465|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433466|NCT01321671|Pregabalin|pregabalin|mesh-list
20433467|NCT01321671|Analgesics|analgesics|mesh-ancestor
20433468|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
20433469|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433470|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433471|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
20433472|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20433473|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20433474|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433475|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20433476|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20433477|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20433478|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433479|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20433480|NCT01321775|Paclitaxel|paclitaxel|mesh-list
20433481|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
20433482|NCT01321775|Bevacizumab|bevacizumab|mesh-list
20433483|NCT01321775|Trastuzumab|trastuzumab|mesh-list
20433484|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20433485|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433486|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
20433487|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
20433488|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
20433489|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433490|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433491|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
20433492|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433493|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433494|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20433495|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
20433496|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20433497|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20433498|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20433499|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20433500|NCT01321775|Growth Substances|growth substances|mesh-ancestor
20433501|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
20433502|NCT01321788|Tinzaparin|tinzaparin|mesh-list
20433503|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20433504|NCT01321788|Dalteparin|dalteparin|mesh-list
20433505|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
20433506|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20433507|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20433508|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433509|NCT01321801|Pregabalin|pregabalin|mesh-list
20433510|NCT01321801|Analgesics|analgesics|mesh-ancestor
20433511|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
20433512|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433513|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433514|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
20433515|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20433516|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20433517|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433518|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20433519|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20433520|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20433521|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433522|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20433523|NCT01321827|Itraconazole|itraconazole|mesh-list
20433524|NCT01321827|Prednisolone|prednisolone|mesh-list
20433525|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
20433526|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433527|NCT01321827|Hormones|hormones|mesh-ancestor
20433528|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20433529|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433530|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20433531|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433532|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
20433533|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433534|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20433535|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20433536|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433537|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433538|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20433539|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
20433540|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20433541|NCT01321905|Vitamin D|vitamin d|mesh-list
20433542|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
20433543|NCT01321905|Vitamins|vitamins|mesh-ancestor
20433544|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
20433545|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433546|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20433547|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20433548|NCT01321931|Nicotine|nicotine|mesh-list
20433549|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20433550|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
20433551|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433552|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433553|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20433554|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20433555|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
20433556|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433557|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433558|NCT01321944|Nicotine|nicotine|mesh-list
20433559|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20433560|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
20433561|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433562|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433563|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20433564|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20433565|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
20433566|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433567|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433568|NCT01321957|Bevacizumab|bevacizumab|mesh-list
20433569|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
20433570|NCT01321957|Irinotecan|irinotecan|mesh-list
20433571|NCT01321957|Fluorouracil|fluorouracil|mesh-list
20433572|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20433573|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433574|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20433575|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20433576|NCT01321957|Growth Substances|growth substances|mesh-ancestor
20433577|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433578|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
20433579|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20433580|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20433581|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433582|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433583|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
20433584|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20433585|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433586|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
20433587|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
20433588|NCT01322061|Vitamins|vitamins|mesh-ancestor
20433589|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
20433590|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433591|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
20433592|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433593|NCT01322061|Protective Agents|protective agents|mesh-ancestor
20433594|NCT01322100|Bleomycin|bleomycin|mesh-list
20433595|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20433596|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433597|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
20433598|NCT01322139|Nabiximols|nabiximols|mesh-list
20433599|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20613370|NCT02254655|Puerarin|puerarin|mesh-list
20433600|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20433601|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433602|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20433603|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20433604|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433605|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433606|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433607|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20433608|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
20433609|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20433610|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433611|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20433612|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20433613|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20433614|NCT01322139|Analgesics|analgesics|mesh-ancestor
19693273|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20218435|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
20218436|NCT00313131|Metronidazole|metronidazole|mesh-list
20218437|NCT00313131|Fluconazole|fluconazole|mesh-list
20218438|NCT00313131|Clotrimazole|clotrimazole|mesh-list
20218439|NCT00313131|Miconazole|miconazole|mesh-list
20218440|NCT00313131|Tinidazole|tinidazole|mesh-list
20218441|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218442|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20218443|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20433615|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
20433616|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433617|NCT01322152|Capecitabine|capecitabine|mesh-list
20433618|NCT01322152|Irinotecan|irinotecan|mesh-list
20433619|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20433620|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
20433621|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433622|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433623|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20433624|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20433625|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433626|NCT01322178|Cetuximab|cetuximab|mesh-list
20433627|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20433628|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433629|NCT01322191|Morphine|morphine|mesh-list
20433630|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20433631|NCT01322191|Narcotics|narcotics|mesh-ancestor
20433632|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433633|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433634|NCT01322191|Analgesics|analgesics|mesh-ancestor
20433635|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
20433636|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433637|NCT01322204|Codeine|codeine|mesh-list
20433638|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20433639|NCT01322204|Narcotics|narcotics|mesh-ancestor
20433640|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433641|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433642|NCT01322204|Analgesics|analgesics|mesh-ancestor
20433643|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
20433644|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433645|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
20433646|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
20433647|NCT01322282|Cetirizine|cetirizine|mesh-list
20433648|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20433649|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20433650|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20433651|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
20433652|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
20433653|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433654|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433655|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433656|NCT01322308|Pioglitazone|pioglitazone|mesh-list
19405072|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405073|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
19693274|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19693275|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693276|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693277|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
20218444|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20433657|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218445|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
20433658|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433659|NCT01322438|Rifampin|rifampin|mesh-list
20433660|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20433661|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
19405074|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405075|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405076|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
19405077|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405078|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19405079|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19405080|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
19405081|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433662|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20433663|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433664|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
20433665|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20433666|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433667|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433668|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20433669|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20433670|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20433671|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20433672|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20433673|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20433674|NCT01322464|Nabiximols|nabiximols|mesh-list
20433675|NCT01322464|Analgesics|analgesics|mesh-ancestor
20433676|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
20433677|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433678|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433679|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20433680|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20433681|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433682|NCT01322711|Atorvastatin|atorvastatin|mesh-list
20433683|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20433684|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20433685|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
20433686|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433687|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20433688|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20433689|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433690|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
20433691|NCT01322776|Fludarabine|fludarabine|mesh-list
20433692|NCT01322776|Bortezomib|bortezomib|mesh-list
20433693|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433694|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
20433695|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433696|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433697|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20433698|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
20433699|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433700|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433701|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20523807|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20523808|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
20523809|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20523810|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20523811|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20523812|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523813|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523814|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20523815|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20523816|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523817|NCT01748318|Renal Agents|renal agents|mesh-ancestor
20523818|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20523819|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
20523820|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20523821|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20523822|NCT01748344|Cetirizine|cetirizine|mesh-list
20523823|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20523824|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20523825|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20523826|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
20523827|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
20433702|NCT01322867|Alprazolam|alprazolam|mesh-list
20433703|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20433704|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433705|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433706|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20433707|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20433708|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20433709|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
20433710|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
20433711|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433712|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433713|NCT01323062|Bavituximab|bavituximab|mesh-list
20433714|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20433715|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433716|NCT01323101|Doxycycline|doxycycline|mesh-list
20433717|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20433718|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433719|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
20433720|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20433721|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20433722|NCT01323218|Vitamin D|vitamin d|mesh-list
20433723|NCT01323218|Vitamins|vitamins|mesh-ancestor
20433724|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
20433725|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433726|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20433727|NCT01323244|Simeprevir|simeprevir|mesh-list
20433728|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
20433729|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433730|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
20433731|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433732|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433733|NCT01323257|Ritonavir|ritonavir|mesh-list
20433734|NCT01323257|Darunavir|darunavir|mesh-list
20433735|NCT01323257|Erythromycin|erythromycin|mesh-list
20433736|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
20433737|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20433738|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
20433739|NCT01323257|Simeprevir|simeprevir|mesh-list
20433740|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20433741|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20433742|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
20433743|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433744|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433745|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20433746|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20433747|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
20433748|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433749|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20433750|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20433751|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20433752|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433753|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20433754|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20433755|NCT01323296|Hematinics|hematinics|mesh-ancestor
20433756|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20433757|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20433758|NCT01323335|Rasburicase|rasburicase|mesh-list
20433759|NCT01323335|Uric Acid|uric acid|mesh-list
20433760|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
20433761|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433762|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
20433763|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433764|NCT01323335|Protective Agents|protective agents|mesh-ancestor
20433765|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433766|NCT01323374|Carbidopa|carbidopa|mesh-list
20433767|NCT01323374|Droxidopa|droxidopa|mesh-list
20433768|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20433769|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20433770|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
20433771|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433772|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433773|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433774|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20433775|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433776|NCT01323452|Entecavir|entecavir|mesh-list
20433777|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
20433778|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433779|NCT01323465|Rifampin|rifampin|mesh-list
20433780|NCT01323465|Ketoconazole|ketoconazole|mesh-list
20433781|NCT01323465|Nabiximols|nabiximols|mesh-list
20433782|NCT01323465|Omeprazole|omeprazole|mesh-list
20433783|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20433784|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433785|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20218446|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20218447|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20218448|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218449|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218450|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20218451|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
20218452|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218453|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218454|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19848349|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19848350|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848351|NCT00693472|Propranolol|propranolol|mesh-list
19848352|NCT00693472|Haloperidol|haloperidol|mesh-list
19848353|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
19848354|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19848355|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
19848356|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
20218455|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20218456|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20613371|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
20613372|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
20613373|NCT02254668|Everolimus|everolimus|mesh-list
20613374|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613375|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20613376|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
20613377|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613378|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20613379|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20613380|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
20433786|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433787|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433788|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20433789|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
20433790|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19405082|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19405083|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
20613381|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20613382|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613383|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613384|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613385|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20613386|NCT02254759|Midazolam|midazolam|mesh-list
20613387|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19405084|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
20433791|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405085|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848357|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848358|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433792|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
20433793|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20433794|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20433795|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20433796|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20433797|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20433798|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20433799|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20433800|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
20613388|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19405086|NCT03589690|Protective Agents|protective agents|mesh-ancestor
19405087|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405088|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
19405089|NCT03589690|Vitamins|vitamins|mesh-ancestor
19405090|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
19405091|NCT03589547|Durvalumab|durvalumab|mesh-list
19405092|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405093|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848359|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433801|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20433802|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19693278|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19693279|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
19693280|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19693281|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19693282|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
20433803|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20433804|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
20433805|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20433806|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433807|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20433808|NCT01323465|Analgesics|analgesics|mesh-ancestor
20433809|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
20433810|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433811|NCT01323491|Nicotine|nicotine|mesh-list
20433812|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20433813|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
20433814|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433815|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433816|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20433817|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20433818|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
20433819|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433820|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433821|NCT01323569|Nabiximols|nabiximols|mesh-list
20433822|NCT01323569|Dronabinol|dronabinol|mesh-list
20433823|NCT01323569|Analgesics|analgesics|mesh-ancestor
20433824|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
20433825|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433826|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433827|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
20433828|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20433829|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20433830|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20433831|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20433832|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433833|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433834|NCT01323569|Hormones|hormones|mesh-ancestor
20433835|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20433836|NCT01323608|Vitamin D|vitamin d|mesh-list
20433837|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
20433838|NCT01323608|Vitamins|vitamins|mesh-ancestor
20433839|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
20433840|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433841|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20433842|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20433843|NCT01323712|Vitamin D|vitamin d|mesh-list
20433844|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
20433845|NCT01323712|Vitamins|vitamins|mesh-ancestor
20433846|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
20433847|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433848|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20433849|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20433850|NCT01323751|Ricolinostat|ricolinostat|mesh-list
20433851|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433852|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20433853|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433854|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433855|NCT01324063|Cytarabine|cytarabine|mesh-list
20433856|NCT01324063|Daunorubicin|daunorubicin|mesh-list
20433857|NCT01324063|Amsacrine|amsacrine|mesh-list
20433858|NCT01324063|Sargramostim|sargramostim|mesh-list
20433859|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19693283|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19693284|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19693285|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19693286|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19693287|NCT04982211|Propranolol|propranolol|mesh-list
19693288|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19848360|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19848361|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20433860|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
20523828|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848362|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848363|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19848364|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19848365|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
19848366|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848367|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848368|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19848369|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
19848370|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19848371|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19848372|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
20433861|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433862|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433863|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
20433864|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433865|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433866|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
20433867|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433868|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20433869|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20433870|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20433871|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433872|NCT01324076|Doxorubicin|doxorubicin|mesh-list
20433873|NCT01324076|Sorafenib|sorafenib|mesh-list
20433874|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20433875|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433876|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20433877|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20433878|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433879|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433880|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433881|NCT01324089|Resveratrol|resveratrol|mesh-list
20433882|NCT01324089|Piperine|piperine|mesh-list
20433883|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
20433884|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848373|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19848374|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848375|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
19848376|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19848377|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848378|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19848379|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19848380|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19848381|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
19848382|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855577|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693289|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19693290|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
19693291|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693292|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693293|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693294|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19693295|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19693296|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
19693297|NCT04981093|Dexamethasone|dexamethasone|mesh-list
19693298|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
20218457|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20433885|NCT01324089|Protective Agents|protective agents|mesh-ancestor
20433886|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433887|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433888|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20433889|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20218458|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
20218459|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20218460|NCT00313157|Metoprolol|metoprolol|mesh-list
20218461|NCT00313157|Verapamil|verapamil|mesh-list
20218462|NCT00313157|Carvedilol|carvedilol|mesh-list
20218463|NCT00313157|Diltiazem|diltiazem|mesh-list
20218464|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20218465|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218466|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
20218467|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
19693299|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693300|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
20433890|NCT01324115|Nitroarginine|nitroarginine|mesh-list
20433891|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433892|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433893|NCT01324180|Metformin|metformin|mesh-list
20433894|NCT01324180|Dexamethasone|dexamethasone|mesh-list
20433895|NCT01324180|Doxorubicin|doxorubicin|mesh-list
20433896|NCT01324180|Vincristine|vincristine|mesh-list
20433897|NCT01324180|Asparaginase|asparaginase|mesh-list
20433898|NCT01324180|Pegaspargase|pegaspargase|mesh-list
20433899|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433900|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
20433901|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
20433902|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433903|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433904|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20433905|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
20433906|NCT01324180|Hormones|hormones|mesh-ancestor
20433907|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20433908|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20433909|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433910|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20433911|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20433912|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20433913|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20433914|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433915|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433916|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20433917|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
20433918|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
20433919|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
20433920|NCT01324245|Fenoldopam|fenoldopam|mesh-list
20433921|NCT01324245|Enalaprilat|enalaprilat|mesh-list
20433922|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20433923|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
20433924|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
20433925|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
20433926|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20433927|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433928|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433929|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20433930|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
20218468|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218469|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218470|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20218471|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20218472|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20218473|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
20433931|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433932|NCT01324258|Gemcitabine|gemcitabine|mesh-list
20433933|NCT01324258|Trametinib|trametinib|mesh-list
20433934|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20433935|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
20433936|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433937|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433938|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
19693301|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
19693302|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218474|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218475|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218476|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
19405094|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
20433939|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20433940|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433941|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433942|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
20433943|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693303|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433944|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20433945|NCT01324284|Lubiprostone|lubiprostone|mesh-list
20433946|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20433947|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20433948|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433949|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
20433950|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
19405095|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20433951|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20433952|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20433953|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433954|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433955|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
20433956|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433957|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20433958|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20433959|NCT01324492|Everolimus|everolimus|mesh-list
20433960|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433961|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433962|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
20433963|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433964|NCT01324544|Buprenorphine|buprenorphine|mesh-list
20433965|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20433966|NCT01324544|Narcotics|narcotics|mesh-ancestor
20433967|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20433968|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433969|NCT01324544|Analgesics|analgesics|mesh-ancestor
20433970|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
20433971|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20433972|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20433973|NCT01324583|Prednisolone|prednisolone|mesh-list
20433974|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20433975|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
20433976|NCT01324583|Hormones|hormones|mesh-ancestor
20433977|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20433978|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433979|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20433980|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20433981|NCT01324596|Prednisolone|prednisolone|mesh-list
20433982|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20433983|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
20433984|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20433985|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
20433986|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
20433987|NCT01324596|Rituximab|rituximab|mesh-list
20433988|NCT01324596|Doxorubicin|doxorubicin|mesh-list
20433989|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20433990|NCT01324596|Vincristine|vincristine|mesh-list
20433991|NCT01324596|Bortezomib|bortezomib|mesh-list
20433992|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20433993|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
20433994|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20433995|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
20433996|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20433997|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20433998|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20433999|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
20434000|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434001|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434002|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20434003|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434004|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20434005|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20434006|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434007|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434008|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20434009|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
20434010|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
20434011|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
20434012|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434013|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
20434014|NCT01324596|Hormones|hormones|mesh-ancestor
20434015|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434016|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20434017|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
20434018|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
20434019|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434020|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20434021|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20434022|NCT01324596|Protective Agents|protective agents|mesh-ancestor
20434023|NCT01324635|Panobinostat|panobinostat|mesh-list
20434024|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20434025|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434026|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434027|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434028|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20434029|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
20434030|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434031|NCT01324752|Losartan|losartan|mesh-list
20434032|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20434033|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20434034|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20434035|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20434036|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523829|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523830|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523831|NCT01748370|Vitamin D|vitamin d|mesh-list
20523832|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
20523833|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
20523834|NCT01748370|Vitamins|vitamins|mesh-list
20523835|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
20523836|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523837|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20523838|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20523839|NCT01748396|Calcitriol|calcitriol|mesh-list
20523840|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
20523841|NCT01748396|Calcium|calcium|mesh-list
20523842|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20523843|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523844|NCT01748396|Antacids|antacids|mesh-ancestor
20523845|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523846|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523847|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20523848|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523849|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20523850|NCT01748396|Vitamins|vitamins|mesh-ancestor
20523851|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
20523852|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20530311|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530312|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530313|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
20530314|NCT01787669|Hormones|hormones|mesh-ancestor
20530315|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530316|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20530317|NCT01788007|Imiquimod|imiquimod|mesh-list
20530318|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20530319|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
20530320|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530321|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530322|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
20530323|NCT01788072|Oxytocin|oxytocin|mesh-list
20530324|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
20530325|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20530326|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530327|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
20530328|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20530329|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530330|NCT01788189|Lenalidomide|lenalidomide|mesh-list
20530331|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
20530332|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530333|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20530334|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20530335|NCT01788189|Growth Substances|growth substances|mesh-ancestor
20530336|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
20530337|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530338|NCT01788254|Talinolol|talinolol|mesh-list
20530339|NCT01788254|Torsemide|torsemide|mesh-list
20530340|NCT01788254|Midazolam|midazolam|mesh-list
20530341|NCT01788254|Codeine|codeine|mesh-list
20530342|NCT01788254|Pravastatin|pravastatin|mesh-list
20530343|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20530344|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20530345|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530346|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530347|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20530348|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20530349|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530350|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20530351|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
20434037|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20434038|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
20434039|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
20434040|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434041|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434042|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
20434043|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434044|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20434045|NCT01324960|Aldesleukin|aldesleukin|mesh-list
20434046|NCT01324960|Azacitidine|azacitidine|mesh-list
20434047|NCT01324960|Histamine|histamine|mesh-list
20434048|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20434049|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
20434050|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434051|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434052|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434053|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434054|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20434055|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20434056|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
20434057|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434058|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
20434059|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
20434060|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434061|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
20434062|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20434063|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20434064|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
20434065|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434066|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20434067|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20434068|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434069|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434070|NCT01325168|Oxytocin|oxytocin|mesh-list
20434071|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
20434072|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20434073|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434074|NCT01325194|Cytarabine|cytarabine|mesh-list
20434075|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20434076|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
20434077|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434078|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434079|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
20434080|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434081|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434082|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
20434083|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434084|NCT01325220|Baclofen|baclofen|mesh-list
20434085|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20434086|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434087|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19848383|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848384|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434088|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434089|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20434090|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
20434091|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
20434092|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434093|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434094|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20434095|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20434096|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434097|NCT01325298|Riboflavin|riboflavin|mesh-list
20434098|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
20434099|NCT01325298|Vitamins|vitamins|mesh-ancestor
19848385|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
19855578|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434100|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
20434101|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434102|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20434103|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
20434104|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
20434105|NCT01325415|Naloxegol|naloxegol|mesh-list
20434106|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434107|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434108|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20434109|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434110|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434111|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434112|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434113|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434114|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20434115|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
20434116|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434117|NCT01325558|Gemcitabine|gemcitabine|mesh-list
20434118|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20434119|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
20434120|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434121|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434122|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
20434123|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434124|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434125|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434126|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
20434127|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434128|NCT01325571|Tacrolimus|tacrolimus|mesh-list
20434129|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434130|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
20434131|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434132|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20434133|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434134|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434135|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
20434136|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20434137|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434138|NCT01325610|Vitamins|vitamins|mesh-ancestor
20434139|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
20434140|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20434141|NCT01325779|Heparin|heparin|mesh-list
20434142|NCT01325779|Enoxaparin|enoxaparin|mesh-list
20434143|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
19405096|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
19405097|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434144|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20434145|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20434146|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434147|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20434148|NCT01325818|Pravastatin|pravastatin|mesh-list
20434149|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20434150|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20434151|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
20434152|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434153|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20434154|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20434155|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434156|NCT01325844|Anesthetics|anesthetics|mesh-list
20434157|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434158|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434159|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20434160|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
20434161|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434162|NCT01325935|Clopidogrel|clopidogrel|mesh-list
20434163|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20434164|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20434165|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20434166|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20434167|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
20434168|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434169|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434170|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434171|NCT01325987|Vitamin D|vitamin d|mesh-list
20434172|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
20434173|NCT01325987|Vitamins|vitamins|mesh-list
20434174|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
20434175|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434176|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20434177|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20434178|NCT01326000|Cetuximab|cetuximab|mesh-list
20613389|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613390|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434179|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434180|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434181|NCT01326039|Bupivacaine|bupivacaine|mesh-list
20434182|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
20434183|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
20434184|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434185|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434186|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
20434187|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434188|NCT01326078|Propofol|propofol|mesh-list
20434189|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20434190|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434191|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434192|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20434193|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
20434194|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
20434195|NCT01326117|Tadalafil|tadalafil|mesh-list
20434196|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
20434197|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20434198|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20434199|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434200|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434201|NCT01326117|Urological Agents|urological agents|mesh-ancestor
20434202|NCT01326221|Tenofovir|tenofovir|mesh-list
20434203|NCT01326221|Emtricitabine|emtricitabine|mesh-list
20434204|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
20434205|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434206|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20434207|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20434208|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434209|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434210|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20434211|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20434212|NCT01326312|Leuprolide|leuprolide|mesh-list
20434213|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20434214|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
19693304|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693305|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
20434215|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20434216|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434217|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20434218|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434219|NCT01326325|Ketamine|ketamine|mesh-list
19693306|NCT04981093|Hormones|hormones|mesh-ancestor
19693307|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434220|NCT01326325|Analgesics|analgesics|mesh-ancestor
20434221|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
20434222|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434223|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434224|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20434225|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20434226|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
20434227|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
20434228|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434229|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20434230|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20434231|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434232|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434233|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
20434234|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20434235|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434236|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
20434237|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20434238|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20434239|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434240|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
20434241|NCT01326403|Coagulants|coagulants|mesh-ancestor
20523853|NCT01748422|Capsaicin|capsaicin|mesh-list
20523854|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
20523855|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
20523856|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
20523857|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523858|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523859|NCT01748435|Capsaicin|capsaicin|mesh-list
20523860|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
20523861|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
20434242|NCT01326442|Vitamin D|vitamin d|mesh-list
20434243|NCT01326442|Vitamins|vitamins|mesh-ancestor
20434244|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
20434245|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434246|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20434247|NCT01326468|Sirolimus|sirolimus|mesh-list
20434248|NCT01326468|Cisplatin|cisplatin|mesh-list
20434249|NCT01326468|Cetuximab|cetuximab|mesh-list
20434250|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434251|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434252|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434253|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434254|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20434255|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
20434256|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19405098|NCT03589495|Expectorants|expectorants|mesh-ancestor
19405099|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
19405100|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19405101|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
19405102|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405103|NCT03589495|Protective Agents|protective agents|mesh-ancestor
19405104|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405105|NCT03589495|Antidotes|antidotes|mesh-ancestor
19405106|NCT03589430|Protein C|protein c|mesh-list
19405107|NCT03589430|Antithrombins|antithrombins|mesh-list
19405108|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
19405109|NCT03589430|Protein S|protein s|mesh-list
19405110|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19405111|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
19405112|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405113|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405114|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
19405115|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20613391|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20613392|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20613393|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613394|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20613395|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
20613396|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
20613397|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
20613398|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
20613399|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218477|NCT00313157|Protective Agents|protective agents|mesh-ancestor
20218478|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20218479|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20218480|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20218481|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
20218482|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20218483|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20218484|NCT00313183|Pramlintide|pramlintide|mesh-list
20218485|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218486|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218487|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
20218488|NCT00313235|Vaccines|vaccines|mesh-list
20218489|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
20218490|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218491|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218492|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20218493|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20218494|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
20247161|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20613400|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405116|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19405117|NCT03589222|Dexamethasone|dexamethasone|mesh-list
19405118|NCT03589222|Bortezomib|bortezomib|mesh-list
19405119|NCT03589222|Daratumumab|daratumumab|mesh-list
19405120|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405121|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
19405122|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
19405123|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405124|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405125|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405126|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
19405127|NCT03589222|Hormones|hormones|mesh-ancestor
19405128|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19405129|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20434257|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
20434258|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434259|NCT01326494|Prednisone|prednisone|mesh-list
20434260|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434261|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
20434262|NCT01326494|Hormones|hormones|mesh-ancestor
20434263|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434264|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434265|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20434266|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434267|NCT01326559|Docetaxel|docetaxel|mesh-list
20434268|NCT01326559|Cetuximab|cetuximab|mesh-list
20434269|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434270|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
20434271|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
20434272|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
20434273|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434274|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434275|NCT01326585|Dexamethasone|dexamethasone|mesh-list
20434276|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
20434277|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20434278|NCT01326585|BB 1101|bb 1101|mesh-list
20434279|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434280|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
20434281|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
20434282|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434283|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434284|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20434285|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
20434286|NCT01326585|Hormones|hormones|mesh-ancestor
20434287|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434288|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20434289|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434290|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
20434291|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434292|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434293|NCT01326611|Clarithromycin|clarithromycin|mesh-list
20434294|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434295|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434296|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20434297|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434298|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434299|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20434300|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20434301|NCT01326650|Vitamin D|vitamin d|mesh-list
20434302|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
20434303|NCT01326650|Vitamins|vitamins|mesh-list
20434304|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20434305|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
20434306|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434307|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20434308|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20434309|NCT01326754|Artesunate|artesunate|mesh-list
20434310|NCT01326754|Lumefantrine|lumefantrine|mesh-list
20434311|NCT01326754|Artemether|artemether|mesh-list
20434312|NCT01326754|Piperaquine|piperaquine|mesh-list
20434313|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20434314|NCT01326754|Amodiaquine|amodiaquine|mesh-list
20434315|NCT01326754|Artenimol|artenimol|mesh-list
20434316|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
20434317|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
20434318|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20434319|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20434320|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434321|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434322|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
20434323|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
20434324|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20434325|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
20434326|NCT01326767|Paclitaxel|paclitaxel|mesh-list
20434327|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20434328|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20434329|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434330|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
20434331|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
20434332|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
20434333|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434334|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20434335|NCT01326858|Ketotifen|ketotifen|mesh-list
20434336|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20434337|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20434338|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20434339|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20434340|NCT01326858|Analgesics|analgesics|mesh-ancestor
20434341|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
20434342|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434343|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434344|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434345|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20434346|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20434347|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20434348|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19693308|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693309|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693310|NCT04980885|Azacitidine|azacitidine|mesh-list
20434349|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
20434350|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
20434351|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434352|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434353|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
20434354|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
20434355|NCT01326871|Gemcitabine|gemcitabine|mesh-list
20434356|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434357|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20434358|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
20434359|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434360|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
20434361|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434362|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434363|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693311|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20434364|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
20434365|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434366|NCT01326988|Anesthetics|anesthetics|mesh-list
20434367|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434368|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434369|NCT01327027|Vasopressins|vasopressins|mesh-list
20434370|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
20434371|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
20434372|NCT01327027|Coagulants|coagulants|mesh-ancestor
20434373|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20434374|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20434375|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
20434376|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434377|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
20434378|NCT01327066|Droxidopa|droxidopa|mesh-list
20434379|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434380|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434381|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20434382|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434383|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434384|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434385|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434386|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20434387|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20434388|NCT01327079|Methadone|methadone|mesh-list
20434389|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20434390|NCT01327079|Narcotics|narcotics|mesh-ancestor
20434391|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434392|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434393|NCT01327079|Analgesics|analgesics|mesh-ancestor
20434394|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
20434395|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434396|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
20434397|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
20434398|NCT01327118|Dinoprost|dinoprost|mesh-list
20434399|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
20434400|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20434401|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
20434402|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20434403|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434404|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
19693312|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
19693313|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434405|NCT01327144|Acyclovir|acyclovir|mesh-list
20434406|NCT01327144|Famciclovir|famciclovir|mesh-list
20434407|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
20434408|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434409|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20434410|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434411|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434412|NCT01327222|Bevacizumab|bevacizumab|mesh-list
20434413|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434414|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434415|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20434416|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20434417|NCT01327222|Growth Substances|growth substances|mesh-ancestor
20434418|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434419|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
20434420|NCT01327235|Cisplatin|cisplatin|mesh-list
20434421|NCT01327235|Endostar protein|endostar protein|mesh-list
20434422|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434423|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20434424|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20434425|NCT01327235|Growth Substances|growth substances|mesh-ancestor
20434426|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434427|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
20434428|NCT01327261|Levodopa|levodopa|mesh-list
20434429|NCT01327261|Benserazide|benserazide|mesh-list
20434430|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20434431|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20434432|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
20434433|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434434|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434435|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434436|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434437|NCT01327326|Naltrexone|naltrexone|mesh-list
20434438|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20434439|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20434440|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434441|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
20434442|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434443|NCT01327469|Albendazole|albendazole|mesh-list
20434444|NCT01327469|Mebendazole|mebendazole|mesh-list
20434445|NCT01327469|Piperazine|piperazine|mesh-list
20434446|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
20434447|NCT01327469|Pyrantel|pyrantel|mesh-list
20434448|NCT01327469|Oxantel|oxantel|mesh-list
20434449|NCT01327469|DMP 777|dmp 777|mesh-list
20434450|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
20434451|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20434452|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434453|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
20434454|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20434455|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20434456|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
20434457|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
20434458|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
20434459|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434460|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434461|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
20434462|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434463|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20434464|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20434465|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20434466|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218495|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218496|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218497|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20218498|NCT00313261|Clevudine|clevudine|mesh-list
20218499|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
20218500|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218501|NCT00313274|Clevudine|clevudine|mesh-list
20218502|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
20218503|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218504|NCT00313287|Clevudine|clevudine|mesh-list
20218505|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
20218506|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434467|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434468|NCT01327521|Gemcitabine|gemcitabine|mesh-list
20434469|NCT01327521|Cisplatin|cisplatin|mesh-list
20434470|NCT01327521|Doxorubicin|doxorubicin|mesh-list
20434471|NCT01327521|Fluorouracil|fluorouracil|mesh-list
20434472|NCT01327521|Epirubicin|epirubicin|mesh-list
20434473|NCT01327521|Mitomycins|mitomycins|mesh-list
20434474|NCT01327521|Mitomycin|mitomycin|mesh-list
20434475|NCT01327521|Maleic acid|maleic acid|mesh-list
20434476|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434477|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20434478|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
20434479|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434480|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
20434481|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434482|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434483|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434484|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
20434485|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434486|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20434487|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20434488|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434489|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
20434490|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20434491|NCT01327534|Clopidogrel|clopidogrel|mesh-list
20434492|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20434493|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20434494|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20434495|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20434496|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20434497|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
20434498|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434499|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434500|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434501|NCT01327625|Azithromycin|azithromycin|mesh-list
20434502|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434503|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434504|NCT01327729|Interferons|interferons|mesh-list
20434505|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
20434506|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
20434507|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20434508|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434509|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
20434510|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434511|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
20434512|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434513|NCT01327755|Selenium|selenium|mesh-list
20434514|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
20434515|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434516|NCT01327755|Protective Agents|protective agents|mesh-ancestor
20434517|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434518|NCT01327755|Trace Elements|trace elements|mesh-ancestor
20434519|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
20434520|NCT01327859|Donepezil|donepezil|mesh-list
20434521|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20434522|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434523|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434524|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
20434525|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434526|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434527|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
20434528|NCT01328015|Oxybutynin|oxybutynin|mesh-list
20434529|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20434530|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
20434531|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
20434532|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434533|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434534|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20434535|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
20434536|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434537|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434538|NCT01328015|Urological Agents|urological agents|mesh-ancestor
20434539|NCT01328106|Trametinib|trametinib|mesh-list
20434540|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434541|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20434542|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434543|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434544|NCT01328145|Aspirin|aspirin|mesh-list
20434545|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20434546|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613401|NCT02254824|Atorvastatin|atorvastatin|mesh-list
20434547|NCT01328145|Analgesics|analgesics|mesh-ancestor
20434548|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
20434549|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434550|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434551|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434552|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20434553|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20434554|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20434555|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434556|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20434557|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20434558|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434559|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
20434560|NCT01328171|Folic Acid|folic acid|mesh-list
20434561|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
20434562|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
20434563|NCT01328171|Irinotecan|irinotecan|mesh-list
20434564|NCT01328171|Panitumumab|panitumumab|mesh-list
20434565|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434566|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20434567|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434568|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434569|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434570|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434571|NCT01328171|Hematinics|hematinics|mesh-ancestor
20434572|NCT01328171|Vitamins|vitamins|mesh-ancestor
20434573|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
20434574|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434575|NCT01328223|Sorafenib|sorafenib|mesh-list
20434576|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848386|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19848387|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19848388|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19848389|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
19848390|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848391|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848392|NCT00693719|Irinotecan|irinotecan|mesh-list
19848393|NCT00693719|Etoposide|etoposide|mesh-list
20434577|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20434578|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434579|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434580|NCT01328236|Dexamethasone|dexamethasone|mesh-list
20434581|NCT01328236|Doxorubicin|doxorubicin|mesh-list
20434582|NCT01328236|Bortezomib|bortezomib|mesh-list
20434583|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434584|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
20434585|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
20434586|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434587|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434588|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20434589|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
20434590|NCT01328236|Hormones|hormones|mesh-ancestor
20434591|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434592|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20434593|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434594|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20434595|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20434596|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434597|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434598|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434599|NCT01328301|Methamphetamine|methamphetamine|mesh-list
20434600|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20434601|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434602|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
20434603|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
20434604|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434605|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
20434606|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434607|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434608|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
20434609|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20434610|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20434611|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20434612|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20434613|NCT01328340|Methamphetamine|methamphetamine|mesh-list
20434614|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20434615|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434616|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
20434617|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
20434618|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434619|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
20434620|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434621|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434622|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
20434623|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20434624|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20434625|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20434626|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20434627|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
20434628|NCT01328392|Lansoprazole|lansoprazole|mesh-list
20434629|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20434630|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20434631|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20434632|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434633|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523862|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
20523863|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523864|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523865|NCT01748487|Dexamethasone|dexamethasone|mesh-list
20523866|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
20523867|NCT01748487|BB 1101|bb 1101|mesh-list
20523868|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523869|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
20523870|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
20523871|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523872|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523873|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523874|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
20523875|NCT01748487|Hormones|hormones|mesh-ancestor
20523876|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20523877|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20523878|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523879|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
20523880|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523881|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523882|NCT01748500|Pantoprazole|pantoprazole|mesh-list
20523883|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20523884|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523885|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20523886|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523887|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523888|NCT01748526|Canagliflozin|canagliflozin|mesh-list
20523889|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20523890|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523891|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20523892|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523893|NCT01748539|Brodalumab|brodalumab|mesh-list
20523894|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
20523895|NCT01748630|Fentanyl|fentanyl|mesh-list
20523896|NCT01748630|Midazolam|midazolam|mesh-list
20523897|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
20523898|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20523899|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523900|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523901|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523902|NCT01748630|Analgesics|analgesics|mesh-ancestor
20523903|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
20523904|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523905|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20523906|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20523907|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20523908|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523909|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523910|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523911|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20523912|NCT01748630|Narcotics|narcotics|mesh-ancestor
20523913|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20523914|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20523915|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
20434634|NCT01328457|Paromomycin|paromomycin|mesh-list
20434635|NCT01328457|Neomycin|neomycin|mesh-list
20434636|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434637|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434638|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20434639|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20434640|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20434641|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434642|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434643|NCT01328470|Cilostazol|cilostazol|mesh-list
20434644|NCT01328470|Clopidogrel|clopidogrel|mesh-list
20434645|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20434646|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20434647|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20434648|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20434649|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
20434650|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434651|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434652|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434653|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20434654|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
20434655|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434656|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20434657|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
20434658|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20434659|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20434660|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
20434661|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20434662|NCT01328470|Protective Agents|protective agents|mesh-ancestor
20434663|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20434664|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20434665|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434666|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
20434667|NCT01328652|Lansoprazole|lansoprazole|mesh-list
20434668|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20434669|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434670|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434671|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20434672|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20434673|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
20434674|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20434675|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434676|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434677|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20434678|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20434679|NCT01328821|Protective Agents|protective agents|mesh-ancestor
20434680|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434681|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
20434682|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20434683|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
20434684|NCT01328834|Tacrolimus|tacrolimus|mesh-list
20434685|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434686|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
20434687|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434688|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20434689|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434690|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434691|NCT01328886|Omalizumab|omalizumab|mesh-list
20434692|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20434693|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20434694|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
20434695|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
20434696|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20434697|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434698|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
20434699|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
20434700|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20434701|NCT01328990|Amodiaquine|amodiaquine|mesh-list
20434702|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
19405130|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405131|NCT03589066|Rotigotine|rotigotine|mesh-list
20434703|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20434704|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20434705|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434706|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20434707|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434708|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434709|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20434710|NCT01328990|Renal Agents|renal agents|mesh-ancestor
20434711|NCT01329016|Metformin|metformin|mesh-list
20434712|NCT01329016|Glyburide|glyburide|mesh-list
19405132|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
19405133|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
19405134|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405135|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405136|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405137|NCT03589040|Darunavir|darunavir|mesh-list
19405138|NCT03589040|Rilpivirine|rilpivirine|mesh-list
19405139|NCT03589040|Etonogestrel|etonogestrel|mesh-list
19405140|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19405141|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19405142|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
19405143|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405144|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405145|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19405146|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19405147|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
19405148|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405149|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19405150|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19405151|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19405152|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
19405153|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20434713|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20434714|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434715|NCT01329042|Citric Acid|citric acid|mesh-list
20434716|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
20434717|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
20434718|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20434719|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
20434720|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
20434721|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434722|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
20434723|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434724|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434725|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20434726|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434727|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434728|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405154|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405155|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19405156|NCT03589027|Ritonavir|ritonavir|mesh-list
20613402|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20613403|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20613404|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
20613405|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613406|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19405157|NCT03589027|Darunavir|darunavir|mesh-list
19405158|NCT03589027|Rilpivirine|rilpivirine|mesh-list
19405159|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
19693314|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613407|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20613408|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613409|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20613410|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613411|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613412|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
20613413|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20613414|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
20613415|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613416|NCT02254954|Temozolomide|temozolomide|mesh-list
20613417|NCT02254954|Macitentan|macitentan|mesh-list
19405160|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19693315|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693316|NCT04980404|Decitabine|decitabine|mesh-list
19693317|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19693318|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
19693319|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693320|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693321|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434729|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434730|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20434731|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20434732|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
20434733|NCT01329289|Dexamethasone|dexamethasone|mesh-list
20434734|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
20434735|NCT01329289|Bortezomib|bortezomib|mesh-list
20434736|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20434737|NCT01329289|Pasireotide|pasireotide|mesh-list
20434738|NCT01329289|BB 1101|bb 1101|mesh-list
20434739|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434740|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
20434741|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
19405161|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19405162|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
19405163|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405164|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405165|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19405166|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19405167|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
19405168|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405169|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19405170|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19405171|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19405172|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
19405173|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19405174|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405175|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19405176|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19405177|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19405178|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19693322|NCT04980170|Amoxicillin|amoxicillin|mesh-list
19693323|NCT04980170|Clindamycin|clindamycin|mesh-list
20434742|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434743|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434744|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20434745|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
20434746|NCT01329289|Hormones|hormones|mesh-ancestor
20434747|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434748|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20434749|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434750|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
20434751|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434752|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434753|NCT01329367|Antioxidants|antioxidants|mesh-list
20434754|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434755|NCT01329367|Protective Agents|protective agents|mesh-ancestor
20434756|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434757|NCT01329406|Milnacipran|milnacipran|mesh-list
20434758|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
20434759|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20434760|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20434761|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20434762|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434763|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434764|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434765|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20434766|NCT01329406|Analgesics|analgesics|mesh-ancestor
20434767|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
20434768|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434769|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
20434770|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20434771|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20434772|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434773|NCT01329614|Nicotine|nicotine|mesh-list
20434774|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20434775|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
20434776|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434777|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434778|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20434779|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20434780|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
20434781|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523916|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
20434782|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434783|NCT01329627|Paclitaxel|paclitaxel|mesh-list
20434784|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20434785|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
20434786|NCT01329627|Doxorubicin|doxorubicin|mesh-list
20434787|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20434788|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20434789|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434790|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
20434791|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
20434792|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
20434793|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434794|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434795|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
20434796|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434797|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20434798|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20434799|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
20434800|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20434801|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20434802|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20434803|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20434804|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434805|NCT01329640|Paclitaxel|paclitaxel|mesh-list
20434806|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
20434807|NCT01329640|Trastuzumab|trastuzumab|mesh-list
20434808|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20434809|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434810|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
20434811|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
20434812|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
20434813|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434814|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434815|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
20434816|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434817|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20434818|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20434819|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
20434820|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20434821|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434822|NCT01329666|Vitamin D|vitamin d|mesh-list
20434823|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
20434824|NCT01329666|Vitamins|vitamins|mesh-ancestor
20434825|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
20434826|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434827|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20434828|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20434829|NCT01329731|Olaflur|olaflur|mesh-list
20434830|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
20434831|NCT01329731|Protective Agents|protective agents|mesh-ancestor
20434832|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434833|NCT01329744|Mecasermin|mecasermin|mesh-list
20434834|NCT01329744|Growth Substances|growth substances|mesh-ancestor
20434835|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434836|NCT01329770|Vitamins|vitamins|mesh-list
20434837|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
20434838|NCT01329770|Vitamin E|vitamin e|mesh-list
20434839|NCT01329770|Tocopherols|tocopherols|mesh-list
20434840|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
20434841|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
20434842|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434843|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
20434844|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434845|NCT01329770|Protective Agents|protective agents|mesh-ancestor
20434846|NCT01329783|Maraviroc|maraviroc|mesh-list
20434847|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20434848|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20434849|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434850|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20434851|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20434852|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
20434853|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693324|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
19693325|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
20434854|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20434855|NCT01329796|Lidocaine|lidocaine|mesh-list
20434856|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
20434857|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
20434858|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434859|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434860|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
20434861|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434862|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20434863|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20434864|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20434865|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20434866|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434867|NCT01329809|Molgramostim|molgramostim|mesh-list
20434868|NCT01329809|Sargramostim|sargramostim|mesh-list
20434869|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
20434870|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434871|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434872|NCT01329887|Ketanserin|ketanserin|mesh-list
20434873|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20434874|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20434875|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20434876|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
20434877|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434878|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434879|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434880|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
20434881|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
20434882|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
20434883|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20434884|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523917|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20523918|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20523919|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523920|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
20523921|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
20523922|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
20523923|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
20523924|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523925|NCT01748669|Protective Agents|protective agents|mesh-ancestor
20523926|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523927|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20523928|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523929|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20523930|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523931|NCT01748721|Antibodies|antibodies|mesh-list
20523932|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20523933|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
20523934|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523935|NCT01748773|Capecitabine|capecitabine|mesh-list
20523936|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
20523937|NCT01748773|Trastuzumab|trastuzumab|mesh-list
20523938|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20523939|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
20523940|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523941|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523942|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20523943|NCT01748838|Mannitol|mannitol|mesh-list
20523944|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20523945|NCT01748838|Diuretics|diuretics|mesh-ancestor
20523946|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
20523947|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523948|NCT01748929|Albendazole|albendazole|mesh-list
20523949|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
20523950|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20523951|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523952|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
20523953|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20523954|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20523955|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
20523956|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
20523957|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
20523958|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523959|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523960|NCT01749072|Vinorelbine|vinorelbine|mesh-list
20523961|NCT01749072|Ifosfamide|ifosfamide|mesh-list
20523962|NCT01749072|Gefitinib|gefitinib|mesh-list
20523963|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20523964|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434885|NCT01330472|Alprazolam|alprazolam|mesh-list
20434886|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20434887|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434888|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434889|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20434890|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20434891|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20434892|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
20434893|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
20434894|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434895|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434896|NCT01330524|Triamcinolone|triamcinolone|mesh-list
20434897|NCT01330524|Bevacizumab|bevacizumab|mesh-list
20434898|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20434899|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434900|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20434901|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20434902|NCT01330524|Growth Substances|growth substances|mesh-ancestor
20434903|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434904|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
20434905|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434906|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
20434907|NCT01330524|Hormones|hormones|mesh-ancestor
20434908|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434909|NCT01330563|Ketoconazole|ketoconazole|mesh-list
20434910|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
20434911|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434912|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20434913|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20434914|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434915|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434916|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20434917|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
20434918|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20434919|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434920|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20434921|NCT01330615|Lidocaine|lidocaine|mesh-list
20434922|NCT01330615|Prilocaine|prilocaine|mesh-list
20434923|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20434924|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
20434925|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
20434926|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20434927|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434928|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
20434929|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434930|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20434931|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20434932|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20434933|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20434934|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434935|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20434936|NCT01330654|Metoprolol|metoprolol|mesh-list
20434937|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20434938|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20434939|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
20434940|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
20434941|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434942|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434943|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20434944|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20434945|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20434946|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
20434947|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434948|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434949|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20434950|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20434951|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20434952|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20434953|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434954|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20434955|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20434956|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434957|NCT01330706|Polihexanide|polihexanide|mesh-list
20434958|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
20434959|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434960|NCT01330810|Curcumin|curcumin|mesh-list
20434961|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20434962|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20434963|NCT01330810|Analgesics|analgesics|mesh-ancestor
20434964|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
20434965|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20434966|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434967|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20434968|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20434969|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434970|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434971|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434972|NCT01330901|Ustekinumab|ustekinumab|mesh-list
20434973|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
20434974|NCT01331122|Droxidopa|droxidopa|mesh-list
20434975|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20434976|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20434977|NCT01331135|Sirolimus|sirolimus|mesh-list
20434978|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20434979|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20434980|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20434981|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20434982|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
20434983|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20434984|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
20434985|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434986|NCT01331148|Vitamin D|vitamin d|mesh-list
20434987|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
20434988|NCT01331148|Vitamins|vitamins|mesh-ancestor
20434989|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
20434990|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434991|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20434992|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20434993|NCT01331382|Resveratrol|resveratrol|mesh-list
20434994|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
20434995|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20434996|NCT01331382|Protective Agents|protective agents|mesh-ancestor
20434997|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20434998|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20434999|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20435000|NCT01331421|Exemestane|exemestane|mesh-list
20435001|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435002|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20435003|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20435004|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435005|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435006|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20435007|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
20435008|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435009|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435010|NCT01331434|Exemestane|exemestane|mesh-list
20435011|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435012|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20435013|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20435014|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435015|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435016|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20435017|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
20435018|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435019|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435020|NCT01331447|Exemestane|exemestane|mesh-list
20435021|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435022|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19693326|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19693327|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
19693328|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
19693329|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19693330|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435023|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20435024|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693331|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19693332|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693333|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693334|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19693335|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
19693336|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19693337|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19693338|NCT04980105|Prednisolone|prednisolone|mesh-list
19693339|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
19693340|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19693341|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
20435025|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435026|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20435027|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
20435028|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435029|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435030|NCT01331525|Ipilimumab|ipilimumab|mesh-list
20435031|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20435032|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435033|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20435034|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435035|NCT01331590|Dexamethasone|dexamethasone|mesh-list
20435036|NCT01331590|Etoposide|etoposide|mesh-list
20435037|NCT01331590|Ifosfamide|ifosfamide|mesh-list
20435038|NCT01331590|Lenograstim|lenograstim|mesh-list
20435039|NCT01331590|Sargramostim|sargramostim|mesh-list
20435040|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435041|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
20435042|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
20435043|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435044|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435045|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20435046|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
20435047|NCT01331590|Hormones|hormones|mesh-ancestor
20435048|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435049|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20435050|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435051|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20435052|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20435053|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20435054|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435055|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435056|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20435057|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
20435058|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20435059|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
20435060|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
20435061|NCT01331655|Drospirenone|drospirenone|mesh-list
20435062|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20435063|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
20435064|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435065|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435066|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20435067|NCT01331655|Diuretics|diuretics|mesh-ancestor
20435068|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
20435069|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
20435070|NCT01331655|Vitamins|vitamins|mesh-ancestor
20435071|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
20435072|NCT01331707|Everolimus|everolimus|mesh-list
20435073|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435074|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435075|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
20435076|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435077|NCT01331785|Midodrine|midodrine|mesh-list
20435078|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
20435079|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
20435080|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435081|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435082|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20435083|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20435084|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20435085|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20435086|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
20435087|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435088|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435089|NCT01331902|Nicorandil|nicorandil|mesh-list
20435090|NCT01331902|Adenosine|adenosine|mesh-list
20435091|NCT01331902|Analgesics|analgesics|mesh-ancestor
20435092|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
20435093|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435094|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435095|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20435096|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
20435097|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20435098|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
20435099|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
20435100|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435101|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435102|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20435103|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
20435104|NCT01331902|Vitamins|vitamins|mesh-ancestor
20435105|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
20435106|NCT01331928|Docetaxel|docetaxel|mesh-list
20435107|NCT01331928|Capecitabine|capecitabine|mesh-list
20435108|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
20435109|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435110|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435111|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435112|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435113|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435114|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435115|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
20435116|NCT01331941|Paclitaxel|paclitaxel|mesh-list
20435117|NCT01331941|Trebananib|trebananib|mesh-list
20435118|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20435119|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435120|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435121|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435122|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435123|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435124|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20435125|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20435126|NCT01331941|Growth Substances|growth substances|mesh-ancestor
20435127|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435128|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
20435129|NCT01331967|Pioglitazone|pioglitazone|mesh-list
20435130|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435131|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435132|NCT01331993|Naproxen|naproxen|mesh-list
20435133|NCT01331993|Esomeprazole|esomeprazole|mesh-list
20435134|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20435135|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20435136|NCT01331993|Analgesics|analgesics|mesh-ancestor
20435137|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
20435138|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435139|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435140|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435141|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20435142|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
20435143|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20435144|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435145|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435146|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20435147|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20435148|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20523965|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
20523966|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
20523967|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
20523968|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523969|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20523970|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
20523971|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20523972|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523973|NCT01749085|Ketoconazole|ketoconazole|mesh-list
20523974|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
20523975|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523976|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20523977|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20523978|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530352|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
20435149|NCT01332097|Prednisone|prednisone|mesh-list
20435150|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435151|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
20435152|NCT01332097|Hormones|hormones|mesh-ancestor
20435153|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435154|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435155|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20435156|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435157|NCT01332201|Tacrolimus|tacrolimus|mesh-list
20435158|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435159|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
20435160|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435161|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20435162|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435163|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435164|NCT01332279|Everolimus|everolimus|mesh-list
20435165|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20435166|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435167|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435168|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
20435169|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435170|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20435171|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435172|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435173|NCT01332344|Fluticasone|fluticasone|mesh-list
20435174|NCT01332344|Xhance|xhance|mesh-list
20435175|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20435176|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435177|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20435178|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
20435179|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435180|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435181|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20435182|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
20435183|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
19693342|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
20218507|NCT00313391|Risperidone|risperidone|mesh-list
20218508|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20218509|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
20218510|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218511|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218512|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218513|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20218514|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20218515|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218516|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218517|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20218518|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
20218519|NCT00313456|Satraplatin|satraplatin|mesh-list
20435184|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20435185|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20435186|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20435187|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20435188|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
20435189|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435190|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435191|NCT01332370|Metformin|metformin|mesh-list
20435192|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20435193|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
20435194|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435195|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435196|NCT01332370|Incretins|incretins|mesh-ancestor
20435197|NCT01332370|Hormones|hormones|mesh-ancestor
20435198|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435199|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20435200|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
20435201|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435202|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435203|NCT01332383|Naratriptan|naratriptan|mesh-list
20435204|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20435205|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20435206|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20435207|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
20435208|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435209|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435210|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435211|NCT01332396|Lapatinib|lapatinib|mesh-list
20435212|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435213|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20435214|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435215|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435216|NCT01332409|Fluticasone|fluticasone|mesh-list
20435217|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20435218|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20435219|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435220|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20435221|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
20435222|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435223|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435224|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20435225|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
20435226|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
20435227|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20435228|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20435229|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20435230|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20435231|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
20435232|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435233|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435234|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
20435235|NCT01332409|Hormones|hormones|mesh-ancestor
20435236|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435237|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
20435238|NCT01332422|Fluticasone|fluticasone|mesh-list
20435239|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20435240|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20435241|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435242|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20435243|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
20435244|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435245|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435246|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20435247|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
20435248|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
20435249|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20435250|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20435251|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20435252|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20435253|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
20435254|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435255|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435256|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
20435257|NCT01332422|Hormones|hormones|mesh-ancestor
20435258|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435259|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
20435260|NCT01332448|Orlistat|orlistat|mesh-list
20435261|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435262|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435263|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20435264|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20435265|NCT01332552|Ritonavir|ritonavir|mesh-list
20435266|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20435267|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20435268|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
20435269|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435270|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435271|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20435272|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20435273|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
20435274|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435275|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20435276|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20435277|NCT01332565|Dolutegravir|dolutegravir|mesh-list
20435278|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20435279|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20613418|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19405179|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20435280|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435281|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435282|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20435283|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20435284|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
20435285|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435286|NCT01332604|Bevacizumab|bevacizumab|mesh-list
20435287|NCT01332604|Capecitabine|capecitabine|mesh-list
20435288|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20435289|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435290|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20435291|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20435292|NCT01332604|Growth Substances|growth substances|mesh-ancestor
20435293|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435294|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
20435295|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435296|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
20435297|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435298|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
20435299|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
20435300|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20435301|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20435302|NCT01332617|Prednisolone|prednisolone|mesh-list
20435303|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
20435304|NCT01332617|Diclofenac|diclofenac|mesh-list
20435305|NCT01332617|Bortezomib|bortezomib|mesh-list
20435306|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20435307|NCT01332617|Simvastatin|simvastatin|mesh-list
20435308|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20435309|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
20435310|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435311|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435312|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
20435313|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
20435314|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435315|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435316|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20435317|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
20435318|NCT01332617|Hormones|hormones|mesh-ancestor
20435319|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435320|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20435321|NCT01332617|Protective Agents|protective agents|mesh-ancestor
20435322|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20435323|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20435324|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20435325|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
20435326|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435327|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20435328|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20435329|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435330|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20435331|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20435332|NCT01332617|Analgesics|analgesics|mesh-ancestor
20435333|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
20435334|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20435335|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20435336|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20435337|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
20435338|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20435339|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
20435340|NCT01332734|Analgesics|analgesics|mesh-ancestor
20435341|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
20435342|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435343|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435344|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
20435345|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20435346|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20435347|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
20435348|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20435349|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20435350|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435351|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20435352|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
20435353|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20435354|NCT01332747|Atorvastatin|atorvastatin|mesh-list
20435355|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20435356|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20435357|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
20435358|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435359|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20435360|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20435361|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435362|NCT01332786|Tigecycline|tigecycline|mesh-list
20435363|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20435364|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435365|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20435366|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435367|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435368|NCT01332929|Bevacizumab|bevacizumab|mesh-list
20435369|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20435370|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435371|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20435372|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20435373|NCT01332929|Growth Substances|growth substances|mesh-ancestor
20435374|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435375|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
20435376|NCT01332955|Ribavirin|ribavirin|mesh-list
20435377|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20435378|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
20435379|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435380|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
20435381|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435382|NCT01333085|Paclitaxel|paclitaxel|mesh-list
20435383|NCT01333085|Carboplatin|carboplatin|mesh-list
20435384|NCT01333085|Everolimus|everolimus|mesh-list
20435385|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20435386|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435387|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435388|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435389|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435390|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435391|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435392|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
20435393|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435394|NCT01333124|Gemcitabine|gemcitabine|mesh-list
20435395|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435396|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
20435397|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435398|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435399|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
20435400|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435401|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435402|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435403|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
20435404|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435405|NCT01333137|Gemcitabine|gemcitabine|mesh-list
20435406|NCT01333137|Carboplatin|carboplatin|mesh-list
20435407|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435408|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435409|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
20435410|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435411|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
20435412|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435413|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435414|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435415|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
20435416|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435417|NCT01333150|Propranolol|propranolol|mesh-list
20435418|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20435419|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20435420|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
20435421|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435422|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435423|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435424|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20613419|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
20435425|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20435426|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
20435427|NCT01333267|Hormones|hormones|mesh-list
20435428|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
20435429|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
20435430|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
20435431|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
20435432|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435433|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435434|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20435435|NCT01333332|Capecitabine|capecitabine|mesh-list
20435436|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435437|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
20435438|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435439|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435440|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
20435441|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20435442|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435443|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
20435444|NCT01333410|Tacrolimus|tacrolimus|mesh-list
20435445|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435446|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
20435447|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435448|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20435449|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435450|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435451|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435452|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
20435453|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20435454|NCT01333423|Roscovitine|roscovitine|mesh-list
20435455|NCT01333423|Doxorubicin|doxorubicin|mesh-list
20435456|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20435457|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20435458|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435459|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20435460|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20435461|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435462|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435463|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
20435464|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435465|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20435466|NCT01333449|Decitabine|decitabine|mesh-list
20435467|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435468|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
20435469|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435470|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435471|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435472|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
20435473|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
20435474|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20435475|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435476|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435477|NCT01333631|Valproic Acid|valproic acid|mesh-list
20435478|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
20435479|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435480|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435481|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
20435482|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435483|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435484|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
20435485|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20435486|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20435487|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20435488|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20435489|NCT01333696|Pemetrexed|pemetrexed|mesh-list
20435490|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435491|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435492|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435493|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20435494|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20435495|NCT01333709|Folfirinox|folfirinox|mesh-list
20435496|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435497|NCT01333774|Acarbose|acarbose|mesh-list
20435498|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19405180|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
19405181|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20435499|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405182|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405183|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405184|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405185|NCT03588988|Analgesics|analgesics|mesh-ancestor
20218520|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435500|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435501|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435502|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435503|NCT01333800|Ciclesonide|ciclesonide|mesh-list
20435504|NCT01333800|Beclomethasone|beclomethasone|mesh-list
20435505|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435506|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
20435507|NCT01333800|Hormones|hormones|mesh-ancestor
20435508|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435509|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435510|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20435511|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
20435512|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20435513|NCT01333852|Metformin|metformin|mesh-list
20435514|NCT01333852|Paclitaxel|paclitaxel|mesh-list
20435515|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20435516|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435517|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435518|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435519|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435520|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435521|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435522|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435523|NCT01333878|Abatacept|abatacept|mesh-list
20435524|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20435525|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435526|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435527|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435528|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
20435529|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435530|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20435531|NCT01333891|Nitroprusside|nitroprusside|mesh-list
20435532|NCT01333891|Phenylephrine|phenylephrine|mesh-list
20435533|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
20435534|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20435535|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
19693343|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693344|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
19693345|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
19693346|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693347|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693348|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693349|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
19693350|NCT04980105|Hormones|hormones|mesh-ancestor
19693351|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693352|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19693353|NCT04980105|Protective Agents|protective agents|mesh-ancestor
20435536|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
20435537|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435538|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435539|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
20435540|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20435541|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
20435542|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
20435543|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20435544|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20435545|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20435546|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
20435547|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435548|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435549|NCT01333891|Protective Agents|protective agents|mesh-ancestor
20435550|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218521|NCT00313482|Prednisone|prednisone|mesh-list
20218522|NCT00313482|Docetaxel|docetaxel|mesh-list
20218523|NCT00313482|Sargramostim|sargramostim|mesh-list
20218524|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218525|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218526|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218527|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218528|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435551|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
20435552|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20523979|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523980|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20523981|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
20523982|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20523983|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523984|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20523985|NCT01749098|Ketamine|ketamine|mesh-list
20523986|NCT01749098|Analgesics|analgesics|mesh-ancestor
20523987|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
20523988|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523989|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523990|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20523991|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20523992|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
20523993|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
20523994|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523995|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20523996|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20523997|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523998|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523999|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
20524000|NCT01749111|Methotrexate|methotrexate|mesh-list
20524001|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20524002|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20524003|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
20524004|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524005|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524006|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20524007|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
20524008|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524009|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524010|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20524011|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20524012|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
20524013|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20524014|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20524015|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
20524016|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
20524017|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524018|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20524019|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20524020|NCT01749150|Ritonavir|ritonavir|mesh-list
20524021|NCT01749150|Ribavirin|ribavirin|mesh-list
20524022|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20524023|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
20524024|NCT01749150|Lactams|lactams|mesh-list
20524025|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20524026|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20524027|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
20524028|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524029|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524030|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20524031|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20524032|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
20524033|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524034|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20524035|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20524036|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
20524037|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
20524038|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524039|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20524040|NCT01749228|Etodolac|etodolac|mesh-list
20524041|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20524042|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20524043|NCT01749228|Analgesics|analgesics|mesh-ancestor
20524044|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
20524045|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524046|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524047|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20524048|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524049|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20435553|NCT01333917|Curcumin|curcumin|mesh-list
20435554|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20435555|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20435556|NCT01333917|Analgesics|analgesics|mesh-ancestor
20435557|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
20435558|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435559|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435560|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435561|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20435562|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435563|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435564|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435565|NCT01333982|Amoxicillin|amoxicillin|mesh-list
20435566|NCT01333982|Gentamicins|gentamicins|mesh-list
20435567|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20435568|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435569|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20435570|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435571|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435572|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
20435573|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435574|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435575|NCT01334047|Vaccines|vaccines|mesh-list
20435576|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
20435577|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435578|NCT01334060|Vaccines|vaccines|mesh-list
20435579|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
20435580|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435581|NCT01334073|Everolimus|everolimus|mesh-list
20435582|NCT01334073|Axitinib|axitinib|mesh-list
20435583|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435584|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435585|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
20435586|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435587|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20435588|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435589|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435590|NCT01334099|Tremelimumab|tremelimumab|mesh-list
20435591|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435592|NCT01334112|Axitinib|axitinib|mesh-list
20435593|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435594|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20435595|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435596|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435597|NCT01334151|Insulin|insulin|mesh-list
20218529|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20218530|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
20218531|NCT00313482|Hormones|hormones|mesh-ancestor
20218532|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218533|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218534|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218535|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
20218536|NCT00313508|Vidarabine|vidarabine|mesh-list
20218537|NCT00313508|Fludarabine|fludarabine|mesh-list
20218538|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
20435598|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20435599|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
20435600|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19405186|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
20435601|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435602|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20435603|NCT01334177|Cetuximab|cetuximab|mesh-list
20435604|NCT01334177|Antibodies|antibodies|mesh-list
20435605|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
20435606|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20435607|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
20435608|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435609|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435610|NCT01334203|Ranolazine|ranolazine|mesh-list
20435611|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20435612|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20435613|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435614|NCT01334268|Paclitaxel|paclitaxel|mesh-list
20435615|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20218539|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435616|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435617|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435618|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435619|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435620|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435621|NCT01334333|Tacrolimus|tacrolimus|mesh-list
20435622|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435623|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
20435624|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435625|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20435626|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435627|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435628|NCT01334424|Propofol|propofol|mesh-list
20435629|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20435630|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20435631|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435632|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19405187|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405188|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19405189|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19405190|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19405191|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
19405192|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405193|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405194|NCT03588936|Nivolumab|nivolumab|mesh-list
19405195|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405196|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848394|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19848395|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19848396|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848397|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848398|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848399|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19405197|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19416485|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20435633|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
20435634|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
20435635|NCT01334502|Prednisone|prednisone|mesh-list
20435636|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
20435637|NCT01334502|Rituximab|rituximab|mesh-list
20435638|NCT01334502|Doxorubicin|doxorubicin|mesh-list
20435639|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20435640|NCT01334502|Vincristine|vincristine|mesh-list
20435641|NCT01334502|Everolimus|everolimus|mesh-list
20435642|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435643|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
20435644|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435645|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20435646|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20435647|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
20435648|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435649|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435650|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20435651|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20435652|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20435653|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20435654|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20435655|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435656|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435657|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
20435658|NCT01334502|Hormones|hormones|mesh-ancestor
20435659|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435660|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218540|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218541|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
20218542|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218543|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218544|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
20218545|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218546|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
20218547|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435661|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20435662|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435663|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435664|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435665|NCT01334567|Tenofovir|tenofovir|mesh-list
20435666|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
20435667|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435668|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20435669|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20435670|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435671|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435672|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20435673|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20435674|NCT01334580|Methadone|methadone|mesh-list
20435675|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20435676|NCT01334580|Narcotics|narcotics|mesh-ancestor
20435677|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20435678|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435679|NCT01334580|Analgesics|analgesics|mesh-ancestor
20435680|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
20435681|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435682|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
20435683|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
20435684|NCT01334619|Ropivacaine|ropivacaine|mesh-list
20435685|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
20435686|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
20435687|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20435688|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435689|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
20435690|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435691|NCT01334632|Morphine|morphine|mesh-list
20435692|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20435693|NCT01334632|Narcotics|narcotics|mesh-ancestor
20435694|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20435695|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435696|NCT01334632|Analgesics|analgesics|mesh-ancestor
20435697|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
20435698|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435699|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
20435700|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
20435701|NCT01334645|Coagulants|coagulants|mesh-ancestor
20435702|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20435703|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20435704|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
20435705|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435706|NCT01334671|Atorvastatin|atorvastatin|mesh-list
20435707|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20435708|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20435709|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
20435710|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435711|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20435712|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20435713|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435714|NCT01334684|Metformin|metformin|mesh-list
20435715|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435716|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435717|NCT01334762|Letrozole|letrozole|mesh-list
20435718|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435719|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20435720|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20435721|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435722|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435723|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20435724|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
20435725|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435726|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435727|NCT01334879|Ranibizumab|ranibizumab|mesh-list
20435728|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20435729|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20435730|NCT01334879|Growth Substances|growth substances|mesh-ancestor
20435731|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435732|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
20435733|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435734|NCT01334892|Cyclosporine|cyclosporine|mesh-list
20435735|NCT01334892|Cyclosporins|cyclosporins|mesh-list
20435736|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435737|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530353|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
20435738|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435739|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
20435740|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435741|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
20435742|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435743|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
20435744|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20435745|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20435746|NCT01334905|Mirabegron|mirabegron|mesh-list
20435747|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20435748|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20435749|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20435750|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
20435751|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435752|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435753|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435754|NCT01334905|Urological Agents|urological agents|mesh-ancestor
20435755|NCT01335035|Deferasirox|deferasirox|mesh-list
20435756|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20435757|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
20435758|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
20435759|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435760|NCT01335048|Clopidogrel|clopidogrel|mesh-list
20435761|NCT01335048|Atorvastatin|atorvastatin|mesh-list
20435762|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20435763|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20435764|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
20435765|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218548|NCT00313521|Thiotepa|thiotepa|mesh-list
20218549|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20218550|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
20435766|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20435767|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20435768|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435769|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20218551|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218552|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435770|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20435771|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20435772|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20435773|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
20435774|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435775|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435776|NCT01335074|Sirolimus|sirolimus|mesh-list
20435777|NCT01335074|Sorafenib|sorafenib|mesh-list
20435778|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435779|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20435780|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435781|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405198|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405199|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19405200|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19405201|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405202|NCT03588767|Vitamin D|vitamin d|mesh-list
19405203|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
20435782|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20435783|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435784|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20435785|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
20435786|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435787|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
20435788|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435789|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
20435790|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20435791|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20218553|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20218554|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218555|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
20218556|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218557|NCT00313534|Masoprocol|masoprocol|mesh-list
20218558|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
20218559|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435792|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
20435793|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435794|NCT01335321|Triamcinolone|triamcinolone|mesh-list
20435795|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
20435796|NCT01335321|Hylan|hylan|mesh-list
20435797|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435798|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
20435799|NCT01335321|Hormones|hormones|mesh-ancestor
20435800|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435801|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435802|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
20435803|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
20435804|NCT01335321|Protective Agents|protective agents|mesh-ancestor
20435805|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20435806|NCT01335334|Metronidazole|metronidazole|mesh-list
20435807|NCT01335334|Tetracycline|tetracycline|mesh-list
20435808|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20435809|NCT01335334|Omeprazole|omeprazole|mesh-list
20435810|NCT01335334|Bismuth|bismuth|mesh-list
20435811|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435812|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20435813|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20435814|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20435815|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20435816|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20435817|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20435818|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435819|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435820|NCT01335334|Antacids|antacids|mesh-ancestor
20435821|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20435822|NCT01335360|Nevirapine|nevirapine|mesh-list
20435823|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20435824|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20435825|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435826|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435827|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
20435828|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435829|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20435830|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20435831|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20435832|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20435833|NCT01335373|Metronidazole|metronidazole|mesh-list
20435834|NCT01335373|Miconazole|miconazole|mesh-list
20435835|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435836|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20435837|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20435838|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20435839|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
20435840|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20435841|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20435842|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435843|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435844|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20435845|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
20435846|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435847|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435848|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20435849|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20435850|NCT01335386|Glycerol|glycerol|mesh-list
20435851|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20435852|NCT01335386|Protective Agents|protective agents|mesh-ancestor
20435853|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435854|NCT01335516|Terlipressin|terlipressin|mesh-list
20435855|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20435856|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20435857|NCT01335529|Interferons|interferons|mesh-list
20435858|NCT01335529|Ribavirin|ribavirin|mesh-list
20435859|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
20435860|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
20435861|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20435862|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435863|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
20435864|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435865|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
20435866|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435867|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
20435868|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524050|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20435869|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20435870|NCT01335646|Analgesics|analgesics|mesh-list
20435871|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
20435872|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435873|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435874|NCT01335685|Prednisone|prednisone|mesh-list
20435875|NCT01335685|Melphalan|melphalan|mesh-list
20435876|NCT01335685|Ixazomib|ixazomib|mesh-list
20435877|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20435878|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
20435879|NCT01335685|Hormones|hormones|mesh-ancestor
20435880|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435881|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435882|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20435883|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435884|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20435885|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
20435886|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435887|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20435888|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435889|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
20435890|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
20435891|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435892|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
20435893|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435894|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435895|NCT01336010|Ribavirin|ribavirin|mesh-list
20435896|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20435897|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
20435898|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435899|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
20435900|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435901|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
20435902|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20435903|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435904|NCT01336062|Paclitaxel|paclitaxel|mesh-list
20435905|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20435906|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20435907|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435908|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435909|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435910|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435911|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435912|NCT01336166|Vaccines|vaccines|mesh-list
20435913|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
20435914|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435915|NCT01336192|Gemcitabine|gemcitabine|mesh-list
20435916|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435917|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
20435918|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435919|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435920|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
20435921|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435922|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435923|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435924|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
20435925|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435926|NCT01336218|Rifampin|rifampin|mesh-list
20435927|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20435928|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
20435929|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20435930|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435931|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
20435932|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19693354|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693355|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693356|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19693357|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
19693358|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
19693359|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
19693360|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20435933|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435934|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435935|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19693361|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20435936|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20435937|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20435938|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20435939|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20435940|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20435941|NCT01336322|Metformin|metformin|mesh-list
20435942|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20435943|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20435944|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435945|NCT01336322|Incretins|incretins|mesh-ancestor
20435946|NCT01336322|Hormones|hormones|mesh-ancestor
20435947|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20435948|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20435949|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
20435950|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435951|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435952|NCT01336348|Tirofiban|tirofiban|mesh-list
20435953|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20435954|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20435955|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20435956|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20435957|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435958|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
20435959|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20435960|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20435961|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20435962|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20435963|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435964|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
20435965|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20435966|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405204|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
19405205|NCT03588767|Vitamins|vitamins|mesh-list
19405206|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
19405207|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
19405208|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435967|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20435968|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20435969|NCT01336543|Gemcitabine|gemcitabine|mesh-list
20435970|NCT01336543|Cisplatin|cisplatin|mesh-list
20435971|NCT01336543|Etoposide|etoposide|mesh-list
20435972|NCT01336543|Pemetrexed|pemetrexed|mesh-list
20435973|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435974|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20435975|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
20435976|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435977|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
20435978|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20435979|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20435980|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20435981|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
20435982|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435983|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20435984|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20435985|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20435986|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20435987|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20435988|NCT01336582|Docetaxel|docetaxel|mesh-list
20435989|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20435990|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20435991|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20435992|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20435993|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20435994|NCT01336595|Cobalt|cobalt|mesh-list
20435995|NCT01336595|Triamcinolone|triamcinolone|mesh-list
20435996|NCT01336595|Trace Elements|trace elements|mesh-ancestor
20435997|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
20435998|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20435999|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436000|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
20436001|NCT01336595|Hormones|hormones|mesh-ancestor
20436002|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19405209|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20436003|NCT01336621|Ezogabine|ezogabine|mesh-list
20436004|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
20436005|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20436006|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436007|NCT01336660|Antivenins|antivenins|mesh-list
20436008|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
20436009|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436010|NCT01336751|Insulin|insulin|mesh-list
20436011|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20436012|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
20436013|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
20436014|NCT01336751|Protamines|protamines|mesh-list
20436015|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436016|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436017|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
20436018|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436019|NCT01336751|Coagulants|coagulants|mesh-ancestor
20436020|NCT01336829|Rilpivirine|rilpivirine|mesh-list
20436021|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20436022|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436023|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436024|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436025|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
20436026|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436027|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20436028|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20436029|NCT01336842|Pemetrexed|pemetrexed|mesh-list
20436030|NCT01336842|Panobinostat|panobinostat|mesh-list
20436031|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436032|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436033|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436034|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20436035|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436036|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20436037|NCT01336985|Irinotecan|irinotecan|mesh-list
20436038|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20436039|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20436040|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436041|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613420|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613421|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613422|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19405210|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19405211|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
19405212|NCT03588767|Hormones|hormones|mesh-ancestor
19405213|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436042|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436043|NCT01337219|Tobramycin|tobramycin|mesh-list
20436044|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436045|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436046|NCT01337258|Dutasteride|dutasteride|mesh-list
19405214|NCT03588715|Interferons|interferons|mesh-list
19405215|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
20218560|NCT00313534|Protective Agents|protective agents|mesh-ancestor
20218561|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218562|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20436047|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19405216|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
19405217|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19405218|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
19405219|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405220|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
20218563|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218564|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20218565|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20218566|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20218567|NCT00313534|Analgesics|analgesics|mesh-ancestor
20218568|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
20218569|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218570|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20218571|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20218572|NCT00313547|Amlodipine|amlodipine|mesh-list
20218573|NCT00313547|Quinapril|quinapril|mesh-list
20218574|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218575|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20436048|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20436049|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436050|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436051|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
20436052|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436053|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436054|NCT01337323|Fluticasone|fluticasone|mesh-list
20436055|NCT01337323|Xhance|xhance|mesh-list
20436056|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436057|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20436058|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
20613423|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20613424|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20613425|NCT02254967|Vancomycin|vancomycin|mesh-list
20613426|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
20613427|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20613428|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613429|NCT02254980|Vitamin E|vitamin e|mesh-list
20613430|NCT02254980|Vitamins|vitamins|mesh-ancestor
20613431|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
20613432|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613433|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
20613434|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613435|NCT02254980|Protective Agents|protective agents|mesh-ancestor
20613436|NCT02255006|Glyburide|glyburide|mesh-list
20613437|NCT02255006|Celecoxib|celecoxib|mesh-list
20613438|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20613439|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613440|NCT02255006|Analgesics|analgesics|mesh-ancestor
20613441|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
20613442|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613443|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218576|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613444|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20613445|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613446|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20613447|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20613448|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405221|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405222|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
19405223|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405224|NCT03588689|Ropivacaine|ropivacaine|mesh-list
19405225|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
19405226|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
19405227|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218577|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218578|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20218579|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218580|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
20218581|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20218582|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
20218583|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218584|NCT00313599|Paclitaxel|paclitaxel|mesh-list
20218585|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20218586|NCT00313599|Lapatinib|lapatinib|mesh-list
20218587|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20218588|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218589|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218590|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218591|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218592|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218593|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20218594|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218595|NCT00313625|Methotrexate|methotrexate|mesh-list
20218596|NCT00313625|Melphalan|melphalan|mesh-list
20218597|NCT00313625|Busulfan|busulfan|mesh-list
20218598|NCT00313625|Tacrolimus|tacrolimus|mesh-list
20218599|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20218600|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
20218601|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20218602|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218603|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218604|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
20613449|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613450|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436059|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436060|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436061|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20436062|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
20436063|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
20436064|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20436065|NCT01337362|Insulin|insulin|mesh-list
20436066|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20436067|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436068|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436069|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20436070|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
20436071|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
20436072|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436073|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
20436074|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436075|NCT01337401|Cediranib|cediranib|mesh-list
20436076|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436077|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20436078|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436079|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436080|NCT01337427|Interferons|interferons|mesh-list
20436081|NCT01337427|Interferon-beta|interferon-beta|mesh-list
20436082|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
20436083|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436084|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
20436085|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436086|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
20218605|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218606|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218607|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
20218608|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218609|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20218610|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218611|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
20218612|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20218613|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20218614|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20218615|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20218616|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
20218617|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20218618|NCT00313690|Docetaxel|docetaxel|mesh-list
20218619|NCT00313690|Bortezomib|bortezomib|mesh-list
20218620|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218621|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218622|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218623|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218624|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218625|NCT00313742|Insulin|insulin|mesh-list
20218626|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20218627|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
20218628|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
20436087|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436088|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20436089|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20436090|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20436091|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436092|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436093|NCT01337440|Incretins|incretins|mesh-ancestor
20436094|NCT01337440|Hormones|hormones|mesh-ancestor
20436095|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436096|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20436097|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
20436098|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436099|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436100|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20436101|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524051|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524052|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524053|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20524054|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20524055|NCT01749319|Baclofen|baclofen|mesh-list
20524056|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20218629|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
20218630|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
20218631|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
20436102|NCT01337466|Fialuridine|fialuridine|mesh-list
20436103|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
20436104|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436105|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436106|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436107|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436108|NCT01337492|Sorafenib|sorafenib|mesh-list
20436109|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436110|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20436111|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436112|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436113|NCT01337518|Androgens|androgens|mesh-list
20436114|NCT01337518|Hormones|hormones|mesh-ancestor
20436115|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436116|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436117|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
20436118|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20436119|NCT01337570|Dapivirine|dapivirine|mesh-list
20436120|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20436121|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20436122|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
20436123|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436124|NCT01337583|Dapivirine|dapivirine|mesh-list
20436125|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20436126|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20436127|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
20436128|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436129|NCT01337765|Dactolisib|dactolisib|mesh-list
20436130|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436131|NCT01337791|Telbivudine|telbivudine|mesh-list
20436132|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
20436133|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436134|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436135|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436136|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436137|NCT01337804|Omeprazole|omeprazole|mesh-list
20436138|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20436139|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436140|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20436141|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436142|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436143|NCT01338077|Omeprazole|omeprazole|mesh-list
20436144|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20436145|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436146|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20436147|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436148|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436149|NCT01338090|Bevacizumab|bevacizumab|mesh-list
20436150|NCT01338090|Everolimus|everolimus|mesh-list
20436151|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20436152|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20436153|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436154|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20436155|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20436156|NCT01338090|Growth Substances|growth substances|mesh-ancestor
20436157|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436158|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
20436159|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436160|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
20436161|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20436162|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436163|NCT01338103|Rituximab|rituximab|mesh-list
20436164|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20436165|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436166|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
20436167|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436168|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436169|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20436170|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436171|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
20436172|NCT01338129|Vitamins|vitamins|mesh-ancestor
20436173|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
20436174|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693362|NCT04979663|Gemcitabine|gemcitabine|mesh-list
20436175|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
20436176|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436177|NCT01338129|Protective Agents|protective agents|mesh-ancestor
20436178|NCT01338311|Albuterol|albuterol|mesh-list
20436179|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20436180|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
20436181|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436182|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436183|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20436184|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
20436185|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
20436186|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20436187|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20436188|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20436189|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20436190|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
20436191|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436192|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436193|NCT01338324|Simvastatin|simvastatin|mesh-list
20436194|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20436195|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20436196|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
20436197|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436198|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20436199|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20436200|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436201|NCT01338337|Azacitidine|azacitidine|mesh-list
20436202|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20436203|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
20436204|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436205|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436206|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436207|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20436208|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
20436209|NCT01338441|Erythromycin|erythromycin|mesh-list
20436210|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
20436211|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20436212|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
20436213|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436214|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436215|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436216|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20436217|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436218|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436219|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
20436220|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20436221|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20436222|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436223|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
20436224|NCT01338454|Coagulants|coagulants|mesh-ancestor
20436225|NCT01338558|Bevacizumab|bevacizumab|mesh-list
20436226|NCT01338558|Cetuximab|cetuximab|mesh-list
20436227|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20436228|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436229|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20436230|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20436231|NCT01338558|Growth Substances|growth substances|mesh-ancestor
20436232|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436233|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
20436234|NCT01338675|Busulfan|busulfan|mesh-list
20436235|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
20436236|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436237|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436238|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
20436239|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436240|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436241|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436242|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20436243|NCT01338740|Adalimumab|adalimumab|mesh-list
20436244|NCT01338740|Infliximab|infliximab|mesh-list
20436245|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436246|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436247|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
20436248|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436249|NCT01338753|Bevacizumab|bevacizumab|mesh-list
20436250|NCT01338753|Docetaxel|docetaxel|mesh-list
20436251|NCT01338753|Doxorubicin|doxorubicin|mesh-list
20436252|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20436253|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436254|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20436255|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20436256|NCT01338753|Growth Substances|growth substances|mesh-ancestor
20436257|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436258|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
20436259|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
20436260|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
20436261|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
20436262|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436263|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20436264|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20436265|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20436266|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436267|NCT01338844|Inositol|inositol|mesh-list
20436268|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
20436269|NCT01338844|Vitamins|vitamins|mesh-ancestor
20436270|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
20436271|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436272|NCT01338896|Rotigotine|rotigotine|mesh-list
20436273|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
20436274|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
20436275|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436276|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436277|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436278|NCT01338909|Clopidogrel|clopidogrel|mesh-list
20436279|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20436280|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20436281|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20436282|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20436283|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20436284|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
20436285|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436286|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436287|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436288|NCT01338922|Insulin|insulin|mesh-list
20436289|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436290|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436291|NCT01339026|Clopidogrel|clopidogrel|mesh-list
20436292|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20436293|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20436294|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20436295|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20436296|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20436297|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
20436298|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436299|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436300|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436301|NCT01339039|Plerixafor|plerixafor|mesh-list
19693363|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
19693364|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20218632|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218633|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218634|NCT00313833|Buprenorphine|buprenorphine|mesh-list
20218635|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20218636|NCT00313833|Narcotics|narcotics|mesh-ancestor
20218637|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218638|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218639|NCT00313833|Analgesics|analgesics|mesh-ancestor
20218640|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
20218641|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218642|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20218643|NCT00313859|Simvastatin|simvastatin|mesh-list
20218644|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20218645|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20218646|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
20218647|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218648|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20218649|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20218650|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218651|NCT00313885|SR 46349B|sr 46349b|mesh-list
20218652|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20218653|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20247162|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
20436302|NCT01339039|Bevacizumab|bevacizumab|mesh-list
20436303|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20436304|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436305|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20436306|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20436307|NCT01339039|Growth Substances|growth substances|mesh-ancestor
20436308|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436309|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
20436310|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20436311|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20436312|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
20436313|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436314|NCT01339065|Ketamine|ketamine|mesh-list
20436315|NCT01339065|Analgesics|analgesics|mesh-ancestor
20436316|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
20436317|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436318|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436319|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20436320|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20436321|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
20436322|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
20436323|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436324|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20436325|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20436326|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693365|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
19693366|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436327|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436328|NCT01339143|Pioglitazone|pioglitazone|mesh-list
20436329|NCT01339143|Vildagliptin|vildagliptin|mesh-list
20436330|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436331|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436332|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20436333|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
20436334|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436335|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436336|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20436337|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20436338|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20436339|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20436340|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436341|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
20436342|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436343|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436344|NCT01339312|Vaccines|vaccines|mesh-list
20436345|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
20436346|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524057|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524058|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20524059|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524060|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20524061|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
20524062|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
20524063|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524064|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524065|NCT01749371|Vitamins|vitamins|mesh-list
20524066|NCT01749371|Vitamin E|vitamin e|mesh-list
20524067|NCT01749371|Tocopherols|tocopherols|mesh-list
20524068|NCT01749371|Tocotrienols|tocotrienols|mesh-list
20524069|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
20524070|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
19693367|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693368|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
19693369|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218654|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218655|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20218656|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20218657|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
20218658|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218659|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218660|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
20218661|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
20218662|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20524071|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436347|NCT01339442|Fulvestrant|fulvestrant|mesh-list
20436348|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20436349|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436350|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20436351|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20436352|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
20436353|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436354|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436355|NCT01339468|Tacrolimus|tacrolimus|mesh-list
20436356|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436357|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
20436358|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436359|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20436360|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436361|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436362|NCT01339481|Abatacept|abatacept|mesh-list
20436363|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20436364|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436365|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436366|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436367|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
20436368|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436369|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436370|NCT01339572|Plerixafor|plerixafor|mesh-list
20436371|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20436372|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20436373|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
20436374|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436375|NCT01339624|Ketorolac|ketorolac|mesh-list
20436376|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20436377|NCT01339624|Fentanyl|fentanyl|mesh-list
20436378|NCT01339624|Morphine|morphine|mesh-list
20436379|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20436380|NCT01339624|Narcotics|narcotics|mesh-ancestor
20436381|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436382|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436383|NCT01339624|Analgesics|analgesics|mesh-ancestor
20436384|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
20436385|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436386|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20436387|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20436388|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
20436389|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
20436390|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20436391|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20436392|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436393|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436394|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20436395|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436396|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436397|NCT01339663|Aldesleukin|aldesleukin|mesh-list
20436398|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
20436399|NCT01339663|Interleukin-2|interleukin-2|mesh-list
20436400|NCT01339663|Vaccines|vaccines|mesh-list
20436401|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
20436402|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436403|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436404|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436405|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436406|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
20436407|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436408|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436409|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20436410|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20436411|NCT01339663|Analgesics|analgesics|mesh-ancestor
20436412|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
20436413|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436414|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20436415|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20436416|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
20436417|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436418|NCT01339676|Vitamin D|vitamin d|mesh-list
20436419|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
20436420|NCT01339676|Vitamins|vitamins|mesh-ancestor
20436421|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
20436422|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524072|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
20436423|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20436424|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20436425|NCT01339741|Vitamin D|vitamin d|mesh-list
20436426|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
20436427|NCT01339741|Vitamins|vitamins|mesh-ancestor
20436428|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
20436429|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436430|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20436431|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20436432|NCT01339754|Trabectedin|trabectedin|mesh-list
20436433|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436434|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
20436435|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436436|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436437|NCT01339819|Dabigatran|dabigatran|mesh-list
20436438|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
20436439|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
20436440|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20436441|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
20436442|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436443|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436444|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
20436445|NCT01339871|Vorinostat|vorinostat|mesh-list
20436446|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436447|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20436448|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436449|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436450|NCT01339884|Resveratrol|resveratrol|mesh-list
20436451|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
20436452|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436453|NCT01339884|Protective Agents|protective agents|mesh-ancestor
20436454|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436455|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436456|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20436457|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
20436458|NCT01339988|Busulfan|busulfan|mesh-list
20436459|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436460|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
20436461|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436462|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436463|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436464|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
20436465|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436466|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436467|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20436468|NCT01340118|Budesonide|budesonide|mesh-list
20436469|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436470|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20436471|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
20436472|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436473|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436474|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20436475|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
20436476|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
20436477|NCT01340118|Hormones|hormones|mesh-ancestor
20436478|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436479|NCT01340235|Erythromycin|erythromycin|mesh-list
20436480|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
20436481|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20436482|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
20436483|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436484|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436485|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436486|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20436487|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436488|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436489|NCT01340248|Carvedilol|carvedilol|mesh-list
20436490|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20436491|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20436492|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
20436493|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436494|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436495|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436496|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20436497|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
20436498|NCT01340248|Protective Agents|protective agents|mesh-ancestor
20436499|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20436500|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20436501|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20436502|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
20436503|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20436504|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20436505|NCT01340326|Valsartan|valsartan|mesh-list
20436506|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20436507|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20436508|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19405228|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405229|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
19405230|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405231|NCT03588676|Melatonin|melatonin|mesh-list
19405232|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
19405233|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405234|NCT03588676|Protective Agents|protective agents|mesh-ancestor
19405235|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405236|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405237|NCT03588611|Hirudins|hirudins|mesh-list
19693370|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693371|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693372|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
19693373|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693374|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
19693375|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19693376|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19693377|NCT04979650|Prednisolone|prednisolone|mesh-list
19693378|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
19693379|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19693380|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
19693381|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436509|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436510|NCT01340417|Melatonin|melatonin|mesh-list
20436511|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
20436512|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436513|NCT01340417|Protective Agents|protective agents|mesh-ancestor
20436514|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436515|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436516|NCT01340456|Rifampin|rifampin|mesh-list
20436517|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20436518|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
20436519|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436520|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436521|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
20436522|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436523|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436524|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436525|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20436526|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20436527|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20436528|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20436529|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20436530|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20436531|NCT01340521|Clomiphene|clomiphene|mesh-list
20436532|NCT01340521|Enclomiphene|enclomiphene|mesh-list
20436533|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
20436534|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20436535|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
20436536|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436537|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436538|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20436539|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
20436540|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20436541|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20436542|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20436543|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
20436544|NCT01340547|Ifosfamide|ifosfamide|mesh-list
20436545|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436546|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
20436547|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436548|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436549|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20436550|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
20436551|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436552|NCT01340599|Protective Agents|protective agents|mesh-ancestor
20436553|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436554|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20436555|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20436556|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436557|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20436558|NCT01340677|Canagliflozin|canagliflozin|mesh-list
20436559|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20436560|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436561|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436562|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436563|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
20436564|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20436565|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
20436566|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436567|NCT01340833|Dabrafenib|dabrafenib|mesh-list
20436568|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436569|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20436570|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436571|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436572|NCT01340846|Ketoconazole|ketoconazole|mesh-list
20436573|NCT01340846|Dabrafenib|dabrafenib|mesh-list
20436574|NCT01340846|Warfarin|warfarin|mesh-list
20436575|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
20436576|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
20436577|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
20436578|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436579|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20436580|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20436581|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436582|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436583|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20436584|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
20436585|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436586|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436587|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20436588|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436589|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20436590|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20436591|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
20436592|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20436593|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20436594|NCT01340950|Tenofovir|tenofovir|mesh-list
20436595|NCT01340950|Lamivudine|lamivudine|mesh-list
20436596|NCT01340950|Zidovudine|zidovudine|mesh-list
20436597|NCT01340950|Efavirenz|efavirenz|mesh-list
20436598|NCT01340950|Nevirapine|nevirapine|mesh-list
20436599|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20436600|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
20436601|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436602|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20436603|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436604|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436605|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436606|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20436607|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20436608|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
20436609|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20436610|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20436611|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20436612|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20436613|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20436614|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20436615|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
20436616|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
20436617|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
20436618|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405238|NCT03588611|Bivalirudin|bivalirudin|mesh-list
20436619|NCT01341080|Varenicline|varenicline|mesh-list
20436620|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20436621|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20436622|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
20436623|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436624|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436625|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436626|NCT01341106|Entecavir|entecavir|mesh-list
20436627|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
20436628|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436629|NCT01341158|Interferons|interferons|mesh-list
20436630|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436631|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
20436632|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524073|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524074|NCT01749371|Protective Agents|protective agents|mesh-ancestor
20524075|NCT01749384|Bevacizumab|bevacizumab|mesh-list
20524076|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20524077|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
20524078|NCT01749384|Antibodies|antibodies|mesh-list
20524079|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
20524080|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20524081|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
20524082|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524083|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20524084|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20524085|NCT01749384|Growth Substances|growth substances|mesh-ancestor
20524086|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524087|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
20524088|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
20524089|NCT01749397|Fluorouracil|fluorouracil|mesh-list
20524090|NCT01749397|Floxuridine|floxuridine|mesh-list
20524091|NCT01749397|Veliparib|veliparib|mesh-list
20524092|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
20524093|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
20524094|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524095|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20524096|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524097|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20524098|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
20524099|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524100|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20524101|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524102|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
20524103|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20524104|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20524105|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20524106|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524107|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524108|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
20524109|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524110|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524111|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20524112|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524113|NCT01749475|Midazolam|midazolam|mesh-list
20524114|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20524115|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20524116|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524117|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524118|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20524119|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20524120|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524121|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20524122|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
20524123|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
20524124|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
20524125|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
20524126|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524127|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524128|NCT01749514|Luspatercept|luspatercept|mesh-list
20613451|NCT02255045|Diclofenac|diclofenac|mesh-list
20524129|NCT01749514|Hematinics|hematinics|mesh-ancestor
20524130|NCT01749540|Luspatercept|luspatercept|mesh-list
20524131|NCT01749540|Hematinics|hematinics|mesh-ancestor
20524132|NCT01749566|Maraviroc|maraviroc|mesh-list
20524133|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20524134|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20613452|NCT02255045|Meloxicam|meloxicam|mesh-list
20436633|NCT01341184|Rifampin|rifampin|mesh-list
20436634|NCT01341184|Rifabutin|rifabutin|mesh-list
20436635|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20436636|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
20436637|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436638|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436639|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
20436640|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436641|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436642|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436643|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19693382|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
19693383|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
19693384|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693385|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693386|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436644|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20436645|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20436646|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20436647|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20436648|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20436649|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
20436650|NCT01341262|Thalidomide|thalidomide|mesh-list
20436651|NCT01341262|Dexamethasone|dexamethasone|mesh-list
20436652|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
20436653|NCT01341262|Melphalan|melphalan|mesh-list
20436654|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436655|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
20436656|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436657|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436658|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436659|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
20436660|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436661|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436662|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20436663|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436664|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
20436665|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
20436666|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436667|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436668|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
20436669|NCT01341262|Hormones|hormones|mesh-ancestor
20436670|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436671|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20436672|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
19693387|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
20436673|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436674|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436675|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20436676|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20436677|NCT01341262|Growth Substances|growth substances|mesh-ancestor
20436678|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
20436679|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20436680|NCT01341275|Vaccines|vaccines|mesh-list
20436681|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
20436682|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436683|NCT01341340|Everolimus|everolimus|mesh-list
20436684|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436685|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436686|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
20436687|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436688|NCT01341353|Amiodarone|amiodarone|mesh-list
20436689|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
20436690|NCT01341353|Calcium|calcium|mesh-list
20436691|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20436692|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436693|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19693388|NCT04979650|Hormones|hormones|mesh-ancestor
19693389|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693390|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19693391|NCT04979650|Protective Agents|protective agents|mesh-ancestor
19693392|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693393|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436694|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
20436695|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20436696|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20436697|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436698|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20436699|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20436700|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20436701|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436702|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20436703|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20436704|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20436705|NCT01341392|Amlodipine|amlodipine|mesh-list
20436706|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20436707|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20436708|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20436709|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436710|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20436711|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436712|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
20436713|NCT01341405|Celecoxib|celecoxib|mesh-list
20436714|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20436715|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20436716|NCT01341405|Analgesics|analgesics|mesh-ancestor
20436717|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
20436718|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436719|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436720|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436721|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436722|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20436723|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20436724|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436725|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436726|NCT01341496|Celecoxib|celecoxib|mesh-list
20436727|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
20436728|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436729|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
20436730|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436731|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436732|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436733|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
20436734|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436735|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436736|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20436737|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20436738|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20436739|NCT01341496|Analgesics|analgesics|mesh-ancestor
20436740|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
20436741|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436742|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436743|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20436744|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20436745|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436746|NCT01341717|Metformin|metformin|mesh-list
20436747|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20436748|NCT01341717|Glimepiride|glimepiride|mesh-list
20436749|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436750|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436751|NCT01341717|Incretins|incretins|mesh-ancestor
20436752|NCT01341717|Hormones|hormones|mesh-ancestor
20436753|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436754|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20436755|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
20436756|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436757|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436758|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20436759|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436760|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
20436761|NCT01341743|Entecavir|entecavir|mesh-list
20436762|NCT01341743|Adefovir|adefovir|mesh-list
20436763|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20436764|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
20436765|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436766|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20436767|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20436768|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436769|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436770|NCT01341834|Everolimus|everolimus|mesh-list
20436771|NCT01341834|Panobinostat|panobinostat|mesh-list
20436772|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436773|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436774|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
20436775|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436776|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20436777|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436778|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436779|NCT01341886|Metformin|metformin|mesh-list
20436780|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436781|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436782|NCT01341938|Nicotine|nicotine|mesh-list
20436783|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20436784|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
20436785|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436786|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436787|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20436788|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20436789|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
20436790|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436791|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436792|NCT01341951|Sargramostim|sargramostim|mesh-list
20436793|NCT01341951|Lenograstim|lenograstim|mesh-list
20436794|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
20436795|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436796|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20436797|NCT01341964|Aspirin|aspirin|mesh-list
20436798|NCT01341964|Clopidogrel|clopidogrel|mesh-list
20436799|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20436800|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20436801|NCT01341964|Analgesics|analgesics|mesh-ancestor
20436802|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
20436803|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436804|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436805|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436806|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436807|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20436808|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20436809|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436810|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20436811|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20436812|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436813|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
20436814|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20436815|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20436816|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20436817|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
20436818|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436819|NCT01342016|Prednisone|prednisone|mesh-list
20436820|NCT01342016|Tacrolimus|tacrolimus|mesh-list
20436821|NCT01342016|Leflunomide|leflunomide|mesh-list
20436822|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436823|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
20436824|NCT01342016|Hormones|hormones|mesh-ancestor
20436825|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436826|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436827|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20436828|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436829|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436830|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
20436831|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20436832|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436833|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436834|NCT01342146|Hormones|hormones|mesh-list
20436835|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20436836|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436837|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
20436838|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20436839|NCT01342198|Erythromycin|erythromycin|mesh-list
20436840|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
20436841|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19405239|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
20436842|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
20436843|NCT01342198|Pregabalin|pregabalin|mesh-list
20436844|NCT01342198|Analgesics|analgesics|mesh-ancestor
20436845|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
20436846|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436847|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436848|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
20436849|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20436850|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20436851|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436852|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20436853|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20436854|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20436855|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436856|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20436857|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436858|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436859|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20436860|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20436861|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436862|NCT01342224|Gemcitabine|gemcitabine|mesh-list
20436863|NCT01342224|Tadalafil|tadalafil|mesh-list
20436864|NCT01342224|Sargramostim|sargramostim|mesh-list
20436865|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
20436866|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436867|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20436868|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
20436869|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436870|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436871|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
20436872|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436873|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436874|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436875|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
20436876|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20436877|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20436878|NCT01342224|Urological Agents|urological agents|mesh-ancestor
20436879|NCT01342237|Carboplatin|carboplatin|mesh-list
20436880|NCT01342237|Etoposide|etoposide|mesh-list
20436881|NCT01342237|Melphalan|melphalan|mesh-list
20436882|NCT01342237|Topotecan|topotecan|mesh-list
20436883|NCT01342237|Thiotepa|thiotepa|mesh-list
20436884|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436885|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20436886|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20436887|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20436888|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436889|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436890|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436891|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
20436892|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20436893|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436894|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
20436895|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436896|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20436897|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
20436898|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
20436899|NCT01342289|Fludarabine|fludarabine|mesh-list
20436900|NCT01342289|Tacrolimus|tacrolimus|mesh-list
20436901|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20436902|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
20436903|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436904|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20436905|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20436906|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
20436907|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436908|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436909|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20436910|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20436911|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436912|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20436913|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20436914|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
20436915|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436916|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436917|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
20436918|NCT01342328|Propofol|propofol|mesh-list
20436919|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20436920|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436921|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436922|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20436923|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
20436924|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
20436925|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20436926|NCT01342328|Analgesics|analgesics|mesh-ancestor
20436927|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
20436928|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20436929|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20436930|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20436931|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20436932|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
20436933|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436934|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436935|NCT01342562|Anesthetics|anesthetics|mesh-list
20436936|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436937|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436938|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20436939|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20436940|NCT01342614|Metformin|metformin|mesh-list
20436941|NCT01342614|Fosinopril|fosinopril|mesh-list
20436942|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436943|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436944|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20436945|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
20436946|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436947|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436948|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20436949|NCT01342627|Sorafenib|sorafenib|mesh-list
20436950|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436951|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20436952|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436953|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436954|NCT01342679|Dasatinib|dasatinib|mesh-list
20436955|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436956|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20436957|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436958|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436959|NCT01342692|Lenalidomide|lenalidomide|mesh-list
20436960|NCT01342692|Azacitidine|azacitidine|mesh-list
20436961|NCT01342692|Idarubicin|idarubicin|mesh-list
20436962|NCT01342692|Valproic Acid|valproic acid|mesh-list
20436963|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
20436964|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436965|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20436966|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20436967|NCT01342692|Growth Substances|growth substances|mesh-ancestor
20436968|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
20436969|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20436970|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20436971|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
20436972|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436973|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436974|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
20436975|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
20436976|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20436977|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
20436978|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20436979|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436980|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20436981|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20436982|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20436983|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20436984|NCT01342731|Tigecycline|tigecycline|mesh-list
20436985|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20436986|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20436987|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20436988|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20436989|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20436990|NCT01342744|Metformin|metformin|mesh-list
20436991|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20436992|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436993|NCT01342835|Propofol|propofol|mesh-list
20436994|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20436995|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20436996|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20436997|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20436998|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
20436999|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
20437000|NCT01342874|Inositol|inositol|mesh-list
20437001|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
20437002|NCT01342874|Vitamins|vitamins|mesh-ancestor
20437003|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
20437004|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437005|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20437006|NCT01342939|Incretins|incretins|mesh-list
20437007|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20437008|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437009|NCT01342939|Hormones|hormones|mesh-ancestor
20437010|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437011|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20437012|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
20437013|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437014|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437015|NCT05251584|Gentamicins|gentamicins|mesh-list
20437016|NCT05251584|Mupirocin|mupirocin|mesh-list
20437017|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20437018|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437019|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20437020|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437021|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524135|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524136|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20524137|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20524138|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
20524139|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405240|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19405241|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
19405242|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405243|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524140|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20524141|NCT01749579|Fentanyl|fentanyl|mesh-list
20524142|NCT01749579|Midazolam|midazolam|mesh-list
20524143|NCT01749579|Propofol|propofol|mesh-list
20524144|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20524145|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524146|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524147|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20524148|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
20524149|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
20524150|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20524151|NCT01749579|Narcotics|narcotics|mesh-ancestor
20524152|NCT01749579|Analgesics|analgesics|mesh-ancestor
20524153|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
20524154|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524155|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20524156|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20524157|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19405244|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
20218663|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20524158|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524159|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
20524160|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
20218664|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218665|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218666|NCT00313898|Urological Agents|urological agents|mesh-ancestor
20218667|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20218668|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20218669|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20218670|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
20218671|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218672|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218673|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218674|NCT00313924|Urological Agents|urological agents|mesh-ancestor
20218675|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
20218676|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218677|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218678|NCT00313950|Vaccines|vaccines|mesh-list
19405245|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19405246|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19405247|NCT03588533|Capecitabine|capecitabine|mesh-list
19405248|NCT03588533|Trastuzumab|trastuzumab|mesh-list
19405249|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405250|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405251|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
19405252|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405253|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405254|NCT03588494|Endostar protein|endostar protein|mesh-list
19405255|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19405256|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20218679|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
20218680|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218681|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
20218682|NCT00313963|Analgesics|analgesics|mesh-ancestor
20218683|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
20218684|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218685|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218686|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
20218687|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218688|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20437022|NCT05251493|Iron|iron|mesh-list
20437023|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20437024|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20437025|NCT05251493|Trace Elements|trace elements|mesh-ancestor
20437026|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
20437027|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437028|NCT05251493|Hematinics|hematinics|mesh-ancestor
20437029|NCT05251038|Leucovorin|leucovorin|mesh-list
20437030|NCT05251038|Gemcitabine|gemcitabine|mesh-list
20437031|NCT05251038|Paclitaxel|paclitaxel|mesh-list
20437032|NCT05251038|Fluorouracil|fluorouracil|mesh-list
20437033|NCT05251038|Irinotecan|irinotecan|mesh-list
20437034|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20437035|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437036|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218689|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
20437037|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
20437038|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
20530354|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
20530355|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530356|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530357|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20530358|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20530359|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
20530360|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20530361|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20530362|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530363|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20530364|NCT01788254|Narcotics|narcotics|mesh-ancestor
20530365|NCT01788254|Analgesics|analgesics|mesh-ancestor
20530366|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
20530367|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530368|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
20530369|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
20530370|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20530371|NCT01788254|Diuretics|diuretics|mesh-ancestor
20530372|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
20530373|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20530374|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530375|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20530376|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20530377|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
20530378|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20530379|NCT01788280|Bevacizumab|bevacizumab|mesh-list
20530380|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20530381|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530382|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20530383|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20530384|NCT01788280|Growth Substances|growth substances|mesh-ancestor
20530385|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530386|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
20530387|NCT01788332|Olaparib|olaparib|mesh-list
20530388|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20530389|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437039|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437040|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20437041|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
20437042|NCT05251038|Antiviral Agents|antiviral agents|mesh-ancestor
20437043|NCT05251038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437044|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437045|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20437046|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
20437047|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437048|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20437049|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20437050|NCT05251038|Antidotes|antidotes|mesh-ancestor
20437051|NCT05251038|Protective Agents|protective agents|mesh-ancestor
20437052|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
20437053|NCT05251038|Vitamins|vitamins|mesh-ancestor
20437054|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
20437055|NCT05250843|Lenvatinib|lenvatinib|mesh-list
20437056|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437057|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437058|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437059|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437060|NCT05250791|Lidocaine|lidocaine|mesh-list
20437061|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
20437062|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
20437063|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437064|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437065|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
20437066|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437067|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20437068|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20437069|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20437070|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20437071|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437072|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
20437073|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20437074|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437075|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20437076|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437077|NCT05250661|Propolis|propolis|mesh-list
20437078|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437079|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20437080|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20437081|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20437082|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
20437083|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437084|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437085|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437086|NCT05250245|Urological Agents|urological agents|mesh-ancestor
20437087|NCT05249972|Calcitriol|calcitriol|mesh-list
20437088|NCT05249972|Betamethasone|betamethasone|mesh-list
20437089|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
20437090|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20437091|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
20437092|NCT05249972|Calcipotriene|calcipotriene|mesh-list
20437093|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20437094|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437095|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
20437096|NCT05249972|Hormones|hormones|mesh-ancestor
20437097|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437098|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437099|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20437100|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
20437101|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
20437102|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20437103|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20437104|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20437105|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437106|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20437107|NCT05249972|Vitamins|vitamins|mesh-ancestor
20437108|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
20437109|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20437110|NCT05249933|Benzocaine|benzocaine|mesh-list
20437111|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
20437112|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
20437113|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437114|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437115|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
20437116|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437117|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
20437118|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
20437119|NCT05249751|Coagulants|coagulants|mesh-ancestor
20437120|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20437121|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20437122|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
20437123|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437124|NCT05249712|Androgens|androgens|mesh-list
20437125|NCT05249712|Hormones|hormones|mesh-ancestor
20437126|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437127|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437128|NCT05246046|Bromides|bromides|mesh-list
20437129|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
20437130|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20437131|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
20437132|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437133|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437134|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20437135|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
20437136|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
20437137|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20437138|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
20437139|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437140|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437141|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
20437142|NCT05227612|Psilocybin|psilocybin|mesh-list
20437143|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
20437144|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437145|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20437146|NCT05226442|Heparin|heparin|mesh-list
20437147|NCT05226442|Calcium heparin|calcium heparin|mesh-list
20437148|NCT05226442|Argatroban|argatroban|mesh-list
20437149|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
20437150|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20437151|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20437152|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437153|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
20437154|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20437155|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
20437156|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437157|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20437158|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
20437159|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20437160|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20437161|NCT05220319|Prednisolone|prednisolone|mesh-list
20437162|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
20437163|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20437164|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
20437165|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437166|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
20437167|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
20437168|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437169|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437170|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20437171|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
20613453|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405257|NCT03588494|Growth Substances|growth substances|mesh-ancestor
19405258|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405259|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
19405260|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405261|NCT03588429|Sevoflurane|sevoflurane|mesh-list
19405262|NCT03588429|Isoflurane|isoflurane|mesh-list
20437172|NCT05220319|Hormones|hormones|mesh-ancestor
20437173|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613454|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613455|NCT02255045|Analgesics|analgesics|mesh-ancestor
20613456|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
19405263|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19405264|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20437174|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20437175|NCT05220319|Protective Agents|protective agents|mesh-ancestor
20437176|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19405265|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
20437177|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524161|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524162|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524163|NCT01750060|Fentanyl|fentanyl|mesh-list
20524164|NCT01750060|Naltrexone|naltrexone|mesh-list
20524165|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20524166|NCT01750060|Narcotics|narcotics|mesh-ancestor
20524167|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524168|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524169|NCT01750060|Analgesics|analgesics|mesh-ancestor
20524170|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
20524171|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524172|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20524173|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20524174|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
20524175|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
20524176|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20524177|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20524178|NCT01750099|Lidocaine|lidocaine|mesh-list
20524179|NCT01750099|Epinephrine|epinephrine|mesh-list
20524180|NCT01750099|Fentanyl|fentanyl|mesh-list
20524181|NCT01750099|Bupivacaine|bupivacaine|mesh-list
20524182|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
20524183|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
20524184|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524185|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524186|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
20524187|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524188|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20524189|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20524190|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20524191|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524192|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524193|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20524194|NCT01750099|Narcotics|narcotics|mesh-ancestor
20524195|NCT01750099|Analgesics|analgesics|mesh-ancestor
20524196|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20524197|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20524198|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
20524199|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20524200|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19848400|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19848401|NCT00693992|Sunitinib|sunitinib|mesh-list
20524201|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
20524202|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524203|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20524204|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20524205|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
20524206|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20524207|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
20524208|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
20524209|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
20524210|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20530390|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530391|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530392|NCT01788371|Lamivudine|lamivudine|mesh-list
20530393|NCT01788371|Telbivudine|telbivudine|mesh-list
20530394|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20530395|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20530396|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530397|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530398|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
20530399|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405266|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
19405267|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405268|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405269|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
19405270|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19405271|NCT03588351|Chitosan|chitosan|mesh-list
19405272|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19405273|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848402|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848403|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20530400|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20530401|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20530402|NCT01788384|Clindamycin|clindamycin|mesh-list
19405274|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
19405275|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
19405276|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19405277|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19405278|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
19405279|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405280|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19405281|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
19405282|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
19405283|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
19405284|NCT03588351|Coagulants|coagulants|mesh-ancestor
19405285|NCT03588338|Acetaminophen|acetaminophen|mesh-list
19405286|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405287|NCT03588338|Analgesics|analgesics|mesh-ancestor
19405288|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
19405289|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437178|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
20437179|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
20437180|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437181|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20437182|NCT05211024|Penicillins|penicillins|mesh-list
20437183|NCT05211024|Penicillin G|penicillin g|mesh-list
20437184|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20437185|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
20437186|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20437187|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437188|NCT05206266|Turmeric extract|turmeric extract|mesh-list
20437189|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
20437190|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437191|NCT05206266|Protective Agents|protective agents|mesh-ancestor
20437192|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437193|NCT05198128|Calcium|calcium|mesh-list
20437194|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20437195|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437196|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
20437197|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437198|NCT05178888|Palbociclib|palbociclib|mesh-list
20437199|NCT05178888|Adagrasib|adagrasib|mesh-list
20437200|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437201|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437202|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437203|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437204|NCT05170334|Belinostat|belinostat|mesh-list
20437205|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437206|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20437207|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437208|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437209|NCT05164549|Buprenorphine|buprenorphine|mesh-list
20437210|NCT05164549|Methadone|methadone|mesh-list
20437211|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20437212|NCT05164549|Narcotics|narcotics|mesh-ancestor
20437213|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437214|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437215|NCT05164549|Analgesics|analgesics|mesh-ancestor
20437216|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
20437217|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437218|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20437219|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
20437220|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
20437221|NCT05162274|Lazertinib|lazertinib|mesh-list
20437222|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437223|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437224|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437225|NCT05157698|Naltrexone|naltrexone|mesh-list
20437226|NCT05157698|Bupropion|bupropion|mesh-list
20437227|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20437228|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20437229|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437230|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
20437231|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437232|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19405290|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405291|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
20437233|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
20437234|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20437235|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20437236|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20437237|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20437238|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437239|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
20437240|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437241|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20437242|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20437243|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437244|NCT05148312|Budesonide|budesonide|mesh-list
20437245|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437246|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20437247|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
20437248|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437249|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437250|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20437251|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
20437252|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
20437253|NCT05148312|Hormones|hormones|mesh-ancestor
20437254|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437255|NCT05124691|Ivermectin|ivermectin|mesh-list
20437256|NCT05124691|Albendazole|albendazole|mesh-list
20437257|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20437258|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437259|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
20437260|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
20437261|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20437262|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20437263|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
20437264|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
20437265|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
20437266|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437267|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437268|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
20437269|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437270|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437271|NCT05119101|Analgesics|analgesics|mesh-ancestor
20437272|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
20437273|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437274|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437275|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
20437276|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20437277|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
20437278|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20437279|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20437280|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20437281|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
20437282|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20437283|NCT05118477|Caffeine|caffeine|mesh-list
20437284|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20437285|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437286|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20437287|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437288|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437289|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20437290|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20437291|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
20437292|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437293|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
20437294|NCT05109455|Procyanidin|procyanidin|mesh-list
20437295|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
20437296|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437297|NCT05109455|Protective Agents|protective agents|mesh-ancestor
20437298|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437299|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20437300|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20437301|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437302|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
20437303|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20437304|NCT05090657|Methylene Blue|methylene blue|mesh-list
20437305|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20437306|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437307|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
20437308|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
20437309|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524211|NCT01750359|Curcumin|curcumin|mesh-list
20530403|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
20437310|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437311|NCT05073250|Rituximab|rituximab|mesh-list
20437312|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437313|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437314|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
20437315|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437316|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20437317|NCT05070403|Afatinib|afatinib|mesh-list
20437318|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437319|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437320|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437321|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437322|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
20437323|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20437324|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
20437325|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437326|NCT05034562|Edetic Acid|edetic acid|mesh-list
20437327|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20437328|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
20437329|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
20437330|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437331|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
20437332|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20437333|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20437334|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
20437335|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20437336|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437337|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437338|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20437339|NCT05031026|Analgesics|analgesics|mesh-ancestor
20437340|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
20437341|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437342|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20437343|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20437344|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20437345|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
20437346|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437347|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437348|NCT05027919|Lofexidine|lofexidine|mesh-list
20437349|NCT05027919|Clonidine|clonidine|mesh-list
20437350|NCT05027919|Morphine|morphine|mesh-list
20437351|NCT05027919|Naloxone|naloxone|mesh-list
20437352|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20437353|NCT05027919|Narcotics|narcotics|mesh-ancestor
20437354|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437355|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437356|NCT05027919|Analgesics|analgesics|mesh-ancestor
20437357|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
20437358|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437359|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20437360|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20437361|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20437362|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20437363|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20437364|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
20437365|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437366|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437367|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
20437368|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
20437369|NCT05027048|Calcium|calcium|mesh-list
20437370|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20437371|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437372|NCT04999228|Mesalamine|mesalamine|mesh-list
20437373|NCT04999228|Infliximab|infliximab|mesh-list
20437374|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
20437375|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20437376|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20437377|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20437378|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20437379|NCT04999228|Analgesics|analgesics|mesh-ancestor
20437380|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
20437381|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437382|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437383|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437384|NCT04983407|Gemcitabine|gemcitabine|mesh-list
20437385|NCT04983407|Paclitaxel|paclitaxel|mesh-list
20437386|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20437387|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437388|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
20437389|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
20437390|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
20437391|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437392|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20437393|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
20437394|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
20437395|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437396|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437397|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20437398|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
20437399|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437400|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
20437401|NCT04955743|Lenvatinib|lenvatinib|mesh-list
20437402|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437403|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437404|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437405|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437406|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437407|NCT04920331|Erenumab|erenumab|mesh-list
20437408|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20437409|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437410|NCT04920331|Analgesics|analgesics|mesh-ancestor
20437411|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
20437412|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437413|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437414|NCT04863885|Nivolumab|nivolumab|mesh-list
19405292|NCT03588273|Amoxicillin|amoxicillin|mesh-list
19405293|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19405294|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416486|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
19416487|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19416488|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19416489|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416490|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19416491|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416492|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19416493|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416494|NCT02413827|Ipilimumab|ipilimumab|mesh-list
20437415|NCT04863885|Ipilimumab|ipilimumab|mesh-list
20437416|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437417|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437418|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20437419|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437420|NCT04861987|Capecitabine|capecitabine|mesh-list
20437421|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20437422|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
20437423|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437424|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437425|NCT04832438|Carboplatin|carboplatin|mesh-list
20437426|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437427|NCT04832087|Teduglutide|teduglutide|mesh-list
20437428|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20437429|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20437430|NCT04832087|Protective Agents|protective agents|mesh-ancestor
20437431|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437432|NCT04761848|Cilostazol|cilostazol|mesh-list
20437433|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20437434|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
20437435|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437436|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437437|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20437438|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
20437439|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20437440|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20437441|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530404|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
19416495|NCT02413827|Poly ICLC|poly iclc|mesh-list
19416496|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19416497|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416498|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416499|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20437442|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20437443|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
20437444|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20437445|NCT04761848|Protective Agents|protective agents|mesh-ancestor
20437446|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20437447|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20437448|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524212|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20524213|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20524214|NCT01750359|Analgesics|analgesics|mesh-ancestor
20524215|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
20524216|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524217|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524218|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20524219|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524220|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524221|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524222|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524223|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20524224|NCT01750385|Cephalosporins|cephalosporins|mesh-list
20524225|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524226|NCT01750437|Esomeprazole|esomeprazole|mesh-list
20524227|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20524228|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524229|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20524230|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524231|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524232|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20524233|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
20524234|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20524235|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
20524236|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20524237|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524238|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20524239|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20524240|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20524241|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20524242|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20524243|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524244|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20524245|NCT01750541|Valproic Acid|valproic acid|mesh-list
20524246|NCT01750541|Haloperidol|haloperidol|mesh-list
20524247|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
20524248|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
20524249|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
20524250|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524251|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524252|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524253|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20524254|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20524255|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524256|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524257|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20524258|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
20524259|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524260|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524261|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20524262|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
20524263|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524264|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
20524265|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
20524266|NCT01750580|Ipilimumab|ipilimumab|mesh-list
20524267|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20524268|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524269|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20524270|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524271|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
20524272|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20524273|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524274|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524275|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
20524276|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524277|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524278|NCT01750723|Acetazolamide|acetazolamide|mesh-list
20437449|NCT04757571|Paroxetine|paroxetine|mesh-list
20437450|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20437451|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20437452|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20437453|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437454|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437455|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
20437456|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437457|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20437458|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
20437459|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20437460|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20437461|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20437462|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437463|NCT04736394|Epirubicin|epirubicin|mesh-list
20437464|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20437465|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437466|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20437467|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20437468|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437469|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437470|NCT04721132|Bevacizumab|bevacizumab|mesh-list
20437471|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20437472|NCT04721132|Atezolizumab|atezolizumab|mesh-list
20437473|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
20437474|NCT04721132|Antibodies|antibodies|mesh-list
20437475|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
20437476|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20437477|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
20437478|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437479|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20437480|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20437481|NCT04721132|Growth Substances|growth substances|mesh-ancestor
20437482|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437483|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
20437484|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
20437485|NCT04718155|Atorvastatin|atorvastatin|mesh-list
20437486|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20437487|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20437488|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
20437489|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437490|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20437491|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20437492|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437493|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20437494|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20437495|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
20437496|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437497|NCT04693689|Vaccines|vaccines|mesh-list
20437498|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
20437499|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437500|NCT04661514|Psilocybin|psilocybin|mesh-list
20437501|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
20437502|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437503|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20437504|NCT04588545|Trastuzumab|trastuzumab|mesh-list
20437505|NCT04588545|Pertuzumab|pertuzumab|mesh-list
20437506|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437507|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437508|NCT04577755|Pomalidomide|pomalidomide|mesh-list
20437509|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
20437510|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437511|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20437512|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20437513|NCT04577755|Growth Substances|growth substances|mesh-ancestor
20437514|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
20437515|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437516|NCT04563273|Vaccines|vaccines|mesh-list
20437517|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
20437518|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
20437519|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405295|NCT03588091|Docetaxel|docetaxel|mesh-list
19405296|NCT03588091|Trastuzumab|trastuzumab|mesh-list
20437520|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20437521|NCT04541108|Paclitaxel|paclitaxel|mesh-list
20437522|NCT04541108|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20437523|NCT04541108|Carboplatin|carboplatin|mesh-list
20437524|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
20437525|NCT04541108|Fluorouracil|fluorouracil|mesh-list
20437526|NCT04541108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20437527|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437528|NCT04541108|Tubulin Modulators|tubulin modulators|mesh-ancestor
20437529|NCT04541108|Antimitotic Agents|antimitotic agents|mesh-ancestor
20437530|NCT04541108|Mitosis Modulators|mitosis modulators|mesh-ancestor
20437531|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437532|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437533|NCT04541108|Antimetabolites|antimetabolites|mesh-ancestor
19405297|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437534|NCT04541108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20437535|NCT04541108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20437536|NCT04541108|Immunologic Factors|immunologic factors|mesh-ancestor
20437537|NCT04541108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437538|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
20437539|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20437540|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437541|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20437542|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437543|NCT04490993|Epirubicin|epirubicin|mesh-list
20437544|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20437545|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437546|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20437547|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20437548|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437549|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437550|NCT04420624|Colchicine|colchicine|mesh-list
20437551|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
20437552|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20437553|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
20437554|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
20437555|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
20437556|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437557|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437558|NCT04409964|Lidocaine|lidocaine|mesh-list
20437559|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
20437560|NCT04409964|Remifentanil|remifentanil|mesh-list
20437561|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
20437562|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
20437563|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437564|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437565|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
20437566|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437567|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20437568|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20437569|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20437570|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20437571|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437572|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20437573|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20437574|NCT04409964|Analgesics|analgesics|mesh-ancestor
20437575|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20437576|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20437577|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20437578|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
20437579|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437580|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20437581|NCT04409964|Narcotics|narcotics|mesh-ancestor
20437582|NCT04377997|Heparin|heparin|mesh-list
20437583|NCT04377997|Calcium heparin|calcium heparin|mesh-list
20437584|NCT04377997|Enoxaparin|enoxaparin|mesh-list
20437585|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20437586|NCT04377997|Tinzaparin|tinzaparin|mesh-list
20437587|NCT04377997|Dalteparin|dalteparin|mesh-list
20437588|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
20437589|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20437590|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20437591|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437592|NCT04346394|Yohimbine|yohimbine|mesh-list
20437593|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
20437594|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
19848404|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20437595|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437596|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437597|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20437598|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20437599|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20437600|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
20437601|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437602|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437603|NCT04346394|Urological Agents|urological agents|mesh-ancestor
20437604|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
20437605|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437606|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437607|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437608|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437609|NCT04258488|Vitamin K|vitamin k|mesh-list
20437610|NCT04258488|Warfarin|warfarin|mesh-list
20437611|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
20437612|NCT04258488|Vitamins|vitamins|mesh-ancestor
20437613|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
20437614|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437615|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
20437616|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20437617|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
20437618|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20437619|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
20437620|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437621|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437622|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20437623|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20437624|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
20437625|NCT04258488|Coagulants|coagulants|mesh-ancestor
20437626|NCT04216134|Edetic Acid|edetic acid|mesh-list
20437627|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20437628|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
20437629|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
20437630|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437631|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
20437632|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20437633|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20437634|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
20437635|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20437636|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437637|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20437638|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437639|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
20437640|NCT04179110|Ramucirumab|ramucirumab|mesh-list
20437641|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437642|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437643|NCT04091022|Eflornithine|eflornithine|mesh-list
20437644|NCT04091022|Diclofenac|diclofenac|mesh-list
20437645|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20437646|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20437647|NCT04091022|Analgesics|analgesics|mesh-ancestor
20437648|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
20437649|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437650|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437651|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437652|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20437653|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20437654|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437655|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437656|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437657|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20437658|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20437659|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20437660|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437661|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20437662|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
20437663|NCT04090775|Nivolumab|nivolumab|mesh-list
20437664|NCT04090775|Ipilimumab|ipilimumab|mesh-list
20437665|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20437666|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
20437667|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437668|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20437669|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20437670|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
20437671|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437672|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437673|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20437674|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437675|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20437676|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
20437677|NCT04052334|Fludarabine|fludarabine|mesh-list
20437678|NCT04052334|Interleukin-2|interleukin-2|mesh-list
20437679|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20437680|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
20437681|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437682|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20437683|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20437684|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
20437685|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437686|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437687|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20437688|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20437689|NCT04052334|Analgesics|analgesics|mesh-ancestor
20437690|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
20437691|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437692|NCT03981614|Trifluridine|trifluridine|mesh-list
20437693|NCT03981614|Palbociclib|palbociclib|mesh-list
20437694|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437695|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437696|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437697|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437698|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
20437699|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
20437700|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524279|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
20524280|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20524281|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524282|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524283|NCT01750723|Diuretics|diuretics|mesh-ancestor
20524284|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
20524285|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524286|NCT01750762|Lenalidomide|lenalidomide|mesh-list
20524287|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
20524288|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524289|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20524290|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20524291|NCT01750762|Growth Substances|growth substances|mesh-ancestor
20524292|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
20524293|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524294|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
20524295|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20524296|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
20524297|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20524298|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
20524299|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524300|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524301|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
20524302|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
20524303|NCT01750801|Propolis|propolis|mesh-list
20524304|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20524305|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524306|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
20524307|NCT01750866|Prednisone|prednisone|mesh-list
20524308|NCT01750866|Sargramostim|sargramostim|mesh-list
20524309|NCT01750866|Lenograstim|lenograstim|mesh-list
20524310|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20524311|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
20524312|NCT01750866|Hormones|hormones|mesh-ancestor
20524313|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524314|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524315|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20524316|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524317|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
20524318|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20524319|NCT01750983|Lenalidomide|lenalidomide|mesh-list
20524320|NCT01750983|Ipilimumab|ipilimumab|mesh-list
20524321|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
20524322|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524323|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20524324|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20524325|NCT01750983|Growth Substances|growth substances|mesh-ancestor
20524326|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
20524327|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437701|NCT03951649|Acetaminophen|acetaminophen|mesh-list
20437702|NCT03951649|Caffeine|caffeine|mesh-list
20437703|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20437704|NCT03951649|Analgesics|analgesics|mesh-ancestor
20437705|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
20437706|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437707|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437708|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
20437709|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20437710|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20437711|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437712|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437713|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20437714|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20437715|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
20437716|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437717|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
20437718|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20437719|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20437720|NCT03875690|Prednisolone|prednisolone|mesh-list
20437721|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
20437722|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20437723|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
20437724|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437725|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
20437726|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
20437727|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437728|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437729|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20437730|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
20437731|NCT03875690|Hormones|hormones|mesh-ancestor
20437732|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437733|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20437734|NCT03875690|Protective Agents|protective agents|mesh-ancestor
20437735|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20437736|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437737|NCT03860038|Dexamethasone|dexamethasone|mesh-list
20437738|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437739|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
20437740|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
20437741|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437742|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437743|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20437744|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
20437745|NCT03860038|Hormones|hormones|mesh-ancestor
20437746|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437747|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20437748|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437749|NCT03845296|Rucaparib|rucaparib|mesh-list
20437750|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20437751|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437752|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437753|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437754|NCT03809013|Trastuzumab|trastuzumab|mesh-list
20437755|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437756|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437757|NCT03807765|Nivolumab|nivolumab|mesh-list
20437758|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437759|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437760|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20437761|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437762|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
20437763|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
20437764|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
20437765|NCT03785249|Cetuximab|cetuximab|mesh-list
20437766|NCT03785249|Afatinib|afatinib|mesh-list
20437767|NCT03785249|Adagrasib|adagrasib|mesh-list
20437768|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437769|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437770|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20437771|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437772|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437773|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
19405298|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
20437774|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20437775|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
20437776|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20437777|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
20437778|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437779|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
20437780|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20437781|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
20437782|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20437783|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
20437784|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437785|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437786|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
20437787|NCT03740958|Argatroban|argatroban|mesh-list
20437788|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
20437789|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20437790|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
20437791|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437792|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437793|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
20437794|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20437795|NCT03711318|Buprenorphine|buprenorphine|mesh-list
20437796|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20437797|NCT03711318|Naloxone|naloxone|mesh-list
20437798|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20437799|NCT03711318|Narcotics|narcotics|mesh-ancestor
20437800|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437801|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437802|NCT03711318|Analgesics|analgesics|mesh-ancestor
20437803|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
20437804|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437805|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20437806|NCT03686488|Ramucirumab|ramucirumab|mesh-list
20437807|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437808|NCT03685188|Sufentanil|sufentanil|mesh-list
19405299|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
19405300|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
20613457|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613458|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613459|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20613460|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613461|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20613462|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613463|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613464|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20613465|NCT02255084|Menthol|menthol|mesh-list
20613466|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
20613467|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
20613468|NCT02255162|Cytarabine|cytarabine|mesh-list
20613469|NCT02255162|Lenalidomide|lenalidomide|mesh-list
19405301|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405302|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405303|NCT03588078|Azacitidine|azacitidine|mesh-list
19405304|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405305|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
19405306|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405307|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405308|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405309|NCT03588039|Paclitaxel|paclitaxel|mesh-list
19405310|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
19405311|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19405312|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405313|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
19405314|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
19405315|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
19405316|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405317|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437809|NCT03685188|Oxycodone|oxycodone|mesh-list
20437810|NCT03685188|Dsuvia|dsuvia|mesh-list
20613470|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20613471|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
20613472|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613473|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613474|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
20437811|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20437812|NCT03685188|Narcotics|narcotics|mesh-ancestor
20437813|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437814|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437815|NCT03685188|Analgesics|analgesics|mesh-ancestor
20437816|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
20437817|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437818|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20437819|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20437820|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
19848405|NCT00693992|Growth Substances|growth substances|mesh-ancestor
19848406|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848407|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19848408|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848409|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848410|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848411|NCT00694096|Sunitinib|sunitinib|mesh-list
19848412|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848413|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20437821|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
20437822|NCT03649880|Misonidazole|misonidazole|mesh-list
20437823|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437824|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20437825|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20437826|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437827|NCT03635749|Aspirin|aspirin|mesh-list
20437828|NCT03635749|Atorvastatin|atorvastatin|mesh-list
20437829|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20437830|NCT03635749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20437831|NCT03635749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20437832|NCT03635749|Analgesics|analgesics|mesh-ancestor
20437833|NCT03635749|Sensory System Agents|sensory system agents|mesh-ancestor
20437834|NCT03635749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437835|NCT03635749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437836|NCT03635749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437837|NCT03635749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20437838|NCT03635749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20437839|NCT03635749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20437840|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437841|NCT03635749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20437842|NCT03635749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20437843|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437844|NCT03635749|Antipyretics|antipyretics|mesh-ancestor
20437845|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20437846|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20437847|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
20437848|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20437849|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
20437850|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437851|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437852|NCT03599791|Fluticasone|fluticasone|mesh-list
20437853|NCT03599791|Xhance|xhance|mesh-list
20437854|NCT03599791|Azelastine|azelastine|mesh-list
20437855|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437856|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20437857|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
20437858|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437859|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437860|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20437861|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
20437862|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
20437863|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20437864|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20437865|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437866|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437867|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20437868|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20437869|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
20437870|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
20437871|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437872|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
20437873|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
20437874|NCT03526432|Bevacizumab|bevacizumab|mesh-list
20437875|NCT03526432|Atezolizumab|atezolizumab|mesh-list
20437876|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848414|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20437877|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530405|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20437878|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20437879|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20437880|NCT03526432|Growth Substances|growth substances|mesh-ancestor
20437881|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437882|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
20437883|NCT03502330|Nivolumab|nivolumab|mesh-list
20437884|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437885|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437886|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20437887|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437888|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
20437889|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20437890|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
20437891|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437892|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
20437893|NCT03429140|Protective Agents|protective agents|mesh-ancestor
20437894|NCT03363035|Enoxaparin|enoxaparin|mesh-list
20437895|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
20437896|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20437897|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
20437898|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20437899|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
20437900|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437901|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437902|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
20437903|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20437904|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20437905|NCT03327805|Choline|choline|mesh-list
20437906|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
20437907|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20437908|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
20437909|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437910|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20437911|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20437912|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
20437913|NCT03246958|Nivolumab|nivolumab|mesh-list
20437914|NCT03246958|Ipilimumab|ipilimumab|mesh-list
20437915|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437916|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437917|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20437918|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437919|NCT03160521|Risperidone|risperidone|mesh-list
20437920|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20437921|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
20437922|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437923|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437924|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437925|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20437926|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20437927|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437928|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20437929|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20437930|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
20437931|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
20437932|NCT03150329|Vorinostat|vorinostat|mesh-list
20437933|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20437934|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437935|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20437936|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437937|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437938|NCT03143816|Insulin|insulin|mesh-list
20437939|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20437940|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437941|NCT03133988|Margetuximab|margetuximab|mesh-list
20437942|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437943|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
20437944|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20437945|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20437946|NCT03122847|Prednisolone|prednisolone|mesh-list
20437947|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
20437948|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20437949|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
20437950|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437951|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
20613475|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20437952|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
20437953|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437954|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437955|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20437956|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
20437957|NCT03122847|Hormones|hormones|mesh-ancestor
20437958|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437959|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20437960|NCT03122847|Protective Agents|protective agents|mesh-ancestor
20437961|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20437962|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437963|NCT03078192|Xenon|xenon|mesh-list
20437964|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20437965|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
20437966|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
20437967|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20437968|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437969|NCT03004131|Fluticasone|fluticasone|mesh-list
20437970|NCT03004131|Xhance|xhance|mesh-list
20437971|NCT03004131|Loratadine|loratadine|mesh-list
20437972|NCT03004131|Azelastine|azelastine|mesh-list
20437973|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437974|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20437975|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
20437976|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20437977|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437978|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20437979|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
20437980|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
20437981|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20437982|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
20437983|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20437984|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20437985|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
20437986|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
20437987|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20437988|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20437989|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20437990|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20437991|NCT02959944|Prednisone|prednisone|mesh-list
20437992|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20437993|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
20437994|NCT02959944|Hormones|hormones|mesh-ancestor
20437995|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20437996|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20437997|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20437998|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20437999|NCT02903823|Baclofen|baclofen|mesh-list
20438000|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20438001|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438002|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20438003|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438004|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20438005|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
20438006|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
20438007|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438008|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438009|NCT02876302|Paclitaxel|paclitaxel|mesh-list
20438010|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
20438011|NCT02876302|Doxorubicin|doxorubicin|mesh-list
20438012|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20438013|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438014|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20438015|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
20438016|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
20438017|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438018|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20438019|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
20438020|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438021|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438022|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20438023|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
20438024|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20438025|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20438026|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20438027|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20438028|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438029|NCT02869009|Aspirin|aspirin|mesh-list
20438030|NCT02869009|Clopidogrel|clopidogrel|mesh-list
20438031|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438032|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438033|NCT02869009|Analgesics|analgesics|mesh-ancestor
20438034|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
20438035|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438036|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438037|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438038|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438039|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20438040|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20438041|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438042|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20438043|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438044|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438045|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
20438046|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20438047|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20438048|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20438049|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
20438050|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438051|NCT02855697|Olaparib|olaparib|mesh-list
20438052|NCT02855697|Cediranib|cediranib|mesh-list
20438053|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20438054|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438055|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438056|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438057|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20438058|NCT02710097|Ethanol|ethanol|mesh-list
20438059|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20438060|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438061|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438062|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438063|NCT02709954|Ethanol|ethanol|mesh-list
20438064|NCT02709954|Dronabinol|dronabinol|mesh-list
20438065|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20438066|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438067|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438068|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438069|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
20438070|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20438071|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438072|NCT02709954|Analgesics|analgesics|mesh-ancestor
20438073|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
20438074|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438075|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20438076|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20438077|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438078|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438079|NCT02709954|Hormones|hormones|mesh-ancestor
20438080|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438081|NCT02681549|Bevacizumab|bevacizumab|mesh-list
20438082|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
20438083|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20438084|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438085|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19693394|NCT04979611|Exenatide|exenatide|mesh-list
19693395|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19693396|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693397|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19693398|NCT04979611|Incretins|incretins|mesh-ancestor
19693399|NCT04979611|Hormones|hormones|mesh-ancestor
19693400|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693401|NCT04979585|Paclitaxel|paclitaxel|mesh-list
19693402|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19693403|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693404|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
19693405|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
19693406|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
19848415|NCT00694096|Growth Substances|growth substances|mesh-ancestor
19855579|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20438086|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20438087|NCT02681549|Growth Substances|growth substances|mesh-ancestor
20438088|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438089|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
20438090|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
20438091|NCT02616302|Lansoprazole|lansoprazole|mesh-list
20438092|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20438093|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438094|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20438095|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438096|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438097|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
20438098|NCT02615184|Lansoprazole|lansoprazole|mesh-list
20438099|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20438100|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438101|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20438102|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438103|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438104|NCT02607319|Bemiparin|bemiparin|mesh-list
20438105|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
20438129|NCT02562599|Raltitrexed|raltitrexed|mesh-list
20438130|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438131|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20438132|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
20438133|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438134|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20438135|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438136|NCT02489448|Durvalumab|durvalumab|mesh-list
20438137|NCT02489448|Tremelimumab|tremelimumab|mesh-list
20438138|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20438139|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438140|NCT02456012|Esomeprazole|esomeprazole|mesh-list
20438141|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20438142|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438143|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20438144|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438145|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524328|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20524329|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20524330|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524331|NCT01751009|Vitamins|vitamins|mesh-list
20524332|NCT01751009|Vitamin A|vitamin a|mesh-list
20524333|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
20524334|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
20524335|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524336|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
20524337|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524338|NCT01751009|Protective Agents|protective agents|mesh-ancestor
20524339|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20524340|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524341|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20524342|NCT01751074|Darapladib|darapladib|mesh-list
20524343|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20524344|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20438146|NCT02250157|Irinotecan|irinotecan|mesh-list
20438147|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20438148|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20438149|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438150|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438151|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438152|NCT02225405|Cisplatin|cisplatin|mesh-list
20438153|NCT02225405|Docetaxel|docetaxel|mesh-list
20438154|NCT02225405|Nintedanib|nintedanib|mesh-list
20438155|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438156|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
20438157|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
20438158|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
20438159|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438160|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20438161|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438162|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
20438163|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
20438164|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438165|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
20438166|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218690|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20218691|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20438167|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438168|NCT01431508|Losartan|losartan|mesh-list
20438169|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20438170|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20438171|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20438172|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20438173|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438174|NCT00871351|Atorvastatin|atorvastatin|mesh-list
20438175|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20438176|NCT00871351|Ezetimibe|ezetimibe|mesh-list
19405318|NCT03587961|Ivacaftor|ivacaftor|mesh-list
19405319|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19405320|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19405321|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405322|NCT03587779|Sevoflurane|sevoflurane|mesh-list
19405323|NCT03587779|Desflurane|desflurane|mesh-list
19405324|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19405325|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19405326|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
19405327|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
19405328|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405329|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405330|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19405331|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405332|NCT03587662|Gemcitabine|gemcitabine|mesh-list
19405333|NCT03587662|Doxorubicin|doxorubicin|mesh-list
20438177|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20438178|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20438179|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
20438180|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438181|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20438182|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20438183|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613476|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218692|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218693|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20218694|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
20218695|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20218696|NCT00313976|Interferons|interferons|mesh-list
20218697|NCT00313976|Interferon-beta|interferon-beta|mesh-list
20218698|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
20438184|NCT00832455|Montelukast|montelukast|mesh-list
20438185|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20438186|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
20438187|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20438188|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
20438189|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19405334|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20218699|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438190|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438191|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20438192|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20438193|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438194|NCT00812006|Rizatriptan|rizatriptan|mesh-list
20438195|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20438196|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
20438197|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438198|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438199|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438200|NCT00777582|Olaparib|olaparib|mesh-list
20438201|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20438202|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438203|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438204|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438205|NCT00739050|Simvastatin|simvastatin|mesh-list
20438206|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20438207|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20438208|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
20438209|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438210|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20438211|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20438212|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438213|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
20438214|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438215|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
20438216|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20438217|NCT00654628|Simvastatin|simvastatin|mesh-list
20438218|NCT00654628|Ezetimibe|ezetimibe|mesh-list
20438219|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20438220|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20438221|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
20438222|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438223|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20438224|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20438225|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438226|NCT00604812|Rizatriptan|rizatriptan|mesh-list
20438227|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20438228|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
20438229|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438230|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438231|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438232|NCT00536380|Loratadine|loratadine|mesh-list
20438233|NCT00536380|Desloratadine|desloratadine|mesh-list
20438234|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20438235|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
20438236|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438237|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438238|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438239|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20438240|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19693407|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438241|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
20438242|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
20438243|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
20438244|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
20438245|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20438246|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
20438247|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438248|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
20438249|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20438250|NCT00496834|Losartan|losartan|mesh-list
20438251|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20438252|NCT00496834|Carvedilol|carvedilol|mesh-list
20438253|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20438254|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20438255|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20438256|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20438257|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438258|NCT00496834|Diuretics|diuretics|mesh-ancestor
20438259|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
20438260|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438261|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20438262|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20438263|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20438264|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20438265|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
20438266|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438267|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
20438268|NCT00496834|Protective Agents|protective agents|mesh-ancestor
20438269|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20438270|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20438271|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
20438272|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20438273|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20438274|NCT00442897|Atorvastatin|atorvastatin|mesh-list
20438275|NCT00442897|Simvastatin|simvastatin|mesh-list
20438276|NCT00442897|Ezetimibe|ezetimibe|mesh-list
20438277|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20438278|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20438279|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
20438280|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438281|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20438282|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20438283|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438284|NCT00423579|Simvastatin|simvastatin|mesh-list
20438285|NCT00423579|Ezetimibe|ezetimibe|mesh-list
20438286|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20438287|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20438288|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20438289|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
20438290|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438291|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20438292|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20438293|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438294|NCT00394355|Fluticasone|fluticasone|mesh-list
20438295|NCT00394355|Xhance|xhance|mesh-list
20438296|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
20438297|NCT00394355|Montelukast|montelukast|mesh-list
20438298|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438299|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20438300|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
20438301|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438302|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438303|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20438304|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
20438305|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
20438306|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20438307|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20438308|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
20438309|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438310|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20438311|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20438312|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438313|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
20438314|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438315|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
20438316|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20438317|NCT00189280|Imiquimod|imiquimod|mesh-list
20438318|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20438319|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
20438320|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438321|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438322|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
20438323|NCT00166504|Atorvastatin|atorvastatin|mesh-list
20438324|NCT00166504|Simvastatin|simvastatin|mesh-list
20438325|NCT00166504|Ezetimibe|ezetimibe|mesh-list
20438326|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20438327|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20438328|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
20438329|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438330|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20438331|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20438332|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438333|NCT00101972|Antibodies|antibodies|mesh-list
20438334|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20438335|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
20438336|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438337|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
20438338|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438339|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20438340|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438341|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438342|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20438343|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
20438344|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
20438345|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438346|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
20438347|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438348|NCT01343225|Ritonavir|ritonavir|mesh-list
20438349|NCT01343225|Darunavir|darunavir|mesh-list
20438350|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
20438351|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20438352|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20438353|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20438354|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
20438355|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438356|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438357|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20438358|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20438359|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
20438360|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438361|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20438362|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20438363|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20438364|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20438365|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20438366|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20438367|NCT01343290|Canagliflozin|canagliflozin|mesh-list
20438368|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20438369|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438370|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20438371|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438372|NCT01343303|Naproxen|naproxen|mesh-list
20438373|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438374|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438375|NCT01343303|Analgesics|analgesics|mesh-ancestor
20438376|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
20438377|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438378|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438379|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438380|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438381|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
20438382|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438383|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438384|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438385|NCT01343329|Propranolol|propranolol|mesh-list
20438386|NCT01343329|Esmolol|esmolol|mesh-list
20438387|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20438388|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20438389|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
20438390|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218700|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
20218701|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218702|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
20218703|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218704|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20218705|NCT00314080|Antitoxins|antitoxins|mesh-list
19405335|NCT03587662|Daunorubicin|daunorubicin|mesh-list
19405336|NCT03587662|Ixazomib|ixazomib|mesh-list
20438391|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438392|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438393|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20438394|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20438395|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
20438396|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20438397|NCT01343381|Heparin|heparin|mesh-list
20438398|NCT01343381|Calcium heparin|calcium heparin|mesh-list
19405337|NCT03587662|Glycine|glycine|mesh-list
20218706|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
20218707|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
20218708|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218709|NCT00314158|Timolol|timolol|mesh-list
19693408|NCT04979884|Cyclosporine|cyclosporine|mesh-list
20438399|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
20438400|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20438401|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20438402|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438403|NCT01343498|Dactolisib|dactolisib|mesh-list
20438404|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438405|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20438406|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20438407|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20438408|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20438409|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438410|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
20438411|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438412|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438413|NCT01343680|Heparin|heparin|mesh-list
20438414|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
20438415|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20438416|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20438417|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438418|NCT01343706|BI 409306|bi 409306|mesh-list
20438419|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20438420|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438421|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438422|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
20438423|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20438424|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
20438425|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438426|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438427|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20438428|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
20438429|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20438430|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20438431|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20438432|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
20438433|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438434|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438435|NCT01343862|Cycloserine|cycloserine|mesh-list
20438436|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20438437|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438438|NCT01343862|Renal Agents|renal agents|mesh-ancestor
20438439|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20438440|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
20438441|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20438442|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
20438443|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438444|NCT01344031|Fulvestrant|fulvestrant|mesh-list
20438445|NCT01344031|Anastrozole|anastrozole|mesh-list
20438446|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20438447|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438448|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20438449|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20438450|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
20438451|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438452|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438453|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20438454|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20438455|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438456|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438457|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20438458|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438459|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438460|NCT01344083|Analgesics|analgesics|mesh-ancestor
20438461|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
20438462|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438463|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438464|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438465|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438466|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20438467|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20438468|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20438469|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
20438470|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
20438471|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438472|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438473|NCT01344174|Lamivudine|lamivudine|mesh-list
20438474|NCT01344174|Dexamethasone|dexamethasone|mesh-list
20438475|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438476|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
20438477|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
20438478|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438479|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438480|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438481|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
20438482|NCT01344174|Hormones|hormones|mesh-ancestor
20438483|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438484|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20438485|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438486|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20438487|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20438488|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438489|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438490|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
20438491|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438492|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20438493|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20438494|NCT01344200|Celecoxib|celecoxib|mesh-list
20438495|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438496|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438497|NCT01344200|Analgesics|analgesics|mesh-ancestor
20438498|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
20438499|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438500|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438501|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438502|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438503|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20438504|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438505|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438506|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438507|NCT01344213|Celecoxib|celecoxib|mesh-list
20438508|NCT01344213|Pregabalin|pregabalin|mesh-list
20438509|NCT01344213|Analgesics|analgesics|mesh-ancestor
20438510|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
20438511|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438512|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438513|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
20438514|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20438515|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20438516|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438517|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20438518|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20438519|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20438520|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438521|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20438522|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438523|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438524|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438525|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438526|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20438527|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438528|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524345|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
20524346|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524347|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20524348|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20524349|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524350|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20524351|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
20524352|NCT01751204|Calcium|calcium|mesh-list
20524353|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20524354|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524355|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20524356|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
20524357|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693409|NCT04979884|Interleukin-2|interleukin-2|mesh-list
20438529|NCT01344252|Lidocaine|lidocaine|mesh-list
20438530|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
20438531|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
20438532|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438533|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438534|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
20438535|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438536|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20438537|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20438538|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20438539|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20438540|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438541|NCT01344291|Curcumin|curcumin|mesh-list
20438542|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438543|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438544|NCT01344291|Analgesics|analgesics|mesh-ancestor
20438545|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
20438546|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438547|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438548|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438549|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438550|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438551|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438552|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438553|NCT01344304|Aprepitant|aprepitant|mesh-list
20438554|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
20438555|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
20438556|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
20438557|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438558|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438559|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438560|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20438561|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438562|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438563|NCT01344395|Ketorolac|ketorolac|mesh-list
20438564|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20438565|NCT01344395|Ropivacaine|ropivacaine|mesh-list
20438566|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
20438567|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
20438568|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438569|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438570|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
20438571|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438572|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438573|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438574|NCT01344395|Analgesics|analgesics|mesh-ancestor
20438575|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438576|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438577|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438578|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438579|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438580|NCT01344473|Caseins|caseins|mesh-list
20438581|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
20438582|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
20438583|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438584|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
20438585|NCT01344512|Ceftazidime|ceftazidime|mesh-list
20438586|NCT01344512|Voriconazole|voriconazole|mesh-list
20438587|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20438588|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438589|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20438590|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20438591|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438592|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438593|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438594|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20438595|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20438596|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
20438597|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20438598|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20438599|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
20438600|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438601|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438602|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20438603|NCT01344564|Leuprolide|leuprolide|mesh-list
20438604|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20438605|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
20438606|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20438607|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438608|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20438609|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438610|NCT01344590|Ethanol|ethanol|mesh-list
20438611|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20438612|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438613|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438614|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438615|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20438616|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20438617|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
20438618|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438619|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438620|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20438621|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
20438622|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20438623|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20438624|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20438625|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
20438626|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438627|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438628|NCT01344681|Itraconazole|itraconazole|mesh-list
20438629|NCT01344681|Micafungin|micafungin|mesh-list
20438630|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
20438631|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438632|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20438633|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20438634|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438635|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438636|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20438637|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
20438638|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438639|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438640|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20438641|NCT01344720|Etoricoxib|etoricoxib|mesh-list
20438642|NCT01344720|Oxycodone|oxycodone|mesh-list
20438643|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20438644|NCT01344720|Narcotics|narcotics|mesh-ancestor
20438645|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438646|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438647|NCT01344720|Analgesics|analgesics|mesh-ancestor
20438648|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
20438649|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438650|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438651|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438652|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438653|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438654|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20438655|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438656|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438657|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438658|NCT01344863|Trastuzumab|trastuzumab|mesh-list
20438659|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20438660|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438661|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
20438662|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20218710|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20218711|NCT00314158|Brinzolamide|brinzolamide|mesh-list
20218712|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20218713|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20218714|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20218715|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
20218716|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218717|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218718|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218719|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20438663|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20438664|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
20438665|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20438666|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
20438667|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438668|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438669|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
20438670|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
20438671|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438672|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
20438673|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20438674|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438675|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
20438676|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613477|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
20613478|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613479|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20613480|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20613481|NCT02255162|Growth Substances|growth substances|mesh-ancestor
20613482|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
20613483|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20613484|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
20613485|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405338|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405339|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
19405340|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405341|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405342|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
19405343|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405344|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405345|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19405346|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
19405347|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405348|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19405349|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19405350|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19405351|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
19405352|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
19405353|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405354|NCT03587610|Vaccines|vaccines|mesh-list
19405355|NCT03587610|Immunologic Factors|immunologic factors|mesh-ancestor
19405356|NCT03587610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405357|NCT03587558|Flecainide|flecainide|mesh-list
19405358|NCT03587558|Carvedilol|carvedilol|mesh-list
19405359|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19405360|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19405361|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
19405362|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405363|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405364|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613486|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20613487|NCT02255253|Telmisartan|telmisartan|mesh-list
20613488|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20613489|NCT02255253|Diuretics|diuretics|mesh-ancestor
19405365|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19405366|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
19405367|NCT03587558|Protective Agents|protective agents|mesh-ancestor
19405368|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19405369|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19405370|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19405371|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
19405372|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19405373|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19405374|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19405375|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20613490|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
20613491|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613492|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20613493|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19405376|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19405377|NCT03587441|Neostigmine|neostigmine|mesh-list
19405378|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19405379|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405380|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438677|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20438678|NCT01345240|Vaccines|vaccines|mesh-list
20438679|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
20438680|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438681|NCT01345279|Paclitaxel|paclitaxel|mesh-list
20438682|NCT01345279|Topotecan|topotecan|mesh-list
20438683|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20438684|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438685|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
20438686|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
19693410|NCT04979884|Cyclosporins|cyclosporins|mesh-list
19693411|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693412|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693413|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693414|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
19693415|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405381|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
19405382|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405383|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405384|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19405385|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
19405386|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405387|NCT03587324|Clopidogrel|clopidogrel|mesh-list
19405388|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19405389|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19405390|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19405391|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19693416|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
19693417|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693418|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
19693419|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693420|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19693421|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693422|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19693423|NCT04979884|Analgesics|analgesics|mesh-ancestor
19693424|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
19693425|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693426|NCT04979832|Metronidazole|metronidazole|mesh-list
19693427|NCT04979832|Fosfomycin|fosfomycin|mesh-list
19693428|NCT04979832|Molgramostim|molgramostim|mesh-list
19693429|NCT04979832|Sargramostim|sargramostim|mesh-list
20438687|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
20438688|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438689|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20438690|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20438691|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438692|NCT01345357|Gemcitabine|gemcitabine|mesh-list
20438693|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438694|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20438695|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
20438696|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438697|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
20438698|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438699|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405392|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
20438700|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20438701|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
20438702|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438703|NCT01345370|Temozolomide|temozolomide|mesh-list
20438704|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20438705|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
20438706|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438707|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438708|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20438709|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20438710|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20438711|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20438712|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20438713|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
20438714|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438715|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438716|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438717|NCT01345604|Ropivacaine|ropivacaine|mesh-list
19693430|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693431|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20438718|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
20438719|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
20438720|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438721|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438722|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
20438723|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438724|NCT01345708|Prednisone|prednisone|mesh-list
20438725|NCT01345708|Rituximab|rituximab|mesh-list
20438726|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20438727|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438728|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
20438729|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438730|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438731|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438732|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
20438733|NCT01345708|Hormones|hormones|mesh-ancestor
20438734|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438735|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20438736|NCT01345734|Liraglutide|liraglutide|mesh-list
20438737|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218720|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20438738|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438739|NCT01345734|Incretins|incretins|mesh-ancestor
20438740|NCT01345734|Hormones|hormones|mesh-ancestor
20438741|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438742|NCT01345851|Paclitaxel|paclitaxel|mesh-list
19405393|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218721|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20218722|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218723|NCT00314171|Timolol|timolol|mesh-list
20218724|NCT00314171|Dorzolamide|dorzolamide|mesh-list
20218725|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20218726|NCT00314171|Brinzolamide|brinzolamide|mesh-list
20438743|NCT01345851|Carboplatin|carboplatin|mesh-list
20438744|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20438745|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438746|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
19405394|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405395|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405396|NCT03587285|Goserelin|goserelin|mesh-list
19405397|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
19693432|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20218727|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20218728|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20218729|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20218730|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
20218731|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218732|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218733|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218734|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20218735|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218736|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20218737|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218738|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20218739|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
20218740|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218741|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20218742|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20218743|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218744|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218745|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20218746|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
20218747|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218748|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20218749|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20218750|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218751|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218752|NCT00314314|Insulin|insulin|mesh-list
20218753|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218754|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218755|NCT00314379|Vitamin E|vitamin e|mesh-list
20218756|NCT00314379|Vitamins|vitamins|mesh-ancestor
20218757|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
20218758|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218759|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
20438747|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
20438748|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
20438749|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438750|NCT01345864|Scopolamine|scopolamine|mesh-list
20438751|NCT01345864|Donepezil|donepezil|mesh-list
20438752|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20438753|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20438754|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438755|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438756|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
20438757|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438758|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438759|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
20438760|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20438761|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
20438762|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
20438763|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438764|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438765|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
20438766|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20438767|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20438768|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
20438769|NCT01345981|Lidocaine|lidocaine|mesh-list
20438770|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
20438771|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
20438772|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438773|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438774|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
20438775|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438776|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20438777|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20438778|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20438779|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20438780|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405398|NCT03587285|Bicalutamide|bicalutamide|mesh-list
19405399|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19405400|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405401|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19405402|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405403|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405404|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
19405405|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19405406|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405407|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19405408|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
19405409|NCT03587220|Lidocaine|lidocaine|mesh-list
19405410|NCT03587220|Capsaicin|capsaicin|mesh-list
19405411|NCT03587220|Histamine|histamine|mesh-list
19405412|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
19405413|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
19405414|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405415|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405416|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
19405417|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405418|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19693433|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20524358|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524359|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20524360|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524361|NCT01751295|Atorvastatin|atorvastatin|mesh-list
20524362|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20524363|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20524364|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
20524365|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524366|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20524367|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20524368|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524369|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20524370|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20524371|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524372|NCT01751321|Incretins|incretins|mesh-ancestor
20524373|NCT01751321|Hormones|hormones|mesh-ancestor
19693434|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
20530406|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20438781|NCT01346007|Vaccines|vaccines|mesh-list
19405419|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19405420|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19405421|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19405422|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405423|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
19405424|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
19405425|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
19405426|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
19405427|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405428|NCT03587194|Apremilast|apremilast|mesh-list
19405429|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405430|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405431|NCT03587194|Analgesics|analgesics|mesh-ancestor
19405432|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
19405433|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218760|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218761|NCT00314379|Protective Agents|protective agents|mesh-ancestor
20218762|NCT00314405|Methylene Blue|methylene blue|mesh-list
20218763|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218764|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218765|NCT00314457|Bupivacaine|bupivacaine|mesh-list
20218766|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
20218767|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
20218768|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218769|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218770|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
20218771|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247163|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
20247164|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247165|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438782|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20438783|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
20438784|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438785|NCT01346137|Meloxicam|meloxicam|mesh-list
20438786|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438787|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438788|NCT01346137|Analgesics|analgesics|mesh-ancestor
20438789|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
20438790|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438791|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438792|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438793|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438794|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20438795|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438796|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438797|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438798|NCT01346215|Heparin|heparin|mesh-list
20438799|NCT01346215|Calcium heparin|calcium heparin|mesh-list
20247166|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247167|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
20247168|NCT00431236|Hormones|hormones|mesh-ancestor
20247169|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247170|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20247171|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247172|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
20247173|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
20247174|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20247175|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
20247176|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247177|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247178|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20247179|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20438800|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
19405434|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438801|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20438802|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20438803|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438804|NCT01346254|Pioglitazone|pioglitazone|mesh-list
20438805|NCT01346254|Vildagliptin|vildagliptin|mesh-list
20438806|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20438807|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405435|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438808|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20438809|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
20438810|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438811|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438812|NCT01346670|Lovastatin|lovastatin|mesh-list
20438813|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20438814|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19405436|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438815|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
20438816|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438817|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20438818|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20438819|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438820|NCT01346800|Ritonavir|ritonavir|mesh-list
20438821|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20438822|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20438823|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20438824|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
20438825|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438826|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438827|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20438828|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20438829|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
20438830|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438831|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20218772|NCT00314509|Ciclesonide|ciclesonide|mesh-list
20218773|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
20218774|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20218775|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
20218776|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218777|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218778|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20218779|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
20218780|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20218781|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20438832|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20438833|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20438834|NCT01346826|Infliximab|infliximab|mesh-list
20438835|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
20438836|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438837|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438838|NCT01346865|Cilostazol|cilostazol|mesh-list
20438839|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20438840|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
20438841|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438842|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438843|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20438844|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
20438845|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20438846|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20438847|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438848|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20438849|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
20438850|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20438851|NCT01346865|Protective Agents|protective agents|mesh-ancestor
20438852|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20438853|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20438854|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438855|NCT01346917|Lidocaine|lidocaine|mesh-list
20438856|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
20438857|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
20438858|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438859|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438860|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
20438861|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848416|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848417|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
20218782|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20438862|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19405437|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20438863|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20438864|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20438865|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20438866|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438867|NCT01346930|Macitentan|macitentan|mesh-list
20438868|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20438869|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20438870|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438871|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20438872|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20438873|NCT01347268|Hormones|hormones|mesh-ancestor
20438874|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20438875|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438876|NCT01347294|Bleomycin|bleomycin|mesh-list
20438877|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20438878|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438879|NCT01347424|Paclitaxel|paclitaxel|mesh-list
20438880|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20438881|NCT01347424|Carboplatin|carboplatin|mesh-list
20438882|NCT01347424|Endostatins|endostatins|mesh-list
20438883|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20438884|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438885|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
20438886|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
20438887|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
20438888|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438889|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20438890|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20438891|NCT01347424|Growth Substances|growth substances|mesh-ancestor
20438892|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438893|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
20438894|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
20438895|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20438896|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20438897|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
20438898|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
20438899|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20438900|NCT01347814|Domperidone|domperidone|mesh-list
20438901|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
20438902|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
20438903|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438904|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438905|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20438906|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20438907|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
20438908|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438909|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438910|NCT01347853|Ketorolac|ketorolac|mesh-list
20438911|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20438912|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20438913|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438914|NCT01347853|Analgesics|analgesics|mesh-ancestor
20438915|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
20438916|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438917|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438918|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20438919|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438920|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20438921|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438922|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524374|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524375|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20524376|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
20524377|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524378|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524379|NCT01751347|Lidocaine|lidocaine|mesh-list
20524380|NCT01751347|Bupivacaine|bupivacaine|mesh-list
20524381|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
20524382|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
20524383|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524384|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524385|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
20524386|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524387|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20524388|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20438923|NCT01347944|Lenalidomide|lenalidomide|mesh-list
20438924|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
20438925|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438926|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20438927|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20438928|NCT01347944|Growth Substances|growth substances|mesh-ancestor
20438929|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
20438930|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438931|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
20438932|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20438933|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
20438934|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438935|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438936|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20438937|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
20438938|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20438939|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
20438940|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438941|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438942|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20438943|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
20438944|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
20438945|NCT01347957|Protective Agents|protective agents|mesh-ancestor
20438946|NCT01347983|Methotrexate|methotrexate|mesh-list
20438947|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20438948|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
20438949|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20438950|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438951|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20438952|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
20438953|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438954|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438955|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
20438956|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20438957|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20438958|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20438959|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
20438960|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20438961|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20438962|NCT01347996|Interleukin-2|interleukin-2|mesh-list
20438963|NCT01347996|Histamine|histamine|mesh-list
20438964|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
20438965|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438966|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20438967|NCT01347996|Analgesics|analgesics|mesh-ancestor
20438968|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
20438969|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20438970|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438971|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
20438972|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
20438973|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20438974|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438975|NCT01348009|Cisplatin|cisplatin|mesh-list
20438976|NCT01348009|Capecitabine|capecitabine|mesh-list
20438977|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438978|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20438979|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
20438980|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438981|NCT01348126|Docetaxel|docetaxel|mesh-list
20438982|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20438983|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
20438984|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
20438985|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
20438986|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438987|NCT01348204|Quercetin|quercetin|mesh-list
20438988|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
20438989|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20438990|NCT01348204|Protective Agents|protective agents|mesh-ancestor
20438991|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438992|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
20438993|NCT01348243|Lidocaine|lidocaine|mesh-list
20438994|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
20438995|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
20438996|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20438997|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20438998|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
20438999|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439000|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20439001|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20439002|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20439003|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439004|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439005|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20439006|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
20439007|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20439008|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439009|NCT01348282|Rivastigmine|rivastigmine|mesh-list
20439010|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439011|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439012|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439013|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20439014|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
20439015|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439016|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20439017|NCT01348282|Protective Agents|protective agents|mesh-ancestor
20439018|NCT01348308|Maraviroc|maraviroc|mesh-list
20439019|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20439020|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20439021|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439022|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20439023|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20439024|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
20439025|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439026|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20439027|NCT01348321|Levamisole|levamisole|mesh-list
20439028|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20439029|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
20439030|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439031|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
20439032|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
20439033|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20439034|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439035|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20439036|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
20439037|NCT01348412|Raltitrexed|raltitrexed|mesh-list
20439038|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439039|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20613494|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613495|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20613496|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20613497|NCT02255266|Liraglutide|liraglutide|mesh-list
20613498|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20613499|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613500|NCT02255266|Incretins|incretins|mesh-ancestor
20613501|NCT02255266|Hormones|hormones|mesh-ancestor
20613502|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613503|NCT02255292|Cannabidiol|cannabidiol|mesh-list
20613504|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
20613505|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
19405438|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19405439|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405440|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405441|NCT03587129|Apatinib|apatinib|mesh-list
19405442|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405443|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19405444|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405445|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405446|NCT03587077|Isosorbide|isosorbide|mesh-list
19405447|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20613506|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20613507|NCT02255370|Curcumin|curcumin|mesh-list
19405448|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19405449|NCT03587077|Misoprostol|misoprostol|mesh-list
19405450|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19405451|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
19405452|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19405453|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405454|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20613508|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405455|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405456|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
19405457|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19405458|NCT03587077|Diuretics|diuretics|mesh-ancestor
19405459|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
19405460|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
19405461|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19405462|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405463|NCT03587038|Temozolomide|temozolomide|mesh-list
19405464|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19405465|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
19405466|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405467|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439040|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
20439041|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439042|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20439043|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439044|NCT01348503|Lenalidomide|lenalidomide|mesh-list
20439045|NCT01348503|Sorafenib|sorafenib|mesh-list
20439046|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
20439047|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439048|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20439049|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20439050|NCT01348503|Growth Substances|growth substances|mesh-ancestor
20439051|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
20439052|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439053|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20439054|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439055|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439056|NCT01348724|Naloxegol|naloxegol|mesh-list
20439057|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20439058|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439059|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
20439060|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439061|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20439062|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
20439063|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20439064|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20439065|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439066|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439067|NCT01348880|Urological Agents|urological agents|mesh-ancestor
19405468|NCT03587025|Amitriptyline|amitriptyline|mesh-list
19405469|NCT03587025|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19405470|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19405471|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
19405472|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19405473|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405474|NCT03587025|Analgesics|analgesics|mesh-ancestor
19405475|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
19405476|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405477|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405478|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19405479|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19405480|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19405481|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405482|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
19405483|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405484|NCT03587025|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19405485|NCT03587025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19405486|NCT03587025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439068|NCT01348984|Fentanyl|fentanyl|mesh-list
20439069|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20439070|NCT01348984|Narcotics|narcotics|mesh-ancestor
20439071|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439072|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439073|NCT01348984|Analgesics|analgesics|mesh-ancestor
19405487|NCT03586947|Vitamin D|vitamin d|mesh-list
19405488|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
19405489|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
19405490|NCT03586947|Vitamins|vitamins|mesh-list
19405491|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
19405492|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693435|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439074|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
20439075|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439076|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20439077|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20439078|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
20439079|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
20439080|NCT01349010|Probucol|probucol|mesh-list
20439081|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20439082|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19405493|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19405494|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20439083|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
20439084|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439085|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20439086|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
20439087|NCT01349010|Protective Agents|protective agents|mesh-ancestor
20439088|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439089|NCT01349088|Niacinamide|niacinamide|mesh-list
20439090|NCT01349088|Capecitabine|capecitabine|mesh-list
20439091|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
20439092|NCT01349088|Imetelstat|imetelstat|mesh-list
20439093|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20439094|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
20439095|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439096|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439097|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20439098|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439099|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
20439100|NCT01349088|Vitamins|vitamins|mesh-ancestor
20439101|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
20439102|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439103|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
20439104|NCT01349127|Vitamin D|vitamin d|mesh-list
20439105|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
20439106|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
20439107|NCT01349127|Vitamins|vitamins|mesh-list
20439108|NCT01349127|Calcium|calcium|mesh-list
20218783|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439109|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
20439110|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439111|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20439112|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20439113|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
20439114|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
20439115|NCT01349205|Caffeine|caffeine|mesh-list
20439116|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20439117|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439118|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20439119|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439120|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439121|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20439122|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20439123|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
20439124|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439125|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
20439126|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439127|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20439128|NCT01349205|Protective Agents|protective agents|mesh-ancestor
20439129|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439130|NCT01349205|Analgesics|analgesics|mesh-ancestor
20218784|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405495|NCT03586934|Acetaminophen|acetaminophen|mesh-list
19405496|NCT03586934|Celecoxib|celecoxib|mesh-list
19405497|NCT03586934|Ketorolac|ketorolac|mesh-list
19855580|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20218785|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218786|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
20218787|NCT00314509|Hormones|hormones|mesh-ancestor
20218788|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218789|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20218790|NCT00314548|Epoprostenol|epoprostenol|mesh-list
20218791|NCT00314548|Alprostadil|alprostadil|mesh-list
20439131|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
20439132|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405498|NCT03586934|Meloxicam|meloxicam|mesh-list
19405499|NCT03586934|Morphine|morphine|mesh-list
20439133|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
20439134|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20439135|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
20439136|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439137|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439138|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20439139|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
20439140|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20439141|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20439142|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20439143|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439144|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439145|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439146|NCT01349270|Prednisone|prednisone|mesh-list
20439147|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
20439148|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20439149|NCT01349270|Antibodies|antibodies|mesh-list
20439150|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20439151|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
20439152|NCT01349270|Hormones|hormones|mesh-ancestor
20439153|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20439154|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439155|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20439156|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405500|NCT03586934|Oxycodone|oxycodone|mesh-list
19405501|NCT03586934|Tramadol|tramadol|mesh-list
19405502|NCT03586934|Hydrocodone|hydrocodone|mesh-list
19405503|NCT03586934|Ropivacaine|ropivacaine|mesh-list
19405504|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19405505|NCT03586934|Narcotics|narcotics|mesh-ancestor
19405506|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405507|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439157|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
20439158|NCT01349296|Everolimus|everolimus|mesh-list
20439159|NCT01349296|Nintedanib|nintedanib|mesh-list
20439160|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439161|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20439162|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
20439163|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439164|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20439165|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439166|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439167|NCT01349335|Tolvaptan|tolvaptan|mesh-list
20439168|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20439169|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439170|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
20439171|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439172|NCT01349348|Tolvaptan|tolvaptan|mesh-list
20439173|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20439174|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439175|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
20439176|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439177|NCT01349387|Metformin|metformin|mesh-list
20439178|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20439179|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439180|NCT01349413|Esomeprazole|esomeprazole|mesh-list
20439181|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20439182|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20439183|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20439184|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439185|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439186|NCT01349439|Propranolol|propranolol|mesh-list
20439187|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20439188|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20439189|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439190|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439191|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439192|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439193|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20439194|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20439195|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
20439196|NCT01349452|Ganciclovir|ganciclovir|mesh-list
20439197|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20439198|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
20439199|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
19405508|NCT03586934|Analgesics|analgesics|mesh-ancestor
19405509|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
19855581|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
20439200|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439201|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20439202|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439203|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439204|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20439205|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20439206|NCT01349556|Tretinoin|tretinoin|mesh-list
20439207|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439208|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
20439209|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
20524389|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20524390|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524391|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524392|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
20524393|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20524394|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20524395|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524396|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524397|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
20524398|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524399|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524400|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20524401|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524402|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
20524403|NCT01751425|Dasatinib|dasatinib|mesh-list
20524404|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
20524405|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524406|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20524407|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524408|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524409|NCT01751763|Sorafenib|sorafenib|mesh-list
20524410|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524411|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20524412|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524413|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524414|NCT01751828|Sertraline|sertraline|mesh-list
20524415|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
20524416|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524417|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20524418|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20524419|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524420|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524421|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524422|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
20524423|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524424|NCT01751854|Citalopram|citalopram|mesh-list
20524425|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20524426|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20524427|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524428|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524429|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524430|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
20524431|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524432|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20524433|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
20524434|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524435|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
20524436|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524437|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20524438|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524439|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218792|NCT00314548|Tezosentan|tezosentan|mesh-list
20218793|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20218794|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
20218795|NCT00314548|Urological Agents|urological agents|mesh-ancestor
20218796|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218797|NCT00314561|Pioglitazone|pioglitazone|mesh-list
20218798|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
20218799|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20218800|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218801|NCT00314613|Risperidone|risperidone|mesh-list
20218802|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
20218803|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19405510|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405511|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
19405512|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
19405513|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405514|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
20439210|NCT01349647|Vaccines|vaccines|mesh-list
20439211|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
20439212|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439213|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20439214|NCT01349699|Deferasirox|deferasirox|mesh-list
19405515|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405516|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405517|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405518|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19405519|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19405520|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405521|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405522|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
19405523|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
20439215|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20439216|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
20439217|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
20439218|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439219|NCT01349699|Hematinics|hematinics|mesh-ancestor
20439220|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20439221|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
20439222|NCT01349738|Levofloxacin|levofloxacin|mesh-list
20439223|NCT01349738|Ofloxacin|ofloxacin|mesh-list
20439224|NCT01349738|Gentamicins|gentamicins|mesh-list
20439225|NCT01349738|Cefazolin|cefazolin|mesh-list
20439226|NCT01349738|Tobramycin|tobramycin|mesh-list
20439227|NCT01349738|Ampicillin|ampicillin|mesh-list
20439228|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20439229|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
20439230|NCT01349738|Sulbactam|sulbactam|mesh-list
20439231|NCT01349738|Trimethoprim|trimethoprim|mesh-list
20439232|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
20439233|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439234|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20439235|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20439236|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439237|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439238|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439239|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20439240|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20439241|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20439242|NCT01349738|Renal Agents|renal agents|mesh-ancestor
20439243|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20439244|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
20439245|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20439246|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20439247|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20439248|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20439249|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20439250|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20439251|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
20439252|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
20439253|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
20439254|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439255|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439256|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
20439257|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439258|NCT01349764|Vitamin D|vitamin d|mesh-list
20439259|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
20439260|NCT01349764|Vitamins|vitamins|mesh-ancestor
20439261|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
20439262|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439263|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20439264|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20439265|NCT01349777|Clopidogrel|clopidogrel|mesh-list
20439266|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20439267|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19405524|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20439268|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20439269|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20439270|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
20439271|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439272|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439273|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439274|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
20439275|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20439276|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439277|NCT01350024|Lidocaine|lidocaine|mesh-list
20439278|NCT01350024|Epinephrine|epinephrine|mesh-list
20439279|NCT01350024|Racepinephrine|racepinephrine|mesh-list
20439280|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
20439281|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
20439282|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
20439283|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439284|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218804|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
20439285|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
20439286|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439287|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20439288|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20439289|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20439290|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439291|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439292|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20439293|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20439294|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439295|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439296|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20439297|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20439298|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
20439299|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20439300|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
20439301|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
20439302|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
20439303|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20439304|NCT01350037|Remifentanil|remifentanil|mesh-list
20439305|NCT01350037|Alfentanil|alfentanil|mesh-list
20439306|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20439307|NCT01350037|Narcotics|narcotics|mesh-ancestor
20439308|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439309|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439310|NCT01350037|Analgesics|analgesics|mesh-ancestor
20439311|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
20218805|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218806|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218807|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218808|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20218809|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218810|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218811|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20218812|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
20218813|NCT00314626|Lamivudine|lamivudine|mesh-list
20218814|NCT00314626|Efavirenz|efavirenz|mesh-list
20439312|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439313|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20439314|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
20439315|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
20439316|NCT01350050|Carticaine|carticaine|mesh-list
20439317|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
20439318|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
20439319|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439320|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439321|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
20439322|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439323|NCT01350063|Troclosene|troclosene|mesh-list
20439324|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
20439325|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439326|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
20439327|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
20439328|NCT01350089|Ethanol|ethanol|mesh-list
20439329|NCT01350089|Caffeine|caffeine|mesh-list
20439330|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20439331|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218815|NCT00314626|Abacavir|abacavir|mesh-list
20439332|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439333|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218816|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20439334|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20439335|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20439336|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439337|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439338|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20439339|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20439340|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
20439341|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439342|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
20439343|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
20439344|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20439345|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20439346|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439347|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439348|NCT01350154|Urological Agents|urological agents|mesh-ancestor
20439349|NCT01350323|Bevacizumab|bevacizumab|mesh-list
20439350|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20439351|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439352|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20439353|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20439354|NCT01350323|Growth Substances|growth substances|mesh-ancestor
20439355|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439356|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
20439357|NCT01350570|Loperamide|loperamide|mesh-list
20439358|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
20439359|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20439360|NCT01350596|Ibuprofen|ibuprofen|mesh-list
20439361|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20439362|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439363|NCT01350596|Analgesics|analgesics|mesh-ancestor
20439364|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
20439365|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439366|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439367|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20439368|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20439369|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20439370|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439371|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439372|NCT01350609|Candesartan|candesartan|mesh-list
20439373|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
20439374|NCT01350609|Nifedipine|nifedipine|mesh-list
20439375|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20439376|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20439377|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20439378|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439379|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20439380|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439381|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20439382|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439383|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
20439384|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
20439385|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20439386|NCT01350622|Diclofenac|diclofenac|mesh-list
20439387|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20439388|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20439389|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439390|NCT01350622|Analgesics|analgesics|mesh-ancestor
20439391|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
20439392|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439393|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439394|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20439395|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20439396|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20439397|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439398|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439399|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
20439400|NCT01350713|Povidone|povidone|mesh-list
20439401|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
20439402|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
20439403|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20439404|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439405|NCT01350817|Docetaxel|docetaxel|mesh-list
20439406|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20439407|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439408|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
20439409|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
20439410|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
20439411|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439412|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20439413|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439414|NCT01350856|Artesunate|artesunate|mesh-list
20439415|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
20439416|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20439417|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20439418|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439419|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439420|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
20439421|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
20439422|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20439423|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
20439424|NCT01350882|Rituximab|rituximab|mesh-list
20439425|NCT01350882|Citric Acid|citric acid|mesh-list
20439426|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
20439427|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20439428|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439429|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
20439430|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439431|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20439432|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
20439433|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20439434|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
20439435|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
20439436|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439437|NCT01350921|Ticagrelor|ticagrelor|mesh-list
20439438|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20439439|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20439440|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20439441|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20439442|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
20439443|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439444|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439445|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439446|NCT01351038|Capecitabine|capecitabine|mesh-list
20439447|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
20439448|NCT01351038|Panitumumab|panitumumab|mesh-list
20439449|NCT01351038|Epirubicin|epirubicin|mesh-list
20439450|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20439451|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
20439452|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613509|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613510|NCT02255370|Analgesics|analgesics|mesh-ancestor
19405525|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19405526|NCT03586869|Leucovorin|leucovorin|mesh-list
19405527|NCT03586869|Paclitaxel|paclitaxel|mesh-list
19405528|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
19405529|NCT03586869|Bevacizumab|bevacizumab|mesh-list
19405530|NCT03586869|Fluorouracil|fluorouracil|mesh-list
19405531|NCT03586869|Capecitabine|capecitabine|mesh-list
19405532|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
19405533|NCT03586869|Avelumab|avelumab|mesh-list
19405534|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19405535|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613511|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
20613512|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613513|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613514|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20613515|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405536|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
19405537|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
19405538|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
19405539|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405540|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19405541|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
20613516|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613517|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613518|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613519|NCT02255396|Estradiol|estradiol|mesh-list
19405542|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405543|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20439453|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439454|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20439455|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20439456|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20439457|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20439458|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439459|NCT01351168|Levodopa|levodopa|mesh-list
20439460|NCT01351168|Zolpidem|zolpidem|mesh-list
20439461|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20439462|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20439463|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
20439464|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439465|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439466|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439467|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20439468|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20439469|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439470|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20439471|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
20439472|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
20439473|NCT01351272|Methylphenidate|methylphenidate|mesh-list
20439474|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20439475|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439476|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20439477|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20439478|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439479|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439480|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
20439481|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439482|NCT01351285|Remifentanil|remifentanil|mesh-list
20439483|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20439484|NCT01351285|Narcotics|narcotics|mesh-ancestor
20439485|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439486|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439487|NCT01351285|Analgesics|analgesics|mesh-ancestor
20439488|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
20439489|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439490|NCT01351298|Lidocaine|lidocaine|mesh-list
20439491|NCT01351298|Xylometazoline|xylometazoline|mesh-list
20439492|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
20439493|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
20439494|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439495|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439496|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
20439497|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439498|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20439499|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20439500|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20439501|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439502|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439503|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
20439504|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20439505|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
20439506|NCT01351428|Nifedipine|nifedipine|mesh-list
20439507|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20439508|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439509|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439510|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20439511|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439512|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
20439513|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
20439514|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20439515|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
20439516|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20439517|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
20439518|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439519|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439520|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20439521|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
20439522|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20439523|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
20439524|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439525|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439526|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20439527|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
20439528|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
20439529|NCT01351493|Protective Agents|protective agents|mesh-ancestor
20439530|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20439531|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20439532|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
20524440|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
20524441|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530407|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530408|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20530409|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530410|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530411|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
20530412|NCT01788462|Tesamorelin|tesamorelin|mesh-list
20530413|NCT01788462|Growth Substances|growth substances|mesh-ancestor
20530414|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530415|NCT01788501|Cyclosporine|cyclosporine|mesh-list
20530416|NCT01788501|Methotrexate|methotrexate|mesh-list
19405544|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19405545|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
19405546|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19405547|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405548|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19405549|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19405550|NCT03586869|Growth Substances|growth substances|mesh-ancestor
19405551|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
20530417|NCT01788501|Tacrolimus|tacrolimus|mesh-list
20530418|NCT01788501|Cyclosporins|cyclosporins|mesh-list
20530419|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20530420|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
19848418|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19693436|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530421|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20530422|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530423|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20530424|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
20530425|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530426|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530427|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
19405552|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
19405553|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405554|NCT03586869|Antidotes|antidotes|mesh-ancestor
19405555|NCT03586869|Protective Agents|protective agents|mesh-ancestor
19405556|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
19405557|NCT03586869|Vitamins|vitamins|mesh-ancestor
19405558|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
19693437|NCT04979923|Lidocaine|lidocaine|mesh-list
19693438|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
19693439|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
20530428|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530429|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20530430|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20530431|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
20530432|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530433|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20530434|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20530435|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
20530436|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530437|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20530438|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20530439|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20530440|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20530882|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530883|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20530884|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20530885|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530886|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693440|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693441|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693442|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
19693443|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693444|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19848419|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405559|NCT03586817|Palonosetron|palonosetron|mesh-list
19405560|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
19405561|NCT03586817|Aprepitant|aprepitant|mesh-list
19693445|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20439533|NCT01351597|Docetaxel|docetaxel|mesh-list
20439534|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
20439535|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439536|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
20439537|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
20439538|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
20439539|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439540|NCT01351636|Arotinolol|arotinolol|mesh-list
20439541|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20439542|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20439543|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439544|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439545|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439546|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439547|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20439548|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20439549|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20439550|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
20439551|NCT01351818|Hormones|hormones|mesh-list
20439552|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20439553|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439554|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20439555|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20439556|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
20439557|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439558|NCT01351948|Antacids|antacids|mesh-ancestor
20439559|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439560|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20439561|NCT01352026|Metformin|metformin|mesh-list
20439562|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20439563|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439564|NCT01352039|Heparin|heparin|mesh-list
20439565|NCT01352039|Calcium heparin|calcium heparin|mesh-list
20439566|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
20439567|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20439568|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20439569|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439570|NCT01352065|Bosentan|bosentan|mesh-list
20439571|NCT01352065|Ambrisentan|ambrisentan|mesh-list
20439572|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20439573|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20439574|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439575|NCT01352091|Goserelin|goserelin|mesh-list
20439576|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20439577|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439578|NCT01352130|Ondansetron|ondansetron|mesh-list
20439579|NCT01352130|Granisetron|granisetron|mesh-list
20439580|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
20439581|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
20439582|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
20439583|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439584|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439585|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20439586|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
20439587|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
20439588|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20439589|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
20439590|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439591|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439592|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20439593|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20439594|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439595|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20439596|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20439597|NCT01352143|Thrombin|thrombin|mesh-list
20439598|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
20439599|NCT01352143|Coagulants|coagulants|mesh-ancestor
20439600|NCT01352234|Aspirin|aspirin|mesh-list
20439601|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20439602|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439603|NCT01352234|Analgesics|analgesics|mesh-ancestor
20439604|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
20439605|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693446|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20439606|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439607|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20439608|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20439609|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20439610|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20439611|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439612|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20439613|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20439614|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439615|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
20439616|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
20439617|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
20439618|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
20439619|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20439620|NCT01352312|Ofatumumab|ofatumumab|mesh-list
20439621|NCT01352312|Pentostatin|pentostatin|mesh-list
20439622|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20439623|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
20439624|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439625|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439626|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20439627|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439628|NCT01352338|Prednisone|prednisone|mesh-list
20439629|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
20439630|NCT01352338|Lenalidomide|lenalidomide|mesh-list
20439631|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20439632|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
20439633|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439634|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20439635|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20439636|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
20439637|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439638|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439639|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20439640|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20439641|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
20439642|NCT01352338|Hormones|hormones|mesh-ancestor
20439643|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20439644|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20439645|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20439646|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20439647|NCT01352338|Growth Substances|growth substances|mesh-ancestor
20439648|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
20439649|NCT01352494|Gemcitabine|gemcitabine|mesh-list
20439650|NCT01352494|Docetaxel|docetaxel|mesh-list
20439651|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20439652|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
20439653|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439654|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439655|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
20439656|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439657|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439658|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20439659|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
20439660|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439661|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
20439662|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
20439663|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
20439664|NCT01352559|Milnacipran|milnacipran|mesh-list
20439665|NCT01352559|Mirtazapine|mirtazapine|mesh-list
20439666|NCT01352559|Sertraline|sertraline|mesh-list
20439667|NCT01352559|Fluoxetine|fluoxetine|mesh-list
20439668|NCT01352559|Paroxetine|paroxetine|mesh-list
20439669|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20439670|NCT01352559|Nortriptyline|nortriptyline|mesh-list
20439671|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
20439672|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20439673|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20439674|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20439675|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439676|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439677|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439678|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
20439679|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439680|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20439681|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20439682|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20439683|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439684|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20439685|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20439686|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
20439687|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
20439688|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20439689|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20439690|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439691|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20439692|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20439693|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20439694|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439695|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20439696|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20439697|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20439698|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439699|NCT01352559|Analgesics|analgesics|mesh-ancestor
20439700|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
20439701|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439702|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20439703|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20439704|NCT01352572|Milnacipran|milnacipran|mesh-list
20439705|NCT01352572|Mirtazapine|mirtazapine|mesh-list
20439706|NCT01352572|Sertraline|sertraline|mesh-list
20439707|NCT01352572|Fluoxetine|fluoxetine|mesh-list
20439708|NCT01352572|Paroxetine|paroxetine|mesh-list
20439709|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19405562|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
19405563|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
19405564|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405565|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405566|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405567|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19405568|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20439710|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
20439711|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
20218817|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20218818|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218819|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218820|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
20218821|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218822|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20218823|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20218824|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20218825|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20218826|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20439712|NCT01352572|Nortriptyline|nortriptyline|mesh-list
20439713|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20439714|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20439715|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20439716|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20439717|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439718|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439719|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
20439720|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439721|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20439722|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20439723|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20439724|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439725|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20439726|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20439727|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
20439728|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
20439729|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20439730|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20439731|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439732|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20439733|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20439734|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20439735|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
19405569|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
20439736|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20439737|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20439738|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20439739|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439740|NCT01352572|Analgesics|analgesics|mesh-ancestor
20439741|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
20439742|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439743|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20439744|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20439745|NCT01352611|Baclofen|baclofen|mesh-list
20439746|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20439747|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439748|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20439749|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439750|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20439751|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
20439752|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
20439753|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439754|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439755|NCT01352650|Plerixafor|plerixafor|mesh-list
20439756|NCT01352650|Decitabine|decitabine|mesh-list
20439757|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20439758|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
20439759|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439760|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439761|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439762|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20439763|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20439764|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
20439765|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439766|NCT01352663|Insulin|insulin|mesh-list
20439767|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
20439768|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20439769|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439770|NCT01352702|Dabigatran|dabigatran|mesh-list
20439771|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
20439772|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
20439773|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20439774|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
20439775|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439776|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439777|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
20439778|NCT01352728|Axitinib|axitinib|mesh-list
20439779|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439780|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20439781|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439782|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439783|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20439784|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
20439785|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20439786|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
20439787|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439788|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
20439789|NCT01353170|Calcium|calcium|mesh-list
20439790|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20439791|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439792|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20439793|NCT01353209|Letrozole|letrozole|mesh-list
20439794|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439795|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20439796|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20439797|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439798|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439799|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20439800|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
20439801|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20439802|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439803|NCT01353235|Prednisolone|prednisolone|mesh-list
20613520|NCT02255396|Estrogens|estrogens|mesh-ancestor
20439804|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20439805|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
20439806|NCT01353235|Hormones|hormones|mesh-ancestor
20439807|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20439808|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439809|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20439810|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439811|NCT01353339|Levofloxacin|levofloxacin|mesh-list
20439812|NCT01353339|Ofloxacin|ofloxacin|mesh-list
20439813|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20439814|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439815|NCT01353339|Renal Agents|renal agents|mesh-ancestor
20439816|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20439817|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20439818|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20439819|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405570|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405571|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405572|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19405573|NCT03586791|Anesthetics|anesthetics|mesh-list
20218827|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20218828|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20218829|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20218830|NCT00314639|Modafinil|modafinil|mesh-list
20218831|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20218832|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439820|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439821|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439822|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20439823|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20439824|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
20439825|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20439826|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439827|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439828|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439829|NCT01353378|Analgesics|analgesics|mesh-ancestor
20439830|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
20218833|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20218834|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20218835|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20218836|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218837|NCT00314652|Buprenorphine|buprenorphine|mesh-list
20218838|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20218839|NCT00314652|Narcotics|narcotics|mesh-ancestor
20218840|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218841|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218842|NCT00314652|Analgesics|analgesics|mesh-ancestor
20218843|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
20218844|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439831|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439832|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20439833|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20439834|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20439835|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439836|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439837|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524442|NCT01752075|Lenalidomide|lenalidomide|mesh-list
20524443|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
20524444|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524445|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20524446|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20524447|NCT01752075|Growth Substances|growth substances|mesh-ancestor
20524448|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
20524449|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524450|NCT01752153|Silymarin|silymarin|mesh-list
20524451|NCT01752153|Deferoxamine|deferoxamine|mesh-list
20524452|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
20524453|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524454|NCT01752153|Protective Agents|protective agents|mesh-ancestor
20524455|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524456|NCT01752153|Siderophores|siderophores|mesh-ancestor
20524457|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20524458|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
20524459|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
20524460|NCT01752205|Paclitaxel|paclitaxel|mesh-list
20524461|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20524462|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20524463|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439838|NCT01353391|Metformin|metformin|mesh-list
20439839|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20439840|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439841|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
20439842|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19405574|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405575|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405576|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19405577|NCT03586674|Fenofibrate|fenofibrate|mesh-list
19405578|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19405579|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
19405580|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405581|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19405582|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19405583|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405584|NCT03586661|Niraparib|niraparib|mesh-list
20439843|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20439844|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439845|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20439846|NCT01353456|Analgesics|analgesics|mesh-ancestor
20439847|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
20439848|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439849|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20439850|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20439851|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20439852|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
20439853|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20439854|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439855|NCT01353469|Insulin|insulin|mesh-list
20439856|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20439857|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20439858|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439859|NCT01353482|Pemetrexed|pemetrexed|mesh-list
20439860|NCT01353482|Vorinostat|vorinostat|mesh-list
20439861|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439862|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439863|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439864|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20439865|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20439866|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20439867|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
20439868|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20439869|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
20439870|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20439871|NCT01353716|Dolutegravir|dolutegravir|mesh-list
20439872|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20439873|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20439874|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439875|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439876|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20439877|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20439878|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
20439879|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439880|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
20439881|NCT01353729|Zanamivir|zanamivir|mesh-list
20439882|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20439883|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20439884|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439885|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20439886|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20439887|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439888|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439889|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439890|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20439891|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
20439892|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20439893|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405585|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19405586|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439894|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20439895|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20439896|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20439897|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
20439898|NCT01353742|Lamivudine|lamivudine|mesh-list
20439899|NCT01353742|Adefovir|adefovir|mesh-list
20439900|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20439901|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20439902|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20439903|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439904|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439905|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
20439906|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405587|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405588|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416500|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416501|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
19416502|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
19416503|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416504|NCT02406209|Prednisolone|prednisolone|mesh-list
19416505|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19416506|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
19416507|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19416508|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
19416509|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19416510|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
19693447|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613521|NCT02255396|Hormones|hormones|mesh-ancestor
20613522|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613523|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613524|NCT02255578|Clomiphene|clomiphene|mesh-list
20613525|NCT02255578|Enclomiphene|enclomiphene|mesh-list
20613526|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
20613527|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20613528|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
20613529|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20613530|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613531|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20613532|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
20613533|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20613534|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20613535|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20613536|NCT02255591|Lidocaine|lidocaine|mesh-list
20613537|NCT02255591|Epinephrine|epinephrine|mesh-list
20613538|NCT02255591|Racepinephrine|racepinephrine|mesh-list
20613539|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
20613540|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
20613541|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
20613542|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613543|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613544|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
20613545|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613546|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20613547|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20613548|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20613549|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613550|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613551|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20613552|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20613553|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613554|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613555|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20613556|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20613557|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
20613558|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20613559|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
20613560|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
20613561|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
20613562|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20439907|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20439908|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20439909|NCT01353794|Sorafenib|sorafenib|mesh-list
20439910|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439911|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20439912|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439913|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439914|NCT01353833|Aldesleukin|aldesleukin|mesh-list
20439915|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439916|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613563|NCT02255682|Simvastatin|simvastatin|mesh-list
20439917|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20439918|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
20439919|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439920|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20439921|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20439922|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20439923|NCT01353846|Estradiol|estradiol|mesh-list
20439924|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20439925|NCT01353846|Progesterone|progesterone|mesh-list
20439926|NCT01353846|Estrogens|estrogens|mesh-ancestor
20439927|NCT01353846|Hormones|hormones|mesh-ancestor
20439928|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20439929|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439930|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20439931|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
20439932|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20439933|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20439934|NCT01353846|Progestins|progestins|mesh-ancestor
20439935|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
20439936|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20439937|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439938|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
20439939|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20439940|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
20439941|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439942|NCT01353937|Plerixafor|plerixafor|mesh-list
20439943|NCT01353937|Becaplermin|becaplermin|mesh-list
20439944|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20439945|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20439946|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
20439947|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439948|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
20439949|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20439950|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20439951|NCT01353937|Growth Substances|growth substances|mesh-ancestor
20439952|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439953|NCT01354158|Droxidopa|droxidopa|mesh-list
20439954|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20439955|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20439956|NCT01354262|Vitamin D|vitamin d|mesh-list
20439957|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
20439958|NCT01354262|Vitamins|vitamins|mesh-list
20439959|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
20439960|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439961|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20439962|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20439963|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20439964|NCT01354275|Hormones|hormones|mesh-ancestor
20439965|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20439966|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439967|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
20439968|NCT01354301|Everolimus|everolimus|mesh-list
20439969|NCT01354301|Tacrolimus|tacrolimus|mesh-list
20439970|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
20439971|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20439972|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
20439973|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439974|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20439975|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20439976|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20439977|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439978|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20439979|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20439980|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
20439981|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20439982|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20439983|NCT01354405|Lanreotide|lanreotide|mesh-list
20439984|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20439985|NCT01354418|Phenylephrine|phenylephrine|mesh-list
20439986|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
20439987|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20439988|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
20439989|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
20439990|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20439991|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20439992|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
20439993|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20439994|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
20439995|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
20439996|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20439997|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20439998|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20439999|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
20440000|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440001|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440002|NCT01354418|Protective Agents|protective agents|mesh-ancestor
20440003|NCT01354457|Epratuzumab|epratuzumab|mesh-list
20440004|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20440005|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440006|NCT01354470|Modafinil|modafinil|mesh-list
20440007|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20440008|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440009|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20440010|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20440011|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20440012|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440013|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
20440014|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20440015|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20440016|NCT01354483|Prednisolone|prednisolone|mesh-list
20440017|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
20440018|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
20440019|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20440020|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
20440021|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440022|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
20440023|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
20440024|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440025|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440026|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440027|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
20440028|NCT01354483|Hormones|hormones|mesh-ancestor
20440029|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20218845|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20218846|NCT00314665|Thalidomide|thalidomide|mesh-list
20218847|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218848|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
20218849|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218850|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
20218851|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20440030|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20440031|NCT01354483|Protective Agents|protective agents|mesh-ancestor
20440032|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20440033|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440034|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
20440035|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218852|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218853|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20440036|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440037|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440038|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
20440039|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440040|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440041|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
20440042|NCT01354522|Docetaxel|docetaxel|mesh-list
20440043|NCT01354522|Doxorubicin|doxorubicin|mesh-list
20440044|NCT01354522|Capecitabine|capecitabine|mesh-list
20440045|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20440046|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
20440047|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440048|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440049|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20440050|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
20440051|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440052|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218854|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20218855|NCT00314665|Growth Substances|growth substances|mesh-ancestor
20440053|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20440054|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
20440055|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
20440056|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
20440057|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20440058|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20440059|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20440060|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440061|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20440062|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
20440063|NCT01354613|Amlodipine|amlodipine|mesh-list
20440064|NCT01354613|Dobutamine|dobutamine|mesh-list
20440065|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20440066|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20440067|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440068|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440069|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440070|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440071|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440072|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20440073|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
20440074|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
20440075|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440076|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20440077|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20440078|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20440079|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
20440080|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440081|NCT01354613|Protective Agents|protective agents|mesh-ancestor
20440082|NCT01354665|Interferons|interferons|mesh-list
20440083|NCT01354665|Interferon-beta|interferon-beta|mesh-list
20440084|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
20440085|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440086|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
20440087|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440088|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
20440089|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440090|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20440091|NCT01354704|Enoxaparin|enoxaparin|mesh-list
20440092|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
20440093|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20440094|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20440095|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440096|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20440097|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20440098|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440099|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440100|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
20440101|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440102|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440103|NCT01354860|Lobeline|lobeline|mesh-list
20440104|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20440105|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
20440106|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440107|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440108|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20440109|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20440110|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
20440111|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440112|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440113|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
20440114|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20440115|NCT01354886|Hormones|hormones|mesh-ancestor
20440116|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440117|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440118|NCT01354925|Insulin|insulin|mesh-list
20440119|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20440120|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440121|NCT01355120|Ipilimumab|ipilimumab|mesh-list
20440122|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20440123|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440124|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20440125|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524464|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
20524465|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
20524466|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
20524467|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440126|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
20440127|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20440128|NCT01355198|Glycine|glycine|mesh-list
20440129|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
20440130|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440131|NCT01355198|Expectorants|expectorants|mesh-ancestor
20440132|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
20440133|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20440134|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
20440135|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440136|NCT01355198|Protective Agents|protective agents|mesh-ancestor
20440137|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440138|NCT01355198|Antidotes|antidotes|mesh-ancestor
20440139|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
20440140|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440141|NCT01355263|Vitamin A|vitamin a|mesh-list
20440142|NCT01355263|Vitamins|vitamins|mesh-ancestor
20440143|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
20440144|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440145|NCT01355276|Domperidone|domperidone|mesh-list
20440146|NCT01355276|Cinitapride|cinitapride|mesh-list
20440147|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
20440148|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
20440149|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440150|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440151|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440152|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20440153|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
20440154|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440155|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440156|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20440157|NCT01355354|Digoxin|digoxin|mesh-list
20440158|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20440159|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20440160|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440161|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440162|NCT01355354|Protective Agents|protective agents|mesh-ancestor
20440163|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440164|NCT01355367|Nifedipine|nifedipine|mesh-list
20440165|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20440166|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440167|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440168|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440169|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440170|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440171|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
20440172|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20440173|NCT01355380|Iloprost|iloprost|mesh-list
20440174|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20440175|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440176|NCT01355445|Irinotecan|irinotecan|mesh-list
20440177|NCT01355445|Vincristine|vincristine|mesh-list
20440178|NCT01355445|Temozolomide|temozolomide|mesh-list
20440179|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20440180|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20440181|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440182|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440183|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440184|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20440185|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
20440186|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
19405589|NCT03586466|Buprenorphine|buprenorphine|mesh-list
20218856|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
20218857|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218858|NCT00314678|Paclitaxel|paclitaxel|mesh-list
20218859|NCT00314678|Topotecan|topotecan|mesh-list
20218860|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20218861|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218862|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218863|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218864|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218865|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218866|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20218867|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20218868|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218869|NCT00314704|Dopamine|dopamine|mesh-list
20218870|NCT00314704|Norepinephrine|norepinephrine|mesh-list
20440187|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
20440188|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20440189|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
20440190|NCT01355562|Interleukin-2|interleukin-2|mesh-list
20440191|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440192|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440193|NCT01355562|Analgesics|analgesics|mesh-ancestor
19405590|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19405591|NCT03586466|Naloxone|naloxone|mesh-list
19405592|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19405593|NCT03586466|Narcotics|narcotics|mesh-ancestor
19405594|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405595|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405596|NCT03586466|Analgesics|analgesics|mesh-ancestor
20440194|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
20440195|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440196|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440197|NCT01355614|Infliximab|infliximab|mesh-list
20440198|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
20440199|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405597|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
20218871|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20218872|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20440200|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440201|NCT01355718|Repaglinide|repaglinide|mesh-list
20440202|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20440203|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440204|NCT01355757|Anesthetics|anesthetics|mesh-list
20440205|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
20440206|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440207|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440208|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
20440209|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440210|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
20440211|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
20440212|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
20440213|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20440214|NCT01355939|Protective Agents|protective agents|mesh-ancestor
20440215|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440216|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
20440217|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
20440218|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440219|NCT01355952|Protective Agents|protective agents|mesh-ancestor
20440220|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440221|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
20440222|NCT01355952|Vitamins|vitamins|mesh-ancestor
20440223|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
20440224|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
20440225|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20440226|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20218873|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
20218874|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218875|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218876|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218877|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
20218878|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
20440227|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
20440228|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440229|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440230|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20440231|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
20440232|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
20440233|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20218879|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218880|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20218881|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20440234|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
20440235|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440236|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218882|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
20440237|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20440238|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19405598|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440239|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20440240|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
20440241|NCT01356017|Amlodipine|amlodipine|mesh-list
20440242|NCT01356017|Telmisartan|telmisartan|mesh-list
20440243|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20440244|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20440245|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440246|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440247|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440248|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440249|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440250|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20440251|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20440252|NCT01356043|Niacin|niacin|mesh-list
20440253|NCT01356043|Amlodipine|amlodipine|mesh-list
20440254|NCT01356043|Telmisartan|telmisartan|mesh-list
20440255|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20440256|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20440257|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440258|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440259|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440260|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440261|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440262|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20440263|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20440264|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20440265|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
20440266|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20440267|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
20440268|NCT01356043|Vitamins|vitamins|mesh-ancestor
20440269|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
20440270|NCT01356121|Midazolam|midazolam|mesh-list
20440271|NCT01356121|Propofol|propofol|mesh-list
19405599|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19405600|NCT03586453|Osimertinib|osimertinib|mesh-list
19405601|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405602|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20440272|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20440273|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440274|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440275|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20440276|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
20440277|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
20440278|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20440279|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20440280|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440281|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20440282|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
20440283|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
20440284|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440285|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440286|NCT01356212|Ketorolac|ketorolac|mesh-list
20440287|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20440288|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20440289|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440290|NCT01356212|Analgesics|analgesics|mesh-ancestor
20440291|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
20440292|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440293|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440294|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440295|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440296|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20440297|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440298|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440299|NCT01356225|Ketorolac|ketorolac|mesh-list
20440300|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20440301|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20440302|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440303|NCT01356225|Analgesics|analgesics|mesh-ancestor
20440304|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
20440305|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440306|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440307|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440308|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405603|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440309|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19405604|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440310|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440311|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440312|NCT01356303|Docetaxel|docetaxel|mesh-list
20440313|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440314|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
20440315|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
20440316|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
20440317|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440318|NCT01356329|Heparin|heparin|mesh-list
20440319|NCT01356329|Enoxaparin|enoxaparin|mesh-list
20440320|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
20440321|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20440322|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20440323|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440324|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20440325|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20440326|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20440327|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
20440328|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440329|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440330|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440331|NCT01356355|Urological Agents|urological agents|mesh-ancestor
20440332|NCT01356368|Docetaxel|docetaxel|mesh-list
20440333|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440334|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20440335|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20440336|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20440337|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440338|NCT01356381|Vildagliptin|vildagliptin|mesh-list
20440339|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20440340|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440341|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20440342|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
20440343|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440344|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440345|NCT01356433|Vitamins|vitamins|mesh-list
20440346|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
20440347|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
20440348|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440349|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
20440350|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440351|NCT01356433|Protective Agents|protective agents|mesh-ancestor
20440352|NCT01356472|Imipenem|imipenem|mesh-list
20440353|NCT01356472|Cilastatin|cilastatin|mesh-list
20440354|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20440355|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440356|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
20440357|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440358|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440359|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20440360|NCT01356511|Dexamethasone|dexamethasone|mesh-list
20440361|NCT01356511|Prednisone|prednisone|mesh-list
20440362|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440363|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
20440364|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
20440365|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440366|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440367|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440368|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
20440369|NCT01356511|Hormones|hormones|mesh-ancestor
20218883|NCT00314704|Protective Agents|protective agents|mesh-ancestor
20218884|NCT00314743|Dexamethasone|dexamethasone|mesh-list
20218885|NCT00314743|Ondansetron|ondansetron|mesh-list
20218886|NCT00314743|Aprepitant|aprepitant|mesh-list
20218887|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20218888|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
20218889|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
20218890|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20218891|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218892|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440370|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440371|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218893|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
20218894|NCT00314743|Hormones|hormones|mesh-ancestor
20218895|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440372|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440373|NCT01356524|Progesterone|progesterone|mesh-list
20440374|NCT01356524|Progestins|progestins|mesh-ancestor
20440375|NCT01356524|Hormones|hormones|mesh-ancestor
20440376|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440377|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440378|NCT01356615|Heparin|heparin|mesh-list
20440379|NCT01356615|Calcium heparin|calcium heparin|mesh-list
20440380|NCT01356615|Enoxaparin|enoxaparin|mesh-list
20440381|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20440382|NCT01356615|Tinzaparin|tinzaparin|mesh-list
20440383|NCT01356615|Dalteparin|dalteparin|mesh-list
20440384|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
20440385|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
20440386|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20613564|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19405605|NCT03586414|Ubiquinone|ubiquinone|mesh-list
19405606|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
19405607|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405608|NCT03586323|Lidocaine|lidocaine|mesh-list
19405609|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
19405610|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
19405611|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405612|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613565|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20613566|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
20613567|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613568|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20613569|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19405613|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
19405614|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405615|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19405616|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19405617|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20613570|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613571|NCT02255734|Acyclovir|acyclovir|mesh-list
20613572|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
20613573|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613574|NCT02255747|Lactulose|lactulose|mesh-list
20613575|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20613576|NCT02255812|Quinine|quinine|mesh-list
20613577|NCT02255812|Citric Acid|citric acid|mesh-list
20613578|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
20613579|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
19405618|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19405619|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405620|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
19405621|NCT03586219|Narcotics|narcotics|mesh-ancestor
19405622|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405623|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405624|NCT03586219|Analgesics|analgesics|mesh-ancestor
19405625|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
19405626|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405627|NCT03586154|Ketamine|ketamine|mesh-list
19405628|NCT03586154|Bupivacaine|bupivacaine|mesh-list
19405629|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
19405630|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
19405631|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405632|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405633|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
19405634|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405635|NCT03586154|Analgesics|analgesics|mesh-ancestor
19405636|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19405637|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19405638|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
19405639|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20218896|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20218897|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218898|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
20218899|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
20218900|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20218901|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
20218902|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218903|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218904|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20218905|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440387|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20440388|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440389|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20440390|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440391|NCT01356680|Prednisone|prednisone|mesh-list
20440392|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
20440393|NCT01356680|Dacarbazine|dacarbazine|mesh-list
20440394|NCT01356680|Etoposide|etoposide|mesh-list
20440395|NCT01356680|Vincristine|vincristine|mesh-list
20440396|NCT01356680|Doxorubicin|doxorubicin|mesh-list
20440397|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20440398|NCT01356680|Bleomycin|bleomycin|mesh-list
20440399|NCT01356680|Vinblastine|vinblastine|mesh-list
20440400|NCT01356680|Procarbazine|procarbazine|mesh-list
20440401|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20440402|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
20440403|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440404|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440405|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20440406|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
20440407|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405640|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19405641|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405642|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405643|NCT03586089|Diazepam|diazepam|mesh-list
20440408|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440409|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20440410|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440411|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
20440412|NCT01356680|Hormones|hormones|mesh-ancestor
20440413|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440414|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20440415|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20440416|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20440417|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20440418|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440419|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
20440420|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
20440421|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
20440422|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20440423|NCT01356732|Sufentanil|sufentanil|mesh-list
20440424|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20440425|NCT01356732|Narcotics|narcotics|mesh-ancestor
20440426|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440427|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440428|NCT01356732|Analgesics|analgesics|mesh-ancestor
20440429|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
20440430|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440431|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20440432|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20440433|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
20440434|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
20440435|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
20440436|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20440437|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
19405644|NCT03586089|Phenobarbital|phenobarbital|mesh-list
19405645|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19405646|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
19405647|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
19405648|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
19405649|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405650|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218906|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218907|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20218908|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20218909|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20440438|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
20440439|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20218910|NCT00314756|Imiquimod|imiquimod|mesh-list
20218911|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20218912|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
20218913|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218914|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218915|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
20218916|NCT00314782|Docetaxel|docetaxel|mesh-list
20218917|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440440|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440441|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440442|NCT01356745|Analgesics|analgesics|mesh-ancestor
20440443|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
20440444|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440445|NCT01356758|Adalimumab|adalimumab|mesh-list
20218918|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
19405651|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405652|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19405653|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405654|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19405655|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19405656|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19405657|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19405658|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19405659|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19405660|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
19405661|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
19405662|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
19405663|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
19405664|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440446|NCT01356758|Etanercept|etanercept|mesh-list
20440447|NCT01356758|Infliximab|infliximab|mesh-list
20440448|NCT01356758|Ustekinumab|ustekinumab|mesh-list
20440449|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440450|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440451|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
20440452|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440453|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405665|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440454|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440455|NCT01356758|Analgesics|analgesics|mesh-ancestor
20440456|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
20440457|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440458|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440459|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20440460|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
20440461|NCT01356797|Fentanyl|fentanyl|mesh-list
20440462|NCT01356797|Bupivacaine|bupivacaine|mesh-list
20440463|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
20440464|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
20440465|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
20440466|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440467|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440468|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
20440469|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440470|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20440471|NCT01356797|Narcotics|narcotics|mesh-ancestor
20440472|NCT01356797|Analgesics|analgesics|mesh-ancestor
20440473|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20440474|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20440475|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
19405666|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19405667|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20218919|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218920|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218921|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218922|NCT00314821|Ropinirole|ropinirole|mesh-list
20218923|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20218924|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20218925|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
20218926|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
20218927|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218928|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218929|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218930|NCT00314860|Ropinirole|ropinirole|mesh-list
20218931|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20218932|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20218933|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
20218934|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
20218935|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218936|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218937|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218938|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
20218939|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218940|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20218941|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440476|NCT01356862|Pasireotide|pasireotide|mesh-list
20440477|NCT01356862|Hormones|hormones|mesh-ancestor
20440478|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440479|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524468|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20524469|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524470|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
20524471|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20524472|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20524473|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524474|NCT01752244|Vitamins|vitamins|mesh-ancestor
20524475|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
20524476|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
20524477|NCT01752270|Cyproterone|cyproterone|mesh-list
20524478|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
20524479|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
20524480|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
20524481|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524482|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524483|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524484|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20524485|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
20524486|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20524487|NCT01752322|Lidocaine|lidocaine|mesh-list
20524488|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
20524489|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
20524490|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524491|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524492|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
20524493|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524494|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20524495|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20524496|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20524497|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524498|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524499|NCT01752517|Vinorelbine|vinorelbine|mesh-list
20524500|NCT01752517|Ifosfamide|ifosfamide|mesh-list
20524501|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20524502|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524503|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
20524504|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
20524505|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
20524506|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524507|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20524508|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
20524509|NCT01752543|Conivaptan|conivaptan|mesh-list
20524510|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20524511|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524512|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
20218942|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218943|NCT00314912|Tramiprosate|tramiprosate|mesh-list
20218944|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
20218945|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
20218946|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
20218947|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20218948|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218949|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218950|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
20218951|NCT00314977|Docetaxel|docetaxel|mesh-list
20218952|NCT00314977|Doxorubicin|doxorubicin|mesh-list
20218953|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20218954|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20218955|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
20218956|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218957|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20218958|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20524513|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524514|NCT01752686|Carboplatin|carboplatin|mesh-list
20524515|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524516|NCT01752699|Methadone|methadone|mesh-list
20524517|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20524518|NCT01752699|Narcotics|narcotics|mesh-ancestor
20524519|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524520|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524521|NCT01752699|Analgesics|analgesics|mesh-ancestor
20524522|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
20530441|NCT01788605|Ramosetron|ramosetron|mesh-list
20440480|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20440481|NCT01356927|Etonogestrel|etonogestrel|mesh-list
20440482|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19693448|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693449|NCT04979468|Lamivudine|lamivudine|mesh-list
19693450|NCT04979468|Dolutegravir|dolutegravir|mesh-list
19693451|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19693452|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19693453|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440483|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
20440484|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20440485|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440486|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20440487|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20440488|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20440489|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440490|NCT01356992|Enoxaparin|enoxaparin|mesh-list
20440491|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
20440492|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20440493|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20440494|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440495|NCT01357031|Amitriptyline|amitriptyline|mesh-list
20440496|NCT01357031|Melatonin|melatonin|mesh-list
20440497|NCT01357031|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20440498|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
19405668|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19405669|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20440499|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440500|NCT01357031|Protective Agents|protective agents|mesh-ancestor
20440501|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440502|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440503|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20440504|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
20440505|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20440506|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440507|NCT01357031|Analgesics|analgesics|mesh-ancestor
19405670|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19405671|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
19405672|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405673|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405674|NCT03585998|Cisplatin|cisplatin|mesh-list
19405675|NCT03585998|Etoposide|etoposide|mesh-list
19405676|NCT03585998|Durvalumab|durvalumab|mesh-list
19405677|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405678|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20440508|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
19405679|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19405680|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19405681|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405682|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405683|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405684|NCT03585894|Ketorolac|ketorolac|mesh-list
19405685|NCT03585894|Sumatriptan|sumatriptan|mesh-list
19405686|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405687|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405688|NCT03585894|Analgesics|analgesics|mesh-ancestor
19405689|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
19405690|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405691|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405692|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20218959|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
20218960|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218961|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20218962|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20218963|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
20218964|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
20218965|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
20218966|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20218967|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20218968|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20218969|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218970|NCT00314990|Folic Acid|folic acid|mesh-list
20218971|NCT00314990|Pyridoxine|pyridoxine|mesh-list
20218972|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
19405693|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405694|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19405695|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405696|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405697|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19405698|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19405699|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20440509|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440510|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20440511|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20440512|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440513|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
20440514|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440515|NCT01357031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20440516|NCT01357031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440517|NCT01357109|Bosentan|bosentan|mesh-list
20440518|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20440519|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20440520|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405700|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
20440521|NCT01357252|Vildagliptin|vildagliptin|mesh-list
20440522|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19693454|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440523|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440524|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20440525|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
20440526|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440527|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440528|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
20440529|NCT01357317|Calcium|calcium|mesh-list
19693455|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
19693456|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693457|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19693458|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19693459|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20440530|NCT01357317|Calcium acetate|calcium acetate|mesh-list
20440531|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440532|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440533|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20440534|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
20440535|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
20440536|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440537|NCT01357486|Sorafenib|sorafenib|mesh-list
20440538|NCT01357486|Pravastatin|pravastatin|mesh-list
20440539|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440540|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20440541|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440542|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440543|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20440544|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19405701|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405702|NCT03585829|Prednisolone|prednisolone|mesh-list
19405703|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
19405704|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405705|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
19405706|NCT03585829|Hormones|hormones|mesh-ancestor
19405707|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440545|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
19405708|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405709|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19405710|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405711|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19405712|NCT03585751|Simvastatin|simvastatin|mesh-list
19405713|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405714|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19405715|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19405716|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
19405717|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405718|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19405719|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19693460|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19693461|NCT04979520|Brodalumab|brodalumab|mesh-list
20440546|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19405720|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405721|NCT03585738|Folic Acid|folic acid|mesh-list
19405722|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
20440547|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20440548|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
20440549|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20440550|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440551|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20440552|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
20440553|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440554|NCT01357681|Protective Agents|protective agents|mesh-ancestor
20440555|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440556|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20440557|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20440558|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440559|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20440560|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
20440561|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
20440562|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20440563|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20440564|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20440565|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440566|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440567|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
20440568|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440569|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405723|NCT03585738|Inositol|inositol|mesh-list
19405724|NCT03585738|Hematinics|hematinics|mesh-ancestor
19405725|NCT03585738|Vitamins|vitamins|mesh-ancestor
19405726|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
19405727|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405728|NCT03585725|Ribavirin|ribavirin|mesh-list
19405729|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
19405730|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405731|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
19405732|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405733|NCT03585686|Cytarabine|cytarabine|mesh-list
19405734|NCT03585686|Vemurafenib|vemurafenib|mesh-list
19405735|NCT03585686|Cladribine|cladribine|mesh-list
19405736|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405737|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
19693462|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
20440570|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20440571|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440572|NCT01357811|Digoxin|digoxin|mesh-list
20440573|NCT01357811|Eliglustat|eliglustat|mesh-list
20440574|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20440575|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20440576|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440577|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440578|NCT01357811|Protective Agents|protective agents|mesh-ancestor
20440579|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440580|NCT01357876|Metformin|metformin|mesh-list
20440581|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20440582|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440583|NCT01357902|Lamotrigine|lamotrigine|mesh-list
20440584|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
20440585|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20440586|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440587|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440588|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440589|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440590|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20440591|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440592|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693463|NCT04979273|Epinephrine|epinephrine|mesh-list
19693464|NCT04979273|Racepinephrine|racepinephrine|mesh-list
19693465|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
20440593|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20440594|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19405738|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405739|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440595|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19693466|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19693467|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19405740|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
19405741|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440596|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
20440597|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20440598|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20440599|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440600|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440601|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440602|NCT01358045|Calcitriol|calcitriol|mesh-list
20440603|NCT01358045|Diclofenac|diclofenac|mesh-list
20440604|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20440605|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440606|NCT01358045|Analgesics|analgesics|mesh-ancestor
20440607|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
20440608|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440609|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440610|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693468|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
20440611|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440612|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20440613|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440614|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440615|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440616|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20440617|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440618|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20440619|NCT01358045|Vitamins|vitamins|mesh-ancestor
20440620|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
20440621|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20440622|NCT01358071|Doxorubicin|doxorubicin|mesh-list
20440623|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20440624|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20440625|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440626|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20440627|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20440628|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440629|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440630|NCT01358240|Econazole|econazole|mesh-list
20440631|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
20440632|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440633|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20440634|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20440635|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440636|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440637|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20440638|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
20440639|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440640|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440641|NCT01358253|Cytarabine|cytarabine|mesh-list
20440642|NCT01358253|Dexamethasone|dexamethasone|mesh-list
20440643|NCT01358253|Prednisone|prednisone|mesh-list
20440644|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
20440645|NCT01358253|Rituximab|rituximab|mesh-list
20440646|NCT01358253|Doxorubicin|doxorubicin|mesh-list
20440647|NCT01358253|Methotrexate|methotrexate|mesh-list
20440648|NCT01358253|Vincristine|vincristine|mesh-list
20440649|NCT01358253|Asparaginase|asparaginase|mesh-list
20440650|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
20440651|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20440652|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
20440653|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440654|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440655|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20440656|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
20440657|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440658|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440659|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20440660|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20440661|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440662|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
20440663|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
20440664|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440665|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440666|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
19693469|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440667|NCT01358253|Hormones|hormones|mesh-ancestor
20440668|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440669|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20440670|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20440671|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20440672|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20440673|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440674|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20440675|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
20440676|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20440677|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20440678|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
20440679|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
20440680|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20440681|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20440682|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
20440683|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440684|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20440685|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
20440686|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
20440687|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
20440688|NCT01358344|Pantoprazole|pantoprazole|mesh-list
20440689|NCT01358344|Vorapaxar|vorapaxar|mesh-list
20440690|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20440691|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440692|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20440693|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440694|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440695|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20440696|NCT01358383|Naproxen|naproxen|mesh-list
20440697|NCT01358383|Esomeprazole|esomeprazole|mesh-list
20440698|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20440699|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440700|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20440701|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440702|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440703|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20440704|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440705|NCT01358383|Analgesics|analgesics|mesh-ancestor
20440706|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
20440707|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440708|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440709|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440710|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440711|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
20440712|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20440713|NCT01358409|Nebivolol|nebivolol|mesh-list
20440714|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20440715|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440716|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20440717|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20440718|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20440719|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
20440720|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440721|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440722|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440723|NCT01358435|Insulin|insulin|mesh-list
20440724|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20440725|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
20440726|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
20440727|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
20440728|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20440729|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440730|NCT01358500|Fentanyl|fentanyl|mesh-list
20440731|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20440732|NCT01358500|Narcotics|narcotics|mesh-ancestor
20440733|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440734|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440735|NCT01358500|Analgesics|analgesics|mesh-ancestor
20440736|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
20440737|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440738|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20440739|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19405742|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19405743|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
20440740|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
20440741|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
20440742|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
20440743|NCT01358591|Calcium|calcium|mesh-list
20440744|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440745|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440746|NCT01358591|Antacids|antacids|mesh-ancestor
20440747|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440748|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524523|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524524|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
20524525|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
19693470|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693471|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693472|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19693473|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19693474|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
19693475|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693476|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19693477|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
19693478|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
19693479|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
19693480|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19693481|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
19693482|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
20524526|NCT01752790|Azathioprine|azathioprine|mesh-list
20524527|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524528|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
20524529|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524530|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20524531|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524532|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20524533|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
20524534|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524535|NCT01752881|Vaccines|vaccines|mesh-list
20524536|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
20524537|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524538|NCT01752959|Remifentanil|remifentanil|mesh-list
20524539|NCT01752959|Esmolol|esmolol|mesh-list
20524540|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20524541|NCT01752959|Narcotics|narcotics|mesh-ancestor
20524542|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524543|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524544|NCT01752959|Analgesics|analgesics|mesh-ancestor
20524545|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
20524546|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524547|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20524548|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20524549|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20218973|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
20218974|NCT00314990|Hematinics|hematinics|mesh-ancestor
20218975|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
20524550|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
20524551|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524552|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524553|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
20524554|NCT01752998|Narcotics|narcotics|mesh-ancestor
20524555|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524556|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524557|NCT01752998|Analgesics|analgesics|mesh-ancestor
20524558|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
20524559|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524560|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19405744|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405745|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19405746|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218976|NCT00314990|Vitamins|vitamins|mesh-ancestor
20218977|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
20218978|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218979|NCT00315003|Azithromycin|azithromycin|mesh-list
20218980|NCT00315003|Telithromycin|telithromycin|mesh-list
20218981|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20218982|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20218983|NCT00315016|Eplerenone|eplerenone|mesh-list
20218984|NCT00315016|Fosinopril|fosinopril|mesh-list
20218985|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20218986|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
20218987|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440749|NCT01358812|Panitumumab|panitumumab|mesh-list
20440750|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20440751|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440752|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20440753|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440754|NCT01359020|Acetaminophen|acetaminophen|mesh-list
20440755|NCT01359020|Dipyrone|dipyrone|mesh-list
20440756|NCT01359020|Ibuprofen|ibuprofen|mesh-list
20440757|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20440758|NCT01359020|Analgesics|analgesics|mesh-ancestor
20440759|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
20440760|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440761|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440762|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
20440763|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20440764|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440765|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20440766|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20440767|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440768|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440769|NCT01359059|Pregabalin|pregabalin|mesh-list
20440770|NCT01359059|Analgesics|analgesics|mesh-ancestor
20440771|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
20440772|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440773|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440774|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
20440775|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20440776|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440777|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440778|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440779|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20440780|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440781|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440782|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20440783|NCT01359085|Pregabalin|pregabalin|mesh-list
20440784|NCT01359085|Analgesics|analgesics|mesh-ancestor
20440785|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
20440786|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440787|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440788|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
20440789|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20440790|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440791|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440792|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440793|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20440794|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440795|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440796|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20440797|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
20440798|NCT01359098|Dexamethasone|dexamethasone|mesh-list
20440799|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440800|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
20440801|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
20440802|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440803|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440804|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693483|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
19693484|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693485|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19693486|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
19693487|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
19693488|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693489|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848420|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440805|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
20440806|NCT01359098|Hormones|hormones|mesh-ancestor
20440807|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440808|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20440809|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440810|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440811|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440812|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19848421|NCT00694109|Mipomersen|mipomersen|mesh-list
20440813|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440814|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20440815|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20440816|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20440817|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20440818|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
20440819|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20440820|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20440821|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20440822|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
20440823|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20440824|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440825|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20440826|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20440827|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20440828|NCT01359228|Rifaximin|rifaximin|mesh-list
20440829|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20440830|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440831|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440832|NCT01359241|Insulin|insulin|mesh-list
20440833|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20440834|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440835|NCT01359397|Bevacizumab|bevacizumab|mesh-list
20440836|NCT01359397|Trastuzumab|trastuzumab|mesh-list
20440837|NCT01359397|Docetaxel|docetaxel|mesh-list
20440838|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
19405747|NCT03585673|Docetaxel|docetaxel|mesh-list
19405748|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
19405749|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405750|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
19405751|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
19405752|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
19405753|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405754|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19405755|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19405756|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19405757|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19405758|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405759|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
19405760|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405761|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405762|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19405763|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693490|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693491|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19693492|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
19693493|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19693494|NCT04979091|Hormones|hormones|mesh-list
19707712|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
20440839|NCT01359397|Capecitabine|capecitabine|mesh-list
20440840|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20440841|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440842|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20440843|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20440844|NCT01359397|Growth Substances|growth substances|mesh-ancestor
20440845|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440846|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
20440847|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
20440848|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
20440849|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
20440850|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440851|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20440852|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
20440853|NCT01359423|Cilostazol|cilostazol|mesh-list
20440854|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20440855|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
20440856|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440857|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440858|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20440859|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
20440860|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20440861|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20440862|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440863|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19405764|NCT03585556|Prednisolone|prednisolone|mesh-list
20440864|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440865|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20440866|NCT01359423|Protective Agents|protective agents|mesh-ancestor
20440867|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20440868|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20440869|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440870|NCT01359436|Antibodies|antibodies|mesh-list
20440871|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
20440872|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440873|NCT01359462|Tolvaptan|tolvaptan|mesh-list
20440874|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20440875|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440876|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
20440877|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440878|NCT01359488|Hormones|hormones|mesh-list
20440879|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
20440880|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440881|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440882|NCT01359514|Pregabalin|pregabalin|mesh-list
20440883|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
20440884|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20440885|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20440886|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440887|NCT01359514|Analgesics|analgesics|mesh-ancestor
20440888|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
20440889|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440890|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
20440891|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440892|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440893|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20440894|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20440895|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20440896|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20440897|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20440898|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20440899|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440900|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
20440901|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
20440902|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
20440903|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20440904|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440905|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440906|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
20440907|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20440908|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440909|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440910|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
20440911|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20440912|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20440913|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440914|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20440915|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20440916|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440917|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440918|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440919|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20440920|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
20440921|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20440922|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440923|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20440924|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20440925|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20440926|NCT01359657|Dexamethasone|dexamethasone|mesh-list
20440927|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
20440928|NCT01359657|Lenalidomide|lenalidomide|mesh-list
20440929|NCT01359657|Bortezomib|bortezomib|mesh-list
20440930|NCT01359657|BB 1101|bb 1101|mesh-list
20440931|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20440932|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20440933|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
20440934|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
20440935|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530442|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
20440936|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440937|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20440938|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
20440939|NCT01359657|Hormones|hormones|mesh-ancestor
20440940|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20440941|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20440942|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440943|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
20440944|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440945|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440946|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
20440947|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20440948|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20440949|NCT01359657|Growth Substances|growth substances|mesh-ancestor
20440950|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
20440951|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
20440952|NCT01359670|Tadalafil|tadalafil|mesh-list
20440953|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
20440954|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20440955|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20440956|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440957|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440958|NCT01359670|Urological Agents|urological agents|mesh-ancestor
20440959|NCT01359696|Gemcitabine|gemcitabine|mesh-list
20440960|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20440961|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
20440962|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440963|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20440964|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
20440965|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440966|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20440967|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20440968|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
20440969|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440970|NCT01359709|Nicotine|nicotine|mesh-list
20440971|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20440972|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
20440973|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20440974|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440975|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20440976|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20440977|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
20440978|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440979|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440980|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
20440981|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20440982|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
20440983|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20440984|NCT01359722|Expectorants|expectorants|mesh-ancestor
20440985|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
20440986|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20440987|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
20440988|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440989|NCT01359722|Protective Agents|protective agents|mesh-ancestor
20440990|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20440991|NCT01359722|Antidotes|antidotes|mesh-ancestor
20440992|NCT01359826|Milnacipran|milnacipran|mesh-list
20440993|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
20440994|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20440995|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20440996|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20440997|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20440998|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20440999|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441000|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441001|NCT01359826|Analgesics|analgesics|mesh-ancestor
20441002|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
20441003|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441004|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
20441005|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20441006|NCT01359930|Naltrexone|naltrexone|mesh-list
20441007|NCT01359930|Bupropion|bupropion|mesh-list
20441008|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20441009|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20530443|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
20441010|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441011|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
20441012|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441013|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20441014|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
20441015|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20441016|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20441017|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20441018|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441019|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441020|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
20441021|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441022|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20441023|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20441024|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441025|NCT01360034|Indomethacin|indomethacin|mesh-list
20218988|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20218989|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20218990|NCT00315016|Diuretics|diuretics|mesh-ancestor
20218991|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
20218992|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20218993|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20218994|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
20218995|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20218996|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20218997|NCT00315042|Penicillins|penicillins|mesh-list
20218998|NCT00315042|Telithromycin|telithromycin|mesh-list
20441026|NCT01360034|Nifedipine|nifedipine|mesh-list
20441027|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20441028|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441029|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441030|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441031|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441032|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
20441033|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
20441034|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20441035|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441036|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441037|NCT01360034|Analgesics|analgesics|mesh-ancestor
20441038|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
20441039|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441040|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441041|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441042|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
20441043|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20441044|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441045|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
20441046|NCT01360060|Analgesics|analgesics|mesh-ancestor
20441047|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
20441048|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441049|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441050|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
20441051|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441052|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20441053|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
20441054|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20441055|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441056|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441057|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441058|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
20441059|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20441060|NCT01360086|Leucovorin|leucovorin|mesh-list
20441061|NCT01360086|Fluorouracil|fluorouracil|mesh-list
20441062|NCT01360086|Cetuximab|cetuximab|mesh-list
20441063|NCT01360086|Calcium|calcium|mesh-list
20441064|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
20441065|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441066|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441067|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441068|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
20441069|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405765|NCT03585556|Bevacizumab|bevacizumab|mesh-list
20218999|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219000|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219001|NCT00315081|Bromocriptine|bromocriptine|mesh-list
20219002|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20219003|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20441070|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20441071|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441072|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
20441073|NCT01360086|Antidotes|antidotes|mesh-ancestor
20441074|NCT01360086|Protective Agents|protective agents|mesh-ancestor
20441075|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
20441076|NCT01360086|Vitamins|vitamins|mesh-ancestor
20441077|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
20441078|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20441079|NCT01360151|Ranibizumab|ranibizumab|mesh-list
20441080|NCT01360151|Verteporfin|verteporfin|mesh-list
20441081|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20441082|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20441083|NCT01360151|Growth Substances|growth substances|mesh-ancestor
20441084|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441085|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
20441086|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441087|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20441088|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
20441089|NCT01360190|Fluoxetine|fluoxetine|mesh-list
20441090|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20441091|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20441092|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441093|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441094|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441095|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
20441096|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441097|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20441098|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
20441099|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20441100|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20441101|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20441102|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524561|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20524562|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
20524563|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524564|NCT01753102|Estradiol|estradiol|mesh-list
20524565|NCT01753102|Estrogens|estrogens|mesh-ancestor
20524566|NCT01753102|Hormones|hormones|mesh-ancestor
20524567|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524568|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524569|NCT01753128|Imipramine|imipramine|mesh-list
20524570|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20524571|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
20524572|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524573|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20524574|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20524575|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524576|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524577|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
20524578|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524579|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524580|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20524581|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
20524582|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20524583|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20524584|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19405766|NCT03585556|Ranibizumab|ranibizumab|mesh-list
20219004|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
20219005|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219006|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219007|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
20219008|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
20219009|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219010|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219011|NCT00315185|Cetuximab|cetuximab|mesh-list
20219012|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20219013|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219014|NCT00315211|Docetaxel|docetaxel|mesh-list
20219015|NCT00315211|Topotecan|topotecan|mesh-list
20441103|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
20441104|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441105|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441106|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
20441107|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441108|NCT01360424|Teriparatide|teriparatide|mesh-list
20441109|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441110|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441111|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20441112|NCT01360437|Ticagrelor|ticagrelor|mesh-list
20441113|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20441114|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20441115|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20441116|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20441117|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20441118|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
20441119|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441120|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441121|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441122|NCT01360463|Methadone|methadone|mesh-list
20441123|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20441124|NCT01360463|Narcotics|narcotics|mesh-ancestor
20441125|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441126|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693495|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20441127|NCT01360463|Analgesics|analgesics|mesh-ancestor
20441128|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
20441129|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441130|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
20441131|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20441132|NCT01360476|Vitamin D|vitamin d|mesh-list
20441133|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
20441134|NCT01360476|Vitamins|vitamins|mesh-ancestor
20441135|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
20441136|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441137|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20441138|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441139|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
20441140|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20441141|NCT01360658|Antibodies|antibodies|mesh-list
20441142|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
20441143|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19693496|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693497|NCT04978675|Fluorides|fluorides|mesh-list
19693498|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
19693499|NCT04978675|Protective Agents|protective agents|mesh-ancestor
19693500|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441144|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
20441145|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441146|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
20441147|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
20441148|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20441149|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20441150|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441151|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441152|NCT01360671|Urological Agents|urological agents|mesh-ancestor
20441153|NCT01360710|Irbesartan|irbesartan|mesh-list
20441154|NCT01360710|Moxonidine|moxonidine|mesh-list
20441155|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19693501|NCT04978688|Relugolix|relugolix|mesh-list
19693502|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
20219016|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219017|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
20219018|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
20219019|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
20219020|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219021|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20219022|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20219023|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219024|NCT00315276|Modafinil|modafinil|mesh-list
20219025|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20219026|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219027|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20441156|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20441157|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20441158|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441159|NCT01360749|Lidocaine|lidocaine|mesh-list
20441160|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
20441161|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
19848422|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19405767|NCT03585556|Aflibercept|aflibercept|mesh-list
19405768|NCT03585556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405769|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405770|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19405771|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19405772|NCT03585556|Growth Substances|growth substances|mesh-ancestor
19405773|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405774|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
19405775|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405776|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
19405777|NCT03585556|Hormones|hormones|mesh-ancestor
19405778|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19405779|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19405780|NCT03585530|Raltitrexed|raltitrexed|mesh-list
19405781|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405782|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
19405783|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405784|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405785|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19405786|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405787|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
19405788|NCT03585465|Capecitabine|capecitabine|mesh-list
19405789|NCT03585465|Nivolumab|nivolumab|mesh-list
19405790|NCT03585465|Vinblastine|vinblastine|mesh-list
19405791|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693503|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
19693504|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693505|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693506|NCT04978649|Amlodipine|amlodipine|mesh-list
19693507|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19693508|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19693509|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693510|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693511|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19693512|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848423|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19848424|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
19848425|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848426|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19848427|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
19848428|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19848429|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219028|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20219029|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19848430|NCT00694304|Vortioxetine|vortioxetine|mesh-list
19848431|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
19848432|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19848433|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19848434|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19848435|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219030|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219031|NCT00315367|Donepezil|donepezil|mesh-list
19405792|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
19405793|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405794|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405795|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20613580|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20613581|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20613582|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219032|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20219033|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441162|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441163|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441164|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
20441165|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613583|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19405796|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
19693513|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
20441166|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20441167|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20441168|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20441169|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441170|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441171|NCT01360788|Albuterol|albuterol|mesh-list
20441172|NCT01360788|Ipratropium|ipratropium|mesh-list
20441173|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20441174|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
20441175|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441176|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441177|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20441178|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
20441179|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
20441180|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20441181|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20441182|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20441183|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20441184|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
20441185|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441186|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441187|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20441188|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
20441189|NCT01360827|Cisplatin|cisplatin|mesh-list
20441190|NCT01360827|Fluorouracil|fluorouracil|mesh-list
20441191|NCT01360827|Cetuximab|cetuximab|mesh-list
20441192|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441193|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
20441194|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441195|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20441196|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441197|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
20441198|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441199|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20441200|NCT01361022|Brotizolam|brotizolam|mesh-list
20441201|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20441202|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441203|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441204|NCT01361269|Clindamycin|clindamycin|mesh-list
20441205|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
20441206|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
20441207|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
20441208|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20441209|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441210|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20441211|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441212|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441213|NCT01361373|Levodopa|levodopa|mesh-list
20441214|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20441215|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20441216|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
20441217|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441218|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441219|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441220|NCT01361399|Aspirin|aspirin|mesh-list
20441221|NCT01361399|Lidocaine|lidocaine|mesh-list
20441222|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
20441223|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
20441224|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441225|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441226|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
20441227|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441228|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20441229|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20441230|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20441231|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441232|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441233|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441234|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441235|NCT01361399|Analgesics|analgesics|mesh-ancestor
20441236|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441237|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441238|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20441239|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20441240|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20441241|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20441242|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441243|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
20441244|NCT01361425|Methyldopa|methyldopa|mesh-list
20441245|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20441246|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
20441247|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
20441248|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441249|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441250|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20441251|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20441252|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20441253|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
20441254|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441255|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441256|NCT01361516|Anesthetics|anesthetics|mesh-list
20441257|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441258|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441259|NCT01361542|Etanercept|etanercept|mesh-list
20441260|NCT01361542|Infliximab|infliximab|mesh-list
20441261|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
20441262|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20441263|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441264|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441265|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441266|NCT01361542|Analgesics|analgesics|mesh-ancestor
20441267|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
20441268|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441269|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441270|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441271|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441272|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
20441273|NCT01361763|Dabigatran|dabigatran|mesh-list
20441274|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
20441275|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20441276|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
20441277|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441278|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441279|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
20441280|NCT01361789|Dexamethasone|dexamethasone|mesh-list
20441281|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
20441282|NCT01361789|Etoricoxib|etoricoxib|mesh-list
20441283|NCT01361789|Parecoxib|parecoxib|mesh-list
20441284|NCT01361789|Valdecoxib|valdecoxib|mesh-list
20441285|NCT01361789|BB 1101|bb 1101|mesh-list
20441286|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441287|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
20441288|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
20441289|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441290|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441291|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20441292|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
20441293|NCT01361789|Hormones|hormones|mesh-ancestor
20441294|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20441295|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20441296|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441297|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
20441298|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441299|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441300|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441301|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441302|NCT01361789|Analgesics|analgesics|mesh-ancestor
20441303|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
20441304|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441305|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20441306|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20441307|NCT01361841|Bimatoprost|bimatoprost|mesh-list
20441308|NCT01361841|Travoprost|travoprost|mesh-list
20441309|NCT01361841|Latanoprost|latanoprost|mesh-list
20441310|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20441311|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20441312|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20441313|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20441314|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
20441315|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19405797|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405798|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405799|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19405800|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19405801|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
19405802|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19405803|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19405804|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19405805|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
19405806|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
19405807|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
19405808|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
19405809|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19405810|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405811|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405812|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405813|NCT03585452|Analgesics|analgesics|mesh-ancestor
20441316|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
20441317|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441318|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441319|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20441320|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
20441321|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20441322|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20441323|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20441324|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
19405814|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
19405815|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405816|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19405817|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19405818|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19405819|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
19405820|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405821|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405822|NCT03585426|Vancomycin|vancomycin|mesh-list
19405823|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19405824|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405825|NCT03585413|Micronutrients|micronutrients|mesh-list
19405826|NCT03585413|Trace Elements|trace elements|mesh-list
19405827|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405828|NCT03585374|Acetaminophen|acetaminophen|mesh-list
19405829|NCT03585374|Ketoprofen|ketoprofen|mesh-list
19405830|NCT03585374|Morphine|morphine|mesh-list
19405831|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
19405832|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19405833|NCT03585374|Narcotics|narcotics|mesh-ancestor
19405834|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405835|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405836|NCT03585374|Analgesics|analgesics|mesh-ancestor
19405837|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
19405838|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405839|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405840|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
19405841|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405842|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405843|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405844|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19405845|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405846|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441325|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524585|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524586|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524587|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
20524588|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524589|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524590|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20524591|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524592|NCT01753375|Vitamin D|vitamin d|mesh-list
20524593|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
20524594|NCT01753375|Vitamins|vitamins|mesh-ancestor
20524595|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
20524596|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524597|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20524598|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441326|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441327|NCT01361997|Ethanol|ethanol|mesh-list
20441328|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
20441329|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20441330|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441331|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441332|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441333|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
20441334|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20441335|NCT01362010|Minocycline|minocycline|mesh-list
20441336|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524599|NCT01753453|Plerixafor|plerixafor|mesh-list
20524600|NCT01753453|Sargramostim|sargramostim|mesh-list
20524601|NCT01753453|Lenograstim|lenograstim|mesh-list
20524602|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
20524603|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524604|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20524605|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20524606|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20524607|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
20524608|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524609|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20524610|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20524611|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
20524612|NCT01753752|Chitosan|chitosan|mesh-list
20524613|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20524614|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20524615|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20524616|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
20524617|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524618|NCT01753752|Expectorants|expectorants|mesh-ancestor
20524619|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
20524620|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20524621|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
20524622|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524623|NCT01753752|Protective Agents|protective agents|mesh-ancestor
20524624|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524625|NCT01753752|Antidotes|antidotes|mesh-ancestor
20524626|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20524627|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20524628|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
20524629|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20524630|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
20524631|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
20524632|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
20524633|NCT01753752|Coagulants|coagulants|mesh-ancestor
20530444|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530445|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530446|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530447|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20530448|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
20530449|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530450|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530451|NCT01788670|Ethanol|ethanol|mesh-list
20530452|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20530453|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530454|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530455|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530456|NCT01788722|Dienogest|dienogest|mesh-list
20530457|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20530458|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
20530459|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20530460|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530461|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20530462|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20530463|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20530464|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20530465|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
20530466|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530467|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20530468|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530469|NCT01788774|Risperidone|risperidone|mesh-list
20530470|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20530471|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
20530472|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530473|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441337|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20441338|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20441339|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
20441340|NCT01362153|Golimumab|golimumab|mesh-list
19405847|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19405848|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
19405849|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
19405850|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19405851|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19405852|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441341|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20441342|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20441343|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441344|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441345|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
20441346|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441347|NCT01362218|Aspirin|aspirin|mesh-list
20441348|NCT01362218|Ramipril|ramipril|mesh-list
20441349|NCT01362218|Simvastatin|simvastatin|mesh-list
20441350|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20441351|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20441352|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
20441353|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441354|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20441355|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20441356|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441357|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441358|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441359|NCT01362218|Analgesics|analgesics|mesh-ancestor
20441360|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
20441361|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441362|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441363|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441364|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441365|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20441366|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20441367|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20441368|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20441369|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
20441370|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19405853|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405854|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
19405855|NCT03585179|Hydroquinone|hydroquinone|mesh-list
20441371|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
20441372|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20441373|NCT01362309|Cycloserine|cycloserine|mesh-list
20441374|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20441375|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441376|NCT01362309|Renal Agents|renal agents|mesh-ancestor
20441377|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20441378|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
20441379|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20441380|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
20441381|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441382|NCT01362361|Nintedanib|nintedanib|mesh-list
20441383|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441384|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20441385|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441386|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441387|NCT01362400|Docetaxel|docetaxel|mesh-list
20441388|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441389|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
20441390|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
20441391|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
20441392|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441393|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20441394|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20441395|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20441396|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441397|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441398|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20441399|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20441400|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19405856|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19405857|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20441401|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
20441402|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441403|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441404|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20441405|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20441406|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
20441407|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
20441408|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441409|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20441410|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441411|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441412|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
20441413|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20441414|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441415|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20441416|NCT01363037|Maraviroc|maraviroc|mesh-list
20441417|NCT01363037|Dapivirine|dapivirine|mesh-list
20441418|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20441419|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20441420|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441421|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20441422|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20441423|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
20441424|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441425|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20441426|NCT01363063|Ketorolac|ketorolac|mesh-list
20441427|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20441428|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441429|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441430|NCT01363063|Analgesics|analgesics|mesh-ancestor
20441431|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
20441432|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441433|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441434|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441435|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441436|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20441437|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441438|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441439|NCT01363089|Ketorolac|ketorolac|mesh-list
20441440|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20441441|NCT01363089|Phenylephrine|phenylephrine|mesh-list
20441442|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
20441443|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441444|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441445|NCT01363089|Analgesics|analgesics|mesh-ancestor
20441446|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
20441447|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441448|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441449|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441450|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441451|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20441452|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441453|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441454|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20441455|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20441456|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
20441457|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441458|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
20441459|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
20441460|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
20441461|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20441462|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
20441463|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20441464|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
20441465|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20441466|NCT01363089|Protective Agents|protective agents|mesh-ancestor
20441467|NCT01363115|Vitamin D|vitamin d|mesh-list
20441468|NCT01363115|Calcium|calcium|mesh-list
20441469|NCT01363115|Vitamins|vitamins|mesh-ancestor
20441470|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
20441471|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441472|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441473|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20441474|NCT01363167|Vitamin D|vitamin d|mesh-list
20441475|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
20441476|NCT01363167|Vitamins|vitamins|mesh-ancestor
20219034|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219035|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
20219036|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219037|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219038|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
20219039|NCT00315432|Interferons|interferons|mesh-list
20219040|NCT00315432|Ribavirin|ribavirin|mesh-list
20219041|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219042|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
20219043|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219044|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
20219045|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441477|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
20441478|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441479|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20441480|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441481|NCT01363193|Heparin|heparin|mesh-list
20441482|NCT01363193|Calcium heparin|calcium heparin|mesh-list
20441483|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
20441484|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20441485|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20441486|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441487|NCT01363206|Ipilimumab|ipilimumab|mesh-list
20441488|NCT01363206|Molgramostim|molgramostim|mesh-list
20441489|NCT01363206|Sargramostim|sargramostim|mesh-list
20441490|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20441491|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441492|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20441493|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441494|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
20441495|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441496|NCT01363271|Vancomycin|vancomycin|mesh-list
20441497|NCT01363271|Linezolid|linezolid|mesh-list
20441498|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20441499|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441500|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20441501|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441502|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441503|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20441504|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20441505|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20441506|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441507|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441508|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441509|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441510|NCT01363284|Analgesics|analgesics|mesh-ancestor
20441511|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
20441512|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441513|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
20441514|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20441515|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
20441516|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20441517|NCT01363310|Citalopram|citalopram|mesh-list
20441518|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20441519|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20441520|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441521|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441522|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441523|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
20441524|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441525|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20441526|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
20441527|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20441528|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20441529|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20441530|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441531|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
20441532|NCT01363323|Naltrexone|naltrexone|mesh-list
20441533|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
20441534|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20441535|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441536|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20441537|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20441538|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441539|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441540|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441541|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441542|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441543|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
20441544|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441545|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20441546|NCT01363336|Nifedipine|nifedipine|mesh-list
20441547|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20441548|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441549|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441550|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441551|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441552|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
20441553|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
20441554|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20441555|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
20441556|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20441557|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441558|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
20441559|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20441560|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
20441561|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441562|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
19405858|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405859|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
19405860|NCT03585179|Coagulants|coagulants|mesh-ancestor
19405861|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
20441563|NCT01363414|Protective Agents|protective agents|mesh-ancestor
20441564|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20441565|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405862|NCT03585179|Protective Agents|protective agents|mesh-ancestor
20441566|NCT01363544|Methylphenidate|methylphenidate|mesh-list
20441567|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20441568|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441569|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20441570|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20441571|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441572|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441573|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
20441574|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441575|NCT01363557|Gefitinib|gefitinib|mesh-list
20441576|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441577|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20441578|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441579|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441580|NCT01363570|Ranibizumab|ranibizumab|mesh-list
20441581|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20441582|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20441583|NCT01363570|Growth Substances|growth substances|mesh-ancestor
20441584|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405863|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219046|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
20219047|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
20219048|NCT00315484|Hematinics|hematinics|mesh-ancestor
20219049|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20219050|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20219051|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20219052|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
20219053|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219054|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20219055|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20219056|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219057|NCT00315523|Levocetirizine|levocetirizine|mesh-list
20219058|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20219059|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20219060|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
20219061|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
20219062|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219063|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405864|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20441585|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
20441586|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441587|NCT01363583|Epoprostenol|epoprostenol|mesh-list
20441588|NCT01363583|Tezosentan|tezosentan|mesh-list
20441589|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20441590|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20441591|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
20441592|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
20441593|NCT01363609|Liraglutide|liraglutide|mesh-list
20441594|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20441595|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441596|NCT01363609|Incretins|incretins|mesh-ancestor
20441597|NCT01363609|Hormones|hormones|mesh-ancestor
20441598|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20441599|NCT01363648|Choline|choline|mesh-list
20441600|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
20441601|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20441602|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
20441603|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441604|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20441605|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20441606|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
20441607|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
20441608|NCT01363752|Sirolimus|sirolimus|mesh-list
20441609|NCT01363752|Tacrolimus|tacrolimus|mesh-list
20441610|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441611|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
20441612|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441613|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20441614|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441615|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441616|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20441617|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441618|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20441619|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
20441620|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20441621|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441622|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
20441623|NCT01363817|Dexamethasone|dexamethasone|mesh-list
20441624|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441625|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
20441626|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
20441627|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441628|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441629|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20441630|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
20441631|NCT01363817|Hormones|hormones|mesh-ancestor
20441632|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20441633|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20441634|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524634|NCT01753882|Citalopram|citalopram|mesh-list
20524635|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20524636|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20524637|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20524638|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524639|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524640|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
20524641|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524642|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20524643|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
20524644|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524645|NCT01754116|Cabotegravir|cabotegravir|mesh-list
20524646|NCT01754116|Midazolam|midazolam|mesh-list
20524647|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20524648|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20524649|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524650|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524651|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20524652|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20524653|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524654|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19405865|NCT03585140|Doxycycline|doxycycline|mesh-list
19405866|NCT03585140|Adapalene|adapalene|mesh-list
20524655|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
20524656|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
19405867|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19693514|NCT04978597|Opicapone|opicapone|mesh-list
20441635|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
20441636|NCT01363934|Hematinics|hematinics|mesh-ancestor
20441637|NCT01364012|Paclitaxel|paclitaxel|mesh-list
20441638|NCT01364012|Bevacizumab|bevacizumab|mesh-list
20441639|NCT01364012|Carboplatin|carboplatin|mesh-list
20441640|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20441641|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441642|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
20441643|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
20441644|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
20441645|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441646|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20441647|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20441648|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20441649|NCT01364012|Growth Substances|growth substances|mesh-ancestor
20441650|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441651|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
20441652|NCT01364181|Udenafil|udenafil|mesh-list
20441653|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20441654|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20441655|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441656|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441657|NCT01364194|Bupivacaine|bupivacaine|mesh-list
20441658|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
20441659|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
20441660|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441661|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441662|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
20441663|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441664|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20441665|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20441666|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20441667|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
20441668|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441669|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20441670|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20441671|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441672|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
20441673|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20441674|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441675|NCT01364376|Leucovorin|leucovorin|mesh-list
20441676|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
20441677|NCT01364376|Calcium|calcium|mesh-list
20441678|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
20441679|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20441680|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441681|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441682|NCT01364376|Antidotes|antidotes|mesh-ancestor
20441683|NCT01364376|Protective Agents|protective agents|mesh-ancestor
20441684|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
20441685|NCT01364376|Vitamins|vitamins|mesh-ancestor
20441686|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
20441687|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
20441688|NCT01364402|Hematinics|hematinics|mesh-ancestor
20441689|NCT01364415|Pasireotide|pasireotide|mesh-list
20441690|NCT01364415|Hormones|hormones|mesh-ancestor
20441691|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20441692|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441693|NCT01364493|Capecitabine|capecitabine|mesh-list
20441694|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
20441695|NCT01364493|Trastuzumab|trastuzumab|mesh-list
20441696|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20441697|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
20441698|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441699|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441700|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20441701|NCT01364519|Fluticasone|fluticasone|mesh-list
20441702|NCT01364519|Xhance|xhance|mesh-list
20441703|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441704|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20441705|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
20441706|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441707|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441708|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20441709|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
20441710|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
20441711|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20441712|NCT01364571|Vaccines|vaccines|mesh-list
20441713|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
20441714|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441715|NCT01364675|Metformin|metformin|mesh-list
20441716|NCT01364675|Enalapril|enalapril|mesh-list
20441717|NCT01364675|Simvastatin|simvastatin|mesh-list
20441718|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20441719|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441720|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20441721|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20441722|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
20441723|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441724|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20441725|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20441726|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441727|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20441728|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
20441729|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20441730|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
19405868|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405869|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
20219064|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441731|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20441732|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20441733|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441734|NCT01364688|Vitamins|vitamins|mesh-ancestor
20441735|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
20441736|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
20441737|NCT01364701|Tadalafil|tadalafil|mesh-list
20441738|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
20441739|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20441740|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20441741|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441742|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441743|NCT01364701|Urological Agents|urological agents|mesh-ancestor
20441744|NCT01364792|Valacyclovir|valacyclovir|mesh-list
20441745|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
20441746|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441747|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
20441748|NCT01364805|Gemcitabine|gemcitabine|mesh-list
20441749|NCT01364805|Vitamins|vitamins|mesh-ancestor
20441750|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
20441751|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441752|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20441753|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
20441754|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441755|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441756|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
20441757|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441758|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441759|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441760|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
20441761|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
20441762|NCT01364805|Protective Agents|protective agents|mesh-ancestor
20441763|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
20219065|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
20219066|NCT00315536|Remifentanil|remifentanil|mesh-list
20219067|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20219068|NCT00315536|Narcotics|narcotics|mesh-ancestor
20219069|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219070|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219071|NCT00315536|Analgesics|analgesics|mesh-ancestor
20219072|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
20219073|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219074|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20219075|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20219076|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20219077|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
20219078|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219079|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441764|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
20219080|NCT00315549|Penicillins|penicillins|mesh-list
20219081|NCT00315549|Telithromycin|telithromycin|mesh-list
20441765|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
20441766|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219082|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219083|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441767|NCT01364883|Vaccines|vaccines|mesh-list
20441768|NCT01364883|Immunologic Factors|immunologic factors|mesh-ancestor
20441769|NCT01364883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441770|NCT01364961|Resveratrol|resveratrol|mesh-list
20441771|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
20441772|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441773|NCT01364961|Protective Agents|protective agents|mesh-ancestor
20441774|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441775|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441776|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20441777|NCT01364974|Peficitinib|peficitinib|mesh-list
20441778|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441779|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441780|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441781|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
20441782|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441783|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
20441784|NCT01364987|Peficitinib|peficitinib|mesh-list
20441785|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20441786|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441787|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20441788|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
20441789|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20441790|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441791|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441792|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441793|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441794|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
20441795|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441796|NCT01365000|Naloxegol|naloxegol|mesh-list
20441797|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441798|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441799|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
20441800|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441801|NCT01365065|Vorinostat|vorinostat|mesh-list
20441802|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441803|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20441804|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441805|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441806|NCT01365104|Deferoxamine|deferoxamine|mesh-list
20441807|NCT01365104|Siderophores|siderophores|mesh-ancestor
20441808|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20441809|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
20441810|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
20441811|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441812|NCT01365117|Insulin|insulin|mesh-list
20441813|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20441814|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20441815|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441816|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20441817|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20441818|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
20441819|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20441820|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
20441821|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693515|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19693516|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693517|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693518|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20219084|NCT00315601|Azithromycin|azithromycin|mesh-list
20219085|NCT00315601|Telithromycin|telithromycin|mesh-list
20219086|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219087|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219088|NCT00315666|Memantine|memantine|mesh-list
19693519|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20219089|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20219090|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20219091|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
20441822|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
20441823|NCT01365260|Protective Agents|protective agents|mesh-ancestor
20441824|NCT01365312|Ethanol|ethanol|mesh-list
20441825|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20219092|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441826|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441827|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441828|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441829|NCT01365351|Hormones|hormones|mesh-list
20441830|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20441831|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441832|NCT01365403|Carbamazepine|carbamazepine|mesh-list
20441833|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
20441834|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
20441835|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20441836|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441837|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441838|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20441839|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441840|NCT01365403|Analgesics|analgesics|mesh-ancestor
20441841|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
20441842|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441843|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20441844|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441845|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441846|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20441847|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20441848|NCT01365598|Primaquine|primaquine|mesh-list
20441849|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
20441850|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20441851|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20441852|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441853|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20441854|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20524657|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
20524658|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
20524659|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524660|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524661|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20524662|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20524663|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524664|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20524665|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20524666|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
20524667|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524668|NCT01754181|Insulin|insulin|mesh-list
20524669|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20524670|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524671|NCT01754220|Montelukast|montelukast|mesh-list
20524672|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20524673|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
20524674|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20524675|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
20524676|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524677|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524678|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20524679|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20524680|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524681|NCT01754285|Octreotide|octreotide|mesh-list
20524682|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524683|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20524684|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524685|NCT01754324|Methadone|methadone|mesh-list
20524686|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20524687|NCT01754324|Narcotics|narcotics|mesh-ancestor
20524688|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524689|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524690|NCT01754324|Analgesics|analgesics|mesh-ancestor
20524691|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
20524692|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524693|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
20524694|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
20524695|NCT01754649|Misoprostol|misoprostol|mesh-list
20524696|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20524697|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
20524698|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20524699|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613584|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613585|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20441855|NCT01365871|Anesthetics|anesthetics|mesh-list
20441856|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441857|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441858|NCT01365897|Modafinil|modafinil|mesh-list
20441859|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20441860|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441861|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20441862|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20441863|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20441864|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441865|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
20441866|NCT01365923|Remifentanil|remifentanil|mesh-list
19693520|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
19693521|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19693522|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693523|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
19693524|NCT04978584|Prednisone|prednisone|mesh-list
19693525|NCT04978584|Cortisone|cortisone|mesh-list
19693526|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
19693527|NCT04978584|Rituximab|rituximab|mesh-list
19693528|NCT04978584|Doxorubicin|doxorubicin|mesh-list
19693529|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19693530|NCT04978584|Vincristine|vincristine|mesh-list
19693531|NCT04978584|Lenalidomide|lenalidomide|mesh-list
20219093|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219094|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219095|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20219096|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20219097|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
20219098|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20219099|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219100|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219101|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20219102|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19693532|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
19693533|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19693534|NCT04978584|Antibodies|antibodies|mesh-list
20219103|NCT00315679|Protective Agents|protective agents|mesh-ancestor
20441867|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20441868|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441869|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441870|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441871|NCT01365923|Analgesics|analgesics|mesh-ancestor
20441872|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
20441873|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441874|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20441875|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20441876|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20441877|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
20441878|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20441879|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441880|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20441881|NCT01365923|Narcotics|narcotics|mesh-ancestor
20441882|NCT01365936|Menotropins|menotropins|mesh-list
20613586|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613587|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613588|NCT02255812|Analgesics|analgesics|mesh-ancestor
20613589|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
20613590|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
20613591|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20613592|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
20613593|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
20613594|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693535|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
19693536|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19693537|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20441883|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20441884|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
20441885|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20441886|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441887|NCT01366001|Buprenorphine|buprenorphine|mesh-list
20441888|NCT01366001|ALKS-33|alks-33|mesh-list
20441889|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20441890|NCT01366001|Narcotics|narcotics|mesh-ancestor
20441891|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441892|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441893|NCT01366001|Analgesics|analgesics|mesh-ancestor
20441894|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
20441895|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441896|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441897|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
20441898|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20441899|NCT01366183|Paclitaxel|paclitaxel|mesh-list
20441900|NCT01366183|Carboplatin|carboplatin|mesh-list
20441901|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20441902|NCT01366183|Lenograstim|lenograstim|mesh-list
20441903|NCT01366183|Sargramostim|sargramostim|mesh-list
20441904|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20441905|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693538|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
19693539|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441906|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
20441907|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
20441908|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
20441909|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441910|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20441911|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
20441912|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441913|NCT01366235|Chloroquine|chloroquine|mesh-list
20441914|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20441915|NCT01366235|Amebicides|amebicides|mesh-ancestor
19693540|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693541|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19693542|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
19693543|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693544|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693545|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19693546|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19693547|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20441916|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20441917|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20441918|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441919|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
20441920|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20441921|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20441922|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441923|NCT01366235|Analgesics|analgesics|mesh-ancestor
20441924|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
20441925|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441926|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441927|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20441928|NCT01366235|Filaricides|filaricides|mesh-ancestor
20441929|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
20441930|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
20441931|NCT01366300|Lidocaine|lidocaine|mesh-list
20441932|NCT01366300|Propofol|propofol|mesh-list
20441933|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
20441934|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
20441935|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441936|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441937|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
20441938|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441939|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20441940|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20441941|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20441942|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20441943|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441944|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19693548|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20441945|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20441946|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
20441947|NCT01366313|Acetaminophen|acetaminophen|mesh-list
20441948|NCT01366313|Morphine|morphine|mesh-list
20441949|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20441950|NCT01366313|Narcotics|narcotics|mesh-ancestor
20441951|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20441952|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441953|NCT01366313|Analgesics|analgesics|mesh-ancestor
20441954|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
20441955|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441956|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20441957|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
20441958|NCT01366326|Bromides|bromides|mesh-list
20441959|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
20441960|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
20441961|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441962|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441963|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
20441964|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441965|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
20441966|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441967|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219104|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219105|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
20219106|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20219107|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
20219108|NCT00315744|Fluticasone|fluticasone|mesh-list
20219109|NCT00315744|Xhance|xhance|mesh-list
20219110|NCT00315744|Albuterol|albuterol|mesh-list
20219111|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20219112|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219113|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20219114|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
20219115|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219116|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441968|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
20441969|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441970|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
20441971|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441972|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441973|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
20441974|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441975|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
20441976|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441977|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441978|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
20613595|NCT02255942|Zinc|zinc|mesh-list
20613596|NCT02255942|Iron|iron|mesh-list
20613597|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
20613598|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
20613599|NCT02255942|Trace Elements|trace elements|mesh-ancestor
20613600|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
19405870|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19405871|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19405872|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405873|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405874|NCT03585140|Analgesics|analgesics|mesh-ancestor
19405875|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
19405876|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405877|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405878|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405879|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405880|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
20219117|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20441979|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441980|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
20441981|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20441982|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441983|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
20441984|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20441985|NCT01366391|Metformin|metformin|mesh-list
20441986|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20441987|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20441988|NCT01366547|Lamivudine|lamivudine|mesh-list
20441989|NCT01366547|Abacavir|abacavir|mesh-list
20441990|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
20441991|NCT01366547|Dolutegravir|dolutegravir|mesh-list
20613601|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613602|NCT02255942|Astringents|astringents|mesh-ancestor
19405881|NCT03585101|Grazoprevir|grazoprevir|mesh-list
19405882|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
20613603|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
20441992|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20441993|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20441994|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20441995|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20441996|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
20441997|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20441998|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20441999|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20442000|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
20442001|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20442002|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20442003|NCT01366651|Doripenem|doripenem|mesh-list
20442004|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20442005|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442006|NCT01367028|Bevacizumab|bevacizumab|mesh-list
20442007|NCT01367028|Trastuzumab|trastuzumab|mesh-list
20442008|NCT01367028|Docetaxel|docetaxel|mesh-list
20442009|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20442010|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442011|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442012|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442013|NCT01367028|Growth Substances|growth substances|mesh-ancestor
20442014|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442015|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442016|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
20442017|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20442018|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
20442019|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442020|NCT01367054|Metformin|metformin|mesh-list
20442021|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20442022|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442023|NCT01367210|Maraviroc|maraviroc|mesh-list
20442024|NCT01367210|Darunavir|darunavir|mesh-list
20442025|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20442026|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19693549|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693550|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693551|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
19693552|NCT04978584|Hormones|hormones|mesh-ancestor
19693553|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693554|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693555|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19693556|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
19693557|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
19693558|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
19693559|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19693560|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19693561|NCT04978584|Growth Substances|growth substances|mesh-ancestor
19693562|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442027|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20442028|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442029|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20442030|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
20442031|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442032|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20442033|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20442034|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20442035|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
20442036|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442037|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
20442038|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20442039|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20442040|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
20442041|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20442042|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442043|NCT01367301|Paclitaxel|paclitaxel|mesh-list
20442044|NCT01367301|Carboplatin|carboplatin|mesh-list
20442045|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20442046|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442047|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
20442048|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
20442049|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
20442050|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693563|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20442051|NCT01367418|Sufentanil|sufentanil|mesh-list
20442052|NCT01367418|Morphine|morphine|mesh-list
20442053|NCT01367418|Bupivacaine|bupivacaine|mesh-list
20442054|NCT01367418|Ropivacaine|ropivacaine|mesh-list
20442055|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
20442056|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
20442057|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442058|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442059|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
20442060|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442061|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20442062|NCT01367418|Narcotics|narcotics|mesh-ancestor
20219118|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
20219119|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
20219120|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20219121|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20219122|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20219123|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20219124|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
20219125|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219126|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219127|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
20442063|NCT01367418|Analgesics|analgesics|mesh-ancestor
20442064|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20442065|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20442066|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
20442067|NCT01367431|Xanthohumol|xanthohumol|mesh-list
20442068|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442069|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442070|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442071|NCT01367431|Growth Substances|growth substances|mesh-ancestor
20442072|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442073|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442074|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
20442075|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442076|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442077|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
20442078|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442079|NCT01367496|Naltrexone|naltrexone|mesh-list
20442080|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
20442081|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442082|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442083|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
20442084|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442085|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20442086|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
20442087|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442088|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442089|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
20442090|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442091|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
20442092|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442093|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442094|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
20442095|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442096|NCT01367535|Naltrexone|naltrexone|mesh-list
20442097|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
20442098|NCT01367535|Paroxetine|paroxetine|mesh-list
20442099|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442100|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442101|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442102|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442103|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442104|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
20442105|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219128|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20219129|NCT00315835|Buprenorphine|buprenorphine|mesh-list
20219130|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20219131|NCT00315835|Narcotics|narcotics|mesh-ancestor
20219132|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219133|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219134|NCT00315835|Analgesics|analgesics|mesh-ancestor
20442106|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442107|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442108|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442109|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20524700|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20442110|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20442111|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442112|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442113|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
20442114|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442115|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20524701|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524702|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
20524703|NCT01754701|Iron|iron|mesh-list
20524704|NCT01754701|Trace Elements|trace elements|mesh-ancestor
20524705|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
20524706|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524707|NCT01754792|Inositol|inositol|mesh-list
20524708|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
20524709|NCT01754792|Vitamins|vitamins|mesh-ancestor
20524710|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
20524711|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524712|NCT01754805|Methotrexate|methotrexate|mesh-list
20524713|NCT01754805|Peficitinib|peficitinib|mesh-list
20524714|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20524715|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
19405883|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405884|NCT03585062|Paclitaxel|paclitaxel|mesh-list
19405885|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19405886|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19405887|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19405888|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
19405889|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19405890|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405891|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19405892|NCT03585036|Tramadol|tramadol|mesh-list
19405893|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19405894|NCT03585036|Narcotics|narcotics|mesh-ancestor
19405895|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405896|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405897|NCT03585036|Analgesics|analgesics|mesh-ancestor
19405898|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
19405899|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405900|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20524716|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20524717|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524718|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20524719|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
20524720|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524721|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524722|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
20524723|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524724|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20524725|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20524726|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
20524727|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524728|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20524729|NCT01754831|Fluorides|fluorides|mesh-list
20524730|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
20524731|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
20524732|NCT01754831|Protective Agents|protective agents|mesh-ancestor
20524733|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524734|NCT01754844|AZD7624|azd7624|mesh-list
20524735|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20524736|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524737|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524738|NCT01754870|Rituximab|rituximab|mesh-list
20524739|NCT01754870|Lenalidomide|lenalidomide|mesh-list
20524740|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19405901|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20524741|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20524742|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524743|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
20524744|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524745|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524746|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20524747|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20524748|NCT01754870|Growth Substances|growth substances|mesh-ancestor
20524749|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
19405902|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20524750|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20442116|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
20442117|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442118|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442119|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
20442120|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442121|NCT01367561|Naloxone|naloxone|mesh-list
20442122|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
20442123|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442124|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442125|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
20442126|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442127|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
20442128|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442129|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442130|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
20442131|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442132|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
20442133|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442134|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442135|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
20442136|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442137|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
20442138|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442139|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442140|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
20442141|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442142|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
20442143|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442144|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442145|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
20442146|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442147|NCT01367626|Letrozole|letrozole|mesh-list
20442148|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442149|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20442150|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20442151|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442152|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442153|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20442154|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
20442155|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442156|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442157|NCT01367652|Letrozole|letrozole|mesh-list
20442158|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442159|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20442160|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20442161|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442162|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442163|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20442164|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
20442165|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442166|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442167|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
20442168|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20442169|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442170|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
20442171|NCT01367743|Epinephrine|epinephrine|mesh-list
20442172|NCT01367743|Norepinephrine|norepinephrine|mesh-list
20442173|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20442174|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20442175|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20442176|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
20442177|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442178|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442179|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442180|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20442181|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20442182|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
20442183|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442184|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20442185|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
20442186|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
19405903|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405904|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
20442187|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
20442188|NCT01367756|Citalopram|citalopram|mesh-list
20442189|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442190|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442191|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442192|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442193|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442194|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
20442195|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442196|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442197|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442198|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442199|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20442200|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20442201|NCT01367912|Estradiol|estradiol|mesh-list
20442202|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20442203|NCT01367912|Estrogens|estrogens|mesh-ancestor
20442204|NCT01367912|Hormones|hormones|mesh-ancestor
20442205|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442206|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442207|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20442208|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
20442209|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20442210|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20442211|NCT01367964|Hormones|hormones|mesh-list
20442212|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20442213|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20442214|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
20442215|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442216|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442217|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442218|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442219|NCT01367990|Norepinephrine|norepinephrine|mesh-list
20442220|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20442221|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20442222|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
20442223|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442224|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442225|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442226|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
20442227|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
20442228|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442229|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20442230|NCT01368003|Dutasteride|dutasteride|mesh-list
20442231|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20442232|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20442233|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442234|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442235|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
20442236|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442237|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442238|NCT01368016|Nicotine|nicotine|mesh-list
20442239|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20442240|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
20442241|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442242|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442243|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20442244|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20442245|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
20442246|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442247|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442248|NCT01368068|Tibolone|tibolone|mesh-list
20442249|NCT01368068|Citalopram|citalopram|mesh-list
20442250|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442251|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442252|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442253|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442254|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442255|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
20442256|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442257|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442258|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442259|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442260|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
20442261|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
20442262|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442263|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20442264|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20442265|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442266|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20442267|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
20442268|NCT01368068|Hormones|hormones|mesh-ancestor
20442269|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20442270|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
20442271|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20442272|NCT01368328|Chromium|chromium|mesh-list
20442273|NCT01368328|Niacin|niacin|mesh-list
20442274|NCT01368328|Trace Elements|trace elements|mesh-ancestor
20442275|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
20442276|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442277|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20442278|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
20442279|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442280|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20442281|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
20442282|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
20442283|NCT01368328|Vitamins|vitamins|mesh-ancestor
20442284|NCT01368341|Amoxicillin|amoxicillin|mesh-list
20442285|NCT01368341|Doxycycline|doxycycline|mesh-list
20442286|NCT01368341|Penicillin V|penicillin v|mesh-list
20442287|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20442288|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442289|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
20442290|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20442291|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20442292|NCT01368419|Endostar protein|endostar protein|mesh-list
20442293|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442294|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442295|NCT01368419|Growth Substances|growth substances|mesh-ancestor
20442296|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442297|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442298|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442299|NCT01368445|Azelastine|azelastine|mesh-list
20442300|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20442301|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
20442302|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442303|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442304|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20442305|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
20219135|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
20219136|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219137|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20219138|NCT00315848|Buprenorphine|buprenorphine|mesh-list
20219139|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20219140|NCT00315848|Narcotics|narcotics|mesh-ancestor
20219141|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219142|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219143|NCT00315848|Analgesics|analgesics|mesh-ancestor
20219144|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
20219145|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219146|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20219147|NCT00315861|Pemetrexed|pemetrexed|mesh-list
20219148|NCT00315861|Topotecan|topotecan|mesh-list
20442306|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20442307|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442308|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442309|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20442310|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20442311|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20442312|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
20442313|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
20442314|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442315|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
20442316|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20442317|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442318|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442319|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442320|NCT01368627|Sirolimus|sirolimus|mesh-list
20219149|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219150|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442321|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20442322|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442323|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20442324|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442325|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
20442326|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20442327|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
20442328|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442329|NCT01368757|Lenalidomide|lenalidomide|mesh-list
20442330|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
20442331|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442332|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442333|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442334|NCT01368757|Growth Substances|growth substances|mesh-ancestor
20442335|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442336|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442337|NCT01368783|Ritonavir|ritonavir|mesh-list
20442338|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20442339|NCT01368783|Tenofovir|tenofovir|mesh-list
20442340|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20442341|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20442342|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
20442343|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442344|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442345|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20442346|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20442347|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
20442348|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219151|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219152|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20442349|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20442350|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20442351|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20442352|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20442353|NCT01368848|Bevacizumab|bevacizumab|mesh-list
20442354|NCT01368848|Docetaxel|docetaxel|mesh-list
20442355|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20442356|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442357|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442358|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442359|NCT01368848|Growth Substances|growth substances|mesh-ancestor
20442360|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442361|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442362|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
20442363|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
19848436|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848437|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19848438|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19848439|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848440|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848441|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848442|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
19848443|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19848444|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19848445|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19848446|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19848447|NCT00694551|Poly I-C|poly i-c|mesh-list
20219153|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20219154|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20219155|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20219156|NCT00315874|Buprenorphine|buprenorphine|mesh-list
20219157|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20219158|NCT00315874|Narcotics|narcotics|mesh-ancestor
20219159|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219160|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219161|NCT00315874|Analgesics|analgesics|mesh-ancestor
20219162|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
20219163|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219164|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20219165|NCT00315887|Buprenorphine|buprenorphine|mesh-list
20219166|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20219167|NCT00315887|Narcotics|narcotics|mesh-ancestor
20442364|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
19405905|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
20442365|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442366|NCT01368887|Niacinamide|niacinamide|mesh-list
20442367|NCT01368887|Niacin|niacin|mesh-list
20442368|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
20442369|NCT01368887|Calcipotriene|calcipotriene|mesh-list
20442370|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
20442371|NCT01368887|Vitamins|vitamins|mesh-ancestor
20442372|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
20442373|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442374|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20442375|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
20442376|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442377|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20442378|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
20442379|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
20442380|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20442381|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20442382|NCT01369043|Vitamins|vitamins|mesh-list
20442383|NCT01369043|Ascorbic Acid|ascorbic acid|mesh-list
20442384|NCT01369043|Vitamin E|vitamin e|mesh-list
20442385|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
20442386|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442387|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
20442388|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442389|NCT01369043|Protective Agents|protective agents|mesh-ancestor
20442390|NCT01369082|Cyclosporine|cyclosporine|mesh-list
20442391|NCT01369082|Sirolimus|sirolimus|mesh-list
20442392|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
20442393|NCT01369082|Tacrolimus|tacrolimus|mesh-list
20442394|NCT01369082|Cyclosporins|cyclosporins|mesh-list
20442395|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20442396|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
20442397|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442398|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20442399|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442400|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442401|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
20442402|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442403|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
20442404|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20442405|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20442406|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442407|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20442408|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
20442409|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20442410|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20442411|NCT01369121|Hormones|hormones|mesh-ancestor
20442412|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442413|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442414|NCT01369186|Morphine|morphine|mesh-list
20442415|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20442416|NCT01369186|Narcotics|narcotics|mesh-ancestor
20442417|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442418|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442419|NCT01369186|Analgesics|analgesics|mesh-ancestor
20442420|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
20442421|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442422|NCT01369212|Tenofovir|tenofovir|mesh-list
20442423|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20442424|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
20442425|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442426|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20442427|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20442428|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442429|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442430|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20442431|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20442432|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
20442433|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20442434|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20442435|NCT01369238|Analgesics|analgesics|mesh-ancestor
20442436|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
19405906|NCT03584984|Coagulants|coagulants|mesh-ancestor
19693564|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20442437|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442438|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405907|NCT03584919|Doxycycline|doxycycline|mesh-list
20442439|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20442440|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20442441|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
20524751|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
20524752|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524753|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
20524754|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
20524755|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20524756|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524757|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524758|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
20524759|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20524760|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20524761|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524762|NCT01754961|Vitamin D|vitamin d|mesh-list
20524763|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
20524764|NCT01754961|Vitamins|vitamins|mesh-list
20524765|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
20524766|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524767|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20524768|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20524769|NCT01754974|Ribavirin|ribavirin|mesh-list
20524770|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20524771|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
20524772|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524773|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
20524774|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524775|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
20524776|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
19693565|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19693566|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693567|NCT04977960|Canrenone|canrenone|mesh-list
19693568|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
19693569|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20524777|NCT01755078|Calcium|calcium|mesh-list
20524778|NCT01755078|Sevelamer|sevelamer|mesh-list
20524779|NCT01755078|Calcium acetate|calcium acetate|mesh-list
20524780|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20524781|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693570|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
19693571|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693572|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693573|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19693574|NCT04977960|Diuretics|diuretics|mesh-ancestor
19693575|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
19693576|NCT04978155|Anesthetics|anesthetics|mesh-list
19693577|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693578|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693579|NCT04977778|Fluorides|fluorides|mesh-list
19693580|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
19693581|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
20219168|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219169|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219170|NCT00315887|Analgesics|analgesics|mesh-ancestor
20219171|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
20219172|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524782|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20524783|NCT01755078|Antacids|antacids|mesh-ancestor
20524784|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524785|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524786|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
20524787|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
20524788|NCT01755117|Ropivacaine|ropivacaine|mesh-list
20524789|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
20524790|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
19693582|NCT04977778|Protective Agents|protective agents|mesh-ancestor
20219173|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20219174|NCT00315900|Valproic Acid|valproic acid|mesh-list
20219175|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20219176|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
20219177|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219178|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20524791|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693583|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219179|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19405908|NCT03584919|Cefuroxime|cefuroxime|mesh-list
20219180|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219181|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219182|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
20219183|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219184|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219185|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
20219186|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219187|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
20219188|NCT00315913|Propranolol|propranolol|mesh-list
20219189|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20219190|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20219191|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
20219192|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219193|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442442|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
20442443|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
20442444|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442445|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442446|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
20442447|NCT01369277|Vitamins|vitamins|mesh-ancestor
20442448|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
20442449|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442450|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20442451|NCT01369290|Citalopram|citalopram|mesh-list
20442452|NCT01369290|Bupropion|bupropion|mesh-list
20442453|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20442454|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442455|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442456|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442457|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442458|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442459|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
20442460|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442461|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442462|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442463|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442464|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442465|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20442466|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
20442467|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20442468|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20442469|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442470|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20442471|NCT01369290|Analgesics|analgesics|mesh-ancestor
20442472|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
20442473|NCT01369303|Tenofovir|tenofovir|mesh-list
20442474|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
20442475|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442476|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20442477|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20442478|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442479|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442480|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20442481|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20442482|NCT01369368|Azacitidine|azacitidine|mesh-list
20442483|NCT01369368|Valproic Acid|valproic acid|mesh-list
20442484|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20442485|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
20442486|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442487|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442488|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442489|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
20442490|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
20442491|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442492|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442493|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
20442494|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20442495|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442496|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442497|NCT01369472|Carvedilol|carvedilol|mesh-list
20442498|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20442499|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20219194|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442500|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
20442501|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442502|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442503|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442504|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20442505|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
20442506|NCT01369472|Protective Agents|protective agents|mesh-ancestor
20442507|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20442508|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442509|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20442510|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
20442511|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20442512|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20442513|NCT01369576|Zopiclone|zopiclone|mesh-list
20442514|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20442515|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442516|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442517|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
20442518|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
20442519|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442520|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442521|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
20442522|NCT01369602|Vitamins|vitamins|mesh-ancestor
20442523|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
20442524|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442525|NCT01369667|Vitamin D|vitamin d|mesh-list
20442526|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
20442527|NCT01369667|Vitamins|vitamins|mesh-ancestor
20442528|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
20442529|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442530|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20442531|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20442532|NCT01369693|Lobeline|lobeline|mesh-list
20442533|NCT01369693|Nicotine|nicotine|mesh-list
20442534|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20442535|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
20442536|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442537|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442538|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20442539|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20442540|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
20442541|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442542|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442543|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
20442544|NCT01369719|Deferasirox|deferasirox|mesh-list
20442545|NCT01369719|Deferoxamine|deferoxamine|mesh-list
20442546|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20442547|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
20442548|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
20442549|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442550|NCT01369719|Siderophores|siderophores|mesh-ancestor
20442551|NCT01369979|Imidacloprid|imidacloprid|mesh-list
20442552|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
20442553|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442554|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442555|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442556|NCT01370031|Charcoal|charcoal|mesh-list
20442557|NCT01370031|Antidotes|antidotes|mesh-ancestor
20442558|NCT01370031|Protective Agents|protective agents|mesh-ancestor
20442559|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442560|NCT01370096|Epoprostenol|epoprostenol|mesh-list
20442561|NCT01370096|Vasopressins|vasopressins|mesh-list
20442562|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
20442563|NCT01370096|Tezosentan|tezosentan|mesh-list
20442564|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
20442565|NCT01370096|Coagulants|coagulants|mesh-ancestor
20442566|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20442567|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20442568|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
20442569|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442570|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20442571|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20442572|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
20442573|NCT01370135|Ranibizumab|ranibizumab|mesh-list
19405909|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
20442574|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442575|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442576|NCT01370135|Growth Substances|growth substances|mesh-ancestor
20442577|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442578|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442579|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442580|NCT01370148|Conivaptan|conivaptan|mesh-list
20442581|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20442582|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442583|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
20442584|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442585|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20442586|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20442587|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
20442588|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442589|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442590|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442591|NCT01370187|Montelukast|montelukast|mesh-list
20442592|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20442593|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
20442594|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20442595|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
20442596|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442597|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442598|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20442599|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20442600|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442601|NCT01370291|Risperidone|risperidone|mesh-list
20442602|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20442603|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
20442604|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442605|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442606|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442607|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20442608|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20442609|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442610|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442611|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20442612|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
20442613|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20442614|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20442615|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442616|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442617|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442618|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442619|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442620|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442621|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442622|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442623|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
20442624|NCT01370343|Cyclosporine|cyclosporine|mesh-list
20442625|NCT01370343|Cyclosporins|cyclosporins|mesh-list
20442626|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
20442627|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442628|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442629|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20442630|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
20442631|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442632|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
20442633|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219195|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20219196|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20219197|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
20219198|NCT00315926|Melatonin|melatonin|mesh-list
20219199|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
20219200|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219201|NCT00315926|Protective Agents|protective agents|mesh-ancestor
19693584|NCT04977674|Naltrexone|naltrexone|mesh-list
20219202|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405910|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19693585|NCT04977674|Ketamine|ketamine|mesh-list
20442634|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
20442635|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20442636|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20442637|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
20442638|NCT01370343|Vitamins|vitamins|mesh-ancestor
20442639|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
20442640|NCT01370434|Dexamethasone|dexamethasone|mesh-list
20442641|NCT01370434|Doxorubicin|doxorubicin|mesh-list
20442642|NCT01370434|Vincristine|vincristine|mesh-list
20442643|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20442644|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
20442645|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
20442646|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442647|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442648|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20442649|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
20442650|NCT01370434|Hormones|hormones|mesh-ancestor
20442651|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442652|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20442653|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442654|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442655|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442656|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20442657|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20442658|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19405911|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19405912|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
19405913|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19405914|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19405915|NCT03584854|Methylergonovine|methylergonovine|mesh-list
19405916|NCT03584854|Carboprost|carboprost|mesh-list
19405917|NCT03584854|Dinoprost|dinoprost|mesh-list
19405918|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
19405919|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
19405920|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19405921|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405922|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19405923|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
19405924|NCT03584841|Pilocarpine|pilocarpine|mesh-list
19405925|NCT03584841|Miotics|miotics|mesh-ancestor
19405926|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
19405927|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405928|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405929|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19405930|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19405931|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
19405932|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19405933|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416511|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416512|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
19416513|NCT02406209|Hormones|hormones|mesh-ancestor
19416514|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416515|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416516|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19416517|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416518|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
19416519|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
19416520|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416521|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19416522|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19416523|NCT02406209|Protective Agents|protective agents|mesh-ancestor
19416524|NCT02405585|Leucovorin|leucovorin|mesh-list
19416525|NCT02405585|Gemcitabine|gemcitabine|mesh-list
19416526|NCT02405585|Fluorouracil|fluorouracil|mesh-list
19416527|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
19416528|NCT02405585|Irinotecan|irinotecan|mesh-list
19416529|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19416530|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
19416531|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416532|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416533|NCT02405585|Antiviral Agents|antiviral agents|mesh-ancestor
19416534|NCT02405585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416535|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416536|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19416537|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
19416538|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442659|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20442660|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
20442661|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
20442662|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
20442663|NCT01370486|Melatonin|melatonin|mesh-list
20442664|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
20442665|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442666|NCT01370486|Protective Agents|protective agents|mesh-ancestor
20442667|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442668|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442669|NCT01370707|Metformin|metformin|mesh-list
20442670|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20442671|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442672|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
20442673|NCT01370772|Rituximab|rituximab|mesh-list
20442674|NCT01370772|Fludarabine|fludarabine|mesh-list
20442675|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20442676|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
20442677|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442678|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20442679|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20442680|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
20442681|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442682|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442683|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20442684|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20442685|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20442686|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
20442687|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442688|NCT01370889|Resveratrol|resveratrol|mesh-list
20442689|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
20442690|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442691|NCT01370889|Protective Agents|protective agents|mesh-ancestor
20442692|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442693|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442694|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20442695|NCT01370915|Vitamins|vitamins|mesh-list
20442696|NCT01370915|Pregabalin|pregabalin|mesh-list
20442697|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
20442698|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442699|NCT01370915|Analgesics|analgesics|mesh-ancestor
20442700|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
20442701|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442702|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
20442703|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20442704|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442705|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442706|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20442707|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20442708|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20442709|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442710|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442711|NCT01371058|Clopidogrel|clopidogrel|mesh-list
20442712|NCT01371058|Policosanol|policosanol|mesh-list
20442713|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20442714|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20442715|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20442716|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20442717|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
20442718|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442719|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442720|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442721|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20442722|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20442723|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
20442724|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20442725|NCT01371201|Sunitinib|sunitinib|mesh-list
20442726|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442727|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442728|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442729|NCT01371201|Growth Substances|growth substances|mesh-ancestor
20442730|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442731|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442732|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20442733|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524792|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442734|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442735|NCT01371240|Secretin|secretin|mesh-list
20442736|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20442737|NCT01371240|Hormones|hormones|mesh-ancestor
20442738|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442739|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524793|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
20524794|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524795|NCT01755182|Somatostatin|somatostatin|mesh-list
20524796|NCT01755182|Hormones|hormones|mesh-ancestor
20524797|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524798|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524799|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
20524800|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20524801|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524802|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20524803|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20524804|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524805|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524806|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524807|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20524808|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20524809|NCT01755299|Caffeine|caffeine|mesh-list
20524810|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20524811|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524812|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20524813|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524814|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524815|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20524816|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20524817|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
20524818|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524819|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
20524820|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20524821|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20524822|NCT01755338|Prednisolone|prednisolone|mesh-list
20524823|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
20524824|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20524825|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
20524826|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20524827|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
20524828|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
20524829|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524830|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524831|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524832|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
20524833|NCT01755338|Hormones|hormones|mesh-ancestor
20524834|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524835|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20524836|NCT01755338|Protective Agents|protective agents|mesh-ancestor
20524837|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20524838|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524839|NCT01755377|Benzonidazole|benzonidazole|mesh-list
20524840|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20524841|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
20524842|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524843|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20524844|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20524845|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20524846|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524847|NCT01755403|Benzonidazole|benzonidazole|mesh-list
20524848|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20524849|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
20524850|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524851|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20524852|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20524853|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20524854|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524855|NCT01755468|Insulin|insulin|mesh-list
20524856|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20524857|NCT01755468|Metformin|metformin|mesh-list
20613604|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
20613605|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19405934|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
20442740|NCT01371331|Tacrolimus|tacrolimus|mesh-list
20442741|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20442742|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
20442743|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442744|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20442745|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442746|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442747|NCT01371344|Tacrolimus|tacrolimus|mesh-list
20442748|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20442749|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
20442750|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442751|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20442752|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442753|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442754|NCT01371435|Paroxetine|paroxetine|mesh-list
20442755|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442756|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442757|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442758|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442759|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442760|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
20442761|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442762|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442763|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442764|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442765|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20442766|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20442767|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442768|NCT01371448|Paroxetine|paroxetine|mesh-list
20442769|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442770|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442771|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442772|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442773|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442774|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
20442775|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442776|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442777|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442778|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442779|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20442780|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20442781|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442782|NCT01371461|Paroxetine|paroxetine|mesh-list
20442783|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442784|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442785|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442786|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442787|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442788|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
20442789|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442790|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442791|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442792|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20442793|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20442794|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20442795|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442796|NCT01371474|Paroxetine|paroxetine|mesh-list
20442797|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20442798|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20442799|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442800|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442801|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442802|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
20442803|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442804|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20442805|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
20442806|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19405935|NCT03584698|Misoprostol|misoprostol|mesh-list
19405936|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19693586|NCT04977674|Analgesics|analgesics|mesh-ancestor
20442807|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20442808|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20442809|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442810|NCT01371487|Trametinib|trametinib|mesh-list
20442811|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442812|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20442813|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442814|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442815|NCT01371526|Cosyntropin|cosyntropin|mesh-list
20442816|NCT01371526|Hormones|hormones|mesh-ancestor
20442817|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442818|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442819|NCT01371604|Ribavirin|ribavirin|mesh-list
20442820|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20442821|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
20442822|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442823|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
20442824|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442825|NCT01371682|Ropinirole|ropinirole|mesh-list
19693587|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
19693588|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693589|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693590|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19693591|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19693592|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
19693593|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
19693594|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442826|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20442827|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20442828|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
20442829|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
20442830|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442831|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442832|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442833|NCT01371968|Alfentanil|alfentanil|mesh-list
20442834|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20442835|NCT01371968|Narcotics|narcotics|mesh-ancestor
20442836|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20442837|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442838|NCT01371968|Analgesics|analgesics|mesh-ancestor
20442839|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
20442840|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693595|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19693596|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19693597|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693598|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219203|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219204|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
20219205|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
20219206|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20219207|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
20219208|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219209|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219210|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19693599|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19693600|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19693601|NCT04977908|Insulin|insulin|mesh-list
20219211|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
20219212|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20219213|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
20219214|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219215|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219216|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20219217|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
20219218|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
20219219|NCT00315965|Protective Agents|protective agents|mesh-ancestor
20219220|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
20219221|NCT00316030|Bexarotene|bexarotene|mesh-list
20219222|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219223|NCT00316095|Telmisartan|telmisartan|mesh-list
20219224|NCT00316095|Simvastatin|simvastatin|mesh-list
20219225|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20219226|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20219227|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
20524858|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
20442841|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20442842|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
20442843|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
20442844|NCT01372007|Lanreotide|lanreotide|mesh-list
20442845|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442846|NCT01372111|Cisplatin|cisplatin|mesh-list
20442847|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442848|NCT01372280|Galantamine|galantamine|mesh-list
20442849|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20442850|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442851|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442852|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
20442853|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442854|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442855|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20442856|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
20442857|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442858|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
20442859|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
20442860|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
20442861|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20442862|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20442863|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442864|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20442865|NCT01372306|Galantamine|galantamine|mesh-list
20442866|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20442867|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442868|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442869|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
20442870|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442871|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442872|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20442873|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
20442874|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442875|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
20442876|NCT01372371|Vancomycin|vancomycin|mesh-list
20442877|NCT01372371|Gentamicins|gentamicins|mesh-list
20442878|NCT01372371|Cefuroxime|cefuroxime|mesh-list
20442879|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
20442880|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20442881|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20442882|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20442883|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442884|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442885|NCT01372423|Lubiprostone|lubiprostone|mesh-list
20442886|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20442887|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20442888|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442889|NCT01372449|Memantine|memantine|mesh-list
20442890|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20442891|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20442892|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
20442893|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442894|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442895|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442896|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20442897|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20442898|NCT01372540|Filanesib|filanesib|mesh-list
20442899|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
20442900|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
20442901|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442902|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442903|NCT01372579|Carboplatin|carboplatin|mesh-list
20442904|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442905|NCT01372644|Pasireotide|pasireotide|mesh-list
20442906|NCT01372644|Hormones|hormones|mesh-ancestor
20442907|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442908|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442909|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
20442910|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
20442911|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
20613606|NCT02255942|Protective Agents|protective agents|mesh-ancestor
20442912|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20613607|NCT02255955|Acetaminophen|acetaminophen|mesh-list
20442913|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
20442914|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
20442915|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20442916|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442917|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442918|NCT01372761|CKD732|ckd732|mesh-list
20442919|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20442920|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20442921|NCT01372761|Growth Substances|growth substances|mesh-ancestor
20442922|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442923|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
20442924|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442925|NCT01372826|Naloxegol|naloxegol|mesh-list
20442926|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20442927|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442928|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
20442929|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442930|NCT01372839|Atorvastatin|atorvastatin|mesh-list
20442931|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20442932|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20442933|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
20442934|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442935|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20442936|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19693602|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19693603|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707713|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442937|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442938|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
20442939|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20442940|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
20442941|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20442942|NCT01372904|Dexamethasone|dexamethasone|mesh-list
20442943|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
20442944|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20442945|NCT01372904|BB 1101|bb 1101|mesh-list
20442946|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20442947|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
20442948|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
20442949|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442950|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442951|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20442952|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
20442953|NCT01372904|Hormones|hormones|mesh-ancestor
20442954|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442955|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20442956|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442957|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
20442958|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442959|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442960|NCT01372930|Etanercept|etanercept|mesh-list
20442961|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20442962|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20442963|NCT01372930|Analgesics|analgesics|mesh-ancestor
20442964|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
20442965|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442966|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442967|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707714|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707715|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707716|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707717|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19707718|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19707719|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707720|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19707721|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19707722|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707723|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
19707724|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20442968|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20442969|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20442970|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20442971|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
20442972|NCT01372982|Letrozole|letrozole|mesh-list
20442973|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20442974|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20524859|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
20442975|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20442976|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20442977|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20442978|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20442979|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
20442980|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19405937|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
19405938|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19405939|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405940|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19405941|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19405942|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
19405943|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405944|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405945|NCT03584698|Analgesics|analgesics|mesh-ancestor
19405946|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
19848448|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20442981|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442982|NCT01373008|Beclomethasone|beclomethasone|mesh-list
20442983|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20442984|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
20442985|NCT01373008|Hormones|hormones|mesh-ancestor
20442986|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20442987|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442988|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20442989|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
20442990|NCT01373021|Fentanyl|fentanyl|mesh-list
20442991|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
20442992|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20442993|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848449|NCT00694551|Vaccines|vaccines|mesh-list
19848450|NCT00694551|Poly ICLC|poly iclc|mesh-list
19848451|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
19848452|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848453|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
19848454|NCT00694551|Laxatives|laxatives|mesh-ancestor
19848455|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848456|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
19848457|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848458|NCT00694603|Cetuximab|cetuximab|mesh-list
20219228|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219229|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20442994|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20442995|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20442996|NCT01373021|Analgesics|analgesics|mesh-ancestor
20442997|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
20442998|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20442999|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20443000|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20443001|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20443002|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
20443003|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443004|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443005|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20443006|NCT01373021|Narcotics|narcotics|mesh-ancestor
20219230|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20219231|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219232|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20219233|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20219234|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20247180|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20247181|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20247182|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20247183|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20247184|NCT00431249|Cilostazol|cilostazol|mesh-list
20247185|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20247186|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
20247187|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247188|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247189|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20247190|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
20247191|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19405947|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443007|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20443008|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20443009|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
20443010|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
20524860|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20524861|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524862|NCT01755494|Metformin|metformin|mesh-list
20524863|NCT01755494|Saxagliptin|saxagliptin|mesh-list
20524864|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20524865|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524866|NCT01755494|Incretins|incretins|mesh-ancestor
20524867|NCT01755494|Hormones|hormones|mesh-ancestor
20524868|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524869|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20524870|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
20524871|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524872|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524873|NCT01755520|Aspirin|aspirin|mesh-list
20524874|NCT01755520|Ticagrelor|ticagrelor|mesh-list
20524875|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20524876|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20524877|NCT01755520|Analgesics|analgesics|mesh-ancestor
20524878|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
20524879|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524880|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524881|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20524882|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524883|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20524884|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20524885|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524886|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20524887|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20524888|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524889|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
20524890|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20524891|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20524892|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20524893|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
20524894|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524895|NCT01755559|Artesunate|artesunate|mesh-list
20524896|NCT01755559|Lumefantrine|lumefantrine|mesh-list
20524897|NCT01755559|Artemether|artemether|mesh-list
20524898|NCT01755559|Piperaquine|piperaquine|mesh-list
20524899|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20524900|NCT01755559|Amodiaquine|amodiaquine|mesh-list
20524901|NCT01755559|Artenimol|artenimol|mesh-list
20524902|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
20524903|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20524904|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20524905|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524906|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524907|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
20524908|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
20524909|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20524910|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
20524911|NCT01755572|Liraglutide|liraglutide|mesh-list
20524912|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20524913|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524914|NCT01755572|Incretins|incretins|mesh-ancestor
20524915|NCT01755572|Hormones|hormones|mesh-ancestor
20524916|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530474|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530475|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20530476|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20530477|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530478|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530479|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20530480|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
20530481|NCT01788969|Citalopram|citalopram|mesh-list
20530482|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20530483|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20530484|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530485|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530486|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530487|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
20530488|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443011|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
20443012|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20443013|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443014|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20443015|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443016|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
20443017|NCT01373138|Ephedrine|ephedrine|mesh-list
20443018|NCT01373138|Desloratadine|desloratadine|mesh-list
20443019|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20443020|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
20443021|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443022|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443023|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443024|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20443025|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20443026|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
20443027|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
20443028|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20443029|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
20443030|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443031|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20443032|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
20443033|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
20443034|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20443035|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20443036|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
20443037|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
20443038|NCT01373216|Exenatide|exenatide|mesh-list
20443039|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20443040|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443041|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20443042|NCT01373216|Incretins|incretins|mesh-ancestor
20443043|NCT01373216|Hormones|hormones|mesh-ancestor
20443044|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443045|NCT01373333|Amifampridine|amifampridine|mesh-list
20443046|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20443047|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443048|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443049|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20443050|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443051|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443052|NCT01373359|Misoprostol|misoprostol|mesh-list
20443053|NCT01373359|Oxytocin|oxytocin|mesh-list
19693604|NCT04977661|Vitamin E|vitamin e|mesh-list
19405948|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405949|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405950|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19405951|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
19405952|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405953|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19405954|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
19405955|NCT03584529|Vitamin D|vitamin d|mesh-list
19405956|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
19693605|NCT04977661|Tocopherols|tocopherols|mesh-list
20443054|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
20443055|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20443056|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443057|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20443058|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
20443059|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20443060|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20443061|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20443062|NCT01373372|Hormones|hormones|mesh-ancestor
20443063|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20524917|NCT01755611|Minocycline|minocycline|mesh-list
20524918|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19405957|NCT03584529|Vitamins|vitamins|mesh-ancestor
19405958|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
19693606|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
20524919|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20524920|NCT01755663|Metoprolol|metoprolol|mesh-list
20524921|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20524922|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20524923|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
20524924|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
20524925|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19405959|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443064|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443065|NCT01373398|Apaziquone|apaziquone|mesh-list
20443066|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443067|NCT01373411|Ticagrelor|ticagrelor|mesh-list
20443068|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20443069|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20443070|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20443071|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20443072|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
20443073|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443074|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443075|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443076|NCT01373463|Carboplatin|carboplatin|mesh-list
20443077|NCT01373463|Pemetrexed|pemetrexed|mesh-list
20443078|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443079|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443080|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443081|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20443082|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20443083|NCT01373528|Budesonide|budesonide|mesh-list
20443084|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443085|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20443086|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
20443087|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443088|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443089|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20443090|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
20443091|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
20443092|NCT01373528|Hormones|hormones|mesh-ancestor
20443093|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443094|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
20443095|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443096|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443097|NCT01373554|Oltipraz|oltipraz|mesh-list
20443098|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
20443099|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443100|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
20443101|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20443102|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
20443103|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20443104|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20443105|NCT01373554|Protective Agents|protective agents|mesh-ancestor
20443106|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443107|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443108|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20443109|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20443110|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443111|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443112|NCT01373593|Lidocaine|lidocaine|mesh-list
20443113|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
20443114|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
20443115|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443116|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443117|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
20443118|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443119|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20443120|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20443121|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20443122|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443123|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443124|NCT01373606|Terlipressin|terlipressin|mesh-list
20443125|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20443126|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20443127|NCT01373632|Sirolimus|sirolimus|mesh-list
20443128|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20443129|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443130|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20443131|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443132|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
20443133|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443134|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
20443135|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693607|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
20443136|NCT01373684|Tenofovir|tenofovir|mesh-list
20443137|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20443138|NCT01373684|Entecavir|entecavir|mesh-list
20443139|NCT01373684|Adefovir|adefovir|mesh-list
20443140|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
20443141|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443142|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20443143|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20443144|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443145|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443146|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20443147|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20443148|NCT01373697|Ibuprofen|ibuprofen|mesh-list
20443149|NCT01373697|Ketoprofen|ketoprofen|mesh-list
20443150|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20443151|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20443152|NCT01373697|Analgesics|analgesics|mesh-ancestor
20443153|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
20443154|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443155|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443156|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443157|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443158|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20443159|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443160|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443161|NCT01373710|Trastuzumab|trastuzumab|mesh-list
20443162|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20443163|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443164|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20443165|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443166|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443167|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443168|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20443169|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
20443170|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
20443171|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20443172|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20443173|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443174|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443175|NCT01373749|Urological Agents|urological agents|mesh-ancestor
20443176|NCT01373970|Pantoprazole|pantoprazole|mesh-list
20443177|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20443178|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20443179|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20443180|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443181|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443182|NCT01373983|Ziconotide|ziconotide|mesh-list
20443183|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20443184|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443185|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443186|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19405960|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19405961|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20219235|NCT00316160|Bupropion|bupropion|mesh-list
20219236|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20219237|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20219238|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
20219239|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219240|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20219241|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20219242|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20219243|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219244|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
20219245|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219246|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219247|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20219248|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20219249|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219250|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20219251|NCT00316212|INS 50589|ins 50589|mesh-list
20219252|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20443187|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443188|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20443189|NCT01373983|Protective Agents|protective agents|mesh-ancestor
20443190|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20443191|NCT01373983|Analgesics|analgesics|mesh-ancestor
20443192|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
20443193|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443194|NCT01374126|Azithromycin|azithromycin|mesh-list
20443195|NCT01374126|Artesunate|artesunate|mesh-list
20443196|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20443197|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443198|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
20443199|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20443200|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20443201|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443202|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
20443203|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
20443204|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20443205|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
20443206|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
20443207|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20443208|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20443209|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20443210|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443211|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443212|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
20443213|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443214|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443215|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20443216|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443217|NCT01374282|Penicillamine|penicillamine|mesh-list
20443218|NCT01374282|Antidotes|antidotes|mesh-ancestor
20443219|NCT01374282|Protective Agents|protective agents|mesh-ancestor
20443220|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443221|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
20443222|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
20443223|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443224|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443225|NCT01374308|Interferons|interferons|mesh-list
20443226|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
20443227|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
20443228|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20443229|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443230|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
20443231|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443232|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
20443233|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443234|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
20443235|NCT01374373|Hematinics|hematinics|mesh-ancestor
20443236|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
20443237|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
20443238|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
20443239|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443240|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443241|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
20443242|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443243|NCT01374581|Artesunate|artesunate|mesh-list
20443244|NCT01374581|Lumefantrine|lumefantrine|mesh-list
20443245|NCT01374581|Artemether|artemether|mesh-list
20443246|NCT01374581|Amodiaquine|amodiaquine|mesh-list
20443247|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20443248|NCT01374581|Quinine|quinine|mesh-list
20443249|NCT01374581|Clindamycin|clindamycin|mesh-list
20443250|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
20443251|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
20443252|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
20443253|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20443254|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20443255|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443256|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443257|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
20443258|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
20443259|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20443260|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
20443261|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20443262|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20443263|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443264|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443265|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20443266|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443267|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20443268|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443269|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20443270|NCT01374581|Analgesics|analgesics|mesh-ancestor
20443271|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
20443272|NCT01374620|Paclitaxel|paclitaxel|mesh-list
20443273|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20443274|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
20443275|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20443276|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443277|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
20443278|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
20443279|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
20443280|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443281|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443282|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
20443283|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443284|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443285|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20443286|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
20443287|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20443288|NCT01374633|Sevoflurane|sevoflurane|mesh-list
20443289|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19405962|NCT03584373|Acetaminophen|acetaminophen|mesh-list
19405963|NCT03584373|Ketorolac|ketorolac|mesh-list
19405964|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19405965|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19405966|NCT03584373|Oxycodone|oxycodone|mesh-list
19405967|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19405968|NCT03584373|Analgesics|analgesics|mesh-ancestor
19405969|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
19405970|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693608|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19693609|NCT04977661|Vitamins|vitamins|mesh-ancestor
20443290|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20443291|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
20443292|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
20443293|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443294|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443295|NCT01374698|Aspirin|aspirin|mesh-list
20443296|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20443297|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20443298|NCT01374698|Analgesics|analgesics|mesh-ancestor
20443299|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
20443300|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443301|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443302|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443303|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693610|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
19693611|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693612|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
19693613|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693614|NCT04977661|Protective Agents|protective agents|mesh-ancestor
19693615|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19693616|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693617|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20219253|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20219254|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
20219255|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219256|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219257|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219258|NCT00316238|Olanzapine|olanzapine|mesh-list
20219259|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
20219260|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
20219261|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219262|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219263|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20219264|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20219265|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20219266|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219267|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219268|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19693618|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20219269|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20443304|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20443305|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20443306|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443307|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20443308|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20443309|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443310|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
20524926|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524927|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20524928|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20524929|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20524930|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
20524931|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20524932|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524933|NCT01755676|Orlistat|orlistat|mesh-list
20524934|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524935|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524936|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20524937|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20524938|NCT01755728|Acetaminophen|acetaminophen|mesh-list
20524939|NCT01755728|Ibuprofen|ibuprofen|mesh-list
20524940|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20524941|NCT01755728|Analgesics|analgesics|mesh-ancestor
20524942|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
20524943|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20524944|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524945|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
20524946|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20524947|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20524948|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20524949|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20524950|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524951|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524952|NCT01755845|Paclitaxel|paclitaxel|mesh-list
20524953|NCT01755845|Cisplatin|cisplatin|mesh-list
20524954|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20524955|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524956|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
20524957|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
20524958|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
20524959|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524960|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20524961|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19848459|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848460|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524962|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524963|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20524964|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
20524965|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524966|NCT01755897|Paclitaxel|paclitaxel|mesh-list
20524967|NCT01755897|Cisplatin|cisplatin|mesh-list
20524968|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20524969|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524970|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
20524971|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
20524972|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
20524973|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524974|NCT01755923|Docetaxel|docetaxel|mesh-list
20524975|NCT01755923|Gefitinib|gefitinib|mesh-list
20524976|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524977|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
20524978|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
20524979|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
20524980|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20524981|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20524982|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524983|NCT01756040|Lactulose|lactulose|mesh-list
20524984|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20524985|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20524986|NCT01756105|Insulin|insulin|mesh-list
20524987|NCT01756105|Metformin|metformin|mesh-list
19405971|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848461|NCT00694707|Risperidone|risperidone|mesh-list
20524988|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
20443311|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
20443312|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20443313|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443314|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443315|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20443316|NCT01374737|Analgesics|analgesics|mesh-ancestor
20443317|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
20443318|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443319|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20443320|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20443321|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20443322|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
20443323|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443324|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443325|NCT01374750|Cyclosporine|cyclosporine|mesh-list
20443326|NCT01374750|Sirolimus|sirolimus|mesh-list
20443327|NCT01374750|Tacrolimus|tacrolimus|mesh-list
20443328|NCT01374750|Cyclosporins|cyclosporins|mesh-list
20443329|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443330|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
20443331|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443332|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20443333|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443334|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443335|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
20443336|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443337|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20443338|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443339|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20443340|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20443341|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443342|NCT01374763|Oxycodone|oxycodone|mesh-list
20443343|NCT01374763|Naloxone|naloxone|mesh-list
20443344|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20443345|NCT01374763|Narcotics|narcotics|mesh-ancestor
20443346|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443347|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443348|NCT01374763|Analgesics|analgesics|mesh-ancestor
20443349|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
20443350|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443351|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20443352|NCT01374789|Panitumumab|panitumumab|mesh-list
20443353|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20443354|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443355|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20443356|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20443357|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20443358|NCT01374828|Analgesics|analgesics|mesh-ancestor
20443359|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
20443360|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443361|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443362|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443363|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443364|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20443365|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443366|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443367|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
20443368|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443369|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
20443370|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443371|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443372|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20443373|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
20443374|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443375|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443376|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20443377|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
20443378|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
20443379|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20443380|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20443381|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
20443382|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443383|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
19405972|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
20443384|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20443385|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
20443386|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443387|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443388|NCT01375088|Propolis|propolis|mesh-list
20443389|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443390|NCT01375101|Quercetin|quercetin|mesh-list
20443391|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
20443392|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443393|NCT01375101|Protective Agents|protective agents|mesh-ancestor
20443394|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443395|NCT01375244|Lisinopril|lisinopril|mesh-list
20443396|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20443397|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
20443398|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443399|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443400|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20443401|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20443402|NCT01375244|Protective Agents|protective agents|mesh-ancestor
20443403|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443404|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20443405|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20443406|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443407|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
20443408|NCT01375322|Amlodipine|amlodipine|mesh-list
20443409|NCT01375322|Valsartan|valsartan|mesh-list
20443410|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20443411|NCT01375322|Benazepril|benazepril|mesh-list
20443412|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20443413|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20443414|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443415|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443416|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20443417|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443418|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
20443419|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20443420|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20443421|NCT01375322|Diuretics|diuretics|mesh-ancestor
20443422|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
20443423|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20443424|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20443425|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
20443426|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443427|NCT01375335|Dobutamine|dobutamine|mesh-list
20443428|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20443429|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
20443430|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
20443431|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443432|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443433|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20443434|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20443435|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20443436|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
20443437|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443438|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443439|NCT01375335|Protective Agents|protective agents|mesh-ancestor
20443440|NCT01375348|Remifentanil|remifentanil|mesh-list
20443441|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20443442|NCT01375348|Narcotics|narcotics|mesh-ancestor
20443443|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443444|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443445|NCT01375348|Analgesics|analgesics|mesh-ancestor
20443446|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
20443447|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443448|NCT01375361|Albuterol|albuterol|mesh-list
20443449|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20443450|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
20443451|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443452|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443453|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20443454|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
20443455|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
20443456|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20443457|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20443458|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20443459|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20443460|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
20443461|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443462|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443463|NCT01375387|Lacosamide|lacosamide|mesh-list
20443464|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
20443465|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20443466|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20443467|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443468|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443469|NCT01375400|Aspirin|aspirin|mesh-list
20443470|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20443471|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20443472|NCT01375400|Analgesics|analgesics|mesh-ancestor
20443473|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
20443474|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443475|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443476|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443477|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443478|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20443479|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20443480|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443481|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20443482|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20443483|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443484|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
20443485|NCT01375426|Amoxicillin|amoxicillin|mesh-list
20443486|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20443487|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443488|NCT01375452|Letrozole|letrozole|mesh-list
19405973|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19405974|NCT03584373|Narcotics|narcotics|mesh-ancestor
19405975|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19405976|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19405977|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405978|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19405979|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19405980|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19405981|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19405982|NCT03584360|Calcitriol|calcitriol|mesh-list
19405983|NCT03584360|Betamethasone|betamethasone|mesh-list
19405984|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
19405985|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19405986|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
19405987|NCT03584360|Calcipotriene|calcipotriene|mesh-list
19405988|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19405989|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19405990|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
19405991|NCT03584360|Hormones|hormones|mesh-ancestor
19405992|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19405993|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19405994|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19405995|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
19405996|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
19405997|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19405998|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19405999|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406000|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406001|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19406002|NCT03584360|Vitamins|vitamins|mesh-ancestor
19406003|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
19693619|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
19693620|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19693621|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19406004|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19406005|NCT03584178|Budesonide|budesonide|mesh-list
19406006|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406007|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19406008|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
19406009|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406010|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443489|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443490|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20443491|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20443492|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406011|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19406012|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
19406013|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
20443493|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443494|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20443495|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
20443496|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443497|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443498|NCT01375556|Ethanol|ethanol|mesh-list
20443499|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20219270|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20219271|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219272|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219273|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
20219274|NCT00316329|Artesunate|artesunate|mesh-list
20219275|NCT00316329|Amodiaquine|amodiaquine|mesh-list
20219276|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
20219277|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20219278|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20219279|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219280|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219281|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
20219282|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
20219283|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20219284|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
20219285|NCT00316407|Paclitaxel|paclitaxel|mesh-list
20219286|NCT00316407|Carboplatin|carboplatin|mesh-list
20219287|NCT00316407|Lapatinib|lapatinib|mesh-list
20219288|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20219289|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219290|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
20219291|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
20219292|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
20219293|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219294|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20443500|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443501|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443502|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443503|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20443504|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
20443505|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20443506|NCT01375634|Midazolam|midazolam|mesh-list
20443507|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20443508|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20443509|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443510|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443511|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20443512|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20443513|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20443514|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20443515|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
20443516|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
20443517|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
20219295|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219296|NCT00316420|Gemcitabine|gemcitabine|mesh-list
20219297|NCT00316420|Capecitabine|capecitabine|mesh-list
20443518|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
20443519|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443520|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443521|NCT01375699|Doxorubicin|doxorubicin|mesh-list
20443522|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20443523|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
20443524|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20443525|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443526|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20443527|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20443528|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443529|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406014|NCT03584178|Hormones|hormones|mesh-ancestor
19406015|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406016|NCT03584087|Terlipressin|terlipressin|mesh-list
19693622|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693623|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20219298|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20219299|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
20443530|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
20443531|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20443532|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20443533|NCT01375699|Urological Agents|urological agents|mesh-ancestor
20443534|NCT01375816|Leucovorin|leucovorin|mesh-list
20443535|NCT01375816|Bevacizumab|bevacizumab|mesh-list
20443536|NCT01375816|Fluorouracil|fluorouracil|mesh-list
20443537|NCT01375816|Irinotecan|irinotecan|mesh-list
20443538|NCT01375816|Calcium|calcium|mesh-list
20443539|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
20443540|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20443541|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443542|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20443543|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20443544|NCT01375816|Growth Substances|growth substances|mesh-ancestor
20443545|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443546|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
20443547|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20443548|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
20443549|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443550|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20443551|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443552|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
20443553|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20443554|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20443555|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443556|NCT01375816|Antidotes|antidotes|mesh-ancestor
20443557|NCT01375816|Protective Agents|protective agents|mesh-ancestor
20443558|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
20443559|NCT01375816|Vitamins|vitamins|mesh-ancestor
20443560|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
20443561|NCT01375842|Atezolizumab|atezolizumab|mesh-list
20443562|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443563|NCT01375881|Ritonavir|ritonavir|mesh-list
20443564|NCT01375881|Darunavir|darunavir|mesh-list
20443565|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20443566|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20443567|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
20443568|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443569|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443570|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20443571|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20443572|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
20443573|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443574|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20443575|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20443576|NCT01375920|Metyrapone|metyrapone|mesh-list
20443577|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
20443578|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443579|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443580|NCT01375972|Gemcitabine|gemcitabine|mesh-list
20443581|NCT01375972|Cisplatin|cisplatin|mesh-list
20443582|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443583|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20443584|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
20443585|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443586|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
20443587|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443588|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443589|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443590|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
20443591|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443592|NCT01375985|Radavirsen|radavirsen|mesh-list
20443593|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
20443594|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443595|NCT01376011|Quercetin|quercetin|mesh-list
20443596|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
20443597|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443598|NCT01376011|Protective Agents|protective agents|mesh-ancestor
20443599|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443600|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
20443601|NCT01376076|Risperidone|risperidone|mesh-list
19406017|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19693624|NCT04977791|Antibodies|antibodies|mesh-list
20443602|NCT01376076|Cariprazine|cariprazine|mesh-list
20443603|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20443604|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20443605|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443606|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20443607|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20443608|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443609|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443610|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443611|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20443612|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
20443613|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20443614|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443615|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20443616|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20443617|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20443618|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20443619|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
20443620|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443621|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20443622|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20443623|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443624|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20443625|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20443626|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
20443627|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
20443628|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20443629|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443630|NCT01376128|Paroxetine|paroxetine|mesh-list
20443631|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20443632|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20443633|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443634|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443635|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443636|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
20443637|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443638|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20443639|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
20443640|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20443641|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20443642|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20443643|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443644|NCT01376141|Sumatriptan|sumatriptan|mesh-list
20443645|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20443646|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20443647|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20443648|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
20443649|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443650|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443651|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443652|NCT01376154|Lamivudine|lamivudine|mesh-list
20443653|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20443654|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20443655|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443656|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443657|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
20443658|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443659|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20443660|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20443661|NCT01376180|Lamotrigine|lamotrigine|mesh-list
20443662|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
20443663|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20443664|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443665|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443666|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20443667|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443668|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20443669|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20443670|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443671|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20443672|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20443673|NCT01376193|Naratriptan|naratriptan|mesh-list
20443674|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20443675|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20443676|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20443677|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
20443678|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443679|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443680|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443681|NCT01376206|Fluticasone|fluticasone|mesh-list
20443682|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443683|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20443684|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
20443685|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443686|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443687|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20443688|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
20443689|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
20443690|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20443691|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
20443692|NCT01376232|Glycine|glycine|mesh-list
20443693|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
20443694|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443695|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443696|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443697|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20443698|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
20443699|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19406018|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19406019|NCT03584074|Celecoxib|celecoxib|mesh-list
19406020|NCT03584074|Pregabalin|pregabalin|mesh-list
19406021|NCT03584074|Analgesics|analgesics|mesh-ancestor
19406022|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
20219300|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219301|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443700|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20443701|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20443702|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443703|NCT01376258|Finasteride|finasteride|mesh-list
20443704|NCT01376258|Dutasteride|dutasteride|mesh-list
20443705|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20443706|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20443707|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443708|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443709|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
20443710|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443711|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443712|NCT01376258|Urological Agents|urological agents|mesh-ancestor
20443713|NCT01376271|Paroxetine|paroxetine|mesh-list
20443714|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20443715|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20443716|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20443717|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443718|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443719|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
20443720|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443721|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20443722|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
20443723|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20443724|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20443725|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20443726|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443727|NCT01376284|Dutasteride|dutasteride|mesh-list
20443728|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20443729|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19406023|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219302|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
20219303|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219304|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219305|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219306|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
20219307|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219308|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
20219309|NCT00316433|Irinotecan|irinotecan|mesh-list
20219310|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219311|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20219312|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20219313|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219314|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406024|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443730|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443731|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443732|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
20443733|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443734|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443735|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20443736|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20443737|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443738|NCT01376323|Incretins|incretins|mesh-ancestor
20443739|NCT01376323|Hormones|hormones|mesh-ancestor
20443740|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443741|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20443742|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
20443743|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443744|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443745|NCT01376401|Prednisone|prednisone|mesh-list
20443746|NCT01376401|Bortezomib|bortezomib|mesh-list
20443747|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20443748|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443749|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
20443750|NCT01376401|Hormones|hormones|mesh-ancestor
20443751|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443752|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443753|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20443754|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443755|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20443756|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
20443757|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443758|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20443759|NCT01376440|Eusol|eusol|mesh-list
20443760|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
20443761|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443762|NCT01376453|Fluorouracil|fluorouracil|mesh-list
20443763|NCT01376453|Sorafenib|sorafenib|mesh-list
20443764|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
20530887|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
19406025|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
19406026|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19406027|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406028|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406029|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19406030|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19406031|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19406032|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406033|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19406034|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406035|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406036|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406037|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406038|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19406039|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19406040|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406041|NCT03583892|Gabapentin|gabapentin|mesh-list
20219315|NCT00316472|Niacinamide|niacinamide|mesh-list
20219316|NCT00316472|Niacin|niacin|mesh-list
20219317|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
20219318|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
20219319|NCT00316472|Vitamins|vitamins|mesh-ancestor
20219320|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
20219321|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219322|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20219323|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
20219324|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219325|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20219326|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
20219327|NCT00316498|Miglustat|miglustat|mesh-list
20219328|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219329|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219330|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20219331|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20219332|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
20219333|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219334|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20530888|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443765|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443766|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20443767|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443768|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20443769|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
20443770|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443771|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20443772|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524989|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
20524990|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
20524991|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20524992|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20524993|NCT01756118|Dactolisib|dactolisib|mesh-list
20524994|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20524995|NCT01756131|Cabotegravir|cabotegravir|mesh-list
20524996|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20524997|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20524998|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20524999|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525000|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20525001|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20525002|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
20525003|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525004|NCT01756170|Paclitaxel|paclitaxel|mesh-list
20525005|NCT01756170|Cisplatin|cisplatin|mesh-list
20525006|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20525007|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525008|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
20525009|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
20525010|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
20525011|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525012|NCT01756183|Paclitaxel|paclitaxel|mesh-list
20525013|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20525014|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525015|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
20525016|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
20525017|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
20525018|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525019|NCT01756248|Aflibercept|aflibercept|mesh-list
20525020|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20525021|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20525022|NCT01756248|Growth Substances|growth substances|mesh-ancestor
20525023|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525024|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
20525025|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525026|NCT01756261|Aflibercept|aflibercept|mesh-list
20525027|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20525028|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20525029|NCT01756261|Growth Substances|growth substances|mesh-ancestor
20525030|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525031|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
20525032|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525033|NCT01756404|Canagliflozin|canagliflozin|mesh-list
20525034|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20525035|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525036|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19848462|NCT00694707|Cariprazine|cariprazine|mesh-list
19848463|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19848464|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
19848465|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848466|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848467|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848468|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19848469|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19848470|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848471|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19848472|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19848473|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
19848474|NCT00695019|Interferons|interferons|mesh-list
19848475|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
19848476|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
19848477|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19848478|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525037|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525038|NCT01756417|Metformin|metformin|mesh-list
20525039|NCT01756417|Canagliflozin|canagliflozin|mesh-list
19848479|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
19848480|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848481|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
19848482|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848483|NCT00695097|Rituximab|rituximab|mesh-list
20443773|NCT01376505|Vaccines|vaccines|mesh-list
20443774|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
20443775|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443776|NCT01376713|Dacarbazine|dacarbazine|mesh-list
20443777|NCT01376713|Ofatumumab|ofatumumab|mesh-list
20443778|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20443779|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20443780|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
20443781|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443782|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443783|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
20443784|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443785|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20443786|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20443787|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
20443788|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443789|NCT01376765|Antacids|antacids|mesh-ancestor
20443790|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443791|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20443792|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20443793|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20443794|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20443795|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20443796|NCT01376882|Caffeine|caffeine|mesh-list
20443797|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20443798|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443799|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20443800|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443801|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443802|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20443803|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20443804|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
20443805|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443806|NCT01376999|Hormones|hormones|mesh-list
20443807|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443808|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443809|NCT01377025|Sorafenib|sorafenib|mesh-list
20443810|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443811|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20443812|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443813|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443814|NCT01377051|Maleic acid|maleic acid|mesh-list
20443815|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443816|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443817|NCT01377103|Testosterone|testosterone|mesh-list
20443818|NCT01377103|Androgens|androgens|mesh-ancestor
20443819|NCT01377103|Hormones|hormones|mesh-ancestor
20443820|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443821|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443822|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
20443823|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20443824|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443825|NCT01377168|Naltrexone|naltrexone|mesh-list
20443826|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20443827|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20443828|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443829|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
20443830|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443831|NCT01377220|Choline|choline|mesh-list
20443832|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
20443833|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20443834|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
20443835|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443836|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20443837|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20443838|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
19848484|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20443839|NCT01377246|Octreotide|octreotide|mesh-list
20525040|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20443840|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20443841|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20443842|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443843|NCT01377259|Anesthetics|anesthetics|mesh-list
20443844|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443845|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443846|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
20443847|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20443848|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20443849|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443850|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443851|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20443852|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20443853|NCT01377285|Protective Agents|protective agents|mesh-ancestor
20443854|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443855|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
20443856|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20219335|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20219336|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219337|NCT00316563|Dronabinol|dronabinol|mesh-list
20219338|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
20219339|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219340|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219341|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219342|NCT00316563|Analgesics|analgesics|mesh-ancestor
20219343|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
20219344|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443857|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
20443858|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20443859|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20443860|NCT01377324|Estradiol|estradiol|mesh-list
20443861|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20443862|NCT01377324|Estrogens|estrogens|mesh-ancestor
20443863|NCT01377324|Hormones|hormones|mesh-ancestor
20443864|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443865|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443866|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20443867|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
20443868|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20443869|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20443870|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20443871|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443872|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20443873|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443874|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443875|NCT01377415|Bupivacaine|bupivacaine|mesh-list
20443876|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
20443877|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
20443878|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443879|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443880|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
20443881|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443882|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
20443883|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20443884|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
20443885|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443886|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443887|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20443888|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
20443889|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20443890|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20443891|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20443892|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
20443893|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20443894|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443895|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20443896|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443897|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443898|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443899|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20443900|NCT01377545|Anesthetics|anesthetics|mesh-list
20443901|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
19693625|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19693626|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
20443902|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443903|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443904|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
20443905|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443906|NCT01377597|Ranibizumab|ranibizumab|mesh-list
20443907|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20443908|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20443909|NCT01377597|Growth Substances|growth substances|mesh-ancestor
20443910|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443911|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
20443912|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443913|NCT01377610|Naltrexone|naltrexone|mesh-list
20443914|NCT01377610|Buprenorphine|buprenorphine|mesh-list
20443915|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20443916|NCT01377610|Narcotics|narcotics|mesh-ancestor
20443917|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20443918|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443919|NCT01377610|Analgesics|analgesics|mesh-ancestor
20443920|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
20443921|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443922|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20443923|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20443924|NCT01377961|Lycopene|lycopene|mesh-list
19406042|NCT03583892|Analgesics|analgesics|mesh-ancestor
19406043|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
19406044|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406045|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406046|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
19406047|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19406048|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19406049|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406050|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19406051|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19406052|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19406053|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406054|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406055|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
19406056|NCT03583866|Candesartan|candesartan|mesh-list
19406057|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19406058|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20443925|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443926|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
20443927|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443928|NCT01377961|Protective Agents|protective agents|mesh-ancestor
20443929|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443930|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20443931|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20443932|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443933|NCT01377974|Miltefosine|miltefosine|mesh-list
20443934|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20443935|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
20443936|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406059|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19406060|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406061|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19406062|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19406063|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406064|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
19406065|NCT03583710|Cisplatin|cisplatin|mesh-list
20219345|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20219346|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20219347|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219348|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219349|NCT00316563|Hormones|hormones|mesh-ancestor
20219350|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219351|NCT00316680|Vaccines|vaccines|mesh-list
20219352|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
20219353|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219354|NCT00316745|Leucovorin|leucovorin|mesh-list
20219355|NCT00316745|Fluorouracil|fluorouracil|mesh-list
20219356|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
20443937|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443938|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20443939|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20443940|NCT01378039|Budesonide|budesonide|mesh-list
19406066|NCT03583710|Etoposide|etoposide|mesh-list
19406067|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
19406068|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
19406069|NCT03583710|Mitotane|mitotane|mesh-list
20443941|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443942|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20443943|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
20443944|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20443945|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443946|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20443947|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
20443948|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
20443949|NCT01378039|Hormones|hormones|mesh-ancestor
20443950|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443951|NCT01378091|Prednisone|prednisone|mesh-list
20443952|NCT01378091|Docetaxel|docetaxel|mesh-list
20443953|NCT01378091|Lenalidomide|lenalidomide|mesh-list
20443954|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443955|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
20443956|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
20443957|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
20443958|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443959|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20443960|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
20443961|NCT01378091|Hormones|hormones|mesh-ancestor
20443962|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20443963|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443964|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20443965|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
20443966|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20443967|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20443968|NCT01378091|Growth Substances|growth substances|mesh-ancestor
20443969|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
20443970|NCT01378143|Pentamidine|pentamidine|mesh-list
20219357|NCT00316745|Irinotecan|irinotecan|mesh-list
20219358|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
19848485|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848486|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
19848487|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848488|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848489|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
19848490|NCT00695110|Testosterone|testosterone|mesh-list
20443971|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
20443972|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443973|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20443974|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20443975|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20525041|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525042|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20525043|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525044|NCT01756430|Carvedilol|carvedilol|mesh-list
20525045|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20525046|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20525047|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
20525048|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525049|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525050|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525051|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20525052|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
19406070|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406071|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19406072|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19406073|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19406074|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406075|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406076|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
20219359|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219360|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20219361|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219362|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219363|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
20219364|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219365|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19406077|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848491|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
19848492|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
19848493|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19848494|NCT00695110|Androgens|androgens|mesh-ancestor
19848495|NCT00695110|Hormones|hormones|mesh-ancestor
19848496|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848497|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848498|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848499|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848500|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
19406078|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406079|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406080|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406081|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19406082|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
19406083|NCT03583567|Ranitidine|ranitidine|mesh-list
19406084|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19406085|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20443976|NCT01378156|Vaccines|vaccines|mesh-list
20443977|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
20443978|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20443979|NCT01378286|Artesunate|artesunate|mesh-list
20443980|NCT01378286|Chloroquine|chloroquine|mesh-list
20443981|NCT01378286|Amodiaquine|amodiaquine|mesh-list
20443982|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
20443983|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20443984|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20443985|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20443986|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443987|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
20443988|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
20443989|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20443990|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
20443991|NCT01378286|Amebicides|amebicides|mesh-ancestor
20443992|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20443993|NCT01378481|Vorinostat|vorinostat|mesh-list
20443994|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20443995|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20443996|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20443997|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20443998|NCT01378533|Paclitaxel|paclitaxel|mesh-list
20443999|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
20444000|NCT01378533|Carboplatin|carboplatin|mesh-list
20444001|NCT01378533|Epirubicin|epirubicin|mesh-list
20444002|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20444003|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444004|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
20444005|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
20444006|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
20444007|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444008|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20444009|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
20444010|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406086|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19406087|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19406088|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
20444011|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444012|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20444013|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
20444014|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20444015|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20444016|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20444017|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20444018|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444019|NCT01378546|Amifampridine|amifampridine|mesh-list
20444020|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20444021|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444022|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444023|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20444024|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20444025|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444026|NCT01378650|Cilostazol|cilostazol|mesh-list
19406089|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
19848501|NCT00695136|Donepezil|donepezil|mesh-list
20444027|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20444028|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
20444029|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525053|NCT01756430|Protective Agents|protective agents|mesh-ancestor
20444030|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444031|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20444032|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
20444033|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19848502|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20444034|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20444035|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444036|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444037|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444038|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20444039|NCT01378650|Protective Agents|protective agents|mesh-ancestor
20444040|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20444041|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20444042|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444043|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20444044|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20444045|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20444046|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
20444047|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444048|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20444049|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20444050|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444051|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
20444052|NCT01378741|Propofol|propofol|mesh-list
20444053|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20444054|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20444055|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444056|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20444057|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
20444058|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
20444059|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444060|NCT01378741|Analgesics|analgesics|mesh-ancestor
20444061|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
20444062|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444063|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20444064|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20444065|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20444066|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
20444067|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444068|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444069|NCT01378754|Fospropofol|fospropofol|mesh-list
20444070|NCT01378754|Propofol|propofol|mesh-list
20444071|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20444072|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20444073|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444074|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20444075|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
20444076|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
20444077|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20444078|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444079|NCT01378845|Bosentan|bosentan|mesh-list
20444080|NCT01378845|Alprostadil|alprostadil|mesh-list
20444081|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20444082|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20444083|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444084|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444085|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444086|NCT01378845|Urological Agents|urological agents|mesh-ancestor
20444087|NCT01378884|Domperidone|domperidone|mesh-list
20444088|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
20444089|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
20444090|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444091|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444092|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20444093|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20444094|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
20444095|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444096|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444097|NCT01378949|Morphine|morphine|mesh-list
20444098|NCT01378949|Bupivacaine|bupivacaine|mesh-list
20444099|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
19848503|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444100|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
20444101|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20444102|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444103|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
20444104|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444105|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20444106|NCT01378949|Narcotics|narcotics|mesh-ancestor
20444107|NCT01378949|Analgesics|analgesics|mesh-ancestor
20444108|NCT01379001|Scopolamine|scopolamine|mesh-list
20444109|NCT01379001|Donepezil|donepezil|mesh-list
20444110|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20444111|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20444112|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444113|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444114|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
20444115|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444116|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444117|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
20444118|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20444119|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
20444120|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
20444121|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444122|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20444123|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
20444124|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20444125|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20444126|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
20444127|NCT01379079|Aspirin|aspirin|mesh-list
20444128|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
20444129|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
20444130|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
20444131|NCT01379079|Calcium|calcium|mesh-list
20444132|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20444133|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444134|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20444135|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20444136|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444137|NCT01379079|Analgesics|analgesics|mesh-ancestor
20444138|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
20444139|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444140|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444141|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444142|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20444143|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20444144|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444145|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444146|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20444147|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444148|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
20444149|NCT01379144|Latanoprost|latanoprost|mesh-list
20444150|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20444151|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20444152|NCT01379157|Imipenem|imipenem|mesh-list
20444153|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444154|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444155|NCT01379196|Azithromycin|azithromycin|mesh-list
20444156|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444157|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444158|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
20444159|NCT01379300|Dabigatran|dabigatran|mesh-list
20444160|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20444161|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
20444162|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20444163|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
20444164|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444165|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444166|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
20444167|NCT01379326|Mebendazole|mebendazole|mesh-list
20444168|NCT01379326|Piperazine|piperazine|mesh-list
20444169|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
20444170|NCT01379326|DMP 777|dmp 777|mesh-list
20444171|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
20444172|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
20444173|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20444174|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444175|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20444176|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20444177|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20444178|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444179|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444180|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444181|NCT01379482|Paclitaxel|paclitaxel|mesh-list
20444182|NCT01379482|Docetaxel|docetaxel|mesh-list
20444183|NCT01379482|Cisplatin|cisplatin|mesh-list
20444184|NCT01379482|Doxorubicin|doxorubicin|mesh-list
20444185|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
20444186|NCT01379482|Irinotecan|irinotecan|mesh-list
20444187|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20444188|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444189|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
20444190|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
20444191|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
20444192|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444193|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20444194|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20444195|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20444196|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444197|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20444198|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20444199|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444200|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
20444201|NCT01379560|Dinoprost|dinoprost|mesh-list
20444202|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20444203|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20444204|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
20444205|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20444206|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444207|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
20444208|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
20444209|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20613608|NCT02255955|Naproxen|naproxen|mesh-list
20613609|NCT02255955|Codeine|codeine|mesh-list
20613610|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613611|NCT02255955|Analgesics|analgesics|mesh-ancestor
20613612|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
20613613|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613614|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613615|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
20613616|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20613617|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848504|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848505|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
19848506|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848507|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444210|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613618|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613619|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
20613620|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20613621|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613622|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613623|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20613624|NCT02255955|Narcotics|narcotics|mesh-ancestor
20613625|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613626|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
20613627|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
20613628|NCT02256033|Istradefylline|istradefylline|mesh-list
20613629|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20613630|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20613631|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20613632|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
20613633|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613634|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613635|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613636|NCT02256124|Lamotrigine|lamotrigine|mesh-list
20613637|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
19406090|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406091|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406092|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406093|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
19406094|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
19406095|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19406096|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20444211|NCT01379807|Docetaxel|docetaxel|mesh-list
20613638|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20444212|NCT01379807|Panitumumab|panitumumab|mesh-list
20444213|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444214|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
20444215|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
20444216|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
20444217|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444218|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20525054|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20525055|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20525056|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20525057|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
20525058|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20525059|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20525060|NCT01756443|Lidocaine|lidocaine|mesh-list
20525061|NCT01756443|Epinephrine|epinephrine|mesh-list
20525062|NCT01756443|Racepinephrine|racepinephrine|mesh-list
20525063|NCT01756443|Bupivacaine|bupivacaine|mesh-list
20525064|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
20525065|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
20525066|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
20525067|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525068|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525069|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
20525070|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525071|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20525072|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20525073|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20525074|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20525075|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525076|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20525077|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20525078|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
20525079|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525080|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20525081|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20525082|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
20525083|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20525084|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
20525085|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
20525086|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
20525087|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20525088|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
20525089|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20525090|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20525091|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525092|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20525093|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20525094|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525095|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525096|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525097|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20525098|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
20525099|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19693627|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693628|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693629|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693630|NCT04978051|Icatibant|icatibant|mesh-list
19693631|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19693632|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19693633|NCT04978051|Analgesics|analgesics|mesh-ancestor
19693634|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
19693635|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693636|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693637|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693638|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693639|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19693640|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19693641|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693642|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19693643|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406097|NCT03583489|Ondansetron|ondansetron|mesh-list
19406098|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
19406099|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
19406100|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406101|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406102|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19406103|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
19693644|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
19693645|NCT04977427|Prednisolone|prednisolone|mesh-list
19693646|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19693647|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
19693648|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19693649|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
19693650|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19693651|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
19693652|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693653|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
19693654|NCT04977427|Hormones|hormones|mesh-ancestor
19693655|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693656|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848508|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
19848509|NCT00695188|Methotrexate|methotrexate|mesh-list
19848510|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19848511|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
19848512|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19848513|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848514|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19848515|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
19848516|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848517|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693657|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693658|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444219|NCT01379846|Vaccines|vaccines|mesh-list
20444220|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
20444221|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444222|NCT01379898|Doxazosin|doxazosin|mesh-list
20444223|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
20444224|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20444225|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20444226|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20444227|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20444228|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
20444229|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444230|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444231|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444232|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444233|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
20444234|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
20444235|NCT01379976|Vitamins|vitamins|mesh-ancestor
20444236|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
20444237|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444238|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
20444239|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
20444240|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20444241|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444242|NCT01380015|Analgesics|analgesics|mesh-ancestor
20444243|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
20444244|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444245|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444246|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444247|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444248|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
20444249|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444250|NCT01380015|Protective Agents|protective agents|mesh-ancestor
20444251|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444252|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20444253|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
20444254|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444255|NCT01380249|Bromides|bromides|mesh-list
20444256|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
19406104|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
19693659|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
19848518|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848519|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848520|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20444257|NCT01380275|Docetaxel|docetaxel|mesh-list
20444258|NCT01380275|Irinotecan|irinotecan|mesh-list
19693660|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
20444259|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444260|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
20444261|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
20444262|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
20444263|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444264|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20219366|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20219367|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219368|NCT00316745|Antidotes|antidotes|mesh-ancestor
19406105|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19406106|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
19406107|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219369|NCT00316745|Protective Agents|protective agents|mesh-ancestor
20219370|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
20219371|NCT00316745|Vitamins|vitamins|mesh-ancestor
20219372|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
20219373|NCT00316758|Metformin|metformin|mesh-list
20219374|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20219375|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219376|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
20444265|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20444266|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444267|NCT01380288|Rivastigmine|rivastigmine|mesh-list
20444268|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20444269|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444270|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444271|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
20444272|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444273|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444274|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20444275|NCT01380288|Protective Agents|protective agents|mesh-ancestor
20444276|NCT01380301|Miltefosine|miltefosine|mesh-list
20444277|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
20444278|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444279|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444280|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20444281|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20444282|NCT01380314|Miltefosine|miltefosine|mesh-list
20444283|NCT01380314|Imiquimod|imiquimod|mesh-list
20444284|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20444285|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
20444286|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444287|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444288|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
20444289|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
20444290|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444291|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20444292|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20444293|NCT01380353|Diclofenac|diclofenac|mesh-list
20444294|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20444295|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20444296|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444297|NCT01380353|Analgesics|analgesics|mesh-ancestor
20444298|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
20444299|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444300|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444301|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444302|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444303|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20444304|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444305|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444306|NCT01380431|Lisinopril|lisinopril|mesh-list
20444307|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20444308|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
20444309|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444310|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444311|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20444312|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20444313|NCT01380431|Protective Agents|protective agents|mesh-ancestor
20444314|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219377|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
20219378|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444315|NCT01380457|Dronabinol|dronabinol|mesh-list
19707725|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20444316|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
20444317|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444318|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20444319|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444320|NCT01380457|Analgesics|analgesics|mesh-ancestor
20444321|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
20444322|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444323|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20444324|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20444325|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444326|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444327|NCT01380457|Hormones|hormones|mesh-ancestor
20444328|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20444329|NCT01380483|Doxycycline|doxycycline|mesh-list
20444330|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444331|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444332|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
20444333|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20444334|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20444335|NCT01380496|Doxycycline|doxycycline|mesh-list
20444336|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444337|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444338|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
20444339|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20219379|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219380|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
20444340|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20444341|NCT01380509|Metronidazole|metronidazole|mesh-list
20444342|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444343|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444344|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20444345|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20444346|NCT01380522|Metronidazole|metronidazole|mesh-list
20444347|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444348|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444349|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20444350|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20444351|NCT01380548|Iron|iron|mesh-list
20444352|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20444353|NCT01380548|Trace Elements|trace elements|mesh-ancestor
20444354|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
20444355|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444356|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20444357|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
20444358|NCT01380600|Molgramostim|molgramostim|mesh-list
20444359|NCT01380600|Sargramostim|sargramostim|mesh-list
20444360|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
20444361|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444362|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444363|NCT01380678|Bevacizumab|bevacizumab|mesh-list
20444364|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20444365|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
20444366|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20444367|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444368|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444369|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20444370|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19406108|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219381|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219382|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219383|NCT00316849|Sirolimus|sirolimus|mesh-list
20219384|NCT00316849|Temozolomide|temozolomide|mesh-list
20219385|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20219386|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
20219387|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219388|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219389|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219390|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219391|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20219392|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
20219393|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219394|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
20219395|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219396|NCT00316875|Doxorubicin|doxorubicin|mesh-list
20219397|NCT00316875|Lapatinib|lapatinib|mesh-list
20219398|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20219399|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444371|NCT01380678|Growth Substances|growth substances|mesh-ancestor
20444372|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444373|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
20444374|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
20444375|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444376|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444377|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
20444378|NCT01380717|Calcium|calcium|mesh-list
20444379|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20444380|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20444381|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20444382|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444383|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20444384|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
20444385|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444386|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444387|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
20444388|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444389|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20444390|NCT01380808|Capecitabine|capecitabine|mesh-list
20444391|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20444392|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
20444393|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444394|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444395|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20444396|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
20444397|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20444398|NCT01380912|Prednisolone|prednisolone|mesh-list
20444399|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
20444400|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20444401|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
20444402|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444403|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
20444404|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
20444405|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444406|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444407|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20444408|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
20444409|NCT01380912|Hormones|hormones|mesh-ancestor
20444410|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20444411|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20444412|NCT01380912|Protective Agents|protective agents|mesh-ancestor
20444413|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20444414|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444415|NCT01380951|Telbivudine|telbivudine|mesh-list
20444416|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
20444417|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444418|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20444419|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444420|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444421|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
20444422|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20444423|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444424|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444425|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444426|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20444427|NCT01381055|Protective Agents|protective agents|mesh-ancestor
20444428|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444429|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444430|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20444431|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
20444432|NCT01381185|Aspirin|aspirin|mesh-list
20444433|NCT01381185|Clopidogrel|clopidogrel|mesh-list
20444434|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20444435|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444436|NCT01381185|Analgesics|analgesics|mesh-ancestor
20444437|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
20444438|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444439|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444440|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444441|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444442|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20444443|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20444444|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444445|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444446|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20444447|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444448|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
20444449|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20444450|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20444451|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20444452|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
20444453|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444454|NCT01381276|Beta Carotene|beta carotene|mesh-list
20444455|NCT01381276|Vitamin A|vitamin a|mesh-list
20444456|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
20444457|NCT01381276|Carotenoids|carotenoids|mesh-list
20444458|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
20444459|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444460|NCT01381276|Protective Agents|protective agents|mesh-ancestor
20444461|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444462|NCT01381276|Provitamins|provitamins|mesh-ancestor
20444463|NCT01381276|Vitamins|vitamins|mesh-ancestor
20444464|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
20444465|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20444466|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444467|NCT01381289|Ivacaftor|ivacaftor|mesh-list
20444468|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20444469|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20444470|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444471|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
20444472|NCT01381354|Riboflavin|riboflavin|mesh-list
20444473|NCT01381354|Thiamine|thiamine|mesh-list
20444474|NCT01381354|Niacinamide|niacinamide|mesh-list
20444475|NCT01381354|Niacin|niacin|mesh-list
20444476|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
20444477|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
20444478|NCT01381354|Ubiquinone|ubiquinone|mesh-list
20444479|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
20444480|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
20444481|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20444482|NCT01381354|Vitamins|vitamins|mesh-ancestor
20444483|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
20444484|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444485|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
20444486|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444487|NCT01381354|Expectorants|expectorants|mesh-ancestor
20444488|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
20444489|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20444490|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
20444491|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444492|NCT01381354|Protective Agents|protective agents|mesh-ancestor
20444493|NCT01381354|Antidotes|antidotes|mesh-ancestor
20444494|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
20444495|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20444496|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
20444497|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20444498|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
20444499|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20444500|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444501|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444502|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
19848521|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848522|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
20444503|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20444504|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
20444505|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444506|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
20444507|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20444508|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444509|NCT01381432|Azathioprine|azathioprine|mesh-list
20444510|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
20444511|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444512|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20444513|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848523|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848524|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20444514|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848525|NCT00695292|Carboplatin|carboplatin|mesh-list
20444515|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
20444516|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444517|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444518|NCT01381445|Clobetasol|clobetasol|mesh-list
19848526|NCT00695292|Irinotecan|irinotecan|mesh-list
20444519|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444520|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
19848527|NCT00695292|Sunitinib|sunitinib|mesh-list
19848528|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848529|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19848530|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19848531|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848532|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444521|NCT01381445|Hormones|hormones|mesh-ancestor
20444522|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219400|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20219401|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20219402|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219403|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219404|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20219405|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20219406|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20444523|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444524|NCT01381497|Naproxen|naproxen|mesh-list
20444525|NCT01381497|Sumatriptan|sumatriptan|mesh-list
20444526|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20444527|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444528|NCT01381497|Analgesics|analgesics|mesh-ancestor
20444529|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
20444530|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444531|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444532|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444533|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444534|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
20444535|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20444536|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444537|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444538|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20444539|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20444540|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20444541|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
20444542|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444543|NCT01381510|Finasteride|finasteride|mesh-list
20444544|NCT01381510|Dutasteride|dutasteride|mesh-list
20444545|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
20444546|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20444547|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444548|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444549|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
20444550|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20444551|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444552|NCT01381510|Urological Agents|urological agents|mesh-ancestor
20444553|NCT01381523|Naproxen|naproxen|mesh-list
20444554|NCT01381523|Sumatriptan|sumatriptan|mesh-list
20444555|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20444556|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444557|NCT01381523|Analgesics|analgesics|mesh-ancestor
20444558|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
20444559|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444560|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444561|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444562|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444563|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
20444564|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20444565|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613639|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406109|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19406110|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19406111|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406112|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19406113|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19406114|NCT03583476|Amoxicillin|amoxicillin|mesh-list
19406115|NCT03583476|Metronidazole|metronidazole|mesh-list
19406116|NCT03583476|Clarithromycin|clarithromycin|mesh-list
19848533|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19848534|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20219407|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219408|NCT00316927|Aspirin|aspirin|mesh-list
20444566|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444567|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20444568|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20444569|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20444570|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
20444571|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444572|NCT01381536|Belimumab|belimumab|mesh-list
20444573|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20444574|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
20444575|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444576|NCT01381601|Bevacizumab|bevacizumab|mesh-list
20444577|NCT01381601|Sunitinib|sunitinib|mesh-list
20444578|NCT01381601|Sorafenib|sorafenib|mesh-list
20444579|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444580|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444581|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20444582|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20444583|NCT01381601|Growth Substances|growth substances|mesh-ancestor
20444584|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444585|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
20444586|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20444587|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444588|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444589|NCT01381614|Bevacizumab|bevacizumab|mesh-list
20444590|NCT01381614|Sunitinib|sunitinib|mesh-list
20444591|NCT01381614|Sorafenib|sorafenib|mesh-list
20444592|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444593|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444594|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20444595|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20444596|NCT01381614|Growth Substances|growth substances|mesh-ancestor
20444597|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444598|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
20444599|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20444600|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444601|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525100|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525101|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20525102|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20525103|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20525104|NCT01756508|Eculizumab|eculizumab|mesh-list
20525105|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20525106|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525107|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
20525108|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525109|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
20525110|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20525111|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525112|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20525113|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20525114|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525115|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525116|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525117|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
20525118|NCT01756547|Diuretics|diuretics|mesh-ancestor
20525119|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
20525120|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525121|NCT01756547|Expectorants|expectorants|mesh-ancestor
20525122|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
20525123|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
20525124|NCT01756612|Hematinics|hematinics|mesh-ancestor
20525125|NCT01756638|Prednisolone|prednisolone|mesh-list
20525126|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20525127|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
20525128|NCT01756638|Hormones|hormones|mesh-ancestor
19406117|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19406118|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19406119|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406120|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19406121|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19406122|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19406123|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525129|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525130|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525131|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19406124|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406125|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19406126|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19406127|NCT03583424|Cytarabine|cytarabine|mesh-list
19406128|NCT03583424|Etoposide|etoposide|mesh-list
19406129|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
19406130|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
19406131|NCT03583424|Melphalan|melphalan|mesh-list
19406132|NCT03583424|Venetoclax|venetoclax|mesh-list
19406133|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
19406134|NCT03583424|Carmustine|carmustine|mesh-list
19406135|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19406136|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19406137|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406138|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19406139|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20444602|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
20444603|NCT01381627|Remifentanil|remifentanil|mesh-list
20444604|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20444605|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20444606|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444607|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444608|NCT01381627|Analgesics|analgesics|mesh-ancestor
20444609|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
20444610|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444611|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20444612|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20444613|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20444614|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20444615|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444616|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444617|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20444618|NCT01381627|Narcotics|narcotics|mesh-ancestor
20444619|NCT01381640|Acetaminophen|acetaminophen|mesh-list
20444620|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444621|NCT01381640|Analgesics|analgesics|mesh-ancestor
20444622|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
20444623|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444624|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444625|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
20444626|NCT01381705|Rituximab|rituximab|mesh-list
20444627|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444628|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444629|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
20444630|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444631|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444632|NCT01381796|Sumatriptan|sumatriptan|mesh-list
20444633|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20444634|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20444635|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20444636|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
20444637|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444638|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444639|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444640|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
20444641|NCT01381809|Hematinics|hematinics|mesh-ancestor
20444642|NCT01381835|Simeprevir|simeprevir|mesh-list
20444643|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
20444644|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444645|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
20444646|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444647|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444648|NCT01381848|Doripenem|doripenem|mesh-list
20444649|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444650|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444651|NCT01381887|Canagliflozin|canagliflozin|mesh-list
20444652|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20444653|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444654|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20444655|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444656|NCT01382004|Azithromycin|azithromycin|mesh-list
20444657|NCT01382004|Penicillins|penicillins|mesh-list
20444658|NCT01382004|Penicillin G|penicillin g|mesh-list
19693661|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444659|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20444660|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
20444661|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444662|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444663|NCT01382017|Lacosamide|lacosamide|mesh-list
20444664|NCT01382017|Carbamazepine|carbamazepine|mesh-list
20444665|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
20444666|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20444667|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20444668|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20444669|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444670|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
20444671|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20444672|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20444673|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444674|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20444675|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406140|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406141|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219409|NCT00316927|Dexamethasone|dexamethasone|mesh-list
20219410|NCT00316927|Fosfestrol|fosfestrol|mesh-list
20219411|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
20444676|NCT01382017|Analgesics|analgesics|mesh-ancestor
20444677|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
20444678|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444679|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20444680|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20444681|NCT01382134|Aspirin|aspirin|mesh-list
20444682|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20444683|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20444684|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20444685|NCT01382134|Analgesics|analgesics|mesh-ancestor
20444686|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
20444687|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444688|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444689|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444690|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444691|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20444692|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20444693|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444694|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444695|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19848535|NCT00695292|Growth Substances|growth substances|mesh-ancestor
19848536|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848537|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
19848538|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848539|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19848540|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848541|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
19848542|NCT00695318|Hormones|hormones|mesh-ancestor
19848543|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848544|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848545|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
19848546|NCT00695396|Hematinics|hematinics|mesh-ancestor
19848547|NCT00695409|Cytarabine|cytarabine|mesh-list
19848548|NCT00695409|Rituximab|rituximab|mesh-list
19848549|NCT00695409|Etoposide|etoposide|mesh-list
19848550|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
19848551|NCT00695409|Melphalan|melphalan|mesh-list
19848552|NCT00695409|Carmustine|carmustine|mesh-list
20219412|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219413|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
20219414|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
20219415|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219416|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219417|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20219418|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
20219419|NCT00316927|Hormones|hormones|mesh-ancestor
20219420|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219421|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20219422|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219423|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20219424|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219425|NCT00316927|Analgesics|analgesics|mesh-ancestor
20219426|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
19848553|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20219427|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444696|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444697|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
20444698|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
20444699|NCT01382134|Coagulants|coagulants|mesh-ancestor
20444700|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20444701|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
20444702|NCT01382147|Daunorubicin|daunorubicin|mesh-list
20444703|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
20444704|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20444705|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444706|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20444707|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20444708|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444709|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444710|NCT01382147|Analgesics|analgesics|mesh-ancestor
20444711|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
20444712|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444713|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444714|NCT01382160|Adalimumab|adalimumab|mesh-list
20444715|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20444716|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444717|NCT01382199|Lactoferrin|lactoferrin|mesh-list
20444718|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444719|NCT01382238|Dolutegravir|dolutegravir|mesh-list
20444720|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20444721|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20444722|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444723|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444724|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20444725|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20444726|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
20444727|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444728|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20444729|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20444730|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19693662|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693663|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19693664|NCT04977427|Protective Agents|protective agents|mesh-ancestor
19693665|NCT04977336|Acetaminophen|acetaminophen|mesh-list
19693666|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19693667|NCT04977336|Analgesics|analgesics|mesh-ancestor
19693668|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
19693669|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219428|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20219429|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20219430|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219431|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20219432|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20219433|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219434|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
20444731|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
20444732|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693670|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693671|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
19693672|NCT04977544|Sertraline|sertraline|mesh-list
19693673|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
19848554|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848555|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848556|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
19848557|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848558|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848559|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19848560|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19848561|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19848562|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848563|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848564|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19848565|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
19848566|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
19848567|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848568|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848569|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20444733|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19693674|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530889|NCT01791231|Canagliflozin|canagliflozin|mesh-list
20530890|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20444734|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20444735|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444736|NCT01382342|Rasagiline|rasagiline|mesh-list
20444737|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19406142|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406143|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
20444738|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444739|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444740|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20444741|NCT01382342|Protective Agents|protective agents|mesh-ancestor
20444742|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848570|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
19848571|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19848572|NCT00695435|Tobramycin|tobramycin|mesh-list
19848573|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19848574|NCT00695435|Dexamethasone|dexamethasone|mesh-list
19848575|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19848576|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848577|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
20444743|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
20444744|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444745|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20444746|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20444747|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444748|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444749|NCT01382368|Urological Agents|urological agents|mesh-ancestor
20444750|NCT01382407|Cetuximab|cetuximab|mesh-list
20444751|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444752|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444753|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20444754|NCT01382472|Simvastatin|simvastatin|mesh-list
20444755|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20444756|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20444757|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
20444758|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444759|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20444760|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20444761|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444762|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
20444763|NCT01382498|Calcium|calcium|mesh-list
19848578|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
19848579|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848580|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444764|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20444765|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444766|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
20444767|NCT01382498|Coagulants|coagulants|mesh-ancestor
20444768|NCT01382511|Simvastatin|simvastatin|mesh-list
20444769|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20444770|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20444771|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
20444772|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444773|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20444774|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20444775|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444776|NCT01382589|Afamelanotide|afamelanotide|mesh-list
20444777|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
20444778|NCT01382706|Docetaxel|docetaxel|mesh-list
20444779|NCT01382706|Lapatinib|lapatinib|mesh-list
19406144|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
19406145|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693675|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19693676|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19693677|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693678|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693679|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693680|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
19693681|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693682|NCT04977401|Glycerol|glycerol|mesh-list
19693683|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19693684|NCT04977401|Protective Agents|protective agents|mesh-ancestor
19693685|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693686|NCT04977557|Thiamine|thiamine|mesh-list
19693687|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
19693688|NCT04977557|Vitamins|vitamins|mesh-ancestor
20444780|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444781|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
20444782|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
20444783|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
20444784|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444785|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20444786|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444787|NCT01382732|Oxytocin|oxytocin|mesh-list
20444788|NCT01382732|Carbetocin|carbetocin|mesh-list
20444789|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
20444790|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20444791|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444792|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
20444793|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444794|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444795|NCT01382888|Heparin|heparin|mesh-list
20444796|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
20444797|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20444798|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20444799|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444800|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
20444801|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20444802|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444803|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
20444804|NCT01383044|Carvedilol|carvedilol|mesh-list
20444805|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20444806|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20444807|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
20444808|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444809|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444810|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444811|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20444812|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
20444813|NCT01383044|Protective Agents|protective agents|mesh-ancestor
20444814|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20444815|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20444816|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20444817|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444818|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20444819|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20444820|NCT01383148|Gemcitabine|gemcitabine|mesh-list
20444821|NCT01383148|Paclitaxel|paclitaxel|mesh-list
20444822|NCT01383148|Cisplatin|cisplatin|mesh-list
20444823|NCT01383148|Carboplatin|carboplatin|mesh-list
20444824|NCT01383148|Pemetrexed|pemetrexed|mesh-list
20444825|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20444826|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444827|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
20444828|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
20444829|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
20444830|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444831|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444832|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20444833|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
20444834|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
20444835|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444836|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444837|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20444838|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
20444839|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20444840|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20444841|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
19848581|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848582|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
19848583|NCT00695435|Hormones|hormones|mesh-ancestor
19848584|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848585|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848586|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848587|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19848588|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20444842|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20444843|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444844|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
20444845|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20444846|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444847|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
20444848|NCT01383343|Leucovorin|leucovorin|mesh-list
20444849|NCT01383343|Folic Acid|folic acid|mesh-list
20444850|NCT01383343|Bevacizumab|bevacizumab|mesh-list
20444851|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20444852|NCT01383343|Fluorouracil|fluorouracil|mesh-list
20444853|NCT01383343|Irinotecan|irinotecan|mesh-list
20444854|NCT01383343|Sorafenib|sorafenib|mesh-list
20444855|NCT01383343|Camptothecin|camptothecin|mesh-list
20444856|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
20444857|NCT01383343|Antibodies|antibodies|mesh-list
20444858|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
20444859|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20444860|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
20444861|NCT01383343|Calcium|calcium|mesh-list
20444862|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
20444863|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444864|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20444865|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20444866|NCT01383343|Growth Substances|growth substances|mesh-ancestor
20444867|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444868|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
20444869|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
20444870|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20444871|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20444872|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
20444873|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444874|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20444875|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20444876|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20444877|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20444878|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444879|NCT01383343|Antidotes|antidotes|mesh-ancestor
20444880|NCT01383343|Protective Agents|protective agents|mesh-ancestor
20444881|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
20444882|NCT01383343|Vitamins|vitamins|mesh-ancestor
20444883|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
20444884|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20444885|NCT01383343|Hematinics|hematinics|mesh-ancestor
20444886|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20525132|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525133|NCT01756651|Fentanyl|fentanyl|mesh-list
20525134|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20525135|NCT01756651|Narcotics|narcotics|mesh-ancestor
20525136|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525137|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525138|NCT01756651|Analgesics|analgesics|mesh-ancestor
20525139|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
20525140|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525141|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20525142|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20525143|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
20525144|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
20525145|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
20525146|NCT01756664|Petrolatum|petrolatum|mesh-list
20525147|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20525148|NCT01756664|Protective Agents|protective agents|mesh-ancestor
20525149|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525150|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
20525151|NCT01756664|Emollients|emollients|mesh-ancestor
20525152|NCT01756768|Palbociclib|palbociclib|mesh-list
20525153|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525154|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20525155|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525156|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525157|NCT01756781|Palbociclib|palbociclib|mesh-list
20525158|NCT01756781|Midazolam|midazolam|mesh-list
20525159|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20525160|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20525161|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525162|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525163|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20525164|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20525165|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20525166|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20525167|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
20525168|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
20525169|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
20525170|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
20525171|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444887|NCT01383395|Cilostazol|cilostazol|mesh-list
20444888|NCT01383395|Simvastatin|simvastatin|mesh-list
20444889|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20444890|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20444891|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
20444892|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444893|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20444894|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20444895|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444896|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20444897|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
20444898|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444899|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444900|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20444901|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
20444902|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20444903|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20444904|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444905|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
20444906|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20444907|NCT01383395|Protective Agents|protective agents|mesh-ancestor
20444908|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20444909|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20444910|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
20444911|NCT01383460|Sargramostim|sargramostim|mesh-list
20444912|NCT01383460|Lenograstim|lenograstim|mesh-list
20444913|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
20444914|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444915|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19406146|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406147|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
19406148|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406149|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19406150|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
19406151|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19406152|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
19406153|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
19406154|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406155|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406156|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406157|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19406158|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19406159|NCT03583242|Growth Substances|growth substances|mesh-ancestor
19406160|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406161|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
19406162|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613640|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219435|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20219436|NCT00316927|Estrogens|estrogens|mesh-ancestor
20219437|NCT00316940|Bortezomib|bortezomib|mesh-list
20219438|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
20219439|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219440|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219441|NCT00316940|Analgesics|analgesics|mesh-ancestor
20219442|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
20613641|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20613642|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406163|NCT03583229|Aspirin|aspirin|mesh-list
19406164|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406165|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406166|NCT03583229|Analgesics|analgesics|mesh-ancestor
20613643|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20613644|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20613645|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613646|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613647|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20613648|NCT02256150|Mizoribine|mizoribine|mesh-list
19406167|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
19406168|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406169|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406170|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406171|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406172|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20444916|NCT01383460|Hematinics|hematinics|mesh-ancestor
20444917|NCT01383538|Leucovorin|leucovorin|mesh-list
20444918|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
20444919|NCT01383538|Irinotecan|irinotecan|mesh-list
20444920|NCT01383538|Folfirinox|folfirinox|mesh-list
20444921|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444922|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20444923|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20444924|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444925|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444926|NCT01383538|Antidotes|antidotes|mesh-ancestor
20444927|NCT01383538|Protective Agents|protective agents|mesh-ancestor
20444928|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444929|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
20444930|NCT01383538|Vitamins|vitamins|mesh-ancestor
20444931|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
20444932|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
20444933|NCT01383655|Analgesics|analgesics|mesh-ancestor
20444934|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
20444935|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444936|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444937|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
20444938|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20444939|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20444940|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
20444941|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20444942|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20444943|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444944|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20444945|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
20444946|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20444947|NCT01383668|Sirolimus|sirolimus|mesh-list
20444948|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
19848589|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848590|NCT00695500|Varenicline|varenicline|mesh-list
19848591|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19848592|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19848593|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
19848594|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848595|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848596|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848597|NCT00695565|Clonidine|clonidine|mesh-list
19848598|NCT00695565|Analgesics|analgesics|mesh-ancestor
19848599|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
19848600|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848601|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848602|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848603|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
19848604|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
19848605|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20444949|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19693689|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
19693690|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693691|NCT04977388|Droxidopa|droxidopa|mesh-list
19693692|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19693693|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19693694|NCT04976816|Triamcinolone|triamcinolone|mesh-list
19693695|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19848606|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20444950|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444951|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20444952|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444953|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
20444954|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20444955|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
20444956|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444957|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20444958|NCT01383694|Piperine|piperine|mesh-list
20444959|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20444960|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444961|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444962|NCT01383785|Abciximab|abciximab|mesh-list
20444963|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
20444964|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20444965|NCT01384058|Simvastatin|simvastatin|mesh-list
20444966|NCT01384058|Ezetimibe|ezetimibe|mesh-list
19848607|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19848608|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
20444967|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19693696|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20444968|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20444969|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
20444970|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444971|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20444972|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20444973|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20444974|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
20444975|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20444976|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20444977|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20444978|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20444979|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20444980|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
20444981|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20444982|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444983|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20444984|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20444985|NCT01384227|Proflavine|proflavine|mesh-list
20444986|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20444987|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444988|NCT01384240|Proflavine|proflavine|mesh-list
20444989|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20444990|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20444991|NCT01384253|Trastuzumab|trastuzumab|mesh-list
20444992|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20444993|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20444994|NCT01384279|Metformin|metformin|mesh-list
20444995|NCT01384279|Topiramate|topiramate|mesh-list
20444996|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20444997|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20444998|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
20444999|NCT01384331|NuvaRing|nuvaring|mesh-list
20445000|NCT01384331|Desogestrel|desogestrel|mesh-list
20445001|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20445002|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
20445003|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20445004|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445005|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20445006|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20445007|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20445008|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19693697|NCT04976816|Betamethasone|betamethasone|mesh-list
19693698|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
19693699|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19693700|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
19693701|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19693702|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19693703|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693704|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
19693705|NCT04976816|Hormones|hormones|mesh-ancestor
19693706|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693707|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693708|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693709|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
19693710|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693711|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693712|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19693713|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
19693714|NCT04976673|Triamcinolone|triamcinolone|mesh-list
19693715|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19693716|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19693717|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19848609|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848610|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848611|NCT00695578|Bacitracin|bacitracin|mesh-list
19848612|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19848613|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848614|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19848615|NCT00695786|Rituximab|rituximab|mesh-list
19848616|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19848617|NCT00695786|Lenalidomide|lenalidomide|mesh-list
19848618|NCT00695786|Antibodies|antibodies|mesh-list
19693718|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848619|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
19848620|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20445009|NCT01384331|Progestins|progestins|mesh-ancestor
20445010|NCT01384331|Hormones|hormones|mesh-ancestor
20445011|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445012|NCT01384448|Dobutamine|dobutamine|mesh-list
20445013|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20445014|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
20445015|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
20445016|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445017|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445018|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20445019|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20445020|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20445021|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
20445022|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445023|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445024|NCT01384448|Protective Agents|protective agents|mesh-ancestor
20445025|NCT01384513|Vidarabine|vidarabine|mesh-list
20445026|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
20445027|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
20445028|NCT01384513|Busulfan|busulfan|mesh-list
20445029|NCT01384513|Fludarabine|fludarabine|mesh-list
20445030|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
20445031|NCT01384513|Tacrolimus|tacrolimus|mesh-list
20445032|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445033|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
20445034|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445035|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20445036|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20445037|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
20445038|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445039|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445040|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20445041|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445042|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
20445043|NCT01384513|Antiviral Agents|antiviral agents|mesh-ancestor
20445044|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445045|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20445046|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445047|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20445048|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20445049|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
20445050|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20445051|NCT01384578|Vitamins|vitamins|mesh-list
20445052|NCT01384578|Vitamin E|vitamin e|mesh-list
20445053|NCT01384578|Tocopherols|tocopherols|mesh-list
20445054|NCT01384578|Tocotrienols|tocotrienols|mesh-list
20445055|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
20445056|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
20445057|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
20445058|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445059|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
20445060|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445061|NCT01384578|Protective Agents|protective agents|mesh-ancestor
20445062|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20445063|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445064|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20445065|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20445066|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
20445067|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20445068|NCT01384643|Propofol|propofol|mesh-list
20445069|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20445070|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445071|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445072|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20445073|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
20445074|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
20445075|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20445076|NCT01384682|Maraviroc|maraviroc|mesh-list
20445077|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20445078|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20445079|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445080|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20445081|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20445082|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
20445083|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445084|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20445085|NCT01384695|Proflavine|proflavine|mesh-list
20613649|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
20445086|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20445087|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445088|NCT01384708|Proflavine|proflavine|mesh-list
20445089|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19848621|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
19848622|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848623|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848624|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848625|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19848626|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20445090|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445091|NCT01384773|Riboflavin|riboflavin|mesh-list
20445092|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20445093|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20445094|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
20445095|NCT01384773|Vitamins|vitamins|mesh-ancestor
20445096|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
20445097|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445098|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20445099|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
20445100|NCT01384799|Cisplatin|cisplatin|mesh-list
20445101|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445102|NCT01384812|Dinoprostone|dinoprostone|mesh-list
20445103|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
20445104|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20445105|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445106|NCT01384864|Proflavine|proflavine|mesh-list
20445107|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20445108|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445109|NCT01384903|Antithrombins|antithrombins|mesh-list
20445110|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
20445111|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20445112|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
20445113|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445114|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445115|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
20525172|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525173|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525174|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20525175|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525176|NCT01756989|Thalidomide|thalidomide|mesh-list
20525177|NCT01756989|Celecoxib|celecoxib|mesh-list
20525178|NCT01756989|Etoposide|etoposide|mesh-list
20525179|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
20525180|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20525181|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525182|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20525183|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20525184|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525185|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525186|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20525187|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20525188|NCT01756989|Analgesics|analgesics|mesh-ancestor
20525189|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
20525190|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525191|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525192|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20525193|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525194|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20525195|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20525196|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525197|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
20525198|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
20525199|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20525200|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525201|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20525202|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20525203|NCT01756989|Growth Substances|growth substances|mesh-ancestor
20525204|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
20525205|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
20525206|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20525207|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20525208|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19848627|NCT00695786|Growth Substances|growth substances|mesh-ancestor
20525209|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
20525210|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445116|NCT01384994|Folic Acid|folic acid|mesh-list
20445117|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
20445118|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
20445119|NCT01384994|Fluorouracil|fluorouracil|mesh-list
20445120|NCT01384994|Panitumumab|panitumumab|mesh-list
20445121|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445122|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
20445123|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445124|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445125|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445126|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
20445127|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445128|NCT01384994|Hematinics|hematinics|mesh-ancestor
20445129|NCT01384994|Vitamins|vitamins|mesh-ancestor
20445130|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
20445131|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445132|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
20445133|NCT01385020|Red yeast rice|red yeast rice|mesh-list
20445134|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20445135|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
20445136|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445137|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20445138|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20445139|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20445140|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445141|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20445142|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20445143|NCT01385059|Axitinib|axitinib|mesh-list
20445144|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445145|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20445146|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445147|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445148|NCT01385124|Cannabidiol|cannabidiol|mesh-list
20445149|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
20445150|NCT01385228|Prednisone|prednisone|mesh-list
20445151|NCT01385228|Docetaxel|docetaxel|mesh-list
20445152|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445153|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
20445154|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
20445155|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
20445156|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445157|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20445158|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
20445159|NCT01385228|Hormones|hormones|mesh-ancestor
20445160|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445161|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445162|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20445163|NCT01385345|Vitamin D|vitamin d|mesh-list
20445164|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
20445165|NCT01385345|Vitamins|vitamins|mesh-ancestor
20445166|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
20445167|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445168|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20445169|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20445170|NCT01385527|Triamcinolone|triamcinolone|mesh-list
20445171|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20445172|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
20445173|NCT01385527|Hormones|hormones|mesh-ancestor
20445174|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406173|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19406174|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406175|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19406176|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19406177|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406178|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
19406179|NCT03583164|Olorofim|olorofim|mesh-list
19406180|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
19406181|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406182|NCT03583138|Buprenorphine|buprenorphine|mesh-list
19406183|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19406184|NCT03583138|Narcotics|narcotics|mesh-ancestor
19406185|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406186|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445175|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406187|NCT03583138|Analgesics|analgesics|mesh-ancestor
19406188|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
20445176|NCT01385631|Ezetimibe|ezetimibe|mesh-list
19848628|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
19848629|NCT00695864|Ondansetron|ondansetron|mesh-list
19848630|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
19848631|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
19406189|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848632|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445177|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20445178|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20445179|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
20445180|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445181|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20445182|NCT01385683|Clarithromycin|clarithromycin|mesh-list
20445183|NCT01385683|Dabigatran|dabigatran|mesh-list
20445184|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20445185|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445186|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20445187|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445188|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445189|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20445190|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20445191|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
20445192|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20445193|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
20445194|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
20445195|NCT01385735|Rasagiline|rasagiline|mesh-list
20445196|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20445197|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445198|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219443|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219444|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219445|NCT00316953|Dasatinib|dasatinib|mesh-list
20219446|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219447|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20219448|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219449|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219450|NCT00317031|Naltrexone|naltrexone|mesh-list
20219451|NCT00317031|Acamprosate|acamprosate|mesh-list
20219452|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20219453|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20445199|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20445200|NCT01385735|Protective Agents|protective agents|mesh-ancestor
20445201|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445202|NCT01385826|Antibodies|antibodies|mesh-list
20445203|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20445204|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
20445205|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445206|NCT01385891|Etoposide|etoposide|mesh-list
20445207|NCT01385891|Clofarabine|clofarabine|mesh-list
20445208|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20445209|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445210|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20445211|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20445212|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445213|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445214|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445215|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
20445216|NCT01385956|Gemcitabine|gemcitabine|mesh-list
20445217|NCT01385956|Pasireotide|pasireotide|mesh-list
20445218|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19848633|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848634|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848635|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
19848636|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848637|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19848638|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
19848639|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848640|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848641|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19848642|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19848643|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848644|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19848645|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20445219|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
19848646|NCT00695903|Vancomycin|vancomycin|mesh-list
20445220|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445221|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445222|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
20445223|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445224|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445225|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445226|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
20445227|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445228|NCT01385956|Hormones|hormones|mesh-ancestor
20445229|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445230|NCT01386086|Aripiprazole|aripiprazole|mesh-list
20445231|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
20445232|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20445233|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20445234|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20445235|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445236|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445237|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
20445238|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
20445239|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445240|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445241|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20445242|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20445243|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
20445244|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20445245|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20445246|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20445247|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20445248|NCT01386151|Mitogens|mitogens|mesh-list
20445249|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
20445250|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445251|NCT01386164|Vaccines|vaccines|mesh-list
20445252|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
20445253|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445254|NCT01386177|Doxazosin|doxazosin|mesh-list
20445255|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20445256|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20445257|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20445258|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20445259|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20445260|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
20445261|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445262|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445263|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445264|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
20445265|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20445266|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
20445267|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20445268|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20445269|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20445270|NCT01386229|Ketamine|ketamine|mesh-list
20445271|NCT01386229|Etomidate|etomidate|mesh-list
20445272|NCT01386229|Analgesics|analgesics|mesh-ancestor
20445273|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
20445274|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445275|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445276|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19848647|NCT00695903|Daptomycin|daptomycin|mesh-list
19848648|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19848649|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848650|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19848651|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
20445277|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20445278|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
20445279|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
20445280|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445281|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20445282|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20445283|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445284|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445285|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19848652|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19848653|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848654|NCT00695955|Diuretics|diuretics|mesh-ancestor
19848655|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
19848656|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848657|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19848658|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848659|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848660|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19848661|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19848662|NCT00696020|Bromides|bromides|mesh-list
19848663|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
19848664|NCT00696020|Olodaterol|olodaterol|mesh-list
19848665|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19848666|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
19848667|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848668|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848669|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19848670|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
19848671|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
19848672|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19848673|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
19848674|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848675|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848676|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
19848677|NCT00696072|Letrozole|letrozole|mesh-list
19848678|NCT00696072|Dasatinib|dasatinib|mesh-list
19848679|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848680|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20445286|NCT01386242|Interferons|interferons|mesh-list
20445287|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445288|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
20445289|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445290|NCT01386255|Baclofen|baclofen|mesh-list
20445291|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20445292|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219454|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219455|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
20219456|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219457|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20219458|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20219459|NCT00317070|Protective Agents|protective agents|mesh-ancestor
20219460|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219461|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20445293|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20445294|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445295|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20445296|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
20445297|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
20445298|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219462|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
20219463|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219464|NCT00317096|Rituximab|rituximab|mesh-list
20219465|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20219466|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219467|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
20445299|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445300|NCT01386268|Factor VIII|factor viii|mesh-list
20445301|NCT01386268|Coagulants|coagulants|mesh-ancestor
19848681|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19848682|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445302|NCT01386294|Tenofovir|tenofovir|mesh-list
20445303|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
20445304|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445305|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20445306|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20445307|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445308|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445309|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20445310|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20445311|NCT01386333|Oxytocin|oxytocin|mesh-list
20445312|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
20445313|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20445314|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445315|NCT01386346|Capecitabine|capecitabine|mesh-list
20445316|NCT01386346|Azacitidine|azacitidine|mesh-list
20445317|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
19855582|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445318|NCT01386346|Epirubicin|epirubicin|mesh-list
20445319|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445320|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
20445321|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445322|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445323|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445324|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20445325|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20445326|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20445327|NCT01386372|Tolvaptan|tolvaptan|mesh-list
20445328|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20445329|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445330|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
20445331|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445332|NCT01386398|Bortezomib|bortezomib|mesh-list
20445333|NCT01386398|Vorinostat|vorinostat|mesh-list
20445334|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445335|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20445336|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445337|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445338|NCT01386502|Pidilizumab|pidilizumab|mesh-list
20445339|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445340|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445341|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
20445342|NCT01386567|Citric Acid|citric acid|mesh-list
20445343|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
20445344|NCT01386567|Enclomiphene|enclomiphene|mesh-list
20445345|NCT01386567|Clomiphene|clomiphene|mesh-list
20445346|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
20445347|NCT01386567|Testosterone|testosterone|mesh-list
20445348|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
20445349|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
19406190|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19406191|NCT03583086|Nivolumab|nivolumab|mesh-list
19406192|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406193|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406194|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19406195|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406196|NCT03583021|Neostigmine|neostigmine|mesh-list
20613650|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20613651|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
20613652|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219468|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219469|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406197|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19406198|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406199|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613653|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613654|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20613655|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
20613656|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693719|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
19693720|NCT04976673|Hormones|hormones|mesh-ancestor
19693721|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693722|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693723|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19693724|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
19693725|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219470|NCT00317135|Vaccines|vaccines|mesh-list
20613657|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613658|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20613659|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406200|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
19406201|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406202|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406203|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19406204|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
19693726|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219471|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
20219472|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219473|NCT00317187|Vaccines|vaccines|mesh-list
20219474|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
20219475|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219476|NCT00317200|Paclitaxel|paclitaxel|mesh-list
20445350|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20445351|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
20219477|NCT00317200|Bevacizumab|bevacizumab|mesh-list
20219478|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20219479|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219480|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
20219481|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
20219482|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20445352|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20445353|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
20445354|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
20445355|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445356|NCT01386567|Androgens|androgens|mesh-ancestor
20445357|NCT01386567|Hormones|hormones|mesh-ancestor
20445358|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219483|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445359|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445360|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20445361|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445362|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
20445363|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20445364|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
20445365|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20445366|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
20445367|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20445368|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20445369|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20445370|NCT01386580|Doxorubicin|doxorubicin|mesh-list
20445371|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20445372|NCT01386580|Trastuzumab|trastuzumab|mesh-list
20445373|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20445374|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445375|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20445376|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20219484|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20219485|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20219486|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20219487|NCT00317200|Growth Substances|growth substances|mesh-ancestor
20219488|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445377|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445378|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445379|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445380|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
20445381|NCT01386593|Rifampin|rifampin|mesh-list
20445382|NCT01386593|Fluconazole|fluconazole|mesh-list
20445383|NCT01386593|Paroxetine|paroxetine|mesh-list
20445384|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20445385|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445386|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20445387|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20445388|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445389|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445390|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445391|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20445392|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20445393|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20445394|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20445395|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20445396|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445397|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
19693727|NCT04976543|Heparin|heparin|mesh-list
19693728|NCT04976543|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19693729|NCT04976543|Tinzaparin|tinzaparin|mesh-list
19693730|NCT04976543|Dalteparin|dalteparin|mesh-list
19693731|NCT04976543|Warfarin|warfarin|mesh-list
19693732|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
19693733|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19693734|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19693735|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693736|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19693737|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693738|NCT04976855|Buprenorphine|buprenorphine|mesh-list
19693739|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19693740|NCT04976855|Naloxone|naloxone|mesh-list
19693741|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19693742|NCT04976855|Narcotics|narcotics|mesh-ancestor
20445398|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445399|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20445400|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
20445401|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20445402|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20445403|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
20445404|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20445405|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20445406|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
20445407|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445408|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20445409|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20445410|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20445411|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
20445412|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
20445413|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20445414|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20445415|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20445416|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20445417|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20445418|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20445419|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20525211|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525212|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525213|NCT01757106|Sevoflurane|sevoflurane|mesh-list
20525214|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20525215|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20525216|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
20525217|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
20525218|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525219|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525220|NCT01757236|Vancomycin|vancomycin|mesh-list
20525221|NCT01757236|Rifampin|rifampin|mesh-list
20525222|NCT01757236|Clindamycin|clindamycin|mesh-list
20525223|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
20525224|NCT01757236|Linezolid|linezolid|mesh-list
20525225|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20525226|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
20525227|NCT01757236|Trimethoprim|trimethoprim|mesh-list
20525228|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
20525229|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20525230|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525231|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20525232|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
20525233|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
20525234|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20525235|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525236|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525237|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20525238|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20525239|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19848683|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848684|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19848685|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
19848686|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848687|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848688|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848689|NCT00696137|Fentanyl|fentanyl|mesh-list
20525240|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20525241|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20525242|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20525243|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20525244|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20525245|NCT01757236|Renal Agents|renal agents|mesh-ancestor
20525246|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
20525247|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20525248|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20525249|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20525250|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20525251|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20445420|NCT01386658|Icatibant|icatibant|mesh-list
20445421|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20445422|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20445423|NCT01386658|Analgesics|analgesics|mesh-ancestor
20445424|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
20445425|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445426|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445427|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20445428|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20445429|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20445430|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20445431|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445432|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20445433|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445434|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
20445435|NCT01386671|Metformin|metformin|mesh-list
20445436|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20445437|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445438|NCT01386710|Bevacizumab|bevacizumab|mesh-list
20445439|NCT01386710|Carboplatin|carboplatin|mesh-list
20445440|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445441|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445442|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20445443|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20445444|NCT01386710|Growth Substances|growth substances|mesh-ancestor
20445445|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445446|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
20445447|NCT01386736|Vitamin D|vitamin d|mesh-list
20445448|NCT01386736|Vitamins|vitamins|mesh-ancestor
20445449|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
20445450|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445451|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20445452|NCT01386827|Vaccines|vaccines|mesh-list
20445453|NCT01386827|Immunologic Factors|immunologic factors|mesh-ancestor
20445454|NCT01386827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445455|NCT01386853|Atorvastatin|atorvastatin|mesh-list
20445456|NCT01386853|Pitavastatin|pitavastatin|mesh-list
20445457|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20445458|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20445459|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
20445460|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445461|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20445462|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20445463|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445464|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
20445465|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20445466|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445467|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445468|NCT01386879|Methylene Blue|methylene blue|mesh-list
20445469|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445470|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445471|NCT01386996|Budesonide|budesonide|mesh-list
20445472|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
20445473|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20445474|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20445475|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20445476|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
20445477|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445478|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445479|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20445480|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
20445481|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
20445482|NCT01386996|Hormones|hormones|mesh-ancestor
20445483|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445484|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20445485|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19848690|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19848691|NCT00696137|Narcotics|narcotics|mesh-ancestor
19848692|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848693|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848694|NCT00696137|Analgesics|analgesics|mesh-ancestor
19848695|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
19848696|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445486|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20445487|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20445488|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445489|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445490|NCT01387048|Adapalene|adapalene|mesh-list
20445491|NCT01387048|Azelaic acid|azelaic acid|mesh-list
20445492|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19848697|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19848698|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19848699|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
19848700|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
19848701|NCT00696241|Olmesartan|olmesartan|mesh-list
19848702|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19848703|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19848704|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848705|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19848706|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19848707|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445493|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20445494|NCT01387048|Analgesics|analgesics|mesh-ancestor
20445495|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
20445496|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445497|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445498|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20445499|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20445500|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
20445501|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445502|NCT01387087|Peficitinib|peficitinib|mesh-list
20445503|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445504|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445505|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445506|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
20445507|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445508|NCT01387191|Epoprostenol|epoprostenol|mesh-list
20445509|NCT01387191|Tezosentan|tezosentan|mesh-list
19406205|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848708|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19848709|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19848710|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19848711|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848712|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848713|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848714|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848715|NCT00696293|Analgesics|analgesics|mesh-ancestor
19848716|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
19848717|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848718|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
19848719|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19848720|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
19848721|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
19848722|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
19848723|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19848724|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19848725|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19848726|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848727|NCT00696384|Diuretics|diuretics|mesh-ancestor
19848728|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
19848729|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848730|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19848731|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848732|NCT00696410|Zinc|zinc|mesh-list
20219489|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
20219490|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20219491|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
20219492|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219493|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219494|NCT00317330|Rifampin|rifampin|mesh-list
20219495|NCT00317330|Isoniazid|isoniazid|mesh-list
20219496|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
20219497|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20219498|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
20219499|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219500|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219501|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
20445510|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20445511|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20445512|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
20445513|NCT01387204|Trametinib|trametinib|mesh-list
20445514|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445515|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20445516|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848733|NCT00696410|Trace Elements|trace elements|mesh-ancestor
19848734|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
19848735|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855583|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855584|NCT00749515|Deferasirox|deferasirox|mesh-list
20219502|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20445517|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445518|NCT01387243|Orlistat|orlistat|mesh-list
20445519|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445520|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445521|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20445522|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20445523|NCT01387295|Capecitabine|capecitabine|mesh-list
20445524|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
20445525|NCT01387295|Trastuzumab|trastuzumab|mesh-list
20445526|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445527|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
20445528|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445529|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445530|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445531|NCT01387373|Capecitabine|capecitabine|mesh-list
20445532|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
20445533|NCT01387373|Trastuzumab|trastuzumab|mesh-list
20445534|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445535|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
20445536|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445537|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445538|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445539|NCT01387399|Cisplatin|cisplatin|mesh-list
20445540|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445541|NCT01387425|Varenicline|varenicline|mesh-list
20445542|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20445543|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20445544|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
19406206|NCT03582930|Calfactant|calfactant|mesh-list
19406207|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19406208|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
19406209|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
19406210|NCT03582878|Sirolimus|sirolimus|mesh-list
19406211|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19406212|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406213|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19406214|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
19406215|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19406216|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406217|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406218|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406219|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
19406220|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406221|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
19406222|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406223|NCT03582865|Tamoxifen|tamoxifen|mesh-list
19406224|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19406225|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
19406226|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406227|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855585|NCT00749515|Deferoxamine|deferoxamine|mesh-list
20219503|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219504|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219505|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20219506|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20219507|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20219508|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20445545|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525252|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20525253|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
19855586|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20445546|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445547|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445548|NCT01387568|Lidocaine|lidocaine|mesh-list
20445549|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
20445550|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
20445551|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445552|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445553|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
20445554|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445555|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20445556|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20445557|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19406228|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19406229|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406230|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19406231|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19406232|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19406233|NCT03582605|Amoxicillin|amoxicillin|mesh-list
19406234|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20445558|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20445559|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445560|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
20445561|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20445562|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
20445563|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445564|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
20445565|NCT01387620|Protective Agents|protective agents|mesh-ancestor
20445566|NCT01387880|Everolimus|everolimus|mesh-list
20445567|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445568|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848736|NCT00696436|Valsartan|valsartan|mesh-list
19848737|NCT00696436|Olmesartan|olmesartan|mesh-list
19848738|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19848739|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848740|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19848741|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19848742|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848743|NCT00696449|Adapalene|adapalene|mesh-list
20445569|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
20445570|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445571|NCT01387906|Bimatoprost|bimatoprost|mesh-list
20445572|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20445573|NCT01387997|Antibodies|antibodies|mesh-list
20445574|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
20445575|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848744|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19848745|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19848746|NCT00696449|Analgesics|analgesics|mesh-ancestor
20445576|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
20445577|NCT01388023|Listerine|listerine|mesh-list
20445578|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20445579|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445580|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
20445581|NCT01388036|Esmolol|esmolol|mesh-list
20445582|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19848747|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
19848748|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848749|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848750|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19848751|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848752|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
19848753|NCT00696488|Fluorouracil|fluorouracil|mesh-list
19848754|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
20445583|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20445584|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20445585|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
20445586|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445587|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445588|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406235|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848755|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848756|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445589|NCT01388049|Antibodies|antibodies|mesh-list
19406236|NCT03582332|Indomethacin|indomethacin|mesh-list
20445590|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
20445591|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445592|NCT01388062|Antibodies|antibodies|mesh-list
20445593|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
20445594|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445595|NCT01388075|Rifampin|rifampin|mesh-list
20445596|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20445597|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
20445598|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20445599|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445600|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
20445601|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20445602|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445603|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445604|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20445605|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20445606|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20445607|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20445608|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20445609|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20445610|NCT01388088|Amiloride|amiloride|mesh-list
20445611|NCT01388088|Spironolactone|spironolactone|mesh-list
20445612|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20445613|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
20445614|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445615|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445616|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20445617|NCT01388088|Diuretics|diuretics|mesh-ancestor
20445618|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
20445619|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20445620|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20445621|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20445622|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445623|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20445624|NCT01388101|Antibodies|antibodies|mesh-list
20445625|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
20445626|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445627|NCT01388114|Antibodies|antibodies|mesh-list
20445628|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
20445629|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445630|NCT01388153|Acarbose|acarbose|mesh-list
20445631|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20445632|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848757|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848758|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848759|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
19848760|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848761|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
19848762|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19848763|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19848764|NCT00696657|Liraglutide|liraglutide|mesh-list
19848765|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19848766|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848767|NCT00696657|Incretins|incretins|mesh-ancestor
20445633|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445634|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20445635|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445636|NCT01388270|Heparin|heparin|mesh-list
20445637|NCT01388270|Calcium heparin|calcium heparin|mesh-list
20445638|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
20445639|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20445640|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20445641|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848768|NCT00696657|Hormones|hormones|mesh-ancestor
19848769|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525254|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20525255|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20525256|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
20525257|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20525258|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20525259|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525260|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20445642|NCT01388322|Enoxaparin|enoxaparin|mesh-list
20445643|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
20445644|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20445645|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20445646|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445647|NCT01388387|Tacrolimus|tacrolimus|mesh-list
20445648|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445649|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
20445650|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445651|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20445652|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445653|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445654|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20445655|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445656|NCT01388439|Oseltamivir|oseltamivir|mesh-list
20445657|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
20445658|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445659|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445660|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445661|NCT01388517|Vitamin D|vitamin d|mesh-list
20445662|NCT01388517|Calcitriol|calcitriol|mesh-list
20445663|NCT01388517|Petrolatum|petrolatum|mesh-list
20445664|NCT01388517|Tacrolimus|tacrolimus|mesh-list
20445665|NCT01388517|Vitamins|vitamins|mesh-ancestor
20445666|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
20445667|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445668|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20445669|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445670|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
20445671|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20445672|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445673|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445674|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20445675|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20445676|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20445677|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20445678|NCT01388517|Emollients|emollients|mesh-ancestor
20445679|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
20445680|NCT01388582|Copper|copper|mesh-list
20445681|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
20445682|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
20445683|NCT01388582|Etonogestrel|etonogestrel|mesh-list
20445684|NCT01388582|Desogestrel|desogestrel|mesh-list
20445685|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
20445686|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20445687|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445688|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20445689|NCT01388582|Trace Elements|trace elements|mesh-ancestor
20445690|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
20445691|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20445692|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20445693|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20445694|NCT01388582|Progestins|progestins|mesh-ancestor
20445695|NCT01388582|Hormones|hormones|mesh-ancestor
20445696|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445697|NCT01388595|Fluticasone|fluticasone|mesh-list
20445698|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20445699|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20445700|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20445701|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
20445702|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445703|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445704|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20445705|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
20445706|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
19406237|NCT03582332|Etoricoxib|etoricoxib|mesh-list
20445707|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20445708|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20445709|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20445710|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20445711|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
20445712|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406238|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406239|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20445713|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445714|NCT01388621|Gemcitabine|gemcitabine|mesh-list
20445715|NCT01388621|Carboplatin|carboplatin|mesh-list
20445716|NCT01388621|Doxorubicin|doxorubicin|mesh-list
20445717|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20445718|NCT01388621|Panitumumab|panitumumab|mesh-list
20445719|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445720|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445721|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
20445722|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445723|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
20445724|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445725|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445726|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445727|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
20445728|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445729|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20445730|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20445731|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20445732|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445733|NCT01388660|Clopidogrel|clopidogrel|mesh-list
20445734|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20445735|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20445736|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20445737|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20445738|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
20445739|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445740|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445741|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445742|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
20445743|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20445744|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
20445745|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20445746|NCT01388738|Protective Agents|protective agents|mesh-ancestor
20445747|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445748|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
20445749|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20445750|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
20445751|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445752|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445753|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20445754|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
20445755|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20219509|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20445756|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
20445757|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445758|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445759|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20445760|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
20445761|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
20445762|NCT01388842|Protective Agents|protective agents|mesh-ancestor
20445763|NCT01388855|Vitamin D|vitamin d|mesh-list
20445764|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
20445765|NCT01388855|Vitamins|vitamins|mesh-ancestor
20445766|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
20445767|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445768|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20445769|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20445770|NCT01388959|Rituximab|rituximab|mesh-list
20445771|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445772|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445773|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
20445774|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445775|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20445776|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
20445777|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445778|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
20445779|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219510|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20219511|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20219512|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20219513|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
20219514|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20219515|NCT00317343|Anticoagulants|anticoagulants|mesh-list
20219516|NCT00317343|Bivalirudin|bivalirudin|mesh-list
20219517|NCT00317343|Thrombin|thrombin|mesh-list
20219518|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
20445780|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445781|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20445782|NCT01389063|Maraviroc|maraviroc|mesh-list
20445783|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20445784|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20445785|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445786|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20445787|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20445788|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
20445789|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445790|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20445791|NCT01389167|Naltrexone|naltrexone|mesh-list
19848770|NCT00696696|Gemcitabine|gemcitabine|mesh-list
19848771|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19848772|NCT00696696|Sorafenib|sorafenib|mesh-list
19848773|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19848774|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
19848775|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848776|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848777|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
19848778|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848779|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848780|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848781|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
20445792|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20445793|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20445794|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445795|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
20445796|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445797|NCT01389193|Ibudilast|ibudilast|mesh-list
20445798|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20445799|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
20445800|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445801|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445802|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20445803|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
20445804|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20445805|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445806|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445807|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20445808|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
20445809|NCT01389206|Bosentan|bosentan|mesh-list
20445810|NCT01389206|Selexipag|selexipag|mesh-list
20445811|NCT01389206|Iloprost|iloprost|mesh-list
20445812|NCT01389206|Macitentan|macitentan|mesh-list
20445813|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20445814|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
20445815|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20445816|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20445817|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445818|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20445819|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20445820|NCT01389271|Iloprost|iloprost|mesh-list
20445821|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20445822|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
20445823|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20445824|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20445825|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20445826|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
20445827|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445828|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20445829|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20445830|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445831|NCT01389401|Omeprazole|omeprazole|mesh-list
20445832|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20445833|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20445834|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20445835|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445836|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445837|NCT01389414|Gemcitabine|gemcitabine|mesh-list
20445838|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
20445839|NCT01389414|Panitumumab|panitumumab|mesh-list
20445840|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445841|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
19848782|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855587|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
20445842|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445843|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445844|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
19848783|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19848784|NCT00696761|Alfuzosin|alfuzosin|mesh-list
19848785|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19848786|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19848787|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19848788|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
20445845|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445846|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445847|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445848|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
20445849|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445850|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445851|NCT01389427|Sirolimus|sirolimus|mesh-list
20445852|NCT01389427|Prednisone|prednisone|mesh-list
20445853|NCT01389427|Doxorubicin|doxorubicin|mesh-list
20445854|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
20445855|NCT01389427|Vincristine|vincristine|mesh-list
20445856|NCT01389427|Rituximab|rituximab|mesh-list
20445857|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20445858|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445859|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20445860|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445861|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
20445862|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445863|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
20445864|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445865|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20445866|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20445867|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
20445868|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445869|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20445870|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20445871|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
20445872|NCT01389427|Hormones|hormones|mesh-ancestor
20445873|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445874|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20445875|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20445876|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
20613660|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613661|NCT02256150|Analgesics|analgesics|mesh-ancestor
20613662|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
20613663|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613664|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406240|NCT03582332|Analgesics|analgesics|mesh-ancestor
19406241|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
19406242|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406243|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406244|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406245|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406246|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
19406247|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
19406248|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19406249|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19406250|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406251|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406252|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19693743|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693744|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693745|NCT04976855|Analgesics|analgesics|mesh-ancestor
19693746|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
19693747|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693748|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19693749|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
19693750|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693751|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693752|NCT04976088|Diclofenac|diclofenac|mesh-list
19693753|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
19693754|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19693755|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19693756|NCT04976088|Analgesics|analgesics|mesh-ancestor
19693757|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
20445877|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
20445878|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
20445879|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445880|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20445881|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20445882|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445883|NCT01389440|Gemcitabine|gemcitabine|mesh-list
20445884|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20445885|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20445886|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
20445887|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848789|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848790|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848791|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848792|NCT00696761|Urological Agents|urological agents|mesh-ancestor
19848793|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19848794|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19848795|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19848796|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848797|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848798|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848799|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848800|NCT00696774|Analgesics|analgesics|mesh-ancestor
19848801|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
19848802|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848803|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
19848804|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19848805|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
19848806|NCT00696787|Pregabalin|pregabalin|mesh-list
19848807|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19848808|NCT00696787|Analgesics|analgesics|mesh-ancestor
20445888|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445889|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
20445890|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445891|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445892|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20445893|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
20445894|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445895|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20445896|NCT01389505|Bevacizumab|bevacizumab|mesh-list
20445897|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20445898|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445899|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20445900|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20445901|NCT01389505|Growth Substances|growth substances|mesh-ancestor
20445902|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445903|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
20445904|NCT01389544|Ritonavir|ritonavir|mesh-list
20445905|NCT01389544|Methadone|methadone|mesh-list
19848809|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
19848810|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848811|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445906|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20445907|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20445908|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
20445909|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20445910|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445911|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20445912|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20445913|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
20445914|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445915|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19406253|NCT03582319|Formaldehyde|formaldehyde|mesh-list
19406254|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
19406255|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406256|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
19406257|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19406258|NCT03582306|Protective Agents|protective agents|mesh-ancestor
19406259|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406260|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
19406261|NCT03582280|Calcium|calcium|mesh-list
19406262|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19406263|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406264|NCT03582280|Antacids|antacids|mesh-ancestor
19848812|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
19848813|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19848814|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848815|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848816|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19848817|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19848818|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19848819|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445916|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20445917|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20445918|NCT01389544|Narcotics|narcotics|mesh-ancestor
20445919|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445920|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445921|NCT01389544|Analgesics|analgesics|mesh-ancestor
20445922|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
20445923|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445924|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
20445925|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
20445926|NCT01389557|Piperaquine|piperaquine|mesh-list
20445927|NCT01389557|Primaquine|primaquine|mesh-list
20445928|NCT01389557|Artenimol|artenimol|mesh-list
20445929|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
20445930|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20445931|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20445932|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20445933|NCT01389609|Doxazosin|doxazosin|mesh-list
20445934|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20445935|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20445936|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20445937|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19848820|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219519|NCT00317343|Coagulants|coagulants|mesh-ancestor
20219520|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
20219521|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19848821|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19848822|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19848823|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445938|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
20445939|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445940|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445941|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445942|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20445943|NCT01389713|Clomiphene|clomiphene|mesh-list
20445944|NCT01389713|Enclomiphene|enclomiphene|mesh-list
20445945|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
20445946|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19848824|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
19848825|NCT00697073|Idebenone|idebenone|mesh-list
19848826|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
19848827|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848828|NCT00697073|Protective Agents|protective agents|mesh-ancestor
19848829|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848830|NCT00697112|Sirolimus|sirolimus|mesh-list
19848831|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219522|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
20219523|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219524|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219525|NCT00317408|Leucovorin|leucovorin|mesh-list
20219526|NCT00317408|Cytarabine|cytarabine|mesh-list
20219527|NCT00317408|Cyclosporine|cyclosporine|mesh-list
20219528|NCT00317408|Dexamethasone|dexamethasone|mesh-list
20445947|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
20445948|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20445949|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445950|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20445951|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
20445952|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20445953|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20445954|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20445955|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
20445956|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20445957|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
20219529|NCT00317408|Prednisolone|prednisolone|mesh-list
20219530|NCT00317408|Carboplatin|carboplatin|mesh-list
20219531|NCT00317408|Methotrexate|methotrexate|mesh-list
20445958|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20445959|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20445960|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445961|NCT01389778|Metformin|metformin|mesh-list
20445962|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20445963|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445964|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
20445965|NCT01389791|Rocuronium|rocuronium|mesh-list
19848832|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19848833|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19848834|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445966|NCT01389791|Analgesics|analgesics|mesh-ancestor
20445967|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
20445968|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445969|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445970|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
20445971|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445972|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20445973|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
20445974|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20445975|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20445976|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445977|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20445978|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
20445979|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20445980|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20445981|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20445982|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20445983|NCT01389908|Olanzapine|olanzapine|mesh-list
20445984|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
20445985|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
20445986|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20445987|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20445988|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20445989|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20445990|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20445991|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20445992|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20445993|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20445994|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20445995|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20445996|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20445997|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20445998|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
20525261|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20525262|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20525263|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20525264|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20525265|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19848835|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
19848836|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19848837|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
19848838|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525266|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20525267|NCT01757262|Clopidogrel|clopidogrel|mesh-list
20525268|NCT01757262|Ticagrelor|ticagrelor|mesh-list
20525269|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19406265|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406266|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693758|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848839|NCT00697203|Pravastatin|pravastatin|mesh-list
19406267|NCT03582124|Panitumumab|panitumumab|mesh-list
19693759|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693760|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693761|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693762|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19693763|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693764|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693765|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
19693766|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19693767|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693768|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
19707726|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
19848840|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
19848841|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19848842|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19848843|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
19848844|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848845|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19406268|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693769|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19693770|NCT04975932|Estrogens|estrogens|mesh-ancestor
19406269|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20445999|NCT01390012|Dexamethasone|dexamethasone|mesh-list
20446000|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
20446001|NCT01390012|BB 1101|bb 1101|mesh-list
20446002|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446003|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
20446004|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
20446005|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446006|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446007|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446008|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
20446009|NCT01390012|Hormones|hormones|mesh-ancestor
20446010|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848846|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19848847|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848848|NCT00697463|Teriparatide|teriparatide|mesh-list
19848849|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19848850|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848851|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19848852|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19848853|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19848854|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19848855|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848856|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19848857|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20446011|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20446012|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446013|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
20446014|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446015|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446016|NCT01390051|Tinzaparin|tinzaparin|mesh-list
20446017|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20446018|NCT01390051|Dalteparin|dalteparin|mesh-list
20446019|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
20446020|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20446021|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20446022|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446023|NCT01390311|Azacitidine|azacitidine|mesh-list
20446024|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20446025|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
20446026|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446027|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446028|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446029|NCT01390324|Naproxen|naproxen|mesh-list
20446030|NCT01390324|Naratriptan|naratriptan|mesh-list
20446031|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20446032|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20446033|NCT01390324|Analgesics|analgesics|mesh-ancestor
20446034|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
20446035|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446036|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693771|NCT04975932|Hormones|hormones|mesh-ancestor
19693772|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693773|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693774|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693775|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693776|NCT04975971|Dexamethasone|dexamethasone|mesh-list
19693777|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693778|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
19693779|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
19693780|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693781|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693782|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19848858|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20446037|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446038|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446039|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
20446040|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20446041|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446042|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446043|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20446044|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20446045|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20446046|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
20446047|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446048|NCT01390337|Cytarabine|cytarabine|mesh-list
20446049|NCT01390337|Daunorubicin|daunorubicin|mesh-list
20446050|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20446051|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
20446052|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446053|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446054|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
20446055|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446056|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446057|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
20446058|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446059|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20446060|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20446061|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20446062|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446063|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
20446064|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20446065|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446066|NCT01390480|Vitamins|vitamins|mesh-ancestor
20446067|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
20446068|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20446069|NCT01390506|Selenious Acid|selenious acid|mesh-list
20446070|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
20446071|NCT01390506|Trace Elements|trace elements|mesh-ancestor
20446072|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
20446073|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446074|NCT01390519|Everolimus|everolimus|mesh-list
20446075|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446076|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446077|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
20446078|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446079|NCT01390571|Temozolomide|temozolomide|mesh-list
20446080|NCT01390571|Olaparib|olaparib|mesh-list
20446081|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20446082|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
20446083|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446084|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446085|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20446086|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446087|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
20219532|NCT00317408|Etoposide|etoposide|mesh-list
20219533|NCT00317408|Melphalan|melphalan|mesh-list
20219534|NCT00317408|Busulfan|busulfan|mesh-list
20219535|NCT00317408|Ifosfamide|ifosfamide|mesh-list
20219536|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
20219537|NCT00317408|Idarubicin|idarubicin|mesh-list
20219538|NCT00317408|Thiotepa|thiotepa|mesh-list
20219539|NCT00317408|Carmustine|carmustine|mesh-list
20219540|NCT00317408|Vinblastine|vinblastine|mesh-list
20219541|NCT00317408|Lomustine|lomustine|mesh-list
20219542|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
20219543|NCT00317408|Vindesine|vindesine|mesh-list
20219544|NCT00317408|Cyclosporins|cyclosporins|mesh-list
20219545|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20219546|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
20219547|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219548|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
20219549|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
20219550|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219551|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219552|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20219553|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
20219554|NCT00317408|Hormones|hormones|mesh-ancestor
20219555|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219556|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20219557|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219558|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20219559|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
20446088|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20446089|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446090|NCT01390662|Vitamin D|vitamin d|mesh-list
20219560|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20219561|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20219562|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
20219563|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219564|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
20219565|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219566|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20219567|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219568|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
20219569|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20219570|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20446091|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
20446092|NCT01390662|Vitamins|vitamins|mesh-ancestor
20446093|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
20446094|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446095|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20446096|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20446097|NCT01390766|Azathioprine|azathioprine|mesh-list
19848859|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
19848860|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848861|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848862|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848863|NCT00697593|Antibodies|antibodies|mesh-list
20446098|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
20446099|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446100|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20446101|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446102|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446103|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
20219571|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20219572|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20219573|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20219574|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
20219575|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219576|NCT00317408|Antidotes|antidotes|mesh-ancestor
20219577|NCT00317408|Protective Agents|protective agents|mesh-ancestor
19848864|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19693783|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
19693784|NCT04975971|Hormones|hormones|mesh-ancestor
19693785|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19693786|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693787|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693788|NCT04975724|Citalopram|citalopram|mesh-list
19693789|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19693790|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20446104|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446105|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446106|NCT01390792|Zanamivir|zanamivir|mesh-list
20446107|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
20446108|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446109|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446110|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693791|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693792|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693793|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693794|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
19693795|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693796|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19693797|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
19693798|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19693799|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
19693800|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19693801|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
19693802|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693803|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
19693804|NCT04975373|Protective Agents|protective agents|mesh-ancestor
19693805|NCT04975360|Caffeine|caffeine|mesh-list
19848865|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
20446111|NCT01390805|Valacyclovir|valacyclovir|mesh-list
20446112|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
19848866|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446113|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446114|NCT01390883|PENTA|penta|mesh-list
20446115|NCT01390883|Fondaparinux|fondaparinux|mesh-list
20446116|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20446117|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
20446118|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20446119|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
20446120|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446121|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446122|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
20446123|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20446124|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20446125|NCT01390896|PENTA|penta|mesh-list
20446126|NCT01390896|Fondaparinux|fondaparinux|mesh-list
20446127|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20446128|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
20446129|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20446130|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
20446131|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446132|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446133|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
20446134|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20446135|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20446136|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
20446137|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20446138|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20446139|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20446140|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446141|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446142|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
20446143|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446144|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446145|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20446146|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446147|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20446148|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
20446149|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446150|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446151|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20446152|NCT01390935|Diuretics|diuretics|mesh-ancestor
20446153|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
20446154|NCT01390961|Pheniramine|pheniramine|mesh-list
20446155|NCT01390961|Naphazoline|naphazoline|mesh-list
20446156|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446157|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20446158|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20446159|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
20446160|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446161|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446162|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
20446163|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20446164|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
20446165|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20446166|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
20446167|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
20446168|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
20446169|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
20446170|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20446171|NCT01391052|Norethindrone|norethindrone|mesh-list
20446172|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
20446173|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20446174|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20446175|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20446176|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
20446177|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20446178|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446179|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20446180|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20446181|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
20446182|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
20446183|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20446184|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20446185|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446186|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446187|NCT01391104|Urological Agents|urological agents|mesh-ancestor
20446188|NCT01391156|Minoxidil|minoxidil|mesh-list
20446189|NCT01391156|Finasteride|finasteride|mesh-list
20446190|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20446191|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
20446192|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20446193|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19848867|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
19848868|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19848869|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848870|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
19848871|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19848872|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848873|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446194|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446195|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446196|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
19848874|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219578|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
20446197|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446198|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446199|NCT01391156|Urological Agents|urological agents|mesh-ancestor
20446200|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20446201|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20446202|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20446203|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446204|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446205|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446206|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446207|NCT01391221|Analgesics|analgesics|mesh-ancestor
20446208|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
20446209|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446210|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
20446211|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20446212|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
20446213|NCT01391260|Gefitinib|gefitinib|mesh-list
20219579|NCT00317408|Vitamins|vitamins|mesh-ancestor
20219580|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
20219581|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
20219582|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20219583|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20219584|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
20219585|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20219586|NCT00317408|Analgesics|analgesics|mesh-ancestor
20219587|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
20219588|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20219589|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
20219590|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
20219591|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
20219592|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
20247192|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20446214|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446215|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20446216|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446217|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446218|NCT01391377|Niacin|niacin|mesh-list
20446219|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20446220|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
20446221|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446222|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20446223|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
20446224|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
20446225|NCT01391377|Vitamins|vitamins|mesh-ancestor
19406270|NCT03582098|Rituximab|rituximab|mesh-list
19693806|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19693807|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693808|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19693809|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693810|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693811|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19693812|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19693813|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
19848875|NCT00697788|Analgesics|analgesics|mesh-ancestor
19855588|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
19406271|NCT03582098|Idelalisib|idelalisib|mesh-list
19693814|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707727|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19707728|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19406272|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406273|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406274|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
20613665|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20613666|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613667|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20613668|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
20613669|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20613670|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20613671|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613672|NCT02256215|Vitamin D|vitamin d|mesh-list
20613673|NCT02256215|Vitamins|vitamins|mesh-ancestor
20613674|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
20613675|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613676|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20613677|NCT02256228|Ropivacaine|ropivacaine|mesh-list
20613678|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
20613679|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
20613680|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613681|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613682|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
20219593|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219594|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
20219595|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20219596|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20219597|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219598|NCT00317421|Urological Agents|urological agents|mesh-ancestor
20613683|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613684|NCT02256254|Simvastatin|simvastatin|mesh-list
20613685|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20613686|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20613687|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
20613688|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613689|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20613690|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19848876|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
19848877|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848878|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19848879|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19848880|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19848881|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
19848882|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848883|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848884|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
19848885|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19848886|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20219599|NCT00317434|Lapatinib|lapatinib|mesh-list
19406275|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406276|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446226|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
20446227|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446228|NCT01391390|Melatonin|melatonin|mesh-list
20446229|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
20446230|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446231|NCT01391390|Protective Agents|protective agents|mesh-ancestor
20446232|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446233|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446234|NCT01391403|Artemisinins|artemisinins|mesh-list
20613691|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613692|NCT02256280|Neostigmine|neostigmine|mesh-list
20613693|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20613694|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707729|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19707730|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19707731|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19707732|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
19707733|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707734|NCT04824352|Apatinib|apatinib|mesh-list
19848887|NCT00698035|Testosterone|testosterone|mesh-list
20219600|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446235|NCT01391403|Artemisinin|artemisinin|mesh-list
20219601|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20446236|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
20446237|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20446238|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20446239|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446240|NCT01391520|Deferiprone|deferiprone|mesh-list
20446241|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20446242|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
20446243|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
20446244|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446245|NCT01391572|Fluorouracil|fluorouracil|mesh-list
20446246|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446247|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
20446248|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693815|NCT04975022|Insulin|insulin|mesh-list
19693816|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19693817|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693818|NCT04975074|Iron|iron|mesh-list
19693819|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
19693820|NCT04975074|Trace Elements|trace elements|mesh-ancestor
19693821|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
19693822|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693823|NCT04975074|Hematinics|hematinics|mesh-ancestor
19693824|NCT04974827|Carboplatin|carboplatin|mesh-list
19693825|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693826|NCT04974723|Teriparatide|teriparatide|mesh-list
19693827|NCT04974723|Abaloparatide|abaloparatide|mesh-list
20446249|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20446250|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446251|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
20446252|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446253|NCT01391598|Lidocaine|lidocaine|mesh-list
20446254|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
20446255|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
20446256|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446257|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446258|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
20446259|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446260|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20446261|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20446262|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20446263|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446264|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446265|NCT01391624|Mineral Oil|mineral oil|mesh-list
20446266|NCT01391624|Emollients|emollients|mesh-ancestor
20446267|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
20446268|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20446269|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20446270|NCT01391689|Protective Agents|protective agents|mesh-ancestor
20446271|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446272|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446273|NCT01391715|Rabeprazole|rabeprazole|mesh-list
20446274|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20446275|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446276|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20446277|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446278|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219602|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219603|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219604|NCT00317447|Prednisone|prednisone|mesh-list
20219605|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219606|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
20219607|NCT00317447|Hormones|hormones|mesh-ancestor
20219608|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219609|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219610|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20219611|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219612|NCT00317499|Etanercept|etanercept|mesh-list
20219613|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20219614|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219615|NCT00317499|Analgesics|analgesics|mesh-ancestor
20219616|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
19693828|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19693829|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693830|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20446279|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
20446280|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20446281|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
20446282|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20446283|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446284|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20525270|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20525271|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20525272|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20525273|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
20525274|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525275|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525276|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525277|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
20525278|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20525279|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530489|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20530490|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
20530491|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530492|NCT01788982|Nintedanib|nintedanib|mesh-list
20530493|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530494|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20530495|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530496|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530497|NCT01789086|Liraglutide|liraglutide|mesh-list
20530498|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20530499|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530500|NCT01789086|Incretins|incretins|mesh-ancestor
20530501|NCT01789086|Hormones|hormones|mesh-ancestor
20530502|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530503|NCT01789099|Sargramostim|sargramostim|mesh-list
20530504|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
20530505|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530506|NCT01789125|Nicotine|nicotine|mesh-list
20530507|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20530508|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
20530509|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530510|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530511|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20530512|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20530513|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
20530514|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530515|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530516|NCT01789216|Ketorolac|ketorolac|mesh-list
20530517|NCT01789216|Meloxicam|meloxicam|mesh-list
20530518|NCT01789216|Pregabalin|pregabalin|mesh-list
20530519|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20530520|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530521|NCT01789216|Analgesics|analgesics|mesh-ancestor
20530522|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
20530523|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530524|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530525|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406277|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406278|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219617|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219618|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219619|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219620|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20219621|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20219622|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219623|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
20219624|NCT00317512|HBOC 201|hboc 201|mesh-list
20219625|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
20219626|NCT00317538|Etanercept|etanercept|mesh-list
20219627|NCT00317538|Infliximab|infliximab|mesh-list
20219628|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
20219629|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20219630|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20219631|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20219632|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219633|NCT00317538|Analgesics|analgesics|mesh-ancestor
20219634|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
20530526|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446285|NCT01392014|Piperaquine|piperaquine|mesh-list
20446286|NCT01392014|Primaquine|primaquine|mesh-list
20446287|NCT01392014|Artenimol|artenimol|mesh-list
20446288|NCT01392014|Artemisinins|artemisinins|mesh-list
20446289|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
20446290|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20446291|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20446292|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446293|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
20219635|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219636|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219637|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219638|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219639|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
20219640|NCT00317577|Timolol|timolol|mesh-list
20219641|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20446294|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20446295|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446296|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
20446297|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20446298|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
20446299|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446300|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446301|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20446302|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
20446303|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20446304|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
20446305|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446306|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446307|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20446308|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
20446309|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
20446310|NCT01392144|Protective Agents|protective agents|mesh-ancestor
20446311|NCT01392157|Copper|copper|mesh-list
20446312|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
20446313|NCT01392157|Trace Elements|trace elements|mesh-ancestor
20446314|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
20446315|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446316|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20446317|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
20446318|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20446319|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20446320|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20446321|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20446322|NCT01392209|Bevacizumab|bevacizumab|mesh-list
20446323|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20446324|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446325|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20446326|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20446327|NCT01392209|Growth Substances|growth substances|mesh-ancestor
20446328|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446329|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
20446330|NCT01392287|Memantine|memantine|mesh-list
20446331|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20446332|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20446333|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
20446334|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446335|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446336|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446337|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20446338|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20446339|NCT01392430|Azithromycin|azithromycin|mesh-list
20446340|NCT01392430|Dapsone|dapsone|mesh-list
20446341|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20219642|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20219643|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20219644|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
20219645|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219646|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219647|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219648|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20219649|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20446342|NCT01392430|Itraconazole|itraconazole|mesh-list
20446343|NCT01392430|Fluconazole|fluconazole|mesh-list
20446344|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20446345|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446346|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
20446347|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20446348|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20446349|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446350|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446351|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20446352|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
20446353|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446354|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446355|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20446356|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20446357|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20446358|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
20446359|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20446360|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20446361|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20446362|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
20446363|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20446364|NCT01392430|Renal Agents|renal agents|mesh-ancestor
20446365|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20446366|NCT01392534|Telmisartan|telmisartan|mesh-list
20446367|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20446368|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20446369|NCT01392534|Diuretics|diuretics|mesh-ancestor
20446370|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
20446371|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446372|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20446373|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446374|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446375|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20446376|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20446377|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
20446378|NCT01392612|Hematinics|hematinics|mesh-ancestor
20446379|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
20446380|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
20446381|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20446382|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20446383|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446384|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446385|NCT01392638|Urological Agents|urological agents|mesh-ancestor
20446386|NCT01392716|Rituximab|rituximab|mesh-list
20446387|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20446388|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446389|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
20446390|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446391|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446392|NCT01392755|Ritonavir|ritonavir|mesh-list
20446393|NCT01392755|Omeprazole|omeprazole|mesh-list
19848888|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
19848889|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
19848890|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19848891|NCT00698035|Estradiol|estradiol|mesh-list
19848892|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19848893|NCT00698035|Androgens|androgens|mesh-ancestor
19848894|NCT00698035|Hormones|hormones|mesh-ancestor
19848895|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848896|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848897|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848898|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848899|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
19848900|NCT00698035|Estrogens|estrogens|mesh-ancestor
19848901|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19848902|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
19848903|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19848904|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19848905|NCT00698204|Celecoxib|celecoxib|mesh-list
19848906|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19848907|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19848908|NCT00698204|Analgesics|analgesics|mesh-ancestor
19848909|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
19848910|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848911|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848912|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446394|NCT01392755|Ranitidine|ranitidine|mesh-list
20446395|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19848913|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19848914|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19848915|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19848916|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848917|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848918|NCT00698451|Bevacizumab|bevacizumab|mesh-list
19848919|NCT00698451|Carboplatin|carboplatin|mesh-list
19848920|NCT00698451|Doxorubicin|doxorubicin|mesh-list
19848921|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19848922|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848923|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848924|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19848925|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19848926|NCT00698451|Growth Substances|growth substances|mesh-ancestor
19848927|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848928|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
19848929|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19848930|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19848931|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19848932|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848933|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848934|NCT00698516|Bevacizumab|bevacizumab|mesh-list
20219650|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20446396|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20446397|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20446398|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
20446399|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446400|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446401|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20446402|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20446403|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
20219651|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20219652|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20219653|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20219654|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
20219655|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20219656|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
20446404|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446405|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20446406|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20446407|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20446408|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446409|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20446410|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20446411|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
20446412|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
20446413|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446414|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446415|NCT01392768|Levetiracetam|levetiracetam|mesh-list
20446416|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
20446417|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
20446418|NCT01392794|Ramosetron|ramosetron|mesh-list
20446419|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
20446420|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
20446421|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446422|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446423|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446424|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20446425|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
20446426|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446427|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446428|NCT01392807|Naloxegol|naloxegol|mesh-list
20446429|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19406279|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20219657|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219658|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219659|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20219660|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
20219661|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20219662|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
20219663|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446430|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446431|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
20446432|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446433|NCT01392833|Prednisone|prednisone|mesh-list
20446434|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
20446435|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20446436|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20446437|NCT01392833|Prednisolone|prednisolone|mesh-list
20446438|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
20446439|NCT01392833|Azathioprine|azathioprine|mesh-list
20446440|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20446441|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
20446442|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446443|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
20446444|NCT01392833|Hormones|hormones|mesh-ancestor
20446445|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446446|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446447|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20446448|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446449|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
20446450|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
20446451|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693831|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
19693832|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
19693833|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693834|NCT04974944|Paclitaxel|paclitaxel|mesh-list
19693835|NCT04974944|Bevacizumab|bevacizumab|mesh-list
20446452|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446453|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20446454|NCT01392833|Protective Agents|protective agents|mesh-ancestor
20446455|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
19848935|NCT00698516|Topotecan|topotecan|mesh-list
19848936|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848937|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848938|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19848939|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20446456|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446457|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20446458|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446459|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
20446460|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446461|NCT01392898|Liraglutide|liraglutide|mesh-list
20446462|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20446463|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446464|NCT01392898|Incretins|incretins|mesh-ancestor
20446465|NCT01392898|Hormones|hormones|mesh-ancestor
20446466|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446467|NCT01392911|Rifampin|rifampin|mesh-list
20446468|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20446469|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
20446470|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20446471|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446472|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
20446473|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20446474|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446475|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446476|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20446477|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20446478|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20446479|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20446480|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20446481|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20446482|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
20446483|NCT01393080|Cisplatin|cisplatin|mesh-list
20446484|NCT01393080|Paclitaxel|paclitaxel|mesh-list
19693836|NCT04974944|Carboplatin|carboplatin|mesh-list
19693837|NCT04974944|Apatinib|apatinib|mesh-list
19693838|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19693839|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446485|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20446486|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693840|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
19848940|NCT00698516|Growth Substances|growth substances|mesh-ancestor
20446487|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20446488|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
20446489|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
20446490|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
20446491|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446492|NCT01393145|Fluticasone|fluticasone|mesh-list
20446493|NCT01393145|Xhance|xhance|mesh-list
20446494|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
20446495|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20446496|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20446497|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446498|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20446499|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
20446500|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446501|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446502|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20446503|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
20446504|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
20446505|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20446506|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20446507|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20446508|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20446509|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
20446510|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446511|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446512|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
20446513|NCT01393145|Hormones|hormones|mesh-ancestor
20446514|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446515|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
20446516|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
20446517|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20446518|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446519|NCT01393288|Lorazepam|lorazepam|mesh-list
20446520|NCT01393288|Ondansetron|ondansetron|mesh-list
20446521|NCT01393288|Aprepitant|aprepitant|mesh-list
20446522|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
20446523|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
20446524|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446525|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446526|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446527|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
20446528|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
20446529|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20446530|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
20446531|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446532|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446533|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20446534|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20446535|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446536|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20446537|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20446538|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20446539|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
20446540|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20446541|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
19406280|NCT03582007|Murepavadin|murepavadin|mesh-list
19406281|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406282|NCT03581968|Pancrelipase|pancrelipase|mesh-list
19406283|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19406284|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
19406285|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19406286|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406287|NCT03581903|Vaccines|vaccines|mesh-list
19406288|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
19406289|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406290|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19693841|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
19693842|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
19693843|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693844|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693845|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19693846|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19693847|NCT04974944|Growth Substances|growth substances|mesh-ancestor
19693848|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693849|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
20446542|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
20446543|NCT01393340|Omalizumab|omalizumab|mesh-list
20446544|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20446545|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20446546|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
20446547|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
20446548|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446549|NCT01393522|Milnacipran|milnacipran|mesh-list
20446550|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
20446551|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20446552|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19848941|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848942|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
19848943|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19848944|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20446553|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446554|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446555|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446556|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446557|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20446558|NCT01393522|Analgesics|analgesics|mesh-ancestor
20446559|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
20446560|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446561|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
20446562|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20446563|NCT01393548|Brompheniramine|brompheniramine|mesh-list
20446564|NCT01393548|Phenylephrine|phenylephrine|mesh-list
20446565|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
20446566|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
20446567|NCT01393548|Ephedrine|ephedrine|mesh-list
20446568|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20446569|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
20446570|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
20446571|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446572|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446573|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
20446574|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20446575|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
20446576|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
20446577|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20446578|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20446579|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20446580|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613695|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406291|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19406292|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19406293|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406294|NCT03581773|Folic Acid|folic acid|mesh-list
19406295|NCT03581773|Hematinics|hematinics|mesh-ancestor
19406296|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
19406297|NCT03581773|Vitamins|vitamins|mesh-ancestor
19406298|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
19406299|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406300|NCT03581630|Naltrexone|naltrexone|mesh-list
19406301|NCT03581630|Bupropion|bupropion|mesh-list
19406302|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19406303|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19406304|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406305|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
19693850|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19693851|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693852|NCT04974580|Nicotine|nicotine|mesh-list
19693853|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19693854|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
19693855|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693856|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693857|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19693858|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19693859|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
19693860|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693861|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693862|NCT04974814|Atorvastatin|atorvastatin|mesh-list
19693863|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19848945|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446581|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446582|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446583|NCT01393548|Protective Agents|protective agents|mesh-ancestor
20446584|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20446585|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20446586|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20446587|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20446588|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
20446589|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
20446590|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20446591|NCT01393574|Melatonin|melatonin|mesh-list
20446592|NCT01393574|Methylphenidate|methylphenidate|mesh-list
20446593|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
20446594|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446595|NCT01393574|Protective Agents|protective agents|mesh-ancestor
20446596|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219664|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219665|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20219666|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
20219667|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
20219668|NCT00317629|Protective Agents|protective agents|mesh-ancestor
20219669|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20219670|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20219671|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446597|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446598|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20446599|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20446600|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20446601|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446602|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
20446603|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525287|NCT01757431|Eculizumab|eculizumab|mesh-list
20525288|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20525289|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525290|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
20525291|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525292|NCT01757457|Abciximab|abciximab|mesh-list
20525293|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
20525294|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20525295|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
20525296|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20525297|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525298|NCT01757587|Insulin|insulin|mesh-list
20525299|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20525300|NCT01757587|Metformin|metformin|mesh-list
20525301|NCT01757587|Vildagliptin|vildagliptin|mesh-list
20525302|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20525303|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525304|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20525305|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
20525306|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525307|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525308|NCT01757639|Ipilimumab|ipilimumab|mesh-list
20525309|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20525310|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525311|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20525312|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525313|NCT01757756|Midazolam|midazolam|mesh-list
20525314|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20525315|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20525316|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525317|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525318|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20525319|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20525320|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20525321|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20525322|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
20525323|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
20525324|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
20525325|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
20525326|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525327|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525328|NCT01757769|Silodosin|silodosin|mesh-list
20446604|NCT01393756|Lenalidomide|lenalidomide|mesh-list
20446605|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
20446606|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446607|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20446608|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20446609|NCT01393756|Growth Substances|growth substances|mesh-ancestor
20446610|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
20446611|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446612|NCT01393769|Melphalan|melphalan|mesh-list
20446613|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20446614|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
20446615|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446616|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446617|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20446618|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446619|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
20446620|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446621|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
20446622|NCT01393782|Giapreza|giapreza|mesh-list
20446623|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
20446624|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20446625|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20446626|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
20446627|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446628|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446629|NCT01393795|Capsaicin|capsaicin|mesh-list
20446630|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
20446631|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
20446632|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
20446633|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446634|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446635|NCT01393912|Crenolanib|crenolanib|mesh-list
20446636|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446637|NCT01393925|Parecoxib|parecoxib|mesh-list
20446638|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20446639|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20446640|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446641|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446642|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20446643|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20446644|NCT01393925|Analgesics|analgesics|mesh-ancestor
20446645|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
20446646|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446647|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446648|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446649|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446650|NCT01394016|Fulvestrant|fulvestrant|mesh-list
20446651|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20446652|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446653|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20446654|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20446655|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
20530527|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20530528|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693864|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19693865|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19693866|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
19693867|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693868|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19693869|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19693870|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693871|NCT04974281|Lenvatinib|lenvatinib|mesh-list
19693872|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693873|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19693874|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693875|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219672|NCT00317655|Ibuprofen|ibuprofen|mesh-list
20219673|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20219674|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219675|NCT00317655|Analgesics|analgesics|mesh-ancestor
20219676|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
20219677|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219678|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219679|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446656|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446657|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446658|NCT01394029|Deferasirox|deferasirox|mesh-list
20446659|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20446660|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
20446661|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
20446662|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446663|NCT01394094|Calcium|calcium|mesh-list
20446664|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20446665|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446666|NCT01394133|Ritonavir|ritonavir|mesh-list
20446667|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20446668|NCT01394133|Tenofovir|tenofovir|mesh-list
20446669|NCT01394133|Emtricitabine|emtricitabine|mesh-list
20446670|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20446671|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20446672|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
20446673|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446674|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219680|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20219681|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20219682|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219683|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219684|NCT00317681|Tacrolimus|tacrolimus|mesh-list
20219685|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219686|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
20219687|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219688|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20219689|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693876|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19693877|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
19693878|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693879|NCT04974060|Remifentanil|remifentanil|mesh-list
19693880|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19693881|NCT04974060|Narcotics|narcotics|mesh-ancestor
19693882|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693883|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693884|NCT04974060|Analgesics|analgesics|mesh-ancestor
19693885|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
19693886|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693887|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19693888|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
20219690|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219691|NCT00317733|Ketoprofen|ketoprofen|mesh-list
20446675|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20446676|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20446677|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
20446678|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446679|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20446680|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20446681|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20446682|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20446683|NCT01394224|Levetiracetam|levetiracetam|mesh-list
20446684|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
20446685|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
20446686|NCT01394263|Goserelin|goserelin|mesh-list
20446687|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20446688|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446689|NCT01394341|Liraglutide|liraglutide|mesh-list
20446690|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20446691|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446692|NCT01394341|Incretins|incretins|mesh-ancestor
20446693|NCT01394341|Hormones|hormones|mesh-ancestor
20446694|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446695|NCT01394354|Dexamethasone|dexamethasone|mesh-list
20446696|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
20446697|NCT01394354|Doxorubicin|doxorubicin|mesh-list
20446698|NCT01394354|Bortezomib|bortezomib|mesh-list
20446699|NCT01394354|Vorinostat|vorinostat|mesh-list
20446700|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446701|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
20446702|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
20446703|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693889|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20446704|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446705|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446706|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
20446707|NCT01394354|Hormones|hormones|mesh-ancestor
20446708|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446709|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20446710|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446711|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20446712|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20446713|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20446714|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446715|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446716|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20446717|NCT01394406|Ketamine|ketamine|mesh-list
20446718|NCT01394406|Analgesics|analgesics|mesh-ancestor
20446719|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
20446720|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446721|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446722|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20446723|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20446724|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
20446725|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
20446726|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446727|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20446728|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20446729|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446730|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446731|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
20446732|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20446733|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
20219692|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20219693|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219694|NCT00317733|Analgesics|analgesics|mesh-ancestor
19848946|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848947|NCT00698581|Brivaracetam|brivaracetam|mesh-list
19848948|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
19848949|NCT00698646|Valsartan|valsartan|mesh-list
19848950|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19848951|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848952|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19848953|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19848954|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848955|NCT00698646|Diuretics|diuretics|mesh-ancestor
19848956|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
19848957|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219695|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
20446734|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446735|NCT01394419|Expectorants|expectorants|mesh-ancestor
20446736|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
20446737|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20446738|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
20446739|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446740|NCT01394419|Protective Agents|protective agents|mesh-ancestor
20446741|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446742|NCT01394419|Antidotes|antidotes|mesh-ancestor
20446743|NCT01394445|Physostigmine|physostigmine|mesh-list
20446744|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20446745|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446746|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446747|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
20446748|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446749|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446750|NCT01394445|Miotics|miotics|mesh-ancestor
20446751|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
20446752|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446753|NCT01394458|Ethanol|ethanol|mesh-list
20219696|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219697|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219698|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219699|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20219700|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20219701|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219702|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848958|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19848959|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446754|NCT01394458|Heparin|heparin|mesh-list
20446755|NCT01394458|Citric Acid|citric acid|mesh-list
20446756|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
20446757|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
20446758|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20446759|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
20446760|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
20446761|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446762|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20446763|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20446764|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20446765|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446766|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446767|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446768|NCT01394471|Oxytocin|oxytocin|mesh-list
20446769|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
20446770|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20446771|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446772|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
20446773|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
20446774|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446775|NCT01394497|Expectorants|expectorants|mesh-ancestor
20446776|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
20446777|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20446778|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
20446779|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446780|NCT01394497|Protective Agents|protective agents|mesh-ancestor
20446781|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446782|NCT01394640|Vaccines|vaccines|mesh-list
20446783|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
20446784|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446785|NCT01394653|Ramosetron|ramosetron|mesh-list
20446786|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
20446787|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
20446788|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446789|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446790|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446791|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20446792|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
20446793|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446794|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446795|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
20446796|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446797|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
20446798|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
20446799|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446800|NCT01394731|Acetaminophen|acetaminophen|mesh-list
20446801|NCT01394731|Meperidine|meperidine|mesh-list
20446802|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20446803|NCT01394731|Analgesics|analgesics|mesh-ancestor
20446804|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
20219703|NCT00317746|Citalopram|citalopram|mesh-list
20219704|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20219705|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20219706|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20219707|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446805|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446806|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406306|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406307|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19406308|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
19406309|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19406310|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19406311|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19406312|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20219708|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219709|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
20219710|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219711|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20219712|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
20219713|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219714|NCT00317759|Fludarabine|fludarabine|mesh-list
20446807|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
20446808|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20446809|NCT01394731|Narcotics|narcotics|mesh-ancestor
20613696|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
20446810|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446811|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20446812|NCT01394757|Ketamine|ketamine|mesh-list
20446813|NCT01394757|Esketamine|esketamine|mesh-list
20446814|NCT01394757|Analgesics|analgesics|mesh-ancestor
20446815|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
20446816|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446817|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446818|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20446819|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20446820|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
20446821|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
20446822|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406313|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406314|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
19406315|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406316|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19406317|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19406318|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406319|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19406320|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19406321|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406322|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19406323|NCT03581370|Cephalosporins|cephalosporins|mesh-list
19406324|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
19406325|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19693890|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
20446823|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20446824|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20446825|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446826|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446827|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
20446828|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20446829|NCT01394770|Amlodipine|amlodipine|mesh-list
20446830|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20446831|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20446832|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446833|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446834|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20446835|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446836|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
20446837|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20446838|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
20446839|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446840|NCT01394796|Protective Agents|protective agents|mesh-ancestor
20446841|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446842|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20446843|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20446844|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446845|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20446846|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20446847|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
20446848|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20446849|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20446850|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
20446851|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446852|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613697|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613698|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406326|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613699|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20613700|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
20613701|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613702|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
20613703|NCT02256319|Propofol|propofol|mesh-list
20613704|NCT02256319|Imidazole|imidazole|mesh-list
20613705|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20613706|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613707|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613708|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19406327|NCT03581370|Renal Agents|renal agents|mesh-ancestor
19406328|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19693891|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19848960|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
19848961|NCT00698685|Pentostatin|pentostatin|mesh-list
19848962|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20446853|NCT01394848|Everolimus|everolimus|mesh-list
20446854|NCT01394848|Clopidogrel|clopidogrel|mesh-list
20446855|NCT01394848|Atorvastatin|atorvastatin|mesh-list
20446856|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20446857|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20446858|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
20446859|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446860|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20446861|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20446862|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446863|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446864|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446865|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
20446866|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446867|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20446868|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20446869|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20446870|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20446871|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
20446872|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446873|NCT01394887|Metformin|metformin|mesh-list
20446874|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20446875|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446876|NCT01394913|Etanercept|etanercept|mesh-list
20446877|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20446878|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20446879|NCT01394913|Analgesics|analgesics|mesh-ancestor
20446880|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
20446881|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446882|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446883|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446884|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446885|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20446886|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20446887|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
20446888|NCT01395069|Ketorolac|ketorolac|mesh-list
20446889|NCT01395069|Nepafenac|nepafenac|mesh-list
20446890|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20446891|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20446892|NCT01395069|Analgesics|analgesics|mesh-ancestor
20446893|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
20446894|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446895|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446896|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219715|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
20219716|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219717|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20219718|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
20219719|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219720|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219721|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
20219722|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446897|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20446898|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20446899|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446900|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446901|NCT01395147|Vortioxetine|vortioxetine|mesh-list
20446902|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
20446903|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19693892|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693893|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19693894|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19693895|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693896|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
19693897|NCT04973904|Paclitaxel|paclitaxel|mesh-list
19693898|NCT04973904|Bevacizumab|bevacizumab|mesh-list
19693899|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19693900|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446904|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19693901|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
20446905|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20446906|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20446907|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446908|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20446909|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20446910|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446911|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446912|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446913|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
20446914|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20446915|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20446916|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20446917|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20446918|NCT01395199|Amlodipine|amlodipine|mesh-list
20446919|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20446920|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20446921|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446922|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693902|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
19693903|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
19693904|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693905|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693906|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19693907|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19693908|NCT04973904|Growth Substances|growth substances|mesh-ancestor
19693909|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693910|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
19693911|NCT04973462|Oseltamivir|oseltamivir|mesh-list
19693912|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
19693913|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19693914|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693915|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693916|NCT04973722|Denosumab|denosumab|mesh-list
19693917|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19693918|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693919|NCT04973579|Anesthetics|anesthetics|mesh-list
19693920|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406329|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19406330|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406331|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406332|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
19406333|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
19406334|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
19406335|NCT03581149|Laxatives|laxatives|mesh-list
19416539|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20219723|NCT00317785|Cyclosporine|cyclosporine|mesh-list
20219724|NCT00317785|Sirolimus|sirolimus|mesh-list
20219725|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
20219726|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
20219727|NCT00317785|Methotrexate|methotrexate|mesh-list
20219728|NCT00317785|Tacrolimus|tacrolimus|mesh-list
20219729|NCT00317785|Cyclosporins|cyclosporins|mesh-list
20219730|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219731|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
20219732|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219733|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20219734|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20219735|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
20219736|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219737|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219738|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20219739|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20219740|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
20219741|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20219742|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20219743|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
20219744|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
20219745|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219746|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20219747|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20219748|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20219749|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
20219750|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219751|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20219752|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20446923|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20446924|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446925|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
20446926|NCT01395251|Prednisolone|prednisolone|mesh-list
20446927|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
20446928|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20446929|NCT01395251|Hormones|hormones|mesh-ancestor
20446930|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20446931|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446932|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20446933|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446934|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
20446935|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20446936|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446937|NCT01395290|Vitamins|vitamins|mesh-ancestor
20446938|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
20446939|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20446940|NCT01395381|Albendazole|albendazole|mesh-list
20446941|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
20446942|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20446943|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446944|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
20446945|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20446946|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20219753|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
20219754|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219755|NCT00317798|Sirolimus|sirolimus|mesh-list
20446947|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
20446948|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
20446949|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
20446950|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446951|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20446952|NCT01395420|Ceftazidime|ceftazidime|mesh-list
20446953|NCT01395420|Avibactam|avibactam|mesh-list
20446954|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20446955|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20446956|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20446957|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20446958|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525329|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20525330|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20525331|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20525332|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
20525333|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525334|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525335|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525336|NCT01757769|Urological Agents|urological agents|mesh-ancestor
20525337|NCT01757795|Otaplimastat|otaplimastat|mesh-list
20525338|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20525339|NCT01757795|Protective Agents|protective agents|mesh-ancestor
20525340|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525341|NCT01757808|Ranolazine|ranolazine|mesh-list
20525342|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20525343|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20525344|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525345|NCT01757860|Vitamin D|vitamin d|mesh-list
20525346|NCT01757860|Vitamins|vitamins|mesh-ancestor
20525347|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
20525348|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525349|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20525350|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
20525351|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20525352|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20219756|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20219757|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219758|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219759|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20219760|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219761|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
20219762|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219763|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
20525353|NCT01757899|Prednisolone|prednisolone|mesh-list
20525354|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
20219764|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219765|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
20219766|NCT00317811|Bortezomib|bortezomib|mesh-list
20219767|NCT00317811|Melphalan|melphalan|mesh-list
20219768|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219769|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20219770|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
20219771|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219772|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20219773|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219774|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
20446959|NCT01395433|Dexetimide|dexetimide|mesh-list
20446960|NCT01395433|Citalopram|citalopram|mesh-list
20613709|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
20446961|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20446962|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20446963|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20446964|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446965|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446966|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
20446967|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446968|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20446969|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
20446970|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20446971|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20446972|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20446973|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
20446974|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
20446975|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20446976|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20446977|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20446978|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
20446979|NCT01395485|Brodalumab|brodalumab|mesh-list
20446980|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
20446981|NCT01395589|Vitamin D|vitamin d|mesh-list
20446982|NCT01395589|Vitamins|vitamins|mesh-ancestor
20446983|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
20446984|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446985|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20446986|NCT01395602|Cabergoline|cabergoline|mesh-list
20446987|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20446988|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20446989|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
20446990|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
20446991|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20446992|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20446993|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20446994|NCT01395654|Rifampin|rifampin|mesh-list
20446995|NCT01395654|Isoniazid|isoniazid|mesh-list
20446996|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
20446997|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20446998|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
20446999|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447000|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447001|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
20447002|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20447003|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447004|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447005|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20447006|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20447007|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20447008|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20447009|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20447010|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20447011|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20447012|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20447013|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
20447014|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20447015|NCT01395667|Leucovorin|leucovorin|mesh-list
20447016|NCT01395667|Fluorouracil|fluorouracil|mesh-list
20447017|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
20447018|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447019|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447020|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
20219775|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447021|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447022|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447023|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447024|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
20447025|NCT01395667|Antidotes|antidotes|mesh-ancestor
20447026|NCT01395667|Protective Agents|protective agents|mesh-ancestor
20447027|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
20447028|NCT01395667|Vitamins|vitamins|mesh-ancestor
20447029|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
20447030|NCT01395732|Bosentan|bosentan|mesh-list
20447031|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20447032|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20447033|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447034|NCT01395849|Fluticasone|fluticasone|mesh-list
20447035|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20447036|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20447037|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447038|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20447039|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
20447040|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447041|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447042|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20447043|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
20447044|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
20447045|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20447046|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20447047|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20447048|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20447049|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
20447050|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447051|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447052|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
20447053|NCT01395849|Hormones|hormones|mesh-ancestor
20447054|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447055|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
20447056|NCT01395862|Fluticasone|fluticasone|mesh-list
20447057|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20447058|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20447059|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447060|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20447061|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
20447062|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447063|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447064|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20447065|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
20447066|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
20447067|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20447068|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20447069|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20447070|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20447071|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
20447072|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447073|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447074|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
20447075|NCT01395862|Hormones|hormones|mesh-ancestor
20447076|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447077|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
20447078|NCT01395875|Fluticasone|fluticasone|mesh-list
20447079|NCT01395875|Xhance|xhance|mesh-list
20447080|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20447081|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20447082|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447083|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20447084|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
20447085|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447086|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447087|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20447088|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
20447089|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
20447090|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20447091|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20447092|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20447093|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20447094|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
20447095|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447096|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447097|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
20447098|NCT01395927|Canagliflozin|canagliflozin|mesh-list
20447099|NCT01395927|Rifampin|rifampin|mesh-list
20447100|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20447101|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
20447102|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447103|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447104|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
20447105|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20447106|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447107|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447108|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20447109|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20447110|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20447111|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20447112|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20447113|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20447114|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20447115|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20447116|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447117|NCT01395953|Buspirone|buspirone|mesh-list
20447118|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20219776|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
20219777|NCT00317811|Protective Agents|protective agents|mesh-ancestor
20219778|NCT00317811|Vitamins|vitamins|mesh-ancestor
20613710|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
20613711|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613712|NCT02256319|Analgesics|analgesics|mesh-ancestor
20219779|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
20219780|NCT00317850|Gabapentin|gabapentin|mesh-list
20219781|NCT00317850|Analgesics|analgesics|mesh-ancestor
20447119|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447120|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447121|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447122|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447123|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20447124|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
20447125|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447126|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447127|NCT01395992|Asenapine|asenapine|mesh-list
20447128|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20447129|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447130|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447131|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447132|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613713|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
19693921|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693922|NCT04973033|Tofacitinib|tofacitinib|mesh-list
19693923|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19693924|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693925|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693926|NCT04973319|Trastuzumab|trastuzumab|mesh-list
19693927|NCT04973319|Pertuzumab|pertuzumab|mesh-list
19693928|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693929|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693930|NCT04972942|Daratumumab|daratumumab|mesh-list
19693931|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693932|NCT04973293|Bevacizumab|bevacizumab|mesh-list
19693933|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19693934|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693935|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19693936|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19693937|NCT04973293|Growth Substances|growth substances|mesh-ancestor
19693938|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693939|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
19693940|NCT04972656|Ambrisentan|ambrisentan|mesh-list
20219782|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
20219783|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219784|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219785|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
20219786|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20219787|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20219788|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219789|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219790|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20219791|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20219792|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219793|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219794|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
20247193|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247194|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20447133|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
20447134|NCT01396200|Sirolimus|sirolimus|mesh-list
20447135|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
20447136|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20447137|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20447138|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447139|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447140|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447141|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20447142|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447143|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20447144|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247195|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247196|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20247197|NCT00431249|Protective Agents|protective agents|mesh-ancestor
20247198|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20247199|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20247200|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247201|NCT00431262|Disulfiram|disulfiram|mesh-list
20247202|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20247203|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20247204|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247205|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447145|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
20447146|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247206|NCT00431275|Tremelimumab|tremelimumab|mesh-list
20247207|NCT00431275|Ipilimumab|ipilimumab|mesh-list
20247208|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247209|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247210|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20247211|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247212|NCT00431340|Belinostat|belinostat|mesh-list
20447147|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
20447148|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447149|NCT01396291|Asenapine|asenapine|mesh-list
20447150|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20447151|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20247213|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447152|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19693941|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20447153|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447154|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447155|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20447156|NCT01396304|Calcium|calcium|mesh-list
20447157|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20447158|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447159|NCT01396304|Laxatives|laxatives|mesh-ancestor
20447160|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20447161|NCT01396564|Metformin|metformin|mesh-list
20447162|NCT01396564|Pioglitazone|pioglitazone|mesh-list
20447163|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19406336|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447164|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613714|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406337|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
19406338|NCT03581149|Protective Agents|protective agents|mesh-ancestor
19406339|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406340|NCT03581149|Vitamins|vitamins|mesh-ancestor
19406341|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
19406342|NCT03581149|Cathartics|cathartics|mesh-ancestor
19406343|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19416540|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19416541|NCT02405585|Antidotes|antidotes|mesh-ancestor
20447165|NCT01396642|Emollients|emollients|mesh-list
20447166|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
20447167|NCT01396655|Docetaxel|docetaxel|mesh-list
20447168|NCT01396655|Doxorubicin|doxorubicin|mesh-list
20447169|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447170|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
20447171|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
20447172|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
20447173|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447174|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20447175|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20447176|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20447177|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447178|NCT01396668|Gemcitabine|gemcitabine|mesh-list
20447179|NCT01396668|Capecitabine|capecitabine|mesh-list
20447180|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447181|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447182|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
20447183|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447184|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
20447185|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447186|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447187|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447188|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
20447189|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447190|NCT01396681|Gemcitabine|gemcitabine|mesh-list
19848963|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848964|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19848965|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219795|NCT00317876|Cyclosporine|cyclosporine|mesh-list
20219796|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
20219797|NCT00317876|Methotrexate|methotrexate|mesh-list
20219798|NCT00317876|Cyclosporins|cyclosporins|mesh-list
20219799|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219800|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
20219801|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219802|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20219803|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20219804|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
20219805|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219806|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447191|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447192|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447193|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
20447194|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447195|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
20447196|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447197|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447198|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447199|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
20447200|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447201|NCT01396707|Capecitabine|capecitabine|mesh-list
20447202|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
20447203|NCT01396707|Trastuzumab|trastuzumab|mesh-list
20447204|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447205|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
20447206|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447207|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447208|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447209|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
20447210|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20447211|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447212|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447213|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447214|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447215|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19848966|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848967|NCT00698841|Cetuximab|cetuximab|mesh-list
20447216|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20613715|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19406344|NCT03580980|Acetaminophen|acetaminophen|mesh-list
19406345|NCT03580980|Ketamine|ketamine|mesh-list
19406346|NCT03580980|Morphine|morphine|mesh-list
19406347|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
19406348|NCT03580980|Analgesics|analgesics|mesh-ancestor
19848968|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19848969|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19848970|NCT00698932|Saxagliptin|saxagliptin|mesh-list
20219807|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20447217|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20447218|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447219|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447220|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
20447221|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20447222|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
20447223|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20447224|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20447225|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447226|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20447227|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
20447228|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
20447229|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447230|NCT01396733|Protective Agents|protective agents|mesh-ancestor
20447231|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447232|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
20447233|NCT01396733|Vitamins|vitamins|mesh-ancestor
20447234|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
19693942|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
19693943|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19693944|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
19693945|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693946|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
19693947|NCT04972383|Protective Agents|protective agents|mesh-ancestor
19693948|NCT04972617|Furosemide|furosemide|mesh-list
19693949|NCT04972617|Diuretics|diuretics|mesh-ancestor
19693950|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
19693951|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693952|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19693953|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19693954|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693955|NCT04972292|Dipyrone|dipyrone|mesh-list
19693956|NCT04972292|Codeine|codeine|mesh-list
19693957|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19693958|NCT04972292|Narcotics|narcotics|mesh-ancestor
19693959|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447235|NCT01397006|Pregabalin|pregabalin|mesh-list
20447236|NCT01397006|Analgesics|analgesics|mesh-ancestor
20447237|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
20447238|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447239|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447240|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
20447241|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20447242|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20447243|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447244|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20447245|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20447246|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447247|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447248|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447249|NCT01397019|Leucovorin|leucovorin|mesh-list
20447250|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
20447251|NCT01397019|Irinotecan|irinotecan|mesh-list
20447252|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447253|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20447254|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20447255|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447256|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447257|NCT01397019|Antidotes|antidotes|mesh-ancestor
20447258|NCT01397019|Protective Agents|protective agents|mesh-ancestor
20447259|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447260|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
20447261|NCT01397019|Vitamins|vitamins|mesh-ancestor
20447262|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
20447263|NCT01397097|Etonogestrel|etonogestrel|mesh-list
20447264|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20447265|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
20447266|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20447267|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447268|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20447269|NCT01397175|Everolimus|everolimus|mesh-list
20447270|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19693960|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447271|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447272|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
20447273|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447274|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
20447275|NCT01397214|Megestrol|megestrol|mesh-list
20447276|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19848971|NCT00698932|Incretins|incretins|mesh-ancestor
19848972|NCT00698932|Hormones|hormones|mesh-ancestor
19848973|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19848974|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848975|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19848976|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
20447277|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447278|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
20447279|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20447280|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447281|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20447282|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20447283|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20447284|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
20447285|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20447286|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20447287|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20447288|NCT01397305|Pemetrexed|pemetrexed|mesh-list
20447289|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447290|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447291|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447292|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20447293|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20525355|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20525356|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
20525357|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20525358|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
20525359|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
20525360|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525361|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525362|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20525363|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
20525364|NCT01757899|Hormones|hormones|mesh-ancestor
20525365|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525366|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20525367|NCT01757899|Protective Agents|protective agents|mesh-ancestor
20525368|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20525369|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525370|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
20525371|NCT01758029|Testosterone|testosterone|mesh-list
20525372|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
20525373|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
20525374|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20525375|NCT01758029|Androgens|androgens|mesh-ancestor
20525376|NCT01758029|Hormones|hormones|mesh-ancestor
20525377|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525378|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525379|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20525380|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525381|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
20219808|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20219809|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
20219810|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20219811|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20219812|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
20219813|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
20219814|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219815|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20219816|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20219817|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
20219818|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219819|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20219820|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
20219821|NCT00317902|Hematinics|hematinics|mesh-ancestor
20219822|NCT00317915|Irbesartan|irbesartan|mesh-list
20219823|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20219824|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20525382|NCT01758094|Testosterone|testosterone|mesh-list
20525383|NCT01758094|Androgens|androgens|mesh-ancestor
20525384|NCT01758094|Hormones|hormones|mesh-ancestor
20530906|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447294|NCT01397331|Propofol|propofol|mesh-list
20447295|NCT01397331|Isoflurane|isoflurane|mesh-list
20447296|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20447297|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447298|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447299|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20447300|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
20447301|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
19848977|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19848978|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19848979|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19848980|NCT00699010|Oxycodone|oxycodone|mesh-list
20219825|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20219826|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219827|NCT00317928|Metformin|metformin|mesh-list
20219828|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20219829|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219830|NCT00317954|Spironolactone|spironolactone|mesh-list
20447302|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20447303|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
20447304|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
20447305|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447306|NCT05268835|Clindamycin|clindamycin|mesh-list
20447307|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447308|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447309|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20447310|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447311|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447312|NCT05268718|Voriconazole|voriconazole|mesh-list
20447313|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19848981|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19848982|NCT00699010|Narcotics|narcotics|mesh-ancestor
19848983|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19848984|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447314|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20447315|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
20447316|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447317|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20447318|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20447319|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447320|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613716|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20613717|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19406349|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
19406350|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406351|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406352|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19406353|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19406354|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
19848985|NCT00699010|Analgesics|analgesics|mesh-ancestor
20219831|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19406355|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
19406356|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406357|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19406358|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19406359|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406360|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406361|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19406362|NCT03580980|Narcotics|narcotics|mesh-ancestor
19406363|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406364|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
19406365|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
19406366|NCT03580967|Vortioxetine|vortioxetine|mesh-list
19406367|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
19406368|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19406369|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19406370|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19406371|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406372|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219832|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
20219833|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219834|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848986|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
20447321|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20447322|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
20447323|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447324|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447325|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20447326|NCT05268627|Liraglutide|liraglutide|mesh-list
20447327|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20447328|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447329|NCT05268627|Incretins|incretins|mesh-ancestor
20447330|NCT05268627|Hormones|hormones|mesh-ancestor
20447331|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447332|NCT05268562|Ketamine|ketamine|mesh-list
20447333|NCT05268562|Propofol|propofol|mesh-list
20447334|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20447335|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447336|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447337|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20447338|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
20447339|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
20447340|NCT05268562|Analgesics|analgesics|mesh-ancestor
20447341|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
20447342|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447343|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20447344|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20447345|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20447346|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447347|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447348|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
20447349|NCT05268510|Olaparib|olaparib|mesh-list
20447350|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447351|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447352|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20447353|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447354|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447355|NCT05268237|Liraglutide|liraglutide|mesh-list
20447356|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20447357|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447358|NCT05268237|Incretins|incretins|mesh-ancestor
20447359|NCT05268237|Hormones|hormones|mesh-ancestor
20447360|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447361|NCT05268185|Vaccines|vaccines|mesh-list
20447362|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
20447363|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447364|NCT05268120|Doxycycline|doxycycline|mesh-list
20447365|NCT05268120|Rifampin|rifampin|mesh-list
20447366|NCT05268120|Trimethoprim|trimethoprim|mesh-list
20447367|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447368|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447369|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
20447370|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20447371|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20447372|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20447373|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
20447374|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
20447375|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20447376|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447377|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447378|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20447379|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20447380|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20447381|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20447382|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20447383|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20447384|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20447385|NCT05268120|Renal Agents|renal agents|mesh-ancestor
20447386|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20447387|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20447388|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20447389|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20447390|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20447391|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
20447392|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447393|NCT05267977|Cephalosporins|cephalosporins|mesh-list
20447394|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447395|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447396|NCT05244252|Bupivacaine|bupivacaine|mesh-list
20447397|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
20447398|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
20447399|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447400|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447401|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
20219835|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20219836|NCT00317954|Diuretics|diuretics|mesh-ancestor
20219837|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
20219838|NCT00317967|Atorvastatin|atorvastatin|mesh-list
20219839|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20219840|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20219841|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
20219842|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219843|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20219844|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20219845|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219846|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20219847|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20219848|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20219849|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219850|NCT00317993|Simvastatin|simvastatin|mesh-list
20219851|NCT00317993|Ezetimibe|ezetimibe|mesh-list
20219852|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20219853|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20219854|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
20219855|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219856|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20219857|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20219858|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219859|NCT00318084|Esomeprazole|esomeprazole|mesh-list
20219860|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20219861|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20219862|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20219863|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219864|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219865|NCT00318162|Naltrexone|naltrexone|mesh-list
20219866|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20219867|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20219868|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219869|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
19406373|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20447402|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447403|NCT05243251|Olanzapine|olanzapine|mesh-list
20447404|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
20447405|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
20447406|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406374|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19693961|NCT04972292|Analgesics|analgesics|mesh-ancestor
19693962|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
19693963|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693964|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
19693965|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
19693966|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19693967|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19693968|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19693969|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693970|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
19693971|NCT04972123|Phenylephrine|phenylephrine|mesh-list
19693972|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
19693973|NCT04972123|Caffeine|caffeine|mesh-list
19693974|NCT04972123|Capsaicin|capsaicin|mesh-list
19693975|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19693976|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19693977|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19693978|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19693979|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19693980|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19693981|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19693982|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
19693983|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19693984|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20447407|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447408|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19693985|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
20447409|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20447410|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447411|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447412|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447413|NCT05243251|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20447414|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20447415|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20447416|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447417|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447418|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
20447419|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20447420|NCT05217680|Bevacizumab|bevacizumab|mesh-list
20447421|NCT05217680|Ranibizumab|ranibizumab|mesh-list
20447422|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447423|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447424|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20447425|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20447426|NCT05217680|Growth Substances|growth substances|mesh-ancestor
20447427|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447428|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
20447429|NCT05186558|Gemcitabine|gemcitabine|mesh-list
20447430|NCT05186558|Rituximab|rituximab|mesh-list
20447431|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
20447432|NCT05186558|Lenalidomide|lenalidomide|mesh-list
20447433|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447434|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447435|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
20447436|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447437|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20447438|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447439|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
20447440|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447441|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
20219870|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219871|NCT00318175|Bosentan|bosentan|mesh-list
20219872|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20219873|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20219874|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219875|NCT00318201|Erythromycin|erythromycin|mesh-list
20447442|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447443|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447444|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447445|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20447446|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20447447|NCT05186558|Growth Substances|growth substances|mesh-ancestor
20447448|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
20525385|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525386|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525387|NCT01758107|Cyclosporine|cyclosporine|mesh-list
20525388|NCT01758107|Cyclosporins|cyclosporins|mesh-list
20525389|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525390|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525391|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525392|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
20525393|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525394|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
20525395|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525396|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
20525397|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19693986|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
19693987|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19693988|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
19693989|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19693990|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
19693991|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
19693992|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19693993|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19693994|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19693995|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
20219876|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
20219877|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20525398|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19693996|NCT04972123|Protective Agents|protective agents|mesh-ancestor
20525399|NCT01758120|Prednisone|prednisone|mesh-list
20447449|NCT05092698|Vitamin D|vitamin d|mesh-list
20447450|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
20447451|NCT05092698|Vitamins|vitamins|mesh-ancestor
20447452|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
20447453|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447454|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20447455|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20447456|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
20447457|NCT05077254|Vaccines|vaccines|mesh-list
20447458|NCT05077254|Tacrolimus|tacrolimus|mesh-list
20447459|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
19848987|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848988|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19848989|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20447460|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447461|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447462|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20447463|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447464|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447465|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19406375|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406376|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406377|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19848990|NCT00699192|Amlodipine|amlodipine|mesh-list
19848991|NCT00699192|Valsartan|valsartan|mesh-list
19848992|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19848993|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19848994|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19848995|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406378|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
19406379|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19406380|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19406381|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19406382|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19406383|NCT03580902|Buprenorphine|buprenorphine|mesh-list
19406384|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19406385|NCT03580902|Naloxone|naloxone|mesh-list
19406386|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19406387|NCT03580902|Narcotics|narcotics|mesh-ancestor
19406388|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447466|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447467|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20447468|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
20447469|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447470|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447471|NCT05060913|Lidocaine|lidocaine|mesh-list
19693997|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
19693998|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
19693999|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
19694000|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
19694001|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19694002|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
19694003|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694004|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694005|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19694006|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
19848996|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19848997|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219878|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
20219879|NCT00318201|Diltiazem|diltiazem|mesh-list
20219880|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20219881|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20219882|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20219883|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219884|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20219885|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219886|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
20219887|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219888|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219889|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20219890|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20447472|NCT05060913|Prilocaine|prilocaine|mesh-list
20447473|NCT05060913|Benzocaine|benzocaine|mesh-list
19416542|NCT02405585|Protective Agents|protective agents|mesh-ancestor
20447474|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20219891|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219892|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20219893|NCT00318318|Estrogens|estrogens|mesh-ancestor
20219894|NCT00318318|Hormones|hormones|mesh-ancestor
20219895|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219896|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694007|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19694008|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
20447475|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
20447476|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
20447477|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447478|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447479|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
20447480|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447481|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20447482|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20447483|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20447484|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20447485|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447486|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20447487|NCT05054439|Paclitaxel|paclitaxel|mesh-list
20447488|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20447489|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447490|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
20447491|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
20219897|NCT00318383|Vaccines|vaccines|mesh-list
20219898|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
20447492|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
20447493|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447494|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20447495|NCT05038592|Decitabine|decitabine|mesh-list
20447496|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447497|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
20447498|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447499|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447500|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447501|NCT05011058|Valganciclovir|valganciclovir|mesh-list
20447502|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
20447503|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447504|NCT05009355|Ascorbic Acid|ascorbic acid|mesh-list
20447505|NCT05009355|Vitamins|vitamins|mesh-ancestor
20447506|NCT05009355|Micronutrients|micronutrients|mesh-ancestor
20447507|NCT05009355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447508|NCT05009355|Antioxidants|antioxidants|mesh-ancestor
20447509|NCT05009355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447510|NCT05009355|Protective Agents|protective agents|mesh-ancestor
20447511|NCT04998006|Ethanol|ethanol|mesh-list
20447512|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20447513|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447514|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447515|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447516|NCT04975269|Acetazolamide|acetazolamide|mesh-list
20447517|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
20447518|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20447519|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447520|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447521|NCT04975269|Diuretics|diuretics|mesh-ancestor
20447522|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
20447523|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447524|NCT04971720|Valsartan|valsartan|mesh-list
20447525|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20447526|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20447527|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20447528|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20447529|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447530|NCT04965870|Trifluridine|trifluridine|mesh-list
20447531|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
20447532|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447533|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
19694009|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694010|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694011|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19694012|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
20447534|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447535|NCT04941937|Thalidomide|thalidomide|mesh-list
20447536|NCT04941937|Dexamethasone|dexamethasone|mesh-list
20447537|NCT04941937|Lenalidomide|lenalidomide|mesh-list
20447538|NCT04941937|Pomalidomide|pomalidomide|mesh-list
20447539|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447540|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
20447541|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
20447542|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447543|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447544|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20447545|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
20447546|NCT04941937|Hormones|hormones|mesh-ancestor
20447547|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447548|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20447549|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447550|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
20447551|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20447552|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20447553|NCT04941937|Growth Substances|growth substances|mesh-ancestor
20447554|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
20447555|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447556|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
20447557|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447558|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447559|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
20447560|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694013|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
19694014|NCT04972513|Protective Agents|protective agents|mesh-ancestor
19694015|NCT04972032|Estrogens|estrogens|mesh-list
19694016|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
19694017|NCT04972032|Hormones|hormones|mesh-ancestor
19694018|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19694019|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694020|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19694021|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
20447561|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447562|NCT04920981|Atezolizumab|atezolizumab|mesh-list
20447563|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447564|NCT04893096|Felzartamab|felzartamab|mesh-list
20447565|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447566|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
19694022|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
19694023|NCT04972032|Protective Agents|protective agents|mesh-ancestor
19694024|NCT04972045|Curcumin|curcumin|mesh-list
19694025|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19694026|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694027|NCT04972045|Analgesics|analgesics|mesh-ancestor
19694028|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
19694029|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694030|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694031|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447567|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447568|NCT04835129|Dexamethasone|dexamethasone|mesh-list
20447569|NCT04835129|Pomalidomide|pomalidomide|mesh-list
20447570|NCT04835129|Elotuzumab|elotuzumab|mesh-list
20447571|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20447572|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447573|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
20447574|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
20447575|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447576|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447577|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20447578|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
20447579|NCT04835129|Hormones|hormones|mesh-ancestor
20447580|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447581|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20447582|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447583|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
20447584|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20447585|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20447586|NCT04835129|Growth Substances|growth substances|mesh-ancestor
20447587|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
20447588|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19694032|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694033|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447589|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
20447590|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447591|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20447592|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20447593|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447594|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447595|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20447596|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20447597|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
19406389|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406390|NCT03580902|Analgesics|analgesics|mesh-ancestor
19406391|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
19406392|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19848998|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
20447598|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20447599|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
20447600|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20447601|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
20447602|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447603|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447604|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
20447605|NCT04699240|Clotrimazole|clotrimazole|mesh-list
20447606|NCT04699240|Miconazole|miconazole|mesh-list
20447607|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20447608|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447609|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
20447610|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20447611|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20447612|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447613|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447614|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20447615|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
19406393|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19406394|NCT03580889|Atropine|atropine|mesh-list
19406395|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
19406396|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19406397|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19406398|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19406399|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
19406400|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406401|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406402|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19406403|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
19406404|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
19406405|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
19406406|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19406407|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19406408|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
19406409|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406410|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406411|NCT03580876|Azathioprine|azathioprine|mesh-list
19406412|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
19406413|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406414|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406415|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406416|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406417|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
19406418|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19848999|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19849000|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19849001|NCT00699283|Brivaracetam|brivaracetam|mesh-list
19849002|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
19849003|NCT00699335|Fentanyl|fentanyl|mesh-list
20219899|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219900|NCT00318422|Liraglutide|liraglutide|mesh-list
20219901|NCT00318422|Glimepiride|glimepiride|mesh-list
20219902|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
20219903|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20219904|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219905|NCT00318422|Incretins|incretins|mesh-ancestor
20219906|NCT00318422|Hormones|hormones|mesh-ancestor
20219907|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447616|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447617|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447618|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20447619|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20447620|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20447621|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
20447622|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
20447623|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447624|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447625|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
20447626|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447627|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20447628|NCT04604353|Calcium|calcium|mesh-list
20447629|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20447630|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447631|NCT04598815|Sirolimus|sirolimus|mesh-list
20447632|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447633|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447634|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20447635|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447636|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
20447637|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447638|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
20447639|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447640|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
20447641|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
20447642|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20447643|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20447644|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447645|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447646|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447647|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525400|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
20525401|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525402|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
20525403|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525404|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406419|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406420|NCT03580733|Caspofungin|caspofungin|mesh-list
19406421|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
19406422|NCT03580733|Clotrimazole|clotrimazole|mesh-list
19406423|NCT03580733|Miconazole|miconazole|mesh-list
20219908|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20219909|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20219910|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
20219911|NCT00318448|Zolpidem|zolpidem|mesh-list
20219912|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20219913|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20219914|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406424|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406425|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406426|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406427|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19406428|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19406429|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19406430|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19406431|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
19849004|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20219915|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525405|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20525406|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
20525407|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525408|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525409|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20525410|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20525411|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
20525412|NCT01758120|Hormones|hormones|mesh-ancestor
20525413|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525414|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19406432|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20219916|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20219917|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
20219918|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
20219919|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219920|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219921|NCT00318513|Bevacizumab|bevacizumab|mesh-list
20447648|NCT04510194|Metformin|metformin|mesh-list
20447649|NCT04510194|Ivermectin|ivermectin|mesh-list
20447650|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
20447651|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20447652|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447653|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20447654|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447655|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20447656|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447657|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447658|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447659|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20447660|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20447661|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20447662|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447663|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447664|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
20447665|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20447666|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
20447667|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20447668|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20447669|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447670|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20447671|NCT04500756|Metformin|metformin|mesh-list
20447672|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20447673|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447674|NCT04472416|Analgesics|analgesics|mesh-list
20447675|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
20447676|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447677|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447678|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
20447679|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
20447680|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20447681|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20447682|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447683|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447684|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447685|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20447686|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
20447687|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447688|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
20447689|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
20447690|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
20447691|NCT04453449|Midazolam|midazolam|mesh-list
20447692|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20447693|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20447694|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447695|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447696|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20447697|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447698|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447699|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20447700|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
20447701|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
20447702|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
20447703|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
20447704|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447705|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447706|NCT04415333|Butyric Acid|butyric acid|mesh-list
20447707|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
20447708|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
20447709|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447710|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447711|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447712|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20447713|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19406433|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406434|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19406435|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19406436|NCT03580694|Cemiplimab|cemiplimab|mesh-list
19406437|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406438|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406439|NCT03580681|Vitamin E|vitamin e|mesh-list
19406440|NCT03580681|Vitamins|vitamins|mesh-ancestor
20447714|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447715|NCT04215146|Paclitaxel|paclitaxel|mesh-list
20447716|NCT04215146|Avelumab|avelumab|mesh-list
20447717|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20447718|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447719|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
20447720|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
20447721|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
20447722|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447723|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447724|NCT04182373|Antithrombins|antithrombins|mesh-list
20447725|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
20447726|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19406441|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
19406442|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406443|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
19406444|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406445|NCT03580681|Protective Agents|protective agents|mesh-ancestor
19406446|NCT03580590|Diltiazem|diltiazem|mesh-list
20447727|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
20447728|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447729|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447730|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
20447731|NCT04099888|Gemcitabine|gemcitabine|mesh-list
20447732|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447733|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447734|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
20447735|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447736|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
20447737|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447738|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447739|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447740|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
20447741|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447742|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
20447743|NCT04093596|Fludarabine|fludarabine|mesh-list
20447744|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447745|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
20447746|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447747|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20447748|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20447749|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
20447750|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447751|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447752|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20447753|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
20447754|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447755|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447756|NCT03982693|Edetic Acid|edetic acid|mesh-list
20447757|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
20447758|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
20447759|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20447760|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
20447761|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
20447762|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447763|NCT03982693|Antidotes|antidotes|mesh-ancestor
20447764|NCT03982693|Protective Agents|protective agents|mesh-ancestor
20447765|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447766|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20447767|NCT03937713|Eszopiclone|eszopiclone|mesh-list
20447768|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20447769|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447770|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447771|NCT03817502|Cariprazine|cariprazine|mesh-list
20447772|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20447773|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447774|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447775|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447776|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447777|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
20447778|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447779|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447780|NCT03703297|Durvalumab|durvalumab|mesh-list
20447781|NCT03703297|Tremelimumab|tremelimumab|mesh-list
20447782|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447783|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406447|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
20447784|NCT03623321|Pimavanserin|pimavanserin|mesh-list
20447785|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20447786|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20447787|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20447788|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447789|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447790|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447791|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447792|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20447793|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20447794|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
20447795|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447796|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447797|NCT03602859|Niraparib|niraparib|mesh-list
20447798|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20447799|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447800|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447801|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447802|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
20447803|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
20447804|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
20447805|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447806|NCT03600883|Midazolam|midazolam|mesh-list
20447807|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20447808|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20447809|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447810|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447811|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20447812|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20447813|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447814|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20447815|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
20447816|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
20447817|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
20447818|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
20447819|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20447820|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447821|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
20447822|NCT03580473|Dexamethasone|dexamethasone|mesh-list
20447823|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20447824|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20219922|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20219923|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20219924|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20447825|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
20447826|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
20447827|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447828|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447829|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20447830|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
20447831|NCT03580473|Hormones|hormones|mesh-ancestor
20447832|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447833|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20447834|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447835|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447836|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447837|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20447838|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447839|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20447840|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20613718|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
19406448|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20219925|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20219926|NCT00318513|Growth Substances|growth substances|mesh-ancestor
20219927|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219928|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
20219929|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20219930|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
20219931|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219932|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20219933|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20219934|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20447841|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20447842|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
20447843|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20447844|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20447845|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20447846|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20525415|NCT01758146|Tamoxifen|tamoxifen|mesh-list
20525416|NCT01758146|Letrozole|letrozole|mesh-list
20525417|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525418|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20525419|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20525420|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525421|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525422|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20525423|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
20525424|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525425|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525426|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20525427|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20525428|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20525429|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20525430|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20525431|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
20525432|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
20525433|NCT01758185|Vaccines|vaccines|mesh-list
20525434|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
20525435|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525436|NCT01758198|Methotrexate|methotrexate|mesh-list
20525437|NCT01758198|Abatacept|abatacept|mesh-list
20525438|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20525439|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
20525440|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20525441|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525442|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20525443|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
20525444|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525445|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525446|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
20525447|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525448|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20525449|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525450|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
20525451|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525452|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20525453|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19694034|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694035|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694036|NCT04971759|Fentanyl|fentanyl|mesh-list
19694037|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
19694038|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
20219935|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219936|NCT00318552|Meropenem|meropenem|mesh-list
20219937|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20219938|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20219939|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
20219940|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20219941|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219942|NCT00318669|Paroxetine|paroxetine|mesh-list
20219943|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20219944|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20525454|NCT01758263|Metoprolol|metoprolol|mesh-list
20525455|NCT01758263|Nebivolol|nebivolol|mesh-list
20525456|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20525457|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20525458|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
19406449|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19406450|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406451|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
19406452|NCT03580590|Coagulants|coagulants|mesh-ancestor
19406453|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19406454|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19406455|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406456|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19416543|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
20219945|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19694039|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20447847|NCT03524170|Atezolizumab|atezolizumab|mesh-list
20447848|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447849|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
20447850|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20447851|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20447852|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
20219946|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219947|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219948|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
20219949|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219950|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20219951|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
20219952|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20219953|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20219954|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20219955|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20219956|NCT00318760|Clonidine|clonidine|mesh-list
20219957|NCT00318760|Analgesics|analgesics|mesh-ancestor
20219958|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
20219959|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219960|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219961|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20219962|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
20219963|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
20219964|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20219965|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20219966|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20219967|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
20219968|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219969|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219970|NCT00318773|Sertraline|sertraline|mesh-list
20219971|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
20219972|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20447853|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447854|NCT03481556|Dexamethasone|dexamethasone|mesh-list
20447855|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
20447856|NCT03481556|Bortezomib|bortezomib|mesh-list
20447857|NCT03481556|Melphalan|melphalan|mesh-list
20447858|NCT03481556|Daratumumab|daratumumab|mesh-list
20447859|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447860|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
20447861|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
20447862|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447863|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447864|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20447865|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
20447866|NCT03481556|Hormones|hormones|mesh-ancestor
20447867|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447868|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20447869|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447870|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20447871|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
20447872|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447873|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20447874|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447875|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
20447876|NCT03462342|Olaparib|olaparib|mesh-list
20447877|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20447878|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447879|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447880|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447881|NCT03412747|Adalimumab|adalimumab|mesh-list
20447882|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447883|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20447884|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
20447885|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20447886|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447887|NCT03308578|Atorvastatin|atorvastatin|mesh-list
20447888|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20447889|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20447890|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
20447891|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447892|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20447893|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20447894|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447895|NCT03283813|Inositol|inositol|mesh-list
20447896|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
20447897|NCT03283813|Vitamins|vitamins|mesh-ancestor
20447898|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
20447899|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447900|NCT03283384|Letrozole|letrozole|mesh-list
20447901|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447902|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20447903|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20447904|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447905|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447906|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20447907|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
20447908|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447909|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447910|NCT03268954|Azacitidine|azacitidine|mesh-list
20447911|NCT03268954|Pevonedistat|pevonedistat|mesh-list
20447912|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20447913|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
20447914|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447915|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447916|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447917|NCT03267836|Avelumab|avelumab|mesh-list
20447918|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20447919|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447920|NCT03245827|Clomiphene|clomiphene|mesh-list
20447921|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20447922|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
20447923|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447924|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447925|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20447926|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
20447927|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20447928|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20447929|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20447930|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
20447931|NCT03164993|Doxorubicin|doxorubicin|mesh-list
20447932|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20447933|NCT03164993|Atezolizumab|atezolizumab|mesh-list
20447934|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20447935|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
20447936|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447937|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20447938|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20447939|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
20447940|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447941|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447942|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20447943|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20447944|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19694040|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694041|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694042|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694043|NCT04971759|Analgesics|analgesics|mesh-ancestor
19694044|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
19694045|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694046|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20447945|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20447946|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447947|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
20447948|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447949|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
20447950|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20447951|NCT03129321|Econazole|econazole|mesh-list
20447952|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
20447953|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20447954|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20447955|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20447956|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447957|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447958|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20447959|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
20525459|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
20447960|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447961|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447962|NCT03121534|Dexamethasone|dexamethasone|mesh-list
20447963|NCT03121534|Blinatumomab|blinatumomab|mesh-list
20447964|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447965|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
20447966|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
20447967|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447968|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447969|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20447970|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
20447971|NCT03121534|Hormones|hormones|mesh-ancestor
20447972|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20447973|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20447974|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20447975|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
20447976|NCT03116997|Neostigmine|neostigmine|mesh-list
20447977|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20447978|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20447979|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20447980|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
20447981|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406457|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406458|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
19406459|NCT03580499|Vitamins|vitamins|mesh-list
19406460|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
19406461|NCT03580499|Pyridoxal|pyridoxal|mesh-list
19406462|NCT03580499|Pyridoxine|pyridoxine|mesh-list
19406463|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
19694047|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20447982|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447983|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20447984|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
20447985|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447986|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20447987|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20447988|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20447989|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
20447990|NCT03107611|Tacrolimus|tacrolimus|mesh-list
20447991|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20447992|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20447993|NCT03107611|Analgesics|analgesics|mesh-ancestor
20447994|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
20447995|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20447996|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20447997|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20447998|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20447999|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
20448000|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448001|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
20448002|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20448003|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448004|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448005|NCT03089866|Midazolam|midazolam|mesh-list
20448006|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20448007|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20448008|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448009|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448010|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20448011|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20448012|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20448013|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20448014|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
20448015|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
20448016|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
20448017|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
20448018|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448019|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448020|NCT03040726|Palonosetron|palonosetron|mesh-list
19406464|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
19694048|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19694049|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
19694050|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694051|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694052|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19694053|NCT04971759|Narcotics|narcotics|mesh-ancestor
19849005|NCT00699335|Narcotics|narcotics|mesh-ancestor
20448021|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
20448022|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
20448023|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448024|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448025|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20448026|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20448027|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20448028|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
20448029|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448030|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448031|NCT02871219|Lenalidomide|lenalidomide|mesh-list
20448032|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
20448033|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
20448034|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448035|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20448036|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20448037|NCT02871219|Growth Substances|growth substances|mesh-ancestor
20219973|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20219974|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20219975|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20219976|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448038|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
20448039|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448040|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448041|NCT02607956|Dolutegravir|dolutegravir|mesh-list
20448042|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20448043|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20448044|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20448045|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448046|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448047|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20448048|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20448049|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
20448050|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448051|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20448052|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20448053|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
20448054|NCT02501096|Lenvatinib|lenvatinib|mesh-list
20448055|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448056|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448057|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20448058|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448059|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448060|NCT02499666|Clopidogrel|clopidogrel|mesh-list
20448061|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20448062|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20448063|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20448064|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20448065|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
20448066|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448067|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448068|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448069|NCT02456857|Bevacizumab|bevacizumab|mesh-list
20448070|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20448071|NCT02456857|Doxorubicin|doxorubicin|mesh-list
20448072|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20448073|NCT02456857|Everolimus|everolimus|mesh-list
20448074|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
20448075|NCT02456857|Antibodies|antibodies|mesh-list
20448076|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
20448077|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20448078|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
20448079|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448080|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20448081|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20219977|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20219978|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
20219979|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219980|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
20219981|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
20219982|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20219983|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448082|NCT02456857|Growth Substances|growth substances|mesh-ancestor
20448083|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448084|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
20448085|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
20448086|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20448087|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20448088|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20448089|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406465|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406466|NCT03580408|Nivolumab|nivolumab|mesh-list
19406467|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406468|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406469|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19406470|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448090|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448091|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448092|NCT02420912|Nivolumab|nivolumab|mesh-list
20448093|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448094|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448095|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20448096|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448097|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
20448098|NCT02232152|Fluorouracil|fluorouracil|mesh-list
20448099|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
20448100|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448101|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448102|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448103|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448104|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
20448105|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448106|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
20448107|NCT02232152|Protective Agents|protective agents|mesh-ancestor
20448108|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
20448109|NCT02232152|Vitamins|vitamins|mesh-ancestor
20448110|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
20448111|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20448112|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20448113|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
20448114|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448115|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448116|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20448117|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
20448118|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
20448119|NCT02215122|Hormones|hormones|mesh-ancestor
20448120|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448121|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
20448122|NCT02112734|Vitamin D|vitamin d|mesh-list
20448123|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
20448124|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
20448125|NCT02112734|Vitamins|vitamins|mesh-list
20448126|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
20448127|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448128|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20448129|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20448130|NCT02094716|Permethrin|permethrin|mesh-list
20448131|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448132|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448133|NCT02094261|Osimertinib|osimertinib|mesh-list
20448134|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448135|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20448136|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448137|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448138|NCT01988493|Sorafenib|sorafenib|mesh-list
20448139|NCT01988493|Tepotinib|tepotinib|mesh-list
20448140|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448141|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20448142|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406471|NCT03580395|Paclitaxel|paclitaxel|mesh-list
19406472|NCT03580395|Apatinib|apatinib|mesh-list
19694054|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19694055|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19694056|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
20448143|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448144|NCT01953926|Trastuzumab|trastuzumab|mesh-list
19694057|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
20448145|NCT01953926|Fulvestrant|fulvestrant|mesh-list
19694058|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
19694059|NCT04971343|Antibodies|antibodies|mesh-list
19694060|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
20448146|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448147|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448148|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20448149|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20448150|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20448151|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
20448152|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448153|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448154|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
20448155|NCT01798004|Melphalan|melphalan|mesh-list
20448156|NCT01798004|Busulfan|busulfan|mesh-list
20448157|NCT01798004|Doxorubicin|doxorubicin|mesh-list
20448158|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20448159|NCT01798004|Etoposide|etoposide|mesh-list
20448160|NCT01798004|Vincristine|vincristine|mesh-list
20448161|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
20448162|NCT01798004|Topotecan|topotecan|mesh-list
20448163|NCT01798004|Mesna|mesna|mesh-list
20448164|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448165|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
20448166|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448167|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20448168|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20448169|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
20448170|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448171|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448172|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20448173|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20448174|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20448175|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20448176|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448177|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20448178|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406473|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19406474|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448179|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
20448180|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
20448181|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20448182|NCT01798004|Protective Agents|protective agents|mesh-ancestor
20219984|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
20219985|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20219986|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
20219987|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
20219988|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20219989|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20219990|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20219991|NCT00318825|Analgesics|analgesics|mesh-ancestor
20448183|NCT01724606|Sorafenib|sorafenib|mesh-list
20448184|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448185|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19406475|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406476|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406477|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406478|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694061|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
20448186|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448187|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448188|NCT01460810|Silicon|silicon|mesh-list
20448189|NCT01460810|Trace Elements|trace elements|mesh-ancestor
20448190|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
20448191|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448192|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
20448193|NCT01409200|Axitinib|axitinib|mesh-list
20448194|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
20448195|NCT01409200|Hormones|hormones|mesh-list
20219992|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
20448196|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20448197|NCT01409200|Androgens|androgens|mesh-list
20448198|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
20448199|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448200|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448201|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448202|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694062|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448203|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448204|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448205|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
20448206|NCT01409200|Protective Agents|protective agents|mesh-ancestor
20448207|NCT01409200|Vitamins|vitamins|mesh-ancestor
20448208|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
20448209|NCT01409200|Estrogens|estrogens|mesh-ancestor
20448210|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20448211|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
20448212|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
20448213|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
20448214|NCT01175356|Melphalan|melphalan|mesh-list
20448215|NCT01175356|Busulfan|busulfan|mesh-list
20448216|NCT01175356|Doxorubicin|doxorubicin|mesh-list
20448217|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20219993|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20219994|NCT00318838|Azimilide|azimilide|mesh-list
20219995|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20219996|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20219997|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20219998|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20219999|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20220000|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220001|NCT00318890|Docetaxel|docetaxel|mesh-list
20220002|NCT00318890|Amifostine|amifostine|mesh-list
20220003|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220004|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
20220005|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20220006|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
20220007|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220008|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20220009|NCT00318890|Protective Agents|protective agents|mesh-ancestor
20220010|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220011|NCT00318903|Docetaxel|docetaxel|mesh-list
20220012|NCT00318903|Irinotecan|irinotecan|mesh-list
20220013|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220014|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
20220015|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
20220016|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
20220017|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220018|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220019|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220020|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220021|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
20220022|NCT00318955|Propofol|propofol|mesh-list
20220023|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20220024|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220025|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220026|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20220027|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
20220028|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
20220029|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220030|NCT00318955|Analgesics|analgesics|mesh-ancestor
20220031|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
20220032|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220033|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20220034|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20220035|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20448218|NCT01175356|Etoposide|etoposide|mesh-list
20448219|NCT01175356|Vincristine|vincristine|mesh-list
20448220|NCT01175356|Topotecan|topotecan|mesh-list
20448221|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
20448222|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20448223|NCT01175356|Isotretinoin|isotretinoin|mesh-list
20448224|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448225|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
20448226|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448227|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20448228|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20448229|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
20448230|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448231|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448232|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20220036|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
20220037|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448233|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20448234|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20220038|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220039|NCT00318968|Esomeprazole|esomeprazole|mesh-list
20220040|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20220041|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20220042|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20220043|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220044|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220045|NCT00318981|Methylphenidate|methylphenidate|mesh-list
20448235|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20448236|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448237|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20448238|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
20448239|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
20448240|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
20448241|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20448242|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
20448243|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20448244|NCT00703222|Interleukin-2|interleukin-2|mesh-list
20448245|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448246|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448247|NCT00703222|Analgesics|analgesics|mesh-ancestor
20448248|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
20448249|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448250|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448251|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
20448252|NCT00667329|Rituximab|rituximab|mesh-list
20448253|NCT00667329|Cladribine|cladribine|mesh-list
20448254|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448255|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
20448256|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448257|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20448258|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20448259|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
20448260|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448261|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448262|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20448263|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448264|NCT00492167|Antibodies|antibodies|mesh-list
20448265|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20448266|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
20448267|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448268|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20448269|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20448270|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448271|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448272|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
20448273|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448274|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525460|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525461|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525462|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20525463|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20525464|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20525465|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
20525466|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525467|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525468|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
20613719|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694063|NCT04971356|Aspirin|aspirin|mesh-list
19694064|NCT04971356|Ticagrelor|ticagrelor|mesh-list
19694065|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19694066|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694067|NCT04971356|Analgesics|analgesics|mesh-ancestor
19694068|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
19694069|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694070|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694071|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694072|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694073|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19694074|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19694075|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694076|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20220046|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19406479|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19406480|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406481|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
20448275|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
20448276|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20448277|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448278|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448279|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448280|NCT05274789|Analgesics|analgesics|mesh-ancestor
20448281|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
20613720|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613721|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613722|NCT02256423|Ibuprofen|ibuprofen|mesh-list
20613723|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20613724|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613725|NCT02256423|Analgesics|analgesics|mesh-ancestor
20613726|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
20613727|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613728|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613729|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20613730|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613731|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20613732|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613733|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613734|NCT02256462|Adalimumab|adalimumab|mesh-list
20613735|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20613736|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613737|NCT02256605|Vitamin D|vitamin d|mesh-list
20613738|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
20613739|NCT02256605|Vitamins|vitamins|mesh-ancestor
20613740|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
20613741|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613742|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20613743|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20613744|NCT02256683|Dabigatran|dabigatran|mesh-list
20613745|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
20613746|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
20613747|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20613748|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613749|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613750|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613751|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
20613752|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20613753|NCT02256722|Propranolol|propranolol|mesh-list
20613754|NCT02256722|Bisoprolol|bisoprolol|mesh-list
20613755|NCT02256722|Acipimox|acipimox|mesh-list
20613756|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20613757|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20613758|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
20613759|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613760|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613761|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20613762|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
20613763|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20613764|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20613765|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20613766|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613767|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613768|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613769|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20613770|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20613771|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20613772|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20613773|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
20613774|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
19406482|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19406483|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406484|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19406485|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
19406486|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20448282|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613775|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20613776|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19406487|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406488|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448283|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20448284|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20448285|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20448286|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448287|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448288|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448289|NCT05274633|Ravulizumab|ravulizumab|mesh-list
20448290|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20448291|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448292|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
20448293|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448294|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
20448295|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20448296|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20448297|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448298|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
20448299|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448300|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20448301|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448302|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448303|NCT05274191|Maleic acid|maleic acid|mesh-list
20448304|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448305|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448306|NCT05274139|Cytarabine|cytarabine|mesh-list
20448307|NCT05274139|Dexamethasone|dexamethasone|mesh-list
20448308|NCT05274139|Temozolomide|temozolomide|mesh-list
20448309|NCT05274139|Fotemustine|fotemustine|mesh-list
20448310|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448311|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
20448312|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
20448313|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613777|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
20613778|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20613779|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
20613780|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
19406489|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406490|NCT03580239|Everolimus|everolimus|mesh-list
19406491|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406492|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406493|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
19406494|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406495|NCT03580187|Morphine|morphine|mesh-list
19406496|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19406497|NCT03580187|Narcotics|narcotics|mesh-ancestor
19849006|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406498|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406499|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849007|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220047|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220048|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20220049|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20220050|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220051|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220052|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
20220053|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220054|NCT00318994|Meropenem|meropenem|mesh-list
20220055|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20220056|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220057|NCT00319007|Sulindac|sulindac|mesh-list
20220058|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20220059|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220060|NCT00319007|Analgesics|analgesics|mesh-ancestor
20220061|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
20220062|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220063|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220064|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220065|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220066|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220067|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20220068|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220069|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613781|NCT02256735|Ritobegron|ritobegron|mesh-list
19406500|NCT03580187|Analgesics|analgesics|mesh-ancestor
20448314|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448315|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20448316|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
20448317|NCT05274139|Hormones|hormones|mesh-ancestor
20448318|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448319|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19406501|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
19406502|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406503|NCT03580148|Cortisone|cortisone|mesh-list
19406504|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19406505|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220070|NCT00319033|Bosentan|bosentan|mesh-list
20220071|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20220072|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20220073|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220074|NCT00319059|Annexin A5|annexin a5|mesh-list
19406506|NCT03580135|Propolis|propolis|mesh-list
19406507|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448320|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448321|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448322|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448323|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
20448324|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
20448325|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448326|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448327|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
20448328|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20448329|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
20448330|NCT05274113|Dexamethasone|dexamethasone|mesh-list
20448331|NCT05274113|Ropivacaine|ropivacaine|mesh-list
20448332|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448333|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
20448334|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
20220075|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220076|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220077|NCT00319072|Hormones|hormones|mesh-list
20220078|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220079|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220080|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
20220081|NCT00319150|Hematinics|hematinics|mesh-ancestor
20220082|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
20220083|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20220084|NCT00319163|Estradiol|estradiol|mesh-list
20220085|NCT00319163|Estrogens|estrogens|mesh-ancestor
20220086|NCT00319163|Hormones|hormones|mesh-ancestor
20220087|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220088|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406508|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
19406509|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20448335|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448336|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448337|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19406510|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19406511|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406512|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
19406513|NCT03580018|Coagulants|coagulants|mesh-ancestor
19406514|NCT03580005|Methylphenidate|methylphenidate|mesh-list
19406515|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19406516|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406517|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19406518|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19406519|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406520|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406521|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
19406522|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406523|NCT03579979|Methylene Blue|methylene blue|mesh-list
19406524|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406525|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220089|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20220090|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
20220091|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20220092|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20220093|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20448338|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
20448339|NCT05274113|Hormones|hormones|mesh-ancestor
20448340|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448341|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20448342|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448343|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
20448344|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
20448345|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448346|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
20448347|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19694077|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19694078|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694079|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
19694080|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19694081|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19694082|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20220094|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20220095|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20220096|NCT00319189|Nateglinide|nateglinide|mesh-list
20220097|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20220098|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220099|NCT00319202|Candesartan|candesartan|mesh-list
20220100|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20220101|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20220102|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20220103|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220104|NCT00319215|Zopiclone|zopiclone|mesh-list
20220105|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20220106|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220107|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220108|NCT00319267|Bosentan|bosentan|mesh-list
20220109|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20220110|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20220111|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220112|NCT00319293|Metformin|metformin|mesh-list
20220113|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20220114|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220115|NCT00319306|Budesonide|budesonide|mesh-list
20220116|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
20220117|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20220118|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448348|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
20448349|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448350|NCT05274048|Trastuzumab|trastuzumab|mesh-list
20448351|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448352|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448353|NCT05273944|Doxorubicin|doxorubicin|mesh-list
20448354|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20448355|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20448356|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448357|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20448358|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20448359|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448360|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448361|NCT05273814|Bevacizumab|bevacizumab|mesh-list
20448362|NCT05273814|Pemetrexed|pemetrexed|mesh-list
20448363|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20448364|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448365|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448366|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20448367|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20448368|NCT05273814|Growth Substances|growth substances|mesh-ancestor
20448369|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448370|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
20448371|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448372|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448373|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20448374|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20448375|NCT05273775|Vitamin K|vitamin k|mesh-list
19694083|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
20448376|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
20448377|NCT05273775|Digoxin|digoxin|mesh-list
20448378|NCT05273775|Midazolam|midazolam|mesh-list
20448379|NCT05273775|Omeprazole|omeprazole|mesh-list
20448380|NCT05273775|Warfarin|warfarin|mesh-list
20448381|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20448382|NCT05273775|Vitamins|vitamins|mesh-ancestor
20448383|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
20448384|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448385|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20448386|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20448387|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448388|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20448389|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20448390|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20448391|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20448392|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
20448393|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
20448394|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
20448395|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
20448396|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448397|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448398|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20448399|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20448400|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
20448401|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20448402|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20448403|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448404|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
20448405|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20448406|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20448407|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20448408|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20448409|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20448410|NCT05273775|Protective Agents|protective agents|mesh-ancestor
20448411|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20448412|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20448413|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
20448414|NCT05273775|Coagulants|coagulants|mesh-ancestor
20448415|NCT05273710|Folic Acid|folic acid|mesh-list
20448416|NCT05273710|Hematinics|hematinics|mesh-ancestor
20448417|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
20448418|NCT05273710|Vitamins|vitamins|mesh-ancestor
20448419|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
20448420|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694084|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694085|NCT04971382|Curcumin|curcumin|mesh-list
19694086|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20448421|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
20448422|NCT05273554|Lenvatinib|lenvatinib|mesh-list
20448423|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448424|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448425|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20448426|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448427|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448428|NCT05273528|Vaccines|vaccines|mesh-list
20448429|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
20448430|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448431|NCT05273398|Diazepam|diazepam|mesh-list
20448432|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19406526|NCT03579927|Cytarabine|cytarabine|mesh-list
19406527|NCT03579927|Rituximab|rituximab|mesh-list
19406528|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20448433|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
20448434|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
20448435|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
20448436|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448437|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448438|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20448439|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19406529|NCT03579927|Etoposide|etoposide|mesh-list
19406530|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
19694087|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694088|NCT04971382|Analgesics|analgesics|mesh-ancestor
19694089|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
20448440|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406531|NCT03579927|Melphalan|melphalan|mesh-list
19694090|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448441|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20448442|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20448443|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20448444|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20448445|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20448446|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20448447|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
20448448|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
20448449|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
20448450|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
20448451|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448452|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448453|NCT05273346|Analgesics|analgesics|mesh-list
20220119|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20220120|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
20220121|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220122|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448454|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
20448455|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448456|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448457|NCT05272969|Vitamin D|vitamin d|mesh-list
20448458|NCT05272969|Calcium|calcium|mesh-list
20448459|NCT05272969|Vitamins|vitamins|mesh-ancestor
20448460|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
20448461|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448462|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20448463|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20448464|NCT05272930|Dienogest|dienogest|mesh-list
20448465|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20448466|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
20448467|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20448468|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448469|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20448470|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20448471|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20448472|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20448473|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
20448474|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448475|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20448476|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448477|NCT05272878|Irbesartan|irbesartan|mesh-list
20448478|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20448479|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20448480|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20448481|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448482|NCT05272865|Dronabinol|dronabinol|mesh-list
20448483|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
20448484|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448485|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20448486|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448487|NCT05272865|Analgesics|analgesics|mesh-ancestor
20448488|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
20448489|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448490|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20448491|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20448492|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448493|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448494|NCT05272865|Hormones|hormones|mesh-ancestor
20448495|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220123|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20220124|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
20220125|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
20220126|NCT00319306|Hormones|hormones|mesh-ancestor
20220127|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220128|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20220129|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20220130|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20220131|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448496|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20448497|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448498|NCT05272696|Paclitaxel|paclitaxel|mesh-list
20448499|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
20448500|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20448501|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448502|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
20448503|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
20448504|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
20448505|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448506|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448507|NCT05272462|Minoxidil|minoxidil|mesh-list
20448508|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20448509|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
20448510|NCT05272371|Dinutuximab|dinutuximab|mesh-list
20448511|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525469|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20525470|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20525471|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20525472|NCT01758367|Decitabine|decitabine|mesh-list
20525473|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20525474|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
20525475|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525476|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525477|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525478|NCT01758380|Metformin|metformin|mesh-list
20525479|NCT01758380|Vildagliptin|vildagliptin|mesh-list
20525480|NCT01758380|Gliclazide|gliclazide|mesh-list
20525481|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20525482|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525483|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20525484|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
20525485|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525486|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525487|NCT01758393|Prednisone|prednisone|mesh-list
20525488|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20525489|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
20525490|NCT01758393|Hormones|hormones|mesh-ancestor
20525491|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525492|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525493|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20525494|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525495|NCT01758471|Acarbose|acarbose|mesh-list
20525496|NCT01758471|Glipizide|glipizide|mesh-list
20525497|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20525498|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525499|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525500|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20525501|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525502|NCT01758627|Icodextrin|icodextrin|mesh-list
20525503|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
20525504|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20220132|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220133|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220134|NCT00319319|Mecamylamine|mecamylamine|mesh-list
20220135|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20220136|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20525505|NCT01758640|Warfarin|warfarin|mesh-list
20525506|NCT01758640|Phenindione|phenindione|mesh-list
20525507|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
20525508|NCT01758666|Leucovorin|leucovorin|mesh-list
20525509|NCT01758666|Methotrexate|methotrexate|mesh-list
20525510|NCT01758666|Calcium|calcium|mesh-list
20525511|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
20525512|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20525513|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525514|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20525515|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
20525516|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20525517|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20525518|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
20525519|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525520|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525521|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
20525522|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525523|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20525524|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525525|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
20525526|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525527|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20220137|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
20220138|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220139|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220140|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20525528|NCT01758666|Antidotes|antidotes|mesh-ancestor
20448512|NCT05271578|Nicotine|nicotine|mesh-list
19849008|NCT00699335|Analgesics|analgesics|mesh-ancestor
19849009|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
19849010|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849011|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19849012|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19849013|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
19849014|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
20448513|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20448514|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
20448515|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448516|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448517|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20448518|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20448519|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
20448520|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448521|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448522|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
20448523|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20448524|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849015|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
19849016|NCT00699348|Hematinics|hematinics|mesh-ancestor
19849017|NCT00699374|Sorafenib|sorafenib|mesh-list
20448525|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448526|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448527|NCT05271552|Analgesics|analgesics|mesh-ancestor
20448528|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
20448529|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448530|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20448531|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20448532|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20448533|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448534|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448535|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448536|NCT05271539|Dexamethasone|dexamethasone|mesh-list
20448537|NCT05271539|Ranibizumab|ranibizumab|mesh-list
19849018|NCT00699374|Sunitinib|sunitinib|mesh-list
20220141|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20448538|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448539|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
20448540|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
20448541|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448542|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448543|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20448544|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
20448545|NCT05271539|Hormones|hormones|mesh-ancestor
20448546|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448547|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20448548|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448549|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20448550|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19406532|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
20220142|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
20220143|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220144|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220145|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
20220146|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220147|NCT00319345|Mannitol|mannitol|mesh-list
20220148|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20220149|NCT00319345|Diuretics|diuretics|mesh-ancestor
20220150|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
20220151|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220152|NCT00319358|Antioxidants|antioxidants|mesh-list
20220153|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220154|NCT00319358|Protective Agents|protective agents|mesh-ancestor
20220155|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220156|NCT00319488|Budesonide|budesonide|mesh-list
20220157|NCT00319488|Albuterol|albuterol|mesh-list
20220158|NCT00319488|Montelukast|montelukast|mesh-list
20448551|NCT05271539|Growth Substances|growth substances|mesh-ancestor
20448552|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
19406533|NCT03579927|Carmustine|carmustine|mesh-list
19849019|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849020|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849021|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220159|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
20220160|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448553|NCT05271448|Losartan|losartan|mesh-list
20448554|NCT05271448|Valsartan|valsartan|mesh-list
20448555|NCT05271448|Candesartan|candesartan|mesh-list
20448556|NCT05271448|Ramipril|ramipril|mesh-list
20448557|NCT05271448|Enalapril|enalapril|mesh-list
20448558|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20448559|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20448560|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20448561|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20448562|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448563|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20448564|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
20448565|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448566|NCT05271370|Leronlimab|leronlimab|mesh-list
20448567|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
20448568|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20448569|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20448570|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448571|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20448572|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20448573|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
20448574|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448575|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
20448576|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448577|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
20448578|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448579|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448580|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
20448581|NCT05271253|Bupivacaine|bupivacaine|mesh-list
20448582|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
20448583|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
20448584|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448585|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448586|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
20448587|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448588|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20613782|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20613783|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613784|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20613785|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20613786|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613787|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613788|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613789|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613790|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
20613791|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
20613792|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613793|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
20613794|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20613795|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20613796|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20220161|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20220162|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
20220163|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613797|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
19406534|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
19406535|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19406536|NCT03579927|Antibodies|antibodies|mesh-list
19406537|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
19406538|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19406539|NCT03579927|Lenograstim|lenograstim|mesh-list
19406540|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
19406541|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406542|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220164|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220165|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20220166|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
20220167|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
20220168|NCT00319488|Hormones|hormones|mesh-ancestor
20220169|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220170|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
20220171|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19406543|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406544|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20448589|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448590|NCT05271253|Analgesics|analgesics|mesh-ancestor
20448591|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20448592|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20448593|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20448594|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20220172|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20220173|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220174|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
20220175|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20220176|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20220177|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20220178|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20220179|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
20220180|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220181|NCT00319514|Docetaxel|docetaxel|mesh-list
20220182|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448595|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448596|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448597|NCT05271188|Anesthetics|anesthetics|mesh-list
20448598|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
20448599|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448600|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448601|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
20448602|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448603|NCT05271162|Empagliflozin|empagliflozin|mesh-list
20448604|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20448605|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448606|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20448607|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448608|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
20448609|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20448610|NCT05271136|Protective Agents|protective agents|mesh-ancestor
20448611|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448612|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
20448613|NCT05271058|Dexamethasone|dexamethasone|mesh-list
20448614|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
20448615|NCT05271058|Triamcinolone|triamcinolone|mesh-list
20448616|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20448617|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20448618|NCT05271058|BB 1101|bb 1101|mesh-list
20448619|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20448620|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448621|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
20448622|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
20448623|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448624|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448625|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20448626|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
20448627|NCT05271058|Hormones|hormones|mesh-ancestor
20448628|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448629|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20448630|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448631|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
20448632|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448633|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448634|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448635|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
20448636|NCT05271045|Vitamin D|vitamin d|mesh-list
20448637|NCT05271045|Vitamin A|vitamin a|mesh-list
20448638|NCT05271045|Vitamins|vitamins|mesh-ancestor
20448639|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
20448640|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448641|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20448642|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20220183|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
20220184|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
20220185|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
20220186|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247214|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20247215|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247216|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247217|NCT00431353|Valganciclovir|valganciclovir|mesh-list
20247218|NCT00431353|Ganciclovir|ganciclovir|mesh-list
20448643|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20448644|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448645|NCT05270434|Dipyrone|dipyrone|mesh-list
20448646|NCT05270434|Meperidine|meperidine|mesh-list
20448647|NCT05270434|Morphine|morphine|mesh-list
20448648|NCT05270434|Buprenorphine|buprenorphine|mesh-list
20448649|NCT05270434|Analgesics|analgesics|mesh-list
20448650|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20448651|NCT05270434|Narcotics|narcotics|mesh-ancestor
20448652|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448653|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448654|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
19694091|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694092|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694093|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694094|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220187|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20220188|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
20220189|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20220190|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20220191|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20220192|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20220193|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
20448655|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448656|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20448657|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20448658|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406545|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19406546|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19406547|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406548|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448659|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448660|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448661|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20448662|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
20448663|NCT05270421|Furosemide|furosemide|mesh-list
20448664|NCT05270421|Diuretics|diuretics|mesh-ancestor
20448665|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
20448666|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448667|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20448668|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220194|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20220195|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220196|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20220197|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20220198|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20220199|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20220200|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220201|NCT00319566|Estrogens|estrogens|mesh-ancestor
20220202|NCT00319566|Hormones|hormones|mesh-ancestor
20448669|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448670|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
20448671|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20448672|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448673|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
20448674|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20448675|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448676|NCT05270343|Vitamins|vitamins|mesh-ancestor
20448677|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
20448678|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20525529|NCT01758666|Protective Agents|protective agents|mesh-ancestor
20525530|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
20525531|NCT01758666|Vitamins|vitamins|mesh-ancestor
19406549|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20220203|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220204|NCT00319605|Levetiracetam|levetiracetam|mesh-list
20525532|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
20525533|NCT01758744|Treprostinil|treprostinil|mesh-list
20525534|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20525535|NCT01758809|Bupivacaine|bupivacaine|mesh-list
20525536|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
19406550|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
19406551|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
19406552|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406553|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406554|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19406555|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19406556|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
20220205|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
20220206|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
20220207|NCT00319618|Docetaxel|docetaxel|mesh-list
20220208|NCT00319618|Gefitinib|gefitinib|mesh-list
20220209|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220210|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
20220211|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
20220212|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
20220213|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220214|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20220215|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220216|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20220217|NCT00319670|Laxatives|laxatives|mesh-ancestor
20220218|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20220219|NCT00319683|Eniluracil|eniluracil|mesh-list
20220220|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220221|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220222|NCT00319709|Amibegron|amibegron|mesh-list
20220223|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20220224|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20220225|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
20220226|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220227|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220228|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220229|NCT00319761|Calcitriol|calcitriol|mesh-list
20220230|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20220231|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220232|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20220233|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220234|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220235|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20220236|NCT00319761|Vitamins|vitamins|mesh-ancestor
20220237|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
20220238|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20220239|NCT00319787|Gefitinib|gefitinib|mesh-list
20220240|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448679|NCT05270200|Azacitidine|azacitidine|mesh-list
20448680|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448681|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
20448682|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448683|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448684|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849022|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448685|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
20448686|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20448687|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
20448688|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448689|NCT05269849|Sirolimus|sirolimus|mesh-list
20448690|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20448691|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448692|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20448693|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448694|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
20448695|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448696|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
20448697|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448698|NCT05269654|Mannitol|mannitol|mesh-list
20448699|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20448700|NCT05269654|Diuretics|diuretics|mesh-ancestor
20448701|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
20448702|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849023|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19849024|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19849025|NCT00699374|Growth Substances|growth substances|mesh-ancestor
19849026|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849027|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
19849028|NCT00699491|Sirolimus|sirolimus|mesh-list
19849029|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19849030|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19849031|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849032|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19849033|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849034|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
19849035|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220241|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20448703|NCT05269459|Cannabidiol|cannabidiol|mesh-list
20448704|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
20448705|NCT05269355|Dacarbazine|dacarbazine|mesh-list
20448706|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20448707|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
20448708|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448709|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448710|NCT05268003|Venetoclax|venetoclax|mesh-list
20448711|NCT05268003|Ponatinib|ponatinib|mesh-list
20448712|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448713|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20448714|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220242|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220243|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220244|NCT00319800|Irinotecan|irinotecan|mesh-list
20220245|NCT00319800|Gefitinib|gefitinib|mesh-list
20220246|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220247|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220248|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220249|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220250|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220251|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20220252|NCT00319852|Vaccines|vaccines|mesh-list
20220253|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
20220254|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220255|NCT00319865|Thalidomide|thalidomide|mesh-list
20448715|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448716|NCT05253846|Fluorouracil|fluorouracil|mesh-list
20448717|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
20448718|NCT05253846|Irinotecan|irinotecan|mesh-list
20448719|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
20448720|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448721|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448722|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448723|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448724|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
20448725|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448726|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20448727|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20448728|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448729|NCT05253495|Cytarabine|cytarabine|mesh-list
20448730|NCT05253495|Etoposide|etoposide|mesh-list
20448731|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20448732|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448733|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20448734|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20448735|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448736|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448737|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448738|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
20448739|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
20448740|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448741|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448742|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
20448743|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694095|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694096|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694097|NCT04971577|Simvastatin|simvastatin|mesh-list
19694098|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19694099|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19694100|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
20220256|NCT00319865|Dexamethasone|dexamethasone|mesh-list
20220257|NCT00319865|Doxorubicin|doxorubicin|mesh-list
20220258|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20220259|NCT00319865|Bortezomib|bortezomib|mesh-list
20220260|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220261|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
20220262|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
20220263|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220264|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220265|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20220266|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
20220267|NCT00319865|Hormones|hormones|mesh-ancestor
20220268|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220269|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20220270|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448744|NCT05251714|Fulvestrant|fulvestrant|mesh-list
20448745|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20448746|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694101|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694102|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19694103|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19694104|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220271|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20448747|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20448748|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20448749|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
20448750|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448751|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448752|NCT05251090|Factor VIII|factor viii|mesh-list
20448753|NCT05251090|Coagulants|coagulants|mesh-ancestor
20448754|NCT05250141|Levodopa|levodopa|mesh-list
20448755|NCT05250141|Carbidopa|carbidopa|mesh-list
20448756|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20448757|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20448758|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
20448759|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448760|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448761|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448762|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20448763|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448764|NCT05248724|Ketorolac|ketorolac|mesh-list
20448765|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20448766|NCT05248724|Epinephrine|epinephrine|mesh-list
20448767|NCT05248724|Racepinephrine|racepinephrine|mesh-list
20448768|NCT05248724|Morphine|morphine|mesh-list
20448769|NCT05248724|Ropivacaine|ropivacaine|mesh-list
20448770|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
20448771|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20448772|NCT05248724|Narcotics|narcotics|mesh-ancestor
20448773|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448774|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448775|NCT05248724|Analgesics|analgesics|mesh-ancestor
20448776|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
20448777|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448778|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
20220272|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20220273|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220274|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448779|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
20448780|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20448781|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448782|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20448783|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20448784|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20448785|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448786|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448787|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20448788|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20448789|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448790|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448791|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20448792|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20448793|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
20448794|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20448795|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
20448796|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
20448797|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
20448798|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20448799|NCT05248620|Amoxicillin|amoxicillin|mesh-list
20220275|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220276|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220277|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
20220278|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
20220279|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20220280|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220281|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20220282|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20220283|NCT00319865|Growth Substances|growth substances|mesh-ancestor
20448800|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20448801|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448802|NCT05245760|Paclitaxel|paclitaxel|mesh-list
20220284|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
20220285|NCT00319878|Cyclosporine|cyclosporine|mesh-list
20220286|NCT00319878|Sirolimus|sirolimus|mesh-list
20448803|NCT05245760|Carboplatin|carboplatin|mesh-list
20448804|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20448805|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448806|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
20448807|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
20448808|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
20448809|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448810|NCT05243199|Valsartan|valsartan|mesh-list
20448811|NCT05243199|Irbesartan|irbesartan|mesh-list
20448812|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20448813|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20448814|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20448815|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448816|NCT05242705|Cystatins|cystatins|mesh-list
20448817|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20448818|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
20448819|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448820|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448821|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
20220287|NCT00319878|Cyclosporins|cyclosporins|mesh-list
20220288|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220289|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220290|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448822|NCT05242692|Ketamine|ketamine|mesh-list
20448823|NCT05242692|Esketamine|esketamine|mesh-list
20448824|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20448825|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448826|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448827|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448828|NCT05242692|Analgesics|analgesics|mesh-ancestor
20448829|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
20448830|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448831|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20448832|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20448833|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20220291|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
20220292|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220293|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
20220294|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220295|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
20220296|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220297|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20220298|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20220299|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20220300|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220301|NCT00319917|Tacrolimus|tacrolimus|mesh-list
20448834|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448835|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448836|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220302|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220303|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
20220304|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220305|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20220306|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220307|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220308|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
20448837|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20448838|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20448839|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
20448840|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
19849036|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
20220309|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
20220310|NCT00320021|Vitamins|vitamins|mesh-ancestor
20220311|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
20220312|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220313|NCT00320034|Albuterol|albuterol|mesh-list
20220314|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20220315|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
20220316|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220317|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220318|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20448841|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20525537|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
20220319|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
20220320|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
20220321|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20448842|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20448843|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
20448844|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20448845|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20448846|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20525538|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525539|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525540|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
20525541|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525542|NCT01758835|Calpastatin|calpastatin|mesh-list
20525543|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20525544|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
20525545|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525546|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525547|NCT01758861|Anesthetics|anesthetics|mesh-list
20525548|NCT01758861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525549|NCT01758861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525550|NCT01758913|Ibuprofen|ibuprofen|mesh-list
20525551|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20525552|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20525553|NCT01758913|Analgesics|analgesics|mesh-ancestor
20525554|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
20525555|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525556|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525557|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20525558|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525559|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20525560|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525561|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525562|NCT01758978|Hydrocodone|hydrocodone|mesh-list
20525563|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20220322|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20220323|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20525564|NCT01758978|Narcotics|narcotics|mesh-ancestor
20525565|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525566|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525567|NCT01758978|Analgesics|analgesics|mesh-ancestor
20525568|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
20525569|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525570|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
20525571|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
20530529|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530530|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
20530531|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20530532|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530533|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20530534|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20530535|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20530536|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530537|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530538|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20530539|NCT01789242|Dexamethasone|dexamethasone|mesh-list
20530540|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220324|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20220325|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
20220326|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220327|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220328|NCT00320047|Baclofen|baclofen|mesh-list
20220329|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20220330|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220331|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20220332|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220333|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20220334|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
20220335|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
20220336|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220337|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220338|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
20220339|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
20530541|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
20448847|NCT05238155|Antimetabolites|antimetabolites|mesh-list
20448848|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448849|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
20448850|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20448851|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448852|NCT05233982|Olaparib|olaparib|mesh-list
20220340|NCT00320060|Vitamins|vitamins|mesh-ancestor
20220341|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
20220342|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220343|NCT00320073|Pemetrexed|pemetrexed|mesh-list
20220344|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20220345|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220346|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220347|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220348|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20220349|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20220350|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20220351|NCT00320099|Insulin|insulin|mesh-list
20448853|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20448854|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849037|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849038|NCT00699556|Nicotine|nicotine|mesh-list
20448855|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448856|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448857|NCT05232006|Niraparib|niraparib|mesh-list
20448858|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20448859|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448860|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448861|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448862|NCT05226455|Azacitidine|azacitidine|mesh-list
20448863|NCT05226455|Venetoclax|venetoclax|mesh-list
19406557|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19406558|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
19406559|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
19406560|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406561|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406562|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406563|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
19406564|NCT03579888|Fludarabine|fludarabine|mesh-list
19406565|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406566|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
19406567|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406568|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406569|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19406570|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
19406571|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406572|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406573|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19406574|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
19406575|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
19406576|NCT03579875|Busulfan|busulfan|mesh-list
19406577|NCT03579875|Rituximab|rituximab|mesh-list
19406578|NCT03579875|Fludarabine|fludarabine|mesh-list
19406579|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406580|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
19406581|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406582|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406583|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19406584|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
19406585|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849039|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19849040|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
19849041|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849042|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849043|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19849044|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19849045|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
20220352|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20220353|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
20220354|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20220355|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20220356|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19406586|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406587|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19849046|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220357|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
20448864|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448865|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
20448866|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448867|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448868|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448869|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
20448870|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20448871|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448872|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448873|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20448874|NCT05226325|Analgesics|analgesics|mesh-ancestor
20448875|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
20448876|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448877|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19849047|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849048|NCT00699608|Zopiclone|zopiclone|mesh-list
19849049|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19849050|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849051|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220358|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20448878|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20448879|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20448880|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448881|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448882|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448883|NCT05215418|Topiramate|topiramate|mesh-list
20448884|NCT05215418|Phentermine|phentermine|mesh-list
20448885|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
20448886|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20448887|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448888|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20448889|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
20448890|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20448891|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
20448892|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
20448893|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448894|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448895|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448896|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448897|NCT05209841|Heparin|heparin|mesh-list
20448898|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
20220359|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220360|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220361|NCT00320125|Calcium|calcium|mesh-list
20220362|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20220363|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220364|NCT00320229|Abciximab|abciximab|mesh-list
20220365|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
20220366|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20220367|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20220368|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
20220369|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220370|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20220371|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20220372|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220373|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220374|NCT00320294|Irinotecan|irinotecan|mesh-list
20220375|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220376|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220377|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220378|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220379|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220380|NCT00320307|Abacavir|abacavir|mesh-list
20220381|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20220382|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20220383|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220384|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220385|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
20220386|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220387|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20448899|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19849052|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20220388|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20448900|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19406588|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406589|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406590|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
19406591|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
19406592|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406593|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20448901|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448902|NCT05209035|Trazodone|trazodone|mesh-list
20448903|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20448904|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20448905|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448906|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448907|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20448908|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20448909|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20448910|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20448911|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448912|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448913|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
20448914|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20448915|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
20448916|NCT05207280|Terlipressin|terlipressin|mesh-list
20448917|NCT05207280|Norepinephrine|norepinephrine|mesh-list
20448918|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20448919|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20448920|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20448921|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20448922|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
20448923|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448924|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448925|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448926|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
20448927|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
20448928|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448929|NCT05194397|Niacinamide|niacinamide|mesh-list
20448930|NCT05194397|Niacin|niacin|mesh-list
20448931|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
20448932|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
20448933|NCT05194397|Vitamins|vitamins|mesh-ancestor
20448934|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
20448935|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448936|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20448937|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
20448938|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448939|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20448940|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
20448941|NCT05190471|Decitabine|decitabine|mesh-list
20448942|NCT05190471|Oblimersen|oblimersen|mesh-list
20448943|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448944|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
20448945|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448946|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448947|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448948|NCT05180773|Bromocriptine|bromocriptine|mesh-list
19406594|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
19406595|NCT03579875|Hormones|hormones|mesh-ancestor
19406596|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406597|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19406598|NCT03579875|Protective Agents|protective agents|mesh-ancestor
19406599|NCT03579836|Gemcitabine|gemcitabine|mesh-list
19406600|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406601|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
19406602|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406603|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448949|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
20448950|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20448951|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
20448952|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20448953|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
20448954|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448955|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448956|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
20448957|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19406604|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
20448958|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20448959|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
20448960|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20448961|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448962|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
20448963|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
20448964|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448965|NCT05180240|Cannabidiol|cannabidiol|mesh-list
20448966|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
20448967|NCT05173142|Gemcitabine|gemcitabine|mesh-list
20448968|NCT05173142|Docetaxel|docetaxel|mesh-list
20448969|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20448970|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20448971|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
20448972|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20448973|NCT05173142|Antiviral Agents|antiviral agents|mesh-ancestor
20448974|NCT05173142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20448975|NCT05173142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20448976|NCT05173142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20448977|NCT05173142|Immunologic Factors|immunologic factors|mesh-ancestor
20448978|NCT05173142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448979|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
20448980|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
20448981|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
20448982|NCT05168735|Ketamine|ketamine|mesh-list
20448983|NCT05168735|Analgesics|analgesics|mesh-ancestor
20448984|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
20448985|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20448986|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20448987|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20448988|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20448989|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
20448990|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
20448991|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20448992|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20448993|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20448994|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20448995|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525572|NCT01759030|Rituximab|rituximab|mesh-list
20525573|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20525574|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525575|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
20525576|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525577|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525578|NCT01759108|Rebamipide|rebamipide|mesh-list
20525579|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20525580|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20525581|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
20525582|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525583|NCT01759108|Protective Agents|protective agents|mesh-ancestor
20525584|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525585|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525586|NCT01759238|Bevacizumab|bevacizumab|mesh-list
20220389|NCT00320320|Irinotecan|irinotecan|mesh-list
20220390|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220391|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220392|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220393|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220394|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220395|NCT00320359|Cisplatin|cisplatin|mesh-list
20220396|NCT00320359|Etoposide|etoposide|mesh-list
20220397|NCT00320359|Topotecan|topotecan|mesh-list
20220398|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220399|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20220400|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20220401|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220402|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220403|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220404|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220405|NCT00320476|Bortezomib|bortezomib|mesh-list
20220406|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220407|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20220408|NCT00320567|Norgestimate|norgestimate|mesh-list
20220409|NCT00320567|Estradiol|estradiol|mesh-list
20525587|NCT01759238|Capecitabine|capecitabine|mesh-list
20220410|NCT00320567|Estrogens|estrogens|mesh-ancestor
20448996|NCT05166746|Clindamycin|clindamycin|mesh-list
20448997|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
20448998|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
20448999|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20449000|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449001|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20449002|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449003|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449004|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
20449005|NCT05165875|Lidocaine|lidocaine|mesh-list
20449006|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449007|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
20449008|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449009|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449010|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
20449011|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449012|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20449013|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20449014|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20449015|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20449016|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449017|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449018|NCT05162118|Nivolumab|nivolumab|mesh-list
20449019|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694105|NCT04971304|Sargramostim|sargramostim|mesh-list
19694106|NCT04971304|Lenograstim|lenograstim|mesh-list
19694107|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
19694108|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220411|NCT00320567|Hormones|hormones|mesh-ancestor
20220412|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220413|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220414|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20220415|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
20220416|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20220417|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20220418|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20220419|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20220420|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20220421|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20220422|NCT00320580|Norelgestromin|norelgestromin|mesh-list
20449020|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449021|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20449022|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449023|NCT05157971|Cytarabine|cytarabine|mesh-list
20449024|NCT05157971|Prednisone|prednisone|mesh-list
20449025|NCT05157971|Cortisone|cortisone|mesh-list
20449026|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
20449027|NCT05157971|Methotrexate|methotrexate|mesh-list
20449028|NCT05157971|Vincristine|vincristine|mesh-list
20449029|NCT05157971|Daunorubicin|daunorubicin|mesh-list
20449030|NCT05157971|Asparaginase|asparaginase|mesh-list
20449031|NCT05157971|Venetoclax|venetoclax|mesh-list
20449032|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
20449033|NCT05157971|Pegaspargase|pegaspargase|mesh-list
20449034|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20449035|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
20449036|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220423|NCT00320580|Estradiol|estradiol|mesh-list
20220424|NCT00320580|Estrogens|estrogens|mesh-ancestor
20220425|NCT00320580|Hormones|hormones|mesh-ancestor
20220426|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449037|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449038|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20449039|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
20449040|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449041|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449042|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20449043|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449044|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
20449045|NCT05157971|Hormones|hormones|mesh-ancestor
20449046|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449047|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20220427|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449048|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20449049|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
20449050|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20449051|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20449052|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
20449053|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
20449054|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449055|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20449056|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20449057|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
20449058|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449059|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20449060|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
20449061|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
20449062|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
20449063|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20449064|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20449065|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20449066|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
20449067|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20449068|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449069|NCT05144542|Nicotine|nicotine|mesh-list
20449070|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20449071|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
20449072|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449073|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449074|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20449075|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20449076|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
20449077|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449078|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449079|NCT05142267|Oxycodone|oxycodone|mesh-list
20449080|NCT05142267|Naloxone|naloxone|mesh-list
20449081|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20449082|NCT05142267|Narcotics|narcotics|mesh-ancestor
20449083|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449084|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449085|NCT05142267|Analgesics|analgesics|mesh-ancestor
20449086|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
20449087|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449088|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20449089|NCT05142072|Vitamin D|vitamin d|mesh-list
20449090|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
20449091|NCT05142072|Vitamins|vitamins|mesh-ancestor
20449092|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
20449093|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449094|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20449095|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20449096|NCT05138029|Dexamethasone|dexamethasone|mesh-list
20449097|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
20449098|NCT05138029|Ranibizumab|ranibizumab|mesh-list
20449099|NCT05138029|BB 1101|bb 1101|mesh-list
20220428|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20220429|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
20220430|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20220431|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20220432|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20220433|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20220434|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
20220435|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20220436|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20449100|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449101|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
20449102|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
20449103|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449104|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449105|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20449106|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
20449107|NCT05138029|Hormones|hormones|mesh-ancestor
20449108|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20220437|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220438|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
20220439|NCT00320619|Coagulants|coagulants|mesh-ancestor
20220440|NCT00320632|Desipramine|desipramine|mesh-list
20449109|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20449110|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449111|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
20449112|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525588|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20220441|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20449113|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449114|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20449115|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20449116|NCT05138029|Growth Substances|growth substances|mesh-ancestor
20449117|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
20449118|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20449119|NCT05137119|Vancomycin|vancomycin|mesh-list
20449120|NCT05137119|Clindamycin|clindamycin|mesh-list
20449121|NCT05137119|Cefazolin|cefazolin|mesh-list
20449122|NCT05137119|Daptomycin|daptomycin|mesh-list
20449123|NCT05137119|Penicillins|penicillins|mesh-list
20449124|NCT05137119|Penicillin G|penicillin g|mesh-list
20220442|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
20220443|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220444|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220445|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220446|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20449125|NCT05137119|Lincomycin|lincomycin|mesh-list
20449126|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449127|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20449128|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449129|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449130|NCT05135039|Canagliflozin|canagliflozin|mesh-list
20449131|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20449132|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449133|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20220447|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20220448|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220449|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
20220450|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220451|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220452|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20220453|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20220454|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
20220455|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220456|NCT00320658|Antacids|antacids|mesh-ancestor
20220457|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220458|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20220459|NCT00320697|Bupropion|bupropion|mesh-list
20220460|NCT00320697|Nicotine|nicotine|mesh-list
20220461|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20449134|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449135|NCT05129332|Vitamin E|vitamin e|mesh-list
20449136|NCT05129332|Vitamins|vitamins|mesh-ancestor
20449137|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
20449138|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449139|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
20449140|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449141|NCT05129332|Protective Agents|protective agents|mesh-ancestor
20449142|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
20449143|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20449144|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
20449145|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20449146|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
20449147|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449148|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449149|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
20449150|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
20449151|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20449152|NCT05112991|Lenvatinib|lenvatinib|mesh-list
20449153|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449154|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19406605|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406606|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406607|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406608|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
19406609|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449155|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449156|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449157|NCT05099471|Dexamethasone|dexamethasone|mesh-list
19406610|NCT03579823|Adalimumab|adalimumab|mesh-list
20220462|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
20220463|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449158|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
20449159|NCT05099471|Rituximab|rituximab|mesh-list
20449160|NCT05099471|Venetoclax|venetoclax|mesh-list
20449161|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20449162|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
20449163|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449164|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449165|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20449166|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
20449167|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449168|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449169|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20449170|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449171|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449172|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
20449173|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
20449174|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449175|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20449176|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
20449177|NCT05099471|Hormones|hormones|mesh-ancestor
20449178|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449179|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20449180|NCT05090033|Ofatumumab|ofatumumab|mesh-list
20449181|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449182|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
20449183|NCT05088928|Apixaban|apixaban|mesh-list
20449184|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20449185|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
20449186|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20449187|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
20449188|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449189|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449190|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
20449191|NCT05087771|Naltrexone|naltrexone|mesh-list
20449192|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20449193|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20449194|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449195|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
20449196|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449197|NCT05087030|Denosumab|denosumab|mesh-list
20449198|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20449199|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449200|NCT05084859|Prednisone|prednisone|mesh-list
20449201|NCT05084859|Docetaxel|docetaxel|mesh-list
20449202|NCT05084859|Panitumumab|panitumumab|mesh-list
20449203|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449204|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
20449205|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
20449206|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
20449207|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449208|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449209|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
20449210|NCT05084859|Hormones|hormones|mesh-ancestor
20449211|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449212|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449213|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20449214|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449215|NCT05080959|Ropivacaine|ropivacaine|mesh-list
20449216|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449217|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
20449218|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613798|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220464|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220465|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20220466|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20220467|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
20220468|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220469|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220470|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20220471|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
20220472|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220473|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20220474|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20220475|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220476|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
20449219|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449220|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
20220477|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20220478|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20220479|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220480|NCT00320723|Bupropion|bupropion|mesh-list
20220481|NCT00320723|Nicotine|nicotine|mesh-list
20220482|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20220483|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
20449221|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449222|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
20449223|NCT05075122|Sargramostim|sargramostim|mesh-list
20220484|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220485|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220486|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20220487|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20220488|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
20449224|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449225|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449226|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
20449227|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525589|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220489|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220490|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220491|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20220492|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
20220493|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220494|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20220495|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20525590|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20525591|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20525592|NCT01759238|Growth Substances|growth substances|mesh-ancestor
20525593|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525594|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
20525595|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20525596|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
20525597|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525598|NCT01759394|Maleic acid|maleic acid|mesh-list
20525599|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525600|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525601|NCT01759459|Lidocaine|lidocaine|mesh-list
20525602|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
20525603|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
20525604|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525605|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525606|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
20525607|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525608|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20525609|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20525610|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20525611|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20525612|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525613|NCT01759485|Vitamin D|vitamin d|mesh-list
20525614|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
20525615|NCT01759485|Vitamins|vitamins|mesh-ancestor
19694109|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19694110|NCT04971291|Bupropion|bupropion|mesh-list
20220496|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220497|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
20220498|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20220499|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19694111|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19694112|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
19694113|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694114|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19694115|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20220500|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220501|NCT00320736|Galantamine|galantamine|mesh-list
20220502|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20220503|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220504|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220505|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
20220506|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449228|NCT05074056|Ketorolac|ketorolac|mesh-list
20449229|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20449230|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20449231|NCT05074056|Analgesics|analgesics|mesh-ancestor
20449232|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
20449233|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449234|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449235|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449236|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449237|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20449238|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449239|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449240|NCT05071833|Peppermint oil|peppermint oil|mesh-list
20449241|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
20449242|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
20449243|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449244|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449245|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20449246|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
20449247|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
20449248|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449249|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449250|NCT05067439|Efavirenz|efavirenz|mesh-list
20449251|NCT05067439|Caffeine|caffeine|mesh-list
20449252|NCT05067439|Omeprazole|omeprazole|mesh-list
20449253|NCT05067439|Abrocitinib|abrocitinib|mesh-list
20449254|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20449255|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20449256|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20449257|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449258|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449259|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20449260|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449261|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20449262|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20449263|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20449264|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
20449265|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449266|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20449267|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20449268|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
20449269|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449270|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20449271|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20449272|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20449273|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20449274|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20449275|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20449276|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20449277|NCT05064319|Gabapentin|gabapentin|mesh-list
20449278|NCT05064319|Analgesics|analgesics|mesh-ancestor
20449279|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
19406611|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220507|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220508|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20220509|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
20220510|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220511|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
20220512|NCT00320775|Aflibercept|aflibercept|mesh-list
20220513|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20220514|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20220515|NCT00320775|Growth Substances|growth substances|mesh-ancestor
20220516|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220517|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
20220518|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220519|NCT00320814|Aflibercept|aflibercept|mesh-list
20220520|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20220521|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20220522|NCT00320814|Growth Substances|growth substances|mesh-ancestor
20220523|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220524|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
20220525|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220526|NCT00320827|Antibodies|antibodies|mesh-list
20220527|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
20525616|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
20449280|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449281|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449282|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
20449283|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20449284|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20449285|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449286|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20449287|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20449288|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20449289|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449290|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449291|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
20449292|NCT05064137|Listerine|listerine|mesh-list
20449293|NCT05064137|Fluorides|fluorides|mesh-list
20449294|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
20449295|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
20449296|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
20449297|NCT05064137|Protective Agents|protective agents|mesh-ancestor
20449298|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449299|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20449300|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449301|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
20449302|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
20449303|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449304|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
20449305|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449306|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449307|NCT05055726|Benzydamine|benzydamine|mesh-list
20449308|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449309|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
20449310|NCT05052528|Rituximab|rituximab|mesh-list
20449311|NCT05052528|Fludarabine|fludarabine|mesh-list
20449312|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
20449313|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20449314|NCT05052528|Antibodies|antibodies|mesh-list
20449315|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
20449316|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20449317|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20449318|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
20449319|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449320|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449321|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20449322|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
20449323|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449324|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449325|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20449326|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20449327|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
20449328|NCT05051150|Epinephrine|epinephrine|mesh-list
20449329|NCT05051150|Racepinephrine|racepinephrine|mesh-list
20449330|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
20449331|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20449332|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20449333|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
20449334|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449335|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449336|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449337|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20449338|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20449339|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
20449340|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449341|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20449342|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
20449343|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
20449344|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
19694116|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19694117|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694118|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
19694119|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694120|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449345|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20449346|NCT05045313|Probenecid|probenecid|mesh-list
19406612|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449347|NCT05045313|Digoxin|digoxin|mesh-list
19694121|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20449348|NCT05045313|Warfarin|warfarin|mesh-list
19694122|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19694123|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694124|NCT04971239|Methotrexate|methotrexate|mesh-list
19694125|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19694126|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
19694127|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19694128|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694129|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19694130|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
20220528|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220529|NCT00320853|Vitamin D|vitamin d|mesh-list
20220530|NCT00320853|Vitamins|vitamins|mesh-ancestor
20220531|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
20220532|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220533|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20220534|NCT00320879|Irbesartan|irbesartan|mesh-list
20220535|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20220536|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20220537|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20220538|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220539|NCT00320892|Atropine|atropine|mesh-list
20449349|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
20449350|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20449351|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20220540|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20220541|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20220542|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20220543|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20220544|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
20220545|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220546|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220547|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20220548|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
20220549|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
20449352|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449353|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449354|NCT05045313|Protective Agents|protective agents|mesh-ancestor
20449355|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449356|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
20449357|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
20449358|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449359|NCT05045313|Renal Agents|renal agents|mesh-ancestor
20449360|NCT05032508|Lidocaine|lidocaine|mesh-list
20449361|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449362|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
20449363|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449364|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449365|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
20449366|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449367|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20449368|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20449369|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20449370|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20449371|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449372|NCT05030194|Nicotine|nicotine|mesh-list
20449373|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20449374|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
20449375|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449376|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449377|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20449378|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20449379|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
20449380|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449381|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449382|NCT05020574|Cephalexin|cephalexin|mesh-list
20449383|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20449384|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449385|NCT05018117|Nicotine|nicotine|mesh-list
20449386|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20449387|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
20449388|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220550|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
20220551|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20449389|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449390|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20449391|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20449392|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
20449393|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449394|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449395|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
20449396|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
20449397|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20449398|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20449399|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449400|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449401|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449402|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449403|NCT05015439|Cannabidiol|cannabidiol|mesh-list
20449404|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
20449405|NCT05007561|Naltrexone|naltrexone|mesh-list
20449406|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20449407|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20449408|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449409|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
20449410|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449411|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20449412|NCT05002738|Desogestrel|desogestrel|mesh-list
20449413|NCT05002738|Estradiol|estradiol|mesh-list
20449414|NCT05002738|Estrogens|estrogens|mesh-ancestor
20449415|NCT05002738|Hormones|hormones|mesh-ancestor
19849053|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849054|NCT00699803|Prednisone|prednisone|mesh-list
19849055|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
19849056|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19849057|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
19849058|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19849059|NCT00699803|Prednisolone|prednisolone|mesh-list
19849060|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20449416|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449417|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449418|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20449419|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
20449420|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20449421|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20449422|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20449423|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20449424|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20449425|NCT05002738|Progestins|progestins|mesh-ancestor
20449426|NCT05001724|Docetaxel|docetaxel|mesh-list
20449427|NCT05001724|Lenvatinib|lenvatinib|mesh-list
20449428|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449429|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
20449430|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
20449431|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
20449432|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449433|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20449434|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449435|NCT04997759|Neostigmine|neostigmine|mesh-list
20449436|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20449437|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449438|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449439|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
19694131|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449440|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449441|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449442|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20449443|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
20449444|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406613|NCT03579784|Paclitaxel|paclitaxel|mesh-list
19694132|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694133|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
19694134|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694135|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19694136|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694137|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
19694138|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694139|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19849061|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
20449445|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
20449446|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849062|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449447|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449448|NCT04990778|Venetoclax|venetoclax|mesh-list
20449449|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449450|NCT04981158|Anesthetics|anesthetics|mesh-list
20449451|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
20449452|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449453|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406614|NCT03579784|Durvalumab|durvalumab|mesh-list
19406615|NCT03579784|Olaparib|olaparib|mesh-list
19406616|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19406617|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406618|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406619|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406620|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
19694140|NCT04970719|Remdesivir|remdesivir|mesh-list
19694141|NCT04970719|Dexamethasone|dexamethasone|mesh-list
19694142|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19694143|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694144|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
19694145|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
19694146|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449454|NCT04972110|Olaparib|olaparib|mesh-list
20449455|NCT04972110|Niraparib|niraparib|mesh-list
20449456|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20449457|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449458|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449459|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449460|NCT04968522|Methylphenidate|methylphenidate|mesh-list
20449461|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
20449462|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20449463|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449464|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20449465|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20449466|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20449467|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449468|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
20449469|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449470|NCT04961801|Methotrexate|methotrexate|mesh-list
20449471|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
20449472|NCT04961801|Tacrolimus|tacrolimus|mesh-list
20449473|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20449474|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
20449475|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20449476|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449477|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20449478|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
20449479|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449480|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449481|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
20449482|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449483|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20449484|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20449485|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
20449486|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449487|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20449488|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20525617|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525618|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20525619|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20525620|NCT01759524|Lidocaine|lidocaine|mesh-list
20525621|NCT01759524|Clonidine|clonidine|mesh-list
20525622|NCT01759524|Bupivacaine|bupivacaine|mesh-list
20525623|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
20525624|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
20525625|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525626|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525627|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
20525628|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525629|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20525630|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20525631|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19406621|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694147|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525632|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530542|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
20449489|NCT04961281|Triamcinolone|triamcinolone|mesh-list
20449490|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
20449491|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20449492|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449493|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449494|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20449495|NCT04961281|Analgesics|analgesics|mesh-ancestor
20449496|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
20449497|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449498|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20449499|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20449500|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20449501|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
20449502|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449503|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449504|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449505|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
20449506|NCT04961281|Hormones|hormones|mesh-ancestor
20449507|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449508|NCT04959799|Dalbavancin|dalbavancin|mesh-list
20449509|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20449510|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449511|NCT04949633|Oxytocin|oxytocin|mesh-list
20449512|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
20449513|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20449514|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449515|NCT04943900|Nivolumab|nivolumab|mesh-list
20449516|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449517|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449518|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20449519|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449520|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
20449521|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449522|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
20449523|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449524|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449525|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
20449526|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449527|NCT04919564|Furosemide|furosemide|mesh-list
20449528|NCT04919564|Diuretics|diuretics|mesh-ancestor
20449529|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
20449530|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449531|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20449532|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20449533|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449534|NCT04918823|Cyclosporine|cyclosporine|mesh-list
20449535|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20449536|NCT04918823|Cyclosporins|cyclosporins|mesh-list
20449537|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449538|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449539|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20449540|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
20449541|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449542|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
20220552|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20220553|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
20220554|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220555|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220556|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20220557|NCT00320970|Candesartan|candesartan|mesh-list
20449543|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449544|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
20449545|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613799|NCT02256748|Midazolam|midazolam|mesh-list
19406622|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406623|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19406624|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406625|NCT03579771|Gemcitabine|gemcitabine|mesh-list
20613800|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20220558|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20220559|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20220560|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20220561|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406626|NCT03579771|Paclitaxel|paclitaxel|mesh-list
19406627|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19406628|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19406629|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406630|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
19849063|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
19849064|NCT00699803|Hormones|hormones|mesh-ancestor
19849065|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849066|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449546|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20449547|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20449548|NCT04918147|Acetaminophen|acetaminophen|mesh-list
20449549|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
20449550|NCT04918147|Promethazine|promethazine|mesh-list
20449551|NCT04918147|Prednisone|prednisone|mesh-list
20449552|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
20449553|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20449554|NCT04918147|Elotuzumab|elotuzumab|mesh-list
20449555|NCT04918147|Famotidine|famotidine|mesh-list
20449556|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449557|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
20449558|NCT04918147|Hormones|hormones|mesh-ancestor
20449559|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449560|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449561|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20449562|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449563|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20449564|NCT04918147|Analgesics|analgesics|mesh-ancestor
20449565|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
20449566|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449567|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
20449568|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
20449569|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
20449570|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20449571|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20449572|NCT04918147|Protective Agents|protective agents|mesh-ancestor
20449573|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20449574|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20449575|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449576|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449577|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
20449578|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20449579|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
20449580|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
20449581|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449582|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449583|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20449584|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
20449585|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
20449586|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20449587|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20449588|NCT04908371|Lidocaine|lidocaine|mesh-list
20449589|NCT04908371|Epinephrine|epinephrine|mesh-list
20449590|NCT04908371|Racepinephrine|racepinephrine|mesh-list
20449591|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
20449592|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
20449593|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449594|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
20449595|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449596|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449597|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
20449598|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449599|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20449600|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20449601|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20449602|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20449603|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449604|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20449605|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20449606|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
20449607|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449608|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20449609|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20449610|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
20449611|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20449612|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
20449613|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
20449614|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
20449615|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20449616|NCT04907825|Warfarin|warfarin|mesh-list
20449617|NCT04907825|Anticoagulants|anticoagulants|mesh-list
20449618|NCT04896645|Albuterol|albuterol|mesh-list
20449619|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20449620|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
20449621|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449622|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449623|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19849067|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19849068|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849069|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
19849070|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
19849071|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849072|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19849073|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19849074|NCT00699803|Protective Agents|protective agents|mesh-ancestor
19849075|NCT00699907|Flutamide|flutamide|mesh-list
19849076|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
19849077|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
19849078|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849079|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849080|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19849081|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849082|NCT00699998|Aspirin|aspirin|mesh-list
19849083|NCT00699998|Clopidogrel|clopidogrel|mesh-list
19849084|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19849085|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19849086|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19849087|NCT00699998|Analgesics|analgesics|mesh-ancestor
19849088|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
19849089|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849090|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849091|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449624|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
20449625|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
20449626|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20449627|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20449628|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20449629|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20449630|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
20449631|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449632|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449633|NCT04895579|Durvalumab|durvalumab|mesh-list
20449634|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449635|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449636|NCT04894435|Vaccines|vaccines|mesh-list
20449637|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
20449638|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449639|NCT04888858|Fentanyl|fentanyl|mesh-list
20449640|NCT04888858|Bupivacaine|bupivacaine|mesh-list
20449641|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449642|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
20449643|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449644|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449645|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
20449646|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449647|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20449648|NCT04888858|Narcotics|narcotics|mesh-ancestor
20449649|NCT04888858|Analgesics|analgesics|mesh-ancestor
19849092|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849093|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19849094|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20220562|NCT00320983|Topotecan|topotecan|mesh-list
20220563|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220564|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220565|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220566|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220567|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220568|NCT00321009|Enoxaparin|enoxaparin|mesh-list
20220569|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
20220570|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20220571|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20220572|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449650|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20449651|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20449652|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
20449653|NCT04886284|Ertapenem|ertapenem|mesh-list
20449654|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20449655|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449656|NCT04883281|Paclitaxel|paclitaxel|mesh-list
20449657|NCT04883281|Carboplatin|carboplatin|mesh-list
20449658|NCT04883281|Cetuximab|cetuximab|mesh-list
20449659|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20449660|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449661|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
20449662|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
20449663|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
20449664|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449665|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449666|NCT04879823|Acetaminophen|acetaminophen|mesh-list
20449667|NCT04879823|Dexamethasone|dexamethasone|mesh-list
20449668|NCT04879823|Ibuprofen|ibuprofen|mesh-list
20449669|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449670|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
20449671|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
20449672|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449673|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449674|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20449675|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
20449676|NCT04879823|Hormones|hormones|mesh-ancestor
20449677|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449678|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20449679|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449680|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20449681|NCT04879823|Analgesics|analgesics|mesh-ancestor
20449682|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
20449683|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
20449684|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20449685|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449686|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20449687|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449688|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449689|NCT04870333|Ciclesonide|ciclesonide|mesh-list
20449690|NCT04870333|Niclosamide|niclosamide|mesh-list
20449691|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
20449692|NCT04870333|Hormones|hormones|mesh-ancestor
20449693|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449694|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449695|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20449696|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
20449697|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20449698|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
20449699|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20449700|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449701|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
20449702|NCT04869449|Ketoconazole|ketoconazole|mesh-list
20449703|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
20449704|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449705|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20449706|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20449707|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449708|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449709|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20449710|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
20449711|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449712|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449713|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20449714|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
20449715|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20449716|NCT04859829|Antibodies|antibodies|mesh-list
20449717|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
20449718|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20449719|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
20449720|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525633|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525634|NCT01759524|Analgesics|analgesics|mesh-ancestor
20525635|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20525636|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
20525637|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
20449721|NCT04848480|Insulin|insulin|mesh-list
19406631|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406632|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406633|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406634|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406635|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
19406636|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
19406637|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406638|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406639|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20449722|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20449723|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
20449724|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20449725|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449726|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
20220573|NCT00321074|Tacrolimus|tacrolimus|mesh-list
20220574|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220575|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
20449727|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449728|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449729|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20449730|NCT04818957|Vitamin D|vitamin d|mesh-list
20449731|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
20449732|NCT04818957|Vitamins|vitamins|mesh-ancestor
20449733|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
20449734|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449735|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20449736|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20449737|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
20449738|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449739|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449740|NCT04801641|Nabilone|nabilone|mesh-list
20449741|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
20449742|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
20449743|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449744|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449745|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20449746|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20449747|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20449748|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449749|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20449750|NCT04800302|Morphine|morphine|mesh-list
20449751|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20449752|NCT04800302|Narcotics|narcotics|mesh-ancestor
20449753|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449754|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449755|NCT04800302|Analgesics|analgesics|mesh-ancestor
20449756|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
20449757|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449758|NCT04791761|Acetaminophen|acetaminophen|mesh-list
20449759|NCT04791761|Ibuprofen|ibuprofen|mesh-list
20449760|NCT04791761|Oxycodone|oxycodone|mesh-list
20449761|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
20449762|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406640|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
19406641|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449763|NCT04791761|Analgesics|analgesics|mesh-ancestor
20449764|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
20449765|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449766|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449767|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
20449768|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406642|NCT03579758|Gemcitabine|gemcitabine|mesh-list
19406643|NCT03579758|Capecitabine|capecitabine|mesh-list
19406644|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406645|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406646|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
20220576|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220577|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20220578|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220579|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449769|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416544|NCT02405585|Vitamins|vitamins|mesh-ancestor
20449770|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449771|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20449772|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613801|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20449773|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449774|NCT04791761|Narcotics|narcotics|mesh-ancestor
20449775|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449776|NCT04786093|Durvalumab|durvalumab|mesh-list
20449777|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20449778|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449779|NCT04783376|Insulin|insulin|mesh-list
20449780|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20449781|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20449782|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449783|NCT04777071|Edetic Acid|edetic acid|mesh-list
20449784|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20449785|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
20449786|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
20449787|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449788|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
20449789|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20449790|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20449791|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
20449792|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20449793|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449794|NCT04767022|Paclitaxel|paclitaxel|mesh-list
20449795|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20449796|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20449797|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449798|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
20449799|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
20449800|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
20449801|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449802|NCT04760912|Bromides|bromides|mesh-list
20449803|NCT04760912|Anesthetics|anesthetics|mesh-list
20449804|NCT04760912|Rocuronium|rocuronium|mesh-list
20449805|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449806|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449807|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
20449808|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20449809|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20449810|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20449811|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449812|NCT04760691|Tenofovir|tenofovir|mesh-list
20449813|NCT04760691|Emtricitabine|emtricitabine|mesh-list
19406647|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406648|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
19406649|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406650|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406651|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406652|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
19406653|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406654|NCT03579732|Aspirin|aspirin|mesh-list
19406655|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406656|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406657|NCT03579732|Analgesics|analgesics|mesh-ancestor
19406658|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
19406659|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406660|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406661|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406662|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406663|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19406664|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20220580|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
20220581|NCT00321113|Tacrolimus|tacrolimus|mesh-list
20220582|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220583|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
20220584|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220585|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20220586|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220587|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220588|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20220589|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220590|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20220591|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
20449814|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20449815|NCT04760691|Leuprolide|leuprolide|mesh-list
20449816|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20449817|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20449818|NCT04760691|Estradiol|estradiol|mesh-list
20449819|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20449820|NCT04760691|Estrogens|estrogens|mesh-list
20449821|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
20449822|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449823|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20449824|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20449825|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449826|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449827|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20449828|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20449829|NCT04760691|Hormones|hormones|mesh-ancestor
20449830|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449831|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449832|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20449833|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
20449834|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20449835|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20449836|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20449837|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
20449838|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20449839|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449840|NCT04745299|Riluzole|riluzole|mesh-list
20449841|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
20449842|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20449843|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20449844|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449845|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449846|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449847|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20449848|NCT04745299|Protective Agents|protective agents|mesh-ancestor
20449849|NCT04742751|Metformin|metformin|mesh-list
20449850|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20449851|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449852|NCT04710641|Sorafenib|sorafenib|mesh-list
20449853|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449854|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20449855|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449856|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449857|NCT04707664|Sargramostim|sargramostim|mesh-list
20449858|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
20449859|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449860|NCT04706767|Lidocaine|lidocaine|mesh-list
20449861|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
20449862|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
20449863|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
20449864|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449865|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449866|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
20449867|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449868|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20449869|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20449870|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20449871|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20449872|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449873|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20449874|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20449875|NCT04706767|Analgesics|analgesics|mesh-ancestor
20449876|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20449877|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20449878|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20449879|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
20449880|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525638|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20525639|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20525640|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20525641|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
20525642|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525643|NCT01759576|Canagliflozin|canagliflozin|mesh-list
20525644|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20525645|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525646|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20525647|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449881|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20449882|NCT04699383|Allopurinol|allopurinol|mesh-list
20449883|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
20449884|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449885|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449886|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
20449887|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449888|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20449889|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
20449890|NCT04699383|Protective Agents|protective agents|mesh-ancestor
20449891|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449892|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20449893|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20449894|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449895|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
20449896|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20449897|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
20449898|NCT04697719|Aspirin|aspirin|mesh-list
20449899|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20449900|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20449901|NCT04697719|Analgesics|analgesics|mesh-ancestor
20449902|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
20449903|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449904|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449905|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449906|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20449907|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20449908|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20449909|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449910|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20449911|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20449912|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449913|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
20449914|NCT04690686|Paclitaxel|paclitaxel|mesh-list
20449915|NCT04690686|Atezolizumab|atezolizumab|mesh-list
20449916|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20449917|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449918|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
20449919|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
20449920|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
20449921|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449922|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
20449923|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20449924|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449925|NCT04682626|Vitamins|vitamins|mesh-ancestor
20449926|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
20449927|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20449928|NCT04679818|Fentanyl|fentanyl|mesh-list
20449929|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
20449930|NCT04679818|Narcotics|narcotics|mesh-ancestor
20449931|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20449932|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449933|NCT04679818|Analgesics|analgesics|mesh-ancestor
20449934|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
20449935|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449936|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20449937|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20449938|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
20449939|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
20449940|NCT04674514|Dexamethasone|dexamethasone|mesh-list
20449941|NCT04674514|Lenalidomide|lenalidomide|mesh-list
20449942|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20449943|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
20449944|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
20449945|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449946|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449947|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19406665|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849095|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449948|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
19849096|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20449949|NCT04674514|Hormones|hormones|mesh-ancestor
20449950|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20449951|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20449952|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449953|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
20449954|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20449955|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20449956|NCT04674514|Growth Substances|growth substances|mesh-ancestor
20449957|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
20449958|NCT04672941|Bromides|bromides|mesh-list
20449959|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
20449960|NCT04672941|Olodaterol|olodaterol|mesh-list
20449961|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20449962|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
20449963|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20449964|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449965|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20449966|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
20449967|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
20449968|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20449969|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
20449970|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20449971|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449972|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
20449973|NCT04667572|Riboflavin|riboflavin|mesh-list
20449974|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
20449975|NCT04667572|Vitamins|vitamins|mesh-ancestor
20449976|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
20449977|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449978|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20449979|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
20449980|NCT04660240|Sirolimus|sirolimus|mesh-list
20449981|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20449982|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20449983|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20449984|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449985|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
20449986|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20449987|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
20449988|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20449989|NCT04655391|Decitabine|decitabine|mesh-list
20449990|NCT04655391|Venetoclax|venetoclax|mesh-list
20449991|NCT04655391|Ivosidenib|ivosidenib|mesh-list
20449992|NCT04655391|Maleic acid|maleic acid|mesh-list
20449993|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20449994|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
20449995|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20449996|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20449997|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20449998|NCT04652414|Prednisone|prednisone|mesh-list
20449999|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20450000|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
20450001|NCT04652414|Hormones|hormones|mesh-ancestor
20450002|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450003|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450004|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20450005|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450006|NCT04641702|Atropine|atropine|mesh-list
20450007|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20450008|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20450009|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20450010|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
20450011|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450012|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450013|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20450014|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
20450015|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
20450016|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
19406666|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19406667|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19406668|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406669|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
19406670|NCT03579589|Neostigmine|neostigmine|mesh-list
19406671|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19406672|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416545|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
20450017|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20450018|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20450019|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
20450020|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450021|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450022|NCT04640636|Midazolam|midazolam|mesh-list
20450023|NCT04640636|Ketamine|ketamine|mesh-list
20450024|NCT04640636|Analgesics|analgesics|mesh-ancestor
20450025|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
20450026|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450027|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450028|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20450029|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20450030|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
20450031|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
20450032|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450033|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20450034|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20450035|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450036|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450037|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20450038|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20450039|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20450040|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20450041|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20450042|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
20450043|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
20450044|NCT04640376|Acetaminophen|acetaminophen|mesh-list
20450045|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450046|NCT04640376|Analgesics|analgesics|mesh-ancestor
20450047|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
20450048|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450049|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450050|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
20450051|NCT04635683|Lenalidomide|lenalidomide|mesh-list
20450052|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
20450053|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450054|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20450055|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20450056|NCT04635683|Growth Substances|growth substances|mesh-ancestor
20450057|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
20450058|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450059|NCT04622735|Acetaminophen|acetaminophen|mesh-list
20450060|NCT04622735|Nefopam|nefopam|mesh-list
20450061|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450062|NCT04622735|Analgesics|analgesics|mesh-ancestor
20450063|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
20450064|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450065|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450066|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
20450067|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20450068|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450069|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19406673|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406674|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
19406675|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406676|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220592|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20220593|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220594|NCT00321126|Zinc|zinc|mesh-list
20220595|NCT00321126|Trace Elements|trace elements|mesh-ancestor
20220596|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
20220597|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220598|NCT00321165|Taurolidine|taurolidine|mesh-list
20220599|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220600|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20220601|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220602|NCT00321178|Clarithromycin|clarithromycin|mesh-list
20220603|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20220604|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220605|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20220606|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220607|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220608|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20220609|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20220610|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
20220611|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20220612|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
20220613|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
20450070|NCT04606264|Lidocaine|lidocaine|mesh-list
20450071|NCT04606264|Ketamine|ketamine|mesh-list
20450072|NCT04606264|Morphine|morphine|mesh-list
20450073|NCT04606264|Gabapentin|gabapentin|mesh-list
20450074|NCT04606264|Hydromorphone|hydromorphone|mesh-list
20450075|NCT04606264|Aprepitant|aprepitant|mesh-list
20450076|NCT04606264|Anesthetics|anesthetics|mesh-list
19406677|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19406678|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
19406679|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406680|NCT03579576|Ribavirin|ribavirin|mesh-list
19406681|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
20220614|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220615|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220616|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220617|NCT00321191|Analgesics|analgesics|mesh-ancestor
20220618|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
20220619|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220620|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
20220621|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20450077|NCT04606264|Perphenazine|perphenazine|mesh-list
20450078|NCT04606264|Anesthetics, Local|anesthetics, local|mesh-ancestor
20450079|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450080|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450081|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
20450082|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450083|NCT04606264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20450084|NCT04606264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20450085|NCT04606264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20450086|NCT04606264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20450087|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450088|NCT04606264|Analgesics|analgesics|mesh-ancestor
20450089|NCT04606264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20450090|NCT04606264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20450091|NCT04606264|Anesthetics, General|anesthetics, general|mesh-ancestor
20450092|NCT04606264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20450093|NCT04606264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20450094|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450095|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20450096|NCT04606264|Narcotics|narcotics|mesh-ancestor
20450097|NCT04606264|Anticonvulsants|anticonvulsants|mesh-ancestor
20450098|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20450099|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20450100|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20450101|NCT04606264|Antimanic Agents|antimanic agents|mesh-ancestor
20450102|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
20450103|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
20450104|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20450105|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20450106|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20450107|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20450108|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
20450109|NCT04604691|Blinatumomab|blinatumomab|mesh-list
20450110|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450111|NCT04604132|Paclitaxel|paclitaxel|mesh-list
20450112|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20450113|NCT04604132|Atezolizumab|atezolizumab|mesh-list
20450114|NCT04604132|Ramucirumab|ramucirumab|mesh-list
20450115|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20450116|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450117|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450118|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
20450119|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
20450120|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
20450121|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450122|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
20450123|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450124|NCT04602494|Varenicline|varenicline|mesh-list
20450125|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20450126|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20450127|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
20450128|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450129|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406682|NCT03579576|Velpatasvir|velpatasvir|mesh-list
19406683|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
20220622|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
20450130|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525648|NCT01759589|Remifentanil|remifentanil|mesh-list
20525649|NCT01759589|Propofol|propofol|mesh-list
20525650|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
20220623|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220624|NCT00321230|Protective Agents|protective agents|mesh-ancestor
20220625|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220626|NCT00321230|Vitamins|vitamins|mesh-ancestor
20220627|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
20220628|NCT00321230|Laxatives|laxatives|mesh-ancestor
20220629|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20220630|NCT00321347|Lidocaine|lidocaine|mesh-list
20220631|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
20220632|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
20450131|NCT04598321|Talazoparib|talazoparib|mesh-list
20450132|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20450133|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450134|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450135|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450136|NCT04583501|Omalizumab|omalizumab|mesh-list
20450137|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20450138|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20450139|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
20450140|NCT04580381|Natalizumab|natalizumab|mesh-list
20450141|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
20450142|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450143|NCT04579848|Folic Acid|folic acid|mesh-list
20450144|NCT04579848|Methotrexate|methotrexate|mesh-list
20450145|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20450146|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
20450147|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20450148|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450149|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450150|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
20450151|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450152|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450153|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
20450154|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450155|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20450156|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450157|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
20450158|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450159|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20450160|NCT04579848|Hematinics|hematinics|mesh-ancestor
20450161|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
20450162|NCT04579848|Vitamins|vitamins|mesh-ancestor
20450163|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
20450164|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
20450165|NCT04571632|Ipilimumab|ipilimumab|mesh-list
20450166|NCT04571632|Avelumab|avelumab|mesh-list
20450167|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450168|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450169|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20450170|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450171|NCT04564612|Itraconazole|itraconazole|mesh-list
20450172|NCT04564612|Rabeprazole|rabeprazole|mesh-list
20450173|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
20450174|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450175|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20450176|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20450177|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450178|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450179|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20450180|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
20450181|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450182|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450183|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20450184|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20450185|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20450186|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20450187|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
20450188|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20450189|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450190|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
20450191|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450192|NCT04562597|Expectorants|expectorants|mesh-ancestor
20450193|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
20450194|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20450195|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
20220633|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450196|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450197|NCT04562597|Protective Agents|protective agents|mesh-ancestor
20450198|NCT04562597|Antidotes|antidotes|mesh-ancestor
20450199|NCT04561648|Heparin|heparin|mesh-list
20450200|NCT04561648|Calcium heparin|calcium heparin|mesh-list
20450201|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
20450202|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20450203|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20450204|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450205|NCT04551963|Clarithromycin|clarithromycin|mesh-list
20450206|NCT04551963|Fluconazole|fluconazole|mesh-list
20450207|NCT04551963|Voriconazole|voriconazole|mesh-list
20450208|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
20450209|NCT04551963|Diltiazem|diltiazem|mesh-list
20450210|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450211|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450212|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20450213|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450214|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849097|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19849098|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849099|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
20450215|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20450216|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20450217|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
20450218|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20450219|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20450220|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
20450221|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450222|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450223|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20450224|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20450225|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20450226|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20450227|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20450228|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20450229|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
20450230|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450231|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20450232|NCT04551430|Nivolumab|nivolumab|mesh-list
20220634|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220635|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
20220636|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220637|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20220638|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20220639|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20220640|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20450233|NCT04551430|Ipilimumab|ipilimumab|mesh-list
20450234|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450235|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450236|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20450237|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450238|NCT04544475|Estrogens|estrogens|mesh-list
20450239|NCT04544475|Estradiol|estradiol|mesh-list
20450240|NCT04544475|Hormones|hormones|mesh-ancestor
20450241|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450242|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450243|NCT04543682|Iloprost|iloprost|mesh-list
20450244|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20450245|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
20450246|NCT04530981|Repaglinide|repaglinide|mesh-list
20450247|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20450248|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220641|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220642|NCT00321360|Propofol|propofol|mesh-list
20220643|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20220644|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220645|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220646|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20220647|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
20220648|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
20247219|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20247220|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
20450249|NCT04530006|Amantadine|amantadine|mesh-list
20450250|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20450251|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20450252|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
20450253|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450254|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
20450255|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450256|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450257|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450258|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450259|NCT04530006|Analgesics|analgesics|mesh-ancestor
20450260|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
20450261|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450262|NCT04525755|Nicotine|nicotine|mesh-list
20450263|NCT04525755|Varenicline|varenicline|mesh-list
20450264|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20450265|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
20450266|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450267|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450268|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20450269|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20450270|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
20450271|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450272|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450273|NCT04516447|Gemcitabine|gemcitabine|mesh-list
20450274|NCT04516447|Paclitaxel|paclitaxel|mesh-list
20450275|NCT04516447|Carboplatin|carboplatin|mesh-list
20450276|NCT04516447|Doxorubicin|doxorubicin|mesh-list
20450277|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20450278|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450279|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450280|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
20450281|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
20450282|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
20450283|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450284|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450285|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
20450286|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
20450287|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450288|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450289|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450290|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
20450291|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450292|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20450293|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20450294|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20450295|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20450296|NCT04515628|Branebrutinib|branebrutinib|mesh-list
20450297|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20450298|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20450299|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
20450300|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450301|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20450302|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19406684|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406685|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
19406686|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406687|NCT03579472|Halichondrin B|halichondrin b|mesh-list
19406688|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406689|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406690|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406691|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406692|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416546|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19416547|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19416548|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416549|NCT02405260|Incretins|incretins|mesh-ancestor
19416550|NCT02405260|Hormones|hormones|mesh-ancestor
19416551|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416552|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20450303|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450304|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20450305|NCT04501978|Remdesivir|remdesivir|mesh-list
20450306|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
20450307|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406693|NCT03579082|Decitabine|decitabine|mesh-list
19406694|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406695|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
19406696|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406697|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406698|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406699|NCT03579043|Cocaine|cocaine|mesh-list
20450308|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
20450309|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450310|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
20450311|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20450312|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
20450313|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450314|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20450315|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20450316|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
20450317|NCT04482803|Hormones|hormones|mesh-ancestor
20450318|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450319|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450320|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450321|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450322|NCT04481412|Cetirizine|cetirizine|mesh-list
20450323|NCT04481412|Ethanol|ethanol|mesh-list
20450324|NCT04481412|Minoxidil|minoxidil|mesh-list
20450325|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20450326|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450327|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450328|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450329|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20450330|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20450331|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20450332|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
20450333|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
20450334|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450335|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450336|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20450337|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
20450338|NCT04476745|Vitamin D|vitamin d|mesh-list
20450339|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
20220649|NCT00321477|Casopitant|casopitant|mesh-list
20220650|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
20450340|NCT04476745|Vitamins|vitamins|mesh-ancestor
20450341|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
20450342|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450343|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20450344|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20450345|NCT04475991|Maraviroc|maraviroc|mesh-list
20450346|NCT04475991|Favipiravir|favipiravir|mesh-list
20450347|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20450348|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20450349|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450350|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20450351|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20450352|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
20450353|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450354|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20525651|NCT01759589|Sevoflurane|sevoflurane|mesh-list
20525652|NCT01759589|Anesthetics|anesthetics|mesh-list
20525653|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20525654|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525655|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525656|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
20525657|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20525658|NCT01759589|Narcotics|narcotics|mesh-ancestor
20525659|NCT01759589|Analgesics|analgesics|mesh-ancestor
20525660|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
20525661|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849100|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20220651|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
20220652|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220653|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220654|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20220655|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20220656|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525662|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20450355|NCT04463680|Rifampin|rifampin|mesh-list
20450356|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20450357|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
20450358|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450359|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450360|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
20450361|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20450362|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450363|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694148|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19694149|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
19694150|NCT04970719|Hormones|hormones|mesh-ancestor
19694151|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450364|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20450365|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20450366|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20450367|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20450368|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20450369|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20450370|NCT04454203|Anesthetics|anesthetics|mesh-list
20450371|NCT04454203|Mepivacaine|mepivacaine|mesh-list
20450372|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
20450373|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450374|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450375|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
20450376|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450377|NCT04433390|Naloxegol|naloxegol|mesh-list
20450378|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20450379|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450380|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
20450381|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450382|NCT04432610|Nebivolol|nebivolol|mesh-list
20450383|NCT04432610|Bisoprolol|bisoprolol|mesh-list
20450384|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20450385|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
20450386|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20450387|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20450388|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20450389|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
20450390|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450391|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450392|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450393|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
20450394|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
20450395|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450396|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20450397|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20450398|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20450399|NCT04429685|Ketamine|ketamine|mesh-list
20450400|NCT04429685|Analgesics|analgesics|mesh-ancestor
19406700|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
19406701|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
19406702|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406703|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406704|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
19406705|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406706|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19406707|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19406708|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19406709|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406710|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406711|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
19694152|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19694153|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694154|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
19694155|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694156|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
19694157|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694158|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694159|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694160|NCT04970576|Warfarin|warfarin|mesh-list
19694161|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
20450401|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
20450402|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450403|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450404|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20450405|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20450406|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
20450407|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
20450408|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450409|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20450410|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20450411|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450412|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450413|NCT04418466|Risperidone|risperidone|mesh-list
20450414|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20450415|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
20450416|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450417|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450418|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450419|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20450420|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20450421|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450422|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20450423|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20450424|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
20450425|NCT04416451|Rituximab|rituximab|mesh-list
20450426|NCT04416451|Venetoclax|venetoclax|mesh-list
20450427|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406712|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406713|NCT03579004|Paclitaxel|paclitaxel|mesh-list
20450428|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450429|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
20450430|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450431|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450432|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
20450433|NCT04399746|Azithromycin|azithromycin|mesh-list
20220657|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220658|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20220659|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20220660|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
20220661|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220662|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20220663|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20220664|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220665|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220666|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20220667|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20220668|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220669|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220670|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220671|NCT00321490|Analgesics|analgesics|mesh-ancestor
20220672|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
20220673|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450434|NCT04399746|Ivermectin|ivermectin|mesh-list
20450435|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20450436|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450437|NCT04399746|Vitamins|vitamins|mesh-ancestor
20450438|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
20450439|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20450440|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450441|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450442|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19406714|NCT03579004|Fluorouracil|fluorouracil|mesh-list
19406715|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450443|NCT04397484|Lidocaine|lidocaine|mesh-list
20450444|NCT04397484|Epinephrine|epinephrine|mesh-list
20450445|NCT04397484|Racepinephrine|racepinephrine|mesh-list
20450446|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
20450447|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
20450448|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
20450449|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
20450450|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450451|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450452|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
20450453|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406716|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450454|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20450455|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20450456|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20450457|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20450458|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450459|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20450460|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20450461|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
20450462|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450463|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20450464|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20450465|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
20450466|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20450467|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
20450468|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
20450469|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
20450470|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20450471|NCT04394130|Ropivacaine|ropivacaine|mesh-list
20450472|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
20450473|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
20450474|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450475|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450476|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
20450477|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450478|NCT04391608|Tenofovir|tenofovir|mesh-list
20450479|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
20450480|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450481|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20450482|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20450483|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450484|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450485|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20450486|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20450487|NCT04389177|Paclitaxel|paclitaxel|mesh-list
20450488|NCT04389177|Cisplatin|cisplatin|mesh-list
20450489|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
20450490|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450491|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450492|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
20450493|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
20450494|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
20450495|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450496|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450497|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
20450498|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450499|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
20450500|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450501|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220674|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
20220675|NCT00321516|Aripiprazole|aripiprazole|mesh-list
20220676|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
20220677|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220678|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20220679|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20450502|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20450503|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
20450504|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450505|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450506|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20450507|NCT04368091|Sirolimus|sirolimus|mesh-list
20450508|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450509|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450510|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20450511|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220680|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220681|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220682|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
20220683|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
20220684|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220685|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220686|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20220687|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20220688|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
20220689|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20450512|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
20450513|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450514|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
20450515|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450516|NCT04367883|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20450517|NCT04367883|Protease Inhibitors|protease inhibitors|mesh-ancestor
20450518|NCT04367883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450519|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450520|NCT04356950|Thrombin|thrombin|mesh-list
20450521|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
20450522|NCT04356950|Coagulants|coagulants|mesh-ancestor
20450523|NCT04341350|Analgesics|analgesics|mesh-list
20450524|NCT04341350|Propofol|propofol|mesh-list
20450525|NCT04341350|Isoflurane|isoflurane|mesh-list
20450526|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20450527|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613802|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406717|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19406718|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19406719|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406720|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406721|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
19406722|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406723|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406724|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
20613803|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613804|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20613805|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20613806|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613807|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20613808|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
20613809|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
20613810|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
20613811|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
20613812|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613813|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613814|NCT02256774|Ritonavir|ritonavir|mesh-list
20613815|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20613816|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613817|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613818|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613819|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613820|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613821|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613822|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613823|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
20613824|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613825|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613826|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613827|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20613828|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20613829|NCT02256813|Vitamin K|vitamin k|mesh-list
20613830|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
20613831|NCT02256813|Midazolam|midazolam|mesh-list
20613832|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
20613833|NCT02256813|Caffeine|caffeine|mesh-list
20613834|NCT02256813|Omeprazole|omeprazole|mesh-list
20613835|NCT02256813|Warfarin|warfarin|mesh-list
20613836|NCT02256813|Vitamins|vitamins|mesh-ancestor
20613837|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
20613838|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406725|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406726|NCT03578900|Citric Acid|citric acid|mesh-list
19406727|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
19406728|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
19406729|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19406730|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
19406731|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
19406732|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406733|NCT03578874|Capecitabine|capecitabine|mesh-list
19406734|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
19406735|NCT03578874|Sorafenib|sorafenib|mesh-list
19406736|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450528|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613839|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20613840|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20613841|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613842|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20450529|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20450530|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
20450531|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
20450532|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
20450533|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450534|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20450535|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
20450536|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20450537|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20450538|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450539|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
20450540|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450541|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450542|NCT04302168|Choline|choline|mesh-list
20450543|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
20450544|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20450545|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
20450546|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450547|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20450548|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20450549|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
20450550|NCT04301271|Simvastatin|simvastatin|mesh-list
20450551|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20450552|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20450553|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
20450554|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450555|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20450556|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20450557|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406737|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
19406738|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406739|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406740|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19406741|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406742|NCT03578822|Aspirin|aspirin|mesh-list
19406743|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406744|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406745|NCT03578822|Analgesics|analgesics|mesh-ancestor
19406746|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
19406747|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406748|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406749|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406750|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406751|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20450558|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
20450559|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450560|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450561|NCT04300127|Pioglitazone|pioglitazone|mesh-list
20450562|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20450563|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450564|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
20450565|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20450566|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450567|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525663|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20525664|NCT01759706|Dexamethasone|dexamethasone|mesh-list
20525665|NCT01759706|Sufentanil|sufentanil|mesh-list
20525666|NCT01759706|Diazepam|diazepam|mesh-list
19406752|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20220690|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20220691|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20220692|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20220693|NCT00321581|Cediranib|cediranib|mesh-list
20220694|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220695|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20220696|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220697|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220698|NCT00321633|Carboplatin|carboplatin|mesh-list
20220699|NCT00321633|Docetaxel|docetaxel|mesh-list
20220700|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220701|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
20220702|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
20220703|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
20525667|NCT01759706|Ondansetron|ondansetron|mesh-list
20525668|NCT01759706|Anesthetics|anesthetics|mesh-list
20525669|NCT01759706|Ropivacaine|ropivacaine|mesh-list
20525670|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220704|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220705|NCT00321724|Cediranib|cediranib|mesh-list
20220706|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450568|NCT04287049|Azithromycin|azithromycin|mesh-list
20450569|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450570|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450571|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
20450572|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20450573|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20450574|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450575|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
20220707|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220708|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220709|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20220710|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
20220711|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20220712|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220713|NCT00321750|Analgesics|analgesics|mesh-ancestor
20220714|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
20220715|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220716|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220717|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220718|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220719|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20450576|NCT04274335|Coagulants|coagulants|mesh-ancestor
20450577|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
20450578|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450579|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20450580|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450581|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450582|NCT04268277|Rituximab|rituximab|mesh-list
20450583|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
20450584|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450585|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450586|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
20450587|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450588|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406753|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406754|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19406755|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19406756|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406757|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
20220720|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220721|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
20450589|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
20450590|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450591|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450592|NCT04245644|Aspirin|aspirin|mesh-list
20450593|NCT04245644|Metformin|metformin|mesh-list
20450594|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20450595|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20450596|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450597|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20450598|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450599|NCT04245644|Analgesics|analgesics|mesh-ancestor
20450600|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
20450601|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450602|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20450603|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450604|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20450605|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20220722|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20220723|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220724|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220725|NCT00321802|Simvastatin|simvastatin|mesh-list
20220726|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20220727|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20450606|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450607|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20450608|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20450609|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450610|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
20220728|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
20450611|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
20450612|NCT04238845|Vitamin A|vitamin a|mesh-list
20450613|NCT04238845|Vitamins|vitamins|mesh-ancestor
19406758|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20450614|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
20450615|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450616|NCT04236609|Sirolimus|sirolimus|mesh-list
20450617|NCT04236609|Everolimus|everolimus|mesh-list
20450618|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450619|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406759|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
19406760|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
19406761|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406762|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450620|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
19694162|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
19694163|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19694164|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
19694165|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19694166|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
19694167|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694168|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694169|NCT04970667|Flupenthixol|flupenthixol|mesh-list
19406763|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
19406764|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694170|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
19406765|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19406766|NCT03578679|Ivermectin|ivermectin|mesh-list
19406767|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19694171|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19694172|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20450621|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220729|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220730|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20450622|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450623|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450624|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20450625|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
20450626|NCT04223037|Vaccines|vaccines|mesh-list
20450627|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
20450628|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450629|NCT04212013|Rituximab|rituximab|mesh-list
20450630|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450631|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450632|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
20450633|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450634|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450635|NCT04195776|Tenofovir|tenofovir|mesh-list
19406768|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406769|NCT03578640|Grazoprevir|grazoprevir|mesh-list
19406770|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
19406771|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406772|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20220731|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20220732|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220733|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20220734|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20220735|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
19694173|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849101|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19849102|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19849103|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
20220736|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220737|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220738|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
20220739|NCT00322036|Analgesics|analgesics|mesh-ancestor
20220740|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
20220741|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450636|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
20450637|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849104|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849105|NCT00700011|Clofarabine|clofarabine|mesh-list
19849106|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19849107|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
19849108|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849109|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450638|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20450639|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20450640|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450641|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450642|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20450643|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20450644|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20450645|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20450646|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450647|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450648|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20220742|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220743|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20220744|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220745|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20450649|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
20450650|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450651|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450652|NCT04186663|Fluorides|fluorides|mesh-list
20450653|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
20450654|NCT04186663|Protective Agents|protective agents|mesh-ancestor
20450655|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450656|NCT04173338|Pemetrexed|pemetrexed|mesh-list
20450657|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450658|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450659|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450660|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20450661|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20450662|NCT04167462|BMS-986165|bms-986165|mesh-list
20450663|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
20450664|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20450665|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450666|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450667|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20450668|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20450669|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
20450670|NCT04164199|Capecitabine|capecitabine|mesh-list
20450671|NCT04164199|Pemetrexed|pemetrexed|mesh-list
20450672|NCT04164199|Temozolomide|temozolomide|mesh-list
20450673|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450674|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
20450675|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450676|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450677|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450678|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20450679|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20450680|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20450681|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
20450682|NCT04157075|Bupivacaine|bupivacaine|mesh-list
20450683|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
20450684|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
20450685|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450686|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450687|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
20450688|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450689|NCT04154189|Etoposide|etoposide|mesh-list
20450690|NCT04154189|Ifosfamide|ifosfamide|mesh-list
20450691|NCT04154189|Lenvatinib|lenvatinib|mesh-list
20450692|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450693|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450694|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20450695|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20450696|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450697|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450698|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20450699|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
20450700|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20220746|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220747|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20220748|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220749|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220750|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
20450701|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
20450702|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20525671|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
20220751|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20220752|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
20220753|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220754|NCT00322062|Protective Agents|protective agents|mesh-ancestor
20220755|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220756|NCT00322062|Vitamins|vitamins|mesh-ancestor
20220757|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
20220758|NCT00322062|Laxatives|laxatives|mesh-ancestor
20220759|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20220760|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
20220761|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20220762|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220763|NCT00322114|Lycopene|lycopene|mesh-list
20220764|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220765|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
20220766|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220767|NCT00322114|Protective Agents|protective agents|mesh-ancestor
20220768|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220769|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20220770|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20220771|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220772|NCT00322127|Plerixafor|plerixafor|mesh-list
20220773|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20220774|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20220775|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
20220776|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220777|NCT00322166|Calcium|calcium|mesh-list
20220778|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20220779|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220780|NCT00322296|Bexarotene|bexarotene|mesh-list
20220781|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220782|NCT00322400|Paclitaxel|paclitaxel|mesh-list
20220783|NCT00322400|Docetaxel|docetaxel|mesh-list
20220784|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
20220785|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20220786|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220787|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
20220788|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
20220789|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
20220790|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220791|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20220792|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220793|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
20220794|NCT00322413|Hematinics|hematinics|mesh-ancestor
20220795|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
20220796|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20220797|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220798|NCT00322543|Analgesics|analgesics|mesh-ancestor
20220799|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
20220800|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220801|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220802|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20220803|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220804|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
20220805|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220806|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
20220807|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20220808|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220809|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220810|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
20220811|NCT00322569|Paclitaxel|paclitaxel|mesh-list
20220812|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20220813|NCT00322569|Tacrolimus|tacrolimus|mesh-list
20220814|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20220815|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220816|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
20220817|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
20220818|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
20220819|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220820|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20220821|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220822|NCT00322569|Analgesics|analgesics|mesh-ancestor
19406773|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220823|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
20220824|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220825|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220826|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20450703|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525672|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
20525673|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525674|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525675|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20525676|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
20525677|NCT01759706|Hormones|hormones|mesh-ancestor
20525678|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525679|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20525680|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525681|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525682|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
20525683|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
20525684|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20525685|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
20613843|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20613844|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613845|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20613846|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
20613847|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
20613848|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
20613849|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
20613850|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613851|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613852|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
19406774|NCT03578432|Everolimus|everolimus|mesh-list
19406775|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406776|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694174|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694175|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694176|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19694177|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
19694178|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406777|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
19406778|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406779|NCT03578354|Atenolol|atenolol|mesh-list
19406780|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
19406781|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19406782|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19406783|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
19406784|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
19406785|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406786|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406787|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19406788|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19406789|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19406790|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
19406791|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19406792|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406793|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19406794|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406795|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
19406796|NCT03578276|Prednisolone|prednisolone|mesh-list
19406797|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19406798|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
19406799|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19694179|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220827|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220828|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
20220829|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220830|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
20220831|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20220832|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220833|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20220834|NCT00322595|Paroxetine|paroxetine|mesh-list
20220835|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
20220836|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220837|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20220838|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20220839|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220840|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849110|NCT00700102|Bevacizumab|bevacizumab|mesh-list
20220841|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20525686|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220842|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20220843|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20220844|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694180|NCT04970602|Methylene Blue|methylene blue|mesh-list
19694181|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220845|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450704|NCT04108026|Durvalumab|durvalumab|mesh-list
20450705|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450706|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450707|NCT04100135|Clopidogrel|clopidogrel|mesh-list
20220846|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
20220847|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20220848|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20220849|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20220850|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220851|NCT00322660|Epinephrine|epinephrine|mesh-list
20450708|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20450709|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20220852|NCT00322660|Racepinephrine|racepinephrine|mesh-list
20220853|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
20220854|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20450710|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20450711|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20450712|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20450713|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
20450714|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450715|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450716|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450717|NCT04095104|Topiramate|topiramate|mesh-list
20450718|NCT04095104|Phentermine|phentermine|mesh-list
20450719|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
20450720|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20450721|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450722|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20450723|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
20450724|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20450725|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
20450726|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
20450727|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450728|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
20450729|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450730|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450731|NCT04074512|Copper|copper|mesh-list
20450732|NCT04074512|Trace Elements|trace elements|mesh-ancestor
20450733|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
20450734|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450735|NCT04060342|Gemcitabine|gemcitabine|mesh-list
20450736|NCT04060342|Paclitaxel|paclitaxel|mesh-list
20450737|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
20450738|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450739|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450740|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
20450741|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
20450742|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
20450743|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450744|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450745|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
20450746|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
20450747|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450748|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450749|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450750|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
20450751|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450752|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450753|NCT04057131|Icatibant|icatibant|mesh-list
20450754|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20450755|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450756|NCT04057131|Analgesics|analgesics|mesh-ancestor
20450757|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
20450758|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450759|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450760|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406800|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
20220855|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20450761|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450762|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20450763|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20220856|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
20220857|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220858|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220859|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220860|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19406801|NCT03578276|Bromfenac|bromfenac|mesh-list
19406802|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19406803|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
19406804|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406805|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
19406806|NCT03578276|Hormones|hormones|mesh-ancestor
19406807|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406808|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406809|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19406810|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406811|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
20450764|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450765|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20450766|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450767|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
19406812|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
19406813|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406814|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19406815|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19406816|NCT03578276|Protective Agents|protective agents|mesh-ancestor
19406817|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19406818|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19406819|NCT03578276|Analgesics|analgesics|mesh-ancestor
19406820|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
19406821|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19406822|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19406823|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406824|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19406825|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19406826|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20450768|NCT04055389|Antithrombins|antithrombins|mesh-list
19406827|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19406828|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406829|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406830|NCT03578263|Oxytocin|oxytocin|mesh-list
19406831|NCT03578263|Carbetocin|carbetocin|mesh-list
19406832|NCT03578263|Ergonovine|ergonovine|mesh-list
19406833|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
19406834|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19406835|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406836|NCT03578042|Losartan|losartan|mesh-list
19406837|NCT03578042|Amlodipine|amlodipine|mesh-list
19406838|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19406839|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19406840|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19406841|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406842|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406843|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19406844|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406845|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
19406846|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19406847|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19406848|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19406849|NCT03578042|Diuretics|diuretics|mesh-ancestor
20220861|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20220862|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
20220863|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220864|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20220865|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
20220866|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
20220867|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
20220868|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20220869|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20220870|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
20220871|NCT00322699|Trioxsalen|trioxsalen|mesh-list
20220872|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406850|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
20450769|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
20450770|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20450771|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
20450772|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450773|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450774|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
20450775|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
20450776|NCT04050540|Doxycycline|doxycycline|mesh-list
20450777|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450778|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450779|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
20450780|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20450781|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20450782|NCT04044729|Cannabidiol|cannabidiol|mesh-list
20450783|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
20450784|NCT04037527|Gemcitabine|gemcitabine|mesh-list
20450785|NCT04037527|Docetaxel|docetaxel|mesh-list
20450786|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450787|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
20450788|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450789|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450790|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
20450791|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450792|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450793|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450794|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
20450795|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450796|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
20450797|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
20450798|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
20450799|NCT04020718|Nicotine|nicotine|mesh-list
20450800|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20450801|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
20450802|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450803|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450804|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20450805|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20450806|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
20450807|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450808|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220873|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
20220874|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20220875|NCT00322751|Topotecan|topotecan|mesh-list
20220876|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220877|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20450809|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
20450810|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450811|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450812|NCT04011150|Fentanyl|fentanyl|mesh-list
20450813|NCT04011150|Ropivacaine|ropivacaine|mesh-list
20450814|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
20450815|NCT04011150|Anesthetics|anesthetics|mesh-list
20450816|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20450817|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450818|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
20450819|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450820|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20450821|NCT04011150|Narcotics|narcotics|mesh-ancestor
20450822|NCT04011150|Analgesics|analgesics|mesh-ancestor
20450823|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20450824|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20450825|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
20220878|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220879|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220880|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220881|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
20220882|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
20220883|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20220884|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20220885|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220886|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220887|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20220888|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20450826|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
20450827|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450828|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450829|NCT04008082|Lenvatinib|lenvatinib|mesh-list
20450830|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450831|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20450832|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450833|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450834|NCT04002180|Vedolizumab|vedolizumab|mesh-list
20450835|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20450836|NCT03997968|Gemcitabine|gemcitabine|mesh-list
20450837|NCT03997968|Rituximab|rituximab|mesh-list
20450838|NCT03997968|Capecitabine|capecitabine|mesh-list
20450839|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20450840|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450841|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450842|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
20450843|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450844|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450845|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450846|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
20450847|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450848|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
20450849|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450850|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450851|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450852|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20450853|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
20450854|NCT03997786|Etanercept|etanercept|mesh-list
19694182|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694183|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19694184|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694185|NCT04970251|Aflibercept|aflibercept|mesh-list
20450855|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20450856|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20450857|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450858|NCT03997786|Analgesics|analgesics|mesh-ancestor
20450859|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
20450860|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450861|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450862|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20450863|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450864|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20450865|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450866|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
20450867|NCT03994874|Furosemide|furosemide|mesh-list
20450868|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
20450869|NCT03994874|Diuretics|diuretics|mesh-list
20450870|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20450871|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
20450872|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450873|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20450874|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450875|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20450876|NCT03980925|Carboplatin|carboplatin|mesh-list
20450877|NCT03980925|Nivolumab|nivolumab|mesh-list
20450878|NCT03980925|Etoposide|etoposide|mesh-list
20450879|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450880|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450881|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20450882|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450883|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450884|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20450885|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20450886|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450887|NCT03980509|Curcumin|curcumin|mesh-list
20450888|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20450889|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450890|NCT03980509|Analgesics|analgesics|mesh-ancestor
20450891|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
20450892|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450893|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450894|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20450895|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450896|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450897|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450898|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450899|NCT03974243|Chiauranib|chiauranib|mesh-list
20450900|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450901|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20450902|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450903|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450904|NCT03972657|Cemiplimab|cemiplimab|mesh-list
20450905|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450906|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450907|NCT03967925|Prednisone|prednisone|mesh-list
20450908|NCT03967925|Prednisolone|prednisolone|mesh-list
20450909|NCT03967925|Rituximab|rituximab|mesh-list
20450910|NCT03967925|Belimumab|belimumab|mesh-list
20450911|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450912|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450913|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
20450914|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450915|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20450916|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20450917|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
20450918|NCT03967925|Hormones|hormones|mesh-ancestor
20450919|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20450920|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20450921|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450922|NCT03955042|Pemetrexed|pemetrexed|mesh-list
20450923|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450924|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450925|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450926|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20450927|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20450928|NCT03954743|Vaccines|vaccines|mesh-list
20450929|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
20450930|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450931|NCT03947671|Acetaminophen|acetaminophen|mesh-list
20450932|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20450933|NCT03947671|Analgesics|analgesics|mesh-ancestor
20450934|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
20450935|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450936|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450937|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
20450938|NCT03946969|Paclitaxel|paclitaxel|mesh-list
20450939|NCT03946969|Cisplatin|cisplatin|mesh-list
20450940|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450941|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450942|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
20450943|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
20450944|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
19406851|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19406852|NCT03577977|Interferons|interferons|mesh-list
19406853|NCT03577977|Interferon-beta|interferon-beta|mesh-list
19406854|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
19406855|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406856|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
19406857|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19406858|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
19406859|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450945|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450946|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
20450947|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
20450948|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20450949|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20450950|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450951|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450952|NCT03945643|Urological Agents|urological agents|mesh-ancestor
20450953|NCT03937219|Nivolumab|nivolumab|mesh-list
20450954|NCT03937219|Ipilimumab|ipilimumab|mesh-list
20450955|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450956|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450957|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20450958|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450959|NCT03932318|Azacitidine|azacitidine|mesh-list
20450960|NCT03932318|Venetoclax|venetoclax|mesh-list
20450961|NCT03932318|Lintuzumab|lintuzumab|mesh-list
20450962|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20450963|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
19406860|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20450964|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406861|NCT03577912|Anesthetics|anesthetics|mesh-list
20450965|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450966|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20450967|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20450968|NCT03913832|Sirolimus|sirolimus|mesh-list
20450969|NCT03913832|Paclitaxel|paclitaxel|mesh-list
20450970|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20450971|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20450972|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
20450973|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
20450974|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
20450975|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450976|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20450977|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20450978|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20450979|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
20450980|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20450981|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
20450982|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450983|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20450984|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
20450985|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450986|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450987|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525687|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525688|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20525689|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20525690|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20525691|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20525692|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20525693|NCT01759706|Narcotics|narcotics|mesh-ancestor
20525694|NCT01759706|Analgesics|analgesics|mesh-ancestor
20525695|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
20525696|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20525697|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20525698|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
20525699|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
20525700|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
20525701|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20525702|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20525703|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20525704|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
20525705|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
20525706|NCT01759719|Chromium|chromium|mesh-list
20525707|NCT01759719|Trace Elements|trace elements|mesh-ancestor
20525708|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
20525709|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525710|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
20525711|NCT01759732|Fludarabine|fludarabine|mesh-list
20525712|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20525713|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525714|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
20525715|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525716|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525717|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20525718|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
20525719|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525720|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525721|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20525722|NCT01759771|Vitamin D|vitamin d|mesh-list
20525723|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
20525724|NCT01759771|Vitamins|vitamins|mesh-ancestor
20525725|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
20525726|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525727|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20525728|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20525729|NCT01759810|Vaccines|vaccines|mesh-list
20525730|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
20525731|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525732|NCT01759875|Ritonavir|ritonavir|mesh-list
20525733|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20525734|NCT01759875|Rabeprazole|rabeprazole|mesh-list
20525735|NCT01759875|Betaine|betaine|mesh-list
20525736|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20525737|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20525738|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
20525739|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525740|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20450988|NCT03897439|Bupropion|bupropion|mesh-list
20450989|NCT03897439|Nicotine|nicotine|mesh-list
20450990|NCT03897439|Varenicline|varenicline|mesh-list
20450991|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20450992|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
20450993|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20450994|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20450995|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20450996|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20450997|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
20450998|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20450999|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451000|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20451001|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
20451002|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20451003|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20451004|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20451005|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451006|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
20451007|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20451008|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20451009|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451010|NCT03883412|Liraglutide|liraglutide|mesh-list
20451011|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20451012|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451013|NCT03883412|Incretins|incretins|mesh-ancestor
20220889|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
20451014|NCT03883412|Hormones|hormones|mesh-ancestor
20451015|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451016|NCT03867682|Venetoclax|venetoclax|mesh-list
20451017|NCT03867682|Lintuzumab|lintuzumab|mesh-list
20451018|NCT03867682|Spironolactone|spironolactone|mesh-list
20451019|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451020|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20451021|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
20451022|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451023|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451024|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20451025|NCT03867682|Diuretics|diuretics|mesh-ancestor
20451026|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
20451027|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451028|NCT03864419|Prednisone|prednisone|mesh-list
20451029|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
20451030|NCT03864419|Rituximab|rituximab|mesh-list
20451031|NCT03864419|Doxorubicin|doxorubicin|mesh-list
20451032|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20451033|NCT03864419|Methotrexate|methotrexate|mesh-list
20451034|NCT03864419|Etoposide|etoposide|mesh-list
20451035|NCT03864419|Vincristine|vincristine|mesh-list
20451036|NCT03864419|Daunorubicin|daunorubicin|mesh-list
20451037|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
20451038|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20451039|NCT03864419|Antibodies|antibodies|mesh-list
20451040|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
19406862|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406863|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406864|NCT03577899|Aflibercept|aflibercept|mesh-list
19406865|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19406866|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19406867|NCT03577899|Growth Substances|growth substances|mesh-ancestor
19406868|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406869|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
20220890|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
20220891|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20220892|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220893|NCT00322907|Mefloquine|mefloquine|mesh-list
20220894|NCT00322907|Quinine|quinine|mesh-list
20220895|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
20220896|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20220897|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20220898|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220899|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20451041|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20451042|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451043|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
20451044|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451045|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451046|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20451047|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
20451048|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451049|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451050|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20451051|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20451052|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20451053|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20451054|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451055|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451056|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
20451057|NCT03864419|Hormones|hormones|mesh-ancestor
20451058|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451059|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451060|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20451061|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
19406870|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220900|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220901|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20220902|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220903|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20220904|NCT00322907|Analgesics|analgesics|mesh-ancestor
20220905|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
20220906|NCT00322920|Topotecan|topotecan|mesh-list
20220907|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406871|NCT03577860|Bupivacaine|bupivacaine|mesh-list
19406872|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
19406873|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
19406874|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406875|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406876|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
19406877|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406878|NCT03577834|Acetic Acid|acetic acid|mesh-list
19406879|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19406880|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451062|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20451063|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451064|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
20451065|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
20451066|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20451067|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20451068|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20451069|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
20451070|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
20451071|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
20451072|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
20451073|NCT03858621|Fentanyl|fentanyl|mesh-list
20451074|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20451075|NCT03858621|Narcotics|narcotics|mesh-ancestor
20451076|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451077|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451078|NCT03858621|Analgesics|analgesics|mesh-ancestor
20451079|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
20451080|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451081|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20451082|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20451083|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
19406881|NCT03577782|Vedolizumab|vedolizumab|mesh-list
20220908|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220909|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220910|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220911|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220912|NCT00322972|Azithromycin|azithromycin|mesh-list
20220913|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20220914|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220915|NCT00322985|Lenalidomide|lenalidomide|mesh-list
20220916|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
20220917|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220918|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20220919|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20220920|NCT00322985|Growth Substances|growth substances|mesh-ancestor
20220921|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
20220922|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220923|NCT00323011|Leucovorin|leucovorin|mesh-list
20220924|NCT00323011|Folic Acid|folic acid|mesh-list
20451084|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
20451085|NCT03845270|Docetaxel|docetaxel|mesh-list
20451086|NCT03845270|Trastuzumab|trastuzumab|mesh-list
20451087|NCT03845270|Pertuzumab|pertuzumab|mesh-list
20451088|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451089|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
20451090|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
20451091|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
20451092|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451093|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451094|NCT03836651|Antioxidants|antioxidants|mesh-list
20451095|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451096|NCT03836651|Protective Agents|protective agents|mesh-ancestor
20451097|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451098|NCT03813121|Midazolam|midazolam|mesh-list
20451099|NCT03813121|Ketamine|ketamine|mesh-list
20451100|NCT03813121|Analgesics|analgesics|mesh-ancestor
20451101|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
20451102|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451103|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451104|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20451105|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20451106|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
20451107|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
20451108|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451109|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20451110|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20451111|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451112|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451113|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20451114|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20451115|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20451116|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20451117|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20451118|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
20451119|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
20613853|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20613854|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20613855|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20613856|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406882|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19406883|NCT03577743|Bevacizumab|bevacizumab|mesh-list
19406884|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20613857|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20613858|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20613859|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19406885|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406886|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19406887|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19406888|NCT03577743|Growth Substances|growth substances|mesh-ancestor
19406889|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406890|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
19406891|NCT03577652|Ticagrelor|ticagrelor|mesh-list
19406892|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19406893|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19406894|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19406895|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19406896|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
19406897|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613860|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20613861|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
20613862|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20220925|NCT00323011|Bevacizumab|bevacizumab|mesh-list
20220926|NCT00323011|Fluorouracil|fluorouracil|mesh-list
20220927|NCT00323011|Irinotecan|irinotecan|mesh-list
20220928|NCT00323011|Dalteparin|dalteparin|mesh-list
20220929|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
20220930|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416553|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
20220931|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220932|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20220933|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20220934|NCT00323011|Growth Substances|growth substances|mesh-ancestor
20220935|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220936|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
20220937|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
20451123|NCT03807921|Aspirin|aspirin|mesh-list
20451124|NCT03807921|Warfarin|warfarin|mesh-list
20451125|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20451126|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451127|NCT03807921|Analgesics|analgesics|mesh-ancestor
20451128|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
20451129|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451130|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451131|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694186|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19694187|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20451132|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451133|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20451134|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19694188|NCT04970251|Growth Substances|growth substances|mesh-ancestor
19694189|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694190|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
19694191|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694192|NCT04970069|Analgesics|analgesics|mesh-list
19694193|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
20220938|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220939|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20220940|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220941|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
20220942|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20220943|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20220944|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220945|NCT00323011|Antidotes|antidotes|mesh-ancestor
20220946|NCT00323011|Protective Agents|protective agents|mesh-ancestor
20220947|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
20220948|NCT00323011|Vitamins|vitamins|mesh-ancestor
20220949|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
20220950|NCT00323011|Hematinics|hematinics|mesh-ancestor
20220951|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
20220952|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20220953|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20451135|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451136|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20451137|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20451138|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451139|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
20451140|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
20451141|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
20451142|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
20451143|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
20451144|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451145|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451146|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20451147|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
20451148|NCT03778944|Dopamine|dopamine|mesh-list
20451149|NCT03778944|Mannitol|mannitol|mesh-list
20451150|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20451151|NCT03778944|Diuretics|diuretics|mesh-ancestor
20451152|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
19694194|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694195|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694196|NCT04970303|Methylphenidate|methylphenidate|mesh-list
20220954|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20220955|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20220956|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220957|NCT00323154|Nalbuphine|nalbuphine|mesh-list
20220958|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20220959|NCT00323154|Narcotics|narcotics|mesh-ancestor
20220960|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20220961|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220962|NCT00323154|Analgesics|analgesics|mesh-ancestor
20220963|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
20220964|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220965|NCT00323206|Interleukin-12|interleukin-12|mesh-list
20220966|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20451153|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451154|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20451155|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
20451156|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
20451157|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451158|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
20451159|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451160|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451161|NCT03778944|Protective Agents|protective agents|mesh-ancestor
20451162|NCT03777462|Gemcitabine|gemcitabine|mesh-list
20451163|NCT03777462|Paclitaxel|paclitaxel|mesh-list
20451164|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20451165|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20451166|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451167|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
20451168|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
20451169|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
20451170|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451171|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451172|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
20451173|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
20451174|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451175|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451176|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451177|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
20451178|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451179|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
20451180|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
20451181|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
20451182|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451183|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451184|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
20451185|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451186|NCT03768440|Ropivacaine|ropivacaine|mesh-list
20451187|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
20451188|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
20451189|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451190|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451191|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
20451192|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451193|NCT03758170|Dexamethasone|dexamethasone|mesh-list
20451194|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451195|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
20451196|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
20451197|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451198|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451199|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451200|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
20451201|NCT03758170|Hormones|hormones|mesh-ancestor
20451202|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451203|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451204|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451205|NCT03754049|Dexamethasone|dexamethasone|mesh-list
20451206|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
20451207|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19406898|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406899|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406900|NCT03577626|Hemay005|hemay005|mesh-list
19406901|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
20451208|NCT03754049|BB 1101|bb 1101|mesh-list
20451209|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406902|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19416554|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694197|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19694198|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694199|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20220967|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
20220968|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220969|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20220970|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20220971|NCT00323206|Growth Substances|growth substances|mesh-ancestor
20220972|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
20220973|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220974|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
20220975|NCT00323219|Cefazolin|cefazolin|mesh-list
20220976|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20220977|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20220978|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20220979|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19694200|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19694201|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451210|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
20451211|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
20451212|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451213|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451214|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451215|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
20451216|NCT03754049|Hormones|hormones|mesh-ancestor
20451217|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451218|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451219|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451220|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
20451221|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451222|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451223|NCT03749109|Quinagolide|quinagolide|mesh-list
20451224|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
20451225|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
20451226|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451227|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451228|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451229|NCT03733119|TIC10 compound|tic10 compound|mesh-list
20451230|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451231|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20451232|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20451233|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451234|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
20525741|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20525742|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20525743|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
20525744|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525745|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20525746|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20525747|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20525748|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20525749|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20525750|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
20525751|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20525752|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
20525753|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20525754|NCT01759940|Ropivacaine|ropivacaine|mesh-list
20525755|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
20525756|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
20525757|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525758|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525759|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
20525760|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525761|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20525762|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
20525763|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525764|NCT01760018|Desflurane|desflurane|mesh-list
20525765|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20525766|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
20525767|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
20525768|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525769|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525770|NCT01760096|Cyclosporine|cyclosporine|mesh-list
20525771|NCT01760096|Levamisole|levamisole|mesh-list
20525772|NCT01760096|Cyclosporins|cyclosporins|mesh-list
20525773|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
20525774|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525775|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525776|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525777|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
20525778|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525779|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
20525780|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525781|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
20525782|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525783|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20525784|NCT01760096|Hormones|hormones|mesh-ancestor
20525785|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406903|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20525786|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20525787|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
20451235|NCT03705962|Tobramycin|tobramycin|mesh-list
20451236|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20451237|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451238|NCT03705338|Propofol|propofol|mesh-list
20451239|NCT03705338|Anesthetics|anesthetics|mesh-list
20451240|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
20451241|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20451242|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451243|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451244|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20451245|NCT03704285|Propofol|propofol|mesh-list
20451246|NCT03704285|Anesthetics|anesthetics|mesh-list
20451247|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
20451248|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20451249|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451250|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451251|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20451252|NCT03702179|Durvalumab|durvalumab|mesh-list
20451253|NCT03702179|Tremelimumab|tremelimumab|mesh-list
20451254|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451255|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451256|NCT03696537|Fludarabine|fludarabine|mesh-list
20451257|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451258|NCT03695380|Atezolizumab|atezolizumab|mesh-list
20451259|NCT03695380|Niraparib|niraparib|mesh-list
20451260|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451261|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20451262|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451263|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451264|NCT03669523|Denosumab|denosumab|mesh-list
20451265|NCT03669523|Nivolumab|nivolumab|mesh-list
20451266|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451267|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451268|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20451269|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451270|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20451271|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451272|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
20451273|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20451274|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451275|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451276|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451277|NCT03668951|Analgesics|analgesics|mesh-ancestor
20451278|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
20451279|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451280|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20451281|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20451282|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20451283|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
20451284|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451285|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451286|NCT03665207|Insulin|insulin|mesh-list
20451287|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20451288|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451289|NCT03663335|Tacrolimus|tacrolimus|mesh-list
20451290|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451291|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
20451292|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451293|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20451294|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451295|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451296|NCT03661996|Lidocaine|lidocaine|mesh-list
20451297|NCT03661996|Epinephrine|epinephrine|mesh-list
20451298|NCT03661996|Capsaicin|capsaicin|mesh-list
20451299|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
20451300|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
20451301|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451302|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451303|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
20451304|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451305|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20451306|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20451307|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20451308|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451309|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451310|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20451311|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20451312|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20451313|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451314|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20451315|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20451316|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
20451317|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20451318|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
20451319|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
20451320|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
20451321|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20451322|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
20451323|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
20451324|NCT03659799|Insulin|insulin|mesh-list
20451325|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20451326|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
20451327|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20451328|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451329|NCT03638999|Ketorolac|ketorolac|mesh-list
20451330|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20451331|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20451332|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451333|NCT03638999|Analgesics|analgesics|mesh-ancestor
20451334|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
20451335|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20220980|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20220981|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220982|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220983|NCT00323323|Prednisone|prednisone|mesh-list
20220984|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
20220985|NCT00323323|Doxorubicin|doxorubicin|mesh-list
20220986|NCT00323323|Vincristine|vincristine|mesh-list
20220987|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
20220988|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20220989|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
20220990|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20220991|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20220992|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20220993|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
20220994|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20220995|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20220996|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20220997|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20451336|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451337|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451338|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451339|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20451340|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451341|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451342|NCT03635021|Bevacizumab|bevacizumab|mesh-list
20451343|NCT03635021|Panitumumab|panitumumab|mesh-list
20451344|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451345|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451346|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20451347|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20451348|NCT03635021|Growth Substances|growth substances|mesh-ancestor
20451349|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451350|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
20451351|NCT03626922|Folic Acid|folic acid|mesh-list
20451352|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
20451353|NCT03626922|Hydroxocobalamin|hydroxocobalamin|mesh-list
20451354|NCT03626922|Dexamethasone|dexamethasone|mesh-list
20451355|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
20451356|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
20451357|NCT03626922|Pemetrexed|pemetrexed|mesh-list
20451358|NCT03626922|Vitamins|vitamins|mesh-ancestor
20451359|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
20451360|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451361|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451362|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
20220998|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20451363|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
20451364|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451365|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451366|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
20451367|NCT03626922|Hormones|hormones|mesh-ancestor
20451368|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451369|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451370|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451371|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451372|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451373|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451374|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20451375|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20451376|NCT03626922|Hematinics|hematinics|mesh-ancestor
20451377|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
20451378|NCT03625141|Atezolizumab|atezolizumab|mesh-list
20451379|NCT03625141|Vemurafenib|vemurafenib|mesh-list
20451380|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451381|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20451382|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451383|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451384|NCT03620942|Phenylephrine|phenylephrine|mesh-list
20451385|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
20451386|NCT03620942|Ephedrine|ephedrine|mesh-list
20451387|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20451388|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20451389|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
20451390|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
20451391|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451392|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451393|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
20451394|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
20451395|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
20451396|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20451397|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20451398|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20451399|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
20451400|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451401|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451402|NCT03620942|Protective Agents|protective agents|mesh-ancestor
20451403|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20451404|NCT03620903|Rituximab|rituximab|mesh-list
20451405|NCT03620903|Bortezomib|bortezomib|mesh-list
20451406|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451407|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451408|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
20451409|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451410|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451411|NCT03618550|Gemcitabine|gemcitabine|mesh-list
20451412|NCT03618550|Doxorubicin|doxorubicin|mesh-list
20451413|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20451414|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
20451415|NCT03618550|Vinorelbine|vinorelbine|mesh-list
20451416|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451417|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
20451418|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451419|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451420|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
20451421|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451422|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451423|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451424|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
20451425|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451426|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20451427|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20451428|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20451429|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451430|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20451431|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
20451432|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
20451433|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
20451434|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
20451435|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451436|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451437|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
20451438|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451439|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451440|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
20451441|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451442|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451443|NCT03593434|Xenon|xenon|mesh-list
20451444|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20451445|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
20451446|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
20451447|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451448|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451449|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
20451450|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451451|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451452|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
20451453|NCT03589339|Nivolumab|nivolumab|mesh-list
20451454|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451455|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451456|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20451457|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451458|NCT03584516|Prednisone|prednisone|mesh-list
20451459|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
20451460|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20451461|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20451462|NCT03584516|Prednisolone|prednisolone|mesh-list
20451463|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
20220999|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20221000|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221001|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451464|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20451465|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
20451466|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451467|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
20451468|NCT03584516|Hormones|hormones|mesh-ancestor
20451469|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451470|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451471|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451472|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451473|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
20451474|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
20451475|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451476|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451477|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20451478|NCT03584516|Protective Agents|protective agents|mesh-ancestor
20451479|NCT03580317|Carbamazepine|carbamazepine|mesh-list
20451480|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
20451481|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
20451482|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221002|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
20221003|NCT00323323|Hormones|hormones|mesh-ancestor
20221004|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221005|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19849111|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849112|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849113|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20221006|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20221007|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
20221008|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
20221009|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
20221010|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20221011|NCT00323375|Chloroquine|chloroquine|mesh-list
20221012|NCT00323375|Amebicides|amebicides|mesh-ancestor
20221013|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20221014|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20221015|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221016|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
20221017|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20221018|NCT00323505|Interferons|interferons|mesh-list
20221019|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
20221020|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
20221021|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221022|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
20221023|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451483|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849114|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19849115|NCT00700102|Growth Substances|growth substances|mesh-ancestor
19849116|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849117|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
19849118|NCT00700115|Ritonavir|ritonavir|mesh-list
20451484|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849119|NCT00700115|Lopinavir|lopinavir|mesh-list
20221024|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
20451485|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221025|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221026|NCT00323544|Tenofovir|tenofovir|mesh-list
20451486|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451487|NCT03580317|Analgesics|analgesics|mesh-ancestor
20451488|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
20451489|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451490|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20451491|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451492|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451493|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20451494|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20451495|NCT03579966|Amifampridine|amifampridine|mesh-list
20451496|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19406904|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406905|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406906|NCT03577574|Anesthetics|anesthetics|mesh-list
19406907|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849120|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
20451497|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451498|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451499|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20451500|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451501|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451502|NCT03563690|Celecoxib|celecoxib|mesh-list
20451503|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20451504|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451505|NCT03563690|Analgesics|analgesics|mesh-ancestor
20451506|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
20451507|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451508|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451509|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451510|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451511|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20451512|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20221027|NCT00323544|Lamivudine|lamivudine|mesh-list
20221028|NCT00323544|Zidovudine|zidovudine|mesh-list
20221029|NCT00323544|Emtricitabine|emtricitabine|mesh-list
20221030|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20221031|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
20221032|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221033|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20221034|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20221035|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221036|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221037|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20451513|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451514|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451515|NCT03555877|Letrozole|letrozole|mesh-list
20451516|NCT03555877|Fulvestrant|fulvestrant|mesh-list
20451517|NCT03555877|Anastrozole|anastrozole|mesh-list
20451518|NCT03555877|Exemestane|exemestane|mesh-list
20451519|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451520|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20451521|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20451522|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451523|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451524|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20451525|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
20451526|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451527|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451528|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451529|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20451530|NCT03527576|Dexamethasone|dexamethasone|mesh-list
20451531|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451532|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
20221038|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20221039|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
20221040|NCT00323583|Leucovorin|leucovorin|mesh-list
20221041|NCT00323583|Paclitaxel|paclitaxel|mesh-list
20221042|NCT00323583|Fluorouracil|fluorouracil|mesh-list
20221043|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
20221044|NCT00323583|Calcium|calcium|mesh-list
20221045|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20221046|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451533|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
20451534|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451535|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451536|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451537|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
20451538|NCT03527576|Hormones|hormones|mesh-ancestor
20451539|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451540|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451541|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451542|NCT03523585|Capecitabine|capecitabine|mesh-list
20451543|NCT03523585|Trastuzumab|trastuzumab|mesh-list
20451544|NCT03523585|Lapatinib|lapatinib|mesh-list
20451545|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451546|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
20451547|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451548|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451549|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451550|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20451551|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451552|NCT03522584|Durvalumab|durvalumab|mesh-list
20451553|NCT03522584|Ipilimumab|ipilimumab|mesh-list
20451554|NCT03522584|Tremelimumab|tremelimumab|mesh-list
20451555|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
20451556|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20451557|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
20451558|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451559|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451560|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
20451561|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451562|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20451563|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451564|NCT03517722|Ustekinumab|ustekinumab|mesh-list
20451565|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
20451566|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
20451567|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20451568|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20451569|NCT03511625|Prednisolone|prednisolone|mesh-list
20451570|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
20451571|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20451572|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
20451573|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20451574|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451575|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
20451576|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
20451577|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451578|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451579|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451580|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
20451581|NCT03511625|Hormones|hormones|mesh-ancestor
20451582|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451583|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20451584|NCT03511625|Protective Agents|protective agents|mesh-ancestor
20451585|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451586|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451587|NCT03489018|Vaccines|vaccines|mesh-list
20451588|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20451589|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
20451590|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525788|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
20525789|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20525790|NCT01760109|Piperacillin|piperacillin|mesh-list
20525791|NCT01760109|Sulbactam|sulbactam|mesh-list
20525792|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20525793|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525794|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20525795|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525796|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525797|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20525798|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
20525799|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525800|NCT01760148|Interferons|interferons|mesh-list
20525801|NCT01760148|Ribavirin|ribavirin|mesh-list
20525802|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
20525803|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
20525804|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525805|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
20525806|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451591|NCT03479476|Metformin|metformin|mesh-list
20451592|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20451593|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451594|NCT03478488|Gemcitabine|gemcitabine|mesh-list
20451595|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
20451596|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451597|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
20451598|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451599|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451600|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
20451601|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451602|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451603|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451604|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
20451605|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451606|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
20451607|NCT03467386|Tacrolimus|tacrolimus|mesh-list
20451608|NCT03467386|Lenograstim|lenograstim|mesh-list
20451609|NCT03467386|Sargramostim|sargramostim|mesh-list
20451610|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451611|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
20451612|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451613|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451614|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20451615|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
20451616|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451617|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451618|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20451619|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20451620|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20451621|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221047|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
20221048|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
20221049|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
20451622|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20451623|NCT03439254|Cathartics|cathartics|mesh-ancestor
20451624|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451625|NCT03439124|Cephalosporins|cephalosporins|mesh-list
20451626|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
20451627|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20451628|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20451629|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451630|NCT03436368|Anesthetics|anesthetics|mesh-list
20451631|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451632|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451633|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20451634|NCT03422536|Cetuximab|cetuximab|mesh-list
20451635|NCT03422536|Antibodies|antibodies|mesh-list
20451636|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
20451637|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20451638|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
20451639|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451640|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451641|NCT03410355|Cortisone|cortisone|mesh-list
20221050|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221051|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221052|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221053|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
20221054|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20221055|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221056|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
20221057|NCT00323583|Antidotes|antidotes|mesh-ancestor
20221058|NCT00323583|Protective Agents|protective agents|mesh-ancestor
20221059|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
20221060|NCT00323583|Vitamins|vitamins|mesh-ancestor
20221061|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
20221062|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20221063|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247221|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247222|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20247223|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247224|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247225|NCT00431379|Tenecteplase|tenecteplase|mesh-list
19406908|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247226|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20451642|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451643|NCT03406897|Vitamin D|vitamin d|mesh-list
20451644|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
20451645|NCT03406897|Vitamins|vitamins|mesh-ancestor
20451646|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
20451647|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451648|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20451649|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20451650|NCT03399617|Micronutrients|micronutrients|mesh-list
20451651|NCT03399617|Trace Elements|trace elements|mesh-list
20451652|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451653|NCT03399552|Avelumab|avelumab|mesh-list
20451654|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451655|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451656|NCT03393884|Paclitaxel|paclitaxel|mesh-list
20451657|NCT03393884|Carboplatin|carboplatin|mesh-list
20451658|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20451659|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451660|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
20451661|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
20451662|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
20451663|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451664|NCT03386162|Fulvestrant|fulvestrant|mesh-list
20451665|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451666|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451667|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20451668|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20451669|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
20451670|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451671|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451672|NCT03360214|Bupivacaine|bupivacaine|mesh-list
20451673|NCT03360214|Ropivacaine|ropivacaine|mesh-list
20451674|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
20451675|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
20451676|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451677|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451678|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
20451679|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451680|NCT03359239|Atezolizumab|atezolizumab|mesh-list
20451681|NCT03359239|Poly ICLC|poly iclc|mesh-list
20451682|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451683|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
20451684|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
20451685|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451686|NCT03352765|Rituximab|rituximab|mesh-list
20451687|NCT03352765|Melphalan|melphalan|mesh-list
20451688|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20451689|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451690|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451691|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
20451692|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451693|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451694|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20451695|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
20451696|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451697|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20451698|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451699|NCT03343054|Talazoparib|talazoparib|mesh-list
20451700|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20451701|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451702|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451703|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451704|NCT03335163|Topiramate|topiramate|mesh-list
20451705|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
20451706|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20451707|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451708|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
20451709|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451710|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20451711|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451712|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451713|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
20451714|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20451715|NCT03328676|Protective Agents|protective agents|mesh-ancestor
20451716|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849121|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20451717|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20451718|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20451719|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
20451720|NCT03317405|Tamoxifen|tamoxifen|mesh-list
20451721|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20451722|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
20451723|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451724|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451725|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451726|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406909|NCT03577496|Peppermint oil|peppermint oil|mesh-list
19406910|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
19406911|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
19406912|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406913|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406914|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20451727|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20451728|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20451729|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20451730|NCT03315039|Annamycin|annamycin|mesh-list
20451731|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20451732|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451733|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20451734|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
20451735|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20451736|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
20451737|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451738|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451739|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451740|NCT03291847|Buprenorphine|buprenorphine|mesh-list
20451741|NCT03291847|Methadone|methadone|mesh-list
20451742|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20451743|NCT03291847|Naloxone|naloxone|mesh-list
19694202|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694203|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
19694204|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694205|NCT04970108|Empagliflozin|empagliflozin|mesh-list
19694206|NCT04970108|Telmisartan|telmisartan|mesh-list
20451744|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20451745|NCT03291847|Narcotics|narcotics|mesh-ancestor
20451746|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221064|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20221065|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20221066|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20221067|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221068|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221069|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
20451747|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451748|NCT03291847|Analgesics|analgesics|mesh-ancestor
20451749|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
20451750|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451751|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20451752|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
20451753|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
20451754|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
20451755|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20451756|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451757|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451758|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451759|NCT03289325|Analgesics|analgesics|mesh-ancestor
20451760|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
20451761|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451762|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20451763|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19406915|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
19694207|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20221070|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221071|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20221072|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20221073|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
20221074|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20221075|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
20221076|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221077|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
20451764|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20451765|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
20451766|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451767|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451768|NCT03279289|Leucovorin|leucovorin|mesh-list
19694208|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19694209|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20221078|NCT00323778|Protective Agents|protective agents|mesh-ancestor
20221079|NCT00323791|Gemcitabine|gemcitabine|mesh-list
20221080|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
19694210|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694211|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19694212|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694213|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694214|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19694215|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19694216|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19694217|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451769|NCT03279289|Folic Acid|folic acid|mesh-list
20451770|NCT03279289|Fluorouracil|fluorouracil|mesh-list
20451771|NCT03279289|Irinotecan|irinotecan|mesh-list
20451772|NCT03279289|Aflibercept|aflibercept|mesh-list
20451773|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
20451774|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
20451775|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451776|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451777|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451778|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20451779|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
20451780|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221081|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20221082|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
20221083|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221084|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221085|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
20221086|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221087|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221088|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221089|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
20221090|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406916|NCT03577457|Oxytocin|oxytocin|mesh-list
19406917|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
19406918|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19406919|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406920|NCT03577392|Capecitabine|capecitabine|mesh-list
19406921|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
19406922|NCT03577392|Endostatins|endostatins|mesh-list
19406923|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406924|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
19694218|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694219|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694220|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221091|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20221092|NCT00323804|Ribavirin|ribavirin|mesh-list
20221093|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20221094|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
20221095|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221096|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
20221097|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221098|NCT00323817|Z 338|z 338|mesh-list
20221099|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20221100|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221101|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221102|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
20221103|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221104|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221105|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221106|NCT00323830|Capecitabine|capecitabine|mesh-list
20451781|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20451782|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20451783|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451784|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20451785|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20451786|NCT03279289|Growth Substances|growth substances|mesh-ancestor
20451787|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
20451788|NCT03279289|Antidotes|antidotes|mesh-ancestor
20451789|NCT03279289|Protective Agents|protective agents|mesh-ancestor
20451790|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
20451791|NCT03279289|Vitamins|vitamins|mesh-ancestor
20451792|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
20451793|NCT03279289|Hematinics|hematinics|mesh-ancestor
20451794|NCT03276533|Lidocaine|lidocaine|mesh-list
20451795|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
20451796|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
20451797|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
20451798|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451799|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451800|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
20451801|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451802|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20451803|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20451804|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20451805|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451806|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451807|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20451808|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451809|NCT03276533|Analgesics|analgesics|mesh-ancestor
20451810|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20451811|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20451812|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20451813|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
20451814|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451815|NCT03262935|Capecitabine|capecitabine|mesh-list
20451816|NCT03262935|Trastuzumab|trastuzumab|mesh-list
20451817|NCT03262935|Vinorelbine|vinorelbine|mesh-list
20451818|NCT03262935|Lapatinib|lapatinib|mesh-list
20451819|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451820|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
20451821|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451822|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451823|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451824|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20451825|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
20451826|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
20451827|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
20451828|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20451829|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451830|NCT03254394|Lidocaine|lidocaine|mesh-list
20451831|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
20451832|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
20451833|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451834|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451835|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
20451836|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451837|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20451838|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20451839|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20451840|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451841|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525807|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
20525808|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525809|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
20525810|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525811|NCT01760161|Ropivacaine|ropivacaine|mesh-list
20525812|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
20525813|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
20525814|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525815|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525816|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
20525817|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525818|NCT01760174|Bupivacaine|bupivacaine|mesh-list
20525819|NCT01760174|Ropivacaine|ropivacaine|mesh-list
20525820|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
20525821|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
20525822|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525823|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525824|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
20525825|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406925|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406926|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406927|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19406928|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19406929|NCT03577392|Growth Substances|growth substances|mesh-ancestor
19406930|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406931|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
19406932|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
19406933|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19406934|NCT03577184|Metformin|metformin|mesh-list
19406935|NCT03577184|Vildagliptin|vildagliptin|mesh-list
19406936|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694221|NCT04970121|Analgesics|analgesics|mesh-ancestor
19694222|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
20451842|NCT03215940|Dronabinol|dronabinol|mesh-list
20451843|NCT03215940|Cannabidiol|cannabidiol|mesh-list
20451844|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
20451845|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
20451846|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451847|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20451848|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20451849|NCT03215940|Analgesics|analgesics|mesh-ancestor
20451850|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
20451851|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451852|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20451853|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20451854|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451855|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451856|NCT03215940|Hormones|hormones|mesh-ancestor
20451857|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451858|NCT03209687|Menotropins|menotropins|mesh-list
20451859|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20451860|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
20451861|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20451862|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451863|NCT03203876|Nivolumab|nivolumab|mesh-list
20451864|NCT03203876|Ipilimumab|ipilimumab|mesh-list
20451865|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451866|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451867|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20451868|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451869|NCT03191240|Vasopressins|vasopressins|mesh-list
20451870|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
20451871|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
20451872|NCT03191240|Coagulants|coagulants|mesh-ancestor
20451873|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20451874|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20451875|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
20451876|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451877|NCT03180294|Bupropion|bupropion|mesh-list
20451878|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20451879|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
20451880|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20451881|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20451882|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20451883|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20451884|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451885|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
20451886|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451887|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451888|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20451889|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20451890|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451891|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
20451892|NCT03179930|Entinostat|entinostat|mesh-list
20451893|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451894|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451895|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19694223|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694224|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
19694225|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20451896|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525826|NCT01760226|Prednisone|prednisone|mesh-list
19406937|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406938|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20451897|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451898|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
20451899|NCT03169881|Hematinics|hematinics|mesh-ancestor
20451900|NCT03151408|Azacitidine|azacitidine|mesh-list
20451901|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20451902|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
20451903|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451904|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451905|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451906|NCT03141671|Prednisone|prednisone|mesh-list
20451907|NCT03141671|Bicalutamide|bicalutamide|mesh-list
20451908|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20451909|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
20451910|NCT03141671|Hormones|hormones|mesh-ancestor
20451911|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20451912|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451913|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20451914|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451915|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
20451916|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
20451917|NCT03137173|Vancomycin|vancomycin|mesh-list
20451918|NCT03137173|Aztreonam|aztreonam|mesh-list
20451919|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
20451920|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20451921|NCT03137173|Cephalosporins|cephalosporins|mesh-list
20451922|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20451923|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20451924|NCT03129828|Bortezomib|bortezomib|mesh-list
20451925|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451926|NCT03110107|Nivolumab|nivolumab|mesh-list
20451927|NCT03110107|Ipilimumab|ipilimumab|mesh-list
20451928|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451929|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451930|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20451931|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451932|NCT03092011|Clonidine|clonidine|mesh-list
20451933|NCT03092011|Morphine|morphine|mesh-list
20451934|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20221107|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221108|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20221109|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
20451935|NCT03092011|Narcotics|narcotics|mesh-ancestor
20451936|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451937|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451938|NCT03092011|Analgesics|analgesics|mesh-ancestor
20451939|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
20451940|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451941|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19406939|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
19406940|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406941|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406942|NCT03577158|Insulin|insulin|mesh-list
19406943|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19406944|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406945|NCT03577132|Atezolizumab|atezolizumab|mesh-list
19406946|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221110|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451942|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
20451943|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
20451944|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20451945|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20451946|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20451947|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
20451948|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20451949|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406947|NCT03576963|Nivolumab|nivolumab|mesh-list
20221111|NCT00323843|Isoproterenol|isoproterenol|mesh-list
20221112|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20221113|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20221114|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
20221115|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221116|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221117|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221118|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20221119|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
20221120|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221121|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20221122|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
20221123|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20221124|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
20221125|NCT00323843|Protective Agents|protective agents|mesh-ancestor
20221126|NCT00323856|Factor VIII|factor viii|mesh-list
20221127|NCT00323856|Coagulants|coagulants|mesh-ancestor
20221128|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
20221129|NCT00323934|Mocetinostat|mocetinostat|mesh-list
20221130|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20451950|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20451951|NCT03091660|Vaccines|vaccines|mesh-list
20451952|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
20451953|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
20451954|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451955|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20451956|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
20451957|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20451958|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
20451959|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451960|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451961|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20451962|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
20451963|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20451964|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
20451965|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451966|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694226|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
19694227|NCT04970329|Dextrans|dextrans|mesh-list
19694228|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
20221131|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20451967|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20451968|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
20451969|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
20451970|NCT03081052|Protective Agents|protective agents|mesh-ancestor
20451971|NCT03080935|Evolocumab|evolocumab|mesh-list
20451972|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20451973|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20451974|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
20451975|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20451976|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20451977|NCT03078855|Vitamin D|vitamin d|mesh-list
20451978|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
20451979|NCT03078855|Rituximab|rituximab|mesh-list
20451980|NCT03078855|Vitamins|vitamins|mesh-ancestor
20451981|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
20451982|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451983|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20451984|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20451985|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
20451986|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20451987|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20451988|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20613863|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20613864|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
20221132|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221133|NCT00323947|Methylphenidate|methylphenidate|mesh-list
20221134|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20221135|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221136|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20221137|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20221138|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221139|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221140|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
20221141|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221142|NCT00323973|Bisoprolol|bisoprolol|mesh-list
20221143|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20221144|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
20221145|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
20221146|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221147|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221148|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20221149|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20221150|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20451989|NCT03071601|Lidocaine|lidocaine|mesh-list
20613865|NCT02256813|Coagulants|coagulants|mesh-ancestor
19694229|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
20221151|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
20221152|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221153|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221154|NCT00323986|Azithromycin|azithromycin|mesh-list
20221155|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20221156|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221157|NCT00324012|Docetaxel|docetaxel|mesh-list
20221158|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221159|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
20221160|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
20451990|NCT03071601|Epinephrine|epinephrine|mesh-list
20451991|NCT03071601|Prilocaine|prilocaine|mesh-list
20451992|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20451993|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
20451994|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
20451995|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20451996|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20451997|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
20451998|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20451999|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20452000|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20452001|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20452002|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20452003|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452004|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19406948|NCT03576963|Guadecitabine|guadecitabine|mesh-list
19406949|NCT03576963|Azacitidine|azacitidine|mesh-list
19406950|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19406951|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406952|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20221161|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
20221162|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221163|NCT00324025|Efungumab|efungumab|mesh-list
20221164|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
20221165|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221166|NCT00324051|Olanzapine|olanzapine|mesh-list
20221167|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
20221168|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
20221169|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221170|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221171|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221172|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20221173|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221174|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221175|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221176|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20221177|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20221178|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221179|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221180|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221181|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
20221182|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
20221183|NCT00324077|Dasatinib|dasatinib|mesh-list
20221184|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221185|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20221186|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221187|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221188|NCT00324129|Mocetinostat|mocetinostat|mesh-list
20221189|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20221190|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221191|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221192|NCT00324142|Tinidazole|tinidazole|mesh-list
20221193|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
20221194|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221195|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20221196|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221197|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20221198|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20221199|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20221200|NCT00324194|Mocetinostat|mocetinostat|mesh-list
20221201|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20221202|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221203|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221204|NCT00324298|Etoposide|etoposide|mesh-list
20221205|NCT00324298|Bleomycin|bleomycin|mesh-list
20221206|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221207|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20221208|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20221209|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20221210|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221211|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221212|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20221213|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
20221214|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20221215|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20221216|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221217|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20221218|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20221219|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221220|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221221|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221222|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20221223|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
20221224|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20221225|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221226|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20221227|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20221228|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20221229|NCT00324363|Exenatide|exenatide|mesh-list
20221230|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20221231|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221232|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20221233|NCT00324363|Incretins|incretins|mesh-ancestor
20221234|NCT00324363|Hormones|hormones|mesh-ancestor
20221235|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221236|NCT00324376|Sevelamer|sevelamer|mesh-list
20221237|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
20221238|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
20452005|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20452006|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
20452007|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20452008|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20452009|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20452010|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
20452011|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20452012|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
20452013|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
20452014|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
20452015|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20452016|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20452017|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
20452018|NCT03070327|Lenalidomide|lenalidomide|mesh-list
20221239|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221240|NCT00324389|Interferons|interferons|mesh-list
20221241|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
20221242|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221243|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
20221244|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221245|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
20221246|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221247|NCT00324454|Levetiracetam|levetiracetam|mesh-list
20221248|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
20221249|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
20221250|NCT00324467|Acetaminophen|acetaminophen|mesh-list
20221251|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
20221252|NCT00324467|Promethazine|promethazine|mesh-list
20452019|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452020|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
20452021|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452022|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452023|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452024|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
20452025|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452026|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452027|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20452028|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452029|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452030|NCT03070327|Growth Substances|growth substances|mesh-ancestor
20452031|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452032|NCT03069326|Thalidomide|thalidomide|mesh-list
20452033|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452034|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
20452035|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452036|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
20452037|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20452038|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452039|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452040|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452041|NCT03069326|Growth Substances|growth substances|mesh-ancestor
20452042|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452043|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452044|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20452045|NCT03061903|Laxatives|laxatives|mesh-ancestor
20452046|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20452047|NCT03061643|Docetaxel|docetaxel|mesh-list
20452048|NCT03061643|Androgens|androgens|mesh-list
20452049|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452050|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452051|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452052|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452053|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406953|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406954|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19406955|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
19406956|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406957|NCT03576911|Ubiquinone|ubiquinone|mesh-list
19406958|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
19406959|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
19406960|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406961|NCT03576911|Vitamins|vitamins|mesh-ancestor
19406962|NCT03576820|Lidocaine|lidocaine|mesh-list
19406963|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19406964|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
19406965|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
19406966|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19406967|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849122|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19849123|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19849124|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
19406968|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
19406969|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19406970|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19406971|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19406972|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19406973|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406974|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406975|NCT03576794|Prednisolone|prednisolone|mesh-list
19406976|NCT03576794|Leflunomide|leflunomide|mesh-list
19406977|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19406978|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
20452054|NCT03061643|Hormones|hormones|mesh-ancestor
20452055|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452056|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452057|NCT03061630|Gemcitabine|gemcitabine|mesh-list
20452058|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452059|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452060|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
20452061|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452062|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
20452063|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452064|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452065|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452066|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
20452067|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452068|NCT03055390|Scopolamine|scopolamine|mesh-list
20452069|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20452070|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20452071|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
20452072|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
20452073|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452074|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452075|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20452076|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
20452077|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19406979|NCT03576794|Hormones|hormones|mesh-ancestor
19694230|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
19694231|NCT04970238|Simendan|simendan|mesh-list
19694232|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19694233|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
20452078|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
20452079|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20452080|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452081|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20452082|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
20452083|NCT03038802|Vaccines|vaccines|mesh-list
20452084|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
20452085|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452086|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
20452087|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20613866|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
20613867|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
20613868|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20613869|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20613870|NCT02256826|Ritonavir|ritonavir|mesh-list
20613871|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613872|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613873|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613874|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613875|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613876|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613877|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613878|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
20613879|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613880|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613881|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613882|NCT02256878|Amitriptyline|amitriptyline|mesh-list
20613883|NCT02256878|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20613884|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19406980|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406981|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613885|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
20613886|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613887|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613888|NCT02256878|Analgesics|analgesics|mesh-ancestor
20613889|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
20613890|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613891|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613892|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20613893|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20613894|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19406982|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19406983|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19406984|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19406985|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19406986|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19406987|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
19406988|NCT03576755|Spironolactone|spironolactone|mesh-list
19406989|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19406990|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
19406991|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19406992|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19406993|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19406994|NCT03576755|Diuretics|diuretics|mesh-ancestor
19406995|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
19406996|NCT03576677|Simendan|simendan|mesh-list
19406997|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19406998|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
19406999|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19407000|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19694234|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19694235|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19694236|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694237|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694238|NCT04970238|Protective Agents|protective agents|mesh-ancestor
19694239|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694240|NCT04970342|Alprazolam|alprazolam|mesh-list
20452088|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452089|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20452090|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20452091|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
20452092|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452093|NCT03012672|Cytarabine|cytarabine|mesh-list
20452094|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
20452095|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
20452096|NCT03012672|Cladribine|cladribine|mesh-list
20452097|NCT03012672|Lenograstim|lenograstim|mesh-list
20452098|NCT03012672|Sargramostim|sargramostim|mesh-list
20452099|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452100|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
20452101|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452102|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452103|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
20452104|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452105|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452106|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
20452107|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452108|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20452109|NCT03012672|Analgesics|analgesics|mesh-ancestor
20452110|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
20452111|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452112|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20452113|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20452114|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452115|NCT03011775|Aspirin|aspirin|mesh-list
20452116|NCT03011775|Pioglitazone|pioglitazone|mesh-list
20452117|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20221253|NCT00324467|Dexamethasone|dexamethasone|mesh-list
20221254|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
20452118|NCT03011775|Ramipril|ramipril|mesh-list
20452119|NCT03011775|Bisoprolol|bisoprolol|mesh-list
20452120|NCT03011775|Isosorbide|isosorbide|mesh-list
20452121|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20452122|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20452123|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
20452124|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20452125|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20452126|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452127|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20452128|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20452129|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
20452130|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452131|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20452132|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20452133|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452134|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20452135|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20452136|NCT03011775|Analgesics|analgesics|mesh-ancestor
20452137|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
20452138|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452139|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452140|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694241|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694242|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694243|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694244|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694245|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19694246|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694247|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19694248|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19694249|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
20221255|NCT00324467|Prednisone|prednisone|mesh-list
20221256|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
20221257|NCT00324467|Ifosfamide|ifosfamide|mesh-list
20221258|NCT00324467|Rituximab|rituximab|mesh-list
20221259|NCT00324467|Carboplatin|carboplatin|mesh-list
20221260|NCT00324467|Doxorubicin|doxorubicin|mesh-list
20221261|NCT00324467|Etoposide|etoposide|mesh-list
20221262|NCT00324467|Vincristine|vincristine|mesh-list
20221263|NCT00324467|Ondansetron|ondansetron|mesh-list
20221264|NCT00324467|BB 1101|bb 1101|mesh-list
20452141|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20221265|NCT00324467|Mesna|mesna|mesh-list
20221266|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221267|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
20452142|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20221268|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452143|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20452144|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
20452145|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20452146|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
20452147|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20452148|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
20452149|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
20452150|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20452151|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20452152|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20452153|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
20452154|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20452155|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20452156|NCT03011775|Diuretics|diuretics|mesh-ancestor
20452157|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
20452158|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20452159|NCT02998047|Lintuzumab|lintuzumab|mesh-list
20452160|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452161|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452162|NCT02996110|Nivolumab|nivolumab|mesh-list
20452163|NCT02996110|Ipilimumab|ipilimumab|mesh-list
20452164|NCT02996110|Linrodostat|linrodostat|mesh-list
20452165|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452166|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452167|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20452168|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452169|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452170|NCT02970318|Rituximab|rituximab|mesh-list
20452171|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20452172|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
20452173|NCT02970318|Idelalisib|idelalisib|mesh-list
20452174|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452175|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452176|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
20452177|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452178|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452179|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452180|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
20452181|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452182|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452183|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
20452184|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452185|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452186|NCT02960997|Sirolimus|sirolimus|mesh-list
20452187|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20452188|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452189|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20452190|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221269|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20221270|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20221271|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
20221272|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221273|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221274|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20221275|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20221276|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20221277|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
20452191|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
20452192|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452193|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
20452194|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452195|NCT02949128|Ravulizumab|ravulizumab|mesh-list
20452196|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20452197|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452198|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
20452199|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407001|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407002|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407003|NCT03576677|Protective Agents|protective agents|mesh-ancestor
19407004|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407005|NCT03576664|Carvedilol|carvedilol|mesh-list
20452207|NCT02924480|Lidocaine|lidocaine|mesh-list
20452208|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
20452209|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
20452210|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20452211|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452212|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
20452213|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452214|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20452215|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20452216|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20452217|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20452218|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452219|NCT02924064|Metformin|metformin|mesh-list
20452220|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20452221|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452222|NCT02917993|Osimertinib|osimertinib|mesh-list
20452223|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452224|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452225|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452226|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452227|NCT02889900|Olaparib|olaparib|mesh-list
19694250|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
19694251|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
20452228|NCT02889900|Cediranib|cediranib|mesh-list
20452229|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20452230|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452231|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452232|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452233|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452234|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20452235|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20452236|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452237|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
20452238|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
20452239|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452240|NCT02879942|Growth Substances|growth substances|mesh-ancestor
20452241|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452242|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452243|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452244|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
20452245|NCT02873819|Sargramostim|sargramostim|mesh-list
20452246|NCT02873819|Poly ICLC|poly iclc|mesh-list
20452247|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407006|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19407007|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19407008|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
20221278|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
20221279|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221280|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221281|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
20221282|NCT00324467|Hormones|hormones|mesh-ancestor
20221283|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221284|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20221285|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
20221286|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221287|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20221288|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20221289|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20221290|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20221291|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
20221292|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
20221293|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
20221294|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20221295|NCT00324467|Analgesics|analgesics|mesh-ancestor
20221296|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
20221297|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
20221298|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
20221299|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
20452248|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
19407009|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221300|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20221301|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
20221302|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221303|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20221304|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20452249|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452250|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452251|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452252|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
20452253|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694252|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19694253|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
19694254|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20221305|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221306|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221307|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20221308|NCT00324467|Protective Agents|protective agents|mesh-ancestor
20221309|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20221310|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20221311|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
20221312|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
20221313|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20221314|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
20221315|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
20221316|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20221317|NCT00324480|Vorinostat|vorinostat|mesh-list
20221318|NCT00324480|Alvocidib|alvocidib|mesh-list
20221319|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221320|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20221321|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221322|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221323|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
20221324|NCT00324480|Growth Substances|growth substances|mesh-ancestor
20221325|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221326|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20221327|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
20452254|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452255|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20452256|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
20452257|NCT02872467|Oxytocin|oxytocin|mesh-list
20452258|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
20452259|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20452260|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525827|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
20525828|NCT01760226|Rituximab|rituximab|mesh-list
20525829|NCT01760226|Doxorubicin|doxorubicin|mesh-list
20525830|NCT01760226|Methotrexate|methotrexate|mesh-list
20525831|NCT01760226|Etoposide|etoposide|mesh-list
20525832|NCT01760226|Vincristine|vincristine|mesh-list
20525833|NCT01760226|Sargramostim|sargramostim|mesh-list
20525834|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525835|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
20525836|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525837|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525838|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20525839|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
20525840|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525841|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525842|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20525843|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20525844|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20525845|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20525846|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20525847|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525848|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20525849|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
20525850|NCT01760226|Hormones|hormones|mesh-ancestor
20525851|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525852|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20525853|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20525854|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
20525855|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20525856|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20525857|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
20613895|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694255|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
20452261|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
20452262|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20452263|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
20452264|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20452265|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452266|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20452267|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20452268|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20452269|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
20452270|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20452271|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
20452272|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20452273|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452274|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20452275|NCT02854436|Niraparib|niraparib|mesh-list
20452276|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20452277|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452278|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452279|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452280|NCT02810457|Paclitaxel|paclitaxel|mesh-list
20452281|NCT02810457|Bevacizumab|bevacizumab|mesh-list
20452282|NCT02810457|Carboplatin|carboplatin|mesh-list
20452283|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452284|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452285|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452286|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452287|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452288|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452289|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452290|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452291|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452292|NCT02810457|Growth Substances|growth substances|mesh-ancestor
20452293|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452294|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452295|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
19407010|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407011|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407012|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19407013|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
19407014|NCT03576664|Protective Agents|protective agents|mesh-ancestor
19407015|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19407016|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407017|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20452296|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452297|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452298|NCT02754856|Durvalumab|durvalumab|mesh-list
20452299|NCT02754856|Ipilimumab|ipilimumab|mesh-list
20452300|NCT02754856|Tremelimumab|tremelimumab|mesh-list
20452301|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
20452302|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20452303|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
20452304|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452305|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452306|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
20452307|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452308|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20452309|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452310|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
20452311|NCT02745535|Velpatasvir|velpatasvir|mesh-list
20452312|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
20452313|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452314|NCT02740699|Atorvastatin|atorvastatin|mesh-list
20452315|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20452316|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20452317|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20452318|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
20452319|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452320|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20452321|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20452322|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452323|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
20452324|NCT02729701|Estrogens|estrogens|mesh-list
20452325|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20452326|NCT02729701|Hormones|hormones|mesh-ancestor
20525858|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
20221328|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19849125|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221329|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221330|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20221331|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
20221332|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20221333|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221334|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221335|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221336|NCT00324519|Misoprostol|misoprostol|mesh-list
20221337|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20221338|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
20221339|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20221340|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221341|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20221342|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221343|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
20221344|NCT00324558|Bemiparin|bemiparin|mesh-list
20221345|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
20221346|NCT00324571|Calcium|calcium|mesh-list
20221347|NCT00324571|Sevelamer|sevelamer|mesh-list
20221348|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221349|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221350|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
20221351|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
20221352|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221353|NCT00324597|Gemcitabine|gemcitabine|mesh-list
20221354|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
20221355|NCT00324597|Imetelstat|imetelstat|mesh-list
20221356|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20221357|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
20221358|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221359|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221360|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
20221361|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221362|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221363|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221364|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
20221365|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221366|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20221367|NCT00324610|Capecitabine|capecitabine|mesh-list
20221368|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20221369|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
20221370|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221371|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221372|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
20221373|NCT00324623|Fludarabine|fludarabine|mesh-list
19849126|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849127|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19849128|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
19849129|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849130|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19849131|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19849132|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19849133|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19849134|NCT00700180|Bevacizumab|bevacizumab|mesh-list
19849135|NCT00700180|Carboplatin|carboplatin|mesh-list
19849136|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849137|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849138|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20221374|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
20221375|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221376|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
20221377|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221378|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20221379|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452327|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452328|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452329|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20452330|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20452331|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
20452332|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20221380|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
20247227|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20452333|NCT02723331|Gemcitabine|gemcitabine|mesh-list
20452334|NCT02723331|Paclitaxel|paclitaxel|mesh-list
20452335|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20452336|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452337|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452338|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452339|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452340|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452341|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452342|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452343|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
20452344|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
20452345|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452346|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452347|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452348|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
20452349|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452350|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
20452351|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
20452352|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452353|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
20452354|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
20452355|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452356|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452357|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221381|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407018|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
19407019|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19407020|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19407021|NCT03576651|Bevacizumab|bevacizumab|mesh-list
19407022|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407023|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407024|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19407025|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19407026|NCT03576651|Growth Substances|growth substances|mesh-ancestor
19694256|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221382|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221383|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20221384|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20221385|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
20221386|NCT00324688|Tenofovir|tenofovir|mesh-list
20221387|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
20221388|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221389|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20221390|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20221391|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221392|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221393|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20221394|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20221395|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
20221396|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20221397|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221398|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221399|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20452358|NCT02719314|Hormones|hormones|mesh-ancestor
20525859|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20525860|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20525861|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20525862|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
20525863|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
20525864|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
20525865|NCT01760252|Capecitabine|capecitabine|mesh-list
20525866|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
20525867|NCT01760252|Irinotecan|irinotecan|mesh-list
20525868|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20525869|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
20525870|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525871|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525872|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20525873|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20525874|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525875|NCT01760278|Cetrorelix|cetrorelix|mesh-list
20525876|NCT01760278|Hormones|hormones|mesh-list
20525877|NCT01760278|Progesterone|progesterone|mesh-list
20525878|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20221400|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221401|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20221402|NCT00324727|Melphalan|melphalan|mesh-list
20452359|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452360|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20452361|NCT02719314|Protective Agents|protective agents|mesh-ancestor
20452362|NCT02711826|Acetaminophen|acetaminophen|mesh-list
20452363|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
20452364|NCT02711826|Promethazine|promethazine|mesh-list
20452365|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
20452366|NCT02711826|Everolimus|everolimus|mesh-list
20452367|NCT02711826|Tacrolimus|tacrolimus|mesh-list
20452368|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452369|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
20452370|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452371|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19407027|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407028|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
19407029|NCT03576638|Levodopa|levodopa|mesh-list
19407030|NCT03576638|Carbidopa|carbidopa|mesh-list
19407031|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19407032|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19407033|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19407034|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
19407035|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407036|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407037|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407038|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19407039|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407040|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19407041|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
20221403|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452372|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452373|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452374|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20452375|NCT02711826|Analgesics|analgesics|mesh-ancestor
20452376|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
20452377|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452378|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
20452379|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452380|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20452381|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20452382|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
20452383|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20452384|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452385|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20452386|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20452387|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20452388|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
20452389|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
20452390|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
20452391|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
20452392|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20452393|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20452394|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
20452395|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
20452396|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20452397|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20452398|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
19407042|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
20221404|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
20221405|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221406|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221407|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20221408|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221409|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
20221410|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221411|NCT00324766|Simendan|simendan|mesh-list
20221412|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20221413|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
20452399|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
20452400|NCT02684253|Nivolumab|nivolumab|mesh-list
19407043|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
20452401|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452402|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452403|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20452404|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452405|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20452406|NCT02666794|Sufentanil|sufentanil|mesh-list
20452407|NCT02666794|Morphine|morphine|mesh-list
20452408|NCT02666794|Dsuvia|dsuvia|mesh-list
20452409|NCT02666794|Bupivacaine|bupivacaine|mesh-list
20452410|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
20452411|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
20452412|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20452413|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452414|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
20452415|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452416|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20452417|NCT02666794|Narcotics|narcotics|mesh-ancestor
20452418|NCT02666794|Analgesics|analgesics|mesh-ancestor
20452419|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20452420|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20452421|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
20452422|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
20452423|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
20452424|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452425|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452426|NCT02642094|Sirolimus|sirolimus|mesh-list
20452427|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20452428|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452429|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20452430|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452431|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
20452432|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452433|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
20452434|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452435|NCT02636569|Diclofenac|diclofenac|mesh-list
20452436|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20452437|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20452438|NCT02636569|Analgesics|analgesics|mesh-ancestor
20452439|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
20452440|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452441|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452442|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452443|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452444|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20452445|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452446|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452447|NCT02636322|Prednisone|prednisone|mesh-list
20452448|NCT02636322|Cortisone|cortisone|mesh-list
20613896|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
20221414|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20221415|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20221416|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221417|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221418|NCT00324766|Protective Agents|protective agents|mesh-ancestor
20221419|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221420|NCT00324779|Rituximab|rituximab|mesh-list
20221421|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20221422|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221423|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
20221424|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221425|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20221426|NCT00324792|Insulin|insulin|mesh-list
20221427|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20221428|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221429|NCT00324818|Azithromycin|azithromycin|mesh-list
20221430|NCT00324818|Metronidazole|metronidazole|mesh-list
20221431|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20221432|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221433|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20221434|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20221435|NCT00324831|Prednisone|prednisone|mesh-list
20221436|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
20221437|NCT00324831|Rituximab|rituximab|mesh-list
20221438|NCT00324831|Doxorubicin|doxorubicin|mesh-list
20221439|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20221440|NCT00324831|Vincristine|vincristine|mesh-list
20452449|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
20452450|NCT02636322|Rituximab|rituximab|mesh-list
20452451|NCT02636322|Doxorubicin|doxorubicin|mesh-list
20452452|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20452453|NCT02636322|Etoposide|etoposide|mesh-list
20452454|NCT02636322|Vincristine|vincristine|mesh-list
20452455|NCT02636322|Lenalidomide|lenalidomide|mesh-list
20452456|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
20452457|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
20452458|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20452459|NCT02636322|Antibodies|antibodies|mesh-list
20452460|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
20452461|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20452462|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452463|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
20452464|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452465|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452466|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452467|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
20452468|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407044|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19407045|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407046|NCT03576547|Dexamethasone|dexamethasone|mesh-list
19407047|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
19407048|NCT03576547|Rituximab|rituximab|mesh-list
19407049|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19407050|NCT03576547|Venetoclax|venetoclax|mesh-list
19407051|NCT03576547|Ponatinib|ponatinib|mesh-list
19407052|NCT03576547|Antibodies|antibodies|mesh-list
19407053|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
19407054|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19407055|NCT03576547|BB 1101|bb 1101|mesh-list
19407056|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
19407057|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407058|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407059|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407060|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407061|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
19407062|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
19407063|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407064|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407065|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
19407066|NCT03576547|Hormones|hormones|mesh-ancestor
19407067|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407068|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407069|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
19407070|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407071|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407072|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19407073|NCT03576508|Lidocaine|lidocaine|mesh-list
19407074|NCT03576508|Epinephrine|epinephrine|mesh-list
20452469|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452470|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20452471|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20452472|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20452473|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20452474|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452475|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452476|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
20452477|NCT02636322|Hormones|hormones|mesh-ancestor
20452478|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452479|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20452480|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452481|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452482|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452483|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452484|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452485|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452486|NCT02636322|Growth Substances|growth substances|mesh-ancestor
20452487|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452488|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
20452489|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
20452490|NCT02619552|Prednisone|prednisone|mesh-list
20452491|NCT02619552|Budesonide|budesonide|mesh-list
20452492|NCT02619552|Adalimumab|adalimumab|mesh-list
20452493|NCT02619552|Infliximab|infliximab|mesh-list
20452494|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
20452495|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452496|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
19407075|NCT03576508|Capsaicin|capsaicin|mesh-list
20452497|NCT02619552|Hormones|hormones|mesh-ancestor
20530543|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407076|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
19407077|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
19407078|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20452498|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452499|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452500|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20452501|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452502|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20452503|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
20452504|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452505|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20452506|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
20452507|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452508|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
20452509|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20452510|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452511|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
20452512|NCT02603328|Atorvastatin|atorvastatin|mesh-list
20452513|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20452514|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20221441|NCT00324831|Vaccines|vaccines|mesh-list
20221442|NCT00324831|Antibodies|antibodies|mesh-list
20221443|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
20221444|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20452515|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
20452516|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452517|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20452518|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20452519|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452520|NCT02578368|Leucovorin|leucovorin|mesh-list
20452521|NCT02578368|Docetaxel|docetaxel|mesh-list
20452522|NCT02578368|Fluorouracil|fluorouracil|mesh-list
20452523|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
20452524|NCT02578368|Trastuzumab|trastuzumab|mesh-list
20452525|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
20452526|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452527|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452528|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452529|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452530|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452531|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452532|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
20452533|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452534|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452535|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
19407079|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407080|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
19407081|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613897|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613898|NCT02256878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20613899|NCT02256878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20613900|NCT02256878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20613901|NCT02256943|Amitriptyline|amitriptyline|mesh-list
20613902|NCT02256943|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20613903|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20613904|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20613905|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19407082|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19407083|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19407084|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19407085|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407086|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221445|NCT00324831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20221446|NCT00324831|Sargramostim|sargramostim|mesh-list
19407087|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19407088|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19407089|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19407090|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407091|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19407092|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19407093|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
19407094|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20221447|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20221448|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
20221449|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221450|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221451|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452536|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452537|NCT02578368|Antidotes|antidotes|mesh-ancestor
20452538|NCT02578368|Protective Agents|protective agents|mesh-ancestor
20452539|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
20452540|NCT02578368|Vitamins|vitamins|mesh-ancestor
20452541|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
20452542|NCT02575963|Cytarabine|cytarabine|mesh-list
20452543|NCT02575963|Lintuzumab|lintuzumab|mesh-list
20452544|NCT02575963|Furosemide|furosemide|mesh-list
20452545|NCT02575963|Spironolactone|spironolactone|mesh-list
20452546|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452547|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
20452548|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452549|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452550|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
20452551|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452552|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452553|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
20452554|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452555|NCT02575963|Diuretics|diuretics|mesh-ancestor
20452556|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
20452557|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20452558|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20452559|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20452560|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
20452561|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452562|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20452563|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452564|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20452565|NCT02568553|Lenalidomide|lenalidomide|mesh-list
20452566|NCT02568553|Blinatumomab|blinatumomab|mesh-list
20452567|NCT02568553|Antibodies|antibodies|mesh-list
20452568|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
20452569|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20452570|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
19849139|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19849140|NCT00700180|Growth Substances|growth substances|mesh-ancestor
20221452|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452571|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20452572|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
20452573|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452574|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452575|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452576|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452577|NCT02568553|Growth Substances|growth substances|mesh-ancestor
20452578|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452579|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452580|NCT02551991|Leucovorin|leucovorin|mesh-list
20452581|NCT02551991|Fluorouracil|fluorouracil|mesh-list
20452582|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
20452583|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
20452584|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452585|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20221453|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
20221454|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221455|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221456|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20221457|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20221458|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20221459|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20221460|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20221461|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221462|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20221463|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
20221464|NCT00324831|Hormones|hormones|mesh-ancestor
20221465|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221466|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20221467|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20221468|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452586|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452587|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452588|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
20452589|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452590|NCT02551991|Antidotes|antidotes|mesh-ancestor
20221469|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452591|NCT02551991|Protective Agents|protective agents|mesh-ancestor
20452592|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
20452593|NCT02551991|Vitamins|vitamins|mesh-ancestor
20452594|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
20452595|NCT02539225|Paclitaxel|paclitaxel|mesh-list
20452596|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
20452597|NCT02539225|Ramucirumab|ramucirumab|mesh-list
20452598|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452599|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452600|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452601|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452602|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452603|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452604|NCT02535650|Tipifarnib|tipifarnib|mesh-list
20452605|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452606|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
20452607|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20452608|NCT02527681|Cephalosporins|cephalosporins|mesh-list
20452609|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20452610|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452611|NCT02526017|Nivolumab|nivolumab|mesh-list
20452612|NCT02526017|Sargramostim|sargramostim|mesh-list
20452613|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452614|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452615|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20452616|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452617|NCT02526017|Immunologic Factors|immunologic factors|mesh-ancestor
20452618|NCT02526017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452619|NCT02520362|Denosumab|denosumab|mesh-list
20452620|NCT02520362|Diphosphonates|diphosphonates|mesh-list
20452621|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20452622|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452623|NCT02516657|Liraglutide|liraglutide|mesh-list
20452624|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20452625|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452626|NCT02516657|Incretins|incretins|mesh-ancestor
20452627|NCT02516657|Hormones|hormones|mesh-ancestor
20452628|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452629|NCT02500849|Busulfan|busulfan|mesh-list
20452630|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
20452631|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452632|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452633|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
20452634|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452635|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452636|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452637|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20221470|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
20221471|NCT00324922|Vancomycin|vancomycin|mesh-list
20221472|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20221473|NCT00324922|Trimethoprim|trimethoprim|mesh-list
20221474|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
20221475|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20221476|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221477|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20221478|NCT00324922|Renal Agents|renal agents|mesh-ancestor
20221479|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
20221480|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20221481|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20221482|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20221483|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221484|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221485|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20221486|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20221487|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20221488|NCT00324948|Alprostadil|alprostadil|mesh-list
20452638|NCT02482233|Nicotine|nicotine|mesh-list
20452639|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20452640|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
20452641|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452642|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452643|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20452644|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20452645|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
20452646|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20452647|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452648|NCT02454855|Melatonin|melatonin|mesh-list
20452649|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
20452650|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452651|NCT02454855|Protective Agents|protective agents|mesh-ancestor
20452652|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452653|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20452654|NCT02450331|Atezolizumab|atezolizumab|mesh-list
20452655|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525879|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525880|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525881|NCT01760278|Progestins|progestins|mesh-ancestor
20525882|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20525883|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
20525884|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20525885|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
20525886|NCT01760330|Acetaminophen|acetaminophen|mesh-list
20525887|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20525888|NCT01760330|Analgesics|analgesics|mesh-ancestor
20525889|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
20525890|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525891|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525892|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
20525893|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
20525894|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
20525895|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20525896|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20525897|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525898|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525899|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525900|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525901|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
20525902|NCT01760460|Anacetrapib|anacetrapib|mesh-list
20525903|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20525904|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20525905|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
20525906|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525907|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20525908|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525909|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20525910|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407095|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
19407096|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
19407097|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
19407098|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19407099|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
19407100|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407101|NCT03576469|Complement C1s|complement c1s|mesh-list
19407102|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19407103|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19407104|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
19407105|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407106|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19407107|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407108|NCT03576456|Alprazolam|alprazolam|mesh-list
19407109|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19407110|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407111|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407112|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19407113|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407114|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19407115|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
20221489|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20221490|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
20221491|NCT00324948|Urological Agents|urological agents|mesh-ancestor
20221492|NCT00324974|Lansoprazole|lansoprazole|mesh-list
20221493|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
20221494|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20221495|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221496|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20221497|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407116|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
19407117|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407118|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407119|NCT03576378|Prednisone|prednisone|mesh-list
20613906|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
19407120|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
19407121|NCT03576378|Etoposide|etoposide|mesh-list
20525911|NCT01760564|Miglustat|miglustat|mesh-list
20525912|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452656|NCT02427620|Cytarabine|cytarabine|mesh-list
20452657|NCT02427620|Dexamethasone|dexamethasone|mesh-list
20452658|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
20452659|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
20452660|NCT02427620|Rituximab|rituximab|mesh-list
20452661|NCT02427620|Doxorubicin|doxorubicin|mesh-list
20452662|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20452663|NCT02427620|Methotrexate|methotrexate|mesh-list
20452664|NCT02427620|Vincristine|vincristine|mesh-list
20452665|NCT02427620|Daunorubicin|daunorubicin|mesh-list
20452666|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20452667|NCT02427620|Antibodies|antibodies|mesh-list
19407122|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
19407123|NCT03576378|Procarbazine|procarbazine|mesh-list
19407124|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407125|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
19407126|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452668|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
20452669|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20452670|NCT02427620|BB 1101|bb 1101|mesh-list
20452671|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452672|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
20452673|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452674|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452675|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452676|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
20452677|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452678|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452679|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20452680|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452681|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
20452682|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
20452683|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452684|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20452685|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
20452686|NCT02427620|Hormones|hormones|mesh-ancestor
20452687|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452688|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20221498|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221499|NCT00325000|Amitriptyline|amitriptyline|mesh-list
20221500|NCT00325000|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20221501|NCT00325000|Sertraline|sertraline|mesh-list
20221502|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
20221503|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221504|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20221505|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20452689|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
20452690|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452691|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20452692|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20452693|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20452694|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20452695|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
20452696|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20452697|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452698|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
20452699|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
20452700|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20452701|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20452702|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
20452703|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452704|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452705|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452706|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452707|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452708|NCT02427581|Poly I-C|poly i-c|mesh-list
20452709|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20452710|NCT02427581|Poly ICLC|poly iclc|mesh-list
20452711|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
20452712|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
20452713|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452714|NCT02427581|Laxatives|laxatives|mesh-ancestor
20452715|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407127|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452716|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
20452717|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452718|NCT02423525|Afatinib|afatinib|mesh-list
20452719|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407128|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407129|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
19407130|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407131|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407132|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19407133|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407134|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
20452720|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452721|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452722|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452723|NCT02369653|Apixaban|apixaban|mesh-list
20452724|NCT02369653|Anticoagulants|anticoagulants|mesh-list
20452725|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20452726|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
20452727|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20452728|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
20452729|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452730|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452731|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
19407135|NCT03576378|Hormones|hormones|mesh-ancestor
19407136|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407137|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407138|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19407139|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19407140|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19407141|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452732|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452733|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452734|NCT02326974|Pertuzumab|pertuzumab|mesh-list
20452735|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452736|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452737|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
20452738|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20452739|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20452740|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452741|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
20452742|NCT02314988|Coagulants|coagulants|mesh-ancestor
20452743|NCT02299999|Gemcitabine|gemcitabine|mesh-list
20452744|NCT02299999|Paclitaxel|paclitaxel|mesh-list
20452745|NCT02299999|Vincristine|vincristine|mesh-list
20452746|NCT02299999|Vinorelbine|vinorelbine|mesh-list
20452747|NCT02299999|Vinblastine|vinblastine|mesh-list
20452748|NCT02299999|Docetaxel|docetaxel|mesh-list
20452749|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
20452750|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
20452751|NCT02299999|Bevacizumab|bevacizumab|mesh-list
20452752|NCT02299999|Cisplatin|cisplatin|mesh-list
20452753|NCT02299999|Carboplatin|carboplatin|mesh-list
20452754|NCT02299999|Doxorubicin|doxorubicin|mesh-list
20452755|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20452756|NCT02299999|Capecitabine|capecitabine|mesh-list
20452757|NCT02299999|Methotrexate|methotrexate|mesh-list
20452758|NCT02299999|Durvalumab|durvalumab|mesh-list
20452759|NCT02299999|Epirubicin|epirubicin|mesh-list
20452760|NCT02299999|Olaparib|olaparib|mesh-list
20452761|NCT02299999|Mitomycins|mitomycins|mesh-list
20452762|NCT02299999|Mitomycin|mitomycin|mesh-list
20452763|NCT02299999|Bicalutamide|bicalutamide|mesh-list
20452764|NCT02299999|Taxane|taxane|mesh-list
20452765|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452766|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452767|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452768|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452769|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452770|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452771|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452772|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
20452773|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452774|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452775|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452776|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
20452777|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20452778|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452779|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452780|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452781|NCT02299999|Growth Substances|growth substances|mesh-ancestor
20452782|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452783|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452784|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
20452785|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
20452786|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452787|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452788|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20452789|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20452790|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20452791|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20452792|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
20452793|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20452794|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
20452795|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20452796|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20452797|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20452798|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
20452799|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
20452800|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452801|NCT02293109|Leucovorin|leucovorin|mesh-list
20452802|NCT02293109|Cytarabine|cytarabine|mesh-list
20452803|NCT02293109|Dexamethasone|dexamethasone|mesh-list
20452804|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
20452805|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20452806|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20452807|NCT02293109|Prednisolone|prednisolone|mesh-list
20452808|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
20452809|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
20452810|NCT02293109|Rituximab|rituximab|mesh-list
20452811|NCT02293109|Doxorubicin|doxorubicin|mesh-list
20452812|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20452813|NCT02293109|Methotrexate|methotrexate|mesh-list
20452814|NCT02293109|Vincristine|vincristine|mesh-list
20452815|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20452816|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
20452817|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
20452818|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452819|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
20452820|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452821|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452822|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452823|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
19694257|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694258|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
19694259|NCT04970043|Pemetrexed|pemetrexed|mesh-list
19694260|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694261|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221506|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20452824|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452825|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452826|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20452827|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452828|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452829|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
20452830|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
20452831|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452832|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20452833|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
20452834|NCT02293109|Hormones|hormones|mesh-ancestor
20452835|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452836|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20452837|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20452838|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20452839|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20452840|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221507|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221508|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221509|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
20221510|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221511|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20221512|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20221513|NCT00325000|Analgesics|analgesics|mesh-ancestor
20221514|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
20221515|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221516|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20221517|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
20452841|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20452842|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
20452843|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20452844|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20452845|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
20452846|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
20452847|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20452848|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20452849|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
20221518|NCT00325000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20221519|NCT00325000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221520|NCT00325000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221521|NCT00325026|Misoprostol|misoprostol|mesh-list
20221522|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20452850|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452851|NCT02293109|Antidotes|antidotes|mesh-ancestor
20452852|NCT02293109|Protective Agents|protective agents|mesh-ancestor
20452853|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
20452854|NCT02293109|Vitamins|vitamins|mesh-ancestor
20452855|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
20452856|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452857|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452858|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452859|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452860|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20452861|NCT02270034|Crizotinib|crizotinib|mesh-list
20452862|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452863|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452864|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452865|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452866|NCT02195986|Estradiol|estradiol|mesh-list
20452867|NCT02195986|Estrogens|estrogens|mesh-ancestor
20452868|NCT02195986|Hormones|hormones|mesh-ancestor
20452869|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452870|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452871|NCT02183883|Afatinib|afatinib|mesh-list
20452872|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452873|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452874|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452875|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452876|NCT02158507|Lapatinib|lapatinib|mesh-list
20452877|NCT02158507|Veliparib|veliparib|mesh-list
20452878|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452879|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452880|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452881|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221523|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
20221524|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20221525|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221526|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20221527|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221528|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
20221529|NCT00325104|Calcium|calcium|mesh-list
20221530|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
20221531|NCT00325104|Hormones|hormones|mesh-list
20221532|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221533|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221534|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221535|NCT00325117|Vildagliptin|vildagliptin|mesh-list
20221536|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20221537|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221538|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20221539|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
20221540|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221541|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221542|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
20221543|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20221544|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20221545|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
20452882|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20452883|NCT01982630|Liraglutide|liraglutide|mesh-list
20613907|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221546|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221547|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452884|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20452885|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452886|NCT01982630|Incretins|incretins|mesh-ancestor
20452887|NCT01982630|Hormones|hormones|mesh-ancestor
20452888|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452889|NCT01982448|Paclitaxel|paclitaxel|mesh-list
20452890|NCT01982448|Cisplatin|cisplatin|mesh-list
20452891|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20452892|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452893|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
20452894|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
20452895|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
20452896|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452897|NCT01951469|Pemetrexed|pemetrexed|mesh-list
20452898|NCT01951469|Gefitinib|gefitinib|mesh-list
20452899|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452900|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452901|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452902|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20452903|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20452904|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452905|NCT01940809|Nivolumab|nivolumab|mesh-list
20452906|NCT01940809|Ipilimumab|ipilimumab|mesh-list
20452907|NCT01940809|Trametinib|trametinib|mesh-list
20452908|NCT01940809|Dabrafenib|dabrafenib|mesh-list
20452909|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452910|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452911|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20452912|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452913|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20452914|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452915|NCT01891747|Ascorbic Acid|ascorbic acid|mesh-list
20452916|NCT01891747|Bevacizumab|bevacizumab|mesh-list
20452917|NCT01891747|Temozolomide|temozolomide|mesh-list
20452918|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452919|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452920|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452921|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452922|NCT01891747|Growth Substances|growth substances|mesh-ancestor
20452923|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452924|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452925|NCT01891747|Vitamins|vitamins|mesh-ancestor
20452926|NCT01891747|Micronutrients|micronutrients|mesh-ancestor
20452927|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20452928|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
20452929|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452930|NCT01891747|Antioxidants|antioxidants|mesh-ancestor
20452931|NCT01891747|Protective Agents|protective agents|mesh-ancestor
20452932|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20452933|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20452934|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452935|NCT01879228|Incretins|incretins|mesh-ancestor
20452936|NCT01879228|Hormones|hormones|mesh-ancestor
19407142|NCT03576378|Analgesics|analgesics|mesh-ancestor
19407143|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
19407144|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407145|NCT03576287|Apremilast|apremilast|mesh-list
19407146|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19407147|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19407148|NCT03576287|Analgesics|analgesics|mesh-ancestor
19407149|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
19407150|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407151|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407152|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407153|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407154|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20452937|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452938|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20452939|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
20452940|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452941|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452942|NCT01829958|Prednisone|prednisone|mesh-list
20452943|NCT01829958|Rituximab|rituximab|mesh-list
20452944|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452945|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452946|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
20452947|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407155|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20452948|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452949|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452950|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
20452951|NCT01829958|Hormones|hormones|mesh-ancestor
20452952|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20452953|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20452954|NCT01805271|Everolimus|everolimus|mesh-list
20452955|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452956|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452957|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
20452958|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452959|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
20452960|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20452961|NCT01744093|Doxycycline|doxycycline|mesh-list
20452962|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20452963|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20452964|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
20452965|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20452966|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20452967|NCT01740297|Ipilimumab|ipilimumab|mesh-list
20452968|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20452969|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20452970|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452971|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20452972|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452973|NCT01729754|Etanercept|etanercept|mesh-list
20452974|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20452975|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20452976|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20452977|NCT01729754|Analgesics|analgesics|mesh-ancestor
20452978|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
20452979|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20452980|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452981|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20452982|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20452983|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20452984|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20452985|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
20452986|NCT01718743|Lenalidomide|lenalidomide|mesh-list
20452987|NCT01718743|Ixazomib|ixazomib|mesh-list
20452988|NCT01718743|Glycine|glycine|mesh-list
19694262|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694263|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19694264|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19694265|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
19694266|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19694267|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694268|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694269|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694270|NCT04969705|Analgesics|analgesics|mesh-ancestor
19694271|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
20452989|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
20452990|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20452991|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20452992|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20452993|NCT01718743|Growth Substances|growth substances|mesh-ancestor
20452994|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
20452995|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20452996|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20452997|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
20452998|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20452999|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
20453000|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453001|NCT01668784|Nivolumab|nivolumab|mesh-list
20453002|NCT01668784|Everolimus|everolimus|mesh-list
20453003|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20453004|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453005|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20453006|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453007|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20453008|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
20453009|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453010|NCT01622998|Nicotine|nicotine|mesh-list
20453011|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20453012|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
20221548|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20221549|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
20221550|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
20221551|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20221552|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
20221553|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221554|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221555|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
20221556|NCT00325169|Hormones|hormones|mesh-ancestor
20453013|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453014|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453015|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20453016|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20453017|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
20453018|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453019|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453020|NCT01595620|Dronabinol|dronabinol|mesh-list
20453021|NCT01595620|Capsaicin|capsaicin|mesh-list
20453022|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
20453023|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453024|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453025|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694272|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694273|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19694274|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19694275|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19694276|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
19694277|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694278|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694279|NCT04969263|Vaccines|vaccines|mesh-list
19694280|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
19694281|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453026|NCT01595620|Analgesics|analgesics|mesh-ancestor
20453027|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
20453028|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453029|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20453030|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20453031|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453032|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453033|NCT01595620|Hormones|hormones|mesh-ancestor
20453034|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453035|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
20453036|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
20453037|NCT01591629|Dronabinol|dronabinol|mesh-list
20453038|NCT01591629|Naloxone|naloxone|mesh-list
20453039|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20453040|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453041|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
20453042|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453043|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
20453044|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453045|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20453046|NCT01591629|Analgesics|analgesics|mesh-ancestor
20453047|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20453048|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20453049|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453050|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453051|NCT01591629|Hormones|hormones|mesh-ancestor
19407156|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407157|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407158|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
19407159|NCT03576105|Methylene Blue|methylene blue|mesh-list
19407160|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407161|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407162|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407163|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
19407164|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407165|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
19407166|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
19407167|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407168|NCT03576053|Lidocaine|lidocaine|mesh-list
19407169|NCT03576053|Serotonin|serotonin|mesh-list
19407170|NCT03576053|Histamine|histamine|mesh-list
19407171|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
19407172|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
20453052|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453053|NCT01564537|Dexamethasone|dexamethasone|mesh-list
20453054|NCT01564537|Lenalidomide|lenalidomide|mesh-list
20453055|NCT01564537|Ixazomib|ixazomib|mesh-list
20453056|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453057|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
20453058|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
20453059|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453060|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453061|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453062|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
20453063|NCT01564537|Hormones|hormones|mesh-ancestor
20453064|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407173|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407174|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407175|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
19407176|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407177|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19407178|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19407179|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19407180|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407181|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407182|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19407183|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
19407184|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407185|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
19407186|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
19407187|NCT03576040|Edotreotide|edotreotide|mesh-list
19407188|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19407189|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407190|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
19407191|NCT03576001|Testosterone|testosterone|mesh-list
20221557|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221558|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
20221559|NCT00325182|Levetiracetam|levetiracetam|mesh-list
20221560|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
20221561|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
20221562|NCT00325286|Carbamazepine|carbamazepine|mesh-list
20221563|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221564|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221565|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
20221566|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221567|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221568|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221569|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
20221570|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20221571|NCT00325286|Analgesics|analgesics|mesh-ancestor
20221572|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
20221573|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221574|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20221575|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221576|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20221577|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20221578|NCT00325325|Everolimus|everolimus|mesh-list
20221579|NCT00325325|Tacrolimus|tacrolimus|mesh-list
20221580|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221581|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
20221582|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453065|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20613908|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407192|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
19407193|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
19407194|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20613909|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613910|NCT02256943|Urological Agents|urological agents|mesh-ancestor
20613911|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20613912|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
20613913|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613914|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613915|NCT02256943|Analgesics|analgesics|mesh-ancestor
20613916|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
20613917|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613918|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20453066|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453067|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
20453068|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20453069|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20453070|NCT01564537|Growth Substances|growth substances|mesh-ancestor
20453071|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
20453072|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
20453073|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453074|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453075|NCT01538966|Octreotide|octreotide|mesh-list
20453076|NCT01538966|Lanreotide|lanreotide|mesh-list
20453077|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453078|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453079|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453080|NCT01525069|Gemcitabine|gemcitabine|mesh-list
20453081|NCT01525069|Dexamethasone|dexamethasone|mesh-list
20453082|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
20453083|NCT01525069|Floxuridine|floxuridine|mesh-list
20453084|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453085|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
20453086|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
20453087|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453088|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453089|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453090|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
20453091|NCT01525069|Hormones|hormones|mesh-ancestor
20453092|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453093|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453094|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453095|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453096|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
20453097|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453098|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
20453099|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453100|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453101|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20453102|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
20453103|NCT01515306|Paclitaxel|paclitaxel|mesh-list
20453104|NCT01515306|Ramucirumab|ramucirumab|mesh-list
20453105|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20453106|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453107|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
20453108|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
20453109|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
20453110|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453111|NCT01513187|Interferons|interferons|mesh-list
20453112|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
20453113|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
20453114|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453115|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
20453116|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453117|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
20453118|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453119|NCT01464268|Riboflavin|riboflavin|mesh-list
20453120|NCT01464268|Dextrans|dextrans|mesh-list
20453121|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
20453122|NCT01464268|Vitamins|vitamins|mesh-ancestor
20453123|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
20453124|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453125|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20453126|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
20453127|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
20453128|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
20221583|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20221584|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221585|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221586|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221587|NCT00325351|Carboplatin|carboplatin|mesh-list
20221588|NCT00325351|Sagopilone|sagopilone|mesh-list
20221589|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221590|NCT00325390|Clopidogrel|clopidogrel|mesh-list
20221591|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20221592|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20221593|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20221594|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20221595|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
20453129|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
20453130|NCT01433965|Lenalidomide|lenalidomide|mesh-list
20453131|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
20453132|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453133|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20453134|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20453135|NCT01433965|Growth Substances|growth substances|mesh-ancestor
20453136|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
20453137|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525913|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525914|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20525915|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20525916|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
20525917|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525918|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20525919|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20525920|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525921|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
20525922|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20525923|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20525924|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
20525925|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20525926|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20525927|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525928|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
20525929|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525930|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525931|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20525932|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20525933|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20525934|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
20525935|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
20525936|NCT01760577|Protective Agents|protective agents|mesh-ancestor
20530544|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530545|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530546|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
20530547|NCT01789242|Hormones|hormones|mesh-ancestor
19694282|NCT04969211|Iloperidone|iloperidone|mesh-list
19694283|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19694284|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19694285|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694286|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694287|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694288|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
19694289|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20530548|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530549|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20530550|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530551|NCT01789294|Mesalamine|mesalamine|mesh-list
20530552|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20530553|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530554|NCT01789294|Analgesics|analgesics|mesh-ancestor
20530555|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
19694290|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19694291|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
19694292|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694293|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694294|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694295|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
19694296|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
19694297|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
19694298|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694299|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694300|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
19694301|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694302|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
19694303|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19694304|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19694305|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694306|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694307|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
19694308|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694309|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530556|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453138|NCT01360593|Gemcitabine|gemcitabine|mesh-list
20453139|NCT01360593|Capecitabine|capecitabine|mesh-list
20453140|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453141|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
19849141|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849142|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
19849143|NCT00700271|Amlodipine|amlodipine|mesh-list
19849144|NCT00700271|Valsartan|valsartan|mesh-list
19849145|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19849146|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19849147|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849148|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453142|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453143|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453144|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
20453145|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453146|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453147|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20453148|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
20453149|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453150|NCT01354977|Resveratrol|resveratrol|mesh-list
20453151|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
20453152|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453153|NCT01354977|Protective Agents|protective agents|mesh-ancestor
20453154|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453155|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221596|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221597|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221598|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221599|NCT00325429|Vildagliptin|vildagliptin|mesh-list
20221600|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20221601|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221602|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20221603|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
20221604|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221605|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453156|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20453157|NCT01334606|Insulin|insulin|mesh-list
20453158|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453159|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453160|NCT01233297|Azithromycin|azithromycin|mesh-list
20453161|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20453162|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453163|NCT01226732|Capecitabine|capecitabine|mesh-list
20453164|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453165|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
20453166|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453167|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453168|NCT01216683|Rituximab|rituximab|mesh-list
20453169|NCT01216683|Lenalidomide|lenalidomide|mesh-list
20453170|NCT01216683|Bortezomib|bortezomib|mesh-list
20453171|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20453172|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20453173|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453174|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
20453175|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453176|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20453177|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20453178|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19694310|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
19694311|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
19694312|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19694313|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694314|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694315|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694316|NCT04968392|Analgesics|analgesics|mesh-ancestor
19694317|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
19694318|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694319|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19694320|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19694321|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19694322|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
20453179|NCT01216683|Growth Substances|growth substances|mesh-ancestor
20453180|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
20525937|NCT01760642|Rifampin|rifampin|mesh-list
19694323|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694324|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694325|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19694326|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
19694327|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19694328|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19694329|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19694330|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
19694331|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694332|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694333|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19694334|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
19694335|NCT04968132|Narcotics|narcotics|mesh-ancestor
19694336|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694337|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694338|NCT04968132|Analgesics|analgesics|mesh-ancestor
19694339|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
19694340|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707735|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707736|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19707737|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707738|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707739|NCT04824404|Buprenorphine|buprenorphine|mesh-list
19707740|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19707741|NCT04824404|Narcotics|narcotics|mesh-ancestor
19707742|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707743|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707744|NCT04824404|Analgesics|analgesics|mesh-ancestor
19707745|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
19707746|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707747|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19707748|NCT04824261|Clotrimazole|clotrimazole|mesh-list
19707749|NCT04824261|Miconazole|miconazole|mesh-list
19707750|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19707751|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707752|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
19707753|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19707754|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19707755|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707756|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221606|NCT00325455|Anacetrapib|anacetrapib|mesh-list
20221607|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20221608|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20221609|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
20221610|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221611|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247228|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247229|NCT00431392|Atropine|atropine|mesh-list
20247230|NCT00431392|Propranolol|propranolol|mesh-list
20247231|NCT00431392|Phenylephrine|phenylephrine|mesh-list
20247232|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
20247233|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20247234|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20247235|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
20247236|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
20247237|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247238|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247239|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
20247240|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20247241|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
20247242|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
20247243|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20247244|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20247245|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20247246|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
20247247|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247248|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247249|NCT00431392|Protective Agents|protective agents|mesh-ancestor
20247250|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20247251|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20247252|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20247253|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20247254|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
20247255|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20247256|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20221612|NCT00325546|Rimonabant|rimonabant|mesh-list
20221613|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20221614|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20221615|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20221616|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221617|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221618|NCT00325546|Hormones|hormones|mesh-ancestor
20221619|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221620|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221621|NCT00325637|Losartan|losartan|mesh-list
20221622|NCT00325637|Cilnidipine|cilnidipine|mesh-list
20221623|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20221624|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20221625|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20221626|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20221627|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453181|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20453182|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
20453183|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453184|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
20453185|NCT01162109|Astringents|astringents|mesh-ancestor
20453186|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453187|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
20453188|NCT01152541|Riboflavin|riboflavin|mesh-list
20453189|NCT01152541|Dextrans|dextrans|mesh-list
20453190|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20453191|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
20453192|NCT01152541|Vitamins|vitamins|mesh-ancestor
20453193|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
20453194|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453195|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20453196|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
20453197|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
20453198|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
20453199|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
20453200|NCT01112072|Riboflavin|riboflavin|mesh-list
20453201|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
19849149|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19849150|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849151|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
19849152|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19849153|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19849154|NCT00700336|Cisplatin|cisplatin|mesh-list
19849155|NCT00700336|Pemetrexed|pemetrexed|mesh-list
19849156|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849157|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849158|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849159|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20453202|NCT01112072|Vitamins|vitamins|mesh-ancestor
20453203|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
20453204|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453205|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20453206|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
20453207|NCT01107717|Metformin|metformin|mesh-list
20453208|NCT01107717|Pioglitazone|pioglitazone|mesh-list
20453209|NCT01107717|Exenatide|exenatide|mesh-list
20453210|NCT01107717|Glyburide|glyburide|mesh-list
20453211|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453212|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453213|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20453214|NCT01107717|Incretins|incretins|mesh-ancestor
20453215|NCT01107717|Hormones|hormones|mesh-ancestor
20453216|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453217|NCT01104350|Gemcitabine|gemcitabine|mesh-list
20453218|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453219|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
20453220|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453221|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453222|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
20453223|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849160|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19849161|NCT00700401|Ribavirin|ribavirin|mesh-list
19849162|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20453224|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453225|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20453226|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
20453227|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453228|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
20453229|NCT01085097|Prednisone|prednisone|mesh-list
20453230|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
20453231|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20453232|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20453233|NCT01085097|Prednisolone|prednisolone|mesh-list
20453234|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
20453235|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20453236|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
20453237|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453238|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
20453239|NCT01085097|Hormones|hormones|mesh-ancestor
20453240|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453241|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453242|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453243|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453244|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20453245|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20453246|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
20453247|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20453248|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453249|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453250|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453251|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
20453252|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
20453253|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453254|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453255|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20453256|NCT01085097|Protective Agents|protective agents|mesh-ancestor
20453274|NCT00962988|Bupropion|bupropion|mesh-list
20453275|NCT00962988|Nicotine|nicotine|mesh-list
20453276|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19407195|NCT03576001|Androgens|androgens|mesh-ancestor
19407196|NCT03576001|Hormones|hormones|mesh-ancestor
19407197|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453277|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
20453278|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453279|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453280|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20453281|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20453282|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
20453283|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453284|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453285|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20453286|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
20453287|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453288|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20453289|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20453290|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20453291|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
20453292|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20453293|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20453294|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453295|NCT00920621|Vitamin D|vitamin d|mesh-list
19694341|NCT04968002|Apatinib|apatinib|mesh-list
20453296|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
20453297|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
20453298|NCT00920621|Vitamins|vitamins|mesh-list
20453299|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
20453300|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453301|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20453302|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20453303|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
20453304|NCT00916747|Pravastatin|pravastatin|mesh-list
20453305|NCT00916747|Lonafarnib|lonafarnib|mesh-list
20453306|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20453307|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453308|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20453309|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20453310|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
20453311|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453312|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20453313|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20453314|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453315|NCT00856947|Vitamin D|vitamin d|mesh-list
20453316|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
20453317|NCT00856947|Vitamins|vitamins|mesh-ancestor
20453318|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
20453319|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453320|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20453321|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20453322|NCT00785525|Lenograstim|lenograstim|mesh-list
20453323|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20453324|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
20453325|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453326|NCT00768820|Risperidone|risperidone|mesh-list
20453327|NCT00768820|Methylphenidate|methylphenidate|mesh-list
20453328|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20453329|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
20453330|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453331|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453332|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453333|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20453334|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20453335|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20453336|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453337|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20453338|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
20453339|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20453340|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20453341|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20453342|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20453343|NCT00682318|Ethanol|ethanol|mesh-list
20453344|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20453345|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453346|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20453347|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453348|NCT00680901|Capecitabine|capecitabine|mesh-list
20453349|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
20453350|NCT00680901|Lapatinib|lapatinib|mesh-list
20453351|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453352|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
20453353|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453354|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453355|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453356|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453357|NCT00678730|Dronabinol|dronabinol|mesh-list
20453358|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
20453359|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453360|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453361|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20453362|NCT00678730|Analgesics|analgesics|mesh-ancestor
20453363|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
20453364|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453365|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20453366|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19407198|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407199|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453367|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453368|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453369|NCT00678730|Hormones|hormones|mesh-ancestor
20221628|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20221629|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221630|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221631|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221632|NCT00325676|Pantoprazole|pantoprazole|mesh-list
20221633|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20221634|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221635|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20221636|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221637|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221638|NCT00325689|Risperidone|risperidone|mesh-list
20221639|NCT00325689|Aripiprazole|aripiprazole|mesh-list
20221640|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20221641|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20221642|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
20221643|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221644|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221645|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453370|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453371|NCT00667251|Paclitaxel|paclitaxel|mesh-list
20453372|NCT00667251|Docetaxel|docetaxel|mesh-list
20453373|NCT00667251|Trastuzumab|trastuzumab|mesh-list
20453374|NCT00667251|Lapatinib|lapatinib|mesh-list
20453375|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20453376|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453377|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
20453378|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
20453379|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
20453380|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453381|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20453382|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453383|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453384|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20453385|NCT00600015|Sorafenib|sorafenib|mesh-list
20453386|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453387|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453388|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453389|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453390|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20453391|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20453392|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453393|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20453394|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20453395|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20453396|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453397|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
20453398|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453399|NCT00447122|Gemcitabine|gemcitabine|mesh-list
20453400|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
20453401|NCT00447122|Lapatinib|lapatinib|mesh-list
20453402|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453403|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
20453404|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453405|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453406|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
20453407|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453408|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453409|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20453410|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
20453411|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453412|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453413|NCT00430040|Carvedilol|carvedilol|mesh-list
20453414|NCT00430040|Lisinopril|lisinopril|mesh-list
20453415|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20453416|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20453417|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
20453418|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453419|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453420|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453421|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20453422|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
20453423|NCT00430040|Protective Agents|protective agents|mesh-ancestor
19849163|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
20221646|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20453424|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20453425|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20453426|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20453427|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
20453428|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20453429|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20453430|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20453431|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
20453432|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453433|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20453434|NCT00324805|Gemcitabine|gemcitabine|mesh-list
20453435|NCT00324805|Bevacizumab|bevacizumab|mesh-list
20453436|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20453437|NCT00324805|Cisplatin|cisplatin|mesh-list
20453438|NCT00324805|Docetaxel|docetaxel|mesh-list
20453439|NCT00324805|Pemetrexed|pemetrexed|mesh-list
20453440|NCT00324805|Vinorelbine|vinorelbine|mesh-list
20453441|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
20453442|NCT00324805|Antibodies|antibodies|mesh-list
20453443|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
20453444|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20453445|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
20453446|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453447|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20453448|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20453449|NCT00324805|Growth Substances|growth substances|mesh-ancestor
20453450|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453451|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
20453452|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
20453453|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453454|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
20453455|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453456|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
20221647|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221648|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221649|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221650|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20221651|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
20453457|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453458|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453459|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20453460|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
20453461|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
20453462|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
20453463|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20453464|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20453465|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20453466|NCT00310180|Tamoxifen|tamoxifen|mesh-list
19407200|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407201|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
19849164|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453467|NCT00310180|Letrozole|letrozole|mesh-list
20453468|NCT00310180|Anastrozole|anastrozole|mesh-list
20453469|NCT00310180|Exemestane|exemestane|mesh-list
20453470|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453471|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453472|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20453473|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20453474|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453475|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20453476|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
20453477|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453478|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453479|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453480|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20453481|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20453482|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20453483|NCT00309985|Docetaxel|docetaxel|mesh-list
20453484|NCT00309985|Androgens|androgens|mesh-list
20453485|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453486|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
20221652|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
20221653|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
20221654|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20221655|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20453487|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
20221656|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20221657|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20453488|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
20453489|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453490|NCT00309985|Hormones|hormones|mesh-ancestor
20453491|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453492|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453493|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
20453494|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20453495|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
20453496|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20453497|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453498|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20453499|NCT00214916|Insulin|insulin|mesh-list
20453500|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20453501|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453502|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453503|NCT00066963|Fluorides|fluorides|mesh-list
20453504|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
20453505|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
20453506|NCT00066963|Protective Agents|protective agents|mesh-ancestor
20453507|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453508|NCT00055731|Aspirin|aspirin|mesh-list
20453509|NCT00055731|Docetaxel|docetaxel|mesh-list
20453510|NCT00055731|Goserelin|goserelin|mesh-list
20453511|NCT00055731|Bicalutamide|bicalutamide|mesh-list
20221658|NCT00325715|Esomeprazole|esomeprazole|mesh-list
20221659|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20221660|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221661|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20221662|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221663|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221664|NCT00325767|Albuterol|albuterol|mesh-list
20221665|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20221666|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
20221667|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221668|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221669|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20221670|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
20221671|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
20221672|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20221673|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20221674|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20221675|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20221676|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
20221677|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221678|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221679|NCT00325793|Nicardipine|nicardipine|mesh-list
20221680|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20221681|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20221682|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221683|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221684|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221685|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221686|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
20221687|NCT00325806|Ramipril|ramipril|mesh-list
20221688|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20221689|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
20221690|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221691|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221692|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20221693|NCT00325845|Hylan|hylan|mesh-list
20221694|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
20221695|NCT00325845|Protective Agents|protective agents|mesh-ancestor
20221696|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221697|NCT00325858|Tramadol|tramadol|mesh-list
20221698|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20221699|NCT00325858|Narcotics|narcotics|mesh-ancestor
20221700|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221701|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221702|NCT00325858|Analgesics|analgesics|mesh-ancestor
20453512|NCT00055731|Estramustine|estramustine|mesh-list
20453513|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221703|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
20221704|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221705|NCT00325910|Metformin|metformin|mesh-list
20221706|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20221707|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221708|NCT00325936|Cilnidipine|cilnidipine|mesh-list
20221709|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20221710|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221711|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221712|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221713|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221714|NCT00325949|Acetaminophen|acetaminophen|mesh-list
20221715|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20221716|NCT00325949|Hydrocodone|hydrocodone|mesh-list
20221717|NCT00325949|Oxycodone|oxycodone|mesh-list
20221718|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20221719|NCT00325949|Analgesics|analgesics|mesh-ancestor
20453514|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
20453515|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
20453516|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
20453517|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453518|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20453519|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20453520|NCT00055731|Analgesics|analgesics|mesh-ancestor
20453521|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
20453522|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453523|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453524|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453525|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20453526|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20453527|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20453528|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20453529|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20453530|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453531|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
20453532|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453533|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
20453534|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
20453535|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453536|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20453537|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
20453538|NCT01397500|Testosterone|testosterone|mesh-list
20453539|NCT01397500|Androgens|androgens|mesh-ancestor
20453540|NCT01397500|Hormones|hormones|mesh-ancestor
20453541|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453542|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453543|NCT01397513|Aspirin|aspirin|mesh-list
20453544|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20453545|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20453546|NCT01397513|Analgesics|analgesics|mesh-ancestor
20453547|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
20453548|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453549|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453550|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453551|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20453552|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20453553|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20453554|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453555|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20453556|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20453557|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453558|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
20453559|NCT01397630|Oxytocin|oxytocin|mesh-list
20453560|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
20453561|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20453562|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453563|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
20453564|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453565|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
20453566|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453567|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453568|NCT01397994|Nicorandil|nicorandil|mesh-list
20453569|NCT01397994|Atenolol|atenolol|mesh-list
20453570|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20221720|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
20453571|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20453572|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
20453573|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
20453574|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453575|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453576|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20453577|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20453578|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20453579|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
20453580|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453581|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453582|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
20453583|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
20453584|NCT01397994|Vitamins|vitamins|mesh-ancestor
20453585|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
20453586|NCT01398033|Paclitaxel|paclitaxel|mesh-list
20453587|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20453588|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453589|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
20453590|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
20453591|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
20221721|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221722|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221723|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
20221724|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20221725|NCT00325949|Narcotics|narcotics|mesh-ancestor
20221726|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221727|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
20221728|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
20221729|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20221730|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20221731|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20221732|NCT00325962|Verapamil|verapamil|mesh-list
20221733|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20221734|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20221735|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221736|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221737|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221738|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221739|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
20221740|NCT00326027|Pantoprazole|pantoprazole|mesh-list
20221741|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20221742|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453592|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453593|NCT01398046|Dasatinib|dasatinib|mesh-list
20453594|NCT01398046|Rabeprazole|rabeprazole|mesh-list
20453595|NCT01398046|Betaine|betaine|mesh-list
20453596|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453597|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453598|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453599|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453600|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20453601|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453602|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20453603|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
20453604|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20453605|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
20453606|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20453607|NCT01398072|Azithromycin|azithromycin|mesh-list
20453608|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
19694342|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453609|NCT01398072|Doxycycline|doxycycline|mesh-list
20453610|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20453611|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694343|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453612|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19694344|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694345|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694346|NCT04967859|Gentamicins|gentamicins|mesh-list
19694347|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19694348|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694349|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19694350|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694351|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694352|NCT04968054|Propofol|propofol|mesh-list
19694353|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19694354|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694355|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694356|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19694357|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
19694358|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
19694359|NCT04967469|Calcitriol|calcitriol|mesh-list
19694360|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
20453613|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20453614|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453615|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453616|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453617|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
20453618|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20453619|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20453620|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
20453621|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
20453622|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20453623|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
20453624|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453625|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453626|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20453627|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
20453628|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20453629|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20453630|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20453631|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
20453632|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453633|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453634|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20453635|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20453636|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20453637|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
20453638|NCT01398189|Clozapine|clozapine|mesh-list
20453639|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20453640|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
20453641|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453642|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453643|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453644|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20453645|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20453646|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20453647|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453648|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
20453649|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
20453650|NCT01398202|Vitamin D|vitamin d|mesh-list
20453651|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
20453652|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20453653|NCT01398202|Calcifediol|calcifediol|mesh-list
20453654|NCT01398202|Vitamins|vitamins|mesh-ancestor
20453655|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
20453656|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453657|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20453658|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20525938|NCT01760642|Ketoconazole|ketoconazole|mesh-list
20525939|NCT01760642|Midazolam|midazolam|mesh-list
20525940|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20525941|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20525942|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20525943|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525944|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20525945|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20525946|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20525947|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20525948|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
20525949|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
20525950|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
20525951|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
20525952|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20525953|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525954|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20525955|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
20525956|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20525957|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525958|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
19694361|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20221743|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20221744|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221745|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221746|NCT00326053|Budesonide|budesonide|mesh-list
20221747|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
20221748|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20221749|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20221750|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
20221751|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221752|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221753|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20221754|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
20221755|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
20221756|NCT00326053|Hormones|hormones|mesh-ancestor
20453659|NCT01398267|Lisinopril|lisinopril|mesh-list
20453660|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20453661|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
20453662|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221757|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221758|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20221759|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20221760|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20221761|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
19694362|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19694363|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694364|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19694365|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19694366|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221762|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221763|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221764|NCT00326092|Timolol|timolol|mesh-list
20221765|NCT00326092|Brinzolamide|brinzolamide|mesh-list
20221766|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20221767|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20221768|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
20221769|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221770|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453663|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453664|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20453665|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20453666|NCT01398267|Protective Agents|protective agents|mesh-ancestor
20453667|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453668|NCT01398293|Ritonavir|ritonavir|mesh-list
20453669|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
20453670|NCT01398293|Lactams|lactams|mesh-list
20453671|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20453672|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20453673|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20453674|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
20453675|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453676|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453677|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20453678|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20453679|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
20453680|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453681|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20453682|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20453683|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20453684|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20453685|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20453686|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453687|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19694367|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19694368|NCT04967469|Vitamins|vitamins|mesh-ancestor
20221771|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221772|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20221773|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20221774|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20221775|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221776|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20221777|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
20221778|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453688|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
20453689|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20453690|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453691|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20453692|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20453693|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20453694|NCT01398371|Digoxin|digoxin|mesh-list
20453695|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20453696|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20453697|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453698|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453699|NCT01398371|Protective Agents|protective agents|mesh-ancestor
20453700|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453701|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
20453702|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20453703|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
20453704|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453705|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453706|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20453707|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
20453708|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20453709|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
20453710|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453711|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453712|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20453713|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
20453714|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
20453715|NCT01398384|Protective Agents|protective agents|mesh-ancestor
20453716|NCT01398501|Sorafenib|sorafenib|mesh-list
20453717|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453718|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453719|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453720|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453721|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20453722|NCT01398592|Vildagliptin|vildagliptin|mesh-list
20453723|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453724|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453725|NCT01398592|Incretins|incretins|mesh-ancestor
20453726|NCT01398592|Hormones|hormones|mesh-ancestor
20453727|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453728|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20453729|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
20453730|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453731|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453732|NCT01398618|Rifampin|rifampin|mesh-list
20453733|NCT01398618|Isoniazid|isoniazid|mesh-list
20453734|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20453735|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
20453736|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20453737|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453738|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
20453739|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20453740|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453741|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453742|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20453743|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20453744|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20453745|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20453746|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20453747|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20453748|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20453749|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20453750|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
20453751|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20453752|NCT01398657|Androgens|androgens|mesh-list
20453753|NCT01398657|Hormones|hormones|mesh-ancestor
20453754|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453755|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453756|NCT01398670|Insulin|insulin|mesh-list
20453757|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20453758|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
20453759|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694369|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
19849165|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
20453760|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453761|NCT01398722|Insulin|insulin|mesh-list
20453762|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20453763|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20221779|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20221780|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221781|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221782|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221783|NCT00326131|Taxane|taxane|mesh-list
20221784|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221785|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20221786|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
20221787|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221788|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20221789|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221790|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221791|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221792|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20221793|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
20221794|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221795|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20221796|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20453764|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453765|NCT01398995|Insulin|insulin|mesh-list
20453766|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453767|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453768|NCT01399086|Fulvestrant|fulvestrant|mesh-list
20453769|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453770|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453771|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20453772|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20453773|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
20453774|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453775|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453776|NCT01399151|Vitamin D|vitamin d|mesh-list
20453777|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
20453778|NCT01399151|Vitamins|vitamins|mesh-list
20453779|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
20453780|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453781|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20453782|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20453783|NCT01399216|Fucoidan|fucoidan|mesh-list
20453784|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20453785|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453786|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
20453787|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453788|NCT01399242|Everolimus|everolimus|mesh-list
20453789|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20453790|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
20453791|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453792|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453793|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
20453794|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453795|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453796|NCT01399346|Insulin|insulin|mesh-list
20453797|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20453798|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
20221797|NCT00326235|Buspirone|buspirone|mesh-list
20221798|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20221799|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221800|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221801|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221802|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20221803|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20221804|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
20221805|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221806|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221807|NCT00326248|Casopitant|casopitant|mesh-list
20221808|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
20221809|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
20221810|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221811|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221812|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247257|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
20453799|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
20453800|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20453801|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20221813|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20221814|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453802|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453803|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20453804|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20453805|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20221815|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221816|NCT00326300|Methylphenidate|methylphenidate|mesh-list
19849166|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849167|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19407209|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
19407210|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407211|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221817|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20221818|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221819|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20221820|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20221821|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221822|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221823|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
20221824|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221825|NCT00326352|Remifentanil|remifentanil|mesh-list
20221826|NCT00326352|Propofol|propofol|mesh-list
20221827|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20221828|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221829|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221830|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20221831|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
20221832|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
20221833|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20221834|NCT00326352|Narcotics|narcotics|mesh-ancestor
20221835|NCT00326352|Analgesics|analgesics|mesh-ancestor
20221836|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
20221837|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221838|NCT00326378|Docetaxel|docetaxel|mesh-list
20221839|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221840|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20221841|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20221842|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
20221843|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221844|NCT00326391|Methylphenidate|methylphenidate|mesh-list
20221845|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20221846|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221847|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20221848|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20221849|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221850|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221851|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
20221852|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221853|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20221854|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20221855|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20221856|NCT00326404|Desogestrel|desogestrel|mesh-list
20221857|NCT00326404|Estradiol|estradiol|mesh-list
20221858|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20221859|NCT00326404|Estrogens|estrogens|mesh-ancestor
20221860|NCT00326404|Hormones|hormones|mesh-ancestor
20221861|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221862|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221863|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20221864|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
20221865|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20453806|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20453807|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453808|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453809|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20453810|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20453811|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
20453812|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416555|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416556|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19416557|NCT02402270|Laxatives|laxatives|mesh-ancestor
19416558|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453813|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453814|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20453815|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20453816|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
20453817|NCT01399463|Paclitaxel|paclitaxel|mesh-list
20453818|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20453819|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453820|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
20453821|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
20453822|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
20453823|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453824|NCT01399515|Valproic Acid|valproic acid|mesh-list
20453825|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
20453826|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453827|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453828|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
20453829|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453830|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453831|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
20453832|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20453833|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20453834|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453835|NCT01399645|Insulin|insulin|mesh-list
20453836|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20453837|NCT01399645|Metformin|metformin|mesh-list
20453838|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
20453839|NCT01399645|Liraglutide|liraglutide|mesh-list
20453840|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453841|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453842|NCT01399645|Incretins|incretins|mesh-ancestor
20453843|NCT01399645|Hormones|hormones|mesh-ancestor
20453844|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453845|NCT01399840|Talazoparib|talazoparib|mesh-list
20453846|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20453847|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453848|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453849|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453850|NCT01399853|Vaccines|vaccines|mesh-list
20453851|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
20453852|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453853|NCT01400009|Vitamin D|vitamin d|mesh-list
20453854|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
20453855|NCT01400009|Vitamins|vitamins|mesh-ancestor
20453856|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
20221866|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20221867|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20221868|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19849168|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19849169|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19849170|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849171|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849172|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
19849173|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849174|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849175|NCT00700440|Cetuximab|cetuximab|mesh-list
19849176|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849177|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849178|NCT00700570|Bevacizumab|bevacizumab|mesh-list
19849179|NCT00700570|Capecitabine|capecitabine|mesh-list
20221869|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20221870|NCT00326404|Progestins|progestins|mesh-ancestor
20221871|NCT00326456|Paclitaxel|paclitaxel|mesh-list
20221872|NCT00326456|Carboplatin|carboplatin|mesh-list
20221873|NCT00326456|Doxorubicin|doxorubicin|mesh-list
20221874|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20221875|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20221876|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221877|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
20221878|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
20221879|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
20221880|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849180|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
20221881|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20221882|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20453857|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221883|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20221884|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221885|NCT00326469|Lanreotide|lanreotide|mesh-list
20221886|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221887|NCT00326508|Daclizumab|daclizumab|mesh-list
20221888|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20221889|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
20221890|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221891|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
20221892|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
20221893|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
20221894|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221895|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221896|NCT00326664|Cediranib|cediranib|mesh-list
20221897|NCT00326664|Maleic acid|maleic acid|mesh-list
20221898|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221899|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221900|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221901|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20221902|NCT00326768|Telmisartan|telmisartan|mesh-list
20221903|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20453858|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19849181|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849182|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849183|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19849184|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20453859|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20525959|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20525960|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525961|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20525962|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20525963|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20525964|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20525965|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20525966|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20525967|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
20525968|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20525969|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20525970|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20525971|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
20525972|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20525973|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20525974|NCT01760655|Vidarabine|vidarabine|mesh-list
20525975|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
20525976|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
20525977|NCT01760655|Thiotepa|thiotepa|mesh-list
20525978|NCT01760655|Fludarabine|fludarabine|mesh-list
20525979|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
20525980|NCT01760655|Tacrolimus|tacrolimus|mesh-list
20525981|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20525982|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
20525983|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20525984|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20525985|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20525986|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
20525987|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20525988|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20525989|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20525990|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20525991|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
20525992|NCT01760655|Antiviral Agents|antiviral agents|mesh-ancestor
20525993|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20525994|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20525995|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20525996|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20525997|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20525998|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
20525999|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526000|NCT01760694|Leucovorin|leucovorin|mesh-list
20526001|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
20526002|NCT01760694|Irinotecan|irinotecan|mesh-list
19849185|NCT00700570|Growth Substances|growth substances|mesh-ancestor
20221904|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20526003|NCT01760694|Folfirinox|folfirinox|mesh-list
20453860|NCT01400022|Cortisone|cortisone|mesh-list
20453861|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453862|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
20453863|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453864|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20453865|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453866|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453867|NCT01400100|Octreotide|octreotide|mesh-list
20221905|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20221906|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20221907|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453868|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20453869|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20453870|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20453871|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221908|NCT00326768|Diuretics|diuretics|mesh-ancestor
20221909|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
20221910|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221911|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20453872|NCT01400165|Pindolol|pindolol|mesh-list
20453873|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20453874|NCT01400165|Trazodone|trazodone|mesh-list
20453875|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
20453876|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20453877|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20453878|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20453879|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20453880|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453881|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20453882|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20453883|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20453884|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20453885|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453886|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20453887|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
20453888|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20453889|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20453890|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20453891|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
20453892|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20453893|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20453894|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
20453895|NCT01400191|Metformin|metformin|mesh-list
20453896|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20453897|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453898|NCT01400217|Beclomethasone|beclomethasone|mesh-list
20453899|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453900|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
20453901|NCT01400217|Hormones|hormones|mesh-ancestor
20453902|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453903|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453904|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20453905|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
20453906|NCT01400256|Valsartan|valsartan|mesh-list
20453907|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20453908|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20453909|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20453910|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453911|NCT01400308|Mupirocin|mupirocin|mesh-list
20453912|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20453913|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453914|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20453915|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453916|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453917|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
20453918|NCT01400464|Prednisone|prednisone|mesh-list
20453919|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453920|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
20453921|NCT01400464|Hormones|hormones|mesh-ancestor
20453922|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20453923|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453924|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407212|NCT03575637|Olanzapine|olanzapine|mesh-list
19407213|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
20453925|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453926|NCT01400568|Fluticasone|fluticasone|mesh-list
20453927|NCT01400568|Xhance|xhance|mesh-list
20453928|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453929|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20453930|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
20453931|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453932|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453933|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20453934|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
20453935|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
20453936|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20453937|NCT01400633|Decitabine|decitabine|mesh-list
20453938|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20453939|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
20453940|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453941|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453942|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453943|NCT01400646|Vitamins|vitamins|mesh-list
20453944|NCT01400646|Vitamin K|vitamin k|mesh-list
20453945|NCT01400646|Warfarin|warfarin|mesh-list
20453946|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
20453947|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
20453948|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453949|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
20453950|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20453951|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
20453952|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20453953|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
20453954|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453955|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453956|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20453957|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20453958|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
20453959|NCT01400646|Coagulants|coagulants|mesh-ancestor
20453960|NCT01400672|Imiquimod|imiquimod|mesh-list
20453961|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20453962|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
20453963|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453964|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453965|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
20453966|NCT01400685|Rituximab|rituximab|mesh-list
20453967|NCT01400685|Lenalidomide|lenalidomide|mesh-list
20453968|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20453969|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20453970|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20453971|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
20453972|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453973|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20453974|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20453975|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20453976|NCT01400685|Growth Substances|growth substances|mesh-ancestor
20453977|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
20453978|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20453979|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
20453980|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453981|NCT01400737|Ibuprofen|ibuprofen|mesh-list
20453982|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20453983|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20453984|NCT01400737|Analgesics|analgesics|mesh-ancestor
20453985|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
20453986|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20453987|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20453988|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20453989|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20453990|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20453991|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20453992|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20453993|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
20453994|NCT01400750|Tobramycin|tobramycin|mesh-list
20453995|NCT01400750|Colistin|colistin|mesh-list
20453996|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20453997|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20453998|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20453999|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20454000|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454001|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849186|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849187|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
19849188|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19849189|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
20454002|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454003|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20454004|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20454005|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
20454006|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
20454007|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454008|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454009|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
20454010|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454011|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454012|NCT01400828|Desloratadine|desloratadine|mesh-list
20454013|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20454014|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
20454015|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454016|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454017|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454018|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20454019|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20454020|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
20454021|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
20454022|NCT01400867|Vancomycin|vancomycin|mesh-list
20454023|NCT01400867|Clindamycin|clindamycin|mesh-list
20454024|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
20454025|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
20454026|NCT01400867|Cefazolin|cefazolin|mesh-list
20454027|NCT01400867|Linezolid|linezolid|mesh-list
20454028|NCT01400867|Cephalexin|cephalexin|mesh-list
20454029|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20454030|NCT01400867|Aztreonam|aztreonam|mesh-list
20454031|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454032|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407214|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
19849190|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849191|NCT00700622|Insulin|insulin|mesh-list
19849192|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19849193|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
19849194|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
19849195|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19849196|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849197|NCT00700817|Metformin|metformin|mesh-list
19849198|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19849199|NCT00700817|Liraglutide|liraglutide|mesh-list
19849200|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19849201|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849202|NCT00700817|Incretins|incretins|mesh-ancestor
19849203|NCT00700817|Hormones|hormones|mesh-ancestor
20221912|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221913|NCT00326807|Naltrexone|naltrexone|mesh-list
20221914|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20221915|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20221916|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221917|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
20221918|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20221919|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
20221920|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
20221921|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20221922|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221923|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
20221924|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
20221925|NCT00326833|Vitamins|vitamins|mesh-ancestor
20221926|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
20221927|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221928|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
20221929|NCT00326833|Hematinics|hematinics|mesh-ancestor
20221930|NCT00326859|Remifentanil|remifentanil|mesh-list
20221931|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20221932|NCT00326859|Narcotics|narcotics|mesh-ancestor
20221933|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20221934|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849204|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20221935|NCT00326859|Analgesics|analgesics|mesh-ancestor
20221936|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
20221937|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454033|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20221938|NCT00327080|Acetylcholine|acetylcholine|mesh-list
20454034|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454035|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454036|NCT01400945|Pantoprazole|pantoprazole|mesh-list
20454037|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20454038|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454039|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20454040|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454041|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454042|NCT01401036|Umirolimus|umirolimus|mesh-list
20454043|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407215|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407216|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407217|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407218|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19407219|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407220|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407221|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19407222|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19407223|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19407224|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407225|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407226|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407227|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
19407228|NCT03575598|Nivolumab|nivolumab|mesh-list
19407229|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407230|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407231|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19407232|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407233|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
19407234|NCT03575520|Doxorubicin|doxorubicin|mesh-list
19407235|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407236|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
19407237|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849205|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19849206|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
19407238|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407239|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407240|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
19407241|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407242|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407243|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19407244|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19849207|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849208|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849209|NCT00700882|Dasatinib|dasatinib|mesh-list
19849210|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849211|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849212|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221939|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
20221940|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20221941|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
20221942|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20221943|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221944|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221945|NCT00327093|Bevacizumab|bevacizumab|mesh-list
20221946|NCT00327093|Cetuximab|cetuximab|mesh-list
20221947|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20221948|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221949|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20221950|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20454044|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454045|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
20454046|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454047|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
20454048|NCT01401075|Doxifluridine|doxifluridine|mesh-list
20454049|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454050|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20454051|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20454052|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
20454053|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454054|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454055|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
20454056|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454057|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454058|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
20454059|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454060|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
20454061|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20454062|NCT01401179|Clarithromycin|clarithromycin|mesh-list
20454063|NCT01401179|Cefazolin|cefazolin|mesh-list
20454064|NCT01401179|Erythromycin|erythromycin|mesh-list
20454065|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
20454066|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20454067|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
20454068|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454069|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454070|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20221951|NCT00327093|Growth Substances|growth substances|mesh-ancestor
20221952|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221953|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
20221954|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
20221955|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20454071|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454072|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454073|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20454074|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20454075|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454076|NCT01401192|Gemcitabine|gemcitabine|mesh-list
20454077|NCT01401192|Cisplatin|cisplatin|mesh-list
20454078|NCT01401192|Pemetrexed|pemetrexed|mesh-list
20454079|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454080|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407245|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19407246|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19407247|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407248|NCT03575325|Cytarabine|cytarabine|mesh-list
19407249|NCT03575325|Daunorubicin|daunorubicin|mesh-list
19407250|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407251|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
19407252|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407253|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407254|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
19407255|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407256|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407257|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
19407258|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407259|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19407260|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19407261|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19407262|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221956|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20221957|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454081|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
20454082|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454083|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
20454084|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454085|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454086|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454087|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
20454088|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454089|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20454090|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20454091|NCT01401387|Pancreatin|pancreatin|mesh-list
20454092|NCT01401387|Pancrelipase|pancrelipase|mesh-list
20454093|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454094|NCT01401491|Clozapine|clozapine|mesh-list
20221958|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
20221959|NCT00327106|Coagulants|coagulants|mesh-ancestor
20221960|NCT00327119|Panitumumab|panitumumab|mesh-list
20221961|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20221962|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20221963|NCT00327132|Amoxicillin|amoxicillin|mesh-list
20221964|NCT00327132|Clarithromycin|clarithromycin|mesh-list
20221965|NCT00327132|Omeprazole|omeprazole|mesh-list
20221966|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454095|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
20221967|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20221968|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20454096|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20454097|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
20454098|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407263|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
19407264|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19407265|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407266|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
19407267|NCT03575247|Hormones|hormones|mesh-ancestor
19407268|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407269|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221969|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20221970|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20221971|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20221972|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221973|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20221974|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20221975|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20221976|NCT00327145|Amlodipine|amlodipine|mesh-list
20221977|NCT00327145|Valsartan|valsartan|mesh-list
20221978|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20221979|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20221980|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20221981|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20221982|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221983|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20221984|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20221985|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
20221986|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20454099|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454100|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454101|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20454102|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20454103|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454104|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454105|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
20454106|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
20454107|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20454108|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20454109|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20454110|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20454111|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20454112|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
20454113|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20454114|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20454115|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454116|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20454117|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20454118|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20454119|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20454120|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454121|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
20454122|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454123|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526004|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526005|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20526006|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20526007|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526008|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526009|NCT01760694|Antidotes|antidotes|mesh-ancestor
20526010|NCT01760694|Protective Agents|protective agents|mesh-ancestor
20526011|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526012|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
20526013|NCT01760694|Vitamins|vitamins|mesh-ancestor
20526014|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
20526015|NCT01760746|Bevacizumab|bevacizumab|mesh-list
20526016|NCT01760746|Ranibizumab|ranibizumab|mesh-list
20526017|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20526018|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526019|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20526020|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20526021|NCT01760746|Growth Substances|growth substances|mesh-ancestor
19694370|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20454124|NCT01401933|Rifampin|rifampin|mesh-list
20454125|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20454126|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
20454127|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454128|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454129|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
20454130|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20454131|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454132|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454133|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20454134|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20454135|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20454136|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20454137|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20454138|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20454139|NCT01402024|Aprepitant|aprepitant|mesh-list
20454140|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
20454141|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
20454142|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454143|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454144|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454145|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20454146|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454147|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454148|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
19407270|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
19407271|NCT03575234|Nivolumab|nivolumab|mesh-list
19407272|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407273|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
20454149|NCT01402076|Midazolam|midazolam|mesh-list
20454150|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20454151|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20454152|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454153|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454154|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20454155|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20454156|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454157|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20454158|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
20454159|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
20454160|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
20454161|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
20454162|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454163|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454164|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454165|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20454166|NCT01402089|Sunitinib|sunitinib|mesh-list
20454167|NCT01402089|Midazolam|midazolam|mesh-list
20454168|NCT01402089|Caffeine|caffeine|mesh-list
20454169|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20454170|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20454171|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407274|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407275|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407276|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407277|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
19407278|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407279|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454172|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454173|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20454174|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407280|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19407281|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20613919|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20454175|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454176|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20454177|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
20454178|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
20454179|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
20454180|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
20454181|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407282|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19407283|NCT03575195|Rifaximin|rifaximin|mesh-list
20454182|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454183|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454184|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20454185|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454186|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20454187|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20454188|NCT01402089|Growth Substances|growth substances|mesh-ancestor
20454189|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
20454190|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20454191|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20454192|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20454193|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20454194|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
20454195|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
20454196|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20454197|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454198|NCT01402193|Anastrozole|anastrozole|mesh-list
20454199|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20454200|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454201|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20454202|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20454203|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454204|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454205|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20454206|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
20454207|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454208|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454209|NCT01402245|Vaccines|vaccines|mesh-list
20454210|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20454211|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
20454212|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454213|NCT01402271|Paclitaxel|paclitaxel|mesh-list
20454214|NCT01402271|Carboplatin|carboplatin|mesh-list
20454215|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20454216|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454217|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
20454218|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
20454219|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
20454220|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454221|NCT01402297|Acetovanillone|acetovanillone|mesh-list
20454222|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20454223|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20454224|NCT01402297|Analgesics|analgesics|mesh-ancestor
20454225|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
19849213|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849214|NCT00700999|Paroxetine|paroxetine|mesh-list
19849215|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19849216|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19849217|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20454226|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454227|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454228|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454229|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454230|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
20454231|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454232|NCT01402297|Protective Agents|protective agents|mesh-ancestor
20454233|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416559|NCT02401815|Sunitinib|sunitinib|mesh-list
20221987|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20221988|NCT00327145|Diuretics|diuretics|mesh-ancestor
20221989|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
20221990|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20221991|NCT00327184|PENTA|penta|mesh-list
20221992|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
20221993|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20221994|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20221995|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20221996|NCT00327197|Prednisolone|prednisolone|mesh-list
20221997|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20221998|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
20221999|NCT00327197|Hormones|hormones|mesh-ancestor
20222000|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222001|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222002|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20222003|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454234|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20454235|NCT01402336|Cetrorelix|cetrorelix|mesh-list
20454236|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20454237|NCT01402336|Hormones|hormones|mesh-ancestor
20454238|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454239|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454240|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
20454241|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20454242|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
20454243|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20454244|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20454245|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20454246|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454247|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20454248|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
20454249|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
20454250|NCT01402479|Ramipril|ramipril|mesh-list
20454251|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20454252|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
20454253|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454254|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454255|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20454256|NCT01402583|Ribavirin|ribavirin|mesh-list
20454257|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
20454258|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454259|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
20454260|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454261|NCT01402596|Midazolam|midazolam|mesh-list
20454262|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
20454263|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20454264|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20454265|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454266|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454267|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20454268|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20454269|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454270|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20454271|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
20454272|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
20454273|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
20454274|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
20454275|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454276|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454277|NCT01402622|Propofol|propofol|mesh-list
20454278|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
20454279|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454280|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454281|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20454282|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20454283|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
20454284|NCT01402674|Phentermine|phentermine|mesh-list
20454285|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20454286|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454287|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
20454288|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20454289|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
20454290|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
20454291|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454292|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
20454293|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454294|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454295|NCT01402843|Valsartan|valsartan|mesh-list
20454296|NCT01402843|Pitavastatin|pitavastatin|mesh-list
20454297|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20454298|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20454299|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20454300|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454301|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20454302|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20454303|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20454304|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
20454305|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454306|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20454307|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
20454308|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20454309|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20454310|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454311|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
20454312|NCT01402882|Coagulants|coagulants|mesh-ancestor
20454313|NCT01403025|Liraglutide|liraglutide|mesh-list
20454314|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454315|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454316|NCT01403025|Incretins|incretins|mesh-ancestor
20454317|NCT01403025|Hormones|hormones|mesh-ancestor
20454318|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454319|NCT01403103|Vitamin D|vitamin d|mesh-list
20454320|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
20454321|NCT01403103|Vitamins|vitamins|mesh-ancestor
20454322|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
20454323|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454324|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20454325|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20454326|NCT01403168|Analgesics|analgesics|mesh-list
20454327|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
19694371|NCT04967950|Methotrexate|methotrexate|mesh-list
19694372|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20454328|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454329|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454330|NCT01403181|Ribavirin|ribavirin|mesh-list
20454331|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20454332|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
20454333|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454334|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
20454335|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454336|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
20454337|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454338|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
20454339|NCT01403285|Molgramostim|molgramostim|mesh-list
20454340|NCT01403285|Imiquimod|imiquimod|mesh-list
20454341|NCT01403285|Sargramostim|sargramostim|mesh-list
20454342|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454343|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
20454344|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454345|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454346|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20454347|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
20454348|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454349|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454350|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20454351|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20454352|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
20454353|NCT01403363|Fentanyl|fentanyl|mesh-list
20454354|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19694373|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19694374|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
19694375|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19694376|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454355|NCT01403363|Narcotics|narcotics|mesh-ancestor
20454356|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454357|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454358|NCT01403363|Analgesics|analgesics|mesh-ancestor
20454359|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
20454360|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454361|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20454362|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20454363|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
20454364|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
20454365|NCT01403389|Eculizumab|eculizumab|mesh-list
20454366|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20454367|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454368|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
20454369|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454370|NCT01403415|Sirolimus|sirolimus|mesh-list
20454371|NCT01403415|Dexamethasone|dexamethasone|mesh-list
20454372|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
20454373|NCT01403415|Methotrexate|methotrexate|mesh-list
20454374|NCT01403415|Vincristine|vincristine|mesh-list
20454375|NCT01403415|Asparaginase|asparaginase|mesh-list
20454376|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
20454377|NCT01403415|Pegaspargase|pegaspargase|mesh-list
20454378|NCT01403415|BB 1101|bb 1101|mesh-list
20454379|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454380|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
20454381|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
20454382|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454383|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454384|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454385|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
20454386|NCT01403415|Hormones|hormones|mesh-ancestor
20454387|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454388|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20454389|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454390|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20454391|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
20454392|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20454393|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454394|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
20454395|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454396|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
20454397|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454398|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20454399|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454400|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
20454401|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454402|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20454403|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20454404|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
20454405|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
20454406|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
20454407|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454408|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454409|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20454410|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
20454411|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
20454412|NCT01403415|Analgesics|analgesics|mesh-ancestor
20454413|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
20454414|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20454415|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20454416|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
20454417|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20454418|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
20454419|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454420|NCT01403506|Expectorants|expectorants|mesh-ancestor
20454421|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
20454422|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20454423|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
20454424|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454425|NCT01403506|Protective Agents|protective agents|mesh-ancestor
20454426|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454427|NCT01403506|Antidotes|antidotes|mesh-ancestor
20454428|NCT01403545|Curcumin|curcumin|mesh-list
20454429|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20454430|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20454431|NCT01403545|Analgesics|analgesics|mesh-ancestor
20454432|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
20454433|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454434|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454435|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454436|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454437|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454438|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454439|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454440|NCT01403649|Vaccines|vaccines|mesh-list
20454441|NCT01403649|Immunologic Factors|immunologic factors|mesh-ancestor
20454442|NCT01403649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454443|NCT01403662|Minocycline|minocycline|mesh-list
20454444|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454445|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526022|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526023|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
20526024|NCT01760798|Teriparatide|teriparatide|mesh-list
20526025|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20526026|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526027|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20526028|NCT01760811|Cetuximab|cetuximab|mesh-list
20526029|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20526030|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526031|NCT01760824|Amoxicillin|amoxicillin|mesh-list
20526032|NCT01760824|Metronidazole|metronidazole|mesh-list
20454446|NCT01403740|Cyclosporine|cyclosporine|mesh-list
20454447|NCT01403740|Rituximab|rituximab|mesh-list
20454448|NCT01403740|Azathioprine|azathioprine|mesh-list
20454449|NCT01403740|Cyclosporins|cyclosporins|mesh-list
20454450|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20454451|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454452|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
20454453|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454454|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454455|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454456|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454457|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454458|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
20454459|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454460|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
20454461|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20454462|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
20454463|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454464|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
20454465|NCT01403818|Mitiglinide|mitiglinide|mesh-list
20454466|NCT01403818|Calcium|calcium|mesh-list
20454467|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20454468|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849218|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454469|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20454470|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454471|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454472|NCT01403844|Carotenoids|carotenoids|mesh-list
20454473|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
20454474|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454475|NCT01403844|Protective Agents|protective agents|mesh-ancestor
20454476|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454477|NCT01403896|Plerixafor|plerixafor|mesh-list
20454478|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20454479|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20454480|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
20454481|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454482|NCT01403948|BI 836826|bi 836826|mesh-list
20454483|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20454484|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454485|NCT01404000|Charcoal|charcoal|mesh-list
20454486|NCT01404000|Antidotes|antidotes|mesh-ancestor
20454487|NCT01404000|Protective Agents|protective agents|mesh-ancestor
20454488|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454489|NCT01404013|Montelukast|montelukast|mesh-list
20454490|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20454491|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20454492|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
20454493|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20454494|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
20454495|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454496|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454497|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20454498|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20454499|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454500|NCT01404104|Sirolimus|sirolimus|mesh-list
20454501|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454502|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454503|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20454504|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454505|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
20454506|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454507|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
20454508|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454509|NCT01404117|Interferons|interferons|mesh-list
20454510|NCT01404117|Interferon-beta|interferon-beta|mesh-list
20454511|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
20454512|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
20454513|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613920|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613921|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
20454514|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
20454515|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454516|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
20454517|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454518|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20454519|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454520|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454521|NCT01404130|Isotretinoin|isotretinoin|mesh-list
20454522|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
20454523|NCT01404156|Leucovorin|leucovorin|mesh-list
20454524|NCT01404156|Paclitaxel|paclitaxel|mesh-list
20222004|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
20222005|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222006|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20222007|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222008|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247258|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20247259|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20247260|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20247261|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247262|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247263|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
20247264|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247265|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20454525|NCT01404156|Docetaxel|docetaxel|mesh-list
20454526|NCT01404156|Carboplatin|carboplatin|mesh-list
20454527|NCT01404156|Fluorouracil|fluorouracil|mesh-list
20454528|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
20454529|NCT01404156|Epirubicin|epirubicin|mesh-list
20454530|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20454531|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454532|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
20454533|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
20454534|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
20454535|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454536|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
20454537|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454538|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454539|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
20454540|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454541|NCT01404156|Antidotes|antidotes|mesh-ancestor
20454542|NCT01404156|Protective Agents|protective agents|mesh-ancestor
20454543|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
20454544|NCT01404156|Vitamins|vitamins|mesh-ancestor
20454545|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
20454546|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20454547|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20454548|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20454549|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454550|NCT01404169|Donepezil|donepezil|mesh-list
20454551|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20454552|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454553|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407284|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19407285|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407286|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407287|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19407288|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19407289|NCT03575078|Olaparib|olaparib|mesh-list
19407290|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20454554|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
20454555|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454556|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454557|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
20454558|NCT01404182|Vaccines|vaccines|mesh-list
20454559|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
20454560|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454561|NCT01404312|Pyridoxine|pyridoxine|mesh-list
20454562|NCT01404312|Pyridoxal|pyridoxal|mesh-list
20454563|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
20454564|NCT01404312|Isoniazid|isoniazid|mesh-list
20454565|NCT01404312|Rifapentine|rifapentine|mesh-list
20454566|NCT01404312|Vitamins|vitamins|mesh-ancestor
20454567|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
20454568|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407291|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454569|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
20454570|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
19416560|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454571|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454572|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454573|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20454574|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20454575|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
20222009|NCT00327288|Docetaxel|docetaxel|mesh-list
20222010|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222011|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
20222012|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
20222013|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
20222014|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222015|NCT00327327|Gemcitabine|gemcitabine|mesh-list
20222016|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20222017|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
20454576|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454577|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20454578|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20454579|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
20454580|NCT01404338|Halobetasol|halobetasol|mesh-list
20454581|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20454582|NCT01404364|Triamcinolone|triamcinolone|mesh-list
20222018|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222019|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222020|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
20454583|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
19694377|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454584|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454585|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
20454586|NCT01404364|Hormones|hormones|mesh-ancestor
20454587|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454588|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454589|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454590|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
20454591|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
20454592|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454593|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454594|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20454595|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20454596|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454597|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454598|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19407292|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407293|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407294|NCT03575013|Docetaxel|docetaxel|mesh-list
19694378|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
19694379|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694380|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694381|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
19694382|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694383|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20222021|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222022|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222023|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20222024|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
20222025|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407295|NCT03575013|Avelumab|avelumab|mesh-list
19407296|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407297|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
19407298|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
20222026|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
20222027|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20454599|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
20454600|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454601|NCT01404377|Ropivacaine|ropivacaine|mesh-list
19407299|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
19407300|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407301|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407302|NCT03575000|Bromocriptine|bromocriptine|mesh-list
19407303|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19407304|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19407305|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
19407306|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407307|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222028|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20222029|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
20454602|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
20454603|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
20454604|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454605|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454606|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
19694384|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694385|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
19694386|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694387|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20454607|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454608|NCT01404442|Midazolam|midazolam|mesh-list
20454609|NCT01404442|Ketamine|ketamine|mesh-list
20454610|NCT01404442|Analgesics|analgesics|mesh-ancestor
20454611|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
20454612|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454613|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454614|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20454615|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20454616|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
20454617|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
20454618|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454619|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20454620|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20454621|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454622|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454623|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20454624|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20454625|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20454626|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20454627|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19407308|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
19407309|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
20454628|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
20454629|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
20454630|NCT01404468|Lidocaine|lidocaine|mesh-list
20454631|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
20454632|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
20454633|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454634|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454635|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
20454636|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454637|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20454638|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20454639|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20454640|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20454641|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454642|NCT01404507|Abciximab|abciximab|mesh-list
20454643|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
20454644|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20454645|NCT01404598|Naproxen|naproxen|mesh-list
20454646|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
20454647|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20454648|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20454649|NCT01404598|Analgesics|analgesics|mesh-ancestor
20454650|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
20454651|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454652|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454653|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454654|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454655|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
20454656|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20454657|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454658|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454659|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20454660|NCT01404637|Tamsulosin|tamsulosin|mesh-list
20454661|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20454662|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20454663|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20454664|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
20454665|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454666|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454667|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454668|NCT01404637|Urological Agents|urological agents|mesh-ancestor
20454669|NCT01404676|Glimepiride|glimepiride|mesh-list
20454670|NCT01404676|Vildagliptin|vildagliptin|mesh-list
19407310|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694388|NCT04967326|Carbamazepine|carbamazepine|mesh-list
20454671|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20454672|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454673|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454674|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454675|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
20454676|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20454677|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
20454678|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454679|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454680|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
20454681|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20454682|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454683|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454684|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20454685|NCT01404689|Analgesics|analgesics|mesh-ancestor
20454686|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
20454687|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454688|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20454689|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20454690|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20454691|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
20454692|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454693|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454694|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
20454695|NCT01404702|Aldesleukin|aldesleukin|mesh-list
20454696|NCT01404702|Interleukin-2|interleukin-2|mesh-list
20454697|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454698|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20454699|NCT01404702|Analgesics|analgesics|mesh-ancestor
20454700|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
20454701|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454702|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454703|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20454704|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20454705|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
20454706|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454707|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20454708|NCT01404715|Metformin|metformin|mesh-list
20454709|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
20454710|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454711|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454712|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454713|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20454714|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454715|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454716|NCT01404741|Azacitidine|azacitidine|mesh-list
20454717|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454718|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
20454719|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454720|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454721|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454722|NCT01404767|Metoprolol|metoprolol|mesh-list
20454723|NCT01404767|Esmolol|esmolol|mesh-list
20454724|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20454725|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20454726|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
20454727|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
20454728|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454729|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454730|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20454731|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20454732|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20454733|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
20454734|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454735|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454736|NCT01404793|Rocuronium|rocuronium|mesh-list
20454737|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20454738|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20454739|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20454740|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454741|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407311|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407312|NCT03574909|Aspirin|aspirin|mesh-list
19407313|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20454742|NCT01404806|Dolutegravir|dolutegravir|mesh-list
19407314|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20454743|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20454744|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20454745|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454746|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454747|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20454748|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20454749|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
20454750|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454751|NCT01404819|Anesthetics|anesthetics|mesh-list
20454752|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454753|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454754|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20454755|NCT01404871|Citalopram|citalopram|mesh-list
20454756|NCT01404871|Clomipramine|clomipramine|mesh-list
20454757|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19407315|NCT03574909|Analgesics|analgesics|mesh-ancestor
19407316|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
19407317|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454758|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20454759|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20454760|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454761|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454762|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
20454763|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454764|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20454765|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
20454766|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454767|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454768|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20454769|NCT01404871|Analgesics|analgesics|mesh-ancestor
20454770|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
20454771|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
20454772|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20454773|NCT01405079|Vinorelbine|vinorelbine|mesh-list
20454774|NCT01405079|Gefitinib|gefitinib|mesh-list
20454775|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454776|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20454777|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
20454778|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
20454779|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
20454780|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454781|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20454782|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454783|NCT01405118|Metformin|metformin|mesh-list
20454784|NCT01405118|Tofacitinib|tofacitinib|mesh-list
20454785|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20454786|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454787|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20454788|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454789|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454790|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
20454791|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20454792|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20454793|NCT01405131|Prednisolone|prednisolone|mesh-list
20454794|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
20454795|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20454796|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
20454797|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454798|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
20454799|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
20454800|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454801|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454802|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454803|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
20454804|NCT01405131|Hormones|hormones|mesh-ancestor
20454805|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454806|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20454807|NCT01405131|Protective Agents|protective agents|mesh-ancestor
20454808|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20613922|NCT02256943|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19407318|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454809|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454810|NCT01405144|Fluorouracil|fluorouracil|mesh-list
20454811|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
20454812|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454813|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454814|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454815|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454816|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
20454817|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454818|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
20454819|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20454820|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20454821|NCT01405157|Prednisolone|prednisolone|mesh-list
20454822|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
20454823|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20454824|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
20454825|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454826|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
20454827|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
20454828|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454829|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454830|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454831|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
20454832|NCT01405157|Hormones|hormones|mesh-ancestor
20454833|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454834|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20454835|NCT01405157|Protective Agents|protective agents|mesh-ancestor
20454836|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20454837|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454838|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
20454839|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20454840|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20454841|NCT01405170|Prednisolone|prednisolone|mesh-list
20454842|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
20454843|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20454844|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
20454845|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454846|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
20454847|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
20454848|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454849|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454850|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20454851|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
20454852|NCT01405170|Hormones|hormones|mesh-ancestor
20222030|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222031|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222032|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20222033|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
20454853|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454854|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20454855|NCT01405170|Protective Agents|protective agents|mesh-ancestor
20454856|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20454857|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454858|NCT01405235|Paclitaxel|paclitaxel|mesh-list
20454859|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20454860|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20454861|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454862|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
19694389|NCT04967326|Phenytoin|phenytoin|mesh-list
20222034|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20222035|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20222036|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20222037|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
20222038|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222039|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222040|NCT00327379|Aprotinin|aprotinin|mesh-list
20222041|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
20222042|NCT00327379|Coagulants|coagulants|mesh-ancestor
20222043|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20222044|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20222045|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
20222046|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222047|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222048|NCT00327418|Atorvastatin|atorvastatin|mesh-list
20222049|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20222050|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20454863|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
20454864|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
20454865|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454866|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
20454867|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20454868|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20454869|NCT01405248|Protective Agents|protective agents|mesh-ancestor
20454870|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526033|NCT01760824|Clarithromycin|clarithromycin|mesh-list
20526034|NCT01760824|Tetracycline|tetracycline|mesh-list
20526035|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20526036|NCT01760824|Esomeprazole|esomeprazole|mesh-list
20526037|NCT01760824|Bismuth|bismuth|mesh-list
20526038|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526039|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526040|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20526041|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20526042|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20526043|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407319|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407320|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407321|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19407322|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19407323|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407324|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19407325|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19407326|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526044|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20526045|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526046|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526047|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20526048|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20526049|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20526050|NCT01760824|Antacids|antacids|mesh-ancestor
20526051|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20526052|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526053|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
20526054|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20526055|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20526056|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526057|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526058|NCT01760967|Analgesics|analgesics|mesh-ancestor
20526059|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
20526060|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526061|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20526062|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20526063|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20526064|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
20526065|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526066|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526067|NCT01760980|Exemestane|exemestane|mesh-list
20526068|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526069|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20526070|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20526071|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526072|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526073|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20526074|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
20526075|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526076|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526077|NCT01761071|Diclofenac|diclofenac|mesh-list
20526078|NCT01761071|Ketorolac|ketorolac|mesh-list
20526079|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526080|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526081|NCT01761071|Analgesics|analgesics|mesh-ancestor
20526082|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
20526083|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526084|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526085|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526086|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526087|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20526088|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526089|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526090|NCT01761110|Buprenorphine|buprenorphine|mesh-list
20454871|NCT01405326|Adalimumab|adalimumab|mesh-list
20454872|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454873|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20454874|NCT01405339|Budesonide|budesonide|mesh-list
20454875|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20454876|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20454877|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
20454878|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454879|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454880|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19407327|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
19407328|NCT03574857|Metolazone|metolazone|mesh-list
19407329|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
19407330|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19407331|NCT03574857|Diuretics|diuretics|mesh-ancestor
19407332|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
19407333|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454881|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
20454882|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
20454883|NCT01405339|Hormones|hormones|mesh-ancestor
20454884|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454885|NCT01405352|Vitamin A|vitamin a|mesh-list
20454886|NCT01405352|Vitamins|vitamins|mesh-ancestor
20454887|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
20454888|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454889|NCT01405365|Metronidazole|metronidazole|mesh-list
20454890|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454891|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454892|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20454893|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20454894|NCT01405430|Bevacizumab|bevacizumab|mesh-list
20454895|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20454896|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454897|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20454898|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20454899|NCT01405430|Growth Substances|growth substances|mesh-ancestor
20454900|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454901|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
20454902|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
20454903|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20454904|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20454905|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20454906|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20454907|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454908|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
20454909|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454910|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454911|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20454912|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20454913|NCT01405521|Vaccines|vaccines|mesh-list
20454914|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
20454915|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454916|NCT01405573|Sorafenib|sorafenib|mesh-list
20454917|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454918|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20454919|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454920|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454921|NCT01405586|Gemcitabine|gemcitabine|mesh-list
20454922|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454923|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20454924|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
20454925|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454926|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
20454927|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454928|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454929|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20454930|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
20454931|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454932|NCT01405612|Midazolam|midazolam|mesh-list
20454933|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20454934|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19407334|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20454935|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20454936|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454937|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20454938|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20454939|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454940|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20454941|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
20454942|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
20454943|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
19694390|NCT04967326|Valproic Acid|valproic acid|mesh-list
19694391|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
19694392|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694393|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694394|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
19694395|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694396|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694397|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
19694398|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19694399|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694400|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19849219|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849220|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
20454944|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
20454945|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20454946|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454947|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
20454948|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20454949|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454950|NCT01405846|Gefitinib|gefitinib|mesh-list
20454951|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454952|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20454953|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454954|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454955|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
20454956|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20454957|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
20454958|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454959|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20454960|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
20454961|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454962|NCT01405989|Ketoconazole|ketoconazole|mesh-list
20454963|NCT01405989|Darexaban|darexaban|mesh-list
20454964|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
20454965|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407335|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407336|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407337|NCT03574701|Vitamin A|vitamin a|mesh-list
20454966|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20454967|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20454968|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454969|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20454970|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20454971|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
20454972|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20454973|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20454974|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20454975|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20454976|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
20454977|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19849221|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849222|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20454978|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
20454979|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
20454980|NCT01406002|Rifampin|rifampin|mesh-list
20454981|NCT01406002|Darexaban|darexaban|mesh-list
20454982|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20454983|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
20454984|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20454985|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20454986|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
20454987|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20454988|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20454989|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849223|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
19849224|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20454990|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19694401|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19849225|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20454991|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20454992|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20454993|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20454994|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20454995|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20454996|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20454997|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
20454998|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20454999|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
20455000|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
20455001|NCT01406080|Adapalene|adapalene|mesh-list
20455002|NCT01406080|Tretinoin|tretinoin|mesh-list
20455003|NCT01406080|Emollients|emollients|mesh-list
20455004|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20455005|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20455006|NCT01406080|Analgesics|analgesics|mesh-ancestor
20455007|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
20455008|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455009|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455010|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455011|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20455012|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455013|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455014|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
20455015|NCT01406132|Peficitinib|peficitinib|mesh-list
20455016|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455017|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455018|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455019|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
20455020|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455021|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
20455022|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20455023|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20455024|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
20455025|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455026|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455027|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455028|NCT01406158|Urological Agents|urological agents|mesh-ancestor
20455029|NCT01406171|Isavuconazole|isavuconazole|mesh-list
20455030|NCT01406171|Midazolam|midazolam|mesh-list
20455031|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20455032|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20455033|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455034|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455035|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20455036|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20455037|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20455038|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20455039|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
20455040|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
20455041|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
20455042|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
20455043|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455044|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455045|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
20455046|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455047|NCT01406197|Progesterone|progesterone|mesh-list
19407338|NCT03574701|Vitamins|vitamins|mesh-ancestor
19407339|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
19694402|NCT04967326|Analgesics|analgesics|mesh-ancestor
19694403|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
19694404|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694405|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19694406|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19694407|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19694408|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19694409|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19694410|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19694411|NCT04967417|Paclitaxel|paclitaxel|mesh-list
19694412|NCT04967417|Carboplatin|carboplatin|mesh-list
19694413|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
20455048|NCT01406197|Progestins|progestins|mesh-ancestor
20455049|NCT01406197|Hormones|hormones|mesh-ancestor
20455050|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455051|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455052|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
20455053|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
20455054|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20455055|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455056|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20455057|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20455058|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455059|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455060|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455061|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455062|NCT01406262|Incretins|incretins|mesh-ancestor
19694414|NCT04967417|Pemetrexed|pemetrexed|mesh-list
19694415|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19694416|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694417|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
20455063|NCT01406262|Hormones|hormones|mesh-ancestor
20455064|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455065|NCT01406275|Amoxicillin|amoxicillin|mesh-list
20455066|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
20455067|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
20455068|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20455069|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455070|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20455071|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455072|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455073|NCT01406301|PENTA|penta|mesh-list
20455074|NCT01406301|Fondaparinux|fondaparinux|mesh-list
20455075|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20455076|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
20455077|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20455078|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
20455079|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455080|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455081|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
20455082|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20455083|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20455084|NCT01406327|Ambrisentan|ambrisentan|mesh-list
20455085|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20455086|NCT01406392|Misoprostol|misoprostol|mesh-list
20455087|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20455088|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
20455089|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20455090|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455091|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20455092|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455093|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
20455094|NCT01406431|Valsartan|valsartan|mesh-list
20455095|NCT01406431|Pitavastatin|pitavastatin|mesh-list
20455096|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20455097|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20455098|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20455099|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455100|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20455101|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20455102|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20455103|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
20455104|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455105|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20455106|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
20455107|NCT01406470|Antibodies|antibodies|mesh-list
20455108|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
20455109|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20455110|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20455111|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
20613923|NCT02256943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407340|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407341|NCT03574649|Paclitaxel|paclitaxel|mesh-list
19407342|NCT03574649|Docetaxel|docetaxel|mesh-list
19407343|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
19407344|NCT03574649|Carboplatin|carboplatin|mesh-list
19407345|NCT03574649|Fluorouracil|fluorouracil|mesh-list
19407346|NCT03574649|Avelumab|avelumab|mesh-list
20455112|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
20455113|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407347|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19407348|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694418|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
20455114|NCT01406496|Insulin|insulin|mesh-list
20455115|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20455116|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20455117|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455118|NCT01406522|Tacrine|tacrine|mesh-list
20455119|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20455120|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455121|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455122|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
20455123|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455124|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455125|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20455126|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
20455127|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455128|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
20455129|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20455130|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
20455131|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20455132|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20455133|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455134|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455135|NCT01406535|Urological Agents|urological agents|mesh-ancestor
20455136|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20455137|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
20455138|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455139|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20455140|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20455141|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455142|NCT01406639|Ranibizumab|ranibizumab|mesh-list
20455143|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20455144|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20455145|NCT01406639|Growth Substances|growth substances|mesh-ancestor
20455146|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455147|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
20455148|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455149|NCT01406678|Sufentanil|sufentanil|mesh-list
20455150|NCT01406678|Dsuvia|dsuvia|mesh-list
20455151|NCT01406678|Isoflurane|isoflurane|mesh-list
20455152|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
20455153|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455154|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455155|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20455156|NCT01406678|Narcotics|narcotics|mesh-ancestor
20455157|NCT01406678|Analgesics|analgesics|mesh-ancestor
20455158|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
20455159|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455160|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20455161|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20455162|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
20455163|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20455164|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
20455165|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
20455166|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20455167|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455168|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
20455169|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455170|NCT01406704|Protective Agents|protective agents|mesh-ancestor
20455171|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
20455172|NCT01406704|Vitamins|vitamins|mesh-ancestor
20455173|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
20455174|NCT01406782|Rituximab|rituximab|mesh-list
20455175|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20455176|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455177|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
20455178|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455179|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526091|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20526092|NCT01761110|Narcotics|narcotics|mesh-ancestor
20526093|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20526094|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526095|NCT01761110|Analgesics|analgesics|mesh-ancestor
20526096|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
20526097|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526098|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19407349|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
20526099|NCT01761136|Vaccines|vaccines|mesh-list
20526100|NCT01761136|Immunologic Factors|immunologic factors|mesh-ancestor
20526101|NCT01761136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455180|NCT01407016|Metronidazole|metronidazole|mesh-list
20455181|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455182|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20455183|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20455184|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20455185|NCT01407211|Vitamin A|vitamin a|mesh-list
20455186|NCT01407211|Vitamins|vitamins|mesh-ancestor
20455187|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
20455188|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455189|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
20455190|NCT01407237|Giapreza|giapreza|mesh-list
19694419|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
19694420|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694421|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694422|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455191|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
20455192|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20455193|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20455194|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
20455195|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455196|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455197|NCT01407289|Insulin|insulin|mesh-list
20455198|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
20455199|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
20455200|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20455201|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455202|NCT01407432|Folic Acid|folic acid|mesh-list
20455203|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
20455204|NCT01407432|Hematinics|hematinics|mesh-ancestor
20455205|NCT01407432|Vitamins|vitamins|mesh-ancestor
20455206|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
20455207|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455208|NCT01407471|Clobetasol|clobetasol|mesh-list
20455209|NCT01407471|Spironolactone|spironolactone|mesh-list
20455210|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20455211|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
20455212|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455213|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455214|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20455215|NCT01407471|Diuretics|diuretics|mesh-ancestor
20455216|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
20455217|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455218|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
20455219|NCT01407471|Hormones|hormones|mesh-ancestor
20455220|NCT01407484|Prednisone|prednisone|mesh-list
20455221|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455222|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
20455223|NCT01407484|Hormones|hormones|mesh-ancestor
20455224|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455225|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455226|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20455227|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455228|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20455229|NCT01407562|Paclitaxel|paclitaxel|mesh-list
20455230|NCT01407562|Carboplatin|carboplatin|mesh-list
20455231|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20455232|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455233|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
20455234|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
20455235|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
20455236|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455237|NCT01407666|Anesthetics|anesthetics|mesh-list
20455238|NCT01407666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455239|NCT01407666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455240|NCT01407679|Alitretinoin|alitretinoin|mesh-list
20455241|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455242|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455243|NCT01407822|Gemcitabine|gemcitabine|mesh-list
20455244|NCT01407822|Cisplatin|cisplatin|mesh-list
20455245|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20455246|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455247|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20455248|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
20455249|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455250|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
20455251|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455252|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455253|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455254|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
20455255|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455256|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20455257|NCT01407848|Furosemide|furosemide|mesh-list
20455258|NCT01407848|Diuretics|diuretics|mesh-ancestor
20455259|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
20455260|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455261|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20455262|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455263|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455264|NCT01407887|Artesunate|artesunate|mesh-list
20455265|NCT01407887|Amodiaquine|amodiaquine|mesh-list
20455266|NCT01407887|Methylene Blue|methylene blue|mesh-list
20455267|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
20455268|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20455269|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20455270|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455271|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455272|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
20455273|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
20455274|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20455275|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
20455276|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455277|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455278|NCT01407978|Vaccines|vaccines|mesh-list
20455279|NCT01407978|Immunologic Factors|immunologic factors|mesh-ancestor
20455280|NCT01407978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455281|NCT01408004|Everolimus|everolimus|mesh-list
20455282|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455283|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455284|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
20455285|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455286|NCT01408056|Mupirocin|mupirocin|mesh-list
20455287|NCT01408056|Timolol|timolol|mesh-list
20455288|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20455289|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20455290|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
20455291|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455292|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455293|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455294|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20455295|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20455296|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20455297|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455298|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20455299|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455300|NCT01408095|Glimepiride|glimepiride|mesh-list
20455301|NCT01408095|Globalagliatin|globalagliatin|mesh-list
20455302|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20455303|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20455304|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455305|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455306|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
20455307|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
20455308|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455309|NCT01408160|Cytarabine|cytarabine|mesh-list
20455310|NCT01408160|Immunotoxins|immunotoxins|mesh-list
20455311|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20455312|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
20455313|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455314|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455315|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
20455316|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455317|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455318|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
20455319|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407350|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
19407351|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
19407352|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694423|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20455320|NCT01408173|Caffeine|caffeine|mesh-list
20455321|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
20455322|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455323|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20455324|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455325|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20455326|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455327|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20455328|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20455329|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
20455330|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455331|NCT01408186|Rabeprazole|rabeprazole|mesh-list
20455332|NCT01408186|Famotidine|famotidine|mesh-list
20455333|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20455334|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455335|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20455336|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455337|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455338|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20455339|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
20455340|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
20455341|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455342|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455343|NCT01408199|Lenalidomide|lenalidomide|mesh-list
20455344|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
20455345|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455346|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20455347|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20455348|NCT01408199|Growth Substances|growth substances|mesh-ancestor
20455349|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
20455350|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455351|NCT01408290|Vaccines|vaccines|mesh-list
20455352|NCT01408290|Immunologic Factors|immunologic factors|mesh-ancestor
20455353|NCT01408290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455354|NCT01408342|Rituximab|rituximab|mesh-list
20455355|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
20455356|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20455357|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455358|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
20455359|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455360|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20455361|NCT01408394|Ecopipam|ecopipam|mesh-list
20455362|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20455363|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20455364|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455365|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455366|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20455367|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20455368|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
20455369|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455370|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455371|NCT01408446|Menthol|menthol|mesh-list
20455372|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
20455373|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455374|NCT01408498|Testosterone|testosterone|mesh-list
20455375|NCT01408498|Androgens|androgens|mesh-ancestor
20455376|NCT01408498|Hormones|hormones|mesh-ancestor
20455377|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455378|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455379|NCT01408524|Diltiazem|diltiazem|mesh-list
20455380|NCT01408524|Labetalol|labetalol|mesh-list
20455381|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20455382|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20455383|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455384|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455385|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20455386|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455387|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
20455388|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20455389|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20455390|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
20455391|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455392|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
20455393|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
20455394|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455395|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20455396|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20455397|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20455398|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20455399|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20455400|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455401|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455402|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
20455403|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455404|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526102|NCT01761149|Remifentanil|remifentanil|mesh-list
20526103|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20526104|NCT01761149|Narcotics|narcotics|mesh-ancestor
20526105|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20526106|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526107|NCT01761149|Analgesics|analgesics|mesh-ancestor
20526108|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
20526109|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526110|NCT01761201|Levofloxacin|levofloxacin|mesh-list
20526111|NCT01761201|Ofloxacin|ofloxacin|mesh-list
20526112|NCT01761201|Isoniazid|isoniazid|mesh-list
20526113|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20526114|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526115|NCT01761201|Renal Agents|renal agents|mesh-ancestor
20526116|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19407353|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407354|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
20526117|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20526118|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20526119|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526120|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526121|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526122|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20526123|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20526124|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
20526125|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20526126|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20526127|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
20526128|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20526129|NCT01761214|Amoxicillin|amoxicillin|mesh-list
20526130|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
20526131|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
20526132|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
20526133|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20526134|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
20526135|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526136|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526137|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20526138|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20526139|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526140|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526141|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526142|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20526143|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20526144|NCT01761318|Liraglutide|liraglutide|mesh-list
19694424|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19694425|NCT04967196|Nivolumab|nivolumab|mesh-list
19694426|NCT04967196|Ipilimumab|ipilimumab|mesh-list
19694427|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694428|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526145|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20526146|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526147|NCT01761318|Incretins|incretins|mesh-ancestor
20526148|NCT01761318|Hormones|hormones|mesh-ancestor
20526149|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526150|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
20526151|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526152|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
20526153|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526154|NCT01761487|Gentamicins|gentamicins|mesh-list
20526155|NCT01761487|Polymyxins|polymyxins|mesh-list
20526156|NCT01761487|Colistin|colistin|mesh-list
20526157|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526158|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526159|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20526160|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694429|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19694430|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694431|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
20222051|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
20222052|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222053|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20222054|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20222055|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222056|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20222057|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
20455405|NCT01408680|Ubiquinone|ubiquinone|mesh-list
20455406|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
20455407|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
20455408|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455409|NCT01408680|Vitamins|vitamins|mesh-ancestor
20455410|NCT01408797|Bortezomib|bortezomib|mesh-list
20455411|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455412|NCT01408810|Infliximab|infliximab|mesh-list
20455413|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455414|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455415|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20455416|NCT01408836|Prednisolone|prednisolone|mesh-list
20455417|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20455418|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
20455419|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20455420|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
20455421|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20455422|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
20455423|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455424|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
20455425|NCT01408836|Hormones|hormones|mesh-ancestor
20455426|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455427|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455428|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20455429|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455430|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
20455431|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
20455432|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455433|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455434|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20455435|NCT01408836|Protective Agents|protective agents|mesh-ancestor
20455436|NCT01408849|Omeprazole|omeprazole|mesh-list
20455437|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20455438|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455439|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20455440|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455441|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455442|NCT01408927|Aspirin|aspirin|mesh-list
20455443|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20455444|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20455445|NCT01408927|Analgesics|analgesics|mesh-ancestor
20455446|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
20455447|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455448|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455449|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455450|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222058|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222059|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
20222060|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
20222061|NCT00327535|Hematinics|hematinics|mesh-ancestor
20222062|NCT00327587|Amlodipine|amlodipine|mesh-list
20222063|NCT00327587|Valsartan|valsartan|mesh-list
20222064|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20222065|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20222066|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20222067|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222068|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222069|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20222070|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222071|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
20222072|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20222073|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20222074|NCT00327587|Diuretics|diuretics|mesh-ancestor
20222075|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
20222076|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20222077|NCT00327665|Vaccines|vaccines|mesh-list
20455451|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20455452|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20455453|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455454|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20455455|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20455456|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455457|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
20455458|NCT01408953|Bevacizumab|bevacizumab|mesh-list
20455459|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20455460|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455461|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20455462|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20455463|NCT01408953|Growth Substances|growth substances|mesh-ancestor
20455464|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455465|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
20455466|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
20455467|NCT01408979|Analgesics|analgesics|mesh-ancestor
20455468|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
20455469|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455470|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455471|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
20455472|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455473|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20455474|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
20455475|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20455476|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455477|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455478|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20455479|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
20455480|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20455481|NCT01409005|Gemcitabine|gemcitabine|mesh-list
20455482|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20455483|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
20455484|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455485|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455486|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
20455487|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455488|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455489|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455490|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
20455491|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455492|NCT01409018|Itraconazole|itraconazole|mesh-list
20455493|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20455494|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
20455495|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455496|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20455497|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20455498|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455499|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455500|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20455501|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
20455502|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455503|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455504|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20455505|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20455506|NCT01409148|Antibodies|antibodies|mesh-list
20455507|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20455508|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
20455509|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455510|NCT01409174|Interferons|interferons|mesh-list
20455511|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
20455512|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
20455513|NCT01409174|Aldesleukin|aldesleukin|mesh-list
20455514|NCT01409174|Cisplatin|cisplatin|mesh-list
20455515|NCT01409174|Temozolomide|temozolomide|mesh-list
20455516|NCT01409174|Ipilimumab|ipilimumab|mesh-list
20455517|NCT01409174|Interleukin-2|interleukin-2|mesh-list
20455518|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455519|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
20455520|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455521|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20455522|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
20455523|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455524|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20455525|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20455526|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
20455527|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455528|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20455529|NCT01409174|Analgesics|analgesics|mesh-ancestor
20455530|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
20455531|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455532|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20455533|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20455534|NCT01409187|Interferons|interferons|mesh-list
20455535|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
20455536|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
20455537|NCT01409187|Aldesleukin|aldesleukin|mesh-list
20455538|NCT01409187|Ipilimumab|ipilimumab|mesh-list
20455539|NCT01409187|Interleukin-2|interleukin-2|mesh-list
20455540|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455541|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
20455542|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455543|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20455544|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20455545|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455546|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
20455547|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455548|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19849226|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20455549|NCT01409187|Analgesics|analgesics|mesh-ancestor
20455550|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
20455551|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455552|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20455553|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20455554|NCT01409278|Ropivacaine|ropivacaine|mesh-list
20455555|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
20455556|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
20455557|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455558|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455559|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
20455560|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455561|NCT01409369|Charcoal|charcoal|mesh-list
20455562|NCT01409369|Antidotes|antidotes|mesh-ancestor
20455563|NCT01409369|Protective Agents|protective agents|mesh-ancestor
20455564|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455565|NCT01409395|Metformin|metformin|mesh-list
20613924|NCT02256943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407355|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407356|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407357|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407358|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
19407359|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19407360|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
19407361|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407362|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407363|NCT03574402|Gemcitabine|gemcitabine|mesh-list
19407364|NCT03574402|Carboplatin|carboplatin|mesh-list
19407365|NCT03574402|Pemetrexed|pemetrexed|mesh-list
19407366|NCT03574402|Afatinib|afatinib|mesh-list
19407367|NCT03574402|Crizotinib|crizotinib|mesh-list
19407368|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
19407369|NCT03574402|Ensartinib|ensartinib|mesh-list
19407370|NCT03574402|Maleic acid|maleic acid|mesh-list
19407371|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407372|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407373|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
19407374|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407375|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
20613925|NCT02256956|Amitriptyline|amitriptyline|mesh-list
20613926|NCT02256956|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20613927|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20613928|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20613929|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19407376|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407377|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407378|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407379|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
19407380|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455566|NCT01409395|Nizatidine|nizatidine|mesh-list
19407381|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19407382|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20455567|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20455568|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455569|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20455570|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455571|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20455572|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
20455573|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
20455574|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455575|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455576|NCT01409408|Amlodipine|amlodipine|mesh-list
20455577|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20455578|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20455579|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19694432|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19694433|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
19694434|NCT04967495|Sorafenib|sorafenib|mesh-list
19694435|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
19694436|NCT04967495|Lenvatinib|lenvatinib|mesh-list
20455580|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455581|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20455582|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455583|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
20455584|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20455585|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20455586|NCT01409499|Sorafenib|sorafenib|mesh-list
20455587|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455588|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20455589|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455590|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455591|NCT01409603|Naproxen|naproxen|mesh-list
20455592|NCT01409603|Darexaban|darexaban|mesh-list
20455593|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20455594|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20455595|NCT01409603|Analgesics|analgesics|mesh-ancestor
20455596|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
20455597|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455598|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455599|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455600|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20455601|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
20455602|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19694437|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694438|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694439|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694440|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694441|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19694442|NCT04967495|Estrogens|estrogens|mesh-ancestor
19694443|NCT04967495|Hormones|hormones|mesh-ancestor
19694444|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19694445|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694446|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19694447|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
19694448|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
19694449|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694450|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
20222078|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20222079|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
20222080|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222081|NCT00327678|Rituximab|rituximab|mesh-list
20222082|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
20222083|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20222084|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222085|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
20222086|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222087|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222088|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20222089|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222090|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222091|NCT00327691|Atorvastatin|atorvastatin|mesh-list
20222092|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20222093|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222094|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
20455603|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530557|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694451|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222095|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455604|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455605|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20455606|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
20455607|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20455608|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
20455609|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
20455610|NCT01409616|Aspirin|aspirin|mesh-list
20455611|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
20455612|NCT01409616|Salicylates|salicylates|mesh-list
20455613|NCT01409616|Darexaban|darexaban|mesh-list
20455614|NCT01409616|Clopidogrel|clopidogrel|mesh-list
20455615|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20455616|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20455617|NCT01409616|Analgesics|analgesics|mesh-ancestor
20455618|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
20455619|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455620|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455621|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455622|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20455623|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20455624|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20455625|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455626|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20455627|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20455628|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455629|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
20455630|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20455631|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20455632|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20455633|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
20455634|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455635|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455636|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
20455637|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
20455638|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455639|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20455640|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
20455641|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20455642|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
20455643|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
20455644|NCT01409694|Vitamin D|vitamin d|mesh-list
20455645|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
20455646|NCT01409694|Vitamins|vitamins|mesh-list
20455647|NCT01409694|Memantine|memantine|mesh-list
20455648|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
20455649|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455650|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20455651|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20455652|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20455653|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20455654|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
20455655|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455656|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455657|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20455658|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20455659|NCT01409733|Doxorubicin|doxorubicin|mesh-list
20455660|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20455661|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455662|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20455663|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20455664|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455665|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455666|NCT01409772|Ethanol|ethanol|mesh-list
20455667|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20613930|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
20222096|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20222097|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20222098|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222099|NCT00327730|Eperisone|eperisone|mesh-list
20222100|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
20222101|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20222102|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222103|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222104|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20222105|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455668|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455669|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455670|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455671|NCT01410162|Tacrolimus|tacrolimus|mesh-list
20455672|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455673|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
20455674|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455675|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20455676|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455677|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455678|NCT01410201|Dexamethasone|dexamethasone|mesh-list
20455679|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
20455680|NCT01410201|BB 1101|bb 1101|mesh-list
20455681|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455682|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
20455683|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
20455684|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455685|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455686|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455687|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
20455688|NCT01410201|Hormones|hormones|mesh-ancestor
20455689|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455690|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20455691|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455692|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
20455693|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455694|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455695|NCT01410214|Cisplatin|cisplatin|mesh-list
20455696|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20455697|NCT01410214|Vinorelbine|vinorelbine|mesh-list
20455698|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455699|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20455700|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455701|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455702|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20455703|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
20455704|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
20455705|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
20455706|NCT01410370|Endostar protein|endostar protein|mesh-list
20455707|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20455708|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20455709|NCT01410370|Growth Substances|growth substances|mesh-ancestor
20455710|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455711|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
20455712|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526161|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526162|NCT01761513|Esomeprazole|esomeprazole|mesh-list
20526163|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20526164|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20526165|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20526166|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526167|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526168|NCT01761526|Rotigotine|rotigotine|mesh-list
20526169|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
20526170|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
20526171|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526172|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526173|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526174|NCT01761552|Atropine|atropine|mesh-list
20526175|NCT01761552|Neostigmine|neostigmine|mesh-list
20526176|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20526177|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20526178|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20526179|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
20526180|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526181|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526182|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20526183|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
20526184|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
20526185|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
20526186|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20526187|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19849227|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526188|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
20526189|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455713|NCT01410630|Telbivudine|telbivudine|mesh-list
20455714|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
20455715|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455716|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20455717|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455718|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455719|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
20455720|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20455721|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455722|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
20455723|NCT01410708|Dasatinib|dasatinib|mesh-list
20455724|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455725|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20455726|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455727|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455728|NCT01410747|Tacrolimus|tacrolimus|mesh-list
20455729|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455730|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
20455731|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455732|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20455733|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455734|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455735|NCT01410916|Eculizumab|eculizumab|mesh-list
20455736|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20455737|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455738|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
20455739|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455740|NCT01410942|Methylphenidate|methylphenidate|mesh-list
20455741|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20455742|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407383|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19407384|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407385|NCT03574376|Bupivacaine|bupivacaine|mesh-list
20455743|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20455744|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20455745|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455746|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455747|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
20455748|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455749|NCT01410968|Poly ICLC|poly iclc|mesh-list
20455750|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
20455751|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
20455752|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455753|NCT01411072|Gemcitabine|gemcitabine|mesh-list
20455754|NCT01411072|Fluorouracil|fluorouracil|mesh-list
20455755|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20455756|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
20455757|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455758|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455759|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
20455760|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455761|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455762|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455763|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
20455764|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455765|NCT01411098|Etoposide|etoposide|mesh-list
20455766|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
20455767|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455768|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20455769|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20455770|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20455771|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455772|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455773|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20455774|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20455775|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20455776|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
20455777|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455778|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20455779|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20455780|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455781|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
20455782|NCT01411124|Promethazine|promethazine|mesh-list
20455783|NCT01411124|Gabapentin|gabapentin|mesh-list
20455784|NCT01411124|Analgesics|analgesics|mesh-ancestor
20455785|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
20455786|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455787|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455788|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
20455789|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20455790|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20455791|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455792|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20455793|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20455794|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20455795|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455796|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455797|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
20455798|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20455799|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20455800|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
20455801|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
20455802|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
20455803|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
20455804|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455805|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20455806|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
20455807|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
20455808|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20455809|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
20455810|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455811|NCT01411176|Menthol|menthol|mesh-list
20455812|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
20455813|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455814|NCT01411189|Menthol|menthol|mesh-list
20455815|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
20455816|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
20455817|NCT01411202|Doxycycline|doxycycline|mesh-list
20455818|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20455819|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455820|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
20455821|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20455822|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20455823|NCT01411254|Betamethasone|betamethasone|mesh-list
20455824|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
20455825|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20455826|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
20455827|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20613931|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407386|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
20222106|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20222107|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20222108|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222109|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
20222110|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
20222111|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
20222112|NCT00327756|Ubiquinone|ubiquinone|mesh-list
20222113|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
20222114|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
20222115|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222116|NCT00327756|Vitamins|vitamins|mesh-ancestor
20222117|NCT00327769|Fulvestrant|fulvestrant|mesh-list
20222118|NCT00327769|Anastrozole|anastrozole|mesh-list
20222119|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20222120|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222121|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20222122|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20222123|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222124|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222125|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222126|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20222127|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20222128|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222129|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222130|NCT00327808|Budesonide|budesonide|mesh-list
19407387|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
20222131|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222132|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19407388|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455828|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455829|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
20455830|NCT01411254|Hormones|hormones|mesh-ancestor
20455831|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455832|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455833|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20455834|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
20455835|NCT01411280|Methylphenidate|methylphenidate|mesh-list
20455836|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20455837|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455838|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20455839|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20455840|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455841|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455842|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
20455843|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455844|NCT01411410|Paclitaxel|paclitaxel|mesh-list
20455845|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20455846|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455847|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
20455848|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
20455849|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
20455850|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455851|NCT01411423|Sorafenib|sorafenib|mesh-list
20455852|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455853|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20455854|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455855|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455856|NCT01411436|Sorafenib|sorafenib|mesh-list
20455857|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455858|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20455859|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455860|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455861|NCT01411514|Prednisone|prednisone|mesh-list
20455862|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20455863|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
20455864|NCT01411514|Hormones|hormones|mesh-ancestor
20455865|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20455866|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455867|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20455868|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455869|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20455870|NCT01411670|Protein C|protein c|mesh-list
20455871|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
20455872|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20455873|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20455874|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455875|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20455876|NCT01411735|Enalapril|enalapril|mesh-list
20455877|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20455878|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
20455879|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20455880|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455881|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20455882|NCT01411930|Olanzapine|olanzapine|mesh-list
20455883|NCT01411930|Aripiprazole|aripiprazole|mesh-list
20455884|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
20455885|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
20455886|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455887|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455888|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455889|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20455890|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20455891|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455892|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20455893|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20455894|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20455895|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455896|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455897|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455898|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
20455899|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
20455900|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
20455901|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
20455902|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20455903|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20455904|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20455905|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20455906|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20455907|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20455908|NCT01411969|Phenylephrine|phenylephrine|mesh-list
20455909|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
20455910|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20455911|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20455912|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
20455913|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455914|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455915|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455916|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
20455917|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
20455918|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20455919|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
20455920|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20455921|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
20455922|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20455923|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
20455924|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20455925|NCT01411969|Protective Agents|protective agents|mesh-ancestor
20455926|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
20455927|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20455928|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455929|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455930|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
20455931|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20455932|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455933|NCT01412073|Misoprostol|misoprostol|mesh-list
20455934|NCT01412073|Oxytocin|oxytocin|mesh-list
20455935|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
20455936|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20455937|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455938|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20455939|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
20455940|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20455941|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20455942|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
20455943|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20455944|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
20455945|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455946|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
20455947|NCT01412190|Protective Agents|protective agents|mesh-ancestor
20526190|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526191|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20526192|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526193|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20526194|NCT01761656|Atorvastatin|atorvastatin|mesh-list
20526195|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20526196|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20526197|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
20613932|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407389|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407390|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
20222133|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
20222134|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222135|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222136|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19407391|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407392|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
19407393|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19407394|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19407395|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407396|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19407397|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20222137|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
20222138|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
20222139|NCT00327808|Hormones|hormones|mesh-ancestor
20222140|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526198|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407398|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
20455948|NCT01412294|Capecitabine|capecitabine|mesh-list
20455949|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455950|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20455951|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
20455952|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455953|NCT01412307|Lenalidomide|lenalidomide|mesh-list
20455954|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20455955|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
20455956|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455957|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20455958|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20455959|NCT01412307|Growth Substances|growth substances|mesh-ancestor
20455960|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
20455961|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455962|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20455963|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
20455964|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455965|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
20455966|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20455967|NCT01412385|Antibodies|antibodies|mesh-list
20455968|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
20455969|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20455970|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
20455971|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
20455972|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455973|NCT01412411|Micronutrients|micronutrients|mesh-list
20455974|NCT01412411|Trace Elements|trace elements|mesh-list
20455975|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455976|NCT01412437|Verapamil|verapamil|mesh-list
20455977|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20455978|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20455979|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20455980|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20455981|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20455982|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455983|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
20455984|NCT01412515|Everolimus|everolimus|mesh-list
20455985|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20455986|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20455987|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
20455988|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455989|NCT01412567|Vaccines|vaccines|mesh-list
20455990|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
20455991|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455992|NCT01412632|Remifentanil|remifentanil|mesh-list
20455993|NCT01412632|Propofol|propofol|mesh-list
20455994|NCT01412632|Prilocaine|prilocaine|mesh-list
20455995|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20455996|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20455997|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20455998|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20455999|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
20456000|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
20456001|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20456002|NCT01412632|Narcotics|narcotics|mesh-ancestor
19849228|NCT00701090|Metformin|metformin|mesh-list
19849229|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20456003|NCT01412632|Analgesics|analgesics|mesh-ancestor
20456004|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
20456005|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849230|NCT00701090|Glimepiride|glimepiride|mesh-list
19849231|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19849232|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849233|NCT00701090|Incretins|incretins|mesh-ancestor
19849234|NCT00701090|Hormones|hormones|mesh-ancestor
20456006|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
20456007|NCT01412645|Resveratrol|resveratrol|mesh-list
20456008|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
20456009|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456010|NCT01412645|Protective Agents|protective agents|mesh-ancestor
20456011|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456012|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613933|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849235|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456013|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20456014|NCT01412658|Caseins|caseins|mesh-list
20456015|NCT01412658|Glycerol|glycerol|mesh-list
20456016|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
20456017|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
20456018|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456019|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20456020|NCT01412658|Protective Agents|protective agents|mesh-ancestor
20456021|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456022|NCT01412671|Sorafenib|sorafenib|mesh-list
20456023|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456024|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20456025|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456026|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456027|NCT01412840|Diclofenac|diclofenac|mesh-list
20456028|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20456029|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20456030|NCT01412840|Analgesics|analgesics|mesh-ancestor
20456031|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
20456032|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456033|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456034|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20456035|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20456036|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20456037|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456038|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456039|NCT01412892|Everolimus|everolimus|mesh-list
20456040|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456041|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456042|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
20456043|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456044|NCT01413022|Leucovorin|leucovorin|mesh-list
20456045|NCT01413022|Fluorouracil|fluorouracil|mesh-list
20456046|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
20456047|NCT01413022|Irinotecan|irinotecan|mesh-list
20456048|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
20456049|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456050|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456051|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456052|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456053|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
20456054|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456055|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20456056|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20456057|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456058|NCT01413022|Antidotes|antidotes|mesh-ancestor
20456059|NCT01413022|Protective Agents|protective agents|mesh-ancestor
20456060|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
20456061|NCT01413022|Vitamins|vitamins|mesh-ancestor
20456062|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
20456063|NCT01413048|Carvedilol|carvedilol|mesh-list
20456064|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20456065|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20456066|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456067|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456068|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456069|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456070|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20456071|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
20456072|NCT01413048|Protective Agents|protective agents|mesh-ancestor
20456073|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20456074|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456075|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20456076|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
20456077|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20456078|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20456079|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
20456080|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20456081|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456082|NCT01413230|Vitamins|vitamins|mesh-ancestor
20456083|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
20456084|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456085|NCT01413477|Calcitriol|calcitriol|mesh-list
19407399|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456086|NCT01413477|Betamethasone|betamethasone|mesh-list
20456087|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
20456088|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20456089|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
20456090|NCT01413477|Calcipotriene|calcipotriene|mesh-list
20456091|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20456092|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20456093|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
20456094|NCT01413477|Hormones|hormones|mesh-ancestor
20456095|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456096|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456097|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20456098|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
20456099|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
20456100|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20456101|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20456102|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456103|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456104|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20456105|NCT01413477|Vitamins|vitamins|mesh-ancestor
20456106|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
20456107|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456108|NCT01413490|Rimantadine|rimantadine|mesh-list
20456109|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
20456110|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456111|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20456112|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456113|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456114|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
20456115|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456116|NCT01413620|Vitamins|vitamins|mesh-list
20456117|NCT01413620|Vitamin E|vitamin e|mesh-list
20456118|NCT01413620|Tocopherols|tocopherols|mesh-list
20456119|NCT01413620|Tocotrienols|tocotrienols|mesh-list
20456120|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
20456121|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
20456122|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456123|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
20456124|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456125|NCT01413620|Protective Agents|protective agents|mesh-ancestor
20456126|NCT01413711|Vigabatrin|vigabatrin|mesh-list
20456127|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
20456128|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456129|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456130|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
20456131|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456132|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456133|NCT01413763|Imiquimod|imiquimod|mesh-list
20456134|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20456135|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
20456136|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456137|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456138|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
20456139|NCT01413854|Diclofenac|diclofenac|mesh-list
20222141|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20222142|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20456140|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20456141|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20456142|NCT01413854|Analgesics|analgesics|mesh-ancestor
20456143|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
20456144|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456145|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456146|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20456147|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20456148|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20456149|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456150|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222143|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20222144|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222145|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222146|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
20222147|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222148|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222149|NCT00327847|Vitamin D|vitamin d|mesh-list
20222150|NCT00327847|Vitamins|vitamins|mesh-ancestor
20222151|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
20222152|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222153|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20526199|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20456151|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
20456152|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20456153|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
20456154|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20456155|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456156|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20456157|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20456158|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20456159|NCT01414231|Cytarabine|cytarabine|mesh-list
20456160|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456161|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
20456162|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456163|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456164|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
20456165|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456166|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456167|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
20456168|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456169|NCT01414465|Orlistat|orlistat|mesh-list
20456170|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456171|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456172|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20456173|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20456174|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20456175|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
20456176|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456177|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
20456178|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
20456179|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20456180|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456181|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20456182|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20456183|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456184|NCT01414556|Incretins|incretins|mesh-ancestor
20456185|NCT01414556|Hormones|hormones|mesh-ancestor
20456186|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456187|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456188|NCT01414569|Dexamethasone|dexamethasone|mesh-list
19407400|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407401|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
19407402|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20456189|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
20456190|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20456191|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
20456192|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
20456193|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456194|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456195|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456196|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
20456197|NCT01414569|Hormones|hormones|mesh-ancestor
20456198|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456199|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20456200|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456201|NCT01414608|Paclitaxel|paclitaxel|mesh-list
20456202|NCT01414608|Cisplatin|cisplatin|mesh-list
20456203|NCT01414608|Carboplatin|carboplatin|mesh-list
20456204|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20456205|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20456206|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456207|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
20456208|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
20456209|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
20456210|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456211|NCT01414816|Interferons|interferons|mesh-list
20456212|NCT01414816|Interferon-beta|interferon-beta|mesh-list
20456213|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
20456214|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456215|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
20456216|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456217|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
20456218|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456219|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20456220|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
20456221|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20456222|NCT01414868|Montelukast|montelukast|mesh-list
20613934|NCT02256956|Urological Agents|urological agents|mesh-ancestor
20456223|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
20456224|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20456225|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
20456226|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
20456227|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456228|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456229|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20456230|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20456231|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456232|NCT01414881|Mipomersen|mipomersen|mesh-list
20456233|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20456234|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20456235|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
20456236|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456237|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20456238|NCT01414972|Vitamin A|vitamin a|mesh-list
20456239|NCT01414972|Vitamins|vitamins|mesh-ancestor
20456240|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
20456241|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456242|NCT01414998|Nicotine|nicotine|mesh-list
20456243|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20456244|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
20456245|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456246|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456247|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20456248|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20456249|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
20456250|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456251|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456252|NCT01415011|Afatinib|afatinib|mesh-list
20456253|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456254|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20456255|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456256|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456257|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
20456258|NCT01415128|Desipramine|desipramine|mesh-list
20456259|NCT01415128|Omeprazole|omeprazole|mesh-list
20456260|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20456261|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456262|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20456263|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456264|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456265|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20456266|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456267|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20456268|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
20456269|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20456270|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20456271|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20456272|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456273|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456274|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456275|NCT01415141|Ribavirin|ribavirin|mesh-list
20456276|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20456277|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
20456278|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456279|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
20456280|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456281|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20456282|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
20456283|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
20456284|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
20456285|NCT01415336|Doxorubicin|doxorubicin|mesh-list
20456286|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20456287|NCT01415336|Capecitabine|capecitabine|mesh-list
20456288|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456289|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
20456290|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456291|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20456292|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20456293|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
20456294|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456295|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407403|NCT03574246|Benzydamine|benzydamine|mesh-list
20456296|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20456297|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20456298|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20456299|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20456300|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456301|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456302|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
20456303|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20456304|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20456305|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20456306|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20456307|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456308|NCT01415505|Valsartan|valsartan|mesh-list
20456309|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20456310|NCT01415505|Nebivolol|nebivolol|mesh-list
20456311|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20456312|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20456313|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20456314|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456315|NCT01415505|Diuretics|diuretics|mesh-ancestor
20456316|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
20456317|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456318|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20456319|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456320|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
20456321|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20456322|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20456323|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20456324|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456325|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456326|NCT01415557|Micronutrients|micronutrients|mesh-list
20456327|NCT01415557|Trace Elements|trace elements|mesh-list
20456328|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456329|NCT01415596|Albuterol|albuterol|mesh-list
20456330|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20456331|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
20456332|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456333|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456334|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20456335|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
20456336|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
20456337|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20456338|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20456339|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20456340|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20456341|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456342|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456343|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456344|NCT01415687|Bisacodyl|bisacodyl|mesh-list
20456345|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
20456346|NCT01415687|Citric Acid|citric acid|mesh-list
20456347|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
20456348|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
20456349|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20456350|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
20456351|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
20456352|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456353|NCT01415687|Cathartics|cathartics|mesh-ancestor
20456354|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456355|NCT01415687|Laxatives|laxatives|mesh-ancestor
20526200|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20526201|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526202|NCT01761669|Vitamin D|vitamin d|mesh-list
20526203|NCT01761669|Vitamins|vitamins|mesh-ancestor
20526204|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
20526205|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526206|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20526207|NCT01761877|Sulindac|sulindac|mesh-list
20526208|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526209|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526210|NCT01761877|Analgesics|analgesics|mesh-ancestor
20526211|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
20526212|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526213|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526214|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20456356|NCT01415713|Leucovorin|leucovorin|mesh-list
20456357|NCT01415713|Gemcitabine|gemcitabine|mesh-list
20456358|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
20456359|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456360|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
20456361|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456362|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456363|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
20456364|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456365|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456366|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456367|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
20456368|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456369|NCT01415713|Antidotes|antidotes|mesh-ancestor
20456370|NCT01415713|Protective Agents|protective agents|mesh-ancestor
20456371|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
20456372|NCT01415713|Vitamins|vitamins|mesh-ancestor
20456373|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
20456374|NCT01415765|Prednisone|prednisone|mesh-list
20456375|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
20456376|NCT01415765|Rituximab|rituximab|mesh-list
20456377|NCT01415765|Doxorubicin|doxorubicin|mesh-list
20456378|NCT01415765|Etoposide|etoposide|mesh-list
20456379|NCT01415765|Vincristine|vincristine|mesh-list
20456380|NCT01415765|Pevonedistat|pevonedistat|mesh-list
20456381|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456382|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
20456383|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456384|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20456385|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20456386|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
20456387|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456388|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456389|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20456390|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20456391|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20456392|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20456393|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20456394|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456395|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20456396|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
20456397|NCT01415765|Hormones|hormones|mesh-ancestor
20456398|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456399|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20456400|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20456401|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
20456402|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
20456403|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
20456404|NCT01415778|Bicalutamide|bicalutamide|mesh-list
20456405|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
20456406|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
20456407|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456408|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456409|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456410|NCT01415791|Bicalutamide|bicalutamide|mesh-list
20456411|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
20456412|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
20456413|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456414|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456415|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456416|NCT01415895|Clonidine|clonidine|mesh-list
20456417|NCT01415895|Naltrexone|naltrexone|mesh-list
20456418|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20456419|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20456420|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456421|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
20456422|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456423|NCT01415895|Analgesics|analgesics|mesh-ancestor
20456424|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20456425|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
19407404|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19407405|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407406|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
19407407|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407408|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20456426|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
20456427|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20456428|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20456429|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20456430|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456431|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456432|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456433|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
20456434|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456435|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
20456436|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456437|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20456438|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20456439|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
20456440|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456441|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456442|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20456443|NCT01416116|Lidocaine|lidocaine|mesh-list
20456444|NCT01416116|Tramadol|tramadol|mesh-list
20456445|NCT01416116|Capsaicin|capsaicin|mesh-list
20456446|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
20456447|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
20456448|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20456449|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456450|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
20456451|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456452|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20456453|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20456454|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20456455|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456456|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456457|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20456458|NCT01416116|Narcotics|narcotics|mesh-ancestor
20456459|NCT01416116|Analgesics|analgesics|mesh-ancestor
20456460|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
20456461|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
20456462|NCT01416207|Interferons|interferons|mesh-list
20456463|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
20456464|NCT01416207|Interferon-beta|interferon-beta|mesh-list
20456465|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456466|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
19407409|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
19407410|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407411|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407412|NCT03574090|Amoxicillin|amoxicillin|mesh-list
19407413|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
19407414|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
19407415|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19407416|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19407417|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407418|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19407419|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407420|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407421|NCT03574064|Glucagon|glucagon|mesh-list
19407422|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
19407423|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19407424|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407425|NCT03574064|Hormones|hormones|mesh-ancestor
19407426|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407427|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407428|NCT03574064|Incretins|incretins|mesh-ancestor
19416561|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19416562|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19416563|NCT02401815|Growth Substances|growth substances|mesh-ancestor
19416564|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613935|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20613936|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
20613937|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20613938|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20613939|NCT02256956|Analgesics|analgesics|mesh-ancestor
19416565|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
20456467|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456468|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20456469|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
20456470|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456471|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
20456472|NCT01416220|Paroxetine|paroxetine|mesh-list
20456473|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
20456474|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20456475|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456476|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456477|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
20456478|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20456479|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20456480|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456481|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20456482|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20456483|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456484|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456485|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
20456486|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20456487|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20456488|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20456489|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
20456490|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20456491|NCT01416337|Trametinib|trametinib|mesh-list
20456492|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456493|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20456494|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456495|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456496|NCT01416350|Azithromycin|azithromycin|mesh-list
20456497|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20456498|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456499|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20456500|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20456501|NCT01416480|Theobromine|theobromine|mesh-list
20456502|NCT01416480|Dipropizine|dipropizine|mesh-list
20456503|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20456504|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
20456505|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456506|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456507|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20456508|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
20456509|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
20456510|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
20456511|NCT01416558|Paclitaxel|paclitaxel|mesh-list
20456512|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20456513|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456514|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
20456515|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
20456516|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
20456517|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456518|NCT01416649|Exenatide|exenatide|mesh-list
20456519|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20456520|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456521|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20456522|NCT01416649|Incretins|incretins|mesh-ancestor
20456523|NCT01416649|Hormones|hormones|mesh-ancestor
20456524|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407429|NCT03573999|Mannitol|mannitol|mesh-list
20222154|NCT00327925|Antibodies|antibodies|mesh-list
20222155|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
20222156|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222157|NCT00327990|Alendronate|alendronate|mesh-list
20222158|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
20222159|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20222160|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222161|NCT00328029|Busulfan|busulfan|mesh-list
20222162|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
20222163|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222164|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20222165|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
20222166|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222167|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20222168|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222169|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20222170|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
20222171|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
20222172|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
20222173|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222174|NCT00328120|Fulvestrant|fulvestrant|mesh-list
19407430|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20456525|NCT01416662|Gemcitabine|gemcitabine|mesh-list
20456526|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456527|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
20456528|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456529|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456530|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
20456531|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456532|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456533|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456534|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
20456535|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456536|NCT01416701|Vitamin D|vitamin d|mesh-list
20456537|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
20456538|NCT01416701|Vitamins|vitamins|mesh-list
20456539|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
20456540|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456541|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456542|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20456543|NCT01416831|Interleukin-2|interleukin-2|mesh-list
20456544|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456545|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20456546|NCT01416831|Analgesics|analgesics|mesh-ancestor
20456547|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
20456548|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456549|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456550|NCT01416870|Bicalutamide|bicalutamide|mesh-list
20456551|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
20456552|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
20456553|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456554|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456555|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456556|NCT01416883|Bicalutamide|bicalutamide|mesh-list
20456557|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
20456558|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
20456559|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456560|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456561|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456562|NCT01416909|Laxatives|laxatives|mesh-list
20456563|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456564|NCT01416948|Methylphenidate|methylphenidate|mesh-list
20456565|NCT01416948|Galantamine|galantamine|mesh-list
20456566|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20456567|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456568|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20456569|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19407431|NCT03573999|Diuretics|diuretics|mesh-ancestor
19407432|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
19407433|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407434|NCT03573986|Bevacizumab|bevacizumab|mesh-list
19407435|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407436|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407437|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19407438|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19407439|NCT03573986|Growth Substances|growth substances|mesh-ancestor
19407440|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407441|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
19407442|NCT03573934|Glucagon|glucagon|mesh-list
19407443|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19407444|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407445|NCT03573934|Hormones|hormones|mesh-ancestor
19407446|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407447|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407448|NCT03573934|Incretins|incretins|mesh-ancestor
19407449|NCT03573687|Caseins|caseins|mesh-list
20456570|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456571|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456572|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
20456573|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456574|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20456575|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456576|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
20456577|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20456578|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
20456579|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456580|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
20456581|NCT01416961|Etoposide|etoposide|mesh-list
20456582|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
20456583|NCT01416961|Cisplatin|cisplatin|mesh-list
20456584|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20456585|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456586|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20456587|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20456588|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456589|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456590|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
20456591|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456592|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
20456593|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456594|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20456595|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20456596|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
20456597|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456598|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456599|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20456600|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20456601|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
20456602|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20456603|NCT01417065|Sirolimus|sirolimus|mesh-list
20456604|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20456605|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456606|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20456607|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456608|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
20456609|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456610|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
20456611|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456612|NCT01417169|Micafungin|micafungin|mesh-list
20456613|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
20456614|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456615|NCT01417273|Vitamin A|vitamin a|mesh-list
20456616|NCT01417273|Vitamins|vitamins|mesh-ancestor
20456617|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
20456618|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456619|NCT01417351|Vitamin D|vitamin d|mesh-list
20456620|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
20456621|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
20456622|NCT01417351|Vitamins|vitamins|mesh-list
20456623|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
20456624|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456625|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456626|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20456627|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
20456628|NCT01417364|Testosterone|testosterone|mesh-list
20456629|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
20456630|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
20456631|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20456632|NCT01417364|Androgens|androgens|mesh-ancestor
20456633|NCT01417364|Hormones|hormones|mesh-ancestor
20456634|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456635|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456636|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20456637|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456638|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
20456639|NCT01417390|Gemcitabine|gemcitabine|mesh-list
20456640|NCT01417390|Cisplatin|cisplatin|mesh-list
20456641|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456642|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456643|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
20456644|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456645|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
20456646|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456647|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456648|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456649|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
20456650|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456651|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
20456652|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
20456653|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20456654|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20456655|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456656|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456657|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456658|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20456659|NCT01417429|Galantamine|galantamine|mesh-list
20456660|NCT01417429|Nicotine|nicotine|mesh-list
20456661|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20456662|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
20456663|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456664|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456665|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20456666|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20456667|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
20456668|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456669|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456670|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20456671|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456672|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20456673|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
20456674|NCT01417494|Leucovorin|leucovorin|mesh-list
20456675|NCT01417494|Bevacizumab|bevacizumab|mesh-list
20456676|NCT01417494|Fluorouracil|fluorouracil|mesh-list
20456677|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
20456678|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20456679|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456680|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20456681|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20456682|NCT01417494|Growth Substances|growth substances|mesh-ancestor
20456683|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456684|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
20456685|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
20456686|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456687|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456688|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456689|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
20456690|NCT01417494|Antidotes|antidotes|mesh-ancestor
20456691|NCT01417494|Protective Agents|protective agents|mesh-ancestor
20456692|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
20456693|NCT01417494|Vitamins|vitamins|mesh-ancestor
20456694|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
20526215|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526216|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526217|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20526218|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526219|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526220|NCT01761916|Clonidine|clonidine|mesh-list
20526221|NCT01761916|Captopril|captopril|mesh-list
20526222|NCT01761916|Analgesics|analgesics|mesh-ancestor
20526223|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
20526224|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526225|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526226|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20526227|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
20526228|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
20526229|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20526230|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20526231|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20526232|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
20526233|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526234|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526235|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20526236|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
20526237|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526238|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
20526239|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20526240|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526241|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526242|NCT01761994|Nafamostat|nafamostat|mesh-list
20526243|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526244|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526245|NCT01761994|Analgesics|analgesics|mesh-ancestor
20526246|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
20526247|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694452|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694453|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19694454|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20526248|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526249|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694455|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694456|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694457|NCT04966507|Listerine|listerine|mesh-list
19694458|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19694459|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694460|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
19694461|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
19849236|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20456695|NCT01417572|Lidocaine|lidocaine|mesh-list
20456696|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
20456697|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
20456698|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20456699|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456700|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
20456701|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456702|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20456703|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20456704|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20456705|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456706|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456707|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20456708|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20456709|NCT01417754|Toremifene|toremifene|mesh-list
20456710|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20456711|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456712|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20456713|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20456714|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
20456715|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456716|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456717|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456718|NCT01417767|Decitabine|decitabine|mesh-list
20456719|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20456720|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
20456721|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456722|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456723|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456724|NCT01417806|Topotecan|topotecan|mesh-list
20456725|NCT01417806|Pasireotide|pasireotide|mesh-list
20456726|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20456727|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20456728|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456729|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456730|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456731|NCT01417806|Hormones|hormones|mesh-ancestor
20456732|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456733|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456734|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20456735|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20456736|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19407450|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
19407451|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
19416566|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20456737|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20456738|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20456739|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456740|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456741|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456742|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456743|NCT01417897|Insulin|insulin|mesh-list
20456744|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20456745|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
20456746|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
20456747|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694462|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694463|NCT04966299|Erythritol|erythritol|mesh-list
19694464|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
19694465|NCT04966234|Posaconazole|posaconazole|mesh-list
19694466|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
19694467|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694468|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19694469|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20456748|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456749|NCT01417923|Vitamin D|vitamin d|mesh-list
20456750|NCT01417923|Vitamins|vitamins|mesh-ancestor
20456751|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
20456752|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456753|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456754|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20456755|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
20456756|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456757|NCT01418118|Dobutamine|dobutamine|mesh-list
20456758|NCT01418118|Epinephrine|epinephrine|mesh-list
20456759|NCT01418118|Norepinephrine|norepinephrine|mesh-list
20456760|NCT01418118|Dopexamine|dopexamine|mesh-list
20456761|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20456762|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20456763|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456764|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456765|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456766|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456767|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20456768|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20456769|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
20456770|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456771|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20456772|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
20456773|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
20456774|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
20456775|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20456776|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20456777|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20456778|NCT01418118|Protective Agents|protective agents|mesh-ancestor
20456779|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
20456780|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
20456781|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
20456782|NCT01418131|Tacrolimus|tacrolimus|mesh-list
20456783|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20456784|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456785|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
20456786|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456787|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456788|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456789|NCT01418144|Ropivacaine|ropivacaine|mesh-list
20456790|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
20456791|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
20456792|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20456793|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456794|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
20456795|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456796|NCT01418157|Acetazolamide|acetazolamide|mesh-list
20456797|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
20456798|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20456799|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456800|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456801|NCT01418157|Diuretics|diuretics|mesh-ancestor
20456802|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
20456803|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456804|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
20456805|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
20456806|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
20456807|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20456808|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456809|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
20456810|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456811|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20456812|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20456813|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
20456814|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456815|NCT01418274|Ritonavir|ritonavir|mesh-list
20456816|NCT01418274|Citalopram|citalopram|mesh-list
20456817|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20456818|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20456819|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
19694470|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19694471|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19694472|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19694473|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456820|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456821|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456822|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20456823|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20456824|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
20456825|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456826|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20456827|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19407452|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407453|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
19407454|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19407455|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19407456|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407457|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19407458|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19407459|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
19407460|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407461|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407462|NCT03573596|Dasatinib|dasatinib|mesh-list
19407463|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407464|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19407465|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407466|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407467|NCT03573349|Ketamine|ketamine|mesh-list
19407468|NCT03573349|Analgesics|analgesics|mesh-ancestor
19407469|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
19407470|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407471|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407472|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19407473|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19407474|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
19407475|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
19407476|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407477|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19407478|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19407479|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407480|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407481|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
19407482|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19407483|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
19407484|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407485|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407486|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19407487|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
19407488|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19407489|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
19407490|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407491|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407492|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19407493|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
19407494|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
19407495|NCT03573284|Protective Agents|protective agents|mesh-ancestor
19407496|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
19407497|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19407498|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19407499|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407500|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
19407501|NCT03573245|Coagulants|coagulants|mesh-ancestor
19407502|NCT03573102|Aspirin|aspirin|mesh-list
19407503|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19407504|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19407505|NCT03573102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19407506|NCT03573102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19407507|NCT03573102|Analgesics|analgesics|mesh-ancestor
19407508|NCT03573102|Sensory System Agents|sensory system agents|mesh-ancestor
19407509|NCT03573102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407510|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456828|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20456829|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20456830|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456831|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456832|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
20456833|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456834|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20456835|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
20456836|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20456837|NCT01418417|Pantoprazole|pantoprazole|mesh-list
20456838|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20456839|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456840|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20456841|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456842|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456843|NCT01418430|Daclizumab|daclizumab|mesh-list
20456844|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456845|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
20456846|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456847|NCT01418443|Pantoprazole|pantoprazole|mesh-list
20456848|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20456849|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456850|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20456851|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456852|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456853|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20456854|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456855|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20456856|NCT01418534|Isosorbide|isosorbide|mesh-list
20456857|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20456858|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20456859|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20456860|NCT01418534|Diuretics|diuretics|mesh-ancestor
20456861|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
20456862|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456863|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
20456864|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20456865|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456866|NCT01418547|Isosorbide|isosorbide|mesh-list
20456867|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20456868|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19849237|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
19849238|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849239|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849240|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19849241|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456869|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20456870|NCT01418547|Diuretics|diuretics|mesh-ancestor
20222175|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20222176|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222177|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20222178|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20222179|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222180|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222181|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222182|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
20456871|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
20456872|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456873|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
20456874|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20456875|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456876|NCT01418586|Alfuzosin|alfuzosin|mesh-list
20456877|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20456878|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20456879|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20456880|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456881|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456882|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849242|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
19849243|NCT00701129|Rituximab|rituximab|mesh-list
19849244|NCT00701129|Methotrexate|methotrexate|mesh-list
19849245|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849246|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849247|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
19849248|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849249|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849250|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20222183|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20456883|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456884|NCT01418586|Urological Agents|urological agents|mesh-ancestor
20456885|NCT01418599|Alfuzosin|alfuzosin|mesh-list
20456886|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20456887|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20456888|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20456889|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
20456890|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456891|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456892|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456893|NCT01418599|Urological Agents|urological agents|mesh-ancestor
20456894|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20456895|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20456896|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20456897|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456898|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456899|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456900|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456901|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20456902|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
20456903|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20456904|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20456905|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20456906|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20456907|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456908|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456909|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456910|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456911|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20456912|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
20456913|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20456914|NCT01418651|Milnacipran|milnacipran|mesh-list
20456915|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20456916|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20456917|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456918|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456919|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456920|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456921|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20456922|NCT01418651|Analgesics|analgesics|mesh-ancestor
20456923|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
20456924|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20456925|NCT01418729|Pravastatin|pravastatin|mesh-list
20456926|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20456927|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222184|NCT00328302|Candesartan|candesartan|mesh-list
20222185|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20222186|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20222187|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20222188|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456928|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
20456929|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456930|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20456931|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20456932|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456933|NCT01418742|Doxycycline|doxycycline|mesh-list
20456934|NCT01418742|Panitumumab|panitumumab|mesh-list
20222189|NCT00328367|Aripiprazole|aripiprazole|mesh-list
20222190|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222191|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222192|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20222193|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20222194|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20222195|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222196|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
20222197|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
20222198|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222199|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222200|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20222201|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20222202|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
20456935|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20456936|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456937|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
20456938|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20456939|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20456940|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20456941|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456942|NCT01418794|Sirolimus|sirolimus|mesh-list
20456943|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20456944|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20456945|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20456946|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456947|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
20456948|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20456949|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
20456950|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456951|NCT01419041|Crizotinib|crizotinib|mesh-list
20456952|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20456953|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20456954|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456955|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526250|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526251|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
20526252|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
20526253|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526254|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526255|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20526256|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20526257|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20526258|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526259|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
20526260|NCT01762046|Metformin|metformin|mesh-list
20526261|NCT01762046|Glipizide|glipizide|mesh-list
20526262|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20526263|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526264|NCT01762150|Gemcitabine|gemcitabine|mesh-list
20526265|NCT01762150|Sorafenib|sorafenib|mesh-list
20526266|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526267|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20526268|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
20526269|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526270|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
20222203|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20222204|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20222205|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20526271|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526272|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526273|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526274|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
20526275|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526276|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20526277|NCT01762163|Aspirin|aspirin|mesh-list
20526278|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526279|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526280|NCT01762163|Analgesics|analgesics|mesh-ancestor
20526281|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
20526282|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526283|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526284|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526285|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222206|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20222207|NCT00328380|Rifaximin|rifaximin|mesh-list
20222208|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20222209|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222210|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20222211|NCT00328393|Pioglitazone|pioglitazone|mesh-list
20222212|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20222213|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526286|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20526287|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20526288|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694474|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694475|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19694476|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222214|NCT00328432|Celecoxib|celecoxib|mesh-list
20222215|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20456956|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
20456957|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20456958|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20456959|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456960|NCT01419119|Vitamins|vitamins|mesh-ancestor
20456961|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
20456962|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456963|NCT01419132|Furosemide|furosemide|mesh-list
20456964|NCT01419132|Diuretics|diuretics|mesh-list
20456965|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
20456966|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456967|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20456968|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20456969|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456970|NCT01419262|Vitamin D|vitamin d|mesh-list
20456971|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
20456972|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
20456973|NCT01419262|Vitamins|vitamins|mesh-list
20456974|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
20456975|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456976|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20456977|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20456978|NCT01419340|Donepezil|donepezil|mesh-list
20456979|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20456980|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20456981|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20456982|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
20456983|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20456984|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456985|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
20456986|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20456987|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20456988|NCT01419353|Estradiol|estradiol|mesh-list
20456989|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20456990|NCT01419353|Estrogens|estrogens|mesh-ancestor
20456991|NCT01419353|Hormones|hormones|mesh-ancestor
20456992|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20456993|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20456994|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20456995|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
20456996|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20456997|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20456998|NCT01419366|Donepezil|donepezil|mesh-list
20456999|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20457000|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457001|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457002|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
20457003|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457004|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457005|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
20457006|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
20457007|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457008|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
20457009|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20457010|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20457011|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457012|NCT01419392|Urological Agents|urological agents|mesh-ancestor
20457013|NCT01419405|Pregabalin|pregabalin|mesh-list
20457014|NCT01419405|Remifentanil|remifentanil|mesh-list
20457015|NCT01419405|Analgesics|analgesics|mesh-ancestor
20457016|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
20457017|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457018|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457019|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
20457020|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20457021|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222216|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222217|NCT00328432|Analgesics|analgesics|mesh-ancestor
20222218|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
20222219|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222220|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222221|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222222|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457022|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457023|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20457024|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20457025|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20457026|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457027|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457028|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20457029|NCT01419405|Narcotics|narcotics|mesh-ancestor
20457030|NCT01419457|Favipiravir|favipiravir|mesh-list
20457031|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
20457032|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457033|NCT01419548|Paclitaxel|paclitaxel|mesh-list
20457034|NCT01419548|Carboplatin|carboplatin|mesh-list
20457035|NCT01419548|Veliparib|veliparib|mesh-list
20457036|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20457037|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457038|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
20457039|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
20457040|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
20457041|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457042|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20457043|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457044|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20457045|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457046|NCT01419691|Auranofin|auranofin|mesh-list
20457047|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457048|NCT01419730|Vitamin D|vitamin d|mesh-list
20457049|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
20457050|NCT01419730|Vitamins|vitamins|mesh-ancestor
20457051|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
20457052|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457053|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20457054|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20457055|NCT01419821|Vitamin D|vitamin d|mesh-list
20457056|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
20457057|NCT01419821|Vitamins|vitamins|mesh-list
20457058|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
20457059|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457060|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20457061|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20457062|NCT01419834|Antibodies|antibodies|mesh-list
20457063|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20457064|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
20457065|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457066|NCT01419847|Ciclopirox|ciclopirox|mesh-list
20457067|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
20457068|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457069|NCT01419873|Insulin|insulin|mesh-list
20457070|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20457071|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20457072|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457073|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20457074|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20457075|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457076|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457077|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
20457078|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457079|NCT01420094|Aspirin|aspirin|mesh-list
20457080|NCT01420094|Acetaminophen|acetaminophen|mesh-list
20457081|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20457082|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20457083|NCT01420094|Analgesics|analgesics|mesh-ancestor
20457084|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
20457085|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457086|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457087|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457088|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457089|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20457090|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20457091|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457092|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20457093|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20457094|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457095|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
20457096|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
20457097|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20457098|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
20457099|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
20457100|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457101|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457102|NCT01420250|Bicalutamide|bicalutamide|mesh-list
20457103|NCT01420250|Hormones|hormones|mesh-list
20457104|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20457105|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
20457106|NCT01420250|Androgens|androgens|mesh-list
20457107|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457108|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457109|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
20457110|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457111|NCT01420302|Insulin|insulin|mesh-list
20457112|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20457113|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20457114|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457115|NCT01420328|Simvastatin|simvastatin|mesh-list
20457116|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20457117|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20457118|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20457119|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
20457120|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457121|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20457122|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20457123|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457124|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20457125|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20457126|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457127|NCT01420341|Renal Agents|renal agents|mesh-ancestor
20457128|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20457129|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
20457130|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20457131|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20457132|NCT01420367|Metronidazole|metronidazole|mesh-list
20457133|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457134|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20457135|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20457136|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20457137|NCT01420406|Vitamin A|vitamin a|mesh-list
20457138|NCT01420406|Vitamins|vitamins|mesh-ancestor
20457139|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
20457140|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457141|NCT01420471|Triamcinolone|triamcinolone|mesh-list
20457142|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20457143|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20457144|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20457145|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457146|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
20457147|NCT01420471|Hormones|hormones|mesh-ancestor
20457148|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457149|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457150|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457151|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
20457152|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457153|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457154|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
20457155|NCT01420523|Maraviroc|maraviroc|mesh-list
20457156|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20457157|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20457158|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
20457159|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457160|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20457161|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20457162|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457163|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457164|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20457165|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20457166|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20457167|NCT01420575|Olanzapine|olanzapine|mesh-list
20457168|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
20457169|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
20457170|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457171|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457172|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457173|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20457174|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20457175|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457176|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457177|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20457178|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20457179|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20457180|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457181|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457182|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
20457183|NCT01420666|Acetaminophen|acetaminophen|mesh-list
20457184|NCT01420666|Ibuprofen|ibuprofen|mesh-list
20457185|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20457186|NCT01420666|Analgesics|analgesics|mesh-ancestor
20457187|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
20457188|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457189|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457190|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
20457191|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20457192|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457193|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457194|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20457195|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457196|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457197|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
20457198|NCT01420692|Gliclazide|gliclazide|mesh-list
20457199|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20457200|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526289|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20526290|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20526291|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526292|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
20530558|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530559|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530560|NCT01789333|Riboflavin|riboflavin|mesh-list
20530561|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20530562|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20530563|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
20530564|NCT01789333|Vitamins|vitamins|mesh-ancestor
20530565|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
20530566|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530567|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20530568|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
20530569|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
20530570|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20530571|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530572|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530573|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530574|NCT01789385|Analgesics|analgesics|mesh-ancestor
20530575|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
20530576|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530577|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20530578|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20530579|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20530580|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
20530581|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530582|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530583|NCT01789437|Dexamethasone|dexamethasone|mesh-list
20530584|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530585|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
20530586|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
20530587|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530588|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530589|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530590|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
20530591|NCT01789437|Hormones|hormones|mesh-ancestor
20530592|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530593|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20530594|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530595|NCT01789619|Tacrolimus|tacrolimus|mesh-list
20530596|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20530597|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
20530598|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694477|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530599|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20457201|NCT01420822|Fluticasone|fluticasone|mesh-list
20457202|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457203|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20457204|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
20457205|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457206|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457207|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20457208|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
20457209|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
20457210|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20457211|NCT01420900|Tacrine|tacrine|mesh-list
20457212|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20457213|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457214|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457215|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
20457216|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457217|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457218|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20457219|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
20457220|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457221|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
20457222|NCT01420913|Pregabalin|pregabalin|mesh-list
20457223|NCT01420913|Analgesics|analgesics|mesh-ancestor
20457224|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
20457225|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457226|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457227|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
20457228|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20457229|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20457230|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457231|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20457232|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20457233|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20457234|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457235|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457236|NCT01421043|Triazolam|triazolam|mesh-list
20457237|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20457238|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20457239|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20457240|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457241|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457242|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457243|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
20457244|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
20457245|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457246|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457247|NCT01421069|Etanercept|etanercept|mesh-list
20457248|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20457249|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20457250|NCT01421069|Analgesics|analgesics|mesh-ancestor
20457251|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
20457252|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457253|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457254|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457255|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457256|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457257|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457258|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
20457259|NCT01421121|Vaccines|vaccines|mesh-list
20457260|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
20457261|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457262|NCT01421160|Citric Acid|citric acid|mesh-list
20457263|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
20457264|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
20457265|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20457266|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
20457267|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
20457268|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457269|NCT01421173|Gemcitabine|gemcitabine|mesh-list
20457270|NCT01421173|Dexamethasone|dexamethasone|mesh-list
20457271|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
20457272|NCT01421173|Rituximab|rituximab|mesh-list
20457273|NCT01421173|Melphalan|melphalan|mesh-list
20457274|NCT01421173|Busulfan|busulfan|mesh-list
20457275|NCT01421173|Vorinostat|vorinostat|mesh-list
20457276|NCT01421173|BB 1101|bb 1101|mesh-list
20457277|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20457278|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457279|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
20457280|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457281|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457282|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457283|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
19694478|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694479|NCT04966429|Maraviroc|maraviroc|mesh-list
19694480|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19694481|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19694482|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694483|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20457284|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
20457285|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694484|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19694485|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
19694486|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694487|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19694488|NCT04965818|Futibatinib|futibatinib|mesh-list
20457286|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457287|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
20457288|NCT01421173|Hormones|hormones|mesh-ancestor
20457289|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457290|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457291|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20457292|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
20457293|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457294|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
20457295|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457296|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457297|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457298|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20457299|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
20457300|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20457301|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20457302|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
20457303|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
20457304|NCT01421212|Antibodies|antibodies|mesh-list
20457305|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
20457306|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20457307|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20457308|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
20457309|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
20457310|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457311|NCT01421264|Gabapentin|gabapentin|mesh-list
20457312|NCT01421264|Analgesics|analgesics|mesh-ancestor
20457313|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
20457314|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457315|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457316|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
19407511|NCT03573102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407512|NCT03573102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407513|NCT03573102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19407514|NCT03573102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19407515|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407516|NCT03573102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19407517|NCT03573102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19407518|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407519|NCT03573102|Antipyretics|antipyretics|mesh-ancestor
19407520|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
19407521|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19407522|NCT03573063|Androgens|androgens|mesh-list
19407523|NCT03573063|Hormones|hormones|mesh-ancestor
19407524|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407525|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457317|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20457318|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20526293|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
20526294|NCT01762202|Fludarabine|fludarabine|mesh-list
20526295|NCT01762202|Ofatumumab|ofatumumab|mesh-list
20526296|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526297|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
20526298|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526299|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530600|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222223|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20222224|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20222225|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222226|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222227|NCT00328458|Epothilones|epothilones|mesh-list
20457319|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457320|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457321|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20457322|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20457323|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457324|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407526|NCT03573050|Rivastigmine|rivastigmine|mesh-list
19407527|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19407528|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407529|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457325|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
20457326|NCT01421368|Tenofovir|tenofovir|mesh-list
20457327|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20457328|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
20457329|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
20457330|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
20457331|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
20457332|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457333|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20457334|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20457335|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457336|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457337|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19407530|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
19407531|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407532|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407533|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19407534|NCT03573050|Protective Agents|protective agents|mesh-ancestor
19407535|NCT03573037|Anticoagulants|anticoagulants|mesh-list
19407536|NCT03572959|Triamcinolone|triamcinolone|mesh-list
19407537|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19407538|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19407539|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20457338|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20457339|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20457340|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457341|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20457342|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20457343|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20457344|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20457345|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20457346|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457347|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457348|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
20457349|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
20457350|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20457351|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457352|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20457353|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20457354|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20457355|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20457356|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457357|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457358|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457359|NCT01421706|Clarithromycin|clarithromycin|mesh-list
20457360|NCT01421706|Sibutramine|sibutramine|mesh-list
20457361|NCT01421706|Clopidogrel|clopidogrel|mesh-list
20457362|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20457363|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20457364|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20457365|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20222228|NCT00328458|Epothilone B|epothilone b|mesh-list
20222229|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
20222230|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
20457366|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
20457367|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407540|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457368|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457369|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457370|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20457371|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457372|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20457373|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457374|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20457375|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20457376|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
20457377|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457378|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
20457379|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20457380|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
20457381|NCT01421797|Dexamethasone|dexamethasone|mesh-list
20457382|NCT01421797|Cosyntropin|cosyntropin|mesh-list
20457383|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457384|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
20457385|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
20457386|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457387|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457388|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457389|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
20457390|NCT01421797|Hormones|hormones|mesh-ancestor
20457391|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457392|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457393|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457394|NCT01421810|Dexamethasone|dexamethasone|mesh-list
20457395|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457396|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
20457397|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
20457398|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457399|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457400|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457401|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
20457402|NCT01421810|Hormones|hormones|mesh-ancestor
20457403|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457404|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457405|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457406|NCT01421901|Ertapenem|ertapenem|mesh-list
20457407|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20457408|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457409|NCT01421914|Bupivacaine|bupivacaine|mesh-list
20457410|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
20457411|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
20457412|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457413|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457414|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
20457415|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457416|NCT01421927|Lenalidomide|lenalidomide|mesh-list
20457417|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
20457418|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457419|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20457420|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20457421|NCT01421927|Growth Substances|growth substances|mesh-ancestor
20457422|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
20457423|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457424|NCT01421940|Udenafil|udenafil|mesh-list
20457425|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20457426|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20457427|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457428|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457429|NCT01421979|Caffeine|caffeine|mesh-list
20457430|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20457431|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457432|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20457433|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457434|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457435|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20457436|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20457437|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
20457438|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457439|NCT01421992|Methylphenidate|methylphenidate|mesh-list
20457440|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20457441|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407541|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
19407542|NCT03572959|Hormones|hormones|mesh-ancestor
20457442|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20457443|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20457444|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20457445|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694489|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707757|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19707758|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
19707759|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707760|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707761|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19707762|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20457446|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
20457447|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457448|NCT01422018|Bevacizumab|bevacizumab|mesh-list
20457449|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20457450|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457451|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20457452|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20457453|NCT01422018|Growth Substances|growth substances|mesh-ancestor
20457454|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457455|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
20457456|NCT01422096|Leuprolide|leuprolide|mesh-list
20457457|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20457458|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
20457459|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20457460|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457461|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457462|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457463|NCT01422109|Aspirin|aspirin|mesh-list
20457464|NCT01422109|Clopidogrel|clopidogrel|mesh-list
20457465|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20457466|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20457467|NCT01422109|Analgesics|analgesics|mesh-ancestor
20457468|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
20457469|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457470|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457471|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457472|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457473|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20457474|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20457475|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457476|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20457477|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20457478|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457479|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
20457480|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20457481|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20457482|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20457483|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
20457484|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457485|NCT01422122|Vitamin D|vitamin d|mesh-list
20457486|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
20457487|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
20457488|NCT01422122|Vitamins|vitamins|mesh-list
20457489|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
20457490|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457491|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20457492|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20457493|NCT01422291|Acetaminophen|acetaminophen|mesh-list
20457494|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20457495|NCT01422291|Morphine|morphine|mesh-list
20457496|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20457497|NCT01422291|Narcotics|narcotics|mesh-ancestor
20457498|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457499|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457500|NCT01422291|Analgesics|analgesics|mesh-ancestor
20457501|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
20457502|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457503|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20457504|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
20457505|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20222231|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
20222232|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222233|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457506|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457507|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457508|NCT01422317|Tocopherols|tocopherols|mesh-list
20457509|NCT01422317|Vitamin E|vitamin e|mesh-list
20457510|NCT01422317|Tocotrienols|tocotrienols|mesh-list
20457511|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
20457512|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
20457513|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457514|NCT01422317|Protective Agents|protective agents|mesh-ancestor
20457515|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457516|NCT01422317|Vitamins|vitamins|mesh-ancestor
20457517|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
20457518|NCT01422330|Etravirine|etravirine|mesh-list
20457519|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20457520|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20457521|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457522|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457523|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
20457524|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457525|NCT01422460|Mitogens|mitogens|mesh-list
20457526|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
20457527|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457528|NCT01422499|Vorinostat|vorinostat|mesh-list
20457529|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457530|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20457531|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222234|NCT00328497|Bevacizumab|bevacizumab|mesh-list
20222235|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
20222236|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20457532|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457533|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20457534|NCT01422590|Mitiglinide|mitiglinide|mesh-list
20457535|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20457536|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457537|NCT01422590|Incretins|incretins|mesh-ancestor
20457538|NCT01422590|Hormones|hormones|mesh-ancestor
20457539|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457540|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20457541|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20457542|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457543|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457544|NCT01422603|Clofarabine|clofarabine|mesh-list
19849251|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
19849252|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19849253|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19849254|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
19849255|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849256|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
20222237|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222238|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20222239|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20222240|NCT00328497|Growth Substances|growth substances|mesh-ancestor
20222241|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222242|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
20222243|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
20222244|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
20222245|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
20222246|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222247|NCT00328549|Interferons|interferons|mesh-list
20222248|NCT00328549|Ribavirin|ribavirin|mesh-list
20222249|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222250|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
20222251|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222252|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
20222253|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849257|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849258|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20222254|NCT00328692|Rolofylline|rolofylline|mesh-list
20457545|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20457546|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
20222255|NCT00328692|Diuretics|diuretics|mesh-ancestor
20457547|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457548|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457549|NCT01422616|Metoprolol|metoprolol|mesh-list
20457550|NCT01422616|Clonidine|clonidine|mesh-list
20457551|NCT01422616|Hydralazine|hydralazine|mesh-list
20457552|NCT01422616|Labetalol|labetalol|mesh-list
20457553|NCT01422616|Nicardipine|nicardipine|mesh-list
20457554|NCT01422616|Phentolamine|phentolamine|mesh-list
20457555|NCT01422616|Urapidil|urapidil|mesh-list
20457556|NCT01422616|Enalaprilat|enalaprilat|mesh-list
20457557|NCT01422616|Enalapril|enalapril|mesh-list
20457558|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20457559|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
20457560|NCT01422616|Esmolol|esmolol|mesh-list
20457561|NCT01422616|Glycerol|glycerol|mesh-list
20457562|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20457563|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20457564|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
20457565|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
20457566|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457567|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457568|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20457569|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20457570|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20457571|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
20457572|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457573|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457574|NCT01422616|Analgesics|analgesics|mesh-ancestor
20457575|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
20457576|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20457577|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20457578|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20457579|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20457580|NCT01422616|Protective Agents|protective agents|mesh-ancestor
20457581|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
20457582|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
20457583|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20457584|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20457585|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20457586|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20457587|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20457588|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20457589|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20457590|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20457591|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
20457592|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20457593|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
20457594|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526300|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20526301|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
20526302|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526303|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526304|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20526305|NCT01762306|Folic Acid|folic acid|mesh-list
20526306|NCT01762306|Diclofenac|diclofenac|mesh-list
20526307|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526308|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526309|NCT01762306|Analgesics|analgesics|mesh-ancestor
20526310|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
20526311|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526312|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526313|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526314|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526315|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20526316|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526317|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526318|NCT01762306|Hematinics|hematinics|mesh-ancestor
20526319|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
20526320|NCT01762306|Vitamins|vitamins|mesh-ancestor
20526321|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
20526322|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
20526323|NCT01762319|Pyridoxal|pyridoxal|mesh-list
20526324|NCT01762319|Pyridoxine|pyridoxine|mesh-list
20526325|NCT01762319|Misoprostol|misoprostol|mesh-list
20526326|NCT01762319|Vitamins|vitamins|mesh-ancestor
20526327|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
20526328|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526329|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20457595|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
20457596|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457597|NCT01422733|Dexamethasone|dexamethasone|mesh-list
20457598|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
20457599|NCT01422733|Cosyntropin|cosyntropin|mesh-list
20457600|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457601|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
20457602|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
19407543|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407544|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407545|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407546|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
19407547|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407548|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407549|NCT03572933|Pregnanolone|pregnanolone|mesh-list
20457603|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457604|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457605|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457606|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
20457607|NCT01422733|Hormones|hormones|mesh-ancestor
20457608|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457609|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457610|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457611|NCT01422746|Metformin|metformin|mesh-list
20457612|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20457613|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457614|NCT01422759|Spironolactone|spironolactone|mesh-list
20457615|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20457616|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
20457617|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457618|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457619|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20457620|NCT01422759|Diuretics|diuretics|mesh-ancestor
20457621|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
20457622|NCT01422785|Clindamycin|clindamycin|mesh-list
20457623|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
20457624|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
20457625|NCT01422785|Tretinoin|tretinoin|mesh-list
20457626|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20457627|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20457628|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457629|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20457630|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457631|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407550|NCT03572933|Ganaxolone|ganaxolone|mesh-list
19407551|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
19407552|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407553|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407554|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407555|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
19407556|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
19407557|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
19407558|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407559|NCT03572829|Dexamethasone|dexamethasone|mesh-list
19407560|NCT03572829|Ondansetron|ondansetron|mesh-list
19407561|NCT03572829|Aprepitant|aprepitant|mesh-list
19407562|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407563|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
19407564|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
19407565|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407566|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407567|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407568|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
19407569|NCT03572829|Hormones|hormones|mesh-ancestor
19407570|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407571|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407572|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407573|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457632|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
20457633|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457634|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
19407574|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
20457635|NCT01422954|Chloroquine|chloroquine|mesh-list
20457636|NCT01422954|Mefloquine|mefloquine|mesh-list
20457637|NCT01422954|Proguanil|proguanil|mesh-list
20457638|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20457639|NCT01422954|Vaccines|vaccines|mesh-list
20457640|NCT01422954|Amebicides|amebicides|mesh-ancestor
20457641|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20457642|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20457643|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457644|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
20457645|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457646|NCT01422954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457647|NCT01422954|Immunologic Factors|immunologic factors|mesh-ancestor
20457648|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
20457649|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457650|NCT01423019|Synephrine|synephrine|mesh-list
20457651|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20457652|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20457653|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
20457654|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457655|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457656|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457657|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
20457658|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
20457659|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457660|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20457661|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
20457662|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
20457663|NCT01423032|Fludarabine|fludarabine|mesh-list
20457664|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20457665|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457666|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457667|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20457668|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
20457669|NCT01423123|Paclitaxel|paclitaxel|mesh-list
20457670|NCT01423123|Trastuzumab|trastuzumab|mesh-list
20457671|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20457672|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457673|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
20457674|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
20457675|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
20457676|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457677|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20457678|NCT01423175|Clofarabine|clofarabine|mesh-list
20457679|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20457680|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
20457681|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457682|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457683|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20457684|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20457685|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20457686|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457687|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457688|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457689|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20457690|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20457691|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20457692|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
20457693|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457694|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457695|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20457696|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20457697|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
20457698|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20457699|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20457700|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
20457701|NCT01423292|Bupivacaine|bupivacaine|mesh-list
20457702|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
20457703|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
20457704|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457705|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457706|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
20457707|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457708|NCT01423305|Budesonide|budesonide|mesh-list
20457709|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
20457710|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20457711|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457712|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20457713|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
20457714|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457715|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457716|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20457717|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
20457718|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
20457719|NCT01423305|Hormones|hormones|mesh-ancestor
20457720|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457721|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20457722|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20457723|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20457724|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
20457725|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457726|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457727|NCT01423370|Tadalafil|tadalafil|mesh-list
20457728|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
20457729|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20457730|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20457731|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457732|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457733|NCT01423370|Urological Agents|urological agents|mesh-ancestor
20457734|NCT01423435|Beraprost|beraprost|mesh-list
20457735|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20457736|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
20457737|NCT01423487|Metformin|metformin|mesh-list
20457738|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20457739|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457740|NCT01423500|Fludarabine|fludarabine|mesh-list
20457741|NCT01423500|Etoposide|etoposide|mesh-list
20457742|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
20457743|NCT01423500|Thiotepa|thiotepa|mesh-list
20457744|NCT01423500|Treosulfan|treosulfan|mesh-list
20457745|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457746|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457747|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457748|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
20457749|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457750|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20457751|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20457752|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20457753|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457754|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20457755|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
20457756|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20457757|NCT01423539|Rituximab|rituximab|mesh-list
20457758|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20457759|NCT01423539|Navitoclax|navitoclax|mesh-list
20457760|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20457761|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457762|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
20457763|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457764|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457765|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20457766|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
20457767|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457768|NCT01423591|Infliximab|infliximab|mesh-list
20457769|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
20457770|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457771|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457772|NCT01423695|Paclitaxel|paclitaxel|mesh-list
20457773|NCT01423695|Trastuzumab|trastuzumab|mesh-list
20457774|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20457775|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694490|NCT04965831|Aflutinib|aflutinib|mesh-list
19694491|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20457776|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
20457777|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
20457778|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
20457779|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457780|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20457781|NCT01423708|Everolimus|everolimus|mesh-list
20457782|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457783|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457784|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
20457785|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457786|NCT01423747|Fludarabine|fludarabine|mesh-list
20457787|NCT01423747|Etoposide|etoposide|mesh-list
20457788|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
20457789|NCT01423747|Thiotepa|thiotepa|mesh-list
20457790|NCT01423747|Treosulfan|treosulfan|mesh-list
20457791|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457792|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457793|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457794|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
20457795|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457796|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20457797|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20457798|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20457799|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457800|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20457801|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
20457802|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20457803|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
20457804|NCT01423838|Oxybutynin|oxybutynin|mesh-list
20457805|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20457806|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20457807|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
20457808|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457809|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457810|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457811|NCT01423838|Urological Agents|urological agents|mesh-ancestor
20457812|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
20457813|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
20457814|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457815|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20457816|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20457817|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
20457818|NCT01423864|Prednisolone|prednisolone|mesh-list
20457819|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
20457820|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20457821|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20457822|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
19407575|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407576|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19407577|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
19407578|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407579|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19407580|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407581|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457823|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457824|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
20457825|NCT01423864|Hormones|hormones|mesh-ancestor
20457826|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457827|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457828|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20457829|NCT01423864|Protective Agents|protective agents|mesh-ancestor
20457830|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457831|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457832|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
20457833|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
20457834|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457835|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457836|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
20457837|NCT01423955|Hematinics|hematinics|mesh-ancestor
20457838|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
20457839|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20457840|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457841|NCT01424111|Citalopram|citalopram|mesh-list
20457842|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20457843|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20457844|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20457845|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457846|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457847|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
20457848|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457849|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20457850|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
20457851|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19407582|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457852|NCT01424124|Montelukast|montelukast|mesh-list
20457853|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20457854|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
20457855|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20457856|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
20457857|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457858|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457859|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20457860|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20457861|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457862|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20457863|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20457864|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
20457865|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457866|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457867|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20457868|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
20457869|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
20457870|NCT01424137|Hormones|hormones|mesh-ancestor
20457871|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457872|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
20457873|NCT01424176|Pramipexole|pramipexole|mesh-list
20457874|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
20457875|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457876|NCT01424176|Protective Agents|protective agents|mesh-ancestor
20457877|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457878|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20457879|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20457880|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
20457881|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
20457882|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457883|NCT01424241|Octreotide|octreotide|mesh-list
20457884|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20457885|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457886|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457887|NCT01424319|Atrasentan|atrasentan|mesh-list
20457888|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457889|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20457890|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20457891|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457892|NCT01424332|Aspirin|aspirin|mesh-list
20457893|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
20457894|NCT01424332|Salicylates|salicylates|mesh-list
20457895|NCT01424332|Darexaban|darexaban|mesh-list
20457896|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20457897|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20457898|NCT01424332|Analgesics|analgesics|mesh-ancestor
20457899|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
20457900|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20457901|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457902|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20457903|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20457904|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20457905|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20457906|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457907|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19694492|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694493|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694494|NCT04965545|Copper|copper|mesh-list
19694495|NCT04965545|Trace Elements|trace elements|mesh-ancestor
20457908|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20457909|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457910|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
20457911|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457912|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
20457913|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
19694496|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
20457914|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
20457915|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20457916|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
20457917|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20457918|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
20457919|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
20526330|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
19694497|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694498|NCT04965532|Anesthetics|anesthetics|mesh-list
20457920|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20457921|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
20457922|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457923|NCT01424384|Citalopram|citalopram|mesh-list
20457924|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20457925|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20457926|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20457927|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457928|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457929|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
20457930|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457931|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20457932|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
20457933|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457934|NCT01424449|Aripiprazole|aripiprazole|mesh-list
20457935|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
20457936|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20457937|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20457938|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20457939|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20457940|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457941|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
20457942|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
20457943|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20457944|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457945|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20457946|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20457947|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
20457948|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20457949|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20457950|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20457951|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20457952|NCT01424618|Leuprolide|leuprolide|mesh-list
20457953|NCT01424618|Ganirelix|ganirelix|mesh-list
20457954|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20457955|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
20457956|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20457957|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457958|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20457959|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457960|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
20457961|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20457962|NCT01424709|Gemcitabine|gemcitabine|mesh-list
20457963|NCT01424709|Cisplatin|cisplatin|mesh-list
20457964|NCT01424709|Docetaxel|docetaxel|mesh-list
20457965|NCT01424709|Irinotecan|irinotecan|mesh-list
20457966|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20457967|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20457968|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
20457969|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457970|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
20457971|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457972|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457973|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20457974|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
20457975|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457976|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
20457977|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
20457978|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
20457979|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20457980|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20457981|NCT01424761|Ubiquinone|ubiquinone|mesh-list
20457982|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
20457983|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
20457984|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20457985|NCT01424761|Vitamins|vitamins|mesh-ancestor
20457986|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
20457987|NCT01424826|Rifampin|rifampin|mesh-list
20457988|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20457989|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20457990|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
20457991|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20457992|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20457993|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20457994|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20457995|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20457996|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20457997|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
20457998|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20457999|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
20458000|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20458001|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20458002|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20458003|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20458004|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20458005|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20458006|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20458007|NCT01424839|Cisplatin|cisplatin|mesh-list
20458008|NCT01424839|Carboplatin|carboplatin|mesh-list
20458009|NCT01424839|Etoposide|etoposide|mesh-list
20458010|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
20458011|NCT01424839|Ifosfamide|ifosfamide|mesh-list
20458012|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
20458013|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458014|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20458015|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20458016|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20458017|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458018|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458019|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20458020|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
20458021|NCT01424891|Simvastatin|simvastatin|mesh-list
20458022|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20458023|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20458024|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
20458025|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458026|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20458027|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20458028|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458029|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
20458030|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20458031|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458032|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20458033|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20458034|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458035|NCT01425073|Renal Agents|renal agents|mesh-ancestor
20458036|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20458037|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
20458038|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20458039|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20458040|NCT01425099|Dolutegravir|dolutegravir|mesh-list
20458041|NCT01425099|Prednisone|prednisone|mesh-list
20458042|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458043|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
20458044|NCT01425099|Hormones|hormones|mesh-ancestor
20458045|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458046|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458047|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20458048|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458049|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20458050|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20458051|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458052|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458053|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20458054|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20458055|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
20458056|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458057|NCT01425125|Tolvaptan|tolvaptan|mesh-list
20458058|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20458059|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458060|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
20458061|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458062|NCT01425164|Carvedilol|carvedilol|mesh-list
20458063|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20458064|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20458065|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
20458066|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458067|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613940|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
20458068|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458069|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20458070|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
20458071|NCT01425164|Protective Agents|protective agents|mesh-ancestor
20458072|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20458073|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20458074|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20458075|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
20458076|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20458077|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20458078|NCT01425216|Sorafenib|sorafenib|mesh-list
20458079|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458080|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20458081|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458082|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458083|NCT01425242|Amlodipine|amlodipine|mesh-list
20458084|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20458085|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20458086|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20458087|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458088|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20458089|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458090|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
20458091|NCT01425320|Dapsone|dapsone|mesh-list
20458092|NCT01425320|Adapalene|adapalene|mesh-list
20458093|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20458094|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20458095|NCT01425320|Analgesics|analgesics|mesh-ancestor
20458096|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
20458097|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458098|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458099|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458100|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458101|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458102|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458103|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
20458104|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20458105|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20458106|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20458107|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458108|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458109|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
20458110|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20458111|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20458112|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20458113|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20458114|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
20458115|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458116|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20458117|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20458118|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458119|NCT01425411|Valsartan|valsartan|mesh-list
20458120|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20458121|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20458122|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20458123|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458124|NCT01425424|Vitamin D|vitamin d|mesh-list
19694499|NCT04965532|Propofol|propofol|mesh-list
20222256|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
20222257|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222258|NCT00328718|Fluticasone|fluticasone|mesh-list
20222259|NCT00328718|Xhance|xhance|mesh-list
20222260|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20222261|NCT00328718|Montelukast|montelukast|mesh-list
20222262|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222263|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20222264|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
20222265|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222266|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222267|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20222268|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
20222269|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
20222270|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19694500|NCT04965532|Sevoflurane|sevoflurane|mesh-list
20458125|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
20458126|NCT01425424|Vitamins|vitamins|mesh-list
20458127|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
20458128|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458129|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20458130|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20458131|NCT01425476|Vitamin D|vitamin d|mesh-list
20458132|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
20458133|NCT01425476|Celecoxib|celecoxib|mesh-list
20458134|NCT01425476|Vitamins|vitamins|mesh-ancestor
20458135|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
20458136|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458137|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20458138|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20458139|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20458140|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20458141|NCT01425476|Analgesics|analgesics|mesh-ancestor
20458142|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
20458143|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458144|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458145|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458146|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20458147|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20458148|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458149|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458150|NCT01425541|Progesterone|progesterone|mesh-list
20458151|NCT01425541|Estradiol|estradiol|mesh-list
20458152|NCT01425541|Estrogens|estrogens|mesh-list
20458153|NCT01425541|Progestins|progestins|mesh-ancestor
20458154|NCT01425541|Hormones|hormones|mesh-ancestor
20458155|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458156|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458157|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
20458158|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20458159|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20458160|NCT01425580|Metformin|metformin|mesh-list
20458161|NCT01425580|Liraglutide|liraglutide|mesh-list
20458162|NCT01425580|Glimepiride|glimepiride|mesh-list
20458163|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20458164|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458165|NCT01425580|Incretins|incretins|mesh-ancestor
20458166|NCT01425580|Hormones|hormones|mesh-ancestor
20458167|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458168|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20458169|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458170|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
20458171|NCT01425619|Lidocaine|lidocaine|mesh-list
20458172|NCT01425619|Prilocaine|prilocaine|mesh-list
20458173|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458174|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
20458175|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458176|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458177|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
20458178|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458179|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20458180|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20458181|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20458182|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20458183|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458184|NCT01425658|Clonidine|clonidine|mesh-list
20458185|NCT01425658|Fentanyl|fentanyl|mesh-list
20458186|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20458187|NCT01425658|Narcotics|narcotics|mesh-ancestor
20458188|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458189|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458190|NCT01425658|Analgesics|analgesics|mesh-ancestor
20458191|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
20458192|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458193|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20458194|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20458195|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
20458196|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
20458197|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20458198|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
20458199|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
20458200|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20458201|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20458202|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20458203|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
20458204|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458205|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458206|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
20458207|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20458208|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20458209|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458210|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
20458211|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458212|NCT01425736|Cisplatin|cisplatin|mesh-list
20458213|NCT01425736|Docetaxel|docetaxel|mesh-list
20458214|NCT01425736|Fluorouracil|fluorouracil|mesh-list
20458215|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
20458216|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458217|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
20458218|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
20458219|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
20458220|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458221|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
20458222|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20458223|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458224|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
20613941|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613942|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20613943|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20613944|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613945|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
20613946|NCT02256956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19407583|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19407584|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19407585|NCT03572790|Prucalopride|prucalopride|mesh-list
19407586|NCT03572790|Laxatives|laxatives|mesh-ancestor
19407587|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407588|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19407589|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19407590|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
19407591|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407592|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407593|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407594|NCT03572686|Dexamethasone|dexamethasone|mesh-list
19407595|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
19407596|NCT03572686|Ropivacaine|ropivacaine|mesh-list
19407597|NCT03572686|BB 1101|bb 1101|mesh-list
19407598|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407599|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
19407600|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
19407601|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407602|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407603|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407604|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
19407605|NCT03572686|Hormones|hormones|mesh-ancestor
19407606|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407607|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407608|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407609|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
19407610|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407611|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407612|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458225|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458226|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458227|NCT01425775|Vitamin D|vitamin d|mesh-list
20458228|NCT01425775|Vitamins|vitamins|mesh-ancestor
20458229|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
20458230|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458231|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20458232|NCT05386914|Sirolimus|sirolimus|mesh-list
20458233|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20458234|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458235|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20458236|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458237|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
20458238|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458239|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
20458240|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526331|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20526332|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20526333|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20526334|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
20526335|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
20526336|NCT01762332|Remifentanil|remifentanil|mesh-list
20526337|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20526338|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20526339|NCT01762332|Narcotics|narcotics|mesh-ancestor
20526340|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20526341|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526342|NCT01762332|Analgesics|analgesics|mesh-ancestor
20526343|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
20526344|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526345|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20526346|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
20526347|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526348|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526349|NCT01762436|Atenolol|atenolol|mesh-list
20526350|NCT01762436|Bisoprolol|bisoprolol|mesh-list
20526351|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20526352|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20526353|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
20526354|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
20526355|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526356|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526357|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20526358|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20526359|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20526360|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
20526361|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526362|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526363|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
20526364|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
20526365|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20526366|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20526367|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526368|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526369|NCT01762475|Urological Agents|urological agents|mesh-ancestor
20526370|NCT01762514|Amifostine|amifostine|mesh-list
19849259|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849260|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19849261|NCT00701311|Apremilast|apremilast|mesh-list
19849262|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19849263|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19849264|NCT00701311|Analgesics|analgesics|mesh-ancestor
20222271|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20526371|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20526372|NCT01762514|Protective Agents|protective agents|mesh-ancestor
20526373|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526374|NCT01762540|Prednisolone|prednisolone|mesh-list
20526375|NCT01762540|Calcium|calcium|mesh-list
20526376|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
20526377|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20526378|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526379|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849265|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
19849266|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222272|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20222273|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20222274|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
20222275|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222276|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222277|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20222278|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222279|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222280|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20222281|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20222282|NCT00328796|Lidocaine|lidocaine|mesh-list
20222283|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458244|NCT05386706|Metformin|metformin|mesh-list
20458245|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20458246|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458247|NCT05386576|Venetoclax|venetoclax|mesh-list
20458248|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458249|NCT05386472|Ritonavir|ritonavir|mesh-list
20458250|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20458251|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20458252|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
20458253|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458254|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458255|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20458256|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20458257|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
20458258|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458259|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20458260|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20458261|NCT05386446|Interferons|interferons|mesh-list
20458262|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
20458263|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458264|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
20458265|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458266|NCT05386290|Mesalamine|mesalamine|mesh-list
20458267|NCT05386290|Infliximab|infliximab|mesh-list
20458268|NCT05386290|Ustekinumab|ustekinumab|mesh-list
20458269|NCT05386290|Vedolizumab|vedolizumab|mesh-list
20458270|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458271|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19694501|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694502|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694503|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20458272|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458273|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20458274|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694504|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19694505|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
19694506|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19694507|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19694508|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
19694509|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458275|NCT05386290|Analgesics|analgesics|mesh-ancestor
20458276|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
20458277|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458278|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458279|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458280|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20458281|NCT05386186|Glimepiride|glimepiride|mesh-list
20458282|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19694510|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694511|NCT04965701|Osimertinib|osimertinib|mesh-list
19694512|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694513|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694514|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458283|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20458284|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458285|NCT05386186|Incretins|incretins|mesh-ancestor
20458286|NCT05386186|Hormones|hormones|mesh-ancestor
20458287|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458288|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
20458289|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458290|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458291|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20458292|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458293|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
20458294|NCT05386160|Ranibizumab|ranibizumab|mesh-list
20458295|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20458296|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20458297|NCT05386160|Growth Substances|growth substances|mesh-ancestor
20458298|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458299|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
20458300|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458301|NCT05386121|Fentanyl|fentanyl|mesh-list
20458302|NCT05386121|Meperidine|meperidine|mesh-list
20458303|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20458304|NCT05386121|Narcotics|narcotics|mesh-ancestor
20458305|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458306|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458307|NCT05386121|Analgesics|analgesics|mesh-ancestor
20458308|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
20458309|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458310|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20458311|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20458312|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
20458313|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
20458314|NCT05386095|Bupivacaine|bupivacaine|mesh-list
20458315|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458316|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
20458317|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458318|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458319|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
20458320|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458321|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
20458322|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458323|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458324|NCT05386030|Lidocaine|lidocaine|mesh-list
20458325|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458326|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
20458327|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458328|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458329|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
20458330|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458331|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20458332|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20458333|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20458334|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20458335|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458336|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
20458337|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458338|NCT05385887|Metronidazole|metronidazole|mesh-list
20458339|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
20458340|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458341|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20458342|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20458343|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20458344|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20458345|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20458346|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458347|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458348|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458349|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20458350|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20458351|NCT05385861|Carboplatin|carboplatin|mesh-list
20458352|NCT05385861|Irinotecan|irinotecan|mesh-list
20458353|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458354|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20458355|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20458356|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458357|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458358|NCT05385744|Teriflunomide|teriflunomide|mesh-list
20458359|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20458360|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20458361|NCT05385744|Analgesics|analgesics|mesh-ancestor
20458362|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
20458363|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458364|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458365|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458366|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694515|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694516|NCT04965662|Tenofovir|tenofovir|mesh-list
19694517|NCT04965662|Emtricitabine|emtricitabine|mesh-list
19694518|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19694519|NCT04965662|Maraviroc|maraviroc|mesh-list
19694520|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
19694521|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458367|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458368|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
20458369|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
20458370|NCT05385705|Trastuzumab|trastuzumab|mesh-list
20458371|NCT05385705|Interleukin-2|interleukin-2|mesh-list
20458372|NCT05385705|Pertuzumab|pertuzumab|mesh-list
20458373|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458374|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
20458375|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458376|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458377|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20458378|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
20458379|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458380|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458381|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20458382|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458383|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20458384|NCT05385705|Analgesics|analgesics|mesh-ancestor
20458385|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
20458386|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458399|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
20458400|NCT05385432|Tacrolimus|tacrolimus|mesh-list
20458401|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20458402|NCT05385432|Basiliximab|basiliximab|mesh-list
20458403|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20458404|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
20458405|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
20458406|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458407|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20458408|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458409|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458410|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20458411|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458412|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20458413|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
20458414|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20458415|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458416|NCT05385406|Acetic Acid|acetic acid|mesh-list
20458417|NCT05385406|Retinol acetate|retinol acetate|mesh-list
20458418|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20458419|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458420|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20458421|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
20458422|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458423|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20458424|NCT05385406|Protective Agents|protective agents|mesh-ancestor
20458425|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458426|NCT05385367|Anesthetics|anesthetics|mesh-list
20458427|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
20458428|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458429|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458430|NCT05385185|Endostatins|endostatins|mesh-list
20458431|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458432|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20458433|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20458434|NCT05385185|Growth Substances|growth substances|mesh-ancestor
20458435|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458436|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
20526380|NCT01762540|Hormones|hormones|mesh-ancestor
20526381|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526382|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20526383|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526384|NCT01762644|Cyclosporine|cyclosporine|mesh-list
20526385|NCT01762644|Omeprazole|omeprazole|mesh-list
20526386|NCT01762644|Cyclosporins|cyclosporins|mesh-list
20613947|NCT02256956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407613|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
19416567|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526387|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526388|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458437|NCT05385094|Cystatins|cystatins|mesh-list
20458438|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20458439|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
20458440|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458441|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458442|NCT05385068|Niraparib|niraparib|mesh-list
20458443|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20458444|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458445|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458446|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458447|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
20458448|NCT05385042|Hydroxocobalamin|hydroxocobalamin|mesh-list
20458449|NCT05385042|Thiamine|thiamine|mesh-list
20458450|NCT05385042|Vitamins|vitamins|mesh-ancestor
20458451|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
20458452|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458453|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
20458454|NCT05385042|Hematinics|hematinics|mesh-ancestor
20458455|NCT05385029|Carbimazole|carbimazole|mesh-list
20458456|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
20458457|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
20458458|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458459|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458460|NCT05384951|Vitamin D|vitamin d|mesh-list
20458461|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
20458462|NCT05384951|Vitamins|vitamins|mesh-ancestor
20458463|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
20458464|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458465|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20458466|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20458467|NCT05380024|Ensartinib|ensartinib|mesh-list
20458468|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458469|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20458470|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458471|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458472|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
20458473|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20458474|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20458475|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20458476|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20458477|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458478|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
20458479|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458480|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458481|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20458482|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458483|NCT05379374|Morphine|morphine|mesh-list
20458484|NCT05379374|Bupivacaine|bupivacaine|mesh-list
20458485|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458486|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
20458487|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458488|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458489|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
20458490|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458491|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20458492|NCT05379374|Narcotics|narcotics|mesh-ancestor
20458493|NCT05379374|Analgesics|analgesics|mesh-ancestor
20458494|NCT05379179|Fentanyl|fentanyl|mesh-list
20458495|NCT05379179|Ketamine|ketamine|mesh-list
20458496|NCT05379179|Analgesics|analgesics|mesh-ancestor
20458497|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
20458498|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458499|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458500|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20458501|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20458502|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
20458503|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
20458504|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458505|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20458506|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20458507|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458508|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458509|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20458510|NCT05379179|Narcotics|narcotics|mesh-ancestor
20458511|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20458512|NCT05378750|Diuretics|diuretics|mesh-list
20458513|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
20458514|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458515|NCT05375903|Imiquimod|imiquimod|mesh-list
20458516|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20458517|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20458518|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
20458519|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458520|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458521|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
20458522|NCT05375708|Bevacizumab|bevacizumab|mesh-list
20458523|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458524|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458525|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20458526|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20458527|NCT05375708|Growth Substances|growth substances|mesh-ancestor
20458528|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458529|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
20458530|NCT05375097|Erenumab|erenumab|mesh-list
20458531|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20458532|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458533|NCT05375097|Analgesics|analgesics|mesh-ancestor
20458534|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
20458535|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458536|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458537|NCT05370040|Vaccines|vaccines|mesh-list
20458538|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
20458539|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458540|NCT05361499|Phenethicillin|phenethicillin|mesh-list
20458541|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20458542|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458543|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
20458544|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20458545|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458546|NCT05317000|Nivolumab|nivolumab|mesh-list
20458547|NCT05317000|Azacitidine|azacitidine|mesh-list
20458548|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458549|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458550|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20458551|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458552|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20458553|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
20458554|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458555|NCT05316428|Ethanol|ethanol|mesh-list
20458556|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20458557|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458558|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407614|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407615|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
19407616|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
19849267|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849268|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849269|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849270|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19849271|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19849272|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407617|NCT03572647|Hematinics|hematinics|mesh-ancestor
19407618|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19407619|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19407620|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407621|NCT03572582|Nivolumab|nivolumab|mesh-list
19407622|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407623|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407624|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19407625|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407626|NCT03572517|Morphine|morphine|mesh-list
19407627|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19849273|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849274|NCT00701363|Lanreotide|lanreotide|mesh-list
19849275|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849276|NCT00701376|Liver Extracts|liver extracts|mesh-list
19849277|NCT00701376|Hematinics|hematinics|mesh-ancestor
20458559|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407628|NCT03572517|Narcotics|narcotics|mesh-ancestor
19407629|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458560|NCT05316220|Mesalamine|mesalamine|mesh-list
20458561|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20458562|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20458563|NCT05316220|Analgesics|analgesics|mesh-ancestor
20458564|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
20458565|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458566|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458567|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458568|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458569|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20458570|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20458571|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20458572|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458573|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458574|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20458575|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20458576|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458577|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
20458578|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458579|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20458580|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458581|NCT05304949|Ranibizumab|ranibizumab|mesh-list
20458582|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20222284|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
20222285|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20222286|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458583|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20458584|NCT05304949|Growth Substances|growth substances|mesh-ancestor
20458585|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458586|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
20458587|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458588|NCT05295784|Caffeine|caffeine|mesh-list
20458589|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
20458590|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458591|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20458592|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458593|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20458594|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458595|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20458596|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19694522|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19694523|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19694524|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222287|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
20222288|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222289|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20222290|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20222291|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20222292|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20458597|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
20458598|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458599|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20458600|NCT05283395|Latanoprost|latanoprost|mesh-list
20458601|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20458602|NCT05279183|Erythritol|erythritol|mesh-list
20458603|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
20458604|NCT05275400|Insulin|insulin|mesh-list
20458605|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20458606|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458607|NCT05265247|Esomeprazole|esomeprazole|mesh-list
20458608|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20458609|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20458610|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20458611|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458612|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458613|NCT05260021|Tirzepatide|tirzepatide|mesh-list
20458614|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20458615|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458616|NCT05260021|Incretins|incretins|mesh-ancestor
20458617|NCT05260021|Hormones|hormones|mesh-ancestor
20458618|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526389|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526390|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
20458619|NCT05244525|Epinephrine|epinephrine|mesh-list
20458620|NCT05244525|Bupivacaine|bupivacaine|mesh-list
20458621|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458622|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
20458623|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458624|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458625|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
20458626|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458627|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20458628|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20458629|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
20458630|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458631|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458632|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20458633|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20458634|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
20458635|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20458636|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
20458637|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
20458638|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
20458639|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20458640|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
20458641|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458642|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458643|NCT05223478|Phentolamine|phentolamine|mesh-list
20458644|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20458645|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19694525|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694526|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20458646|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20458647|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20458648|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
20458649|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458650|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458651|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458652|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20458653|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20458654|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20458655|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458656|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
20458657|NCT05198830|Cisplatin|cisplatin|mesh-list
20458658|NCT05198830|Pemetrexed|pemetrexed|mesh-list
20458659|NCT05198830|Durvalumab|durvalumab|mesh-list
20458660|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
20458661|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20458662|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
20458663|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458664|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458665|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458666|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20458667|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20458668|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458669|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
20458670|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458671|NCT05176379|Fluconazole|fluconazole|mesh-list
20458672|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
20458673|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458674|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20458675|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20458676|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458677|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458678|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20458679|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
20458680|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458681|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458682|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20458683|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20458684|NCT05174039|Miglustat|miglustat|mesh-list
20458685|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458686|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458687|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20458688|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20458689|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
19694527|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20458690|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458691|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20458692|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20458693|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458694|NCT05171647|Gemcitabine|gemcitabine|mesh-list
20458695|NCT05171647|Rituximab|rituximab|mesh-list
20458696|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
20458697|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458698|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458699|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
20458700|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458701|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458702|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20458703|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
20458704|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458705|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
20458706|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458707|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458708|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458709|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
20458710|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458711|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
20458712|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458713|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458714|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20458715|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
20458716|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458717|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458718|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20458719|NCT05144009|Rituximab|rituximab|mesh-list
20458720|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20458721|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458722|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458723|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
20458724|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458725|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458726|NCT05139017|Gemcitabine|gemcitabine|mesh-list
20458727|NCT05139017|Rituximab|rituximab|mesh-list
20458728|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
20458729|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20458730|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694528|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19694529|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19694530|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19694531|NCT04965181|Nicotine|nicotine|mesh-list
19694532|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19694533|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
19694534|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694535|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694536|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19694537|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19694538|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
19694539|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458731|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458732|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
20458733|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458734|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458735|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20458736|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
20458737|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458738|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
20458739|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458740|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458741|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458742|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20458743|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
20458744|NCT05130268|Dronedarone|dronedarone|mesh-list
20458745|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20458746|NCT05115110|Risdiplam|risdiplam|mesh-list
20458747|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20458748|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458749|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694540|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458750|NCT05113615|Bromides|bromides|mesh-list
20458751|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
20458752|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20458753|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
20458754|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458755|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458756|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20458757|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
20458758|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
20458759|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20458760|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
20458761|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458762|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458763|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
20458764|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
20458765|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20458766|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
20458767|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458768|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458769|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20458770|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
20458771|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20458772|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
20458773|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458774|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458775|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20458776|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
20458777|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
20458778|NCT05109611|Protective Agents|protective agents|mesh-ancestor
20458779|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20458780|NCT05102409|Lifitegrast|lifitegrast|mesh-list
20458781|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20458782|NCT05093205|Midazolam|midazolam|mesh-list
20458783|NCT05093205|Atorvastatin|atorvastatin|mesh-list
20458784|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
20458785|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20458786|NCT05093205|Estradiol|estradiol|mesh-list
20458787|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20458788|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20458789|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
20458790|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458791|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20458792|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20458793|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458794|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20222293|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222294|NCT00328809|Spironolactone|spironolactone|mesh-list
20222295|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20222296|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222297|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222298|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222299|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20222300|NCT00328809|Diuretics|diuretics|mesh-ancestor
20222301|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
20222302|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20222303|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222304|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222305|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20222306|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20222307|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20222308|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222309|NCT00328874|Ubiquinone|ubiquinone|mesh-list
20222310|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
20222311|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
20222312|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222313|NCT00328874|Vitamins|vitamins|mesh-ancestor
20222314|NCT00328900|Atropine|atropine|mesh-list
20222315|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20222316|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20222317|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20222318|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
20222319|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222320|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222321|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20222322|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
20222323|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
20222324|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
19694541|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
19694542|NCT04965116|Progestins|progestins|mesh-list
19694543|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19694544|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458795|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20458796|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458797|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458798|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20458799|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20458800|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20458801|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20458802|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
20458803|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
20458804|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
20458805|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
20458806|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458807|NCT05093205|Estrogens|estrogens|mesh-ancestor
20458808|NCT05093205|Hormones|hormones|mesh-ancestor
20458809|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458810|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20458811|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
20458812|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20458813|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20458814|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20458815|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20458816|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20458817|NCT05089916|Osimertinib|osimertinib|mesh-list
20458818|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458819|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20458820|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458821|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458822|NCT05065372|Metformin|metformin|mesh-list
20458823|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20458824|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458825|NCT05058651|Cisplatin|cisplatin|mesh-list
20458826|NCT05058651|Carboplatin|carboplatin|mesh-list
20458827|NCT05058651|Etoposide|etoposide|mesh-list
20458828|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
20458829|NCT05058651|Atezolizumab|atezolizumab|mesh-list
20458830|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
20458831|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20458832|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458833|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20458834|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20458835|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20458836|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458837|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458838|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
20458839|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458840|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
19407630|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407631|NCT03572517|Analgesics|analgesics|mesh-ancestor
19407632|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
19407633|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407634|NCT03572400|Gemcitabine|gemcitabine|mesh-list
19407635|NCT03572400|Durvalumab|durvalumab|mesh-list
19407636|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407637|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
19407638|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407639|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407640|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
19407641|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407642|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407643|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407644|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
19407645|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407646|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407647|NCT03572387|Azacitidine|azacitidine|mesh-list
19407648|NCT03572387|Tretinoin|tretinoin|mesh-list
19407649|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407650|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
19407651|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407652|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407653|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694545|NCT04965116|Hormones|hormones|mesh-ancestor
20458841|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458842|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
20458843|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
20458844|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
20458845|NCT05041647|Dronabinol|dronabinol|mesh-list
20458846|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
20458847|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458848|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20458849|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20458850|NCT05041647|Analgesics|analgesics|mesh-ancestor
20458851|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
20458852|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458853|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20458854|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20458855|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458856|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458857|NCT05041647|Hormones|hormones|mesh-ancestor
20458858|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458859|NCT05030415|Ixekizumab|ixekizumab|mesh-list
20458860|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458861|NCT05020782|Belimumab|belimumab|mesh-list
20458862|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458863|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
20458864|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458865|NCT05007652|Plerixafor|plerixafor|mesh-list
20458866|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20458867|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20458868|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
20458869|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458870|NCT05001880|Bevacizumab|bevacizumab|mesh-list
20458871|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20458872|NCT05001880|Carboplatin|carboplatin|mesh-list
20458873|NCT05001880|Pemetrexed|pemetrexed|mesh-list
20458874|NCT05001880|Atezolizumab|atezolizumab|mesh-list
20458875|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
20458876|NCT05001880|Antibodies|antibodies|mesh-list
20458877|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
20458878|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20458879|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
20458880|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458881|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20458882|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20458883|NCT05001880|Growth Substances|growth substances|mesh-ancestor
20458884|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458885|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
20458886|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
20458887|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458888|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458889|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20458890|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20458900|NCT04992312|Glucagon|glucagon|mesh-list
20458901|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20458902|NCT04992312|Hormones|hormones|mesh-ancestor
20458903|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458904|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526391|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526392|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
20526393|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526394|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
20526395|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526396|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20526397|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20526398|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20526399|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20526400|NCT01762657|Cyclosporine|cyclosporine|mesh-list
19407654|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
19707763|NCT04824391|Vaccines|vaccines|mesh-list
20526401|NCT01762657|Lansoprazole|lansoprazole|mesh-list
20613948|NCT02256956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20526402|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
20458905|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
20458906|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
20458907|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
20458908|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
20458909|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458910|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458911|NCT04930042|Ustekinumab|ustekinumab|mesh-list
20458912|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458913|NCT04910568|Dexamethasone|dexamethasone|mesh-list
20458914|NCT04910568|Daratumumab|daratumumab|mesh-list
19407655|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407656|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19407657|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
19407658|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19407659|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19407660|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407661|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20222325|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20222326|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19407662|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407663|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
19407664|NCT03572231|Mirabegron|mirabegron|mesh-list
19407665|NCT03572231|Fesoterodine|fesoterodine|mesh-list
19407666|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19407667|NCT03572231|Oxybutynin|oxybutynin|mesh-list
19407668|NCT03572231|Darifenacin|darifenacin|mesh-list
19407669|NCT03572231|Propiverine|propiverine|mesh-list
19407670|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19407671|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19407672|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
19407673|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407674|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407675|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407676|NCT03572231|Urological Agents|urological agents|mesh-ancestor
19407677|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19407678|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19407679|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19407680|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
19407681|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
19407682|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
19407683|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407684|NCT03572088|Terlipressin|terlipressin|mesh-list
19407685|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19407686|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19416568|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416569|NCT02401750|Naltrexone|naltrexone|mesh-list
19416570|NCT02401750|Oxycodone|oxycodone|mesh-list
19416571|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19416572|NCT02401750|Narcotics|narcotics|mesh-ancestor
19416573|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416574|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416575|NCT02401750|Analgesics|analgesics|mesh-ancestor
19416576|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
19416577|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416578|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19416579|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19416580|NCT02398500|Ranibizumab|ranibizumab|mesh-list
19416581|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19416582|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19416583|NCT02398500|Growth Substances|growth substances|mesh-ancestor
19416584|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416585|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
19416586|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416587|NCT02393937|Metronidazole|metronidazole|mesh-list
20222327|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
20222328|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222329|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222330|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
20222331|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20222332|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222333|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20247266|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20247267|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247268|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458915|NCT04910568|Pomalidomide|pomalidomide|mesh-list
19416588|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20458916|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458917|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
20458918|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
20458919|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458920|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458921|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20458922|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
20458923|NCT04910568|Hormones|hormones|mesh-ancestor
20458924|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458925|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20458926|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458927|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
20458928|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20458929|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20458930|NCT04910568|Growth Substances|growth substances|mesh-ancestor
20458931|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
20458932|NCT04908189|Apremilast|apremilast|mesh-list
20458933|NCT04908189|BMS-986165|bms-986165|mesh-list
20458934|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20458935|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20458936|NCT04908189|Analgesics|analgesics|mesh-ancestor
20458937|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
20458938|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458939|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458940|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458941|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20458942|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20458943|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20458944|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20458945|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458946|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458947|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20458948|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
20458949|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20458950|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458951|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
20458952|NCT04862221|Promethazine|promethazine|mesh-list
19407687|NCT03572010|Fesoterodine|fesoterodine|mesh-list
19407688|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19407689|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19407690|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
19407691|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407692|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407693|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407694|NCT03572010|Urological Agents|urological agents|mesh-ancestor
19407695|NCT03571932|Vaccines|vaccines|mesh-list
19407696|NCT03571932|Immunologic Factors|immunologic factors|mesh-ancestor
19407697|NCT03571932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407698|NCT03571919|Lidocaine|lidocaine|mesh-list
19407699|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
19407700|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
19407701|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20458953|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
20458954|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20458955|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20458956|NCT04862221|Prednisolone|prednisolone|mesh-list
20458957|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
20458958|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20458959|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
20458960|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20458961|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20458962|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
20458963|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
20458964|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20458965|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20458966|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20458967|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
20458968|NCT04862221|Hormones|hormones|mesh-ancestor
20458969|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458970|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20458971|NCT04862221|Protective Agents|protective agents|mesh-ancestor
20458972|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20458973|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20458974|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
19407702|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694546|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20458975|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20458976|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20458977|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20458978|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407703|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
19407704|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407705|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19694547|NCT04965298|Lansoprazole|lansoprazole|mesh-list
20458979|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
20458980|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
20458981|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
20458982|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20458983|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
20458984|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
20458985|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20458986|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458987|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20458988|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
20458989|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
20458990|NCT04860960|Betadex|betadex|mesh-list
20458991|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
20458992|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20458993|NCT04850378|Dalteparin|dalteparin|mesh-list
20458994|NCT04850378|Tinzaparin|tinzaparin|mesh-list
20458995|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20458996|NCT04850378|Apixaban|apixaban|mesh-list
20458997|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20458998|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
20458999|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20459000|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
20459001|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459002|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459003|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
20459004|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20459005|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20459006|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
20459007|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20459008|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
20459009|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20459010|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
20459011|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459012|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459013|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
20459014|NCT04809103|Cisplatin|cisplatin|mesh-list
20459015|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459016|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20459017|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20459018|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459019|NCT04789070|Sirolimus|sirolimus|mesh-list
20459020|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20459021|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459022|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20459023|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459024|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
20459025|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459026|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
20459027|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459028|NCT04775953|Vancomycin|vancomycin|mesh-list
20459029|NCT04775953|Cefazolin|cefazolin|mesh-list
20459030|NCT04775953|Daptomycin|daptomycin|mesh-list
20459031|NCT04775953|Dalbavancin|dalbavancin|mesh-list
20459032|NCT04775953|Oxacillin|oxacillin|mesh-list
20459033|NCT04775953|Nafcillin|nafcillin|mesh-list
20459034|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20459035|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459036|NCT04775082|Liraglutide|liraglutide|mesh-list
20459037|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20459038|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459039|NCT04775082|Incretins|incretins|mesh-ancestor
20459040|NCT04775082|Hormones|hormones|mesh-ancestor
20459041|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459042|NCT04765371|Dexamethasone|dexamethasone|mesh-list
20459043|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
20459044|NCT04765371|Prednisolone|prednisolone|mesh-list
19694548|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
19694549|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20459045|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20459046|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
20459047|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20459048|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
20459049|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20459050|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
20459051|NCT04765371|BB 1101|bb 1101|mesh-list
20459052|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459053|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
20459054|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
20459055|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459056|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459057|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459058|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
20459059|NCT04765371|Hormones|hormones|mesh-ancestor
20459060|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459061|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20459062|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459063|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
20459064|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459065|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459066|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20459067|NCT04765371|Protective Agents|protective agents|mesh-ancestor
20459068|NCT04744363|Ustekinumab|ustekinumab|mesh-list
20459069|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
20459070|NCT04740918|Trastuzumab|trastuzumab|mesh-list
20459071|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20459072|NCT04740918|Atezolizumab|atezolizumab|mesh-list
20459073|NCT04740918|Maytansine|maytansine|mesh-list
20459074|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459075|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459076|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459077|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459078|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459079|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459080|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459088|NCT04736199|Androgens|androgens|mesh-list
20459089|NCT04736199|Hormones|hormones|mesh-ancestor
20459090|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459091|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459092|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
20459093|NCT04735471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20459094|NCT04735471|Fludarabine|fludarabine|mesh-list
20459095|NCT04735471|Interleukin-2|interleukin-2|mesh-list
20459096|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459097|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
20459098|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459099|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459100|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459101|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
20459102|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459103|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459104|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20459105|NCT04735471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20459106|NCT04735471|Analgesics|analgesics|mesh-ancestor
20459107|NCT04735471|Sensory System Agents|sensory system agents|mesh-ancestor
20459108|NCT04735471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459109|NCT04729517|Azelastine|azelastine|mesh-list
20459110|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20459111|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
20459112|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459113|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459114|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20459115|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
20459116|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20459117|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459118|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459119|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19707764|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
20459120|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20459121|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20459122|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
20459123|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
20459124|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459125|NCT04717414|Luspatercept|luspatercept|mesh-list
20459126|NCT04717414|Hematinics|hematinics|mesh-ancestor
20459127|NCT04707196|Fulvestrant|fulvestrant|mesh-list
20459128|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19694550|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19694551|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19694552|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694553|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694554|NCT04965324|Anesthetics|anesthetics|mesh-list
20459129|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20459130|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459131|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20459132|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20459133|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
20459134|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459135|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459136|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20459137|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459138|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459139|NCT04701333|Cabergoline|cabergoline|mesh-list
19694555|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694556|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459140|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20459141|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20459142|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
20459143|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
20459144|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459145|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459146|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459147|NCT04698525|Valproic Acid|valproic acid|mesh-list
20459148|NCT04698525|Memantine|memantine|mesh-list
20459149|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20459150|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20459151|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
20459152|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459153|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459154|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459155|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20459156|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20459157|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
20459158|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459159|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
20459160|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
20459161|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20459162|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459163|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20459164|NCT04675151|Phentolamine|phentolamine|mesh-list
20459165|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20459166|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20459167|NCT04675151|Pilocarpine|pilocarpine|mesh-list
20459168|NCT04675151|Miotics|miotics|mesh-ancestor
20459169|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
20459170|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459171|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459172|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20459173|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20459174|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
20459175|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459176|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459177|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20459178|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20459179|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
20459180|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20459181|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
20459182|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20459183|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20459184|NCT04673162|Prednisolone|prednisolone|mesh-list
20459185|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
20459186|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19694557|NCT04965051|Insulin|insulin|mesh-list
19694558|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19694559|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
20459187|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
20459188|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459189|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
20459190|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
20459191|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459192|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459193|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459194|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
20459195|NCT04673162|Hormones|hormones|mesh-ancestor
20459196|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459197|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20459198|NCT04673162|Protective Agents|protective agents|mesh-ancestor
20459199|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20459200|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459201|NCT04671043|Caffeine|caffeine|mesh-list
20459202|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20459203|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459204|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20459205|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459206|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459207|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20459208|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20459209|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
20459210|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526403|NCT01762657|Cyclosporins|cyclosporins|mesh-list
20526404|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526405|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526406|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526407|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
20526408|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526409|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
20526410|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526411|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
20526412|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526413|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20526414|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20526415|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20526416|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20526417|NCT01762670|Metronidazole|metronidazole|mesh-list
20526418|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526419|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526420|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20526421|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20526422|NCT01762787|Aspirin|aspirin|mesh-list
20526423|NCT01762787|Prednisolone|prednisolone|mesh-list
20526424|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20526425|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
20526426|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20526427|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
20526428|NCT01762787|Cantharidin|cantharidin|mesh-list
20526429|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20526430|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
20526431|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526432|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526433|NCT01762787|Analgesics|analgesics|mesh-ancestor
20526434|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
20526435|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526436|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526437|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526438|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526439|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20526440|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20526441|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526442|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20526443|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20526444|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526445|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
20526446|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
20526447|NCT01762787|Hormones|hormones|mesh-ancestor
20526448|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526449|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20526450|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526451|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
20526452|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
20526453|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459211|NCT04638660|Phentolamine|phentolamine|mesh-list
20459212|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20459213|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20459214|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20459215|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20459216|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
20459217|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459218|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459219|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459220|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20459221|NCT04628767|Gemcitabine|gemcitabine|mesh-list
20222334|NCT00328939|Enoxaparin|enoxaparin|mesh-list
20222335|NCT00328939|PENTA|penta|mesh-list
20222336|NCT00328939|Fondaparinux|fondaparinux|mesh-list
20222337|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
20222338|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20222339|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20222340|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222341|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20222342|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
20222343|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20222344|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
20222345|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222346|NCT00328965|Lacidipine|lacidipine|mesh-list
20222347|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20222348|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20222349|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222350|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222351|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20222352|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222353|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20222354|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222355|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222356|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20222357|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20222358|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20222359|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222360|NCT00329069|Atorvastatin|atorvastatin|mesh-list
20222361|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20222362|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222363|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
19694560|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20222364|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222365|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20222366|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20222367|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222368|NCT00329095|Bimatoprost|bimatoprost|mesh-list
20222369|NCT00329095|Travoprost|travoprost|mesh-list
20222370|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
20222371|NCT00329095|Latanoprost|latanoprost|mesh-list
20222372|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20222373|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20222374|NCT00329134|Quinine|quinine|mesh-list
20222375|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
20222376|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20222377|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20222378|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222379|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20222380|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222381|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20222382|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222383|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222384|NCT00329134|Analgesics|analgesics|mesh-ancestor
20222385|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
20222386|NCT00329147|Paroxetine|paroxetine|mesh-list
20222387|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20222388|NCT00329147|Desipramine|desipramine|mesh-list
20459222|NCT04628767|Cisplatin|cisplatin|mesh-list
20459223|NCT04628767|Doxorubicin|doxorubicin|mesh-list
20459224|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20459225|NCT04628767|Methotrexate|methotrexate|mesh-list
19694561|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222389|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20222390|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20222391|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247269|NCT00431418|Urological Agents|urological agents|mesh-ancestor
20459226|NCT04628767|Durvalumab|durvalumab|mesh-list
20459227|NCT04628767|Vinblastine|vinblastine|mesh-list
20459228|NCT04628767|Lenograstim|lenograstim|mesh-list
20459229|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
20459230|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20459231|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
20459232|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459233|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20459234|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
20459235|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459236|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
20459237|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459238|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459239|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459240|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
20459241|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459242|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20459243|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20459244|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20459245|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20459246|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
20459247|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20459248|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
20459249|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20459250|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459251|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20459252|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20459253|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459254|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459255|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459256|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459257|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459258|NCT04622020|Anesthetics|anesthetics|mesh-list
20459259|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459260|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459261|NCT04585958|Trastuzumab|trastuzumab|mesh-list
20459262|NCT04585958|Olaparib|olaparib|mesh-list
20459263|NCT04585958|Camptothecin|camptothecin|mesh-list
20459264|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20459265|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
20459266|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459267|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459268|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459269|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459270|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459271|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20459272|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20459273|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
20459274|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459275|NCT04579224|Gemcitabine|gemcitabine|mesh-list
20459276|NCT04579224|Paclitaxel|paclitaxel|mesh-list
20459277|NCT04579224|Docetaxel|docetaxel|mesh-list
20459278|NCT04579224|Halichondrin B|halichondrin b|mesh-list
20459279|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20459280|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459281|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459282|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459283|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459284|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459285|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459286|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20459287|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
20459288|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
20459289|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459290|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459291|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459292|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
19694562|NCT04964869|Epinephrine|epinephrine|mesh-list
19694563|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19694564|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19694565|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
19694566|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459293|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459294|NCT04560556|Antibodies|antibodies|mesh-list
20459295|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
19849278|NCT00701389|Sumatriptan|sumatriptan|mesh-list
20459296|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459297|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
20459298|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
20459299|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
20459300|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20459301|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459302|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
20459303|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
20459304|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459305|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459306|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459307|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
20222392|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222393|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222394|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
20222395|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459308|NCT04548999|Hormones|hormones|mesh-ancestor
20459309|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459310|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20459311|NCT04548999|Protective Agents|protective agents|mesh-ancestor
20459312|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
20459313|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
20459314|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459315|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459316|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
20459317|NCT04548752|Olaparib|olaparib|mesh-list
20459318|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20459319|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459320|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222396|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20222397|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222398|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222399|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20222400|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20459321|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459322|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459323|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
20459324|NCT04510051|Fludarabine|fludarabine|mesh-list
20459325|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459326|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
20459327|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459328|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459329|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459330|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
20459331|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459332|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459333|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20459334|NCT04477850|Luspatercept|luspatercept|mesh-list
20459335|NCT04477850|Hematinics|hematinics|mesh-ancestor
20459336|NCT04472429|Paclitaxel|paclitaxel|mesh-list
20459337|NCT04472429|Carboplatin|carboplatin|mesh-list
20459338|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459339|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459340|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459341|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459342|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459343|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459344|NCT04449874|Bevacizumab|bevacizumab|mesh-list
20459345|NCT04449874|Cetuximab|cetuximab|mesh-list
20459346|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20459347|NCT04449874|Atezolizumab|atezolizumab|mesh-list
20459348|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459349|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694567|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222401|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222402|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20222403|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20222404|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20222405|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
20222406|NCT00329173|Atorvastatin|atorvastatin|mesh-list
20222407|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20459350|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20459351|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20459352|NCT04449874|Growth Substances|growth substances|mesh-ancestor
20459353|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459354|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
20459355|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20459356|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459357|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459358|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
20459359|NCT04425902|Metoprolol|metoprolol|mesh-list
20459360|NCT04425902|Digoxin|digoxin|mesh-list
20459361|NCT04425902|Midazolam|midazolam|mesh-list
20459362|NCT04425902|Caffeine|caffeine|mesh-list
20459363|NCT04425902|Omeprazole|omeprazole|mesh-list
20459364|NCT04425902|Pravastatin|pravastatin|mesh-list
20459365|NCT04425902|Montelukast|montelukast|mesh-list
20459366|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20459367|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20459368|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459369|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459370|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20459371|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20459372|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20459373|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20459374|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
19849279|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19849280|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19849281|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19849282|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
19849283|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849284|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849285|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849286|NCT00701558|Gemcitabine|gemcitabine|mesh-list
19849287|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19849288|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19849289|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
19849290|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849291|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849292|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
19849293|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849294|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849295|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849296|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
19849297|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849298|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849299|NCT00701636|Daptomycin|daptomycin|mesh-list
19849300|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19849301|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849302|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
19849303|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
19849304|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459375|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
20459376|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
20459377|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
20459378|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459379|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459380|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20459381|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459382|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20459383|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459384|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20459385|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20459386|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20459387|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20459388|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
20459389|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20459390|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
20459391|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20459392|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
20459393|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459394|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20459395|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20459396|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20459397|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19849305|NCT00701675|Sertraline|sertraline|mesh-list
19849306|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
20459398|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
20459399|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
19407706|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19407707|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20459400|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459401|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20459402|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20459403|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20459404|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
20459405|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20459406|NCT04425902|Protective Agents|protective agents|mesh-ancestor
20459407|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20459408|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20459409|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
20459410|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20459411|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20459412|NCT04425902|Analgesics|analgesics|mesh-ancestor
20459413|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
20459414|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20459415|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20459416|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459417|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459418|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20459419|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20459420|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459421|NCT04370093|Pioglitazone|pioglitazone|mesh-list
20459422|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20459423|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459424|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
20459425|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
20459426|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20459427|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20459428|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459429|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459430|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459431|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459432|NCT04339738|Paclitaxel|paclitaxel|mesh-list
20459433|NCT04339738|Nivolumab|nivolumab|mesh-list
20459434|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20459435|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459436|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459437|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459438|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459439|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459440|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459441|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459442|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20459443|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
20459444|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20459445|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20459446|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459447|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
20459448|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
20459449|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459450|NCT04311762|Cisplatin|cisplatin|mesh-list
20459451|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459452|NCT04310007|Gemcitabine|gemcitabine|mesh-list
20459453|NCT04310007|Paclitaxel|paclitaxel|mesh-list
20459454|NCT04310007|Docetaxel|docetaxel|mesh-list
20459455|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20459456|NCT04310007|Nivolumab|nivolumab|mesh-list
20459457|NCT04310007|Ramucirumab|ramucirumab|mesh-list
20459458|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20459459|NCT04310007|Antibodies|antibodies|mesh-list
20459460|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
20459461|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20459462|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459463|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459464|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459465|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459466|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459467|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459468|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
20459469|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459470|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19694568|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459471|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
20459472|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
20459473|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459474|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459475|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459476|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20459477|NCT04302025|Atezolizumab|atezolizumab|mesh-list
20459478|NCT04302025|Vemurafenib|vemurafenib|mesh-list
20459479|NCT04302025|Pralsetinib|pralsetinib|mesh-list
20459480|NCT04302025|Entrectinib|entrectinib|mesh-list
20459481|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459482|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20459483|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459484|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459485|NCT04301076|Prednisone|prednisone|mesh-list
20459486|NCT04301076|Cortisone|cortisone|mesh-list
20459487|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
20459488|NCT04301076|Doxorubicin|doxorubicin|mesh-list
20459489|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20459490|NCT04301076|Etoposide|etoposide|mesh-list
20459491|NCT04301076|Vincristine|vincristine|mesh-list
20459492|NCT04301076|Lenalidomide|lenalidomide|mesh-list
20459493|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
20459494|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
20459495|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459496|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
20459497|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459498|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459499|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459500|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
20459501|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459502|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459503|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20459504|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20459505|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20459506|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20459507|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459508|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459509|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
20459510|NCT04301076|Hormones|hormones|mesh-ancestor
20459511|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459512|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20459513|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459514|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459515|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459516|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459517|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20459518|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20459519|NCT04301076|Growth Substances|growth substances|mesh-ancestor
20459520|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
20459521|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
20459522|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
20459523|NCT04266249|Paclitaxel|paclitaxel|mesh-list
20459524|NCT04266249|Maytansine|maytansine|mesh-list
20459525|NCT04266249|Docetaxel|docetaxel|mesh-list
20459526|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20459527|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20459528|NCT04266249|Trastuzumab|trastuzumab|mesh-list
20459529|NCT04266249|Pertuzumab|pertuzumab|mesh-list
20459530|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20459531|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20459532|NCT04266249|Antibodies|antibodies|mesh-list
20459533|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
20459534|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20459535|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
20459536|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459537|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459538|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459539|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459540|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459541|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459542|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
20459543|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459544|NCT04261075|Durvalumab|durvalumab|mesh-list
20459545|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459546|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459547|NCT04255433|Dulaglutide|dulaglutide|mesh-list
20459548|NCT04255433|Tirzepatide|tirzepatide|mesh-list
20459549|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20459550|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459551|NCT04255433|Incretins|incretins|mesh-ancestor
20459552|NCT04255433|Hormones|hormones|mesh-ancestor
20459553|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459554|NCT04246762|Vitamin K|vitamin k|mesh-list
20459555|NCT04246762|Midazolam|midazolam|mesh-list
20459556|NCT04246762|Caffeine|caffeine|mesh-list
20459557|NCT04246762|Omeprazole|omeprazole|mesh-list
20459558|NCT04246762|Warfarin|warfarin|mesh-list
20459559|NCT04246762|Vitamins|vitamins|mesh-ancestor
20459560|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
20459561|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459562|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20459563|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20459564|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459565|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20459566|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20459567|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20459568|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20459569|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
20459570|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
20459571|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
20459572|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
20459573|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459574|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459575|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
20459576|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20459577|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459578|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20459579|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459580|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20459581|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20459582|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20459583|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20459584|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
20459585|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20459586|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20459587|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
20459588|NCT04246762|Coagulants|coagulants|mesh-ancestor
20459589|NCT04238819|Irinotecan|irinotecan|mesh-list
20459590|NCT04238819|Temozolomide|temozolomide|mesh-list
20459591|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20459592|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20459593|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459594|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459595|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459596|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459597|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
20459598|NCT04232553|Mirikizumab|mirikizumab|mesh-list
20459599|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20459600|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20459601|NCT04232553|Analgesics|analgesics|mesh-ancestor
20459602|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
20459603|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459604|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459605|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459606|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459607|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20459608|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20526454|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20526455|NCT01762787|Protective Agents|protective agents|mesh-ancestor
20526456|NCT01762826|Inositol|inositol|mesh-list
20526457|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
20526458|NCT01762826|Vitamins|vitamins|mesh-ancestor
20526459|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
20526460|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222408|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20222409|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222410|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
20222411|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222412|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20222413|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20222414|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222415|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20222416|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20526461|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
20526462|NCT01762839|Oritavancin|oritavancin|mesh-list
20526463|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526464|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613949|NCT02257008|Ritonavir|ritonavir|mesh-list
20222417|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20459609|NCT04221477|Acetaminophen|acetaminophen|mesh-list
20459610|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
20459611|NCT04221477|Promethazine|promethazine|mesh-list
20459612|NCT04221477|Prednisone|prednisone|mesh-list
20459613|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
20459614|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
20459615|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459616|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
20459617|NCT04221477|Hormones|hormones|mesh-ancestor
20459618|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459619|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459620|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20459621|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459622|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20459623|NCT04221477|Analgesics|analgesics|mesh-ancestor
20459624|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
20459625|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459626|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
20459627|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
20459628|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
20459629|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459630|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20459631|NCT04221477|Protective Agents|protective agents|mesh-ancestor
20459632|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459633|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20459634|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20459635|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459636|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
20459637|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
20459638|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20459639|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
20459640|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
20459641|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459642|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459643|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20459644|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
20459645|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
20459646|NCT04203472|Budesonide|budesonide|mesh-list
20459647|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459648|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20459649|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
20459650|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459651|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459652|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20459653|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
20459654|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
20459655|NCT04203472|Hormones|hormones|mesh-ancestor
20459656|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459657|NCT04199819|Entecavir|entecavir|mesh-list
20459658|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
20459659|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459660|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
20459661|NCT04196491|Fludarabine|fludarabine|mesh-list
20459662|NCT04196491|Lenalidomide|lenalidomide|mesh-list
20459663|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459664|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
20459665|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459666|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459667|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459668|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
20459669|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459670|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459671|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20222418|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20222419|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222420|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222421|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222422|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222423|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20459672|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20459673|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20459674|NCT04196491|Growth Substances|growth substances|mesh-ancestor
19849307|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20459675|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
20459676|NCT04193774|Benoxinate|benoxinate|mesh-list
20459677|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20459678|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
20459679|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20459680|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
20459681|NCT04193774|Anesthetics|anesthetics|mesh-ancestor
20459682|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459683|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459684|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
20459685|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459686|NCT04191499|Fulvestrant|fulvestrant|mesh-list
20459687|NCT04191499|Palbociclib|palbociclib|mesh-list
20459688|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20459689|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459690|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20459691|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20459692|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
20459693|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459694|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459695|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20459696|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459697|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459698|NCT04181060|Bevacizumab|bevacizumab|mesh-list
20459699|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20459700|NCT04181060|Osimertinib|osimertinib|mesh-list
20459701|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
20459702|NCT04181060|Antibodies|antibodies|mesh-list
20459703|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
20222424|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
20459704|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20459705|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
20459706|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459707|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20459708|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20459709|NCT04181060|Growth Substances|growth substances|mesh-ancestor
20459710|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459711|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
20459712|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
20459713|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459714|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20459715|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459716|NCT04166773|Tirzepatide|tirzepatide|mesh-list
20459717|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20459718|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459719|NCT04166773|Incretins|incretins|mesh-ancestor
20459720|NCT04166773|Hormones|hormones|mesh-ancestor
20459721|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20459722|NCT04166071|Naltrexone|naltrexone|mesh-list
20459723|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20459724|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20459725|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459726|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
20459727|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459728|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
20459729|NCT04145349|Vinorelbine|vinorelbine|mesh-list
20459730|NCT04145349|Ramucirumab|ramucirumab|mesh-list
20459731|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459732|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
20459733|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459734|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459735|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459736|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
20459737|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222425|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222426|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
20222427|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20222428|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222429|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20222430|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222431|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222432|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20222433|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20459738|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459739|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20222434|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459740|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20459741|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
20459742|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
20459743|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
20459744|NCT04137120|Aflibercept|aflibercept|mesh-list
20459745|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20459746|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20459747|NCT04137120|Growth Substances|growth substances|mesh-ancestor
20459748|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459749|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
20459750|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459751|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
20222435|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222436|NCT00329316|Progesterone|progesterone|mesh-list
20222437|NCT00329316|Progestins|progestins|mesh-ancestor
20459752|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459753|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459754|NCT04083170|Vidarabine|vidarabine|mesh-list
20459755|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
20459756|NCT04083170|Thiotepa|thiotepa|mesh-list
20459757|NCT04083170|Fludarabine|fludarabine|mesh-list
20459758|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
20459759|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459760|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
20459761|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459762|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459763|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459764|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
20459765|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459766|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459767|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20459768|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20459769|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
20459770|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
20459771|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459772|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20459773|NCT04072146|Varenicline|varenicline|mesh-list
20459774|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20459775|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20459776|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
20459777|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459778|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459779|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459780|NCT04071236|Avelumab|avelumab|mesh-list
20459781|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20459782|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20459783|NCT04071236|Peposertib|peposertib|mesh-list
20459784|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459785|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459786|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
20459787|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222438|NCT00329316|Hormones|hormones|mesh-ancestor
20222439|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222440|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222441|NCT00329329|Capecitabine|capecitabine|mesh-list
20222442|NCT00329329|Satraplatin|satraplatin|mesh-list
20222443|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20222444|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
20222445|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222446|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222447|NCT00329355|Naproxen|naproxen|mesh-list
20222448|NCT00329355|Sumatriptan|sumatriptan|mesh-list
20222449|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20222450|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222451|NCT00329355|Analgesics|analgesics|mesh-ancestor
20222452|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
20222453|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222454|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222455|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222456|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222457|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
20222458|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19694569|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20222459|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247270|NCT00431522|Valproic Acid|valproic acid|mesh-list
20613950|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20459788|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20459789|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459790|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459791|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20459792|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459793|NCT04064060|Luspatercept|luspatercept|mesh-list
20459794|NCT04064060|Hematinics|hematinics|mesh-ancestor
20459795|NCT04039607|Nivolumab|nivolumab|mesh-list
20459796|NCT04039607|Ipilimumab|ipilimumab|mesh-list
20459797|NCT04039607|Sorafenib|sorafenib|mesh-list
20459798|NCT04039607|Lenvatinib|lenvatinib|mesh-list
20459799|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459800|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459801|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20459802|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459803|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20459804|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459805|NCT04012996|Meloxicam|meloxicam|mesh-list
20459806|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20459807|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20459808|NCT04012996|Analgesics|analgesics|mesh-ancestor
20459809|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
20459810|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459811|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459812|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459813|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459814|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20459815|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20459816|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459817|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459818|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
20459819|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459820|NCT03996265|Bupropion|bupropion|mesh-list
20459821|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20459822|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
20459823|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20459824|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20459825|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20459826|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20459827|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459828|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
19407708|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407709|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407710|NCT03571815|Listerine|listerine|mesh-list
19407711|NCT03571815|Fluorides|fluorides|mesh-list
19407712|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
19407713|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
19407714|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
19407715|NCT03571815|Protective Agents|protective agents|mesh-ancestor
19407716|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407717|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19407718|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407719|NCT03571737|Ibuprofen|ibuprofen|mesh-list
19407720|NCT03571737|Lidocaine|lidocaine|mesh-list
19407721|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
19407722|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
19407723|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407724|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407725|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
19407726|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407727|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19407728|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19407729|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19407730|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407731|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407732|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19407733|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694570|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19694571|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
19694572|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694573|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19694574|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
20459829|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20459830|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459831|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20459832|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20459833|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459834|NCT03945084|Niraparib|niraparib|mesh-list
20459835|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20459836|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459837|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459838|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459839|NCT03926130|Mirikizumab|mirikizumab|mesh-list
20459840|NCT03926130|Ustekinumab|ustekinumab|mesh-list
20459841|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
20459842|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20459843|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20459844|NCT03926130|Analgesics|analgesics|mesh-ancestor
20459845|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
20459846|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459847|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459848|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459849|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459850|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20459851|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20459852|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20459853|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459854|NCT03924856|Gemcitabine|gemcitabine|mesh-list
20459855|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
20459856|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459857|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20459858|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
20459859|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459860|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
20459861|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459862|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459863|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459864|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
20459865|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459866|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459867|NCT03882463|Insulin|insulin|mesh-list
20459868|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20459869|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459870|NCT03866382|Nivolumab|nivolumab|mesh-list
20459871|NCT03866382|Ipilimumab|ipilimumab|mesh-list
20459872|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459873|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459874|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20459875|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459876|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
20459877|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459878|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
20459879|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459880|NCT03837626|Amiloride|amiloride|mesh-list
20459881|NCT03837626|Diuretics|diuretics|mesh-ancestor
20459882|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
20459883|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459884|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20459885|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20459886|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20459887|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459888|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20459889|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20459890|NCT03821649|Naloxone|naloxone|mesh-list
20459891|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20459892|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459893|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
20459894|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459895|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
20459896|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
20459897|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
20459898|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459899|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459900|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
20459901|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459902|NCT03809767|Antibodies|antibodies|mesh-list
20459903|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19407734|NCT03571737|Analgesics|analgesics|mesh-ancestor
20459904|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
20459905|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459906|NCT03771612|Naproxen|naproxen|mesh-list
20459907|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20459908|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19849308|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19849309|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19849310|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849311|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849312|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849313|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
19849314|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855589|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855590|NCT00749515|Siderophores|siderophores|mesh-ancestor
20459909|NCT03771612|Analgesics|analgesics|mesh-ancestor
20459910|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
20459911|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459912|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459913|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459914|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459915|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
20459916|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20459917|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459918|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855591|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
19855592|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19855593|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19855594|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
20459919|NCT03759028|Acetaminophen|acetaminophen|mesh-list
20459920|NCT03759028|Ibuprofen|ibuprofen|mesh-list
20459921|NCT03759028|Oxycodone|oxycodone|mesh-list
20459922|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20459923|NCT03759028|Analgesics|analgesics|mesh-ancestor
20459924|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
20459925|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459926|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459927|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
20459928|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20459929|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20459930|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459931|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20459932|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459933|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459934|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20459935|NCT03759028|Narcotics|narcotics|mesh-ancestor
20459936|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459937|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
20459938|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20459939|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459940|NCT03737292|Bupivacaine|bupivacaine|mesh-list
20459941|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
20459942|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
20459943|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459944|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459945|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
20459946|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20459947|NCT03734211|Evolocumab|evolocumab|mesh-list
20459948|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20459949|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20459950|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
20459951|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459952|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20459953|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
20459954|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20459955|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20459956|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459957|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
20459958|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
20459959|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20459960|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459961|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459962|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855595|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855596|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20459963|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20459964|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
20459965|NCT03709680|Temozolomide|temozolomide|mesh-list
20459966|NCT03709680|Irinotecan|irinotecan|mesh-list
20459967|NCT03709680|Topotecan|topotecan|mesh-list
20459968|NCT03709680|Palbociclib|palbociclib|mesh-list
20459969|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20459970|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
20459971|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459972|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20459973|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20459974|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
20459975|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20459976|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20459977|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20459978|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20459979|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20459980|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20459981|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20459982|NCT03708198|Bupivacaine|bupivacaine|mesh-list
20459983|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
20459984|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
20459985|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20459986|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20459987|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
20459988|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526465|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20526466|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20526467|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526468|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526469|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526470|NCT01762852|Belimumab|belimumab|mesh-list
20526471|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526472|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
20526473|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526474|NCT01762878|Nemiralisib|nemiralisib|mesh-list
20526475|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20526476|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526477|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526478|NCT01762891|Acetaminophen|acetaminophen|mesh-list
20526479|NCT01762891|Celecoxib|celecoxib|mesh-list
20526480|NCT01762891|Rofecoxib|rofecoxib|mesh-list
20526481|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526482|NCT01762891|Analgesics|analgesics|mesh-ancestor
20526483|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
20526484|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526485|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526486|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
20526487|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526488|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526489|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526490|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20526491|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20526492|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526493|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526494|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
20526495|NCT01762995|Dolutegravir|dolutegravir|mesh-list
20526496|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
20526497|NCT01762995|Calcium|calcium|mesh-list
20526498|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20526499|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526500|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20526501|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20526502|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526503|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526504|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20526505|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20526506|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
20526507|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526508|NCT01762995|Antacids|antacids|mesh-ancestor
20526509|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20526510|NCT01762995|Trace Elements|trace elements|mesh-ancestor
20526511|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
20526512|NCT01763021|Rifampin|rifampin|mesh-list
20526513|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20526514|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
20526515|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20459989|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
20459990|NCT03682536|Luspatercept|luspatercept|mesh-list
20459991|NCT03682536|Hematinics|hematinics|mesh-ancestor
20459992|NCT03678688|Bedaquiline|bedaquiline|mesh-list
20459993|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
20459994|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
20459995|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20459996|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20459997|NCT03666065|Insulin|insulin|mesh-list
20459998|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20459999|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
20460000|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20460001|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460002|NCT03599622|BMS-986165|bms-986165|mesh-list
20460003|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
20460004|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20460005|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460006|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460007|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
20460008|NCT03596424|Ketamine|ketamine|mesh-list
19407735|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407736|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407737|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19407738|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407739|NCT03571711|Meropenem|meropenem|mesh-list
19407740|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20460009|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20460010|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460011|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460012|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20460013|NCT03596424|Analgesics|analgesics|mesh-ancestor
20460014|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
20460015|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460016|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20460017|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20460018|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20460019|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
20460020|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460021|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460022|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20460023|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20460024|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
20460025|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
20460026|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20460027|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20460028|NCT03580356|Omalizumab|omalizumab|mesh-list
20460029|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20460030|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20460031|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
20460032|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20460033|NCT03563222|SMOFlipid|smoflipid|mesh-list
20460034|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20460035|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20460036|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20460037|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
20460038|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20460039|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460040|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460041|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20460042|NCT03540758|Niacin|niacin|mesh-list
20460043|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
20460044|NCT03540758|Niacinamide|niacinamide|mesh-list
20460045|NCT03540758|Diazoxide|diazoxide|mesh-list
20460046|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20460047|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
20460048|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460049|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20460050|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
20460051|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
20460052|NCT03540758|Vitamins|vitamins|mesh-ancestor
20460053|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
20460054|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460055|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19407741|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407742|NCT03571594|Octreotide|octreotide|mesh-list
20460056|NCT03519945|Mirikizumab|mirikizumab|mesh-list
20460057|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20460058|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20460059|NCT03519945|Analgesics|analgesics|mesh-ancestor
20460060|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
20460061|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460062|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460063|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460064|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460065|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20460066|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460067|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20460068|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
20460069|NCT03512405|Blinatumomab|blinatumomab|mesh-list
20460070|NCT03512405|Antibodies|antibodies|mesh-list
20460071|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
20460072|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20460073|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
20460074|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20460075|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
20460076|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460077|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460078|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460079|NCT03507699|Nivolumab|nivolumab|mesh-list
20460080|NCT03507699|Ipilimumab|ipilimumab|mesh-list
20460081|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460082|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460083|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20460084|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460085|NCT03495713|Nivolumab|nivolumab|mesh-list
20460086|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460087|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460088|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20460089|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460093|NCT03452137|Atezolizumab|atezolizumab|mesh-list
20460094|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460095|NCT03448042|Trastuzumab|trastuzumab|mesh-list
20460096|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460097|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460098|NCT03444753|Nivolumab|nivolumab|mesh-list
20460099|NCT03444753|Ipilimumab|ipilimumab|mesh-list
20460100|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460101|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613951|NCT02257008|Nelfinavir|nelfinavir|mesh-list
19407743|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407744|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407745|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407746|NCT03571490|Ropivacaine|ropivacaine|mesh-list
19407747|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
19407748|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
19407749|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407750|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407751|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
19407752|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407753|NCT03571438|Sirolimus|sirolimus|mesh-list
19407754|NCT03571438|Sunitinib|sunitinib|mesh-list
19407755|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407756|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19407757|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19407758|NCT03571438|Growth Substances|growth substances|mesh-ancestor
19407759|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407760|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
19407761|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20613952|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613953|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613954|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613955|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613956|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613957|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613958|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613959|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
19407762|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694575|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
20460102|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20460103|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460104|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
20460105|NCT03417154|Nivolumab|nivolumab|mesh-list
20460106|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460107|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
20460108|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460109|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460110|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460111|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
20460112|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460113|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460114|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460115|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460116|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20460117|NCT03407144|Prednisone|prednisone|mesh-list
20460118|NCT03407144|Prednisolone|prednisolone|mesh-list
20460119|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
20460120|NCT03407144|Dacarbazine|dacarbazine|mesh-list
20460121|NCT03407144|Doxorubicin|doxorubicin|mesh-list
20460122|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
20460123|NCT03407144|Etoposide|etoposide|mesh-list
20460124|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
20460125|NCT03407144|Vincristine|vincristine|mesh-list
20460126|NCT03407144|Bleomycin|bleomycin|mesh-list
20460127|NCT03407144|Vinblastine|vinblastine|mesh-list
20460128|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460129|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
20460130|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460131|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460132|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460133|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
20460134|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460135|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460136|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460137|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20460138|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20460139|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460140|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460141|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460142|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460143|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
20460144|NCT03407144|Hormones|hormones|mesh-ancestor
20460145|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460146|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460147|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460148|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
20460149|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
20460150|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
20460151|NCT03375203|Zolpidem|zolpidem|mesh-list
20460152|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20460153|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20460154|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460155|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460156|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20460157|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
20460158|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
20460159|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460160|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460161|NCT03290287|Bromides|bromides|mesh-list
20460162|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
20460163|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
20460164|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460165|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460166|NCT03231722|Leucovorin|leucovorin|mesh-list
20460167|NCT03231722|Fluorouracil|fluorouracil|mesh-list
20460168|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
20460169|NCT03231722|Irinotecan|irinotecan|mesh-list
20460170|NCT03231722|Panitumumab|panitumumab|mesh-list
20460171|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
20460172|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
20460173|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460174|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20460175|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460176|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460177|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
20460178|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460179|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20460180|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460181|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460182|NCT03231722|Antidotes|antidotes|mesh-ancestor
20460183|NCT03231722|Protective Agents|protective agents|mesh-ancestor
20460184|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
20460185|NCT03231722|Vitamins|vitamins|mesh-ancestor
20460186|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
20460187|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460188|NCT03194542|Luspatercept|luspatercept|mesh-list
20460189|NCT03194542|Hematinics|hematinics|mesh-ancestor
20460190|NCT03158389|Sirolimus|sirolimus|mesh-list
20460191|NCT03158389|Atezolizumab|atezolizumab|mesh-list
20460192|NCT03158389|Palbociclib|palbociclib|mesh-list
20460193|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460194|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20460195|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460196|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460197|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20460198|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460199|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20460200|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
20460201|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460202|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
20460203|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460204|NCT03142035|Dienogest|dienogest|mesh-list
20460205|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20460206|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
20460207|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20460208|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460209|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20460210|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20460211|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20460212|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20460213|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
20460214|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460215|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460216|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460217|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
20460218|NCT03082534|Cetuximab|cetuximab|mesh-list
20460219|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460220|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460221|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
20460222|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460223|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460224|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
20460225|NCT02926833|Fludarabine|fludarabine|mesh-list
20460226|NCT02926833|Atezolizumab|atezolizumab|mesh-list
20460227|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460228|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
20460229|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460230|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460231|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460232|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
20460233|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460234|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460235|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460236|NCT02899299|Carboplatin|carboplatin|mesh-list
20460237|NCT02899299|Nivolumab|nivolumab|mesh-list
20460238|NCT02899299|Pemetrexed|pemetrexed|mesh-list
20460239|NCT02899299|Ipilimumab|ipilimumab|mesh-list
20460240|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460241|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460242|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20460243|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460244|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460245|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20460246|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20460247|NCT02860000|Fulvestrant|fulvestrant|mesh-list
20460248|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460249|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460250|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20460251|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20460252|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
20460253|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460254|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460255|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
20460256|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460257|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460258|NCT02786875|Vitamin D|vitamin d|mesh-list
20460259|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
20460260|NCT02786875|Vitamins|vitamins|mesh-list
20460261|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
20460262|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460263|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20460264|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20460265|NCT02767882|Dexamethasone|dexamethasone|mesh-list
20460266|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460267|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
20460268|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
20460269|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460270|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460271|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460272|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
20460273|NCT02767882|Hormones|hormones|mesh-ancestor
20460274|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460275|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460276|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460277|NCT02547662|Dexamethasone|dexamethasone|mesh-list
20460278|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
20460279|NCT02547662|Pomalidomide|pomalidomide|mesh-list
20460280|NCT02547662|Ixazomib|ixazomib|mesh-list
20460281|NCT02547662|Ichthammol|ichthammol|mesh-list
20460282|NCT02547662|BB 1101|bb 1101|mesh-list
20460283|NCT02547662|Glycine|glycine|mesh-list
20460284|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460285|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
20460286|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
20460287|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460288|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460289|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460290|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
20460291|NCT02547662|Hormones|hormones|mesh-ancestor
20460292|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460293|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460294|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460295|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460296|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
20460297|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460298|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
20460299|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20460300|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20460301|NCT02547662|Growth Substances|growth substances|mesh-ancestor
20460302|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
20460303|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20460304|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
20460305|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460306|NCT02531126|Ozanimod|ozanimod|mesh-list
20460307|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20460308|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460309|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460310|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
20460311|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460312|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20460313|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20460314|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
20460315|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20460316|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460317|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20460318|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20460319|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460320|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460321|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
20460322|NCT02443831|Fludarabine|fludarabine|mesh-list
20460323|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460324|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
20460325|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460326|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460327|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19849315|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
20460328|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
20460329|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460330|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849316|NCT00701714|Hematinics|hematinics|mesh-ancestor
20460331|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460332|NCT02443077|Cytarabine|cytarabine|mesh-list
20460333|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
20460334|NCT02443077|Melphalan|melphalan|mesh-list
20460335|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
20460336|NCT02443077|Carmustine|carmustine|mesh-list
20460337|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20460338|NCT02443077|Etoposide|etoposide|mesh-list
20460339|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
20460340|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
20460341|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460342|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
20460343|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460344|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460345|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460346|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
20460347|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460348|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460349|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460350|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460351|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20460352|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460353|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460354|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20460355|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
20460356|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
20460357|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460358|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
20460359|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
20460360|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
20460361|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
20460362|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
20460363|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
20460364|NCT02348216|Fludarabine|fludarabine|mesh-list
20460365|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460366|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
20460367|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460368|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460369|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460370|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
20460371|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460372|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460373|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460374|NCT02246257|Metformin|metformin|mesh-list
20460375|NCT02246257|Losartan|losartan|mesh-list
20222460|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222461|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20460376|NCT02246257|Simvastatin|simvastatin|mesh-list
19694576|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
19694577|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19694578|NCT04964583|Azithromycin|azithromycin|mesh-list
19694579|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
19694580|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19694581|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694582|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
19694583|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19694584|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19694585|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694586|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694587|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694588|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
19694589|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694590|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694591|NCT04964505|Azacitidine|azacitidine|mesh-list
20222462|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20222463|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20222464|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
20222465|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222466|NCT00329368|Folic Acid|folic acid|mesh-list
20460377|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694592|NCT04964505|Venetoclax|venetoclax|mesh-list
19694593|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19694594|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
19694595|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460378|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460379|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20460380|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222467|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
20222468|NCT00329368|Interferons|interferons|mesh-list
20222469|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
20222470|NCT00329368|Interleukin-2|interleukin-2|mesh-list
20222471|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20460381|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
20460382|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460383|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20460384|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20460385|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460386|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20460387|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20460388|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20460389|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20460390|NCT02197221|Bortezomib|bortezomib|mesh-list
20460391|NCT02197221|Melphalan|melphalan|mesh-list
20460392|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460393|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460394|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
20460395|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460396|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460397|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460398|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
20460399|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460400|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
20460401|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20460402|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
20460403|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460404|NCT02124941|Expectorants|expectorants|mesh-ancestor
20460405|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
20460406|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20460407|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
20460408|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460409|NCT02124941|Protective Agents|protective agents|mesh-ancestor
20460410|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460411|NCT02124941|Antidotes|antidotes|mesh-ancestor
20460412|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
20460413|NCT02094794|Etoposide|etoposide|mesh-list
20460414|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
20460415|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460416|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
20460417|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460418|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460419|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460420|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
20460421|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460422|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460423|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460424|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460425|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20460426|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460427|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460428|NCT02010385|Octreotide|octreotide|mesh-list
20460429|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460430|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460431|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460432|NCT01949714|Epinephrine|epinephrine|mesh-list
20460433|NCT01949714|Racepinephrine|racepinephrine|mesh-list
20460434|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
20460435|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20460436|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20460437|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
20460438|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460439|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460440|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460441|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20460442|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19849317|NCT00701727|Ezetimibe|ezetimibe|mesh-list
20222472|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222473|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
20222474|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222475|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
20222476|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222477|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222478|NCT00329368|Analgesics|analgesics|mesh-ancestor
20460443|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
20460444|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460445|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20460446|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
20460447|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
20460448|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
20460449|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20460450|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20460451|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460452|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
20460453|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460454|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460455|NCT01451515|Cytarabine|cytarabine|mesh-list
20460456|NCT01451515|Dexamethasone|dexamethasone|mesh-list
20460457|NCT01451515|Prednisone|prednisone|mesh-list
20460458|NCT01451515|Prednisolone|prednisolone|mesh-list
20460459|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
20460460|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
20460461|NCT01451515|Doxorubicin|doxorubicin|mesh-list
20460462|NCT01451515|Methotrexate|methotrexate|mesh-list
20460463|NCT01451515|Etoposide|etoposide|mesh-list
20460464|NCT01451515|Vincristine|vincristine|mesh-list
20460465|NCT01451515|Daunorubicin|daunorubicin|mesh-list
20460466|NCT01451515|Asparaginase|asparaginase|mesh-list
20460467|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
20460468|NCT01451515|Clofarabine|clofarabine|mesh-list
20460469|NCT01451515|Pegaspargase|pegaspargase|mesh-list
20460470|NCT01451515|Thioguanine|thioguanine|mesh-list
20460471|NCT01451515|Antimetabolites|antimetabolites|mesh-list
20460472|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460473|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
20460474|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460475|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460476|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460477|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
20460478|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460479|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460480|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460481|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460482|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
20460483|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
20460484|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460485|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460486|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
20460487|NCT01451515|Hormones|hormones|mesh-ancestor
20460488|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460489|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460490|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20460491|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20460492|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460493|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460494|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20460495|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
20460496|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20460497|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20460498|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
20460499|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20460500|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20460501|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460502|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
20460503|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460504|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
20460505|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
19407763|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222479|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
20222480|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222481|NCT00329368|Hematinics|hematinics|mesh-ancestor
20222482|NCT00329368|Vitamins|vitamins|mesh-ancestor
20222483|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
20222484|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20222485|NCT00329381|Omalizumab|omalizumab|mesh-list
20222486|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20222487|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19407764|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20460506|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
20460507|NCT01332968|Prednisone|prednisone|mesh-list
20460508|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
20460509|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20222488|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20460510|NCT01332968|Rituximab|rituximab|mesh-list
20460511|NCT01332968|Doxorubicin|doxorubicin|mesh-list
20460512|NCT01332968|Vincristine|vincristine|mesh-list
20460513|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
20460514|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460515|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
20460516|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460517|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460518|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460519|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
20460520|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460521|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460522|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460523|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460524|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20460525|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20460526|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460527|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460528|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460529|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
20460530|NCT01332968|Hormones|hormones|mesh-ancestor
20460531|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460532|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460533|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460534|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
20460535|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
20460536|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
20460537|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
20460538|NCT01231906|Ifosfamide|ifosfamide|mesh-list
20460539|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
20460540|NCT01231906|Doxorubicin|doxorubicin|mesh-list
20460541|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20460542|NCT01231906|Etoposide|etoposide|mesh-list
20460543|NCT01231906|Vincristine|vincristine|mesh-list
20460544|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
20460545|NCT01231906|Topotecan|topotecan|mesh-list
20460546|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
20460547|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
20460548|NCT01231906|Razoxane|razoxane|mesh-list
20460549|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
20460550|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460551|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
20460552|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460553|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460554|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460555|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
20460556|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460557|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460558|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460559|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20460560|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20460561|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460562|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460563|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460564|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
20460565|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
20460566|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
20460567|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20460568|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
20460569|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
20460570|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20460571|NCT01231906|Protective Agents|protective agents|mesh-ancestor
20460572|NCT00223145|Goserelin|goserelin|mesh-list
20460573|NCT00223145|Bicalutamide|bicalutamide|mesh-list
20460574|NCT00223145|Androgens|androgens|mesh-list
20460575|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460576|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460577|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
20460578|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
20460579|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460580|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460581|NCT00223145|Hormones|hormones|mesh-ancestor
20460582|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20460583|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20460584|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20460585|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20460586|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460587|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460588|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460589|NCT01425827|Analgesics|analgesics|mesh-ancestor
20460590|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
20460591|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460592|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
20460593|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20460594|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
20460595|NCT01425840|Lidocaine|lidocaine|mesh-list
20460596|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
20460597|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
20460598|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460599|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460600|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
20460601|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460602|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20460603|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20460604|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20460605|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20460606|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460607|NCT01425996|Camptothecin|camptothecin|mesh-list
20460608|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460609|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460610|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20460611|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20460612|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460613|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460614|NCT01426022|Ethanol|ethanol|mesh-list
20460615|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20460616|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460617|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460618|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460619|NCT01426074|Bevacizumab|bevacizumab|mesh-list
19407765|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407766|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19407767|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
19407768|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407769|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
19407770|NCT03571321|Cytarabine|cytarabine|mesh-list
19407771|NCT03571321|Dexamethasone|dexamethasone|mesh-list
19407772|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
19407773|NCT03571321|Rituximab|rituximab|mesh-list
19407774|NCT03571321|Doxorubicin|doxorubicin|mesh-list
19407775|NCT03571321|Methotrexate|methotrexate|mesh-list
19407776|NCT03571321|Vincristine|vincristine|mesh-list
19407777|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
19407778|NCT03571321|Pegaspargase|pegaspargase|mesh-list
19407779|NCT03571321|Thioguanine|thioguanine|mesh-list
19407780|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407781|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
19407782|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407783|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407784|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407785|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
19407786|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407787|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407788|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19407789|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19407790|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407791|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
19407792|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
19407793|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407794|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460620|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460621|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460622|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20460623|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20460624|NCT01426074|Growth Substances|growth substances|mesh-ancestor
20460625|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460626|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
20460627|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20460628|NCT01426087|Somatostatin|somatostatin|mesh-list
20460629|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460630|NCT01426087|Hormones|hormones|mesh-ancestor
20460631|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460632|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460633|NCT01426100|Telmisartan|telmisartan|mesh-list
19849318|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19849319|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19849320|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
19849321|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849322|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19849323|NCT00701779|Tamsulosin|tamsulosin|mesh-list
19849324|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19849325|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19849326|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19849327|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
20460634|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20460635|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20460636|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20460637|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460638|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
20460639|NCT01426165|Analgesics|analgesics|mesh-ancestor
20460640|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
20460641|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460642|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460643|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
20460644|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460645|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20460646|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
20460647|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20460648|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20460649|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460650|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20460651|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
20460652|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20460653|NCT01426243|Vaccines|vaccines|mesh-list
20460654|NCT01426243|Immunologic Factors|immunologic factors|mesh-ancestor
20460655|NCT01426243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460656|NCT01426256|Vitamin D|vitamin d|mesh-list
20460657|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
20460658|NCT01426256|Vitamins|vitamins|mesh-ancestor
20460659|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
20460660|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460661|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20460662|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20460663|NCT01426334|Cyclosporine|cyclosporine|mesh-list
20460664|NCT01426334|Dasatinib|dasatinib|mesh-list
20460665|NCT01426334|Cyclosporins|cyclosporins|mesh-list
20460666|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460667|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460668|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460669|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
20460670|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460671|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
20460672|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460673|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
20460674|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460675|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20460676|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460677|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20460678|NCT01426399|Metformin|metformin|mesh-list
20460679|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20460680|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460681|NCT01426464|Latanoprost|latanoprost|mesh-list
20460682|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20460683|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20460684|NCT01426490|Vitamins|vitamins|mesh-list
20460685|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
20460686|NCT01426490|Folic Acid|folic acid|mesh-list
20460687|NCT01426490|Pyridoxine|pyridoxine|mesh-list
20460688|NCT01426490|Pyridoxal|pyridoxal|mesh-list
20460689|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
20460690|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
20460691|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
20460692|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460693|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
20460694|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460695|NCT01426490|Protective Agents|protective agents|mesh-ancestor
20460696|NCT01426490|Hematinics|hematinics|mesh-ancestor
20460697|NCT01426542|Topiramate|topiramate|mesh-list
20460698|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
20460699|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20460700|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460701|NCT01426633|Gemcitabine|gemcitabine|mesh-list
20460702|NCT01426633|Trabectedin|trabectedin|mesh-list
20460703|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20460704|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
20460705|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460706|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460707|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
20460708|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460709|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460710|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460711|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
20460712|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460713|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460714|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
20460715|NCT01426646|Cisplatin|cisplatin|mesh-list
20460716|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460717|NCT01426737|Vildagliptin|vildagliptin|mesh-list
20460718|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20460719|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460720|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20460721|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
20460722|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460723|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460724|NCT01426802|Vildagliptin|vildagliptin|mesh-list
20460725|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20460726|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460727|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20460728|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
20460729|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460730|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460731|NCT01426815|Golimumab|golimumab|mesh-list
20460732|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20460733|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460734|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460735|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
20460736|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460737|NCT01426880|Paclitaxel|paclitaxel|mesh-list
20460738|NCT01426880|Carboplatin|carboplatin|mesh-list
20460739|NCT01426880|Lapatinib|lapatinib|mesh-list
20460740|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460741|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460742|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
20460743|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
20460744|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
20460745|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460746|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20460747|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460748|NCT01426906|Rifampin|rifampin|mesh-list
20460749|NCT01426906|Ketoconazole|ketoconazole|mesh-list
20460750|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20460751|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
20460752|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20460753|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460754|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
20460755|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20460756|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460757|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460758|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20460759|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20460760|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20460761|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20460762|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20460763|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20460764|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
20460765|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20460766|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20460767|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20460768|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
20460769|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460770|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460771|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20460772|NCT01426971|Ibuprofen|ibuprofen|mesh-list
20460773|NCT01426971|Caffeine|caffeine|mesh-list
20460774|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20460775|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20460776|NCT01426971|Analgesics|analgesics|mesh-ancestor
20460777|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
20460778|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460779|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460780|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460781|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460782|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20460783|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460784|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460785|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20460786|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20460787|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20460788|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20460789|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
20460790|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460791|NCT01426984|Methylphenidate|methylphenidate|mesh-list
20460792|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20460793|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460794|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20460795|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20460796|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20460797|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460798|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
20460799|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526516|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526517|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
20526518|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20526519|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526520|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526521|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20526522|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20526523|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20526524|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20526525|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20526526|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19849328|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849329|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849330|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849331|NCT00701779|Urological Agents|urological agents|mesh-ancestor
19849332|NCT00701896|Nicotine|nicotine|mesh-list
19849333|NCT00701896|Varenicline|varenicline|mesh-list
19849334|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19849335|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
19849336|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849337|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849338|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19849339|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19849340|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
19849341|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849342|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849343|NCT00701935|Exenatide|exenatide|mesh-list
19849344|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20526527|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20526528|NCT01763281|Hormones|hormones|mesh-ancestor
19407795|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
19407796|NCT03571321|Hormones|hormones|mesh-ancestor
19407797|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407798|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407799|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19407800|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19407801|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19407802|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407803|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20460800|NCT01427114|Prednisolone|prednisolone|mesh-list
20460801|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
20460802|NCT01427114|Rituximab|rituximab|mesh-list
19407804|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
19407805|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19407806|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407807|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
19407808|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407809|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19407810|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19407811|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
19407812|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20460803|NCT01427114|Vincristine|vincristine|mesh-list
20460804|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460805|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
20460806|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460807|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460808|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407813|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19407814|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
19407815|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
19407816|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
19407817|NCT03571308|Prednisolone|prednisolone|mesh-list
20460809|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
20460810|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460811|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460812|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20460813|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460814|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20460815|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
20460816|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
20460817|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
20460818|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460819|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
20460820|NCT01427114|Hormones|hormones|mesh-ancestor
20460821|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460822|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20460823|NCT01427127|Ramosetron|ramosetron|mesh-list
20460824|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
20460825|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
20460826|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460827|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460828|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460829|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20460830|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
20460831|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460832|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460833|NCT01427192|Acetazolamide|acetazolamide|mesh-list
20460834|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
20460835|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20460836|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460837|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460838|NCT01427192|Diuretics|diuretics|mesh-ancestor
20460839|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
20460840|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460841|NCT01427205|Cetuximab|cetuximab|mesh-list
20460842|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460843|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407818|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
19407819|NCT03571308|Doxorubicin|doxorubicin|mesh-list
20222489|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
20222490|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
20222491|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222492|NCT00329394|Ketamine|ketamine|mesh-list
20222493|NCT00329394|Analgesics|analgesics|mesh-ancestor
20222494|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
20222495|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222496|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222497|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20222498|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20222499|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
20460844|NCT01427244|Trastuzumab|trastuzumab|mesh-list
19407820|NCT03571308|Vincristine|vincristine|mesh-list
20222500|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
20222501|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407821|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
20460845|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20460846|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460847|NCT01427270|Oxycodone|oxycodone|mesh-list
20460848|NCT01427270|Naloxone|naloxone|mesh-list
20460849|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20460850|NCT01427270|Narcotics|narcotics|mesh-ancestor
20460851|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460852|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460853|NCT01427270|Analgesics|analgesics|mesh-ancestor
20613960|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613961|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613962|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613963|NCT02257021|Ritonavir|ritonavir|mesh-list
19407822|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407823|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
20613964|NCT02257021|Tipranavir|tipranavir|mesh-list
20613965|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20613966|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20613967|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
20613968|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613969|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407824|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407825|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407826|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407827|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
19407828|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407829|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407830|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19407831|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19407832|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19407833|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19407834|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460854|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
20460855|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460856|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20460857|NCT01427283|Oxycodone|oxycodone|mesh-list
20460858|NCT01427283|Naloxone|naloxone|mesh-list
20460859|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20460860|NCT01427283|Narcotics|narcotics|mesh-ancestor
20460861|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460862|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460863|NCT01427283|Analgesics|analgesics|mesh-ancestor
20460864|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
20460865|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460866|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20460867|NCT01427322|Lapatinib|lapatinib|mesh-list
19407835|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19407836|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
19407837|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
19407838|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
19407839|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19407840|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
20613970|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20613971|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20613972|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
20613973|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20613974|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20613975|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20613976|NCT02257138|Decitabine|decitabine|mesh-list
20613977|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20613978|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
19407841|NCT03571308|Hormones|hormones|mesh-ancestor
19407842|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222502|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20222503|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20222504|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222505|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222506|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20222507|NCT00329446|Citalopram|citalopram|mesh-list
20222508|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20222509|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20222510|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20613979|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460868|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460869|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20460870|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460871|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460872|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
20460873|NCT01427335|Calcium|calcium|mesh-list
20460874|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20460875|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20613980|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407843|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407844|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19407845|NCT03571230|Amoxicillin|amoxicillin|mesh-list
19407846|NCT03571230|Metronidazole|metronidazole|mesh-list
19407847|NCT03571230|Clarithromycin|clarithromycin|mesh-list
19407848|NCT03571230|Levofloxacin|levofloxacin|mesh-list
19407849|NCT03571230|Tetracycline|tetracycline|mesh-list
19407850|NCT03571230|Tinidazole|tinidazole|mesh-list
19407851|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19407852|NCT03571230|Furazolidone|furazolidone|mesh-list
19407853|NCT03571230|Bismuth|bismuth|mesh-list
19407854|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19407855|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407856|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
19407857|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19407858|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19407859|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19407860|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407861|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407862|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19407863|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19407864|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19407865|NCT03571230|Renal Agents|renal agents|mesh-ancestor
19407866|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19407867|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19407868|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407869|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19407870|NCT03571230|Antacids|antacids|mesh-ancestor
19407871|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407872|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
19407873|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19407874|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19407875|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19407876|NCT03571126|Olanzapine|olanzapine|mesh-list
19407877|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
19407878|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
19407879|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407880|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407881|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407882|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19407883|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19407884|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407885|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19407886|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19407887|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19407888|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19407889|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407890|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222511|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222512|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20613981|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20613982|NCT02257242|Rituximab|rituximab|mesh-list
20613983|NCT02257242|Vincristine|vincristine|mesh-list
20613984|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20613985|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20613986|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20613987|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
20222513|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
20222514|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222515|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20222516|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222517|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222518|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20222519|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20613988|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407891|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
19407892|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
20613989|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20613990|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20613991|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
19407893|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19407894|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19407895|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407896|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
19407897|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
19407898|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19407899|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19407900|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19694596|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694597|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460876|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20460877|NCT01427387|Linaclotide|linaclotide|mesh-list
20460878|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20460879|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
20460880|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460881|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460882|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
20460883|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20460884|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20460885|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20460886|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20460887|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460888|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
20460889|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460890|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460891|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20460892|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460893|NCT01427478|Afatinib|afatinib|mesh-list
20460894|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460895|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20460896|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460897|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460898|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20460899|NCT01427491|Laxatives|laxatives|mesh-ancestor
20460900|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460901|NCT01427582|Trabectedin|trabectedin|mesh-list
20460902|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20460903|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
20460904|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460905|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460906|NCT01427686|Dobutamine|dobutamine|mesh-list
20460907|NCT01427686|Dopamine|dopamine|mesh-list
20460908|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20460909|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
20460910|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
20460911|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460912|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460913|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20460914|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20460915|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20460916|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
20460917|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460918|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460919|NCT01427686|Protective Agents|protective agents|mesh-ancestor
20460920|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
20460921|NCT01427699|Antibodies|antibodies|mesh-list
19694598|NCT04964180|Indomethacin|indomethacin|mesh-list
19694599|NCT04964180|Lidocaine|lidocaine|mesh-list
19694600|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
19694601|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
19694602|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694603|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694604|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
19694605|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694606|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19694607|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19694608|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19694609|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855597|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20460922|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
20613992|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
19407901|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
19407902|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407903|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19407904|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19407905|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407906|NCT03570983|Cytarabine|cytarabine|mesh-list
19407907|NCT03570983|Etoposide|etoposide|mesh-list
19407908|NCT03570983|Melphalan|melphalan|mesh-list
20460923|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460924|NCT01427842|Vancomycin|vancomycin|mesh-list
20460925|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20460926|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407909|NCT03570983|Carmustine|carmustine|mesh-list
19407910|NCT03570983|Allopurinol|allopurinol|mesh-list
19407911|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19407912|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407913|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19849345|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849346|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19849347|NCT00701935|Incretins|incretins|mesh-ancestor
19849348|NCT00701935|Hormones|hormones|mesh-ancestor
19849349|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849350|NCT00702052|Everolimus|everolimus|mesh-list
19849351|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849352|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407914|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19407915|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19407916|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407917|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19407918|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
19407919|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
19407920|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19407921|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19407922|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
19407923|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407924|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19407925|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
19407926|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19407927|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
19407928|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19407929|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19407930|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
19407931|NCT03570983|Protective Agents|protective agents|mesh-ancestor
20222520|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20222521|NCT00329459|Naproxen|naproxen|mesh-list
20222522|NCT00329459|Sumatriptan|sumatriptan|mesh-list
20222523|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20613993|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
20613994|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20613995|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20613996|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
20222524|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222525|NCT00329459|Analgesics|analgesics|mesh-ancestor
20222526|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
20222527|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222528|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222529|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222530|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222531|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
20222532|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20222533|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222534|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460927|NCT01427868|Maleic acid|maleic acid|mesh-list
19407948|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
19407949|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19407950|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19407951|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407952|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
19407953|NCT03570710|Coagulants|coagulants|mesh-ancestor
19407954|NCT03570645|Dexamethasone|dexamethasone|mesh-list
19407955|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
19407956|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849353|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
20460928|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460929|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460930|NCT01427946|Everolimus|everolimus|mesh-list
19407957|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
19407958|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
19407959|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19407960|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407961|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19407962|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
19407963|NCT03570645|Hormones|hormones|mesh-ancestor
19407964|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19407965|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19407966|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407967|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19407968|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407969|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19407970|NCT03570645|Analgesics|analgesics|mesh-ancestor
19407971|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
20460931|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20460932|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20460933|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
20460934|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460935|NCT01427985|Atropine|atropine|mesh-list
20460936|NCT01427985|Fentanyl|fentanyl|mesh-list
20460937|NCT01427985|Mivacurium|mivacurium|mesh-list
20460938|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20460939|NCT01427985|Narcotics|narcotics|mesh-ancestor
20460940|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20460941|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460942|NCT01427985|Analgesics|analgesics|mesh-ancestor
20460943|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
19407972|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19407973|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19407974|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19407975|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
19407976|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19407977|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407978|NCT03570541|Acetaminophen|acetaminophen|mesh-list
19407979|NCT03570541|Morphine|morphine|mesh-list
19407980|NCT03570541|Ropivacaine|ropivacaine|mesh-list
19407981|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19407982|NCT03570541|Narcotics|narcotics|mesh-ancestor
19407983|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19407984|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19407985|NCT03570541|Analgesics|analgesics|mesh-ancestor
19407986|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
19407987|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613997|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19694610|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694611|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19694612|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694613|NCT04964180|Analgesics|analgesics|mesh-ancestor
20460944|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20613998|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20613999|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20614000|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19407988|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
19407989|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
19407990|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19407991|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
19407992|NCT03570359|Interferons|interferons|mesh-list
19407993|NCT03570359|Interferon-beta|interferon-beta|mesh-list
19407994|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
19407995|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19407996|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
19407997|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614001|NCT02257346|Lidocaine|lidocaine|mesh-list
20614002|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
20614003|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
20614004|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20614005|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614006|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
20614007|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614008|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20614009|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19407998|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
19407999|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408000|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20460945|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20614010|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20614011|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614012|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408001|NCT03570346|Hemay005|hemay005|mesh-list
19408002|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
20460946|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20460947|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
20460948|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
20460949|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20460950|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20460951|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
20460952|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20460953|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
20460954|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
20460955|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
20460956|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20460957|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20460958|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
20614013|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
20614014|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20614015|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614016|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614017|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20614018|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20614019|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614020|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614021|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614022|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20614023|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
20614024|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20460959|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20460960|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460961|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20460962|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20614025|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408003|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19408004|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19408005|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408006|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408007|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
19408008|NCT03570320|Narcotics|narcotics|mesh-ancestor
20460963|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20460964|NCT01428037|Misoprostol|misoprostol|mesh-list
19408009|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408010|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408011|NCT03570320|Analgesics|analgesics|mesh-ancestor
19408012|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
19408013|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408014|NCT03570294|Atosiban|atosiban|mesh-list
20460965|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19408015|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
20460966|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
20460967|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20460968|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460969|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20460970|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20460971|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
20460972|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20460973|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
20460974|NCT01428154|Hematinics|hematinics|mesh-ancestor
20460975|NCT01428180|Ibuprofen|ibuprofen|mesh-list
20460976|NCT01428180|Indomethacin|indomethacin|mesh-list
20460977|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20460978|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20460979|NCT01428180|Analgesics|analgesics|mesh-ancestor
20460980|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
20460981|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20460982|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460983|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20460984|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20460985|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20460986|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20460987|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460988|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
20614026|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20614027|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20614028|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20614029|NCT02257463|Theophylline|theophylline|mesh-list
20614030|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
20614031|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
20614032|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614033|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614034|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20614035|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20614036|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614037|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614038|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20614039|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614040|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614041|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20614042|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20614043|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
20614044|NCT02257476|Dexamethasone|dexamethasone|mesh-list
20614045|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20614046|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
20614047|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
20614048|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614049|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614050|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20614051|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
20614052|NCT02257476|Hormones|hormones|mesh-ancestor
20614053|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20460989|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
20460990|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20460991|NCT01428284|Canagliflozin|canagliflozin|mesh-list
20460992|NCT01428284|Probenecid|probenecid|mesh-list
20460993|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20460994|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20460995|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20460996|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20460997|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
20460998|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
20460999|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614054|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20614055|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614056|NCT02257502|Aflibercept|aflibercept|mesh-list
20614057|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20614058|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20614059|NCT02257502|Growth Substances|growth substances|mesh-ancestor
20614060|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614061|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
20614062|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614063|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
20614064|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
20614065|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20461000|NCT01428284|Renal Agents|renal agents|mesh-ancestor
20461001|NCT01428375|Acetaminophen|acetaminophen|mesh-list
20461002|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461003|NCT01428375|Analgesics|analgesics|mesh-ancestor
20461004|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
20461005|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461006|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461007|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
20461008|NCT01428388|Bevacizumab|bevacizumab|mesh-list
20461009|NCT01428388|Ranibizumab|ranibizumab|mesh-list
20614066|NCT02257671|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20614067|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
20614068|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20614069|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614070|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20614071|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20614072|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20614073|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20614074|NCT02257671|Estrogens|estrogens|mesh-ancestor
20614075|NCT02257671|Hormones|hormones|mesh-ancestor
19855598|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461010|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20461011|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461012|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20614076|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20614077|NCT02257671|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20614078|NCT02257697|Mizoribine|mizoribine|mesh-list
20614079|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
20614080|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461013|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20461014|NCT01428388|Growth Substances|growth substances|mesh-ancestor
20461015|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461016|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
20461017|NCT01428414|Paclitaxel|paclitaxel|mesh-list
20461018|NCT01428414|Carboplatin|carboplatin|mesh-list
20461019|NCT01428414|Trastuzumab|trastuzumab|mesh-list
20614081|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
20614082|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614083|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614084|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20614085|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
20614086|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614087|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614088|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20614089|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20614090|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614091|NCT02257697|Analgesics|analgesics|mesh-ancestor
20614092|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
20461020|NCT01428414|Epirubicin|epirubicin|mesh-list
20461021|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20461022|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461023|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
20614093|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614094|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20614095|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614096|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614097|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20614098|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
20614099|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20614100|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20614101|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408016|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408017|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461024|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
20461025|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
19849354|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849355|NCT00702221|Vaccines|vaccines|mesh-list
19849356|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
19849357|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849358|NCT00702299|Paclitaxel|paclitaxel|mesh-list
19849359|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20461026|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614102|NCT02257788|Leronlimab|leronlimab|mesh-list
20614103|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20614104|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20614105|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614106|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20614107|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20614108|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
20614109|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614110|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
20614111|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614112|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614113|NCT02258009|Ranibizumab|ranibizumab|mesh-list
20614114|NCT02258009|Aflibercept|aflibercept|mesh-list
20614115|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20614116|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20614117|NCT02258009|Growth Substances|growth substances|mesh-ancestor
20614118|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614119|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
20614120|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614121|NCT02258204|Ketamine|ketamine|mesh-list
20614122|NCT02258204|Analgesics|analgesics|mesh-ancestor
20614123|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
20222535|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20222536|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20222537|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20222538|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
20222539|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222540|NCT00329472|Gemcitabine|gemcitabine|mesh-list
20222541|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222542|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20222543|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
20461027|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20461028|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20461029|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20222544|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222545|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
20222546|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222547|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222548|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20222549|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
20222550|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222551|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
20461030|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20614124|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614125|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614126|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20614127|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20614128|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
20614129|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
20614130|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20614131|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20614132|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20614133|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614134|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614135|NCT02258282|Etanercept|etanercept|mesh-list
20614136|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20614137|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614138|NCT02258282|Analgesics|analgesics|mesh-ancestor
20461031|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461032|NCT01428427|Gemcitabine|gemcitabine|mesh-list
20461033|NCT01428427|Trametinib|trametinib|mesh-list
20461034|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20461035|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
20461036|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614139|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
20222552|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
20614140|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849360|NCT00702299|Cisplatin|cisplatin|mesh-list
19849361|NCT00702299|Pemetrexed|pemetrexed|mesh-list
20614141|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614142|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20614143|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614144|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20614145|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20614146|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
20614147|NCT02258542|Benralizumab|benralizumab|mesh-list
19408018|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
20461037|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461038|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
20461039|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461040|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461041|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461042|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
20461043|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461044|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20461045|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20461046|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461047|NCT01428492|Dexamethasone|dexamethasone|mesh-list
20461048|NCT01428492|Bortezomib|bortezomib|mesh-list
20461049|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461050|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
20461051|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
20461052|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461053|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461054|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20461055|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
20461056|NCT01428492|Hormones|hormones|mesh-ancestor
20614148|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20614149|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
20614150|NCT02258581|Tenofovir|tenofovir|mesh-list
20614151|NCT02258581|Vesatolimod|vesatolimod|mesh-list
20614152|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
20614153|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614154|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20614155|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20614156|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614157|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614158|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20614159|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20614160|NCT02258607|Trametinib|trametinib|mesh-list
20614161|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
20614162|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614163|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20614164|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614165|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614166|NCT02258620|Isosorbide|isosorbide|mesh-list
20614167|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20614168|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20614169|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
20614170|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614171|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20614172|NCT02258620|Diuretics|diuretics|mesh-ancestor
20614173|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
20614174|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614175|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20614176|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614177|NCT02258763|Amoxicillin|amoxicillin|mesh-list
20614178|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
20614179|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
20614180|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20614181|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614182|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614183|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20614184|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614185|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614186|NCT02258815|Dinutuximab|dinutuximab|mesh-list
20614187|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614188|NCT02258828|Memantine|memantine|mesh-list
20614189|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19408019|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20461057|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20614190|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20614191|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
20614192|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614193|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614194|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614195|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20614196|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20614197|NCT02258906|Urinastatin|urinastatin|mesh-list
20614198|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20614199|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20614200|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
20614201|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614202|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614203|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
20614204|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20614205|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20461058|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20461059|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461060|NCT01428518|Lamotrigine|lamotrigine|mesh-list
20461061|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
20461062|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20461063|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461064|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461065|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614206|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20614207|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614208|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614209|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
20614210|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614211|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614212|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20614213|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614214|NCT02259179|Naltrexone|naltrexone|mesh-list
20614215|NCT02259179|Bupropion|bupropion|mesh-list
20614216|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20614217|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20614218|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614219|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
20614220|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614221|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20614222|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
20614223|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20614224|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20614225|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20614226|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614227|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614228|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
20614229|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614230|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20614231|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20614232|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614233|NCT02259309|Misoprostol|misoprostol|mesh-list
20614234|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20614235|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
20614236|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20614237|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614238|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20614239|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20614240|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
19408020|NCT03570281|Enoxaparin|enoxaparin|mesh-list
19408021|NCT03570281|Edoxaban|edoxaban|mesh-list
19408022|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
19408023|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19408024|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19408025|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408026|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20222553|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222554|NCT00329498|Protective Agents|protective agents|mesh-ancestor
20247271|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
20461066|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461067|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20461068|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20461069|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461070|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20614241|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
20614242|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20614243|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614244|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614245|NCT02259374|Ropivacaine|ropivacaine|mesh-list
20614246|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
20614247|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
20614248|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461071|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20461072|NCT01428531|PENTA|penta|mesh-list
20461073|NCT01428531|Fondaparinux|fondaparinux|mesh-list
20461074|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20461075|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
20461076|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20461077|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
20461078|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461079|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461080|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
20461081|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20461082|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20614249|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614250|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
20614251|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614252|NCT02259426|Piperaquine|piperaquine|mesh-list
20614253|NCT02259426|Primaquine|primaquine|mesh-list
20614254|NCT02259426|Artenimol|artenimol|mesh-list
20614255|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
20614256|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20614257|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20614258|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461083|NCT01428544|PENTA|penta|mesh-list
20461084|NCT01428544|Fondaparinux|fondaparinux|mesh-list
20461085|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20461086|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
20461087|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20461088|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
20461089|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461090|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461091|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
20461092|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20461093|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20461094|NCT01428622|Olodaterol|olodaterol|mesh-list
20461095|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20461096|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
20461097|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461098|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461099|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20461100|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
20526529|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526530|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526531|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20526532|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526533|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20526534|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526535|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694614|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694615|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694616|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
19694617|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
19694618|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19694619|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19694620|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694621|NCT04964427|Methylphenidate|methylphenidate|mesh-list
19694622|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20526536|NCT01763424|Calcitriol|calcitriol|mesh-list
20526537|NCT01763424|Niacinamide|niacinamide|mesh-list
20614259|NCT02259491|Calcium|calcium|mesh-list
20461101|NCT01428817|Carbetocin|carbetocin|mesh-list
20461102|NCT01428817|Oxytocin|oxytocin|mesh-list
20461103|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
20461104|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20461105|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461106|NCT01428908|Vaccines|vaccines|mesh-list
20461107|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
19694623|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694624|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19694625|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19694626|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19694627|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694628|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
20461108|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461109|NCT01428986|Maraviroc|maraviroc|mesh-list
20461110|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20461111|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20461112|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461113|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20461114|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20461115|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
19694629|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694630|NCT04964414|Budesonide|budesonide|mesh-list
20526538|NCT01763424|Niacin|niacin|mesh-list
20526539|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
20526540|NCT01763424|Calcipotriene|calcipotriene|mesh-list
20526541|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
20526542|NCT01763424|Vitamins|vitamins|mesh-ancestor
20526543|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
20526544|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526545|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20526546|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
20526547|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526548|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20526549|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
20526550|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
20526551|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20526552|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20526553|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20526554|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20526555|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20526556|NCT01763437|Tetracycline|tetracycline|mesh-list
20526557|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526558|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526559|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20526560|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526561|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526562|NCT01763450|Bevacizumab|bevacizumab|mesh-list
20526563|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20526564|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526565|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20526566|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20526567|NCT01763450|Growth Substances|growth substances|mesh-ancestor
20526568|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526569|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20526570|NCT01763463|Fluticasone|fluticasone|mesh-list
20526571|NCT01763463|Xhance|xhance|mesh-list
20526572|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20526573|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20526574|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
20526575|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526576|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
20526577|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526578|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526579|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20526580|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20526581|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
20526582|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20526583|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20526584|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20526585|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20526586|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
20526587|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461116|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461117|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20461118|NCT01429025|Rituximab|rituximab|mesh-list
20461119|NCT01429025|Lenalidomide|lenalidomide|mesh-list
20461120|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20222555|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222556|NCT00329498|Vitamins|vitamins|mesh-ancestor
20222557|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
20222558|NCT00329511|Clonidine|clonidine|mesh-list
20222559|NCT00329511|Methyldopa|methyldopa|mesh-list
20222560|NCT00329511|Analgesics|analgesics|mesh-ancestor
20222561|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
20614260|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614261|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614262|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
20614263|NCT02259543|Tetracycline|tetracycline|mesh-list
20614264|NCT02259543|Citric Acid|citric acid|mesh-list
20614265|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
20614266|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614267|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614268|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20614269|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614270|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614271|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
20614272|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20614273|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
20614274|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
20614275|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
20614276|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20614277|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
20614278|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
20614279|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614280|NCT02259595|Expectorants|expectorants|mesh-ancestor
20614281|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
20614282|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20614283|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
20614284|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614285|NCT02259595|Protective Agents|protective agents|mesh-ancestor
20614286|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614287|NCT02259595|Antidotes|antidotes|mesh-ancestor
20614288|NCT02259621|Paclitaxel|paclitaxel|mesh-list
20614289|NCT02259621|Carboplatin|carboplatin|mesh-list
20614290|NCT02259621|Nivolumab|nivolumab|mesh-list
20614291|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20614292|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614293|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
20614294|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
20614295|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
20461121|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20461122|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614296|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614297|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20614298|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20222562|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222563|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222564|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20222565|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
20222566|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
20461123|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
20461124|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614299|NCT02259647|Sorafenib|sorafenib|mesh-list
20614300|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614301|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694631|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
19694632|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694633|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20461125|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461126|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19694634|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
19694635|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694636|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694637|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19694638|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461127|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20222567|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20614302|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614303|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614304|NCT02259738|Kallikreins|kallikreins|mesh-list
20614305|NCT02259738|Coagulants|coagulants|mesh-ancestor
20614306|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
20614307|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
20614308|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20614309|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614310|NCT02259777|Amlodipine|amlodipine|mesh-list
20614311|NCT02259777|Telmisartan|telmisartan|mesh-list
20614312|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20614313|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614314|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20614315|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614316|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614317|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614318|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461128|NCT01429025|Growth Substances|growth substances|mesh-ancestor
20461129|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
20461130|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20461131|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
20461132|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461133|NCT01429090|Methantheline|methantheline|mesh-list
19408027|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
19408028|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19408029|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
19408030|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408031|NCT03570164|Sevoflurane|sevoflurane|mesh-list
19408032|NCT03570164|Desflurane|desflurane|mesh-list
19408033|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20461134|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20614319|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614320|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614321|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614322|NCT02259790|Amlodipine|amlodipine|mesh-list
20614323|NCT02259790|Telmisartan|telmisartan|mesh-list
20614324|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20614325|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614326|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20614327|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614328|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614329|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614330|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614331|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614332|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614333|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614334|NCT02259803|Amlodipine|amlodipine|mesh-list
20614335|NCT02259803|Telmisartan|telmisartan|mesh-list
19694639|NCT04964414|Hormones|hormones|mesh-ancestor
19694640|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19694641|NCT04964219|Ketamine|ketamine|mesh-list
20461135|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20461136|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
20461137|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461138|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461139|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461140|NCT01429129|Nicotine|nicotine|mesh-list
20461141|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20461142|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
20461143|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461144|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461145|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20461146|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20461147|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
20461148|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461149|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461150|NCT01429181|Methadone|methadone|mesh-list
20461151|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20461152|NCT01429181|Narcotics|narcotics|mesh-ancestor
20461153|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461154|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461155|NCT01429181|Analgesics|analgesics|mesh-ancestor
20461156|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
20461157|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461158|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
19408034|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20461159|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
20614336|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20614337|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614338|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20614339|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614340|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614341|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614342|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614343|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614344|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614345|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614346|NCT02259816|Amlodipine|amlodipine|mesh-list
20614347|NCT02259816|Telmisartan|telmisartan|mesh-list
20614348|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614349|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20614350|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614351|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614352|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614353|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614354|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614355|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614356|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614357|NCT02259829|Amlodipine|amlodipine|mesh-list
20614358|NCT02259829|Telmisartan|telmisartan|mesh-list
20614359|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20614360|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614361|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20614362|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614363|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614364|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614365|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614366|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614367|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614368|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614369|NCT02259855|Interferons|interferons|mesh-list
20614370|NCT02259855|Ritonavir|ritonavir|mesh-list
20614371|NCT02259855|Ribavirin|ribavirin|mesh-list
20461160|NCT01429337|Midostaurin|midostaurin|mesh-list
20461161|NCT01429337|Staurosporine|staurosporine|mesh-list
20461162|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461163|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20461164|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461165|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461166|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
20614372|NCT02259855|Tipranavir|tipranavir|mesh-list
20614373|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614374|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
20614375|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614376|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20614377|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20461167|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20461168|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20461169|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20461170|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461171|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461172|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
20461173|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461174|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461175|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20461176|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461177|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
20461178|NCT01429415|Analgesics|analgesics|mesh-ancestor
20461179|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
20461180|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461181|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461182|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
20461183|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461184|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20461185|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
20461186|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20461187|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461188|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694642|NCT04964219|Esketamine|esketamine|mesh-list
19694643|NCT04964219|Analgesics|analgesics|mesh-ancestor
19694644|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
19694645|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694646|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461189|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20461190|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
20461191|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20461192|NCT01429545|Nifedipine|nifedipine|mesh-list
19694647|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19694648|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19694649|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
19694650|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
19694651|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694652|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20461193|NCT01429545|Vasotocin|vasotocin|mesh-list
20461194|NCT01429545|Atosiban|atosiban|mesh-list
20461195|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20461196|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461197|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461198|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20461199|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461200|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
20461201|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
20461202|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20461203|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
20461204|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461205|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
19694653|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19694654|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694655|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694656|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
19694657|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694658|NCT04964089|Aflibercept|aflibercept|mesh-list
19694659|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19694660|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19694661|NCT04964089|Growth Substances|growth substances|mesh-ancestor
19849362|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20461206|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19849363|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849364|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
20222568|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20461207|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20461208|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461209|NCT01429610|Cytarabine|cytarabine|mesh-list
20461210|NCT01429610|Rituximab|rituximab|mesh-list
20461211|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20461212|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461213|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
20461214|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461215|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461216|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20461217|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
20222569|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20222570|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
20222571|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222572|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222573|NCT00329537|Sargramostim|sargramostim|mesh-list
20222574|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
20222575|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222576|NCT00329589|Bortezomib|bortezomib|mesh-list
20222577|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222578|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
20222579|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
20222580|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
20222581|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20222582|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222583|NCT00329628|Enoxaparin|enoxaparin|mesh-list
20222584|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
20222585|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20222586|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
20222587|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20222588|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
20461218|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614378|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
20614379|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614380|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614381|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20614382|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20614383|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20614384|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20614385|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
20614386|NCT02259868|Ritonavir|ritonavir|mesh-list
20614387|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20614388|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20614389|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
20614390|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614391|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461219|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
19849365|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
19849366|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
20461220|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461221|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461222|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
20461223|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20461224|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461225|NCT01429701|Gentamicins|gentamicins|mesh-list
20461226|NCT01429701|Polymyxins|polymyxins|mesh-list
20461227|NCT01429701|Polymyxin B|polymyxin b|mesh-list
20461228|NCT01429701|Prednisolone|prednisolone|mesh-list
20461229|NCT01429701|Betamethasone|betamethasone|mesh-list
20461230|NCT01429701|Benzocaine|benzocaine|mesh-list
20461231|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461232|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
20461233|NCT01429701|Hormones|hormones|mesh-ancestor
20461234|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461235|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461236|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20461237|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461238|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461239|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20461240|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461241|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614392|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20614393|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20614394|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
20614395|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614396|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20614397|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20614398|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
20614399|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
20614400|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
20614401|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614402|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614403|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
20614404|NCT02259946|Bromides|bromides|mesh-list
20614405|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
20614406|NCT02259946|Olodaterol|olodaterol|mesh-list
20614407|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20614408|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
20614409|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614410|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614411|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20614412|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
20614413|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
19694662|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694663|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
19694664|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694665|NCT04964024|Antibodies|antibodies|mesh-list
19694666|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
19694667|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694668|NCT04963998|Copper|copper|mesh-list
19694669|NCT04963998|Trace Elements|trace elements|mesh-ancestor
19694670|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
19849367|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461242|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461243|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20614414|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20614415|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
19694671|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614416|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614417|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614418|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
20614419|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20614420|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
20614421|NCT02259959|Olodaterol|olodaterol|mesh-list
20614422|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19694672|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19694673|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461244|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461245|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461246|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
20461247|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
20461248|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461249|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
20461250|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
20461251|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20461252|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20461253|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
20461254|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461255|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461256|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461257|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
20461258|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
20461259|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461260|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
20461261|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20461262|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461263|NCT01429818|Metformin|metformin|mesh-list
20461264|NCT01429818|Glimepiride|glimepiride|mesh-list
20461265|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20461266|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461267|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20461268|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461269|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
20461270|NCT01429831|Aripiprazole|aripiprazole|mesh-list
20461271|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
20461272|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20461273|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20461274|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20461275|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461276|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461277|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
20461278|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
20461279|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461280|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461281|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20461282|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20461283|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
20461284|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20461285|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20461286|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20461287|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19694674|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694675|NCT04963764|Amoxicillin|amoxicillin|mesh-list
19694676|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19694677|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694678|NCT04963712|Thymalfasin|thymalfasin|mesh-list
20461288|NCT01429844|Cyclosporine|cyclosporine|mesh-list
20614423|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
20614424|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614425|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614426|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20614427|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
20614428|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
20614429|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20614430|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
20614431|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614432|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614433|NCT02259985|Itasetron|itasetron|mesh-list
20461289|NCT01429844|Tacrolimus|tacrolimus|mesh-list
20461290|NCT01429844|Cyclosporins|cyclosporins|mesh-list
20461291|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694679|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20614434|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
20614435|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
20461292|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
20461293|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461294|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20461295|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461296|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461297|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
20461298|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461299|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461300|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614436|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614437|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614438|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20614439|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20614440|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20614441|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
20614442|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614443|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614444|NCT02259998|Dipyridamole|dipyridamole|mesh-list
20614445|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20614446|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614447|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614448|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20614449|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614450|NCT02260011|Bromides|bromides|mesh-list
20614451|NCT02260011|Norflurane|norflurane|mesh-list
20614452|NCT02260011|Ipratropium|ipratropium|mesh-list
20614453|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
20614454|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20614455|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
20614456|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614457|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614458|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20614459|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
20614460|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20614461|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
20614462|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614463|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614464|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
20614465|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20614466|NCT02260024|Pramipexole|pramipexole|mesh-list
20614467|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
20614468|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614469|NCT02260024|Protective Agents|protective agents|mesh-ancestor
20614470|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614471|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20614472|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20614473|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
20614474|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
20614475|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614476|NCT02260037|Epinastine|epinastine|mesh-list
20614477|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20614478|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
20614479|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
20614480|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614481|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614482|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614483|NCT02260050|Epinastine|epinastine|mesh-list
20614484|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20614485|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
20614486|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
19408035|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
19408036|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
19408037|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408038|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416589|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19416590|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20614487|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614488|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461301|NCT01429870|Triamcinolone|triamcinolone|mesh-list
20461302|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461303|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
20461304|NCT01429870|Hormones|hormones|mesh-ancestor
20614489|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614490|NCT02260063|Epinastine|epinastine|mesh-list
19416591|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20461305|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461306|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461307|NCT01429935|Ibuprofen|ibuprofen|mesh-list
20461308|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20461309|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461310|NCT01429935|Analgesics|analgesics|mesh-ancestor
20461311|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
20461312|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461313|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461314|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461315|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461316|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20461317|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614491|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20614492|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
20614493|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
20614494|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614495|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614496|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614497|NCT02260089|Telmisartan|telmisartan|mesh-list
20614498|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614499|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614500|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614501|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614505|NCT02260206|Colchicine|colchicine|mesh-list
20614506|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
20614507|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849368|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849369|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20614508|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
20614509|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
20614510|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
20614511|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614512|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614513|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
20614514|NCT02260336|Celecoxib|celecoxib|mesh-list
20614515|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20614516|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614517|NCT02260336|Analgesics|analgesics|mesh-ancestor
20614518|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
20614519|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614520|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614521|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20614522|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614523|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20614524|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20461318|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461319|NCT01430013|Endostar protein|endostar protein|mesh-list
20461320|NCT01430013|Endostatins|endostatins|mesh-list
20461321|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20461322|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20461323|NCT01430013|Growth Substances|growth substances|mesh-ancestor
20461324|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614525|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614526|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614527|NCT02260414|Tinzaparin|tinzaparin|mesh-list
20461325|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
20461326|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614528|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20614529|NCT02260414|Dalteparin|dalteparin|mesh-list
20614530|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
20614531|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20614532|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20614533|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614534|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
20614535|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614536|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20614537|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614538|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614539|NCT02260544|Doxorubicin|doxorubicin|mesh-list
20461327|NCT01430052|Gemcitabine|gemcitabine|mesh-list
20614540|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20461328|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20461329|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
20461330|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461331|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461332|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
20461333|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461334|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461335|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461336|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
20461337|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461338|NCT01430065|Tacrolimus|tacrolimus|mesh-list
20461339|NCT01430065|Peficitinib|peficitinib|mesh-list
20461340|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461341|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
20461342|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461343|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20461344|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461345|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461346|NCT01430078|Niacinamide|niacinamide|mesh-list
20461347|NCT01430078|Peficitinib|peficitinib|mesh-list
20461348|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461349|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461350|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461351|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
20461352|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461353|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
20461354|NCT01430078|Vitamins|vitamins|mesh-ancestor
20461355|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
20461356|NCT01430195|Afamelanotide|afamelanotide|mesh-list
20461357|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461358|NCT01430234|Pancreatin|pancreatin|mesh-list
20461359|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20461360|NCT01430260|Ciclesonide|ciclesonide|mesh-list
20461361|NCT01430260|Cetirizine|cetirizine|mesh-list
20461362|NCT01430260|Levocetirizine|levocetirizine|mesh-list
20461363|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
20461364|NCT01430260|Hormones|hormones|mesh-ancestor
20461365|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461366|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461367|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20461368|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20461369|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20461370|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
20461371|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
20461372|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461373|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461374|NCT01430312|Azelaic acid|azelaic acid|mesh-list
20461375|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461376|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461377|NCT01430351|Metformin|metformin|mesh-list
20461378|NCT01430351|Mefloquine|mefloquine|mesh-list
20461379|NCT01430351|Temozolomide|temozolomide|mesh-list
20461380|NCT01430351|Memantine|memantine|mesh-list
20461381|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20461382|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461383|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20461384|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
20461385|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461386|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461387|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20461388|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20461389|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
20461390|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461391|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20461392|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20461393|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
20461394|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20461395|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20461396|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461397|NCT01430520|Citalopram|citalopram|mesh-list
20461398|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20461399|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20461400|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614541|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20461401|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461402|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461403|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
20461404|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461405|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20461406|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
20461407|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20526588|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526589|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
20526590|NCT01763463|Hormones|hormones|mesh-ancestor
20526591|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526592|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
19694680|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
19694681|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707765|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707766|NCT04823962|Molgramostim|molgramostim|mesh-list
19707767|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707768|NCT04824053|Selenium|selenium|mesh-list
19707769|NCT04824053|Caseins|caseins|mesh-list
19707770|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
19707771|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526593|NCT01763476|Paclitaxel|paclitaxel|mesh-list
20526594|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20526595|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526596|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
20526597|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
20526598|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
20526599|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526600|NCT01763541|Anastrozole|anastrozole|mesh-list
20526601|NCT01763541|Leuprolide|leuprolide|mesh-list
20526602|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20526603|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526604|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20526605|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20526606|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526607|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526608|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20526609|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
20526610|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526611|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526612|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20526613|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
20526614|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20526615|NCT01763580|Prednisolone|prednisolone|mesh-list
20526616|NCT01763580|Tacrolimus|tacrolimus|mesh-list
20526617|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526618|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
20526619|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526620|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20526621|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526622|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526623|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526624|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
20526625|NCT01763580|Hormones|hormones|mesh-ancestor
20526626|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526627|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20526628|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526629|NCT01763658|Dexamethasone|dexamethasone|mesh-list
20526630|NCT01763658|Prednisolone|prednisolone|mesh-list
20526631|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20526632|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
20526633|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20526634|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
20526635|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20526636|NCT01763658|Antioxidants|antioxidants|mesh-list
20526637|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526638|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
20526639|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
20526640|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526641|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526642|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20526643|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
20526644|NCT01763658|Hormones|hormones|mesh-ancestor
20614542|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461408|NCT01430533|Azelaic acid|azelaic acid|mesh-list
20461409|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461410|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461411|NCT01430572|Everolimus|everolimus|mesh-list
20614543|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20614544|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20614545|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614546|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614547|NCT02260557|Selexipag|selexipag|mesh-list
20614548|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614549|NCT02260570|Tolcapone|tolcapone|mesh-list
20614550|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20614551|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20614552|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20614553|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614554|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614555|NCT02260661|Fulvestrant|fulvestrant|mesh-list
20614556|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20614557|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614558|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20614559|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20614560|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
20614561|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20614562|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614563|NCT02260687|Aflibercept|aflibercept|mesh-list
20614564|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20614565|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20614566|NCT02260687|Growth Substances|growth substances|mesh-ancestor
20614567|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614568|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
20461412|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461413|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20614569|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614570|NCT02260908|Enoxaparin|enoxaparin|mesh-list
20614571|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
20614572|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20614573|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20614574|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614575|NCT02260947|Ibuprofen|ibuprofen|mesh-list
20614576|NCT02260947|Pregabalin|pregabalin|mesh-list
20614577|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20614578|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614579|NCT02260947|Analgesics|analgesics|mesh-ancestor
20614580|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
20614581|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614582|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614583|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461414|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
20461415|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461416|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
20614584|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614585|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20461417|NCT01430650|Urological Agents|urological agents|mesh-ancestor
20461418|NCT01430689|Vaccines|vaccines|mesh-list
20461419|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
20461420|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461421|NCT01430793|Vitamin D|vitamin d|mesh-list
20461422|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
20461423|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
20461424|NCT01430793|Vitamins|vitamins|mesh-list
20461425|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
20461426|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461427|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20461428|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20461429|NCT01430806|Dronedarone|dronedarone|mesh-list
20461430|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20461431|NCT01430910|Ceftazidime|ceftazidime|mesh-list
20461432|NCT01430910|Avibactam|avibactam|mesh-list
20461433|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20461434|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461435|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20614586|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614587|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461436|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461437|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614588|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
20614589|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20614590|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614591|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614592|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20614593|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20614594|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20614595|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20461438|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20461439|NCT01430923|Latanoprost|latanoprost|mesh-list
20461440|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20461441|NCT01431053|Aspirin|aspirin|mesh-list
20461442|NCT01431053|Exemestane|exemestane|mesh-list
20461443|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20461444|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461445|NCT01431053|Analgesics|analgesics|mesh-ancestor
20461446|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
20614596|NCT02261025|Aspirin|aspirin|mesh-list
20614597|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20614598|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614599|NCT02261025|Analgesics|analgesics|mesh-ancestor
20614600|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
20614601|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614602|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614603|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20614604|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614605|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20614606|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20614607|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614608|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20614609|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20614610|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614611|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
20614612|NCT02261064|Amlodipine|amlodipine|mesh-list
20614613|NCT02261064|Telmisartan|telmisartan|mesh-list
20614614|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20614615|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614616|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20461447|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461448|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461449|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461450|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461451|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20461452|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20461453|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461454|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20461455|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20461456|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461457|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
20461458|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461459|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20461460|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20461461|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20461462|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
20461463|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461464|NCT01431092|Melatonin|melatonin|mesh-list
20461465|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
20461466|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461467|NCT01431092|Protective Agents|protective agents|mesh-ancestor
20461468|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461469|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461470|NCT01431118|Camphor|camphor|mesh-list
20614617|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614618|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614619|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20614620|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614621|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
20614622|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614623|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614624|NCT02261077|Scopolamine|scopolamine|mesh-list
20614625|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20614626|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20614627|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
20614628|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
20461471|NCT01431118|Salicylates|salicylates|mesh-list
20222589|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222590|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222591|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
20222592|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20222593|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20222594|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
20222595|NCT00329680|Antioxidants|antioxidants|mesh-list
20222596|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222597|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461472|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
20461473|NCT01431118|Menthol|menthol|mesh-list
20461474|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20461475|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461476|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
20461477|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461478|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20461479|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461480|NCT01431118|Analgesics|analgesics|mesh-ancestor
20461481|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
20461482|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461483|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461484|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461485|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461486|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20461487|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461488|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461489|NCT01431183|Vaccines|vaccines|mesh-list
20461490|NCT01431183|Immunologic Factors|immunologic factors|mesh-ancestor
20461491|NCT01431183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461492|NCT01431196|Vaccines|vaccines|mesh-list
20461493|NCT01431196|Immunologic Factors|immunologic factors|mesh-ancestor
20461494|NCT01431196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461495|NCT01431326|Vancomycin|vancomycin|mesh-list
20461496|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
20461497|NCT01431326|Tazobactam|tazobactam|mesh-list
20461498|NCT01431326|Piperacillin|piperacillin|mesh-list
20461499|NCT01431326|Tobramycin|tobramycin|mesh-list
20461500|NCT01431326|Amikacin|amikacin|mesh-list
20461501|NCT01431326|Fosfomycin|fosfomycin|mesh-list
20461502|NCT01431326|Cefepime|cefepime|mesh-list
20461503|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20461504|NCT01431326|Nafcillin|nafcillin|mesh-list
20461505|NCT01431326|Cidofovir|cidofovir|mesh-list
20461506|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
20461507|NCT01431326|Bosentan|bosentan|mesh-list
20461508|NCT01431326|Labetalol|labetalol|mesh-list
20461509|NCT01431326|Nifedipine|nifedipine|mesh-list
20461510|NCT01431326|Spironolactone|spironolactone|mesh-list
20461511|NCT01431326|Pentobarbital|pentobarbital|mesh-list
20461512|NCT01431326|Oxycodone|oxycodone|mesh-list
20461513|NCT01431326|Alfentanil|alfentanil|mesh-list
20461514|NCT01431326|Haloperidol|haloperidol|mesh-list
20461515|NCT01431326|Zolpidem|zolpidem|mesh-list
20461516|NCT01431326|Ziprasidone|ziprasidone|mesh-list
20461517|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20461518|NCT01431326|Clozapine|clozapine|mesh-list
20461519|NCT01431326|Molindone|molindone|mesh-list
20461520|NCT01431326|Warfarin|warfarin|mesh-list
20461521|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
20461522|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
20461523|NCT01431326|Rocuronium|rocuronium|mesh-list
20461524|NCT01431326|Sevelamer|sevelamer|mesh-list
20461525|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461526|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
20461527|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
20461528|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461529|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461530|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20461531|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
20461532|NCT01431326|Hormones|hormones|mesh-ancestor
20461533|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461534|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20461535|NCT01431326|Protective Agents|protective agents|mesh-ancestor
20461536|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461537|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20461538|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20461539|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461540|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
20461541|NCT01431326|Coagulants|coagulants|mesh-ancestor
20461542|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20461543|NCT01431326|Narcotics|narcotics|mesh-ancestor
20461544|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461545|NCT01431326|Analgesics|analgesics|mesh-ancestor
20461546|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
20461547|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
20461548|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20461549|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461550|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20461551|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20461552|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20461553|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20461554|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20461555|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461556|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20461557|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20461558|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20461559|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
20461560|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20461561|NCT01431326|Diuretics|diuretics|mesh-ancestor
20461562|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
20461563|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20461564|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461565|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20461566|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
20461567|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
20461568|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20614629|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614630|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614631|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20614632|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
20614633|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20614634|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
20614635|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614636|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614637|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20614638|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
19849370|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19849371|NCT00702325|Budesonide|budesonide|mesh-list
19849372|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
19849373|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19849374|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849375|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19849376|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
19849377|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849378|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849379|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19849380|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
19849381|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
19849382|NCT00702325|Hormones|hormones|mesh-ancestor
19849383|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849384|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19849385|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19849386|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19849387|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
20222598|NCT00329680|Protective Agents|protective agents|mesh-ancestor
20461569|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20222599|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20222600|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222601|NCT00329680|Analgesics|analgesics|mesh-ancestor
20222602|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
20222603|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222604|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222605|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222606|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222607|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
20222608|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20222609|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20222610|NCT00329693|Quinagolide|quinagolide|mesh-list
20222611|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
20222612|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
20222613|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222614|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461570|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20461571|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20461572|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20461573|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20461574|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
20461575|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461576|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20461577|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20461578|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20461579|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20461580|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
20461581|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
20461582|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20461583|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
20461584|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20461585|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20461586|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
20461587|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
20461588|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20461589|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20461590|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20461591|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
20461592|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20461593|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19849388|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849389|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849390|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19849391|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19849392|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19849393|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461594|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
20461595|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19849394|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461596|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
20461597|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20461598|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20461599|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
20461600|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
20461601|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
20461602|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20614639|NCT02261090|Pramipexole|pramipexole|mesh-list
20614640|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
20614641|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614642|NCT02261090|Protective Agents|protective agents|mesh-ancestor
20614643|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614644|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20614645|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20614646|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
20614647|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
20614648|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614649|NCT02261103|Pramipexole|pramipexole|mesh-list
19694682|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
19694683|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
19694684|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694685|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461603|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
20461604|NCT01431352|Letrozole|letrozole|mesh-list
20461605|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461606|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20461607|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20461608|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461609|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461610|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20461611|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
20614650|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
19694686|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694687|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
19694688|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19694689|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694690|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694691|NCT04963881|Antibodies|antibodies|mesh-list
19849395|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
19849396|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461612|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20614651|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614652|NCT02261103|Protective Agents|protective agents|mesh-ancestor
20614653|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614654|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20614655|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20614656|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
20614657|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
20614658|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614659|NCT02261116|Telmisartan|telmisartan|mesh-list
20614660|NCT02261116|Candesartan|candesartan|mesh-list
20614661|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614662|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614663|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614664|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614665|NCT02261129|Telmisartan|telmisartan|mesh-list
20614666|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614667|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614668|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614669|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614670|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20614671|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20614672|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614673|NCT02261207|Axitinib|axitinib|mesh-list
20614674|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614675|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20614676|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461613|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461614|NCT01431404|Etanercept|etanercept|mesh-list
20461615|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20461616|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461617|NCT01431404|Analgesics|analgesics|mesh-ancestor
20461618|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
20461619|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461620|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461621|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461622|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461623|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20461624|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461625|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
20461626|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
20461627|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20461628|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461629|NCT01431430|Vitamins|vitamins|mesh-ancestor
20461630|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
20614677|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614678|NCT02261220|Durvalumab|durvalumab|mesh-list
20614679|NCT02261220|Tremelimumab|tremelimumab|mesh-list
20614680|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20614681|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614682|NCT02261298|Nivolumab|nivolumab|mesh-list
20614683|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20614684|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614685|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20614686|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614687|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20614688|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20614689|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614690|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
20614691|NCT02261662|Ribavirin|ribavirin|mesh-list
20614692|NCT02261662|Betamethasone|betamethasone|mesh-list
20614693|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
20614694|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614695|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
20614696|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614697|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20614698|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
20614699|NCT02261662|Hormones|hormones|mesh-ancestor
20614700|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20614701|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614702|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20614703|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461631|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20461632|NCT01431443|Theobromine|theobromine|mesh-list
20614704|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
20461633|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20461634|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
20461635|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461636|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461637|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20461638|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461639|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
20461640|NCT01431456|Nadroparin|nadroparin|mesh-list
20461641|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
20461642|NCT01431456|Dabigatran|dabigatran|mesh-list
20461643|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20461644|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
20461645|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20461646|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
20461647|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461648|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461649|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
20461650|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20461651|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20614705|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20614706|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20614707|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614708|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614709|NCT02261675|Analgesics|analgesics|mesh-ancestor
20614710|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
20614711|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614712|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20614713|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20614714|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20614715|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
20614716|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614717|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614718|NCT02261779|Tretinoin|tretinoin|mesh-list
20614719|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
20614720|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614721|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
20614722|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
20614723|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
20614724|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20614725|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20614726|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614727|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614728|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20614729|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20614730|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20614731|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614732|NCT02261844|Resveratrol|resveratrol|mesh-list
20222615|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222616|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20222617|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20222618|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222619|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
20222620|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222621|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20222622|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20222623|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222624|NCT00329810|Aripiprazole|aripiprazole|mesh-list
20222625|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222626|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222627|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20461652|NCT01431495|Clopidogrel|clopidogrel|mesh-list
20614733|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
20614734|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614735|NCT02261844|Protective Agents|protective agents|mesh-ancestor
20614736|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614737|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614738|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20614739|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
20614740|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614741|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614742|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20614743|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20222628|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20461653|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20461654|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20461655|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20461656|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20461657|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
20461658|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461659|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461660|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461661|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20461662|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
20461663|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461664|NCT01431612|Phenylephrine|phenylephrine|mesh-list
20461665|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
20461666|NCT01431612|Esmolol|esmolol|mesh-list
20461667|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20461668|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
20461669|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
20461670|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461671|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461672|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
20461673|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20461674|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
20461675|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461676|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20461677|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20461678|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20461679|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
20461680|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461681|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461682|NCT01431612|Protective Agents|protective agents|mesh-ancestor
20461683|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20461684|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20461685|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20461686|NCT01431690|Warfarin|warfarin|mesh-list
20461687|NCT01431690|Anticoagulants|anticoagulants|mesh-list
20461688|NCT01431729|Propolis|propolis|mesh-list
20461689|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461690|NCT01431742|Buprenorphine|buprenorphine|mesh-list
20461691|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20461692|NCT01431742|Narcotics|narcotics|mesh-ancestor
20461693|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461694|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461695|NCT01431742|Analgesics|analgesics|mesh-ancestor
20461696|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
20461697|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461698|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20461699|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20461700|NCT01431781|Somatostatin|somatostatin|mesh-list
20461701|NCT01431781|Hormones|hormones|mesh-ancestor
20461702|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461703|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461704|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
20461705|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20461706|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461707|NCT01431924|Fluticasone|fluticasone|mesh-list
20461708|NCT01431924|Xhance|xhance|mesh-list
20461709|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20461710|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461711|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20461712|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
20461713|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461714|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461715|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20461716|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461717|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461718|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20461719|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20461720|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20461721|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20461722|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
20461723|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461724|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461725|NCT01432028|Drospirenone|drospirenone|mesh-list
20461726|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20461727|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20461728|NCT01432028|Estradiol|estradiol|mesh-list
20461729|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20461730|NCT01432028|Progesterone|progesterone|mesh-list
20461731|NCT01432028|Estrogens|estrogens|mesh-ancestor
20461732|NCT01432028|Hormones|hormones|mesh-ancestor
20461733|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461734|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461735|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20461736|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
20461737|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20461738|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20461739|NCT01432028|Progestins|progestins|mesh-ancestor
20461740|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20461741|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
20461742|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20614744|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408039|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
19408040|NCT03570112|Velpatasvir|velpatasvir|mesh-list
19849397|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849398|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
20222629|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461743|NCT01432028|Diuretics|diuretics|mesh-ancestor
20461744|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
20461745|NCT01432080|Azithromycin|azithromycin|mesh-list
20461746|NCT01432080|Prednisone|prednisone|mesh-list
20461747|NCT01432080|Budesonide|budesonide|mesh-list
20461748|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
20461749|NCT01432080|Montelukast|montelukast|mesh-list
20461750|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20222630|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222631|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
20222632|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
20222633|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222634|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222635|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20222636|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20222637|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
20222638|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20461751|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461752|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
20461753|NCT01432080|Hormones|hormones|mesh-ancestor
20461754|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461755|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461756|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20461757|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461758|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20461759|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
20461760|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461761|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20461762|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461763|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20461764|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461765|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20461766|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20461767|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20461768|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
20461769|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461770|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461771|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20461772|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
20461773|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20461774|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20461775|NCT01432106|Valsartan|valsartan|mesh-list
20461776|NCT01432106|Ramipril|ramipril|mesh-list
20461777|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20461778|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20461779|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20461780|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461781|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20461782|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
20461783|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461784|NCT01432119|Cetuximab|cetuximab|mesh-list
20461785|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20614745|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614746|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614747|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20614748|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20614749|NCT02261922|Ticagrelor|ticagrelor|mesh-list
20614750|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20614751|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20614752|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20614753|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20614754|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20614755|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
20614756|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614757|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614758|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614759|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20614760|NCT02262143|Fenofibrate|fenofibrate|mesh-list
20614761|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20614762|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20614763|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
20614764|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614765|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20614766|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20614767|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614768|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
20614769|NCT02262156|Serotonin|serotonin|mesh-list
20614770|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20614771|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20614772|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20614773|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
20614774|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614775|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614776|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614777|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20614778|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614779|NCT02262169|Omeprazole|omeprazole|mesh-list
20614780|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20614781|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20614782|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20614783|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614784|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614785|NCT02262299|Pirfenidone|pirfenidone|mesh-list
20614786|NCT02262299|Analgesics|analgesics|mesh-ancestor
20614787|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
20614788|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614789|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614790|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20614791|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614792|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20614793|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20614794|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614795|NCT02262325|Etoposide|etoposide|mesh-list
20614796|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
20614797|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408041|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
19408042|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694692|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
20461786|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408043|NCT03570099|Naloxone|naloxone|mesh-list
20461787|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461788|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20461789|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461790|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461791|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20461792|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
20461793|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461794|NCT01432223|Paclitaxel|paclitaxel|mesh-list
20461795|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20461796|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461797|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
19408044|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19408045|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408046|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
19694693|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694694|NCT04963595|Vinorelbine|vinorelbine|mesh-list
19694695|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19694696|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694697|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
19694698|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
20614798|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20461798|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
20461799|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
20461800|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461801|NCT01432249|Etanercept|etanercept|mesh-list
20461802|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20461803|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461804|NCT01432249|Analgesics|analgesics|mesh-ancestor
20461805|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
20461806|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461807|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461808|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461809|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461810|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20461811|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20461812|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
20526645|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526646|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20526647|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526648|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408047|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408048|NCT03569995|Cytarabine|cytarabine|mesh-list
19408049|NCT03569995|Rituximab|rituximab|mesh-list
19694699|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
20526649|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19694700|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694701|NCT04963257|Aripiprazole|aripiprazole|mesh-list
20526650|NCT01763658|Protective Agents|protective agents|mesh-ancestor
19408050|NCT03569995|Methotrexate|methotrexate|mesh-list
20526651|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
20526652|NCT01763671|Paclitaxel|paclitaxel|mesh-list
20526653|NCT01763671|Docetaxel|docetaxel|mesh-list
20526654|NCT01763671|Bevacizumab|bevacizumab|mesh-list
20526655|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20526656|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526657|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
20526658|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
20526659|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
20526660|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526661|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20526662|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20526663|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20526664|NCT01763671|Growth Substances|growth substances|mesh-ancestor
20526665|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526666|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
20526667|NCT01763710|Paclitaxel|paclitaxel|mesh-list
20526668|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20526669|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20526670|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526671|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
20526672|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
20526673|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
20526674|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530601|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530602|NCT01789710|Bupropion|bupropion|mesh-list
20530603|NCT01789710|Nicotine|nicotine|mesh-list
20530604|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20530605|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
20530606|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530607|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530608|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20530609|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20530610|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
20530611|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530612|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530613|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20461813|NCT01432470|Oxytocin|oxytocin|mesh-list
20461814|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
20461815|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20461816|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461817|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
20461818|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849399|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849400|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849401|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849402|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849403|NCT00702468|Nabiximols|nabiximols|mesh-list
19849404|NCT00702468|Analgesics|analgesics|mesh-ancestor
19849405|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
20461819|NCT01432496|Ropivacaine|ropivacaine|mesh-list
20461820|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
20461821|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
20461822|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461823|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461824|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
20614799|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20461825|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461826|NCT01432522|Epinephrine|epinephrine|mesh-list
20461827|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20461828|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20461829|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
20461830|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461831|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461832|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461833|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20461834|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20461835|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
20461836|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461837|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20461838|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
20461839|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
20461840|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
20461841|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20461842|NCT01432587|Diflunisal|diflunisal|mesh-list
20461843|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20461844|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461845|NCT01432587|Analgesics|analgesics|mesh-ancestor
20461846|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
20461847|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461848|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461849|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20461850|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20461851|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20461852|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461853|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461854|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
20461855|NCT01432665|Testosterone|testosterone|mesh-list
20461856|NCT01432665|Androgens|androgens|mesh-ancestor
20461857|NCT01432665|Hormones|hormones|mesh-ancestor
20461858|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20461859|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461860|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
20461861|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20461862|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20461863|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461864|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461865|NCT01432665|Urological Agents|urological agents|mesh-ancestor
20461866|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
20461867|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20461868|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461869|NCT01432704|Vitamins|vitamins|mesh-ancestor
20461870|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
20461871|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20461872|NCT01432717|Luspatercept|luspatercept|mesh-list
20461873|NCT01432717|Hematinics|hematinics|mesh-ancestor
20461874|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
20461875|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20461876|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20461877|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20614800|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19694702|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
19694703|NCT04963257|Sertraline|sertraline|mesh-list
19694704|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
20614801|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461878|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461879|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461880|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
20461881|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461882|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461883|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20461884|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614802|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614803|NCT02262416|Leuprolide|leuprolide|mesh-list
20614804|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20614805|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
20614806|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20614807|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614808|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20614809|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614810|NCT02262455|Doxorubicin|doxorubicin|mesh-list
20614811|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20614812|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20614813|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694705|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694706|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19694707|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19694708|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694709|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694710|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
19694711|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
19849406|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849407|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614814|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20614815|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20614816|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614817|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614818|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
20614819|NCT02262481|Progestins|progestins|mesh-ancestor
20614820|NCT02262481|Hormones|hormones|mesh-ancestor
20614821|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20614822|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614823|NCT02262520|Digoxin|digoxin|mesh-list
20614824|NCT02262520|Apixaban|apixaban|mesh-list
20614825|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19849408|NCT00702507|Miconazole|miconazole|mesh-list
19849409|NCT00702507|Clotrimazole|clotrimazole|mesh-list
19849410|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
20461885|NCT01432821|Apomorphine|apomorphine|mesh-list
20461886|NCT01432821|Emetics|emetics|mesh-ancestor
20461887|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461888|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
20461889|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461890|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20461891|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
20461892|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
20461893|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461894|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461895|NCT01432873|Selenium|selenium|mesh-list
20461896|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
20461897|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461898|NCT01432873|Protective Agents|protective agents|mesh-ancestor
20461899|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461900|NCT01432873|Trace Elements|trace elements|mesh-ancestor
20461901|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
20461902|NCT01432977|Acetaminophen|acetaminophen|mesh-list
20461903|NCT01432977|Droperidol|droperidol|mesh-list
20461904|NCT01432977|Ondansetron|ondansetron|mesh-list
20461905|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20461906|NCT01432977|Analgesics|analgesics|mesh-ancestor
20461907|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
20461908|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614826|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
19694712|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849411|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461909|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614827|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19408051|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408052|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408053|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
19408054|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408055|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408056|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19408057|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
19408058|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408059|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408060|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
19408061|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408062|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
19408063|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408064|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19694713|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694714|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19694715|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20222639|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20222640|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20222641|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20222642|NCT00329823|Etanercept|etanercept|mesh-list
20461910|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
20461911|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
20461912|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
20461913|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20222643|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20222644|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222645|NCT00329823|Analgesics|analgesics|mesh-ancestor
20222646|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
20222647|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461914|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
20461915|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461916|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20461917|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
20461918|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20461919|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461920|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20461921|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20461922|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461923|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20461924|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20461925|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20461926|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20461927|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20461928|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
20461929|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20461930|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
20614828|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
20614829|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614830|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614831|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
20614832|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20614833|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20614834|NCT02262520|Protective Agents|protective agents|mesh-ancestor
20614835|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614836|NCT02262533|Atenolol|atenolol|mesh-list
20614837|NCT02262533|Apixaban|apixaban|mesh-list
20614838|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20614839|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
20614840|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20614841|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
20614842|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614843|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614844|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
20614845|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20614846|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614847|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
20614848|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
20614849|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614850|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614851|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20461931|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614852|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19416592|NCT02392026|Metronidazole|metronidazole|mesh-list
20461932|NCT01433289|Protective Agents|protective agents|mesh-ancestor
20461933|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614853|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20614854|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
20614855|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614856|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
20614857|NCT02262546|Pramipexole|pramipexole|mesh-list
20614858|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20614859|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20614860|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614861|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20614862|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20614863|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461934|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20461935|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20461936|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461937|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20461938|NCT01433328|Lidocaine|lidocaine|mesh-list
20461939|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
20461940|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
20461941|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20461942|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461943|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
20461944|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20461945|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20461946|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20461947|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20461948|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20461949|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461950|NCT01433445|Panobinostat|panobinostat|mesh-list
20461951|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461952|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20461953|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461954|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461955|NCT01433614|Paclitaxel|paclitaxel|mesh-list
20461956|NCT01433614|Capecitabine|capecitabine|mesh-list
20461957|NCT01433614|Epirubicin|epirubicin|mesh-list
20461958|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20461959|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20461960|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
20461961|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
20461962|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
20461963|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461964|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20461965|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
20461966|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20614864|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614865|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614866|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20614867|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
20614868|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20614869|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614870|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20614871|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19849412|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20614872|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20614873|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
20614874|NCT02262546|Protective Agents|protective agents|mesh-ancestor
20614875|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20614876|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20614877|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
20614878|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
20614879|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614880|NCT02262559|Telmisartan|telmisartan|mesh-list
20614881|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614882|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20461967|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20461968|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20461969|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461970|NCT01433627|Hirudins|hirudins|mesh-list
20614883|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20461971|NCT01433627|Bivalirudin|bivalirudin|mesh-list
20461972|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
20614884|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614885|NCT02262572|Telmisartan|telmisartan|mesh-list
20614886|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20614887|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614888|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614889|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614890|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614891|NCT02262572|Diuretics|diuretics|mesh-ancestor
20614892|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
20614893|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614894|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20614895|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614896|NCT02262585|Telmisartan|telmisartan|mesh-list
20614897|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614898|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614899|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614900|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614901|NCT02262598|Telmisartan|telmisartan|mesh-list
20614902|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20614903|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614904|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614905|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614906|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614907|NCT02262598|Diuretics|diuretics|mesh-ancestor
20614908|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
20614909|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614910|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20614911|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614912|NCT02262611|Telmisartan|telmisartan|mesh-list
20614913|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20614914|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614915|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614916|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614917|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614918|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20614919|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614920|NCT02262611|Diuretics|diuretics|mesh-ancestor
20614921|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
20614922|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614923|NCT02262624|Telmisartan|telmisartan|mesh-list
20614924|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20614925|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614926|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614927|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614928|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694716|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
19694717|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19694718|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19694719|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19694720|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19694721|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19694722|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19694723|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19694724|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19694725|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19849413|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20461973|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20461974|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
20461975|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461976|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461977|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
20461978|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20461979|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20461980|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
20461981|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20461982|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20461983|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461984|NCT01433705|Regadenoson|regadenoson|mesh-list
20614929|NCT02262624|Diuretics|diuretics|mesh-ancestor
20614930|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
20461985|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20461986|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20461987|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20461988|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
20461989|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
20461990|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614931|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614932|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20614933|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614934|NCT02262637|Telmisartan|telmisartan|mesh-list
20614935|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
20614936|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614937|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614938|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614939|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614940|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20614941|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20614942|NCT02262637|Diuretics|diuretics|mesh-ancestor
20614943|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
20614944|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614945|NCT02262650|Telmisartan|telmisartan|mesh-list
20461991|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461992|NCT01433757|Ampicillin|ampicillin|mesh-list
20461993|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20461994|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20461995|NCT01433770|Alefacept|alefacept|mesh-list
20461996|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
20461997|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
20461998|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20461999|NCT01433887|Ribavirin|ribavirin|mesh-list
20462000|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20462001|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
20462002|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462003|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
20462004|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462005|NCT01433900|Latanoprost|latanoprost|mesh-list
20462006|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20462007|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20462008|NCT01433952|Thiamine|thiamine|mesh-list
20462009|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
20462010|NCT01433952|Vitamins|vitamins|mesh-ancestor
20462011|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
20462012|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462013|NCT01434017|Dexamethasone|dexamethasone|mesh-list
20462014|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
20462015|NCT01434017|Droperidol|droperidol|mesh-list
20462016|NCT01434017|Ondansetron|ondansetron|mesh-list
20462017|NCT01434017|BB 1101|bb 1101|mesh-list
20614946|NCT02262650|Clopidogrel|clopidogrel|mesh-list
20614947|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20614948|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20614949|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20614950|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20614951|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
20614952|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20614953|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614954|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614955|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614956|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614957|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614958|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
20614959|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20614960|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
20614961|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20614962|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
20614963|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614964|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614965|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
20614966|NCT02262702|Acetaminophen|acetaminophen|mesh-list
20462018|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20462019|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
20462020|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
20462021|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614967|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20614968|NCT02262702|Analgesics|analgesics|mesh-ancestor
20614969|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
20614970|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614971|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614972|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
20614973|NCT02262715|Oseltamivir|oseltamivir|mesh-list
20614974|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
20614975|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20614976|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20614977|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462022|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462023|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20462024|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
20462025|NCT01434017|Hormones|hormones|mesh-ancestor
20462026|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462027|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20462028|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462029|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
20462030|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462031|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462032|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
20462033|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
20462034|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20462035|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
20462036|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462037|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20462038|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20462039|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462040|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20462041|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20462042|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20462043|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20462044|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20462045|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
20462046|NCT01434069|Leucovorin|leucovorin|mesh-list
20462047|NCT01434069|Fluorouracil|fluorouracil|mesh-list
20462048|NCT01434069|Pasireotide|pasireotide|mesh-list
20462049|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
20462050|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462051|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20462052|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462053|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462054|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
20462055|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462056|NCT01434069|Antidotes|antidotes|mesh-ancestor
20462057|NCT01434069|Protective Agents|protective agents|mesh-ancestor
20462058|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
20462059|NCT01434069|Vitamins|vitamins|mesh-ancestor
20462060|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
20462061|NCT01434069|Hormones|hormones|mesh-ancestor
20462062|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462063|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
20462064|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20462065|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
20462066|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462067|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462068|NCT01434134|Metoprolol|metoprolol|mesh-list
20462069|NCT01434134|Candesartan|candesartan|mesh-list
20462070|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20614978|NCT02262741|Durvalumab|durvalumab|mesh-list
20614979|NCT02262741|Tremelimumab|tremelimumab|mesh-list
20614980|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20614981|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20614982|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
20614983|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
20614984|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
20614985|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20614986|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20614987|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20614988|NCT02262780|Telmisartan|telmisartan|mesh-list
20614989|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614990|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614991|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614992|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614993|NCT02262793|Telmisartan|telmisartan|mesh-list
20614994|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20614995|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20614996|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20614997|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20614998|NCT02262858|Telmisartan|telmisartan|mesh-list
20614999|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20615000|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615001|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20615002|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20615003|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615004|NCT02262858|Diuretics|diuretics|mesh-ancestor
20615005|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
20615006|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615007|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20615008|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615009|NCT02262897|Paclitaxel|paclitaxel|mesh-list
20615010|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20615011|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20615012|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615013|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
20615014|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
20615015|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
20615016|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615017|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20615018|NCT02262936|Fesoterodine|fesoterodine|mesh-list
20615019|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20615020|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20615021|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
20526675|NCT01763749|Clopidogrel|clopidogrel|mesh-list
20526676|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20526677|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20526678|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20526679|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20526680|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
20526681|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526682|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526683|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526684|NCT01763788|Gemcitabine|gemcitabine|mesh-list
20526685|NCT01763788|Necitumumab|necitumumab|mesh-list
20526686|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526687|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20526688|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
20526689|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526690|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
20526691|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462071|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20462072|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
20462073|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
20462074|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462075|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462076|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20462077|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20615022|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615023|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615024|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615025|NCT02262936|Urological Agents|urological agents|mesh-ancestor
20615026|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
20615027|NCT02262936|Coagulants|coagulants|mesh-ancestor
20615028|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20615029|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
20615030|NCT02263027|Vaccines|vaccines|mesh-list
20615031|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
20222648|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462078|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20462079|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19849414|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849415|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849416|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19849417|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222649|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222650|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222651|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20222652|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20222653|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
20222654|NCT00329914|Progesterone|progesterone|mesh-list
20222655|NCT00329914|Progestins|progestins|mesh-ancestor
20222656|NCT00329914|Hormones|hormones|mesh-ancestor
20222657|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222658|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222659|NCT00329940|Letrozole|letrozole|mesh-list
20222660|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222661|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20222662|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20462080|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462081|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462082|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20462083|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20462084|NCT01434147|Bevacizumab|bevacizumab|mesh-list
20462085|NCT01434147|Capecitabine|capecitabine|mesh-list
20462086|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
20462087|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20462088|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222663|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222664|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615032|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615033|NCT02263066|Factor VIII|factor viii|mesh-list
20615034|NCT02263066|Coagulants|coagulants|mesh-ancestor
20615035|NCT02263105|Temozolomide|temozolomide|mesh-list
20615036|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20615037|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
20615038|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615039|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694726|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19694727|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19694728|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694729|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19694730|NCT04963088|Capecitabine|capecitabine|mesh-list
19694731|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
19694732|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19694733|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
19694734|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707772|NCT04824053|Protective Agents|protective agents|mesh-ancestor
20222665|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20462089|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20462090|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20462091|NCT01434147|Growth Substances|growth substances|mesh-ancestor
20615040|NCT02263170|Phenobarbital|phenobarbital|mesh-list
20615041|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
20615042|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19849418|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849419|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849420|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19849421|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19849422|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19849423|NCT00702650|Testosterone|testosterone|mesh-list
19408065|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19408066|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19408067|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
19408068|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408069|NCT03569839|Propofol|propofol|mesh-list
19408070|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19408071|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408072|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408073|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19408074|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
19408075|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
19408076|NCT03569696|Nivolumab|nivolumab|mesh-list
19408077|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408078|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408079|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19408080|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408081|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
19408082|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19408083|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
19408084|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462092|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462093|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
20462094|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408085|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
19408086|NCT03569683|Protective Agents|protective agents|mesh-ancestor
19408087|NCT03569579|Memantine|memantine|mesh-list
20462095|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
20462096|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849424|NCT00702650|Androgens|androgens|mesh-ancestor
19849425|NCT00702650|Hormones|hormones|mesh-ancestor
19849426|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849427|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849428|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
19408088|NCT03569579|Donepezil|donepezil|mesh-list
19408089|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19694735|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462097|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
20462098|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20462099|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
20462100|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20462101|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462102|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20462103|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20462104|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19694736|NCT04962672|Anesthetics|anesthetics|mesh-list
19694737|NCT04962672|Propofol|propofol|mesh-list
20462105|NCT01434173|Amoxicillin|amoxicillin|mesh-list
20462106|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
20462107|NCT01434173|Clarithromycin|clarithromycin|mesh-list
20462108|NCT01434173|Doxycycline|doxycycline|mesh-list
20462109|NCT01434173|Levofloxacin|levofloxacin|mesh-list
20462110|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
20462111|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
19694738|NCT04962672|Sevoflurane|sevoflurane|mesh-list
19694739|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694740|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694741|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19694742|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20222666|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222667|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19694743|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
20222668|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222669|NCT00330018|Valganciclovir|valganciclovir|mesh-list
20222670|NCT00330018|Acyclovir|acyclovir|mesh-list
20222671|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
20222672|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222673|NCT00330044|Carboplatin|carboplatin|mesh-list
20222674|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222675|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
20222676|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20462112|NCT01434173|Cefuroxime|cefuroxime|mesh-list
20462113|NCT01434173|Telithromycin|telithromycin|mesh-list
20462114|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20462115|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20462116|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462117|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20462118|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20462119|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222677|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
20615043|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615044|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615045|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20615046|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20615047|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615048|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615049|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
20615050|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
20615051|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20615052|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20615053|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20615054|NCT02263196|Ethanol|ethanol|mesh-list
20615055|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
20615056|NCT02263196|Povidone|povidone|mesh-list
20615057|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20615058|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615059|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615060|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615061|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
20462120|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462121|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462122|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20462123|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
20462124|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20462125|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462126|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20462127|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20462128|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20462129|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20462130|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20462131|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20222678|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222679|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
20222680|NCT00330135|Protective Agents|protective agents|mesh-ancestor
20222681|NCT00330148|Eflornithine|eflornithine|mesh-list
20222682|NCT00330148|Nifurtimox|nifurtimox|mesh-list
20222683|NCT00330148|Melarsoprol|melarsoprol|mesh-list
20222684|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222685|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20222686|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20222687|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20222688|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615062|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
20615063|NCT02263248|Buprenorphine|buprenorphine|mesh-list
20615064|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20615065|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20615066|NCT02263248|Narcotics|narcotics|mesh-ancestor
20615067|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615068|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615069|NCT02263248|Analgesics|analgesics|mesh-ancestor
20615070|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
20615071|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615072|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20615073|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19408090|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222689|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20222690|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222691|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222692|NCT00330239|Paroxetine|paroxetine|mesh-list
20222693|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20222694|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20462132|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
20462133|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20462134|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20615074|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20615075|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615076|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615077|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615078|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20615079|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
20615080|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20615081|NCT02263352|Carotenoids|carotenoids|mesh-list
20615082|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
20462135|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20462136|NCT01434173|Renal Agents|renal agents|mesh-ancestor
20462137|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20462138|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20462139|NCT01434212|Interferons|interferons|mesh-list
20462140|NCT01434212|Ribavirin|ribavirin|mesh-list
20462141|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
20462142|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
20462143|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462144|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
20462145|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462146|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
20462147|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462148|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
20462149|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526692|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526693|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20615083|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615084|NCT02263352|Protective Agents|protective agents|mesh-ancestor
20615085|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615086|NCT02263495|Gemcitabine|gemcitabine|mesh-list
20615087|NCT02263495|Paclitaxel|paclitaxel|mesh-list
20615088|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20615089|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526694|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
20526695|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526696|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20526697|NCT01764087|Paclitaxel|paclitaxel|mesh-list
20526698|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
20526699|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20526700|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526701|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
20615090|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
20615091|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
20615092|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
20615093|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615094|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20615095|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
20615096|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
20615097|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615098|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615099|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20615100|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
20615101|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615102|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20615103|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526702|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
20526703|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20526704|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526705|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526706|NCT01764126|Vaccines|vaccines|mesh-list
20526707|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
20526708|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526709|NCT01764139|Vitamin D|vitamin d|mesh-list
20526710|NCT01764139|Vitamins|vitamins|mesh-ancestor
20526711|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
20615104|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20615105|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694744|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19694745|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20615106|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694749|NCT04962958|Leucovorin|leucovorin|mesh-list
19694750|NCT04962958|Fluorouracil|fluorouracil|mesh-list
20526712|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615107|NCT02263677|Incretins|incretins|mesh-ancestor
20615108|NCT02263677|Hormones|hormones|mesh-ancestor
20615109|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20615110|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20222695|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222696|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222697|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222698|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
20222699|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222700|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20462150|NCT01434225|Bumetanide|bumetanide|mesh-list
20462151|NCT01434225|Diuretics|diuretics|mesh-ancestor
20615111|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
20615112|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615113|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615114|NCT02263690|Lidocaine|lidocaine|mesh-list
20615115|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
20615116|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
20615117|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615118|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615119|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
20615120|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462152|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
20462153|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462154|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20462155|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462156|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462157|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
20615121|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20615122|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20615123|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20615124|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615125|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615126|NCT02263872|Minocycline|minocycline|mesh-list
20615127|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20615128|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615129|NCT02263924|Tocotrienols|tocotrienols|mesh-list
20615130|NCT02263924|Vitamin E|vitamin e|mesh-list
20462158|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20462159|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20462160|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20462161|NCT01434303|Trastuzumab|trastuzumab|mesh-list
20615131|NCT02263924|Tocopherols|tocopherols|mesh-list
20615132|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
20615133|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615134|NCT02263924|Protective Agents|protective agents|mesh-ancestor
20615135|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615136|NCT02263924|Vitamins|vitamins|mesh-ancestor
20615137|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
20615138|NCT02263950|Artemether|artemether|mesh-list
19849429|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615139|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
20615140|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20615141|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20615142|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615143|NCT02263976|Bromides|bromides|mesh-list
19849430|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849431|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849432|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222701|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222702|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222703|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20222704|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20222705|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222706|NCT00330252|Rituximab|rituximab|mesh-list
20222707|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
20222708|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20222709|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222710|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
20222711|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222712|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222713|NCT00330278|Cefazolin|cefazolin|mesh-list
20615144|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
20615145|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
20615146|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20615147|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
20615148|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615149|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615150|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20615151|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
20615152|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
20615153|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20615154|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
20615155|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615156|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615157|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
20615158|NCT02263976|Miotics|miotics|mesh-ancestor
20615159|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20615160|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20615161|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20615162|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20615163|NCT02263989|Telmisartan|telmisartan|mesh-list
20615164|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615165|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20615166|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20615167|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615168|NCT02264002|Metoprolol|metoprolol|mesh-list
20615169|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20615170|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615171|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
20615172|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
20615173|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615174|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615175|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20615176|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20615177|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20615178|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615179|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615180|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615181|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
20615182|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20615183|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615184|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20615185|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19694751|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
20615186|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462162|NCT01434303|Lapatinib|lapatinib|mesh-list
20462163|NCT01434303|Entinostat|entinostat|mesh-list
20462164|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20462165|NCT01434303|Antibodies|antibodies|mesh-list
20462166|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
20462167|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20462168|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20462169|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
20462170|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462171|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462172|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20462173|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462174|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615187|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615188|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615189|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20615190|NCT02264041|Itraconazole|itraconazole|mesh-list
20615191|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
19694752|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
19694753|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694754|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20615192|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615193|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20615194|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20615195|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615196|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615197|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20615198|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
20615199|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462175|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20615200|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615201|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20615202|NCT02264093|Propranolol|propranolol|mesh-list
20615203|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20615204|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20615205|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615206|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615207|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615208|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615209|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20615210|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615211|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
20615212|NCT02264106|Pantoprazole|pantoprazole|mesh-list
20615213|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20615214|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20615215|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20615216|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615217|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222714|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20222715|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222716|NCT00330304|Isoniazid|isoniazid|mesh-list
20222717|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20222718|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
20222719|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20222720|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222721|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20222722|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222723|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
20222724|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615218|NCT02264119|Pantoprazole|pantoprazole|mesh-list
20615219|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20615220|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20615221|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20615222|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615223|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615224|NCT02264132|Pramipexole|pramipexole|mesh-list
20615225|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
20615226|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615227|NCT02264132|Protective Agents|protective agents|mesh-ancestor
20462176|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20462177|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
20462178|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462179|NCT01434381|Antacids|antacids|mesh-ancestor
20462180|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462181|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20462182|NCT01434394|Cetuximab|cetuximab|mesh-list
20462183|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20462184|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462185|NCT01434459|Gemcitabine|gemcitabine|mesh-list
20462186|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20462187|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
20462188|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462189|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462190|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
20462191|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462192|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462193|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462194|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
20462195|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462196|NCT01434849|Timolol|timolol|mesh-list
20462197|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20462198|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20462199|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615228|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222725|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20615229|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20222726|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20222727|NCT00330304|Renal Agents|renal agents|mesh-ancestor
20615230|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20615231|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
20615232|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
20615233|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462200|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615234|NCT02264145|Norflurane|norflurane|mesh-list
20462201|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462202|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462203|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20462204|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20462205|NCT01434862|Pramlintide|pramlintide|mesh-list
20462206|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20462207|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462208|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462209|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
20462210|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20462211|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
20462212|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462213|NCT01434888|Timolol|timolol|mesh-list
20462214|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20462215|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20462216|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20462217|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20462218|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
20462219|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462220|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462221|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462222|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20462223|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20462224|NCT01434901|Bethanechol|bethanechol|mesh-list
20462225|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20462226|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
20462227|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462228|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462229|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20462230|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20462231|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462232|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462233|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462234|NCT01434914|Octenidine|octenidine|mesh-list
20462235|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462236|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20462237|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20462238|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
20462239|NCT01435083|Coagulants|coagulants|mesh-ancestor
20462240|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20462241|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
20462242|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462243|NCT01435161|Telmisartan|telmisartan|mesh-list
20462244|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
20462245|NCT01435161|Nifedipine|nifedipine|mesh-list
20462246|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20462247|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20462248|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462249|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20462250|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462251|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20462252|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462253|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
20462254|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
20462255|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20462256|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20462257|NCT01435200|Hematinics|hematinics|mesh-ancestor
20462258|NCT01435213|Insulin|insulin|mesh-list
20462259|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20462260|NCT01435213|Ketamine|ketamine|mesh-list
20462261|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20462262|NCT01435213|Atipamezole|atipamezole|mesh-list
20462263|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462264|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462265|NCT01435213|Analgesics|analgesics|mesh-ancestor
20462266|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
20462267|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462268|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20462269|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20462270|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
20462271|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
20462272|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462273|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20462274|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20615235|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20615236|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
20615237|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615238|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615239|NCT02264158|Telmisartan|telmisartan|mesh-list
20615240|NCT02264158|Lacidipine|lacidipine|mesh-list
20615241|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615242|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20615243|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20615244|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615245|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20615246|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615247|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20615248|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615249|NCT02264171|Ketoconazole|ketoconazole|mesh-list
20615250|NCT02264171|Tamsulosin|tamsulosin|mesh-list
20615251|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20615252|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20615253|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20615254|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615255|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615256|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462275|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462276|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462277|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20462278|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20462279|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462280|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
20462281|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20462282|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20462283|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20462284|NCT01435252|Cetuximab|cetuximab|mesh-list
20615257|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615258|NCT02264171|Urological Agents|urological agents|mesh-ancestor
20615259|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
20615260|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615261|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20615262|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20615263|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615264|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20615265|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
20615266|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20615267|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20615268|NCT02264184|Paroxetine|paroxetine|mesh-list
20615269|NCT02264184|Tamsulosin|tamsulosin|mesh-list
20615270|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20615271|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20615272|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615273|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615274|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615275|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
20615276|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615277|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20615278|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
20615279|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20615280|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20615281|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20615282|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615283|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20615284|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20615285|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20222728|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
20222729|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20222730|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20222731|NCT00330317|Letrozole|letrozole|mesh-list
20222732|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222733|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20222734|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20222735|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222736|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222737|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20462285|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20462286|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462287|NCT01435291|Tacrolimus|tacrolimus|mesh-list
20462288|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462289|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
20462290|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462291|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20462292|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462293|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462294|NCT01435343|Cytarabine|cytarabine|mesh-list
20462295|NCT01435343|Plerixafor|plerixafor|mesh-list
20462296|NCT01435343|Fludarabine|fludarabine|mesh-list
20462297|NCT01435343|Idarubicin|idarubicin|mesh-list
20462298|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462299|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20462300|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
20462301|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462302|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462303|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
20462304|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462305|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
20462306|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462307|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20462308|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20462309|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20462310|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462311|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20462312|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20462313|NCT01435395|Bevacizumab|bevacizumab|mesh-list
20462314|NCT01435395|Bortezomib|bortezomib|mesh-list
20462315|NCT01435395|Temozolomide|temozolomide|mesh-list
20462316|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20615286|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615287|NCT02264184|Urological Agents|urological agents|mesh-ancestor
20615288|NCT02264236|Vaccines|vaccines|mesh-list
20615289|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
20615290|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615291|NCT02264301|Puerarin|puerarin|mesh-list
20615292|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
20222738|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222739|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222740|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222741|NCT00330395|Caspofungin|caspofungin|mesh-list
20222742|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
20222743|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222744|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222745|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222746|NCT00330486|Acamprosate|acamprosate|mesh-list
19694755|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462317|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462318|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20462319|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20615293|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
20615294|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20615295|NCT02264561|Caffeine|caffeine|mesh-list
20615296|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20615297|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615298|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20615299|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615300|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615301|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20615302|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20615303|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
20615304|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615305|NCT02264587|Domperidone|domperidone|mesh-list
20615306|NCT02264587|Mosapride|mosapride|mesh-list
20615307|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
20615308|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
20615309|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615310|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615311|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20615312|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20615313|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
20615314|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615315|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615316|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20615317|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
20615318|NCT02264626|Remifentanil|remifentanil|mesh-list
20615319|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20615320|NCT02264626|Narcotics|narcotics|mesh-ancestor
20615321|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615322|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615323|NCT02264626|Analgesics|analgesics|mesh-ancestor
20615324|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
20615325|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615326|NCT02264665|Everolimus|everolimus|mesh-list
20615327|NCT02264665|Sunitinib|sunitinib|mesh-list
20615328|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615329|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20615330|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
20615331|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615332|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20615333|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20615334|NCT02264665|Growth Substances|growth substances|mesh-ancestor
20615335|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
20615336|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20615337|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615338|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615339|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20615340|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20615341|NCT02264743|Estradiol|estradiol|mesh-list
20615342|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20615343|NCT02264743|Estrogens|estrogens|mesh-ancestor
20615344|NCT02264743|Hormones|hormones|mesh-ancestor
20615345|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20615346|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615347|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20615348|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
20615349|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20615350|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20462320|NCT01435395|Growth Substances|growth substances|mesh-ancestor
20462321|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462322|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
20462323|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20462324|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
20462325|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462326|NCT01435486|Caffeine|caffeine|mesh-list
20462327|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
20462328|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462329|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20462330|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462331|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20462332|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615351|NCT02264769|Carbetocin|carbetocin|mesh-list
20615352|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
19416593|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462333|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20462334|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20462335|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
20462336|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462337|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
20462338|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462339|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
20462340|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462341|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20462342|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20462343|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
20462344|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462345|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462346|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20462347|NCT01435707|Triamcinolone|triamcinolone|mesh-list
20462348|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20462349|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20462350|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20462351|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20462352|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
20462353|NCT01435707|Hormones|hormones|mesh-ancestor
20462354|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462355|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462356|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462357|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
20462358|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462359|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462360|NCT01435837|Caffeine|caffeine|mesh-list
20462361|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20615353|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20615354|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615355|NCT02264795|Lidocaine|lidocaine|mesh-list
20615356|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
20615357|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
20615358|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615359|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615360|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
20615361|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615362|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20615363|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20462362|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462363|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20462364|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462365|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462366|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20462367|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20462368|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
20462369|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462370|NCT01435902|Fluticasone|fluticasone|mesh-list
20462371|NCT01435902|Xhance|xhance|mesh-list
20615364|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20615365|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615366|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694756|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694757|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
20615367|NCT02264834|Sufentanil|sufentanil|mesh-list
20462372|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20462373|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20615368|NCT02264834|Dsuvia|dsuvia|mesh-list
20615369|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
20615370|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
20615371|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
20615372|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615373|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462374|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
20615374|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
20615375|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615376|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20615377|NCT02264834|Narcotics|narcotics|mesh-ancestor
20615378|NCT02264834|Analgesics|analgesics|mesh-ancestor
20615379|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20615380|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20462375|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462376|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615381|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
19694758|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408091|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408092|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
19408093|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408094|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408095|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
19408096|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19408097|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19408098|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
19408099|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20462377|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20462378|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
20462379|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
20462380|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20462381|NCT01435915|Ropinirole|ropinirole|mesh-list
20462382|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20462383|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20462384|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
20462385|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
20462386|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462387|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462388|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462389|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20462390|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19408100|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19408101|NCT03569540|Glyburide|glyburide|mesh-list
19408102|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19408103|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408104|NCT03569241|Androgens|androgens|mesh-list
19408105|NCT03569241|Hormones|hormones|mesh-ancestor
19408106|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408107|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615382|NCT02264847|Clomiphene|clomiphene|mesh-list
20615383|NCT02264847|Enclomiphene|enclomiphene|mesh-list
20615384|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
20615385|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20615386|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20615387|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
20615388|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20615389|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615390|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20615391|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
20615392|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20615393|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20615394|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20462391|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20462392|NCT01435941|Analgesics|analgesics|mesh-ancestor
20462393|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
20462394|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462395|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462396|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20462397|NCT01435954|Doxazosin|doxazosin|mesh-list
20462398|NCT01435954|Tamsulosin|tamsulosin|mesh-list
20462399|NCT01435954|Finasteride|finasteride|mesh-list
20462400|NCT01435954|Silodosin|silodosin|mesh-list
20462401|NCT01435954|Terazosin|terazosin|mesh-list
20462402|NCT01435954|Alfuzosin|alfuzosin|mesh-list
20615395|NCT02264873|Decitabine|decitabine|mesh-list
20615396|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20615397|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
20615398|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615399|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615400|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615401|NCT02264912|Clopidogrel|clopidogrel|mesh-list
20615402|NCT02264912|Ticagrelor|ticagrelor|mesh-list
20615403|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20615404|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20615405|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20615406|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20615407|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19408108|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
19408109|NCT03569046|Bupivacaine|bupivacaine|mesh-list
19694759|NCT04962958|Antidotes|antidotes|mesh-ancestor
20615408|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
19694760|NCT04962958|Protective Agents|protective agents|mesh-ancestor
20462403|NCT01435954|Dutasteride|dutasteride|mesh-list
20615409|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615410|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615411|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615412|NCT02264938|Antioxidants|antioxidants|mesh-list
20615413|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615414|NCT02264938|Protective Agents|protective agents|mesh-ancestor
20615415|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615416|NCT02265068|Ticagrelor|ticagrelor|mesh-list
20615417|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20615418|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20615419|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20615420|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20462404|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20462405|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20462406|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20462407|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
20462408|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462409|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462410|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462411|NCT01435954|Urological Agents|urological agents|mesh-ancestor
20462412|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20462413|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20462414|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462415|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
20615421|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
20615422|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615423|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615424|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615425|NCT02265276|Pioglitazone|pioglitazone|mesh-list
20615426|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20615427|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615428|NCT02265289|Clopidogrel|clopidogrel|mesh-list
20615429|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20462416|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462417|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20462418|NCT01435980|Exenatide|exenatide|mesh-list
20462419|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462420|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462421|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20462422|NCT01435980|Incretins|incretins|mesh-ancestor
20462423|NCT01435980|Hormones|hormones|mesh-ancestor
20462424|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526713|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20526714|NCT01764178|Valsartan|valsartan|mesh-list
20526715|NCT01764178|Pitavastatin|pitavastatin|mesh-list
20526716|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20526717|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20526718|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20526719|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526720|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20526721|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20526722|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20526723|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
20526724|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526725|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20526726|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20615430|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20615431|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20615432|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20615433|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
20615434|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615435|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615436|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615437|NCT02265328|Prednisolone|prednisolone|mesh-list
20615438|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615439|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
20615440|NCT02265328|Hormones|hormones|mesh-ancestor
20615441|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526727|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
20526728|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20615442|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615443|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20615444|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615445|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
20615446|NCT02265445|beta-Lactams|beta-lactams|mesh-list
20615447|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20615448|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615449|NCT02265562|Alprostadil|alprostadil|mesh-list
20615450|NCT02265562|Misoprostol|misoprostol|mesh-list
19408110|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
19408111|NCT03569046|Anesthetics|anesthetics|mesh-list
19408112|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
19408113|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408114|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462425|NCT01436123|Everolimus|everolimus|mesh-list
20462426|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615451|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20615452|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
20615453|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20615454|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615455|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20615456|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20615457|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
20615458|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20615459|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
20615460|NCT02265562|Urological Agents|urological agents|mesh-ancestor
20615461|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
20615462|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20615463|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
20615464|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615465|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
20615466|NCT02265575|Protective Agents|protective agents|mesh-ancestor
20615467|NCT02265718|Methylphenidate|methylphenidate|mesh-list
20615468|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20615469|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615470|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20615471|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20615472|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615473|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615474|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
20615475|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615476|NCT02265731|Rituximab|rituximab|mesh-list
20615477|NCT02265731|Venetoclax|venetoclax|mesh-list
20615478|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20615479|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615480|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
20615481|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615482|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20615483|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
20615484|NCT02265770|Cisplatin|cisplatin|mesh-list
20615485|NCT02265770|Carboplatin|carboplatin|mesh-list
20615486|NCT02265770|Methotrexate|methotrexate|mesh-list
20615487|NCT02265770|Etoposide|etoposide|mesh-list
20462427|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462428|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
20462429|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462430|NCT01436188|Ibuprofen|ibuprofen|mesh-list
20462431|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20462432|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20462433|NCT01436188|Analgesics|analgesics|mesh-ancestor
20462434|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
20462435|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462436|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462437|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20462438|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20462439|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20462440|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462441|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615488|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
20615489|NCT02265770|Vincristine|vincristine|mesh-list
20615490|NCT02265770|Valproic Acid|valproic acid|mesh-list
20615491|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20615492|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
20615493|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615494|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20615495|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20615496|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
20615497|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615498|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615499|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20615500|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20615501|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
20615502|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20615503|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20615504|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
20615505|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
20615506|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615507|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20615508|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20615509|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20615510|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20615511|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20615512|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
20615513|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
20615514|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
20615515|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
20615516|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
20615517|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615518|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
20615519|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20615520|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615521|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20615522|NCT02265809|Aldesleukin|aldesleukin|mesh-list
20615523|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615524|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20615525|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20462442|NCT01436422|Vaccines|vaccines|mesh-list
20462443|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
20462444|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462445|NCT01436474|Varenicline|varenicline|mesh-list
20462446|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20462447|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20462448|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462449|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462450|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462451|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462452|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20462453|NCT01436513|Estrogens|estrogens|mesh-ancestor
20462454|NCT01436513|Hormones|hormones|mesh-ancestor
20462455|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462456|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462457|NCT01436539|Adefovir|adefovir|mesh-list
20462458|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20462459|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
20462460|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
20462461|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462462|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20615526|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
20615527|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615528|NCT02265822|Midazolam|midazolam|mesh-list
20615529|NCT02265822|Melatonin|melatonin|mesh-list
20615530|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20615531|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20615532|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615533|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615534|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19408115|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
20222747|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20222748|NCT00330499|Cisplatin|cisplatin|mesh-list
20222749|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222750|NCT00330525|Sibutramine|sibutramine|mesh-list
20222751|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222752|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20222753|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
20222754|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20222755|NCT00330577|Timolol|timolol|mesh-list
20222756|NCT00330577|Latanoprost|latanoprost|mesh-list
20222757|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
20222758|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20222759|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20462463|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20462464|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222760|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615535|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20462465|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615536|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20615537|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20615538|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
20615539|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
20615540|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
20615541|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
20615542|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615543|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615544|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
20615545|NCT02265822|Protective Agents|protective agents|mesh-ancestor
20615546|NCT02265874|Nicotine|nicotine|mesh-list
20615547|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20615548|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
20462466|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20462467|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
20462468|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20462469|NCT01436578|Posaconazole|posaconazole|mesh-list
20462470|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
20462471|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462472|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20462473|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20462474|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20462475|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20615549|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615550|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615551|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20615552|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20615553|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
20615554|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615555|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408116|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222761|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222762|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222763|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222764|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20222765|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20222766|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20222767|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20222768|NCT00330655|Memantine|memantine|mesh-list
20222769|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20222770|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20222771|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
20222772|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222773|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222774|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222775|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20222776|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20222777|NCT00330707|Interferons|interferons|mesh-list
20222778|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
20222779|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
20222780|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222781|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
20222782|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222783|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
20222784|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462476|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20462477|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462478|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462479|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20462480|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
20462481|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462482|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462483|NCT01436825|Factor VIII|factor viii|mesh-list
20462484|NCT01436825|Coagulants|coagulants|mesh-ancestor
20462485|NCT01436838|Interferons|interferons|mesh-list
20462486|NCT01436838|Interferon-beta|interferon-beta|mesh-list
20462487|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
20462488|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462489|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
20462490|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462491|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
20462492|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462493|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20462494|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
20462495|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20615556|NCT02266030|Aspirin|aspirin|mesh-list
19849433|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19849434|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
19849435|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19849436|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19849437|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20615557|NCT02266030|Cilostazol|cilostazol|mesh-list
20615558|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20615559|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20615560|NCT02266030|Analgesics|analgesics|mesh-ancestor
20615561|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
20615562|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615563|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615564|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615565|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20615566|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20615567|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20615568|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615569|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20615570|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20615571|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615572|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
20615573|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20615574|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
20615575|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20615576|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
20615577|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
20615578|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20615579|NCT02266030|Protective Agents|protective agents|mesh-ancestor
20615580|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20615581|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20615582|NCT02266056|Rocuronium|rocuronium|mesh-list
20615583|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19849438|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849439|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849440|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
19849441|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849442|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222785|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20222786|NCT00330746|Gemcitabine|gemcitabine|mesh-list
20222787|NCT00330746|Cetuximab|cetuximab|mesh-list
20222788|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20222789|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
20222790|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222791|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222792|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
20222793|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222794|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222795|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20222796|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
20222797|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222798|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20222799|NCT00330772|Aspirin|aspirin|mesh-list
20222800|NCT00330772|Clopidogrel|clopidogrel|mesh-list
20462496|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462497|NCT01436916|Vitamins|vitamins|mesh-ancestor
20462498|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
20462499|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20462500|NCT01436929|Silymarin|silymarin|mesh-list
20462501|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
20462502|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462503|NCT01436929|Protective Agents|protective agents|mesh-ancestor
20462504|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462505|NCT01436968|Valacyclovir|valacyclovir|mesh-list
20462506|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
20462507|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462508|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
20462509|NCT01436994|Carbimazole|carbimazole|mesh-list
20462510|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
20615584|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20615585|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20615586|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615587|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615588|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20615589|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
20615590|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
20615591|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615592|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615593|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
20615594|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615595|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20615596|NCT02266173|Pertuzumab|pertuzumab|mesh-list
20615597|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20615598|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615599|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
20615600|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20615601|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615602|NCT02266303|Insulin|insulin|mesh-list
20615603|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20615604|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615605|NCT02266329|Prazosin|prazosin|mesh-list
20615606|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615607|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20615608|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20615609|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20615610|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615611|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615612|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615613|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615614|NCT02266355|Omalizumab|omalizumab|mesh-list
20615615|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20615616|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20615617|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
20615618|NCT02266485|Pravastatin|pravastatin|mesh-list
20615619|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19694761|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
19694762|NCT04962958|Vitamins|vitamins|mesh-ancestor
19694763|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
19694764|NCT04962425|Trastuzumab|trastuzumab|mesh-list
19694765|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694766|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694767|NCT04962451|Ticagrelor|ticagrelor|mesh-list
19694768|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19694769|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19694770|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19694771|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19694772|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
19694773|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694774|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694775|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222801|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20222802|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20222803|NCT00330772|Analgesics|analgesics|mesh-ancestor
20222804|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
20222805|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222806|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222807|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20462511|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462512|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
20462513|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
20462514|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462515|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462516|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20462517|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
20462518|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462519|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20462520|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20462521|NCT01437046|Doxazosin|doxazosin|mesh-list
20462522|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20462523|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20462524|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20462525|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20462526|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
20462527|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462528|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615620|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20615621|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
20615622|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615623|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20615624|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20615625|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615626|NCT02266511|Tamsulosin|tamsulosin|mesh-list
20615627|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20615628|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20615629|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19408117|NCT03568968|Niacinamide|niacinamide|mesh-list
19408118|NCT03568968|Niacin|niacin|mesh-list
19408119|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
19408120|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
19408121|NCT03568968|Vitamins|vitamins|mesh-ancestor
20615630|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615631|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615632|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615633|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615634|NCT02266511|Urological Agents|urological agents|mesh-ancestor
20615635|NCT02266524|Tamsulosin|tamsulosin|mesh-list
20615636|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20615637|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20615638|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20615639|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615640|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615641|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615642|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615643|NCT02266524|Urological Agents|urological agents|mesh-ancestor
20615644|NCT02266537|Doxazosin|doxazosin|mesh-list
20615645|NCT02266537|Tamsulosin|tamsulosin|mesh-list
20615646|NCT02266537|Alfuzosin|alfuzosin|mesh-list
20615647|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20615648|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20615649|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20615650|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615651|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615652|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615653|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615654|NCT02266537|Urological Agents|urological agents|mesh-ancestor
20615655|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615656|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
20615657|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615658|NCT02266784|Nicotine|nicotine|mesh-list
20615659|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20615660|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
20615661|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408122|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
19408123|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408124|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19408125|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
19408126|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408127|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19408128|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
19408129|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
19408130|NCT03568916|Apixaban|apixaban|mesh-list
19408131|NCT03568916|Dabigatran|dabigatran|mesh-list
19408132|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20615662|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615663|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20615664|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20615665|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
20615666|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615667|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615668|NCT02266849|Loperamide|loperamide|mesh-list
20615669|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
20615670|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20615671|NCT02265484|Rifaximin|rifaximin|mesh-list
20615672|NCT02265484|Bromocriptine|bromocriptine|mesh-list
20615673|NCT02265484|Lactulose|lactulose|mesh-list
20615674|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20615675|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615676|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20615677|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20615678|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20615679|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
20615680|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20615681|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615682|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
20615683|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
20615684|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615685|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615686|NCT02266927|Fluticasone|fluticasone|mesh-list
20615687|NCT02266927|Xhance|xhance|mesh-list
20615688|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615689|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20615690|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
20615691|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615692|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615693|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20615694|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
20615695|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
20615696|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20615697|NCT02267044|Ropivacaine|ropivacaine|mesh-list
20615698|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
20615699|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
20615700|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615701|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615702|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
20462529|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462530|NCT01437189|Sertraline|sertraline|mesh-list
20462531|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
20462532|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20462533|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20462534|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20462535|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462536|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462537|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462538|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
20462539|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462540|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
20462541|NCT01437228|Povidone|povidone|mesh-list
20615703|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615704|NCT02267057|Acetaminophen|acetaminophen|mesh-list
20615705|NCT02267057|Buprenorphine|buprenorphine|mesh-list
20615706|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20615707|NCT02267057|Analgesics|analgesics|mesh-ancestor
20615708|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
20615709|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615710|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615711|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
20615712|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20462542|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
20462543|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
20462544|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20462545|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462546|NCT01437293|Carbidopa|carbidopa|mesh-list
20462547|NCT01437293|Entacapone|entacapone|mesh-list
20462548|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20462549|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20615713|NCT02267057|Narcotics|narcotics|mesh-ancestor
20615714|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462550|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
20615715|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20462551|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615716|NCT02267122|Mupirocin|mupirocin|mesh-list
20462552|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462553|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462554|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20462555|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462556|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20462557|NCT01437306|Lofexidine|lofexidine|mesh-list
20462558|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20462559|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20615717|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20615718|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615719|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20615720|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615721|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615722|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
20615723|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20615724|NCT02267239|Listerine|listerine|mesh-list
20615725|NCT02267239|Hexetidine|hexetidine|mesh-list
20615726|NCT02267239|Menthol|menthol|mesh-list
20615727|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
20615728|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20615729|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615730|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
20615731|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
20615732|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
20615733|NCT02267239|Protective Agents|protective agents|mesh-ancestor
20615734|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615735|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
20615736|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
20615737|NCT02267304|Morphine|morphine|mesh-list
20615738|NCT02267304|Naloxone|naloxone|mesh-list
20615739|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19694776|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19694777|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19694778|NCT04962386|Hormones|hormones|mesh-list
19694779|NCT04962386|Estradiol|estradiol|mesh-list
19694780|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19694781|NCT04962386|Progesterone|progesterone|mesh-list
19694782|NCT04962386|Estrogens|estrogens|mesh-list
20222808|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20615740|NCT02267304|Narcotics|narcotics|mesh-ancestor
20615741|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615742|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615743|NCT02267304|Analgesics|analgesics|mesh-ancestor
20615744|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
20615745|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615746|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20615747|NCT02267408|Warfarin|warfarin|mesh-list
20615748|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
20615749|NCT02267616|Etonogestrel|etonogestrel|mesh-list
20615750|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20615751|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
20615752|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20615753|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615754|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20615755|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
20615756|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20615757|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
20615758|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615759|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615760|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20615761|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
20615762|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20615763|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
20615764|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615765|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615766|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20222809|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19694783|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849443|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20222810|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20222811|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222812|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20222813|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20222814|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222815|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
20222816|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20615767|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
20615768|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
20615769|NCT02267655|Protective Agents|protective agents|mesh-ancestor
20615770|NCT02267681|Fentanyl|fentanyl|mesh-list
20615771|NCT02267681|Alfentanil|alfentanil|mesh-list
20615772|NCT02267681|Propofol|propofol|mesh-list
20615773|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20615774|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615775|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615776|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20615777|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
20615778|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
20615779|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20615780|NCT02267681|Narcotics|narcotics|mesh-ancestor
20615781|NCT02267681|Analgesics|analgesics|mesh-ancestor
20615782|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
20615783|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615784|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20615785|NCT02267707|Gemcitabine|gemcitabine|mesh-list
20615786|NCT02267707|Paclitaxel|paclitaxel|mesh-list
20615787|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20615788|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615789|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
20615790|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
20615791|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
20615792|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615793|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20615794|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
20615795|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
20615796|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615797|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615798|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20615799|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
20615800|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615801|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
20615802|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615803|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
20462560|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615804|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
20615805|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
20462561|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
20462562|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462563|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20462564|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20462565|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20462566|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
20462567|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462568|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462569|NCT01437371|Ramipril|ramipril|mesh-list
20462570|NCT01437371|Enalapril|enalapril|mesh-list
20462571|NCT01437371|Lisinopril|lisinopril|mesh-list
20462572|NCT01437371|Captopril|captopril|mesh-list
20462573|NCT01437371|Trandolapril|trandolapril|mesh-list
20462574|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20462575|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20462576|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
20462577|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462578|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20462579|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20615806|NCT02267915|Rituximab|rituximab|mesh-list
20615807|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20615808|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615809|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
20615810|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615811|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20615812|NCT02267980|Ketamine|ketamine|mesh-list
20615813|NCT02267980|Sevoflurane|sevoflurane|mesh-list
20615814|NCT02267980|Analgesics|analgesics|mesh-ancestor
20615815|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
20615816|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615817|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462580|NCT01437371|Protective Agents|protective agents|mesh-ancestor
20462581|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462582|NCT01437462|Propofol|propofol|mesh-list
20462583|NCT01437462|Sevoflurane|sevoflurane|mesh-list
20462584|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20462585|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462586|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615818|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20615819|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20615820|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
20462587|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20462588|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
20462589|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
20462590|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20462591|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20462592|NCT01437566|Fulvestrant|fulvestrant|mesh-list
20462593|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20462594|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462595|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20462596|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20462597|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
20462598|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462599|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462600|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
20615821|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
20615822|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615823|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20615824|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20615825|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615826|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615827|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20615828|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20615829|NCT02268006|Capecitabine|capecitabine|mesh-list
20615830|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20615831|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
20615832|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615833|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615834|NCT02268019|Epinephrine|epinephrine|mesh-list
20615835|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20615836|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20615837|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615838|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615839|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615840|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615841|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20615842|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20615843|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
20615844|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615845|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20615846|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
20615847|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
20615848|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
20615849|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20615850|NCT02268032|Androgens|androgens|mesh-list
20615851|NCT02268032|Hormones|hormones|mesh-ancestor
20615852|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20615853|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408133|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
20615854|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
20615855|NCT02268149|Prednisone|prednisone|mesh-list
20615856|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615857|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
19408134|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20615858|NCT02268149|Hormones|hormones|mesh-ancestor
20615859|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20615860|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615861|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20615862|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615863|NCT02268201|Tacrolimus|tacrolimus|mesh-list
20615864|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20615865|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
20615866|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615867|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20615868|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615869|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615870|NCT02268279|Solithromycin|solithromycin|mesh-list
20462601|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20462602|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462603|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462604|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462605|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462606|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462607|NCT01437592|Insulin|insulin|mesh-list
20462608|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462609|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462610|NCT01437618|Bevacizumab|bevacizumab|mesh-list
20462611|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20462612|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462613|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19694784|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694785|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19694786|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
19408135|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
19408136|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408137|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408138|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
19694787|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19849444|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849445|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19849446|NCT00702780|Citalopram|citalopram|mesh-list
19849447|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19849448|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19849449|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849450|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222817|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19849451|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849452|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
19849453|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849454|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19849455|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
20222818|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20222819|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
20222820|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20222821|NCT00330785|Amlodipine|amlodipine|mesh-list
20222822|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
20222823|NCT00330785|Atorvastatin|atorvastatin|mesh-list
20462614|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19408139|NCT03568890|Aspirin|aspirin|mesh-list
19408140|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
19694788|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19694789|NCT04962386|Progestins|progestins|mesh-ancestor
19694790|NCT04962308|Vaccines|vaccines|mesh-list
19694791|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
20222824|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20222825|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222826|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
20222827|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222828|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20222829|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20222830|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222831|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20222832|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20462615|NCT01437618|Growth Substances|growth substances|mesh-ancestor
20462616|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462617|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
20615871|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20615872|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20615873|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
20615874|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615875|NCT02268357|Propranolol|propranolol|mesh-list
20615876|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20615877|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20615878|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
20615879|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615880|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615881|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615882|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20615883|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20615884|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
20615885|NCT02268370|Dasatinib|dasatinib|mesh-list
20615886|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615887|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20615888|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615889|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615890|NCT02268383|Luspatercept|luspatercept|mesh-list
20615891|NCT02268383|Hematinics|hematinics|mesh-ancestor
20615892|NCT02268409|Luspatercept|luspatercept|mesh-list
20462618|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
20462619|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20462620|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462621|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462622|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462623|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462624|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462625|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
20462626|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20462627|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20462628|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462629|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462630|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462631|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462632|NCT01437670|Urological Agents|urological agents|mesh-ancestor
20462633|NCT01437696|Vitamin D|vitamin d|mesh-list
20462634|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
20462635|NCT01437696|Vitamins|vitamins|mesh-list
20462636|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
20462637|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462638|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20462639|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20462640|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20462641|NCT01437709|Ofatumumab|ofatumumab|mesh-list
20462642|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20462643|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20462644|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
20462645|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462646|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462647|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
20462648|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462649|NCT01437748|Bromides|bromides|mesh-list
20462650|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
20462651|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20615893|NCT02268409|Hematinics|hematinics|mesh-ancestor
20615894|NCT02268422|Buprenorphine|buprenorphine|mesh-list
20615895|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20615896|NCT02268422|Narcotics|narcotics|mesh-ancestor
20615897|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615898|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615899|NCT02268422|Analgesics|analgesics|mesh-ancestor
20615900|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
20615901|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615902|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20615903|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
20615904|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615905|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20615906|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615907|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615908|NCT02268487|Sertraline|sertraline|mesh-list
20615909|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
19408141|NCT03568890|Apixaban|apixaban|mesh-list
20615910|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20615911|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20615912|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20615913|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615914|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615915|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20615916|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
20615917|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615918|NCT02268565|Aspirin|aspirin|mesh-list
20615919|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20615920|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20615921|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20615922|NCT02268565|Analgesics|analgesics|mesh-ancestor
20615923|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
20615924|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615925|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615926|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20615927|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20615928|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20462652|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
20615929|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615930|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20615931|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20615932|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615933|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
20615934|NCT02268656|Propofol|propofol|mesh-list
20615935|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20615936|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20615937|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615938|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20615939|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
20615940|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
20615941|NCT02268695|Docetaxel|docetaxel|mesh-list
20615942|NCT02268695|Cetuximab|cetuximab|mesh-list
20615943|NCT02268695|Sargramostim|sargramostim|mesh-list
20615944|NCT02268695|Lenograstim|lenograstim|mesh-list
20615945|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615946|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
20615947|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
20615948|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
20615949|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615950|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20615951|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
20615952|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615953|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20615954|NCT02268773|Aspirin|aspirin|mesh-list
20615955|NCT02268773|Dipyridamole|dipyridamole|mesh-list
20615956|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20615957|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20615958|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20615959|NCT02268773|Analgesics|analgesics|mesh-ancestor
20615960|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
20615961|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694792|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694793|NCT04962438|Bevacizumab|bevacizumab|mesh-list
19694794|NCT04962438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694795|NCT04962438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694796|NCT04962438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20615962|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615963|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20615964|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20462653|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462654|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462655|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20462656|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
20462657|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
20462658|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20462659|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
19408142|NCT03568890|Edoxaban|edoxaban|mesh-list
19408143|NCT03568890|Dabigatran|dabigatran|mesh-list
19408144|NCT03568890|Clopidogrel|clopidogrel|mesh-list
19408145|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19408146|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20615965|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20615966|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19408147|NCT03568890|Analgesics|analgesics|mesh-ancestor
19408148|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
19408149|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408150|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408151|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408152|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408153|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19408154|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20462660|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462661|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462662|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
20462663|NCT01437800|Metformin|metformin|mesh-list
20462664|NCT01437800|Glimepiride|glimepiride|mesh-list
20462665|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462666|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462667|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20462668|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462669|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
20462670|NCT01437813|Metformin|metformin|mesh-list
20462671|NCT01437813|Glimepiride|glimepiride|mesh-list
20462672|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462673|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462674|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20462675|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462676|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
20462677|NCT01437826|Selenium|selenium|mesh-list
20462678|NCT01437826|Antioxidants|antioxidants|mesh-list
20462679|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462680|NCT01437826|Protective Agents|protective agents|mesh-ancestor
20462681|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462682|NCT01437826|Trace Elements|trace elements|mesh-ancestor
20462683|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
20462684|NCT01437839|Apixaban|apixaban|mesh-list
20462685|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20462686|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
20462687|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20462688|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
20462689|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462690|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462691|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
20526729|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
20526730|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20526731|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526732|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20526733|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20526734|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526735|NCT01764295|Olmesartan|olmesartan|mesh-list
20526736|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20526737|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20526738|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20526739|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
20526740|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526741|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20526742|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20526743|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526744|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20526745|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20526746|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20526747|NCT01764451|Simvastatin|simvastatin|mesh-list
20526748|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20526749|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20526750|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
20526751|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526752|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20526753|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20526754|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526755|NCT01764555|Acetaminophen|acetaminophen|mesh-list
20526756|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526757|NCT01764555|Analgesics|analgesics|mesh-ancestor
20526758|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
20526759|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526760|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526761|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
20526762|NCT01764581|Tacrolimus|tacrolimus|mesh-list
20526763|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20222833|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20222834|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20222835|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222836|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247272|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247273|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247274|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
20247275|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247276|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247277|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
20247278|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20247279|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20247280|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20247281|NCT00431561|Temozolomide|temozolomide|mesh-list
20247282|NCT00431561|Lomustine|lomustine|mesh-list
20247283|NCT00431561|Trabedersen|trabedersen|mesh-list
20247284|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20247285|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
20247286|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247287|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408155|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408156|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20247288|NCT00431613|Gemcitabine|gemcitabine|mesh-list
20462692|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20462693|NCT01437982|Prednisolone|prednisolone|mesh-list
20462694|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20462695|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
20462696|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20615967|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615968|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20615969|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20615970|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615971|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
20615972|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20615973|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
20615974|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
20615975|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20615976|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615977|NCT02268890|Bortezomib|bortezomib|mesh-list
20462697|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
20462698|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20462699|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
20462700|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20462701|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
20462702|NCT01437982|Hormones|hormones|mesh-ancestor
20462703|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462704|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462705|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20462706|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462707|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
20462708|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
20462709|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462710|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20462711|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20462712|NCT01437982|Protective Agents|protective agents|mesh-ancestor
20462713|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20462714|NCT01438021|Methotrexate|methotrexate|mesh-list
20462715|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20615978|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20615979|NCT02268903|Furosemide|furosemide|mesh-list
20615980|NCT02268903|Diuretics|diuretics|mesh-list
20615981|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
20615982|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20615983|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20615984|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615985|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615986|NCT02268968|Lidocaine|lidocaine|mesh-list
20615987|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
20615988|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
20615989|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20247289|NCT00431613|Carboplatin|carboplatin|mesh-list
20462716|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
20247290|NCT00431613|Docetaxel|docetaxel|mesh-list
20462717|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20615990|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462718|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462719|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20462720|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
20462721|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462722|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462723|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
20462724|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20615991|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
20615992|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20615993|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20462725|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20462726|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462727|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
20462728|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20462729|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20615994|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20615995|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20615996|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20615997|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20615998|NCT02269046|Simvastatin|simvastatin|mesh-list
20615999|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20616000|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20616001|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
20616002|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616003|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20616004|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20616005|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616006|NCT02269072|Anastrozole|anastrozole|mesh-list
20616007|NCT02269072|Leuprolide|leuprolide|mesh-list
20616008|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20616009|NCT02269072|Testosterone|testosterone|mesh-list
20616010|NCT02269072|Androgens|androgens|mesh-ancestor
20616011|NCT02269072|Hormones|hormones|mesh-ancestor
20616012|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616013|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616014|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20616015|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616016|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20616017|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20616018|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616019|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616020|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20616021|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
20616022|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20616023|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
20616024|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20616025|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
20616026|NCT02269176|Losartan|losartan|mesh-list
20616027|NCT02269176|Telmisartan|telmisartan|mesh-list
20616028|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20616029|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20616030|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20462730|NCT01438073|Hormones|hormones|mesh-list
20462731|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462732|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462733|NCT01438086|Mecasermin|mecasermin|mesh-list
20462734|NCT01438086|Growth Substances|growth substances|mesh-ancestor
20462735|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462736|NCT01438112|Gemcitabine|gemcitabine|mesh-list
20462737|NCT01438112|Interferons|interferons|mesh-list
20462738|NCT01438112|Mitomycins|mitomycins|mesh-list
20462739|NCT01438112|Mitomycin|mitomycin|mesh-list
20616031|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20616032|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616033|NCT02269202|Midazolam|midazolam|mesh-list
20616034|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20616035|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20616036|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462740|NCT01438112|Valrubicin|valrubicin|mesh-list
20462741|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20462742|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
20462743|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462744|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462745|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
20616037|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616038|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20616039|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20616040|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616041|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20462746|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462747|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462748|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462749|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
20462750|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462751|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20462752|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
20462753|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20462754|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20462755|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20462756|NCT01438190|Metformin|metformin|mesh-list
20616042|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
20616043|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
20616044|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
20616045|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
20616046|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616047|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616048|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616049|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616050|NCT02269280|Azacitidine|azacitidine|mesh-list
20616051|NCT02269280|Decitabine|decitabine|mesh-list
20616052|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20616053|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
20616054|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616055|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616056|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616057|NCT02269293|Paclitaxel|paclitaxel|mesh-list
20616058|NCT02269293|Carboplatin|carboplatin|mesh-list
20616059|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20616060|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616061|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
20616062|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
20616063|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
20616064|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616065|NCT02269319|Linezolid|linezolid|mesh-list
20616066|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20616067|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616068|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20616069|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616070|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616071|NCT02269358|Methotrexate|methotrexate|mesh-list
20616072|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20616073|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
20616074|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20616075|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462757|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462758|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462759|NCT01438320|Quercetin|quercetin|mesh-list
20462760|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
20462761|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462762|NCT01438320|Protective Agents|protective agents|mesh-ancestor
20462763|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462764|NCT01438359|Furosemide|furosemide|mesh-list
20462765|NCT01438359|Diuretics|diuretics|mesh-ancestor
20462766|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
20462767|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462768|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20462769|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462770|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462771|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20462772|NCT01438372|Hematinics|hematinics|mesh-ancestor
20462773|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
20462774|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20462775|NCT01438515|Doxycycline|doxycycline|mesh-list
20462776|NCT01438515|Rifampin|rifampin|mesh-list
20462777|NCT01438515|Mupirocin|mupirocin|mesh-list
19849456|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19849457|NCT00702884|Sunitinib|sunitinib|mesh-list
20616076|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20616077|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
20616078|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616079|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616080|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
20616081|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616082|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20616083|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616084|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
20616085|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616086|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20616087|NCT02269449|Hemostatics|hemostatics|mesh-list
20616088|NCT02269449|Coagulants|coagulants|mesh-ancestor
20616089|NCT02269462|Efavirenz|efavirenz|mesh-list
20616090|NCT02269462|Nevirapine|nevirapine|mesh-list
20616091|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20616092|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20616093|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616094|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616095|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
20616096|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616097|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20616098|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20616099|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20616100|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20616101|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20616102|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20616103|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20616104|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20616105|NCT02269514|Nicotine|nicotine|mesh-list
20616106|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20616107|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
20616108|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616109|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616110|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20616111|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20616112|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
20616113|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616114|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694797|NCT04962438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19694798|NCT04962438|Growth Substances|growth substances|mesh-ancestor
19694799|NCT04962438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694800|NCT04962438|Growth Inhibitors|growth inhibitors|mesh-ancestor
19694801|NCT04962152|Nalbuphine|nalbuphine|mesh-list
19694802|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19694803|NCT04962152|Narcotics|narcotics|mesh-ancestor
19694804|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694805|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694806|NCT04962152|Analgesics|analgesics|mesh-ancestor
19694807|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
19694808|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694809|NCT04961970|Leucovorin|leucovorin|mesh-list
19694810|NCT04961970|Gemcitabine|gemcitabine|mesh-list
19694811|NCT04961970|Fluorouracil|fluorouracil|mesh-list
19694812|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
19694813|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694814|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19694815|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
19694816|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694817|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
19694818|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694819|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694820|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694821|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
19694822|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694823|NCT04961970|Antidotes|antidotes|mesh-ancestor
19694824|NCT04961970|Protective Agents|protective agents|mesh-ancestor
19694825|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
19849458|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849459|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19849460|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19849461|NCT00702884|Growth Substances|growth substances|mesh-ancestor
19849462|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849463|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
19849464|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849465|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849466|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849467|NCT00702923|Tremelimumab|tremelimumab|mesh-list
19849468|NCT00702923|Bicalutamide|bicalutamide|mesh-list
19849469|NCT00702923|Ipilimumab|ipilimumab|mesh-list
19849470|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19849471|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849472|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
19849473|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462778|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20462779|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20462780|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
19849474|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
19849475|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
19849476|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849477|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849478|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19849479|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616115|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
20616116|NCT02269540|Sertraline|sertraline|mesh-list
20616117|NCT02269540|Citalopram|citalopram|mesh-list
20616118|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20616119|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
20616120|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616121|NCT02269540|Expectorants|expectorants|mesh-ancestor
19694826|NCT04961970|Vitamins|vitamins|mesh-ancestor
19694827|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
19694828|NCT04961684|Amorolfine|amorolfine|mesh-list
19694829|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
19694830|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694831|NCT04961918|Durvalumab|durvalumab|mesh-list
19694832|NCT04961918|Lenvatinib|lenvatinib|mesh-list
19694833|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694834|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694835|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694836|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694837|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694838|NCT04961931|Empagliflozin|empagliflozin|mesh-list
19694839|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19694840|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694841|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694842|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694843|NCT04961788|Antibodies|antibodies|mesh-list
19849480|NCT00702949|Pregabalin|pregabalin|mesh-list
19849481|NCT00702949|Analgesics|analgesics|mesh-ancestor
19849482|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
19849483|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849484|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849485|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
19849486|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19849487|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462781|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
20462782|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20462783|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
20462784|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20462785|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20462786|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20462787|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
20462788|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
20462789|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20462790|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462791|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462792|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20616122|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
19694844|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
20616123|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20616124|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
19694845|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694846|NCT04961632|Tamoxifen|tamoxifen|mesh-list
19849488|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849489|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19849490|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20616125|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616126|NCT02269540|Protective Agents|protective agents|mesh-ancestor
20616127|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616128|NCT02269540|Antidotes|antidotes|mesh-ancestor
20616129|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
19849491|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19849492|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849493|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19849494|NCT00703118|Ribavirin|ribavirin|mesh-list
19849495|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
20616130|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616131|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20616132|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20616133|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20616134|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616135|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
20616136|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20616137|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
19849496|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20616138|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20616139|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
20616140|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616141|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616142|NCT02269644|Azithromycin|azithromycin|mesh-list
20616143|NCT02269644|Linezolid|linezolid|mesh-list
20616144|NCT02269644|Dalbavancin|dalbavancin|mesh-list
19849497|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
19849498|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849499|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
19849500|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849501|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849502|NCT00703261|Atorvastatin|atorvastatin|mesh-list
19849503|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19849504|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19849505|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
19849506|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849507|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20462793|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20462794|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20462795|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20462796|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20462797|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20462798|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20462799|NCT01438554|Trametinib|trametinib|mesh-list
19408157|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19408158|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462800|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462801|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20462802|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462803|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462804|NCT01438567|Oxycodone|oxycodone|mesh-list
20462805|NCT01438567|Naloxone|naloxone|mesh-list
20462806|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20462807|NCT01438567|Narcotics|narcotics|mesh-ancestor
20462808|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462809|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462810|NCT01438567|Analgesics|analgesics|mesh-ancestor
20462811|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
20462812|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462813|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20462814|NCT01438580|Aspirin|aspirin|mesh-list
20462815|NCT01438580|Warfarin|warfarin|mesh-list
20462816|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20462817|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20616145|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20616146|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616147|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20616148|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616149|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616150|NCT02269696|Metoprolol|metoprolol|mesh-list
20462818|NCT01438580|Analgesics|analgesics|mesh-ancestor
19408159|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
20462819|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
20462820|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462821|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462822|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20462823|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20462824|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20462825|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20462826|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462827|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20462828|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20462829|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462830|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
20462831|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
20462832|NCT01438632|Insulin|insulin|mesh-list
20462833|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462834|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462835|NCT01438723|Metformin|metformin|mesh-list
20462836|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462837|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462838|NCT01438736|Etonogestrel|etonogestrel|mesh-list
20462839|NCT01438736|Desogestrel|desogestrel|mesh-list
20462840|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20462841|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
20462842|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20462843|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462844|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20462845|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20462846|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20462847|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20462848|NCT01438736|Progestins|progestins|mesh-ancestor
20462849|NCT01438736|Hormones|hormones|mesh-ancestor
20462850|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462851|NCT01438749|Diazepam|diazepam|mesh-list
20462852|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20462853|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
20462854|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
20462855|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
20462856|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462857|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462858|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20462859|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20462860|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462861|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20462862|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20462863|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20462864|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20462865|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20462866|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20462867|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
20462868|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
20462869|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
20462870|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
20462871|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462872|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462873|NCT01438866|Fluorides|fluorides|mesh-list
20462874|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
20462875|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
20462876|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
20462877|NCT01438866|Protective Agents|protective agents|mesh-ancestor
20462878|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462879|NCT01438944|Nicotine|nicotine|mesh-list
20462880|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20462881|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
20462882|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462883|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462884|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20462885|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20462886|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462887|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462888|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462889|NCT01439100|Oxycodone|oxycodone|mesh-list
20462890|NCT01439100|Naloxone|naloxone|mesh-list
20462891|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20616151|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20462892|NCT01439100|Narcotics|narcotics|mesh-ancestor
20462893|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462894|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462895|NCT01439100|Analgesics|analgesics|mesh-ancestor
20462896|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
20462897|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616152|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20616153|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
20616154|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
20616155|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462898|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20462899|NCT01439152|Maytansine|maytansine|mesh-list
20462900|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
20462901|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20462902|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462903|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
20462904|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
20462905|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
20462906|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616156|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616157|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20616158|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20616159|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20616160|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
20616161|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616162|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616163|NCT02269735|Insulin|insulin|mesh-list
20616164|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20616165|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
20616166|NCT02269735|MK-2640|mk-2640|mesh-list
20462907|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
20462908|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462909|NCT01439178|Bevacizumab|bevacizumab|mesh-list
20616167|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20616168|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616169|NCT02269748|Analgesics|analgesics|mesh-list
20616170|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
20616171|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462910|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20462911|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462912|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20462913|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20462914|NCT01439178|Growth Substances|growth substances|mesh-ancestor
20462915|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462916|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
20616172|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616173|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
20616174|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20616175|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616176|NCT02269904|Fluorouracil|fluorouracil|mesh-list
20462917|NCT01439191|Vinorelbine|vinorelbine|mesh-list
20462918|NCT01439191|Antibodies|antibodies|mesh-list
20616177|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
20616178|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616179|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408160|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19408161|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19408162|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19694847|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19694848|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
19694849|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462919|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
20462920|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616180|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616181|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462921|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20462922|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462923|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
20462924|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
20462925|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
20616182|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
20616183|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694850|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694851|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20462926|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462927|NCT01439230|Donepezil|donepezil|mesh-list
20616184|NCT02269969|Tobramycin|tobramycin|mesh-list
20616185|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20616186|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616187|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
20616188|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20616189|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616190|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616191|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20616192|NCT02270281|Analgesics|analgesics|mesh-ancestor
20616193|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
20616194|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616195|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20616196|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20616197|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20616198|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
20616199|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462928|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20462929|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462930|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462931|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462932|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462933|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462934|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
20462935|NCT01439243|Donepezil|donepezil|mesh-list
20462936|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20462937|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20462938|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462939|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
20462940|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462941|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462942|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
20462943|NCT01439399|Lidocaine|lidocaine|mesh-list
20462944|NCT01439399|Ketamine|ketamine|mesh-list
20462945|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
20462946|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
20462947|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20462948|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462949|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
20462950|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20462951|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20462952|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20462953|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20462954|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462955|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462956|NCT01439399|Analgesics|analgesics|mesh-ancestor
20616200|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616201|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
20616202|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616203|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
20616204|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849508|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19849509|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849510|NCT00703508|Metformin|metformin|mesh-list
20462957|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20616205|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616206|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20616207|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
20616208|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616209|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616210|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20616211|NCT02270424|Fluticasone|fluticasone|mesh-list
20616212|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20616213|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20616214|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694852|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694853|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19694854|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19694855|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19694856|NCT04961359|Vaccines|vaccines|mesh-list
19694857|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
19694858|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707773|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616215|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20222837|NCT00330798|Ketorolac|ketorolac|mesh-list
20222838|NCT00330798|Nepafenac|nepafenac|mesh-list
20222839|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20222840|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20462958|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20462959|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
20462960|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20462961|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20462962|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462963|NCT01439438|Topiramate|topiramate|mesh-list
20462964|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
20462965|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20462966|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462967|NCT01439542|Hormones|hormones|mesh-list
20462968|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20462969|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20462970|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526764|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
20526765|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526766|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20526767|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526768|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526769|NCT01764672|Methylphenidate|methylphenidate|mesh-list
20526770|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20222841|NCT00330798|Analgesics|analgesics|mesh-ancestor
20222842|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
20222843|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222844|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222845|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222846|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222847|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20222848|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222849|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222850|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20526771|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526772|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20526773|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20526774|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20526775|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526776|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
20526777|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526778|NCT01764750|Vancomycin|vancomycin|mesh-list
20526779|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526780|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526781|NCT01764828|Gemcitabine|gemcitabine|mesh-list
20526782|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20526783|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
20526784|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526785|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526786|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
20526787|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222851|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
20222852|NCT00330824|Dexamethasone|dexamethasone|mesh-list
20222853|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
20526788|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526789|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20526790|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
20526791|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526792|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20526793|NCT01764867|Dexetimide|dexetimide|mesh-list
20526794|NCT01764867|Mirtazapine|mirtazapine|mesh-list
20526795|NCT01764867|Trazodone|trazodone|mesh-list
20526796|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
20526797|NCT01764867|Citalopram|citalopram|mesh-list
20526798|NCT01764867|Bupropion|bupropion|mesh-list
20526799|NCT01764867|Fluoxetine|fluoxetine|mesh-list
20526800|NCT01764867|Paroxetine|paroxetine|mesh-list
20526801|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20526802|NCT01764867|Sertraline|sertraline|mesh-list
20526803|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20526804|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20526805|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20526806|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526807|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616216|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
20616217|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616218|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616219|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20616220|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
20616221|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
20616222|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20462971|NCT01439750|Rituximab|rituximab|mesh-list
20462972|NCT01439750|Bortezomib|bortezomib|mesh-list
20462973|NCT01439750|Cladribine|cladribine|mesh-list
20462974|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20462975|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20462976|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
20462977|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462978|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20462979|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20462980|NCT01439802|Copper|copper|mesh-list
20462981|NCT01439802|Trace Elements|trace elements|mesh-ancestor
20462982|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
20462983|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462984|NCT01439984|Clomipramine|clomipramine|mesh-list
20462985|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20462986|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
20462987|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20462988|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20462989|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20462990|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20462991|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20462992|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20462993|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
20462994|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20462995|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20462996|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
20616223|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20616224|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20616225|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20616226|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
20616227|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616228|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616229|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
20616230|NCT02270424|Hormones|hormones|mesh-ancestor
20616231|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616232|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
20462997|NCT01439997|Coagulants|coagulants|mesh-ancestor
20462998|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20462999|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
20463000|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463001|NCT01440062|Vitamin D|vitamin d|mesh-list
20463002|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
20463003|NCT01440062|Vitamins|vitamins|mesh-list
20463004|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
20463005|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616233|NCT02270437|Epinephrine|epinephrine|mesh-list
20616234|NCT02270437|Racepinephrine|racepinephrine|mesh-list
20616235|NCT02270437|Fentanyl|fentanyl|mesh-list
20616236|NCT02270437|Ropivacaine|ropivacaine|mesh-list
20616237|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
20616238|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
20616239|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
20616240|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616241|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616242|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
20616243|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616244|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20616245|NCT02270437|Narcotics|narcotics|mesh-ancestor
20616246|NCT02270437|Analgesics|analgesics|mesh-ancestor
20616247|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20616248|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20616249|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
20616250|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20616251|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20616252|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
20616253|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616254|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616255|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20616256|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20463006|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616257|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
20616258|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20616259|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
20616260|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
20616261|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
20616262|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20616263|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
20616264|NCT02270606|Leucovorin|leucovorin|mesh-list
20616265|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
20616266|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
20616267|NCT02270606|Fluorouracil|fluorouracil|mesh-list
20616268|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
19849511|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19849512|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463007|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20463008|NCT01440088|Doxorubicin|doxorubicin|mesh-list
20463009|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20463010|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20463011|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463012|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20463013|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20463014|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463015|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463016|NCT01440114|Fentanyl|fentanyl|mesh-list
20463017|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20463018|NCT01440114|Narcotics|narcotics|mesh-ancestor
20463019|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463020|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463021|NCT01440114|Analgesics|analgesics|mesh-ancestor
20463022|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
20463023|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463024|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20463025|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20463026|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
20463027|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
20463028|NCT01440127|Metformin|metformin|mesh-list
20463029|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463030|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463031|NCT01440140|Insulin|insulin|mesh-list
20463032|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463033|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463034|NCT01440270|Cetuximab|cetuximab|mesh-list
20463035|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463036|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463037|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20463038|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20463039|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20463040|NCT01440335|Fenoterol|fenoterol|mesh-list
20463041|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20463042|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
20463043|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463044|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463045|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20463046|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
20463047|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
19849513|NCT00703664|Bortezomib|bortezomib|mesh-list
19849514|NCT00703664|Vorinostat|vorinostat|mesh-list
19849515|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849516|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19849517|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849518|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463048|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
20463049|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20463050|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20463051|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20463052|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20463053|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
20463054|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463055|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463056|NCT01440361|Belimumab|belimumab|mesh-list
20463057|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463058|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
20463059|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616269|NCT02270606|Calcium|calcium|mesh-list
20616270|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
20616271|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20463060|NCT01440400|Anesthetics|anesthetics|mesh-list
19849519|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
19849520|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
19849521|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19849522|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463061|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463062|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463063|NCT01440439|Insulin|insulin|mesh-list
20463064|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20463065|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
20463066|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
20463067|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463068|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463069|NCT01440582|Dexamethasone|dexamethasone|mesh-list
20463070|NCT01440582|Lenalidomide|lenalidomide|mesh-list
20463071|NCT01440582|Bortezomib|bortezomib|mesh-list
20463072|NCT01440582|Panobinostat|panobinostat|mesh-list
20463073|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20463074|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
20463075|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
20463076|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463077|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463078|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20463079|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
20463080|NCT01440582|Hormones|hormones|mesh-ancestor
20463081|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20463082|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20463083|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463084|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
20463085|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20463086|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20463087|NCT01440582|Growth Substances|growth substances|mesh-ancestor
20463088|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
20463089|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20463090|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463091|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463092|NCT01440608|Albendazole|albendazole|mesh-list
20463093|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
20463094|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20463095|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463096|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
20463097|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20463098|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20463099|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
20463100|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
20463101|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
20463102|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463103|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463104|NCT01440621|Pyridoxine|pyridoxine|mesh-list
20463105|NCT01440621|Modafinil|modafinil|mesh-list
20463106|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20463107|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463108|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20463109|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20463110|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20463111|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463112|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
20463113|NCT01440621|Vitamins|vitamins|mesh-ancestor
20463114|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
20463115|NCT01440673|Aprepitant|aprepitant|mesh-list
20463116|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
20463117|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
20463118|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463119|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463120|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20463121|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20463122|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463123|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463124|NCT01440725|Mitogens|mitogens|mesh-list
20463125|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
20463126|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463127|NCT01440751|Mitomycins|mitomycins|mesh-list
20463128|NCT01440751|Mitomycin|mitomycin|mesh-list
20463129|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20463130|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463131|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
20463132|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463133|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20463134|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463135|NCT01440790|Vitamins|vitamins|mesh-list
20463136|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
20463137|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
20463138|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463139|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
20463140|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463141|NCT01440790|Protective Agents|protective agents|mesh-ancestor
20463142|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
20463143|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20463144|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20616272|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616273|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616274|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
20616275|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616276|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20616277|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616278|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616279|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
20616280|NCT02270606|Antidotes|antidotes|mesh-ancestor
20616281|NCT02270606|Protective Agents|protective agents|mesh-ancestor
20616282|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
20616283|NCT02270606|Vitamins|vitamins|mesh-ancestor
20616284|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
20616285|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
20616286|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
20616287|NCT02270749|Vitamins|vitamins|mesh-ancestor
20616288|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
20616289|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616290|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
20616291|NCT02270749|Hematinics|hematinics|mesh-ancestor
20616292|NCT02270788|Leucovorin|leucovorin|mesh-list
20616293|NCT02270788|Cytarabine|cytarabine|mesh-list
20616294|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
20616295|NCT02270788|Methotrexate|methotrexate|mesh-list
20616296|NCT02270788|Sorafenib|sorafenib|mesh-list
20616297|NCT02270788|Crenolanib|crenolanib|mesh-list
20616298|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20616299|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
20616300|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20616301|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616302|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20616303|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
20616304|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616305|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616306|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
20616307|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616308|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20616309|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616310|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
20616311|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616312|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20616313|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
20616314|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463145|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463146|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463147|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463148|NCT01440842|Insulin|insulin|mesh-list
20463149|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20463150|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463151|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463152|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
20463153|NCT01440933|Analgesics|analgesics|mesh-ancestor
20463154|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
20463155|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616315|NCT02270788|Antidotes|antidotes|mesh-ancestor
20616316|NCT02270788|Protective Agents|protective agents|mesh-ancestor
20463156|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616317|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
20616318|NCT02270788|Vitamins|vitamins|mesh-ancestor
20616319|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
20616320|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20616321|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20616322|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
20463157|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
20463158|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463159|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20616323|NCT02270827|Aminophylline|aminophylline|mesh-list
20616324|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20616325|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20616326|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
20616327|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616328|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616329|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20616330|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
20616331|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20616332|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20616333|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616334|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616335|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20616336|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20616337|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
20616338|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616339|NCT02270827|Protective Agents|protective agents|mesh-ancestor
20616340|NCT02270918|Apixaban|apixaban|mesh-list
20616341|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20616342|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
20616343|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20463160|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
20463161|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20463162|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20463163|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463164|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20463165|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
20463166|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20463167|NCT01440985|Nicotine|nicotine|mesh-list
20616344|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
20616345|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616346|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616347|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
20616348|NCT02270970|Belimumab|belimumab|mesh-list
20616349|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616350|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
20616351|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616352|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
20616353|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20616354|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
20616355|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20616356|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
20616357|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616358|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
20463168|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20463169|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
20463170|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463171|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463172|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20616359|NCT02271035|Protective Agents|protective agents|mesh-ancestor
20616360|NCT02271113|Enoxaparin|enoxaparin|mesh-list
20616361|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
20616362|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
20616363|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20616364|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20616365|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616366|NCT02271126|Heparin|heparin|mesh-list
20616367|NCT02271126|Thromboplastin|thromboplastin|mesh-list
20616368|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
20616369|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20616370|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20616371|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616372|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
20616373|NCT02271126|Coagulants|coagulants|mesh-ancestor
20463173|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20463174|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
20463175|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463176|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616374|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
20616375|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20616376|NCT02271165|Antibodies|antibodies|mesh-list
20616377|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
20463177|NCT01440998|Paclitaxel|paclitaxel|mesh-list
20616378|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616379|NCT02271191|Nicardipine|nicardipine|mesh-list
20616380|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20616381|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20616382|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20616383|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616384|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20616385|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616386|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
20463178|NCT01440998|Carboplatin|carboplatin|mesh-list
20463179|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20463180|NCT01440998|Dasatinib|dasatinib|mesh-list
20463181|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20463182|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463183|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
20463184|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
20463185|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
20463186|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463187|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20463188|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463189|NCT01441128|Crizotinib|crizotinib|mesh-list
19849523|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849524|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
19849525|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19849526|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849527|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849528|NCT00703781|Bromfenac|bromfenac|mesh-list
19849529|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19849530|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19849531|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19849532|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20463190|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463191|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849533|NCT00703781|Analgesics|analgesics|mesh-ancestor
19849534|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
19849535|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849536|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463192|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463193|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463194|NCT01441193|Vaccines|vaccines|mesh-list
20463195|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
20463196|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849537|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849538|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849539|NCT00703820|Cytarabine|cytarabine|mesh-list
19849540|NCT00703820|Etoposide|etoposide|mesh-list
19849541|NCT00703820|Daunorubicin|daunorubicin|mesh-list
19849542|NCT00703820|Clofarabine|clofarabine|mesh-list
19849543|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20463197|NCT01441206|Rifampin|rifampin|mesh-list
20463198|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20463199|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
20463200|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20463201|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463202|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
20463203|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20463204|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463205|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463206|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20463207|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20463208|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20463209|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20463210|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20463211|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20463212|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20463213|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20463214|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463215|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463216|NCT01441232|Incretins|incretins|mesh-ancestor
20463217|NCT01441232|Hormones|hormones|mesh-ancestor
20463218|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20463219|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20463220|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
20463221|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463222|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463223|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20463224|NCT01441284|Pramipexole|pramipexole|mesh-list
20463225|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
20463226|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463227|NCT01441284|Protective Agents|protective agents|mesh-ancestor
20463228|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463229|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20463230|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20463231|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
20463232|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
20463233|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463234|NCT01441297|Nintedanib|nintedanib|mesh-list
20463235|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463236|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20463237|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463238|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849544|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849545|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19849546|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19849547|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849548|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849549|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19849550|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
19849551|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
19849552|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849553|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849554|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
20463239|NCT01441388|Bevacizumab|bevacizumab|mesh-list
20616387|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
20616388|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616389|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616390|NCT02271282|Toremifene|toremifene|mesh-list
20616391|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20616392|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616393|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20616394|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20616395|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
20616396|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616397|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616398|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616399|NCT02271295|Enoxaparin|enoxaparin|mesh-list
20616400|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
20616401|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20616402|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20616403|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616404|NCT02271347|Brincidofovir|brincidofovir|mesh-list
20616405|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
20616406|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616407|NCT02271360|Cabergoline|cabergoline|mesh-list
20463240|NCT01441388|Sunitinib|sunitinib|mesh-list
20463241|NCT01441388|Sorafenib|sorafenib|mesh-list
20463242|NCT01441388|Axitinib|axitinib|mesh-list
20463243|NCT01441388|Crizotinib|crizotinib|mesh-list
20463244|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463245|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463246|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20463247|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20616408|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
20616409|NCT02271360|Calcium|calcium|mesh-list
20616410|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20616411|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616412|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20616413|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20616414|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
20616415|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
20616416|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616417|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616418|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
20222854|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20222855|NCT00330824|BB 1101|bb 1101|mesh-list
20222856|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222857|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
20222858|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
20616419|NCT02271360|Coagulants|coagulants|mesh-ancestor
20616420|NCT02271399|Aspirin|aspirin|mesh-list
20616421|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
20616422|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20616423|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20616424|NCT02271399|Analgesics|analgesics|mesh-ancestor
20616425|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
20616426|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616427|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849555|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222859|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222860|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222861|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20222862|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
20222863|NCT00330824|Hormones|hormones|mesh-ancestor
20222864|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222865|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20463248|NCT01441388|Growth Substances|growth substances|mesh-ancestor
20616428|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20463249|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616429|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616430|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20616431|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20616432|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616433|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616434|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20616435|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463250|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
20463251|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20616436|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
20616437|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20616438|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
20616439|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20616440|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
19694859|NCT04961268|Acetaminophen|acetaminophen|mesh-list
20463252|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463253|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463254|NCT01441427|Lenograstim|lenograstim|mesh-list
20463255|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20463256|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
20463257|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463258|NCT01441505|Midazolam|midazolam|mesh-list
20463259|NCT01441505|Ketamine|ketamine|mesh-list
20463260|NCT01441505|Analgesics|analgesics|mesh-ancestor
20463261|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
20463262|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463263|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463264|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20463265|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20463266|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
20463267|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
20463268|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463269|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20463270|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20463271|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463272|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463273|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20463274|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20463275|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20463276|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20463277|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20463278|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
20463279|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
20463280|NCT01441531|Gabapentin|gabapentin|mesh-list
20463281|NCT01441531|Analgesics|analgesics|mesh-ancestor
20463282|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
20463283|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463284|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463285|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
20463286|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20463287|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20463288|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463289|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20463290|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20463291|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20463292|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463293|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463294|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
20463295|NCT01441557|Amifampridine|amifampridine|mesh-list
20463296|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20463297|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463298|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463299|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20463300|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20463301|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526808|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
20526809|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526810|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20526811|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
20616441|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
19694860|NCT04961268|Ibuprofen|ibuprofen|mesh-list
19694861|NCT04961268|Tramadol|tramadol|mesh-list
20526812|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20526813|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20616442|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20616443|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20616444|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20616445|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20616446|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616447|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616448|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616449|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
20616450|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616451|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
20616452|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20616453|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20616454|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616455|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20616456|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20616457|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616458|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616459|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222866|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222867|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
20222868|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222869|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222870|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222871|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20222872|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20222873|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20222874|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
20222875|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20222876|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20222877|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20222878|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20463302|NCT01441700|Anesthetics|anesthetics|mesh-list
20463303|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463304|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463305|NCT01441804|Ribavirin|ribavirin|mesh-list
20463306|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20463307|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
20463308|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
20463309|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463310|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
20463311|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463312|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
20463313|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463314|NCT01441869|Metformin|metformin|mesh-list
20463315|NCT01441869|Saxagliptin|saxagliptin|mesh-list
20463316|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463317|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463318|NCT01441869|Incretins|incretins|mesh-ancestor
20463319|NCT01441869|Hormones|hormones|mesh-ancestor
20463320|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20463321|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20463322|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
20463323|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463324|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463325|NCT01441908|Pravastatin|pravastatin|mesh-list
20463326|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20463327|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20463328|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
20463329|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463330|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20463331|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20463332|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463333|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
20463334|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463335|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
20463336|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20463337|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20463338|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463339|NCT01441934|Urological Agents|urological agents|mesh-ancestor
20463340|NCT01441947|Fulvestrant|fulvestrant|mesh-list
20463341|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20222879|NCT00330902|Artesunate|artesunate|mesh-list
20616460|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20616461|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
20616462|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20616463|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616464|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19694862|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694863|NCT04961268|Analgesics|analgesics|mesh-ancestor
19694864|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
19694865|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616465|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20616466|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20616467|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
20616468|NCT02271464|Bevacizumab|bevacizumab|mesh-list
20616469|NCT02271464|Capecitabine|capecitabine|mesh-list
20616470|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616471|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
20463342|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463343|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20463344|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20463345|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
20463346|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20463347|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463348|NCT01441986|Amantadine|amantadine|mesh-list
20463349|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
20463350|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
20463351|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
20616472|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616473|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616474|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20616475|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
20616476|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616477|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616478|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20616479|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20616480|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20616481|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20616482|NCT02271464|Growth Substances|growth substances|mesh-ancestor
20616483|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
20616484|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20616485|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
20616486|NCT02271542|Propofol|propofol|mesh-list
20616487|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20616488|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616489|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616490|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20616491|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
20616492|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
20616493|NCT02271555|Remifentanil|remifentanil|mesh-list
20616494|NCT02271555|Sevoflurane|sevoflurane|mesh-list
20616495|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20616496|NCT02271555|Narcotics|narcotics|mesh-ancestor
20616497|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616498|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616499|NCT02271555|Analgesics|analgesics|mesh-ancestor
20616500|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
20616501|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616502|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616503|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19694866|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463352|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20463353|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20463354|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463355|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463356|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463357|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20463358|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20463359|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
20463360|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463361|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
20463362|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20463363|NCT01441986|Analgesics|analgesics|mesh-ancestor
20463364|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
20463365|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463366|NCT01442025|Infliximab|infliximab|mesh-list
20463367|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
20463368|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20463369|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20463370|NCT01442168|Atovaquone|atovaquone|mesh-list
20463371|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463372|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
20463373|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20463374|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20463375|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463376|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463377|NCT01442246|Leuprolide|leuprolide|mesh-list
20463378|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20463379|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
20463380|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20463381|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463382|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20463383|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463384|NCT01442272|Calcifediol|calcifediol|mesh-list
20616504|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
20616505|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
20616506|NCT02271646|Bupivacaine|bupivacaine|mesh-list
20616507|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
20616508|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
20616509|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616510|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616511|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
20616512|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616513|NCT02271802|Butyric Acid|butyric acid|mesh-list
20616514|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
20616515|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
20616516|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616517|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616518|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616519|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
20616520|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
20616521|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
20616522|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20616523|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20616524|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616525|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616526|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616527|NCT02271958|Mifepristone|mifepristone|mesh-list
20616528|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20616529|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
20616530|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20616531|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616532|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20616533|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20616534|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20616535|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
20616536|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20616537|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20616538|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
20616539|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616540|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
20616541|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20616542|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20616543|NCT02271971|Vitamin D|vitamin d|mesh-list
20616544|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
20616545|NCT02271971|Vitamins|vitamins|mesh-ancestor
20616546|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
20616547|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616548|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20463385|NCT01442272|Vitamins|vitamins|mesh-ancestor
20463386|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
20463387|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463388|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20463389|NCT01442311|Interferons|interferons|mesh-list
20463390|NCT01442311|Ribavirin|ribavirin|mesh-list
20463391|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
20616549|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20616550|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
20616551|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
20616552|NCT02271997|Trace Elements|trace elements|mesh-ancestor
20463392|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
20616553|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
20463393|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20463394|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463395|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
20616554|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616555|NCT02271997|Hematinics|hematinics|mesh-ancestor
20616556|NCT02272049|Xenon|xenon|mesh-list
20616557|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20616558|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
20616559|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
20616560|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616561|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616562|NCT02272101|Vitamin D|vitamin d|mesh-list
20616563|NCT02272101|Vitamins|vitamins|mesh-ancestor
20616564|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
20616565|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463396|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463397|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
20463398|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463399|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
20463400|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463401|NCT01442428|Dexamethasone|dexamethasone|mesh-list
20463402|NCT01442428|Naproxen|naproxen|mesh-list
20463403|NCT01442428|Atorvastatin|atorvastatin|mesh-list
20463404|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20463405|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
20463406|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
20463407|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463408|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616566|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616567|NCT02272166|Propofol|propofol|mesh-list
20616568|NCT02272166|Sevoflurane|sevoflurane|mesh-list
20616569|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20616570|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616571|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616572|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20616573|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
20616574|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
20463409|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20463410|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
20463411|NCT01442428|Hormones|hormones|mesh-ancestor
20463412|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20463413|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20463414|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463415|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20463416|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20463417|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
20463418|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463419|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20463420|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20463421|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463422|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20463423|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20616575|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616576|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20616577|NCT02272270|Minocycline|minocycline|mesh-list
20616578|NCT02272270|Temozolomide|temozolomide|mesh-list
20616579|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20616580|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
20616581|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616582|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616583|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20616584|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616585|NCT02272387|Vitamin D|vitamin d|mesh-list
20616586|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
20616587|NCT02272387|Vitamins|vitamins|mesh-ancestor
20616588|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
20616589|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616590|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616591|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20616592|NCT02272478|Decitabine|decitabine|mesh-list
20616593|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
20463424|NCT01442428|Analgesics|analgesics|mesh-ancestor
20463425|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
20463426|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20463427|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
20616594|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20616595|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
20463428|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20463429|NCT01442519|Mitomycins|mitomycins|mesh-list
20463430|NCT01442519|Mitomycin|mitomycin|mesh-list
20463431|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
20463432|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20463433|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463434|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
20463435|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463436|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20463437|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463438|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20463439|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
20463440|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463441|NCT01442532|Midazolam|midazolam|mesh-list
20463442|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20463443|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20463444|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463445|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463446|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20463447|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20463448|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20463449|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20463450|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
20463451|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
20463452|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
20463453|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
20463454|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463455|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463456|NCT01442558|Bupivacaine|bupivacaine|mesh-list
20616596|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616597|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616598|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616599|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20616600|NCT02272517|Vortioxetine|vortioxetine|mesh-list
20616601|NCT02272517|Citalopram|citalopram|mesh-list
20616602|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20616603|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20616604|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20616605|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616606|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616607|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
20616608|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616609|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20616610|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
20616611|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616612|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20616613|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20616614|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616615|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20616616|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20616617|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20616618|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20616619|NCT02272582|Heparin|heparin|mesh-list
20616620|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
20616621|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20616622|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20616623|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616624|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20616625|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20616626|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20616627|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
20616628|NCT02272647|Estradiol|estradiol|mesh-list
20616629|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20616630|NCT02272647|Progesterone|progesterone|mesh-list
20616631|NCT02272647|Estrogens|estrogens|mesh-ancestor
20616632|NCT02272647|Hormones|hormones|mesh-ancestor
20616633|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616634|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616635|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20616636|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
20616637|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20616638|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20463457|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
20616639|NCT02272647|Progestins|progestins|mesh-ancestor
20463458|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
20616640|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20616641|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20616642|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20616643|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20616644|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20616645|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463459|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463460|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463461|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
20463462|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463463|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
20463464|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20463465|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
20463466|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463467|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
20463468|NCT01442571|Protective Agents|protective agents|mesh-ancestor
20463469|NCT01442610|Rasagiline|rasagiline|mesh-list
20463470|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20463471|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463472|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463473|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20463474|NCT01442610|Protective Agents|protective agents|mesh-ancestor
20463475|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463476|NCT01442662|Gemcitabine|gemcitabine|mesh-list
20463477|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20463478|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
20463479|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616646|NCT02272660|Parecoxib|parecoxib|mesh-list
20616647|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20616648|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20616649|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616650|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616651|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20616652|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20616653|NCT02272660|Analgesics|analgesics|mesh-ancestor
20616654|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
20616655|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616656|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616657|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20616658|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616659|NCT02272699|Paclitaxel|paclitaxel|mesh-list
20616660|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
20616661|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20616662|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616663|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
20616664|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
20616665|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
20616666|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616667|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20616668|NCT02272738|Gemcitabine|gemcitabine|mesh-list
20616669|NCT02272738|Paclitaxel|paclitaxel|mesh-list
20616670|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20616671|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20616672|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616673|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
20616674|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
20616675|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
20616676|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616677|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20463480|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463481|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
20463482|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463483|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463484|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463485|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
20463486|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616678|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
20616679|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
20616680|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616681|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616682|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616683|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
20616684|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616685|NCT02272764|Itraconazole|itraconazole|mesh-list
20616686|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
20616687|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
20616688|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616689|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20616690|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20616691|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616692|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616693|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20616694|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
20616695|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616696|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616697|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20616698|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
20616699|NCT02272829|Narcotics|narcotics|mesh-ancestor
20616700|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694867|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
19694868|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19694869|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20463487|NCT01442701|Triclosan|triclosan|mesh-list
20616701|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616702|NCT02272829|Analgesics|analgesics|mesh-ancestor
20616703|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
20616704|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616705|NCT02272855|Ipilimumab|ipilimumab|mesh-list
20616706|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20616707|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616708|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20616709|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616710|NCT02272868|Rifaximin|rifaximin|mesh-list
20616711|NCT02272868|Omeprazole|omeprazole|mesh-list
20616712|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20616713|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20616714|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20616715|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20616716|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616717|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616718|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20616719|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616720|NCT02272868|Laxatives|laxatives|mesh-ancestor
20463488|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20463489|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463490|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20463491|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20463492|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
20463493|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463494|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20463495|NCT01442727|Selenium|selenium|mesh-list
20463496|NCT01442727|Selenious Acid|selenious acid|mesh-list
19694870|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20463497|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
20616721|NCT02272998|Ponatinib|ponatinib|mesh-list
20616722|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616723|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20616724|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616725|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616726|NCT02273102|Tretinoin|tretinoin|mesh-list
20616727|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
20616728|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616729|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
20616730|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
20616731|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
20616732|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616733|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20463498|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
20463499|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463500|NCT01442727|Protective Agents|protective agents|mesh-ancestor
20463501|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463502|NCT01442727|Trace Elements|trace elements|mesh-ancestor
20463503|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
20463504|NCT01442766|Donepezil|donepezil|mesh-list
20616734|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616735|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616736|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20616737|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20616738|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616739|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616740|NCT02273128|Calcitonin|calcitonin|mesh-list
20616741|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20616742|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616743|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616744|NCT02273154|Buspirone|buspirone|mesh-list
20616745|NCT02273154|Paroxetine|paroxetine|mesh-list
20616746|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20616747|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20616748|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20616749|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616750|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616751|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
20616752|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616753|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20616754|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
20616755|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616756|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20616757|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20616758|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616759|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20616760|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20616761|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616762|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20616763|NCT02273258|Insulin|insulin|mesh-list
20222880|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
20222881|NCT00330902|Primaquine|primaquine|mesh-list
20222882|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
20222883|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20222884|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
20222885|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20463505|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20463506|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463507|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463508|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
20463509|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463510|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463511|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
20463512|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
20463513|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20463514|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
20463515|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20463516|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
20463517|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222886|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20222887|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222888|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222889|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
20222890|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
20222891|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20616764|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20616765|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
20616766|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20616767|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616768|NCT02273271|Alovudine|alovudine|mesh-list
20616769|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
20616770|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616771|NCT02273440|Theophylline|theophylline|mesh-list
20616772|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20616773|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
20616774|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616775|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616776|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20616777|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
20616778|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20616779|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616780|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616781|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
20616782|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20616783|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20616784|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
20616785|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616786|NCT02273453|Oxazepam|oxazepam|mesh-list
20616787|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20616788|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20616789|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616790|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20616791|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20463518|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463519|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
20463520|NCT01442818|Hydromorphone|hydromorphone|mesh-list
20463521|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20463522|NCT01442818|Narcotics|narcotics|mesh-ancestor
20463523|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463524|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463525|NCT01442818|Analgesics|analgesics|mesh-ancestor
20463526|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
20616792|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616793|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
20616794|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
20616795|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616796|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616797|NCT02273466|Desipramine|desipramine|mesh-list
20616798|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20616799|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
19694871|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19694872|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463527|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463528|NCT01442870|Metformin|metformin|mesh-list
20463529|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463530|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463531|NCT01442909|Docetaxel|docetaxel|mesh-list
20463532|NCT01442909|Pemetrexed|pemetrexed|mesh-list
20463533|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463534|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
20463535|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
20463536|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
20463537|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463538|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694873|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694874|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20463539|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20463540|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20463541|NCT01442935|Leucovorin|leucovorin|mesh-list
20463542|NCT01442935|Folic Acid|folic acid|mesh-list
19694875|NCT04961268|Narcotics|narcotics|mesh-ancestor
19694876|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694877|NCT04961554|Anesthetics|anesthetics|mesh-list
19694878|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694879|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694880|NCT04961502|Vaccines|vaccines|mesh-list
20463543|NCT01442935|Bevacizumab|bevacizumab|mesh-list
20463544|NCT01442935|Cetuximab|cetuximab|mesh-list
20616800|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20616801|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694881|NCT04961502|Immunologic Factors|immunologic factors|mesh-ancestor
20463545|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
20463546|NCT01442935|Irinotecan|irinotecan|mesh-list
19694882|NCT04961502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694883|NCT04961307|Trastuzumab|trastuzumab|mesh-list
19694884|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463547|NCT01442935|Fluorouracil|fluorouracil|mesh-list
20463548|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
20463549|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463550|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463551|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20463552|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20463553|NCT01442935|Growth Substances|growth substances|mesh-ancestor
20463554|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463555|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
20463556|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20463557|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20463558|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463559|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463560|NCT01442935|Antidotes|antidotes|mesh-ancestor
20463561|NCT01442935|Protective Agents|protective agents|mesh-ancestor
20463562|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
20463563|NCT01442935|Vitamins|vitamins|mesh-ancestor
20463564|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
20463565|NCT01442935|Hematinics|hematinics|mesh-ancestor
20463566|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
20463567|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20463568|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463569|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
20463570|NCT01442974|Gemcitabine|gemcitabine|mesh-list
20463571|NCT01442974|Paclitaxel|paclitaxel|mesh-list
20463572|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20616802|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616803|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20616804|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20616805|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20616806|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
20616807|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20616808|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616809|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616810|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616811|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616812|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616813|NCT02273505|Aspirin|aspirin|mesh-list
20616814|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
19694885|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694886|NCT04961138|Lenvatinib|lenvatinib|mesh-list
19694887|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694888|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694889|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694890|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694891|NCT04960943|Trastuzumab|trastuzumab|mesh-list
19694892|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694893|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222892|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
20222893|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20616815|NCT02273505|Salicylates|salicylates|mesh-list
20616816|NCT02273505|Dipyridamole|dipyridamole|mesh-list
20616817|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616818|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616819|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
20222894|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222895|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222896|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20222897|NCT00330902|Renal Agents|renal agents|mesh-ancestor
20222898|NCT00330941|Lidocaine|lidocaine|mesh-list
20222899|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
20222900|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
20222901|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20222902|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222903|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
20222904|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222905|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20222906|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20616820|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
19694894|NCT04960618|Gemcitabine|gemcitabine|mesh-list
20463573|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463574|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
20463575|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
20616821|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
20616822|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20616823|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20616824|NCT02273505|Analgesics|analgesics|mesh-ancestor
20463576|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
20463577|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463578|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20463579|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
20463580|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
20463581|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463582|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463583|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616825|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
20616826|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616827|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616828|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20616829|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616830|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20616831|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616832|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616833|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616834|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20616835|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20616836|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
20616837|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20616838|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
20616839|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616840|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616841|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616842|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616843|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616844|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616845|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20616846|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616847|NCT02273570|Vitamin D|vitamin d|mesh-list
20616848|NCT02273570|Calcium|calcium|mesh-list
20616849|NCT02273570|Vitamins|vitamins|mesh-ancestor
20616850|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
20616851|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616852|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20616853|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616854|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
20616855|NCT02273583|Methotrexate|methotrexate|mesh-list
20616856|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20616857|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
20616858|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616859|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19694895|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
19694896|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19694897|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
19694898|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694899|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694900|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
19694901|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694902|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694903|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694904|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
19694905|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694906|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694907|NCT04960657|Glyburide|glyburide|mesh-list
19694908|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
20463584|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
20463585|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463586|NCT01442987|Irbesartan|irbesartan|mesh-list
20463587|NCT01442987|Atorvastatin|atorvastatin|mesh-list
20463588|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20463589|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20463590|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
20463591|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616860|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20616861|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
20463592|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20463593|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20463594|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463595|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20463596|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20463597|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20463598|NCT01443065|Leucovorin|leucovorin|mesh-list
20463599|NCT01443065|Folic Acid|folic acid|mesh-list
20463600|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
20463601|NCT01443065|Panitumumab|panitumumab|mesh-list
20463602|NCT01443065|Fluorouracil|fluorouracil|mesh-list
20463603|NCT01443065|Rilotumumab|rilotumumab|mesh-list
20463604|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
20463605|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463606|NCT01443065|Antidotes|antidotes|mesh-ancestor
20463607|NCT01443065|Protective Agents|protective agents|mesh-ancestor
20463608|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463609|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
20463610|NCT01443065|Vitamins|vitamins|mesh-ancestor
20463611|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
20463612|NCT01443065|Hematinics|hematinics|mesh-ancestor
20463613|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463614|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
20463615|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463616|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20463617|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463618|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
20463619|NCT01443104|Sirolimus|sirolimus|mesh-list
20463620|NCT01443104|Everolimus|everolimus|mesh-list
20463621|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463622|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463623|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
20463624|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463625|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20463626|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463627|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20463628|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
20463629|NCT01443117|Vaccines|vaccines|mesh-list
20616862|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616863|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616864|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20616865|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20616866|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
20616867|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20616868|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20616869|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
20616870|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
20616871|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616872|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20616873|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20616874|NCT02273609|Vitamin K|vitamin k|mesh-list
20616875|NCT02273609|Warfarin|warfarin|mesh-list
20616876|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
20616877|NCT02273609|Vitamins|vitamins|mesh-ancestor
19694909|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19694910|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694911|NCT04960657|Growth Substances|growth substances|mesh-ancestor
19694912|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
19694913|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19694914|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694915|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19694916|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
19694917|NCT04960293|Coagulants|coagulants|mesh-ancestor
19694918|NCT04959721|Triamcinolone|triamcinolone|mesh-list
20463630|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
20616878|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
20616879|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616880|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
20616881|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20616882|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20616883|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616884|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
20463631|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463632|NCT01443169|Pregabalin|pregabalin|mesh-list
20463633|NCT01443169|Analgesics|analgesics|mesh-ancestor
20463634|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
20463635|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616885|NCT02273609|Coagulants|coagulants|mesh-ancestor
20463636|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463637|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
20463638|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20463639|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20463640|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463641|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20463642|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20616886|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
20616887|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616888|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
20616889|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616890|NCT02273622|Protective Agents|protective agents|mesh-ancestor
20616891|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616892|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616893|NCT02273635|Andrographolide|andrographolide|mesh-list
20616894|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20616895|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20616896|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20616897|NCT02273635|Analgesics|analgesics|mesh-ancestor
20616898|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
20616899|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616900|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616901|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20616902|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20616903|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20616904|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616905|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
20616906|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20616907|NCT02273661|Amphotericin B|amphotericin b|mesh-list
20616908|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20616909|NCT02273661|Amebicides|amebicides|mesh-ancestor
20616910|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20616911|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20616912|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616913|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20616914|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
20616915|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
20616916|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20616917|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
20616918|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20616919|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
20616920|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616921|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616922|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
20616923|NCT02273713|Paclitaxel|paclitaxel|mesh-list
20616924|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20616925|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20616926|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
20616927|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
20463643|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20463644|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463645|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20463646|NCT01443195|Iron|iron|mesh-list
20463647|NCT01443195|Trace Elements|trace elements|mesh-ancestor
20463648|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
20463649|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616928|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
20616929|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616930|NCT02273765|Tenofovir|tenofovir|mesh-list
20616931|NCT02273765|Lamivudine|lamivudine|mesh-list
20616932|NCT02273765|Efavirenz|efavirenz|mesh-list
20616933|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
20616934|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
20616935|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20616936|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20616937|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20616938|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20616939|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20616940|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20463650|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20463651|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20463652|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20616941|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20616942|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20616943|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20616944|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20463653|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20463654|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463655|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463656|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463657|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
20463658|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20463659|NCT01443221|Metformin|metformin|mesh-list
20616945|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20616946|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20616947|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20616948|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20616949|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20616950|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20616951|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20616952|NCT02273791|Clomiphene|clomiphene|mesh-list
20616953|NCT02273791|Enclomiphene|enclomiphene|mesh-list
20616954|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
20616955|NCT02273791|Estradiol|estradiol|mesh-list
20616956|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20616957|NCT02273791|Estrogens|estrogens|mesh-ancestor
20616958|NCT02273791|Hormones|hormones|mesh-ancestor
20616959|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616960|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616961|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20616962|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
20616963|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20463660|NCT01443221|Mitiglinide|mitiglinide|mesh-list
20463661|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463662|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463663|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
20463664|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20463665|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20463666|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
20463667|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526814|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20526815|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
20526816|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
20616964|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20616965|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20616966|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
20616967|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20616968|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
20616969|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20616970|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20616971|NCT02273804|Topiramate|topiramate|mesh-list
20616972|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
20616973|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20616974|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526817|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526818|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20526819|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20526820|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
20616975|NCT02273817|Ciclesonide|ciclesonide|mesh-list
20616976|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
20616977|NCT02273817|Hormones|hormones|mesh-ancestor
20616978|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20616979|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616980|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20616981|NCT02273843|Vitamin D|vitamin d|mesh-list
20616982|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
20616983|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
20616984|NCT02273843|Vitamins|vitamins|mesh-list
20616985|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
20616986|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20616987|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20616988|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20616989|NCT02273895|Scopolamine|scopolamine|mesh-list
20616990|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20616991|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20616992|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
20616993|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
20616994|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20616995|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526821|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20616996|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20616997|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
20616998|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20616999|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
20617000|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617001|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617002|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20617003|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
20617004|NCT02273947|BMS-955176|bms-955176|mesh-list
20617005|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20617006|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20617007|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
20617008|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617009|NCT02273986|Digoxin|digoxin|mesh-list
20617010|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20617011|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20617012|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617013|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617014|NCT02273986|Protective Agents|protective agents|mesh-ancestor
20617015|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617016|NCT02274012|Paclitaxel|paclitaxel|mesh-list
20617017|NCT02274012|Afatinib|afatinib|mesh-list
20617018|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20617019|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617020|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
20617021|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
20617022|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
20617023|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617024|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20617025|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617026|NCT02274051|Kinetin|kinetin|mesh-list
20617027|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20617028|NCT02274051|Growth Substances|growth substances|mesh-ancestor
20617029|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617030|NCT02274077|Bupivacaine|bupivacaine|mesh-list
20617031|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
20617032|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
20617033|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617034|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617035|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
20617036|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617037|NCT02274090|Metformin|metformin|mesh-list
20617038|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617039|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617040|NCT02274142|Methamphetamine|methamphetamine|mesh-list
20617041|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20617042|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617043|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
20617044|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
20617045|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617046|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
20617047|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617048|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617049|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
20617050|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20617051|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20617052|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20617053|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20617054|NCT02274181|Enclomiphene|enclomiphene|mesh-list
20617055|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20617056|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
20617057|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617058|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617059|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20617060|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
20617061|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20617062|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20617063|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20617064|NCT02274259|Ranibizumab|ranibizumab|mesh-list
20617065|NCT02274259|Aflibercept|aflibercept|mesh-list
20617066|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20617067|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20617068|NCT02274259|Growth Substances|growth substances|mesh-ancestor
20617069|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617070|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
20617071|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617072|NCT02274337|Abivertinib|abivertinib|mesh-list
20617073|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20617074|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617075|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617076|NCT02274415|Vaccines|vaccines|mesh-list
20617077|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20617078|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
20617079|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617080|NCT02274454|Oxytocin|oxytocin|mesh-list
20617081|NCT02274454|Calcium|calcium|mesh-list
20617082|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20617083|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617084|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
20617085|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20617086|NCT02274506|Vidarabine|vidarabine|mesh-list
20463668|NCT01443325|Lidocaine|lidocaine|mesh-list
20463669|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
20463670|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
20463671|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463672|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463673|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
20463674|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463675|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20463676|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20463677|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20463678|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20463679|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463680|NCT01443338|Acitretin|acitretin|mesh-list
20463681|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
20463682|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
20463683|NCT01443377|Panitumumab|panitumumab|mesh-list
20463684|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463685|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463686|NCT01443416|Vaccines|vaccines|mesh-list
20463687|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20463688|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
20463689|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463690|NCT01443429|Beraprost|beraprost|mesh-list
20463691|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20463692|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
20463693|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20463694|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20463695|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20463696|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20463697|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20463698|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463699|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463700|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463701|NCT01443520|Analgesics|analgesics|mesh-ancestor
20617087|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
20617088|NCT02274506|Fludarabine|fludarabine|mesh-list
20617089|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
20617090|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617091|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
20617092|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617093|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617094|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20617095|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
20617096|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617097|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617098|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20617099|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20617100|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
20617101|NCT02274506|Antiviral Agents|antiviral agents|mesh-ancestor
20617102|NCT02274506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617103|NCT02274545|Vaccines|vaccines|mesh-list
20617104|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
20617105|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617106|NCT02274610|Docetaxel|docetaxel|mesh-list
20617107|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617108|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
20617109|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
20617110|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
20617111|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617112|NCT02274623|Calcifediol|calcifediol|mesh-list
20617113|NCT02274623|Vitamins|vitamins|mesh-ancestor
20617114|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
20617115|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617116|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20617117|NCT02274740|Metformin|metformin|mesh-list
20617118|NCT02274740|Lixisenatide|lixisenatide|mesh-list
20617119|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617120|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617121|NCT02274961|Pantoprazole|pantoprazole|mesh-list
20617122|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20617123|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617124|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20617125|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617126|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617127|NCT02274974|Lidocaine|lidocaine|mesh-list
20617128|NCT02274974|Epinephrine|epinephrine|mesh-list
20617129|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
20617130|NCT02274974|Anesthetics|anesthetics|mesh-list
20463702|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
20463703|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463704|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
20463705|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20463706|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
20463707|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20463708|NCT01443572|Sevoflurane|sevoflurane|mesh-list
20463709|NCT01443572|Desflurane|desflurane|mesh-list
20463710|NCT01443572|Anesthetics|anesthetics|mesh-list
20463711|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20463712|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20463713|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
20463714|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463715|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463716|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20463717|NCT01443624|Hematinics|hematinics|mesh-ancestor
20463718|NCT01443676|Bevacizumab|bevacizumab|mesh-list
20617131|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617132|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617133|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
20463719|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463720|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463721|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20463722|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20463723|NCT01443676|Growth Substances|growth substances|mesh-ancestor
20463724|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463725|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
20463726|NCT01443741|Insulin|insulin|mesh-list
20463727|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20463728|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463729|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463730|NCT01443780|Selenium|selenium|mesh-list
20463731|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
20463732|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463733|NCT01443780|Protective Agents|protective agents|mesh-ancestor
20463734|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463735|NCT01443780|Trace Elements|trace elements|mesh-ancestor
20463736|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
20617134|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617135|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20617136|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20617137|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20617138|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20617139|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617140|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20617141|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20463737|NCT01443806|Oseltamivir|oseltamivir|mesh-list
20617142|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
20463738|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
20463739|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617143|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617144|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20617145|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20463740|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463741|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463742|NCT01443897|Vitamin D|vitamin d|mesh-list
20463743|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
20463744|NCT01443897|Vitamins|vitamins|mesh-list
20463745|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
20463746|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463747|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20463748|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20463749|NCT01443936|Vaccines|vaccines|mesh-list
20463750|NCT01443936|Immunologic Factors|immunologic factors|mesh-ancestor
20463751|NCT01443936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463752|NCT01443988|Travoprost|travoprost|mesh-list
20617146|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
20617147|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20617148|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
20617149|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
20617150|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
20617151|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20617152|NCT02275013|Simendan|simendan|mesh-list
20617153|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20617154|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
20617155|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20463753|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20463754|NCT01444001|Vaccines|vaccines|mesh-list
20463755|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20463756|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
20463757|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617156|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20617157|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617158|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617159|NCT02275013|Protective Agents|protective agents|mesh-ancestor
20617160|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617161|NCT02275039|Gemcitabine|gemcitabine|mesh-list
20617162|NCT02275039|Vaccines|vaccines|mesh-list
20617163|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
20617164|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617165|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20617166|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
20617167|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617168|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617169|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
20617170|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617171|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617172|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617173|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
20617174|NCT02275130|Calcium|calcium|mesh-list
20617175|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20617176|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617177|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20463758|NCT01444040|Travoprost|travoprost|mesh-list
20463759|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20463760|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
20463761|NCT01444118|Vaccines|vaccines|mesh-list
20463762|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
20463763|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463764|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617178|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
20617179|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20617180|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617181|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617182|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20617183|NCT02275182|Analgesics|analgesics|mesh-ancestor
20617184|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
20617185|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617186|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20617187|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20617188|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20617189|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
20617190|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463765|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20463766|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20463767|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
20463768|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463769|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463770|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20463771|NCT01444131|Nicotine|nicotine|mesh-list
20463772|NCT01444131|Varenicline|varenicline|mesh-list
20463773|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20463774|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
20463775|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463776|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463777|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20617191|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617192|NCT02275247|Ropivacaine|ropivacaine|mesh-list
20617193|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
20617194|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617195|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617196|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
20617197|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
20617198|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617199|NCT02275286|Trabectedin|trabectedin|mesh-list
20617200|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20617201|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
20617202|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617203|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617204|NCT02275299|Methotrexate|methotrexate|mesh-list
20617205|NCT02275299|Leflunomide|leflunomide|mesh-list
20617206|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20617207|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
20617208|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20617209|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617210|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20617211|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
20617212|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617213|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617214|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
20617215|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617216|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20617217|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617218|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
20617219|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617220|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20617221|NCT02275416|Ipilimumab|ipilimumab|mesh-list
20617222|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20617223|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617224|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20617225|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617226|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20617227|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20617228|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617229|NCT02275663|Cytarabine|cytarabine|mesh-list
20617230|NCT02275663|Fludarabine|fludarabine|mesh-list
20617231|NCT02275663|Azacitidine|azacitidine|mesh-list
20617232|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617233|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20617234|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
20617235|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617236|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617237|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
20617238|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617239|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
20617240|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617241|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617242|NCT02275702|Dexamethasone|dexamethasone|mesh-list
20463778|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20463779|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
20463780|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463781|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463782|NCT01444196|Desloratadine|desloratadine|mesh-list
20463783|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20463784|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
20463785|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463786|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463787|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463788|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20463789|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20617243|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617244|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
20463790|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
20463791|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
20463792|NCT01444248|Metformin|metformin|mesh-list
20463793|NCT01444248|Glimepiride|glimepiride|mesh-list
20463794|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20463795|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463796|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20463797|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463798|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
20463799|NCT01444339|Vaccines|vaccines|mesh-list
20617245|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
20617246|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617247|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617248|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617249|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
20617250|NCT02275702|Hormones|hormones|mesh-ancestor
20617251|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617252|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20617253|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617254|NCT02275806|Irinotecan|irinotecan|mesh-list
20617255|NCT02275806|Camptothecin|camptothecin|mesh-list
20617256|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617257|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20617258|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20617259|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617260|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617261|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20617262|NCT02275832|Minoxidil|minoxidil|mesh-list
19694919|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19694920|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19694921|NCT04959721|Bupivacaine|bupivacaine|mesh-list
19694922|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19694923|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
19694924|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
19694925|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19694926|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463800|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20463801|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
20617263|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20617264|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
20617265|NCT02275845|Metformin|metformin|mesh-list
20617266|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617267|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617268|NCT02275897|Methamphetamine|methamphetamine|mesh-list
20617269|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20617270|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463802|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463803|NCT01444352|Vaccines|vaccines|mesh-list
20463804|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20463805|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
20463806|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463807|NCT01444469|Azithromycin|azithromycin|mesh-list
20463808|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20463809|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463810|NCT01444521|Irinotecan|irinotecan|mesh-list
20463811|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463812|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20463813|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20463814|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463815|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463816|NCT01444547|Paclitaxel|paclitaxel|mesh-list
20463817|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20463818|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20463819|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463820|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
20463821|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
20463822|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
20463823|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463824|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
20463825|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20463826|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
20463827|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20617271|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
19694927|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
20617272|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
20617273|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617274|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
20617275|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617276|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617277|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
20617278|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20617279|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20617280|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20617281|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20617282|NCT02275962|Rifampin|rifampin|mesh-list
20617283|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20617284|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
20617285|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20617286|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617287|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
20617288|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20617289|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617290|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617291|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20617292|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20617293|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20617294|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20617295|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20617296|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20617297|NCT02275975|Fluconazole|fluconazole|mesh-list
20617298|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
20617299|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617300|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20617301|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20617302|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617303|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617304|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20617305|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
20617306|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408163|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
19408164|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408165|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19408166|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
19408167|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20617307|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617308|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20617309|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20617310|NCT02275988|Clarithromycin|clarithromycin|mesh-list
20617311|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20617312|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617313|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20617314|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617315|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617316|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20617317|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20617318|NCT02276001|Cyclosporine|cyclosporine|mesh-list
20617319|NCT02276001|Cyclosporins|cyclosporins|mesh-list
20617320|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617321|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617322|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463828|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
20463829|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463830|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463831|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
20463832|NCT01444612|Heparin|heparin|mesh-list
20463833|NCT01444612|Calcium heparin|calcium heparin|mesh-list
20463834|NCT01444612|Enoxaparin|enoxaparin|mesh-list
20463835|NCT01444612|Dalteparin|dalteparin|mesh-list
20463836|NCT01444612|Tinzaparin|tinzaparin|mesh-list
20463837|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20463838|NCT01444612|PENTA|penta|mesh-list
20463839|NCT01444612|Fondaparinux|fondaparinux|mesh-list
20463840|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
19408168|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
20463841|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19408169|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
20463842|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20463843|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463844|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20463845|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
20463846|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20463847|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
20617323|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
20617324|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617325|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
20617326|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617327|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
20617328|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617329|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20617330|NCT02276014|Beta Carotene|beta carotene|mesh-list
20617331|NCT02276014|Carotenoids|carotenoids|mesh-list
20617332|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
20617333|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617334|NCT02276014|Protective Agents|protective agents|mesh-ancestor
20617335|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617336|NCT02276014|Provitamins|provitamins|mesh-ancestor
20463848|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463849|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
20463850|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463851|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20463852|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20463853|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617337|NCT02276014|Vitamins|vitamins|mesh-ancestor
20617338|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
20617339|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
20617340|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20617341|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
20617342|NCT02276196|Lixisenatide|lixisenatide|mesh-list
20617343|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617344|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222907|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20222908|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20617345|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
20617346|NCT02276300|Imiquimod|imiquimod|mesh-list
20617347|NCT02276300|Sargramostim|sargramostim|mesh-list
20617348|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617349|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
20617350|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617351|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617352|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20617353|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
20617354|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617355|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617356|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20617357|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20617358|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
20617359|NCT02276365|Pioglitazone|pioglitazone|mesh-list
20617360|NCT02276365|Empagliflozin|empagliflozin|mesh-list
20617361|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617362|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617363|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20617364|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617365|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20617366|NCT02276378|Telmisartan|telmisartan|mesh-list
20617367|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20617368|NCT02276378|Diuretics|diuretics|mesh-ancestor
20617369|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
20617370|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617371|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20617372|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20617373|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617374|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20222909|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222910|NCT00330980|Simvastatin|simvastatin|mesh-list
20222911|NCT00330980|Pravastatin|pravastatin|mesh-list
20222912|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20222913|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20222914|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
20222915|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222916|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20617375|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20617376|NCT02276391|Telmisartan|telmisartan|mesh-list
20617377|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20617378|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20617379|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20617380|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222917|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20222918|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222919|NCT00330993|Misoprostol|misoprostol|mesh-list
20222920|NCT00330993|Mifepristone|mifepristone|mesh-list
20222921|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20222922|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
20222923|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20222924|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222925|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20222926|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20222927|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
20222928|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20222929|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20463854|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463855|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
20463856|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20463857|NCT01444807|Sorafenib|sorafenib|mesh-list
20463858|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463859|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20463860|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463861|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463862|NCT01444833|Candesartan|candesartan|mesh-list
20463863|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20463864|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20463865|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20463866|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463867|NCT01444846|Ebselen|ebselen|mesh-list
20463868|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20463869|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20463870|NCT01444846|Analgesics|analgesics|mesh-ancestor
20463871|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
20463872|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463873|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463874|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20463875|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20463876|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20463877|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20463878|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
20463879|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463880|NCT01444846|Protective Agents|protective agents|mesh-ancestor
20463881|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20463882|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463883|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20463884|NCT01444885|Amlodipine|amlodipine|mesh-list
20463885|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
20463886|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20463887|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20463888|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20463889|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463890|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20463891|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463892|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
20463893|NCT01444976|Midazolam|midazolam|mesh-list
20463894|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
20463895|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463896|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463897|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20463898|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20463899|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20463900|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20617381|NCT02276495|Ketorolac|ketorolac|mesh-list
20617382|NCT02276495|Clonidine|clonidine|mesh-list
20617383|NCT02276495|Epinephrine|epinephrine|mesh-list
20617384|NCT02276495|Ropivacaine|ropivacaine|mesh-list
20617385|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
20617386|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
20617387|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617388|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617389|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
20617390|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849556|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19849557|NCT00703846|Ketoconazole|ketoconazole|mesh-list
19849558|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
19849559|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849560|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19849561|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19849562|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849563|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849564|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19849565|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
20463901|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20463902|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20463903|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
20463904|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
20463905|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
20463906|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463907|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526822|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
20526823|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20526824|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20526825|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526826|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20617391|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20617392|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20617393|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
20617394|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617395|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617396|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20617397|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20617398|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
20617399|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20617400|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
20617401|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
20617402|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
20617403|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20617404|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20617405|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20617406|NCT02276495|Analgesics|analgesics|mesh-ancestor
20617407|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617408|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617409|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20617410|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617411|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20617412|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
20617413|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20526827|NCT01764867|Analgesics|analgesics|mesh-ancestor
20526828|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
20526829|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20526830|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
20526831|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
20526832|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20617414|NCT02276677|Oxytocin|oxytocin|mesh-list
20617415|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
20617416|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20617417|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617418|NCT02276690|Hepcidins|hepcidins|mesh-list
20617419|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617420|NCT02276755|Vitamin D|vitamin d|mesh-list
20617421|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
20617422|NCT02276755|Vitamins|vitamins|mesh-ancestor
19849566|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617423|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
20617424|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617425|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20617426|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20617427|NCT02276768|Trimebutine|trimebutine|mesh-list
20617428|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617429|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
20617430|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
20617431|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617432|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617433|NCT02276846|Paclitaxel|paclitaxel|mesh-list
20617434|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20617435|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617436|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
20617437|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
20617438|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
20617439|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617440|NCT02276859|Insulin|insulin|mesh-list
20617441|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20617442|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
20617443|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
20617444|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
20463908|NCT01445067|Calcitonin|calcitonin|mesh-list
20463909|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20463910|NCT01445067|Katacalcin|katacalcin|mesh-list
20463911|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
20463912|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20463913|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463914|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20463915|NCT01445106|Nelfinavir|nelfinavir|mesh-list
20463916|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20463917|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20463918|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
20463919|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463920|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463921|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20463922|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20463923|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
20463924|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463925|NCT01445119|Carboplatin|carboplatin|mesh-list
20463926|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463927|NCT01445210|Ropivacaine|ropivacaine|mesh-list
20463928|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
20463929|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
20463930|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20463931|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463932|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
20617445|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20222930|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20222931|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20222932|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
20222933|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20222934|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20222935|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
20222936|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617446|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617447|NCT02276911|Ibuprofen|ibuprofen|mesh-list
20617448|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20617449|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20463933|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617450|NCT02276911|Analgesics|analgesics|mesh-ancestor
20617451|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
20617452|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617453|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617454|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617455|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617456|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20617457|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617458|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617459|NCT02276989|Riboflavin|riboflavin|mesh-list
20617460|NCT02276989|Quinine|quinine|mesh-list
20463934|NCT01445223|Ritonavir|ritonavir|mesh-list
20617461|NCT02276989|Acetazolamide|acetazolamide|mesh-list
20222937|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
20463935|NCT01445223|Lopinavir|lopinavir|mesh-list
20617462|NCT02276989|Vitamins|vitamins|mesh-ancestor
20617463|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
20617464|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617465|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
20463936|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20463937|NCT01445223|Efavirenz|efavirenz|mesh-list
20463938|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20463939|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20463940|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
20463941|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463942|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463943|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20463944|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20463945|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
20463946|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694928|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20463947|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20463948|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20463949|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20463950|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20463951|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20463952|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20463953|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20463954|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20463955|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20463956|NCT01445236|Cyclosporine|cyclosporine|mesh-list
20463957|NCT01445236|Tacrolimus|tacrolimus|mesh-list
20463958|NCT01445236|Cyclosporins|cyclosporins|mesh-list
20463959|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20463960|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
20463961|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463962|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20463963|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463964|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463965|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
20463966|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20463967|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
20463968|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20463969|NCT01445262|Levocetirizine|levocetirizine|mesh-list
20463970|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20463971|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20463972|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
20463973|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
20463974|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20463975|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463976|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463977|NCT01445340|Romidepsin|romidepsin|mesh-list
20463978|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20463979|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463980|NCT01445379|Ipilimumab|ipilimumab|mesh-list
20463981|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463982|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463983|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20463984|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463985|NCT01445392|Pemetrexed|pemetrexed|mesh-list
20463986|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20463987|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463988|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20463989|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20463990|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20463991|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20463992|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
20463993|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20463994|NCT01445405|Cetuximab|cetuximab|mesh-list
20463995|NCT01445405|Bortezomib|bortezomib|mesh-list
20463996|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20463997|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20463998|NCT01445418|Carboplatin|carboplatin|mesh-list
20463999|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464000|NCT01445431|Mineral Oil|mineral oil|mesh-list
20464001|NCT01445431|Emollients|emollients|mesh-ancestor
20464002|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
20464003|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
19694929|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19694930|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
20464004|NCT01445522|Veliparib|veliparib|mesh-list
20617466|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19849567|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849568|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19849569|NCT00703924|Paromomycin|paromomycin|mesh-list
19849570|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19849571|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849572|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19849573|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19849574|NCT00703976|Bevacizumab|bevacizumab|mesh-list
19849575|NCT00703976|Cetuximab|cetuximab|mesh-list
19849576|NCT00703976|Pemetrexed|pemetrexed|mesh-list
19849577|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849578|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849579|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19849580|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19849581|NCT00703976|Growth Substances|growth substances|mesh-ancestor
19849582|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849583|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
19849584|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849585|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222938|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20464005|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20464006|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
20464007|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464008|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464009|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20464010|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
20464011|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464012|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464013|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20464014|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20464015|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222939|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20464016|NCT01445561|Interleukin-2|interleukin-2|mesh-list
20464017|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464018|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464019|NCT01445561|Analgesics|analgesics|mesh-ancestor
19849586|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20222940|NCT00331045|Alvimopan|alvimopan|mesh-list
20222941|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20222942|NCT00331058|Prednisolone|prednisolone|mesh-list
20222943|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222944|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
20222945|NCT00331058|Hormones|hormones|mesh-ancestor
20222946|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20222947|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526833|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20526834|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20526835|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20526836|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20526837|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20526838|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
20526839|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20526840|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20526841|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20526842|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20526843|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20526844|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
20526845|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20526846|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20526847|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
20526848|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526849|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526850|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526851|NCT01764893|Urological Agents|urological agents|mesh-ancestor
20526852|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
20526853|NCT01765010|Calcitriol|calcitriol|mesh-list
20526854|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
20526855|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20526856|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20526857|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526858|NCT01765010|Vitamins|vitamins|mesh-ancestor
20526859|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
20222948|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20222949|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617467|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
20617468|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
20617469|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20617470|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617471|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617472|NCT02276989|Diuretics|diuretics|mesh-ancestor
20617473|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
20617474|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
20617475|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20222950|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
20222951|NCT00331071|Ortho Evra|ortho evra|mesh-list
20222952|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
20222953|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20222954|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222955|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20222956|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20222957|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20222958|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
20222959|NCT00331084|Dexamethasone|dexamethasone|mesh-list
20222960|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
20222961|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20222962|NCT00331084|BB 1101|bb 1101|mesh-list
20222963|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20222964|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
20222965|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
20222966|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20222967|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222968|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20222969|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
20222970|NCT00331084|Hormones|hormones|mesh-ancestor
20222971|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617476|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20617477|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617478|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20617479|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20617480|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617481|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20617482|NCT02276989|Analgesics|analgesics|mesh-ancestor
20222972|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20222973|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222974|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
20464020|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
20464021|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464022|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464023|NCT01445587|Bortezomib|bortezomib|mesh-list
20464024|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464025|NCT01445600|Retapamulin|retapamulin|mesh-list
20464026|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20464027|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464028|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
20464029|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20464030|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464031|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464032|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464033|NCT01445639|Analgesics|analgesics|mesh-ancestor
20464034|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
20464035|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464036|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20617483|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
20617484|NCT02277041|Misoprostol|misoprostol|mesh-list
20617485|NCT02277041|Carbetocin|carbetocin|mesh-list
20617486|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20617487|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
20617488|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20617489|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617490|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20617491|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19408170|NCT03568838|Enoxaparin|enoxaparin|mesh-list
19408171|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
20617492|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
20464037|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20617493|NCT02277067|Misoprostol|misoprostol|mesh-list
19408172|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20222975|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617494|NCT02277067|Carbetocin|carbetocin|mesh-list
20617495|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20617496|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
20617497|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20617498|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617499|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20617500|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617501|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
20617502|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
20617503|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
20617504|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20617505|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20617506|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617507|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617508|NCT02277132|Urological Agents|urological agents|mesh-ancestor
20617509|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
20617510|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20617511|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
20617512|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617513|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617514|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20617515|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
20617516|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20464038|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20464039|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464040|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617517|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
20617518|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617519|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617520|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20617521|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
20617522|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
20617523|NCT02277171|Protective Agents|protective agents|mesh-ancestor
20617524|NCT02277184|Cisplatin|cisplatin|mesh-list
20617525|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617526|NCT02277197|Cetuximab|cetuximab|mesh-list
20617527|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20617528|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617529|NCT02277223|Curcumin|curcumin|mesh-list
20617530|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20617531|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20617532|NCT02277223|Analgesics|analgesics|mesh-ancestor
20617533|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
20617534|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694931|NCT04959721|Hormones|hormones|mesh-ancestor
19694932|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19694933|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19694934|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
20464041|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464042|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20464043|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20464044|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
20617535|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617536|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617537|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617538|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617539|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617540|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617541|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20617542|NCT02277457|Crizotinib|crizotinib|mesh-list
20617543|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617544|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20617545|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617546|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408173|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19408174|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464045|NCT01445743|Vaccines|vaccines|mesh-list
20464046|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
19408175|NCT03568721|Acetaminophen|acetaminophen|mesh-list
19408176|NCT03568721|Ibuprofen|ibuprofen|mesh-list
19408177|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694935|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464047|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464048|NCT01445756|Lidocaine|lidocaine|mesh-list
20464049|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
20464050|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
20617547|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
20617548|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20617549|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20617550|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20617551|NCT02277587|Cortisone|cortisone|mesh-list
20617552|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
20617553|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617554|NCT02277587|Hormones|hormones|mesh-ancestor
20617555|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617556|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617557|NCT02277600|Darunavir|darunavir|mesh-list
20617558|NCT02277600|Cobicistat|cobicistat|mesh-list
20617559|NCT02277600|Fostemsavir|fostemsavir|mesh-list
20617560|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20617561|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20617562|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
20617563|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617564|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617565|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20617566|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19694936|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694937|NCT04959786|Ribavirin|ribavirin|mesh-list
19694938|NCT04959786|Ivermectin|ivermectin|mesh-list
19694939|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
19694940|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
19694941|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617567|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
19694942|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
19694943|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694944|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19694945|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
20222976|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222977|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20222978|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20222979|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20222980|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20222981|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
20222982|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20464051|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464052|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464053|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
20464054|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464055|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20464056|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20464057|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20464058|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20464059|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464060|NCT01445860|Simvastatin|simvastatin|mesh-list
20464061|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20464062|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20464063|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
20464064|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464065|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20464066|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20464067|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464068|NCT01445938|Lumefantrine|lumefantrine|mesh-list
20464069|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
20464070|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20464071|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20464072|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464073|NCT01445964|Atenolol|atenolol|mesh-list
20464074|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20464075|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464076|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
20464077|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
20464078|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464079|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464080|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20617568|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617569|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19694946|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
19694947|NCT04959578|Hematinics|hematinics|mesh-ancestor
19694948|NCT04959591|Acetaminophen|acetaminophen|mesh-list
20617570|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20617571|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20617572|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20617573|NCT02277678|Morphine|morphine|mesh-list
20617574|NCT02277678|Oxycodone|oxycodone|mesh-list
20617575|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
20617576|NCT02277678|Narcotics|narcotics|mesh-ancestor
20617577|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617578|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617579|NCT02277678|Analgesics|analgesics|mesh-ancestor
20617580|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
20617581|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617582|NCT02277717|Trastuzumab|trastuzumab|mesh-list
20617583|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20617584|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617585|NCT02277730|Phenylephrine|phenylephrine|mesh-list
20617586|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
20617587|NCT02277730|Ephedrine|ephedrine|mesh-list
19694949|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19694950|NCT04959591|Analgesics|analgesics|mesh-ancestor
19694951|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
19694952|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19694953|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694954|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
20617588|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20617589|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20617590|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
20617591|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
20617592|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617593|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617594|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
20617595|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
20617596|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
20617597|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20617598|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20617599|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20617600|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
20617601|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617602|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617603|NCT02277730|Protective Agents|protective agents|mesh-ancestor
20617604|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20617605|NCT02277808|Amikacin|amikacin|mesh-list
20617606|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20617607|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617608|NCT02277847|Cytarabine|cytarabine|mesh-list
20617609|NCT02277847|Idarubicin|idarubicin|mesh-list
20617610|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20464081|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20464082|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20464083|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464084|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464085|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464086|NCT01446094|Regadenoson|regadenoson|mesh-list
20464087|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20464088|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20464089|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
20464090|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
20464091|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464092|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464093|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464094|NCT01446107|Fluorides|fluorides|mesh-list
20617611|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
20617612|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617613|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617614|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
20617615|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617616|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617617|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
20617618|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617619|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20617620|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19694955|NCT04959331|Fosfomycin|fosfomycin|mesh-list
19694956|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
19849587|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20617621|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20617622|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222983|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20222984|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20222985|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20222986|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
20222987|NCT00331097|Docetaxel|docetaxel|mesh-list
20617623|NCT02277886|Esomeprazole|esomeprazole|mesh-list
20617624|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20617625|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617626|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20617627|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617628|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617629|NCT02277938|Amantadine|amantadine|mesh-list
20617630|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20617631|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20617632|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
20617633|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617634|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
20617635|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617636|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617637|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617638|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20617639|NCT02277938|Analgesics|analgesics|mesh-ancestor
20617640|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
20617641|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617642|NCT02278081|Lansoprazole|lansoprazole|mesh-list
20617643|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
20617644|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20617645|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617646|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20617647|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617648|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694957|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
19694958|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19694959|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19694960|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19694961|NCT04959331|Renal Agents|renal agents|mesh-ancestor
19694962|NCT04959253|Psilocybin|psilocybin|mesh-list
20222988|NCT00331097|Fluorouracil|fluorouracil|mesh-list
20222989|NCT00331097|Methotrexate|methotrexate|mesh-list
19694963|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
20222990|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19707774|NCT04824053|Trace Elements|trace elements|mesh-ancestor
20464095|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
20464096|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
20464097|NCT01446107|Protective Agents|protective agents|mesh-ancestor
20464098|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464099|NCT01446120|Insulin|insulin|mesh-list
20464100|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20464101|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
20617649|NCT02278172|Vitamin D|vitamin d|mesh-list
20617650|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
20617651|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
20617652|NCT02278172|Vitamins|vitamins|mesh-list
20617653|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
20617654|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617655|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20617656|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20617657|NCT02278250|Carboplatin|carboplatin|mesh-list
20617658|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617659|NCT02278302|Ethanol|ethanol|mesh-list
20617660|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
20617661|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20617662|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617663|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617664|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617665|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20617666|NCT02278315|Dexamethasone|dexamethasone|mesh-list
20617667|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617668|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
20617669|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
20617670|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617671|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617672|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617673|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
20617674|NCT02278315|Hormones|hormones|mesh-ancestor
20617675|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617676|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20617677|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617678|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
20617679|NCT02278419|Simeprevir|simeprevir|mesh-list
20617680|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
20617681|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617682|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
20617683|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20222991|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
20222992|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20222993|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20222994|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20222995|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
20222996|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20222997|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20222998|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20222999|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
20223000|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
20223001|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
20223002|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
20223003|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20223004|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20223005|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
20223006|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20223007|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
20223008|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223009|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20223010|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20223011|NCT00331123|Testosterone|testosterone|mesh-list
20223012|NCT00331123|Androgens|androgens|mesh-ancestor
20223013|NCT00331123|Hormones|hormones|mesh-ancestor
20223014|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223015|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223016|NCT00331149|Ropinirole|ropinirole|mesh-list
20223017|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20223018|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20223019|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
20464102|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
20617684|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617685|NCT02278458|Gemcitabine|gemcitabine|mesh-list
20617686|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20617687|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
19849588|NCT00704028|Dextrans|dextrans|mesh-list
19849589|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
19849590|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
19849591|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
19849592|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
19849593|NCT00704028|Hematinics|hematinics|mesh-ancestor
19849594|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19849595|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20464103|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
20464104|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20464105|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464106|NCT01446211|Gusperimus|gusperimus|mesh-list
20464107|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
20464108|NCT01446211|Methotrexate|methotrexate|mesh-list
20464109|NCT01446211|Azathioprine|azathioprine|mesh-list
20464110|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
20464111|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20464112|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
20464113|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464114|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464115|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20464116|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
20464117|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464118|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464119|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20464120|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20464121|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
20464122|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20464123|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20464124|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
20464125|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
20464126|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464127|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20464128|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20464129|NCT01446211|Hormones|hormones|mesh-ancestor
20464130|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20464131|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20464132|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20464133|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20464134|NCT01446211|Protective Agents|protective agents|mesh-ancestor
20464135|NCT01446224|Bevacizumab|bevacizumab|mesh-list
20464136|NCT01446224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464137|NCT01446224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464138|NCT01446224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20464139|NCT01446224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20464140|NCT01446224|Growth Substances|growth substances|mesh-ancestor
20464141|NCT01446224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464142|NCT01446224|Growth Inhibitors|growth inhibitors|mesh-ancestor
20464143|NCT01446276|Resveratrol|resveratrol|mesh-list
20464144|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
20464145|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464146|NCT01446276|Protective Agents|protective agents|mesh-ancestor
20464147|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464148|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464149|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20464150|NCT01446328|Olanzapine|olanzapine|mesh-list
20464151|NCT01446328|Aripiprazole|aripiprazole|mesh-list
20464152|NCT01446328|Amisulpride|amisulpride|mesh-list
20464153|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
20464154|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
20464155|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464156|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464157|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464158|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20464159|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20464160|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464161|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464162|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20464163|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20464164|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20464165|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464166|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464167|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
20464168|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
20617688|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617689|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617690|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
20617691|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617692|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617693|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20617694|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
20617695|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617696|NCT02278510|Topotecan|topotecan|mesh-list
20617697|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20464169|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
20464170|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
20464171|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20464172|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19849596|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849597|NCT00704132|Incretins|incretins|mesh-ancestor
19849598|NCT00704132|Hormones|hormones|mesh-ancestor
19849599|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849600|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20464173|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20464174|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20464175|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20464176|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20464177|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20464178|NCT01446445|Valganciclovir|valganciclovir|mesh-list
20464179|NCT01446445|Ganciclovir|ganciclovir|mesh-list
20464180|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20464181|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
20464182|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464183|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20464184|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464185|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464186|NCT01446458|Folfirinox|folfirinox|mesh-list
19849601|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
19849602|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849603|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464187|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464188|NCT01446484|Cyclosporine|cyclosporine|mesh-list
20464189|NCT01446484|Sirolimus|sirolimus|mesh-list
20464190|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
20464191|NCT01446484|Everolimus|everolimus|mesh-list
20464192|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
20617698|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20617699|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617700|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617701|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617702|NCT02278575|Antithrombins|antithrombins|mesh-list
20617703|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
20617704|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20617705|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
20617706|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617707|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408178|NCT03568721|Analgesics|analgesics|mesh-ancestor
19408179|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
19408180|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464193|NCT01446484|Tacrolimus|tacrolimus|mesh-list
20464194|NCT01446484|Cyclosporins|cyclosporins|mesh-list
20464195|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20464196|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
20464197|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464198|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20464199|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464200|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464201|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
20464202|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464203|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
19408181|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408182|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
19408183|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19408184|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408185|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849604|NCT00704184|Interferons|interferons|mesh-list
20464204|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617708|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
19408186|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20617709|NCT02278588|Rasagiline|rasagiline|mesh-list
20617710|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20617711|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617712|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617713|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20617714|NCT02278588|Protective Agents|protective agents|mesh-ancestor
19408187|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408188|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408189|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19408190|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19408191|NCT03568708|Estradiol|estradiol|mesh-list
19408192|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19408193|NCT03568708|Estrogens|estrogens|mesh-list
19408194|NCT03568708|Hormones|hormones|mesh-ancestor
19408195|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408196|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408197|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19408198|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
19408199|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408200|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19408201|NCT03568643|Amoxicillin|amoxicillin|mesh-list
20617715|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617716|NCT02278601|Fentanyl|fentanyl|mesh-list
20617717|NCT02278601|Ropivacaine|ropivacaine|mesh-list
20617718|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
20617719|NCT02278601|Anesthetics|anesthetics|mesh-list
20617720|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617721|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617722|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
20617723|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617724|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20617725|NCT02278601|Narcotics|narcotics|mesh-ancestor
20617726|NCT02278601|Analgesics|analgesics|mesh-ancestor
20617727|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20617728|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20617729|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
20617730|NCT02278692|Vitamin K|vitamin k|mesh-list
20617731|NCT02278692|Vitamins|vitamins|mesh-ancestor
20617732|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
20617733|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464205|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464206|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20464207|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20617734|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20617735|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20617736|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617737|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
20617738|NCT02278692|Coagulants|coagulants|mesh-ancestor
20617739|NCT02278861|Tretinoin|tretinoin|mesh-list
20617740|NCT02278861|Isotretinoin|isotretinoin|mesh-list
20617741|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
20617742|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
20617743|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617744|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
20617745|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20617746|NCT02278861|Protective Agents|protective agents|mesh-ancestor
20617747|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464208|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
20464209|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20464210|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464211|NCT01446497|Timolol|timolol|mesh-list
20464212|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20464213|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20464214|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20464215|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464216|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464217|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464218|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464219|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20464220|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464221|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20617748|NCT02278913|Insulin|insulin|mesh-list
19408202|NCT03568643|Azithromycin|azithromycin|mesh-list
19408203|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20617749|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
20617750|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20617751|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617752|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617753|NCT02278926|Insulin|insulin|mesh-list
20617754|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617755|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617756|NCT02278965|Metformin|metformin|mesh-list
20617757|NCT02278965|Biguanides|biguanides|mesh-list
20617758|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617759|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849605|NCT00704184|Ribavirin|ribavirin|mesh-list
19849606|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464222|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20464223|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20464224|NCT01446523|Lactulose|lactulose|mesh-list
20464225|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464226|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20464227|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
20464228|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849607|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
19849608|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849609|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
19849610|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849611|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
19849612|NCT00704262|Calcipotriene|calcipotriene|mesh-list
19849613|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849614|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
19849615|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
19849616|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
19849617|NCT00704353|Hematinics|hematinics|mesh-ancestor
19849618|NCT00704379|Sertraline|sertraline|mesh-list
19849619|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
19849620|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464229|NCT01446679|Atorvastatin|atorvastatin|mesh-list
20464230|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20464231|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20464232|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
20464233|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464234|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20464235|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20464236|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464237|NCT01446731|Docetaxel|docetaxel|mesh-list
20464238|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464239|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
20464240|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
20464241|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
20617760|NCT02278978|Nintedanib|nintedanib|mesh-list
20617761|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617762|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20617763|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617764|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617765|NCT02279121|Taurolidine|taurolidine|mesh-list
19849621|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19849622|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19849623|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849624|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849625|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849626|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
19849627|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849628|NCT00704405|Interferons|interferons|mesh-list
19849629|NCT00704405|Ribavirin|ribavirin|mesh-list
19849630|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849631|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
19849632|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849633|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
19849634|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617766|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20617767|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849635|NCT00704418|Bromfenac|bromfenac|mesh-list
19849636|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223020|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
20223021|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223022|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223023|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223024|NCT00331188|Vapreotide|vapreotide|mesh-list
20223025|NCT00331188|Analgesics|analgesics|mesh-ancestor
20223026|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
20223027|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617768|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20617769|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617770|NCT02279134|Paclitaxel|paclitaxel|mesh-list
20617771|NCT02279134|Nedaplatin|nedaplatin|mesh-list
20617772|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20617773|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617774|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
20617775|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
20617776|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
20617777|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617778|NCT02279147|Neostigmine|neostigmine|mesh-list
20617779|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20617780|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464242|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464243|NCT01446783|Mecasermin|mecasermin|mesh-list
20464244|NCT01446783|Growth Substances|growth substances|mesh-ancestor
20464245|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464246|NCT01446900|Rituximab|rituximab|mesh-list
20464247|NCT01446900|Cladribine|cladribine|mesh-list
20464248|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464249|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464250|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
20464251|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849637|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19849638|NCT00704418|Analgesics|analgesics|mesh-ancestor
19849639|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
19849640|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849641|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849642|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849643|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849644|NCT00704522|Ribavirin|ribavirin|mesh-list
19849645|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19849646|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
19849647|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849648|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
19849649|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849650|NCT00704717|Ribavirin|ribavirin|mesh-list
19849651|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20617781|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617782|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
20617783|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617784|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617785|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20617786|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
20617787|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617788|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
20617789|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20617790|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20617791|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617792|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
20617793|NCT02279186|Coagulants|coagulants|mesh-ancestor
20617794|NCT02279316|Vitamin D|vitamin d|mesh-list
20617795|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
20617796|NCT02279316|Vitamins|vitamins|mesh-ancestor
20617797|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
19849652|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
19849653|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
20464252|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464253|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20464254|NCT01446926|Vaccines|vaccines|mesh-list
20464255|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20464256|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
20464257|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464258|NCT01446952|Vitamin E|vitamin e|mesh-list
20464259|NCT01446952|Tocopherols|tocopherols|mesh-list
20464260|NCT01446952|Tocotrienols|tocotrienols|mesh-list
20464261|NCT01446952|Vitamins|vitamins|mesh-ancestor
20464262|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
20464263|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849654|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464264|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
20464265|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617798|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849655|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
19849656|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464266|NCT01446952|Protective Agents|protective agents|mesh-ancestor
20526860|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20617799|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20464267|NCT01446978|Vaccines|vaccines|mesh-list
20464268|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
20464269|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617800|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20617801|NCT02279342|Febuxostat|febuxostat|mesh-list
20617802|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
20617803|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20617804|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
20617805|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20617806|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617807|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
20617808|NCT02279394|Dexamethasone|dexamethasone|mesh-list
20617809|NCT02279394|Lenalidomide|lenalidomide|mesh-list
20617810|NCT02279394|Elotuzumab|elotuzumab|mesh-list
20617811|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617812|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
20617813|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
20617814|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617815|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223028|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464270|NCT01447043|Ranibizumab|ranibizumab|mesh-list
20464271|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20464272|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20464273|NCT01447043|Growth Substances|growth substances|mesh-ancestor
20464274|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464275|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
20464276|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464277|NCT01447069|Albuterol|albuterol|mesh-list
20464278|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20464279|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
20464280|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464281|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464282|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20464283|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
20464284|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
20464285|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20464286|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20464287|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20464288|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20464289|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464290|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464291|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464292|NCT01447095|Epoprostenol|epoprostenol|mesh-list
20464293|NCT01447095|Tezosentan|tezosentan|mesh-list
20464294|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464295|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20464296|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
20464297|NCT01447160|Cortisone|cortisone|mesh-list
20464298|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464299|NCT01447173|Vitamin D|vitamin d|mesh-list
20464300|NCT01447173|Vitamins|vitamins|mesh-ancestor
20464301|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
20464302|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464303|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20464304|NCT01447212|Hydromorphone|hydromorphone|mesh-list
20464305|NCT01447212|Heroin|heroin|mesh-list
20223029|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223030|NCT00331214|Testosterone|testosterone|mesh-list
20223031|NCT00331214|Androgens|androgens|mesh-ancestor
20223032|NCT00331214|Hormones|hormones|mesh-ancestor
20223033|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223034|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223035|NCT00331240|Timolol|timolol|mesh-list
20223036|NCT00331240|Travoprost|travoprost|mesh-list
20223037|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
20223038|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223039|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223040|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223041|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223042|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223043|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464306|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20464307|NCT01447212|Narcotics|narcotics|mesh-ancestor
20464308|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617816|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464309|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464310|NCT01447212|Analgesics|analgesics|mesh-ancestor
20617817|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
20223044|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20617818|NCT02279394|Hormones|hormones|mesh-ancestor
20617819|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20617820|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20617821|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617822|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
20617823|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20617824|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20617825|NCT02279394|Growth Substances|growth substances|mesh-ancestor
20617826|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
20617827|NCT02279511|Adenosine|adenosine|mesh-list
20617828|NCT02279511|Analgesics|analgesics|mesh-ancestor
20617829|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
20617830|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617831|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617832|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20617833|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
20617834|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20617835|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
20617836|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
20617837|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617838|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617839|NCT02279537|Aflibercept|aflibercept|mesh-list
20617840|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20617841|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20617842|NCT02279537|Growth Substances|growth substances|mesh-ancestor
20617843|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617844|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
20617845|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617846|NCT02279563|Fluticasone|fluticasone|mesh-list
20617847|NCT02279563|Xhance|xhance|mesh-list
20617848|NCT02279563|Azelastine|azelastine|mesh-list
20617849|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20617850|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20617851|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
20617852|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617853|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617854|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20617855|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
20617856|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
20617857|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20617858|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20617859|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617860|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617861|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20617862|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20617863|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
20617864|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
20464311|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
20464312|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464313|NCT01447355|Vitamin D|vitamin d|mesh-list
20464314|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
20464315|NCT01447355|Vitamins|vitamins|mesh-ancestor
20464316|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
20464317|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464318|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20464319|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20464320|NCT01447368|Cinacalcet|cinacalcet|mesh-list
20617865|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223045|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223046|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20223047|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20223048|NCT00331305|Sertraline|sertraline|mesh-list
20223049|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
20223050|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223051|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20223052|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20617866|NCT02279576|Paclitaxel|paclitaxel|mesh-list
20617867|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20617868|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20617869|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617870|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
20617871|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
20464321|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20617872|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
20223053|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20223054|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223055|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223056|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
20223057|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223058|NCT00331435|Verteporfin|verteporfin|mesh-list
20223059|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20223060|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
20223061|NCT00331487|Pioglitazone|pioglitazone|mesh-list
20223062|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
20223063|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20223064|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223065|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20223066|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20223067|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20223068|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223069|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223070|NCT00331500|Analgesics|analgesics|mesh-ancestor
20223071|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
20223072|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223073|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223074|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223075|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223076|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20223077|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20223078|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20223079|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
20223080|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
20223081|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223082|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223083|NCT00331513|Vorinostat|vorinostat|mesh-list
20223084|NCT00331513|Idarubicin|idarubicin|mesh-list
20223085|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223086|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20223087|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464322|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464323|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20464324|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
20464325|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20464326|NCT01447394|Interferons|interferons|mesh-list
20464327|NCT01447394|Ribavirin|ribavirin|mesh-list
20464328|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
20464329|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
20464330|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20464331|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464332|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
20464333|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464334|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
20464335|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464336|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
20464337|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464338|NCT01447485|Valsartan|valsartan|mesh-list
20464339|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464340|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20464341|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20464342|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464343|NCT01447550|Bosentan|bosentan|mesh-list
20464344|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464345|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20464346|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464347|NCT01447563|Clopidogrel|clopidogrel|mesh-list
20464348|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20464349|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20464350|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20464351|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20464352|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
20464353|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464354|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464355|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464356|NCT01447589|Nelfinavir|nelfinavir|mesh-list
20464357|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20464358|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20464359|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
19694964|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694965|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19694966|NCT04959500|Temozolomide|temozolomide|mesh-list
19694967|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19694968|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
19694969|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694970|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707775|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
19707776|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
20464360|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464361|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464362|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20464363|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20464364|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
20464365|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464366|NCT01447654|Losartan|losartan|mesh-list
20464367|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20464368|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464369|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20464370|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20464371|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464372|NCT01447797|Irbesartan|irbesartan|mesh-list
20464373|NCT01447797|Atorvastatin|atorvastatin|mesh-list
20464374|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20464375|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20464376|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
20464377|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464378|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20464379|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20464380|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464381|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464382|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20464383|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20464384|NCT01447862|Ibutilide|ibutilide|mesh-list
20464385|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20464386|NCT01447875|Propofol|propofol|mesh-list
20464387|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20464388|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464389|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464390|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20464391|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
20464392|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
20464393|NCT01447979|Pancrelipase|pancrelipase|mesh-list
20464394|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464395|NCT01447992|Pancrelipase|pancrelipase|mesh-list
20464396|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464397|NCT01448018|Ranibizumab|ranibizumab|mesh-list
20464398|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20464399|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20464400|NCT01448018|Growth Substances|growth substances|mesh-ancestor
20464401|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464402|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
20464403|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464404|NCT01448031|Esomeprazole|esomeprazole|mesh-list
20464405|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20464406|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464407|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20464408|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464409|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464410|NCT01448070|Insulin|insulin|mesh-list
20464411|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20464412|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20464413|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464414|NCT01448096|Rituximab|rituximab|mesh-list
20464415|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464416|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464417|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
20464418|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464419|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464420|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
20464421|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20464422|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464423|NCT01448174|Atorvastatin|atorvastatin|mesh-list
20617873|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617874|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20617875|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
20617876|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617877|NCT02279615|Tamsulosin|tamsulosin|mesh-list
20617878|NCT02279615|Mirabegron|mirabegron|mesh-list
20617879|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20617880|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20617881|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20617882|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
20617883|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617884|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617885|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617886|NCT02279615|Urological Agents|urological agents|mesh-ancestor
20617887|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20617888|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20617889|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20617890|NCT02279628|Morphine|morphine|mesh-list
20617891|NCT02279628|Ropivacaine|ropivacaine|mesh-list
20617892|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20617893|NCT02279628|Narcotics|narcotics|mesh-ancestor
20617894|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617895|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617896|NCT02279628|Analgesics|analgesics|mesh-ancestor
20617897|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
20617898|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617899|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
19849657|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
19849658|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849659|NCT00704808|Temozolomide|temozolomide|mesh-list
19849660|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19849661|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
19849662|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849663|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223088|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223089|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20223090|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20223091|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20223092|NCT00331526|Aldesleukin|aldesleukin|mesh-list
20223093|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223094|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20464424|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20464425|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20464426|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
20464427|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849664|NCT00704847|Calcitonin|calcitonin|mesh-list
19849665|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
19849666|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20464428|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20464429|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19849667|NCT00704847|Katacalcin|katacalcin|mesh-list
19849668|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19849669|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849670|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20464430|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464431|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20464432|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
20464433|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464434|NCT01448252|Vaccines|vaccines|mesh-list
19849671|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
19849672|NCT00704912|Orlistat|orlistat|mesh-list
19849673|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
19849674|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19849675|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
19849676|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19849677|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849678|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20223095|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20223096|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
20223097|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223098|NCT00331604|Insulin|insulin|mesh-list
20464435|NCT01448252|Immunologic Factors|immunologic factors|mesh-ancestor
20617900|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
20464436|NCT01448252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464437|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20464438|NCT01448291|Etonogestrel|etonogestrel|mesh-list
20464439|NCT01448291|NuvaRing|nuvaring|mesh-list
20464440|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
20464441|NCT01448291|Estradiol|estradiol|mesh-list
20464442|NCT01448291|Estrogens|estrogens|mesh-ancestor
20464443|NCT01448291|Hormones|hormones|mesh-ancestor
20464444|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20464445|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464446|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20464447|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20464448|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20464449|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20464450|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20464451|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20464452|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20464453|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
20464454|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464455|NCT01448330|Aspirin|aspirin|mesh-list
20464456|NCT01448330|Clopidogrel|clopidogrel|mesh-list
20464457|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223099|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20223100|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
20223101|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
20464458|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464459|NCT01448330|Analgesics|analgesics|mesh-ancestor
20464460|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
20464461|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464462|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464463|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464464|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464465|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20464466|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20464467|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464468|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20464469|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20617909|NCT02279758|Metformin|metformin|mesh-list
20617910|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20617911|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617912|NCT02279875|Rifampin|rifampin|mesh-list
20617913|NCT02279875|Isoniazid|isoniazid|mesh-list
20617914|NCT02279875|Linezolid|linezolid|mesh-list
20617915|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
20223102|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20223103|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
20223104|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20223105|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223106|NCT00331643|Epothilones|epothilones|mesh-list
20223107|NCT00331643|Epothilone B|epothilone b|mesh-list
20223108|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
20223109|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
20223110|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
20223111|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223112|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223113|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20223114|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20223115|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20223116|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
20223117|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223118|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223119|NCT00331695|Progestins|progestins|mesh-ancestor
20223120|NCT00331695|Hormones|hormones|mesh-ancestor
20223121|NCT00331708|Artesunate|artesunate|mesh-list
20223122|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
20223123|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
20617916|NCT02279875|Ethambutol|ethambutol|mesh-list
20464470|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617917|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20464471|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
20464472|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20464473|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20464474|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19849679|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849680|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849681|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19849682|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19849683|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19849684|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19849685|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19849686|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19849687|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19849688|NCT00704938|Aldesleukin|aldesleukin|mesh-list
19849689|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
19849690|NCT00704938|Fludarabine|fludarabine|mesh-list
19849691|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
19849692|NCT00704938|Sargramostim|sargramostim|mesh-list
19849693|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849694|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
19849695|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849696|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849697|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19849698|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
19849699|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464475|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
20464476|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849700|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849701|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19849702|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19849703|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
19849704|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19849705|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19849706|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
19849707|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849708|NCT00704964|Ribavirin|ribavirin|mesh-list
19849709|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19849710|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
19849711|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
19849712|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849713|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
19849714|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849715|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
19849716|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849717|NCT00705003|Melatonin|melatonin|mesh-list
19849718|NCT00705003|Buspirone|buspirone|mesh-list
19849719|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
19849720|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849721|NCT00705003|Protective Agents|protective agents|mesh-ancestor
19849722|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849723|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849724|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20464477|NCT01448395|Avibactam|avibactam|mesh-list
20464478|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20464479|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464480|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464481|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20464482|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464483|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
20464484|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20464485|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20464486|NCT01448499|Clozapine|clozapine|mesh-list
20464487|NCT01448499|Amisulpride|amisulpride|mesh-list
20464488|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20464489|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
20464490|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464491|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464492|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464493|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20464494|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20464495|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464496|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464497|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
20464498|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
20464499|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19694971|NCT04959409|Tetracaine|tetracaine|mesh-list
19694972|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
19694973|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
19694974|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223124|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20464500|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
20464501|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20464502|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
20464503|NCT01448538|Bevacizumab|bevacizumab|mesh-list
20464504|NCT01448538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464505|NCT01448538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464506|NCT01448538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20464507|NCT01448538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20464508|NCT01448538|Growth Substances|growth substances|mesh-ancestor
20464509|NCT01448538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464510|NCT01448538|Growth Inhibitors|growth inhibitors|mesh-ancestor
20526861|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20526862|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20526863|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526864|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20526865|NCT01765023|Metformin|metformin|mesh-list
20526866|NCT01765023|Atorvastatin|atorvastatin|mesh-list
20526867|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20526868|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526869|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20617918|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
20617919|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20617920|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20617921|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
20617922|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20617923|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617924|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617925|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20617926|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20617927|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20617928|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20617929|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20617930|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20617931|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20617932|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20617933|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
20617934|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20617935|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20617936|NCT02279914|Misoprostol|misoprostol|mesh-list
20617937|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20617938|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
20617939|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20617940|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617941|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20617942|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20617943|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
20617944|NCT02279953|Vortioxetine|vortioxetine|mesh-list
20617945|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
20617946|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20617947|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20617948|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20617949|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617950|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617951|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20223125|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
20223126|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20223127|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20223128|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223129|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223130|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
20223131|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
20223132|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20223133|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
20223134|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20223135|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223136|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707777|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
20464511|NCT01448642|Atorvastatin|atorvastatin|mesh-list
20464512|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20464513|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20464514|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
20464515|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464516|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20617952|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20617953|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20617954|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617955|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617956|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
20617957|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20617958|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20617959|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20617960|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20617961|NCT02279966|Vortioxetine|vortioxetine|mesh-list
20617962|NCT02279966|Paroxetine|paroxetine|mesh-list
20617963|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20617964|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20223137|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20223138|NCT00331708|Renal Agents|renal agents|mesh-ancestor
20223139|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
20223140|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
20464517|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20464518|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464519|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20464520|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20464521|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20464522|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464523|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464524|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464525|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20464526|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20464527|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
20464528|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464529|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464530|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20464531|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20464532|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
20464533|NCT01448733|Clindamycin|clindamycin|mesh-list
20617965|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20617966|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617967|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20617968|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
20617969|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617970|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20617971|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
20617972|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20617973|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20617974|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20617975|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20617976|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20617977|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20617978|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20617979|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20617980|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20617981|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20617982|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20223141|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20223142|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
20223143|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223144|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20223145|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223146|NCT00331786|Aspirin|aspirin|mesh-list
20223147|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
20223148|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
20223149|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20464534|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
20464535|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
20464536|NCT01448733|Tretinoin|tretinoin|mesh-list
20464537|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20464538|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20464539|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464540|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20464541|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464542|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464543|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
20464544|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464545|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
20464546|NCT01448746|Heparin|heparin|mesh-list
20464547|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20464548|NCT01448746|Tinzaparin|tinzaparin|mesh-list
20464549|NCT01448746|Dalteparin|dalteparin|mesh-list
20464550|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
20617983|NCT02279992|Carboplatin|carboplatin|mesh-list
20617984|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20617985|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20617986|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
20617987|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20617988|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20617989|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694975|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19694976|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
20223150|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20617990|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20617991|NCT02279992|Urological Agents|urological agents|mesh-ancestor
20617992|NCT02280031|Aspirin|aspirin|mesh-list
20617993|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20617994|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20617995|NCT02280031|Analgesics|analgesics|mesh-ancestor
20617996|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
20617997|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20617998|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20617999|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618000|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618001|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20618002|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20618003|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618004|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20618005|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20618006|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618007|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
20618008|NCT02280057|Metformin|metformin|mesh-list
20618009|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20618010|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618011|NCT02280070|Leucovorin|leucovorin|mesh-list
20223151|NCT00331786|Analgesics|analgesics|mesh-ancestor
20223152|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
20223153|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223154|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223155|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223156|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223157|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20223158|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20223159|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223160|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20223161|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20223162|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618012|NCT02280070|Fluorouracil|fluorouracil|mesh-list
20618013|NCT02280070|Tegafur|tegafur|mesh-list
20618014|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
20618015|NCT02280070|Antibodies|antibodies|mesh-list
20618016|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
20618017|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
20618018|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
20618019|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618020|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
20618021|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618022|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618023|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618024|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618025|NCT02280070|Antidotes|antidotes|mesh-ancestor
20464551|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20618026|NCT02280070|Protective Agents|protective agents|mesh-ancestor
20618027|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
20464552|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20464553|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707778|NCT04823390|Fentanyl|fentanyl|mesh-list
20464554|NCT01448772|Dronabinol|dronabinol|mesh-list
20464555|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
20464556|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464557|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464558|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464559|NCT01448772|Analgesics|analgesics|mesh-ancestor
20464560|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
20464561|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464562|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20464563|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20464564|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464565|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464566|NCT01448772|Hormones|hormones|mesh-ancestor
20464567|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20464568|NCT01448798|Thrombin|thrombin|mesh-list
20464569|NCT01448798|Hemostatics|hemostatics|mesh-list
20464570|NCT01448798|Coagulants|coagulants|mesh-ancestor
20464571|NCT01448837|Timolol|timolol|mesh-list
20464572|NCT01448837|Bimatoprost|bimatoprost|mesh-list
20464573|NCT01448837|Latanoprost|latanoprost|mesh-list
20464574|NCT01448837|Cloprostenol|cloprostenol|mesh-list
20464575|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20464576|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20464577|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464578|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464579|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464580|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464581|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20464582|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20464583|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20464584|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20464585|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
20464586|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20464587|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
20464588|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20464589|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20464590|NCT01448993|Azithromycin|azithromycin|mesh-list
20464591|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20464592|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464593|NCT01449045|Lumefantrine|lumefantrine|mesh-list
20464594|NCT01449045|Artemether|artemether|mesh-list
20464595|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20464596|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
20464597|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20464598|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20464599|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464600|NCT01449110|Resveratrol|resveratrol|mesh-list
20464601|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
20464602|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464603|NCT01449110|Protective Agents|protective agents|mesh-ancestor
20464604|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464605|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464606|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20464607|NCT01449123|Mannitol|mannitol|mesh-list
20464608|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20464609|NCT01449123|Diuretics|diuretics|mesh-ancestor
20464610|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
20464611|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464612|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20464613|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464614|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
20464615|NCT01449188|Ondansetron|ondansetron|mesh-list
20464616|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20464617|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464618|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20464619|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20464620|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464621|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464622|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464623|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464624|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
20464625|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
20618028|NCT02280070|Vitamins|vitamins|mesh-ancestor
20618029|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
20618030|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
20618031|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20618032|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20618033|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20618034|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20618035|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618036|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
20464626|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464627|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464628|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
20464629|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
20464630|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20464631|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
20464632|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464633|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20464634|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20464635|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464636|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464637|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20464638|NCT01449253|Bosentan|bosentan|mesh-list
20464639|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
20464640|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
20464641|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19694977|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464642|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20464643|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464644|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464645|NCT01449253|Urological Agents|urological agents|mesh-ancestor
20618037|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618038|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618039|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19694978|NCT04958746|Propofol|propofol|mesh-list
19694979|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19694980|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464646|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20618040|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618041|NCT02280109|Tenofovir|tenofovir|mesh-list
20618042|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
20618043|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618044|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20618045|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20618046|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618047|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618048|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20618049|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20618050|NCT02280148|Propofol|propofol|mesh-list
20618051|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
20618052|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464647|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20464648|NCT01449344|Cytarabine|cytarabine|mesh-list
20464649|NCT01449344|Dexamethasone|dexamethasone|mesh-list
20618053|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618054|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20618055|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20618056|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
20618057|NCT02280174|Linagliptin|linagliptin|mesh-list
20618058|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20464650|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
20464651|NCT01449344|Rituximab|rituximab|mesh-list
20464652|NCT01449344|Bortezomib|bortezomib|mesh-list
20464653|NCT01449344|BB 1101|bb 1101|mesh-list
20464654|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464655|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464656|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
20464657|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464658|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618059|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618060|NCT02280174|Incretins|incretins|mesh-ancestor
20618061|NCT02280174|Hormones|hormones|mesh-ancestor
20618062|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618063|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19707779|NCT04823390|Midazolam|midazolam|mesh-list
20464659|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464660|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
20464661|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
20464662|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464663|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20464664|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
20464665|NCT01449344|Hormones|hormones|mesh-ancestor
20464666|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20464667|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20464668|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
20464669|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408204|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408205|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19694981|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464670|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464671|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20464672|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
20464673|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
20464674|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464675|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20464676|NCT01449357|Zalutumumab|zalutumumab|mesh-list
20464677|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464678|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464679|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
20464680|NCT01449435|Miotics|miotics|mesh-ancestor
20464681|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
20464682|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464683|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464684|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20618064|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
20618065|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618066|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618067|NCT02280239|Acetaminophen|acetaminophen|mesh-list
20618068|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618069|NCT02280239|Analgesics|analgesics|mesh-ancestor
20618070|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
20618071|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618072|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618073|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
20618074|NCT02280265|Factor VIII|factor viii|mesh-list
20618075|NCT02280265|Coagulants|coagulants|mesh-ancestor
20618076|NCT02280447|Vaccines|vaccines|mesh-list
20618077|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
20618078|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618079|NCT02280486|Glimepiride|glimepiride|mesh-list
20464685|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20464686|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
20464687|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20464688|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20464689|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
20618080|NCT02280486|Saxagliptin|saxagliptin|mesh-list
20618081|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20618082|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20618083|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618084|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618085|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
20618086|NCT02280486|Incretins|incretins|mesh-ancestor
20618087|NCT02280486|Hormones|hormones|mesh-ancestor
20618088|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618089|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20618090|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
20618091|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618092|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618093|NCT02280525|Vidarabine|vidarabine|mesh-list
20618094|NCT02280525|Cytarabine|cytarabine|mesh-list
20618095|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
20618096|NCT02280525|Rituximab|rituximab|mesh-list
20618097|NCT02280525|Fludarabine|fludarabine|mesh-list
20618098|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
19694982|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19694983|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
19694984|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
19694985|NCT04958486|Trastuzumab|trastuzumab|mesh-list
19694986|NCT04958486|Azacitidine|azacitidine|mesh-list
20464690|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464691|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618099|NCT02280525|Lenalidomide|lenalidomide|mesh-list
20618100|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618101|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
20618102|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464692|NCT01449448|Triamcinolone|triamcinolone|mesh-list
20464693|NCT01449448|Ketorolac|ketorolac|mesh-list
20464694|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464695|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
20464696|NCT01449448|Hormones|hormones|mesh-ancestor
20464697|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20464698|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464699|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464700|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464701|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20464702|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618103|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618104|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20618105|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
20618106|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618107|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618108|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20618109|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20618110|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618111|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
20618112|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
20618113|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618114|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20618115|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20618116|NCT02280525|Growth Substances|growth substances|mesh-ancestor
20618117|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
20618118|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
20618119|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20618120|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
20618121|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618122|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
20618123|NCT02280538|Protective Agents|protective agents|mesh-ancestor
20618124|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20618125|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20618126|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20618127|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
20618128|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618129|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20618130|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20618131|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618132|NCT02280603|Minoxidil|minoxidil|mesh-list
20618133|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20618134|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
20618135|NCT02280616|Budesonide|budesonide|mesh-list
20618136|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618137|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20223163|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
20464703|NCT01449448|Analgesics|analgesics|mesh-ancestor
20464704|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
20464705|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464706|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464707|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20464708|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
20223164|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20223165|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
20223166|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20223167|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
20223168|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20223169|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
20223170|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223171|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20223172|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
20223173|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
20223174|NCT00331786|Protective Agents|protective agents|mesh-ancestor
20223175|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20223176|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
20223177|NCT00331825|Olanzapine|olanzapine|mesh-list
20223178|NCT00331825|Risperidone|risperidone|mesh-list
20223179|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20223180|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
20223181|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223182|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464709|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20223183|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223184|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20618138|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
20618139|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618140|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618141|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20618142|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
20618143|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
20618144|NCT02280616|Hormones|hormones|mesh-ancestor
20618145|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618146|NCT02280629|Mesalamine|mesalamine|mesh-list
20618147|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20618148|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618149|NCT02280629|Analgesics|analgesics|mesh-ancestor
20618150|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
20618151|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618152|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618153|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464710|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20464711|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464712|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
20464713|NCT01449552|Coagulants|coagulants|mesh-ancestor
20464714|NCT01449565|Naltrexone|naltrexone|mesh-list
20464715|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20464716|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20464717|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464718|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
20464719|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464720|NCT01449578|Pramipexole|pramipexole|mesh-list
20464721|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
20464722|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464723|NCT01449578|Protective Agents|protective agents|mesh-ancestor
20464724|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464725|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20464726|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20464727|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
20464728|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
20464729|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618154|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618155|NCT02280694|Celecoxib|celecoxib|mesh-list
20618156|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
20618157|NCT02280694|Capecitabine|capecitabine|mesh-list
20618158|NCT02280694|Methotrexate|methotrexate|mesh-list
20618159|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618160|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
20618161|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618162|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618163|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20618164|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
20618165|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618166|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618167|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20618168|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618169|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
20618170|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20618171|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
20618172|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20618173|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
20618174|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618175|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20618176|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20618177|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20618178|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618179|NCT02280694|Analgesics|analgesics|mesh-ancestor
20618180|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
20618181|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618182|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618183|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20618184|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20618185|NCT02280720|Tryptophan|tryptophan|mesh-list
20618186|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20618187|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
20618188|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20618189|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20464730|NCT01449617|Aspirin|aspirin|mesh-list
20618190|NCT02280772|Cathartics|cathartics|mesh-ancestor
20464731|NCT01449617|Clopidogrel|clopidogrel|mesh-list
20464732|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20464733|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464734|NCT01449617|Analgesics|analgesics|mesh-ancestor
20464735|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
20464736|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464737|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464738|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464739|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464740|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20618191|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20618192|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20464741|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20464742|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464743|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20464744|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20464745|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464746|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
20618193|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20618194|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618195|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
20618196|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
20618197|NCT02280876|Andrographolide|andrographolide|mesh-list
20618198|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618199|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20618200|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618201|NCT02280876|Analgesics|analgesics|mesh-ancestor
20618202|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
20618203|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618204|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618205|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618206|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20618207|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20618208|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618209|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
20618210|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20618211|NCT02280993|Dexamethasone|dexamethasone|mesh-list
20618212|NCT02280993|Cisplatin|cisplatin|mesh-list
20618213|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20618214|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618215|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618216|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
20618217|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
20618218|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618219|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618220|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20618221|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
20618222|NCT02280993|Hormones|hormones|mesh-ancestor
20618223|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618224|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20618225|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20618226|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
20618227|NCT02281006|Antidotes|antidotes|mesh-ancestor
20618228|NCT02281006|Protective Agents|protective agents|mesh-ancestor
20618229|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618230|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
20618231|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618232|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
20618233|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20618234|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618235|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
20618236|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
20618237|NCT02281045|Citric Acid|citric acid|mesh-list
20618238|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
20618239|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
20618240|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20618241|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
20618242|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
20618243|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618244|NCT02281058|Abatacept|abatacept|mesh-list
20618245|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20618246|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618247|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618248|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19707780|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20618249|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
20464747|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20464748|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20618250|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618251|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618252|NCT02281201|Thrombin|thrombin|mesh-list
20618253|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
20618254|NCT02281201|Coagulants|coagulants|mesh-ancestor
20618255|NCT02281240|Oprelvekin|oprelvekin|mesh-list
20618256|NCT02281240|Heparin|heparin|mesh-list
20464749|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20464750|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
20464751|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464752|NCT01449799|Fluticasone|fluticasone|mesh-list
20464753|NCT01449799|Xhance|xhance|mesh-list
20464754|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618257|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
20618258|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20618259|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20618260|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618261|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618262|NCT02281266|Entecavir|entecavir|mesh-list
20618263|NCT02281266|Thymalfasin|thymalfasin|mesh-list
20618264|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
20618265|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618266|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20618267|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
20618268|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618269|NCT02281279|Rituximab|rituximab|mesh-list
20618270|NCT02281279|Lenalidomide|lenalidomide|mesh-list
20618271|NCT02281279|Romidepsin|romidepsin|mesh-list
20618272|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20618273|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618274|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
20618275|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618276|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618277|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20618278|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20618279|NCT02281279|Growth Substances|growth substances|mesh-ancestor
20618280|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
20618281|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20618282|NCT02281292|Ranibizumab|ranibizumab|mesh-list
20618283|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20618284|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20618285|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20618286|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20618287|NCT02281292|Growth Substances|growth substances|mesh-ancestor
20618288|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618289|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
20618290|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618291|NCT02281305|Colchicine|colchicine|mesh-list
20618292|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
20618293|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618294|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
20618295|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
20618296|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
20618297|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618298|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618299|NCT02281370|Cyclosporine|cyclosporine|mesh-list
20618300|NCT02281370|Cyclosporins|cyclosporins|mesh-list
20618301|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618302|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618303|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618304|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
20618305|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618306|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
20618307|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618308|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
20618309|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618310|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20618311|NCT02281396|Vaccines|vaccines|mesh-list
20464755|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20464756|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
20464757|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464758|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618312|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
20618313|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618314|NCT02281643|Doxycycline|doxycycline|mesh-list
20618315|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20618316|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618317|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
20618318|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20618319|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20618320|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20618321|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20618322|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20618323|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618324|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
20618325|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20618326|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
20618327|NCT02281682|Fluorouracil|fluorouracil|mesh-list
20618328|NCT02281682|Imiquimod|imiquimod|mesh-list
20618329|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20618330|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
20618331|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618332|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618333|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618334|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618335|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
20618336|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618337|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20464759|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20464760|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
20464761|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
20464762|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20464763|NCT01449825|Bevacizumab|bevacizumab|mesh-list
20464764|NCT01449825|Sunitinib|sunitinib|mesh-list
20464765|NCT01449825|Sorafenib|sorafenib|mesh-list
20464766|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20464767|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464768|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20464769|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20464770|NCT01449825|Growth Substances|growth substances|mesh-ancestor
20464771|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464772|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
20464773|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20464774|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464775|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464776|NCT01449877|Trimethoprim|trimethoprim|mesh-list
20464777|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20464778|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
20464779|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20464780|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464781|NCT01449877|Renal Agents|renal agents|mesh-ancestor
20464782|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
20464783|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20464784|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20464785|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20464786|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618338|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
20618339|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20618340|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
20618341|NCT02281708|Cisplatin|cisplatin|mesh-list
20618342|NCT02281708|Vinorelbine|vinorelbine|mesh-list
20618343|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694987|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19694988|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694989|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20464787|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694990|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
19694991|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694992|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19694993|NCT04958187|Mitogens|mitogens|mesh-list
19694994|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
19694995|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19694996|NCT04958473|Axitinib|axitinib|mesh-list
19694997|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19694998|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19694999|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695000|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695001|NCT04957940|SMOFlipid|smoflipid|mesh-list
20464788|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20618344|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20618345|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
20618346|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
20223185|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20223186|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223187|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223188|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20223189|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
20464789|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20464790|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20464791|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20464792|NCT01450046|Vitamin E|vitamin e|mesh-list
20464793|NCT01450046|Tocopherols|tocopherols|mesh-list
20464794|NCT01450046|Tocotrienols|tocotrienols|mesh-list
20464795|NCT01450046|Vitamins|vitamins|mesh-ancestor
20464796|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
20464797|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464798|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
20464799|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464800|NCT01450046|Protective Agents|protective agents|mesh-ancestor
20464801|NCT01450111|Lacosamide|lacosamide|mesh-list
20464802|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
20464803|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20464804|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20464805|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20223190|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
20223191|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
20223192|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223193|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223194|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20223195|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20223196|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20223197|NCT00331838|Enoxaparin|enoxaparin|mesh-list
20223198|NCT00331838|Semuloparin|semuloparin|mesh-list
20223199|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20223200|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
20223201|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
20223202|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20464806|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618347|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
20618348|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618349|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
20618350|NCT02281721|Antacids|antacids|mesh-ancestor
19408206|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19408207|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
19408208|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408209|NCT03568578|Entecavir|entecavir|mesh-list
19408210|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
19408211|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408212|NCT03568513|Curcumin|curcumin|mesh-list
20618351|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618352|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19408213|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19695002|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19695003|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19695004|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19695005|NCT04958122|Penicillins|penicillins|mesh-list
19695006|NCT04958122|Cefixime|cefixime|mesh-list
19695007|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19695008|NCT04958122|Penicillin G|penicillin g|mesh-list
19695009|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
19695010|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20223203|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19695011|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464807|NCT01450124|Boswellic acid|boswellic acid|mesh-list
20618353|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
20618354|NCT02281799|Azathioprine|azathioprine|mesh-list
20618355|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
20618356|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618357|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618358|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618359|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618360|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
20618361|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618362|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20464808|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20464809|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464810|NCT01450124|Analgesics|analgesics|mesh-ancestor
20618363|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618364|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618365|NCT02281929|Amoxicillin|amoxicillin|mesh-list
20618366|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
20618367|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
19695012|NCT04957927|Fluticasone|fluticasone|mesh-list
19695013|NCT04957927|Xhance|xhance|mesh-list
20464811|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
20618368|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20618369|NCT02281929|Prednisolone|prednisolone|mesh-list
20618370|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20618371|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618372|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618373|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
20618374|NCT02281929|Hormones|hormones|mesh-ancestor
20618375|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618376|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618377|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20618378|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618379|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618380|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618381|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20618382|NCT02281968|Naproxen|naproxen|mesh-list
20618383|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20618384|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618385|NCT02281968|Analgesics|analgesics|mesh-ancestor
20618386|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
20618387|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618388|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618389|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618390|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618391|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
20618392|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20464812|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464813|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464814|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618393|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618394|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618395|NCT02281981|Curcumin|curcumin|mesh-list
20618396|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20618397|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618398|NCT02281981|Analgesics|analgesics|mesh-ancestor
20618399|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
20618400|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618401|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618402|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618403|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618404|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618405|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618406|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223204|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223205|NCT00331851|Metformin|metformin|mesh-list
20223206|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
20223207|NCT00331851|Liraglutide|liraglutide|mesh-list
20223208|NCT00331851|Glimepiride|glimepiride|mesh-list
20223209|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19695014|NCT04957927|Montelukast|montelukast|mesh-list
19695015|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707781|NCT04823390|Narcotics|narcotics|mesh-ancestor
20223210|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223211|NCT00331851|Incretins|incretins|mesh-ancestor
20223212|NCT00331851|Hormones|hormones|mesh-ancestor
19695016|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19695017|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
19695018|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695019|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695020|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19695021|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
19695022|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
19695023|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19695024|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20223213|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223214|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223215|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20223216|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
20223217|NCT00331890|Choline|choline|mesh-list
20223218|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20223219|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
20223220|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20223221|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
20223222|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223223|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223224|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20223225|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
20223226|NCT00331955|Doxorubicin|doxorubicin|mesh-list
20464815|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464816|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
20464817|NCT01450163|Pregabalin|pregabalin|mesh-list
20464818|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464819|NCT01450163|Analgesics|analgesics|mesh-ancestor
20464820|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
20464821|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464822|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464823|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
20464824|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20464825|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20464826|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464827|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20464828|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20464829|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20464830|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464831|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464832|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20464833|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
20464834|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20464835|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20464836|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20464837|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464838|NCT01450176|Analgesics|analgesics|mesh-ancestor
20464839|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
20464840|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464841|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464842|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464843|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20464844|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20464845|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20464846|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20464847|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
20464848|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
20464849|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464850|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464851|NCT01450215|Lenalidomide|lenalidomide|mesh-list
20464852|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
20464853|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464854|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20464855|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20464856|NCT01450215|Growth Substances|growth substances|mesh-ancestor
20464857|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
20464858|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464859|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20464860|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464861|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20464862|NCT01450345|Pregabalin|pregabalin|mesh-list
20464863|NCT01450345|Analgesics|analgesics|mesh-ancestor
20464864|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
20223227|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20223228|NCT00331955|Vorinostat|vorinostat|mesh-list
20223229|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20223230|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223231|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20223232|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20223233|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223234|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223235|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20223236|NCT00331981|Amisulpride|amisulpride|mesh-list
20223237|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20223238|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20618407|NCT02282059|Sunitinib|sunitinib|mesh-list
20618408|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464865|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464866|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464867|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
20464868|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20464869|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20464870|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464871|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20464872|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20464873|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20618409|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20618410|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20618411|NCT02282059|Growth Substances|growth substances|mesh-ancestor
20618412|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618413|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
20618414|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20618415|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618416|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618417|NCT02282085|Olanzapine|olanzapine|mesh-list
20618418|NCT02282085|Risperidone|risperidone|mesh-list
20618419|NCT02282085|Aripiprazole|aripiprazole|mesh-list
20618420|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19695025|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
19695026|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695027|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19695028|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20464874|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618421|NCT02282085|Ziprasidone|ziprasidone|mesh-list
20618422|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
20618423|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20618424|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20618425|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
20618426|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618427|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464875|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464876|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20464877|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526870|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20526871|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
20526872|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526873|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20526874|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20526875|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526876|NCT01765088|Temozolomide|temozolomide|mesh-list
20526877|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20526878|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
20526879|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526880|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526881|NCT01765231|Entecavir|entecavir|mesh-list
20526882|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
20618428|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618429|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20618430|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618431|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20618432|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20618433|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
20223239|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20526883|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526884|NCT01765257|Rasagiline|rasagiline|mesh-list
20618434|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
20618435|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
20464878|NCT01450384|Pemetrexed|pemetrexed|mesh-list
20464879|NCT01450384|Sorafenib|sorafenib|mesh-list
20464880|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618436|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618437|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20618438|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20618439|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20618440|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20618441|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
20618442|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
20618443|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20618444|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20618445|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20618446|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20618447|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20618448|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20618449|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20618450|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
20618451|NCT02282098|Colchicine|colchicine|mesh-list
20618452|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
20618453|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20618454|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
20618455|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
20618456|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
20618457|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618458|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618459|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20618460|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20618461|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618462|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
20618463|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20618464|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20618465|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20618466|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618467|NCT02282176|Azithromycin|azithromycin|mesh-list
20618468|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20618469|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618470|NCT02282241|Melatonin|melatonin|mesh-list
20618471|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
20618472|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618473|NCT02282241|Protective Agents|protective agents|mesh-ancestor
20618474|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618475|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618476|NCT02282267|Gefitinib|gefitinib|mesh-list
20464881|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464882|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464883|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20464884|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20464885|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20464886|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
20464887|NCT01450410|Niacin|niacin|mesh-list
20464888|NCT01450410|Niacinamide|niacinamide|mesh-list
20464889|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
20464890|NCT01450410|Vitamins|vitamins|mesh-ancestor
20464891|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
20464892|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464893|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20464894|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
20464895|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464896|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20464897|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
20464898|NCT01450462|Vitamin D|vitamin d|mesh-list
20464899|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
20464900|NCT01450462|Vitamins|vitamins|mesh-ancestor
20464901|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
20464902|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464903|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20464904|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20464905|NCT01450514|Pipamperone|pipamperone|mesh-list
20464906|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20464907|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
20464908|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464909|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464910|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464911|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20618477|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20464912|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20464913|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464914|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20464915|NCT01450566|Lidocaine|lidocaine|mesh-list
20464916|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
20464917|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
20464918|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464919|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618478|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20618479|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618480|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464920|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
20464921|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464922|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20618481|NCT02282280|Prilocaine|prilocaine|mesh-list
20618482|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
19408214|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19408215|NCT03568513|Analgesics|analgesics|mesh-ancestor
19408216|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
20618483|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
20618484|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223240|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223241|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223242|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20223243|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
19408217|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408218|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408219|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408220|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408221|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408222|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408223|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464923|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20464924|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20464925|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20464926|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464927|NCT01450774|Beclomethasone|beclomethasone|mesh-list
20464928|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
20223244|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223245|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223246|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20464929|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20618485|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618486|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
20618487|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618488|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
20618489|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
20618490|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20618491|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618492|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618493|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618494|NCT02282319|Analgesics|analgesics|mesh-ancestor
20618495|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
20618496|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618497|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20618498|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20618499|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20618500|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
20618501|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408224|NCT03568474|Fluorides|fluorides|mesh-list
19408225|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
20464930|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
20464931|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464932|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464933|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20464934|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
20464935|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20464936|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19408226|NCT03568474|Protective Agents|protective agents|mesh-ancestor
19408227|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223247|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
20464937|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20464938|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464939|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464940|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464941|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464942|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
20464943|NCT01450774|Hormones|hormones|mesh-ancestor
20464944|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20464945|NCT01450865|Flupirtine|flupirtine|mesh-list
20464946|NCT01450865|Analgesics|analgesics|mesh-ancestor
20618502|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618503|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
20618504|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
20618505|NCT02282358|Mocetinostat|mocetinostat|mesh-list
20618506|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20618507|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618508|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618509|NCT02282371|Cetuximab|cetuximab|mesh-list
20618510|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20618511|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618512|NCT02282384|Oseltamivir|oseltamivir|mesh-list
20618513|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
20618514|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
20618515|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618516|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618517|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618518|NCT02282384|Antacids|antacids|mesh-ancestor
20618519|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20618520|NCT02282410|Factor VIII|factor viii|mesh-list
20618521|NCT02282410|Coagulants|coagulants|mesh-ancestor
20618522|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
20618523|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20618524|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618525|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618526|NCT02282683|Prednisone|prednisone|mesh-list
20618527|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618528|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
20618529|NCT02282683|Hormones|hormones|mesh-ancestor
20618530|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618531|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618532|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20618533|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618534|NCT02282709|Asunaprevir|asunaprevir|mesh-list
20618535|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
20618536|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618537|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618538|NCT02282774|Lidocaine|lidocaine|mesh-list
20618539|NCT02282774|Bupivacaine|bupivacaine|mesh-list
20618540|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
20618541|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
20618542|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618543|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618544|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
20618545|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618546|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20618547|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20618548|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20618549|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20618550|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618551|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
20618552|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20618553|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618554|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618555|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618556|NCT02282787|Analgesics|analgesics|mesh-ancestor
20618557|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
20618558|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618559|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20618560|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20618561|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20618562|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
19849725|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19849726|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19849727|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20464947|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
20464948|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464949|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464950|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
20464951|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20464952|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20618563|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618564|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618565|NCT02282800|Vitamin D|vitamin d|mesh-list
20618566|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
20618567|NCT02282800|Vitamins|vitamins|mesh-ancestor
20618568|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
20618569|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618570|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20618571|NCT02282826|Acyclovir|acyclovir|mesh-list
20618572|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
20618573|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618574|NCT02282891|Ketamine|ketamine|mesh-list
20618575|NCT02282891|Propofol|propofol|mesh-list
20618576|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20618577|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618578|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618579|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20618580|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
20618581|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
20618582|NCT02282891|Analgesics|analgesics|mesh-ancestor
20618583|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
20618584|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618585|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20618586|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20618587|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20618588|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618589|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618590|NCT02282956|Droperidol|droperidol|mesh-list
20618591|NCT02282956|Morphine|morphine|mesh-list
20618592|NCT02282956|Ropivacaine|ropivacaine|mesh-list
20618593|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20618594|NCT02282956|Narcotics|narcotics|mesh-ancestor
20618595|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618596|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618597|NCT02282956|Analgesics|analgesics|mesh-ancestor
20618598|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
20618599|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618600|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
19408228|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19408229|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
19408230|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408231|NCT03567941|Acetaminophen|acetaminophen|mesh-list
19408232|NCT03567941|Hydrocodone|hydrocodone|mesh-list
19408233|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19408234|NCT03567941|Analgesics|analgesics|mesh-ancestor
19408235|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
19408236|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408237|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408238|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
19408239|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20464953|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20464954|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20464955|NCT01450956|Sevoflurane|sevoflurane|mesh-list
20618601|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
20618602|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19408240|NCT03567941|Narcotics|narcotics|mesh-ancestor
19408241|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408242|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
19408243|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
20618603|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
20618604|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
20618605|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20618606|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20618607|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20618608|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19408244|NCT03567928|Propofol|propofol|mesh-list
19408245|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19408246|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707782|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618609|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20618610|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20618611|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
20618612|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618613|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618614|NCT02283060|Tenofovir|tenofovir|mesh-list
20618615|NCT02283060|Emtricitabine|emtricitabine|mesh-list
20618616|NCT02283060|Efavirenz|efavirenz|mesh-list
20618617|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20618618|NCT02283060|Cobicistat|cobicistat|mesh-list
20618619|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20618620|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20618621|NCT02283060|Elvitegravir|elvitegravir|mesh-list
20618622|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
20618623|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618624|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20618625|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20618626|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618627|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618628|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20618629|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20618630|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20618631|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20618632|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20618633|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20618634|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20618635|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20618636|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20618637|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20618638|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
20618639|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20618640|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
20618641|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
20618642|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
20618643|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20618644|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618645|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20223248|NCT00331994|Metronidazole|metronidazole|mesh-list
20223249|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223250|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20223251|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20223252|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20618646|NCT02283177|Cytarabine|cytarabine|mesh-list
20618647|NCT02283177|Daunorubicin|daunorubicin|mesh-list
20618648|NCT02283177|Idarubicin|idarubicin|mesh-list
20618649|NCT02283177|Crenolanib|crenolanib|mesh-list
20618650|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618651|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
20618652|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618653|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618654|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
20618655|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618656|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618657|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
20618658|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618659|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20618660|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20223253|NCT00332020|Enoxaparin|enoxaparin|mesh-list
20223254|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
20223255|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20464956|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20464957|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20464958|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
20464959|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
20464960|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20464961|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464962|NCT01450995|Sumatriptan|sumatriptan|mesh-list
20223256|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
20223257|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20223258|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
20223259|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20464963|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20464964|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20464965|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20464966|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
20618661|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20618662|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618663|NCT02283190|Asparaginase|asparaginase|mesh-list
20618664|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618665|NCT02283203|Acetaminophen|acetaminophen|mesh-list
20618666|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618667|NCT02283203|Analgesics|analgesics|mesh-ancestor
20618668|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
20618669|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618670|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618671|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
20618672|NCT02283242|Galantamine|galantamine|mesh-list
20618673|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20618674|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618675|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464967|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464968|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464969|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464970|NCT01451060|Ephedrine|ephedrine|mesh-list
20464971|NCT01451060|Metaraminol|metaraminol|mesh-list
20618676|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
20618677|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618678|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618679|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20618680|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
20618681|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618682|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
20618683|NCT02283320|Docetaxel|docetaxel|mesh-list
20618684|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618685|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
20618686|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
20618687|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
20618688|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618689|NCT02283359|Irinotecan|irinotecan|mesh-list
20464972|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20464973|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464974|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
20464975|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
20464976|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618690|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20618691|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20618692|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618693|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618694|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618695|NCT02283372|Gemcitabine|gemcitabine|mesh-list
20618696|NCT02283372|Paclitaxel|paclitaxel|mesh-list
20618697|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20464977|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20464978|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464979|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464980|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20464981|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20464982|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20464983|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20464984|NCT01451086|Vaccines|vaccines|mesh-list
20464985|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
20464986|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464987|NCT01451229|Higenamine|higenamine|mesh-list
20618698|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20618699|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618700|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
20464988|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20464989|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20464990|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
20464991|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20464992|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618701|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
20618702|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
20618703|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618704|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618705|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
20464993|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20464994|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20618706|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
20618707|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20464995|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20464996|NCT01451229|Analgesics|analgesics|mesh-ancestor
20464997|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
20464998|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20464999|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465000|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465001|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20465002|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20465003|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465004|NCT01451229|Protective Agents|protective agents|mesh-ancestor
20465005|NCT01451268|Panobinostat|panobinostat|mesh-list
20465006|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465007|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20465008|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465009|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465010|NCT01451294|Phenylephrine|phenylephrine|mesh-list
20465011|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
20465012|NCT01451294|Ephedrine|ephedrine|mesh-list
20465013|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20465014|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
20465015|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
20465016|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465017|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465018|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
20465019|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20465020|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
20465021|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
20465022|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20465023|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20465024|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20465025|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465026|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465027|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465028|NCT01451294|Protective Agents|protective agents|mesh-ancestor
20465029|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20465030|NCT01451320|Plasminogen|plasminogen|mesh-list
20465031|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20465032|NCT01451320|Streptokinase|streptokinase|mesh-list
20465033|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20465034|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465035|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465036|NCT01451333|Efavirenz|efavirenz|mesh-list
20465037|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20465038|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20465039|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465040|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465041|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
20465042|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465043|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20465044|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20465045|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20465046|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20465047|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20465048|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20465049|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
20465050|NCT01451489|Tacrolimus|tacrolimus|mesh-list
20465051|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465052|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
20465053|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465054|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465055|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20465056|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
20465057|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618708|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618709|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618710|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
20618711|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618712|NCT02283424|Carboplatin|carboplatin|mesh-list
20618713|NCT02283424|Docetaxel|docetaxel|mesh-list
20465058|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465059|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20465060|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20618714|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465061|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618715|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
20618716|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
20618717|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
20618718|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695029|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695030|NCT04957615|Nivolumab|nivolumab|mesh-list
20465062|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20465063|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20465064|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465065|NCT01451593|Phenytoin|phenytoin|mesh-list
20465066|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
20465067|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20465068|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20465069|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20465070|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465071|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19695031|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695032|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695033|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19695034|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695035|NCT04957420|Rotigotine|rotigotine|mesh-list
19695036|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
19695037|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
19695038|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223260|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223261|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
20223262|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20223263|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465072|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20465073|NCT01451658|Propranolol|propranolol|mesh-list
20465074|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20465075|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20465076|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465077|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465078|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223264|NCT00332033|Pirfenidone|pirfenidone|mesh-list
20223265|NCT00332033|Analgesics|analgesics|mesh-ancestor
20223266|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
20223267|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223268|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618719|NCT02283476|Gemcitabine|gemcitabine|mesh-list
20618720|NCT02283476|Endostar protein|endostar protein|mesh-list
20618721|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618722|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618723|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
20618724|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618725|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
20618726|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618727|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618728|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618729|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
20618730|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618731|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20618732|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20618733|NCT02283476|Growth Substances|growth substances|mesh-ancestor
20618734|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
20618735|NCT02283489|Paclitaxel|paclitaxel|mesh-list
20618736|NCT02283489|Endostatins|endostatins|mesh-list
20618737|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20618738|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223269|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223270|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223271|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465079|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465080|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20465081|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20465082|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
20465083|NCT01451710|Prednisone|prednisone|mesh-list
20465084|NCT01451710|Prednisolone|prednisolone|mesh-list
20465085|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20465086|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
20465087|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20465088|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
20465089|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20465090|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
20465091|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465092|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
20465093|NCT01451710|Hormones|hormones|mesh-ancestor
20465094|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465095|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465096|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20465097|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618739|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
20618740|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
20618741|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
20618742|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618743|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20618744|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20618745|NCT02283489|Growth Substances|growth substances|mesh-ancestor
20618746|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618747|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
20618748|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20618749|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20618750|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20618751|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
20618752|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618753|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20618754|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20618755|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618756|NCT02283554|Metformin|metformin|mesh-list
20618757|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20223272|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223273|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223274|NCT00332046|Casopitant|casopitant|mesh-list
20223275|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
20223276|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
20223277|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223278|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223279|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223280|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20223281|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223282|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618758|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223283|NCT00332059|Timolol|timolol|mesh-list
20618759|NCT02283645|Minoxidil|minoxidil|mesh-list
20465098|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
20465099|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
20465100|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465101|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465102|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20465103|NCT01451710|Protective Agents|protective agents|mesh-ancestor
20465104|NCT01451788|Thrombin|thrombin|mesh-list
20465105|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
20465106|NCT01451788|Coagulants|coagulants|mesh-ancestor
20465107|NCT01451840|Lidocaine|lidocaine|mesh-list
20465108|NCT01451840|Remifentanil|remifentanil|mesh-list
20465109|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
20465110|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
20465111|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465112|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465113|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
20465114|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695039|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618760|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20618761|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
20618762|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
20618763|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20618764|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618765|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618766|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20618767|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20618768|NCT02283710|Protective Agents|protective agents|mesh-ancestor
20618769|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618770|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
20618771|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20618772|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
20618773|NCT02283775|Dexamethasone|dexamethasone|mesh-list
19695040|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695041|NCT04957329|Latanoprost|latanoprost|mesh-list
19695042|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20465115|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20465116|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20465117|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20465118|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20465119|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465120|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20465121|NCT01451840|Narcotics|narcotics|mesh-ancestor
20465122|NCT01451840|Analgesics|analgesics|mesh-ancestor
20465123|NCT01451853|Ebselen|ebselen|mesh-list
20465124|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20465125|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465126|NCT01451853|Analgesics|analgesics|mesh-ancestor
20465127|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
20465128|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465129|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465130|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465131|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465132|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465133|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465134|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
20618774|NCT02283775|Pomalidomide|pomalidomide|mesh-list
20618775|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618776|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
20618777|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
20618778|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618779|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618780|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20618781|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
20618782|NCT02283775|Hormones|hormones|mesh-ancestor
20618783|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618784|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20618785|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618786|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
20618787|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20618788|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20618789|NCT02283775|Growth Substances|growth substances|mesh-ancestor
20618790|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
20465135|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465136|NCT01451853|Protective Agents|protective agents|mesh-ancestor
20618791|NCT02283801|Lamotrigine|lamotrigine|mesh-list
20618792|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20465137|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20465138|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465139|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20465140|NCT01451879|Miglustat|miglustat|mesh-list
20465141|NCT01451879|Rituximab|rituximab|mesh-list
20465142|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849728|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
19849729|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849730|NCT00705016|Fluorouracil|fluorouracil|mesh-list
19849731|NCT00705016|Cetuximab|cetuximab|mesh-list
19849732|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849733|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
19849734|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849735|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20465143|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465144|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
20465145|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465146|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465147|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465148|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465149|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20465150|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20465151|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
20618793|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
20618794|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20618795|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20618796|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618797|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20618798|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618799|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20618800|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20618801|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618802|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20618803|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20618804|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20618805|NCT02283866|Desflurane|desflurane|mesh-list
20618806|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20618807|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
20618808|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
20618809|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618810|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618811|NCT02283905|Voriconazole|voriconazole|mesh-list
20618812|NCT02283905|Amphotericin B|amphotericin b|mesh-list
20618813|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20465152|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465153|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20465154|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465155|NCT01451905|Liraglutide|liraglutide|mesh-list
20465156|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465157|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465158|NCT01451905|Incretins|incretins|mesh-ancestor
20465159|NCT01451905|Hormones|hormones|mesh-ancestor
20465160|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618814|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
19849736|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849737|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
19849738|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849739|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20618815|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618816|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20618817|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20618818|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618819|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618820|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20618821|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
20618822|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618823|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849740|NCT00705107|Ribavirin|ribavirin|mesh-list
19849741|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19849742|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
19849743|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
20465161|NCT01451918|Resveratrol|resveratrol|mesh-list
19849744|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618824|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20618825|NCT02283905|Amebicides|amebicides|mesh-ancestor
20618826|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20618827|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20618828|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20618829|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
20618830|NCT02284035|Lamivudine|lamivudine|mesh-list
20618831|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20618832|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20618833|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
20618834|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618835|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20618836|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20618837|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618838|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618839|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20618840|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20618841|NCT02284048|Ticagrelor|ticagrelor|mesh-list
20618842|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20618843|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20618844|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20618845|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20618846|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
20618847|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618848|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618849|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618850|NCT02284204|Midazolam|midazolam|mesh-list
20618851|NCT02284204|Ketamine|ketamine|mesh-list
20618852|NCT02284204|Sevoflurane|sevoflurane|mesh-list
20618853|NCT02284204|Analgesics|analgesics|mesh-ancestor
20618854|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
20465162|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
20465163|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465164|NCT01451918|Protective Agents|protective agents|mesh-ancestor
20465165|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465166|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408247|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408248|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19408249|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
19408250|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
19408251|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
19408252|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
20465167|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465168|NCT01452009|Travoprost|travoprost|mesh-list
20465169|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20618855|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618856|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618857|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20618858|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20618859|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
20618860|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
20465170|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20465171|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20465172|NCT01452100|Prednisone|prednisone|mesh-list
20465173|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465174|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
20465175|NCT01452100|Hormones|hormones|mesh-ancestor
20465176|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465177|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465178|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20465179|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465180|NCT01452113|Vildagliptin|vildagliptin|mesh-list
20465181|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465182|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465183|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20465184|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
20465185|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465186|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465187|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20465188|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465189|NCT01452217|Secretin|secretin|mesh-list
20465190|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465191|NCT01452217|Hormones|hormones|mesh-ancestor
20618861|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408253|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20618862|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20618863|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20618864|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618865|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618866|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20618867|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20618868|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20618869|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20618870|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20618871|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
20618872|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
20618873|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20618874|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20618875|NCT02284230|Liraglutide|liraglutide|mesh-list
20618876|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20618877|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618878|NCT02284230|Incretins|incretins|mesh-ancestor
20618879|NCT02284230|Hormones|hormones|mesh-ancestor
20618880|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20618881|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20618882|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223284|NCT00332059|Bimatoprost|bimatoprost|mesh-list
20223285|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223286|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223287|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223288|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223289|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223290|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223291|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223292|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223293|NCT00332072|Timolol|timolol|mesh-list
20223294|NCT00332072|Bimatoprost|bimatoprost|mesh-list
20465192|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465193|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465194|NCT01452243|Vitamin D|vitamin d|mesh-list
20465195|NCT01452243|Calcium|calcium|mesh-list
20465196|NCT01452243|Vitamins|vitamins|mesh-ancestor
20465197|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
20465198|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465199|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20465200|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20526885|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20526886|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526887|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526888|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20526889|NCT01765257|Protective Agents|protective agents|mesh-ancestor
20526890|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526891|NCT01765296|Celecoxib|celecoxib|mesh-list
20526892|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20526893|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20526894|NCT01765296|Analgesics|analgesics|mesh-ancestor
20526895|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
20526896|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20526897|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526898|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20526899|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526900|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20526901|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20526902|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526903|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526904|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
20526905|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20526906|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20526907|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526908|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
20526909|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526910|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526911|NCT01765374|Rituximab|rituximab|mesh-list
20526912|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20526913|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618883|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20223295|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223296|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223297|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223298|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223299|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223300|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223301|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223302|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223303|NCT00332085|Chromium|chromium|mesh-list
20223304|NCT00332085|Picolinic acid|picolinic acid|mesh-list
20223305|NCT00332085|Trace Elements|trace elements|mesh-ancestor
20223306|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
20223307|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223308|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20223309|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
20223310|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
20223311|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223312|NCT00332124|Choline|choline|mesh-list
20223313|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
20223314|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20223315|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
20223316|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465201|NCT01452256|Propofol|propofol|mesh-list
20618884|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618885|NCT02284282|Lidocaine|lidocaine|mesh-list
20618886|NCT02284282|Morphine|morphine|mesh-list
20618887|NCT02284282|Bupivacaine|bupivacaine|mesh-list
20618888|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
20618889|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
20618890|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618891|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618892|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
20618893|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465202|NCT01452256|Desflurane|desflurane|mesh-list
20465203|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20465204|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465205|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465206|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20465207|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
20465208|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
20465209|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20465210|NCT01452334|BMS-936559|bms-936559|mesh-list
20465211|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20465212|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465213|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20465214|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20465215|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
20465216|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465217|NCT01452477|Tanshinone|tanshinone|mesh-list
20465218|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465219|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20465220|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465221|NCT01452477|Analgesics|analgesics|mesh-ancestor
20618894|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20618895|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20618896|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20618897|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20465222|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
20465223|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618898|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618899|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20618900|NCT02284282|Narcotics|narcotics|mesh-ancestor
20618901|NCT02284282|Analgesics|analgesics|mesh-ancestor
20618902|NCT02284412|Neostigmine|neostigmine|mesh-list
20618903|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20618904|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223317|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223318|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20223319|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
20223320|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20223321|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20223322|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20223323|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
20465224|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465225|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20618905|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618906|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
19695043|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19695044|NCT04957212|Carboplatin|carboplatin|mesh-list
19695045|NCT04957212|Docetaxel|docetaxel|mesh-list
19695046|NCT04957212|Trastuzumab|trastuzumab|mesh-list
19695047|NCT04957212|Pertuzumab|pertuzumab|mesh-list
19695048|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695049|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
19695050|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
19695051|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
19695052|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695053|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707783|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465226|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707784|NCT04823390|Analgesics|analgesics|mesh-ancestor
19707785|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
19707786|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707787|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19707788|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19707789|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
19707790|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
20465227|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
20465228|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20465229|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707791|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19707792|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19707793|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19707794|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19707795|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
19707796|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
19707797|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465230|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465231|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
19849745|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
19849746|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849747|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
19849748|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849749|NCT00705133|Treprostinil|treprostinil|mesh-list
19849750|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19849751|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19849752|NCT00705159|Tobramycin|tobramycin|mesh-list
19849753|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19849754|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849755|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19849756|NCT00705224|Interferons|interferons|mesh-list
19849757|NCT00705224|Ribavirin|ribavirin|mesh-list
19849758|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849759|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
19849760|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849761|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
19707798|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707799|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19707800|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707801|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707802|NCT04823403|Nivolumab|nivolumab|mesh-list
19849762|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465232|NCT01452542|Eliglustat|eliglustat|mesh-list
20465233|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465234|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465235|NCT01452568|Aspirin|aspirin|mesh-list
20465236|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
20465237|NCT01452568|Salicylates|salicylates|mesh-list
20465238|NCT01452568|Warfarin|warfarin|mesh-list
20465239|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20465240|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465241|NCT01452568|Analgesics|analgesics|mesh-ancestor
20465242|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
20465243|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707803|NCT04823403|Ipilimumab|ipilimumab|mesh-list
19707804|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849763|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19849764|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20526914|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
20526915|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526916|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20526917|NCT01765400|Clopidogrel|clopidogrel|mesh-list
20526918|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20618907|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618908|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618909|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20618910|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
20618911|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618912|NCT02284490|Pemetrexed|pemetrexed|mesh-list
20618913|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618914|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618915|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618916|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20618917|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20618918|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20618919|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20618920|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20618921|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
20618922|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618923|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20618924|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20618925|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618926|NCT02284529|Leucovorin|leucovorin|mesh-list
20618927|NCT02284529|Fluorouracil|fluorouracil|mesh-list
20618928|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
20618929|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618930|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20618931|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618932|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618933|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
20618934|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618935|NCT02284529|Antidotes|antidotes|mesh-ancestor
20618936|NCT02284529|Protective Agents|protective agents|mesh-ancestor
20465244|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465245|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465246|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465247|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20465248|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465249|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465250|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465251|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20465252|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618937|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
20618938|NCT02284529|Vitamins|vitamins|mesh-ancestor
20618939|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
20465253|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
20465254|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
20618940|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
20618941|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20618942|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20618943|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618944|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20618945|NCT02284672|Analgesics|analgesics|mesh-ancestor
20618946|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
20618947|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20618948|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20618949|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20618950|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20618951|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
20618952|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20618953|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618954|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
20618955|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
20618956|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20618957|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20618958|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618959|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618960|NCT02284737|Urological Agents|urological agents|mesh-ancestor
20618961|NCT02284984|Rituximab|rituximab|mesh-list
20618962|NCT02284984|Belimumab|belimumab|mesh-list
20618963|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20618964|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20618965|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
20618966|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618967|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849765|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
20465255|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618968|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20618969|NCT02285036|Vaccines|vaccines|mesh-list
20618970|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20618971|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
20618972|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618973|NCT02285075|Temocillin|temocillin|mesh-list
20618974|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20618975|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618976|NCT02285101|BCT-100|bct-100|mesh-list
20618977|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408254|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19408255|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19695054|NCT04956939|Levodopa|levodopa|mesh-list
19695055|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19695056|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19695057|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
19695058|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695059|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465256|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
20465257|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
20465258|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
19695060|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695061|NCT04956432|Allopurinol|allopurinol|mesh-list
19695062|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
19695063|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695064|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695065|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
19695066|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695067|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20465259|NCT01452607|Ebselen|ebselen|mesh-list
20465260|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20465261|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465262|NCT01452607|Analgesics|analgesics|mesh-ancestor
19408256|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408257|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19408258|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19408259|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19408260|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19408261|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
19408262|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408263|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408264|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19695068|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
19695069|NCT04956432|Protective Agents|protective agents|mesh-ancestor
20465263|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
20465264|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465265|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465266|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465267|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465268|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465269|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465270|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
20465271|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465272|NCT01452607|Protective Agents|protective agents|mesh-ancestor
20465273|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20465274|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465275|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20465276|NCT01452633|Bupivacaine|bupivacaine|mesh-list
20465277|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
20465278|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
20465279|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465280|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465281|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
20465282|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465283|NCT01452659|Relugolix|relugolix|mesh-list
20618978|NCT02285309|Enoximone|enoximone|mesh-list
20618979|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20618980|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
20618981|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20618982|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20618983|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618984|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618985|NCT02285309|Protective Agents|protective agents|mesh-ancestor
20618986|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20618987|NCT02285374|Tenofovir|tenofovir|mesh-list
20618988|NCT02285374|Emtricitabine|emtricitabine|mesh-list
20618989|NCT02285374|Efavirenz|efavirenz|mesh-list
20618990|NCT02285374|Dolutegravir|dolutegravir|mesh-list
20618991|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20618992|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
20618993|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20618994|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20618995|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20618996|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20618997|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20618998|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20618999|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20619000|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20619001|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20619002|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20619003|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20619004|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20619005|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20619006|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20619007|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19849766|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849767|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849768|NCT00705263|Ribavirin|ribavirin|mesh-list
19849769|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19849770|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
19849771|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465284|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
20465285|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
20465286|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465287|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465288|NCT01452685|Leuprolide|leuprolide|mesh-list
20465289|NCT01452685|Relugolix|relugolix|mesh-list
20465290|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20465291|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
20465292|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20465293|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619008|NCT02285413|Cisplatin|cisplatin|mesh-list
20619009|NCT02285413|Vaccines|vaccines|mesh-list
20619010|NCT02285413|Immunologic Factors|immunologic factors|mesh-ancestor
20619011|NCT02285413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619012|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619013|NCT02285491|Bupivacaine|bupivacaine|mesh-list
20619014|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
20619015|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
20619016|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619017|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619018|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
20619019|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619020|NCT02285647|Rolapitant|rolapitant|mesh-list
20619021|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20619022|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849772|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
20465294|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20465295|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465296|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
20465297|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
20465298|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465299|NCT01452698|Lansoprazole|lansoprazole|mesh-list
20465300|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
20465301|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465302|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465303|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19849773|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619023|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619024|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619025|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
20619026|NCT02285699|Citalopram|citalopram|mesh-list
20619027|NCT02285699|Fluoxetine|fluoxetine|mesh-list
20619028|NCT02285699|Paroxetine|paroxetine|mesh-list
20619029|NCT02285699|Sertraline|sertraline|mesh-list
20619030|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20619031|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20619032|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619033|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619034|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619035|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
20619036|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619037|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20619038|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
20619039|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619040|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20619041|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20619042|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619043|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20619044|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20619045|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619046|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20619047|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20619048|NCT02285738|Aspirin|aspirin|mesh-list
20619049|NCT02285738|Simvastatin|simvastatin|mesh-list
20619050|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20465304|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465305|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465306|NCT01452711|Lansoprazole|lansoprazole|mesh-list
20465307|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
20465308|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465309|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619051|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619052|NCT02285738|Analgesics|analgesics|mesh-ancestor
20619053|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
20619054|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619055|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619056|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619057|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619058|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20619059|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20619060|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619061|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20619062|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20619063|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619064|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
20619065|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20619066|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20619067|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
20619068|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20619069|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20619070|NCT02285751|Aspirin|aspirin|mesh-list
20619071|NCT02285751|Clopidogrel|clopidogrel|mesh-list
20619072|NCT02285751|Ticagrelor|ticagrelor|mesh-list
20619073|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20619074|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20619075|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465310|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20465311|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465312|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465313|NCT01452724|Lansoprazole|lansoprazole|mesh-list
20465314|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
20465315|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465316|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465317|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20465318|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465319|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465320|NCT01452737|Bisacodyl|bisacodyl|mesh-list
20465321|NCT01452737|Cathartics|cathartics|mesh-ancestor
20465322|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19849774|NCT00705289|Infliximab|infliximab|mesh-list
20465323|NCT01452737|Laxatives|laxatives|mesh-ancestor
20465324|NCT01452750|Lansoprazole|lansoprazole|mesh-list
19408265|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20465325|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
19408266|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19408267|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408268|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
19408269|NCT03567629|Leucovorin|leucovorin|mesh-list
19849775|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
19849776|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19849777|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849778|NCT00705341|Fluticasone|fluticasone|mesh-list
19849779|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849780|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19849781|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
19849782|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849783|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849784|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20223324|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223325|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223326|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223327|NCT00332137|Urological Agents|urological agents|mesh-ancestor
20223328|NCT00332176|Ribavirin|ribavirin|mesh-list
20223329|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20223330|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
20223331|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223332|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
20223333|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223334|NCT00332228|Naltrexone|naltrexone|mesh-list
20223335|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20223336|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20223337|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223338|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
20223339|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223340|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20223341|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223342|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
20223343|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20223344|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20223345|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20223346|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20223347|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223348|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20223349|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20223350|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223351|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223352|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223353|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20223354|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
20223355|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20223356|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223357|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20223358|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20223359|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20223360|NCT00332306|Lamivudine|lamivudine|mesh-list
20223361|NCT00332306|Efavirenz|efavirenz|mesh-list
20223362|NCT00332306|Nevirapine|nevirapine|mesh-list
20223363|NCT00332306|Didanosine|didanosine|mesh-list
20223364|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20223365|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20223366|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223367|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223368|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
20223369|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223370|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20223371|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20223372|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20223373|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20223374|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20223375|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20223376|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20223377|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20223378|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
20223379|NCT00332319|Casopitant|casopitant|mesh-list
20465326|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19408270|NCT03567629|Bevacizumab|bevacizumab|mesh-list
19849785|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
19849786|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
19849787|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19849788|NCT00705367|Abatacept|abatacept|mesh-list
19849789|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19849790|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849791|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849792|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849793|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
19849794|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849795|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223380|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
20465327|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465328|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20465329|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465330|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465331|NCT01452763|Lansoprazole|lansoprazole|mesh-list
20465332|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
20465333|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465334|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465335|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20465336|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465337|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465338|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
20465339|NCT01452828|Tedizolid|tedizolid|mesh-list
20465340|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
20465341|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20465342|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465343|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20465344|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465345|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465346|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
20465347|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20465348|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465349|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
20465350|NCT01452880|Remifentanil|remifentanil|mesh-list
20465351|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20465352|NCT01452880|Narcotics|narcotics|mesh-ancestor
20465353|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465354|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465355|NCT01452880|Analgesics|analgesics|mesh-ancestor
20465356|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
20465357|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465358|NCT01452906|Omeprazole|omeprazole|mesh-list
20465359|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20619076|NCT02285751|Analgesics|analgesics|mesh-ancestor
20619077|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
20619078|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619079|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695070|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695071|NCT04956419|Fluconazole|fluconazole|mesh-list
19695072|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
19695073|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695074|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19695075|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19695076|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695077|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849796|NCT00705406|Peramivir|peramivir|mesh-list
20223381|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
20223382|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223383|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223384|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223385|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20223386|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223387|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223388|NCT00332345|Timolol|timolol|mesh-list
20223389|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20223390|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223391|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223392|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223393|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223394|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465360|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465361|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19849797|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
19849798|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849799|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465362|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465363|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465364|NCT01453062|Ofatumumab|ofatumumab|mesh-list
20465365|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465366|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
20465367|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20465368|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20465369|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
20465370|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465371|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20465372|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20465373|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465374|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465375|NCT01453283|Trabectedin|trabectedin|mesh-list
20465376|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20465377|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
20465378|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465379|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465380|NCT01453400|Aspirin|aspirin|mesh-list
20465381|NCT01453400|Acetaminophen|acetaminophen|mesh-list
20465382|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20465383|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465384|NCT01453400|Analgesics|analgesics|mesh-ancestor
20465385|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
20465386|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849800|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849801|NCT00705432|Ribavirin|ribavirin|mesh-list
19849802|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19849803|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
19849804|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849805|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
19849806|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849807|NCT00705484|Infliximab|infliximab|mesh-list
19849808|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
19849809|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223395|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223396|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20619080|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619081|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619082|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19849810|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223397|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223398|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20223399|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20223400|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20223401|NCT00332384|Timolol|timolol|mesh-list
20223402|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20223403|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223404|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223405|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223406|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223407|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223408|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223409|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223410|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223411|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20223412|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20223413|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20223414|NCT00332397|Sirolimus|sirolimus|mesh-list
20223415|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20223416|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223417|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20223418|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223419|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
20223420|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20223421|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
20223422|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465387|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465388|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849811|NCT00705523|Varenicline|varenicline|mesh-list
20223423|NCT00332436|Timolol|timolol|mesh-list
20465389|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619083|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465390|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20465391|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465392|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465393|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465394|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20465395|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465396|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
20465397|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20465398|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
20465399|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465400|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
20465401|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465402|NCT01453504|Everolimus|everolimus|mesh-list
20619084|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619085|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20619086|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20619087|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619088|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
20619089|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20619090|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20619091|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20619092|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
20619093|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619094|NCT02285829|Bromides|bromides|mesh-list
20619095|NCT02285829|Rocuronium|rocuronium|mesh-list
20619096|NCT02285829|Cisatracurium|cisatracurium|mesh-list
20619097|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
20619098|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20619099|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20619100|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20619101|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619102|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619103|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20619104|NCT02285972|Tenoxicam|tenoxicam|mesh-list
20619105|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20619106|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619107|NCT02285972|Analgesics|analgesics|mesh-ancestor
20619108|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
20619109|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619110|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619111|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619112|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619113|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20619114|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465403|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465404|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465405|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
20465406|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465407|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
20465408|NCT01453530|Neostigmine|neostigmine|mesh-list
20465409|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20465410|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465411|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465412|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
20465413|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465414|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465415|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20465416|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
20465417|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223424|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20223425|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223426|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223427|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223428|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223429|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223430|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223431|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223432|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20619115|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619116|NCT02285985|Saxagliptin|saxagliptin|mesh-list
20619117|NCT02285985|Incretins|incretins|mesh-ancestor
20619118|NCT02285985|Hormones|hormones|mesh-ancestor
20465418|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20619119|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20619120|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619121|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20619122|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
20619123|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619124|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619125|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20223433|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20223434|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20223435|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20223436|NCT00332540|Timolol|timolol|mesh-list
20465419|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20619126|NCT02286206|Clozapine|clozapine|mesh-list
20619127|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20619128|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
20619129|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619130|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619131|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619132|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20619133|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20619134|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619135|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619136|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
20619137|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
20619138|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
20619139|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
20465420|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20465421|NCT01453582|Propolis|propolis|mesh-list
20465422|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465423|NCT01453660|Cisplatin|cisplatin|mesh-list
20465424|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465425|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
20465426|NCT01453686|Clobetasol|clobetasol|mesh-list
20465427|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465428|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
20465429|NCT01453686|Hormones|hormones|mesh-ancestor
20465430|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465431|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465432|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
20465433|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20465434|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20465435|NCT01453881|Beclomethasone|beclomethasone|mesh-list
20465436|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
20465437|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20465438|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
20465439|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465440|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465441|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20465442|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
20465443|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20465444|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20465445|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20465446|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465447|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465448|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465449|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465450|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
20465451|NCT01453881|Hormones|hormones|mesh-ancestor
20619140|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
20619141|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223437|NCT00332540|Bimatoprost|bimatoprost|mesh-list
20223438|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223439|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223440|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223441|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223442|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223443|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223444|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223445|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223446|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20223447|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20223448|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20465452|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465453|NCT01453920|Ranibizumab|ranibizumab|mesh-list
20619142|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
20619143|NCT02286258|Edetic Acid|edetic acid|mesh-list
20619144|NCT02286258|Calcium|calcium|mesh-list
20619145|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20619146|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619147|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20619148|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
20619149|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
20619150|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619151|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
20619152|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20619153|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20619154|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619155|NCT02286453|Diclofenac|diclofenac|mesh-list
20619156|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20619157|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619158|NCT02286453|Analgesics|analgesics|mesh-ancestor
20619159|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
20619160|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619161|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619162|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619163|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619164|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20619165|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619166|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619167|NCT02286544|Atorvastatin|atorvastatin|mesh-list
20619168|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20619169|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20619170|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
19408271|NCT03567629|Cetuximab|cetuximab|mesh-list
19408272|NCT03567629|Fluorouracil|fluorouracil|mesh-list
19408273|NCT03567629|Capecitabine|capecitabine|mesh-list
19408274|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
19408275|NCT03567629|Irinotecan|irinotecan|mesh-list
19408276|NCT03567629|Calcium|calcium|mesh-list
19408277|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
19408278|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408279|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408280|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20223449|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20465454|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20465455|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20465456|NCT01453920|Growth Substances|growth substances|mesh-ancestor
20465457|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223450|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
20619171|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619172|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20619173|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20619174|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619175|NCT02286596|Heparin|heparin|mesh-list
20223451|NCT00332553|Estradiol|estradiol|mesh-list
20223452|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20223453|NCT00332553|Estrogens|estrogens|mesh-list
20223454|NCT00332553|Hormones|hormones|mesh-ancestor
20223455|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223456|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223457|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20223458|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
20223459|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20223460|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20223461|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20465458|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
20465459|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465460|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
20465461|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20465462|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20465463|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
20465464|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465465|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20619176|NCT02286596|Dextrans|dextrans|mesh-list
20619177|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
20619178|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20619179|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19408281|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19408282|NCT03567629|Growth Substances|growth substances|mesh-ancestor
20465466|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20619180|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619181|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
20619182|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
20619183|NCT02286609|Deflazacort|deflazacort|mesh-list
20619184|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619185|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619186|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
20465467|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619187|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619188|NCT02286622|Deflazacort|deflazacort|mesh-list
20619189|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619190|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619191|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
20619192|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619193|NCT02286635|Clarithromycin|clarithromycin|mesh-list
19849812|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19849813|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20619194|NCT02286635|Rifampin|rifampin|mesh-list
20619195|NCT02286635|Deflazacort|deflazacort|mesh-list
20619196|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20619197|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619198|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20619199|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619200|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619201|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20619202|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20619203|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20619204|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
20619205|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
20619206|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20619207|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20619208|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19695078|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19695079|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
19695080|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695081|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695082|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20223462|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19849814|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
20619209|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20619210|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20619211|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19695083|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19695084|NCT04956484|Belimumab|belimumab|mesh-list
19849815|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849816|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223463|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20223464|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20223465|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20223466|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223467|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20223468|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
20223469|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20465468|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465469|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
20465470|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465471|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
20465472|NCT01454011|Testosterone|testosterone|mesh-list
20465473|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
20465474|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
20465475|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20465476|NCT01454011|Androgens|androgens|mesh-ancestor
20465477|NCT01454011|Hormones|hormones|mesh-ancestor
20465478|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465479|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465480|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20465481|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849817|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849818|NCT00705536|Insulin|insulin|mesh-list
19849819|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19849820|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
19849821|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465482|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
20526919|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20526920|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20526921|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20526922|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20526923|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
20526924|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526925|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526926|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530614|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
20530615|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530616|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20530617|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20530618|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530619|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
20530620|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20530621|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20530622|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530623|NCT01789723|Leucovorin|leucovorin|mesh-list
19695085|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619212|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20619213|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619214|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619215|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
20619216|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619217|NCT02286687|Talazoparib|talazoparib|mesh-list
19695086|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
19695087|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695088|NCT04956094|Uric Acid|uric acid|mesh-list
19695089|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
19695090|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695091|NCT04956094|Protective Agents|protective agents|mesh-ancestor
19695092|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695093|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
20619218|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20619219|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619220|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619221|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619222|NCT02286700|Desonide|desonide|mesh-list
20619223|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619224|NCT02286752|Neostigmine|neostigmine|mesh-list
20619225|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20619226|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619227|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619228|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
20619229|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619230|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619231|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20619232|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
20619233|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619234|NCT02286934|Carvedilol|carvedilol|mesh-list
20619235|NCT02286934|Isoproterenol|isoproterenol|mesh-list
20619236|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20619237|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20619238|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
20619239|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619240|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619241|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695094|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19695095|NCT04955678|Sorbitol|sorbitol|mesh-list
19695096|NCT04955678|Calcium|calcium|mesh-list
19695097|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19695098|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695099|NCT04955678|Cathartics|cathartics|mesh-ancestor
20530624|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
20530625|NCT01789723|Antidotes|antidotes|mesh-ancestor
20530626|NCT01789723|Protective Agents|protective agents|mesh-ancestor
20530627|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530628|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
20619242|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20530629|NCT01789723|Vitamins|vitamins|mesh-ancestor
20530630|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
20530631|NCT01789827|Interleukin-2|interleukin-2|mesh-list
19695100|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530632|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619243|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
20619244|NCT02286934|Protective Agents|protective agents|mesh-ancestor
20619245|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20465483|NCT01454154|Glyburide|glyburide|mesh-list
20465484|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465485|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619246|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619247|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20619248|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
20619249|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20619250|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20619251|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20619252|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20619253|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20619254|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
20619255|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619256|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20619257|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
20619258|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20619259|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
20465486|NCT01454180|Leucovorin|leucovorin|mesh-list
20465487|NCT01454180|Gemcitabine|gemcitabine|mesh-list
20465488|NCT01454180|Capecitabine|capecitabine|mesh-list
20465489|NCT01454180|Fluorouracil|fluorouracil|mesh-list
20465490|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20465491|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
20465492|NCT01454180|Folfirinox|folfirinox|mesh-list
20465493|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20465494|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
20465495|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465496|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465497|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
20465498|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465499|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465500|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465501|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
20465502|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465503|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20465504|NCT01454180|Antidotes|antidotes|mesh-ancestor
20465505|NCT01454180|Protective Agents|protective agents|mesh-ancestor
20465506|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
20465507|NCT01454180|Vitamins|vitamins|mesh-ancestor
20223470|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20223471|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20223472|NCT00332618|Glycerol|glycerol|mesh-list
20223473|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20223474|NCT00332618|Protective Agents|protective agents|mesh-ancestor
20223475|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223476|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
20223477|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20223478|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
20223479|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223480|NCT00332631|Expectorants|expectorants|mesh-ancestor
20223481|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
20223482|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20223483|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
20223484|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223485|NCT00332631|Protective Agents|protective agents|mesh-ancestor
20223486|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223487|NCT00332631|Antidotes|antidotes|mesh-ancestor
20247291|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247292|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20247293|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
20247294|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247295|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
20247296|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465508|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
20465509|NCT01454440|Eptifibatide|eptifibatide|mesh-list
20465510|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465511|NCT01454479|Lapatinib|lapatinib|mesh-list
20465512|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465513|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20223488|NCT00332735|Bupivacaine|bupivacaine|mesh-list
20223489|NCT00332735|Carticaine|carticaine|mesh-list
20223490|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
20223491|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
20223492|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223493|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465514|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465515|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465516|NCT01454518|Anesthetics|anesthetics|mesh-list
20465517|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
20465518|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465519|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465520|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
20465521|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465522|NCT01454609|Clonidine|clonidine|mesh-list
20465523|NCT01454609|Bupivacaine|bupivacaine|mesh-list
20465524|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
20465525|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
20465526|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465527|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465528|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
20465529|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465530|NCT01454609|Analgesics|analgesics|mesh-ancestor
20465531|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20619260|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
20619261|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20619262|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20619263|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619264|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
20619265|NCT02286973|Coagulants|coagulants|mesh-ancestor
20619266|NCT02286986|Cannabidiol|cannabidiol|mesh-list
20619267|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
20619268|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
20619269|NCT02287064|Antibodies|antibodies|mesh-list
19849822|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849823|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19849824|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20619270|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
20619271|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20619272|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20619273|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
20619274|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619275|NCT02287129|Paclitaxel|paclitaxel|mesh-list
19849825|NCT00705575|Diuretics|diuretics|mesh-ancestor
19849826|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
19849827|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849828|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19849829|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849830|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849831|NCT00705614|Infliximab|infliximab|mesh-list
19849832|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
19849833|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19849834|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19849835|NCT00705666|Ribavirin|ribavirin|mesh-list
19849836|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19849837|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
19849838|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223494|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
20223495|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223496|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
20223497|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20223498|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20223499|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
20223500|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223501|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20223502|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223503|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20223504|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20223505|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20223506|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465532|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
20465533|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
20619276|NCT02287129|Carboplatin|carboplatin|mesh-list
20619277|NCT02287129|Capecitabine|capecitabine|mesh-list
20619278|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
20619279|NCT02287129|Epirubicin|epirubicin|mesh-list
20465534|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20465535|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20465536|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20465537|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465538|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465539|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465540|NCT01454622|Metformin|metformin|mesh-list
20465541|NCT01454622|Canagliflozin|canagliflozin|mesh-list
20465542|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465543|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465544|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20465545|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465546|NCT01454635|Sertraline|sertraline|mesh-list
20465547|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
20465548|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20465549|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20465550|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20465551|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20465552|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465553|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465554|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
20465555|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465556|NCT01454700|Insulin|insulin|mesh-list
20465557|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20465558|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465559|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465560|NCT01454804|Trastuzumab|trastuzumab|mesh-list
20465561|NCT01454804|Lapatinib|lapatinib|mesh-list
20465562|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20465563|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465564|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20619280|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20619281|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619282|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
20619283|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
20619284|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
20619285|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619286|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20619287|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
20619288|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20619289|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20619290|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20619291|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619292|NCT02287181|Remifentanil|remifentanil|mesh-list
20619293|NCT02287181|Propofol|propofol|mesh-list
20619294|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20619295|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619296|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619297|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20619298|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
20619299|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
20619300|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20619301|NCT02287181|Narcotics|narcotics|mesh-ancestor
20619302|NCT02287181|Analgesics|analgesics|mesh-ancestor
20619303|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
20619304|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619305|NCT02287233|Cytarabine|cytarabine|mesh-list
20619306|NCT02287233|Venetoclax|venetoclax|mesh-list
20619307|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20465565|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619308|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
20619309|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619310|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619311|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
20619312|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619313|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619314|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
20619315|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619316|NCT02287246|Bupivacaine|bupivacaine|mesh-list
20465566|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465567|NCT01454869|Heparin|heparin|mesh-list
20465568|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
20619317|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
20619318|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
20465569|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20465570|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465571|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465572|NCT01455025|Plerixafor|plerixafor|mesh-list
20465573|NCT01455025|Sargramostim|sargramostim|mesh-list
20465574|NCT01455025|Lenograstim|lenograstim|mesh-list
20465575|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
20465576|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465577|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20465578|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20465579|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20465580|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
20465581|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465582|NCT01455103|BMS-936559|bms-936559|mesh-list
20465583|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20465584|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20465585|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465586|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
20465587|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465588|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
20465589|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20465590|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
20465591|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465592|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465593|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20619319|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619320|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619321|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
20465594|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
20619322|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619323|NCT02287259|Olanzapine|olanzapine|mesh-list
20619324|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
20619325|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
20619326|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619327|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619328|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619329|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20619330|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20619331|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223507|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20223508|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223509|NCT00332774|Ketorolac|ketorolac|mesh-list
20223510|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20223511|NCT00332774|Nepafenac|nepafenac|mesh-list
20223512|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20223513|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20223514|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223515|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223516|NCT00332774|Analgesics|analgesics|mesh-ancestor
20223517|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
20223518|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223519|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223520|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223521|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223522|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20223523|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223524|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223525|NCT00332787|Fluoxetine|fluoxetine|mesh-list
20223526|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20223527|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20223528|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20223529|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223530|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223531|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
20223532|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223533|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20223534|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
20223535|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223536|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20223537|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20223538|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465595|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
20465596|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20465597|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
19695101|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19695102|NCT04955574|Metronidazole|metronidazole|mesh-list
19695103|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19695104|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695105|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
19695106|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20223539|NCT00332826|Insulin|insulin|mesh-list
20223540|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20619332|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619333|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20619334|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20619335|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619336|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619337|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619338|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
20619339|NCT02287272|Cimetidine|cimetidine|mesh-list
20619340|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20619341|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619342|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20619343|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
20619344|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
20619345|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619346|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619347|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619348|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20619349|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20619350|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619351|NCT02287389|Mitomycins|mitomycins|mesh-list
20619352|NCT02287389|Mitomycin|mitomycin|mesh-list
20619353|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20619354|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619355|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
20619356|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619357|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20619358|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223541|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223542|NCT00332852|Letrozole|letrozole|mesh-list
20223543|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223544|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20223545|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20223546|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223547|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223548|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20223549|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
20223550|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465598|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465599|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465600|NCT01455142|Insulin|insulin|mesh-list
20465601|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
20465602|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465603|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465604|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
20223551|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223552|NCT00332891|Amibegron|amibegron|mesh-list
20223553|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20223554|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20223555|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223556|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223557|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223558|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223559|NCT00332904|Propranolol|propranolol|mesh-list
20223560|NCT00332904|Spironolactone|spironolactone|mesh-list
20223561|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20223562|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20465605|NCT01455233|Besifloxacin|besifloxacin|mesh-list
20465606|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20465607|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20465608|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20465609|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20465610|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619359|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
19695107|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20223563|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465611|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20619360|NCT02287428|Temozolomide|temozolomide|mesh-list
20619361|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20619362|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619363|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20619364|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
20619365|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619366|NCT02287558|Pomalidomide|pomalidomide|mesh-list
20619367|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
20619368|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619369|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20619370|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20619371|NCT02287558|Growth Substances|growth substances|mesh-ancestor
20465612|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20465613|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465614|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465615|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465616|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20465617|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
20465618|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20619372|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
20619373|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619374|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20619375|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20619376|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619377|NCT02287857|Tenofovir|tenofovir|mesh-list
20619378|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
20619379|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619380|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20619381|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20619382|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619383|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619384|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20619385|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20619386|NCT02287870|Lidocaine|lidocaine|mesh-list
20619387|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
20619388|NCT02287870|Procaine|procaine|mesh-list
20619389|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
20619390|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
20619391|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619392|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619393|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
20619394|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619395|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20619396|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20619397|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20619398|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619399|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619400|NCT02288000|Memantine|memantine|mesh-list
20619401|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20619402|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20619403|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
20619404|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619405|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619406|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619407|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20619408|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20619409|NCT02288078|Dexamethasone|dexamethasone|mesh-list
20619410|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20619411|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619412|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
20619413|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
20619414|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619415|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619416|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619417|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
20619418|NCT02288078|Hormones|hormones|mesh-ancestor
20619419|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20619420|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20619421|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619422|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619423|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619424|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
20465619|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619425|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20619426|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
20619427|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20619428|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465620|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20465621|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20465622|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20465623|NCT01455246|Meropenem|meropenem|mesh-list
20465624|NCT01455246|Daptomycin|daptomycin|mesh-list
20465625|NCT01455246|Ceftazidime|ceftazidime|mesh-list
20465626|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20465627|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619429|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20619430|NCT02288195|Capecitabine|capecitabine|mesh-list
20619431|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
20619432|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20619433|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
20619434|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619435|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619436|NCT02288208|Tenofovir|tenofovir|mesh-list
19408283|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408284|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
19695108|NCT04955834|Insulin|insulin|mesh-list
20619437|NCT02288208|Entecavir|entecavir|mesh-list
20619438|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
20619439|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619440|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20619441|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20619442|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619443|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619444|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20619445|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20619446|NCT02288234|Telavancin|telavancin|mesh-list
20619447|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20619448|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619449|NCT02288286|Vaccines|vaccines|mesh-list
20619450|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
20619451|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619452|NCT02288338|Atorvastatin|atorvastatin|mesh-list
20619453|NCT02288338|Ezetimibe|ezetimibe|mesh-list
20223564|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223565|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223566|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223567|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223568|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223569|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
20223570|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20223571|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
20223572|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223573|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20223574|NCT00332904|Diuretics|diuretics|mesh-ancestor
20223575|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
20223576|NCT00332930|Interferons|interferons|mesh-list
20223577|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
20223578|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223579|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
20223580|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223581|NCT00332969|Octreotide|octreotide|mesh-list
20223582|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223583|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20223584|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223585|NCT00332995|Dapivirine|dapivirine|mesh-list
20223586|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20223587|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20223588|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
20223589|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223590|NCT00333008|Prednisone|prednisone|mesh-list
20223591|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
20223592|NCT00333008|Rituximab|rituximab|mesh-list
20223593|NCT00333008|Vincristine|vincristine|mesh-list
20223594|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619454|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19408285|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20223595|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
20465628|NCT01455337|Prednisolone|prednisolone|mesh-list
20465629|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
20619455|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20619456|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
20619457|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619458|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20619459|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20619460|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619461|NCT02288429|Colistin|colistin|mesh-list
20619462|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20619463|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619464|NCT02288507|Sorafenib|sorafenib|mesh-list
20619465|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619466|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20619467|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619468|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465630|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465631|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
20465632|NCT01455337|Hormones|hormones|mesh-ancestor
20465633|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465634|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695109|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19695110|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695111|NCT04955262|Nivolumab|nivolumab|mesh-list
20465635|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20465636|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465637|NCT01455337|Protective Agents|protective agents|mesh-ancestor
20465638|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20465639|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695112|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695113|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695114|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19695115|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695116|NCT04955366|Abatacept|abatacept|mesh-list
19695117|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19695118|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695119|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695120|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19695121|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
19695122|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695123|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707805|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707806|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19707807|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708512|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408286|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19408287|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
19408288|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408289|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408290|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19408291|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
19408292|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19408293|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19408294|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408295|NCT03567629|Antidotes|antidotes|mesh-ancestor
19408296|NCT03567629|Protective Agents|protective agents|mesh-ancestor
20619469|NCT02288741|Dexamethasone|dexamethasone|mesh-list
19695124|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
19695125|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
19695126|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
19695127|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695128|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695129|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19695130|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19695131|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
19695132|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
19695133|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695134|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695135|NCT04954560|Losartan|losartan|mesh-list
19695136|NCT04954560|Eprosartan|eprosartan|mesh-list
19695137|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19695138|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19695139|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19695140|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19695141|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465640|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465641|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465642|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20465643|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
20465644|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20465645|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
20465646|NCT01455350|Lidocaine|lidocaine|mesh-list
20465647|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
20465648|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
20465649|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465650|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465651|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
20465652|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465653|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19695142|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
19695143|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19695144|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
19695145|NCT04954638|Eusol|eusol|mesh-list
19695146|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
19695147|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695148|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
19695149|NCT04953754|Melatonin|melatonin|mesh-list
19695150|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
20223596|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223597|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223598|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20223599|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
20223600|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223601|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223602|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20223603|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20223604|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223605|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
20223606|NCT00333008|Hormones|hormones|mesh-ancestor
20465654|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20465655|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20465656|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20465657|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465658|NCT01455441|Liraglutide|liraglutide|mesh-list
20465659|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465660|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465661|NCT01455441|Incretins|incretins|mesh-ancestor
20465662|NCT01455441|Hormones|hormones|mesh-ancestor
20465663|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465664|NCT01455506|Fludarabine|fludarabine|mesh-list
20465665|NCT01455506|Busulfan|busulfan|mesh-list
20465666|NCT01455506|Decitabine|decitabine|mesh-list
20465667|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465668|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20465669|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
20465670|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465671|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465672|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
20465673|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465674|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
20619470|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
20619471|NCT02288741|Melphalan|melphalan|mesh-list
20619472|NCT02288741|BB 1101|bb 1101|mesh-list
20619473|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619474|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
20619475|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
20619476|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619477|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619478|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619479|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
20619480|NCT02288741|Hormones|hormones|mesh-ancestor
20619481|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20619482|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20619483|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619484|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
20619485|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408297|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
19408298|NCT03567629|Vitamins|vitamins|mesh-ancestor
19695151|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695152|NCT04953754|Protective Agents|protective agents|mesh-ancestor
19695153|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695154|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695155|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
19695156|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695157|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695158|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19408299|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
19408300|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19408301|NCT03567447|Droxidopa|droxidopa|mesh-list
19408302|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19408303|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19408304|NCT03567434|Ethanol|ethanol|mesh-list
19408305|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19408306|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223607|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223608|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20223609|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20223610|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20223611|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20223612|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20223613|NCT00333021|PENTA|penta|mesh-list
20223614|NCT00333021|Fondaparinux|fondaparinux|mesh-list
20223615|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20223616|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
20223617|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20223618|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
20223619|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223620|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223621|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
20223622|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20223623|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20223624|NCT00333034|Etanercept|etanercept|mesh-list
20223625|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223626|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695159|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19695160|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695161|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695162|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695163|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
20223627|NCT00333034|Analgesics|analgesics|mesh-ancestor
19695164|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19695165|NCT04953741|Fluticasone|fluticasone|mesh-list
19695166|NCT04953741|Xhance|xhance|mesh-list
19695167|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19695168|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19695169|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
19695170|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695171|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695172|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19695173|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
19695174|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
20223628|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
19408307|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619486|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223629|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619487|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20619488|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
20619489|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19849839|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
19849840|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849841|NCT00705679|Tenofovir|tenofovir|mesh-list
19849842|NCT00705679|Emtricitabine|emtricitabine|mesh-list
19849843|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19849844|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
20223630|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223631|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223632|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223633|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223634|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20223635|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
20465675|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20465676|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20465677|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465678|NCT01455532|Gemcitabine|gemcitabine|mesh-list
20465679|NCT01455532|Carboplatin|carboplatin|mesh-list
20465680|NCT01455532|Doxorubicin|doxorubicin|mesh-list
20465681|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20465682|NCT01455532|Iniparib|iniparib|mesh-list
20223636|NCT00333047|Letrozole|letrozole|mesh-list
20619490|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619491|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
20619492|NCT02288832|Azithromycin|azithromycin|mesh-list
19695175|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20223637|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465683|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465684|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20465685|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
20465686|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465687|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
20465688|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619493|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20619494|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619495|NCT02288923|Acetaminophen|acetaminophen|mesh-list
20223638|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20223639|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20223640|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223641|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223642|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20223643|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
20223644|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223645|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223646|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20223647|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20223648|NCT00333086|Letrozole|letrozole|mesh-list
20223649|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223650|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20223651|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20223652|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223653|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223654|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20223655|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
20223656|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223657|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223658|NCT00333112|Tamsulosin|tamsulosin|mesh-list
20223659|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
20223660|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20223661|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20223662|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223663|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465689|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695176|NCT04954014|Bevacizumab|bevacizumab|mesh-list
19695177|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695178|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695179|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19695180|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19695181|NCT04954014|Growth Substances|growth substances|mesh-ancestor
19707808|NCT04823260|Niacinamide|niacinamide|mesh-list
20619496|NCT02288923|Ibuprofen|ibuprofen|mesh-list
20223664|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465690|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619497|NCT02288923|Morphine|morphine|mesh-list
20465691|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
20465692|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465693|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20465694|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20465695|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20465696|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20465697|NCT01455636|Micronutrients|micronutrients|mesh-list
20465698|NCT01455636|Trace Elements|trace elements|mesh-list
20465699|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
20465700|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465701|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20465702|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465703|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
19695182|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695183|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
19695184|NCT04954040|Azithromycin|azithromycin|mesh-list
19695185|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
19695186|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695187|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695188|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
19408308|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408309|NCT03567408|Bivalirudin|bivalirudin|mesh-list
19408310|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
19695189|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19695190|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19695191|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408311|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20619498|NCT02288923|Antiemetics|antiemetics|mesh-list
20619499|NCT02288923|Anesthetics|anesthetics|mesh-list
20619500|NCT02288923|Emetics|emetics|mesh-list
20619501|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619502|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619503|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20619504|NCT02288923|Narcotics|narcotics|mesh-ancestor
20619505|NCT02288923|Analgesics|analgesics|mesh-ancestor
20619506|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
20619507|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619508|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20619509|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619510|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619511|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619512|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20619513|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619514|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619515|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
20619516|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
20619517|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19408312|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
19695192|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695193|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223665|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465704|NCT01455649|Cyclosporine|cyclosporine|mesh-list
20465705|NCT01455649|Everolimus|everolimus|mesh-list
20465706|NCT01455649|Tacrolimus|tacrolimus|mesh-list
20465707|NCT01455649|Cyclosporins|cyclosporins|mesh-list
20465708|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20223666|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223667|NCT00333112|Urological Agents|urological agents|mesh-ancestor
20223668|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20223669|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20223670|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
20223671|NCT00333125|Timolol|timolol|mesh-list
20223672|NCT00333125|Travoprost|travoprost|mesh-list
20223673|NCT00333125|Dorzolamide|dorzolamide|mesh-list
20223674|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20223675|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20223676|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20465709|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465710|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
20619518|NCT02288962|Cabergoline|cabergoline|mesh-list
19408313|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408314|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223677|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20223678|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
19408315|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
19408316|NCT03567395|Melatonin|melatonin|mesh-list
20465711|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619519|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19408317|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
19408318|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408319|NCT03567395|Protective Agents|protective agents|mesh-ancestor
19408320|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408321|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408322|NCT03567369|Dexamethasone|dexamethasone|mesh-list
19408323|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
20619520|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20619521|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
20619522|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
20619523|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619524|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619525|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619526|NCT02289027|Vaccines|vaccines|mesh-list
20619527|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
20465712|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465713|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465714|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
20465715|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465716|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
20465717|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465718|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526927|NCT01765452|Clopidogrel|clopidogrel|mesh-list
20526928|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20526929|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20619528|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619529|NCT02289144|Ceritinib|ceritinib|mesh-list
20619530|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619531|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20619532|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619533|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619534|NCT02289248|Ketamine|ketamine|mesh-list
20619535|NCT02289248|Analgesics|analgesics|mesh-ancestor
20619536|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
19408324|NCT03567369|BB 1101|bb 1101|mesh-list
19408325|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408326|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
19408327|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
19408328|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408329|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408330|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19408331|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
20223679|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223680|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223681|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223682|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20223683|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223684|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20223685|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223686|NCT00333151|Metformin|metformin|mesh-list
20223687|NCT00333151|Liraglutide|liraglutide|mesh-list
20223688|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
20223689|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20223690|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223691|NCT00333151|Incretins|incretins|mesh-ancestor
20223692|NCT00333151|Hormones|hormones|mesh-ancestor
20223693|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223694|NCT00333164|Cilostazol|cilostazol|mesh-list
20223695|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20223696|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
20223697|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223698|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223699|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20223700|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
20223701|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20223702|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20223703|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223704|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20223705|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
20223706|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20223707|NCT00333164|Protective Agents|protective agents|mesh-ancestor
20619537|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408332|NCT03567369|Hormones|hormones|mesh-ancestor
20223708|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20619538|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619539|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20619540|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20619541|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
20619542|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
20619543|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619544|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20619545|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20619546|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619547|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619548|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
20619549|NCT02289261|Morphine|morphine|mesh-list
20465719|NCT01455831|Tinzaparin|tinzaparin|mesh-list
20465720|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20465721|NCT01455831|Dalteparin|dalteparin|mesh-list
20465722|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
20465723|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20465724|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465725|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465726|NCT01455883|Glimepiride|glimepiride|mesh-list
20465727|NCT01455883|Exenatide|exenatide|mesh-list
20465728|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20465729|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465730|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465731|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20223709|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20619550|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20619551|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619552|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619553|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619554|NCT02289261|Analgesics|analgesics|mesh-ancestor
20619555|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
19408333|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223710|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465732|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
20465733|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20465734|NCT01455883|Incretins|incretins|mesh-ancestor
20465735|NCT01455883|Hormones|hormones|mesh-ancestor
20465736|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465737|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20465738|NCT01455909|Exenatide|exenatide|mesh-list
20465739|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465740|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223711|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
20223712|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
20223713|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
20223714|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20223715|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20223716|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223717|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223718|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223719|NCT00333255|Nepafenac|nepafenac|mesh-list
20223720|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223721|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223722|NCT00333255|Analgesics|analgesics|mesh-ancestor
20223723|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
20223724|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223725|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223726|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223727|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223728|NCT00333281|Tadalafil|tadalafil|mesh-list
19408334|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19408335|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408336|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
19408337|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408338|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223729|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
20223730|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20465741|NCT01455909|Incretins|incretins|mesh-ancestor
20465742|NCT01455909|Hormones|hormones|mesh-ancestor
20619556|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223731|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20465743|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20619557|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20619558|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20619559|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20619560|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
20619561|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619562|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619563|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20223732|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465744|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20465745|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
20465746|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465747|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465748|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20465749|NCT01455922|Glimepiride|glimepiride|mesh-list
20465750|NCT01455922|Exenatide|exenatide|mesh-list
20465751|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20465752|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465753|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465754|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465755|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
20465756|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20465757|NCT01455922|Incretins|incretins|mesh-ancestor
20465758|NCT01455922|Hormones|hormones|mesh-ancestor
20465759|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20465760|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20465761|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20465762|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20465763|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465764|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
20465765|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20465766|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20465767|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20465768|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465769|NCT01456117|Pioglitazone|pioglitazone|mesh-list
20465770|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20465771|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465772|NCT01456208|Norepinephrine|norepinephrine|mesh-list
20465773|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
20465774|NCT01456208|Giapreza|giapreza|mesh-list
20465775|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
20465776|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20465777|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20465778|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465779|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465780|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619564|NCT02289261|Narcotics|narcotics|mesh-ancestor
20619565|NCT02289274|Aceclofenac|aceclofenac|mesh-list
20223733|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223734|NCT00333281|Urological Agents|urological agents|mesh-ancestor
20223735|NCT00333294|Vinorelbine|vinorelbine|mesh-list
20223736|NCT00333294|Gefitinib|gefitinib|mesh-list
20223737|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619566|NCT02289274|Eperisone|eperisone|mesh-list
20619567|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20619568|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619569|NCT02289274|Analgesics|analgesics|mesh-ancestor
20619570|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
20619571|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223738|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20223739|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
20223740|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
20223741|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
20223742|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223743|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20223744|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223745|NCT00333307|Methocarbamol|methocarbamol|mesh-list
20223746|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20223747|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223748|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20223749|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223750|NCT00333346|Tramadol|tramadol|mesh-list
20223751|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20465781|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465782|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
20619572|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619573|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619574|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619575|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
20619576|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20619577|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619578|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223752|NCT00333346|Narcotics|narcotics|mesh-ancestor
20223753|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223754|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223755|NCT00333346|Analgesics|analgesics|mesh-ancestor
20619579|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20619580|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20619581|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20619582|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
20619583|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
20619584|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
20619585|NCT02289378|Docetaxel|docetaxel|mesh-list
20619586|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
20465783|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
20465784|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465785|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20465786|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20465787|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
20465788|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465789|NCT01456234|Oseltamivir|oseltamivir|mesh-list
20465790|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
20619587|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619588|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20619589|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20619590|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
20619591|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619592|NCT02289391|Anesthetics|anesthetics|mesh-list
20619593|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619594|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223756|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
20223757|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223758|NCT00333372|Z 338|z 338|mesh-list
20223759|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20223760|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223761|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223762|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
20223763|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223764|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223765|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619595|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20619596|NCT02289430|Ezetimibe|ezetimibe|mesh-list
20619597|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20619598|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20619599|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
20619600|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223766|NCT00333385|Ceftazidime|ceftazidime|mesh-list
20223767|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20223768|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223769|NCT00333398|Vaccines|vaccines|mesh-list
20223770|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
20223771|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223772|NCT00333424|Vaccines|vaccines|mesh-list
20223773|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
20223774|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223775|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20223776|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
20223777|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223778|NCT00333476|Squalamine|squalamine|mesh-list
20223779|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20223780|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223781|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20223782|NCT00333476|Protective Agents|protective agents|mesh-ancestor
20223783|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223784|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223785|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20247297|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465791|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465792|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619601|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20465793|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465794|NCT01456247|Lansoprazole|lansoprazole|mesh-list
20465795|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
20465796|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465797|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465798|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20465799|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465800|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465801|NCT01456260|Lansoprazole|lansoprazole|mesh-list
20465802|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
20465803|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20465804|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20465805|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20465806|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465807|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465808|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20465809|NCT01456312|Entecavir|entecavir|mesh-list
20619602|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20619603|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223786|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20223787|NCT00333476|Growth Substances|growth substances|mesh-ancestor
20223788|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
20223789|NCT00333489|Valsartan|valsartan|mesh-list
20223790|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20223791|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20223792|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20223793|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223794|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
20223795|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20223796|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20223797|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223798|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223799|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223800|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223801|NCT00333567|Analgesics|analgesics|mesh-ancestor
20223802|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
20223803|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223804|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223805|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223806|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223807|NCT00333632|Fentanyl|fentanyl|mesh-list
20223808|NCT00333632|Midazolam|midazolam|mesh-list
20223809|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
20223810|NCT00333632|Propofol|propofol|mesh-list
20223811|NCT00333632|Isoflurane|isoflurane|mesh-list
20223812|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20223813|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223814|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223815|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20223816|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
20223817|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
20223818|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223819|NCT00333632|Analgesics|analgesics|mesh-ancestor
20223820|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
20223821|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223822|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20223823|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20223824|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20223825|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223826|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223827|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223828|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20223829|NCT00333632|Narcotics|narcotics|mesh-ancestor
20223830|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20223831|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20223832|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20223833|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223834|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
20223835|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
20223836|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19408339|NCT03567343|Melatonin|melatonin|mesh-list
19408340|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
20223837|NCT00333645|Caspofungin|caspofungin|mesh-list
20223838|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
20223839|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223840|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465810|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
20465811|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465812|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20465813|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465814|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20223841|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223842|NCT00333671|Glycerol|glycerol|mesh-list
20223843|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20223844|NCT00333671|Protective Agents|protective agents|mesh-ancestor
20223845|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223846|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
20223847|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20223848|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223849|NCT00333918|Bromfenac|bromfenac|mesh-list
20223850|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20223851|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20223852|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20223853|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223854|NCT00333918|Analgesics|analgesics|mesh-ancestor
20223855|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
20223856|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223857|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223858|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223859|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20223860|NCT00333931|Phenytoin|phenytoin|mesh-list
20223861|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
20223862|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20223863|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20223864|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20223865|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223866|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20223867|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20223868|NCT00333944|Pralidoxime|pralidoxime|mesh-list
20223869|NCT00333944|Antidotes|antidotes|mesh-ancestor
20223870|NCT00333944|Protective Agents|protective agents|mesh-ancestor
20223871|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223872|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
20223873|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
20223874|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223875|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
20223876|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223877|NCT00333996|Dexamethasone|dexamethasone|mesh-list
20223878|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20223879|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
20223880|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
20223881|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223882|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223883|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223884|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
20223885|NCT00333996|Hormones|hormones|mesh-ancestor
20223886|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20223887|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20223888|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223889|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
20223890|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20223891|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20223892|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223893|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20223894|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20223895|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
20223896|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223897|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20223898|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
20223899|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223900|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19695194|NCT04953117|Paclitaxel|paclitaxel|mesh-list
19695195|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19695196|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695197|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
19695198|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
19695199|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
20223901|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20223902|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223903|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223904|NCT00334048|Ropinirole|ropinirole|mesh-list
20223905|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20465815|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465816|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465817|NCT01456351|Rituximab|rituximab|mesh-list
20465818|NCT01456351|Fludarabine|fludarabine|mesh-list
20465819|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20465820|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20465821|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465822|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
20465823|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465824|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465825|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465826|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20619604|NCT02289482|Ritonavir|ritonavir|mesh-list
20619605|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
20619606|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20619607|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20619608|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
20619609|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619610|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619611|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20619612|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20619613|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
20619614|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619615|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20619616|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20619617|NCT02289495|Ritonavir|ritonavir|mesh-list
20619618|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
20619619|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20619620|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20619621|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
20619622|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619623|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695200|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695201|NCT04953130|Vaccines|vaccines|mesh-list
19695202|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
19695203|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695204|NCT04953104|Nivolumab|nivolumab|mesh-list
19695205|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695206|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695207|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19695208|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707809|NCT04823260|Niacin|niacin|mesh-list
19707810|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
19707811|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
19707812|NCT04823260|Vitamins|vitamins|mesh-ancestor
19707813|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
19707814|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707815|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19707816|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
19707817|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707818|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19849845|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19849846|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19849847|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19849848|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849849|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707819|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
19707820|NCT04822909|Thalidomide|thalidomide|mesh-list
20465827|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
20465828|NCT01456364|Ticagrelor|ticagrelor|mesh-list
20465829|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20465830|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465831|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20619624|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20619625|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19408341|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408342|NCT03567343|Protective Agents|protective agents|mesh-ancestor
19408343|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408344|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408345|NCT03567304|Rilpivirine|rilpivirine|mesh-list
19408346|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19408347|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19707821|NCT04822909|Apremilast|apremilast|mesh-list
19707822|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19408348|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408349|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408350|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
19408351|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408352|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19408353|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19408354|NCT03567135|Temozolomide|temozolomide|mesh-list
19408355|NCT03567135|Apatinib|apatinib|mesh-list
19408356|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19408357|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
19408358|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408359|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408360|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19408361|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408362|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
19408363|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408364|NCT03566914|Tadalafil|tadalafil|mesh-list
19408365|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
19695209|NCT04952792|Apixaban|apixaban|mesh-list
19695210|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19695211|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
19695212|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19695213|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
20465832|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20465833|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20465834|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
20465835|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465836|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465837|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695214|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695215|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695216|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
19695217|NCT04952571|Bevacizumab|bevacizumab|mesh-list
19695218|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695219|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695220|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19695221|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19695222|NCT04952571|Growth Substances|growth substances|mesh-ancestor
19695223|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695224|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
19695225|NCT04952519|Amantadine|amantadine|mesh-list
19695226|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19695227|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19695228|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
19695229|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695230|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
19695231|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223906|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20223907|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
20223908|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
20223909|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223910|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223911|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223912|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20223913|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20223914|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
20223915|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223916|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19695232|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695233|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695234|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695235|NCT04952519|Analgesics|analgesics|mesh-ancestor
19695236|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
20223917|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20465838|NCT01456468|Tretinoin|tretinoin|mesh-list
20465839|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465840|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
20465841|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
20465842|NCT01456481|Midodrine|midodrine|mesh-list
20465843|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
20465844|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
20223918|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465845|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408366|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19695237|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465846|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465847|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20465848|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20465849|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20465850|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20465851|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
20619626|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
20619627|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465852|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465853|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465854|NCT01456507|Naltrexone|naltrexone|mesh-list
20465855|NCT01456507|Oxycodone|oxycodone|mesh-list
20465856|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20465857|NCT01456507|Narcotics|narcotics|mesh-ancestor
20465858|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465859|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465860|NCT01456507|Analgesics|analgesics|mesh-ancestor
20223919|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223920|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19408367|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19408368|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408369|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408370|NCT03566914|Urological Agents|urological agents|mesh-ancestor
19408371|NCT03566576|Docetaxel|docetaxel|mesh-list
20223921|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20223922|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
20223923|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223924|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223925|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20223926|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20223927|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
20223928|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
20223929|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20223930|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223931|NCT00334152|Casopitant|casopitant|mesh-list
20223932|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
20223933|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
20223934|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223935|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223936|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20223937|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20223938|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223939|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223940|NCT00334256|Tenofovir|tenofovir|mesh-list
20223941|NCT00334256|Emtricitabine|emtricitabine|mesh-list
20223942|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
20223943|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20223944|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20223945|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20223946|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223947|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223948|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20223949|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20223950|NCT00334308|Caseins|caseins|mesh-list
20223951|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
20223952|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
20223953|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223954|NCT00334321|Paclitaxel|paclitaxel|mesh-list
20223955|NCT00334321|Carboplatin|carboplatin|mesh-list
20223956|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20223957|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20223958|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
20223959|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
20223960|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
20223961|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223962|NCT00334347|Valproic Acid|valproic acid|mesh-list
20223963|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
20223964|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20223965|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223966|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
20223967|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465861|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
19408372|NCT03566576|Pemetrexed|pemetrexed|mesh-list
20223968|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465862|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408373|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465863|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20465864|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20465865|NCT01456546|Proguanil|proguanil|mesh-list
20465866|NCT01456546|Clopidogrel|clopidogrel|mesh-list
20465867|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20465868|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20465869|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20465870|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20465871|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
20465872|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619628|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20223969|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
20223970|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20223971|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223972|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223973|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
20223974|NCT00334360|Buspirone|buspirone|mesh-list
20223975|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19695238|NCT04952194|Levodopa|levodopa|mesh-list
19695239|NCT04952194|Carbidopa|carbidopa|mesh-list
19695240|NCT04952194|Entacapone|entacapone|mesh-list
19695241|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20223976|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20223977|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223978|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20223979|NCT00334360|Analgesics|analgesics|mesh-ancestor
20223980|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
20223981|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223982|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19408374|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
19408375|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
19408376|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
19408377|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408378|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408379|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19408380|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19416594|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19416595|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19416596|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19416597|NCT02391571|Naltrexone|naltrexone|mesh-list
19416598|NCT02391571|Oxycodone|oxycodone|mesh-list
19416599|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19416600|NCT02391571|Narcotics|narcotics|mesh-ancestor
19416601|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416602|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416603|NCT02391571|Analgesics|analgesics|mesh-ancestor
19416604|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
19416605|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20223983|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20223984|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20223985|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
20223986|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20223987|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20223988|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20223989|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20223990|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20223991|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20223992|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
20223993|NCT00334386|Torsemide|torsemide|mesh-list
20223994|NCT00334386|Diuretics|diuretics|mesh-list
20223995|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20223996|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
20223997|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20223998|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20223999|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224000|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20224001|NCT00334399|Miglitol|miglitol|mesh-list
20224002|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224003|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224004|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20619629|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19416606|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19416607|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19695242|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20619630|NCT02289547|Capecitabine|capecitabine|mesh-list
20619631|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20619632|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
20619633|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619634|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619635|NCT02289586|Fentanyl|fentanyl|mesh-list
20619636|NCT02289586|Midazolam|midazolam|mesh-list
20224005|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224006|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20247298|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247299|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
20247300|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247301|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247302|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
20247303|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
20247304|NCT00431665|Heparin|heparin|mesh-list
20247305|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20247306|NCT00431665|Somatostatin|somatostatin|mesh-list
20247307|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20247308|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247309|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
20247310|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20247311|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20247312|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247313|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20465873|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465874|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465875|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
20465876|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20465877|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20465878|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465879|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
20465880|NCT01456585|Gemcitabine|gemcitabine|mesh-list
20619637|NCT02289586|Remifentanil|remifentanil|mesh-list
19408381|NCT03566394|Gabapentin|gabapentin|mesh-list
19408382|NCT03566394|Analgesics|analgesics|mesh-ancestor
19408383|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
19408384|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408385|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408386|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
20247314|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20247315|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20247316|NCT00431665|Hormones|hormones|mesh-ancestor
20247317|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247318|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247319|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
20247320|NCT00431678|Levofloxacin|levofloxacin|mesh-list
20247321|NCT00431678|Ofloxacin|ofloxacin|mesh-list
20247322|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
20247323|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20247324|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20247325|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247326|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20247327|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20247328|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247329|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247330|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247331|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20247332|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
20247333|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20247334|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247335|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20247336|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20247337|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20247338|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20247339|NCT00431678|Renal Agents|renal agents|mesh-ancestor
20247340|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20247341|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20247342|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
20247343|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247344|NCT00431704|Carboplatin|carboplatin|mesh-list
20247345|NCT00431704|Trastuzumab|trastuzumab|mesh-list
20247346|NCT00431704|Vinorelbine|vinorelbine|mesh-list
20465881|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20619638|NCT02289586|Dezocine|dezocine|mesh-list
20619639|NCT02289586|Propofol|propofol|mesh-list
20465882|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
20465883|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465884|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408387|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19408388|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19408389|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408390|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19408391|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19408392|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19408393|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408394|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408395|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
20619640|NCT02289586|Rocuronium|rocuronium|mesh-list
20619641|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
19408396|NCT03566329|Lidocaine|lidocaine|mesh-list
20619642|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408397|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
19408398|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19408399|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
19408400|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408401|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408402|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
20224007|NCT00334412|Caspofungin|caspofungin|mesh-list
20224008|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20224009|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
20224010|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224011|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224012|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224013|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20224014|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20465885|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
20465886|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20465887|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465888|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465889|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
20465890|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465891|NCT01456611|Diclofenac|diclofenac|mesh-list
20465892|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20224015|NCT00334425|Menotropins|menotropins|mesh-list
20465893|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465894|NCT01456611|Analgesics|analgesics|mesh-ancestor
20465895|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
20465896|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465897|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465898|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20465899|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20465900|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20465901|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465902|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465903|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
20465904|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20465905|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465906|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
20465907|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20465908|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465909|NCT01456650|Glyburide|glyburide|mesh-list
20465910|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20224016|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20224017|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
20224018|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20224019|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247347|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247348|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247349|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20247350|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
20465911|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465912|NCT01456689|Midazolam|midazolam|mesh-list
20465913|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20465914|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19416608|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
20465915|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20465916|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465917|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20619643|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465918|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20465919|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20465920|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20224020|NCT00334438|Rituximab|rituximab|mesh-list
20224021|NCT00334438|Bortezomib|bortezomib|mesh-list
20224022|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20224023|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224024|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224025|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
20224026|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224027|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224028|NCT00334464|Warfarin|warfarin|mesh-list
20224029|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
20224030|NCT00334477|Tadalafil|tadalafil|mesh-list
20224031|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
20224032|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20224033|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20224034|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224035|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224036|NCT00334477|Urological Agents|urological agents|mesh-ancestor
20224037|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
20224038|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
20224039|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20224040|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20224041|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224042|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224043|NCT00334490|Urological Agents|urological agents|mesh-ancestor
20224044|NCT00334503|Miglitol|miglitol|mesh-list
20224045|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465921|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
20465922|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
20465923|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
19695243|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
19695244|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695245|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695246|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224046|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224047|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20224048|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224049|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20224050|NCT00334529|Oseltamivir|oseltamivir|mesh-list
20224051|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
20224052|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224053|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224054|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224055|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
20224056|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20224057|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224058|NCT00334581|Irbesartan|irbesartan|mesh-list
20224059|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20224060|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20224061|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20224062|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224063|NCT00334594|Pemetrexed|pemetrexed|mesh-list
20224064|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224065|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224066|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224067|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20224068|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20224069|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
20224070|NCT00334646|Casopitant|casopitant|mesh-list
20224071|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224072|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
20224073|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224074|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224075|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19695247|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19695248|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695249|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19695250|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
19695251|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
19695252|NCT04952207|Grazoprevir|grazoprevir|mesh-list
19695253|NCT04952207|Ledipasvir|ledipasvir|mesh-list
20224076|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
20465924|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
20619644|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20619645|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20619646|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
20619647|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20619648|NCT02289586|Narcotics|narcotics|mesh-ancestor
20619649|NCT02289586|Analgesics|analgesics|mesh-ancestor
20619650|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
20465925|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849850|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19849851|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20619651|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849852|NCT00705757|Bimatoprost|bimatoprost|mesh-list
20224077|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465926|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465927|NCT01456715|Vaccines|vaccines|mesh-list
20465928|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
20465929|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465930|NCT01457001|Vitamin D|vitamin d|mesh-list
20465931|NCT01457001|Vitamins|vitamins|mesh-list
20465932|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
20465933|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224078|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224079|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20224080|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
20465934|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20465935|NCT01457040|Etoposide|etoposide|mesh-list
20465936|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
20465937|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20465938|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465939|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20465940|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20465941|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20465942|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465943|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
20465944|NCT01457131|Fludarabine|fludarabine|mesh-list
19849853|NCT00705757|Travoprost|travoprost|mesh-list
19849854|NCT00705757|Latanoprost|latanoprost|mesh-list
20224081|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
20224082|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224083|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20224084|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20224085|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224086|NCT00334672|Cyclosporine|cyclosporine|mesh-list
20224087|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
20224088|NCT00334672|Dexamethasone|dexamethasone|mesh-list
20224089|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
20224090|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20224091|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20224092|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20224093|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
20224094|NCT00334672|Busulfan|busulfan|mesh-list
20224095|NCT00334672|Methotrexate|methotrexate|mesh-list
20224096|NCT00334672|Etoposide|etoposide|mesh-list
20224097|NCT00334672|Cyclosporins|cyclosporins|mesh-list
20224098|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20224099|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224100|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
20224101|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224102|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224103|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20224104|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
20224105|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465945|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20465946|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
20465947|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465948|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619652|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19849855|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19849856|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19849857|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19849858|NCT00705783|Aripiprazole|aripiprazole|mesh-list
19849859|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
20224106|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619653|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19849860|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619654|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19849861|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20224107|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20619655|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619656|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
20619657|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
20619658|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619659|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619660|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20619661|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20619662|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20619663|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
20619664|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20619665|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
20224108|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224109|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
20224110|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
20224111|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224112|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19408403|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224113|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
20224114|NCT00334672|Hormones|hormones|mesh-ancestor
20224115|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224116|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20224117|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20224118|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
20224119|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20224120|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224121|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
20224122|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
20224123|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224124|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20224125|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20224126|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20224127|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224128|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224129|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
20224130|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224131|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20224132|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20224133|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20224134|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
20224135|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224136|NCT00334685|Pregabalin|pregabalin|mesh-list
20224137|NCT00334685|Reboxetine|reboxetine|mesh-list
20224138|NCT00334685|Analgesics|analgesics|mesh-ancestor
20224139|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
20224140|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224141|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224142|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
20224143|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20224144|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20224145|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224146|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20224147|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20224148|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20224149|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224150|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20224151|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
20224152|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20224153|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20224154|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
20224155|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224156|NCT00334698|Cetirizine|cetirizine|mesh-list
20224157|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
20224158|NCT00334698|Ephedrine|ephedrine|mesh-list
20224159|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20224160|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20224161|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20224162|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
20224163|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
20224164|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224165|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224166|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224167|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20619666|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19416609|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
19849862|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19849863|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224168|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
20224169|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224170|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20224171|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
20224172|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
20224173|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20224174|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20224175|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
20224176|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
20224177|NCT00334763|Paclitaxel|paclitaxel|mesh-list
20224178|NCT00334763|Bevacizumab|bevacizumab|mesh-list
20224179|NCT00334763|Carboplatin|carboplatin|mesh-list
20224180|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20224181|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224182|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
20224183|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
20224184|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
20224185|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224186|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224187|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20224188|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20224189|NCT00334763|Growth Substances|growth substances|mesh-ancestor
20224190|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224191|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
20224192|NCT00334789|Vitamin A|vitamin a|mesh-list
20224193|NCT00334789|Tretinoin|tretinoin|mesh-list
20224194|NCT00334789|Belinostat|belinostat|mesh-list
20224195|NCT00334789|Isotretinoin|isotretinoin|mesh-list
20224196|NCT00334789|Vitamins|vitamins|mesh-ancestor
20224197|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
20224198|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849864|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849865|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
19849866|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
19849867|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224199|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224200|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
20224201|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
20224202|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224203|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20224204|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224205|NCT00334854|Doxorubicin|doxorubicin|mesh-list
19695254|NCT04952207|Velpatasvir|velpatasvir|mesh-list
19695255|NCT04952207|Asunaprevir|asunaprevir|mesh-list
20224206|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20224207|NCT00334854|Ifosfamide|ifosfamide|mesh-list
20224208|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20224209|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224210|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224211|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224212|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224213|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224214|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20224215|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
20224216|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
20224217|NCT00334867|Ifosfamide|ifosfamide|mesh-list
20224218|NCT00334867|Doxorubicin|doxorubicin|mesh-list
20224219|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20224220|NCT00334867|Etoposide|etoposide|mesh-list
20224221|NCT00334867|Vincristine|vincristine|mesh-list
20224222|NCT00334867|Topotecan|topotecan|mesh-list
19695256|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695257|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
19695258|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695259|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695260|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
19695261|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19695262|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
19695263|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695264|NCT04951856|Evolocumab|evolocumab|mesh-list
19695265|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19695266|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19695267|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
19707823|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20224223|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
20224224|NCT00334867|Razoxane|razoxane|mesh-list
20224225|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849868|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849869|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19849870|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19849871|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
19849872|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19849873|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20224226|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
20224227|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849874|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19849875|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19849876|NCT00705874|Leucovorin|leucovorin|mesh-list
20224228|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224229|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20465949|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20465950|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
20465951|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465952|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20465953|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20465954|NCT01457261|Albuterol|albuterol|mesh-list
20465955|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20465956|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
20465957|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465958|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465959|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20224230|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
20224231|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224232|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224233|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20224234|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20224235|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224236|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224237|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224238|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20224239|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
20224240|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
20224241|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
20224242|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20224243|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20224244|NCT00334867|Protective Agents|protective agents|mesh-ancestor
20224245|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20224246|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20224247|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224248|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20224249|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20224250|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20224251|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224252|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
20224253|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224254|NCT00334906|Memantine|memantine|mesh-list
20224255|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20224256|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20224257|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
20224258|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224259|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224260|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224261|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20224262|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20224263|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20224264|NCT00334932|Doxorubicin|doxorubicin|mesh-list
20224265|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20224266|NCT00334932|Bortezomib|bortezomib|mesh-list
20224267|NCT00334932|Melphalan|melphalan|mesh-list
20224268|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20224269|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224270|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224271|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224272|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224273|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465960|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
19408404|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19408405|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19408406|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20465961|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
20465962|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20465963|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20465964|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20465965|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20465966|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
20465967|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465968|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465969|NCT01457469|Nicotine|nicotine|mesh-list
20465970|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20619667|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
20619668|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619669|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619670|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
20619671|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
20619672|NCT02289768|Salicylates|salicylates|mesh-list
20619673|NCT02289768|Fluorouracil|fluorouracil|mesh-list
20619674|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
20619675|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619676|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20619677|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619678|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619679|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
20619680|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619681|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20619682|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
19408407|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19408408|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408409|NCT03566329|Analgesics|analgesics|mesh-ancestor
20224274|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20224275|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
20224276|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20465971|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
20465972|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20465973|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465974|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20465975|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20465976|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
20465977|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20465978|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526930|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20526931|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20526932|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
20224277|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224278|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
20526933|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20526934|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224279|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224280|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
20224281|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
20224282|NCT00335075|Temozolomide|temozolomide|mesh-list
20224283|NCT00335075|Semustine|semustine|mesh-list
20224284|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20224285|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
20224286|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224287|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224288|NCT00335088|Iodine|iodine|mesh-list
20224289|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
20224290|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
20224291|NCT00335088|Povidone|povidone|mesh-list
20224292|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224293|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526935|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526936|NCT01765556|Ketoconazole|ketoconazole|mesh-list
20526937|NCT01765556|Vemurafenib|vemurafenib|mesh-list
20526938|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
20526939|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526940|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20526941|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20526942|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526943|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526944|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20526945|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
20530633|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20465979|NCT01457495|Edetic Acid|edetic acid|mesh-list
20465980|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
20465981|NCT01457495|Antidotes|antidotes|mesh-ancestor
20465982|NCT01457495|Protective Agents|protective agents|mesh-ancestor
20465983|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224294|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224295|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224296|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619683|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
20619684|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
20619685|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20619686|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619687|NCT02289768|Analgesics|analgesics|mesh-ancestor
20619688|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
20619689|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619690|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619691|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619692|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20619693|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619694|NCT02289807|Cisplatin|cisplatin|mesh-list
20619695|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619696|NCT02289924|Aflibercept|aflibercept|mesh-list
20619697|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20619698|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20619699|NCT02289924|Growth Substances|growth substances|mesh-ancestor
20619700|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619701|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
20619702|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619703|NCT02289937|Ropivacaine|ropivacaine|mesh-list
20619704|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
20619705|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
20619706|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619707|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465984|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
20465985|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
20465986|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465987|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20465988|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
20465989|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20465990|NCT01457508|Edetic Acid|edetic acid|mesh-list
20465991|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
20465992|NCT01457508|Antidotes|antidotes|mesh-ancestor
20465993|NCT01457508|Protective Agents|protective agents|mesh-ancestor
20465994|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20465995|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
20465996|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
20465997|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20465998|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20619708|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
20619709|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619710|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
20619711|NCT02290002|Calcium|calcium|mesh-list
20619712|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20619713|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619714|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
20224297|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224298|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224299|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224300|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20224301|NCT00335088|Trace Elements|trace elements|mesh-ancestor
20224302|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
20224303|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
20224304|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
20224305|NCT00335114|Cyclosporine|cyclosporine|mesh-list
20224306|NCT00335114|Cyclosporins|cyclosporins|mesh-list
20465999|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
20466000|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20466001|NCT01457547|Edetic Acid|edetic acid|mesh-list
20224307|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224308|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224309|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224310|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
20224311|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224312|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
20224313|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466002|NCT01457547|Vaccines|vaccines|mesh-list
20466003|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
20619715|NCT02290002|Coagulants|coagulants|mesh-ancestor
20619716|NCT02290054|Anesthetics|anesthetics|mesh-list
20619717|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849877|NCT00705874|Gemcitabine|gemcitabine|mesh-list
19849878|NCT00705874|Bevacizumab|bevacizumab|mesh-list
19849879|NCT00705874|Sunitinib|sunitinib|mesh-list
20619718|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619719|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
20619720|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
20619721|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619722|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20619723|NCT02290327|Pantoprazole|pantoprazole|mesh-list
20619724|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20619725|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619726|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20619727|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619728|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619729|NCT02290431|Dexamethasone|dexamethasone|mesh-list
20619730|NCT02290431|Bortezomib|bortezomib|mesh-list
20619731|NCT02290431|Panobinostat|panobinostat|mesh-list
20619732|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619733|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
20619734|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
20619735|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619736|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619737|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20466004|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
20466005|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466006|NCT01457547|Antidotes|antidotes|mesh-ancestor
20466007|NCT01457547|Protective Agents|protective agents|mesh-ancestor
20466008|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
20466009|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
20466010|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466011|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20466012|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
20466013|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20466014|NCT01457690|Tocopherols|tocopherols|mesh-list
20466015|NCT01457690|Vitamin E|vitamin e|mesh-list
20466016|NCT01457690|Tocotrienols|tocotrienols|mesh-list
20466017|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
20466018|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
20466019|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466020|NCT01457690|Protective Agents|protective agents|mesh-ancestor
20466021|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466022|NCT01457690|Vitamins|vitamins|mesh-ancestor
20466023|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
20466024|NCT01457716|Budesonide|budesonide|mesh-list
20466025|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
20466026|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20466027|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20466028|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
20466029|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466030|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466031|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20466032|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
20619738|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
20619739|NCT02290431|Hormones|hormones|mesh-ancestor
20619740|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20619741|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20619742|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619743|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20619744|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849880|NCT00705874|Docetaxel|docetaxel|mesh-list
19849881|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19849882|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19849883|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224314|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
20224315|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224316|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20224317|NCT00335166|Pramipexole|pramipexole|mesh-list
20224318|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
20224319|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224320|NCT00335166|Protective Agents|protective agents|mesh-ancestor
20224321|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224322|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20466033|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
20466034|NCT01457716|Hormones|hormones|mesh-ancestor
20619745|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619746|NCT02290470|Dexamethasone|dexamethasone|mesh-list
20619747|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
20619748|NCT02290470|Paclitaxel|paclitaxel|mesh-list
20619749|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20619750|NCT02290470|Carboplatin|carboplatin|mesh-list
20619751|NCT02290470|Olanzapine|olanzapine|mesh-list
20619752|NCT02290470|Palonosetron|palonosetron|mesh-list
20619753|NCT02290470|BB 1101|bb 1101|mesh-list
20619754|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20619755|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619756|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20619757|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20619758|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20466035|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466036|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20466037|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20466038|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20466039|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
20466040|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466041|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466042|NCT01457820|Allopurinol|allopurinol|mesh-list
20466043|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
20466044|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466045|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466046|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
19408410|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
19408411|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19408412|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19408413|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
19408414|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408415|NCT03566316|Amlodipine|amlodipine|mesh-list
19408416|NCT03566316|Telmisartan|telmisartan|mesh-list
19408417|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20619759|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619760|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619761|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
19408418|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19408419|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19408420|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19408421|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19408422|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408423|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19408424|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466047|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20466048|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20466049|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
20466050|NCT01457820|Protective Agents|protective agents|mesh-ancestor
20466051|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466052|NCT01457859|Triclosan|triclosan|mesh-list
20466053|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20466054|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408425|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
19408426|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20466055|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20466056|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20466057|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
20466058|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466059|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20466060|NCT01457911|Metformin|metformin|mesh-list
20466061|NCT01457911|Glimepiride|glimepiride|mesh-list
20466062|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466063|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619762|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
20619763|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619764|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619765|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619766|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
20619767|NCT02290470|Hormones|hormones|mesh-ancestor
20619768|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408427|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19408428|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
20466064|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20619769|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20619770|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
20619771|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466065|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466066|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
20466067|NCT01457937|Interferons|interferons|mesh-list
20466068|NCT01457937|Ribavirin|ribavirin|mesh-list
20466069|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20466070|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466071|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
20466072|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466073|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
20466074|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466075|NCT01457989|Ezogabine|ezogabine|mesh-list
20466076|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
20466077|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466078|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466079|NCT01458015|Oxycodone|oxycodone|mesh-list
20466080|NCT01458015|Tapentadol|tapentadol|mesh-list
20466081|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20466082|NCT01458015|Narcotics|narcotics|mesh-ancestor
20466083|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466084|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466085|NCT01458015|Analgesics|analgesics|mesh-ancestor
20466086|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
20466087|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466088|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20466089|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20466090|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466091|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466092|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
20466093|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466094|NCT01458041|Iloprost|iloprost|mesh-list
20466095|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20466096|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
20466097|NCT01458054|Ritonavir|ritonavir|mesh-list
20466098|NCT01458054|Omeprazole|omeprazole|mesh-list
20466099|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20466100|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20466101|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
20466102|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466103|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466104|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20466105|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20466106|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
20466107|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466108|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20466109|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20466110|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20466111|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619772|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20619773|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20619774|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619775|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619776|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20619777|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20619778|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619779|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619780|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
20619781|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20619782|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20619783|NCT02290717|Fluticasone|fluticasone|mesh-list
20619784|NCT02290717|Xhance|xhance|mesh-list
20619785|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20619786|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20619787|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
20619788|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619789|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619790|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20619791|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
20619792|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
20619793|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20619794|NCT02291055|Durvalumab|durvalumab|mesh-list
20619795|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707824|NCT04822909|Analgesics|analgesics|mesh-ancestor
20466112|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20466113|NCT01458067|GSK2636771|gsk2636771|mesh-list
20619796|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619797|NCT02291094|Lidocaine|lidocaine|mesh-list
20466114|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466115|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20466116|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466117|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408429|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247351|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
20466118|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20466119|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20466120|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466121|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
20466122|NCT01458236|Beraprost|beraprost|mesh-list
20466123|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20466124|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
20466125|NCT01458301|Leuprolide|leuprolide|mesh-list
20466126|NCT01458301|Relugolix|relugolix|mesh-list
20466127|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20466128|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
20466129|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20466130|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466131|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20466132|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466133|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
20466134|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
20466135|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466136|NCT01458431|Anesthetics|anesthetics|mesh-list
20466137|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
20466138|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
20466139|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466140|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466141|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
20466142|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466143|NCT01458470|Memantine|memantine|mesh-list
20466144|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20466145|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20466146|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
20466147|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466148|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466149|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466150|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20466151|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20466152|NCT01458548|Rituximab|rituximab|mesh-list
20466153|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20466154|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466155|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
20466156|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466157|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20466158|NCT01458600|Diclofenac|diclofenac|mesh-list
20466159|NCT01458600|Propranolol|propranolol|mesh-list
20466160|NCT01458600|Metoprolol|metoprolol|mesh-list
20466161|NCT01458600|Methimazole|methimazole|mesh-list
20466162|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20466163|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20466164|NCT01458600|Analgesics|analgesics|mesh-ancestor
20466165|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
20466166|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466167|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466168|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20466169|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20466170|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20466171|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466172|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466173|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20466174|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20466175|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
20466176|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466177|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20247352|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
20247353|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247354|NCT00431769|Bortezomib|bortezomib|mesh-list
20247355|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247356|NCT00431795|Doxorubicin|doxorubicin|mesh-list
20247357|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20247358|NCT00431795|Epirubicin|epirubicin|mesh-list
20619798|NCT02291094|Remifentanil|remifentanil|mesh-list
19695268|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695269|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19695270|NCT04952129|Selenium|selenium|mesh-list
19695271|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
19695272|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
19695273|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695274|NCT04952129|Protective Agents|protective agents|mesh-ancestor
20466178|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20619799|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
20619800|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
20619801|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619802|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619803|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
20619804|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619805|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20619806|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20619807|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20619808|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619809|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619810|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20619811|NCT02291094|Narcotics|narcotics|mesh-ancestor
20619812|NCT02291094|Analgesics|analgesics|mesh-ancestor
20619813|NCT02291211|Cisplatin|cisplatin|mesh-list
20619814|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619815|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20466179|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
20466180|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
20466181|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
20466182|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20466183|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
20466184|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
20466185|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466186|NCT01458626|Mirtazapine|mirtazapine|mesh-list
20466187|NCT01458626|Paroxetine|paroxetine|mesh-list
20466188|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20466189|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20466190|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466191|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466192|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466193|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
20466194|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466195|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20466196|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
20466197|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619816|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20619817|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20619818|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619819|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619820|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619821|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466198|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20466199|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20466200|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466201|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20466202|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
20466203|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
20466204|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20466205|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20466206|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466207|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20466208|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20466209|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20466210|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
20466211|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20466212|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20619822|NCT02291341|Analgesics|analgesics|mesh-ancestor
20619823|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
20619824|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619825|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
20619826|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619827|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
20619828|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20619829|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20619830|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20466213|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20466214|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20466215|NCT01458743|Cephalosporins|cephalosporins|mesh-list
20466216|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466217|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466218|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20466219|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20466220|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20466221|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
20466222|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466223|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619831|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619832|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619833|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619834|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619835|NCT02291367|Analgesics|analgesics|mesh-ancestor
20619836|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
19408430|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19408431|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466224|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20466225|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20466226|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
20466227|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466228|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
20466229|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20619837|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619838|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
20619839|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619840|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
20619841|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
20619842|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20619843|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20619844|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20619845|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19408432|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19408433|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19408434|NCT03566303|Vitamin K|vitamin k|mesh-list
20619846|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619847|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
20619848|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619849|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619850|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19408435|NCT03566303|Warfarin|warfarin|mesh-list
20619851|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619852|NCT02291471|T0001|t0001|mesh-list
20619853|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
20619854|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20619855|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
20619856|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619857|NCT02291536|Dronabinol|dronabinol|mesh-list
20619858|NCT02291536|Cannabidiol|cannabidiol|mesh-list
20619859|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
20619860|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
19408436|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
19408437|NCT03566303|Vitamins|vitamins|mesh-ancestor
20224323|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20224324|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
20224325|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
20224326|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224327|NCT00335179|Imiquimod|imiquimod|mesh-list
20224328|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20224329|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
20224330|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224331|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224332|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
20224333|NCT00335192|Tenofovir|tenofovir|mesh-list
20224334|NCT00335192|Lamivudine|lamivudine|mesh-list
20224335|NCT00335192|Lopinavir|lopinavir|mesh-list
20224336|NCT00335192|Abacavir|abacavir|mesh-list
20224337|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
20224338|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224339|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20224340|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20466230|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20466231|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20466232|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
20466233|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20466234|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20466235|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20466236|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466237|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466238|NCT01458977|Tenofovir|tenofovir|mesh-list
20466239|NCT01458977|Emtricitabine|emtricitabine|mesh-list
20466240|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20466241|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
20466242|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466243|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20466244|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20466245|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466246|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466247|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20466248|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20466249|NCT01459081|Zanamivir|zanamivir|mesh-list
20466250|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
20466251|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466252|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466253|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466254|NCT01459133|Insulin|insulin|mesh-list
20466255|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466256|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466257|NCT01459146|Lumefantrine|lumefantrine|mesh-list
20466258|NCT01459146|Artemether|artemether|mesh-list
20466259|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20466260|NCT01459146|Albendazole|albendazole|mesh-list
20466261|NCT01459146|Praziquantel|praziquantel|mesh-list
20466262|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
20466263|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20466264|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20466265|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466266|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
20466267|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
20466268|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20466269|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
20466270|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
20619861|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619862|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619863|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619864|NCT02291536|Analgesics|analgesics|mesh-ancestor
20619865|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
20466271|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
20466272|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466273|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466274|NCT01459198|Vaccines|vaccines|mesh-list
20466275|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
20466276|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466277|NCT01459211|Dexamethasone|dexamethasone|mesh-list
20466278|NCT01459211|Lenalidomide|lenalidomide|mesh-list
20466279|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20466280|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
20466281|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
20466282|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466283|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466284|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20466285|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
20466286|NCT01459211|Hormones|hormones|mesh-ancestor
20466287|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466288|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20466289|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466290|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
20466291|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20466292|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20466293|NCT01459211|Growth Substances|growth substances|mesh-ancestor
20466294|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
20526946|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20526947|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526948|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19408438|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
20530634|NCT01789827|Analgesics|analgesics|mesh-ancestor
20466295|NCT01459250|S 20098|s 20098|mesh-list
20466296|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20466297|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466298|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466299|NCT01459276|Vaccines|vaccines|mesh-list
20466300|NCT01459276|Immunologic Factors|immunologic factors|mesh-ancestor
20466301|NCT01459276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466302|NCT01459315|Dolutegravir|dolutegravir|mesh-list
20466303|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20466304|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20466305|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466306|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466307|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20466308|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20466309|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
20466310|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466311|NCT01459367|Lansoprazole|lansoprazole|mesh-list
20466312|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
20466313|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20466314|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20466315|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20466316|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466317|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466318|NCT01459380|Bevacizumab|bevacizumab|mesh-list
20466319|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20466320|NCT01459380|Carboplatin|carboplatin|mesh-list
20466321|NCT01459380|Doxorubicin|doxorubicin|mesh-list
20466322|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20466323|NCT01459380|Veliparib|veliparib|mesh-list
20466324|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
20466325|NCT01459380|Antibodies|antibodies|mesh-list
20619866|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619867|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20619868|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20466326|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
20466327|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20466328|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
20466329|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466330|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20466331|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20466332|NCT01459380|Growth Substances|growth substances|mesh-ancestor
20466333|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466334|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
20466335|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
20466336|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20466337|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20466338|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20466339|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466340|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466341|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20466342|NCT01459406|Levan|levan|mesh-list
20466343|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466344|NCT01459419|Antibodies|antibodies|mesh-list
20466345|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20466346|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
20619869|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619870|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619871|NCT02291536|Hormones|hormones|mesh-ancestor
20619872|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20619873|NCT02291562|Dronabinol|dronabinol|mesh-list
20619874|NCT02291562|Cannabidiol|cannabidiol|mesh-list
20619875|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
20619876|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
20619877|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466347|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466348|NCT01459445|Metformin|metformin|mesh-list
20466349|NCT01459445|Drospirenone|drospirenone|mesh-list
20466350|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20466351|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466352|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466353|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20466354|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20466355|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20466356|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
20619878|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20466357|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20466358|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20466359|NCT01459445|Estrogens|estrogens|mesh-ancestor
20466360|NCT01459445|Hormones|hormones|mesh-ancestor
20466361|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466362|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20466363|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
20466364|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20619879|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20619880|NCT02291562|Analgesics|analgesics|mesh-ancestor
20619881|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
20619882|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619883|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20619884|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20619885|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619886|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619887|NCT02291562|Hormones|hormones|mesh-ancestor
20619888|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20619889|NCT02291666|Tolbutamide|tolbutamide|mesh-list
20619890|NCT02291666|Midazolam|midazolam|mesh-list
20619891|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
20619892|NCT02291666|Caffeine|caffeine|mesh-list
20619893|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
20619894|NCT02291666|Bupropion|bupropion|mesh-list
20619895|NCT02291666|Omeprazole|omeprazole|mesh-list
20619896|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20619897|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20466365|NCT01459445|Diuretics|diuretics|mesh-ancestor
20466366|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
20466367|NCT01459484|Cisplatin|cisplatin|mesh-list
20619898|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619899|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619900|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20619901|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20619902|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20619903|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20619904|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
20619905|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
20619906|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
20619907|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
20619908|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20619909|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619910|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20619911|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20619912|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20619913|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619914|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20619915|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20619916|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20619917|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20619918|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
20619919|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20619920|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
20466368|NCT01459484|Doxorubicin|doxorubicin|mesh-list
20466369|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20466370|NCT01459484|Methotrexate|methotrexate|mesh-list
20466371|NCT01459484|Ifosfamide|ifosfamide|mesh-list
20466372|NCT01459484|Mifamurtide|mifamurtide|mesh-list
20466373|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
20619921|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20619922|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20619923|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619924|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
20224341|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224342|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224343|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20224344|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20224345|NCT00335192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20224346|NCT00335192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20224347|NCT00335192|Protease Inhibitors|protease inhibitors|mesh-ancestor
20224348|NCT00335192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20224349|NCT00335192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20224350|NCT00335205|Ropinirole|ropinirole|mesh-list
20224351|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20224352|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20224353|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
20224354|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
20466374|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466375|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20466376|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20466377|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20466378|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466379|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466380|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20466381|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
20466382|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20619925|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20619926|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20619927|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
20619928|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
20619929|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20619930|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20619931|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20619932|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20619933|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20619934|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619935|NCT02291705|Tramadol|tramadol|mesh-list
20619936|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20619937|NCT02291705|Narcotics|narcotics|mesh-ancestor
20619938|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20619939|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619940|NCT02291705|Analgesics|analgesics|mesh-ancestor
20619941|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
20619942|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20619943|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20619944|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20619945|NCT02291796|Bezafibrate|bezafibrate|mesh-list
20619946|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20619947|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
20619948|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619949|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20619950|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
20619951|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20619952|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619953|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20619954|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619955|NCT02291887|Ranibizumab|ranibizumab|mesh-list
20619956|NCT02291887|Aflibercept|aflibercept|mesh-list
20619957|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20619958|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20619959|NCT02291887|Growth Substances|growth substances|mesh-ancestor
20619960|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619961|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
20619962|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619963|NCT02292069|Amlodipine|amlodipine|mesh-list
20619964|NCT02292069|Atorvastatin|atorvastatin|mesh-list
20619965|NCT02292069|Calcium|calcium|mesh-list
20619966|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19408439|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408440|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
19408441|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20466383|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466384|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20466385|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
20466386|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
20466387|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20466388|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466389|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
20466390|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408442|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
19408443|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20619967|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619968|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20619969|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20619970|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
20619971|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619972|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20619973|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19408444|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
20466391|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20466392|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19695275|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695276|NCT04952129|Trace Elements|trace elements|mesh-ancestor
19695277|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
19695278|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19695279|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695280|NCT04952051|Folic Acid|folic acid|mesh-list
19695281|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
19695282|NCT04952051|Amlodipine|amlodipine|mesh-list
19695283|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19695284|NCT04952051|Enalapril|enalapril|mesh-list
19695285|NCT04952051|Enalaprilat|enalaprilat|mesh-list
19695286|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19695287|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19695288|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19695289|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695290|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19695291|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466393|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
20466394|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20466395|NCT01459601|Cabergoline|cabergoline|mesh-list
20466396|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20466397|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20466398|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
20466399|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
20466400|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466401|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466402|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466403|NCT01459627|Ticagrelor|ticagrelor|mesh-list
20466404|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20466405|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20466406|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20466407|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20466408|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20466409|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
20466410|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466411|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466412|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466413|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
20466414|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20466415|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
20466416|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466417|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
20466418|NCT01459640|Protective Agents|protective agents|mesh-ancestor
20466419|NCT01459809|Metformin|metformin|mesh-list
20466420|NCT01459809|Glimepiride|glimepiride|mesh-list
20466421|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466422|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466423|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20466424|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466425|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
20466426|NCT01459887|Prednisone|prednisone|mesh-list
20466427|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
20466428|NCT01459887|Doxorubicin|doxorubicin|mesh-list
20619974|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695292|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
19695293|NCT04952051|Diuretics|diuretics|mesh-ancestor
19695294|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
19695295|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19695296|NCT04952051|Hematinics|hematinics|mesh-ancestor
19695297|NCT04952051|Vitamins|vitamins|mesh-ancestor
19695298|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
19695299|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20466429|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20466430|NCT01459887|Vincristine|vincristine|mesh-list
20466431|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466432|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
20466433|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466434|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20466435|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20466436|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
19695300|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
19695301|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466437|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695302|NCT04951791|SMOFlipid|smoflipid|mesh-list
19695303|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19695304|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19695305|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19695306|NCT04951713|Clarithromycin|clarithromycin|mesh-list
19695307|NCT04951713|Rifampin|rifampin|mesh-list
19695308|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695309|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408445|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408446|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408447|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20466438|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466439|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20466440|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20466441|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20466442|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20466443|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466444|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20466445|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
20466446|NCT01459887|Hormones|hormones|mesh-ancestor
20466447|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466448|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20466449|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20466450|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
20466451|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
20224355|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224356|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466452|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
20466453|NCT01460030|Cinacalcet|cinacalcet|mesh-list
20466454|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20466455|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466456|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20619975|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20619976|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20619977|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20619978|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
19408448|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19408449|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
20619979|NCT02292121|Mannitol|mannitol|mesh-list
19408450|NCT03566303|Coagulants|coagulants|mesh-ancestor
19408451|NCT03566225|Metformin|metformin|mesh-list
19408452|NCT03566225|Pioglitazone|pioglitazone|mesh-list
19408453|NCT03566225|Clomiphene|clomiphene|mesh-list
19408454|NCT03566225|Enclomiphene|enclomiphene|mesh-list
19408455|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
19408456|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19408457|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408458|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19408459|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
19408460|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408461|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19408462|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
19408463|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408464|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19695310|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19695311|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695312|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224357|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224358|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
20224359|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224360|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224361|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20224362|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20224363|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224364|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224365|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224366|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224367|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224368|NCT00335270|Ritonavir|ritonavir|mesh-list
20224369|NCT00335270|Amprenavir|amprenavir|mesh-list
20224370|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
20224371|NCT00335270|Lamivudine|lamivudine|mesh-list
20224372|NCT00335270|Abacavir|abacavir|mesh-list
20224373|NCT00335270|Calcium|calcium|mesh-list
20224374|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20466457|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
20224375|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408465|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19408466|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
19408467|NCT03566134|DA-8010|da-8010|mesh-list
19408468|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19408469|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19408470|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
19408471|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408472|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408473|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408474|NCT03566134|Urological Agents|urological agents|mesh-ancestor
20466458|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466459|NCT01460069|Liraglutide|liraglutide|mesh-list
20466460|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466461|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466462|NCT01460069|Incretins|incretins|mesh-ancestor
20466463|NCT01460069|Hormones|hormones|mesh-ancestor
20466464|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466465|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20466466|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
20466467|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466468|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
20466469|NCT01460212|Citalopram|citalopram|mesh-list
20466470|NCT01460212|Fluoxetine|fluoxetine|mesh-list
20466471|NCT01460212|Paroxetine|paroxetine|mesh-list
20466472|NCT01460212|Sertraline|sertraline|mesh-list
20466473|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
20466474|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20466475|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20466476|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466477|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466478|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466479|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
20466480|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466481|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20466482|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20466483|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20466484|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20466485|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466486|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20466487|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20466488|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466489|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20466490|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20466491|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
20466492|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20466493|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20466494|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20466495|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20224376|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20224377|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20224378|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
20466496|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466497|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
19408475|NCT03566069|Oxytocin|oxytocin|mesh-list
19408476|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
20224379|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224380|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224381|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20224382|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20224383|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
20224384|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224385|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20224386|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20224387|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20224388|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20224389|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20224390|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
20224391|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224392|NCT00335309|Amoxicillin|amoxicillin|mesh-list
20224393|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
20224394|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
20224395|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19408477|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408478|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408479|NCT03566030|Tenofovir|tenofovir|mesh-list
19408480|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
19408481|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408482|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19408483|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19408484|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408485|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408486|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19408487|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19408488|NCT03565536|Sorafenib|sorafenib|mesh-list
19408489|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408490|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19408491|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466498|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466499|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408492|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408493|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
19408494|NCT03565458|Empagliflozin|empagliflozin|mesh-list
20619980|NCT02292121|Lactitol|lactitol|mesh-list
20619981|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20619982|NCT02292121|Diuretics|diuretics|mesh-ancestor
20619983|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
20619984|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20619985|NCT02292121|Cathartics|cathartics|mesh-ancestor
20619986|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20466500|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20466501|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466502|NCT01460420|Lenalidomide|lenalidomide|mesh-list
20466503|NCT01460420|Bortezomib|bortezomib|mesh-list
20466504|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
20466505|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466506|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20466507|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20466508|NCT01460420|Growth Substances|growth substances|mesh-ancestor
20466509|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
20466510|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466511|NCT01460498|Azacitidine|azacitidine|mesh-list
20466512|NCT01460498|Decitabine|decitabine|mesh-list
20466513|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20466514|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
20466515|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466516|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466517|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466518|NCT01460537|Gemcitabine|gemcitabine|mesh-list
20466519|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466520|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20466521|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
20466522|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466523|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
20466524|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466525|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466526|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224396|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224397|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20224398|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224399|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224400|NCT00335348|Dexamethasone|dexamethasone|mesh-list
20224401|NCT00335348|Bortezomib|bortezomib|mesh-list
20224402|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224403|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
20619987|NCT02292173|Sorafenib|sorafenib|mesh-list
20619988|NCT02292173|Trametinib|trametinib|mesh-list
20619989|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619990|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20619991|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20619992|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20619993|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
19408495|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19408496|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408497|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19408498|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408499|NCT03565406|Nivolumab|nivolumab|mesh-list
19408500|NCT03565406|Ipilimumab|ipilimumab|mesh-list
19408501|NCT03565406|Mocetinostat|mocetinostat|mesh-list
19408502|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408503|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695313|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19695314|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19695315|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19695316|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
19695317|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
19695318|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19695319|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20224404|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
20224405|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224406|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224407|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20224408|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
20224409|NCT00335348|Hormones|hormones|mesh-ancestor
20224410|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224411|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20224412|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224413|NCT00335400|Anesthetics|anesthetics|mesh-list
20224414|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224415|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224416|NCT00335413|Spironolactone|spironolactone|mesh-list
20224417|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20224418|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
20224419|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224420|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224421|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20224422|NCT00335413|Diuretics|diuretics|mesh-ancestor
20224423|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
20224424|NCT00335439|Ketorolac|ketorolac|mesh-list
20224425|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20224426|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20224427|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20224428|NCT00335439|Analgesics|analgesics|mesh-ancestor
20224429|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
20224430|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224431|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224432|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224433|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224434|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20224435|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224436|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224437|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
20224438|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20224439|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224440|NCT00335543|Gemcitabine|gemcitabine|mesh-list
20224441|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224442|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224443|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
20224444|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224445|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
20224446|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224447|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224448|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224449|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
19695320|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19695321|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20466527|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
20466528|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466529|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
20466530|NCT01460563|Analgesics|analgesics|mesh-ancestor
20466531|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
20466532|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466533|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466534|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
20466535|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466536|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20466537|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
20466538|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20466539|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466540|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466541|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20466542|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
20466543|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20466544|NCT01460602|Rituximab|rituximab|mesh-list
20619994|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20619995|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20619996|NCT02292238|Benphothiamine|benphothiamine|mesh-list
20619997|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20619998|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
20619999|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620000|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
20620001|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
20620002|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620003|NCT02292277|Ticagrelor|ticagrelor|mesh-list
20620004|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20620005|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20620006|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20620007|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20620008|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
20620009|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620010|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620011|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620012|NCT02292290|Pioglitazone|pioglitazone|mesh-list
19408504|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19408505|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408506|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19408507|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408508|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19408509|NCT03565354|Hematinics|hematinics|mesh-ancestor
19408510|NCT03565302|Terbutaline|terbutaline|mesh-list
19408511|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
19408512|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19408513|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
19408514|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408515|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408516|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19408517|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
19408518|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19408519|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19408520|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19408521|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
19408522|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408523|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408524|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
19408525|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
19408526|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408527|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
19408528|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19408529|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19408530|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408531|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
19408532|NCT03565276|Coagulants|coagulants|mesh-ancestor
19408533|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19408534|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
19408535|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408536|NCT03565133|Quinine|quinine|mesh-list
20466545|NCT01460602|Bortezomib|bortezomib|mesh-list
20466546|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408537|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
19408538|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19408539|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19408540|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408541|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19408542|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408543|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19849884|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19849885|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20466547|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466548|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
20466549|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466550|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20466551|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
20466552|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20466553|NCT01460654|Alendronate|alendronate|mesh-list
20466554|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
20466555|NCT01460654|Testosterone|testosterone|mesh-list
20466556|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
20466557|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
20466558|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20466559|NCT01460654|Androgens|androgens|mesh-ancestor
20466560|NCT01460654|Hormones|hormones|mesh-ancestor
20466561|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466562|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466563|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20466564|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466565|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
20466566|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20466567|NCT01460667|Acetaminophen|acetaminophen|mesh-list
20466568|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20466569|NCT01460667|Analgesics|analgesics|mesh-ancestor
20466570|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
20466571|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466572|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466573|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
20466574|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
20466575|NCT01460693|Dasatinib|dasatinib|mesh-list
20466576|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466577|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20466578|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466579|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466580|NCT01460706|Edotreotide|edotreotide|mesh-list
20466581|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20466582|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466583|NCT01460797|Metformin|metformin|mesh-list
20466584|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466585|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466586|NCT01460836|Tobramycin|tobramycin|mesh-list
20466587|NCT01460836|Aztreonam|aztreonam|mesh-list
20466588|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466589|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466590|NCT01460888|Olaparib|olaparib|mesh-list
20466591|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20466592|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466593|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466594|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466595|NCT01460979|Sirolimus|sirolimus|mesh-list
20466596|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466597|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466598|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20466599|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466600|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
20466601|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466602|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
20466603|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526949|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20526950|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20526951|NCT01765608|Zonisamide|zonisamide|mesh-list
20526952|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
20526953|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20526954|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20526955|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526956|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20466604|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
20466605|NCT01461018|Antibodies|antibodies|mesh-list
20466606|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
20466607|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20620013|NCT02292290|Liraglutide|liraglutide|mesh-list
20620014|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20620015|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620016|NCT02292290|Incretins|incretins|mesh-ancestor
20620017|NCT02292290|Hormones|hormones|mesh-ancestor
20466608|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20466609|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
20466610|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466611|NCT01461031|Nefopam|nefopam|mesh-list
20466612|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20466613|NCT01461031|Analgesics|analgesics|mesh-ancestor
20466614|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
20466615|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466616|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466617|NCT01461174|Memantine|memantine|mesh-list
20466618|NCT01461174|Modafinil|modafinil|mesh-list
20466619|NCT01461174|Donepezil|donepezil|mesh-list
20466620|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20466621|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466622|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466623|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
20466624|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466625|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466626|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
20466627|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20466628|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20466629|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
20466630|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20466631|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20466632|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20466633|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20466634|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20466635|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20620018|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620019|NCT02292303|Zinc|zinc|mesh-list
20620020|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
20620021|NCT02292303|Trace Elements|trace elements|mesh-ancestor
20620022|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
20620023|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620024|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
20620025|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
20620026|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20620027|NCT02292303|Protective Agents|protective agents|mesh-ancestor
20620028|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20620029|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20620030|NCT02292459|Laxatives|laxatives|mesh-ancestor
20620031|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620032|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
20620033|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20620034|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20620035|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20620036|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466636|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
20466637|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
20466638|NCT01461460|Tedizolid|tedizolid|mesh-list
20466639|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
20620037|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620038|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
20620039|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466640|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466641|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466642|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20466643|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20466644|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466645|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466646|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466647|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20466648|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
20466649|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466650|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466651|NCT01461616|Insulin|insulin|mesh-list
20466652|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20620040|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466653|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
20466654|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
20466655|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466656|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466657|NCT01461746|Docetaxel|docetaxel|mesh-list
20466658|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466659|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
20466660|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
20466661|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
20466662|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466663|NCT01461759|Cisplatin|cisplatin|mesh-list
20466664|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466665|NCT01461772|Carboplatin|carboplatin|mesh-list
20466666|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466667|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20466668|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
20466669|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466670|NCT01462006|Sirolimus|sirolimus|mesh-list
20620041|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20620042|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620043|NCT02292550|Ceritinib|ceritinib|mesh-list
20620044|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620045|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20620046|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620047|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620048|NCT02292667|Acetaminophen|acetaminophen|mesh-list
20620049|NCT02292667|Morphine|morphine|mesh-list
20620050|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20620051|NCT02292667|Narcotics|narcotics|mesh-ancestor
20620052|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620053|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224450|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224451|NCT00335582|Clonidine|clonidine|mesh-list
20224452|NCT00335582|Analgesics|analgesics|mesh-ancestor
20224453|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
20224454|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224455|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224456|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20224457|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
20224458|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
20224459|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20224460|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20466671|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466672|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466673|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20466674|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466675|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
20466676|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466677|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
20466678|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466679|NCT01462058|Vitamin D|vitamin d|mesh-list
20224461|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20224462|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
20224463|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224464|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224465|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
20224466|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20224467|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
20224468|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224469|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224470|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20224471|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
20224472|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
20224473|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20224474|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
20224475|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224476|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224477|NCT00335647|Fluphenazine|fluphenazine|mesh-list
20224478|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
20224479|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
20224480|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20224481|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20224482|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620054|NCT02292667|Analgesics|analgesics|mesh-ancestor
20466680|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
20466681|NCT01462058|Vitamins|vitamins|mesh-ancestor
20466682|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
19849886|NCT00705874|Growth Substances|growth substances|mesh-ancestor
19849887|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849888|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
19408544|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408545|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19408546|NCT03565133|Analgesics|analgesics|mesh-ancestor
19408547|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
19408548|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
19408549|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19408550|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
19408551|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408552|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408553|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408554|NCT03564912|Capecitabine|capecitabine|mesh-list
19408555|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
19408556|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408557|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
19408558|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408559|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408560|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
19408561|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19408562|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19408563|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408564|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19408565|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19408566|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
19695322|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20620055|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
20620056|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620057|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19849889|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19849890|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
19849891|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466683|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466684|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20466685|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20466686|NCT01462149|Carboplatin|carboplatin|mesh-list
20466687|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620058|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
20620059|NCT02292732|Trametinib|trametinib|mesh-list
20466688|NCT01462214|Everolimus|everolimus|mesh-list
20466689|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466690|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620060|NCT02292732|Norinyl|norinyl|mesh-list
20620061|NCT02292732|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20620062|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620063|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20620064|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620065|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695323|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19695324|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19695325|NCT04951752|Ropivacaine|ropivacaine|mesh-list
19695326|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
19695327|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
20620066|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20620067|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20620068|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20620069|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
19695328|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620070|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20620071|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620072|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20620073|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20620074|NCT02292732|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20620075|NCT02292732|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20620076|NCT02292966|Asunaprevir|asunaprevir|mesh-list
20620077|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
20620078|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408567|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19849892|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
19849893|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695329|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695330|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
19695331|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695332|NCT04951505|Cefepime|cefepime|mesh-list
19695333|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695334|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695335|NCT04951726|Neostigmine|neostigmine|mesh-list
19695336|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19695337|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695338|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695339|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
20466691|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
20466692|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466693|NCT01462422|Misoprostol|misoprostol|mesh-list
20466694|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20466695|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
20466696|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20466697|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466698|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20466699|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19695340|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466700|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
20466701|NCT01462474|Cisplatin|cisplatin|mesh-list
19408568|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
19408569|NCT03564756|Vitamins|vitamins|mesh-ancestor
20466702|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408570|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
19408571|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408572|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
19408573|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408574|NCT03564756|Protective Agents|protective agents|mesh-ancestor
19416610|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19416611|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19416612|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416613|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416614|NCT02390960|Urological Agents|urological agents|mesh-ancestor
19416615|NCT02389985|Paclitaxel|paclitaxel|mesh-list
19416616|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19416617|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416618|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
19695341|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695342|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20224483|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224484|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20224485|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20224486|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
20224487|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224488|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224489|NCT00335673|Irbesartan|irbesartan|mesh-list
20224490|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20224491|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20224492|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20224493|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224494|NCT00335686|Lopinavir|lopinavir|mesh-list
20224495|NCT00335686|Nevirapine|nevirapine|mesh-list
20224496|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20224497|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20224498|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
20224499|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224500|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224501|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20224502|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20224503|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
20224504|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224505|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20224506|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20224507|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20224508|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20224509|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20224510|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20224511|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20224512|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20224513|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20620079|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620080|NCT02292979|Doxorubicin|doxorubicin|mesh-list
20620081|NCT02292979|Bleomycin|bleomycin|mesh-list
20620082|NCT02292979|Dacarbazine|dacarbazine|mesh-list
20620083|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20620084|NCT02292979|Vinblastine|vinblastine|mesh-list
20620085|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20620086|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620087|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20620088|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20620089|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620090|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620091|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20620092|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
20620093|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20620094|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20620095|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
20620096|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
20620097|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
20620098|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
20620099|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20620100|NCT02293148|Glycine|glycine|mesh-list
20620101|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20620102|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620103|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20620104|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20620105|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620106|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620107|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620108|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20620109|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
20620110|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20620111|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620112|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20620113|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20620114|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20620115|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
20620116|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620117|NCT02293187|Vitamin D|vitamin d|mesh-list
20620118|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
20620119|NCT02293187|Vitamins|vitamins|mesh-ancestor
20620120|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
20620121|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620122|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20224514|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
20224515|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466703|NCT01462487|Zanamivir|zanamivir|mesh-list
20620123|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620124|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
20620125|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
20620126|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20620127|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620128|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466704|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
20466705|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466706|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466707|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466708|NCT01462500|Miltefosine|miltefosine|mesh-list
20466709|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
20466710|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466711|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620129|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
20620130|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20620131|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224516|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20224517|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20224518|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224519|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20224520|NCT00335920|Dexamethasone|dexamethasone|mesh-list
20224521|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224522|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
20224523|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
20224524|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466712|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20466713|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20466714|NCT01462617|Nemiralisib|nemiralisib|mesh-list
20620132|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620133|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
19408575|NCT03564704|Cytarabine|cytarabine|mesh-list
19408576|NCT03564704|Dexamethasone|dexamethasone|mesh-list
19408577|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
19408578|NCT03564704|Methotrexate|methotrexate|mesh-list
19408579|NCT03564704|Etoposide|etoposide|mesh-list
19408580|NCT03564704|Vincristine|vincristine|mesh-list
19408581|NCT03564704|Doxorubicin|doxorubicin|mesh-list
20620134|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
20620135|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
20620136|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620137|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620138|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
20620139|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620140|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
20620141|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20620142|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849894|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849895|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849896|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
19849897|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
19849898|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
20224525|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466715|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20466716|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466717|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466718|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20466719|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20224526|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20224527|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
20224528|NCT00335920|Hormones|hormones|mesh-ancestor
20620143|NCT02293447|Lidocaine|lidocaine|mesh-list
20620144|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
20620145|NCT02293447|Anesthetics|anesthetics|mesh-list
20620146|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408582|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
19408583|NCT03564704|Idarubicin|idarubicin|mesh-list
19408584|NCT03564704|Pegaspargase|pegaspargase|mesh-list
20620147|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620148|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
20620149|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620150|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20620151|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20620152|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20620153|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20620154|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620155|NCT02293525|Morphine|morphine|mesh-list
20620156|NCT02293525|Oxycodone|oxycodone|mesh-list
20224529|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224530|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20466720|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466721|NCT01462669|Ezogabine|ezogabine|mesh-list
20466722|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
20466723|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466724|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466725|NCT01462890|Paclitaxel|paclitaxel|mesh-list
20466726|NCT01462890|Bevacizumab|bevacizumab|mesh-list
20620157|NCT02293525|Ropivacaine|ropivacaine|mesh-list
19408585|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19849899|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
20466727|NCT01462890|Carboplatin|carboplatin|mesh-list
19849900|NCT00705874|Antidotes|antidotes|mesh-ancestor
20224531|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224532|NCT00335933|Gabapentin|gabapentin|mesh-list
20466728|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19849901|NCT00705874|Protective Agents|protective agents|mesh-ancestor
19849902|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
19849903|NCT00705874|Vitamins|vitamins|mesh-ancestor
19849904|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
20466729|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408586|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
19849905|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20224533|NCT00335933|Analgesics|analgesics|mesh-ancestor
19408587|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849906|NCT00706004|Lubiprostone|lubiprostone|mesh-list
20620158|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20620159|NCT02293525|Narcotics|narcotics|mesh-ancestor
20620160|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620161|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620162|NCT02293525|Analgesics|analgesics|mesh-ancestor
20620163|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
20620164|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620165|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
20620166|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
20620167|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
19408588|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408589|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19408590|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
19408591|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408592|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408593|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19408594|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408595|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
20620168|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20620169|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620170|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
20620171|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
20620172|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620173|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
20620174|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408596|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
19408597|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408598|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19408599|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
19408600|NCT03564704|Hormones|hormones|mesh-ancestor
19408601|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620175|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620176|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620177|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620178|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20620179|NCT02293590|Analgesics|analgesics|mesh-ancestor
20620180|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
20620181|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620182|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620183|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620184|NCT02293668|Letrozole|letrozole|mesh-list
19695343|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
20466730|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
20466731|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20466732|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
19695344|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695345|NCT04951349|Petrolatum|petrolatum|mesh-list
19695346|NCT04951349|Emollients|emollients|mesh-ancestor
19695347|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
19695348|NCT04951167|Norepinephrine|norepinephrine|mesh-list
19695349|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19695350|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19695351|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
19695352|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695353|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695354|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695355|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
19695356|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
19695357|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695358|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19695359|NCT04950933|Riluzole|riluzole|mesh-list
19695360|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
19695361|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19695362|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19695363|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466733|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466734|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20466735|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20466736|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20466737|NCT01462890|Growth Substances|growth substances|mesh-ancestor
20466738|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466739|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
20620185|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695364|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620186|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20620187|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20620188|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620189|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466740|NCT01462968|Heparin|heparin|mesh-list
20466741|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
20466742|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20466743|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20466744|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466745|NCT01463046|Cytarabine|cytarabine|mesh-list
20466746|NCT01463046|Daunorubicin|daunorubicin|mesh-list
20466747|NCT01463046|Panobinostat|panobinostat|mesh-list
20466748|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20620190|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20620191|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
20620192|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620193|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620194|NCT02293681|Infliximab|infliximab|mesh-list
20620195|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
20620196|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20466749|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
20466750|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466751|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466752|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
20466753|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466754|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466755|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
20466756|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466757|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20466758|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20466759|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20466760|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466761|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20466762|NCT01463072|Paclitaxel|paclitaxel|mesh-list
20466763|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20466764|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20466765|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466766|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
20466767|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
20466768|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
20466769|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466770|NCT01463150|Clopidogrel|clopidogrel|mesh-list
20466771|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20466772|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20466773|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20466774|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20466775|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20466776|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
20466777|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466778|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466779|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620197|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620198|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20620199|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
20620200|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20620201|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20466780|NCT01463163|Ticagrelor|ticagrelor|mesh-list
20466781|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20466782|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20466783|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20466784|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20466785|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20466786|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
20466787|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466788|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466789|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466790|NCT01463215|Ambroxol|ambroxol|mesh-list
20466791|NCT01463215|Expectorants|expectorants|mesh-ancestor
20466792|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
20466793|NCT01463228|Metformin|metformin|mesh-list
20466794|NCT01463228|Canagliflozin|canagliflozin|mesh-list
20466795|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20620202|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20620203|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
20466796|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466797|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20466798|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466799|NCT01463280|Lidocaine|lidocaine|mesh-list
20466800|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
20466801|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
19849907|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19849908|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19849909|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466802|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466803|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466804|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
20466805|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466806|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20466807|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20466808|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20466809|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466810|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466811|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
20466812|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20466813|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466814|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466815|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20466816|NCT01463332|Analgesics|analgesics|mesh-ancestor
20466817|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
20466818|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466819|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20466820|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20466821|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20466822|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
20466823|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20466824|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466825|NCT01463371|Azithromycin|azithromycin|mesh-list
20466826|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466827|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466828|NCT01463592|Iodine|iodine|mesh-list
20466829|NCT01463592|Interferons|interferons|mesh-list
20466830|NCT01463592|Ribavirin|ribavirin|mesh-list
20466831|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
20466832|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
20466833|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
20466834|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466835|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
20466836|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466837|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
20466838|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466839|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
20466840|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466841|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20466842|NCT01463592|Trace Elements|trace elements|mesh-ancestor
20466843|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
20466844|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
20466845|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20466846|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466847|NCT01463735|Vitamin E|vitamin e|mesh-list
20466848|NCT01463735|Vitamins|vitamins|mesh-ancestor
20466849|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
20466850|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466851|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
20466852|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466853|NCT01463735|Protective Agents|protective agents|mesh-ancestor
20466854|NCT01463774|Metformin|metformin|mesh-list
20466855|NCT01463774|Canagliflozin|canagliflozin|mesh-list
20466856|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466857|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466858|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20466859|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466860|NCT01463813|Vitamin D|vitamin d|mesh-list
20466861|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
20466862|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
20466863|NCT01463813|Vitamins|vitamins|mesh-list
20466864|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
20466865|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466866|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20620204|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20620205|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620206|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20620207|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20466867|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20466868|NCT01463852|Vincristine|vincristine|mesh-list
20466869|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20466870|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466871|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
20466872|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
20466873|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
20466874|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466875|NCT01463865|Ropivacaine|ropivacaine|mesh-list
20466876|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
20466877|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
20466878|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20466879|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466880|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
20466881|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466882|NCT01463956|Interferons|interferons|mesh-list
20620208|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20620209|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20620210|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620211|NCT02293785|Oxycodone|oxycodone|mesh-list
20620212|NCT02293785|Naloxone|naloxone|mesh-list
20620213|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20620214|NCT02293785|Narcotics|narcotics|mesh-ancestor
20620215|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620216|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620217|NCT02293785|Analgesics|analgesics|mesh-ancestor
20620218|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
20620219|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620220|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20466883|NCT01463956|Ribavirin|ribavirin|mesh-list
20466884|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466885|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
20466886|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466887|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
20466888|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466889|NCT01464008|Interferons|interferons|mesh-list
20466890|NCT01464008|Ribavirin|ribavirin|mesh-list
20466891|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
20466892|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
20466893|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20466894|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466895|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
20466896|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466897|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
20466898|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466899|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
20466900|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466901|NCT01464034|Dexamethasone|dexamethasone|mesh-list
20466902|NCT01464034|Pomalidomide|pomalidomide|mesh-list
20466903|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20466904|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
20466905|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
20466906|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466907|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466908|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20466909|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
20466910|NCT01464034|Hormones|hormones|mesh-ancestor
20466911|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466912|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20466913|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466914|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
20466915|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20466916|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20466917|NCT01464034|Growth Substances|growth substances|mesh-ancestor
20466918|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
20466919|NCT01464060|Amoxicillin|amoxicillin|mesh-list
20620221|NCT02293824|Caffeine|caffeine|mesh-list
20620222|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
20620223|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620224|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20620225|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620226|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20620227|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620228|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20620229|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20620230|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
20620231|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620232|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20620233|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20620234|NCT02293889|Vitamin D|vitamin d|mesh-list
20620235|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
20620236|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
20620237|NCT02293889|Vitamins|vitamins|mesh-list
20620238|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
20620239|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224534|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
20224535|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224536|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224537|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
20224538|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20224539|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19408602|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19408603|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19408604|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
19408605|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408606|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408607|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
19408608|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
19408609|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408610|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20620240|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20620241|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620242|NCT02293954|Antibodies|antibodies|mesh-list
20620243|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20620244|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
20620245|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620246|NCT02293980|Nivolumab|nivolumab|mesh-list
20620247|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20620248|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620249|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20620250|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224540|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224541|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20224542|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20224543|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20224544|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224545|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224546|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
20224547|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
20224548|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20224549|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
20224550|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20224551|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
20224552|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224553|NCT00335998|Cisplatin|cisplatin|mesh-list
20224554|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224555|NCT00336141|Vorinostat|vorinostat|mesh-list
20224556|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224557|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20224558|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224559|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224560|NCT00336154|Tetracycline|tetracycline|mesh-list
20224561|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224562|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224563|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20224564|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224565|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408611|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19408612|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19408613|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19408614|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20466920|NCT01464060|Metronidazole|metronidazole|mesh-list
20620251|NCT02294006|Metformin|metformin|mesh-list
20620252|NCT02294006|Everolimus|everolimus|mesh-list
20620253|NCT02294006|Octreotide|octreotide|mesh-list
20620254|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20620255|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620256|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620257|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620258|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
20466921|NCT01464060|Clarithromycin|clarithromycin|mesh-list
20466922|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466923|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466924|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20466925|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20466926|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20620259|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620260|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20620261|NCT02294071|Acetaminophen|acetaminophen|mesh-list
20620262|NCT02294071|Ibuprofen|ibuprofen|mesh-list
20620263|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20620264|NCT02294071|Analgesics|analgesics|mesh-ancestor
20620265|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
20620266|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620267|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620268|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
19408615|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
19408616|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408617|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
19408618|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
19408619|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
20620269|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620270|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620271|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620272|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20620273|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408620|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19408621|NCT03564652|Azithromycin|azithromycin|mesh-list
19408622|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19408623|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408624|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19408625|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19408626|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19408627|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19408628|NCT03564548|Morphine|morphine|mesh-list
19408629|NCT03564548|Oxycodone|oxycodone|mesh-list
19408630|NCT03564548|Hydromorphone|hydromorphone|mesh-list
19408631|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19408632|NCT03564548|Narcotics|narcotics|mesh-ancestor
19408633|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408634|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408635|NCT03564548|Analgesics|analgesics|mesh-ancestor
19408636|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
19408637|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695365|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695366|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20224566|NCT00336167|Bezafibrate|bezafibrate|mesh-list
20224567|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20466927|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466928|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466929|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20466930|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20466931|NCT01464099|Insulin|insulin|mesh-list
20466932|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20466933|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
20620274|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408638|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20620275|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20620276|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19695367|NCT04950933|Protective Agents|protective agents|mesh-ancestor
19695368|NCT04951128|Anesthetics|anesthetics|mesh-list
19695369|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
19695370|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
19695371|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695372|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695373|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19695374|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19695375|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466934|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
20466935|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20466936|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20466937|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466938|NCT01464112|Dexamethasone|dexamethasone|mesh-list
20466939|NCT01464112|Bortezomib|bortezomib|mesh-list
20466940|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20466941|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
20466942|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
19695376|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
19695377|NCT04951128|Coagulants|coagulants|mesh-ancestor
19408639|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19408640|NCT03564509|Hormones|hormones|mesh-ancestor
19408641|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408642|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408643|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19408644|NCT03564470|Dasatinib|dasatinib|mesh-list
19408645|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408646|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19408647|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408648|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408649|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
19408650|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408651|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408652|NCT03564301|Metronidazole|metronidazole|mesh-list
19695378|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
19695379|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707825|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
19707826|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707827|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707828|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707829|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707830|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19707831|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19707832|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707833|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707834|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20466943|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466944|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466945|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20466946|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
20466947|NCT01464112|Hormones|hormones|mesh-ancestor
20466948|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20466949|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20466950|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20466951|NCT01464125|Azithromycin|azithromycin|mesh-list
19408653|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408654|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19408655|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19408656|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19408657|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
19408658|NCT03564158|Meropenem|meropenem|mesh-list
19408659|NCT03564158|Vaborbactam|vaborbactam|mesh-list
20620277|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620278|NCT02294084|Incretins|incretins|mesh-ancestor
20620279|NCT02294084|Hormones|hormones|mesh-ancestor
20620280|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408660|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19408661|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707835|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
19707836|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
20466952|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
20466953|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695380|NCT04951232|Cinepazide|cinepazide|mesh-list
20466954|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408662|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19408663|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19408664|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620281|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20620282|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
20620283|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620284|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620285|NCT02294110|Anesthetics|anesthetics|mesh-list
20620286|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620287|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408665|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408666|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408667|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20620288|NCT02294162|Ketamine|ketamine|mesh-list
20620289|NCT02294162|Analgesics|analgesics|mesh-ancestor
20620290|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
19408668|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
19408669|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19408670|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19408671|NCT03564106|Prednisolone|prednisolone|mesh-list
19408672|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
19408673|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19408674|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
19408675|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408676|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
19408677|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
19695381|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
20620291|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620292|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620293|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20620294|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20620295|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
20620296|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
20620297|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620298|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20620299|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20620300|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620301|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620302|NCT02294240|Folic Acid|folic acid|mesh-list
20620303|NCT02294240|Hematinics|hematinics|mesh-ancestor
20620304|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
20620305|NCT02294240|Vitamins|vitamins|mesh-ancestor
20620306|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
20620307|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620308|NCT02294266|Ethanol|ethanol|mesh-list
20620309|NCT02294266|Methamphetamine|methamphetamine|mesh-list
20620310|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20620311|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620312|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620313|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620314|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20620315|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
20620316|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
20620317|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620318|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
20620319|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620320|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620321|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
20620322|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20620323|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20620324|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466955|NCT01464138|Clindamycin|clindamycin|mesh-list
20466956|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
20466957|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
20466958|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
20466959|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20466960|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466961|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20466962|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620325|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20620326|NCT02294279|Beclomethasone|beclomethasone|mesh-list
19408678|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20466963|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466964|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20466965|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
20466966|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20466967|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466968|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466969|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20466970|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20466971|NCT01464242|Protective Agents|protective agents|mesh-ancestor
19849910|NCT00706030|Vinorelbine|vinorelbine|mesh-list
19849911|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19849912|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849913|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
19849914|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
19849915|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
19849916|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849917|NCT00706121|Vitamins|vitamins|mesh-list
19849918|NCT00706121|Vitamin E|vitamin e|mesh-list
20620327|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620328|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
20620329|NCT02294279|Hormones|hormones|mesh-ancestor
20620330|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620331|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620332|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20620333|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
20620334|NCT02294292|Carvedilol|carvedilol|mesh-list
20620335|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20620336|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20620337|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
20620338|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620339|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620340|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620341|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20620342|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
20620343|NCT02294292|Protective Agents|protective agents|mesh-ancestor
20620344|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20620345|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20620346|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620347|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
20620348|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20620349|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19849919|NCT00706121|Tocopherols|tocopherols|mesh-list
19849920|NCT00706121|Tocotrienols|tocotrienols|mesh-list
19849921|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
19849922|NCT00706121|Selenium|selenium|mesh-list
19849923|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
20466972|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466973|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
20466974|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20466975|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
20466976|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20466977|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20466978|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466979|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20466980|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
20466981|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20466982|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
20620350|NCT02294305|Vortioxetine|vortioxetine|mesh-list
20620351|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
20620352|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20620353|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20620354|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20620355|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620356|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620357|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20620358|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20620359|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20620360|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620361|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620362|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
20620363|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19849924|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849925|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
20224568|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
20466983|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20466984|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
20620364|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20620365|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20620366|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20620367|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
20620368|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620369|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
20620370|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466985|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20466986|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
20466987|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20466988|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466989|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
20466990|NCT01464476|Azimilide|azimilide|mesh-list
20466991|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20466992|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20466993|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20466994|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20466995|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20466996|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20466997|NCT01464489|Atropine|atropine|mesh-list
20466998|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20466999|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20467000|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20467001|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
20467002|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467003|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467004|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20467005|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
20467006|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
20467007|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
20467008|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20467009|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20467010|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
20467011|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467012|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467013|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
20467014|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20467015|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
20467016|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467017|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
20467018|NCT01464528|Protective Agents|protective agents|mesh-ancestor
20467019|NCT01464593|Doxorubicin|doxorubicin|mesh-list
20467020|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20467021|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20467022|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467023|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20467024|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20620371|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620372|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20620373|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
20620374|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408679|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408680|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19408681|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
19408682|NCT03564106|Hormones|hormones|mesh-ancestor
19408683|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408684|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19408685|NCT03564106|Protective Agents|protective agents|mesh-ancestor
19408686|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19408687|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408688|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
19408689|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19408690|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408691|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408692|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19408693|NCT03564093|Analgesics|analgesics|mesh-ancestor
19408694|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
19408695|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408696|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19408697|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19408698|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20620375|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620376|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20620377|NCT02294357|Dexamethasone|dexamethasone|mesh-list
20620378|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
20467025|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467026|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467027|NCT01464606|Dactinomycin|dactinomycin|mesh-list
20467028|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
20467029|NCT01464606|Ifosfamide|ifosfamide|mesh-list
20467030|NCT01464606|Doxorubicin|doxorubicin|mesh-list
20467031|NCT01464606|Vincristine|vincristine|mesh-list
20467032|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20467033|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
20467034|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467035|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467036|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20467037|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
20467038|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467039|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467040|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20467041|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20467042|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20467043|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20467044|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467045|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20467046|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
20467047|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
20467048|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
20467049|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20467050|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467051|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20467052|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20467053|NCT01464671|Heparin|heparin|mesh-list
20467054|NCT01464671|Bivalirudin|bivalirudin|mesh-list
20467055|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
20467056|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467057|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20467058|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467059|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
20467060|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20467061|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
20467062|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408699|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
19408700|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408701|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408702|NCT03563963|Lidocaine|lidocaine|mesh-list
19408703|NCT03563963|Ropivacaine|ropivacaine|mesh-list
19408704|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19408705|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
19408706|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
19408707|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408708|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408709|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
19408710|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408711|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19408712|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19408713|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19408714|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416619|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
20526957|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526958|NCT01765738|Minocycline|minocycline|mesh-list
20526959|NCT01765738|Rifampin|rifampin|mesh-list
20526960|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20526961|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20526962|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20526963|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
20526964|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
20526965|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20526966|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20526967|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526968|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20526969|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20526970|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20526971|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20526972|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20526973|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20467063|NCT01464762|Bedaquiline|bedaquiline|mesh-list
19408715|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408716|NCT03563950|Rifampin|rifampin|mesh-list
19408717|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19408718|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
19408719|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19408720|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408721|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
19408722|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19408723|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408724|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408725|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19408726|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19408727|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19408728|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19408729|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19408730|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19408731|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
19408732|NCT03563937|Apixaban|apixaban|mesh-list
19408733|NCT03563937|Edoxaban|edoxaban|mesh-list
19408734|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
19408735|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19408736|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
19408737|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19408738|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
20620379|NCT02294357|Prednisone|prednisone|mesh-list
20620380|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
20620381|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20620382|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20620383|NCT02294357|Prednisolone|prednisolone|mesh-list
20620384|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
20620385|NCT02294357|Lenalidomide|lenalidomide|mesh-list
20620386|NCT02294357|Pomalidomide|pomalidomide|mesh-list
20620387|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20620388|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
20620389|NCT02294357|BB 1101|bb 1101|mesh-list
20620390|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620391|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
20620392|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
20620393|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620394|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408739|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467064|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
20467065|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20467066|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467067|NCT01464801|Resveratrol|resveratrol|mesh-list
20467068|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
20467069|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467070|NCT01464801|Protective Agents|protective agents|mesh-ancestor
20467071|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467072|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467073|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467074|NCT01464944|Aspirin|aspirin|mesh-list
20467075|NCT01464944|Acetaminophen|acetaminophen|mesh-list
20467076|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20467077|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467078|NCT01464944|Analgesics|analgesics|mesh-ancestor
20467079|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
20467080|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467081|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467082|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467083|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467084|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467085|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20467086|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467087|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467088|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20467089|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467090|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
20467091|NCT01464983|Aspirin|aspirin|mesh-list
20467092|NCT01464983|Ibuprofen|ibuprofen|mesh-list
20467093|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20467094|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467095|NCT01464983|Analgesics|analgesics|mesh-ancestor
20467096|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
20620395|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620396|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
20467097|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467098|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467099|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224569|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224570|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247359|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20247360|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247361|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20247362|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20247363|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620397|NCT02294357|Hormones|hormones|mesh-ancestor
20247364|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247365|NCT00431990|Dexamethasone|dexamethasone|mesh-list
20247366|NCT00431990|Bortezomib|bortezomib|mesh-list
20247367|NCT00431990|Romidepsin|romidepsin|mesh-list
20620398|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620399|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20620400|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620401|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
20620402|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620403|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849926|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849927|NCT00706121|Protective Agents|protective agents|mesh-ancestor
19849928|NCT00706121|Trace Elements|trace elements|mesh-ancestor
19849929|NCT00706264|Silicon|silicon|mesh-list
19849930|NCT00706264|Trace Elements|trace elements|mesh-ancestor
19849931|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
19849932|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849933|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19849934|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19849935|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19849936|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19849937|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19849938|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
19855599|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620404|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
20620405|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20620406|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20620407|NCT02294357|Growth Substances|growth substances|mesh-ancestor
20620408|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
20620409|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20620410|NCT02294357|Protective Agents|protective agents|mesh-ancestor
20620411|NCT02294539|Losartan|losartan|mesh-list
20620412|NCT02294539|Amlodipine|amlodipine|mesh-list
20620413|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20620414|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20620415|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20620416|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19408740|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408741|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
19408742|NCT03563833|Anesthetics|anesthetics|mesh-list
19408743|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408744|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408745|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
19408746|NCT03563794|Vildagliptin|vildagliptin|mesh-list
19408747|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19855600|NCT00749684|Interferons|interferons|mesh-list
20247368|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247369|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
20247370|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
20247371|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247372|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247373|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247374|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
20247375|NCT00431990|Hormones|hormones|mesh-ancestor
20247376|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247377|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20247378|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467100|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467101|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467102|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20467103|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467104|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467105|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19408748|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224571|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
20224572|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224573|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224574|NCT00336219|Pantoprazole|pantoprazole|mesh-list
20224575|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20224576|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20224577|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20467106|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467107|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
20467108|NCT01465009|Aspirin|aspirin|mesh-list
20467109|NCT01465009|Acetaminophen|acetaminophen|mesh-list
19849939|NCT00706446|Fluticasone|fluticasone|mesh-list
19849940|NCT00706446|Xhance|xhance|mesh-list
19849941|NCT00706446|Budesonide|budesonide|mesh-list
19849942|NCT00706446|Bromides|bromides|mesh-list
19849943|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
19849944|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
19849945|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19849946|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224578|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467110|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20467111|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467112|NCT01465009|Analgesics|analgesics|mesh-ancestor
20467113|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
20467114|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467115|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467116|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467117|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467118|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467119|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20467120|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467121|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467122|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20467123|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467124|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
20467125|NCT01465074|Nicotine|nicotine|mesh-list
20467126|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20467127|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
20467128|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467129|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467130|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20467131|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20467132|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
20467133|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408749|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19408750|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
19408751|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408752|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408753|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
19408754|NCT03563729|Nivolumab|nivolumab|mesh-list
20224579|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224580|NCT00336245|Copper|copper|mesh-list
20467134|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408755|NCT03563729|Ipilimumab|ipilimumab|mesh-list
19408756|NCT03563729|Trametinib|trametinib|mesh-list
19408757|NCT03563729|Dabrafenib|dabrafenib|mesh-list
19408758|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408759|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408760|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19408761|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849947|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19849948|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
19849949|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467135|NCT01465113|Vitamin D|vitamin d|mesh-list
20467136|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
20467137|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
20467138|NCT01465113|Vitamins|vitamins|mesh-list
20467139|NCT01465113|Metformin|metformin|mesh-list
20467140|NCT01465113|Omeprazole|omeprazole|mesh-list
20467141|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
20467142|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467143|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467144|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20467145|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467146|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20467147|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20467148|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20467149|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467150|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467151|NCT01465152|Metformin|metformin|mesh-list
20467152|NCT01465152|Repaglinide|repaglinide|mesh-list
20467153|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467154|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467155|NCT01465256|Aspirin|aspirin|mesh-list
20467156|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20467157|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467158|NCT01465256|Analgesics|analgesics|mesh-ancestor
20467159|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
20467160|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467161|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467162|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467163|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467164|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467165|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20467166|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467167|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19408762|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19408763|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620417|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620418|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620419|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620420|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
20620421|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20467168|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20467169|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467170|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
20467171|NCT01465373|Progesterone|progesterone|mesh-list
20620422|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20620423|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20620424|NCT02294539|Diuretics|diuretics|mesh-ancestor
20620425|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
20620426|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20620427|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
20224581|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
20224582|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20224583|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620428|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
20620429|NCT02294552|Busulfan|busulfan|mesh-list
20620430|NCT02294552|Fludarabine|fludarabine|mesh-list
20620431|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
20620432|NCT02294552|Tacrolimus|tacrolimus|mesh-list
20620433|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620434|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
20620435|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620436|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695382|NCT04951115|Carboplatin|carboplatin|mesh-list
20224584|NCT00336245|Trace Elements|trace elements|mesh-ancestor
20224585|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
20224586|NCT00336310|Repaglinide|repaglinide|mesh-list
20224587|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20224588|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224589|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20224590|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20224591|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20224592|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
20224593|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224594|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20224595|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20224596|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224597|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
20224598|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20224599|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20224600|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20224601|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20224602|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224603|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
20224604|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224605|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224606|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20224607|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620437|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20620438|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
20620439|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620440|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408764|NCT03563664|Danazol|danazol|mesh-list
19408765|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19408766|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
19408767|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408768|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408769|NCT03563625|Bupivacaine|bupivacaine|mesh-list
19408770|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
19408771|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
20224608|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
20224609|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224610|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
20224611|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224612|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224613|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20224614|NCT00336375|Lumefantrine|lumefantrine|mesh-list
20224615|NCT00336375|Artemether|artemether|mesh-list
20224616|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20224617|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
20224618|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20224619|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20467172|NCT01465373|Progestins|progestins|mesh-ancestor
20467173|NCT01465373|Hormones|hormones|mesh-ancestor
20467174|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467175|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467176|NCT01465399|Mitogens|mitogens|mesh-list
20467177|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
19408772|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19408773|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620441|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20620442|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20620443|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
20620444|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20620445|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620446|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20620447|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20620448|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
20620449|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20620450|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620451|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
20620452|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20620453|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
20620454|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408774|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
19408775|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408776|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19408777|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408778|NCT03563534|Fluorides|fluorides|mesh-list
19408779|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
20620455|NCT02294591|Expectorants|expectorants|mesh-ancestor
20620456|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
20620457|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20467178|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467179|NCT01465438|Adalimumab|adalimumab|mesh-list
20467180|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467181|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467182|NCT01465503|Heparin|heparin|mesh-list
20467183|NCT01465503|Calcium heparin|calcium heparin|mesh-list
20467184|NCT01465503|Hirudins|hirudins|mesh-list
20467185|NCT01465503|Bivalirudin|bivalirudin|mesh-list
20467186|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
20467187|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467188|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20467189|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467190|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
20467191|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20467192|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
20467193|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467194|NCT01465568|Denosumab|denosumab|mesh-list
19408780|NCT03563534|Protective Agents|protective agents|mesh-ancestor
20224620|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224621|NCT00336401|Propofol|propofol|mesh-list
20467195|NCT01465568|Diphosphonates|diphosphonates|mesh-list
20467196|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19849950|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849951|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19849952|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
19849953|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
19849954|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19849955|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
20467197|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467198|NCT01465685|Methylphenidate|methylphenidate|mesh-list
20467199|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20467200|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20467201|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467202|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20467203|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20467204|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467205|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467206|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
20467207|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467208|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
20467209|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20467210|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
20467211|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20467212|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
20467213|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20467214|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467215|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20467216|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467217|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467218|NCT01465828|Clopidogrel|clopidogrel|mesh-list
20467219|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20467220|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467221|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20467222|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20467223|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20467224|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
20467225|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467226|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467227|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467228|NCT01465867|Selenium|selenium|mesh-list
20467229|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
20467230|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467231|NCT01465867|Protective Agents|protective agents|mesh-ancestor
20467232|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467233|NCT01465867|Trace Elements|trace elements|mesh-ancestor
20467234|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
20467235|NCT01465893|Vitamin D|vitamin d|mesh-list
20467236|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
20467237|NCT01465893|Vitamins|vitamins|mesh-list
20467238|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
20467239|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467240|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20467241|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467242|NCT01465906|Bromides|bromides|mesh-list
20467243|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
20467244|NCT01465906|Tulobuterol|tulobuterol|mesh-list
20467245|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20467246|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
20467247|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467248|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467249|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20467250|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
20467251|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
20467252|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20467253|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
20467254|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467255|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467256|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
20467257|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20467258|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20467259|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
20467260|NCT01465919|Mirtazapine|mirtazapine|mesh-list
20467261|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
20467262|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20467263|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20620458|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
20620459|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620460|NCT02294591|Protective Agents|protective agents|mesh-ancestor
20620461|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620462|NCT02294591|Antidotes|antidotes|mesh-ancestor
20620463|NCT02294617|Nicotine|nicotine|mesh-list
20620464|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20620465|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
20620466|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620467|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620468|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20620469|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20224622|NCT00336401|Sevoflurane|sevoflurane|mesh-list
20467264|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
20467265|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
20467266|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467267|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467268|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467269|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20467270|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20467271|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620470|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
20620471|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620472|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620473|NCT02294643|Aspirin|aspirin|mesh-list
20620474|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
19408781|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408782|NCT03563365|Adapalene|adapalene|mesh-list
19408783|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19408784|NCT03563365|Resveratrol|resveratrol|mesh-list
19408785|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
19408786|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408787|NCT03563365|Protective Agents|protective agents|mesh-ancestor
19408788|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408789|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408790|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19408791|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
19408792|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19408793|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19408794|NCT03563365|Analgesics|analgesics|mesh-ancestor
19408795|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
19408796|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408797|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408798|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408799|NCT03563248|Nivolumab|nivolumab|mesh-list
19408800|NCT03563248|Folfirinox|folfirinox|mesh-list
19408801|NCT03563248|Losartan|losartan|mesh-list
19408802|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408803|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408804|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19408805|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408806|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19408807|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19408808|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19408809|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19408810|NCT03563235|Calcitriol|calcitriol|mesh-list
19408811|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19695383|NCT04951115|Etoposide|etoposide|mesh-list
19695384|NCT04951115|Durvalumab|durvalumab|mesh-list
19408812|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695385|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695386|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19695387|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224623|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20224624|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224625|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467272|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20467273|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20467274|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20467275|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
20467276|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20467277|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20467278|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
20467279|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20620475|NCT02294643|Clopidogrel|clopidogrel|mesh-list
20620476|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620477|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20620478|NCT02294643|Analgesics|analgesics|mesh-ancestor
20620479|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
20620480|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620481|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620482|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620483|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620484|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20620485|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20620486|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620487|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19408813|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19408814|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19408815|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408816|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19408817|NCT03563235|Vitamins|vitamins|mesh-ancestor
19408818|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
20620488|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20620489|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620490|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
20620491|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20620492|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20620493|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20467280|NCT01465984|Acetaminophen|acetaminophen|mesh-list
20467281|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467282|NCT01465984|Analgesics|analgesics|mesh-ancestor
20620494|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
20620495|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620496|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20620497|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
20620498|NCT02294656|Triamcinolone|triamcinolone|mesh-list
20620499|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20620500|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20620501|NCT02294656|Ranibizumab|ranibizumab|mesh-list
20620502|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20620503|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19408819|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19408820|NCT03563170|Leucovorin|leucovorin|mesh-list
19408821|NCT03563170|Paclitaxel|paclitaxel|mesh-list
19408822|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
19408823|NCT03563170|Fluorouracil|fluorouracil|mesh-list
19408824|NCT03563170|Capecitabine|capecitabine|mesh-list
19408825|NCT03563170|Cetuximab|cetuximab|mesh-list
19408826|NCT03563170|Sorafenib|sorafenib|mesh-list
19408827|NCT03563170|Avelumab|avelumab|mesh-list
19408828|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20467283|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
20467284|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467285|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467286|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
20467287|NCT01466101|Pregabalin|pregabalin|mesh-list
20467288|NCT01466101|Analgesics|analgesics|mesh-ancestor
20467289|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
20620504|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20620505|NCT02294656|Growth Substances|growth substances|mesh-ancestor
20620506|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620507|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
20620508|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620509|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620510|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
20467290|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467291|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467292|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
20467293|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20467294|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467295|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467296|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467297|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20467298|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20467299|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620511|NCT02294656|Hormones|hormones|mesh-ancestor
20620512|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408829|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408830|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
20467300|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20467301|NCT01466114|Norethindrone|norethindrone|mesh-list
20467302|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
20467303|NCT01466114|Progestins|progestins|mesh-list
20467304|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20467305|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20467306|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20467307|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
20467308|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20467309|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467310|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20467311|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20467312|NCT01466114|Hormones|hormones|mesh-ancestor
20620513|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620514|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
20620515|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620516|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620517|NCT02294838|Citric Acid|citric acid|mesh-list
20620518|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
20620519|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
20620520|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20620521|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
20620522|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
20620523|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620524|NCT02294955|Amiodarone|amiodarone|mesh-list
20620525|NCT02294955|Sotalol|sotalol|mesh-list
20620526|NCT02294955|Flecainide|flecainide|mesh-list
20620527|NCT02294955|Dronedarone|dronedarone|mesh-list
20620528|NCT02294955|Propafenone|propafenone|mesh-list
20620529|NCT02294955|Disopyramide|disopyramide|mesh-list
20620530|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19695388|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20467313|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695389|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695390|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695391|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695392|NCT04950569|Simendan|simendan|mesh-list
19695393|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19695394|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
19695395|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20467314|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
20467315|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
20467316|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
20467317|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467318|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467319|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467320|NCT01466231|Everolimus|everolimus|mesh-list
20467321|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467322|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20467323|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
20467324|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467325|NCT01466244|Cetuximab|cetuximab|mesh-list
20467326|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467327|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20467328|NCT01466257|Cetuximab|cetuximab|mesh-list
20467329|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467330|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20467331|NCT01466452|Aspirin|aspirin|mesh-list
20467332|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620531|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
19695396|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19695397|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695398|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695399|NCT04950569|Protective Agents|protective agents|mesh-ancestor
19695400|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695401|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
19695402|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695403|NCT04950205|Sevoflurane|sevoflurane|mesh-list
19695404|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19695405|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19695406|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
19695407|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
20467333|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467334|NCT01466452|Analgesics|analgesics|mesh-ancestor
20620532|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20620533|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467335|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
20467336|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467337|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408831|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
19408832|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
19408833|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408834|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19408835|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
19695408|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695409|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695410|NCT04950049|Dexamethasone|dexamethasone|mesh-list
19695411|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
19695412|NCT04950049|BB 1101|bb 1101|mesh-list
19695413|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19849956|NCT00706446|Hormones|hormones|mesh-ancestor
19849957|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19849958|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19849959|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19849960|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19849961|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
19849962|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849963|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849964|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
19849965|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19695414|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
19849966|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
20224626|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20224627|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
20224628|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
20224629|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467338|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467339|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467340|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467341|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19695415|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
20224630|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20224631|NCT00336414|Prednisone|prednisone|mesh-list
20224632|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
20224633|NCT00336414|Azathioprine|azathioprine|mesh-list
20224634|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224635|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
20224636|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224637|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224638|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20224639|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
20224640|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224641|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224642|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20224643|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224644|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
20224645|NCT00336414|Hormones|hormones|mesh-ancestor
20224646|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224647|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20224648|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
20224649|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224650|NCT00336453|Vaccines|vaccines|mesh-list
20224651|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
20224652|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
20224653|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224654|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
20224655|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
20224656|NCT00336466|Hematinics|hematinics|mesh-ancestor
20224657|NCT00336518|Ribavirin|ribavirin|mesh-list
20224658|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20224659|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
20224660|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224661|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
20224662|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224663|NCT00336531|Itraconazole|itraconazole|mesh-list
20224664|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
20224665|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224666|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20224667|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20224668|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695416|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19849967|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
19849968|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19849969|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
19849970|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467342|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467343|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467344|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20467345|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467346|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
20467347|NCT01466465|Vitamin D|vitamin d|mesh-list
20467348|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
20467349|NCT01466465|Vitamins|vitamins|mesh-ancestor
20467350|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
20467351|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467352|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20467353|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467354|NCT01466478|Calcitriol|calcitriol|mesh-list
19408836|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408837|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408838|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19408839|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
19408840|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19408841|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
19408842|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408843|NCT03563170|Antidotes|antidotes|mesh-ancestor
19408844|NCT03563170|Protective Agents|protective agents|mesh-ancestor
19408845|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
19849971|NCT00706589|Aripiprazole|aripiprazole|mesh-list
19849972|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
19849973|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19849974|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19849975|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19849976|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19849977|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19849978|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
19849979|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
19849980|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19849981|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849982|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19849983|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19849984|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
19849985|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19849986|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19849987|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19849988|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19849989|NCT00706628|Nintedanib|nintedanib|mesh-list
19849990|NCT00706628|Afatinib|afatinib|mesh-list
19849991|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849992|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849993|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849994|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19849995|NCT00706641|Dasatinib|dasatinib|mesh-list
19849996|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19849997|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19849998|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19849999|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850000|NCT00706654|Aripiprazole|aripiprazole|mesh-list
19850001|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
19850002|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19850003|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19850004|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19850005|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850006|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850007|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
19850008|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
19850009|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850010|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850011|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19850012|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19850013|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
20467355|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20467356|NCT01466478|Calcipotriene|calcipotriene|mesh-list
19408846|NCT03563170|Vitamins|vitamins|mesh-ancestor
19408847|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
19408848|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20467357|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
20467358|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467359|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467360|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20467361|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467362|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467363|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20467364|NCT01466478|Vitamins|vitamins|mesh-ancestor
20467365|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
20467366|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19408849|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19408850|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408851|NCT03563144|Leucovorin|leucovorin|mesh-list
20467367|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467368|NCT01466517|Ibuprofen|ibuprofen|mesh-list
20467369|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20467370|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467371|NCT01466517|Analgesics|analgesics|mesh-ancestor
20467372|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
20467373|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467374|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467375|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467376|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467377|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20467378|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620534|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620535|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19850014|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19850015|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19850016|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20620536|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20620537|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20620538|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620539|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20620540|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20620541|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20620542|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20620543|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20620544|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
20620545|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620546|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620547|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
20620548|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
20620549|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620550|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20620551|NCT02294994|Tirofiban|tirofiban|mesh-list
20620552|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20620553|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20620554|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695417|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695418|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19695419|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
19695420|NCT04950049|Hormones|hormones|mesh-ancestor
19695421|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695422|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19695423|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695424|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
19695425|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695426|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695427|NCT04950400|Apatinib|apatinib|mesh-list
19695428|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467379|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408852|NCT03563144|Gemcitabine|gemcitabine|mesh-list
19408853|NCT03563144|Paclitaxel|paclitaxel|mesh-list
19408854|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
19408855|NCT03563144|Bevacizumab|bevacizumab|mesh-list
19408856|NCT03563144|Fluorouracil|fluorouracil|mesh-list
19408857|NCT03563144|Capecitabine|capecitabine|mesh-list
19408858|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
19408859|NCT03563144|Avelumab|avelumab|mesh-list
19408860|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20224669|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467380|NCT01466530|Misoprostol|misoprostol|mesh-list
20467381|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20467382|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
20467383|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20467384|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467385|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20620555|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20620556|NCT02295046|Amlodipine|amlodipine|mesh-list
20620557|NCT02295046|Atorvastatin|atorvastatin|mesh-list
20467386|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20467387|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
20526974|NCT01765790|Antibodies|antibodies|mesh-list
20526975|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
20526976|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
20526977|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526978|NCT01765829|Droperidol|droperidol|mesh-list
20526979|NCT01765829|Haloperidol|haloperidol|mesh-list
20526980|NCT01765829|Pimozide|pimozide|mesh-list
20526981|NCT01765829|Olanzapine|olanzapine|mesh-list
20526982|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
20526983|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
20526984|NCT01765829|Risperidone|risperidone|mesh-list
20526985|NCT01765829|Aripiprazole|aripiprazole|mesh-list
20620558|NCT02295046|Calcium|calcium|mesh-list
20620559|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620560|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620561|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20620562|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20620563|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
20620564|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620565|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20620566|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20620567|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620568|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20620569|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20620570|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20620571|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
20620572|NCT02295124|Oxycodone|oxycodone|mesh-list
20620573|NCT02295124|Hydromorphone|hydromorphone|mesh-list
20620574|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20620575|NCT02295124|Narcotics|narcotics|mesh-ancestor
20620576|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620577|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408861|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408862|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
19695429|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19695430|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695431|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695432|NCT04950530|Emtricitabine|emtricitabine|mesh-list
20224670|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20224671|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
19408863|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
19408864|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
19695433|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
20224672|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224673|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224674|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20224675|NCT00336648|Gemcitabine|gemcitabine|mesh-list
20224676|NCT00336648|Bevacizumab|bevacizumab|mesh-list
20224677|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224678|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224679|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20224680|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20224681|NCT00336648|Growth Substances|growth substances|mesh-ancestor
20224682|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224683|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
20224684|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224685|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
20224686|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20526986|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20526987|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20526988|NCT01765829|Ziprasidone|ziprasidone|mesh-list
20526989|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
20526990|NCT01765829|Clozapine|clozapine|mesh-list
20526991|NCT01765829|Asenapine|asenapine|mesh-list
20620578|NCT02295124|Analgesics|analgesics|mesh-ancestor
20620579|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
20620580|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620581|NCT02295150|Nadroparin|nadroparin|mesh-list
20620582|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
20620583|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20620584|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20620585|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467388|NCT01466543|Udenafil|udenafil|mesh-list
20467389|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20467390|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20467391|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467392|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467393|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20467394|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20467395|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20467396|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
20467397|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467398|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20467399|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20467400|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467401|NCT01466686|Temozolomide|temozolomide|mesh-list
20467402|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20467403|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
20467404|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467405|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467406|NCT01466712|Beclomethasone|beclomethasone|mesh-list
20467407|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
20467408|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
20467409|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20467410|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
20467411|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467412|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467413|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20467414|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
20467415|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20467416|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20467417|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20467418|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
20467419|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467420|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467421|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
20467422|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20467423|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
20467424|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467425|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
20467426|NCT01466712|Hormones|hormones|mesh-ancestor
20467427|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467428|NCT01466829|Hormones|hormones|mesh-list
20467429|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
20467430|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467431|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467432|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467433|NCT01466855|Topotecan|topotecan|mesh-list
20467434|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20467435|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20467436|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467437|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467438|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467439|NCT01466959|Acetic Acid|acetic acid|mesh-list
20467440|NCT01466959|Retinol acetate|retinol acetate|mesh-list
20467441|NCT01466959|Citric Acid|citric acid|mesh-list
20467442|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
20467443|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
20467444|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20467445|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
20467446|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
20467447|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467448|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20467449|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20467450|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620586|NCT02295189|Triamcinolone|triamcinolone|mesh-list
20620587|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20620588|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20620589|NCT02295189|Ketorolac|ketorolac|mesh-list
20620590|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20620591|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20620592|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620593|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
20620594|NCT02295189|Hormones|hormones|mesh-ancestor
20620595|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620596|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467451|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20467452|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
20467453|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467454|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20467455|NCT01466959|Protective Agents|protective agents|mesh-ancestor
19695434|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695435|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19695436|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20467456|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467457|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
20467458|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20467459|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467460|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20467461|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
20467462|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20467463|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467464|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467465|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467466|NCT01467115|Leucovorin|leucovorin|mesh-list
20467467|NCT01467115|Docetaxel|docetaxel|mesh-list
20467468|NCT01467115|Fluorouracil|fluorouracil|mesh-list
20467469|NCT01467115|Cetuximab|cetuximab|mesh-list
20467470|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
20467471|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
20467472|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467473|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
20467474|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
20467475|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
20467476|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467477|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
20467478|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20467479|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20467480|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
20467481|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467482|NCT01467115|Antidotes|antidotes|mesh-ancestor
20467483|NCT01467115|Protective Agents|protective agents|mesh-ancestor
20467484|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
20467485|NCT01467115|Vitamins|vitamins|mesh-ancestor
20467486|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
20467487|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20467488|NCT01467115|Hematinics|hematinics|mesh-ancestor
20467489|NCT01467141|Insulin|insulin|mesh-list
20467490|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20467491|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
20467492|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
20620597|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620598|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
20620599|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620600|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620601|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620602|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20620603|NCT02295189|Analgesics|analgesics|mesh-ancestor
20620604|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
20620605|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408865|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408866|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19408867|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
19416620|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
19695437|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695438|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695439|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19695440|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20467493|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
20467494|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
20467495|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467496|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408868|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224687|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
20224688|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224689|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224690|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224691|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
20224692|NCT00336674|Insulin|insulin|mesh-list
20467497|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20467498|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20467499|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467500|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20467501|NCT01467258|Amantadine|amantadine|mesh-list
20467502|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20467503|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20467504|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
20224693|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20224694|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620606|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620607|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20620608|NCT02295475|Warfarin|warfarin|mesh-list
20620609|NCT02295475|Apixaban|apixaban|mesh-list
20620610|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
20620611|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20620612|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
20620613|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20620614|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
20620615|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620616|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467505|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467506|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
20467507|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467508|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467509|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467510|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695441|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
19695442|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
19695443|NCT04950270|Coagulants|coagulants|mesh-ancestor
20467511|NCT01467258|Analgesics|analgesics|mesh-ancestor
20467512|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
20467513|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467514|NCT01467297|Levofloxacin|levofloxacin|mesh-list
20467515|NCT01467297|Ofloxacin|ofloxacin|mesh-list
20467516|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20467517|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467518|NCT01467297|Renal Agents|renal agents|mesh-ancestor
20467519|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695444|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19695445|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20224695|NCT00336739|Cinacalcet|cinacalcet|mesh-list
19408869|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408870|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19408871|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
19408872|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19408873|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224696|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20224697|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224698|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20224699|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
19408874|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19695446|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
20467520|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20467521|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20467522|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467523|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467524|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467525|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20467526|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20467527|NCT01467310|Trametinib|trametinib|mesh-list
20467528|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467529|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20467530|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467531|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467532|NCT01467323|Insulin|insulin|mesh-list
20467533|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20467534|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
19408875|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20467535|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
20467536|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467537|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467538|NCT01467362|Desonide|desonide|mesh-list
20467539|NCT01467362|V0034CR|v0034cr|mesh-list
20467540|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224700|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620617|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
20620618|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20620619|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
20620620|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620621|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620622|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20620623|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
20620624|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20620625|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
20620626|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620627|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620628|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20467541|NCT01467362|Emollients|emollients|mesh-ancestor
20467542|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
20467543|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
20467544|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
20467545|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467546|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467547|NCT01467401|Insulin|insulin|mesh-list
20467548|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20467549|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
20467550|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
20467551|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467552|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467553|NCT01467414|Insulin|insulin|mesh-list
20620629|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
20620630|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
20620631|NCT02295566|Protective Agents|protective agents|mesh-ancestor
20620632|NCT02295709|Dexamethasone|dexamethasone|mesh-list
19408876|NCT03563144|Growth Substances|growth substances|mesh-ancestor
19408877|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
19408878|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19408879|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
19408880|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
19408881|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408882|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408883|NCT03563144|Antidotes|antidotes|mesh-ancestor
19408884|NCT03563144|Protective Agents|protective agents|mesh-ancestor
19408885|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
19408886|NCT03563144|Vitamins|vitamins|mesh-ancestor
19408887|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
20224701|NCT00336765|XL647|xl647|mesh-list
20224702|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224703|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20224704|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224705|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224706|NCT00336791|Paclitaxel|paclitaxel|mesh-list
20224707|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
20224708|NCT00336791|Doxorubicin|doxorubicin|mesh-list
20224709|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20224710|NCT00336791|Fluorouracil|fluorouracil|mesh-list
20224711|NCT00336791|Epirubicin|epirubicin|mesh-list
20224712|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19416621|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467554|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467555|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467556|NCT01467518|Dolutegravir|dolutegravir|mesh-list
19408888|NCT03563040|Methoxsalen|methoxsalen|mesh-list
19408889|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19408890|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
20467557|NCT01467518|Methadone|methadone|mesh-list
20467558|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20467559|NCT01467518|Narcotics|narcotics|mesh-ancestor
20467560|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20467561|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467562|NCT01467518|Analgesics|analgesics|mesh-ancestor
20467563|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
20467564|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467565|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
20467566|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
20467567|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19408891|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19408892|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408893|NCT03563001|Budesonide|budesonide|mesh-list
19408894|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
19408895|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408896|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19408897|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
19408898|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620633|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
20620634|NCT02295709|BB 1101|bb 1101|mesh-list
20620635|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620636|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
20620637|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
20620638|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620639|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620640|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620641|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
20620642|NCT02295709|Hormones|hormones|mesh-ancestor
20620643|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620644|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20620645|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620646|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
20620647|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620648|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620649|NCT02295722|Gemcitabine|gemcitabine|mesh-list
20620650|NCT02295722|Melphalan|melphalan|mesh-list
20620651|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20620652|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
20620653|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620654|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620655|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
20620656|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620657|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620658|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620659|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
20620660|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620661|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20620662|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
20620663|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20620664|NCT02295748|Deflazacort|deflazacort|mesh-list
20620665|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620666|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620667|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
20620668|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620669|NCT02295787|Ketamine|ketamine|mesh-list
20620670|NCT02295787|Analgesics|analgesics|mesh-ancestor
20620671|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
19408899|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408900|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19408901|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
19408902|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
20467568|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20467569|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467570|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467571|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20467572|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20467573|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
20467574|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19408903|NCT03563001|Hormones|hormones|mesh-ancestor
19416622|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
20467575|NCT01467531|Dolutegravir|dolutegravir|mesh-list
20467576|NCT01467531|Cabotegravir|cabotegravir|mesh-list
20620672|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408904|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695447|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695448|NCT04949867|Glucagon|glucagon|mesh-list
19695449|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19695450|NCT04949867|Hormones|hormones|mesh-ancestor
20467577|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20620673|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620674|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20467578|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20467579|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467580|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467581|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20467582|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20467583|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
20467584|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467585|NCT01467596|Lidocaine|lidocaine|mesh-list
20467586|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
20467587|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
20467588|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
20467589|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20467590|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467591|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
20467592|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467593|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20467594|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20467595|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20620675|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20620676|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
20620677|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
20620678|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620679|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20620680|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20620681|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620682|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620683|NCT02295826|Aspirin|aspirin|mesh-list
20620684|NCT02295826|Dabigatran|dabigatran|mesh-list
20620685|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620686|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20620687|NCT02295826|Analgesics|analgesics|mesh-ancestor
20620688|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
20620689|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620690|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620691|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620692|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620693|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20620694|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20620695|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620696|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20620697|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20620698|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620699|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
20620700|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
20620701|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20467596|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467597|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467598|NCT01467648|Doripenem|doripenem|mesh-list
20467599|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20467600|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620702|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
20620703|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
20620704|NCT02295852|Calcium|calcium|mesh-list
20620705|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620706|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620707|NCT02295930|Bevacizumab|bevacizumab|mesh-list
20467601|NCT01467687|Verapamil|verapamil|mesh-list
20467602|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20467603|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20467604|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20620708|NCT02295930|Cetuximab|cetuximab|mesh-list
20620709|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20620710|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467605|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695451|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620711|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20620712|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20620713|NCT02295930|Growth Substances|growth substances|mesh-ancestor
20620714|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620715|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
20620716|NCT02296021|Amoxicillin|amoxicillin|mesh-list
20620717|NCT02296021|Clarithromycin|clarithromycin|mesh-list
20620718|NCT02296021|Esomeprazole|esomeprazole|mesh-list
20620719|NCT02296021|Bismuth|bismuth|mesh-list
20467606|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467607|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467608|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
20467609|NCT01467804|Sertraline|sertraline|mesh-list
20467610|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
20467611|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20467612|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19850017|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19850018|NCT00706706|Sunitinib|sunitinib|mesh-list
19850019|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850020|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19850021|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20620720|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20620721|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620722|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20620723|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620724|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20620725|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620726|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620727|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20467613|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20467614|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467615|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467616|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467617|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
20467618|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467619|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
20467620|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467621|NCT01467986|Sirolimus|sirolimus|mesh-list
20467622|NCT01467986|Irinotecan|irinotecan|mesh-list
20467623|NCT01467986|Temozolomide|temozolomide|mesh-list
20467624|NCT01467986|Dasatinib|dasatinib|mesh-list
20467625|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20467626|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20467627|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467628|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408905|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19408906|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19408907|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19850022|NCT00706706|Growth Substances|growth substances|mesh-ancestor
20467629|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467630|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20467631|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
20467632|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20467633|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467634|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20467635|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
20467636|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20467637|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
20467638|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467639|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20467640|NCT01468025|Naproxen|naproxen|mesh-list
20467641|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20467642|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19850023|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850024|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
19850025|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850026|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850027|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850028|NCT00706719|Enclomiphene|enclomiphene|mesh-list
19850029|NCT00706719|Clomiphene|clomiphene|mesh-list
19850030|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
20620728|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20620729|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20620730|NCT02296021|Antacids|antacids|mesh-ancestor
19850031|NCT00706719|Testosterone|testosterone|mesh-list
19850032|NCT00706719|Androgens|androgens|mesh-ancestor
19408908|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
19408909|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19408910|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408911|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
19408912|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
19408913|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620731|NCT02296047|Bromides|bromides|mesh-list
20620732|NCT02296047|Albuterol|albuterol|mesh-list
20620733|NCT02296047|Ipratropium|ipratropium|mesh-list
20620734|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
20620735|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20620736|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
20620737|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620738|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620739|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20620740|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
20620741|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
20620742|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20620743|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20620744|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20620745|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20620746|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
20620747|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620748|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620749|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19695452|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695453|NCT04949932|Turmeric extract|turmeric extract|mesh-list
19695454|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
19695455|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695456|NCT04949932|Protective Agents|protective agents|mesh-ancestor
19695457|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620750|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
20467643|NCT01468025|Analgesics|analgesics|mesh-ancestor
20467644|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
20467645|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467646|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467647|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467648|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467649|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
20467650|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20467651|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467652|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467653|NCT01468038|Trazodone|trazodone|mesh-list
19408914|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19408915|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19408916|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
20620751|NCT02296073|Fentanyl|fentanyl|mesh-list
20620752|NCT02296073|Midazolam|midazolam|mesh-list
20620753|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
20620754|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20620755|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620756|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620757|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19408917|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19408918|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408919|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19408920|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19408921|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
20467654|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20467655|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20467656|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20467657|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467658|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20467659|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20467660|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20467661|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467662|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467663|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467664|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
19408922|NCT03562923|Hormones|hormones|mesh-ancestor
20467665|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19695458|NCT04949464|Nicotine|nicotine|mesh-list
20620758|NCT02296073|Analgesics|analgesics|mesh-ancestor
20620759|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
20620760|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620761|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20620762|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20620763|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20620764|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
20620765|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620766|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620767|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20620768|NCT02296073|Narcotics|narcotics|mesh-ancestor
20620769|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20620770|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20620771|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
20620772|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
20620773|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20620774|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20620775|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20620776|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
20467666|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
20467667|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20467668|NCT01468051|Vaccines|vaccines|mesh-list
20467669|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
20467670|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467671|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20467672|NCT01468051|Antacids|antacids|mesh-ancestor
20467673|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467674|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20467675|NCT01468155|Dabigatran|dabigatran|mesh-list
20467676|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
20467677|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20620777|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
20620778|NCT02296203|Irinotecan|irinotecan|mesh-list
20620779|NCT02296203|Cetuximab|cetuximab|mesh-list
20620780|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20620781|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20620782|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620783|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620784|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620785|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20620786|NCT02296281|Pirfenidone|pirfenidone|mesh-list
20620787|NCT02296281|Analgesics|analgesics|mesh-ancestor
20620788|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
20620789|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620790|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620791|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620792|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20620793|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620794|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620795|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620796|NCT02296333|Ondansetron|ondansetron|mesh-list
20620797|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
20620798|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
20620799|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620800|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620801|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620802|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
20620803|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
20620804|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20620805|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
19408923|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19408924|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
19850033|NCT00706719|Hormones|hormones|mesh-ancestor
20467678|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
20467679|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620806|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467680|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467681|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
20467682|NCT01468259|Droxidopa|droxidopa|mesh-list
20467683|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20620807|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620808|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20620809|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20620810|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620811|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19408925|NCT03562780|Acetaminophen|acetaminophen|mesh-list
19408926|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467684|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19695459|NCT04949464|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20467685|NCT01468272|Beclomethasone|beclomethasone|mesh-list
20620812|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20620813|NCT02296359|Vaccines|vaccines|mesh-list
20620814|NCT02296359|Immunologic Factors|immunologic factors|mesh-ancestor
20620815|NCT02296359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467686|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
20467687|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20467688|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
20467689|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467690|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467691|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20467692|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
20467693|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20467694|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20467695|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20467696|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
20467697|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467698|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467699|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467700|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
20467701|NCT01468272|Hormones|hormones|mesh-ancestor
20467702|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467703|NCT01468285|Betahistine|betahistine|mesh-list
20467704|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
20467705|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
20467706|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
20467707|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467708|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467709|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20526992|NCT01765829|Amisulpride|amisulpride|mesh-list
20526993|NCT01765829|Perphenazine|perphenazine|mesh-list
20526994|NCT01765829|Sertindole|sertindole|mesh-list
20526995|NCT01765829|Sulpiride|sulpiride|mesh-list
20526996|NCT01765829|Clopenthixol|clopenthixol|mesh-list
20526997|NCT01765829|Clothiapine|clothiapine|mesh-list
20526998|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20526999|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
20527000|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527001|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620816|NCT02296398|Romidepsin|romidepsin|mesh-list
20620817|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20620818|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620819|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
20620820|NCT02296411|Bromides|bromides|mesh-list
20620821|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
20620822|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20620823|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20620824|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20620825|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
20620826|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620827|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620828|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620829|NCT02296463|Vaccines|vaccines|mesh-list
20620830|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
20620831|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527002|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527003|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20527004|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620832|NCT02296567|Bevacizumab|bevacizumab|mesh-list
20620833|NCT02296567|Ranibizumab|ranibizumab|mesh-list
20620834|NCT02296567|Aflibercept|aflibercept|mesh-list
20620835|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19408927|NCT03562780|Analgesics|analgesics|mesh-ancestor
19408928|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
19695460|NCT04949464|Autonomic Agents|autonomic agents|mesh-ancestor
20527005|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20527006|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20527007|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
20527008|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
20527009|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
20527010|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527011|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527012|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20620836|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620837|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20620838|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20467710|NCT01468389|Capecitabine|capecitabine|mesh-list
19408929|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620839|NCT02296567|Growth Substances|growth substances|mesh-ancestor
20620840|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408930|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408931|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
19408932|NCT03562754|Heparin|heparin|mesh-list
19408933|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
19408934|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620841|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
20620842|NCT02296671|Leucovorin|leucovorin|mesh-list
20620843|NCT02296671|Fluorouracil|fluorouracil|mesh-list
20620844|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
20620845|NCT02296671|Pemetrexed|pemetrexed|mesh-list
20620846|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
20620847|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620848|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20620849|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620850|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224713|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224714|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
20224715|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
20224716|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
20224717|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224718|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224719|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
20224720|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620851|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
20620852|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620853|NCT02296671|Antidotes|antidotes|mesh-ancestor
20620854|NCT02296671|Protective Agents|protective agents|mesh-ancestor
20620855|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
20620856|NCT02296671|Vitamins|vitamins|mesh-ancestor
20620857|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
20620858|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620859|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20620860|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20620861|NCT02296723|Valganciclovir|valganciclovir|mesh-list
20620862|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
20467711|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20467712|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
20467713|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467714|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467715|NCT01468415|Phenol|phenol|mesh-list
20467716|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20467717|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467718|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
20467719|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20467720|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20467721|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20467722|NCT01468441|Cetrorelix|cetrorelix|mesh-list
20467723|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
20467724|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20467725|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
20467726|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20467727|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467728|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20467729|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20467730|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467731|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20467732|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
20467733|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
20620863|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620864|NCT02296749|Sirolimus|sirolimus|mesh-list
20620865|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20620866|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620867|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20620868|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620869|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
19408935|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467734|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467735|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
20467736|NCT01468480|Calcium|calcium|mesh-list
20467737|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620870|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620871|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
20620872|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408936|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19408937|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
19408938|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19408939|NCT03562611|Nalbuphine|nalbuphine|mesh-list
19408940|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20467738|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467739|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20467740|NCT01468519|Insulin|insulin|mesh-list
20467741|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20467742|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467743|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467744|NCT01468545|Iloprost|iloprost|mesh-list
20467745|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467746|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
20467747|NCT01468571|Spironolactone|spironolactone|mesh-list
20467748|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20467749|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
20467750|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467751|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467752|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20467753|NCT01468571|Diuretics|diuretics|mesh-ancestor
20467754|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
20467755|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20467756|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20467757|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20467758|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20467759|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467760|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467761|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467762|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
20467763|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20467764|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
20620873|NCT02296762|Sirolimus|sirolimus|mesh-list
20620874|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224721|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224722|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19408941|NCT03562611|Narcotics|narcotics|mesh-ancestor
19408942|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850034|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850035|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850036|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19850037|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
19850038|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19850039|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
19408943|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408944|NCT03562611|Analgesics|analgesics|mesh-ancestor
19408945|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
19695461|NCT04949464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695462|NCT04949464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695463|NCT04949464|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19695464|NCT04949464|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19695465|NCT04949464|Cholinergic Agents|cholinergic agents|mesh-ancestor
19695466|NCT04949464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695467|NCT04949464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695468|NCT04949516|Aspirin|aspirin|mesh-list
19695469|NCT04949516|Colchicine|colchicine|mesh-list
19695470|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19695471|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695472|NCT04949516|Analgesics|analgesics|mesh-ancestor
19695473|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
19695474|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695475|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850040|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20224723|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
20224724|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20224725|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19408946|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224726|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224727|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224728|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224729|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
20224730|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224731|NCT00336882|Midazolam|midazolam|mesh-list
20224732|NCT00336882|Propofol|propofol|mesh-list
19408947|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19408948|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19408949|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19408950|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19408951|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19408952|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408953|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408954|NCT03562585|Antibodies|antibodies|mesh-list
19408955|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19408956|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
19408957|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408958|NCT03562533|Paclitaxel|paclitaxel|mesh-list
19408959|NCT03562533|Carboplatin|carboplatin|mesh-list
19408960|NCT03562533|Doxorubicin|doxorubicin|mesh-list
19408961|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19408962|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19408963|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408964|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
19408965|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
20620875|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620876|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20620877|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620878|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
20620879|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20620880|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
20620881|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620882|NCT02296996|Trametinib|trametinib|mesh-list
20620883|NCT02296996|Dabrafenib|dabrafenib|mesh-list
20620884|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620885|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19408966|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
19408967|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408968|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19408969|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19408970|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19408971|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408972|NCT03562507|Nivolumab|nivolumab|mesh-list
19408973|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20620886|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620887|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620888|NCT02297204|Aflibercept|aflibercept|mesh-list
20620889|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20620890|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20620891|NCT02297204|Growth Substances|growth substances|mesh-ancestor
20620892|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620893|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
20620894|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620895|NCT02297217|Paclitaxel|paclitaxel|mesh-list
19408974|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408975|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19408976|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408977|NCT03562468|Niacinamide|niacinamide|mesh-list
19408978|NCT03562468|Niacin|niacin|mesh-list
19408979|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
19408980|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
19408981|NCT03562468|Vitamins|vitamins|mesh-ancestor
19408982|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
19408983|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19408984|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20224733|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20224734|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224735|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224736|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20224737|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
20224738|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
20224739|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20224740|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20224741|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20224742|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20224743|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
20224744|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
20224745|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620896|NCT02297217|Carboplatin|carboplatin|mesh-list
19408985|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
20224746|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224747|NCT00336921|Alfuzosin|alfuzosin|mesh-list
20620897|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19408986|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408987|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19408988|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
19408989|NCT03562416|Nintedanib|nintedanib|mesh-list
20620898|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620899|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20620900|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20620901|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20620902|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408990|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19408991|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19408992|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408993|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408994|NCT03562390|Irinotecan|irinotecan|mesh-list
19408995|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20467765|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467766|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20467767|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467768|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408996|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19408997|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19408998|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19408999|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409000|NCT03562169|Thalidomide|thalidomide|mesh-list
19409001|NCT03562169|Dexamethasone|dexamethasone|mesh-list
19409002|NCT03562169|Ixazomib|ixazomib|mesh-list
19409003|NCT03562169|Glycine|glycine|mesh-list
19409004|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19409005|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
19409006|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
19409007|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409008|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409009|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409010|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
19409011|NCT03562169|Hormones|hormones|mesh-ancestor
19409012|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409013|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19409014|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409015|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409016|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
20467769|NCT01468714|Ketoconazole|ketoconazole|mesh-list
20467770|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
20467771|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467772|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20467773|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20467774|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467775|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467776|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20467777|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
20467778|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467779|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467780|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19695476|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19695477|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695478|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19409017|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
19695479|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19695480|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695481|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19695482|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19695483|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695484|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
19695485|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
19695486|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
19695487|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
19695488|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
19695489|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467781|NCT01468740|Prednisone|prednisone|mesh-list
20467782|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
20467783|NCT01468740|Dacarbazine|dacarbazine|mesh-list
19695490|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19695491|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19695492|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467784|NCT01468740|Doxorubicin|doxorubicin|mesh-list
20467785|NCT01468740|Etoposide|etoposide|mesh-list
20467786|NCT01468740|Vincristine|vincristine|mesh-list
20467787|NCT01468740|Bleomycin|bleomycin|mesh-list
20467788|NCT01468740|Vinblastine|vinblastine|mesh-list
20467789|NCT01468740|Procarbazine|procarbazine|mesh-list
20467790|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20467791|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
20467792|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467793|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467794|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20467795|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
20467796|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467797|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467798|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20467799|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20467800|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20467801|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20467802|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467803|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467804|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
20467805|NCT01468740|Hormones|hormones|mesh-ancestor
20467806|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467807|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20467808|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20467809|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
20467810|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
20467811|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
20467812|NCT01469143|Insulin|insulin|mesh-list
20467813|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20620903|NCT02297386|Testosterone|testosterone|mesh-list
19695493|NCT04949113|Nivolumab|nivolumab|mesh-list
19695494|NCT04949113|Ipilimumab|ipilimumab|mesh-list
19695495|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695496|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695497|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19850041|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19850042|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20620904|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
19409018|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19409019|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409020|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19409021|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19409022|NCT03562169|Growth Substances|growth substances|mesh-ancestor
19409023|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
19409024|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
19409025|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409026|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409027|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
19409028|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409029|NCT03562143|Iron|iron|mesh-list
20467814|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
20620905|NCT02297386|Androgens|androgens|mesh-ancestor
20620906|NCT02297386|Hormones|hormones|mesh-ancestor
20620907|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20620908|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620909|NCT02297477|Artesunate|artesunate|mesh-list
19409030|NCT03562143|Trace Elements|trace elements|mesh-ancestor
20467815|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
20467816|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20620910|NCT02297477|Atovaquone|atovaquone|mesh-list
20620911|NCT02297477|Proguanil|proguanil|mesh-list
20620912|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20620913|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
20620914|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20620915|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20620916|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620917|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620918|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
20467817|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467818|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467819|NCT01469156|Ranibizumab|ranibizumab|mesh-list
20467820|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20620919|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
20620920|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20620921|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
20620922|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695498|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467821|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20467822|NCT01469156|Growth Substances|growth substances|mesh-ancestor
20467823|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467824|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
20467825|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467826|NCT01469169|Iloprost|iloprost|mesh-list
20467827|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467828|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
20467829|NCT01469338|Prednisone|prednisone|mesh-list
20467830|NCT01469338|Octreotide|octreotide|mesh-list
20467831|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467832|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
20467833|NCT01469338|Hormones|hormones|mesh-ancestor
20467834|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467835|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467836|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20467837|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467838|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20467839|NCT01469351|Liraglutide|liraglutide|mesh-list
19695499|NCT04949347|Glycerol|glycerol|mesh-list
19695500|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19695501|NCT04949347|Protective Agents|protective agents|mesh-ancestor
19695502|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695503|NCT04948814|Vancomycin|vancomycin|mesh-list
19695504|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695505|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695506|NCT04948749|Sirolimus|sirolimus|mesh-list
19695507|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695508|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695509|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20467840|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467841|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467842|NCT01469351|Incretins|incretins|mesh-ancestor
20467843|NCT01469351|Hormones|hormones|mesh-ancestor
20467844|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467845|NCT01469416|Clopidogrel|clopidogrel|mesh-list
20467846|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20467847|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467848|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20467849|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19695510|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695511|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
19695512|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19695513|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
19695514|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707837|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19707838|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707839|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19707840|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19707841|NCT04822909|Growth Substances|growth substances|mesh-ancestor
20467850|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20467851|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
20467852|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467853|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707842|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
20467854|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620923|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620924|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
20467855|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20467856|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20467857|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
20467858|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20467859|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20467860|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467861|NCT01469468|Simvastatin|simvastatin|mesh-list
20467862|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20467863|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20467864|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
20467865|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467866|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20467867|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20467868|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467869|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
20467870|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467871|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467872|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
20467873|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20467874|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
20467875|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467876|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
20467877|NCT01469507|Protective Agents|protective agents|mesh-ancestor
20467878|NCT01469520|Lamivudine|lamivudine|mesh-list
20467879|NCT01469520|Zidovudine|zidovudine|mesh-list
20467880|NCT01469520|Nevirapine|nevirapine|mesh-list
20467881|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20467882|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20467883|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467884|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467885|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
20467886|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467887|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20467888|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20467889|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
19695515|NCT04948788|Gemcitabine|gemcitabine|mesh-list
19695516|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
19695517|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19695518|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
19695519|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695520|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695521|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
19409031|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
19409032|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409033|NCT03562130|Teduglutide|teduglutide|mesh-list
19409034|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409035|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19409036|NCT03562130|Protective Agents|protective agents|mesh-ancestor
19409037|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409038|NCT03561935|Propafenone|propafenone|mesh-list
19409039|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19409040|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19409041|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19409042|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409043|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409044|NCT03561740|Capecitabine|capecitabine|mesh-list
19409045|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19409046|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
19409047|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409048|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409049|NCT03561675|Acetazolamide|acetazolamide|mesh-list
19409050|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
20620925|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20620926|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20620927|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620928|NCT02297568|Vitamin D|vitamin d|mesh-list
20620929|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
19409051|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19409052|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409053|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409054|NCT03561675|Diuretics|diuretics|mesh-ancestor
20467890|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20620930|NCT02297568|Vitamins|vitamins|mesh-ancestor
19409055|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
20467891|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20467892|NCT01469559|Insulin|insulin|mesh-list
20467893|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20467894|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467895|NCT01469572|Everolimus|everolimus|mesh-list
20467896|NCT01469572|Pasireotide|pasireotide|mesh-list
20467897|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467898|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20467899|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
20467900|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467901|NCT01469572|Hormones|hormones|mesh-ancestor
20467902|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467903|NCT01469598|Gemcitabine|gemcitabine|mesh-list
20467904|NCT01469598|Docetaxel|docetaxel|mesh-list
20467905|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20467906|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
20467907|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620931|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
20620932|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409056|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409057|NCT03561649|Adalimumab|adalimumab|mesh-list
19409058|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224748|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20224749|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20224750|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20224751|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
20224752|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20467908|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467909|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
20467910|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467911|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467912|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409059|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19409060|NCT03561558|Ibuprofen|ibuprofen|mesh-list
19409061|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19409062|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19409063|NCT03561558|Analgesics|analgesics|mesh-ancestor
19409064|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
19409065|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409066|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409067|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850043|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
20620933|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20620934|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20620935|NCT02297594|Ziresovir|ziresovir|mesh-list
20620936|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
20620937|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620938|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
20620939|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20620940|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620941|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850044|NCT00706810|Verapamil|verapamil|mesh-list
19850045|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850046|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
19850047|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850048|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850049|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19850050|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19850051|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20224753|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224754|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224755|NCT00336921|Urological Agents|urological agents|mesh-ancestor
20224756|NCT00336947|Tegafur|tegafur|mesh-list
20224757|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224758|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
20224759|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224760|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224761|NCT00336960|Celecoxib|celecoxib|mesh-list
20224762|NCT00336960|Fluorouracil|fluorouracil|mesh-list
20224763|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
20224764|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409068|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467913|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
20467914|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695522|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695523|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695524|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19695525|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
19695526|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695527|NCT04948697|Bevacizumab|bevacizumab|mesh-list
19695528|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20467915|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
20467916|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
20467917|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
20467918|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
20467919|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20467920|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467921|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467922|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467923|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20467924|NCT01469624|Protective Agents|protective agents|mesh-ancestor
20467925|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467926|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
20467927|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20467928|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
20467929|NCT01469650|Vitamin D|vitamin d|mesh-list
20467930|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
20467931|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
20467932|NCT01469650|Vitamins|vitamins|mesh-list
20467933|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
20467934|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467935|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20467936|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20467937|NCT01469702|Azithromycin|azithromycin|mesh-list
20467938|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20467939|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467940|NCT01469884|Cyclosporine|cyclosporine|mesh-list
20467941|NCT01469884|Everolimus|everolimus|mesh-list
20467942|NCT01469884|Tacrolimus|tacrolimus|mesh-list
20467943|NCT01469884|Cyclosporins|cyclosporins|mesh-list
20467944|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20467945|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
20467946|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467947|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20467948|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467949|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467950|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
20467951|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20467952|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
20467953|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620942|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620943|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20620944|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
20620945|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20620946|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20620947|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20620948|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20620949|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620950|NCT02297854|Valganciclovir|valganciclovir|mesh-list
20620951|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
20620952|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620953|NCT02297906|Ketorolac|ketorolac|mesh-list
20620954|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20620955|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20620956|NCT02297906|Analgesics|analgesics|mesh-ancestor
20620957|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
20620958|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620959|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620960|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620961|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620962|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20620963|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20620964|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620965|NCT02297945|Metyrapone|metyrapone|mesh-list
20620966|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
20620967|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620968|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467954|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20467955|NCT01469975|Edetic Acid|edetic acid|mesh-list
20467956|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
20467957|NCT01469975|Antidotes|antidotes|mesh-ancestor
20467958|NCT01469975|Protective Agents|protective agents|mesh-ancestor
20467959|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467960|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
19850052|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19850053|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19850054|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467961|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
20467962|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467963|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20467964|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
20467965|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20467966|NCT01469988|Testosterone|testosterone|mesh-list
20467967|NCT01469988|Androgens|androgens|mesh-ancestor
20467968|NCT01469988|Hormones|hormones|mesh-ancestor
20467969|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20467970|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467971|NCT01470040|Aspirin|aspirin|mesh-list
20467972|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20467973|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20467974|NCT01470040|Analgesics|analgesics|mesh-ancestor
20467975|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
20467976|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467977|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467978|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20620969|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
20620970|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20620971|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20620972|NCT02298010|Capecitabine|capecitabine|mesh-list
20620973|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
20620974|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20620975|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
19409069|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19409070|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409071|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409072|NCT03561415|Posaconazole|posaconazole|mesh-list
19409073|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
19695529|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695530|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19695531|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19695532|NCT04948697|Growth Substances|growth substances|mesh-ancestor
19695533|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695534|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
19695535|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
19695536|NCT04948957|Esmolol|esmolol|mesh-list
19695537|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
19695538|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19695539|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19695540|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19695541|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
19409074|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409075|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19409076|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19409077|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19409078|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19409079|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19409080|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409081|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409082|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19409083|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
19409084|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409085|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416623|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19416624|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
19416625|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416626|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416627|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19416628|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
19695542|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695543|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620976|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409086|NCT03561402|Teriflunomide|teriflunomide|mesh-list
20620977|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20620978|NCT02298062|Infliximab|infliximab|mesh-list
20620979|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
20620980|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20620981|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20620982|NCT02298088|Clopidogrel|clopidogrel|mesh-list
20620983|NCT02298088|Ticagrelor|ticagrelor|mesh-list
20620984|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20620985|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20620986|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20620987|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20620988|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
20620989|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20620990|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20620991|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620992|NCT02298101|Edetic Acid|edetic acid|mesh-list
20467979|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20467980|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20467981|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20467982|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20467983|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20467984|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20467985|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20467986|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
20467987|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
20467988|NCT01470053|Azelastine|azelastine|mesh-list
20467989|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20467990|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
20467991|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20467992|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20467993|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
20467994|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20467995|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20467996|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20467997|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
20467998|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20467999|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468000|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468001|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20468002|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20468003|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
20468004|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
20468005|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468006|NCT01470092|Tibolone|tibolone|mesh-list
20468007|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
20468008|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
20468009|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468010|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468011|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20468012|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20468013|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468014|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20468015|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
20468016|NCT01470092|Hormones|hormones|mesh-ancestor
20468017|NCT01470157|Ketamine|ketamine|mesh-list
20468018|NCT01470157|Analgesics|analgesics|mesh-ancestor
20468019|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
20620993|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
20620994|NCT02298101|Antidotes|antidotes|mesh-ancestor
20620995|NCT02298101|Protective Agents|protective agents|mesh-ancestor
20620996|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20620997|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
19409087|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19409088|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19409089|NCT03561402|Analgesics|analgesics|mesh-ancestor
19409090|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
19409091|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409092|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409093|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20468020|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20620998|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
20620999|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621000|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19409094|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20468021|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468022|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19409095|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409096|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
19409097|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
19409098|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409099|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19409100|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409101|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621001|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
20621002|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20621003|NCT02298153|Atezolizumab|atezolizumab|mesh-list
20621004|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621005|NCT02298166|Cytarabine|cytarabine|mesh-list
20621006|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
20621007|NCT02298166|Crenolanib|crenolanib|mesh-list
20621008|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20621009|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
20621010|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621011|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621012|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
20621013|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468023|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20468024|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
20468025|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
19409102|NCT03561233|Omeprazole|omeprazole|mesh-list
19409103|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19409104|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409105|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19409106|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621014|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621015|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
20621016|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621017|NCT02298166|Analgesics|analgesics|mesh-ancestor
20621018|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
20621019|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621020|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20621021|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20621022|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621023|NCT02298205|Beclomethasone|beclomethasone|mesh-list
20621024|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621025|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
20621026|NCT02298205|Hormones|hormones|mesh-ancestor
20621027|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621028|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621029|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19409107|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409108|NCT03561181|Vaccines|vaccines|mesh-list
20224765|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224766|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409109|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
19409110|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409111|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19409112|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19409113|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409114|NCT03560973|Gemcitabine|gemcitabine|mesh-list
19409115|NCT03560973|Ramucirumab|ramucirumab|mesh-list
20468026|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20468027|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19850055|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
20468028|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19409116|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224767|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224768|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
20224769|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224770|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20224771|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20224772|NCT00336960|Analgesics|analgesics|mesh-ancestor
20224773|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
20468029|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468030|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468031|NCT01470209|Everolimus|everolimus|mesh-list
20468032|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468033|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468034|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
19409117|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
19409118|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409119|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409120|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
19409121|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409122|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409123|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409124|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
19409125|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621030|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
20621031|NCT02298218|Meloxicam|meloxicam|mesh-list
20621032|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20621033|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621034|NCT02298218|Analgesics|analgesics|mesh-ancestor
20621035|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
20621036|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621037|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621038|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621039|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621040|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20621041|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20621042|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468035|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527013|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20527014|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527015|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
20527016|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
20527017|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20527018|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20527019|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20527020|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20527021|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20527022|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
20527023|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
20527024|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20527025|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20527026|NCT01765842|Rituximab|rituximab|mesh-list
20527027|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20527028|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527029|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
20527030|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527031|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527032|NCT01765855|Betrixaban|betrixaban|mesh-list
20527033|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20527034|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
20621043|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621044|NCT02298283|Prednisone|prednisone|mesh-list
20621045|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
20621046|NCT02298283|Doxorubicin|doxorubicin|mesh-list
20621047|NCT02298283|Etoposide|etoposide|mesh-list
20621048|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20621049|NCT02298283|Vincristine|vincristine|mesh-list
20527035|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20527036|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
20527037|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527038|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527039|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
20527040|NCT01765868|Betrixaban|betrixaban|mesh-list
20527041|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20527042|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
20527043|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20621050|NCT02298283|Bleomycin|bleomycin|mesh-list
20621051|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20621052|NCT02298283|Procarbazine|procarbazine|mesh-list
20527044|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
20527045|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530635|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
20621053|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621054|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
20621055|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621056|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621057|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20621058|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
19409140|NCT03560908|Dasatinib|dasatinib|mesh-list
19409141|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409142|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19409143|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409144|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409145|NCT03560856|Fulvestrant|fulvestrant|mesh-list
19409146|NCT03560856|Palbociclib|palbociclib|mesh-list
19409147|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19409148|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409149|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19409150|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19409151|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
19409152|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468036|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
20468037|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20468038|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20468039|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
20468040|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468041|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468042|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20468043|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20468044|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20468045|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20468046|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20468047|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468048|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468049|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468050|NCT01470339|Analgesics|analgesics|mesh-ancestor
20468051|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
19409153|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409154|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19409155|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409156|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409157|NCT03560804|Olmesartan|olmesartan|mesh-list
19409158|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
19409159|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19409160|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19409161|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19409162|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409163|NCT03560804|Diuretics|diuretics|mesh-ancestor
19409164|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
19409165|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409166|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19409167|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409168|NCT03560752|Vaccines|vaccines|mesh-list
19409169|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
19409170|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468052|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468053|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
20468054|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20468055|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
20468056|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20468057|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20468058|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20468059|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20468060|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409171|NCT03560583|Metoclopramide|metoclopramide|mesh-list
19695544|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468061|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468062|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468063|NCT01470352|Analgesics|analgesics|mesh-ancestor
20468064|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
20468065|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468066|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
20468067|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20468068|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
20468069|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
20468070|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468071|NCT01470456|Rituximab|rituximab|mesh-list
20468072|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468073|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468074|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
20468075|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468076|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20468077|NCT01470495|Sorafenib|sorafenib|mesh-list
20468078|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468079|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19409172|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
19409173|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
19409174|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409175|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409176|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409177|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19409178|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19409179|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
20621059|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621060|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409180|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468080|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468081|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468082|NCT01470690|Omeprazole|omeprazole|mesh-list
20468083|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20468084|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468085|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20468086|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468087|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468088|NCT01470742|Capecitabine|capecitabine|mesh-list
20468089|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468090|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
20468091|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468092|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468093|NCT01470755|Albuterol|albuterol|mesh-list
20468094|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20468095|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
20468096|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468097|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468098|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20468099|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
20468100|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
20468101|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20468102|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20468103|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20468104|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20468105|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468106|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468107|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468108|NCT01470794|Flucytosine|flucytosine|mesh-list
20468109|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
20468110|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468111|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
19409181|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409182|NCT03560440|Vancomycin|vancomycin|mesh-list
19850056|NCT00706836|Pregabalin|pregabalin|mesh-list
19850057|NCT00706836|Analgesics|analgesics|mesh-ancestor
20224774|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224775|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224776|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224777|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20224778|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20224779|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224780|NCT00337051|Propofol|propofol|mesh-list
20224781|NCT00337051|Sevoflurane|sevoflurane|mesh-list
20224782|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19409183|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19409184|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409185|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19409186|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19409187|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19409188|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409189|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409190|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409191|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409192|NCT03560427|Analgesics|analgesics|mesh-ancestor
19409193|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
19409194|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409195|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
19409196|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19409197|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
19409198|NCT03560375|Empagliflozin|empagliflozin|mesh-list
19409199|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19409200|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409201|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19409202|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850058|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
20621061|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20468112|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468113|NCT01470807|Pancrelipase|pancrelipase|mesh-list
20468114|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468115|NCT01470937|Acarbose|acarbose|mesh-list
20468116|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20468117|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468118|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468119|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20468120|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621062|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20621063|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20621064|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20621065|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850059|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850060|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850061|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
19850062|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19850063|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20468121|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
20468122|NCT01471067|Rituximab|rituximab|mesh-list
20468123|NCT01471067|Fludarabine|fludarabine|mesh-list
20468124|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
20468125|NCT01471067|Melphalan|melphalan|mesh-list
20468126|NCT01471067|Busulfan|busulfan|mesh-list
20468127|NCT01471067|Clofarabine|clofarabine|mesh-list
20468128|NCT01471067|Tacrolimus|tacrolimus|mesh-list
20468129|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
20468130|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20468131|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468132|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468133|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
20468134|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468135|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621066|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621067|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
20621068|NCT02298283|Hormones|hormones|mesh-ancestor
20621069|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621070|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20621071|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20621072|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
20468136|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468137|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
20468138|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468139|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468140|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468141|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20468142|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468143|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20468144|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20468145|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
20621073|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
20621074|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
20621075|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621076|NCT02298335|Prednisone|prednisone|mesh-list
20621077|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621078|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
20621079|NCT02298335|Hormones|hormones|mesh-ancestor
20621080|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409203|NCT03560362|Epinephrine|epinephrine|mesh-list
20468146|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20468147|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20468148|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
20468149|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20468150|NCT01471132|Paclitaxel|paclitaxel|mesh-list
20468151|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
20468152|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20468153|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468154|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
20468155|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
20468156|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
20468157|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468158|NCT01471145|Naltrexone|naltrexone|mesh-list
20468159|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20468160|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19409204|NCT03560362|Bupivacaine|bupivacaine|mesh-list
19409205|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
19409206|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
19409207|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409208|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409209|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
19409210|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409211|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19409212|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19409213|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
19409214|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409215|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409216|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19409217|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20468161|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468162|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
20468163|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468164|NCT01471158|Timolol|timolol|mesh-list
20468165|NCT01471158|Dorzolamide|dorzolamide|mesh-list
20468166|NCT01471158|Maleic acid|maleic acid|mesh-list
20468167|NCT01471158|Brinzolamide|brinzolamide|mesh-list
20468168|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20621081|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621082|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20621083|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468169|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20468170|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468171|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468172|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468173|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468174|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20468175|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20468176|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468177|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20468178|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20468179|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20468180|NCT01471262|Liver Extracts|liver extracts|mesh-list
20468181|NCT01471262|Hematinics|hematinics|mesh-ancestor
20468182|NCT01471275|Metformin|metformin|mesh-list
20468183|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621084|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
20621085|NCT02298348|Sorafenib|sorafenib|mesh-list
20621086|NCT02298348|Topotecan|topotecan|mesh-list
20621087|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621088|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
20621089|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621090|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621091|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20621092|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
20468184|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621093|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468185|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20468186|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20621094|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621095|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20621096|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20621097|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621098|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20621099|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20621100|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20621101|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
20621102|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621103|NCT02298530|Caffeine|caffeine|mesh-list
20621104|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20621105|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468187|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468188|NCT01471470|Bevacizumab|bevacizumab|mesh-list
20468189|NCT01471470|Docetaxel|docetaxel|mesh-list
20468190|NCT01471470|Capecitabine|capecitabine|mesh-list
20468191|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468192|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468193|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20468194|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20468195|NCT01471470|Growth Substances|growth substances|mesh-ancestor
20468196|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468197|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
20468198|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20468199|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
19409218|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
19409219|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19409220|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
19409221|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
19409222|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
20468200|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20468201|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468202|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468203|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
20468204|NCT01471535|Interferons|interferons|mesh-list
20468205|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
19850064|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850065|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19850066|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19850067|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19850068|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850069|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19850070|NCT00706849|Mipomersen|mipomersen|mesh-list
19850071|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19850072|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19850073|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
19850074|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850075|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19850076|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
20468206|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
19409223|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19409224|NCT03560349|Lidocaine|lidocaine|mesh-list
19409225|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
20468207|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20468208|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468209|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
20468210|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468211|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
20468212|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468213|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
20468214|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
20468215|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20468216|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409226|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
19409227|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409228|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409229|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
19409230|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409231|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19409232|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19409233|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19409234|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19850077|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20468217|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409235|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409236|NCT03560336|Liraglutide|liraglutide|mesh-list
19409237|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19409238|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409239|NCT03560336|Incretins|incretins|mesh-ancestor
20468218|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
20468219|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20468220|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409240|NCT03560336|Hormones|hormones|mesh-ancestor
19409241|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409242|NCT03560310|Ticagrelor|ticagrelor|mesh-list
19409243|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20468221|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468222|NCT01471678|Tamsulosin|tamsulosin|mesh-list
20468223|NCT01471678|Dutasteride|dutasteride|mesh-list
20468224|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20468225|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20468226|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19409244|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19409245|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19409246|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19409247|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
20621106|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20621107|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621108|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621109|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20621110|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19695545|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
19695546|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19695547|NCT04948801|Velpatasvir|velpatasvir|mesh-list
19695548|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
19695549|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695550|NCT04948489|Norethindrone|norethindrone|mesh-list
19695551|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
19695552|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19695553|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19695554|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19850078|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
20468227|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468228|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468229|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468230|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468231|NCT01471678|Urological Agents|urological agents|mesh-ancestor
20468232|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20468233|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20468234|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468235|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
20468236|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468237|NCT01471704|Verapamil|verapamil|mesh-list
20468238|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20468239|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20468240|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20468241|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468242|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20468243|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468244|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
20468245|NCT01471730|Thrombin|thrombin|mesh-list
20468246|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
20468247|NCT01471730|Coagulants|coagulants|mesh-ancestor
20468248|NCT01471808|Metformin|metformin|mesh-list
20468249|NCT01471808|Pioglitazone|pioglitazone|mesh-list
20468250|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20468251|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20468252|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468253|NCT01471808|Incretins|incretins|mesh-ancestor
20468254|NCT01471808|Hormones|hormones|mesh-ancestor
20468255|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468256|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20468257|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
20468258|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621111|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
20621112|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695555|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
20468259|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468260|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20468261|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
20468262|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468263|NCT01471847|Capecitabine|capecitabine|mesh-list
20468264|NCT01471847|Trastuzumab|trastuzumab|mesh-list
20468265|NCT01471847|Lapatinib|lapatinib|mesh-list
20468266|NCT01471847|Dactolisib|dactolisib|mesh-list
20468267|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468268|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
20468269|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468270|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468271|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468272|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20468273|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468274|NCT01471886|Ketorolac|ketorolac|mesh-list
20468275|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20468276|NCT01471886|Naproxen|naproxen|mesh-list
20468277|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20468278|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468279|NCT01471886|Analgesics|analgesics|mesh-ancestor
20468280|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
20468281|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468282|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468283|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20468284|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20468285|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19695556|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19695557|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695558|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19695559|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19695560|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
19695561|NCT04948567|Analgesics|analgesics|mesh-ancestor
19695562|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
19695563|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695564|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695565|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
19695566|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695567|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19695568|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
19695569|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19695570|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19695571|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621113|NCT02298582|Fentanyl|fentanyl|mesh-list
20621114|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20621115|NCT02298582|Narcotics|narcotics|mesh-ancestor
20621116|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621117|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409248|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409249|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409250|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409251|NCT03560232|Clindamycin|clindamycin|mesh-list
19695572|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20621118|NCT02298582|Analgesics|analgesics|mesh-ancestor
20621119|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
20621120|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621121|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20621122|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20621123|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
20621124|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
20621125|NCT02298595|Cetuximab|cetuximab|mesh-list
20621126|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621127|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621128|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
20621129|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20621130|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20621131|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20621132|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20621133|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621134|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
20621135|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621136|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468286|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468287|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468288|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
20468289|NCT01471899|Ketorolac|ketorolac|mesh-list
20468290|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20468291|NCT01471899|Naproxen|naproxen|mesh-list
20621137|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20468292|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20468293|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468294|NCT01471899|Analgesics|analgesics|mesh-ancestor
20468295|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
20468296|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468297|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468298|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20468299|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695573|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
19695574|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19695575|NCT04948203|Sirolimus|sirolimus|mesh-list
20468300|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20468301|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468302|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468303|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
20468304|NCT01471925|Esomeprazole|esomeprazole|mesh-list
20468305|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20468306|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468307|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20468308|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468309|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527046|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527047|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
20527048|NCT01765881|Misoprostol|misoprostol|mesh-list
20527049|NCT01765881|Dinoprostone|dinoprostone|mesh-list
20527050|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20527051|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
20527052|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20527053|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527054|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20527055|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527056|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
20527057|NCT01765946|Metformin|metformin|mesh-list
20527058|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20527059|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527060|NCT01766063|Interferons|interferons|mesh-list
20527061|NCT01766063|Interferon-beta|interferon-beta|mesh-list
20527062|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
20527063|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527064|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
20527065|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527066|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
20527067|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527068|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20527069|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
20527070|NCT01766089|Remifentanil|remifentanil|mesh-list
20527071|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19695576|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19695577|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527072|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409252|NCT03560232|Gentamicins|gentamicins|mesh-list
19409253|NCT03560232|Cefazolin|cefazolin|mesh-list
19409254|NCT03560232|Tazobactam|tazobactam|mesh-list
19409255|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
19409256|NCT03560232|Piperacillin|piperacillin|mesh-list
19409257|NCT03560232|Ampicillin|ampicillin|mesh-list
19409258|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19409259|NCT03560232|Sulbactam|sulbactam|mesh-list
19409260|NCT03560232|Sultamicillin|sultamicillin|mesh-list
19409261|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19409262|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409263|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19409264|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409265|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409266|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19409267|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
20527073|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409268|NCT03560024|Growth Substances|growth substances|mesh-ancestor
19416629|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
19695578|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19409269|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468310|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20468311|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468312|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20468313|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468314|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468315|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
20468316|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
20468317|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468318|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
20468319|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20468320|NCT01471990|Protective Agents|protective agents|mesh-ancestor
20468321|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468322|NCT01471990|Growth Substances|growth substances|mesh-ancestor
20468323|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468324|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468325|NCT01472016|Docetaxel|docetaxel|mesh-list
20468326|NCT01472016|Cetuximab|cetuximab|mesh-list
20468327|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20468328|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468329|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
20468330|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
19409270|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
20621138|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621139|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
19409271|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409272|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409273|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
19409274|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19409275|NCT03560011|Antibodies|antibodies|mesh-list
19409276|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
19409277|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409278|NCT03559985|Acetaminophen|acetaminophen|mesh-list
19409279|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468331|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
20468332|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409280|NCT03559985|Analgesics|analgesics|mesh-ancestor
19409281|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
19409282|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409283|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409284|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
19695579|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695580|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
20468333|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468334|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20468335|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409285|NCT03559920|Propofol|propofol|mesh-list
19409286|NCT03559920|Sevoflurane|sevoflurane|mesh-list
19409287|NCT03559920|Anesthetics|anesthetics|mesh-list
19409288|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20468336|NCT01472029|Leucovorin|leucovorin|mesh-list
20468337|NCT01472029|Docetaxel|docetaxel|mesh-list
20468338|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
20468339|NCT01472029|Trastuzumab|trastuzumab|mesh-list
20468340|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468341|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
20468342|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
20468343|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
20468344|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468345|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468346|NCT01472029|Antidotes|antidotes|mesh-ancestor
20468347|NCT01472029|Protective Agents|protective agents|mesh-ancestor
20468348|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468349|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
19409289|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409290|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409291|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19409292|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
19409293|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19409294|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19409295|NCT03559868|Digoxin|digoxin|mesh-list
19409296|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19409297|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19409298|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409299|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409300|NCT03559868|Protective Agents|protective agents|mesh-ancestor
19409301|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409302|NCT03559803|Cisplatin|cisplatin|mesh-list
19409303|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409304|NCT03559790|Tenofovir|tenofovir|mesh-list
19409305|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
19409306|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409307|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20468350|NCT01472029|Vitamins|vitamins|mesh-ancestor
20468351|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
20468352|NCT01472055|Fludarabine|fludarabine|mesh-list
20468353|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468354|NCT01472146|Doxorubicin|doxorubicin|mesh-list
20468355|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468356|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20468357|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20468358|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20468359|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468360|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468361|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
20468362|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20468363|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468364|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468365|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20468366|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20468367|NCT01472263|Protective Agents|protective agents|mesh-ancestor
20468368|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468369|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
20468370|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20468371|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
20468372|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20468373|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
20468374|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20468375|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20468376|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20468377|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
20468378|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20468379|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468380|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20468381|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20468382|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20468383|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20621140|NCT02298985|Curcumin|curcumin|mesh-list
20621141|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
19409308|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20621142|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20621143|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621144|NCT02298985|Analgesics|analgesics|mesh-ancestor
20621145|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
20621146|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621147|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621148|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621149|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621150|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621151|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621152|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621153|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20468384|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468385|NCT01472406|Pancrelipase|pancrelipase|mesh-list
20468386|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468387|NCT01472497|Pioglitazone|pioglitazone|mesh-list
20468388|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20468389|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468390|NCT01472510|Ranibizumab|ranibizumab|mesh-list
20468391|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20468392|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20468393|NCT01472510|Growth Substances|growth substances|mesh-ancestor
20468394|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409309|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224783|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20468395|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
20468396|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468397|NCT01472640|Liraglutide|liraglutide|mesh-list
20468398|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20468399|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468400|NCT01472640|Incretins|incretins|mesh-ancestor
20468401|NCT01472640|Hormones|hormones|mesh-ancestor
20468402|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468403|NCT01472653|Cetuximab|cetuximab|mesh-list
20621154|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621155|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20621156|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
20621157|NCT02299024|Narcotics|narcotics|mesh-ancestor
20621158|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621159|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621160|NCT02299024|Analgesics|analgesics|mesh-ancestor
20621161|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
20621162|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621163|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
20621164|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20621165|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621166|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621167|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621168|NCT02299063|Analgesics|analgesics|mesh-ancestor
20621169|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
20621170|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621171|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20621172|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20621173|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20621174|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621175|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621176|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621177|NCT02299115|Prednisolone|prednisolone|mesh-list
20621178|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20621179|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
20621180|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20621181|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
20621182|NCT02299115|Vigabatrin|vigabatrin|mesh-list
20621183|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19409310|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224784|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224785|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20224786|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
20224787|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
20224788|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20224789|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20224790|NCT00337090|Mirabegron|mirabegron|mesh-list
20468404|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468405|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621184|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
20621185|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621186|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
19695581|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19695582|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
19695583|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695584|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
19695585|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
20468406|NCT01472666|Caseins|caseins|mesh-list
20468407|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
20468408|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
20468409|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468410|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20468411|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
20468412|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468413|NCT01472770|Gemcitabine|gemcitabine|mesh-list
20468414|NCT01472770|Capecitabine|capecitabine|mesh-list
20468415|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468416|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
19695586|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
19695587|NCT04948125|Apatinib|apatinib|mesh-list
19695588|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695589|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19409311|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19409312|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19409313|NCT03559751|Nicotine|nicotine|mesh-list
19409314|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19409315|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
19409316|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409317|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409318|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19409319|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19409320|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
19409321|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409322|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409323|NCT03559725|Menthol|menthol|mesh-list
19409324|NCT03559725|Nicotine|nicotine|mesh-list
19409325|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19409326|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
19409327|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409328|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409329|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19409330|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19409331|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
19409332|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409333|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409334|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
19695590|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695591|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621187|NCT02299115|Hormones|hormones|mesh-ancestor
20468417|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468418|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695592|NCT04948385|Propofol|propofol|mesh-list
19695593|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19695594|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20468419|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
20468420|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468421|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468422|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468423|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
20468424|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468425|NCT01472783|Veliparib|veliparib|mesh-list
20468426|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20468427|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468428|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468429|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468430|NCT01472796|Vitamin D|vitamin d|mesh-list
20468431|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
20468432|NCT01472796|Vitamins|vitamins|mesh-ancestor
20468433|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
20468434|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621188|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409335|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
19695595|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468435|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19409336|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
20621189|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621190|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20621191|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621192|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
20224791|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20224792|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20224793|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20224794|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
20224795|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695596|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19695597|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
19695598|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
19695599|NCT04948372|Terlipressin|terlipressin|mesh-list
19695600|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19695601|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19695602|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19695603|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695604|NCT04948164|Naproxen|naproxen|mesh-list
19695605|NCT04948164|Sumatriptan|sumatriptan|mesh-list
19695606|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19695607|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695608|NCT04948164|Analgesics|analgesics|mesh-ancestor
19695609|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
19695610|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695611|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695612|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19695613|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20468436|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20468437|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20621193|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
20621194|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621195|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20621196|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20621197|NCT02299115|Protective Agents|protective agents|mesh-ancestor
20621198|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
20621199|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621200|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621201|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
20621202|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621203|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
20621204|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20621205|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621206|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468438|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
20468439|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20468440|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
20468441|NCT01472913|Coagulants|coagulants|mesh-ancestor
20468442|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20468443|NCT01472926|Plasminogen|plasminogen|mesh-list
20468444|NCT01472926|Tenecteplase|tenecteplase|mesh-list
20468445|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20468446|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20468447|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468448|NCT01472978|Metronidazole|metronidazole|mesh-list
20468449|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468450|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20468451|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20468452|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20468453|NCT01473043|Axitinib|axitinib|mesh-list
20468454|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468455|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20468456|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621207|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621208|NCT02299232|Analgesics|analgesics|mesh-ancestor
20621209|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
20621210|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695614|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
20224796|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224797|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224798|NCT00337090|Urological Agents|urological agents|mesh-ancestor
20224799|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20224800|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224801|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
20224802|NCT00337246|Rituximab|rituximab|mesh-list
20224803|NCT00337246|Fludarabine|fludarabine|mesh-list
20224804|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
20224805|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
20621211|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20621212|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20621213|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20621214|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621215|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621216|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409337|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409338|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
19409339|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409340|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19409341|NCT03559673|Lacosamide|lacosamide|mesh-list
19409342|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
19409343|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19409344|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19409345|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409346|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409347|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
19409348|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409349|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
19409350|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695615|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19695616|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621217|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20621218|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20621219|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20621220|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
20621221|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621222|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20621223|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20468457|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468458|NCT01473069|Ketoconazole|ketoconazole|mesh-list
20468459|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
20468460|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468461|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20468462|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20468463|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468464|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468465|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20468466|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
20468467|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468468|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468469|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20468470|NCT01473147|Exenatide|exenatide|mesh-list
20468471|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20468472|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468473|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20468474|NCT01473147|Incretins|incretins|mesh-ancestor
20468475|NCT01473147|Hormones|hormones|mesh-ancestor
20468476|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468477|NCT01473173|Esomeprazole|esomeprazole|mesh-list
20468478|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20621224|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621225|NCT02299271|Ropivacaine|ropivacaine|mesh-list
20621226|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
20621227|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
19695617|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850079|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850080|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850081|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19850082|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
20468479|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20621228|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695618|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19695619|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19695620|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19695621|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
19695622|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695623|NCT04947956|Apatinib|apatinib|mesh-list
19695624|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695625|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20468480|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20468481|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468482|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468483|NCT01473251|Bevacizumab|bevacizumab|mesh-list
20468484|NCT01473251|Ranibizumab|ranibizumab|mesh-list
20468485|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468486|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468487|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20468488|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20468489|NCT01473251|Growth Substances|growth substances|mesh-ancestor
20468490|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468491|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
20468492|NCT01473277|Triamcinolone|triamcinolone|mesh-list
20468493|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20468494|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20468495|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20468496|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20468497|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20468498|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
20468499|NCT01473277|Hormones|hormones|mesh-ancestor
20468500|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621229|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621230|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
19695626|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695627|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695628|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
19695629|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
19695630|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19695631|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19695632|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695633|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695634|NCT04948151|Urological Agents|urological agents|mesh-ancestor
19695635|NCT04947826|Antibodies|antibodies|mesh-list
19695636|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
19695637|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
19695638|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468501|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468502|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468503|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
20468504|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468505|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468506|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20468507|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20468508|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
20468509|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468510|NCT01473303|Leucovorin|leucovorin|mesh-list
20468511|NCT01473303|Fluorouracil|fluorouracil|mesh-list
20468512|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
20468513|NCT01473303|Irinotecan|irinotecan|mesh-list
20468514|NCT01473303|Calcium|calcium|mesh-list
20468515|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
20468516|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20468517|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468518|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
20468519|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468520|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468521|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468522|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468523|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
20468524|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20468525|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20468526|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468527|NCT01473303|Antidotes|antidotes|mesh-ancestor
20468528|NCT01473303|Protective Agents|protective agents|mesh-ancestor
20468529|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
20468530|NCT01473303|Vitamins|vitamins|mesh-ancestor
19695639|NCT04947566|Ibuprofen|ibuprofen|mesh-list
19695640|NCT04947566|Naproxen|naproxen|mesh-list
19695641|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19695642|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695643|NCT04947566|Analgesics|analgesics|mesh-ancestor
19695644|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
19695645|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695646|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468531|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
20468532|NCT01473316|Ketoconazole|ketoconazole|mesh-list
20621231|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468533|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
20468534|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468535|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20468536|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20468537|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468538|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468539|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20468540|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
20621232|NCT02299310|Valsartan|valsartan|mesh-list
20621233|NCT02299310|Perindopril|perindopril|mesh-list
19409351|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416630|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19416631|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
19416632|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416633|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416634|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19416635|NCT02372578|Pregabalin|pregabalin|mesh-list
19416636|NCT02372578|Analgesics|analgesics|mesh-ancestor
19416637|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
20468541|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468542|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468543|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20468544|NCT01473472|Tenofovir|tenofovir|mesh-list
20468545|NCT01473472|Emtricitabine|emtricitabine|mesh-list
20468546|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20468547|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
20468548|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468549|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20468550|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20468551|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468552|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416638|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416639|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416640|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
20621234|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20621235|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20621236|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20621237|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621238|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20621239|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
20621240|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621241|NCT02299401|Misoprostol|misoprostol|mesh-list
20621242|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20621243|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
20621244|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20621245|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621246|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20621247|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20621248|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
20621249|NCT02299440|Ketamine|ketamine|mesh-list
20621250|NCT02299440|Analgesics|analgesics|mesh-ancestor
20468553|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20468554|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20468555|NCT01473537|Calcium|calcium|mesh-list
20468556|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20468557|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621251|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
20621252|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621253|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621254|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20621255|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20621256|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
20621257|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
20621258|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621259|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20621260|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20621261|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621262|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621263|NCT02299518|Cytarabine|cytarabine|mesh-list
20621264|NCT02299518|Etoposide|etoposide|mesh-list
20621265|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
20621266|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
19416641|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20224806|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224807|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
19409352|NCT03559504|Sevoflurane|sevoflurane|mesh-list
19409353|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19409354|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19409355|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
19409356|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
19409357|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409358|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409359|NCT03559413|Imiquimod|imiquimod|mesh-list
19409360|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
19409361|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695647|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224808|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224809|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224810|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20224811|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
20224812|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224813|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468558|NCT01473797|Cladribine|cladribine|mesh-list
20468559|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468560|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468561|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
20468562|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527074|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20527075|NCT01766089|Analgesics|analgesics|mesh-ancestor
20527076|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
20527077|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527078|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20527079|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20527080|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20527081|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
20527082|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527083|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527084|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20527085|NCT01766089|Narcotics|narcotics|mesh-ancestor
20527086|NCT01766154|Tirofiban|tirofiban|mesh-list
20224814|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20527087|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20527088|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20527089|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527090|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20527091|NCT01766180|Resveratrol|resveratrol|mesh-list
20527092|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
20527093|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527094|NCT01766180|Protective Agents|protective agents|mesh-ancestor
20527095|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527096|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527097|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20527098|NCT01766258|Carbidopa|carbidopa|mesh-list
20527099|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20527100|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20527101|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
20527102|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527103|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527104|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527105|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20527106|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527107|NCT01766323|Modafinil|modafinil|mesh-list
20527108|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20527109|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527110|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20527111|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20527112|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20527113|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527114|NCT01766375|Cyclosporine|cyclosporine|mesh-list
20527115|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
20527116|NCT01766375|Methotrexate|methotrexate|mesh-list
20527117|NCT01766375|Cyclosporins|cyclosporins|mesh-list
20527118|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20527119|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
20527120|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20527121|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621267|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20621268|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621269|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20621270|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20621271|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621272|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621273|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20621274|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
20621275|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
20621276|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409362|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19409363|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409364|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
19409365|NCT03559387|Sargramostim|sargramostim|mesh-list
19409366|NCT03559387|Lenograstim|lenograstim|mesh-list
19409367|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
19409368|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409369|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20468563|NCT01473810|Endocine|endocine|mesh-list
20468564|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20468565|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
20468566|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468567|NCT01473901|Temozolomide|temozolomide|mesh-list
20468568|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20468569|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
20468570|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409370|NCT03559348|Leucovorin|leucovorin|mesh-list
19409371|NCT03559348|Gemcitabine|gemcitabine|mesh-list
19409372|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19409373|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
19409374|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409375|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409376|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
19409377|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409378|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409379|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409380|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
19409381|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409382|NCT03559348|Antidotes|antidotes|mesh-ancestor
19409383|NCT03559348|Protective Agents|protective agents|mesh-ancestor
19409384|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
19409385|NCT03559348|Vitamins|vitamins|mesh-ancestor
19409386|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
20468571|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468572|NCT01473914|Vitamins|vitamins|mesh-list
20468573|NCT01473914|Vitamin E|vitamin e|mesh-list
20468574|NCT01473914|Tocopherols|tocopherols|mesh-list
20468575|NCT01473914|Tocotrienols|tocotrienols|mesh-list
20468576|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
20468577|NCT01473914|Zinc|zinc|mesh-list
20468578|NCT01473914|Selenium|selenium|mesh-list
20468579|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
20468580|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468581|NCT01473914|Trace Elements|trace elements|mesh-ancestor
20468582|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
20468583|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468584|NCT01473914|Protective Agents|protective agents|mesh-ancestor
20468585|NCT01474174|Vaccines|vaccines|mesh-list
20468586|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
20468587|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468588|NCT01474187|Capecitabine|capecitabine|mesh-list
20621277|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621278|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
20621279|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409387|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19409388|NCT03559114|Dalteparin|dalteparin|mesh-list
19409389|NCT03559114|Tinzaparin|tinzaparin|mesh-list
20224815|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224816|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224817|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
20224818|NCT00337246|Analgesics|analgesics|mesh-ancestor
20224819|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
20224820|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224821|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20224822|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20224823|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224824|NCT00337259|Gemcitabine|gemcitabine|mesh-list
20468589|NCT01474187|Irinotecan|irinotecan|mesh-list
20468590|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468591|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
19695648|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695649|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20468592|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468593|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468594|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20468595|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20468596|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468597|NCT01474265|Varenicline|varenicline|mesh-list
20468598|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20468599|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20468600|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
20468601|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468602|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468603|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468604|NCT01474304|Acetaminophen|acetaminophen|mesh-list
20468605|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621280|NCT02299518|Analgesics|analgesics|mesh-ancestor
20621281|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
20621282|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621283|NCT02299557|Phenylephrine|phenylephrine|mesh-list
20621284|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
19695650|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695651|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468606|NCT01474304|Analgesics|analgesics|mesh-ancestor
20468607|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
20468608|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468609|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468610|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
20468611|NCT01474330|Pomalidomide|pomalidomide|mesh-list
20468612|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
20468613|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468614|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20468615|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20468616|NCT01474330|Growth Substances|growth substances|mesh-ancestor
20468617|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
20468618|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468619|NCT01474382|Phentolamine|phentolamine|mesh-list
20468620|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20468621|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20468622|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468623|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468624|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468625|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468626|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20468627|NCT01474460|Vitamin K|vitamin k|mesh-list
20468628|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
20468629|NCT01474460|Vitamins|vitamins|mesh-ancestor
20468630|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
20468631|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468632|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20468633|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20468634|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468635|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
20468636|NCT01474460|Coagulants|coagulants|mesh-ancestor
20468637|NCT01474473|Calpastatin|calpastatin|mesh-list
20468638|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20468639|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
20468640|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468641|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468642|NCT01474499|Sorbitol|sorbitol|mesh-list
20468643|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20468644|NCT01474499|Glycerol|glycerol|mesh-list
20621285|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19409390|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19409391|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
19409392|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19409393|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19409394|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409395|NCT03559049|Carboplatin|carboplatin|mesh-list
19409396|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
20468645|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20468646|NCT01474499|Protective Agents|protective agents|mesh-ancestor
20468647|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468648|NCT01474499|Cathartics|cathartics|mesh-ancestor
20621286|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20468649|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468650|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
20468651|NCT01474642|Capecitabine|capecitabine|mesh-list
20468652|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468653|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20468654|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
20468655|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468656|NCT01474902|Enoxaparin|enoxaparin|mesh-list
20468657|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
20468658|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20468659|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20468660|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468661|NCT01474967|Metformin|metformin|mesh-list
20468662|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20468663|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468664|NCT01475019|Orlistat|orlistat|mesh-list
20468665|NCT01475019|Sibutramine|sibutramine|mesh-list
20468666|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468667|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468668|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20468669|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20468670|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
20468671|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20468672|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
20468673|NCT01475032|Beclomethasone|beclomethasone|mesh-list
19409397|NCT03559049|Pemetrexed|pemetrexed|mesh-list
19409398|NCT03559049|Rucaparib|rucaparib|mesh-list
19409399|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468674|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
20468675|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20468676|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
20468677|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468678|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409400|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19409401|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409402|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409403|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19409404|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19409405|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19409406|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
20621287|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621288|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621289|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409407|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19409408|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
19409409|NCT03558919|Mirabegron|mirabegron|mesh-list
19409410|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19409411|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19409412|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
19409413|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695652|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
19695653|NCT04947423|Scopolamine|scopolamine|mesh-list
19695654|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19695655|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
19695656|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
19409414|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409415|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409416|NCT03558919|Urological Agents|urological agents|mesh-ancestor
19409417|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19409418|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19695657|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695658|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695659|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19695660|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
19695661|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19695662|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
19695663|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695664|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695665|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19695666|NCT04947267|Epinephrine|epinephrine|mesh-list
19695667|NCT04947267|Mepivacaine|mepivacaine|mesh-list
19695668|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20468679|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19695669|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19695670|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621290|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621291|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
20621292|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
20621293|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621294|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
20621295|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20621296|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
20621297|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20621298|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
20621299|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20621300|NCT02299557|Protective Agents|protective agents|mesh-ancestor
20621301|NCT02299687|Omeprazole|omeprazole|mesh-list
20621302|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20621303|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20621304|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20621305|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621306|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621307|NCT02299726|Spironolactone|spironolactone|mesh-list
20468680|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
20468681|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20468682|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20468683|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20468684|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468685|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468686|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468687|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621308|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20621309|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
20621310|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621311|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621312|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20621313|NCT02299726|Diuretics|diuretics|mesh-ancestor
20621314|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
20621315|NCT02299765|Gemcitabine|gemcitabine|mesh-list
20621316|NCT02299765|Carboplatin|carboplatin|mesh-list
20621317|NCT02299765|Gefitinib|gefitinib|mesh-list
20621318|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621319|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20621320|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
20468688|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
20468689|NCT01475032|Hormones|hormones|mesh-ancestor
20468690|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468691|NCT01475227|Zinc|zinc|mesh-list
20468692|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
20468693|NCT01475227|Trace Elements|trace elements|mesh-ancestor
20468694|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
20468695|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468696|NCT01475227|Astringents|astringents|mesh-ancestor
20468697|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
20468698|NCT01475266|Apaziquone|apaziquone|mesh-list
20468699|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468700|NCT01475279|Warfarin|warfarin|mesh-list
20621321|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621322|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
20621323|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621324|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621325|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621326|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
20621327|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621328|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20621329|NCT02299817|Denosumab|denosumab|mesh-list
20621330|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20621331|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621332|NCT02299882|Vancomycin|vancomycin|mesh-list
20621333|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20621334|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621335|NCT02299908|Bupivacaine|bupivacaine|mesh-list
20468701|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
20468702|NCT01475318|Letrozole|letrozole|mesh-list
20621336|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
20621337|NCT02299908|Anesthetics|anesthetics|mesh-list
20468703|NCT01475318|Misoprostol|misoprostol|mesh-list
20468704|NCT01475318|Mifepristone|mifepristone|mesh-list
20468705|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468706|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20468707|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20621338|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20621339|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621340|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621341|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
20621342|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409419|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19409420|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468708|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468709|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468710|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20468711|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
20468712|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468713|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468714|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20468715|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
20468716|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20468717|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20468718|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468719|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
20468720|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20468721|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20468722|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20468723|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20468724|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
20468725|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20224825|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224826|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
20224827|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468726|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20468727|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
20468728|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20468729|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20468730|NCT01475552|Aspirin|aspirin|mesh-list
20468731|NCT01475552|Abciximab|abciximab|mesh-list
20468732|NCT01475552|Clopidogrel|clopidogrel|mesh-list
19409421|NCT03558880|Anesthetics|anesthetics|mesh-list
19409422|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409423|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409424|NCT03558867|Metformin|metformin|mesh-list
19409425|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19409426|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468733|NCT01475552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20468734|NCT01475552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468735|NCT01475552|Analgesics|analgesics|mesh-ancestor
20468736|NCT01475552|Sensory System Agents|sensory system agents|mesh-ancestor
20468737|NCT01475552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468738|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468739|NCT01475552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20468740|NCT01475552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20468741|NCT01475552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20468742|NCT01475552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20468743|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468744|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20468745|NCT01475552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20468746|NCT01475552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468747|NCT01475552|Antipyretics|antipyretics|mesh-ancestor
20468748|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20468749|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20468750|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20468751|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
20468752|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468753|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
20468754|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
20621343|NCT02300038|Lidocaine|lidocaine|mesh-list
20621344|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
20224828|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621345|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
20621346|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621347|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224829|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
20621348|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
19409427|NCT03558750|Rituximab|rituximab|mesh-list
20224830|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224831|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224832|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224833|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
20468755|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
20468756|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20468757|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20468758|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468759|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468760|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621349|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621350|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20621351|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20621352|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20621353|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20621354|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621355|NCT02300064|Antioxidants|antioxidants|mesh-list
20621356|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409428|NCT03558750|Nivolumab|nivolumab|mesh-list
19409429|NCT03558750|Lenalidomide|lenalidomide|mesh-list
19409430|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468761|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409431|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409432|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
19409433|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468762|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
20468763|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
20468764|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
20468765|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
20468766|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
20468767|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
20468768|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
20468769|NCT01475617|Calcium|calcium|mesh-list
20468770|NCT01475617|Vitamins|vitamins|mesh-ancestor
20468771|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
20468772|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468773|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20468774|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20468775|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
20468776|NCT01475617|Hematinics|hematinics|mesh-ancestor
20468777|NCT01475656|Levetiracetam|levetiracetam|mesh-list
20468778|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
20468779|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
20468780|NCT01475708|Doxycycline|doxycycline|mesh-list
20468781|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20468782|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409434|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19409435|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19409436|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468783|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
20468784|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20468785|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20468786|NCT01475760|Chitosan|chitosan|mesh-list
20468787|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20468788|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20468789|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
19409437|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19409438|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19409439|NCT03558750|Growth Substances|growth substances|mesh-ancestor
19409440|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
19409441|NCT03558477|Esomeprazole|esomeprazole|mesh-list
19409442|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19409443|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20621357|NCT02300064|Protective Agents|protective agents|mesh-ancestor
20621358|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621359|NCT02300194|Morphine|morphine|mesh-list
20621360|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20621361|NCT02300194|Narcotics|narcotics|mesh-ancestor
19409444|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19409445|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409446|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409447|NCT03558412|Decitabine|decitabine|mesh-list
19409448|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19409449|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
19409450|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409451|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468790|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468791|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20468792|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
20468793|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
19409452|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409453|NCT03558295|Anticoagulants|anticoagulants|mesh-list
19409454|NCT03558243|Hemostatics|hemostatics|mesh-list
19409455|NCT03558243|Coagulants|coagulants|mesh-ancestor
19409456|NCT03558139|Avelumab|avelumab|mesh-list
19409457|NCT03558139|Magrolimab|magrolimab|mesh-list
20468794|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
20621362|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621363|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621364|NCT02300194|Analgesics|analgesics|mesh-ancestor
20621365|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
20621366|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621367|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20621368|NCT02300350|Digoxin|digoxin|mesh-list
20621369|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20621370|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20621371|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621372|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621373|NCT02300350|Protective Agents|protective agents|mesh-ancestor
20621374|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621375|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20621376|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621377|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20621378|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20621379|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20468795|NCT01475760|Coagulants|coagulants|mesh-ancestor
20527122|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20527123|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
20527124|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527125|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527126|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
20527127|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527128|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20527129|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527130|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
20527131|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527132|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20527133|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
20527134|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527135|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20527136|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20621380|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20621381|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
20621382|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621383|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20621384|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20621385|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621386|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20621387|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621388|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621389|NCT02300376|Edetic Acid|edetic acid|mesh-list
20621390|NCT02300376|Calcium|calcium|mesh-list
20621391|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
20621392|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20621393|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621394|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
20621395|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20621396|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
20621397|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
20621398|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527137|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20527138|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
20527139|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527140|NCT01766414|Complement C1s|complement c1s|mesh-list
20527141|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20527142|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20527143|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
20527144|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527145|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19409458|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19409459|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409460|NCT03557996|Listerine|listerine|mesh-list
20468796|NCT01475877|Bromfenac|bromfenac|mesh-list
20468797|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20468798|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468799|NCT01475877|Analgesics|analgesics|mesh-ancestor
20468800|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
20468801|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468802|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468803|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20468804|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20468805|NCT01475890|Vitamin D|vitamin d|mesh-list
20468806|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
20468807|NCT01475890|Vitamins|vitamins|mesh-ancestor
20468808|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
20468809|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468810|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20468811|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20468812|NCT01476007|Vitamins|vitamins|mesh-list
20468813|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
20468814|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
20621399|NCT02300376|Antidotes|antidotes|mesh-ancestor
20621400|NCT02300376|Protective Agents|protective agents|mesh-ancestor
20621401|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20621402|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
20468815|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
20468816|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
20468817|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468818|NCT01476007|Hematinics|hematinics|mesh-ancestor
20468819|NCT01476124|Morphine|morphine|mesh-list
20468820|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20468821|NCT01476124|Narcotics|narcotics|mesh-ancestor
20468822|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20468823|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621403|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
20621404|NCT02300428|Trace Elements|trace elements|mesh-ancestor
20621405|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
20621406|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621407|NCT02300428|Hematinics|hematinics|mesh-ancestor
20621408|NCT02300623|Lamivudine|lamivudine|mesh-list
20468824|NCT01476124|Analgesics|analgesics|mesh-ancestor
20468825|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
20468826|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468827|NCT01476137|Trametinib|trametinib|mesh-list
20468828|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468829|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20468830|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468831|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468832|NCT01476176|Acetaminophen|acetaminophen|mesh-list
20468833|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468834|NCT01476176|Analgesics|analgesics|mesh-ancestor
20468835|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
20468836|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409461|NCT03557996|Fluorides|fluorides|mesh-list
19409462|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
19409463|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
19409464|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
19409465|NCT03557996|Protective Agents|protective agents|mesh-ancestor
19409466|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409467|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19409468|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409469|NCT03557983|Fenofibrate|fenofibrate|mesh-list
19409470|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19409471|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
19409472|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409473|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19409474|NCT03557853|Golimumab|golimumab|mesh-list
20468837|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468838|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
20468839|NCT01476189|Acetaminophen|acetaminophen|mesh-list
20468840|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468841|NCT01476189|Analgesics|analgesics|mesh-ancestor
20468842|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
19409475|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19409476|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20468843|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409477|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468844|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468845|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
20468846|NCT01476215|Acetaminophen|acetaminophen|mesh-list
20621409|NCT02300623|Stavudine|stavudine|mesh-list
20621410|NCT02300623|Indinavir|indinavir|mesh-list
19409478|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
19409479|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621411|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20621412|NCT02300623|Interleukin-2|interleukin-2|mesh-list
20621413|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20621414|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20621415|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621416|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468847|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20468848|NCT01476215|Analgesics|analgesics|mesh-ancestor
20621417|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
20621418|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621419|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20621420|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621421|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621422|NCT02300623|Analgesics|analgesics|mesh-ancestor
20621423|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
20621424|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621425|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621426|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
20621427|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20621428|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19416642|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416643|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416644|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19416645|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19416646|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19416647|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416648|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19416649|NCT02365649|Upadacitinib|upadacitinib|mesh-list
19416650|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20621429|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
20621430|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
20621431|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19416651|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19416652|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416653|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416654|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416655|NCT02358538|Ganaxolone|ganaxolone|mesh-list
19416656|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
19416657|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416658|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416659|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695671|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621432|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621433|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621434|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621435|NCT02300649|Analgesics|analgesics|mesh-ancestor
20468849|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
20468850|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468851|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468852|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
20468853|NCT01476280|Palonosetron|palonosetron|mesh-list
20468854|NCT01476280|Ramosetron|ramosetron|mesh-list
20468855|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
20468856|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
20468857|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468858|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468859|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468860|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20468861|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20468862|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
20468863|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468864|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468865|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20468866|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20468867|NCT01476358|Vitamin A|vitamin a|mesh-list
20468868|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
20468869|NCT01476358|Vitamins|vitamins|mesh-ancestor
20468870|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
20621436|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
19409483|NCT03557580|Isosorbide|isosorbide|mesh-list
19409484|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19409485|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19409486|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19409487|NCT03557580|Diuretics|diuretics|mesh-ancestor
19409488|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
20621437|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621438|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20621439|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20621440|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20621441|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621442|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621443|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621444|NCT02300688|Maleic acid|maleic acid|mesh-list
20621445|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621446|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621447|NCT02300701|Omalizumab|omalizumab|mesh-list
20621448|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20621449|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20621450|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
20468871|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468872|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
20468873|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409489|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409490|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
19409491|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19409492|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409493|NCT03557437|Amoxicillin|amoxicillin|mesh-list
19409494|NCT03557437|Metronidazole|metronidazole|mesh-list
19409495|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
19409496|NCT03557437|Esomeprazole|esomeprazole|mesh-list
19409497|NCT03557437|Bismuth|bismuth|mesh-list
19409498|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409499|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19409500|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409501|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19409502|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19409503|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19409504|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409505|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19409506|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409507|NCT03557437|Antacids|antacids|mesh-ancestor
19850083|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20468874|NCT01476358|Protective Agents|protective agents|mesh-ancestor
20468875|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20468876|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468877|NCT01476410|Doxorubicin|doxorubicin|mesh-list
20468878|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20468879|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20468880|NCT01476410|Dacarbazine|dacarbazine|mesh-list
20468881|NCT01476410|Vinblastine|vinblastine|mesh-list
20468882|NCT01476410|Antibodies|antibodies|mesh-list
20468883|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
20468884|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20468885|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
20468886|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20468887|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
20468888|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409508|NCT03557437|Diuretics|diuretics|mesh-ancestor
19409509|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
19409510|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468889|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20621451|NCT02300740|Niacinamide|niacinamide|mesh-list
20621452|NCT02300740|Niacin|niacin|mesh-list
20468890|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468891|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20468892|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20468893|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468894|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468895|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468896|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20468897|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
20468898|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20468899|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20468900|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
20621453|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
20621454|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
20621455|NCT02300740|Vitamins|vitamins|mesh-ancestor
20621456|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
20621457|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621458|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20621459|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
20621460|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621461|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20621462|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
19409511|NCT03557437|Expectorants|expectorants|mesh-ancestor
19409512|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
19409513|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
19409514|NCT03557424|Cathartics|cathartics|mesh-ancestor
19409515|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409516|NCT03557255|Simendan|simendan|mesh-list
19409517|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20224834|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224835|NCT00337298|Amlodipine|amlodipine|mesh-list
20224836|NCT00337298|Lisinopril|lisinopril|mesh-list
20224837|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20224838|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20224839|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20224840|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224841|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20224842|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224843|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
20224844|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20224845|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
20224846|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224847|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20224848|NCT00337298|Protective Agents|protective agents|mesh-ancestor
20224849|NCT00337376|Sirolimus|sirolimus|mesh-list
20224850|NCT00337376|Paclitaxel|paclitaxel|mesh-list
20224851|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20224852|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20224853|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224854|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
20224855|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
20224856|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
20224857|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224858|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224859|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224860|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20224861|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
20224862|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224863|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
20224864|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224865|NCT00337389|Leucovorin|leucovorin|mesh-list
20224866|NCT00337389|Bevacizumab|bevacizumab|mesh-list
20224867|NCT00337389|Fluorouracil|fluorouracil|mesh-list
20224868|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224869|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224870|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20224871|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20224872|NCT00337389|Growth Substances|growth substances|mesh-ancestor
20224873|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224874|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
20224875|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
20224876|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621463|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20621464|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20621465|NCT02300922|Antibodies|antibodies|mesh-list
20621466|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
19409518|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
19409519|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19409520|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19409521|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409522|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409523|NCT03557255|Protective Agents|protective agents|mesh-ancestor
19409524|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409525|NCT03557229|Vitamins|vitamins|mesh-list
19409526|NCT03557229|Ascorbic Acid|ascorbic acid|mesh-list
19409527|NCT03557229|Vitamin E|vitamin e|mesh-list
19409528|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
20224877|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20224878|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224879|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
20224880|NCT00337389|Antidotes|antidotes|mesh-ancestor
20224881|NCT00337389|Protective Agents|protective agents|mesh-ancestor
20468901|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
20468902|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
20468903|NCT01476488|Tacrolimus|tacrolimus|mesh-list
20468904|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468905|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
20468906|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468907|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20468908|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468909|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468910|NCT01476501|Vitamin D|vitamin d|mesh-list
20468911|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
20468912|NCT01476501|Vitamins|vitamins|mesh-ancestor
20468913|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
20468914|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468915|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20468916|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20468917|NCT01476592|Resveratrol|resveratrol|mesh-list
20468918|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
20468919|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468920|NCT01476592|Protective Agents|protective agents|mesh-ancestor
20468921|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468922|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468923|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20224882|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
20224883|NCT00337389|Vitamins|vitamins|mesh-ancestor
19695672|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695673|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695674|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19695675|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19695676|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
19695677|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695678|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20468924|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
20468925|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20468926|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20468927|NCT01476683|Racecadotril|racecadotril|mesh-list
20468928|NCT01476683|Thiorphan|thiorphan|mesh-list
20468929|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
20468930|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20468931|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
20468932|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468933|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468934|NCT01476774|Buprenorphine|buprenorphine|mesh-list
20468935|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20468936|NCT01476774|Narcotics|narcotics|mesh-ancestor
20468937|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20468938|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468939|NCT01476774|Analgesics|analgesics|mesh-ancestor
20468940|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
20468941|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20468942|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20468943|NCT01476787|Rituximab|rituximab|mesh-list
20468944|NCT01476787|Lenalidomide|lenalidomide|mesh-list
20468945|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19409529|NCT03557229|Melatonin|melatonin|mesh-list
20224884|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
20224885|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
20468946|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20468947|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468948|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
19695679|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
19695680|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
19695681|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
19695682|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19695683|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
20468949|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468950|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19409530|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19409531|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
19409532|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409533|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
19409534|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409535|NCT03557229|Protective Agents|protective agents|mesh-ancestor
19409536|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409537|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
19695684|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
20468951|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20468952|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20468953|NCT01476787|Growth Substances|growth substances|mesh-ancestor
20468954|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
20468955|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20468956|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
20468957|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468958|NCT01476800|Ketoconazole|ketoconazole|mesh-list
20468959|NCT01476800|Mirabegron|mirabegron|mesh-list
20468960|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
20468961|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20468962|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20468963|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20468964|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20468965|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468966|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20468967|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
20468968|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20468969|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468970|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20468971|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20468972|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20468973|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20468974|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
20468975|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468976|NCT01476800|Urological Agents|urological agents|mesh-ancestor
20468977|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
20468978|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20468979|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20468980|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20468981|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
20468982|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20468983|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468984|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468985|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
20468986|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20468987|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
20468988|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20468989|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20468990|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20468991|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
20468992|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20468993|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20468994|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20468995|NCT01477034|Vitamin D|vitamin d|mesh-list
20468996|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
20468997|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
20468998|NCT01477034|Vitamins|vitamins|mesh-list
20468999|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
20469000|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469001|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20469002|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469003|NCT01477060|Metformin|metformin|mesh-list
20469004|NCT01477060|Lapatinib|lapatinib|mesh-list
20469005|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20469006|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469007|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621467|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621468|NCT02300935|Paclitaxel|paclitaxel|mesh-list
20621469|NCT02300935|Trametinib|trametinib|mesh-list
20621470|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20621471|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621472|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
20621473|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
19409538|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409539|NCT03557229|Expectorants|expectorants|mesh-ancestor
19409540|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
19409541|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19409542|NCT03557229|Antidotes|antidotes|mesh-ancestor
19409543|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
19409544|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409545|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19409546|NCT03556917|Caffeine|caffeine|mesh-list
20621474|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
20621475|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621476|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20621477|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621478|NCT02300948|Folic Acid|folic acid|mesh-list
20621479|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
20621480|NCT02300948|Hematinics|hematinics|mesh-ancestor
20621481|NCT02300948|Vitamins|vitamins|mesh-ancestor
19409547|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19409548|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409549|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19409550|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409551|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409552|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19409553|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19409554|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
19409555|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409556|NCT03556852|Misoprostol|misoprostol|mesh-list
20469008|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20469009|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469010|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469011|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20469012|NCT01477073|Hormones|hormones|mesh-ancestor
20469013|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469014|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469015|NCT01477112|Beta Carotene|beta carotene|mesh-list
20469016|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469017|NCT01477112|Provitamins|provitamins|mesh-ancestor
20469018|NCT01477112|Vitamins|vitamins|mesh-ancestor
20469019|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
20469020|NCT01477151|Anesthetics|anesthetics|mesh-list
20469021|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20469022|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469023|NCT01477190|Morphine|morphine|mesh-list
20469024|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20469025|NCT01477190|Narcotics|narcotics|mesh-ancestor
20469026|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20469027|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469028|NCT01477190|Analgesics|analgesics|mesh-ancestor
20469029|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
20469030|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469031|NCT01477203|Citalopram|citalopram|mesh-list
20469032|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20469033|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20469034|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469035|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469036|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469037|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
20469038|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469039|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20469040|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
20469041|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469042|NCT01477242|Ondansetron|ondansetron|mesh-list
20621482|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
19409557|NCT03556852|Carbetocin|carbetocin|mesh-list
19409558|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19409559|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
20469043|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
20469044|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
20621483|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469045|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469046|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469047|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469048|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
20469049|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
20469050|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20469051|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
20469052|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469053|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469054|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20469055|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20469056|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20469057|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469058|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20469059|NCT01477268|Sertraline|sertraline|mesh-list
20469060|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
20469061|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469062|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20469063|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20469064|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469065|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469066|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469067|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
20469068|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469069|NCT01477294|Caffeine|caffeine|mesh-list
20469070|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20469071|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469072|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20469073|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409560|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19409561|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409562|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19409563|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409564|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
20469074|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469075|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20469076|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20469077|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
20469078|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469079|NCT01477385|Fluorides|fluorides|mesh-list
20469080|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
20469081|NCT01477385|Protective Agents|protective agents|mesh-ancestor
20469082|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527146|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527147|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
20527148|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19409565|NCT03556839|Paclitaxel|paclitaxel|mesh-list
19409566|NCT03556839|Bevacizumab|bevacizumab|mesh-list
19409567|NCT03556839|Carboplatin|carboplatin|mesh-list
19409568|NCT03556839|Atezolizumab|atezolizumab|mesh-list
20224886|NCT00337441|Hematinics|hematinics|mesh-ancestor
20224887|NCT00337493|Cyclosporine|cyclosporine|mesh-list
20224888|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
20224889|NCT00337493|Tacrolimus|tacrolimus|mesh-list
20224890|NCT00337493|Cyclosporins|cyclosporins|mesh-list
20224891|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224892|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
20224893|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224894|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20224895|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224896|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527149|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527150|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20527151|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
20527152|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527153|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527154|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224897|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
20224898|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224899|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
20224900|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20224901|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20224902|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621484|NCT02301000|Metronidazole|metronidazole|mesh-list
20224903|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20224904|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
20469083|NCT01477411|Digoxin|digoxin|mesh-list
20469084|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20469085|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20224905|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20224906|NCT00337506|Dexamethasone|dexamethasone|mesh-list
20224907|NCT00337506|Bortezomib|bortezomib|mesh-list
20224908|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224909|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
20224910|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
19409569|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19409570|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409571|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
19409572|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19409573|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19409574|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409575|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19409576|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19409577|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19409578|NCT03556839|Growth Substances|growth substances|mesh-ancestor
19409579|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224911|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469086|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469087|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469088|NCT01477411|Protective Agents|protective agents|mesh-ancestor
20469089|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469090|NCT01477424|Warfarin|warfarin|mesh-list
20469091|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
20469092|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20469093|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469094|NCT01477489|Veliparib|veliparib|mesh-list
20469095|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20469096|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469097|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469098|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469099|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20469100|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20469101|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
20469102|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469103|NCT01477580|Antacids|antacids|mesh-ancestor
19409580|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
19409581|NCT03556592|Metoprolol|metoprolol|mesh-list
19409582|NCT03556592|Midazolam|midazolam|mesh-list
19409583|NCT03556592|Caffeine|caffeine|mesh-list
20469104|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469105|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469106|NCT01477606|Cytarabine|cytarabine|mesh-list
20469107|NCT01477606|Daunorubicin|daunorubicin|mesh-list
20469108|NCT01477606|Midostaurin|midostaurin|mesh-list
20469109|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20469110|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
20469111|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469112|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469113|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
20469114|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409584|NCT03556592|Omeprazole|omeprazole|mesh-list
19409585|NCT03556592|Warfarin|warfarin|mesh-list
19409586|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19409587|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19409588|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409589|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409590|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19409591|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19409592|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19409593|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19409594|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
19409595|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
19409596|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
19409597|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
19409598|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409599|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409600|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
19409601|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19850084|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20224912|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469115|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409602|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409603|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20469116|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
20469117|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469118|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19850085|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20469119|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20469120|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20469121|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469122|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20469123|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20469124|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20469125|NCT01477632|Norethindrone|norethindrone|mesh-list
20469126|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
20469127|NCT01477632|Estradiol|estradiol|mesh-list
20469128|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20469129|NCT01477632|Estrogens|estrogens|mesh-ancestor
20469130|NCT01477632|Hormones|hormones|mesh-ancestor
20469131|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469132|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469133|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20469134|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
20469135|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20469136|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20469137|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20469138|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20469139|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20469140|NCT01477736|Oxybutynin|oxybutynin|mesh-list
20469141|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
20469142|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20469143|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20469144|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20469145|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469146|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469147|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
20469148|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469149|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469150|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20469151|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469152|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
20469153|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
20469154|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20469155|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20469156|NCT01477736|Urological Agents|urological agents|mesh-ancestor
20469157|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
20469158|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469159|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469160|NCT01477801|Vitamins|vitamins|mesh-ancestor
20469161|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
20469162|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19409604|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409605|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19409606|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19409607|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19409608|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19409609|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
19409610|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19409611|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20224913|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20224914|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
20224915|NCT00337506|Hormones|hormones|mesh-ancestor
20224916|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224917|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20224918|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224919|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
20224920|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224921|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224922|NCT00337545|Everolimus|everolimus|mesh-list
20469163|NCT01477840|Misoprostol|misoprostol|mesh-list
19409612|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
19409613|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
19409614|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409615|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19409616|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19850086|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
20224923|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409617|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20469164|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20469165|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
20469166|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20469167|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469168|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20469169|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469170|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
20469171|NCT01477931|Bupropion|bupropion|mesh-list
20469172|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20469173|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
20469174|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469175|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20469176|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20469177|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469178|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469179|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
20469180|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469181|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469182|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20469183|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20469184|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469185|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20469186|NCT01477983|Flecainide|flecainide|mesh-list
20469187|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20469188|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19409618|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
19409619|NCT03556384|Temozolomide|temozolomide|mesh-list
19409620|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19409621|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
19409622|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409623|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695685|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224924|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20224925|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
20224926|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224927|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
20224928|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20224929|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20224930|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
20224931|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224932|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224933|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224934|NCT00337558|Urological Agents|urological agents|mesh-ancestor
20224935|NCT00337623|Prednisolone|prednisolone|mesh-list
20224936|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20224937|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
20224938|NCT00337623|Hormones|hormones|mesh-ancestor
20224939|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20224940|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224941|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20224942|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224943|NCT00337649|Trastuzumab|trastuzumab|mesh-list
20224944|NCT00337649|Epothilones|epothilones|mesh-list
20224945|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
20224946|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20224947|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20224948|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
20224949|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
20224950|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
20224951|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224952|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
20224953|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20224954|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20224955|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224956|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20224957|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20224958|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
20224959|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20224960|NCT00337740|Propranolol|propranolol|mesh-list
20224961|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20224962|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20469189|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469190|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469191|NCT01478022|Ibuprofen|ibuprofen|mesh-list
19409624|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
19409625|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19409626|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
19409627|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409628|NCT03556371|Expectorants|expectorants|mesh-ancestor
19409629|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
19695686|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
19695687|NCT04947111|Antibodies|antibodies|mesh-list
19695688|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
19695689|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
19695690|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
19695691|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469192|NCT01478022|Isosorbide|isosorbide|mesh-list
20469193|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20469194|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19409630|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19409631|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
19409632|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409633|NCT03556371|Protective Agents|protective agents|mesh-ancestor
19409634|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409635|NCT03556371|Antidotes|antidotes|mesh-ancestor
19409636|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
19409637|NCT03556098|Hormones|hormones|mesh-list
19409638|NCT03556098|Incretins|incretins|mesh-list
19409639|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409640|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409641|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469195|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20469196|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20469197|NCT01478022|Analgesics|analgesics|mesh-ancestor
20469198|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
20469199|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469200|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469201|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469202|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469203|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20469204|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469205|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469206|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20469207|NCT01478022|Diuretics|diuretics|mesh-ancestor
20621485|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621486|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19409642|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
19409643|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19409644|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409645|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19409646|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409647|NCT03555994|Liraglutide|liraglutide|mesh-list
19409648|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19409649|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409650|NCT03555994|Incretins|incretins|mesh-ancestor
20621487|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20621488|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19409651|NCT03555994|Hormones|hormones|mesh-ancestor
19409652|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409653|NCT03555929|Dexamethasone|dexamethasone|mesh-list
19409654|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19409655|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
19409656|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
19409657|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409658|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409659|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409660|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
19409661|NCT03555929|Hormones|hormones|mesh-ancestor
19409662|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409663|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19409664|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409665|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19409666|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19695692|NCT04946929|Heparin|heparin|mesh-list
19695693|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19695694|NCT04946929|Tinzaparin|tinzaparin|mesh-list
19695695|NCT04946929|Dalteparin|dalteparin|mesh-list
19695696|NCT04946929|Ticagrelor|ticagrelor|mesh-list
19695697|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
20469208|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
20469209|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
20469210|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20469211|NCT01478035|Phenytoin|phenytoin|mesh-list
20469212|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
20469213|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20469214|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20469215|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469216|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469217|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20469218|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20469219|NCT01478074|Cytarabine|cytarabine|mesh-list
19695698|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19695699|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19695700|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695701|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19695702|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19695703|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19695704|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19695705|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
19695706|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695707|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695708|NCT04947345|Propofol|propofol|mesh-list
20469220|NCT01478074|Fludarabine|fludarabine|mesh-list
20469221|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469222|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20469223|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
20469224|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469225|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409667|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409668|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224963|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
20224964|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224965|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224966|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224967|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20224968|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19409669|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19409670|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409671|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409672|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
19409673|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224969|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
20224970|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20224971|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
20224972|NCT00337766|Coagulants|coagulants|mesh-ancestor
20224973|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20224974|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
20224975|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224976|NCT00337792|Fentanyl|fentanyl|mesh-list
20224977|NCT00337792|Midazolam|midazolam|mesh-list
20224978|NCT00337792|Oxycodone|oxycodone|mesh-list
20621489|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20621490|NCT02301026|Hematinics|hematinics|mesh-ancestor
20621491|NCT02301091|Mitomycins|mitomycins|mesh-list
20621492|NCT02301091|Mitomycin|mitomycin|mesh-list
19416660|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
19416661|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
19416662|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20621493|NCT02301091|Pirarubicin|pirarubicin|mesh-list
19416663|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416664|NCT02342249|Oseltamivir|oseltamivir|mesh-list
19416665|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
19416666|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416667|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416668|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416669|NCT02339129|Ibuprofen|ibuprofen|mesh-list
19416670|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416671|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695709|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20224979|NCT00337792|Lorazepam|lorazepam|mesh-list
20224980|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20224981|NCT00337792|Narcotics|narcotics|mesh-ancestor
20469226|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
20469227|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469228|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
20469229|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469230|NCT01478165|Palonosetron|palonosetron|mesh-list
20469231|NCT01478165|Anesthetics|anesthetics|mesh-list
20469232|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20469233|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469234|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
20469235|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
20469236|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469237|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469238|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20469239|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20469240|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
20469241|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469242|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469243|NCT01478230|Nicotine|nicotine|mesh-list
20469244|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20469245|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
20469246|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469247|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469248|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20469249|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20469250|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
20469251|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469252|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469253|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
20469254|NCT01478282|Dabigatran|dabigatran|mesh-list
20469255|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20469256|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
20469257|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20469258|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
20469259|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469260|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469261|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
20469262|NCT01478308|Metformin|metformin|mesh-list
20469263|NCT01478308|Prednisone|prednisone|mesh-list
20469264|NCT01478308|Docetaxel|docetaxel|mesh-list
20469265|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20469266|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469267|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469268|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
20469269|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
20469270|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
20469271|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469272|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469273|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
20469274|NCT01478308|Hormones|hormones|mesh-ancestor
20469275|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469276|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20469277|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
20469278|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20469279|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
20469280|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469281|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
20469282|NCT01478386|Protective Agents|protective agents|mesh-ancestor
20469283|NCT01478490|Metoprolol|metoprolol|mesh-list
20469284|NCT01478490|Mirabegron|mirabegron|mesh-list
20469285|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20469286|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19409674|NCT03555617|Itraconazole|itraconazole|mesh-list
19409675|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
19409676|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409677|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19409678|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19409679|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409680|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409681|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19409682|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
19409683|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409684|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409685|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20469287|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
20621494|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20469288|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
20469289|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469290|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469291|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20469292|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20469293|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20469294|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
20469295|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469296|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469297|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20469298|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20469299|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20469300|NCT01478490|Urological Agents|urological agents|mesh-ancestor
20469301|NCT01478503|Mirabegron|mirabegron|mesh-list
19409686|NCT03555526|Amoxicillin|amoxicillin|mesh-list
19409687|NCT03555526|Metronidazole|metronidazole|mesh-list
19409688|NCT03555526|Clarithromycin|clarithromycin|mesh-list
19409689|NCT03555526|Levofloxacin|levofloxacin|mesh-list
19409690|NCT03555526|Ofloxacin|ofloxacin|mesh-list
19409691|NCT03555526|Tetracycline|tetracycline|mesh-list
19409692|NCT03555526|Esomeprazole|esomeprazole|mesh-list
19409693|NCT03555526|Bismuth|bismuth|mesh-list
19409694|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19409695|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409696|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19409697|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19409698|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19409699|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409700|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19409701|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409702|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409703|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19409704|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19409705|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20621495|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621496|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
20621497|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621498|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20621499|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621500|NCT02301130|Durvalumab|durvalumab|mesh-list
20621501|NCT02301130|Tremelimumab|tremelimumab|mesh-list
20621502|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
20621503|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20621504|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621505|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621506|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
20621507|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621508|NCT02301208|Nedaplatin|nedaplatin|mesh-list
19409706|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19409707|NCT03555526|Renal Agents|renal agents|mesh-ancestor
19409708|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19409709|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19409710|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409711|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19409712|NCT03555526|Antacids|antacids|mesh-ancestor
19409713|NCT03555487|Choline|choline|mesh-list
19409714|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
19409715|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19409716|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
19409717|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409718|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409719|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19409720|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
19409721|NCT03555383|Hemostatics|hemostatics|mesh-list
19409722|NCT03555383|Coagulants|coagulants|mesh-ancestor
19409723|NCT03555188|Ondansetron|ondansetron|mesh-list
19409724|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
19409725|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
19409726|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409727|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409728|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409729|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
19409730|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
19409731|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19409732|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
19409733|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621509|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621510|NCT02301221|Vancomycin|vancomycin|mesh-list
19850087|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850088|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850089|NCT00706966|Dutasteride|dutasteride|mesh-list
19850090|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20469302|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19409734|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409735|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19409736|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19409737|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409738|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19409739|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19409740|NCT03555136|Vortioxetine|vortioxetine|mesh-list
19409741|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
20469303|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20469304|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20469305|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
20469306|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469307|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469308|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469309|NCT01478503|Urological Agents|urological agents|mesh-ancestor
20469310|NCT01478529|Mirabegron|mirabegron|mesh-list
20469311|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20469312|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20469313|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20469314|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
20469315|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469316|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409742|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19409743|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19409744|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19409745|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409746|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409747|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19695710|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695711|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695712|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19695713|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
19695714|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
19695715|NCT04947189|Dexamethasone|dexamethasone|mesh-list
20469317|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469318|NCT01478529|Urological Agents|urological agents|mesh-ancestor
20469319|NCT01478568|Desipramine|desipramine|mesh-list
20469320|NCT01478568|Mirabegron|mirabegron|mesh-list
20469321|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20469322|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20469323|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20469324|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
19409748|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19409749|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409750|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409751|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409752|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
19409753|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19409754|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19409755|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19695716|NCT04947189|Docetaxel|docetaxel|mesh-list
19695717|NCT04947189|Seviteronel|seviteronel|mesh-list
19695718|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19695719|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
19695720|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
19695721|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850091|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19850092|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850093|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850094|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
19850095|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850096|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850097|NCT00706979|Nicotine|nicotine|mesh-list
19850098|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19850099|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
19850100|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850101|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469325|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469326|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469327|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469328|NCT01478568|Urological Agents|urological agents|mesh-ancestor
20469329|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20224982|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20224983|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20224984|NCT00337792|Analgesics|analgesics|mesh-ancestor
20224985|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
20469330|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
20469331|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469332|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20224986|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20224987|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20224988|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19850102|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19850103|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19850104|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
19850105|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850106|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850107|NCT00706992|Aldesleukin|aldesleukin|mesh-list
19850108|NCT00706992|Vaccines|vaccines|mesh-list
19850109|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
19850110|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
19850111|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850112|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850113|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19850114|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19850115|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
19850116|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469333|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20469334|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19409756|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20621511|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20621512|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621513|NCT02301286|Aspirin|aspirin|mesh-list
20621514|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19850117|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20224989|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
20469335|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469336|NCT01478607|Capsaicin|capsaicin|mesh-list
20469337|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
20469338|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
20469339|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
20469340|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469341|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469342|NCT01478633|Galantamine|galantamine|mesh-list
20469343|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20469344|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469345|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469346|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
20469347|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469348|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469349|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20469350|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
20469351|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469352|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
20469353|NCT01478685|Paclitaxel|paclitaxel|mesh-list
20469354|NCT01478685|Carboplatin|carboplatin|mesh-list
20469355|NCT01478685|Azacitidine|azacitidine|mesh-list
20469356|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20621515|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621516|NCT02301286|Analgesics|analgesics|mesh-ancestor
20621517|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
19409757|NCT03555071|Vaccines|vaccines|mesh-list
19409758|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
19409759|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409760|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19409761|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19409762|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409763|NCT03554980|Listerine|listerine|mesh-list
19409764|NCT03554980|Fluorides|fluorides|mesh-list
19409765|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
19409766|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
19409767|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
19409768|NCT03554980|Protective Agents|protective agents|mesh-ancestor
19416672|NCT02339129|Analgesics|analgesics|mesh-ancestor
20621518|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621519|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409769|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409770|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19409771|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409772|NCT03554915|Midazolam|midazolam|mesh-list
19409773|NCT03554915|Ketamine|ketamine|mesh-list
19409774|NCT03554915|Analgesics|analgesics|mesh-ancestor
19409775|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
19409776|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409777|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469357|NCT01478685|Cc-486|cc-486|mesh-list
20469358|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20469359|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469360|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
20469361|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
20469362|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
20469363|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469364|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20469365|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
20469366|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469367|NCT01478724|Caseins|caseins|mesh-list
20469368|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
20469369|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
20469370|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469371|NCT01478737|Dexamethasone|dexamethasone|mesh-list
20469372|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
20469373|NCT01478737|BB 1101|bb 1101|mesh-list
20469374|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469375|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
20469376|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
20469377|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469378|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469379|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469380|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
20469381|NCT01478737|Hormones|hormones|mesh-ancestor
20469382|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469383|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20469384|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469385|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
20469386|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469387|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850118|NCT00707031|Metformin|metformin|mesh-list
19850119|NCT00707031|Exenatide|exenatide|mesh-list
19850120|NCT00707031|Lixisenatide|lixisenatide|mesh-list
19850121|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850122|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850123|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19850124|NCT00707031|Incretins|incretins|mesh-ancestor
19850125|NCT00707031|Hormones|hormones|mesh-ancestor
19850126|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850127|NCT00707057|Ibuprofen|ibuprofen|mesh-list
19850128|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19850129|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20469388|NCT01478997|Acetaminophen|acetaminophen|mesh-list
20469389|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20469390|NCT01478997|Analgesics|analgesics|mesh-ancestor
20469391|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
20469392|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469393|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469394|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
20469395|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20469396|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
20469397|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469398|NCT01479036|Docetaxel|docetaxel|mesh-list
20469399|NCT01479036|Epirubicin|epirubicin|mesh-list
20469400|NCT01479036|Endostatins|endostatins|mesh-list
20469401|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469402|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
20469403|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
20469404|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
19409778|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19409779|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19850130|NCT00707057|Analgesics|analgesics|mesh-ancestor
20469405|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850131|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
19850132|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409780|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
19409781|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
19409782|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409783|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20621520|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469406|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20469407|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20469408|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20469409|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469410|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19695722|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695723|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19695724|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
19695725|NCT04947189|Hormones|hormones|mesh-ancestor
19695726|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695727|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19695728|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695729|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
19695730|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
19695731|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
19695732|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695733|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20469411|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20469412|NCT01479036|Growth Substances|growth substances|mesh-ancestor
20469413|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469414|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
20469415|NCT01479075|Insulin|insulin|mesh-list
20469416|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20469417|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20469418|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527155|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527156|NCT01766583|Lenalidomide|lenalidomide|mesh-list
20527157|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
20527158|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527159|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20527160|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20527161|NCT01766583|Growth Substances|growth substances|mesh-ancestor
20527162|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
20527163|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527164|NCT01766609|Triamcinolone|triamcinolone|mesh-list
20527165|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20527166|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20527167|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20527168|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20527169|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
20527170|NCT01766609|Hormones|hormones|mesh-ancestor
20527171|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527172|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527173|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527174|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
20527175|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527176|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527177|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
20527178|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
19695734|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695735|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
19695736|NCT04947254|Prednisone|prednisone|mesh-list
19695737|NCT04947254|Cortisone|cortisone|mesh-list
19695738|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
19695739|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
19695740|NCT04947254|Niraparib|niraparib|mesh-list
19695741|NCT04947254|Hormones|hormones|mesh-list
19695742|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20527179|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
20527180|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527181|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20527182|NCT01766843|Charcoal|charcoal|mesh-list
20527183|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20527184|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
19409784|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19409785|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409786|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409787|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19695743|NCT04947254|Androgens|androgens|mesh-list
20527185|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469419|NCT01479088|Cinacalcet|cinacalcet|mesh-list
20469420|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469421|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469422|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20469423|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
20469424|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469425|NCT01479114|Sargramostim|sargramostim|mesh-list
20469426|NCT01479114|Lenograstim|lenograstim|mesh-list
20469427|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
20469428|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469429|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20469430|NCT01479179|Trastuzumab|trastuzumab|mesh-list
20469431|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20469432|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469433|NCT01479192|Fenretinide|fenretinide|mesh-list
20469434|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469435|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20469436|NCT01479192|Protective Agents|protective agents|mesh-ancestor
20469437|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469438|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
20469439|NCT01479231|Lansoprazole|lansoprazole|mesh-list
20469440|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20469441|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469442|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20469443|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469444|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469445|NCT01479244|Molgramostim|molgramostim|mesh-list
20469446|NCT01479244|Sargramostim|sargramostim|mesh-list
20469447|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
20621521|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19409788|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19409789|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19409790|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19409791|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20621522|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20621523|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20621524|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621525|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20621526|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20621527|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621528|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
20621529|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
20621530|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621531|NCT02301494|Fluocinonide|fluocinonide|mesh-list
20621532|NCT02301494|Imiquimod|imiquimod|mesh-list
19409792|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
19409793|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
19409794|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
19409795|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20469448|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469449|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469450|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20469451|NCT01479283|Cefazolin|cefazolin|mesh-list
20469452|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20469453|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469454|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
20469455|NCT01479296|Vaccines|vaccines|mesh-list
20469456|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
20469457|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469458|NCT01479361|Atovaquone|atovaquone|mesh-list
19409796|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409797|NCT03554590|Insulin|insulin|mesh-list
19409798|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19695744|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
19695745|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19695746|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
19695747|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695748|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695749|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19409799|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409800|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
19409801|NCT03554447|Dexetimide|dexetimide|mesh-list
20469459|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409802|NCT03554447|Citalopram|citalopram|mesh-list
19409803|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20469460|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
20469461|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20621533|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20469462|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20469463|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469464|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469465|NCT01479504|Cisplatin|cisplatin|mesh-list
20469466|NCT01479504|Docetaxel|docetaxel|mesh-list
20469467|NCT01479504|Nedaplatin|nedaplatin|mesh-list
20469468|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469469|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
20469470|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
20469471|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
20469472|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409804|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19409805|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409806|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469473|NCT01479556|Pregabalin|pregabalin|mesh-list
20469474|NCT01479556|Analgesics|analgesics|mesh-ancestor
20469475|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
20469476|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469477|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469478|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
20469479|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20469480|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469481|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469482|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469483|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20469484|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20469485|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20469486|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469487|NCT01479634|Efavirenz|efavirenz|mesh-list
20621534|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
20621535|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621536|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621537|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
20621538|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621539|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
20224990|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
20224991|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20224992|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19409807|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409808|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
19409809|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409810|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19409811|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
19409812|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19409813|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19409814|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19695750|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621540|NCT02301494|Hormones|hormones|mesh-ancestor
20621541|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621542|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20621543|NCT02301650|Tenofovir|tenofovir|mesh-list
20621544|NCT02301650|Lamivudine|lamivudine|mesh-list
20621545|NCT02301650|Telbivudine|telbivudine|mesh-list
20621546|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
19695751|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19695752|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695753|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695754|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
19695755|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19695756|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
19695757|NCT04947254|Protective Agents|protective agents|mesh-ancestor
20224993|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20224994|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20224995|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
20224996|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
20224997|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20224998|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20224999|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
20225000|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
20225001|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
20225002|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225003|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20225004|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
20225005|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
20225006|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20469488|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20469489|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20469490|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469491|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469492|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
20469493|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469494|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20469495|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20469496|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20469497|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20469498|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20469499|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20469500|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
20469501|NCT01479751|Ketamine|ketamine|mesh-list
20469502|NCT01479751|Rocuronium|rocuronium|mesh-list
20469503|NCT01479751|Analgesics|analgesics|mesh-ancestor
20469504|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
20469505|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621547|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621548|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20621549|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19409815|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
19409816|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
19409817|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409818|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19409819|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19409820|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
19409821|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19409822|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409823|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19409824|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19409825|NCT03554447|Protective Agents|protective agents|mesh-ancestor
19409826|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
20621550|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621551|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621552|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20621553|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20621554|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
20621555|NCT02301676|Propofol|propofol|mesh-list
20621556|NCT02301676|Sevoflurane|sevoflurane|mesh-list
20621557|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20621558|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409827|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19695758|NCT04947254|Vitamins|vitamins|mesh-ancestor
19695759|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
19695760|NCT04947254|Estrogens|estrogens|mesh-ancestor
19695761|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
19695762|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19695763|NCT04947241|Gemcitabine|gemcitabine|mesh-list
19695764|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20469506|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469507|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20469508|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19695765|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695766|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19695767|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
19695768|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695769|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
19695770|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695771|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695772|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19695773|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
19695774|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695775|NCT04946825|Nicotine|nicotine|mesh-list
19695776|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19695777|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
19695778|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469509|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
20469510|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
19409828|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
19409829|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19409830|NCT03554408|Antibodies|antibodies|mesh-list
19409831|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
19409832|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19409833|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
20469511|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20469512|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20469513|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20225007|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225008|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20225009|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225010|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409834|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409835|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409836|NCT03554395|Antibodies|antibodies|mesh-list
19409837|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19409838|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
19409839|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409840|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
19409841|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19409842|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19409843|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409844|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19409845|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19409846|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409847|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409848|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409849|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19409850|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
19409851|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19409852|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409853|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19409854|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19409855|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19409856|NCT03554291|Famotidine|famotidine|mesh-list
19409857|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19409858|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19409859|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19409860|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
19409861|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
19409862|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409863|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409864|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469514|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469515|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469516|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20469517|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
20469518|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20469519|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469520|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469521|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
20469522|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20469523|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20469524|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20469525|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20469526|NCT01479842|Rituximab|rituximab|mesh-list
20469527|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19409865|NCT03554200|Empagliflozin|empagliflozin|mesh-list
19409866|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19409867|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409868|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19409869|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409870|NCT03554109|Leucovorin|leucovorin|mesh-list
19409871|NCT03554109|Paclitaxel|paclitaxel|mesh-list
19409872|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19409873|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
19409874|NCT03554109|Doxorubicin|doxorubicin|mesh-list
20225011|NCT00337922|Lamivudine|lamivudine|mesh-list
20225012|NCT00337922|Abacavir|abacavir|mesh-list
20225013|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20225014|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20225015|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225016|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225017|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
20225018|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225019|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20225020|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20469528|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20469529|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469530|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
20469531|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409875|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19409876|NCT03554109|Fluorouracil|fluorouracil|mesh-list
19409877|NCT03554109|Avelumab|avelumab|mesh-list
20469532|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469533|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20469534|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
20469535|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469536|NCT01479881|Cyclosporine|cyclosporine|mesh-list
20469537|NCT01479881|Simeprevir|simeprevir|mesh-list
19409878|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19409879|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409880|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
19409881|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
19409882|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
19409883|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409884|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409885|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
19409886|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409887|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19409888|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19409889|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
19409890|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19409891|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19409892|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19409893|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19409894|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409895|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
19409896|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19409897|NCT03554109|Antidotes|antidotes|mesh-ancestor
20469538|NCT01479881|Tacrolimus|tacrolimus|mesh-list
20469539|NCT01479881|Cyclosporins|cyclosporins|mesh-list
20469540|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20469541|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
20469542|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469543|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20469544|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469545|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469546|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
20469547|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469548|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
20469549|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469550|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
20469551|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
20469552|NCT01479920|Fluoxetine|fluoxetine|mesh-list
20469553|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20469554|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20469555|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19409898|NCT03554109|Protective Agents|protective agents|mesh-ancestor
19409899|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
19409900|NCT03554109|Vitamins|vitamins|mesh-ancestor
19409901|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
19409902|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416673|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
20225021|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
20225022|NCT00337948|Hematinics|hematinics|mesh-ancestor
20225023|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
20225024|NCT00338000|Hematinics|hematinics|mesh-ancestor
20225025|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20225026|NCT00338052|Norethindrone|norethindrone|mesh-list
20225027|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
20225028|NCT00338052|Estradiol|estradiol|mesh-list
20225029|NCT00338052|Estrogens|estrogens|mesh-ancestor
20225030|NCT00338052|Hormones|hormones|mesh-ancestor
20225031|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225032|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225033|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20225034|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
20225035|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20225036|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20225037|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20225038|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20225039|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20469556|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469557|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469558|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
20469559|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409903|NCT03554031|Hormones|hormones|mesh-list
19409904|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409905|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409906|NCT03553875|Memantine|memantine|mesh-list
19409907|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19409908|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19409909|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
19409910|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409911|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409912|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409913|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19850133|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850134|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850135|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469560|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20469561|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
20469562|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469563|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20469564|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20469565|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469566|NCT01479933|Vitamin D|vitamin d|mesh-list
20469567|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
20469568|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
20469569|NCT01479933|Vitamins|vitamins|mesh-list
20469570|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
20469571|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469572|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19850136|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19850137|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850138|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850139|NCT00707174|Imiquimod|imiquimod|mesh-list
19850140|NCT00707174|Tazarotene|tazarotene|mesh-list
20469573|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469574|NCT01480050|Temozolomide|temozolomide|mesh-list
20469575|NCT01480050|Mibefradil|mibefradil|mesh-list
20469576|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20469577|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
20469578|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469579|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469580|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20469581|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20469582|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469583|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469584|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469585|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
20469586|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20469587|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20469588|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469589|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
20469590|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20469591|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469592|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469593|NCT01480141|Afatinib|afatinib|mesh-list
20469594|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469595|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20469596|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469597|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469598|NCT01480323|Aldesleukin|aldesleukin|mesh-list
20469599|NCT01480323|Ipilimumab|ipilimumab|mesh-list
20469600|NCT01480323|Interleukin-2|interleukin-2|mesh-list
20469601|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20469602|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469603|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19409914|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19409915|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
19850141|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19409916|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20225040|NCT00338091|Losartan|losartan|mesh-list
20469604|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469605|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19409917|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409918|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
19409919|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19409920|NCT03553628|Propolis|propolis|mesh-list
19409921|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19409922|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409923|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
19409924|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
20469606|NCT01480323|Analgesics|analgesics|mesh-ancestor
20469607|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
20469608|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469609|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469610|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20469611|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20469612|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
20469613|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469614|NCT01480336|Amiodarone|amiodarone|mesh-list
20469615|NCT01480336|Ranolazine|ranolazine|mesh-list
20469616|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20469617|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
20469618|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20469619|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469620|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469621|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20469622|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20469623|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20469624|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469625|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20469626|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20469627|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20469628|NCT01480492|Telbivudine|telbivudine|mesh-list
20469629|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
20469630|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469631|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20469632|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469633|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469634|NCT01480531|Clevidipine|clevidipine|mesh-list
20469635|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20469636|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469637|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469638|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469639|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469640|NCT01480609|Ezogabine|ezogabine|mesh-list
20469641|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
20469642|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469643|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469644|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
20469645|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19409925|NCT03553615|Ivermectin|ivermectin|mesh-list
19409926|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19409927|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19409928|NCT03553537|Prednisone|prednisone|mesh-list
19409929|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
19409930|NCT03553537|Doxorubicin|doxorubicin|mesh-list
19409931|NCT03553537|Vincristine|vincristine|mesh-list
19409932|NCT03553537|Decitabine|decitabine|mesh-list
19409933|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850142|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
19409934|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
19409935|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409936|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225041|NCT00338091|Benazepril|benazepril|mesh-list
20225042|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20225043|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20225044|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20225045|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20225046|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225047|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20225048|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
20225049|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469646|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
20469647|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469648|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20469649|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
20469650|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20469651|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20469652|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
19409937|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19409938|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
19409939|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409940|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409941|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19409942|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20469653|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469654|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20469655|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20469656|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469657|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469658|NCT01480752|Lornoxicam|lornoxicam|mesh-list
20469659|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20469660|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20469661|NCT01480752|Analgesics|analgesics|mesh-ancestor
20469662|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
20469663|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469664|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469665|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469666|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469667|NCT01480765|Pregabalin|pregabalin|mesh-list
20469668|NCT01480765|Ketamine|ketamine|mesh-list
20469669|NCT01480765|Analgesics|analgesics|mesh-ancestor
20469670|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
20469671|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469672|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469673|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20469674|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20469675|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
20469676|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
20469677|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20469678|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20621559|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621560|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19409943|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19409944|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19409945|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409946|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19409947|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
19409948|NCT03553537|Hormones|hormones|mesh-ancestor
19409949|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19409950|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19409951|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19409952|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19409953|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19409954|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19409955|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19409956|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
19409957|NCT03553446|Sevoflurane|sevoflurane|mesh-list
19409958|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19409959|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19409960|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
19409961|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
19409962|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19409963|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409964|NCT03553433|Apremilast|apremilast|mesh-list
19409965|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19409966|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19409967|NCT03553433|Analgesics|analgesics|mesh-ancestor
19409968|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
19409969|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19409970|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19409971|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19409972|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695779|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469679|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20621561|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
20469680|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19409973|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20469681|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469682|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
20469683|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20469684|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469685|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469686|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20469687|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20469688|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20469689|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20469690|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20469691|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20469692|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20469693|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
20469694|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20469695|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469696|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20469697|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20469698|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20469699|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20469700|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20469701|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20469702|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20469703|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20469704|NCT01480791|Diuretics|diuretics|mesh-ancestor
20469705|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
20469706|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469707|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20469708|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469709|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469710|NCT01480817|Sorafenib|sorafenib|mesh-list
20469711|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469712|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20469713|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469714|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527186|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527187|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20527188|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
20527189|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
20527190|NCT01766843|Hormones|hormones|mesh-ancestor
20527191|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527192|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
20527193|NCT01766843|Antidotes|antidotes|mesh-ancestor
20527194|NCT01766843|Protective Agents|protective agents|mesh-ancestor
20527195|NCT01766960|Morphine|morphine|mesh-list
20527196|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20527197|NCT01766960|Narcotics|narcotics|mesh-ancestor
20527198|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20527199|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527200|NCT01766960|Analgesics|analgesics|mesh-ancestor
20527201|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
20527202|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527203|NCT01767025|Oxytocin|oxytocin|mesh-list
20527204|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
20527205|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20527206|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527207|NCT01767090|Leuprolide|leuprolide|mesh-list
20527208|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20527209|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
20527210|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20527211|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527212|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20527213|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695780|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19695781|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19695782|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
19695783|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695784|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695785|NCT04946864|Palbociclib|palbociclib|mesh-list
19695786|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469715|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
20469716|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
20469717|NCT01480869|Calcium|calcium|mesh-list
20469718|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20469719|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469720|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20469721|NCT01480869|Vitamins|vitamins|mesh-ancestor
20469722|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
20621562|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
20621563|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19409974|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19409975|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409976|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621564|NCT02301676|Analgesics|analgesics|mesh-ancestor
20621565|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
20621566|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621567|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20621568|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20621569|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20621570|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621571|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621572|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409977|NCT03553329|Trametinib|trametinib|mesh-list
19409978|NCT03553329|Dabrafenib|dabrafenib|mesh-list
19409979|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19409980|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20621573|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20621574|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20621575|NCT02301715|Oxytocin|oxytocin|mesh-list
19409981|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19409982|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409983|NCT03553303|Valsartan|valsartan|mesh-list
19409984|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19409985|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19409986|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19409987|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19409988|NCT03553238|Cytarabine|cytarabine|mesh-list
19409989|NCT03553238|Dexamethasone|dexamethasone|mesh-list
19409990|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
19409991|NCT03553238|Methotrexate|methotrexate|mesh-list
19409992|NCT03553238|Etoposide|etoposide|mesh-list
19409993|NCT03553238|Vincristine|vincristine|mesh-list
19409994|NCT03553238|Doxorubicin|doxorubicin|mesh-list
19409995|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
19409996|NCT03553238|Idarubicin|idarubicin|mesh-list
19409997|NCT03553238|Pegaspargase|pegaspargase|mesh-list
19409998|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19409999|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
19410000|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621576|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
20621577|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20621578|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850143|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850144|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621579|NCT02301780|Aspirin|aspirin|mesh-list
20621580|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20621581|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20621582|NCT02301780|Analgesics|analgesics|mesh-ancestor
20621583|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
20621584|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410001|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225050|NCT00338117|Galantamine|galantamine|mesh-list
20225051|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20225052|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225053|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225054|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
20225055|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225056|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225057|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20225058|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
20225059|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225060|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
20225061|NCT00338130|Temozolomide|temozolomide|mesh-list
20225062|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20225063|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
20225064|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621585|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621586|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621587|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621588|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20621589|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20621590|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621591|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20621592|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20621593|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410002|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20469723|NCT01480986|Irinotecan|irinotecan|mesh-list
20469724|NCT01480986|Octreotide|octreotide|mesh-list
20469725|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469726|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20469727|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20469728|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469729|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469730|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469731|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20469732|NCT01481194|Dexamethasone|dexamethasone|mesh-list
20469733|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
20469734|NCT01481194|Doxorubicin|doxorubicin|mesh-list
20469735|NCT01481194|Lenalidomide|lenalidomide|mesh-list
20469736|NCT01481194|Bortezomib|bortezomib|mesh-list
20469737|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20469738|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
20469739|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469740|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469741|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20469742|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
20469743|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469744|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469745|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20469746|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469747|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
20469748|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
20469749|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469750|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469751|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
20469752|NCT01481194|Hormones|hormones|mesh-ancestor
20469753|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469754|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20469755|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20469756|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20469757|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20469758|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469759|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20469760|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20469761|NCT01481194|Growth Substances|growth substances|mesh-ancestor
20469762|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
20469763|NCT01481233|Colchicine|colchicine|mesh-list
20469764|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
20469765|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469766|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
20469767|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
20469768|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
20469769|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469770|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469771|NCT01481259|Pemetrexed|pemetrexed|mesh-list
20469772|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469773|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469774|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469775|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20469776|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20469777|NCT01481311|Bromides|bromides|mesh-list
20469778|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
20469779|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
20469780|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
20469781|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20469782|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20469783|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621594|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
20469784|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621595|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20469785|NCT01481350|Urological Agents|urological agents|mesh-ancestor
20469786|NCT01481389|Theobromine|theobromine|mesh-list
20469787|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20469788|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
20469789|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469790|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469791|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20469792|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
20469793|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
20469794|NCT01481454|Vaccines|vaccines|mesh-list
20469795|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
20469796|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469797|NCT01481467|Vaccines|vaccines|mesh-list
20469798|NCT01481467|Immunologic Factors|immunologic factors|mesh-ancestor
20469799|NCT01481467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469800|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
20469801|NCT01481519|Dexamethasone|dexamethasone|mesh-list
20469802|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
20469803|NCT01481519|Povidone|povidone|mesh-list
20469804|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
20469805|NCT01481519|BB 1101|bb 1101|mesh-list
20621596|NCT02301806|Glimepiride|glimepiride|mesh-list
20621597|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621598|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621599|NCT02301806|Incretins|incretins|mesh-ancestor
20621600|NCT02301806|Hormones|hormones|mesh-ancestor
20621601|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621602|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20621603|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
19410003|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
19410004|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410005|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410006|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19410007|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410008|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
19410009|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
19410010|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410011|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19410012|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
19410013|NCT03553238|Hormones|hormones|mesh-ancestor
19410014|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410015|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19410016|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19410017|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
19410018|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410019|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19410020|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
20621604|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621605|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621606|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19410021|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
19410022|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410023|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20621607|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19410024|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19410025|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19410026|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19410027|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19410028|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
19410029|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410030|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
19410031|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
19410032|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
19410033|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19410034|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
19410035|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19410036|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19410037|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410038|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
19410039|NCT03553186|Coagulants|coagulants|mesh-ancestor
19410040|NCT03553173|Bupropion|bupropion|mesh-list
20469806|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469807|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
20469808|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
20621608|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
19410041|NCT03553173|Varenicline|varenicline|mesh-list
19410042|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19410043|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
19410044|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19410045|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19410046|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19410047|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20469809|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469810|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469811|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469812|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
20469813|NCT01481519|Hormones|hormones|mesh-ancestor
20469814|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469815|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20469816|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469817|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
20469818|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469819|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469820|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
20469821|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
20469822|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20469823|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20469824|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19410048|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410049|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
20225065|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621609|NCT02301910|Tenecteplase|tenecteplase|mesh-list
20621610|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20469825|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20469826|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
20469827|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
20469828|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469829|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469830|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469831|NCT01481610|Diclofenac|diclofenac|mesh-list
20469832|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
20469833|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20469834|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20469835|NCT01481610|Analgesics|analgesics|mesh-ancestor
20469836|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
20469837|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469838|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469839|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20469840|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20469841|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20469842|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469843|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469844|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20469845|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
20469846|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469847|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
20469848|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
20469849|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
20469850|NCT01481714|Citric Acid|citric acid|mesh-list
20621611|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20621612|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621613|NCT02301949|Thalidomide|thalidomide|mesh-list
20621614|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621615|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
20621616|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621617|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
20621618|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20621619|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621620|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20621621|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20621622|NCT02301949|Growth Substances|growth substances|mesh-ancestor
20469851|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
20225066|NCT00338195|Caffeine|caffeine|mesh-list
20225067|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20225068|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225069|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20225070|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225071|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225072|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20225073|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20469852|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20469853|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
20469854|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
20469855|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469856|NCT01481714|Cathartics|cathartics|mesh-ancestor
20469857|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469858|NCT01481714|Antacids|antacids|mesh-ancestor
20469859|NCT01481831|Palonosetron|palonosetron|mesh-list
20225074|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
20225075|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225076|NCT00338221|Glycine|glycine|mesh-list
20225077|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
20225078|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225079|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225080|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225081|NCT00338247|Capecitabine|capecitabine|mesh-list
20225082|NCT00338247|Lapatinib|lapatinib|mesh-list
20225083|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225084|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
20225085|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225086|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225087|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20225088|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225089|NCT00338273|Aripiprazole|aripiprazole|mesh-list
20225090|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
20225091|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225092|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20225093|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20225094|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225095|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469860|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
20469861|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
20469862|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469863|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469864|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469865|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20469866|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20469867|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
20469868|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469869|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469870|NCT01481844|Amoxicillin|amoxicillin|mesh-list
20469871|NCT01481844|Metronidazole|metronidazole|mesh-list
20469872|NCT01481844|Clarithromycin|clarithromycin|mesh-list
20469873|NCT01481844|Tetracycline|tetracycline|mesh-list
20469874|NCT01481844|Tinidazole|tinidazole|mesh-list
20469875|NCT01481844|Lansoprazole|lansoprazole|mesh-list
20469876|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
20469877|NCT01481844|Bismuth|bismuth|mesh-list
20469878|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20225096|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
20225097|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
20225098|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469879|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20469880|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410050|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410051|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410052|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19410053|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19410054|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410055|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19410056|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19410057|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
19410058|NCT03553108|Olaparib|olaparib|mesh-list
19410059|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19410060|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410061|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410062|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410063|NCT03553082|Propofol|propofol|mesh-list
19410064|NCT03553082|Sevoflurane|sevoflurane|mesh-list
19410065|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19410066|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410067|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469881|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20469882|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20469883|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20469884|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469885|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621623|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
20621624|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621625|NCT02301962|Panitumumab|panitumumab|mesh-list
20621626|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621627|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621628|NCT02302170|Vaccines|vaccines|mesh-list
20621629|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
20621630|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410068|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19410069|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
19410070|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
19410071|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20469886|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20469887|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20469888|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20469889|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469890|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20469891|NCT01481844|Antacids|antacids|mesh-ancestor
20469892|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
20469893|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20469894|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
20469895|NCT01481870|Sorafenib|sorafenib|mesh-list
20469896|NCT01481870|Sunitinib|sunitinib|mesh-list
20469897|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410072|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20621631|NCT02302209|Oxytocin|oxytocin|mesh-list
20621632|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
20469898|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20469899|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469900|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469901|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20469902|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20469903|NCT01481870|Growth Substances|growth substances|mesh-ancestor
20469904|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469905|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
20469906|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20469907|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20469908|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
20469909|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410073|NCT03552770|Bevacizumab|bevacizumab|mesh-list
19410074|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19410075|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410076|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19410077|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19410078|NCT03552770|Growth Substances|growth substances|mesh-ancestor
19410079|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410080|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
19410081|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
19410082|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19410083|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19410084|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410085|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
19410086|NCT03552705|Coagulants|coagulants|mesh-ancestor
20469910|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469911|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20621633|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410087|NCT03552666|Vitamin D|vitamin d|mesh-list
19410088|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
19410089|NCT03552666|Vitamins|vitamins|mesh-ancestor
19410090|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
19410091|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410092|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19410093|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19410094|NCT03552653|Vitamin D|vitamin d|mesh-list
19410095|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
19410096|NCT03552653|Vitamins|vitamins|mesh-list
19410097|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
19410098|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410099|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20469912|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20469913|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20621634|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410100|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19410101|NCT03552601|Methamphetamine|methamphetamine|mesh-list
19410102|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19410103|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410104|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
19410105|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
19410106|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410107|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
19410108|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410109|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410110|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
19410111|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19410112|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20621635|NCT02302274|Flecainide|flecainide|mesh-list
20621636|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20621637|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20621638|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20621639|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20621640|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621641|NCT02302326|Folic Acid|folic acid|mesh-list
20621642|NCT02302326|Inositol|inositol|mesh-list
20621643|NCT02302326|Metformin|metformin|mesh-list
20621644|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621645|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621646|NCT02302326|Hematinics|hematinics|mesh-ancestor
20621647|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
20621648|NCT02302326|Vitamins|vitamins|mesh-ancestor
20621649|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
19410113|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19410114|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19410115|NCT03552575|Valsartan|valsartan|mesh-list
19410116|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20469914|NCT01482052|Vaccines|vaccines|mesh-list
20469915|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
20469916|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469917|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20469918|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20469919|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20469920|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
20469921|NCT01482117|Cilostazol|cilostazol|mesh-list
20469922|NCT01482117|Clopidogrel|clopidogrel|mesh-list
19410117|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19410118|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19410119|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416674|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416675|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416676|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416677|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416678|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416679|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416680|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416681|NCT02339064|Apomorphine|apomorphine|mesh-list
19416682|NCT02339064|Emetics|emetics|mesh-ancestor
19416683|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416684|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
19416685|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416686|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19416687|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
19416688|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
20225099|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225100|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20225101|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20225102|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
19416689|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416690|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416691|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19416692|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
19416693|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416694|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20225103|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20225104|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20225105|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20225106|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20225107|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
20621650|NCT02302378|Bupivacaine|bupivacaine|mesh-list
20621651|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
20469923|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20469924|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20469925|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19850145|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
19850146|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
20225108|NCT00338299|Hematinics|hematinics|mesh-ancestor
20225109|NCT00338312|Testosterone|testosterone|mesh-list
20225110|NCT00338312|Androgens|androgens|mesh-ancestor
20469926|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20469927|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
20469928|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20469929|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469930|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469931|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20469932|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
20469933|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410120|NCT03552406|Cetuximab|cetuximab|mesh-list
19410121|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19410122|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469934|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20469935|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
20469936|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20469937|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20469938|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
20469939|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20469940|NCT01482117|Protective Agents|protective agents|mesh-ancestor
20469941|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19410123|NCT03552354|Argatroban|argatroban|mesh-list
19410124|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
19410125|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19410126|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
19410127|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410128|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410129|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
19410130|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19410131|NCT03552315|Chromium|chromium|mesh-list
19410132|NCT03552315|Trace Elements|trace elements|mesh-ancestor
19410133|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
19410134|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410135|NCT03552211|Biotin|biotin|mesh-list
19410136|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
19695787|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19695788|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695789|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695790|NCT04946734|Aspirin|aspirin|mesh-list
19695791|NCT04946734|Clopidogrel|clopidogrel|mesh-list
19695792|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19695793|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19695794|NCT04946734|Analgesics|analgesics|mesh-ancestor
19695795|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
19695796|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695797|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695798|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225111|NCT00338312|Hormones|hormones|mesh-ancestor
20225112|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225113|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225114|NCT00338338|Amlodipine|amlodipine|mesh-list
20225115|NCT00338338|Lacidipine|lacidipine|mesh-list
20225116|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20225117|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20225118|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225119|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225120|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20225121|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225122|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
20225123|NCT00338377|Vidarabine|vidarabine|mesh-list
20225124|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
20225125|NCT00338377|Fludarabine|fludarabine|mesh-list
20225126|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
20225127|NCT00338377|Interleukin-2|interleukin-2|mesh-list
20225128|NCT00338377|Vaccines|vaccines|mesh-list
20469942|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20225129|NCT00338377|Mesna|mesna|mesh-list
19410137|NCT03552211|Vitamins|vitamins|mesh-ancestor
20225130|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225131|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
19695799|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695800|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19695801|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19695802|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695803|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19695804|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19695805|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695806|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
19695807|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19695808|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19695809|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19695810|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
20469943|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469944|NCT01482156|Everolimus|everolimus|mesh-list
20469945|NCT01482156|Dactolisib|dactolisib|mesh-list
20469946|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469947|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20469948|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
20469949|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469950|NCT01482299|Everolimus|everolimus|mesh-list
20469951|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469952|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20469953|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
20469954|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469955|NCT01482338|Drospirenone|drospirenone|mesh-list
20469956|NCT01482338|Desogestrel|desogestrel|mesh-list
20469957|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20469958|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
20469959|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469960|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469961|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20469962|NCT01482338|Diuretics|diuretics|mesh-ancestor
20469963|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
20469964|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20469965|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20469966|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20469967|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
20469968|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20469969|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20469970|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20469971|NCT01482338|Progestins|progestins|mesh-ancestor
20469972|NCT01482338|Hormones|hormones|mesh-ancestor
20469973|NCT01482377|Cetuximab|cetuximab|mesh-list
20469974|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20469975|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20469976|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469977|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20469978|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469979|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469980|NCT01482416|Estrogens|estrogens|mesh-list
20469981|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19695811|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695812|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19410138|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
19410139|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410140|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
19410141|NCT03552146|Propofol|propofol|mesh-list
20469982|NCT01482416|Hormones|hormones|mesh-ancestor
20469983|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20469984|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469985|NCT01482442|Sorafenib|sorafenib|mesh-list
20469986|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20469987|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20469988|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20469989|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20469990|NCT01482468|Palonosetron|palonosetron|mesh-list
20469991|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
20469992|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
19410142|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19410143|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410144|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410145|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20469993|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20469994|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20469995|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20469996|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20469997|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20469998|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
20621652|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
19410146|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
19410147|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
19410148|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410149|NCT03552146|Analgesics|analgesics|mesh-ancestor
19410150|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
19410151|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410152|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19410153|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19410154|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19410155|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
19410156|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410157|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410158|NCT03552016|Riboflavin|riboflavin|mesh-list
19410159|NCT03552016|Vitamins|vitamins|mesh-ancestor
19410160|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
19410161|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410162|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
19410163|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19410164|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
19410165|NCT03551964|Ticagrelor|ticagrelor|mesh-list
19410166|NCT03551964|Cangrelor|cangrelor|mesh-list
19410167|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19410168|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19410169|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19410170|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19410171|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
19410172|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410173|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410174|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410175|NCT03551873|Plecanatide|plecanatide|mesh-list
19410176|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19410177|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
19410178|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410179|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19410180|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19410181|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19410182|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410183|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
19410184|NCT03551808|Ketorolac|ketorolac|mesh-list
19410185|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19410186|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19410187|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19410188|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19410189|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410190|NCT03551808|Analgesics|analgesics|mesh-ancestor
19410191|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
19410192|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410193|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410194|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410195|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19410196|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19410197|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410198|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410199|NCT03551652|Rocuronium|rocuronium|mesh-list
19410200|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19410201|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19410202|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19410203|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410204|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410205|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
19850147|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
19410206|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19410207|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20469999|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470000|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527214|NCT01767259|Valsartan|valsartan|mesh-list
20527215|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20527216|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20527217|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20527218|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19695813|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
19695814|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19410208|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470001|NCT01482559|Dopamine|dopamine|mesh-list
20470002|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20470003|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
20470004|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
20470005|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470006|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470007|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
20470008|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470009|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470010|NCT01482559|Protective Agents|protective agents|mesh-ancestor
20470011|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
20621653|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621654|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621655|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
20621656|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621657|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20225132|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225133|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225134|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20225135|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
20225136|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225137|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225138|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20470012|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19410209|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
19410210|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
19695815|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410211|NCT03551548|Spironolactone|spironolactone|mesh-list
19410212|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19410213|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
19410214|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410215|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410216|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19410217|NCT03551548|Diuretics|diuretics|mesh-ancestor
19410218|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
19410219|NCT03551210|Levofloxacin|levofloxacin|mesh-list
19410220|NCT03551210|Ofloxacin|ofloxacin|mesh-list
19410221|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19410222|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695816|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19695817|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20470013|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
19410223|NCT03551210|Renal Agents|renal agents|mesh-ancestor
19695818|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19695819|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695820|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
19695821|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707843|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707844|NCT04823065|Scopolamine|scopolamine|mesh-list
19850148|NCT00707239|Imipenem|imipenem|mesh-list
19850149|NCT00707239|Tigecycline|tigecycline|mesh-list
19850150|NCT00707239|Cilastatin|cilastatin|mesh-list
19850151|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19850152|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850153|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19850154|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850155|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850156|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
19850157|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19850158|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
19850159|NCT00707486|Coagulants|coagulants|mesh-ancestor
19850160|NCT00707655|Zalutumumab|zalutumumab|mesh-list
19707845|NCT04823065|Loperamide|loperamide|mesh-list
19707846|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
19707847|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19707848|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707849|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19707850|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
19707851|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
19707852|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707853|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707854|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
19707855|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19850161|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850162|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621658|NCT02302430|Oxytocin|oxytocin|mesh-list
20621659|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
20621660|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20621661|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621662|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
20621663|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20621664|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20621665|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621666|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
20470014|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470015|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
20470016|NCT01482624|Protective Agents|protective agents|mesh-ancestor
20470017|NCT01482728|Dasatinib|dasatinib|mesh-list
20470018|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470019|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20470020|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621667|NCT02302456|Coagulants|coagulants|mesh-ancestor
20621668|NCT02302469|Lenalidomide|lenalidomide|mesh-list
20621669|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
20621670|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621671|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20621672|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20621673|NCT02302469|Growth Substances|growth substances|mesh-ancestor
20621674|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
20470021|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470022|NCT01482754|Rituximab|rituximab|mesh-list
20470023|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20470024|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470025|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
20470026|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470027|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20470028|NCT01482897|Prednisolone|prednisolone|mesh-list
20470029|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20470030|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
20470031|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20470032|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
20470033|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20470034|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
20470035|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707856|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
19707857|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850163|NCT00707746|Mipomersen|mipomersen|mesh-list
19850164|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20470036|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
20621675|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621676|NCT02302495|Prednisone|prednisone|mesh-list
20470037|NCT01482897|Hormones|hormones|mesh-ancestor
20470038|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20470039|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470040|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20470041|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470042|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
20470043|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
20470044|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470045|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20621677|NCT02302495|Melphalan|melphalan|mesh-list
20621678|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621679|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
20621680|NCT02302495|Hormones|hormones|mesh-ancestor
20621681|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621682|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621683|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20621684|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621685|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20621686|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
20470046|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20470047|NCT01482897|Protective Agents|protective agents|mesh-ancestor
20470048|NCT01482936|Oxycodone|oxycodone|mesh-list
20470049|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20470050|NCT01482936|Narcotics|narcotics|mesh-ancestor
20470051|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470052|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470053|NCT01482936|Analgesics|analgesics|mesh-ancestor
20470054|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
20470055|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470056|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
20470057|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470058|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20470059|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470060|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470061|NCT01483053|S 20098|s 20098|mesh-list
20470062|NCT01483053|Citalopram|citalopram|mesh-list
20470063|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20621687|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621688|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20621689|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621690|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
20621691|NCT02302508|Clopidogrel|clopidogrel|mesh-list
20621692|NCT02302508|Ticagrelor|ticagrelor|mesh-list
20621693|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20470064|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20470065|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20470066|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470067|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470068|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
20470069|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470070|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20470071|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
20470072|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20470073|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20470074|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621694|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20621695|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20621696|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20621697|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20621698|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
20225139|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225140|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
20225141|NCT00338377|Antiviral Agents|antiviral agents|mesh-ancestor
20225142|NCT00338377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225143|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20225144|NCT00338377|Analgesics|analgesics|mesh-ancestor
20225145|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
20225146|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225147|NCT00338377|Protective Agents|protective agents|mesh-ancestor
20470075|NCT01483248|Interferons|interferons|mesh-list
20225148|NCT00338390|Lamivudine|lamivudine|mesh-list
20470076|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20225149|NCT00338390|Abacavir|abacavir|mesh-list
20225150|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
20621699|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410224|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19410225|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19410226|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20470077|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470078|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
20470079|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470080|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20470081|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470082|NCT01483274|Vaccines|vaccines|mesh-list
20470083|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
20470084|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470085|NCT01483300|Cisplatin|cisplatin|mesh-list
20470086|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410227|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410228|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410229|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470087|NCT01483365|Progesterone|progesterone|mesh-list
20470088|NCT01483365|Progestins|progestins|mesh-ancestor
20470089|NCT01483365|Hormones|hormones|mesh-ancestor
20470090|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20470091|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470092|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
20470093|NCT01483508|Procyanidin|procyanidin|mesh-list
20470094|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
20470095|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470096|NCT01483508|Protective Agents|protective agents|mesh-ancestor
20470097|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410230|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19410231|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19410232|NCT03551197|Budesonide|budesonide|mesh-list
19410233|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
19410234|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410235|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19410236|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
19410237|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410238|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470098|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20470099|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20470100|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470101|NCT01483638|Axitinib|axitinib|mesh-list
20470102|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470103|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20470104|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470105|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470106|NCT01483729|Ritonavir|ritonavir|mesh-list
20470107|NCT01483729|Lactams|lactams|mesh-list
20470108|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20470109|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19410239|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19410240|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
19410241|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
19410242|NCT03551197|Hormones|hormones|mesh-ancestor
19410243|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410244|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19410245|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19410246|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19410247|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
20470110|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
20470111|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470112|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470113|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20470114|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20470115|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
20470116|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470117|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20470118|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19410248|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410249|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470119|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20470120|NCT01483781|Canagliflozin|canagliflozin|mesh-list
20470121|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20470122|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470123|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470124|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470125|NCT01483859|Liver Extracts|liver extracts|mesh-list
20470126|NCT01483859|Hematinics|hematinics|mesh-ancestor
20470127|NCT01483911|Gontivimab|gontivimab|mesh-list
20470128|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
20470129|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470130|NCT01484015|Cefepime|cefepime|mesh-list
20470131|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20470132|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470133|NCT01484080|Paclitaxel|paclitaxel|mesh-list
20470134|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20470135|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20470136|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470137|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470138|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470139|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470140|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470141|NCT01484145|Terbinafine|terbinafine|mesh-list
20470142|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
20470143|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470144|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470145|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470146|NCT01484171|Idarubicin|idarubicin|mesh-list
20470147|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20470148|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470149|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20470150|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20470151|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470152|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470153|NCT01484184|Levodopa|levodopa|mesh-list
20470154|NCT01484184|Buspirone|buspirone|mesh-list
20470155|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20470156|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20470157|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
20470158|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470159|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695822|NCT04946669|Abatacept|abatacept|mesh-list
20225151|NCT00338390|Didanosine|didanosine|mesh-list
20225152|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20225153|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20225154|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225155|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225156|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
20470160|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470161|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470162|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470163|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470164|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20470165|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20470166|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
20225157|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470167|NCT01484262|Liraglutide|liraglutide|mesh-list
20470168|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470169|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470170|NCT01484262|Incretins|incretins|mesh-ancestor
20470171|NCT01484262|Hormones|hormones|mesh-ancestor
20470172|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527219|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527220|NCT01767259|Diuretics|diuretics|mesh-ancestor
20527221|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
20527222|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527223|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20527224|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527225|NCT01767272|Fexofenadine|fexofenadine|mesh-list
20527226|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20527227|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20527228|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19695823|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19695824|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695825|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225158|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20225159|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20225160|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
20225161|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
20527229|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
20527230|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
19410250|NCT03551171|Niraparib|niraparib|mesh-list
19410251|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19410252|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410253|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410254|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410255|NCT03551067|Midazolam|midazolam|mesh-list
19410256|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
19410257|NCT03551067|Ketamine|ketamine|mesh-list
19410258|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19410259|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410260|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410261|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410262|NCT03551067|Analgesics|analgesics|mesh-ancestor
19410263|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
19410264|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410265|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19410266|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19410267|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19410268|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
19410269|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410270|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410271|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19410272|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19410273|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
19410274|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
19410275|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19410276|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19410277|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19410278|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19410279|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19410280|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19410281|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
19410282|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
19410283|NCT03550859|Telmisartan|telmisartan|mesh-list
19410284|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19410285|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19410286|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19410287|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
19410288|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410289|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19410290|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19410291|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410292|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19410293|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19410294|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19410295|NCT03550794|Thiamine|thiamine|mesh-list
19410296|NCT03550794|Vitamins|vitamins|mesh-ancestor
19410297|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
19410298|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410299|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
19410300|NCT03550781|Prednisone|prednisone|mesh-list
19410301|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
19410302|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470173|NCT01484327|Carvedilol|carvedilol|mesh-list
20470174|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20470175|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20470176|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
20470177|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470178|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470179|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470180|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20470181|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
20470182|NCT01484327|Protective Agents|protective agents|mesh-ancestor
20470183|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20470184|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20470185|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20470186|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
20470187|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20470188|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20470189|NCT01484457|Pancrelipase|pancrelipase|mesh-list
20470190|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470191|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20470192|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
20470193|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470194|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20470195|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20470196|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
20470197|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20470198|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470199|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20470200|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20470201|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20470202|NCT01484691|Budesonide|budesonide|mesh-list
20470203|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470204|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20470205|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
19850165|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20225162|NCT00338416|Hematinics|hematinics|mesh-ancestor
19410303|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
19410304|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410305|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19410306|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19410307|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
19410308|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410309|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410310|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19410311|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410312|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
19410313|NCT03550781|Hormones|hormones|mesh-ancestor
19410314|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410315|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19416695|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416696|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
19416697|NCT02335918|Nivolumab|nivolumab|mesh-list
19416698|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416699|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416700|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19416701|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416702|NCT02333643|Digoxin|digoxin|mesh-list
19416703|NCT02333643|Furosemide|furosemide|mesh-list
19416704|NCT02333643|Diuretics|diuretics|mesh-ancestor
19416705|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
19416706|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416707|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19416708|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416709|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416710|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19416711|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19416712|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416713|NCT02333643|Protective Agents|protective agents|mesh-ancestor
19416714|NCT02332655|Cannabidiol|cannabidiol|mesh-list
19416715|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
19416716|NCT02329834|Furosemide|furosemide|mesh-list
19416717|NCT02329834|Diuretics|diuretics|mesh-ancestor
19416718|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
19416719|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416720|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19416721|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416722|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416723|NCT02326454|Talaporfin|talaporfin|mesh-list
19416724|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416725|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19416726|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
19416727|NCT02324985|Ibuprofen|ibuprofen|mesh-list
19416728|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416729|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416730|NCT02324985|Analgesics|analgesics|mesh-ancestor
20225163|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
20225164|NCT00338468|Hematinics|hematinics|mesh-ancestor
20225165|NCT00338481|Morphine|morphine|mesh-list
20225166|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20225167|NCT00338481|Narcotics|narcotics|mesh-ancestor
20225168|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225169|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225170|NCT00338481|Analgesics|analgesics|mesh-ancestor
20225171|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
20225172|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225173|NCT00338494|Clofarabine|clofarabine|mesh-list
19410316|NCT03550677|Anesthetics|anesthetics|mesh-list
20470206|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470207|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470208|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20470209|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
20470210|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
20470211|NCT01484691|Hormones|hormones|mesh-ancestor
20470212|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20470213|NCT01484717|Nicotine|nicotine|mesh-list
20470214|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20470215|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
20470216|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470217|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470218|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20470219|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20470220|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
19410317|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410318|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410319|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
19850166|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
19850167|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850168|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20470221|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470222|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470223|NCT01484756|Micronutrients|micronutrients|mesh-list
20470224|NCT01484756|Trace Elements|trace elements|mesh-list
20470225|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470226|NCT01484964|Peficitinib|peficitinib|mesh-list
20470227|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621700|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621701|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621702|NCT02302547|Ritonavir|ritonavir|mesh-list
20621703|NCT02302547|Lopinavir|lopinavir|mesh-list
20621704|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20621705|NCT02302547|Darunavir|darunavir|mesh-list
20621706|NCT02302547|Indinavir|indinavir|mesh-list
20621707|NCT02302547|Saquinavir|saquinavir|mesh-list
20621708|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
19410320|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19410321|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19410322|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410323|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
19410324|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
19410325|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
19410326|NCT03550534|Calcium|calcium|mesh-list
19410327|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19410328|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410329|NCT03550534|Antacids|antacids|mesh-ancestor
19410330|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410331|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19410332|NCT03550508|Antibodies|antibodies|mesh-list
19410333|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19410334|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
19410335|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410336|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
19410337|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19410338|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19410339|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19410340|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19410341|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410342|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
19410343|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410344|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695826|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19695827|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
19695828|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695829|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695830|NCT04946383|Dasatinib|dasatinib|mesh-list
19695831|NCT04946383|Quercetin|quercetin|mesh-list
19695832|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695833|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19695834|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850169|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
20470228|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621709|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20621710|NCT02302547|Tenofovir|tenofovir|mesh-list
19410345|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20470229|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470230|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
20470231|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470232|NCT01484990|Levodopa|levodopa|mesh-list
20470233|NCT01484990|Carbidopa|carbidopa|mesh-list
20470234|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20470235|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20470236|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20470237|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
20470238|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470239|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470240|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470241|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20470242|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470243|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20470244|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
20470245|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
20470246|NCT01485003|Natalizumab|natalizumab|mesh-list
20470247|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
20470248|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470249|NCT01485068|Paclitaxel|paclitaxel|mesh-list
20470250|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20470251|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470252|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470253|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470254|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470255|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470256|NCT01485081|Paclitaxel|paclitaxel|mesh-list
20470257|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20470258|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470259|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470260|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470261|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470262|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470263|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
20470264|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19410346|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850170|NCT00707759|Prednisone|prednisone|mesh-list
19850171|NCT00707759|Prednisolone|prednisolone|mesh-list
19850172|NCT00707759|Tacrolimus|tacrolimus|mesh-list
19410347|NCT03549923|Esmolol|esmolol|mesh-list
19410348|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19410349|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19410350|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19410351|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
19410352|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410353|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410354|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410355|NCT03549897|Albuterol|albuterol|mesh-list
19410356|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19850173|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850174|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
20225174|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19410357|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
19410358|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410359|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410360|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19410361|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
19410362|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
19410363|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410364|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20225175|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
20225176|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225177|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225178|NCT00338507|Erdosteine|erdosteine|mesh-list
20225179|NCT00338507|Expectorants|expectorants|mesh-ancestor
20225180|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
19850175|NCT00707759|Hormones|hormones|mesh-ancestor
19850176|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850177|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850178|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19850179|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225181|NCT00338546|Cocaine|cocaine|mesh-list
19410365|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19410366|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19410367|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
19410368|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410369|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410370|NCT03549832|Ritonavir|ritonavir|mesh-list
19410371|NCT03549832|Ribavirin|ribavirin|mesh-list
19410372|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
19410373|NCT03549832|Simeprevir|simeprevir|mesh-list
19410374|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19410375|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19410376|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
19410377|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410378|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410379|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19410380|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19410381|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
19410382|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410383|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19410384|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19410385|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
19410386|NCT03549819|Cannabidiol|cannabidiol|mesh-list
19410387|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
19410388|NCT03549741|Cabergoline|cabergoline|mesh-list
20470265|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
20470266|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470267|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20470268|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470269|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850180|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850181|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
19850182|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19850183|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850184|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850185|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19850186|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19850187|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
19850188|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19850189|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410389|NCT03549741|Clomiphene|clomiphene|mesh-list
19410390|NCT03549741|Enclomiphene|enclomiphene|mesh-list
19410391|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
19410392|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410393|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19410394|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
19410395|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410396|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410397|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19410398|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
19410399|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410400|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19410401|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19410402|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19410403|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19410404|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
19410405|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
19410406|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410407|NCT03549728|Sargramostim|sargramostim|mesh-list
19410408|NCT03549728|Lenograstim|lenograstim|mesh-list
19410409|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
20470270|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470271|NCT01485185|Gabapentin|gabapentin|mesh-list
20470272|NCT01485185|Donepezil|donepezil|mesh-list
20470273|NCT01485185|Analgesics|analgesics|mesh-ancestor
20470274|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
20470275|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470276|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470277|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
20470278|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470279|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470280|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470281|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19410410|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410411|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19410412|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
20470282|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20470283|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20470284|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470285|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470286|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
20470287|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20470288|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470289|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
20470290|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
20470291|NCT01485198|Acetaminophen|acetaminophen|mesh-list
20470292|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20470293|NCT01485198|Analgesics|analgesics|mesh-ancestor
20470294|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
20470295|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470296|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470297|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
20470298|NCT01485211|Riboflavin|riboflavin|mesh-list
20470299|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
20470300|NCT01485211|Vitamins|vitamins|mesh-ancestor
20470301|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
20470302|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470303|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20470304|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
20470305|NCT01485224|Thalidomide|thalidomide|mesh-list
20470306|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470307|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
20470308|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470309|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
20470310|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20470311|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470312|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20470313|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20470314|NCT01485224|Growth Substances|growth substances|mesh-ancestor
20470315|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
19410413|NCT03549702|Povidone|povidone|mesh-list
19410414|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
19410415|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
19410416|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19410417|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410418|NCT03549689|Tenofovir|tenofovir|mesh-list
19695835|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695836|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
19695837|NCT04946383|Protective Agents|protective agents|mesh-ancestor
19695838|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695839|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
19695840|NCT04946370|Edetic Acid|edetic acid|mesh-list
19695841|NCT04946370|Androgens|androgens|mesh-list
19695842|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19695843|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695844|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695845|NCT04946370|Hormones|hormones|mesh-ancestor
19695846|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695847|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695848|NCT04946370|Anticoagulants|anticoagulants|mesh-ancestor
19695849|NCT04946370|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19695850|NCT04946370|Chelating Agents|chelating agents|mesh-ancestor
19695851|NCT04946370|Sequestering Agents|sequestering agents|mesh-ancestor
19695852|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695853|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20225182|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
19410419|NCT03549689|Lamivudine|lamivudine|mesh-list
19410420|NCT03549689|Dolutegravir|dolutegravir|mesh-list
19410421|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
19410422|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695854|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
19695855|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225183|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20225184|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225185|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225186|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20225187|NCT00338546|Analgesics|analgesics|mesh-ancestor
20225188|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
20225189|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225190|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20225191|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20225192|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20225193|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
20470316|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470317|NCT01485315|Mannitol|mannitol|mesh-list
20470318|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19410423|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19410424|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19410425|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410426|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410427|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19410428|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19410429|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19410430|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19410431|NCT03549663|Prednisone|prednisone|mesh-list
20470319|NCT01485315|Diuretics|diuretics|mesh-ancestor
20470320|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
20470321|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470322|NCT01485367|Adapalene|adapalene|mesh-list
20470323|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20470324|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20470325|NCT01485367|Analgesics|analgesics|mesh-ancestor
20470326|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
20470327|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470328|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470329|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470330|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20470331|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
20470332|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20470333|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
20470334|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470335|NCT01485445|Fluticasone|fluticasone|mesh-list
20470336|NCT01485445|Xhance|xhance|mesh-list
20470337|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470338|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20470339|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
20470340|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470341|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470342|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20470343|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
20470344|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
20470345|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20470346|NCT01485562|Misoprostol|misoprostol|mesh-list
20470347|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20470348|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
20470349|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20470350|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470351|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20470352|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470353|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
20470354|NCT01485653|Mepivacaine|mepivacaine|mesh-list
20470355|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
20470356|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
20470357|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470358|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470359|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
20470360|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470361|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
20470362|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
20470363|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470364|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
20470365|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470366|NCT01485692|Promethazine|promethazine|mesh-list
20470367|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
20470368|NCT01485692|Midazolam|midazolam|mesh-list
20470369|NCT01485692|Haloperidol|haloperidol|mesh-list
20470370|NCT01485692|Olanzapine|olanzapine|mesh-list
20470371|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
20470372|NCT01485692|Ziprasidone|ziprasidone|mesh-list
20470373|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20470374|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20470375|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470376|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470377|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470378|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470379|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20470380|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20470381|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
20470382|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
19410432|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
19410433|NCT03549663|Tacrolimus|tacrolimus|mesh-list
19410434|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410435|NCT03549663|Hormones|hormones|mesh-ancestor
19410436|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410437|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410438|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19410439|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410440|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19410441|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
20470383|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
20470384|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
20470385|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470386|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470387|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
20470388|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
20470389|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470390|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470391|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20470392|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20470393|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20470394|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20470395|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
20470396|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20470397|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
20470398|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20470399|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20470400|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
20470401|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
20470402|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20470403|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
20470404|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
20470405|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19410442|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19410443|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410444|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470406|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20470407|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
20470408|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
20470409|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20470410|NCT01485718|Cathartics|cathartics|mesh-ancestor
20470411|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470412|NCT01485731|Nelfinavir|nelfinavir|mesh-list
20470413|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20470414|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20470415|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
20470416|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410445|NCT03549611|Acetaminophen|acetaminophen|mesh-list
19410446|NCT03549611|Celecoxib|celecoxib|mesh-list
19410447|NCT03549611|Oxycodone|oxycodone|mesh-list
19410448|NCT03549611|Gabapentin|gabapentin|mesh-list
19410449|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20470417|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470418|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20470419|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20470420|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
20470421|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410450|NCT03549611|Analgesics|analgesics|mesh-ancestor
19410451|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
19410452|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410453|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410454|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
19410455|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19410456|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410457|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19410458|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19410459|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19410460|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410461|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470422|NCT01485744|Leucovorin|leucovorin|mesh-list
20470423|NCT01485744|Fluorouracil|fluorouracil|mesh-list
19410462|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19410463|NCT03549611|Narcotics|narcotics|mesh-ancestor
19410464|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470424|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
20470425|NCT01485744|Irinotecan|irinotecan|mesh-list
20470426|NCT01485744|Folfirinox|folfirinox|mesh-list
20470427|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
19410465|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
19410466|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470428|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470429|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20470430|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470431|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470432|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
20470433|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470434|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20470435|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20470436|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470437|NCT01485744|Antidotes|antidotes|mesh-ancestor
19410467|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19410468|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19410469|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19410470|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19410471|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410472|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
19410473|NCT03549312|Tenofovir|tenofovir|mesh-list
19410474|NCT03549312|Emtricitabine|emtricitabine|mesh-list
19410475|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
19410476|NCT03549312|Cobicistat|cobicistat|mesh-list
19410477|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20470438|NCT01485744|Protective Agents|protective agents|mesh-ancestor
20470439|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
20470440|NCT01485744|Vitamins|vitamins|mesh-ancestor
20470441|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
20470442|NCT01485809|Gefitinib|gefitinib|mesh-list
20470443|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470444|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20470445|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410478|NCT03549312|Velpatasvir|velpatasvir|mesh-list
19410479|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19410480|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19410481|NCT03549312|Elvitegravir|elvitegravir|mesh-list
19695856|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
19695857|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470446|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470447|NCT01485822|Travoprost|travoprost|mesh-list
20470448|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20470449|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20470450|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20470451|NCT01485835|Dexamethasone|dexamethasone|mesh-list
20470452|NCT01485835|Bortezomib|bortezomib|mesh-list
20470453|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470454|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
20470455|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
20470456|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470457|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850190|NCT00707863|Citalopram|citalopram|mesh-list
19850191|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20470458|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470459|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
20470460|NCT01485835|Hormones|hormones|mesh-ancestor
19695858|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695859|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19695860|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
19695861|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695862|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695863|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19695864|NCT04946162|Tadalafil|tadalafil|mesh-list
19695865|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
19695866|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19695867|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19695868|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695869|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695870|NCT04946162|Urological Agents|urological agents|mesh-ancestor
19695871|NCT04946227|Paclitaxel|paclitaxel|mesh-list
19695872|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
19850192|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20470461|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20470462|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19410482|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
19410483|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470463|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470464|NCT01485848|Paclitaxel|paclitaxel|mesh-list
20470465|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20470466|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470467|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470468|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470469|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470470|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470471|NCT01485926|Carboplatin|carboplatin|mesh-list
20470472|NCT01485926|Docetaxel|docetaxel|mesh-list
20470473|NCT01485926|Trastuzumab|trastuzumab|mesh-list
20470474|NCT01485926|Lapatinib|lapatinib|mesh-list
20470475|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470476|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470477|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470478|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470479|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470480|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621711|NCT02302547|Emtricitabine|emtricitabine|mesh-list
19410484|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19410485|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19410486|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410487|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410488|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19410489|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19410490|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19410491|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19410492|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19410493|NCT03549221|Ketorolac|ketorolac|mesh-list
19410494|NCT03549221|Epinephrine|epinephrine|mesh-list
19410495|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
19410496|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19410497|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19410498|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
19410499|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410500|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410501|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410502|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19410503|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19410504|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
19410505|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410506|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19410507|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
19410508|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
19410509|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
19410510|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19410511|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19410512|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410513|NCT03549221|Analgesics|analgesics|mesh-ancestor
19695873|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19695874|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695875|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19410514|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
19410515|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410516|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19410517|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19410518|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410519|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
19410520|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
19410521|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410522|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19410523|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
19410524|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410525|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19410526|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19410527|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19410528|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19695876|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19695877|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19695878|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695879|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19695880|NCT04946123|Selenium|selenium|mesh-list
19695881|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
19410529|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410530|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410531|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410532|NCT03549026|Analgesics|analgesics|mesh-ancestor
19410533|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
19410534|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410535|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
19410536|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19410537|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
19416731|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
19416732|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416733|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416734|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416735|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20470481|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20470482|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470483|NCT01485939|Lidocaine|lidocaine|mesh-list
20470484|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
20470485|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
20470486|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470487|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470488|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
20470489|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470490|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20470491|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20470492|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19416736|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416737|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416738|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470493|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20470494|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470495|NCT01485978|Ramipril|ramipril|mesh-list
20470496|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20470497|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
20470498|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470499|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470500|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20527231|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527232|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527233|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527234|NCT01767298|Valsartan|valsartan|mesh-list
20527235|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20527236|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20527237|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20527238|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20527239|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527240|NCT01767298|Diuretics|diuretics|mesh-ancestor
20527241|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
20527242|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527243|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20527244|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530636|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530637|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530638|NCT01789879|Efavirenz|efavirenz|mesh-list
19416739|NCT02324725|Naltrexone|naltrexone|mesh-list
19416740|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19416741|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19416742|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416743|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
19416744|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416745|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
19416746|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19416747|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416748|NCT02320708|Acetaminophen|acetaminophen|mesh-list
19416749|NCT02320708|Ibuprofen|ibuprofen|mesh-list
19416750|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416751|NCT02320708|Analgesics|analgesics|mesh-ancestor
20530639|NCT01789879|Nevirapine|nevirapine|mesh-list
20530640|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
20530641|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19416752|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
19416753|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416754|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410538|NCT03548948|Iron|iron|mesh-list
19410539|NCT03548948|Trace Elements|trace elements|mesh-ancestor
19410540|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
19410541|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621712|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
20621713|NCT02302547|Nevirapine|nevirapine|mesh-list
20621714|NCT02302547|Maraviroc|maraviroc|mesh-list
20621715|NCT02302547|Dolutegravir|dolutegravir|mesh-list
20621716|NCT02302547|Cobicistat|cobicistat|mesh-list
20621717|NCT02302547|Rilpivirine|rilpivirine|mesh-list
20621718|NCT02302547|Tipranavir|tipranavir|mesh-list
20621719|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
20621720|NCT02302547|Elvitegravir|elvitegravir|mesh-list
20621721|NCT02302547|Efavirenz|efavirenz|mesh-list
20621722|NCT02302547|Etravirine|etravirine|mesh-list
20621723|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20621724|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
20621725|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
20621726|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20621727|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621728|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621729|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20621730|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20621731|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
19410542|NCT03548818|Interferons|interferons|mesh-list
19410543|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
19410544|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410545|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
19410546|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410547|NCT03548714|Ethanol|ethanol|mesh-list
19410548|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19410549|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410550|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410551|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470501|NCT01486004|Simeprevir|simeprevir|mesh-list
20470502|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
20470503|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470504|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
19410552|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
19410553|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19410554|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
19410555|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410556|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
19410557|NCT03548662|Protective Agents|protective agents|mesh-ancestor
19410558|NCT03548571|Temozolomide|temozolomide|mesh-list
19410559|NCT03548571|Vaccines|vaccines|mesh-list
19410560|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19410561|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
19410562|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410563|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410564|NCT03548571|Immunologic Factors|immunologic factors|mesh-ancestor
19410565|NCT03548571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410566|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
19410567|NCT03548493|Fentanyl|fentanyl|mesh-list
19410568|NCT03548493|Propofol|propofol|mesh-list
19410569|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19410570|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410571|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410572|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19410573|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
19410574|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
19410575|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20470505|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470506|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470507|NCT01486017|Peficitinib|peficitinib|mesh-list
20621732|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621733|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20621734|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20621735|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19410576|NCT03548493|Narcotics|narcotics|mesh-ancestor
20621736|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20621737|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19410577|NCT03548493|Analgesics|analgesics|mesh-ancestor
19410578|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
19410579|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470508|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621738|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20621739|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20621740|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20621741|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20621742|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20621743|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20621744|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20621745|NCT02302586|Morphine|morphine|mesh-list
20621746|NCT02302586|Bupivacaine|bupivacaine|mesh-list
20621747|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
20621748|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
20621749|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621750|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621751|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
20621752|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621753|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20621754|NCT02302586|Narcotics|narcotics|mesh-ancestor
20621755|NCT02302586|Analgesics|analgesics|mesh-ancestor
20621756|NCT02302729|Micronutrients|micronutrients|mesh-list
20621757|NCT02302729|Trace Elements|trace elements|mesh-list
20621758|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621759|NCT02302768|Selenium|selenium|mesh-list
20621760|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
20621761|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621762|NCT02302768|Protective Agents|protective agents|mesh-ancestor
19410580|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19410581|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20621763|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621764|NCT02302768|Trace Elements|trace elements|mesh-ancestor
20621765|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
20621766|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
20621767|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20621768|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20621769|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
20621770|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621771|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20621772|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20621773|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621774|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621775|NCT02302976|Exenatide|exenatide|mesh-list
20621776|NCT02302976|Cocaine|cocaine|mesh-list
20621777|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621778|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621779|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20621780|NCT02302976|Incretins|incretins|mesh-ancestor
20621781|NCT02302976|Hormones|hormones|mesh-ancestor
20621782|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621783|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
20621784|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
20621785|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621786|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
20621787|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621788|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20621789|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20621790|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20621791|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20621792|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621793|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
20621794|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621795|NCT02302989|Ranibizumab|ranibizumab|mesh-list
20621796|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20621797|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20621798|NCT02302989|Growth Substances|growth substances|mesh-ancestor
20621799|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621800|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
20621801|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621802|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
20621803|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20621804|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20621805|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20621806|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20621807|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621808|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
20621809|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410582|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
19410583|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20621810|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621811|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20470509|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470510|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470511|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
20470512|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470513|NCT01486082|Amoxicillin|amoxicillin|mesh-list
20470514|NCT01486082|Clarithromycin|clarithromycin|mesh-list
20470515|NCT01486082|Omeprazole|omeprazole|mesh-list
20470516|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20470517|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470518|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20470519|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470520|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20470521|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470522|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470523|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20470524|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20470525|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20470526|NCT01486251|Axitinib|axitinib|mesh-list
20470527|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470528|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20470529|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470530|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470531|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
20470532|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
20470533|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20470534|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470535|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470536|NCT01486433|Aspirin|aspirin|mesh-list
20470537|NCT01486433|Simvastatin|simvastatin|mesh-list
20470538|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20470539|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20470540|NCT01486433|Analgesics|analgesics|mesh-ancestor
20470541|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
20470542|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470543|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470544|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470545|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20470546|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20470547|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20470548|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470549|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20470550|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20470551|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470552|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
20470553|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20470554|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20470555|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
20470556|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20470557|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20470558|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
20470559|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
20470560|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20470561|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470562|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470563|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
20470564|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470565|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470566|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470567|NCT01486485|Nafamostat|nafamostat|mesh-list
20470568|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20470569|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20470570|NCT01486485|Analgesics|analgesics|mesh-ancestor
20470571|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
20470572|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470573|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470574|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470575|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20470576|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
20470577|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
20470578|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470579|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470580|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20470581|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20621812|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621813|NCT02303028|Topotecan|topotecan|mesh-list
20621814|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19410584|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19410585|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410586|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19410587|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
19410588|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20621815|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20621816|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621817|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621818|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621819|NCT02303106|Lamotrigine|lamotrigine|mesh-list
20621820|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
20621821|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20621822|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20470582|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20470583|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470584|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
20470585|NCT01486511|Liver Extracts|liver extracts|mesh-list
20470586|NCT01486511|Hematinics|hematinics|mesh-ancestor
20470587|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20470588|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
20470589|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
20470590|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20470591|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
20470592|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
20470593|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20470594|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
20621823|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621824|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20621825|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470595|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
20470596|NCT01486602|Paclitaxel|paclitaxel|mesh-list
20470597|NCT01486602|Carboplatin|carboplatin|mesh-list
20470598|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20470599|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470600|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470601|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470602|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470603|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470604|NCT01486706|Gabapentin|gabapentin|mesh-list
20470605|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
20470606|NCT01486706|Analgesics|analgesics|mesh-ancestor
20470607|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
19410589|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
19410590|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
19410591|NCT03548311|Vitamins|vitamins|mesh-ancestor
19410592|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
19410593|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410594|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
19410595|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19695882|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695883|NCT04946123|Protective Agents|protective agents|mesh-ancestor
19695884|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695885|NCT04946123|Trace Elements|trace elements|mesh-ancestor
19695886|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
19695887|NCT04945824|Dexamethasone|dexamethasone|mesh-list
20470608|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470609|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470610|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
20470611|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470612|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470613|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470614|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20621826|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20621827|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20621828|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695888|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470615|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20621829|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20470616|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19410596|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
19410597|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695889|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
20621830|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20621831|NCT02303119|Rituximab|rituximab|mesh-list
20621832|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621833|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621834|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
20621835|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621836|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621837|NCT02303171|Enoxaparin|enoxaparin|mesh-list
19410598|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
19410599|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19410600|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410601|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410602|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19410603|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19410604|NCT03548129|Fosfomycin|fosfomycin|mesh-list
19410605|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
19410606|NCT03547895|Vitamin K|vitamin k|mesh-list
19410607|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
19410608|NCT03547895|Ribavirin|ribavirin|mesh-list
19410609|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
19410610|NCT03547895|Furosemide|furosemide|mesh-list
19410611|NCT03547895|Spironolactone|spironolactone|mesh-list
19410612|NCT03547895|Silymarin|silymarin|mesh-list
19410613|NCT03547895|Vitamins|vitamins|mesh-ancestor
19410614|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
20621838|NCT02303171|Warfarin|warfarin|mesh-list
20621839|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
20621840|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20621841|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20621842|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621843|NCT02303223|Propofol|propofol|mesh-list
20621844|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20621845|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410615|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410616|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
20470617|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470618|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470619|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
20470620|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20470621|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20470622|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
20470623|NCT01486706|Urological Agents|urological agents|mesh-ancestor
20470624|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20470625|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
20470626|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470627|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
20470628|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
20470629|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20470630|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470631|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470632|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
20470633|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
20470634|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20470635|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470636|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470637|NCT01486888|Insulin|insulin|mesh-list
20470638|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20470639|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470640|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470641|NCT01486901|Insulin|insulin|mesh-list
20470642|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20470643|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
20470644|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
20470645|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
20470646|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470647|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470648|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
20470649|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470650|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410617|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410618|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
19410619|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410620|NCT03547895|Diuretics|diuretics|mesh-ancestor
19410621|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
19410622|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19410623|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20470651|NCT01486940|Insulin|insulin|mesh-list
20621846|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410624|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19410625|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
19410626|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410627|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19410628|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19410629|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19410630|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
19410631|NCT03547895|Coagulants|coagulants|mesh-ancestor
19410632|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
19410633|NCT03547895|Protective Agents|protective agents|mesh-ancestor
19410634|NCT03547830|Plerixafor|plerixafor|mesh-list
19410635|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19410636|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19410637|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
19410638|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410639|NCT03547804|Apatinib|apatinib|mesh-list
19410640|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410641|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19410642|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410643|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410644|NCT03547791|Betamethasone|betamethasone|mesh-list
19410645|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
19410646|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19410647|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
19410648|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19410649|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
19410650|NCT03547791|Hormones|hormones|mesh-ancestor
19410651|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410652|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410653|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410654|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19410655|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
19410656|NCT03547778|Misoprostol|misoprostol|mesh-list
19410657|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19410658|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
19410659|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410660|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410661|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19410662|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19410663|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
19410664|NCT03547700|Ixazomib|ixazomib|mesh-list
19410665|NCT03547700|Romidepsin|romidepsin|mesh-list
19410666|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410667|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
20470652|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20470653|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
20470654|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
19410668|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410669|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410670|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19410671|NCT03547622|Galantamine|galantamine|mesh-list
19410672|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19410673|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410674|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470655|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
20470656|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
20470657|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
20470658|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470659|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470660|NCT01486953|Sevoflurane|sevoflurane|mesh-list
20470661|NCT01486953|Desflurane|desflurane|mesh-list
20470662|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20470663|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20470664|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
20470665|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
20470666|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470667|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470668|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20470669|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20470670|NCT01486979|Estradiol|estradiol|mesh-list
20470671|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20470672|NCT01486979|Estrogens|estrogens|mesh-ancestor
20470673|NCT01486979|Hormones|hormones|mesh-ancestor
19695890|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
19410675|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
20470674|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20470675|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470676|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20470677|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
20470678|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20470679|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20470680|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
20470681|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20470682|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470683|NCT01487096|Teriflunomide|teriflunomide|mesh-list
20470684|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20470685|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410676|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470686|NCT01487096|Analgesics|analgesics|mesh-ancestor
20470687|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
20470688|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470689|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470690|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20470691|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20470692|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470693|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
19695891|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695892|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470694|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
20470695|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20470696|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410677|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410678|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19410679|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
19410680|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470697|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20470698|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20470699|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470700|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410681|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
19410682|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19410683|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
19410684|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19410685|NCT03547505|Protective Agents|protective agents|mesh-ancestor
19410686|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410687|NCT03547375|Apatinib|apatinib|mesh-list
19410688|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470701|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470702|NCT01487226|Paclitaxel|paclitaxel|mesh-list
20470703|NCT01487226|Cisplatin|cisplatin|mesh-list
20470704|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20470705|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470706|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470707|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470708|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470709|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470710|NCT01487278|Misoprostol|misoprostol|mesh-list
20470711|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20470712|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
20470713|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20470714|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410689|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19410690|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410691|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410692|NCT03547362|Caseins|caseins|mesh-list
19410693|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
19410694|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
19410695|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410696|NCT03547232|Indomethacin|indomethacin|mesh-list
19410697|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19410698|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410699|NCT03547232|Analgesics|analgesics|mesh-ancestor
19410700|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
19410701|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410702|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410703|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410704|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695893|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19695894|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
20470715|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20470716|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20470717|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
20470718|NCT01487304|Hormones|hormones|mesh-list
20470719|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410705|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
19410706|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
19410707|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410708|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19410709|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410710|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410711|NCT03547219|Citalopram|citalopram|mesh-list
19410712|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19410713|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19410714|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19410715|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410716|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410717|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
19410718|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410719|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19410720|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
19410721|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19416755|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
19416756|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416757|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416758|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416759|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416760|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416761|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416762|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19416763|NCT02309671|Hormones|hormones|mesh-ancestor
19416764|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416765|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416766|NCT02306291|Cytarabine|cytarabine|mesh-list
19416767|NCT02306291|Etoposide|etoposide|mesh-list
19416768|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
19416769|NCT02306291|Idarubicin|idarubicin|mesh-list
19416770|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19416771|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416772|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20470720|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470721|NCT01487317|Rivastigmine|rivastigmine|mesh-list
20470722|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20470723|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470724|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470725|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
20470726|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416773|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19416774|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416775|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416776|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19416777|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
19416778|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
19416779|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416780|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19416781|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
19416782|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416783|NCT02306291|Analgesics|analgesics|mesh-ancestor
19416784|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
19416785|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416786|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19416787|NCT02302079|Ranibizumab|ranibizumab|mesh-list
19416788|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19416789|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19416790|NCT02302079|Growth Substances|growth substances|mesh-ancestor
19416791|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416792|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
19416793|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416794|NCT02301234|Celecoxib|celecoxib|mesh-list
19416795|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19416796|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416797|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416798|NCT02301234|Analgesics|analgesics|mesh-ancestor
19695895|NCT04945824|Hormones|hormones|mesh-ancestor
19416799|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
20470727|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470728|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20470729|NCT01487317|Protective Agents|protective agents|mesh-ancestor
20470730|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
20470731|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470732|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470733|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
20470734|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470735|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470736|NCT01487395|Donepezil|donepezil|mesh-list
19410722|NCT03547024|Midazolam|midazolam|mesh-list
20621847|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20621848|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
20621849|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
20621850|NCT02303327|Androgens|androgens|mesh-list
20621851|NCT02303327|Hormones|hormones|mesh-ancestor
20621852|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621853|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621854|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
20621855|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20621856|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621857|NCT02303405|Pioglitazone|pioglitazone|mesh-list
20621858|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
20621859|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621860|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621861|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
20621862|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19410723|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
19410724|NCT03547024|Omeprazole|omeprazole|mesh-list
19410725|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
19410726|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19410727|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19410728|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
19410729|NCT03547024|Estradiol|estradiol|mesh-list
19410730|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19410731|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19410732|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19695896|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695897|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19695898|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695899|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19695900|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
19695901|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695902|NCT04945694|Fentanyl|fentanyl|mesh-list
19695903|NCT04945694|Propofol|propofol|mesh-list
19695904|NCT04945694|Sevoflurane|sevoflurane|mesh-list
20470737|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20470738|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470739|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470740|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
20470741|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470742|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470743|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
20470744|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
20470745|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470746|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470747|NCT01487421|Insulin|insulin|mesh-list
20470748|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20470749|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
20470750|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
20470751|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470752|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470753|NCT01487512|Hydromorphone|hydromorphone|mesh-list
20470754|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20470755|NCT01487512|Narcotics|narcotics|mesh-ancestor
20470756|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470757|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470758|NCT01487512|Analgesics|analgesics|mesh-ancestor
20470759|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
20470760|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470761|NCT01487564|Hydromorphone|hydromorphone|mesh-list
20470762|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20621863|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19410733|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410734|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470763|NCT01487564|Narcotics|narcotics|mesh-ancestor
20470764|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470765|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470766|NCT01487564|Analgesics|analgesics|mesh-ancestor
20470767|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
20470768|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527245|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
20527246|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
20527247|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20527248|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
20527249|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527250|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527251|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527252|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20527253|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527254|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
20527255|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527256|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20527257|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
20621864|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621865|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621866|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621867|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20621868|NCT02303418|Oxytocin|oxytocin|mesh-list
20621869|NCT02303418|Carbetocin|carbetocin|mesh-list
20621870|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
20621871|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20621872|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621873|NCT02303444|Sorafenib|sorafenib|mesh-list
20621874|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621875|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20621876|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621877|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621878|NCT02303483|Niacinamide|niacinamide|mesh-list
20621879|NCT02303483|Niacin|niacin|mesh-list
20621880|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
20621881|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
20621882|NCT02303483|Vitamins|vitamins|mesh-ancestor
20621883|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
20621884|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621885|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20621886|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
20621887|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621888|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20621889|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
20621890|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
20621891|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20621892|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20621893|NCT02303587|Prednisolone|prednisolone|mesh-list
20621894|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
20621895|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20621896|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
20527258|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527259|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527260|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20527261|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621897|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20621898|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
20621899|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
20621900|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621901|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621902|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20621903|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
20621904|NCT02303587|Hormones|hormones|mesh-ancestor
20621905|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621906|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20621907|NCT02303587|Protective Agents|protective agents|mesh-ancestor
20621908|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20621909|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621910|NCT02303600|Montelukast|montelukast|mesh-list
20621911|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20621912|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
20621913|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20621914|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
19695905|NCT04945694|Atracurium|atracurium|mesh-list
20621915|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621916|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621917|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20621918|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20621919|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621920|NCT02303639|Amiodarone|amiodarone|mesh-list
20621921|NCT02303639|Sotalol|sotalol|mesh-list
20621922|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20621923|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
20621924|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20621925|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20621926|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621927|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20621928|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20621929|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20621930|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621931|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20621932|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20621933|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20621934|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20621935|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20621936|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621937|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621938|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621939|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
20621940|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
20621941|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621942|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
20621943|NCT02303730|Exenatide|exenatide|mesh-list
20621944|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20621945|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621946|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20621947|NCT02303730|Incretins|incretins|mesh-ancestor
20621948|NCT02303730|Hormones|hormones|mesh-ancestor
20621949|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20621950|NCT02303769|Tamsulosin|tamsulosin|mesh-list
20621951|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20621952|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20621953|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20621954|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
20621955|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470769|NCT01487629|Bevacizumab|bevacizumab|mesh-list
20470770|NCT01487629|Ranibizumab|ranibizumab|mesh-list
20470771|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20470772|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470773|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20470774|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20470775|NCT01487629|Growth Substances|growth substances|mesh-ancestor
20470776|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470777|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
20470778|NCT01487785|Gemcitabine|gemcitabine|mesh-list
20470779|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20470780|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
20470781|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470782|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470783|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
20621956|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621957|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621958|NCT02303769|Urological Agents|urological agents|mesh-ancestor
20621959|NCT02303782|Azacitidine|azacitidine|mesh-list
20621960|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20621961|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
20621962|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621963|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621964|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621965|NCT02303847|Ketamine|ketamine|mesh-list
20621966|NCT02303847|Analgesics|analgesics|mesh-ancestor
20621967|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
20621968|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20621969|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621970|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20621971|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20621972|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
20621973|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
20621974|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20621975|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20621976|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20621977|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20621978|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621979|NCT02303873|Alendronate|alendronate|mesh-list
20621980|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20621981|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470784|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470785|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470786|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470787|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
19410735|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19410736|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19410737|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19410738|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
19410739|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
19410740|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
20470788|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470789|NCT01487798|Insulin|insulin|mesh-list
20470790|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20621982|NCT02303886|Methylene Blue|methylene blue|mesh-list
20621983|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621984|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621985|NCT02303899|Gemcitabine|gemcitabine|mesh-list
20621986|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
20470791|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
20470792|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
20470793|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20621987|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20621988|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
20621989|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20621990|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20621991|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
20621992|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20621993|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20621994|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20621995|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
20621996|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20621997|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19410741|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
19410742|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410743|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410744|NCT03547024|Estrogens|estrogens|mesh-ancestor
19410745|NCT03547024|Hormones|hormones|mesh-ancestor
19410746|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410747|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19410748|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
19410749|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410750|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19850193|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19850194|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850195|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850196|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
19850197|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855601|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225194|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225195|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225196|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
20225197|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
20225198|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20225199|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20225200|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20225201|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225202|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
20225203|NCT00338624|Oxybutynin|oxybutynin|mesh-list
20225204|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
20225205|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
20225206|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225207|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225208|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20225209|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20225210|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
20621998|NCT02303912|Carboplatin|carboplatin|mesh-list
20621999|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622000|NCT02303951|Atezolizumab|atezolizumab|mesh-list
20622001|NCT02303951|Vemurafenib|vemurafenib|mesh-list
20622002|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622003|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20622004|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622005|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850198|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19850199|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
19850200|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19850201|NCT00707967|Vaccines|vaccines|mesh-list
19850202|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
19850203|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850204|NCT00707980|Vortioxetine|vortioxetine|mesh-list
20470794|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470795|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470796|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
20470797|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
20470798|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20470799|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470800|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470801|NCT01487993|Metformin|metformin|mesh-list
19850205|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
20225211|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225212|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225213|NCT00338624|Urological Agents|urological agents|mesh-ancestor
20225214|NCT00338650|Adalimumab|adalimumab|mesh-list
20225215|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225216|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225217|NCT00338754|Adalimumab|adalimumab|mesh-list
20225218|NCT00338754|Antibodies|antibodies|mesh-list
20225219|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20225220|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
20225221|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225222|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225223|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225224|NCT00338767|Fluoxetine|fluoxetine|mesh-list
20470802|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470803|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470804|NCT01488045|Fentanyl|fentanyl|mesh-list
20470805|NCT01488045|Midazolam|midazolam|mesh-list
20470806|NCT01488045|Propofol|propofol|mesh-list
20470807|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20470808|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470809|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470810|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20470811|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
20470812|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
20470813|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20470814|NCT01488045|Narcotics|narcotics|mesh-ancestor
20470815|NCT01488045|Analgesics|analgesics|mesh-ancestor
19410751|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19410752|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19410753|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19410754|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410755|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19410756|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19410757|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20470816|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
20470817|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470818|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20622006|NCT02304042|Oxytocin|oxytocin|mesh-list
20622007|NCT02304042|Carbetocin|carbetocin|mesh-list
20622008|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
20622009|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20622010|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622011|NCT02304055|Oxytocin|oxytocin|mesh-list
20622012|NCT02304055|Carbetocin|carbetocin|mesh-list
20622013|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
20622014|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20622015|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622016|NCT02304081|Saxagliptin|saxagliptin|mesh-list
20622017|NCT02304081|Incretins|incretins|mesh-ancestor
20622018|NCT02304081|Hormones|hormones|mesh-ancestor
20622019|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622020|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622021|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20622022|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
20622023|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622024|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622025|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19410758|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
19410759|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
19410760|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19410761|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19410762|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19410763|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
19410764|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19410765|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19410766|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
19410767|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
19410768|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20225225|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20225226|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19410769|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19410770|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225227|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225228|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225229|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225230|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
20225231|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225232|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20225233|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
20225234|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225235|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20470819|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470820|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470821|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622026|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
20622027|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20470822|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
20470823|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
20622028|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20622029|NCT02304094|Prednisolone|prednisolone|mesh-list
20622030|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
20622031|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20622032|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
20622033|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622034|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
20622035|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
20622036|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622037|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622038|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622039|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
20622040|NCT02304094|Hormones|hormones|mesh-ancestor
20622041|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622042|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20622043|NCT02304094|Protective Agents|protective agents|mesh-ancestor
20622044|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20622045|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622046|NCT02304107|Letrozole|letrozole|mesh-list
20622047|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622048|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20622049|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20622050|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622051|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622052|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20622053|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
20622054|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622055|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622056|NCT02304198|Udenafil|udenafil|mesh-list
20622057|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20622058|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20622059|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622060|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622061|NCT02304211|Insulin|insulin|mesh-list
20622062|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19410771|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
19410772|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410773|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410774|NCT03546855|Apatinib|apatinib|mesh-list
19410775|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410776|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19410777|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410778|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410779|NCT03546803|Protective Agents|protective agents|mesh-list
20225236|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20225237|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225238|NCT00338780|Lamivudine|lamivudine|mesh-list
20225239|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20225240|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20225241|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470824|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410780|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410781|NCT03546634|Vaccines|vaccines|mesh-list
19410782|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
19410783|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410784|NCT03546608|Tepotinib|tepotinib|mesh-list
19410785|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410786|NCT03546530|Interferons|interferons|mesh-list
19410787|NCT03546530|Resveratrol|resveratrol|mesh-list
19410788|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470825|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470826|NCT01488136|Diazoxide|diazoxide|mesh-list
20470827|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20470828|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
20470829|NCT01488201|Brodalumab|brodalumab|mesh-list
20470830|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
20470831|NCT01488227|Vitamin D|vitamin d|mesh-list
19410789|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
19410790|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410791|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
19410792|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410793|NCT03546530|Protective Agents|protective agents|mesh-ancestor
19410794|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410795|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470832|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
20470833|NCT01488227|Vitamins|vitamins|mesh-list
20470834|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
20470835|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470836|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20470837|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20470838|NCT01488253|Sirolimus|sirolimus|mesh-list
20470839|NCT01488253|Tacrolimus|tacrolimus|mesh-list
20470840|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470841|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
20470842|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470843|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20470844|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470845|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470846|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20470847|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470848|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19410796|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19410797|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
19410798|NCT03546426|Interleukin-2|interleukin-2|mesh-list
19410799|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19410800|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410801|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410802|NCT03546426|Analgesics|analgesics|mesh-ancestor
19410803|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
19410804|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410805|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410806|NCT03546400|Methylphenidate|methylphenidate|mesh-list
20470849|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470850|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
20470851|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20470852|NCT01488266|Milnacipran|milnacipran|mesh-list
20470853|NCT01488266|Aripiprazole|aripiprazole|mesh-list
20470854|NCT01488266|Mirtazapine|mirtazapine|mesh-list
20470855|NCT01488266|Citalopram|citalopram|mesh-list
20470856|NCT01488266|Bupropion|bupropion|mesh-list
20470857|NCT01488266|Fluoxetine|fluoxetine|mesh-list
20470858|NCT01488266|Paroxetine|paroxetine|mesh-list
20470859|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20470860|NCT01488266|Sertraline|sertraline|mesh-list
20470861|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
20470862|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20470863|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20470864|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20470865|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470866|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470867|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
19410807|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19410808|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695906|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20622063|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622064|NCT02304237|Progesterone|progesterone|mesh-list
20622065|NCT02304237|Progestins|progestins|mesh-ancestor
20622066|NCT02304237|Hormones|hormones|mesh-ancestor
20622067|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622068|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622069|NCT02304250|Dexamethasone|dexamethasone|mesh-list
20622070|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622071|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
20622072|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
20622073|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622074|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410809|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19410810|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19410811|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19410812|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410813|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
19410814|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622075|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622076|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
20622077|NCT02304250|Hormones|hormones|mesh-ancestor
19410815|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
19410816|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19410817|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470868|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622078|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622079|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20622080|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622081|NCT02304276|Calcium|calcium|mesh-list
20622082|NCT02304276|Fluorides|fluorides|mesh-list
20622083|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20622084|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622085|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
20622086|NCT02304276|Protective Agents|protective agents|mesh-ancestor
20622087|NCT02304289|Artesunate|artesunate|mesh-list
20622088|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
20622089|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20622090|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20622091|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622092|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622093|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
20622094|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
20622095|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20622096|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
20622097|NCT02304354|Rituximab|rituximab|mesh-list
20622098|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20622099|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622100|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
20622101|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622102|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622103|NCT02304393|Atezolizumab|atezolizumab|mesh-list
20622104|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622105|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
20622106|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20470869|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20470870|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20470871|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470872|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20470873|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
20470874|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20470875|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20470876|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470877|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20470878|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470879|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470880|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
20470881|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20470882|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20470883|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20470884|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20622107|NCT02304445|Estrogens|estrogens|mesh-ancestor
20622108|NCT02304445|Hormones|hormones|mesh-ancestor
20622109|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622110|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622111|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20622112|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622113|NCT02304627|Insulin|insulin|mesh-list
20622114|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20622115|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622116|NCT02304783|Acetaminophen|acetaminophen|mesh-list
20622117|NCT02304783|Piroxicam|piroxicam|mesh-list
20622118|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622119|NCT02304783|Analgesics|analgesics|mesh-ancestor
20622120|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
20622121|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622122|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622123|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
20622124|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19410818|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
19410819|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20470885|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20470886|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20470887|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20470888|NCT01488266|Analgesics|analgesics|mesh-ancestor
20470889|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
20470890|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20470891|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
20622125|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19410820|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19410821|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622126|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622127|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20622128|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470892|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
20470893|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20470894|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20470895|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20622129|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622130|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
20622131|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20622132|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622133|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20622134|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20622135|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622136|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470896|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20470897|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
20470898|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20470899|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20470900|NCT01488305|Micronutrients|micronutrients|mesh-list
20470901|NCT01488305|Trace Elements|trace elements|mesh-list
20470902|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622137|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622138|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20622139|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20622140|NCT02304887|Denosumab|denosumab|mesh-list
20622141|NCT02304887|Teriparatide|teriparatide|mesh-list
20622142|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20622143|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622144|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20622145|NCT02305030|Opicapone|opicapone|mesh-list
20622146|NCT02305030|Warfarin|warfarin|mesh-list
20622147|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
20622148|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20622149|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622150|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622151|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20622152|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20622153|NCT02305069|Pioglitazone|pioglitazone|mesh-list
20622154|NCT02305069|Octreotide|octreotide|mesh-list
20470903|NCT01488344|Nintedanib|nintedanib|mesh-list
20470904|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470905|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20470906|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470907|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470908|NCT01488396|Cyclosporine|cyclosporine|mesh-list
20470909|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20470910|NCT01488396|Cyclosporins|cyclosporins|mesh-list
20622155|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20622156|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622157|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622158|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20622159|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622160|NCT02305160|Poractant alfa|poractant alfa|mesh-list
20622161|NCT02305160|Beractant|beractant|mesh-list
20622162|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20622163|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
20622164|NCT02305173|Dexamethasone|dexamethasone|mesh-list
20470911|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470912|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470913|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470914|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
20470915|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470916|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
20470917|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470918|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
20470919|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20470920|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20470921|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19410822|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410823|NCT03546283|Protective Agents|protective agents|mesh-ancestor
19410824|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410825|NCT03546088|Anesthetics|anesthetics|mesh-list
19410826|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410827|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695907|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20470922|NCT01488526|Tenofovir|tenofovir|mesh-list
20622165|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622166|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
20622167|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
20622168|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622169|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622170|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622171|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
20622172|NCT02305173|Hormones|hormones|mesh-ancestor
20622173|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622174|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20622175|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622176|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
20622177|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20622178|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622179|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20622180|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20622181|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20622182|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622183|NCT02305355|Atorvastatin|atorvastatin|mesh-list
20622184|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20622185|NCT02305355|Simvastatin|simvastatin|mesh-list
20622186|NCT02305355|Pravastatin|pravastatin|mesh-list
20622187|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20622188|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20622189|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
20622190|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622191|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20470923|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
20470924|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470925|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19850206|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19850207|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19850208|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20470926|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20470927|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470928|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470929|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20470930|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20470931|NCT01488552|Metformin|metformin|mesh-list
20470932|NCT01488552|Gemcitabine|gemcitabine|mesh-list
20470933|NCT01488552|Paclitaxel|paclitaxel|mesh-list
20470934|NCT01488552|Folfirinox|folfirinox|mesh-list
20470935|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20470936|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470937|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
20470938|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
20470939|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
20470940|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470941|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20470942|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
20470943|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
20470944|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20470945|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470946|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20470947|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
20470948|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470949|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20470950|NCT01488565|Azacitidine|azacitidine|mesh-list
20622192|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19850209|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850210|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850211|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19850212|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19850213|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19850214|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850215|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850216|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
19850217|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19850218|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19850219|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19850220|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20470951|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19410828|NCT03546075|Resveratrol|resveratrol|mesh-list
20470952|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
20622193|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622194|NCT02305394|Ketamine|ketamine|mesh-list
20622195|NCT02305394|Propofol|propofol|mesh-list
20622196|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20622197|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622198|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622199|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20622200|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
20622201|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
20622202|NCT02305394|Analgesics|analgesics|mesh-ancestor
20622203|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
20622204|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622205|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20622206|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20622207|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20622208|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622209|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622210|NCT02305485|Everolimus|everolimus|mesh-list
20622211|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622212|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20622213|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
19410829|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
20622214|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622215|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
19410830|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410831|NCT03546075|Protective Agents|protective agents|mesh-ancestor
19410832|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410833|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410834|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19410835|NCT03545997|Montelukast|montelukast|mesh-list
19410836|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19410837|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
20470953|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470954|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470955|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20470956|NCT01488656|Vitamin D|vitamin d|mesh-list
20470957|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20470958|NCT01488656|Antioxidants|antioxidants|mesh-list
20470959|NCT01488656|Vitamins|vitamins|mesh-ancestor
19410838|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19410839|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
19410840|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19410841|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410842|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19410843|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19410844|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225242|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225243|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
20470960|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
20470961|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470962|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20470963|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622216|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20622217|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
20225244|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225245|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20225246|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20225247|NCT00338793|Prednisolone|prednisolone|mesh-list
20225248|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225249|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
20225250|NCT00338793|Hormones|hormones|mesh-ancestor
20225251|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225252|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225253|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20225254|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225255|NCT00338910|Metronidazole|metronidazole|mesh-list
20225256|NCT00338910|Budesonide|budesonide|mesh-list
20225257|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225258|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20225259|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
20225260|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225261|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225262|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20622218|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622219|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622220|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20622221|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
20622222|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20622223|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
20470964|NCT01488656|Protective Agents|protective agents|mesh-ancestor
20470965|NCT01488734|Vitamin D|vitamin d|mesh-list
20470966|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
20470967|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
20470968|NCT01488734|Vitamins|vitamins|mesh-list
20470969|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
20470970|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470971|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20470972|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20470973|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20470974|NCT01488773|Montelukast|montelukast|mesh-list
20470975|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20470976|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
20470977|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20470978|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20470979|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20470980|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
20470981|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20470982|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20470983|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20470984|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
20470985|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20470986|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20470987|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20470988|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
20470989|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20470990|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20470991|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20470992|NCT01488838|Cisplatin|cisplatin|mesh-list
20470993|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20470994|NCT01488955|Fosfomycin|fosfomycin|mesh-list
20470995|NCT01488955|Ibuprofen|ibuprofen|mesh-list
20470996|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20470997|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20470998|NCT01488955|Analgesics|analgesics|mesh-ancestor
20470999|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
20471000|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471001|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471002|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471003|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471004|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20471005|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471006|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471007|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20471008|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471009|NCT01489059|Ipilimumab|ipilimumab|mesh-list
20471010|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20471011|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471012|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20471013|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471014|NCT01489072|Remifentanil|remifentanil|mesh-list
20471015|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20471016|NCT01489072|Narcotics|narcotics|mesh-ancestor
20471017|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471018|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471019|NCT01489072|Analgesics|analgesics|mesh-ancestor
20471020|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
20471021|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471022|NCT01489124|Imipenem|imipenem|mesh-list
20471023|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20471024|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471025|NCT01489137|Remifentanil|remifentanil|mesh-list
20471026|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20471027|NCT01489137|Narcotics|narcotics|mesh-ancestor
20471028|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471029|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622224|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850221|NCT00707993|Alogliptin|alogliptin|mesh-list
19850222|NCT00707993|Glipizide|glipizide|mesh-list
19850223|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850224|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850225|NCT00707993|Incretins|incretins|mesh-ancestor
19850226|NCT00707993|Hormones|hormones|mesh-ancestor
19850227|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850228|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19850229|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
19850230|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850231|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471030|NCT01489137|Analgesics|analgesics|mesh-ancestor
20471031|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
20471032|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471033|NCT01489176|Regadenoson|regadenoson|mesh-list
20471034|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20471035|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20471036|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
20471037|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
20471038|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471039|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850232|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19850233|NCT00708071|Thrombin|thrombin|mesh-list
20471040|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471041|NCT01489202|Cobalt|cobalt|mesh-list
20471042|NCT01489202|Chromium|chromium|mesh-list
20471043|NCT01489202|Everolimus|everolimus|mesh-list
20471044|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471045|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471046|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
20471047|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471048|NCT01489202|Trace Elements|trace elements|mesh-ancestor
20471049|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
20471050|NCT01489228|Benzonidazole|benzonidazole|mesh-list
20471051|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471052|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
20471053|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471054|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20471055|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20471056|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20471057|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527262|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20527263|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
20527264|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527265|NCT01767428|Acetaminophen|acetaminophen|mesh-list
20527266|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20527267|NCT01767428|Analgesics|analgesics|mesh-ancestor
20527268|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
20527269|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527270|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527271|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
20527272|NCT01767454|Ipilimumab|ipilimumab|mesh-list
20527273|NCT01767454|Trametinib|trametinib|mesh-list
20527274|NCT01767454|Dabrafenib|dabrafenib|mesh-list
20527275|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20527276|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527277|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20527278|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527279|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20527280|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527281|NCT01767532|Cephalexin|cephalexin|mesh-list
20527282|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527283|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527284|NCT01767545|Dexamethasone|dexamethasone|mesh-list
20527285|NCT01767545|Bevacizumab|bevacizumab|mesh-list
20527286|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20527287|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527288|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20527289|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20527290|NCT01767545|Growth Substances|growth substances|mesh-ancestor
20527291|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527292|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
20527293|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20527294|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
20527295|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
19410845|NCT03545711|Irinotecan|irinotecan|mesh-list
19410846|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20471058|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20471059|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
20471060|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20471061|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20471062|NCT01489319|Analgesics|analgesics|mesh-ancestor
20471063|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
20471064|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471065|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410847|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19410848|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410849|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410850|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471066|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471067|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471068|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20471069|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471070|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471071|NCT01489371|Doxorubicin|doxorubicin|mesh-list
20471072|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20471073|NCT01489371|Interleukin-12|interleukin-12|mesh-list
20471074|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20471075|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471076|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20471077|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20471078|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471079|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471080|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20471081|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
20471082|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471083|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20471084|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20471085|NCT01489371|Growth Substances|growth substances|mesh-ancestor
20471086|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
20471087|NCT01489410|Ethanol|ethanol|mesh-list
20471088|NCT01489410|Doxorubicin|doxorubicin|mesh-list
20471089|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20471090|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
20471091|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20471092|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471093|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20471094|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20471095|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471096|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471097|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20471098|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471099|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471100|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471101|NCT01489488|Riociguat|riociguat|mesh-list
20471102|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
20471103|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471104|NCT01489566|Fluorouracil|fluorouracil|mesh-list
20471105|NCT01489566|Mitomycins|mitomycins|mesh-list
20471106|NCT01489566|Mitomycin|mitomycin|mesh-list
20471107|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
20471108|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471109|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471110|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471111|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471112|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
20471113|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471114|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20471115|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
20471116|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20471117|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471118|NCT01489592|Turmeric extract|turmeric extract|mesh-list
20471119|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
20471120|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471121|NCT01489592|Protective Agents|protective agents|mesh-ancestor
20471122|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471123|NCT01489631|Sufentanil|sufentanil|mesh-list
20622225|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622226|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20622227|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
20622228|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
20622229|NCT02305550|Protective Agents|protective agents|mesh-ancestor
19410851|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
19410852|NCT03545516|Bupivacaine|bupivacaine|mesh-list
19410853|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
19410854|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
19410855|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471124|NCT01489631|Gabapentin|gabapentin|mesh-list
20471125|NCT01489631|Bupivacaine|bupivacaine|mesh-list
20471126|NCT01489631|Ropivacaine|ropivacaine|mesh-list
20471127|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
20471128|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
20471129|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410856|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850234|NCT00708071|Aprotinin|aprotinin|mesh-list
19850235|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
20225263|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
20225264|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
20225265|NCT00338910|Hormones|hormones|mesh-ancestor
20225266|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225267|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225268|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20225269|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20225270|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20225271|NCT00338936|Valsartan|valsartan|mesh-list
20225272|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20225273|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20471130|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471131|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
20471132|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471133|NCT01489631|Analgesics|analgesics|mesh-ancestor
20471134|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
20471135|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20471136|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20471137|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20471138|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20471139|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20471140|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471141|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471142|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
20471143|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20471144|NCT01489631|Narcotics|narcotics|mesh-ancestor
20471145|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20471146|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20471147|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
20471148|NCT01489644|Metformin|metformin|mesh-list
20471149|NCT01489644|Repaglinide|repaglinide|mesh-list
20471150|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471151|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410857|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
19850236|NCT00708071|Coagulants|coagulants|mesh-ancestor
20471152|NCT01489683|Lidocaine|lidocaine|mesh-list
20471153|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
20471154|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
20471155|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471156|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471157|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
20471158|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471159|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20471160|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20471161|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20471162|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471163|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471164|NCT01489696|Tamsulosin|tamsulosin|mesh-list
20471165|NCT01489696|Mirabegron|mirabegron|mesh-list
20471166|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20471167|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20471168|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20471169|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
20471170|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471171|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225274|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20471172|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471173|NCT01489696|Urological Agents|urological agents|mesh-ancestor
20471174|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20225275|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20225276|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225277|NCT00338936|Diuretics|diuretics|mesh-ancestor
20225278|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
20225279|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471175|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20622230|NCT02305615|Bevacizumab|bevacizumab|mesh-list
20622231|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20622232|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622233|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20622234|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20622235|NCT02305615|Growth Substances|growth substances|mesh-ancestor
20622236|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622237|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
20622238|NCT02305654|Paclitaxel|paclitaxel|mesh-list
20622239|NCT02305654|Ifosfamide|ifosfamide|mesh-list
20471176|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20471177|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
20622240|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20622241|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622242|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
20622243|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
20622244|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
20622245|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622246|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20622247|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
20622248|NCT02305693|Letrozole|letrozole|mesh-list
20622249|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622250|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20622251|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20622252|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622253|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622254|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20622255|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
20622256|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622257|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622258|NCT02305810|Everolimus|everolimus|mesh-list
20622259|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622260|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20622261|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
20622262|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622263|NCT02305823|Aripiprazole|aripiprazole|mesh-list
20225280|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20225281|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225282|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
19695908|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695909|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19695910|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
19695911|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
20225283|NCT00339001|Hematinics|hematinics|mesh-ancestor
20225284|NCT00339014|Zonisamide|zonisamide|mesh-list
20471178|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20471179|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20471180|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
20471181|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471182|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471183|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471184|NCT01489709|Urological Agents|urological agents|mesh-ancestor
19695912|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20225285|NCT00339014|Bupropion|bupropion|mesh-list
20225286|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20225287|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
20225288|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225289|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20225290|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20225291|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225292|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471185|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20471186|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20471187|NCT01489852|Estradiol|estradiol|mesh-list
20471188|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20471189|NCT01489852|Estrogens|estrogens|mesh-ancestor
20471190|NCT01489852|Hormones|hormones|mesh-ancestor
20471191|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471192|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471193|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20471194|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
20471195|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20471196|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20471197|NCT01489865|Fluorouracil|fluorouracil|mesh-list
20471198|NCT01489865|Veliparib|veliparib|mesh-list
20471199|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
20471200|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471201|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471202|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471203|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471204|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
20471205|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471206|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20471207|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471208|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
20471209|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20471210|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20471211|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20471212|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471213|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471214|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
20471215|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471216|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471217|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20471218|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471219|NCT01489917|Heparin|heparin|mesh-list
20471220|NCT01489917|Hemostatics|hemostatics|mesh-list
20471221|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
20471222|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20471223|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20471224|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471225|NCT01489917|Coagulants|coagulants|mesh-ancestor
20471226|NCT01489943|Pioglitazone|pioglitazone|mesh-list
20471227|NCT01489943|Midazolam|midazolam|mesh-list
20471228|NCT01489943|Omeprazole|omeprazole|mesh-list
20471229|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20471230|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20471231|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20471232|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471233|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471234|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20471235|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20471236|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20471237|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20471238|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
20471239|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
20471240|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
20471241|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
20471242|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471243|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471244|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20471245|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20225293|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
20225294|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225295|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225296|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20471246|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
20471247|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20471248|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20471249|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471250|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471251|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20471252|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20471253|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20471254|NCT01489982|Zopiclone|zopiclone|mesh-list
20471255|NCT01489982|Doxepin|doxepin|mesh-list
20471256|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20471257|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471258|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471259|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20471260|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20471261|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
20471262|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20471263|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
20471264|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
20471265|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471266|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471267|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
20471268|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
20471269|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471270|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471271|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471272|NCT01490047|Etanercept|etanercept|mesh-list
20471273|NCT01490047|Doxorubicin|doxorubicin|mesh-list
20471274|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20471275|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20471276|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471277|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20471278|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20471279|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225297|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20225298|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225299|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
20225300|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20225301|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20225302|NCT00339066|Sertraline|sertraline|mesh-list
20225303|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
20225304|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225305|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19410858|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410859|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19410860|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19410861|NCT03545516|Analgesics|analgesics|mesh-ancestor
19410862|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19695913|NCT04945694|Narcotics|narcotics|mesh-ancestor
20622264|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20622265|NCT02305823|Ziprasidone|ziprasidone|mesh-list
20622266|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
20622267|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622268|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20622269|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20622270|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622271|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622272|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
20622273|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
20622274|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622275|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622276|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20622277|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20471280|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471281|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622278|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
20622279|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20622280|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20622281|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20622282|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20622283|NCT02305836|Donepezil|donepezil|mesh-list
20622284|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20622285|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622286|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622287|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
20622288|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622289|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622290|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
20622291|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20622292|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20622293|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20622294|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
20622295|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622296|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20622297|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20622298|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622299|NCT02305901|Repaglinide|repaglinide|mesh-list
20622300|NCT02305901|Bupropion|bupropion|mesh-list
20622301|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20622302|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
20622303|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622304|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20622305|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20622306|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20622307|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622308|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
20622309|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622310|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622311|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20622312|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20622313|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622314|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20622315|NCT02305927|Vitamin D|vitamin d|mesh-list
20622316|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
20622317|NCT02305927|Vitamins|vitamins|mesh-ancestor
20622318|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
20622319|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622320|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20622321|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20622322|NCT02305940|Doxycycline|doxycycline|mesh-list
20622323|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20622324|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622325|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
20622326|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20471282|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20471283|NCT01490047|Analgesics|analgesics|mesh-ancestor
20471284|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
20471285|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471286|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471287|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471288|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471289|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20471290|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20622327|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20622328|NCT02305979|Loratadine|loratadine|mesh-list
20622329|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
20622330|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
20622331|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20622332|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20622333|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20622334|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
20622335|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
19695914|NCT04945694|Analgesics|analgesics|mesh-ancestor
19695915|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
19695916|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471291|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
20471292|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
19695917|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20471293|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19695918|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20471294|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471295|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
20471296|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471297|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471298|NCT01490203|Edetic Acid|edetic acid|mesh-list
20471299|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
20471300|NCT01490203|Antidotes|antidotes|mesh-ancestor
20471301|NCT01490203|Protective Agents|protective agents|mesh-ancestor
20471302|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471303|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
20471304|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
20471305|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471306|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20471307|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
20471308|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20471309|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20471310|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20471311|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471312|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20471313|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20471314|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471315|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471316|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
20471317|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471318|NCT01490229|Ezetimibe|ezetimibe|mesh-list
20471319|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20471320|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20471321|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
20471322|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471323|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20471324|NCT01490255|Amlodipine|amlodipine|mesh-list
20471325|NCT01490255|Ranolazine|ranolazine|mesh-list
20471326|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20471327|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20471328|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471329|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622336|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19695919|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19695920|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19695921|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19695922|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19695923|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20622337|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622338|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622339|NCT02305992|Bupivacaine|bupivacaine|mesh-list
20622340|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
20622341|NCT02305992|Anesthetics|anesthetics|mesh-list
20622342|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622343|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622344|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
20622345|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622346|NCT02306031|Diclofenac|diclofenac|mesh-list
20622347|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
20622348|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622349|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622350|NCT02306031|Analgesics|analgesics|mesh-ancestor
20622351|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
20622352|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622353|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622354|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622355|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622356|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20622357|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622358|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622359|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20622360|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20622361|NCT02306070|Metformin|metformin|mesh-list
20622362|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20622363|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622364|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
20622365|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19695924|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19695925|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
19695926|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622366|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622367|NCT02306239|Terlipressin|terlipressin|mesh-list
20622368|NCT02306239|Norepinephrine|norepinephrine|mesh-list
20622369|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20622370|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20622371|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
20622372|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622373|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622374|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622375|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
20622376|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
20622377|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622378|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20622379|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20622380|NCT02306278|Gabapentin|gabapentin|mesh-list
20622381|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622382|NCT02306278|Analgesics|analgesics|mesh-ancestor
20622383|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
20622384|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622385|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
20622386|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20622387|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20622388|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622389|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622390|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20622391|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20622392|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622393|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622394|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
20622395|NCT02306473|Mannitol|mannitol|mesh-list
20622396|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20622397|NCT02306473|Diuretics|diuretics|mesh-ancestor
20622398|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
20622399|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622400|NCT02306564|Cabergoline|cabergoline|mesh-list
20622401|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20622402|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20622403|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
20622404|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
20622405|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622406|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471330|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20471331|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471332|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
20471333|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20471334|NCT01490268|Sufentanil|sufentanil|mesh-list
20471335|NCT01490268|Dsuvia|dsuvia|mesh-list
20471336|NCT01490268|Hydromorphone|hydromorphone|mesh-list
20471337|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20471338|NCT01490268|Narcotics|narcotics|mesh-ancestor
20471339|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471340|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471341|NCT01490268|Analgesics|analgesics|mesh-ancestor
20471342|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
20471343|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471344|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20471345|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20471346|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
20471347|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
20471348|NCT01490333|Vitamin D|vitamin d|mesh-list
20471349|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
20471350|NCT01490333|Vitamins|vitamins|mesh-ancestor
20471351|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
20471352|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622407|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622408|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20622409|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20622410|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20622411|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
20622412|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622413|NCT02306629|Epratuzumab|epratuzumab|mesh-list
20622414|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20471353|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20471354|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20471355|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20622415|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622416|NCT02306733|Oxytocin|oxytocin|mesh-list
20622417|NCT02306733|Ergonovine|ergonovine|mesh-list
20622418|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
20622419|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20622420|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622421|NCT02306772|Mesalamine|mesalamine|mesh-list
20622422|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622423|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622424|NCT02306772|Analgesics|analgesics|mesh-ancestor
20622425|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
20622426|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622427|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622428|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622429|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622430|NCT02306785|Mesalamine|mesalamine|mesh-list
20622431|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622432|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622433|NCT02306785|Analgesics|analgesics|mesh-ancestor
20622434|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
20622435|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622436|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622437|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622438|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622439|NCT02306798|Mesalamine|mesalamine|mesh-list
20622440|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622441|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622442|NCT02306798|Analgesics|analgesics|mesh-ancestor
20622443|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
20622444|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622445|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622446|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622447|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622448|NCT02306889|Fenofibrate|fenofibrate|mesh-list
20622449|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20622450|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
20622451|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622452|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20622453|NCT02306902|Fenofibrate|fenofibrate|mesh-list
20622454|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20622455|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
20471356|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
20471357|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471358|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20622456|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622457|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20622458|NCT02306954|Aldesleukin|aldesleukin|mesh-list
20622459|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622460|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20622461|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20622462|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
20622463|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622464|NCT02307006|Vancomycin|vancomycin|mesh-list
20622465|NCT02307006|Cefazolin|cefazolin|mesh-list
20622466|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20622467|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20471359|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20471360|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20471361|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
20471362|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471363|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20471364|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20471365|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471366|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
20471367|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471368|NCT01490437|Dexamethasone|dexamethasone|mesh-list
20471369|NCT01490437|Pemetrexed|pemetrexed|mesh-list
20471370|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471371|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471372|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471373|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
20622468|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622469|NCT02307045|Nicotine|nicotine|mesh-list
19695927|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622470|NCT02307045|Varenicline|varenicline|mesh-list
20622471|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20622472|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
20471374|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
20471375|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471376|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20471377|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
20471378|NCT01490437|Hormones|hormones|mesh-ancestor
20471379|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471380|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20471381|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471382|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471383|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20471384|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20471385|NCT01490476|Everolimus|everolimus|mesh-list
20471386|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471387|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471388|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
20471389|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471390|NCT01490502|Vitamin D|vitamin d|mesh-list
20471391|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
20471392|NCT01490502|Vitamins|vitamins|mesh-ancestor
20471393|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
20471394|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471395|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20471396|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20471397|NCT01490567|Donepezil|donepezil|mesh-list
20471398|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20471399|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471400|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471401|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
20471402|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471403|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471404|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
20471405|NCT01490658|Metformin|metformin|mesh-list
20471406|NCT01490658|Repaglinide|repaglinide|mesh-list
20471407|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471408|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471409|NCT01490671|Tenofovir|tenofovir|mesh-list
20471410|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
20471411|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622473|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622474|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622475|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20622476|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20622477|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
20622478|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622479|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622480|NCT02307149|Ipilimumab|ipilimumab|mesh-list
20622481|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20622482|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622483|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20622484|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622485|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
20622486|NCT02307201|Analgesics|analgesics|mesh-ancestor
20622487|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
20622488|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622489|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622490|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
20622491|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622492|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20622493|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
20622494|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20471412|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20471413|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20471414|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471415|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471416|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20471417|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20471418|NCT01490749|Carboplatin|carboplatin|mesh-list
20471419|NCT01490749|Capecitabine|capecitabine|mesh-list
20471420|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
19410863|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19695928|NCT04945577|Vitamin D|vitamin d|mesh-list
19695929|NCT04945577|Vitamins|vitamins|mesh-ancestor
20471421|NCT01490749|Everolimus|everolimus|mesh-list
20622495|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19695930|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
20471422|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622496|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622497|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20622498|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
20622499|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20471423|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471424|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
20471425|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471426|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471427|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
20471428|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471429|NCT01490762|Insulin|insulin|mesh-list
20471430|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20471431|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471432|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471433|NCT01490905|Ibuprofen|ibuprofen|mesh-list
20471434|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20471435|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20471436|NCT01490905|Analgesics|analgesics|mesh-ancestor
20471437|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
20471438|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471439|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471440|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471441|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471442|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20471443|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410864|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19410865|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
20471444|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471445|NCT01490944|Iron|iron|mesh-list
20471446|NCT01490944|Folic Acid|folic acid|mesh-list
20471447|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
20471448|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
20471449|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
19410866|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471450|NCT01490944|Trace Elements|trace elements|mesh-ancestor
19850237|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19850238|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20471451|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
20471452|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471453|NCT01490944|Hematinics|hematinics|mesh-ancestor
20471454|NCT01490944|Vitamins|vitamins|mesh-ancestor
20527296|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527297|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527298|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
20527299|NCT01767545|Hormones|hormones|mesh-ancestor
20527300|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527301|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20527302|NCT01767571|Cephalexin|cephalexin|mesh-list
20527303|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527304|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527305|NCT01767584|Cephalexin|cephalexin|mesh-list
20622500|NCT02307227|Paclitaxel|paclitaxel|mesh-list
20622501|NCT02307227|Docetaxel|docetaxel|mesh-list
20622502|NCT02307227|Trastuzumab|trastuzumab|mesh-list
20622503|NCT02307227|Epirubicin|epirubicin|mesh-list
20622504|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20622505|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622506|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
20622507|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
20622508|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
20622509|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622510|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20622511|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20622512|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20622513|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20622514|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622515|NCT02307305|Acetaminophen|acetaminophen|mesh-list
20622516|NCT02307305|Celecoxib|celecoxib|mesh-list
20622517|NCT02307305|Naproxen|naproxen|mesh-list
20622518|NCT02307305|Oxycodone|oxycodone|mesh-list
20622519|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20622520|NCT02307305|Tramadol|tramadol|mesh-list
20622521|NCT02307305|Naloxone|naloxone|mesh-list
20622522|NCT02307305|Esomeprazole|esomeprazole|mesh-list
20622523|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622524|NCT02307305|Analgesics|analgesics|mesh-ancestor
20622525|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
20622526|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622527|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622528|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
20622529|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622530|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622531|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622532|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20622533|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20622534|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622535|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622536|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20622537|NCT02307305|Narcotics|narcotics|mesh-ancestor
20622538|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622539|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20622540|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622541|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20622542|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20622543|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20622544|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20622545|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410867|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410868|NCT03545373|Amoxicillin|amoxicillin|mesh-list
19410869|NCT03545373|Azithromycin|azithromycin|mesh-list
19410870|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19410871|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416800|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416801|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416802|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416803|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416804|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20527306|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20622546|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
20622547|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622548|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
20622549|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
20622550|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20622551|NCT02307383|Lactitol|lactitol|mesh-list
20622552|NCT02307383|Cathartics|cathartics|mesh-ancestor
20471455|NCT01490996|Curcumin|curcumin|mesh-list
20471456|NCT01490996|Capecitabine|capecitabine|mesh-list
20471457|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471458|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
20471459|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471460|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471461|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622553|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622554|NCT02307396|Haloperidol|haloperidol|mesh-list
20622555|NCT02307396|Pimozide|pimozide|mesh-list
20622556|NCT02307396|Olanzapine|olanzapine|mesh-list
20622557|NCT02307396|Risperidone|risperidone|mesh-list
20622558|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20622559|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20622560|NCT02307396|Ziprasidone|ziprasidone|mesh-list
20622561|NCT02307396|Amisulpride|amisulpride|mesh-list
20622562|NCT02307396|Perphenazine|perphenazine|mesh-list
20622563|NCT02307396|Sertindole|sertindole|mesh-list
20622564|NCT02307396|Fluphenazine|fluphenazine|mesh-list
20622565|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
20622566|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
20622567|NCT02307396|Sulpiride|sulpiride|mesh-list
20622568|NCT02307396|Thioridazine|thioridazine|mesh-list
20622569|NCT02307396|Clopenthixol|clopenthixol|mesh-list
20622570|NCT02307396|Fluspirilene|fluspirilene|mesh-list
20622571|NCT02307396|Benperidol|benperidol|mesh-list
20622572|NCT02307396|Bromperidol|bromperidol|mesh-list
20622573|NCT02307396|Perazine|perazine|mesh-list
20622574|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20622575|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
20622576|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622577|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622578|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622579|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20622580|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20622581|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622582|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622583|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20622584|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
20622585|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
20622586|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
20622587|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622588|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622589|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20622590|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20622591|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20622592|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
20622593|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20622594|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20622595|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20622596|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20622597|NCT02307487|Mitomycins|mitomycins|mesh-list
20622598|NCT02307487|Mitomycin|mitomycin|mesh-list
20622599|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20622600|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622601|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
20622602|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622603|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20225306|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20225307|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225308|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225309|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225310|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
20225311|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225312|NCT00339118|Doxorubicin|doxorubicin|mesh-list
20471462|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20471463|NCT01490996|Analgesics|analgesics|mesh-ancestor
20622604|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622605|NCT02307565|Midodrine|midodrine|mesh-list
20622606|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
20622607|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
20622608|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622609|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622610|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20471464|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
20471465|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471466|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471467|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225313|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
20225314|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20225315|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225316|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20225317|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20225318|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225319|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225320|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225321|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
20225322|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225323|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225324|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20471468|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471469|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471470|NCT01491009|Midazolam|midazolam|mesh-list
20471471|NCT01491009|Remifentanil|remifentanil|mesh-list
20225325|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
20225326|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20225327|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20225328|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471472|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20471473|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20471474|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471475|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471476|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20471477|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20471478|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20471479|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20471480|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
20471481|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
20471482|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
20471483|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
20471484|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471485|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471486|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20471487|NCT01491009|Narcotics|narcotics|mesh-ancestor
20471488|NCT01491009|Analgesics|analgesics|mesh-ancestor
20471489|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
20471490|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622611|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20622612|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20622613|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20225329|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225330|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225331|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20225332|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20225333|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225334|NCT00339196|Azacitidine|azacitidine|mesh-list
20225335|NCT00339196|Tretinoin|tretinoin|mesh-list
20225336|NCT00339196|Valproic Acid|valproic acid|mesh-list
20225337|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225338|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
20622614|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
20622615|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622616|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622617|NCT02307591|Amiodarone|amiodarone|mesh-list
20622618|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19410872|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
19410873|NCT03545347|Nandrolone|nandrolone|mesh-list
19410874|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
20225339|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225340|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225341|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225342|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
20225343|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
20225344|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
20225345|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
20225346|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471491|NCT01491048|Tacrine|tacrine|mesh-list
20471492|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19410875|NCT03545347|Androgens|androgens|mesh-ancestor
20471493|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471494|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471495|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
20471496|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471497|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622619|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
20622620|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20622621|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20622622|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622623|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20622624|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20622625|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20622626|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622627|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20622628|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20622629|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20622630|NCT02307695|Saxagliptin|saxagliptin|mesh-list
20622631|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20622632|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20622633|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622634|NCT02307695|Incretins|incretins|mesh-ancestor
20622635|NCT02307695|Hormones|hormones|mesh-ancestor
20622636|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622637|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
20622638|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622639|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622640|NCT02307721|Remifentanil|remifentanil|mesh-list
20622641|NCT02307721|Naloxone|naloxone|mesh-list
20622642|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20622643|NCT02307721|Narcotics|narcotics|mesh-ancestor
20471498|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20471499|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
20471500|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471501|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
20471502|NCT01491061|Ranolazine|ranolazine|mesh-list
20471503|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20471504|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20622644|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622645|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622646|NCT02307721|Analgesics|analgesics|mesh-ancestor
20622647|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
20622648|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622649|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20622650|NCT02307825|Azithromycin|azithromycin|mesh-list
20471505|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622651|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20622652|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622653|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
20622654|NCT02307864|Tramadol|tramadol|mesh-list
20622655|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20622656|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20622657|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622658|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20622659|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20622660|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622661|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622662|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622663|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20622664|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
20622665|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20622666|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622667|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20622668|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20622669|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20622670|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20622671|NCT02307864|Narcotics|narcotics|mesh-ancestor
20622672|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622673|NCT02307864|Analgesics|analgesics|mesh-ancestor
20622674|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
20622675|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622676|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
20622677|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
20622678|NCT02307955|Protective Agents|protective agents|mesh-ancestor
20471506|NCT01491100|Interferons|interferons|mesh-list
20622679|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622680|NCT02307968|Insulin|insulin|mesh-list
20622681|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19410876|NCT03545347|Hormones|hormones|mesh-ancestor
19410877|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471507|NCT01491100|Interferon-beta|interferon-beta|mesh-list
20471508|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
20471509|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471510|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
20471511|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471512|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
20471513|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471514|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20471515|NCT01491139|Olaparib|olaparib|mesh-list
20471516|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471517|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20471518|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471519|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471520|NCT01491191|Palmidrol|palmidrol|mesh-list
20471521|NCT01491191|Analgesics|analgesics|mesh-ancestor
19695931|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695932|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19695933|NCT04945226|Finasteride|finasteride|mesh-list
19695934|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20471522|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
20471523|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471524|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471525|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20471526|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20471527|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471528|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471529|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
20471530|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471531|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20471532|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20471533|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471534|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471535|NCT01491191|Hormones|hormones|mesh-ancestor
20471536|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471537|NCT01491204|Paclitaxel|paclitaxel|mesh-list
20471538|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20471539|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471540|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
20471541|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
20471542|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
20471543|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471544|NCT01491217|Paclitaxel|paclitaxel|mesh-list
20471545|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20471546|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410878|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410879|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
19410880|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19410881|NCT03545308|Rocuronium|rocuronium|mesh-list
19410882|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19410883|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19410884|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19410885|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410886|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695935|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20471547|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20471548|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20471549|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20471550|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471551|NCT01491256|Atorvastatin|atorvastatin|mesh-list
20471552|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20471553|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20471554|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
20471555|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471556|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20471557|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20471558|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695936|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471559|NCT01491295|Tenofovir|tenofovir|mesh-list
19695937|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695938|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
19695939|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695940|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695941|NCT04945226|Urological Agents|urological agents|mesh-ancestor
19695942|NCT04945434|Methamphetamine|methamphetamine|mesh-list
19695943|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19695944|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695945|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
19695946|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
19695947|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19695948|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
19695949|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471560|NCT01491295|Lamivudine|lamivudine|mesh-list
20471561|NCT01491295|Adefovir|adefovir|mesh-list
19410887|NCT03545243|Pantoprazole|pantoprazole|mesh-list
19410888|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19410889|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19410890|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19410891|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410892|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410893|NCT03544996|Insulin|insulin|mesh-list
19410894|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19410895|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410896|NCT03544827|Atropine|atropine|mesh-list
19410897|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20471562|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
20471563|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471564|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20471565|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20471566|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471567|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471568|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20471569|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20471570|NCT01491321|Loxoprofen|loxoprofen|mesh-list
20471571|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20471572|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20471573|NCT01491321|Analgesics|analgesics|mesh-ancestor
20471574|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
20471575|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471576|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471577|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471578|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471579|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20471580|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20471581|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471582|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
20471583|NCT01491503|Cetirizine|cetirizine|mesh-list
20471584|NCT01491503|Montelukast|montelukast|mesh-list
20471585|NCT01491503|Levocetirizine|levocetirizine|mesh-list
20471586|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20471587|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
20471588|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20471589|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
20471590|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471591|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471592|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20471593|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20471594|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471595|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20471596|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20471597|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
20471598|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
20471599|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471600|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20471601|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20471602|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20471603|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20471604|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
20471605|NCT01491815|Abatacept|abatacept|mesh-list
20471606|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20471607|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471608|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622682|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622683|NCT02308072|Olaparib|olaparib|mesh-list
20622684|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622685|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20622686|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622687|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622688|NCT02308098|Budesonide|budesonide|mesh-list
20225347|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225348|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
20225349|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20622689|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
20622690|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20622691|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622692|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20622693|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
20622694|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622695|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622696|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20622697|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
20622698|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
20622699|NCT02308098|Hormones|hormones|mesh-ancestor
20622700|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622701|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20622702|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20622703|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20622704|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
20622705|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622706|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622707|NCT02308137|Domperidone|domperidone|mesh-list
20622708|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622709|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
20622710|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
20622711|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622712|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622713|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622714|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20622715|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
20622716|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622717|NCT02308254|Lixisenatide|lixisenatide|mesh-list
20622718|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20622719|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622720|NCT02308280|Bortezomib|bortezomib|mesh-list
20622721|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622722|NCT02308319|Tenofovir|tenofovir|mesh-list
20622723|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
20622724|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622725|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20622726|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20622727|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622728|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622729|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20622730|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20622731|NCT02308332|Tenofovir|tenofovir|mesh-list
20622732|NCT02308332|Emtricitabine|emtricitabine|mesh-list
20225350|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225351|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225352|NCT00339417|Ivermectin|ivermectin|mesh-list
20225353|NCT00339417|Albendazole|albendazole|mesh-list
20225354|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20225355|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225356|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
20225357|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
20225358|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20225359|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20225360|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
20225361|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
20225362|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
20225363|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225364|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225365|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20225366|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622733|NCT02308332|Rilpivirine|rilpivirine|mesh-list
20622734|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
20622735|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225367|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20622736|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20622737|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20622738|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622739|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622740|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20622741|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20622742|NCT02308553|Paclitaxel|paclitaxel|mesh-list
20622743|NCT02308553|Nintedanib|nintedanib|mesh-list
20622744|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20622745|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622746|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
20622747|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
20622748|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
20622749|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622750|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20622751|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622752|NCT02308644|Bevacizumab|bevacizumab|mesh-list
20622753|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20622754|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622755|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20622756|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20622757|NCT02308644|Growth Substances|growth substances|mesh-ancestor
20622758|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471609|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471610|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
20471611|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471612|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471613|NCT01491867|Travoprost|travoprost|mesh-list
20471614|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20471615|NCT01492062|Pancrelipase|pancrelipase|mesh-list
20471616|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20471617|NCT01492114|Resveratrol|resveratrol|mesh-list
20471618|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
20471619|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471620|NCT01492114|Protective Agents|protective agents|mesh-ancestor
20471621|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471622|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471623|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20471624|NCT01492153|Insulin|insulin|mesh-list
20471625|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20471626|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
20471627|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
20622759|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
20622760|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20622761|NCT02308930|Vitamin D|vitamin d|mesh-list
20622762|NCT02308930|Vitamins|vitamins|mesh-list
20622763|NCT02308930|Vitamin A|vitamin a|mesh-list
20622764|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
20622765|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
20622766|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622767|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
20622768|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622769|NCT02308930|Protective Agents|protective agents|mesh-ancestor
20622770|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20622771|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622772|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20622773|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
20622774|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
20622775|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622776|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622777|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20622778|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
20622779|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622780|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622781|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20622782|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
20622783|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20622784|NCT02308982|Antibodies|antibodies|mesh-list
20622785|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
20622786|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20622787|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
20622788|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410898|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20225368|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471628|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
20622789|NCT02309177|Gemcitabine|gemcitabine|mesh-list
20622790|NCT02309177|Paclitaxel|paclitaxel|mesh-list
20622791|NCT02309177|Carboplatin|carboplatin|mesh-list
20622792|NCT02309177|Nivolumab|nivolumab|mesh-list
20622793|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20622794|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622795|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
20622796|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
20622797|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
20622798|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622799|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20622800|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
20622801|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
20622802|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622803|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622804|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20622805|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
20622806|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622807|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20622808|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20622809|NCT02309281|Aflibercept|aflibercept|mesh-list
20622810|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20622811|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20622812|NCT02309281|Growth Substances|growth substances|mesh-ancestor
20622813|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622814|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
20622815|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622816|NCT02309320|Gontivimab|gontivimab|mesh-list
20622817|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
20622818|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622819|NCT02309346|Clindamycin|clindamycin|mesh-list
20622820|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
20622821|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
20622822|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20622823|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471629|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471630|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471631|NCT01492166|Insulin|insulin|mesh-list
20471632|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20471633|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471634|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471635|NCT01492179|Lidocaine|lidocaine|mesh-list
20471636|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
20471637|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
20471638|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471639|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471640|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
20471641|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622824|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20622825|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622826|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622827|NCT02309385|Dexamethasone|dexamethasone|mesh-list
20622828|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
20622829|NCT02309385|Prednisolone|prednisolone|mesh-list
20622830|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20622831|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
20622832|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20622833|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
20622834|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20622835|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
20471642|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20471643|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20471644|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20471645|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471646|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471647|NCT01492205|Insulin|insulin|mesh-list
20471648|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20471649|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471650|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471651|NCT01492218|Insulin|insulin|mesh-list
20471652|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20471653|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471654|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471655|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20622836|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20622837|NCT02309385|BB 1101|bb 1101|mesh-list
20622838|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622839|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
20622840|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
20622841|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622842|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622843|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622844|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
20622845|NCT02309385|Hormones|hormones|mesh-ancestor
20622846|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622847|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20622848|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622849|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
20622850|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622851|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622852|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20622853|NCT02309385|Protective Agents|protective agents|mesh-ancestor
20622854|NCT02309424|Acetic Acid|acetic acid|mesh-list
20622855|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20622856|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622857|NCT02309437|Oxycodone|oxycodone|mesh-list
20622858|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20622859|NCT02309437|Narcotics|narcotics|mesh-ancestor
20622860|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622861|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622862|NCT02309437|Analgesics|analgesics|mesh-ancestor
20622863|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
20622864|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622865|NCT02309450|Asunaprevir|asunaprevir|mesh-list
20622866|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
20622867|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622868|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622869|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
20622870|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622871|NCT02309554|Nonoxynol|nonoxynol|mesh-list
20622872|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19410899|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19410900|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
19410901|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410902|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410903|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19410904|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
19410905|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
19410906|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
19410907|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19410908|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19410909|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
19410910|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410911|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410912|NCT03544814|Cisplatin|cisplatin|mesh-list
19410913|NCT03544814|Pemetrexed|pemetrexed|mesh-list
19410914|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410915|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471656|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471657|NCT01492504|Asunaprevir|asunaprevir|mesh-list
20471658|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
20471659|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471660|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471661|NCT01492543|Tegafur|tegafur|mesh-list
20471662|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471663|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
20471664|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471665|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471666|NCT01492556|Etoposide|etoposide|mesh-list
20471667|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20471668|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471669|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20471670|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20471671|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471672|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471673|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
20471674|NCT01492608|Analgesics|analgesics|mesh-ancestor
20471675|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
20471676|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471677|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622873|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20471678|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
20471679|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471680|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19410916|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410917|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19410918|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20622874|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622875|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20471681|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
19410919|NCT03544775|Anesthetics|anesthetics|mesh-list
19410920|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19410921|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410922|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
19410923|NCT03544723|Nivolumab|nivolumab|mesh-list
19410924|NCT03544723|Durvalumab|durvalumab|mesh-list
20471682|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20622876|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
20622877|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20622878|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20622879|NCT02309658|Gemcitabine|gemcitabine|mesh-list
20622880|NCT02309658|Cisplatin|cisplatin|mesh-list
20622881|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622882|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20622883|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
20622884|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622885|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
20622886|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20622887|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622888|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20622889|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
20622890|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622891|NCT02309801|Daidzin|daidzin|mesh-list
20622892|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20622893|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622894|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622895|NCT02309879|Lidocaine|lidocaine|mesh-list
20622896|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
20622897|NCT02309879|Remifentanil|remifentanil|mesh-list
20622898|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
20622899|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
20622900|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20622901|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622902|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
20622903|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622904|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20622905|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20622906|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20622907|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20622908|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622909|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20622910|NCT02309879|Narcotics|narcotics|mesh-ancestor
20622911|NCT02309879|Analgesics|analgesics|mesh-ancestor
20622912|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
20622913|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20622914|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20622915|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
20622916|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20622917|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
20622918|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20622919|NCT02309970|Aspirin|aspirin|mesh-list
20622920|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20247379|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20471683|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471684|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622921|NCT02309970|Warfarin|warfarin|mesh-list
20622922|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
20247380|NCT00432016|Zidovudine|zidovudine|mesh-list
20247381|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
20247382|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247383|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20247384|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20247385|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247386|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
20247387|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247388|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20622923|NCT02309970|Dabigatran|dabigatran|mesh-list
20622924|NCT02309970|Apixaban|apixaban|mesh-list
20622925|NCT02309970|Clopidogrel|clopidogrel|mesh-list
20622926|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20622927|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622928|NCT02309970|Analgesics|analgesics|mesh-ancestor
20622929|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
20622930|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622931|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622932|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622933|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20622934|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20622935|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20471685|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20471686|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
20471687|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20471688|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20471689|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20622936|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410925|NCT03544723|Atezolizumab|atezolizumab|mesh-list
19410926|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19410927|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410928|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19410929|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410930|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19410931|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19410932|NCT03544671|Vitamin D|vitamin d|mesh-list
19410933|NCT03544671|Vitamins|vitamins|mesh-ancestor
20471690|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20471691|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471692|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471693|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622937|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20622938|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20622939|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622940|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
20622941|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20622942|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20622943|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20622944|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
20622945|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20622946|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
20622947|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20622948|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
20622949|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20622950|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
20622951|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20471694|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471695|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
20471696|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20471697|NCT01492712|Propofol|propofol|mesh-list
20471698|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20471699|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471700|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471701|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20471702|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
20471703|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
20527307|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527308|NCT01767610|Infliximab|infliximab|mesh-list
20622952|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19410934|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
19410935|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410936|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19410937|NCT03544606|Pyridoxine|pyridoxine|mesh-list
19410938|NCT03544606|Isosorbide|isosorbide|mesh-list
19410939|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19410940|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19410941|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19410942|NCT03544606|Diuretics|diuretics|mesh-ancestor
19410943|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
19410944|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622953|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20622954|NCT02310074|Hormones|hormones|mesh-list
19410945|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
19410946|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20622955|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20622956|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622957|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622958|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20622959|NCT02310087|Vitamin E|vitamin e|mesh-list
20622960|NCT02310087|Vitamins|vitamins|mesh-ancestor
20622961|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
20622962|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622963|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
20622964|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622965|NCT02310087|Protective Agents|protective agents|mesh-ancestor
20622966|NCT02310243|Palbociclib|palbociclib|mesh-list
20622967|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622968|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20622969|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622970|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622971|NCT02310295|Triamcinolone|triamcinolone|mesh-list
20622972|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20622973|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20622974|NCT02310295|Bevacizumab|bevacizumab|mesh-list
20622975|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20622976|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20471704|NCT01492725|Plasminogen|plasminogen|mesh-list
20471705|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20471706|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20471707|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20471708|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471709|NCT01492881|Doxorubicin|doxorubicin|mesh-list
20471710|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19410947|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410948|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
19410949|NCT03544606|Vitamins|vitamins|mesh-ancestor
19410950|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
19410951|NCT03544567|Paclitaxel|paclitaxel|mesh-list
19410952|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19410953|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410954|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
19410955|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
19410956|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
20622977|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20622978|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20622979|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20622980|NCT02310295|Growth Substances|growth substances|mesh-ancestor
20622981|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622982|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
20622983|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20622984|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
20622985|NCT02310295|Hormones|hormones|mesh-ancestor
20622986|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20622987|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20622988|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
20622989|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20622990|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20622991|NCT02310347|Dronabinol|dronabinol|mesh-list
20622992|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
20622993|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20622994|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20622995|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20622996|NCT02310347|Analgesics|analgesics|mesh-ancestor
20622997|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
20622998|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20622999|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20623000|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20623001|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623002|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410957|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410958|NCT03544229|Maleic acid|maleic acid|mesh-list
19410959|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623003|NCT02310347|Hormones|hormones|mesh-ancestor
20623004|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623005|NCT02310360|Fallypride|fallypride|mesh-list
19410960|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471711|NCT01492881|Bortezomib|bortezomib|mesh-list
20471712|NCT01492881|Vorinostat|vorinostat|mesh-list
19410961|NCT03544125|Durvalumab|durvalumab|mesh-list
19410962|NCT03544125|Olaparib|olaparib|mesh-list
19410963|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19410964|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
19410965|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20471713|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20471714|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471715|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20471716|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20623006|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20623007|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20623008|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
20623009|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623010|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623011|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623012|NCT02310373|Nicotine|nicotine|mesh-list
19695950|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695951|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
19695952|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19410966|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
19410967|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19410968|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410969|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
19410970|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410971|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410972|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410973|NCT03544073|Leuprolide|leuprolide|mesh-list
19410974|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19410975|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
19410976|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19410977|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410978|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19410979|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410980|NCT03544047|Paclitaxel|paclitaxel|mesh-list
19410981|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19410982|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695953|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20471717|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471718|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471719|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20471720|NCT01492894|Cyclosporine|cyclosporine|mesh-list
20471721|NCT01492894|Sirolimus|sirolimus|mesh-list
20471722|NCT01492894|Tacrolimus|tacrolimus|mesh-list
20471723|NCT01492894|Cyclosporins|cyclosporins|mesh-list
20471724|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471725|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
20471726|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471727|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20471728|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471729|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471730|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
20471731|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471732|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
20471733|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471734|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20471735|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20471736|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471737|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
20471738|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
20471739|NCT01492920|Vitamins|vitamins|mesh-ancestor
20471740|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
20471741|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623013|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20623014|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
19410983|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
20623015|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623016|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623017|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20623018|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20623019|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
20623020|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19410984|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
19695954|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471742|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
20471743|NCT01492959|Insulin|insulin|mesh-list
19410985|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
20623021|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623022|NCT02310490|Mannitol|mannitol|mesh-list
20623023|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20623024|NCT02310490|Diuretics|diuretics|mesh-ancestor
20623025|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
20623026|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471744|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20471745|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471746|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471747|NCT01492972|Leuprolide|leuprolide|mesh-list
20471748|NCT01492972|Goserelin|goserelin|mesh-list
20471749|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20471750|NCT01492972|Buserelin|buserelin|mesh-list
20471751|NCT01492972|Androgens|androgens|mesh-list
20471752|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19410986|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410987|NCT03543969|Vemurafenib|vemurafenib|mesh-list
19410988|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850239|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
20225369|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247389|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20247390|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
20247391|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20247392|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20247393|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20247394|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247395|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247396|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
20247397|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247398|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247399|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20247400|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247401|NCT00432068|Octreotide|octreotide|mesh-list
20247402|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247403|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20247404|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247405|NCT00432081|Indomethacin|indomethacin|mesh-list
20247406|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20247407|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20247408|NCT00432081|Analgesics|analgesics|mesh-ancestor
20247409|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
20247410|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247411|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247412|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247413|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247414|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
20247415|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
20247416|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20247417|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20247418|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247419|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471753|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
19410989|NCT03543969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19695955|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19695956|NCT04945070|Insulin|insulin|mesh-list
19695957|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19695958|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695959|NCT04945096|Cytarabine|cytarabine|mesh-list
19695960|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
19695961|NCT04945096|Cyclosporine|cyclosporine|mesh-list
19695962|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
19695963|NCT04945096|Busulfan|busulfan|mesh-list
19695964|NCT04945096|Semustine|semustine|mesh-list
19695965|NCT04945096|Decitabine|decitabine|mesh-list
19695966|NCT04945096|Cyclosporins|cyclosporins|mesh-list
19695967|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
19695968|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19695969|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19695970|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
19850240|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471754|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20471755|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471756|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20471757|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471758|NCT01492972|Hormones|hormones|mesh-ancestor
20471759|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471760|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
20471761|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20471762|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
20471763|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20471764|NCT01492985|Vaccines|vaccines|mesh-list
20471765|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
20471766|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471767|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
20471768|NCT01493050|Calcium|calcium|mesh-list
20471769|NCT01493050|Sevelamer|sevelamer|mesh-list
20471770|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20471771|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471772|NCT01493050|Antacids|antacids|mesh-ancestor
20471773|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471774|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20471775|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
20471776|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
20471777|NCT01493102|Vasopressins|vasopressins|mesh-list
20471778|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
20471779|NCT01493102|Norepinephrine|norepinephrine|mesh-list
20471780|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20471781|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20471782|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
20471783|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471784|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471785|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471786|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
20471787|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
20471788|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471789|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20471790|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
20471791|NCT01493102|Coagulants|coagulants|mesh-ancestor
20471792|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20471793|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
20471794|NCT01493115|Insulin|insulin|mesh-list
20471795|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20471796|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
20471797|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471798|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471799|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
20471800|NCT01493154|Vaccines|vaccines|mesh-list
20471801|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
20471802|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471803|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471804|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471805|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20471806|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
20471807|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471808|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471809|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20471810|NCT01493310|Paclitaxel|paclitaxel|mesh-list
20471811|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20471812|NCT01493310|Mifepristone|mifepristone|mesh-list
20471813|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20471814|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19410990|NCT03543969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19410991|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19410992|NCT03543826|Rocuronium|rocuronium|mesh-list
19410993|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19410994|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20471815|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
20471816|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
19410995|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19410996|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19410997|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19410998|NCT03543774|Simvastatin|simvastatin|mesh-list
19410999|NCT03543774|Ezetimibe|ezetimibe|mesh-list
19411000|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19411001|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19411002|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19411003|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
19411004|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411005|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19411006|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19411007|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416805|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416806|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416807|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471817|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
20471818|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471819|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20471820|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
20471821|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20471822|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623027|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
20623028|NCT02310997|Melphalan|melphalan|mesh-list
20623029|NCT02310997|Busulfan|busulfan|mesh-list
20623030|NCT02310997|Fludarabine|fludarabine|mesh-list
20623031|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623032|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
20623033|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623034|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20623035|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20623036|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
20623037|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623038|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623039|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20623040|NCT02311010|Tacrolimus|tacrolimus|mesh-list
20623041|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623042|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
20623043|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623044|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20623045|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623046|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623047|NCT02311088|Caffeine|caffeine|mesh-list
20623048|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20623049|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623050|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20623051|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623052|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623053|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20623054|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20623055|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
20623056|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471823|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20471824|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20471825|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20471826|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
20471827|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20471828|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20471829|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
20471830|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471831|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
20527309|NCT01767610|Fenofibrate|fenofibrate|mesh-list
20623057|NCT02311101|Mitomycins|mitomycins|mesh-list
19695971|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623058|NCT02311101|Mitomycin|mitomycin|mesh-list
20623059|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20623060|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623061|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
20623062|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623063|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20623064|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471832|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20471833|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20471834|NCT01493336|Capecitabine|capecitabine|mesh-list
20471835|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471836|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
20471837|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471838|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471839|NCT01493388|Insulin|insulin|mesh-list
19411008|NCT03543683|Aspirin|aspirin|mesh-list
19411009|NCT03543683|Osimertinib|osimertinib|mesh-list
19411010|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19411011|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19411012|NCT03543683|Analgesics|analgesics|mesh-ancestor
19411013|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
19411014|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411015|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411016|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20471840|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20471841|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471842|NCT01493440|Atosiban|atosiban|mesh-list
20471843|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
20471844|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20471845|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471846|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
20471847|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20471848|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
20623065|NCT02311179|Cimetidine|cimetidine|mesh-list
20623066|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20623067|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623068|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20623069|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
20623070|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
20623071|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623072|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623073|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623074|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20623075|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19411017|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411018|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19411019|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20225370|NCT00339768|Amoxicillin|amoxicillin|mesh-list
20471849|NCT01493453|Fludarabine|fludarabine|mesh-list
20471850|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20471851|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
20527310|NCT01767610|Pitavastatin|pitavastatin|mesh-list
19411020|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225371|NCT00339768|Omeprazole|omeprazole|mesh-list
20225372|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20225373|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225374|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20225375|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225376|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20225377|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225378|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225379|NCT00340080|Abacavir|abacavir|mesh-list
20225380|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20225381|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20225382|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225383|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225384|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
20225385|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225386|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20225387|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20225388|NCT00340184|Paclitaxel|paclitaxel|mesh-list
20225389|NCT00340184|Carboplatin|carboplatin|mesh-list
20225390|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20225391|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471852|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471853|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471854|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20471855|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
20471856|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471857|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471858|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20623076|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623077|NCT02311205|Sorafenib|sorafenib|mesh-list
20623078|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623079|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20623080|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623081|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623082|NCT02311231|Heparin|heparin|mesh-list
20623083|NCT02311231|Calcium heparin|calcium heparin|mesh-list
20623084|NCT02311231|Bivalirudin|bivalirudin|mesh-list
20623085|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
20471859|NCT01493479|Rituximab|rituximab|mesh-list
20471860|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20471861|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471862|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
20471863|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471864|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471865|NCT01493570|BI 409306|bi 409306|mesh-list
20471866|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20471867|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471868|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471869|NCT01493622|Minocycline|minocycline|mesh-list
20471870|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20471871|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471872|NCT01493635|Analgesics|analgesics|mesh-list
20623086|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20623087|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20623088|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623089|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
20623090|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20623091|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
20623092|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623093|NCT02311439|Folfirinox|folfirinox|mesh-list
20623094|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623095|NCT02311517|Ropivacaine|ropivacaine|mesh-list
20623096|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
20623097|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
20471873|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
20471874|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471875|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471876|NCT01493648|Vitamin D|vitamin d|mesh-list
20471877|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
20471878|NCT01493648|Vitamins|vitamins|mesh-ancestor
20471879|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
20471880|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471881|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20471882|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20471883|NCT01493674|Folic Acid|folic acid|mesh-list
20471884|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
20471885|NCT01493674|Hematinics|hematinics|mesh-ancestor
20471886|NCT01493674|Vitamins|vitamins|mesh-ancestor
20471887|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
20471888|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471889|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
20471890|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20471891|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
20471892|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20471893|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471894|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20471895|NCT01493843|Paclitaxel|paclitaxel|mesh-list
20471896|NCT01493843|Bevacizumab|bevacizumab|mesh-list
20471897|NCT01493843|Carboplatin|carboplatin|mesh-list
20471898|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623098|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623099|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623100|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
20471899|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471900|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
20471901|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
20623101|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623102|NCT02311530|Felodipine|felodipine|mesh-list
20623103|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20623104|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20623105|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20623106|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623107|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623108|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20623109|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623110|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
20623111|NCT02311569|Mirabegron|mirabegron|mesh-list
20623112|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20471902|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
20471903|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471904|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20471905|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20471906|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20471907|NCT01493843|Growth Substances|growth substances|mesh-ancestor
20471908|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471909|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
20471910|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20471911|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20471912|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20471913|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20471914|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471915|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
20471916|NCT01493973|Hematinics|hematinics|mesh-ancestor
20471917|NCT01493986|Ropivacaine|ropivacaine|mesh-list
20471918|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
20471919|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
20471920|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471921|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471922|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
20623113|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20623114|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20623115|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
20623116|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623117|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623118|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623119|NCT02311569|Urological Agents|urological agents|mesh-ancestor
20623120|NCT02311608|Octreotide|octreotide|mesh-list
20623121|NCT02311608|Terlipressin|terlipressin|mesh-list
20623122|NCT02311608|Somatostatin|somatostatin|mesh-list
20623123|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623124|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20623125|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623126|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20623127|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20623128|NCT02311608|Hormones|hormones|mesh-ancestor
20623129|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623130|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471923|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471924|NCT01493999|Clopidogrel|clopidogrel|mesh-list
20471925|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20623131|NCT02311686|Ethanol|ethanol|mesh-list
20623132|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20623133|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623134|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623135|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623136|NCT02311764|Carboplatin|carboplatin|mesh-list
20623137|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623138|NCT02311777|Pregabalin|pregabalin|mesh-list
20623139|NCT02311777|Ketamine|ketamine|mesh-list
20623140|NCT02311777|Analgesics|analgesics|mesh-ancestor
20623141|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
20623142|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623143|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623144|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20623145|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20623146|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
20623147|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
20623148|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623149|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20623150|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20623151|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471926|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20471927|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20471928|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20471929|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20471930|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
20471931|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471932|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471933|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471934|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20471935|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20471936|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471937|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20471938|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20471939|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20471940|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
20471941|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471942|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20471943|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20471944|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471945|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
20471946|NCT01494155|Capecitabine|capecitabine|mesh-list
20471947|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471948|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
20471949|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471950|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471951|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
20471952|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20471953|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20471954|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20471955|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20471956|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20471957|NCT01494259|Epinephrine|epinephrine|mesh-list
20471958|NCT01494259|Bupivacaine|bupivacaine|mesh-list
20471959|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
20471960|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
20471961|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471962|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471963|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
20471964|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471965|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20471966|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20471967|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
20471968|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20471969|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471970|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20471971|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20471972|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
20471973|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20471974|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
20471975|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
20471976|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
20471977|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20527311|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20527312|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
20527313|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527314|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20527315|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20527316|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20527317|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527318|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
20527319|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527320|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527321|NCT01767623|Vemurafenib|vemurafenib|mesh-list
20527322|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527323|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20527324|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527325|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527326|NCT01767714|Plerixafor|plerixafor|mesh-list
20527327|NCT01767714|Sargramostim|sargramostim|mesh-list
20527328|NCT01767714|Lenograstim|lenograstim|mesh-list
20527329|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
20527330|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623152|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623153|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
20623154|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20623155|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623156|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20623157|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20623158|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20623159|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20623160|NCT02311946|Palbociclib|palbociclib|mesh-list
20623161|NCT02311946|Rabeprazole|rabeprazole|mesh-list
20623162|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20623163|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623164|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20623165|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623166|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623167|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20623168|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623169|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
20623170|NCT02312037|Antibodies|antibodies|mesh-list
20623171|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
20623172|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
20623173|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623174|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623175|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623176|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20623177|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
20623178|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20623179|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
20623180|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20623181|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623182|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20623183|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20623184|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623185|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20623186|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
20623187|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20623188|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
20623189|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20623190|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623191|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19695972|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19695973|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19695974|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
20471978|NCT01494311|Lidocaine|lidocaine|mesh-list
20471979|NCT01494311|Tetracaine|tetracaine|mesh-list
20471980|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
20225392|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
20471981|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
19695975|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19695976|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19695977|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19695978|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225393|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
20225394|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
20471982|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20471983|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20471984|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
20471985|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20471986|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20471987|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20471988|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20225395|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225396|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20225397|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20225398|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20225399|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
20225400|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225401|NCT00340574|Antacids|antacids|mesh-ancestor
20225402|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225403|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225404|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
20225405|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20225406|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623192|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19411021|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19411022|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19695979|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
20471989|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20471990|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471991|NCT01494363|Leucovorin|leucovorin|mesh-list
20471992|NCT01494363|Fluorouracil|fluorouracil|mesh-list
20471993|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
20471994|NCT01494363|Irinotecan|irinotecan|mesh-list
20471995|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
20471996|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20471997|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20471998|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20471999|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472000|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
20472001|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472002|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20472003|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20472004|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472005|NCT01494363|Antidotes|antidotes|mesh-ancestor
20472006|NCT01494363|Protective Agents|protective agents|mesh-ancestor
20472007|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
20472008|NCT01494363|Vitamins|vitamins|mesh-ancestor
20472009|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
20472010|NCT01494402|Aspirin|aspirin|mesh-list
20472011|NCT01494402|Esomeprazole|esomeprazole|mesh-list
20472012|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20472013|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20472014|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20472015|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472016|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472017|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20472018|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472019|NCT01494402|Analgesics|analgesics|mesh-ancestor
20472020|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
20472021|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472022|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472023|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472024|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472025|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20472026|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20472027|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20472028|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20472029|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
20472030|NCT01494415|Paclitaxel|paclitaxel|mesh-list
20472031|NCT01494415|Carboplatin|carboplatin|mesh-list
20472032|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20472033|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472034|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
20472035|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
20472036|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
20472037|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472038|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
20472039|NCT01494441|Calcium|calcium|mesh-list
20472040|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20472041|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472042|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20472043|NCT01494597|Cyclosporine|cyclosporine|mesh-list
20472044|NCT01494597|Isavuconazole|isavuconazole|mesh-list
20472045|NCT01494597|Cyclosporins|cyclosporins|mesh-list
20472046|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472047|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472048|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472049|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
20472050|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472051|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
20472052|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472053|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
20472054|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472055|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20472056|NCT01494636|Lidocaine|lidocaine|mesh-list
20472057|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20472058|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
20472059|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
20623193|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623194|NCT02312102|Lenalidomide|lenalidomide|mesh-list
20623195|NCT02312102|Bortezomib|bortezomib|mesh-list
20623196|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
20623197|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623198|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20623199|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20623200|NCT02312102|Growth Substances|growth substances|mesh-ancestor
20623201|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472060|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472061|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472062|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
20472063|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472064|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20623202|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623203|NCT02312115|Furosemide|furosemide|mesh-list
20623204|NCT02312115|Diuretics|diuretics|mesh-ancestor
20623205|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
20623206|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225407|NCT00340691|Doxycycline|doxycycline|mesh-list
20225408|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20225409|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225410|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
20225411|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20225412|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20225413|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
20225414|NCT00341055|Hematinics|hematinics|mesh-ancestor
20472065|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20472066|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20472067|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472068|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472069|NCT01494688|Paclitaxel|paclitaxel|mesh-list
20472070|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20472071|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472072|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
20472073|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
20472074|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
20472075|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472076|NCT01494714|Petrolatum|petrolatum|mesh-list
20472077|NCT01494714|Emollients|emollients|mesh-ancestor
20472078|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
20472079|NCT01494727|Amlodipine|amlodipine|mesh-list
20472080|NCT01494727|Valsartan|valsartan|mesh-list
20472081|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20472082|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20472083|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20472084|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472085|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472086|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20472087|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472088|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
20472089|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20472090|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20472091|NCT01494740|Vaccines|vaccines|mesh-list
20472092|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
20472093|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472094|NCT01494805|Ranibizumab|ranibizumab|mesh-list
20472095|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20472096|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20472097|NCT01494805|Growth Substances|growth substances|mesh-ancestor
20472098|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472099|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472100|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472101|NCT01494857|Adalimumab|adalimumab|mesh-list
20472102|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472103|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472104|NCT01495026|Tamsulosin|tamsulosin|mesh-list
20472105|NCT01495026|Dutasteride|dutasteride|mesh-list
20472106|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20472107|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20623207|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20225415|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20225416|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20225417|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
20623208|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623209|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623210|NCT02312180|Plasminogen|plasminogen|mesh-list
20623211|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20623212|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20623213|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623214|NCT02312232|Levodopa|levodopa|mesh-list
20623215|NCT02312232|Carbidopa|carbidopa|mesh-list
20623216|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20623217|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20623218|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
20623219|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623220|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623221|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623222|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20623223|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623224|NCT02312297|Minocycline|minocycline|mesh-list
20623225|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20623226|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623227|NCT02312375|Amlodipine|amlodipine|mesh-list
20623228|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20623229|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20623230|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623231|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623232|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20623233|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623234|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
20472108|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20472109|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
20472110|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472111|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472112|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472113|NCT01495026|Urological Agents|urological agents|mesh-ancestor
20472114|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20623235|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20623236|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
20623237|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623238|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623239|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623240|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623241|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
20623242|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20623243|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20623244|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623245|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
20623246|NCT02312440|Coagulants|coagulants|mesh-ancestor
20225418|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225419|NCT00341250|Antacids|antacids|mesh-ancestor
20225420|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411023|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225421|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247420|NCT00432120|Clopidogrel|clopidogrel|mesh-list
20247421|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20247422|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20247423|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20247424|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20247425|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
20472115|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20472116|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472117|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
20472118|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472119|NCT01495039|Nystatin|nystatin|mesh-list
20472120|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20472121|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247426|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247427|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247428|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411024|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
19411025|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623247|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
20623248|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623249|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623250|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
20623251|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20623252|NCT02312531|Antibodies|antibodies|mesh-list
20623253|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
20623254|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623255|NCT02312544|Timolol|timolol|mesh-list
20623256|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20623257|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19411026|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19411027|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
20472122|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
20472123|NCT01495039|Ionophores|ionophores|mesh-ancestor
20472124|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472125|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472126|NCT01495104|Valproic Acid|valproic acid|mesh-list
20472127|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
20472128|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472129|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472130|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
20472131|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472132|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472133|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
20472134|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20472135|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472136|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20472137|NCT01495117|Iodine|iodine|mesh-list
20472138|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
20472139|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20472140|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
20472141|NCT01495117|Povidone|povidone|mesh-list
20472142|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20472143|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20472144|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623258|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
20623259|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623260|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623261|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623262|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20623263|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20472145|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
20472146|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
20472147|NCT01495117|Trace Elements|trace elements|mesh-ancestor
20472148|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
20472149|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472150|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
20472151|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
20623264|NCT02312609|Minocycline|minocycline|mesh-list
20623265|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20623266|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623267|NCT02312635|Cycloserine|cycloserine|mesh-list
20472152|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
20472153|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20472154|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20472155|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472156|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472157|NCT01495169|Iloperidone|iloperidone|mesh-list
20472158|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20472159|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20623268|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20623269|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411028|NCT03543657|Hematinics|hematinics|mesh-ancestor
19411029|NCT03543436|Meropenem|meropenem|mesh-list
19411030|NCT03543436|Imipenem|imipenem|mesh-list
19411031|NCT03543436|Temocillin|temocillin|mesh-list
19411032|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19411033|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472160|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472161|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623270|NCT02312635|Renal Agents|renal agents|mesh-ancestor
19411034|NCT03543306|Trametinib|trametinib|mesh-list
19411035|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472162|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20472163|NCT01495195|Selegiline|selegiline|mesh-list
20623271|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20623272|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
20623273|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20623274|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
20623275|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623276|NCT02312661|Metformin|metformin|mesh-list
20623277|NCT02312661|Paclitaxel|paclitaxel|mesh-list
20623278|NCT02312661|Carboplatin|carboplatin|mesh-list
20623279|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623280|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623281|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
20623282|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
19695980|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
19695981|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19695982|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19695983|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
19695984|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
19695985|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19695986|NCT04945096|Expectorants|expectorants|mesh-ancestor
19695987|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
19695988|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19695989|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
19695990|NCT04945096|Protective Agents|protective agents|mesh-ancestor
20623283|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
20472164|NCT01495195|Donepezil|donepezil|mesh-list
20472165|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20472166|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472167|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472168|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
19411036|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19411037|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411038|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472169|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472170|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472171|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
20472172|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
20472173|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20472174|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20472175|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20472176|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20472177|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20472178|NCT01495195|Protective Agents|protective agents|mesh-ancestor
20472179|NCT01495208|Aflibercept|aflibercept|mesh-list
20472180|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20472181|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20623284|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623285|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623286|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623287|NCT02312804|Paclitaxel|paclitaxel|mesh-list
20623288|NCT02312804|Carboplatin|carboplatin|mesh-list
20623289|NCT02312804|Infigratinib|infigratinib|mesh-list
20623290|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623291|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623292|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
20623293|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
20623294|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
20623295|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623296|NCT02312908|Clonazepam|clonazepam|mesh-list
20623297|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
19411039|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
19411040|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19411041|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19411042|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19411043|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19411044|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411045|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
19411046|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411047|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411048|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19411049|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411050|NCT03543202|Anesthetics|anesthetics|mesh-list
19411051|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411052|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695991|NCT04944836|Clomiphene|clomiphene|mesh-list
20623298|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
19695992|NCT04944836|Enclomiphene|enclomiphene|mesh-list
20623299|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
20623300|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623301|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623302|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623303|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
20623304|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20623305|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19695993|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
19695994|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19695995|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
19695996|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19695997|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19695998|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19695999|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
19696000|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19696001|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20623306|NCT02313051|Everolimus|everolimus|mesh-list
20623307|NCT02313051|Letrozole|letrozole|mesh-list
20623308|NCT02313051|Goserelin|goserelin|mesh-list
20623309|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472182|NCT01495208|Growth Substances|growth substances|mesh-ancestor
20472183|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472184|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472185|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472186|NCT01495260|Vitamin E|vitamin e|mesh-list
20472187|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
20472188|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
20623310|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623311|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
20623312|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623313|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20623314|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20623315|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472189|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20472190|NCT01495260|Vitamins|vitamins|mesh-ancestor
20472191|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
20472192|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411053|NCT03543072|Diphosphonates|diphosphonates|mesh-list
19411054|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19411055|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411056|NCT03542955|Etoricoxib|etoricoxib|mesh-list
19411057|NCT03542955|Analgesics|analgesics|mesh-list
19411058|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
19411059|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472193|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
20623316|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623317|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20623318|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
20623319|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411060|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696002|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19696003|NCT04944966|Lumefantrine|lumefantrine|mesh-list
19696004|NCT04944966|Artemether|artemether|mesh-list
19696005|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19850241|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623320|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19411061|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19411062|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19411063|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20623321|NCT02313064|CXA-10|cxa-10|mesh-list
20623322|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411064|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20623323|NCT02313103|Lofexidine|lofexidine|mesh-list
20623324|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19850242|NCT00708097|Fluorides|fluorides|mesh-list
20225422|NCT00341432|Nicotine|nicotine|mesh-list
20225423|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20225424|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
20225425|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225426|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225427|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19411065|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20225428|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20225429|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
20225430|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225431|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472194|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472195|NCT01495260|Expectorants|expectorants|mesh-ancestor
20472196|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
20472197|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20472198|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
20472199|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225432|NCT00342381|Amifampridine|amifampridine|mesh-list
20225433|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20225434|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225435|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225436|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20225437|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225438|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472200|NCT01495260|Protective Agents|protective agents|mesh-ancestor
20472201|NCT01495260|Antidotes|antidotes|mesh-ancestor
20472202|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
20472203|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20472204|NCT01495338|Cetirizine|cetirizine|mesh-list
20623325|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20623326|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623327|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
20623328|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623329|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20623330|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20623331|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20623332|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
20623333|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623334|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623335|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
20623336|NCT02313220|Exenatide|exenatide|mesh-list
20623337|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20623338|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623339|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623340|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623341|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20623342|NCT02313220|Incretins|incretins|mesh-ancestor
20623343|NCT02313220|Hormones|hormones|mesh-ancestor
20623344|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472205|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20472206|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472207|NCT01495338|Analgesics|analgesics|mesh-ancestor
20472208|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
20623345|NCT02313272|Bevacizumab|bevacizumab|mesh-list
20623346|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
20472209|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472210|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472211|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472212|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472213|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20472214|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20472215|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20472216|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
20472217|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
20472218|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472219|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472220|NCT01495351|Bortezomib|bortezomib|mesh-list
20472221|NCT01495351|Veliparib|veliparib|mesh-list
20472222|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472223|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20472224|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472225|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472226|NCT01495377|Remifentanil|remifentanil|mesh-list
20472227|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20472228|NCT01495377|Narcotics|narcotics|mesh-ancestor
20623347|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850243|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
19850244|NCT00708097|Protective Agents|protective agents|mesh-ancestor
20225439|NCT00342849|Succimer|succimer|mesh-list
20225440|NCT00342849|Antidotes|antidotes|mesh-ancestor
20225441|NCT00342849|Protective Agents|protective agents|mesh-ancestor
20225442|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225443|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
20225444|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
20225445|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472229|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472230|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472231|NCT01495377|Analgesics|analgesics|mesh-ancestor
20472232|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
20472233|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472234|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
20472235|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
20472236|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20472237|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20472238|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472239|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472240|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472241|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472242|NCT01495468|Hormones|hormones|mesh-list
20472243|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623348|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623349|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20623350|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20623351|NCT02313272|Growth Substances|growth substances|mesh-ancestor
20623352|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623353|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
20623354|NCT02313337|Fentanyl|fentanyl|mesh-list
20623355|NCT02313337|Midazolam|midazolam|mesh-list
20623356|NCT02313337|Anesthetics|anesthetics|mesh-list
20623357|NCT02313337|Propofol|propofol|mesh-list
20623358|NCT02313337|Atracurium|atracurium|mesh-list
20623359|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623360|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623361|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20623362|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20623363|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
20623364|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20623365|NCT02313337|Narcotics|narcotics|mesh-ancestor
20623366|NCT02313337|Analgesics|analgesics|mesh-ancestor
20623367|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
20623368|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623369|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20623370|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20623371|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20623372|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20623373|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
20623374|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
20623375|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623376|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472244|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472245|NCT01495520|Ranolazine|ranolazine|mesh-list
20225446|NCT00342862|Alefacept|alefacept|mesh-list
20225447|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
20472246|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20472247|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472248|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472249|NCT01495624|Dexamethasone|dexamethasone|mesh-list
20472250|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
20472251|NCT01495624|Ropivacaine|ropivacaine|mesh-list
20472252|NCT01495624|Anesthetics|anesthetics|mesh-list
20472253|NCT01495624|BB 1101|bb 1101|mesh-list
20623377|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20623378|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20623379|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20623380|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20623381|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20623382|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
20623383|NCT02313584|Dabigatran|dabigatran|mesh-list
20623384|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
20225448|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
20225449|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225450|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20225451|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20225452|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
20225453|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225454|NCT00343005|Antacids|antacids|mesh-ancestor
20225455|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225456|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247429|NCT00432146|Lugol's solution|lugol's solution|mesh-list
20247430|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
20472254|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472255|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
20472256|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
20472257|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472258|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472259|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20472260|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
20472261|NCT01495624|Hormones|hormones|mesh-ancestor
20623385|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20623386|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
20623387|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623388|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623389|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
20472262|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472263|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20472264|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472265|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
20472266|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472267|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472268|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
20472269|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472270|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
20472271|NCT01495715|Idebenone|idebenone|mesh-list
20472272|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
20472273|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472274|NCT01495715|Protective Agents|protective agents|mesh-ancestor
20472275|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472276|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20472277|NCT01495806|Cathartics|cathartics|mesh-ancestor
20472278|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20472279|NCT01495845|Clopidogrel|clopidogrel|mesh-list
20472280|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20472281|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20472282|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20472283|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20472284|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
20472285|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472286|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472287|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472288|NCT01495884|Lapatinib|lapatinib|mesh-list
20472289|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472290|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20472291|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472292|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623390|NCT02313727|Pamidronate|pamidronate|mesh-list
20623391|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20623392|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623393|NCT02313805|Insulin|insulin|mesh-list
20623394|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623395|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623396|NCT02313883|Taurolidine|taurolidine|mesh-list
20623397|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623398|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20623399|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623400|NCT02313922|Etanercept|etanercept|mesh-list
20623401|NCT02313922|Methotrexate|methotrexate|mesh-list
20623402|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20623403|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
20623404|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20623405|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623406|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20623407|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
20623408|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623409|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623410|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
19411066|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19411067|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411068|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411069|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
20472293|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
20472294|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472295|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20472296|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623411|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623412|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19696006|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
19696007|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19696008|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19696009|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225457|NCT00343070|Citalopram|citalopram|mesh-list
20225458|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20225459|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20225460|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225461|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225462|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225463|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
20225464|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225465|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20225466|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
20225467|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225468|NCT00343096|Lorazepam|lorazepam|mesh-list
20225469|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
20225470|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
20225471|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
20225472|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472297|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472298|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
20472299|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472300|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472301|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20472302|NCT01495949|Thiopental|thiopental|mesh-list
20472303|NCT01495949|Etomidate|etomidate|mesh-list
20472304|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20472305|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472306|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472307|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20472308|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
20472309|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
20472310|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
20472311|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
20472312|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
20472313|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472314|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472315|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
20472316|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20472317|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20472318|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20472319|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472320|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472321|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
20472322|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472323|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472324|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20472325|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527331|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20527332|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20527333|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20527334|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
20527335|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527336|NCT01767896|Vaccines|vaccines|mesh-list
20527337|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
20527338|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527339|NCT01768039|Vitamin D|vitamin d|mesh-list
20527340|NCT01768039|Vitamins|vitamins|mesh-ancestor
20527341|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
20527342|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527343|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20527344|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20527345|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20527346|NCT01768078|Betamethasone|betamethasone|mesh-list
20527347|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527348|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
20527349|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20527350|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
20527351|NCT01768078|Hormones|hormones|mesh-ancestor
20527352|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527353|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527354|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20623413|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623414|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
20623415|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20623416|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20623417|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20623418|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20623419|NCT02313922|Analgesics|analgesics|mesh-ancestor
20623420|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
20472326|NCT01496105|Lidocaine|lidocaine|mesh-list
20472327|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
20623421|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623422|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20623423|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623424|NCT02314013|Metronidazole|metronidazole|mesh-list
20623425|NCT02314013|Cephalosporins|cephalosporins|mesh-list
20623426|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623427|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20623428|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20472328|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
20472329|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472330|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472331|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
20472332|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623429|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20623430|NCT02314182|Bevacizumab|bevacizumab|mesh-list
20623431|NCT02314182|Capecitabine|capecitabine|mesh-list
20623432|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
20623433|NCT02314182|Irinotecan|irinotecan|mesh-list
20623434|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623435|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623436|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20623437|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20623438|NCT02314182|Growth Substances|growth substances|mesh-ancestor
20623439|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623440|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
20623441|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20623442|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
20623443|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623444|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20623445|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20623446|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623447|NCT02314195|Serotonin|serotonin|mesh-list
20623448|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20623449|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20623450|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
20623451|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623452|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623453|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623454|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19850245|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850246|NCT00708110|Dolutegravir|dolutegravir|mesh-list
20225473|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225474|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225475|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20225476|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225477|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20225478|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20225479|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225480|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
20225481|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
20225482|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225483|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225484|NCT00343135|Amoxicillin|amoxicillin|mesh-list
20225485|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
20225486|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
20225487|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20225488|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20225489|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472333|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20472334|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20472335|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20472336|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623455|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623456|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20623457|NCT02314208|Resveratrol|resveratrol|mesh-list
20623458|NCT02314208|Atorvastatin|atorvastatin|mesh-list
20623459|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20623460|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20623461|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
20623462|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623463|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20623464|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20623465|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623466|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
20623467|NCT02314208|Protective Agents|protective agents|mesh-ancestor
20623468|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623469|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20623470|NCT02314208|Cathartics|cathartics|mesh-ancestor
20623471|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20472337|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472338|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
20472339|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20472340|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20472341|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472342|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
20472343|NCT01496196|Coagulants|coagulants|mesh-ancestor
20472344|NCT01496261|Aspirin|aspirin|mesh-list
20472345|NCT01496261|Clopidogrel|clopidogrel|mesh-list
20472346|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20472347|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472348|NCT01496261|Analgesics|analgesics|mesh-ancestor
20472349|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
20623472|NCT02314273|Oprelvekin|oprelvekin|mesh-list
20623473|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623474|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20623475|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20623476|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20623477|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
20623478|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623479|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20623480|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20623481|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623482|NCT02314312|Cyclosporine|cyclosporine|mesh-list
20623483|NCT02314312|Prednisolone|prednisolone|mesh-list
20623484|NCT02314312|Everolimus|everolimus|mesh-list
20623485|NCT02314312|Cyclosporins|cyclosporins|mesh-list
20623486|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472350|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472351|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472352|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472353|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20623487|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623488|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225490|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20225491|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225492|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225493|NCT00343161|Esomeprazole|esomeprazole|mesh-list
20225494|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20225495|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
20225496|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20623489|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
20623490|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623491|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
20623492|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411070|NCT03542851|Convulsants|convulsants|mesh-ancestor
20472354|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20472355|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20472356|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472357|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20472358|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20472359|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472360|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
20472361|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20472362|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20472363|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20472364|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
20472365|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472366|NCT01496326|Ibuprofen|ibuprofen|mesh-list
19411071|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19411072|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411073|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
19411074|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
19411075|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411076|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411077|NCT03542825|Iron|iron|mesh-list
19411078|NCT03542825|Lactoferrin|lactoferrin|mesh-list
19411079|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
19411080|NCT03542825|Trace Elements|trace elements|mesh-ancestor
19411081|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
19411082|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411083|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411084|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
19411085|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
19411086|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696010|NCT04944381|Vaccines|vaccines|mesh-list
19696011|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
19696012|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696013|NCT04944602|Omalizumab|omalizumab|mesh-list
19696014|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19696015|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19696016|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
19707858|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707859|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19707860|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
20225497|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623493|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
20623494|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411087|NCT03542760|Methylene Blue|methylene blue|mesh-list
19696017|NCT04944524|Methotrexate|methotrexate|mesh-list
20623495|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20623496|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623497|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20623498|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
19411088|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411089|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472367|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20472368|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472369|NCT01496326|Analgesics|analgesics|mesh-ancestor
20472370|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
20472371|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411090|NCT03542617|Dexamethasone|dexamethasone|mesh-list
19411091|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411092|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
19411093|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
19411094|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411095|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411096|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19411097|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
19411098|NCT03542617|Hormones|hormones|mesh-ancestor
19411099|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411100|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19411101|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411102|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
19411103|NCT03542552|Nifedipine|nifedipine|mesh-list
19411104|NCT03542552|Analgesics|analgesics|mesh-ancestor
19411105|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
20623499|NCT02314312|Hormones|hormones|mesh-ancestor
20623500|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623501|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20623502|NCT02314325|Factor VIII|factor viii|mesh-list
20623503|NCT02314325|Coagulants|coagulants|mesh-ancestor
20623504|NCT02314351|Fentanyl|fentanyl|mesh-list
20623505|NCT02314351|Metoclopramide|metoclopramide|mesh-list
20623506|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20623507|NCT02314351|Narcotics|narcotics|mesh-ancestor
20623508|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623509|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472372|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472373|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472374|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472375|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20472376|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472377|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472378|NCT01496417|Abatacept|abatacept|mesh-list
20472379|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20472380|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472381|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411106|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411107|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411108|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
20472382|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472383|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
20472384|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472385|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472386|NCT01496443|Glimepiride|glimepiride|mesh-list
20472387|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20472388|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472389|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472390|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472391|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
20472392|NCT01496521|Aspirin|aspirin|mesh-list
20472393|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20472394|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472395|NCT01496521|Analgesics|analgesics|mesh-ancestor
20472396|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
20472397|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472398|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623510|NCT02314351|Analgesics|analgesics|mesh-ancestor
20623511|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
19411109|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696018|NCT04944524|Tofacitinib|tofacitinib|mesh-list
20623512|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623513|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20472399|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472400|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472401|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20472402|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20472403|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472404|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20472405|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20472406|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472407|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
19411110|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19411111|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
19411112|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19411113|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19411114|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411115|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411116|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
19411117|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411118|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
19411119|NCT03542461|Nivolumab|nivolumab|mesh-list
20472408|NCT01496534|Carboplatin|carboplatin|mesh-list
20472409|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472410|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
20472411|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20472412|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472413|NCT01496690|Pregabalin|pregabalin|mesh-list
19411120|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19411121|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472414|NCT01496690|Analgesics|analgesics|mesh-ancestor
20472415|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
20472416|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472417|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411122|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19411123|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411124|NCT03542422|Apatinib|apatinib|mesh-list
19411125|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411126|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850247|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19850248|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19850249|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850250|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850251|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19850252|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19850253|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
19850254|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850255|NCT00708123|Listerine|listerine|mesh-list
20225498|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20225499|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225500|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225501|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20225502|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
20225503|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225504|NCT00343161|Antacids|antacids|mesh-ancestor
20225505|NCT00343174|Ancrod|ancrod|mesh-list
20225506|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
20225507|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20225508|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20225509|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225510|NCT00343187|Dapsone|dapsone|mesh-list
20225511|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225512|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
20225513|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20225514|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20225515|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20225516|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225517|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472418|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
20472419|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20472420|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472421|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472422|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20472423|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20472424|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20472425|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411127|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411128|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411129|NCT03542357|Calcitonin|calcitonin|mesh-list
19411130|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
19411131|NCT03542357|Sumatriptan|sumatriptan|mesh-list
19411132|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19696019|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20472426|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20472427|NCT01496742|Paclitaxel|paclitaxel|mesh-list
20472428|NCT01496742|Bevacizumab|bevacizumab|mesh-list
20472429|NCT01496742|Carboplatin|carboplatin|mesh-list
19411133|NCT03542357|Katacalcin|katacalcin|mesh-list
19411134|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19411135|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19411136|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19411137|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
19696020|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
19696021|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19696022|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696023|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19696024|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
19696025|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696026|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696027|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
19696028|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696029|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19696030|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696031|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
19696032|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696033|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19696034|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19696035|NCT04943952|Asparaginase|asparaginase|mesh-list
20225518|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
20225519|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20225520|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
20472430|NCT01496742|Pemetrexed|pemetrexed|mesh-list
20472431|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20472432|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472433|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
20472434|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
20472435|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
20472436|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472437|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20472438|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20472439|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20472440|NCT01496742|Growth Substances|growth substances|mesh-ancestor
20472441|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472442|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472443|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472444|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20472445|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20472446|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
20472447|NCT01496911|Levocetirizine|levocetirizine|mesh-list
20472448|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20472449|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20472450|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
20472451|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
20472452|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472453|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472454|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472455|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
20472456|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
20472457|NCT01496989|Interleukin-12|interleukin-12|mesh-list
20472458|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20472459|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
20225521|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225522|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
19696036|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225523|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20225524|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20225525|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225526|NCT00343200|Urological Agents|urological agents|mesh-ancestor
19411138|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623514|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20623515|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
20623516|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
20623517|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
20623518|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
20623519|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623520|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20623521|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20623522|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
20623523|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623524|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623525|NCT02314377|Bevacizumab|bevacizumab|mesh-list
20623526|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623527|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623528|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20623529|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20623530|NCT02314377|Growth Substances|growth substances|mesh-ancestor
20623531|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623532|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
20623533|NCT02314468|Glycerol|glycerol|mesh-list
20623534|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20623535|NCT02314468|Protective Agents|protective agents|mesh-ancestor
20623536|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623537|NCT02314481|Trastuzumab|trastuzumab|mesh-list
20623538|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20472460|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472461|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20472462|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20472463|NCT01496989|Growth Substances|growth substances|mesh-ancestor
20472464|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472465|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472466|NCT01497002|Cytarabine|cytarabine|mesh-list
20472467|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20472468|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
20472469|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472470|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472471|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
20472472|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472473|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472474|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
20472475|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472476|NCT01497041|Docetaxel|docetaxel|mesh-list
20472477|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
19411139|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411140|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411141|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411142|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19411143|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
19411144|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
20472478|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472479|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
20472480|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
20472481|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
20472482|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623539|NCT02314481|Atezolizumab|atezolizumab|mesh-list
20623540|NCT02314481|Vemurafenib|vemurafenib|mesh-list
20623541|NCT02314481|Maytansine|maytansine|mesh-list
20623542|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623543|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623544|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20623545|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623546|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472483|NCT01497093|Thalidomide|thalidomide|mesh-list
19411145|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411146|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
19411147|NCT03542279|Hormones|hormones|mesh-ancestor
19411148|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411149|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411150|NCT03542240|Curcumin|curcumin|mesh-list
19411151|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20472484|NCT01497093|Dexamethasone|dexamethasone|mesh-list
20472485|NCT01497093|Bortezomib|bortezomib|mesh-list
20472486|NCT01497093|Pomalidomide|pomalidomide|mesh-list
20623547|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623548|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
20623549|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
19411152|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19411153|NCT03542240|Analgesics|analgesics|mesh-ancestor
19411154|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
19411155|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411156|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411157|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225527|NCT00343226|Basiliximab|basiliximab|mesh-list
20225528|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472487|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472488|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
20472489|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
20472490|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472491|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472492|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20472493|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
20472494|NCT01497093|Hormones|hormones|mesh-ancestor
20472495|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472496|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20623550|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
20623551|NCT02314533|Fenofibrate|fenofibrate|mesh-list
19850256|NCT00708123|Fluorides|fluorides|mesh-list
20225529|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
20225530|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225531|NCT00343239|Docetaxel|docetaxel|mesh-list
20225532|NCT00343239|Fluorouracil|fluorouracil|mesh-list
20225533|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225534|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
20225535|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
20225536|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
20225537|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225538|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
20225539|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225540|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225541|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
20225542|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225543|NCT00343265|Progesterone|progesterone|mesh-list
20225544|NCT00343265|Progestins|progestins|mesh-ancestor
20225545|NCT00343265|Hormones|hormones|mesh-ancestor
20225546|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225547|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472497|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472498|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
20623552|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20623553|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
20623554|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623555|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20623556|NCT02314559|Propofol|propofol|mesh-list
20623557|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20623558|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623559|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623560|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20623561|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
20623562|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
20623563|NCT02314754|Misoprostol|misoprostol|mesh-list
20623564|NCT02314754|Mifepristone|mifepristone|mesh-list
20623565|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20623566|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
20623567|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20623568|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623569|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20623570|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623571|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
20623572|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19696037|NCT04944069|Bevacizumab|bevacizumab|mesh-list
19696038|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696039|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696040|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19696041|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19696042|NCT04944069|Growth Substances|growth substances|mesh-ancestor
19696043|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696044|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
19696045|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
20623573|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19696046|NCT04944082|Ivermectin|ivermectin|mesh-list
19850257|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
20225548|NCT00343278|Valacyclovir|valacyclovir|mesh-list
20225549|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
20225550|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225551|NCT00343317|Cefoxitin|cefoxitin|mesh-list
20225552|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20472499|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20472500|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20472501|NCT01497093|Growth Substances|growth substances|mesh-ancestor
20472502|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472503|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696047|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19696048|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696049|NCT04944095|Antibodies|antibodies|mesh-list
19696050|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
20472504|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
20472505|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20472506|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472507|NCT01497132|Vitamin D|vitamin d|mesh-list
20623574|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20623575|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20623576|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
20623577|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20623578|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20623579|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
20623580|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623581|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
20623582|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20623583|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20623584|NCT02314806|Clindamycin|clindamycin|mesh-list
20623585|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
20623586|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
20623587|NCT02314806|Gentamicins|gentamicins|mesh-list
20472508|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
20472509|NCT01497132|Vitamins|vitamins|mesh-ancestor
20472510|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
20472511|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472512|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20472513|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20472514|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
20472515|NCT01497145|Hematinics|hematinics|mesh-ancestor
20472516|NCT01497288|Fentanyl|fentanyl|mesh-list
20472517|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20623588|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20623589|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20623590|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623591|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20623592|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623593|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623594|NCT02314871|Morphine|morphine|mesh-list
20623595|NCT02314871|Pirinitramide|pirinitramide|mesh-list
20623596|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20623597|NCT02314871|Narcotics|narcotics|mesh-ancestor
20623598|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623599|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472518|NCT01497288|Narcotics|narcotics|mesh-ancestor
20472519|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472520|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472521|NCT01497288|Analgesics|analgesics|mesh-ancestor
20623600|NCT02314871|Analgesics|analgesics|mesh-ancestor
20623601|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
20623602|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623603|NCT02315001|Liraglutide|liraglutide|mesh-list
20623604|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623605|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623606|NCT02315001|Incretins|incretins|mesh-ancestor
20623607|NCT02315001|Hormones|hormones|mesh-ancestor
20623608|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623609|NCT02315118|Rituximab|rituximab|mesh-list
20623610|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20225553|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225554|NCT00343369|Cytarabine|cytarabine|mesh-list
20225555|NCT00343369|Dexamethasone|dexamethasone|mesh-list
20623611|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623612|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
20225556|NCT00343369|Prednisolone|prednisolone|mesh-list
20225557|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
20225558|NCT00343369|Doxorubicin|doxorubicin|mesh-list
20472522|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
20472523|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623613|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623614|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20623615|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20623616|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20623617|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
20472524|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20472525|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20472526|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
20472527|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
20472528|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
20472529|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
20472530|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472531|NCT01497392|Gemcitabine|gemcitabine|mesh-list
20472532|NCT01497392|Capecitabine|capecitabine|mesh-list
20472533|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20472534|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
20472535|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472536|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472537|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
20472538|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472539|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472540|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472541|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
20472542|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472543|NCT01497431|Selenium|selenium|mesh-list
20472544|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
20472545|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
20472546|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472547|NCT01497431|Protective Agents|protective agents|mesh-ancestor
20472548|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623618|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623619|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623620|NCT02315196|Paclitaxel|paclitaxel|mesh-list
20623621|NCT02315196|Carboplatin|carboplatin|mesh-list
20623622|NCT02315196|Doxorubicin|doxorubicin|mesh-list
20623623|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20623624|NCT02315196|Epirubicin|epirubicin|mesh-list
20623625|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623626|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623627|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
20623628|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
20623629|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
20623630|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623631|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20623632|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20623633|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20623634|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623635|NCT02315287|Pioglitazone|pioglitazone|mesh-list
20623636|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850258|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
20623637|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623638|NCT02315326|Rituximab|rituximab|mesh-list
20623639|NCT02315326|Methotrexate|methotrexate|mesh-list
20623640|NCT02315326|Procarbazine|procarbazine|mesh-list
20623641|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623642|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623643|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
20623644|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623645|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225559|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20225560|NCT00343369|Methotrexate|methotrexate|mesh-list
19850259|NCT00708123|Protective Agents|protective agents|mesh-ancestor
20225561|NCT00343369|Vincristine|vincristine|mesh-list
20225562|NCT00343369|Daunorubicin|daunorubicin|mesh-list
20225563|NCT00343369|Asparaginase|asparaginase|mesh-list
20225564|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
20225565|NCT00343369|Pegaspargase|pegaspargase|mesh-list
20225566|NCT00343369|Thioguanine|thioguanine|mesh-list
20225567|NCT00343369|Teniposide|teniposide|mesh-list
20225568|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225569|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
20225570|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472549|NCT01497431|Trace Elements|trace elements|mesh-ancestor
20472550|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
20623646|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20225571|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247431|NCT00432146|Coagulants|coagulants|mesh-ancestor
20472551|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20472552|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623647|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
19696051|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472553|NCT01497444|Sorafenib|sorafenib|mesh-list
20472554|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472555|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20472556|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472557|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696052|NCT04944212|Vitamin D|vitamin d|mesh-list
19696053|NCT04944212|Vitamins|vitamins|mesh-ancestor
19696054|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
20472558|NCT01497470|Paclitaxel|paclitaxel|mesh-list
20472559|NCT01497470|Carboplatin|carboplatin|mesh-list
20472560|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20472561|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472562|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20472563|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20472564|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20472565|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472566|NCT01497483|Cyclosporine|cyclosporine|mesh-list
20472567|NCT01497483|Pravastatin|pravastatin|mesh-list
20472568|NCT01497483|Cyclosporins|cyclosporins|mesh-list
20472569|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472570|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472571|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472572|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
20472573|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472574|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
20472575|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472576|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
20472577|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472578|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20472579|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20472580|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20472581|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
20472582|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20472583|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20472584|NCT01497522|Vildagliptin|vildagliptin|mesh-list
20472585|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472586|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472587|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20472588|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
20472589|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472590|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472591|NCT01497535|Insulin|insulin|mesh-list
20472592|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20472593|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
20472594|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
20472595|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472596|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472597|NCT01497548|Methylphenidate|methylphenidate|mesh-list
20472598|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20472599|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472600|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20472601|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20472602|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472603|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472604|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
20472605|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472606|NCT01497561|Insulin|insulin|mesh-list
20472607|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20472608|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
20472609|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
20472610|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
20472611|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
20472612|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472613|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472614|NCT01497574|Insulin|insulin|mesh-list
20472615|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20472616|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
20472617|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
20472618|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472619|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472620|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
20472621|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472622|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472623|NCT01497600|Insulin|insulin|mesh-list
20472624|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20472625|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
20472626|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
20472627|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
20472628|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
20623648|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20623649|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20623650|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
20623651|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623652|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
20623653|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623654|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20623655|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623656|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20623657|NCT02315391|Glycine|glycine|mesh-list
20623658|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
20623659|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623660|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623661|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623662|NCT02315495|Saxagliptin|saxagliptin|mesh-list
20623663|NCT02315495|Acarbose|acarbose|mesh-list
20623664|NCT02315495|Incretins|incretins|mesh-ancestor
20623665|NCT02315495|Hormones|hormones|mesh-ancestor
20623666|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623667|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623668|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20623669|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
20623670|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623671|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623672|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623673|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20623674|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20623675|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472629|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472630|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472631|NCT01497626|Bortezomib|bortezomib|mesh-list
20472632|NCT01497626|Lapatinib|lapatinib|mesh-list
20472633|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472634|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20472635|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472636|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472637|NCT01497652|Rasagiline|rasagiline|mesh-list
20472638|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20472639|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472640|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472641|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20472642|NCT01497652|Protective Agents|protective agents|mesh-ancestor
20472643|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472644|NCT01497717|Adalimumab|adalimumab|mesh-list
20472645|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472646|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527355|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
20527356|NCT01768182|Leucovorin|leucovorin|mesh-list
20527357|NCT01768182|Folic Acid|folic acid|mesh-list
20527358|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
20527359|NCT01768182|Antidotes|antidotes|mesh-ancestor
20527360|NCT01768182|Protective Agents|protective agents|mesh-ancestor
20527361|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527362|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
20527363|NCT01768182|Vitamins|vitamins|mesh-ancestor
20623676|NCT02315573|Lidocaine|lidocaine|mesh-list
20623677|NCT02315573|Epinephrine|epinephrine|mesh-list
20623678|NCT02315573|Racepinephrine|racepinephrine|mesh-list
20623679|NCT02315573|Bupivacaine|bupivacaine|mesh-list
20623680|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
20623681|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
20623682|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
20623683|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623684|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527364|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
20527365|NCT01768182|Hematinics|hematinics|mesh-ancestor
20527366|NCT01768195|Entecavir|entecavir|mesh-list
20527367|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
20527368|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527369|NCT01768208|Saxagliptin|saxagliptin|mesh-list
20527370|NCT01768208|Incretins|incretins|mesh-ancestor
20623685|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
20623686|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472647|NCT01497873|Topotecan|topotecan|mesh-list
20225572|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20225573|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
20225574|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225575|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225576|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20225577|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472648|NCT01497873|Belotecan|belotecan|mesh-list
20472649|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20472650|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20472651|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472652|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225578|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
20472653|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472654|NCT01497912|Atorvastatin|atorvastatin|mesh-list
20472655|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20472656|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20472657|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
20472658|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472659|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20472660|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20472661|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472662|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
20472663|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20472664|NCT01497977|Estrogens|estrogens|mesh-ancestor
20472665|NCT01497977|Hormones|hormones|mesh-ancestor
20472666|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472667|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472668|NCT01497990|Ertapenem|ertapenem|mesh-list
20472669|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20472670|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472671|NCT01498003|Tirofiban|tirofiban|mesh-list
20472672|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20472673|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20472674|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527371|NCT01768208|Hormones|hormones|mesh-ancestor
20623687|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20623688|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20623689|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20623690|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623691|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623692|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20623693|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20623694|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
20623695|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623696|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20623697|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20623698|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
20623699|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20623700|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
20623701|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
20623702|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
20623703|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20623704|NCT02315651|Ubiquinone|ubiquinone|mesh-list
20623705|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
20623706|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
20623707|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623708|NCT02315651|Vitamins|vitamins|mesh-ancestor
20623709|NCT02315690|Piperaquine|piperaquine|mesh-list
20623710|NCT02315690|Artenimol|artenimol|mesh-list
20623711|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
20225579|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
20225580|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225581|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225582|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
20225583|NCT00343369|Hormones|hormones|mesh-ancestor
20225584|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225585|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20225586|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20225587|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20225588|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20225589|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225590|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20225591|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
20225592|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20623712|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20623713|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19850260|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850261|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19850262|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850263|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
19850264|NCT00708162|Elvitegravir|elvitegravir|mesh-list
20472675|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20472676|NCT01498016|Busulfan|busulfan|mesh-list
20472677|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
20472678|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472679|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472680|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
20472681|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472682|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20472683|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472684|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20472685|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
20472686|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20623714|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623715|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
20623716|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623717|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623718|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20623719|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20623720|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20623721|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623722|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
20623723|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20623724|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623725|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623726|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
20623727|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623728|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850265|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19850266|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19850267|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
20225593|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19850268|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850269|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20225594|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
20225595|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
20225596|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20225597|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20225598|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
20225599|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225600|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20225601|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
20225602|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
20225603|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
20225604|NCT00343408|Leucovorin|leucovorin|mesh-list
20225605|NCT00343408|Gemcitabine|gemcitabine|mesh-list
20225606|NCT00343408|Fluorouracil|fluorouracil|mesh-list
20225607|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
20225608|NCT00343408|Cediranib|cediranib|mesh-list
20225609|NCT00343408|Calcium|calcium|mesh-list
20225610|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
20225611|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225612|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225613|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
20225614|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225615|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
20225616|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225617|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225618|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225619|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
20225620|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225621|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20225622|NCT00343408|Antidotes|antidotes|mesh-ancestor
20225623|NCT00343408|Protective Agents|protective agents|mesh-ancestor
19411158|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411159|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411160|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411161|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411162|NCT03542214|Calcium|calcium|mesh-list
19411163|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411164|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411165|NCT03542149|Tocopherols|tocopherols|mesh-list
19411166|NCT03542149|Vitamin E|vitamin e|mesh-list
20472687|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
20472688|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472689|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472690|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20472691|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
20472692|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
19696055|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696056|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19696057|NCT04943692|Metformin|metformin|mesh-list
19696058|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623729|NCT02316028|Decitabine|decitabine|mesh-list
20623730|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20623731|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
20623732|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623733|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623734|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623735|NCT02316197|Peposertib|peposertib|mesh-list
20623736|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20623737|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623738|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623739|NCT02316249|Estradiol|estradiol|mesh-list
20623740|NCT02316249|Hormones|hormones|mesh-ancestor
20623741|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623742|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623743|NCT02316249|Estrogens|estrogens|mesh-ancestor
20623744|NCT02316301|Misoprostol|misoprostol|mesh-list
20623745|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20623746|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
20623747|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19696059|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696060|NCT04944173|Durvalumab|durvalumab|mesh-list
19696061|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696062|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696063|NCT04943588|Antibodies|antibodies|mesh-list
19696064|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
19696065|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
19696066|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696067|NCT04943653|Paclitaxel|paclitaxel|mesh-list
20225624|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
20225625|NCT00343408|Vitamins|vitamins|mesh-ancestor
20472693|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20472694|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
20472695|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472696|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472697|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
20472698|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20472699|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472700|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472701|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472702|NCT01498380|Analgesics|analgesics|mesh-ancestor
20472703|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
20472704|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472705|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20225626|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
20225627|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20225628|NCT00343421|Vaccines|vaccines|mesh-list
20225629|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20623748|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696068|NCT04943653|Capecitabine|capecitabine|mesh-list
20225630|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
19850270|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19850271|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850272|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850273|NCT00708175|Pioglitazone|pioglitazone|mesh-list
19850274|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850275|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472706|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20472707|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20472708|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
20472709|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472710|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472711|NCT01498406|Vitamin D|vitamin d|mesh-list
20472712|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
20472713|NCT01498406|Vitamins|vitamins|mesh-list
20623749|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20623750|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623751|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
20623752|NCT02316327|Gemcitabine|gemcitabine|mesh-list
20623753|NCT02316327|Bevacizumab|bevacizumab|mesh-list
20623754|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623755|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623756|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20623757|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20623758|NCT02316327|Growth Substances|growth substances|mesh-ancestor
20623759|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623760|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
20623761|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20472714|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
20472715|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472716|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20472717|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20472718|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20472719|NCT01498562|Gefitinib|gefitinib|mesh-list
20472720|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
20472721|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472722|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20225631|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225632|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
20225633|NCT00343447|Rituximab|rituximab|mesh-list
20225634|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623762|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
20623763|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623764|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
20472723|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472724|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472725|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20472726|NCT01498718|Vaccines|vaccines|mesh-list
20472727|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
20472728|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472729|NCT01498783|Fluorouracil|fluorouracil|mesh-list
20472730|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
20472731|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472732|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20472733|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472734|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472735|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
20623765|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623766|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225635|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
20225636|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225637|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225638|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20225639|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
20225640|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225641|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225642|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19850276|NCT00708201|Alvimopan|alvimopan|mesh-list
19850277|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19850278|NCT00708214|Letrozole|letrozole|mesh-list
19850279|NCT00708214|Afatinib|afatinib|mesh-list
20472736|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472737|NCT01498796|Ketorolac|ketorolac|mesh-list
20472738|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19850280|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850281|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19696069|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
19696070|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623767|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623768|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
20623769|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
20623770|NCT02316340|Vorinostat|vorinostat|mesh-list
20623771|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
20623772|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20623773|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20623774|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20623775|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623776|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623777|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696071|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472739|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472740|NCT01498796|Analgesics|analgesics|mesh-ancestor
20472741|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
20472742|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472743|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472744|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472745|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472746|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20623778|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623779|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20623780|NCT02316379|Xenon|xenon|mesh-list
20623781|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20623782|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
20623783|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
20623784|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623785|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623786|NCT02316496|Irinotecan|irinotecan|mesh-list
20623787|NCT02316496|Cetuximab|cetuximab|mesh-list
20623788|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20623789|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20623790|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623791|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623792|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623793|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20623794|NCT02316535|Capecitabine|capecitabine|mesh-list
20623795|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20623796|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
20623797|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623798|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623799|NCT02316626|Progesterone|progesterone|mesh-list
20623800|NCT02316626|Progestins|progestins|mesh-ancestor
20623801|NCT02316626|Hormones|hormones|mesh-ancestor
20623802|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623803|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623804|NCT02316704|Tacrine|tacrine|mesh-list
20623805|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20623806|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623807|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623808|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
20623809|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623810|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623811|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20623812|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
20623813|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623814|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
20623815|NCT02316899|Linaclotide|linaclotide|mesh-list
20623816|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20623817|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
20623818|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623819|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623820|NCT02316964|Aldesleukin|aldesleukin|mesh-list
20623821|NCT02316964|Decitabine|decitabine|mesh-list
20623822|NCT02316964|Azacitidine|azacitidine|mesh-list
20623823|NCT02316964|Interleukin-2|interleukin-2|mesh-list
20623824|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20623825|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
20623826|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623827|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623828|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623829|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20472747|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623830|NCT02316964|Analgesics|analgesics|mesh-ancestor
20472748|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472749|NCT01498809|Midodrine|midodrine|mesh-list
20472750|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
20472751|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
20623831|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
20623832|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623833|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623834|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20623835|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20623836|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
20623837|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472752|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472753|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472754|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20472755|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20472756|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20472757|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20472758|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
20472759|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472760|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472761|NCT01498835|Sunitinib|sunitinib|mesh-list
20472762|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472763|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20472764|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20472765|NCT01498835|Growth Substances|growth substances|mesh-ancestor
20472766|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472767|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472768|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20472769|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472770|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472771|NCT01498861|Dolutegravir|dolutegravir|mesh-list
20472772|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
20472773|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20472774|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20472775|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20623838|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
19696072|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
19696073|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
19696074|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
19696075|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623839|NCT02317146|Analgesics|analgesics|mesh-ancestor
20623840|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
20623841|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623842|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623843|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
20623844|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623845|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19696076|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19696077|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
20472776|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623846|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
20623847|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20623848|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623849|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623850|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20623851|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
20623852|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20623853|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
20623854|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623855|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20623856|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623857|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623858|NCT02317198|Clopidogrel|clopidogrel|mesh-list
20623859|NCT02317198|Ticagrelor|ticagrelor|mesh-list
20623860|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20623861|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20623862|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20623863|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19696078|NCT04943536|Bicalutamide|bicalutamide|mesh-list
19696079|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
19696080|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
20623864|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19696081|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623865|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
20623866|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623867|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623868|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623869|NCT02317237|Anesthetics|anesthetics|mesh-list
20623870|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623871|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623872|NCT02317263|Testosterone|testosterone|mesh-list
19850282|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19850283|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20623873|NCT02317263|Androgens|androgens|mesh-ancestor
20623874|NCT02317263|Hormones|hormones|mesh-ancestor
20623875|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623876|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623877|NCT02317341|Midazolam|midazolam|mesh-list
20623878|NCT02317341|Ketamine|ketamine|mesh-list
20623879|NCT02317341|Analgesics|analgesics|mesh-ancestor
20623880|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
20623881|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623882|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623883|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20623884|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20623885|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
20623886|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
20623887|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623888|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20623889|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20623890|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623891|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623892|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20623893|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20623894|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20623895|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20623896|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20623897|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
20623898|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
20623899|NCT02317419|Gemcitabine|gemcitabine|mesh-list
20623900|NCT02317419|Paclitaxel|paclitaxel|mesh-list
20623901|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623902|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623903|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
20623904|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
20623905|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
20623906|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623907|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20623908|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
20623909|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
20623910|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850284|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850285|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19850286|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
19850287|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850288|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850289|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850290|NCT00708305|Listerine|listerine|mesh-list
19850291|NCT00708305|Fluorides|fluorides|mesh-list
19850292|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
19850293|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
20623911|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225643|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20225644|NCT00343486|Solabegron|solabegron|mesh-list
20225645|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20225646|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20225647|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20225648|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
20225649|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225650|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225651|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225652|NCT00343499|Valsartan|valsartan|mesh-list
20225653|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20225654|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20623912|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20623913|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
19850294|NCT00708305|Protective Agents|protective agents|mesh-ancestor
20472777|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472778|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20472779|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20472780|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
20472781|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472782|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20472783|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20472784|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20472785|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472786|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20472787|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
20472788|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411167|NCT03542149|Tocotrienols|tocotrienols|mesh-list
19411168|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
20623914|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623915|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
20623916|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623917|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20623918|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
20623919|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623920|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623921|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623922|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20623923|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
20623924|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20623925|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20623926|NCT02317601|Prednisolone|prednisolone|mesh-list
20623927|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
20623928|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20623929|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
20623930|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20623931|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
20623932|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
20623933|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623934|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623935|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20623936|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
19411169|NCT03542149|Piperaquine|piperaquine|mesh-list
19696082|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472789|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472790|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20472791|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20472792|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20472793|NCT01498900|Repaglinide|repaglinide|mesh-list
20472794|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20623937|NCT02317601|Hormones|hormones|mesh-ancestor
20623938|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623939|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20623940|NCT02317601|Protective Agents|protective agents|mesh-ancestor
20623941|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20623942|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623943|NCT02317640|Testosterone|testosterone|mesh-list
20623944|NCT02317640|Androgens|androgens|mesh-ancestor
20623945|NCT02317640|Hormones|hormones|mesh-ancestor
20623946|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20623947|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623948|NCT02317679|Bosentan|bosentan|mesh-list
20472795|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472796|NCT01498913|Repaglinide|repaglinide|mesh-list
20472797|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472798|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472799|NCT01498926|Insulin|insulin|mesh-list
20623949|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20623950|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20623951|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411170|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
19411171|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19411172|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19411173|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411174|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
20472800|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20472801|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
20623952|NCT02317770|Lidocaine|lidocaine|mesh-list
20623953|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
20623954|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
20623955|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20623956|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623957|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
20623958|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623959|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20623960|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20623961|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20623962|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623963|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623964|NCT02317861|Febuxostat|febuxostat|mesh-list
20623965|NCT02317861|Verinurad|verinurad|mesh-list
20623966|NCT02317861|Benzbromarone|benzbromarone|mesh-list
20623967|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
20623968|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20623969|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
20623970|NCT02317861|Renal Agents|renal agents|mesh-ancestor
20623971|NCT02317991|Paclitaxel|paclitaxel|mesh-list
20623972|NCT02317991|Ramucirumab|ramucirumab|mesh-list
19696083|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696084|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19696085|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19696086|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696087|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
20472802|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472803|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472804|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
19696088|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19696089|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696090|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20623973|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20623974|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20623975|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
20623976|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
20623977|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
20623978|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623979|NCT02318017|Methylphenidate|methylphenidate|mesh-list
20623980|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20225655|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20225656|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225657|NCT00343525|Bavituximab|bavituximab|mesh-list
19696091|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19696092|NCT04943237|Analgesics|analgesics|mesh-ancestor
20225658|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20472805|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472806|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472807|NCT01499004|Tofacitinib|tofacitinib|mesh-list
20472808|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20623981|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623982|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20623983|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20623984|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20623985|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20623986|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
20623987|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20623988|NCT02318043|Fluticasone|fluticasone|mesh-list
20623989|NCT02318043|Budesonide|budesonide|mesh-list
20623990|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20623991|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20623992|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225659|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225660|NCT00343629|Sulindac|sulindac|mesh-list
20225661|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20225662|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20225663|NCT00343629|Analgesics|analgesics|mesh-ancestor
20225664|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
20225665|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225666|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472809|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472810|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696093|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
20623993|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20623994|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
20623995|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20623996|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20623997|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20623998|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
20623999|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
20624000|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20624001|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
20624002|NCT02318043|Hormones|hormones|mesh-ancestor
20624003|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624004|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20624005|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20624006|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20624007|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
20624008|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624009|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624010|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
20624011|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20624012|NCT02318056|Bacitracin|bacitracin|mesh-list
20624013|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20624014|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624015|NCT02318056|Laxatives|laxatives|mesh-ancestor
20624016|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20624017|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20624018|NCT02318082|Aldesleukin|aldesleukin|mesh-list
20624019|NCT02318082|Interleukin-2|interleukin-2|mesh-list
20624020|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624021|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20624022|NCT02318082|Analgesics|analgesics|mesh-ancestor
20624023|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
20624024|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624025|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624026|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20624027|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20624028|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
20472811|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
20472812|NCT01499069|Fesoterodine|fesoterodine|mesh-list
20472813|NCT01499069|Propiverine|propiverine|mesh-list
20472814|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20472815|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20472816|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
20472817|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472818|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624029|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624030|NCT02318121|Oxytocin|oxytocin|mesh-list
20624031|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
20624032|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20472819|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472820|NCT01499069|Urological Agents|urological agents|mesh-ancestor
20472821|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
20472822|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
20624033|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624034|NCT02318199|Anesthetics|anesthetics|mesh-list
20624035|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624036|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624037|NCT02318225|Misoprostol|misoprostol|mesh-list
20624038|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20624039|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
20624040|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20624041|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624042|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19696094|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472823|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472824|NCT01499108|Liraglutide|liraglutide|mesh-list
20472825|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20472826|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472827|NCT01499108|Incretins|incretins|mesh-ancestor
20624043|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19696095|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696096|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20472828|NCT01499108|Hormones|hormones|mesh-ancestor
20624044|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
19696097|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19416808|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
20624045|NCT02318290|Analgesics|analgesics|mesh-list
20624046|NCT02318290|Narcotics|narcotics|mesh-list
19696098|NCT04943029|Paclitaxel|paclitaxel|mesh-list
19696099|NCT04943029|Carboplatin|carboplatin|mesh-list
20472829|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472830|NCT01499121|Sunitinib|sunitinib|mesh-list
20472831|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411175|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411176|NCT03542149|Protective Agents|protective agents|mesh-ancestor
19411177|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411178|NCT03542149|Vitamins|vitamins|mesh-ancestor
19411179|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
19411180|NCT03542058|Carvedilol|carvedilol|mesh-list
20624047|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
20624048|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624049|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624050|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624051|NCT02318433|Dexamethasone|dexamethasone|mesh-list
20624052|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624053|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
20624054|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
20624055|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624056|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624057|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19411181|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19411182|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19411183|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
19411184|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411185|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411186|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411187|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19411188|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
19411189|NCT03542058|Protective Agents|protective agents|mesh-ancestor
19411190|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20472832|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20472833|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20472834|NCT01499121|Growth Substances|growth substances|mesh-ancestor
20624058|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
20624059|NCT02318433|Hormones|hormones|mesh-ancestor
20624060|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624061|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20624062|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624063|NCT02318446|Folic Acid|folic acid|mesh-list
20624064|NCT02318446|Hematinics|hematinics|mesh-ancestor
20624065|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
20624066|NCT02318446|Vitamins|vitamins|mesh-ancestor
20624067|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
20624068|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624069|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
20624070|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20624071|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
20624072|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624073|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
19411191|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20472835|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696100|NCT04943029|Pemetrexed|pemetrexed|mesh-list
19696101|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20472836|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
20472837|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20472838|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472839|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472840|NCT01499225|Doxycycline|doxycycline|mesh-list
20472841|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19411192|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19696102|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696103|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
19696104|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
19696105|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
19696106|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696107|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696108|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19696109|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19696110|NCT04943198|Vemurafenib|vemurafenib|mesh-list
19696111|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696112|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20624074|NCT02318511|Protective Agents|protective agents|mesh-ancestor
20624075|NCT02318537|Cannabidiol|cannabidiol|mesh-list
20472842|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472843|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
19850295|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850296|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19850297|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850298|NCT00708422|Travoprost|travoprost|mesh-list
19850299|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20472844|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19850300|NCT00708422|Latanoprost|latanoprost|mesh-list
19850301|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19850302|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19850303|NCT00708435|Protein C|protein c|mesh-list
19850304|NCT00708435|Protein S|protein s|mesh-list
19850305|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
20225667|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225668|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225669|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225670|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20225671|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225672|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225673|NCT00343655|Atorvastatin|atorvastatin|mesh-list
20225674|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20225675|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20225676|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
20225677|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225678|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20225679|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20225680|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225681|NCT00343668|Irinotecan|irinotecan|mesh-list
20225682|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20225683|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20225684|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225685|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225686|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225687|NCT00343707|Paroxetine|paroxetine|mesh-list
20225688|NCT00343707|Vestipitant|vestipitant|mesh-list
20472845|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20472846|NCT01499251|Temozolomide|temozolomide|mesh-list
20472847|NCT01499251|Macitentan|macitentan|mesh-list
20472848|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20472849|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
20472850|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472851|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472852|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20472853|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20472854|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20472855|NCT01499407|Abciximab|abciximab|mesh-list
20472856|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
20472857|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20472858|NCT01499433|Caspofungin|caspofungin|mesh-list
20472859|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
20472860|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472861|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472862|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472863|NCT01499446|Fluticasone|fluticasone|mesh-list
20472864|NCT01499446|Xhance|xhance|mesh-list
20472865|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20472866|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20472867|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
20472868|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472869|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472870|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20472871|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
20472872|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
20472873|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20472874|NCT01499485|Acetazolamide|acetazolamide|mesh-list
20472875|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
20472876|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20472877|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472878|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472879|NCT01499485|Diuretics|diuretics|mesh-ancestor
20472880|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
20472881|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472882|NCT01499589|Anesthetics|anesthetics|mesh-list
20472883|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472884|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472885|NCT01499602|Norethindrone|norethindrone|mesh-list
20472886|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
20472887|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20472888|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
20472889|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20472890|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472891|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20472892|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20472893|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20472894|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20472895|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
20472896|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20225689|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20225690|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20225691|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225692|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225693|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225694|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
20225695|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225696|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20472897|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20472898|NCT01499641|Prednisolone|prednisolone|mesh-list
20624076|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20624077|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
20624078|NCT02318563|Cannabidiol|cannabidiol|mesh-list
20624079|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20624080|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
20472899|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
20472900|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20472901|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
20472902|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624081|NCT02318758|Ethanol|ethanol|mesh-list
20624082|NCT02318758|Treprostinil|treprostinil|mesh-list
20472903|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
20472904|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
19411193|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
19411194|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19411195|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19411196|NCT03542006|Brinzolamide|brinzolamide|mesh-list
19411197|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20624083|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20624084|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624085|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624086|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624087|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20624088|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
20624089|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20624090|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624091|NCT02318810|Rocuronium|rocuronium|mesh-list
20624092|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20624093|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20624094|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20624095|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624096|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624097|NCT02318836|Lofexidine|lofexidine|mesh-list
20624098|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20624099|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20624100|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624101|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
20624102|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624103|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20624104|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20624105|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20624106|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
20624107|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624108|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696113|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472905|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472906|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472907|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19696114|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411198|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472908|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
20472909|NCT01499641|Hormones|hormones|mesh-ancestor
20472910|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20472911|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20472912|NCT01499641|Protective Agents|protective agents|mesh-ancestor
20472913|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20472914|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472915|NCT01499693|Pantoprazole|pantoprazole|mesh-list
20472916|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20472917|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20472918|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20472919|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472920|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472921|NCT01499758|Atorvastatin|atorvastatin|mesh-list
20472922|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20472923|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20472924|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
19411199|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411200|NCT03541993|Resveratrol|resveratrol|mesh-list
19696115|NCT04942899|Capecitabine|capecitabine|mesh-list
19696116|NCT04942899|Letrozole|letrozole|mesh-list
19696117|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19696118|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
19696119|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696120|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696121|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19696122|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19696123|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696124|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19696125|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
19696126|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696127|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696128|NCT04943146|Aspirin|aspirin|mesh-list
20472925|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472926|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20472927|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20472928|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527372|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527373|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527374|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20527375|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
19411201|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
19411202|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411203|NCT03541993|Protective Agents|protective agents|mesh-ancestor
19411204|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411205|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411206|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19416809|NCT02300142|Vaccines|vaccines|mesh-list
19416810|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
19416811|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416812|NCT02296645|Ethanol|ethanol|mesh-list
19416813|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
20225697|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
20225698|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20225699|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19416814|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19416815|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20225700|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20225701|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225702|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20225703|NCT00343720|Bortezomib|bortezomib|mesh-list
20225704|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225705|NCT00343733|Fentanyl|fentanyl|mesh-list
20225706|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20225707|NCT00343733|Narcotics|narcotics|mesh-ancestor
20225708|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225709|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225710|NCT00343733|Analgesics|analgesics|mesh-ancestor
20225711|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
19416816|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696129|NCT04943146|Prednisone|prednisone|mesh-list
19696130|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225712|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472929|NCT01499771|Atorvastatin|atorvastatin|mesh-list
20472930|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20472931|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20472932|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
20472933|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472934|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20472935|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19850306|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19850307|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19850308|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850309|NCT00708500|Interferons|interferons|mesh-list
19850310|NCT00708500|Ribavirin|ribavirin|mesh-list
19850311|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
19850312|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
19850313|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19850314|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850315|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
20472936|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20472937|NCT01499875|Penicillin V|penicillin v|mesh-list
20225713|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20225714|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20225715|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
20225716|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
20225717|NCT00343759|Lapatinib|lapatinib|mesh-list
20225718|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225719|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20225720|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225721|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225722|NCT00343798|Cyclosporine|cyclosporine|mesh-list
20472938|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20472939|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472940|NCT01499914|Vaccines|vaccines|mesh-list
20472941|NCT01499914|Immunologic Factors|immunologic factors|mesh-ancestor
20472942|NCT01499914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472943|NCT01499953|PENTA|penta|mesh-list
20472944|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
20472945|NCT01499953|Fondaparinux|fondaparinux|mesh-list
20472946|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20472947|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
20472948|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20472949|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
20472950|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696131|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
19696132|NCT04943146|Hormones|hormones|mesh-ancestor
19696133|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696134|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696135|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19696136|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696137|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19696138|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19696139|NCT04943146|Analgesics|analgesics|mesh-ancestor
19850316|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20472951|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472952|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
20472953|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20472954|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20472955|NCT01500005|Vitamin D|vitamin d|mesh-list
20472956|NCT01500005|Vitamins|vitamins|mesh-ancestor
20472957|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
20472958|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472959|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20472960|NCT01500018|Phentermine|phentermine|mesh-list
20472961|NCT01500018|Ketamine|ketamine|mesh-list
20472962|NCT01500018|Analgesics|analgesics|mesh-ancestor
20472963|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
20472964|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20472965|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472966|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20472967|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20472968|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
20472969|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
20472970|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20472971|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20472972|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20472973|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20472974|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624109|NCT02318888|Icodextrin|icodextrin|mesh-list
20225723|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
20225724|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
20225725|NCT00343798|Fludarabine|fludarabine|mesh-list
19850317|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
19850318|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225726|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
20472975|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20472976|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
20472977|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20472978|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
20472979|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
20472980|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
20472981|NCT01500070|Everolimus|everolimus|mesh-list
20472982|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472983|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472984|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
20472985|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20472986|NCT01500161|Cytarabine|cytarabine|mesh-list
20472987|NCT01500161|Fludarabine|fludarabine|mesh-list
20472988|NCT01500161|Etoposide|etoposide|mesh-list
20472989|NCT01500161|Melphalan|melphalan|mesh-list
20472990|NCT01500161|Busulfan|busulfan|mesh-list
20472991|NCT01500161|Carmustine|carmustine|mesh-list
20472992|NCT01500161|Clofarabine|clofarabine|mesh-list
20472993|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20472994|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20472995|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
20472996|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20472997|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20472998|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
20472999|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473000|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20473001|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20473002|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20473003|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473004|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
20473005|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473006|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20473007|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
20473008|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20473009|NCT01500408|Interferons|interferons|mesh-list
20473010|NCT01500408|Interferon-beta|interferon-beta|mesh-list
20473011|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
20473012|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473013|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
20473014|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473015|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
20473016|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473017|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20473018|NCT01500473|Desogestrel|desogestrel|mesh-list
20473019|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20473020|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20473021|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20473022|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
20473023|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20473024|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473025|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20473026|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20473027|NCT01500473|Progestins|progestins|mesh-ancestor
20473028|NCT01500473|Hormones|hormones|mesh-ancestor
20473029|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473030|NCT01500538|Vorinostat|vorinostat|mesh-list
20473031|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473032|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20473033|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411207|NCT03541928|Valacyclovir|valacyclovir|mesh-list
20225727|NCT00343798|Cyclosporins|cyclosporins|mesh-list
20225728|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225729|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
20225730|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225731|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247432|NCT00432198|Zolpidem|zolpidem|mesh-list
20473034|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473035|NCT01500577|Nimesulide|nimesulide|mesh-list
20473036|NCT01500577|Simvastatin|simvastatin|mesh-list
20473037|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20473038|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20473039|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
20473040|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473041|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20473042|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20473043|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473044|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20473045|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20624110|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
20624111|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20624112|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
20624113|NCT02319018|Leucovorin|leucovorin|mesh-list
20624114|NCT02319018|Folic Acid|folic acid|mesh-list
20624115|NCT02319018|Fluorouracil|fluorouracil|mesh-list
20624116|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
20624117|NCT02319018|Calcium|calcium|mesh-list
20624118|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
20624119|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20624120|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624121|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20624122|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
19411208|NCT03541928|Leuprolide|leuprolide|mesh-list
19411209|NCT03541928|Bicalutamide|bicalutamide|mesh-list
20225732|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19411210|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19411211|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
19411212|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411213|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411214|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19411215|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411216|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
19411217|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
19850319|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
19850320|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850321|NCT00708526|Anesthetics|anesthetics|mesh-list
19850322|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850323|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850324|NCT00708552|Donepezil|donepezil|mesh-list
19850325|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19850326|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850327|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850328|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
20225733|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
20225734|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225735|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225736|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20225737|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225738|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
20225739|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225740|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
20225741|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225742|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
20225743|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20225744|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20225745|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20225746|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
20225747|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20225748|NCT00343811|Modafinil|modafinil|mesh-list
20225749|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20225750|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225751|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20225752|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20225753|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20225754|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225755|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20225756|NCT00343824|Laxatives|laxatives|mesh-ancestor
20225757|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225758|NCT00343850|Mesalamine|mesalamine|mesh-list
20225759|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20225760|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20225761|NCT00343850|Analgesics|analgesics|mesh-ancestor
20473046|NCT01500577|Analgesics|analgesics|mesh-ancestor
20624123|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624124|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20624125|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624126|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624127|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
20624128|NCT02319018|Antidotes|antidotes|mesh-ancestor
20624129|NCT02319018|Protective Agents|protective agents|mesh-ancestor
20624130|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
20624131|NCT02319018|Vitamins|vitamins|mesh-ancestor
20624132|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
20624133|NCT02319018|Hematinics|hematinics|mesh-ancestor
20624134|NCT02319135|Cytarabine|cytarabine|mesh-list
20624135|NCT02319135|Fludarabine|fludarabine|mesh-list
20624136|NCT02319135|Lenograstim|lenograstim|mesh-list
20624137|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624138|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20624139|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
20624140|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624141|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624142|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
20624143|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624144|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
20624145|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624146|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20624147|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
20624148|NCT02319161|Calcium|calcium|mesh-list
20624149|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20624150|NCT02319161|Esmolol|esmolol|mesh-list
20624151|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20624152|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624153|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20624154|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
20624155|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624156|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624157|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20624158|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20624159|NCT02319187|Irinotecan|irinotecan|mesh-list
20624160|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19696140|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
19696141|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696142|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225762|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
20225763|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225764|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225765|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225766|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225767|NCT00343876|Aspirin|aspirin|mesh-list
20225768|NCT00343876|Clopidogrel|clopidogrel|mesh-list
20225769|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19696143|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19696144|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19696145|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624161|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20624162|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624163|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624164|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624165|NCT02319200|Metformin|metformin|mesh-list
20624166|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624167|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624168|NCT02319265|Melatonin|melatonin|mesh-list
20624169|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
19411218|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696146|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19696147|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19696148|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225770|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20225771|NCT00343876|Analgesics|analgesics|mesh-ancestor
20225772|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
20225773|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225774|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225775|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225776|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225777|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20624170|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624171|NCT02319265|Protective Agents|protective agents|mesh-ancestor
19411219|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
19411220|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473047|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
20473048|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473049|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473050|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473051|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473052|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20473053|NCT01500590|Ramipril|ramipril|mesh-list
20473054|NCT01500590|Irbesartan|irbesartan|mesh-list
20473055|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20473056|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20473057|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473058|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473059|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20473060|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20473061|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20473062|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
20473063|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
20473064|NCT01500785|Simendan|simendan|mesh-list
20473065|NCT01500785|Vitamins|vitamins|mesh-ancestor
20473066|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
20473067|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473068|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
20473069|NCT01500785|Hematinics|hematinics|mesh-ancestor
20624172|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624173|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624174|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20624175|NCT02319278|Hematinics|hematinics|mesh-ancestor
20624176|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20624177|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20624178|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
20624179|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20624180|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20624181|NCT02319343|Prednisolone|prednisolone|mesh-list
20624182|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
20624183|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20624184|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
20624185|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624186|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
20624187|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
20624188|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624189|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624190|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20624191|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
20624192|NCT02319343|Hormones|hormones|mesh-ancestor
20624193|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624194|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20624195|NCT02319343|Protective Agents|protective agents|mesh-ancestor
20624196|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20624197|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624198|NCT02319460|Thrombin|thrombin|mesh-list
20624199|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
20624200|NCT02319460|Coagulants|coagulants|mesh-ancestor
20624201|NCT02319499|Vitamin A|vitamin a|mesh-list
20624202|NCT02319499|Iron|iron|mesh-list
20624203|NCT02319499|Zinc|zinc|mesh-list
20624204|NCT02319499|Vitamins|vitamins|mesh-ancestor
20624205|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
20624206|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624207|NCT02319499|Trace Elements|trace elements|mesh-ancestor
20624208|NCT02319564|Beclomethasone|beclomethasone|mesh-list
20624209|NCT02319564|Albuterol|albuterol|mesh-list
20624210|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20624211|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
20624212|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624213|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624214|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20624215|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
20624216|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
20624217|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20624218|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20624219|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20624220|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19411221|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
20624221|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
20624222|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473070|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20473071|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
20473072|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20624223|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624224|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624225|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
20624226|NCT02319564|Hormones|hormones|mesh-ancestor
20624227|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624228|NCT02319577|Vinorelbine|vinorelbine|mesh-list
20624229|NCT02319577|Gefitinib|gefitinib|mesh-list
20624230|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20624231|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624232|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
20624233|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
20624234|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
20624235|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624236|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20624237|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225778|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20225779|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225780|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20225781|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20225782|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225783|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
20225784|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20225785|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20225786|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20473073|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20473074|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473075|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473076|NCT01500785|Protective Agents|protective agents|mesh-ancestor
20473077|NCT01500824|Crizotinib|crizotinib|mesh-list
19411222|NCT03541915|Analgesics|analgesics|mesh-ancestor
19411223|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
20473078|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473079|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20473080|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696149|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
19696150|NCT04943224|Trametinib|trametinib|mesh-list
19696151|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696152|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19696153|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473081|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473082|NCT01500837|Levofloxacin|levofloxacin|mesh-list
20473083|NCT01500837|Ofloxacin|ofloxacin|mesh-list
20473084|NCT01500837|Rifampin|rifampin|mesh-list
19411224|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411225|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411226|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
19411227|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411228|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19411229|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
19411230|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19411231|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473085|NCT01500837|Clindamycin|clindamycin|mesh-list
20473086|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
20473087|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
19411232|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411233|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411234|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
19411235|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19696154|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696155|NCT04942886|Entecavir|entecavir|mesh-list
20624238|NCT02319616|Clobetasol|clobetasol|mesh-list
19411236|NCT03541902|Sunitinib|sunitinib|mesh-list
19411237|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411238|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20225787|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
20225788|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225789|NCT00343980|Insulin|insulin|mesh-list
20225790|NCT00343980|Glimepiride|glimepiride|mesh-list
19411239|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20624239|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624240|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
20624241|NCT02319616|Hormones|hormones|mesh-ancestor
20624242|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624243|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624244|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20624245|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20624246|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20624247|NCT02319707|Oxytocin|oxytocin|mesh-list
20624248|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
20624249|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20624250|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624251|NCT02319772|Galidesivir|galidesivir|mesh-list
20624252|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
20624253|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624254|NCT02319889|Paclitaxel|paclitaxel|mesh-list
20624255|NCT02319889|Carboplatin|carboplatin|mesh-list
20624256|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20624257|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20624258|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624259|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
20624260|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
20624261|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
20624262|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624263|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
20624264|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20624265|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20624266|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624267|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
20624268|NCT02319915|Coagulants|coagulants|mesh-ancestor
20624269|NCT02319941|Clopidogrel|clopidogrel|mesh-list
20624270|NCT02319941|Ticagrelor|ticagrelor|mesh-list
20624271|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20624272|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20624273|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20624274|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20624275|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
20624276|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624277|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624278|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624279|NCT02320032|Aripiprazole|aripiprazole|mesh-list
20624280|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
20624281|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
20624282|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20624283|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20624284|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20624285|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624286|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624287|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
20624288|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
20624289|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624290|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411240|NCT03541902|Growth Substances|growth substances|mesh-ancestor
20225791|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
20225792|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20225793|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20225794|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225795|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20225796|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225797|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
20225798|NCT00344006|Artesunate|artesunate|mesh-list
20225799|NCT00344006|Lumefantrine|lumefantrine|mesh-list
20225800|NCT00344006|Artemether|artemether|mesh-list
20225801|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20225802|NCT00344006|Dapsone|dapsone|mesh-list
20225803|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
20624291|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20624292|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19411241|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411242|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
19411243|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19411244|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411245|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411246|NCT03541837|Ropivacaine|ropivacaine|mesh-list
19411247|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
19411248|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
19411249|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225804|NCT00344006|Proguanil|proguanil|mesh-list
20624293|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
20624294|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20624295|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20624296|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20624297|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20624298|NCT02320045|Exenatide|exenatide|mesh-list
20624299|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624300|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624301|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20624302|NCT02320045|Incretins|incretins|mesh-ancestor
20624303|NCT02320045|Hormones|hormones|mesh-ancestor
20624304|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624305|NCT02320084|Nitisinone|nitisinone|mesh-list
20624306|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624307|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624308|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20624309|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
20624310|NCT02320240|Citalopram|citalopram|mesh-list
20624311|NCT02320240|Fluoxetine|fluoxetine|mesh-list
20624312|NCT02320240|Paroxetine|paroxetine|mesh-list
20624313|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20624314|NCT02320240|Sertraline|sertraline|mesh-list
20624315|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20624316|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20624317|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20624318|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20624319|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624320|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624321|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
20624322|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624323|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20624324|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
20624325|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20624326|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624327|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20624328|NCT02320240|Analgesics|analgesics|mesh-ancestor
20624329|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
20624330|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
20624331|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20473088|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20473089|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473090|NCT01500837|Renal Agents|renal agents|mesh-ancestor
20473091|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473092|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20473093|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19411250|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696156|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
20225805|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
19696157|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225806|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20225807|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20225808|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473094|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473095|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225809|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225810|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
20225811|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
20473096|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473097|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20473098|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20473099|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20473100|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
20473101|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
20473102|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20624332|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20624333|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624334|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20624335|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20624336|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225812|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20225813|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
20225814|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20225815|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225816|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225817|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
20225818|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20225819|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
20624337|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20624338|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20624339|NCT02320357|Clopidogrel|clopidogrel|mesh-list
20624340|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20624341|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20624342|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20624343|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20624344|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
20624345|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624346|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624347|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624348|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19411251|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
19411252|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411253|NCT03541798|Anesthetics|anesthetics|mesh-list
19411254|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411255|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411256|NCT03541759|Hydromorphone|hydromorphone|mesh-list
19411257|NCT03541759|Pirinitramide|pirinitramide|mesh-list
19411258|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19411259|NCT03541759|Narcotics|narcotics|mesh-ancestor
19411260|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411261|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411262|NCT03541759|Analgesics|analgesics|mesh-ancestor
19411263|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
19411264|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411265|NCT03541681|Anesthetics|anesthetics|mesh-list
19411266|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
19411267|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411268|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225820|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
20225821|NCT00344058|Analgesics|analgesics|mesh-ancestor
20225822|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
20225823|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225824|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225825|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
20225826|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20225827|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20225828|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
20225829|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20225830|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20225831|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225832|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20225833|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
20225834|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20225835|NCT00344123|Ritonavir|ritonavir|mesh-list
20225836|NCT00344123|Tipranavir|tipranavir|mesh-list
20225837|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20225838|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20225839|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20473103|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20473104|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20473105|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20473106|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20473107|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20473108|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20473109|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20225840|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
19696158|NCT04942626|Capecitabine|capecitabine|mesh-list
20473110|NCT01500850|Insulin|insulin|mesh-list
20473111|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20473112|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
20473113|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
20624349|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
20624350|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20624351|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
20624352|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624353|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624354|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473114|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
20473115|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
20473116|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
20473117|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624355|NCT02320448|Cisplatin|cisplatin|mesh-list
20624356|NCT02320448|Doxorubicin|doxorubicin|mesh-list
20624357|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
20624358|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624359|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20624360|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20624361|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20624362|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624363|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624364|NCT02320474|Aflibercept|aflibercept|mesh-list
20624365|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20624366|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20624367|NCT02320474|Growth Substances|growth substances|mesh-ancestor
20624368|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624369|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
20624370|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624371|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20624372|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
20624373|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624374|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20624375|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20624376|NCT02320734|Rocuronium|rocuronium|mesh-list
20624377|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20624378|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20225841|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624379|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20624380|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696159|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19696160|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19696161|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
20225842|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225843|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20225844|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20225845|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
20225846|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225847|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20225848|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20225849|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20225850|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20225851|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
20225852|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20225853|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20225854|NCT00344149|Rituximab|rituximab|mesh-list
20225855|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20225856|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225857|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
20225858|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225859|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225860|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20225861|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
20225862|NCT00344201|Coagulants|coagulants|mesh-ancestor
19696162|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696163|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696164|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696165|NCT04942860|Methotrexate|methotrexate|mesh-list
19696166|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19696167|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
20225863|NCT00344227|Ranibizumab|ranibizumab|mesh-list
20473118|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473119|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19411269|NCT03541681|Hormones|hormones|mesh-ancestor
19411270|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411271|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19411272|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19850329|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473120|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20473121|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20473122|NCT01500863|Estradiol|estradiol|mesh-list
20473123|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20473124|NCT01500863|Progesterone|progesterone|mesh-list
20473125|NCT01500863|Estrogens|estrogens|mesh-ancestor
20473126|NCT01500863|Hormones|hormones|mesh-ancestor
20473127|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473128|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473129|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20473130|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
20473131|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20473132|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20473133|NCT01500863|Progestins|progestins|mesh-ancestor
20473134|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
20473135|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20473136|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473137|NCT01500915|Ranibizumab|ranibizumab|mesh-list
20473138|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20473139|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19850330|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850331|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
19850332|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20473140|NCT01500915|Growth Substances|growth substances|mesh-ancestor
20473141|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473142|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
20624381|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624382|NCT02320773|Mirabegron|mirabegron|mesh-list
20624383|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20624384|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20624385|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19850333|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
19850334|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850335|NCT00708708|Etanercept|etanercept|mesh-list
19850336|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19850337|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19850338|NCT00708708|Analgesics|analgesics|mesh-ancestor
19850339|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
19850340|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850341|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850342|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473143|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624386|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
20624387|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624388|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624389|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624390|NCT02320773|Urological Agents|urological agents|mesh-ancestor
20624391|NCT02320877|Methaqualone|methaqualone|mesh-list
20624392|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20624393|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624394|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624395|NCT02321176|Resveratrol|resveratrol|mesh-list
20624396|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
20624397|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624398|NCT02321176|Protective Agents|protective agents|mesh-ancestor
20624399|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624400|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624401|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20624402|NCT02321241|Aflibercept|aflibercept|mesh-list
20624403|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20624404|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20624405|NCT02321241|Growth Substances|growth substances|mesh-ancestor
20624406|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624407|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
20624408|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850343|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473144|NCT01500928|Insulin|insulin|mesh-list
20473145|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624409|NCT02321267|Ranibizumab|ranibizumab|mesh-list
20624410|NCT02321267|Aflibercept|aflibercept|mesh-list
20624411|NCT02321267|Verteporfin|verteporfin|mesh-list
20624412|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20624413|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20624414|NCT02321267|Growth Substances|growth substances|mesh-ancestor
20624415|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624416|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
20624417|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624418|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20624419|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
20225864|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20225865|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20225866|NCT00344227|Growth Substances|growth substances|mesh-ancestor
20624420|NCT02321280|Denosumab|denosumab|mesh-list
20624421|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20624422|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624423|NCT02321293|Curcumin|curcumin|mesh-list
20624424|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20624425|NCT02321293|Gefitinib|gefitinib|mesh-list
20624426|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624427|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20624428|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624429|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624430|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20624431|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20624432|NCT02321293|Analgesics|analgesics|mesh-ancestor
20624433|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
19411273|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19411274|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411275|NCT03541603|Simendan|simendan|mesh-list
19411276|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19411277|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
19696168|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20473146|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225867|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225868|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
20225869|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225870|NCT00344253|Interferons|interferons|mesh-list
20225871|NCT00344253|Interferon-beta|interferon-beta|mesh-list
20225872|NCT00344253|Methotrexate|methotrexate|mesh-list
20225873|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20225874|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
20225875|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20225876|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225877|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225878|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
20225879|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225880|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225881|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
20225882|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225883|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20225884|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225885|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
20225886|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20225887|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20473147|NCT01500980|Chloroquine|chloroquine|mesh-list
20473148|NCT01500980|Primaquine|primaquine|mesh-list
20473149|NCT01500980|Amebicides|amebicides|mesh-ancestor
20473150|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20473151|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20473152|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473153|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
20473154|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473155|NCT01500993|Fluorouracil|fluorouracil|mesh-list
20473156|NCT01500993|Capecitabine|capecitabine|mesh-list
20473157|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
20473158|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473159|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20473160|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473161|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20473162|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
19707861|NCT04822649|Adenosine|adenosine|mesh-list
20624434|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473163|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473164|NCT01501032|Pancrelipase|pancrelipase|mesh-list
20624435|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624436|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411278|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19411279|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19411280|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411281|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411282|NCT03541603|Protective Agents|protective agents|mesh-ancestor
19411283|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411284|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
19411285|NCT03541564|BMS-986165|bms-986165|mesh-list
19411286|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20624437|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411287|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411288|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19411289|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20225888|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
19696169|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696170|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19411290|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416817|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696171|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
20225889|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225890|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20225891|NCT00344383|Norgestimate|norgestimate|mesh-list
20225892|NCT00344383|Estradiol|estradiol|mesh-list
20225893|NCT00344383|Estrogens|estrogens|mesh-ancestor
20225894|NCT00344383|Hormones|hormones|mesh-ancestor
20225895|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225896|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225897|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20225898|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
20225899|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20225900|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20225901|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20225902|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20473165|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473166|NCT01501084|Exenatide|exenatide|mesh-list
20473167|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20473168|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473169|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20473170|NCT01501084|Incretins|incretins|mesh-ancestor
20473171|NCT01501084|Hormones|hormones|mesh-ancestor
20473172|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473173|NCT01501123|Midazolam|midazolam|mesh-list
20473174|NCT01501123|Haloperidol|haloperidol|mesh-list
20473175|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
20473176|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20473177|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20473178|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473179|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473180|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20473181|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473182|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473183|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20473184|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
20624438|NCT02321371|Rifaximin|rifaximin|mesh-list
20624439|NCT02321371|Lactulose|lactulose|mesh-list
20624440|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20624441|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624442|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20624443|NCT02321384|Ritonavir|ritonavir|mesh-list
20624444|NCT02321384|Midazolam|midazolam|mesh-list
20624445|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20624446|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20624447|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624448|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624449|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20624450|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20624451|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20624452|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20624453|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
20624454|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
20624455|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
20624456|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
20624457|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624458|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624459|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20624460|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20624461|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
20624462|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411291|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411292|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411293|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
19411294|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19411295|NCT03541265|Bupivacaine|bupivacaine|mesh-list
19411296|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
19411297|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
19411298|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411299|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411300|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
19850344|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19850345|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624463|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20624464|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20624465|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
20624466|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624467|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20624468|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20624469|NCT02321397|Oxycodone|oxycodone|mesh-list
20624470|NCT02321397|Naloxone|naloxone|mesh-list
20624471|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20624472|NCT02321397|Narcotics|narcotics|mesh-ancestor
20624473|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624474|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624475|NCT02321397|Analgesics|analgesics|mesh-ancestor
20624476|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
20624477|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624478|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20624479|NCT02321501|Everolimus|everolimus|mesh-list
20624480|NCT02321501|Ceritinib|ceritinib|mesh-list
20624481|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624482|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624483|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
20624484|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624485|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20624486|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624487|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624488|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
20624489|NCT02321579|Pyridoxal|pyridoxal|mesh-list
20624490|NCT02321579|Pyridoxine|pyridoxine|mesh-list
20624491|NCT02321579|Vitamins|vitamins|mesh-ancestor
20624492|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
20624493|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624494|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
20624495|NCT02321761|Amantadine|amantadine|mesh-list
20624496|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20624497|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20624498|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
19411301|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624499|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624500|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
20624501|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624502|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624503|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624504|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20624505|NCT02321761|Analgesics|analgesics|mesh-ancestor
20624506|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
20624507|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624508|NCT02321839|Ranibizumab|ranibizumab|mesh-list
20624509|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20624510|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20624511|NCT02321839|Growth Substances|growth substances|mesh-ancestor
20624512|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624513|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
20624514|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624515|NCT02321852|Mannitol|mannitol|mesh-list
20624516|NCT02321852|Triflusal|triflusal|mesh-list
20624517|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20624518|NCT02321852|Diuretics|diuretics|mesh-ancestor
20624519|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
20624520|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624521|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20624522|NCT02321878|Liraglutide|liraglutide|mesh-list
20624523|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624524|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624525|NCT02321878|Incretins|incretins|mesh-ancestor
20624526|NCT02321878|Hormones|hormones|mesh-ancestor
20624527|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624528|NCT02322008|Adalimumab|adalimumab|mesh-list
20624529|NCT02322008|Infliximab|infliximab|mesh-list
20624530|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624531|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20624532|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
20624533|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20624534|NCT02322203|Niacin|niacin|mesh-list
20624535|NCT02322203|Niacinamide|niacinamide|mesh-list
20624536|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
19411302|NCT03541031|Micronutrients|micronutrients|mesh-list
19411303|NCT03541031|Trace Elements|trace elements|mesh-list
19411304|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411305|NCT03540979|Letrozole|letrozole|mesh-list
19411306|NCT03540979|Progesterone|progesterone|mesh-list
19411307|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411308|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19411309|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19411310|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411311|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411312|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19411313|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
19411314|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411315|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411316|NCT03540979|Progestins|progestins|mesh-ancestor
19411317|NCT03540979|Hormones|hormones|mesh-ancestor
19411318|NCT03540953|Mitomycins|mitomycins|mesh-list
19411319|NCT03540953|Mitomycin|mitomycin|mesh-list
19411320|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19411321|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411322|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
20473185|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
20473186|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
20473187|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
20473188|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473189|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473190|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
20624537|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20624538|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
20473191|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
20473192|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473193|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473194|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20473195|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20473196|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
20473197|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20473198|NCT01501136|Gemcitabine|gemcitabine|mesh-list
20624539|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411323|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473199|NCT01501136|Dexamethasone|dexamethasone|mesh-list
20473200|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
20473201|NCT01501136|Cisplatin|cisplatin|mesh-list
20473202|NCT01501136|Etoposide|etoposide|mesh-list
20624540|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20624541|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
20624542|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
20624543|NCT02322203|Vitamins|vitamins|mesh-ancestor
20624544|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
20624545|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624546|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
20624547|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
20624548|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
20624549|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624550|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624551|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
20473203|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
20473204|NCT01501136|Ifosfamide|ifosfamide|mesh-list
20473205|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
20473206|NCT01501136|Pegaspargase|pegaspargase|mesh-list
20473207|NCT01501136|Asparaginase|asparaginase|mesh-list
20624552|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624553|NCT02322372|Bupivacaine|bupivacaine|mesh-list
20624554|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
20624555|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624556|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696172|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696173|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696174|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
19696175|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696176|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19696177|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696178|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
19696179|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696180|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20473208|NCT01501136|BB 1101|bb 1101|mesh-list
19411324|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19411325|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624557|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
20624558|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
20624559|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624560|NCT02322502|Propofol|propofol|mesh-list
20624561|NCT02322502|Sevoflurane|sevoflurane|mesh-list
20624562|NCT02322502|Desflurane|desflurane|mesh-list
20624563|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20624564|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624565|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624566|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20624567|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
20624568|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
20624569|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20624570|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20624571|NCT02322580|Etanercept|etanercept|mesh-list
20624572|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20624573|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20624574|NCT02322580|Analgesics|analgesics|mesh-ancestor
20473209|NCT01501136|Mesna|mesna|mesh-list
20473210|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473211|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473212|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
20473213|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
20473214|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473215|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473216|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473217|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
20473218|NCT01501136|Hormones|hormones|mesh-ancestor
20473219|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473220|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20473221|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
20473222|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473223|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473224|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20473225|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
20473226|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
20473227|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473228|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20473229|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
20473230|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20473231|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20527376|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624575|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
19411326|NCT03540914|Acetazolamide|acetazolamide|mesh-list
20624576|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473232|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20473233|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20473234|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
20473235|NCT01501136|Protective Agents|protective agents|mesh-ancestor
20473236|NCT01501149|Gemcitabine|gemcitabine|mesh-list
20473237|NCT01501149|Dexamethasone|dexamethasone|mesh-list
20473238|NCT01501149|Etoposide|etoposide|mesh-list
20624577|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624578|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624579|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20624580|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20624581|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624582|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
20624583|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
20624584|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20624585|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225903|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20225904|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
20225905|NCT00344409|Hematinics|hematinics|mesh-ancestor
20624586|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20624587|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20225906|NCT00344422|Dexamethasone|dexamethasone|mesh-list
20473239|NCT01501149|Pegaspargase|pegaspargase|mesh-list
20473240|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473241|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473242|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
20473243|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
20473244|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473245|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473246|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473247|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
20473248|NCT01501149|Hormones|hormones|mesh-ancestor
20473249|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473250|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20473251|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20473252|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
20473253|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473254|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
20473255|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473256|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473257|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20473258|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
20473259|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20473260|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20473261|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19411327|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
20225907|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
20473262|NCT01501214|Atosiban|atosiban|mesh-list
20473263|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
20473264|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473265|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473266|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
20473267|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20473268|NCT01501253|Amlodipine|amlodipine|mesh-list
20473269|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20473270|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20473271|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473272|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473273|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20473274|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225908|NCT00344422|Doxorubicin|doxorubicin|mesh-list
20225909|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20225910|NCT00344422|Vincristine|vincristine|mesh-list
20225911|NCT00344422|BB 1101|bb 1101|mesh-list
20225912|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20225913|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
20225914|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
20225915|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225916|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473275|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
20624588|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411328|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19411329|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225917|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225918|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
20624589|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624590|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624591|NCT02322645|Eszopiclone|eszopiclone|mesh-list
20624592|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20624593|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624594|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624595|NCT02322658|Eszopiclone|eszopiclone|mesh-list
20624596|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20624597|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624598|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624599|NCT02322671|Montelukast|montelukast|mesh-list
20624600|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20624601|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
20225919|NCT00344422|Hormones|hormones|mesh-ancestor
20225920|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225921|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20225922|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225923|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
20225924|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20225925|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473276|NCT01501344|Calcium|calcium|mesh-list
20473277|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20624602|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20624603|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
20624604|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624605|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624606|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20624607|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20624608|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624609|NCT02322853|Tamoxifen|tamoxifen|mesh-list
20624610|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20624611|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
20624612|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624613|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624614|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20624615|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624616|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20624617|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20624618|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19411330|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411331|NCT03540914|Diuretics|diuretics|mesh-ancestor
19411332|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
19411333|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411334|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19411335|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19411336|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411337|NCT03540836|Cortisone|cortisone|mesh-list
19411338|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411339|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
19411340|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
19411341|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20225926|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20473278|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473279|NCT01501370|Dexamethasone|dexamethasone|mesh-list
20473280|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
20473281|NCT01501370|Lenalidomide|lenalidomide|mesh-list
20473282|NCT01501370|Vorinostat|vorinostat|mesh-list
20473283|NCT01501370|BB 1101|bb 1101|mesh-list
20473284|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473285|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
20473286|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
20473287|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473288|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473289|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19411342|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20473290|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
20473291|NCT01501370|Hormones|hormones|mesh-ancestor
20473292|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624619|NCT02323139|Azacitidine|azacitidine|mesh-list
20624620|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20624621|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
20624622|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411343|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473293|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20473294|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473295|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
20473296|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473297|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473298|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
20473299|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20473300|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20473301|NCT01501370|Growth Substances|growth substances|mesh-ancestor
20473302|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
20473303|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20473304|NCT01501396|Megestrol|megestrol|mesh-list
20473305|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
20473306|NCT01501396|Mirtazapine|mirtazapine|mesh-list
20624623|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624624|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411344|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411345|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411346|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411347|NCT03540628|Ascorbic Acid|ascorbic acid|mesh-list
19411348|NCT03540628|Thiamine|thiamine|mesh-list
19411349|NCT03540628|Vitamins|vitamins|mesh-ancestor
19411350|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
19411351|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411352|NCT03540628|Antioxidants|antioxidants|mesh-ancestor
19411353|NCT03540628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411354|NCT03540628|Protective Agents|protective agents|mesh-ancestor
19411355|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
19411356|NCT03540485|Melatonin|melatonin|mesh-list
19411357|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
19411358|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411359|NCT03540485|Protective Agents|protective agents|mesh-ancestor
20225927|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20624625|NCT02323191|Atezolizumab|atezolizumab|mesh-list
20624626|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624627|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
20624628|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225928|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20225929|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20225930|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
20225931|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
20225932|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
20624629|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
20624630|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624631|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20624632|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20624633|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
20624634|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624635|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624636|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20624637|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20624638|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
20624639|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624640|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
20624641|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624642|NCT02323282|Ropivacaine|ropivacaine|mesh-list
20624643|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
20624644|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
20624645|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624646|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624647|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
20624648|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624649|NCT02323347|Progesterone|progesterone|mesh-list
20624650|NCT02323347|Progestins|progestins|mesh-ancestor
19411360|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225933|NCT00344513|Carvedilol|carvedilol|mesh-list
20225934|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20225935|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20225936|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19696181|NCT04942834|Amiodarone|amiodarone|mesh-list
20624651|NCT02323347|Hormones|hormones|mesh-ancestor
20473307|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
20473308|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473309|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20473310|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
20473311|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
20473312|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473313|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473314|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473315|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20473316|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473317|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473318|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20473319|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19411361|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411362|NCT03540472|Tacrolimus|tacrolimus|mesh-list
19411363|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19411364|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
19411365|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411366|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19411367|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411368|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411369|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
19411370|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19411371|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19411372|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411373|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
19411374|NCT03540368|Coagulants|coagulants|mesh-ancestor
19411375|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19411376|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20473320|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20473321|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
20225937|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
20225938|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20225939|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225940|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225941|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20225942|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
20225943|NCT00344513|Protective Agents|protective agents|mesh-ancestor
20225944|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20225945|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473322|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20473323|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20473324|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
20473325|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20473326|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20473327|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20473328|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20473329|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
20473330|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20473331|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20473332|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20473333|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20473334|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473335|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
20473336|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20473337|NCT01501422|Estrogens|estrogens|mesh-list
20473338|NCT01501422|Hormones|hormones|mesh-ancestor
20473339|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473340|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473341|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
20473342|NCT01501435|Fenofibrate|fenofibrate|mesh-list
20473343|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20473344|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20473345|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
20473346|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473347|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20473348|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20473349|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20473350|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
20473351|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20473352|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20473353|NCT01501448|Estradiol|estradiol|mesh-list
20225946|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20473354|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20473355|NCT01501448|Estrogens|estrogens|mesh-ancestor
20473356|NCT01501448|Hormones|hormones|mesh-ancestor
20473357|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473358|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473359|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20473360|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
20473361|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20473362|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20473363|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20473364|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20473365|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20473366|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20473367|NCT01501487|Paclitaxel|paclitaxel|mesh-list
20473368|NCT01501487|Docetaxel|docetaxel|mesh-list
20473369|NCT01501487|Trastuzumab|trastuzumab|mesh-list
20473370|NCT01501487|Pertuzumab|pertuzumab|mesh-list
20473371|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20473372|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473373|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
20624652|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624653|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624654|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
20624655|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20624656|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20624657|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624658|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
20225947|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
19411377|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20624659|NCT02323373|Coagulants|coagulants|mesh-ancestor
20624660|NCT02323399|Phenylephrine|phenylephrine|mesh-list
20624661|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
20624662|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20624663|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
20624664|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
20624665|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624666|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624667|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
20624668|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20624669|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
20624670|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
20624671|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20624672|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20624673|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20624674|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
20624675|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624676|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624677|NCT02323399|Protective Agents|protective agents|mesh-ancestor
20624678|NCT02323412|Amoxicillin|amoxicillin|mesh-list
20624679|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20624680|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624681|NCT02323438|Menthol|menthol|mesh-list
20624682|NCT02323438|Nicotine|nicotine|mesh-list
20624683|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20624684|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
20624685|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624686|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624687|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20624688|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20624689|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
20624690|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624691|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624692|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
19411378|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
19411379|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411380|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19411381|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19411382|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416818|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225948|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20225949|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20225950|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
20225951|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624693|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
20624694|NCT02323451|Chitosan|chitosan|mesh-list
20624695|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
20624696|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20624697|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
20624698|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624699|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
20624700|NCT02323451|Protective Agents|protective agents|mesh-ancestor
20624701|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20624702|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20624703|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
20624704|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624705|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20624706|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
19696182|NCT04942834|Sotalol|sotalol|mesh-list
19696183|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19696184|NCT04942834|Dronedarone|dronedarone|mesh-list
19696185|NCT04942834|Propafenone|propafenone|mesh-list
19696186|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
19696187|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19696188|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696189|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473374|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
20473375|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
20473376|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473377|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473378|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20473379|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20473380|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473381|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473382|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20473383|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473384|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473385|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
20473386|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527377|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527378|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20527379|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20527380|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20527381|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696190|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19707862|NCT04822649|Analgesics|analgesics|mesh-ancestor
20624707|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
20624708|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
20624709|NCT02323451|Coagulants|coagulants|mesh-ancestor
20527382|NCT01768260|Aspirin|aspirin|mesh-list
20527383|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20527384|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20527385|NCT01768260|Analgesics|analgesics|mesh-ancestor
20527386|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
20624710|NCT02323516|Aspirin|aspirin|mesh-list
20624711|NCT02323516|Loperamide|loperamide|mesh-list
20624712|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
20624713|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20624714|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20624715|NCT02323516|Analgesics|analgesics|mesh-ancestor
20527387|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527388|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527389|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20527390|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527391|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20527392|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20527393|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527394|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20527395|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20527396|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527397|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
20527398|NCT01768273|Midazolam|midazolam|mesh-list
20527399|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20527400|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20527401|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624716|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
20624717|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411383|NCT03540225|Progesterone|progesterone|mesh-list
19411384|NCT03540225|Progestins|progestins|mesh-ancestor
20624718|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624719|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20624720|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20624721|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20624722|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20624723|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624724|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20624725|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20624726|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624727|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
20624728|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20624729|NCT02323529|Nitisinone|nitisinone|mesh-list
20624730|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624731|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624732|NCT02323594|Asunaprevir|asunaprevir|mesh-list
20624733|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
20624734|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624735|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624736|NCT02323607|Cytarabine|cytarabine|mesh-list
20624737|NCT02323607|Decitabine|decitabine|mesh-list
20624738|NCT02323607|Daunorubicin|daunorubicin|mesh-list
20624739|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20624740|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
20624741|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624742|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624743|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
20624744|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624745|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624746|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
20624747|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624748|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624749|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20624750|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20624751|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20624752|NCT02323737|Cisplatin|cisplatin|mesh-list
20624753|NCT02323737|Irinotecan|irinotecan|mesh-list
20624754|NCT02323737|Etoposide|etoposide|mesh-list
20624755|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624756|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20624757|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20624758|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624759|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624760|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20624761|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20624762|NCT02323906|Sorafenib|sorafenib|mesh-list
20624763|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624764|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20225952|NCT00344526|Dexamethasone|dexamethasone|mesh-list
20225953|NCT00344526|Melphalan|melphalan|mesh-list
20473387|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
20624765|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624766|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624767|NCT02323971|Ticagrelor|ticagrelor|mesh-list
20624768|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20624769|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20473388|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
20473389|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
20473390|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20473391|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
20473392|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
20473393|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473394|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473395|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473396|NCT01501669|Capecitabine|capecitabine|mesh-list
20473397|NCT01501669|Irinotecan|irinotecan|mesh-list
20473398|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20624770|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20624771|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20624772|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
19850346|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
19850347|NCT00708721|Clofarabine|clofarabine|mesh-list
19850348|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20225954|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850349|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
20473399|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
20624773|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473400|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473401|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473402|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20473403|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20473404|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473405|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
20473406|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20473407|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473408|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473409|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473410|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473411|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20473412|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
20473413|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473414|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473415|NCT01501708|Voriconazole|voriconazole|mesh-list
20473416|NCT01501708|Amphotericin B|amphotericin b|mesh-list
20473417|NCT01501708|Caspofungin|caspofungin|mesh-list
20473418|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
20473419|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473420|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20473421|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20473422|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473423|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473424|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20473425|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
20473426|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473427|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473428|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20473429|NCT01501708|Amebicides|amebicides|mesh-ancestor
20473430|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20473431|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20624774|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624775|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624776|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20624777|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624778|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624779|NCT02324010|Incretins|incretins|mesh-ancestor
20624780|NCT02324010|Hormones|hormones|mesh-ancestor
20624781|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473432|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473433|NCT01501747|Acetaminophen|acetaminophen|mesh-list
20473434|NCT01501747|Cephalexin|cephalexin|mesh-list
20624782|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20624783|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
20624784|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624785|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624786|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
20624787|NCT02324088|Docetaxel|docetaxel|mesh-list
20624788|NCT02324088|Epirubicin|epirubicin|mesh-list
20624789|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624790|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
20624791|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624792|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20624793|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20624794|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
20624795|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624796|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624797|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20624798|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20624799|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20624800|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20624801|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20624802|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20624803|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20624804|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473435|NCT01501747|Ibuprofen|ibuprofen|mesh-list
20473436|NCT01501747|Caffeine|caffeine|mesh-list
20473437|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20473438|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20473439|NCT01501747|Analgesics|analgesics|mesh-ancestor
20473440|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
20473441|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624805|NCT02324166|Cefazolin|cefazolin|mesh-list
20624806|NCT02324166|Lidocaine|lidocaine|mesh-list
20624807|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
20624808|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
20624809|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624810|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624811|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
20624812|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624813|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20624814|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20624815|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19696191|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19696192|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19696193|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624816|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20624817|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473442|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473443|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473444|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473445|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20473446|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473447|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473448|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
20473449|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20473450|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20473451|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20473452|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20473453|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
20624818|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20624819|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624820|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
20624821|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20624822|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624823|NCT02324296|Cisplatin|cisplatin|mesh-list
20473454|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473455|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473456|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473457|NCT01501760|Bevacizumab|bevacizumab|mesh-list
20473458|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473459|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473460|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20473461|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20473462|NCT01501760|Growth Substances|growth substances|mesh-ancestor
20473463|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473464|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
20473465|NCT01501786|Ketamine|ketamine|mesh-list
20473466|NCT01501786|Propofol|propofol|mesh-list
20473467|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20473468|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473469|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473470|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20473471|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
20473472|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
20473473|NCT01501786|Analgesics|analgesics|mesh-ancestor
20473474|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
20473475|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473476|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20473477|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20624824|NCT02324296|Etoposide|etoposide|mesh-list
20624825|NCT02324296|Ifosfamide|ifosfamide|mesh-list
20624826|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624827|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20624828|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20624829|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20624830|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624831|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624832|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20624833|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
20624834|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20624835|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20624836|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624837|NCT02324413|Clonidine|clonidine|mesh-list
20473478|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20473479|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473480|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473481|NCT01501799|Adapalene|adapalene|mesh-list
20473482|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20473483|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
20473484|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20473485|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20473486|NCT01501799|Analgesics|analgesics|mesh-ancestor
20473487|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
20473488|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473489|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473490|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473491|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473492|NCT01501890|Algestone|algestone|mesh-list
20473493|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20473494|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20473495|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20473496|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
20473497|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473498|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473499|NCT01501890|Progestins|progestins|mesh-ancestor
20473500|NCT01501890|Hormones|hormones|mesh-ancestor
20473501|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20473502|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20473503|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20473504|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
20473505|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20624838|NCT02324413|Analgesics|analgesics|mesh-ancestor
20624839|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
20624840|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624841|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696194|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19696195|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19696196|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20473506|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19696197|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19696198|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19696199|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
19696200|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696201|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696202|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
19696203|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
19696204|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696205|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19696206|NCT04942652|Itraconazole|itraconazole|mesh-list
19696207|NCT04942652|Esomeprazole|esomeprazole|mesh-list
19696208|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19696209|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19696210|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20473507|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20624842|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20624843|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
20624844|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
20624845|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20624846|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20624847|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20624848|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
20624849|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624850|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624851|NCT02324452|Fluorouracil|fluorouracil|mesh-list
20624852|NCT02324452|Capecitabine|capecitabine|mesh-list
20624853|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
20624854|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624855|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20624856|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624857|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20624858|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
20624859|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624860|NCT02324491|CKD732|ckd732|mesh-list
20624861|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20624862|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20624863|NCT02324491|Growth Substances|growth substances|mesh-ancestor
20624864|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624865|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
19696211|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473508|NCT01501916|Vitamin D|vitamin d|mesh-list
20473509|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
20473510|NCT01501916|Vitamins|vitamins|mesh-ancestor
20473511|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
20473512|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473513|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20473514|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20473515|NCT01501942|Glycine|glycine|mesh-list
20473516|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
20473517|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473518|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473519|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473520|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
20473521|NCT01501968|Colistin|colistin|mesh-list
20473522|NCT01501968|Vitamins|vitamins|mesh-ancestor
20473523|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
20473524|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473525|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
20473526|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473527|NCT01501968|Protective Agents|protective agents|mesh-ancestor
20473528|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473529|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411385|NCT03540225|Hormones|hormones|mesh-ancestor
19411386|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696212|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624866|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624867|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
20624868|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20624869|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624870|NCT02324621|TIC10 compound|tic10 compound|mesh-list
20624871|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624872|NCT02324686|Vitamin K|vitamin k|mesh-list
20624873|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
20624874|NCT02324686|Vitamins|vitamins|mesh-ancestor
20624875|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
20624876|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624877|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20624878|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20624879|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624880|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
20624881|NCT02324686|Coagulants|coagulants|mesh-ancestor
20624882|NCT02324738|Piperaquine|piperaquine|mesh-list
20624883|NCT02324738|Artenimol|artenimol|mesh-list
20624884|NCT02324738|Mefloquine|mefloquine|mesh-list
20473530|NCT01502020|Imiquimod|imiquimod|mesh-list
20473531|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20473532|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
20473533|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473534|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473535|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
20473536|NCT01502046|Dronabinol|dronabinol|mesh-list
20473537|NCT01502046|Cannabidiol|cannabidiol|mesh-list
20473538|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
20473539|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
20624885|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
20624886|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20624887|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20624888|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473540|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473541|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473542|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20473543|NCT01502046|Analgesics|analgesics|mesh-ancestor
20473544|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
20624889|NCT02324933|Fentanyl|fentanyl|mesh-list
20624890|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20624891|NCT02324933|Narcotics|narcotics|mesh-ancestor
20624892|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624893|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624894|NCT02324933|Analgesics|analgesics|mesh-ancestor
20624895|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
20624896|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624897|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20624898|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20624899|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
20624900|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
20624901|NCT02324998|Olaparib|olaparib|mesh-list
20624902|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20624903|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624904|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624905|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624906|NCT02325011|Fluconazole|fluconazole|mesh-list
20624907|NCT02325011|Nabiximols|nabiximols|mesh-list
20624908|NCT02325011|Dronabinol|dronabinol|mesh-list
20624909|NCT02325011|Cannabidiol|cannabidiol|mesh-list
20473545|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473546|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20473547|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20624910|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
20624911|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20225955|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
20225956|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
20624912|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20624913|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20624914|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624915|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624916|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20624917|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
20624918|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20624919|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473548|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473549|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473550|NCT01502046|Hormones|hormones|mesh-ancestor
20473551|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473552|NCT01502202|Pemetrexed|pemetrexed|mesh-list
20473553|NCT01502202|Gefitinib|gefitinib|mesh-list
20473554|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473555|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20624920|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19696213|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
20473556|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473557|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20473558|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20473559|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20473560|NCT01502241|Temozolomide|temozolomide|mesh-list
20473561|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20473562|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
20473563|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473564|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473565|NCT01502267|Rituximab|rituximab|mesh-list
20473566|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20225957|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225958|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225959|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225960|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
20225961|NCT00344526|Hormones|hormones|mesh-ancestor
20225962|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20225963|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20225964|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225965|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20225966|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
20225967|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225968|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20225969|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20225970|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
20225971|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20473567|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473568|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473569|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
20473570|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473571|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473572|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
20473573|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20473574|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
20473575|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473576|NCT01502280|Protective Agents|protective agents|mesh-ancestor
20624921|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20624922|NCT02325011|Analgesics|analgesics|mesh-ancestor
20624923|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
20624924|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624925|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
20624926|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
20624927|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20624928|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20473577|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473578|NCT01502280|Vitamins|vitamins|mesh-ancestor
20473579|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
20473580|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20473581|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
20624929|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20624930|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20624931|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624932|NCT02325011|Hormones|hormones|mesh-ancestor
20624933|NCT02325024|Nabiximols|nabiximols|mesh-list
20624934|NCT02325024|Analgesics|analgesics|mesh-ancestor
20624935|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
20624936|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20624937|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624938|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
20624939|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20624940|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20624941|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624942|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
20624943|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20624944|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624945|NCT02325180|Lumefantrine|lumefantrine|mesh-list
20624946|NCT02325180|Artemether|artemether|mesh-list
20624947|NCT02325180|Piperaquine|piperaquine|mesh-list
20624948|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20624949|NCT02325180|Artenimol|artenimol|mesh-list
20624950|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
20473582|NCT01502358|Vaccines|vaccines|mesh-list
20473583|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
20473584|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473585|NCT01502592|Ipilimumab|ipilimumab|mesh-list
20473586|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473587|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473588|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20473589|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473590|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20473591|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20473592|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
20473593|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
20624951|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20624952|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20624953|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624954|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
20624955|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20624956|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624957|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624958|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624959|NCT02325245|Metformin|metformin|mesh-list
20624960|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624961|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624962|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
20624963|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624964|NCT02325362|Miglustat|miglustat|mesh-list
20624965|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
20624966|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473594|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20624967|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624968|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20225972|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20225973|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
20225974|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225975|NCT00344539|Antacids|antacids|mesh-ancestor
20225976|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225977|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20225978|NCT00344552|Paclitaxel|paclitaxel|mesh-list
20225979|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20225980|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225981|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
20225982|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
20225983|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
20225984|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225985|NCT00344565|Modafinil|modafinil|mesh-list
20225986|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20473595|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
20473596|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473597|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473598|NCT01502774|Cyclosporine|cyclosporine|mesh-list
20473599|NCT01502774|Cyclosporins|cyclosporins|mesh-list
20473600|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473601|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473602|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20473603|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
20473604|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411387|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411388|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
19411389|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
19411390|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411391|NCT03540199|Antibodies|antibodies|mesh-list
19411392|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19411393|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
19411394|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624969|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20624970|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
20624971|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20624972|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20624973|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20624974|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624975|NCT02325440|Natalizumab|natalizumab|mesh-list
20624976|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20624977|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
19411395|NCT03540095|Bupivacaine|bupivacaine|mesh-list
19411396|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
19411397|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
20624978|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411398|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411399|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411400|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
20624979|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20624980|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624981|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19411401|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411402|NCT03540017|Cisplatin|cisplatin|mesh-list
19411403|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411404|NCT03539887|Ketamine|ketamine|mesh-list
19411405|NCT03539887|Analgesics|analgesics|mesh-ancestor
19411406|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
19411407|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20225987|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225988|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20225989|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20225990|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20225991|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20225992|NCT00344617|Bevacizumab|bevacizumab|mesh-list
20473605|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
20473606|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473607|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
20473608|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473609|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20473610|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
20473611|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473612|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20473613|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20624982|NCT02325479|Enoxaparin|enoxaparin|mesh-list
20473614|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473615|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473616|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
20473617|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
20473618|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
20473619|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473620|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473621|NCT01502904|Sirolimus|sirolimus|mesh-list
20473622|NCT01502904|Pravastatin|pravastatin|mesh-list
20624983|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
20624984|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20624985|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20624986|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20624987|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
20624988|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20624989|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20624990|NCT02325583|Midazolam|midazolam|mesh-list
20624991|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20624992|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20473623|NCT01502904|Pitavastatin|pitavastatin|mesh-list
20473624|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473625|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473626|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20473627|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473628|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
20473629|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20473630|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
20624993|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20624994|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20624995|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20624996|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20624997|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20624998|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20624999|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
20625000|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
20625001|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
20625002|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
20625003|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625004|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625005|NCT02325882|Fentanyl|fentanyl|mesh-list
20625006|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
20625007|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20625008|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625009|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625010|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20625011|NCT02325882|Analgesics|analgesics|mesh-ancestor
20625012|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
20625013|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625014|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20625015|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20625016|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20625017|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
20625018|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625019|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625020|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20625021|NCT02325882|Narcotics|narcotics|mesh-ancestor
20625022|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20625023|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20625024|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
20625025|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
20625026|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20625027|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20625028|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20625029|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
20225993|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20225994|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20225995|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20225996|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20225997|NCT00344617|Growth Substances|growth substances|mesh-ancestor
20225998|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20225999|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
20226000|NCT00344669|Albendazole|albendazole|mesh-list
20226001|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
20473631|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473632|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19411408|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473633|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20473634|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
19850350|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850351|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850352|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19850353|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19850354|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
19850355|NCT00709059|Ribavirin|ribavirin|mesh-list
19850356|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19850357|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
19850358|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
19850359|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850360|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
19411409|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19411410|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19411411|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
19411412|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
19850361|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850362|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
20473635|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473636|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20473637|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20473638|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473639|NCT01502943|Aspirin|aspirin|mesh-list
20473640|NCT01502943|Atorvastatin|atorvastatin|mesh-list
20473641|NCT01502943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473642|NCT01502943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20473643|NCT01502943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20473644|NCT01502943|Analgesics|analgesics|mesh-ancestor
20473645|NCT01502943|Sensory System Agents|sensory system agents|mesh-ancestor
20473646|NCT01502943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473647|NCT01502943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473648|NCT01502943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473649|NCT01502943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20473650|NCT01502943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20473651|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625030|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226002|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20226003|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226004|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
20226005|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20226006|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20226007|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
20226008|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
20226009|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
20226010|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226011|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226012|NCT00344695|Bupropion|bupropion|mesh-list
20226013|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20226014|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
20226015|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20226016|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20226017|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20226018|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20226019|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226020|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
20226021|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625031|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20625032|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625033|NCT05144282|Bevacizumab|bevacizumab|mesh-list
20625034|NCT05144282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625035|NCT05144282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625036|NCT05144282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20625037|NCT05144282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20625038|NCT05144282|Growth Substances|growth substances|mesh-ancestor
20625039|NCT05144282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625040|NCT05144282|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625041|NCT05144100|Cisplatin|cisplatin|mesh-list
20625042|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411413|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411414|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19411415|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19411416|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226022|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625043|NCT05143723|Hormones|hormones|mesh-list
20625044|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473652|NCT01502943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20473653|NCT01502943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20473654|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473655|NCT01502943|Antipyretics|antipyretics|mesh-ancestor
20473656|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20473657|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20473658|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
20625045|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625046|NCT05143281|Dexamethasone|dexamethasone|mesh-list
20625047|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
20625048|NCT05143281|BB 1101|bb 1101|mesh-list
20625049|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625050|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
20625051|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
20625052|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625053|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625054|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625055|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
20625056|NCT05143281|Hormones|hormones|mesh-ancestor
20625057|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625058|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20625059|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625060|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
20625061|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625062|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625063|NCT05143125|Decitabine|decitabine|mesh-list
20625064|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20625065|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
20625066|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473659|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20473660|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20473661|NCT01503008|Metformin|metformin|mesh-list
20473662|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20473663|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20473664|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
20473665|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20473666|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625067|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625068|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625069|NCT05142904|Iodine|iodine|mesh-list
20625070|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
20625071|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20473667|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473668|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625072|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625073|NCT05142904|Trace Elements|trace elements|mesh-ancestor
20625074|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
20625075|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625076|NCT05142865|Carboplatin|carboplatin|mesh-list
20625077|NCT05142865|Etoposide|etoposide|mesh-list
20625078|NCT05142865|Apatinib|apatinib|mesh-list
20625079|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625080|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20625081|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20625082|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20625083|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226023|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20226024|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20226025|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226026|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20226027|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226028|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226029|NCT00344760|Tenofovir|tenofovir|mesh-list
20226030|NCT00344760|Lamivudine|lamivudine|mesh-list
20226031|NCT00344760|Efavirenz|efavirenz|mesh-list
20226032|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
20226033|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
20625084|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625085|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20625086|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20625087|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625088|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625089|NCT05118737|Colchicine|colchicine|mesh-list
20625090|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
20625091|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625092|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
20226034|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226035|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20226036|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20226037|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226038|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226039|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20625093|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
20625094|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
20625095|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625096|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625097|NCT05118685|Estrogens|estrogens|mesh-list
20625098|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20625099|NCT05118685|Hormones|hormones|mesh-ancestor
20625100|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625101|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625102|NCT05109364|Terazosin|terazosin|mesh-list
20625103|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20625104|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20625105|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20625106|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
20625107|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625108|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473669|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
20473670|NCT01503060|Lidocaine|lidocaine|mesh-list
20473671|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
20473672|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
20473673|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473674|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473675|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
20473676|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473677|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20473678|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20473679|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20473680|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473681|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527402|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527403|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20527404|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20527405|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20527406|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20625109|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625110|NCT05109364|Urological Agents|urological agents|mesh-ancestor
20625111|NCT05042466|Psilocybin|psilocybin|mesh-list
20625112|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
20625113|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625114|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625115|NCT05037552|Hemostatics|hemostatics|mesh-list
20625116|NCT05037552|Coagulants|coagulants|mesh-ancestor
20625117|NCT05021926|Lidocaine|lidocaine|mesh-list
20625118|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
20625119|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
20625120|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
20625121|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625122|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625123|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
20625124|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625125|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20625126|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20625127|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20625128|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625129|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625130|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20625131|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
20625132|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
20226040|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20226041|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20625133|NCT05021926|Protective Agents|protective agents|mesh-ancestor
20625134|NCT05021913|Lidocaine|lidocaine|mesh-list
20625135|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
20625136|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
20625137|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
20625138|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625139|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625140|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
20625141|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625142|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20625143|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20625144|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20625145|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625146|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625147|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20625148|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
20625149|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
20473682|NCT01503216|Vitamin D|vitamin d|mesh-list
20473683|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
20473684|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
20473685|NCT01503216|Vitamins|vitamins|mesh-ancestor
20473686|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
20473687|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473688|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20473689|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20473690|NCT01503242|Cyclosporine|cyclosporine|mesh-list
20473691|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
20473692|NCT01503242|Fludarabine|fludarabine|mesh-list
20473693|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
20473694|NCT01503242|Antibodies|antibodies|mesh-list
20473695|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20473696|NCT01503242|Cyclosporins|cyclosporins|mesh-list
20473697|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
20473698|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473699|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473700|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20473701|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
20473702|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473703|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20473704|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473705|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
20473706|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473707|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
20473708|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473709|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20473710|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20473711|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20473712|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
20473713|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473714|NCT01503359|Glycine|glycine|mesh-list
20473715|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
20625150|NCT05021913|Protective Agents|protective agents|mesh-ancestor
20625151|NCT04987931|Talazoparib|talazoparib|mesh-list
20625152|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20625153|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625154|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625155|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625156|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
20625157|NCT04929847|Emollients|emollients|mesh-list
20625158|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
20625159|NCT04929834|Emollients|emollients|mesh-list
20625160|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20625161|NCT04881955|Ecopipam|ecopipam|mesh-list
20625162|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19696214|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473716|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473717|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473718|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473719|NCT01503372|Leucovorin|leucovorin|mesh-list
19696215|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19696216|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19855602|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
20473720|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
20473721|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473722|NCT01503372|Antidotes|antidotes|mesh-ancestor
20473723|NCT01503372|Protective Agents|protective agents|mesh-ancestor
20625163|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473724|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473725|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
20473726|NCT01503372|Vitamins|vitamins|mesh-ancestor
20625164|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625165|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625166|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625167|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20625168|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
20625169|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696217|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19696218|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
19696219|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696220|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696221|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19696222|NCT04942769|Selenium|selenium|mesh-list
19696223|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
20473727|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
20625170|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625171|NCT04850222|Fluoxetine|fluoxetine|mesh-list
20625172|NCT04850222|Calcium|calcium|mesh-list
20625173|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20625174|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625175|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20625176|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20625177|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625178|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625179|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625180|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
20625181|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20625182|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
20625183|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625184|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20625185|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20625186|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411417|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473728|NCT01503385|Celecoxib|celecoxib|mesh-list
20473729|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20473730|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20473731|NCT01503385|Analgesics|analgesics|mesh-ancestor
20473732|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
20473733|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473734|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473735|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473736|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473737|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20473738|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20473739|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473740|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473741|NCT01503398|Olanzapine|olanzapine|mesh-list
19411418|NCT03539731|Piperazine|piperazine|mesh-list
19411419|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
19411420|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
19411421|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19411422|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411423|NCT03539718|Taurolidine|taurolidine|mesh-list
19411424|NCT03539718|Heparin|heparin|mesh-list
19411425|NCT03539718|Calcium heparin|calcium heparin|mesh-list
19696224|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473742|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
19411426|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
20473743|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
20625187|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
20625188|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625189|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625190|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
20625191|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
20625192|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
20625193|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625194|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625195|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625196|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20625197|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
20625198|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
20625199|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625200|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625201|NCT04722952|Cytarabine|cytarabine|mesh-list
20625202|NCT04722952|Azacitidine|azacitidine|mesh-list
20625203|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
20625204|NCT04722952|Visilizumab|visilizumab|mesh-list
20625205|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20625206|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
20625207|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625208|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625209|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
20625210|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625211|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20625212|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
20625213|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625214|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625215|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20625216|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20625217|NCT04716933|Carboplatin|carboplatin|mesh-list
20625218|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
20625219|NCT04716933|Pemetrexed|pemetrexed|mesh-list
20625220|NCT04716933|Lenvatinib|lenvatinib|mesh-list
20625221|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625222|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625223|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625224|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625225|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20625226|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20625227|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20625228|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
20625229|NCT04715191|Fludarabine|fludarabine|mesh-list
20625230|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
20625231|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20625232|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
20625233|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625234|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625235|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20625236|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
20625237|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625238|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625239|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20625240|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20625241|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
20625242|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20625243|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
20625244|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625245|NCT04703361|Niacin|niacin|mesh-list
20625246|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20625247|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
20625248|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625249|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20625250|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
20625251|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
20625252|NCT04703361|Vitamins|vitamins|mesh-ancestor
20625253|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
20625254|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625255|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
20625256|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20625257|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625258|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625259|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20625260|NCT04674241|Analgesics|analgesics|mesh-ancestor
20625261|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
20625262|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625263|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20625264|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20625265|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20625266|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
20625267|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625268|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625280|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
20625281|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
20625282|NCT04641728|Olaparib|olaparib|mesh-list
20625283|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625284|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625285|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20625286|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411427|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19411428|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20473744|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473745|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473746|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473747|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20473748|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473749|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473750|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473751|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20473752|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20473753|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473754|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473755|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473756|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
20473757|NCT01503424|Olanzapine|olanzapine|mesh-list
20473758|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
20473759|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
20473760|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473761|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473762|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625287|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625288|NCT04600895|Favipiravir|favipiravir|mesh-list
20625289|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
20625290|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625291|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
20625292|NCT04558359|Giapreza|giapreza|mesh-list
20625293|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
20625294|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20625295|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20625296|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
20625297|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625298|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625299|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
20625300|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20625301|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20625302|NCT04551144|Estradiol|estradiol|mesh-list
20625303|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19850363|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850364|NCT00709098|Iloprost|iloprost|mesh-list
19850365|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20625304|NCT04551144|Testosterone|testosterone|mesh-list
20625305|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
20625306|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
20625307|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20625308|NCT04551144|Estrogens|estrogens|mesh-ancestor
19411429|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411430|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850366|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
20625309|NCT04551144|Hormones|hormones|mesh-ancestor
19411431|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19411432|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411433|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19411434|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19411435|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19411436|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411437|NCT03539562|Promethazine|promethazine|mesh-list
19411438|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
19411439|NCT03539562|Morphine|morphine|mesh-list
19411440|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20473763|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20473764|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473765|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473766|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473767|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20473768|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20473769|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473770|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473771|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473772|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
20473773|NCT01503437|Olanzapine|olanzapine|mesh-list
20473774|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
20473775|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
20473776|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473777|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473778|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473779|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20473780|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473781|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473782|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473783|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20473784|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20473785|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473786|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473787|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473788|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
20473789|NCT01503450|Olanzapine|olanzapine|mesh-list
20473790|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
20473791|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
20473792|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473793|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473794|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473795|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20473796|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473797|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473798|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473799|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20473800|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20473801|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20473802|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473803|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473804|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
20473805|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
20473806|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
20473807|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473808|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20473809|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473810|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473811|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
20473812|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20473813|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20473814|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20473815|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
20473816|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473817|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473818|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473819|NCT01503580|Urological Agents|urological agents|mesh-ancestor
20473820|NCT01503593|Calcium|calcium|mesh-list
20473821|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20473822|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473823|NCT01503658|Aspirin|aspirin|mesh-list
20625310|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625311|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625312|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20625313|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
20625314|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20625315|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20625316|NCT04551144|Androgens|androgens|mesh-ancestor
20625317|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20625318|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625319|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
20625320|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20625321|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
20625322|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625323|NCT04534881|Progesterone|progesterone|mesh-list
20625324|NCT04534881|Progestins|progestins|mesh-ancestor
20625325|NCT04534881|Hormones|hormones|mesh-ancestor
20625326|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625327|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625328|NCT04532502|Anesthetics|anesthetics|mesh-list
20625329|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
20625330|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625331|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625332|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
20625333|NCT04496908|Misoprostol|misoprostol|mesh-list
20625334|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20625335|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
20625336|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20625337|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625338|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20625339|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625340|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
20625341|NCT04452747|Dinoprostone|dinoprostone|mesh-list
20625342|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
20625343|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20625344|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625345|NCT04384107|Vaccines|vaccines|mesh-list
20625346|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
20625347|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625348|NCT04382924|Ifenprodil|ifenprodil|mesh-list
20625349|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20625350|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20625351|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
20625352|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625353|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625354|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625355|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
20625356|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20625357|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20625358|NCT04371640|Sirolimus|sirolimus|mesh-list
20625359|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20625360|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625361|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20625362|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625363|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
20625364|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20625365|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
19411441|NCT03539562|Narcotics|narcotics|mesh-ancestor
20226042|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20226043|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20473824|NCT01503658|Clopidogrel|clopidogrel|mesh-list
20473825|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20473826|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20473827|NCT01503658|Analgesics|analgesics|mesh-ancestor
20473828|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
20473829|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226044|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20226045|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20226046|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20226047|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20473830|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473831|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473832|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625366|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625367|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19411442|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411443|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411444|NCT03539562|Analgesics|analgesics|mesh-ancestor
19411445|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
19411446|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850367|NCT00709111|Maraviroc|maraviroc|mesh-list
20473833|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20473834|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20473835|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473836|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20473837|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20473838|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473839|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
20473840|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20473841|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20625368|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20625369|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20625370|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20625371|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625372|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625373|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625374|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625375|NCT04364997|Analgesics|analgesics|mesh-ancestor
20625376|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
20625377|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625378|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
20625379|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625380|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
20625381|NCT04356196|Verapamil|verapamil|mesh-list
20625382|NCT04356196|Bisoprolol|bisoprolol|mesh-list
20625383|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20625384|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20625385|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625386|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625387|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20625388|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625389|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
20625390|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20625391|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
20625392|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
20625393|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625394|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20625395|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20625396|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20625397|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
20625398|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625399|NCT04306315|Brodalumab|brodalumab|mesh-list
20625400|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
20625401|NCT04258410|Quercetin|quercetin|mesh-list
20625402|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
20625403|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625404|NCT04258410|Protective Agents|protective agents|mesh-ancestor
20625405|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625406|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20625407|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20625408|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20625409|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625410|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625411|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625412|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625413|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20625414|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
20625415|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625416|NCT04191616|Dexamethasone|dexamethasone|mesh-list
20625417|NCT04191616|Pomalidomide|pomalidomide|mesh-list
20625418|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625419|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
20625420|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
20625421|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625422|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625423|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625424|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
20625425|NCT04191616|Hormones|hormones|mesh-ancestor
20625426|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625427|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20625428|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625429|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
20625430|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20625431|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20625432|NCT04191616|Growth Substances|growth substances|mesh-ancestor
20625433|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625434|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
20625435|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20625436|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625437|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20625438|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625439|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20625440|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
20625441|NCT04120454|Ramucirumab|ramucirumab|mesh-list
19850368|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19850369|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19850370|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850371|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19850372|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19850373|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
19850374|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850375|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19850376|NCT00709202|Betahistine|betahistine|mesh-list
19850377|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
19850378|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
19850379|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
19850380|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850381|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850382|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850383|NCT00709228|Ribavirin|ribavirin|mesh-list
19850384|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19850385|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
19850386|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850387|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
20473842|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19411447|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
19411448|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
20473843|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
20625442|NCT04120454|Antibodies|antibodies|mesh-list
20473844|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473845|NCT01503671|Atorvastatin|atorvastatin|mesh-list
20473846|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20473847|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20473848|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
20473849|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473850|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20473851|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20473852|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473853|NCT01503736|Citric Acid|citric acid|mesh-list
20473854|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
20625443|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
20625444|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20625445|NCT04120454|Lexatumumab|lexatumumab|mesh-list
20625446|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
20625447|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625448|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625449|NCT04107168|Bevacizumab|bevacizumab|mesh-list
20625450|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
20625451|NCT04107168|Nivolumab|nivolumab|mesh-list
20625452|NCT04107168|Ipilimumab|ipilimumab|mesh-list
20625453|NCT04107168|Durvalumab|durvalumab|mesh-list
20625454|NCT04107168|Atezolizumab|atezolizumab|mesh-list
20625455|NCT04107168|Tremelimumab|tremelimumab|mesh-list
20473855|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
20473856|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
20473857|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20625456|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850388|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850389|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
20473858|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
20625457|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625458|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20473859|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
20473860|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473861|NCT01503736|Hematinics|hematinics|mesh-ancestor
19411449|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19411450|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
19411451|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
20625459|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20625460|NCT04107168|Growth Substances|growth substances|mesh-ancestor
20625461|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625462|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625463|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20625464|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625465|NCT04098237|Pancrelipase|pancrelipase|mesh-list
20625466|NCT04098237|Pancreatin|pancreatin|mesh-list
20625467|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625468|NCT04097730|Riboflavin|riboflavin|mesh-list
20625469|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
20625470|NCT04097730|Difluprednate|difluprednate|mesh-list
20625471|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20625472|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625473|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20625474|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20625475|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625476|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625477|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625478|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625479|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
20625480|NCT04097730|Vitamins|vitamins|mesh-ancestor
19411452|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473862|NCT01503788|Midazolam|midazolam|mesh-list
20473863|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20473864|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19850390|NCT00709592|Tacrolimus|tacrolimus|mesh-list
19850391|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
19850392|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19850393|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850394|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
19850395|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850396|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19850397|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850398|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850399|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20625481|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
20625482|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20625483|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
20625484|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
20625485|NCT04097730|Hormones|hormones|mesh-ancestor
20625486|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625487|NCT04034459|Leucovorin|leucovorin|mesh-list
20625488|NCT04034459|Folic Acid|folic acid|mesh-list
20625489|NCT04034459|Bevacizumab|bevacizumab|mesh-list
19850400|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850401|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19850402|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
19850403|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20473865|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20473866|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473867|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20473868|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20473869|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20473870|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20473871|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
20473872|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
20473873|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
20625490|NCT04034459|Cetuximab|cetuximab|mesh-list
20625491|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
20625492|NCT04034459|Irinotecan|irinotecan|mesh-list
20625493|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
19411453|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473874|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
19850404|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473875|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473876|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625494|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625495|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625496|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20625497|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20473877|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
20473878|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
20473879|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20473880|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
20473881|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473882|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473883|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20473884|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
20473885|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20473886|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
20473887|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473888|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473889|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
20473890|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
20473891|NCT01503801|Protective Agents|protective agents|mesh-ancestor
20473892|NCT01503905|Tamoxifen|tamoxifen|mesh-list
20473893|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
20473894|NCT01503905|Docetaxel|docetaxel|mesh-list
20473895|NCT01503905|Trastuzumab|trastuzumab|mesh-list
20473896|NCT01503905|Epirubicin|epirubicin|mesh-list
20473897|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20473898|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
20473899|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473900|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20473901|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20473902|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
20473903|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473904|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473905|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20625498|NCT04034459|Growth Substances|growth substances|mesh-ancestor
20625499|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625500|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625501|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20625502|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20625503|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625504|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625505|NCT04034459|Antidotes|antidotes|mesh-ancestor
20625506|NCT04034459|Protective Agents|protective agents|mesh-ancestor
20625507|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
20625508|NCT04034459|Vitamins|vitamins|mesh-ancestor
20625509|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
20625510|NCT04034459|Hematinics|hematinics|mesh-ancestor
20625511|NCT04030052|Factor VIII|factor viii|mesh-list
20625512|NCT04030052|Coagulants|coagulants|mesh-ancestor
20625513|NCT04005729|Cangrelor|cangrelor|mesh-list
20625514|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20625515|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20625516|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20625517|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20625518|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
20625519|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625520|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625521|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625522|NCT04000737|Sorafenib|sorafenib|mesh-list
20625523|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625524|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20625525|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625526|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473906|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
20473907|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
20625527|NCT03950076|Edoxaban|edoxaban|mesh-list
19696225|NCT04942769|Protective Agents|protective agents|mesh-ancestor
19696226|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473908|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
20473909|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473910|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20473911|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20473912|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20473913|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473914|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20473915|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
20473916|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473917|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20473918|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20473919|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20473920|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20473921|NCT01503918|Valacyclovir|valacyclovir|mesh-list
20473922|NCT01503918|Valganciclovir|valganciclovir|mesh-list
20473923|NCT01503918|Acyclovir|acyclovir|mesh-list
20473924|NCT01503918|Ganciclovir|ganciclovir|mesh-list
20473925|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20473926|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
20473927|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20473928|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20473929|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20473930|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473931|NCT01503983|Capecitabine|capecitabine|mesh-list
20473932|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
20473933|NCT01503983|Trastuzumab|trastuzumab|mesh-list
20473934|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20473935|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
20473936|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473937|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20473938|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473939|NCT01504074|Triamcinolone|triamcinolone|mesh-list
20473940|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20473941|NCT01504074|Levobunolol|levobunolol|mesh-list
20473942|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20473943|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
20473944|NCT01504074|Hormones|hormones|mesh-ancestor
20473945|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20473946|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473947|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473948|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19850405|NCT00709618|Vinorelbine|vinorelbine|mesh-list
19850406|NCT00709618|Lapatinib|lapatinib|mesh-list
19850407|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20473949|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473950|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20473951|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20473952|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
20473953|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473954|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
20473955|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
20473956|NCT01504126|Propranolol|propranolol|mesh-list
19696227|NCT04942769|Trace Elements|trace elements|mesh-ancestor
19696228|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
19696229|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
19696230|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
19696231|NCT04942730|Busulfan|busulfan|mesh-list
19696232|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19696233|NCT04942730|Fludarabine|fludarabine|mesh-list
20226048|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20226049|NCT00344812|Buprenorphine|buprenorphine|mesh-list
20226050|NCT00344812|Methadone|methadone|mesh-list
20226051|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226052|NCT00344812|Narcotics|narcotics|mesh-ancestor
20226053|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226054|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226055|NCT00344812|Analgesics|analgesics|mesh-ancestor
20226056|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
20226057|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226058|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20226059|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
20226060|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
20226061|NCT00344825|Fludarabine|fludarabine|mesh-list
20625528|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20625529|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
20625530|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20625531|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
20625532|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625533|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625534|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
20625535|NCT03914885|Fludarabine|fludarabine|mesh-list
20625536|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20625537|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625538|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625539|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20625540|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
20625541|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
20625542|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625543|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625544|NCT03885089|Infliximab|infliximab|mesh-list
20625545|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
20625546|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625547|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625548|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20625549|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20625550|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20625551|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625552|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625553|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
20625554|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625555|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20625556|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20625557|NCT03823534|Acetaminophen|acetaminophen|mesh-list
20473957|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20473958|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20473959|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
20625558|NCT03823534|Ketorolac|ketorolac|mesh-list
20625559|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19696234|NCT04942730|Tacrolimus|tacrolimus|mesh-list
19696235|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696236|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
19696237|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696238|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696239|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19696240|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
20473960|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473961|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625560|NCT03823534|Morphine|morphine|mesh-list
20625561|NCT03823534|Oxycodone|oxycodone|mesh-list
20625562|NCT03823534|Hydrocodone|hydrocodone|mesh-list
20625563|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20625564|NCT03823534|Narcotics|narcotics|mesh-ancestor
20625565|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625566|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625567|NCT03823534|Analgesics|analgesics|mesh-ancestor
19411454|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19411455|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19411456|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19411457|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
19411458|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
19411459|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
19411460|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
19411461|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473962|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473963|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20473964|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20473965|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
20473966|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20473967|NCT01504139|Estradiol|estradiol|mesh-list
20473968|NCT01504139|Progesterone|progesterone|mesh-list
20473969|NCT01504139|Estrogens|estrogens|mesh-ancestor
20473970|NCT01504139|Hormones|hormones|mesh-ancestor
20473971|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625568|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
20625569|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625570|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20625571|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
19411462|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19707863|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
19411463|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19411464|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19411465|NCT03539445|Protective Agents|protective agents|mesh-ancestor
19411466|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411467|NCT03539367|Acetazolamide|acetazolamide|mesh-list
19411468|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
19411469|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19411470|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625572|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20625573|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625574|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625575|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20625576|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625577|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625578|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
20625579|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
20473972|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473973|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20473974|NCT01504139|Progestins|progestins|mesh-ancestor
19411471|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411472|NCT03539367|Diuretics|diuretics|mesh-ancestor
19411473|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
19411474|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411475|NCT03539328|Gemcitabine|gemcitabine|mesh-list
20473975|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20625580|NCT03812991|Calcitonin|calcitonin|mesh-list
20625581|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
20625582|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20625583|NCT03812991|Katacalcin|katacalcin|mesh-list
20625584|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20625585|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625586|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20625587|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
20625588|NCT03779243|Melatonin|melatonin|mesh-list
20625589|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
20625590|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625591|NCT03779243|Protective Agents|protective agents|mesh-ancestor
20625592|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625593|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625594|NCT03757013|Apremilast|apremilast|mesh-list
20625595|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20625596|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20625597|NCT03757013|Analgesics|analgesics|mesh-ancestor
20625598|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
20625599|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625600|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625601|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625602|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625603|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20625604|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20625605|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625606|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625607|NCT03729271|Rifaximin|rifaximin|mesh-list
20625608|NCT03729271|Lactulose|lactulose|mesh-list
20625609|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19411476|NCT03539328|Paclitaxel|paclitaxel|mesh-list
19411477|NCT03539328|Doxorubicin|doxorubicin|mesh-list
20473976|NCT01504178|Levodopa|levodopa|mesh-list
20473977|NCT01504178|Apomorphine|apomorphine|mesh-list
20473978|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20473979|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20473980|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20473981|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19411478|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19411479|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
20473982|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20473983|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20473984|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20473985|NCT01504178|Analgesics|analgesics|mesh-ancestor
20473986|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
20473987|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20473988|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
20473989|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19411480|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19411481|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625610|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625611|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625612|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
20625613|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20625614|NCT03696784|Fludarabine|fludarabine|mesh-list
20625615|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20625616|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
20625617|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625618|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625619|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20625620|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
20625621|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625622|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625623|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20625624|NCT03693846|Nivolumab|nivolumab|mesh-list
20625625|NCT03693846|Ipilimumab|ipilimumab|mesh-list
20625626|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625627|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625628|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20625629|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625630|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
20625631|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20625632|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
20625633|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625634|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625635|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20625636|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
20625637|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20625638|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20625639|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20625640|NCT03635788|Rilpivirine|rilpivirine|mesh-list
20625641|NCT03635788|Cabotegravir|cabotegravir|mesh-list
20625642|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19411482|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
19411483|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
19411484|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
19411485|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411486|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19411487|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
19411488|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
19411489|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411490|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411491|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19411492|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
20625643|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20625644|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625645|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625646|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
20625647|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625648|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20625649|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20625650|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20625651|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20625652|NCT03601455|Durvalumab|durvalumab|mesh-list
20625653|NCT03601455|Ipilimumab|ipilimumab|mesh-list
20625654|NCT03601455|Tremelimumab|tremelimumab|mesh-list
20625655|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
20625656|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20625657|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
20625658|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625659|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625660|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
20625661|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625662|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20625663|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625664|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
20625665|NCT03594162|Fludarabine|fludarabine|mesh-list
20625666|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20625667|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
20625668|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625669|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625670|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20625671|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
19411493|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411494|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19411495|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19411496|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19411497|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20473990|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
20473991|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20473992|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20473993|NCT01504178|Emetics|emetics|mesh-ancestor
20625672|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625673|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625674|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20625675|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
20625676|NCT03437330|Empagliflozin|empagliflozin|mesh-list
20625677|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19411498|NCT03539224|Lamivudine|lamivudine|mesh-list
19411499|NCT03539224|Dolutegravir|dolutegravir|mesh-list
19411500|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19411501|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19411502|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411503|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411504|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
20473994|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
19411505|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411506|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19411507|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19411508|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19411509|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19411510|NCT03539198|Nivolumab|nivolumab|mesh-list
19411511|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19411512|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411513|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19411514|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411515|NCT03539172|Apatinib|apatinib|mesh-list
19411516|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226062|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
20226063|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
20226064|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226065|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20226066|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
20226067|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226068|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226069|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
20473995|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20473996|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
20473997|NCT01504256|Leucovorin|leucovorin|mesh-list
20473998|NCT01504256|Docetaxel|docetaxel|mesh-list
20473999|NCT01504256|Fluorouracil|fluorouracil|mesh-list
20474000|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
20474001|NCT01504256|Catumaxomab|catumaxomab|mesh-list
20474002|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20474003|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
20474004|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474005|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
20474006|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
20226070|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226071|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247433|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20247434|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20247435|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20247436|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247437|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20247438|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
20247439|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
20474007|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
20474008|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474009|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
20474010|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20474011|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20474012|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
20474013|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625678|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411517|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20474014|NCT01504256|Antidotes|antidotes|mesh-ancestor
20474015|NCT01504256|Protective Agents|protective agents|mesh-ancestor
20625679|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20625680|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625681|NCT03261830|Clindamycin|clindamycin|mesh-list
20625682|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
20625683|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
20625684|NCT03261830|Cefazolin|cefazolin|mesh-list
20625685|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20625686|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625687|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20625688|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625689|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625690|NCT03219528|Rifaximin|rifaximin|mesh-list
20625691|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20625692|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20625693|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625694|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
20625695|NCT03111732|Capecitabine|capecitabine|mesh-list
20625696|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
20625697|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625698|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625699|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20625700|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
20625701|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625702|NCT03088059|Durvalumab|durvalumab|mesh-list
20625703|NCT03088059|Palbociclib|palbociclib|mesh-list
20625704|NCT03088059|Niraparib|niraparib|mesh-list
20625705|NCT03088059|Afatinib|afatinib|mesh-list
20625706|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625707|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625708|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20625709|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625710|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625711|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20625712|NCT03065244|Infliximab|infliximab|mesh-list
20625713|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
20625714|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20625715|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
20625716|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20625717|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
20625718|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625719|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
20625720|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625721|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625722|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
20625723|NCT03007732|Prednisone|prednisone|mesh-list
20625724|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
20625725|NCT03007732|Leuprolide|leuprolide|mesh-list
20625726|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
20625727|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
20625728|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20474016|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
20474017|NCT01504256|Vitamins|vitamins|mesh-ancestor
20474018|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
20474019|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474020|NCT01504282|Mitomycins|mitomycins|mesh-list
20474021|NCT01504282|Mitomycin|mitomycin|mesh-list
20474022|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20474023|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474024|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
20474025|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625729|NCT03007732|Androgens|androgens|mesh-list
19411518|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411519|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411520|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19411521|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19411522|NCT03539055|Dabigatran|dabigatran|mesh-list
20226072|NCT00344851|Metformin|metformin|mesh-list
19411523|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
20226073|NCT00344851|Exenatide|exenatide|mesh-list
20527407|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
20527408|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
20527409|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
20527410|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
20527411|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527412|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527413|NCT01768299|Misoprostol|misoprostol|mesh-list
20527414|NCT01768299|Mifepristone|mifepristone|mesh-list
20527415|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20527416|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
19411524|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19411525|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
19411526|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411527|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474026|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20474027|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474028|NCT01504295|Metadoxine|metadoxine|mesh-list
19411528|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
19411529|NCT03539003|Remifentanil|remifentanil|mesh-list
19411530|NCT03539003|Propofol|propofol|mesh-list
19411531|NCT03539003|Sevoflurane|sevoflurane|mesh-list
19411532|NCT03539003|Desflurane|desflurane|mesh-list
20625730|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625731|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625732|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625733|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
20625734|NCT03007732|Hormones|hormones|mesh-ancestor
19411533|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19411534|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411535|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474029|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20474030|NCT01504321|Moxonidine|moxonidine|mesh-list
20474031|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474032|NCT01504334|Pirfenidone|pirfenidone|mesh-list
20474033|NCT01504334|Analgesics|analgesics|mesh-ancestor
20474034|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
20474035|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474036|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474037|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20474038|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20474039|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625735|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625736|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625737|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20625738|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20625739|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
20625740|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411536|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19411537|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
19411538|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
19411539|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19411540|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19411541|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19411542|NCT03539003|Narcotics|narcotics|mesh-ancestor
20625741|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20625742|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625743|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625744|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
20625745|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20625746|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
20625747|NCT03007732|Protective Agents|protective agents|mesh-ancestor
20625748|NCT03007732|Vitamins|vitamins|mesh-ancestor
19411543|NCT03539003|Analgesics|analgesics|mesh-ancestor
19411544|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
19411545|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411546|NCT03538704|Metformin|metformin|mesh-list
19411547|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19411548|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411549|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19411550|NCT03538691|Dexetimide|dexetimide|mesh-list
19411551|NCT03538691|Citalopram|citalopram|mesh-list
19411552|NCT03538691|Fluoxetine|fluoxetine|mesh-list
19411553|NCT03538691|Paroxetine|paroxetine|mesh-list
19411554|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19411555|NCT03538691|Sertraline|sertraline|mesh-list
19411556|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
19411557|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19411558|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19411559|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19411560|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696241|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696242|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696243|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19696244|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20474040|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411561|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411562|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
20625749|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
20625750|NCT03007732|Estrogens|estrogens|mesh-ancestor
20625751|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
20625752|NCT02952924|Midazolam|midazolam|mesh-list
20625753|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20625754|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20625755|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625756|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625757|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20625758|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20625759|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625760|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20625761|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
20625762|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
20625763|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
20625764|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
20625765|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625766|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625767|NCT02934529|Leucovorin|leucovorin|mesh-list
20625768|NCT02934529|Folic Acid|folic acid|mesh-list
20625769|NCT02934529|Bevacizumab|bevacizumab|mesh-list
20625770|NCT02934529|Cetuximab|cetuximab|mesh-list
20226074|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20226075|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226076|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20226077|NCT00344851|Incretins|incretins|mesh-ancestor
20226078|NCT00344851|Hormones|hormones|mesh-ancestor
20226079|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20226080|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20226081|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226082|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226083|NCT00344942|Triamcinolone|triamcinolone|mesh-list
20226084|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20226085|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20226086|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20226087|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226088|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
20226089|NCT00344942|Hormones|hormones|mesh-ancestor
20226090|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20226091|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226092|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226093|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
20226094|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226095|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226096|NCT00344955|Atorvastatin|atorvastatin|mesh-list
20226097|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20474041|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474042|NCT01504347|Vaccines|vaccines|mesh-list
20474043|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
20474044|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474045|NCT01504386|Ropivacaine|ropivacaine|mesh-list
20474046|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
20474047|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
20474048|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625771|NCT02934529|Fluorouracil|fluorouracil|mesh-list
19411563|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411564|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19411565|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
19411566|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19411567|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19411568|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19411569|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
19411570|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
19411571|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411572|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19411573|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19411574|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
19411575|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19411576|NCT03538691|Analgesics|analgesics|mesh-ancestor
19411577|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
19411578|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
20226098|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20226099|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
20226100|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625772|NCT02934529|Capecitabine|capecitabine|mesh-list
20625773|NCT02934529|Irinotecan|irinotecan|mesh-list
20625774|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
19411579|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19411580|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20625775|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625776|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625777|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20625778|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20625779|NCT02934529|Growth Substances|growth substances|mesh-ancestor
20625780|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625781|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625782|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
20625783|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625784|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20625785|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20625786|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
20625787|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20625788|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20625789|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625790|NCT02934529|Antidotes|antidotes|mesh-ancestor
20625791|NCT02934529|Protective Agents|protective agents|mesh-ancestor
20625792|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
20625793|NCT02934529|Vitamins|vitamins|mesh-ancestor
20625794|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
20625795|NCT02934529|Hematinics|hematinics|mesh-ancestor
20625796|NCT02816736|Valsartan|valsartan|mesh-list
20625797|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20625798|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20625799|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20625800|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20625801|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625802|NCT02774421|Trastuzumab|trastuzumab|mesh-list
20625803|NCT02774421|Molgramostim|molgramostim|mesh-list
20625804|NCT02774421|Sargramostim|sargramostim|mesh-list
20625805|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625806|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625807|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
19411581|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411582|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
19411583|NCT03538496|Bupivacaine|bupivacaine|mesh-list
19411584|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
19411585|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
19411586|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411587|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411588|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
19411589|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411590|NCT03538483|Bupivacaine|bupivacaine|mesh-list
20625808|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625809|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20625810|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
20625811|NCT02713373|Cetuximab|cetuximab|mesh-list
20625812|NCT02713373|Antibodies|antibodies|mesh-list
20625813|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
20625814|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20625815|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
20625816|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625817|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625818|NCT02681302|Nivolumab|nivolumab|mesh-list
20625819|NCT02681302|Ipilimumab|ipilimumab|mesh-list
20625820|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474049|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474050|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
20474051|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474052|NCT01504490|Bexarotene|bexarotene|mesh-list
20474053|NCT01504490|Efatutazone|efatutazone|mesh-list
20474054|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474055|NCT01504503|Donepezil|donepezil|mesh-list
20474056|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20474057|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625821|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625822|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20625823|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411591|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
19411592|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
20625824|NCT02590094|Bevacizumab|bevacizumab|mesh-list
20474058|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625825|NCT02590094|Aflibercept|aflibercept|mesh-list
20625826|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625827|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625828|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20625829|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20625830|NCT02590094|Growth Substances|growth substances|mesh-ancestor
20474059|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474060|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474061|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474062|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
20474063|NCT01504516|Donepezil|donepezil|mesh-list
20474064|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20474065|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474066|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474067|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474068|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474069|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625831|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625832|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625833|NCT02431702|Haloperidol|haloperidol|mesh-list
20625834|NCT02431702|Olanzapine|olanzapine|mesh-list
20625835|NCT02431702|Risperidone|risperidone|mesh-list
20625836|NCT02431702|Aripiprazole|aripiprazole|mesh-list
20625837|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20625838|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20625839|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
20625840|NCT02431702|Perphenazine|perphenazine|mesh-list
20625841|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20625842|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
20625843|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625844|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625845|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625846|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20625847|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20625848|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625849|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625850|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20625851|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
20625852|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
20625853|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
20625854|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625855|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625856|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20625857|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20625858|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625859|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
20625860|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
20474070|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
20474071|NCT01504542|Vaccines|vaccines|mesh-list
20474072|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
20474073|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474074|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20474075|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
20474076|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527417|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20527418|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527419|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19411593|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411594|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411595|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
19411596|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527420|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527421|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
20625861|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20625862|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20625863|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20625864|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20625865|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20625866|NCT02136069|Infliximab|infliximab|mesh-list
20527422|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20527423|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20527424|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20527425|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20527426|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
20625867|NCT02136069|Etrolizumab|etrolizumab|mesh-list
20625868|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
20625869|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625870|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20625871|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
20625872|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625873|NCT02096874|Bevacizumab|bevacizumab|mesh-list
20625874|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625875|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625876|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20625877|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474077|NCT01504620|Insulin|insulin|mesh-list
20474078|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20474079|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474080|NCT01504646|Lyprinol|lyprinol|mesh-list
20474081|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20474082|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
20474083|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474084|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474085|NCT01504659|Ketamine|ketamine|mesh-list
20474086|NCT01504659|Analgesics|analgesics|mesh-ancestor
20474087|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
20474088|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625878|NCT02096874|Growth Substances|growth substances|mesh-ancestor
20625879|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625880|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625881|NCT02086552|Lenalidomide|lenalidomide|mesh-list
20625882|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
20474089|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474090|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20474091|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20474092|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
20474093|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
20474094|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474095|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20474096|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20625883|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625884|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20625885|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20625886|NCT02086552|Growth Substances|growth substances|mesh-ancestor
20625887|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
20625888|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625889|NCT01024608|Beclomethasone|beclomethasone|mesh-list
20625890|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625891|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
20625892|NCT01024608|Hormones|hormones|mesh-ancestor
20625893|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625894|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625895|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20625896|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
20625897|NCT00988247|Beclomethasone|beclomethasone|mesh-list
20625898|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625899|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
19850408|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850409|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
19850410|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
19850411|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
19850412|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850413|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850414|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850415|NCT00709696|Varenicline|varenicline|mesh-list
19850416|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19850417|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20226101|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20226102|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20226103|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226104|NCT00344981|Tenofovir|tenofovir|mesh-list
20226105|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
20226106|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
20226107|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226108|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20226109|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20226110|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226111|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474097|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625900|NCT00988247|Hormones|hormones|mesh-ancestor
19850418|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
19411597|NCT03538457|Acetaminophen|acetaminophen|mesh-list
19696245|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696246|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19696247|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19696248|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
19696249|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19696250|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696251|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
19696252|NCT04942340|Caffeine|caffeine|mesh-list
20625901|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625902|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625903|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20625904|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
20625905|NCT00838981|Methadone|methadone|mesh-list
20625906|NCT00838981|Modafinil|modafinil|mesh-list
20625907|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20625908|NCT00838981|Narcotics|narcotics|mesh-ancestor
20625909|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625910|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625911|NCT00838981|Analgesics|analgesics|mesh-ancestor
20625912|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
20625913|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625914|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
20625915|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
20625916|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20625917|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20625918|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20625919|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20625920|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625921|NCT00730639|Nivolumab|nivolumab|mesh-list
20625922|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20625923|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625924|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20625925|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625926|NCT00363038|Vitamins|vitamins|mesh-list
20625927|NCT00363038|Vitamin K|vitamin k|mesh-list
20625928|NCT00363038|Vitamin A|vitamin a|mesh-list
20625929|NCT00363038|Petrolatum|petrolatum|mesh-list
20625930|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
20625931|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625932|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20625933|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20625934|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625935|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
20625936|NCT00363038|Coagulants|coagulants|mesh-ancestor
20625937|NCT00363038|Emollients|emollients|mesh-ancestor
20625938|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
20474098|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474099|NCT01504724|Bevacizumab|bevacizumab|mesh-list
20474100|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474101|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474102|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20474103|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474104|NCT01504724|Growth Substances|growth substances|mesh-ancestor
20474105|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474106|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
20474107|NCT01504776|Bortezomib|bortezomib|mesh-list
20474108|NCT01504776|Panobinostat|panobinostat|mesh-list
20474109|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696253|NCT04942340|Atipamezole|atipamezole|mesh-list
20474110|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20474111|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20625939|NCT05146453|Anesthetics|anesthetics|mesh-list
20625940|NCT05146453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474112|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474113|NCT01504815|Cisplatin|cisplatin|mesh-list
20474114|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474115|NCT01504828|Ramipril|ramipril|mesh-list
20474116|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20474117|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
20226112|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20226113|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20226114|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416819|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
20226115|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
20226116|NCT00344994|Pramipexole|pramipexole|mesh-list
20226117|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
20226118|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226119|NCT00344994|Protective Agents|protective agents|mesh-ancestor
20226120|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226121|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20226122|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20226123|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
20226124|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
20226125|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226126|NCT00345059|Gemcitabine|gemcitabine|mesh-list
20226127|NCT00345059|Capecitabine|capecitabine|mesh-list
20226128|NCT00345059|Docetaxel|docetaxel|mesh-list
20226129|NCT00345059|Vinorelbine|vinorelbine|mesh-list
20226130|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20226131|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
20226132|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474118|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474119|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474120|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474121|NCT01504906|Cyclosporine|cyclosporine|mesh-list
20474122|NCT01504906|Ticagrelor|ticagrelor|mesh-list
20474123|NCT01504906|Cyclosporins|cyclosporins|mesh-list
20474124|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474125|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474126|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20474127|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
20474128|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474129|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
20474130|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474131|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
20474132|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20474133|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20474134|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20474135|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20474136|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20474137|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20474138|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
20474139|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474150|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
20474151|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474152|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20474153|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474154|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474155|NCT01505049|Vaccines|vaccines|mesh-list
20474156|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
20474157|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474158|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
20474159|NCT01505088|Dexamethasone|dexamethasone|mesh-list
20474160|NCT01505088|Prednisolone|prednisolone|mesh-list
20474161|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20474162|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
19411598|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19411599|NCT03538457|Analgesics|analgesics|mesh-ancestor
19411600|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
19411601|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411602|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411603|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
19411604|NCT03538327|Silybin|silybin|mesh-list
19411605|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19411606|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411607|NCT03538327|Protective Agents|protective agents|mesh-ancestor
19411608|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226133|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226134|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
20226135|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226136|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226137|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226138|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
20474163|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20474164|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
20474165|NCT01505088|Citric Acid|citric acid|mesh-list
20474166|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
20474167|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20474168|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20474169|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20474170|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
20474171|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20474172|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20474173|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
20474174|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
20474175|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474176|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416820|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
20226139|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226140|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
20226141|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
20226142|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
20226143|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20226144|NCT00345098|Amibegron|amibegron|mesh-list
20226145|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20226146|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20474177|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474178|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
20474179|NCT01505088|Hormones|hormones|mesh-ancestor
20474180|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474181|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20474182|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474183|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
20474184|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20474185|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
20474186|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
20474187|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474188|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20474189|NCT01505088|Protective Agents|protective agents|mesh-ancestor
20474190|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20474191|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474192|NCT01505127|Amoxicillin|amoxicillin|mesh-list
20474193|NCT01505127|Clarithromycin|clarithromycin|mesh-list
20474194|NCT01505127|Lansoprazole|lansoprazole|mesh-list
20474195|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
20474196|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20474197|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474198|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20474199|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474200|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474201|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20474202|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20474203|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20474204|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474205|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20474206|NCT01505218|Propofol|propofol|mesh-list
20474207|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20474208|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474209|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474210|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20474211|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
19411609|NCT03538171|Exemestane|exemestane|mesh-list
20474212|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
20474213|NCT01505231|Vasopressins|vasopressins|mesh-list
20474214|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
20474215|NCT01505231|Norepinephrine|norepinephrine|mesh-list
20474216|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20474217|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20474218|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
20474219|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474220|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474221|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474222|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
20474223|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
20474224|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625941|NCT05146453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625942|NCT05146271|Anesthetics|anesthetics|mesh-list
20625943|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625944|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625945|NCT05146245|Risperidone|risperidone|mesh-list
20625946|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20625947|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
20625948|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474225|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20474226|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
20474227|NCT01505231|Coagulants|coagulants|mesh-ancestor
20474228|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20625949|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625950|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625951|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20625952|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20625953|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625954|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20625955|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20625956|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
20625957|NCT05146089|Bosentan|bosentan|mesh-list
20625958|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20625959|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20625960|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625961|NCT05145660|Cisplatin|cisplatin|mesh-list
20625962|NCT05145660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20625963|NCT05145634|Anticoagulants|anticoagulants|mesh-list
20625964|NCT05145543|Dexamethasone|dexamethasone|mesh-list
20625965|NCT05145543|Fentanyl|fentanyl|mesh-list
20625966|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
20625967|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20625968|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
20625969|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
20625970|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20625971|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625972|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20625973|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
20625974|NCT05145543|Hormones|hormones|mesh-ancestor
20625975|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20625976|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20625977|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696254|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19696255|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696256|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696257|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20625978|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20625979|NCT05145543|Narcotics|narcotics|mesh-ancestor
20625980|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20625981|NCT05145543|Analgesics|analgesics|mesh-ancestor
20625982|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
19411610|NCT03538171|Entinostat|entinostat|mesh-list
20625983|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20625984|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20625985|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
19411611|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411612|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19411613|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19411614|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696258|NCT04942340|Analgesics|analgesics|mesh-ancestor
19696259|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
20474229|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
20625986|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
19411615|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625987|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
20625988|NCT05145270|Sulforaphane|sulforaphane|mesh-list
20625989|NCT05145270|Dexetimide|dexetimide|mesh-list
20625990|NCT05145270|Citalopram|citalopram|mesh-list
20625991|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20625992|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20625993|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20625994|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20625995|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20625996|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
20625997|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20625998|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20625999|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
20626000|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20626001|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20626002|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20626003|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
20626004|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
20626005|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626006|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20626007|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20474230|NCT01505283|Lidocaine|lidocaine|mesh-list
20474231|NCT01505283|Sufentanil|sufentanil|mesh-list
20474232|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
20474233|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
19411616|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19411617|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
19411618|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411619|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411620|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19411621|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
19411622|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
19411623|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
19411624|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19411625|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19411626|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411627|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411628|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411629|NCT03537950|Cannabidiol|cannabidiol|mesh-list
19411630|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
19411631|NCT03537924|Acetazolamide|acetazolamide|mesh-list
19411632|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
19411633|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19411634|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411635|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474234|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474235|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626008|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
20626009|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20626010|NCT05145270|Protective Agents|protective agents|mesh-ancestor
20626011|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626012|NCT05131386|Trabectedin|trabectedin|mesh-list
20626013|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20626014|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
20626015|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474236|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
20474237|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474238|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20474239|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20474240|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20474241|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20474242|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474243|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20474244|NCT01505283|Narcotics|narcotics|mesh-ancestor
20474245|NCT01505283|Analgesics|analgesics|mesh-ancestor
20474246|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20474247|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20474248|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
20474249|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20474250|NCT01505413|Gemcitabine|gemcitabine|mesh-list
20474251|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
20626016|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626017|NCT05100134|Ceritinib|ceritinib|mesh-list
19411636|NCT03537924|Diuretics|diuretics|mesh-ancestor
20474252|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19411637|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
19411638|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411639|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19411640|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
19411641|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19411642|NCT03537807|Riluzole|riluzole|mesh-list
19411643|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
19411644|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19411645|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19411646|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626018|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626019|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20626020|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626021|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626022|NCT05079620|Amoxicillin|amoxicillin|mesh-list
20626023|NCT05079620|Vancomycin|vancomycin|mesh-list
20626024|NCT05079620|Levofloxacin|levofloxacin|mesh-list
20626025|NCT05079620|Ofloxacin|ofloxacin|mesh-list
20626026|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
20626027|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20626028|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
20626029|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
20626030|NCT05079620|Cefepime|cefepime|mesh-list
20626031|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20626032|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626033|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20626034|NCT05079620|Renal Agents|renal agents|mesh-ancestor
20626035|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20626036|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20626037|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626038|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411647|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411648|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411649|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19411650|NCT03537807|Protective Agents|protective agents|mesh-ancestor
20626039|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626040|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20626041|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20626042|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20626043|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
20626044|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
20626045|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
20626046|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20626047|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20626048|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411651|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
19411652|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
19411653|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19411654|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
20474253|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20474254|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
20474255|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474256|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474257|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
20474258|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474259|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474260|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20474261|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
20474262|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474263|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20626049|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626050|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626051|NCT05019430|Cocaine|cocaine|mesh-list
20626052|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
20474264|NCT01505426|Metformin|metformin|mesh-list
20474265|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
20474266|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20474267|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474268|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20474269|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474270|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
20474271|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20626053|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626054|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
19416821|NCT02295865|Toreforant|toreforant|mesh-list
20626055|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626056|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626057|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
20626058|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626059|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20626060|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20474272|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20474273|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474274|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626061|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20626062|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20626063|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626064|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
20626065|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626066|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20626067|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20626068|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
20626069|NCT04987294|Rasburicase|rasburicase|mesh-list
20626070|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
20474275|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474276|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474277|NCT01505439|Urological Agents|urological agents|mesh-ancestor
20474278|NCT01505504|Mirtazapine|mirtazapine|mesh-list
20474279|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
20474280|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20474281|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20474282|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
20474283|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
20474284|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474285|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474286|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474287|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20474288|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20626071|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20626072|NCT04956302|Dexamethasone|dexamethasone|mesh-list
20626073|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
20626074|NCT04956302|Bortezomib|bortezomib|mesh-list
20626075|NCT04956302|Daratumumab|daratumumab|mesh-list
20626076|NCT04956302|Panobinostat|panobinostat|mesh-list
20626077|NCT04956302|Ichthammol|ichthammol|mesh-list
20626078|NCT04956302|BB 1101|bb 1101|mesh-list
20626079|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20626080|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626081|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
20626082|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
20626083|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626084|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626085|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474289|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474290|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20474291|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20474292|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20474293|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
20474294|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20626086|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
20626087|NCT04956302|Hormones|hormones|mesh-ancestor
20626088|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626089|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626090|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626091|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
20626092|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626093|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626094|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
20626095|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20626096|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
20626097|NCT04907032|Mirabegron|mirabegron|mesh-list
20626098|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20626099|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20474295|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20474296|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
20474297|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20626100|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20626101|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
20626102|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626103|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626104|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850419|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850420|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850421|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850422|NCT00709722|Gusperimus|gusperimus|mesh-list
19850423|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19850424|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850425|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850426|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474298|NCT01505777|Mosapride|mosapride|mesh-list
20474299|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474300|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20474301|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
20474302|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474303|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474304|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474305|NCT01505790|Clopidogrel|clopidogrel|mesh-list
20474306|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20474307|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20474308|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20474309|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20474310|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20474311|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
20474312|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474313|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850427|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850428|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
19850429|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19850430|NCT00709722|Protective Agents|protective agents|mesh-ancestor
19850431|NCT00709735|Propranolol|propranolol|mesh-list
19850432|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19850433|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19850434|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
19850435|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850436|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850437|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626105|NCT04907032|Urological Agents|urological agents|mesh-ancestor
20626106|NCT04834362|Insulin|insulin|mesh-list
20626107|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20626108|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
20626109|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
20626110|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626111|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474314|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474315|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20474316|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
20474317|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474318|NCT01505894|BI 409306|bi 409306|mesh-list
20474319|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19411655|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411656|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411657|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19850438|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19850439|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19850440|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
19850441|NCT00709761|Paclitaxel|paclitaxel|mesh-list
19850442|NCT00709761|Lapatinib|lapatinib|mesh-list
19850443|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19850444|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226147|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226148|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226149|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226150|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226151|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20226152|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226153|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226154|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20226155|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226156|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474320|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626112|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20474321|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626113|NCT04826354|Ezetimibe|ezetimibe|mesh-list
20626114|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20626115|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20626116|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
20626117|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626118|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20626119|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20626120|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626121|NCT04802356|Dexamethasone|dexamethasone|mesh-list
20626122|NCT04802356|Lenalidomide|lenalidomide|mesh-list
20626123|NCT04802356|Bortezomib|bortezomib|mesh-list
20626124|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626125|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
20626126|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
20626127|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626128|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626129|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626130|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
20626131|NCT04802356|Hormones|hormones|mesh-ancestor
20626132|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626133|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626134|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626135|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
20626136|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20626137|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19411658|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19411659|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19411660|NCT03537612|Clonidine|clonidine|mesh-list
19411661|NCT03537612|Morphine|morphine|mesh-list
19411662|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19411663|NCT03537612|Narcotics|narcotics|mesh-ancestor
19411664|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411665|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411666|NCT03537612|Analgesics|analgesics|mesh-ancestor
19411667|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
19696260|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626138|NCT04802356|Growth Substances|growth substances|mesh-ancestor
20626139|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
19411668|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226157|NCT00345163|Bevacizumab|bevacizumab|mesh-list
20474322|NCT01505920|Lidocaine|lidocaine|mesh-list
20474323|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
20474324|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
20474325|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474326|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474327|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
20474328|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474329|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20474330|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20474331|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20474332|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20474333|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474334|NCT01505946|Thrombin|thrombin|mesh-list
20474335|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
20474336|NCT01505946|Coagulants|coagulants|mesh-ancestor
20474337|NCT01505998|Amlodipine|amlodipine|mesh-list
20474338|NCT01505998|Benazepril|benazepril|mesh-list
20474339|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474340|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20474341|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20474342|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474343|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20474344|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474345|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
20474346|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20474347|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
20626140|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20626141|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20226158|NCT00345163|Irinotecan|irinotecan|mesh-list
20226159|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226160|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226161|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226162|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20226163|NCT00345163|Growth Substances|growth substances|mesh-ancestor
20626142|NCT04777006|Amitriptyline|amitriptyline|mesh-list
20626143|NCT04777006|Fluoxetine|fluoxetine|mesh-list
20626144|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
20626145|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20626146|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20626147|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20626148|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626149|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626150|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
20626151|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626152|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20626153|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20626154|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20626155|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20626156|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474348|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474349|NCT01506011|Amlodipine|amlodipine|mesh-list
20474350|NCT01506011|Benazepril|benazepril|mesh-list
20474351|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474352|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20474353|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20474354|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474355|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20474356|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626157|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20626158|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20626159|NCT04777006|Analgesics|analgesics|mesh-ancestor
20626160|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
20626161|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626162|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20626163|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
20626164|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
20626165|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20626166|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626167|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
20626168|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474357|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
20474358|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20474359|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
20474360|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411669|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19411670|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
20474361|NCT01506024|Tacrine|tacrine|mesh-list
20474362|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20626169|NCT04708613|Corticosterone|corticosterone|mesh-list
20626170|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626171|NCT04681482|Apixaban|apixaban|mesh-list
20626172|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20626173|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
20626174|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20626175|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
20626176|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626177|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626178|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
20626179|NCT04635943|Ivermectin|ivermectin|mesh-list
20626180|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20626181|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626182|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
20626183|NCT04629729|Fludarabine|fludarabine|mesh-list
20626184|NCT04629729|Interleukin-2|interleukin-2|mesh-list
20626185|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626186|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
20626187|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626188|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20626189|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20626190|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
20626191|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626192|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626193|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20626194|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20626195|NCT04629729|Analgesics|analgesics|mesh-ancestor
20626196|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
20626197|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696261|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19696262|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19696263|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19696264|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
19696265|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696266|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696267|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19696268|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19696269|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696270|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19696271|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19850445|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
19850446|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
20626198|NCT04512534|Antibodies|antibodies|mesh-list
20626199|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20626200|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
20626201|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626202|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626203|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626204|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
20626205|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626206|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626207|NCT04425447|Anesthetics|anesthetics|mesh-list
20474363|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474364|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474365|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474366|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474367|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850447|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
19850448|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850449|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850450|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850451|NCT00709826|Gemcitabine|gemcitabine|mesh-list
19850452|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19850453|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19850454|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
19850455|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474368|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20474369|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
20474370|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474371|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
20474372|NCT01506037|Desloratadine|desloratadine|mesh-list
20626208|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626209|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411671|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
19850456|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850457|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
19850458|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474373|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20474374|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474375|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474376|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474377|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474378|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20474379|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20474380|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
20626210|NCT04355728|Heparin|heparin|mesh-list
20626211|NCT04355728|Calcium heparin|calcium heparin|mesh-list
20626212|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
20226164|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626213|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20626214|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20626215|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626216|NCT04328714|Interferons|interferons|mesh-list
20626217|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
20626218|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626219|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
20626220|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626221|NCT04303780|Docetaxel|docetaxel|mesh-list
19696272|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
19696273|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19696274|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19696275|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19696276|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
19696277|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19696278|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19696279|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696280|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
19850459|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226165|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
20226166|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20226167|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20226168|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226169|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226170|NCT00345202|Atorvastatin|atorvastatin|mesh-list
20226171|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20226172|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20226173|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
20226174|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226175|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20226176|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20226177|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226178|NCT00345306|Progesterone|progesterone|mesh-list
20226179|NCT00345306|Progestins|progestins|mesh-ancestor
20226180|NCT00345306|Hormones|hormones|mesh-ancestor
20226181|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20226182|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226183|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20226184|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
20226185|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226186|NCT00345501|Iloprost|iloprost|mesh-list
20226187|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20226188|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
20226189|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
20226190|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
20226191|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20226192|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20226193|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226194|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20226195|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226196|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20226197|NCT00345657|Niacin|niacin|mesh-list
20226198|NCT00345657|Lovastatin|lovastatin|mesh-list
20226199|NCT00345657|L 647318|l 647318|mesh-list
20226200|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
20226201|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20474381|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
20474382|NCT01506050|Desloratadine|desloratadine|mesh-list
20626222|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626223|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
20626224|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
20626225|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20626226|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626227|NCT04227288|Betamethasone|betamethasone|mesh-list
20626228|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
20626229|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20626230|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
20626231|NCT04227288|Calcipotriene|calcipotriene|mesh-list
20626232|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20626233|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626234|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
20626235|NCT04227288|Hormones|hormones|mesh-ancestor
20626236|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626237|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626238|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20474383|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20474384|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474385|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474386|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474387|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474388|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20474389|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20474390|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
20626239|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
20626240|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
20626241|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
20626242|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626243|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626244|NCT04194554|Leuprolide|leuprolide|mesh-list
20626245|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
20626246|NCT04194554|Niraparib|niraparib|mesh-list
20626247|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20626248|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
20226202|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
20226203|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226204|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20226205|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
20474391|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
20474392|NCT01506063|Levocetirizine|levocetirizine|mesh-list
20474393|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20474394|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20474395|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
20474396|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
20474397|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474398|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474399|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474400|NCT01506076|Levocetirizine|levocetirizine|mesh-list
20474401|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20474402|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20474403|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
20474404|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
20474405|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474406|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474407|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474408|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20474409|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
20474410|NCT01506115|Trioxsalen|trioxsalen|mesh-list
20474411|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474412|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
20474413|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20474414|NCT01506167|Leucovorin|leucovorin|mesh-list
20474415|NCT01506167|Folic Acid|folic acid|mesh-list
20474416|NCT01506167|Bevacizumab|bevacizumab|mesh-list
20474417|NCT01506167|Fluorouracil|fluorouracil|mesh-list
20474418|NCT01506167|Capecitabine|capecitabine|mesh-list
20226206|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
20226207|NCT00345657|Vitamins|vitamins|mesh-ancestor
20226208|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
20226209|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226210|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20226211|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20626249|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20626250|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626251|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626252|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626253|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20626254|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626255|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626256|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
20626257|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626258|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20626259|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20626260|NCT04182997|Dexamethasone|dexamethasone|mesh-list
20626261|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626262|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
20626263|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
20626264|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626265|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626266|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626267|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
20626268|NCT04182997|Hormones|hormones|mesh-ancestor
20626269|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474419|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
20474420|NCT01506167|Irinotecan|irinotecan|mesh-list
20474421|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
20474422|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474423|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474424|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20474425|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474426|NCT01506167|Growth Substances|growth substances|mesh-ancestor
20474427|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474428|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
20626270|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626271|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626272|NCT04137354|Vitamins|vitamins|mesh-list
20626273|NCT04137354|Vitamin A|vitamin a|mesh-list
20626274|NCT04137354|Iron|iron|mesh-list
20626275|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
20626276|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
20626277|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626278|NCT04137354|Trace Elements|trace elements|mesh-ancestor
20626279|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
20626280|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626281|NCT04137354|Protective Agents|protective agents|mesh-ancestor
20626282|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20626283|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626284|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
20626285|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20626286|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626287|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626288|NCT04033068|Vaccines|vaccines|mesh-list
20626289|NCT04033068|Immunologic Factors|immunologic factors|mesh-ancestor
20626290|NCT04033068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626291|NCT04023227|Valsartan|valsartan|mesh-list
20626292|NCT04023227|Enalapril|enalapril|mesh-list
20626293|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20626294|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20226212|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226213|NCT00345696|Bevacizumab|bevacizumab|mesh-list
20226214|NCT00345696|Capecitabine|capecitabine|mesh-list
20226215|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
20226216|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226217|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226218|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226219|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20226220|NCT00345696|Growth Substances|growth substances|mesh-ancestor
20474429|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
20474430|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474431|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20474432|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20474433|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
20474434|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20474435|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20474436|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626295|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20626296|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696281|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
20474437|NCT01506167|Antidotes|antidotes|mesh-ancestor
20474438|NCT01506167|Protective Agents|protective agents|mesh-ancestor
20474439|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
20474440|NCT01506167|Vitamins|vitamins|mesh-ancestor
20474441|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
20474442|NCT01506167|Hematinics|hematinics|mesh-ancestor
20527427|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20527428|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20527429|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
20527430|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527431|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
20527432|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20626297|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20626298|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
20626299|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226221|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226222|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
20626300|NCT04002037|Dexamethasone|dexamethasone|mesh-list
20626301|NCT04002037|Triamcinolone|triamcinolone|mesh-list
20626302|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20626303|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20626304|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20626305|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626306|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
20626307|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
20626308|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626309|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626310|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626311|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
20626312|NCT04002037|Hormones|hormones|mesh-ancestor
20626313|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626314|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626315|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626316|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626317|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
20626318|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626319|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626320|NCT03954938|Cocaine|cocaine|mesh-list
20626321|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626322|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
20626323|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626324|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626325|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
19411672|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20226223|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20226224|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
20226225|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226226|NCT00345735|Fentanyl|fentanyl|mesh-list
20226227|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226228|NCT00345735|Narcotics|narcotics|mesh-ancestor
20226229|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226230|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226231|NCT00345735|Analgesics|analgesics|mesh-ancestor
20226232|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
20226233|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226234|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20226235|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20226236|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
20226237|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
20226238|NCT00345761|Bevacizumab|bevacizumab|mesh-list
20226239|NCT00345761|Capecitabine|capecitabine|mesh-list
20226240|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
20226241|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226242|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226243|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226244|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20226245|NCT00345761|Growth Substances|growth substances|mesh-ancestor
20226246|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226247|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
20226248|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20226249|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
20226250|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226251|NCT00345787|Buprenorphine|buprenorphine|mesh-list
20226252|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226253|NCT00345787|Narcotics|narcotics|mesh-ancestor
20626326|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626327|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20626328|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20626329|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20626330|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20626331|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626332|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
20626333|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626334|NCT03822897|Cisplatin|cisplatin|mesh-list
20626335|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626336|NCT03749616|Acetaminophen|acetaminophen|mesh-list
20626337|NCT03749616|Ibuprofen|ibuprofen|mesh-list
20626338|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20626339|NCT03749616|Analgesics|analgesics|mesh-ancestor
20626340|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
20626341|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626342|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626343|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
20626344|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20626345|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626346|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20626347|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20626348|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626349|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626350|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
20626351|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626352|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20626353|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626354|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626355|NCT03612466|Plerixafor|plerixafor|mesh-list
20626356|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
20626357|NCT03612466|Calcium|calcium|mesh-list
20626358|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20626359|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626360|NCT03612466|Antacids|antacids|mesh-ancestor
20626361|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626362|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626363|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20626364|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20626365|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
20626366|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626367|NCT03599635|Bupivacaine|bupivacaine|mesh-list
20626368|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626369|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
20626370|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626371|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626372|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
20626373|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626374|NCT03570632|Metformin|metformin|mesh-list
19411673|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19411674|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19411675|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226254|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226255|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226256|NCT00345787|Analgesics|analgesics|mesh-ancestor
20226257|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
20226258|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226259|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20226260|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
20226261|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20474443|NCT01506336|Sunitinib|sunitinib|mesh-list
20474444|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474445|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20474446|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474447|NCT01506336|Growth Substances|growth substances|mesh-ancestor
20474448|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474449|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
20474450|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20474451|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474452|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626375|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626376|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411676|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226262|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20474453|NCT01506388|Misoprostol|misoprostol|mesh-list
20626377|NCT03565835|Prednisone|prednisone|mesh-list
20626378|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
20626379|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626380|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
20626381|NCT03565835|Hormones|hormones|mesh-ancestor
20626382|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626383|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626384|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626385|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626386|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20626387|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626388|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474454|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20474455|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
20474456|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20474457|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474458|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20474459|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474460|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
20626389|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
20626390|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20474461|NCT01506414|Rituximab|rituximab|mesh-list
20474462|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474463|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474464|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
20474465|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474466|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20474467|NCT01506505|Aspirin|aspirin|mesh-list
20474468|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20474469|NCT01506505|Lisinopril|lisinopril|mesh-list
20474470|NCT01506505|Simvastatin|simvastatin|mesh-list
20474471|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20474472|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20474473|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
20474474|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626391|NCT03546829|Vancomycin|vancomycin|mesh-list
20626392|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20626393|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626394|NCT03543839|Belimumab|belimumab|mesh-list
20626395|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626396|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
20626397|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626398|NCT03499119|Erenumab|erenumab|mesh-list
20626399|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20626400|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626401|NCT03499119|Analgesics|analgesics|mesh-ancestor
20626402|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
20226263|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
20226264|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
20226265|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226266|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226267|NCT00345826|Dasatinib|dasatinib|mesh-list
19411677|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411678|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
19411679|NCT03537573|Narcotics|narcotics|mesh-ancestor
20474475|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20474476|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20474477|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474478|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474479|NCT01506505|Diuretics|diuretics|mesh-ancestor
20474480|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
20474481|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474482|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20474483|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20474484|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20474485|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20474486|NCT01506505|Analgesics|analgesics|mesh-ancestor
20474487|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
20474488|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474489|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20474490|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20474491|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20474492|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20474493|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20474494|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20474495|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
20626403|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626404|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626405|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20626406|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19411680|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411681|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411682|NCT03537573|Analgesics|analgesics|mesh-ancestor
19411683|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
19411684|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226268|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226269|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20226270|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226271|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226272|NCT00345982|Sertindole|sertindole|mesh-list
20226273|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20226274|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20226275|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226276|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226277|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20226278|NCT00346047|Buprenorphine|buprenorphine|mesh-list
20226279|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226280|NCT00346047|Narcotics|narcotics|mesh-ancestor
20226281|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226282|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226283|NCT00346047|Analgesics|analgesics|mesh-ancestor
20226284|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
20226285|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226286|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20226287|NCT00346099|Capecitabine|capecitabine|mesh-list
20226288|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
20474496|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20226289|NCT00346099|Panitumumab|panitumumab|mesh-list
20474497|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
20474498|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20474499|NCT01506505|Protective Agents|protective agents|mesh-ancestor
20474500|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
20474501|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474502|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
20474503|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474504|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474505|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20474506|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
20474507|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20474508|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474509|NCT01506557|Vitamins|vitamins|mesh-ancestor
20474510|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
20474511|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20474512|NCT01506570|Vaccines|vaccines|mesh-list
20626407|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20626408|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626409|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626410|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
20626411|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626412|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20626413|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20626414|NCT03451825|Avelumab|avelumab|mesh-list
20626415|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20626416|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626417|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626418|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
20626419|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626420|NCT03439046|Letrozole|letrozole|mesh-list
20626421|NCT03439046|Fulvestrant|fulvestrant|mesh-list
20626422|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626423|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20626424|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20626425|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626426|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626427|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20626428|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
20626429|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626430|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626431|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626432|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20626433|NCT03350984|Insulin|insulin|mesh-list
20626434|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20474513|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
20474514|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474515|NCT01506622|Fentanyl|fentanyl|mesh-list
20474516|NCT01506622|Propofol|propofol|mesh-list
20474517|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20474518|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474519|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474520|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20474521|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
20474522|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
20474523|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20474524|NCT01506622|Narcotics|narcotics|mesh-ancestor
20626435|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
20626436|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
20626437|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
20626438|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
20626439|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
20626440|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626441|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474525|NCT01506622|Analgesics|analgesics|mesh-ancestor
20474526|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
20474527|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474528|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20474529|NCT01506635|Timolol|timolol|mesh-list
20474530|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20474531|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20474532|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
20474533|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626442|NCT03328845|Insulin|insulin|mesh-list
20474534|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626443|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20474535|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411685|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
19411686|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
19411687|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
19411688|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19411689|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411690|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411691|NCT03537534|Lidocaine|lidocaine|mesh-list
19411692|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
19411693|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
19411694|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411695|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411696|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
19411697|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411698|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19411699|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19411700|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20474536|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20474537|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474538|NCT01506713|Clopidogrel|clopidogrel|mesh-list
20474539|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20474540|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20474541|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20474542|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20474543|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
20474544|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474545|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474546|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474547|NCT01506739|Donepezil|donepezil|mesh-list
20474548|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20474549|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474550|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474551|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474552|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474553|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474554|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
20474555|NCT01506752|Donepezil|donepezil|mesh-list
20474556|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20474557|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474558|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474559|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474560|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474561|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474562|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
20474563|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
20474564|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20474565|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
20474566|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474567|NCT01506765|Expectorants|expectorants|mesh-ancestor
20474568|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
20474569|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19411701|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19411702|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411703|NCT03537495|Linezolid|linezolid|mesh-list
19411704|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19411705|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411706|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19411707|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411708|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474570|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
20474571|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474572|NCT01506765|Protective Agents|protective agents|mesh-ancestor
20474573|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474574|NCT01506765|Antidotes|antidotes|mesh-ancestor
20474575|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
20474576|NCT01506791|Ephedrine|ephedrine|mesh-list
20474577|NCT01506791|Desloratadine|desloratadine|mesh-list
20474578|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20474579|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474580|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474581|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474582|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474583|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20474584|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20626444|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
20626445|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
20626446|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626447|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474585|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
20474586|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
20626448|NCT03305341|Molgramostim|molgramostim|mesh-list
20474587|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20474588|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
20474589|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474590|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20474591|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
20474592|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
20626449|NCT03305341|Sargramostim|sargramostim|mesh-list
20626450|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
20626451|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626452|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626453|NCT03300427|Valsartan|valsartan|mesh-list
20626454|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20626455|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474593|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20474594|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20474595|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
20474596|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
20474597|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
20474598|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20474599|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20474600|NCT01506804|Prednisolone|prednisolone|mesh-list
20474601|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
20474602|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20474603|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
20626456|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20626457|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20626458|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626459|NCT03288324|Tofacitinib|tofacitinib|mesh-list
20626460|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20626461|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626462|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626463|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
20626464|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20626465|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20626466|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20626467|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20626468|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626469|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
20626470|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626471|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626472|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20626473|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626474|NCT03277261|Teriflunomide|teriflunomide|mesh-list
20626475|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20626476|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20626477|NCT03277261|Analgesics|analgesics|mesh-ancestor
20626478|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
20626479|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626480|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626481|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626482|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20626483|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626484|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
20626485|NCT03277248|Teriflunomide|teriflunomide|mesh-list
20626486|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20626487|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20626488|NCT03277248|Analgesics|analgesics|mesh-ancestor
20626489|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
20626490|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626491|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626492|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626493|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20626494|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626495|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
20626496|NCT03229499|Anastrozole|anastrozole|mesh-list
20474604|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20474605|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
20474606|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
20626497|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20626498|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626499|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20626500|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19411709|NCT03537443|Vitamin D|vitamin d|mesh-list
19411710|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
19411711|NCT03537443|Vitamins|vitamins|mesh-ancestor
19411712|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
19411713|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626501|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626502|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626503|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20626504|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
20626505|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626506|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626507|NCT03203850|Deferasirox|deferasirox|mesh-list
20626508|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20626509|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
20626510|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
20626511|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626512|NCT03190174|Sirolimus|sirolimus|mesh-list
20626513|NCT03190174|Nivolumab|nivolumab|mesh-list
20626514|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626515|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626516|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20626517|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626518|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20626519|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626520|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20626521|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
20626522|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626523|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
20626524|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626525|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20626526|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20626527|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626528|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20626529|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20626530|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20626531|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626532|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
20626533|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626534|NCT03148899|Oxytocin|oxytocin|mesh-list
20626535|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
20626536|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20626537|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626538|NCT03136627|Nivolumab|nivolumab|mesh-list
19411714|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20474607|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474608|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474609|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474610|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
20474611|NCT01506804|Hormones|hormones|mesh-ancestor
20474612|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474613|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20474614|NCT01506804|Protective Agents|protective agents|mesh-ancestor
20474615|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20474616|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474617|NCT01506856|Paclitaxel|paclitaxel|mesh-list
20474618|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20474619|NCT01506856|Carboplatin|carboplatin|mesh-list
20474620|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20626539|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626540|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474621|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474622|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
20474623|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
20474624|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
20474625|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474626|NCT01506895|Darapladib|darapladib|mesh-list
20474627|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20474628|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411715|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19850460|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850461|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
20474629|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474630|NCT01506921|Ketamine|ketamine|mesh-list
20474631|NCT01506921|Esketamine|esketamine|mesh-list
20474632|NCT01506921|Analgesics|analgesics|mesh-ancestor
20474633|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
20474634|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474635|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474636|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20474637|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20474638|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
20474639|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
20626541|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20626542|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626543|NCT03084549|Ropivacaine|ropivacaine|mesh-list
20626544|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626545|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
20626546|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626547|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626548|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
20626549|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626550|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20626551|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626552|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626553|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
20626554|NCT03026348|Vaccines|vaccines|mesh-list
20626555|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
20626556|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626557|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20626558|NCT03026348|Antacids|antacids|mesh-ancestor
20626559|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626560|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626561|NCT02966548|Nivolumab|nivolumab|mesh-list
20626562|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626563|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626564|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20626565|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626566|NCT02959164|Gemcitabine|gemcitabine|mesh-list
20626567|NCT02959164|Decitabine|decitabine|mesh-list
20626568|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626569|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
20626570|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626571|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626572|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
20626573|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626574|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626575|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626576|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
20626577|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626578|NCT02922985|Acetaminophen|acetaminophen|mesh-list
20626579|NCT02922985|Ketorolac|ketorolac|mesh-list
20626580|NCT02922985|Bupivacaine|bupivacaine|mesh-list
20626581|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626582|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
20626583|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626584|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626585|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
20626586|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626587|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20626588|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20626589|NCT02922985|Analgesics|analgesics|mesh-ancestor
20626590|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626591|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20626592|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20626593|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626594|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626595|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
20626596|NCT02837783|Linaclotide|linaclotide|mesh-list
19850462|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850463|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20626597|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20626598|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
20626599|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626600|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626601|NCT02827201|Gemcitabine|gemcitabine|mesh-list
20626602|NCT02827201|Paclitaxel|paclitaxel|mesh-list
20626603|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20626604|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626605|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
20626606|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
19850464|NCT00709956|Iloprost|iloprost|mesh-list
19850465|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19850466|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
19850467|NCT00709995|Sunitinib|sunitinib|mesh-list
20626607|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
20626608|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626609|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626610|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
20626611|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
20626612|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626613|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626614|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626615|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
20626616|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626617|NCT02786537|Ritonavir|ritonavir|mesh-list
20626618|NCT02786537|Ribavirin|ribavirin|mesh-list
20226290|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20226291|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
20226292|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226293|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226294|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226295|NCT00346190|Alendronate|alendronate|mesh-list
20226296|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20226297|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226298|NCT00346229|Doxorubicin|doxorubicin|mesh-list
20226299|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20226300|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20226301|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226302|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20226303|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20226304|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626619|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
20626620|NCT02786537|Grazoprevir|grazoprevir|mesh-list
20626621|NCT02786537|Ledipasvir|ledipasvir|mesh-list
20626622|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20626623|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20626624|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
20626625|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626626|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626627|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20626628|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19850468|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474640|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474641|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20474642|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20474643|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474644|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474645|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
20474646|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20474647|NCT01507064|Sorafenib|sorafenib|mesh-list
20474648|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626629|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
20626630|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626631|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20626632|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20626633|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
20626634|NCT02710084|Oxytocin|oxytocin|mesh-list
20626635|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
20226305|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226306|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
20226307|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20226308|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226309|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
20474649|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20626636|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19850469|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19850470|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474650|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474651|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474652|NCT01507077|CKD732|ckd732|mesh-list
20474653|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20474654|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474655|NCT01507077|Growth Substances|growth substances|mesh-ancestor
20474656|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474657|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
20474658|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474659|NCT01507194|Ondansetron|ondansetron|mesh-list
20474660|NCT01507194|Vestipitant|vestipitant|mesh-list
20474661|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
20474662|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
20474663|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474664|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474665|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474666|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
20474667|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
20474668|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20226310|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226311|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226312|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20626637|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626638|NCT02645474|Ropivacaine|ropivacaine|mesh-list
20626639|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626640|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
20626641|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20474669|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
20474670|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626642|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626643|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
20626644|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626645|NCT02494258|Azacitidine|azacitidine|mesh-list
20626646|NCT02494258|Cc-486|cc-486|mesh-list
20626647|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626648|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
20626649|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626650|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626651|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626652|NCT02352337|Gemcitabine|gemcitabine|mesh-list
20626653|NCT02352337|Folfirinox|folfirinox|mesh-list
20626654|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626655|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
20626656|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626657|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626658|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
20626659|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626660|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626661|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626662|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
20626663|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626664|NCT02338609|Everolimus|everolimus|mesh-list
20626665|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626666|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626667|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
20226313|NCT00346294|Etanercept|etanercept|mesh-list
20226314|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20226315|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20226316|NCT00346294|Analgesics|analgesics|mesh-ancestor
20226317|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
20226318|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226319|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226320|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226321|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226322|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20226323|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226324|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
20226325|NCT00346359|Methotrexate|methotrexate|mesh-list
20226326|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
20226327|NCT00346359|Fludarabine|fludarabine|mesh-list
20226328|NCT00346359|Busulfan|busulfan|mesh-list
20226329|NCT00346359|Tacrolimus|tacrolimus|mesh-list
20226330|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20226331|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20226332|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
20226333|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20474671|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474672|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20474673|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20474674|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626668|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626669|NCT02229149|Paclitaxel|paclitaxel|mesh-list
20626670|NCT02229149|Vinorelbine|vinorelbine|mesh-list
20626671|NCT02229149|Docetaxel|docetaxel|mesh-list
20626672|NCT02229149|Capecitabine|capecitabine|mesh-list
20626673|NCT02229149|Trastuzumab|trastuzumab|mesh-list
20626674|NCT02229149|Pertuzumab|pertuzumab|mesh-list
20626675|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20626676|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626677|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
20626678|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
20626679|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
20626680|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626681|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626682|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
20626683|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626684|NCT02182687|Doxorubicin|doxorubicin|mesh-list
20626685|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20626686|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20626687|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626688|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20626689|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20626690|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626691|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474675|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20474676|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20474677|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20474678|NCT01507272|Liraglutide|liraglutide|mesh-list
20474679|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20474680|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474681|NCT01507272|Incretins|incretins|mesh-ancestor
20474682|NCT01507272|Hormones|hormones|mesh-ancestor
20474683|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474684|NCT01507285|Liraglutide|liraglutide|mesh-list
20474685|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626692|NCT01976273|Glycolic acid|glycolic acid|mesh-list
20626693|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
20626694|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
20626695|NCT01802086|Lidocaine|lidocaine|mesh-list
20626696|NCT01802086|Prilocaine|prilocaine|mesh-list
20626697|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20626698|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626699|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
20626700|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626701|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626702|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
20626703|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850471|NCT00709995|Growth Substances|growth substances|mesh-ancestor
19850472|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850473|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
20226334|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626704|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19411716|NCT03537326|Budesonide|budesonide|mesh-list
19850474|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850475|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226335|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20226336|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
20226337|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226338|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226339|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
20226340|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226341|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20226342|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226343|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
20226344|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226345|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20226346|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20226347|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
19850476|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226348|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20226349|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20226350|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
20226351|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226352|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474686|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474687|NCT01507285|Incretins|incretins|mesh-ancestor
20474688|NCT01507285|Hormones|hormones|mesh-ancestor
20474689|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474690|NCT01507311|Liraglutide|liraglutide|mesh-list
20474691|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20226353|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20226354|NCT00346463|Allopurinol|allopurinol|mesh-list
20226355|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
20226356|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226357|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226358|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
20226359|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226360|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20226361|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
20226362|NCT00346463|Protective Agents|protective agents|mesh-ancestor
20226363|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226364|NCT00346489|Fluorouracil|fluorouracil|mesh-list
20226365|NCT00346489|Mitomycins|mitomycins|mesh-list
20226366|NCT00346489|Mitomycin|mitomycin|mesh-list
20226367|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
20226368|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226369|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20226370|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226371|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226372|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
20226373|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226374|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20226375|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
20226376|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20226377|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226378|NCT00346502|Betulinic acid|betulinic acid|mesh-list
20226379|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20226380|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20226381|NCT00346502|Analgesics|analgesics|mesh-ancestor
20226382|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
20226383|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226384|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226385|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226386|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226387|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
20226388|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20474692|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474693|NCT01507311|Incretins|incretins|mesh-ancestor
20474694|NCT01507311|Hormones|hormones|mesh-ancestor
20474695|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474696|NCT01507337|Liraglutide|liraglutide|mesh-list
20474697|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20474698|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474699|NCT01507337|Incretins|incretins|mesh-ancestor
20474700|NCT01507337|Hormones|hormones|mesh-ancestor
20474701|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474702|NCT01507363|Gabapentin|gabapentin|mesh-list
20474703|NCT01507363|Analgesics|analgesics|mesh-ancestor
20474704|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
20474705|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474706|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474707|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
20474708|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20474709|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20474710|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626705|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20626706|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20626707|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696282|NCT04942301|Endostar protein|endostar protein|mesh-list
20226389|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20474711|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20474712|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20474713|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20474714|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474715|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474716|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
20474717|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20474718|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20474719|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474720|NCT01507389|Liraglutide|liraglutide|mesh-list
20474721|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20474722|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474723|NCT01507389|Incretins|incretins|mesh-ancestor
20474724|NCT01507389|Hormones|hormones|mesh-ancestor
20474725|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474726|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
20474727|NCT01507428|Misonidazole|misonidazole|mesh-list
20474728|NCT01507428|Paclitaxel|paclitaxel|mesh-list
20626708|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626709|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20626710|NCT01525316|Lactoferrin|lactoferrin|mesh-list
20626711|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626712|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20626713|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20626714|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19411717|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226390|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226391|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20226392|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226393|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
20226394|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
20226395|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20226396|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20226397|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20226398|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
20226399|NCT00346567|Tenofovir|tenofovir|mesh-list
20226400|NCT00346567|Lamivudine|lamivudine|mesh-list
20226401|NCT00346567|Zidovudine|zidovudine|mesh-list
20226402|NCT00346567|Emtricitabine|emtricitabine|mesh-list
20474729|NCT01507428|Carboplatin|carboplatin|mesh-list
20474730|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20474731|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20474732|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20474733|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474734|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
20474735|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
20474736|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
20474737|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474738|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20474739|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
20474740|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
20474741|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474742|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20474743|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20474744|NCT01507454|Estradiol|estradiol|mesh-list
20474745|NCT01507454|Estrogens|estrogens|mesh-ancestor
20474746|NCT01507454|Hormones|hormones|mesh-ancestor
20474747|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474748|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474749|NCT01507467|Nimorazole|nimorazole|mesh-list
20474750|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20474751|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20474752|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20474753|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474754|NCT01507480|Bevacizumab|bevacizumab|mesh-list
20474755|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474756|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474757|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20474758|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474759|NCT01507480|Growth Substances|growth substances|mesh-ancestor
20474760|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474761|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
20474762|NCT01507519|Sirolimus|sirolimus|mesh-list
20474763|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20474764|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474765|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20474766|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474767|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
20474768|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626715|NCT01388491|Desogestrel|desogestrel|mesh-list
20626716|NCT01388491|Estradiol|estradiol|mesh-list
19411718|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19411719|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
19411720|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411721|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411722|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19411723|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
19411724|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
19696283|NCT04942301|Endostatins|endostatins|mesh-list
19696284|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19696285|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19696286|NCT04942301|Growth Substances|growth substances|mesh-ancestor
20474769|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
20474770|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474771|NCT01507558|Dexamethasone|dexamethasone|mesh-list
20474772|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
20474773|NCT01507558|BB 1101|bb 1101|mesh-list
20474774|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20474775|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
20474776|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
20474777|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474778|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474779|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474780|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
20474781|NCT01507558|Hormones|hormones|mesh-ancestor
20474782|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474783|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20474784|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474785|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
20474786|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474787|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474788|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
20474789|NCT01507597|Glucagon|glucagon|mesh-list
20474790|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20474791|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474792|NCT01507597|Hormones|hormones|mesh-ancestor
20474793|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474794|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474795|NCT01507597|Incretins|incretins|mesh-ancestor
20474796|NCT01507701|Clonidine|clonidine|mesh-list
20474797|NCT01507701|Analgesics|analgesics|mesh-ancestor
20474798|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
20474799|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474800|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474801|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20474802|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
20474803|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
20474804|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20474805|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20474806|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20474807|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
20474808|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474809|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474810|NCT01507727|Tolvaptan|tolvaptan|mesh-list
20474811|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20474812|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474813|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
20474814|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474815|NCT01507740|Bevacizumab|bevacizumab|mesh-list
20474816|NCT01507740|Sorafenib|sorafenib|mesh-list
20474817|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474818|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474819|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20474820|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474821|NCT01507740|Growth Substances|growth substances|mesh-ancestor
20474822|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474823|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
20474824|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20474825|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474826|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474827|NCT01507792|Loratadine|loratadine|mesh-list
20474828|NCT01507792|Omeprazole|omeprazole|mesh-list
20626717|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20626718|NCT01388491|Estrogens|estrogens|mesh-ancestor
19411725|NCT03537326|Hormones|hormones|mesh-ancestor
20226403|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20226404|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20226405|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
20226406|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226407|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20226408|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20226409|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626719|NCT01388491|Hormones|hormones|mesh-ancestor
20626720|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626721|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626722|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20626723|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
20626724|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20626725|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20626726|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20474829|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20474830|NCT01507792|Histamine|histamine|mesh-list
20474831|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20474832|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474833|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474834|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626727|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20626728|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20626729|NCT01388491|Progestins|progestins|mesh-ancestor
20626730|NCT01373151|Adalimumab|adalimumab|mesh-list
20626731|NCT01373151|Methotrexate|methotrexate|mesh-list
20626732|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20626733|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
20626734|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20626735|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626736|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626737|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
20626738|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626739|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626740|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
20226410|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226411|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20226412|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20226413|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
20226414|NCT00346580|Nelfinavir|nelfinavir|mesh-list
20226415|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20626741|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626742|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20626743|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626744|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
20626745|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20626746|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20626747|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20626748|NCT01351103|Spartalizumab|spartalizumab|mesh-list
20474835|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
20474836|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
20474837|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20626749|NCT01351103|LGK974|lgk974|mesh-list
20226416|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20226417|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
20226418|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226419|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226420|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20226421|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20226422|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
20226423|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226424|NCT00346619|Nelfinavir|nelfinavir|mesh-list
20226425|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20226426|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20226427|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
20226428|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226429|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226430|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20226431|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20226432|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
20626750|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20226433|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474838|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20474839|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20474840|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
20474841|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
20474842|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474843|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474844|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
20474845|NCT01507857|Vaccines|vaccines|mesh-list
20474846|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
20474847|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474848|NCT01507922|Fenoverine|fenoverine|mesh-list
20474849|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
20474850|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
20474851|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20474852|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474853|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20474854|NCT01507974|Amoxicillin|amoxicillin|mesh-list
20474855|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
20474856|NCT01507974|Cephalexin|cephalexin|mesh-list
20474857|NCT01507974|Cefuroxime|cefuroxime|mesh-list
20474858|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
20474859|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20474860|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20474861|NCT01507974|Trimethoprim|trimethoprim|mesh-list
20474862|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
20474863|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474864|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
20474865|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20474866|NCT01507974|Renal Agents|renal agents|mesh-ancestor
20474867|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
20474868|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20474869|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20474870|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20474871|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474872|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474873|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20474874|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20474875|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20474876|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20474877|NCT01508000|Bevacizumab|bevacizumab|mesh-list
20474878|NCT01508000|Panitumumab|panitumumab|mesh-list
20474879|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474880|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474881|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20474882|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20474883|NCT01508000|Growth Substances|growth substances|mesh-ancestor
20474884|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474885|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
20474886|NCT01508104|Everolimus|everolimus|mesh-list
20474887|NCT01508104|Dactolisib|dactolisib|mesh-list
20474888|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474889|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20474890|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
20474891|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527433|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20527434|NCT01768312|Cyclosporine|cyclosporine|mesh-list
20527435|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20527436|NCT01768312|Cyclosporins|cyclosporins|mesh-list
20527437|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527438|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527439|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527440|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
20527441|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527442|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
20527443|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527444|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
20527445|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527446|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20527447|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20527448|NCT01768338|Ofatumumab|ofatumumab|mesh-list
20527449|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527450|NCT01768351|Calcitriol|calcitriol|mesh-list
20527451|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20527452|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527453|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20527454|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527455|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474892|NCT01507610|Sumatriptan|sumatriptan|mesh-list
20474893|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20474894|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20474895|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20474896|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
20474897|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626751|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626752|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626753|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474898|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474899|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850477|NCT00710021|Vitamin D|vitamin d|mesh-list
20226434|NCT00346645|Bortezomib|bortezomib|mesh-list
20226435|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247440|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247441|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247442|NCT00432302|Sagopilone|sagopilone|mesh-list
20247443|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247444|NCT00432315|Docetaxel|docetaxel|mesh-list
20247445|NCT00432315|Cisplatin|cisplatin|mesh-list
20247446|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247447|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247448|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
20247449|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
20247450|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247451|NCT00432354|Atorvastatin|atorvastatin|mesh-list
20626754|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
20626755|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20626756|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20626757|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20626758|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20626759|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626760|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
20626761|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474900|NCT01508143|Misoprostol|misoprostol|mesh-list
20474901|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20474902|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
20474903|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20474904|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474905|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20474906|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474907|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
20474908|NCT01508182|Metformin|metformin|mesh-list
20474909|NCT01508182|Canagliflozin|canagliflozin|mesh-list
20626762|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626763|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20626764|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626765|NCT00960297|Paclitaxel|paclitaxel|mesh-list
20626766|NCT00960297|Bevacizumab|bevacizumab|mesh-list
20626767|NCT00960297|Carboplatin|carboplatin|mesh-list
20626768|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20626769|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626770|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
20626771|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
20626772|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
20626773|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626774|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626775|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20626776|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20626777|NCT00960297|Growth Substances|growth substances|mesh-ancestor
20626778|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626779|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
20626780|NCT00910650|Aldesleukin|aldesleukin|mesh-list
20626781|NCT00910650|Interleukin-2|interleukin-2|mesh-list
20626782|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626783|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20626784|NCT00910650|Analgesics|analgesics|mesh-ancestor
20626785|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
20626786|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626787|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626788|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20626789|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20626790|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
20626791|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626792|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
20626793|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
20626794|NCT00703326|Docetaxel|docetaxel|mesh-list
20626795|NCT00703326|Ramucirumab|ramucirumab|mesh-list
20626796|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626797|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20626798|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20626799|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20626800|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626801|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
20626802|NCT00602667|Cisplatin|cisplatin|mesh-list
20626803|NCT00602667|Carboplatin|carboplatin|mesh-list
20626804|NCT00602667|Methotrexate|methotrexate|mesh-list
20626805|NCT00602667|Etoposide|etoposide|mesh-list
20626806|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
20626807|NCT00602667|Vincristine|vincristine|mesh-list
20626808|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20626809|NCT00602667|Topotecan|topotecan|mesh-list
20626810|NCT00602667|Vinblastine|vinblastine|mesh-list
20626811|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626812|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
20626813|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626814|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696287|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696288|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
19696289|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696290|NCT04941976|Benzydamine|benzydamine|mesh-list
19696291|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20474910|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626815|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20474911|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474912|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20474913|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474914|NCT01508195|Metformin|metformin|mesh-list
20474915|NCT01508195|Canagliflozin|canagliflozin|mesh-list
20474916|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20474917|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474918|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19696292|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
19696293|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19696294|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19696295|NCT04942002|Prednisolone|prednisolone|mesh-list
19696296|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
19696297|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19696298|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
19696299|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696300|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
20626816|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
20626817|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626818|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626819|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20626820|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20626821|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
20626822|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20626823|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626824|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
20626825|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
20626826|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626827|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20626828|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20626829|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20626830|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20626831|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20626832|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
20626833|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
20626834|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
20626835|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20626836|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20626837|NCT00472186|Lansoprazole|lansoprazole|mesh-list
20626838|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
20626839|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20474919|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474920|NCT01508221|Vitamin E|vitamin e|mesh-list
20474921|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
20474922|NCT01508221|Vitamins|vitamins|mesh-ancestor
20474923|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
20474924|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474925|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
20474926|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474927|NCT01508221|Protective Agents|protective agents|mesh-ancestor
20474928|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20474929|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474930|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20474931|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20474932|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
20474933|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20474934|NCT01508260|Furosemide|furosemide|mesh-list
20474935|NCT01508260|Diuretics|diuretics|mesh-ancestor
20474936|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
20474937|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474938|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20474939|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20474940|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626840|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626841|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20626842|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626843|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626844|NCT05148000|Botulinum Toxins|botulinum toxins|mesh-list
20626845|NCT05148000|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20626846|NCT05148000|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20626847|NCT05148000|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20626848|NCT05148000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696301|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
20626849|NCT05148000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626850|NCT05148000|Cholinergic Agents|cholinergic agents|mesh-ancestor
20626851|NCT05148000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20626852|NCT05148000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626853|NCT05148000|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20626854|NCT05148000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626855|NCT05147857|Misoprostol|misoprostol|mesh-list
20626856|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20626857|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
20626858|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20626859|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626860|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20626861|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20626862|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
20626863|NCT05147753|Moxonidine|moxonidine|mesh-list
20626864|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20626865|NCT05147727|Fluconazole|fluconazole|mesh-list
20626866|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
20626867|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626868|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20626869|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20626870|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626871|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626872|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20626873|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
20626874|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20626875|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626876|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20626877|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20626878|NCT05147194|Trimetazidine|trimetazidine|mesh-list
20626879|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
20626880|NCT05147090|Empagliflozin|empagliflozin|mesh-list
20626881|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20626882|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626883|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626884|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626885|NCT05146895|Imiquimod|imiquimod|mesh-list
20626886|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20626887|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
20626888|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626889|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626890|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
20626891|NCT05146713|Propolis|propolis|mesh-list
20626892|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20626893|NCT05146713|Eusol|eusol|mesh-list
20626894|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626895|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
20626896|NCT05145608|Lamotrigine|lamotrigine|mesh-list
20626897|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
20626898|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20626899|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20626900|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626901|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20626902|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626903|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20626904|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20626905|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626906|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20626907|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20626908|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
20626909|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20626910|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626911|NCT05118308|Liver Extracts|liver extracts|mesh-list
20626912|NCT05118308|Hematinics|hematinics|mesh-ancestor
20626913|NCT05116800|Gemcitabine|gemcitabine|mesh-list
20626914|NCT05116800|Docetaxel|docetaxel|mesh-list
20626915|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626916|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
20626917|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626918|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626919|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
20626920|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626921|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626922|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626923|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
20626924|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626925|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
20626926|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
20626927|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
20626928|NCT05112861|Bevacizumab|bevacizumab|mesh-list
20626929|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626930|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626931|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20626932|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20626933|NCT05112861|Growth Substances|growth substances|mesh-ancestor
20626934|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626935|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
20626936|NCT05089565|Interferons|interferons|mesh-list
20626937|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
20626938|NCT05089565|Antibodies|antibodies|mesh-list
20626939|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
20626940|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
20626941|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626942|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626943|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
20626944|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626945|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
20626946|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20626947|NCT05085327|Protective Agents|protective agents|mesh-ancestor
20626948|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626949|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
20626950|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20626951|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
20626952|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
20626953|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
20626954|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20626955|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626956|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
20626957|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20626958|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20626959|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20626960|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
20626961|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626962|NCT05078463|Protective Agents|protective agents|mesh-ancestor
20626963|NCT04984837|Gemcitabine|gemcitabine|mesh-list
20626964|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
20626965|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20626966|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
20474941|NCT01508286|Ribavirin|ribavirin|mesh-list
20474942|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
20474943|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474944|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
20474945|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20474946|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20474947|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20474948|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474949|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474950|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
20474951|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474952|NCT01508364|Sorafenib|sorafenib|mesh-list
20474953|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474954|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20474955|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20474956|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474957|NCT01508429|Misoprostol|misoprostol|mesh-list
20474958|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20474959|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
20474960|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20474961|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474962|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20474963|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474964|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
20474965|NCT01508468|Rituximab|rituximab|mesh-list
20474966|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
20474967|NCT01508468|Giapreza|giapreza|mesh-list
20474968|NCT01508468|Calcium|calcium|mesh-list
20474969|NCT01508468|Diuretics|diuretics|mesh-list
20474970|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20474971|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20474972|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
20626967|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626968|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626969|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
20626970|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626971|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626972|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20626973|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
20626974|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20626975|NCT04948463|Vancomycin|vancomycin|mesh-list
20626976|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
20626977|NCT04948463|Tazobactam|tazobactam|mesh-list
20626978|NCT04948463|Piperacillin|piperacillin|mesh-list
20626979|NCT04948463|Amikacin|amikacin|mesh-list
20626980|NCT04948463|Ceftazidime|ceftazidime|mesh-list
20626981|NCT04948463|Cefepime|cefepime|mesh-list
20626982|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20626983|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20626984|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20626985|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20626986|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20626987|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20626988|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626989|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20626990|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20626991|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20626992|NCT04939363|Venetoclax|venetoclax|mesh-list
20626993|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
20626994|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20626995|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20626996|NCT04894721|Ivermectin|ivermectin|mesh-list
20626997|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20626998|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696302|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696303|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696304|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19696305|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
19696306|NCT04942002|Hormones|hormones|mesh-ancestor
19696307|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696308|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19696309|NCT04942002|Protective Agents|protective agents|mesh-ancestor
19850478|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
20626999|NCT04874311|Doxorubicin|doxorubicin|mesh-list
20627000|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20627001|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627002|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20627003|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20627004|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627005|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627006|NCT04825197|Poractant alfa|poractant alfa|mesh-list
20627007|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20627008|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
20627009|NCT04817956|Trastuzumab|trastuzumab|mesh-list
20627010|NCT04817956|Pertuzumab|pertuzumab|mesh-list
20627011|NCT04817956|Atezolizumab|atezolizumab|mesh-list
20627012|NCT04817956|Vemurafenib|vemurafenib|mesh-list
20627013|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20627014|NCT04817956|Entrectinib|entrectinib|mesh-list
20627015|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627016|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627017|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627018|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
20627019|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627020|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627021|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627022|NCT04793659|Fasudil|fasudil|mesh-list
20627023|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
20627024|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20627025|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627026|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627027|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20627028|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627029|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
20627030|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627031|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627032|NCT04783675|Rituximab|rituximab|mesh-list
20627033|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627034|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627035|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
20627036|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627037|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627038|NCT04776148|Trifluridine|trifluridine|mesh-list
20627039|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
20627040|NCT04776148|Lenvatinib|lenvatinib|mesh-list
20627041|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627042|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627043|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627044|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627045|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627046|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
20627047|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
20627048|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627049|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
20627050|NCT04742140|Analgesics|analgesics|mesh-ancestor
20627051|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
20627052|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627053|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627054|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
20627055|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627056|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20627057|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
20627058|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20627059|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627060|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627061|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20627062|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
20627063|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20627064|NCT04715230|Lorazepam|lorazepam|mesh-list
20627065|NCT04715230|Haloperidol|haloperidol|mesh-list
20627066|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
20627067|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
20627068|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
20627069|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627070|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627071|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20627072|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20627073|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20627074|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627075|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20627076|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20627077|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
20627078|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627079|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627080|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20627081|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
20627082|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20627083|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20627084|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
20627085|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
20627086|NCT04677387|Naloxone|naloxone|mesh-list
20627087|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20627088|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627089|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
20627090|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627091|NCT04643379|Carboplatin|carboplatin|mesh-list
20627092|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
20627093|NCT04643379|Olaparib|olaparib|mesh-list
20627094|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627095|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627096|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20627097|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627098|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627099|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
20627100|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627101|NCT04590274|Azithromycin|azithromycin|mesh-list
20627102|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
20627103|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20627104|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627105|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
20627106|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20627107|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20627108|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627109|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627110|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627111|NCT04567784|Cannabidiol|cannabidiol|mesh-list
20627112|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
20627113|NCT04440358|Carboplatin|carboplatin|mesh-list
20627114|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627115|NCT04339140|Zafirlukast|zafirlukast|mesh-list
20627116|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20627117|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
20627118|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20627119|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
20627120|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627121|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627122|NCT04294810|Atezolizumab|atezolizumab|mesh-list
20627123|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627124|NCT04283617|Insulin|insulin|mesh-list
20627125|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627126|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627127|NCT04246372|Tofacitinib|tofacitinib|mesh-list
20627128|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627129|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627130|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627131|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20627132|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627133|NCT04182321|Metformin|metformin|mesh-list
20627134|NCT04182321|Entecavir|entecavir|mesh-list
20627135|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627136|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627137|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
20627138|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627139|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20627140|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627141|NCT04143282|Metformin|metformin|mesh-list
20627142|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627143|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627144|NCT04124588|Hemostatics|hemostatics|mesh-list
20627145|NCT04124588|Coagulants|coagulants|mesh-ancestor
20627146|NCT04062279|Autoantibodies|autoantibodies|mesh-list
20627147|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
20627148|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627149|NCT04035278|Vaccines|vaccines|mesh-list
20627150|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
20627151|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627152|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
20627153|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20627154|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
20627155|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627156|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627157|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20627158|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
20627159|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
20627160|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20627161|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
20627162|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627163|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226436|NCT00346684|Rituximab|rituximab|mesh-list
20226437|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226438|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226439|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
20226440|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226441|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226442|NCT00346749|Fluticasone|fluticasone|mesh-list
20226443|NCT00346749|Xhance|xhance|mesh-list
20226444|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20226445|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226446|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20226447|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
20226448|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226449|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226450|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20627164|NCT03916341|Nicotine|nicotine|mesh-list
20627165|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20627166|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
20627167|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627168|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627169|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20627170|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20627171|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
20627172|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627173|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627174|NCT03881020|Fluorides|fluorides|mesh-list
20627175|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
20627176|NCT03881020|Protective Agents|protective agents|mesh-ancestor
20627177|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627178|NCT03872401|Evolocumab|evolocumab|mesh-list
20627179|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20627180|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20627181|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
20627182|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627183|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20627184|NCT03797261|Venetoclax|venetoclax|mesh-list
20627185|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627186|NCT03719924|Paclitaxel|paclitaxel|mesh-list
20627187|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20627188|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627189|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
20627190|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
20627191|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
20627192|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627193|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
20627194|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
20627195|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20627196|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20627197|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627198|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627199|NCT03686306|Urological Agents|urological agents|mesh-ancestor
20627200|NCT03661138|Upadacitinib|upadacitinib|mesh-list
20627201|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20627202|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627203|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627204|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627205|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627206|NCT03589976|Sirolimus|sirolimus|mesh-list
20627207|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20627208|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627209|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20627210|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627211|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
20627212|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20627213|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
20627214|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627215|NCT03579615|Insulin|insulin|mesh-list
20627216|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
20627217|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627218|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474973|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20474974|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20474975|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20474976|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
20474977|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474978|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20474979|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20474980|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
19850479|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
19850480|NCT00710021|Vitamins|vitamins|mesh-list
19850481|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
19850482|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850483|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19850484|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19850485|NCT00710034|Nicotine|nicotine|mesh-list
20474981|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20474982|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
20627219|NCT03532139|Enoxaparin|enoxaparin|mesh-list
19850486|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20474983|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627220|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
20627221|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20627222|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20627223|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20627224|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
20627225|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627226|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20627227|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20627228|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627229|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
20627230|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20627231|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20627232|NCT03475953|Avelumab|avelumab|mesh-list
20627233|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20627234|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627235|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627236|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
20627237|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627238|NCT03447574|Ethanol|ethanol|mesh-list
20627239|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20627240|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627241|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627242|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627243|NCT03368729|Trastuzumab|trastuzumab|mesh-list
20627244|NCT03368729|Niraparib|niraparib|mesh-list
20627245|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627246|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627247|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20627248|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627249|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627250|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
20627251|NCT03344341|Acarbose|acarbose|mesh-list
20627252|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20627253|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627254|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627255|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627256|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20627257|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627258|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
20627259|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627260|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627261|NCT03276468|Atezolizumab|atezolizumab|mesh-list
20627262|NCT03276468|Venetoclax|venetoclax|mesh-list
20627263|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
20627264|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627265|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627266|NCT03260881|Liraglutide|liraglutide|mesh-list
20627267|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627268|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627269|NCT03260881|Incretins|incretins|mesh-ancestor
20627270|NCT03260881|Hormones|hormones|mesh-ancestor
20627271|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627272|NCT03238495|Metformin|metformin|mesh-list
20627273|NCT03238495|Carboplatin|carboplatin|mesh-list
20627274|NCT03238495|Docetaxel|docetaxel|mesh-list
20627275|NCT03238495|Trastuzumab|trastuzumab|mesh-list
20627276|NCT03238495|Pertuzumab|pertuzumab|mesh-list
20627277|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627278|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627279|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627280|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
20627281|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
20627282|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
20627283|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627284|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627285|NCT03232138|Sulforaphane|sulforaphane|mesh-list
20627286|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20627287|NCT03232138|Protective Agents|protective agents|mesh-ancestor
20627288|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627289|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627290|NCT03212963|Clobetasol|clobetasol|mesh-list
20627291|NCT03212963|Halobetasol|halobetasol|mesh-list
20627292|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20627293|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20627294|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
19850487|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
20627295|NCT03212963|Hormones|hormones|mesh-ancestor
20627296|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627297|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627298|NCT03135262|Rituximab|rituximab|mesh-list
20627299|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
20627300|NCT03135262|Venetoclax|venetoclax|mesh-list
20627301|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627302|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627303|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
20627304|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627305|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627306|NCT03104075|Vaccines|vaccines|mesh-list
20627307|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20627308|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
20627309|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627310|NCT03072628|Nicotine|nicotine|mesh-list
20627311|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20627312|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
20627313|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627314|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627315|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20627316|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20627317|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
20627318|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627319|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627320|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20627321|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20627322|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627323|NCT02907983|Bupivacaine|bupivacaine|mesh-list
20627324|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
20627325|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
20627326|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627327|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627328|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
20627329|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627330|NCT02880540|Fentanyl|fentanyl|mesh-list
20627331|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
20627332|NCT02880540|Morphine|morphine|mesh-list
20627333|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20627334|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627335|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627336|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20627337|NCT02880540|Analgesics|analgesics|mesh-ancestor
20627338|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
19696310|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19696311|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627339|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627340|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20627341|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20627342|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20627343|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
20627344|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627345|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627346|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20627347|NCT02880540|Narcotics|narcotics|mesh-ancestor
20627348|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20627349|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20627350|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
20627351|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
20627352|NCT02841215|Ivermectin|ivermectin|mesh-list
20627353|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20627354|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627355|NCT02802566|Vitamins|vitamins|mesh-list
20627356|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
20627357|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627358|NCT02799641|Lidocaine|lidocaine|mesh-list
20627359|NCT02799641|Diazepam|diazepam|mesh-list
20627360|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
20627361|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
20627362|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627363|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627364|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
20627365|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627366|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20627367|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19696312|NCT04941872|FAPI-46|fapi-46|mesh-list
20627368|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20627369|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627370|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627371|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20627372|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
20627373|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
20627374|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
20627375|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20474984|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474985|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20474986|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20474987|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
20627376|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20627377|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20627378|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20627379|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20627380|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20627381|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20627382|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20627383|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
20627384|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
20627385|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
20627386|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226451|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
20226452|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
20226453|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20226454|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20226455|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20226456|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20226457|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226458|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226459|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226460|NCT00346801|Celecoxib|celecoxib|mesh-list
20226461|NCT00346801|Cisplatin|cisplatin|mesh-list
20474988|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
20474989|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20474990|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20474991|NCT01508494|Galantamine|galantamine|mesh-list
20474992|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20627387|NCT02782663|Upadacitinib|upadacitinib|mesh-list
19696313|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19696314|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696315|NCT04941898|Factor VIII|factor viii|mesh-list
19696316|NCT04941898|BAX 855|bax 855|mesh-list
19696317|NCT04941898|Coagulants|coagulants|mesh-ancestor
20627388|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20627389|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627390|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627391|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627392|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627393|NCT02755844|Metformin|metformin|mesh-list
20627394|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
20627395|NCT02755844|Olaparib|olaparib|mesh-list
20627396|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20627397|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
20627398|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627399|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627400|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20627401|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
20627402|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627403|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627404|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20627405|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627406|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20627407|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627408|NCT02741388|Gemcitabine|gemcitabine|mesh-list
20627409|NCT02741388|Cytarabine|cytarabine|mesh-list
20474993|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696318|NCT04941833|Desogestrel|desogestrel|mesh-list
19696319|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19696320|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19696321|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19696322|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
20226462|NCT00346801|Irinotecan|irinotecan|mesh-list
20627410|NCT02741388|Dexamethasone|dexamethasone|mesh-list
20226463|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627411|NCT02741388|Rituximab|rituximab|mesh-list
20627412|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
20627413|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627414|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627415|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
20627416|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627417|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627418|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20627419|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
20627420|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
20627421|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627422|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20627423|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
20627424|NCT02741388|Hormones|hormones|mesh-ancestor
20627425|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627426|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20627427|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20627428|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
20627429|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627430|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
20627431|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627432|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627433|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20627434|NCT02686346|Etoposide|etoposide|mesh-list
20627435|NCT02686346|Ifosfamide|ifosfamide|mesh-list
20627436|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20627437|NCT02686346|Carboplatin|carboplatin|mesh-list
20627438|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20627439|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627440|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20627441|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20627442|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627443|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627444|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20627445|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
20627446|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627447|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20627448|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
20627449|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627450|NCT02536339|Trastuzumab|trastuzumab|mesh-list
20627451|NCT02536339|Pertuzumab|pertuzumab|mesh-list
20627452|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627453|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627454|NCT02229136|Prednisolone|prednisolone|mesh-list
20474994|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20474995|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
20474996|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20474997|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20474998|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20474999|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
20475000|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475001|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
20475002|NCT01508572|Bevacizumab|bevacizumab|mesh-list
20475003|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20475004|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475005|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20475006|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20475007|NCT01508572|Growth Substances|growth substances|mesh-ancestor
20475008|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475009|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
20475010|NCT01508611|Fluorides|fluorides|mesh-list
20475011|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
20475012|NCT01508611|Protective Agents|protective agents|mesh-ancestor
20475013|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475014|NCT01508637|Terazosin|terazosin|mesh-list
20475015|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20475016|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20475017|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20475018|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
20475019|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475020|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475021|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627455|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
20627456|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20627457|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
20627458|NCT02229136|Hormones|hormones|mesh-ancestor
20627459|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627460|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627461|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20627462|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627463|NCT02189798|Imidacloprid|imidacloprid|mesh-list
20627464|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
20627465|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627466|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627467|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627468|NCT02050308|Nicotine|nicotine|mesh-list
20627469|NCT02050308|Varenicline|varenicline|mesh-list
20627470|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20627471|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
20627472|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627473|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627474|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20627475|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20627476|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
20627477|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627478|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627479|NCT01869361|Indomethacin|indomethacin|mesh-list
20627480|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20627481|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20627482|NCT01869361|Analgesics|analgesics|mesh-ancestor
20627483|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
20627484|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627485|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627486|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20627487|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627488|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
20627489|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
20627490|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20627491|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20627492|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627493|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627494|NCT01828099|Carboplatin|carboplatin|mesh-list
20627495|NCT01828099|Pemetrexed|pemetrexed|mesh-list
20627496|NCT01828099|Ceritinib|ceritinib|mesh-list
20627497|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627498|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627499|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627500|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20627501|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20627502|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627503|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20627504|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627505|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627506|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
20627507|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627508|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627509|NCT00943618|Bupropion|bupropion|mesh-list
20627510|NCT00943618|Varenicline|varenicline|mesh-list
20627511|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20627512|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
20627513|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20627514|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20627515|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20627516|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627517|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627518|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
20627519|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627520|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627521|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20627522|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20627523|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627524|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20627525|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20627526|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
20627527|NCT00914823|Hormones|hormones|mesh-list
20627528|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627529|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627530|NCT05149378|Azacitidine|azacitidine|mesh-list
20627531|NCT05149378|Venetoclax|venetoclax|mesh-list
20627532|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20627533|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
20627534|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627535|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627536|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627537|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
20627538|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20627539|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627540|NCT05149339|Vitamins|vitamins|mesh-ancestor
20627541|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
20627542|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20627543|NCT05149248|Vaccines|vaccines|mesh-list
20627544|NCT05149248|Immunologic Factors|immunologic factors|mesh-ancestor
20627545|NCT05149248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627546|NCT05149170|Antibodies|antibodies|mesh-list
20627547|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20627548|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
20627549|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627550|NCT05149092|Caseins|caseins|mesh-list
20627551|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
20627552|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
20627553|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627554|NCT05148910|Copper|copper|mesh-list
20627555|NCT05148910|Trace Elements|trace elements|mesh-ancestor
20226464|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20226465|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20226466|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627556|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
20627557|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627558|NCT05148884|Befiradol|befiradol|mesh-list
20627559|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20627560|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20627561|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
20627562|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627563|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627564|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627565|NCT05148767|Irinotecan|irinotecan|mesh-list
20627566|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20627567|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20627568|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627569|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627570|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627571|NCT05148715|Tacrolimus|tacrolimus|mesh-list
20627572|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20627573|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
20627574|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627575|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20627576|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627577|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627578|NCT05148689|Phenylephrine|phenylephrine|mesh-list
19850488|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850489|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850490|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19850491|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19850492|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
19850493|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850494|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475022|NCT01508637|Urological Agents|urological agents|mesh-ancestor
20475023|NCT01508663|Everolimus|everolimus|mesh-list
20627579|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
20627580|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20627581|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20627582|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
20627583|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627584|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627585|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475024|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20475025|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475026|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20627586|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
20627587|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
20627588|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226467|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226468|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20226469|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20226470|NCT00346801|Analgesics|analgesics|mesh-ancestor
20226471|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
20226472|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475027|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
20475028|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475029|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
20475030|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475031|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475032|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20475033|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20475034|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
20475035|NCT01508806|Liraglutide|liraglutide|mesh-list
20475036|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475037|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475038|NCT01508806|Incretins|incretins|mesh-ancestor
20475039|NCT01508806|Hormones|hormones|mesh-ancestor
20475040|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475041|NCT01508845|Vitamin D|vitamin d|mesh-list
20627589|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
20627590|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20627591|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
20627592|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20627593|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
20627594|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20627595|NCT05148689|Protective Agents|protective agents|mesh-ancestor
20627596|NCT05148442|Azacitidine|azacitidine|mesh-list
20627597|NCT05148442|Decitabine|decitabine|mesh-list
20627598|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20627599|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
20627600|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627601|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627602|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627603|NCT05148403|Glyburide|glyburide|mesh-list
20627604|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627605|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627606|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
20627607|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20627608|NCT05148169|Sulforaphane|sulforaphane|mesh-list
20627609|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20627610|NCT05148169|Protective Agents|protective agents|mesh-ancestor
20627611|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627612|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627613|NCT05148143|Raltitrexed|raltitrexed|mesh-list
20627614|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20627615|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
20627616|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627617|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627618|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20627619|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411726|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411727|NCT03537287|Progesterone|progesterone|mesh-list
19411728|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
19411729|NCT03537287|Progestins|progestins|mesh-ancestor
20627620|NCT05148026|Heparin|heparin|mesh-list
20627621|NCT05148026|Calcium heparin|calcium heparin|mesh-list
20627622|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
20627623|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
20627624|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20627625|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20627626|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627627|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20627628|NCT05145218|Paclitaxel|paclitaxel|mesh-list
20627629|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20627630|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627631|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
20627632|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
20627633|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
20627634|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627635|NCT05136040|Bupivacaine|bupivacaine|mesh-list
20627636|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
20627637|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
20627638|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627639|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627640|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
20627641|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627642|NCT05121298|Upadacitinib|upadacitinib|mesh-list
20627643|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20627644|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627645|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627646|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627647|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627648|NCT05103644|Atorvastatin|atorvastatin|mesh-list
20627649|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20627650|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20627651|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
20627652|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627653|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20627654|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20627655|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627656|NCT05100264|Acetic Acid|acetic acid|mesh-list
20627657|NCT05100264|Retinol acetate|retinol acetate|mesh-list
20627658|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20627659|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627660|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20627661|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
20627662|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627663|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20627664|NCT05100264|Protective Agents|protective agents|mesh-ancestor
20627665|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627666|NCT05084521|Famotidine|famotidine|mesh-list
20627667|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20627668|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20627669|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20627670|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
20627671|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
20627672|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627673|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627674|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627675|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
20627676|NCT05078931|Lenvatinib|lenvatinib|mesh-list
20627677|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627678|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627679|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627680|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627681|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627685|NCT05012631|Losartan|losartan|mesh-list
20627686|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20627687|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20627688|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20627689|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20627690|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627691|NCT04992260|Vaccines|vaccines|mesh-list
20627692|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
20627693|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627694|NCT04989491|Rituximab|rituximab|mesh-list
20627695|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627696|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627697|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
20627698|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627699|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20627700|NCT04989322|Carboplatin|carboplatin|mesh-list
20627701|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
20627702|NCT04989322|Pemetrexed|pemetrexed|mesh-list
20627703|NCT04989322|Lenvatinib|lenvatinib|mesh-list
20627704|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627705|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627706|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627707|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627708|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20627709|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20627710|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627711|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20627712|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20627713|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20627714|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627715|NCT04935112|Pantoprazole|pantoprazole|mesh-list
20627716|NCT04935112|Famotidine|famotidine|mesh-list
20627717|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20627718|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20627719|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20627720|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627721|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627722|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20627723|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
20627724|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
20627725|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627726|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627727|NCT04931511|Betamethasone|betamethasone|mesh-list
20627728|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
20627729|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20627730|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
20627731|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20627732|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20627733|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
20627734|NCT04931511|Hormones|hormones|mesh-ancestor
20627735|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627736|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627737|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20627738|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
20627739|NCT04920942|Ivermectin|ivermectin|mesh-list
20627740|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20627741|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627742|NCT04901754|Apatinib|apatinib|mesh-list
20627743|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627744|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627745|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627746|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627747|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
20627748|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
20627749|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627750|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627751|NCT04804709|Panobinostat|panobinostat|mesh-list
20627752|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627753|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20627754|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627755|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627756|NCT04731103|Lamivudine|lamivudine|mesh-list
20627757|NCT04731103|Zidovudine|zidovudine|mesh-list
20627758|NCT04731103|Abacavir|abacavir|mesh-list
20627759|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
20627760|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20627761|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20627762|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627763|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627764|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
20627765|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627766|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20627767|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20627768|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
20627769|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
20627770|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627771|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627772|NCT04690673|Acetaminophen|acetaminophen|mesh-list
20627773|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20627774|NCT04690673|Analgesics|analgesics|mesh-ancestor
20627775|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
20627776|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627777|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627778|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
20627779|NCT04682288|Levofloxacin|levofloxacin|mesh-list
20627780|NCT04682288|Ofloxacin|ofloxacin|mesh-list
20627781|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20627782|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627783|NCT04682288|Renal Agents|renal agents|mesh-ancestor
20627784|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20627785|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20627786|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20627787|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627788|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627789|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627790|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20627791|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20627792|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20627793|NCT04608409|Paclitaxel|paclitaxel|mesh-list
20627794|NCT04608409|Lapatinib|lapatinib|mesh-list
20627795|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20627796|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627797|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
20627798|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
20627799|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
19850495|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19850496|NCT00710385|Buprenorphine|buprenorphine|mesh-list
19850497|NCT00710385|Heroin|heroin|mesh-list
19850498|NCT00710385|Naloxone|naloxone|mesh-list
19850499|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20627800|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627801|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20627802|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627803|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20627804|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20627805|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627806|NCT04580992|Ajmaline|ajmaline|mesh-list
20627807|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19850500|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850501|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
19850502|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850503|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20627808|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20627809|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20627810|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627811|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627812|NCT04554732|Mitogens|mitogens|mesh-list
20627813|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
20627814|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627815|NCT04536467|Goserelin|goserelin|mesh-list
20627816|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20627817|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627818|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
20627819|NCT04523480|Testosterone|testosterone|mesh-list
20627820|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
20627821|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
20627822|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19850504|NCT00710385|Narcotics|narcotics|mesh-ancestor
20475042|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
20475043|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
20475044|NCT01508845|Vitamins|vitamins|mesh-list
20475045|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
20475046|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475047|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20475048|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20475049|NCT01508858|Liraglutide|liraglutide|mesh-list
20475050|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
20475051|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20475052|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475053|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627823|NCT04523480|Androgens|androgens|mesh-ancestor
20627824|NCT04523480|Hormones|hormones|mesh-ancestor
20627825|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627826|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627827|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20627828|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627829|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
19696323|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19696324|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226473|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226474|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226475|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226476|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20226477|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20226478|NCT00346827|Apomorphine|apomorphine|mesh-list
19696325|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19696326|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19696327|NCT04941833|Progestins|progestins|mesh-ancestor
20226479|NCT00346827|Emetics|emetics|mesh-ancestor
20475054|NCT01508858|Incretins|incretins|mesh-ancestor
20475055|NCT01508858|Hormones|hormones|mesh-ancestor
20475056|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475057|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20475058|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
20475059|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20475060|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20475061|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20475062|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20475063|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20475064|NCT01508858|Estrogens|estrogens|mesh-ancestor
20475065|NCT01508884|Imiquimod|imiquimod|mesh-list
20475066|NCT01508884|Vaccines|vaccines|mesh-list
20475067|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
20475068|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475069|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20475070|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475071|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
20475072|NCT01508897|Liraglutide|liraglutide|mesh-list
20475073|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20226480|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475074|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475075|NCT01508897|Incretins|incretins|mesh-ancestor
20475076|NCT01508897|Hormones|hormones|mesh-ancestor
20627830|NCT04469634|Antibodies|antibodies|mesh-list
20627831|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
20627832|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627833|NCT04455178|Indapamide|indapamide|mesh-list
20627834|NCT04455178|Spironolactone|spironolactone|mesh-list
20627835|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20627836|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
20627837|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627838|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627839|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20627840|NCT04455178|Diuretics|diuretics|mesh-ancestor
20475077|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475078|NCT01508923|Liraglutide|liraglutide|mesh-list
20475079|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627841|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
20627842|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20627843|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20627844|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627845|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627846|NCT04400110|Amoxicillin|amoxicillin|mesh-list
20627847|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
20627848|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
20627849|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20627850|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627851|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627852|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627853|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20627854|NCT04388501|Atorvastatin|atorvastatin|mesh-list
20627855|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20627856|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20627857|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
20627858|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627859|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20627860|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20627861|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627862|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
20627863|NCT04308837|Promethazine|promethazine|mesh-list
20627864|NCT04308837|Dexamethasone|dexamethasone|mesh-list
20627865|NCT04308837|Paclitaxel|paclitaxel|mesh-list
20627866|NCT04308837|Carboplatin|carboplatin|mesh-list
20627867|NCT04308837|Palonosetron|palonosetron|mesh-list
20627868|NCT04308837|Famotidine|famotidine|mesh-list
20627869|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20627870|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627871|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
20627872|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
20627873|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
20627874|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627875|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20627876|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
20627877|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
20627878|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627879|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627880|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20627881|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
20627882|NCT04308837|Hormones|hormones|mesh-ancestor
20627883|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627884|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20627885|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20627886|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20627887|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20627888|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
20627889|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
20627890|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
20627891|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20627892|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
20627893|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
20475080|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475081|NCT01508923|Incretins|incretins|mesh-ancestor
20475082|NCT01508923|Hormones|hormones|mesh-ancestor
20475083|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475084|NCT01508949|Liraglutide|liraglutide|mesh-list
20475085|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475086|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627894|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627895|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20627896|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
20627897|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
20627898|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20627899|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20627900|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
20627901|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20627902|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20627903|NCT04298034|Labetalol|labetalol|mesh-list
20627904|NCT04298034|Nifedipine|nifedipine|mesh-list
20627905|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20627906|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627907|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627908|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20627909|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627910|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
20627911|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
20627912|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20627913|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20627914|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20627915|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
20627916|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20627917|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20226481|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
20226482|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226483|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20226484|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
20226485|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
20627918|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
20627919|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
20627920|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20627921|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20627922|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20627923|NCT04254549|Rifaximin|rifaximin|mesh-list
20627924|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20627925|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627926|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20627927|NCT04252287|Canagliflozin|canagliflozin|mesh-list
20627928|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20627929|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627930|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20627931|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627932|NCT04231318|Triamcinolone|triamcinolone|mesh-list
20627933|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20627934|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20627935|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20627936|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20627937|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
20627938|NCT04231318|Hormones|hormones|mesh-ancestor
20627939|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627940|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627941|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20627942|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
20627943|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627944|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226486|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226487|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226488|NCT00346840|Misoprostol|misoprostol|mesh-list
20226489|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20226490|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
20475087|NCT01508949|Incretins|incretins|mesh-ancestor
20475088|NCT01508949|Hormones|hormones|mesh-ancestor
20475089|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475090|NCT01509001|Metformin|metformin|mesh-list
20475091|NCT01509001|Glimepiride|glimepiride|mesh-list
20475092|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475093|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475094|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20475095|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475096|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
20475097|NCT01509131|Bisacodyl|bisacodyl|mesh-list
20475098|NCT01509131|Cathartics|cathartics|mesh-ancestor
20475099|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20627945|NCT04198649|Azithromycin|azithromycin|mesh-list
19696328|NCT04941833|Hormones|hormones|mesh-ancestor
19696329|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20627946|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20627947|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627948|NCT04177654|Albendazole|albendazole|mesh-list
20627949|NCT04177654|Mebendazole|mebendazole|mesh-list
20627950|NCT04177654|Benzimidazole|benzimidazole|mesh-list
20627951|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
20627952|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20627953|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627954|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
20627955|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20627956|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20627957|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
20627958|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
20627959|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
20627960|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627961|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627962|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
20627963|NCT04172402|Gemcitabine|gemcitabine|mesh-list
20627964|NCT04172402|Nivolumab|nivolumab|mesh-list
20627965|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20627966|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
20627967|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627968|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20627969|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
20627970|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20627971|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627972|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20627973|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
20627974|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627975|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20627976|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20627977|NCT04111419|Amlodipine|amlodipine|mesh-list
20627978|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
20627979|NCT04111419|Atorvastatin|atorvastatin|mesh-list
20627980|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20627981|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20627982|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
20627983|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627984|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20627985|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20627986|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20627987|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20627988|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20627989|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20627990|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20627991|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20627992|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
20627993|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20627994|NCT04071613|Plasminogen|plasminogen|mesh-list
20627995|NCT04071613|Tenecteplase|tenecteplase|mesh-list
20627996|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20627997|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20627998|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20627999|NCT04062708|Durvalumab|durvalumab|mesh-list
20628000|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628001|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628002|NCT04040231|Nivolumab|nivolumab|mesh-list
20628003|NCT04040231|Sargramostim|sargramostim|mesh-list
20628004|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628005|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628006|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20628007|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628008|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
20628009|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628010|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
20628011|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20628012|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
20628013|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628014|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
20628015|NCT04026191|Protective Agents|protective agents|mesh-ancestor
20628016|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
19696330|NCT04941911|Octreotide|octreotide|mesh-list
20628017|NCT04006769|Entacapone|entacapone|mesh-list
20628018|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628019|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20628020|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628021|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628022|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20628023|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20628024|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20628025|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
20628026|NCT03970746|Pemetrexed|pemetrexed|mesh-list
20628027|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628028|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628029|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628030|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628031|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20628032|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20628033|NCT03962894|Prednisolone|prednisolone|mesh-list
20628034|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628035|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
20628036|NCT03962894|Hormones|hormones|mesh-ancestor
20628037|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628038|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628039|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20628040|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628041|NCT03916627|Cemiplimab|cemiplimab|mesh-list
20628042|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628043|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628044|NCT03893318|Lidocaine|lidocaine|mesh-list
20628045|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
20628046|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
20628047|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628048|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628049|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
20628050|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628051|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20628052|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20628053|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20628054|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628055|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628056|NCT03832010|Triamcinolone|triamcinolone|mesh-list
20628057|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
20628058|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628059|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
20628060|NCT03832010|Hormones|hormones|mesh-ancestor
20628061|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628062|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628063|NCT03733132|Metformin|metformin|mesh-list
20628064|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20628065|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628066|NCT03625466|Ivacaftor|ivacaftor|mesh-list
20628067|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20628068|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628069|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628070|NCT03605719|Dexamethasone|dexamethasone|mesh-list
20628071|NCT03605719|Nivolumab|nivolumab|mesh-list
20628072|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628073|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
20628074|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
20628075|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628076|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628077|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20628078|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
20628079|NCT03605719|Hormones|hormones|mesh-ancestor
20628080|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628081|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20628082|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628083|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628084|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20628085|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628086|NCT03529890|Nivolumab|nivolumab|mesh-list
20628087|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628088|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628089|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20628090|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628091|NCT03451799|Temozolomide|temozolomide|mesh-list
20628092|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20628093|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
20628094|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628095|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628096|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
20628097|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
20628098|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20628099|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20628100|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628101|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628102|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628103|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628104|NCT03417479|Gabapentin|gabapentin|mesh-list
20628105|NCT03417479|Analgesics|analgesics|mesh-ancestor
20628106|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
20628107|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628108|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628109|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
20628110|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20628111|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20628112|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628113|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20628114|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20628115|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20628116|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628117|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628118|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
20628119|NCT03400306|Paclitaxel|paclitaxel|mesh-list
20628120|NCT03400306|Carboplatin|carboplatin|mesh-list
20628121|NCT03400306|Veliparib|veliparib|mesh-list
20628122|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20628123|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628124|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
20628125|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
20628126|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
20628127|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628128|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20628129|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628130|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
20628131|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
20628132|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20628133|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20628134|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628135|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
20628136|NCT03317795|Coagulants|coagulants|mesh-ancestor
20628137|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20628138|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
20628139|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20628140|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628141|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20628142|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20628143|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19696331|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20628144|NCT03214250|Gemcitabine|gemcitabine|mesh-list
20628145|NCT03214250|Paclitaxel|paclitaxel|mesh-list
20628146|NCT03214250|Nivolumab|nivolumab|mesh-list
20628147|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20628148|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628149|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
20628150|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
20628151|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
20628152|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628153|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20628154|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
20628155|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
20628156|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628157|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628158|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628159|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
20628160|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628161|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628162|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20628173|NCT03115294|Theophylline|theophylline|mesh-list
20628174|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20628175|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
20628176|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628177|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628178|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20628179|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
20628180|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20628181|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628182|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628183|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
20628184|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20628185|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20628186|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
20628187|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628188|NCT03087656|Levofloxacin|levofloxacin|mesh-list
20628189|NCT03087656|Ofloxacin|ofloxacin|mesh-list
20628190|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
20628191|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20628192|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628193|NCT03087656|Renal Agents|renal agents|mesh-ancestor
20628194|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20628195|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20628196|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20628197|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628198|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628199|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628200|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20628201|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20628202|NCT03033069|Sertraline|sertraline|mesh-list
20628203|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
20628204|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
20628205|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20628206|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20628207|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20628208|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628209|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628210|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628211|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
20628212|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628213|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
20628214|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
20628215|NCT02946424|Simvastatin|simvastatin|mesh-list
20628216|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20628217|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20628218|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
20628219|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628220|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20628221|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20628222|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628223|NCT02891954|Canagliflozin|canagliflozin|mesh-list
20628224|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20628225|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628226|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20628227|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628228|NCT02863770|Pancrelipase|pancrelipase|mesh-list
20628229|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20628230|NCT02663622|Methotrexate|methotrexate|mesh-list
20628231|NCT02663622|Tacrolimus|tacrolimus|mesh-list
20628232|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20628233|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
20628234|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20628235|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628236|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20628237|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
20628238|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628239|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628240|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
20628241|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628242|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20628243|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628244|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
20628245|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628246|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20628247|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20628248|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
20628249|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628250|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628251|NCT02587598|Cytarabine|cytarabine|mesh-list
20628252|NCT02587598|Azacitidine|azacitidine|mesh-list
20628253|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20628254|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
20628255|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628256|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628257|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
20628258|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628259|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628260|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
20628261|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628262|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628263|NCT02485574|Calcium|calcium|mesh-list
20628264|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20628265|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628266|NCT02350764|Nivolumab|nivolumab|mesh-list
20628267|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628268|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628269|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20628270|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628271|NCT02091934|Dipivefrin|dipivefrin|mesh-list
20628272|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20628273|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
20628274|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628275|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628276|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628277|NCT02023996|Trastuzumab|trastuzumab|mesh-list
20628278|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628279|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628280|NCT01639690|Busulfan|busulfan|mesh-list
20628281|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
20628282|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628283|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628284|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
20628285|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628286|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20628287|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628288|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19411730|NCT03537287|Hormones|hormones|mesh-ancestor
19411731|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628289|NCT01460160|Dasatinib|dasatinib|mesh-list
20628290|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628291|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20628292|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628293|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628294|NCT01291004|Drospirenone|drospirenone|mesh-list
20628295|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20628296|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20628297|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
20628298|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20628299|NCT01291004|Desogestrel|desogestrel|mesh-list
20628300|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
20475100|NCT01509131|Laxatives|laxatives|mesh-ancestor
20475101|NCT01509144|Vaccines|vaccines|mesh-list
20475102|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
20628301|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
20628302|NCT01291004|Estradiol|estradiol|mesh-list
20628303|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20628304|NCT01291004|Estrogens|estrogens|mesh-ancestor
20628305|NCT01291004|Hormones|hormones|mesh-ancestor
20628306|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628307|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628308|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20628309|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20628310|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20628311|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20628312|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20628313|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20628314|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
20628315|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20628316|NCT01291004|Diuretics|diuretics|mesh-ancestor
20628317|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
20628318|NCT01291004|Progestins|progestins|mesh-ancestor
20628319|NCT01170702|Ropivacaine|ropivacaine|mesh-list
20628320|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
20628321|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
20628322|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628323|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628324|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
20628325|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628326|NCT01018563|Farletuzumab|farletuzumab|mesh-list
20628327|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628328|NCT00805961|Bevacizumab|bevacizumab|mesh-list
19696332|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20628329|NCT00805961|Everolimus|everolimus|mesh-list
20628330|NCT00805961|Temozolomide|temozolomide|mesh-list
20628331|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628332|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628333|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20628334|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20628335|NCT00805961|Growth Substances|growth substances|mesh-ancestor
19696333|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696334|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
19696335|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696336|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
19696337|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696338|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696339|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19696340|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
19696341|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696342|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696343|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20475103|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475104|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
20475105|NCT01509209|Ephedrine|ephedrine|mesh-list
20475106|NCT01509209|Levocetirizine|levocetirizine|mesh-list
20475107|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20475108|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20475109|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
20475110|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
20475111|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475112|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628336|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475113|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628337|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
20628338|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696344|NCT04941846|Nimodipine|nimodipine|mesh-list
20628339|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
20628340|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20628341|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
20628342|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628343|NCT00600496|Sirolimus|sirolimus|mesh-list
20628344|NCT00600496|Docetaxel|docetaxel|mesh-list
20628345|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20628346|NCT00600496|Dacarbazine|dacarbazine|mesh-list
20628347|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628348|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
20628349|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
20628350|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
20628351|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628352|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19696345|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19696346|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19696347|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696348|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696349|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19696350|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696351|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
19696352|NCT04941625|Cystatins|cystatins|mesh-list
19696353|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19696354|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
20475114|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20475115|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
20628353|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628354|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20628355|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628356|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20628357|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
20628358|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628359|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
20628360|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628361|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20628362|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
20628363|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
20628364|NCT00374660|Irofulven|irofulven|mesh-list
20628365|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628366|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20628367|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
20628368|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628369|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
20628370|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
20628371|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628372|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628373|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20628374|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
20628375|NCT00109668|Beclomethasone|beclomethasone|mesh-list
20628376|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628377|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
20628378|NCT00109668|Hormones|hormones|mesh-ancestor
20628379|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628380|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628381|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20628382|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
20628383|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
20628384|NCT05152420|Apixaban|apixaban|mesh-list
20628385|NCT05152420|Edoxaban|edoxaban|mesh-list
20628386|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20628387|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
20628388|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20628389|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
20628390|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475116|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475117|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20475118|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
20475119|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
20475120|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20475121|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20475122|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
20628391|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628392|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
20628393|NCT05152355|Budesonide|budesonide|mesh-list
20628394|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628395|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20628396|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
20628397|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628398|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628399|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20628400|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
20628401|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
20628402|NCT05152355|Hormones|hormones|mesh-ancestor
20628403|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628404|NCT05152303|Propofol|propofol|mesh-list
20628405|NCT05152303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19696355|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226491|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20226492|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226493|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20475123|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
20475124|NCT01509261|Lansoprazole|lansoprazole|mesh-list
20475125|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
20475126|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20475127|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475128|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20475129|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475130|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475131|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
20475132|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
20475133|NCT01509300|Rituximab|rituximab|mesh-list
20475134|NCT01509300|Fludarabine|fludarabine|mesh-list
20475135|NCT01509300|Tacrolimus|tacrolimus|mesh-list
20475136|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20475137|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475138|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
20475139|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475140|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20475141|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20475142|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
20475143|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475144|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475145|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20475146|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20475147|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20475148|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475149|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20475150|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20475151|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
20475152|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20475153|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475154|NCT01509365|Clopidogrel|clopidogrel|mesh-list
20475155|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20475156|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20475157|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20475158|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20475159|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
20475160|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475161|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475162|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475163|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20475164|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20475165|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
20475166|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475167|NCT01509469|Caseins|caseins|mesh-list
20475168|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
20226494|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20226495|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
20226496|NCT00346853|Fomepizole|fomepizole|mesh-list
20226497|NCT00346853|Antidotes|antidotes|mesh-ancestor
20226498|NCT00346853|Protective Agents|protective agents|mesh-ancestor
20226499|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226500|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226501|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226502|NCT00346866|Anecortave|anecortave|mesh-list
20226503|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20475169|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
20628406|NCT05152303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628407|NCT05152303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628408|NCT05152303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20628409|NCT05152303|Anesthetics, General|anesthetics, general|mesh-ancestor
20628410|NCT05152303|Anesthetics|anesthetics|mesh-ancestor
20628411|NCT05152264|Analgesics|analgesics|mesh-list
20628412|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
20628413|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628414|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628415|NCT05152186|Disinfectants|disinfectants|mesh-list
20628416|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628417|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20628418|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20628419|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20628420|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628421|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628422|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
20628423|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628424|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628425|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20628426|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628427|NCT05151796|Aspirin|aspirin|mesh-list
20628428|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20628429|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20628430|NCT05151796|Analgesics|analgesics|mesh-ancestor
20628431|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
20628432|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628433|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628434|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628435|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628436|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20628437|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20628438|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628439|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20628440|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20628441|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628442|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
19411732|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411733|NCT03537196|Ribavirin|ribavirin|mesh-list
20628443|NCT05151679|Iron|iron|mesh-list
20628444|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20628445|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
20628446|NCT05151679|Trace Elements|trace elements|mesh-ancestor
20628447|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
20628448|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628449|NCT05151679|Hematinics|hematinics|mesh-ancestor
20628450|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
20628451|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
20628452|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628453|NCT05151614|Colchicine|colchicine|mesh-list
20628454|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
20628455|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628456|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
20628457|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
20628458|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
20628459|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628460|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628461|NCT05151549|Carboplatin|carboplatin|mesh-list
20628462|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628463|NCT05151510|Lidocaine|lidocaine|mesh-list
20628464|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
20628465|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
20628466|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628467|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628468|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
20628469|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628470|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20628471|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20628472|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20628473|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628474|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628475|NCT05151393|Vitamin D|vitamin d|mesh-list
20628476|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
20628477|NCT05151393|Vitamins|vitamins|mesh-ancestor
20628478|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
20628479|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628480|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20628481|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20628482|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
20628483|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628484|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
20628485|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
20628486|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
20628487|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20628488|NCT05151016|Mifepristone|mifepristone|mesh-list
20628489|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20628490|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
20628491|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20628492|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628493|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20628494|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20628495|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20628496|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
20628497|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20628498|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20628499|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
20628500|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628501|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
20628502|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20628503|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20628504|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20628505|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475170|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475171|NCT01509521|Phenylephrine|phenylephrine|mesh-list
20475172|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
20475173|NCT01509521|Ephedrine|ephedrine|mesh-list
20475174|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
20475175|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20475176|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
20475177|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
20475178|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475179|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475180|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
20475181|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20628506|NCT05150899|Fexofenadine|fexofenadine|mesh-list
20628507|NCT05150899|Tamsulosin|tamsulosin|mesh-list
20628508|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20628509|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20628510|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20628511|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
20628512|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628513|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628514|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628515|NCT05150899|Urological Agents|urological agents|mesh-ancestor
20628516|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20628517|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20628518|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20628519|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
20628520|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
20628521|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
20628522|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20628523|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20628524|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
20628525|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628526|NCT05133817|Norepinephrine|norepinephrine|mesh-list
20628527|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20628528|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20628529|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20628530|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
20628531|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628532|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628533|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628534|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
20628535|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
20628536|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628537|NCT05108740|Everolimus|everolimus|mesh-list
20628538|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628539|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628540|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
20628541|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628542|NCT05076513|Niraparib|niraparib|mesh-list
20628543|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20628544|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628545|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628546|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628547|NCT05051891|Prednisone|prednisone|mesh-list
20628548|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
20628549|NCT05051891|Vincristine|vincristine|mesh-list
20628550|NCT05051891|Rituximab|rituximab|mesh-list
20628551|NCT05051891|Doxorubicin|doxorubicin|mesh-list
20628552|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628553|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
20628554|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628555|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628556|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20628557|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
20628558|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628559|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628560|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20628561|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628562|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
20628563|NCT05051891|Hormones|hormones|mesh-ancestor
20628564|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628565|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20628566|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20628567|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
20628568|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
20628569|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
20628570|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628571|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20628572|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20628573|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20628574|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628575|NCT04998981|Fenofibrate|fenofibrate|mesh-list
20628576|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20628577|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
20628578|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628579|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20628580|NCT04991350|Bevacizumab|bevacizumab|mesh-list
20628581|NCT04991350|Ranibizumab|ranibizumab|mesh-list
20628582|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628583|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628584|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20628585|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20628586|NCT04991350|Growth Substances|growth substances|mesh-ancestor
20628587|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628588|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
20628589|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20628590|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20628591|NCT04940572|Valproic Acid|valproic acid|mesh-list
20628592|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
20628593|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628594|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628595|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
20628596|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628597|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628598|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
20628599|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20628600|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628601|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20628602|NCT04933058|Acetaminophen|acetaminophen|mesh-list
20628603|NCT04933058|Fentanyl|fentanyl|mesh-list
20628604|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20628605|NCT04933058|Narcotics|narcotics|mesh-ancestor
20628606|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628607|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628608|NCT04933058|Analgesics|analgesics|mesh-ancestor
20475182|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
20475183|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
20475184|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20475185|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20475186|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20475187|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
20475188|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475189|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475190|NCT01509521|Protective Agents|protective agents|mesh-ancestor
20628609|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
20628610|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628611|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20628612|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20628613|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
20628614|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
20628615|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20628616|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
20628617|NCT04924062|Gemcitabine|gemcitabine|mesh-list
20628618|NCT04924062|Cisplatin|cisplatin|mesh-list
20628619|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
20628620|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628621|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20628622|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
20628623|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628624|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
20628625|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628626|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628627|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628628|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
20628629|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628630|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20475191|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20628631|NCT04899583|Sirolimus|sirolimus|mesh-list
20628632|NCT04899583|Paclitaxel|paclitaxel|mesh-list
20628633|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20628634|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628635|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
20628636|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
20628637|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
20628638|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628639|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20628640|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628641|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20628642|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
20628643|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628644|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
20628645|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628646|NCT04891991|Infliximab|infliximab|mesh-list
20628647|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
20628648|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20628649|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628650|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
20628651|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628652|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628653|NCT04777851|Nivolumab|nivolumab|mesh-list
20628654|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628655|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628656|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20628657|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628658|NCT04761887|Ropivacaine|ropivacaine|mesh-list
20628659|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
20628660|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
20628661|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628662|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628663|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
20628664|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628665|NCT04750759|Niclosamide|niclosamide|mesh-list
20628666|NCT04750759|Camostat|camostat|mesh-list
20628667|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
19696356|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696357|NCT04941573|Xenon|xenon|mesh-list
19696358|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20628668|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628669|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628670|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20628671|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20628672|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
20628673|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20628674|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
20226504|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20226505|NCT00346866|Growth Substances|growth substances|mesh-ancestor
20628675|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20628676|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628677|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
20628678|NCT04720716|Sorafenib|sorafenib|mesh-list
20628679|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628680|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20628681|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628682|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628683|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20628684|NCT04602975|Vaccines|vaccines|mesh-list
20628685|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
20628686|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696359|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
20628687|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20628688|NCT04602975|Antacids|antacids|mesh-ancestor
20628689|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628690|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19411734|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
19696360|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
19696361|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696362|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411735|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
19411736|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411737|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
20226506|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628691|NCT04597372|Tamsulosin|tamsulosin|mesh-list
20628692|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20628693|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20628694|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20628695|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
20628696|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628697|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628698|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628699|NCT04597372|Urological Agents|urological agents|mesh-ancestor
20628700|NCT04574154|Anesthetics|anesthetics|mesh-list
20628701|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628702|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628703|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
20628704|NCT04558866|Testosterone|testosterone|mesh-list
20628705|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
20628706|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
20628707|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20628708|NCT04558866|Androgens|androgens|mesh-ancestor
20628709|NCT04558866|Hormones|hormones|mesh-ancestor
20628710|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628711|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628712|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20628713|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628714|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
20628715|NCT04556370|Norepinephrine|norepinephrine|mesh-list
20628716|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20628717|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20628718|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
20628719|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628720|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628721|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628722|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
20628723|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
20628724|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628725|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20628726|NCT04526821|Lactoferrin|lactoferrin|mesh-list
20628727|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628728|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20628729|NCT04445389|Vaccines|vaccines|mesh-list
20628730|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
20628731|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628732|NCT04365088|Deflazacort|deflazacort|mesh-list
20628733|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411738|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411739|NCT03537157|Rifaximin|rifaximin|mesh-list
19411740|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19411741|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628734|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628735|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
20628736|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628737|NCT04349579|Rifamycins|rifamycins|mesh-list
20628738|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
20628739|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20628740|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628741|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628742|NCT04234529|Caffeine|caffeine|mesh-list
19411742|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19411743|NCT03537144|Acetaminophen|acetaminophen|mesh-list
20628743|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20628744|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628745|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20628746|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628747|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628748|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20628749|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20628750|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
20628751|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628752|NCT04217954|Bevacizumab|bevacizumab|mesh-list
20628753|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628754|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411744|NCT03537144|Indomethacin|indomethacin|mesh-list
20628755|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20628756|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20628757|NCT04217954|Growth Substances|growth substances|mesh-ancestor
19411745|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19411746|NCT03537144|Analgesics|analgesics|mesh-ancestor
20226507|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
20628758|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628759|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
20628760|NCT04192110|Diuretics|diuretics|mesh-list
20628761|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
20628762|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628763|NCT04182100|Aspirin|aspirin|mesh-list
20628764|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20628765|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20628766|NCT04182100|Analgesics|analgesics|mesh-ancestor
20628767|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
20628768|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628769|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628770|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628771|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20628772|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20628773|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20628774|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628775|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20628776|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20628777|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628778|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
20628779|NCT04179019|Amlodipine|amlodipine|mesh-list
20628780|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20628781|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20628782|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628783|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628784|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20628785|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628786|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
20628787|NCT04084717|Crizotinib|crizotinib|mesh-list
20628788|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628789|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20628790|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628791|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628792|NCT04056182|Lofexidine|lofexidine|mesh-list
20628793|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20628794|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20628795|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628796|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
20628797|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628798|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20628799|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20628800|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20628801|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
20628802|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628803|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628804|NCT04049851|Ivermectin|ivermectin|mesh-list
20628805|NCT04049851|Moxidectin|moxidectin|mesh-list
20628806|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20628807|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628808|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
20628809|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
19411747|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
20628810|NCT03966625|Autoantibodies|autoantibodies|mesh-list
20628811|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
20628812|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628813|NCT03961568|Cenobamate|cenobamate|mesh-list
20628814|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
20628815|NCT03959358|Lenalidomide|lenalidomide|mesh-list
20628816|NCT03959358|Pomalidomide|pomalidomide|mesh-list
20628817|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
20628818|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628819|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20628820|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20628821|NCT03959358|Growth Substances|growth substances|mesh-ancestor
20628822|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
20628823|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628824|NCT03954106|Defibrotide|defibrotide|mesh-list
20628825|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20628826|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20628827|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628828|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20628829|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
20628830|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628831|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
20628832|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628833|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628834|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20628835|NCT03944356|Trametinib|trametinib|mesh-list
20628836|NCT03944356|Dabrafenib|dabrafenib|mesh-list
20628837|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628838|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20628839|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628840|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628841|NCT03930498|Antibodies|antibodies|mesh-list
20628842|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
20628843|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
20628844|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628845|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20628846|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
20628847|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628848|NCT03831932|Osimertinib|osimertinib|mesh-list
20628849|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628850|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20628851|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628852|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628853|NCT03817554|Dopamine|dopamine|mesh-list
20628854|NCT03817554|Pramipexole|pramipexole|mesh-list
20628855|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
20628856|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
20628857|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628858|NCT03817554|Protective Agents|protective agents|mesh-ancestor
19411748|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411749|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411750|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
19411751|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20475192|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20475193|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20475194|NCT01509560|Everolimus|everolimus|mesh-list
20475195|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475196|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475197|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
20475198|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475199|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
20475200|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20475201|NCT01509742|Liraglutide|liraglutide|mesh-list
20475202|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475203|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475204|NCT01509742|Incretins|incretins|mesh-ancestor
20475205|NCT01509742|Hormones|hormones|mesh-ancestor
20475206|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475207|NCT01509755|Liraglutide|liraglutide|mesh-list
20475208|NCT01509755|Glimepiride|glimepiride|mesh-list
20475209|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475210|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475211|NCT01509755|Incretins|incretins|mesh-ancestor
20475212|NCT01509755|Hormones|hormones|mesh-ancestor
20527456|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20628859|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475213|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475214|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20475215|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475216|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
20527457|NCT01768351|Vitamins|vitamins|mesh-ancestor
20527458|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
20527459|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20527460|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20527461|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20527462|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527463|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20527464|NCT01768364|Renal Agents|renal agents|mesh-ancestor
20527465|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
20527466|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20527467|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20527468|NCT01768377|Lidocaine|lidocaine|mesh-list
20527469|NCT01768377|Fentanyl|fentanyl|mesh-list
20527470|NCT01768377|Midazolam|midazolam|mesh-list
20527471|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
20527472|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
20527473|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20527474|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527475|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
20527476|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527477|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20527478|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20527479|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20527480|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527481|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527482|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20527483|NCT01768377|Narcotics|narcotics|mesh-ancestor
20527484|NCT01768377|Analgesics|analgesics|mesh-ancestor
20527485|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20527486|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20527487|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
20527488|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20527489|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20527490|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20527491|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20527492|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
20527493|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
20527494|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527495|NCT01768390|Fluorides|fluorides|mesh-list
20527496|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
20527497|NCT01768390|Protective Agents|protective agents|mesh-ancestor
20527498|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527499|NCT01768455|Glimepiride|glimepiride|mesh-list
20527500|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20527501|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20527502|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527503|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527504|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
20527505|NCT01768481|Atorvastatin|atorvastatin|mesh-list
20527506|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20527507|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20527508|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
20527509|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527510|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20527511|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20527512|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527513|NCT01768507|Resveratrol|resveratrol|mesh-list
20527514|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
20527515|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527516|NCT01768507|Protective Agents|protective agents|mesh-ancestor
20527517|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527518|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527519|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20527520|NCT01768663|Itraconazole|itraconazole|mesh-list
20527521|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
20527522|NCT01768663|Rifampin|rifampin|mesh-list
20527523|NCT01768663|Ivacaftor|ivacaftor|mesh-list
20527524|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
20527525|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527526|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20628860|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20628861|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20628862|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
20628863|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628864|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20628865|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
20628866|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
20628867|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628868|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
20628869|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628870|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
20628871|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628872|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628873|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20628874|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
20628875|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20628876|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628877|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20628878|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628879|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
20628880|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20628881|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
20628882|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
20628883|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628884|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628885|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20628886|NCT03736538|Analgesics|analgesics|mesh-ancestor
20628887|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
20628888|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628889|NCT03717896|Thiamine|thiamine|mesh-list
20628890|NCT03717896|Vitamins|vitamins|mesh-ancestor
20628891|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
20628892|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628893|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
20628894|NCT03678753|Cenobamate|cenobamate|mesh-list
20628895|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
20628896|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
20628897|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20628898|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20628899|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20628900|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628901|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628902|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
20628903|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628904|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628905|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20628906|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628907|NCT03593252|Metronidazole|metronidazole|mesh-list
20628908|NCT03593252|Cefazolin|cefazolin|mesh-list
20628909|NCT03593252|Neomycin|neomycin|mesh-list
20628910|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
20628911|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
20628912|NCT03593252|Citric Acid|citric acid|mesh-list
20628913|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
20628914|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20628915|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20628916|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20628917|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20628918|NCT03593252|Cathartics|cathartics|mesh-ancestor
20628919|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20628920|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
20628921|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20628922|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
20628923|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
20628924|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628925|NCT03593252|Antacids|antacids|mesh-ancestor
20628926|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20628927|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628928|NCT03582488|Corticosterone|corticosterone|mesh-list
20628929|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20628930|NCT03574792|Oxycodone|oxycodone|mesh-list
19696363|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20628931|NCT03574792|Methadone|methadone|mesh-list
20628932|NCT03574792|Gabapentin|gabapentin|mesh-list
20628933|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20628934|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20628935|NCT03574792|Narcotics|narcotics|mesh-ancestor
20628936|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20628937|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628938|NCT03574792|Analgesics|analgesics|mesh-ancestor
20628939|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
20628940|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628941|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
20628942|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20628943|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20628944|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20628945|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20628946|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20628947|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20628948|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628949|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
20628950|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
20628951|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
20628952|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20628953|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20628954|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20628955|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20628956|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
20628957|NCT03450707|Thiamine|thiamine|mesh-list
20628958|NCT03450707|Vitamins|vitamins|mesh-ancestor
20628959|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
20628960|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628961|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
20628962|NCT03391479|Avelumab|avelumab|mesh-list
20628963|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20628964|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20628965|NCT03368066|Cosyntropin|cosyntropin|mesh-list
20628966|NCT03368066|Hormones|hormones|mesh-ancestor
20628967|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20628968|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628969|NCT03365622|Acetaminophen|acetaminophen|mesh-list
20628970|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20628971|NCT03365622|Analgesics|analgesics|mesh-ancestor
20628972|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
20628973|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20628974|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628975|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
20628976|NCT03356483|Niacin|niacin|mesh-list
20628977|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
20628978|NCT03356483|Psilocybin|psilocybin|mesh-list
20628979|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20628980|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
20628981|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628982|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20628983|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
20628984|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
20628985|NCT03356483|Vitamins|vitamins|mesh-ancestor
20628986|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
20628987|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628988|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
20628989|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20628990|NCT03289650|Tacrolimus|tacrolimus|mesh-list
20628991|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20628992|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
20628993|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20628994|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20628995|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20628996|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20628997|NCT03276052|Bromides|bromides|mesh-list
20628998|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
20628999|NCT03275857|Cisplatin|cisplatin|mesh-list
20629000|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629001|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
20629002|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20629003|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629004|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629005|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629006|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20629007|NCT03219437|Methotrexate|methotrexate|mesh-list
20629008|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20629009|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
20629010|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20629011|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629012|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20629013|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
20629014|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629015|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629016|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20629017|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629018|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20629019|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629020|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
20629021|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20629022|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19411752|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411753|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411754|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
19411755|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
19411756|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411757|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19411758|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411759|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411760|NCT03537027|Vitamin D|vitamin d|mesh-list
20629023|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
20629024|NCT03202537|Lansoprazole|lansoprazole|mesh-list
20629025|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20629026|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629027|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20629028|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629029|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629030|NCT03150511|Tesamorelin|tesamorelin|mesh-list
20629031|NCT03150511|Growth Substances|growth substances|mesh-ancestor
20629032|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629033|NCT03042819|Doxorubicin|doxorubicin|mesh-list
20629034|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20629035|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629036|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20629037|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20629038|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629039|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629040|NCT03030222|Empagliflozin|empagliflozin|mesh-list
20629041|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20629042|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629043|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20629044|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411761|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
20475217|NCT01509911|Gemcitabine|gemcitabine|mesh-list
20629045|NCT02892604|Insulin|insulin|mesh-list
20629046|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20629047|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629048|NCT02832687|Acetaminophen|acetaminophen|mesh-list
20629049|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20629050|NCT02832687|Analgesics|analgesics|mesh-ancestor
20629051|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
20629052|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475218|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20475219|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
19850505|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226508|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226509|NCT00346879|PENTA|penta|mesh-list
20475220|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475221|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475222|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
20475223|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411762|NCT03537027|Vitamins|vitamins|mesh-ancestor
19411763|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
20226510|NCT00346879|Fondaparinux|fondaparinux|mesh-list
20226511|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20475224|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475225|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850506|NCT00710385|Analgesics|analgesics|mesh-ancestor
20226512|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
20226513|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20226514|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
20226515|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226516|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226517|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
20226518|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20226519|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20226520|NCT00346918|Sirolimus|sirolimus|mesh-list
20226521|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20629053|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629054|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
20629055|NCT02830477|Factor VIII|factor viii|mesh-list
20629056|NCT02830477|Coagulants|coagulants|mesh-ancestor
20629057|NCT02789345|Osimertinib|osimertinib|mesh-list
20629058|NCT02789345|Ramucirumab|ramucirumab|mesh-list
20629059|NCT02789345|Necitumumab|necitumumab|mesh-list
20629060|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629061|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20629062|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629063|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629064|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629065|NCT02703220|Acetazolamide|acetazolamide|mesh-list
20629066|NCT02703220|Finasteride|finasteride|mesh-list
20629067|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
20629068|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20629069|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475226|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
20629070|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629071|NCT02703220|Diuretics|diuretics|mesh-ancestor
20629072|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
20629073|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629074|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20629075|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20629076|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
20629077|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629078|NCT02703220|Urological Agents|urological agents|mesh-ancestor
20629093|NCT02568449|Nintedanib|nintedanib|mesh-list
20629094|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629095|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20629096|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629097|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629098|NCT02546622|Factor VIII|factor viii|mesh-list
20629099|NCT02546622|Coagulants|coagulants|mesh-ancestor
20629100|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
20629101|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
20629102|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20629103|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
20629104|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629105|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629106|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20475227|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475228|NCT01509976|Triclosan|triclosan|mesh-list
20475229|NCT01509976|Triclocarban|triclocarban|mesh-list
20475230|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20475231|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475232|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20475233|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20475234|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
20475235|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475236|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20475237|NCT01510015|Risperidone|risperidone|mesh-list
20629107|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
20629108|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629109|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
20629110|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629111|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629112|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20629113|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20629114|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
20629115|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629116|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629117|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20629118|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20629119|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20629120|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
20629121|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629122|NCT01530997|Cisplatin|cisplatin|mesh-list
20629123|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629124|NCT01331616|Bevacizumab|bevacizumab|mesh-list
20629125|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629126|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629127|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20629128|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20629129|NCT01331616|Growth Substances|growth substances|mesh-ancestor
20629130|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629131|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
20629132|NCT01109004|Dexamethasone|dexamethasone|mesh-list
20629133|NCT01109004|Lenalidomide|lenalidomide|mesh-list
20629134|NCT01109004|Bortezomib|bortezomib|mesh-list
20629135|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629136|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
20629137|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
20629138|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629139|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629140|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629141|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
20629142|NCT01109004|Hormones|hormones|mesh-ancestor
20629143|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629144|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20629145|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629146|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
20629147|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20629148|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20629149|NCT01109004|Growth Substances|growth substances|mesh-ancestor
20629150|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
20629151|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
20629152|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
19411764|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411765|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19411766|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411767|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
20475238|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20475239|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
20475240|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475241|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475242|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475243|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20475244|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20475245|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475246|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20475247|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20475248|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
20475249|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
20475250|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475251|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475252|NCT01510132|Timolol|timolol|mesh-list
20475253|NCT01510132|Travoprost|travoprost|mesh-list
20475254|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20475255|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20475256|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
20475257|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475258|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629153|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20629154|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
20629155|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629156|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629157|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20629158|NCT00593905|Bosentan|bosentan|mesh-list
20629159|NCT00593905|Ambrisentan|ambrisentan|mesh-list
20629160|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
20629161|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19411768|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
19411769|NCT03536910|Coagulants|coagulants|mesh-ancestor
19411770|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20629162|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20629163|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629164|NCT00548912|Spironolactone|spironolactone|mesh-list
20629165|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20629166|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
20629167|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629168|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629169|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20629170|NCT00548912|Diuretics|diuretics|mesh-ancestor
20226522|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226523|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20226524|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226525|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
20226526|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226527|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
20226528|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226529|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
20226530|NCT00346957|Anecortave|anecortave|mesh-list
20226531|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226532|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20226533|NCT00346957|Growth Substances|growth substances|mesh-ancestor
20226534|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226535|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
20475259|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629171|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
20629172|NCT00501826|Cytarabine|cytarabine|mesh-list
20629173|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
20629174|NCT00501826|Dexamethasone|dexamethasone|mesh-list
20629175|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
20629176|NCT00501826|Prednisone|prednisone|mesh-list
20629177|NCT00501826|Cortisone|cortisone|mesh-list
20629178|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
20629179|NCT00501826|Doxorubicin|doxorubicin|mesh-list
20629180|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20629181|NCT00501826|Methotrexate|methotrexate|mesh-list
20629182|NCT00501826|Vincristine|vincristine|mesh-list
20629183|NCT00501826|Asparaginase|asparaginase|mesh-list
20629184|NCT00501826|Venetoclax|venetoclax|mesh-list
20629185|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
20629186|NCT00501826|Pegaspargase|pegaspargase|mesh-list
20629187|NCT00501826|BB 1101|bb 1101|mesh-list
20629188|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629189|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
20629190|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629191|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20629192|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20629193|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
20629194|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629195|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629196|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20629197|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629198|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
20629199|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
20629200|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629201|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629202|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
20629203|NCT00501826|Hormones|hormones|mesh-ancestor
20629204|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629205|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19411771|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19411772|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
20475260|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20475261|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20475262|NCT01510171|Ticagrelor|ticagrelor|mesh-list
20475263|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20475264|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20475265|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20629206|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
20629207|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629208|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20629209|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20629210|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20629211|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20629212|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
20629213|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20629214|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20629215|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
20629216|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
20629217|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20629218|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20629219|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
20629220|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629221|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20629222|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
20629223|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
20629224|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
20629225|NCT05153928|Norethindrone|norethindrone|mesh-list
20629226|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
20629227|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20629228|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20629229|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20629230|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
20629231|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20629232|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629233|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20629234|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20629235|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20629236|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
20629237|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629238|NCT05153785|Lidocaine|lidocaine|mesh-list
20629239|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
20629240|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
20629241|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629242|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629243|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
20629244|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629245|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20629246|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20629247|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20629248|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20629249|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629250|NCT05153668|Everolimus|everolimus|mesh-list
20629251|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629252|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629253|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
20629254|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629255|NCT05153603|Olaparib|olaparib|mesh-list
20629256|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20629257|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629258|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629259|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629260|NCT05153486|Ethanol|ethanol|mesh-list
20629261|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20629262|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629263|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629264|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629265|NCT05153304|Nivolumab|nivolumab|mesh-list
20629266|NCT05153304|Ipilimumab|ipilimumab|mesh-list
20629267|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629268|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629269|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20629270|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629271|NCT05153200|Adalimumab|adalimumab|mesh-list
20629272|NCT05153200|Upadacitinib|upadacitinib|mesh-list
20629273|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629274|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20629275|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20629276|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20629277|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629278|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629279|NCT05153070|Cyclosporine|cyclosporine|mesh-list
20629280|NCT05153070|Cyclosporins|cyclosporins|mesh-list
20629281|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629282|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629283|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629284|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
20629285|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629286|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
20629287|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629288|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
20629289|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20629290|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20629291|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
20629292|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20629293|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629294|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20629295|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629296|NCT05152901|Epinephrine|epinephrine|mesh-list
20629297|NCT05152901|Racepinephrine|racepinephrine|mesh-list
20629298|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
20629299|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20629300|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20629301|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
20629302|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629303|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629304|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629305|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20629306|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20629307|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
20629308|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629309|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20629310|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
20629311|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
20629312|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
20629313|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20629314|NCT05152667|Dienogest|dienogest|mesh-list
20629315|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
20629316|NCT05152667|Progestins|progestins|mesh-list
20629317|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20629318|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
20629319|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20629320|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629321|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20629322|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20629323|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20629324|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20629325|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20629326|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
20629327|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629328|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20629329|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629330|NCT05152667|Hormones|hormones|mesh-ancestor
20629331|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
20629332|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20629333|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629334|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629335|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20629336|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20629337|NCT05152511|Protective Agents|protective agents|mesh-ancestor
20226536|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629338|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629339|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
20629340|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20629341|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
20629342|NCT05132985|Carboplatin|carboplatin|mesh-list
20629343|NCT05132985|Pemetrexed|pemetrexed|mesh-list
20629344|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629345|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629346|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629347|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20629348|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19411773|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411774|NCT03536845|Vitamin D|vitamin d|mesh-list
19411775|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
19411776|NCT03536845|Vitamins|vitamins|mesh-ancestor
19411777|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
19411778|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850507|NCT00710424|Nabiximols|nabiximols|mesh-list
20629349|NCT05118399|Bupivacaine|bupivacaine|mesh-list
20629350|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
20629351|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
20629352|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629353|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629354|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
20629355|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629356|NCT05095922|Valsartan|valsartan|mesh-list
20629357|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
20475266|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20475267|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20629358|NCT05095922|Calcium|calcium|mesh-list
20629359|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20629360|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629361|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20629362|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20629363|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20629364|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629365|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
20629366|NCT05095922|Coagulants|coagulants|mesh-ancestor
19411779|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19411780|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411781|NCT03536806|Canrenone|canrenone|mesh-list
19411782|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19411783|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
19411784|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411785|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411786|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19411787|NCT03536806|Diuretics|diuretics|mesh-ancestor
19411788|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
19411789|NCT03536780|Gemcitabine|gemcitabine|mesh-list
19411790|NCT03536780|Avelumab|avelumab|mesh-list
19411791|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20475268|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
20475269|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475270|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475271|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475272|NCT01510288|Ipilimumab|ipilimumab|mesh-list
20475273|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629367|NCT05010304|Amoxicillin|amoxicillin|mesh-list
20629368|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20629369|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629370|NCT04947631|Tadalafil|tadalafil|mesh-list
20629371|NCT04947631|Dutasteride|dutasteride|mesh-list
20629372|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
20629373|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20629374|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20629375|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629376|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629377|NCT04947631|Urological Agents|urological agents|mesh-ancestor
20629378|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20629379|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20629380|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
20629381|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629382|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629383|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
20629384|NCT04905316|Durvalumab|durvalumab|mesh-list
20629385|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629386|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629387|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
20475274|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475275|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20475276|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475277|NCT01510366|Vaccines|vaccines|mesh-list
20475278|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
20475279|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475280|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
20475281|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475282|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
20475283|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475284|NCT01510509|Everolimus|everolimus|mesh-list
20629388|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629389|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629390|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
20629391|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20629392|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
20629393|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
20629394|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629395|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629396|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20629397|NCT04884893|Analgesics|analgesics|mesh-ancestor
20629398|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
20629399|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629400|NCT04877379|Ceftibuten|ceftibuten|mesh-list
20629401|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20629402|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629403|NCT04778267|Dexamethasone|dexamethasone|mesh-list
20629404|NCT04778267|Bupivacaine|bupivacaine|mesh-list
20629405|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20629406|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629407|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
20629408|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
20629409|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629410|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629411|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629412|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
20629413|NCT04778267|Hormones|hormones|mesh-ancestor
20629414|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629415|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20629416|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629417|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
20629418|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
20629419|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226537|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226538|NCT00346970|Niacin|niacin|mesh-list
20226539|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20226540|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
20226541|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226542|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20226543|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
20226544|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
20226545|NCT00346970|Vitamins|vitamins|mesh-ancestor
20226546|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
20475285|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475286|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629420|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
20629421|NCT04760717|Spironolactone|spironolactone|mesh-list
20629422|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20629423|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
20629424|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629425|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629426|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20629427|NCT04760717|Diuretics|diuretics|mesh-ancestor
20629428|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
20629429|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
20629430|NCT04702256|Prednisone|prednisone|mesh-list
20629431|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
20629432|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20629433|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20629434|NCT04702256|Prednisolone|prednisolone|mesh-list
20629435|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
20629436|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
20629437|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20629438|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
20629439|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20629440|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629441|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
20226547|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226548|NCT00346996|Insulin|insulin|mesh-list
20226549|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20226550|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
20629442|NCT04702256|Hormones|hormones|mesh-ancestor
20629443|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629444|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629445|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20629446|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629447|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20629448|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20629449|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
20629450|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20629451|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629452|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629453|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629454|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
20629455|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
20629456|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629457|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629458|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20629459|NCT04702256|Protective Agents|protective agents|mesh-ancestor
20629460|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629461|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20629462|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
20629463|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
20629464|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629465|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
20629466|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
20629467|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629468|NCT05259709|Cemiplimab|cemiplimab|mesh-list
20629469|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629470|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629471|NCT05259319|Atezolizumab|atezolizumab|mesh-list
20629472|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629473|NCT05259241|Thrombin|thrombin|mesh-list
20629474|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
20629475|NCT05259241|Coagulants|coagulants|mesh-ancestor
20629476|NCT05259137|Enalapril|enalapril|mesh-list
20629477|NCT05259137|Enalaprilat|enalaprilat|mesh-list
20629478|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20629479|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
20629480|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629481|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629482|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20629483|NCT05259098|Sufentanil|sufentanil|mesh-list
20629484|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20629485|NCT05259098|Narcotics|narcotics|mesh-ancestor
20629486|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411792|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
19411793|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411794|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226551|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
20629487|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629488|NCT05259098|Analgesics|analgesics|mesh-ancestor
19411795|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
19411796|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475287|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
19850508|NCT00710424|Analgesics|analgesics|mesh-ancestor
19850509|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
19850510|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850511|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850512|NCT00710554|Nabiximols|nabiximols|mesh-list
19850513|NCT00710554|Analgesics|analgesics|mesh-ancestor
19411797|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411798|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19411799|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
19411800|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411801|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19411802|NCT03536741|Anesthetics|anesthetics|mesh-list
19411803|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
19411804|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411805|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411806|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
19411807|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19411808|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19411809|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411810|NCT03536611|Warfarin|warfarin|mesh-list
19411811|NCT03536611|Dabigatran|dabigatran|mesh-list
19411812|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
19850514|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
19850515|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850516|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850517|NCT00710606|NuvaRing|nuvaring|mesh-list
19850518|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19850519|NCT00710606|Desogestrel|desogestrel|mesh-list
19850520|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20475288|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411813|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
19411814|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19411815|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
19411816|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411817|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850521|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
20475289|NCT01510522|Metformin|metformin|mesh-list
20475290|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475291|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475292|NCT01510548|Adalimumab|adalimumab|mesh-list
20475293|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475294|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20475295|NCT01510561|Gemcitabine|gemcitabine|mesh-list
20475296|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20475297|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
20475298|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20475299|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
20475300|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475301|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475302|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
20475303|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475304|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475305|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475306|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
20475307|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475308|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
20475309|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
20475310|NCT01510574|Misoprostol|misoprostol|mesh-list
20475311|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20475312|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
20475313|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20475314|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475315|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20475316|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475317|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
20475318|NCT01510613|Dexamethasone|dexamethasone|mesh-list
20475319|NCT01510613|Pomalidomide|pomalidomide|mesh-list
20475320|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475321|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
20475322|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
20475323|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475324|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475325|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19411818|NCT03536598|Amlodipine|amlodipine|mesh-list
19411819|NCT03536598|Valsartan|valsartan|mesh-list
19411820|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19411821|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19411822|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19411823|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19411824|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411825|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20629489|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
20629490|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629491|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20629492|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20629493|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
20629494|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
20629495|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
20629496|NCT05259046|Vitamin K|vitamin k|mesh-list
20629497|NCT05259046|Vitamin MK 7|vitamin mk 7|mesh-list
20629498|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20629499|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20629500|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629501|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
20629502|NCT05259046|Coagulants|coagulants|mesh-ancestor
20629503|NCT05259046|Vitamins|vitamins|mesh-ancestor
20629504|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
20629505|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411826|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850522|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20475326|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
20475327|NCT01510613|Hormones|hormones|mesh-ancestor
20475328|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475329|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20475330|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475331|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
20475332|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20475333|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20475334|NCT01510613|Growth Substances|growth substances|mesh-ancestor
20475335|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
20475336|NCT01510626|Omalizumab|omalizumab|mesh-list
20475337|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20226552|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
20226553|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
20226554|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20226555|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226556|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20226557|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20226558|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20226559|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20226560|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20226561|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226562|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226563|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226564|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629506|NCT05259007|Amoxicillin|amoxicillin|mesh-list
20629507|NCT05259007|Clarithromycin|clarithromycin|mesh-list
20629508|NCT05259007|Propolis|propolis|mesh-list
20629509|NCT05259007|Lansoprazole|lansoprazole|mesh-list
20629510|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
20629511|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20629512|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629513|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20629514|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629515|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629516|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20629517|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20629518|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20629519|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629520|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20629521|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
20629522|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20629523|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20629524|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629525|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
20629526|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
20629527|NCT05258799|Cytarabine|cytarabine|mesh-list
20629528|NCT05258799|Decitabine|decitabine|mesh-list
20629529|NCT05258799|Aclarubicin|aclarubicin|mesh-list
20629530|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20629531|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
20629532|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629533|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629534|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
20629535|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629536|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226565|NCT00347048|Tacrolimus|tacrolimus|mesh-list
20226566|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226567|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
20226568|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226569|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20226570|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226571|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226572|NCT00347087|Irbesartan|irbesartan|mesh-list
20629537|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
20629538|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629539|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629540|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20629541|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20629542|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20629543|NCT05258721|Fluorides|fluorides|mesh-list
20629544|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
20629545|NCT05258721|Protective Agents|protective agents|mesh-ancestor
20629546|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629547|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
20629548|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20629549|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
20629550|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629551|NCT05258682|Expectorants|expectorants|mesh-ancestor
20629552|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
20629553|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20629554|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
20629555|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629556|NCT05258682|Protective Agents|protective agents|mesh-ancestor
20629557|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629558|NCT05258682|Antidotes|antidotes|mesh-ancestor
20629559|NCT05258565|Plasminogen|plasminogen|mesh-list
20629560|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20629561|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20629562|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20629563|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629564|NCT05258474|Niacinamide|niacinamide|mesh-list
20629565|NCT05258474|Niacin|niacin|mesh-list
20629566|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
20629567|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
20629568|NCT05258474|Vitamins|vitamins|mesh-ancestor
19707864|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226573|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20629569|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
20629570|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629571|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20629572|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
20629573|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629574|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20629575|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
20629576|NCT05258292|Insulin|insulin|mesh-list
20629577|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20629578|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629579|NCT05258279|Carboplatin|carboplatin|mesh-list
20629580|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
20629581|NCT05258279|Pemetrexed|pemetrexed|mesh-list
20629582|NCT05258279|Lenvatinib|lenvatinib|mesh-list
20629583|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629584|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629585|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629586|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629587|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20629588|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20629589|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20629590|NCT05258136|Antibodies|antibodies|mesh-list
20629591|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20629592|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
20629593|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629594|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20629595|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20629596|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629597|NCT05257148|Nebivolol|nebivolol|mesh-list
20629598|NCT05257148|Zofenopril|zofenopril|mesh-list
20629599|NCT05257148|Captopril|captopril|mesh-list
20629600|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20629601|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
20629602|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20629603|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20629604|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20629605|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
20629606|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629607|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629608|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629609|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20629610|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
20629611|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629612|NCT05256056|Bupivacaine|bupivacaine|mesh-list
20629613|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
20629614|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
20629615|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629616|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629617|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
20629618|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629619|NCT05222139|Vaccines|vaccines|mesh-list
20629620|NCT05222139|Immunologic Factors|immunologic factors|mesh-ancestor
20629621|NCT05222139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629622|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
20629623|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
20629624|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20629625|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20629626|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629627|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20629628|NCT05211609|Methyldopa|methyldopa|mesh-list
20226574|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20226575|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20226576|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226577|NCT00347100|Metformin|metformin|mesh-list
20475338|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20475339|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
20475340|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
20475341|NCT01510665|Cathartics|cathartics|mesh-ancestor
20475342|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475343|NCT01510795|Spironolactone|spironolactone|mesh-list
20475344|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20475345|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
20475346|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475347|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475348|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20475349|NCT01510795|Diuretics|diuretics|mesh-ancestor
20475350|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
20629629|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20629630|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
20629631|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
19411827|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
19411828|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20475351|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
20629632|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629633|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629634|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20629635|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20629636|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20629637|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
20629638|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629639|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629640|NCT05195450|Tenofovir|tenofovir|mesh-list
20629641|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
20629642|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629643|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20629644|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20629645|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629646|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629647|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20629648|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20629649|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
20629650|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629651|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20629652|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629653|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629654|NCT05137626|Digoxin|digoxin|mesh-list
20629655|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20629656|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20629657|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629658|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629659|NCT05137626|Protective Agents|protective agents|mesh-ancestor
20629660|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629661|NCT05084599|Metaraminol|metaraminol|mesh-list
20629662|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
20629663|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
20629664|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629665|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629666|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20629667|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20629668|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20629669|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20629670|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
20629671|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629672|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629673|NCT05033808|Epirubicin|epirubicin|mesh-list
20629674|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20629675|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629676|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20629677|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20629678|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629679|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629680|NCT05012644|Palbociclib|palbociclib|mesh-list
20629681|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20629682|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629683|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20629684|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629685|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629686|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20629687|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20629688|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
19411829|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20475352|NCT01510847|Androgens|androgens|mesh-ancestor
20475353|NCT01510847|Hormones|hormones|mesh-ancestor
20475354|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475355|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475356|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20475357|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20475358|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475359|NCT01510977|Bisacodyl|bisacodyl|mesh-list
20475360|NCT01510977|Cathartics|cathartics|mesh-ancestor
20475361|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475362|NCT01510977|Laxatives|laxatives|mesh-ancestor
19411830|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
20629689|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629690|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629691|NCT05008003|Vitamin D|vitamin d|mesh-list
20629692|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
20629693|NCT05008003|Vitamins|vitamins|mesh-ancestor
20629694|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
20629695|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629696|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20629697|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411831|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19411832|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19411833|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411834|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19411835|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19411836|NCT03536494|Mirabegron|mirabegron|mesh-list
19411837|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19411838|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19411839|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19411840|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
19411841|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411842|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411843|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411844|NCT03536494|Urological Agents|urological agents|mesh-ancestor
20629698|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
20629699|NCT04990804|Analgesics|analgesics|mesh-list
20629700|NCT04990804|Narcotics|narcotics|mesh-ancestor
20629701|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629702|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629703|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
20629704|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629705|NCT04950465|Fluorides|fluorides|mesh-list
20629706|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
20629707|NCT04950465|Protective Agents|protective agents|mesh-ancestor
20629708|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629709|NCT04906278|Oxytocin|oxytocin|mesh-list
20629710|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
20629711|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20629712|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629713|NCT04859608|Eculizumab|eculizumab|mesh-list
20629714|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20629715|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629716|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
20629717|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629718|NCT04827953|Gemcitabine|gemcitabine|mesh-list
20629719|NCT04827953|Paclitaxel|paclitaxel|mesh-list
20629720|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20629721|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629722|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
20629723|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
20629724|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20629725|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629726|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20629727|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
20629728|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
20629729|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629730|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629731|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629732|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
20629733|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629734|NCT04820452|Aflibercept|aflibercept|mesh-list
20629735|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20629736|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20629737|NCT04820452|Growth Substances|growth substances|mesh-ancestor
20629738|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629739|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
20629740|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629741|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
20629742|NCT04818177|Antibodies|antibodies|mesh-list
20629743|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
20629744|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20629745|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20629746|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
20629747|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629748|NCT04780061|Vitamin D|vitamin d|mesh-list
20629749|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
20629750|NCT04780061|Vitamins|vitamins|mesh-list
20629751|NCT04780061|Vitamin K|vitamin k|mesh-list
20629752|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
20629753|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
20629754|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629755|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20629756|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20629757|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629758|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20629759|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20629760|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
20629761|NCT04780061|Coagulants|coagulants|mesh-ancestor
20629762|NCT04754386|Antibodies|antibodies|mesh-list
20629763|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
20629764|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629765|NCT04738149|Bimatoprost|bimatoprost|mesh-list
20629766|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20629767|NCT04711356|Vaccines|vaccines|mesh-list
20629768|NCT04711356|Immunologic Factors|immunologic factors|mesh-ancestor
19411845|NCT03536481|Ensartinib|ensartinib|mesh-list
20629769|NCT04711356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629770|NCT04660747|Anticoagulants|anticoagulants|mesh-list
20629771|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
20629772|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629773|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629774|NCT04594733|Minocycline|minocycline|mesh-list
20629775|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20629776|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629777|NCT04583969|Remdesivir|remdesivir|mesh-list
20629778|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
20629779|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629780|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
20629781|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629782|NCT04583956|Remdesivir|remdesivir|mesh-list
20629783|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
20629784|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629785|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
20629786|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629787|NCT04526574|Vaccines|vaccines|mesh-list
20629788|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20629789|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
20629790|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629791|NCT04524455|Dexamethasone|dexamethasone|mesh-list
20629792|NCT04524455|Blinatumomab|blinatumomab|mesh-list
20629793|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629794|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
20629795|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
20629796|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629797|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629798|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629799|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
20629800|NCT04524455|Hormones|hormones|mesh-ancestor
20629801|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629802|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20629803|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629804|NCT04482673|Vitamin D|vitamin d|mesh-list
20629805|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
20629806|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
20226578|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
20226579|NCT00347100|Glyburide|glyburide|mesh-list
20226580|NCT00347100|Glipizide|glipizide|mesh-list
20226581|NCT00347100|Gliclazide|gliclazide|mesh-list
20226582|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20226583|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629807|NCT04482673|Vitamins|vitamins|mesh-list
20629808|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
20629809|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629810|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20629811|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20629812|NCT04472299|Ropivacaine|ropivacaine|mesh-list
20629813|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
19696364|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696365|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696366|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
19696367|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20629814|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
20629815|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629816|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629817|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
20629818|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629819|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20629820|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20226584|NCT00347113|Albendazole|albendazole|mesh-list
20226585|NCT00347113|Praziquantel|praziquantel|mesh-list
20629821|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20629822|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
20629823|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629824|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629825|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20629826|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20629827|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
20629828|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629829|NCT04431258|Folfirinox|folfirinox|mesh-list
20629830|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629831|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20629832|NCT04401553|Vancomycin|vancomycin|mesh-list
20629833|NCT04401553|Cephalosporins|cephalosporins|mesh-list
20629834|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629835|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20629836|NCT04390646|Hormones|hormones|mesh-ancestor
19696368|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
19696369|NCT04941131|Povidone|povidone|mesh-list
20629837|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629838|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629839|NCT04379011|Brivaracetam|brivaracetam|mesh-list
20629840|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
20629841|NCT04370418|Fluorouracil|fluorouracil|mesh-list
20629842|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
20629843|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629844|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20629845|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629846|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629847|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
20629848|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629849|NCT04337580|Omeprazole|omeprazole|mesh-list
20629850|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20629851|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629852|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20629853|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629854|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629855|NCT04294550|Naloxegol|naloxegol|mesh-list
20629856|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20629857|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629858|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
20629859|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629860|NCT04282187|Azacitidine|azacitidine|mesh-list
20629861|NCT04282187|Decitabine|decitabine|mesh-list
20629862|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
20629863|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20629864|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
20629865|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629866|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629867|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475363|NCT01510990|Gefitinib|gefitinib|mesh-list
20475364|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475365|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20475366|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475367|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475368|NCT01511003|Tacrolimus|tacrolimus|mesh-list
20475369|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629868|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20475370|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
20475371|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475372|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20475373|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475374|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475375|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
20475376|NCT01511029|Pramipexole|pramipexole|mesh-list
20475377|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20475378|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475379|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20475380|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20475381|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475382|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475383|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475384|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475385|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
20475386|NCT01511029|Protective Agents|protective agents|mesh-ancestor
20475387|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20475388|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20475389|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
20475390|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
20475391|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475392|NCT01511042|Norepinephrine|norepinephrine|mesh-list
20475393|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
20475394|NCT01511042|Giapreza|giapreza|mesh-list
20475395|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
20475396|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20629869|NCT04207190|Talazoparib|talazoparib|mesh-list
20629870|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
20629871|NCT04207190|Calicheamicins|calicheamicins|mesh-list
20629872|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20629873|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629874|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629875|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629876|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629877|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20629878|NCT04175431|Prednisone|prednisone|mesh-list
20629879|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
20629880|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629881|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
20629882|NCT04175431|Hormones|hormones|mesh-ancestor
20629883|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629884|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629885|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20629886|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629887|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20629888|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629889|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629890|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
20629891|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20629892|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20629893|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629894|NCT04107038|Anesthetics|anesthetics|mesh-list
20629895|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629896|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629897|NCT04058067|Aflibercept|aflibercept|mesh-list
20629898|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20629899|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20629900|NCT04058067|Growth Substances|growth substances|mesh-ancestor
20629901|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629902|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
20629903|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629904|NCT03993717|Vaccines|vaccines|mesh-list
20629905|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
20629906|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629907|NCT03993262|Bortezomib|bortezomib|mesh-list
20629908|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629909|NCT03954899|Melatonin|melatonin|mesh-list
20629910|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
20629911|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629912|NCT03954899|Protective Agents|protective agents|mesh-ancestor
20629913|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629914|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629915|NCT03951025|Melatonin|melatonin|mesh-list
20629916|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
20629917|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629918|NCT03951025|Protective Agents|protective agents|mesh-ancestor
20629919|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629920|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629921|NCT03948074|Dronabinol|dronabinol|mesh-list
20629922|NCT03948074|Cannabidiol|cannabidiol|mesh-list
20629923|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
20629924|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
20629925|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629926|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20629927|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20629928|NCT03948074|Analgesics|analgesics|mesh-ancestor
20629929|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
20629930|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629931|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20629932|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20629933|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629934|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629935|NCT03948074|Hormones|hormones|mesh-ancestor
20629936|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629937|NCT03908307|Dexamethasone|dexamethasone|mesh-list
20629938|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
20629939|NCT03908307|BB 1101|bb 1101|mesh-list
20629940|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20629941|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
20629942|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
20226586|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
19850523|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850524|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19850525|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19850526|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19850527|NCT00710606|Estrogens|estrogens|mesh-ancestor
20629943|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629944|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629945|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20629946|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
20629947|NCT03908307|Hormones|hormones|mesh-ancestor
20629948|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20629949|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20629950|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629951|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
20629952|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475397|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20475398|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
20475399|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475400|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475401|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475402|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
20475403|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
20475404|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475405|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20475406|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20475407|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
20629953|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629954|NCT03878979|Nivolumab|nivolumab|mesh-list
20629955|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629956|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629957|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19850528|NCT00710606|Hormones|hormones|mesh-ancestor
19850529|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850530|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19850531|NCT00710606|Progestins|progestins|mesh-ancestor
19850532|NCT00710684|Donepezil|donepezil|mesh-list
19850533|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20629958|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629959|NCT03865940|Lidocaine|lidocaine|mesh-list
20629960|NCT03865940|Guanfacine|guanfacine|mesh-list
20629961|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
20629962|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
20629963|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20629964|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629965|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
19850534|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850535|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850536|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
19850537|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850538|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850539|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
19850540|NCT00710762|Nintedanib|nintedanib|mesh-list
19850541|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850542|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850543|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850544|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855603|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20629966|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20629967|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20629968|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20629969|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20629970|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20629971|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629972|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20629973|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20629974|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20629975|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20629976|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
20629977|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20629978|NCT03792750|Nivolumab|nivolumab|mesh-list
20629979|NCT03792750|Linrodostat|linrodostat|mesh-list
20629980|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20629981|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20629982|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20629983|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20629984|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20629985|NCT03779854|Vidarabine|vidarabine|mesh-list
20629986|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
20629987|NCT03779854|Busulfan|busulfan|mesh-list
20629988|NCT03779854|Thiotepa|thiotepa|mesh-list
20629989|NCT03779854|Methotrexate|methotrexate|mesh-list
20629990|NCT03779854|Fludarabine|fludarabine|mesh-list
20629991|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
20629992|NCT03779854|Tacrolimus|tacrolimus|mesh-list
20629993|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20629994|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
20629995|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20629996|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20629997|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20629998|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
20629999|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630000|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630001|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20630002|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20630003|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
20630004|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20630005|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630006|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
20630007|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
20630008|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630009|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20630010|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630011|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20630012|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
20630013|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630014|NCT03765619|Aspirin|aspirin|mesh-list
20630015|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20630016|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630017|NCT03765619|Analgesics|analgesics|mesh-ancestor
20630018|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
20630019|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630020|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630021|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630022|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630023|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20630024|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20630025|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630026|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20630027|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20630028|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630029|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
20630030|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
20630031|NCT03761056|Fludarabine|fludarabine|mesh-list
20630032|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630033|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
20630034|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630035|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630036|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20630037|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
20630038|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630039|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630040|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20630041|NCT03739593|Dexamethasone|dexamethasone|mesh-list
20630042|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
20630043|NCT03739593|BB 1101|bb 1101|mesh-list
20630044|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630045|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
20630046|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
20630047|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630048|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630049|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19696370|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19696371|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696372|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
20630050|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
20630051|NCT03739593|Hormones|hormones|mesh-ancestor
19696373|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
19696374|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
19696375|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
20630052|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20630053|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20630054|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630055|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
20630056|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630057|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630058|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
20630059|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630060|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630061|NCT03737994|Cisplatin|cisplatin|mesh-list
20630062|NCT03737994|Carboplatin|carboplatin|mesh-list
20630063|NCT03737994|Pemetrexed|pemetrexed|mesh-list
20226587|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20226588|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226589|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
20226590|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20226591|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20226592|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
20226593|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
20226594|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
20226595|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226596|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226597|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20226598|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20226599|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
20226600|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226601|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226602|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20226603|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
20226604|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20226605|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20226606|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20226607|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226608|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226609|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226610|NCT00347152|Valproic Acid|valproic acid|mesh-list
20630064|NCT03737994|Crizotinib|crizotinib|mesh-list
20630065|NCT03737994|Ceritinib|ceritinib|mesh-list
20630066|NCT03737994|Ensartinib|ensartinib|mesh-list
20630067|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630068|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630069|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630070|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20630071|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630072|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630073|NCT03724019|Ketamine|ketamine|mesh-list
20630074|NCT03724019|Analgesics|analgesics|mesh-ancestor
20630075|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
20630076|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630077|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630078|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20630079|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20630080|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
20630081|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
20630082|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630083|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20630084|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20630085|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630086|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630087|NCT03660930|Sirolimus|sirolimus|mesh-list
20630088|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20630089|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850545|NCT00711009|Ritonavir|ritonavir|mesh-list
19850546|NCT00711009|Lopinavir|lopinavir|mesh-list
20630090|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20630091|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850547|NCT00711009|Tenofovir|tenofovir|mesh-list
19850548|NCT00711009|Emtricitabine|emtricitabine|mesh-list
19850549|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
19850550|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19850551|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19850552|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19850553|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
19850554|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855604|NCT00749749|Bupivacaine|bupivacaine|mesh-list
19855605|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
20226611|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
20226612|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475408|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475409|NCT01511146|Gemcitabine|gemcitabine|mesh-list
20475410|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
20475411|NCT01511146|Mitomycins|mitomycins|mesh-list
20475412|NCT01511146|Mitomycin|mitomycin|mesh-list
20475413|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20475414|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
20475415|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475416|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475417|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
20475418|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475419|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475420|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475421|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
20475422|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475423|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20475424|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
20475425|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20475426|NCT01511159|Insulin|insulin|mesh-list
20475427|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20475428|NCT01511159|Liraglutide|liraglutide|mesh-list
20475429|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475430|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475431|NCT01511159|Incretins|incretins|mesh-ancestor
20475432|NCT01511159|Hormones|hormones|mesh-ancestor
20475433|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475434|NCT01511172|Metformin|metformin|mesh-list
20475435|NCT01511172|Liraglutide|liraglutide|mesh-list
20475436|NCT01511172|Glimepiride|glimepiride|mesh-list
20475437|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475438|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475439|NCT01511172|Incretins|incretins|mesh-ancestor
19411846|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411847|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19411848|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411849|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411850|NCT03536390|Methylphenidate|methylphenidate|mesh-list
19411851|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19696376|NCT04941105|Evolocumab|evolocumab|mesh-list
19696377|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19696378|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19696379|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
19696380|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696381|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19696382|NCT04941118|Anesthetics|anesthetics|mesh-list
19696383|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
19696384|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226613|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475440|NCT01511172|Hormones|hormones|mesh-ancestor
20475441|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475442|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20475443|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475444|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
20475445|NCT01511185|Liraglutide|liraglutide|mesh-list
20475446|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475447|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475448|NCT01511185|Incretins|incretins|mesh-ancestor
20475449|NCT01511185|Hormones|hormones|mesh-ancestor
20475450|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475451|NCT01511198|Metformin|metformin|mesh-list
20475452|NCT01511198|Liraglutide|liraglutide|mesh-list
20475453|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475454|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475455|NCT01511198|Incretins|incretins|mesh-ancestor
20226614|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
20226615|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226616|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226617|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
20226618|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19696385|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696386|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
20226619|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850555|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850556|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19850557|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19850558|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
19850559|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850560|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19850561|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19850562|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19850563|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19411852|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411853|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19411854|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19411855|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19411856|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411857|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
19411858|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416822|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
19416823|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
19416824|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416825|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416826|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416827|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19416828|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
19416829|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850564|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19850565|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19850566|NCT00711191|Antibodies|antibodies|mesh-list
19850567|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19850568|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
19850569|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850570|NCT00711243|Docetaxel|docetaxel|mesh-list
19850571|NCT00711243|Fluorouracil|fluorouracil|mesh-list
19850572|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
19850573|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630092|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
20630093|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630094|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
20630095|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630096|NCT03655197|Doxycycline|doxycycline|mesh-list
20630097|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20630098|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630099|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
20630100|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20630101|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20630102|NCT03617718|Glycine|glycine|mesh-list
20630103|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
20630104|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630105|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630106|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630107|NCT03614728|Azacitidine|azacitidine|mesh-list
20630108|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
20630109|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630110|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
20630111|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630112|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630113|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630114|NCT03535272|Bismuth|bismuth|mesh-list
20630115|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20630116|NCT03535272|Antacids|antacids|mesh-ancestor
20630117|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850574|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19850575|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
19850576|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
20630118|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630119|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
20630120|NCT03520842|Methotrexate|methotrexate|mesh-list
20630121|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20630122|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
20630123|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20630124|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630125|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630126|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
20630127|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630128|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630129|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
20630130|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630131|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20630132|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630133|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
20630134|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630135|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630136|NCT03518086|Mirikizumab|mirikizumab|mesh-list
20630137|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20630138|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630139|NCT03518086|Analgesics|analgesics|mesh-ancestor
20630140|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
20630141|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630142|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630143|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630144|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630145|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20630146|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630147|NCT03473730|Daratumumab|daratumumab|mesh-list
20630148|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630149|NCT03450122|Aldesleukin|aldesleukin|mesh-list
20630150|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
20630151|NCT03450122|Interleukin-2|interleukin-2|mesh-list
20630152|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630153|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
20630154|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630155|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630156|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20630157|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
20630158|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630159|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630160|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20630161|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630162|NCT03450122|Analgesics|analgesics|mesh-ancestor
20630163|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
20630164|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630165|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20630166|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20630167|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
20630168|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630169|NCT03447808|Daratumumab|daratumumab|mesh-list
20630170|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630171|NCT03389477|Cisplatin|cisplatin|mesh-list
20630172|NCT03389477|Cetuximab|cetuximab|mesh-list
20630173|NCT03389477|Palbociclib|palbociclib|mesh-list
20630174|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630175|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630176|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630177|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630178|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630179|NCT03347123|Nivolumab|nivolumab|mesh-list
20630180|NCT03347123|Ipilimumab|ipilimumab|mesh-list
20630181|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630182|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630183|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20630184|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630185|NCT03309007|Metformin|metformin|mesh-list
20630186|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
20630187|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20630188|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630189|NCT03309007|Antacids|antacids|mesh-ancestor
20630190|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630191|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630192|NCT03307616|Nivolumab|nivolumab|mesh-list
20630193|NCT03307616|Ipilimumab|ipilimumab|mesh-list
20630194|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630195|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630196|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20630197|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630198|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
20630199|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20630200|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
20630201|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411859|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19411860|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
20630202|NCT03306979|Expectorants|expectorants|mesh-ancestor
20630203|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
20630204|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20630205|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
20630206|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630207|NCT03306979|Protective Agents|protective agents|mesh-ancestor
20630208|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630209|NCT03306979|Antidotes|antidotes|mesh-ancestor
20226620|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20226621|NCT00347165|Bevacizumab|bevacizumab|mesh-list
20226622|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226623|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226624|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226625|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20226626|NCT00347165|Growth Substances|growth substances|mesh-ancestor
20226627|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226628|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
20226629|NCT00347204|Ketorolac|ketorolac|mesh-list
20226630|NCT00347204|Nepafenac|nepafenac|mesh-list
20226631|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19850577|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696387|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696388|NCT04940689|Lidocaine|lidocaine|mesh-list
19696389|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
19696390|NCT04940689|Remifentanil|remifentanil|mesh-list
19696391|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
20226632|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19696392|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
19696393|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696394|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630210|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20630211|NCT03290937|Cetuximab|cetuximab|mesh-list
20630212|NCT03290937|Irinotecan|irinotecan|mesh-list
20630213|NCT03290937|Camptothecin|camptothecin|mesh-list
20630214|NCT03290937|Antibodies|antibodies|mesh-list
20630215|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
20630216|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20630217|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
20630218|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
20630219|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630220|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630221|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20630222|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20630223|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630224|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630225|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20630226|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
20630227|NCT03260894|Sunitinib|sunitinib|mesh-list
20630228|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630229|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630230|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20630231|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20630232|NCT03260894|Growth Substances|growth substances|mesh-ancestor
20630233|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630234|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
20630235|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630236|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630237|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630238|NCT03252587|BMS-986165|bms-986165|mesh-list
20630239|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
20630240|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630241|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630242|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630243|NCT03177460|Daratumumab|daratumumab|mesh-list
20630244|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630245|NCT03150732|Nalbuphine|nalbuphine|mesh-list
20630246|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20630247|NCT03150732|Narcotics|narcotics|mesh-ancestor
20630248|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630249|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630250|NCT03150732|Analgesics|analgesics|mesh-ancestor
20630251|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
20630252|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630253|NCT03047993|Azacitidine|azacitidine|mesh-list
20630254|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630255|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
20630256|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630257|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630258|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630259|NCT03015740|Nivolumab|nivolumab|mesh-list
20630260|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630261|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630262|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20630263|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630264|NCT02986269|Anesthetics|anesthetics|mesh-list
20630265|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630266|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630267|NCT02940496|Ribavirin|ribavirin|mesh-list
20630268|NCT02940496|Grazoprevir|grazoprevir|mesh-list
20630269|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
20630270|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630271|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630272|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
20630273|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630274|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
20630275|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630276|NCT02891226|Mirikizumab|mirikizumab|mesh-list
20630277|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20630278|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630279|NCT02891226|Analgesics|analgesics|mesh-ancestor
20630280|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
19696395|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
19696396|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696397|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19696398|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20630281|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630282|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630283|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630284|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630285|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20630286|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630287|NCT02761694|Paclitaxel|paclitaxel|mesh-list
20630288|NCT02761694|Fulvestrant|fulvestrant|mesh-list
20630289|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20630290|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630291|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
20630292|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
20630293|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
20630294|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630295|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20630296|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20630297|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20630298|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
20630299|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20630300|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630301|NCT02553161|Citalopram|citalopram|mesh-list
20630302|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20630303|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20630304|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20630305|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630306|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630307|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
20630308|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630309|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20630310|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
20630311|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20630312|NCT02549092|Levodopa|levodopa|mesh-list
20630313|NCT02549092|Carbidopa|carbidopa|mesh-list
20630314|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20630315|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20630316|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20630317|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
20630318|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630319|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630320|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630321|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20630322|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630323|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20630324|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
20630325|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
20630326|NCT02518555|Vaccines|vaccines|mesh-list
20630327|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
20630328|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630329|NCT02515773|Metformin|metformin|mesh-list
20630330|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20630331|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630332|NCT02478788|Amphetamine|amphetamine|mesh-list
20630333|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20630334|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630335|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
20630336|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
20630337|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630338|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
20630339|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630340|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630341|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
20630342|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20630343|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20630344|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20630345|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20630346|NCT02431715|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20630347|NCT02431715|Dopamine Agents|dopamine agents|mesh-ancestor
20630348|NCT02431715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630349|NCT02431715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630350|NCT02431715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630351|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
19411861|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630352|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
20630353|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20630354|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20630355|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630356|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630357|NCT02335242|Urological Agents|urological agents|mesh-ancestor
20630358|NCT02323126|Nivolumab|nivolumab|mesh-list
20630359|NCT02323126|Nazartinib|nazartinib|mesh-list
20630360|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630361|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630362|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20630363|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630364|NCT01902290|Brodalumab|brodalumab|mesh-list
20630365|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
20630366|NCT01712763|Goserelin|goserelin|mesh-list
20630367|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20630368|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20630369|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630370|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
20630371|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20630372|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
20630373|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20630374|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630375|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20630376|NCT01366612|Vidarabine|vidarabine|mesh-list
20630377|NCT01366612|Fludarabine|fludarabine|mesh-list
19850578|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
19850579|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630378|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
20630379|NCT01366612|Busulfan|busulfan|mesh-list
20630380|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630381|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630382|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
20630383|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630384|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630385|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
20630386|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630387|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
20630388|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630389|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
20630390|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20630391|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20630392|NCT01126749|Gemcitabine|gemcitabine|mesh-list
20630393|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850580|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850581|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
20630394|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630395|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
20630396|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630397|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
20630398|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630399|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630400|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630401|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
20630402|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850582|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850583|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
20630403|NCT01064245|Mannitol|mannitol|mesh-list
20630404|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
20630405|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20630406|NCT01064245|Diuretics|diuretics|mesh-ancestor
20630407|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
20630408|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630409|NCT01064245|Miotics|miotics|mesh-ancestor
20630410|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
20630411|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630412|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20630413|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20630414|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
20630415|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20630416|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20630417|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
20630418|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630419|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411862|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20630420|NCT01059448|Brodalumab|brodalumab|mesh-list
20630421|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
20630422|NCT00821587|Cyclosporine|cyclosporine|mesh-list
20630423|NCT00821587|Tacrolimus|tacrolimus|mesh-list
20630424|NCT00821587|Cyclosporins|cyclosporins|mesh-list
20630425|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630426|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
20630427|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630428|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20630429|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630430|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630431|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
20630432|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630433|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
20630434|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630435|NCT00585195|Itraconazole|itraconazole|mesh-list
20630436|NCT00585195|Rifampin|rifampin|mesh-list
20630437|NCT00585195|Crizotinib|crizotinib|mesh-list
20630438|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
20630439|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630440|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20630441|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19411863|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
19411864|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19411865|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
19411866|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411867|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411868|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20630442|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630443|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630444|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20630445|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
20630446|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20630447|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630448|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20630449|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20630450|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
20630451|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20630452|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
20630453|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630454|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20630455|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20630456|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20630457|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20630458|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20630459|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20630460|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630461|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630462|NCT00278915|Fulvestrant|fulvestrant|mesh-list
20630463|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20630464|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630465|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20630466|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20630467|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
20630468|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20630469|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630470|NCT04570839|Nivolumab|nivolumab|mesh-list
20630471|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630472|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630473|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20630474|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630475|NCT04561180|Dexamethasone|dexamethasone|mesh-list
20630476|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630477|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
20630478|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
20630479|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630480|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630481|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630482|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
20630483|NCT04561180|Hormones|hormones|mesh-ancestor
20630484|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20630485|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20630486|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630487|NCT04527003|Cannabidiol|cannabidiol|mesh-list
20630488|NCT04527003|Norethindrone|norethindrone|mesh-list
20630489|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
20630490|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
20630491|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20630492|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20630493|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20630494|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
19850584|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19850585|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
19850586|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850587|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
19850588|NCT00711347|Protective Agents|protective agents|mesh-ancestor
19850589|NCT00711412|Capecitabine|capecitabine|mesh-list
19850590|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
20630495|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20630496|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630497|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20630498|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19411869|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19850591|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19850592|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
20475456|NCT01511198|Hormones|hormones|mesh-ancestor
20475457|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475458|NCT01511211|Dexamethasone|dexamethasone|mesh-list
20475459|NCT01511211|Ropivacaine|ropivacaine|mesh-list
20475460|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475461|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
20475462|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
20475463|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475464|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630499|NCT04457323|Metoprolol|metoprolol|mesh-list
20630500|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20630501|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19850593|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850594|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850595|NCT00711464|Modafinil|modafinil|mesh-list
20630502|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
20630503|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
20630504|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630505|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630506|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20630507|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20630508|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20630509|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
20630510|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630511|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630512|NCT04448431|Vortioxetine|vortioxetine|mesh-list
20630513|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20630514|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
20630515|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20630516|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20630517|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20630518|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630519|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630520|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20630521|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20630522|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20630523|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630524|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630525|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
20630526|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20630527|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20630528|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20630529|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19850596|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19850597|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850598|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19850599|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20630530|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20630531|NCT04372017|Vitamin D|vitamin d|mesh-list
20630532|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
20630533|NCT04372017|Vitamins|vitamins|mesh-ancestor
20630534|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
20630535|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630536|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20630537|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
20630538|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20630539|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20630540|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630541|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630542|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630543|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630544|NCT04339049|Lidocaine|lidocaine|mesh-list
20630545|NCT04339049|Misoprostol|misoprostol|mesh-list
20630546|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
20630547|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
20630548|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630549|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630550|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
20630551|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630552|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20630553|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20630554|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20630555|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20630556|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630557|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20630558|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
20630559|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20630560|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20630561|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630562|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
20630563|NCT04312971|Norepinephrine|norepinephrine|mesh-list
20630564|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20630565|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20630566|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
20630567|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630568|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630569|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630570|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
20630571|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
20630572|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630573|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20630574|NCT04282278|Apatinib|apatinib|mesh-list
20630575|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630576|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630577|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630578|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630579|NCT04243629|Pramlintide|pramlintide|mesh-list
20630580|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
19850600|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19850601|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850602|NCT00711477|Naltrexone|naltrexone|mesh-list
19850603|NCT00711477|Bupropion|bupropion|mesh-list
19850604|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19850605|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19850606|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850607|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
20630581|NCT04243629|Pancrelipase|pancrelipase|mesh-list
20630582|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20630583|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630584|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630585|NCT04194528|Acetaminophen|acetaminophen|mesh-list
19850608|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850609|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19850610|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
19850611|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20630586|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20630587|NCT04194528|Oxycodone|oxycodone|mesh-list
20630588|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630589|NCT04194528|Analgesics|analgesics|mesh-ancestor
20630590|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
20630591|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630592|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630593|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
20630594|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20630595|NCT04194528|Narcotics|narcotics|mesh-ancestor
20630596|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630597|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20630598|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630599|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630600|NCT04179162|Gemcitabine|gemcitabine|mesh-list
20630601|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
20630602|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630603|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
20630604|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630605|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630606|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
20630607|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630608|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630609|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630610|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
20630611|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630612|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20630613|NCT04170998|Metformin|metformin|mesh-list
20630614|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
20630615|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20630616|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630617|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20630618|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630619|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20630620|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20630621|NCT04082442|Evolocumab|evolocumab|mesh-list
20630622|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19850612|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19850613|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19850614|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855606|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
20226633|NCT00347204|Analgesics|analgesics|mesh-ancestor
20226634|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
20226635|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630623|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20630624|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
20630625|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630626|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20630627|NCT04070573|Aspirin|aspirin|mesh-list
20630628|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20630629|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630630|NCT04070573|Analgesics|analgesics|mesh-ancestor
20630631|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
20630632|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630633|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630634|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630635|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630636|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20630637|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20630638|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630639|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20630640|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20630641|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630642|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
20630643|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
20630644|NCT04070443|Ponatinib|ponatinib|mesh-list
20630645|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630646|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630647|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630648|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630649|NCT03990077|Docetaxel|docetaxel|mesh-list
20226636|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226637|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696399|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19696400|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696401|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696402|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19696403|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19696404|NCT04940689|Analgesics|analgesics|mesh-ancestor
19696405|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19696406|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19850615|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850616|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
19411870|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411871|NCT03536208|Warfarin|warfarin|mesh-list
19411872|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
19411873|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
19411874|NCT03536065|Narcotics|narcotics|mesh-ancestor
20226638|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226639|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20630650|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630651|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
20630652|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
20630653|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
20630654|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630655|NCT03842696|Cyclosporine|cyclosporine|mesh-list
20630656|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
20630657|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
20630658|NCT03842696|Methotrexate|methotrexate|mesh-list
20630659|NCT03842696|Vorinostat|vorinostat|mesh-list
20630660|NCT03842696|Tacrolimus|tacrolimus|mesh-list
20630661|NCT03842696|Cyclosporins|cyclosporins|mesh-list
20630662|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630663|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
20630664|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630665|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630666|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20630667|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
20630668|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630669|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630670|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20630671|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20630672|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
20630673|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19411875|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411876|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630674|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630675|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
20630676|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
20630677|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630678|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20630679|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630680|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20630681|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
20630682|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630683|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20630684|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20630685|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
20630686|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20630687|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20630688|NCT03761277|Morphine|morphine|mesh-list
20630689|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20630690|NCT03761277|Narcotics|narcotics|mesh-ancestor
20630691|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630692|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630693|NCT03761277|Analgesics|analgesics|mesh-ancestor
20630694|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
20630695|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630696|NCT03729258|Amantadine|amantadine|mesh-list
20630697|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20630698|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20226640|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226641|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226642|NCT00347256|Cisplatin|cisplatin|mesh-list
20226643|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630699|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
20630700|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630701|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
20630702|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630703|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630704|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630705|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630706|NCT03729258|Analgesics|analgesics|mesh-ancestor
20630707|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
20630708|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630709|NCT03716349|Anesthetics|anesthetics|mesh-list
20630710|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
20630711|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630712|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630713|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
20630714|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630715|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
20630716|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630717|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
20630718|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630719|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630720|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630721|NCT03573960|Lenvatinib|lenvatinib|mesh-list
20630722|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630723|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630724|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630725|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630726|NCT03527238|Tacrolimus|tacrolimus|mesh-list
20630727|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630728|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
20630729|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630730|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20630731|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630732|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630733|NCT03490864|Melatonin|melatonin|mesh-list
20630734|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
20630735|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630736|NCT03490864|Protective Agents|protective agents|mesh-ancestor
20630737|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630738|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630739|NCT03455764|Trametinib|trametinib|mesh-list
20630740|NCT03455764|Dabrafenib|dabrafenib|mesh-list
20630741|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630742|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20226644|NCT00347295|Estazolam|estazolam|mesh-list
20630743|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630744|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630745|NCT03380507|Thiamine|thiamine|mesh-list
20630746|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
20630747|NCT03380507|Vitamins|vitamins|mesh-ancestor
20630748|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
20630749|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630750|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630751|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
19411877|NCT03536065|Analgesics|analgesics|mesh-ancestor
19411878|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
19411879|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411880|NCT03536039|Prednisone|prednisone|mesh-list
19411881|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
19850617|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850618|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19411882|NCT03536039|Rituximab|rituximab|mesh-list
19411883|NCT03536039|Doxorubicin|doxorubicin|mesh-list
20630752|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
20630753|NCT03321630|Lenvatinib|lenvatinib|mesh-list
20630754|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630755|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630756|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630757|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630758|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630759|NCT03194165|Ritonavir|ritonavir|mesh-list
20630760|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20630761|NCT03194165|Darunavir|darunavir|mesh-list
20630762|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
20630763|NCT03194165|Nevirapine|nevirapine|mesh-list
20630764|NCT03194165|Dolutegravir|dolutegravir|mesh-list
20630765|NCT03194165|Rilpivirine|rilpivirine|mesh-list
20630766|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20630767|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20630768|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
20630769|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630770|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630771|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20630772|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20630773|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
20630774|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630775|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20630776|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20630777|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20630778|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20630779|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20630780|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630781|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20630782|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20630783|NCT03179475|Oxycodone|oxycodone|mesh-list
20630784|NCT03179475|Naloxone|naloxone|mesh-list
20630785|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20630786|NCT03179475|Narcotics|narcotics|mesh-ancestor
20630787|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630788|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630789|NCT03179475|Analgesics|analgesics|mesh-ancestor
20630790|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
20630791|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630792|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20630793|NCT03136497|Rituximab|rituximab|mesh-list
20630794|NCT03136497|Venetoclax|venetoclax|mesh-list
20630795|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630796|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630797|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
20630798|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630799|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630800|NCT03132129|Manganese|manganese|mesh-list
20630801|NCT03132129|Calcium|calcium|mesh-list
20630802|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20630803|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630804|NCT03132129|Trace Elements|trace elements|mesh-ancestor
20630805|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
20630806|NCT02910700|Nivolumab|nivolumab|mesh-list
20630807|NCT02910700|Trametinib|trametinib|mesh-list
20630808|NCT02910700|Dabrafenib|dabrafenib|mesh-list
20630809|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630810|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630811|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20630812|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630813|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20630814|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630815|NCT02898207|Olaparib|olaparib|mesh-list
20630816|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20630817|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630818|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630819|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630820|NCT02777372|Sertraline|sertraline|mesh-list
20630821|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
20630822|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20630823|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20630824|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20630825|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20630826|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630827|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19411884|NCT03536039|Vincristine|vincristine|mesh-list
19411885|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19411886|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
19411887|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411888|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411889|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19411890|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
19411891|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411892|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411893|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19411894|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19411895|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20630828|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
20630829|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630830|NCT02682901|Bromocriptine|bromocriptine|mesh-list
19411896|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19411897|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19411898|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411899|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411900|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
20630831|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20630832|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20630833|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
19850619|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19850620|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630834|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20630835|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630836|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
20630837|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
20630838|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20630839|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630840|NCT02567825|Amoxicillin|amoxicillin|mesh-list
20630841|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
20630842|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
20630843|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
20630844|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20630845|NCT02567825|Ofloxacin|ofloxacin|mesh-list
19850621|NCT00711490|Sirolimus|sirolimus|mesh-list
19850622|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19850623|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630846|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20630847|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630848|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20630849|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630850|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850624|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19850625|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850626|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
19850627|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850628|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
19850629|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850630|NCT00711516|Modafinil|modafinil|mesh-list
20226645|NCT00347295|Brotizolam|brotizolam|mesh-list
20226646|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20226647|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226648|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226649|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
20226650|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20226651|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20226652|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20226653|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
20226654|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
20226655|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226656|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226657|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
20226658|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696407|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19696408|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
19696409|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696410|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19696411|NCT04940689|Narcotics|narcotics|mesh-ancestor
19696412|NCT04940845|Denosumab|denosumab|mesh-list
19696413|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19696414|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696415|NCT04940871|Favipiravir|favipiravir|mesh-list
19411901|NCT03536039|Hormones|hormones|mesh-ancestor
19411902|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411903|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19411904|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19411905|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
19411906|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
19411907|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
19411908|NCT03535961|Etoposide|etoposide|mesh-list
19411909|NCT03535961|Apatinib|apatinib|mesh-list
19411910|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19411911|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475465|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20226659|NCT00347386|Astringents|astringents|mesh-ancestor
20226660|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
20226661|NCT00347399|Bevacizumab|bevacizumab|mesh-list
20226662|NCT00347399|Verteporfin|verteporfin|mesh-list
20226663|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226664|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226665|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226666|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20226667|NCT00347399|Growth Substances|growth substances|mesh-ancestor
20226668|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630851|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20630852|NCT02567825|Renal Agents|renal agents|mesh-ancestor
20630853|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20630854|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20630855|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630856|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20630857|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20630858|NCT02555657|Gemcitabine|gemcitabine|mesh-list
20630859|NCT02555657|Capecitabine|capecitabine|mesh-list
20630860|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
20630861|NCT02555657|Vinorelbine|vinorelbine|mesh-list
20630862|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630863|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
20630864|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630865|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630866|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
20630867|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630868|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630869|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630870|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
20630871|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630872|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630873|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20630874|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
20630875|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
20630876|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
20630877|NCT02457156|Octreotide|octreotide|mesh-list
20630878|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20630879|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20475466|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
20475467|NCT01511211|Hormones|hormones|mesh-ancestor
20475468|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475469|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20475470|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475471|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
20475472|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
20475473|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475474|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
20475475|NCT01511237|Lamivudine|lamivudine|mesh-list
20475476|NCT01511237|Zidovudine|zidovudine|mesh-list
20475477|NCT01511237|Nevirapine|nevirapine|mesh-list
20475478|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20475479|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20475480|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475481|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475482|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
20475483|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475484|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20475485|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20475486|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
20630880|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411912|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20226669|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
20630881|NCT02272348|Insulin|insulin|mesh-list
20630882|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20630883|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630884|NCT02190721|Lenograstim|lenograstim|mesh-list
20226670|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20226671|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
20226672|NCT00347412|Paclitaxel|paclitaxel|mesh-list
20226673|NCT00347412|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20226674|NCT00347412|Carboplatin|carboplatin|mesh-list
20226675|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20226676|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226677|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
20226678|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
20226679|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
20226680|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226681|NCT00347425|Olanzapine|olanzapine|mesh-list
20226682|NCT00347425|Risperidone|risperidone|mesh-list
20226683|NCT00347425|Aripiprazole|aripiprazole|mesh-list
20226684|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19696416|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
19696417|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226685|NCT00347425|Ziprasidone|ziprasidone|mesh-list
20226686|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20226687|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
20226688|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226689|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226690|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226691|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20226692|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20226693|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226694|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20226695|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20226696|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
20226697|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
20226698|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
20226699|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226700|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20226701|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20226702|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20226703|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20226704|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
20226705|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
20226706|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20226707|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20226708|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20226709|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20226710|NCT00347490|Enoxaparin|enoxaparin|mesh-list
20226711|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
20226712|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20226713|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20226714|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226715|NCT00347503|Ketorolac|ketorolac|mesh-list
20226716|NCT00347503|Bromfenac|bromfenac|mesh-list
20226717|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20630885|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20630886|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
20630887|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630888|NCT01740557|Aldesleukin|aldesleukin|mesh-list
20630889|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
20630890|NCT01740557|Fludarabine|fludarabine|mesh-list
20226718|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19696418|NCT04940546|Bevacizumab|bevacizumab|mesh-list
19696419|NCT04940546|Capecitabine|capecitabine|mesh-list
19696420|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
19696421|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696422|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696423|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19696424|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19696425|NCT04940546|Growth Substances|growth substances|mesh-ancestor
19696426|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696427|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
20630891|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
20630892|NCT01740557|Interleukin-2|interleukin-2|mesh-list
20630893|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226719|NCT00347503|Analgesics|analgesics|mesh-ancestor
20226720|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
20630894|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
19850631|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19850632|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850633|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19850634|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19850635|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19850636|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850637|NCT00711529|Gabapentin|gabapentin|mesh-list
19850638|NCT00711529|Analgesics|analgesics|mesh-ancestor
19850639|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
20630895|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630896|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630897|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20630898|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
20630899|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630900|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630901|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20630902|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630903|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
20630904|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630905|NCT01740557|Analgesics|analgesics|mesh-ancestor
20630906|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
20630907|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630908|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20630909|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20630910|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
20630911|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630912|NCT00308516|Leucovorin|leucovorin|mesh-list
20630913|NCT00308516|Bevacizumab|bevacizumab|mesh-list
20630914|NCT00308516|Fluorouracil|fluorouracil|mesh-list
20630915|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
20630916|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630917|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630918|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20630919|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20630920|NCT00308516|Growth Substances|growth substances|mesh-ancestor
20630921|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630922|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
20630923|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
20630924|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630925|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20630926|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630927|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
19696428|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19696429|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
19696430|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696431|NCT04940273|Remifentanil|remifentanil|mesh-list
19696432|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19696433|NCT04940273|Narcotics|narcotics|mesh-ancestor
19696434|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696435|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696436|NCT04940273|Analgesics|analgesics|mesh-ancestor
20630928|NCT00308516|Antidotes|antidotes|mesh-ancestor
20630929|NCT00308516|Protective Agents|protective agents|mesh-ancestor
20630930|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
20630931|NCT00308516|Vitamins|vitamins|mesh-ancestor
20630932|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
20630933|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
20630934|NCT02325960|Exenatide|exenatide|mesh-list
20630935|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20630936|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630937|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20630938|NCT02325960|Incretins|incretins|mesh-ancestor
20630939|NCT02325960|Hormones|hormones|mesh-ancestor
20630940|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20630941|NCT05155592|Adalimumab|adalimumab|mesh-list
20630942|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630943|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630944|NCT05155527|Ivermectin|ivermectin|mesh-list
20630945|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20630946|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630947|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
19850640|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850641|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630948|NCT05155215|Fludarabine|fludarabine|mesh-list
20630949|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20630950|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
19850642|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
20630951|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630952|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19850643|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19850644|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19850645|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850646|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19850647|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19850648|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19850649|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850650|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850651|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
19850652|NCT00711594|Afatinib|afatinib|mesh-list
19850653|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850654|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850655|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850656|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850657|NCT00711646|Nabiximols|nabiximols|mesh-list
19850658|NCT00711646|Analgesics|analgesics|mesh-ancestor
20226721|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630953|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20630954|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
20630955|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630956|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630957|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20630958|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
20630959|NCT05155124|Cetuximab|cetuximab|mesh-list
20630960|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20630961|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630962|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20630963|NCT05154747|Rilpivirine|rilpivirine|mesh-list
20630964|NCT05154747|Cabotegravir|cabotegravir|mesh-list
20630965|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20630966|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20630967|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630968|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630969|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
20630970|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20630971|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20630972|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20630973|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20630974|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20630975|NCT05154682|Acetaminophen|acetaminophen|mesh-list
20630976|NCT05154682|Naproxen|naproxen|mesh-list
20630977|NCT05154682|Oxycodone|oxycodone|mesh-list
20630978|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20630979|NCT05154682|Analgesics|analgesics|mesh-ancestor
20630980|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
20630981|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20630982|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20630983|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
20630984|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20630985|NCT05154682|Narcotics|narcotics|mesh-ancestor
20630986|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20630987|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20630988|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20630989|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20630990|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
20630991|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20630992|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20630993|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20630994|NCT05154487|Fulvestrant|fulvestrant|mesh-list
20630995|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20630996|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20630997|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20630998|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20630999|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
20631000|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631001|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631002|NCT05154396|Loperamide|loperamide|mesh-list
20631003|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
20631004|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631005|NCT05154383|Vaccines|vaccines|mesh-list
20631006|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
20631007|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631008|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
20631009|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
20631010|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631011|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20631012|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20631013|NCT05134584|Lactulose|lactulose|mesh-list
20631014|NCT05134584|Linaclotide|linaclotide|mesh-list
20631015|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631016|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20631017|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
20631018|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631019|NCT05134415|Menthol|menthol|mesh-list
20631020|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
20631021|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
20631022|NCT05052710|Midazolam|midazolam|mesh-list
20631023|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20631024|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20631025|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631026|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631027|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20631028|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20631029|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631030|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20631031|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
20631032|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
20631033|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
20631034|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
20631035|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631036|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631037|NCT05051293|Testosterone|testosterone|mesh-list
20631038|NCT05051293|Estrogens|estrogens|mesh-list
20631039|NCT05051293|Androgens|androgens|mesh-ancestor
20631040|NCT05051293|Hormones|hormones|mesh-ancestor
20631041|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631042|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631043|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
20631044|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
20631045|NCT05005897|Vitamins|vitamins|mesh-ancestor
20631046|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
20631047|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631048|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
20631049|NCT05005897|Hematinics|hematinics|mesh-ancestor
20631050|NCT04881032|Temozolomide|temozolomide|mesh-list
20631051|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20631052|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
20631053|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631054|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631055|NCT04849650|Amisulpride|amisulpride|mesh-list
20631056|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20631057|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20631058|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631059|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631060|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631061|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20631062|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
20631063|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631064|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631065|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20631066|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
20631067|NCT04765137|Atorvastatin|atorvastatin|mesh-list
20631068|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20631069|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20631070|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
20631071|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696437|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
19696438|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696439|NCT04940299|Nivolumab|nivolumab|mesh-list
19696440|NCT04940299|Ipilimumab|ipilimumab|mesh-list
19696441|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
19696442|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
19696443|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696444|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696445|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19696446|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696447|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
19696448|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696449|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
19696450|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19696451|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20631072|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20631073|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20631074|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631075|NCT04721821|Tofacitinib|tofacitinib|mesh-list
20631076|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631077|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631078|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631079|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
20631080|NCT04721457|Listerine|listerine|mesh-list
20631081|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20631082|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
20631083|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20631084|NCT04721457|Eusol|eusol|mesh-list
20631085|NCT04721457|Povidone|povidone|mesh-list
20631086|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
20631087|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
20631088|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
20631089|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20631090|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631091|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
20631092|NCT04721457|Protective Agents|protective agents|mesh-ancestor
20631093|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631094|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
20631107|NCT04586920|Itraconazole|itraconazole|mesh-list
20631108|NCT04586920|Midazolam|midazolam|mesh-list
20631109|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20631110|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19850659|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
19850660|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850661|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850662|NCT00711802|Daptomycin|daptomycin|mesh-list
19850663|NCT00711802|Cloxacillin|cloxacillin|mesh-list
20631111|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631112|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631113|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20631114|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20631115|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631116|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20631117|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
20631118|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
20631119|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
20631120|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
20631121|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631122|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631123|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
19850664|NCT00711802|Oxacillin|oxacillin|mesh-list
20631124|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631125|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19850665|NCT00711802|Nafcillin|nafcillin|mesh-list
20631126|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20631127|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631128|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20631129|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
20631130|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631131|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20631132|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
20631133|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20631134|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
20631135|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631136|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20631137|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631138|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20631139|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631140|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20631141|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631142|NCT04454905|Apatinib|apatinib|mesh-list
20631143|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631144|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631145|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631146|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631147|NCT04285684|Ketamine|ketamine|mesh-list
20631148|NCT04285684|Analgesics|analgesics|mesh-ancestor
20631149|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
20631150|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631151|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631152|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20631153|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20631154|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
20631155|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
20631156|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631157|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20631158|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20631159|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631160|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411913|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19411914|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411915|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411916|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631161|NCT04144023|Molgramostim|molgramostim|mesh-list
20631162|NCT04144023|Vaccines|vaccines|mesh-list
20631163|NCT04144023|Sargramostim|sargramostim|mesh-list
20631164|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
20631165|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631166|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631167|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20631168|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20631169|NCT04079218|Estradiol|estradiol|mesh-list
20631170|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20631171|NCT04079218|Estrogens|estrogens|mesh-ancestor
20631172|NCT04079218|Hormones|hormones|mesh-ancestor
20631173|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631174|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631175|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20631176|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
20631177|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20631178|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20631179|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
20631180|NCT04013555|Tryptophan|tryptophan|mesh-list
20631181|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20631182|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
20631183|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631184|NCT04013555|Expectorants|expectorants|mesh-ancestor
20631185|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
20631186|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20631187|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
20631188|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631189|NCT04013555|Protective Agents|protective agents|mesh-ancestor
20631190|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631191|NCT04013555|Antidotes|antidotes|mesh-ancestor
20631192|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20631193|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
20631194|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631195|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
20631196|NCT03994172|Vitamin D|vitamin d|mesh-list
20631197|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
20631198|NCT03994172|Teriparatide|teriparatide|mesh-list
20631199|NCT03994172|Citric Acid|citric acid|mesh-list
20631200|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
20631201|NCT03994172|Calcium|calcium|mesh-list
20631202|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
20631203|NCT03994172|Cinacalcet|cinacalcet|mesh-list
20631204|NCT03994172|Hormones|hormones|mesh-list
20631205|NCT03994172|Vitamins|vitamins|mesh-ancestor
20631206|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
20631207|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631208|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20631209|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20631210|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
20631211|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20631212|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
20631213|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
20631214|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631215|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631216|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19411917|NCT03535883|Anticoagulants|anticoagulants|mesh-list
20631217|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
20631218|NCT03924947|Pancrelipase|pancrelipase|mesh-list
20631219|NCT03924947|Pancreatin|pancreatin|mesh-list
20631220|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631221|NCT03919435|Trimethoprim|trimethoprim|mesh-list
20631222|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20631223|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
20631224|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20631225|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631226|NCT03919435|Renal Agents|renal agents|mesh-ancestor
20631227|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
20631228|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20631229|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20631230|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20631231|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631232|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696452|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19696453|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696454|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696455|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
19696456|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696457|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696458|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20631233|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20631234|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20631235|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20631236|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20631237|NCT03887936|Testosterone|testosterone|mesh-list
20631238|NCT03887936|Androgens|androgens|mesh-ancestor
20631239|NCT03887936|Hormones|hormones|mesh-ancestor
20631240|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631241|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631242|NCT03884439|Infliximab|infliximab|mesh-list
20631243|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20631244|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631245|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20631246|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
20631247|NCT03831711|Bombesin|bombesin|mesh-list
20631248|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631249|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631250|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631251|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631252|NCT03829462|Irinotecan|irinotecan|mesh-list
20631253|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20631254|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20631255|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631256|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631257|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631258|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
20631259|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631260|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631261|NCT03774641|Lamotrigine|lamotrigine|mesh-list
20631262|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
20631263|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20631264|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20631265|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631266|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20631267|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631268|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20631269|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20631270|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631271|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631272|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20631273|NCT03643965|Budesonide|budesonide|mesh-list
20631274|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20631275|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20631276|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
20631277|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631278|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631279|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20631280|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
20631281|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
20631282|NCT03643965|Hormones|hormones|mesh-ancestor
20631283|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631284|NCT03595566|Vancomycin|vancomycin|mesh-list
20631285|NCT03595566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20631286|NCT03595566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631287|NCT03595553|Vancomycin|vancomycin|mesh-list
20631288|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20631289|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631290|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20631291|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20631292|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631293|NCT03530397|Carboplatin|carboplatin|mesh-list
20631294|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
20631295|NCT03530397|Pemetrexed|pemetrexed|mesh-list
20631296|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631297|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631298|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631299|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631300|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20631301|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20631302|NCT03516292|Mitogens|mitogens|mesh-list
20631303|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
20631304|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631305|NCT03336541|Ketamine|ketamine|mesh-list
20631306|NCT03336541|Analgesics|analgesics|mesh-ancestor
20631307|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
20631308|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631309|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631310|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20631311|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20631312|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
20631313|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
20631314|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631315|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20631316|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20631317|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631318|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631319|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
20631320|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20631321|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20631322|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
20631323|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631324|NCT03241732|Expectorants|expectorants|mesh-ancestor
20631325|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
20631326|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20631327|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
20631328|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631329|NCT03241732|Protective Agents|protective agents|mesh-ancestor
20631330|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631331|NCT03241732|Antidotes|antidotes|mesh-ancestor
20631332|NCT03230916|Relebactam|relebactam|mesh-list
20631333|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20631334|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631335|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631336|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20631337|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631338|NCT03202667|Empagliflozin|empagliflozin|mesh-list
20631339|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20631340|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631341|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20631342|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631343|NCT03021993|Nivolumab|nivolumab|mesh-list
20631344|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631345|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631346|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20631347|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631348|NCT02954081|Apremilast|apremilast|mesh-list
20631349|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20631350|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20631351|NCT02954081|Analgesics|analgesics|mesh-ancestor
20631352|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
20631353|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631354|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631355|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20631356|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19411918|NCT03535883|Coagulants|coagulants|mesh-list
19411919|NCT03535870|Fluticasone|fluticasone|mesh-list
19411920|NCT03535870|Xhance|xhance|mesh-list
20631357|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20631358|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20631359|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631360|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631361|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
20631362|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20631363|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20631364|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631365|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
20631366|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631367|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631368|NCT02763319|Rituximab|rituximab|mesh-list
20631369|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20631370|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631371|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631372|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
20631373|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631374|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20631375|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20631376|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
20631377|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631378|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20631379|NCT02673567|Antibodies|antibodies|mesh-list
20631380|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
20631381|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20631382|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
20631383|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631384|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631385|NCT02628626|Clonidine|clonidine|mesh-list
20631386|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20631387|NCT02628626|Analgesics|analgesics|mesh-ancestor
20631388|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
20631389|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631390|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631391|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20631392|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
20631393|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
20631394|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20631395|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20631396|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20631397|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
20631398|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631399|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631400|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20631401|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20631402|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
20631403|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20631404|NCT02536183|Doxorubicin|doxorubicin|mesh-list
19696459|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696460|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
19696461|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19696462|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19696463|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20631405|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20631406|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20631407|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631408|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20631409|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20631410|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631411|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631412|NCT02523313|Nivolumab|nivolumab|mesh-list
20631413|NCT02523313|Ipilimumab|ipilimumab|mesh-list
20631414|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631415|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631416|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20631417|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631418|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
20631419|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631420|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696464|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696465|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696466|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
19696467|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475487|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20475488|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20475489|NCT01511263|Amiodarone|amiodarone|mesh-list
20475490|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20475491|NCT01511263|Diuretics|diuretics|mesh-list
20475492|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
20475493|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475494|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
20475495|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20475496|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20475497|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475498|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20475499|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20475500|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20475501|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475502|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20475503|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20475504|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20475505|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
20475506|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475507|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20475508|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475509|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475510|NCT01511302|Budesonide|budesonide|mesh-list
20475511|NCT01511302|RNS60|rns60|mesh-list
20475512|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475513|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20475514|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
20475515|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475516|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475517|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20475518|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
20475519|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
20475520|NCT01511302|Hormones|hormones|mesh-ancestor
20475521|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475522|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20475523|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20475524|NCT01511302|Analgesics|analgesics|mesh-ancestor
20475525|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
20475526|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20475527|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20475528|NCT01511367|Fluticasone|fluticasone|mesh-list
20475529|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20475530|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20475531|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
20475532|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475533|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475534|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20475535|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
20475536|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
20475537|NCT01511367|Hormones|hormones|mesh-ancestor
20475538|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475539|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
20475540|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475541|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
20475542|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20475543|NCT01511471|Ticagrelor|ticagrelor|mesh-list
20475544|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20475545|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20475546|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20475547|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20475548|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
20475549|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475550|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475551|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527527|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20527528|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527529|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527530|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20527531|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
20631421|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20631422|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20631423|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631424|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631425|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20631426|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20631427|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631428|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
20631429|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631430|NCT01602666|Carboplatin|carboplatin|mesh-list
20631431|NCT01602666|Etoposide|etoposide|mesh-list
20631432|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
20631433|NCT01602666|Ifosfamide|ifosfamide|mesh-list
20631434|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
20631435|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
20631436|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631437|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20631438|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20631439|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20631440|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631441|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631442|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20631443|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
20631444|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
20631445|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
20631446|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
20631447|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
20631448|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
20631449|NCT01489813|Genistein|genistein|mesh-list
20631450|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20631451|NCT01489813|Protective Agents|protective agents|mesh-ancestor
20631452|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631453|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631454|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631455|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631456|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631457|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
20631458|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20631459|NCT01489813|Estrogens|estrogens|mesh-ancestor
20631460|NCT01489813|Hormones|hormones|mesh-ancestor
20631461|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631462|NCT01375959|Resveratrol|resveratrol|mesh-list
20631463|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
20631464|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631465|NCT01375959|Protective Agents|protective agents|mesh-ancestor
20631466|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631467|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631468|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20631469|NCT00380653|Sapacitabine|sapacitabine|mesh-list
20475552|NCT01511562|Cytarabine|cytarabine|mesh-list
20475553|NCT01511562|Etoposide|etoposide|mesh-list
20475554|NCT01511562|Thiotepa|thiotepa|mesh-list
20475555|NCT01511562|Carmustine|carmustine|mesh-list
20475556|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20475557|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475558|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20475559|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20475560|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475561|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475562|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20475563|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
20475564|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
20631470|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631471|NCT00354835|Dactinomycin|dactinomycin|mesh-list
20631472|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
20475565|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475566|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475567|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
20475568|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631473|NCT00354835|Irinotecan|irinotecan|mesh-list
20631474|NCT00354835|Vincristine|vincristine|mesh-list
20631475|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20631476|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
20631477|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475569|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20475570|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
20631478|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20631479|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20631480|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
20631481|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631482|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631483|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20631484|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20631485|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20631486|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631487|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20631488|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20631489|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20631490|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
20631491|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20631492|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631493|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20631494|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20631495|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20631496|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
20631497|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20631498|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631499|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
20631500|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20631501|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631502|NCT05156970|Carboplatin|carboplatin|mesh-list
20631503|NCT05156970|Docetaxel|docetaxel|mesh-list
20631504|NCT05156970|Apatinib|apatinib|mesh-list
20631505|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631506|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20631507|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
20631508|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20631509|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631510|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631511|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631512|NCT05156892|Tamoxifen|tamoxifen|mesh-list
20631513|NCT05156892|Itraconazole|itraconazole|mesh-list
20631514|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20631515|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
20631516|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631517|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631518|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20631519|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631520|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20631521|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20631522|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20631523|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
20631524|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631525|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20631526|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20631527|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631528|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631529|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20631530|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20631531|NCT05156788|Lenvatinib|lenvatinib|mesh-list
20631532|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631533|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631534|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631535|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631536|NCT05156749|Calpastatin|calpastatin|mesh-list
20631537|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20631538|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
20631539|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631540|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631541|NCT05156658|Etonogestrel|etonogestrel|mesh-list
20631542|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20631543|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
20631544|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20631545|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631546|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20631547|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20631548|NCT05156632|Vaccines|vaccines|mesh-list
20631549|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
20631550|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411921|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20631551|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20631552|NCT05156632|Antacids|antacids|mesh-ancestor
20631553|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631554|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631555|NCT05156541|Interferons|interferons|mesh-list
20631556|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
20631557|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631558|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
20631559|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631560|NCT05156450|Prednisone|prednisone|mesh-list
20631561|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
20631562|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20631563|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
20631564|NCT05156450|Hormones|hormones|mesh-ancestor
20631565|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631566|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631567|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20631568|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631569|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20631570|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631571|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631572|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
20631573|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20631574|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
20631575|NCT05156021|Bevacizumab|bevacizumab|mesh-list
20631576|NCT05156021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631577|NCT05156021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631578|NCT05156021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20631579|NCT05156021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20631580|NCT05156021|Growth Substances|growth substances|mesh-ancestor
19696468|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696469|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19696470|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696471|NCT04939883|Carvedilol|carvedilol|mesh-list
19696472|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19411922|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19411923|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19411924|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19696473|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20631581|NCT05156021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631582|NCT05156021|Growth Inhibitors|growth inhibitors|mesh-ancestor
20631583|NCT05155969|Ketamine|ketamine|mesh-list
20631584|NCT05155969|Esketamine|esketamine|mesh-list
20631585|NCT05155969|Analgesics|analgesics|mesh-ancestor
20631586|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
20631587|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631588|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631589|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20631590|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20631591|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
20631592|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
20631593|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631594|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20631595|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20631596|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631597|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631598|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
20631599|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631600|NCT05150496|Vaccines|vaccines|mesh-list
20631601|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
20631602|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631603|NCT05112913|Vaccines|vaccines|mesh-list
20631604|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
20631605|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631606|NCT05112549|Nivolumab|nivolumab|mesh-list
20631607|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631608|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631609|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20631610|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631611|NCT04952324|Folic Acid|folic acid|mesh-list
20631612|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
20631613|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
20631614|NCT04952324|Vitamins|vitamins|mesh-ancestor
20631615|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
20631616|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631617|NCT04952324|Hematinics|hematinics|mesh-ancestor
20631618|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
19411925|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
20631619|NCT04934020|Metronidazole|metronidazole|mesh-list
20631620|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631621|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20631622|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20631623|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20631624|NCT04910061|Niacinamide|niacinamide|mesh-list
20631625|NCT04910061|Niacin|niacin|mesh-list
20631626|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
20631627|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
20631628|NCT04910061|Vitamins|vitamins|mesh-ancestor
20631629|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
20631630|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631631|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20631632|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
20631633|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631634|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20631635|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
20631636|NCT04901702|Irinotecan|irinotecan|mesh-list
20631637|NCT04901702|Temozolomide|temozolomide|mesh-list
20631638|NCT04901702|Talazoparib|talazoparib|mesh-list
20631639|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20631640|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20631641|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631642|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631643|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631644|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20631645|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
20631646|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20631647|NCT04862338|Niacinamide|niacinamide|mesh-list
20631648|NCT04862338|Niacin|niacin|mesh-list
20631649|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
20631650|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
20631651|NCT04862338|Vitamins|vitamins|mesh-ancestor
20631652|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
20631653|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631654|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20631655|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
20631656|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631657|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20631658|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
20631659|NCT04843423|Cariprazine|cariprazine|mesh-list
20631660|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20631661|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20631662|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631663|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631664|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20631665|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
20631666|NCT04798469|Testosterone|testosterone|mesh-list
20631667|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
20631668|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
20631669|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20631670|NCT04798469|Androgens|androgens|mesh-ancestor
20631671|NCT04798469|Hormones|hormones|mesh-ancestor
20631672|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631673|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631674|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20631675|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631676|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
20631677|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20631678|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
20631679|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631680|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20631681|NCT04774250|Zonisamide|zonisamide|mesh-list
20631682|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
20631683|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20631684|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20631685|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631686|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20631687|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631688|NCT04768569|Zonisamide|zonisamide|mesh-list
20631689|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
20631690|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20631691|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696474|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
20631692|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631693|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20631694|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631695|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
20631696|NCT04645602|Lenvatinib|lenvatinib|mesh-list
20631697|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631698|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631699|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631700|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631701|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631702|NCT04560725|Choline|choline|mesh-list
20631703|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
20631704|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20631705|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
20631706|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631707|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631708|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20631709|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
20631710|NCT04549051|Anesthetics|anesthetics|mesh-list
20631711|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
20631712|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631713|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631714|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
20631715|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631716|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
20631717|NCT04530539|Melatonin|melatonin|mesh-list
20631718|NCT04530539|Vitamins|vitamins|mesh-ancestor
20631719|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
20631720|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631721|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
20631722|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631723|NCT04530539|Protective Agents|protective agents|mesh-ancestor
20631724|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631725|NCT04518306|Amlodipine|amlodipine|mesh-list
20631726|NCT04518306|Telmisartan|telmisartan|mesh-list
20631727|NCT04518306|Indapamide|indapamide|mesh-list
20631728|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20631729|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20631730|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20631731|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631732|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20631733|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631734|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
20631735|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20631736|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20631737|NCT04518306|Diuretics|diuretics|mesh-ancestor
20631738|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
20631739|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20631740|NCT04518293|Amlodipine|amlodipine|mesh-list
20631741|NCT04518293|Telmisartan|telmisartan|mesh-list
20631742|NCT04518293|Indapamide|indapamide|mesh-list
20631743|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20631744|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20631745|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20631746|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631747|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19411926|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411927|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475571|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20475572|NCT01511627|Anesthetics|anesthetics|mesh-list
20475573|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475574|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475575|NCT01511692|Liraglutide|liraglutide|mesh-list
19411928|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19411929|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
19411930|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
19411931|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19411932|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19411933|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19411934|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20475576|NCT01511692|Glimepiride|glimepiride|mesh-list
20475577|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475578|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475579|NCT01511692|Incretins|incretins|mesh-ancestor
20475580|NCT01511692|Hormones|hormones|mesh-ancestor
20475581|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696475|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696476|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696477|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631748|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631749|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
20631750|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20631751|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20631752|NCT04518293|Diuretics|diuretics|mesh-ancestor
20631753|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
20631754|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20631755|NCT04506138|Paclitaxel|paclitaxel|mesh-list
20631756|NCT04506138|Carboplatin|carboplatin|mesh-list
20631757|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20631758|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631759|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
20631760|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
20631761|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
20631762|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631763|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20631764|NCT04503707|Hormones|hormones|mesh-ancestor
20631765|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631766|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631767|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
20631768|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631769|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631770|NCT04456153|Atovaquone|atovaquone|mesh-list
20631771|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631772|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
20631773|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20631774|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20631775|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631776|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631777|NCT04455464|Midodrine|midodrine|mesh-list
20631778|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
20631779|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
20631780|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631781|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631782|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20631783|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20631784|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20631785|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20631786|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
20631787|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631788|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631789|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
20631790|NCT04403971|Listerine|listerine|mesh-list
20631791|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20631792|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631793|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
20631794|NCT04351243|Gimsilumab|gimsilumab|mesh-list
20631795|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20631796|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
20631797|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631798|NCT04351061|Acetazolamide|acetazolamide|mesh-list
20631799|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
20631800|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20631801|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631802|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631803|NCT04351061|Diuretics|diuretics|mesh-ancestor
20631804|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
20631805|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631806|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20631807|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631808|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631809|NCT04325659|Lofexidine|lofexidine|mesh-list
20631810|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20631811|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20631812|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631813|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
20631814|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631815|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20631816|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20631817|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20631818|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
20631819|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631820|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631821|NCT04321174|Ritonavir|ritonavir|mesh-list
20631822|NCT04321174|Lopinavir|lopinavir|mesh-list
20631823|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20631824|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20631825|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
20631826|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631827|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631828|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20631829|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20631830|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
20631831|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631832|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20631833|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20631834|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20631835|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
20631836|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
20631837|NCT04206761|Bromides|bromides|mesh-list
20631838|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
20631839|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20631840|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
20631841|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20631842|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20631843|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20631844|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20631845|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
20631846|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631847|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631848|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631849|NCT04194814|Betamethasone|betamethasone|mesh-list
20631850|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
20631851|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20631852|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
20631853|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20631854|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20631855|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
20631856|NCT04194814|Hormones|hormones|mesh-ancestor
20631857|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631858|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631859|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20631860|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
20631861|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
20631862|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631863|NCT04143204|Insulin|insulin|mesh-list
20631864|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20631865|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631866|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
20631867|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
20631868|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631869|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20631870|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631871|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631872|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20631873|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
20631874|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631875|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
20631876|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631877|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631878|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
20631879|NCT04093752|Tirzepatide|tirzepatide|mesh-list
20631880|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20631881|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631882|NCT04093752|Incretins|incretins|mesh-ancestor
20631883|NCT04093752|Hormones|hormones|mesh-ancestor
20631884|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631885|NCT04055428|Valsartan|valsartan|mesh-list
20631886|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20631887|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20631888|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20631889|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631890|NCT03998293|Somatostatin|somatostatin|mesh-list
20631891|NCT03998293|Hormones|hormones|mesh-ancestor
20631892|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631893|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631894|NCT03962998|Lactulose|lactulose|mesh-list
20631895|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631896|NCT03925246|Nivolumab|nivolumab|mesh-list
20631897|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20631898|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631899|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20631900|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631901|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20631902|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20631903|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
20631904|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
20631905|NCT03743402|Narcotics|narcotics|mesh-ancestor
20631906|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631907|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631908|NCT03743402|Analgesics|analgesics|mesh-ancestor
20631909|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
20631910|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631911|NCT03668639|Dexamethasone|dexamethasone|mesh-list
20631912|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20631913|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
20631914|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
20631915|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20631916|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631917|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20631918|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
20631919|NCT03668639|Hormones|hormones|mesh-ancestor
20631920|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20631921|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20631922|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631923|NCT03618693|Anesthetics|anesthetics|mesh-list
20631924|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20631925|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631926|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20631927|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20631928|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
20631929|NCT03600714|Interferons|interferons|mesh-list
20631930|NCT03600714|Ritonavir|ritonavir|mesh-list
20631931|NCT03600714|Lonafarnib|lonafarnib|mesh-list
20631932|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631933|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
20631934|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631935|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20631936|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20631937|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
20631938|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631939|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631940|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20631941|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20631942|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20631943|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20631944|NCT03530124|Vaccines|vaccines|mesh-list
20631945|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20631946|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
20631947|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631948|NCT03518203|Eculizumab|eculizumab|mesh-list
20631949|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20631950|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20631951|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
20631952|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631953|NCT03479307|Ketotifen|ketotifen|mesh-list
20631954|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20631955|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20631956|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
20631957|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
20631958|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20631959|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
20631960|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
20631961|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20631962|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631963|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631964|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20631965|NCT03474640|Antibodies|antibodies|mesh-list
20631966|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20631967|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
20631968|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20631969|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20631970|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
20631971|NCT03393741|Paclitaxel|paclitaxel|mesh-list
20631972|NCT03393741|Vinorelbine|vinorelbine|mesh-list
20631973|NCT03393741|Docetaxel|docetaxel|mesh-list
20631974|NCT03393741|Epothilones|epothilones|mesh-list
20631975|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
20631976|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20631977|NCT03393741|Taxane|taxane|mesh-list
20631978|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20631979|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20631980|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
20631981|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
20631982|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
20631983|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631984|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20631985|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
20631986|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
20631987|NCT03379389|Methenamine|methenamine|mesh-list
20631988|NCT03379389|Acriflavine|acriflavine|mesh-list
20631989|NCT03379389|Methylene Blue|methylene blue|mesh-list
20631990|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20631991|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631992|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20631993|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20631994|NCT03379389|Renal Agents|renal agents|mesh-ancestor
20631995|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20631996|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20631997|NCT03377803|Cantharidin|cantharidin|mesh-list
20631998|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20631999|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632000|NCT03283371|Natalizumab|natalizumab|mesh-list
20632001|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
20632002|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632003|NCT03257254|Polidocanol|polidocanol|mesh-list
20632004|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20632005|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20632006|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20632007|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
20632008|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
20632009|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20632010|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
20632011|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20632012|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20632013|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
20632014|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632015|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632016|NCT03153319|Adalimumab|adalimumab|mesh-list
20632017|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632018|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632019|NCT03084718|Beclomethasone|beclomethasone|mesh-list
20632020|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632021|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
20632022|NCT03084718|Hormones|hormones|mesh-ancestor
20632023|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632024|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632025|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20632026|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
20632027|NCT03059511|Nalbuphine|nalbuphine|mesh-list
20632028|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20632029|NCT03059511|Narcotics|narcotics|mesh-ancestor
20632030|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632031|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632032|NCT03059511|Analgesics|analgesics|mesh-ancestor
20632033|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
20632034|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632035|NCT03033303|Isotretinoin|isotretinoin|mesh-list
20632036|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632037|NCT02944578|Curcumin|curcumin|mesh-list
20632038|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20632039|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20632040|NCT02944578|Analgesics|analgesics|mesh-ancestor
20632041|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
20632042|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632043|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632044|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632045|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632046|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632047|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632048|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411935|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
20475582|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20475583|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475584|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
20475585|NCT01511705|Ondansetron|ondansetron|mesh-list
20475586|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
20475587|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
20475588|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475589|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475590|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475591|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
20475592|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
20475593|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20475594|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
20475595|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475596|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475597|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20475598|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20475599|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475600|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20475601|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20475602|NCT01511718|Ondansetron|ondansetron|mesh-list
20475603|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
20475604|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
20475605|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475606|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475607|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475608|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
20475609|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
20475610|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20475611|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
20475612|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475613|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475614|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20475615|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20475616|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475617|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20475618|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20475619|NCT01511731|Famotidine|famotidine|mesh-list
20475620|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20475621|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475622|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20475623|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
20475624|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
20475625|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475626|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475627|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475628|NCT01511757|Fluconazole|fluconazole|mesh-list
20475629|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
20475630|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475631|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20475632|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20475633|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475634|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475635|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20475636|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
20475637|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475638|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475639|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20475640|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20475641|NCT01511770|Fluconazole|fluconazole|mesh-list
20475642|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
20475643|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475644|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20475645|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20475646|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475647|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475648|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20475649|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
20475650|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475651|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632049|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
20632050|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632051|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632052|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
20632053|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20632054|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20632055|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632056|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
20632057|NCT02866838|Coagulants|coagulants|mesh-ancestor
20632058|NCT02824679|Scopolamine|scopolamine|mesh-list
20632059|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20632060|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20632061|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
20632062|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
20632063|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632064|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632065|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632066|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
20632067|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20632068|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
20632069|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226722|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632070|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411936|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696478|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20632071|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20632072|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
20632073|NCT02684461|Paclitaxel|paclitaxel|mesh-list
20632074|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
20632075|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20632076|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632077|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
20632078|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
20632079|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
20632080|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632081|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632082|NCT02437318|Fulvestrant|fulvestrant|mesh-list
20632083|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20632084|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632085|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20632086|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20632087|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
20632088|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632089|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632090|NCT02259517|Guanfacine|guanfacine|mesh-list
20632091|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20632092|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20632093|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632094|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20632095|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20632096|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632097|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632098|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
20632099|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632100|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20632101|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20632102|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20632103|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20632104|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
20632105|NCT02209545|Pyridoxine|pyridoxine|mesh-list
20632106|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
20632107|NCT02209545|Misoprostol|misoprostol|mesh-list
20632108|NCT02209545|Vitamins|vitamins|mesh-ancestor
20632109|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
20632110|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632111|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20632112|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
20632113|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20632114|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20632115|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632116|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
20632117|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
20632118|NCT01585805|Gemcitabine|gemcitabine|mesh-list
19696479|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
20226723|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632119|NCT01585805|Cisplatin|cisplatin|mesh-list
20632120|NCT01585805|Veliparib|veliparib|mesh-list
20632121|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632122|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20632123|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
20632124|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632125|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
20632126|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632127|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632128|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632129|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
20632130|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632131|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20632132|NCT01147822|Sunitinib|sunitinib|mesh-list
20632133|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632134|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20632135|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20632136|NCT01147822|Growth Substances|growth substances|mesh-ancestor
20632137|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632138|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
20632139|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20632140|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632141|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632142|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
20632143|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632144|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
20632145|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632146|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632147|NCT00695279|Vaccines|vaccines|mesh-list
20632148|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
20632149|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632150|NCT00521846|Cimetidine|cimetidine|mesh-list
20632151|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20632152|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632153|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20632154|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
20632155|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
20632156|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632157|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632158|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632159|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20632160|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20632161|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632162|NCT00328653|Cyclosporine|cyclosporine|mesh-list
20632163|NCT00328653|Cyclosporins|cyclosporins|mesh-list
20632164|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632165|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632166|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632167|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
19850666|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19850667|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475652|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20475653|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20475654|NCT01511822|Inositol|inositol|mesh-list
20475655|NCT01511822|Drospirenone|drospirenone|mesh-list
20475656|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20475657|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20475658|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20475659|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20475660|NCT01511822|Estradiol|estradiol|mesh-list
20475661|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20475662|NCT01511822|Estrogens|estrogens|mesh-ancestor
20475663|NCT01511822|Hormones|hormones|mesh-ancestor
20475664|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475665|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475666|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20475667|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
20475668|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20632168|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632169|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
20632170|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850668|NCT00711828|Dexamethasone|dexamethasone|mesh-list
19850669|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
20475669|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20632171|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632172|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632173|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20632174|NCT05158777|Vaccines|vaccines|mesh-list
20632175|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
20632176|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632177|NCT05158699|Dexamethasone|dexamethasone|mesh-list
20632178|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
20632179|NCT05158699|Triamcinolone|triamcinolone|mesh-list
20632180|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20632181|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20632182|NCT05158699|Ketorolac|ketorolac|mesh-list
20632183|NCT05158699|Bromfenac|bromfenac|mesh-list
20632184|NCT05158699|Phenylephrine|phenylephrine|mesh-list
20632185|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20632186|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20632187|NCT05158699|BB 1101|bb 1101|mesh-list
20632188|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20632189|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632190|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
20632191|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
20632192|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632193|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632194|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632195|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
20632196|NCT05158699|Hormones|hormones|mesh-ancestor
20632197|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632198|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20632199|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632200|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
20632201|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632202|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632203|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632204|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
20632205|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20632206|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20632207|NCT05158699|Analgesics|analgesics|mesh-ancestor
20632208|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
20632209|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632210|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20632211|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20632212|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
20632213|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
20632214|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20632215|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
20632216|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
20632217|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20632218|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20632219|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20632220|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
20632221|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632222|NCT05158699|Protective Agents|protective agents|mesh-ancestor
20632223|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
20632224|NCT05158647|Analgesics|analgesics|mesh-ancestor
20632225|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
20632226|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632227|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632228|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
20632229|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632230|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20632231|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
20632232|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20632233|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632234|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632235|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20632236|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
20632237|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20632238|NCT05158517|Vedolizumab|vedolizumab|mesh-list
20632239|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632240|NCT05158426|Propofol|propofol|mesh-list
20632241|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20632242|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632243|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632244|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20632245|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
20632246|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
20632247|NCT05158348|Lidocaine|lidocaine|mesh-list
19850670|NCT00711828|Rituximab|rituximab|mesh-list
19850671|NCT00711828|Bortezomib|bortezomib|mesh-list
20632248|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
20632249|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
20632250|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
20632251|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632252|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632253|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
20632254|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632255|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20632256|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20632257|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20632258|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632259|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632260|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20632261|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20632262|NCT05158348|Analgesics|analgesics|mesh-ancestor
20632263|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20632264|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20632265|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20632266|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
20632267|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632268|NCT05157893|Analgesics|analgesics|mesh-list
20632269|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
20632270|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632271|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632272|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
20632273|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20632274|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
20632275|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632276|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632277|NCT05157542|Paclitaxel|paclitaxel|mesh-list
20632278|NCT05157542|Durvalumab|durvalumab|mesh-list
20632279|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20632280|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20632281|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632282|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
20632283|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
20632284|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
20632285|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632286|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632287|NCT05157360|Vitamins|vitamins|mesh-list
20632288|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
20632289|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
20632290|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632291|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850672|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19411937|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632292|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20632293|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20632294|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20632295|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632296|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632297|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20632298|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632299|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632300|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
20632301|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632302|NCT05080946|Aspirin|aspirin|mesh-list
20632303|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20632304|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20632305|NCT05080946|Analgesics|analgesics|mesh-ancestor
20632306|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
20632307|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632308|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632309|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632310|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632311|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20632312|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20632313|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632314|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20632315|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20632316|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632317|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
20632318|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
20632319|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
20632320|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632321|NCT05079126|Protective Agents|protective agents|mesh-ancestor
20632322|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632323|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20632324|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632325|NCT05076253|Ivermectin|ivermectin|mesh-list
20632326|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19696480|NCT04939883|Protective Agents|protective agents|mesh-ancestor
19696481|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19696482|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696483|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19696484|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
19696485|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19696486|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19696487|NCT04939662|Bevacizumab|bevacizumab|mesh-list
19696488|NCT04939662|Olaparib|olaparib|mesh-list
20475670|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20632327|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632328|NCT05071183|Trametinib|trametinib|mesh-list
20632329|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632330|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20632331|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632332|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632333|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
20632334|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632335|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632336|NCT04983498|Ondansetron|ondansetron|mesh-list
20632337|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
20632338|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
20632339|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632340|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632341|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632342|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
20632343|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632344|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20475671|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20475672|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
20475673|NCT01511822|Vitamins|vitamins|mesh-ancestor
20475674|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
20475675|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20475676|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
20475677|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20475678|NCT01511822|Diuretics|diuretics|mesh-ancestor
20475679|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
20475680|NCT01511835|Folic Acid|folic acid|mesh-list
20475681|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
20632345|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
20632346|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632347|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632348|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20632349|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20632350|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632351|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20632352|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20632353|NCT04963439|Macitentan|macitentan|mesh-list
20632354|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20632355|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20632356|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632357|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19696489|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696490|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696491|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19696492|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19696493|NCT04939662|Growth Substances|growth substances|mesh-ancestor
19696494|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696495|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
20632358|NCT04947592|Fluconazole|fluconazole|mesh-list
20632359|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
20632360|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632361|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20632362|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20632363|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632364|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632365|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20632366|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
20632367|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632368|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632369|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20632370|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20632371|NCT04865939|Gemcitabine|gemcitabine|mesh-list
20632372|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20632373|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
20632374|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632375|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632376|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
20632377|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632378|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632379|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632380|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
20632381|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632382|NCT04831892|Isosorbide|isosorbide|mesh-list
20632383|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20632384|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20632385|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20632386|NCT04831892|Diuretics|diuretics|mesh-ancestor
20632387|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
20632388|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632389|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
19696496|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19696497|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696498|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696499|NCT04939857|Trimetazidine|trimetazidine|mesh-list
19696500|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
19707865|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707866|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19707867|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
19707868|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19707869|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
19707870|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
19707871|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707872|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707873|NCT04822415|Mepivacaine|mepivacaine|mesh-list
19707874|NCT04822415|Carticaine|carticaine|mesh-list
19707875|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
19707876|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
19707877|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411938|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
19707878|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707879|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
20475682|NCT01511835|Inositol|inositol|mesh-list
20475683|NCT01511835|Hematinics|hematinics|mesh-ancestor
20475684|NCT01511835|Vitamins|vitamins|mesh-ancestor
20475685|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
20475686|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632390|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20632391|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632392|NCT04761627|Ustekinumab|ustekinumab|mesh-list
20632393|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632394|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
20632395|NCT04761614|Leucovorin|leucovorin|mesh-list
20632396|NCT04761614|Folic Acid|folic acid|mesh-list
20632397|NCT04761614|Bevacizumab|bevacizumab|mesh-list
20632398|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20632399|NCT04761614|Fluorouracil|fluorouracil|mesh-list
20632400|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
20632401|NCT04761614|Riluzole|riluzole|mesh-list
20632402|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
20632403|NCT04761614|Antibodies|antibodies|mesh-list
20632404|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
20632405|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20632406|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
20632407|NCT04761614|Calcium|calcium|mesh-list
20632408|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
20632409|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632410|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20632411|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20632412|NCT04761614|Growth Substances|growth substances|mesh-ancestor
20632413|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632414|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
20632415|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
20632416|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20632417|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20632418|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
20632419|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632420|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20632421|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632422|NCT04761614|Antidotes|antidotes|mesh-ancestor
20632423|NCT04761614|Protective Agents|protective agents|mesh-ancestor
20632424|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
20632425|NCT04761614|Vitamins|vitamins|mesh-ancestor
20632426|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
20632427|NCT04761614|Hematinics|hematinics|mesh-ancestor
20632428|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
20632429|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20632430|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20632431|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632432|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20632433|NCT04694248|Aspirin|aspirin|mesh-list
20632434|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
20632435|NCT04694248|Anticoagulants|anticoagulants|mesh-list
20632436|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20632437|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20632438|NCT04694248|Analgesics|analgesics|mesh-ancestor
20632439|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
20632440|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632441|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632442|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632443|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632444|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20632445|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20632446|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632447|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20632448|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20475687|NCT01511848|Deferasirox|deferasirox|mesh-list
20475688|NCT01511848|Deferiprone|deferiprone|mesh-list
20475689|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20475690|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
20475691|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
20475692|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475693|NCT01511874|Leuprolide|leuprolide|mesh-list
20475694|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20632449|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632450|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
20632451|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20632452|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
20632453|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20632454|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
20632455|NCT04650152|Fenofibrate|fenofibrate|mesh-list
20632456|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20632457|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
20632458|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632459|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20632460|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20632461|NCT04631601|Androgens|androgens|mesh-list
20632462|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
20632463|NCT04631601|Hormones|hormones|mesh-ancestor
20632464|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632465|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632466|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632467|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632468|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
20632469|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
20632470|NCT04608955|Bedaquiline|bedaquiline|mesh-list
20632471|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
20632472|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20632473|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632474|NCT04579783|Triamcinolone|triamcinolone|mesh-list
20632475|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20632476|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20632477|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20632478|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632479|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
20632480|NCT04579783|Hormones|hormones|mesh-ancestor
20632481|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632482|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632483|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632484|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
20632485|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632486|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632487|NCT04559347|Bupivacaine|bupivacaine|mesh-list
20632488|NCT04559347|Ropivacaine|ropivacaine|mesh-list
20632489|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
20632490|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
20632491|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632492|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632493|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
20632494|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632495|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
20632496|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
20632497|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20632498|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20632499|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632500|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632501|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632502|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632503|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
20632504|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20632505|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20632506|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632507|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
20632508|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632509|NCT04345861|Azithromycin|azithromycin|mesh-list
20632510|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
20632511|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20632512|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632513|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
20632514|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20632515|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20632516|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632517|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632518|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632519|NCT04278404|Metformin|metformin|mesh-list
20632520|NCT04278404|Interferons|interferons|mesh-list
20632521|NCT04278404|Ritonavir|ritonavir|mesh-list
20632522|NCT04278404|Ribavirin|ribavirin|mesh-list
20632523|NCT04278404|Lopinavir|lopinavir|mesh-list
20632524|NCT04278404|Oseltamivir|oseltamivir|mesh-list
20632525|NCT04278404|Remdesivir|remdesivir|mesh-list
20632526|NCT04278404|Azithromycin|azithromycin|mesh-list
20632527|NCT04278404|Clindamycin|clindamycin|mesh-list
20632528|NCT04278404|Meropenem|meropenem|mesh-list
20632529|NCT04278404|Voriconazole|voriconazole|mesh-list
20632530|NCT04278404|Ceftazidime|ceftazidime|mesh-list
20632531|NCT04278404|Fosfomycin|fosfomycin|mesh-list
20632532|NCT04278404|Cefepime|cefepime|mesh-list
20632533|NCT04278404|Cefdinir|cefdinir|mesh-list
20632534|NCT04278404|Dexamethasone|dexamethasone|mesh-list
20632535|NCT04278404|Budesonide|budesonide|mesh-list
20632536|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
20632537|NCT04278404|Colchicine|colchicine|mesh-list
20632538|NCT04278404|Amiodarone|amiodarone|mesh-list
20632539|NCT04278404|Bosentan|bosentan|mesh-list
20632540|NCT04278404|Guanfacine|guanfacine|mesh-list
20632541|NCT04278404|Labetalol|labetalol|mesh-list
20632542|NCT04278404|Nicardipine|nicardipine|mesh-list
20632543|NCT04278404|Nifedipine|nifedipine|mesh-list
20632544|NCT04278404|Milrinone|milrinone|mesh-list
20632545|NCT04278404|Furosemide|furosemide|mesh-list
20632546|NCT04278404|Spironolactone|spironolactone|mesh-list
20632547|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
20632548|NCT04278404|Oxycodone|oxycodone|mesh-list
20632549|NCT04278404|Gabapentin|gabapentin|mesh-list
20632550|NCT04278404|Nalbuphine|nalbuphine|mesh-list
20632551|NCT04278404|Clobazam|clobazam|mesh-list
20632552|NCT04278404|Zolpidem|zolpidem|mesh-list
20632553|NCT04278404|Risperidone|risperidone|mesh-list
20632554|NCT04278404|Amphetamine|amphetamine|mesh-list
20632555|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
20632556|NCT04278404|Sertraline|sertraline|mesh-list
20632557|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
20632558|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
20632559|NCT04278404|Terbutaline|terbutaline|mesh-list
20632560|NCT04278404|Sevelamer|sevelamer|mesh-list
20632561|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20632562|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
20632563|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
20632564|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632565|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632566|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632567|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
20632568|NCT04278404|Hormones|hormones|mesh-ancestor
20632569|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632570|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20632571|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632572|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
20632573|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632574|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632575|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20632576|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
20632577|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632578|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20632579|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632580|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20632581|NCT04278404|Analgesics|analgesics|mesh-ancestor
20632582|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
20632583|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20632584|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20632585|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20632586|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
20632587|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632588|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632589|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20632590|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20632591|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20632592|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20632593|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20632594|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20632595|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20632596|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20632597|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
20632598|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20632599|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20632600|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
20632601|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20632602|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20632603|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
20632604|NCT04278404|Coagulants|coagulants|mesh-ancestor
20632605|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20632606|NCT04278404|Narcotics|narcotics|mesh-ancestor
20632607|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
20632608|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20632609|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20632610|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20632611|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20632612|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20632613|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
20632614|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20632615|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
20632616|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20632617|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20632618|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
20632619|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
20632620|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20632621|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20632622|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632623|NCT04278404|Diuretics|diuretics|mesh-ancestor
20632624|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
20632625|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20632626|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20632627|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
20632628|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20632629|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
20632630|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
20632631|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
20632632|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
20632633|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20632634|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20632635|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20632636|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
20632637|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
20632638|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20632639|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
20632640|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20632641|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20632642|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20632643|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20632644|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
20632645|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
20632646|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20632647|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20632648|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20632649|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20632650|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20632651|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20632652|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20632653|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
20632654|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20632655|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20632656|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20632657|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20632658|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
20632659|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
20632660|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19411939|NCT03535870|Hormones|hormones|mesh-ancestor
20632661|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20632662|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20632663|NCT04278404|Protective Agents|protective agents|mesh-ancestor
20632664|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20632665|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20632666|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20632667|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20632668|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20632669|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20632670|NCT04266379|Insulin|insulin|mesh-list
20632671|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20632672|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20632673|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632674|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
20632675|NCT04240093|Narcotics|narcotics|mesh-ancestor
19696501|NCT04939779|Delpazolid|delpazolid|mesh-list
19696502|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
20632676|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632677|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632678|NCT04240093|Analgesics|analgesics|mesh-ancestor
20632679|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
20632680|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632681|NCT04234477|Metoprolol|metoprolol|mesh-list
20632682|NCT04234477|Verapamil|verapamil|mesh-list
20632683|NCT04234477|Diltiazem|diltiazem|mesh-list
20632684|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
20632685|NCT04234477|Calcium|calcium|mesh-list
20632686|NCT04234477|Esmolol|esmolol|mesh-list
20632687|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20632688|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20632689|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632690|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20632691|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20632692|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
20632693|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
20632694|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632695|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20632696|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20632697|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
20632698|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632699|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632700|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632701|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
20632702|NCT04217967|Lenalidomide|lenalidomide|mesh-list
20632703|NCT04217967|Ixazomib|ixazomib|mesh-list
20632704|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
20632705|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632706|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20632707|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20632708|NCT04217967|Growth Substances|growth substances|mesh-ancestor
20632709|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
19696503|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20475695|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
20475696|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20475697|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632710|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632711|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
20632712|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632713|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632714|NCT04156698|Docetaxel|docetaxel|mesh-list
20632715|NCT04156698|Capecitabine|capecitabine|mesh-list
20632716|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632717|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
20632718|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
20632719|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
20632720|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696504|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475698|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20475699|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475700|NCT01511887|Ibuprofen|ibuprofen|mesh-list
20475701|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20475702|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20475703|NCT01511887|Analgesics|analgesics|mesh-ancestor
20475704|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
20475705|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475706|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632721|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20632722|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
19411940|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411941|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
19411942|NCT03535792|Fentanyl|fentanyl|mesh-list
20632723|NCT04046614|Nivolumab|nivolumab|mesh-list
20632724|NCT04046614|Nintedanib|nintedanib|mesh-list
20632725|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632726|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632727|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20632728|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632729|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20632730|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632731|NCT03916185|Vaccines|vaccines|mesh-list
20632732|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
20632733|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632734|NCT03915860|Trifarotene|trifarotene|mesh-list
20632735|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632736|NCT03852901|Empagliflozin|empagliflozin|mesh-list
20632737|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20632738|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632739|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20632740|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632741|NCT03795233|Vancomycin|vancomycin|mesh-list
20632742|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20632743|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632744|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
20632745|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
20632746|NCT03783091|Hematinics|hematinics|mesh-ancestor
20632747|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
20632748|NCT03783091|Vitamins|vitamins|mesh-ancestor
20632749|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
20632750|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632751|NCT03770286|Fluorides|fluorides|mesh-list
20632752|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
20632753|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
20632754|NCT03770286|Protective Agents|protective agents|mesh-ancestor
20632755|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632756|NCT03769376|Salvin|salvin|mesh-list
20632757|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20632758|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632759|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
20632760|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632761|NCT03769376|Protective Agents|protective agents|mesh-ancestor
20632762|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632763|NCT03645863|Iron|iron|mesh-list
20632764|NCT03645863|Trace Elements|trace elements|mesh-ancestor
20632765|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
20632766|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632767|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20632768|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632769|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20632770|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632771|NCT03476369|Fentanyl|fentanyl|mesh-list
20632772|NCT03476369|Ticagrelor|ticagrelor|mesh-list
20632773|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20632774|NCT03476369|Narcotics|narcotics|mesh-ancestor
20632775|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632776|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632777|NCT03476369|Analgesics|analgesics|mesh-ancestor
20632778|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
20632779|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632780|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20632781|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20632782|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
20632783|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
20632784|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20632785|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20632786|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20632787|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20632788|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
20632789|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632790|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632791|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
19411943|NCT03535792|Nalbuphine|nalbuphine|mesh-list
19411944|NCT03535792|Bupivacaine|bupivacaine|mesh-list
19411945|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
20632792|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20632793|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20632794|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632795|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20632796|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632797|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20632798|NCT03423355|Diuretics|diuretics|mesh-ancestor
20632799|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
20632800|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20632801|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632802|NCT03365635|Ribavirin|ribavirin|mesh-list
20632803|NCT03365635|Grazoprevir|grazoprevir|mesh-list
20632804|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
20632805|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
20632806|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475707|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475708|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20475709|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20475710|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475711|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475712|NCT01511991|Sevoflurane|sevoflurane|mesh-list
20475713|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20475714|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20632807|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
20632808|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632809|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
20632810|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632811|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632812|NCT03254667|Brodalumab|brodalumab|mesh-list
20632813|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632814|NCT03238534|Omeprazole|omeprazole|mesh-list
20632815|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20632816|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632817|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20632818|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632819|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632820|NCT03223350|Capsaicin|capsaicin|mesh-list
20632821|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
20632822|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632823|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
20632824|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632825|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475715|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
20475716|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
20475717|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475718|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475719|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20475720|NCT01512004|Propiverine|propiverine|mesh-list
20475721|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20475722|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20475723|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
20632826|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
20632827|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632828|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632829|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
20632830|NCT03193931|Methotrexate|methotrexate|mesh-list
20632831|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632832|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632833|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20632834|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
20632835|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20632836|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632837|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20632838|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
20632839|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632840|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632841|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632842|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20632843|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632844|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
20632845|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632846|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20632847|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
20632848|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632849|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632850|NCT03181529|Psilocybin|psilocybin|mesh-list
20632851|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
20632852|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632853|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20632854|NCT03164928|Denosumab|denosumab|mesh-list
20632855|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20632856|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632857|NCT02973789|Docetaxel|docetaxel|mesh-list
20632858|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20632859|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632860|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
20632861|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
20632862|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
20632863|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632864|NCT02932475|Metformin|metformin|mesh-list
20632865|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20632866|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632867|NCT02914938|Rituximab|rituximab|mesh-list
20632868|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
20632869|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20632870|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632871|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
20632872|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632873|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632874|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20632875|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632876|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632877|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20632878|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
20632879|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632880|NCT02891538|Protective Agents|protective agents|mesh-ancestor
20632881|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632882|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20632883|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20632884|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632885|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20226724|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226725|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20226726|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226727|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226728|NCT00347542|Vitamin D|vitamin d|mesh-list
20226729|NCT00347542|Vitamins|vitamins|mesh-ancestor
20226730|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
20226731|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226732|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20226733|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
20226734|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20226735|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
20226736|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226737|NCT00347555|Antacids|antacids|mesh-ancestor
20632886|NCT02840136|Meropenem|meropenem|mesh-list
20632887|NCT02840136|Tazobactam|tazobactam|mesh-list
20632888|NCT02840136|Piperacillin|piperacillin|mesh-list
20632889|NCT02840136|Ceftazidime|ceftazidime|mesh-list
20632890|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20632891|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20632892|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20632893|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20632894|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632895|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632896|NCT02820961|Exemestane|exemestane|mesh-list
20632897|NCT02820961|Entinostat|entinostat|mesh-list
20632898|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632899|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20632900|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20632901|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632902|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632903|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20632904|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
20632905|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20632906|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632907|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20632908|NCT02804932|Methamphetamine|methamphetamine|mesh-list
20632909|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20632910|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632911|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
20632912|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
20632913|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632914|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
20632915|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632916|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632917|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
20632918|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20632919|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19696505|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19696506|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696507|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696508|NCT04939675|Lamotrigine|lamotrigine|mesh-list
20632920|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632921|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20632922|NCT02722941|Panobinostat|panobinostat|mesh-list
20632923|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632924|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20632925|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632926|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632927|NCT02704390|Methylphenidate|methylphenidate|mesh-list
20632928|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20632929|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632930|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20632931|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20632932|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20632933|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632934|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
20632935|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632936|NCT02643381|Ketamine|ketamine|mesh-list
20632937|NCT02643381|Etomidate|etomidate|mesh-list
20632938|NCT02643381|Analgesics|analgesics|mesh-ancestor
20632939|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
20632940|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632941|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475724|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475725|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475726|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475727|NCT01512004|Urological Agents|urological agents|mesh-ancestor
20475728|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
20475729|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
19696509|NCT04939675|Zonisamide|zonisamide|mesh-list
19696510|NCT04939675|Levetiracetam|levetiracetam|mesh-list
20475730|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475731|NCT01512017|Petrolatum|petrolatum|mesh-list
20475732|NCT01512017|Emollients|emollients|mesh-ancestor
20475733|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
20475734|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
20475735|NCT01512147|Propofol|propofol|mesh-list
19850673|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
19850674|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850675|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19850676|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19850677|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
20632942|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20632943|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20632944|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
20632945|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
20632946|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632947|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20632948|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20632949|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20632950|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632951|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20632952|NCT02603900|Bupivacaine|bupivacaine|mesh-list
20632953|NCT02603900|Ropivacaine|ropivacaine|mesh-list
19696511|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
19696512|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
19696513|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19696514|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19696515|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696516|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19696517|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696518|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19696519|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19696520|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475736|NCT01512147|Isoflurane|isoflurane|mesh-list
20632954|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
20632955|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
20632956|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20632957|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632958|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
20632959|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20632960|NCT02595372|Omeprazole|omeprazole|mesh-list
20632961|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20632962|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20632963|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20632964|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632965|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632966|NCT02334722|Levetiracetam|levetiracetam|mesh-list
20632967|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
20632968|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
20632969|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
20632970|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
20632971|NCT02251821|Melphalan|melphalan|mesh-list
20632972|NCT02251821|Busulfan|busulfan|mesh-list
20632973|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
20632974|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20632975|NCT02251821|Methotrexate|methotrexate|mesh-list
20632976|NCT02251821|Fludarabine|fludarabine|mesh-list
20632977|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
20632978|NCT02251821|Tacrolimus|tacrolimus|mesh-list
19411946|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
19411947|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19411948|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411949|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
19411950|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19411951|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19411952|NCT03535792|Narcotics|narcotics|mesh-ancestor
19411953|NCT03535792|Analgesics|analgesics|mesh-ancestor
20475737|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20475738|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475739|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475740|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20475741|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
20475742|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
20475743|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20475744|NCT01512147|Analgesics|analgesics|mesh-ancestor
20475745|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
20475746|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475747|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20475748|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20632979|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20632980|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
20632981|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20632982|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20632983|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20632984|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
20632985|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20632986|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20632987|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20632988|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20632989|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
20632990|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20632991|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20632992|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
20632993|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
20632994|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20632995|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20632996|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20632997|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20632998|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20632999|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20633000|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
20633001|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20633002|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633003|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
20633004|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633005|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
20633006|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633007|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633008|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20633009|NCT01952288|Simvastatin|simvastatin|mesh-list
20633010|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19411954|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19411955|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19411956|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
19411957|NCT03535753|Decitabine|decitabine|mesh-list
19411958|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19411959|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
19411960|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411961|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411962|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633011|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20633012|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
20633013|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633014|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20633015|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20633016|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633017|NCT01858740|Methotrexate|methotrexate|mesh-list
20633018|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
20633019|NCT01858740|Fludarabine|fludarabine|mesh-list
20633020|NCT01858740|Thiotepa|thiotepa|mesh-list
20475749|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20475750|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633021|NCT01858740|Tacrolimus|tacrolimus|mesh-list
20633022|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20633023|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
20633024|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20633025|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633026|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633027|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
20633028|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633029|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633030|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633031|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633032|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20633033|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633034|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
19411963|NCT03535701|Paclitaxel|paclitaxel|mesh-list
19411964|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20475751|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475752|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475753|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20475754|NCT01512173|Propranolol|propranolol|mesh-list
20475755|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20475756|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19416830|NCT02282215|Lenograstim|lenograstim|mesh-list
20475757|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633035|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633036|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20633037|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20633038|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20633039|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
20633040|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20633041|NCT01846663|Rifaximin|rifaximin|mesh-list
20633042|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20633043|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633044|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20633045|NCT01844518|Abatacept|abatacept|mesh-list
20633046|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20633047|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633048|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633049|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633050|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
20633051|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633052|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633053|NCT01717586|Pravastatin|pravastatin|mesh-list
20633054|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20633055|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20633056|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
20633057|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633058|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20633059|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20633060|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633061|NCT01398839|Riboflavin|riboflavin|mesh-list
20633062|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
20633063|NCT01398839|Vitamins|vitamins|mesh-ancestor
20633064|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
20633065|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633066|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20633067|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633068|NCT01349959|Azacitidine|azacitidine|mesh-list
20633069|NCT01349959|Entinostat|entinostat|mesh-list
20633070|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20633071|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633072|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
20633073|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633074|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633075|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633076|NCT01331018|Plerixafor|plerixafor|mesh-list
20633077|NCT01331018|Prednisone|prednisone|mesh-list
20633078|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
20633079|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20633080|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20633081|NCT01331018|Prednisolone|prednisolone|mesh-list
20633082|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
20633083|NCT01331018|Cortisone|cortisone|mesh-list
20633084|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20633085|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
20633086|NCT01331018|Lenograstim|lenograstim|mesh-list
20633087|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633088|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
20633089|NCT01331018|Hormones|hormones|mesh-ancestor
20633090|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633091|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633092|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20633093|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475758|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475759|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475760|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475761|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20475762|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20475763|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
20475764|NCT01512199|Paclitaxel|paclitaxel|mesh-list
20475765|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20475766|NCT01512199|Trastuzumab|trastuzumab|mesh-list
20475767|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20475768|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20475769|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475770|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
20475771|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633094|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20633095|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
20633096|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
20633097|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
20633098|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633099|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20633100|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20633101|NCT01331018|Protective Agents|protective agents|mesh-ancestor
20633102|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20633103|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20633104|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
20633105|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633106|NCT01327781|Tamoxifen|tamoxifen|mesh-list
20633107|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20633108|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
20633109|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633110|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696521|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19696522|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19696523|NCT04939766|Insulin|insulin|mesh-list
19696524|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19696525|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633111|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20633112|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633113|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20633114|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20633115|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20633116|NCT01281176|Paclitaxel|paclitaxel|mesh-list
20633117|NCT01281176|Carboplatin|carboplatin|mesh-list
20633118|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20633119|NCT01281176|Vorinostat|vorinostat|mesh-list
20633120|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20633121|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633122|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
20633123|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633124|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
20633125|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633126|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20633127|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633128|NCT01168219|Methotrexate|methotrexate|mesh-list
20633129|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
20633130|NCT01168219|Azacitidine|azacitidine|mesh-list
20633131|NCT01168219|Fludarabine|fludarabine|mesh-list
20633132|NCT01168219|Busulfan|busulfan|mesh-list
20633133|NCT01168219|Tacrolimus|tacrolimus|mesh-list
20633134|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20633135|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20633136|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
20633137|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20633138|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633139|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633140|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
20633141|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633142|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633143|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633144|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226738|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226739|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20633145|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20633146|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633147|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
20633148|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633149|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20633150|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20633151|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
20633152|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20633153|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20633154|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
20633155|NCT01023737|Vorinostat|vorinostat|mesh-list
20633156|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
20633157|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20633158|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20633159|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633160|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633161|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411965|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20226740|NCT00347581|Methamphetamine|methamphetamine|mesh-list
20633162|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696526|NCT04939649|Midazolam|midazolam|mesh-list
20633163|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633164|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20633165|NCT00741988|Bevacizumab|bevacizumab|mesh-list
20633166|NCT00741988|Carboplatin|carboplatin|mesh-list
20633167|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633168|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633169|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20633170|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20633171|NCT00741988|Growth Substances|growth substances|mesh-ancestor
20633172|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633173|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
20633174|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
20633175|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20633176|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633177|NCT00568997|Analgesics|analgesics|mesh-ancestor
20633178|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
20633179|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633180|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633181|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633182|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633183|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633184|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633185|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
20633186|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20633187|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633188|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633189|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20633190|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
20633191|NCT00563576|Estradiol|estradiol|mesh-list
20633192|NCT00563576|Estrogens|estrogens|mesh-ancestor
20633193|NCT00563576|Hormones|hormones|mesh-ancestor
20633194|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633195|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633196|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20633197|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
20633198|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20633199|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20633200|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20633201|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20633202|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20633203|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20633204|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20633205|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633206|NCT00455403|Chloroquine|chloroquine|mesh-list
19411966|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19411967|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
19411968|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633207|NCT00455403|Amebicides|amebicides|mesh-ancestor
20633208|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20633209|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20633210|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633211|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
20633212|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633213|NCT00238420|Paclitaxel|paclitaxel|mesh-list
20633214|NCT00238420|Trastuzumab|trastuzumab|mesh-list
20633215|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20633216|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20633217|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20633218|NCT00238420|Antibodies|antibodies|mesh-list
20633219|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
20633220|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20633221|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20633222|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633223|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
20633224|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633225|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
20633226|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633227|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
20633228|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411969|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
19411970|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411971|NCT03535662|Itraconazole|itraconazole|mesh-list
19411972|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
19850678|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696527|NCT04939649|Ketamine|ketamine|mesh-list
19696528|NCT04939649|Analgesics|analgesics|mesh-ancestor
19696529|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
20633229|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20633230|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20633231|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
20633232|NCT05160623|Povidone|povidone|mesh-list
20633233|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
20633234|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
20633235|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20633236|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633237|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
20633238|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633239|NCT05160298|Ropivacaine|ropivacaine|mesh-list
20633240|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
20633241|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
20633242|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633243|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633244|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
20633245|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633246|NCT05160285|Nivolumab|nivolumab|mesh-list
20633247|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633248|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633249|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20633250|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633251|NCT05160220|Psilocybin|psilocybin|mesh-list
20633252|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
20633253|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633254|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20633255|NCT05160051|FAPI-46|fapi-46|mesh-list
20633256|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20633257|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633258|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
20633259|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20633260|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633261|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20633262|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633263|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20633264|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20633265|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20633266|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20633267|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633268|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633269|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633270|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633271|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
20633272|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633273|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633274|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20633275|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633276|NCT05159674|Analgesics|analgesics|mesh-ancestor
20633277|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
20633278|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633279|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20633280|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20633281|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20633282|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633283|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633284|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633285|NCT05159531|Tenofovir|tenofovir|mesh-list
20633286|NCT05159531|Emtricitabine|emtricitabine|mesh-list
20633287|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
20633288|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633289|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20633290|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20633291|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633292|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633293|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20633294|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20633295|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
20633296|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
20633297|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
20633298|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633299|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20633300|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
20633301|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633302|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
20633303|NCT05159284|Protective Agents|protective agents|mesh-ancestor
20633304|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20633305|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20633306|NCT05159219|Colchicine|colchicine|mesh-list
20633307|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
20633308|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633309|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
20633310|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633311|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
20633312|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633313|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633314|NCT05157087|Omalizumab|omalizumab|mesh-list
20633315|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20633316|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20633317|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
20633318|NCT05150431|Parecoxib|parecoxib|mesh-list
20633319|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20633320|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20633321|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633322|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633323|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20633324|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633325|NCT05150431|Analgesics|analgesics|mesh-ancestor
19411973|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411974|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20633326|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
20633327|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633328|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633329|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633330|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633331|NCT05146687|Bevacizumab|bevacizumab|mesh-list
20633332|NCT05146687|Ranibizumab|ranibizumab|mesh-list
20633333|NCT05146687|Aflibercept|aflibercept|mesh-list
20633334|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633335|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633336|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20633337|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20633338|NCT05146687|Growth Substances|growth substances|mesh-ancestor
20633339|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633340|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
20633341|NCT05142098|Dexamethasone|dexamethasone|mesh-list
20633342|NCT05142098|Etoricoxib|etoricoxib|mesh-list
20633343|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
20633344|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
20633345|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633346|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
20633347|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
20633348|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633349|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633350|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20633351|NCT05142098|Hormones|hormones|mesh-ancestor
20633352|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633353|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20633354|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633355|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20633356|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633357|NCT05142098|Analgesics|analgesics|mesh-ancestor
20633358|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
20633359|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633360|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20633361|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411975|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19411976|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411977|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411978|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19411979|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
19411980|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19411981|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19411982|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19411983|NCT03535558|Azithromycin|azithromycin|mesh-list
20633362|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633363|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20633364|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20633365|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633366|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633367|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
20633368|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633369|NCT05141240|Palbociclib|palbociclib|mesh-list
20633370|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633371|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20633372|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633373|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633374|NCT05137080|Dexamethasone|dexamethasone|mesh-list
20633375|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633376|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
20633377|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
20633378|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633379|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633380|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20633381|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
20633382|NCT05137080|Hormones|hormones|mesh-ancestor
20633383|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633384|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20633385|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633386|NCT05124340|Vaccines|vaccines|mesh-list
20633387|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
20633388|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633389|NCT05117450|Heparin|heparin|mesh-list
20633390|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
20633391|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20633392|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20633393|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633394|NCT05116930|Atropine|atropine|mesh-list
20633395|NCT05116930|Neostigmine|neostigmine|mesh-list
20633396|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20633397|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20633398|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20633399|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
20633400|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633401|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633402|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20633403|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
20633404|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
20633405|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
20633406|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20633407|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20633408|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
20633409|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633410|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633411|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20633412|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633413|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20633414|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
20633415|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20633416|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633417|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633418|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633419|NCT05111431|Analgesics|analgesics|mesh-ancestor
20633420|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
20633421|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633422|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20633423|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20633424|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20633425|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633426|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633427|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633428|NCT05096039|Valsartan|valsartan|mesh-list
20633429|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20633430|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20633431|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20633432|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20633433|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633434|NCT05070650|Acetaminophen|acetaminophen|mesh-list
20633435|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
20633436|NCT05070650|Phenylephrine|phenylephrine|mesh-list
20633437|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
20633438|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20633439|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633440|NCT05070650|Analgesics|analgesics|mesh-ancestor
20633441|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
20633442|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633443|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633444|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
20633445|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
20633446|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633447|NCT05070650|Expectorants|expectorants|mesh-ancestor
20633448|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
20633449|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20633450|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
20633451|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633452|NCT05070650|Protective Agents|protective agents|mesh-ancestor
20633453|NCT05070650|Antidotes|antidotes|mesh-ancestor
19850679|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850680|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19850681|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850682|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850683|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
19850684|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
19850685|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850686|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19850687|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
19850688|NCT00711828|Hormones|hormones|mesh-ancestor
20226741|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20226742|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475772|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
20475773|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475774|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633454|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20633455|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
20633456|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
20633457|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
20633458|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20633459|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
20633460|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20633461|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20633462|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20633463|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633464|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633465|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
20633466|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20633467|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633468|NCT05022472|Vaccines|vaccines|mesh-list
20633469|NCT05022472|Immunologic Factors|immunologic factors|mesh-ancestor
20633470|NCT05022472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633471|NCT05003453|Palmidrol|palmidrol|mesh-list
20633472|NCT05003453|Analgesics|analgesics|mesh-ancestor
20633473|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
20633474|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633475|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633476|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20633477|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19850689|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20226743|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
20226744|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
20226745|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226746|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
20226747|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226748|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475775|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
20475776|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475777|NCT01512316|Cycloserine|cycloserine|mesh-list
20475778|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20475779|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475780|NCT01512316|Renal Agents|renal agents|mesh-ancestor
20475781|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20475782|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
20633478|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633479|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633480|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
20633481|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633482|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20633483|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20633484|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633485|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633486|NCT05003453|Hormones|hormones|mesh-ancestor
20633487|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633488|NCT04888377|Aspirin|aspirin|mesh-list
20633489|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20633490|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633491|NCT04888377|Analgesics|analgesics|mesh-ancestor
20633492|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
20633493|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633494|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633495|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633496|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633497|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20633498|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20633499|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633500|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20633501|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20633502|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633503|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
20226749|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226750|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20226751|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20226752|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20226753|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20226754|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
20226755|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20226756|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20226757|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226758|NCT00347685|Tramadol|tramadol|mesh-list
20226759|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226760|NCT00347685|Narcotics|narcotics|mesh-ancestor
20226761|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226762|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226763|NCT00347685|Analgesics|analgesics|mesh-ancestor
20226764|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
20226765|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226766|NCT00347698|Bevacizumab|bevacizumab|mesh-list
20226767|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633504|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
20633505|NCT04859582|Fluorouracil|fluorouracil|mesh-list
20633506|NCT04859582|Capecitabine|capecitabine|mesh-list
20633507|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
20633508|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633509|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633510|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
20633511|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633512|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633513|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633514|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
20633515|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633516|NCT04713137|Erythritol|erythritol|mesh-list
20633517|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
20633518|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20633519|NCT04682847|Hematinics|hematinics|mesh-ancestor
20633520|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20633521|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20633522|NCT04622553|Mexiletine|mexiletine|mesh-list
20633523|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20633524|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20633525|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20633526|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20633527|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633528|NCT04557085|Cenobamate|cenobamate|mesh-list
20633529|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
20633530|NCT04499677|Ritonavir|ritonavir|mesh-list
20633531|NCT04499677|Lopinavir|lopinavir|mesh-list
20633532|NCT04499677|Favipiravir|favipiravir|mesh-list
20633533|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20633534|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20633535|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
20633536|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633537|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633538|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20633539|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20633540|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
20633541|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633542|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20633543|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20633544|NCT04491526|Tamsulosin|tamsulosin|mesh-list
20633545|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20633546|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20633547|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20633548|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633549|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633550|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633551|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633552|NCT04491526|Urological Agents|urological agents|mesh-ancestor
20633553|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20633554|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696530|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696531|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696532|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19696533|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19696534|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
19696535|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
19696536|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696537|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20475783|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20475784|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
20475785|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475786|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
20475787|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20475788|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475789|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475790|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20475791|NCT01512355|Analgesics|analgesics|mesh-ancestor
20475792|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
20475793|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226768|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226769|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226770|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19411984|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
19416831|NCT02282215|Sargramostim|sargramostim|mesh-list
20226771|NCT00347698|Growth Substances|growth substances|mesh-ancestor
20226772|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226773|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
20226774|NCT00347724|Tramadol|tramadol|mesh-list
20226775|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226776|NCT00347724|Narcotics|narcotics|mesh-ancestor
20226777|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226778|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226779|NCT00347724|Analgesics|analgesics|mesh-ancestor
20475794|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20475795|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20475796|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20475797|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
20475798|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475799|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475800|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20475801|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20475802|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20475803|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20475804|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475805|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475806|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475807|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20475808|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
20475809|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20475810|NCT01512485|Clopidogrel|clopidogrel|mesh-list
20475811|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20475812|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20475813|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20475814|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20475815|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
20475816|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20475817|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475818|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475819|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
20475820|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20475821|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
20475822|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
20475823|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475824|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475825|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20475826|NCT01512511|Analgesics|analgesics|mesh-ancestor
20475827|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
20475828|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475829|NCT01512537|Vitamin D|vitamin d|mesh-list
20475830|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
20475831|NCT01512537|Vitamins|vitamins|mesh-list
20475832|NCT01512537|Calcium|calcium|mesh-list
20475833|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
20475834|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475835|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20475836|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20475837|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20475838|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
20475839|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
20475840|NCT01512680|Insulin|insulin|mesh-list
20475841|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475842|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475843|NCT01512784|Vaccines|vaccines|mesh-list
20475844|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
20475845|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475846|NCT01512862|Calcitriol|calcitriol|mesh-list
20475847|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20475848|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475849|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20475850|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530642|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20633560|NCT04477343|Nivolumab|nivolumab|mesh-list
20633561|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633562|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633563|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20633564|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633565|NCT04452877|Trametinib|trametinib|mesh-list
20633566|NCT04452877|Dabrafenib|dabrafenib|mesh-list
20633567|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633568|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20633569|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633570|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633571|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
20633572|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
20633573|NCT04384692|Melphalan|melphalan|mesh-list
20633574|NCT04384692|Busulfan|busulfan|mesh-list
20633575|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
20633576|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19696538|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20475851|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633577|NCT04384692|Methotrexate|methotrexate|mesh-list
20633578|NCT04384692|Fludarabine|fludarabine|mesh-list
20633579|NCT04384692|Tacrolimus|tacrolimus|mesh-list
20633580|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633581|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
20633582|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633583|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633584|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20633585|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
20633586|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633587|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633588|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20633589|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20633590|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
20633591|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20633592|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633593|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
20633594|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633595|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633596|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20633597|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20633598|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20633599|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20633600|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20633601|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
20633602|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20633603|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633604|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
20633605|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
20633606|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
20633607|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20633608|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20633609|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633610|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633611|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633612|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633613|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
20633614|NCT04328961|Protective Agents|protective agents|mesh-ancestor
20633615|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633616|NCT04328961|Vitamins|vitamins|mesh-ancestor
20633617|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
20633618|NCT04274361|Ketamine|ketamine|mesh-list
20475852|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20475853|NCT01512862|Vitamins|vitamins|mesh-ancestor
20475854|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
20475855|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20475856|NCT01512901|Betamethasone|betamethasone|mesh-list
20475857|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
20633619|NCT04274361|Analgesics|analgesics|mesh-ancestor
20475858|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20475859|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
20633620|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
20633621|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475860|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20633622|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633623|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20633624|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19411985|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19411986|NCT03535558|Trimethoprim|trimethoprim|mesh-list
19411987|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
19411988|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19411989|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19411990|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19411991|NCT03535558|Renal Agents|renal agents|mesh-ancestor
19411992|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
19411993|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19411994|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19411995|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19411996|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19411997|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19411998|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19411999|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19850690|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19850691|NCT00711880|Nabiximols|nabiximols|mesh-list
19850692|NCT00711880|Analgesics|analgesics|mesh-ancestor
20633625|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
20633626|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
20633627|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633628|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20633629|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20633630|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633631|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633632|NCT04263792|Trimethoprim|trimethoprim|mesh-list
20633633|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20633634|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633635|NCT04263792|Renal Agents|renal agents|mesh-ancestor
20633636|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
20633637|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20633638|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20633639|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20633640|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633641|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633642|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20633643|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20633644|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20633645|NCT04259996|Estradiol|estradiol|mesh-list
20633646|NCT04259996|Progesterone|progesterone|mesh-list
20633647|NCT04259996|Estrogens|estrogens|mesh-ancestor
20633648|NCT04259996|Hormones|hormones|mesh-ancestor
20633649|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633650|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633651|NCT04259996|Progestins|progestins|mesh-ancestor
20633652|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20633653|NCT04253626|Hematinics|hematinics|mesh-ancestor
20633654|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20633655|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20633656|NCT04192136|Niacinamide|niacinamide|mesh-list
20633657|NCT04192136|Niacin|niacin|mesh-list
20633658|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
20633659|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
20633660|NCT04192136|Vitamins|vitamins|mesh-ancestor
20633661|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
20633662|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633663|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20633664|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
20633665|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633666|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20633667|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
20633668|NCT04142983|Vaccines|vaccines|mesh-list
20633669|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
20633670|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633671|NCT04076579|Olaparib|olaparib|mesh-list
20633672|NCT04076579|Trabectedin|trabectedin|mesh-list
20633673|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20633674|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633675|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633676|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633677|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20633678|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
20633679|NCT04047472|Aflibercept|aflibercept|mesh-list
19850693|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
20633680|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20633681|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20633682|NCT04047472|Growth Substances|growth substances|mesh-ancestor
20633683|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633684|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
20633685|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633686|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20633687|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
20633688|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633689|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
20633690|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20633691|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633692|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633693|NCT03945448|Fluconazole|fluconazole|mesh-list
20633694|NCT03945448|Amphotericin B|amphotericin b|mesh-list
20633695|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20633696|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
20633697|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633698|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20633699|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20633700|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633701|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633702|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20633703|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
20633704|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633705|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633706|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20633707|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20633708|NCT03945448|Amebicides|amebicides|mesh-ancestor
20633709|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20633710|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20633711|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20633712|NCT03909334|Osimertinib|osimertinib|mesh-list
20633713|NCT03909334|Ramucirumab|ramucirumab|mesh-list
20633714|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633715|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20633716|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633717|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633718|NCT03829722|Paclitaxel|paclitaxel|mesh-list
20633719|NCT03829722|Carboplatin|carboplatin|mesh-list
20633720|NCT03829722|Nivolumab|nivolumab|mesh-list
20633721|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20633722|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633723|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
20633724|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633725|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
20633726|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633727|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633728|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20633729|NCT03782636|Aldesleukin|aldesleukin|mesh-list
20633730|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633731|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20633732|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20633733|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
20633734|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633735|NCT03761810|Tretinoin|tretinoin|mesh-list
20633736|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20633737|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633738|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633739|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
20633740|NCT03761784|Tretinoin|tretinoin|mesh-list
20633741|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20633742|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633743|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633744|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
20633745|NCT03739099|Pancrelipase|pancrelipase|mesh-list
20633746|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20633747|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
20633748|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
20633749|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20633750|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20633751|NCT03703778|Androgens|androgens|mesh-list
20633752|NCT03703778|Hormones|hormones|mesh-ancestor
20633753|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633754|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633755|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
20633756|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633757|NCT03703778|Protective Agents|protective agents|mesh-ancestor
20633758|NCT03703778|Vitamins|vitamins|mesh-ancestor
20633759|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
20633760|NCT03703778|Estrogens|estrogens|mesh-ancestor
20633761|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20633762|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633763|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
20633764|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
20633765|NCT03675737|Fluorouracil|fluorouracil|mesh-list
20633766|NCT03675737|Capecitabine|capecitabine|mesh-list
20633767|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
20633768|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633769|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633770|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
20633771|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633772|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633773|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633774|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
20633775|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633776|NCT03576261|Polygeline|polygeline|mesh-list
20633777|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
20633778|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
20633779|NCT03527186|Risperidone|risperidone|mesh-list
20633780|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20633781|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
20633782|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633783|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633784|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633785|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20633786|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20633787|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633788|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20633789|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20633790|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
20633791|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
20633792|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633793|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633794|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20633795|NCT03320070|Hormones|hormones|mesh-ancestor
20633796|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633797|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696539|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696540|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696541|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19696542|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19696543|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19696544|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19696545|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19696546|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
19696547|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
19696548|NCT04939480|Atezolizumab|atezolizumab|mesh-list
19696549|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696550|NCT04939441|Tenofovir|tenofovir|mesh-list
20633798|NCT03294304|Gemcitabine|gemcitabine|mesh-list
20633799|NCT03294304|Nivolumab|nivolumab|mesh-list
20633800|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633801|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633802|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
20633803|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633804|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
20633805|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633806|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633807|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633808|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
20633809|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696551|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
20633810|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633811|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20633812|NCT03252756|Cannabidiol|cannabidiol|mesh-list
19696552|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696553|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19696554|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19696555|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412000|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19412001|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19412002|NCT03535519|Methotrexate|methotrexate|mesh-list
19412003|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19412004|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
19412005|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19412006|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696556|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696557|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19696558|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19696559|NCT04938583|Paclitaxel|paclitaxel|mesh-list
19696560|NCT04938583|Bevacizumab|bevacizumab|mesh-list
19696561|NCT04938583|Carboplatin|carboplatin|mesh-list
19696562|NCT04938583|Oregovomab|oregovomab|mesh-list
19850694|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633813|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
20633814|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
20633815|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20633816|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633817|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633818|NCT03188796|Vitamin D|vitamin d|mesh-list
20633819|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
20633820|NCT03188796|Vitamins|vitamins|mesh-ancestor
20633821|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
20633822|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633823|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20633824|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20633825|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20633826|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20633827|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633828|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
20633829|NCT03122431|Thalidomide|thalidomide|mesh-list
20633830|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
20633831|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20633832|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20633833|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850695|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850696|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19850697|NCT00712010|Caseins|caseins|mesh-list
19850698|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
19850699|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
19850700|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850701|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
19850702|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19850703|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
20633834|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633835|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633836|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633837|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633838|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
20633839|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633840|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
20633841|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20633842|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20633843|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20633844|NCT03122431|Growth Substances|growth substances|mesh-ancestor
20633845|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
20633846|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633847|NCT03119363|Methamphetamine|methamphetamine|mesh-list
20633848|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20633849|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633850|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
19412007|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412008|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
19412009|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412010|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412011|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
20633851|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
20633852|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633853|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
20633854|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20633855|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633856|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
20633857|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20633858|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20633859|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20633860|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20633861|NCT03099356|Sirolimus|sirolimus|mesh-list
20633862|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
20633863|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633864|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
20633865|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633866|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633867|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20633868|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
20633869|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633870|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633871|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20633872|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20633873|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633874|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20633875|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
20633876|NCT03009201|Doxorubicin|doxorubicin|mesh-list
20633877|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20633878|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20633879|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633880|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20633881|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20633882|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633883|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633884|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20633885|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20633886|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
20633887|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20633888|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633889|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20633890|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20633891|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20633892|NCT02956382|Venetoclax|venetoclax|mesh-list
20633893|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633894|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20633895|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20633896|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20633897|NCT02936843|Analgesics|analgesics|mesh-ancestor
20633898|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
20633899|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633900|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633901|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20633902|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633903|NCT02896855|Docetaxel|docetaxel|mesh-list
20633904|NCT02896855|Trastuzumab|trastuzumab|mesh-list
20633905|NCT02896855|Pertuzumab|pertuzumab|mesh-list
20633906|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633907|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
20633908|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633909|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
20633910|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633911|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633912|NCT02871778|Ivacaftor|ivacaftor|mesh-list
20633913|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20633914|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20633915|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633916|NCT02756208|Vaccines|vaccines|mesh-list
20633917|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
19696563|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19696564|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696565|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
19696566|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
19696567|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
19696568|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633918|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633919|NCT02714218|Nivolumab|nivolumab|mesh-list
20633920|NCT02714218|Ipilimumab|ipilimumab|mesh-list
20633921|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633922|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633923|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20633924|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633925|NCT02621151|Gemcitabine|gemcitabine|mesh-list
20633926|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
20633927|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633928|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
20633929|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633930|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633931|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
20633932|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20633933|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633934|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20633935|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
20633936|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633937|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633938|NCT02564263|Paclitaxel|paclitaxel|mesh-list
20633939|NCT02564263|Docetaxel|docetaxel|mesh-list
20633940|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
20633941|NCT02564263|Irinotecan|irinotecan|mesh-list
20633942|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20633943|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633944|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
20633945|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
20633946|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
20633947|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633948|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633949|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20633950|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20633951|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633952|NCT02421341|Fentanyl|fentanyl|mesh-list
20633953|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
20633954|NCT02421341|Analgesics|analgesics|mesh-list
20633955|NCT02421341|Narcotics|narcotics|mesh-ancestor
20633956|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633957|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633958|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
20633959|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20633960|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20633961|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20633962|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
20633963|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
20633964|NCT02149121|Rituximab|rituximab|mesh-list
20633965|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20633966|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633967|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
20633968|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20633969|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20633970|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20633971|NCT01935921|Cetuximab|cetuximab|mesh-list
20633972|NCT01935921|Ipilimumab|ipilimumab|mesh-list
20633973|NCT01935921|Antibodies|antibodies|mesh-list
20633974|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
19696569|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696570|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19696571|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19696572|NCT04938583|Growth Substances|growth substances|mesh-ancestor
19696573|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696574|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
19696575|NCT04938713|Ketamine|ketamine|mesh-list
19696576|NCT04938713|Esketamine|esketamine|mesh-list
19696577|NCT04938713|Analgesics|analgesics|mesh-ancestor
19696578|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
19696579|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696580|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696581|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19696582|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19696583|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
19696584|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
19696585|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633975|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20633976|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
20633977|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696586|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19696587|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19696588|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696589|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696590|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
19696591|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19696592|NCT04938453|Nintedanib|nintedanib|mesh-list
19696593|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226780|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
20226781|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696594|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19696595|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696596|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696597|NCT04938466|Hormones|hormones|mesh-list
19696598|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696599|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696600|NCT04938297|Rituximab|rituximab|mesh-list
19696601|NCT04938297|Lenalidomide|lenalidomide|mesh-list
20226782|NCT00347737|Teriparatide|teriparatide|mesh-list
20633978|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633979|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20633980|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633981|NCT01889186|Venetoclax|venetoclax|mesh-list
20633982|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633983|NCT01850004|Dasatinib|dasatinib|mesh-list
20633984|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633985|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20633986|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633987|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475861|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475862|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
19696602|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
20226783|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20226784|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226785|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20226786|NCT00347750|Lopinavir|lopinavir|mesh-list
20226787|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20226788|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20226789|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
20226790|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226791|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226792|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20226793|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19696603|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696604|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696605|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
20226794|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
20226795|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226796|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20226797|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20226798|NCT00347763|Permethrin|permethrin|mesh-list
20226799|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226800|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226801|NCT00347802|Bimatoprost|bimatoprost|mesh-list
20226802|NCT00347802|Travoprost|travoprost|mesh-list
20226803|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20226804|NCT00347815|Buprenorphine|buprenorphine|mesh-list
20226805|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226806|NCT00347815|Narcotics|narcotics|mesh-ancestor
20226807|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226808|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226809|NCT00347815|Analgesics|analgesics|mesh-ancestor
20226810|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
20475863|NCT01512901|Hormones|hormones|mesh-ancestor
20475864|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475865|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475866|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20475867|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
20475868|NCT01512914|Ropivacaine|ropivacaine|mesh-list
20475869|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
20475870|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
20475871|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20633988|NCT01757535|Azacitidine|azacitidine|mesh-list
19696606|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696607|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696608|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20633989|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633990|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
20633991|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20633992|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20633993|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20633994|NCT01660971|Gemcitabine|gemcitabine|mesh-list
20633995|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20633996|NCT01660971|Dasatinib|dasatinib|mesh-list
20633997|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20633998|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
20633999|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634000|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634001|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
20634002|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634003|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634004|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634005|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
20634006|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634007|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634008|NCT01523977|Prednisone|prednisone|mesh-list
20634009|NCT01523977|Doxorubicin|doxorubicin|mesh-list
20634010|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
20634011|NCT01523977|Vincristine|vincristine|mesh-list
20634012|NCT01523977|Everolimus|everolimus|mesh-list
20634013|NCT01523977|Asparaginase|asparaginase|mesh-list
20634014|NCT01523977|Pegaspargase|pegaspargase|mesh-list
20634015|NCT01523977|Razoxane|razoxane|mesh-list
20634016|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20634017|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634018|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20634019|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20634020|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634021|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634022|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634023|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
20634024|NCT01523977|Hormones|hormones|mesh-ancestor
20634025|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634026|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634027|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20634028|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20634029|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
20634030|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
20634031|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
20634032|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634033|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
20634034|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20634035|NCT01523977|Protective Agents|protective agents|mesh-ancestor
20634036|NCT01510184|Rituximab|rituximab|mesh-list
20634037|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20634038|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20634039|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634040|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
20634041|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634042|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634043|NCT01471444|Vidarabine|vidarabine|mesh-list
20634044|NCT01471444|Methotrexate|methotrexate|mesh-list
20634045|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
20634046|NCT01471444|Clofarabine|clofarabine|mesh-list
20634047|NCT01471444|Fludarabine|fludarabine|mesh-list
20634048|NCT01471444|Busulfan|busulfan|mesh-list
20634049|NCT01471444|Tacrolimus|tacrolimus|mesh-list
20634050|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
20634051|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20634052|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20634053|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
20634054|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20634055|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634056|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20634057|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
20634058|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634059|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634060|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634061|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634062|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20634063|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634064|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
20634065|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634066|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20634067|NCT01471444|Antiviral Agents|antiviral agents|mesh-ancestor
20634068|NCT01471444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634069|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20634070|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
20634071|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20634072|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20634073|NCT01238211|Cytarabine|cytarabine|mesh-list
20634074|NCT01238211|Daunorubicin|daunorubicin|mesh-list
20634075|NCT01238211|Dasatinib|dasatinib|mesh-list
20634076|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20634077|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
20634078|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634079|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634080|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
20634081|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634082|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634083|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
20634084|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634085|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20634086|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20634087|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20634088|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634089|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634090|NCT05162872|Niraparib|niraparib|mesh-list
20634091|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20634092|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634093|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634094|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634095|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
20634096|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20634097|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634098|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20634099|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634100|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
20634101|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
20634102|NCT05162625|Cefazolin|cefazolin|mesh-list
20634103|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20634104|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20634105|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20634106|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634107|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20634108|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20634109|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634110|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634111|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634112|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20634113|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20634114|NCT05162456|Antibodies|antibodies|mesh-list
20634115|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
20634116|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
20634117|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
20634118|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634119|NCT05162430|Propofol|propofol|mesh-list
20634120|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20634121|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634122|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634123|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20634124|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
20634125|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
20634126|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
20634127|NCT05162417|Methylene Blue|methylene blue|mesh-list
20634128|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634129|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634130|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
20634131|NCT05162417|Coagulants|coagulants|mesh-ancestor
20634132|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
20634133|NCT05162183|Liraglutide|liraglutide|mesh-list
20634134|NCT05162183|Glimepiride|glimepiride|mesh-list
20634135|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20634136|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634137|NCT05162183|Incretins|incretins|mesh-ancestor
20634138|NCT05162183|Hormones|hormones|mesh-ancestor
20634139|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634140|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20634141|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634142|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
20634143|NCT05162053|Clopidogrel|clopidogrel|mesh-list
20634144|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20634145|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20634146|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20634147|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20634148|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
20634149|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634150|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634151|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634152|NCT05162001|Disulfiram|disulfiram|mesh-list
20634153|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20634154|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20634155|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634156|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634157|NCT05161975|Vitamin K|vitamin k|mesh-list
20634158|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
20634159|NCT05161975|Vitamins|vitamins|mesh-ancestor
20634160|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
20634161|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634162|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20634163|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20634164|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634165|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
20634166|NCT05161975|Coagulants|coagulants|mesh-ancestor
20634167|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
20634168|NCT05161572|Tegafur|tegafur|mesh-list
20634169|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634170|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412012|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412013|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19696609|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19696610|NCT04938297|Growth Substances|growth substances|mesh-ancestor
19696611|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
19696612|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19696613|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696614|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696615|NCT04938011|Progesterone|progesterone|mesh-list
19696616|NCT04938011|Progestins|progestins|mesh-ancestor
19696617|NCT04938011|Hormones|hormones|mesh-ancestor
19696618|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696619|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412014|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19412015|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
20634171|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
20634172|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634196|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
20634197|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20634198|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
20634199|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634200|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
20634201|NCT05161403|Protective Agents|protective agents|mesh-ancestor
20634202|NCT05161221|Acetaminophen|acetaminophen|mesh-list
20634203|NCT05161221|Naproxen|naproxen|mesh-list
20634204|NCT05161221|Oxycodone|oxycodone|mesh-list
20634205|NCT05161221|Bupivacaine|bupivacaine|mesh-list
20634206|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
20634207|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
20634208|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634209|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634210|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
20634211|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634212|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20634213|NCT05161221|Narcotics|narcotics|mesh-ancestor
20634214|NCT05161221|Analgesics|analgesics|mesh-ancestor
20634215|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20634216|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20634217|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634218|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634219|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
20634220|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20634221|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634222|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634223|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
20634224|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20634225|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634226|NCT05141838|Vitamin D|vitamin d|mesh-list
20634227|NCT05141838|Vitamins|vitamins|mesh-ancestor
20634228|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
20634229|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634230|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20634231|NCT05137886|Decitabine|decitabine|mesh-list
20634232|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20634233|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20634234|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
20634235|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634236|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634237|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634238|NCT05132231|Brodalumab|brodalumab|mesh-list
20634239|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634240|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20634241|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20634242|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634243|NCT05096728|Nifedipine|nifedipine|mesh-list
20634244|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19412016|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634245|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20634246|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696620|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
20634247|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20634248|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634249|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
20634250|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
20634251|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20634252|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
20634253|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20634254|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634255|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
20634256|NCT05067270|Treprostinil|treprostinil|mesh-list
20634257|NCT05067270|Citric Acid|citric acid|mesh-list
20634258|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
20634259|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
20634260|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20634261|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
20634262|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
20634263|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634264|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20634265|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634266|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20634267|NCT05063851|Memantine|memantine|mesh-list
20634268|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20634269|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20634270|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
20634271|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634272|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634273|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634274|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20634275|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20634276|NCT05046522|Palmidrol|palmidrol|mesh-list
20634277|NCT05046522|Analgesics|analgesics|mesh-ancestor
20634278|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
20634279|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634280|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634281|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20634282|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20634283|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634284|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634285|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
19412017|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19412018|NCT03535480|Sargramostim|sargramostim|mesh-list
19412019|NCT03535480|Lenograstim|lenograstim|mesh-list
19412020|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
19696621|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19696622|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19696623|NCT04938037|Prednisolone|prednisolone|mesh-list
19696624|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
19696625|NCT04938037|Bupivacaine|bupivacaine|mesh-list
19696626|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20475872|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475873|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
20475874|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475875|NCT01512953|Lansoprazole|lansoprazole|mesh-list
20475876|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
20475877|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20475878|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20475879|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20475880|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475881|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475882|NCT01512966|Aflibercept|aflibercept|mesh-list
20475883|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20475884|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20475885|NCT01512966|Growth Substances|growth substances|mesh-ancestor
20475886|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475887|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
20475888|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475889|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
20475890|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20475891|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475892|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20475893|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
20475894|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20634286|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696627|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
20634287|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20634288|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20634289|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634290|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634291|NCT05046522|Hormones|hormones|mesh-ancestor
20634292|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634293|NCT05041946|Methylphenidate|methylphenidate|mesh-list
20634294|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20634295|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634296|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20634297|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20634298|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20634299|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634300|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
20634301|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634302|NCT04998786|Dexamethasone|dexamethasone|mesh-list
20634303|NCT04998786|Ixazomib|ixazomib|mesh-list
20634304|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634305|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
20634306|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
20634307|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634308|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634309|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20634310|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
20634311|NCT04998786|Hormones|hormones|mesh-ancestor
20634312|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634313|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20634314|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634315|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
20634316|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634317|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634318|NCT04991974|Buprenorphine|buprenorphine|mesh-list
20634319|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20634320|NCT04991974|Naloxone|naloxone|mesh-list
20634321|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20634322|NCT04991974|Narcotics|narcotics|mesh-ancestor
20634323|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634324|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634325|NCT04991974|Analgesics|analgesics|mesh-ancestor
20634326|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
20634327|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634328|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20475895|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475896|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475897|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475898|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
20634329|NCT04976192|Omalizumab|omalizumab|mesh-list
20634330|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20634331|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20634332|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
20634333|NCT04869488|Prednisone|prednisone|mesh-list
20634334|NCT04869488|Apatinib|apatinib|mesh-list
20634335|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
20634336|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634337|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
20634338|NCT04869488|Hormones|hormones|mesh-ancestor
20634339|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634340|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634341|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20634342|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634343|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634344|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634345|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634346|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20634347|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
20475899|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20475900|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475901|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20475902|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
20475903|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20475904|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475905|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475906|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475907|NCT01513070|Aspirin|aspirin|mesh-list
20475908|NCT01513070|Isosorbide|isosorbide|mesh-list
20475909|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20475910|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20475911|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19412021|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634348|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20634349|NCT04867798|Tenofovir|tenofovir|mesh-list
20634350|NCT04867798|Lamivudine|lamivudine|mesh-list
20634351|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
20634352|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634353|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20634354|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20634355|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634356|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634357|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20634358|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20634359|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
20634360|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634361|NCT04821284|Leucovorin|leucovorin|mesh-list
20634362|NCT04821284|Gemcitabine|gemcitabine|mesh-list
20634363|NCT04821284|Paclitaxel|paclitaxel|mesh-list
20634364|NCT04821284|Fluorouracil|fluorouracil|mesh-list
20634365|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
20634366|NCT04821284|Irinotecan|irinotecan|mesh-list
20634367|NCT04821284|Calcium|calcium|mesh-list
20634368|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
20634369|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20634370|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634371|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
20634372|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
20634373|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
20634374|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634375|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20634376|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
20634377|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
20634378|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634379|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634380|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634381|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
20226811|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226812|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20226813|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
20226814|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
20226815|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20226816|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20226817|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20226818|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634382|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634383|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20634384|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20634385|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20634386|NCT04821284|Antidotes|antidotes|mesh-ancestor
20634387|NCT04821284|Protective Agents|protective agents|mesh-ancestor
20634388|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
20634389|NCT04821284|Vitamins|vitamins|mesh-ancestor
20634390|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
20634391|NCT04729621|Denosumab|denosumab|mesh-list
20634392|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20634393|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634394|NCT04648826|Azacitidine|azacitidine|mesh-list
20634395|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20634396|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
20634397|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634398|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634399|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634400|NCT04606394|Albuterol|albuterol|mesh-list
20634401|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20634402|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
20634403|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634404|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634405|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20634406|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
20634407|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
20634408|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20634409|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19696628|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
19696629|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
19696630|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226819|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19696631|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226820|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20634410|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20634411|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20226821|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226822|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226823|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226824|NCT00347841|Bimatoprost|bimatoprost|mesh-list
20226825|NCT00347841|Latanoprost|latanoprost|mesh-list
20226826|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20226827|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20226828|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20226829|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20226830|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20226831|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
20226832|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20226833|NCT00347854|Laxatives|laxatives|mesh-ancestor
20226834|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20226835|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
20634412|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
20634413|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634414|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634415|NCT04577690|Epinephrine|epinephrine|mesh-list
20634416|NCT04577690|Racepinephrine|racepinephrine|mesh-list
20634417|NCT04577690|Bupivacaine|bupivacaine|mesh-list
20634418|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
20634419|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
20634420|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
20634421|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634422|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634423|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
20634424|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634425|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20634426|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20634427|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
20634428|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634429|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634430|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20634431|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20634432|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
20634433|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20634434|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
20226836|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
20226837|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20634435|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
20634436|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
20634437|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20634438|NCT04574856|Temozolomide|temozolomide|mesh-list
20634439|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20634440|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
20634441|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634442|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634443|NCT04523922|Oxytocin|oxytocin|mesh-list
20634444|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
20634445|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20634446|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634447|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20634448|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634449|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634450|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634451|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20634452|NCT04496596|Suramin|suramin|mesh-list
20634453|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
20634454|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
20634455|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20634456|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634457|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634458|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20634459|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19696632|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
19696633|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696634|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696635|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
19696636|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
19696637|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19696638|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
19696639|NCT04938037|Hormones|hormones|mesh-ancestor
20634460|NCT04447053|Belimumab|belimumab|mesh-list
20226838|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20634461|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634462|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
19696640|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696641|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20226839|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226840|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634463|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634470|NCT04393298|Leucovorin|leucovorin|mesh-list
20634471|NCT04393298|Trifluridine|trifluridine|mesh-list
20634472|NCT04393298|Fluorouracil|fluorouracil|mesh-list
20634473|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634474|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
20634475|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634476|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20475912|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20475913|NCT01513070|Analgesics|analgesics|mesh-ancestor
20475914|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
20475915|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475916|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475917|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20475918|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634477|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634478|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634479|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
20634480|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
20634481|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634482|NCT04393298|Antidotes|antidotes|mesh-ancestor
20634483|NCT04393298|Protective Agents|protective agents|mesh-ancestor
20634484|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
20634485|NCT04393298|Vitamins|vitamins|mesh-ancestor
20634486|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
20634487|NCT04361799|Insulin|insulin|mesh-list
20634488|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20634489|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634490|NCT04306510|Antibodies|antibodies|mesh-list
20634491|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
20634492|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20634493|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
20634494|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634495|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
20634496|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634497|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634498|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634499|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475919|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20226841|NCT00347867|Urological Agents|urological agents|mesh-ancestor
20226842|NCT00347971|Rituximab|rituximab|mesh-list
20226843|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226844|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226845|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
20226846|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226847|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634500|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20634501|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
20634502|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475920|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20475921|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475922|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20475923|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20475924|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475925|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
20475926|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20475927|NCT01513070|Diuretics|diuretics|mesh-ancestor
20475928|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
20475929|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
20475930|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20475931|NCT01513083|Trastuzumab|trastuzumab|mesh-list
20475932|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20475933|NCT01513083|Maytansine|maytansine|mesh-list
20634503|NCT04132817|Paclitaxel|paclitaxel|mesh-list
20634504|NCT04132817|Nivolumab|nivolumab|mesh-list
20634505|NCT04132817|Ipilimumab|ipilimumab|mesh-list
20634506|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20634507|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634508|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
20634509|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
20634510|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
20634511|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634512|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20634513|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20634514|NCT04101890|Allantoin|allantoin|mesh-list
20634515|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
20634516|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634517|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
20634518|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20634519|NCT04101890|Protective Agents|protective agents|mesh-ancestor
20634520|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634521|NCT04017442|Morphine|morphine|mesh-list
20634522|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19696642|NCT04938037|Protective Agents|protective agents|mesh-ancestor
19696643|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19696644|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696645|NCT04937946|Fentanyl|fentanyl|mesh-list
19696646|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19696647|NCT04937946|Narcotics|narcotics|mesh-ancestor
19696648|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696649|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696650|NCT04937946|Analgesics|analgesics|mesh-ancestor
19696651|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
19696652|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696653|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19696654|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19696655|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
19696656|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
19696657|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
19696658|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19696659|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19696660|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20226848|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20634523|NCT04017442|Narcotics|narcotics|mesh-ancestor
20634524|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634525|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634526|NCT04017442|Analgesics|analgesics|mesh-ancestor
20634527|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
20634528|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634529|NCT03993314|Bupivacaine|bupivacaine|mesh-list
20634530|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
20634531|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
20634532|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
19412022|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20226849|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
20530643|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226850|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20226851|NCT00348010|Tramadol|tramadol|mesh-list
20226852|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20226853|NCT00348010|Narcotics|narcotics|mesh-ancestor
20226854|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20226855|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226856|NCT00348010|Analgesics|analgesics|mesh-ancestor
20226857|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
20226858|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226859|NCT00348023|Timolol|timolol|mesh-list
20226860|NCT00348023|Bimatoprost|bimatoprost|mesh-list
19696661|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20226861|NCT00348023|Travoprost|travoprost|mesh-list
19696662|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696663|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
19696664|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696665|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696666|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19696667|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696668|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
19696669|NCT04937907|Benazepril|benazepril|mesh-list
19696670|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
19696671|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19696672|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19696673|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634533|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634534|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634535|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
20634536|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634537|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
20634538|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20634539|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
20634540|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20634541|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
20634542|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634543|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634544|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
20634545|NCT03949894|Tolvaptan|tolvaptan|mesh-list
20634546|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20634547|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634548|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
20634549|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634550|NCT03942224|Dexamethasone|dexamethasone|mesh-list
20634551|NCT03942224|Bortezomib|bortezomib|mesh-list
20634552|NCT03942224|Daratumumab|daratumumab|mesh-list
20634553|NCT03942224|Ixazomib|ixazomib|mesh-list
20634554|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634555|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
20634556|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
20226862|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20226863|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20475934|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20475935|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475936|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20475937|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
20475938|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
20475939|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
20475940|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527532|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527533|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527534|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20527535|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20634557|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634558|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634559|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20634560|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
20634561|NCT03942224|Hormones|hormones|mesh-ancestor
20634562|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634563|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19412023|NCT03535415|Hormones|hormones|mesh-list
20226864|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226865|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226866|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226867|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226868|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20226869|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20226870|NCT00348062|Bimatoprost|bimatoprost|mesh-list
20226871|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20226872|NCT00348101|Enoximone|enoximone|mesh-list
20226873|NCT00348101|Esmolol|esmolol|mesh-list
20527536|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20634564|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634565|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
20634566|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634567|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634568|NCT03879109|Folfirinox|folfirinox|mesh-list
20634569|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634570|NCT03856359|Rifaximin|rifaximin|mesh-list
20634571|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20634572|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634573|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20634574|NCT03846505|Oxytocin|oxytocin|mesh-list
20634575|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
20634576|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20634577|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634578|NCT03837015|Estradiol|estradiol|mesh-list
20634579|NCT03837015|Estrogens|estrogens|mesh-ancestor
20634580|NCT03837015|Hormones|hormones|mesh-ancestor
20634581|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634582|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634583|NCT03690011|Cyclophosphamide|cyclophosphamide|mesh-list
20634584|NCT03690011|Fludarabine|fludarabine|mesh-list
20634585|NCT03690011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634586|NCT03690011|Immunologic Factors|immunologic factors|mesh-ancestor
20634587|NCT03690011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634588|NCT03690011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634589|NCT03690011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20634590|NCT03690011|Alkylating Agents|alkylating agents|mesh-ancestor
20634591|NCT03690011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475941|NCT01513174|Olaparib|olaparib|mesh-list
20475942|NCT01513174|Gefitinib|gefitinib|mesh-list
20475943|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20475944|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475945|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475946|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475947|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20475948|NCT01513200|Heparin|heparin|mesh-list
20475949|NCT01513200|Calcium heparin|calcium heparin|mesh-list
20475950|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
20475951|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20475952|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20475953|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475954|NCT01513499|Oxytocin|oxytocin|mesh-list
20475955|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
20475956|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20475957|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475958|NCT01513525|Liraglutide|liraglutide|mesh-list
20475959|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20475960|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475961|NCT01513525|Incretins|incretins|mesh-ancestor
20475962|NCT01513525|Hormones|hormones|mesh-ancestor
20634592|NCT03690011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634593|NCT03690011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20634594|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
20634595|NCT03654729|Edetic Acid|edetic acid|mesh-list
20634596|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
20634597|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20634598|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
20634599|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
20634600|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634601|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
20634602|NCT03654729|Vitamins|vitamins|mesh-ancestor
19850704|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850705|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
20634603|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
20634604|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634605|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
20634606|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20634607|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634608|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
20634609|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20634610|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20634611|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20634612|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416832|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20475963|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20475964|NCT01513564|Morphine|morphine|mesh-list
20634613|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634614|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
20475965|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20475966|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475967|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19696674|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696675|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696676|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20475968|NCT01513564|Narcotics|narcotics|mesh-ancestor
20475969|NCT01513564|Analgesics|analgesics|mesh-ancestor
20475970|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
20475971|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475972|NCT01513603|Cytarabine|cytarabine|mesh-list
20226874|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20226875|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20475973|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
20475974|NCT01513603|Cladribine|cladribine|mesh-list
20475975|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20475976|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
20475977|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20475978|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20475979|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
20475980|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20475981|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20475982|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
20475983|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475984|NCT01513603|Analgesics|analgesics|mesh-ancestor
20475985|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
20475986|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475987|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20475988|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20475989|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20475990|NCT01513668|Acetaminophen|acetaminophen|mesh-list
20475991|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20475992|NCT01513668|Analgesics|analgesics|mesh-ancestor
20475993|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
20475994|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20475995|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20475996|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
20475997|NCT01513681|Lamotrigine|lamotrigine|mesh-list
20475998|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
20634615|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634616|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634617|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20634618|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634619|NCT03406286|Tolvaptan|tolvaptan|mesh-list
20634620|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20634621|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634622|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
20634623|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634624|NCT03376763|Aripiprazole|aripiprazole|mesh-list
20634625|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
20634626|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20634627|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20634628|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20475999|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20476000|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20476001|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476002|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20476003|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476004|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20476005|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20476006|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476007|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19416833|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
19850706|NCT00712244|Protective Agents|protective agents|mesh-ancestor
20226876|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20226877|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
20226878|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226879|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226880|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226881|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20226882|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
20226883|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20226884|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20226885|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476008|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20634629|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634630|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634631|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
20634632|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
20634633|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634634|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634635|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20634636|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20634637|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
20634638|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20634639|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20634640|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20634641|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20634642|NCT03296033|Enoxaparin|enoxaparin|mesh-list
20634643|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
20634644|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
20634645|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20634646|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20634647|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634648|NCT03237286|Ketamine|ketamine|mesh-list
20634649|NCT03237286|Analgesics|analgesics|mesh-ancestor
20634650|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
20634651|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634652|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634653|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20634654|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20634655|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
20634656|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
20634657|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634658|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20634659|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20634660|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634661|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634662|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
20634663|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
20634664|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634665|NCT03155061|Nivolumab|nivolumab|mesh-list
20634666|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850707|NCT00712270|Risperidone|risperidone|mesh-list
19850708|NCT00712270|Aripiprazole|aripiprazole|mesh-list
19850709|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19850710|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
19850711|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850712|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850713|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850714|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20634667|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634668|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20634669|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634670|NCT03141424|Fluticasone|fluticasone|mesh-list
20634671|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
20634672|NCT03141424|Ciclesonide|ciclesonide|mesh-list
20476009|NCT01513720|Lamotrigine|lamotrigine|mesh-list
20476010|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
20476011|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20476012|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20476013|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634673|NCT03141424|Budesonide|budesonide|mesh-list
20634674|NCT03141424|Beclomethasone|beclomethasone|mesh-list
20634675|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634676|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20634677|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
19850715|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19850716|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850717|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20476014|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20476015|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476016|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20476017|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20476018|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476019|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20476020|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20634678|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634679|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634680|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20634681|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
20634682|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634683|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20634684|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
20634685|NCT03141424|Hormones|hormones|mesh-ancestor
20634686|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634687|NCT03106688|Carfentanil|carfentanil|mesh-list
20634688|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20634689|NCT03106688|Narcotics|narcotics|mesh-ancestor
20634690|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634691|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634692|NCT03106688|Analgesics|analgesics|mesh-ancestor
20634693|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
20634694|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634695|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
20634696|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634697|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
20634698|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20634699|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
20634700|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634701|NCT02966873|Expectorants|expectorants|mesh-ancestor
20634702|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
20634703|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20634704|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
20634705|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634706|NCT02966873|Protective Agents|protective agents|mesh-ancestor
20634707|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634708|NCT02966873|Antidotes|antidotes|mesh-ancestor
20634709|NCT02685735|Gabapentin|gabapentin|mesh-list
20634710|NCT02685735|Analgesics|analgesics|mesh-ancestor
20634711|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
20634712|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634713|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634714|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
20634715|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20634716|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20634717|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634718|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20634719|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20634720|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20634721|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634722|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634723|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
20634724|NCT02631070|Luspatercept|luspatercept|mesh-list
20634725|NCT02631070|Hematinics|hematinics|mesh-ancestor
20634726|NCT02630641|Hormones|hormones|mesh-list
20634727|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634728|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634729|NCT02616185|Tremelimumab|tremelimumab|mesh-list
20634730|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634731|NCT02513329|Bupivacaine|bupivacaine|mesh-list
20634732|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
20634733|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
20634734|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634735|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634736|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
20634737|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634738|NCT02297139|Dasatinib|dasatinib|mesh-list
20634739|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634740|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634741|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634742|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634743|NCT02281955|Cisplatin|cisplatin|mesh-list
20634744|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634745|NCT02097134|Melphalan|melphalan|mesh-list
20634746|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
20634747|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20634748|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20634749|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
20634750|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634751|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634752|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20634753|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696677|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19696678|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19696679|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19696680|NCT04937699|Aspirin|aspirin|mesh-list
19696681|NCT04937699|Ticagrelor|ticagrelor|mesh-list
19696682|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19696683|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19850718|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20634754|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
20634755|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634756|NCT01588431|Bevacizumab|bevacizumab|mesh-list
20634757|NCT01588431|Cetuximab|cetuximab|mesh-list
19850719|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
19850720|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
19850721|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
19850722|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19696684|NCT04937699|Analgesics|analgesics|mesh-ancestor
19850723|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20634758|NCT01588431|Cisplatin|cisplatin|mesh-list
20634759|NCT01588431|Docetaxel|docetaxel|mesh-list
19412024|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412025|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412026|NCT03535376|Valsartan|valsartan|mesh-list
19412027|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19412028|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19412029|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19412030|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412031|NCT03535298|Interferons|interferons|mesh-list
19412032|NCT03535298|Interferon-beta|interferon-beta|mesh-list
19412033|NCT03535298|Teriflunomide|teriflunomide|mesh-list
19412034|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
20476021|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
20476022|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20476023|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476024|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476025|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476026|NCT01513772|Analgesics|analgesics|mesh-ancestor
20476027|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
20476028|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476029|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20476030|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20476031|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20476032|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
20476033|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476034|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476035|NCT01513785|Amoxicillin|amoxicillin|mesh-list
20476036|NCT01513785|Rabeprazole|rabeprazole|mesh-list
20476037|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476038|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476039|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20476040|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20476041|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20476042|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476043|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476044|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20476045|NCT01513863|Metronidazole|metronidazole|mesh-list
20476046|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476047|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476048|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20476049|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20476050|NCT01513941|Interferons|interferons|mesh-list
20476051|NCT01513941|Ribavirin|ribavirin|mesh-list
20476052|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
20476053|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
20476054|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20476055|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476056|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
20476057|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476058|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
20476059|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476060|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
20476061|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476062|NCT01514019|Acebutolol|acebutolol|mesh-list
20476063|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20476064|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20476065|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
20476066|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
20476067|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476068|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476069|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20476070|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20476071|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20476072|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
20476073|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476074|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476075|NCT01514110|Paclitaxel|paclitaxel|mesh-list
20476076|NCT01514110|Carboplatin|carboplatin|mesh-list
20476077|NCT01514110|Everolimus|everolimus|mesh-list
20476078|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20476079|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476080|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
20476081|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
20476082|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476083|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476084|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476085|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
20476086|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476087|NCT01514123|Bevacizumab|bevacizumab|mesh-list
20476088|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20476089|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476090|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20634760|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20634761|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634762|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20634763|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20634764|NCT01588431|Growth Substances|growth substances|mesh-ancestor
20634765|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634766|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
20634767|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
20634768|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
20634769|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
20634770|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634771|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
20634772|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20634773|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
20634774|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20634775|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634776|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20634777|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20634778|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20634779|NCT00983437|Modafinil|modafinil|mesh-list
20634780|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20634781|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634782|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20634783|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20634784|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20634785|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634786|NCT00893789|Modafinil|modafinil|mesh-list
20634787|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20634788|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634789|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20634790|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20634791|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20634792|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634793|NCT00805129|Everolimus|everolimus|mesh-list
20634794|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634795|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634796|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
20634797|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634798|NCT00708448|Bevacizumab|bevacizumab|mesh-list
20634799|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20634800|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20634801|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634802|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20634803|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20634804|NCT00708448|Growth Substances|growth substances|mesh-ancestor
20634805|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634806|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
20634807|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634808|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634809|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634810|NCT05164614|Teriparatide|teriparatide|mesh-list
20634811|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20634812|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634813|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20634814|NCT05164198|Adalimumab|adalimumab|mesh-list
20634815|NCT05164198|Etanercept|etanercept|mesh-list
20634816|NCT05164198|Golimumab|golimumab|mesh-list
20634817|NCT05164198|Infliximab|infliximab|mesh-list
20634818|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20634819|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634820|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634821|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20634822|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20634823|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20634824|NCT05164198|Analgesics|analgesics|mesh-ancestor
20634825|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
20634826|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634827|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634828|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20634829|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
20634830|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20634831|NCT05164159|Propofol|propofol|mesh-list
20634832|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20634833|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634834|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850724|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19850725|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19850726|NCT00712335|Fluticasone|fluticasone|mesh-list
19850727|NCT00712335|Xhance|xhance|mesh-list
20226886|NCT00348101|Protective Agents|protective agents|mesh-ancestor
20226887|NCT00348153|Adalimumab|adalimumab|mesh-list
20226888|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226889|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247452|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20247453|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20634835|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20634836|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
19696685|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
19696686|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247454|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
20634837|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
20634838|NCT05164146|Propofol|propofol|mesh-list
20634839|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20634840|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634841|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634842|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20634843|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
20634844|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
20634845|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
20634846|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20634847|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634848|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634849|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20634850|NCT05163704|Analgesics|analgesics|mesh-ancestor
20634851|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
20634852|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634853|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20634854|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20634855|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20634856|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
20634857|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634858|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247455|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247456|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247457|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20247458|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247459|NCT00432367|Artesunate|artesunate|mesh-list
20247460|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
20247461|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
20476091|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20476092|NCT01514123|Growth Substances|growth substances|mesh-ancestor
20476093|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476094|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
20476095|NCT01514175|Ibuprofen|ibuprofen|mesh-list
20476096|NCT01514175|Ketorolac|ketorolac|mesh-list
20476097|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20476098|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476099|NCT01514175|Analgesics|analgesics|mesh-ancestor
20476100|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
20476101|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476102|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476103|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696687|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696688|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696689|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696690|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19696691|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19850728|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20476104|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20634859|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
20634860|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
20634861|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634862|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20634863|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20634864|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
20634865|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634866|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634867|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20634868|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20634869|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634870|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634871|NCT05163405|Bortezomib|bortezomib|mesh-list
20634872|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634873|NCT05163366|Ketamine|ketamine|mesh-list
20634874|NCT05163366|Morphine|morphine|mesh-list
20634875|NCT05163366|Analgesics|analgesics|mesh-ancestor
20634876|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
20634877|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226890|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
20226891|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
20476105|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20476106|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476107|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476108|NCT01514188|Doxorubicin|doxorubicin|mesh-list
20634878|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634879|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20634880|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20634881|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
20634882|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
20634883|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634884|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20634885|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20634886|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634887|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634888|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20634889|NCT05163366|Narcotics|narcotics|mesh-ancestor
20634890|NCT05163249|Osimertinib|osimertinib|mesh-list
20634891|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634892|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634893|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634894|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696692|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696693|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19696694|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19696695|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226892|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
20226893|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476109|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20476110|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476111|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20476112|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476113|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476114|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226894|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226895|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
20226896|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20226897|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20226898|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
20226899|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226900|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634895|NCT05162937|Antibodies|antibodies|mesh-list
20634896|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
20634897|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634898|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
20634899|NCT05161611|Astringents|astringents|mesh-ancestor
20634900|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634901|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634902|NCT05160727|Irinotecan|irinotecan|mesh-list
20634903|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20634904|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20634905|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634906|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634907|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634908|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20634909|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
20634910|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634911|NCT05141422|Efavirenz|efavirenz|mesh-list
20634912|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20634913|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20634914|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634915|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696696|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
19696697|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19696698|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19696699|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19696700|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
19696701|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696702|NCT04937673|Paclitaxel|paclitaxel|mesh-list
19696703|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19696704|NCT04937673|Cisplatin|cisplatin|mesh-list
19696705|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19696706|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634916|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
20634917|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634918|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20634919|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20634920|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20634921|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20634922|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20634923|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20634924|NCT05137678|Glyburide|glyburide|mesh-list
20634925|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20634926|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634927|NCT05101018|Denosumab|denosumab|mesh-list
20634928|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20634929|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634930|NCT05097651|Cannabidiol|cannabidiol|mesh-list
20634931|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
20634932|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20634933|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20634934|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
20634935|NCT05040360|Capecitabine|capecitabine|mesh-list
20634936|NCT05040360|Temozolomide|temozolomide|mesh-list
20634937|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20634938|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
20634939|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634940|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634941|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20634942|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
20634943|NCT04820179|Atezolizumab|atezolizumab|mesh-list
20634944|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634945|NCT04809051|Metronidazole|metronidazole|mesh-list
20634946|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20634947|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20634948|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20634949|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20634950|NCT04760730|Vaccines|vaccines|mesh-list
20634951|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
20634952|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634953|NCT04735367|Letrozole|letrozole|mesh-list
20634954|NCT04735367|Palbociclib|palbociclib|mesh-list
20634955|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634956|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19850729|NCT00712335|Montelukast|montelukast|mesh-list
19696707|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
20634957|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20634958|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634959|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634960|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20634961|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
20634962|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20634963|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634964|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634965|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
20634966|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
20634967|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634968|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20634969|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19850730|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
19850731|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850732|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19850733|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
19850734|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850735|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850736|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19850737|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
19850738|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
19850739|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19850740|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19850741|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19850742|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19850743|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
20634970|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
20634971|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20634972|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634973|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20634974|NCT04658173|Alfentanil|alfentanil|mesh-list
20634975|NCT04658173|Propofol|propofol|mesh-list
20634976|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20634977|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20634978|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20634979|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20634980|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
20634981|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
20634982|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20634983|NCT04658173|Narcotics|narcotics|mesh-ancestor
20634984|NCT04658173|Analgesics|analgesics|mesh-ancestor
20634985|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
20634986|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20634987|NCT04627285|Lacosamide|lacosamide|mesh-list
20634988|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
20634989|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20634990|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20634991|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20634992|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634993|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
20634994|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20634995|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20634996|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20634997|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20634998|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20634999|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19696708|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
19696709|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
20226901|NCT00348192|Donepezil|donepezil|mesh-list
20226902|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20226903|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226904|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226905|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
20226906|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696710|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696711|NCT04937894|Tigecycline|tigecycline|mesh-list
19696712|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19696713|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696714|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19696715|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696716|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226907|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696717|NCT04937569|Ivermectin|ivermectin|mesh-list
19696718|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19696719|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476115|NCT01514227|Aspirin|aspirin|mesh-list
20476116|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20476117|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476118|NCT01514227|Analgesics|analgesics|mesh-ancestor
20476119|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
20476120|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476121|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476122|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476123|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635000|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20635001|NCT04587687|Antibodies|antibodies|mesh-list
20635002|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
20635003|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20635004|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
20635005|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
20635006|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635007|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635008|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20635009|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
20635010|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635011|NCT04578600|Lenalidomide|lenalidomide|mesh-list
20635012|NCT04578600|Azacitidine|azacitidine|mesh-list
20635013|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
20635014|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
20635015|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696720|NCT04937634|Melphalan|melphalan|mesh-list
19696721|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19696722|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
20226908|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
20226909|NCT00348231|Insulin|insulin|mesh-list
20226910|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20226911|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226912|NCT00348244|Prednisolone|prednisolone|mesh-list
20226913|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20226914|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
20226915|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20226916|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
20226917|NCT00348244|Ketorolac|ketorolac|mesh-list
20226918|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20226919|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
20226920|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226921|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
20226922|NCT00348244|Hormones|hormones|mesh-ancestor
20226923|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20226924|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226925|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20226926|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20226927|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
20226928|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
20226929|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226930|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20226931|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20226932|NCT00348244|Protective Agents|protective agents|mesh-ancestor
20476124|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20476125|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20476126|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635016|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20226933|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20226934|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20226935|NCT00348244|Analgesics|analgesics|mesh-ancestor
20226936|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
19696723|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696724|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696725|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19696726|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696727|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
19696728|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696729|NCT04937543|Beclomethasone|beclomethasone|mesh-list
19696730|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
19696731|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
20226937|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226938|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20476127|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20635017|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20476128|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20476129|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476130|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
20476131|NCT01514266|Curcumin|curcumin|mesh-list
20476132|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20476133|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476134|NCT01514266|Analgesics|analgesics|mesh-ancestor
20476135|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
20226939|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226940|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226941|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
20226942|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20226943|NCT00348296|Antibodies|antibodies|mesh-list
20226944|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
20226945|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20226946|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
20635018|NCT04578600|Growth Substances|growth substances|mesh-ancestor
20635019|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
20635020|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635021|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20635022|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
20635023|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635024|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635025|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635026|NCT04565392|Famotidine|famotidine|mesh-list
20635027|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20635028|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20635029|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20476136|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476137|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476138|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635030|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
20635031|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
20635032|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635033|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635034|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635035|NCT04478942|Misoprostol|misoprostol|mesh-list
20635036|NCT04478942|Oxytocin|oxytocin|mesh-list
20635037|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
20635038|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20635039|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635040|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20635041|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
20635042|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20635043|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20635044|NCT04463498|Methamphetamine|methamphetamine|mesh-list
20635045|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20635046|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635047|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
20635048|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
20635049|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635050|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
20635051|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635052|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635053|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
20635054|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20635055|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20635056|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20635057|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20635058|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
20635059|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635060|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635061|NCT04373707|Enoxaparin|enoxaparin|mesh-list
20635062|NCT04373707|Dalteparin|dalteparin|mesh-list
20635063|NCT04373707|Tinzaparin|tinzaparin|mesh-list
20635064|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20635065|NCT04373707|Nadroparin|nadroparin|mesh-list
20635066|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
20635067|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
20635068|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20635069|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20635070|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635071|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
20635072|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20476139|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226947|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635073|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635074|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635075|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635076|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
20635077|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635078|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635079|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
20635080|NCT04287816|Antithrombins|antithrombins|mesh-list
20635081|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20635082|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
20635083|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635084|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635085|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
20226948|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20226949|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
20226950|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19850744|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850745|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226951|NCT00348335|Cyclosporine|cyclosporine|mesh-list
19850746|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
19850747|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850748|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19850749|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19850750|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19850751|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
19850752|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850753|NCT00712543|Lactulose|lactulose|mesh-list
19850754|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19850755|NCT00712673|Metformin|metformin|mesh-list
19850756|NCT00712673|Lixisenatide|lixisenatide|mesh-list
19850757|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476140|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476141|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476142|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476143|NCT01514344|Rituximab|rituximab|mesh-list
20635086|NCT04220489|Ketamine|ketamine|mesh-list
20635087|NCT04220489|Analgesics|analgesics|mesh-ancestor
20635088|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
20635089|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635090|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635091|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20635092|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20635093|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
20635094|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
20635095|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635096|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20476144|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20476145|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476146|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
20476147|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476148|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476149|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
20476150|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20476151|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
20476152|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20476153|NCT01514487|Liraglutide|liraglutide|mesh-list
20476154|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635097|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20635098|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635099|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635100|NCT04218786|Colchicine|colchicine|mesh-list
20635101|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
20635102|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635103|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635104|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635105|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635106|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635107|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635108|NCT04206813|Vaccines|vaccines|mesh-list
20635109|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
20635110|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635111|NCT04133376|Nicotine|nicotine|mesh-list
20476155|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476156|NCT01514487|Incretins|incretins|mesh-ancestor
20635112|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20635113|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
20635114|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635115|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635116|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20635117|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20635118|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
20635119|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635120|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635121|NCT04050085|Nivolumab|nivolumab|mesh-list
20635122|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635123|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635124|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20635125|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635126|NCT04002362|Triamcinolone|triamcinolone|mesh-list
20635127|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20635128|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19850758|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850759|NCT00712712|Acetaminophen|acetaminophen|mesh-list
20476157|NCT01514487|Hormones|hormones|mesh-ancestor
20635129|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20635130|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635131|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
20635132|NCT04002362|Hormones|hormones|mesh-ancestor
20635133|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635134|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635135|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635136|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
20635137|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635138|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635139|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20635140|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635141|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635142|NCT03940690|Bevacizumab|bevacizumab|mesh-list
20635143|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635144|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635145|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20635146|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20635147|NCT03940690|Growth Substances|growth substances|mesh-ancestor
20635148|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635149|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
20635150|NCT03901144|Glycerol|glycerol|mesh-list
20635151|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20635152|NCT03901144|Protective Agents|protective agents|mesh-ancestor
20635153|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635154|NCT03765632|Busulfan|busulfan|mesh-list
20635155|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
20635156|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635157|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635158|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
20635159|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635160|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20635161|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635162|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20635163|NCT03695250|Nivolumab|nivolumab|mesh-list
20635164|NCT03695250|Linrodostat|linrodostat|mesh-list
20635165|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635166|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635167|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20635168|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635169|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635170|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
20635171|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635172|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635173|NCT03603912|Metformin|metformin|mesh-list
20635174|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635175|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635176|NCT03558152|Vedolizumab|vedolizumab|mesh-list
20635177|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20635178|NCT03549000|Spartalizumab|spartalizumab|mesh-list
20635179|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20635180|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635181|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635182|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
20635183|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
20635184|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
20635185|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635186|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635187|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20635188|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635189|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635190|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
20635191|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635192|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635193|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20635194|NCT03519295|Atezolizumab|atezolizumab|mesh-list
20635195|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635196|NCT03462459|Vancomycin|vancomycin|mesh-list
20635197|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20635198|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635199|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
20635200|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20635201|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20226952|NCT00348335|Cyclosporins|cyclosporins|mesh-list
20226953|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226954|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226955|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20226956|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
20226957|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226958|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
20226959|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226960|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
20226961|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20226962|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20226963|NCT00348361|Fluticasone|fluticasone|mesh-list
20226964|NCT00348361|Xhance|xhance|mesh-list
20226965|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20226966|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20476158|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476159|NCT01514695|Fentanyl|fentanyl|mesh-list
20476160|NCT01514695|Midazolam|midazolam|mesh-list
20476161|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20476162|NCT01514695|Narcotics|narcotics|mesh-ancestor
20476163|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476164|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476165|NCT01514695|Analgesics|analgesics|mesh-ancestor
20476166|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
20476167|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476168|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20476169|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20476170|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
20476171|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
20476172|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20476173|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20476174|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20476175|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20476176|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
20476177|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
20476178|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476179|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476180|NCT01514721|Timolol|timolol|mesh-list
20476181|NCT01514721|Travoprost|travoprost|mesh-list
20476182|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20476183|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20476184|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
20476185|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476186|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476187|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476188|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20476189|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20476190|NCT01514812|Digoxin|digoxin|mesh-list
20476191|NCT01514812|Darexaban|darexaban|mesh-list
20476192|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20476193|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20476194|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476195|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476196|NCT01514812|Protective Agents|protective agents|mesh-ancestor
20476197|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476198|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20476199|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
20476200|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20476201|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476202|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
20476203|NCT01514825|Darexaban|darexaban|mesh-list
20476204|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20476205|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
20476206|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20476207|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476208|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476209|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476210|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
20476211|NCT01514838|Acarbose|acarbose|mesh-list
20476212|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
20476213|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20476214|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476215|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476216|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476217|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226967|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
20226968|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226969|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20226970|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20476218|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20476219|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
20635202|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635203|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20635204|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635205|NCT03323398|Durvalumab|durvalumab|mesh-list
20635206|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635207|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635208|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20635209|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
20635210|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635211|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20635212|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
20635213|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635214|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635215|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20635216|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20635217|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20635218|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
20635219|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
20635220|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20635221|NCT03166085|Paclitaxel|paclitaxel|mesh-list
20635222|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
20635223|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20635224|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635225|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635226|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635227|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635228|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635229|NCT03161054|Prednisone|prednisone|mesh-list
20635230|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
20635231|NCT03161054|Rituximab|rituximab|mesh-list
20635232|NCT03161054|Etoposide|etoposide|mesh-list
20635233|NCT03161054|Vinorelbine|vinorelbine|mesh-list
20635234|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635235|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
20635236|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635237|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635238|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20635239|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
20635240|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635241|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635242|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20635243|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635244|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635245|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
20635246|NCT03161054|Hormones|hormones|mesh-ancestor
20635247|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635248|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20635249|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20635250|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20635251|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20635252|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635253|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635254|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635255|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476220|NCT01514851|Calcium|calcium|mesh-list
20476221|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20476222|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476223|NCT01514851|Antacids|antacids|mesh-ancestor
20476224|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226971|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
20226972|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
20476225|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20476226|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
20476227|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
20476228|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20476229|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20635256|NCT03050814|Leucovorin|leucovorin|mesh-list
20635257|NCT03050814|Bevacizumab|bevacizumab|mesh-list
20635258|NCT03050814|Avelumab|avelumab|mesh-list
20635259|NCT03050814|Fluorouracil|fluorouracil|mesh-list
20635260|NCT03050814|Capecitabine|capecitabine|mesh-list
20635261|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
20635262|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635263|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635264|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20635265|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20635266|NCT03050814|Growth Substances|growth substances|mesh-ancestor
20635267|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635268|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
20635269|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
20635270|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635271|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20635272|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635273|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
20635274|NCT03050814|Antidotes|antidotes|mesh-ancestor
20635275|NCT03050814|Protective Agents|protective agents|mesh-ancestor
20635276|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
20635277|NCT03050814|Vitamins|vitamins|mesh-ancestor
20635278|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
20635279|NCT02724241|Nicotine|nicotine|mesh-list
20635280|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20635281|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
20635282|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635283|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635284|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20635285|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20635286|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
20635287|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635288|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850760|NCT00712712|Morphine|morphine|mesh-list
19850761|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20635289|NCT02639910|Venetoclax|venetoclax|mesh-list
20635290|NCT02639910|Idelalisib|idelalisib|mesh-list
20635291|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635292|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635293|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635294|NCT02618980|Hemostatics|hemostatics|mesh-list
20635295|NCT02618980|Coagulants|coagulants|mesh-ancestor
20635296|NCT02613598|Bortezomib|bortezomib|mesh-list
20635297|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635298|NCT02595320|Capecitabine|capecitabine|mesh-list
20635299|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20635300|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
20635301|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635302|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635303|NCT02586623|Droxidopa|droxidopa|mesh-list
20635304|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20635305|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20635306|NCT02492867|Paclitaxel|paclitaxel|mesh-list
20635307|NCT02492867|Carboplatin|carboplatin|mesh-list
20635308|NCT02492867|Durvalumab|durvalumab|mesh-list
20635309|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20635310|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635311|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635312|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635313|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635314|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635315|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635316|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
20635317|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20635318|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20635319|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
20635320|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635321|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635322|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635323|NCT02426892|Nivolumab|nivolumab|mesh-list
20635324|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635325|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635326|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20635327|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635328|NCT02409368|Nivolumab|nivolumab|mesh-list
20635329|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635330|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635331|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20635332|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635333|NCT02375555|Dexamethasone|dexamethasone|mesh-list
20635334|NCT02375555|Lenalidomide|lenalidomide|mesh-list
20635335|NCT02375555|Bortezomib|bortezomib|mesh-list
20635336|NCT02375555|Elotuzumab|elotuzumab|mesh-list
20635337|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635338|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
20635339|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
20635340|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635341|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635342|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20635343|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
20635344|NCT02375555|Hormones|hormones|mesh-ancestor
20635345|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635346|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20635347|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635348|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
20635349|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20635350|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20635351|NCT02375555|Growth Substances|growth substances|mesh-ancestor
20635352|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
20635353|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
20635354|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635355|NCT02220894|Paclitaxel|paclitaxel|mesh-list
20635356|NCT02220894|Carboplatin|carboplatin|mesh-list
20635357|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
20635358|NCT02220894|Pemetrexed|pemetrexed|mesh-list
20635359|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20635360|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635361|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
19696732|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19696733|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
20635362|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635363|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635364|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635365|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635366|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635367|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20635368|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20635369|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20635370|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20635371|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20635372|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635373|NCT01772004|Avelumab|avelumab|mesh-list
20635374|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635375|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696734|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696735|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696736|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19696737|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
20635376|NCT01721759|Nivolumab|nivolumab|mesh-list
20635377|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635378|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635379|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20635380|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635381|NCT01633541|Carboplatin|carboplatin|mesh-list
20635382|NCT01633541|Docetaxel|docetaxel|mesh-list
20635383|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635384|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635385|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635386|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635387|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635388|NCT01539447|Naproxen|naproxen|mesh-list
20635389|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20226973|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20226974|NCT00348387|Vaccines|vaccines|mesh-list
20226975|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
20226976|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696738|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19696739|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19696740|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19696741|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
19696742|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696743|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696744|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696745|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
20226977|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20226978|NCT00348400|Dorzolamide|dorzolamide|mesh-list
20226979|NCT00348400|Latanoprost|latanoprost|mesh-list
20226980|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20226981|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20226982|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20226983|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20635390|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20635391|NCT01539447|Analgesics|analgesics|mesh-ancestor
20635392|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
20635393|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635394|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635395|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635396|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635397|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
20635398|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20635399|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226984|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20476230|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476231|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476232|NCT01514903|Urological Agents|urological agents|mesh-ancestor
20476233|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
20476234|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476235|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476236|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20476237|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476238|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476239|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226985|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20226986|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
20635400|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635401|NCT01322971|Metronidazole|metronidazole|mesh-list
20635402|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635403|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20635404|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20635405|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20635406|NCT01285102|Irinotecan|irinotecan|mesh-list
20635407|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20635408|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20635409|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635410|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635411|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635412|NCT00952692|Lapatinib|lapatinib|mesh-list
20635413|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635414|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20635415|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635416|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635417|NCT00424099|Methylphenidate|methylphenidate|mesh-list
20635418|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20635419|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635420|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20635421|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20635422|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20635423|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635424|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
20635425|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635426|NCT05166096|Aspirin|aspirin|mesh-list
20635427|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20635428|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20635429|NCT05166096|Analgesics|analgesics|mesh-ancestor
20635430|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
20635431|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635432|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635433|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850762|NCT00712712|Narcotics|narcotics|mesh-ancestor
19850763|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850764|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850765|NCT00712712|Analgesics|analgesics|mesh-ancestor
19850766|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
19850767|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850768|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19850769|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
19850770|NCT00712920|Azelastine|azelastine|mesh-list
19850771|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19850772|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
19850773|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850774|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850775|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19850776|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
19850777|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20635434|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635435|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20635436|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20635437|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635438|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20635439|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20635440|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635441|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
20635442|NCT05166083|Testosterone|testosterone|mesh-list
20635443|NCT05166083|Androgens|androgens|mesh-ancestor
20635444|NCT05166083|Hormones|hormones|mesh-ancestor
20635445|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635446|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635447|NCT05166005|Vitamin D|vitamin d|mesh-list
20635448|NCT05166005|Vitamins|vitamins|mesh-ancestor
20635449|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
20635450|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635451|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20635452|NCT05165914|Midazolam|midazolam|mesh-list
20635453|NCT05165914|Anesthetics|anesthetics|mesh-list
20635454|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635455|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850778|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855607|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635456|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20226987|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20226988|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20226989|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635457|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20635458|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20635459|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20635460|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20635461|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20635462|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
20635463|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
20635464|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
20635465|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635466|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635467|NCT05165732|Vaccines|vaccines|mesh-list
20635468|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
20635469|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635470|NCT05165641|Anesthetics|anesthetics|mesh-list
20635471|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635472|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635473|NCT05165615|Insulin|insulin|mesh-list
20635474|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635475|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635476|NCT05165303|Lidocaine|lidocaine|mesh-list
20635477|NCT05165303|Propofol|propofol|mesh-list
20635478|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
20635479|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
20635480|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635481|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635482|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
20635483|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635484|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20635485|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20635486|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20635487|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20635488|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635489|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20635490|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20635491|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
20635492|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20635493|NCT05165082|Timolol|timolol|mesh-list
20635494|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20635495|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20635496|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20635497|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20635498|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
20635499|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635500|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635501|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635502|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20635503|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20635504|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
20635505|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20635506|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635507|NCT05164848|Afatinib|afatinib|mesh-list
20635508|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635509|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20635510|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635511|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635512|NCT05164770|Prednisone|prednisone|mesh-list
20635513|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
20635514|NCT05164770|Vincristine|vincristine|mesh-list
20635515|NCT05164770|Rituximab|rituximab|mesh-list
20635516|NCT05164770|Doxorubicin|doxorubicin|mesh-list
20635517|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
20635518|NCT05164770|Etoposide|etoposide|mesh-list
20635519|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635520|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
20635521|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635522|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635523|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20635524|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
20635525|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635526|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635527|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19696746|NCT04937543|Hormones|hormones|mesh-ancestor
19707880|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20226990|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20476240|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476241|NCT01514942|Folic Acid|folic acid|mesh-list
20476242|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
20476243|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
20476244|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
20476245|NCT01514942|Inositol|inositol|mesh-list
20476246|NCT01514942|Manganese|manganese|mesh-list
20476247|NCT01514942|Hematinics|hematinics|mesh-ancestor
20476248|NCT01514942|Vitamins|vitamins|mesh-ancestor
20476249|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
20476250|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476251|NCT01514942|Trace Elements|trace elements|mesh-ancestor
20476252|NCT01514968|Cyclosporine|cyclosporine|mesh-list
20476253|NCT01514968|Ritonavir|ritonavir|mesh-list
20476254|NCT01514968|Cyclosporins|cyclosporins|mesh-list
20476255|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635528|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635529|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
20635530|NCT05164770|Hormones|hormones|mesh-ancestor
20635531|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635532|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20635533|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20635534|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635535|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635536|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635537|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635538|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20635539|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20635540|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20635541|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635542|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20635543|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
20635544|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
20635545|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20635546|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635547|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635548|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20635549|NCT05164627|Analgesics|analgesics|mesh-ancestor
20635550|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
20635551|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635552|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20635553|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20635554|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20635555|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
20635556|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635557|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635558|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
20635559|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20635560|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
20635561|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20635562|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20635563|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20635564|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
20635565|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20635566|NCT05164263|Empagliflozin|empagliflozin|mesh-list
20635567|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20635568|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635569|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635570|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635571|NCT05161741|Insulin|insulin|mesh-list
20635572|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635573|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635574|NCT05153590|Liraglutide|liraglutide|mesh-list
20635575|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635576|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635577|NCT05153590|Incretins|incretins|mesh-ancestor
20226991|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20226992|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
20226993|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20226994|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20226995|NCT00348413|Prednisolone|prednisolone|mesh-list
20226996|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
20226997|NCT00348413|Methotrexate|methotrexate|mesh-list
20635578|NCT05153590|Hormones|hormones|mesh-ancestor
20635579|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635580|NCT05153135|Palbociclib|palbociclib|mesh-list
20635581|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635582|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20635583|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635584|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696747|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696748|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19696749|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19696750|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19696751|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
19696752|NCT04937452|Rotigotine|rotigotine|mesh-list
19696753|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
19696754|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
19696755|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696756|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696757|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696758|NCT04937140|Antibodies|antibodies|mesh-list
19696759|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
19696760|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696761|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
19696762|NCT04937101|Codeine|codeine|mesh-list
19696763|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19696764|NCT04937101|Narcotics|narcotics|mesh-ancestor
19696765|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696766|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696767|NCT04937101|Analgesics|analgesics|mesh-ancestor
19412035|NCT03535298|Ofatumumab|ofatumumab|mesh-list
19696768|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
20635585|NCT05146479|Fluorides|fluorides|mesh-list
20635586|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
20635587|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
20635588|NCT05146479|Protective Agents|protective agents|mesh-ancestor
20635589|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635590|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20635591|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20635592|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635593|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635594|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
20635595|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635596|NCT05110209|Bevacizumab|bevacizumab|mesh-list
20635597|NCT05110209|Ranibizumab|ranibizumab|mesh-list
20635598|NCT05110209|Aflibercept|aflibercept|mesh-list
20635599|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635600|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635601|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20635602|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20635603|NCT05110209|Growth Substances|growth substances|mesh-ancestor
20635604|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635605|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
20635606|NCT05096143|Valsartan|valsartan|mesh-list
20635607|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20635608|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20635609|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20635610|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635611|NCT05039944|Irinotecan|irinotecan|mesh-list
20635612|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20635613|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20635614|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635615|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635616|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635617|NCT05023343|Ropivacaine|ropivacaine|mesh-list
20635618|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
20635619|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
20635620|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635621|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635622|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
20635623|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635624|NCT05007145|Paclitaxel|paclitaxel|mesh-list
20635625|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20635626|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20635627|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20635628|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635629|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635630|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635631|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635632|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635633|NCT04968951|Metronidazole|metronidazole|mesh-list
20635634|NCT04968951|Vancomycin|vancomycin|mesh-list
20635635|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635636|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20635637|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20635638|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20635639|NCT04952857|Vitamin D|vitamin d|mesh-list
20635640|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
20635641|NCT04952857|Vitamins|vitamins|mesh-ancestor
20635642|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
20635643|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635644|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20635645|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20635646|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
20635647|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20635648|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635649|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635650|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635651|NCT04825262|Tacrolimus|tacrolimus|mesh-list
20635652|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635653|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
20635654|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635655|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20635656|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635657|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635658|NCT04821830|Levodopa|levodopa|mesh-list
20635659|NCT04821830|Carbidopa|carbidopa|mesh-list
20635660|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20635661|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20635662|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20635663|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
20635664|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635665|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635666|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635667|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20635668|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635669|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20635670|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
20635671|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
20635672|NCT04803994|Bevacizumab|bevacizumab|mesh-list
20635673|NCT04803994|Atezolizumab|atezolizumab|mesh-list
20635674|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635675|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635676|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20635677|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20635678|NCT04803994|Growth Substances|growth substances|mesh-ancestor
19696769|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635679|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635680|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
19412036|NCT03535298|Cladribine|cladribine|mesh-list
19412037|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
19412038|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19412039|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
19412040|NCT03535298|Natalizumab|natalizumab|mesh-list
19412041|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20635681|NCT04693507|Antarelix|antarelix|mesh-list
20635682|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
20635683|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635684|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635685|NCT04618016|Vitamins|vitamins|mesh-list
20635686|NCT04618016|Vitamin E|vitamin e|mesh-list
20635687|NCT04618016|Tocopherols|tocopherols|mesh-list
20635688|NCT04618016|Tocotrienols|tocotrienols|mesh-list
20635689|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
20635690|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
20635691|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635692|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
20635693|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635694|NCT04618016|Protective Agents|protective agents|mesh-ancestor
20635695|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20635696|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20635697|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635698|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
20635699|NCT04527289|Amantadine|amantadine|mesh-list
20635700|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20635701|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20635702|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
20635703|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635704|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
20635705|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635706|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635707|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635708|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20635709|NCT04527289|Analgesics|analgesics|mesh-ancestor
20635710|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
20635711|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635712|NCT04525898|Methadone|methadone|mesh-list
20635713|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20635714|NCT04525898|Narcotics|narcotics|mesh-ancestor
20635715|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635716|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635717|NCT04525898|Analgesics|analgesics|mesh-ancestor
20635718|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
20635719|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635720|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
20635721|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
20635722|NCT04518124|Propranolol|propranolol|mesh-list
19412042|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
19412043|NCT03535298|Ozanimod|ozanimod|mesh-list
19412044|NCT03535298|Ponesimod|ponesimod|mesh-list
20635723|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20635724|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20635725|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412045|NCT03535298|Siponimod|siponimod|mesh-list
19412046|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635726|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635727|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635728|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635729|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20635730|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20635731|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
20635732|NCT04511052|Carotenoids|carotenoids|mesh-list
20635733|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
20635734|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635735|NCT04511052|Protective Agents|protective agents|mesh-ancestor
20635736|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635737|NCT04433858|Psilocybin|psilocybin|mesh-list
20635738|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
20635739|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635740|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19696770|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
19696771|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
19696772|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
20635741|NCT04339270|Azithromycin|azithromycin|mesh-list
20635742|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20635743|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635744|NCT04282070|Gemcitabine|gemcitabine|mesh-list
20635745|NCT04282070|Paclitaxel|paclitaxel|mesh-list
20635746|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20635747|NCT04282070|Cisplatin|cisplatin|mesh-list
20635748|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20635749|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635750|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635751|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635752|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635753|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635754|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20635755|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
20635756|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
20635757|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635758|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635759|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635760|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
20635761|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635762|NCT04259255|Edaravone|edaravone|mesh-list
20635763|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20635764|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
20635765|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635766|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20635767|NCT04259255|Protective Agents|protective agents|mesh-ancestor
20635768|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635769|NCT04246554|Acetaminophen|acetaminophen|mesh-list
20635770|NCT04246554|Ketorolac|ketorolac|mesh-list
20635771|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20635772|NCT04246554|Oxycodone|oxycodone|mesh-list
20635773|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20635774|NCT04246554|Analgesics|analgesics|mesh-ancestor
20635775|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
20635776|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635777|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635778|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
20635779|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20635780|NCT04246554|Narcotics|narcotics|mesh-ancestor
20635781|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635782|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20635783|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635784|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635785|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20635786|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635787|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412047|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412048|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
19412049|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412050|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412051|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
19412052|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20226998|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20226999|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
20227000|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19412053|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19412054|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19696773|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
20227001|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
20227002|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20227003|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227004|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227005|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
20227006|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476256|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476257|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476258|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
20476259|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476260|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
20476261|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476262|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
20476263|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635788|NCT04101721|Aflibercept|aflibercept|mesh-list
20635789|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20635790|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20635791|NCT04101721|Growth Substances|growth substances|mesh-ancestor
20635792|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412055|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412056|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19412057|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
20635793|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
20635794|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635795|NCT04093570|Decitabine|decitabine|mesh-list
20635796|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20635797|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
20635798|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635799|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635800|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635801|NCT04078906|SMOFlipid|smoflipid|mesh-list
20635802|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
20635803|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20635804|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20635805|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
20635806|NCT04024462|Docetaxel|docetaxel|mesh-list
20635807|NCT04024462|Doxorubicin|doxorubicin|mesh-list
20635808|NCT04024462|Trastuzumab|trastuzumab|mesh-list
20635809|NCT04024462|Pertuzumab|pertuzumab|mesh-list
20635810|NCT04024462|Hormones|hormones|mesh-list
20635811|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20635812|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
20635813|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635814|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635815|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20635816|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
20635817|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635818|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635819|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20635820|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
20635821|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
20635822|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
20635823|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20635824|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20635825|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20635826|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635827|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635828|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635829|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
20635830|NCT03978624|Entinostat|entinostat|mesh-list
20635831|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635832|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635833|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20635834|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635835|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635836|NCT03976310|Benralizumab|benralizumab|mesh-list
20635837|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20635838|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
20635839|NCT03941132|Ustekinumab|ustekinumab|mesh-list
20635840|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
20635841|NCT03934671|Antioxidants|antioxidants|mesh-list
20635842|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635843|NCT03934671|Protective Agents|protective agents|mesh-ancestor
20635844|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635845|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
20635846|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635847|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635848|NCT03737461|Lidocaine|lidocaine|mesh-list
20635849|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
20635850|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
20635851|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635852|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412058|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19412059|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412060|NCT03535298|Analgesics|analgesics|mesh-ancestor
19412061|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
19696774|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20635853|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
20635854|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635855|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20635856|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20635857|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20635858|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20635859|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635860|NCT03712098|Liraglutide|liraglutide|mesh-list
20635861|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20635862|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635863|NCT03712098|Incretins|incretins|mesh-ancestor
20635864|NCT03712098|Hormones|hormones|mesh-ancestor
20635865|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635866|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
20635867|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20476264|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20476265|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20476266|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20476267|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476268|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20476269|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20476270|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
20476271|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20476272|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20476273|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
20476274|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527537|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20635868|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635869|NCT03679091|Clopidogrel|clopidogrel|mesh-list
20635870|NCT03679091|Ticagrelor|ticagrelor|mesh-list
20635871|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20635872|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20635873|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20635874|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20635875|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
20635876|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635877|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635878|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635879|NCT03651518|Rituximab|rituximab|mesh-list
20635880|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20635881|NCT03651518|Ustekinumab|ustekinumab|mesh-list
20635882|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635883|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635884|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
20635885|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635886|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635887|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
20635888|NCT03624517|Octreotide|octreotide|mesh-list
20635889|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20635890|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20635891|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635892|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20635893|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
20635894|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20635895|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20635896|NCT03592212|Albuterol|albuterol|mesh-list
20635897|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20635898|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
20635899|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635900|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635901|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20635902|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
20635903|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
20635904|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20635905|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20635906|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20635907|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20635908|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
20635909|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412062|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412063|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412064|NCT03535259|Sorafenib|sorafenib|mesh-list
20527538|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527539|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20527540|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20527541|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
19412065|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412066|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19412067|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412068|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412069|NCT03535233|Triamcinolone|triamcinolone|mesh-list
19412070|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19412071|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19412072|NCT03535233|Clobetasol|clobetasol|mesh-list
19412073|NCT03535233|Minoxidil|minoxidil|mesh-list
19412074|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19412075|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412076|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
19412077|NCT03535233|Hormones|hormones|mesh-ancestor
19412078|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412079|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635910|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635911|NCT03475381|Ivacaftor|ivacaftor|mesh-list
20635912|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20635913|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20635914|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635915|NCT03465540|Dexamethasone|dexamethasone|mesh-list
20635916|NCT03465540|Azacitidine|azacitidine|mesh-list
20635917|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20635918|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
20635919|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
20635920|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635921|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412080|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19412081|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
19412082|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412083|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412084|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19412085|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
19412086|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20476275|NCT01515020|Vancomycin|vancomycin|mesh-list
20635922|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20635923|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
20635924|NCT03465540|Hormones|hormones|mesh-ancestor
20635925|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20635926|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20635927|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635928|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20635929|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
19412087|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
19412088|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19412089|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412090|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412091|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19412092|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19412093|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19412094|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
19412095|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19412096|NCT03535168|Midazolam|midazolam|mesh-list
19412097|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19412098|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19696775|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
19696776|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
19696777|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696778|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696779|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19707881|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
19707882|NCT04822064|Ketamine|ketamine|mesh-list
19707883|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
19707884|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19707885|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707886|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707887|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476276|NCT01515020|Daptomycin|daptomycin|mesh-list
20476277|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476278|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476279|NCT01515137|Sulindac|sulindac|mesh-list
20476280|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20476281|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476282|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20476283|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412099|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412100|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412101|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19412102|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19412103|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19412104|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19412105|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
19412106|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
20635930|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635931|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635932|NCT03436199|Amantadine|amantadine|mesh-list
20635933|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20635934|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20635935|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
20635936|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635937|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
20635938|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20635939|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635940|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412107|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
19696780|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19696781|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19696782|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20635941|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20635942|NCT03436199|Analgesics|analgesics|mesh-ancestor
20635943|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
20635944|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635945|NCT03353233|Ropivacaine|ropivacaine|mesh-list
20635946|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
20635947|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
20635948|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20635949|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635950|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
20635951|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20635952|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
20635953|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635954|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635955|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
20635956|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20635957|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
20635958|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20635959|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
20635960|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635961|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635962|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
20635963|NCT03255252|Cisplatin|cisplatin|mesh-list
20635964|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635965|NCT03250273|Nivolumab|nivolumab|mesh-list
20635966|NCT03250273|Entinostat|entinostat|mesh-list
20635967|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635968|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635969|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20635970|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635971|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20635972|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635973|NCT03217136|Metronidazole|metronidazole|mesh-list
20635974|NCT03217136|Meropenem|meropenem|mesh-list
20635975|NCT03217136|Tazobactam|tazobactam|mesh-list
20635976|NCT03217136|Ceftolozane|ceftolozane|mesh-list
20635977|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20635978|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635979|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20635980|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19696783|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
19696784|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19696785|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
19696786|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696787|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
20635981|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20635982|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20635983|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20635984|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20635985|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19412108|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
19412109|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696788|NCT04936763|Protective Agents|protective agents|mesh-ancestor
20635986|NCT03217136|Renal Agents|renal agents|mesh-ancestor
19850779|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412110|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412111|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19412112|NCT03535103|Hormones|hormones|mesh-ancestor
19412113|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412114|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412115|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
19412116|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19412117|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19412118|NCT03535090|Prednisolone|prednisolone|mesh-list
19412119|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
19412120|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19412121|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
19412122|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412123|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
19412124|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
19412125|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412126|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412127|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19412128|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
19412129|NCT03535090|Hormones|hormones|mesh-ancestor
19412130|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412131|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19412132|NCT03535090|Protective Agents|protective agents|mesh-ancestor
19412133|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19412134|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412135|NCT03535051|Tacrolimus|tacrolimus|mesh-list
19412136|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19412137|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
19412138|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412139|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19412140|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412141|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412142|NCT03534973|Caffeine|caffeine|mesh-list
19412143|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19412144|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412145|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19412146|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412147|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412148|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19412149|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19412150|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
20635987|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20635988|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20635989|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20635990|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
20635991|NCT05398224|Rituximab|rituximab|mesh-list
20635992|NCT05398224|Methotrexate|methotrexate|mesh-list
20635993|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
20635994|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20635995|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20635996|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
20635997|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20635998|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20635999|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20636000|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
20636001|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20636002|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20636003|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
20636004|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636005|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
20636006|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696789|NCT04936711|Bupivacaine|bupivacaine|mesh-list
19696790|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
19696791|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
20636007|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20636008|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636009|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20636010|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636011|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
20636012|NCT05398081|Cefuroxime|cefuroxime|mesh-list
20636013|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
20636014|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636015|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636016|NCT05398055|Azithromycin|azithromycin|mesh-list
20636017|NCT05398055|Doxycycline|doxycycline|mesh-list
20636018|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636019|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636020|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
20636021|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20636022|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20636023|NCT05397964|Calcium|calcium|mesh-list
20636024|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20636025|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636026|NCT05397938|Alendronate|alendronate|mesh-list
20636027|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20636028|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636029|NCT05397886|Propofol|propofol|mesh-list
20636030|NCT05397886|Flumazenil|flumazenil|mesh-list
20636031|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20636032|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636033|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636034|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20636035|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
20636036|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
20636037|NCT05397886|Antidotes|antidotes|mesh-ancestor
20636038|NCT05397886|Protective Agents|protective agents|mesh-ancestor
20636039|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
20636040|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
20636041|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20636042|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636043|NCT05397834|Fluticasone|fluticasone|mesh-list
20636044|NCT05397834|Xhance|xhance|mesh-list
20636045|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696792|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696793|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696794|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
19696795|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696796|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
19696797|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636046|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20636047|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
20636048|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636049|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636050|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20636051|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
20636052|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
19412151|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412152|NCT03534947|Imiquimod|imiquimod|mesh-list
19412153|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19412154|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
19412155|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412156|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412157|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
19412158|NCT03534895|Midazolam|midazolam|mesh-list
19412159|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
19412160|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412161|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412162|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19412163|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19412164|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19412165|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19412166|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19412167|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20636053|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20636054|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20636055|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20636056|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
20636057|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20636058|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
20636059|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20636060|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636061|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20636062|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636063|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636064|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
20636065|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19412168|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
19412169|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
19412170|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
19412171|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412172|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412173|NCT03534869|Analgesics|analgesics|mesh-list
19412174|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
19412175|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412176|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412177|NCT03534713|Paclitaxel|paclitaxel|mesh-list
19412178|NCT03534713|Carboplatin|carboplatin|mesh-list
19412179|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19412180|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412181|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
19412182|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
19412183|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
19412184|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416834|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416835|NCT02279823|Minoxidil|minoxidil|mesh-list
19416836|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19416837|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19416838|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
19416839|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
19416840|NCT02279602|Combretastatin|combretastatin|mesh-list
19416841|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19416842|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416843|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
19416844|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
19416845|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
19416846|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416847|NCT02278133|Cetuximab|cetuximab|mesh-list
19416848|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416849|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416850|NCT02277106|Brexanolone|brexanolone|mesh-list
19416851|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
19416852|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416853|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416854|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416855|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
19416856|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
19416857|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19416858|NCT02271503|Carbidopa|carbidopa|mesh-list
19412185|NCT03534674|Vitamin D|vitamin d|mesh-list
19850780|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19850781|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20636066|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20636067|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636068|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
20636069|NCT05397652|Coagulants|coagulants|mesh-ancestor
20636070|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
20636071|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20636072|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
20636073|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412186|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
19412187|NCT03534674|Vitamins|vitamins|mesh-ancestor
19412188|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
19412189|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412190|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19412191|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19412192|NCT03534661|Teduglutide|teduglutide|mesh-list
19412193|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20636074|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636075|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636076|NCT05397600|Bimatoprost|bimatoprost|mesh-list
19412194|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412195|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412196|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19412197|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19412198|NCT03534661|Protective Agents|protective agents|mesh-ancestor
19412199|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412200|NCT03534505|Ketorolac|ketorolac|mesh-list
19412201|NCT03534505|Bupivacaine|bupivacaine|mesh-list
19412202|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
19412203|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
19412204|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412205|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412206|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
19412207|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412208|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20636077|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20636078|NCT05397587|Vaccines|vaccines|mesh-list
20636079|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
20636080|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636081|NCT05397262|Fluorouracil|fluorouracil|mesh-list
20636082|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636083|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
20636084|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636085|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20636086|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636087|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
20636088|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636089|NCT05397236|Dexamethasone|dexamethasone|mesh-list
20636090|NCT05397236|Bupivacaine|bupivacaine|mesh-list
20636091|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636092|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
20636093|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
20636094|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636095|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636096|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636097|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
20636098|NCT05397236|Hormones|hormones|mesh-ancestor
20636099|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636100|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636101|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636102|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
20636103|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
19412209|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412210|NCT03534505|Analgesics|analgesics|mesh-ancestor
19696798|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696799|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
19696800|NCT04936971|Everolimus|everolimus|mesh-list
19696801|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696802|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696803|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
19696804|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696805|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20636104|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636105|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
20636106|NCT05396937|Bevacizumab|bevacizumab|mesh-list
20636107|NCT05396937|Atezolizumab|atezolizumab|mesh-list
20636108|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636109|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636110|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20636111|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20636112|NCT05396937|Growth Substances|growth substances|mesh-ancestor
20636113|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636114|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
20636115|NCT05396898|Tacrolimus|tacrolimus|mesh-list
20636116|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636117|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
20636118|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636119|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20636120|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636121|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636122|NCT05396859|Decitabine|decitabine|mesh-list
20636123|NCT05396859|Entrectinib|entrectinib|mesh-list
20636124|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20636125|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
20636126|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636127|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636128|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636129|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636130|NCT05396833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20636131|NCT05396833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636132|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636133|NCT05396781|Proflavine|proflavine|mesh-list
20636134|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20636135|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636136|NCT05396742|Ravulizumab|ravulizumab|mesh-list
20636137|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20636138|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636139|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
20636140|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636141|NCT05396690|Sevoflurane|sevoflurane|mesh-list
20636142|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20636143|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20636144|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
20636145|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
20636146|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636147|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636148|NCT05396677|Acetaminophen|acetaminophen|mesh-list
20636149|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20636150|NCT05396677|Analgesics|analgesics|mesh-ancestor
20636151|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
20636152|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636153|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636154|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
20636155|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
20636156|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636157|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
20636158|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
20636159|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
20636160|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636161|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636162|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636163|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20636164|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
20636165|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
20636166|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20636167|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636168|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
20636169|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20636170|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
20636171|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
20636172|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636173|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636174|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20636175|NCT05396144|Analgesics|analgesics|mesh-ancestor
19412211|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412212|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636176|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
20636177|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412213|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19412214|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412215|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412216|NCT03534492|Durvalumab|durvalumab|mesh-list
19412217|NCT03534492|Olaparib|olaparib|mesh-list
19412218|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412219|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696806|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19696807|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
19696808|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19696809|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696810|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696811|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696812|NCT04936282|Tacrolimus|tacrolimus|mesh-list
19696813|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696814|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
19696815|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696816|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19696817|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850782|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19850783|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
19850784|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
19850785|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850786|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
20476284|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476285|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20476286|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476287|NCT01515137|Analgesics|analgesics|mesh-ancestor
20476288|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
20476289|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476290|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476291|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476292|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476293|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20476294|NCT01515228|Paclitaxel|paclitaxel|mesh-list
20476295|NCT01515228|Everolimus|everolimus|mesh-list
20476296|NCT01515228|Cilostazol|cilostazol|mesh-list
20476297|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19412220|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19412221|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412222|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412223|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
19412224|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
19412225|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412226|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19412227|NCT03534388|Eusol|eusol|mesh-list
19412228|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
19412229|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19412230|NCT03534310|Liraglutide|liraglutide|mesh-list
19412231|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19412232|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412233|NCT03534310|Incretins|incretins|mesh-ancestor
19412234|NCT03534310|Hormones|hormones|mesh-ancestor
19412235|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412236|NCT03534297|Dapansutrile|dapansutrile|mesh-list
19412237|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412238|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
19412239|NCT03534102|Narcotics|narcotics|mesh-ancestor
19412240|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412241|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412242|NCT03534102|Analgesics|analgesics|mesh-ancestor
19412243|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
19412244|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412245|NCT03534037|Febuxostat|febuxostat|mesh-list
19412246|NCT03534037|Benzbromarone|benzbromarone|mesh-list
19412247|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
19412248|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412249|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
19412250|NCT03534037|Renal Agents|renal agents|mesh-ancestor
19696818|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850787|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19850788|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412251|NCT03534024|Curcumin|curcumin|mesh-list
19696819|NCT04936295|Fulvestrant|fulvestrant|mesh-list
20636178|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20636179|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20636180|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636181|NCT05394337|Atezolizumab|atezolizumab|mesh-list
20636182|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636183|NCT05392634|Amoxicillin|amoxicillin|mesh-list
20636184|NCT05392634|Meropenem|meropenem|mesh-list
20636185|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
20636186|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
20636187|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20636188|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636189|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636190|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636191|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636192|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20636193|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20636194|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
20636195|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636196|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
20636197|NCT05389527|Lenvatinib|lenvatinib|mesh-list
20636198|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636199|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636200|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636201|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636202|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227007|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227008|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
20227009|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636203|NCT05389423|Prednisone|prednisone|mesh-list
20636204|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
20636205|NCT05389423|Rituximab|rituximab|mesh-list
20636206|NCT05389423|Doxorubicin|doxorubicin|mesh-list
20636207|NCT05389423|Etoposide|etoposide|mesh-list
20636208|NCT05389423|Vincristine|vincristine|mesh-list
20636209|NCT05389423|Pomalidomide|pomalidomide|mesh-list
20636210|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636211|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
20636212|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412252|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19412253|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19696820|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19696821|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636213|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636214|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20636215|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
20636216|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636217|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636218|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20636219|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636220|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20636221|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20636222|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636223|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636224|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636225|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
20636226|NCT05389423|Hormones|hormones|mesh-ancestor
20636227|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412254|NCT03534024|Analgesics|analgesics|mesh-ancestor
19412255|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
19412256|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696822|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19412257|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412258|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412259|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412260|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412261|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412262|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412263|NCT03533803|Indomethacin|indomethacin|mesh-list
19412264|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227010|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20227011|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636228|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636229|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636230|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
19850789|NCT00713219|Docetaxel|docetaxel|mesh-list
19850790|NCT00713219|Cetuximab|cetuximab|mesh-list
19850791|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850792|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
19850793|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
19850794|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
19850795|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850796|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850797|NCT00713284|Sirolimus|sirolimus|mesh-list
19850798|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19850799|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850800|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19850801|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850802|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
20636231|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636232|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
19412265|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412266|NCT03533803|Analgesics|analgesics|mesh-ancestor
19696823|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19696824|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
19696825|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636233|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20636234|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20636235|NCT05389423|Growth Substances|growth substances|mesh-ancestor
20636236|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
20636237|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
20636238|NCT05388929|Methocarbamol|methocarbamol|mesh-list
20636239|NCT05388929|Narcotics|narcotics|mesh-ancestor
20636240|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636241|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636242|NCT05388929|Analgesics|analgesics|mesh-ancestor
20636243|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
20636244|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636245|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20636246|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20636247|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
20636248|NCT05387408|Narcotics|narcotics|mesh-ancestor
20636249|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636250|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636251|NCT05387408|Analgesics|analgesics|mesh-ancestor
20636252|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
20636253|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636254|NCT05387200|Alendronate|alendronate|mesh-list
20636255|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20636256|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636257|NCT05386810|Vaccines|vaccines|mesh-list
20636258|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
20636259|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636260|NCT05385523|Dexamethasone|dexamethasone|mesh-list
20636261|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636262|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
20636263|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
20636264|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636265|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412267|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
19412268|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412269|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412270|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412271|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412272|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
19412273|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
19412274|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19412275|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19412276|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412277|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412278|NCT03533699|Propranolol|propranolol|mesh-list
19696826|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696827|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
19696828|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19696829|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
19850803|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636266|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636267|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
20636268|NCT05385523|Hormones|hormones|mesh-ancestor
19412279|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19850804|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
19696830|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696831|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
19696832|NCT04936204|Protective Agents|protective agents|mesh-ancestor
19696833|NCT04936126|Amantadine|amantadine|mesh-list
20227012|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
20227013|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227014|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20227015|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227016|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
20227017|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
20227018|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227019|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20227020|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
20636269|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636270|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636271|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636272|NCT05371054|Prednisone|prednisone|mesh-list
20636273|NCT05371054|Venetoclax|venetoclax|mesh-list
20636274|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636275|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
20636276|NCT05371054|Hormones|hormones|mesh-ancestor
20636277|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636278|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636279|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636280|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636281|NCT05370716|Pregabalin|pregabalin|mesh-list
20636282|NCT05370716|Analgesics|analgesics|mesh-ancestor
20636283|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
20636284|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636285|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227021|NCT00348413|Hormones|hormones|mesh-ancestor
20227022|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227023|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20227024|NCT00348413|Protective Agents|protective agents|mesh-ancestor
20227025|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20227026|NCT00348426|Antitoxins|antitoxins|mesh-list
20227027|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
20476298|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476299|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
20476300|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
20476301|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476302|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476303|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476304|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
20476305|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476306|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20476307|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
20476308|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476309|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20476310|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
20476311|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20476312|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20476313|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20476314|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
20476315|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20476316|NCT01515228|Protective Agents|protective agents|mesh-ancestor
20476317|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20527542|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
20636286|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
20636287|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20636288|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20636289|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636290|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20636291|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20636292|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19696834|NCT04936126|Pramipexole|pramipexole|mesh-list
20227028|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
20227029|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227030|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
20227031|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20227032|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20227033|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227034|NCT00348452|Celecoxib|celecoxib|mesh-list
20227035|NCT00348452|Tramadol|tramadol|mesh-list
19696835|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20636293|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636294|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20636295|NCT05360732|Folfirinox|folfirinox|mesh-list
20636296|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636297|NCT05360615|Empagliflozin|empagliflozin|mesh-list
20636298|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20636299|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636300|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20636301|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636302|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20636303|NCT05357833|Hematinics|hematinics|mesh-ancestor
20636304|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20636305|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20636306|NCT05357482|Sirolimus|sirolimus|mesh-list
20636307|NCT05357482|Plerixafor|plerixafor|mesh-list
20636308|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
20636309|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
20227036|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227037|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227038|NCT00348452|Analgesics|analgesics|mesh-ancestor
20227039|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
20227040|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227041|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636310|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
20636311|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636312|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636313|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636314|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19850805|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476318|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20476319|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636315|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636316|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
20636317|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636318|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636319|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
20636320|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636321|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412280|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19412281|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412282|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412283|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412284|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412285|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412286|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19412287|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
20636322|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20636323|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19412288|NCT03533556|Caffeine|caffeine|mesh-list
19412289|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19412290|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412291|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19412292|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412293|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412294|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19412295|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19412296|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
19412297|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412298|NCT03533387|Ibudilast|ibudilast|mesh-list
19696836|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
19696837|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19696838|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19696839|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19696840|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696841|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696842|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
19696843|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476320|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20476321|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20476322|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476323|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476324|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20476325|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20636324|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20636325|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
20636326|NCT05350774|Methylprednisolone|methylprednisolone|mesh-list
20636327|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
20636328|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20636329|NCT05350774|Antibodies|antibodies|mesh-list
20636330|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
20636331|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20636332|NCT05350774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636333|NCT05350774|Antiemetics|antiemetics|mesh-ancestor
20636334|NCT05350774|Autonomic Agents|autonomic agents|mesh-ancestor
20636335|NCT05350774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636336|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636337|NCT05350774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636338|NCT05350774|Glucocorticoids|glucocorticoids|mesh-ancestor
20636339|NCT05350774|Hormones|hormones|mesh-ancestor
20636340|NCT05350774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636341|NCT05350774|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20636342|NCT05350774|Protective Agents|protective agents|mesh-ancestor
20636343|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
20636344|NCT05344469|Interferons|interferons|mesh-list
20636345|NCT05344469|Interferon-beta|interferon-beta|mesh-list
20636346|NCT05344469|Ofatumumab|ofatumumab|mesh-list
20636347|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
20636348|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
20636349|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636350|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
20636351|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636352|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20636353|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
20636354|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636355|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636356|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636357|NCT05341180|Lactulose|lactulose|mesh-list
20636358|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20636359|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636360|NCT05335356|Ustekinumab|ustekinumab|mesh-list
20636361|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
20636362|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
20636363|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20636364|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636365|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20636366|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636367|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
20636368|NCT05327023|Sirolimus|sirolimus|mesh-list
20636369|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
20636370|NCT05327023|Busulfan|busulfan|mesh-list
20636371|NCT05327023|Fludarabine|fludarabine|mesh-list
20636372|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636373|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
20636374|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636375|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636376|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20636377|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
20636378|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636379|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636380|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20636381|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20636382|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20636383|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
20636384|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636385|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636386|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636387|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
20636388|NCT05315713|Atezolizumab|atezolizumab|mesh-list
20636389|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636390|NCT05315479|Meloxicam|meloxicam|mesh-list
20636391|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20636392|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20636393|NCT05315479|Analgesics|analgesics|mesh-ancestor
20636394|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
20636395|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636396|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636397|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636398|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636399|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20636400|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20636401|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636402|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636403|NCT05313659|Ketamine|ketamine|mesh-list
20636404|NCT05313659|Analgesics|analgesics|mesh-ancestor
20636405|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
20636406|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636407|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636408|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20636409|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20636410|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
20636411|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
20636412|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636413|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20636414|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20636415|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20636416|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636417|NCT05307705|Paclitaxel|paclitaxel|mesh-list
20636418|NCT05307705|Letrozole|letrozole|mesh-list
20636419|NCT05307705|Fulvestrant|fulvestrant|mesh-list
20636420|NCT05307705|Anastrozole|anastrozole|mesh-list
20636421|NCT05307705|Exemestane|exemestane|mesh-list
20636422|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636423|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636424|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
20636425|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636426|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
20636427|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636428|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20636429|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20636430|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636431|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20636432|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
20636433|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636434|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636435|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636436|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20636437|NCT05300152|Antibodies|antibodies|mesh-list
20636438|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
20636439|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
20636440|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636441|NCT05298423|Paclitaxel|paclitaxel|mesh-list
20636442|NCT05298423|Etoposide|etoposide|mesh-list
20636443|NCT05298423|Carboplatin|carboplatin|mesh-list
20636444|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
20636445|NCT05298423|Pemetrexed|pemetrexed|mesh-list
20636446|NCT05298423|Durvalumab|durvalumab|mesh-list
20636447|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636448|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636449|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
20636450|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636451|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
20636452|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636453|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636454|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20636455|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636456|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636457|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19412299|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19412300|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
19412301|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412302|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412303|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19412304|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
19412305|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19412306|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412307|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412308|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19412309|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
19412310|NCT03533361|Lenvatinib|lenvatinib|mesh-list
19412311|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636458|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20636459|NCT05293548|Vaccines|vaccines|mesh-list
20636460|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
19850806|NCT00713310|Mesalamine|mesalamine|mesh-list
20636461|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850807|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20636462|NCT05286827|Olaparib|olaparib|mesh-list
19412312|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19412313|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412314|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412315|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
19412316|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
19412317|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19412318|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19412319|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
19412320|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
19412321|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19412322|NCT03533231|Metronidazole|metronidazole|mesh-list
19412323|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
19412324|NCT03533231|Propolis|propolis|mesh-list
19412325|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636463|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20636464|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636465|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636466|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636467|NCT05286814|Leucovorin|leucovorin|mesh-list
20636468|NCT05286814|Gemcitabine|gemcitabine|mesh-list
20636469|NCT05286814|Dexamethasone|dexamethasone|mesh-list
20636470|NCT05286814|Fluorouracil|fluorouracil|mesh-list
20636471|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
20636472|NCT05286814|Irinotecan|irinotecan|mesh-list
20636473|NCT05286814|Floxuridine|floxuridine|mesh-list
20636474|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636475|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
20636476|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
20636477|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636478|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412326|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19412327|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19412328|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19412329|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636479|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636480|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
20636481|NCT05286814|Hormones|hormones|mesh-ancestor
20636482|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636483|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636484|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636485|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20636486|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
20636487|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636488|NCT05286814|Antiviral Agents|antiviral agents|mesh-ancestor
20636489|NCT05286814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636490|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636491|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636492|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
20636493|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20636494|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636495|NCT05286814|Antidotes|antidotes|mesh-ancestor
20636496|NCT05286814|Protective Agents|protective agents|mesh-ancestor
20636497|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
20636498|NCT05286814|Vitamins|vitamins|mesh-ancestor
20636499|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
20636500|NCT05275738|Niacinamide|niacinamide|mesh-list
20636501|NCT05275738|Niacin|niacin|mesh-list
20636502|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
20636503|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
20636504|NCT05275738|Vitamins|vitamins|mesh-ancestor
20636505|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
20636506|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636507|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20636508|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
20636509|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636510|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20636511|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
20636512|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
20636513|NCT05262322|Apixaban|apixaban|mesh-list
20636514|NCT05262322|Edoxaban|edoxaban|mesh-list
20636515|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20636516|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
20636517|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19412330|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412331|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636518|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
20636519|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636520|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412332|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412333|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19412334|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19412335|NCT03533179|Glucagon|glucagon|mesh-list
19412336|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19412337|NCT03533179|Esmolol|esmolol|mesh-list
19412338|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19412339|NCT03533179|Hormones|hormones|mesh-ancestor
19412340|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412341|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412342|NCT03533179|Incretins|incretins|mesh-ancestor
19412343|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19412344|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19412345|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19412346|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412347|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412348|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412349|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
19412350|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19412351|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19412352|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
19696844|NCT04936126|Protective Agents|protective agents|mesh-ancestor
20636521|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
20636522|NCT05238844|Tenofovir|tenofovir|mesh-list
20636523|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
20636524|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636525|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20636526|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20636527|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636528|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636529|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20636530|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20636531|NCT05232734|Caffeine|caffeine|mesh-list
20636532|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
20636533|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636534|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20636535|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636536|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20636537|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636538|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20636539|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20476326|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476327|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
20476328|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476329|NCT01515397|Polygeline|polygeline|mesh-list
20476330|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
19696845|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19696846|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19696847|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
19696848|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
20476331|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
20476332|NCT01515553|Liraglutide|liraglutide|mesh-list
20476333|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20636540|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
20636541|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20636542|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
19412353|NCT03533127|Bevacizumab|bevacizumab|mesh-list
19696849|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696850|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
19696851|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696852|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19696853|NCT04936126|Analgesics|analgesics|mesh-ancestor
20227042|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227043|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227044|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20227045|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20227046|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227047|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227048|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20227049|NCT00348452|Narcotics|narcotics|mesh-ancestor
20227050|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227051|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
20227052|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20227053|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20227054|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850808|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19850809|NCT00713310|Analgesics|analgesics|mesh-ancestor
19850810|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
19850811|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850812|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850813|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850814|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19850815|NCT00713323|Nabiximols|nabiximols|mesh-list
19850816|NCT00713323|Analgesics|analgesics|mesh-ancestor
19850817|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
19412354|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636543|NCT05232461|Celecoxib|celecoxib|mesh-list
20636544|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20636545|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20636546|NCT05232461|Analgesics|analgesics|mesh-ancestor
20636547|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
20636548|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636549|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636550|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636551|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636552|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20636553|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20636554|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636555|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636556|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636557|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636558|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20636559|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636560|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636561|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20636562|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20636563|NCT05228249|Cytarabine|cytarabine|mesh-list
20636564|NCT05228249|Etoposide|etoposide|mesh-list
20636565|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
20636566|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
20636567|NCT05228249|Melphalan|melphalan|mesh-list
20636568|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
20636569|NCT05228249|Carmustine|carmustine|mesh-list
20636570|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20636571|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20636572|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636573|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636574|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20636575|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636576|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636577|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636578|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20636579|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
20636580|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
20636581|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636582|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636583|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
20636584|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636585|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20636586|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
20636587|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20636588|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
20636589|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
20636590|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
20636591|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636592|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
20636593|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636594|NCT05226598|Paclitaxel|paclitaxel|mesh-list
20636595|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20636596|NCT05226598|Carboplatin|carboplatin|mesh-list
20636597|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
20636598|NCT05226598|Pemetrexed|pemetrexed|mesh-list
20636599|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636600|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636601|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
20636602|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636603|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
20636604|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416859|NCT02271503|Levodopa|levodopa|mesh-list
20636605|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850818|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636606|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636607|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20636608|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20636609|NCT05224141|Carboplatin|carboplatin|mesh-list
20636610|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
20636611|NCT05224141|Etoposide|etoposide|mesh-list
20636612|NCT05224141|Atezolizumab|atezolizumab|mesh-list
20636613|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636614|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636615|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636616|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20636617|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636618|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636619|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636620|NCT05211336|Prednisone|prednisone|mesh-list
20636621|NCT05211336|Nivolumab|nivolumab|mesh-list
20636622|NCT05211336|Lenalidomide|lenalidomide|mesh-list
20636623|NCT05211336|Venetoclax|venetoclax|mesh-list
20636624|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
20636625|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636626|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
20636627|NCT05211336|Hormones|hormones|mesh-ancestor
20636628|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636629|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636630|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636631|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636632|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636633|NCT05211336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20636634|NCT05211336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636635|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
20636636|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20636637|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20636638|NCT05211336|Growth Substances|growth substances|mesh-ancestor
20636639|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
20636640|NCT05210582|Afamelanotide|afamelanotide|mesh-list
20636641|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
20636642|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
20636643|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20636644|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636645|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20636646|NCT05185947|Paclitaxel|paclitaxel|mesh-list
20636647|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636648|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636649|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
20636650|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636651|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
20636652|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636653|NCT05176951|Treprostinil|treprostinil|mesh-list
20636654|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20636655|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
20636656|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
20636657|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636658|NCT05174845|Protective Agents|protective agents|mesh-ancestor
20636659|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636660|NCT05174845|Vitamins|vitamins|mesh-ancestor
20636661|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
20636662|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20636663|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
19412355|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412356|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19412357|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19412358|NCT03533127|Growth Substances|growth substances|mesh-ancestor
19412359|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412360|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
19412361|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
19412362|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19412363|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19412364|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19412365|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19412366|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20636664|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636665|NCT05161533|Cisplatin|cisplatin|mesh-list
20636666|NCT05161533|Carboplatin|carboplatin|mesh-list
19416860|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20636667|NCT05161533|Etoposide|etoposide|mesh-list
20636668|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
19696854|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
19696855|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696856|NCT04935814|Vasopressins|vasopressins|mesh-list
19696857|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
19696858|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
19412367|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412368|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
19412369|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412370|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412371|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19696859|NCT04935814|Coagulants|coagulants|mesh-ancestor
19696860|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19696861|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19696862|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
19696863|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636669|NCT05161533|Durvalumab|durvalumab|mesh-list
20636670|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
20636671|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
20636672|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20636673|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
20636674|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636675|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20636676|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20636677|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20636678|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636679|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636680|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636681|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
20636682|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636683|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
19696864|NCT04935931|Naltrexone|naltrexone|mesh-list
19696865|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19696866|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19696867|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696868|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
19850819|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850820|NCT00713479|Varenicline|varenicline|mesh-list
19850821|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19850822|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19850823|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
20227055|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636684|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
20636685|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
20636686|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636687|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
20636688|NCT05155033|Aldesleukin|aldesleukin|mesh-list
20636689|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
20636690|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636691|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636692|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20636693|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20636694|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
20636695|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636696|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
20636697|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20636698|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20636699|NCT05150704|Prednisolone|prednisolone|mesh-list
20636700|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
19412372|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412373|NCT03532919|Cystatins|cystatins|mesh-list
19412374|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19412375|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
19696869|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850824|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227056|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227057|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227058|NCT00348491|Analgesics|analgesics|mesh-ancestor
20227059|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
20227060|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227061|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227062|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227063|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227064|NCT00348504|Simendan|simendan|mesh-list
20227065|NCT00348504|Dobutamine|dobutamine|mesh-list
20227066|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20227067|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
19696870|NCT04935788|Caseins|caseins|mesh-list
20636701|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20636702|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
20636703|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636704|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
20636705|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
20636706|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636707|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636708|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636709|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
20636710|NCT05150704|Hormones|hormones|mesh-ancestor
20636711|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636712|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20636713|NCT05150704|Protective Agents|protective agents|mesh-ancestor
20636714|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636715|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696871|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
19696872|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
19696873|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696874|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20636716|NCT05148234|Decitabine|decitabine|mesh-list
20636717|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20636718|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
20636719|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636720|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636721|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636722|NCT05139095|Apatinib|apatinib|mesh-list
20636723|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636724|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636725|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636726|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636727|NCT05126966|Ranibizumab|ranibizumab|mesh-list
20636728|NCT05126966|Aflibercept|aflibercept|mesh-list
20636729|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20636730|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19696875|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696876|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696877|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19696878|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19696879|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19696880|NCT04935515|Anticoagulants|anticoagulants|mesh-list
19696881|NCT04935515|Coagulants|coagulants|mesh-list
19696882|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
19696883|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19696884|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696885|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
19696886|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
19696887|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696888|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696889|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696890|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
19696891|NCT04935541|Remifentanil|remifentanil|mesh-list
19696892|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19696893|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696894|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636731|NCT05126966|Growth Substances|growth substances|mesh-ancestor
20636732|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412376|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412377|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412378|NCT03532906|Bupivacaine|bupivacaine|mesh-list
19412379|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
19412380|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
19412381|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412382|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696895|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20636733|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
20636734|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636735|NCT05112848|Vaccines|vaccines|mesh-list
20636736|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
20636737|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636738|NCT05104723|Tofacitinib|tofacitinib|mesh-list
19696896|NCT04935541|Analgesics|analgesics|mesh-ancestor
19696897|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
19850825|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636739|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19696898|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696899|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20636740|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636741|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636742|NCT05103358|Sirolimus|sirolimus|mesh-list
20636743|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636744|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636745|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20636746|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636747|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
20636748|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636749|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
20636750|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636751|NCT05089370|Nivolumab|nivolumab|mesh-list
20636752|NCT05089370|Decitabine|decitabine|mesh-list
20636753|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636754|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636755|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20636756|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636757|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20636758|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
20636759|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636760|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
20636761|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636762|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636763|NCT05082155|Bupivacaine|bupivacaine|mesh-list
20636764|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
20636765|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
20636766|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636767|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850826|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850827|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
19850828|NCT00713544|Etanercept|etanercept|mesh-list
20636768|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
20636769|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636770|NCT05078879|Empagliflozin|empagliflozin|mesh-list
20636771|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20636772|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636773|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20636774|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636775|NCT05076175|Ozanimod|ozanimod|mesh-list
20636776|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19850829|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19850830|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19850831|NCT00713544|Analgesics|analgesics|mesh-ancestor
20227068|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20227069|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20636777|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636778|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636779|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
20636780|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636781|NCT05070364|Interferons|interferons|mesh-list
20636782|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696900|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19696901|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20227070|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227071|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696902|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
19696903|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696904|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696905|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19696906|NCT04935541|Narcotics|narcotics|mesh-ancestor
19696907|NCT04935034|Vitamin D|vitamin d|mesh-list
19696908|NCT04935034|Vitamins|vitamins|mesh-ancestor
19696909|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
19696910|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696911|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19696912|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19696913|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
19696914|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19696915|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
20227072|NCT00348504|Protective Agents|protective agents|mesh-ancestor
20227073|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227074|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
20636783|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
20636784|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636785|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
20636786|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636787|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636788|NCT05062174|Mifepristone|mifepristone|mesh-list
20636789|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20636790|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
20636791|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20636792|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636793|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20636794|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20636795|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20636796|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
20636797|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20636798|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20636799|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
20636800|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636801|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
20636802|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20636803|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20636804|NCT05062083|11C-PS13|11c-ps13|mesh-list
20636805|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20636806|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636807|NCT05062044|Folic Acid|folic acid|mesh-list
20636808|NCT05062044|Hematinics|hematinics|mesh-ancestor
20636809|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
20636810|NCT05062044|Vitamins|vitamins|mesh-ancestor
20636811|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
20636812|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636813|NCT05059522|Pemetrexed|pemetrexed|mesh-list
20636814|NCT05059522|Avelumab|avelumab|mesh-list
20636815|NCT05059522|Axitinib|axitinib|mesh-list
20636816|NCT05059522|Talazoparib|talazoparib|mesh-list
20636817|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636818|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636819|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636820|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20636821|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20636822|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636823|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636824|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20636825|NCT05050916|Vitamin D|vitamin d|mesh-list
20636826|NCT05050916|Vitamins|vitamins|mesh-ancestor
20636827|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
20636828|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696916|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696917|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696918|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696919|NCT04935073|Cetrorelix|cetrorelix|mesh-list
19696920|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19696921|NCT04935073|Hormones|hormones|mesh-ancestor
19696922|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19696923|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696924|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19696925|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
19696926|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20227075|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
20227076|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227077|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20227078|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20227079|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20227080|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
20227081|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227082|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20227083|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20636829|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19696927|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
20227084|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
20227085|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20636830|NCT05039619|Acetaminophen|acetaminophen|mesh-list
20636831|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
20636832|NCT05039619|Promethazine|promethazine|mesh-list
20636833|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
20636834|NCT05039619|Prednisone|prednisone|mesh-list
20636835|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
20636836|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
20636837|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20636838|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
20636839|NCT05039619|Hormones|hormones|mesh-ancestor
20636840|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636841|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636842|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20636843|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636844|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20636845|NCT05039619|Analgesics|analgesics|mesh-ancestor
20636846|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
20636847|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636848|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
20636849|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20636850|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20636851|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
20636852|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636853|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636854|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636855|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636856|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
20636857|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
20636858|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20636859|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20636860|NCT05039619|Protective Agents|protective agents|mesh-ancestor
20636861|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636862|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20636863|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20636864|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636865|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
20636866|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
20636867|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20636868|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
20636869|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
20636870|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20636871|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20636872|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
20636873|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
20636874|NCT05039177|Cetuximab|cetuximab|mesh-list
20636875|NCT05039177|Palbociclib|palbociclib|mesh-list
20636876|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636877|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636878|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636879|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636880|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636881|NCT05035407|Aldesleukin|aldesleukin|mesh-list
20636882|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
20636883|NCT05035407|Fludarabine|fludarabine|mesh-list
20636884|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636885|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
20636886|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636887|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636888|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20636889|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
20636890|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636891|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636892|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20636893|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20636894|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20636895|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
20636896|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636897|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
20636898|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20636899|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636900|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20636901|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636902|NCT05032820|Lenalidomide|lenalidomide|mesh-list
20636903|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
20636904|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636905|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20636906|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20636907|NCT05032820|Growth Substances|growth substances|mesh-ancestor
20636908|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
20636909|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636910|NCT05029856|Vaccines|vaccines|mesh-list
20636911|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
19412383|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
19412384|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412385|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
19412386|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
19412387|NCT03532867|Protective Agents|protective agents|mesh-ancestor
20636912|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636913|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
20636914|NCT05027945|Sirolimus|sirolimus|mesh-list
20636915|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
20636916|NCT05027945|Busulfan|busulfan|mesh-list
20636917|NCT05027945|Fludarabine|fludarabine|mesh-list
20636918|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636919|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
20636920|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636921|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636922|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20636923|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
20636924|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636925|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636926|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20636927|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20636928|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20636929|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
20636930|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20636931|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20636932|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636933|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
20636934|NCT05017571|Colchicine|colchicine|mesh-list
20636935|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
20636936|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636937|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
20636938|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
20636939|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
20636940|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636941|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636942|NCT05017025|Osimertinib|osimertinib|mesh-list
20636943|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636944|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636945|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636946|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636947|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20636948|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19412388|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412389|NCT03532854|Valsartan|valsartan|mesh-list
19696928|NCT04934683|Propofol|propofol|mesh-list
19412390|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19412391|NCT03532854|Ezetimibe|ezetimibe|mesh-list
19412392|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19412393|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19412394|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
19412395|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412396|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19412397|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19412398|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412399|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19412400|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19412401|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19412402|NCT03532841|Tramadol|tramadol|mesh-list
19412403|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19412404|NCT03532841|Narcotics|narcotics|mesh-ancestor
19412405|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412406|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412407|NCT03532841|Analgesics|analgesics|mesh-ancestor
19412408|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
19412409|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416861|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
19416862|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416863|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19696929|NCT04934683|Etomidate|etomidate|mesh-list
19696930|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20636949|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696931|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19696932|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696933|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19696934|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
19696935|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
19707888|NCT04822064|Analgesics|analgesics|mesh-ancestor
19707889|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
19707890|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636950|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
20636951|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20636952|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636953|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
20636954|NCT05003895|Fludarabine|fludarabine|mesh-list
20636955|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636956|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
20636957|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636958|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20636959|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20636960|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
20636961|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20636962|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636963|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20636964|NCT04995029|Buprenorphine|buprenorphine|mesh-list
20636965|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20636966|NCT04995029|Narcotics|narcotics|mesh-ancestor
20636967|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20636968|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636969|NCT04995029|Analgesics|analgesics|mesh-ancestor
20636970|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
20636971|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20636972|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20636973|NCT04982354|Fludarabine|fludarabine|mesh-list
20636974|NCT04982354|Melphalan|melphalan|mesh-list
20636975|NCT04982354|Busulfan|busulfan|mesh-list
20636976|NCT04982354|Midostaurin|midostaurin|mesh-list
20636977|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20636978|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707891|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19850832|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
19850833|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850834|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850835|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850836|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227086|NCT00348517|Laxatives|laxatives|mesh-ancestor
20227087|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20227088|NCT00348530|Verapamil|verapamil|mesh-list
20227089|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20476334|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476335|NCT01515553|Incretins|incretins|mesh-ancestor
20227090|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20227091|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227092|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227093|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20476336|NCT01515553|Hormones|hormones|mesh-ancestor
20476337|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476338|NCT01515579|Liraglutide|liraglutide|mesh-list
20476339|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476340|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476341|NCT01515579|Incretins|incretins|mesh-ancestor
20476342|NCT01515579|Hormones|hormones|mesh-ancestor
20476343|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20636979|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20636980|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
20636981|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850837|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19850838|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850839|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
19850840|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19850841|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850842|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19850843|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19850844|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
19850845|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850846|NCT00713583|Levodopa|levodopa|mesh-list
20636982|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20636983|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
20636984|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20636985|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20636986|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20636987|NCT04974528|Insulin|insulin|mesh-list
20636988|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20636989|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
20636990|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
20636991|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
20636992|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
20636993|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20636994|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636995|NCT04962893|Vaccines|vaccines|mesh-list
19696936|NCT04934579|Rituximab|rituximab|mesh-list
19696937|NCT04934579|Methotrexate|methotrexate|mesh-list
19696938|NCT04934579|Lenalidomide|lenalidomide|mesh-list
19696939|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19696940|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696941|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
19696942|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696943|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19696944|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19696945|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
19696946|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19696947|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19696948|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
19696949|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227094|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227095|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
20227096|NCT00348582|Ketorolac|ketorolac|mesh-list
20636996|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
20636997|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20636998|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
20636999|NCT04959175|Sirolimus|sirolimus|mesh-list
20637000|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
20637001|NCT04959175|Fludarabine|fludarabine|mesh-list
20637002|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637003|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
20637004|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637005|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637006|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637007|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
20637008|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637009|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637010|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20637011|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637012|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20637013|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
20637014|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637015|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19412410|NCT03532802|Metoprolol|metoprolol|mesh-list
19412411|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412412|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19412413|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
19412414|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
19412415|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412416|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412417|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19412418|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19412419|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19412420|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412421|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412422|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412423|NCT03532763|Tocotrienols|tocotrienols|mesh-list
19412424|NCT03532763|Vitamin E|vitamin e|mesh-list
19412425|NCT03532763|Tocopherols|tocopherols|mesh-list
19412426|NCT03532763|Tocovid|tocovid|mesh-list
19696950|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
19696951|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696952|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19696953|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696954|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19696955|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19696956|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20227097|NCT00348582|Nepafenac|nepafenac|mesh-list
20637016|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412427|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
19412428|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412429|NCT03532763|Protective Agents|protective agents|mesh-ancestor
19696957|NCT04934579|Growth Substances|growth substances|mesh-ancestor
20637017|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
20637018|NCT04954196|Amlodipine|amlodipine|mesh-list
20637019|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20637020|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20637021|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20637022|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637023|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20637024|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637025|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
20637026|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
20637027|NCT04949256|Leucovorin|leucovorin|mesh-list
20637028|NCT04949256|Paclitaxel|paclitaxel|mesh-list
20637029|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
20637030|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
20637031|NCT04949256|Lenvatinib|lenvatinib|mesh-list
20637032|NCT04949256|Calcium|calcium|mesh-list
20637033|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
20637034|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637035|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637036|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637037|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637038|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637039|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637040|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20637041|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637042|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20637043|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637044|NCT04949256|Antidotes|antidotes|mesh-ancestor
20637045|NCT04949256|Protective Agents|protective agents|mesh-ancestor
20637046|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
20637047|NCT04949256|Vitamins|vitamins|mesh-ancestor
20637048|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
20637049|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637050|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637051|NCT04933617|Prednisone|prednisone|mesh-list
20637052|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
20637053|NCT04933617|Rituximab|rituximab|mesh-list
20637054|NCT04933617|Doxorubicin|doxorubicin|mesh-list
20637055|NCT04933617|Etoposide|etoposide|mesh-list
20637056|NCT04933617|Vincristine|vincristine|mesh-list
20637057|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637058|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
20637059|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637060|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637061|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637062|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
20637063|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637064|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637065|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20637066|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637067|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637068|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20637069|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20637070|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637071|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19696958|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
19696959|NCT04934852|Ephedrine|ephedrine|mesh-list
19696960|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
20637072|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
20637073|NCT04933617|Hormones|hormones|mesh-ancestor
20637074|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412430|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412431|NCT03532763|Vitamins|vitamins|mesh-ancestor
19412432|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
19412433|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
19412434|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412435|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637075|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19412436|NCT03532711|Leucovorin|leucovorin|mesh-list
19850847|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20637076|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637077|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637078|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
19696961|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19696962|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696963|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
19696964|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
19696965|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19696966|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19696967|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
19696968|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19696969|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637079|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637080|NCT04933539|Dexamethasone|dexamethasone|mesh-list
20637081|NCT04933539|Daratumumab|daratumumab|mesh-list
20637082|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637083|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
20637084|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
20637085|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637086|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637087|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20637088|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
20637089|NCT04933539|Hormones|hormones|mesh-ancestor
20637090|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637091|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637092|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637093|NCT04928846|Docetaxel|docetaxel|mesh-list
20637094|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637095|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637096|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637097|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637098|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637099|NCT04921943|Azithromycin|azithromycin|mesh-list
20637100|NCT04921943|Rifampin|rifampin|mesh-list
20637101|NCT04921943|Ethambutol|ethambutol|mesh-list
20637102|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637103|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637104|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20637105|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
20637106|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
20637107|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20637108|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637109|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637110|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20637111|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20637112|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20637113|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20637114|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20637115|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20637116|NCT04920032|Irinotecan|irinotecan|mesh-list
20637117|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20637118|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20637119|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637120|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637121|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637122|NCT04915755|Niraparib|niraparib|mesh-list
20637123|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637124|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637125|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637126|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637127|NCT04915183|Atorvastatin|atorvastatin|mesh-list
20637128|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20637129|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20637130|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
20637131|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637132|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20637133|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20637134|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637135|NCT04904302|Nivolumab|nivolumab|mesh-list
20637136|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637137|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637138|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20637139|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637140|NCT04902443|Nivolumab|nivolumab|mesh-list
20637141|NCT04902443|Pomalidomide|pomalidomide|mesh-list
20637142|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637143|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637144|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20637145|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637146|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
20637147|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637148|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20637149|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20637150|NCT04902443|Growth Substances|growth substances|mesh-ancestor
20637151|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
20637152|NCT04901208|Nicotine|nicotine|mesh-list
20637153|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20637154|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
20637155|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637156|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637157|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20637158|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20637159|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
20637160|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20637161|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637162|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
20637163|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637164|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
20637165|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637166|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637167|NCT04895410|Dexamethasone|dexamethasone|mesh-list
20637168|NCT04895410|Daratumumab|daratumumab|mesh-list
20637169|NCT04895410|Pomalidomide|pomalidomide|mesh-list
20637170|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637171|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
20637172|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
20637173|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637174|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637175|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20637176|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
20637177|NCT04895410|Hormones|hormones|mesh-ancestor
20637178|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637179|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637180|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637181|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
20637182|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20637183|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20637184|NCT04895410|Growth Substances|growth substances|mesh-ancestor
20637185|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
20637186|NCT04892446|Dexamethasone|dexamethasone|mesh-list
20637187|NCT04892446|Bortezomib|bortezomib|mesh-list
20637188|NCT04892446|Daratumumab|daratumumab|mesh-list
20637189|NCT04892446|Pomalidomide|pomalidomide|mesh-list
20637190|NCT04892446|Magrolimab|magrolimab|mesh-list
20637191|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637192|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
20637193|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
20637194|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637195|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637196|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20637197|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
20637198|NCT04892446|Hormones|hormones|mesh-ancestor
20637199|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637200|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637201|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637202|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
20637203|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20637204|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20637205|NCT04892446|Growth Substances|growth substances|mesh-ancestor
20637206|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
20637207|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637208|NCT04892017|Trametinib|trametinib|mesh-list
20637209|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637210|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637211|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637212|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637213|NCT04890093|Vincristine|vincristine|mesh-list
20637214|NCT04890093|Temozolomide|temozolomide|mesh-list
20637215|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637216|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637217|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637218|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637219|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637220|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637221|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637222|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
20637223|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
20637224|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20637225|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637226|NCT04885530|Fluticasone|fluticasone|mesh-list
20637227|NCT04885530|Xhance|xhance|mesh-list
20637228|NCT04885530|Ivermectin|ivermectin|mesh-list
20637229|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
20637230|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637231|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20637232|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
20637233|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637234|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227098|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20637235|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20637236|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
20637237|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
20637238|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20637239|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637240|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637241|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20637242|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637243|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20637244|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20637245|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637246|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20637247|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20637248|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20637249|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20637250|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20637251|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
20637252|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20637253|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
20637254|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20637255|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20637256|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20637257|NCT04884815|Prednisolone|prednisolone|mesh-list
20637258|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637259|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
20637260|NCT04884815|Hormones|hormones|mesh-ancestor
20637261|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637262|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637263|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637264|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637265|NCT04883346|Liraglutide|liraglutide|mesh-list
20637266|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20637267|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637268|NCT04883346|Incretins|incretins|mesh-ancestor
20637269|NCT04883346|Hormones|hormones|mesh-ancestor
20637270|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637271|NCT04862663|Fulvestrant|fulvestrant|mesh-list
20637272|NCT04862663|Palbociclib|palbociclib|mesh-list
20637273|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637274|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637275|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20637276|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20637277|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
20637278|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637279|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637280|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637281|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637282|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637283|NCT04859764|Betamethasone|betamethasone|mesh-list
20227099|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227100|NCT00348582|Analgesics|analgesics|mesh-ancestor
20227101|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
20637284|NCT04859764|Bupivacaine|bupivacaine|mesh-list
20637285|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
20227102|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637286|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
20637287|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637288|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637289|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
20637290|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637291|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637292|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
20637293|NCT04859764|Hormones|hormones|mesh-ancestor
20637294|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637295|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20637296|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
20637297|NCT04851834|Cisplatin|cisplatin|mesh-list
20637298|NCT04851834|Carboplatin|carboplatin|mesh-list
20637299|NCT04851834|Temozolomide|temozolomide|mesh-list
20637300|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637301|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637302|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
20637303|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637304|NCT04849364|Capecitabine|capecitabine|mesh-list
20637305|NCT04849364|Atezolizumab|atezolizumab|mesh-list
20637306|NCT04849364|Talazoparib|talazoparib|mesh-list
20637307|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20637308|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
20637309|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637310|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637311|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637312|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637313|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
20637314|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637315|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637316|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
20637317|NCT04847063|Doxorubicin|doxorubicin|mesh-list
20637318|NCT04847063|Fluorouracil|fluorouracil|mesh-list
20637319|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
20637320|NCT04847063|Mitomycins|mitomycins|mesh-list
20637321|NCT04847063|Mitomycin|mitomycin|mesh-list
20637322|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637323|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637324|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20637325|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20637326|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637327|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637328|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
20637329|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20637330|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637331|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
20637332|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637333|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
19696970|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20227103|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227104|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227105|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476344|NCT01515592|Liraglutide|liraglutide|mesh-list
20227106|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20227107|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476345|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476346|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476347|NCT01515592|Incretins|incretins|mesh-ancestor
20476348|NCT01515592|Hormones|hormones|mesh-ancestor
20476349|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476350|NCT01515683|Anesthetics|anesthetics|mesh-list
20476351|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476352|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227108|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227109|NCT00348634|Tegaserod|tegaserod|mesh-list
20227110|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20227111|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
20227112|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227113|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227114|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476353|NCT01515774|Pramipexole|pramipexole|mesh-list
20476354|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
20637334|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20637335|NCT04847063|Antidotes|antidotes|mesh-ancestor
20637336|NCT04847063|Protective Agents|protective agents|mesh-ancestor
20476355|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476356|NCT01515774|Protective Agents|protective agents|mesh-ancestor
20476357|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476358|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20476359|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20227115|NCT00348712|Insulin|insulin|mesh-list
20227116|NCT00348712|Metformin|metformin|mesh-list
20637337|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
19696971|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19696972|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
19696973|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
19696974|NCT04934618|Irinotecan|irinotecan|mesh-list
19696975|NCT04934618|Apatinib|apatinib|mesh-list
19696976|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19696977|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19696978|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696979|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19696980|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696981|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19696982|NCT04934514|Gemcitabine|gemcitabine|mesh-list
19696983|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696984|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19696985|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
20227117|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
20227118|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20227119|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227120|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227121|NCT00348725|Metformin|metformin|mesh-list
20227122|NCT00348725|Fenofibrate|fenofibrate|mesh-list
20227123|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227124|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227125|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227126|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
20476360|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
19412437|NCT03532711|Fluorouracil|fluorouracil|mesh-list
20476361|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
19412438|NCT03532711|Capecitabine|capecitabine|mesh-list
19412439|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
19412440|NCT03532711|Irinotecan|irinotecan|mesh-list
20476362|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476363|NCT01515813|Tenofovir|tenofovir|mesh-list
20476364|NCT01515813|Emtricitabine|emtricitabine|mesh-list
20476365|NCT01515813|Efavirenz|efavirenz|mesh-list
20476366|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19412441|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
19412442|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412443|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
19412444|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412445|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412446|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19696986|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227127|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412447|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527543|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20527544|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20527545|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20527546|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20527547|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20527548|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20527549|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20527550|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20527551|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527552|NCT01768741|Liver Extracts|liver extracts|mesh-list
20527553|NCT01768741|Hematinics|hematinics|mesh-ancestor
20527554|NCT01768767|Ketamine|ketamine|mesh-list
20527555|NCT01768767|Analgesics|analgesics|mesh-ancestor
20527556|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
20527557|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527558|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527559|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20527560|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20527561|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
20527562|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
20527563|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20527564|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19412448|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
19412449|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20227128|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227129|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
20227130|NCT00348738|Hematinics|hematinics|mesh-ancestor
20227131|NCT00348764|Polidocanol|polidocanol|mesh-list
20227132|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20227133|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20227134|NCT00348894|Reboxetine|reboxetine|mesh-list
20227135|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
20227136|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20227137|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20227138|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20476367|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20476368|NCT01515813|Pravastatin|pravastatin|mesh-list
20476369|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
20476370|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476371|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20476372|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20476373|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476374|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476375|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20476376|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20476377|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20476378|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20476379|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20476380|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20476381|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20476382|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20476383|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20476384|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20476385|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
20476386|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20476387|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20476388|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
20476389|NCT01515826|Dexamethasone|dexamethasone|mesh-list
20476390|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
20476391|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20476392|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20476393|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20476394|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20476395|NCT01515826|BB 1101|bb 1101|mesh-list
20476396|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476397|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
20476398|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
20476399|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476400|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476401|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20476402|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
20476403|NCT01515826|Hormones|hormones|mesh-ancestor
20476404|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476405|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20476406|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476407|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476408|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476409|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476410|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476411|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476412|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20476413|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476414|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20476415|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
20476416|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20476417|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20476418|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20476419|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20476420|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
19412450|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19412451|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227139|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19412452|NCT03532711|Antidotes|antidotes|mesh-ancestor
20637338|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
20637339|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637340|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637341|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
20476421|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
20476422|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
20476423|NCT01515839|Vinpocetine|vinpocetine|mesh-list
20476424|NCT01515839|Huperzine A|huperzine a|mesh-list
20476425|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
20476426|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476427|NCT01515839|Protective Agents|protective agents|mesh-ancestor
20476428|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476429|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
20476430|NCT01515839|Vitamins|vitamins|mesh-ancestor
20476431|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
20476432|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
20476433|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20476434|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476435|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
20476436|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850848|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19850849|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
19850850|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850851|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850852|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850853|NCT00713609|Clindamycin|clindamycin|mesh-list
19850854|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
19850855|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
20476437|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20637342|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
20637343|NCT04840615|Ipilimumab|ipilimumab|mesh-list
20637344|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637345|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637346|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20637347|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637348|NCT04822350|Avelumab|avelumab|mesh-list
20637349|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637350|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637351|NCT04817254|Nivolumab|nivolumab|mesh-list
20637352|NCT04817254|Ipilimumab|ipilimumab|mesh-list
20637353|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637354|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637355|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20637356|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637357|NCT04808843|Dienogest|dienogest|mesh-list
20637358|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20637359|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
20637360|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20637361|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637362|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20637363|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20637364|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20637365|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20637366|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
20637367|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637368|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637369|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637370|NCT04799288|Teriflunomide|teriflunomide|mesh-list
19696987|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
20476438|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
20637371|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19696988|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19696989|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19696990|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19696991|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
19696992|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19696993|NCT04934748|Phenylephrine|phenylephrine|mesh-list
19696994|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
19696995|NCT04934748|Norepinephrine|norepinephrine|mesh-list
19696996|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19696997|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
19696998|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
19850856|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19412453|NCT03532711|Protective Agents|protective agents|mesh-ancestor
19696999|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850857|NCT00713609|Tazarotene|tazarotene|mesh-list
20476439|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697000|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697001|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
20637372|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20637373|NCT04799288|Analgesics|analgesics|mesh-ancestor
20637374|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
20637375|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637376|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637377|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637378|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637379|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697002|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19697003|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
19697004|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
19697005|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19697006|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20637380|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
20637381|NCT04799275|Prednisone|prednisone|mesh-list
20637382|NCT04799275|Cortisone|cortisone|mesh-list
20637383|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
20637384|NCT04799275|Rituximab|rituximab|mesh-list
20637385|NCT04799275|Doxorubicin|doxorubicin|mesh-list
20637386|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20637387|NCT04799275|Vincristine|vincristine|mesh-list
20637388|NCT04799275|Azacitidine|azacitidine|mesh-list
20637389|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20637390|NCT04799275|Antibodies|antibodies|mesh-list
20637391|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
20637392|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20637393|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637394|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
20637395|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637396|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637397|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637398|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
20637399|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637400|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637401|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20637402|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637403|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20637404|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476440|NCT01515839|Expectorants|expectorants|mesh-ancestor
20476441|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
20476442|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20476443|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20637405|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637406|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637407|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
20637408|NCT04799275|Hormones|hormones|mesh-ancestor
20637409|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637410|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637411|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637412|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637413|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637414|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637415|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20637416|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
20637417|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
20637418|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637419|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637420|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20637421|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20637422|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637423|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637424|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697007|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697008|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
20476444|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
20476445|NCT01515852|Anesthetics|anesthetics|mesh-list
20476446|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476447|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476448|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20476449|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
20476450|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20637425|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20637426|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20637427|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
20637428|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
20637429|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637430|NCT04776252|Islatravir|islatravir|mesh-list
20637431|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
20637432|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637433|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637434|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637435|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20637436|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20637437|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20637438|NCT04741997|Nivolumab|nivolumab|mesh-list
20637439|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637440|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637441|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20637442|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637443|NCT04739813|Prednisone|prednisone|mesh-list
20637444|NCT04739813|Lenalidomide|lenalidomide|mesh-list
20637445|NCT04739813|Venetoclax|venetoclax|mesh-list
20637446|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
20637447|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637448|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
20637449|NCT04739813|Hormones|hormones|mesh-ancestor
20637450|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637451|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637452|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637453|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637454|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
20637455|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20637456|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20637457|NCT04739813|Growth Substances|growth substances|mesh-ancestor
20637458|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
20637459|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637460|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
20637461|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637462|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637463|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
20637464|NCT04736706|Lenvatinib|lenvatinib|mesh-list
20637465|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637466|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637467|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637468|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637469|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637470|NCT04727229|Bupivacaine|bupivacaine|mesh-list
20637471|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
20637472|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
20637473|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637474|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637475|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
20637476|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637477|NCT04725188|Docetaxel|docetaxel|mesh-list
20637478|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
20637479|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637480|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637481|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637482|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637483|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637484|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850858|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19850859|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19850860|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19850861|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850862|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637485|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20637486|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
20637487|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20637488|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637489|NCT04715633|Apatinib|apatinib|mesh-list
20637490|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20637491|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637492|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637493|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637494|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412454|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
20637495|NCT04708470|Entinostat|entinostat|mesh-list
20637496|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637497|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20637498|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637499|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637500|NCT04701424|Insulin|insulin|mesh-list
20637501|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20637502|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637503|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20637504|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
20637505|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20637506|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637507|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19412455|NCT03532711|Vitamins|vitamins|mesh-ancestor
19412456|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
19412457|NCT03532698|Aspirin|aspirin|mesh-list
20637508|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637509|NCT04676646|Spironolactone|spironolactone|mesh-list
20637510|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20637511|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
20637512|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637513|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637514|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20637515|NCT04676646|Diuretics|diuretics|mesh-ancestor
20637516|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
20637517|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
20637518|NCT04670068|Fludarabine|fludarabine|mesh-list
20637519|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637520|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
20637521|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637522|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637523|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637524|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
20637525|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637526|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637527|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20637528|NCT04645004|Aspirin|aspirin|mesh-list
20637529|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20637530|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20637531|NCT04645004|Analgesics|analgesics|mesh-ancestor
20637532|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
20637533|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637534|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637535|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637536|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637537|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20637538|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20637539|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637540|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20637541|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20637542|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637543|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
20637544|NCT04639843|Doxorubicin|doxorubicin|mesh-list
20637545|NCT04639843|Romidepsin|romidepsin|mesh-list
20637546|NCT04639843|Azacitidine|azacitidine|mesh-list
20637547|NCT04639843|Cc-486|cc-486|mesh-list
20637548|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637549|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637550|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20637551|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20637552|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637553|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637554|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20637555|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
20637556|NCT04633252|Prednisone|prednisone|mesh-list
20637557|NCT04633252|Docetaxel|docetaxel|mesh-list
20637558|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637559|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637560|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637561|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637562|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637563|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637564|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
20637565|NCT04633252|Hormones|hormones|mesh-ancestor
19412458|NCT03532698|Osimertinib|osimertinib|mesh-list
20637566|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637567|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412459|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19412460|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412461|NCT03532698|Analgesics|analgesics|mesh-ancestor
19412462|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
19412463|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637568|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637569|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
20637570|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20637571|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
20637572|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637573|NCT04627922|Expectorants|expectorants|mesh-ancestor
20637574|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
20637575|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20637576|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
20637577|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637578|NCT04627922|Protective Agents|protective agents|mesh-ancestor
20637579|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637580|NCT04627922|Antidotes|antidotes|mesh-ancestor
20637581|NCT04624243|Risperidone|risperidone|mesh-list
20637582|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20637583|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
20637584|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20637585|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637586|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637587|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20637588|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20637589|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637590|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20637591|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20637592|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
20637593|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
20637594|NCT04624204|Etoposide|etoposide|mesh-list
20637595|NCT04624204|Olaparib|olaparib|mesh-list
20637596|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637597|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637598|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637599|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20637600|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20637601|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637602|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637603|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637604|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
20637605|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20637606|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
20637607|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637608|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637609|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637610|NCT04617002|TIC10 compound|tic10 compound|mesh-list
20637611|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637612|NCT04613492|Durvalumab|durvalumab|mesh-list
20637613|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637614|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637615|NCT04613206|Vaccines|vaccines|mesh-list
20637616|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
20637617|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637618|NCT04599634|Venetoclax|venetoclax|mesh-list
20637619|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
20637620|NCT04599634|Magrolimab|magrolimab|mesh-list
20637621|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637622|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637623|NCT04595981|Cisplatin|cisplatin|mesh-list
20637624|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637625|NCT04594694|Bezafibrate|bezafibrate|mesh-list
20637626|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20637627|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
20637628|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637629|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20637630|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20637631|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637632|NCT04578756|Cariprazine|cariprazine|mesh-list
20637633|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20637634|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19412464|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637635|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637636|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637637|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20637638|NCT04571944|Suvorexant|suvorexant|mesh-list
20637639|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20637640|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20637641|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637642|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637643|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20637644|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20637645|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637646|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
20637647|NCT04566133|Trametinib|trametinib|mesh-list
20637648|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
20637649|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20637650|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20637651|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637652|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637653|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637654|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637655|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637656|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637657|NCT04565236|Factor VIII|factor viii|mesh-list
20637658|NCT04565236|Coagulants|coagulants|mesh-ancestor
20637659|NCT04545736|Metformin|metformin|mesh-list
20637660|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20637661|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637662|NCT04541173|Bevacizumab|bevacizumab|mesh-list
20637663|NCT04541173|Atezolizumab|atezolizumab|mesh-list
20637664|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637665|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637666|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20637667|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20637668|NCT04541173|Growth Substances|growth substances|mesh-ancestor
20637669|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637670|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
20637671|NCT04538378|Durvalumab|durvalumab|mesh-list
20637672|NCT04538378|Olaparib|olaparib|mesh-list
20637673|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637674|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637675|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637676|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637677|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637678|NCT04528329|Dexamethasone|dexamethasone|mesh-list
20637679|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
20637680|NCT04528329|BB 1101|bb 1101|mesh-list
20637681|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637682|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
20637683|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
20637684|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637685|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637686|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20637687|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
20637688|NCT04528329|Hormones|hormones|mesh-ancestor
20637689|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637690|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637691|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637692|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
20637693|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637694|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637695|NCT04511728|Propofol|propofol|mesh-list
20637696|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20637697|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637698|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637699|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20637700|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
20637701|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
20637702|NCT04510506|Pancrelipase|pancrelipase|mesh-list
20637703|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20637704|NCT04496960|Tofacitinib|tofacitinib|mesh-list
20637705|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637706|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637707|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637708|NCT04484818|Leuprolide|leuprolide|mesh-list
20637709|NCT04484818|Goserelin|goserelin|mesh-list
20637710|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20637711|NCT04484818|Tryptophan|tryptophan|mesh-list
20637712|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
20637713|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637714|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637715|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20637716|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
20637717|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20637718|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637719|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637720|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
20637721|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20637722|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
20637723|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20637724|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20637725|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
20637726|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20637727|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
19697009|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707892|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20637728|NCT04481113|Niraparib|niraparib|mesh-list
20637729|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637730|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637731|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637732|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637733|NCT04476277|Biotin|biotin|mesh-list
20637734|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
20637735|NCT04476277|Vitamins|vitamins|mesh-ancestor
20637736|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
20637737|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637738|NCT04472598|Navitoclax|navitoclax|mesh-list
20637739|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637740|NCT04464798|Rituximab|rituximab|mesh-list
20637741|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
20637742|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637743|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637744|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
20637745|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637746|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637747|NCT04458259|Axitinib|axitinib|mesh-list
20637748|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637749|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637750|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637751|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637752|NCT04449549|Paclitaxel|paclitaxel|mesh-list
20637753|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637754|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637755|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637756|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637757|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637758|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637759|NCT04447027|Dexamethasone|dexamethasone|mesh-list
20637760|NCT04447027|Lenalidomide|lenalidomide|mesh-list
20637761|NCT04447027|Azacitidine|azacitidine|mesh-list
20637762|NCT04447027|Romidepsin|romidepsin|mesh-list
20637763|NCT04447027|Cc-486|cc-486|mesh-list
20637764|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637765|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
20637766|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
20637767|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637768|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637769|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20637770|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
20637771|NCT04447027|Hormones|hormones|mesh-ancestor
20637772|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637773|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637774|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637775|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
20637776|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20637777|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20637778|NCT04447027|Growth Substances|growth substances|mesh-ancestor
20637779|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
20637780|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20637781|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
20637782|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637783|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637784|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637785|NCT04428151|Paclitaxel|paclitaxel|mesh-list
20637786|NCT04428151|Docetaxel|docetaxel|mesh-list
20637787|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
20637788|NCT04428151|Capecitabine|capecitabine|mesh-list
20637789|NCT04428151|Cetuximab|cetuximab|mesh-list
20637790|NCT04428151|Lenvatinib|lenvatinib|mesh-list
20637791|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637792|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637793|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637794|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637795|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637796|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637797|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637798|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20637799|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
20637800|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20637801|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637802|NCT04421963|Olaparib|olaparib|mesh-list
20637803|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637804|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637805|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637806|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637807|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20637808|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
20637809|NCT04420585|Coagulants|coagulants|mesh-ancestor
20637810|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20637811|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
20637812|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637813|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
20637814|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20637815|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20637816|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637817|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
20637818|NCT04410042|Coagulants|coagulants|mesh-ancestor
20637819|NCT04407442|Dexamethasone|dexamethasone|mesh-list
20637820|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
20637821|NCT04407442|Azacitidine|azacitidine|mesh-list
20637822|NCT04407442|Daratumumab|daratumumab|mesh-list
20637823|NCT04407442|Ichthammol|ichthammol|mesh-list
20637824|NCT04407442|BB 1101|bb 1101|mesh-list
20637825|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637826|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
20637827|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
20637828|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637829|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637830|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20637831|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
20637832|NCT04407442|Hormones|hormones|mesh-ancestor
20637833|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20637834|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20637835|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637836|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
20637837|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637838|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637839|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20637840|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
20637841|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
19850863|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
19850864|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
19850865|NCT00713817|Nabiximols|nabiximols|mesh-list
19850866|NCT00713817|Analgesics|analgesics|mesh-ancestor
19850867|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
19850868|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850869|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850870|NCT00713830|Metformin|metformin|mesh-list
19850871|NCT00713830|Lixisenatide|lixisenatide|mesh-list
19850872|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850873|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850874|NCT00714233|Metformin|metformin|mesh-list
19850875|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
19850876|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
19850877|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19850878|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19850879|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850880|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637842|NCT04401761|Aspirin|aspirin|mesh-list
20637843|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
20637844|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20637845|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20637846|NCT04401761|Analgesics|analgesics|mesh-ancestor
19850881|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19850882|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19850883|NCT00714259|Fludarabine|fludarabine|mesh-list
19850884|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227140|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227141|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
20476451|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637847|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
20637848|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637849|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637850|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20637851|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637852|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20637853|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20637854|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637855|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20637856|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20637857|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637858|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
20637859|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20637860|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
20637861|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20637862|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
20637863|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
20637864|NCT04396873|11C-PS13|11c-ps13|mesh-list
20637865|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20637866|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637867|NCT04388839|Dactinomycin|dactinomycin|mesh-list
20637868|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
20637869|NCT04388839|Vincristine|vincristine|mesh-list
20637870|NCT04388839|Vinorelbine|vinorelbine|mesh-list
20637871|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637872|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
20637873|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476452|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20476453|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476454|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476455|NCT01516060|Efavirenz|efavirenz|mesh-list
20476456|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20637874|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637875|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637876|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
20637877|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637878|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697010|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697011|NCT04934748|Protective Agents|protective agents|mesh-ancestor
19697012|NCT04934475|Lenalidomide|lenalidomide|mesh-list
19697013|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
20637879|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20637880|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637881|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637882|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19697014|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697015|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19697016|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19697017|NCT04934475|Growth Substances|growth substances|mesh-ancestor
19697018|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
19697019|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697020|NCT04933630|Norepinephrine|norepinephrine|mesh-list
20227142|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227143|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227144|NCT00348920|Bupivacaine|bupivacaine|mesh-list
20227145|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
20476457|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20476458|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476459|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227146|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
20227147|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227148|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476460|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
20476461|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476462|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20637883|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19850885|NCT00714285|Vaccines|vaccines|mesh-list
19850886|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
19850887|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850888|NCT00714493|Infliximab|infliximab|mesh-list
20476463|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20476464|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20476465|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20476466|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20476467|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20476468|NCT01516138|Insulin|insulin|mesh-list
20476469|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476470|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476471|NCT01516255|Liraglutide|liraglutide|mesh-list
20476472|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
20476473|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476474|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476475|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20476476|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476477|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476478|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476479|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476480|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476481|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20637884|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637885|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637886|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637887|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20637888|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637889|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20637890|NCT04380636|Paclitaxel|paclitaxel|mesh-list
20637891|NCT04380636|Etoposide|etoposide|mesh-list
20637892|NCT04380636|Carboplatin|carboplatin|mesh-list
20637893|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
20637894|NCT04380636|Pemetrexed|pemetrexed|mesh-list
20637895|NCT04380636|Durvalumab|durvalumab|mesh-list
20637896|NCT04380636|Olaparib|olaparib|mesh-list
20637897|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20637898|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637899|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
20637900|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
20637901|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
20637902|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637903|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637904|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20637905|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20637906|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637907|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20637908|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20637909|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637910|NCT04380311|Tacrolimus|tacrolimus|mesh-list
20637911|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637912|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
20637913|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637914|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20637915|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637916|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637917|NCT04370795|Sirolimus|sirolimus|mesh-list
20637918|NCT04370795|Busulfan|busulfan|mesh-list
20637919|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637920|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637921|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637922|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637923|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
20637924|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637925|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
20637926|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637927|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
20637928|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637929|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637930|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20637931|NCT04369014|Anesthetics|anesthetics|mesh-list
20637932|NCT04369014|Propofol|propofol|mesh-list
19850889|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
20637933|NCT04369014|Etomidate|etomidate|mesh-list
20637934|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637935|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637936|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20637937|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20637938|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
20637939|NCT04360421|Bupivacaine|bupivacaine|mesh-list
20637940|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
20637941|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
20637942|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20637943|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637944|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
20637945|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20637946|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
20637947|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20637948|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
20637949|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20637950|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
20637951|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637952|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637953|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
20637954|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
20637955|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
20637956|NCT04339777|Busulfan|busulfan|mesh-list
20637957|NCT04339777|Fludarabine|fludarabine|mesh-list
20637958|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
20637959|NCT04339777|Tacrolimus|tacrolimus|mesh-list
20637960|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20637961|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
20637962|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20637963|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20637964|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20637965|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
20637966|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637967|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637968|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20637969|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20637970|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637971|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20637972|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20637973|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
20637974|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637975|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637976|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637977|NCT04339751|Vorinostat|vorinostat|mesh-list
20637978|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637979|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20637980|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637981|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637982|NCT04334941|Atezolizumab|atezolizumab|mesh-list
20637983|NCT04334941|Talazoparib|talazoparib|mesh-list
20476482|NCT01516255|Incretins|incretins|mesh-ancestor
20476483|NCT01516255|Hormones|hormones|mesh-ancestor
20476484|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476485|NCT01516346|Hydralazine|hydralazine|mesh-list
20637984|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20637985|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637986|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
20637987|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476486|NCT01516346|Isosorbide|isosorbide|mesh-list
20476487|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20476488|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20476489|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20476490|NCT01516346|Diuretics|diuretics|mesh-ancestor
20476491|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
20476492|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476493|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
20476494|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20476495|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476496|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20476497|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
20476498|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20476499|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476500|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637988|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20637989|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20637990|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20637991|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
20637992|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20637993|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20637994|NCT04326478|Azithromycin|azithromycin|mesh-list
20637995|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20637996|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20637997|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
20637998|NCT04322643|Nivolumab|nivolumab|mesh-list
20637999|NCT04322643|Durvalumab|durvalumab|mesh-list
20638000|NCT04322643|Avelumab|avelumab|mesh-list
20638001|NCT04322643|Atezolizumab|atezolizumab|mesh-list
20638002|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638003|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638004|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20638005|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638006|NCT04307576|Dexamethasone|dexamethasone|mesh-list
20638007|NCT04307576|Doxorubicin|doxorubicin|mesh-list
20476501|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20476502|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476503|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476504|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476505|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476506|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20476507|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
20638008|NCT04307576|Vincristine|vincristine|mesh-list
20638009|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
20638010|NCT04307576|Blinatumomab|blinatumomab|mesh-list
20638011|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20638012|NCT04307576|Thioguanine|thioguanine|mesh-list
20638013|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638014|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
20638015|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
20638016|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638017|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638018|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20638019|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
20638020|NCT04307576|Hormones|hormones|mesh-ancestor
20638021|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638022|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20638023|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638024|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20638025|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20638026|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20638027|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638028|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638029|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638030|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638031|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638032|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638033|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20638034|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638035|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638036|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
20638037|NCT04304820|Cyclosporine|cyclosporine|mesh-list
20638038|NCT04304820|Cyclosporins|cyclosporins|mesh-list
20638039|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20638040|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638041|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638042|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638043|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
20638044|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638045|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
20638046|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638047|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
20638048|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638049|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20638050|NCT04298567|Aspirin|aspirin|mesh-list
20476508|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20476509|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476510|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20476511|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20638051|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
20638052|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20638053|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
20638054|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20638055|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
20638056|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638057|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638058|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
20638059|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20638060|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638061|NCT04298567|Analgesics|analgesics|mesh-ancestor
20638062|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
20638063|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638064|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638065|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638066|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638067|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20638068|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20638069|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20638070|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20638071|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
20638072|NCT04288089|Palbociclib|palbociclib|mesh-list
20638073|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638074|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20638075|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638076|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638077|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
20638078|NCT04282174|Melphalan|melphalan|mesh-list
20638079|NCT04282174|Busulfan|busulfan|mesh-list
20638080|NCT04282174|Thiotepa|thiotepa|mesh-list
20638081|NCT04282174|Fludarabine|fludarabine|mesh-list
20638082|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638083|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
20638084|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638085|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638086|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638087|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
20638088|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638089|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638090|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638091|NCT04273737|Amantadine|amantadine|mesh-list
20638092|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20638093|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20638094|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
20638095|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638096|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
20638097|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20638098|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638099|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638100|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638101|NCT04273737|Analgesics|analgesics|mesh-ancestor
20638102|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
20638103|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638104|NCT04266795|Azacitidine|azacitidine|mesh-list
20638105|NCT04266795|Venetoclax|venetoclax|mesh-list
20638106|NCT04266795|Pevonedistat|pevonedistat|mesh-list
20638107|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638108|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
20638109|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638110|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638111|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638112|NCT04256824|Triclosan|triclosan|mesh-list
20638113|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20638114|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638115|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20638116|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20638117|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
20638118|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638119|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20638120|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
20638121|NCT04246177|Lenvatinib|lenvatinib|mesh-list
20638122|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638123|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638124|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20638125|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697021|NCT04933630|Serotonin|serotonin|mesh-list
19697022|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19697023|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20638126|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638127|NCT04245280|Ropivacaine|ropivacaine|mesh-list
19697024|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697025|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697026|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476512|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20476513|NCT01516450|Belimumab|belimumab|mesh-list
20476514|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476515|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
20476516|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476517|NCT01516463|Bacitracin|bacitracin|mesh-list
20476518|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20476519|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476520|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476521|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
20476522|NCT01516554|Testosterone|testosterone|mesh-list
20476523|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
20638128|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20638129|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
20638130|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
20638131|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20638132|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638133|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
20638134|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638135|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
20638136|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20638137|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20638138|NCT04233164|Prednisolone|prednisolone|mesh-list
20638139|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
20638140|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20638141|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
20638142|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638143|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
20638144|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
20638145|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638146|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638147|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20638148|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
20638149|NCT04233164|Hormones|hormones|mesh-ancestor
20638150|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638151|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20638152|NCT04233164|Protective Agents|protective agents|mesh-ancestor
20638153|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20638154|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638155|NCT04219735|Minocycline|minocycline|mesh-list
20638156|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20638157|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638158|NCT04216329|Temozolomide|temozolomide|mesh-list
20638159|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638160|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
20638161|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638162|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638163|NCT04216290|Gemcitabine|gemcitabine|mesh-list
20638164|NCT04216290|Cisplatin|cisplatin|mesh-list
20638165|NCT04216290|Fluorouracil|fluorouracil|mesh-list
20638166|NCT04216290|Durvalumab|durvalumab|mesh-list
20638167|NCT04216290|Mitomycins|mitomycins|mesh-list
20638168|NCT04216290|Mitomycin|mitomycin|mesh-list
20638169|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
20638170|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20638171|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
20638172|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638173|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638174|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
20638175|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638176|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
20638177|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638178|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638179|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638180|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
20638181|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638182|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638183|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20476524|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
20476525|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20638184|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
20638185|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20638186|NCT04214262|Atezolizumab|atezolizumab|mesh-list
20638187|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20638188|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638189|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
20638190|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638191|NCT04209595|Rucaparib|rucaparib|mesh-list
20638192|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20638193|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638194|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638195|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638196|NCT04206319|Listerine|listerine|mesh-list
20638197|NCT04206319|Fluorides|fluorides|mesh-list
20638198|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
20638199|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
20638200|NCT04206319|Protective Agents|protective agents|mesh-ancestor
20638201|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638202|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20638203|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638204|NCT04175925|Famotidine|famotidine|mesh-list
20638205|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20638206|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20638207|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20638208|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
20638209|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
20638210|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20638211|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638212|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638213|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
20638214|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20638215|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
20638216|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20638217|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
20638218|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638219|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638220|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
20638221|NCT04166383|Nivolumab|nivolumab|mesh-list
20638222|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638223|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638224|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20638225|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638226|NCT04145518|Naproxen|naproxen|mesh-list
20638227|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20638228|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638229|NCT04145518|Analgesics|analgesics|mesh-ancestor
20638230|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
20638231|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638232|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638233|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638234|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638235|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
20638236|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19697027|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697028|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697029|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
20227149|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
20227150|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476526|NCT01516554|Androgens|androgens|mesh-ancestor
20476527|NCT01516554|Hormones|hormones|mesh-ancestor
20476528|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476529|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476530|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20476531|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476532|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
20476533|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
20476534|NCT01516567|Rituximab|rituximab|mesh-list
20227151|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
20227152|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227153|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227154|NCT00348985|Bortezomib|bortezomib|mesh-list
20227155|NCT00348985|Belinostat|belinostat|mesh-list
20227156|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227157|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20227158|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227159|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227160|NCT00348998|Bevacizumab|bevacizumab|mesh-list
20638237|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638238|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638239|NCT04142658|Warfarin|warfarin|mesh-list
20638240|NCT04142658|Apixaban|apixaban|mesh-list
20638241|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
20638242|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20638243|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
20638244|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20638245|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
20638246|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638247|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638248|NCT04141696|Midazolam|midazolam|mesh-list
20638249|NCT04141696|Ketamine|ketamine|mesh-list
20638250|NCT04141696|Analgesics|analgesics|mesh-ancestor
20638251|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
20638252|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638253|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638254|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20638255|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20638256|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
20638257|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
20638258|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20638259|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20638260|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20638261|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20638262|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638263|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20638264|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20638265|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20638266|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20638267|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20638268|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
20638269|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
20638270|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
20638271|NCT04123366|Olaparib|olaparib|mesh-list
20638272|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638273|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638274|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20638275|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638276|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638277|NCT04102436|Aldesleukin|aldesleukin|mesh-list
20638278|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
20638279|NCT04102436|Fludarabine|fludarabine|mesh-list
20638280|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638281|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
20638282|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638283|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638284|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638285|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
20638286|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638287|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227161|NCT00348998|Goserelin|goserelin|mesh-list
19850890|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19850891|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227162|NCT00348998|Bicalutamide|bicalutamide|mesh-list
20476535|NCT01516567|Doxorubicin|doxorubicin|mesh-list
20476536|NCT01516567|Etoposide|etoposide|mesh-list
20476537|NCT01516567|Vincristine|vincristine|mesh-list
20476538|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476539|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
20476540|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476541|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476542|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20476543|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
20476544|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638288|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638289|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20638290|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20638291|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
19850892|NCT00714688|Methylphenidate|methylphenidate|mesh-list
20227163|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20227164|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227165|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20227166|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20227167|NCT00348998|Growth Substances|growth substances|mesh-ancestor
20227168|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638292|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638293|NCT04102020|Azacitidine|azacitidine|mesh-list
20638294|NCT04102020|Venetoclax|venetoclax|mesh-list
20638295|NCT04102020|Cc-486|cc-486|mesh-list
20638296|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638297|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
20638298|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638299|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638300|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638301|NCT04097561|Belimumab|belimumab|mesh-list
20638302|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638303|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
20638304|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638305|NCT04090398|Paclitaxel|paclitaxel|mesh-list
20638306|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20638307|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20638308|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638309|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638310|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638311|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638312|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638313|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638314|NCT04086485|Olaparib|olaparib|mesh-list
20638315|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20638316|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638317|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638318|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638319|NCT04064684|Budesonide|budesonide|mesh-list
20638320|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638321|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20638322|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
20638323|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638324|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638325|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20638326|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
20638327|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
20638328|NCT04064684|Hormones|hormones|mesh-ancestor
20638329|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638330|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20638331|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19412465|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412466|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412467|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19412468|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19412469|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412470|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19412471|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19412472|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850893|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19850894|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227169|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
20638332|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
20638333|NCT04054752|Vaccines|vaccines|mesh-list
20638334|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
20638335|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638336|NCT04044859|Nivolumab|nivolumab|mesh-list
20638337|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638338|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638339|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20638340|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638341|NCT04041050|Celecoxib|celecoxib|mesh-list
20638342|NCT04041050|Navitoclax|navitoclax|mesh-list
20638343|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20638344|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638345|NCT04041050|Analgesics|analgesics|mesh-ancestor
20638346|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
20638347|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638348|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638349|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638350|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638351|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20638352|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20638353|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638354|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638355|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638356|NCT04038515|Menthol|menthol|mesh-list
20638357|NCT04038515|Nicotine|nicotine|mesh-list
20638358|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20638359|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
20638360|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638361|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638362|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20638363|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20638364|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
20638365|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20638366|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638367|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
20638368|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
20638369|NCT04034251|Paclitaxel|paclitaxel|mesh-list
20638370|NCT04034251|Capecitabine|capecitabine|mesh-list
20638371|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638372|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638373|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638374|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19412473|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
19412474|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412475|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19412476|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
19412477|NCT05263609|Axitinib|axitinib|mesh-list
20638375|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638376|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638377|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638378|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
20638379|NCT04029480|Metformin|metformin|mesh-list
20638380|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
20638381|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20638382|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638383|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20638384|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227170|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20227171|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
20638385|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
20638386|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638387|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638388|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20638389|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638390|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20638391|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20638392|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20638393|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20638394|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
20638395|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20638396|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638397|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20638398|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20638399|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20638400|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20638401|NCT04002947|Rituximab|rituximab|mesh-list
20638402|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
20638403|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412478|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412479|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412480|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19412481|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412482|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227172|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
20227173|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227174|NCT00349024|Povidone|povidone|mesh-list
20227175|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
20227176|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20227177|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
20227178|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227179|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
20227180|NCT00349024|Protective Agents|protective agents|mesh-ancestor
20227181|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
20227182|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
20227183|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
20638404|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638405|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
20638406|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638407|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638408|NCT03986034|Venetoclax|venetoclax|mesh-list
20638409|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638410|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
20638411|NCT03983850|Sirolimus|sirolimus|mesh-list
20638412|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
20638413|NCT03983850|Busulfan|busulfan|mesh-list
20638414|NCT03983850|Fludarabine|fludarabine|mesh-list
20638415|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638416|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
20638417|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638418|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638419|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638420|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
20638421|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638422|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638423|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638424|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20638425|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20638426|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
20638427|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20638428|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638429|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638430|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
20638431|NCT03973268|Complement Factor H|complement factor h|mesh-list
20638432|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20638433|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638434|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
20638435|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638436|NCT03971253|Peficitinib|peficitinib|mesh-list
20638437|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638438|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638439|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638440|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
20638441|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638442|NCT03964090|Cytarabine|cytarabine|mesh-list
20638443|NCT03964090|Isavuconazole|isavuconazole|mesh-list
20638444|NCT03964090|Methotrexate|methotrexate|mesh-list
20638445|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20638446|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
20638447|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20638448|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638449|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638450|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
20638451|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638452|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638453|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
20638454|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638455|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20638456|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638457|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
20638458|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638459|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20638460|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
20638461|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638462|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
20638463|NCT03962465|Cytarabine|cytarabine|mesh-list
20638464|NCT03962465|Prednisone|prednisone|mesh-list
20638465|NCT03962465|Methotrexate|methotrexate|mesh-list
20638466|NCT03962465|Vincristine|vincristine|mesh-list
20638467|NCT03962465|Daunorubicin|daunorubicin|mesh-list
20638468|NCT03962465|Pegaspargase|pegaspargase|mesh-list
20638469|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20638470|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638471|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
20638472|NCT03962465|Hormones|hormones|mesh-ancestor
20227184|NCT00349076|Fluorouracil|fluorouracil|mesh-list
20227185|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227186|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
20227187|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227188|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227189|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227190|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
20227191|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227192|NCT00349089|Pemetrexed|pemetrexed|mesh-list
20638473|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638474|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638475|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20638476|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638477|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20638478|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
20638479|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20638480|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638481|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
20638482|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638483|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
20638484|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638485|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20638486|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638487|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
20638488|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638489|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20638490|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
20638491|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638492|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638493|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638494|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638495|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638496|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20638497|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20638498|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20638499|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638500|NCT03952637|Sirolimus|sirolimus|mesh-list
20638501|NCT03952637|Prednisone|prednisone|mesh-list
20638502|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
20638503|NCT03952637|Rituximab|rituximab|mesh-list
20638504|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638505|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638506|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
20638507|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638508|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638509|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476545|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476546|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20476547|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20476548|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20476549|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20476550|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476551|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476552|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638510|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
20638511|NCT03952637|Hormones|hormones|mesh-ancestor
20638512|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638513|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20638514|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20638515|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638516|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20638517|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
20638518|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638519|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
20638520|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
20638521|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638522|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20638523|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20638524|NCT03952637|Protective Agents|protective agents|mesh-ancestor
20638525|NCT03937830|Bevacizumab|bevacizumab|mesh-list
20638526|NCT03937830|Durvalumab|durvalumab|mesh-list
20638527|NCT03937830|Doxorubicin|doxorubicin|mesh-list
20638528|NCT03937830|Tremelimumab|tremelimumab|mesh-list
20638529|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638530|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638531|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20638532|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20638533|NCT03937830|Growth Substances|growth substances|mesh-ancestor
20638534|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638535|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
20638536|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19697030|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
19707893|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20638537|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20638538|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20638539|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638540|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638541|NCT03926143|Maytansine|maytansine|mesh-list
20638542|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
20638543|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638544|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638545|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638546|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638547|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638548|NCT03912428|Celecoxib|celecoxib|mesh-list
20638549|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20638550|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638551|NCT03912428|Analgesics|analgesics|mesh-ancestor
20638552|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
20638553|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638554|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638555|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638556|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638557|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20638558|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20638559|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638560|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638561|NCT03910452|Sirolimus|sirolimus|mesh-list
20638562|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
20638563|NCT03910452|Busulfan|busulfan|mesh-list
20638564|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
20638565|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638566|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
20638567|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638568|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638569|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638570|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
20638571|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638572|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638573|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638574|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20638575|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638576|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20638577|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
20638578|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638579|NCT03902418|Tenofovir|tenofovir|mesh-list
20638580|NCT03902418|Emtricitabine|emtricitabine|mesh-list
20638581|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
20638582|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638583|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20638584|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20638585|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638586|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638587|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20638588|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20638589|NCT03897998|Naloxone|naloxone|mesh-list
20638590|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20638591|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638592|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
20638593|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638594|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
20638595|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20638596|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
20638597|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20638598|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
20638599|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638600|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227193|NCT00349089|Vinorelbine|vinorelbine|mesh-list
20227194|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227195|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638601|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
20638602|NCT03875573|Durvalumab|durvalumab|mesh-list
20638603|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638604|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638605|NCT03874325|Durvalumab|durvalumab|mesh-list
20638606|NCT03874325|Letrozole|letrozole|mesh-list
20227196|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638607|NCT03874325|Anastrozole|anastrozole|mesh-list
20638608|NCT03874325|Exemestane|exemestane|mesh-list
20638609|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20227197|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20638610|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638611|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20638612|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20638613|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638614|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638615|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20638616|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
20638617|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638618|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638619|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20638620|NCT03864406|Darunavir|darunavir|mesh-list
20638621|NCT03864406|Cobicistat|cobicistat|mesh-list
20638622|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
20638623|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
20638624|NCT03864406|Apixaban|apixaban|mesh-list
20638625|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20638626|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
20638627|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20638628|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
20638629|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638630|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638631|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
20638632|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20638633|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20638634|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20638635|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20638636|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
20638637|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638638|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20638639|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20638640|NCT03861611|Ibuprofen|ibuprofen|mesh-list
20638641|NCT03861611|Diclofenac|diclofenac|mesh-list
20638642|NCT03861611|Ketorolac|ketorolac|mesh-list
20638643|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20638644|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638645|NCT03861611|Analgesics|analgesics|mesh-ancestor
20638646|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
20638647|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638648|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638649|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638650|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638651|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20638652|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638653|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638654|NCT03860987|Prednisone|prednisone|mesh-list
20638655|NCT03860987|Goserelin|goserelin|mesh-list
20638656|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638657|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
20638658|NCT03860987|Hormones|hormones|mesh-ancestor
20638659|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638660|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638661|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20638662|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638663|NCT03854227|Docetaxel|docetaxel|mesh-list
20638664|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638665|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638666|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638667|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638668|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638669|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
20638670|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638671|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638672|NCT03845517|PF-06700841|pf-06700841|mesh-list
20638673|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20638674|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638675|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227198|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20227199|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20227200|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
20227201|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638676|NCT03841617|Hormones|hormones|mesh-list
20227202|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638677|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638678|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638679|NCT03829371|Dexamethasone|dexamethasone|mesh-list
20638680|NCT03829371|Prednisone|prednisone|mesh-list
20638681|NCT03829371|Lenalidomide|lenalidomide|mesh-list
20638682|NCT03829371|Melphalan|melphalan|mesh-list
20638683|NCT03829371|Bortezomib|bortezomib|mesh-list
20638684|NCT03829371|Daratumumab|daratumumab|mesh-list
20638685|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20638686|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
20638687|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
20638688|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638689|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638690|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20638691|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
20638692|NCT03829371|Hormones|hormones|mesh-ancestor
20638693|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638694|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20638695|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638696|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
20638697|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20638698|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20638699|NCT03829371|Growth Substances|growth substances|mesh-ancestor
20638700|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
20638701|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638702|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
20638703|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638704|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638705|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638706|NCT03811886|Natalizumab|natalizumab|mesh-list
20638707|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
20638708|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638709|NCT03811002|Cisplatin|cisplatin|mesh-list
20638710|NCT03811002|Carboplatin|carboplatin|mesh-list
20638711|NCT03811002|Etoposide|etoposide|mesh-list
20638712|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
20638713|NCT03811002|Atezolizumab|atezolizumab|mesh-list
20638714|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
20638715|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19697031|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697032|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19697033|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19697034|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
19697035|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19697036|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20638716|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638717|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638718|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20638719|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20638720|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638721|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638722|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
20638723|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638724|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
20638725|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
20638726|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638727|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638728|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638729|NCT03810976|Gemcitabine|gemcitabine|mesh-list
20227203|NCT00349115|Thalidomide|thalidomide|mesh-list
20227204|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227205|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
20227206|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227207|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
20227208|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20227209|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227210|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20227211|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20638730|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638731|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
19697037|NCT04933864|Methylene Blue|methylene blue|mesh-list
19697038|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707894|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
20638732|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227212|NCT00349115|Growth Substances|growth substances|mesh-ancestor
20638733|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638734|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
20638735|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638736|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638737|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476553|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
20476554|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
20476555|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476556|NCT01516580|Cytarabine|cytarabine|mesh-list
20476557|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
19850895|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20638738|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
20638739|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638740|NCT03805932|Rituximab|rituximab|mesh-list
20638741|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
20638742|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638743|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638744|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
20638745|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638746|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638747|NCT03799835|Atezolizumab|atezolizumab|mesh-list
20638748|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
20638749|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638750|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20638751|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
20638752|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638753|NCT03798626|Leucovorin|leucovorin|mesh-list
20638754|NCT03798626|Paclitaxel|paclitaxel|mesh-list
20638755|NCT03798626|Bevacizumab|bevacizumab|mesh-list
20638756|NCT03798626|Fluorouracil|fluorouracil|mesh-list
20638757|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
20638758|NCT03798626|Irinotecan|irinotecan|mesh-list
20638759|NCT03798626|Ramucirumab|ramucirumab|mesh-list
20638760|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
20638761|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638762|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638763|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638764|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638765|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638766|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638767|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638768|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20638769|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20638770|NCT03798626|Growth Substances|growth substances|mesh-ancestor
20638771|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638772|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
20638773|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
20638774|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638775|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638776|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
20638777|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20638778|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20638779|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638780|NCT03798626|Antidotes|antidotes|mesh-ancestor
20638781|NCT03798626|Protective Agents|protective agents|mesh-ancestor
20638782|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
19850896|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19850897|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19850898|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476558|NCT01516580|Rituximab|rituximab|mesh-list
20476559|NCT01516580|Doxorubicin|doxorubicin|mesh-list
20476560|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20476561|NCT01516580|Methotrexate|methotrexate|mesh-list
20476562|NCT01516580|Vincristine|vincristine|mesh-list
20476563|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476564|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
20476565|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476566|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476567|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20476568|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
20476569|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638783|NCT03798626|Vitamins|vitamins|mesh-ancestor
20476570|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638784|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
20638785|NCT03789240|Rituximab|rituximab|mesh-list
20638786|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638787|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476571|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638788|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
20638789|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638790|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638791|NCT03785210|Vancomycin|vancomycin|mesh-list
20638792|NCT03785210|Nivolumab|nivolumab|mesh-list
20638793|NCT03785210|Tadalafil|tadalafil|mesh-list
20638794|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638795|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638796|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20638797|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638798|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20638799|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638800|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
20638801|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20638802|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20638803|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638804|NCT03785210|Urological Agents|urological agents|mesh-ancestor
20638805|NCT03775265|Gemcitabine|gemcitabine|mesh-list
20638806|NCT03775265|Cisplatin|cisplatin|mesh-list
20638807|NCT03775265|Fluorouracil|fluorouracil|mesh-list
20638808|NCT03775265|Atezolizumab|atezolizumab|mesh-list
20638809|NCT03775265|Mitomycins|mitomycins|mesh-list
20638810|NCT03775265|Mitomycin|mitomycin|mesh-list
20638811|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20638812|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638813|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20638814|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
20638815|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638816|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
20638817|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638818|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638819|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638820|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
20638821|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412483|NCT05263583|Bromides|bromides|mesh-list
19412484|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
19412485|NCT05263505|Methotrexate|methotrexate|mesh-list
19412486|NCT05263505|Azathioprine|azathioprine|mesh-list
19412487|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19412488|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
19412489|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19412490|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412491|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412492|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
20638822|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20638823|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
20638824|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20638825|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
20638826|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20638827|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20638828|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638829|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638830|NCT03757897|Analgesics|analgesics|mesh-ancestor
20638831|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
20638832|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638833|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20638834|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20638835|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20638836|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
20638837|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20638838|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412493|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850899|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
19412494|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638839|NCT03745326|Aldesleukin|aldesleukin|mesh-list
20638840|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
20638841|NCT03745326|Fludarabine|fludarabine|mesh-list
20638842|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638843|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
20638844|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638845|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638846|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638847|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
20638848|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638849|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638850|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638851|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20638852|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20638853|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
20638854|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20638855|NCT03742895|Olaparib|olaparib|mesh-list
20638856|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20638857|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638858|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638859|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638860|NCT03735628|Nivolumab|nivolumab|mesh-list
20638861|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638862|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638863|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20638864|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638865|NCT03733067|Abatacept|abatacept|mesh-list
20638866|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20638867|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227213|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
20227214|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227215|NCT00349128|Metformin|metformin|mesh-list
20227216|NCT00349128|Fenofibrate|fenofibrate|mesh-list
20227217|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227218|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227219|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20638868|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638869|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638870|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
20638871|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638872|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638873|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
20638874|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638875|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638876|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20638877|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
20638878|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638879|NCT03660826|Durvalumab|durvalumab|mesh-list
20638880|NCT03660826|Olaparib|olaparib|mesh-list
20638881|NCT03660826|Cediranib|cediranib|mesh-list
20638882|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20638883|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
20638884|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20638885|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
20638886|NCT03660826|Maleic acid|maleic acid|mesh-list
20638887|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638888|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638889|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
20638890|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638891|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638892|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638893|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20638894|NCT03648892|Raclopride|raclopride|mesh-list
20638895|NCT03648892|Fallypride|fallypride|mesh-list
20638896|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20638897|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20638898|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20638899|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638900|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20638901|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20638902|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
20638903|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20638904|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638905|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20227220|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
20638906|NCT03616587|Everolimus|everolimus|mesh-list
20638907|NCT03616587|Palbociclib|palbociclib|mesh-list
20638908|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638909|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638910|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
20638911|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638912|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20638913|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638914|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638915|NCT03608358|Metformin|metformin|mesh-list
20638916|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
20638917|NCT03608358|Saxagliptin|saxagliptin|mesh-list
20638918|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20638919|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638920|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20638921|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638922|NCT03608358|Incretins|incretins|mesh-ancestor
20638923|NCT03608358|Hormones|hormones|mesh-ancestor
20638924|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20638925|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20638926|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
20638927|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638928|NCT03604406|Vaccines|vaccines|mesh-list
20638929|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
20638930|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638931|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
20638932|NCT03602612|Fludarabine|fludarabine|mesh-list
20638933|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20638934|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
20638935|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638936|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20638937|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20638938|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
20638939|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638940|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638941|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20638942|NCT03602560|Seladelpar|seladelpar|mesh-list
20638943|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20638944|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
20638945|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638946|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20638947|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
20638948|NCT03590054|Abexinostat|abexinostat|mesh-list
20638949|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638950|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638951|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20638952|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697039|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638953|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638954|NCT03574779|Paclitaxel|paclitaxel|mesh-list
20638955|NCT03574779|Bevacizumab|bevacizumab|mesh-list
20638956|NCT03574779|Carboplatin|carboplatin|mesh-list
20638957|NCT03574779|Niraparib|niraparib|mesh-list
20638958|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638959|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638960|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638961|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638962|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638963|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638964|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638965|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20638966|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20638967|NCT03574779|Growth Substances|growth substances|mesh-ancestor
20638968|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638969|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
20638970|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20638971|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638972|NCT03564691|Paclitaxel|paclitaxel|mesh-list
20638973|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20638974|NCT03564691|Cisplatin|cisplatin|mesh-list
20638975|NCT03564691|Carboplatin|carboplatin|mesh-list
20638976|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
20638977|NCT03564691|Pemetrexed|pemetrexed|mesh-list
19412495|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
19412496|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638978|NCT03564691|Lenvatinib|lenvatinib|mesh-list
20638979|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20638980|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20638981|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
20638982|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
20638983|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
20638984|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20638985|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20638986|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20638987|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20638988|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20638989|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20638990|NCT03560934|Dronabinol|dronabinol|mesh-list
20638991|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
20638992|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20638993|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20638994|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20638995|NCT03560934|Analgesics|analgesics|mesh-ancestor
20638996|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
20638997|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20638998|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20638999|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20639000|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639001|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639002|NCT03560934|Hormones|hormones|mesh-ancestor
20639003|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639004|NCT03557840|Temocillin|temocillin|mesh-list
20639005|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639006|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639007|NCT03554473|Temozolomide|temozolomide|mesh-list
20639008|NCT03554473|Topotecan|topotecan|mesh-list
20639009|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639010|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
20639011|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639012|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639013|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20639014|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20639015|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639016|NCT03533283|Atezolizumab|atezolizumab|mesh-list
20639017|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
20639018|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639019|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639020|NCT03529422|Durvalumab|durvalumab|mesh-list
20639021|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639022|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639023|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20639024|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
20639025|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639026|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
20639027|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639028|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
20639029|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639030|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639031|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639032|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
19850900|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850901|NCT00714714|Adapalene|adapalene|mesh-list
19850902|NCT00714714|Tretinoin|tretinoin|mesh-list
19850903|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20476572|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20476573|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20476574|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20476575|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476576|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476577|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20476578|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
20476579|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20476580|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20476581|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
20476582|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
20476583|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20476584|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639033|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639034|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639035|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639036|NCT03510468|Pyridoxine|pyridoxine|mesh-list
20639037|NCT03510468|Isoniazid|isoniazid|mesh-list
20639038|NCT03510468|Rifapentine|rifapentine|mesh-list
20639039|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
20639040|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639041|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639042|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20639043|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20639044|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
20639045|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639046|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20639047|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
20639048|NCT03510468|Vitamins|vitamins|mesh-ancestor
20639049|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
20639050|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697040|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19697041|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697042|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
19697043|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
19697044|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19697045|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19697046|NCT04933292|Prednisolone|prednisolone|mesh-list
19697047|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
20639051|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20639052|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
20639053|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
20639054|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
20639055|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639056|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639057|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20639058|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
20639059|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639060|NCT03492125|Rituximab|rituximab|mesh-list
20639061|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
20639062|NCT03492125|Venetoclax|venetoclax|mesh-list
20639063|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
19697048|NCT04933292|Azathioprine|azathioprine|mesh-list
19697049|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19697050|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
19697051|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19697052|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697053|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19697054|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
19697055|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639064|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639065|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639066|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
20639067|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639068|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639069|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
20639070|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20476585|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
20476586|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476587|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639071|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639072|NCT03478878|Vitamin A|vitamin a|mesh-list
20639073|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
20639074|NCT03478878|Vitamins|vitamins|mesh-ancestor
20639075|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
20639076|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639077|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
20639078|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639079|NCT03478878|Protective Agents|protective agents|mesh-ancestor
19697056|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697057|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707895|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476588|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
20476589|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
20476590|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476591|NCT01516593|Cytarabine|cytarabine|mesh-list
20476592|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19850904|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476593|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
20639080|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20639081|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639082|NCT03478865|Vitamin A|vitamin a|mesh-list
20639083|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
20639084|NCT03478865|Vitamins|vitamins|mesh-ancestor
20639085|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
20639086|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639087|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
20476594|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476595|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476596|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
20476597|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476598|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476599|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
20476600|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476601|NCT01516606|Clarithromycin|clarithromycin|mesh-list
20476602|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476603|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476604|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20476605|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476606|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476607|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20476608|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20639088|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639089|NCT03478865|Protective Agents|protective agents|mesh-ancestor
20639090|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20476609|NCT01516710|Liver Extracts|liver extracts|mesh-list
20476610|NCT01516710|Hematinics|hematinics|mesh-ancestor
20476611|NCT01516723|Sirolimus|sirolimus|mesh-list
20476612|NCT01516723|Everolimus|everolimus|mesh-list
20476613|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476614|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476615|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
19412497|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19412498|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20476616|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476617|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639091|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639092|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
19850905|NCT00714714|Analgesics|analgesics|mesh-ancestor
19850906|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
20476618|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639093|NCT03448393|Fludarabine|fludarabine|mesh-list
20639094|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639095|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
20639096|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639097|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639098|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639099|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
20639100|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639101|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639102|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639103|NCT03443856|Nivolumab|nivolumab|mesh-list
20639104|NCT03443856|Ipilimumab|ipilimumab|mesh-list
20639105|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639106|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639107|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20639108|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639109|NCT03436745|Zolpidem|zolpidem|mesh-list
20639110|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20639111|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20639112|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20639113|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639114|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20639115|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
20639116|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
20639117|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639118|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639119|NCT03418038|Vitamins|vitamins|mesh-list
20639120|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
20639121|NCT03418038|Gemcitabine|gemcitabine|mesh-list
20639122|NCT03418038|Cytarabine|cytarabine|mesh-list
20639123|NCT03418038|Dexamethasone|dexamethasone|mesh-list
20639124|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
20639125|NCT03418038|Cisplatin|cisplatin|mesh-list
20639126|NCT03418038|Rituximab|rituximab|mesh-list
20639127|NCT03418038|Carboplatin|carboplatin|mesh-list
19850907|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476619|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20476620|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
20476621|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20639128|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
20639129|NCT03418038|Etoposide|etoposide|mesh-list
20639130|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
20639131|NCT03418038|Ifosfamide|ifosfamide|mesh-list
20639132|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
20639133|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
20639134|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20639135|NCT03418038|Antibodies|antibodies|mesh-list
20639136|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
20639137|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639138|NCT03418038|BB 1101|bb 1101|mesh-list
20639139|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
19697058|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697059|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639140|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639141|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
20639142|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639143|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639144|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639145|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
20639146|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
20639147|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20639148|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20639149|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
20639150|NCT03418038|Hormones|hormones|mesh-ancestor
20639151|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639152|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639153|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
20639154|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639155|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639156|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20639157|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
20639158|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
20639159|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639160|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639161|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639162|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20639163|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20639164|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
20639165|NCT03418038|Protective Agents|protective agents|mesh-ancestor
20639166|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639167|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
20639168|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
20639169|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
20639170|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639171|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639172|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639173|NCT03412877|Aldesleukin|aldesleukin|mesh-list
20639174|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
20639175|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
20639176|NCT03412877|Fludarabine|fludarabine|mesh-list
20639177|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639178|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
20639179|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639180|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639181|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639182|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
20639183|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639184|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639185|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639186|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639187|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20639188|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20639189|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
20639190|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639191|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639192|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
20639193|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639194|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639195|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
20639196|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639197|NCT03396445|Paclitaxel|paclitaxel|mesh-list
20639198|NCT03396445|Carboplatin|carboplatin|mesh-list
20639199|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
20639200|NCT03396445|Pemetrexed|pemetrexed|mesh-list
20639201|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639202|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639203|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639204|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
19697060|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
19697061|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
19697062|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697063|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697064|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697065|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
19697066|NCT04933292|Hormones|hormones|mesh-ancestor
19697067|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697068|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19697069|NCT04933292|Protective Agents|protective agents|mesh-ancestor
19697070|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639205|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639206|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639207|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19850908|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850909|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476622|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476623|NCT01516814|Heparin|heparin|mesh-list
20476624|NCT01516814|Calcium heparin|calcium heparin|mesh-list
20476625|NCT01516814|Warfarin|warfarin|mesh-list
20476626|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
20476627|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
20639208|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639209|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20639210|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639211|NCT03395184|PF-06700841|pf-06700841|mesh-list
20639212|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20639213|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639214|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639215|NCT03391869|Nivolumab|nivolumab|mesh-list
19697071|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
19697072|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20639216|NCT03391869|Ipilimumab|ipilimumab|mesh-list
20639217|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639218|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639219|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20639220|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639221|NCT03388632|Nivolumab|nivolumab|mesh-list
20639222|NCT03388632|Ipilimumab|ipilimumab|mesh-list
20639223|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639224|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639225|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20639226|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639227|NCT03370510|Oxytocin|oxytocin|mesh-list
20639228|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
20639229|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20639230|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639231|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
20639232|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639233|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639234|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
20639235|NCT03366155|Irinotecan|irinotecan|mesh-list
20639236|NCT03366155|Cetuximab|cetuximab|mesh-list
20639237|NCT03366155|Panitumumab|panitumumab|mesh-list
20639238|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639239|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20639240|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20639241|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639242|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850910|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476628|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20476629|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20476630|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476631|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20476632|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
20476633|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20476634|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476635|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476636|NCT01516840|Heparin|heparin|mesh-list
20476637|NCT01516840|Calcium heparin|calcium heparin|mesh-list
20476638|NCT01516840|Warfarin|warfarin|mesh-list
20476639|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
19850911|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
20476640|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
20476641|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20476642|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19697073|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697074|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
19697075|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697076|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
19697077|NCT04933084|Narcotics|narcotics|mesh-ancestor
19697078|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697079|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697080|NCT04933084|Analgesics|analgesics|mesh-ancestor
19697081|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
19697082|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697083|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
19697084|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697085|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
19697086|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697087|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697088|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
19697089|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697090|NCT04933279|Iodine|iodine|mesh-list
19697091|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
20476643|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476644|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20476645|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
19697092|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19697093|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697094|NCT04933279|Trace Elements|trace elements|mesh-ancestor
19697095|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
19697096|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697097|NCT04932564|Leflunomide|leflunomide|mesh-list
20476646|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20639243|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639244|NCT03366142|Ustekinumab|ustekinumab|mesh-list
20639245|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
20639246|NCT03330405|Avelumab|avelumab|mesh-list
20639247|NCT03330405|Talazoparib|talazoparib|mesh-list
20639248|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639249|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639250|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639251|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
20639252|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639253|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20639254|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639255|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476647|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476648|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476649|NCT01516866|Listerine|listerine|mesh-list
20476650|NCT01516866|Fluorides|fluorides|mesh-list
20476651|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
20476652|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
20476653|NCT01516866|Protective Agents|protective agents|mesh-ancestor
20476654|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476655|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20639256|NCT03326245|Methylphenidate|methylphenidate|mesh-list
20639257|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20639258|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639259|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20639260|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20639261|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697098|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476656|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527565|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20527566|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527567|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527568|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
20527569|NCT01768780|Bupivacaine|bupivacaine|mesh-list
20527570|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20527571|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697099|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227221|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227222|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227223|NCT00349180|Enoxaparin|enoxaparin|mesh-list
20227224|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
20227225|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
20227226|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20227227|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20639262|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639263|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
20639264|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639265|NCT03312400|Danazol|danazol|mesh-list
20639266|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20639267|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
20639268|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639269|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639270|NCT03294460|Ethanol|ethanol|mesh-list
20639271|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20639272|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639273|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20639274|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639275|NCT03274492|Prednisone|prednisone|mesh-list
20639276|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
20639277|NCT03274492|Rituximab|rituximab|mesh-list
20639278|NCT03274492|Doxorubicin|doxorubicin|mesh-list
20639279|NCT03274492|Vincristine|vincristine|mesh-list
20639280|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639281|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
20639282|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639283|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
20639284|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639285|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639286|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639287|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
20639288|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639289|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639290|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639291|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639292|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639293|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19412499|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
19412500|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412501|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19412502|NCT05263284|Venetoclax|venetoclax|mesh-list
19412503|NCT05263284|Adenosine|adenosine|mesh-list
19412504|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412505|NCT05263284|Analgesics|analgesics|mesh-ancestor
19412506|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
19412507|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412508|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412509|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412510|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
19412511|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19412512|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
20639294|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20639295|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639296|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639297|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
20639298|NCT03274492|Hormones|hormones|mesh-ancestor
20639299|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639300|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639301|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639302|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639303|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639304|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639305|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
20639306|NCT03267277|Antidotes|antidotes|mesh-ancestor
20639307|NCT03267277|Protective Agents|protective agents|mesh-ancestor
20639308|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639309|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
20639310|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639311|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
20639312|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639313|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639314|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
20639315|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
20639316|NCT03258593|Durvalumab|durvalumab|mesh-list
20639317|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639318|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639319|NCT03258567|Nivolumab|nivolumab|mesh-list
19412513|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
19412514|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639320|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639321|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639322|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20639323|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639324|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
20639325|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639326|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639327|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
20639328|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639329|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639330|NCT03238196|Fulvestrant|fulvestrant|mesh-list
20639331|NCT03238196|Palbociclib|palbociclib|mesh-list
20639332|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639333|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639334|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20639335|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20639336|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
20639337|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639338|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639339|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20639340|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639341|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639342|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
20639343|NCT03233724|Decitabine|decitabine|mesh-list
20639344|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
20639345|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639346|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639347|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20639348|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
20639349|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639350|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639351|NCT03224104|Temozolomide|temozolomide|mesh-list
20639352|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639353|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
20639354|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639355|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639356|NCT03223610|Prednisone|prednisone|mesh-list
20639357|NCT03223610|Lenalidomide|lenalidomide|mesh-list
20639358|NCT03223610|Venetoclax|venetoclax|mesh-list
20639359|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
20639360|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639361|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
20639362|NCT03223610|Hormones|hormones|mesh-ancestor
20639363|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639364|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639365|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639366|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639367|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
20639368|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20639369|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20639370|NCT03223610|Growth Substances|growth substances|mesh-ancestor
20639371|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
20639372|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639373|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
20639374|NCT03221257|Pirfenidone|pirfenidone|mesh-list
20639375|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639376|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639377|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20639378|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
20639379|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639380|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639381|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639382|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639383|NCT03221257|Analgesics|analgesics|mesh-ancestor
20639384|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
20639385|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20639386|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639387|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20639388|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20639389|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639390|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639391|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20639392|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20639393|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639394|NCT03220022|Prednisone|prednisone|mesh-list
20639395|NCT03220022|Cortisone|cortisone|mesh-list
20639396|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
20639397|NCT03220022|Rituximab|rituximab|mesh-list
20639398|NCT03220022|Doxorubicin|doxorubicin|mesh-list
20639399|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20639400|NCT03220022|Etoposide|etoposide|mesh-list
20639401|NCT03220022|Vincristine|vincristine|mesh-list
20639402|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
20639403|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
20639404|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20639405|NCT03220022|Antibodies|antibodies|mesh-list
20639406|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
20639407|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639408|NCT03220022|Lenograstim|lenograstim|mesh-list
20639409|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639410|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
20639411|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639412|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639413|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639414|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
20639415|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639416|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639417|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639418|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639419|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20639420|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20639421|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639422|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639423|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
20639424|NCT03220022|Hormones|hormones|mesh-ancestor
20639425|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639426|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639427|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639428|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20639429|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639430|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639431|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639432|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
20639433|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
20639434|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20639435|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20639436|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639437|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
20639438|NCT03204188|Fludarabine|fludarabine|mesh-list
20639439|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639440|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639441|NCT03190954|Raclopride|raclopride|mesh-list
20639442|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20639443|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20639444|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20639445|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639446|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20639447|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20639448|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
20639449|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639450|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639451|NCT03190941|Aldesleukin|aldesleukin|mesh-list
20639452|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
20639453|NCT03190941|Fludarabine|fludarabine|mesh-list
20639454|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639455|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
20639456|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639457|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639458|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639459|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
20639460|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639461|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639462|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639463|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20639464|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20639465|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
20639466|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639467|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20639468|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20639469|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639470|NCT03177291|Pirfenidone|pirfenidone|mesh-list
20639471|NCT03177291|Paclitaxel|paclitaxel|mesh-list
20639472|NCT03177291|Carboplatin|carboplatin|mesh-list
20639473|NCT03177291|Pemetrexed|pemetrexed|mesh-list
20639474|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639475|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639476|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639477|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639478|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639479|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227228|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227229|NCT00349206|Sirolimus|sirolimus|mesh-list
20227230|NCT00349206|Sorafenib|sorafenib|mesh-list
20227231|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227232|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227233|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639480|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639481|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20639482|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639483|NCT03177291|Analgesics|analgesics|mesh-ancestor
20639484|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
20639485|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20639486|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639487|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20639488|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20639489|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639490|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639491|NCT03174275|Paclitaxel|paclitaxel|mesh-list
20639492|NCT03174275|Carboplatin|carboplatin|mesh-list
20639493|NCT03174275|Durvalumab|durvalumab|mesh-list
20639494|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639495|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639496|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639497|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639498|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639499|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639500|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639501|NCT03173950|Nivolumab|nivolumab|mesh-list
20639502|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639503|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639504|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20639505|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639506|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20639507|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20639508|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639509|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
20639510|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
20227234|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227235|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20227236|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227237|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20227238|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
20227239|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227240|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
20227241|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227242|NCT00349219|Gemcitabine|gemcitabine|mesh-list
20227243|NCT00349219|Cisplatin|cisplatin|mesh-list
20227244|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20227245|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227246|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20639511|NCT03173053|Clarithromycin|clarithromycin|mesh-list
20227247|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
20227248|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227249|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
20227250|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227251|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227252|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227253|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
20227254|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639512|NCT03173053|Doxycycline|doxycycline|mesh-list
20639513|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
20639514|NCT03173053|Rifampin|rifampin|mesh-list
20639515|NCT03173053|Clindamycin|clindamycin|mesh-list
20639516|NCT03173053|Trimethoprim|trimethoprim|mesh-list
20639517|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
20639518|NCT03173053|Mupirocin|mupirocin|mesh-list
20639519|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
20639520|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20639521|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20639522|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639523|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
20639524|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639525|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20639526|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639527|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639528|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20639529|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20639530|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
20639531|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20639532|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20639533|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20639534|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20639535|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639536|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20639537|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20639538|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
20639539|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
20639540|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639541|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20639542|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20639543|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20639544|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20639545|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20639546|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20639547|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20639548|NCT03173053|Renal Agents|renal agents|mesh-ancestor
20639549|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20639550|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20639551|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20639552|NCT03167437|Vorinostat|vorinostat|mesh-list
20639553|NCT03167437|Ustekinumab|ustekinumab|mesh-list
20639554|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639555|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19412515|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412516|NCT05262985|Durvalumab|durvalumab|mesh-list
19412517|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412518|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412519|NCT05262738|Misoprostol|misoprostol|mesh-list
19412520|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19412521|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
19412522|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19412523|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412524|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19412525|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19412526|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
19412527|NCT05262608|Olaparib|olaparib|mesh-list
19697100|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697101|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
19697102|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697103|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
19412528|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19412529|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412530|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697104|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19697105|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476657|NCT01516944|Capecitabine|capecitabine|mesh-list
20476658|NCT01516944|Tegafur|tegafur|mesh-list
20476659|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
20476660|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20476661|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
20476662|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476663|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476664|NCT01516996|Docetaxel|docetaxel|mesh-list
20476665|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
20476666|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476667|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
20476668|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
20476669|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476670|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639556|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639557|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639558|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20639559|NCT03141684|Bevacizumab|bevacizumab|mesh-list
20639560|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20639561|NCT03141684|Atezolizumab|atezolizumab|mesh-list
20639562|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
20639563|NCT03141684|Antibodies|antibodies|mesh-list
20639564|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
20639565|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639566|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
20639567|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639568|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20639569|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20639570|NCT03141684|Growth Substances|growth substances|mesh-ancestor
20639571|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639572|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
20639573|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
20639574|NCT03109288|Pioglitazone|pioglitazone|mesh-list
20639575|NCT03109288|Clemastine|clemastine|mesh-list
20639576|NCT03109288|Pirfenidone|pirfenidone|mesh-list
20639577|NCT03109288|Dantrolene|dantrolene|mesh-list
20639578|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20639579|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639580|NCT03109288|Analgesics|analgesics|mesh-ancestor
20639581|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
20639582|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20639583|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20639584|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20639585|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639586|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639587|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639588|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
20639589|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
20639590|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20639591|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
20639592|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
20639593|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639594|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639595|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20639596|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20639597|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20639598|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639599|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
20639600|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697106|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697107|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476671|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639601|NCT03101475|Durvalumab|durvalumab|mesh-list
20639602|NCT03101475|Tremelimumab|tremelimumab|mesh-list
20639603|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639604|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639605|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
20639606|NCT03092518|Mitomycins|mitomycins|mesh-list
20639607|NCT03092518|Mitomycin|mitomycin|mesh-list
20639608|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639609|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639610|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
20639611|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697108|NCT04932746|Analgesics|analgesics|mesh-ancestor
20476672|NCT01517009|Docetaxel|docetaxel|mesh-list
20476673|NCT01517009|Capecitabine|capecitabine|mesh-list
20476674|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476675|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
20476676|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
20476677|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476678|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476679|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20476680|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
20476681|NCT01517022|Nicotine|nicotine|mesh-list
20476682|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20476683|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
20476684|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476685|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639612|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639613|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639614|NCT03092518|Antidotes|antidotes|mesh-ancestor
20639615|NCT03092518|Protective Agents|protective agents|mesh-ancestor
20639616|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639617|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
20639618|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
20639619|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639620|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639621|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
20639622|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
20639623|NCT03077542|Sirolimus|sirolimus|mesh-list
20639624|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
20639625|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
20639626|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
20639627|NCT03077542|Pentostatin|pentostatin|mesh-list
20639628|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639629|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
20639630|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639631|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639632|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639633|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
20639634|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639635|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639636|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639637|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639638|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639639|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639640|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
20639641|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639642|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
20639643|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639644|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639645|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20639646|NCT03076554|Avelumab|avelumab|mesh-list
20639647|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639648|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639649|NCT03065335|Ketamine|ketamine|mesh-list
20639650|NCT03065335|Analgesics|analgesics|mesh-ancestor
20639651|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
20639652|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20639653|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639654|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20639655|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20639656|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
20639657|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
20639658|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20639659|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20639660|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20639661|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639662|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639663|NCT03052608|Crizotinib|crizotinib|mesh-list
20639664|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639665|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20639666|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639667|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639668|NCT03049462|Ascorbic Acid|ascorbic acid|mesh-list
20639669|NCT03049462|Mirabegron|mirabegron|mesh-list
20639670|NCT03049462|Vitamins|vitamins|mesh-ancestor
20639671|NCT03049462|Micronutrients|micronutrients|mesh-ancestor
20639672|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476686|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20476687|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20476688|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
20476689|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476690|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476691|NCT01517165|Pioglitazone|pioglitazone|mesh-list
20476692|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476693|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476694|NCT01517308|Interferons|interferons|mesh-list
20476695|NCT01517308|Ribavirin|ribavirin|mesh-list
20476696|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
20476697|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
20476698|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20476699|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476700|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
20476701|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476702|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
20476703|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639673|NCT03049462|Antioxidants|antioxidants|mesh-ancestor
20639674|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639675|NCT03049462|Protective Agents|protective agents|mesh-ancestor
20639676|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20639677|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20639678|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20639679|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
20639680|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639681|NCT03049462|Urological Agents|urological agents|mesh-ancestor
20639682|NCT03027388|LB100|lb100|mesh-list
20639683|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639684|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639685|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639686|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
20639687|NCT03018288|Temozolomide|temozolomide|mesh-list
20639688|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639689|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639690|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639691|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
20639692|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639693|NCT03018080|Paclitaxel|paclitaxel|mesh-list
20639694|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
20639695|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639696|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639697|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639698|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639699|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639700|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639701|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639702|NCT03015610|Lansoprazole|lansoprazole|mesh-list
20639703|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
20639704|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20639705|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20639706|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20639707|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639708|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639709|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20639710|NCT03008278|Olaparib|olaparib|mesh-list
20639711|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20639712|NCT03008278|Ramucirumab|ramucirumab|mesh-list
20639713|NCT03008278|Antibodies|antibodies|mesh-list
20639714|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
20639715|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639716|NCT03008278|Lexatumumab|lexatumumab|mesh-list
20639717|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
20639718|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639719|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639720|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639721|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639722|NCT03003962|Gemcitabine|gemcitabine|mesh-list
20639723|NCT03003962|Paclitaxel|paclitaxel|mesh-list
20639724|NCT03003962|Cisplatin|cisplatin|mesh-list
20639725|NCT03003962|Carboplatin|carboplatin|mesh-list
20639726|NCT03003962|Pemetrexed|pemetrexed|mesh-list
20639727|NCT03003962|Durvalumab|durvalumab|mesh-list
20639728|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639729|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639730|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639731|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639732|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639733|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639734|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20639735|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
20639736|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
20639737|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639738|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639739|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639740|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
20639741|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639742|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19697109|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
19697110|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697111|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19697112|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20639743|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639744|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639745|NCT02997228|Leucovorin|leucovorin|mesh-list
20639746|NCT02997228|Bevacizumab|bevacizumab|mesh-list
20639747|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20639748|NCT02997228|Fluorouracil|fluorouracil|mesh-list
20639749|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
20639750|NCT02997228|Atezolizumab|atezolizumab|mesh-list
20639751|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
20639752|NCT02997228|Antibodies|antibodies|mesh-list
20639753|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
20639754|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20639755|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
20639756|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639757|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20639758|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20639759|NCT02997228|Growth Substances|growth substances|mesh-ancestor
20639760|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639761|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
20639762|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
20639763|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
20639764|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639765|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20639766|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639767|NCT02997228|Antidotes|antidotes|mesh-ancestor
20639768|NCT02997228|Protective Agents|protective agents|mesh-ancestor
20639769|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
20639770|NCT02997228|Vitamins|vitamins|mesh-ancestor
20639771|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
20639772|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
20639773|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
20639774|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20639775|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20639776|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639777|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639778|NCT02983461|Urological Agents|urological agents|mesh-ancestor
20639779|NCT02979873|Sirolimus|sirolimus|mesh-list
20639780|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639781|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639782|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639783|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639784|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
20639785|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639786|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
20476704|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
20476705|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476706|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20476707|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476708|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639787|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639788|NCT02977494|Dexamethasone|dexamethasone|mesh-list
20639789|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
20639790|NCT02977494|Bortezomib|bortezomib|mesh-list
20639791|NCT02977494|Daratumumab|daratumumab|mesh-list
20639792|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639793|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
20639794|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
20639795|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20639796|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639797|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20639798|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
20639799|NCT02977494|Hormones|hormones|mesh-ancestor
20639800|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639801|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639802|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639803|NCT02968212|Clofazimine|clofazimine|mesh-list
20639804|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476709|NCT01517321|Incretins|incretins|mesh-ancestor
20476710|NCT01517321|Hormones|hormones|mesh-ancestor
20476711|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476712|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20476713|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
20639805|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
20639806|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639807|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639808|NCT02960659|Metformin|metformin|mesh-list
20639809|NCT02960659|Liraglutide|liraglutide|mesh-list
20639810|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20639811|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639812|NCT02960659|Incretins|incretins|mesh-ancestor
20639813|NCT02960659|Hormones|hormones|mesh-ancestor
20639814|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639815|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
20639816|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639817|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639818|NCT02948660|Zolpidem|zolpidem|mesh-list
20639819|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20639820|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20639821|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20639822|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639823|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20639824|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
20639825|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
20639826|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639827|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639828|NCT02946788|Minocycline|minocycline|mesh-list
20639829|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639830|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639831|NCT02944071|Paclitaxel|paclitaxel|mesh-list
20639832|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639833|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639834|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639835|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639836|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639837|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639838|NCT02935309|Capecitabine|capecitabine|mesh-list
20639839|NCT02935309|Lenvatinib|lenvatinib|mesh-list
20639840|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20639841|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
20639842|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639843|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639844|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20639845|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639846|NCT02933255|Nivolumab|nivolumab|mesh-list
20639847|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639848|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639849|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20639850|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639851|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
20639852|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20639853|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
20639854|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20639855|NCT02921893|Dexamethasone|dexamethasone|mesh-list
20639856|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
20639857|NCT02921893|Lenalidomide|lenalidomide|mesh-list
20639858|NCT02921893|Ixazomib|ixazomib|mesh-list
20639859|NCT02921893|Ichthammol|ichthammol|mesh-list
20639860|NCT02921893|BB 1101|bb 1101|mesh-list
20639861|NCT02921893|Glycine|glycine|mesh-list
20639862|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639863|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
20639864|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
20639865|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20639866|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639867|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20227255|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227256|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
20227257|NCT00349245|Remifentanil|remifentanil|mesh-list
20227258|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20227259|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20639868|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
20639869|NCT02921893|Hormones|hormones|mesh-ancestor
20639870|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639871|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639872|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639873|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
20639874|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639875|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639876|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
20639877|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20639878|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20227260|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639879|NCT02921893|Growth Substances|growth substances|mesh-ancestor
20639880|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
20639881|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
20639882|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
20639883|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20639884|NCT02911142|Prednisone|prednisone|mesh-list
20639885|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
20639886|NCT02911142|Rituximab|rituximab|mesh-list
20639887|NCT02911142|Doxorubicin|doxorubicin|mesh-list
20639888|NCT02911142|Vincristine|vincristine|mesh-list
20639889|NCT02911142|Lenalidomide|lenalidomide|mesh-list
20639890|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639891|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
20639892|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639893|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639894|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639895|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
20639896|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639897|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639898|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639899|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20639900|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639901|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20639902|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20639903|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639904|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20639905|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
20639906|NCT02911142|Hormones|hormones|mesh-ancestor
20639907|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20639908|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20639909|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20639910|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
20639911|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
20639912|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
20639913|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20639914|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20639915|NCT02911142|Growth Substances|growth substances|mesh-ancestor
20639916|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
20639917|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
20639918|NCT02900443|Azathioprine|azathioprine|mesh-list
20639919|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639920|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639921|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20639922|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
20639923|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639924|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639925|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639926|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639927|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
20639928|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20476714|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476715|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639929|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639930|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
20639931|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639932|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412531|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412532|NCT05262556|Nivolumab|nivolumab|mesh-list
20476716|NCT01517334|Minocycline|minocycline|mesh-list
20476717|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476718|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476719|NCT01517347|Interleukin-2|interleukin-2|mesh-list
20476720|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476721|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476722|NCT01517347|Analgesics|analgesics|mesh-ancestor
20476723|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
20476724|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476725|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476726|NCT01517360|Oxytocin|oxytocin|mesh-list
20476727|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
20476728|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20476729|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476730|NCT01517399|Vitamin K|vitamin k|mesh-list
20476731|NCT01517399|Digoxin|digoxin|mesh-list
20476732|NCT01517399|Midazolam|midazolam|mesh-list
19412533|NCT05262556|Ipilimumab|ipilimumab|mesh-list
19697113|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20476733|NCT01517399|Caffeine|caffeine|mesh-list
20476734|NCT01517399|Omeprazole|omeprazole|mesh-list
20476735|NCT01517399|Warfarin|warfarin|mesh-list
20639933|NCT02858310|Aldesleukin|aldesleukin|mesh-list
20639934|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
20639935|NCT02858310|Fludarabine|fludarabine|mesh-list
20639936|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639937|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
20639938|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639939|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639940|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639941|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
20639942|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639943|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639944|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639945|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20639946|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20639947|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
20639948|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639949|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
20639950|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639951|NCT02830724|Aldesleukin|aldesleukin|mesh-list
20639952|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
20639953|NCT02830724|Fludarabine|fludarabine|mesh-list
20639954|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20639955|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
20639956|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20639957|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20639958|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20639959|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
20639960|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639961|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639962|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20639963|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20639964|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20639965|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
20639966|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639967|NCT02821832|Rifampin|rifampin|mesh-list
20639968|NCT02821832|Isoniazid|isoniazid|mesh-list
20639969|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
20639970|NCT02821832|Ethambutol|ethambutol|mesh-list
20639971|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20639972|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
20639973|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20639974|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20639975|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
20639976|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639977|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639978|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639979|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20639980|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20639981|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20639982|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20639983|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20639984|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20639985|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20639986|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20639987|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
20639988|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20639989|NCT02805257|Mitomycins|mitomycins|mesh-list
20639990|NCT02805257|Mitomycin|mitomycin|mesh-list
20639991|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20639992|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20639993|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
20639994|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20639995|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20639996|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20639997|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
20639998|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20639999|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20640000|NCT02798523|Prednisolone|prednisolone|mesh-list
20640001|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
20640002|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
20640003|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20640004|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
20640005|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640006|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
20640007|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
20640008|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640009|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640010|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640011|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
20640012|NCT02798523|Hormones|hormones|mesh-ancestor
20640013|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640014|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20640015|NCT02798523|Protective Agents|protective agents|mesh-ancestor
20640016|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640017|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640018|NCT02784210|Prednisone|prednisone|mesh-list
20640019|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
20640020|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20640021|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20640022|NCT02784210|Prednisolone|prednisolone|mesh-list
20640023|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
20640024|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20640025|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
20640026|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640027|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
20640028|NCT02784210|Hormones|hormones|mesh-ancestor
20640029|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640030|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640031|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640032|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640033|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
20640034|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
20640035|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640036|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640037|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20640038|NCT02784210|Protective Agents|protective agents|mesh-ancestor
20640039|NCT02780609|Dexamethasone|dexamethasone|mesh-list
20640040|NCT02780609|Melphalan|melphalan|mesh-list
20640041|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
20640042|NCT02780609|Aprepitant|aprepitant|mesh-list
20640043|NCT02780609|Antiemetics|antiemetics|mesh-list
20640044|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640045|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
20640046|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640047|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640048|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640049|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
20640050|NCT02780609|Hormones|hormones|mesh-ancestor
20640051|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640052|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640053|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640054|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640055|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
20640056|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640057|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640058|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640059|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
20640060|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20640061|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640062|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
20640063|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20640064|NCT02774239|Antibodies|antibodies|mesh-list
20640065|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
20640066|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
20640067|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640068|NCT02769962|Olaparib|olaparib|mesh-list
20640069|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20640070|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640071|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640072|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640073|NCT02759835|Osimertinib|osimertinib|mesh-list
20640074|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640075|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640076|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640077|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640078|NCT02707042|Amoxicillin|amoxicillin|mesh-list
20640079|NCT02707042|Azithromycin|azithromycin|mesh-list
20640080|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640081|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640082|NCT02659930|Doxorubicin|doxorubicin|mesh-list
20640083|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20640084|NCT02659930|Pomalidomide|pomalidomide|mesh-list
20640085|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20640086|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640087|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20640088|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20640089|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640090|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640091|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
20640092|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640093|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640094|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640095|NCT02659930|Growth Substances|growth substances|mesh-ancestor
20640096|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640097|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
20640098|NCT02650986|Decitabine|decitabine|mesh-list
20640099|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640100|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
20640101|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640102|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640103|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640104|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
20640105|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640106|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640107|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640108|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640109|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
20640110|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640111|NCT02639273|Nalmefene|nalmefene|mesh-list
20640112|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20640113|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640114|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
20640115|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640116|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20640117|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
20640118|NCT02636387|Coagulants|coagulants|mesh-ancestor
20640119|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20640120|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
20640121|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640122|NCT02621021|Aldesleukin|aldesleukin|mesh-list
20640123|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
20640124|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
20640125|NCT02621021|Fludarabine|fludarabine|mesh-list
20640126|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640127|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
20640128|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640129|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640130|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640131|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
20640132|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640133|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640134|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640135|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640136|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640137|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640138|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
20640139|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640140|NCT02595944|Nivolumab|nivolumab|mesh-list
20640141|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640142|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640143|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20640144|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640145|NCT02576574|Gemcitabine|gemcitabine|mesh-list
20640146|NCT02576574|Paclitaxel|paclitaxel|mesh-list
20640147|NCT02576574|Carboplatin|carboplatin|mesh-list
20640148|NCT02576574|Pemetrexed|pemetrexed|mesh-list
20640149|NCT02576574|Avelumab|avelumab|mesh-list
20640150|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20640151|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640152|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640153|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
20640154|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
20640155|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
20640156|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640157|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640158|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
20640159|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
20640160|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640161|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640162|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640163|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
20640164|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640165|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20640166|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20640167|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640168|NCT02567435|Sirolimus|sirolimus|mesh-list
20640169|NCT02567435|Dactinomycin|dactinomycin|mesh-list
20640170|NCT02567435|Cactinomycin|cactinomycin|mesh-list
20640171|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
20640172|NCT02567435|Irinotecan|irinotecan|mesh-list
19412534|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412535|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412536|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19412537|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412538|NCT05262465|Azacitidine|azacitidine|mesh-list
19412539|NCT05262465|Venetoclax|venetoclax|mesh-list
19412540|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412541|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
19412542|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640173|NCT02567435|Vincristine|vincristine|mesh-list
20640174|NCT02567435|Vinorelbine|vinorelbine|mesh-list
20640175|NCT02567435|Camptothecin|camptothecin|mesh-list
20640176|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640177|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
19412543|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412544|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412545|NCT05262452|Folfirinox|folfirinox|mesh-list
19412546|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412547|NCT05262413|Lenvatinib|lenvatinib|mesh-list
19412548|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412549|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19412550|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412551|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412552|NCT05262335|Paclitaxel|paclitaxel|mesh-list
19412553|NCT05262335|Docetaxel|docetaxel|mesh-list
19412554|NCT05262335|Capecitabine|capecitabine|mesh-list
19697114|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697115|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640178|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640179|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640180|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640181|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
20640182|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640183|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640184|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640185|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20640186|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20640187|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640188|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640189|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
20640190|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
20640191|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
20640192|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640193|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640194|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20640195|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
20640196|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20640197|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20640198|NCT02564978|Minocycline|minocycline|mesh-list
20640199|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640200|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640201|NCT02543983|Ketamine|ketamine|mesh-list
20640202|NCT02543983|Analgesics|analgesics|mesh-ancestor
20640203|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
19697116|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707896|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707897|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19707898|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19707899|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
19707900|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
20640204|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640205|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412555|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
19412556|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640206|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20640207|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20640208|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
20640209|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
20640210|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20640211|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20640212|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20640213|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640214|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640215|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20640216|NCT02511028|Hematinics|hematinics|mesh-ancestor
20640217|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20640218|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20640219|NCT02484404|Durvalumab|durvalumab|mesh-list
20640220|NCT02484404|Olaparib|olaparib|mesh-list
20640221|NCT02484404|Cediranib|cediranib|mesh-list
20640222|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640223|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640224|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20640225|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640226|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640227|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640228|NCT02478320|Ilorasertib|ilorasertib|mesh-list
20640229|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640230|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640231|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697117|NCT04932434|Psilocybin|psilocybin|mesh-list
19697118|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19697119|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
19697120|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697121|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19697122|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19697123|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
19697124|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697125|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412557|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412558|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
19412559|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
19412560|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
19412561|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697126|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19697127|NCT04932135|Hormones|hormones|mesh-list
19697128|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697129|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850912|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640232|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640233|NCT02466971|Cisplatin|cisplatin|mesh-list
20640234|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640235|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20640236|NCT02465060|Nivolumab|nivolumab|mesh-list
20640237|NCT02465060|Trastuzumab|trastuzumab|mesh-list
20640238|NCT02465060|Pertuzumab|pertuzumab|mesh-list
20640239|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20640240|NCT02465060|Sunitinib|sunitinib|mesh-list
20640241|NCT02465060|Dasatinib|dasatinib|mesh-list
20640242|NCT02465060|Palbociclib|palbociclib|mesh-list
20640243|NCT02465060|Trametinib|trametinib|mesh-list
20640244|NCT02465060|Osimertinib|osimertinib|mesh-list
20640245|NCT02465060|Afatinib|afatinib|mesh-list
19697130|NCT04932096|Melatonin|melatonin|mesh-list
19697131|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
19697132|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640246|NCT02465060|Dabrafenib|dabrafenib|mesh-list
20640247|NCT02465060|Crizotinib|crizotinib|mesh-list
20640248|NCT02465060|Maytansine|maytansine|mesh-list
20640249|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20640250|NCT02465060|GSK2636771|gsk2636771|mesh-list
20640251|NCT02465060|Antibodies|antibodies|mesh-list
20640252|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
20640253|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19412562|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412563|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
20227261|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20640254|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
20640255|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
20227262|NCT00349245|Analgesics|analgesics|mesh-ancestor
20640256|NCT02465060|Adavosertib|adavosertib|mesh-list
20640257|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
20640258|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640259|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640260|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20640261|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640262|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640263|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640264|NCT02465060|Growth Substances|growth substances|mesh-ancestor
20640265|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640266|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640267|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640268|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640269|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
20640270|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
20640271|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
20640272|NCT02451423|Atezolizumab|atezolizumab|mesh-list
20640273|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640274|NCT02437110|Ritonavir|ritonavir|mesh-list
20640275|NCT02437110|Darunavir|darunavir|mesh-list
20640276|NCT02437110|Tenofovir|tenofovir|mesh-list
20640277|NCT02437110|Dolutegravir|dolutegravir|mesh-list
20640278|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20640279|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20640280|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
20640281|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640282|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640283|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640284|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640285|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
20640286|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640287|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20640288|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20640289|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20640290|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20640291|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20640292|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20640293|NCT02432547|Aflibercept|aflibercept|mesh-list
20640294|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640295|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640296|NCT02432547|Growth Substances|growth substances|mesh-ancestor
20640297|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640298|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640299|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640300|NCT02404870|Canagliflozin|canagliflozin|mesh-list
20640301|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20640302|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640303|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20640304|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640305|NCT02379416|Paclitaxel|paclitaxel|mesh-list
20640306|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640307|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640308|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
20640309|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
20640310|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
20640311|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640312|NCT02367456|Azacitidine|azacitidine|mesh-list
20640313|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640314|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
20640315|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640316|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640317|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640318|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20640319|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20640320|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640321|NCT02363335|Incretins|incretins|mesh-ancestor
20640322|NCT02363335|Hormones|hormones|mesh-ancestor
20640323|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640324|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20640325|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
20640326|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640327|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640328|NCT02356159|Rituximab|rituximab|mesh-list
20640329|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640330|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640331|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
20640332|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640333|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640334|NCT02319837|Leuprolide|leuprolide|mesh-list
20640335|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20640336|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
20640337|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20640338|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640339|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640340|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640341|NCT02279654|Lenalidomide|lenalidomide|mesh-list
20640342|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
20640343|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640344|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640345|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640346|NCT02279654|Growth Substances|growth substances|mesh-ancestor
20640347|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640348|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640349|NCT02260102|Temocillin|temocillin|mesh-list
20640350|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640351|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640352|NCT02233829|Dopamine|dopamine|mesh-list
20640353|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20640354|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
20640355|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
20640356|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640357|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640358|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
20640359|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640360|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640361|NCT02233829|Protective Agents|protective agents|mesh-ancestor
20640362|NCT02211755|Bortezomib|bortezomib|mesh-list
20640363|NCT02211755|Clofarabine|clofarabine|mesh-list
20640364|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640365|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640366|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
20640367|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640368|NCT02203526|Cytarabine|cytarabine|mesh-list
20640369|NCT02203526|Isavuconazole|isavuconazole|mesh-list
20640370|NCT02203526|Rituximab|rituximab|mesh-list
20640371|NCT02203526|Methotrexate|methotrexate|mesh-list
20640372|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640373|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640374|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
20640375|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640376|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640377|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20640378|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
20640379|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20640380|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640381|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
20640382|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640383|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
20640384|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640385|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20640386|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640387|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20640388|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
20640389|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640390|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
20640391|NCT02196181|Trametinib|trametinib|mesh-list
20640392|NCT02196181|Dabrafenib|dabrafenib|mesh-list
20640393|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20640394|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640395|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640396|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640397|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640398|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20640399|NCT02196181|Protective Agents|protective agents|mesh-ancestor
20640400|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640401|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20640402|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
19697133|NCT04932096|Protective Agents|protective agents|mesh-ancestor
20640403|NCT02194738|Gemcitabine|gemcitabine|mesh-list
20640404|NCT02194738|Paclitaxel|paclitaxel|mesh-list
20640405|NCT02194738|Cisplatin|cisplatin|mesh-list
20640406|NCT02194738|Carboplatin|carboplatin|mesh-list
20640407|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
20640408|NCT02194738|Nivolumab|nivolumab|mesh-list
20640409|NCT02194738|Pemetrexed|pemetrexed|mesh-list
20640410|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20640411|NCT02194738|Crizotinib|crizotinib|mesh-list
20640412|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640413|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640414|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
20640415|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
20640416|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
20640417|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640418|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640419|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
20640420|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
20640421|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640422|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640423|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640424|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
20640425|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640426|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640427|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20640428|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20640429|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20640430|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640431|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20640432|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20640433|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640434|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20640435|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640436|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640437|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640438|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640439|NCT02169310|Raclopride|raclopride|mesh-list
20640440|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20640441|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20640442|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20640443|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640444|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20640445|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20640446|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
20640447|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640448|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640449|NCT02143401|Sorafenib|sorafenib|mesh-list
20640450|NCT02143401|Navitoclax|navitoclax|mesh-list
20640451|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640452|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640453|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640454|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640455|NCT02133196|Aldesleukin|aldesleukin|mesh-list
20640456|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
20640457|NCT02133196|Fludarabine|fludarabine|mesh-list
20640458|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640459|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
20640460|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640461|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640462|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640463|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
20640464|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640465|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640466|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640467|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640468|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640469|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
20640470|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640471|NCT02107976|Ascorbic Acid|ascorbic acid|mesh-list
20640472|NCT02107976|Vitamins|vitamins|mesh-ancestor
20640473|NCT02107976|Micronutrients|micronutrients|mesh-ancestor
20640474|NCT02107976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640475|NCT02107976|Antioxidants|antioxidants|mesh-ancestor
20640476|NCT02107976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640477|NCT02107976|Protective Agents|protective agents|mesh-ancestor
20640478|NCT02105766|Sirolimus|sirolimus|mesh-list
20640479|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
20640480|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
20640481|NCT02105766|Pentostatin|pentostatin|mesh-list
20640482|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640483|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
20640484|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640485|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640486|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640487|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
20640488|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640489|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640490|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640491|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640492|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640493|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20640494|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
20640495|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640496|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20640497|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640498|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
20640499|NCT02101853|Leucovorin|leucovorin|mesh-list
20640500|NCT02101853|Folic Acid|folic acid|mesh-list
20640501|NCT02101853|Cytarabine|cytarabine|mesh-list
20640502|NCT02101853|Dexamethasone|dexamethasone|mesh-list
20640503|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
20640504|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
20640505|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20640506|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20640507|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20640508|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
20640509|NCT02101853|Methotrexate|methotrexate|mesh-list
20640510|NCT02101853|Etoposide|etoposide|mesh-list
20640511|NCT02101853|Vincristine|vincristine|mesh-list
20640512|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
20640513|NCT02101853|Asparaginase|asparaginase|mesh-list
20640514|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
20640515|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
20640516|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
20640517|NCT02101853|Pegaspargase|pegaspargase|mesh-list
20640518|NCT02101853|Thioguanine|thioguanine|mesh-list
20640519|NCT02101853|Blinatumomab|blinatumomab|mesh-list
20640520|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20640521|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
20640522|NCT02101853|Antibodies|antibodies|mesh-list
20640523|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
20640524|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20640525|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20640526|NCT02101853|BB 1101|bb 1101|mesh-list
20640527|NCT02101853|Calcium|calcium|mesh-list
20640528|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
20640529|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
20640530|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640531|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
20640532|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640533|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640534|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640535|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
20640536|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640537|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640538|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640539|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640540|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
20640541|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
20640542|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640543|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640544|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
20640545|NCT02101853|Hormones|hormones|mesh-ancestor
20640546|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640547|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640548|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
20640549|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640550|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20640551|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20640552|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20640553|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
20640554|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20640555|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640556|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
20640557|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
20640558|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20640559|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20640560|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640561|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20640562|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20640563|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
20640564|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640565|NCT02101853|Antidotes|antidotes|mesh-ancestor
20640566|NCT02101853|Protective Agents|protective agents|mesh-ancestor
20640567|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
20640568|NCT02101853|Vitamins|vitamins|mesh-ancestor
20640569|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
20640570|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
20640571|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
20640572|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
20640573|NCT02101853|Hematinics|hematinics|mesh-ancestor
20640574|NCT02101853|Analgesics|analgesics|mesh-ancestor
20640575|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
20640576|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
20640577|NCT02065596|Vidarabine|vidarabine|mesh-list
20640578|NCT02065596|Fludarabine|fludarabine|mesh-list
20640579|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
20640580|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640581|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640582|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
20640583|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640584|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640585|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
20640586|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640587|NCT02065596|Antiviral Agents|antiviral agents|mesh-ancestor
20640588|NCT02065596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640589|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20640590|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
20640591|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640592|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640593|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640594|NCT02015013|Plerixafor|plerixafor|mesh-list
20640595|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640596|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640597|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
20640598|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640599|NCT01993719|Aldesleukin|aldesleukin|mesh-list
20640600|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
20640601|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
20640602|NCT01993719|Fludarabine|fludarabine|mesh-list
20640603|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640604|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
20640605|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640606|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640607|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640608|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
20640609|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640610|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640611|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640612|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640613|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640614|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640615|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
20640616|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640617|NCT01950520|Topiramate|topiramate|mesh-list
20640618|NCT01950520|Phentermine|phentermine|mesh-list
20640619|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
20640620|NCT01950520|Propranolol|propranolol|mesh-list
20640621|NCT01950520|Pindolol|pindolol|mesh-list
20640622|NCT01950520|Naltrexone|naltrexone|mesh-list
20640623|NCT01950520|Caffeine|caffeine|mesh-list
20640624|NCT01950520|Dantrolene|dantrolene|mesh-list
20640625|NCT01950520|Mirabegron|mirabegron|mesh-list
20640626|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20640627|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20640628|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640629|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
20640630|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640631|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20640632|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20640633|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640634|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640635|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20640636|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20640637|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
20640638|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640639|NCT01950520|Analgesics|analgesics|mesh-ancestor
20640640|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
19850913|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
19850914|NCT00715117|Naltrexone|naltrexone|mesh-list
19850915|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19850916|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19850917|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850918|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
19850919|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850920|NCT00715208|Prednisone|prednisone|mesh-list
19850921|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
19850922|NCT00715208|Rituximab|rituximab|mesh-list
19850923|NCT00715208|Doxorubicin|doxorubicin|mesh-list
20227263|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
20227264|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227265|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20227266|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20227267|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20227268|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
20227269|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227270|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476736|NCT01517399|Vitamins|vitamins|mesh-ancestor
20476737|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
20476738|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476739|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20476740|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20476741|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476742|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20476743|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20476744|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20476745|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20476746|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
20476747|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
20476748|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
20476749|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
20476750|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476751|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476752|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
20476753|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20476754|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20476755|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20476756|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476757|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20476758|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20476759|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20476760|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20476761|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
20476762|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20476763|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20476764|NCT01517399|Protective Agents|protective agents|mesh-ancestor
20476765|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20476766|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20476767|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
20476768|NCT01517399|Coagulants|coagulants|mesh-ancestor
20476769|NCT01517490|Insulin|insulin|mesh-list
20476770|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20476771|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476772|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476773|NCT01517555|Acetaminophen|acetaminophen|mesh-list
20476774|NCT01517555|Liraglutide|liraglutide|mesh-list
20476775|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476776|NCT01517555|Analgesics|analgesics|mesh-ancestor
20476777|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
20476778|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476779|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476780|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
20476781|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476782|NCT01517555|Incretins|incretins|mesh-ancestor
20476783|NCT01517555|Hormones|hormones|mesh-ancestor
20476784|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476785|NCT01517568|Liraglutide|liraglutide|mesh-list
20476786|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476787|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476788|NCT01517568|Incretins|incretins|mesh-ancestor
20476789|NCT01517568|Hormones|hormones|mesh-ancestor
20476790|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476791|NCT01517607|Mesalamine|mesalamine|mesh-list
20476792|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20640641|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20640642|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20640643|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
20640644|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20640645|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20640646|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20640647|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
20640648|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20640649|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20640650|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20640651|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
20640652|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20640653|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
20640654|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20640655|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20640656|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20640657|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20640658|NCT01950520|Urological Agents|urological agents|mesh-ancestor
20640659|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
20640660|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20640661|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
20640662|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
20640663|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20640664|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
20640665|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20640666|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20640667|NCT01946477|Dexamethasone|dexamethasone|mesh-list
20640668|NCT01946477|Daratumumab|daratumumab|mesh-list
20640669|NCT01946477|Pomalidomide|pomalidomide|mesh-list
20640670|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640671|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
20640672|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
20640673|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640674|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640675|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640676|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
20640677|NCT01946477|Hormones|hormones|mesh-ancestor
20640678|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640679|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640680|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640681|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
20640682|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640683|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640684|NCT01946477|Growth Substances|growth substances|mesh-ancestor
20640685|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640686|NCT01887522|Vinblastine|vinblastine|mesh-list
20640687|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20640688|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640689|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
20640690|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
20640691|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
20640692|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640693|NCT01867333|Metronidazole|metronidazole|mesh-list
20640694|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640695|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640696|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20640697|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20640698|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
20640699|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640700|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640701|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
20640702|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640703|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20640704|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20640705|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640706|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640707|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
20640708|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
20640709|NCT01861106|Busulfan|busulfan|mesh-list
20640710|NCT01861106|Fludarabine|fludarabine|mesh-list
20640711|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
20640712|NCT01861106|Tacrolimus|tacrolimus|mesh-list
20640713|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20640714|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640715|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
20640716|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640717|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640718|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640719|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
20640720|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640721|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640722|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640723|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640724|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
20640725|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20640726|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640727|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20640728|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20640729|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
20640730|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640731|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640732|NCT01842399|Resveratrol|resveratrol|mesh-list
20640733|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
20476793|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476794|NCT01517607|Analgesics|analgesics|mesh-ancestor
20476795|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
20476796|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476797|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476798|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476799|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476800|NCT01517711|Tramadol|tramadol|mesh-list
20476801|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20640734|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640735|NCT01842399|Protective Agents|protective agents|mesh-ancestor
20640736|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640737|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640738|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20640739|NCT01842386|Rituximab|rituximab|mesh-list
20640740|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640741|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640742|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
20640743|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640744|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640745|NCT01823198|Aldesleukin|aldesleukin|mesh-list
20640746|NCT01823198|Fludarabine|fludarabine|mesh-list
20640747|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
20640748|NCT01823198|Busulfan|busulfan|mesh-list
20640749|NCT01823198|Interleukin-2|interleukin-2|mesh-list
20640750|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640751|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640752|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
20640753|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640754|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640755|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
20640756|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640757|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
20640758|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640759|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640760|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20640761|NCT01823198|Analgesics|analgesics|mesh-ancestor
20640762|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
20640763|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476802|NCT01517711|Narcotics|narcotics|mesh-ancestor
20476803|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476804|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476805|NCT01517711|Analgesics|analgesics|mesh-ancestor
19850924|NCT00715208|Bortezomib|bortezomib|mesh-list
19850925|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19850926|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
19850927|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850928|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19850929|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20476806|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
20640764|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640765|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640766|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
19850930|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
20476807|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850931|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850932|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850933|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19850934|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640767|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640768|NCT01799538|Albuterol|albuterol|mesh-list
20640769|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20640770|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
20640771|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640772|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640773|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20640774|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
20640775|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
20640776|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20640777|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20640778|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20640779|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20640780|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
20640781|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640782|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640783|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
20640784|NCT01757418|Antibodies|antibodies|mesh-list
20640785|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
20640786|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20640787|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20640788|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
20640789|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640790|NCT01734928|Thalidomide|thalidomide|mesh-list
20640791|NCT01734928|Dexamethasone|dexamethasone|mesh-list
20640792|NCT01734928|Bortezomib|bortezomib|mesh-list
20640793|NCT01734928|Pomalidomide|pomalidomide|mesh-list
20640794|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640795|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
20640796|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
20640797|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640798|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640799|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640800|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
20640801|NCT01734928|Hormones|hormones|mesh-ancestor
20640802|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640803|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640804|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640805|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
20640806|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640807|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640808|NCT01734928|Growth Substances|growth substances|mesh-ancestor
20640809|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640810|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640811|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
20640812|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640813|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640814|NCT01720836|Poly ICLC|poly iclc|mesh-list
20640815|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
20640816|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
20640817|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640818|NCT01712620|Spironolactone|spironolactone|mesh-list
20640819|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20640820|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
20640821|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640822|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640823|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20640824|NCT01712620|Diuretics|diuretics|mesh-ancestor
20640825|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
20640826|NCT01631617|Doxycycline|doxycycline|mesh-list
20640827|NCT01631617|Cephalexin|cephalexin|mesh-list
20640828|NCT01631617|Trimethoprim|trimethoprim|mesh-list
19850935|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19850936|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19850937|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19850938|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850939|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19850940|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
19850941|NCT00715208|Hormones|hormones|mesh-ancestor
20227271|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20640829|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
20640830|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20640831|NCT01631617|Eusol|eusol|mesh-list
20640832|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20640833|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640834|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
20640835|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20640836|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20640837|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20640838|NCT01631617|Renal Agents|renal agents|mesh-ancestor
20640839|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20640840|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640841|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640842|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19850942|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19850943|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640843|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20640844|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20640845|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
20640846|NCT01572506|Biotin|biotin|mesh-list
20640847|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
20640848|NCT01572506|Vitamins|vitamins|mesh-ancestor
20640849|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
20640850|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640851|NCT01559363|XL647|xl647|mesh-list
20640852|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640853|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640854|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640855|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640856|NCT01553214|Dexamethasone|dexamethasone|mesh-list
20640857|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640858|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
20640859|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
20640860|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640861|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640862|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640863|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
20640864|NCT01553214|Hormones|hormones|mesh-ancestor
20640865|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640866|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640867|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640868|NCT01517100|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20640869|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640870|NCT01504919|Nicotine|nicotine|mesh-list
20640871|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20640872|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
20640873|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640874|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640875|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20640876|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20640877|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
20640878|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640879|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640880|NCT01495598|Pomalidomide|pomalidomide|mesh-list
20640881|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
20640882|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640883|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640884|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640885|NCT01495598|Growth Substances|growth substances|mesh-ancestor
20640886|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640887|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640888|NCT01445509|Bevacizumab|bevacizumab|mesh-list
20640889|NCT01445509|Dasatinib|dasatinib|mesh-list
20640890|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640891|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640892|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640893|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640894|NCT01445509|Growth Substances|growth substances|mesh-ancestor
20640895|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640896|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640897|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640898|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640899|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640900|NCT01419561|Zidovudine|zidovudine|mesh-list
20640901|NCT01419561|Rituximab|rituximab|mesh-list
20640902|NCT01419561|Doxorubicin|doxorubicin|mesh-list
20640903|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20640904|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20640905|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640906|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
20640907|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640908|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640909|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20640910|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20640911|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20640912|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640913|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640914|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
20640915|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20640916|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20640917|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
20640918|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640919|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640920|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640921|NCT01415882|Dexamethasone|dexamethasone|mesh-list
20640922|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
20640923|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
20640924|NCT01415882|Daratumumab|daratumumab|mesh-list
20640925|NCT01415882|Ixazomib|ixazomib|mesh-list
20640926|NCT01415882|Ichthammol|ichthammol|mesh-list
20640927|NCT01415882|BB 1101|bb 1101|mesh-list
20640928|NCT01415882|Glycine|glycine|mesh-list
20640929|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640930|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
20640931|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640932|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640933|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640934|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
20640935|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640936|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640937|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640938|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20640939|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
20640940|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
20640941|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20640942|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20640943|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
20640944|NCT01415882|Hormones|hormones|mesh-ancestor
20640945|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20640946|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20640947|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
20640948|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640949|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
20640950|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
20640951|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20640952|NCT01391962|Sunitinib|sunitinib|mesh-list
20640953|NCT01391962|Cediranib|cediranib|mesh-list
20640954|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640955|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640956|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640957|NCT01391962|Growth Substances|growth substances|mesh-ancestor
20640958|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640959|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640960|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20640961|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640962|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640963|NCT01352962|Gemcitabine|gemcitabine|mesh-list
20640964|NCT01352962|Carboplatin|carboplatin|mesh-list
20640965|NCT01352962|Lenalidomide|lenalidomide|mesh-list
20640966|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640967|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20640968|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
20640969|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640970|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
20640971|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640972|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20640973|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640974|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
20640975|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640976|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20640977|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20640978|NCT01352962|Growth Substances|growth substances|mesh-ancestor
20640979|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
20640980|NCT01319565|Aldesleukin|aldesleukin|mesh-list
20640981|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
20640982|NCT01319565|Fludarabine|fludarabine|mesh-list
20640983|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20640984|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
20640985|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20640986|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20640987|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20640988|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
20640989|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20640990|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20640991|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20640992|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20640993|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20640994|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
20640995|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20640996|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20640997|NCT01306045|Sunitinib|sunitinib|mesh-list
20640998|NCT01306045|Lapatinib|lapatinib|mesh-list
20640999|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641000|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20641001|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641002|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641003|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20641004|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20641005|NCT01306045|Growth Substances|growth substances|mesh-ancestor
20641006|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641007|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
20641008|NCT01306019|Busulfan|busulfan|mesh-list
20641009|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
20641010|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641011|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227272|NCT00349245|Narcotics|narcotics|mesh-ancestor
20227273|NCT00349258|Leuprolide|leuprolide|mesh-list
20227274|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20227275|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
20227276|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20227277|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227278|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20227279|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227280|NCT00349284|Ezetimibe|ezetimibe|mesh-list
20227281|NCT00349284|Fenofibrate|fenofibrate|mesh-list
20227282|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20641012|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
20641013|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641014|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641015|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641016|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20641017|NCT01275677|Paclitaxel|paclitaxel|mesh-list
20641018|NCT01275677|Docetaxel|docetaxel|mesh-list
20641019|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
20641020|NCT01275677|Doxorubicin|doxorubicin|mesh-list
20641021|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20641022|NCT01275677|Trastuzumab|trastuzumab|mesh-list
20641023|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20641024|NCT01275677|Daunorubicin|daunorubicin|mesh-list
20641025|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20641026|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20641027|NCT01275677|Antibodies|antibodies|mesh-list
20641028|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
20641029|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20641030|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20641031|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641032|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
20641033|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
20641034|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
20227283|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227284|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
20476808|NCT01517724|Bortezomib|bortezomib|mesh-list
20476809|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476810|NCT01517815|Tazobactam|tazobactam|mesh-list
20476811|NCT01517815|Piperacillin|piperacillin|mesh-list
20476812|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20476813|NCT01517815|Doripenem|doripenem|mesh-list
20476814|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20476815|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476816|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20641035|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641036|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641037|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
20641038|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641039|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641040|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641041|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
20641042|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20641043|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20641044|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20641045|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20641046|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641047|NCT01272037|Tamoxifen|tamoxifen|mesh-list
20641048|NCT01272037|Letrozole|letrozole|mesh-list
20641049|NCT01272037|Anastrozole|anastrozole|mesh-list
20641050|NCT01272037|Exemestane|exemestane|mesh-list
20641051|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641052|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641053|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20641054|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20641055|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697134|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697135|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697136|NCT04932187|Capecitabine|capecitabine|mesh-list
19697137|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20641056|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20641057|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
20641058|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641059|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641060|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20641061|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20641062|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20641063|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20641064|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
20641065|NCT01176006|Busulfan|busulfan|mesh-list
20641066|NCT01176006|Fludarabine|fludarabine|mesh-list
20641067|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
20641068|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641069|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
20641070|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641071|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641072|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641073|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
20641074|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641075|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641076|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20641077|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20641078|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
20641079|NCT01174121|Aldesleukin|aldesleukin|mesh-list
20641080|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
20641081|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
20641082|NCT01174121|Fludarabine|fludarabine|mesh-list
20641083|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641084|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
20641085|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641086|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641087|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641088|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
20641089|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641090|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641091|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20641092|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641093|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20641094|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20641095|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
20641096|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641097|NCT01130519|Bevacizumab|bevacizumab|mesh-list
20641098|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20641099|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641100|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641101|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20641102|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20641103|NCT01130519|Growth Substances|growth substances|mesh-ancestor
20641104|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641105|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
20641106|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20641107|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641108|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641109|NCT01103349|Montelukast|montelukast|mesh-list
20641110|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20641111|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
20641112|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20641113|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
20641114|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641115|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641116|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20641117|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20641118|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641119|NCT01092143|Fluticasone|fluticasone|mesh-list
20641120|NCT01092143|Xhance|xhance|mesh-list
20641121|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20641122|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20641123|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
20641124|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20641125|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641126|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20641127|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
20641128|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
20641129|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20641130|NCT01064648|Cisplatin|cisplatin|mesh-list
20641131|NCT01064648|Pemetrexed|pemetrexed|mesh-list
20641132|NCT01064648|Cediranib|cediranib|mesh-list
20641133|NCT01064648|Maleic acid|maleic acid|mesh-list
20641134|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641135|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641136|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641137|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20641138|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20641139|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20641140|NCT01059786|Rituximab|rituximab|mesh-list
20641141|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20641142|NCT01059786|Pentostatin|pentostatin|mesh-list
20641143|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641144|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641145|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
20641146|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641147|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641148|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641149|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
20641150|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641151|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20641152|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641153|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
20641154|NCT01025089|Doxorubicin|doxorubicin|mesh-list
20641155|NCT01025089|Cetuximab|cetuximab|mesh-list
20641156|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641157|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
20641158|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641159|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641160|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641161|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
20641162|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641163|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641164|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20641165|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20641166|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19697138|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
19697139|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697140|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697141|NCT04931693|Acetaminophen|acetaminophen|mesh-list
19697142|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19697143|NCT04931693|Analgesics|analgesics|mesh-ancestor
19697144|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
19697145|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697146|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641167|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20641168|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697147|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
20641169|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641170|NCT00977977|Cyclosporine|cyclosporine|mesh-list
20641171|NCT00977977|Rituximab|rituximab|mesh-list
20641172|NCT00977977|Cyclosporins|cyclosporins|mesh-list
20641173|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641174|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641175|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
19850944|NCT00715403|Nintedanib|nintedanib|mesh-list
19850945|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850946|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19850947|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850948|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850949|NCT00715429|Vitamin D|vitamin d|mesh-list
19850950|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
19850951|NCT00715429|Vitamins|vitamins|mesh-ancestor
19850952|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
19850953|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641176|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641177|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641178|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641179|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641180|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641181|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
20641182|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697148|NCT04931433|Lidocaine|lidocaine|mesh-list
19697149|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697150|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
19697151|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697152|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697153|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
19697154|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20641183|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
20641184|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20641185|NCT00967785|Plerixafor|plerixafor|mesh-list
20641186|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20641187|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20641188|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
20641189|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641190|NCT00923013|Rituximab|rituximab|mesh-list
20641191|NCT00923013|Cladribine|cladribine|mesh-list
20641192|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641193|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641194|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
20641195|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641196|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641197|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641198|NCT00862433|Vitamins|vitamins|mesh-list
20641199|NCT00862433|Vitamin E|vitamin e|mesh-list
20641200|NCT00862433|Tocopherols|tocopherols|mesh-list
20641201|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
20641202|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
20641203|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641204|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
20641205|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641206|NCT00862433|Protective Agents|protective agents|mesh-ancestor
20641207|NCT00720785|Bortezomib|bortezomib|mesh-list
20641208|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697155|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697156|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19697157|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19697158|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697159|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641209|NCT00593567|Levofloxacin|levofloxacin|mesh-list
20641210|NCT00593567|Ofloxacin|ofloxacin|mesh-list
20641211|NCT00593567|Gentamicins|gentamicins|mesh-list
20641212|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19697160|NCT04931524|Mitogens|mitogens|mesh-list
19697161|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
19697162|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697163|NCT04931355|Cetrorelix|cetrorelix|mesh-list
19697164|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697165|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850954|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20641213|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641214|NCT00593567|Renal Agents|renal agents|mesh-ancestor
20641215|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20641216|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20641217|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20641218|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641219|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641220|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641221|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20641222|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20641223|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20641224|NCT00588770|Bevacizumab|bevacizumab|mesh-list
20641225|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20641226|NCT00588770|Cisplatin|cisplatin|mesh-list
20641227|NCT00588770|Carboplatin|carboplatin|mesh-list
20641228|NCT00588770|Docetaxel|docetaxel|mesh-list
20641229|NCT00588770|Fluorouracil|fluorouracil|mesh-list
20641230|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
20641231|NCT00588770|Antibodies|antibodies|mesh-list
20641232|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
20641233|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20641234|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
20641235|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641236|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20641237|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20641238|NCT00588770|Growth Substances|growth substances|mesh-ancestor
20641239|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641240|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
20641241|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
20641242|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
20641243|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
19697166|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20641244|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
20641245|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641246|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
20641247|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20641248|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641249|NCT00353158|Doxycycline|doxycycline|mesh-list
20641250|NCT00353158|Voriconazole|voriconazole|mesh-list
20641251|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20641252|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641253|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
20641254|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20641255|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20641256|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
20641257|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20641258|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20641259|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641260|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641261|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20641262|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
20641263|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641264|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641265|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20641266|NCT00295646|Tamoxifen|tamoxifen|mesh-list
20641267|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
20641268|NCT00295646|Anastrozole|anastrozole|mesh-list
20641269|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20641270|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
20641271|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641272|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641273|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20641274|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641275|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20641276|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20641277|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20641278|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20641279|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20641280|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641281|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641282|NCT00254423|Dasatinib|dasatinib|mesh-list
19697167|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
19697168|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19697169|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
19412574|NCT05262270|Naltrexone|naltrexone|mesh-list
19412575|NCT05262270|Buprenorphine|buprenorphine|mesh-list
19412576|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19697170|NCT04930952|Ethanol|ethanol|mesh-list
20641283|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641284|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20641285|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641286|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641287|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
20641288|NCT00097474|Melatonin|melatonin|mesh-list
20641289|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20641290|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
20641291|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641292|NCT00097474|Protective Agents|protective agents|mesh-ancestor
20641293|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641294|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20641295|NCT00092222|Interferons|interferons|mesh-list
20641296|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
20641297|NCT00092222|Zidovudine|zidovudine|mesh-list
20641298|NCT00092222|Valganciclovir|valganciclovir|mesh-list
20641299|NCT00092222|Sirolimus|sirolimus|mesh-list
20641300|NCT00092222|Prednisone|prednisone|mesh-list
20641301|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
20641302|NCT00092222|Rituximab|rituximab|mesh-list
20641303|NCT00092222|Doxorubicin|doxorubicin|mesh-list
20641304|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20641305|NCT00092222|Etoposide|etoposide|mesh-list
20641306|NCT00092222|Vincristine|vincristine|mesh-list
20641307|NCT00092222|Bortezomib|bortezomib|mesh-list
20641308|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641309|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
20641310|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641311|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641312|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641313|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
20641314|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641315|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641316|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20641317|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641318|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20641319|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20641320|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20641321|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641322|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20641323|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
20641324|NCT00092222|Hormones|hormones|mesh-ancestor
20641325|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641326|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20641327|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20641328|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
20641329|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641330|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
19412577|NCT05262270|Narcotics|narcotics|mesh-ancestor
19412578|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412579|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412580|NCT05262270|Analgesics|analgesics|mesh-ancestor
19412581|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
19697171|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20641331|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
20641332|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
20641333|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20641334|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
20641335|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
20641336|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20641337|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20641338|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20641339|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20641340|NCT00065676|Quercetin|quercetin|mesh-list
20641341|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
20641342|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641343|NCT00065676|Protective Agents|protective agents|mesh-ancestor
20641344|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641345|NCT00061568|Sirolimus|sirolimus|mesh-list
20641346|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
20641347|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20641348|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641349|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20641350|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412582|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20641351|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
20641352|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641353|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
20641354|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641355|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641356|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
20641357|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641358|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20641359|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641360|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641361|NCT00018057|Fluoxetine|fluoxetine|mesh-list
20641362|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20641363|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20641364|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20641365|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641366|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20641367|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
20641368|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641369|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20641370|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
20641371|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20641372|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20641373|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20641374|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641375|NCT00006455|Leucovorin|leucovorin|mesh-list
20641376|NCT00006455|Cytarabine|cytarabine|mesh-list
20641377|NCT00006455|Dexamethasone|dexamethasone|mesh-list
20641378|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
20641379|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20641380|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20641381|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20641382|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
20641383|NCT00006455|Ifosfamide|ifosfamide|mesh-list
20641384|NCT00006455|Doxorubicin|doxorubicin|mesh-list
20641385|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20641386|NCT00006455|Methotrexate|methotrexate|mesh-list
20641387|NCT00006455|Etoposide|etoposide|mesh-list
20641388|NCT00006455|Vinblastine|vinblastine|mesh-list
20641389|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
20641390|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20641391|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
20641392|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641393|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641394|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20641395|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
20641396|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641397|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641398|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20641399|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20641400|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
20641401|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
20641402|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20641403|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20641404|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
20641405|NCT00006455|Hormones|hormones|mesh-ancestor
20641406|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641407|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20641408|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20641409|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20641410|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20641411|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641412|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20641413|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
20641414|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20641415|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20641416|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
20641417|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
20641418|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20641419|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20641420|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20641421|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
20641422|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641423|NCT00006455|Antidotes|antidotes|mesh-ancestor
20641424|NCT00006455|Protective Agents|protective agents|mesh-ancestor
20641425|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
20641426|NCT00006455|Vitamins|vitamins|mesh-ancestor
20641427|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
20641428|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
20641429|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
20641430|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
20641431|NCT00003716|Rituximab|rituximab|mesh-list
20641432|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641433|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641434|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
20641435|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641436|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641437|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
20641438|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
20641439|NCT00001521|Letrozole|letrozole|mesh-list
20641440|NCT00001521|Flutamide|flutamide|mesh-list
20641441|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641442|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20641443|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20641444|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20641445|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641446|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20641447|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
20641448|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641449|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641450|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20641451|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
20641452|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20641453|NCT00001481|Estradiol|estradiol|mesh-list
20641454|NCT00001481|Progesterone|progesterone|mesh-list
20641455|NCT00001481|Estrogens|estrogens|mesh-ancestor
20641456|NCT00001481|Hormones|hormones|mesh-ancestor
20641457|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20641458|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641459|NCT00001481|Progestins|progestins|mesh-ancestor
20641460|NCT00001379|Interferons|interferons|mesh-list
20641461|NCT00001379|Rituximab|rituximab|mesh-list
20641462|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641463|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
20641464|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20641465|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641466|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
20641467|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641468|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641469|NCT00001337|Rituximab|rituximab|mesh-list
20641470|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20641471|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20641472|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
20641473|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641474|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20641475|NCT00001309|Ascorbic Acid|ascorbic acid|mesh-list
20641476|NCT00001309|Vitamins|vitamins|mesh-ancestor
20641477|NCT00001309|Micronutrients|micronutrients|mesh-ancestor
20641478|NCT00001309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20641479|NCT00001309|Antioxidants|antioxidants|mesh-ancestor
20641480|NCT00001309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20641481|NCT00001309|Protective Agents|protective agents|mesh-ancestor
19697172|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697173|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697174|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227285|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227286|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227287|NCT00349310|Pramipexole|pramipexole|mesh-list
20227288|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
20227289|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227290|NCT00349310|Protective Agents|protective agents|mesh-ancestor
20227291|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227292|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20227293|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20227294|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
20227295|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
20227296|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227297|NCT00349362|Testosterone|testosterone|mesh-list
20227298|NCT00349362|Androgens|androgens|mesh-ancestor
20227299|NCT00349362|Hormones|hormones|mesh-ancestor
19697175|NCT04931225|Landiolol|landiolol|mesh-list
19697176|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19697177|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19697178|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697179|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697180|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697181|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697182|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697183|NCT04931108|Atenolol|atenolol|mesh-list
19697184|NCT04931108|Nitrendipine|nitrendipine|mesh-list
19697185|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697186|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19697187|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
19697188|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
19697189|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412583|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19697190|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697191|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19697192|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19697193|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19697194|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697195|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697196|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697197|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19697198|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20476817|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476818|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476819|NCT01517828|Midazolam|midazolam|mesh-list
20476820|NCT01517828|Ketamine|ketamine|mesh-list
20476821|NCT01517828|Analgesics|analgesics|mesh-ancestor
20476822|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
20476823|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476824|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476825|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20476826|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20476827|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
20476828|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
20476829|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476830|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20476831|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20476832|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476833|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476834|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20476835|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20476836|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20476837|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20476838|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20476839|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
20476840|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
20476841|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
20476842|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
20476843|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20476844|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20476845|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527572|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
20527573|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20527574|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527575|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
20527576|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527577|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20527578|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20527579|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
20527580|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527581|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527582|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
20527583|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20527584|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
20527585|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527586|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527587|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20527588|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
20527589|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20527590|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
20527591|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412584|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19850955|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19850956|NCT00715520|Levodopa|levodopa|mesh-list
19850957|NCT00715520|Carbidopa|carbidopa|mesh-list
19850958|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19850959|NCT00715520|Methylphenidate|methylphenidate|mesh-list
19697199|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20227300|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227301|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227302|NCT00349375|Simvastatin|simvastatin|mesh-list
20227303|NCT00349375|Fenofibrate|fenofibrate|mesh-list
20227304|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20227305|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227306|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
20227307|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697200|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
19697201|NCT04931121|Viscosupplements|viscosupplements|mesh-list
19697202|NCT04931121|Protective Agents|protective agents|mesh-ancestor
19697203|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697204|NCT04930744|Metformin|metformin|mesh-list
20476846|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476847|NCT01517854|Urological Agents|urological agents|mesh-ancestor
20476848|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
20476849|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20476850|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476851|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476852|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476853|NCT01517932|Analgesics|analgesics|mesh-ancestor
20476854|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
20476855|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476856|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20476857|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20476858|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697205|NCT04930744|Rifampin|rifampin|mesh-list
19697206|NCT04930744|Isoniazid|isoniazid|mesh-list
19697207|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
19697208|NCT04930744|Ethambutol|ethambutol|mesh-list
19697209|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19697210|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412585|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
20227308|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227309|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20227310|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412586|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19412587|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412588|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412589|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412590|NCT05262166|Analgesics|analgesics|mesh-ancestor
19412591|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
19412592|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697211|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19697212|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
19697213|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19697214|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697215|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
19697216|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19697217|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697218|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476859|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
20476860|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20476861|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476862|NCT01517997|Paclitaxel|paclitaxel|mesh-list
20476863|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20476864|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476865|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
20476866|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
20476867|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
20476868|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476869|NCT01518062|Estrogens|estrogens|mesh-list
20476870|NCT01518062|Hormones|hormones|mesh-ancestor
20476871|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476872|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476873|NCT01518101|Metformin|metformin|mesh-list
20476874|NCT01518101|Liraglutide|liraglutide|mesh-list
20476875|NCT01518101|Vildagliptin|vildagliptin|mesh-list
20476876|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476877|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476878|NCT01518101|Incretins|incretins|mesh-ancestor
20476879|NCT01518101|Hormones|hormones|mesh-ancestor
20476880|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697219|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19697220|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19697221|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19697222|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19697223|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19697224|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19697225|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19697226|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19697227|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
19697228|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19697229|NCT04930627|Empagliflozin|empagliflozin|mesh-list
19697230|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19412593|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19412594|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19697231|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850960|NCT00715520|Amphetamine|amphetamine|mesh-list
19850961|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19850962|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850963|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20227311|NCT00349401|Ketorolac|ketorolac|mesh-list
19412595|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19412596|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412597|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412598|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412599|NCT05261997|Metformin|metformin|mesh-list
19412600|NCT05261997|Acarbose|acarbose|mesh-list
19412601|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19850964|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19850965|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19850966|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850967|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
19850968|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19850969|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19850970|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19850971|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20476881|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20476882|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476883|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476884|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476885|NCT01518166|Liraglutide|liraglutide|mesh-list
20476886|NCT01518166|Griseofulvin|griseofulvin|mesh-list
20476887|NCT01518166|Digoxin|digoxin|mesh-list
20476888|NCT01518166|Lisinopril|lisinopril|mesh-list
20476889|NCT01518166|Atorvastatin|atorvastatin|mesh-list
20476890|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20476891|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20476892|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
20476893|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476894|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19412602|NCT05261997|Pancreatin|pancreatin|mesh-list
20227312|NCT00349401|Morphine|morphine|mesh-list
20227313|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20227314|NCT00349401|Narcotics|narcotics|mesh-ancestor
20227315|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227316|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227317|NCT00349401|Analgesics|analgesics|mesh-ancestor
20227318|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
20227319|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227320|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227321|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227322|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476895|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20476896|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476897|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476898|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476899|NCT01518166|Incretins|incretins|mesh-ancestor
20476900|NCT01518166|Hormones|hormones|mesh-ancestor
20476901|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476902|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20476903|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20476904|NCT01518166|Protective Agents|protective agents|mesh-ancestor
20476905|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20476906|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476907|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20476908|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
20476909|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20476910|NCT01518231|Aspirin|aspirin|mesh-list
20476911|NCT01518231|Edaravone|edaravone|mesh-list
20476912|NCT01518231|Warfarin|warfarin|mesh-list
20227323|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476913|NCT01518231|Atorvastatin|atorvastatin|mesh-list
19412603|NCT05261997|Pancrelipase|pancrelipase|mesh-list
19412604|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850972|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850973|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
19697232|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20476914|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20476915|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20476916|NCT01518231|Analgesics|analgesics|mesh-ancestor
20476917|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
20476918|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476919|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476920|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476921|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476922|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20476923|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20476924|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476925|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20476926|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20227324|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20227325|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227326|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227327|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
20227328|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227329|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227330|NCT00349440|Cyclosporine|cyclosporine|mesh-list
20227331|NCT00349440|Cyclosporins|cyclosporins|mesh-list
20227332|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227333|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227334|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227335|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
20227336|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227337|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
20227338|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227339|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
20227340|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20476927|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476928|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
20476929|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20476930|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20476931|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
20476932|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20476933|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20476934|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
20476935|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20476936|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
20476937|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20476938|NCT01518231|Protective Agents|protective agents|mesh-ancestor
20476939|NCT01518413|Irinotecan|irinotecan|mesh-list
20476940|NCT01518413|Sorafenib|sorafenib|mesh-list
20476941|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20476942|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20476943|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476944|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476945|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476946|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20476947|NCT01518465|Dexamethasone|dexamethasone|mesh-list
20476948|NCT01518465|Lenalidomide|lenalidomide|mesh-list
20476949|NCT01518465|Dalteparin|dalteparin|mesh-list
20476950|NCT01518465|Tinzaparin|tinzaparin|mesh-list
20476951|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20476952|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20476953|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
20476954|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
20476955|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476956|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476957|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20476958|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
20476959|NCT01518465|Hormones|hormones|mesh-ancestor
20476960|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20476961|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20476962|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476963|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
20476964|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20476965|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20476966|NCT01518465|Growth Substances|growth substances|mesh-ancestor
20476967|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
20476968|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
20476969|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20476970|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20476971|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476972|NCT01518569|Urinastatin|urinastatin|mesh-list
20476973|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20476974|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20476975|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
20476976|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476977|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476978|NCT01518595|Bosentan|bosentan|mesh-list
20476979|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20476980|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20476981|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476982|NCT01518608|Alfentanil|alfentanil|mesh-list
20476983|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20476984|NCT01518608|Narcotics|narcotics|mesh-ancestor
20227341|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20227342|NCT00349453|Deferiprone|deferiprone|mesh-list
20227343|NCT00349453|Deferoxamine|deferoxamine|mesh-list
20227344|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20227345|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
20227346|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
20227347|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227348|NCT00349453|Siderophores|siderophores|mesh-ancestor
20227349|NCT00349492|Cisplatin|cisplatin|mesh-list
20227350|NCT00349492|Irinotecan|irinotecan|mesh-list
20227351|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227352|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20227353|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20227354|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227355|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227356|NCT00349518|Dasatinib|dasatinib|mesh-list
20227357|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227358|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227359|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476985|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20476986|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20476987|NCT01518608|Analgesics|analgesics|mesh-ancestor
20476988|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
20476989|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20476990|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20476991|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
20227360|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227361|NCT00349531|Pramipexole|pramipexole|mesh-list
20227362|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
20227363|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227364|NCT00349531|Protective Agents|protective agents|mesh-ancestor
20227365|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227366|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20227367|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20227368|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
20227369|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
20227370|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227371|NCT00349557|Bevacizumab|bevacizumab|mesh-list
20476992|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
19697233|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697234|NCT04930471|Metformin|metformin|mesh-list
19697235|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19697236|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697237|NCT04930211|Dexamethasone|dexamethasone|mesh-list
19697238|NCT04930211|Lidocaine|lidocaine|mesh-list
19697239|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19697240|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
19697241|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
19697242|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697243|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697244|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697245|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
19697246|NCT04930211|Hormones|hormones|mesh-ancestor
19697247|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697248|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19697249|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697250|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697251|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
19697252|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697253|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
19697254|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697255|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19697256|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19697257|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697258|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707901|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19707902|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19707903|NCT04822012|Antibodies|antibodies|mesh-list
19707904|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
19707905|NCT04822012|Progesterone|progesterone|mesh-list
19707906|NCT04822012|Estrogens|estrogens|mesh-list
19707907|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
19707908|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707909|NCT04822012|Progestins|progestins|mesh-ancestor
19707910|NCT04822012|Hormones|hormones|mesh-ancestor
19707911|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707912|NCT04822038|Vitamin D|vitamin d|mesh-list
19697259|NCT04930185|Vaccines|vaccines|mesh-list
19697260|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
19697261|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697262|NCT04930055|Vaccines|vaccines|mesh-list
19697263|NCT04930055|Immunologic Factors|immunologic factors|mesh-ancestor
19697264|NCT04930055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697265|NCT04930133|Afatinib|afatinib|mesh-list
19697266|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697267|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19697268|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697269|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697270|NCT04929652|Irinotecan|irinotecan|mesh-list
19697271|NCT04929652|Molgramostim|molgramostim|mesh-list
19697272|NCT04929652|Sargramostim|sargramostim|mesh-list
19697273|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19697274|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19697275|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697276|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697277|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227372|NCT00349557|Goserelin|goserelin|mesh-list
20227373|NCT00349557|Bicalutamide|bicalutamide|mesh-list
20227374|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20227375|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227376|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20227377|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20227378|NCT00349557|Growth Substances|growth substances|mesh-ancestor
20227379|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227380|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
20227381|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20227382|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
20227383|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
20227384|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227385|NCT00349583|Cyclosporine|cyclosporine|mesh-list
20227386|NCT00349583|Cyclosporins|cyclosporins|mesh-list
20227387|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227388|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227389|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227390|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
20227391|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227392|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
20227393|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227394|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
20227395|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227396|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20227397|NCT00349596|Decitabine|decitabine|mesh-list
20227398|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227399|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
20227400|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227401|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227402|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19850974|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
19850975|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19850976|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697278|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
19697279|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697280|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
19697281|NCT04929626|Albuterol|albuterol|mesh-list
20476993|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20476994|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20476995|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20476996|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20476997|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20476998|NCT01518634|Imipramine|imipramine|mesh-list
20476999|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20477000|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
20477001|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19697282|NCT04929626|Analgesics|analgesics|mesh-ancestor
20227403|NCT00349635|Metformin|metformin|mesh-list
20227404|NCT00349635|Fenofibrate|fenofibrate|mesh-list
20227405|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227406|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227407|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227408|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
20227409|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227410|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227411|NCT00349674|Methotrexate|methotrexate|mesh-list
20227412|NCT00349674|Azathioprine|azathioprine|mesh-list
20227413|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20227414|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
20227415|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20227416|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227417|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227418|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
20227419|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227420|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227421|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
20227422|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227423|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20227424|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227425|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
20477002|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20477003|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20477004|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477005|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477006|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
20477007|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477008|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527592|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527593|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20527594|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
20527595|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
20527596|NCT01768884|Protective Agents|protective agents|mesh-ancestor
20527597|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
20527598|NCT01768897|Cytarabine|cytarabine|mesh-list
20527599|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
20527600|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412605|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19412606|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412607|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412608|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19412609|NCT05261971|Etodolac|etodolac|mesh-list
19412610|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19697283|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
19697284|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697285|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227426|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227427|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19412611|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412612|NCT05261971|Analgesics|analgesics|mesh-ancestor
20227428|NCT00349726|Inositol|inositol|mesh-list
19412613|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
19412614|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412615|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412616|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412617|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412618|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19412619|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19412620|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412621|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416864|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20227429|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
19412622|NCT05261672|Midazolam|midazolam|mesh-list
19850977|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19850978|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19850979|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
19850980|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
19850981|NCT00715559|Cysteamine|cysteamine|mesh-list
19850982|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19850983|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850984|NCT00715624|Metformin|metformin|mesh-list
19850985|NCT00715624|Lixisenatide|lixisenatide|mesh-list
19850986|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19850987|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850988|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19850989|NCT00715676|Vitamins|vitamins|mesh-ancestor
19850990|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
20227430|NCT00349726|Vitamins|vitamins|mesh-ancestor
20227431|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
20227432|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227433|NCT00349739|Anecortave|anecortave|mesh-list
20227434|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20227435|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20227436|NCT00349739|Growth Substances|growth substances|mesh-ancestor
20227437|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227438|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
20227439|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247462|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20247463|NCT00432367|Amodiaquine|amodiaquine|mesh-list
20247464|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
20247465|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20247466|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20247467|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247468|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247469|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
20247470|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
20247471|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20247472|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
20247473|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20247474|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247475|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247476|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20247477|NCT00432367|Renal Agents|renal agents|mesh-ancestor
20247478|NCT00432393|Levodopa|levodopa|mesh-list
20247479|NCT00432393|Carbidopa|carbidopa|mesh-list
20247480|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20247481|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20247482|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20247483|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
20247484|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247485|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247486|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477009|NCT01518712|Metformin|metformin|mesh-list
19697286|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
19697287|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477010|NCT01518712|Canagliflozin|canagliflozin|mesh-list
20477011|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477012|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477013|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20477014|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477015|NCT01518725|Vitamin D|vitamin d|mesh-list
20477016|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
20477017|NCT01518725|Vitamins|vitamins|mesh-ancestor
20477018|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
20477019|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477020|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20477021|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477022|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20227440|NCT00349791|Testosterone|testosterone|mesh-list
20227441|NCT00349791|Androgens|androgens|mesh-ancestor
20477023|NCT01518790|Laxatives|laxatives|mesh-ancestor
20477024|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20477025|NCT01518855|Amlodipine|amlodipine|mesh-list
20477026|NCT01518855|Nifedipine|nifedipine|mesh-list
20477027|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20477028|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20477029|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477030|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477031|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477032|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477033|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
20477034|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
20227442|NCT00349791|Hormones|hormones|mesh-ancestor
20477035|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20477036|NCT01518933|Silybin|silybin|mesh-list
20477037|NCT01518933|Silymarin|silymarin|mesh-list
20227443|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227444|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227445|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
20227446|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227447|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227448|NCT00350038|Irbesartan|irbesartan|mesh-list
20227449|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
20477038|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
19697288|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697289|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
20477039|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477040|NCT01518933|Protective Agents|protective agents|mesh-ancestor
20477041|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477042|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20477043|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477044|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
20477045|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477046|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477047|NCT01518959|Vitamins|vitamins|mesh-ancestor
20477048|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
20477049|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20477050|NCT01518998|Amlodipine|amlodipine|mesh-list
20477051|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20477052|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20477053|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477054|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477055|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477056|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477057|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
20477058|NCT01519011|Azacitidine|azacitidine|mesh-list
20477059|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20477060|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
20477061|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477062|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477063|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477064|NCT01519037|Cinacalcet|cinacalcet|mesh-list
20477065|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477066|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477067|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20477068|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
20477069|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477070|NCT01519076|Coal Tar|coal tar|mesh-list
20477071|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
20477072|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
20477073|NCT01519102|Hormones|hormones|mesh-list
20477074|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477075|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477076|NCT01519128|Rilpivirine|rilpivirine|mesh-list
20477077|NCT01519128|Digoxin|digoxin|mesh-list
20477078|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20477079|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20477080|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477081|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477082|NCT01519128|Protective Agents|protective agents|mesh-ancestor
20477083|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477084|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20477085|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20477086|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
20477087|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477088|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20477089|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20477090|NCT01519154|Ketamine|ketamine|mesh-list
20477091|NCT01519154|Propofol|propofol|mesh-list
20477092|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20477093|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19850991|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19850992|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19850993|NCT00715793|Temozolomide|temozolomide|mesh-list
19850994|NCT00715793|Decitabine|decitabine|mesh-list
19850995|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19850996|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
19850997|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19850998|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19850999|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412623|NCT05261672|Bupivacaine|bupivacaine|mesh-list
19851000|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
19851001|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412624|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
19412625|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
19412626|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412627|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412628|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
19412629|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412630|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19412631|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19412632|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19412633|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19851002|NCT00715884|Sirolimus|sirolimus|mesh-list
19851003|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19412634|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19412635|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19412636|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
19412637|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
19697290|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19697291|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697292|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412638|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
19412639|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412640|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412641|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19412642|NCT05261581|Analgesics|analgesics|mesh-list
19412643|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
19412644|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412645|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707913|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
19697293|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19697294|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
19697295|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19697296|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19697297|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
19697298|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19697299|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
19697300|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19697301|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19697302|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697303|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697304|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697305|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19697306|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19697307|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697308|NCT04929522|Anesthetics|anesthetics|mesh-list
19851004|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851005|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19851006|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851007|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
19851008|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851009|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
19707914|NCT04822038|Vitamins|vitamins|mesh-ancestor
19851010|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851011|NCT00715910|Vaccines|vaccines|mesh-list
19851012|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
19851013|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851014|NCT00716079|Metoprolol|metoprolol|mesh-list
19851015|NCT00716079|Clonidine|clonidine|mesh-list
19851016|NCT00716079|Hydralazine|hydralazine|mesh-list
19851017|NCT00716079|Labetalol|labetalol|mesh-list
19851018|NCT00716079|Nicardipine|nicardipine|mesh-list
19851019|NCT00716079|Phentolamine|phentolamine|mesh-list
19851020|NCT00716079|Urapidil|urapidil|mesh-list
19851021|NCT00716079|Enalaprilat|enalaprilat|mesh-list
19851022|NCT00716079|Esmolol|esmolol|mesh-list
19851023|NCT00716079|Glycerol|glycerol|mesh-list
19851024|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19851025|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19851026|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
20477094|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477095|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20477096|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
20477097|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
20477098|NCT01519154|Analgesics|analgesics|mesh-ancestor
20477099|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
20477100|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477101|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20477102|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20477103|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20477104|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477105|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477106|NCT01519297|Irbesartan|irbesartan|mesh-list
20477107|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20477108|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20477109|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20527601|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
19851027|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
19851028|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697309|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697310|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697311|NCT04929509|Listerine|listerine|mesh-list
19697312|NCT04929509|Fluorides|fluorides|mesh-list
20227450|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20227451|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20227452|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20227453|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227454|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227455|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
20227456|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227457|NCT00350051|Prednisone|prednisone|mesh-list
20227458|NCT00350051|Sagopilone|sagopilone|mesh-list
20227459|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227460|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
20227461|NCT00350051|Hormones|hormones|mesh-ancestor
20227462|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227463|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227464|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20227465|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227466|NCT00350077|Vitamins|vitamins|mesh-list
20227467|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
20227468|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
19412646|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
19412647|NCT05261516|Analgesics|analgesics|mesh-ancestor
19412648|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
19412649|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412650|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412651|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
19412652|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412653|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412654|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
19412655|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19412656|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19412657|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412658|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19412659|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
19412660|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19412661|NCT05261269|Niraparib|niraparib|mesh-list
19412662|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19412663|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412664|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412665|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412666|NCT05241496|Lidocaine|lidocaine|mesh-list
19412667|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
19412668|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
19412669|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697313|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
19697314|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
19697315|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
19697316|NCT04929509|Protective Agents|protective agents|mesh-ancestor
19707915|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
20227469|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227470|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
20227471|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227472|NCT00350077|Protective Agents|protective agents|mesh-ancestor
20227473|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
20227474|NCT00350090|Hematinics|hematinics|mesh-ancestor
20227475|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
20227476|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
20227477|NCT00350116|Vitamins|vitamins|mesh-ancestor
20227478|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
20227479|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477110|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477111|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20477112|NCT01519310|Metronidazole|metronidazole|mesh-list
20477113|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
20477114|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477115|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20477116|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20477117|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20477118|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20477119|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227480|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
20227481|NCT00350116|Hematinics|hematinics|mesh-ancestor
20227482|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
20227483|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20227484|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20227485|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477120|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477121|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477122|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20477123|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20477124|NCT01519336|Ritonavir|ritonavir|mesh-list
20477125|NCT01519336|Darunavir|darunavir|mesh-list
20477126|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20477127|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20477128|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
20477129|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477130|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412670|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227486|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227487|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227488|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227489|NCT00350155|Analgesics|analgesics|mesh-ancestor
20227490|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
20227491|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227492|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227493|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227494|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227495|NCT00350168|Amlodipine|amlodipine|mesh-list
20227496|NCT00350168|Valsartan|valsartan|mesh-list
20227497|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20227498|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20227499|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248103|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20227500|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227501|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20227502|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227503|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
20227504|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20227505|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20227506|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
20227507|NCT00350181|Sirolimus|sirolimus|mesh-list
20227508|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
20227509|NCT00350181|Busulfan|busulfan|mesh-list
20227510|NCT00350181|Carmustine|carmustine|mesh-list
20227511|NCT00350181|Etoposide|etoposide|mesh-list
20227512|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227513|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
20227514|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851029|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851030|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20227515|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20248104|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20477131|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20477132|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20477133|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
20477134|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477135|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20477136|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20477137|NCT01519401|Drospirenone|drospirenone|mesh-list
19412671|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
19412672|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412673|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412674|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19412675|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19412676|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19412677|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412678|NCT05232071|Empagliflozin|empagliflozin|mesh-list
19412679|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19412680|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412681|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477138|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20477139|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20477140|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20477141|NCT01519401|Estradiol|estradiol|mesh-list
20477142|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20477143|NCT01519401|Estrogens|estrogens|mesh-ancestor
20477144|NCT01519401|Hormones|hormones|mesh-ancestor
20477145|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477146|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477147|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20477148|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
20477149|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20477150|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19416865|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
19697317|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697318|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19697319|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697320|NCT04928365|Antibodies|antibodies|mesh-list
19697321|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19697322|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
19697323|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412682|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412683|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
19412684|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412685|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412686|NCT05224401|Amoxicillin|amoxicillin|mesh-list
19412687|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
19412688|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19412689|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
19412690|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
19412691|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
19412692|NCT05224401|Trimethoprim|trimethoprim|mesh-list
19412693|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
19412694|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19412695|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19412696|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19412697|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19697324|NCT04928495|Ascorbic Acid|ascorbic acid|mesh-list
19697325|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
19412698|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412699|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412700|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412701|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19412702|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19412703|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19697326|NCT04928495|Bromhexine|bromhexine|mesh-list
19697327|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19697328|NCT04928495|Vitamins|vitamins|mesh-ancestor
19697329|NCT04928495|Micronutrients|micronutrients|mesh-ancestor
19697330|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412704|NCT05224401|Renal Agents|renal agents|mesh-ancestor
19412705|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
19412706|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19697331|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
19851031|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19851032|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19851033|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
19851034|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851035|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851036|NCT00716079|Analgesics|analgesics|mesh-ancestor
19851037|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
19851038|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19851039|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19851040|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19851041|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19851042|NCT00716079|Protective Agents|protective agents|mesh-ancestor
19851043|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
19851044|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
19851045|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19851046|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19851047|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19851048|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19851049|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19851050|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19851051|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
19851052|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19851053|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
19851054|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851055|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19851056|NCT00716092|Linagliptin|linagliptin|mesh-list
19851057|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19851058|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851059|NCT00716092|Incretins|incretins|mesh-ancestor
19851060|NCT00716092|Hormones|hormones|mesh-ancestor
19851061|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851062|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19851063|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
19851064|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851065|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851066|NCT00716144|R 115866|r 115866|mesh-list
19851067|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19412707|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19416866|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
19707916|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851068|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851069|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851070|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19851071|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19851072|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19851073|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19851074|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851075|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
19851076|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851077|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855608|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855609|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
19855610|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855611|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19855612|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855613|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19855614|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697332|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697333|NCT04928495|Protective Agents|protective agents|mesh-ancestor
19697334|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
19697335|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697336|NCT04928495|Expectorants|expectorants|mesh-ancestor
19697337|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
19697338|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19697339|NCT04928495|Antidotes|antidotes|mesh-ancestor
19697340|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
19697341|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
19697342|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19697343|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
19697344|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697345|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227516|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20227517|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
20227518|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227519|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227520|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20227521|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20227522|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20227523|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19851078|NCT00716417|Afatinib|afatinib|mesh-list
19851079|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851080|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851081|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851082|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851083|NCT00716443|Lidocaine|lidocaine|mesh-list
19851084|NCT00716443|Tetracaine|tetracaine|mesh-list
19851085|NCT00716443|Benzocaine|benzocaine|mesh-list
19851086|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
19851087|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
19851088|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227524|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227525|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20227526|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20227527|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
20227528|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20227529|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227530|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
20227531|NCT00350311|Nicotine|nicotine|mesh-list
19697346|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227532|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19412708|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19412709|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19412710|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19412711|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19412712|NCT05223101|Telmisartan|telmisartan|mesh-list
19412713|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19412714|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19412715|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19412716|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412717|NCT05219942|Insulin|insulin|mesh-list
19412718|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
19412719|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19412720|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412721|NCT05216211|Bupivacaine|bupivacaine|mesh-list
19412722|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
19412723|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
19412724|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412725|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412726|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
19412727|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412728|NCT05201300|Propofol|propofol|mesh-list
19412729|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19412730|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412731|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412732|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19412733|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
19697347|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
20227533|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
20227534|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227535|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227536|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20227537|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20227538|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
20227539|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227540|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227541|NCT00350415|Mesalamine|mesalamine|mesh-list
20227542|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20477151|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20477152|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20477153|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20477154|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
20477155|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20477156|NCT01519401|Diuretics|diuretics|mesh-ancestor
20477157|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
20477158|NCT01519544|Acetazolamide|acetazolamide|mesh-list
20477159|NCT01519544|Temazepam|temazepam|mesh-list
20477160|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
20477161|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19697348|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20477162|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477163|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477164|NCT01519544|Diuretics|diuretics|mesh-ancestor
20477165|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
20477166|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477167|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20477168|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697349|NCT04928066|Prednisone|prednisone|mesh-list
20227543|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227544|NCT00350415|Analgesics|analgesics|mesh-ancestor
20227545|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
20227546|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227547|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227548|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227549|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227550|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
20248105|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19412734|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
20477169|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20477170|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20477171|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19412735|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
19412736|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19412737|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412738|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412739|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412740|NCT05197439|Analgesics|analgesics|mesh-ancestor
19412741|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
19412742|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412743|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19412744|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19412745|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19412746|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412747|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412748|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412749|NCT05195775|Tadalafil|tadalafil|mesh-list
19412750|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
19412751|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19412752|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19412753|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412754|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412755|NCT05195775|Urological Agents|urological agents|mesh-ancestor
19412756|NCT05190315|Temozolomide|temozolomide|mesh-list
19412757|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
19412758|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19697350|NCT04928066|Tofacitinib|tofacitinib|mesh-list
19697351|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19697352|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
19697353|NCT04928066|Hormones|hormones|mesh-ancestor
19697354|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697355|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697356|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19697357|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697358|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19697359|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697360|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697361|NCT04927936|Vaccines|vaccines|mesh-list
19697362|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
19697363|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697364|NCT04927949|Cangrelor|cangrelor|mesh-list
19697365|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19697366|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19697367|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20477172|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
20477173|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
20477174|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477175|NCT01519687|Tofisopam|tofisopam|mesh-list
20477176|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
20477177|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20477178|NCT01519726|Midazolam|midazolam|mesh-list
20477179|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20477180|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20477181|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477182|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477183|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20477184|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20477185|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20477186|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20477187|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
20477188|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
20477189|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
20477190|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
20477191|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477192|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477193|NCT01519752|Oxiconazole|oxiconazole|mesh-list
20477194|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
20477195|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477196|NCT01519856|Piribedil|piribedil|mesh-list
20477197|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20477198|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20477199|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
20477200|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
20477201|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477202|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477203|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477204|NCT01519986|Vitamin D|vitamin d|mesh-list
20477205|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
20477206|NCT01519986|Vitamins|vitamins|mesh-ancestor
20477207|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
20477208|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477209|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20477210|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477211|NCT01520012|Esomeprazole|esomeprazole|mesh-list
20477212|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20477213|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20477214|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20477215|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477216|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477217|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20477218|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20477219|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477220|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20477221|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20477222|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20477223|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
20477224|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477225|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20477226|NCT01520103|Everolimus|everolimus|mesh-list
19697368|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19697369|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
19697370|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697371|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697372|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697373|NCT04928586|Pirfenidone|pirfenidone|mesh-list
19697374|NCT04928586|Analgesics|analgesics|mesh-ancestor
20227551|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227552|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
20227553|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20227554|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20227555|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227556|NCT00350441|Urological Agents|urological agents|mesh-ancestor
20227557|NCT00350454|Sirolimus|sirolimus|mesh-list
20227558|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20227559|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227560|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20227561|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227562|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
20477227|NCT01520103|Vinorelbine|vinorelbine|mesh-list
20477228|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477229|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477230|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
20227563|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477231|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477232|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20477233|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
20477234|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
20477235|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
20477236|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227564|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
20227565|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227566|NCT00350467|Olanzapine|olanzapine|mesh-list
20227567|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20227568|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
20227569|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
20227570|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227571|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227572|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20227573|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20477237|NCT01520116|Timolol|timolol|mesh-list
20477238|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20477239|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20477240|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
20477241|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477242|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477243|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477244|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20477245|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20477246|NCT01520181|Lactams|lactams|mesh-list
20477247|NCT01520181|beta-Lactams|beta-lactams|mesh-list
20477248|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20477249|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477250|NCT01520285|Felodipine|felodipine|mesh-list
20477251|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20477252|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19412759|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
20477253|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20477254|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477255|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477256|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477257|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477258|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
20477259|NCT01520298|Acetaminophen|acetaminophen|mesh-list
20477260|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20477261|NCT01520298|Analgesics|analgesics|mesh-ancestor
20477262|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
20477263|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477264|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697375|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
19697376|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697377|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697378|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19697379|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19697380|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19697381|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697382|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697383|NCT04928651|Clonidine|clonidine|mesh-list
19697384|NCT04928651|Analgesics|analgesics|mesh-ancestor
19697385|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
19697386|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697387|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851089|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227574|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20477265|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
20477266|NCT01520350|Aripiprazole|aripiprazole|mesh-list
20477267|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
20477268|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20477269|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20477270|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20477271|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477272|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477273|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
20477274|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
20477275|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477276|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477277|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20477278|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20477279|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
20477280|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20477281|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19697388|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19697389|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
19697390|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
20477282|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20477283|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19697391|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19697392|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19697393|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697394|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697395|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697396|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697397|NCT04928820|Edetic Acid|edetic acid|mesh-list
19697398|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19697399|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
19697400|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
19697401|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697402|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
19697403|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19697404|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20477284|NCT01520389|Irinotecan|irinotecan|mesh-list
20477285|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20477286|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20477287|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20477288|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477289|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477290|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477291|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
20477292|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477293|NCT01520415|Lidocaine|lidocaine|mesh-list
20477294|NCT01520415|Bupivacaine|bupivacaine|mesh-list
20477295|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
20477296|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
20477297|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477298|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477299|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
20477300|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707917|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20477301|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20477302|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20477303|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20477304|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477305|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477306|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20477307|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20477308|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477309|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477310|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19697405|NCT04927858|Empagliflozin|empagliflozin|mesh-list
20227575|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227576|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20227577|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20227578|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20227579|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227580|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227581|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227582|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
20227583|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20227584|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20227585|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20227586|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20227587|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
20227588|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20227589|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
20227590|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20227591|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20227592|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
20227593|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20227594|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227595|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20227596|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20477311|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477312|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477313|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
20477314|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477315|NCT01520467|Anastrozole|anastrozole|mesh-list
20477316|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20477317|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477318|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20477319|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20477320|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477321|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477322|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20227597|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20477323|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
20477324|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412760|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412761|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412762|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
19412763|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
19412764|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412765|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412766|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19412767|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19412768|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19412769|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412770|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19412771|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19412772|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
19412773|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412774|NCT05186129|Clopidogrel|clopidogrel|mesh-list
19412775|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19412776|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19412777|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19412778|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19412779|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
19412780|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412781|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412782|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412783|NCT05175001|Betamethasone|betamethasone|mesh-list
19412784|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
19412785|NCT05175001|Ropivacaine|ropivacaine|mesh-list
19412786|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
19412787|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
19412788|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412789|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412790|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
19412791|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477325|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477326|NCT01520584|Vitamins|vitamins|mesh-list
19412792|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412793|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
19697406|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20477327|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
20477328|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412794|NCT05175001|Hormones|hormones|mesh-ancestor
20527602|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527603|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527604|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
20527605|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527606|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527607|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
20527608|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527609|NCT01768897|Analgesics|analgesics|mesh-ancestor
20527610|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
20527611|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697407|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697408|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19697409|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697410|NCT04927585|Vaccines|vaccines|mesh-list
19697411|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
19697412|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697413|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
19697414|NCT04927481|Analgesics|analgesics|mesh-ancestor
19697415|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
19697416|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851090|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
19851091|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851092|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412795|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412796|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19412797|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
19412798|NCT05172167|Antibodies|antibodies|mesh-list
19412799|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
19412800|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412801|NCT05171231|Hemostatics|hemostatics|mesh-list
19412802|NCT05171231|Coagulants|coagulants|mesh-ancestor
19412803|NCT05164978|Antibodies|antibodies|mesh-list
19412804|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
19697417|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697418|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227598|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412805|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851093|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19851094|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19851095|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19851096|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851097|NCT00716456|Cetuximab|cetuximab|mesh-list
19851098|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19851099|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19697419|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19697420|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19697421|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697422|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227599|NCT00350597|Molgramostim|molgramostim|mesh-list
20227600|NCT00350597|Sargramostim|sargramostim|mesh-list
20227601|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
20227602|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227603|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227604|NCT00350662|Deferiprone|deferiprone|mesh-list
20477329|NCT01520753|Insulin|insulin|mesh-list
20477330|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20477331|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
20477332|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
20477333|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20477334|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
20477335|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477336|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477337|NCT01520766|Methamphetamine|methamphetamine|mesh-list
20477338|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20477339|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477340|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
20477341|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
20477342|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477343|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
20477344|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477345|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477346|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
20477347|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20477348|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20477349|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477350|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20477351|NCT01520792|Acetaminophen|acetaminophen|mesh-list
20477352|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20477353|NCT01520792|Analgesics|analgesics|mesh-ancestor
20477354|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
20477355|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477356|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477357|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
20477358|NCT01520818|Insulin|insulin|mesh-list
19697423|NCT04927299|Losartan|losartan|mesh-list
20227605|NCT00350662|Deferoxamine|deferoxamine|mesh-list
20227606|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20227607|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
20477359|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19412806|NCT05162976|Nivolumab|nivolumab|mesh-list
19412807|NCT05162976|Azacitidine|azacitidine|mesh-list
19412808|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412809|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851100|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227608|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
20227609|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227610|NCT00350662|Siderophores|siderophores|mesh-ancestor
20227611|NCT00350753|Bevacizumab|bevacizumab|mesh-list
20477360|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
20477361|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
20477362|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20477363|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
20477364|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477365|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477366|NCT01520831|Insulin|insulin|mesh-list
20477367|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20477368|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
19851101|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851102|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851103|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851104|NCT00716586|Dorzolamide|dorzolamide|mesh-list
19851105|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19851106|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19851107|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851108|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851109|NCT00716625|Sunitinib|sunitinib|mesh-list
19851110|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851111|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20227612|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20227613|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20227614|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227615|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20227616|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20227617|NCT00350753|Growth Substances|growth substances|mesh-ancestor
19851112|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19851113|NCT00716625|Growth Substances|growth substances|mesh-ancestor
19851114|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851115|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
19851116|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851117|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851118|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851119|NCT00716742|Bimatoprost|bimatoprost|mesh-list
19851120|NCT00716742|Travoprost|travoprost|mesh-list
19851121|NCT00716742|Latanoprost|latanoprost|mesh-list
20477369|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
20477370|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20477371|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
20477372|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20477373|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477374|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477375|NCT01520896|Ketoconazole|ketoconazole|mesh-list
20477376|NCT01520896|Naloxegol|naloxegol|mesh-list
20477377|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
20477378|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477379|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20477380|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20477381|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477382|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477383|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20227618|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227619|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
20227620|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227621|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227622|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227623|NCT00350818|Azacitidine|azacitidine|mesh-list
20227624|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227625|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
19697424|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19697425|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
19697426|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697427|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19697428|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19697429|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19697430|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697431|NCT04927299|Diuretics|diuretics|mesh-ancestor
19697432|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
19697433|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697434|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19851122|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20227626|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227627|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227628|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227629|NCT00350857|Carbamazepine|carbamazepine|mesh-list
20227630|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
19697435|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227631|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
20227632|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20227633|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227634|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227635|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20227636|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227637|NCT00350857|Analgesics|analgesics|mesh-ancestor
19412810|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20227638|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
20227639|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477384|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
20477385|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477386|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477387|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20477388|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20477389|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
19412811|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412812|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412813|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
19412814|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412815|NCT05161806|Aflibercept|aflibercept|mesh-list
19412816|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19412817|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19412818|NCT05161806|Growth Substances|growth substances|mesh-ancestor
19412819|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412820|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
19697436|NCT04926844|Midazolam|midazolam|mesh-list
19412821|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227640|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20227641|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227642|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227643|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19697437|NCT04926844|Levetiracetam|levetiracetam|mesh-list
19697438|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19697439|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19697440|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697441|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697442|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19697443|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20227644|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20227645|NCT00350948|Doxorubicin|doxorubicin|mesh-list
20227646|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19697444|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19697445|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19697446|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
19697447|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
19697448|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
19697449|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
19697450|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697451|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697452|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
20227647|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20227648|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227649|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20227650|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20227651|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227652|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227653|NCT00350961|Gemcitabine|gemcitabine|mesh-list
20227654|NCT00350961|Capecitabine|capecitabine|mesh-list
20477390|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227655|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
20227656|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227657|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
20227658|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227659|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477391|NCT01521130|Levetiracetam|levetiracetam|mesh-list
20477392|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
20477393|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
20477394|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
20477395|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477396|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
20477397|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477398|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477399|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20477400|NCT01521312|Saxagliptin|saxagliptin|mesh-list
20477401|NCT01521312|Incretins|incretins|mesh-ancestor
20477402|NCT01521312|Hormones|hormones|mesh-ancestor
20477403|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477404|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477405|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20477406|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
20477407|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477408|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477409|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477410|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20477411|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
20477412|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477413|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
20477414|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20477415|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20477416|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477417|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20477418|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20477419|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477420|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477421|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477422|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20477423|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
20477424|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20477425|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477426|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20227660|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
19851123|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19851124|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19851125|NCT00716820|Sunitinib|sunitinib|mesh-list
19851126|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851127|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851128|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19851129|NCT00716820|Growth Substances|growth substances|mesh-ancestor
19851130|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851131|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
19851132|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851133|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851134|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851135|NCT00716859|Timolol|timolol|mesh-list
20477427|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20477428|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20477429|NCT01521403|Metronidazole|metronidazole|mesh-list
20477430|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477431|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20477432|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20477433|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20477434|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19851136|NCT00716859|Latanoprost|latanoprost|mesh-list
19851137|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19851138|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19851139|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
19851140|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851141|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851142|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851143|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19851144|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19851145|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19851146|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19851147|NCT00716963|Fluticasone|fluticasone|mesh-list
19851148|NCT00716963|Xhance|xhance|mesh-list
19851149|NCT00716963|Budesonide|budesonide|mesh-list
19851150|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19851151|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19851152|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
19697453|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
19697454|NCT04927000|Tofacitinib|tofacitinib|mesh-list
19697455|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227661|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227662|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227663|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20227664|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
20227665|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227666|NCT00351026|Methadone|methadone|mesh-list
20227667|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20227668|NCT00351026|Narcotics|narcotics|mesh-ancestor
20227669|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697456|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697457|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697458|NCT04927052|Lidocaine|lidocaine|mesh-list
19697459|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697460|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
19697461|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697462|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697463|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
19697464|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697465|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697466|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19697467|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19697468|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697469|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697470|NCT04926753|Fluorouracil|fluorouracil|mesh-list
19697471|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697472|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
19697473|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697474|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851153|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851154|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477435|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20477436|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
20477437|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477438|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477439|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20477440|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
20477441|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
20477442|NCT01521455|Hormones|hormones|mesh-ancestor
20477443|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477444|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
20477445|NCT01521481|Anesthetics|anesthetics|mesh-list
20227670|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227671|NCT00351026|Analgesics|analgesics|mesh-ancestor
20227672|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
20227673|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227674|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
20227675|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
20227676|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
20227677|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227678|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227679|NCT00351052|Analgesics|analgesics|mesh-ancestor
20227680|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
19697475|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697476|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
19697477|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697478|NCT04926480|Anesthetics|anesthetics|mesh-list
19697479|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697480|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697481|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19697482|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697483|NCT04927039|Iloprost|iloprost|mesh-list
20227681|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227682|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227683|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227684|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227685|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
20477446|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477447|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477448|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20477449|NCT01521520|Hematinics|hematinics|mesh-ancestor
20477450|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20477451|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20477452|NCT01521572|Albuterol|albuterol|mesh-list
19697484|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19697485|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
19697486|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19697487|NCT04926545|Fluorouracil|fluorouracil|mesh-list
19697488|NCT04926545|Irinotecan|irinotecan|mesh-list
19697489|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
20227686|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477453|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19697490|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227687|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
20227688|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20227689|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227690|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227691|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
20477454|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
20477455|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477456|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697491|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19697492|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697493|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697494|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
19697495|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227692|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20227693|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227694|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227695|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20227696|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227697|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20477457|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20477458|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
20477459|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
20477460|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20477461|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20477462|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20477463|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20477464|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
20477465|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477466|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697496|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19697497|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19697498|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697499|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19697500|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
19697501|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697502|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20227698|NCT00351104|Ketoprofen|ketoprofen|mesh-list
20227699|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227700|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19697503|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19851155|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19851156|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
20227701|NCT00351104|Analgesics|analgesics|mesh-ancestor
20227702|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
20227703|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227704|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227705|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227706|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20227707|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20227708|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227709|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227710|NCT00351130|Amlodipine|amlodipine|mesh-list
20227711|NCT00351130|Valsartan|valsartan|mesh-list
20227712|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20227713|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20227714|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227715|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477467|NCT01521624|Metformin|metformin|mesh-list
20477468|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477469|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477470|NCT01521689|Rituximab|rituximab|mesh-list
20477471|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20477472|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477473|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
20477474|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477475|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20477476|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20477477|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19697504|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19697505|NCT04926532|Sorafenib|sorafenib|mesh-list
19697506|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697507|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227716|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20227717|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227718|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
20227719|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20477478|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20477479|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
20477480|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477481|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477482|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227720|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20227721|NCT00351143|Fluticasone|fluticasone|mesh-list
20227722|NCT00351143|Xhance|xhance|mesh-list
20227723|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20227724|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20227725|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20227726|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
20477483|NCT01521767|Urological Agents|urological agents|mesh-ancestor
20477484|NCT01521793|Retinol acetate|retinol acetate|mesh-list
20477485|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20477486|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
20477487|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477488|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20477489|NCT01521793|Protective Agents|protective agents|mesh-ancestor
20477490|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477491|NCT01521819|Ranibizumab|ranibizumab|mesh-list
20477492|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20477493|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20477494|NCT01521819|Growth Substances|growth substances|mesh-ancestor
20477495|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697508|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697509|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697510|NCT04925973|Tofacitinib|tofacitinib|mesh-list
19697511|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227727|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697512|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697513|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697514|NCT04926155|Metformin|metformin|mesh-list
19697515|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227728|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227729|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20227730|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
20227731|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
20227732|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20227733|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20227734|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20227735|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20227736|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
20227737|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227738|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227739|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20227740|NCT00351169|Citalopram|citalopram|mesh-list
20227741|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20227742|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20227743|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227744|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477496|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
20477497|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227745|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227746|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
20227747|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227748|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20227749|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
20227750|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20227751|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20477498|NCT01521936|Vitamin D|vitamin d|mesh-list
20477499|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
20477500|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
20477501|NCT01521936|Vitamins|vitamins|mesh-list
20477502|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
20477503|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477504|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20477505|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477506|NCT01521962|Alogliptin|alogliptin|mesh-list
20477507|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477508|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477509|NCT01521962|Incretins|incretins|mesh-ancestor
20227752|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20227753|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227754|NCT00351182|Doxycycline|doxycycline|mesh-list
20227755|NCT00351182|Telithromycin|telithromycin|mesh-list
20227756|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20227757|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227758|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
20227759|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20227760|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20227761|NCT00351195|Capecitabine|capecitabine|mesh-list
20477510|NCT01521962|Hormones|hormones|mesh-ancestor
20477511|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477512|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20477513|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
20477514|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477515|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477516|NCT01521975|Adefovir|adefovir|mesh-list
20477517|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20477518|NCT01521975|Telbivudine|telbivudine|mesh-list
20477519|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
20477520|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477521|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20477522|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20477523|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477524|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477525|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
20477526|NCT01522040|Analgesics|analgesics|mesh-ancestor
20477527|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
20477528|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477529|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477530|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
20477531|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477532|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20477533|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
20477534|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20477535|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477536|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227762|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
20227763|NCT00351195|Etoposide|etoposide|mesh-list
20227764|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227765|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
20227766|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227767|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227768|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20227769|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20227770|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20227771|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227772|NCT00351221|Mecasermin|mecasermin|mesh-list
20227773|NCT00351221|Growth Substances|growth substances|mesh-ancestor
20227774|NCT00351221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227775|NCT00351286|Simvastatin|simvastatin|mesh-list
20227776|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20227777|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227778|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
20227779|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227780|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227781|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20227782|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227783|NCT00351364|Montelukast|montelukast|mesh-list
20227784|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20227785|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
20227786|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20227787|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
19412822|NCT05151484|Alendronate|alendronate|mesh-list
20247487|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20227788|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227789|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227790|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20227791|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20227792|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227793|NCT00351403|Ribavirin|ribavirin|mesh-list
20227794|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20227795|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
20227796|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227797|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
19697516|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697517|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20227798|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227799|NCT00351507|Vildagliptin|vildagliptin|mesh-list
20227800|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227801|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227802|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20227803|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
20227804|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227805|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477537|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477538|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
20477539|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20477540|NCT01522092|Citalopram|citalopram|mesh-list
20477541|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20477542|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20477543|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477544|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477545|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477546|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
20477547|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477548|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20477549|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
19697518|NCT04925531|Ampicillin|ampicillin|mesh-list
19697519|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697520|NCT04925505|Anesthetics|anesthetics|mesh-list
19697521|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477550|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20477551|NCT01522105|Daptomycin|daptomycin|mesh-list
20477552|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20477553|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527612|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20527613|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20527614|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527615|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
20527616|NCT01768897|Protective Agents|protective agents|mesh-ancestor
20527617|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
20527618|NCT01768897|Vitamins|vitamins|mesh-ancestor
20527619|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
20527620|NCT01768988|Pregabalin|pregabalin|mesh-list
20527621|NCT01768988|Analgesics|analgesics|mesh-ancestor
20527622|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
20527623|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527624|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527625|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
20527626|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20527627|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527628|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527629|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20527630|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20527631|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20527632|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20527633|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530644|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530645|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
20530646|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530647|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20530648|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20530649|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20530650|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20530651|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20530652|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20530653|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20530654|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
20530655|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20530656|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530657|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20530658|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20530659|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20530660|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20530661|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20530662|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
20530663|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20530664|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19697522|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697523|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
19697524|NCT04925557|Siponimod|siponimod|mesh-list
19697525|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
19697526|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697527|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19697528|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227806|NCT00351546|Vildagliptin|vildagliptin|mesh-list
20227807|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227808|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227809|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20227810|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
19697529|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19707918|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19707919|NCT04821947|Bupivacaine|bupivacaine|mesh-list
19707920|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
19851157|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
19851158|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19851159|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
19851160|NCT00716963|Hormones|hormones|mesh-ancestor
19851161|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851162|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
19851163|NCT00716976|Antidotes|antidotes|mesh-ancestor
19851164|NCT00716976|Protective Agents|protective agents|mesh-ancestor
19851165|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707921|NCT04821947|Anesthetics|anesthetics|mesh-list
19851166|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
19697530|NCT04925141|Dasatinib|dasatinib|mesh-list
19697531|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697532|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19697533|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697534|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697535|NCT04925063|Metformin|metformin|mesh-list
19697536|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19697537|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697538|NCT04925076|Ethanol|ethanol|mesh-list
19697539|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19697540|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697541|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697542|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697543|NCT04925167|Heparin|heparin|mesh-list
19697544|NCT04925167|Calcium heparin|calcium heparin|mesh-list
19412823|NCT05151484|Teriparatide|teriparatide|mesh-list
19412824|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19412825|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412826|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19412827|NCT05140148|Amantadine|amantadine|mesh-list
19412828|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19412829|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19412830|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
19412831|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19412832|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
19412833|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412834|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412835|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412836|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19412837|NCT05140148|Analgesics|analgesics|mesh-ancestor
19412838|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
19412839|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412840|NCT05092841|Naltrexone|naltrexone|mesh-list
19412841|NCT05092841|Baclofen|baclofen|mesh-list
19412842|NCT05092841|Sorbitol|sorbitol|mesh-list
19412843|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19412844|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19412845|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412846|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
19412847|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412848|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19412849|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19412850|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19412851|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
19697545|NCT04925167|Argatroban|argatroban|mesh-list
19697546|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
19697547|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19697548|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19697549|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697550|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
19697551|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19697552|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
19697553|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697554|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19697555|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19697556|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19697557|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697558|NCT04924647|Dexamethasone|dexamethasone|mesh-list
20227811|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227812|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247488|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247489|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19697559|NCT04924647|Lenalidomide|lenalidomide|mesh-list
19697560|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19697561|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
19697562|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
20247490|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
20247491|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
20247492|NCT00432406|Etanercept|etanercept|mesh-list
20247493|NCT00432406|Infliximab|infliximab|mesh-list
19697563|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247494|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
19697564|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227813|NCT00351585|Vildagliptin|vildagliptin|mesh-list
20227814|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227815|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227816|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20227817|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
20227818|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227819|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227820|NCT00351637|Methadone|methadone|mesh-list
20227821|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20227822|NCT00351637|Narcotics|narcotics|mesh-ancestor
20227823|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227824|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227825|NCT00351637|Analgesics|analgesics|mesh-ancestor
20227826|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
20227827|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227828|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
20227829|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
20227830|NCT00351663|Enoxaparin|enoxaparin|mesh-list
20227831|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
20227832|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20227833|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19412852|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
20227834|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227835|NCT00351702|Isoniazid|isoniazid|mesh-list
20227836|NCT00351702|Ethambutol|ethambutol|mesh-list
20227837|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
20227838|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20227839|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477554|NCT01522326|Ibuprofen|ibuprofen|mesh-list
20477555|NCT01522326|Metoclopramide|metoclopramide|mesh-list
20477556|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20227840|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20227841|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227842|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
20227843|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227844|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20477557|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20477558|NCT01522326|Analgesics|analgesics|mesh-ancestor
20477559|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
20477560|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477561|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227845|NCT00351715|Methadone|methadone|mesh-list
20227846|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20227847|NCT00351715|Narcotics|narcotics|mesh-ancestor
20227848|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227849|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227850|NCT00351715|Analgesics|analgesics|mesh-ancestor
19851167|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851168|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
19851169|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19851170|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851171|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
20477562|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20477563|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20477564|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20477565|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477566|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477567|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
20477568|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
20477569|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20227851|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
20227852|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527634|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20227853|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
20227854|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
20227855|NCT00351832|Vildagliptin|vildagliptin|mesh-list
20227856|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227857|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227858|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20227859|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
20227860|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227861|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227862|NCT00351871|Ribavirin|ribavirin|mesh-list
20227863|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20227864|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
20227865|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227866|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
20227867|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227868|NCT00351884|Vildagliptin|vildagliptin|mesh-list
20227869|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227870|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227871|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20227872|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
20227873|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227874|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227875|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20227876|NCT00351910|Amitriptyline|amitriptyline|mesh-list
20227877|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20227878|NCT00351910|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20227879|NCT00351910|Citalopram|citalopram|mesh-list
20227880|NCT00351910|Bupropion|bupropion|mesh-list
20227881|NCT00351910|Fluoxetine|fluoxetine|mesh-list
20227882|NCT00351910|Paroxetine|paroxetine|mesh-list
20227883|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20227884|NCT00351910|Sertraline|sertraline|mesh-list
20227885|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20227886|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20227887|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20227888|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227889|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227890|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
20227891|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227892|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20227893|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
20227894|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20227895|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20227896|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20227897|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
20227898|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20227899|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20227900|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227901|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20477570|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20477571|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20477572|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
20477573|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477574|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20477575|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477576|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477577|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477578|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20477579|NCT01522534|Morphine|morphine|mesh-list
20477580|NCT01522534|Mepivacaine|mepivacaine|mesh-list
20227902|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20477581|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20477582|NCT01522534|Narcotics|narcotics|mesh-ancestor
20477583|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477584|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477585|NCT01522534|Analgesics|analgesics|mesh-ancestor
20477586|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
20477587|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477588|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
20477589|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
20477590|NCT01522547|Pomalidomide|pomalidomide|mesh-list
20227903|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227904|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20227905|NCT00351910|Analgesics|analgesics|mesh-ancestor
20227906|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
20227907|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20227908|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20227909|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20227910|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
20227911|NCT00351975|Azacitidine|azacitidine|mesh-list
20227912|NCT00351975|Belinostat|belinostat|mesh-list
20227913|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20227914|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
20227915|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227916|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227917|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227918|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20227919|NCT00352079|Gefitinib|gefitinib|mesh-list
20227920|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
20227921|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227922|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20227923|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227924|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227925|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20227926|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
20227927|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227928|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
20477591|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
20477592|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477593|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20477594|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20477595|NCT01522547|Growth Substances|growth substances|mesh-ancestor
20477596|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
20477597|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477598|NCT01522612|Leucovorin|leucovorin|mesh-list
20477599|NCT01522612|Fluorouracil|fluorouracil|mesh-list
20477600|NCT01522612|Cetuximab|cetuximab|mesh-list
20477601|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
20477602|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477603|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20477604|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477605|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477606|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
20477607|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477608|NCT01522612|Antidotes|antidotes|mesh-ancestor
20477609|NCT01522612|Protective Agents|protective agents|mesh-ancestor
20227929|NCT00352092|Sirolimus|sirolimus|mesh-list
20227930|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20227931|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20227932|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227933|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20227934|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
20227935|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20227936|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20227937|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227938|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227939|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
20227940|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477610|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
20477611|NCT01522612|Vitamins|vitamins|mesh-ancestor
20227941|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
20227942|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227943|NCT00352144|Eszopiclone|eszopiclone|mesh-list
20227944|NCT00352144|Zopiclone|zopiclone|mesh-list
20227945|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20227946|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227947|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227948|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
20227949|NCT00352170|Vitamin D|vitamin d|mesh-list
20227950|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
20227951|NCT00352170|Calcium|calcium|mesh-list
20227952|NCT00352170|Vitamins|vitamins|mesh-ancestor
20227953|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
20227954|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227955|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20227956|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20227957|NCT00352183|Simvastatin|simvastatin|mesh-list
20227958|NCT00352183|Fenofibrate|fenofibrate|mesh-list
20227959|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20227960|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20227961|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
20227962|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697565|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697566|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
19697567|NCT04924647|Hormones|hormones|mesh-ancestor
20227963|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20227964|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20227965|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227966|NCT00352196|Risperidone|risperidone|mesh-list
20227967|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20227968|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
20227969|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20227970|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227971|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227972|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20227973|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20227974|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20227975|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20227976|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20227977|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
20227978|NCT00352235|KRN 7000|krn 7000|mesh-list
20227979|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20227980|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
20227981|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227982|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20227983|NCT00352261|Esomeprazole|esomeprazole|mesh-list
20227984|NCT00352261|Lansoprazole|lansoprazole|mesh-list
20227985|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
20227986|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20227987|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20227988|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20227989|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20227990|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20227991|NCT00352287|Pioglitazone|pioglitazone|mesh-list
20227992|NCT00352287|Hormones|hormones|mesh-list
20227993|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20227994|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20227995|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20227996|NCT00352300|Paclitaxel|paclitaxel|mesh-list
20227997|NCT00352300|Carboplatin|carboplatin|mesh-list
20227998|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20227999|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228000|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
19412853|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412854|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412855|NCT05092841|Cathartics|cathartics|mesh-ancestor
19412856|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19412857|NCT05090358|Canagliflozin|canagliflozin|mesh-list
19412858|NCT05090358|Fulvestrant|fulvestrant|mesh-list
19412859|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19412860|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851172|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
19412861|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19412862|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20228001|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
20228002|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
20228003|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228004|NCT00352313|Carboplatin|carboplatin|mesh-list
20228005|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228006|NCT00352339|Aripiprazole|aripiprazole|mesh-list
20228007|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
20228008|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228009|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20228010|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20228011|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228012|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228013|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
20228014|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
20228015|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228016|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228017|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20228018|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20228019|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
19412863|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
20228020|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20228021|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20228022|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20228023|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20228024|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
20228025|NCT00352378|Docetaxel|docetaxel|mesh-list
20228026|NCT00352378|Doxorubicin|doxorubicin|mesh-list
20228027|NCT00352378|Capecitabine|capecitabine|mesh-list
20228028|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228029|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
20228030|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228031|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228032|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20228033|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
20228034|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228035|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228036|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20228037|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
20228038|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
20228039|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
20228040|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20228041|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20228042|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20228043|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228044|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20477612|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
20477613|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20477614|NCT01522625|Tenofovir|tenofovir|mesh-list
20477615|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
20477616|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477617|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20477618|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20477619|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477620|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477621|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20477622|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20228045|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
20477623|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20477624|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20477625|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
20477626|NCT01522729|Fentanyl|fentanyl|mesh-list
20477627|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20477628|NCT01522729|Narcotics|narcotics|mesh-ancestor
20477629|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477630|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477631|NCT01522729|Analgesics|analgesics|mesh-ancestor
20477632|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
20477633|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477634|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20477635|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20477636|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
20477637|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
20477638|NCT01522768|Paclitaxel|paclitaxel|mesh-list
20477639|NCT01522768|Afatinib|afatinib|mesh-list
20477640|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20477641|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477642|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
20477643|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
20477644|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
20477645|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477646|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20477647|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477648|NCT01522820|Sirolimus|sirolimus|mesh-list
20477649|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20477650|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477651|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20477652|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477653|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
20477654|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477655|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
20477656|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477657|NCT01522846|Heparin|heparin|mesh-list
20477658|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
20477659|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20477660|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20477661|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477662|NCT01522872|Dexamethasone|dexamethasone|mesh-list
20228046|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
20228047|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20228048|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
20228049|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228050|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228051|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20228052|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
20228053|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20228054|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
20228055|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228056|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228057|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20228058|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
20228059|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
20228060|NCT00352430|Protective Agents|protective agents|mesh-ancestor
20228061|NCT00352443|Everolimus|everolimus|mesh-list
20228062|NCT00352443|Lapatinib|lapatinib|mesh-list
20228063|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697568|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697569|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19697570|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697571|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
20228064|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697572|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19697573|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20228065|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
20228066|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228067|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20228068|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228069|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228070|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19697574|NCT04924647|Growth Substances|growth substances|mesh-ancestor
19697575|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
19697576|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
19697577|NCT04924192|Irinotecan|irinotecan|mesh-list
19697578|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19697579|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19697580|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697581|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697582|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697583|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19697584|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19697585|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19697586|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
19707922|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228071|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
20228072|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228073|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20228074|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20228075|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228076|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228077|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
20228078|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
20477663|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
20477664|NCT01522872|Bortezomib|bortezomib|mesh-list
20477665|NCT01522872|Pomalidomide|pomalidomide|mesh-list
20477666|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
20228079|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20228080|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20228081|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228082|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228083|NCT00352482|Urological Agents|urological agents|mesh-ancestor
20228084|NCT00352495|Carboplatin|carboplatin|mesh-list
20228085|NCT00352495|Vinblastine|vinblastine|mesh-list
20228086|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477667|NCT01522872|BB 1101|bb 1101|mesh-list
20477668|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20477669|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
20477670|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
20477671|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477672|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477673|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228087|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20228088|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
20228089|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
20228090|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
20228091|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228092|NCT00352521|Bevacizumab|bevacizumab|mesh-list
20228093|NCT00352521|Irinotecan|irinotecan|mesh-list
20477674|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
20477675|NCT01522872|Hormones|hormones|mesh-ancestor
20477676|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477677|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20477678|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477679|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
20477680|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527635|NCT01769027|Azithromycin|azithromycin|mesh-list
20228094|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20228095|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228096|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20228097|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20228098|NCT00352521|Growth Substances|growth substances|mesh-ancestor
20228099|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228100|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
20228101|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20228102|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20228103|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228104|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228105|NCT00352599|Lovastatin|lovastatin|mesh-list
20228106|NCT00352599|L 647318|l 647318|mesh-list
20228107|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
20228108|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20228109|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20228110|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
20228111|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228112|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20228113|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20228114|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228115|NCT00352625|Ketoprofen|ketoprofen|mesh-list
20228116|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20228117|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20228118|NCT00352625|Analgesics|analgesics|mesh-ancestor
20228119|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
20228120|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228121|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228122|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20228123|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228124|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20228125|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228126|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228127|NCT00352651|Pregabalin|pregabalin|mesh-list
20228128|NCT00352651|Analgesics|analgesics|mesh-ancestor
20228129|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
20228130|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228131|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228132|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
20228133|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20228134|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228135|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228136|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20228137|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20228138|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20228139|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228140|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228141|NCT00352677|Bafetinib|bafetinib|mesh-list
20228142|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20228143|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228144|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228145|NCT00352742|Bortezomib|bortezomib|mesh-list
19851173|NCT00717054|Scopolamine|scopolamine|mesh-list
19412864|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20228146|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20228147|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228148|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
20228149|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
20228150|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228151|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228152|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20228153|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20228154|NCT00352742|Growth Substances|growth substances|mesh-ancestor
20228155|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228156|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
20228157|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
20228158|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228159|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477681|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477682|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
20477683|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20477684|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20477685|NCT01522872|Growth Substances|growth substances|mesh-ancestor
20477686|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
20477687|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20477688|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
20477689|NCT01522989|Fluorouracil|fluorouracil|mesh-list
20477690|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
20477691|NCT01522989|Palbociclib|palbociclib|mesh-list
20477692|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
20477693|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477694|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20477695|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477696|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477697|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
20477698|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477699|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20477700|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477701|NCT01523002|Artesunate|artesunate|mesh-list
20477702|NCT01523002|Pyronaridine|pyronaridine|mesh-list
20477703|NCT01523002|Metoprolol|metoprolol|mesh-list
20477704|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20477705|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20477706|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
20477707|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
20477708|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228160|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20228161|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20228162|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228163|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697587|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697588|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697589|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19707923|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707924|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
19707925|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707926|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
19707927|NCT04822090|Antibodies|antibodies|mesh-list
19707928|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
19707929|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19707930|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19707931|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
20228164|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19697590|NCT04922827|Infliximab|infliximab|mesh-list
19851174|NCT00717054|Aprepitant|aprepitant|mesh-list
20228165|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20228166|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20228167|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697591|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19697592|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697593|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697594|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
19697595|NCT04922996|Calcium|calcium|mesh-list
19697596|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19697597|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697598|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
19697599|NCT04922996|Coagulants|coagulants|mesh-ancestor
19851175|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19851176|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
19851177|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
19851178|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228168|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228169|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
20228170|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20228171|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
20228172|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20228173|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20228174|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20228175|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20228176|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20228177|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20228178|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20228179|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20228180|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
20228181|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228182|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228183|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228184|NCT00352833|Catumaxomab|catumaxomab|mesh-list
20228185|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228186|NCT00352859|Gemcitabine|gemcitabine|mesh-list
20228187|NCT00352859|Interferons|interferons|mesh-list
20228188|NCT00352859|Sorafenib|sorafenib|mesh-list
20228189|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228190|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
20228191|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228192|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228193|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
20228194|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477709|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477710|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20477711|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19697600|NCT04923113|Amoxicillin|amoxicillin|mesh-list
19697601|NCT04923113|Minocycline|minocycline|mesh-list
19412865|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412866|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19412867|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697602|NCT04923113|Rabeprazole|rabeprazole|mesh-list
19697603|NCT04923113|Bismuth|bismuth|mesh-list
19697604|NCT04923113|Antibodies|antibodies|mesh-list
19697605|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
20477712|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20477713|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
20477714|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477715|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477716|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
20477717|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20477718|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20477719|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477720|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477721|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
20477722|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
20477723|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20477724|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
20477725|NCT01523015|Docetaxel|docetaxel|mesh-list
20477726|NCT01523015|Fluorouracil|fluorouracil|mesh-list
20477727|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
20477728|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477729|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
20477730|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
20477731|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
19412868|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19412869|NCT05084638|Ofatumumab|ofatumumab|mesh-list
19412870|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412871|NCT05079217|Vaccines|vaccines|mesh-list
19412872|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
19697606|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697607|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20477732|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697608|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697609|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20228195|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412873|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412874|NCT05057130|Cisplatin|cisplatin|mesh-list
20228196|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228197|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
20228198|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228199|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19412875|NCT05057130|Doxorubicin|doxorubicin|mesh-list
19412876|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19412877|NCT05057130|Methotrexate|methotrexate|mesh-list
19412878|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412879|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19412880|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19412881|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19412882|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412883|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412884|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19412885|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
19412886|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19412887|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228200|NCT00352950|Panitumumab|panitumumab|mesh-list
20228201|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20228202|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228203|NCT00353002|Lidocaine|lidocaine|mesh-list
20228204|NCT00353002|Tetracaine|tetracaine|mesh-list
20228205|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
20228206|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
20228207|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228208|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228209|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
20228210|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228211|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20228212|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20228213|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20228214|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228215|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228216|NCT00353015|Cisplatin|cisplatin|mesh-list
20228217|NCT00353015|Irinotecan|irinotecan|mesh-list
20228218|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228219|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19412888|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412889|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
19412890|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
19412891|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19412892|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19412893|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
19412894|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228220|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20228221|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412895|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19412896|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
20228222|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228223|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
20228224|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228225|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228226|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20228227|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20228228|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228229|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477733|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
20477734|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228230|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228231|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20477735|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477736|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
20477737|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477738|NCT01523041|Insulin|insulin|mesh-list
20477739|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20477740|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
20477741|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
20477742|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20477743|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
20477744|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477745|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477746|NCT01523054|Metoprolol|metoprolol|mesh-list
20477747|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412897|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19412898|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19412899|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20228232|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20228233|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228234|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228235|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
20228236|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20477748|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20477749|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
20477750|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
20477751|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477752|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477753|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20477754|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20477755|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20477756|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
20477757|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228237|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
20228238|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20228239|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20228240|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20228241|NCT00353041|Lidocaine|lidocaine|mesh-list
20228242|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
20228243|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
20228244|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228245|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228246|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
20228247|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228248|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20228249|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20228250|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20228251|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228252|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228253|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
20228254|NCT00353054|Antacids|antacids|mesh-ancestor
20228255|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228256|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228257|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
20228258|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20228259|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20228260|NCT00353067|Analgesics|analgesics|mesh-ancestor
20228261|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
19697610|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697611|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20228262|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228263|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228264|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20228265|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228266|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20228267|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228268|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228269|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
20228270|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20228271|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228272|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477758|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477759|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
20477760|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
20477761|NCT01523080|Acetaminophen|acetaminophen|mesh-list
20477762|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20477763|NCT01523080|Analgesics|analgesics|mesh-ancestor
20477764|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
20477765|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697612|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477766|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477767|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
20477768|NCT01523093|Ondansetron|ondansetron|mesh-list
20477769|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
19412900|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19412901|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412902|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
19412903|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412904|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412905|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19412906|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412907|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19412908|NCT05055713|Somatostatin|somatostatin|mesh-list
19412909|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19412910|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412911|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412912|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412913|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412914|NCT05055713|Hormones|hormones|mesh-ancestor
19412915|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19412916|NCT05042791|Capecitabine|capecitabine|mesh-list
20228273|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20228274|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228275|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20228276|NCT00353145|Gemcitabine|gemcitabine|mesh-list
20228277|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
20228278|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228279|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
20228280|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228281|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228282|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
20228283|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228284|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228285|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228286|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
20228287|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228288|NCT00353184|Montelukast|montelukast|mesh-list
20477770|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
20477771|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477772|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477773|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20477774|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
20477775|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
20477776|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20477777|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
20477778|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477779|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477780|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20477781|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20477782|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477783|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228289|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20228290|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
20228291|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20228292|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
20228293|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20228294|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228295|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20228296|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20228297|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412917|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19412918|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
19697613|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697614|NCT04923113|Antacids|antacids|mesh-ancestor
19697615|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19697616|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19697617|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
20228298|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
20228299|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20228300|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
20228301|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228302|NCT00353340|Expectorants|expectorants|mesh-ancestor
20228303|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
20228304|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20228305|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
20228306|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228307|NCT00353340|Protective Agents|protective agents|mesh-ancestor
20228308|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228309|NCT00353340|Antidotes|antidotes|mesh-ancestor
20247495|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247496|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247497|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20247498|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20247499|NCT00432406|Analgesics|analgesics|mesh-ancestor
20247500|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
20247501|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247502|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247503|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247504|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247505|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
20247506|NCT00432432|Infliximab|infliximab|mesh-list
20247507|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
20247508|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247509|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247510|NCT00432510|Complement C1s|complement c1s|mesh-list
20247511|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19412919|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247512|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19851179|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851180|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19851181|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19851182|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851183|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851184|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20228310|NCT00353379|Guanfacine|guanfacine|mesh-list
20228311|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20228312|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20228313|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20228314|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20228315|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
20228316|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228317|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228318|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228319|NCT00353561|Fluconazole|fluconazole|mesh-list
20228320|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
20228321|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228322|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20228323|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20228324|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228325|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228326|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20228327|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
20228328|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20228329|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851185|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
20228330|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20228331|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20228332|NCT00353665|Riluzole|riluzole|mesh-list
20228333|NCT00353665|Memantine|memantine|mesh-list
20228334|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19851186|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19851187|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
19851188|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19851189|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
19851190|NCT00717067|Ritonavir|ritonavir|mesh-list
19851191|NCT00717067|Saquinavir|saquinavir|mesh-list
19851192|NCT00717067|Maraviroc|maraviroc|mesh-list
19851193|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19851194|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19851195|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
19851196|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851197|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851198|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19851199|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20228335|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20228336|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
20228337|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228338|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228339|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228340|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20228341|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19697618|NCT04922359|Lidocaine|lidocaine|mesh-list
19697619|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697620|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
19697621|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697622|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697623|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
19697624|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697625|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697626|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19697627|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19697628|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19851200|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
19851201|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228342|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
20228343|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20228344|NCT00353665|Protective Agents|protective agents|mesh-ancestor
20228345|NCT00353678|Darexaban|darexaban|mesh-list
20228346|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20228347|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
20228348|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20228349|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
20228350|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228351|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228352|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
19412920|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412921|NCT05041062|Nivolumab|nivolumab|mesh-list
19412922|NCT05041062|Ipilimumab|ipilimumab|mesh-list
20228353|NCT00353691|Metformin|metformin|mesh-list
20228354|NCT00353691|Glimepiride|glimepiride|mesh-list
20228355|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20228356|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228357|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20228358|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228359|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
20228360|NCT00353717|Paclitaxel|paclitaxel|mesh-list
20228361|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20228362|NCT00353717|Cetuximab|cetuximab|mesh-list
20228363|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20228364|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228365|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
20228366|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
20228367|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
20228368|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228369|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20228370|NCT00353743|Metronidazole|metronidazole|mesh-list
20228371|NCT00353743|Doxycycline|doxycycline|mesh-list
20228372|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228373|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228374|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20228375|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20228376|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
20228377|NCT00353808|Reboxetine|reboxetine|mesh-list
20228378|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
20228379|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228380|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20228381|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20228382|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228383|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228384|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
20228385|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228386|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228387|NCT00353912|Amlodipine|amlodipine|mesh-list
20228388|NCT00353912|Valsartan|valsartan|mesh-list
20228389|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20228390|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20228391|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228392|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477784|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20477785|NCT01523119|Ondansetron|ondansetron|mesh-list
20477786|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
20477787|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
20477788|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477789|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477790|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20477791|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
20477792|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
20477793|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20477794|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
20477795|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20477796|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477797|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20477798|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20477799|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477800|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20477801|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20477802|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
20477803|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20477804|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
19412923|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412924|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412925|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19412926|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228393|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477805|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20228394|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228395|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
20228396|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20228397|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20228398|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
20228399|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20228400|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228401|NCT00354068|Temozolomide|temozolomide|mesh-list
20228402|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
20228403|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20228404|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
20228405|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228406|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228407|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20228408|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228409|NCT00354081|Vitamins|vitamins|mesh-list
20228410|NCT00354081|Folic Acid|folic acid|mesh-list
20228411|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
20228412|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
20228413|NCT00354081|Pyridoxine|pyridoxine|mesh-list
20228414|NCT00354081|Pyridoxal|pyridoxal|mesh-list
20228415|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
20228416|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
20228417|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
20228418|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228419|NCT00354081|Hematinics|hematinics|mesh-ancestor
19851202|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19851203|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19851204|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19851205|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20228420|NCT00354094|Reboxetine|reboxetine|mesh-list
20228421|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
20228422|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228423|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20228424|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20228425|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228426|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228427|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
20228428|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228429|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228430|NCT00354146|Tipifarnib|tipifarnib|mesh-list
20477806|NCT01523314|Dexamethasone|dexamethasone|mesh-list
20477807|NCT01523314|Bevacizumab|bevacizumab|mesh-list
20477808|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20477809|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20477810|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
20477811|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
20477812|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477813|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477814|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20477815|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
20477816|NCT01523314|Hormones|hormones|mesh-ancestor
20477817|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477818|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20477819|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477820|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851206|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19851207|NCT00717093|Varenicline|varenicline|mesh-list
19851208|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19851209|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19851210|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
19851211|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851212|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851213|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228431|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228432|NCT00354185|Belinostat|belinostat|mesh-list
20228433|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228434|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20228435|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228436|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228437|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20228438|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
19697629|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697630|NCT04922567|Prednisone|prednisone|mesh-list
19697631|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
19697632|NCT04922567|Doxorubicin|doxorubicin|mesh-list
19697633|NCT04922567|Vincristine|vincristine|mesh-list
19697634|NCT04922567|Lenalidomide|lenalidomide|mesh-list
19697635|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697636|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
19412927|NCT05030519|Trastuzumab|trastuzumab|mesh-list
19412928|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412929|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412930|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
19412931|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412932|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
19412933|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19412934|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
19412935|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228439|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20228440|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697637|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697638|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19412936|NCT04985604|Niacinamide|niacinamide|mesh-list
19412937|NCT04985604|Vitamin B Complex|vitamin b complex|mesh-ancestor
19412938|NCT04985604|Vitamins|vitamins|mesh-ancestor
19412939|NCT04985604|Micronutrients|micronutrients|mesh-ancestor
19412940|NCT04985604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412941|NCT04983589|Pilocarpine|pilocarpine|mesh-list
19412942|NCT04983589|Miotics|miotics|mesh-ancestor
19412943|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
19412944|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412945|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412946|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19412947|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19412948|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
19412949|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412950|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412951|NCT04961619|Trametinib|trametinib|mesh-list
19412952|NCT04961619|Dabrafenib|dabrafenib|mesh-list
19412953|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228441|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228442|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20228443|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20228444|NCT00354198|Protective Agents|protective agents|mesh-ancestor
20228445|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228446|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
20228447|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20228448|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
20228449|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19412954|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19697639|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19697640|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
19697641|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697642|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697643|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19697644|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19697645|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19697646|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19697647|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697648|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19697649|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
19697650|NCT04922567|Hormones|hormones|mesh-ancestor
19412955|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19412956|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851214|NCT00717197|Capecitabine|capecitabine|mesh-list
20228450|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
20228451|NCT00354198|Hormones|hormones|mesh-ancestor
20228452|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20228453|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20228454|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20228455|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412957|NCT04947007|Bupivacaine|bupivacaine|mesh-list
19412958|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19412959|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
19412960|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19412961|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412962|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
19412963|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19412964|NCT04943445|Paclitaxel|paclitaxel|mesh-list
19697651|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697652|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19697653|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20228456|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20228457|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228458|NCT00354276|Cytarabine|cytarabine|mesh-list
20228459|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228460|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
20228461|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228462|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228463|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
20228464|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228465|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228466|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
20228467|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477821|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20477822|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20477823|NCT01523314|Growth Substances|growth substances|mesh-ancestor
20477824|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
20477825|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20477826|NCT01523327|Uric Acid|uric acid|mesh-list
20477827|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
20477828|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477829|NCT01523327|Protective Agents|protective agents|mesh-ancestor
20477830|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477831|NCT01523379|Parecoxib|parecoxib|mesh-list
20477832|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20477833|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20477834|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477835|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477836|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20477837|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20477838|NCT01523379|Analgesics|analgesics|mesh-ancestor
20477839|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
20477840|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477841|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697654|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
19697655|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
19697656|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
19697657|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19697658|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19697659|NCT04922567|Growth Substances|growth substances|mesh-ancestor
19697660|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
19697661|NCT04922450|Paclitaxel|paclitaxel|mesh-list
19851215|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228468|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
20228469|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
20228470|NCT00354302|Alendronate|alendronate|mesh-list
20228471|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
20228472|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
20228473|NCT00354302|Calcium|calcium|mesh-list
20228474|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20228475|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228476|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20228477|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228478|NCT00354302|Vitamins|vitamins|mesh-ancestor
19851216|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
19851217|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851218|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851219|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
19851220|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851221|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
19851222|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228479|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
20228480|NCT00354302|Antacids|antacids|mesh-ancestor
20477842|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20477843|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20477844|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
20477845|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20477846|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
20477847|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20477848|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
20477849|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477850|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477851|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
20477852|NCT01523431|Leucovorin|leucovorin|mesh-list
20477853|NCT01523431|Fluorouracil|fluorouracil|mesh-list
20477854|NCT01523431|Irinotecan|irinotecan|mesh-list
20477855|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
20477856|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851223|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851224|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
20228481|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19851225|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19851226|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851227|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
19851228|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20228482|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20477857|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228483|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19412965|NCT04943445|Carboplatin|carboplatin|mesh-list
20228484|NCT00354354|Ipratropium|ipratropium|mesh-list
20228485|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20228486|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
20228487|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228488|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228489|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20228490|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
20228491|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228492|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228493|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20228494|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
20228495|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
20228496|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228497|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
20228498|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228499|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228500|NCT00354380|Artesunate|artesunate|mesh-list
20228501|NCT00354380|Amodiaquine|amodiaquine|mesh-list
20228502|NCT00354380|Methylene Blue|methylene blue|mesh-list
20228503|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
20228504|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20228505|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20228506|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228507|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228508|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
20228509|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
20228510|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20228511|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
20228512|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228513|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228514|NCT00354393|Methotrexate|methotrexate|mesh-list
20228515|NCT00354393|Vinorelbine|vinorelbine|mesh-list
20228516|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228517|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20228518|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
19697662|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19697663|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19851229|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851230|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19851231|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
19851232|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19851233|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851234|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851235|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851236|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
20477858|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477859|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851237|NCT00717366|Hematinics|hematinics|mesh-ancestor
19412966|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
19697664|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851238|NCT00717405|Bevacizumab|bevacizumab|mesh-list
19851239|NCT00717405|Trastuzumab|trastuzumab|mesh-list
19851240|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851241|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851242|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851243|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19697665|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
20477860|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
20477861|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477862|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19697666|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
19697667|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
19697668|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697669|NCT04922658|Vinorelbine|vinorelbine|mesh-list
19697670|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19697671|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697672|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
19697673|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
19851244|NCT00717405|Growth Substances|growth substances|mesh-ancestor
20228519|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20228520|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228521|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228522|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
20477863|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20477864|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477865|NCT01523431|Antidotes|antidotes|mesh-ancestor
20477866|NCT01523431|Protective Agents|protective agents|mesh-ancestor
20477867|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
20477868|NCT01523431|Vitamins|vitamins|mesh-ancestor
20477869|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
20477870|NCT01523483|Progesterone|progesterone|mesh-list
20477871|NCT01523483|Progestins|progestins|mesh-ancestor
20477872|NCT01523483|Hormones|hormones|mesh-ancestor
20477873|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477874|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477875|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
20477876|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
20477877|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851245|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228523|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228524|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
20228525|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228526|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20477878|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
19851246|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
19412967|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
20228527|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228528|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
20228529|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228530|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20228531|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20228532|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
20228533|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
20477879|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412968|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19412969|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19412970|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
19412971|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
20477880|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477881|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
20477882|NCT01523574|Vitamin E|vitamin e|mesh-list
20477883|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
20228534|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
20228535|NCT00354406|Abciximab|abciximab|mesh-list
20228536|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
20228537|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20228538|NCT00354419|Cyclosporine|cyclosporine|mesh-list
20228539|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
19412972|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
19412973|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228540|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
20228541|NCT00354419|Cyclosporins|cyclosporins|mesh-list
20228542|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
20228543|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20228544|NCT00354419|Lenograstim|lenograstim|mesh-list
20228545|NCT00354419|Sargramostim|sargramostim|mesh-list
20228546|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
20228547|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228548|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
20228549|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228550|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228551|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20228552|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
20228553|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228554|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228555|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20228556|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20228557|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228558|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
20228559|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228560|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
20228561|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20228562|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20477884|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
20477885|NCT01523574|Calcium|calcium|mesh-list
20477886|NCT01523574|Vitamins|vitamins|mesh-ancestor
20477887|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
20477888|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477889|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20477890|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20477891|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477892|NCT01523574|Analgesics|analgesics|mesh-ancestor
20477893|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
20477894|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477895|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
20228563|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20228564|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
20527636|NCT01769027|Penicillins|penicillins|mesh-list
19697674|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
19697675|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697676|NCT04922723|Daratumumab|daratumumab|mesh-list
19697677|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228565|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228566|NCT00354458|Rolofylline|rolofylline|mesh-list
20228567|NCT00354458|Diuretics|diuretics|mesh-ancestor
20228568|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
20228569|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228570|NCT00354523|Capecitabine|capecitabine|mesh-list
20228571|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
20228572|NCT00354523|Dacarbazine|dacarbazine|mesh-list
20228573|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228574|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
20228575|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228576|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228577|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20228578|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228579|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20228580|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
20228581|NCT00354549|Gemcitabine|gemcitabine|mesh-list
20228582|NCT00354549|Bevacizumab|bevacizumab|mesh-list
20228583|NCT00354549|Carboplatin|carboplatin|mesh-list
20228584|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20228585|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20228586|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228587|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20228588|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20228589|NCT00354549|Growth Substances|growth substances|mesh-ancestor
20228590|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228591|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
20228592|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20228593|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
20228594|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228595|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
20228596|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228597|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228598|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228599|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
20228600|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20228601|NCT00354562|Docetaxel|docetaxel|mesh-list
20228602|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228603|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
20228604|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
20228605|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
20228606|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228607|NCT00354627|Etravirine|etravirine|mesh-list
20228608|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20228609|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20228610|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228611|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228612|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
20228613|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228614|NCT00354653|Lamivudine|lamivudine|mesh-list
20228615|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20228616|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20228617|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228618|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228619|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
20228620|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228621|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20228622|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20228623|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20228624|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
20228625|NCT00354692|Hematinics|hematinics|mesh-ancestor
20228626|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
20228627|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20228628|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228629|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228630|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20228631|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20228632|NCT00354731|Protective Agents|protective agents|mesh-ancestor
20228633|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228634|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
20228635|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20228636|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
20228637|NCT00354757|Rabeprazole|rabeprazole|mesh-list
20228638|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20228639|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228640|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20228641|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228642|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228643|NCT00354809|Casopitant|casopitant|mesh-list
20228644|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
20228645|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
20228646|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228647|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477896|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477897|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20477898|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
20477899|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20477900|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20477901|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477902|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
20477903|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20477904|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
20477905|NCT01523574|Protective Agents|protective agents|mesh-ancestor
20477906|NCT01523639|Metformin|metformin|mesh-list
20477907|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20477908|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477909|NCT01523678|Paclitaxel|paclitaxel|mesh-list
20477910|NCT01523678|Carboplatin|carboplatin|mesh-list
20477911|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20477912|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477913|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
20477914|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
20228648|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228649|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20228650|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228651|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228652|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
20228653|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20228654|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
20228655|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228656|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20228657|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20228658|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
20228659|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228660|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228661|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20228662|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
20228663|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20228664|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20228665|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20228666|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
20228667|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228668|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228669|NCT00354900|Aprotinin|aprotinin|mesh-list
20228670|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
20228671|NCT00354900|Coagulants|coagulants|mesh-ancestor
20228672|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20228673|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20228674|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
20228675|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228676|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228677|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
20228678|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20228679|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228680|NCT00354952|Azithromycin|azithromycin|mesh-list
20228681|NCT00354952|Clarithromycin|clarithromycin|mesh-list
20228682|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228683|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228684|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20228685|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228686|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228687|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20228688|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20228689|NCT00354965|Amoxicillin|amoxicillin|mesh-list
20228690|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
20228691|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
20228692|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20228693|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228694|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228695|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20228696|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228697|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228698|NCT00354991|Losartan|losartan|mesh-list
20228699|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20228700|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20228701|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20228702|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20228703|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20228704|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228705|NCT00354991|Diuretics|diuretics|mesh-ancestor
20228706|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
20228707|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228708|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20228709|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228710|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
20228711|NCT00355043|Astringents|astringents|mesh-ancestor
20228712|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228713|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
20228714|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
20228715|NCT00355095|Hematinics|hematinics|mesh-ancestor
20228716|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
20228717|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20228718|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20228719|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228720|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
20228721|NCT00355108|Coagulants|coagulants|mesh-ancestor
20247513|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
20247514|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247515|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20247516|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247517|NCT00432549|Topiramate|topiramate|mesh-list
20247518|NCT00432549|Almotriptan|almotriptan|mesh-list
20247519|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
20247520|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20247521|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247522|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20247523|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
20247524|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247525|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247526|NCT00432575|Surinabant|surinabant|mesh-list
20247527|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20247528|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20247529|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851247|NCT00717418|Cyclosporine|cyclosporine|mesh-list
20228722|NCT00355251|Atorvastatin|atorvastatin|mesh-list
20228723|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20228724|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20228725|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
20228726|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228727|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20228728|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20228729|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228730|NCT00355277|Amitriptyline|amitriptyline|mesh-list
19851248|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
20228731|NCT00355277|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20228732|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20228733|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
20228734|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20228735|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20228736|NCT00355277|Analgesics|analgesics|mesh-ancestor
20228737|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
20228738|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228739|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228740|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20228741|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20477915|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
20477916|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477917|NCT01523847|Doxorubicin|doxorubicin|mesh-list
20477918|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20477919|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477920|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20477921|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20477922|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477923|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851249|NCT00717418|Cyclosporins|cyclosporins|mesh-list
19851250|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851251|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477924|NCT01523860|Rituximab|rituximab|mesh-list
20477925|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20477926|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
19851252|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477927|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20477928|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477929|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
20477930|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477931|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20477932|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19851253|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
19851254|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851255|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
19851256|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851257|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
19412974|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19412975|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412976|NCT04929808|Emollients|emollients|mesh-list
19412977|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
19412978|NCT04910100|Timolol|timolol|mesh-list
19412979|NCT04910100|Nebivolol|nebivolol|mesh-list
19412980|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19412981|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20228742|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228743|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228744|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
20228745|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228746|NCT00355277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20228747|NCT00355277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20228748|NCT00355277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228749|NCT00355290|Vitamin K|vitamin k|mesh-list
20228750|NCT00355290|Vitamins|vitamins|mesh-ancestor
20228751|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
20228752|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228753|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20228754|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20228755|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228756|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
20228757|NCT00355290|Coagulants|coagulants|mesh-ancestor
20477933|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
20477934|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228758|NCT00355303|Misoprostol|misoprostol|mesh-list
20228759|NCT00355303|Dinoprostone|dinoprostone|mesh-list
20228760|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20228761|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
20228762|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20228763|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228764|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20477935|NCT01523860|Analgesics|analgesics|mesh-ancestor
20477936|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
20477937|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477938|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20477939|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20477940|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477941|NCT01524068|Rituximab|rituximab|mesh-list
20228765|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228766|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
20228767|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
20228768|NCT00355407|Hematinics|hematinics|mesh-ancestor
20228769|NCT00355446|Bimatoprost|bimatoprost|mesh-list
20228770|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20228771|NCT00355459|Doxycycline|doxycycline|mesh-list
20228772|NCT00355459|Tetracycline|tetracycline|mesh-list
20228773|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228774|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228775|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
20228776|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20228777|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20228778|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20530665|NCT01789892|Prednisolone|prednisolone|mesh-list
20477942|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20477943|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477944|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
19412982|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19412983|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19412984|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
19412985|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19412986|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477945|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477946|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20477947|NCT01524081|Amoxicillin|amoxicillin|mesh-list
19412987|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412988|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19412989|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20477948|NCT01524081|Metronidazole|metronidazole|mesh-list
20228779|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228780|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228781|NCT00355524|Ritonavir|ritonavir|mesh-list
20228782|NCT00355524|Darunavir|darunavir|mesh-list
20228783|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20228784|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20228785|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
20228786|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697678|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19697679|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697680|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697681|NCT04922034|Amoxicillin|amoxicillin|mesh-list
19697682|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19697683|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697684|NCT04922008|Capecitabine|capecitabine|mesh-list
19697685|NCT04922008|Trastuzumab|trastuzumab|mesh-list
19697686|NCT04922008|Vinorelbine|vinorelbine|mesh-list
19851258|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228787|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697687|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19697688|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
19697689|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697690|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851259|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20477949|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
20477950|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
20477951|NCT01524081|Cefuroxime|cefuroxime|mesh-list
20477952|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
20477953|NCT01524081|Fluconazole|fluconazole|mesh-list
20477954|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20477955|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228788|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20228789|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20228790|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
20228791|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228792|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20228793|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20228794|NCT00355537|Testosterone|testosterone|mesh-list
20228795|NCT00355537|Androgens|androgens|mesh-ancestor
20228796|NCT00355537|Hormones|hormones|mesh-ancestor
20228797|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20228798|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228799|NCT00355576|Minocycline|minocycline|mesh-list
20228800|NCT00355576|Celecoxib|celecoxib|mesh-list
20228801|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20228802|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20228803|NCT00355576|Analgesics|analgesics|mesh-ancestor
20477956|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477957|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20477958|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20477959|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
20477960|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20477961|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20477962|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20477963|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477964|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20477965|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
20477966|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20477967|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697691|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20228804|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
20228805|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228806|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228807|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20228808|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228809|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20228810|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20228811|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228812|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228813|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228814|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228815|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20228816|NCT00355589|Ramipril|ramipril|mesh-list
20228817|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20228818|NCT00355589|Diuretics|diuretics|mesh-ancestor
20228819|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
20228820|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228821|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20228822|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228823|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228824|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20228825|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
20228826|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228827|NCT00355602|Metronidazole|metronidazole|mesh-list
20228828|NCT00355602|Vancomycin|vancomycin|mesh-list
20228829|NCT00355602|Clarithromycin|clarithromycin|mesh-list
20228830|NCT00355602|Doxycycline|doxycycline|mesh-list
20228831|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
20228832|NCT00355602|Rifaximin|rifaximin|mesh-list
20228833|NCT00355602|Cefuroxime|cefuroxime|mesh-list
20228834|NCT00355602|Neomycin|neomycin|mesh-list
20228835|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20228836|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20477968|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20477969|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20228837|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20477970|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20527637|NCT01769027|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20527638|NCT01769027|Sertraline|sertraline|mesh-list
20527639|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20527640|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527641|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
20527642|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20527643|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19697692|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19851260|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19851261|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19851262|NCT00717522|Pomalidomide|pomalidomide|mesh-list
19851263|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
19851264|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851265|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851266|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19851267|NCT00717522|Growth Substances|growth substances|mesh-ancestor
19851268|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
19851269|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851270|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
19851271|NCT00717574|Propofol|propofol|mesh-list
19851272|NCT00717574|Sevoflurane|sevoflurane|mesh-list
19851273|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20228838|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228839|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19851274|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19851275|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851276|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19851277|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
20228840|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20228841|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20228842|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228843|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228844|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20228845|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20228846|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
20228847|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20228848|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20228849|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228850|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20228851|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228852|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20228853|NCT00355602|Renal Agents|renal agents|mesh-ancestor
20228854|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20228855|NCT00355628|Fentanyl|fentanyl|mesh-list
20228856|NCT00355628|Citric Acid|citric acid|mesh-list
19412990|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
19851278|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
20228857|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
20228858|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20228859|NCT00355628|Narcotics|narcotics|mesh-ancestor
20228860|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228861|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228862|NCT00355628|Analgesics|analgesics|mesh-ancestor
20228863|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
20228864|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20228865|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20228866|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20228867|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
20228868|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
20228869|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
20228870|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20228871|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
20228872|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
20228873|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228874|NCT00355641|Ropinirole|ropinirole|mesh-list
20228875|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20228876|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20228877|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
20228878|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
20228879|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228880|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228881|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228882|NCT00355667|Furosemide|furosemide|mesh-list
20228883|NCT00355667|Azosemide|azosemide|mesh-list
20228884|NCT00355667|Diuretics|diuretics|mesh-ancestor
20228885|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
20228886|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477971|NCT01524094|Leucovorin|leucovorin|mesh-list
20477972|NCT01524094|Fluorouracil|fluorouracil|mesh-list
20477973|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
20477974|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
20477975|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
20477976|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20477977|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20477978|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20477979|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20477980|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
20477981|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477982|NCT01524094|Antidotes|antidotes|mesh-ancestor
20477983|NCT01524094|Protective Agents|protective agents|mesh-ancestor
20477984|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
20477985|NCT01524094|Vitamins|vitamins|mesh-ancestor
20477986|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
20477987|NCT01524237|Ketamine|ketamine|mesh-list
20477988|NCT01524237|Analgesics|analgesics|mesh-ancestor
20477989|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
20477990|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20477991|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20477992|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20477993|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20477994|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
20477995|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
20477996|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20477997|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20477998|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20477999|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478000|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478001|NCT01524315|Vitamins|vitamins|mesh-list
20478002|NCT01524315|Thiamine|thiamine|mesh-list
20478003|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
20478004|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
20478005|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478006|NCT01524354|Anesthetics|anesthetics|mesh-list
20478007|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478008|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478009|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
20478010|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20478011|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478012|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478013|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20478014|NCT01524367|Analgesics|analgesics|mesh-ancestor
20478015|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
20478016|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478017|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20228887|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20228888|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228889|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228890|NCT00355693|Propofol|propofol|mesh-list
20228891|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20228892|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228893|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228894|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20478018|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20478019|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20478020|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
20478021|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478022|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478023|NCT01524432|Clotrimazole|clotrimazole|mesh-list
20478024|NCT01524432|Miconazole|miconazole|mesh-list
20478025|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
20478026|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20478027|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478028|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20478029|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20478030|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478031|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478032|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20478033|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
20228895|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
20228896|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
20228897|NCT00355719|Ritonavir|ritonavir|mesh-list
20228898|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20228899|NCT00355719|Nevirapine|nevirapine|mesh-list
20228900|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20228901|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20228902|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
20228903|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228904|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228905|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20228906|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20228907|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
20228908|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228909|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20228910|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20228911|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20228912|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20228913|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20228914|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20228915|NCT00355771|Levocetirizine|levocetirizine|mesh-list
20228916|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20228917|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20228918|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
20228919|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
20228920|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228921|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228922|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228923|NCT00355862|Cyclosporine|cyclosporine|mesh-list
20228924|NCT00355862|Sirolimus|sirolimus|mesh-list
20228925|NCT00355862|Prednisolone|prednisolone|mesh-list
20228926|NCT00355862|Azathioprine|azathioprine|mesh-list
20228927|NCT00355862|Tacrolimus|tacrolimus|mesh-list
20228928|NCT00355862|Cyclosporins|cyclosporins|mesh-list
20228929|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20228930|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
20228931|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228932|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20228933|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478034|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478035|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478036|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20478037|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20478038|NCT01524445|Bortezomib|bortezomib|mesh-list
20478039|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478040|NCT01524497|Trazodone|trazodone|mesh-list
20228934|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228935|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
20228936|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228937|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
20228938|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20228939|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228940|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20228941|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228942|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20228943|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
20228944|NCT00355862|Hormones|hormones|mesh-ancestor
20228945|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20228946|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20228947|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
19412991|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19412992|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20228948|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478041|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20478042|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20478043|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478044|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478045|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478046|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20478047|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20478048|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20478049|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478050|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228949|NCT00355901|Visilizumab|visilizumab|mesh-list
20228950|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
20228951|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228952|NCT00355927|Propofol|propofol|mesh-list
20228953|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20228954|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20228955|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228956|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20228957|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
20228958|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
20228959|NCT00355953|Genistein|genistein|mesh-list
19412993|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19412994|NCT04907214|Empagliflozin|empagliflozin|mesh-list
20228960|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20228961|NCT00355953|Protective Agents|protective agents|mesh-ancestor
20228962|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228963|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228964|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20228965|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20228966|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228967|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
20478051|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
20478052|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20478053|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
20478054|NCT01524575|Gemcitabine|gemcitabine|mesh-list
20478055|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
20478056|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478057|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
20228968|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20228969|NCT00355953|Estrogens|estrogens|mesh-ancestor
20228970|NCT00355953|Hormones|hormones|mesh-ancestor
20228971|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20228972|NCT00355966|Misoprostol|misoprostol|mesh-list
20228973|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20228974|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
20228975|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20228976|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20228977|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20478058|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478059|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478060|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
20478061|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478062|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478063|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478064|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
20478065|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478066|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20478067|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478068|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20478069|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
20478070|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478071|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20478072|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20478073|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478074|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20478075|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478076|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20478077|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
20478078|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478079|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20478080|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20478081|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478082|NCT01524705|Insulin|insulin|mesh-list
20478083|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20478084|NCT01524705|Metformin|metformin|mesh-list
20478085|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
20478086|NCT01524705|Exenatide|exenatide|mesh-list
20478087|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20478088|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478089|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478090|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20478091|NCT01524705|Incretins|incretins|mesh-ancestor
20478092|NCT01524705|Hormones|hormones|mesh-ancestor
20478093|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478094|NCT01524731|Dexamethasone|dexamethasone|mesh-list
20478095|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
20478096|NCT01524731|BB 1101|bb 1101|mesh-list
20478097|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478098|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
20478099|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
20478100|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478101|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851279|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20228978|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228979|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
20228980|NCT00356005|Azithromycin|azithromycin|mesh-list
20228981|NCT00356005|Artesunate|artesunate|mesh-list
20228982|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20228983|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20228984|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
20228985|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20478102|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20228986|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20478103|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
20478104|NCT01524731|Hormones|hormones|mesh-ancestor
20478105|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478106|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20478107|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478108|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
20478109|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530666|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
20228987|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20228988|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
20228989|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
20228990|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20228991|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
20228992|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20228993|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20228994|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20228995|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20228996|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20228997|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
20228998|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20228999|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229000|NCT00356083|Methadone|methadone|mesh-list
20229001|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20229002|NCT00356083|Narcotics|narcotics|mesh-ancestor
19697693|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20229003|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229004|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229005|NCT00356083|Analgesics|analgesics|mesh-ancestor
20229006|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
20229007|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229008|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
20229009|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
20229010|NCT00356096|Pramipexole|pramipexole|mesh-list
20229011|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
20229012|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229013|NCT00356096|Protective Agents|protective agents|mesh-ancestor
20229014|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229015|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20229016|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20229017|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
20229018|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
20229019|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229020|NCT00356226|Clonidine|clonidine|mesh-list
20229021|NCT00356226|Analgesics|analgesics|mesh-ancestor
20229022|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
20229023|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229024|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229025|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20229026|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
20229027|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
20229028|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20229029|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20229030|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20478110|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478111|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
20478112|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20478113|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20478114|NCT01524744|Analgesics|analgesics|mesh-ancestor
20478115|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
20478116|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478117|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478118|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478119|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229031|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
20229032|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229033|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229034|NCT00356252|Carotenoids|carotenoids|mesh-list
20229035|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
20229036|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229037|NCT00356252|Protective Agents|protective agents|mesh-ancestor
20229038|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229039|NCT00356356|Etanercept|etanercept|mesh-list
20229040|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20229041|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20229042|NCT00356356|Analgesics|analgesics|mesh-ancestor
20229043|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
20229044|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229045|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229046|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229047|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851280|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19851281|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20229048|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229049|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229050|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
20229051|NCT00356395|Candesartan|candesartan|mesh-list
20229052|NCT00356395|Ramipril|ramipril|mesh-list
20229053|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20229054|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20478120|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
20478121|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478122|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
20478123|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20478124|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851282|NCT00717574|Analgesics|analgesics|mesh-ancestor
19851283|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
19851284|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478125|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478126|NCT01524757|Pantoprazole|pantoprazole|mesh-list
20478127|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19851285|NCT00717626|Factor VIII|factor viii|mesh-list
19851286|NCT00717626|Coagulants|coagulants|mesh-ancestor
19851287|NCT00717756|Lenalidomide|lenalidomide|mesh-list
19851288|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
19851289|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851290|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851291|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19851292|NCT00717756|Growth Substances|growth substances|mesh-ancestor
19851293|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
19851294|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851295|NCT00717860|Caspofungin|caspofungin|mesh-list
19851296|NCT00717860|Micafungin|micafungin|mesh-list
19851297|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
19851298|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851299|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851300|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851301|NCT00718081|Sufentanil|sufentanil|mesh-list
19851302|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19851303|NCT00718081|Narcotics|narcotics|mesh-ancestor
20229055|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20478128|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229056|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229057|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20229058|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
20229059|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229060|NCT00356447|Estradiol|estradiol|mesh-list
20229061|NCT00356447|Estrogens|estrogens|mesh-ancestor
20229062|NCT00356447|Hormones|hormones|mesh-ancestor
20229063|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229064|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851304|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229065|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20229066|NCT00356460|Antibodies|antibodies|mesh-list
20229067|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
20229068|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20229069|NCT00356460|Mitogens|mitogens|mesh-list
20229070|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
20229071|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229072|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229073|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
20229074|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229075|NCT00356473|Atorvastatin|atorvastatin|mesh-list
20229076|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20229077|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20229078|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
20229079|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229080|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20229081|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20229082|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229083|NCT00356486|Ribavirin|ribavirin|mesh-list
20229084|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20229085|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
20478129|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20478130|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478131|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478132|NCT01524809|Insulin|insulin|mesh-list
20478133|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20478134|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
20478135|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
20478136|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20478137|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
20478138|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20478139|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478140|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478141|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
20478142|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
20478143|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
19851305|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851306|NCT00718081|Analgesics|analgesics|mesh-ancestor
19851307|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
19851308|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851309|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19851310|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19851311|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
19851312|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
19851313|NCT00718315|Erythromycin|erythromycin|mesh-list
19851314|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
19851315|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19851316|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
19851317|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
19851318|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19851319|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851320|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851321|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851322|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229086|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
20229087|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229088|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
20229089|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229090|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
20229091|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412995|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19697694|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20229092|NCT00356616|Tenofovir|tenofovir|mesh-list
20229093|NCT00356616|Abacavir|abacavir|mesh-list
20229094|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
20229095|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229096|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20229097|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20229098|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478144|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478145|NCT01524861|Protective Agents|protective agents|mesh-ancestor
20478146|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478147|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
20478148|NCT01524861|Vitamins|vitamins|mesh-ancestor
20478149|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
20478150|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
20478151|NCT01524874|Vitamin D|vitamin d|mesh-list
20478152|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
20478153|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
20478154|NCT01524874|Calcitriol|calcitriol|mesh-list
20478155|NCT01524874|Vitamins|vitamins|mesh-list
20478156|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
20478157|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478158|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20478159|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20478160|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20478161|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20229099|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229100|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20229101|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20229102|NCT00356720|Azithromycin|azithromycin|mesh-list
20229103|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229104|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229105|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
20229106|NCT00356733|Hematinics|hematinics|mesh-ancestor
20229107|NCT00356772|Azithromycin|azithromycin|mesh-list
20229108|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229109|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229110|NCT00356824|Artesunate|artesunate|mesh-list
20229111|NCT00356824|Amodiaquine|amodiaquine|mesh-list
20229112|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
20229113|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20229114|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20229115|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229116|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229117|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
20229118|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
20229119|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20229120|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
20229121|NCT00356850|Azithromycin|azithromycin|mesh-list
20229122|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229123|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229124|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
20229125|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229126|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
20229127|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229128|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229129|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20229130|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
20229131|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229132|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229133|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20229134|NCT00356941|Docetaxel|docetaxel|mesh-list
20229135|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
20478162|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478163|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20478164|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
20478165|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20478166|NCT01524939|Antibodies|antibodies|mesh-list
20478167|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
20478168|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
20478169|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229136|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229137|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
20229138|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478170|NCT01525004|Vaccines|vaccines|mesh-list
20478171|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
20229139|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478172|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229140|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229141|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
20229142|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
20229143|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229144|NCT00356954|Protective Agents|protective agents|mesh-ancestor
20229145|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229146|NCT00356954|Vitamins|vitamins|mesh-ancestor
20229147|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
20229148|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
20229149|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20229150|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
20229151|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229152|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229153|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20229154|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
20229155|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20229156|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
20229157|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
20229158|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229159|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229160|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20229161|NCT00357019|Protective Agents|protective agents|mesh-ancestor
20229162|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20229163|NCT00357045|Paroxetine|paroxetine|mesh-list
20229164|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20229165|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19697695|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20229166|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20229167|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229168|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229169|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
20229170|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229171|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20229172|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
20229173|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20229174|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20229175|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20229176|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229177|NCT00357084|Prednisone|prednisone|mesh-list
20229178|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
20229179|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20229180|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20229181|NCT00357084|Prednisolone|prednisolone|mesh-list
20229182|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
20229183|NCT00357084|Methotrexate|methotrexate|mesh-list
20229184|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20229185|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
20229186|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229187|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
20229188|NCT00357084|Hormones|hormones|mesh-ancestor
20478173|NCT01525043|Naproxen|naproxen|mesh-list
19697696|NCT04922151|Ranibizumab|ranibizumab|mesh-list
19697697|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19697698|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20478174|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20478175|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20478176|NCT01525043|Analgesics|analgesics|mesh-ancestor
20478177|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
20478178|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478179|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697699|NCT04922151|Growth Substances|growth substances|mesh-ancestor
20229189|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478180|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229190|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229191|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20229192|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229193|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20229194|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
20229195|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229196|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229197|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
20229198|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229199|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
20229200|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229201|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20229202|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229203|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
20229204|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229205|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20229206|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
20229207|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
20229208|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229209|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19851323|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19851324|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851325|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19851326|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19851327|NCT00718328|Simvastatin|simvastatin|mesh-list
19851328|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19851329|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19851330|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
19851331|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229210|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20229211|NCT00357084|Protective Agents|protective agents|mesh-ancestor
20229212|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19851332|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20229213|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20229214|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20229215|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
20229216|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229217|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20229218|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20229219|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229220|NCT00357149|Cisplatin|cisplatin|mesh-list
20229221|NCT00357149|Docetaxel|docetaxel|mesh-list
20229222|NCT00357149|Fluorouracil|fluorouracil|mesh-list
20229223|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229224|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
20229225|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
20229226|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
20229227|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229228|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
20229229|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229230|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229231|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
20229232|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247530|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247531|NCT00432575|Hormones|hormones|mesh-ancestor
20247532|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247533|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247534|NCT00432588|Misoprostol|misoprostol|mesh-list
20247535|NCT00432588|Dinoprostone|dinoprostone|mesh-list
20247536|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20247537|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
19851333|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19851334|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851335|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19851336|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
19851337|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851338|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
19851339|NCT00718549|Rituximab|rituximab|mesh-list
19851340|NCT00718549|Cladribine|cladribine|mesh-list
19851341|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851342|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
19851343|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851344|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851345|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19851346|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
19851347|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851348|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851349|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19851350|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851351|NCT00718718|Methotrexate|methotrexate|mesh-list
20229233|NCT00357188|Ritonavir|ritonavir|mesh-list
20229234|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20229235|NCT00357188|Efavirenz|efavirenz|mesh-list
20229236|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20229237|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20229238|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
20229239|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229240|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229241|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20229242|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20229243|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
20229244|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229245|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20229246|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20229247|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20229248|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20229249|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20229250|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20229251|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20229252|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20229253|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20229254|NCT00357240|Ritonavir|ritonavir|mesh-list
20229255|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20229256|NCT00357240|Omeprazole|omeprazole|mesh-list
20229257|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20229258|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20229259|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
20229260|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229261|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229262|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20229263|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20229264|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
20229265|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229266|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20229267|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20229268|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20229269|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229270|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20229271|NCT00357253|Capecitabine|capecitabine|mesh-list
20229272|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229273|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
20229274|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229275|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229276|NCT00357292|Azithromycin|azithromycin|mesh-list
20229277|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229278|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229279|NCT00357305|Cytarabine|cytarabine|mesh-list
20229280|NCT00357305|Etoposide|etoposide|mesh-list
20229281|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
20229282|NCT00357305|Vorinostat|vorinostat|mesh-list
20478181|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20478182|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
20478183|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20478184|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478185|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478186|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20478187|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20478188|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20478189|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478190|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
20478191|NCT01525394|Lenvatinib|lenvatinib|mesh-list
20478192|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20478193|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478194|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20478195|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20478196|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478197|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229283|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20478198|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229284|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478199|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20478200|NCT01525537|Sufentanil|sufentanil|mesh-list
20478201|NCT01525537|Dsuvia|dsuvia|mesh-list
20478202|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20478203|NCT01525537|Narcotics|narcotics|mesh-ancestor
20478204|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478205|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478206|NCT01525537|Analgesics|analgesics|mesh-ancestor
20478207|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
20478208|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478209|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20229285|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20229286|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20229287|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478210|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20229288|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229289|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229290|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
20229291|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
20229292|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229293|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229294|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
20229295|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229296|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20229297|NCT00357318|Bevacizumab|bevacizumab|mesh-list
20229298|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20229299|NCT00357318|Sunitinib|sunitinib|mesh-list
20229300|NCT00357318|Antibodies|antibodies|mesh-list
20229301|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
20229302|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20229303|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229304|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20478211|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
20478212|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
20229305|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20229306|NCT00357318|Growth Substances|growth substances|mesh-ancestor
20229307|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229308|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
19697700|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697701|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
20229309|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
20229310|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20229311|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229312|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229313|NCT00357383|Azithromycin|azithromycin|mesh-list
20229314|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229315|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229316|NCT00357422|Ethanol|ethanol|mesh-list
20229317|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20229318|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697702|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697703|NCT04921930|Artesunate|artesunate|mesh-list
20229319|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229320|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229321|NCT00357448|Interleukin-2|interleukin-2|mesh-list
20229322|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
20229323|NCT00357448|Immunotoxins|immunotoxins|mesh-list
20229324|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229325|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20478213|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
20478214|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229326|NCT00357448|Analgesics|analgesics|mesh-ancestor
20229327|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
20229328|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229329|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229330|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
20229331|NCT00357461|Ipilimumab|ipilimumab|mesh-list
20229332|NCT00357461|Vaccines|vaccines|mesh-list
20229333|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
19851352|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19851353|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19851354|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
19851355|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229334|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
20229335|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478215|NCT01525706|Ethanol|ethanol|mesh-list
20478216|NCT01525706|Paclitaxel|paclitaxel|mesh-list
20478217|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20478218|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20478219|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478220|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478221|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478222|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478223|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478224|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20229336|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20478225|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478226|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478227|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478228|NCT01525719|Everolimus|everolimus|mesh-list
20478229|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478230|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478231|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
20478232|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478233|NCT01525771|Cisplatin|cisplatin|mesh-list
20478234|NCT01525771|Docetaxel|docetaxel|mesh-list
20478235|NCT01525771|Capecitabine|capecitabine|mesh-list
20478236|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229337|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229338|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20478237|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478238|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
19851356|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851357|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851358|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
19851359|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229339|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229340|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20229341|NCT00357474|Ethanol|ethanol|mesh-list
19412996|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19412997|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19412998|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19412999|NCT04907071|Coal Tar|coal tar|mesh-list
19413000|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
19413001|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
19416867|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416868|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416869|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19416870|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416871|NCT02271334|Albuterol|albuterol|mesh-list
19416872|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19416873|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
19416874|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416875|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416876|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19416877|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
20229342|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20229343|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229344|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416878|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
19416879|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19416880|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19416881|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20229345|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229346|NCT00357539|Azithromycin|azithromycin|mesh-list
20229347|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229348|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229349|NCT00357604|Ritonavir|ritonavir|mesh-list
20229350|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20229351|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
20229352|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20229353|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20229354|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20229355|NCT00357604|Norgestimate|norgestimate|mesh-list
20229356|NCT00357604|Norgestrel|norgestrel|mesh-list
20229357|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20229358|NCT00357604|Estradiol|estradiol|mesh-list
20229359|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20229360|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20229361|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20229362|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
20229363|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229364|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229365|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20229366|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20229367|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
20229368|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229369|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20229370|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20229371|NCT00357604|Estrogens|estrogens|mesh-ancestor
20229372|NCT00357604|Hormones|hormones|mesh-ancestor
20229373|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229374|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229375|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20229376|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
20229377|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229378|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20478239|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478240|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478241|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478242|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
20478243|NCT01525823|Metformin|metformin|mesh-list
20478244|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478245|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478246|NCT01525836|Rituximab|rituximab|mesh-list
20478247|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20478248|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478249|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
20478250|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478251|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20478252|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20229379|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20229380|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20229381|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20229382|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20229383|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229384|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20229385|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20229386|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229387|NCT00357617|Celecoxib|celecoxib|mesh-list
20229388|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20229389|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20229390|NCT00357617|Analgesics|analgesics|mesh-ancestor
20229391|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
20229392|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229393|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229394|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229395|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229396|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20229397|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20478253|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20478254|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20478255|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478256|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
20478257|NCT01525914|Dutasteride|dutasteride|mesh-list
20478258|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20478259|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20478260|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478261|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478262|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
20478263|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478264|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478265|NCT01525966|Paclitaxel|paclitaxel|mesh-list
20478266|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20478267|NCT01525966|Carboplatin|carboplatin|mesh-list
20478268|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20478269|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478270|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478271|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478272|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
20229398|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229399|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229400|NCT00357630|Gemcitabine|gemcitabine|mesh-list
20229401|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229402|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
20229403|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229404|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229405|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
20229406|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229407|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229408|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697704|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
19697705|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19697706|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20229409|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
20229410|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229411|NCT00357643|Vitamin D|vitamin d|mesh-list
20229412|NCT00357643|Calcium|calcium|mesh-list
20229413|NCT00357643|Vitamins|vitamins|mesh-ancestor
20229414|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
20229415|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229416|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20229417|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20229418|NCT00357669|Brivaracetam|brivaracetam|mesh-list
20229419|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
20229420|NCT00357682|Aspirin|aspirin|mesh-list
20229421|NCT00357682|Esomeprazole|esomeprazole|mesh-list
20229422|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20229423|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20229424|NCT00357682|Analgesics|analgesics|mesh-ancestor
19413002|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
19413003|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19413004|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19413005|NCT04873583|Prednisolone|prednisolone|mesh-list
19413006|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
19413007|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19413008|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
19413009|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413010|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
19697707|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697708|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697709|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
19697710|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
19697711|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19697712|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
19413011|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
19697713|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
19697714|NCT04921878|Analgesics|analgesics|mesh-ancestor
20229425|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
19413012|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229426|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229427|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229428|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229429|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229430|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20229431|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20229432|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229433|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20229434|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20229435|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229436|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
20229437|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19413013|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413014|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413015|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
19413016|NCT04873583|Hormones|hormones|mesh-ancestor
19413017|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19413018|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19413019|NCT04873583|Protective Agents|protective agents|mesh-ancestor
19413020|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19413021|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413022|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
19413023|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19413024|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20229438|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229439|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20229440|NCT00357708|Decitabine|decitabine|mesh-list
20229441|NCT00357708|Azacitidine|azacitidine|mesh-list
20229442|NCT00357708|Vorinostat|vorinostat|mesh-list
20229443|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229444|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
20229445|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229446|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229447|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229448|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20229449|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20229450|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20229451|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20229452|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
20229453|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229454|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229455|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20229456|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20229457|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
20229458|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229459|NCT00357747|Docetaxel|docetaxel|mesh-list
20229460|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229461|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
20229462|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
20229463|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
20229464|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413025|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413026|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
19413027|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
19413028|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413029|NCT04815590|Buprenorphine|buprenorphine|mesh-list
19413030|NCT04815590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19413031|NCT04815590|Narcotics|narcotics|mesh-ancestor
19413032|NCT04815590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413033|NCT04815590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413034|NCT04815590|Analgesics|analgesics|mesh-ancestor
19413035|NCT04815590|Sensory System Agents|sensory system agents|mesh-ancestor
19413036|NCT04815590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229465|NCT00357773|Azithromycin|azithromycin|mesh-list
20229466|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229467|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229468|NCT00357825|Reboxetine|reboxetine|mesh-list
20478273|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527644|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20527645|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527646|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229469|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
20229470|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20229471|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20527647|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527648|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
20527649|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527650|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
20527651|NCT01769040|Rifaximin|rifaximin|mesh-list
20527652|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527653|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527654|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527655|NCT01769066|Pemetrexed|pemetrexed|mesh-list
19413037|NCT04815590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20229472|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19413038|NCT04806386|Psyllium|psyllium|mesh-list
20478274|NCT01526005|Nicotine|nicotine|mesh-list
20478275|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20478276|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
20478277|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478278|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229473|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20229474|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229475|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
20229476|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229477|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229478|NCT00357851|Aprotinin|aprotinin|mesh-list
20229479|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
20229480|NCT00357851|Coagulants|coagulants|mesh-ancestor
20229481|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20229482|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20229483|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
20229484|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229485|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478279|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20478280|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20478281|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
20478282|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229486|NCT00357864|Carbachol|carbachol|mesh-list
20229487|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20229488|NCT00357864|Miotics|miotics|mesh-ancestor
20229489|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
20478283|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478284|NCT01526070|Aflibercept|aflibercept|mesh-list
20478285|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20478286|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20478287|NCT01526070|Growth Substances|growth substances|mesh-ancestor
20478288|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478289|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
20478290|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478291|NCT01526083|Lacosamide|lacosamide|mesh-list
20478292|NCT01526083|Warfarin|warfarin|mesh-list
20229490|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478293|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
20229491|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478294|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
20229492|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20229493|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
20229494|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229495|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229496|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20229497|NCT00357864|Analgesics|analgesics|mesh-ancestor
20229498|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
20229499|NCT00357864|Protective Agents|protective agents|mesh-ancestor
20229500|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
20229501|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20229502|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229503|NCT00357942|Morphine|morphine|mesh-list
20229504|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20229505|NCT00357942|Narcotics|narcotics|mesh-ancestor
20229506|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229507|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229508|NCT00357942|Analgesics|analgesics|mesh-ancestor
20229509|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
20229510|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229511|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
20229512|NCT00357981|Ortho Evra|ortho evra|mesh-list
20229513|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229514|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229515|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20229516|NCT00358020|Thalidomide|thalidomide|mesh-list
20229517|NCT00358020|Bortezomib|bortezomib|mesh-list
20229518|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229519|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229520|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
20229521|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229522|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
20229523|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19413039|NCT04806386|Cathartics|cathartics|mesh-ancestor
19413040|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413041|NCT04779554|Mitomycins|mitomycins|mesh-list
19413042|NCT04779554|Mitomycin|mitomycin|mesh-list
19413043|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19413044|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413045|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
19413046|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413047|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19413048|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413049|NCT04772248|Adalimumab|adalimumab|mesh-list
19413050|NCT04772248|Etanercept|etanercept|mesh-list
19413051|NCT04772248|Golimumab|golimumab|mesh-list
19413052|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19413053|NCT04772248|Infliximab|infliximab|mesh-list
19413054|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
19413055|NCT04772248|Tofacitinib|tofacitinib|mesh-list
19413056|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413057|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413058|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
19413059|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413060|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413061|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413062|NCT04772248|Analgesics|analgesics|mesh-ancestor
19413063|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
19413064|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413065|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413066|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229524|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229525|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20229526|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20229527|NCT00358020|Growth Substances|growth substances|mesh-ancestor
20229528|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
20229529|NCT00358124|Metformin|metformin|mesh-list
20229530|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
20229531|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
20229532|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20229533|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229534|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
20229535|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20229536|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19851360|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851361|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
19851362|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851363|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19851364|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851365|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
19851366|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851367|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19851368|NCT00718770|Bexarotene|bexarotene|mesh-list
19851369|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851370|NCT00718809|Saracatinib|saracatinib|mesh-list
19851371|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851372|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851373|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229537|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229538|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20229539|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229540|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20229541|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
20229542|NCT00358202|Cefepime|cefepime|mesh-list
20229543|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229544|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229545|NCT00358228|Rimonabant|rimonabant|mesh-list
20229546|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20229547|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20229548|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20229549|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229550|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229551|NCT00358228|Hormones|hormones|mesh-ancestor
19851374|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
20247538|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229552|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229553|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229554|NCT00358280|Bupivacaine|bupivacaine|mesh-list
20229555|NCT00358280|Ropivacaine|ropivacaine|mesh-list
20229556|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
20229557|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
20229558|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229559|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229560|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
20229561|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229562|NCT00358293|Tizanidine|tizanidine|mesh-list
19697715|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
19697716|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697717|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697718|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697719|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20229563|NCT00358293|Analgesics|analgesics|mesh-ancestor
20229564|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
20229565|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229566|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229567|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
20229568|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20229569|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20229570|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
20229571|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
20229572|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20229573|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20229574|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20229575|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
20229576|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229577|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229578|NCT00358319|Valproic Acid|valproic acid|mesh-list
20229579|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
20229580|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229581|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229582|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
20229583|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229584|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229585|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
20229586|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20229587|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229588|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20229589|NCT00358358|Fluticasone|fluticasone|mesh-list
20229590|NCT00358358|Xhance|xhance|mesh-list
20229591|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20229592|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20229593|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229594|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20229595|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
19413067|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
19697720|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20229596|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697721|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229597|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229598|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20229599|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
20229600|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
20229601|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20229602|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20229603|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20229604|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20229605|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
20229606|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229607|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229608|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
20229609|NCT00358358|Hormones|hormones|mesh-ancestor
20229610|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229611|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
20229612|NCT00358371|Floxacillin|floxacillin|mesh-list
20229613|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229614|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229615|NCT00358384|Betamethasone|betamethasone|mesh-list
20229616|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
20229617|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20229618|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
20229619|NCT00358384|Calcipotriene|calcipotriene|mesh-list
20229620|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20229621|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229622|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
19413068|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19413069|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413070|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413071|NCT04768010|Misoprostol|misoprostol|mesh-list
20229623|NCT00358384|Hormones|hormones|mesh-ancestor
20229624|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229625|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229626|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19413072|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19413073|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
19413074|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19413075|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413076|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19697722|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697723|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20229627|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
20229628|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
20229629|NCT00358410|Casopitant|casopitant|mesh-list
20229630|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
20229631|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
19697724|NCT04921657|Simvastatin|simvastatin|mesh-list
20229632|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413077|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19851375|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19851376|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851377|NCT00718887|Entecavir|entecavir|mesh-list
19851378|NCT00718887|Adefovir|adefovir|mesh-list
19851379|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
19851380|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851381|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19851382|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19851383|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851384|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851385|NCT00719043|Vaccines|vaccines|mesh-list
20229633|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229634|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229635|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20229636|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229637|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229638|NCT00358488|Albuterol|albuterol|mesh-list
20229639|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20229640|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20229641|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
20229642|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229643|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229644|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20229645|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
20229646|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20229647|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20229648|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20229649|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
20229650|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229651|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229652|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
20229653|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229654|NCT00358553|Insulin|insulin|mesh-list
20229655|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20229656|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229657|NCT00358566|Gemcitabine|gemcitabine|mesh-list
20229658|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478295|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20478296|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20478297|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20478298|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478299|NCT01526096|Plerixafor|plerixafor|mesh-list
20478300|NCT01526096|Melphalan|melphalan|mesh-list
20478301|NCT01526096|Basiliximab|basiliximab|mesh-list
20478302|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20478303|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
20478304|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478305|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478306|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20478307|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478308|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
20478309|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478310|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20478311|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20478312|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
20478313|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478314|NCT01526122|Aspirin|aspirin|mesh-list
20478315|NCT01526122|Clopidogrel|clopidogrel|mesh-list
20478316|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20478317|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20478318|NCT01526122|Analgesics|analgesics|mesh-ancestor
20229659|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
20229660|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229661|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229662|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
20229663|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229664|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229665|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229666|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
20229667|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229668|NCT00358618|Propofol|propofol|mesh-list
20229669|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20229670|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229671|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229672|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20229673|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
20229674|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
20229675|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
20229676|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229677|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
20229678|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229679|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229680|NCT00358696|Tenofovir|tenofovir|mesh-list
20229681|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
20229682|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229683|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20229684|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20229685|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229686|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413078|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
20229687|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20229688|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20229689|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
20229690|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229691|NCT00358813|Casopitant|casopitant|mesh-list
20229692|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
20229693|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
20229694|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229695|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229696|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229697|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20229698|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229699|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229700|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
20229701|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229702|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19697725|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19697726|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19697727|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
19697728|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697729|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20229703|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20229704|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229705|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229706|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
20247539|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247540|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20247541|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247542|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
20247543|NCT00432614|Citalopram|citalopram|mesh-list
20247544|NCT00432614|Amibegron|amibegron|mesh-list
20247545|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20247546|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20247547|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247548|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247549|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247550|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
20247551|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247552|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19697730|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19697731|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247553|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
20247554|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478319|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
20478320|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478321|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478322|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478323|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20478324|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20478325|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20527656|NCT01769066|Gefitinib|gefitinib|mesh-list
19697732|NCT04921670|Infliximab|infliximab|mesh-list
19697733|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
20527657|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527658|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527659|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527660|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20527661|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20527662|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20527663|NCT01769079|Isosorbide|isosorbide|mesh-list
20527664|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20527665|NCT01769079|Diuretics|diuretics|mesh-ancestor
20527666|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
20527667|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527668|NCT01769118|Caffeine|caffeine|mesh-list
20527669|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20229707|NCT00358969|Guanfacine|guanfacine|mesh-list
20229708|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20229709|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19851386|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
20229710|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20229711|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20229712|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
20229713|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229714|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229715|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229716|NCT00359112|Metformin|metformin|mesh-list
20229717|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478326|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478327|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20478328|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20478329|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478330|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
20478331|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20478332|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20478333|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20478334|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
20478335|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478336|NCT01526161|Fluticasone|fluticasone|mesh-list
20478337|NCT01526161|Xhance|xhance|mesh-list
20478338|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20478339|NCT01526161|Montelukast|montelukast|mesh-list
20478340|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478341|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20478342|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
20478343|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478344|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478345|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20478346|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
20478347|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
20478348|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20478349|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20478350|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20478351|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20478352|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
20478353|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478354|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478355|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20478356|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
20478357|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478358|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20478359|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20478360|NCT01526174|Golimumab|golimumab|mesh-list
20229718|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229719|NCT00359125|Mifepristone|mifepristone|mesh-list
20229720|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20229721|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
20229722|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229723|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229724|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20229725|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20229726|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20229727|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
20229728|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20478361|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20478362|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19851387|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851388|NCT00719134|Rizatriptan|rizatriptan|mesh-list
19851389|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19851390|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
19851391|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851392|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478363|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851393|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851394|NCT00719160|Esomeprazole|esomeprazole|mesh-list
19851395|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19851396|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19851397|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20478364|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
20478365|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478366|NCT01526278|Alendronate|alendronate|mesh-list
20478367|NCT01526278|Calcitriol|calcitriol|mesh-list
20478368|NCT01526278|Maxmarvil|maxmarvil|mesh-list
20478369|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20229729|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20229730|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
20229731|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229732|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
19851398|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851399|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229733|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20229734|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19413079|NCT04747236|Gemcitabine|gemcitabine|mesh-list
19413080|NCT04747236|Azacitidine|azacitidine|mesh-list
20229735|NCT00359151|Celecoxib|celecoxib|mesh-list
20229736|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20229737|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20229738|NCT00359151|Analgesics|analgesics|mesh-ancestor
20229739|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
20229740|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229741|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229742|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229743|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229744|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20229745|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20229746|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229747|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229748|NCT00359164|Bevacizumab|bevacizumab|mesh-list
20229749|NCT00359164|Verteporfin|verteporfin|mesh-list
20229750|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20229751|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413081|NCT04747236|Romidepsin|romidepsin|mesh-list
20229752|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20229753|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20229754|NCT00359164|Growth Substances|growth substances|mesh-ancestor
20229755|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229756|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
19697734|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697735|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697736|NCT04921904|Ramucirumab|ramucirumab|mesh-list
19697737|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697738|NCT04921566|Torsemide|torsemide|mesh-list
19697739|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19697740|NCT04921566|Diuretics|diuretics|mesh-ancestor
19697741|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
19697742|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697743|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19697744|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697745|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229757|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20229758|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
20229759|NCT00359177|Casopitant|casopitant|mesh-list
20229760|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
20229761|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
19697746|NCT04921306|Clenbuterol|clenbuterol|mesh-list
19851400|NCT00719186|Letrozole|letrozole|mesh-list
19851401|NCT00719186|Clomiphene|clomiphene|mesh-list
19851402|NCT00719186|Enclomiphene|enclomiphene|mesh-list
19851403|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
19851404|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229762|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229763|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478370|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478371|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20478372|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20478373|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20478374|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478375|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20478376|NCT01526278|Vitamins|vitamins|mesh-ancestor
20478377|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
20478378|NCT01526317|Metformin|metformin|mesh-list
20478379|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20478380|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19851405|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229764|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229765|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20229766|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229767|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229768|NCT00359190|Lapatinib|lapatinib|mesh-list
20229769|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478381|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478382|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478383|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20478384|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
20478385|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478386|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20478387|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20478388|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478389|NCT01526369|Paclitaxel|paclitaxel|mesh-list
20478390|NCT01526369|Trastuzumab|trastuzumab|mesh-list
20478391|NCT01526369|Lapatinib|lapatinib|mesh-list
20478392|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20478393|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478394|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478395|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478396|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478397|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478398|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20478399|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20478400|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478401|NCT01526395|Propofol|propofol|mesh-list
20478402|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20478403|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478404|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478405|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20478406|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
20478407|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
20478408|NCT01526460|Atorvastatin|atorvastatin|mesh-list
20478409|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20478410|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478411|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20478412|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
19697747|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19697748|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697749|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697750|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697751|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697752|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697753|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19697754|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
19697755|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697756|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19697757|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
19697758|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
19697759|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
19697760|NCT04921111|Vaccines|vaccines|mesh-list
19697761|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
19697762|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697763|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19697764|NCT04921111|Antacids|antacids|mesh-ancestor
19697765|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697766|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707932|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707933|NCT04821843|Paclitaxel|paclitaxel|mesh-list
19707934|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
20229770|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20229771|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229772|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229773|NCT00359229|Zolpidem|zolpidem|mesh-list
20229774|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20229775|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20229776|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229777|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229778|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20229779|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
20229780|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
20229781|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229782|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229783|NCT00359333|Gemcitabine|gemcitabine|mesh-list
20229784|NCT00359333|Docetaxel|docetaxel|mesh-list
20229785|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229786|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
20229787|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229788|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229789|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
20229790|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229791|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229792|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229793|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
20229794|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229795|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
20229796|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
20229797|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478413|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478414|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20478415|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20478416|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478417|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
20478418|NCT01526499|Docetaxel|docetaxel|mesh-list
20478419|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478420|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
20478421|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478422|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707935|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19707936|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229798|NCT00359359|Sagopilone|sagopilone|mesh-list
20229799|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229800|NCT00359385|Alendronate|alendronate|mesh-list
20229801|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20229802|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229803|NCT00359567|Palonosetron|palonosetron|mesh-list
20229804|NCT00359567|Granisetron|granisetron|mesh-list
20229805|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
20229806|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
20229807|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20229808|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229809|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229810|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20229811|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20229812|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
20229813|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229814|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229815|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
20229816|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
20229817|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229818|NCT00359658|Cyclosporine|cyclosporine|mesh-list
20229819|NCT00359658|Prednisolone|prednisolone|mesh-list
20229820|NCT00359658|Cyclosporins|cyclosporins|mesh-list
20229821|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229822|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229823|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229824|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
20229825|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229826|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
20229827|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229828|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
20229829|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229830|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20229831|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20229832|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
20229833|NCT00359658|Hormones|hormones|mesh-ancestor
20229834|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229835|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20229836|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851406|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19851407|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19851408|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229837|NCT00359671|Docetaxel|docetaxel|mesh-list
20229838|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851409|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19851410|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
19851411|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851412|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851413|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19851414|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
19851415|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229839|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
20229840|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
20229841|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
20229842|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229843|NCT00359697|Mannitol|mannitol|mesh-list
20229844|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20229845|NCT00359697|Diuretics|diuretics|mesh-ancestor
20478423|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20478424|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
20478425|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478426|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478427|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20478428|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478429|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478430|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478431|NCT01526525|Acetaminophen|acetaminophen|mesh-list
20478432|NCT01526525|Parecoxib|parecoxib|mesh-list
20478433|NCT01526525|Ketamine|ketamine|mesh-list
19851416|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19851417|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19851418|NCT00719264|Interferons|interferons|mesh-list
19851419|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
19851420|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
19851421|NCT00719264|Bevacizumab|bevacizumab|mesh-list
20229846|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
20229847|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229848|NCT00359723|Methylphenidate|methylphenidate|mesh-list
20229849|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20229850|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229851|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20229852|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20229853|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20229854|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229855|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
20229856|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229857|NCT00359814|Cyclosporine|cyclosporine|mesh-list
19697767|NCT04921124|Teriparatide|teriparatide|mesh-list
19697768|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19697769|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697770|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19697771|NCT04921046|Lidocaine|lidocaine|mesh-list
19697772|NCT04921046|Midazolam|midazolam|mesh-list
20229858|NCT00359814|Cyclosporins|cyclosporins|mesh-list
20229859|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229860|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229861|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229862|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
20229863|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229864|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
20229865|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697773|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20229866|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
20229867|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229868|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20229869|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
20229870|NCT00359840|Hematinics|hematinics|mesh-ancestor
20229871|NCT00359853|Norfloxacin|norfloxacin|mesh-list
20229872|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229873|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229874|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20229875|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20229876|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229877|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229878|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229879|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20229880|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20229881|NCT00359879|Exenatide|exenatide|mesh-list
20229882|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20229883|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229884|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20229885|NCT00359879|Incretins|incretins|mesh-ancestor
20229886|NCT00359879|Hormones|hormones|mesh-ancestor
20229887|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20229888|NCT00359892|Obatoclax|obatoclax|mesh-list
20229889|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229890|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229891|NCT00359905|Tamsulosin|tamsulosin|mesh-list
20229892|NCT00359905|Silodosin|silodosin|mesh-list
20229893|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20229894|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20229895|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20229896|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
20229897|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229898|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229899|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229900|NCT00359905|Urological Agents|urological agents|mesh-ancestor
20229901|NCT00359970|Azithromycin|azithromycin|mesh-list
20229902|NCT00359970|Loperamide|loperamide|mesh-list
20229903|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
20229904|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229905|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229906|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20229907|NCT00360048|Oxytocin|oxytocin|mesh-list
20229908|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
20229909|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20229910|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229911|NCT00360087|Bosentan|bosentan|mesh-list
20229912|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20229913|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20229914|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229915|NCT00360178|Amlodipine|amlodipine|mesh-list
20229916|NCT00360178|Valsartan|valsartan|mesh-list
20229917|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20229918|NCT00360178|Candesartan|candesartan|mesh-list
20229919|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20229920|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20229921|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20229922|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229923|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20229924|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229925|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
20229926|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20229927|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20229928|NCT00360178|Diuretics|diuretics|mesh-ancestor
20229929|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
20229930|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20229931|NCT00360191|Buspirone|buspirone|mesh-list
20229932|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20229933|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20229934|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20229935|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229936|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20229937|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20229938|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
20229939|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229940|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229941|NCT00360295|Azithromycin|azithromycin|mesh-list
20229942|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229943|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229944|NCT00360386|Clopidogrel|clopidogrel|mesh-list
20229945|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20229946|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20229947|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20229948|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20229949|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
20229950|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20229951|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229952|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229953|NCT00360438|Rasburicase|rasburicase|mesh-list
20229954|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
20229955|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20229956|NCT00360464|Azithromycin|azithromycin|mesh-list
20229957|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229958|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229959|NCT00360594|Acamprosate|acamprosate|mesh-list
20229960|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20229961|NCT00360607|Metronidazole|metronidazole|mesh-list
20229962|NCT00360607|Amikacin|amikacin|mesh-list
20229963|NCT00360607|Ceftazidime|ceftazidime|mesh-list
20229964|NCT00360607|Sulbactam|sulbactam|mesh-list
20229965|NCT00360607|Cefoperazone|cefoperazone|mesh-list
20229966|NCT00360607|Sulperazone|sulperazone|mesh-list
20229967|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229968|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20229969|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20229970|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20229971|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20229972|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229973|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229974|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20229975|NCT00360607|Renal Agents|renal agents|mesh-ancestor
20229976|NCT00360737|Antitoxins|antitoxins|mesh-list
20229977|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
20229978|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
20229979|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229980|NCT00360750|Cytarabine|cytarabine|mesh-list
20229981|NCT00360750|Carboplatin|carboplatin|mesh-list
20229982|NCT00360750|Etoposide|etoposide|mesh-list
20229983|NCT00360750|Vincristine|vincristine|mesh-list
20229984|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20229985|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20229986|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20229987|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20229988|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20229989|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20229990|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20229991|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
20229992|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
20229993|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20229994|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20229995|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
20229996|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20229997|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
20229998|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
20229999|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
20230000|NCT00360763|Candesartan|candesartan|mesh-list
20230001|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
20230002|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20230003|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20230004|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20230005|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230006|NCT00360776|Tipifarnib|tipifarnib|mesh-list
20230007|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230008|NCT00360815|Insulin|insulin|mesh-list
20230009|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230010|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413082|NCT04747236|Belinostat|belinostat|mesh-list
20230011|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20230012|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230013|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20230014|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230015|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230016|NCT00360945|Temozolomide|temozolomide|mesh-list
20230017|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230018|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20230019|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
20230020|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230021|NCT00360984|Insulin|insulin|mesh-list
20230022|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20230023|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
20230024|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230025|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247555|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20247556|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19413083|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19413084|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
19413085|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413086|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247557|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
20247558|NCT00432627|Deferasirox|deferasirox|mesh-list
20247559|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20247560|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
20247561|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
20247562|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247563|NCT00432653|Rituximab|rituximab|mesh-list
20247564|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247565|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247566|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
20247567|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247568|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247569|NCT00432757|Ketotifen|ketotifen|mesh-list
20247570|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
20247571|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
20247572|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20247573|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
20247574|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
19697774|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19413087|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
20247575|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230026|NCT00361010|Levetiracetam|levetiracetam|mesh-list
20230027|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
20230028|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
20230029|NCT00361023|Losartan|losartan|mesh-list
19413088|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413089|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413090|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19413091|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
19413092|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413093|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19413094|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19413095|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
19413096|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19413097|NCT04740580|Glycine|glycine|mesh-list
19413098|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
19697775|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697776|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230030|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20230031|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20230032|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20230033|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20230034|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230035|NCT00361075|Estradiol|estradiol|mesh-list
20230036|NCT00361075|Estrogens|estrogens|mesh-list
20230037|NCT00361075|Progesterone|progesterone|mesh-list
20230038|NCT00361075|Hormones|hormones|mesh-ancestor
20230039|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230040|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230041|NCT00361075|Progestins|progestins|mesh-ancestor
20230042|NCT00361088|Bortezomib|bortezomib|mesh-list
20230043|NCT00361088|Tipifarnib|tipifarnib|mesh-list
20230044|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230045|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
20230046|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
20230047|NCT00361114|Dapsone|dapsone|mesh-list
20230048|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20230049|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
20230050|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
20230051|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19413099|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230052|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20478434|NCT01526525|Morphine|morphine|mesh-list
20478435|NCT01526525|Tramadol|tramadol|mesh-list
20478436|NCT01526525|Analgesics|analgesics|mesh-ancestor
20478437|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
20478438|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478439|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478440|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20478441|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20230053|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230054|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20478442|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
19413100|NCT04740580|Expectorants|expectorants|mesh-ancestor
19697777|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20230055|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478443|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
20230056|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230057|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20230058|NCT00361114|Renal Agents|renal agents|mesh-ancestor
20230059|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
20230060|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230061|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20230062|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20230063|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230064|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
20230065|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230066|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230067|NCT00361166|Pimavanserin|pimavanserin|mesh-list
20230068|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20230069|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20230070|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20230071|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230072|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230073|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230074|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230075|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20230076|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20230077|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
20230078|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230079|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478444|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478445|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20478446|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20478447|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478448|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478449|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20230080|NCT00361244|Irinotecan|irinotecan|mesh-list
20230081|NCT00361244|Cetuximab|cetuximab|mesh-list
20230082|NCT00361244|Sunitinib|sunitinib|mesh-list
20230083|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20230084|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230085|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230086|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478450|NCT01526525|Narcotics|narcotics|mesh-ancestor
20478451|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20478452|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
20478453|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20478454|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20478455|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478456|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20478457|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478458|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20478459|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
20478460|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
20478461|NCT01526564|Vitamins|vitamins|mesh-ancestor
20478462|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
20478463|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478464|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
20478465|NCT01526616|Metformin|metformin|mesh-list
20478466|NCT01526616|Spironolactone|spironolactone|mesh-list
20478467|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478468|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478469|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20478470|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
20478471|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478472|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20478473|NCT01526616|Diuretics|diuretics|mesh-ancestor
20478474|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
20478475|NCT01526694|Thalidomide|thalidomide|mesh-list
20478476|NCT01526694|Dexamethasone|dexamethasone|mesh-list
20478477|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20478478|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478479|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
20478480|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
20478481|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478482|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478483|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20478484|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
20478485|NCT01526694|Hormones|hormones|mesh-ancestor
20478486|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230087|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230088|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20230089|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20230090|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20230091|NCT00361244|Growth Substances|growth substances|mesh-ancestor
20230092|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230093|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
20230094|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20230095|NCT00361309|Sunitinib|sunitinib|mesh-list
20230096|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230097|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20230098|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20230099|NCT00361309|Growth Substances|growth substances|mesh-ancestor
20230100|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230101|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
20230102|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20230103|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230104|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230105|NCT00361322|Clindamycin|clindamycin|mesh-list
20230106|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
20230107|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
20230108|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
20230109|NCT00361322|Salicylates|salicylates|mesh-list
20230110|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230111|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230112|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20230113|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230114|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230115|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
20230116|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
20230117|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
20230118|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20230119|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20230120|NCT00361322|Analgesics|analgesics|mesh-ancestor
20230121|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
20230122|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230123|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230124|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478487|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20478488|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478489|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20478490|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
20478491|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478492|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478493|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
20478494|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
20478495|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20478496|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478497|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20478498|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20478499|NCT01526694|Growth Substances|growth substances|mesh-ancestor
20478500|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
20478501|NCT01526837|Bevacizumab|bevacizumab|mesh-list
20478502|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20478503|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478504|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20478505|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20478506|NCT01526837|Growth Substances|growth substances|mesh-ancestor
20478507|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230125|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20230126|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20230127|NCT00361348|Heparin|heparin|mesh-list
20230128|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
20230129|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20230130|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20230131|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230132|NCT00361387|Methylphenidate|methylphenidate|mesh-list
20230133|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20230134|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230135|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20230136|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20230137|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20230138|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230139|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
20230140|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230141|NCT00361413|Alefacept|alefacept|mesh-list
20230142|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
20230143|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
20230144|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230145|NCT00361452|Epinephrine|epinephrine|mesh-list
20230146|NCT00361452|Albuterol|albuterol|mesh-list
20230147|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20230148|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20230149|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
20230150|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230151|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230152|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230153|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20230154|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20230155|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
20230156|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230157|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20230158|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
20230159|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
20230160|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
20230161|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20230162|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
19697778|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230163|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20230164|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19697779|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230165|NCT00361517|Amphotericin B|amphotericin b|mesh-list
20230166|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20230167|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20230168|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
20230169|NCT00361517|Amebicides|amebicides|mesh-ancestor
20230170|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20230171|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20230172|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230173|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230174|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
20230175|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20230176|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230177|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19697780|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19697781|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
19697782|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
19697783|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
19697784|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
19697785|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230178|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20230179|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
19707937|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
20230180|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230181|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230182|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20230183|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20230184|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20230185|NCT00361621|Prednisone|prednisone|mesh-list
20230186|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
20230187|NCT00361621|Rituximab|rituximab|mesh-list
20230188|NCT00361621|Doxorubicin|doxorubicin|mesh-list
20230189|NCT00361621|Vincristine|vincristine|mesh-list
20230190|NCT00361621|Bortezomib|bortezomib|mesh-list
20230191|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20230192|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
20230193|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230194|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20230195|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20230196|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
20230197|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230198|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230199|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20230200|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20230201|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20230202|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20230203|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230204|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230205|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230206|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
20230207|NCT00361621|Hormones|hormones|mesh-ancestor
20230208|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230209|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19851422|NCT00719264|Everolimus|everolimus|mesh-list
19851423|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851424|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851425|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851426|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19851427|NCT00719264|Growth Substances|growth substances|mesh-ancestor
19851428|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230210|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20230211|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
20230212|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
20230213|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
20230214|NCT00361686|Tramadol|tramadol|mesh-list
20230215|NCT00361686|Remifentanil|remifentanil|mesh-list
20230216|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20230217|NCT00361686|Narcotics|narcotics|mesh-ancestor
20230218|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230219|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230220|NCT00361686|Analgesics|analgesics|mesh-ancestor
19413101|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
19851429|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
20230221|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
20230222|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230223|NCT00361751|Fenofibrate|fenofibrate|mesh-list
20230224|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230225|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
20230226|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230227|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230228|NCT00361790|Aripiprazole|aripiprazole|mesh-list
20230229|NCT00361790|Citalopram|citalopram|mesh-list
20230230|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20230231|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20230232|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20230233|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230234|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697786|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697787|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697788|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
19697789|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697790|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19697791|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19697792|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19697793|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19697794|NCT04920968|Rituximab|rituximab|mesh-list
19697795|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
19697796|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19697797|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697798|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
19697799|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697800|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697801|NCT04920838|Acetaminophen|acetaminophen|mesh-list
19697802|NCT04920838|Ciclesonide|ciclesonide|mesh-list
19697803|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
19697804|NCT04920838|Telmisartan|telmisartan|mesh-list
19697805|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19697806|NCT04920838|Analgesics|analgesics|mesh-ancestor
19697807|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
20230235|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
20230236|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697808|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230237|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20230238|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
20230239|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230240|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20230241|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230242|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230243|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
20230244|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
20230245|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20230246|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20230247|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20230248|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20230249|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20230250|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20230251|NCT00361803|Topotecan|topotecan|mesh-list
20230252|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20230253|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230254|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230255|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230256|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230257|NCT00361868|Metformin|metformin|mesh-list
20230258|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
20230259|NCT00361868|Fenofibrate|fenofibrate|mesh-list
20230260|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230261|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230262|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230263|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
20230264|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230265|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230266|NCT00361881|Acyclovir|acyclovir|mesh-list
20230267|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
20230268|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
20230269|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230270|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230271|NCT00361894|Enoxaparin|enoxaparin|mesh-list
20478508|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
20478509|NCT01526850|Cyclosporine|cyclosporine|mesh-list
20478510|NCT01526850|Cyclosporins|cyclosporins|mesh-list
20478511|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
20478512|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230272|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
20230273|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20230274|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
20230275|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20230276|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
20230277|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230278|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230279|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
20230280|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20230281|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20230282|NCT00361907|Insulin|insulin|mesh-list
20478513|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478514|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478515|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
19413102|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19413103|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
19413104|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413105|NCT04740580|Protective Agents|protective agents|mesh-ancestor
19413106|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413107|NCT04740580|Antidotes|antidotes|mesh-ancestor
20478516|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478517|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
20230283|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20478518|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413108|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
20230284|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230285|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230286|NCT00361920|Prednisone|prednisone|mesh-list
20230287|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230288|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
20230289|NCT00361920|Hormones|hormones|mesh-ancestor
20230290|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230291|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230292|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20230293|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230294|NCT00361933|Valganciclovir|valganciclovir|mesh-list
20230295|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
20230296|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230297|NCT00361959|Fluticasone|fluticasone|mesh-list
20230298|NCT00361959|Xhance|xhance|mesh-list
20230299|NCT00361959|Bromides|bromides|mesh-list
20230300|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
20230301|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20230302|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230303|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20230304|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
20230305|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697809|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697810|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
19697811|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19697812|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20230306|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230307|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20230308|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
20230309|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
20230310|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20230311|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
20230312|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20230313|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
20230314|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230315|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230316|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20230317|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20230318|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20230319|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
20230320|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
20230321|NCT00361985|Esomeprazole|esomeprazole|mesh-list
20230322|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20230323|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230324|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20230325|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230326|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230327|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
20230328|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20230329|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230330|NCT00361998|Renal Agents|renal agents|mesh-ancestor
20230331|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230332|NCT00362037|Irbesartan|irbesartan|mesh-list
20230333|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20230334|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19697813|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19697814|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697815|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
19697816|NCT04920838|Hormones|hormones|mesh-ancestor
19697817|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697818|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20230335|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20230336|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230337|NCT00362063|Hormones|hormones|mesh-list
20230338|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230339|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230340|NCT00362089|Dronabinol|dronabinol|mesh-list
20230341|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
20230342|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230343|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230344|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20230345|NCT00362089|Analgesics|analgesics|mesh-ancestor
20230346|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
20230347|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230348|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20230349|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20230350|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230351|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230352|NCT00362089|Hormones|hormones|mesh-ancestor
20230353|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230354|NCT00362102|Cetuximab|cetuximab|mesh-list
20230355|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20230356|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230357|NCT00362141|Levetiracetam|levetiracetam|mesh-list
20230358|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
20230359|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
20230360|NCT00362206|Simvastatin|simvastatin|mesh-list
20230361|NCT00362206|Pravastatin|pravastatin|mesh-list
20230362|NCT00362206|Fenofibrate|fenofibrate|mesh-list
20230363|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20230364|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230365|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
20230366|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230367|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230368|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20230369|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230370|NCT00362245|Amikacin|amikacin|mesh-list
20230371|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230372|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230373|NCT00362258|Irbesartan|irbesartan|mesh-list
20230374|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20230375|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20230376|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20230377|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230378|NCT00362271|Aripiprazole|aripiprazole|mesh-list
20230379|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20230380|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
20230381|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230382|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20230383|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230384|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230385|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230386|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
20230387|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
19697819|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19697820|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230388|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478519|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
20478520|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20478521|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20478522|NCT01526850|Hormones|hormones|mesh-ancestor
20478523|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478524|NCT01526876|Clevidipine|clevidipine|mesh-list
20478525|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20478526|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20230389|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230390|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20230391|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20230392|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
20230393|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20230394|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20230395|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20230396|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20478527|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478528|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20478529|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478530|NCT01526941|Insulin|insulin|mesh-list
20478531|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20478532|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
20478533|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
20478534|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20478535|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
20230397|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20230398|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20230399|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20230400|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20230401|NCT00362310|Indinavir|indinavir|mesh-list
20230402|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20230403|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20230404|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
20230405|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230406|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230407|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20478536|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20478537|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478538|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478539|NCT01526980|Insulin|insulin|mesh-list
20478540|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20478541|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
19851430|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
20478542|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
19697821|NCT04920747|Taxane|taxane|mesh-list
19413109|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697822|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697823|NCT04920760|Vitamin A|vitamin a|mesh-list
19697824|NCT04920760|Vitamins|vitamins|mesh-ancestor
19697825|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
19697826|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697827|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
19851431|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851432|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851433|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
19851434|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
19851435|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19851436|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413110|NCT04676555|Ofatumumab|ofatumumab|mesh-list
19697828|NCT04920669|Bupivacaine|bupivacaine|mesh-list
19697829|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
19697830|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
19697831|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697832|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697833|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
19697834|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697835|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19851437|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
19697836|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19697837|NCT04920669|Analgesics|analgesics|mesh-ancestor
20230408|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20230409|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
20230410|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230411|NCT00362323|Metformin|metformin|mesh-list
20230412|NCT00362323|Fenofibrate|fenofibrate|mesh-list
20230413|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230414|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230415|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230416|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
20230417|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230418|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230419|NCT00362505|Clevudine|clevudine|mesh-list
20230420|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
20230421|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230422|NCT00362531|Prednisone|prednisone|mesh-list
20230423|NCT00362531|Tacrolimus|tacrolimus|mesh-list
20230424|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230425|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
20230426|NCT00362531|Hormones|hormones|mesh-ancestor
20230427|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230428|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230429|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20230430|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230431|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20230432|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
20230433|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20230434|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230435|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230436|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20230437|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
20230438|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230439|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20230440|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20230441|NCT00362570|Temozolomide|temozolomide|mesh-list
20230442|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20230443|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
20230444|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230445|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230446|NCT00362583|Fentanyl|fentanyl|mesh-list
19851438|NCT00719472|Antipyretics|antipyretics|mesh-list
19851439|NCT00719472|Prednisone|prednisone|mesh-list
19851440|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
19851441|NCT00719472|Rituximab|rituximab|mesh-list
19851442|NCT00719472|Doxorubicin|doxorubicin|mesh-list
19851443|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19851444|NCT00719472|Vincristine|vincristine|mesh-list
19851445|NCT00719472|Analgesics|analgesics|mesh-list
19851446|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
19851447|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19851448|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851449|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
19851450|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851451|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851452|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19851453|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
19851454|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851455|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851456|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20478543|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20478544|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
20478545|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20478546|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478547|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478548|NCT01527019|Cephalosporins|cephalosporins|mesh-list
20478549|NCT01527019|Norfloxacin|norfloxacin|mesh-list
20230447|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20230448|NCT00362583|Narcotics|narcotics|mesh-ancestor
20230449|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230450|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851457|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20478550|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19851458|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20230451|NCT00362583|Analgesics|analgesics|mesh-ancestor
19413111|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
20230452|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
20230453|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851459|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19851460|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19851461|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478551|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478552|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20478553|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20478554|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478555|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478556|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478557|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19851462|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19851463|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
19851464|NCT00719472|Hormones|hormones|mesh-ancestor
19851465|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230454|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20230455|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20230456|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
20230457|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
20230458|NCT00362596|Acyclovir|acyclovir|mesh-list
20230459|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
20230460|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230461|NCT00362635|Clevudine|clevudine|mesh-list
20230462|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
20230463|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230464|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
20230465|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20230466|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20230467|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20230468|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230469|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20230470|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20230471|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20230472|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230473|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230474|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
19416882|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20230475|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230476|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20230477|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20230478|NCT00362700|Clevudine|clevudine|mesh-list
20230479|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
20230480|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230481|NCT00362713|Ipilimumab|ipilimumab|mesh-list
20230482|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20230483|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230484|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20230485|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230486|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
20230487|NCT00362726|Ritonavir|ritonavir|mesh-list
20478558|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20230488|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20230489|NCT00362726|Maleic acid|maleic acid|mesh-list
20230490|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20230491|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20230492|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
20230493|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230494|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230495|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20230496|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20478559|NCT01527032|Thalidomide|thalidomide|mesh-list
20478560|NCT01527032|Dexamethasone|dexamethasone|mesh-list
20478561|NCT01527032|Melphalan|melphalan|mesh-list
20478562|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478563|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
20478564|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
20478565|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478566|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478567|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230497|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
20230498|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230499|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20230500|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20230501|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230502|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230503|NCT00362752|Norfloxacin|norfloxacin|mesh-list
20230504|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19413112|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413113|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
19413114|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697838|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19697839|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19697840|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697841|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697842|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697843|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697844|NCT04920604|Anesthetics|anesthetics|mesh-list
20230505|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230506|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20230507|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230508|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697845|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697846|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697847|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
19697848|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19697849|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
19697850|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697851|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230509|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230510|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230511|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20230512|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20230513|NCT00362765|Metformin|metformin|mesh-list
20230514|NCT00362765|Fenofibrate|fenofibrate|mesh-list
20230515|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413115|NCT04674683|Nivolumab|nivolumab|mesh-list
20230516|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851466|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19851467|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19851468|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19851469|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19851470|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
19851471|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
19851472|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851473|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
19851474|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851475|NCT00719537|Aspirin|aspirin|mesh-list
19851476|NCT00719537|Progesterone|progesterone|mesh-list
19851477|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19851478|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19851479|NCT00719537|Analgesics|analgesics|mesh-ancestor
19851480|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
19851481|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851482|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851483|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19851484|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851485|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19851486|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19851487|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851488|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19851489|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19851490|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851491|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
19851492|NCT00719537|Progestins|progestins|mesh-ancestor
19851493|NCT00719537|Hormones|hormones|mesh-ancestor
19851494|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230517|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230518|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
20230519|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230520|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230521|NCT00362778|Insulin|insulin|mesh-list
20230522|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230523|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247576|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247577|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247578|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19697852|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19697853|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
19697854|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19697855|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
19697856|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697857|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697858|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19697859|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
19697860|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
19697861|NCT04920695|Protective Agents|protective agents|mesh-ancestor
20247579|NCT00432796|Dalteparin|dalteparin|mesh-list
19697862|NCT04920708|Fulvestrant|fulvestrant|mesh-list
19697863|NCT04920708|Palbociclib|palbociclib|mesh-list
19697864|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19697865|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697866|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19697867|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19697868|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
20247580|NCT00432796|Tinzaparin|tinzaparin|mesh-list
20247581|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20247582|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
20247583|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20247584|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20247585|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247586|NCT00432861|Pancrelipase|pancrelipase|mesh-list
20247587|NCT00432861|Pancreatin|pancreatin|mesh-list
20247588|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247589|NCT00432887|Caffeine|caffeine|mesh-list
20247590|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20247591|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247592|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20247593|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247594|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247595|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19697869|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697870|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697871|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851495|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
19851496|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
19851497|NCT00719706|Vitamins|vitamins|mesh-ancestor
19851498|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
20247596|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20247597|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
19851499|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230524|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
20230525|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20230526|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20230527|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20230528|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230529|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
20230530|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230531|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230532|NCT00362869|Levofloxacin|levofloxacin|mesh-list
20230533|NCT00362869|Ofloxacin|ofloxacin|mesh-list
20230534|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20230535|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230536|NCT00362869|Renal Agents|renal agents|mesh-ancestor
20230537|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230538|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20230539|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230540|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230541|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230542|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230543|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20230544|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20230545|NCT00362895|Tobramycin|tobramycin|mesh-list
20230546|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
20230547|NCT00362895|Dexamethasone|dexamethasone|mesh-list
20230548|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
20230549|NCT00362895|BB 1101|bb 1101|mesh-list
20230550|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230551|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
20230552|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
20230553|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230554|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230555|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230556|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
20230557|NCT00362895|Hormones|hormones|mesh-ancestor
20230558|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230559|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20230560|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230561|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
20230562|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230563|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230564|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230565|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230566|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20230567|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20230568|NCT00362921|Carmustine|carmustine|mesh-list
19697872|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697873|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697874|NCT04920565|Polymyxins|polymyxins|mesh-list
19697875|NCT04920565|Polymyxin B|polymyxin b|mesh-list
20230569|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19416883|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
20478568|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
20478569|NCT01527032|Hormones|hormones|mesh-ancestor
20478570|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478571|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20478572|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478573|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20478574|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
20478575|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478576|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20478577|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478578|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
20478579|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
20478580|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20478581|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478582|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20478583|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20478584|NCT01527032|Growth Substances|growth substances|mesh-ancestor
20478585|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
20478586|NCT01527097|Atorvastatin|atorvastatin|mesh-list
20478587|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478588|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20478589|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
20478590|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230570|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20230571|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
20230572|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230573|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230574|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230575|NCT00362934|Atorvastatin|atorvastatin|mesh-list
20230576|NCT00362934|Simvastatin|simvastatin|mesh-list
20230577|NCT00362934|Fenofibrate|fenofibrate|mesh-list
20230578|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20230579|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230580|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
20230581|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230582|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230583|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20230584|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230585|NCT00362947|Parnaparin|parnaparin|mesh-list
20230586|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
20230587|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20230588|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20230589|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230590|NCT00362960|Losartan|losartan|mesh-list
20230591|NCT00362960|Olmesartan|olmesartan|mesh-list
20230592|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20230593|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20230594|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20230595|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20230596|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20230597|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230598|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20230599|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20230600|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478591|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20478592|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20478593|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478594|NCT01527279|Antazoline|antazoline|mesh-list
20478595|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20230601|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
20230602|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20230603|NCT00362986|Protective Agents|protective agents|mesh-ancestor
20230604|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230605|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
20230606|NCT00363025|Daunorubicin|daunorubicin|mesh-list
20230607|NCT00363025|Idarubicin|idarubicin|mesh-list
20230608|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20230609|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697876|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230610|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20230611|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230612|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230613|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697877|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697878|NCT04921033|Prednisolone|prednisolone|mesh-list
19697879|NCT04921033|Budesonide|budesonide|mesh-list
19697880|NCT04921033|Azathioprine|azathioprine|mesh-list
19697881|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19697882|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
19697883|NCT04921033|Hormones|hormones|mesh-ancestor
19697884|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19697885|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697886|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19697887|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697888|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
19697889|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697890|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19697891|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19697892|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
19697893|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
20478596|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
20478597|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
20478598|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478599|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478600|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478601|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20478602|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20478603|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20478604|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19697894|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697895|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478605|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478606|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478607|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478608|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20478609|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20478610|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
20478611|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478612|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478613|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19413116|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413117|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230614|NCT00363090|Prednisone|prednisone|mesh-list
20478614|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20478615|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
19697896|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697897|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
19697898|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697899|NCT04920357|Vaccines|vaccines|mesh-list
20230615|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
20230616|NCT00363090|Doxorubicin|doxorubicin|mesh-list
19697900|NCT04920357|Immunologic Factors|immunologic factors|mesh-ancestor
19697901|NCT04920357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697902|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
20230617|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20230618|NCT00363090|Vincristine|vincristine|mesh-list
20230619|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
20230620|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20230621|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
20230622|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230623|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20230624|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20478616|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
19413118|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19413119|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413120|NCT04659161|Xanomeline|xanomeline|mesh-list
19413121|NCT04659161|Trospium chloride|trospium chloride|mesh-list
19413122|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
19413123|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
20230625|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
20230626|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478617|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478618|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20478619|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
20478620|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478621|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20478622|NCT01527422|Prednisone|prednisone|mesh-list
20478623|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
20478624|NCT01527422|Doxorubicin|doxorubicin|mesh-list
20478625|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20478626|NCT01527422|Vincristine|vincristine|mesh-list
20478627|NCT01527422|Sargramostim|sargramostim|mesh-list
20478628|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478629|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
20478630|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478631|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19697903|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20478632|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20230627|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230628|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20230629|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20230630|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20230631|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230632|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230633|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230634|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
20230635|NCT00363090|Hormones|hormones|mesh-ancestor
20230636|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230637|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20230638|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20230639|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
20230640|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
20230641|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
20230642|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20230643|NCT00363116|Daclizumab|daclizumab|mesh-list
20230644|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20230645|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
20230646|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230647|NCT00363155|KRN 7000|krn 7000|mesh-list
20230648|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20230649|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
20230650|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230651|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230652|NCT00363259|Ribavirin|ribavirin|mesh-list
20230653|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20230654|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
20230655|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230656|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
20230657|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230658|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
20230659|NCT00363285|Hormones|hormones|mesh-list
20230660|NCT00363285|Cyproterone|cyproterone|mesh-list
20230661|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230662|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230663|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
20230664|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
20230665|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230666|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20230667|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
20230668|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20230669|NCT00363337|Aripiprazole|aripiprazole|mesh-list
20230670|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
19697904|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
19697905|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697906|NCT04920448|Expectorants|expectorants|mesh-ancestor
19697907|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
19697908|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19697909|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
19697910|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697911|NCT04920448|Protective Agents|protective agents|mesh-ancestor
19697912|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230671|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230672|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20230673|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230674|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230675|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230676|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
20230677|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
20230678|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230679|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230680|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20230681|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20230682|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
20230683|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20230684|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20230685|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20230686|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20230687|NCT00363350|Rituximab|rituximab|mesh-list
20230688|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20230689|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230690|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
20230691|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230692|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20230693|NCT00363376|Zonisamide|zonisamide|mesh-list
20230694|NCT00363376|Olanzapine|olanzapine|mesh-list
20230695|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
20230696|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
20230697|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697913|NCT04920448|Antidotes|antidotes|mesh-ancestor
20230698|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230699|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230700|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20230701|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230702|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230703|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230704|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20230705|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19697914|NCT04920500|Cytarabine|cytarabine|mesh-list
20230706|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20478633|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
20478634|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478635|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478636|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20478637|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20478638|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20478639|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20478640|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478641|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478642|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
20478643|NCT01527422|Hormones|hormones|mesh-ancestor
20478644|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478645|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20478646|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20230707|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230708|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230709|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
20230710|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
20230711|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20230712|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20230713|NCT00363389|Misoprostol|misoprostol|mesh-list
20230714|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20230715|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
20230716|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20230717|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230718|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20478647|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478648|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478649|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478650|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20478651|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
20478652|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478653|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20478654|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20478655|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478656|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478657|NCT01527474|Citalopram|citalopram|mesh-list
20478658|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20478659|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20230719|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20478660|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527670|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230720|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
20230721|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20230722|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413124|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413125|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230723|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478661|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478662|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478663|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
20478664|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478665|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20478666|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
20478667|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478668|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
20478669|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
20478670|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20478671|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478672|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478673|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
20478674|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
20478675|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478676|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478677|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
19413126|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19413127|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20230724|NCT00363519|Incretins|incretins|mesh-ancestor
20230725|NCT00363519|Hormones|hormones|mesh-ancestor
20230726|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230727|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20230728|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
19413128|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413129|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413130|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413131|NCT04659161|Urological Agents|urological agents|mesh-ancestor
19413132|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19413133|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19413134|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19413135|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19413136|NCT04634799|Plasminogen|plasminogen|mesh-list
19413137|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
19413138|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
19413139|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19413140|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19413141|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413142|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19413143|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
19413144|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413145|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
19413146|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19413147|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19413148|NCT04624776|Prednisolone|prednisolone|mesh-list
19413149|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
19413150|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19413151|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
19413152|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413153|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
19413154|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
19413155|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413156|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413157|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413158|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
19413159|NCT04624776|Hormones|hormones|mesh-ancestor
19413160|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478678|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
19413161|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20230729|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230730|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230731|NCT00363532|Calcitonin|calcitonin|mesh-list
20230732|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
20230733|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20230734|NCT00363532|Katacalcin|katacalcin|mesh-list
20230735|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20230736|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230737|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20230738|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
20230739|NCT00363571|Acetazolamide|acetazolamide|mesh-list
20230740|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
20230741|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20230742|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230743|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230744|NCT00363571|Diuretics|diuretics|mesh-ancestor
20230745|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
20230746|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230747|NCT00363584|Capecitabine|capecitabine|mesh-list
20230748|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20230749|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
20230750|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230751|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230752|NCT00363610|Pegaspargase|pegaspargase|mesh-list
20230753|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230754|NCT00363688|Penicillins|penicillins|mesh-list
20230755|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20230756|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230757|NCT00363701|Esomeprazole|esomeprazole|mesh-list
20230758|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20230759|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230760|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19697915|NCT04920500|Daunorubicin|daunorubicin|mesh-list
19697916|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20230761|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697917|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
20230762|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707938|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
20230763|NCT00363727|Ropinirole|ropinirole|mesh-list
20230764|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20230765|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20230766|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
20230767|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
20230768|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230769|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230770|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230771|NCT00363753|Aspirin|aspirin|mesh-list
20230772|NCT00363753|Clopidogrel|clopidogrel|mesh-list
20230773|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20230774|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20230775|NCT00363753|Analgesics|analgesics|mesh-ancestor
20478679|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478680|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478681|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20478682|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
20478683|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478684|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
20478685|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
20478686|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478687|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478688|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
20478689|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
20478690|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478691|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478692|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
20478693|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
20478694|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478695|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478696|NCT01527669|Lovastatin|lovastatin|mesh-list
20478697|NCT01527669|L 647318|l 647318|mesh-list
20478698|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
20478699|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478700|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20478701|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
20478702|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478703|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20478704|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20478705|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527671|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20527672|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527673|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527674|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20527675|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20527676|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
20527677|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527678|NCT01769183|Squalamine|squalamine|mesh-list
20527679|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20527680|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20527681|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527682|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527683|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20527684|NCT01769183|Protective Agents|protective agents|mesh-ancestor
20527685|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527686|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527687|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20527688|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20527689|NCT01769183|Growth Substances|growth substances|mesh-ancestor
20527690|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
20527691|NCT01769235|Clindamycin|clindamycin|mesh-list
20527692|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
20527693|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
20527694|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20527695|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527696|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527697|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20527698|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527699|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527700|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
20230776|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
20527701|NCT01769482|Udenafil|udenafil|mesh-list
20230777|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230778|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230779|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230780|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20478706|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
19851500|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
19851501|NCT00719810|Tigecycline|tigecycline|mesh-list
19851502|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
19851503|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19851504|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851505|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19851506|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19697918|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697919|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697920|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
19697921|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697922|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19697923|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
19697924|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697925|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19697926|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19697927|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19697928|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851507|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851508|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19851509|NCT00719849|Cyclosporine|cyclosporine|mesh-list
19851510|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
20478707|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
20478708|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
20478709|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478710|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478711|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
20478712|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478713|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20478714|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20478715|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478716|NCT01527747|Saxagliptin|saxagliptin|mesh-list
20478717|NCT01527747|Incretins|incretins|mesh-ancestor
20478718|NCT01527747|Hormones|hormones|mesh-ancestor
20478719|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20478720|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478721|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20478722|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
20478723|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230781|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20230782|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20230783|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697935|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
19697936|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
19697937|NCT04919460|Coagulants|coagulants|mesh-ancestor
19697938|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
19697939|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697940|NCT04919317|Dexamethasone|dexamethasone|mesh-list
19697941|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20478724|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478725|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478726|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20478727|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20478728|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20478729|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527702|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19413162|NCT04624776|Protective Agents|protective agents|mesh-ancestor
19413163|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19413164|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413165|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19413166|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
19413167|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413168|NCT04581473|Paclitaxel|paclitaxel|mesh-list
19413169|NCT04581473|Irinotecan|irinotecan|mesh-list
19413170|NCT04581473|Apatinib|apatinib|mesh-list
19413171|NCT04581473|Antibodies|antibodies|mesh-list
19413172|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19413173|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413174|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
19413175|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
19413176|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
19697942|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
19697943|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
19697944|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697945|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697946|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697947|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
19697948|NCT04919317|Hormones|hormones|mesh-ancestor
19697949|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230784|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20230785|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20230786|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230787|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
20230788|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20230789|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20230790|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20230791|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
20230792|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230793|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
19697950|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19697951|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19697952|NCT04919252|Vedolizumab|vedolizumab|mesh-list
19697953|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697954|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
19697955|NCT04919174|Remifentanil|remifentanil|mesh-list
19697956|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19697957|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697958|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697959|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19697960|NCT04919174|Analgesics|analgesics|mesh-ancestor
19697961|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
19697962|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19697963|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20230794|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
20230795|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
20230796|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230797|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20230798|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230799|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19697964|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19697965|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19697966|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
19697967|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19697968|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697969|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19697970|NCT04919174|Narcotics|narcotics|mesh-ancestor
19697971|NCT04918914|Dapsone|dapsone|mesh-list
19697972|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19697973|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
19697974|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20230800|NCT00363844|Incretins|incretins|mesh-ancestor
20230801|NCT00363844|Hormones|hormones|mesh-ancestor
20230802|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230803|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20230804|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
20230805|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230806|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230807|NCT00363857|Ropinirole|ropinirole|mesh-list
20230808|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20230809|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20230810|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
20230811|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
20230812|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230813|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230814|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230815|NCT00363909|Dexetimide|dexetimide|mesh-list
19413177|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413178|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
19697975|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19697976|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19413179|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413180|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19413181|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19413182|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413183|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19413184|NCT04571645|Heparin|heparin|mesh-list
19697977|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413185|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
19413186|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19413187|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19851511|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
19851512|NCT00719849|Fludarabine|fludarabine|mesh-list
19851513|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
19851514|NCT00719849|Cyclosporins|cyclosporins|mesh-list
19851515|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19851516|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851517|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
19851518|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478730|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478731|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478732|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478733|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
20478734|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478735|NCT01527864|Paclitaxel|paclitaxel|mesh-list
20478736|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20478737|NCT01527864|Carboplatin|carboplatin|mesh-list
20478738|NCT01527864|Endostatins|endostatins|mesh-list
20478739|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20478740|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478741|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478742|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478743|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478744|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478745|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851519|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851520|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19851521|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
19851522|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851523|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851524|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19851525|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851526|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
19851527|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851528|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
19851529|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851530|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
19851531|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19851532|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19851533|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19851534|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
19851535|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20478746|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20478747|NCT01527864|Growth Substances|growth substances|mesh-ancestor
20478748|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478749|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
20478750|NCT01527890|Fentanyl|fentanyl|mesh-list
20478751|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20478752|NCT01527890|Narcotics|narcotics|mesh-ancestor
20478753|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478754|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478755|NCT01527890|Analgesics|analgesics|mesh-ancestor
20478756|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
20478757|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478758|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20478759|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20478760|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
20478761|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
20478762|NCT01527903|Midazolam|midazolam|mesh-list
20478763|NCT01527903|Propofol|propofol|mesh-list
20478764|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20478765|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19697978|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697979|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
19697980|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19707939|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707940|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707941|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707942|NCT04821817|Rocuronium|rocuronium|mesh-list
19707943|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19707944|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19707945|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19707946|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707947|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707948|NCT04821778|Paclitaxel|paclitaxel|mesh-list
19707949|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
19707950|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19707951|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707952|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
19707953|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
19851536|NCT00719862|Azelastine|azelastine|mesh-list
19851537|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19851538|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
19851539|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851540|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851541|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19851542|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
19851543|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20230816|NCT00363909|Citalopram|citalopram|mesh-list
20230817|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20230818|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20230819|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20230820|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230821|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230822|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
20230823|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478766|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478767|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20478768|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
20478769|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
20478770|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20478771|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20478772|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20478773|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478774|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
20478775|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
20478776|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478777|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478778|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
20478779|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
20478780|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20478781|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20478782|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478783|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
20478784|NCT01527968|Coagulants|coagulants|mesh-ancestor
20478785|NCT01527994|Aprepitant|aprepitant|mesh-list
20478786|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
20478787|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
20230824|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20230825|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
20230826|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230827|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20230828|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20230829|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
20230830|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
20230831|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230832|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20230833|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20230834|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
20230835|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
20230836|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20230837|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230838|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230839|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20478788|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478789|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478790|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20478791|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20478792|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478793|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478794|NCT01528007|Naltrexone|naltrexone|mesh-list
20478795|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20478796|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20478797|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478798|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
20478799|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478800|NCT01528137|Lactoferrin|lactoferrin|mesh-list
20478801|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
20478802|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478803|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478804|NCT01528163|Methotrexate|methotrexate|mesh-list
20478805|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20478806|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
20478807|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20478808|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230840|NCT00363935|Analgesics|analgesics|mesh-ancestor
20230841|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
20230842|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230843|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20230844|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20230845|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20230846|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
20230847|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230848|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230849|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20478809|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478810|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
20478811|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478812|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478813|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
20478814|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478815|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20478816|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478817|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
20478818|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20478819|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20230850|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230851|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230852|NCT00363948|Incretins|incretins|mesh-ancestor
20230853|NCT00363948|Hormones|hormones|mesh-ancestor
20230854|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20230855|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20230856|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
20230857|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230858|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230859|NCT00364000|Calcium|calcium|mesh-list
20230860|NCT00364000|Sevelamer|sevelamer|mesh-list
20230861|NCT00364000|Calcium acetate|calcium acetate|mesh-list
20230862|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20230863|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230864|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
20230865|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
20230866|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230867|NCT00364026|Darusentan|darusentan|mesh-list
20230868|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20230869|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230870|NCT00364052|Valganciclovir|valganciclovir|mesh-list
20230871|NCT00364052|Ganciclovir|ganciclovir|mesh-list
19413188|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413189|NCT04569747|Tamoxifen|tamoxifen|mesh-list
20230872|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20230873|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
20230874|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20230875|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20230876|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230877|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230878|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20230879|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20230880|NCT00364143|Irinotecan|irinotecan|mesh-list
20230881|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20230882|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20230883|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230884|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230885|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230886|NCT00364195|Tesmilifene|tesmilifene|mesh-list
20230887|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
20230888|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
20230889|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230890|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230891|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230892|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20230893|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
20230894|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20230895|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230896|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
20230897|NCT00364260|Hematinics|hematinics|mesh-ancestor
20230898|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20230899|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20230900|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
20230901|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230902|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230903|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20230904|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
20230905|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20230906|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20230907|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20230908|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
20230909|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230910|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230911|NCT00364429|Lorazepam|lorazepam|mesh-list
20230912|NCT00364429|Risperidone|risperidone|mesh-list
20230913|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20230914|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
20230915|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230916|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230917|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230918|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20230919|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230920|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20230921|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20230922|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20230923|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
20478820|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
20478821|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20478822|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230924|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
20230925|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
20230926|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
20230927|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230928|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230929|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20230930|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20230931|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
20230932|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
20230933|NCT00364442|Fluticasone|fluticasone|mesh-list
20230934|NCT00364442|Xhance|xhance|mesh-list
20230935|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20230936|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230937|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20230938|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
20230939|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230940|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230941|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20230942|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
20478823|NCT01528176|Vitamins|vitamins|mesh-ancestor
20478824|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
20478825|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20478826|NCT01528280|Vaccines|vaccines|mesh-list
20478827|NCT01528280|Immunologic Factors|immunologic factors|mesh-ancestor
20478828|NCT01528280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478829|NCT01528371|Midazolam|midazolam|mesh-list
20478830|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20230943|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
20230944|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20230945|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20230946|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20230947|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20230948|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
20230949|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230950|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230951|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
20230952|NCT00364455|Hematinics|hematinics|mesh-ancestor
20230953|NCT00364481|Omeprazole|omeprazole|mesh-list
20230954|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20230955|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230956|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20230957|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230958|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230959|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20230960|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20478831|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20230961|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20230962|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
20230963|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230964|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20230965|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20230966|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20230967|NCT00364572|Etanercept|etanercept|mesh-list
20478832|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478833|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478834|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20478835|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20478836|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478837|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20478838|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
20478839|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
20478840|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
20478841|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
20478842|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20478843|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478844|NCT01528501|Panobinostat|panobinostat|mesh-list
19413190|NCT04569747|Trastuzumab|trastuzumab|mesh-list
20478845|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20230968|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20230969|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20230970|NCT00364572|Analgesics|analgesics|mesh-ancestor
20230971|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
20230972|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20230973|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230974|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20230975|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20230976|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20230977|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20230978|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
20247598|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247599|NCT00432978|Bosentan|bosentan|mesh-list
20247600|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20247601|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20247602|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247603|NCT00433043|Metoprolol|metoprolol|mesh-list
20247604|NCT00433043|Carvedilol|carvedilol|mesh-list
20247605|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20478846|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20478847|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478848|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478849|NCT01528540|Pregabalin|pregabalin|mesh-list
20478850|NCT01528540|Antioxidants|antioxidants|mesh-list
20478851|NCT01528540|Analgesics|analgesics|mesh-ancestor
20478852|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
20478853|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478854|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247606|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20247607|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20247608|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
20247609|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
20247610|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247611|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478855|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
20478856|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20478857|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20478858|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478859|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20478860|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20478861|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20230979|NCT00364702|Methylphenidate|methylphenidate|mesh-list
20230980|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20230981|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230982|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20230983|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20230984|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20230985|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230986|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
20230987|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230988|NCT00364754|Tesmilifene|tesmilifene|mesh-list
20230989|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
20230990|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
20230991|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20230992|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20230993|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20230994|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20230995|NCT00364806|Metoclopramide|metoclopramide|mesh-list
20230996|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
20230997|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
20230998|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
20230999|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231000|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231001|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231002|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20231003|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20231004|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
20231005|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231006|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231007|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20231008|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20231009|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231010|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231011|NCT00364871|Naltrexone|naltrexone|mesh-list
20231012|NCT00364871|Bupropion|bupropion|mesh-list
20231013|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20231014|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20478862|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478863|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20478864|NCT01528540|Protective Agents|protective agents|mesh-ancestor
20478865|NCT01528618|Gemcitabine|gemcitabine|mesh-list
20231015|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231016|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
20231017|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231018|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20231019|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
20231020|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19413191|NCT04569747|Pertuzumab|pertuzumab|mesh-list
19413192|NCT04569747|Letrozole|letrozole|mesh-list
19413193|NCT04569747|Anastrozole|anastrozole|mesh-list
19413194|NCT04569747|Leuprolide|leuprolide|mesh-list
19413195|NCT04569747|Exemestane|exemestane|mesh-list
19413196|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413197|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478866|NCT01528618|Cisplatin|cisplatin|mesh-list
20478867|NCT01528618|Fluorouracil|fluorouracil|mesh-list
20478868|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413198|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20478869|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478870|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
20478871|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478872|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
20478873|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478874|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478875|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478876|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
20231021|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20231022|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20478877|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231023|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231024|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231025|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
20231026|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231027|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20231028|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20231029|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231030|NCT00364988|Pioglitazone|pioglitazone|mesh-list
20231031|NCT00364988|Losartan|losartan|mesh-list
20231032|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231033|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231034|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20231035|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231036|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20231037|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20231038|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231039|NCT00365001|Methotrexate|methotrexate|mesh-list
20231040|NCT00365001|Simvastatin|simvastatin|mesh-list
20231041|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20231042|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
20231043|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20231044|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231045|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478878|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
20478879|NCT01528644|Iron|iron|mesh-list
20478880|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
20478881|NCT01528644|Calcium|calcium|mesh-list
19851544|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478882|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20478883|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478884|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20478885|NCT01528644|Trace Elements|trace elements|mesh-ancestor
20478886|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
19697981|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
20231046|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
20478887|NCT01528644|Hematinics|hematinics|mesh-ancestor
20478888|NCT01528722|Bupivacaine|bupivacaine|mesh-list
20478889|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
20478890|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
20478891|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20478892|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478893|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
20478894|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20478895|NCT01528800|Vitamin K|vitamin k|mesh-list
20478896|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
19697982|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19697983|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19697984|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697985|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
19697986|NCT04918589|Coagulants|coagulants|mesh-ancestor
19697987|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
19697988|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19697989|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20478897|NCT01528800|Vitamins|vitamins|mesh-ancestor
20231047|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231048|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231049|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
20231050|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231051|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20231052|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231053|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
20231054|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231055|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20231056|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20231057|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20231058|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19851545|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851546|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19851547|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19851548|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19851549|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
19851550|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
19851551|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231059|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20231060|NCT00365040|Mitomycins|mitomycins|mesh-list
20231061|NCT00365040|Mitomycin|mitomycin|mesh-list
20231062|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20231063|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231064|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
20231065|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478898|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
20478899|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478900|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20478901|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20478902|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478903|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
20478904|NCT01528800|Coagulants|coagulants|mesh-ancestor
20478905|NCT01528813|Amorolfine|amorolfine|mesh-list
20478906|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
20478907|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478908|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
20478909|NCT01528826|Vinorelbine|vinorelbine|mesh-list
20478910|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478911|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20478912|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
20478913|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
20478914|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
20478915|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478916|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
20478917|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20478918|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20231066|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20231067|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231068|NCT00365170|Insulin|insulin|mesh-list
20231069|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20231070|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
20231071|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231072|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231073|NCT00365183|Pemetrexed|pemetrexed|mesh-list
20231074|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
20231075|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231076|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231077|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231078|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20231079|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20231080|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20231081|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
20231082|NCT00365222|Temozolomide|temozolomide|mesh-list
20231083|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20231084|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
20231085|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231086|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231087|NCT00365287|Cyclosporine|cyclosporine|mesh-list
20231088|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
20231089|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
20231090|NCT00365287|Fludarabine|fludarabine|mesh-list
20231091|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
20231092|NCT00365287|Cyclosporins|cyclosporins|mesh-list
20231093|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19413199|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19413200|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231094|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231095|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
20231096|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231097|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231098|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20231099|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
20231100|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231101|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231102|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20231103|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20231104|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
20231105|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231106|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
20231107|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231108|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
20231109|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20231110|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20231111|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20231112|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
20231113|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231114|NCT00365313|Celecoxib|celecoxib|mesh-list
20231115|NCT00365313|Esomeprazole|esomeprazole|mesh-list
19413201|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413202|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19413203|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
19413204|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19413205|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413206|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19851552|NCT00719901|Bortezomib|bortezomib|mesh-list
19851553|NCT00719901|Obatoclax|obatoclax|mesh-list
19851554|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851555|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851556|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851557|NCT00720057|Naproxen|naproxen|mesh-list
19851558|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231116|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231117|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231118|NCT00365313|Analgesics|analgesics|mesh-ancestor
20231119|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
20231120|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231121|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231122|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231123|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231124|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20231125|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231126|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231127|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231128|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20231129|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231130|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20231131|NCT00365339|Ritonavir|ritonavir|mesh-list
20231132|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20231133|NCT00365339|Tenofovir|tenofovir|mesh-list
20231134|NCT00365339|Aripiprazole|aripiprazole|mesh-list
20231135|NCT00365339|Famotidine|famotidine|mesh-list
20231136|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20231137|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20231138|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
20231139|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231140|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231141|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20231142|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20231143|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
20231144|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231145|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20478919|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478920|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
20478921|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
20478922|NCT01528865|Tenofovir|tenofovir|mesh-list
20478923|NCT01528865|Lamivudine|lamivudine|mesh-list
20478924|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
20478925|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478926|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20478927|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20478928|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478929|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478930|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20478931|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20478932|NCT01528930|Amikacin|amikacin|mesh-list
20478933|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20478934|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478935|NCT01528943|Epoprostenol|epoprostenol|mesh-list
20478936|NCT01528943|Tezosentan|tezosentan|mesh-list
20478937|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20478938|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20478939|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
20478940|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
20478941|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20478942|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478943|NCT01529125|Lamivudine|lamivudine|mesh-list
20478944|NCT01529125|Zidovudine|zidovudine|mesh-list
19413207|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20478945|NCT01529125|Nevirapine|nevirapine|mesh-list
20478946|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20231146|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20231147|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20231148|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20231149|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
20231150|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231151|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20231152|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20231153|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231154|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231155|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
19413208|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19413209|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19413210|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19413211|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
20231156|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
20231157|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231158|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20231159|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20231160|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
20231161|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20231162|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20231163|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20231164|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20231165|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20231166|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231167|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20231168|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
20231169|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
20231170|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
20231171|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20478947|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20478948|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478949|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478950|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
20478951|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478952|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20478953|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20478954|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
20478955|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20478956|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20478957|NCT01529138|Sirolimus|sirolimus|mesh-list
20478958|NCT01529138|Axitinib|axitinib|mesh-list
20478959|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20478960|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20478961|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20478962|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478963|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
20478964|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478965|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
20478966|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478967|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20478968|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20478969|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231172|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
20231173|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231174|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231175|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20231176|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
20231177|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
20231178|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20231179|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
20231180|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231181|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231182|NCT00365586|Ketoprofen|ketoprofen|mesh-list
20231183|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231184|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231185|NCT00365586|Analgesics|analgesics|mesh-ancestor
20231186|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
20231187|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231188|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231189|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231190|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231191|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231192|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231193|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231194|NCT00365612|Tenofovir|tenofovir|mesh-list
20231195|NCT00365612|Emtricitabine|emtricitabine|mesh-list
20231196|NCT00365612|Efavirenz|efavirenz|mesh-list
20231197|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
20231198|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231199|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20231200|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20231201|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248106|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231202|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231203|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19413212|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19697990|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19697991|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
19697992|NCT04918576|Coagulants|coagulants|mesh-ancestor
19697993|NCT04918758|Sucralfate|sucralfate|mesh-list
19697994|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19697995|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19697996|NCT04918524|Aspirin|aspirin|mesh-list
19697997|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
20231204|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20231205|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20231206|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20231207|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19697998|NCT04918524|Prednisone|prednisone|mesh-list
20231208|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20231209|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20231210|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20231211|NCT00365638|Simvastatin|simvastatin|mesh-list
20231212|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20231213|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20231214|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
20231215|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231216|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20231217|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20231218|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231219|NCT00365742|Simvastatin|simvastatin|mesh-list
20231220|NCT00365742|Red yeast rice|red yeast rice|mesh-list
20231221|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20231222|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20231223|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
20478970|NCT01529164|Leucovorin|leucovorin|mesh-list
20478971|NCT01529164|Fluorouracil|fluorouracil|mesh-list
20478972|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
20478973|NCT01529164|Endostar protein|endostar protein|mesh-list
20478974|NCT01529164|Endostatins|endostatins|mesh-list
20478975|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
20478976|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20478977|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20478978|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20478979|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20478980|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
20478981|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478982|NCT01529164|Antidotes|antidotes|mesh-ancestor
20478983|NCT01529164|Protective Agents|protective agents|mesh-ancestor
20478984|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
20478985|NCT01529164|Vitamins|vitamins|mesh-ancestor
20478986|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
20478987|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20478988|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20478989|NCT01529164|Growth Substances|growth substances|mesh-ancestor
20478990|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
20478991|NCT01529177|Metformin|metformin|mesh-list
20478992|NCT01529177|Citric Acid|citric acid|mesh-list
20478993|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
20478994|NCT01529177|Clomiphene|clomiphene|mesh-list
20478995|NCT01529177|Enclomiphene|enclomiphene|mesh-list
20478996|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
20478997|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20478998|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20478999|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
20479000|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20479001|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
20479002|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
20479003|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479004|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20479005|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
20479006|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479007|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20479008|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
20479009|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20479010|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20479011|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20479012|NCT01529190|Pregabalin|pregabalin|mesh-list
20479013|NCT01529190|Analgesics|analgesics|mesh-ancestor
20479014|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
20479015|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479016|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479017|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
20479018|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20479019|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479020|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479021|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20479022|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20479023|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20479024|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479025|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20479026|NCT01529229|Prednisolone|prednisolone|mesh-list
20479027|NCT01529229|Betamethasone|betamethasone|mesh-list
20479028|NCT01529229|Desloratadine|desloratadine|mesh-list
20231224|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231225|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20231226|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20231227|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231228|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
20231229|NCT00365755|Melphalan|melphalan|mesh-list
20231230|NCT00365755|Carboplatin|carboplatin|mesh-list
20231231|NCT00365755|Etoposide|etoposide|mesh-list
20231232|NCT00365755|Vincristine|vincristine|mesh-list
20231233|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231234|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
20231235|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231236|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231237|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20231238|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
20231239|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231240|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231241|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20231242|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20231243|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20231244|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20231245|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231246|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
20231247|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
20231248|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
19413213|NCT04554693|Metronidazole|metronidazole|mesh-list
19413214|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413215|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231249|NCT00365820|Tegaserod|tegaserod|mesh-list
20231250|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20231251|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
20231252|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231253|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231254|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231255|NCT00365898|Hydromorphone|hydromorphone|mesh-list
20231256|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20231257|NCT00365898|Narcotics|narcotics|mesh-ancestor
20231258|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231259|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231260|NCT00365898|Analgesics|analgesics|mesh-ancestor
20231261|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
20231262|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231263|NCT00365924|Teriparatide|teriparatide|mesh-list
20231264|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20231265|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231266|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20231267|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
20231268|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
20231269|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231270|NCT00365950|Warfarin|warfarin|mesh-list
20231271|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
20231272|NCT00366002|Darifenacin|darifenacin|mesh-list
20231273|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20231274|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20231275|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
20231276|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231277|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231278|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231279|NCT00366002|Urological Agents|urological agents|mesh-ancestor
20231280|NCT00366067|Phenytoin|phenytoin|mesh-list
20231281|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
20231282|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20231283|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20231284|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231285|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231286|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20231287|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20231288|NCT00366093|Eszopiclone|eszopiclone|mesh-list
20231289|NCT00366093|Zopiclone|zopiclone|mesh-list
20231290|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20231291|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231292|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231293|NCT00366119|Ramipril|ramipril|mesh-list
20231294|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19697999|NCT04918524|Heparin|heparin|mesh-list
19698000|NCT04918524|Enoxaparin|enoxaparin|mesh-list
19698001|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19698002|NCT04918524|Tinzaparin|tinzaparin|mesh-list
19698003|NCT04918524|Dalteparin|dalteparin|mesh-list
19698004|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698005|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
19698006|NCT04918524|Hormones|hormones|mesh-ancestor
20479029|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20479030|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20479031|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
20479032|NCT01529229|Hormones|hormones|mesh-ancestor
20479033|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479034|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479035|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479036|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479037|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20479038|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
19413216|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20231295|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
20231296|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231297|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698007|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231298|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231299|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
20479039|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20479040|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479041|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479042|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479043|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20479044|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20479045|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
20479046|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
20479047|NCT01529242|Prednisolone|prednisolone|mesh-list
20479048|NCT01529242|Betamethasone|betamethasone|mesh-list
20479049|NCT01529242|Desloratadine|desloratadine|mesh-list
20479050|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20479051|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231300|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20231301|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231302|NCT00366262|Naproxen|naproxen|mesh-list
20231303|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231304|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231305|NCT00366262|Analgesics|analgesics|mesh-ancestor
20231306|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
20231307|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231308|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231309|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231310|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231311|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
20231312|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231313|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479052|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
20479053|NCT01529242|Hormones|hormones|mesh-ancestor
20479054|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479055|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479056|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479057|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479058|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20479059|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
20479060|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20479061|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479062|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231314|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231315|NCT00366418|Rituximab|rituximab|mesh-list
20231316|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20231317|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231318|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
20231319|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231320|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231321|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
20231322|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20231323|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231324|NCT00366470|Vitamins|vitamins|mesh-ancestor
20231325|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
20231326|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20247612|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20247613|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20247614|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
20247615|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247616|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247617|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
20247618|NCT00433043|Protective Agents|protective agents|mesh-ancestor
20479063|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479064|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20479065|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20231327|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20231328|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20231329|NCT00366652|Desipramine|desipramine|mesh-list
19413217|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19413218|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19413219|NCT04549116|Progesterone|progesterone|mesh-list
20231330|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20479066|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
20479067|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
20479068|NCT01529255|Telbivudine|telbivudine|mesh-list
20479069|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
20479070|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479071|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20479072|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479073|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479074|NCT01529294|Iloperidone|iloperidone|mesh-list
20479075|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20479076|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20479077|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479078|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479079|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20479080|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
20479081|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20231331|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20231332|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231333|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231334|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413220|NCT04549116|Progestins|progestins|mesh-ancestor
19413221|NCT04549116|Hormones|hormones|mesh-ancestor
20479082|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20231335|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231336|NCT00366652|Analgesics|analgesics|mesh-ancestor
20231337|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
20231338|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231339|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
20231340|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231341|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
20231342|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19413222|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707954|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
20231343|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231344|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20231345|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
20231346|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20231347|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20231348|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
20231349|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20231350|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231351|NCT00366834|Dexamethasone|dexamethasone|mesh-list
20231352|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
20231353|NCT00366834|Ondansetron|ondansetron|mesh-list
20231354|NCT00366834|Casopitant|casopitant|mesh-list
20231355|NCT00366834|BB 1101|bb 1101|mesh-list
20231356|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231357|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
20231358|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
20231359|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231360|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231361|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231362|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
20231363|NCT00366834|Hormones|hormones|mesh-ancestor
20231364|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231365|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479083|NCT01529320|Prednisolone|prednisolone|mesh-list
20479084|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
20479085|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
20479086|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19851559|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19851560|NCT00720057|Analgesics|analgesics|mesh-ancestor
19851561|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
20479087|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
20231366|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231367|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
20231368|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479088|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20479089|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
20231369|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231370|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
20231371|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20231372|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20231373|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
20479090|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
20479091|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479092|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479093|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20479094|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
20479095|NCT01529320|Hormones|hormones|mesh-ancestor
19851562|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851563|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851564|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19851565|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851566|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
20479096|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479097|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20231374|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231375|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20479098|NCT01529320|Protective Agents|protective agents|mesh-ancestor
20479099|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479100|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479101|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
20479102|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479103|NCT01529476|Levofloxacin|levofloxacin|mesh-list
20231376|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20231377|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231378|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20479104|NCT01529476|Ofloxacin|ofloxacin|mesh-list
20479105|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20479106|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479107|NCT01529476|Renal Agents|renal agents|mesh-ancestor
20479108|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231379|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20231380|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20231381|NCT00366873|Calcium|calcium|mesh-list
20231382|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20231383|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231384|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
20231385|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20231386|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231387|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231388|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231389|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231390|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231391|NCT00366938|Analgesics|analgesics|mesh-ancestor
20231392|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
20231393|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231394|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231395|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231396|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231397|NCT00367068|Baclofen|baclofen|mesh-list
20231398|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20231399|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231400|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20231401|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231402|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20231403|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
20231404|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
20231405|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231406|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479109|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20231407|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
20231408|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20231409|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
20479110|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20231410|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
20231411|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20231412|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20231413|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231414|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20231415|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231416|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231417|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20231418|NCT00367081|Renal Agents|renal agents|mesh-ancestor
20231419|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231420|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
20231421|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20231422|NCT00367094|Benazepril|benazepril|mesh-list
20231423|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231424|NCT00367094|Diuretics|diuretics|mesh-ancestor
20231425|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
20231426|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231427|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20231428|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231429|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231430|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20231431|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
20231432|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479111|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479112|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479113|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479114|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20479115|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20527703|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20527704|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527705|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527706|NCT01769625|Vitamin D|vitamin d|mesh-list
20527707|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
20527708|NCT01769625|Celecoxib|celecoxib|mesh-list
20231433|NCT00367120|Amoxicillin|amoxicillin|mesh-list
20231434|NCT00367120|Azithromycin|azithromycin|mesh-list
20527709|NCT01769625|Vitamins|vitamins|mesh-ancestor
20527710|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
20527711|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527712|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20527713|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19413223|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413224|NCT04546841|Vaccines|vaccines|mesh-list
19413225|NCT04546841|Immunologic Factors|immunologic factors|mesh-ancestor
19413226|NCT04546841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413227|NCT04544202|Trametinib|trametinib|mesh-list
19413228|NCT04544202|Dabrafenib|dabrafenib|mesh-list
19413229|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413230|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19413231|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413232|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413233|NCT04542408|Heparin|heparin|mesh-list
19413234|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19413235|NCT04542408|Tinzaparin|tinzaparin|mesh-list
19413236|NCT04542408|Dalteparin|dalteparin|mesh-list
19413237|NCT04542408|Edoxaban|edoxaban|mesh-list
19413238|NCT04542408|Anticoagulants|anticoagulants|mesh-list
20231435|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
20231436|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
20231437|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20231438|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231439|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231440|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20231441|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231442|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231443|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20231444|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
20231445|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231446|NCT00367185|Thalidomide|thalidomide|mesh-list
20231447|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231448|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
20231449|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231450|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
20231451|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231452|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231453|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479116|NCT01529528|Anagliptin|anagliptin|mesh-list
20479117|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20479118|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
20479119|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479120|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479121|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413239|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19413240|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20479122|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479123|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20479124|NCT01529541|Anagliptin|anagliptin|mesh-list
20479125|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20479126|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479127|NCT01529541|Incretins|incretins|mesh-ancestor
20479128|NCT01529541|Hormones|hormones|mesh-ancestor
20479129|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479130|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20479131|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
20479132|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479133|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479134|NCT01529554|Everolimus|everolimus|mesh-list
19413241|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413242|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19413243|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
19413244|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19413245|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
19413246|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479135|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231454|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20231455|NCT00367185|Growth Substances|growth substances|mesh-ancestor
20231456|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
20231457|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231458|NCT00367211|Naproxen|naproxen|mesh-list
20231459|NCT00367211|Omeprazole|omeprazole|mesh-list
20231460|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20231461|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231462|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20231463|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231464|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231465|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231466|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231467|NCT00367211|Analgesics|analgesics|mesh-ancestor
20231468|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
20231469|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231470|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231471|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231472|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231473|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
20231474|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231475|NCT00367250|Trastuzumab|trastuzumab|mesh-list
20231476|NCT00367250|Cetuximab|cetuximab|mesh-list
20231477|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20479136|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20479137|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
20479138|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479139|NCT01529619|Rivastigmine|rivastigmine|mesh-list
20479140|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20479141|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479142|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479143|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479144|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479145|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479146|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20479147|NCT01529619|Protective Agents|protective agents|mesh-ancestor
20479148|NCT01529710|Praziquantel|praziquantel|mesh-list
20479149|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
19698008|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413247|NCT04530383|Metformin|metformin|mesh-list
19413248|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231478|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413249|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231479|NCT00367263|Ciclesonide|ciclesonide|mesh-list
19413250|NCT04528563|Ketorolac|ketorolac|mesh-list
20231480|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
20231481|NCT00367263|Hormones|hormones|mesh-ancestor
20231482|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231483|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231484|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20231485|NCT00367276|Drospirenone|drospirenone|mesh-list
19413251|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20231486|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20231487|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
19413252|NCT04528563|Morphine|morphine|mesh-list
20231488|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231489|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231490|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20231491|NCT00367276|Diuretics|diuretics|mesh-ancestor
20231492|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
20231493|NCT00367302|Buprenorphine|buprenorphine|mesh-list
20231494|NCT00367302|Methadone|methadone|mesh-list
20231495|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20231496|NCT00367302|Narcotics|narcotics|mesh-ancestor
20231497|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231498|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231499|NCT00367302|Analgesics|analgesics|mesh-ancestor
20231500|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
20231501|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231502|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20231503|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
20231504|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
20231505|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
20231506|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20231507|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231508|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231509|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231510|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231511|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231512|NCT00367315|Analgesics|analgesics|mesh-ancestor
20231513|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
20231514|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231515|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413253|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19413254|NCT04528563|Narcotics|narcotics|mesh-ancestor
19413255|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413256|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413257|NCT04528563|Analgesics|analgesics|mesh-ancestor
20231516|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231517|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231518|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
20231519|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231520|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231521|NCT00367393|Analgesics|analgesics|mesh-ancestor
20231522|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
20231523|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231524|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231525|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698009|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698010|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698011|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19698012|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19698013|NCT04918524|Analgesics|analgesics|mesh-ancestor
19698014|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
19698015|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698016|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231526|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231527|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
20231528|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231529|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
20231530|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20231531|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231532|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231533|NCT00367419|Erythromycin|erythromycin|mesh-list
20231534|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
20479150|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20479151|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479152|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20479153|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20479154|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20479155|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479156|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479157|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20479158|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479159|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479160|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479161|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479162|NCT01529892|Methamphetamine|methamphetamine|mesh-list
19413258|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
20231535|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20231536|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
20231537|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231538|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231539|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231540|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20231541|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231542|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231543|NCT00367445|Insulin|insulin|mesh-list
20231544|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20231545|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
20231546|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231547|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231548|NCT00367471|Paclitaxel|paclitaxel|mesh-list
20231549|NCT00367471|Carboplatin|carboplatin|mesh-list
20231550|NCT00367471|Trastuzumab|trastuzumab|mesh-list
20231551|NCT00367471|Lapatinib|lapatinib|mesh-list
20231552|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20231553|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231554|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
20231555|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
20231556|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
20231557|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231558|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20231559|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20231560|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231561|NCT00367497|Cytarabine|cytarabine|mesh-list
19413259|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413260|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413261|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413262|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413263|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413264|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231562|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
20231563|NCT00367497|Rituximab|rituximab|mesh-list
20231564|NCT00367497|Etoposide|etoposide|mesh-list
20231565|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231566|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20231567|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
20231568|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231569|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231570|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20231571|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20231572|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20231573|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231574|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231575|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20231576|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
20231577|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
19413265|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413266|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413267|NCT04521335|Copper|copper|mesh-list
19413268|NCT04521335|Disulfiram|disulfiram|mesh-list
19413269|NCT04521335|Trace Elements|trace elements|mesh-ancestor
19413270|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
20231578|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231579|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231580|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231581|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
20231582|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
20231583|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231584|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413271|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413272|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19413273|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20231585|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
20231586|NCT00367497|Hormones|hormones|mesh-ancestor
19413274|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413275|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413276|NCT04516278|Bevacizumab|bevacizumab|mesh-list
20231587|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479163|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20479164|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479165|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
20479166|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
20479167|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231588|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20231589|NCT00367497|Protective Agents|protective agents|mesh-ancestor
20231590|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
20479168|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
20479169|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479170|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413277|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413278|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413279|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20231591|NCT00367536|Estrogens|estrogens|mesh-list
20231592|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20231593|NCT00367536|Hormones|hormones|mesh-ancestor
19413280|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19413281|NCT04516278|Growth Substances|growth substances|mesh-ancestor
19413282|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479171|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479172|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20479173|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19851567|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19851568|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851569|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851570|NCT00720096|Doxorubicin|doxorubicin|mesh-list
19851571|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19851572|NCT00720096|Topotecan|topotecan|mesh-list
19851573|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19851574|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851575|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19851576|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19851577|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851578|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851579|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19851580|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
19851581|NCT00720109|Leucovorin|leucovorin|mesh-list
19851582|NCT00720109|Folic Acid|folic acid|mesh-list
19851583|NCT00720109|Cytarabine|cytarabine|mesh-list
19851584|NCT00720109|Dexamethasone|dexamethasone|mesh-list
19851585|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
19851586|NCT00720109|Prednisone|prednisone|mesh-list
19851587|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
19851588|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20231594|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231595|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231596|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20231597|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20231598|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
19413283|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
19413284|NCT04507178|Nadroparin|nadroparin|mesh-list
19413285|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
19698017|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19698018|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19698019|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698020|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20231599|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20231600|NCT00367562|Valsartan|valsartan|mesh-list
20479174|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479175|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20479176|NCT01530009|Amoxicillin|amoxicillin|mesh-list
20479177|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479178|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698021|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19698022|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413286|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19413287|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19413288|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698023|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
19698024|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
19698025|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
19698026|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19698027|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19698028|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698029|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
19698030|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19698031|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
19698032|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479179|NCT01530022|Lacosamide|lacosamide|mesh-list
19413289|NCT04500899|Phenylephrine|phenylephrine|mesh-list
19698033|NCT04918719|Expectorants|expectorants|mesh-ancestor
19851589|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19851590|NCT00720109|Prednisolone|prednisolone|mesh-list
19851591|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
19851592|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
19851593|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19851594|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19851595|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19851596|NCT00720109|Cortisone|cortisone|mesh-list
19851597|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
19851598|NCT00720109|Ifosfamide|ifosfamide|mesh-list
19851599|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
19851600|NCT00720109|Methotrexate|methotrexate|mesh-list
19851601|NCT00720109|Etoposide|etoposide|mesh-list
20231601|NCT00367562|Enalapril|enalapril|mesh-list
20231602|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231603|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20231604|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20231605|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231606|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20231607|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
20231608|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231609|NCT00367614|Pantoprazole|pantoprazole|mesh-list
20231610|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20231611|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231612|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19851602|NCT00720109|Vincristine|vincristine|mesh-list
19851603|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
19851604|NCT00720109|Daunorubicin|daunorubicin|mesh-list
19851605|NCT00720109|Asparaginase|asparaginase|mesh-list
20231613|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231614|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698034|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
20231615|NCT00367627|Albendazole|albendazole|mesh-list
20231616|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
19698035|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19698036|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
19698037|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698038|NCT04918719|Protective Agents|protective agents|mesh-ancestor
19698039|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698040|NCT04918719|Antidotes|antidotes|mesh-ancestor
20231617|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20231618|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231619|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
20231620|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20231621|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20231622|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
20231623|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
20231624|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
20231625|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231626|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231627|NCT00367653|Azithromycin|azithromycin|mesh-list
20231628|NCT00367653|Chloroquine|chloroquine|mesh-list
20231629|NCT00367653|Mefloquine|mefloquine|mesh-list
20231630|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231631|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231632|NCT00367653|Amebicides|amebicides|mesh-ancestor
20231633|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20231634|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20231635|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
20231636|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231637|NCT00367718|Bortezomib|bortezomib|mesh-list
20231638|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231639|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19698041|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
19851606|NCT00720109|Dasatinib|dasatinib|mesh-list
19851607|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
19851608|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
19851609|NCT00720109|Pegaspargase|pegaspargase|mesh-list
20231640|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
20231641|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851610|NCT00720109|Lenograstim|lenograstim|mesh-list
19851611|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20231642|NCT00367822|Ropinirole|ropinirole|mesh-list
20231643|NCT00367822|Lisuride|lisuride|mesh-list
20231644|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20231645|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20231646|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
20231647|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
20231648|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231649|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413290|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19413291|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
19413292|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
19413293|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413294|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413295|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
19413296|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19413297|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
19413298|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
19851612|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
20231650|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479180|NCT01530022|Carbamazepine|carbamazepine|mesh-list
20479181|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
20479182|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20479183|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20479184|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479185|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479186|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
20479187|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20479188|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479189|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413299|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19851613|NCT00720109|BB 1101|bb 1101|mesh-list
19851614|NCT00720109|Calcium|calcium|mesh-list
19851615|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
19851616|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851617|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
19851618|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851619|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851620|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19851621|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
19851622|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851623|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231651|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20231652|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
20231653|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
20231654|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231655|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20231656|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231657|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231658|NCT00367874|Buprenorphine|buprenorphine|mesh-list
20231659|NCT00367874|Valproic Acid|valproic acid|mesh-list
20231660|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20231661|NCT00367874|Narcotics|narcotics|mesh-ancestor
19413300|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20479190|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19413301|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20479191|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20479192|NCT01530022|Analgesics|analgesics|mesh-ancestor
20479193|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
19413302|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
19413303|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413304|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413305|NCT04500899|Protective Agents|protective agents|mesh-ancestor
19413306|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
20231662|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231663|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231664|NCT00367874|Analgesics|analgesics|mesh-ancestor
20231665|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
20231666|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231667|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20231668|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
20231669|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231670|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231671|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
20231672|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231673|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
20231674|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20231675|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231676|NCT00367913|Clarithromycin|clarithromycin|mesh-list
20231677|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
20231678|NCT00367913|Rifampin|rifampin|mesh-list
20479194|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479195|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20479196|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20479197|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
20479198|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20479199|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479200|NCT01530126|Becaplermin|becaplermin|mesh-list
20479201|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
20479202|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20479203|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479204|NCT01530126|Growth Substances|growth substances|mesh-ancestor
20479205|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231679|NCT00367913|Ethambutol|ethambutol|mesh-list
20231680|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231681|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231682|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20231683|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231684|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231685|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20231686|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20231687|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20231688|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20479206|NCT01530152|Lidocaine|lidocaine|mesh-list
20479207|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
20479208|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
20479209|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479210|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479211|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
20479212|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479213|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20479214|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20479215|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20479216|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479217|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479218|NCT01530217|Ibuprofen|ibuprofen|mesh-list
20479219|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20479220|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20479221|NCT01530217|Analgesics|analgesics|mesh-ancestor
20479222|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
20479223|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479224|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479225|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413307|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20479226|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231689|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231690|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20231691|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20231692|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
20231693|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
20231694|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20231695|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20231696|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20231697|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20231698|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20231699|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20231700|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20231701|NCT00367939|Amlodipine|amlodipine|mesh-list
20231702|NCT00367939|Valsartan|valsartan|mesh-list
20231703|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231704|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20231705|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231706|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231707|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20231708|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231709|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
20231710|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20231711|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20231712|NCT00367965|Eszopiclone|eszopiclone|mesh-list
20231713|NCT00367965|Zopiclone|zopiclone|mesh-list
20231714|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20231715|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698042|NCT04918563|Acetylcholine|acetylcholine|mesh-list
19698043|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
20231716|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231717|NCT00367978|Amlodipine|amlodipine|mesh-list
20231718|NCT00367978|Benazepril|benazepril|mesh-list
20231719|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231720|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20231721|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231722|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231723|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20231724|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231725|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
20231726|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20231727|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
19698044|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19698045|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
20231728|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231729|NCT00368017|Pioglitazone|pioglitazone|mesh-list
20231730|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231731|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231732|NCT00368030|Eszopiclone|eszopiclone|mesh-list
20231733|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20231734|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231735|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231736|NCT00368056|Eszopiclone|eszopiclone|mesh-list
20231737|NCT00368056|Zopiclone|zopiclone|mesh-list
20231738|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19698046|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231739|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231740|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231741|NCT00368121|Dexamethasone|dexamethasone|mesh-list
20231742|NCT00368121|Cetuximab|cetuximab|mesh-list
20231743|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231744|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
20231745|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
20231746|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231747|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231748|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413308|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413309|NCT04465760|Antibodies|antibodies|mesh-list
19413310|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
19413311|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
20231749|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
20231750|NCT00368121|Hormones|hormones|mesh-ancestor
20231751|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231752|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20231753|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231754|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20231755|NCT00368134|Vildagliptin|vildagliptin|mesh-list
20231756|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231757|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231758|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20231759|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
20231760|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231761|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231762|NCT00368160|Eszopiclone|eszopiclone|mesh-list
20231763|NCT00368160|Zopiclone|zopiclone|mesh-list
20231764|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20231765|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231766|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231767|NCT00368238|Aspirin|aspirin|mesh-list
20231768|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
19413312|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413313|NCT04459286|Ritonavir|ritonavir|mesh-list
20231769|NCT00368238|Clopidogrel|clopidogrel|mesh-list
20231770|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20231771|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20231772|NCT00368238|Analgesics|analgesics|mesh-ancestor
20231773|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
20231774|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231775|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231776|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231777|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231778|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20231779|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20231780|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231781|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20479227|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20479228|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479229|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231782|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20231783|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231784|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
20231785|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20231786|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20231787|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20231788|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
20231789|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231790|NCT00368238|Hematinics|hematinics|mesh-ancestor
20231791|NCT00368264|Infliximab|infliximab|mesh-list
20231792|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
20231793|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231794|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20231795|NCT00368303|Paroxetine|paroxetine|mesh-list
20479230|NCT01530230|Oxytocin|oxytocin|mesh-list
20479231|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
20479232|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20479233|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479234|NCT01530295|Docetaxel|docetaxel|mesh-list
20479235|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479236|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
20479237|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
20479238|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
20479239|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479240|NCT01530308|Dopamine|dopamine|mesh-list
20479241|NCT01530308|Haloperidol|haloperidol|mesh-list
20479242|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
20479243|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
20479244|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
20479245|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
20479246|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
20479247|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479248|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479249|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20479250|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20479251|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479252|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20479253|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
20479254|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479255|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479256|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20479257|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20479258|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
20479259|NCT01530308|Protective Agents|protective agents|mesh-ancestor
20479260|NCT01530373|Clonidine|clonidine|mesh-list
20479261|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
20479262|NCT01530373|Analgesics|analgesics|mesh-ancestor
20479263|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
20231796|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20479264|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479265|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231797|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20231798|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231799|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231800|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231801|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
20231802|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231803|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20479266|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20479267|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
19413314|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19413315|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
19413316|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19413317|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19413318|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
19413319|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413320|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413321|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19413322|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19413323|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
19413324|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479268|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
20479269|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20479270|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20479271|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20479272|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479273|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479274|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479275|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20479276|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20479277|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479278|NCT01530373|Urological Agents|urological agents|mesh-ancestor
20479279|NCT01530386|Lacosamide|lacosamide|mesh-list
20479280|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
20479281|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20479282|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20479283|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413325|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20231804|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
20231805|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231806|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20231807|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20231808|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231809|NCT00368329|Carboplatin|carboplatin|mesh-list
20231810|NCT00368329|Fluorouracil|fluorouracil|mesh-list
20231811|NCT00368329|Capecitabine|capecitabine|mesh-list
20231812|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20231813|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231814|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
20231815|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479284|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479285|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20479286|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20231816|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20231817|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231818|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
20231819|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231820|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20231821|NCT00368342|Azithromycin|azithromycin|mesh-list
20231822|NCT00368342|Clarithromycin|clarithromycin|mesh-list
20231823|NCT00368342|Erythromycin|erythromycin|mesh-list
20231824|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
20231825|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20231826|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
20231827|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231828|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231829|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20231830|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231831|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231832|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20231833|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20231834|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247619|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20247620|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247621|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20247622|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247623|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20247624|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20247625|NCT00433069|Pioglitazone|pioglitazone|mesh-list
20247626|NCT00433069|Interferons|interferons|mesh-list
20247627|NCT00433069|Ribavirin|ribavirin|mesh-list
20247628|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
20247629|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
20247630|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247631|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
20247632|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247633|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
20247634|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247635|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
20247636|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247637|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20247638|NCT00433095|Trastuzumab|trastuzumab|mesh-list
20247639|NCT00433095|Vinorelbine|vinorelbine|mesh-list
20231835|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
20231836|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231837|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
20231838|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413326|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19413327|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19413328|NCT04453852|Vaccines|vaccines|mesh-list
19413329|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
19413330|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413331|NCT04448834|Vincristine|vincristine|mesh-list
19413332|NCT04448834|Blinatumomab|blinatumomab|mesh-list
19413333|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19413334|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413335|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
19413336|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
19413337|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
19413338|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698047|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698048|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698049|NCT04918862|Granisetron|granisetron|mesh-list
19698050|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698051|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
19698052|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
19698053|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231839|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231840|NCT00368498|Teicoplanin|teicoplanin|mesh-list
20231841|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231842|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231843|NCT00368589|Atorvastatin|atorvastatin|mesh-list
20231844|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19413339|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20231845|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20231846|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
19413340|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20231847|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231848|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20231849|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20231850|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231851|NCT00368602|Timolol|timolol|mesh-list
20231852|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20231853|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
20231854|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
20231855|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231856|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231857|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231858|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20231859|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231860|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
20231861|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20231862|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20231863|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20231864|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
19851624|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19851625|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19851626|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
19851627|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
19851628|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851629|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20231865|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231866|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231867|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231868|NCT00368706|Urological Agents|urological agents|mesh-ancestor
20231869|NCT00368719|Tacrolimus|tacrolimus|mesh-list
20231870|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231871|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
20231872|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231873|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20231874|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20231875|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231876|NCT00368862|Memantine|memantine|mesh-list
20231877|NCT00368862|Citalopram|citalopram|mesh-list
19413341|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19851630|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
19851631|NCT00720109|Hormones|hormones|mesh-ancestor
20231878|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20231879|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20231880|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231881|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231882|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231883|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
20231884|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231885|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20231886|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
20231887|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231888|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20231889|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20231890|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
20231891|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20231892|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20231893|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
20231894|NCT00368901|Hematinics|hematinics|mesh-ancestor
20231895|NCT00368914|Sirolimus|sirolimus|mesh-list
20231896|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20231897|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231898|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20231899|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231900|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
20231901|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20231902|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
20231903|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231904|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20231905|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20231906|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20231907|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
20231908|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
20231909|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20231910|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
20231911|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231912|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20231913|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231914|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
20231915|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20231916|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
20231917|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20231918|NCT00369031|Protective Agents|protective agents|mesh-ancestor
20231919|NCT00369044|Prednisone|prednisone|mesh-list
20231920|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231921|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
20231922|NCT00369044|Hormones|hormones|mesh-ancestor
20247640|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20231923|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231924|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231925|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20231926|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231927|NCT00369096|Bemiparin|bemiparin|mesh-list
20231928|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
20231929|NCT00369148|Nateglinide|nateglinide|mesh-list
20231930|NCT00369148|Mitiglinide|mitiglinide|mesh-list
20231931|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231932|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231933|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
20231934|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20231935|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231936|NCT00369239|Risperidone|risperidone|mesh-list
20231937|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20231938|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
20231939|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231940|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231941|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231942|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20231943|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20231944|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20231945|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231946|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20231947|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
20231948|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
20231949|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20231950|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231951|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
20231952|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20231953|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
20231954|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231955|NCT00369356|Prednisone|prednisone|mesh-list
20231956|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20231957|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
20231958|NCT00369356|Hormones|hormones|mesh-ancestor
20231959|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20231960|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231961|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20231962|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479287|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479288|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20479289|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
20479290|NCT01530451|Coagulants|coagulants|mesh-ancestor
20479291|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20479292|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
20479293|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479294|NCT01530490|Cabergoline|cabergoline|mesh-list
20479295|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20479296|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20479297|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20479298|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
20479299|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
20479300|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479301|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479302|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479303|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
20479304|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
20479305|NCT01530503|Capecitabine|capecitabine|mesh-list
20479306|NCT01530503|Mitomycins|mitomycins|mesh-list
20479307|NCT01530503|Mitomycin|mitomycin|mesh-list
20479308|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20479309|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
20479310|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231963|NCT00369395|Volociximab|volociximab|mesh-list
20479311|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231964|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20231965|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20231966|NCT00369395|Growth Substances|growth substances|mesh-ancestor
20231967|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231968|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
20231969|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231970|NCT00369408|Naltrexone|naltrexone|mesh-list
20231971|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20231972|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20231973|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231974|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
20231975|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20231976|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20231977|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20231978|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20231979|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20231980|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231981|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20231982|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231983|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
20231984|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20231985|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
20231986|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20231987|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20231988|NCT00369538|Losartan|losartan|mesh-list
20231989|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19698054|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698055|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19698056|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
19698057|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698058|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698059|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
19698060|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19698061|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20231990|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20231991|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20231992|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19698062|NCT04918953|Prednisolone|prednisolone|mesh-list
19698063|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
20231993|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20231994|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20231995|NCT00369538|Diuretics|diuretics|mesh-ancestor
20231996|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
20231997|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20231998|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20231999|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232000|NCT00369551|Paclitaxel|paclitaxel|mesh-list
20232001|NCT00369551|Bevacizumab|bevacizumab|mesh-list
20232002|NCT00369551|Carboplatin|carboplatin|mesh-list
20232003|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20232004|NCT00369551|Antibodies|antibodies|mesh-list
20232005|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
20232006|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20232007|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20232008|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232009|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
20232010|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
20232011|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
20232012|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232013|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232014|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232015|NCT00369551|Growth Substances|growth substances|mesh-ancestor
20232016|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232017|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232018|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
20232019|NCT00369603|Donepezil|donepezil|mesh-list
20232020|NCT00369603|Galantamine|galantamine|mesh-list
20232021|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20232022|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232023|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232024|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
20232025|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232026|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232027|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
20232028|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20232029|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
20232030|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232031|NCT00369694|Terlipressin|terlipressin|mesh-list
20232032|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20232033|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19413342|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232034|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
20232035|NCT00369733|Hematinics|hematinics|mesh-ancestor
20232036|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
20232037|NCT00369772|Hematinics|hematinics|mesh-ancestor
20232038|NCT00369798|Rolipram|rolipram|mesh-list
20232039|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
20232040|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20232041|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20232042|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19851632|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851633|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19851634|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
19851635|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232043|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232044|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232045|NCT00369811|Fentanyl|fentanyl|mesh-list
20232046|NCT00369811|Oxycodone|oxycodone|mesh-list
20232047|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20232048|NCT00369811|Narcotics|narcotics|mesh-ancestor
20232049|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20232050|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698064|NCT04918953|Budesonide|budesonide|mesh-list
19698065|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19698066|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
19698067|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698068|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
19698069|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
19698070|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232051|NCT00369811|Analgesics|analgesics|mesh-ancestor
19851636|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19851637|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19851638|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19851639|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
20232052|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
20232053|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232054|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20232055|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19698071|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698072|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698073|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
19698074|NCT04918953|Hormones|hormones|mesh-ancestor
19698075|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698076|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19698077|NCT04918953|Protective Agents|protective agents|mesh-ancestor
20232056|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
20232057|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
20232058|NCT00369837|Clevidipine|clevidipine|mesh-list
20232059|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20232060|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232061|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232062|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20232063|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232064|NCT00369863|Triamcinolone|triamcinolone|mesh-list
20232065|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20232066|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20232067|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20232068|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232069|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
20232070|NCT00369863|Hormones|hormones|mesh-ancestor
20232071|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232072|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232073|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232074|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
20232075|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232076|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232077|NCT00369889|Bevacizumab|bevacizumab|mesh-list
20232078|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20232079|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232080|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232081|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232082|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232083|NCT00369889|Growth Substances|growth substances|mesh-ancestor
20232084|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232085|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232086|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232087|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232088|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232089|NCT00369954|Gemcitabine|gemcitabine|mesh-list
20232090|NCT00369954|Carboplatin|carboplatin|mesh-list
20232091|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232092|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20232093|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
20232094|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232095|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
20232096|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232097|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232098|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232099|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
20232100|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232101|NCT00369993|Fluticasone|fluticasone|mesh-list
20232102|NCT00369993|Xhance|xhance|mesh-list
20232103|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20232104|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232105|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20232106|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
20232107|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232108|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232109|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20232110|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
20232111|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232112|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20232113|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20232114|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20232115|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20232116|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
20232117|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416884|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232118|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232119|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20232120|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
20232121|NCT00370019|Estradiol|estradiol|mesh-list
20232122|NCT00370019|Estrogens|estrogens|mesh-ancestor
20232123|NCT00370019|Hormones|hormones|mesh-ancestor
20232124|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232125|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232126|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20232127|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
20232128|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20232129|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20232130|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20232131|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20232132|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20232133|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20232134|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20232135|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232136|NCT00370045|Bivalirudin|bivalirudin|mesh-list
20232137|NCT00370045|Eptifibatide|eptifibatide|mesh-list
20232138|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
20232139|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20232140|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
20232141|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232142|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232143|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
20232144|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20232145|NCT00370097|Fluticasone|fluticasone|mesh-list
20232146|NCT00370097|Xhance|xhance|mesh-list
20232147|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232148|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20232149|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
20232150|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232151|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232152|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20232153|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
20232154|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232155|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20232156|NCT00370188|Topiramate|topiramate|mesh-list
20232157|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
20232158|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20232159|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232160|NCT00370201|Colchicine|colchicine|mesh-list
20232161|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
20232162|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232163|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
20232164|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
20232165|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
20232166|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479312|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20479313|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
20479314|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20479315|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479316|NCT01530542|Oxycodone|oxycodone|mesh-list
20479317|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20479318|NCT01530542|Narcotics|narcotics|mesh-ancestor
20479319|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479320|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479321|NCT01530542|Analgesics|analgesics|mesh-ancestor
20479322|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
20479323|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479324|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
20232167|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232168|NCT00370240|Ropivacaine|ropivacaine|mesh-list
20232169|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
20232170|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
20232171|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20232172|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232173|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
20232174|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232175|NCT00370253|Terlipressin|terlipressin|mesh-list
20232176|NCT00370253|Norepinephrine|norepinephrine|mesh-list
20232177|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20232178|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20232179|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20232180|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20232181|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20232182|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232183|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232184|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232185|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
20232186|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
20232187|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232188|NCT00370266|Triamcinolone|triamcinolone|mesh-list
20232189|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232190|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
20232191|NCT00370266|Hormones|hormones|mesh-ancestor
20232192|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232193|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232194|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
20232195|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20232196|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232197|NCT00370318|Acetaminophen|acetaminophen|mesh-list
20232198|NCT00370318|Vaccines|vaccines|mesh-list
20232199|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20232200|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
20232201|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232202|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232203|NCT00370318|Analgesics|analgesics|mesh-ancestor
20232204|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
20232205|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232206|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
20247641|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232207|NCT00370370|Triamcinolone|triamcinolone|mesh-list
20232208|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20232209|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20232210|NCT00370370|Bevacizumab|bevacizumab|mesh-list
20232211|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20232212|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232213|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232214|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232215|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232216|NCT00370370|Growth Substances|growth substances|mesh-ancestor
20232217|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232218|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232219|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232220|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
20232221|NCT00370370|Hormones|hormones|mesh-ancestor
20232222|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232223|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232224|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
20232225|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232226|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232227|NCT00370422|Triamcinolone|triamcinolone|mesh-list
20479325|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
20479326|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479327|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20479328|NCT01530594|Lenalidomide|lenalidomide|mesh-list
20479329|NCT01530594|Bortezomib|bortezomib|mesh-list
20479330|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
20479331|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479332|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479333|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479334|NCT01530594|Growth Substances|growth substances|mesh-ancestor
20479335|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232228|NCT00370422|Bevacizumab|bevacizumab|mesh-list
20232229|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232230|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232231|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232232|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232233|NCT00370422|Growth Substances|growth substances|mesh-ancestor
20232234|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232235|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232236|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232237|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
20232238|NCT00370422|Hormones|hormones|mesh-ancestor
20232239|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232240|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20232241|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
20232242|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20232243|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20232244|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20232245|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20232246|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232247|NCT00370539|Triamcinolone|triamcinolone|mesh-list
20232248|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20232249|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20232250|NCT00370539|Bevacizumab|bevacizumab|mesh-list
20232251|NCT00370539|Verteporfin|verteporfin|mesh-list
20232252|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19413343|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413344|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19413345|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413346|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413347|NCT04424641|Antibodies|antibodies|mesh-list
19413348|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19413349|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
19413350|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413351|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
19413352|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
19413353|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19413354|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232253|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232254|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232255|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232256|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232257|NCT00370539|Growth Substances|growth substances|mesh-ancestor
20232258|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232259|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232260|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232261|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
20232262|NCT00370539|Hormones|hormones|mesh-ancestor
19413355|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247642|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20479336|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479337|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
20479338|NCT01530607|Goserelin|goserelin|mesh-list
20479339|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20479340|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
20479341|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479342|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20479343|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20479344|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
20479345|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479346|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479347|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20247643|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247644|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
20247645|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
20247646|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247647|NCT00433121|Olanzapine|olanzapine|mesh-list
20247648|NCT00433121|Risperidone|risperidone|mesh-list
20247649|NCT00433121|Citalopram|citalopram|mesh-list
20247650|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20247651|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
20247652|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247653|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247654|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232263|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232264|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232265|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
20232266|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232267|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232268|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20232269|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232270|NCT00370565|Insulin|insulin|mesh-list
20232271|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20232272|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20232273|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232274|NCT00370591|Fluticasone|fluticasone|mesh-list
20232275|NCT00370591|Xhance|xhance|mesh-list
20232276|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20232277|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232278|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20232279|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
20232280|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232281|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232282|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20232283|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
20232284|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232285|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20232286|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20232287|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20232288|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20232289|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
20232290|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232291|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232292|NCT00370617|Metformin|metformin|mesh-list
20232293|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20232294|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232295|NCT00370630|Triamcinolone|triamcinolone|mesh-list
20232296|NCT00370630|Bevacizumab|bevacizumab|mesh-list
20479348|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479349|NCT01530620|Propiverine|propiverine|mesh-list
20479350|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
20479351|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
20479352|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479353|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698078|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698079|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698080|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20479354|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20479355|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19851640|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20247655|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19698081|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19698082|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698083|NCT04918433|Anesthetics|anesthetics|mesh-list
19698084|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698085|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698086|NCT04918264|Capecitabine|capecitabine|mesh-list
19698087|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19698088|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
19698089|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698090|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698091|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
20232297|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232298|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232299|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232300|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232301|NCT00370630|Growth Substances|growth substances|mesh-ancestor
20232302|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232303|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232304|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232305|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
20232306|NCT00370630|Hormones|hormones|mesh-ancestor
20232307|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232308|NCT00370643|Insulin|insulin|mesh-list
20479356|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479357|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479358|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479359|NCT01530620|Urological Agents|urological agents|mesh-ancestor
20479360|NCT01530698|Vaccines|vaccines|mesh-list
20479361|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
20479362|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479363|NCT01530711|Terlipressin|terlipressin|mesh-list
20479364|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20479365|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20479366|NCT01530737|Antithrombins|antithrombins|mesh-list
20479367|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
20479368|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20232309|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20232310|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20232311|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232312|NCT00370656|Pregabalin|pregabalin|mesh-list
20232313|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20232314|NCT00370656|Amitriptyline|amitriptyline|mesh-list
20232315|NCT00370656|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20232316|NCT00370656|Analgesics|analgesics|mesh-ancestor
20232317|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
20232318|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232319|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232320|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
20232321|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20232322|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232323|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413356|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413357|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19698092|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698093|NCT04917718|Tacrolimus|tacrolimus|mesh-list
19698094|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698095|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
19698096|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698097|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19413358|NCT04379518|Interferons|interferons|mesh-list
19698098|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247656|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20479369|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
20232324|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20232325|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19413359|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
19413360|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
19413361|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19413362|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232326|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20479370|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479371|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479372|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
20232327|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20232328|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20232329|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20232330|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20232331|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232332|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
20232333|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
20232334|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20232335|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232336|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20232337|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
20232338|NCT00370656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20232339|NCT00370669|Triamcinolone|triamcinolone|mesh-list
20232340|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20232341|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20232342|NCT00370669|Bevacizumab|bevacizumab|mesh-list
20479373|NCT01530763|Amoxicillin|amoxicillin|mesh-list
20479374|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
20479375|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
20479376|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
20479377|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20479378|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20232343|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20479379|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479380|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232344|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20479381|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20479382|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479383|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479384|NCT01530815|Bupivacaine|bupivacaine|mesh-list
20232345|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232346|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479385|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
20479386|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
20479387|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479388|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232347|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232348|NCT00370669|Growth Substances|growth substances|mesh-ancestor
20232349|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413363|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
19413364|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232350|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232351|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232352|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
20232353|NCT00370669|Hormones|hormones|mesh-ancestor
20232354|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232355|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232356|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
20232357|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232358|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232359|NCT00370721|Bevacizumab|bevacizumab|mesh-list
20232360|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232361|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851641|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851642|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
19851643|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
19851644|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19851645|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19851646|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19851647|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19851648|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20232362|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479389|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
20479390|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479391|NCT01530984|Ipilimumab|ipilimumab|mesh-list
20479392|NCT01530984|Sargramostim|sargramostim|mesh-list
20479393|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20479394|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479395|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20479396|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479397|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
20479398|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479399|NCT01531049|Nicotine|nicotine|mesh-list
20479400|NCT01531049|Varenicline|varenicline|mesh-list
20479401|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20479402|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
20479403|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479404|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413365|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
19413366|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413367|NCT04378114|Acetaminophen|acetaminophen|mesh-list
20232363|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232364|NCT00370721|Growth Substances|growth substances|mesh-ancestor
20232365|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232366|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232367|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
20232368|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20232369|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20232370|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20232371|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232372|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232373|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
20232374|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232375|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232376|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20232377|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232378|NCT00370747|Ecabet|ecabet|mesh-list
20232379|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232380|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20232381|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20232382|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
20232383|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232384|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232385|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20232386|NCT00370747|Protective Agents|protective agents|mesh-ancestor
20232387|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232388|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232389|NCT00370760|Dexamethasone|dexamethasone|mesh-list
20232390|NCT00370760|Colchicine|colchicine|mesh-list
20232391|NCT00370760|Heparin|heparin|mesh-list
20232392|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20232393|NCT00370760|Tinzaparin|tinzaparin|mesh-list
20232394|NCT00370760|Dalteparin|dalteparin|mesh-list
20232395|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232396|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
20232397|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
20232398|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232399|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232400|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20232401|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
20232402|NCT00370760|Hormones|hormones|mesh-ancestor
20232403|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232404|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479405|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20479406|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20479407|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479408|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479409|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479410|NCT01531114|Ticagrelor|ticagrelor|mesh-list
20479411|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20479412|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19413368|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413369|NCT04378114|Analgesics|analgesics|mesh-ancestor
19413370|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
20232405|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232406|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
20232407|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20232408|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20232409|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232410|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
20232411|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232412|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
20232413|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
20232414|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
20232415|NCT00370786|Bevacizumab|bevacizumab|mesh-list
20232416|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232417|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232418|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232419|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232420|NCT00370786|Growth Substances|growth substances|mesh-ancestor
20232421|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232422|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232423|NCT00370799|Betamethasone|betamethasone|mesh-list
20232424|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
20232425|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20232426|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
20232427|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20232428|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20232429|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232430|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
20232431|NCT00370799|Hormones|hormones|mesh-ancestor
19413371|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232432|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232433|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232434|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20232435|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
20232436|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20232437|NCT00370825|Miltefosine|miltefosine|mesh-list
20232438|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
20232439|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413372|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479413|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20479414|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19413373|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
19413374|NCT04349124|Antihypertensive Agents|antihypertensive agents|mesh-list
19413375|NCT04349124|Nifedipine|nifedipine|mesh-list
19413376|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19413377|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413378|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479415|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20479416|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
20479417|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479418|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479419|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479420|NCT01531140|Bisacodyl|bisacodyl|mesh-list
20479421|NCT01531140|Senna Extract|senna extract|mesh-list
20479422|NCT01531140|Sennosides|sennosides|mesh-list
20479423|NCT01531140|Cathartics|cathartics|mesh-ancestor
20232440|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20232441|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20232442|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232443|NCT00370851|Bevacizumab|bevacizumab|mesh-list
20232444|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232445|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232446|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232447|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232448|NCT00370851|Growth Substances|growth substances|mesh-ancestor
20232449|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232450|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232451|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
20232452|NCT00370968|Astringents|astringents|mesh-ancestor
20232453|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232454|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232455|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20232456|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20232457|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851649|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
20232458|NCT00371007|Incretins|incretins|mesh-ancestor
20232459|NCT00371007|Hormones|hormones|mesh-ancestor
20232460|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232461|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20232462|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
20232463|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232464|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232465|NCT00371020|Heparin|heparin|mesh-list
20232466|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20232467|NCT00371020|Tinzaparin|tinzaparin|mesh-list
20232468|NCT00371020|Dalteparin|dalteparin|mesh-list
20232469|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
20232470|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19413379|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19413380|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413381|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
19413382|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
19413383|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19413384|NCT04333160|Hylan|hylan|mesh-list
20479424|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20479425|NCT01531140|Laxatives|laxatives|mesh-ancestor
20479426|NCT01531166|Interferons|interferons|mesh-list
20479427|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
19413385|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
19413386|NCT04333160|Protective Agents|protective agents|mesh-ancestor
19413387|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413388|NCT04326283|Trametinib|trametinib|mesh-list
19413389|NCT04326283|Riluzole|riluzole|mesh-list
19413390|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698099|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698100|NCT04917692|Empagliflozin|empagliflozin|mesh-list
19698101|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19698102|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698103|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19698104|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698105|NCT04917627|Vancomycin|vancomycin|mesh-list
19698106|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19698107|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698108|NCT04917900|Paclitaxel|paclitaxel|mesh-list
20479428|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
20479429|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20479430|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479431|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
20479432|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479433|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
20479434|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527714|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20527715|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20527716|NCT01769625|Analgesics|analgesics|mesh-ancestor
20527717|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
20527718|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527719|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20527720|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527721|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20527722|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20527723|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527724|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527725|NCT01769651|Methadone|methadone|mesh-list
20527726|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20527727|NCT01769651|Narcotics|narcotics|mesh-ancestor
20527728|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413391|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232471|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19698109|NCT04917900|Trastuzumab|trastuzumab|mesh-list
20527729|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527730|NCT01769651|Analgesics|analgesics|mesh-ancestor
20527731|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
20479435|NCT01531192|Nystatin|nystatin|mesh-list
19698110|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19698111|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19698112|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698113|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
19698114|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20479436|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479437|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479438|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
20479439|NCT01531192|Ionophores|ionophores|mesh-ancestor
20479440|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479441|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479442|NCT01531218|Azithromycin|azithromycin|mesh-list
20479443|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479444|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479445|NCT01531244|Dactinomycin|dactinomycin|mesh-list
20479446|NCT01531244|Cactinomycin|cactinomycin|mesh-list
20479447|NCT01531244|Melphalan|melphalan|mesh-list
19413392|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698115|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
19698116|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698117|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698118|NCT04917757|Dexamethasone|dexamethasone|mesh-list
19698119|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20479448|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20232472|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232473|NCT00371033|Pregabalin|pregabalin|mesh-list
20232474|NCT00371033|Analgesics|analgesics|mesh-ancestor
20232475|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
20232476|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232477|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232478|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
20232479|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20232480|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232481|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232482|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20479449|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
20479450|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479451|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479452|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20479453|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20479454|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
20479455|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479456|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479457|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479458|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20479459|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20479460|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479461|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20479462|NCT01531309|S 20098|s 20098|mesh-list
20479463|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20479464|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479465|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479466|NCT01531322|Vaccines|vaccines|mesh-list
20479467|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20479468|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
20479469|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479470|NCT01531361|Sorafenib|sorafenib|mesh-list
20479471|NCT01531361|Vemurafenib|vemurafenib|mesh-list
20479472|NCT01531361|Crizotinib|crizotinib|mesh-list
20479473|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479474|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20479475|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479476|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479477|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
20479478|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479479|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
20479480|NCT01531517|Propolis|propolis|mesh-list
20479481|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
19698120|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
20232483|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20232484|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20232485|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20232486|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20232487|NCT00371072|Mitomycins|mitomycins|mesh-list
20232488|NCT00371072|Mitomycin|mitomycin|mesh-list
20232489|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20232490|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232491|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
20232492|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232493|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20232494|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232495|NCT00371098|Vaccines|vaccines|mesh-list
20232496|NCT00371098|Immunologic Factors|immunologic factors|mesh-ancestor
20232497|NCT00371098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232498|NCT00371111|Triamcinolone|triamcinolone|mesh-list
20232499|NCT00371111|Bevacizumab|bevacizumab|mesh-list
20232500|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232501|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232502|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232503|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232504|NCT00371111|Growth Substances|growth substances|mesh-ancestor
20232505|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232506|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232507|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232508|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
20479482|NCT01531517|Vitamins|vitamins|mesh-ancestor
20232509|NCT00371111|Hormones|hormones|mesh-ancestor
20232510|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232511|NCT00371124|Atropine|atropine|mesh-list
20232512|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20232513|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20232514|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20232515|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20232516|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20232517|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
20232518|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232519|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232520|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20479483|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
20479484|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479485|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479486|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
20479487|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
20479488|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19851650|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851651|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19851652|NCT00720109|Antidotes|antidotes|mesh-ancestor
20232521|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
20479489|NCT01531569|Estrogens|estrogens|mesh-ancestor
20479490|NCT01531569|Hormones|hormones|mesh-ancestor
20232522|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
20232523|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
20232524|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20232525|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20232526|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
19698121|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
19698122|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698123|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232527|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232528|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232529|NCT00371306|Metformin|metformin|mesh-list
20232530|NCT00371306|Glyburide|glyburide|mesh-list
20232531|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20479491|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479492|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479493|NCT01531582|Minocycline|minocycline|mesh-list
20479494|NCT01531582|Tetracycline|tetracycline|mesh-list
20479495|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479496|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479497|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20479498|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479499|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479500|NCT01531595|Bevacizumab|bevacizumab|mesh-list
20479501|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
20479502|NCT01531595|Irinotecan|irinotecan|mesh-list
19698124|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698125|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
20479503|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413393|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413394|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
19413395|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19413396|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19413397|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413398|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413399|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19413400|NCT04326283|Protective Agents|protective agents|mesh-ancestor
19413401|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19413402|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
19413403|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413404|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19413405|NCT04285671|Trastuzumab|trastuzumab|mesh-list
19698126|NCT04917757|Hormones|hormones|mesh-ancestor
20479504|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479505|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479506|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479507|NCT01531595|Growth Substances|growth substances|mesh-ancestor
20479508|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479509|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
20479510|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20479511|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20479512|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479513|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479514|NCT01531647|Ritonavir|ritonavir|mesh-list
20479515|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
20479516|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20479517|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20479518|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
19413406|NCT04285671|Necitumumab|necitumumab|mesh-list
19413407|NCT04285671|Cetuximab|cetuximab|mesh-list
20232532|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232533|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
20232534|NCT00371319|Tacrolimus|tacrolimus|mesh-list
20232535|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232536|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
20232537|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232538|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20232539|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232540|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232541|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20232542|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232543|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20232544|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
20232545|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20232546|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232547|NCT00371332|Minocycline|minocycline|mesh-list
20232548|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20232549|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232550|NCT00371410|Triamcinolone|triamcinolone|mesh-list
20232551|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20232552|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20232553|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20232554|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232555|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
20232556|NCT00371410|Hormones|hormones|mesh-ancestor
20232557|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232558|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232559|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232560|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
20232561|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232562|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232563|NCT00371488|Lapatinib|lapatinib|mesh-list
20232564|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232565|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232566|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232567|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232568|NCT00371501|Aspirin|aspirin|mesh-list
20232569|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20232570|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20232571|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232572|NCT00371501|Analgesics|analgesics|mesh-ancestor
20232573|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
20232574|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232575|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698127|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698128|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20232576|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232577|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232578|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20232579|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20232580|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232581|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20232582|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19698129|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698130|NCT04917497|Simendan|simendan|mesh-list
20232583|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413408|NCT04285671|Osimertinib|osimertinib|mesh-list
20232584|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
20232585|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20232586|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20232587|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
20232588|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20232589|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20232590|NCT00371527|Ipratropium|ipratropium|mesh-list
20232591|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20479519|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479520|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479521|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20479522|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20479523|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
20479524|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479525|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20479526|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20479527|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20232592|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
19698131|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19698132|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
19698133|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19698134|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19698135|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698136|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698137|NCT04917497|Protective Agents|protective agents|mesh-ancestor
19698138|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698139|NCT04917458|Vitamin D|vitamin d|mesh-list
19698140|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
19698141|NCT04917458|Vitamins|vitamins|mesh-ancestor
19698142|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
19698143|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698144|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19698145|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19698146|NCT04917484|Octreotide|octreotide|mesh-list
19698147|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19698148|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20232593|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479528|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20479529|NCT01531712|Gemcitabine|gemcitabine|mesh-list
20479530|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
20479531|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20479532|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20479533|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
20479534|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479535|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479536|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
20479537|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479538|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479539|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20479540|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
20479541|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479542|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20479543|NCT01531764|Vinorelbine|vinorelbine|mesh-list
20479544|NCT01531764|Afatinib|afatinib|mesh-list
20479545|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20479546|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479547|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
20479548|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
20479549|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
20479550|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479551|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20479552|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479553|NCT01531777|Apatinib|apatinib|mesh-list
20479554|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479555|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20479556|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479557|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479558|NCT01531790|Carboplatin|carboplatin|mesh-list
20479559|NCT01531790|Pemetrexed|pemetrexed|mesh-list
20479560|NCT01531790|Endostar protein|endostar protein|mesh-list
20232594|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232595|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20232596|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
20232597|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20232598|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
20232599|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232600|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232601|NCT00371553|Sunitinib|sunitinib|mesh-list
20232602|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232603|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232604|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232605|NCT00371553|Growth Substances|growth substances|mesh-ancestor
20232606|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232607|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232608|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232609|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232610|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479561|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479562|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527732|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232611|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20232612|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20232613|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20232614|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
20232615|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232616|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19413409|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20527733|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
19413410|NCT04285671|Antibodies|antibodies|mesh-list
20527734|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
20527735|NCT01769664|Clindamycin|clindamycin|mesh-list
20527736|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
20527737|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
20527738|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20527739|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20527740|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527741|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20527742|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527743|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232617|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20232618|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232619|NCT00371592|Acyclovir|acyclovir|mesh-list
19698149|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20232620|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
20232621|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232622|NCT00371696|Acetaminophen|acetaminophen|mesh-list
20232623|NCT00371696|Diclofenac|diclofenac|mesh-list
20232624|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232625|NCT00371696|Analgesics|analgesics|mesh-ancestor
19698150|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698151|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19698152|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698153|NCT04917406|Dexamethasone|dexamethasone|mesh-list
19698154|NCT04917406|Lidocaine|lidocaine|mesh-list
19698155|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698156|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
19698157|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
20232626|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
20232627|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232628|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232629|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
20232630|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20232631|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232632|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232633|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20232634|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232635|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698158|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698159|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698160|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698161|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
19698162|NCT04917406|Hormones|hormones|mesh-ancestor
19698163|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698164|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698165|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698166|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
19698167|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
19698168|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698169|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
19698170|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19698171|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19698172|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19698173|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19698174|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698175|NCT04917055|Dexamethasone|dexamethasone|mesh-list
19698176|NCT04917055|Epinephrine|epinephrine|mesh-list
19698177|NCT04917055|Ropivacaine|ropivacaine|mesh-list
20232636|NCT00371735|Artesunate|artesunate|mesh-list
20232637|NCT00371735|Dapsone|dapsone|mesh-list
20232638|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
20232639|NCT00371735|Proguanil|proguanil|mesh-list
20232640|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
20232641|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20232642|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20232643|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232644|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232645|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
20232646|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
19698178|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698179|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
19698180|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
19698181|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698182|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698183|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698184|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
19698185|NCT04917055|Hormones|hormones|mesh-ancestor
19698186|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232647|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20232648|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
20232649|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20232650|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232651|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232652|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
20232653|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20232654|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
19698187|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698188|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698189|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
19698190|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
19698191|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698192|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
19698193|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19698194|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19698195|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20232655|NCT00371813|Varenicline|varenicline|mesh-list
19698196|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232656|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19851653|NCT00720109|Protective Agents|protective agents|mesh-ancestor
19851654|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
19851655|NCT00720109|Vitamins|vitamins|mesh-ancestor
19851656|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
19851657|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
19851658|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
19851659|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
19851660|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19851661|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19851662|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851663|NCT00720109|Hematinics|hematinics|mesh-ancestor
19851664|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
19851665|NCT00720122|Insulin|insulin|mesh-list
19851666|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19413411|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
20232657|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20232658|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
20232659|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698197|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698198|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20232660|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232661|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232662|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20232663|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
19698199|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20232664|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232665|NCT00371904|Rituximab|rituximab|mesh-list
20232666|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232667|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232668|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
20232669|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232670|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232671|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20232672|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20232673|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
20232674|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232675|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232676|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20232677|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20232678|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20232679|NCT00371995|Amphotericin B|amphotericin b|mesh-list
20232680|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20232681|NCT00371995|Miltefosine|miltefosine|mesh-list
20232682|NCT00371995|Amebicides|amebicides|mesh-ancestor
20232683|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20232684|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20232685|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232686|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20232687|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
20232688|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232689|NCT00372008|Testosterone|testosterone|mesh-list
20232690|NCT00372008|Androgens|androgens|mesh-ancestor
20232691|NCT00372008|Hormones|hormones|mesh-ancestor
20232692|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232693|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698200|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19698201|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698202|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
19698203|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
19698204|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19698205|NCT04917250|Gemcitabine|gemcitabine|mesh-list
19698206|NCT04917250|Dexamethasone|dexamethasone|mesh-list
19698207|NCT04917250|Etoposide|etoposide|mesh-list
19698208|NCT04917250|Pegaspargase|pegaspargase|mesh-list
19698209|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232694|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
20232695|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19698210|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
19698211|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
20232696|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232697|NCT00372099|Calcitonin|calcitonin|mesh-list
20232698|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
20232699|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20232700|NCT00372099|Katacalcin|katacalcin|mesh-list
20232701|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20232702|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232703|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20232704|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247657|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20247658|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20247659|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20247660|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
20247661|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20247662|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20247663|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247664|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20247665|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
20247666|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
20247667|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247668|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
19413412|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19413413|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
19413414|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413415|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413416|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413417|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19413418|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413419|NCT04279561|Edetic Acid|edetic acid|mesh-list
19413420|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19413421|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
20247669|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247670|NCT00433173|Anastrozole|anastrozole|mesh-list
20247671|NCT00433173|Goserelin|goserelin|mesh-list
20247672|NCT00433173|Testosterone|testosterone|mesh-list
20247673|NCT00433173|Androgens|androgens|mesh-ancestor
20247674|NCT00433173|Hormones|hormones|mesh-ancestor
20247675|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19413422|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
20247676|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232705|NCT00372138|Thrombin|thrombin|mesh-list
20232706|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
20232707|NCT00372138|Coagulants|coagulants|mesh-ancestor
20232708|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
20232709|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
20232710|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232711|NCT00372216|Clopidogrel|clopidogrel|mesh-list
19698212|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698213|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698214|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698215|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
19698216|NCT04917250|Hormones|hormones|mesh-ancestor
19698217|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698218|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698219|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698220|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19698221|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
19698222|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698223|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
19698224|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698225|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698226|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851667|NCT00720122|Mitogens|mitogens|mesh-list
19851668|NCT00720122|Mecasermin|mecasermin|mesh-list
19851669|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19851670|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851671|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
19851672|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232712|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20232713|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20479563|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479564|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20479565|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20479566|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479567|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479568|NCT01531790|Growth Substances|growth substances|mesh-ancestor
20479569|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479570|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
20479571|NCT01531829|Heparin|heparin|mesh-list
19698227|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
19698228|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19698229|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19698230|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19698231|NCT04916925|Vitamin D|vitamin d|mesh-list
19698232|NCT04916925|Vitamins|vitamins|mesh-ancestor
19698233|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
20479572|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20479573|NCT01531829|Tinzaparin|tinzaparin|mesh-list
19698234|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698235|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19707955|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479574|NCT01531829|Dalteparin|dalteparin|mesh-list
20232714|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20232715|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20232716|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
20479575|NCT01531829|Plasminogen|plasminogen|mesh-list
20479576|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20479577|NCT01531829|Nadroparin|nadroparin|mesh-list
20479578|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
20479579|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19851673|NCT00720122|Growth Substances|growth substances|mesh-ancestor
19851674|NCT00720226|Losartan|losartan|mesh-list
19851675|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19851676|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19851677|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19851678|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20479580|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20479581|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479582|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20479583|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479584|NCT01531855|Insulin|insulin|mesh-list
20232717|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232718|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232719|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232720|NCT00372229|Valganciclovir|valganciclovir|mesh-list
20232721|NCT00372229|Ganciclovir|ganciclovir|mesh-list
20232722|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20232723|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
20232724|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232725|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20232726|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232727|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232728|NCT00372294|Clindamycin|clindamycin|mesh-list
20232729|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
20232730|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
20232731|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
20232732|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
20232733|NCT00372294|Dexamethasone|dexamethasone|mesh-list
20232734|NCT00372294|Prednisolone|prednisolone|mesh-list
20232735|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232736|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
20232737|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
20232738|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232739|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232740|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20232741|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
20232742|NCT00372294|Hormones|hormones|mesh-ancestor
20232743|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232744|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20232745|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232746|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20232747|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232748|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20232749|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232750|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232751|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
20232752|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20232753|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20232754|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20232755|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
20232756|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
20232757|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20232758|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232759|NCT00372307|Analgesics|analgesics|mesh-ancestor
20232760|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
20232761|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232762|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232763|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232764|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232765|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232766|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232767|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
20232768|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20232769|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232770|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232771|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
20232772|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20232773|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232774|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232775|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20232776|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232777|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20232778|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
20232779|NCT00372476|Vinorelbine|vinorelbine|mesh-list
20232780|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232781|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232782|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232783|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479585|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
20479586|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
20479587|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20479588|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479589|NCT01531920|Ethanol|ethanol|mesh-list
20479590|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20479591|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479592|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479593|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232784|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20232785|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
20232786|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
20232787|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
20232788|NCT00372515|Gefitinib|gefitinib|mesh-list
20232789|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232790|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232791|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698236|NCT04916951|Amoxicillin|amoxicillin|mesh-list
19698237|NCT04916951|Cephalexin|cephalexin|mesh-list
19698238|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19698239|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698240|NCT04916899|Rifampin|rifampin|mesh-list
19698241|NCT04916899|Isoniazid|isoniazid|mesh-list
20232792|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232793|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
20232794|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20232795|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232796|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
20232797|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
20232798|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20232799|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
20232800|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20232801|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20232802|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232803|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20232804|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232805|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232806|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20232807|NCT00372632|Renal Agents|renal agents|mesh-ancestor
20232808|NCT00372645|Folic Acid|folic acid|mesh-list
20232809|NCT00372645|Hematinics|hematinics|mesh-ancestor
20479594|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20479595|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479596|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20479597|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479598|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479599|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20479600|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
20479601|NCT01532076|Coagulants|coagulants|mesh-ancestor
20232810|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
20232811|NCT00372645|Vitamins|vitamins|mesh-ancestor
20479602|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
20232812|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
20232813|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232814|NCT00372658|Lidocaine|lidocaine|mesh-list
20232815|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
20232816|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
20232817|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20232818|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232819|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
20232820|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232821|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20232822|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20232823|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20232824|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232825|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232826|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
20232827|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20232828|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232829|NCT00372723|Infliximab|infliximab|mesh-list
20232830|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232831|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20232832|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232833|NCT00372736|Docetaxel|docetaxel|mesh-list
19413423|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413424|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
19413425|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19413426|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19413427|NCT04269408|Nicardipine|nicardipine|mesh-list
19413428|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19851679|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232834|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232835|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
19413429|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19413430|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232836|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
20232837|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
20232838|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232839|NCT00372762|Furosemide|furosemide|mesh-list
20232840|NCT00372762|Bumetanide|bumetanide|mesh-list
20232841|NCT00372762|Diuretics|diuretics|mesh-ancestor
20232842|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
20479603|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479604|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
20479605|NCT01532115|Opicapone|opicapone|mesh-list
20479606|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20232843|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232844|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20479607|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479608|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20479609|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20479610|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479611|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232845|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20232846|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232847|NCT00372788|Pemetrexed|pemetrexed|mesh-list
20232848|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232849|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479612|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479613|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20479614|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20479615|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20479616|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
20479617|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20479618|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479619|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479620|NCT01532232|Varenicline|varenicline|mesh-list
20479621|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20479622|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20479623|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479624|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479625|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232850|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232851|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20232852|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20232853|NCT00372801|Ibuprofen|ibuprofen|mesh-list
20232854|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20232855|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232856|NCT00372801|Analgesics|analgesics|mesh-ancestor
20232857|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
20232858|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20232859|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232860|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232861|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232862|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20232863|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232864|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232865|NCT00372827|Travoprost|travoprost|mesh-list
20232866|NCT00372827|Brinzolamide|brinzolamide|mesh-list
20232867|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20232868|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20232869|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232870|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479626|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479627|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
20479628|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20479629|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20479630|NCT01532466|Rocuronium|rocuronium|mesh-list
20479631|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20479632|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20479633|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20479634|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479635|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479636|NCT01532518|MEN 11420|men 11420|mesh-list
20232871|NCT00372853|Tremelimumab|tremelimumab|mesh-list
19851680|NCT00720278|Azelastine|azelastine|mesh-list
19851681|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19851682|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
19851683|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851684|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851685|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19851686|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
20232872|NCT00372853|Ipilimumab|ipilimumab|mesh-list
20232873|NCT00372853|Sunitinib|sunitinib|mesh-list
20232874|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232875|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232876|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20232877|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232878|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20232879|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20232880|NCT00372853|Growth Substances|growth substances|mesh-ancestor
20232881|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232882|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
20232883|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232884|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232885|NCT00372879|Vitamin E|vitamin e|mesh-list
20232886|NCT00372879|Vitamins|vitamins|mesh-ancestor
20232887|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
20232888|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232889|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
20232890|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232891|NCT00372879|Protective Agents|protective agents|mesh-ancestor
20232892|NCT00372892|Rituximab|rituximab|mesh-list
20232893|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20232894|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232895|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
20232896|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232897|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232898|NCT00373048|Mefloquine|mefloquine|mesh-list
20232899|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
20232900|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20232901|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20232902|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232903|NCT00373061|Omalizumab|omalizumab|mesh-list
20232904|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20232905|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20232906|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
20232907|NCT00373087|Entacapone|entacapone|mesh-list
20232908|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19851687|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19851688|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851689|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851690|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19851691|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19851692|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19851693|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
19851694|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
19851695|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851696|NCT00720330|Lidocaine|lidocaine|mesh-list
20232909|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20232910|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232911|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20232912|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232913|NCT00373126|Nicotine|nicotine|mesh-list
20232914|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20232915|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
20232916|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851697|NCT00720330|Ketamine|ketamine|mesh-list
19851698|NCT00720330|Ropivacaine|ropivacaine|mesh-list
19851699|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
19851700|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
20232917|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232918|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20232919|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20232920|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
19851701|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19851702|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851703|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
19851704|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851705|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19851706|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19851707|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19851708|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19851709|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851710|NCT00720330|Analgesics|analgesics|mesh-ancestor
19851711|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19851712|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19851713|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
19851714|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19851715|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19851716|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479637|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20479638|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
20479639|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851717|NCT00720356|Bevacizumab|bevacizumab|mesh-list
19851718|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20232921|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20232922|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232923|NCT00373165|Ganciclovir|ganciclovir|mesh-list
20232924|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20232925|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
20232926|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20232927|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20479640|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479641|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20479642|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
20479643|NCT01532544|Heparin|heparin|mesh-list
20479644|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20479645|NCT01532544|Tinzaparin|tinzaparin|mesh-list
20479646|NCT01532544|Dalteparin|dalteparin|mesh-list
20232928|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232929|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232930|NCT00373178|Metformin|metformin|mesh-list
20232931|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
20232932|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20232933|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232934|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
20232935|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851719|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851720|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851721|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851722|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19851723|NCT00720356|Growth Substances|growth substances|mesh-ancestor
19851724|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851725|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
19851726|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232936|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20232937|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
20232938|NCT00373217|Paclitaxel|paclitaxel|mesh-list
20232939|NCT00373217|Carboplatin|carboplatin|mesh-list
20232940|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20232941|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232942|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
20232943|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
20232944|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
20232945|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232946|NCT00373282|Triamcinolone|triamcinolone|mesh-list
20232947|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20232948|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20232949|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20232950|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232951|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
20232952|NCT00373282|Hormones|hormones|mesh-ancestor
20232953|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20232954|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232955|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20232956|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
20232957|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232958|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232959|NCT00373373|Sorafenib|sorafenib|mesh-list
20232960|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20232961|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20232962|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232963|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232964|NCT00373412|Vaccines|vaccines|mesh-list
20232965|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
20232966|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232967|NCT00373451|Heparin|heparin|mesh-list
20232968|NCT00373451|Calcium heparin|calcium heparin|mesh-list
20232969|NCT00373451|Bivalirudin|bivalirudin|mesh-list
20232970|NCT00373451|Abciximab|abciximab|mesh-list
20232971|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
20232972|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20232973|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20232974|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232975|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
20232976|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20232977|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
20232978|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232979|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20232980|NCT00373464|Etoricoxib|etoricoxib|mesh-list
20232981|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20232982|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232983|NCT00373464|Analgesics|analgesics|mesh-ancestor
20232984|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
20232985|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479647|NCT01532544|Eptifibatide|eptifibatide|mesh-list
20479648|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
20479649|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20479650|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20479651|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479652|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20479653|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
20479654|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20479655|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20479656|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
20479657|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20479658|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20479659|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479660|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479661|NCT01532804|Bevacizumab|bevacizumab|mesh-list
20479662|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
20479663|NCT01532804|Raltitrexed|raltitrexed|mesh-list
20479664|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20479665|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479666|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479667|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479668|NCT01532804|Growth Substances|growth substances|mesh-ancestor
20479669|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698242|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
20232986|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232987|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20232988|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20232989|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20232990|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20232991|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20232992|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20232993|NCT00373503|Lofexidine|lofexidine|mesh-list
20232994|NCT00373503|Dronabinol|dronabinol|mesh-list
20232995|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
20232996|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20232997|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20232998|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20232999|NCT00373503|Analgesics|analgesics|mesh-ancestor
20233000|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
20233001|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233002|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20233003|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20233004|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233005|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233006|NCT00373503|Hormones|hormones|mesh-ancestor
20233007|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233008|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20233009|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20233010|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20233011|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20233012|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20233013|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
20233014|NCT00373542|Ropinirole|ropinirole|mesh-list
20233015|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20233016|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20233017|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
20233018|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
20233019|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247677|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479670|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
20479671|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20479672|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
20479673|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479674|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20479675|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479676|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20479677|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
20233020|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233021|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233022|NCT00373568|Miltefosine|miltefosine|mesh-list
20233023|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
19413431|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413432|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19413433|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413434|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
19413435|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19413436|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19413437|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19413438|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413439|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413440|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19413441|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413442|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413443|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413444|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413445|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
19413446|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19413447|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413448|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233024|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698243|NCT04916899|Ethambutol|ethambutol|mesh-list
19698244|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19698245|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
19698246|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19698247|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698248|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
19698249|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20233025|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233026|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20233027|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20233028|NCT00373581|Cocaine|cocaine|mesh-list
20233029|NCT00373581|Vigabatrin|vigabatrin|mesh-list
19698250|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698251|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698252|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19698253|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19698254|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19698255|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19698256|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20233030|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
20233031|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
20233032|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233033|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233034|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
20233035|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698257|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19698258|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19698259|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20233036|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20479678|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479679|NCT01532856|Thalidomide|thalidomide|mesh-list
20479680|NCT01532856|Dexamethasone|dexamethasone|mesh-list
20479681|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
20479682|NCT01532856|Prednisone|prednisone|mesh-list
20479683|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
20479684|NCT01532856|Melphalan|melphalan|mesh-list
20479685|NCT01532856|BB 1101|bb 1101|mesh-list
20479686|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20479687|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
20233037|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20233038|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20233039|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233040|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233041|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
20233042|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233043|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
20233044|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233045|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
20233046|NCT00373594|Rituximab|rituximab|mesh-list
20233047|NCT00373594|Fludarabine|fludarabine|mesh-list
20233048|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20233049|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233050|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
20479688|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479689|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20479690|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20479691|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
19413449|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413450|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233051|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233052|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20479692|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479693|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479694|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20479695|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20479696|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
20479697|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
20479698|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479699|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233053|NCT00373607|Artesunate|artesunate|mesh-list
20233054|NCT00373607|Piperaquine|piperaquine|mesh-list
20233055|NCT00373607|Mefloquine|mefloquine|mesh-list
20233056|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
20233057|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20233058|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20233059|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233060|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233061|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
20233062|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
20233063|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20233064|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
20233065|NCT00373620|Paclitaxel|paclitaxel|mesh-list
20233066|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20233067|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233068|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
20233069|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
20233070|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
20233071|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233072|NCT00373646|Thalidomide|thalidomide|mesh-list
20233073|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233074|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
20233075|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233076|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
20233077|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479700|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
20479701|NCT01532856|Hormones|hormones|mesh-ancestor
20479702|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479703|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479704|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
20479705|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479706|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
20479707|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479708|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479709|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479710|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479711|NCT01532856|Growth Substances|growth substances|mesh-ancestor
20479712|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
20233078|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233079|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20233080|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479713|NCT01532895|Hydromorphone|hydromorphone|mesh-list
19698260|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
19698261|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19698262|NCT04916886|Vaccines|vaccines|mesh-list
20233081|NCT00373646|Growth Substances|growth substances|mesh-ancestor
20233082|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
20233083|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233084|NCT00373659|Ranibizumab|ranibizumab|mesh-list
20233085|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20233086|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20233087|NCT00373659|Growth Substances|growth substances|mesh-ancestor
20233088|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233089|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
20233090|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233091|NCT00373672|Modafinil|modafinil|mesh-list
20233092|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20233093|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233094|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20233095|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20233096|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20233097|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233098|NCT00373711|Iodine|iodine|mesh-list
20233099|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
20233100|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20233101|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20479714|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20479715|NCT01532895|Narcotics|narcotics|mesh-ancestor
20479716|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479717|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479718|NCT01532895|Analgesics|analgesics|mesh-ancestor
20479719|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
19413451|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413452|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
19413453|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19413454|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413455|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413456|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413457|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413458|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698263|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
20479720|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479721|NCT01532960|Poly ICLC|poly iclc|mesh-list
20479722|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
20479723|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
20479724|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527744|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
20527745|NCT01769677|Hydrocodone|hydrocodone|mesh-list
20527746|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20527747|NCT01769677|Narcotics|narcotics|mesh-ancestor
20527748|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20527749|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233102|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233103|NCT00373711|Trace Elements|trace elements|mesh-ancestor
20233104|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
20233105|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233106|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20233107|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233108|NCT00373776|Miltefosine|miltefosine|mesh-list
20233109|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
20233110|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233111|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233112|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20233113|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20233114|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
20233115|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20233116|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20233117|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20233118|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233119|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233120|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
20233121|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233122|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233123|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20233124|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233125|NCT00373802|Phenylephrine|phenylephrine|mesh-list
20233126|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
20233127|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20233128|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
20233129|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
20233130|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233131|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233132|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
20233133|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20233134|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
20233135|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
20233136|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20233137|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20233138|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20233139|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
19413459|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
20233140|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233141|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233142|NCT00373802|Protective Agents|protective agents|mesh-ancestor
20233143|NCT00373815|Everolimus|everolimus|mesh-list
20233144|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233145|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233146|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
20233147|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233148|NCT00373893|Lidocaine|lidocaine|mesh-list
20233149|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
20233150|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
20233151|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233152|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233153|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
20233154|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233155|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20233156|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19413460|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19413461|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19698264|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233157|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20233158|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233159|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247678|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247679|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20247680|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20247681|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479725|NCT01533090|Bisacodyl|bisacodyl|mesh-list
19413462|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413463|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413464|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413465|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413466|NCT04229368|Vitamin D|vitamin d|mesh-list
19413467|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
19413468|NCT04229368|Vitamins|vitamins|mesh-ancestor
20479726|NCT01533090|Cathartics|cathartics|mesh-ancestor
20479727|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20479728|NCT01533090|Laxatives|laxatives|mesh-ancestor
20479729|NCT01533129|Testosterone|testosterone|mesh-list
20479730|NCT01533129|Androgens|androgens|mesh-ancestor
20479731|NCT01533129|Hormones|hormones|mesh-ancestor
20479732|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479733|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479734|NCT01533155|Quinidine|quinidine|mesh-list
20479735|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
20479736|NCT01533155|Morphine|morphine|mesh-list
20233160|NCT00373906|Bortezomib|bortezomib|mesh-list
20233161|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233162|NCT00373919|Erythromycin|erythromycin|mesh-list
20233163|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
20233164|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20233165|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
20233166|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233167|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233168|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698265|NCT04916821|Propolis|propolis|mesh-list
20233169|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20233170|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233171|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233172|NCT00374023|Vitamin A|vitamin a|mesh-list
20233173|NCT00374023|Vitamins|vitamins|mesh-ancestor
20233174|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
20233175|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233176|NCT00374075|Valproic Acid|valproic acid|mesh-list
20233177|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
20233178|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233179|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233180|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
20233181|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233182|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233183|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
20233184|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20233185|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233186|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233187|NCT00374101|Omeprazole|omeprazole|mesh-list
20233188|NCT00374101|Pantoprazole|pantoprazole|mesh-list
20233189|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20233190|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233191|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20233192|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233193|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233194|NCT00374192|Eszopiclone|eszopiclone|mesh-list
20233195|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20233196|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233197|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233198|NCT00374205|Artesunate|artesunate|mesh-list
20233199|NCT00374205|Lumefantrine|lumefantrine|mesh-list
20233200|NCT00374205|Artemether|artemether|mesh-list
20233201|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20233202|NCT00374205|Amodiaquine|amodiaquine|mesh-list
20233203|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
20233204|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20479737|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20479738|NCT01533155|Narcotics|narcotics|mesh-ancestor
19698266|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698267|NCT04916522|Colchicine|colchicine|mesh-list
20479739|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479740|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479741|NCT01533155|Analgesics|analgesics|mesh-ancestor
20479742|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
20479743|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479744|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20479745|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20479746|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479747|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479748|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479749|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20479750|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
20479751|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20479752|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20479753|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479754|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479755|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20479756|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19698268|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
20233205|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20233206|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233207|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479757|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
19698269|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20233208|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
20233209|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
20233210|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20233211|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
20233212|NCT00374348|Aripiprazole|aripiprazole|mesh-list
20233213|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
20233214|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233215|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20233216|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20233217|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233218|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233219|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
20233220|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
20233221|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233222|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233223|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20233224|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20233225|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
20233226|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20233227|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20479758|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20479759|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20479760|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20479761|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20479762|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20479763|NCT01533220|Pheniramine|pheniramine|mesh-list
20479764|NCT01533220|Naphazoline|naphazoline|mesh-list
20479765|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479766|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20233228|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20479767|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20479768|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479769|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479770|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479771|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
20479772|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20479773|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
20479774|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
20479775|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
20479776|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19698270|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
20233229|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20233230|NCT00374387|NuvaRing|nuvaring|mesh-list
19851727|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851728|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479777|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
20479778|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
20479779|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20479780|NCT01533272|Tenofovir|tenofovir|mesh-list
20479781|NCT01533272|Emtricitabine|emtricitabine|mesh-list
20479782|NCT01533272|Lopinavir|lopinavir|mesh-list
20479783|NCT01533272|Maraviroc|maraviroc|mesh-list
20479784|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
20479785|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851729|NCT00720369|Ubiquinone|ubiquinone|mesh-list
19851730|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
19851731|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
19851732|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851733|NCT00720369|Vitamins|vitamins|mesh-ancestor
19851734|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
19851735|NCT00720382|Azelastine|azelastine|mesh-list
19851736|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19851737|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
19851738|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19851739|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19851740|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
19851741|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851742|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851743|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19851744|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
19851745|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19851746|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851747|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851748|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19851749|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20479786|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20233231|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20233232|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
20233233|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20233234|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233235|NCT00374426|Sertraline|sertraline|mesh-list
20233236|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
20233237|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233238|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20233239|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20233240|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233241|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233242|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233243|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
20233244|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233245|NCT00374465|Verapamil|verapamil|mesh-list
20233246|NCT00374465|Carvedilol|carvedilol|mesh-list
20233247|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20233248|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20233249|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
20233250|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233251|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527750|NCT01769677|Analgesics|analgesics|mesh-ancestor
20527751|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
20527752|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527753|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
20527754|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
20527755|NCT01769703|Dabigatran|dabigatran|mesh-list
20527756|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
20527757|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20527758|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
20527759|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527760|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527761|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
20527762|NCT01769768|Bupropion|bupropion|mesh-list
20527763|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20527764|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
20527765|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20527766|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20527767|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20527768|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20527769|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233252|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233253|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20233254|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
20233255|NCT00374465|Protective Agents|protective agents|mesh-ancestor
20233256|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20233257|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233258|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20233259|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
20233260|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20233261|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20233262|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20233263|NCT00374478|Scopolamine|scopolamine|mesh-list
20233264|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20233265|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20479787|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20479788|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479789|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479790|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20479791|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20479792|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20479793|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20479794|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
20479795|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20479796|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20479797|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20479798|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20233266|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
20233267|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
20233268|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233269|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233270|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233271|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
20233272|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20233273|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
20233274|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233275|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233276|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20479799|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20479800|NCT01533324|Leucovorin|leucovorin|mesh-list
20479801|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
20479802|NCT01533324|Antidotes|antidotes|mesh-ancestor
20479803|NCT01533324|Protective Agents|protective agents|mesh-ancestor
20479804|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413469|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
19851750|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
19851751|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
19851752|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851753|NCT00720473|Lamotrigine|lamotrigine|mesh-list
19851754|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
19851755|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19851756|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233277|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
20233278|NCT00374621|Isosorbide|isosorbide|mesh-list
20233279|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20233280|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20233281|NCT00374621|Misoprostol|misoprostol|mesh-list
20233282|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20233283|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
20479805|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
20479806|NCT01533324|Vitamins|vitamins|mesh-ancestor
20479807|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
20479808|NCT01533376|Timolol|timolol|mesh-list
20479809|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
20479810|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20479811|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20479812|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479813|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479814|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851757|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851758|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19851759|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233284|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20479815|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479816|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20479817|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19851760|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19851761|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19851762|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19851763|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19851764|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19851765|NCT00720499|Bromides|bromides|mesh-list
19851766|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
19851767|NCT00720499|Olodaterol|olodaterol|mesh-list
20233285|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233286|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20233287|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233288|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
20233289|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20233290|NCT00374621|Diuretics|diuretics|mesh-ancestor
20233291|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
20233292|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
20233293|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20479818|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20479819|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20479820|NCT01533389|Silodosin|silodosin|mesh-list
20479821|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20479822|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20479823|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20479824|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479825|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479826|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479827|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851768|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19851769|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
19851770|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851771|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233294|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233295|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
20233296|NCT00374647|Sirolimus|sirolimus|mesh-list
20233297|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20233298|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233299|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20233300|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
20479828|NCT01533389|Urological Agents|urological agents|mesh-ancestor
20479829|NCT01533441|Vitamin K|vitamin k|mesh-list
20479830|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
20479831|NCT01533441|Vitamins|vitamins|mesh-ancestor
20479832|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
20479833|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479834|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20479835|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20479836|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479837|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
20479838|NCT01533441|Coagulants|coagulants|mesh-ancestor
20479839|NCT01533506|Stiripentol|stiripentol|mesh-list
20479840|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
20479841|NCT01533545|Epinephrine|epinephrine|mesh-list
20479842|NCT01533545|Mepivacaine|mepivacaine|mesh-list
20479843|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20479844|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20479845|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479846|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479847|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479848|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479849|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20479850|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20479851|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
20479852|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479853|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20479854|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
20479855|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
20479856|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
20479857|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20479858|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
20479859|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
20479860|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20479861|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
20479862|NCT01533558|Caspofungin|caspofungin|mesh-list
20479863|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
20479864|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479865|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233301|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233302|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233303|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413470|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413471|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19413472|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19413473|NCT04225273|Lidocaine|lidocaine|mesh-list
19413474|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
19413475|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
19413476|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413477|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851772|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19851773|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
19851774|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
19851775|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19851776|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
19851777|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851778|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851779|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
19851780|NCT00720629|Methotrexate|methotrexate|mesh-list
19851781|NCT00720629|Tacrolimus|tacrolimus|mesh-list
19851782|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
19851783|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19851784|NCT00720629|Visilizumab|visilizumab|mesh-list
19851785|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19851786|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
19851787|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19851788|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413478|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
19851789|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851790|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
19851791|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851792|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851793|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
19851794|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233304|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233305|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
20479866|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479867|NCT01533662|Phenylephrine|phenylephrine|mesh-list
20479868|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
20479869|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20479870|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
20479871|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
20479872|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479873|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479874|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
20479875|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20479876|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
20479877|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
20479878|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19851795|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19851796|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233306|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233307|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
20233308|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233309|NCT00374686|Valganciclovir|valganciclovir|mesh-list
20233310|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
20233311|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233312|NCT00374699|Bortezomib|bortezomib|mesh-list
20233313|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233314|NCT00374764|Risperidone|risperidone|mesh-list
20233315|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20233316|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
20233317|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479879|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19413479|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413480|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19413481|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19413482|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19413483|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413484|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413485|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
19698271|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
19698272|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
20233318|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233319|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233320|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20233321|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20233322|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233323|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233324|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20233325|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
20479880|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20479881|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
20479882|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479883|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479884|NCT01533662|Protective Agents|protective agents|mesh-ancestor
20479885|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20479886|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20479887|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479888|NCT01533740|Leucovorin|leucovorin|mesh-list
20479889|NCT01533740|Folic Acid|folic acid|mesh-list
20479890|NCT01533740|Bevacizumab|bevacizumab|mesh-list
20479891|NCT01533740|Fluorouracil|fluorouracil|mesh-list
20479892|NCT01533740|Irinotecan|irinotecan|mesh-list
19707956|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20479893|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
20479894|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20479895|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233326|NCT00374777|Nitrazepam|nitrazepam|mesh-list
20233327|NCT00374777|Zolpidem|zolpidem|mesh-list
19413486|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19698273|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233328|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20233329|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20233330|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233331|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479896|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20479897|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20479898|NCT01533740|Growth Substances|growth substances|mesh-ancestor
20479899|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479900|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
20479901|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
20479902|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479903|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20233332|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20233333|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
20233334|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
20233335|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233336|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233337|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
20233338|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19413487|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19413488|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233339|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20233340|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233341|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
20233342|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20233343|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20233344|NCT00374855|Diuretics|diuretics|mesh-ancestor
20233345|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
20233346|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233347|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20479904|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20479905|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
20479906|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20479907|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20479908|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233348|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233349|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233350|NCT00374881|Phenylephrine|phenylephrine|mesh-list
20233351|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
20233352|NCT00374881|Morphine|morphine|mesh-list
20233353|NCT00374881|Sorbitol|sorbitol|mesh-list
20233354|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20233355|NCT00374881|Narcotics|narcotics|mesh-ancestor
20233356|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233357|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233358|NCT00374881|Analgesics|analgesics|mesh-ancestor
20233359|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
20233360|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233361|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20233362|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
20233363|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
20233364|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
20233365|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20233366|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
20233367|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
20233368|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20233369|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20479909|NCT01533740|Antidotes|antidotes|mesh-ancestor
20479910|NCT01533740|Protective Agents|protective agents|mesh-ancestor
20479911|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
20479912|NCT01533740|Vitamins|vitamins|mesh-ancestor
20479913|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
20479914|NCT01533740|Hematinics|hematinics|mesh-ancestor
20479915|NCT01533818|Amoxicillin|amoxicillin|mesh-list
20479916|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479917|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479918|NCT01533870|Rifampin|rifampin|mesh-list
20479919|NCT01533870|Naloxegol|naloxegol|mesh-list
20479920|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20479921|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
20479922|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479923|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479924|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
20479925|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20479926|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479927|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479928|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20479929|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20479930|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20479931|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20479932|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20479933|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20479934|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20479935|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479936|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
20479937|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479938|NCT01534026|Aspirin|aspirin|mesh-list
20479939|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20479940|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20479941|NCT01534026|Analgesics|analgesics|mesh-ancestor
20479942|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
20479943|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479944|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479945|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20233370|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20233371|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
20233372|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233373|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233374|NCT00374881|Protective Agents|protective agents|mesh-ancestor
20233375|NCT00374881|Cathartics|cathartics|mesh-ancestor
20233376|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233377|NCT00374894|Succimer|succimer|mesh-list
20233378|NCT00374894|Antidotes|antidotes|mesh-ancestor
20233379|NCT00374894|Protective Agents|protective agents|mesh-ancestor
20233380|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233381|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
20233382|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
20233383|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233384|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
20233385|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233386|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233387|NCT00374985|Docetaxel|docetaxel|mesh-list
20233388|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
19413489|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413490|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413491|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413492|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19413493|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19851797|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
19851798|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851799|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19851800|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19851801|NCT00720759|Cycloserine|cycloserine|mesh-list
19851802|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19851803|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851804|NCT00720759|Renal Agents|renal agents|mesh-ancestor
19851805|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19851806|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
19851807|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19851808|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
19851809|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851810|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19851811|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20233389|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233390|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
20233391|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
20233392|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
20233393|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233394|NCT00375050|Riluzole|riluzole|mesh-list
20233395|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
20233396|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20233397|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20233398|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233399|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233400|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233401|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20233402|NCT00375050|Protective Agents|protective agents|mesh-ancestor
20233403|NCT00375076|Enoxaparin|enoxaparin|mesh-list
20233404|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
20233405|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20479946|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20479947|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20479948|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20233406|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20233407|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233408|NCT00375232|Montelukast|montelukast|mesh-list
20479949|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479950|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20479951|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20479952|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20479953|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
20479954|NCT01534169|Dexamethasone|dexamethasone|mesh-list
20479955|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20479956|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
20479957|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
20479958|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479959|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479960|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20479961|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
20479962|NCT01534169|Hormones|hormones|mesh-ancestor
20479963|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20479964|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20479965|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479966|NCT01534247|Metronidazole|metronidazole|mesh-list
20479967|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20479968|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20479969|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20479970|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20479971|NCT01534312|Mesalamine|mesalamine|mesh-list
20479972|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20479973|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20479974|NCT01534312|Analgesics|analgesics|mesh-ancestor
20479975|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
20479976|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479977|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479978|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20233409|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20233410|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
20233411|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20233412|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
20233413|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233414|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233415|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20233416|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20233417|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233418|NCT00375245|Sirolimus|sirolimus|mesh-list
20233419|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233420|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233421|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20233422|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233423|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
20233424|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233425|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
20233426|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233427|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
20233428|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20233429|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20233430|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233431|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
20233432|NCT00375258|Coagulants|coagulants|mesh-ancestor
20233433|NCT00375284|Pramipexole|pramipexole|mesh-list
20233434|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
20233435|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233436|NCT00375284|Protective Agents|protective agents|mesh-ancestor
20233437|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233438|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20233439|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20233440|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
20233441|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
20233442|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233443|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
20233444|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
20233445|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20233446|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20233447|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233448|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233449|NCT00375297|Urological Agents|urological agents|mesh-ancestor
20233450|NCT00375310|Gemcitabine|gemcitabine|mesh-list
20233451|NCT00375310|Sorafenib|sorafenib|mesh-list
20233452|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20233453|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
20233454|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233455|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233456|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
20233457|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233458|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233459|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233460|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
20233461|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233462|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20233463|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
20233464|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
20233465|NCT00375375|Lactulose|lactulose|mesh-list
20233466|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233467|NCT00375388|Metformin|metformin|mesh-list
20233468|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413494|NCT04209296|Ketamine|ketamine|mesh-list
20233469|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851812|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
19851813|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19851814|NCT00720798|Analgesics|analgesics|mesh-ancestor
19851815|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
19851816|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851817|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851818|NCT00720876|Rituximab|rituximab|mesh-list
19851819|NCT00720876|Vorinostat|vorinostat|mesh-list
19851820|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851821|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851822|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
19851823|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851824|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851825|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19851826|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851827|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851828|NCT00720941|Sunitinib|sunitinib|mesh-list
19851829|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851830|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20233470|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
19413495|NCT04209296|Analgesics|analgesics|mesh-ancestor
19851831|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19851832|NCT00720941|Growth Substances|growth substances|mesh-ancestor
20233471|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20233472|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20233473|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233474|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
20233475|NCT00375440|Coagulants|coagulants|mesh-ancestor
20233476|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
20233477|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20233478|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20233479|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233480|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
20233481|NCT00375466|Coagulants|coagulants|mesh-ancestor
20233482|NCT00375557|Valproic Acid|valproic acid|mesh-list
20233483|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20233484|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
20233485|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233486|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20233487|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20233488|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707957|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
20233489|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233490|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
20233491|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233492|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233493|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
20233494|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233495|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
20247682|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247683|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20247684|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
20247685|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
20247686|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20247687|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707958|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698274|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698275|NCT04916665|Teduglutide|teduglutide|mesh-list
19698276|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698277|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19698278|NCT04916665|Protective Agents|protective agents|mesh-ancestor
19698279|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698280|NCT04916509|Fulvestrant|fulvestrant|mesh-list
19698281|NCT04916509|Palbociclib|palbociclib|mesh-list
19698282|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20233496|NCT00375583|Albendazole|albendazole|mesh-list
20233497|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
20479979|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20479980|NCT01534442|Atropine|atropine|mesh-list
20479981|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20479982|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20479983|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20233498|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20233499|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233500|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
20233501|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19698283|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698284|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698285|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19698286|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19698287|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
19698288|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698289|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698290|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851833|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851834|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
19851835|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851836|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233502|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20233503|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
20233504|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
20233505|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
20233506|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233507|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233508|NCT00375596|Ketotifen|ketotifen|mesh-list
20233509|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20233510|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
20233511|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
19851837|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851838|NCT00721110|Lidocaine|lidocaine|mesh-list
19851839|NCT00721110|Ketamine|ketamine|mesh-list
20233512|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20233513|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
20233514|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
20233515|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233516|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233517|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479984|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
20479985|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20479986|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20479987|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20479988|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
20479989|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
20479990|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
20479991|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20479992|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20479993|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
20479994|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20479995|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20479996|NCT01534455|Lapatinib|lapatinib|mesh-list
20479997|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20479998|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20479999|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480000|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480001|NCT01534494|Psilocybin|psilocybin|mesh-list
20480002|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
20480003|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480004|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20480005|NCT01534546|Capecitabine|capecitabine|mesh-list
20480006|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
20480007|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851840|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
19698291|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698292|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698293|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19698294|NCT04916548|Ketamine|ketamine|mesh-list
19698295|NCT04916548|Analgesics|analgesics|mesh-ancestor
19698296|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
19698297|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698298|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698299|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19698300|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19698301|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
19851841|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
19851842|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19851843|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851844|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
19698302|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
19707959|NCT04821765|Paclitaxel|paclitaxel|mesh-list
19851845|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851846|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19851847|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19851848|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19851849|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19851850|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851851|NCT00721110|Analgesics|analgesics|mesh-ancestor
19851852|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19851853|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19851854|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
19851855|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20233518|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20233519|NCT00375622|Tamoxifen|tamoxifen|mesh-list
20233520|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20233521|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
20233522|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233523|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233524|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20233525|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233526|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20233527|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20233528|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19413496|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
19413497|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413498|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413499|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19413500|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19413501|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
19413502|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
19413503|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413504|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19413505|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19413506|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413507|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416885|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416886|NCT02260193|Glycine|glycine|mesh-list
19416887|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
19416888|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413508|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19413509|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19413510|NCT04196530|Atezolizumab|atezolizumab|mesh-list
19698303|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698304|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20233529|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
20233530|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20233531|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233532|NCT00375661|Interferons|interferons|mesh-list
20233533|NCT00375661|Ribavirin|ribavirin|mesh-list
20233534|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
20233535|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
20233536|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233537|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
20233538|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233539|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
20480008|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
20480009|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413511|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480010|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480011|NCT01534585|Paclitaxel|paclitaxel|mesh-list
20480012|NCT01534585|Mitogens|mitogens|mesh-list
20480013|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20480014|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480015|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
20480016|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
20480017|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
20480018|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480019|NCT01534702|Cytarabine|cytarabine|mesh-list
20480020|NCT01534702|Clofarabine|clofarabine|mesh-list
20480021|NCT01534702|Idarubicin|idarubicin|mesh-list
20480022|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20480023|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
20480024|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480025|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480026|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
20480027|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480028|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19413512|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20480029|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
20480030|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233540|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233541|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
20233542|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233543|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20233544|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
20233545|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20233546|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
20233547|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20233548|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233549|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20480031|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20480032|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20480033|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20480034|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480035|NCT01534754|Mesalamine|mesalamine|mesh-list
20480036|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20480037|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20480038|NCT01534754|Analgesics|analgesics|mesh-ancestor
20480039|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
20480040|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480041|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480042|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480043|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480044|NCT01534806|Ketorolac|ketorolac|mesh-list
20480045|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20480046|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20480047|NCT01534806|Analgesics|analgesics|mesh-ancestor
20480048|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
20233550|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20527770|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
20233551|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233552|NCT00375765|Dutasteride|dutasteride|mesh-list
20233553|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20233554|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20233555|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233556|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233557|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
20233558|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233559|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233560|NCT00375778|Memantine|memantine|mesh-list
20233561|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20233562|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20233563|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
20233564|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233565|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233566|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233567|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20233568|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20233569|NCT00375843|Citalopram|citalopram|mesh-list
20233570|NCT00375843|Sertraline|sertraline|mesh-list
19698305|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20233571|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20233572|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20233573|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233574|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233575|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233576|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
20233577|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233578|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20233579|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
20480049|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233580|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233581|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
20233582|NCT00375869|Hematinics|hematinics|mesh-ancestor
20233583|NCT00375895|Cyclosporine|cyclosporine|mesh-list
20233584|NCT00375895|Cyclosporins|cyclosporins|mesh-list
20233585|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233586|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233587|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233588|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
20233589|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233590|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
20233591|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233592|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
20233593|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20233594|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20233595|NCT00376012|Rifampin|rifampin|mesh-list
20233596|NCT00376012|Isoniazid|isoniazid|mesh-list
20233597|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
20233598|NCT00376012|Ethambutol|ethambutol|mesh-list
20233599|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20233600|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
20233601|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233602|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233603|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
20233604|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20233605|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233606|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233607|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20233608|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20233609|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20233610|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20233611|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20233612|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20480050|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480051|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480052|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480053|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20480054|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698306|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480055|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480056|NCT01534845|Temozolomide|temozolomide|mesh-list
19413513|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20233613|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20233614|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19413514|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413515|NCT04174612|Cytarabine|cytarabine|mesh-list
19413516|NCT04174612|Daunorubicin|daunorubicin|mesh-list
19413517|NCT04174612|Midostaurin|midostaurin|mesh-list
19413518|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19413519|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
19413520|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413521|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413522|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
19413523|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413524|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19413525|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
20233615|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
20233616|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20233617|NCT00376025|Antioxidants|antioxidants|mesh-list
20233618|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233619|NCT00376025|Protective Agents|protective agents|mesh-ancestor
20233620|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233621|NCT00376038|Metformin|metformin|mesh-list
20233622|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413526|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413527|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19413528|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19413529|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19413530|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413531|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19698307|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698308|NCT04916574|Antibodies|antibodies|mesh-list
19698309|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
19698310|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698311|NCT04916418|Ropivacaine|ropivacaine|mesh-list
20233623|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233624|NCT00376051|Citalopram|citalopram|mesh-list
20233625|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20233626|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20233627|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20233628|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233629|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233630|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
20233631|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233632|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20233633|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
20233634|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233635|NCT00376064|Octreotide|octreotide|mesh-list
20233636|NCT00376064|Cabergoline|cabergoline|mesh-list
20233637|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233638|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20233639|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413532|NCT04163432|Carboplatin|carboplatin|mesh-list
19413533|NCT04163432|Pemetrexed|pemetrexed|mesh-list
19413534|NCT04163432|Durvalumab|durvalumab|mesh-list
20233640|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20233641|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20233642|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
20233643|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
20233644|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233645|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233646|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233647|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
20233648|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20233649|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20233650|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
20233651|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20233652|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20233653|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
20233654|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
20233655|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233656|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233657|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233658|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
20233659|NCT00376077|Hormones|hormones|mesh-ancestor
20233660|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233661|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20233662|NCT00376077|Protective Agents|protective agents|mesh-ancestor
20233663|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20233664|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233665|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
20233666|NCT00376103|Temozolomide|temozolomide|mesh-list
20233667|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20233668|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
20233669|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233670|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233671|NCT00376129|Alefacept|alefacept|mesh-list
20233672|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
20233673|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
20233674|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233675|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
19851856|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19851857|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851858|NCT00721136|Heparin|heparin|mesh-list
19851859|NCT00721136|Warfarin|warfarin|mesh-list
19851860|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
19851861|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19851862|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19851863|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851864|NCT00721162|Ramucirumab|ramucirumab|mesh-list
19851865|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233676|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
20233677|NCT00376155|Amodiaquine|amodiaquine|mesh-list
20233678|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
20233679|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20233680|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20233681|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233682|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20233683|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233684|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233685|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20233686|NCT00376155|Renal Agents|renal agents|mesh-ancestor
20233687|NCT00376181|Pioglitazone|pioglitazone|mesh-list
20233688|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20233689|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20233690|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233691|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20233692|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20233693|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233694|NCT00376272|Valsartan|valsartan|mesh-list
20233695|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20233696|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20480057|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20480058|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
20480059|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233697|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20233698|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233699|NCT00376285|Fenofibrate|fenofibrate|mesh-list
20233700|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20233701|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
20233702|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233703|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20233704|NCT00376311|Calcitonin|calcitonin|mesh-list
20233705|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
20233706|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20233707|NCT00376311|Katacalcin|katacalcin|mesh-list
20233708|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20233709|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233710|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20233711|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
20233712|NCT00376324|Tigecycline|tigecycline|mesh-list
20233713|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233714|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233715|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20233716|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233717|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233718|NCT00376337|Micafungin|micafungin|mesh-list
20233719|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
20233720|NCT00376337|Clotrimazole|clotrimazole|mesh-list
20233721|NCT00376337|Miconazole|miconazole|mesh-list
20480060|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480061|NCT01534858|Polihexanide|polihexanide|mesh-list
20480062|NCT01534858|Betaine|betaine|mesh-list
20233722|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233723|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20233724|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20233725|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480063|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480064|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
20480065|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20480066|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
20480067|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233726|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233727|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233728|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20233729|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
20233730|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233731|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233732|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20233733|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20233734|NCT00376376|Levofloxacin|levofloxacin|mesh-list
20233735|NCT00376376|Ofloxacin|ofloxacin|mesh-list
20233736|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20233737|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233738|NCT00376376|Renal Agents|renal agents|mesh-ancestor
20233739|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233740|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19851866|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20233741|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19851867|NCT00721188|Hematinics|hematinics|mesh-ancestor
19851868|NCT00721214|Azacitidine|azacitidine|mesh-list
19851869|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851870|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
19851871|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851872|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851873|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480068|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20480069|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
20480070|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480071|NCT01534884|Rituximab|rituximab|mesh-list
20480072|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20480073|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480074|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
20480075|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480076|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527771|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527772|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527773|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20527774|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480077|NCT01534949|Rituximab|rituximab|mesh-list
20480078|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20233742|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233743|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233744|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233745|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20233746|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20233747|NCT00376428|Gentamicins|gentamicins|mesh-list
20480079|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480080|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
20480081|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480082|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480083|NCT01535027|Alendronate|alendronate|mesh-list
20480084|NCT01535027|Teriparatide|teriparatide|mesh-list
20480085|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20233748|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233749|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480086|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20480087|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480088|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20480089|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20480090|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
20480091|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233750|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20527775|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233751|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233752|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233753|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
20233754|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233755|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20233756|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233757|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233758|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
20233759|NCT00376480|Fludarabine|fludarabine|mesh-list
20233760|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
20233761|NCT00376480|Thiotepa|thiotepa|mesh-list
20233762|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20233763|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233764|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20233765|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
20233766|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233767|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233768|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
20233769|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233770|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20233771|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
20233772|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
20233773|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233774|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20233775|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
20233776|NCT00376480|Hormones|hormones|mesh-ancestor
20233777|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233778|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20233779|NCT00376480|Protective Agents|protective agents|mesh-ancestor
20233780|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20233781|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
20233782|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20233783|NCT00376493|Metronidazole|metronidazole|mesh-list
20233784|NCT00376493|Doxycycline|doxycycline|mesh-list
20233785|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233786|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233787|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19851874|NCT00721279|Pramipexole|pramipexole|mesh-list
19851875|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
19851876|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851877|NCT00721279|Protective Agents|protective agents|mesh-ancestor
19851878|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851879|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19851880|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20233788|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20233789|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
20233790|NCT00376519|Cyclosporine|cyclosporine|mesh-list
20233791|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
19413535|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413536|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698312|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
20233792|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
20233793|NCT00376519|Fludarabine|fludarabine|mesh-list
20233794|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
20233795|NCT00376519|Cyclosporins|cyclosporins|mesh-list
20233796|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233797|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
20233798|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233799|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20233800|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20233801|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
19698313|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
20233802|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233803|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233804|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20233805|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20233806|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
20233807|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233808|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
20233809|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233810|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
20233811|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20233812|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20233813|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20233814|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
20233815|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233816|NCT00376584|Niacin|niacin|mesh-list
20233817|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20233818|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
20233819|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233820|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20233821|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
20233822|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
20233823|NCT00376584|Vitamins|vitamins|mesh-ancestor
20233824|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
20233825|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233826|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
20233827|NCT00376662|Hormones|hormones|mesh-list
20233828|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233829|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233830|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20233831|NCT00376701|Bevacizumab|bevacizumab|mesh-list
20233832|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20233833|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233834|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20233835|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20233836|NCT00376701|Growth Substances|growth substances|mesh-ancestor
20233837|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233838|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
20233839|NCT00376727|Cetuximab|cetuximab|mesh-list
20233840|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20233841|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233842|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
20233843|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20233844|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233845|NCT00376766|Levetiracetam|levetiracetam|mesh-list
20233846|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
20233847|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
20233848|NCT00376792|Docetaxel|docetaxel|mesh-list
20233849|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233850|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
20233851|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
20233852|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
20233853|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233854|NCT00376818|Hormones|hormones|mesh-list
20233855|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233856|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233857|NCT00376831|Fentanyl|fentanyl|mesh-list
20233858|NCT00376831|Midazolam|midazolam|mesh-list
20233859|NCT00376831|Ketamine|ketamine|mesh-list
20233860|NCT00376831|Analgesics|analgesics|mesh-ancestor
20233861|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
20233862|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20233863|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233864|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20233865|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20233866|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
20233867|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
20233868|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20233869|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20233870|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20233871|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233872|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233873|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20233874|NCT00376831|Narcotics|narcotics|mesh-ancestor
20233875|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20233876|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20233877|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20233878|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20233879|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233880|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
20233881|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
19851881|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
19851882|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
20233882|NCT00376870|Pioglitazone|pioglitazone|mesh-list
20233883|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20233884|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233885|NCT00376883|Pamidronate|pamidronate|mesh-list
20233886|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20233887|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233888|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
20233889|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
20233890|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
20480092|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20480093|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20480094|NCT01535079|Ibuprofen|ibuprofen|mesh-list
20480095|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20480096|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20480097|NCT01535079|Analgesics|analgesics|mesh-ancestor
20480098|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
20480099|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480100|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480101|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480102|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480103|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20480104|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480105|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480106|NCT01535092|Silybin|silybin|mesh-list
20233891|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20233892|NCT00376987|Protective Agents|protective agents|mesh-ancestor
20233893|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233894|NCT00377000|Clindamycin|clindamycin|mesh-list
20233895|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
20233896|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
20233897|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20233898|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20233899|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413537|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233900|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20233901|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233902|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233903|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
20233904|NCT00377052|Gemcitabine|gemcitabine|mesh-list
20233905|NCT00377052|Bortezomib|bortezomib|mesh-list
20233906|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20233907|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
20233908|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233909|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233910|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
20233911|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413538|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19413539|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19413540|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413541|NCT04163185|Meloxicam|meloxicam|mesh-list
19413542|NCT04163185|Rizatriptan|rizatriptan|mesh-list
19413543|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413544|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413545|NCT04163185|Analgesics|analgesics|mesh-ancestor
19413546|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
19413547|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413548|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851883|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233912|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233913|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233914|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
20233915|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233916|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
20233917|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20233918|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20233919|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
20233920|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480107|NCT01535092|Protective Agents|protective agents|mesh-ancestor
20480108|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480109|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20480110|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480111|NCT01535157|Ketoconazole|ketoconazole|mesh-list
20480112|NCT01535157|Fenretinide|fenretinide|mesh-list
20480113|NCT01535157|Retinamide|retinamide|mesh-list
20480114|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
20480115|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480116|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20480117|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480118|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480119|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480120|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20480121|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
20480122|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233921|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20233922|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20233923|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233924|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233925|NCT00377078|Lactoferrin|lactoferrin|mesh-list
20233926|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233927|NCT00377091|PENTA|penta|mesh-list
20233928|NCT00377091|Fondaparinux|fondaparinux|mesh-list
20233929|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20233930|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
20480123|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480124|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20480125|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480126|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20480127|NCT01535157|Protective Agents|protective agents|mesh-ancestor
20480128|NCT01535170|Lactoferrin|lactoferrin|mesh-list
20480129|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480130|NCT01535183|Irinotecan|irinotecan|mesh-list
20480131|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20480132|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20480133|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233931|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20233932|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
20233933|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233934|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233935|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
20233936|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20233937|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20233938|NCT00377104|Alvocidib|alvocidib|mesh-list
20233939|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233940|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
20233941|NCT00377104|Growth Substances|growth substances|mesh-ancestor
20233942|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233943|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20233944|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527776|NCT01769781|Anastrozole|anastrozole|mesh-list
20527777|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20527778|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527779|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20527780|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20527781|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527782|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527783|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20527784|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
20527785|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233945|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233946|NCT00377143|Warfarin|warfarin|mesh-list
20233947|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
20233948|NCT00377273|Fluorouracil|fluorouracil|mesh-list
20480134|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480135|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480136|NCT01535417|Celecoxib|celecoxib|mesh-list
20480137|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20480138|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20480139|NCT01535417|Analgesics|analgesics|mesh-ancestor
20480140|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
20480141|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480142|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480143|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480144|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851884|NCT00721396|Vaccines|vaccines|mesh-list
19851885|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19851886|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
19851887|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851888|NCT00721409|Letrozole|letrozole|mesh-list
19851889|NCT00721409|Palbociclib|palbociclib|mesh-list
19851890|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233949|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
20233950|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233951|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20233952|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20233953|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233954|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
20233955|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247688|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20247689|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
20247690|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20247691|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247692|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247693|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247694|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
20247695|NCT00433225|Prednisolone|prednisolone|mesh-list
20247696|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20247697|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
20247698|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20247699|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
20247700|NCT00433225|Ketorolac|ketorolac|mesh-list
20247701|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20247702|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
20480145|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19851891|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19851892|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20247703|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20233956|NCT00377325|Cyclosporine|cyclosporine|mesh-list
20480146|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20480147|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480148|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480149|NCT01535469|Fluconazole|fluconazole|mesh-list
20480150|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
20480151|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698314|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698315|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698316|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
19698317|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698318|NCT04916353|Triamcinolone|triamcinolone|mesh-list
19698319|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19698320|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20233957|NCT00377325|Cyclosporins|cyclosporins|mesh-list
20480152|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20233958|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233959|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233960|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20233961|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
20480153|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480154|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480155|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233962|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233963|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
20233964|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20233965|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
20233966|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20233967|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20233968|NCT00377390|Omalizumab|omalizumab|mesh-list
20233969|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20233970|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20233971|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
20233972|NCT00377442|Simvastatin|simvastatin|mesh-list
20233973|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20233974|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19698321|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19698322|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698323|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
19698324|NCT04916353|Hormones|hormones|mesh-ancestor
19698325|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698326|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698327|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698328|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
19698329|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698330|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698331|NCT04916691|Ropivacaine|ropivacaine|mesh-list
19698332|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
19698333|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
19698334|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698335|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698336|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
19698337|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698338|NCT04916327|Antioxidants|antioxidants|mesh-list
19698339|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698340|NCT04916327|Protective Agents|protective agents|mesh-ancestor
20233975|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
20233976|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233977|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20233978|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20233979|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851893|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20233980|NCT00377468|Dronabinol|dronabinol|mesh-list
20233981|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
20233982|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233983|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20233984|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20233985|NCT00377468|Analgesics|analgesics|mesh-ancestor
20233986|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
20233987|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247704|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
20480156|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20480157|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
20480158|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20480159|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480160|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20480161|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20480162|NCT01535495|Propranolol|propranolol|mesh-list
20480163|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20480164|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20480165|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
20480166|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233988|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20233989|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20480167|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480168|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480169|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20480170|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20480171|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
20480172|NCT01535547|Isavuconazole|isavuconazole|mesh-list
20480173|NCT01535547|Tacrolimus|tacrolimus|mesh-list
20233990|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20233991|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20233992|NCT00377468|Hormones|hormones|mesh-ancestor
20233993|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20233994|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
20233995|NCT00377481|Hematinics|hematinics|mesh-ancestor
20233996|NCT00377494|Vaccines|vaccines|mesh-list
20233997|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
20233998|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20233999|NCT00377546|Ketorolac|ketorolac|mesh-list
20234000|NCT00377546|Nepafenac|nepafenac|mesh-list
20234001|NCT00377546|Bromfenac|bromfenac|mesh-list
20234002|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20234003|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20234004|NCT00377546|Analgesics|analgesics|mesh-ancestor
20234005|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
20234006|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234007|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234008|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234009|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20234010|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20234011|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234012|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234013|NCT00377559|Docetaxel|docetaxel|mesh-list
20234014|NCT00377559|Doxorubicin|doxorubicin|mesh-list
20234015|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20234016|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234017|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234018|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
20234019|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234020|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698341|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698342|NCT04916093|Metformin|metformin|mesh-list
19698343|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19698344|NCT04916093|Vildagliptin|vildagliptin|mesh-list
19698345|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19698346|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698347|NCT04916093|Incretins|incretins|mesh-ancestor
19698348|NCT04916093|Hormones|hormones|mesh-ancestor
19698349|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698350|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20480174|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698351|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
20480175|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
20480176|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480177|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20480178|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480179|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480180|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
20480181|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480182|NCT01535612|Insulin|insulin|mesh-list
20480183|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480184|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480185|NCT01535677|Metformin|metformin|mesh-list
19698352|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234021|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234022|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20234023|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20234024|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234025|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
19698353|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698354|NCT04915846|Tamoxifen|tamoxifen|mesh-list
19698355|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19698356|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
19698357|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698358|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698359|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698360|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698361|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19698362|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19698363|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19698364|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
19698365|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19698366|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851894|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851895|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19851896|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
19851897|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851898|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851899|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851900|NCT00721513|Docetaxel|docetaxel|mesh-list
19851901|NCT00721513|Fluorouracil|fluorouracil|mesh-list
19851902|NCT00721513|Cetuximab|cetuximab|mesh-list
19851903|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851904|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234026|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20234027|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
20234028|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234029|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
20234030|NCT00377624|Protective Agents|protective agents|mesh-ancestor
20234031|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
20234032|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20234033|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20234034|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247705|NCT00433225|Hormones|hormones|mesh-ancestor
20480186|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
20480187|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480188|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480189|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20480190|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480191|NCT01535690|Methylene Blue|methylene blue|mesh-list
20480192|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480193|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851905|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
19851906|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
19851907|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851908|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
19851909|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851910|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19851911|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
19851912|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851913|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851914|NCT00721578|Voriconazole|voriconazole|mesh-list
19851915|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
19851916|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851917|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19851918|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19851919|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851920|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851921|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19851922|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
19851923|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851924|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234035|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234036|NCT00377780|Docetaxel|docetaxel|mesh-list
20234037|NCT00377780|Doxorubicin|doxorubicin|mesh-list
20234038|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20234039|NCT00377780|Trastuzumab|trastuzumab|mesh-list
20234040|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234041|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234042|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
20480194|NCT01535768|Travoprost|travoprost|mesh-list
20480195|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20480196|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20480197|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20234043|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234044|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234045|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234046|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20234047|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20234048|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234049|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20234050|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20234051|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
20234052|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20234053|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20234054|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234055|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234056|NCT00377793|Urological Agents|urological agents|mesh-ancestor
20234057|NCT00377806|Diclofenac|diclofenac|mesh-list
20234058|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20234059|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20234060|NCT00377806|Analgesics|analgesics|mesh-ancestor
20234061|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
20234062|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234063|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234064|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234065|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20234066|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20234067|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234068|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413549|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413550|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413551|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19413552|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19413553|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413554|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413555|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19413556|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
19413557|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234069|NCT00377910|Lidocaine|lidocaine|mesh-list
20234070|NCT00377910|Polidocanol|polidocanol|mesh-list
20234071|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
20234072|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
20234073|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234074|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234075|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
20234076|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234077|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20234078|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20234079|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20234080|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20234081|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234082|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20234083|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19413558|NCT04161456|Apremilast|apremilast|mesh-list
19413559|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413560|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413561|NCT04161456|Analgesics|analgesics|mesh-ancestor
19413562|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
20234084|NCT00377923|Progesterone|progesterone|mesh-list
20234085|NCT00377923|Progestins|progestins|mesh-ancestor
20480198|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20480199|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20480200|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20480201|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20480202|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234086|NCT00377923|Hormones|hormones|mesh-ancestor
19413563|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413564|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413565|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413566|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20234087|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234088|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234089|NCT00377936|Gemcitabine|gemcitabine|mesh-list
20234090|NCT00377936|Paclitaxel|paclitaxel|mesh-list
20234091|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20234092|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
20234093|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234094|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234095|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
20234096|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413567|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19698367|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
20234097|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234098|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234099|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
20234100|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234101|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20234102|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234103|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
20234104|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
20480203|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234105|NCT00377975|Pioglitazone|pioglitazone|mesh-list
20234106|NCT00377975|Ephedrine|ephedrine|mesh-list
20234107|NCT00377975|Caffeine|caffeine|mesh-list
20234108|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20234109|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234110|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20234111|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20234112|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234113|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234114|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20480204|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480205|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698368|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20480206|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
20480207|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20480208|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20480209|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480210|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
20480211|NCT01535781|Coagulants|coagulants|mesh-ancestor
20480212|NCT01535820|Ortho Evra|ortho evra|mesh-list
20480213|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20480214|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
20480215|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20480216|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480217|NCT01535859|Cabergoline|cabergoline|mesh-list
20234115|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20234116|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
20234117|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234118|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
20234119|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
20234120|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234121|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20234122|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234123|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
20234124|NCT00377988|Norgestimate|norgestimate|mesh-list
20234125|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
20234126|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20234127|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234128|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20234129|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20234130|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20234131|NCT00378027|PENTA|penta|mesh-list
20234132|NCT00378027|Fondaparinux|fondaparinux|mesh-list
20234133|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20234134|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
20234135|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20234136|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
20234137|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234138|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234139|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
20480218|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20480219|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20480220|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
20480221|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
20480222|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480223|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480224|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234140|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20234141|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20234142|NCT00378066|Bevacizumab|bevacizumab|mesh-list
20480225|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20480226|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20480227|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
20480228|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480229|NCT01535989|Sirolimus|sirolimus|mesh-list
20480230|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20480231|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480232|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480233|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20480234|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480235|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
19698369|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
20480236|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480237|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
19413568|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20480238|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480239|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20480240|NCT01536002|Propofol|propofol|mesh-list
20480241|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20480242|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480243|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480244|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20480245|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
20480246|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
19698370|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698371|NCT04916080|Expectorants|expectorants|mesh-ancestor
19698372|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698373|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19698374|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
19698375|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698376|NCT04916080|Protective Agents|protective agents|mesh-ancestor
19698377|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698378|NCT04916080|Antidotes|antidotes|mesh-ancestor
19698379|NCT04915963|Vitamin D|vitamin d|mesh-list
19698380|NCT04915963|Vitamins|vitamins|mesh-ancestor
19698381|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
20480247|NCT01536028|Insulin|insulin|mesh-list
20480248|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20480249|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
20480250|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
20234143|NCT00378066|Capecitabine|capecitabine|mesh-list
20234144|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
20234145|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698382|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234146|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234147|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20234148|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20234149|NCT00378066|Growth Substances|growth substances|mesh-ancestor
20234150|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234151|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
20234152|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20234153|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
20234154|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234155|NCT00378092|Risperidone|risperidone|mesh-list
20234156|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20234157|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
19698383|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19698384|NCT04915807|Paclitaxel|paclitaxel|mesh-list
19698385|NCT04915807|Irinotecan|irinotecan|mesh-list
19698386|NCT04915807|Ramucirumab|ramucirumab|mesh-list
19698387|NCT04915807|Taxane|taxane|mesh-list
19698388|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20234158|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698389|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698390|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
19698391|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
19698392|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234159|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234160|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234161|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20234162|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234163|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234164|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234165|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20480251|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20480252|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
20480253|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20480254|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20234166|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
20234167|NCT00378118|Antibodies|antibodies|mesh-list
20234168|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
20234169|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
20234170|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
20234171|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234172|NCT00378144|Acetaminophen|acetaminophen|mesh-list
20234173|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
20234174|NCT00378144|Ephedrine|ephedrine|mesh-list
20480255|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480256|NCT01536054|Sirolimus|sirolimus|mesh-list
20480257|NCT01536054|Sargramostim|sargramostim|mesh-list
20480258|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480259|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413569|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413570|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413571|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
19413572|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
19413573|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19413574|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19413575|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413576|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413577|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413578|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413579|NCT04144582|Docetaxel|docetaxel|mesh-list
19413580|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413581|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
19413582|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
19413583|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
19413584|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413585|NCT04134442|Bupivacaine|bupivacaine|mesh-list
19413586|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
19413587|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
19413588|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413589|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413590|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
19413591|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413592|NCT04129086|Ketamine|ketamine|mesh-list
19413593|NCT04129086|Analgesics|analgesics|mesh-ancestor
19413594|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
19413595|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413596|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413597|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19413598|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20480260|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20480261|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480262|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
20480263|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480264|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
20480265|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480266|NCT01536132|Simendan|simendan|mesh-list
20480267|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20480268|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
20480269|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20234175|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20234176|NCT00378144|Analgesics|analgesics|mesh-ancestor
20234177|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
20234178|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234179|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234180|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
20234181|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20234182|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
20234183|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20234184|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
20234185|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
20234186|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20234187|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20234188|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
20234189|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234190|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234191|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234192|NCT00378183|Risperidone|risperidone|mesh-list
19413599|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
19413600|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
19851925|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19851926|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19851927|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19851928|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19851929|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19851930|NCT00721630|Capecitabine|capecitabine|mesh-list
19851931|NCT00721630|Lapatinib|lapatinib|mesh-list
19851932|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19851933|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
19851934|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851935|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851936|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851937|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851938|NCT00721955|Loxapine|loxapine|mesh-list
19851939|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19851940|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19851941|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19851942|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851943|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19851944|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19851945|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
20234193|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20234194|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
20234195|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234196|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234197|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234198|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20234199|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234200|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234201|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234202|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20234203|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
20234204|NCT00378196|Ranibizumab|ranibizumab|mesh-list
20234205|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20234206|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20234207|NCT00378196|Growth Substances|growth substances|mesh-ancestor
20234208|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234209|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
20234210|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234211|NCT00378287|Rabeprazole|rabeprazole|mesh-list
20234212|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20234213|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234214|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20234215|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234216|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234217|NCT00378313|Gemcitabine|gemcitabine|mesh-list
20480270|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20480271|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480272|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480273|NCT01536132|Protective Agents|protective agents|mesh-ancestor
20480274|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480275|NCT01536158|Acetaminophen|acetaminophen|mesh-list
20480276|NCT01536158|Ibuprofen|ibuprofen|mesh-list
20480277|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20480278|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20480279|NCT01536158|Analgesics|analgesics|mesh-ancestor
20480280|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
20480281|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480282|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480283|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480284|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480285|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20480286|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480287|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480288|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
20480289|NCT01536223|Cisplatin|cisplatin|mesh-list
20480290|NCT01536223|Docetaxel|docetaxel|mesh-list
20480291|NCT01536223|Fluorouracil|fluorouracil|mesh-list
20480292|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480293|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
20480294|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
20480295|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
20480296|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480297|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
20480298|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20480299|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480300|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
20480301|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480302|NCT01536249|Pramipexole|pramipexole|mesh-list
20480303|NCT01536249|Cimetidine|cimetidine|mesh-list
20480304|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20480305|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480306|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20480307|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
20480308|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
20480309|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480310|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480311|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480312|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20480313|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480314|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480315|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
20480316|NCT01536249|Protective Agents|protective agents|mesh-ancestor
20234218|NCT00378313|Paclitaxel|paclitaxel|mesh-list
20480317|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20234219|NCT00378313|Epirubicin|epirubicin|mesh-list
20234220|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20234221|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234222|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234223|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
20234224|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234225|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234226|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20234227|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
20234228|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
20234229|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234230|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234231|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234232|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
20480318|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20480319|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
20480320|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
20480321|NCT01536301|Morphine|morphine|mesh-list
20480322|NCT01536301|Oxycodone|oxycodone|mesh-list
20480323|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20480324|NCT01536301|Narcotics|narcotics|mesh-ancestor
20480325|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480326|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480327|NCT01536301|Analgesics|analgesics|mesh-ancestor
20480328|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
20480329|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480330|NCT01536314|Memantine|memantine|mesh-list
20480331|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20234233|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234234|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234235|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20234236|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20234237|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
20234238|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234239|NCT00378404|Docetaxel|docetaxel|mesh-list
20234240|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234241|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234242|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
20234243|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234244|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234245|NCT00378417|Vaccines|vaccines|mesh-list
20234246|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
20234247|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234248|NCT00378443|Prednisone|prednisone|mesh-list
20234249|NCT00378443|Losartan|losartan|mesh-list
20234250|NCT00378443|Cilazapril|cilazapril|mesh-list
20234251|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234252|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
20234253|NCT00378443|Hormones|hormones|mesh-ancestor
20234254|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234255|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234256|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234257|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234258|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20234259|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20234260|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20234261|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20234262|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234263|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20234264|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
20234265|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234266|NCT00378456|Vitamins|vitamins|mesh-list
20234267|NCT00378456|Leucovorin|leucovorin|mesh-list
20234268|NCT00378456|Folic Acid|folic acid|mesh-list
20234269|NCT00378456|Vitamin A|vitamin a|mesh-list
20234270|NCT00378456|Zinc|zinc|mesh-list
20234271|NCT00378456|Selenium|selenium|mesh-list
20234272|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
20234273|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
19413601|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413602|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19413603|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19413604|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413605|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413606|NCT04114136|Metformin|metformin|mesh-list
19413607|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
19413608|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
19413609|NCT04114136|Nivolumab|nivolumab|mesh-list
19413610|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413611|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413612|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413613|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698393|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698394|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19698395|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20234274|NCT00378456|Antioxidants|antioxidants|mesh-list
20234275|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
20234276|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234277|NCT00378456|Trace Elements|trace elements|mesh-ancestor
20234278|NCT00378456|Antidotes|antidotes|mesh-ancestor
20234279|NCT00378456|Protective Agents|protective agents|mesh-ancestor
20234280|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
20234281|NCT00378456|Hematinics|hematinics|mesh-ancestor
20234282|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234283|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20234284|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234285|NCT00378495|Miltefosine|miltefosine|mesh-list
20234286|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
20234287|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234288|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234289|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20234290|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20234291|NCT00378547|Acetaminophen|acetaminophen|mesh-list
20234292|NCT00378547|Dexamethasone|dexamethasone|mesh-list
20234293|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
20234294|NCT00378547|Pregabalin|pregabalin|mesh-list
20234295|NCT00378547|BB 1101|bb 1101|mesh-list
20234296|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234297|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
20234298|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
20234299|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234300|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234301|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234302|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
20234303|NCT00378547|Hormones|hormones|mesh-ancestor
20234304|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234305|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234306|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234307|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
20234308|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234309|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234310|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20234311|NCT00378547|Analgesics|analgesics|mesh-ancestor
20234312|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
20234313|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
20234314|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
20234315|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20234316|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20234317|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19698396|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698397|NCT04915508|Hormones|hormones|mesh-list
19698398|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698399|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698400|NCT04915612|Cytarabine|cytarabine|mesh-list
19698401|NCT04915612|Daunorubicin|daunorubicin|mesh-list
19698402|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
19698403|NCT04915612|Calicheamicins|calicheamicins|mesh-list
19698404|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19698405|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
19698406|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698407|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698408|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
19698409|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698410|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698411|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
19698412|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698413|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19698414|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19698415|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19698416|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698417|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20234318|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20234319|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234320|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234321|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234322|NCT00378612|Sirolimus|sirolimus|mesh-list
20234323|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20234324|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851946|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19851947|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851948|NCT00722072|Sorafenib|sorafenib|mesh-list
19851949|NCT00722072|Fulvestrant|fulvestrant|mesh-list
19851950|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234325|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234326|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234327|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
20234328|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234329|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
20234330|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234331|NCT00378625|Artesunate|artesunate|mesh-list
20234332|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
20234333|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20234334|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20234335|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234336|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234337|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
20234338|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
20234339|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20234340|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
20234341|NCT00378638|Bevacizumab|bevacizumab|mesh-list
20234342|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20234343|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234344|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20234345|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20234346|NCT00378638|Growth Substances|growth substances|mesh-ancestor
20234347|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234348|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
20234349|NCT00378677|Cyclosporine|cyclosporine|mesh-list
20480332|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20480333|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
20480334|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480335|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480336|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480337|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20480338|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20480339|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19851951|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19851952|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851953|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851954|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19851955|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19851956|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19851957|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
19851958|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851959|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851960|NCT00722137|Prednisone|prednisone|mesh-list
19851961|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
19851962|NCT00722137|Rituximab|rituximab|mesh-list
19851963|NCT00722137|Doxorubicin|doxorubicin|mesh-list
19851964|NCT00722137|Vincristine|vincristine|mesh-list
19851965|NCT00722137|Bortezomib|bortezomib|mesh-list
20234350|NCT00378677|Cyclosporins|cyclosporins|mesh-list
20234351|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851966|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248130|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20234352|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234353|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234354|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
20234355|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234356|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
20234357|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234358|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
20234359|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20234360|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20234361|NCT00378690|Leuprolide|leuprolide|mesh-list
20234362|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20234363|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
20234364|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20234365|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234366|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234367|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234368|NCT00378716|Leucovorin|leucovorin|mesh-list
20234369|NCT00378716|Fluorouracil|fluorouracil|mesh-list
20234370|NCT00378716|Tegafur|tegafur|mesh-list
20234371|NCT00378716|Calcium|calcium|mesh-list
20234372|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
20234373|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20234374|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234375|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
20234376|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234377|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20234378|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234379|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234380|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
20234381|NCT00378716|Antidotes|antidotes|mesh-ancestor
20234382|NCT00378716|Protective Agents|protective agents|mesh-ancestor
20234383|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
20234384|NCT00378716|Vitamins|vitamins|mesh-ancestor
20234385|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
20234386|NCT00378729|Metformin|metformin|mesh-list
20234387|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20234388|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234389|NCT00378755|Bortezomib|bortezomib|mesh-list
20234390|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234391|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20234392|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
20234393|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234394|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234395|NCT00378781|Minocycline|minocycline|mesh-list
20234396|NCT00378781|Heparin|heparin|mesh-list
20234397|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
20234398|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20234399|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20234400|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234401|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20234402|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234403|NCT00378820|Caseins|caseins|mesh-list
20234404|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
20234405|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
20234406|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480340|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19698418|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19698419|NCT04915586|Plasminogen|plasminogen|mesh-list
20480341|NCT01536431|Insulin|insulin|mesh-list
20480342|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20480343|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480344|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480345|NCT01536470|Norepinephrine|norepinephrine|mesh-list
19698420|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19698421|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19698422|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698423|NCT04915482|Rituximab|rituximab|mesh-list
20234407|NCT00378833|Niacin|niacin|mesh-list
20234408|NCT00378833|Niacinamide|niacinamide|mesh-list
20234409|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
20234410|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20234411|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
20234412|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480346|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20480347|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20480348|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
20480349|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480350|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480351|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480352|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
20480353|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
20480354|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480355|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20480356|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
20480357|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
20480358|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20480359|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480360|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480361|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
20480362|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
20480363|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20480364|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480365|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480366|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
20480367|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
20480368|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20480369|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480370|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480371|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
20480372|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
20480373|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20480374|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480375|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480376|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
20480377|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
20480378|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20234413|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20234414|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
20234415|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
20234416|NCT00378833|Vitamins|vitamins|mesh-ancestor
20234417|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
20234418|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234419|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
20234420|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20234421|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20234422|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234423|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
20234424|NCT00378872|Coagulants|coagulants|mesh-ancestor
20234425|NCT00378911|Sunitinib|sunitinib|mesh-list
20234426|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234427|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19698424|NCT04915482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698425|NCT04915482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698426|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
19698427|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698428|NCT04915482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19698429|NCT04915365|Acetazolamide|acetazolamide|mesh-list
19698430|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
19698431|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20234428|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20234429|NCT00378911|Growth Substances|growth substances|mesh-ancestor
20248131|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19698432|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698433|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234430|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480379|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480380|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480381|NCT01536665|Liraglutide|liraglutide|mesh-list
20480382|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480383|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480384|NCT01536665|Incretins|incretins|mesh-ancestor
20480385|NCT01536665|Hormones|hormones|mesh-ancestor
20480386|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234431|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
20234432|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20234433|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234434|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234435|NCT00378937|Acetaminophen|acetaminophen|mesh-list
20234436|NCT00378937|Morphine|morphine|mesh-list
20234437|NCT00378937|Oxycodone|oxycodone|mesh-list
20234438|NCT00378937|Codeine|codeine|mesh-list
20234439|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
19698434|NCT04915365|Diuretics|diuretics|mesh-ancestor
19698435|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
19698436|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698437|NCT04915287|Maleic acid|maleic acid|mesh-list
19698438|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698439|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707960|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19707961|NCT04821765|Antibodies|antibodies|mesh-list
19707962|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20234440|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
20234441|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20234442|NCT00378937|Narcotics|narcotics|mesh-ancestor
20234443|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234444|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234445|NCT00378937|Analgesics|analgesics|mesh-ancestor
19707963|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707964|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234446|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
20234447|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234448|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20234449|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
20234450|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
20234451|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
20234452|NCT00378976|Valacyclovir|valacyclovir|mesh-list
20234453|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
20234454|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234455|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
20234456|NCT00379015|Docetaxel|docetaxel|mesh-list
20234457|NCT00379015|Trastuzumab|trastuzumab|mesh-list
20480387|NCT01536691|Ondansetron|ondansetron|mesh-list
20480388|NCT01536691|Aprepitant|aprepitant|mesh-list
20480389|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
20480390|NCT01536691|Ramosetron|ramosetron|mesh-list
20480391|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
20480392|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
20480393|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480394|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480395|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480396|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
20480397|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
20480398|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20480399|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
20480400|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480401|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480402|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20480403|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20480404|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480405|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234458|NCT00379015|Epirubicin|epirubicin|mesh-list
20234459|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480406|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20480407|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20480408|NCT01536717|Carticaine|carticaine|mesh-list
20480409|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
20234460|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
20234461|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234462|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20234463|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20234464|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
20234465|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234466|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234467|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20234468|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234469|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
20234470|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
20480410|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
19413614|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19413615|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413616|NCT04104685|Minocycline|minocycline|mesh-list
20480411|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480412|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480413|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
20480414|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480415|NCT01536743|Palbociclib|palbociclib|mesh-list
20480416|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480417|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20480418|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527786|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413617|NCT04104685|Adapalene|adapalene|mesh-list
19413618|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19413619|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413620|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413621|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413622|NCT04104685|Analgesics|analgesics|mesh-ancestor
19413623|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
19413624|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413625|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413626|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413627|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413628|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
20234471|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20234472|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234473|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20234474|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20234475|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234476|NCT00379028|Fluticasone|fluticasone|mesh-list
20234477|NCT00379028|Budesonide|budesonide|mesh-list
20234478|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
19698440|NCT04915456|Prednisolone|prednisolone|mesh-list
19698441|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698442|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
19698443|NCT04915456|Hormones|hormones|mesh-ancestor
20234479|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20234480|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234481|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20234482|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
20234483|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234484|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698444|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698445|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698446|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698447|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698448|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
19413629|NCT04093765|Antimalarials|antimalarials|mesh-list
19413630|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19413631|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19413632|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698449|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
19698450|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19698451|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698452|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698453|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
19698454|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234485|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20234486|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
20234487|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
20234488|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20234489|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
20234490|NCT00379028|Hormones|hormones|mesh-ancestor
20234491|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234492|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20234493|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20234494|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20234495|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234496|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480419|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698455|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698456|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851967|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
20248132|NCT00435175|Estradiol|estradiol|mesh-list
20480420|NCT01536873|Dolutegravir|dolutegravir|mesh-list
20480421|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20480422|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20480423|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480424|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480425|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20480426|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20480427|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
19413633|NCT04077424|Vaccines|vaccines|mesh-list
19413634|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
20234497|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234498|NCT00379041|Prednisone|prednisone|mesh-list
20234499|NCT00379041|Doxorubicin|doxorubicin|mesh-list
20234500|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20234501|NCT00379041|Bleomycin|bleomycin|mesh-list
20234502|NCT00379041|Vincristine|vincristine|mesh-list
20234503|NCT00379041|Vinblastine|vinblastine|mesh-list
20480428|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480429|NCT01536964|Morphine|morphine|mesh-list
20480430|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20480431|NCT01536964|Narcotics|narcotics|mesh-ancestor
20480432|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480433|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480434|NCT01536964|Analgesics|analgesics|mesh-ancestor
20480435|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
20234504|NCT00379041|Procarbazine|procarbazine|mesh-list
20234505|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
20234506|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234507|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234508|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20234509|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20234510|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234511|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234512|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234513|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
20234514|NCT00379041|Hormones|hormones|mesh-ancestor
20234515|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234516|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234517|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234518|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20234519|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234520|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
20234521|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234522|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
20234523|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20247706|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20480436|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698457|NCT04914910|Insulin|insulin|mesh-list
19698458|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19698459|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234524|NCT00379067|Tamsulosin|tamsulosin|mesh-list
20234525|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20234526|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20234527|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20234528|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234529|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234530|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234531|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234532|NCT00379067|Urological Agents|urological agents|mesh-ancestor
20234533|NCT00379158|Micronutrients|micronutrients|mesh-list
20234534|NCT00379158|Trace Elements|trace elements|mesh-list
20234535|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234536|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20234537|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20234538|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20234539|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
20234540|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234541|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20234542|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20234543|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234544|NCT00379262|Fluorouracil|fluorouracil|mesh-list
20234545|NCT00379262|Capecitabine|capecitabine|mesh-list
20234546|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
20234547|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234548|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20234549|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234550|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698460|NCT04914936|Rifampin|rifampin|mesh-list
20234551|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
20234552|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234553|NCT00379405|Ritonavir|ritonavir|mesh-list
20234554|NCT00379405|Saquinavir|saquinavir|mesh-list
19698461|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
19698462|NCT04914936|Omeprazole|omeprazole|mesh-list
20234555|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20234556|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20234557|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
20234558|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234559|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234560|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20234561|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20234562|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
20234563|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234564|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20234565|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20234566|NCT00379418|Abciximab|abciximab|mesh-list
20234567|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
20234568|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20234569|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
20234570|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20234571|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20234572|NCT00379431|Prednisolone|prednisolone|mesh-list
20234573|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
20234574|NCT00379431|Rituximab|rituximab|mesh-list
20234575|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20234576|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
20234577|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20234578|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234579|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
20234580|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234581|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413635|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
19413636|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413637|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
19698463|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
20234582|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234583|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
20234584|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
20234585|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234586|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234587|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
20234588|NCT00379431|Hormones|hormones|mesh-ancestor
20234589|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234590|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20234591|NCT00379431|Protective Agents|protective agents|mesh-ancestor
20234592|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234593|NCT00379457|Dactinomycin|dactinomycin|mesh-list
20234594|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
20234595|NCT00379457|Ifosfamide|ifosfamide|mesh-list
20234596|NCT00379457|Carboplatin|carboplatin|mesh-list
20234597|NCT00379457|Doxorubicin|doxorubicin|mesh-list
20234598|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20234599|NCT00379457|Etoposide|etoposide|mesh-list
20234600|NCT00379457|Vincristine|vincristine|mesh-list
20234601|NCT00379457|Topotecan|topotecan|mesh-list
20234602|NCT00379457|Vinorelbine|vinorelbine|mesh-list
20234603|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234604|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
20234605|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234606|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20234607|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20234608|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
20234609|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234610|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234611|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20234612|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234613|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20234614|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20234615|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234616|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20234617|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234618|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
20234619|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234620|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20234621|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20234622|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234623|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20234624|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20234625|NCT00379483|Deferasirox|deferasirox|mesh-list
20234626|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20480437|NCT01537055|Amoxicillin|amoxicillin|mesh-list
20480438|NCT01537055|Levofloxacin|levofloxacin|mesh-list
20480439|NCT01537055|Ofloxacin|ofloxacin|mesh-list
20480440|NCT01537055|Lansoprazole|lansoprazole|mesh-list
20480441|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
20480442|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480443|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480444|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20234627|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
20234628|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
20480445|NCT01537055|Renal Agents|renal agents|mesh-ancestor
20248133|NCT00435175|Estrogens|estrogens|mesh-ancestor
20234629|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234630|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
20234631|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234632|NCT00379509|Lapatinib|lapatinib|mesh-list
20234633|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234634|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20234635|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413649|NCT04051957|Isosorbide|isosorbide|mesh-list
19413650|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20234636|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234637|NCT00379522|Vasopressins|vasopressins|mesh-list
20234638|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
20234639|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
20234640|NCT00379522|Coagulants|coagulants|mesh-ancestor
20234641|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20234642|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20234643|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
19413651|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19413652|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19413653|NCT04051957|Diuretics|diuretics|mesh-ancestor
19413654|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
19413655|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413656|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
19413657|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19413658|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413659|NCT04049864|Lenalidomide|lenalidomide|mesh-list
19413660|NCT04049864|Vaccines|vaccines|mesh-list
19413661|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
20480446|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20480447|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20480448|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480449|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480450|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480451|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20480452|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480453|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20480454|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480455|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20480456|NCT01537094|Vitamins|vitamins|mesh-list
20480457|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
20480458|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
20480459|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480460|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
20480461|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480462|NCT01537094|Protective Agents|protective agents|mesh-ancestor
20480463|NCT01537107|Sirolimus|sirolimus|mesh-list
20480464|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20480465|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19413662|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234644|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480466|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19851968|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480467|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20480468|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480469|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
20480470|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480471|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
20480472|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480473|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20480474|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413663|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19851969|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19851970|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19851971|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
19851972|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851973|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19851974|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19851975|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19851976|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20234645|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
20234646|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20234647|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234648|NCT00379626|Hormones|hormones|mesh-list
20234649|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234650|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234651|NCT00379665|Cisplatin|cisplatin|mesh-list
20234652|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234653|NCT00379691|Phenylephrine|phenylephrine|mesh-list
20234654|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
20234655|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20234656|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
19698464|NCT04914936|Calcium|calcium|mesh-list
19707965|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
19707966|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234657|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
20234658|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234659|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234660|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
20234661|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20234662|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
20234663|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
20234664|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20234665|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20234666|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20234667|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234668|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234669|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234670|NCT00379691|Protective Agents|protective agents|mesh-ancestor
20234671|NCT00379717|Docetaxel|docetaxel|mesh-list
20234672|NCT00379717|Cisplatin|cisplatin|mesh-list
20234673|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234674|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
20234675|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
20480475|NCT01537146|Ropivacaine|ropivacaine|mesh-list
20480476|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
20480477|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
20480478|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480479|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480480|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
20480481|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480482|NCT01537250|Levofloxacin|levofloxacin|mesh-list
20480483|NCT01537250|Ofloxacin|ofloxacin|mesh-list
20480484|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20480485|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480486|NCT01537250|Renal Agents|renal agents|mesh-ancestor
20480487|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480488|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20480489|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20480490|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480491|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480492|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234676|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
20234677|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234678|NCT00379730|Prednisolone|prednisolone|mesh-list
20234679|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234680|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
20234681|NCT00379730|Hormones|hormones|mesh-ancestor
20234682|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234683|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234684|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234685|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234686|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20234687|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
20234688|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20234689|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20234690|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234691|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234692|NCT00379756|Urological Agents|urological agents|mesh-ancestor
20234693|NCT00379847|Conivaptan|conivaptan|mesh-list
20234694|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20234695|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234696|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
20480493|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20480494|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20234697|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234698|NCT00379886|Thiopental|thiopental|mesh-list
20234699|NCT00379886|Propofol|propofol|mesh-list
20234700|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20248134|NCT00435175|Hormones|hormones|mesh-ancestor
20480495|NCT01537354|Poractant alfa|poractant alfa|mesh-list
20480496|NCT01537354|Beractant|beractant|mesh-list
20480497|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20480498|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
20480499|NCT01537380|Cefazolin|cefazolin|mesh-list
20480500|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480501|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480502|NCT01537471|Meclizine|meclizine|mesh-list
20480503|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
20480504|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
20480505|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
20480506|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480507|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480508|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480509|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20480510|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
20480511|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
20480512|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480513|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234701|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234702|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234703|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20234704|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
20234705|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
20234706|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
20234707|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
20234708|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
20234709|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234710|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234711|NCT00379951|Ertapenem|ertapenem|mesh-list
20234712|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20234713|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234714|NCT00379964|Caspofungin|caspofungin|mesh-list
20234715|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
20234716|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234717|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234718|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234719|NCT00379977|Vaccines|vaccines|mesh-list
20234720|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
20234721|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234722|NCT00380120|Warfarin|warfarin|mesh-list
20234723|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
20234724|NCT00380133|Prednisolone|prednisolone|mesh-list
20234725|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234726|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
20234727|NCT00380133|Hormones|hormones|mesh-ancestor
20234728|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234729|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234730|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234731|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234732|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
20234733|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
20234734|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20234735|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
20234736|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20234737|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19698465|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19698466|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698467|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19698468|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698469|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19698470|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234738|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234739|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20234740|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234741|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234742|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20234743|NCT00380146|Renal Agents|renal agents|mesh-ancestor
20234744|NCT00380224|Olanzapine|olanzapine|mesh-list
20234745|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
20234746|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
20234747|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234748|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234749|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234750|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19698471|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698472|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19698473|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
19698474|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19698475|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234751|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234752|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234753|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234754|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20234755|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20234756|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20234757|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234758|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698476|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
19698477|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19698478|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19698479|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19698480|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20234759|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
20234760|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
20234761|NCT00380263|Growth Substances|growth substances|mesh-ancestor
20234762|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234763|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
20234764|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234765|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234766|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20234767|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20234768|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
20480514|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20480515|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
20480516|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20480517|NCT01537575|Antibodies|antibodies|mesh-list
20480518|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
20480519|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20480520|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
20480521|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480522|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20480523|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480524|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20480525|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
20480526|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480527|NCT01537744|Azacitidine|azacitidine|mesh-list
20480528|NCT01537744|Romidepsin|romidepsin|mesh-list
20480529|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20480530|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
20480531|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480532|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480533|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480534|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19698481|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19698482|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19698483|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19698484|NCT04914936|Antacids|antacids|mesh-ancestor
19698485|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698486|NCT04914390|Paclitaxel|paclitaxel|mesh-list
19698487|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19698488|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480535|NCT01537770|Lidocaine|lidocaine|mesh-list
20480536|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
20480537|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
20480538|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480539|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480540|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
20480541|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698489|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
19698490|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
19698491|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
19698492|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19851977|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19851978|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19851979|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19851980|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234769|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234770|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234771|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234772|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
20234773|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20234774|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20234775|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234776|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234777|NCT00380380|Vildagliptin|vildagliptin|mesh-list
20234778|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20234779|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234780|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20234781|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
20234782|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413664|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19698493|NCT04914598|Cisplatin|cisplatin|mesh-list
19698494|NCT04914598|Endostar protein|endostar protein|mesh-list
19698495|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698496|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19698497|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19698498|NCT04914598|Growth Substances|growth substances|mesh-ancestor
19698499|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698500|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
19698501|NCT04913987|Cimetidine|cimetidine|mesh-list
20234783|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234784|NCT00380406|Leuprolide|leuprolide|mesh-list
20234785|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20234786|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
20234787|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20234788|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234789|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234790|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234791|NCT00380445|Vildagliptin|vildagliptin|mesh-list
20234792|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20234793|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234794|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20234795|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
20234796|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234797|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698502|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20234798|NCT00380484|Budesonide|budesonide|mesh-list
20234799|NCT00380484|Montelukast|montelukast|mesh-list
20480542|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20480543|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20480544|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20480545|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20234800|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20234801|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20234802|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
20234803|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234804|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234805|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20234806|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
20234807|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
20234808|NCT00380484|Hormones|hormones|mesh-ancestor
20234809|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234810|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20234811|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
20234812|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20234813|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20234814|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234815|NCT00380575|Conivaptan|conivaptan|mesh-list
20234816|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20234817|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480546|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480547|NCT01537809|Vitamin D|vitamin d|mesh-list
20480548|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
20480549|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
20234818|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
20234819|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234820|NCT00380614|Lamivudine|lamivudine|mesh-list
20234821|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20234822|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20234823|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234824|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234825|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
20234826|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234827|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20234828|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20234829|NCT00380640|Trimethoprim|trimethoprim|mesh-list
19413665|NCT04049864|Growth Substances|growth substances|mesh-ancestor
19698503|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698504|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19698505|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
19698506|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
19698507|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698508|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698509|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234830|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20234831|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480550|NCT01537809|Vitamins|vitamins|mesh-list
20480551|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
20480552|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480553|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20480554|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20480555|NCT01537861|Thalidomide|thalidomide|mesh-list
20480556|NCT01537861|Dexamethasone|dexamethasone|mesh-list
20480557|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
20480558|NCT01537861|Lenalidomide|lenalidomide|mesh-list
20480559|NCT01537861|Bortezomib|bortezomib|mesh-list
20480560|NCT01537861|Pomalidomide|pomalidomide|mesh-list
20480561|NCT01537861|Lenograstim|lenograstim|mesh-list
20480562|NCT01537861|Sargramostim|sargramostim|mesh-list
20480563|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480564|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
20480565|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480566|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480567|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20234832|NCT00380640|Renal Agents|renal agents|mesh-ancestor
20234833|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
20234834|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20234835|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19851981|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
19851982|NCT00722137|Hormones|hormones|mesh-ancestor
19851983|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234836|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20234837|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234838|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234839|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20234840|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19851984|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20234841|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20234842|NCT00380679|Vaccines|vaccines|mesh-list
20234843|NCT00380679|Immunologic Factors|immunologic factors|mesh-ancestor
20234844|NCT00380679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234845|NCT00380770|Lamivudine|lamivudine|mesh-list
20234846|NCT00380770|Stavudine|stavudine|mesh-list
20234847|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
20234848|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20234849|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20234850|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480568|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
20480569|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480570|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480571|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20480572|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480573|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
20480574|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
20480575|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19851985|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19851986|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
20480576|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480577|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
20480578|NCT01537861|Hormones|hormones|mesh-ancestor
20234851|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234852|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
20234853|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234854|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20234855|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20234856|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
20247707|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247708|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20247709|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247710|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
20247711|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
20247712|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247713|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247714|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20247715|NCT00433225|Protective Agents|protective agents|mesh-ancestor
20247716|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20247717|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20247718|NCT00433225|Analgesics|analgesics|mesh-ancestor
20247719|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
20247720|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480579|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20480580|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20480581|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20480582|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20480583|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20480584|NCT01537861|Growth Substances|growth substances|mesh-ancestor
20247721|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20247722|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234857|NCT00380822|Miglitol|miglitol|mesh-list
19413666|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
19413667|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413668|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19413669|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19413670|NCT04030143|Aripiprazole|aripiprazole|mesh-list
19413671|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
19413672|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19413673|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20234858|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234859|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234860|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20234861|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234862|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20234863|NCT00380835|Amrubicin|amrubicin|mesh-list
20234864|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234865|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20234866|NCT00380887|Estrogens|estrogens|mesh-ancestor
20234867|NCT00380887|Hormones|hormones|mesh-ancestor
20234868|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234869|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234870|NCT00380913|Nabilone|nabilone|mesh-list
20234871|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
20234872|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
20234873|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234874|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234875|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234876|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20234877|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234878|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234879|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234880|NCT00380939|Atorvastatin|atorvastatin|mesh-list
20234881|NCT00380939|Pravastatin|pravastatin|mesh-list
20234882|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20234883|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20234884|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
20234885|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234886|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20234887|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20234888|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234889|NCT00380965|Nabilone|nabilone|mesh-list
20234890|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
20234891|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
20234892|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480585|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
20480586|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
20480587|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480588|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413674|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234893|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234894|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234895|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20234896|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234897|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234898|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19413675|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234899|NCT00381017|Interferons|interferons|mesh-list
20480589|NCT01538095|Trebananib|trebananib|mesh-list
20480590|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20480591|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20480592|NCT01538095|Growth Substances|growth substances|mesh-ancestor
20480593|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480594|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
20480595|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480596|NCT01538108|Paclitaxel|paclitaxel|mesh-list
20480597|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20480598|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480599|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
20480600|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
20480601|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
19698510|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19698511|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19698512|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698513|NCT04914247|Selexipag|selexipag|mesh-list
19698514|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19698515|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
19698516|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20234900|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
20234901|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
20234902|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20234903|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234904|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
20234905|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234906|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
20234907|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234908|NCT00381030|Carvedilol|carvedilol|mesh-list
20234909|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20234910|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20234911|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234912|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234913|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234914|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234915|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20234916|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
20234917|NCT00381030|Protective Agents|protective agents|mesh-ancestor
20234918|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20234919|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20234920|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20234921|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
20234922|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20234923|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20234924|NCT00381134|Losartan|losartan|mesh-list
20234925|NCT00381134|Spironolactone|spironolactone|mesh-list
20234926|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20234927|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19698517|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698518|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698519|NCT04913714|Vaccines|vaccines|mesh-list
19698520|NCT04913714|Immunologic Factors|immunologic factors|mesh-ancestor
20234928|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20234929|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20234930|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234931|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20480602|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480603|NCT01538225|Nabiximols|nabiximols|mesh-list
20480604|NCT01538225|Analgesics|analgesics|mesh-ancestor
20480605|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
20480606|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480607|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480608|NCT01538316|Genistein|genistein|mesh-list
20480609|NCT01538316|Quercetin|quercetin|mesh-list
20480610|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
20480611|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480612|NCT01538316|Protective Agents|protective agents|mesh-ancestor
20480613|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480614|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20480615|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480616|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20480617|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698521|NCT04913714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698522|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
20234932|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
20234933|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234934|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234935|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20234936|NCT00381134|Diuretics|diuretics|mesh-ancestor
20234937|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
20234938|NCT00381147|Clarithromycin|clarithromycin|mesh-list
20234939|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20234940|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20234941|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20234942|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20234943|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234944|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20234945|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20234946|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
20234947|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20234948|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
20234949|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234950|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20234951|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20234952|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
19698523|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19698524|NCT04913831|Protective Agents|protective agents|mesh-ancestor
19698525|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698526|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
19698527|NCT04913610|Ivermectin|ivermectin|mesh-list
20234953|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234954|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20234955|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20234956|NCT00381199|Amitriptyline|amitriptyline|mesh-list
20234957|NCT00381199|Nabilone|nabilone|mesh-list
20234958|NCT00381199|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20234959|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20234960|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
20234961|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234962|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20234963|NCT00381199|Analgesics|analgesics|mesh-ancestor
20234964|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
20234965|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234966|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480618|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
19698528|NCT04913610|Albendazole|albendazole|mesh-list
19698529|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20480619|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19851987|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
20480620|NCT01538316|Estrogens|estrogens|mesh-ancestor
20480621|NCT01538316|Hormones|hormones|mesh-ancestor
20480622|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20480623|NCT01538329|Amantadine|amantadine|mesh-list
20480624|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20480625|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20480626|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
20480627|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480628|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
20234967|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20234968|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20234969|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20234970|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234971|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
20234972|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20234973|NCT00381199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20234974|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234975|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20234976|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
20234977|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
20234978|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234979|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20234980|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20234981|NCT00381251|Estrogens|estrogens|mesh-ancestor
20234982|NCT00381251|Hormones|hormones|mesh-ancestor
20234983|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20234984|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234985|NCT00381264|Nabilone|nabilone|mesh-list
20234986|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
20234987|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
20234988|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20234989|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20234990|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20234991|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20234992|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20234993|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480629|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480630|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480631|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480632|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20480633|NCT01538329|Analgesics|analgesics|mesh-ancestor
20480634|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
20480635|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480636|NCT01538381|Afatinib|afatinib|mesh-list
20480637|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480638|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20480639|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480640|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480641|NCT01538394|Nicotine|nicotine|mesh-list
20480642|NCT01538394|Varenicline|varenicline|mesh-list
20480643|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20480644|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
20480645|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480646|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480647|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20480648|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20480649|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
20480650|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480651|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480652|NCT01538446|Clopidogrel|clopidogrel|mesh-list
20480653|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20480654|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20234994|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20234995|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
20234996|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20234997|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20234998|NCT00381342|Exenatide|exenatide|mesh-list
20234999|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20235000|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235001|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20235002|NCT00381342|Incretins|incretins|mesh-ancestor
20235003|NCT00381342|Hormones|hormones|mesh-ancestor
20235004|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235005|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
20235006|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20235007|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235008|NCT00381472|Ropinirole|ropinirole|mesh-list
20235009|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20235010|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20235011|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
20235012|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
20235013|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235014|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235015|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851988|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19851989|NCT00722371|Metformin|metformin|mesh-list
20235016|NCT00381511|Heparin|heparin|mesh-list
20235017|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20235018|NCT00381511|Tinzaparin|tinzaparin|mesh-list
20235019|NCT00381511|Dalteparin|dalteparin|mesh-list
20235020|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
20235021|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20235022|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20235023|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235024|NCT00381537|Carbamazepine|carbamazepine|mesh-list
20235025|NCT00381537|Phenobarbital|phenobarbital|mesh-list
20235026|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
20235027|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
20235028|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20235029|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235030|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235031|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20235032|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20235033|NCT00381537|Analgesics|analgesics|mesh-ancestor
19698530|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698531|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
19698532|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
19698533|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20235034|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
20235035|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235036|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20235037|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235038|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235039|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20235040|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20480655|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20235041|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20235042|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20235043|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20235044|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235045|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
20235046|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
20235047|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20235048|NCT00381589|Bromides|bromides|mesh-list
20235049|NCT00381589|Ipratropium|ipratropium|mesh-list
20235050|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
20235051|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20235052|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
20235053|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235054|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235055|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20480656|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20480657|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20480658|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
20480659|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480660|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480661|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480662|NCT01538459|Dexamethasone|dexamethasone|mesh-list
20235056|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
20235057|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20235058|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
20235059|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480663|NCT01538459|Bupivacaine|bupivacaine|mesh-list
20235060|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480664|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480665|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
20480666|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
20480667|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480668|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235061|NCT00381654|MP 412|mp 412|mesh-list
20235062|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235063|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20235064|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235065|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480669|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480670|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
20235066|NCT00381732|Tadalafil|tadalafil|mesh-list
20235067|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
20235068|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20235069|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20235070|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235071|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480671|NCT01538459|Hormones|hormones|mesh-ancestor
20480672|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20480673|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20235072|NCT00381732|Urological Agents|urological agents|mesh-ancestor
20235073|NCT00381758|Methylphenidate|methylphenidate|mesh-list
20235074|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20235075|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235076|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20235077|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20235078|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235079|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235080|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
20235081|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235082|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
20235083|NCT00381836|Hematinics|hematinics|mesh-ancestor
20235084|NCT00381875|Sargramostim|sargramostim|mesh-list
20235085|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
20235086|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
20235087|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235088|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20235089|NCT00381901|Trastuzumab|trastuzumab|mesh-list
20235090|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235091|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235092|NCT00381914|Vitamin D|vitamin d|mesh-list
20235093|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
20235094|NCT00381914|Vitamins|vitamins|mesh-list
20235095|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
20235096|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527787|NCT01769820|Dexamethasone|dexamethasone|mesh-list
20527788|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20527789|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
20527790|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
20527791|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527792|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527793|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527794|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
20527795|NCT01769820|Hormones|hormones|mesh-ancestor
20530667|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20235097|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20235098|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20235099|NCT00381953|Interferons|interferons|mesh-list
20235100|NCT00381953|Ribavirin|ribavirin|mesh-list
20235101|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
20235102|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
20235103|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20235104|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235105|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
20235106|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235107|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
20235108|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235109|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
20235110|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235111|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
20235112|NCT00382044|Hematinics|hematinics|mesh-ancestor
20235113|NCT00382057|Anastrozole|anastrozole|mesh-list
20235114|NCT00382057|Goserelin|goserelin|mesh-list
20235115|NCT00382057|Testosterone|testosterone|mesh-list
20235116|NCT00382057|Androgens|androgens|mesh-ancestor
20235117|NCT00382057|Hormones|hormones|mesh-ancestor
20235118|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235119|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235120|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20235121|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235122|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20235123|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20235124|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235125|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235126|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20235127|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
20235128|NCT00382083|Acetaminophen|acetaminophen|mesh-list
20235129|NCT00382083|Ibuprofen|ibuprofen|mesh-list
20235130|NCT00382083|Lidocaine|lidocaine|mesh-list
20235131|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
20235132|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
20235133|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235134|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235135|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
20235136|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235137|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20235138|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20235139|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20235140|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235141|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235142|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20235143|NCT00382083|Analgesics|analgesics|mesh-ancestor
20235144|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
20235145|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20235146|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235147|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235148|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20235149|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235150|NCT00382135|Tadalafil|tadalafil|mesh-list
20235151|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
20235152|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20235153|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20235154|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480674|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480675|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
20480676|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
20480677|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20480678|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
20480679|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
20480680|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20480681|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480682|NCT01538485|Vitamins|vitamins|mesh-ancestor
20480683|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
20480684|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20235155|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480685|NCT01538511|Insulin|insulin|mesh-list
20480686|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20480687|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
20480688|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
20480689|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20480690|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
20480691|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20480692|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20235156|NCT00382135|Urological Agents|urological agents|mesh-ancestor
20235157|NCT00382213|Olmesartan|olmesartan|mesh-list
20235158|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20235159|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20235160|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20235161|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20235162|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235163|NCT00382239|Exenatide|exenatide|mesh-list
20235164|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20235165|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235166|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20235167|NCT00382239|Incretins|incretins|mesh-ancestor
20235168|NCT00382239|Hormones|hormones|mesh-ancestor
20235169|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851990|NCT00722371|Pioglitazone|pioglitazone|mesh-list
19851991|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19851992|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19851993|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19851994|NCT00722371|Incretins|incretins|mesh-ancestor
19851995|NCT00722371|Hormones|hormones|mesh-ancestor
19851996|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19851997|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19851998|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
19851999|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852000|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852001|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
19852002|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20235170|NCT00382330|Ciclopirox|ciclopirox|mesh-list
20235171|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
20235172|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235173|NCT00382343|Trimethoprim|trimethoprim|mesh-list
20235174|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20235175|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
20235176|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20235177|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698534|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20235178|NCT00382343|Renal Agents|renal agents|mesh-ancestor
20235179|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
20235180|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20235181|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20235182|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20235183|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235184|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235185|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20235186|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20235187|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20235188|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20235189|NCT00382356|Dutasteride|dutasteride|mesh-list
20235190|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20235191|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20235192|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235193|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235194|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
20235195|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235196|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235197|NCT00382421|Aspirin|aspirin|mesh-list
20235198|NCT00382421|Amlodipine|amlodipine|mesh-list
20235199|NCT00382421|Bisoprolol|bisoprolol|mesh-list
20235200|NCT00382421|Molsidomine|molsidomine|mesh-list
20235201|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20235202|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20235203|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235204|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235205|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20235206|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235207|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
20235208|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20235209|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20235210|NCT00382421|Analgesics|analgesics|mesh-ancestor
20235211|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
20235212|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235213|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235214|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235215|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20235216|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20235217|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20235218|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20235219|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235220|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
20235221|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
20235222|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
20235223|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20235224|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20235225|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19698535|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
19698536|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
19698537|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
19698538|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698539|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698540|NCT04913480|Durvalumab|durvalumab|mesh-list
19698541|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235226|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235227|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235228|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20235229|NCT00382499|Lidocaine|lidocaine|mesh-list
20235230|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
20235231|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
20235232|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235233|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235234|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
20235235|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480693|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480694|NCT01538537|ON 01910|on 01910|mesh-list
20480695|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480696|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20480697|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480698|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480699|NCT01538563|ON 01910|on 01910|mesh-list
20480700|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480701|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20480702|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480703|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480704|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
20235236|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20235237|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20235238|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20235239|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235240|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235241|NCT00382538|Mifepristone|mifepristone|mesh-list
20235242|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20235243|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
20235244|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20235245|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235246|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19698542|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698543|NCT04913922|Nivolumab|nivolumab|mesh-list
19698544|NCT04913922|Azacitidine|azacitidine|mesh-list
19698545|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698546|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698547|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19698548|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698549|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19698550|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
19698551|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698552|NCT04913389|Acetazolamide|acetazolamide|mesh-list
19698553|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
19698554|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19698555|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698556|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698557|NCT04913389|Diuretics|diuretics|mesh-ancestor
19698558|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
19698559|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698560|NCT04913402|Sufentanil|sufentanil|mesh-list
19698561|NCT04913402|Dsuvia|dsuvia|mesh-list
20235247|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20235248|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20235249|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
20235250|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20235251|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20235252|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
20235253|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235254|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
20235255|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20235256|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20235257|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
20235258|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
20235259|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235260|NCT00382629|Protective Agents|protective agents|mesh-ancestor
20480705|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480706|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480707|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
20480708|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20480709|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480710|NCT01538641|Gemcitabine|gemcitabine|mesh-list
20480711|NCT01538641|Rituximab|rituximab|mesh-list
20480712|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
20480713|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235261|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235262|NCT00382642|Ondansetron|ondansetron|mesh-list
20235263|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
20235264|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
20235265|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235266|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235267|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20235268|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
20480714|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698562|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20480715|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
20480716|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480717|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480718|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20480719|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
20480720|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698563|NCT04913402|Narcotics|narcotics|mesh-ancestor
20235269|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
20235270|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20235271|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
20235272|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235273|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235274|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20235275|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20235276|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698564|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698565|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698566|NCT04913402|Analgesics|analgesics|mesh-ancestor
19698567|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
19698568|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698569|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19698570|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19698571|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
19698572|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
19852003|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20235277|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20235278|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20235279|NCT00382668|Dasatinib|dasatinib|mesh-list
20235280|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235281|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20235282|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235283|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235284|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20235285|NCT00382694|Fludarabine|fludarabine|mesh-list
20235286|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247723|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247724|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20247725|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247726|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20247727|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20247728|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20247729|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20247730|NCT00433277|Cyclosporine|cyclosporine|mesh-list
20247731|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20247732|NCT00433277|Cyclosporins|cyclosporins|mesh-list
20247733|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247734|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247735|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247736|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
20247737|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247738|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
20247739|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247740|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
20247741|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247742|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20247743|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20247744|NCT00433316|Ropivacaine|ropivacaine|mesh-list
20247745|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
20247746|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
20247747|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20247748|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698573|NCT04913103|Rituximab|rituximab|mesh-list
20247749|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
20247750|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480721|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
20480722|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480723|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480724|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527796|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530668|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
20235287|NCT00382837|Epratuzumab|epratuzumab|mesh-list
20235288|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235289|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698574|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19698575|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698576|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698577|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
19698578|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698579|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235290|NCT00382889|Beclomethasone|beclomethasone|mesh-list
20235291|NCT00382889|Albuterol|albuterol|mesh-list
20235292|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20235293|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
20235294|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235295|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235296|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20235297|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
20235298|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
20235299|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20235300|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20235301|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20480725|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
20480726|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480727|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480728|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20480729|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20480730|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480731|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480732|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480733|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20480734|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480735|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
20480736|NCT01538693|Dexetimide|dexetimide|mesh-list
20480737|NCT01538693|Citalopram|citalopram|mesh-list
20480738|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20480739|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20480740|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20480741|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480742|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480743|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
20480744|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480745|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20480746|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
20480747|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20480748|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20480749|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20480750|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
20480751|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
20480752|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480753|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20480754|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20480755|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
20480756|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
20480757|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
20480758|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480759|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20480760|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
20480761|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
20480762|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20480763|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20480764|NCT01538732|Alitretinoin|alitretinoin|mesh-list
20480765|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480766|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
20480767|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
20480768|NCT01538771|Hematinics|hematinics|mesh-ancestor
20480769|NCT01538797|Ranitidine|ranitidine|mesh-list
20480770|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20480771|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20480772|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480773|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20480774|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
20480775|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
20480776|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480777|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235302|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20235303|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235304|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235305|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235306|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235307|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
20235308|NCT00382889|Hormones|hormones|mesh-ancestor
20235309|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235310|NCT00382954|Bortezomib|bortezomib|mesh-list
20235311|NCT00382954|Idarubicin|idarubicin|mesh-list
20235312|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235313|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20235314|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20235315|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20235316|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235317|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235318|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20235319|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20235320|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
20235321|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235322|NCT00382980|Antacids|antacids|mesh-ancestor
20235323|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235324|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20235325|NCT00383032|Mifepristone|mifepristone|mesh-list
19413676|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413677|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
19413678|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
19413679|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413680|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413681|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19413682|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19413683|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
19413684|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19413685|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19413686|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19413687|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19413688|NCT04030026|Nalbuphine|nalbuphine|mesh-list
19413689|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19413690|NCT04030026|Narcotics|narcotics|mesh-ancestor
19413691|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413692|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413693|NCT04030026|Analgesics|analgesics|mesh-ancestor
19413694|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
20235326|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20480778|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480779|NCT01538849|Esomeprazole|esomeprazole|mesh-list
20480780|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20480781|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480782|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20480783|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480784|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480785|NCT01538875|Hydralazine|hydralazine|mesh-list
20480786|NCT01538875|Labetalol|labetalol|mesh-list
20480787|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20480788|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
20480789|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20480790|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20480791|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235327|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
20235328|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20235329|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235330|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20235331|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20235332|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20235333|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
20235334|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20235335|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20235336|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
20235337|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235338|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
20235339|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20235340|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20235341|NCT00383045|Naltrexone|naltrexone|mesh-list
20235342|NCT00383045|Buprenorphine|buprenorphine|mesh-list
20235343|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20235344|NCT00383045|Narcotics|narcotics|mesh-ancestor
20235345|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235346|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235347|NCT00383045|Analgesics|analgesics|mesh-ancestor
20235348|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
19698580|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20235349|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235350|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20235351|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20235352|NCT00383136|Tirofiban|tirofiban|mesh-list
20235353|NCT00383136|Abciximab|abciximab|mesh-list
20235354|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
20235355|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20235356|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20235357|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20235358|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235359|NCT00383214|Epratuzumab|epratuzumab|mesh-list
20235360|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235361|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235362|NCT00383357|Zolpidem|zolpidem|mesh-list
20235363|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20235364|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20235365|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235366|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235367|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20235368|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
20235369|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
20235370|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235371|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480792|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698581|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
19698582|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698583|NCT04912934|Insulin|insulin|mesh-list
19698584|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20235372|NCT00383370|Aflibercept|aflibercept|mesh-list
20235373|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20480793|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480794|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480795|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
20480796|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
20480797|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480798|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20235374|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20235375|NCT00383370|Growth Substances|growth substances|mesh-ancestor
20235376|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235377|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
20235378|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235379|NCT00383396|Cyclosporine|cyclosporine|mesh-list
20235380|NCT00383396|Cyclosporins|cyclosporins|mesh-list
20235381|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480799|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20480800|NCT01538901|Imiquimod|imiquimod|mesh-list
20480801|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20480802|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
20480803|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480804|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480805|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
20480806|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20480807|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
20247751|NCT00433342|Floxacillin|floxacillin|mesh-list
20480808|NCT01538927|Coagulants|coagulants|mesh-ancestor
20480809|NCT01538940|Vaccines|vaccines|mesh-list
20235382|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235383|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20235384|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
20235385|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235386|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
20235387|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235388|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
20235389|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235390|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20235391|NCT00383474|Bortezomib|bortezomib|mesh-list
20235392|NCT00383474|Tipifarnib|tipifarnib|mesh-list
20235393|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698585|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707967|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707968|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
19707969|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707970|NCT04821323|Indomethacin|indomethacin|mesh-list
19707971|NCT04821323|Mannitol|mannitol|mesh-list
19707972|NCT04821323|Lactulose|lactulose|mesh-list
19707973|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19707974|NCT04821323|Diuretics|diuretics|mesh-ancestor
19707975|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
19707976|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707977|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19707978|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19707979|NCT04821323|Analgesics|analgesics|mesh-ancestor
19707980|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
20235394|NCT00383487|Calcitriol|calcitriol|mesh-list
19707981|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235395|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
20235396|NCT00383487|Naproxen|naproxen|mesh-list
20235397|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
20235398|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20235399|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20235400|NCT00383487|Analgesics|analgesics|mesh-ancestor
20235401|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
20235402|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235403|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235404|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235405|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235406|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
20235407|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20235408|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235409|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235410|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20235411|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20480810|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
20480811|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480812|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20480813|NCT01538953|Disinfectants|disinfectants|mesh-list
20480814|NCT01538953|Eusol|eusol|mesh-list
20480815|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480816|NCT01539018|Sorafenib|sorafenib|mesh-list
20480817|NCT01539018|Tegafur|tegafur|mesh-list
20480818|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480819|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20480820|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480821|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480822|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20235412|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235413|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20235414|NCT00383487|Vitamins|vitamins|mesh-ancestor
20235415|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
20235416|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20235417|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20235418|NCT00383526|Vaccines|vaccines|mesh-list
20235419|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
20235420|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235421|NCT00383539|Vaccines|vaccines|mesh-list
20235422|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
20235423|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235424|NCT00383591|Vaccines|vaccines|mesh-list
20235425|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
20235426|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235427|NCT00383656|Hormones|hormones|mesh-list
20235428|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235429|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235430|NCT00383682|Mexiletine|mexiletine|mesh-list
20235431|NCT00383682|Morphine|morphine|mesh-list
20235432|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20235433|NCT00383682|Narcotics|narcotics|mesh-ancestor
20235434|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235435|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698586|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19698587|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698588|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698589|NCT04912700|Vaccines|vaccines|mesh-list
20235436|NCT00383682|Analgesics|analgesics|mesh-ancestor
20235437|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
20235438|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235439|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19698590|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
19698591|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698592|NCT04912765|Nivolumab|nivolumab|mesh-list
20235440|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20235441|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20480823|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
20235442|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235443|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480824|NCT01539031|Donepezil|donepezil|mesh-list
20480825|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20480826|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480827|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480828|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
20235444|NCT00383695|Capecitabine|capecitabine|mesh-list
20235445|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
20235446|NCT00383695|Cetuximab|cetuximab|mesh-list
20235447|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20235448|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
20235449|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235450|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235451|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235452|NCT00383708|Lanreotide|lanreotide|mesh-list
20235453|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235454|NCT00383799|Amiodarone|amiodarone|mesh-list
20235455|NCT00383799|Procainamide|procainamide|mesh-list
20235456|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20235457|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
20235458|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19698593|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698594|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698595|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20235459|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235460|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235461|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20235462|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20235463|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20235464|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235465|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20235466|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20235467|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20235468|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20235469|NCT00383812|Bevacizumab|bevacizumab|mesh-list
20235470|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235471|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235472|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20235473|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20235474|NCT00383812|Growth Substances|growth substances|mesh-ancestor
20235475|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235476|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
20235477|NCT00383851|Temozolomide|temozolomide|mesh-list
20235478|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20235479|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20235480|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
20235481|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235482|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235483|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
20235484|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
20235485|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235486|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20235487|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20235488|NCT00383851|Growth Substances|growth substances|mesh-ancestor
20235489|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235490|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
20235491|NCT00383864|Interferons|interferons|mesh-list
20235492|NCT00383864|Ribavirin|ribavirin|mesh-list
20480829|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480830|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480831|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
20480832|NCT01539044|Atropine|atropine|mesh-list
20480833|NCT01539044|Neostigmine|neostigmine|mesh-list
20480834|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20480835|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20480836|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20480837|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
20480838|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480839|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480840|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20480841|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
20480842|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
20235493|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235494|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
20235495|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235496|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
20235497|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235498|NCT00383877|Insulin|insulin|mesh-list
20480843|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
20480844|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20480845|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20235499|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20235500|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
20235501|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
20235502|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
20235503|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
20235504|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20235505|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235506|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
20235507|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20235508|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235509|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235510|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20235511|NCT00383890|Analgesics|analgesics|mesh-ancestor
20235512|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
20480846|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
20480847|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480848|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480849|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20480850|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480851|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19413695|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413696|NCT04029610|Lidocaine|lidocaine|mesh-list
19413697|NCT04029610|Epinephrine|epinephrine|mesh-list
19413698|NCT04029610|Racepinephrine|racepinephrine|mesh-list
19413699|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
19413700|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
19413701|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
19413702|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413703|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413704|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
19413705|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413706|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19413707|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20235513|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698596|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698597|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
19698598|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
19698599|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19698600|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19698601|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413708|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20235514|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20235515|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20235516|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20235517|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235518|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235519|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235520|NCT00383916|Pantoprazole|pantoprazole|mesh-list
20235521|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20235522|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20235523|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20235524|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413709|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413710|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235525|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235526|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20235527|NCT00383929|Candesartan|candesartan|mesh-list
20235528|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
20235529|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20235530|NCT00383929|Diuretics|diuretics|mesh-ancestor
20235531|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
20235532|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235533|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20235534|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235535|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413711|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19413712|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19698602|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413713|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
19413714|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413715|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19413716|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20235536|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20235537|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20235538|NCT00383994|Rituximab|rituximab|mesh-list
20235539|NCT00383994|Sargramostim|sargramostim|mesh-list
20235540|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235541|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235542|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
20235543|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413717|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
19413718|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20235544|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235545|NCT00384020|Citalopram|citalopram|mesh-list
20235546|NCT00384020|Paroxetine|paroxetine|mesh-list
20235547|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20235548|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20235549|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235550|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235551|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235552|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
20235553|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235554|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20235555|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
20235556|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20480852|NCT01539174|Prednisone|prednisone|mesh-list
19698603|NCT04912726|Urological Agents|urological agents|mesh-ancestor
20480853|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
19413719|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698604|NCT04912596|Albuterol|albuterol|mesh-list
20480854|NCT01539174|Rituximab|rituximab|mesh-list
20480855|NCT01539174|Doxorubicin|doxorubicin|mesh-list
20480856|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20480857|NCT01539174|Vincristine|vincristine|mesh-list
20480858|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480859|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
20480860|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480861|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20480862|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20235557|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20235558|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20235559|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235560|NCT00384046|Testosterone|testosterone|mesh-list
20235561|NCT00384046|Androgens|androgens|mesh-ancestor
20235562|NCT00384046|Hormones|hormones|mesh-ancestor
20235563|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235564|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235565|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
20235566|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20235567|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20235568|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
20235569|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235570|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235571|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20235572|NCT00384124|Imiquimod|imiquimod|mesh-list
20235573|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20235574|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
20235575|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235576|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235577|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
20235578|NCT00384137|Tacrolimus|tacrolimus|mesh-list
20235579|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20235580|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
20235581|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235582|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20235583|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235584|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235585|NCT00384202|Tacrolimus|tacrolimus|mesh-list
20235586|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20235587|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
20235588|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235589|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20235590|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235591|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235592|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
20235593|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20235594|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235595|NCT00384280|Rifampin|rifampin|mesh-list
20235596|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20235597|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
20235598|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20235599|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413720|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
19413721|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
19413722|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19413723|NCT04021862|Antibodies|antibodies|mesh-list
19413724|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19413725|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
19413726|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413727|NCT03974100|Denosumab|denosumab|mesh-list
19413728|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19698605|NCT04912596|Procaterol|procaterol|mesh-list
19698606|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
19698607|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19698608|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
19698609|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235600|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
19413729|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235601|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19413730|NCT03970720|Metoclopramide|metoclopramide|mesh-list
19413731|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
20235602|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235603|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235604|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20235605|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20235606|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20235607|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20235608|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20235609|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20235610|NCT00384306|Prednisolone|prednisolone|mesh-list
20235611|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235612|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
20235613|NCT00384306|Hormones|hormones|mesh-ancestor
20235614|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235615|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235616|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20235617|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235618|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
20235619|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20235620|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20235621|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20235622|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235623|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235624|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
20235625|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235626|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235627|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20235628|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235629|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
19413732|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
19413733|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413734|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413735|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413736|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19413737|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19413738|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
20235630|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480863|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
20480864|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480865|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480866|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20480867|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20480868|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20480869|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20480870|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20480871|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480872|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235631|NCT00384410|Nabilone|nabilone|mesh-list
19852004|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852005|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
19852006|NCT00722436|Coagulants|coagulants|mesh-ancestor
19852007|NCT00722553|Vitamins|vitamins|mesh-list
19852008|NCT00722553|Folic Acid|folic acid|mesh-list
19852009|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
19852010|NCT00722553|Hydroxocobalamin|hydroxocobalamin|mesh-list
19852011|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
20235632|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
20235633|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
20235634|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235635|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480873|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
20480874|NCT01539174|Hormones|hormones|mesh-ancestor
19852012|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19852013|NCT00722553|Aminopterin|aminopterin|mesh-list
19852014|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
19852015|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852016|NCT00722553|Hematinics|hematinics|mesh-ancestor
19852017|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19852018|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852019|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852020|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852021|NCT00722566|Bortezomib|bortezomib|mesh-list
19852022|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852023|NCT00722722|Bortezomib|bortezomib|mesh-list
19852024|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852025|NCT00722761|Drospirenone|drospirenone|mesh-list
19852026|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20235636|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527797|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19852027|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19852028|NCT00722761|Estradiol|estradiol|mesh-list
20235637|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20235638|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20235639|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235640|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20235641|NCT00384436|Citalopram|citalopram|mesh-list
20235642|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20235643|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20235644|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235645|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235646|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235647|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
20235648|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235649|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20235650|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
20235651|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20235652|NCT00384475|Ciclesonide|ciclesonide|mesh-list
20235653|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
20235654|NCT00384475|Hormones|hormones|mesh-ancestor
20235655|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235656|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235657|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20235658|NCT00384527|Vancomycin|vancomycin|mesh-list
20235659|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
20235660|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20235661|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235662|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20235663|NCT00384540|Dobutamine|dobutamine|mesh-list
20235664|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20235665|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
20235666|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
20235667|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235668|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235669|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20235670|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20235671|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20235672|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235673|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235674|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235675|NCT00384540|Protective Agents|protective agents|mesh-ancestor
20235676|NCT00384553|Rituximab|rituximab|mesh-list
20235677|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235678|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235679|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
20235680|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235681|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235682|NCT00384566|Metoprolol|metoprolol|mesh-list
20235683|NCT00384566|Carvedilol|carvedilol|mesh-list
20235684|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19698610|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698611|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19698612|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698613|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
19698614|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20235685|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20235686|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
20235687|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
20235688|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235689|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413739|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852029|NCT00722761|Estrogens|estrogens|mesh-ancestor
19852030|NCT00722761|Hormones|hormones|mesh-ancestor
19852031|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852032|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235690|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20235691|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20235692|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20235693|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235694|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235695|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235696|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
20235697|NCT00384566|Protective Agents|protective agents|mesh-ancestor
20235698|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20235699|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235700|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20235701|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
20235702|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20235703|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20235704|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
20235705|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20235706|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20235707|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235708|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
20235709|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235710|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235711|NCT00384592|Esomeprazole|esomeprazole|mesh-list
20235712|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20235713|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20235714|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20235715|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235716|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235717|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20235718|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20235719|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20235720|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235721|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235722|NCT00384605|Hormones|hormones|mesh-ancestor
20235723|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235724|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235725|NCT00384618|Vitamin E|vitamin e|mesh-list
20235726|NCT00384618|Pravastatin|pravastatin|mesh-list
19852033|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19852034|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
19852035|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19852036|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19852037|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19852038|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19852039|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19852040|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
19852041|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19852042|NCT00722761|Diuretics|diuretics|mesh-ancestor
20235727|NCT00384618|Vitamins|vitamins|mesh-ancestor
20235728|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
20235729|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235730|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
20235731|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235732|NCT00384618|Protective Agents|protective agents|mesh-ancestor
20235733|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20235734|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19413740|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416889|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416890|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416891|NCT02257983|Ubiquinone|ubiquinone|mesh-list
19852043|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
19852044|NCT00722800|Drospirenone|drospirenone|mesh-list
19413741|NCT03959592|Carotenoids|carotenoids|mesh-list
20480875|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20480876|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20480877|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20480878|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
20480879|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
20480880|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
20235735|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
20235736|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20480881|NCT01539265|Silodosin|silodosin|mesh-list
20480882|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20480883|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20480884|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20480885|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
20480886|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235737|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20235738|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235739|NCT00384631|Bevacizumab|bevacizumab|mesh-list
20235740|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235741|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235742|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20235743|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20480887|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480888|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235744|NCT00384631|Growth Substances|growth substances|mesh-ancestor
20235745|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235746|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
20247752|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20247753|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247754|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
20247755|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20247756|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20247757|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480889|NCT01539265|Urological Agents|urological agents|mesh-ancestor
20480890|NCT01539330|Voriconazole|voriconazole|mesh-list
20480891|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
20480892|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480893|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20480894|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20480895|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480896|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480897|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20480898|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
20480899|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19413742|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
19413743|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413744|NCT03959592|Protective Agents|protective agents|mesh-ancestor
19413745|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413746|NCT03957590|Paclitaxel|paclitaxel|mesh-list
19413747|NCT03957590|Cisplatin|cisplatin|mesh-list
19413748|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19413749|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413750|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
19413751|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
19413752|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
19413753|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413754|NCT03955783|Venetoclax|venetoclax|mesh-list
19413755|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413756|NCT03949673|Celecoxib|celecoxib|mesh-list
19413757|NCT03949673|Diclofenac|diclofenac|mesh-list
19413758|NCT03949673|Naproxen|naproxen|mesh-list
20480900|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480901|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20480902|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
20480903|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20480904|NCT01539408|Misoprostol|misoprostol|mesh-list
20480905|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20480906|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
20480907|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20480908|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413759|NCT03949673|Fasinumab|fasinumab|mesh-list
19413760|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20247758|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480909|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20480910|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480911|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
20480912|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
20480913|NCT01539473|Tedizolid|tedizolid|mesh-list
20480914|NCT01539473|Tyramine|tyramine|mesh-list
20480915|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480916|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480917|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
20480918|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
20480919|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480920|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480921|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20480922|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19416892|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
19698615|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19698616|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19698617|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19698618|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
19698619|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698620|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698621|NCT04912596|Miotics|miotics|mesh-ancestor
19698622|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19698623|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19698624|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20235747|NCT00384657|Iron|iron|mesh-list
20235748|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20235749|NCT00384657|Trace Elements|trace elements|mesh-ancestor
20235750|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
20235751|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235752|NCT00384657|Hematinics|hematinics|mesh-ancestor
20235753|NCT00384696|Nicotine|nicotine|mesh-list
20235754|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20235755|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
20235756|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235757|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235758|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20235759|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20480923|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20480924|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480925|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235760|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
20235761|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235762|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480926|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480927|NCT01539564|Minocycline|minocycline|mesh-list
20480928|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480929|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480930|NCT01539577|Dexamethasone|dexamethasone|mesh-list
20480931|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20480932|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
20480933|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
20480934|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480935|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480936|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480937|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
20480938|NCT01539577|Hormones|hormones|mesh-ancestor
20480939|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20480940|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20480941|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480942|NCT01539603|Sirolimus|sirolimus|mesh-list
20480943|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20480944|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20480945|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20480946|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480947|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
20480948|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20480949|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
20480950|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480951|NCT01539616|Fenofibrate|fenofibrate|mesh-list
20480952|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20480953|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
20480954|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480955|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20480956|NCT01539655|Omeprazole|omeprazole|mesh-list
20480957|NCT01539655|Ranitidine|ranitidine|mesh-list
20235763|NCT00384800|Thalidomide|thalidomide|mesh-list
20235764|NCT00384800|Tegafur|tegafur|mesh-list
20235765|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20235766|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
20235767|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235768|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
20235769|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20235770|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235771|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20235772|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20480958|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20480959|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20480960|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480961|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20480962|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20480963|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480964|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20480965|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
20480966|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
19852045|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19852046|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20235773|NCT00384800|Growth Substances|growth substances|mesh-ancestor
20480967|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480968|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480969|NCT01539681|Sorafenib|sorafenib|mesh-list
20480970|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20480971|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20480972|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235774|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
20235775|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852047|NCT00722800|Estradiol|estradiol|mesh-list
20480973|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235776|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20235777|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
20235778|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235779|NCT00384826|Paclitaxel|paclitaxel|mesh-list
20235780|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20235781|NCT00384826|Carboplatin|carboplatin|mesh-list
20235782|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20235783|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235784|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
20235785|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
20235786|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
20235787|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235788|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20235789|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235790|NCT00384878|Leucovorin|leucovorin|mesh-list
20235791|NCT00384878|Fluorouracil|fluorouracil|mesh-list
19698625|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19698626|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
19852048|NCT00722800|Estrogens|estrogens|mesh-ancestor
20235792|NCT00384878|Cetuximab|cetuximab|mesh-list
20235793|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235794|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
20235795|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235796|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20235797|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19852049|NCT00722800|Hormones|hormones|mesh-ancestor
19852050|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852051|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852052|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19852053|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
20235798|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
20235799|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235800|NCT00384878|Antidotes|antidotes|mesh-ancestor
20235801|NCT00384878|Protective Agents|protective agents|mesh-ancestor
20235802|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
20235803|NCT00384878|Vitamins|vitamins|mesh-ancestor
20235804|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
20235805|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235806|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
20235807|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20235808|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
20235809|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235810|NCT00384917|Ketoconazole|ketoconazole|mesh-list
20235811|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
20235812|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235813|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20235814|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19698627|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
19698628|NCT04912167|Valsartan|valsartan|mesh-list
19698629|NCT04912167|Enalapril|enalapril|mesh-list
19698630|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19698631|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19698632|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19698633|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19698634|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698635|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19698636|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
19698637|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698638|NCT04912271|Dexamethasone|dexamethasone|mesh-list
19698639|NCT04912271|Aprepitant|aprepitant|mesh-list
19698640|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
19698641|NCT04912271|Palonosetron|palonosetron|mesh-list
19413761|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413762|NCT03949673|Analgesics|analgesics|mesh-ancestor
19413763|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
19413764|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698642|NCT04912271|Granisetron|granisetron|mesh-list
19698643|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698644|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
19698645|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
19698646|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698647|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698648|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698649|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
19698650|NCT04912271|Hormones|hormones|mesh-ancestor
19698651|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698652|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698653|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698654|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19698655|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698656|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698657|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19698658|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19698659|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
19698660|NCT04912193|Antithrombins|antithrombins|mesh-list
19698661|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
19698662|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19698663|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
19698664|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698665|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698666|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
19698667|NCT04912258|Irinotecan|irinotecan|mesh-list
19698668|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19698669|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19413765|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698670|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698671|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235815|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698672|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235816|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235817|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20235818|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
20235819|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698673|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19698674|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
20235820|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235821|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20235822|NCT00384969|Sorafenib|sorafenib|mesh-list
20235823|NCT00384969|Everolimus|everolimus|mesh-list
20235824|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235825|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20235826|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235827|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235828|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20235829|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
20235830|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235831|NCT00385021|Leucovorin|leucovorin|mesh-list
19698675|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698676|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19698677|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19698678|NCT04912128|Growth Substances|growth substances|mesh-ancestor
19698679|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698680|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
19698681|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698682|NCT04911959|Lenvatinib|lenvatinib|mesh-list
19698683|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698684|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19698685|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235832|NCT00385021|Fluorouracil|fluorouracil|mesh-list
20235833|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
20235834|NCT00385021|Bevacizumab|bevacizumab|mesh-list
20235835|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
20235836|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235837|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20235838|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235839|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20235840|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
20235841|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235842|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235843|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20235844|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20235845|NCT00385021|Growth Substances|growth substances|mesh-ancestor
20235846|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
20235847|NCT00385021|Antidotes|antidotes|mesh-ancestor
20235848|NCT00385021|Protective Agents|protective agents|mesh-ancestor
20235849|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
20235850|NCT00385021|Vitamins|vitamins|mesh-ancestor
20235851|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
20235852|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
20235853|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235854|NCT00385125|Rituximab|rituximab|mesh-list
20235855|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20235856|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20235857|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235858|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
20235859|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235860|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20235861|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20235862|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
19698686|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698687|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19698688|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19698689|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698690|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
19698691|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235863|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235864|NCT00385307|Amibegron|amibegron|mesh-list
20235865|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20480974|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
20480975|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20480976|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20480977|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
20480978|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20480979|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20480980|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480981|NCT01539707|Urological Agents|urological agents|mesh-ancestor
20480982|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
20480983|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
20480984|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20480985|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
20480986|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20480987|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480988|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20480989|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20480990|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20480991|NCT01539733|Haloperidol|haloperidol|mesh-list
20235866|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20235867|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235868|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235869|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235870|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235871|NCT00385359|Albuterol|albuterol|mesh-list
20235872|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20235873|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
20235874|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235875|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235876|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20235877|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
20235878|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
20235879|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20235880|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20235881|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20235882|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20235883|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235884|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235885|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413766|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413767|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413768|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19413769|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19413770|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413771|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413772|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
20235886|NCT00385385|KRM 1648|krm 1648|mesh-list
20235887|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19413773|NCT03948646|Bromides|bromides|mesh-list
19698692|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
19698693|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19698694|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
19698695|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698696|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698697|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19698698|NCT04912011|Diuretics|diuretics|mesh-ancestor
19698699|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
19698700|NCT04911621|Temozolomide|temozolomide|mesh-list
19698701|NCT04911621|Vaccines|vaccines|mesh-list
19698702|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19698703|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
20235888|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
20480992|NCT01539733|Olanzapine|olanzapine|mesh-list
20480993|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
20480994|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
20480995|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
20480996|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20480997|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20480998|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20480999|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20481000|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20481001|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481002|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481003|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20481004|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20481005|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481006|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481007|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413774|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
19413775|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
19413776|NCT03943147|BMS-986165|bms-986165|mesh-list
19413777|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19413778|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413779|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19413780|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
19413781|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19413782|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413783|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413784|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698704|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235889|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20235890|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235891|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
20235892|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20235893|NCT00385398|Temozolomide|temozolomide|mesh-list
19698705|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698706|NCT04911621|Immunologic Factors|immunologic factors|mesh-ancestor
20235894|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235895|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20235896|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235897|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235898|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20235899|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
19698707|NCT04911621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698708|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
19698709|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
19698710|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19698711|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20235900|NCT00385411|Valproic Acid|valproic acid|mesh-list
19413785|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
20235901|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
20235902|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235903|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235904|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
20235905|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235906|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235907|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
20235908|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20235909|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235910|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20235911|NCT00385437|Mirtazapine|mirtazapine|mesh-list
20235912|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
20235913|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20235914|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20235915|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
20235916|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
20235917|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20235918|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235919|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235920|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20235921|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20235922|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20235923|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20235924|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20235925|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20235926|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
20235927|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20235928|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20235929|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
20235930|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20235931|NCT00385450|Nelfinavir|nelfinavir|mesh-list
20235932|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20235933|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20235934|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
20235935|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235936|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235937|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20235938|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19413786|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19413787|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
19413788|NCT03941262|Avelumab|avelumab|mesh-list
19413789|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413790|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413791|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19413792|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
20481008|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
20481009|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20481010|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
20235939|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
20235940|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235941|NCT00385463|Montelukast|montelukast|mesh-list
20235942|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20235943|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20235944|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20235945|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20235946|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
20481011|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20481012|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20481013|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
20481014|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20481015|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
20481016|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481017|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481018|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20481019|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
19413793|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413794|NCT03935958|Curcumin|curcumin|mesh-list
19413795|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413796|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413797|NCT03935958|Analgesics|analgesics|mesh-ancestor
19413798|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
19413799|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413800|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413801|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413802|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413803|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413804|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413805|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413806|NCT03928184|Lorecivivint|lorecivivint|mesh-list
19413807|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19852054|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19852055|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19852056|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19852057|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19852058|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20247759|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235947|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235948|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235949|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20235950|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20235951|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235952|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20235953|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
20235954|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235955|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
20235956|NCT00385463|Hormones|hormones|mesh-ancestor
20235957|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
20235958|NCT00385502|Econazole|econazole|mesh-list
20481020|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481021|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481022|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20235959|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
20235960|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235961|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20235962|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20235963|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20235964|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235965|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20235966|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
20235967|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20235968|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235969|NCT00385554|UC-781|uc-781|mesh-list
20235970|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20235971|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
20235972|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698712|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698713|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698714|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235973|NCT00385606|Gemcitabine|gemcitabine|mesh-list
20235974|NCT00385606|Rofecoxib|rofecoxib|mesh-list
20235975|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235976|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20235977|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
20235978|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20235979|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
20235980|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481023|NCT01540032|Salicylates|salicylates|mesh-list
20481024|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20481025|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481026|NCT01540032|Analgesics|analgesics|mesh-ancestor
20481027|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
20481028|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481029|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481030|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481031|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481032|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20481033|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481034|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481035|NCT01540084|Propofol|propofol|mesh-list
20481036|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20481037|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481038|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481039|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20481040|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
20481041|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
20481042|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
20481043|NCT01540110|Docetaxel|docetaxel|mesh-list
20235981|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481044|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20481045|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
20481046|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481047|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481048|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20481049|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
20481050|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481051|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481052|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20481053|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
20481054|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
20481055|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19852059|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
19852060|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19852061|NCT00722800|Diuretics|diuretics|mesh-ancestor
19852062|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
19852063|NCT00722865|Bevacizumab|bevacizumab|mesh-list
19852064|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19852065|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20235982|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20235983|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
20235984|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20235985|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20235986|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20235987|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20235988|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20235989|NCT00385606|Analgesics|analgesics|mesh-ancestor
20235990|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
20235991|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20235992|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20235993|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413808|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19852066|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19852067|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19852068|NCT00722865|Growth Substances|growth substances|mesh-ancestor
20235994|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20235995|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
20235996|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20235997|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20235998|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20235999|NCT00385645|Zidovudine|zidovudine|mesh-list
20236000|NCT00385645|Lamivudine|lamivudine|mesh-list
20236001|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19698715|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19698716|NCT04911127|Cannabidiol|cannabidiol|mesh-list
19698717|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
19698718|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
19698719|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20236002|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20236003|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
20236004|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236005|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236006|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20236007|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20236008|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
20236009|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236010|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20236011|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236012|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
20236013|NCT00385658|Simvastatin|simvastatin|mesh-list
20236014|NCT00385658|Ezetimibe|ezetimibe|mesh-list
19698720|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19698721|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698722|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
19698723|NCT04911413|Coagulants|coagulants|mesh-ancestor
19707982|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707983|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707984|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
19707985|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
19707986|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20236015|NCT00385658|Fenofibrate|fenofibrate|mesh-list
20236016|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20236017|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20236018|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
20236019|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236020|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20236021|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20236022|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481056|NCT01540136|Nedaplatin|nedaplatin|mesh-list
20481057|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481058|NCT01540240|Zidovudine|zidovudine|mesh-list
20481059|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
20481060|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481061|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20481062|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236023|NCT00385710|Valproic Acid|valproic acid|mesh-list
20236024|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
20236025|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236026|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236027|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
20236028|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236029|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236030|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
20236031|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20236032|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236033|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20236034|NCT00385853|Temozolomide|temozolomide|mesh-list
20236035|NCT00385853|Vatalanib|vatalanib|mesh-list
20236036|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20481063|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481064|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
20481065|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481066|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20481067|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20481068|NCT01540253|Docetaxel|docetaxel|mesh-list
20481069|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481070|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
20481071|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
20481072|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
19852069|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236037|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
20236038|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236039|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236040|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236041|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236042|NCT00385931|Valsartan|valsartan|mesh-list
20236043|NCT00385931|Simvastatin|simvastatin|mesh-list
20236044|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20236045|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20236046|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
20236047|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236048|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20236049|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20236050|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236051|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20236052|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20236053|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20236054|NCT00385957|Lamivudine|lamivudine|mesh-list
20236055|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19852070|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852071|NCT00723021|Zileuton|zileuton|mesh-list
19852072|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19852073|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852074|NCT00723021|Analgesics|analgesics|mesh-ancestor
19852075|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
19852076|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852077|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852078|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19852079|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236056|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19852080|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19852081|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852082|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852083|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19852084|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
19852085|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20236057|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236058|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236059|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
20236060|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236061|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20236062|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20236063|NCT00385970|Leucovorin|leucovorin|mesh-list
19852086|NCT00723099|Cyclosporine|cyclosporine|mesh-list
19852087|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
19852088|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
19852089|NCT00723099|Fludarabine|fludarabine|mesh-list
20236064|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
20236065|NCT00385970|Tegafur|tegafur|mesh-list
20236066|NCT00385970|Calcium|calcium|mesh-list
20236067|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
19852090|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
19852091|NCT00723099|Cyclosporins|cyclosporins|mesh-list
19852092|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236068|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20236069|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481073|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527798|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527799|NCT01769833|Interferons|interferons|mesh-list
20527800|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
20527801|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
20527802|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20527803|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852093|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
19852094|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236070|NCT00385970|Antidotes|antidotes|mesh-ancestor
20527804|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
20527805|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236071|NCT00385970|Protective Agents|protective agents|mesh-ancestor
20236072|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
20236073|NCT00385970|Vitamins|vitamins|mesh-ancestor
20236074|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
20236075|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20236076|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
20236077|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236078|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236079|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20236080|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
20236081|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20236082|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
20236083|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236084|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
20236085|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20236086|NCT00386061|Rimonabant|rimonabant|mesh-list
20236087|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20236088|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20236089|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20236090|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236091|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236092|NCT00386061|Hormones|hormones|mesh-ancestor
20236093|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698724|NCT04910477|Atropine|atropine|mesh-list
19698725|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
19698726|NCT04910477|Neostigmine|neostigmine|mesh-list
19698727|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19698728|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236094|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236095|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20236096|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20236097|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
20236098|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
20236099|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236100|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20236101|NCT00386126|Hematinics|hematinics|mesh-ancestor
20236102|NCT00386178|Vitamin E|vitamin e|mesh-list
20236103|NCT00386178|Tocopherols|tocopherols|mesh-list
20236104|NCT00386178|Tocotrienols|tocotrienols|mesh-list
20236105|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
20236106|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
20481074|NCT01540435|Bevacizumab|bevacizumab|mesh-list
20481075|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20481076|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481077|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20481078|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20481079|NCT01540435|Growth Substances|growth substances|mesh-ancestor
20481080|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481081|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236107|NCT00386178|Vitamins|vitamins|mesh-ancestor
20236108|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
19698729|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698730|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19698731|NCT04910477|Analgesics|analgesics|mesh-ancestor
19698732|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
19698733|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698734|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19698735|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20481082|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
20481083|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20481084|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20481085|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481086|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236109|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236110|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
20236111|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236112|NCT00386178|Protective Agents|protective agents|mesh-ancestor
20236113|NCT00386191|Clopidogrel|clopidogrel|mesh-list
20236114|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20236115|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20236116|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20236117|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20236118|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
20236119|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236120|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236121|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236122|NCT00386230|Zidovudine|zidovudine|mesh-list
20236123|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
20236124|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236125|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20236126|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236127|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236128|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
20236129|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236130|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20236131|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20481087|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481088|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20481089|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20481090|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20236132|NCT00386269|Codeine|codeine|mesh-list
20236133|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20236134|NCT00386269|Narcotics|narcotics|mesh-ancestor
20236135|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236136|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236137|NCT00386269|Analgesics|analgesics|mesh-ancestor
20236138|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
20236139|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236140|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
20236141|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
20236142|NCT00386282|Misoprostol|misoprostol|mesh-list
20481091|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698736|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19698737|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
19698738|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698739|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698740|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19698741|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19698742|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19698743|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
20236143|NCT00386282|Mifepristone|mifepristone|mesh-list
19413809|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
20481092|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481093|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
20481094|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20481095|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
20481096|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20481097|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20481098|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481099|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20481100|NCT01540526|Axitinib|axitinib|mesh-list
19413810|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698744|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20236144|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20236145|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
20236146|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20236147|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236148|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20236149|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236150|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
20236151|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20236152|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20236153|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20236154|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20236155|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
20236156|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20236157|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20236158|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
20236159|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20236160|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
20236161|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20236162|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20481101|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481102|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20481103|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481104|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481105|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20481106|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20481107|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20236163|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
20236164|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236165|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19852095|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236166|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236167|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236168|NCT00386399|Mitomycins|mitomycins|mesh-list
20236169|NCT00386399|Mitomycin|mitomycin|mesh-list
20236170|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20236171|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236172|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
20236173|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236174|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236175|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236176|NCT00386412|Valganciclovir|valganciclovir|mesh-list
20236177|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
19413811|NCT03926026|Fluticasone|fluticasone|mesh-list
20236178|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236179|NCT00386503|Artesunate|artesunate|mesh-list
20236180|NCT00386503|Amodiaquine|amodiaquine|mesh-list
20236181|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
20236182|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20236183|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20236184|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236185|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236186|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
20236187|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
20236188|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20236189|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
20236190|NCT00386516|Fluorouracil|fluorouracil|mesh-list
20481108|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20481109|NCT01540682|Cetuximab|cetuximab|mesh-list
20481110|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20481111|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481112|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20481113|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20481114|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
20481115|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236191|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
20236192|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236193|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20236194|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236195|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236196|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
20236197|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236198|NCT00386529|Aspirin|aspirin|mesh-list
20236199|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20236200|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20236201|NCT00386529|Analgesics|analgesics|mesh-ancestor
20236202|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
20236203|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236204|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236205|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20236206|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236207|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20236208|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20236209|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236210|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20236211|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20236212|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481116|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481117|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20481118|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
20481119|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
20481120|NCT01540708|Hormones|hormones|mesh-ancestor
20481121|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481122|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
20236213|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
20236214|NCT00386555|Docetaxel|docetaxel|mesh-list
20236215|NCT00386555|Axitinib|axitinib|mesh-list
20236216|NCT00386555|Crenolanib|crenolanib|mesh-list
20236217|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236218|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
20236219|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
20481123|NCT01540721|Acetaminophen|acetaminophen|mesh-list
20481124|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481125|NCT01540721|Analgesics|analgesics|mesh-ancestor
20481126|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
20481127|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481128|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481129|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
20481130|NCT01540734|Acetaminophen|acetaminophen|mesh-list
20481131|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481132|NCT01540734|Analgesics|analgesics|mesh-ancestor
20481133|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
20481134|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481135|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481136|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
20481137|NCT01540747|Folic Acid|folic acid|mesh-list
20481138|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
20481139|NCT01540747|Inositol|inositol|mesh-list
20481140|NCT01540747|Melatonin|melatonin|mesh-list
20481141|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
20481142|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481143|NCT01540747|Protective Agents|protective agents|mesh-ancestor
20481144|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481145|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236220|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
20481146|NCT01540747|Hematinics|hematinics|mesh-ancestor
20481147|NCT01540747|Vitamins|vitamins|mesh-ancestor
20481148|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
20481149|NCT01540812|Cytarabine|cytarabine|mesh-list
19413812|NCT03926026|Xhance|xhance|mesh-list
20247760|NCT00433407|Trastuzumab|trastuzumab|mesh-list
20481150|NCT01540812|Dexamethasone|dexamethasone|mesh-list
20481151|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
20481152|NCT01540812|Prednisone|prednisone|mesh-list
20481153|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
20236221|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236222|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236223|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236224|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20236225|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20236226|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20236227|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20236228|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236229|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
20236230|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236231|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247761|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247762|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247763|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20247764|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20247765|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247766|NCT00433459|Prednisone|prednisone|mesh-list
20247767|NCT00433459|Prednisolone|prednisolone|mesh-list
20247768|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
20247769|NCT00433459|Dacarbazine|dacarbazine|mesh-list
20247770|NCT00433459|Vincristine|vincristine|mesh-list
20247771|NCT00433459|Procarbazine|procarbazine|mesh-list
20247772|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20247773|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19852096|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19852097|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
19852098|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852099|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852100|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19852101|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19852102|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
19852103|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852104|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
19413813|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19852105|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852106|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
19852107|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19852108|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19852109|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19852110|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
19852111|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20247774|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
20247775|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247776|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247777|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20247778|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
20247779|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247780|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247781|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20247782|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247783|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
20247784|NCT00433459|Hormones|hormones|mesh-ancestor
20247785|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247786|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20247787|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20247788|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
20481154|NCT01540812|Fludarabine|fludarabine|mesh-list
20481155|NCT01540812|Vincristine|vincristine|mesh-list
19852112|NCT00723125|Paclitaxel|paclitaxel|mesh-list
20481156|NCT01540812|Daunorubicin|daunorubicin|mesh-list
20481157|NCT01540812|Idarubicin|idarubicin|mesh-list
20481158|NCT01540812|Methotrexate|methotrexate|mesh-list
20481159|NCT01540812|Pegaspargase|pegaspargase|mesh-list
20481160|NCT01540812|Asparaginase|asparaginase|mesh-list
20481161|NCT01540812|BB 1101|bb 1101|mesh-list
20481162|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481163|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
20481164|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
20236232|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20236233|NCT00386646|Laxatives|laxatives|mesh-ancestor
20236234|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236235|NCT00386659|Ritonavir|ritonavir|mesh-list
20236236|NCT00386659|Lopinavir|lopinavir|mesh-list
20236237|NCT00386659|Tenofovir|tenofovir|mesh-list
20236238|NCT00386659|Abacavir|abacavir|mesh-list
20236239|NCT00386659|Efavirenz|efavirenz|mesh-list
20236240|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
20236241|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20236242|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20236243|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
20236244|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236245|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236246|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20236247|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20236248|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
20236249|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236250|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20236251|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20236252|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20236253|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236254|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20236255|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20236256|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20236257|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20236258|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20236259|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
20236260|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
20236261|NCT00386672|Vitamin D|vitamin d|mesh-list
20236262|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
20236263|NCT00386672|Vitamins|vitamins|mesh-list
20236264|NCT00386672|Calcium|calcium|mesh-list
20481165|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481166|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481167|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20481168|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
20481169|NCT01540812|Hormones|hormones|mesh-ancestor
20481170|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481171|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20236265|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
20236266|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236267|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19413814|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19413815|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
19698745|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698746|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
20481172|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481173|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
20481174|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236268|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20236269|NCT00386685|Trastuzumab|trastuzumab|mesh-list
20236270|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20236271|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236272|NCT00386750|Lumefantrine|lumefantrine|mesh-list
20236273|NCT00386750|Artemether|artemether|mesh-list
20236274|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20236275|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
20236276|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20236277|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20236278|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236279|NCT00386763|Lumefantrine|lumefantrine|mesh-list
20236280|NCT00386763|Artemether|artemether|mesh-list
20236281|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20236282|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
20236283|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20236284|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20236285|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236286|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
20236287|NCT00386802|Clotrimazole|clotrimazole|mesh-list
20236288|NCT00386802|Miconazole|miconazole|mesh-list
20236289|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236290|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20236291|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20236292|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20236293|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236294|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236295|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20236296|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
20236297|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481175|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481176|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20481177|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
20481178|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20481179|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
20481180|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
20481181|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481182|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20481183|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20481184|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20481185|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20481186|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20481187|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20481188|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20481189|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20481190|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
20481191|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20481192|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
20481193|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19698747|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
20236298|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247789|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
20236299|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20236300|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20236301|NCT00386815|Pemetrexed|pemetrexed|mesh-list
20236302|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236303|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236304|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236305|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20236306|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236307|NCT00386828|Bevacizumab|bevacizumab|mesh-list
20236308|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20481194|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481195|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236309|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236310|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20236311|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20236312|NCT00386828|Growth Substances|growth substances|mesh-ancestor
20481196|NCT01540877|Anesthetics|anesthetics|mesh-list
20481197|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20481198|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
20481199|NCT01540877|Capsaicin|capsaicin|mesh-list
20481200|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481201|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481202|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
20481203|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481204|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
20481205|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
20481206|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20481207|NCT01541059|Ropivacaine|ropivacaine|mesh-list
20481208|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
20481209|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
20481210|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481211|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481212|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
20481213|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481214|NCT01541072|Lenograstim|lenograstim|mesh-list
20481215|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20236313|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236314|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236315|NCT00386841|Citalopram|citalopram|mesh-list
20236316|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20236317|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20236318|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20236319|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236320|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236321|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
20236322|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236323|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20236324|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
20236325|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20236326|NCT00386867|Misoprostol|misoprostol|mesh-list
20236327|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20236328|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
20236329|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20236330|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236331|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20236332|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236333|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
20236334|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
20236335|NCT00386958|Povidone|povidone|mesh-list
20236336|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
20236337|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
20236338|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20236339|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236340|NCT00386984|Octreotide|octreotide|mesh-list
20236341|NCT00386984|Somatostatin|somatostatin|mesh-list
20236342|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236343|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20236344|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481216|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
20481217|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481218|NCT01541085|Ritonavir|ritonavir|mesh-list
20481219|NCT01541085|Darunavir|darunavir|mesh-list
20481220|NCT01541085|Efavirenz|efavirenz|mesh-list
20236345|NCT00386984|Hormones|hormones|mesh-ancestor
20236346|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20236347|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236348|NCT00386997|Amphotericin B|amphotericin b|mesh-list
20236349|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20236350|NCT00386997|Amebicides|amebicides|mesh-ancestor
20481221|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20481222|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20236351|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20236352|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20236353|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236354|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20236355|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
20236356|NCT00387114|Ascorbic Acid|ascorbic acid|mesh-list
20236357|NCT00387114|Vitamins|vitamins|mesh-ancestor
20236358|NCT00387114|Micronutrients|micronutrients|mesh-ancestor
20236359|NCT00387114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236360|NCT00387114|Antioxidants|antioxidants|mesh-ancestor
20236361|NCT00387114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236362|NCT00387114|Protective Agents|protective agents|mesh-ancestor
20236363|NCT00387179|Melatonin|melatonin|mesh-list
20236364|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
20236365|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236366|NCT00387179|Protective Agents|protective agents|mesh-ancestor
20236367|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236368|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236369|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
20236370|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20236371|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481223|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
20481224|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481225|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481226|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20481227|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20481228|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
20481229|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698748|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19698749|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19698750|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
19698751|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19698752|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698753|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19698754|NCT04910347|Nivolumab|nivolumab|mesh-list
19698755|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698756|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698757|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19698758|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698759|NCT04910386|Gemcitabine|gemcitabine|mesh-list
19698760|NCT04910386|Cisplatin|cisplatin|mesh-list
19698761|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236372|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
20236373|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852113|NCT00723125|Bevacizumab|bevacizumab|mesh-list
20481230|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20481231|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19698762|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19698763|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
19698764|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698765|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
20236374|NCT00387322|Pemetrexed|pemetrexed|mesh-list
20236375|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20236376|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236377|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236378|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236379|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20236380|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236381|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236382|NCT00387374|Paclitaxel|paclitaxel|mesh-list
20236383|NCT00387374|Bevacizumab|bevacizumab|mesh-list
20236384|NCT00387374|Carboplatin|carboplatin|mesh-list
20236385|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20236386|NCT00387374|Antibodies|antibodies|mesh-list
20236387|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
20236388|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20236389|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20236390|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236391|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
20236392|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
20236393|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
20236394|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236395|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20236396|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20236397|NCT00387374|Growth Substances|growth substances|mesh-ancestor
20236398|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481232|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20481233|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20481234|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20481235|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20481236|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20481237|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20481238|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20481239|NCT01541124|Morphine|morphine|mesh-list
20481240|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20481241|NCT01541124|Narcotics|narcotics|mesh-ancestor
19698766|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698767|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236399|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236400|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
20236401|NCT00387400|Everolimus|everolimus|mesh-list
20236402|NCT00387400|Temozolomide|temozolomide|mesh-list
20236403|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236404|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236405|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
20236406|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236407|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20236408|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
20236409|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236410|NCT00387413|Niacinamide|niacinamide|mesh-list
20236411|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20236412|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20236413|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20236414|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247790|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
20481242|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481243|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481244|NCT01541124|Analgesics|analgesics|mesh-ancestor
20481245|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
20481246|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481247|NCT01541137|Diclofenac|diclofenac|mesh-list
20481248|NCT01541137|Parecoxib|parecoxib|mesh-list
20481249|NCT01541137|Valdecoxib|valdecoxib|mesh-list
20481250|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20481251|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481252|NCT01541137|Analgesics|analgesics|mesh-ancestor
19852114|NCT00723125|Carboplatin|carboplatin|mesh-list
20527806|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
20236415|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236416|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236417|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236418|NCT00387413|Analgesics|analgesics|mesh-ancestor
20236419|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
20236420|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236421|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
20236422|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20236423|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
20236424|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
20236425|NCT00387413|Vitamins|vitamins|mesh-ancestor
20236426|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
20236427|NCT00387504|Fenretinide|fenretinide|mesh-list
20236428|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236429|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20236430|NCT00387504|Protective Agents|protective agents|mesh-ancestor
20236431|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236432|NCT00387530|Valganciclovir|valganciclovir|mesh-list
20236433|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20236434|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
20236435|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236436|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236437|NCT00387556|Ondansetron|ondansetron|mesh-list
20236438|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
20236439|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
20236440|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236441|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413816|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413817|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413818|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19413819|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
19413820|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
19413821|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19413822|NCT03925480|Azithromycin|azithromycin|mesh-list
19413823|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19413824|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413825|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20236442|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236443|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
19852115|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20236444|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
20236445|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20236446|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
20236447|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236448|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236449|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20236450|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20236451|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236452|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20236453|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19852116|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20236454|NCT00387569|Vaccines|vaccines|mesh-list
20236455|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
20236456|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236457|NCT00387582|Ranibizumab|ranibizumab|mesh-list
20236458|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20236459|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20236460|NCT00387582|Growth Substances|growth substances|mesh-ancestor
20236461|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236462|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236463|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236464|NCT00387608|Veliparib|veliparib|mesh-list
20236465|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20236466|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236467|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236468|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236469|NCT00387699|Bevacizumab|bevacizumab|mesh-list
20236470|NCT00387699|Etoposide|etoposide|mesh-list
20481253|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
20481254|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481255|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481256|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481257|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481258|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20481259|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481260|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236471|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20236472|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698768|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698769|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
19698770|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698771|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20236473|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20236474|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20236475|NCT00387699|Growth Substances|growth substances|mesh-ancestor
20481261|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20481262|NCT01541189|Valsartan|valsartan|mesh-list
20481263|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481264|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20481265|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20481266|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481267|NCT01541267|Telmisartan|telmisartan|mesh-list
20236476|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236477|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236478|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20236479|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20236480|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20236481|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236482|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236483|NCT00387738|Histamine|histamine|mesh-list
20236484|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
20236485|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
20236486|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236487|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236488|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236489|NCT00387777|Buprenorphine|buprenorphine|mesh-list
20236490|NCT00387777|Analgesics|analgesics|mesh-list
20236491|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20236492|NCT00387777|Narcotics|narcotics|mesh-ancestor
20236493|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236494|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236495|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
20236496|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236497|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20236498|NCT00387868|Etoposide|etoposide|mesh-list
20236499|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236500|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20236501|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20236502|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20236503|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236504|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236505|NCT00387920|Sunitinib|sunitinib|mesh-list
20236506|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236507|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20236508|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20481268|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481269|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20481270|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20481271|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481272|NCT01541280|Azacitidine|azacitidine|mesh-list
20481273|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20481274|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
20481275|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481276|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481277|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481278|NCT01541293|Lidocaine|lidocaine|mesh-list
20481279|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
20481280|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
20481281|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481282|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481283|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
20481284|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236509|NCT00387920|Growth Substances|growth substances|mesh-ancestor
20236510|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236511|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236512|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236513|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236514|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236515|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
20236516|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
20236517|NCT00387933|Vatalanib|vatalanib|mesh-list
20236518|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236519|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236520|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236521|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236522|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
20236523|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236524|NCT00388011|Morphine|morphine|mesh-list
20236525|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20236526|NCT00388011|Narcotics|narcotics|mesh-ancestor
20236527|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236528|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236529|NCT00388011|Analgesics|analgesics|mesh-ancestor
20236530|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
20236531|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236532|NCT00388076|Paclitaxel|paclitaxel|mesh-list
20236533|NCT00388076|Carboplatin|carboplatin|mesh-list
20236534|NCT00388076|Lapatinib|lapatinib|mesh-list
20236535|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19698772|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698773|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
19698774|NCT04910594|Hematinics|hematinics|mesh-ancestor
19698775|NCT04910126|Doxorubicin|doxorubicin|mesh-list
19698776|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19698777|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19698778|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698779|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19698780|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19698781|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698782|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698783|NCT04910178|Empagliflozin|empagliflozin|mesh-list
19698784|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
20236536|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698785|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19698786|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20236537|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
19698787|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698788|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20236538|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
20236539|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
20236540|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236541|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20481285|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20481286|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20481287|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20481288|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481289|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481290|NCT01541332|Dexamethasone|dexamethasone|mesh-list
20236542|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236543|NCT00388089|Bortezomib|bortezomib|mesh-list
20236544|NCT00388089|Topotecan|topotecan|mesh-list
20236545|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236546|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20481291|NCT01541332|Doxorubicin|doxorubicin|mesh-list
20481292|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20481293|NCT01541332|Pomalidomide|pomalidomide|mesh-list
20481294|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481295|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
20481296|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
19698789|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698790|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19698791|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698792|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19698793|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20481297|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481298|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481299|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20481300|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
20481301|NCT01541332|Hormones|hormones|mesh-ancestor
20481302|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481303|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20481304|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481305|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20481306|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20481307|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20481308|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481309|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698794|NCT04910178|Protective Agents|protective agents|mesh-ancestor
19698795|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
19698796|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19698797|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
19698798|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19698799|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236547|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20236548|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236549|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236550|NCT00388128|Caffeine|caffeine|mesh-list
20236551|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20236552|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236553|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20236554|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236555|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236556|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20236557|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20236558|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
20236559|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481310|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
20481311|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20481312|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20481313|NCT01541332|Growth Substances|growth substances|mesh-ancestor
20236560|NCT00388167|Caspofungin|caspofungin|mesh-list
20236561|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
20236562|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236563|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236564|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236565|NCT00388193|Rituximab|rituximab|mesh-list
20236566|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20481314|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
20481315|NCT01541436|Capsaicin|capsaicin|mesh-list
20481316|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
20481317|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
20481318|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
20481319|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481320|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481321|NCT01541475|Dexetimide|dexetimide|mesh-list
20481322|NCT01541475|Citalopram|citalopram|mesh-list
20481323|NCT01541475|Bupropion|bupropion|mesh-list
20481324|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20481325|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20481326|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481327|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481328|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236567|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236568|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
20236569|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236570|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236571|NCT00388219|Buprenorphine|buprenorphine|mesh-list
20236572|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20236573|NCT00388219|Narcotics|narcotics|mesh-ancestor
20236574|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236575|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236576|NCT00388219|Analgesics|analgesics|mesh-ancestor
20236577|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
20236578|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481329|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
20481330|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481331|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20481332|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
20236579|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20236580|NCT00388258|Alvimopan|alvimopan|mesh-list
20481333|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20236581|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20481334|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20481335|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20481336|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
20481337|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
20481338|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481339|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20481340|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20481341|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
20481342|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20236582|NCT00388271|Alfuzosin|alfuzosin|mesh-list
20236583|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20236584|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20236585|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20236586|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
20236587|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236588|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236589|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236590|NCT00388271|Urological Agents|urological agents|mesh-ancestor
20236591|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
20236592|NCT00388336|Hematinics|hematinics|mesh-ancestor
20236593|NCT00388388|Losartan|losartan|mesh-list
20236594|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20236595|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20236596|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19413826|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19413827|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20236597|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20236598|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20236599|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236600|NCT00388388|Diuretics|diuretics|mesh-ancestor
20236601|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
20236602|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481343|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
20236603|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19852117|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852118|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19852119|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
19852120|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19852121|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852122|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19852123|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19852124|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19852125|NCT00723125|Growth Substances|growth substances|mesh-ancestor
19852126|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852127|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852128|NCT00723177|Ibudilast|ibudilast|mesh-list
19852129|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19852130|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
19852131|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852132|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852133|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20236604|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247791|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20247792|NCT00433485|Sirolimus|sirolimus|mesh-list
20247793|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20236605|NCT00388401|Alvimopan|alvimopan|mesh-list
20236606|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236607|NCT00388427|Cetuximab|cetuximab|mesh-list
20236608|NCT00388427|Dasatinib|dasatinib|mesh-list
20236609|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20236610|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236611|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236612|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236613|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236614|NCT00388479|Alvimopan|alvimopan|mesh-list
20236615|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20481344|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20481345|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20481346|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481347|NCT01541605|Methylphenidate|methylphenidate|mesh-list
20481348|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20481349|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481350|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20481351|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20236616|NCT00388557|Ketoconazole|ketoconazole|mesh-list
20236617|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
20236618|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236619|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20236620|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20236621|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236622|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236623|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20236624|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
20236625|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20236626|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236627|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20236628|NCT00388635|Prednisone|prednisone|mesh-list
20236629|NCT00388635|Melphalan|melphalan|mesh-list
20236630|NCT00388635|Bortezomib|bortezomib|mesh-list
20236631|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20236632|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
20236633|NCT00388635|Hormones|hormones|mesh-ancestor
20236634|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20236635|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236636|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20236637|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236638|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20236639|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
20236640|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236641|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20236642|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20481352|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481353|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481354|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
20481355|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481356|NCT01541631|Albendazole|albendazole|mesh-list
20236643|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
20236644|NCT00388661|Melatonin|melatonin|mesh-list
20236645|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
20236646|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236647|NCT00388661|Protective Agents|protective agents|mesh-ancestor
20236648|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236649|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236650|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20236651|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20236652|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236653|NCT00388700|Leucovorin|leucovorin|mesh-list
20236654|NCT00388700|Bevacizumab|bevacizumab|mesh-list
20236655|NCT00388700|Fluorouracil|fluorouracil|mesh-list
20236656|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20236657|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236658|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20236659|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20236660|NCT00388700|Growth Substances|growth substances|mesh-ancestor
20236661|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236662|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236663|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
20236664|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236665|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20236666|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236667|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
20236668|NCT00388700|Antidotes|antidotes|mesh-ancestor
20236669|NCT00388700|Protective Agents|protective agents|mesh-ancestor
20236670|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
20236671|NCT00388700|Vitamins|vitamins|mesh-ancestor
20236672|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
20236673|NCT00388739|Prednisolone|prednisolone|mesh-list
20236674|NCT00388739|Budesonide|budesonide|mesh-list
20236675|NCT00388739|Albuterol|albuterol|mesh-list
20236676|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20236677|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
19413828|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20236678|NCT00388739|Hormones|hormones|mesh-ancestor
20236679|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20236680|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236681|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20236682|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236683|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
20236684|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236685|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20236686|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20236687|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
20236688|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
20236689|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20236690|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20236691|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20236692|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20236693|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
20236694|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236695|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236696|NCT00388778|Doxycycline|doxycycline|mesh-list
20236697|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20236698|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236699|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
20236700|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20236701|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20236702|NCT00388856|Ascorbic Acid|ascorbic acid|mesh-list
20236703|NCT00388856|Vitamins|vitamins|mesh-ancestor
20236704|NCT00388856|Micronutrients|micronutrients|mesh-ancestor
20236705|NCT00388856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236706|NCT00388856|Antioxidants|antioxidants|mesh-ancestor
20236707|NCT00388856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236708|NCT00388856|Protective Agents|protective agents|mesh-ancestor
20236709|NCT00388882|Bromides|bromides|mesh-list
20236710|NCT00388882|Albuterol|albuterol|mesh-list
20236711|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
20236712|NCT00388882|Ipratropium|ipratropium|mesh-list
20236713|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20236714|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
20236715|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236716|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236717|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20236718|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
20236719|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
20236720|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20236721|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
20236722|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236723|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236724|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
20236725|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
20236726|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20236727|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20236728|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20236729|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20236730|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
20236731|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
20236732|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236733|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236734|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236735|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236736|NCT00388986|Glyburide|glyburide|mesh-list
20236737|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481357|NCT01541631|Praziquantel|praziquantel|mesh-list
20481358|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
20481359|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20481360|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481361|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
20481362|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20481363|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20481364|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
20481365|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
20481366|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
20481367|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481368|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481369|NCT01541670|Antibodies|antibodies|mesh-list
20481370|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
20481371|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236738|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236739|NCT00388999|Lectins|lectins|mesh-list
20481372|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20236740|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
20236741|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
20236742|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236743|NCT00388999|Coagulants|coagulants|mesh-ancestor
20236744|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20236745|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20236746|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20236747|NCT00389025|Analgesics|analgesics|mesh-ancestor
20236748|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
20236749|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236750|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236751|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20236752|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236753|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20236754|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20236755|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20236756|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
20236757|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
20236758|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236759|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236760|NCT00389038|Amitriptyline|amitriptyline|mesh-list
20236761|NCT00389038|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20236762|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20236763|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
20236764|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20236765|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20236766|NCT00389038|Analgesics|analgesics|mesh-ancestor
20236767|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
19413829|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20236768|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236769|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236770|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20236771|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20236772|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20236773|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236774|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
20236775|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20236776|NCT00389038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20236777|NCT00389038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20236778|NCT00389038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236779|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20236780|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20236781|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
20236782|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236783|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236784|NCT00389090|Temozolomide|temozolomide|mesh-list
20236785|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20236786|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20236787|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
20236788|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236789|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236790|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236791|NCT00389129|Aspirin|aspirin|mesh-list
20236792|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20236793|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20236794|NCT00389129|Analgesics|analgesics|mesh-ancestor
20236795|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
20236796|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236797|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236798|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20236799|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236800|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20236801|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20236802|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236803|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20236804|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20236805|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236806|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
20236807|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
20236808|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20236809|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
20236810|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236811|NCT00389233|Protective Agents|protective agents|mesh-ancestor
20236812|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236813|NCT00389233|Vitamins|vitamins|mesh-ancestor
20236814|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
20236815|NCT00389233|Laxatives|laxatives|mesh-ancestor
20236816|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236817|NCT00389272|Acetaminophen|acetaminophen|mesh-list
20236818|NCT00389272|Ibuprofen|ibuprofen|mesh-list
20236819|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20236820|NCT00389272|Analgesics|analgesics|mesh-ancestor
20236821|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
20236822|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236823|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236824|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
20236825|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20236826|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20236827|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481373|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
20481374|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481375|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20481376|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481377|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481378|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20481379|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20481380|NCT01541943|Losartan|losartan|mesh-list
20481381|NCT01541943|Atorvastatin|atorvastatin|mesh-list
20481382|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20481383|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20236828|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20236829|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236830|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236831|NCT00389285|Sorafenib|sorafenib|mesh-list
20236832|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236833|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236834|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236835|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236836|NCT00389311|Nonoxynol|nonoxynol|mesh-list
20236837|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20236838|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20236839|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236840|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20236841|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
20236842|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20236843|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20236844|NCT00389376|Silymarin|silymarin|mesh-list
20236845|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
20236846|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236847|NCT00389376|Protective Agents|protective agents|mesh-ancestor
20236848|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236849|NCT00389402|Ritonavir|ritonavir|mesh-list
20236850|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20236851|NCT00389402|Saquinavir|saquinavir|mesh-list
20236852|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20236853|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20236854|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
20236855|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236856|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236857|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20236858|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20236859|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
20236860|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236861|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20236862|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20236863|NCT00389415|Vildagliptin|vildagliptin|mesh-list
20236864|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20236865|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236866|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20236867|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
20236868|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236869|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236870|NCT00389428|Cytarabine|cytarabine|mesh-list
20236871|NCT00389428|Daunorubicin|daunorubicin|mesh-list
20481384|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
20481385|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481386|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20481387|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20481388|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481389|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20481390|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481391|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20481392|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20481393|NCT01541956|Metformin|metformin|mesh-list
20481394|NCT01541956|Vildagliptin|vildagliptin|mesh-list
20481395|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481396|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481397|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20481398|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
20236872|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20236873|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
20236874|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236875|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481399|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481400|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481401|NCT01542047|Carboplatin|carboplatin|mesh-list
20481402|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481403|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
20481404|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
20481405|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20236876|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
20236877|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236878|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236879|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
20236880|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236881|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20236882|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20236883|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19852134|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
20236884|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236885|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
20236886|NCT00389506|Fludarabine|fludarabine|mesh-list
20236887|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
20236888|NCT00389506|Immunotoxins|immunotoxins|mesh-list
20236889|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236890|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
20236891|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236892|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236893|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20236894|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
20236895|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236896|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236897|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20236898|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20236899|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
20236900|NCT00389558|Amikacin|amikacin|mesh-list
20236901|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20236902|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481406|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481407|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527807|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527808|NCT01769898|Budesonide|budesonide|mesh-list
20527809|NCT01769898|Theophylline|theophylline|mesh-list
20236903|NCT00389584|Irinotecan|irinotecan|mesh-list
20236904|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20236905|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20236906|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236907|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527810|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
20527811|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20527812|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20527813|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
20236908|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527814|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236909|NCT00389636|Becaplermin|becaplermin|mesh-list
20236910|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
20236911|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20236912|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20236913|NCT00389636|Growth Substances|growth substances|mesh-ancestor
20236914|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236915|NCT00389688|Pemetrexed|pemetrexed|mesh-list
20236916|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236917|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236918|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236919|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20236920|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20236921|NCT00389701|Dexamethasone|dexamethasone|mesh-list
20236922|NCT00389701|Bortezomib|bortezomib|mesh-list
20236923|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20236924|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
20236925|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
20236926|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236927|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236928|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20236929|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
20236930|NCT00389701|Hormones|hormones|mesh-ancestor
20236931|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20236932|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20236933|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852135|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19852136|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852137|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852138|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19852139|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
19852140|NCT00723190|Clonidine|clonidine|mesh-list
19852141|NCT00723190|Analgesics|analgesics|mesh-ancestor
19852142|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
19852143|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20236934|NCT00389766|Topotecan|topotecan|mesh-list
19852144|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481408|NCT01542099|Remifentanil|remifentanil|mesh-list
20481409|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20481410|NCT01542099|Narcotics|narcotics|mesh-ancestor
20236935|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19852145|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19852146|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
19852147|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
19852148|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19852149|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19852150|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20236936|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20236937|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20236938|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236939|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236940|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236941|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20236942|NCT00389870|Cyclosporine|cyclosporine|mesh-list
20236943|NCT00389870|Irinotecan|irinotecan|mesh-list
20236944|NCT00389870|Panitumumab|panitumumab|mesh-list
20236945|NCT00389870|Cyclosporins|cyclosporins|mesh-list
20236946|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20236947|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20236948|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236949|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236950|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852151|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
19852152|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413830|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413831|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413832|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19413833|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413834|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236951|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236952|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
20236953|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236954|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
20236955|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236956|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
20236957|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20236958|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20236959|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20236960|NCT00389883|Anesthetics|anesthetics|mesh-list
20236961|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20236962|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236963|NCT00389909|Doxapram|doxapram|mesh-list
20236964|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20236965|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236966|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
20236967|NCT00389922|Vinorelbine|vinorelbine|mesh-list
20236968|NCT00389922|Lapatinib|lapatinib|mesh-list
20236969|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20236970|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236971|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
20236972|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
19413835|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413836|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413837|NCT03912233|Ivacaftor|ivacaftor|mesh-list
19413838|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19413839|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413840|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413841|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20236973|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
20481411|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481412|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481413|NCT01542099|Analgesics|analgesics|mesh-ancestor
20236974|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236975|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20236976|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236977|NCT00389935|Thalidomide|thalidomide|mesh-list
20236978|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20236979|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
20236980|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20236981|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
20481414|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
20236982|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20236983|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236984|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20236985|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20236986|NCT00389935|Growth Substances|growth substances|mesh-ancestor
20236987|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
20236988|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236989|NCT00389987|Tazobactam|tazobactam|mesh-list
20236990|NCT00389987|Piperacillin|piperacillin|mesh-list
20236991|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20236992|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20236993|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20236994|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20236995|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20236996|NCT00390000|Pemetrexed|pemetrexed|mesh-list
20236997|NCT00390000|Vatalanib|vatalanib|mesh-list
20236998|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20236999|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237000|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237001|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20237002|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20237003|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20237004|NCT00390026|Bevacizumab|bevacizumab|mesh-list
20237005|NCT00390026|Verteporfin|verteporfin|mesh-list
20237006|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237007|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237008|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237009|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20237010|NCT00390026|Growth Substances|growth substances|mesh-ancestor
20237011|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237012|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
20237013|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20237014|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
20237015|NCT00390039|Morphine|morphine|mesh-list
20237016|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20237017|NCT00390039|Narcotics|narcotics|mesh-ancestor
20237018|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237019|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237020|NCT00390039|Analgesics|analgesics|mesh-ancestor
20237021|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
20237022|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237023|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
20237024|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20237025|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
20237026|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237027|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481415|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481416|NCT01542138|Niacinamide|niacinamide|mesh-list
20481417|NCT01542138|Niacin|niacin|mesh-list
20481418|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
20481419|NCT01542138|Desonide|desonide|mesh-list
20481420|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
20481421|NCT01542138|Vitamins|vitamins|mesh-ancestor
20481422|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
20481423|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481424|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20481425|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
20481426|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481427|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20481428|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
20481429|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481430|NCT01542190|Ketorolac|ketorolac|mesh-list
20481431|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20481432|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20481433|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481434|NCT01542190|Analgesics|analgesics|mesh-ancestor
20481435|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
20481436|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481437|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481438|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481439|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481440|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20481441|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481442|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237028|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20237029|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
20237030|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20237031|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
20237032|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237033|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237034|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20237035|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
20237036|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
20237037|NCT00390065|Protective Agents|protective agents|mesh-ancestor
20237038|NCT00390091|Abetimus|abetimus|mesh-list
20237039|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237040|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
20237041|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481443|NCT01542242|Liraglutide|liraglutide|mesh-list
20481444|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481445|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481446|NCT01542242|Incretins|incretins|mesh-ancestor
20481447|NCT01542242|Hormones|hormones|mesh-ancestor
20481448|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481449|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
20481450|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20481451|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481452|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481453|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20481454|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20481455|NCT01542268|Protective Agents|protective agents|mesh-ancestor
20481456|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481457|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
20481458|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20237042|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20237043|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
20237044|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237045|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
20237046|NCT00390156|Bevacizumab|bevacizumab|mesh-list
20237047|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
20237048|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237049|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
20237050|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237051|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237052|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20237053|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
20237054|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237055|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237056|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20237057|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237058|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237059|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20481459|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
20481460|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
20237060|NCT00390156|Growth Substances|growth substances|mesh-ancestor
20237061|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
20237062|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20237063|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237064|NCT00390195|Everolimus|everolimus|mesh-list
20237065|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237066|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237067|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
20237068|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237069|NCT00390208|Dexamethasone|dexamethasone|mesh-list
20237070|NCT00390208|Ranibizumab|ranibizumab|mesh-list
20237071|NCT00390208|Verteporfin|verteporfin|mesh-list
20237072|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237073|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
20237074|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
20481461|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237075|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237076|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237077|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237078|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
20237079|NCT00390208|Hormones|hormones|mesh-ancestor
20237080|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237081|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20237082|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237083|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237084|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20237085|NCT00390208|Growth Substances|growth substances|mesh-ancestor
20237086|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
20237087|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20237088|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
20237089|NCT00390247|Thalidomide|thalidomide|mesh-list
20237090|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237091|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
20237092|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237093|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
20237094|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237095|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237096|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237097|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20237098|NCT00390247|Growth Substances|growth substances|mesh-ancestor
20237099|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
20237100|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237101|NCT00390260|Acetaminophen|acetaminophen|mesh-list
20237102|NCT00390260|Rofecoxib|rofecoxib|mesh-list
20237103|NCT00390260|Hydrocodone|hydrocodone|mesh-list
20237104|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20237105|NCT00390260|Analgesics|analgesics|mesh-ancestor
20481462|NCT01542424|Insulin|insulin|mesh-list
20481463|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20481464|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
20481465|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
20481466|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
20481467|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20481468|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481469|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481470|NCT01542437|Afatinib|afatinib|mesh-list
20481471|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481472|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20481473|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481474|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481475|NCT01542450|Insulin|insulin|mesh-list
19698800|NCT04910165|Ropivacaine|ropivacaine|mesh-list
20237106|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
20237107|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237108|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237109|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
20237110|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237111|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
20237112|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20237113|NCT00390260|Narcotics|narcotics|mesh-ancestor
20237114|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237115|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
20237116|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20237117|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20237118|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237119|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20237120|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237121|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237122|NCT00390273|Metformin|metformin|mesh-list
20237123|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20237124|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247794|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247795|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20247796|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247797|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
20247798|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247799|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
20247800|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247801|NCT00433498|Carboplatin|carboplatin|mesh-list
20247802|NCT00433498|Etoposide|etoposide|mesh-list
20247803|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
20247804|NCT00433498|Pravastatin|pravastatin|mesh-list
20247805|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247806|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20247807|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20247808|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20247809|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481476|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20481477|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
20481478|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
20481479|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
20481480|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
20481481|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481482|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481483|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
20481484|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481485|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481486|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
20481487|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481488|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481489|NCT01542489|Insulin|insulin|mesh-list
20481490|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20481491|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
19698801|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
19698802|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
19698803|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698804|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698805|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
20481492|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
20481493|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481494|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237125|NCT00390312|Morphine|morphine|mesh-list
20237126|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20237127|NCT00390312|Narcotics|narcotics|mesh-ancestor
20237128|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237129|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237130|NCT00390312|Analgesics|analgesics|mesh-ancestor
20237131|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
20237132|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237133|NCT00390390|Lansoprazole|lansoprazole|mesh-list
20237134|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
20237135|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20237136|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237137|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20237138|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237139|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237140|NCT00390403|Acetic Acid|acetic acid|mesh-list
20237141|NCT00390403|Temozolomide|temozolomide|mesh-list
20237142|NCT00390403|Retinol acetate|retinol acetate|mesh-list
20237143|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
20237144|NCT00390403|Gossypol|gossypol|mesh-list
20237145|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20237146|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
20237147|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237148|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237149|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237150|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237151|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20237152|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
19698806|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698807|NCT04909931|Vitamin D|vitamin d|mesh-list
19698808|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
20481495|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
20481496|NCT01542697|Analgesics|analgesics|mesh-ancestor
20481497|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
19698809|NCT04909931|Vitamins|vitamins|mesh-ancestor
20237153|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237154|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20237155|NCT00390403|Protective Agents|protective agents|mesh-ancestor
20237156|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20237157|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
20237158|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20237159|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20237160|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20237161|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20237162|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20237163|NCT00390520|Vildagliptin|vildagliptin|mesh-list
20237164|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481498|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481499|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481500|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
20481501|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481502|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20481503|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
20481504|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20481505|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481506|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481507|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20481508|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
20481509|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20481510|NCT01542710|Timolol|timolol|mesh-list
20481511|NCT01542710|Bimatoprost|bimatoprost|mesh-list
20481512|NCT01542710|Travoprost|travoprost|mesh-list
20481513|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20481514|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20481515|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
20481516|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530669|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19698810|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
20237165|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237166|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20237167|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
20237168|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237169|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237170|NCT00390598|Sennosides|sennosides|mesh-list
20237171|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20237172|NCT00390598|Laxatives|laxatives|mesh-ancestor
20237173|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237174|NCT00390624|Mannitol|mannitol|mesh-list
20237175|NCT00390624|Ularitide|ularitide|mesh-list
20237176|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20237177|NCT00390624|Diuretics|diuretics|mesh-ancestor
20237178|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
20237179|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237180|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20237181|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
20237182|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237183|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19413842|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20237184|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
20237185|NCT00390676|Carboplatin|carboplatin|mesh-list
20237186|NCT00390676|Docetaxel|docetaxel|mesh-list
20237187|NCT00390676|Capecitabine|capecitabine|mesh-list
20237188|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237189|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237190|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
20237191|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237192|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237193|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20237194|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
20237195|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
20237196|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20237197|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237198|NCT00390793|Cytarabine|cytarabine|mesh-list
20237199|NCT00390793|Dexamethasone|dexamethasone|mesh-list
20237200|NCT00390793|Prednisone|prednisone|mesh-list
20237201|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
20237202|NCT00390793|Cortisone|cortisone|mesh-list
20237203|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
20237204|NCT00390793|Doxorubicin|doxorubicin|mesh-list
20237205|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20237206|NCT00390793|Methotrexate|methotrexate|mesh-list
20237207|NCT00390793|Vincristine|vincristine|mesh-list
20237208|NCT00390793|Daunorubicin|daunorubicin|mesh-list
20237209|NCT00390793|Dasatinib|dasatinib|mesh-list
20237210|NCT00390793|BB 1101|bb 1101|mesh-list
20237211|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237212|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
20237213|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237214|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19698811|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698812|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19698813|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19698814|NCT04909918|Dexamethasone|dexamethasone|mesh-list
19698815|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
19698816|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19698817|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19698818|NCT04909918|Prednisolone|prednisolone|mesh-list
20237215|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20237216|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
20237217|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237218|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237219|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20237220|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698819|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
19698820|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19698821|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
19698822|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237221|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
20237222|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
20237223|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237224|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237225|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
20237226|NCT00390793|Hormones|hormones|mesh-ancestor
20237227|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237228|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20237229|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20237230|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20237231|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20237232|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481517|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481518|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481519|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20481520|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481521|NCT01542723|Nadroparin|nadroparin|mesh-list
20481522|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
20481523|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20481524|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20481525|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481526|NCT01542762|Nadroparin|nadroparin|mesh-list
20481527|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
20481528|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20481529|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20237233|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20237234|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
20237235|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19852153|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852154|NCT00723203|Panobinostat|panobinostat|mesh-list
19852155|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852156|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19852157|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852158|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852159|NCT00723229|Acyclovir|acyclovir|mesh-list
19852160|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
19852161|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852162|NCT00723255|Sirolimus|sirolimus|mesh-list
19852163|NCT00723255|Bevacizumab|bevacizumab|mesh-list
19852164|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19852165|NCT00723255|Antibodies|antibodies|mesh-list
19852166|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
20237236|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20237237|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
20237238|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
20237239|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20237240|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20237241|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
20237242|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237243|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20237244|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237245|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
20237246|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237247|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20237248|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
20237249|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
20237250|NCT00390832|Hematinics|hematinics|mesh-ancestor
20237251|NCT00390871|Fentanyl|fentanyl|mesh-list
20237252|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
20237253|NCT00390871|Propofol|propofol|mesh-list
19852167|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20237254|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20237255|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237256|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237257|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20237258|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
20237259|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
20237260|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20237261|NCT00390871|Analgesics|analgesics|mesh-ancestor
20237262|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
20237263|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237264|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20237265|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20237266|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20237267|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
20237268|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237269|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237270|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20237271|NCT00390871|Narcotics|narcotics|mesh-ancestor
20237272|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20237273|NCT00390897|Interferons|interferons|mesh-list
20237274|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237275|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
20237276|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237277|NCT00390923|Selegiline|selegiline|mesh-list
20237278|NCT00390923|Nicotine|nicotine|mesh-list
20237279|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20237280|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
20237281|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237282|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237283|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20237284|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20237285|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
20237286|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237287|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237288|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
20237289|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20237290|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20237291|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20237292|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20237293|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237294|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20237295|NCT00390923|Protective Agents|protective agents|mesh-ancestor
20237296|NCT00390975|Tegaserod|tegaserod|mesh-list
20237297|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20237298|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
20237299|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237300|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237301|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237302|NCT00391014|Amphotericin B|amphotericin b|mesh-list
20237303|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20237304|NCT00391014|Amebicides|amebicides|mesh-ancestor
20237305|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20237306|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20237307|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237308|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237309|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
20237310|NCT00391105|Remifentanil|remifentanil|mesh-list
20237311|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20237312|NCT00391105|Narcotics|narcotics|mesh-ancestor
20237313|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237314|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237315|NCT00391105|Analgesics|analgesics|mesh-ancestor
20237316|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
20237317|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481530|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481531|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
20481532|NCT01542801|Norfloxacin|norfloxacin|mesh-list
20481533|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20481534|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481535|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20481536|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20481537|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481538|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481539|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481540|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20481541|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20481542|NCT01542827|Analgesics|analgesics|mesh-list
20481543|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
20481544|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237318|NCT00391144|Triamcinolone|triamcinolone|mesh-list
20237319|NCT00391144|Bevacizumab|bevacizumab|mesh-list
20237320|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237321|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237322|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237323|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20237324|NCT00391144|Growth Substances|growth substances|mesh-ancestor
20237325|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237326|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
20237327|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237328|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
20237329|NCT00391144|Hormones|hormones|mesh-ancestor
20237330|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237331|NCT00391157|Dexamethasone|dexamethasone|mesh-list
20237332|NCT00391157|Bortezomib|bortezomib|mesh-list
20237333|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237334|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
20237335|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
20237336|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237337|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237338|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237339|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
20237340|NCT00391157|Hormones|hormones|mesh-ancestor
19413843|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19698823|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
19698824|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
19698825|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698826|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698827|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19698828|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
19698829|NCT04909918|Hormones|hormones|mesh-ancestor
20237341|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237342|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20237343|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237344|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20237345|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237346|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20237347|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237348|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237349|NCT00391261|Metformin|metformin|mesh-list
20237350|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20237351|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237352|NCT00391313|Chloroquine|chloroquine|mesh-list
20237353|NCT00391313|Amebicides|amebicides|mesh-ancestor
20481545|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481546|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20481547|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20481548|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20481549|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481550|NCT01542879|Hematinics|hematinics|mesh-ancestor
20481551|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20481552|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20481553|NCT01542918|Rituximab|rituximab|mesh-list
20481554|NCT01542918|Lenalidomide|lenalidomide|mesh-list
20481555|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20481556|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481557|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
20481558|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481559|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481560|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20481561|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20481562|NCT01542918|Growth Substances|growth substances|mesh-ancestor
20481563|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
20481564|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20481565|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
20481566|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481567|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20481568|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20481569|NCT01543139|Valproic Acid|valproic acid|mesh-list
20481570|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
20481571|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481572|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481573|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
20481574|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481575|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481576|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
20481577|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20481578|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481579|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481580|NCT01543165|Ketorolac|ketorolac|mesh-list
20481581|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20481582|NCT01543165|Morphine|morphine|mesh-list
20237354|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20237355|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19698830|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698831|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19698832|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237356|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237357|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
20237358|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237359|NCT00391404|Alendronate|alendronate|mesh-list
20237360|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20237361|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237362|NCT00391417|Estradiol|estradiol|mesh-list
20237363|NCT00391417|Estrogens|estrogens|mesh-ancestor
20237364|NCT00391417|Hormones|hormones|mesh-ancestor
20237365|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237366|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237367|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
20237368|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
20237369|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20237370|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20237371|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20237372|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237373|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20237374|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20237375|NCT00391638|Interferons|interferons|mesh-list
20237376|NCT00391638|Tenofovir|tenofovir|mesh-list
20237377|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20237378|NCT00391638|Emtricitabine|emtricitabine|mesh-list
20237379|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20237380|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237381|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
20237382|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481583|NCT01543165|Analgesics|analgesics|mesh-list
20481584|NCT01543165|Nefopam|nefopam|mesh-list
20481585|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20481586|NCT01543165|Narcotics|narcotics|mesh-ancestor
20481587|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481588|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481589|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
20481590|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237383|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20237384|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20237385|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237386|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237387|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20237388|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20237389|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
20237390|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20237391|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237392|NCT00391651|Renal Agents|renal agents|mesh-ancestor
20237393|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237394|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
20237395|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20237396|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237397|NCT00391885|Anesthetics|anesthetics|mesh-list
20237398|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237399|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237400|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
20237401|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20237402|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
20237403|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237404|NCT00391911|Expectorants|expectorants|mesh-ancestor
20237405|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
20237406|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20237407|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
20237408|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237409|NCT00391911|Protective Agents|protective agents|mesh-ancestor
20237410|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237411|NCT00391911|Antidotes|antidotes|mesh-ancestor
20237412|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20237413|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20237414|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
20237415|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237416|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
20237417|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20237418|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237419|NCT00392002|Esomeprazole|esomeprazole|mesh-list
20237420|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20237421|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237422|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20237423|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237424|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413844|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237425|NCT00392028|Ertapenem|ertapenem|mesh-list
20237426|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237427|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237428|NCT00392067|Calcipotriene|calcipotriene|mesh-list
20237429|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
20237430|NCT00392080|Naproxen|naproxen|mesh-list
20237431|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20237432|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20237433|NCT00392080|Analgesics|analgesics|mesh-ancestor
20237434|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
20237435|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237436|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237437|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237438|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237439|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
20237440|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20237441|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237442|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237443|NCT00392093|Estrogens|estrogens|mesh-list
20237444|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20237445|NCT00392093|Hormones|hormones|mesh-ancestor
20237446|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237447|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237448|NCT00392106|Amiodarone|amiodarone|mesh-list
20237449|NCT00392106|Flecainide|flecainide|mesh-list
20237450|NCT00392106|Propafenone|propafenone|mesh-list
20237451|NCT00392106|Dofetilide|dofetilide|mesh-list
20237452|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20237453|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
20237454|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20237455|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20237456|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237457|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20237458|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20237459|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20237460|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237461|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20237462|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20237463|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20237464|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20237465|NCT00392158|Anesthetics|anesthetics|mesh-list
20237466|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237467|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237468|NCT00392262|Amlodipine|amlodipine|mesh-list
20237469|NCT00392262|Valsartan|valsartan|mesh-list
20237470|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20237471|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20237472|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20237473|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237474|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20237475|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237476|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
20237477|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20237478|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20237479|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
20237480|NCT00392275|Levofloxacin|levofloxacin|mesh-list
20237481|NCT00392275|Ofloxacin|ofloxacin|mesh-list
20237482|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237483|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237484|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20237485|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20237486|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237487|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237488|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237489|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20237490|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20237491|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20237492|NCT00392275|Renal Agents|renal agents|mesh-ancestor
20237493|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
20237494|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
20237495|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237496|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
20237497|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237498|NCT00392340|Doxorubicin|doxorubicin|mesh-list
20237499|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20237500|NCT00392340|Vincristine|vincristine|mesh-list
20237501|NCT00392340|Topotecan|topotecan|mesh-list
20237502|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20237503|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237504|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20237505|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20237506|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237507|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237508|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20237509|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237510|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
20237511|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237512|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20247810|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247811|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20247812|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20247813|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
20247814|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247815|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20247816|NCT00433576|Resveratrol|resveratrol|mesh-list
20247817|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
20247818|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247819|NCT00433576|Protective Agents|protective agents|mesh-ancestor
20247820|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247821|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247822|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20247823|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
20247824|NCT00433615|Hematinics|hematinics|mesh-ancestor
20247825|NCT00433641|Sibutramine|sibutramine|mesh-list
20247826|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
20247827|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20247828|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
20247829|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20247830|NCT00433719|Efavirenz|efavirenz|mesh-list
20247831|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20247832|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20247833|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20247834|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527815|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527816|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20527817|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
20527818|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
20527819|NCT01769898|Hormones|hormones|mesh-ancestor
20527820|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20527821|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20237513|NCT00392418|Micronutrients|micronutrients|mesh-list
20237514|NCT00392418|Trace Elements|trace elements|mesh-list
20237515|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237516|NCT00392431|Amiodarone|amiodarone|mesh-list
20237517|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20237518|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
20237519|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20237520|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20237521|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237522|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20237523|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20237524|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20237525|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237526|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20237527|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20237528|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20237529|NCT00392457|Ketoconazole|ketoconazole|mesh-list
20237530|NCT00392457|Hormones|hormones|mesh-list
20237531|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237532|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237533|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
20237534|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237535|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20237536|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20237537|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237538|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237539|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20237540|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
20237541|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20237542|NCT00392470|Irinotecan|irinotecan|mesh-list
20237543|NCT00392470|Cetuximab|cetuximab|mesh-list
20237544|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20237545|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20237546|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237547|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237548|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237549|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237550|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
20237551|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20237552|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
20237553|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
20237554|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237555|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237556|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20237557|NCT00392522|Analgesics|analgesics|mesh-ancestor
20237558|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
20237559|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237560|NCT00392561|Vitamin E|vitamin e|mesh-list
20237561|NCT00392561|Selenium|selenium|mesh-list
20237562|NCT00392561|Vitamins|vitamins|mesh-ancestor
20237563|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
20237564|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237565|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
20237566|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237567|NCT00392561|Protective Agents|protective agents|mesh-ancestor
20237568|NCT00392561|Trace Elements|trace elements|mesh-ancestor
20237569|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20237570|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20237571|NCT00392652|Protective Agents|protective agents|mesh-ancestor
20237572|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237573|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237574|NCT00392691|Rituximab|rituximab|mesh-list
20237575|NCT00392691|Melphalan|melphalan|mesh-list
20237576|NCT00392691|Vinorelbine|vinorelbine|mesh-list
20237577|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237578|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237579|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
19698833|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19698834|NCT04909918|Protective Agents|protective agents|mesh-ancestor
19698835|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
20237580|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237581|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237582|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20237583|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
20237584|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237585|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20237586|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237587|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20237588|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237589|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
20481591|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20481592|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481593|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481594|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481595|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20481596|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481597|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481598|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
20481599|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20481600|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20481601|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481602|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481603|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
20481604|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481605|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481606|NCT01543347|Temocillin|temocillin|mesh-list
20481607|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20481608|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481609|NCT01543386|Curcumin|curcumin|mesh-list
20481610|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20481611|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481612|NCT01543386|Analgesics|analgesics|mesh-ancestor
20481613|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
20481614|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481615|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481616|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481617|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481618|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481619|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481620|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481621|NCT01543399|Tibolone|tibolone|mesh-list
20481622|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
20481623|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
20481624|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481625|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481626|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481627|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20481628|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481629|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20481630|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
20481631|NCT01543399|Hormones|hormones|mesh-ancestor
20481632|NCT01543464|Temozolomide|temozolomide|mesh-list
20481633|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20481634|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
20481635|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481636|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481637|NCT01543555|Atorvastatin|atorvastatin|mesh-list
20481638|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20481639|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20481640|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
20481641|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481642|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20481643|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20481644|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481645|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
20481646|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
20481647|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481648|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481649|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481650|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
20481651|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20481652|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481653|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481654|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
20481655|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20481656|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
20481657|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481658|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
20237590|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237591|NCT00392717|Atorvastatin|atorvastatin|mesh-list
20237592|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20237593|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20237594|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
20237595|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237596|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20237597|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20237598|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237599|NCT00392756|Hormones|hormones|mesh-list
20237600|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237601|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237602|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
20237603|NCT00392886|Temozolomide|temozolomide|mesh-list
19852168|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852169|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237604|NCT00392886|Thiotepa|thiotepa|mesh-list
20237605|NCT00392886|Carboplatin|carboplatin|mesh-list
20237606|NCT00392886|Methotrexate|methotrexate|mesh-list
20237607|NCT00392886|Etoposide|etoposide|mesh-list
20237608|NCT00392886|Vincristine|vincristine|mesh-list
20237609|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237610|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
20237611|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237612|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237613|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20237614|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
20237615|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481659|NCT01543737|Protective Agents|protective agents|mesh-ancestor
20481660|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
20481661|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20481662|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481663|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481664|NCT01543763|Abexinostat|abexinostat|mesh-list
20237616|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237617|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20481665|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20237618|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20237619|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
20237620|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20237621|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20237622|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
20237623|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
20237624|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237625|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20237626|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20237627|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20237628|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20237629|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20237630|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237631|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
20237632|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237633|NCT00392899|Tegafur|tegafur|mesh-list
20237634|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20481666|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481667|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527822|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20527823|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20527824|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
20527825|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527826|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527827|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20527828|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527829|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
20527830|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20527831|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20527832|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
20527833|NCT01769911|Cytarabine|cytarabine|mesh-list
20527834|NCT01769911|Etoposide|etoposide|mesh-list
20527835|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
20237635|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
20237636|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237637|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527836|NCT01769911|Melphalan|melphalan|mesh-list
20481668|NCT01543906|Retinol acetate|retinol acetate|mesh-list
20481669|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20481670|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
20481671|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481672|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20481673|NCT01543906|Protective Agents|protective agents|mesh-ancestor
20481674|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237638|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
20237639|NCT00392912|Testosterone|testosterone|mesh-list
20237640|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
20237641|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
20237642|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20237643|NCT00392912|Androgens|androgens|mesh-ancestor
20237644|NCT00392912|Hormones|hormones|mesh-ancestor
20237645|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237646|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237647|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20237648|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481675|NCT01543932|Clopidogrel|clopidogrel|mesh-list
20481676|NCT01543932|Ticagrelor|ticagrelor|mesh-list
20237649|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
20237650|NCT00392938|Docetaxel|docetaxel|mesh-list
20237651|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
20237652|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237653|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237654|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
20237655|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237656|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237657|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
20237658|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237659|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237660|NCT00393003|Anesthetics|anesthetics|mesh-list
20237661|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237662|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237663|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
20237664|NCT00393107|Rituximab|rituximab|mesh-list
20237665|NCT00393107|Fludarabine|fludarabine|mesh-list
20237666|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237667|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
20237668|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237669|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237670|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20237671|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
20237672|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237673|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237674|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20237675|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237676|NCT00393198|Misoprostol|misoprostol|mesh-list
20237677|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
20237678|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20237679|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
20237680|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20237681|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237682|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20237683|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20237684|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20237685|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20237686|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
20237687|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20237688|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237689|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
20237690|NCT00393263|Clobetasol|clobetasol|mesh-list
20237691|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
20237692|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237693|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
20237694|NCT00393263|Hormones|hormones|mesh-ancestor
20237695|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237696|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237697|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20237698|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20237699|NCT00393263|Analgesics|analgesics|mesh-ancestor
20481677|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20481678|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20481679|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20481680|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20481681|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20481682|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
20481683|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852170|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19852171|NCT00723255|Growth Substances|growth substances|mesh-ancestor
20481684|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852172|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481685|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481686|NCT01543945|Dexamethasone|dexamethasone|mesh-list
20481687|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
20481688|NCT01543945|Ondansetron|ondansetron|mesh-list
20481689|NCT01543945|Antiemetics|antiemetics|mesh-list
20481690|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
20481691|NCT01543945|BB 1101|bb 1101|mesh-list
20481692|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237700|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
20237701|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237702|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237703|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
20237704|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237705|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
20237706|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20237707|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237708|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237709|NCT00393289|Calcium|calcium|mesh-list
20237710|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20237711|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237712|NCT00393315|Paclitaxel|paclitaxel|mesh-list
20237713|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20237714|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237715|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237716|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
20237717|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237718|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237719|NCT00393328|Ritonavir|ritonavir|mesh-list
20237720|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20237721|NCT00393328|Aripiprazole|aripiprazole|mesh-list
19852173|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852174|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
19852175|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19852176|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852177|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19852178|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
19852179|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19852180|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19852181|NCT00723398|Pitavastatin|pitavastatin|mesh-list
19852182|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19852183|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20237722|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20237723|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20237724|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
20237725|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237726|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237727|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20237728|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19852184|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19852185|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
20237729|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
20237730|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237731|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19852186|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852187|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237732|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20237733|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
20237734|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20237735|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20237736|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20237737|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237738|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237739|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
20237740|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
20237741|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237742|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20237743|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20237744|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
20237745|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20237746|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20237747|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20237748|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20237749|NCT00393393|Hylan|hylan|mesh-list
20237750|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
20237751|NCT00393393|Protective Agents|protective agents|mesh-ancestor
20237752|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237753|NCT00393445|Glucagon|glucagon|mesh-list
20237754|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20237755|NCT00393445|Incretins|incretins|mesh-ancestor
20237756|NCT00393445|Hormones|hormones|mesh-ancestor
20237757|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237758|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237759|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237760|NCT00393471|Etanercept|etanercept|mesh-list
20237761|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20237762|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20237763|NCT00393471|Analgesics|analgesics|mesh-ancestor
20237764|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
20237765|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237766|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237767|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237768|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20237769|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237770|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20237771|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
20237772|NCT00393497|Bevacizumab|bevacizumab|mesh-list
20237773|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19852188|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20237774|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237775|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237776|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20237777|NCT00393497|Growth Substances|growth substances|mesh-ancestor
20237778|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237779|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
20237780|NCT00393562|Methylphenidate|methylphenidate|mesh-list
20237781|NCT00393562|Modafinil|modafinil|mesh-list
20237782|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20237783|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237784|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20237785|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20237786|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20237787|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237788|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
20237789|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237790|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20237791|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20237792|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20237793|NCT00393614|Levetiracetam|levetiracetam|mesh-list
20237794|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
20237795|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
20237796|NCT00393679|Artesunate|artesunate|mesh-list
20237797|NCT00393679|Lumefantrine|lumefantrine|mesh-list
20237798|NCT00393679|Artemether|artemether|mesh-list
20237799|NCT00393679|Piperaquine|piperaquine|mesh-list
20237800|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20237801|NCT00393679|Amodiaquine|amodiaquine|mesh-list
20237802|NCT00393679|Artenimol|artenimol|mesh-list
20237803|NCT00393679|Dapsone|dapsone|mesh-list
20237804|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
20237805|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
20237806|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20237807|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19698836|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19698837|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698838|NCT04909619|Anesthetics|anesthetics|mesh-list
19698839|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
19698840|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237808|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237809|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237810|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
20237811|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
20237812|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20237813|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
20237814|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20237815|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237816|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698841|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237817|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
19698842|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
20237818|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237819|NCT00393731|Misoprostol|misoprostol|mesh-list
19852189|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20237820|NCT00393731|Oxytocin|oxytocin|mesh-list
20481693|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
20481694|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481695|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481696|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20481697|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
20481698|NCT01543945|Hormones|hormones|mesh-ancestor
20481699|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481700|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20481701|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481702|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
20481703|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481704|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481705|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
20481706|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
20481707|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20481708|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
20481709|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237821|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
20237822|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20237823|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237824|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20237825|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
20237826|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20237827|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20237828|NCT00393744|Amoxicillin|amoxicillin|mesh-list
20237829|NCT00393744|Pristinamycin|pristinamycin|mesh-list
20237830|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237831|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237832|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
20237833|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
20237834|NCT00393770|Vitamins|vitamins|mesh-ancestor
20237835|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
20237836|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237837|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
20237838|NCT00393783|Trastuzumab|trastuzumab|mesh-list
20237839|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237840|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237841|NCT00393835|Azithromycin|azithromycin|mesh-list
20237842|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20237843|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237844|NCT00394056|Paroxetine|paroxetine|mesh-list
20237845|NCT00394056|Vestipitant|vestipitant|mesh-list
20237846|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20237847|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20237848|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20237849|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237850|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237851|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
20237852|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413845|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413846|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19698843|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237853|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20237854|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
20237855|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481710|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20481711|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20481712|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481713|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481714|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20481715|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20481716|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
20237856|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20237857|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20237858|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237859|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20481717|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
20481718|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20481719|NCT01543971|Lenograstim|lenograstim|mesh-list
20481720|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20481721|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
20481722|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237860|NCT00394147|Gemcitabine|gemcitabine|mesh-list
20237861|NCT00394147|Pemetrexed|pemetrexed|mesh-list
20237862|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19698844|NCT04909775|Gemcitabine|gemcitabine|mesh-list
19698845|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698846|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20237863|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
20237864|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237865|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237866|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
20237867|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237868|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237869|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20481723|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481724|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
20481725|NCT01544075|Vaccines|vaccines|mesh-list
20481726|NCT01544075|Immunologic Factors|immunologic factors|mesh-ancestor
20481727|NCT01544075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481728|NCT01544140|Midazolam|midazolam|mesh-list
19698847|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
19698848|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481729|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20481730|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19698849|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
19698850|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698851|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698852|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698853|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
20237870|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
20237871|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698854|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698855|NCT04909333|Exenatide|exenatide|mesh-list
20237872|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20237873|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20237874|NCT00394186|Solabegron|solabegron|mesh-list
20237875|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20237876|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20237877|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20237878|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
20237879|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237880|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237881|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237882|NCT00394303|Insulin|insulin|mesh-list
20237883|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20237884|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237885|NCT00394368|Fluticasone|fluticasone|mesh-list
20237886|NCT00394368|Xhance|xhance|mesh-list
20237887|NCT00394368|Beclomethasone|beclomethasone|mesh-list
20237888|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
20237889|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20237890|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237891|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20481731|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481732|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481733|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20481734|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20481735|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481736|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20481737|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
20481738|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
19698856|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19698857|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20237892|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
20237893|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237894|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237895|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20237896|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
20237897|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
20237898|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20237899|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20237900|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20237901|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20237902|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
20237903|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237904|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237905|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
20237906|NCT00394368|Hormones|hormones|mesh-ancestor
20237907|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20237908|NCT00394394|Enalapril|enalapril|mesh-list
20237909|NCT00394394|Amiloride|amiloride|mesh-list
20237910|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20237911|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
20237912|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237913|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237914|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20237915|NCT00394394|Diuretics|diuretics|mesh-ancestor
20237916|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
20237917|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237918|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20237919|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20237920|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20237921|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20237922|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20237923|NCT00394407|Insulin|insulin|mesh-list
20237924|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19698858|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698859|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19698860|NCT04909333|Incretins|incretins|mesh-ancestor
19698861|NCT04909333|Hormones|hormones|mesh-ancestor
20237925|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481739|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
20481740|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
20481741|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481742|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481743|NCT01544192|Tocopherols|tocopherols|mesh-list
20481744|NCT01544192|Vitamin E|vitamin e|mesh-list
20481745|NCT01544192|Tocotrienols|tocotrienols|mesh-list
20481746|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
20481747|NCT01544192|Antioxidants|antioxidants|mesh-list
20237926|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852190|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
20481748|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481749|NCT01544192|Protective Agents|protective agents|mesh-ancestor
20481750|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481751|NCT01544192|Vitamins|vitamins|mesh-ancestor
20481752|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
20481753|NCT01544283|Triamcinolone|triamcinolone|mesh-list
20481754|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20481755|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20481756|NCT01544283|Lidocaine|lidocaine|mesh-list
20481757|NCT01544283|Tetracaine|tetracaine|mesh-list
20237927|NCT00394459|Anesthetics|anesthetics|mesh-list
20237928|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237929|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237930|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
20237931|NCT00394485|Procaterol|procaterol|mesh-list
20237932|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20237933|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
20237934|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237935|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237936|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20237937|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
20237938|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
20237939|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20237940|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
20237941|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237942|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237943|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
20237944|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20237945|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19852191|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852192|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852193|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20237946|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20481758|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20481759|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
20481760|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
20237947|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
19698862|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698863|NCT04908982|Aspirin|aspirin|mesh-list
19698864|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20237948|NCT00394498|Sargramostim|sargramostim|mesh-list
20237949|NCT00394498|Lenograstim|lenograstim|mesh-list
20237950|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
20237951|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237952|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20237953|NCT00394537|Labetalol|labetalol|mesh-list
20237954|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20237955|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19698865|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19698866|NCT04908982|Analgesics|analgesics|mesh-ancestor
19698867|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
20237956|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
20237957|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237958|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237959|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237960|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20237961|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
20237962|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
20237963|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20237964|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20237965|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20237966|NCT00394628|Temozolomide|temozolomide|mesh-list
19698868|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698869|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237967|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20237968|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
20237969|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237970|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237971|NCT00394693|Interferons|interferons|mesh-list
20237972|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
20237973|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237974|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
20237975|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20237976|NCT00394745|Valsartan|valsartan|mesh-list
20481761|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20237977|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481762|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481763|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
20481764|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481765|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20481766|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20481767|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20481768|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20481769|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481770|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481771|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
20481772|NCT01544283|Hormones|hormones|mesh-ancestor
20481773|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481774|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20481775|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
20481776|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481777|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
20527837|NCT01769911|Carmustine|carmustine|mesh-list
20527838|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
20527839|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20527840|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527841|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20527842|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20527843|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527844|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527845|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20527846|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
20527847|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
20527848|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527849|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527850|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
20527851|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527852|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20527853|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
20527854|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20527855|NCT01769950|Choline|choline|mesh-list
20527856|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
20527857|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20527858|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
20527859|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527860|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527861|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20527862|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
20527863|NCT01770041|Acetaminophen|acetaminophen|mesh-list
20527864|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19698870|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20237978|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20237979|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20237980|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698871|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413847|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413848|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237981|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
19413849|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413850|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413851|NCT03896009|Meloxicam|meloxicam|mesh-list
19698872|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19698873|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19698874|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698875|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19698876|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19698877|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20237982|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237983|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20237984|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20237985|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20237986|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20237987|NCT00394966|Rolapitant|rolapitant|mesh-list
20237988|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20237989|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20237990|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481778|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481779|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
20481780|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
20481781|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20481782|NCT01544504|Norepinephrine|norepinephrine|mesh-list
20481783|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20481784|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20481785|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
20481786|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481787|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481788|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20237991|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698878|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
19698879|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
19698880|NCT04909255|Mirabegron|mirabegron|mesh-list
19698881|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20237992|NCT00394992|Bevacizumab|bevacizumab|mesh-list
20237993|NCT00394992|Capecitabine|capecitabine|mesh-list
20237994|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
20237995|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20237996|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20237997|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20237998|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19698882|NCT04909255|Oxybutynin|oxybutynin|mesh-list
20237999|NCT00394992|Growth Substances|growth substances|mesh-ancestor
19698883|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19698884|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19698885|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
19698886|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698887|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698888|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698889|NCT04909255|Urological Agents|urological agents|mesh-ancestor
20238000|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238001|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
20238002|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238003|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
20238004|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238005|NCT00395031|Ziprasidone|ziprasidone|mesh-list
20238006|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20238007|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
20238008|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238009|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238010|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238011|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20238012|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20238013|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238014|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238015|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20238016|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
20238017|NCT00395070|Temozolomide|temozolomide|mesh-list
20238018|NCT00395070|Dacarbazine|dacarbazine|mesh-list
20238019|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20238020|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
20238021|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238022|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238023|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
20238024|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
20238025|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698890|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19698891|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19698892|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20238026|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
20238027|NCT00395213|Norepinephrine|norepinephrine|mesh-list
20238028|NCT00395213|Serotonin|serotonin|mesh-list
20238029|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20238030|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20238031|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20238032|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
20238033|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238034|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238035|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238036|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
20238037|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
20238038|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238039|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20238040|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20238041|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
20238042|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20238043|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238044|NCT00395239|Budesonide|budesonide|mesh-list
20238045|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20238046|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20238047|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
20238048|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238049|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238050|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20238051|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
20238052|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
20238053|NCT00395239|Hormones|hormones|mesh-ancestor
20238054|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238055|NCT00395252|Gemcitabine|gemcitabine|mesh-list
20238056|NCT00395252|Cetuximab|cetuximab|mesh-list
20238057|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238058|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
20238059|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238060|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238061|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
20238062|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238063|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238064|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238065|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
20238066|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238067|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238068|NCT00395369|Aprotinin|aprotinin|mesh-list
20238069|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
20238070|NCT00395369|Coagulants|coagulants|mesh-ancestor
20238071|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20238072|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20238073|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238074|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238075|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238076|NCT00395382|Alendronate|alendronate|mesh-list
20238077|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20238078|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238079|NCT00395395|Calcitonin|calcitonin|mesh-list
20238080|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
20238081|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19413852|NCT03896009|Rizatriptan|rizatriptan|mesh-list
20238082|NCT00395395|Katacalcin|katacalcin|mesh-list
20238083|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20238084|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238085|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20238086|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
20238087|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20238088|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
20238089|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238090|NCT00395434|Bevacizumab|bevacizumab|mesh-list
20238091|NCT00395434|Combretastatin|combretastatin|mesh-list
20238092|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
20238093|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238094|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238095|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20238096|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20238097|NCT00395434|Growth Substances|growth substances|mesh-ancestor
20238098|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238099|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
20238100|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20238101|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
20238102|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
20238103|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
20238104|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238105|NCT00395499|Risperidone|risperidone|mesh-list
20238106|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20238107|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
20238108|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238109|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238110|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238111|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20238112|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20238113|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238114|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238115|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19852194|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19852195|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19852196|NCT00723450|Lamotrigine|lamotrigine|mesh-list
19852197|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
19852198|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19852199|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19852200|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852201|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19852202|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852203|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19852204|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19852205|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852206|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238116|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
20238117|NCT00395551|Ranibizumab|ranibizumab|mesh-list
20238118|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20238119|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20238120|NCT00395551|Growth Substances|growth substances|mesh-ancestor
20238121|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238122|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
20238123|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238124|NCT00395655|Hydralazine|hydralazine|mesh-list
20238125|NCT00395655|Valproic Acid|valproic acid|mesh-list
20238126|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
20238127|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852207|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20238128|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238129|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
20238130|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238131|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238132|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
20238133|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20238134|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238135|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238136|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20238137|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
20238138|NCT00395681|Propofol|propofol|mesh-list
20238139|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20238140|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238141|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238142|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20238143|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
20238144|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
20238145|NCT00395707|Ranibizumab|ranibizumab|mesh-list
20238146|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20238147|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20238148|NCT00395707|Growth Substances|growth substances|mesh-ancestor
20238149|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238150|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
20238151|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238152|NCT00395720|Vaccines|vaccines|mesh-list
20238153|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
20238154|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238155|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
20238156|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20238157|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20238158|NCT00395772|Vitamin K|vitamin k|mesh-list
20238159|NCT00395772|Heparin|heparin|mesh-list
20238160|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
20238161|NCT00395772|Vitamins|vitamins|mesh-ancestor
20238162|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
19413853|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413854|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413855|NCT03896009|Analgesics|analgesics|mesh-ancestor
19413856|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
19413857|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413858|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413859|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413860|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413861|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19413862|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19698893|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
19698894|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
19698895|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
19698896|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698897|NCT04909151|Methamphetamine|methamphetamine|mesh-list
19698898|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19698899|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698900|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
19698901|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
19698902|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698903|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
19698904|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698905|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698906|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
19698907|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19698908|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19698909|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19698910|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19698911|NCT04908865|Belimumab|belimumab|mesh-list
19698912|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19698913|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
19698914|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698915|NCT04908566|Folfirinox|folfirinox|mesh-list
19698916|NCT04908566|Antibodies|antibodies|mesh-list
19698917|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
19698918|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
19698919|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698920|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698921|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
20238163|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413863|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238164|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
20238165|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20238166|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20238167|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238168|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20238169|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
20238170|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20238171|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238172|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238173|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20238174|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
20238175|NCT00395772|Coagulants|coagulants|mesh-ancestor
20238176|NCT00395902|Cinacalcet|cinacalcet|mesh-list
20238177|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20238178|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238179|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20238180|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
20238181|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238182|NCT00395915|Aripiprazole|aripiprazole|mesh-list
20238183|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
20238184|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238185|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20238186|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20238187|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238188|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238189|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
20238190|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
20238191|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238192|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238193|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20238194|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19698922|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
19698923|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19698924|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19698925|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698926|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698927|NCT04908657|Urological Agents|urological agents|mesh-ancestor
19413864|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413865|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19413866|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
19413867|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19698928|NCT04908813|Capecitabine|capecitabine|mesh-list
19698929|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
19698930|NCT04908813|Trastuzumab|trastuzumab|mesh-list
19698931|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19698932|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
19698933|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698934|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19698935|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238195|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
20238196|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20238197|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20238198|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20238199|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20238200|NCT00395941|Pioglitazone|pioglitazone|mesh-list
20481789|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
20481790|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
20481791|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481792|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20481793|NCT01544517|Amoxicillin|amoxicillin|mesh-list
20481794|NCT01544517|Levofloxacin|levofloxacin|mesh-list
20238201|NCT00395941|Acitretin|acitretin|mesh-list
20238202|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238203|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238204|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
20481795|NCT01544517|Ofloxacin|ofloxacin|mesh-list
19413868|NCT03888378|Minocycline|minocycline|mesh-list
19413869|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20481796|NCT01544517|Tinidazole|tinidazole|mesh-list
20481797|NCT01544517|Esomeprazole|esomeprazole|mesh-list
20481798|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20481799|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20481800|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481801|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20481802|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20481803|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481804|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481805|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20481806|NCT01544517|Renal Agents|renal agents|mesh-ancestor
20481807|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20481808|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20481809|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413870|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413871|NCT03881852|Reboxetine|reboxetine|mesh-list
20481810|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20238205|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
19413872|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
20527865|NCT01770041|Analgesics|analgesics|mesh-ancestor
19413873|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19413874|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20481811|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20481812|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
20481813|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20481814|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20481815|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20481816|NCT01544634|Beclomethasone|beclomethasone|mesh-list
20481817|NCT01544634|Propranolol|propranolol|mesh-list
20481818|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20481819|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20481820|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
20238206|NCT00396045|Lenalidomide|lenalidomide|mesh-list
20238207|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
20238208|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238209|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20238210|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20238211|NCT00396045|Growth Substances|growth substances|mesh-ancestor
20238212|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
20238213|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238214|NCT00396058|Methylphenidate|methylphenidate|mesh-list
20238215|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20238216|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238217|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20238218|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20238219|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238220|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238221|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
20238222|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238223|NCT00396071|Vildagliptin|vildagliptin|mesh-list
20238224|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238225|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238226|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20238227|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238228|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238229|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698936|NCT04908345|Fentanyl|fentanyl|mesh-list
19698937|NCT04908345|Methadone|methadone|mesh-list
19698938|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19698939|NCT04908345|Narcotics|narcotics|mesh-ancestor
19698940|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698941|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698942|NCT04908345|Analgesics|analgesics|mesh-ancestor
20238230|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20238231|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
20238232|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238233|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20238234|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20238235|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19698943|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
20238236|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238237|NCT00396227|Pioglitazone|pioglitazone|mesh-list
20238238|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
20238239|NCT00396227|Vildagliptin|vildagliptin|mesh-list
20238240|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20238241|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238242|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238243|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20238244|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238245|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238246|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238247|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20238248|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20238249|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20238250|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
20238251|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238252|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20238253|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20238254|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238255|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
20238256|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20238257|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20238258|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20238259|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20238260|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
20238261|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20238262|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
20238263|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238264|NCT00396396|Expectorants|expectorants|mesh-ancestor
20238265|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
20238266|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20238267|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
20238268|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238269|NCT00396396|Protective Agents|protective agents|mesh-ancestor
20238270|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238271|NCT00396396|Antidotes|antidotes|mesh-ancestor
20238272|NCT00396487|Fluorouracil|fluorouracil|mesh-list
20238273|NCT00396487|Capecitabine|capecitabine|mesh-list
20238274|NCT00396487|Irinotecan|irinotecan|mesh-list
20238275|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
20238276|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238277|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238278|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481821|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481822|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481823|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481824|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20481825|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20481826|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
20481827|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481828|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
20481829|NCT01544634|Hormones|hormones|mesh-ancestor
20481830|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481831|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19852208|NCT00723528|Ustekinumab|ustekinumab|mesh-list
20238279|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238280|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
20238281|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238282|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20238283|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20238284|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238285|NCT00396500|Vitamin A|vitamin a|mesh-list
20238286|NCT00396500|Albendazole|albendazole|mesh-list
20238287|NCT00396500|Vitamins|vitamins|mesh-ancestor
20238288|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
20238289|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238290|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238291|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238292|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
20238293|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20238294|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238295|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
20238296|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20238297|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20238298|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
20238299|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
20238300|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
20238301|NCT00396513|Metformin|metformin|mesh-list
19852209|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
19852210|NCT00723554|Iloprost|iloprost|mesh-list
19852211|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19852212|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
19852213|NCT00723580|Risperidone|risperidone|mesh-list
19852214|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19852215|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
19852216|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852217|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852218|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852219|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19852220|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19852221|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852222|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19852223|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19852224|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
19852225|NCT00723606|Haloperidol|haloperidol|mesh-list
19852226|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
19852227|NCT00723606|Ziprasidone|ziprasidone|mesh-list
19852228|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
19852229|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
19852230|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852231|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852232|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20238302|NCT00396513|Simvastatin|simvastatin|mesh-list
20238303|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238304|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238305|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20238306|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20238307|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
20238308|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238309|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20238310|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20238311|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238312|NCT00396526|Amoxicillin|amoxicillin|mesh-list
20238313|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20481832|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
20481833|NCT01544673|Linezolid|linezolid|mesh-list
20481834|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20481835|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20481836|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20481837|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481838|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481839|NCT01544725|Ketamine|ketamine|mesh-list
19852233|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20481840|NCT01544725|Propofol|propofol|mesh-list
20238314|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238315|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238316|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20238317|NCT00396526|Renal Agents|renal agents|mesh-ancestor
20238318|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
20238319|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20238320|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20238321|NCT00396578|Vancomycin|vancomycin|mesh-list
20238322|NCT00396578|Gentamicins|gentamicins|mesh-list
20238323|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238324|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238325|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20238326|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238327|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238328|NCT00396604|Maleic acid|maleic acid|mesh-list
20238329|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238330|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238331|NCT00396669|Bupropion|bupropion|mesh-list
20238332|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20481841|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20481842|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481843|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481844|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20481845|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
20481846|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
20481847|NCT01544725|Analgesics|analgesics|mesh-ancestor
20481848|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
20481849|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481850|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20481851|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20481852|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20481853|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481854|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481855|NCT01544751|Metformin|metformin|mesh-list
20481856|NCT01544751|Atorvastatin|atorvastatin|mesh-list
20238333|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
19413875|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19413876|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413877|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698944|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238334|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20481857|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481858|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238335|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20238336|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20238337|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238338|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238339|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
20238340|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238341|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238342|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20481859|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20481860|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20481861|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
20481862|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481863|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20481864|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20481865|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481866|NCT01544829|Theobromine|theobromine|mesh-list
20481867|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20481868|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
20481869|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413878|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
20238343|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20238344|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247835|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247836|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
20247837|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247838|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20247839|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20247840|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20247841|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20247842|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20247843|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20247844|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20247845|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20247846|NCT00433732|Naproxen|naproxen|mesh-list
20247847|NCT00433732|Sumatriptan|sumatriptan|mesh-list
20247848|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20247849|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20247850|NCT00433732|Analgesics|analgesics|mesh-ancestor
20247851|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
20247852|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247853|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247854|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247855|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247856|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
20247857|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20247858|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247859|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247860|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20247861|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20247862|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20247863|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
20247864|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247865|NCT00433784|Clopidogrel|clopidogrel|mesh-list
20247866|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20247867|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20247868|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20247869|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20247870|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
20247871|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247872|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247873|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247874|NCT00433823|Atorvastatin|atorvastatin|mesh-list
20247875|NCT00433823|Ezetimibe|ezetimibe|mesh-list
20247876|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20481870|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481871|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20481872|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
20481873|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
20481874|NCT01544842|Triamcinolone|triamcinolone|mesh-list
20481875|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20481876|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20481877|NCT01544842|Tacrolimus|tacrolimus|mesh-list
19413879|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413880|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413881|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19413882|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19413883|NCT03879408|Acetaminophen|acetaminophen|mesh-list
19413884|NCT03879408|Naproxen|naproxen|mesh-list
20247877|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20238345|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
20238346|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238347|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
20481878|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20481879|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20481880|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
20481881|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481882|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20238348|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238349|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238350|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20238351|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
20238352|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238353|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238354|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20238355|NCT00396721|Sirolimus|sirolimus|mesh-list
20238356|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20238357|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20238358|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238359|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238360|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20238361|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238362|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
20238363|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238364|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
20238365|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238366|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20238367|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20238368|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
20238369|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238370|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238371|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20238372|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238373|NCT00396734|Topiramate|topiramate|mesh-list
20238374|NCT00396734|Modafinil|modafinil|mesh-list
20238375|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
20238376|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238377|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238378|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20238379|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20238380|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20238381|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20238382|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852234|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20238383|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
20238384|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20238385|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20238386|NCT00396747|Prednisolone|prednisolone|mesh-list
20238387|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
20238388|NCT00396747|Methotrexate|methotrexate|mesh-list
20238389|NCT00396747|Infliximab|infliximab|mesh-list
20238390|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20238391|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
20238392|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20481883|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481884|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481885|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481886|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
20481887|NCT01544842|Hormones|hormones|mesh-ancestor
20238393|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
20238394|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20238395|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238396|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238397|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
20238398|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238399|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238400|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
20238401|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238402|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20238403|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238404|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
20238405|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238406|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20238407|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20238408|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
20238409|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
20238410|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238411|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20238412|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
20238413|NCT00396747|Hormones|hormones|mesh-ancestor
20238414|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238415|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20238416|NCT00396747|Protective Agents|protective agents|mesh-ancestor
20238417|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20238418|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
20238419|NCT00396760|Aprotinin|aprotinin|mesh-list
20238420|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20238421|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20238422|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238423|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
20238424|NCT00396760|Coagulants|coagulants|mesh-ancestor
20238425|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19413885|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20238426|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20238427|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238428|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238429|NCT00396786|Enoxaparin|enoxaparin|mesh-list
20238430|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
20238431|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20238432|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
20238433|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20238434|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238435|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238436|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413886|NCT03879408|Hydrocodone|hydrocodone|mesh-list
20238437|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
20238438|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20238439|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20238440|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
20238441|NCT00396799|Estrogens|estrogens|mesh-list
20238442|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20238443|NCT00396799|Hormones|hormones|mesh-ancestor
20238444|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238445|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238446|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20238447|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20238448|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
20238449|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19698945|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19698946|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19698947|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
19698948|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
19698949|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
19698950|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698951|NCT04907708|Metformin|metformin|mesh-list
19698952|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238450|NCT00396851|Metformin|metformin|mesh-list
19698953|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698954|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
19698955|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19698956|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19698957|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698958|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
19698959|NCT04907812|Coagulants|coagulants|mesh-ancestor
20238451|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238452|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238453|NCT00396929|Paclitaxel|paclitaxel|mesh-list
20238454|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20238455|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238456|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
20238457|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
20238458|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
20238459|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238460|NCT00396968|Plerixafor|plerixafor|mesh-list
20238461|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20238462|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20238463|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
20238464|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238465|NCT00397059|Citalopram|citalopram|mesh-list
20238466|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20238467|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20238468|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238469|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238470|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238471|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
20238472|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238473|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20238474|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
20238475|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238476|NCT00397072|Sagopilone|sagopilone|mesh-list
20238477|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238478|NCT00397098|Amibegron|amibegron|mesh-list
20238479|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20238480|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19698960|NCT04907864|Ibuprofen|ibuprofen|mesh-list
20238481|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
19413887|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19413888|NCT03879408|Analgesics|analgesics|mesh-ancestor
19413889|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
19852235|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852236|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19852237|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19852238|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
19852239|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238482|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238483|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238484|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238485|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20238486|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20238487|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20238488|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238489|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238490|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238491|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238492|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
20238493|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238494|NCT00397241|Timolol|timolol|mesh-list
20238495|NCT00397241|Dorzolamide|dorzolamide|mesh-list
20238496|NCT00397241|Latanoprost|latanoprost|mesh-list
20238497|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
20238498|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20238499|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20238500|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
20238501|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238502|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238503|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238504|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20238505|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20238506|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20481888|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481889|NCT01544881|Insulin|insulin|mesh-list
20481890|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481891|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481892|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20481893|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
20481894|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20481895|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
20481896|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481897|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481898|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20481899|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20481900|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20481901|NCT01544907|Paclitaxel|paclitaxel|mesh-list
20481902|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20481903|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481904|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
20481905|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
20481906|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
20481907|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481908|NCT01544959|Fentanyl|fentanyl|mesh-list
20481909|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20481910|NCT01544959|Esmolol|esmolol|mesh-list
20481911|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20481912|NCT01544959|Narcotics|narcotics|mesh-ancestor
20481913|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481914|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481915|NCT01544959|Analgesics|analgesics|mesh-ancestor
20481916|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
20481917|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481918|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20481919|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20481920|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
20481921|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
20481922|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20481923|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
20481924|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481925|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481926|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19698961|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20238507|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20238508|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20238509|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238510|NCT00397319|Hormones|hormones|mesh-list
20238511|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19698962|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19698963|NCT04907864|Analgesics|analgesics|mesh-ancestor
19698964|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
20238512|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238513|NCT00397332|Alefacept|alefacept|mesh-list
20238514|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
20238515|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
20238516|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238517|NCT00397358|Icodextrin|icodextrin|mesh-list
20238518|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
20238519|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19698965|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698966|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698967|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19698968|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852240|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238520|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20238521|NCT00397384|Cetuximab|cetuximab|mesh-list
20238522|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20238523|NCT00397384|Antibodies|antibodies|mesh-list
20238524|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
20238525|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20238526|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
20238527|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238528|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238529|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20238530|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238531|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238532|NCT00397423|Sargramostim|sargramostim|mesh-list
20238533|NCT00397423|Lenograstim|lenograstim|mesh-list
20238534|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
20238535|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481927|NCT01544972|Acetaminophen|acetaminophen|mesh-list
20481928|NCT01544972|Ibuprofen|ibuprofen|mesh-list
20481929|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20481930|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481931|NCT01544972|Analgesics|analgesics|mesh-ancestor
20481932|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
20481933|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481934|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481935|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20481936|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20481937|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20481938|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481939|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481940|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
20481941|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20481942|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20481943|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481944|NCT01545024|Incretins|incretins|mesh-ancestor
20481945|NCT01545024|Hormones|hormones|mesh-ancestor
20481946|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20481947|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20481948|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
20481949|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481950|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481951|NCT01545271|Xenon|xenon|mesh-list
20481952|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20481953|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
20481954|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
20481955|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481956|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481957|NCT01545284|Acitretin|acitretin|mesh-list
20481958|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
20481959|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
20481960|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
20481961|NCT01545297|Remifentanil|remifentanil|mesh-list
20481962|NCT01545297|Propofol|propofol|mesh-list
20481963|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20481964|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20481965|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481966|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20481967|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
19852241|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19852242|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19852243|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
19852244|NCT00723632|Ribavirin|ribavirin|mesh-list
19852245|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852246|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
19852247|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852248|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
19852249|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852250|NCT00723697|Buprenorphine|buprenorphine|mesh-list
19852251|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19852252|NCT00723697|Narcotics|narcotics|mesh-ancestor
19852253|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852254|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852255|NCT00723697|Analgesics|analgesics|mesh-ancestor
19852256|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
20481968|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
20481969|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20481970|NCT01545297|Analgesics|analgesics|mesh-ancestor
20481971|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
20481972|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20481973|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20238536|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20238537|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
20238538|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20238539|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238540|NCT00397475|Vitamins|vitamins|mesh-ancestor
20238541|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
20238542|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20238543|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
20238544|NCT00397501|Carboplatin|carboplatin|mesh-list
20238545|NCT00397501|Methotrexate|methotrexate|mesh-list
20238546|NCT00397501|Trastuzumab|trastuzumab|mesh-list
20238547|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238548|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20238549|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
20238550|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20238551|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238552|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238553|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
20238554|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238555|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
20238556|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238557|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19852257|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238558|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238559|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
20238560|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238561|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20238562|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238563|NCT00397501|Antidotes|antidotes|mesh-ancestor
20238564|NCT00397501|Protective Agents|protective agents|mesh-ancestor
20238565|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
20238566|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
20238567|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238568|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238569|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
20238570|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
20238571|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
20238572|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20238573|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238574|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
20238575|NCT00397566|BMS-707035|bms-707035|mesh-list
20238576|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
20238577|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238578|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238579|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20238580|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20238581|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
20238582|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238583|NCT00397592|Hormones|hormones|mesh-list
20238584|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852258|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19852259|NCT00723710|Interferons|interferons|mesh-list
19852260|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
19852261|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
19852262|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852263|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
19852264|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852265|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
19852266|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852267|NCT00723749|Buprenorphine|buprenorphine|mesh-list
19852268|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19852269|NCT00723749|Naloxone|naloxone|mesh-list
19852270|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19852271|NCT00723749|Narcotics|narcotics|mesh-ancestor
19852272|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852273|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852274|NCT00723749|Analgesics|analgesics|mesh-ancestor
20238585|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698969|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19698970|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19698971|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698972|NCT04907682|Ribavirin|ribavirin|mesh-list
19698973|NCT04907682|Favipiravir|favipiravir|mesh-list
19698974|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
19698975|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19698976|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
19698977|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19698978|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
19698979|NCT04907838|BQ 788|bq 788|mesh-list
19698980|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19698981|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20238586|NCT00397657|Niacin|niacin|mesh-list
19698982|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852275|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
20238587|NCT00397657|Ezetimibe|ezetimibe|mesh-list
20238588|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20238589|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19698983|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19698984|NCT04907474|Phenylephrine|phenylephrine|mesh-list
19698985|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
19413890|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413891|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413892|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
19413893|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19413894|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413895|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19413896|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
19413897|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19413898|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413899|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413900|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19413901|NCT03879408|Narcotics|narcotics|mesh-ancestor
20238590|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
20238591|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238592|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20238593|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
20238594|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
20238595|NCT00397657|Vitamins|vitamins|mesh-ancestor
20238596|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
20238597|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238598|NCT00397709|Rifampin|rifampin|mesh-list
19413902|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19413903|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
19413904|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
19413905|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19413906|NCT03877289|Oxybutynin|oxybutynin|mesh-list
19413907|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19413908|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
20238599|NCT00397709|Isoniazid|isoniazid|mesh-list
20238600|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20238601|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
20238602|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238603|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238604|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
20238605|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20238606|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238607|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238608|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20238609|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20238610|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20238611|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20238612|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20238613|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20238614|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19413909|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
19413910|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852276|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852277|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19852278|NCT00723801|Losartan|losartan|mesh-list
19852279|NCT00723801|Atenolol|atenolol|mesh-list
19698986|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19698987|NCT04907474|Tropicamide|tropicamide|mesh-list
19698988|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19698989|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19698990|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
19698991|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
19852280|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19852281|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19852282|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20238615|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20238616|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
20238617|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20238618|NCT00397722|Paroxetine|paroxetine|mesh-list
20238619|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20238620|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20238621|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238622|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238623|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238624|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
20238625|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238626|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20238627|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
20238628|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238629|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19852283|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19852284|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852285|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
19852286|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
19852287|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19413911|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413912|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19413913|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19413914|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
19698992|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19698993|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19698994|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
19698995|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19698996|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
19698997|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
19698998|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19698999|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19699000|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19699001|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
19699002|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238630|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20238631|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238632|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
20238633|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20238634|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
20238635|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238636|NCT00397735|Expectorants|expectorants|mesh-ancestor
20238637|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
20238638|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20238639|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
20238640|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238641|NCT00397735|Protective Agents|protective agents|mesh-ancestor
20238642|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238643|NCT00397735|Antidotes|antidotes|mesh-ancestor
20238644|NCT00397761|Paclitaxel|paclitaxel|mesh-list
20238645|NCT00397761|Capecitabine|capecitabine|mesh-list
20238646|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20238647|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20238648|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238649|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
20238650|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
20238651|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
20238652|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238653|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238654|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
20481974|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20481975|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20481976|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
20481977|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20481978|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238655|NCT00397787|Sunitinib|sunitinib|mesh-list
20238656|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238657|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20238658|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20238659|NCT00397787|Growth Substances|growth substances|mesh-ancestor
20238660|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238661|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
20238662|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20238663|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238664|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238665|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
20238666|NCT00397800|Rituximab|rituximab|mesh-list
20238667|NCT00397800|Fludarabine|fludarabine|mesh-list
20238668|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
20238669|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238670|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
20481979|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20481980|NCT01545297|Narcotics|narcotics|mesh-ancestor
20481981|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
20481982|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20481983|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20481984|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238671|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20481985|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238672|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238673|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20238674|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
20238675|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238676|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699003|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699004|NCT04907474|Protective Agents|protective agents|mesh-ancestor
20238677|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20238678|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238679|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238680|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
19699005|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19699006|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19699007|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
20238681|NCT00397826|Simvastatin|simvastatin|mesh-list
20238682|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19699008|NCT04907747|Amoxicillin|amoxicillin|mesh-list
19413915|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413916|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413917|NCT03877289|Urological Agents|urological agents|mesh-ancestor
19413918|NCT03866200|Resveratrol|resveratrol|mesh-list
19413919|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
19413920|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413921|NCT03866200|Protective Agents|protective agents|mesh-ancestor
19413922|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413923|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413924|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19413925|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
19413926|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19413927|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19413928|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413929|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19699009|NCT04907747|Furazolidone|furazolidone|mesh-list
20238683|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20238684|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
20238685|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238686|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20238687|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20238688|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238689|NCT00397917|Folic Acid|folic acid|mesh-list
20481986|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20481987|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
20481988|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238690|NCT00397917|Hematinics|hematinics|mesh-ancestor
20238691|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
20238692|NCT00397917|Vitamins|vitamins|mesh-ancestor
20238693|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
20238694|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238695|NCT00397956|Ertapenem|ertapenem|mesh-list
20238696|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238697|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238698|NCT00398008|Naltrexone|naltrexone|mesh-list
20238699|NCT00398008|Buprenorphine|buprenorphine|mesh-list
20238700|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20238701|NCT00398008|Narcotics|narcotics|mesh-ancestor
20238702|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238703|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238704|NCT00398008|Analgesics|analgesics|mesh-ancestor
20238705|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
20238706|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238707|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20481989|NCT01545479|Captopril|captopril|mesh-list
20481990|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20481991|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
20481992|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20481993|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481994|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20527866|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
20527867|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527868|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527869|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
20527870|NCT01770080|Peppermint oil|peppermint oil|mesh-list
20527871|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20238708|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20238709|NCT00398034|Testosterone|testosterone|mesh-list
19852288|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852289|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19852290|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19852291|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20481995|NCT01545557|Lidocaine|lidocaine|mesh-list
20481996|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
20481997|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
19852292|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
19852293|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238710|NCT00398034|Androgens|androgens|mesh-ancestor
20238711|NCT00398034|Hormones|hormones|mesh-ancestor
20238712|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238713|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238714|NCT00398099|Ertapenem|ertapenem|mesh-list
19852294|NCT00723827|Temozolomide|temozolomide|mesh-list
20238715|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238716|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238717|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20238718|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20238719|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238720|NCT00398281|Dutasteride|dutasteride|mesh-list
20238721|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20238722|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20238723|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238724|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20481998|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
20481999|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482000|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482001|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
20482002|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482003|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20238725|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
20238726|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238727|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238728|NCT00398307|Cisplatin|cisplatin|mesh-list
20238729|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238730|NCT00398372|Rituximab|rituximab|mesh-list
20238731|NCT00398372|Epratuzumab|epratuzumab|mesh-list
20238732|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238733|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238734|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
20238735|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238736|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238737|NCT00398385|Gemcitabine|gemcitabine|mesh-list
19699010|NCT04907747|Esomeprazole|esomeprazole|mesh-list
19699011|NCT04907747|Bismuth|bismuth|mesh-list
19699012|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238738|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238739|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238740|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
20238741|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699013|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699014|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19699015|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699016|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19699017|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238742|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
20247878|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
20238743|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238744|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238745|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238746|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
20238747|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238748|NCT00398424|Cisplatin|cisplatin|mesh-list
20238749|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238750|NCT00398437|Trastuzumab|trastuzumab|mesh-list
20238751|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238752|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238753|NCT00398450|Interferons|interferons|mesh-list
20238754|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
20238755|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
20238756|NCT00398450|Azacitidine|azacitidine|mesh-list
20238757|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238758|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
20238759|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238760|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238761|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
20238762|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238763|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238764|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
20238765|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238766|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
20238767|NCT00398463|Tirofiban|tirofiban|mesh-list
20238768|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20238769|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20238770|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852295|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19852296|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
20238771|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20238772|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20238773|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
20238774|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238775|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20238776|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238777|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
20238778|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238779|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
20238780|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20238781|NCT00398463|Protective Agents|protective agents|mesh-ancestor
20238782|NCT00398489|Tamoxifen|tamoxifen|mesh-list
20238783|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
20238784|NCT00398489|Docetaxel|docetaxel|mesh-list
20482004|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20482005|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20482006|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238785|NCT00398489|Trastuzumab|trastuzumab|mesh-list
20238786|NCT00398489|Epirubicin|epirubicin|mesh-list
20238787|NCT00398489|Anastrozole|anastrozole|mesh-list
20238788|NCT00398489|Goserelin|goserelin|mesh-list
20238789|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238790|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
20238791|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238792|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238793|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20238794|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
20238795|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238796|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238797|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20238798|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
20238799|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
20238800|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
20238801|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20238802|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20238803|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20238804|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20238805|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238806|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20238807|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
20238808|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238809|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20238810|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20238811|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20238812|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20238813|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20238814|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20238815|NCT00398515|Sirolimus|sirolimus|mesh-list
20238816|NCT00398515|Lenalidomide|lenalidomide|mesh-list
20238817|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
20238818|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238819|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20238820|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482007|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482008|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20482009|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
20482010|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
20482011|NCT01545557|Protective Agents|protective agents|mesh-ancestor
20482012|NCT01545596|Anesthetics|anesthetics|mesh-list
20482013|NCT01545596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482014|NCT01545596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482015|NCT01545635|Thrombin|thrombin|mesh-list
20482016|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
20482017|NCT01545635|Coagulants|coagulants|mesh-ancestor
19413930|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238821|NCT00398515|Growth Substances|growth substances|mesh-ancestor
20482018|NCT01545778|Oxycodone|oxycodone|mesh-list
20482019|NCT01545778|Tapentadol|tapentadol|mesh-list
20238822|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
20238823|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238824|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238825|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238826|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20238827|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
20238828|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238829|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
20238830|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
20238831|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20238832|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
20238833|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238834|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238835|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238836|NCT00398554|Prednisone|prednisone|mesh-list
20238837|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
20238838|NCT00398554|Doxorubicin|doxorubicin|mesh-list
20238839|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20238840|NCT00398554|Etoposide|etoposide|mesh-list
20238841|NCT00398554|Vincristine|vincristine|mesh-list
20238842|NCT00398554|Vinblastine|vinblastine|mesh-list
20238843|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20238844|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
20238845|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238846|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20238847|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20238848|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
20238849|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238850|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238851|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20238852|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20238853|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20238854|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20238855|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238856|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20238857|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
20238858|NCT00398554|Hormones|hormones|mesh-ancestor
20238859|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238860|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20482020|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20482021|NCT01545778|Narcotics|narcotics|mesh-ancestor
20482022|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482023|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482024|NCT01545778|Analgesics|analgesics|mesh-ancestor
20482025|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
20482026|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482027|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20482028|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20482029|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482030|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482031|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
20482032|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482033|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
20482034|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482035|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482036|NCT01545804|Lenalidomide|lenalidomide|mesh-list
19852297|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852298|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852299|NCT00723892|Ribavirin|ribavirin|mesh-list
19852300|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852301|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
19852302|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
19852303|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413931|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19699018|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699019|NCT04907747|Antacids|antacids|mesh-ancestor
19699020|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19699021|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19699022|NCT04907747|Renal Agents|renal agents|mesh-ancestor
19699023|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19413932|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19413933|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19413934|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19413935|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19699024|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19699025|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19852304|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
19852305|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852306|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
19852307|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852308|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852309|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
19852310|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852311|NCT00723957|Paclitaxel|paclitaxel|mesh-list
19852312|NCT00723957|Carboplatin|carboplatin|mesh-list
19852313|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20482037|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
20482038|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238861|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20238862|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
20238863|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
20238864|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
20238865|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
20238866|NCT00398580|Testosterone|testosterone|mesh-list
20238867|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
20238868|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
20238869|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20238870|NCT00398580|Dutasteride|dutasteride|mesh-list
20238871|NCT00398580|Androgens|androgens|mesh-ancestor
20238872|NCT00398580|Hormones|hormones|mesh-ancestor
20238873|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20238874|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482039|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482040|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482041|NCT01545804|Growth Substances|growth substances|mesh-ancestor
20482042|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
20482043|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482044|NCT01545830|Vitamin D|vitamin d|mesh-list
20482045|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
20482046|NCT01545830|Vitamins|vitamins|mesh-ancestor
20482047|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
20482048|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482049|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20482050|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20238875|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20482051|NCT01545856|Levodopa|levodopa|mesh-list
20482052|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19852314|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482053|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20238876|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238877|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
20238878|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20238879|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20238880|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238881|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482054|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
20482055|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482056|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482057|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482058|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19852315|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
19852316|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
19852317|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
19852318|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852319|NCT00724009|Clofarabine|clofarabine|mesh-list
20238882|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
20482059|NCT01545947|Azacitidine|azacitidine|mesh-list
20482060|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482061|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20482062|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482063|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482064|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20482065|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
20482066|NCT01546051|BCI-838|bci-838|mesh-list
20482067|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20247879|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852320|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19852321|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
19852322|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852323|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852324|NCT00724061|Interferons|interferons|mesh-list
19852325|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
19852326|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
19852327|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852328|NCT00724061|Furocoumarins|furocoumarins|mesh-list
19852329|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852330|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
19852331|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852332|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
19413936|NCT03856047|Liraglutide|liraglutide|mesh-list
20238883|NCT00398658|Clindamycin|clindamycin|mesh-list
19413937|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19413938|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413939|NCT03856047|Incretins|incretins|mesh-ancestor
19413940|NCT03856047|Hormones|hormones|mesh-ancestor
20238884|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
20238885|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
20238886|NCT00398658|Gentamicins|gentamicins|mesh-list
20238887|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20238888|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238889|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20238890|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238891|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238892|NCT00398684|Nevirapine|nevirapine|mesh-list
20238893|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20238894|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20238895|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238896|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238897|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
20238898|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238899|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20238900|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20482068|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20482069|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482070|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482071|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482072|NCT01546090|Alprazolam|alprazolam|mesh-list
20482073|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482074|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482075|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482076|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20482077|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20482078|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20482079|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
20482080|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
20482081|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482082|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482083|NCT01546103|Vitamin D|vitamin d|mesh-list
20482084|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
20482085|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
20482086|NCT01546103|Vitamins|vitamins|mesh-list
20482087|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
20482088|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482089|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20482090|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20482091|NCT01546116|Lamivudine|lamivudine|mesh-list
20482092|NCT01546116|Adefovir|adefovir|mesh-list
20482093|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20482094|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20482095|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20482096|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482097|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482098|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
20482099|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482100|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20482101|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20482102|NCT01546389|Chloroquine|chloroquine|mesh-list
20482103|NCT01546389|Amebicides|amebicides|mesh-ancestor
20482104|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20482105|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20482106|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482107|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
20482108|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482109|NCT01546558|Metformin|metformin|mesh-list
20482110|NCT01546558|Ranolazine|ranolazine|mesh-list
20482111|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482112|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482113|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20482114|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482115|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482116|NCT01546597|Metformin|metformin|mesh-list
20482117|NCT01546597|Ranolazine|ranolazine|mesh-list
20482118|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482119|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482120|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19413941|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19413942|NCT03844074|Bevacizumab|bevacizumab|mesh-list
19413943|NCT03844074|Ranibizumab|ranibizumab|mesh-list
19413944|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413945|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413946|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19413947|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19413948|NCT03844074|Growth Substances|growth substances|mesh-ancestor
20238901|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20238902|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20238903|NCT00398697|Gemcitabine|gemcitabine|mesh-list
20238904|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20238905|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
20238906|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238907|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238908|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
20238909|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238910|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238911|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19413949|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699026|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20238912|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
20238913|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238914|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
20238915|NCT00398749|Hematinics|hematinics|mesh-ancestor
20238916|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20238917|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20238918|NCT00398788|Hydromorphone|hydromorphone|mesh-list
20238919|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20238920|NCT00398788|Narcotics|narcotics|mesh-ancestor
20238921|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238922|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238923|NCT00398788|Analgesics|analgesics|mesh-ancestor
20238924|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
20238925|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238926|NCT00398814|Sorafenib|sorafenib|mesh-list
20238927|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20238928|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20238929|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238930|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238931|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
20238932|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20238933|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238934|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238935|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20238936|NCT00398827|Analgesics|analgesics|mesh-ancestor
20238937|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
19413950|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
19699027|NCT04907123|Diuretics|diuretics|mesh-list
19699028|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
19699029|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699030|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19699031|NCT04907084|Fenofibrate|fenofibrate|mesh-list
19699032|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19699033|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
19699034|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699035|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19699036|NCT04907110|Niacinamide|niacinamide|mesh-list
20238938|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699037|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
19699038|NCT04907110|Vitamins|vitamins|mesh-ancestor
19699039|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
19699040|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699041|NCT04907344|Paclitaxel|paclitaxel|mesh-list
19699042|NCT04907344|Carboplatin|carboplatin|mesh-list
19699043|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19852333|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238939|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20238940|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19699044|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699045|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
20238941|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20238942|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
20238943|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238944|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238945|NCT00398853|Chromium|chromium|mesh-list
20238946|NCT00398853|Picolinic acid|picolinic acid|mesh-list
20238947|NCT00398853|Trace Elements|trace elements|mesh-ancestor
20238948|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
20238949|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238950|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20238951|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
20238952|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
19699046|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
20238953|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238954|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
20238955|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
20238956|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238957|NCT00398892|Protective Agents|protective agents|mesh-ancestor
20238958|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238959|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
20482121|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482122|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482123|NCT01546701|Morphine|morphine|mesh-list
20482124|NCT01546701|Buprenorphine|buprenorphine|mesh-list
20482125|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20482126|NCT01546701|Narcotics|narcotics|mesh-ancestor
20482127|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482128|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482129|NCT01546701|Analgesics|analgesics|mesh-ancestor
20482130|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
20482131|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482132|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20482133|NCT01546896|Alprazolam|alprazolam|mesh-list
20238960|NCT00398892|Vitamins|vitamins|mesh-ancestor
20238961|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
20238962|NCT00398905|Enoxaparin|enoxaparin|mesh-list
20238963|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
20238964|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20238965|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
20238966|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20238967|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
20238968|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20238969|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20238970|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
20238971|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20238972|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20238973|NCT00398957|Naltrexone|naltrexone|mesh-list
20238974|NCT00398957|Hydromorphone|hydromorphone|mesh-list
20238975|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
20238976|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20238977|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20238978|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
20238979|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238980|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20238981|NCT00398957|Narcotics|narcotics|mesh-ancestor
20482134|NCT01546896|Buspirone|buspirone|mesh-list
20482135|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482136|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482137|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482138|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20482139|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20482140|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19699047|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699048|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699049|NCT04906889|Lidocaine|lidocaine|mesh-list
19699050|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
19699051|NCT04906889|Remifentanil|remifentanil|mesh-list
19699052|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19699053|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
20238982|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20238983|NCT00398957|Analgesics|analgesics|mesh-ancestor
20238984|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19852334|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
20238985|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20238986|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20238987|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20238988|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482141|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
20482142|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
20238989|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20238990|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482143|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482144|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482145|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20482146|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
20482147|NCT01546909|Vaccines|vaccines|mesh-list
20482148|NCT01546909|Immunologic Factors|immunologic factors|mesh-ancestor
20482149|NCT01546909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482150|NCT01546935|Oseltamivir|oseltamivir|mesh-list
20482151|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
20482152|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482153|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482154|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482155|NCT01546961|Chloroquine|chloroquine|mesh-list
20482156|NCT01546961|Amebicides|amebicides|mesh-ancestor
20482157|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20482158|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20482159|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482160|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
20482161|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482162|NCT01546987|Leuprolide|leuprolide|mesh-list
20482163|NCT01546987|Goserelin|goserelin|mesh-list
20482164|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20482165|NCT01546987|Flutamide|flutamide|mesh-list
20482166|NCT01546987|Bicalutamide|bicalutamide|mesh-list
20482167|NCT01546987|Buserelin|buserelin|mesh-list
20482168|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20482169|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
20482170|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20482171|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482172|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20238991|NCT00399022|Analgesics|analgesics|mesh-ancestor
20238992|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
20238993|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20238994|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
20238995|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20238996|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
20238997|NCT00399048|Hydromorphone|hydromorphone|mesh-list
20238998|NCT00399048|Oxycodone|oxycodone|mesh-list
20238999|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20239000|NCT00399048|Narcotics|narcotics|mesh-ancestor
20239001|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239002|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239003|NCT00399048|Analgesics|analgesics|mesh-ancestor
20239004|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
20239005|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239006|NCT00399061|Cyclosporine|cyclosporine|mesh-list
20239007|NCT00399061|Cyclosporins|cyclosporins|mesh-list
20239008|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239009|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239010|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239011|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
20239012|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239013|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
20239014|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239015|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
20239016|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20239017|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20239018|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
19852335|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19852336|NCT00724126|Rifaximin|rifaximin|mesh-list
19852337|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19852338|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852339|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852340|NCT00724243|Infliximab|infliximab|mesh-list
20239019|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
20239020|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20239021|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
20239022|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20239023|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20239024|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239025|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20239026|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239027|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239028|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20239029|NCT00399074|Renal Agents|renal agents|mesh-ancestor
20239030|NCT00399087|Prednisone|prednisone|mesh-list
20239031|NCT00399087|Docetaxel|docetaxel|mesh-list
20239032|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239033|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239034|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239035|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239036|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239037|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239038|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
20239039|NCT00399087|Hormones|hormones|mesh-ancestor
20239040|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239041|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239042|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20239043|NCT00399126|Paclitaxel|paclitaxel|mesh-list
20239044|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20239045|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239046|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239047|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239048|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239049|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239050|NCT00399152|Sunitinib|sunitinib|mesh-list
20239051|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239052|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20239053|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482173|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482174|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-ancestor
20482175|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
20482176|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482177|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
20482178|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20482179|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
20482180|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20482181|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
20482182|NCT01547104|Glimepiride|glimepiride|mesh-list
20482183|NCT01547104|Linagliptin|linagliptin|mesh-list
20482184|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20482185|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482186|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482187|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482188|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
20482189|NCT01547104|Incretins|incretins|mesh-ancestor
20482190|NCT01547104|Hormones|hormones|mesh-ancestor
20482191|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482192|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20482193|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
20482194|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482195|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482196|NCT01547143|Cyclosporine|cyclosporine|mesh-list
20482197|NCT01547143|Dexamethasone|dexamethasone|mesh-list
20482198|NCT01547143|Etoposide|etoposide|mesh-list
19852341|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
20239054|NCT00399152|Growth Substances|growth substances|mesh-ancestor
20239055|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239056|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
20239057|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20239058|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239059|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239060|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
20239061|NCT00399165|Testosterone|testosterone|mesh-list
20239062|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
20239063|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
20239064|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20239065|NCT00399165|Dutasteride|dutasteride|mesh-list
20239066|NCT00399165|Androgens|androgens|mesh-ancestor
20239067|NCT00399165|Hormones|hormones|mesh-ancestor
20239068|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239069|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239070|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20239071|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239072|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
20239073|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20239074|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20239075|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239076|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239077|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
20239078|NCT00399204|Metformin|metformin|mesh-list
20239079|NCT00399204|Pioglitazone|pioglitazone|mesh-list
20239080|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20239081|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239082|NCT00399243|Sumatriptan|sumatriptan|mesh-list
20239083|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20239084|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20239085|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20239086|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
20239087|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239088|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239089|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239090|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
20239091|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20239092|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
20239093|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239094|NCT00399256|Expectorants|expectorants|mesh-ancestor
20239095|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
20239096|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20239097|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
20239098|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239099|NCT00399256|Protective Agents|protective agents|mesh-ancestor
20239100|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239101|NCT00399256|Antidotes|antidotes|mesh-ancestor
20239102|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
20239103|NCT00399269|Hematinics|hematinics|mesh-ancestor
20239104|NCT00399282|Vitamin E|vitamin e|mesh-list
20239105|NCT00399282|Vitamins|vitamins|mesh-ancestor
20239106|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
20239107|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239108|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
20239109|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239110|NCT00399282|Protective Agents|protective agents|mesh-ancestor
20239111|NCT00399295|Naltrexone|naltrexone|mesh-list
20239112|NCT00399295|Hydromorphone|hydromorphone|mesh-list
20239113|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
20239114|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20239115|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239116|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
20239117|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239118|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20482199|NCT01547143|Cyclosporins|cyclosporins|mesh-list
20482200|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
20482201|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20482202|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
20482203|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
20482204|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482205|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482206|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482207|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
19852342|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852343|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852344|NCT00724373|Ribavirin|ribavirin|mesh-list
19852345|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852346|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
19852347|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852348|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
19852349|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852350|NCT00724451|Ribavirin|ribavirin|mesh-list
19852351|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19852352|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852353|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
19852354|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852355|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
19852356|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852357|NCT00724464|Interferons|interferons|mesh-list
20239119|NCT00399295|Narcotics|narcotics|mesh-ancestor
20239120|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239121|NCT00399295|Analgesics|analgesics|mesh-ancestor
20239122|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
20239123|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20239124|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239125|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239126|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20239127|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
20239128|NCT00399399|Azathioprine|azathioprine|mesh-list
20239129|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239130|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
20239131|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239132|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20239133|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20239134|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
19852358|NCT00724464|Ribavirin|ribavirin|mesh-list
19852359|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
20239135|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239136|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413951|NCT03840837|Rivastigmine|rivastigmine|mesh-list
19413952|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19413953|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19413954|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413955|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
19413956|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699054|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699055|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699056|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
19699057|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699058|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19699059|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19699060|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19699061|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19699062|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699063|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19699064|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19699065|NCT04906889|Analgesics|analgesics|mesh-ancestor
19852360|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
19852361|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852362|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239137|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20239138|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
20239139|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239140|NCT00399425|Heparin|heparin|mesh-list
20239141|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20239142|NCT00399425|Tinzaparin|tinzaparin|mesh-list
20239143|NCT00399425|Dalteparin|dalteparin|mesh-list
20239144|NCT00399425|Bemiparin|bemiparin|mesh-list
20239145|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
20239146|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20239147|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20239148|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239149|NCT00399451|Polidocanol|polidocanol|mesh-list
20239150|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20239151|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20239152|NCT00399464|Alfuzosin|alfuzosin|mesh-list
20239153|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20239154|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20239155|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20239156|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
20239157|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239158|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239159|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239160|NCT00399464|Urological Agents|urological agents|mesh-ancestor
20239161|NCT00399477|Levodopa|levodopa|mesh-list
20239162|NCT00399477|Pramipexole|pramipexole|mesh-list
20239163|NCT00399477|Rasagiline|rasagiline|mesh-list
20239164|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20239165|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20239166|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
20239167|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239168|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239169|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239170|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20239171|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239172|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20239173|NCT00399477|Protective Agents|protective agents|mesh-ancestor
20482208|NCT01547143|Hormones|hormones|mesh-ancestor
20482209|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482210|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20482211|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482212|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482213|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482214|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20482215|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19852363|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
19852364|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852365|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
19852366|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239174|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
20482216|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19852367|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
20239175|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
20239176|NCT00399633|Sumatriptan|sumatriptan|mesh-list
19852368|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852369|NCT00724568|Dexamethasone|dexamethasone|mesh-list
19852370|NCT00724568|Lenalidomide|lenalidomide|mesh-list
19852371|NCT00724568|Bortezomib|bortezomib|mesh-list
19852372|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239177|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20239178|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20239179|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20239180|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
20239181|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239182|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239183|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239184|NCT00399659|Tegaserod|tegaserod|mesh-list
19852373|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
19852374|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
20239185|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19413957|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852375|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239186|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
20239187|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239188|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239189|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239190|NCT00399672|Interferons|interferons|mesh-list
20239191|NCT00399672|Ribavirin|ribavirin|mesh-list
20239192|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239193|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
20482217|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482218|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
20482219|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
20482220|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482221|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
20482222|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482223|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20482224|NCT01547169|Insulin|insulin|mesh-list
20482225|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20239194|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239195|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
20239196|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239197|NCT00399685|Efavirenz|efavirenz|mesh-list
20239198|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
20239199|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20239200|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20239201|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20239202|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239203|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239204|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
20239205|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239206|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20239207|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20239208|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20239209|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20239210|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20482226|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
20482227|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482228|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527872|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
20527873|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
20527874|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527875|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527876|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20527877|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
20527878|NCT01770106|Denosumab|denosumab|mesh-list
20527879|NCT01770106|Alendronate|alendronate|mesh-list
20527880|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20527881|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527882|NCT01770119|Vaccines|vaccines|mesh-list
20527883|NCT01770119|Immunologic Factors|immunologic factors|mesh-ancestor
20527884|NCT01770119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527885|NCT01770132|Gemcitabine|gemcitabine|mesh-list
20527886|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20527887|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
20527888|NCT01770132|Trioxsalen|trioxsalen|mesh-list
20527889|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20527890|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
19852376|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852377|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852378|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
19852379|NCT00724568|Hormones|hormones|mesh-ancestor
19852380|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852381|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19852382|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239211|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20239212|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20239213|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20239214|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20239215|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239216|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20239217|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
20239218|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20239219|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239220|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20239221|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20239222|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20239223|NCT00399698|Risperidone|risperidone|mesh-list
20239224|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20239225|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
20239226|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239227|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239228|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239229|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20239230|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20239231|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239232|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20239233|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19413958|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19413959|NCT03840837|Protective Agents|protective agents|mesh-ancestor
19852383|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
19852384|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19852385|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19852386|NCT00724568|Growth Substances|growth substances|mesh-ancestor
19852387|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852388|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
19852389|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19852390|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
19852391|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852392|NCT00724594|Expectorants|expectorants|mesh-ancestor
19852393|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
19852394|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19852395|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
19852396|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852397|NCT00724594|Protective Agents|protective agents|mesh-ancestor
20239234|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
20239235|NCT00399711|Metformin|metformin|mesh-list
20239236|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
20239237|NCT00399711|Repaglinide|repaglinide|mesh-list
20239238|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20239239|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239240|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
20239241|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20239242|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239243|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20239244|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
20239245|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239246|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239247|NCT00399750|Bevacizumab|bevacizumab|mesh-list
20239248|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
20239249|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20239250|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239251|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20239252|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20239253|NCT00399750|Growth Substances|growth substances|mesh-ancestor
20239254|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239255|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
20239256|NCT00399867|Simvastatin|simvastatin|mesh-list
20239257|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20239258|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20239259|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
20239260|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239261|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20239262|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20239263|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239264|NCT00399945|Tobramycin|tobramycin|mesh-list
20239265|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20482229|NCT01547221|Clotrimazole|clotrimazole|mesh-list
20482230|NCT01547221|Miconazole|miconazole|mesh-list
20482231|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20482232|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482233|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
20482234|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20482235|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20482236|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482237|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482238|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20482239|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
20482240|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482241|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482242|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20482243|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20482244|NCT01547260|Gemcitabine|gemcitabine|mesh-list
20482245|NCT01547260|Lenalidomide|lenalidomide|mesh-list
20482246|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20482247|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
19413960|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20239266|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239267|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
19852398|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852399|NCT00724594|Antidotes|antidotes|mesh-ancestor
19852400|NCT00724711|Tenofovir|tenofovir|mesh-list
19852401|NCT00724711|Lamivudine|lamivudine|mesh-list
19852402|NCT00724711|Emtricitabine|emtricitabine|mesh-list
19852403|NCT00724711|Abacavir|abacavir|mesh-list
19852404|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
19852405|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239268|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239269|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
20239270|NCT00400075|Azathioprine|azathioprine|mesh-list
20239271|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239272|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
20239273|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239274|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20239275|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20239276|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
20239277|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239278|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239279|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20239280|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
20239281|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239282|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
19852406|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19852407|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19852408|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239283|NCT00400088|Paroxetine|paroxetine|mesh-list
20239284|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
20239285|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20239286|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239287|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239288|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
20239289|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20239290|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239291|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239292|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20482248|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482249|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239293|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20239294|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20239295|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239296|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
20239297|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20239298|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20239299|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20239300|NCT00400114|Irinotecan|irinotecan|mesh-list
20239301|NCT00400114|Sunitinib|sunitinib|mesh-list
20239302|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239303|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20239304|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20239305|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239306|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482250|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
20482251|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482252|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482253|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482254|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
20482255|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852409|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239307|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20239308|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20239309|NCT00400114|Growth Substances|growth substances|mesh-ancestor
19852410|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20482256|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482257|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482258|NCT01547260|Growth Substances|growth substances|mesh-ancestor
20482259|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
20482260|NCT01547312|Interferons|interferons|mesh-list
20482261|NCT01547312|Ribavirin|ribavirin|mesh-list
20482262|NCT01547312|Grazoprevir|grazoprevir|mesh-list
20482263|NCT01547312|Liver Extracts|liver extracts|mesh-list
20482264|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239310|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239311|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
20239312|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20239313|NCT00400231|Metformin|metformin|mesh-list
20239314|NCT00400231|Fenofibrate|fenofibrate|mesh-list
20239315|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20239316|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239317|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20239318|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
20239319|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239320|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20239321|NCT00400322|Valganciclovir|valganciclovir|mesh-list
20239322|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
20239323|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699066|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20247880|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247881|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20247882|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248107|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248108|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
20248109|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248110|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248111|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20248112|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248113|NCT00434941|Capecitabine|capecitabine|mesh-list
20248114|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20248115|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
20248116|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248117|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248118|NCT00435058|Timolol|timolol|mesh-list
20248119|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20248120|NCT00435058|Travoprost|travoprost|mesh-list
20248121|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20248122|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20248123|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
20248124|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248125|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248126|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248127|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20248128|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20482265|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
20239324|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
20239325|NCT00400335|Testosterone|testosterone|mesh-list
20239326|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
20239327|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
20239328|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20239329|NCT00400335|Dutasteride|dutasteride|mesh-list
20239330|NCT00400335|Androgens|androgens|mesh-ancestor
20239331|NCT00400335|Hormones|hormones|mesh-ancestor
20239332|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239333|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239334|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20239335|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239336|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
20239337|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20239338|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20239339|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239340|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239341|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
20239342|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
19852411|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19852412|NCT00724815|Sumatriptan|sumatriptan|mesh-list
19852413|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19852414|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19852415|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19852416|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
19852417|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19413961|NCT03836287|Bromides|bromides|mesh-list
19413962|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
19413963|NCT03834753|Bevacizumab|bevacizumab|mesh-list
20239343|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239344|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239345|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239346|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239347|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239348|NCT00400374|Celecoxib|celecoxib|mesh-list
20239349|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20239350|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239351|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20239352|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239353|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239354|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20239355|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20239356|NCT00400374|Analgesics|analgesics|mesh-ancestor
19413964|NCT03834753|Ranibizumab|ranibizumab|mesh-list
19413965|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19852418|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413966|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239357|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
20239358|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239359|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239360|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239361|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20239362|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20239363|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20239364|NCT00400387|Riboflavin|riboflavin|mesh-list
20239365|NCT00400387|Thiamine|thiamine|mesh-list
20239366|NCT00400387|Pyridoxine|pyridoxine|mesh-list
20239367|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
20239368|NCT00400387|Folic Acid|folic acid|mesh-list
20239369|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
20239370|NCT00400387|Tocopherols|tocopherols|mesh-list
20239371|NCT00400387|Vitamin E|vitamin e|mesh-list
20239372|NCT00400387|Tocotrienols|tocotrienols|mesh-list
20239373|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
20239374|NCT00400387|Heparin|heparin|mesh-list
20239375|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20239376|NCT00400387|Tinzaparin|tinzaparin|mesh-list
20239377|NCT00400387|Dalteparin|dalteparin|mesh-list
20239378|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239379|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
20239380|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20239381|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20239382|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239383|NCT00400387|Vitamins|vitamins|mesh-ancestor
20239384|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
20239385|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20239386|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
20239387|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
20239388|NCT00400387|Protective Agents|protective agents|mesh-ancestor
20239389|NCT00400387|Hematinics|hematinics|mesh-ancestor
20239390|NCT00400478|Rituximab|rituximab|mesh-list
20239391|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20239392|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239393|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
20239394|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239395|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20239396|NCT00400491|Vitamin D|vitamin d|mesh-list
20239397|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
20239398|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
20239399|NCT00400491|Vitamins|vitamins|mesh-list
20239400|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
20239401|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239402|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20239403|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20239404|NCT00400530|Alendronate|alendronate|mesh-list
20239405|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239406|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20239407|NCT00400556|Lenograstim|lenograstim|mesh-list
20239408|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20239409|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
20239410|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239411|NCT00400582|Candesartan|candesartan|mesh-list
20239412|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20239413|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20239414|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20239415|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239416|NCT00400595|Mupirocin|mupirocin|mesh-list
20239417|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20239418|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239419|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20239420|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239421|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239422|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20239423|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20239424|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
20239425|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239426|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239427|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20239428|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
20239429|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
20239430|NCT00400608|Hormones|hormones|mesh-ancestor
20239431|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239432|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
20239433|NCT00400621|Acetaminophen|acetaminophen|mesh-list
20239434|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20239435|NCT00400621|Analgesics|analgesics|mesh-ancestor
20239436|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
20239437|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239438|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239439|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
20239440|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
20239441|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20239442|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239443|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19699067|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19699068|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19699069|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
19699070|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699071|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20239444|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
20239445|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20239446|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239447|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239448|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239449|NCT00400725|Clobetasol|clobetasol|mesh-list
20239450|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239451|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
20239452|NCT00400725|Hormones|hormones|mesh-ancestor
20239453|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239454|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239455|NCT00400738|Ritonavir|ritonavir|mesh-list
20239456|NCT00400738|Lopinavir|lopinavir|mesh-list
20239457|NCT00400738|Saquinavir|saquinavir|mesh-list
20239458|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20239459|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20239460|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
20239461|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699072|NCT04906889|Narcotics|narcotics|mesh-ancestor
19699073|NCT04906876|Gemcitabine|gemcitabine|mesh-list
20239462|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239463|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20239464|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20239465|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
20239466|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239467|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20239468|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19699074|NCT04906876|Docetaxel|docetaxel|mesh-list
19699075|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699076|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
19699077|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699078|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699079|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
19699080|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699081|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699082|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19699083|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
19699084|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239469|NCT00400777|Amlodipine|amlodipine|mesh-list
20239470|NCT00400777|Valsartan|valsartan|mesh-list
19699085|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239471|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20239472|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20247883|NCT00433927|Leucovorin|leucovorin|mesh-list
20482266|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239473|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20239474|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20239475|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239476|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20239477|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239478|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
20239479|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20239480|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20482267|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
20482268|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482269|NCT01547312|Hematinics|hematinics|mesh-ancestor
20482270|NCT01547325|Doxycycline|doxycycline|mesh-list
20482271|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20482272|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239481|NCT00400777|Diuretics|diuretics|mesh-ancestor
20239482|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
20239483|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20239484|NCT00400790|Propofol|propofol|mesh-list
20239485|NCT00400790|Desflurane|desflurane|mesh-list
20239486|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20239487|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239488|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239489|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19852419|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852420|NCT00724854|Ribavirin|ribavirin|mesh-list
19852421|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852422|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
19852423|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
19852424|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852425|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
20239490|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
20239491|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
20239492|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20239493|NCT00400816|Temozolomide|temozolomide|mesh-list
20239494|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20239495|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
20239496|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239497|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239498|NCT00400855|Fluticasone|fluticasone|mesh-list
20239499|NCT00400855|Xhance|xhance|mesh-list
20239500|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239501|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20239502|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
20482273|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
20482274|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20482275|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20482276|NCT01547377|Zinc|zinc|mesh-list
20482277|NCT01547377|Selenium|selenium|mesh-list
20482278|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20482279|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20482280|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20482281|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
20482282|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239503|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239504|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239505|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20247884|NCT00433927|Folic Acid|folic acid|mesh-list
20482283|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20239506|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
20239507|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
20239508|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20239509|NCT00400998|Fluticasone|fluticasone|mesh-list
20239510|NCT00400998|Xhance|xhance|mesh-list
20239511|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239512|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20239513|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
20239514|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239515|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239516|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20239517|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
20239518|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
19413967|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19413968|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20239519|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20239520|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
20239521|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239522|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20239523|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239524|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239525|NCT00401115|Sirolimus|sirolimus|mesh-list
20239526|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20239527|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239528|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20239529|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239530|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
20239531|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239532|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
20239533|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239534|NCT00401128|Gemcitabine|gemcitabine|mesh-list
20239535|NCT00401128|Irinotecan|irinotecan|mesh-list
20239536|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239537|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
20239538|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239539|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239540|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
20239541|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239542|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239543|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239544|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
20239545|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239546|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20239547|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20239548|NCT00401167|Memantine|memantine|mesh-list
20239549|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20239550|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20239551|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
20239552|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239553|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239554|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239555|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20239556|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20239557|NCT00401180|Docetaxel|docetaxel|mesh-list
20239558|NCT00401180|Temozolomide|temozolomide|mesh-list
20239559|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239560|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239561|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239562|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239563|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239564|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20239565|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
20239566|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
20239567|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19852426|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852427|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
19852428|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852429|NCT00724867|Belimumab|belimumab|mesh-list
20239568|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239569|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239570|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20239571|NCT00401206|Analgesics|analgesics|mesh-ancestor
20239572|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
20239573|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239574|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20239575|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20239576|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20239577|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
20239578|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239579|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239580|NCT00401219|Estrogens|estrogens|mesh-list
20239581|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20239582|NCT00401219|Progestins|progestins|mesh-list
20239583|NCT00401219|Hormones|hormones|mesh-ancestor
20239584|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239585|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239586|NCT00401323|Docetaxel|docetaxel|mesh-list
20239587|NCT00401323|Fluorouracil|fluorouracil|mesh-list
20239588|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239589|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239590|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239591|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239592|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239593|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
20239594|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239595|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239596|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
20239597|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239598|NCT00401362|Naltrexone|naltrexone|mesh-list
20239599|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
20239600|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20239601|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239602|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
20239603|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239604|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20239605|NCT00401427|Trastuzumab|trastuzumab|mesh-list
20239606|NCT00401427|Vinorelbine|vinorelbine|mesh-list
20239607|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20239608|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239609|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20239610|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239611|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
19852430|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239612|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239613|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239614|NCT00401440|Misoprostol|misoprostol|mesh-list
20239615|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19852431|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
19852432|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852433|NCT00724893|Interferons|interferons|mesh-list
19852434|NCT00724893|Ribavirin|ribavirin|mesh-list
19852435|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
19852436|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
20239616|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
20239617|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20239618|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239619|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20239620|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20239621|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
20239622|NCT00401479|Solabegron|solabegron|mesh-list
20239623|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20239624|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20239625|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20239626|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
20239627|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239628|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239629|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239630|NCT00401492|Gemcitabine|gemcitabine|mesh-list
19852437|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20239631|NCT00401492|Vinorelbine|vinorelbine|mesh-list
20239632|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239633|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239634|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
20239635|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239636|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
20239637|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239638|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239639|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239640|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
20239641|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239642|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20239643|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239644|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239645|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239646|NCT00401596|Omalizumab|omalizumab|mesh-list
20239647|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20239648|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20239649|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
20239650|NCT00401609|Gemcitabine|gemcitabine|mesh-list
20239651|NCT00401609|Carboplatin|carboplatin|mesh-list
20239652|NCT00401609|Etoposide|etoposide|mesh-list
20239653|NCT00401609|Vinorelbine|vinorelbine|mesh-list
20239654|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239655|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239656|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
20239657|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239658|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
20239659|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239660|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239661|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239662|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
20239663|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239664|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20239665|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20239666|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20239667|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239668|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239669|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239670|NCT00401635|Carboplatin|carboplatin|mesh-list
20239671|NCT00401635|Doxorubicin|doxorubicin|mesh-list
20239672|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20239673|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852438|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852439|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
19852440|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852441|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
19852442|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852443|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
19852444|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852445|NCT00724932|Atropine|atropine|mesh-list
20239674|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20239675|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20239676|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20239677|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239678|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239679|NCT00401648|Brivaracetam|brivaracetam|mesh-list
20239680|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
20239681|NCT00401661|Alfuzosin|alfuzosin|mesh-list
20239682|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20239683|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20239684|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20239685|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
20239686|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239687|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239688|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239689|NCT00401661|Urological Agents|urological agents|mesh-ancestor
20239690|NCT00401674|Paclitaxel|paclitaxel|mesh-list
20239691|NCT00401674|Carboplatin|carboplatin|mesh-list
20239692|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20239693|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239694|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239695|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239696|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239697|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239698|NCT00401765|Docetaxel|docetaxel|mesh-list
20239699|NCT00401765|Siltuximab|siltuximab|mesh-list
20239700|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239701|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239702|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239703|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239704|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239705|NCT00401804|Dexamethasone|dexamethasone|mesh-list
20239706|NCT00401804|Doxorubicin|doxorubicin|mesh-list
20239707|NCT00401804|Bortezomib|bortezomib|mesh-list
20239708|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239709|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
20239710|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
20239711|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239712|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239713|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20239714|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
20239715|NCT00401804|Hormones|hormones|mesh-ancestor
20239716|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239717|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20239718|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239719|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20239720|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20239721|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20239722|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239723|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239724|NCT00401856|Eplerenone|eplerenone|mesh-list
20239725|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20239726|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
20239727|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239728|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239729|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20239730|NCT00401856|Diuretics|diuretics|mesh-ancestor
20239731|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
20239732|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20239733|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
20239734|NCT00401869|Hematinics|hematinics|mesh-ancestor
20239735|NCT00401921|Minocycline|minocycline|mesh-list
20239736|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20239737|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239738|NCT00402012|Pioglitazone|pioglitazone|mesh-list
20239739|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20239740|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239741|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
20239742|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19852446|NCT00724932|Bromides|bromides|mesh-list
19852447|NCT00724932|Rocuronium|rocuronium|mesh-list
19852448|NCT00724932|Neostigmine|neostigmine|mesh-list
19852449|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
19852450|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19852451|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20239743|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239744|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
20239745|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852452|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19852453|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852454|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852455|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19413969|NCT03834753|Growth Substances|growth substances|mesh-ancestor
19413970|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413971|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
20239746|NCT00402077|Pramlintide|pramlintide|mesh-list
20239747|NCT00402077|Phentermine|phentermine|mesh-list
20239748|NCT00402077|Sibutramine|sibutramine|mesh-list
20239749|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20239750|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239751|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20239752|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
20239753|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20239754|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
20239755|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
20239756|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239757|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
20239758|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239759|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239760|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
20239761|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20239762|NCT00402142|Vaccines|vaccines|mesh-list
20239763|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
20239764|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239765|NCT00402181|Dexamethasone|dexamethasone|mesh-list
20239766|NCT00402181|Siltuximab|siltuximab|mesh-list
20239767|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239768|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
20239769|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
20239770|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482284|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20482285|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482286|NCT01547377|Trace Elements|trace elements|mesh-ancestor
20482287|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
20482288|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482289|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
20482290|NCT01547377|Protective Agents|protective agents|mesh-ancestor
20482291|NCT01547416|Fentanyl|fentanyl|mesh-list
20482292|NCT01547416|Ropivacaine|ropivacaine|mesh-list
20482293|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
20482294|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
20482295|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482296|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482297|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
20482298|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482299|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20482300|NCT01547416|Narcotics|narcotics|mesh-ancestor
20482301|NCT01547416|Analgesics|analgesics|mesh-ancestor
20482302|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20482303|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20482304|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
20482305|NCT01547455|Atorvastatin|atorvastatin|mesh-list
19413972|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
20239771|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239772|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20239773|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
20482306|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20482307|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20239774|NCT00402181|Hormones|hormones|mesh-ancestor
20239775|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20239776|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20239777|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239778|NCT00402207|Fluticasone|fluticasone|mesh-list
20239779|NCT00402207|Beclomethasone|beclomethasone|mesh-list
20239780|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699086|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
19699087|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699088|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
20239781|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20239782|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
20239783|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239784|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239785|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20239786|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
20239787|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
20239788|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20239789|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
20239790|NCT00402207|Hormones|hormones|mesh-ancestor
20239791|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247885|NCT00433927|Bevacizumab|bevacizumab|mesh-list
20247886|NCT00433927|Cetuximab|cetuximab|mesh-list
20247887|NCT00433927|Irinotecan|irinotecan|mesh-list
20247888|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
20247889|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247890|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247891|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20247892|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20247893|NCT00433927|Growth Substances|growth substances|mesh-ancestor
20247894|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247895|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
20247896|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20247897|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20247898|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247899|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247900|NCT00433927|Antidotes|antidotes|mesh-ancestor
20482308|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
20482309|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482310|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20482311|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20482312|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482313|NCT01547494|Vitamins|vitamins|mesh-list
20482314|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
20247901|NCT00433927|Protective Agents|protective agents|mesh-ancestor
20247902|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
20482315|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247903|NCT00433927|Vitamins|vitamins|mesh-ancestor
20239792|NCT00402259|Esomeprazole|esomeprazole|mesh-list
20239793|NCT00402259|Omeprazole|omeprazole|mesh-list
20239794|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20239795|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20239796|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20239797|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239798|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239799|NCT00402272|Everolimus|everolimus|mesh-list
20239800|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239801|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239802|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
20239803|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239804|NCT00402350|Fentanyl|fentanyl|mesh-list
20239805|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20239806|NCT00402350|Narcotics|narcotics|mesh-ancestor
20239807|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239808|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239809|NCT00402350|Analgesics|analgesics|mesh-ancestor
20239810|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
20239811|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239812|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20239813|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20239814|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
20239815|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
20239816|NCT00402376|Carvedilol|carvedilol|mesh-list
20239817|NCT00402376|Perindopril|perindopril|mesh-list
20239818|NCT00402376|Pravastatin|pravastatin|mesh-list
20239819|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20239820|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20239821|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
20239822|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239823|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239824|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239825|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20239826|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
20239827|NCT00402376|Protective Agents|protective agents|mesh-ancestor
20239828|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20239829|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20239830|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20239831|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
20239832|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20239833|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20239834|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20239835|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20239836|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
20239837|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20239838|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20239839|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239840|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20239841|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
20239842|NCT00402415|Sirolimus|sirolimus|mesh-list
20239843|NCT00402415|Sunitinib|sunitinib|mesh-list
20239844|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20239845|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699089|NCT04906772|Ketamine|ketamine|mesh-list
19699090|NCT04906772|Propofol|propofol|mesh-list
19699091|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19699092|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699093|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699094|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19699095|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
19699096|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
19699097|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19699098|NCT04906772|Analgesics|analgesics|mesh-ancestor
19699099|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
19699100|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239846|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20239847|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239848|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
20239849|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239850|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
20239851|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239852|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20239853|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20239854|NCT00402415|Growth Substances|growth substances|mesh-ancestor
20239855|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
20239856|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20239857|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239858|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239859|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
20239860|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20239861|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20239862|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239863|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20239864|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239865|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20239866|NCT00402454|Rifampin|rifampin|mesh-list
20239867|NCT00402454|Isoniazid|isoniazid|mesh-list
20239868|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
20239869|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20239870|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
20239871|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20239872|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239873|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
20239874|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20239875|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239876|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239877|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20239878|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20239879|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20239880|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20239881|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20239882|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20239883|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20239884|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20239885|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
20239886|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20239887|NCT00402467|Enoxaparin|enoxaparin|mesh-list
20239888|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
20239889|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
20239890|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20239891|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
20239892|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20239893|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
20239894|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239895|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239896|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
20239897|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20239898|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20239899|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
20239900|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239901|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
20239902|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239903|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239904|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20239905|NCT00402493|Ibuprofen|ibuprofen|mesh-list
20239906|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20239907|NCT00402493|Latanoprost|latanoprost|mesh-list
20239908|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19699101|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19699102|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19699103|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19699104|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
19699105|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699106|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699107|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19699108|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19699109|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19699110|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
19699111|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19699112|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19699113|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19699114|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
19699115|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699116|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699117|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699118|NCT04906915|Ketamine|ketamine|mesh-list
19699119|NCT04906915|Analgesics|analgesics|mesh-ancestor
19699120|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
19699121|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699122|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699123|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19699124|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19699125|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
20239909|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20239910|NCT00402493|Analgesics|analgesics|mesh-ancestor
20239911|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
20239912|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239913|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239914|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20239915|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20239916|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20239917|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239918|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239919|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20239920|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20239921|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20239922|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20239923|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20239924|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20239925|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
20239926|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239927|NCT00402506|Pyridoxal|pyridoxal|mesh-list
20239928|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
20239929|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
20239930|NCT00402506|Vitamins|vitamins|mesh-ancestor
20239931|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
20239932|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239933|NCT00402532|Everolimus|everolimus|mesh-list
20239934|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239935|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239936|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
20239937|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239938|NCT00402545|Docetaxel|docetaxel|mesh-list
20239939|NCT00402545|Fluorouracil|fluorouracil|mesh-list
20239940|NCT00402545|Cetuximab|cetuximab|mesh-list
20239941|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239942|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
20239943|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
20239944|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
20239945|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239946|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
19699126|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
20239947|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239948|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239949|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
20239950|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239951|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20239952|NCT00402558|Aldesleukin|aldesleukin|mesh-list
20239953|NCT00402558|Methotrexate|methotrexate|mesh-list
20239954|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
20239955|NCT00402558|Fludarabine|fludarabine|mesh-list
20239956|NCT00402558|Busulfan|busulfan|mesh-list
20239957|NCT00402558|Interleukin-2|interleukin-2|mesh-list
20239958|NCT00402558|Tacrolimus|tacrolimus|mesh-list
20239959|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
20239960|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19699127|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20239961|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20239962|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
20239963|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20239964|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239965|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20239966|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
20239967|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239968|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20239969|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
20239970|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20239971|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20239972|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20239973|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
20239974|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20239975|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20239976|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
20239977|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20239978|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20239979|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
20239980|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20239981|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19699128|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19699129|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19699130|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20239982|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20239983|NCT00402558|Analgesics|analgesics|mesh-ancestor
19699131|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20239984|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
20239985|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239986|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19413973|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413974|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413975|NCT03832179|Dexamethasone|dexamethasone|mesh-list
19413976|NCT03832179|Bevacizumab|bevacizumab|mesh-list
19413977|NCT03832179|Ranibizumab|ranibizumab|mesh-list
19852456|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19852457|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19852458|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
19852459|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19852460|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
19852461|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
19852462|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
19852463|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19852464|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19852465|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
19852466|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852467|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852468|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19852469|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852470|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19852471|NCT00724958|Infliximab|infliximab|mesh-list
19852472|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
20239987|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20239988|NCT00402571|Acetaminophen|acetaminophen|mesh-list
20239989|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20239990|NCT00402571|Analgesics|analgesics|mesh-ancestor
20239991|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
20239992|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20239993|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20239994|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
20239995|NCT00402584|Sibutramine|sibutramine|mesh-list
20239996|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
20239997|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20239998|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
20239999|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20240000|NCT00402610|Rifampin|rifampin|mesh-list
20240001|NCT00402610|Isoniazid|isoniazid|mesh-list
20240002|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
20240003|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20240004|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
20240005|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240006|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240007|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
20240008|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20240009|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240010|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240011|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20240012|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20240013|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20240014|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20240015|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20240016|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20240017|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20240018|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20240019|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
20240020|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20240021|NCT00402623|Quercetin|quercetin|mesh-list
20482316|NCT01547520|Meperidine|meperidine|mesh-list
20482317|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20482318|NCT01547520|Narcotics|narcotics|mesh-ancestor
20482319|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482320|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482321|NCT01547520|Analgesics|analgesics|mesh-ancestor
20482322|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
20482323|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482324|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20482325|NCT01547546|GDC-0084|gdc-0084|mesh-list
20482326|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482327|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19413978|NCT03832179|Aflibercept|aflibercept|mesh-list
19852473|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240022|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
20482328|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
20240023|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240024|NCT00402623|Protective Agents|protective agents|mesh-ancestor
20240025|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240026|NCT00402636|Sirolimus|sirolimus|mesh-list
20240027|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240028|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240029|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20240030|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240031|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
20240032|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20240033|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
20240034|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240035|NCT00402662|Everolimus|everolimus|mesh-list
20240036|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
20240037|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240038|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20240039|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
20240040|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240041|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20240042|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240043|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240044|NCT00402766|Dexamethasone|dexamethasone|mesh-list
20240045|NCT00402766|Cisplatin|cisplatin|mesh-list
20240046|NCT00402766|Pemetrexed|pemetrexed|mesh-list
20240047|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
20240048|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240049|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240050|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
20240051|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
20240052|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240053|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240054|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240055|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
20240056|NCT00402766|Hormones|hormones|mesh-ancestor
20240057|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240058|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20240059|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240060|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240061|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20240062|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20240063|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20240064|NCT00402792|Acetaminophen|acetaminophen|mesh-list
20240065|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20240066|NCT00402792|Hydrocodone|hydrocodone|mesh-list
20240067|NCT00402792|Oxycodone|oxycodone|mesh-list
20240068|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240069|NCT00402792|Analgesics|analgesics|mesh-ancestor
19699132|NCT04906720|Colchicine|colchicine|mesh-list
20240070|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
19699133|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
19699134|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240071|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699135|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
20240072|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240073|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
20240074|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20240075|NCT00402792|Narcotics|narcotics|mesh-ancestor
20240076|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240077|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
20240078|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240079|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20240080|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240081|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240082|NCT00402909|Nateglinide|nateglinide|mesh-list
20240083|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20240084|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240085|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
20240086|NCT00402974|Vitamin K|vitamin k|mesh-list
20240087|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
20240088|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20240089|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20240090|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240091|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
20240092|NCT00402974|Coagulants|coagulants|mesh-ancestor
20240093|NCT00402974|Vitamins|vitamins|mesh-ancestor
20240094|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
20240095|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240096|NCT00403000|Dutasteride|dutasteride|mesh-list
20240097|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20240098|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20240099|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240100|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240101|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
20240102|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240103|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240104|NCT00403013|Anesthetics|anesthetics|mesh-list
20240105|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240106|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240107|NCT00403026|Bevacizumab|bevacizumab|mesh-list
20240108|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20240109|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240110|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240111|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240112|NCT00403026|Growth Substances|growth substances|mesh-ancestor
20240113|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240114|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240115|NCT00403039|Ranibizumab|ranibizumab|mesh-list
19413979|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19413980|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413981|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19413982|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19413983|NCT03832179|Growth Substances|growth substances|mesh-ancestor
19413984|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19413985|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
19413986|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413987|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
19413988|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
20240116|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240117|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240118|NCT00403039|Growth Substances|growth substances|mesh-ancestor
20240119|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240120|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240121|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19413989|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240122|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
20240123|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20240124|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
20240125|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240126|NCT00403065|Dexamethasone|dexamethasone|mesh-list
20240127|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240128|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
20240129|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
20240130|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240131|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240132|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240133|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
20240134|NCT00403065|Hormones|hormones|mesh-ancestor
20240135|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240136|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20240137|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240138|NCT00403156|Ranibizumab|ranibizumab|mesh-list
20240139|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
20240140|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240141|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240142|NCT00403156|Growth Substances|growth substances|mesh-ancestor
20240143|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240144|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240145|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240146|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20240147|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240148|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240149|NCT00403182|Letrozole|letrozole|mesh-list
20240150|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240151|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20240152|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20240153|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240154|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240155|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20240156|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
20240157|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240158|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240159|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
20240160|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
20240161|NCT00403247|Pyridoxine|pyridoxine|mesh-list
20240162|NCT00403247|Vitamins|vitamins|mesh-ancestor
20240163|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
20240164|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240165|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
20240166|NCT00403247|Hematinics|hematinics|mesh-ancestor
20240167|NCT00403286|Fluticasone|fluticasone|mesh-list
20240168|NCT00403286|Xhance|xhance|mesh-list
20240169|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
20240170|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20240171|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240172|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20240173|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
20240174|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240175|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240176|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20240177|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240178|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240179|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20240180|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20240181|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20240182|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20240183|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
20240184|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240185|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482329|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20482330|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699136|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
20240186|NCT00403312|Nicotine|nicotine|mesh-list
20240187|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20240188|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
20240189|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240190|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240191|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20240192|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20240193|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
20240194|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247904|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
19699137|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699138|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699139|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240195|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240196|NCT00403325|Ranibizumab|ranibizumab|mesh-list
20240197|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240198|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240199|NCT00403325|Growth Substances|growth substances|mesh-ancestor
20240200|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240201|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240202|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240203|NCT00403338|Sirolimus|sirolimus|mesh-list
20240204|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240205|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240206|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20240207|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240208|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
20240209|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20240210|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
20240211|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240212|NCT00403364|Amoxicillin|amoxicillin|mesh-list
20240213|NCT00403364|Clarithromycin|clarithromycin|mesh-list
20240214|NCT00403364|Tinidazole|tinidazole|mesh-list
20240215|NCT00403364|Pantoprazole|pantoprazole|mesh-list
20240216|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240217|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240218|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20240219|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240220|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240221|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20240222|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20240223|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20240224|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240225|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20240226|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
20482331|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482332|NCT01548001|Methotrexate|methotrexate|mesh-list
20482333|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20482334|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
20482335|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20482336|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482337|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20240227|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20240228|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20482338|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
20482339|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482340|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482341|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
20482342|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482343|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20482344|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482345|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
20240229|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20240230|NCT00403429|Capecitabine|capecitabine|mesh-list
20482346|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240231|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20240232|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
19699140|NCT04906317|Midazolam|midazolam|mesh-list
19699141|NCT04906317|Dezocine|dezocine|mesh-list
19699142|NCT04906317|Propofol|propofol|mesh-list
19699143|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19699144|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699145|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240233|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240234|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240235|NCT00403442|Bevacizumab|bevacizumab|mesh-list
20240236|NCT00403442|Verteporfin|verteporfin|mesh-list
20240237|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20240238|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240239|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240240|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240241|NCT00403442|Growth Substances|growth substances|mesh-ancestor
20240242|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240243|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240244|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20240245|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240246|NCT00403533|Atorvastatin|atorvastatin|mesh-list
20240247|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20240248|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20240249|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
20240250|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240251|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20240252|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20240253|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240254|NCT00403611|Praziquantel|praziquantel|mesh-list
20240255|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
20240256|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20240257|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240258|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
20240259|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240260|NCT00403637|Maleic acid|maleic acid|mesh-list
20240261|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240262|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240263|NCT00403650|Iloprost|iloprost|mesh-list
20240264|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20240265|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
20240266|NCT00403663|Fentanyl|fentanyl|mesh-list
20240267|NCT00403663|Morphine|morphine|mesh-list
20240268|NCT00403663|Bupivacaine|bupivacaine|mesh-list
20240269|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
20240270|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
20240271|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240272|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240273|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
20240274|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240275|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20240276|NCT00403663|Narcotics|narcotics|mesh-ancestor
20240277|NCT00403663|Analgesics|analgesics|mesh-ancestor
20240278|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20240279|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20240280|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
20240281|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20240282|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20240283|NCT00403728|Cyclosporine|cyclosporine|mesh-list
20240284|NCT00403728|Cyclosporins|cyclosporins|mesh-list
20240285|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240286|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240287|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20240288|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
20240289|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240290|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
20240291|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240292|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240293|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240294|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20240295|NCT00403780|Pregabalin|pregabalin|mesh-list
19852474|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240296|NCT00403780|Analgesics|analgesics|mesh-ancestor
20240297|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
20240298|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240299|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240300|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
20240301|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20240302|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20240303|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240304|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20240305|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20240306|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20240307|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240308|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20240309|NCT00403806|Dexamethasone|dexamethasone|mesh-list
20240310|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
20240311|NCT00403806|BB 1101|bb 1101|mesh-list
20240312|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240313|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
20240314|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
20240315|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240316|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240317|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240318|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
20240319|NCT00403806|Hormones|hormones|mesh-ancestor
20240320|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240321|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20240322|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240323|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
20240324|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240325|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240326|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20240327|NCT00403819|Laxatives|laxatives|mesh-ancestor
20482347|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20482348|NCT01548027|Anesthetics|anesthetics|mesh-list
20482349|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
20482350|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482351|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482352|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
20482353|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240328|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240329|NCT00403858|Lactulose|lactulose|mesh-list
20240330|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20240331|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240332|NCT00403858|Laxatives|laxatives|mesh-ancestor
20240333|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20240334|NCT00403897|Laxatives|laxatives|mesh-ancestor
20240335|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240336|NCT00403910|Canrenone|canrenone|mesh-list
20247905|NCT00433927|Hematinics|hematinics|mesh-ancestor
20482354|NCT01548066|Valproic Acid|valproic acid|mesh-list
20482355|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
20482356|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482357|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482358|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
20482359|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482360|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482361|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
20482362|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20482363|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482364|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20482365|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20482366|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20482367|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482368|NCT01548118|Vaccines|vaccines|mesh-list
20482369|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
20482370|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482371|NCT01548144|Pemetrexed|pemetrexed|mesh-list
20482372|NCT01548144|Crizotinib|crizotinib|mesh-list
20482373|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482374|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482375|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482376|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20482377|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20482378|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20482379|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20482380|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20482381|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20482382|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
20482383|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240337|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20240338|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
20240339|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240340|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240341|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20240342|NCT00403910|Diuretics|diuretics|mesh-ancestor
20240343|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
20240344|NCT00403949|Azelaic acid|azelaic acid|mesh-list
20240345|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240346|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240347|NCT00403962|Paroxetine|paroxetine|mesh-list
20240348|NCT00403962|Vestipitant|vestipitant|mesh-list
20240349|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20240350|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20240351|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20240352|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240353|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240354|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
20240355|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240356|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20240357|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
20240358|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20240359|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19413990|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19413991|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
19413992|NCT03832179|Hormones|hormones|mesh-ancestor
19413993|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19413994|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19413995|NCT03827018|Prednisone|prednisone|mesh-list
19413996|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
19413997|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19413998|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
19413999|NCT03827018|Hormones|hormones|mesh-ancestor
20240360|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20240361|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240362|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19699146|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19699147|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
19699148|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
19699149|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19699150|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19699151|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20240363|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20240364|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20240365|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
20240366|NCT00403988|Vinorelbine|vinorelbine|mesh-list
20240367|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482384|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20482385|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20482386|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482387|NCT01548170|Ketoconazole|ketoconazole|mesh-list
20482388|NCT01548170|Sunitinib|sunitinib|mesh-list
20482389|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482390|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482391|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482392|NCT01548170|Growth Substances|growth substances|mesh-ancestor
20482393|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482394|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
20482395|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20482396|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482397|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482398|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
20482399|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482400|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20482401|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20482402|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19699152|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19699153|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
20240368|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20240369|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
20240370|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
20240371|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
20240372|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247906|NCT00433940|Prednisolone|prednisolone|mesh-list
20247907|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247908|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
20247909|NCT00433940|Hormones|hormones|mesh-ancestor
20247910|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699154|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
19699155|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699156|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699157|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19699158|NCT04906317|Narcotics|narcotics|mesh-ancestor
19699159|NCT04906317|Analgesics|analgesics|mesh-ancestor
19699160|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
19699161|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699162|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19699163|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19699164|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19699165|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699166|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
19699167|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19699168|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
20247911|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247912|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20247913|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247914|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
20247915|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20247916|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247917|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20247918|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
20247919|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20247920|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247921|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247922|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247923|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20247924|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
20247925|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247926|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
20247927|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20247928|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
20247929|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247930|NCT00434005|Expectorants|expectorants|mesh-ancestor
20247931|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
20247932|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20247933|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
20247934|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247935|NCT00434005|Protective Agents|protective agents|mesh-ancestor
20247936|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247937|NCT00434005|Antidotes|antidotes|mesh-ancestor
20247938|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
20247939|NCT00434031|Docetaxel|docetaxel|mesh-list
20247940|NCT00434031|Doxorubicin|doxorubicin|mesh-list
20247941|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20247942|NCT00434031|Trastuzumab|trastuzumab|mesh-list
20247943|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247944|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
20247945|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247946|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247947|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20247948|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
20247949|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247950|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247951|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20247952|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247953|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20247954|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20247955|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20482403|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
20482404|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482405|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20482406|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
20247956|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19699169|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
19699170|NCT04906304|Cyclosporine|cyclosporine|mesh-list
19699171|NCT04906304|Everolimus|everolimus|mesh-list
19699172|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699173|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19699174|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
19699175|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699176|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20240373|NCT00404040|Lactulose|lactulose|mesh-list
20240374|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20240375|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240376|NCT00404040|Laxatives|laxatives|mesh-ancestor
20240377|NCT00404053|Clopidogrel|clopidogrel|mesh-list
20240378|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20240379|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20240380|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20482407|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482408|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482409|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240381|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20240382|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
20240383|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240384|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240385|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240386|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20240387|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20240388|NCT00404157|Rituximab|rituximab|mesh-list
20240389|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20240390|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240391|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
20240392|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240393|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240394|NCT00404183|Acetaminophen|acetaminophen|mesh-list
20240395|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20240396|NCT00404183|Hydrocodone|hydrocodone|mesh-list
20240397|NCT00404183|Oxycodone|oxycodone|mesh-list
20240398|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240399|NCT00404183|Analgesics|analgesics|mesh-ancestor
20240400|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
20240401|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240402|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482410|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20482411|NCT01548209|Analgesics|analgesics|mesh-ancestor
20482412|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
20482413|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482414|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20482415|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20482416|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20482417|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
20482418|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482419|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482420|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
20482421|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
20482422|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20482423|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482424|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482425|NCT01548248|Insulin|insulin|mesh-list
19699177|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20240403|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
20240404|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19699178|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
19699179|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240405|NCT00404183|Narcotics|narcotics|mesh-ancestor
20240406|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240407|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
20240408|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240409|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20240410|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240411|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240412|NCT00404196|Calcipotriene|calcipotriene|mesh-list
20240413|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240414|NCT00404222|Acetaminophen|acetaminophen|mesh-list
20240415|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20240416|NCT00404222|Hydrocodone|hydrocodone|mesh-list
20240417|NCT00404222|Oxycodone|oxycodone|mesh-list
20240418|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240419|NCT00404222|Analgesics|analgesics|mesh-ancestor
20240420|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
20240421|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240422|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240423|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
20240424|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20240425|NCT00404222|Narcotics|narcotics|mesh-ancestor
20240426|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240427|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
20240428|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240429|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20240430|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240431|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240432|NCT00404261|Fluticasone|fluticasone|mesh-list
20240433|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20240434|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20240435|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240436|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20240437|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
20240438|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240439|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240440|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20240441|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240442|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240443|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20240444|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20240445|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20240446|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20482426|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20482427|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
19699180|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699181|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699182|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699183|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
19699184|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
19699185|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240447|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
20240448|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240449|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240450|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
20240451|NCT00404261|Hormones|hormones|mesh-ancestor
20240452|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240453|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
20240454|NCT00404274|Casopitant|casopitant|mesh-list
20240455|NCT00404274|Warfarin|warfarin|mesh-list
20240456|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
20240457|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
20240458|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
20240459|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240460|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240461|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240462|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20240463|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240464|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699186|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20240465|NCT00404326|Hydralazine|hydralazine|mesh-list
20240466|NCT00404326|Valproic Acid|valproic acid|mesh-list
20240467|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
20240468|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482428|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
20240469|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240470|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
20240471|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240472|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240473|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
20240474|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20240475|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240476|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20240477|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20240478|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
20240479|NCT00404378|Ketoconazole|ketoconazole|mesh-list
20240480|NCT00404378|Casopitant|casopitant|mesh-list
20240481|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
19852475|NCT00724971|Rituximab|rituximab|mesh-list
19852476|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20240482|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240483|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20240484|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20240485|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240486|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240487|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20240488|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
20240489|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240490|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240491|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20240492|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
20240493|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
20240494|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240495|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240496|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20240497|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482429|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482430|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482431|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
20482432|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20240498|NCT00404391|Acetaminophen|acetaminophen|mesh-list
20240499|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20240500|NCT00404391|Hydrocodone|hydrocodone|mesh-list
20240501|NCT00404391|Oxycodone|oxycodone|mesh-list
20240502|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240503|NCT00404391|Analgesics|analgesics|mesh-ancestor
20240504|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
20240505|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240506|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240507|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
20240508|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20240509|NCT00404391|Narcotics|narcotics|mesh-ancestor
20240510|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240511|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
20240512|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240513|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20240514|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240515|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240516|NCT00404404|Paclitaxel|paclitaxel|mesh-list
20240517|NCT00404404|Bevacizumab|bevacizumab|mesh-list
20240518|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20240519|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20240520|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240521|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
20482433|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20482434|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482435|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20482436|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20482437|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
20482438|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482439|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482440|NCT01548326|Atorvastatin|atorvastatin|mesh-list
20482441|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20482442|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20240522|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
20240523|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
20240524|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482443|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
19852477|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20240525|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20240526|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240527|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240528|NCT00404404|Growth Substances|growth substances|mesh-ancestor
20240529|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240530|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240531|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
20240532|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20240533|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20240534|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20240535|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20240536|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240537|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
20240538|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240539|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240540|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20240541|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240542|NCT00404456|Melatonin|melatonin|mesh-list
20240543|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
20240544|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240545|NCT00404456|Protective Agents|protective agents|mesh-ancestor
20240546|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240547|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240548|NCT00404482|Cyclosporine|cyclosporine|mesh-list
20240549|NCT00404482|Cyclosporins|cyclosporins|mesh-list
20240550|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240551|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240552|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20240553|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
20240554|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240555|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
20240556|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240557|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
19699187|NCT04906096|GDC-0084|gdc-0084|mesh-list
19699188|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699189|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699190|NCT04906083|Mitogens|mitogens|mesh-list
19699191|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699192|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707987|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19707988|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240558|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240559|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20240560|NCT00404508|Hydralazine|hydralazine|mesh-list
20240561|NCT00404508|Valproic Acid|valproic acid|mesh-list
20240562|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
20240563|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240564|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707989|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707990|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707991|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
19707992|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19707993|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
20240565|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
20240566|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240567|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707994|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707995|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
19707996|NCT04821804|Protective Agents|protective agents|mesh-ancestor
19707997|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19707998|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707999|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708000|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
20240568|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
20240569|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20240570|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240571|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20240572|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20240573|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
20240574|NCT00404534|Amoxicillin|amoxicillin|mesh-list
20240575|NCT00404534|Clarithromycin|clarithromycin|mesh-list
20240576|NCT00404534|Omeprazole|omeprazole|mesh-list
20240577|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240578|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240579|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20240580|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240581|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20240582|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240583|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240584|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20240585|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20240586|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20240587|NCT00404573|Cariprazine|cariprazine|mesh-list
20240588|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20240589|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20240590|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240591|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240592|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20240593|NCT00404586|Fluticasone|fluticasone|mesh-list
20240594|NCT00404586|Xhance|xhance|mesh-list
20240595|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240596|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20240597|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
20240598|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240599|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240600|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20240601|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240602|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240603|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20240604|NCT00404599|Simvastatin|simvastatin|mesh-list
20240605|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20240606|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20240607|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
20240608|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240609|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20240610|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20240611|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240612|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20240613|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
20240614|NCT00404703|Bevacizumab|bevacizumab|mesh-list
20240615|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20482444|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482445|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20482446|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20482447|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482448|NCT01548482|Sirolimus|sirolimus|mesh-list
20482449|NCT01548482|Trebananib|trebananib|mesh-list
20482450|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20482451|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482452|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20482453|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482454|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
20482455|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482456|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
20482457|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482458|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482459|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482460|NCT01548482|Growth Substances|growth substances|mesh-ancestor
20482461|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
20482462|NCT01548521|Oxytocin|oxytocin|mesh-list
20482463|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
20482464|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20482465|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482466|NCT01548560|Dapivirine|dapivirine|mesh-list
20482467|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20240616|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482468|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19414000|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699193|NCT04906161|Vitamin D|vitamin d|mesh-list
20240617|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482469|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
20482470|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482471|NCT01548612|Nitroprusside|nitroprusside|mesh-list
20482472|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20240618|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240619|NCT00404703|Growth Substances|growth substances|mesh-ancestor
20240620|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240621|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240622|NCT00404716|Cilostazol|cilostazol|mesh-list
20240623|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20240624|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
20240625|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240626|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240627|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20240628|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240629|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20240630|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20240631|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240632|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20240633|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
20240634|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20240635|NCT00404716|Protective Agents|protective agents|mesh-ancestor
20240636|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20240637|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20240638|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240639|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20240640|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
20240641|NCT00404781|Aspirin|aspirin|mesh-list
20240642|NCT00404781|Cilostazol|cilostazol|mesh-list
20482473|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
20482474|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20482475|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482476|NCT01548677|Trastuzumab|trastuzumab|mesh-list
20482477|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20482478|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482479|NCT01548703|BCI-838|bci-838|mesh-list
20482480|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20482481|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20482482|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240643|NCT00404781|Clopidogrel|clopidogrel|mesh-list
20240644|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20240645|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240646|NCT00404781|Analgesics|analgesics|mesh-ancestor
20240647|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
20240648|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240649|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240650|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240651|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240652|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20240653|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20240654|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240655|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20240656|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20240657|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240658|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
20240659|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20240660|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20240661|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20240662|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
20240663|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240664|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20240665|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
20240666|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20240667|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240668|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
20240669|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20240670|NCT00404781|Protective Agents|protective agents|mesh-ancestor
20240671|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20240672|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20240673|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
20240674|NCT00404794|Prednisolone|prednisolone|mesh-list
20240675|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20240676|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
20240677|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20240678|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
20240679|NCT00404794|Tacrolimus|tacrolimus|mesh-list
20240680|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20240681|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
20240682|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20240683|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
20240684|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240685|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20240686|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240687|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240688|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20240689|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240690|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20482483|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482484|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482485|NCT01548794|Lidocaine|lidocaine|mesh-list
20482486|NCT01548794|Bupivacaine|bupivacaine|mesh-list
20482487|NCT01548794|Anesthetics|anesthetics|mesh-list
20482488|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
20482489|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482490|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482491|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
20482492|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482493|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20482494|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20482495|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20482496|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482497|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482498|NCT01548807|Everolimus|everolimus|mesh-list
20482499|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482500|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482501|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
20482502|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527891|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527892|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527893|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
20527894|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527895|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527896|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482503|NCT01548859|Midazolam|midazolam|mesh-list
20482504|NCT01548859|Sevoflurane|sevoflurane|mesh-list
20482505|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20482506|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482507|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482508|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482509|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20482510|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20482511|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20482512|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20482513|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
20482514|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
20240691|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
20240692|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240693|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240694|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240695|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
20240696|NCT00404794|Hormones|hormones|mesh-ancestor
20240697|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414001|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414002|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19414003|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414004|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414005|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
19414006|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
19414007|NCT03824587|Calcium|calcium|mesh-list
19414008|NCT03824587|Sevelamer|sevelamer|mesh-list
19414009|NCT03824587|Calcium acetate|calcium acetate|mesh-list
19414010|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20240698|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20240699|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
20240700|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
20240701|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240702|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240703|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20240704|NCT00404794|Protective Agents|protective agents|mesh-ancestor
20240705|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
20240706|NCT00404833|Prednisolone|prednisolone|mesh-list
20240707|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20240708|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
20482515|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
19414011|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482516|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
20482517|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482518|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482519|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19414012|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20240709|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20240710|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
20482520|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20482521|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
20482522|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20482523|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
20482524|NCT01548911|Calicheamicins|calicheamicins|mesh-list
20482525|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20482526|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482527|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20482528|NCT01548924|Paclitaxel|paclitaxel|mesh-list
20482529|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20482530|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482531|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
20482532|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
20482533|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
20482534|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482535|NCT01548950|Bosentan|bosentan|mesh-list
20482536|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
19414013|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
19414014|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
19414015|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414016|NCT03824587|Antacids|antacids|mesh-ancestor
19699194|NCT04906161|Calcium|calcium|mesh-list
19699195|NCT04906161|Vitamins|vitamins|mesh-ancestor
20482537|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
20482538|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19699196|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
20240711|NCT00404833|Chlorambucil|chlorambucil|mesh-list
20240712|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20240713|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
20240714|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20240715|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240716|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20240717|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
20240718|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414017|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699197|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240719|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240720|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240721|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240722|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240723|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
20240724|NCT00404833|Hormones|hormones|mesh-ancestor
20240725|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240726|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240727|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20240728|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
20240729|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
20240730|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240731|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240732|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20240733|NCT00404833|Protective Agents|protective agents|mesh-ancestor
19414018|NCT03818828|Iodine|iodine|mesh-list
19414019|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
19414020|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19414021|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414022|NCT03818828|Trace Elements|trace elements|mesh-ancestor
19414023|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
19414024|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414025|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
19414026|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20527897|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
20527898|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527899|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414027|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20527900|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20527901|NCT01770171|Paclitaxel|paclitaxel|mesh-list
20527902|NCT01770171|Bevacizumab|bevacizumab|mesh-list
20527903|NCT01770171|Carboplatin|carboplatin|mesh-list
20527904|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20527905|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527906|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
20240734|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20240735|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
20240736|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20240737|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
20240738|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240739|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240740|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
20240741|NCT00404937|Hormones|hormones|mesh-ancestor
20240742|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240743|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240744|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20240745|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20240746|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
20240747|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20240748|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240749|NCT00405080|Rifampin|rifampin|mesh-list
20240750|NCT00405080|Casopitant|casopitant|mesh-list
20240751|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20240752|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
20240753|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240754|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240755|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
20240756|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20240757|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240758|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240759|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20240760|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20240761|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20240762|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20240763|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20240764|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20240765|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
20240766|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
20240767|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240768|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240769|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240770|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20240771|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240772|NCT00405119|Esomeprazole|esomeprazole|mesh-list
20240773|NCT00405119|Ranitidine|ranitidine|mesh-list
19708001|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240774|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20240775|NCT00405119|Loxtidine|loxtidine|mesh-list
20240776|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20240777|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20240778|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20240779|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240780|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240781|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20240782|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
20240783|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
20240784|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240785|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240786|NCT00405158|Acetaminophen|acetaminophen|mesh-list
20240787|NCT00405158|Antipyretics|antipyretics|mesh-list
20240788|NCT00405158|Penicillins|penicillins|mesh-list
20240789|NCT00405158|Floxacillin|floxacillin|mesh-list
20240790|NCT00405158|Cefadroxil|cefadroxil|mesh-list
20240791|NCT00405158|Oxytocin|oxytocin|mesh-list
20240792|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
20240793|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20240794|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240795|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240796|NCT00405158|Analgesics|analgesics|mesh-ancestor
20240797|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
20240798|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240799|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240800|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240801|NCT00405171|Nevirapine|nevirapine|mesh-list
20240802|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20240803|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20240804|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240805|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240806|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
20240807|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240808|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20240809|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20240810|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20240811|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20240812|NCT00405210|Docetaxel|docetaxel|mesh-list
20240813|NCT00405210|Sorafenib|sorafenib|mesh-list
20240814|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240815|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
20240816|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
20240817|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
20240818|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240819|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20240820|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240821|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
20240822|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20240823|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
20240824|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240825|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414028|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19414029|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19414030|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19699198|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19699199|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19699200|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19699201|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20240826|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20240827|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
20240828|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
20240829|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20240830|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
20240831|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240832|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240833|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
20240834|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20240835|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20240836|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240837|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240838|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
20240839|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240840|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20240841|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20240842|NCT00405262|Ketorolac|ketorolac|mesh-list
20240843|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20240844|NCT00405262|Bupivacaine|bupivacaine|mesh-list
20240845|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
20240846|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
20240847|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240848|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240849|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
20240850|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240851|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20240852|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240853|NCT00405262|Analgesics|analgesics|mesh-ancestor
20240854|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240855|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240856|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20240857|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240858|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240859|NCT00405301|Rifampin|rifampin|mesh-list
20240860|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
20240861|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19699202|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19699203|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19699204|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699205|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
19699206|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699207|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699208|NCT04905953|Neostigmine|neostigmine|mesh-list
19699209|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19699210|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699211|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699212|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19699213|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699214|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699215|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19699216|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
19699217|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699218|NCT04905667|Trastuzumab|trastuzumab|mesh-list
19699219|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699220|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699221|NCT04905563|Acetaminophen|acetaminophen|mesh-list
19699222|NCT04905563|Ibuprofen|ibuprofen|mesh-list
19699223|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19699224|NCT04905563|Hydrocodone|hydrocodone|mesh-list
19699225|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240862|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
20240863|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20240864|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240865|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
20240866|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20240867|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240868|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240869|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20240870|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20240871|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19416893|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699226|NCT04905563|Analgesics|analgesics|mesh-ancestor
19699227|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
19699228|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699229|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699230|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
19699231|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19852478|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852479|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
19852480|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852481|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852482|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19852483|NCT00724984|Abexinostat|abexinostat|mesh-list
19852484|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19852485|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852486|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852487|NCT00725010|Temozolomide|temozolomide|mesh-list
19852488|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20240872|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19699232|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699233|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19699234|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19699235|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699236|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699237|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20240873|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20240874|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20240875|NCT00405340|Rituximab|rituximab|mesh-list
20240876|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20240877|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240878|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
20240879|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699238|NCT04905563|Narcotics|narcotics|mesh-ancestor
20240880|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240881|NCT00405366|Sorafenib|sorafenib|mesh-list
19416894|NCT02257619|Docetaxel|docetaxel|mesh-list
20240882|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240883|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20240884|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240885|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240886|NCT00405405|Bevacizumab|bevacizumab|mesh-list
20240887|NCT00405405|Cisplatin|cisplatin|mesh-list
20240888|NCT00405405|Docetaxel|docetaxel|mesh-list
20240889|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20240890|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20240891|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240892|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240893|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240894|NCT00405405|Growth Substances|growth substances|mesh-ancestor
20240895|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240896|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240897|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
20240898|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
20240899|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
20240900|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240901|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20240902|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240903|NCT00405418|Insulin|insulin|mesh-list
19414031|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414032|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
19414033|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852489|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
20240904|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20240905|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
20240906|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
20240907|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20240908|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240909|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
19414034|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414035|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19852490|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852491|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852492|NCT00725205|Ribavirin|ribavirin|mesh-list
20482539|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20482540|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482541|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482542|NCT01548950|Urological Agents|urological agents|mesh-ancestor
19852493|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852494|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
19852495|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
19852496|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852497|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
19852498|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852499|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
20240910|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20482543|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20482544|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20482545|NCT01549093|Gemcitabine|gemcitabine|mesh-list
20482546|NCT01549093|Carboplatin|carboplatin|mesh-list
20482547|NCT01549093|Endostar protein|endostar protein|mesh-list
20482548|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482549|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20482550|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
20240911|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20240912|NCT00405444|Fentanyl|fentanyl|mesh-list
20240913|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20240914|NCT00405444|Narcotics|narcotics|mesh-ancestor
20240915|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20240916|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240917|NCT00405444|Analgesics|analgesics|mesh-ancestor
20240918|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
20240919|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240920|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20240921|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20240922|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
20240923|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
20240924|NCT00405457|Cyclosporine|cyclosporine|mesh-list
20240925|NCT00405457|Cyclosporins|cyclosporins|mesh-list
20240926|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240927|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240928|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20240929|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
20240930|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240931|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
20240932|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20240933|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240934|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240935|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20240936|NCT00405496|Difluprednate|difluprednate|mesh-list
20240937|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
20240938|NCT00405496|Hormones|hormones|mesh-ancestor
20240939|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240940|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240941|NCT00405535|Glycine|glycine|mesh-list
20240942|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
20240943|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240944|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240945|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240946|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20240947|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
20240948|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
19414036|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414037|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
20240949|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240950|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699239|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699240|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
19699241|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
19699242|NCT04905277|Atenolol|atenolol|mesh-list
19699243|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19699244|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19699245|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
19699246|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
19699247|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699248|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699249|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19699250|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19699251|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19699252|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
20482551|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482552|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
20482553|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482554|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482555|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482556|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
20482557|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482558|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482559|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482560|NCT01549093|Growth Substances|growth substances|mesh-ancestor
20482561|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
20482562|NCT01549158|Torsemide|torsemide|mesh-list
20482563|NCT01549158|Furosemide|furosemide|mesh-list
20482564|NCT01549158|Diuretics|diuretics|mesh-ancestor
20482565|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
20482566|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699253|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699254|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699255|NCT04905108|Riboflavin|riboflavin|mesh-list
19699256|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
19699257|NCT04905108|Vitamins|vitamins|mesh-ancestor
20482567|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20482568|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482569|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482570|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20482571|NCT01549171|Iloprost|iloprost|mesh-list
20482572|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20482573|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
20482574|NCT01549236|Benzonidazole|benzonidazole|mesh-list
20482575|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482576|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
19699258|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
19699259|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699260|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19699261|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
20240951|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20240952|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20240953|NCT00405574|Growth Substances|growth substances|mesh-ancestor
20240954|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240955|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
20240956|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20240957|NCT00405717|Atorvastatin|atorvastatin|mesh-list
20240958|NCT00405717|Pravastatin|pravastatin|mesh-list
20240959|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20240960|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20240961|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
20240962|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240963|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20240964|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20240965|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482577|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482578|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20482579|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20482580|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20482581|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482582|NCT01549301|Lenograstim|lenograstim|mesh-list
20482583|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20482584|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
20482585|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482586|NCT01549418|Aspirin|aspirin|mesh-list
20482587|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20482588|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20482589|NCT01549418|Analgesics|analgesics|mesh-ancestor
20482590|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
20240966|NCT00405730|Ketorolac|ketorolac|mesh-list
20240967|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20240968|NCT00405730|Nepafenac|nepafenac|mesh-list
20240969|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20240970|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19699262|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
20240971|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20240972|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20240973|NCT00405730|Analgesics|analgesics|mesh-ancestor
20240974|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
20240975|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240976|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240977|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20240978|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20240979|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20240980|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20240981|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240982|NCT00405769|Red yeast rice|red yeast rice|mesh-list
20240983|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20240984|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19699263|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699264|NCT04905147|Mosapride|mosapride|mesh-list
20482591|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20240985|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20240986|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
20240987|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240988|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414038|NCT03799627|Glycine|glycine|mesh-list
19414039|NCT03799627|Hematinics|hematinics|mesh-ancestor
19414040|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
20240989|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247957|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20247958|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247959|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247960|NCT00434044|Etanercept|etanercept|mesh-list
20247961|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20247962|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20247963|NCT00434044|Analgesics|analgesics|mesh-ancestor
20247964|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
20247965|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247966|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247967|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247968|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414041|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240990|NCT00405808|Rimonabant|rimonabant|mesh-list
20240991|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20240992|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20240993|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20240994|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20240995|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20240996|NCT00405808|Hormones|hormones|mesh-ancestor
20240997|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20240998|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20240999|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
20241000|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20241001|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414042|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414043|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414044|NCT03798743|Docetaxel|docetaxel|mesh-list
19414045|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414046|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
19414047|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
19414048|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
19852500|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852501|NCT00725270|Mifepristone|mifepristone|mesh-list
19852502|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19852503|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
19852504|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19852505|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852506|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19852507|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19852508|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19852509|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
19852510|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20241002|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241003|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852511|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19852512|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
19852513|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852514|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
19852515|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19852516|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20241004|NCT00405847|Analgesics|analgesics|mesh-ancestor
20241005|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
20241006|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241007|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20241008|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20241009|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20241010|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
20241011|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241012|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241013|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
20241014|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20241015|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241016|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20241017|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
20241018|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241019|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482592|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482593|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20482594|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482595|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20482596|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20482597|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482598|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20482599|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19414049|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482600|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482601|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
19414050|NCT03788967|Ertapenem|ertapenem|mesh-list
19414051|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414052|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414053|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19414054|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20482602|NCT01549431|Dexamethasone|dexamethasone|mesh-list
20482603|NCT01549431|Panobinostat|panobinostat|mesh-list
20482604|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20482605|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
20482606|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
20482607|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482608|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482609|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482610|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
20482611|NCT01549431|Hormones|hormones|mesh-ancestor
20482612|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482613|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20482614|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482615|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20482616|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482617|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482618|NCT01549496|Amlodipine|amlodipine|mesh-list
20482619|NCT01549496|Diltiazem|diltiazem|mesh-list
20482620|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20482621|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20482622|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482623|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482624|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20482625|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482626|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
20482627|NCT01549548|Ponatinib|ponatinib|mesh-list
20482628|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482629|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20482630|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482631|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482632|NCT01549574|Crizotinib|crizotinib|mesh-list
20482633|NCT01549574|Esomeprazole|esomeprazole|mesh-list
20482634|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20482635|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482636|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20482637|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482638|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482639|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482640|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20482641|NCT01549600|Psyllium|psyllium|mesh-list
20482642|NCT01549600|Cathartics|cathartics|mesh-ancestor
20482643|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482644|NCT01549691|Alprazolam|alprazolam|mesh-list
20482645|NCT01549691|Zopiclone|zopiclone|mesh-list
20482646|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482647|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482648|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482649|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20482650|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20482651|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20482652|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
20482653|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
20482654|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482655|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482656|NCT01549704|Ropivacaine|ropivacaine|mesh-list
19414055|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19414056|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482657|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
20482658|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
20482659|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482660|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482661|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
20482662|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482663|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20482664|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20482665|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482666|NCT01549743|Celecoxib|celecoxib|mesh-list
20482667|NCT01549743|Rebamipide|rebamipide|mesh-list
19699265|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699266|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19699267|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
19699268|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699269|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699270|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699271|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
19699272|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20482668|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20482669|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20482670|NCT01549743|Analgesics|analgesics|mesh-ancestor
20482671|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
20482672|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482673|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482674|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20482675|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482676|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20482677|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20482678|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482679|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482680|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20241020|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241021|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241022|NCT00405925|Lamivudine|lamivudine|mesh-list
20482681|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482682|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
20482683|NCT01549743|Protective Agents|protective agents|mesh-ancestor
19852517|NCT00725296|Infliximab|infliximab|mesh-list
19852518|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
19852519|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482684|NCT01549795|Capecitabine|capecitabine|mesh-list
20482685|NCT01549795|Liver Extracts|liver extracts|mesh-list
20482686|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20482687|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
19414057|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414058|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19414059|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19852520|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852521|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
19852522|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19852523|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19852524|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20241023|NCT00405925|Zidovudine|zidovudine|mesh-list
20241024|NCT00405925|Abacavir|abacavir|mesh-list
20241025|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20241026|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20241027|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241028|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241029|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
20241030|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241031|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20241032|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20241033|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
20241034|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
20241035|NCT00405977|Analgesics|analgesics|mesh-ancestor
20241036|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
20241037|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482688|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482689|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482690|NCT01549795|Hematinics|hematinics|mesh-ancestor
20482691|NCT01549847|Piracetam|piracetam|mesh-list
20482692|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20482693|NCT01549847|Protective Agents|protective agents|mesh-ancestor
20482694|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482695|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
20482696|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
20482697|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20482698|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482699|NCT01549938|Vitamins|vitamins|mesh-ancestor
20482700|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
20482701|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20482702|NCT01549990|Sevoflurane|sevoflurane|mesh-list
20482703|NCT01549990|Desflurane|desflurane|mesh-list
20482704|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20482705|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20482706|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
20482707|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
20482708|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482709|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482710|NCT01550055|Irinotecan|irinotecan|mesh-list
20482711|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20482712|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20482713|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482714|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482715|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482716|NCT01550107|Allopurinol|allopurinol|mesh-list
20482717|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
20482718|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482719|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482720|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
20482721|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482722|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20482723|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
20482724|NCT01550107|Protective Agents|protective agents|mesh-ancestor
20482725|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482726|NCT01550146|Dexamethasone|dexamethasone|mesh-list
20482727|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
20482728|NCT01550146|BB 1101|bb 1101|mesh-list
20482729|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20482730|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
20482731|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
20482732|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482733|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482734|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482735|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
20482736|NCT01550146|Hormones|hormones|mesh-ancestor
20482737|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482738|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20482739|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482740|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
20482741|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482742|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482743|NCT01550302|Bupivacaine|bupivacaine|mesh-list
20482744|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
20482745|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
20241038|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241039|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
20241040|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20241041|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20241042|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
20241043|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20241044|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241045|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241046|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20482746|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482747|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699273|NCT04904341|Protective Agents|protective agents|mesh-ancestor
19699274|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482748|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
20482749|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482750|NCT01550354|Alfentanil|alfentanil|mesh-list
20482751|NCT01550354|Propofol|propofol|mesh-list
20482752|NCT01550354|Rocuronium|rocuronium|mesh-list
20482753|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482754|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482755|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482756|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20482757|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
19414060|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699275|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
19699276|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
19699277|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
19699278|NCT04904185|Fludarabine|fludarabine|mesh-list
19699279|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
19699280|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19699281|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
19699282|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699283|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482758|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
20482759|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20482760|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20482761|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20482762|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482763|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20482764|NCT01550354|Narcotics|narcotics|mesh-ancestor
20482765|NCT01550354|Analgesics|analgesics|mesh-ancestor
20482766|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
20482767|NCT01550419|Atorvastatin|atorvastatin|mesh-list
20482768|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20482769|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20482770|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
20482771|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414061|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
20482772|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20482773|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20482774|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482775|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
20482776|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20482777|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
20482778|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482779|NCT01550432|Expectorants|expectorants|mesh-ancestor
20482780|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
20482781|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20482782|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
20482783|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482784|NCT01550432|Protective Agents|protective agents|mesh-ancestor
20482785|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482786|NCT01550432|Antidotes|antidotes|mesh-ancestor
20482787|NCT01550445|Prednisolone|prednisolone|mesh-list
20482788|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20482789|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
20482790|NCT01550445|Hormones|hormones|mesh-ancestor
20482791|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852525|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19852526|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852527|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
19852528|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852529|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852530|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20482792|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482793|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20482794|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482795|NCT01550458|Mibefradil|mibefradil|mesh-list
20482796|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20482797|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20482798|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482799|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482800|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20482801|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482802|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
20482803|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20482804|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20482805|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527907|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
20527908|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
20527909|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527910|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20527911|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20527912|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20527913|NCT01770171|Growth Substances|growth substances|mesh-ancestor
20527914|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527915|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
20527916|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20527917|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20527918|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20527919|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527920|NCT01770210|Atorvastatin|atorvastatin|mesh-list
20527921|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20527922|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20527923|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
20527924|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527925|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20527926|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20527927|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20527928|NCT01770223|Ribavirin|ribavirin|mesh-list
20527929|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852531|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482806|NCT01550640|Remifentanil|remifentanil|mesh-list
20482807|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20482808|NCT01550640|Narcotics|narcotics|mesh-ancestor
20482809|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482810|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482811|NCT01550640|Analgesics|analgesics|mesh-ancestor
20482812|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
20482813|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482814|NCT01550653|Liraglutide|liraglutide|mesh-list
20482815|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482816|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482817|NCT01550653|Incretins|incretins|mesh-ancestor
20482818|NCT01550653|Hormones|hormones|mesh-ancestor
20482819|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482820|NCT01550770|Propofol|propofol|mesh-list
20482821|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482822|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482823|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482824|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20482825|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
20482826|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
20482827|NCT01550848|Gemcitabine|gemcitabine|mesh-list
20482828|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20482829|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20482830|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
20482831|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699284|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19699285|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
19699286|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699287|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699288|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19699289|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20482832|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482833|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
20482834|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482835|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482836|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482837|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
20482838|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482839|NCT01550900|Metformin|metformin|mesh-list
20482840|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482841|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482842|NCT01550926|Orlistat|orlistat|mesh-list
20482843|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482844|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482845|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20482846|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19699290|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699291|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
20482847|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
20482848|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
20482849|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20482850|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20482851|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482852|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482853|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482854|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482855|NCT01551147|Montelukast|montelukast|mesh-list
20482856|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19699292|NCT04904406|Lamivudine|lamivudine|mesh-list
20241047|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
20241048|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20241049|NCT00406003|Paroxetine|paroxetine|mesh-list
20241050|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20241051|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20241052|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241053|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241054|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241055|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
20241056|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241057|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20241058|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
20241059|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20241060|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20241061|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20241062|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482857|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
20482858|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20482859|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
20482860|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482861|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482862|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20482863|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20482864|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482865|NCT01551225|Citalopram|citalopram|mesh-list
20482866|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20482867|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20482868|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482869|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482870|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482871|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
20482872|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482873|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20482874|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
20482875|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20482876|NCT01551290|Infliximab|infliximab|mesh-list
20482877|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
20482878|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20482879|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20482880|NCT01551329|Ketamine|ketamine|mesh-list
19699293|NCT04904406|Abacavir|abacavir|mesh-list
19699294|NCT04904406|Dolutegravir|dolutegravir|mesh-list
20482881|NCT01551329|Analgesics|analgesics|mesh-ancestor
20482882|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
20482883|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482884|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482885|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20482886|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20482887|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
20482888|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
20482889|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414062|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699295|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19699296|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19699297|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708002|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414063|NCT03783923|Deflazacort|deflazacort|mesh-list
20482890|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20482891|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20482892|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482893|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241063|NCT00406042|Prednisolone|prednisolone|mesh-list
20241064|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20482894|NCT01551368|Nimodipine|nimodipine|mesh-list
20482895|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20482896|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20482897|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20482898|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482899|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20482900|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482901|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
20482902|NCT01551394|Gentamicins|gentamicins|mesh-list
20482903|NCT01551394|Meropenem|meropenem|mesh-list
20482904|NCT01551394|Ampicillin|ampicillin|mesh-list
20482905|NCT01551394|Cefotaxime|cefotaxime|mesh-list
20482906|NCT01551394|Cefoxitin|cefoxitin|mesh-list
20482907|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20482908|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482909|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20482910|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482911|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414064|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414065|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414066|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
19414067|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414068|NCT03782103|Ethanol|ethanol|mesh-list
19414069|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
19414070|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19414071|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19414072|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414073|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414074|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241065|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
20241066|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20241067|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
20241068|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20241069|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
20241070|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241071|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
20241072|NCT00406042|Hormones|hormones|mesh-ancestor
20482912|NCT01551459|Sunitinib|sunitinib|mesh-list
20482913|NCT01551459|Dacarbazine|dacarbazine|mesh-list
20482914|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482915|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482916|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482917|NCT01551459|Growth Substances|growth substances|mesh-ancestor
20482918|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482919|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
20482920|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20482921|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482922|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482923|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20482924|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
20482925|NCT01551485|Zolpidem|zolpidem|mesh-list
20241073|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241074|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241075|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20241076|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241077|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
20241078|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
20241079|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241080|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20241081|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20241082|NCT00406042|Protective Agents|protective agents|mesh-ancestor
20241083|NCT00406094|Montelukast|montelukast|mesh-list
20482926|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20482927|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20482928|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20482929|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482930|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20482931|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
20482932|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
20482933|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482934|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482935|NCT01551511|Dronabinol|dronabinol|mesh-list
20482936|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
20482937|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482938|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20482939|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20482940|NCT01551511|Analgesics|analgesics|mesh-ancestor
20482941|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
20482942|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482943|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20482944|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20482945|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20482946|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482947|NCT01551511|Hormones|hormones|mesh-ancestor
20482948|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20482949|NCT01551589|Docetaxel|docetaxel|mesh-list
20482950|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482951|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
20482952|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
20482953|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
20482954|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482955|NCT01551615|Metformin|metformin|mesh-list
20482956|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20482957|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482958|NCT01551628|BCT-100|bct-100|mesh-list
20482959|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482960|NCT01551641|Thalidomide|thalidomide|mesh-list
20482961|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20482962|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
20482963|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482964|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
20482965|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20482966|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482967|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20482968|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20482969|NCT01551641|Growth Substances|growth substances|mesh-ancestor
20482970|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
20482971|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482972|NCT01551667|Antibodies|antibodies|mesh-list
20482973|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
20482974|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482975|NCT01551680|Iniparib|iniparib|mesh-list
20482976|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20482977|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482978|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482979|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20482980|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20482981|NCT01551719|Vancomycin|vancomycin|mesh-list
20482982|NCT01551719|Linezolid|linezolid|mesh-list
20482983|NCT01551719|Daptomycin|daptomycin|mesh-list
20482984|NCT01551719|Penicillins|penicillins|mesh-list
20482985|NCT01551719|Tigecycline|tigecycline|mesh-list
20482986|NCT01551719|Cephalosporins|cephalosporins|mesh-list
20482987|NCT01551719|Teicoplanin|teicoplanin|mesh-list
20482988|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20482989|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20482990|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20482991|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20482992|NCT01551797|Acetaminophen|acetaminophen|mesh-list
20482993|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414075|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
20482994|NCT01551797|Analgesics|analgesics|mesh-ancestor
20482995|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
20482996|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20482997|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20482998|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
20482999|NCT01551810|Vaccines|vaccines|mesh-list
20483000|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
20483001|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483002|NCT01551823|Vaccines|vaccines|mesh-list
20483003|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
20483004|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483005|NCT01551836|Acetaminophen|acetaminophen|mesh-list
20483006|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483007|NCT01551836|Analgesics|analgesics|mesh-ancestor
20483008|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
20483009|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483010|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483011|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
20483012|NCT01552005|Saxagliptin|saxagliptin|mesh-list
20483013|NCT01552005|Incretins|incretins|mesh-ancestor
20483014|NCT01552005|Hormones|hormones|mesh-ancestor
20483015|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483016|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483017|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20483018|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
20483019|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483020|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483021|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20483022|NCT01552018|Saxagliptin|saxagliptin|mesh-list
20483023|NCT01552018|Incretins|incretins|mesh-ancestor
20483024|NCT01552018|Hormones|hormones|mesh-ancestor
20483025|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483026|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483027|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20483028|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
20483029|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483030|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483031|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20483032|NCT01552044|Spironolactone|spironolactone|mesh-list
20483033|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20483034|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
20483035|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483036|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483037|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20483038|NCT01552044|Diuretics|diuretics|mesh-ancestor
20483039|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
20483040|NCT01552122|Vitamin D|vitamin d|mesh-list
20483041|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
20483042|NCT01552122|Alendronate|alendronate|mesh-list
20483043|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
20483044|NCT01552122|Calcium|calcium|mesh-list
20483045|NCT01552122|Vitamins|vitamins|mesh-ancestor
20483046|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
20483047|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483048|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20483049|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20483050|NCT01552122|Antacids|antacids|mesh-ancestor
20527930|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
20483051|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483052|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483053|NCT01552148|Morphine|morphine|mesh-list
20483054|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20483055|NCT01552148|Narcotics|narcotics|mesh-ancestor
20483056|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483057|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483058|NCT01552148|Analgesics|analgesics|mesh-ancestor
20483059|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
20483060|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483061|NCT01552187|Colchicine|colchicine|mesh-list
20483062|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
20483063|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852532|NCT00725361|Ambrisentan|ambrisentan|mesh-list
19852533|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19852534|NCT00725452|Infliximab|infliximab|mesh-list
19852535|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
20241084|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20241085|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
20241086|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20241087|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
20241088|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241089|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241090|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20241091|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20241092|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241093|NCT00406146|Artesunate|artesunate|mesh-list
20241094|NCT00406146|Lumefantrine|lumefantrine|mesh-list
20241095|NCT00406146|Artemether|artemether|mesh-list
20241096|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20241097|NCT00406146|Amodiaquine|amodiaquine|mesh-list
20241098|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
20241099|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20241100|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19852536|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483064|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
20483065|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
20483066|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
20483067|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483068|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527931|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527932|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
20527933|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527934|NCT01770236|Acetaminophen|acetaminophen|mesh-list
20527935|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20527936|NCT01770236|Analgesics|analgesics|mesh-ancestor
20527937|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
20527938|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20527939|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527940|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
20527941|NCT01770301|Paclitaxel|paclitaxel|mesh-list
20527942|NCT01770301|Bevacizumab|bevacizumab|mesh-list
20527943|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20527944|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527945|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
20527946|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
20527947|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
20527948|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527949|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20527950|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19852537|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20527951|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20527952|NCT01770301|Growth Substances|growth substances|mesh-ancestor
20527953|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527954|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
20527955|NCT01770444|Cytarabine|cytarabine|mesh-list
20527956|NCT01770444|Thioguanine|thioguanine|mesh-list
20527957|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20527958|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
20527959|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527960|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20527961|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
20527962|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20527963|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20527964|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
20527965|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852538|NCT00725504|Lidocaine|lidocaine|mesh-list
20527966|NCT01770470|Chitosan|chitosan|mesh-list
20483069|NCT01552330|Artesunate|artesunate|mesh-list
20483070|NCT01552330|Primaquine|primaquine|mesh-list
20483071|NCT01552330|Pyronaridine|pyronaridine|mesh-list
20483072|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
20483073|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20483074|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20241101|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241102|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241103|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
20241104|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
20241105|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20241106|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
20241107|NCT00406172|Bevacizumab|bevacizumab|mesh-list
20241108|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241109|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414076|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414077|NCT03780244|Mannitol|mannitol|mesh-list
19414078|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19414079|NCT03780244|Diuretics|diuretics|mesh-ancestor
19414080|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
19699298|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699299|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
19699300|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699301|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19699302|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20241110|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241111|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241112|NCT00406172|Growth Substances|growth substances|mesh-ancestor
20241113|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241114|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241115|NCT00406237|Tigecycline|tigecycline|mesh-list
20241116|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241117|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241118|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20241119|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241120|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483075|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483076|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483077|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
20483078|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
20483079|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20483080|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
20483081|NCT01552629|Cyclosporine|cyclosporine|mesh-list
20483082|NCT01552629|Cyclosporins|cyclosporins|mesh-list
20483083|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483084|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483085|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20483086|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
20483087|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483088|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
20483089|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483090|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
20483091|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483092|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20483093|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
19699303|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20483094|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414081|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414082|NCT03778554|Metoprolol|metoprolol|mesh-list
20483095|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483096|NCT01552798|Aspirin|aspirin|mesh-list
20483097|NCT01552798|Acetaminophen|acetaminophen|mesh-list
20483098|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20483099|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483100|NCT01552798|Analgesics|analgesics|mesh-ancestor
20483101|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
19414083|NCT03778554|Carvedilol|carvedilol|mesh-list
19414084|NCT03778554|Nebivolol|nebivolol|mesh-list
19414085|NCT03778554|Bisoprolol|bisoprolol|mesh-list
19414086|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19414087|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19414088|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
20483102|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483103|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483104|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414089|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
19414090|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414091|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414092|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19414093|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19414094|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19414095|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
19414096|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414097|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414098|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
20483105|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483106|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20483107|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20483108|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483109|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20483110|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20483111|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483112|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
20483113|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20483114|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
20483115|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20483116|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20483117|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20483118|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483119|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483120|NCT01552850|Oxycodone|oxycodone|mesh-list
20483121|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20483122|NCT01552850|Narcotics|narcotics|mesh-ancestor
20483123|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483124|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483125|NCT01552850|Analgesics|analgesics|mesh-ancestor
20483126|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
20483127|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483128|NCT01552863|Oxycodone|oxycodone|mesh-list
20483129|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20483130|NCT01552863|Narcotics|narcotics|mesh-ancestor
20483131|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483132|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483133|NCT01552863|Analgesics|analgesics|mesh-ancestor
20483134|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
20483135|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483136|NCT01552967|Capecitabine|capecitabine|mesh-list
20483137|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20483138|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
20483139|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483140|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483141|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
20483142|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483143|NCT01552993|Acetaminophen|acetaminophen|mesh-list
20483144|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483145|NCT01552993|Analgesics|analgesics|mesh-ancestor
20483146|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
20483147|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483148|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483149|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
20483150|NCT01553006|Cefditoren|cefditoren|mesh-list
20483151|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
20483152|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20483153|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414099|NCT03778554|Protective Agents|protective agents|mesh-ancestor
19414100|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19414101|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414102|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19414103|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
19414104|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19414105|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19414106|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19414107|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20483154|NCT01553019|Gemcitabine|gemcitabine|mesh-list
20483155|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20483156|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
20483157|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483158|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483159|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
20483160|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483161|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483162|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20483163|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
20483164|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483165|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
20483166|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20483167|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
20483168|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20483169|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483170|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20483171|NCT01553357|Dexamethasone|dexamethasone|mesh-list
20483172|NCT01553357|Lenalidomide|lenalidomide|mesh-list
20483173|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483174|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
20483175|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
20483176|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483177|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483178|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483179|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
20483180|NCT01553357|Hormones|hormones|mesh-ancestor
20483181|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483182|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20483183|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483184|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
20483185|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483186|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483187|NCT01553357|Growth Substances|growth substances|mesh-ancestor
20483188|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
20483189|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
20483190|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
20483191|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
20483192|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20483193|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20483194|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483195|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483196|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483197|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20483198|NCT01553500|Cathartics|cathartics|mesh-ancestor
20483199|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483200|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20483201|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
20483202|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
20483203|NCT01553721|Udenafil|udenafil|mesh-list
20483204|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20483205|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20483206|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483207|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483208|NCT01553773|Estradiol|estradiol|mesh-list
20483209|NCT01553773|Estrogens|estrogens|mesh-ancestor
20483210|NCT01553773|Hormones|hormones|mesh-ancestor
20483211|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483212|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483213|NCT01553786|Lenalidomide|lenalidomide|mesh-list
20483214|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
20483215|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483216|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483217|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483218|NCT01553786|Growth Substances|growth substances|mesh-ancestor
20483219|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
20483220|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483221|NCT01553903|Tamoxifen|tamoxifen|mesh-list
20483222|NCT01553903|Letrozole|letrozole|mesh-list
20483223|NCT01553903|Anastrozole|anastrozole|mesh-list
20483224|NCT01553903|Exemestane|exemestane|mesh-list
20483225|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483226|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20483227|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20483228|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483229|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483230|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20483231|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
20483232|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483233|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483234|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20483235|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20483236|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20483237|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20483238|NCT01553942|Pemetrexed|pemetrexed|mesh-list
20483239|NCT01553942|Afatinib|afatinib|mesh-list
20483240|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483241|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483242|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483243|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20483244|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20483245|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20483246|NCT01553981|Tadalafil|tadalafil|mesh-list
20483247|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
20483248|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20483249|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20483250|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483251|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483252|NCT01553981|Urological Agents|urological agents|mesh-ancestor
20483253|NCT01554059|Bevacizumab|bevacizumab|mesh-list
20483254|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
20483255|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20483256|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483257|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483258|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483259|NCT01554059|Growth Substances|growth substances|mesh-ancestor
20483260|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483261|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
20527967|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20527968|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20527969|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
20527970|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527971|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20527972|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
20527973|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
20527974|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
20527975|NCT01770470|Coagulants|coagulants|mesh-ancestor
20527976|NCT01770496|Vaccines|vaccines|mesh-list
20527977|NCT01770496|Immunologic Factors|immunologic factors|mesh-ancestor
20527978|NCT01770496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527979|NCT01770600|Risperidone|risperidone|mesh-list
20527980|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20527981|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
20527982|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20527983|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20527984|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20527985|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20527986|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20527987|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20527988|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20527989|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20527990|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
20527991|NCT01770769|Cloxacillin|cloxacillin|mesh-list
20527992|NCT01770769|Cephalothin|cephalothin|mesh-list
20527993|NCT01770769|Dalteparin|dalteparin|mesh-list
20527994|NCT01770769|Tinzaparin|tinzaparin|mesh-list
20527995|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20527996|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
20527997|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20527998|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20527999|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528000|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528001|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530670|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530671|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
20530672|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
20530673|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530674|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530675|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530676|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
20530677|NCT01789892|Hormones|hormones|mesh-ancestor
20530678|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530679|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19414108|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20530680|NCT01789892|Protective Agents|protective agents|mesh-ancestor
20530681|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20530682|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483262|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
20483263|NCT01554111|Cathartics|cathartics|mesh-ancestor
20483264|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483265|NCT01554124|Meropenem|meropenem|mesh-list
20483266|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20483267|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483268|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20483269|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20483270|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
20483271|NCT01554345|Vitamin E|vitamin e|mesh-list
20483272|NCT01554345|Selenium|selenium|mesh-list
20483273|NCT01554345|Vitamins|vitamins|mesh-ancestor
19852539|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
19852540|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
19852541|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852542|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852543|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
19852544|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852545|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19852546|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19852547|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19852548|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19852549|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852550|NCT00725543|Infliximab|infliximab|mesh-list
19852551|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
19852552|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852553|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852554|NCT00725608|Buprenorphine|buprenorphine|mesh-list
19852555|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20483274|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
20483275|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483276|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
20483277|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483278|NCT01554345|Protective Agents|protective agents|mesh-ancestor
20483279|NCT01554345|Trace Elements|trace elements|mesh-ancestor
20483280|NCT01554397|Cisplatin|cisplatin|mesh-list
20483281|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483282|NCT01554540|Treprostinil|treprostinil|mesh-list
20483283|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20483284|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20483285|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20483286|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20483287|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
20483288|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483289|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483290|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20483291|NCT01554631|Acarbose|acarbose|mesh-list
19852556|NCT00725608|Naloxone|naloxone|mesh-list
19852557|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19852558|NCT00725608|Narcotics|narcotics|mesh-ancestor
20241121|NCT00406250|Bevacizumab|bevacizumab|mesh-list
20241122|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241123|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241124|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241125|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241126|NCT00406250|Growth Substances|growth substances|mesh-ancestor
20241127|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241128|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241129|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20241130|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20241131|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241132|NCT00406302|Docetaxel|docetaxel|mesh-list
20241133|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
20241134|NCT00406302|Cetuximab|cetuximab|mesh-list
20241135|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241136|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20241137|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
19852559|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483292|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20483293|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699304|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19699305|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19699306|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19699307|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708003|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
19708004|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20483294|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483295|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20483296|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483297|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20483298|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20483299|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483300|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
20483301|NCT01554813|Vaccines|vaccines|mesh-list
20483302|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
20483303|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483304|NCT01554826|Vaccines|vaccines|mesh-list
20483305|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
20483306|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483307|NCT01554852|Thalidomide|thalidomide|mesh-list
20483308|NCT01554852|Dexamethasone|dexamethasone|mesh-list
20483309|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
20483310|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
20483311|NCT01554852|Melphalan|melphalan|mesh-list
20483312|NCT01554852|Lenalidomide|lenalidomide|mesh-list
20483313|NCT01554852|Bortezomib|bortezomib|mesh-list
20483314|NCT01554852|Vorinostat|vorinostat|mesh-list
20483315|NCT01554852|BB 1101|bb 1101|mesh-list
20483316|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20483317|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
20483318|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483319|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483320|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20483321|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
20483322|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483323|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483324|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20483325|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483326|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
20483327|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
20483328|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483329|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483330|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
20483331|NCT01554852|Hormones|hormones|mesh-ancestor
20483332|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483333|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20483334|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
20483335|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483336|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483337|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483338|NCT01554852|Growth Substances|growth substances|mesh-ancestor
20483339|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
20483340|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
20483341|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20483342|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483343|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20483344|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
20483345|NCT01554930|Mannitol|mannitol|mesh-list
20483346|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
20483347|NCT01554930|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20483348|NCT01554930|Antibodies|antibodies|mesh-list
20483349|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483350|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
20483351|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
20483352|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483353|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483354|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483355|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
20483356|NCT01554930|Hormones|hormones|mesh-ancestor
20483357|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483358|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20483359|NCT01554930|Protective Agents|protective agents|mesh-ancestor
20483360|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
20483361|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20483362|NCT01554930|Diuretics|diuretics|mesh-ancestor
20483363|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
20483364|NCT01554956|Plasminogen|plasminogen|mesh-list
20483365|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20483366|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20483367|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483368|NCT01554969|Capecitabine|capecitabine|mesh-list
20483369|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20483370|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
20483371|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483372|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699308|NCT04903847|Tenofovir|tenofovir|mesh-list
19699309|NCT04903847|Lamivudine|lamivudine|mesh-list
19699310|NCT04903847|Dolutegravir|dolutegravir|mesh-list
19699311|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
19699312|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699313|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19699314|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19699315|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483373|NCT01554995|Linezolid|linezolid|mesh-list
20483374|NCT01554995|Delpazolid|delpazolid|mesh-list
20483375|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20483376|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483377|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20483378|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483379|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483380|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19699316|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699317|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19699318|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19699319|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20528002|NCT01770795|Gemcitabine|gemcitabine|mesh-list
19699320|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19699321|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
20483381|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20483382|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483383|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20483384|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483385|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
20483386|NCT01555060|Hematinics|hematinics|mesh-ancestor
20483387|NCT01555099|Budesonide|budesonide|mesh-list
20483388|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483389|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20483390|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
20483391|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483392|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483393|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20483394|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
20483395|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
20483396|NCT01555099|Hormones|hormones|mesh-ancestor
20483397|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483398|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
19699322|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
19699323|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699324|NCT04903808|Protective Agents|protective agents|mesh-ancestor
19699325|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699326|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20241138|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
20241139|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241140|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699327|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699328|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19699329|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699330|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
19699331|NCT04903743|Bupivacaine|bupivacaine|mesh-list
19699332|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
20241141|NCT00406341|Difluprednate|difluprednate|mesh-list
20241142|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
20241143|NCT00406341|Hormones|hormones|mesh-ancestor
20241144|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241145|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241146|NCT00406380|Bevacizumab|bevacizumab|mesh-list
20241147|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241148|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699333|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
20483399|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20483400|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
20483401|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483402|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483403|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20483404|NCT01555112|Protective Agents|protective agents|mesh-ancestor
20483405|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19414109|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
19414110|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19414111|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
19414112|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414113|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
19414114|NCT03777917|Protective Agents|protective agents|mesh-ancestor
19414115|NCT03775421|Macitentan|macitentan|mesh-list
19414116|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20483406|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20483407|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483408|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483409|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
20483410|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483411|NCT01555190|Folic Acid|folic acid|mesh-list
20483412|NCT01555190|Inositol|inositol|mesh-list
20483413|NCT01555190|Hematinics|hematinics|mesh-ancestor
20483414|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
20483415|NCT01555190|Vitamins|vitamins|mesh-ancestor
20483416|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
20483417|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483418|NCT01555216|Ropivacaine|ropivacaine|mesh-list
20483419|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
20483420|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
20483421|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483422|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483423|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
20483424|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414117|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20483425|NCT01555268|Cytarabine|cytarabine|mesh-list
20483426|NCT01555268|Trebananib|trebananib|mesh-list
20483427|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20483428|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
20483429|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483430|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483431|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
20483432|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483433|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20483434|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
20483435|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483436|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483437|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483438|NCT01555268|Growth Substances|growth substances|mesh-ancestor
20483439|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
20483440|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
20483441|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20483442|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20483443|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
20483444|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483445|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20483446|NCT01555476|Ibuprofen|ibuprofen|mesh-list
20483447|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20483448|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483449|NCT01555476|Analgesics|analgesics|mesh-ancestor
20483450|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
20483451|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483452|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483453|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483454|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483455|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20483456|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483457|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483458|NCT01555580|Molgramostim|molgramostim|mesh-list
20483459|NCT01555580|Sargramostim|sargramostim|mesh-list
20483460|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
19699334|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699335|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699336|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
19699337|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699338|NCT04903743|Analgesics|analgesics|mesh-ancestor
19699339|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19699340|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
19699341|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19699342|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20483461|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530683|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19414118|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852560|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483462|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483463|NCT01555632|Atorvastatin|atorvastatin|mesh-list
20483464|NCT01555632|Calcium|calcium|mesh-list
20483465|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20483466|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483467|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20483468|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20483469|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
20483470|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483471|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20483472|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20483473|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483474|NCT01555658|Heparin|heparin|mesh-list
20483475|NCT01555658|Bivalirudin|bivalirudin|mesh-list
20483476|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
20483477|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20483478|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20483479|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483480|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
20483481|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20483482|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
19414119|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19414120|NCT03772964|Metformin|metformin|mesh-list
19414121|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414122|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414123|NCT03768089|Ivacaftor|ivacaftor|mesh-list
19414124|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19414125|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19852561|NCT00725608|Analgesics|analgesics|mesh-ancestor
20483483|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483484|NCT01555710|Carboplatin|carboplatin|mesh-list
20483485|NCT01555710|Etoposide|etoposide|mesh-list
20483486|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
20483487|NCT01555710|Ifosfamide|ifosfamide|mesh-list
20483488|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483489|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20483490|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20483491|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19852562|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
19852563|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852564|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20483492|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483493|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483494|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20483495|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
20528003|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20528004|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
20528005|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528006|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528007|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
20528008|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528009|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528010|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528011|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
20528012|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528013|NCT01770899|Montelukast|montelukast|mesh-list
20528014|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20528015|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
20528016|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20528017|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
20528018|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528019|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483496|NCT01555788|Pancrelipase|pancrelipase|mesh-list
20483497|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483498|NCT01555814|Amisulpride|amisulpride|mesh-list
20241149|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241150|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241151|NCT00406380|Growth Substances|growth substances|mesh-ancestor
20241152|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241153|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241154|NCT00406432|Paroxetine|paroxetine|mesh-list
20241155|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20241156|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20241157|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20483499|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20483500|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20483501|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483502|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483503|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20483504|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20483505|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
20483506|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483507|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483508|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20483509|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
20483510|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20483511|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483512|NCT01555866|Isavuconazole|isavuconazole|mesh-list
20483513|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
20483514|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483515|NCT01555879|Abatacept|abatacept|mesh-list
20483516|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20483517|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483518|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483519|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20483520|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
20483521|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483522|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483523|NCT01555918|Isavuconazole|isavuconazole|mesh-list
20483524|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
20483525|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483526|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
20483527|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20483528|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
20483529|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483530|NCT01555970|Expectorants|expectorants|mesh-ancestor
20483531|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
20483532|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20483533|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
20483534|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483535|NCT01555970|Protective Agents|protective agents|mesh-ancestor
20483536|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483537|NCT01555970|Antidotes|antidotes|mesh-ancestor
20483538|NCT01556035|Lenalidomide|lenalidomide|mesh-list
20483539|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
20483540|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483541|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483542|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483543|NCT01556035|Growth Substances|growth substances|mesh-ancestor
20483544|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
20483545|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483546|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20483547|NCT01556191|Fulvestrant|fulvestrant|mesh-list
20483548|NCT01556191|Gefitinib|gefitinib|mesh-list
20483549|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483550|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20483551|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483552|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483553|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20483554|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20483555|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20483556|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
20483557|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483558|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483559|NCT01556321|Caffeine|caffeine|mesh-list
20483560|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20483561|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483562|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20483563|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483564|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483565|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20483566|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20483567|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
20483568|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483569|NCT01556334|Azithromycin|azithromycin|mesh-list
20483570|NCT01556334|Erythromycin|erythromycin|mesh-list
20483571|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
20483572|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20483573|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
20483574|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20483575|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483576|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483577|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20483578|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483579|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483580|NCT01556477|Lenalidomide|lenalidomide|mesh-list
20483581|NCT01556477|Azacitidine|azacitidine|mesh-list
20483582|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
20483583|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483584|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483585|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483586|NCT01556477|Growth Substances|growth substances|mesh-ancestor
20483587|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
19414126|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414127|NCT03766295|Gemcitabine|gemcitabine|mesh-list
19414128|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19414129|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
19414130|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483588|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483589|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20483590|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
20483591|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483592|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483593|NCT01556529|Unithiol|unithiol|mesh-list
20483594|NCT01556529|Antidotes|antidotes|mesh-ancestor
20483595|NCT01556529|Protective Agents|protective agents|mesh-ancestor
20483596|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483597|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
20483598|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
20483599|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483600|NCT01556542|Paclitaxel|paclitaxel|mesh-list
20483601|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20483602|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483603|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
20483604|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
20483605|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
20483606|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483607|NCT01556646|Tolvaptan|tolvaptan|mesh-list
20483608|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20483609|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483610|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
20483611|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483612|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
20483613|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
20483614|NCT01556672|Adalimumab|adalimumab|mesh-list
20483615|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483616|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483617|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
20483618|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20483619|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
20483620|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483621|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483622|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20483623|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
20483624|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20483625|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
20483626|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483627|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483628|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20483629|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
20483630|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
20483631|NCT01556698|Protective Agents|protective agents|mesh-ancestor
20483632|NCT01556737|Genistein|genistein|mesh-list
20483633|NCT01556737|Daidzein|daidzein|mesh-list
20483634|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20483635|NCT01556737|Protective Agents|protective agents|mesh-ancestor
20483636|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483637|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483638|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20483639|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483640|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483641|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
20483642|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19414131|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483643|NCT01556737|Estrogens|estrogens|mesh-ancestor
19414132|NCT03766295|Antiviral Agents|antiviral agents|mesh-ancestor
20483644|NCT01556737|Hormones|hormones|mesh-ancestor
20483645|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483646|NCT01556815|Sorafenib|sorafenib|mesh-list
20483647|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
20483648|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483649|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20483650|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483651|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483652|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20483653|NCT01556815|Estrogens|estrogens|mesh-ancestor
20483654|NCT01556815|Hormones|hormones|mesh-ancestor
20483655|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483656|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483657|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20483658|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20483659|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483660|NCT01557075|Atorvastatin|atorvastatin|mesh-list
20483661|NCT01557075|Pravastatin|pravastatin|mesh-list
20483662|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20483663|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20483664|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20483665|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
20483666|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483667|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20483668|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483669|NCT01557114|Ipilimumab|ipilimumab|mesh-list
20483670|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20483671|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483672|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20483673|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483674|NCT01557127|Sorafenib|sorafenib|mesh-list
20483675|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483676|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20483677|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483678|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483679|NCT01557140|Carvedilol|carvedilol|mesh-list
20483680|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20483681|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20483682|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
20483683|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483684|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483685|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483686|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20483687|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
20483688|NCT01557140|Protective Agents|protective agents|mesh-ancestor
20483689|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20483690|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20483691|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20483692|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
20483693|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20483694|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20483695|NCT01557153|Amlodipine|amlodipine|mesh-list
20241158|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241159|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483696|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19414133|NCT03766295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414134|NCT03766295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241160|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
20241161|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241162|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20241163|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
20241164|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20241165|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20241166|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20241167|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241168|NCT00406471|Ranibizumab|ranibizumab|mesh-list
20241169|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241170|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241171|NCT00406471|Growth Substances|growth substances|mesh-ancestor
20483697|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20483698|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20483699|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483700|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20241172|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483701|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483702|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
20483703|NCT01557257|Naltrexone|naltrexone|mesh-list
20241173|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241174|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241175|NCT00406497|Difluprednate|difluprednate|mesh-list
20241176|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
20241177|NCT00406497|Hormones|hormones|mesh-ancestor
20241178|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241179|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241180|NCT00406575|Methocarbamol|methocarbamol|mesh-list
20241181|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20241182|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241183|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20241184|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241185|NCT00406601|Sorafenib|sorafenib|mesh-list
20241186|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483704|NCT01557257|Oxycodone|oxycodone|mesh-list
20483705|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20483706|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20483707|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483708|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
20483709|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483710|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20483711|NCT01557257|Narcotics|narcotics|mesh-ancestor
20483712|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483713|NCT01557257|Analgesics|analgesics|mesh-ancestor
20483714|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
20483715|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19852565|NCT00725621|Infliximab|infliximab|mesh-list
20483716|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483717|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483718|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483719|NCT01557270|Analgesics|analgesics|mesh-ancestor
19414135|NCT03766295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414136|NCT03766295|Immunologic Factors|immunologic factors|mesh-ancestor
19414137|NCT03766295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414138|NCT03761225|Prednisone|prednisone|mesh-list
19414139|NCT03761225|Docetaxel|docetaxel|mesh-list
19414140|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414141|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
19414142|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
19414143|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
19414144|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414145|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414146|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
19414147|NCT03761225|Hormones|hormones|mesh-ancestor
19414148|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414149|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414150|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19414151|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19414152|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19414153|NCT03740737|Hormones|hormones|mesh-ancestor
19414154|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414155|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414156|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19414157|NCT03738618|Hormones|hormones|mesh-ancestor
19414158|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414159|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414160|NCT03737123|Gemcitabine|gemcitabine|mesh-list
19414161|NCT03737123|Carboplatin|carboplatin|mesh-list
19414162|NCT03737123|Docetaxel|docetaxel|mesh-list
19414163|NCT03737123|Atezolizumab|atezolizumab|mesh-list
19414164|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414165|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19414166|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
19414167|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414168|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
19414169|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414170|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414171|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414172|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
19414173|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414174|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
19414175|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
19414176|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
20483720|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
20483721|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483722|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19414177|NCT03729362|Miglustat|miglustat|mesh-list
19414178|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483723|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20483724|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20483725|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
20483726|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483727|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483728|NCT01557335|Aspirin|aspirin|mesh-list
20483729|NCT01557335|Omeprazole|omeprazole|mesh-list
20483730|NCT01557335|Clopidogrel|clopidogrel|mesh-list
20483731|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20483732|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483733|NCT01557335|Analgesics|analgesics|mesh-ancestor
20483734|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
20483735|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483736|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483737|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241187|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20241188|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241189|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241190|NCT00406679|Acetaminophen|acetaminophen|mesh-list
20241191|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20241192|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20241193|NCT00406679|Analgesics|analgesics|mesh-ancestor
20241194|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
20241195|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241196|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483738|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483739|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20483740|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20483741|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483742|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20483743|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20483744|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483745|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
20483746|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20483747|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20483748|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20483749|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
20483750|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483751|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20483752|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20483753|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20483754|NCT01557374|Abatacept|abatacept|mesh-list
20483755|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20483756|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483757|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483758|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20483759|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
20483760|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483761|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483762|NCT01557439|Levocetirizine|levocetirizine|mesh-list
20241197|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
20241198|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20241199|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241200|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241201|NCT00406744|Bevacizumab|bevacizumab|mesh-list
20241202|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241203|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241204|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483763|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20483764|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20483765|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
20483766|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
20483767|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483768|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852566|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
19852567|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852568|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852569|NCT00725751|Interferons|interferons|mesh-list
19852570|NCT00725751|Ribavirin|ribavirin|mesh-list
19852571|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
19852572|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
19852573|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852574|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852575|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
19852576|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852577|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
19852578|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852579|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
19852580|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852581|NCT00725842|Ribavirin|ribavirin|mesh-list
19852582|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
19852583|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852584|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
19852585|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852586|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
19852587|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483769|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483770|NCT01557478|Melatonin|melatonin|mesh-list
20483771|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
20483772|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483773|NCT01557478|Protective Agents|protective agents|mesh-ancestor
20483774|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483775|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528020|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20528021|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19414179|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852588|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852589|NCT00725920|Topiramate|topiramate|mesh-list
20483776|NCT01557634|Insulin|insulin|mesh-list
20483777|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20483778|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699343|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699344|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19699345|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
20483779|NCT01557647|Treprostinil|treprostinil|mesh-list
20483780|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20483781|NCT01557660|Treprostinil|treprostinil|mesh-list
20483782|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20483783|NCT01557712|Ketamine|ketamine|mesh-list
20483784|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20483785|NCT01557712|Analgesics|analgesics|mesh-ancestor
20483786|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
20483787|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483788|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483789|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20483790|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20483791|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
20483792|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
20483793|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483794|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20483795|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20483796|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483797|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483798|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20483799|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20483800|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20483801|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20483802|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
20483803|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20483804|NCT01557764|Trastuzumab|trastuzumab|mesh-list
20483805|NCT01557764|Lapatinib|lapatinib|mesh-list
20483806|NCT01557764|Antibodies|antibodies|mesh-list
20483807|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20483808|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
20483809|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483810|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20483811|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414180|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19699346|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20483812|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20483813|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852590|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
19852591|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19852592|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852593|NCT00726375|Etanercept|etanercept|mesh-list
19852594|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19852595|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852596|NCT00726375|Analgesics|analgesics|mesh-ancestor
19852597|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
19852598|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852599|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852600|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19852601|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483814|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483815|NCT01557816|Naproxen|naproxen|mesh-list
20483816|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20483817|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483818|NCT01557816|Analgesics|analgesics|mesh-ancestor
20483819|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
20483820|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483821|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483822|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483823|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483824|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
20483825|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20483826|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483827|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483828|NCT01557829|Silicon|silicon|mesh-list
20483829|NCT01557829|Trace Elements|trace elements|mesh-ancestor
20483830|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
20483831|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483832|NCT01557907|Insulin|insulin|mesh-list
20483833|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20483834|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20483835|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483836|NCT01557985|Bupivacaine|bupivacaine|mesh-list
20483837|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
20483838|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
20483839|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483840|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483841|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
20483842|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483843|NCT01558011|Docetaxel|docetaxel|mesh-list
20483844|NCT01558011|Capecitabine|capecitabine|mesh-list
20483845|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
20483846|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483847|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
20483848|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
20483849|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
20483850|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483851|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20483852|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
20483853|NCT01558115|Denosumab|denosumab|mesh-list
20483854|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20483855|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483856|NCT01558167|Rituximab|rituximab|mesh-list
20483857|NCT01558167|Lenalidomide|lenalidomide|mesh-list
20483858|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20483859|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20483860|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483861|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
19699347|NCT04903483|Anesthetics|anesthetics|mesh-list
19699348|NCT04903483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699349|NCT04903483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699350|NCT04903470|Bisacodyl|bisacodyl|mesh-list
19699351|NCT04903470|Cathartics|cathartics|mesh-ancestor
19699352|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699353|NCT04903470|Laxatives|laxatives|mesh-ancestor
19699354|NCT04903678|Melphalan|melphalan|mesh-list
19699355|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19699356|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
19699357|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699358|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483862|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483863|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483864|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20483865|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20483866|NCT01558167|Growth Substances|growth substances|mesh-ancestor
19699359|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20483867|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
20483868|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20483869|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
20483870|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483871|NCT01558193|Vitamins|vitamins|mesh-list
20483872|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
20483873|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
20483874|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483875|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20483876|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483877|NCT01558193|Analgesics|analgesics|mesh-ancestor
20483878|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
20483879|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483880|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483881|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483882|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20483883|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
20483884|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483885|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20483886|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
20483887|NCT01558245|Kallikreins|kallikreins|mesh-list
20483888|NCT01558245|Coagulants|coagulants|mesh-ancestor
20483889|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
20483890|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
20483891|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20483892|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483893|NCT01558310|Ustekinumab|ustekinumab|mesh-list
20483894|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
20483895|NCT01558336|Praziquantel|praziquantel|mesh-list
20483896|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
20483897|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20483898|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483899|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20483900|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483901|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
20483902|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483903|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
20483904|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
20483905|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20483906|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20483907|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483908|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483909|NCT01558466|Urological Agents|urological agents|mesh-ancestor
19852602|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852603|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19852604|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
19852605|NCT00726388|Diclofenac|diclofenac|mesh-list
19852606|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19852607|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852608|NCT00726388|Analgesics|analgesics|mesh-ancestor
19852609|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
19414181|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19414182|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
20483910|NCT01558622|Ascorbic Acid|ascorbic acid|mesh-list
20483911|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19414183|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414184|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20483912|NCT01558622|Ketoprofen|ketoprofen|mesh-list
20483913|NCT01558622|Meperidine|meperidine|mesh-list
20483914|NCT01558622|Tramadol|tramadol|mesh-list
20483915|NCT01558622|Vitamins|vitamins|mesh-ancestor
20483916|NCT01558622|Micronutrients|micronutrients|mesh-ancestor
20483917|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483918|NCT01558622|Antioxidants|antioxidants|mesh-ancestor
20483919|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483920|NCT01558622|Protective Agents|protective agents|mesh-ancestor
20483921|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20483922|NCT01558622|Narcotics|narcotics|mesh-ancestor
20483923|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483924|NCT01558622|Analgesics|analgesics|mesh-ancestor
20483925|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
20483926|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483927|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20483928|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20483929|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483930|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20483931|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20483932|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20483933|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483934|NCT01558648|Analgesics|analgesics|mesh-list
20483935|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
20483936|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483937|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483938|NCT01558713|Fentanyl|fentanyl|mesh-list
20483939|NCT01558713|Bupivacaine|bupivacaine|mesh-list
20483940|NCT01558713|Ropivacaine|ropivacaine|mesh-list
20483941|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
20483942|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
20483943|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
20483944|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20483945|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241205|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241206|NCT00406744|Growth Substances|growth substances|mesh-ancestor
20483946|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
20483947|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483948|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20483949|NCT01558713|Narcotics|narcotics|mesh-ancestor
20483950|NCT01558713|Analgesics|analgesics|mesh-ancestor
20483951|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20483952|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20483953|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
19414185|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414186|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414187|NCT03727022|Lorecivivint|lorecivivint|mesh-list
19414188|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414189|NCT03724825|Testosterone|testosterone|mesh-list
19414190|NCT03724825|Androgens|androgens|mesh-ancestor
19414191|NCT03724825|Hormones|hormones|mesh-ancestor
20241207|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241208|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241209|NCT00406796|Ranibizumab|ranibizumab|mesh-list
20241210|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19414192|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241211|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241212|NCT00406796|Growth Substances|growth substances|mesh-ancestor
20241213|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241214|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
20483954|NCT01558830|Ranolazine|ranolazine|mesh-list
20483955|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20483956|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19852610|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852611|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483957|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483958|NCT01558869|Capecitabine|capecitabine|mesh-list
20483959|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
20483960|NCT01558869|Irinotecan|irinotecan|mesh-list
20483961|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20483962|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
20483963|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852612|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20483964|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483965|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20483966|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20483967|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483968|NCT01558934|Lofexidine|lofexidine|mesh-list
20483969|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20483970|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20483971|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483972|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
20483973|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20483974|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20483975|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20483976|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19414193|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414194|NCT03721965|Prednisone|prednisone|mesh-list
19414195|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
19414196|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414197|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
19414198|NCT03721965|Hormones|hormones|mesh-ancestor
20241215|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241216|NCT00406861|Montelukast|montelukast|mesh-list
20241217|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20241218|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
20241219|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20241220|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
20241221|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241222|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241223|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20241224|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19414199|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414200|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414201|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19414202|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241225|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241226|NCT00406874|Folic Acid|folic acid|mesh-list
20241227|NCT00406874|Hematinics|hematinics|mesh-ancestor
20241228|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
20241229|NCT00406874|Vitamins|vitamins|mesh-ancestor
20241230|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
20241231|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241232|NCT00406887|Difluprednate|difluprednate|mesh-list
20241233|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
20241234|NCT00406887|Hormones|hormones|mesh-ancestor
20241235|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20483977|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
20483978|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20483979|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483980|NCT01558960|Melphalan|melphalan|mesh-list
20483981|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20483982|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
20483983|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483984|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20483985|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20483986|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20483987|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
19414203|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
19414204|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
19414205|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852613|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852614|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19852615|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852616|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852617|NCT00726414|Quinine|quinine|mesh-list
19852618|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
19414206|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19414207|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19414208|NCT03721965|Protective Agents|protective agents|mesh-ancestor
19414209|NCT03720613|Naloxegol|naloxegol|mesh-list
20483988|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483989|NCT01558986|Cefazolin|cefazolin|mesh-list
20483990|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20483991|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20483992|NCT01559025|Vildagliptin|vildagliptin|mesh-list
20483993|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19852619|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19852620|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19852621|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852622|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19852623|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852624|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19852625|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852626|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852627|NCT00726414|Analgesics|analgesics|mesh-ancestor
19852628|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
19852629|NCT00726557|Interferons|interferons|mesh-list
19852630|NCT00726557|Ribavirin|ribavirin|mesh-list
19852631|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
20483994|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414210|NCT03720613|Lubiprostone|lubiprostone|mesh-list
19414211|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19852632|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
20483995|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20483996|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
20483997|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20483998|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20483999|NCT01559051|Anesthetics|anesthetics|mesh-list
20484000|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484001|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484002|NCT01559142|Azathioprine|azathioprine|mesh-list
20484003|NCT01559142|Infliximab|infliximab|mesh-list
20484004|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
20484005|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20484006|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484007|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
19852633|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852634|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852635|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
19852636|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852637|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
19852638|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852639|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
19852640|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852641|NCT00726609|Posaconazole|posaconazole|mesh-list
19852642|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
19852643|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852644|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19852645|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19852646|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19852647|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19852648|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19852649|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852650|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852651|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19852652|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
19852653|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852654|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852655|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
19852656|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
19852657|NCT00726713|Vitamins|vitamins|mesh-ancestor
19852658|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
20484008|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484009|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20484010|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484011|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484012|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
20484013|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484014|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20484015|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20484016|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20484017|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484018|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484019|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20484020|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20484021|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20484022|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
20484023|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484024|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484025|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20484026|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20484027|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
20484028|NCT01559285|Ropivacaine|ropivacaine|mesh-list
19414212|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414213|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414214|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19414215|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414216|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
20484029|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
19414217|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414218|NCT03712371|Chitosan|chitosan|mesh-list
20484030|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
20241236|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241237|NCT00406913|Mupirocin|mupirocin|mesh-list
20241238|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241239|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241240|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20241241|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241242|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241243|NCT00406952|Sertraline|sertraline|mesh-list
20241244|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
20484031|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484032|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484033|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
20484034|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484035|NCT01559298|Aspirin|aspirin|mesh-list
20484036|NCT01559298|Clopidogrel|clopidogrel|mesh-list
20484037|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20484038|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20484039|NCT01559298|Analgesics|analgesics|mesh-ancestor
20484040|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
20484041|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484042|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484043|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484044|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484045|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19699360|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19699361|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
20484046|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20484047|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484048|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20484049|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20484050|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484051|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
20484052|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20484053|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20484054|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20484055|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
20484056|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528022|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528023|NCT01770964|Pregabalin|pregabalin|mesh-list
20528024|NCT01770964|Analgesics|analgesics|mesh-ancestor
20528025|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
20528026|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528027|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528028|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
20528029|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20528030|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528031|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528032|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20528033|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20528034|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20528035|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528036|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20528037|NCT01771081|Ranibizumab|ranibizumab|mesh-list
20528038|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20528039|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20528040|NCT01771081|Growth Substances|growth substances|mesh-ancestor
20528041|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528042|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
20528043|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528044|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
20528045|NCT01771146|Irinotecan|irinotecan|mesh-list
20528046|NCT01771146|Folfirinox|folfirinox|mesh-list
20528047|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528048|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20528049|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20528050|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528051|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528052|NCT01771185|Metformin|metformin|mesh-list
20528053|NCT01771185|Gliclazide|gliclazide|mesh-list
20528054|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20528055|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528056|NCT01771198|Simvastatin|simvastatin|mesh-list
20528057|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20528058|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20528059|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
20528060|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528061|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20528062|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20528063|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528064|NCT01771289|Docetaxel|docetaxel|mesh-list
20528065|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528066|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
20528067|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
20528068|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
20528069|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528070|NCT01771302|Calcium|calcium|mesh-list
20528071|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20528072|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528073|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
20528074|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20528075|NCT01771328|Cortisone|cortisone|mesh-list
20528076|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528077|NCT01771406|Nebivolol|nebivolol|mesh-list
20528078|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20528079|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
20528080|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20484057|NCT01559480|Desogestrel|desogestrel|mesh-list
20484058|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20484059|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20484060|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20484061|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
20484062|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20484063|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484064|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20484065|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20484066|NCT01559480|Progestins|progestins|mesh-ancestor
20484067|NCT01559480|Hormones|hormones|mesh-ancestor
20484068|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484069|NCT01559545|Metronidazole|metronidazole|mesh-list
20484070|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484071|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484072|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20484073|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20484074|NCT01559584|Triamcinolone|triamcinolone|mesh-list
20484075|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20484076|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20484077|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20484078|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484079|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
20484080|NCT01559584|Hormones|hormones|mesh-ancestor
20484081|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484082|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484083|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484084|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
19414219|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19414220|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19414221|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
19414222|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414223|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19414224|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
19414225|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
19414226|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
19414227|NCT03712371|Coagulants|coagulants|mesh-ancestor
20484085|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241245|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20241246|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20484086|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484087|NCT01559727|Prednisone|prednisone|mesh-list
20484088|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484089|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
20484090|NCT01559727|Hormones|hormones|mesh-ancestor
20484091|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484092|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484093|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20484094|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484095|NCT01559740|Bupivacaine|bupivacaine|mesh-list
20484096|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
20484097|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
20484098|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484099|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484100|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
20484101|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484102|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20484103|NCT01559753|Amoxicillin|amoxicillin|mesh-list
20484104|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
19414228|NCT03710564|Aflibercept|aflibercept|mesh-list
20241247|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20241248|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241249|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241250|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241251|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
20241252|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241253|NCT00406978|Thalidomide|thalidomide|mesh-list
20484105|NCT01559753|Tobramycin|tobramycin|mesh-list
19414229|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19414230|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20484106|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20484107|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
20484108|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
20484109|NCT01559753|Cefotaxime|cefotaxime|mesh-list
20484110|NCT01559753|Cefoxitin|cefoxitin|mesh-list
20484111|NCT01559753|Netilmicin|netilmicin|mesh-list
20484112|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484113|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20484114|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484115|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484116|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20484117|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
20484118|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20484119|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484120|NCT01559974|Vitamins|vitamins|mesh-ancestor
20484121|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
20484122|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20484123|NCT01560013|Naltrexone|naltrexone|mesh-list
20484124|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20484125|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20484126|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484127|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
20484128|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484129|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
20484130|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20484131|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20484132|NCT01560052|Prednisolone|prednisolone|mesh-list
20484133|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
20484134|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20484135|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
20484136|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484137|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
20484138|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
20484139|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484140|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484141|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20484142|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
20484143|NCT01560052|Hormones|hormones|mesh-ancestor
20484144|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484145|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20484146|NCT01560052|Protective Agents|protective agents|mesh-ancestor
20484147|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20484148|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484149|NCT01560065|Folic Acid|folic acid|mesh-list
20484150|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
20484151|NCT01560065|Inositol|inositol|mesh-list
20484152|NCT01560065|Hematinics|hematinics|mesh-ancestor
20484153|NCT01560065|Vitamins|vitamins|mesh-ancestor
20484154|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
20484155|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484156|NCT01560091|Tamsulosin|tamsulosin|mesh-list
20484157|NCT01560091|Silodosin|silodosin|mesh-list
20484158|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20484159|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20484160|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20484161|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
20484162|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484163|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484164|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484165|NCT01560091|Urological Agents|urological agents|mesh-ancestor
19699362|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484166|NCT01560117|Rituximab|rituximab|mesh-list
20484167|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20484168|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484169|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
20484170|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484171|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484172|NCT01560221|Buprenorphine|buprenorphine|mesh-list
20484173|NCT01560221|Methadone|methadone|mesh-list
20484174|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20484175|NCT01560221|Narcotics|narcotics|mesh-ancestor
20484176|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484177|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484178|NCT01560221|Analgesics|analgesics|mesh-ancestor
20484179|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
20484180|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484181|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20484182|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
20484183|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
20484184|NCT01560299|Methimazole|methimazole|mesh-list
20484185|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
19852659|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852660|NCT00726739|Aldesleukin|aldesleukin|mesh-list
19852661|NCT00726739|Interleukin-2|interleukin-2|mesh-list
19852662|NCT00726739|Vaccines|vaccines|mesh-list
19852663|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
19852664|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852665|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852666|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852667|NCT00726739|Analgesics|analgesics|mesh-ancestor
19852668|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
19852669|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852670|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19852671|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19852672|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
19852673|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852674|NCT00726752|Axitinib|axitinib|mesh-list
20241254|NCT00406978|Prednisone|prednisone|mesh-list
20484186|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
20484187|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484188|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484189|NCT01560390|Ketamine|ketamine|mesh-list
20484190|NCT01560390|Analgesics|analgesics|mesh-ancestor
19852675|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241255|NCT00406978|Melphalan|melphalan|mesh-list
20241256|NCT00406978|Defibrotide|defibrotide|mesh-list
20241257|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241258|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
20241259|NCT00406978|Hormones|hormones|mesh-ancestor
20241260|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241261|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241262|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20241263|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241264|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20484191|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
19852676|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20484192|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241265|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
20484193|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484194|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20484195|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20484196|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
20484197|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
20484198|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484199|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20484200|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20484201|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484202|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484203|NCT01560442|Buprenorphine|buprenorphine|mesh-list
20484204|NCT01560442|Methadone|methadone|mesh-list
20484205|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20484206|NCT01560442|Narcotics|narcotics|mesh-ancestor
20484207|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484208|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484209|NCT01560442|Analgesics|analgesics|mesh-ancestor
20484210|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
20484211|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484212|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20484213|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
20484214|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
20484215|NCT01560481|Metformin|metformin|mesh-list
20484216|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20484217|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484218|NCT01560546|Testosterone|testosterone|mesh-list
20484219|NCT01560546|Androgens|androgens|mesh-ancestor
20484220|NCT01560546|Hormones|hormones|mesh-ancestor
19852677|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852678|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852679|NCT00726895|Quinine|quinine|mesh-list
19852680|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
19852681|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20528081|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19852682|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19852683|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852684|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19852685|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852686|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19852687|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484221|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484222|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484223|NCT01560585|Isotretinoin|isotretinoin|mesh-list
20484224|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
20484225|NCT01560637|Treprostinil|treprostinil|mesh-list
20484226|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20484227|NCT01560663|Carboplatin|carboplatin|mesh-list
20484228|NCT01560663|Docetaxel|docetaxel|mesh-list
20484229|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484230|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
20484231|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
20484232|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
20484233|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484234|NCT01560689|Budesonide|budesonide|mesh-list
20484235|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
19852688|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852689|NCT00726895|Analgesics|analgesics|mesh-ancestor
19852690|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
19852691|NCT00726986|Etoposide|etoposide|mesh-list
19852692|NCT00726986|Sorafenib|sorafenib|mesh-list
19852693|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852694|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19852695|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19852696|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19852697|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484236|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484237|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19852698|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484238|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
19852699|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19852700|NCT00726999|Morphine|morphine|mesh-list
19852701|NCT00726999|Gabapentin|gabapentin|mesh-list
19852702|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20484239|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484240|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484241|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20484242|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
20484243|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
20484244|NCT01560689|Hormones|hormones|mesh-ancestor
20484245|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484246|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20484247|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20484248|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20484249|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
20484250|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484251|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484252|NCT01560702|Epinephrine|epinephrine|mesh-list
20484253|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20484254|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20484255|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
20484256|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484257|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484258|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484259|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20484260|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20484261|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
20484262|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484263|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20484264|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
20484265|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
20484266|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
20484267|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20484268|NCT01560754|Nicotine|nicotine|mesh-list
20484269|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20484270|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
20484271|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484272|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484273|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20484274|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20484275|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
20484276|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484277|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484278|NCT01560962|Azithromycin|azithromycin|mesh-list
20484279|NCT01560962|Tobramycin|tobramycin|mesh-list
20484280|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
20484281|NCT01560962|Povidone|povidone|mesh-list
20484282|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484283|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484284|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
20484285|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
20484286|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20484287|NCT01561014|Fluorouracil|fluorouracil|mesh-list
20484288|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
20484289|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20484290|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20484291|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
20484292|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484293|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20484294|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484295|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484296|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
20484297|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484298|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20484299|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484300|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20484301|NCT01561040|Vitamin D|vitamin d|mesh-list
20484302|NCT01561040|Vitamin A|vitamin a|mesh-list
20484303|NCT01561040|Vitamins|vitamins|mesh-ancestor
20484304|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
20484305|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484306|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20484307|NCT01561066|Octreotide|octreotide|mesh-list
20484308|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20484309|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20484310|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20484311|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484312|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
20484313|NCT01561066|Coagulants|coagulants|mesh-ancestor
20484314|NCT01561092|Citalopram|citalopram|mesh-list
20484315|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20484316|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20484317|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20484318|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484319|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484320|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
20484321|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484322|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20484323|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
20484324|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20528082|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20528083|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
20528084|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528085|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528086|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528087|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20528088|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528089|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20528090|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528091|NCT01771458|Tamoxifen|tamoxifen|mesh-list
20528092|NCT01771458|Trastuzumab|trastuzumab|mesh-list
20528093|NCT01771458|Everolimus|everolimus|mesh-list
20528094|NCT01771458|Sorafenib|sorafenib|mesh-list
20528095|NCT01771458|Letrozole|letrozole|mesh-list
20528096|NCT01771458|Dasatinib|dasatinib|mesh-list
20528097|NCT01771458|Lapatinib|lapatinib|mesh-list
20528098|NCT01771458|Vemurafenib|vemurafenib|mesh-list
20528099|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20528100|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528101|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528102|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
20528103|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528104|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20528105|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528106|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528107|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20528108|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20528109|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20528110|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
20528111|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528112|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20528113|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20528114|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20528115|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20528116|NCT05318443|Paclitaxel|paclitaxel|mesh-list
20528117|NCT05318443|Carboplatin|carboplatin|mesh-list
20528118|NCT05318443|Bevacizumab|bevacizumab|mesh-list
20528119|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20528120|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528121|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
20528122|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
20528123|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
20528124|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528125|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20528126|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20528127|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20528128|NCT05318443|Growth Substances|growth substances|mesh-ancestor
20528129|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528130|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
20528131|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20528132|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528133|NCT05318365|Laxatives|laxatives|mesh-ancestor
20528134|NCT05318339|Trastuzumab|trastuzumab|mesh-list
20528135|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699363|NCT04903366|Timolol|timolol|mesh-list
20528136|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528137|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20528138|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20528139|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20528140|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528141|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
20528142|NCT01771822|Ibuprofen|ibuprofen|mesh-list
20528143|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20528144|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20528145|NCT01771822|Analgesics|analgesics|mesh-ancestor
20528146|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
20528147|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528148|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528149|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528150|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528151|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20528152|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699364|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20484325|NCT01561131|Calcium|calcium|mesh-list
20484326|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20484327|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484328|NCT01561209|Amitriptyline|amitriptyline|mesh-list
20484329|NCT01561209|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20484330|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20484331|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
20484332|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20484333|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20484334|NCT01561209|Analgesics|analgesics|mesh-ancestor
20484335|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
20484336|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484337|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484338|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20484339|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20484340|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20484341|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484342|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
20484343|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484344|NCT01561209|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20484345|NCT01561209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19852703|NCT00726999|Narcotics|narcotics|mesh-ancestor
19852704|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852705|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852706|NCT00726999|Analgesics|analgesics|mesh-ancestor
19852707|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
19852708|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484346|NCT01561209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484347|NCT01561222|Calcitriol|calcitriol|mesh-list
20484348|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19852709|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
19852710|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19852711|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19852712|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19852713|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19852714|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19852715|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852716|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414231|NCT03710564|Growth Substances|growth substances|mesh-ancestor
19414232|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414233|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852717|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
20484349|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484350|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20484351|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20484352|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484353|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20484354|NCT01561222|Vitamins|vitamins|mesh-ancestor
20484355|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
20484356|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20484357|NCT01561235|Hormones|hormones|mesh-list
20484358|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484359|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484360|NCT01561274|Bupivacaine|bupivacaine|mesh-list
20484361|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
20484362|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
20484363|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484364|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484365|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
20484366|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484367|NCT01561391|Factor VIII|factor viii|mesh-list
20484368|NCT01561391|Coagulants|coagulants|mesh-ancestor
20241266|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241267|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20241268|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241269|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
20241270|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
20241271|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241272|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484369|NCT01561404|Everolimus|everolimus|mesh-list
20484370|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484371|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484372|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
20484373|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484374|NCT01561456|Docetaxel|docetaxel|mesh-list
20484375|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484376|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
20484377|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
20484378|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
20484379|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484380|NCT01561482|Metformin|metformin|mesh-list
20484381|NCT01561482|Simvastatin|simvastatin|mesh-list
20484382|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20484383|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484384|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20484385|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20484386|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
20484387|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484388|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20484389|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20484390|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484391|NCT01561508|Butyric Acid|butyric acid|mesh-list
20484392|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
20484393|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
20484394|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241273|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241274|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241275|NCT00406978|Growth Substances|growth substances|mesh-ancestor
20241276|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241277|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20241278|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20241279|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20241280|NCT00406991|Aspirin|aspirin|mesh-list
20241281|NCT00406991|Clopidogrel|clopidogrel|mesh-list
20241282|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20241283|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20241284|NCT00406991|Analgesics|analgesics|mesh-ancestor
20241285|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
20241286|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241287|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241288|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241289|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20241290|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20484395|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484396|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484397|NCT01561586|Cisplatin|cisplatin|mesh-list
20484398|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484399|NCT01561742|Minocycline|minocycline|mesh-list
20484400|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484401|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484402|NCT01561781|Digoxin|digoxin|mesh-list
20241291|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20484403|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20484404|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20484405|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484406|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484407|NCT01561781|Protective Agents|protective agents|mesh-ancestor
20484408|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484409|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
20484410|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484411|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484412|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20484413|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20484414|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484415|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484416|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484417|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20484418|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20484419|NCT01561911|Antibodies|antibodies|mesh-list
20484420|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20484421|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
20484422|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484423|NCT01561937|Warfarin|warfarin|mesh-list
20484424|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
20484425|NCT01561950|Clopidogrel|clopidogrel|mesh-list
20484426|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20484427|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20484428|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20484429|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19699365|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19699366|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
19699367|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699368|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699369|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699370|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19699371|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19699372|NCT04903275|Fluorides|fluorides|mesh-list
19699373|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
20241292|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241293|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20241294|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20241295|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241296|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
20241297|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20241298|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20241299|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20241300|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
20484430|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
20484431|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484432|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484433|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484434|NCT01562197|Axitinib|axitinib|mesh-list
20484435|NCT01562197|Lomustine|lomustine|mesh-list
20484436|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484437|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20241301|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699374|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
20241302|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
20241303|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
20241304|NCT00407017|Ketorolac|ketorolac|mesh-list
20241305|NCT00407017|Nepafenac|nepafenac|mesh-list
20241306|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
20241307|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241308|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484438|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484439|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241309|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20241310|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20241311|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241312|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241313|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484440|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20484441|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
20484442|NCT01562210|Olaparib|olaparib|mesh-list
20484443|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484444|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20484445|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484446|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484447|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
20484448|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484449|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20484450|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
20484451|NCT01562301|Carboplatin|carboplatin|mesh-list
20484452|NCT01562301|Docetaxel|docetaxel|mesh-list
20484453|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484454|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
20484455|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
20484456|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
20484457|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484458|NCT01562405|Dexamethasone|dexamethasone|mesh-list
20484459|NCT01562405|Lenalidomide|lenalidomide|mesh-list
20484460|NCT01562405|Pomalidomide|pomalidomide|mesh-list
20484461|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484462|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
20484463|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
20484464|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484465|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484466|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20484467|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
20484468|NCT01562405|Hormones|hormones|mesh-ancestor
20484469|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241314|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241315|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20241316|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20241317|NCT00407017|Analgesics|analgesics|mesh-ancestor
20241318|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
20484470|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20484471|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484472|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
20484473|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20484474|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20484475|NCT01562405|Growth Substances|growth substances|mesh-ancestor
20484476|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
20484477|NCT01562483|Dronabinol|dronabinol|mesh-list
20484478|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
20484479|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484480|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20484481|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20484482|NCT01562483|Analgesics|analgesics|mesh-ancestor
20484483|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
20484484|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414234|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414235|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19414236|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19414237|NCT03706521|Lorecivivint|lorecivivint|mesh-list
20484485|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20484486|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20484487|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484488|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484489|NCT01562483|Hormones|hormones|mesh-ancestor
19414238|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241319|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241320|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241321|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20241322|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20241323|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20241324|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20241325|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20484490|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484491|NCT01562561|Repaglinide|repaglinide|mesh-list
20484492|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
20484493|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
20484494|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
20484495|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20484496|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484497|NCT01562626|Flucytosine|flucytosine|mesh-list
20484498|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
20484499|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484500|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
20484501|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484502|NCT01562691|Petrolatum|petrolatum|mesh-list
20484503|NCT01562691|Emollients|emollients|mesh-ancestor
20484504|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
20484505|NCT01562704|Acetaminophen|acetaminophen|mesh-list
20484506|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20484507|NCT01562704|Analgesics|analgesics|mesh-ancestor
20484508|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
20484509|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484510|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484511|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
20484512|NCT01562717|Ibuprofen|ibuprofen|mesh-list
20484513|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20484514|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20484515|NCT01562717|Analgesics|analgesics|mesh-ancestor
20484516|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
20484517|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484518|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484519|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484520|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484521|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20484522|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484523|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484524|NCT01562795|Fluorometholone|fluorometholone|mesh-list
20484525|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20484526|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
20484527|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20484528|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20484529|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
20484530|NCT01562795|Hormones|hormones|mesh-ancestor
20484531|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484532|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484533|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20484534|NCT01562808|Aripiprazole|aripiprazole|mesh-list
20484535|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
20484536|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20484537|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20484538|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20484539|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484540|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484541|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
19414239|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
20484542|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
20484543|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414240|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20241326|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20241327|NCT00407056|Difluprednate|difluprednate|mesh-list
20241328|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
20241329|NCT00407056|Hormones|hormones|mesh-ancestor
20241330|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241331|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484544|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484545|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20484546|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20484547|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
20484548|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20484549|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20484550|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20484551|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20528153|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528154|NCT01771874|Bupropion|bupropion|mesh-list
20241332|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20241333|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241334|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
20241335|NCT00407082|Hormones|hormones|mesh-ancestor
20241336|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241337|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241338|NCT00407121|Bevacizumab|bevacizumab|mesh-list
20241339|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241340|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241341|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20528155|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
20484552|NCT01562951|Adalimumab|adalimumab|mesh-list
20484553|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484554|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484555|NCT01562977|Gemcitabine|gemcitabine|mesh-list
20484556|NCT01562977|Rituximab|rituximab|mesh-list
20484557|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
20484558|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20484559|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484560|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
20484561|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484562|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484563|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20484564|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
20484565|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484566|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
20484567|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484568|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484569|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484570|NCT01562990|Gemcitabine|gemcitabine|mesh-list
20484571|NCT01562990|Rituximab|rituximab|mesh-list
20484572|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
20484573|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
19699375|NCT04903275|Protective Agents|protective agents|mesh-ancestor
20484574|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20484575|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484576|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
20484577|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484578|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484579|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20484580|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
20484581|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484582|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
20484583|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484584|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484585|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484586|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20484587|NCT01563068|Calcipotriene|calcipotriene|mesh-list
20484588|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
20484589|NCT01563120|Metformin|metformin|mesh-list
20484590|NCT01563120|Glyburide|glyburide|mesh-list
20484591|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20484592|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484593|NCT01563224|Baclofen|baclofen|mesh-list
20484594|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20484595|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484596|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20484597|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484598|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20484599|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
20484600|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
20484601|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484602|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484603|NCT01563289|Ibuprofen|ibuprofen|mesh-list
20484604|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19699376|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699377|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
19699378|NCT04903054|Prednisone|prednisone|mesh-list
19699379|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
19699380|NCT04903054|Tacrolimus|tacrolimus|mesh-list
20484605|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20484606|NCT01563289|Analgesics|analgesics|mesh-ancestor
20484607|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
20484608|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484609|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484610|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484611|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484612|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20484613|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484614|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484615|NCT01563328|Dolutegravir|dolutegravir|mesh-list
20484616|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20484617|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20484618|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484619|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484620|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20484621|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20484622|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
20484623|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484624|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20484625|NCT01563367|Hematinics|hematinics|mesh-ancestor
20484626|NCT01563601|Carboplatin|carboplatin|mesh-list
20484627|NCT01563601|Etoposide|etoposide|mesh-list
20484628|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
20484629|NCT01563601|Obatoclax|obatoclax|mesh-list
20484630|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484631|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20484632|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20484633|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20484634|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484635|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484636|NCT01563614|Cytarabine|cytarabine|mesh-list
20484637|NCT01563614|Lomustine|lomustine|mesh-list
20484638|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20484639|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
20484640|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484641|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484642|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
20484643|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484644|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484645|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
20484646|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484647|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20484648|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
20484649|NCT01563640|Permethrin|permethrin|mesh-list
20484650|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484651|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484652|NCT01563718|Naltrexone|naltrexone|mesh-list
20484653|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20484654|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19699381|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
19699382|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19699383|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699384|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
20484655|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484656|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
20484657|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484658|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
20484659|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
20484660|NCT01563731|Atorvastatin|atorvastatin|mesh-list
20484661|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19699385|NCT04903054|Hormones|hormones|mesh-ancestor
19699386|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484662|NCT01563731|Simvastatin|simvastatin|mesh-list
20484663|NCT01563731|Pravastatin|pravastatin|mesh-list
20484664|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19699387|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699388|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19699389|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699390|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484665|NCT01563731|Diuretics|diuretics|mesh-list
20484666|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20484667|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20484668|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20484669|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20484670|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20484671|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484672|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20484673|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20484674|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
20484675|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484676|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20484677|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20484678|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
20484679|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
19699391|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
20484680|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20484681|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
20484682|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484683|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20484684|NCT01563835|Fentanyl|fentanyl|mesh-list
20484685|NCT01563835|Bupivacaine|bupivacaine|mesh-list
20484686|NCT01563835|Citric Acid|citric acid|mesh-list
20484687|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
20484688|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
20484689|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
20484690|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484691|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414241|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19414242|NCT03704584|Prednisolone|prednisolone|mesh-list
20484692|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
19414243|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
19414244|NCT03704584|Lidocaine|lidocaine|mesh-list
19414245|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19414246|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
19414247|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
19414248|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
19414249|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414250|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414251|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
19414252|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414253|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19414254|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19414255|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19414256|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414257|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414258|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414259|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
19414260|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
19414261|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20484693|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484694|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20484695|NCT01563835|Narcotics|narcotics|mesh-ancestor
20484696|NCT01563835|Analgesics|analgesics|mesh-ancestor
20484697|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20484698|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20484699|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
20484700|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
20484701|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20484702|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
20484703|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
20484704|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484705|NCT01563939|Remifentanil|remifentanil|mesh-list
20484706|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20484707|NCT01563939|Narcotics|narcotics|mesh-ancestor
20484708|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484709|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699392|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19699393|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484710|NCT01563939|Analgesics|analgesics|mesh-ancestor
20484711|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
19699394|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699395|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19699396|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19699397|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
19699398|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484712|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484713|NCT01563952|Sirolimus|sirolimus|mesh-list
20484714|NCT01563952|Umirolimus|umirolimus|mesh-list
20484715|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484716|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484717|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20484718|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484719|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
20484720|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484721|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
20241342|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241343|NCT00407121|Growth Substances|growth substances|mesh-ancestor
20241344|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484722|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484723|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484724|NCT01564095|Tryptophan|tryptophan|mesh-list
20484725|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20484726|NCT01564095|Tacrolimus|tacrolimus|mesh-list
20484727|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484728|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
20484729|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699399|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241345|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241346|NCT00407186|Cisplatin|cisplatin|mesh-list
20241347|NCT00407186|Capecitabine|capecitabine|mesh-list
20241348|NCT00407186|Epirubicin|epirubicin|mesh-list
20241349|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241350|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20241351|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
19414262|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
19414263|NCT03704584|Hormones|hormones|mesh-ancestor
19414264|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414265|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19414266|NCT03704584|Protective Agents|protective agents|mesh-ancestor
19414267|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20484730|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20484731|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484732|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484733|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20484734|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
20484735|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20484736|NCT01564108|Ranibizumab|ranibizumab|mesh-list
20484737|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20484738|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20484739|NCT01564108|Growth Substances|growth substances|mesh-ancestor
20484740|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484741|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
20484742|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484743|NCT01564199|Fluticasone|fluticasone|mesh-list
20484744|NCT01564199|Xhance|xhance|mesh-list
20484745|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19852718|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19852719|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19852720|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19852721|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19852722|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19852723|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852724|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852725|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852726|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19852727|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
19852728|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19852729|NCT00727194|Eculizumab|eculizumab|mesh-list
19852730|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19852731|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19852732|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
19852733|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241352|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241353|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20241354|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20484746|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484747|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20484748|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
20484749|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484750|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484751|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20484752|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
20484753|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
20484754|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20241355|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20241356|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484755|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20484756|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20484757|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20484758|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
20484759|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484760|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484761|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
20484762|NCT01564238|Calcium|calcium|mesh-list
20484763|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20484764|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484765|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20484766|NCT01564251|Gemcitabine|gemcitabine|mesh-list
19414268|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414269|NCT03703102|KHK4083|khk4083|mesh-list
19414270|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414271|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
19414272|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414273|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
19414274|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414275|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414276|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19414277|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
19414278|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414279|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414280|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19414281|NCT03691974|Fasinumab|fasinumab|mesh-list
19414282|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414283|NCT03691974|Analgesics|analgesics|mesh-ancestor
19414284|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
19699400|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
19699401|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
19699402|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699403|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699404|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19699405|NCT04903054|Protective Agents|protective agents|mesh-ancestor
19699406|NCT04902911|Antibodies|antibodies|mesh-list
19699407|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
19699408|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
19699409|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699410|NCT04902885|Carboplatin|carboplatin|mesh-list
19699411|NCT04902885|Etoposide|etoposide|mesh-list
20484767|NCT01564251|GDC-0575|gdc-0575|mesh-list
19414285|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414286|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414287|NCT03684278|Infliximab|infliximab|mesh-list
19414288|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414289|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19414290|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414291|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20241357|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20241358|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
20241359|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20241360|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20241361|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19414292|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
19414293|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414294|NCT03676751|Azithromycin|azithromycin|mesh-list
19414295|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414296|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241362|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20241363|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241364|NCT00407212|Maleic acid|maleic acid|mesh-list
20241365|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241366|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241367|NCT00407225|Difluprednate|difluprednate|mesh-list
20241368|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
20241369|NCT00407225|Hormones|hormones|mesh-ancestor
20241370|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484768|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20484769|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
20484770|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484771|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484772|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
20484773|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484774|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484775|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484776|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
20484777|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484778|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20484779|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
20484780|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20484781|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
20484782|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
19414297|NCT03665038|Brexanolone|brexanolone|mesh-list
19414298|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
20241371|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241372|NCT00407251|Epothilone B|epothilone b|mesh-list
20241373|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241374|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
20484783|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484784|NCT01564303|Expectorants|expectorants|mesh-ancestor
20484785|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
20484786|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20484787|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
20484788|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484789|NCT01564303|Protective Agents|protective agents|mesh-ancestor
20484790|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484791|NCT01564303|Antidotes|antidotes|mesh-ancestor
20484792|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20241375|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
20241376|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
20241377|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241378|NCT00407264|Fluticasone|fluticasone|mesh-list
20241379|NCT00407264|Xhance|xhance|mesh-list
20241380|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484793|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484794|NCT01564329|Endostar protein|endostar protein|mesh-list
20484795|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20484796|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20484797|NCT01564329|Growth Substances|growth substances|mesh-ancestor
20484798|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484799|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
20484800|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484801|NCT01564355|Triamcinolone|triamcinolone|mesh-list
20484802|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484803|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
20484804|NCT01564355|Hormones|hormones|mesh-ancestor
20484805|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484806|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484807|NCT01564381|Resveratrol|resveratrol|mesh-list
20484808|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
20484809|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484810|NCT01564381|Protective Agents|protective agents|mesh-ancestor
20484811|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484812|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484813|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20528156|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20528157|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
20528158|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20528159|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20528160|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20528161|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528162|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528163|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
20528164|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528165|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528166|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20528167|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20528168|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528169|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
20528170|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
20528171|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20528172|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
20528173|NCT01771978|Diltiazem|diltiazem|mesh-list
20528174|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20528175|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20528176|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528177|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852734|NCT00727246|Choline|choline|mesh-list
19852735|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19852736|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
19852737|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20528178|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19852738|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
20484814|NCT01564550|Insulin|insulin|mesh-list
20484815|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19852739|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852740|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852741|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19852742|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
19852743|NCT00727259|Ribavirin|ribavirin|mesh-list
19852744|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852745|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
19852746|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852747|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
19852748|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852749|NCT00727272|Quinine|quinine|mesh-list
19852750|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
19852751|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19852752|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19852753|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484816|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20484817|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484818|NCT01564576|Bromides|bromides|mesh-list
20484819|NCT01564576|Rocuronium|rocuronium|mesh-list
20484820|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
20484821|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19852754|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19852755|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852756|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19852757|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852758|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852759|NCT00727272|Analgesics|analgesics|mesh-ancestor
20241381|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20241382|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
20484822|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19414299|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414300|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414301|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414302|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
19852760|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
19852761|NCT00727298|Infliximab|infliximab|mesh-list
20241383|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241384|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241385|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20241386|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
20241387|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
20241388|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20241389|NCT00407277|Nicotine|nicotine|mesh-list
20241390|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20241391|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
20484823|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20484824|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484825|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484826|NCT01564680|Acetaminophen|acetaminophen|mesh-list
20484827|NCT01564680|Lornoxicam|lornoxicam|mesh-list
20484828|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20241392|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484829|NCT01564680|Analgesics|analgesics|mesh-ancestor
20484830|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
20484831|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484832|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484833|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
19852762|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
20484834|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20484835|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484836|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484837|NCT01564810|Cetuximab|cetuximab|mesh-list
20484838|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20484839|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484840|NCT01564823|Metronidazole|metronidazole|mesh-list
20484841|NCT01564823|Adalimumab|adalimumab|mesh-list
19699412|NCT04902885|Topotecan|topotecan|mesh-list
19699413|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699414|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19699415|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19699416|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19699417|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484842|NCT01564823|Azathioprine|azathioprine|mesh-list
20484843|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20484844|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20484845|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484846|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484847|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20484848|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20484849|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
20484850|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484851|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20484852|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484853|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484854|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
20484855|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484856|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
20484857|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241393|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241394|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20241395|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20241396|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
20241397|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241398|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241399|NCT00407290|Neostigmine|neostigmine|mesh-list
20241400|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20241401|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241402|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241403|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
20241404|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484858|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20484859|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484860|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484861|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
20484862|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20484863|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20484864|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20484865|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20484866|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484867|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
20484868|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484869|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241405|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241406|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20484870|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20484871|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484872|NCT01565018|Rotigotine|rotigotine|mesh-list
20484873|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
20484874|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
20484875|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484876|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484877|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852763|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852764|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852765|NCT00727311|Ribavirin|ribavirin|mesh-list
19852766|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20484878|NCT01565096|Metformin|metformin|mesh-list
20484879|NCT01565096|Glimepiride|glimepiride|mesh-list
20484880|NCT01565096|Vildagliptin|vildagliptin|mesh-list
20484881|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20484882|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484883|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20484884|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20484885|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
20484886|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20484887|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
20484888|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484889|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484890|NCT01565109|Docetaxel|docetaxel|mesh-list
20484891|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484892|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
20484893|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
20484894|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
20484895|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484896|NCT01565200|Trastuzumab|trastuzumab|mesh-list
20484897|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20484898|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20484899|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484900|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
20484901|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
20484902|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20484903|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484904|NCT01565239|Thrombin|thrombin|mesh-list
20484905|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
20484906|NCT01565239|Coagulants|coagulants|mesh-ancestor
20484907|NCT01565265|Cetrorelix|cetrorelix|mesh-list
20484908|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20484909|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20484910|NCT01565265|Hormones|hormones|mesh-ancestor
20484911|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20484912|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484913|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20484914|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
20484915|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20484916|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
20484917|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19852767|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
20484918|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20484919|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20484920|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20484921|NCT01565512|Bupivacaine|bupivacaine|mesh-list
20484922|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
20484923|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
20484924|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484925|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484926|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
20484927|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484928|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
20484929|NCT01565590|Propofol|propofol|mesh-list
20484930|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20484931|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484932|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484933|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20484934|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
20484935|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
20484936|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20484937|NCT01565590|Analgesics|analgesics|mesh-ancestor
20484938|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
20484939|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20484940|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20484941|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20484942|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20484943|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
20484944|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20484945|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484946|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
20484947|NCT01565720|Isavuconazole|isavuconazole|mesh-list
20484948|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484949|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484950|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20484951|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20484952|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484953|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484954|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484955|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
20484956|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
20484957|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
20484958|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20484959|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20484960|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484961|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20484962|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484963|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
20484964|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
20484965|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20484966|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484967|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484968|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
20484969|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20484970|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20484971|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484972|NCT01565772|Etoposide|etoposide|mesh-list
20484973|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484974|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20484975|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20484976|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20484977|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484978|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484979|NCT01565798|Copper|copper|mesh-list
20484980|NCT01565798|Trace Elements|trace elements|mesh-ancestor
20484981|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
20484982|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20484983|NCT01565837|Ipilimumab|ipilimumab|mesh-list
20484984|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20484985|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484986|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20484987|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484988|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
20484989|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
20484990|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20484991|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20484992|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20484993|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
19414303|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
19414304|NCT03662542|Golimumab|golimumab|mesh-list
19414305|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20484994|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20484995|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20484996|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20484997|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20484998|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20484999|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20485000|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485001|NCT01566240|Paclitaxel|paclitaxel|mesh-list
20485002|NCT01566240|Carboplatin|carboplatin|mesh-list
20485003|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20485004|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485005|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
20485006|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
20485007|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
20485008|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485009|NCT01566253|Acetaminophen|acetaminophen|mesh-list
20485010|NCT01566253|Ketoprofen|ketoprofen|mesh-list
20485011|NCT01566253|Morphine|morphine|mesh-list
20485012|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20485013|NCT01566253|Narcotics|narcotics|mesh-ancestor
20485014|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485015|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485016|NCT01566253|Analgesics|analgesics|mesh-ancestor
20485017|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
20485018|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485019|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485020|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
19852768|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
19852769|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852770|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
19852771|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852772|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
20485021|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20485022|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20485023|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485024|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20485025|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485026|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485027|NCT01566266|Amoxicillin|amoxicillin|mesh-list
20485028|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20485029|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485030|NCT01566279|Everolimus|everolimus|mesh-list
20485031|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485032|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485033|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
20485034|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485035|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
20485036|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20485037|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20485038|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19699418|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699419|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19699420|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
19699421|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19699422|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19699423|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699424|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
19699425|NCT04902950|Coagulants|coagulants|mesh-ancestor
20485039|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485040|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485041|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
20485042|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485043|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485044|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20485045|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485046|NCT01566422|Vancomycin|vancomycin|mesh-list
20485047|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20485048|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528179|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528180|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
20528181|NCT01772056|Fluticasone|fluticasone|mesh-list
20528182|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528183|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20528184|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
20528185|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528186|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528187|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20528188|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
20528189|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
20485049|NCT01566474|Melatonin|melatonin|mesh-list
20485050|NCT01566474|Omeprazole|omeprazole|mesh-list
20485051|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
20485052|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485053|NCT01566474|Protective Agents|protective agents|mesh-ancestor
20485054|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485055|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485056|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20485057|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485058|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20485059|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485060|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20485061|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
20485062|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485063|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20485064|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485065|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485066|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485067|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20485068|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
20485069|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485070|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20485071|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20485072|NCT01566565|Theophylline|theophylline|mesh-list
20485073|NCT01566565|Bambuterol|bambuterol|mesh-list
20485074|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20485075|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
20485076|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485077|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485078|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20485079|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
20485080|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20485081|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485082|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485083|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
20485084|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20485085|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20485086|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
20485087|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485088|NCT01566578|Mitogens|mitogens|mesh-list
20485089|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
20485090|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485091|NCT01566643|Metronidazole|metronidazole|mesh-list
19852773|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852774|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
19852775|NCT00727415|Fludarabine|fludarabine|mesh-list
19852776|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
19852777|NCT00727415|Lenalidomide|lenalidomide|mesh-list
20485092|NCT01566643|Rabeprazole|rabeprazole|mesh-list
19852778|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241407|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
20241408|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485093|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485094|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20485095|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20485096|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20485097|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20485098|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485099|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20485100|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485101|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241409|NCT00407342|Alefacept|alefacept|mesh-list
20485102|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19699426|NCT04903002|Oxytocin|oxytocin|mesh-list
19699427|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
19699428|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19699429|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414306|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20241410|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
19699430|NCT04902729|Oxytocin|oxytocin|mesh-list
20485103|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
20485104|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485105|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485106|NCT01566669|Parecoxib|parecoxib|mesh-list
20485107|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20485108|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20485109|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485110|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485111|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20485112|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485113|NCT01566669|Analgesics|analgesics|mesh-ancestor
20485114|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
20485115|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485116|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485117|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20485118|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485119|NCT01566734|Cefazolin|cefazolin|mesh-list
20485120|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20485121|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414307|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414308|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414309|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
20485122|NCT01566760|Fesoterodine|fesoterodine|mesh-list
20485123|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20485124|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20485125|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
20485126|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485127|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485128|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485129|NCT01566760|Urological Agents|urological agents|mesh-ancestor
20485130|NCT01566799|Metformin|metformin|mesh-list
20485131|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20485132|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485133|NCT01566825|Amitriptyline|amitriptyline|mesh-list
20485134|NCT01566825|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20485135|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20485136|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
20485137|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485138|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485139|NCT01566825|Analgesics|analgesics|mesh-ancestor
20485140|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
20485141|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485142|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485143|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20485144|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20485145|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485146|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485147|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
20485148|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241411|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
20241412|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241413|NCT00407394|Amoxicillin|amoxicillin|mesh-list
20241414|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241415|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485149|NCT01566825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20485150|NCT01566825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485151|NCT01566825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485152|NCT01566890|Regadenoson|regadenoson|mesh-list
20485153|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20485154|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20485155|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
20485156|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
20485157|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485158|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485159|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485160|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
20241416|NCT00407407|Carboplatin|carboplatin|mesh-list
20241417|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20241418|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241419|NCT00407433|Gemcitabine|gemcitabine|mesh-list
20241420|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
20241421|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20241422|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
20241423|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485161|NCT01566942|Irinotecan|irinotecan|mesh-list
20485162|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485163|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20485164|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20485165|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485166|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485167|NCT01567072|Ibuprofen|ibuprofen|mesh-list
20485168|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20485169|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485170|NCT01567072|Analgesics|analgesics|mesh-ancestor
20485171|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
20485172|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485173|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485174|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20485175|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485176|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20485177|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485178|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485179|NCT01567111|Metomidate|metomidate|mesh-list
20485180|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20485181|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485182|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485183|NCT01567124|Moxonidine|moxonidine|mesh-list
20485184|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20485185|NCT01567202|Vaccines|vaccines|mesh-list
20485186|NCT01567202|Immunologic Factors|immunologic factors|mesh-ancestor
20485187|NCT01567202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485188|NCT01567215|Ethanol|ethanol|mesh-list
20485189|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
20485190|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20485191|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485192|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485193|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485194|NCT01567358|Infliximab|infliximab|mesh-list
20485195|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
20485196|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485197|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485198|NCT01567384|Pemetrexed|pemetrexed|mesh-list
20485199|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485200|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485201|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485202|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20485203|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20485204|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20485205|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
20485206|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20485207|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20485208|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485209|NCT01567475|Rituximab|rituximab|mesh-list
20485210|NCT01567475|Everolimus|everolimus|mesh-list
20485211|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20485212|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485213|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
20485214|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485215|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485216|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485217|NCT01567488|Everolimus|everolimus|mesh-list
20485218|NCT01567488|Octreotide|octreotide|mesh-list
20485219|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485220|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485221|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
20485222|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485223|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485224|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20485225|NCT01567501|Cetirizine|cetirizine|mesh-list
20485226|NCT01567501|Levocetirizine|levocetirizine|mesh-list
20485227|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20485228|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20485229|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
20485230|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
20485231|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485232|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485233|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485234|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20485235|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20485236|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20485237|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485238|NCT01567540|Incretins|incretins|mesh-ancestor
20485239|NCT01567540|Hormones|hormones|mesh-ancestor
20485240|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485241|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20485242|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
20485243|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485244|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485245|NCT01567605|Lidocaine|lidocaine|mesh-list
20485246|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
20485247|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
20485248|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485249|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485250|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
20485251|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485252|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20485253|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20485254|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20485255|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485256|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485257|NCT01567618|Docetaxel|docetaxel|mesh-list
20485258|NCT01567618|Fluorouracil|fluorouracil|mesh-list
20485259|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485260|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
20485261|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
20485262|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
20485263|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485264|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
20485265|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20485266|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485267|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
20485268|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485269|NCT01567657|Midazolam|midazolam|mesh-list
20485270|NCT01567657|Meperidine|meperidine|mesh-list
20485271|NCT01567657|Propofol|propofol|mesh-list
20485272|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20485273|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485274|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485275|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20485276|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
20485277|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
20485278|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20485279|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20485280|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485281|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485282|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
20485283|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
20485284|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485285|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485286|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20485287|NCT01567657|Narcotics|narcotics|mesh-ancestor
20485288|NCT01567657|Analgesics|analgesics|mesh-ancestor
20485289|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
20485290|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485291|NCT01567670|Naloxone|naloxone|mesh-list
20485292|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20485293|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485294|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
20485295|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485296|NCT01567683|Imiquimod|imiquimod|mesh-list
20485297|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20485298|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
20485299|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485300|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485301|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
20485302|NCT01567709|Vorinostat|vorinostat|mesh-list
20485303|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485304|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20485305|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485306|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485307|NCT01567735|Simeprevir|simeprevir|mesh-list
20485308|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
20485309|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485310|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
20485311|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485312|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485313|NCT01567774|Atorvastatin|atorvastatin|mesh-list
20485314|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20485315|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20485316|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20485317|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
20485318|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485319|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20485320|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20485321|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485322|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
20485323|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20485324|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485325|NCT01567930|Sirolimus|sirolimus|mesh-list
20485326|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20485327|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485328|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20485329|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485330|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
20485331|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485332|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
20485333|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699431|NCT04902729|Carbetocin|carbetocin|mesh-list
19699432|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
19699433|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19699434|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699435|NCT04902638|Dexamethasone|dexamethasone|mesh-list
19699436|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699437|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
19699438|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
19699439|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699440|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699441|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699442|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
19699443|NCT04902638|Hormones|hormones|mesh-ancestor
19699444|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699445|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19699446|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699447|NCT04902261|Gemcitabine|gemcitabine|mesh-list
19699448|NCT04902261|Paclitaxel|paclitaxel|mesh-list
19699449|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19699450|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699451|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
19699452|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
19699453|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699454|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699455|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699456|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
19699457|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
19699458|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699459|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485334|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
20485335|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20485336|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
20485337|NCT01567995|Hormones|hormones|mesh-ancestor
20485338|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485339|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485340|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20485341|NCT01568125|Incretins|incretins|mesh-list
20485342|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485343|NCT01568125|Hormones|hormones|mesh-ancestor
20485344|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485345|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
20485346|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20485347|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485348|NCT01568268|Palonosetron|palonosetron|mesh-list
20485349|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
20485350|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
20485351|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485352|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485353|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485354|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20485355|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20485356|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
20485357|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485358|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485359|NCT01568281|Anastrozole|anastrozole|mesh-list
20485360|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20485361|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485362|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20485363|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20485364|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485365|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485366|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20485367|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
20485368|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485369|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485370|NCT01568294|Pomalidomide|pomalidomide|mesh-list
20485371|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
20485372|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485373|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20485374|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20485375|NCT01568294|Growth Substances|growth substances|mesh-ancestor
20485376|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
20485377|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528190|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20528191|NCT01772212|Terbinafine|terbinafine|mesh-list
20528192|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
20528193|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528194|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528195|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530684|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530685|NCT01789957|Exenatide|exenatide|mesh-list
20530686|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20530687|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530688|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20530689|NCT01789957|Incretins|incretins|mesh-ancestor
20530690|NCT01789957|Hormones|hormones|mesh-ancestor
20530691|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530692|NCT01790009|Acetaminophen|acetaminophen|mesh-list
20530693|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530694|NCT01790009|Analgesics|analgesics|mesh-ancestor
20530695|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
20530696|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530697|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530698|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
20530699|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
20530700|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20530701|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20530702|NCT01790022|Prednisolone|prednisolone|mesh-list
20530703|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
20530704|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20530705|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
20530706|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530707|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
20530708|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
20530709|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530710|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530711|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530712|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
20530713|NCT01790022|Hormones|hormones|mesh-ancestor
20530714|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530715|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20530716|NCT01790022|Protective Agents|protective agents|mesh-ancestor
20530717|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20530718|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530719|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
20485378|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
19414310|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414311|NCT03660943|Capsaicin|capsaicin|mesh-list
19414312|NCT03660943|Antipruritics|antipruritics|mesh-ancestor
19699460|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485379|NCT01568307|Serotonin|serotonin|mesh-list
20485380|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20485381|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485382|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20485383|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
20485384|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485385|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485386|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485387|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20485388|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485389|NCT01568333|Decitabine|decitabine|mesh-list
20485390|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20485391|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
20485392|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485393|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485394|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485395|NCT01568411|Itraconazole|itraconazole|mesh-list
20485396|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
20485397|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485398|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20485399|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20485400|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485401|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485402|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20485403|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
20485404|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485405|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485406|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20485407|NCT01568450|Oxycodone|oxycodone|mesh-list
20485408|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20485409|NCT01568450|Narcotics|narcotics|mesh-ancestor
20485410|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485411|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485412|NCT01568450|Analgesics|analgesics|mesh-ancestor
20485413|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
20485414|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485415|NCT01568632|Imetelstat|imetelstat|mesh-list
20485416|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
20485417|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485418|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485419|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20485420|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
20485421|NCT01568645|Carvedilol|carvedilol|mesh-list
20485422|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485423|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20485424|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485425|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485426|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20485427|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20485428|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
20485429|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485430|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485431|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20485432|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
20485433|NCT01568645|Protective Agents|protective agents|mesh-ancestor
20485434|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20485435|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485436|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20485437|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
20485438|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20485439|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20485440|NCT01568684|Citalopram|citalopram|mesh-list
20485441|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20485442|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20485443|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485444|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485445|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485446|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
20485447|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485448|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20485449|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
20485450|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485451|NCT01568749|Acetaminophen|acetaminophen|mesh-list
20485452|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485453|NCT01568749|Analgesics|analgesics|mesh-ancestor
20485454|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
20485455|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485456|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485457|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
20485458|NCT01568788|Vaccines|vaccines|mesh-list
19414313|NCT03660943|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414314|NCT03660943|Sensory System Agents|sensory system agents|mesh-ancestor
19414315|NCT03660943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699461|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
19699462|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699463|NCT04902495|Pemetrexed|pemetrexed|mesh-list
19699464|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699465|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699466|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699467|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19699468|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19699469|NCT04902222|Morphine|morphine|mesh-list
19699470|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19699471|NCT04902222|Narcotics|narcotics|mesh-ancestor
19699472|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699473|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699474|NCT04902222|Analgesics|analgesics|mesh-ancestor
19699475|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
20485459|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
20485460|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485461|NCT01568853|Norepinephrine|norepinephrine|mesh-list
20485462|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20485463|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20485464|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
20485465|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485466|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699476|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699477|NCT04902378|Insulin|insulin|mesh-list
20241424|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241425|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
20241426|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241427|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241428|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241429|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
20241430|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241431|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
20241432|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
20241433|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20241434|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20241435|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241436|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241437|NCT00407446|Urological Agents|urological agents|mesh-ancestor
20241438|NCT00407459|Bevacizumab|bevacizumab|mesh-list
20241439|NCT00407459|Carboplatin|carboplatin|mesh-list
20241440|NCT00407459|Pemetrexed|pemetrexed|mesh-list
20241441|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241442|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241443|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241444|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241445|NCT00407459|Growth Substances|growth substances|mesh-ancestor
20485467|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485468|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
20485469|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
20485470|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485471|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20485472|NCT01568931|Coal Tar|coal tar|mesh-list
20485473|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
19699478|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20241446|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485474|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
20485475|NCT01568996|Sulforaphane|sulforaphane|mesh-list
20485476|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20485477|NCT01568996|Protective Agents|protective agents|mesh-ancestor
20485478|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485479|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485480|NCT01569035|Warfarin|warfarin|mesh-list
20485481|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
20485482|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
20485483|NCT01569048|Remifentanil|remifentanil|mesh-list
20485484|NCT01569048|Propofol|propofol|mesh-list
20485485|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20485486|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485487|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485488|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20485489|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
20485490|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
20485491|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485492|NCT01569048|Analgesics|analgesics|mesh-ancestor
20485493|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
20485494|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485495|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20485496|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20485497|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20485498|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20485499|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485500|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485501|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20485502|NCT01569048|Narcotics|narcotics|mesh-ancestor
20485503|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
20485504|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20485505|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
20485506|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20485507|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20485508|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20485509|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
20485510|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20485511|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485512|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20485513|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20485514|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20485515|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19699479|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485516|NCT01569113|Estrogens|estrogens|mesh-ancestor
20485517|NCT01569113|Hormones|hormones|mesh-ancestor
20485518|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485519|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20485520|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
20485521|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20485522|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20485523|NCT01569165|Fluorides|fluorides|mesh-list
20485524|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
20485525|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
20485526|NCT01569165|Protective Agents|protective agents|mesh-ancestor
20485527|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485528|NCT01569204|Dexamethasone|dexamethasone|mesh-list
20485529|NCT01569204|Prednisone|prednisone|mesh-list
20485530|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
20485531|NCT01569204|Dacarbazine|dacarbazine|mesh-list
20485532|NCT01569204|Doxorubicin|doxorubicin|mesh-list
20485533|NCT01569204|Etoposide|etoposide|mesh-list
20485534|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20485535|NCT01569204|Procarbazine|procarbazine|mesh-list
20485536|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485537|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
20485538|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485539|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485540|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20485541|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
20485542|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485543|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485544|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20485545|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20485546|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
20485547|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
20485548|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485549|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485550|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
20485551|NCT01569204|Hormones|hormones|mesh-ancestor
20485552|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485553|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20485554|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20485555|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20485556|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20485557|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485558|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20485559|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20485560|NCT01569256|Cabergoline|cabergoline|mesh-list
20485561|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20485562|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20485563|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
20485564|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
20485565|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485566|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485567|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485568|NCT01569633|Erythromycin|erythromycin|mesh-list
20485569|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
20485570|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20485571|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
20485572|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20485573|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485574|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485575|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20485576|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485577|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699480|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
19699481|NCT04902027|Analgesics|analgesics|mesh-ancestor
19699482|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
20485578|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20485579|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20485580|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485581|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485582|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485583|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485584|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20485585|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20485586|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20485587|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
20485588|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485589|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485590|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20485591|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20485592|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
20485593|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20485594|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20485595|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
20485596|NCT01569685|Sertraline|sertraline|mesh-list
20485597|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20485598|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
20485599|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485600|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20485601|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20485602|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485603|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485604|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485605|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
20485606|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485607|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20485608|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20485609|NCT01569919|Folic Acid|folic acid|mesh-list
20485610|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
20485611|NCT01569919|Hydroxocobalamin|hydroxocobalamin|mesh-list
20485612|NCT01569919|Dexamethasone|dexamethasone|mesh-list
20485613|NCT01569919|Pemetrexed|pemetrexed|mesh-list
20485614|NCT01569919|Vitamins|vitamins|mesh-ancestor
20485615|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
20485616|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485617|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485618|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20485619|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
20485620|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
20485621|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485622|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485623|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
20485624|NCT01569919|Hormones|hormones|mesh-ancestor
20485625|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485626|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20485627|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485628|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485629|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20485630|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20485631|NCT01569919|Hematinics|hematinics|mesh-ancestor
20485632|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
20485633|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20485634|NCT01569945|Clomiphene|clomiphene|mesh-list
20485635|NCT01569945|Menotropins|menotropins|mesh-list
20485636|NCT01569945|Estradiol|estradiol|mesh-list
20485637|NCT01569945|Estrogens|estrogens|mesh-ancestor
20485638|NCT01569945|Hormones|hormones|mesh-ancestor
20485639|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485640|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485641|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20485642|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
19699483|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699484|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699485|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852779|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
20485643|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20485644|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20485645|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20485646|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20485647|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20485648|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
20485649|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20485650|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
20485651|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20485652|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20485653|NCT01569984|Bevacizumab|bevacizumab|mesh-list
20485654|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20485655|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485656|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20485657|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20485658|NCT01569984|Growth Substances|growth substances|mesh-ancestor
20485659|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485660|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
20485661|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20485662|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20485663|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
20485664|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485665|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528196|NCT01772238|Amoxicillin|amoxicillin|mesh-list
20528197|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20528198|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
20528199|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
20528200|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528201|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528202|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20528203|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528204|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528205|NCT01772251|Insulin|insulin|mesh-list
20528206|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414316|NCT03660943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414317|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19414318|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20485666|NCT01570088|Folic Acid|folic acid|mesh-list
20485667|NCT01570088|Hematinics|hematinics|mesh-ancestor
20485668|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
19414319|NCT03659929|Amphetamine|amphetamine|mesh-list
19414320|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19414321|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414322|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
19414323|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
19414324|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414325|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
19414326|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414327|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414328|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
20485669|NCT01570088|Vitamins|vitamins|mesh-ancestor
20485670|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
20485671|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485672|NCT01570296|Gefitinib|gefitinib|mesh-list
20485673|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485674|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20485675|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485676|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485677|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20485678|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20485679|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
20485680|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485681|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699486|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19699487|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19699488|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699489|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699490|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
19699491|NCT04902105|Valproic Acid|valproic acid|mesh-list
19699492|NCT04902105|Ecopipam|ecopipam|mesh-list
19699493|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
19699494|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699495|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699496|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
19699497|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699498|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699499|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
19699500|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485682|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20485683|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
19414329|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20485684|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
20485685|NCT01570478|Hormones|hormones|mesh-ancestor
20485686|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485687|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
20485688|NCT01570504|Ivermectin|ivermectin|mesh-list
20485689|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20485690|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485691|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20485692|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485693|NCT01570569|Losartan|losartan|mesh-list
20485694|NCT01570569|Midazolam|midazolam|mesh-list
20485695|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
20485696|NCT01570569|Caffeine|caffeine|mesh-list
20485697|NCT01570569|Omeprazole|omeprazole|mesh-list
20485698|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20485699|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20485700|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485701|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485702|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19699501|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699502|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19699503|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19699504|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19699505|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
19699506|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19699507|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485703|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485704|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485705|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19699508|NCT04902105|Analgesics|analgesics|mesh-ancestor
20485706|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
20485707|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
20485708|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
20485709|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
20485710|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485711|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485712|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20485713|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20485714|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20485715|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20485716|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20485717|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485718|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20485719|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485720|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20485721|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20485722|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20485723|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20485724|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
20485725|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
20485726|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
20485727|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20485728|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20485729|NCT01570582|Gemcitabine|gemcitabine|mesh-list
20485730|NCT01570582|Paclitaxel|paclitaxel|mesh-list
20485731|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20485732|NCT01570582|Carboplatin|carboplatin|mesh-list
20485733|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20485734|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485735|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20485736|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20485737|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20485738|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485739|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20485740|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
20485741|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
20485742|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485743|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485744|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485745|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
20485746|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485747|NCT01570608|Ranibizumab|ranibizumab|mesh-list
20485748|NCT01570608|Verteporfin|verteporfin|mesh-list
20485749|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20485750|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20485751|NCT01570608|Growth Substances|growth substances|mesh-ancestor
20485752|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485753|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
20485754|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485755|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20485756|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
20485757|NCT01570660|Pioglitazone|pioglitazone|mesh-list
20485758|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20485759|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485760|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
20485761|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485762|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
20485763|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485764|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485765|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20485766|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
20485767|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485768|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485769|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20485770|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
20485771|NCT01570790|Combretastatin|combretastatin|mesh-list
20485772|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20485773|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485774|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
20485775|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
20485776|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
20485777|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485778|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20485779|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
20485780|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485781|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20485782|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485783|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485784|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485785|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20485786|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
20485787|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485788|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20485789|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485790|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485791|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485792|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20485793|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
20485794|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485795|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20485796|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485797|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485798|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485799|NCT01570985|Triamcinolone|triamcinolone|mesh-list
20485800|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20485801|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20485802|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20485803|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699509|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
19699510|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699511|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699512|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19699513|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19699514|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
19699515|NCT04902040|Nivolumab|nivolumab|mesh-list
20485804|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
20485805|NCT01570985|Hormones|hormones|mesh-ancestor
20485806|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20485807|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485808|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485809|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
20485810|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485811|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699516|NCT04902040|Durvalumab|durvalumab|mesh-list
19699517|NCT04902040|Avelumab|avelumab|mesh-list
19699518|NCT04902040|Atezolizumab|atezolizumab|mesh-list
19699519|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
20485812|NCT01571024|Leucovorin|leucovorin|mesh-list
19699520|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19699521|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
20485813|NCT01571024|Fluorouracil|fluorouracil|mesh-list
19699522|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699523|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699524|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19699525|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485814|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
20485815|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
20485816|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485817|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20485818|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485819|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20485820|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
20485821|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485822|NCT01571024|Antidotes|antidotes|mesh-ancestor
20485823|NCT01571024|Protective Agents|protective agents|mesh-ancestor
20485824|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
20485825|NCT01571024|Vitamins|vitamins|mesh-ancestor
20485826|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
20485827|NCT01571037|Milrinone|milrinone|mesh-list
20485828|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20485829|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20485830|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
20485831|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20485832|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20485833|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485834|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485835|NCT01571037|Protective Agents|protective agents|mesh-ancestor
20485836|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485837|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
20485838|NCT01571050|Antacids|antacids|mesh-ancestor
20485839|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485840|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485841|NCT01571063|Vitamin D|vitamin d|mesh-list
19699526|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
20485842|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
20485843|NCT01571063|Vitamins|vitamins|mesh-ancestor
20485844|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
20485845|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485846|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20485847|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20485848|NCT01571167|Varenicline|varenicline|mesh-list
20485849|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20485850|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20485851|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20485852|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20485853|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485854|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485855|NCT01571206|Infliximab|infliximab|mesh-list
20485856|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
20485857|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485858|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485859|NCT01571219|Infliximab|infliximab|mesh-list
20485860|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
20485861|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485862|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485863|NCT01571323|Misoprostol|misoprostol|mesh-list
20485864|NCT01571323|Oxytocin|oxytocin|mesh-list
20485865|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
20485866|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20485867|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485868|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20485869|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
20241447|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241448|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485870|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20485871|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20485872|NCT01571414|Ritonavir|ritonavir|mesh-list
20485873|NCT01571414|Lopinavir|lopinavir|mesh-list
20485874|NCT01571414|Efavirenz|efavirenz|mesh-list
20485875|NCT01571414|Rifampin|rifampin|mesh-list
20485876|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20241449|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241450|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20241451|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20247969|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20247970|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247971|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
20247972|NCT00434083|Naproxen|naproxen|mesh-list
20485877|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20485878|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
20485879|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485880|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485881|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20485882|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20485883|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
20485884|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485885|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20485886|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20485887|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20485888|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20485889|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20485890|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20485891|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20485892|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20485893|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20485894|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20247973|NCT00434083|Sumatriptan|sumatriptan|mesh-list
20485895|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
20485896|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20485897|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
20485898|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20485899|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20485900|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20485901|NCT01571466|Vaccines|vaccines|mesh-list
20485902|NCT01571466|Immunologic Factors|immunologic factors|mesh-ancestor
20485903|NCT01571466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485904|NCT01571505|Vaccines|vaccines|mesh-list
20485905|NCT01571505|Immunologic Factors|immunologic factors|mesh-ancestor
20485906|NCT01571505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485907|NCT01571570|Simeprevir|simeprevir|mesh-list
20485908|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
20485909|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485910|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
20485911|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485912|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485913|NCT01571583|Interferons|interferons|mesh-list
20485914|NCT01571583|Ribavirin|ribavirin|mesh-list
20485915|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
20485916|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
20485917|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20485918|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485919|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
20485920|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20485921|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
20485922|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485923|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
20485924|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485925|NCT01571609|Insulin|insulin|mesh-list
20485926|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20485927|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485928|NCT01571648|Azacitidine|azacitidine|mesh-list
20485929|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20485930|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
20485931|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485932|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20485933|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485934|NCT01571687|Antioxidants|antioxidants|mesh-list
20485935|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485936|NCT01571687|Protective Agents|protective agents|mesh-ancestor
20485937|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528207|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528208|NCT01772290|Itraconazole|itraconazole|mesh-list
20528209|NCT01772290|Fluconazole|fluconazole|mesh-list
20528210|NCT01772290|Rabeprazole|rabeprazole|mesh-list
20528211|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
20528212|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528213|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20528214|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20528215|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528216|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528217|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20241452|NCT00407589|Besifloxacin|besifloxacin|mesh-list
20241453|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241454|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241455|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20241456|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20241457|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241458|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241459|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241460|NCT00407641|Heparin|heparin|mesh-list
20241461|NCT00407641|Tinzaparin|tinzaparin|mesh-list
20528218|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
20528219|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528220|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528221|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20528222|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19414330|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19414331|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414332|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20528223|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528224|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20528225|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20528226|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20528227|NCT01772381|Dexamethasone|dexamethasone|mesh-list
20528228|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528229|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
19414333|NCT03657797|Latanoprost|latanoprost|mesh-list
19414334|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19414335|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19414336|NCT03653026|Upadacitinib|upadacitinib|mesh-list
19414337|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19414338|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19414339|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485938|NCT01571791|Ketorolac|ketorolac|mesh-list
20485939|NCT01571791|Lidocaine|lidocaine|mesh-list
20485940|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
20485941|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
20485942|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20485943|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485944|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
20485945|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485946|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20485947|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20485948|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20485949|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485950|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485951|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20485952|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20485953|NCT01571791|Analgesics|analgesics|mesh-ancestor
20485954|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20485955|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20485956|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20485957|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20485958|NCT01571804|Pregabalin|pregabalin|mesh-list
20485959|NCT01571804|Analgesics|analgesics|mesh-ancestor
20485960|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
20485961|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485962|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485963|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
20485964|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20485965|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20485966|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485967|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20485968|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20485969|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20485970|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414340|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414341|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414342|NCT03647592|Bevacizumab|bevacizumab|mesh-list
20485971|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20485972|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
20485973|NCT01571856|Astringents|astringents|mesh-ancestor
20485974|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485975|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
20485976|NCT01571882|Policosanol|policosanol|mesh-list
20485977|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20485978|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20485979|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
20485980|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485981|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20485982|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20485983|NCT01571908|Rocuronium|rocuronium|mesh-list
20485984|NCT01571908|Succinylcholine|succinylcholine|mesh-list
19852780|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852781|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852782|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19852783|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
19852784|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852785|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852786|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19852787|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19852788|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
19852789|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20485985|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20485986|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20485987|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20485988|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20485989|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485990|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20485991|NCT01571921|Tocotrienols|tocotrienols|mesh-list
20485992|NCT01571921|Vitamin E|vitamin e|mesh-list
20485993|NCT01571921|Tocopherols|tocopherols|mesh-list
20485994|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
20485995|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20485996|NCT01571921|Protective Agents|protective agents|mesh-ancestor
20485997|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20485998|NCT01571921|Vitamins|vitamins|mesh-ancestor
20485999|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
20486000|NCT01571960|Vaccines|vaccines|mesh-list
20486001|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
20486002|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486003|NCT01572012|Ondansetron|ondansetron|mesh-list
19414343|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19414344|NCT03647592|Gefitinib|gefitinib|mesh-list
19414345|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20486004|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
20486005|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
20486006|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486007|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486008|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486009|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
20486010|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
20486011|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20486012|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
20486013|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486014|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414346|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699527|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699528|NCT04901923|Itraconazole|itraconazole|mesh-list
20486015|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20486016|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20486017|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486018|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20486019|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20486020|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20486021|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20486022|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
20486023|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486024|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20486025|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486026|NCT01572116|Lidocaine|lidocaine|mesh-list
20486027|NCT01572116|Epinephrine|epinephrine|mesh-list
20486028|NCT01572116|Racepinephrine|racepinephrine|mesh-list
20486029|NCT01572116|Sufentanil|sufentanil|mesh-list
20486030|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
20486031|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
20486032|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
20486033|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486034|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486035|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
20486036|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486037|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20486038|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20486039|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20486040|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486041|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486042|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20486043|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20486044|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
20486045|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486046|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20486047|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20486048|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
20486049|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20486050|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
20486051|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
20486052|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
20486053|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20486054|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20486055|NCT01572116|Narcotics|narcotics|mesh-ancestor
20486056|NCT01572116|Analgesics|analgesics|mesh-ancestor
20486057|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20486058|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20486059|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
20486060|NCT01572129|Clopidogrel|clopidogrel|mesh-list
20486061|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20486062|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20486063|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20486064|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20486065|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
20486066|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486067|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486068|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486069|NCT01572181|Fludarabine|fludarabine|mesh-list
20486070|NCT01572181|Busulfan|busulfan|mesh-list
20486071|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
20486072|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486073|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486074|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20486075|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
20486076|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486077|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
20486078|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20486079|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20486080|NCT01572259|Hormones|hormones|mesh-list
20486081|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486082|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486083|NCT01572285|Dexamethasone|dexamethasone|mesh-list
20486084|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
20486085|NCT01572285|BB 1101|bb 1101|mesh-list
20486086|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486087|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
20486088|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
19414347|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19414348|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19414349|NCT03647592|Growth Substances|growth substances|mesh-ancestor
19414350|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414351|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
19414352|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19414353|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414354|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414355|NCT03647111|Crizotinib|crizotinib|mesh-list
19414356|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414357|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19414358|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414359|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414360|NCT03646994|Crizotinib|crizotinib|mesh-list
19414361|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414362|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19414363|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414364|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486089|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486090|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486091|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486092|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
20486093|NCT01572285|Hormones|hormones|mesh-ancestor
20486094|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486095|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20486096|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486097|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
20486098|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486099|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486100|NCT01572324|Leucovorin|leucovorin|mesh-list
20486101|NCT01572324|Fluorouracil|fluorouracil|mesh-list
20486102|NCT01572324|Capecitabine|capecitabine|mesh-list
20486103|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
20486104|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
20486105|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486106|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20486107|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486108|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20486109|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
20486110|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486111|NCT01572324|Antidotes|antidotes|mesh-ancestor
20486112|NCT01572324|Protective Agents|protective agents|mesh-ancestor
20486113|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
20486114|NCT01572324|Vitamins|vitamins|mesh-ancestor
20486115|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
20486116|NCT01572350|Triamcinolone|triamcinolone|mesh-list
20486117|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20486118|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20486119|NCT01572350|Bevacizumab|bevacizumab|mesh-list
20486120|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20486121|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20486122|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486123|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20486124|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20486125|NCT01572350|Growth Substances|growth substances|mesh-ancestor
20486126|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486127|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
20486128|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486129|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
20486130|NCT01572350|Hormones|hormones|mesh-ancestor
20486131|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486132|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20486133|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
20486134|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486135|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486136|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
20486137|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
20486138|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20486139|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20486140|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486141|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486142|NCT01572363|Urological Agents|urological agents|mesh-ancestor
20486143|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
20486144|NCT01572454|Remifentanil|remifentanil|mesh-list
20486145|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20486146|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486147|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486148|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20486149|NCT01572454|Analgesics|analgesics|mesh-ancestor
20486150|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
20486151|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486152|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20486153|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20486154|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20486155|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
20486156|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486157|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486158|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19699529|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
19699530|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
19699531|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486159|NCT01572454|Narcotics|narcotics|mesh-ancestor
20486160|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
20486161|NCT01572545|Denosumab|denosumab|mesh-list
20486162|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20486163|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486164|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
20486165|NCT01572558|Meropenem|meropenem|mesh-list
20486166|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486167|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486168|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20241462|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20241463|NCT00407641|Dalteparin|dalteparin|mesh-list
20241464|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
20241465|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20241466|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20241467|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241468|NCT00407680|Valsartan|valsartan|mesh-list
20241469|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20241470|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20241471|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20241472|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241473|NCT00407719|Bevacizumab|bevacizumab|mesh-list
20486169|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20486170|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414365|NCT03646968|Docetaxel|docetaxel|mesh-list
20486171|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486172|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486173|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20486174|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20486175|NCT01572597|Metronidazole|metronidazole|mesh-list
20486176|NCT01572597|Clarithromycin|clarithromycin|mesh-list
20486177|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
20486178|NCT01572597|Rabeprazole|rabeprazole|mesh-list
20486179|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486180|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486181|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20486182|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20486183|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20486184|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486185|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20486186|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486187|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486188|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20486189|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20486190|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20486191|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
20486192|NCT01572597|Expectorants|expectorants|mesh-ancestor
20486193|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
20486194|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20486195|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
20486196|NCT01572597|Protective Agents|protective agents|mesh-ancestor
20486197|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486198|NCT01572623|Clopidogrel|clopidogrel|mesh-list
20486199|NCT01572623|Atorvastatin|atorvastatin|mesh-list
20486200|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20486201|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20486202|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
20486203|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486204|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20486205|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20486206|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486207|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20486208|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20486209|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20486210|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20486211|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
20486212|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486213|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486214|NCT01572649|Lixisenatide|lixisenatide|mesh-list
20486215|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486216|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486217|NCT01572688|Melphalan|melphalan|mesh-list
20486218|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20486219|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
20486220|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486221|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486222|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19699532|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19699533|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19699534|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699535|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486223|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20486224|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
20486225|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486226|NCT01572805|Melatonin|melatonin|mesh-list
20486227|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
20486228|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486229|NCT01572805|Protective Agents|protective agents|mesh-ancestor
20486230|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486231|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486232|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
20486233|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
20486234|NCT01572831|Protective Agents|protective agents|mesh-ancestor
20486235|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414366|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486236|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
20486237|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20486238|NCT01572857|Antibodies|antibodies|mesh-list
20486239|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
20486240|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486241|NCT01572961|Aspirin|aspirin|mesh-list
20486242|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20486243|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20486244|NCT01572961|Analgesics|analgesics|mesh-ancestor
20486245|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
20486246|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486247|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486248|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486249|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20486250|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20486251|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20486252|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486253|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20486254|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20486255|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486256|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
20486257|NCT01573013|Iron|iron|mesh-list
20486258|NCT01573013|Trace Elements|trace elements|mesh-ancestor
20486259|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
20486260|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486261|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20486262|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20486263|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20486264|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
20486265|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486266|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20486267|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20486268|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486269|NCT01573286|Glucagon|glucagon|mesh-list
20486270|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20486271|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486272|NCT01573286|Hormones|hormones|mesh-ancestor
20486273|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486274|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699536|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19699537|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
19699538|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699539|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699540|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19699541|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699542|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20486275|NCT01573286|Incretins|incretins|mesh-ancestor
19699543|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19699544|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708005|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
20486276|NCT01573338|Carboplatin|carboplatin|mesh-list
20486277|NCT01573338|Etoposide|etoposide|mesh-list
20486278|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486279|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20486280|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20486281|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20486282|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486283|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486284|NCT01573377|Metformin|metformin|mesh-list
20486285|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
20486286|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20486287|NCT01573377|Cyproterone|cyproterone|mesh-list
20486288|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486289|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486290|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20486291|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20486292|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20486293|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
20486294|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20486295|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20486296|NCT01573377|Estrogens|estrogens|mesh-ancestor
20486297|NCT01573377|Hormones|hormones|mesh-ancestor
20486298|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486299|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
20486300|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
20486301|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486302|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20486303|NCT01573468|Capecitabine|capecitabine|mesh-list
20486304|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20486305|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
20486306|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486307|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528230|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
20528231|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528232|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528233|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708006|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528234|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
20528235|NCT01772381|Hormones|hormones|mesh-ancestor
20528236|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528237|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20486308|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20486309|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
20486310|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20486311|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20486312|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20486313|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486314|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486315|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486316|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
20486317|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486318|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20486319|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20486320|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20486321|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20486322|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
20486323|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486324|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486325|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20486326|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20486327|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20486328|NCT01573663|Dipropizine|dipropizine|mesh-list
20486329|NCT01573663|Ambroxol|ambroxol|mesh-list
20486330|NCT01573663|Expectorants|expectorants|mesh-ancestor
20486331|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
20486332|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
20486333|NCT01573715|Cisatracurium|cisatracurium|mesh-list
20486334|NCT01573715|Atracurium|atracurium|mesh-list
20486335|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20486336|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20486337|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486338|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486339|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20486340|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20486341|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20486342|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
20486343|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486344|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486345|NCT01573741|Ketamine|ketamine|mesh-list
20486346|NCT01573741|Analgesics|analgesics|mesh-ancestor
19699545|NCT04901494|Serotonin|serotonin|mesh-list
19699546|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19699547|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19699548|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
19699549|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699550|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486347|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
20486348|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699551|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486349|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486350|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20486351|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20486352|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
20486353|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
20486354|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486355|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20486356|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20486357|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486358|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486359|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
20486360|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
20486361|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20486362|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20486363|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486364|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486365|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486366|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20486367|NCT01573780|Gemcitabine|gemcitabine|mesh-list
20486368|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20486369|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
20486370|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486371|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486372|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
20486373|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486374|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486375|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20486376|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
20486377|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486378|NCT01573806|Exenatide|exenatide|mesh-list
20486379|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486380|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486381|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20486382|NCT01573806|Incretins|incretins|mesh-ancestor
20486383|NCT01573806|Hormones|hormones|mesh-ancestor
20486384|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486385|NCT01573975|Clarithromycin|clarithromycin|mesh-list
20486386|NCT01573975|Rabeprazole|rabeprazole|mesh-list
20486387|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20486388|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486389|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20486390|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486391|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414367|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
19414368|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
19414369|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699552|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19414370|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852790|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19852791|NCT00727415|Growth Substances|growth substances|mesh-ancestor
20486392|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414371|NCT03635996|Etripamil|etripamil|mesh-list
19414372|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19414373|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486393|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486394|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20486395|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20486396|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20486397|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
20486398|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486399|NCT01574027|Vitamin D|vitamin d|mesh-list
20486400|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
20486401|NCT01574027|Vitamins|vitamins|mesh-ancestor
20486402|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
19416895|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852792|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852793|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
19852794|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19852795|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
19852796|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852797|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19852798|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19416896|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
20486403|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486404|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20486405|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20486406|NCT01574092|Irinotecan|irinotecan|mesh-list
20486407|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486408|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20486409|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20486410|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486411|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486412|NCT01574131|Fenofibrate|fenofibrate|mesh-list
20486413|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20486414|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
20486415|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486416|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20486417|NCT01574261|Inositol|inositol|mesh-list
20486418|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
20486419|NCT01574261|Vitamins|vitamins|mesh-ancestor
20486420|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
20486421|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486422|NCT01574274|Pegaspargase|pegaspargase|mesh-list
20486423|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486424|NCT01574313|Tocopherols|tocopherols|mesh-list
20486425|NCT01574313|Vitamin E|vitamin e|mesh-list
20486426|NCT01574313|Tocotrienols|tocotrienols|mesh-list
20486427|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
20486428|NCT01574313|Niacin|niacin|mesh-list
20486429|NCT01574313|Diphenidol|diphenidol|mesh-list
20486430|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
20486431|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486432|NCT01574313|Protective Agents|protective agents|mesh-ancestor
20486433|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486434|NCT01574313|Vitamins|vitamins|mesh-ancestor
20486435|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
19416897|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
20486436|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20486437|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
20486438|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20486439|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
20486440|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
20486441|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
20486442|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
20486443|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486444|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486445|NCT01574508|Insulin|insulin|mesh-list
20486446|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20486447|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486448|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486449|NCT01574638|Rifapentine|rifapentine|mesh-list
20486450|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20486451|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
20486452|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486453|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486454|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
20486455|NCT01574742|Minocycline|minocycline|mesh-list
20486456|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486457|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486458|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
20486459|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486460|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528238|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528239|NCT01772420|Lenalidomide|lenalidomide|mesh-list
20528240|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
20528241|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528242|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20528243|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20528244|NCT01772420|Growth Substances|growth substances|mesh-ancestor
20528245|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
20528246|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528247|NCT01772563|Itraconazole|itraconazole|mesh-list
20528248|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
20528249|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528250|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20528251|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20528252|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528253|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528254|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20528255|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
20528256|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528257|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528258|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20528259|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
20528260|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
20528261|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
20528262|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
20528263|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528264|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528265|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20528266|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20528267|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528268|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528269|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528270|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20528271|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20528272|NCT01772641|Varenicline|varenicline|mesh-list
20528273|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20528274|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20528275|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
20528276|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528277|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486461|NCT01575158|Citalopram|citalopram|mesh-list
20486462|NCT01575158|Clomipramine|clomipramine|mesh-list
19414374|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414375|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19414376|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416898|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
19416899|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416900|NCT02255409|Vaccines|vaccines|mesh-list
19416901|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
19416902|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416903|NCT02252835|Colchicine|colchicine|mesh-list
19416904|NCT02252835|Febuxostat|febuxostat|mesh-list
19416905|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
20486463|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20486464|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20486465|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486466|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486467|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486468|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
20486469|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486470|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20486471|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
20486472|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20486473|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20486474|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
20486475|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20486476|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486477|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
20486478|NCT01575301|Liraglutide|liraglutide|mesh-list
20486479|NCT01575301|Exenatide|exenatide|mesh-list
20486480|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486481|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486482|NCT01575301|Incretins|incretins|mesh-ancestor
20486483|NCT01575301|Hormones|hormones|mesh-ancestor
20486484|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486485|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20486486|NCT01575405|Tenofovir|tenofovir|mesh-list
20486487|NCT01575405|Glycerol|glycerol|mesh-list
19416906|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416907|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
19416908|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20486488|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
20486489|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486490|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20241474|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20486491|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20486492|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486493|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486494|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20486495|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20486496|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20486497|NCT01575405|Protective Agents|protective agents|mesh-ancestor
20486498|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486499|NCT01575418|Tenofovir|tenofovir|mesh-list
20486500|NCT01575418|Glycerol|glycerol|mesh-list
20241475|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241476|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20486501|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
19414377|NCT03626545|Docetaxel|docetaxel|mesh-list
19414378|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241477|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241478|NCT00407719|Growth Substances|growth substances|mesh-ancestor
20241479|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241480|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241481|NCT00407771|Tirofiban|tirofiban|mesh-list
20241482|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20241483|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20241484|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241485|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20241486|NCT00407784|Eplerenone|eplerenone|mesh-list
20241487|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20486502|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486503|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20486504|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20486505|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486506|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486507|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20486508|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20486509|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20486510|NCT01575418|Protective Agents|protective agents|mesh-ancestor
20486511|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486512|NCT01575483|Saxagliptin|saxagliptin|mesh-list
20486513|NCT01575483|Incretins|incretins|mesh-ancestor
20486514|NCT01575483|Hormones|hormones|mesh-ancestor
20486515|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486516|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486517|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20486518|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
20486519|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486520|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486521|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486522|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20486523|NCT01575613|Lumefantrine|lumefantrine|mesh-list
20486524|NCT01575613|Artemether|artemether|mesh-list
19699553|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19699554|NCT04901663|Amoxicillin|amoxicillin|mesh-list
19699555|NCT04901663|Clarithromycin|clarithromycin|mesh-list
19699556|NCT04901663|Omeprazole|omeprazole|mesh-list
19699557|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19699558|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699559|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19699560|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699561|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19414379|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
19699562|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486525|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19699563|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699564|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19699565|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20486526|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
19699566|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19414380|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
19852799|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
19852800|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852801|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852802|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20486527|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20486528|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20486529|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486530|NCT01575626|Sevoflurane|sevoflurane|mesh-list
20486531|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20486532|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20486533|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
20486534|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
20486535|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486536|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486537|NCT01575639|Prednisolone|prednisolone|mesh-list
20486538|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486539|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
20486540|NCT01575639|Hormones|hormones|mesh-ancestor
20486541|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486542|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486543|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20486544|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486545|NCT01575652|Lisinopril|lisinopril|mesh-list
20486546|NCT01575652|Perindopril|perindopril|mesh-list
20486547|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20486548|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20486549|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
20486550|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486551|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20486552|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20486553|NCT01575652|Protective Agents|protective agents|mesh-ancestor
20486554|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486555|NCT01575678|Melatonin|melatonin|mesh-list
20486556|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
20486557|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486558|NCT01575678|Protective Agents|protective agents|mesh-ancestor
20486559|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486560|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486561|NCT01575717|Vitamin D|vitamin d|mesh-list
20486562|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
20486563|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
20486564|NCT01575717|Vitamins|vitamins|mesh-list
20486565|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
20486566|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486567|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20486568|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20486569|NCT01575782|Chloroquine|chloroquine|mesh-list
20486570|NCT01575782|Amebicides|amebicides|mesh-ancestor
20486571|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20486572|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20486573|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486574|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
20486575|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20486576|NCT01575795|Ticagrelor|ticagrelor|mesh-list
20486577|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20486578|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20486579|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20486580|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20486581|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
20486582|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486583|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486584|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486585|NCT01575925|Thalidomide|thalidomide|mesh-list
20486586|NCT01575925|Dexamethasone|dexamethasone|mesh-list
20486587|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
20486588|NCT01575925|Pomalidomide|pomalidomide|mesh-list
20486589|NCT01575925|BB 1101|bb 1101|mesh-list
20486590|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486591|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
20486592|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
20486593|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486594|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486595|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486596|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
20486597|NCT01575925|Hormones|hormones|mesh-ancestor
20486598|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486599|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20486600|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486601|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
20486602|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486603|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486604|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
20486605|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19414381|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
20486606|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20486607|NCT01575925|Growth Substances|growth substances|mesh-ancestor
20486608|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
20486609|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20486610|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
20486611|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486612|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486613|NCT01576029|Docetaxel|docetaxel|mesh-list
20486614|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486615|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
20486616|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
20486617|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
20486618|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414382|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414383|NCT03624127|Apremilast|apremilast|mesh-list
19414384|NCT03624127|BMS-986165|bms-986165|mesh-list
19414385|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19852803|NCT00727506|Afatinib|afatinib|mesh-list
20486619|NCT01576094|Simendan|simendan|mesh-list
20486620|NCT01576094|Milrinone|milrinone|mesh-list
20486621|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20486622|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
20486623|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20486624|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20486625|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486626|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486627|NCT01576094|Protective Agents|protective agents|mesh-ancestor
20486628|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486629|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20486630|NCT01576185|Sorafenib|sorafenib|mesh-list
20486631|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486632|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20486633|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486634|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486635|NCT01576263|Ropivacaine|ropivacaine|mesh-list
20486636|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
20486637|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
20486638|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486639|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486640|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
20486641|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486642|NCT01576315|Itraconazole|itraconazole|mesh-list
20486643|NCT01576315|Voriconazole|voriconazole|mesh-list
20486644|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
20486645|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486646|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20486647|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20486648|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486649|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486650|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20486651|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
20486652|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486653|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486654|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20486655|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
20486656|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20486657|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486658|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486659|NCT01576419|Celecoxib|celecoxib|mesh-list
20486660|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20486661|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20486662|NCT01576419|Analgesics|analgesics|mesh-ancestor
20486663|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
20486664|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486665|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486666|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486667|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20486668|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20486669|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20486670|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486671|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486672|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20486673|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20486674|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486675|NCT01576627|Zinc|zinc|mesh-list
20486676|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
20486677|NCT01576627|Trace Elements|trace elements|mesh-ancestor
20486678|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
20486679|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486680|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
20486681|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
20486682|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20486683|NCT01576627|Protective Agents|protective agents|mesh-ancestor
20486684|NCT01576640|Bupropion|bupropion|mesh-list
20486685|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20486686|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
20486687|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19414386|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414387|NCT03624127|Analgesics|analgesics|mesh-ancestor
19414388|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
20486688|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20486689|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20486690|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486691|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486692|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
20486693|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486694|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486695|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20486696|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20486697|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486698|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20486699|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20486700|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20486701|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486702|NCT01576692|Aldesleukin|aldesleukin|mesh-list
20486703|NCT01576692|Antibodies|antibodies|mesh-list
20486704|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
20486705|NCT01576692|Sargramostim|sargramostim|mesh-list
20486706|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
20486707|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486708|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486709|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20486710|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20486711|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
20486712|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486713|NCT01576731|Tenofovir|tenofovir|mesh-list
20486714|NCT01576731|Emtricitabine|emtricitabine|mesh-list
20486715|NCT01576731|Lopinavir|lopinavir|mesh-list
20486716|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
20486717|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
20486718|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486719|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20486720|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20486721|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486722|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486723|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20486724|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19416909|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
20486725|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20486726|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20486727|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
20486728|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20486729|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20486730|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20486731|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20486732|NCT01576770|Lidocaine|lidocaine|mesh-list
20486733|NCT01576770|Tetracaine|tetracaine|mesh-list
20486734|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
20486735|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
20486736|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
20486737|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486738|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241488|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
20241489|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241490|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241491|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20241492|NCT00407784|Diuretics|diuretics|mesh-ancestor
20241493|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
20241494|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20241495|NCT00407836|Vaccines|vaccines|mesh-list
20241496|NCT00407836|Immunologic Factors|immunologic factors|mesh-ancestor
20241497|NCT00407836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241498|NCT00407849|Triamcinolone|triamcinolone|mesh-list
20241499|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20241500|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20241501|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20241502|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241503|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
20241504|NCT00407849|Hormones|hormones|mesh-ancestor
20241505|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486739|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
20486740|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486741|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20486742|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20486743|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20486744|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486745|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486746|NCT01576848|Caseins|caseins|mesh-list
20486747|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
19699567|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
19699568|NCT04901312|Narcotics|narcotics|mesh-ancestor
19699569|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699570|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699571|NCT04901312|Analgesics|analgesics|mesh-ancestor
19699572|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
19699573|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486748|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
20486749|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528278|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528279|NCT01772797|Ceritinib|ceritinib|mesh-list
20528280|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528281|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20528282|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528283|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528284|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
20528285|NCT01772836|Biapenem|biapenem|mesh-list
20528286|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528287|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528288|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528289|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528290|NCT01772940|Ritonavir|ritonavir|mesh-list
20528291|NCT01772940|Lopinavir|lopinavir|mesh-list
20528292|NCT01772940|Tenofovir|tenofovir|mesh-list
20528293|NCT01772940|Lamivudine|lamivudine|mesh-list
20528294|NCT01772940|Zidovudine|zidovudine|mesh-list
20528295|NCT01772940|Emtricitabine|emtricitabine|mesh-list
20528296|NCT01772940|Nevirapine|nevirapine|mesh-list
20528297|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20528298|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20528299|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
20528300|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528301|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528302|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20528303|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20528304|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
20528305|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528306|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20528307|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20528308|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20528309|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20528310|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
20528311|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20528312|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20528313|NCT01772953|Treosulfan|treosulfan|mesh-list
20528314|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20528315|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
20528316|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528317|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528318|NCT01772979|Trabectedin|trabectedin|mesh-list
20528319|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20528320|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
20528321|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528322|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528323|NCT01773005|Acetaminophen|acetaminophen|mesh-list
20528324|NCT01773005|Ibuprofen|ibuprofen|mesh-list
20528325|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20528326|NCT01773005|Analgesics|analgesics|mesh-ancestor
20528327|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
20528328|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528329|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528330|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
20528331|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20528332|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528333|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528334|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20528335|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528336|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528337|NCT01773044|Lidocaine|lidocaine|mesh-list
20528338|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
20528339|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
20528340|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528341|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486750|NCT01577017|Letrozole|letrozole|mesh-list
20486751|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20486752|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486753|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20486754|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486755|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486756|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20486757|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
20486758|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486759|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486760|NCT01577043|Racecadotril|racecadotril|mesh-list
20486761|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
20486762|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486763|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
20486764|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486765|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486766|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
20486767|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20486768|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486769|NCT01577121|Indomethacin|indomethacin|mesh-list
20486770|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20486771|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20486772|NCT01577121|Analgesics|analgesics|mesh-ancestor
20486773|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
20486774|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486775|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486776|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20486777|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20486778|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
20486779|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
20486780|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20486781|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19699574|NCT04901117|Amoxicillin|amoxicillin|mesh-list
19699575|NCT04901117|Metronidazole|metronidazole|mesh-list
19699576|NCT04901117|Clarithromycin|clarithromycin|mesh-list
19699577|NCT04901117|Tetracycline|tetracycline|mesh-list
19699578|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
19699579|NCT04901117|Bismuth|bismuth|mesh-list
19699580|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699581|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19699582|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699583|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19699584|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19699585|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19699586|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699587|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19699588|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19699589|NCT04901117|Antacids|antacids|mesh-ancestor
20486782|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486783|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486784|NCT01577199|Clomiphene|clomiphene|mesh-list
20486785|NCT01577199|Enclomiphene|enclomiphene|mesh-list
20486786|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
20486787|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19699590|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486788|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
20486789|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699591|NCT04901117|Diuretics|diuretics|mesh-ancestor
19699592|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
19699593|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486790|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486791|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20486792|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
20486793|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20486794|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20486795|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20486796|NCT01577316|Vaccines|vaccines|mesh-list
20486797|NCT01577316|Immunologic Factors|immunologic factors|mesh-ancestor
20486798|NCT01577316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486799|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
20486800|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486801|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486802|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20486803|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20486804|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486805|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486806|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486807|NCT01577368|Tazobactam|tazobactam|mesh-list
20486808|NCT01577368|Piperacillin|piperacillin|mesh-list
19699594|NCT04901117|Expectorants|expectorants|mesh-ancestor
19699595|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
19699596|NCT04901065|Lidocaine|lidocaine|mesh-list
19699597|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
19699598|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
19699599|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699600|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699601|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
20241506|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241507|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241508|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
20241509|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241510|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241511|NCT00407862|Losartan|losartan|mesh-list
20241512|NCT00407862|Telmisartan|telmisartan|mesh-list
20241513|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20241514|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20486809|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20486810|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486811|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486812|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20486813|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486814|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486815|NCT01577407|Nefopam|nefopam|mesh-list
20486816|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20486817|NCT01577407|Analgesics|analgesics|mesh-ancestor
20486818|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
20486819|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241515|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20241516|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20241517|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241518|NCT00407927|Epinastine|epinastine|mesh-list
19699602|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699603|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20241519|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20486820|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486821|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
20486822|NCT01577459|Tedizolid|tedizolid|mesh-list
20486823|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486824|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486825|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
20486826|NCT01577524|Povidone|povidone|mesh-list
20486827|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
20486828|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
20486829|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20486830|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486831|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20486832|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
20486833|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486834|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20486835|NCT01577589|Cephalosporins|cephalosporins|mesh-list
20486836|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241520|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
20486837|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486838|NCT01577693|Dutasteride|dutasteride|mesh-list
20486839|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20486840|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20486841|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486842|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486843|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
20486844|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20486845|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241521|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
20241522|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241523|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241524|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241525|NCT00408031|Cycloserine|cycloserine|mesh-list
20241526|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20486846|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19414389|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414390|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414391|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414392|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414393|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19414394|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19852804|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852805|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20486847|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
20486848|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486849|NCT01577849|Vitamin D|vitamin d|mesh-list
20486850|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
20486851|NCT01577849|Vitamins|vitamins|mesh-ancestor
20486852|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
20486853|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486854|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20486855|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20486856|NCT01577862|Rifampin|rifampin|mesh-list
20486857|NCT01577862|Colistin|colistin|mesh-list
20486858|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20486859|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
20486860|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20486861|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486862|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
20486863|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20486864|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486865|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486866|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20486867|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20486868|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20486869|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20486870|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20486871|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20486872|NCT01577914|Carvedilol|carvedilol|mesh-list
20486873|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20486874|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20486875|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
20486876|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486877|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486878|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486879|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20486880|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
20486881|NCT01577914|Protective Agents|protective agents|mesh-ancestor
20486882|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20486883|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20486884|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20486885|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
20486886|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20486887|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20486888|NCT01577940|Ropivacaine|ropivacaine|mesh-list
20486889|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
20486890|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
20486891|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486892|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414395|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414396|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486893|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
20486894|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486895|NCT01577992|Levodopa|levodopa|mesh-list
20486896|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20486897|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20486898|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
20486899|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486900|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486901|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486902|NCT01578057|Ethanol|ethanol|mesh-list
20486903|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20486904|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486905|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486906|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486907|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
20486908|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20486909|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
20486910|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
20486911|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
20486912|NCT01578109|Sorafenib|sorafenib|mesh-list
20486913|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486914|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20486915|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20486916|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486917|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
20486918|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20486919|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486920|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486921|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20486922|NCT01578161|Analgesics|analgesics|mesh-ancestor
20486923|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
20486924|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486925|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20486926|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20486927|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20486928|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
20486929|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486930|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486931|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
20486932|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20486933|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486934|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486935|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20486936|NCT01578174|Analgesics|analgesics|mesh-ancestor
20486937|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
20486938|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486939|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20486940|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20486941|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20486942|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
20486943|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486944|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486945|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
20486946|NCT01578200|Calcium|calcium|mesh-list
20486947|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19414397|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
20486948|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486949|NCT01578200|Antacids|antacids|mesh-ancestor
20486950|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486951|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486952|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
20486953|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20486954|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20486955|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414398|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19414399|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20486956|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486957|NCT01578252|Ondansetron|ondansetron|mesh-list
20486958|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
20486959|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
20486960|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486961|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486962|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486963|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
20486964|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
20486965|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20486966|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
20486967|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486968|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486969|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20486970|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20486971|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486972|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20486973|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20486974|NCT01578265|Ondansetron|ondansetron|mesh-list
20486975|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
20486976|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
20486977|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20486978|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486979|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20486980|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
20486981|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
20486982|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20486983|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
20486984|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486985|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486986|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20486987|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20486988|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20486989|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20486990|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20486991|NCT01578304|Fesoterodine|fesoterodine|mesh-list
20486992|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20486993|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20486994|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
20486995|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20486996|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20486997|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20486998|NCT01578304|Urological Agents|urological agents|mesh-ancestor
20486999|NCT01578343|Vidarabine|vidarabine|mesh-list
20487000|NCT01578343|Dexamethasone|dexamethasone|mesh-list
20487001|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
20487002|NCT01578343|Fludarabine|fludarabine|mesh-list
20487003|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
20487004|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
20487005|NCT01578343|Vorinostat|vorinostat|mesh-list
20487006|NCT01578343|BB 1101|bb 1101|mesh-list
20487007|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20487008|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
20487009|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
20487010|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487011|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487012|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20487013|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
20487014|NCT01578343|Hormones|hormones|mesh-ancestor
20487015|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487016|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487017|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487018|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487019|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487020|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487021|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20487022|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
20487023|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20487024|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
20487025|NCT01578343|Antiviral Agents|antiviral agents|mesh-ancestor
20487026|NCT01578343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487027|NCT01578343|Analgesics|analgesics|mesh-ancestor
20487028|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
20487029|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20487030|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20487031|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20487032|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
20487033|NCT01578434|Vitamin D|vitamin d|mesh-list
20487034|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
20487035|NCT01578434|Vitamins|vitamins|mesh-list
20487036|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
20487037|NCT01578434|Calcium|calcium|mesh-list
20487038|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
20487039|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487040|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20487041|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20487042|NCT01578434|Antacids|antacids|mesh-ancestor
20487043|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487044|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20487045|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20487046|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
20487047|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20487048|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
20487049|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20487050|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487051|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20487052|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20487053|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487054|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487055|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20487056|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20487057|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20487058|NCT01578473|Vitamin D|vitamin d|mesh-list
20487059|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
20487060|NCT01578473|Vitamins|vitamins|mesh-list
20487061|NCT01578473|Vitamin E|vitamin e|mesh-list
20487062|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
20487063|NCT01578473|Testosterone|testosterone|mesh-list
20487064|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
20487065|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
20487066|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20487067|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
20487068|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487069|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20487070|NCT01578473|Androgens|androgens|mesh-ancestor
20487071|NCT01578473|Hormones|hormones|mesh-ancestor
20487072|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487073|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487074|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487075|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
20487076|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
20487077|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487078|NCT01578473|Protective Agents|protective agents|mesh-ancestor
20487079|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20487080|NCT01578564|SOR-C13|sor-c13|mesh-list
20487081|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487082|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20487083|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487084|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487085|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20487086|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487087|NCT01578603|Calcium|calcium|mesh-list
20487088|NCT01578603|Caseins|caseins|mesh-list
20487089|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20487090|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414400|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19699604|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19699605|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19699606|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487091|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
20487092|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
20487093|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487094|NCT01578629|Aspirin|aspirin|mesh-list
20487095|NCT01578629|Vitamin E|vitamin e|mesh-list
20487096|NCT01578629|Tocopherols|tocopherols|mesh-list
20487097|NCT01578629|Tocotrienols|tocotrienols|mesh-list
20487098|NCT01578629|Vitamins|vitamins|mesh-ancestor
20487099|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
20487100|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487101|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20487102|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20487103|NCT01578629|Analgesics|analgesics|mesh-ancestor
20487104|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
20487105|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487106|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20487107|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20487108|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20487109|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20487110|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487111|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20487112|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20487113|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487114|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
20487115|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
20487116|NCT01578629|Protective Agents|protective agents|mesh-ancestor
20487117|NCT01578668|Pemetrexed|pemetrexed|mesh-list
20487118|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20487119|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487120|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487121|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487122|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20487123|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20487124|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20528342|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
20528343|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241527|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241528|NCT00408031|Renal Agents|renal agents|mesh-ancestor
20241529|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20241530|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
20241531|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528344|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20528345|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20528346|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20528347|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528348|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528349|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
20528350|NCT01773096|Bisacodyl|bisacodyl|mesh-list
20528351|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20528352|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
20528353|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20528354|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20528355|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528356|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
20528357|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528358|NCT01773096|Cathartics|cathartics|mesh-ancestor
20528359|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528360|NCT01773096|Laxatives|laxatives|mesh-ancestor
20528361|NCT01773096|Antacids|antacids|mesh-ancestor
20528362|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528363|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
20241532|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
20241533|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241534|NCT00408135|Telithromycin|telithromycin|mesh-list
20241535|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241536|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241537|NCT00408148|Rimonabant|rimonabant|mesh-list
20528364|NCT01773174|Dabigatran|dabigatran|mesh-list
20487125|NCT01578720|Aflibercept|aflibercept|mesh-list
20487126|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20487127|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20487128|NCT01578720|Growth Substances|growth substances|mesh-ancestor
20487129|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487130|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
20487131|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487132|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
20487133|NCT01578824|Miotics|miotics|mesh-ancestor
20487134|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
20487135|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241538|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20241539|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20241540|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20241541|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241542|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241543|NCT00408148|Hormones|hormones|mesh-ancestor
20241544|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20241545|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241546|NCT00408174|Balsalazide|balsalazide|mesh-list
20241547|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20241548|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20487136|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487137|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20487138|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20487139|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
20487140|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20487141|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20487142|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
20487143|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487144|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487145|NCT01578889|Vaccines|vaccines|mesh-list
20487146|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
20487147|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487148|NCT01578928|Pasireotide|pasireotide|mesh-list
20487149|NCT01578928|Hormones|hormones|mesh-ancestor
20487150|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487151|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487152|NCT01579019|Ritonavir|ritonavir|mesh-list
20487153|NCT01579019|Ribavirin|ribavirin|mesh-list
20487154|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20487155|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20487156|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20487157|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487158|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487159|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487160|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20487161|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20487162|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
20487163|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487164|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20487165|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20487166|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
19414401|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20487167|NCT01579058|Bisoprolol|bisoprolol|mesh-list
20487168|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20487169|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
20487170|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
20487171|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487172|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487173|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20487174|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20487175|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20487176|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
20487177|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487178|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487179|NCT01579110|Levamisole|levamisole|mesh-list
20487180|NCT01579110|Prednisone|prednisone|mesh-list
20487181|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20487182|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
20487183|NCT01579110|Hormones|hormones|mesh-ancestor
20487184|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487185|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487186|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487187|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487188|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20487189|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
20487190|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
20487191|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
20487192|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20487193|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487194|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20487195|NCT01579149|Plerixafor|plerixafor|mesh-list
20487196|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20487197|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20487198|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
20487199|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487200|NCT01579201|Carbetocin|carbetocin|mesh-list
20487201|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
20487202|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20487203|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487204|NCT01579227|Tamoxifen|tamoxifen|mesh-list
20487205|NCT01579227|Tocotrienols|tocotrienols|mesh-list
20487206|NCT01579227|Vitamin E|vitamin e|mesh-list
20487207|NCT01579227|Tocopherols|tocopherols|mesh-list
20487208|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20487209|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
20487210|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487211|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487212|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487213|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487214|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20487215|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20487216|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20487217|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
20487218|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487219|NCT01579227|Protective Agents|protective agents|mesh-ancestor
20487220|NCT01579227|Vitamins|vitamins|mesh-ancestor
20487221|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
20487222|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20487223|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20487224|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20487225|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487226|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487227|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487228|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487229|NCT01579279|Analgesics|analgesics|mesh-ancestor
20487230|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
20487231|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487232|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
20487233|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20487234|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
20487235|NCT01579383|Sumatriptan|sumatriptan|mesh-list
20487236|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20487237|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20487238|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20487239|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
20487240|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487241|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487242|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487243|NCT01579448|Vaccines|vaccines|mesh-list
20487244|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
20487245|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487246|NCT01579461|Mirabegron|mirabegron|mesh-list
20487247|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20487248|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20487249|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20487250|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
20487251|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528365|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
20487252|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487253|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487254|NCT01579461|Urological Agents|urological agents|mesh-ancestor
20487255|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
20487256|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20487257|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20487258|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20487259|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487260|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487261|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
20487262|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487263|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487264|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20487265|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487266|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
20487267|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20487268|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20487269|NCT01579539|Prednisolone|prednisolone|mesh-list
20487270|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
20487271|NCT01579539|Esomeprazole|esomeprazole|mesh-list
20487272|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20487273|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
20487274|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20487275|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
20487276|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
20487277|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487278|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487279|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20487280|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
20487281|NCT01579539|Hormones|hormones|mesh-ancestor
20487282|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487283|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20487284|NCT01579539|Protective Agents|protective agents|mesh-ancestor
20487285|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708007|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487286|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487287|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20487288|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20487289|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487290|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487291|NCT01579630|Pemetrexed|pemetrexed|mesh-list
20487292|NCT01579630|Gefitinib|gefitinib|mesh-list
20487293|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487294|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487295|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487296|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20487297|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20487298|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20487299|NCT01579695|Tesamorelin|tesamorelin|mesh-list
20487300|NCT01579695|Growth Substances|growth substances|mesh-ancestor
19852806|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852807|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852808|NCT00727532|Sorafenib|sorafenib|mesh-list
20487301|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487302|NCT01579734|Tamoxifen|tamoxifen|mesh-list
20487303|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20487304|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
20487305|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487306|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487307|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487308|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487309|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20487310|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20487311|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20487312|NCT01579760|Aflibercept|aflibercept|mesh-list
20487313|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20487314|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20487315|NCT01579760|Growth Substances|growth substances|mesh-ancestor
20487316|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487317|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
20487318|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487319|NCT01579786|Acetaminophen|acetaminophen|mesh-list
20487320|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20487321|NCT01579786|Analgesics|analgesics|mesh-ancestor
20487322|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
20487323|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487324|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487325|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
20487326|NCT01579838|Eculizumab|eculizumab|mesh-list
20487327|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20487328|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20487329|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
20487330|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487331|NCT01579864|Rocuronium|rocuronium|mesh-list
19852809|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852810|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19852811|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852812|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852813|NCT00727597|Efavirenz|efavirenz|mesh-list
19852814|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
20241549|NCT00408174|Analgesics|analgesics|mesh-ancestor
20241550|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
20241551|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241552|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241553|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241554|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20241555|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20241556|NCT00408187|Cyclosporine|cyclosporine|mesh-list
20241557|NCT00408187|Cyclosporins|cyclosporins|mesh-list
20241558|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241559|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241560|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241561|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
20241562|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241563|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
20241564|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241565|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
20487332|NCT01579864|Succinylcholine|succinylcholine|mesh-list
20487333|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20487334|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20487335|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20487336|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487337|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487338|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20487339|NCT01579890|Diclofenac|diclofenac|mesh-list
20487340|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20487341|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20487342|NCT01579890|Analgesics|analgesics|mesh-ancestor
20487343|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
20487344|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487345|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487346|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20487347|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20487348|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20487349|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487350|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487351|NCT01579903|Factor VIII|factor viii|mesh-list
20487352|NCT01579903|Coagulants|coagulants|mesh-ancestor
20487353|NCT01579929|Etoposide|etoposide|mesh-list
20487354|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487355|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20487356|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20487357|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20487358|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487359|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487360|NCT01579994|Crizotinib|crizotinib|mesh-list
20487361|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487362|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20487363|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487364|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487365|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
20487366|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20487367|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20487368|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487369|NCT01580007|Vitamins|vitamins|mesh-ancestor
20487370|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
20487371|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20487372|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487373|NCT01580033|Vaccines|vaccines|mesh-list
20487374|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
20487375|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487376|NCT01580163|Methadone|methadone|mesh-list
20487377|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20487378|NCT01580163|Narcotics|narcotics|mesh-ancestor
20487379|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487380|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487381|NCT01580163|Analgesics|analgesics|mesh-ancestor
20487382|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
20487383|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487384|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
20487385|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
20487386|NCT01580202|Lamivudine|lamivudine|mesh-list
20487387|NCT01580202|Entecavir|entecavir|mesh-list
20487388|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20487389|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20487390|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487391|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487392|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
20487393|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487394|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20487395|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20487396|NCT01580228|Ofatumumab|ofatumumab|mesh-list
20487397|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487398|NCT01580254|Latanoprost|latanoprost|mesh-list
20487399|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20487400|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20528366|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20528367|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
20528368|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528369|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528370|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
20528371|NCT01773408|Cytarabine|cytarabine|mesh-list
20528372|NCT01773408|Daunorubicin|daunorubicin|mesh-list
20528373|NCT01773408|Idarubicin|idarubicin|mesh-list
20528374|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20528375|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
20528376|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528377|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528378|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
20528379|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528380|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528381|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
20528382|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528383|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20528384|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20528385|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20528386|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528387|NCT01773460|Everolimus|everolimus|mesh-list
20528388|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528389|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528390|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
20528391|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528392|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20487401|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20487402|NCT01580371|CKD-581|ckd-581|mesh-list
20487403|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487404|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487405|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
20487406|NCT01580501|Tadalafil|tadalafil|mesh-list
20487407|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
20487408|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20241566|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20241567|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20241568|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
20241569|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20241570|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241571|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20487409|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20487410|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487411|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241572|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
20241573|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241574|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241575|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241576|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241577|NCT00408226|Pemetrexed|pemetrexed|mesh-list
20241578|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487412|NCT01580501|Urological Agents|urological agents|mesh-ancestor
20487413|NCT01580514|Exenatide|exenatide|mesh-list
20487414|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20487415|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487416|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20487417|NCT01580514|Incretins|incretins|mesh-ancestor
20487418|NCT01580514|Hormones|hormones|mesh-ancestor
20487419|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487420|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
20487421|NCT01580683|Vitamins|vitamins|mesh-ancestor
20487422|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
20487423|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487424|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
20487425|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487426|NCT01580683|Protective Agents|protective agents|mesh-ancestor
20487427|NCT01580813|Acipimox|acipimox|mesh-list
20487428|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20487429|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
20487430|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487431|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20487432|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20487433|NCT01580839|Plasminogen|plasminogen|mesh-list
20487434|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20487435|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20487436|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487437|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
20487438|NCT01580865|Tacrolimus|tacrolimus|mesh-list
20487439|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20487440|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
20487441|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487442|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20487443|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487444|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487445|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20487446|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487447|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20487448|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
20487449|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20487450|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487451|NCT01580878|Butenafine|butenafine|mesh-list
20487452|NCT01580878|Clotrimazole|clotrimazole|mesh-list
20487453|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
20487454|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487455|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20487456|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20487457|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20487458|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487459|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487460|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20487461|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
20487462|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487463|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487464|NCT01580891|Naftifine|naftifine|mesh-list
20487465|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
20487466|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487467|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
20487468|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20487469|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20487470|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487471|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
20487472|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
20487473|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
20487474|NCT01581073|Hematinics|hematinics|mesh-ancestor
20487475|NCT01581151|Dexamethasone|dexamethasone|mesh-list
20487476|NCT01581151|Ranibizumab|ranibizumab|mesh-list
20487477|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20487478|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
20487479|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
20487480|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487481|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487482|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20487483|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
20487484|NCT01581151|Hormones|hormones|mesh-ancestor
20487485|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487486|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487487|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487488|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20487489|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20487490|NCT01581151|Growth Substances|growth substances|mesh-ancestor
20487491|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
20487492|NCT01581164|Vaccines|vaccines|mesh-list
20487493|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
20487494|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487495|NCT01581242|Adefovir|adefovir|mesh-list
20487496|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20487497|NCT01581242|Clevudine|clevudine|mesh-list
20487498|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
20487499|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487500|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20487501|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20487502|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487503|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487504|NCT01581320|Vitamin D|vitamin d|mesh-list
20487505|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
20487506|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
20487507|NCT01581320|Vitamins|vitamins|mesh-ancestor
19699607|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487508|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
20487509|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487510|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20487511|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20487512|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
20487513|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20487514|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20487515|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
20487516|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20487517|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
20487518|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20487519|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487520|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20487521|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487522|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487523|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20487524|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
20487525|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
20487526|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487527|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
20487528|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487529|NCT01581411|Plasminogen|plasminogen|mesh-list
20487530|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20487531|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20487532|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20487533|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487534|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
20487535|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20487536|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
20487537|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
20487538|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487539|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487540|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20487541|NCT01581450|Analgesics|analgesics|mesh-ancestor
20487542|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
20487543|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487544|NCT01581476|Quinapril|quinapril|mesh-list
20487545|NCT01581476|Atorvastatin|atorvastatin|mesh-list
20487546|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20487547|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20487548|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20487549|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
20487550|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487551|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20487552|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20487553|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487554|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487555|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20487556|NCT01581515|Everolimus|everolimus|mesh-list
20487557|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487558|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20487559|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
20487560|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487561|NCT01581736|Insulin|insulin|mesh-list
20487562|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20487563|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20487564|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487565|NCT01581775|Valproic Acid|valproic acid|mesh-list
20487566|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
20487567|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487568|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487569|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
20487570|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487571|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487572|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
20487573|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20487574|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487575|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20487576|NCT01581788|Valproic Acid|valproic acid|mesh-list
20487577|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
20487578|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487579|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487580|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
20487581|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487582|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487583|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
20487584|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20487585|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487586|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20487587|NCT01581814|Metformin|metformin|mesh-list
20487588|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20487589|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20487590|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20487591|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487592|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20487593|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20487594|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20487595|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20487596|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
20487597|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20487598|NCT01581814|Estrogens|estrogens|mesh-ancestor
20487599|NCT01581814|Hormones|hormones|mesh-ancestor
20528393|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20487600|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487601|NCT01581853|Ritonavir|ritonavir|mesh-list
20487602|NCT01581853|Lopinavir|lopinavir|mesh-list
20487603|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20487604|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20487605|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487606|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487607|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487608|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20487609|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20487610|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
20487611|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487612|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20487613|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20487614|NCT01581866|Ziprasidone|ziprasidone|mesh-list
20487615|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20487616|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
20487617|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487618|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487619|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487620|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20487621|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20487622|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487623|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20487624|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20487625|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
20487626|NCT01581879|Ziprasidone|ziprasidone|mesh-list
20487627|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20487628|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
20487629|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487630|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487631|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487632|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20487633|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20487634|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20241579|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241580|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241581|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20241582|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20241583|NCT00408239|Enoxaparin|enoxaparin|mesh-list
20487635|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20487636|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20487637|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
20487638|NCT01581918|Carbamazepine|carbamazepine|mesh-list
20487639|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
20487640|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
20487641|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20487642|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487643|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487644|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20487645|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20487646|NCT01581918|Analgesics|analgesics|mesh-ancestor
20487647|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
20487648|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487649|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20487650|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487651|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487652|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20487653|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20487654|NCT01581944|Goserelin|goserelin|mesh-list
20487655|NCT01581944|Hormones|hormones|mesh-list
20487656|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20487657|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487658|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20487659|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487660|NCT01582022|Bupivacaine|bupivacaine|mesh-list
20487661|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
20487662|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
20487663|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487664|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487665|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
20487666|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487667|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20487668|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
20487669|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20487670|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20487671|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20487672|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
20487673|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487674|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20487675|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20241584|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
20241585|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20241586|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20241587|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241588|NCT00408252|Sunitinib|sunitinib|mesh-list
20241589|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487676|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528394|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20528395|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
20528396|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528397|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20528398|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20528399|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528400|NCT01773538|Rifaximin|rifaximin|mesh-list
20528401|NCT01773538|Lactulose|lactulose|mesh-list
20528402|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528403|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528404|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528405|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
20528406|NCT01773616|Prednisolone|prednisolone|mesh-list
20528407|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19852815|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20528408|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
20528409|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20528410|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
20528411|NCT01773616|Rituximab|rituximab|mesh-list
20528412|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20528413|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
20528414|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20528415|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528416|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
20528417|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528418|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528419|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20528420|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20528421|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
20528422|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528423|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528424|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528425|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487677|NCT01582191|Everolimus|everolimus|mesh-list
20487678|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487679|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20487680|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
20487681|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487682|NCT01582230|Vildagliptin|vildagliptin|mesh-list
20487683|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20487684|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487685|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20487686|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487687|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487688|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487689|NCT01582321|Cantharidin|cantharidin|mesh-list
20487690|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487691|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487692|NCT01582412|Isavuconazole|isavuconazole|mesh-list
20487693|NCT01582412|Digoxin|digoxin|mesh-list
20487694|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20487695|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20487696|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487697|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487698|NCT01582412|Protective Agents|protective agents|mesh-ancestor
20487699|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487700|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
20487701|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487702|NCT01582425|Isavuconazole|isavuconazole|mesh-list
20487703|NCT01582425|Methadone|methadone|mesh-list
20487704|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20241590|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241591|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241592|NCT00408252|Growth Substances|growth substances|mesh-ancestor
20241593|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241594|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241595|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20241596|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241597|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241598|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
20241599|NCT00408278|Analgesics|analgesics|mesh-ancestor
20241600|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
20241601|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241602|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241603|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241604|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20241605|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20241606|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241607|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241608|NCT00408330|Azelaic acid|azelaic acid|mesh-list
20241609|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487705|NCT01582425|Narcotics|narcotics|mesh-ancestor
20487706|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487707|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487708|NCT01582425|Analgesics|analgesics|mesh-ancestor
20487709|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
20487710|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487711|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
20487712|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
20487713|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
20487714|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487715|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
20487716|NCT01582438|Citric Acid|citric acid|mesh-list
20487717|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
20487718|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
20487719|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20487720|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
20487721|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
20241610|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
20487722|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487723|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
20487724|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20487725|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20487726|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487727|NCT01582438|Urological Agents|urological agents|mesh-ancestor
20487728|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20487729|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
20487730|NCT01582542|Coagulants|coagulants|mesh-ancestor
20487731|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20487732|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
20487733|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487734|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
20487735|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20487736|NCT01582555|Antidotes|antidotes|mesh-ancestor
20487737|NCT01582555|Protective Agents|protective agents|mesh-ancestor
20487738|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487739|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
20487740|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487741|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
20487742|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487743|NCT01582555|Expectorants|expectorants|mesh-ancestor
20487744|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
20487745|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20487746|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
20487747|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20487748|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
20487749|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487750|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20487751|NCT01582607|Fentanyl|fentanyl|mesh-list
20487752|NCT01582607|Bupivacaine|bupivacaine|mesh-list
20241611|NCT00408369|Pafuramidine|pafuramidine|mesh-list
20241612|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20487753|NCT01582607|Ropivacaine|ropivacaine|mesh-list
20487754|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
20487755|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
20487756|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
20487757|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487758|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487759|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
20487760|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487761|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20487762|NCT01582607|Narcotics|narcotics|mesh-ancestor
20487763|NCT01582607|Analgesics|analgesics|mesh-ancestor
20487764|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20487765|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20487766|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
20487767|NCT01582646|Terbutaline|terbutaline|mesh-list
20487768|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20487769|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
20487770|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487771|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487772|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20487773|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
20487774|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
20487775|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
20241613|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20241614|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20241615|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241616|NCT00408382|Atorvastatin|atorvastatin|mesh-list
20241617|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20487776|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20487777|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20487778|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20487779|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20487780|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
20487781|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487782|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487783|NCT01582672|Sunitinib|sunitinib|mesh-list
20487784|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852816|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20241618|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20241619|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
20487785|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20487786|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20487787|NCT01582672|Growth Substances|growth substances|mesh-ancestor
20487788|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487789|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
20487790|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20487791|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487792|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487793|NCT01582711|Isoniazid|isoniazid|mesh-list
20487794|NCT01582711|Rifapentine|rifapentine|mesh-list
20487795|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
20487796|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20487797|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487798|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20487799|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20487800|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
20487801|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487802|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20487803|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20487804|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
20487805|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
20487806|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20487807|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
20487808|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20487809|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487810|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487811|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487812|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
20487813|NCT01582932|Calcipotriene|calcipotriene|mesh-list
20487814|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
20487815|NCT01582997|Dabrafenib|dabrafenib|mesh-list
20487816|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487817|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20487818|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487819|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487820|NCT01583023|Bupropion|bupropion|mesh-list
20487821|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20487822|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
20487823|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20487824|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20487825|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20487826|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487827|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487828|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
20487829|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487830|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487831|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20487832|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20487833|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487834|NCT01583036|Digoxin|digoxin|mesh-list
20487835|NCT01583036|Ezogabine|ezogabine|mesh-list
20487836|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20487837|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20487838|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487839|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487840|NCT01583036|Protective Agents|protective agents|mesh-ancestor
20241620|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241621|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20241622|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20487841|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487842|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
20487843|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487844|NCT01583062|Amoxicillin|amoxicillin|mesh-list
20487845|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
20487846|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
20487847|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20487848|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487849|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487850|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487851|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20487852|NCT01583114|Perindopril|perindopril|mesh-list
20487853|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20487854|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487855|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487856|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852817|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241623|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241624|NCT00408447|Fludarabine|fludarabine|mesh-list
20241625|NCT00408447|Busulfan|busulfan|mesh-list
20241626|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
20241627|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241628|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241629|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241630|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
20241631|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241632|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
19852818|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852819|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
19852820|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852821|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19852822|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19852823|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20487857|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20487858|NCT01583244|Abatacept|abatacept|mesh-list
20487859|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20487860|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487861|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487862|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20487863|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
20487864|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487865|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20487866|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
20487867|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487868|NCT01583426|Paclitaxel|paclitaxel|mesh-list
20487869|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20487870|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20487871|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487872|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
20487873|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
20487874|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
20487875|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487876|NCT01583439|Ritonavir|ritonavir|mesh-list
20487877|NCT01583439|Lopinavir|lopinavir|mesh-list
20487878|NCT01583439|Tenofovir|tenofovir|mesh-list
20487879|NCT01583439|Lamivudine|lamivudine|mesh-list
20487880|NCT01583439|Zidovudine|zidovudine|mesh-list
20487881|NCT01583439|Emtricitabine|emtricitabine|mesh-list
20487882|NCT01583439|Efavirenz|efavirenz|mesh-list
20487883|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20487884|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20487885|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20487886|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
20487887|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487888|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487889|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20487890|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
20487891|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487892|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20487893|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20487894|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20487895|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20487896|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
20487897|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20487898|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20487899|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20487900|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20487901|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20487902|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20487903|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20487904|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487905|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487906|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20487907|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20487908|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487909|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
20487910|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487911|NCT01583504|Anesthetics|anesthetics|mesh-list
20487912|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
19699618|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
19699619|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19699620|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19699621|NCT04900948|Prednisolone|prednisolone|mesh-list
19699622|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
19699623|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
19699624|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
19699625|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19699626|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
19699627|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699628|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
20487913|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487914|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487915|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
20487916|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487917|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
20487918|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20487919|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487920|NCT01583621|Vitamins|vitamins|mesh-ancestor
20487921|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
20487922|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20487923|NCT01583660|Acetaminophen|acetaminophen|mesh-list
20487924|NCT01583660|Celecoxib|celecoxib|mesh-list
20487925|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20487926|NCT01583660|Oxycodone|oxycodone|mesh-list
20487927|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20487928|NCT01583660|Analgesics|analgesics|mesh-ancestor
20487929|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
20487930|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20487931|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487932|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
20487933|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20487934|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20487935|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20487936|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20487937|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20487938|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487939|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487940|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20487941|NCT01583660|Narcotics|narcotics|mesh-ancestor
20487942|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20487943|NCT01583777|Belinostat|belinostat|mesh-list
20487944|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487945|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20487946|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487947|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487948|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20487949|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487950|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487951|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487952|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20528426|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528427|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
20528428|NCT01773616|Hormones|hormones|mesh-ancestor
20528429|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528430|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20528431|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
20528432|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
20528433|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528434|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528435|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20528436|NCT01773616|Protective Agents|protective agents|mesh-ancestor
20528437|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
20528438|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528439|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
20528440|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528441|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20487953|NCT01583959|Folic Acid|folic acid|mesh-list
20487954|NCT01583959|Hematinics|hematinics|mesh-ancestor
20487955|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
20487956|NCT01583959|Vitamins|vitamins|mesh-ancestor
20487957|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
20487958|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487959|NCT01583972|Vitamin A|vitamin a|mesh-list
20487960|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
20487961|NCT01583972|Vitamins|vitamins|mesh-ancestor
20487962|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
20487963|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487964|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
20487965|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487966|NCT01583972|Protective Agents|protective agents|mesh-ancestor
20487967|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20487968|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20487969|NCT01584050|Folic Acid|folic acid|mesh-list
20487970|NCT01584050|Hematinics|hematinics|mesh-ancestor
20487971|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
20487972|NCT01584050|Vitamins|vitamins|mesh-ancestor
20487973|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
20487974|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487975|NCT01584076|Donepezil|donepezil|mesh-list
20487976|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20487977|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487978|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487979|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
20487980|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20487981|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487982|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
20487983|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
20487984|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20487985|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
20487986|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20487987|NCT01584206|Ezetimibe|ezetimibe|mesh-list
20487988|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20487989|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20487990|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
20487991|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20487992|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20487993|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20487994|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
20487995|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20487996|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20487997|NCT01584297|Ketoconazole|ketoconazole|mesh-list
20487998|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
20241633|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20241634|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20241635|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241636|NCT00408525|Donepezil|donepezil|mesh-list
20241637|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20241638|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20487999|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488000|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20488001|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20241639|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241640|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
20241641|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241642|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241643|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
20241644|NCT00408538|UC-781|uc-781|mesh-list
20488002|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488003|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488004|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20488005|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
20488006|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488007|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488008|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20488009|NCT01584362|Oxfendazole|oxfendazole|mesh-list
20488010|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
20488011|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20488012|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488013|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
20488014|NCT01584492|Beclomethasone|beclomethasone|mesh-list
20488015|NCT01584492|Albuterol|albuterol|mesh-list
20488016|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
20488017|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20488018|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
20488019|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488020|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488021|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20488022|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
20488023|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20488024|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20488025|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20488026|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
20488027|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488028|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488029|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488030|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
20488031|NCT01584492|Hormones|hormones|mesh-ancestor
20488032|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488033|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
20488034|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20488035|NCT01584557|Tolvaptan|tolvaptan|mesh-list
20488036|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20488037|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488038|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
20488039|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488040|NCT01584687|Omalizumab|omalizumab|mesh-list
20488041|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20488042|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20488043|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
20488044|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
20488045|NCT01584726|Analgesics|analgesics|mesh-ancestor
20488046|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
20488047|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488048|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488049|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
20488050|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488051|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20488052|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
20488053|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20488054|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488055|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488056|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20488057|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
20488058|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20488059|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
20488060|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
20488061|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488062|NCT01584791|Aspirin|aspirin|mesh-list
20488063|NCT01584791|Clopidogrel|clopidogrel|mesh-list
20488064|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20488065|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20488066|NCT01584791|Analgesics|analgesics|mesh-ancestor
20488067|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
20488068|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488069|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488070|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488071|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20488072|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20488073|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20488074|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488075|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20488076|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20488077|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488078|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
20488079|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20488080|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20488081|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19852824|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19852825|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20488082|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
20488083|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488084|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
20488085|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
20488086|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
20488087|NCT01584921|Hematinics|hematinics|mesh-ancestor
20488088|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
20488089|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19414402|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414403|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414404|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19414405|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414406|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414407|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
20488090|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20488091|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
20488092|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
20488093|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488094|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488095|NCT01584947|Bupivacaine|bupivacaine|mesh-list
20488096|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
20488097|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
20488098|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488099|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488100|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
20488101|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488102|NCT01585051|Vitamin D|vitamin d|mesh-list
20488103|NCT01585051|Vitamins|vitamins|mesh-ancestor
20488104|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
19852826|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19852827|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20488105|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488106|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20488107|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
20488108|NCT01585350|Poly ICLC|poly iclc|mesh-list
20488109|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20488110|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
20488111|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488112|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
20488113|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
20488114|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20488115|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488116|NCT01585415|Aldesleukin|aldesleukin|mesh-list
20488117|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
20488118|NCT01585415|Fludarabine|fludarabine|mesh-list
20488119|NCT01585415|Vemurafenib|vemurafenib|mesh-list
20488120|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488121|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
20488122|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488123|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20488124|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20488125|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
20488126|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488127|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488128|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20488129|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20488130|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20488131|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
20488132|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488133|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20488134|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488135|NCT01585623|Metoprolol|metoprolol|mesh-list
20488136|NCT01585623|Midazolam|midazolam|mesh-list
20488137|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20488138|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20488139|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488140|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488141|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20488142|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20488143|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488144|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20488145|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
20488146|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
20488147|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
20488148|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
20488149|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488150|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488151|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20488152|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20488153|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
20488154|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
20488155|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488156|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20488157|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19699629|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
20488158|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20488159|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
20528442|NCT01773772|Progesterone|progesterone|mesh-list
20528443|NCT01773772|Progestins|progestins|mesh-ancestor
20528444|NCT01773772|Hormones|hormones|mesh-ancestor
20528445|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528446|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528447|NCT01773798|Insulin|insulin|mesh-list
20528448|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20528449|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
20528450|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
20528451|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20528452|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20528453|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528454|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20528455|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528456|NCT01773837|Methylphenidate|methylphenidate|mesh-list
20528457|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20528458|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528459|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20528460|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20528461|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528462|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528463|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
20528464|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530720|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20530721|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530722|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20530723|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20530724|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530725|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530726|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530727|NCT01790139|Simethicone|simethicone|mesh-list
20530728|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
20530729|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530730|NCT01790139|Emollients|emollients|mesh-ancestor
20530731|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
20530732|NCT01790165|Terbinafine|terbinafine|mesh-list
20530733|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
20530734|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530735|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530736|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530737|NCT01790282|Estradiol|estradiol|mesh-list
20530738|NCT01790282|Progesterone|progesterone|mesh-list
20530739|NCT01790282|Estrogens|estrogens|mesh-ancestor
20530740|NCT01790282|Hormones|hormones|mesh-ancestor
20530741|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530742|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530743|NCT01790282|Progestins|progestins|mesh-ancestor
20530744|NCT01790308|Liraglutide|liraglutide|mesh-list
20530745|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20530746|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530747|NCT01790308|Incretins|incretins|mesh-ancestor
20530748|NCT01790308|Hormones|hormones|mesh-ancestor
20530749|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530891|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530892|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20530893|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530894|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
20530895|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20530896|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530897|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530898|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530899|NCT01791296|Analgesics|analgesics|mesh-ancestor
20530900|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
20530901|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530902|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19699630|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699631|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699632|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699633|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
19699634|NCT04900948|Hormones|hormones|mesh-ancestor
19699635|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699636|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19699637|NCT04900948|Protective Agents|protective agents|mesh-ancestor
20488160|NCT01585753|Maraviroc|maraviroc|mesh-list
20488161|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20488162|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20488163|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488164|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20488165|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20488166|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
20488167|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488168|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20488169|NCT01585792|Glimepiride|glimepiride|mesh-list
20488170|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20488171|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20488172|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699638|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20488173|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488174|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
20488175|NCT01585870|Sorafenib|sorafenib|mesh-list
20488176|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488177|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20488178|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488179|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488180|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20488181|NCT01585935|SMOFlipid|smoflipid|mesh-list
20488182|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20488183|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20488184|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20488185|NCT01586013|Propofol|propofol|mesh-list
20488186|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19699639|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488187|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488188|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488189|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20488190|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
19699640|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19699641|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19699642|NCT04900948|Analgesics|analgesics|mesh-ancestor
20241645|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
20241646|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20241647|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
20241648|NCT00408551|Leucovorin|leucovorin|mesh-list
20241649|NCT00408551|Fluorouracil|fluorouracil|mesh-list
20241650|NCT00408551|Floxuridine|floxuridine|mesh-list
20241651|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
20241652|NCT00408551|Irinotecan|irinotecan|mesh-list
20241653|NCT00408551|Calcium|calcium|mesh-list
20241654|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
20241655|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20241656|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241657|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
20241658|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241659|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20241660|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241661|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488191|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
20488192|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
20488193|NCT01586052|Hematinics|hematinics|mesh-ancestor
19414408|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414409|NCT03611881|Nicotine|nicotine|mesh-list
19414410|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19414411|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
19414412|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414413|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414414|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19414415|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19414416|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
19414417|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414418|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414419|NCT03611751|Apremilast|apremilast|mesh-list
19414420|NCT03611751|BMS-986165|bms-986165|mesh-list
19414421|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19414422|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414423|NCT03611751|Analgesics|analgesics|mesh-ancestor
19414424|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
19414425|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414426|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414427|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414428|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414429|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19414430|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19414431|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414432|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414433|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414434|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19414435|NCT03611010|Atorvastatin|atorvastatin|mesh-list
20488194|NCT01586117|Amifostine|amifostine|mesh-list
20488195|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20488196|NCT01586117|Protective Agents|protective agents|mesh-ancestor
20488197|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488198|NCT01586143|Acetaminophen|acetaminophen|mesh-list
20241662|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
20488199|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20488200|NCT01586143|Analgesics|analgesics|mesh-ancestor
20488201|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
20488202|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488203|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852828|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19852829|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
19852830|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20488204|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
20488205|NCT01586169|Azithromycin|azithromycin|mesh-list
20488206|NCT01586169|Ivermectin|ivermectin|mesh-list
20488207|NCT01586169|Albendazole|albendazole|mesh-list
20488208|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20488209|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488210|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20488211|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
20488212|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
20488213|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20488214|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20488215|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
20488216|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
20488217|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
20488218|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488219|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488220|NCT01586208|Phenytoin|phenytoin|mesh-list
20488221|NCT01586208|Valproic Acid|valproic acid|mesh-list
20488222|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
20488223|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488224|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488225|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
20488226|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488227|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488228|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
20488229|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20488230|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488231|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488232|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20488233|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20488234|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488235|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20488236|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20488237|NCT01586286|Nifedipine|nifedipine|mesh-list
20488238|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20488239|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488240|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852831|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19852832|NCT00727636|Vaccines|vaccines|mesh-list
19852833|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
19852834|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852835|NCT00727649|Loperamide|loperamide|mesh-list
20241663|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20241664|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20241665|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241666|NCT00408551|Antidotes|antidotes|mesh-ancestor
20241667|NCT00408551|Protective Agents|protective agents|mesh-ancestor
20241668|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
20241669|NCT00408551|Vitamins|vitamins|mesh-ancestor
20241670|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
20241671|NCT00408655|Sirolimus|sirolimus|mesh-list
20241672|NCT00408655|Paclitaxel|paclitaxel|mesh-list
20241673|NCT00408655|Carboplatin|carboplatin|mesh-list
20241674|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20241675|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241676|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
20241677|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
20241678|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
20241679|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852836|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
20241680|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20241681|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852837|NCT00727649|Psyllium|psyllium|mesh-list
19852838|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20488241|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20488242|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488243|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
20488244|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
20488245|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20488246|NCT01586299|Acetaminophen|acetaminophen|mesh-list
20488247|NCT01586299|Ibuprofen|ibuprofen|mesh-list
20488248|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20488249|NCT01586299|Analgesics|analgesics|mesh-ancestor
20488250|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
20488251|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488252|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488253|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
20488254|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20488255|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488256|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20488257|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20488258|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488259|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488260|NCT01586442|Eplerenone|eplerenone|mesh-list
20488261|NCT01586442|Spironolactone|spironolactone|mesh-list
19852839|NCT00727649|Cathartics|cathartics|mesh-ancestor
19852840|NCT00727740|Indomethacin|indomethacin|mesh-list
20528465|NCT01773876|Micafungin|micafungin|mesh-list
19852841|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20488262|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20488263|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
20488264|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488265|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488266|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19699643|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
20488267|NCT01586442|Diuretics|diuretics|mesh-ancestor
19699644|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19699645|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
19699646|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488268|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
20488269|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20488270|NCT01586494|Tramadol|tramadol|mesh-list
20488271|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19699647|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
20488272|NCT01586494|Narcotics|narcotics|mesh-ancestor
20488273|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488274|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488275|NCT01586494|Analgesics|analgesics|mesh-ancestor
20488276|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
20488277|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488278|NCT01586507|Tramadol|tramadol|mesh-list
20488279|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20488280|NCT01586507|Narcotics|narcotics|mesh-ancestor
20488281|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488282|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488283|NCT01586507|Analgesics|analgesics|mesh-ancestor
20488284|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
20488285|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488286|NCT01586533|Mesalamine|mesalamine|mesh-list
20488287|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20488288|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20488289|NCT01586533|Analgesics|analgesics|mesh-ancestor
20488290|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
20488291|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488292|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488293|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488294|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20488295|NCT01586572|Vaccines|vaccines|mesh-list
20488296|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
20488297|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488298|NCT01586611|Leucovorin|leucovorin|mesh-list
20488299|NCT01586611|Gemcitabine|gemcitabine|mesh-list
20488300|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
20488301|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20488302|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
20488303|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488304|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488305|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
20488306|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488307|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488308|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488309|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
20488310|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488311|NCT01586611|Antidotes|antidotes|mesh-ancestor
20488312|NCT01586611|Protective Agents|protective agents|mesh-ancestor
20488313|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
20488314|NCT01586611|Vitamins|vitamins|mesh-ancestor
20488315|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
20488316|NCT01586845|Cyclosporine|cyclosporine|mesh-list
20488317|NCT01586845|Tacrolimus|tacrolimus|mesh-list
20488318|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488319|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
20488320|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488321|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20488322|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488323|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488324|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
20488325|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488326|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
20488327|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20488328|NCT01587066|Valproic Acid|valproic acid|mesh-list
20488329|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20488330|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
20488331|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488332|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20488333|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20488334|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488335|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488336|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
20488337|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488338|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488339|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
20488340|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488341|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
20488342|NCT01587196|Naltrexone|naltrexone|mesh-list
20488343|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20488344|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20488345|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488346|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
19414436|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19414437|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19699648|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20488347|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488348|NCT01587222|Octreotide|octreotide|mesh-list
20488349|NCT01587222|Midodrine|midodrine|mesh-list
20488350|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20488351|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20488352|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488353|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
20488354|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
20488355|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488356|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488357|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19699649|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699650|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699651|NCT04901104|Thymalfasin|thymalfasin|mesh-list
19699652|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20488358|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19699653|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
20488359|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20488360|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20488361|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
20488362|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488363|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488364|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
20488365|NCT01587261|Vitamins|vitamins|mesh-ancestor
20488366|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
20488367|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488368|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
20488369|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488370|NCT01587261|Protective Agents|protective agents|mesh-ancestor
20488371|NCT01587313|Hydralazine|hydralazine|mesh-list
20488372|NCT01587313|Isosorbide|isosorbide|mesh-list
20488373|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20241682|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20241683|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
20241684|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241685|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
20488374|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20488375|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20241686|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241687|NCT00408772|Bevacizumab|bevacizumab|mesh-list
20241688|NCT00408772|Capecitabine|capecitabine|mesh-list
20241689|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
20241690|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241691|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241692|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20241693|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20241694|NCT00408772|Growth Substances|growth substances|mesh-ancestor
20241695|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241696|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
20241697|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20241698|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
20241699|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241700|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
20241701|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20241702|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20241703|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20241704|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241705|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488376|NCT01587313|Diuretics|diuretics|mesh-ancestor
20488377|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
20488378|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488379|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
20488380|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20488381|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488382|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20488383|NCT01587326|Citalopram|citalopram|mesh-list
20488384|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20488385|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20488386|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488387|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488388|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488389|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
20488390|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488391|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20488392|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
20488393|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488394|NCT01587339|Pregabalin|pregabalin|mesh-list
20488395|NCT01587339|Zonisamide|zonisamide|mesh-list
20488396|NCT01587339|Lacosamide|lacosamide|mesh-list
20488397|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20241706|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
20241707|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241708|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241709|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20241710|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241711|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
20241712|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20241713|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20241714|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20488398|NCT01587339|Ezogabine|ezogabine|mesh-list
20488399|NCT01587339|Analgesics|analgesics|mesh-ancestor
20488400|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
20488401|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488402|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488403|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
20488404|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20488405|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488406|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488407|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20488408|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20488409|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20488410|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488411|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488412|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20488413|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20488414|NCT01587378|Metformin|metformin|mesh-list
20488415|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20488416|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488417|NCT01587430|Cytarabine|cytarabine|mesh-list
20488418|NCT01587430|Daunorubicin|daunorubicin|mesh-list
20488419|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
20488420|NCT01587430|Idarubicin|idarubicin|mesh-list
20488421|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20488422|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
20488423|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488424|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488425|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
20488426|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488427|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488428|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
20488429|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488430|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20488431|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20488432|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20488433|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488434|NCT01587430|Analgesics|analgesics|mesh-ancestor
20488435|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
20488436|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488437|NCT01587482|Paclitaxel|paclitaxel|mesh-list
20488438|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20488439|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488440|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
20488441|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
20488442|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
20488443|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488444|NCT01587495|Ertapenem|ertapenem|mesh-list
20488445|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20488446|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528466|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
20528467|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528468|NCT01774370|Dabigatran|dabigatran|mesh-list
20528469|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
20528470|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20528471|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
20528472|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528473|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528474|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
20528475|NCT01774396|Lidocaine|lidocaine|mesh-list
20528476|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
20528477|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
20528478|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528479|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528480|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
20528481|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528482|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20528483|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20528484|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20528485|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528486|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528487|NCT01774474|Dexamethasone|dexamethasone|mesh-list
20528488|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
20528489|NCT01774474|Triamcinolone|triamcinolone|mesh-list
20528490|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20528491|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20528492|NCT01774474|Bromfenac|bromfenac|mesh-list
20528493|NCT01774474|Bevacizumab|bevacizumab|mesh-list
20528494|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20528495|NCT01774474|BB 1101|bb 1101|mesh-list
20528496|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20528497|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20528498|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528499|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20488447|NCT01587508|Meloxicam|meloxicam|mesh-list
20488448|NCT01587508|Amitriptyline|amitriptyline|mesh-list
20488449|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
20488450|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20488451|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20488452|NCT01587508|Analgesics|analgesics|mesh-ancestor
20488453|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
20488454|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488455|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488456|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488457|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20488458|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20488459|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20488460|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488461|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488462|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20488463|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
20488464|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488465|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20488466|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20488467|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20488468|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488469|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20488470|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20488471|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488472|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
20488473|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488474|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20488475|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
20488476|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488477|NCT01587625|Oxytocin|oxytocin|mesh-list
20488478|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
20488479|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20488480|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488481|NCT01587638|Metoprolol|metoprolol|mesh-list
20488482|NCT01587638|Atenolol|atenolol|mesh-list
20488483|NCT01587638|Carvedilol|carvedilol|mesh-list
20488484|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
20488485|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20488486|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20488487|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
20488488|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
20488489|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488490|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488491|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20488492|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20488493|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
20488494|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488495|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488496|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
20488497|NCT01587638|Protective Agents|protective agents|mesh-ancestor
20488498|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20530750|NCT01790464|Lidocaine|lidocaine|mesh-list
20488499|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488500|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20488501|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
20488502|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20488503|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20488504|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
20488505|NCT01587729|Serotonin|serotonin|mesh-list
20488506|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19414438|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
19414439|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414440|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19414441|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19414442|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414443|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19414444|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19414445|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19414446|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414447|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414448|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19414449|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414450|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414451|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
19414452|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414453|NCT03603288|Idebenone|idebenone|mesh-list
19414454|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
19414455|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488507|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488508|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20241715|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241716|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414456|NCT03603288|Protective Agents|protective agents|mesh-ancestor
19414457|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414458|NCT03594747|Paclitaxel|paclitaxel|mesh-list
19414459|NCT03594747|Carboplatin|carboplatin|mesh-list
19414460|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19414461|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414462|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
19414463|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
19414464|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
20241717|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
20241718|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488509|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
19414465|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414466|NCT03594058|Solabegron|solabegron|mesh-list
19414467|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19414468|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19414469|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19414470|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
19414471|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414472|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414473|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414474|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
19414475|NCT03588884|Calcifediol|calcifediol|mesh-list
19414476|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19414477|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414478|NCT03588884|Vitamins|vitamins|mesh-ancestor
19414479|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
19414480|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19414481|NCT03583359|Lidocaine|lidocaine|mesh-list
19414482|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
19414483|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
20488510|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488511|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488512|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488513|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20488514|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488515|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20488516|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488517|NCT01587820|Cisplatin|cisplatin|mesh-list
20488518|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488519|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19414484|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20241719|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241720|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20241721|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241722|NCT00408850|Pioglitazone|pioglitazone|mesh-list
20241723|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20241724|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241725|NCT00408915|Lisuride|lisuride|mesh-list
20241726|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20241727|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20488520|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20241728|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20241729|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
20241730|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241731|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241732|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241733|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
20241734|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
19414485|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414486|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
19414487|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414488|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19699654|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241735|NCT00408941|Propofol|propofol|mesh-list
20488521|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488522|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
20488523|NCT01588002|Ritonavir|ritonavir|mesh-list
20488524|NCT01588002|Efavirenz|efavirenz|mesh-list
20488525|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20488526|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20488527|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
20488528|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488529|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488530|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20488531|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20488532|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
20488533|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488534|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20488535|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20488536|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20488537|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20488538|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20488539|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20488540|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20488541|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20488542|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20488543|NCT01588093|Mecasermin|mecasermin|mesh-list
20488544|NCT01588093|Growth Substances|growth substances|mesh-ancestor
20488545|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488546|NCT01588171|Enoxaparin|enoxaparin|mesh-list
20488547|NCT01588171|Bemiparin|bemiparin|mesh-list
20488548|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
20488549|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20488550|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20488551|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488552|NCT01588314|Gabapentin|gabapentin|mesh-list
20488553|NCT01588314|Analgesics|analgesics|mesh-ancestor
20488554|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
20488555|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488556|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488557|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
20488558|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20488559|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20488560|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488561|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488562|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20488563|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20241736|NCT00408941|Prilocaine|prilocaine|mesh-list
20241737|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20241738|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20241739|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241740|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20241741|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
20241742|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
20241743|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
20241744|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
20488564|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414489|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19414490|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19414491|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414492|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414493|NCT03580369|Omalizumab|omalizumab|mesh-list
20488565|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488566|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
20488567|NCT01588522|Calcitriol|calcitriol|mesh-list
20488568|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19699655|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
19699656|NCT04900792|Temozolomide|temozolomide|mesh-list
19699657|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19699658|NCT04900792|Vitamins|vitamins|mesh-ancestor
19699659|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
19699660|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699661|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19699662|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
19699663|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699664|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414494|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19699665|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
19699666|NCT04900792|Protective Agents|protective agents|mesh-ancestor
20241745|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241746|NCT00409019|Tenofovir|tenofovir|mesh-list
20241747|NCT00409019|Adefovir|adefovir|mesh-list
20241748|NCT00409019|Telbivudine|telbivudine|mesh-list
20241749|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
20241750|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241751|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20241752|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20241753|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241754|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488569|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488570|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20488571|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488572|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488573|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20488574|NCT01588522|Vitamins|vitamins|mesh-ancestor
20488575|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
20530751|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
20488576|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20488577|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20488578|NCT01588587|Vildagliptin|vildagliptin|mesh-list
20488579|NCT01588587|Alogliptin|alogliptin|mesh-list
20488580|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20488581|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488582|NCT01588587|Incretins|incretins|mesh-ancestor
20488583|NCT01588587|Hormones|hormones|mesh-ancestor
20488584|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488585|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20488586|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
19699667|NCT04900792|Hematinics|hematinics|mesh-ancestor
19699668|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19699669|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19699670|NCT04900532|Tocotrienols|tocotrienols|mesh-list
19699671|NCT04900532|Vitamin E|vitamin e|mesh-list
20488587|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488588|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488589|NCT01588626|Ticagrelor|ticagrelor|mesh-list
20488590|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20488591|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20488592|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20488593|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20488594|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
20488595|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488596|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488597|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488598|NCT01588639|Insulin|insulin|mesh-list
20488599|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20488600|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20488601|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488602|NCT01588704|Bevacizumab|bevacizumab|mesh-list
20488603|NCT01588704|Pemetrexed|pemetrexed|mesh-list
20488604|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20488605|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488606|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20488607|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20488608|NCT01588704|Growth Substances|growth substances|mesh-ancestor
20488609|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488610|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
19699672|NCT04900532|Tocopherols|tocopherols|mesh-list
19699673|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
19699674|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488611|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530752|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
20488612|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488613|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20488614|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20488615|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
20488616|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20488617|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20488618|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20488619|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
20488620|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488621|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488622|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488623|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
20488624|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20488625|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488626|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
20488627|NCT01588756|Goralatide|goralatide|mesh-list
20488628|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
20488629|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488630|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20488631|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488632|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852842|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19852843|NCT00727740|Analgesics|analgesics|mesh-ancestor
19852844|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
19852845|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852846|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852847|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19852848|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20241755|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20488633|NCT01588756|Growth Substances|growth substances|mesh-ancestor
20488634|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488635|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20488636|NCT01588756|Protective Agents|protective agents|mesh-ancestor
20488637|NCT01588782|Ketoconazole|ketoconazole|mesh-list
20488638|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
20488639|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488640|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20488641|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20488642|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414495|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20241756|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20241757|NCT00409071|Sinomenine|sinomenine|mesh-list
20241758|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20241759|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
20241760|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20241761|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241762|NCT00409201|Reboxetine|reboxetine|mesh-list
20241763|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
20488643|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488644|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20488645|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
20488646|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488647|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414496|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
20241764|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20488648|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20488649|NCT01588795|Vitamin D|vitamin d|mesh-list
20488650|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
20488651|NCT01588795|Diuretics|diuretics|mesh-list
20488652|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20488653|NCT01588795|Vitamins|vitamins|mesh-ancestor
20488654|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
20488655|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488656|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20488657|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20488658|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
20488659|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488660|NCT01588847|Sufentanil|sufentanil|mesh-list
20488661|NCT01588847|Bupivacaine|bupivacaine|mesh-list
20488662|NCT01588847|Anesthetics|anesthetics|mesh-list
20488663|NCT01588847|Propofol|propofol|mesh-list
20488664|NCT01588847|Sevoflurane|sevoflurane|mesh-list
20488665|NCT01588847|Rocuronium|rocuronium|mesh-list
20488666|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
20488667|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488668|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488669|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
20488670|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488671|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19414497|NCT03571568|Rituximab|rituximab|mesh-list
19414498|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20241765|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20241766|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20241767|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488672|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20488673|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
20488674|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20488675|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20488676|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20488677|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20488678|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20488679|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20488680|NCT01588847|Narcotics|narcotics|mesh-ancestor
20488681|NCT01588847|Analgesics|analgesics|mesh-ancestor
20488682|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20488683|NCT01588873|Desogestrel|desogestrel|mesh-list
20488684|NCT01588873|NuvaRing|nuvaring|mesh-list
20488685|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20488686|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20488687|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20488688|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
20488689|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20488690|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488691|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20488692|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20488693|NCT01588873|Progestins|progestins|mesh-ancestor
20488694|NCT01588873|Hormones|hormones|mesh-ancestor
20488695|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488696|NCT01588912|Tenofovir|tenofovir|mesh-list
20488697|NCT01588912|Entecavir|entecavir|mesh-list
20488698|NCT01588912|Telbivudine|telbivudine|mesh-list
20488699|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
20488700|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488701|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20488702|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20488703|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488704|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488705|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20488706|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20488707|NCT01588925|Dexamethasone|dexamethasone|mesh-list
20488708|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
20488709|NCT01588925|BB 1101|bb 1101|mesh-list
20488710|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
20488711|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488712|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
20488713|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
20488714|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241768|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241769|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
20241770|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241771|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241772|NCT00409214|Talaporfin|talaporfin|mesh-list
20241773|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241774|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20241775|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
20241776|NCT00409227|Alfuzosin|alfuzosin|mesh-list
20241777|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
20241778|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20241779|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20488715|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488716|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20488717|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
20488718|NCT01588925|Hormones|hormones|mesh-ancestor
20488719|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488720|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20488721|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488722|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
20488723|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488724|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488725|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20488726|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
20488727|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
20488728|NCT01588925|Protective Agents|protective agents|mesh-ancestor
20488729|NCT01589055|Nicotine|nicotine|mesh-list
20488730|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20488731|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
20488732|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488733|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414499|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414500|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
19852849|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
19852850|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
19852851|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19852852|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19852853|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852854|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852855|NCT00727844|Linezolid|linezolid|mesh-list
19852856|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19852857|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852858|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20488734|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20488735|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20488736|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
20488737|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488738|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488739|NCT01589068|Nicotine|nicotine|mesh-list
20488740|NCT01589068|Progesterone|progesterone|mesh-list
20488741|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20488742|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
20488743|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488744|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488745|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20488746|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20488747|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
20488748|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488749|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488750|NCT01589068|Progestins|progestins|mesh-ancestor
20488751|NCT01589068|Hormones|hormones|mesh-ancestor
20488752|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488753|NCT01589081|Nicotine|nicotine|mesh-list
19699675|NCT04900532|Protective Agents|protective agents|mesh-ancestor
19699676|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699677|NCT04900532|Vitamins|vitamins|mesh-ancestor
19699678|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
19699679|NCT04900415|Vitamin A|vitamin a|mesh-list
19699680|NCT04900415|Vitamins|vitamins|mesh-ancestor
20488754|NCT01589081|Progesterone|progesterone|mesh-list
20488755|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20488756|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
20488757|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488758|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488759|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20488760|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20488761|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
20488762|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488763|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488764|NCT01589081|Progestins|progestins|mesh-ancestor
20488765|NCT01589081|Hormones|hormones|mesh-ancestor
20488766|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488767|NCT01589146|Heparin|heparin|mesh-list
20488768|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20488769|NCT01589146|Tinzaparin|tinzaparin|mesh-list
20488770|NCT01589146|Dalteparin|dalteparin|mesh-list
20488771|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
20488772|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20488773|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20488774|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488775|NCT01589159|Capecitabine|capecitabine|mesh-list
20488776|NCT01589159|Etoposide|etoposide|mesh-list
20488777|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20488778|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
20488779|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488780|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488781|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20488782|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20488783|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20488784|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488785|NCT01589354|Ropivacaine|ropivacaine|mesh-list
20488786|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
20488787|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
20488788|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488789|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488790|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
20488791|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528500|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20528501|NCT01774474|Growth Substances|growth substances|mesh-ancestor
20528502|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528503|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
20528504|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528505|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
20528506|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
20528507|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528508|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528509|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
20528510|NCT01774474|Hormones|hormones|mesh-ancestor
20528511|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852859|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852860|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852861|NCT00727857|Metformin|metformin|mesh-list
19699681|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
19699682|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699683|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
19699684|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19699685|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699686|NCT04900571|Renal Agents|renal agents|mesh-ancestor
19699687|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19699688|NCT04900623|Paclitaxel|paclitaxel|mesh-list
19699689|NCT04900623|Cisplatin|cisplatin|mesh-list
19699690|NCT04900623|Carboplatin|carboplatin|mesh-list
19699691|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19699692|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699693|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
19699694|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
19852862|NCT00727857|Pioglitazone|pioglitazone|mesh-list
20488792|NCT01589367|Metformin|metformin|mesh-list
20488793|NCT01589367|Letrozole|letrozole|mesh-list
20488794|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20488795|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488796|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488797|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20488798|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20488799|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488800|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488801|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20488802|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
20488803|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852863|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20488804|NCT01589393|Enoxaparin|enoxaparin|mesh-list
20488805|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
20488806|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20488807|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20488808|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488809|NCT01589419|Capecitabine|capecitabine|mesh-list
20488810|NCT01589419|Veliparib|veliparib|mesh-list
20488811|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20488812|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
20488813|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488814|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488815|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20488816|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488817|NCT01589432|Lidocaine|lidocaine|mesh-list
20488818|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
20488819|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
20488820|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488821|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488822|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
20488823|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488824|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20488825|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20488826|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20488827|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488828|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488829|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
20488830|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20488831|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20488832|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20488833|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488834|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488835|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
20488836|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488837|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488838|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19414501|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699695|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
20241780|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
20241781|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241782|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241783|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241784|NCT00409227|Urological Agents|urological agents|mesh-ancestor
20241785|NCT00409253|Nicardipine|nicardipine|mesh-list
20241786|NCT00409253|Urapidil|urapidil|mesh-list
20241787|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20488839|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488840|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
20488841|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488842|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
20488843|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
20488844|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488845|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488846|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20488847|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
20488848|NCT01589549|Hormones|hormones|mesh-ancestor
20488849|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488850|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20488851|NCT01589549|Protective Agents|protective agents|mesh-ancestor
20488852|NCT01589562|Megestrol|megestrol|mesh-list
20488853|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
20488854|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20488855|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20488856|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20488857|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
20488858|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20488859|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488860|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20488861|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20488862|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20488863|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488864|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
20488865|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20488866|NCT01589614|Erythromycin|erythromycin|mesh-list
20488867|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
20488868|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20488869|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
20488870|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20488871|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488872|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20488873|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20488874|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699696|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699697|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
19699698|NCT04900766|Analgesics|analgesics|mesh-ancestor
19699699|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
19699700|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488875|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488876|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20488877|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
20488878|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20488879|NCT01589744|Hemostatics|hemostatics|mesh-list
19699701|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699702|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241788|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20241789|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488880|NCT01589744|Coagulants|coagulants|mesh-ancestor
20488881|NCT01589809|Niacinamide|niacinamide|mesh-list
20488882|NCT01589809|Niacin|niacin|mesh-list
20488883|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
20488884|NCT01589809|Vitamins|vitamins|mesh-ancestor
20488885|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
20488886|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488887|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
20488888|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20241790|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241791|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20241792|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241793|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
19699703|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19699704|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19699705|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241794|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20241795|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
20241796|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241797|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20241798|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20488889|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
20488890|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488891|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20488892|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
20488893|NCT01589861|Lapatinib|lapatinib|mesh-list
20488894|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488895|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20488896|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488897|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488898|NCT01589952|Interferons|interferons|mesh-list
20488899|NCT01589952|Entecavir|entecavir|mesh-list
20488900|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488901|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
20488902|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488903|NCT01590173|Prednisolone|prednisolone|mesh-list
20488904|NCT01590173|Heparin|heparin|mesh-list
20488905|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
20488906|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20488907|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20488908|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488909|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488910|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
20488911|NCT01590173|Hormones|hormones|mesh-ancestor
20488912|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488913|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488914|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20488915|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488916|NCT01590199|Everolimus|everolimus|mesh-list
20488917|NCT01590199|Pasireotide|pasireotide|mesh-list
20488918|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488919|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20488920|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
20488921|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488922|NCT01590199|Hormones|hormones|mesh-ancestor
20488923|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20488924|NCT01590225|Ribavirin|ribavirin|mesh-list
20488925|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20488926|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
20488927|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
20488928|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488929|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
20488930|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488931|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
20488932|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488933|NCT01590277|Ethanol|ethanol|mesh-list
20488934|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20488935|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488936|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20488937|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488938|NCT01590303|Ascorbic Acid|ascorbic acid|mesh-list
20488939|NCT01590303|Vitamins|vitamins|mesh-ancestor
20488940|NCT01590303|Micronutrients|micronutrients|mesh-ancestor
20488941|NCT01590303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488942|NCT01590303|Antioxidants|antioxidants|mesh-ancestor
20488943|NCT01590303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488944|NCT01590303|Protective Agents|protective agents|mesh-ancestor
20488945|NCT01590342|Diclofenac|diclofenac|mesh-list
20488946|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20488947|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20488948|NCT01590342|Analgesics|analgesics|mesh-ancestor
20488949|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
20488950|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488951|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488952|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20488953|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20488954|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20488955|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20488956|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488957|NCT01590537|Copper|copper|mesh-list
20488958|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
20488959|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20488960|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
20488961|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20488962|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488963|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20488964|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20488965|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20488966|NCT01590537|Trace Elements|trace elements|mesh-ancestor
20488967|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
20488968|NCT01590641|Vesatolimod|vesatolimod|mesh-list
20488969|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
20488970|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699706|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699707|NCT04900311|Paclitaxel|paclitaxel|mesh-list
20488971|NCT01590654|Vesatolimod|vesatolimod|mesh-list
20488972|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
20488973|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20488974|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19699708|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19699709|NCT04900311|Trastuzumab|trastuzumab|mesh-list
20488975|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488976|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528512|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20488977|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488978|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20488979|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
20488980|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20488981|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20488982|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20488983|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20488984|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20488985|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
20488986|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20488987|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20488988|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20488989|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20488990|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20488991|NCT01590732|Carboplatin|carboplatin|mesh-list
20488992|NCT01590732|Etoposide|etoposide|mesh-list
20488993|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
20488994|NCT01590732|Ifosfamide|ifosfamide|mesh-list
20488995|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
20488996|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
20488997|NCT01590732|Romidepsin|romidepsin|mesh-list
20488998|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20488999|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20489000|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20489001|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20241799|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20241800|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20241801|NCT00409305|Betahistine|betahistine|mesh-list
20241802|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
20241803|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
20241804|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
20241805|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241806|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241807|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489002|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489003|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489004|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489005|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20489006|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
20489007|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
20489008|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
20489009|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
20489010|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
20489011|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
20489012|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20489013|NCT01590823|Dabigatran|dabigatran|mesh-list
20489014|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
20489015|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20489016|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
20489017|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489018|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489019|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
20489020|NCT01590836|Insulin|insulin|mesh-list
20489021|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20489022|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
20489023|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
20489024|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20489025|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489026|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
20489027|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
20489028|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20489029|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489030|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489031|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20489032|NCT01590901|Probucol|probucol|mesh-list
20489033|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20489034|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20489035|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
20489036|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489037|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20489038|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
20489039|NCT01590901|Protective Agents|protective agents|mesh-ancestor
20489040|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489041|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
20489042|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489043|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
20489044|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489045|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489046|NCT01591031|Sevoflurane|sevoflurane|mesh-list
20489047|NCT01591031|Rocuronium|rocuronium|mesh-list
20489048|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20489049|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20489050|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
20489051|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
20489052|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489053|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489054|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20489055|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20489056|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20489057|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414502|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414503|NCT03553498|Acetaminophen|acetaminophen|mesh-list
19414504|NCT03553498|Hydromorphone|hydromorphone|mesh-list
19699710|NCT04900311|Pertuzumab|pertuzumab|mesh-list
20489058|NCT01591070|Tacrolimus|tacrolimus|mesh-list
20489059|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19699711|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19699712|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414505|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414506|NCT03553498|Analgesics|analgesics|mesh-ancestor
19414507|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
19414508|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414509|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414510|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
19414511|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19414512|NCT03553498|Narcotics|narcotics|mesh-ancestor
19414513|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414514|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
19414515|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
19414516|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414517|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414518|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414519|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19414520|NCT03542669|Doxorubicin|doxorubicin|mesh-list
20489060|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
20489061|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489062|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20489063|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489064|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489065|NCT01591083|Esomeprazole|esomeprazole|mesh-list
20489066|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20489067|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20489068|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20489069|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489070|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489071|NCT01591122|Prednisone|prednisone|mesh-list
20489072|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
20489073|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20489074|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
20489075|NCT01591122|Hormones|hormones|mesh-ancestor
20489076|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489077|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489078|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20489079|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489080|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20489081|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489082|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489083|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
20489084|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20489085|NCT01591135|Paclitaxel|paclitaxel|mesh-list
20489086|NCT01591135|Fluorouracil|fluorouracil|mesh-list
20489087|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20489088|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489089|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
20489090|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
19699713|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
19699714|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
19699715|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699716|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699717|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699718|NCT04900350|Azacitidine|azacitidine|mesh-list
20489091|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
20489092|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489093|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
20489094|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20489095|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489096|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
20489097|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489098|NCT01591148|Propofol|propofol|mesh-list
20489099|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20489100|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489101|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489102|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20489103|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
20489104|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
20528513|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
20528514|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528515|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528516|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19414521|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19699719|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699720|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
19699721|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699722|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241808|NCT00409318|Etanercept|etanercept|mesh-list
20241809|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20241810|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20241811|NCT00409318|Analgesics|analgesics|mesh-ancestor
20241812|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
20241813|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489105|NCT01591226|Mannitol|mannitol|mesh-list
20489106|NCT01591226|Caffeine|caffeine|mesh-list
20489107|NCT01591226|Citric Acid|citric acid|mesh-list
20489108|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
20489109|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
20489110|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20489111|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
20241814|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241815|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241816|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20241817|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20241818|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241819|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
20241820|NCT00409357|Alfuzosin|alfuzosin|mesh-list
20241821|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20241822|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20241823|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20241824|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
20241825|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241826|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241827|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241828|NCT00409357|Urological Agents|urological agents|mesh-ancestor
20241829|NCT00409383|Paclitaxel|paclitaxel|mesh-list
20241830|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20241831|NCT00409383|Temozolomide|temozolomide|mesh-list
20241832|NCT00409383|Oblimersen|oblimersen|mesh-list
20241833|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20241834|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241835|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
20241836|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
20241837|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
20241838|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241839|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20241840|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
20241841|NCT00409461|Sirolimus|sirolimus|mesh-list
20241842|NCT00409461|Tacrolimus|tacrolimus|mesh-list
20489112|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
20489113|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489114|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20489115|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489116|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20489117|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489118|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19699723|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699724|NCT04899921|Nivolumab|nivolumab|mesh-list
19699725|NCT04899921|Ipilimumab|ipilimumab|mesh-list
19699726|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20489119|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19699727|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489120|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
20489121|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489122|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20489123|NCT01591226|Diuretics|diuretics|mesh-ancestor
20489124|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
20489125|NCT01591291|Ondansetron|ondansetron|mesh-list
19699728|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20241843|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241844|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
20241845|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241846|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20241847|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241848|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241849|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19699729|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699730|NCT04900155|Atorvastatin|atorvastatin|mesh-list
19699731|NCT04900155|Ezetimibe|ezetimibe|mesh-list
20241850|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241851|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19699732|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20489126|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
20489127|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
20489128|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489129|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489130|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20489131|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
20489132|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
20489133|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20489134|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
20489135|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489136|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699733|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20241852|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241853|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
20247974|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20247975|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20247976|NCT00434083|Analgesics|analgesics|mesh-ancestor
20247977|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
20247978|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247979|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247980|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247981|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247982|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
20247983|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20247984|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247985|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247986|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20489137|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20489138|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20489139|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489140|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20489141|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20489142|NCT01591421|Panitumumab|panitumumab|mesh-list
20489143|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20489144|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489145|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20489146|NCT01591434|Laxatives|laxatives|mesh-ancestor
20489147|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20489148|NCT01591551|Natalizumab|natalizumab|mesh-list
20489149|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
20489150|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489151|NCT01591668|Vesatolimod|vesatolimod|mesh-list
20489152|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
20489153|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489154|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
20489155|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
20489156|NCT01591850|Ritonavir|ritonavir|mesh-list
20489157|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20489158|NCT01591850|Rifampin|rifampin|mesh-list
20489159|NCT01591850|Ketoconazole|ketoconazole|mesh-list
20489160|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20489161|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20489162|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
20489163|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489164|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489165|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20489166|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20489167|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
20489168|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489169|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20489170|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20489171|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20489172|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
20489173|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20489174|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
20489175|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20489176|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20489177|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20489178|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20489179|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20489180|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20489181|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20489182|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
20489183|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20489184|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20489185|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
20489186|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489187|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489188|NCT01591889|Tinidazole|tinidazole|mesh-list
20489189|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
20489190|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489191|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20489192|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489193|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20489194|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20489195|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20489196|NCT01591902|Tesamorelin|tesamorelin|mesh-list
20489197|NCT01591902|Growth Substances|growth substances|mesh-ancestor
20489198|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489199|NCT01591980|Pregabalin|pregabalin|mesh-list
20489200|NCT01591980|Analgesics|analgesics|mesh-ancestor
20489201|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
20489202|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489203|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489204|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
20489205|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20489206|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20489207|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489208|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20489209|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20489210|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20489211|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489212|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20489213|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20489214|NCT01592019|Diclofenac|diclofenac|mesh-list
20489215|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20489216|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20489217|NCT01592019|Analgesics|analgesics|mesh-ancestor
20489218|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
20489219|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489220|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489221|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20489222|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489223|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20489224|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489225|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489226|NCT01592032|Vancomycin|vancomycin|mesh-list
20489227|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20489228|NCT01592032|Linezolid|linezolid|mesh-list
20489229|NCT01592032|Daptomycin|daptomycin|mesh-list
20489230|NCT01592032|Tigecycline|tigecycline|mesh-list
20489231|NCT01592032|Teicoplanin|teicoplanin|mesh-list
20489232|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
20489233|NCT01592032|Heparin|heparin|mesh-list
20489234|NCT01592032|Calcium heparin|calcium heparin|mesh-list
20489235|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20489236|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
20489237|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20489238|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20489239|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489240|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20489241|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489242|NCT01592110|Risperidone|risperidone|mesh-list
20489243|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20489244|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
20489245|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489246|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489247|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489248|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20489249|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19699734|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
19699735|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699736|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19699737|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20489250|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699738|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489251|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20489252|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20489253|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
20489254|NCT01592136|Ponatinib|ponatinib|mesh-list
20489255|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489256|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20489257|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489258|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489259|NCT01592162|Remifentanil|remifentanil|mesh-list
20489260|NCT01592162|Propofol|propofol|mesh-list
20489261|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20489262|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489263|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489264|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20489265|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
20489266|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
20489267|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20489268|NCT01592162|Narcotics|narcotics|mesh-ancestor
20489269|NCT01592162|Analgesics|analgesics|mesh-ancestor
20489270|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
20489271|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489272|NCT01592201|Olanzapine|olanzapine|mesh-list
20489273|NCT01592201|Risperidone|risperidone|mesh-list
20489274|NCT01592201|Aripiprazole|aripiprazole|mesh-list
20489275|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
20489276|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20489277|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
20489278|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489279|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489280|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489281|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20489282|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489283|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20489284|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20489285|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
20489286|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
20489287|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
20489288|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489289|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20489290|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20489291|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20489292|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20489293|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
20489294|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
20489295|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20489296|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20489297|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20489298|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20489299|NCT01592214|Benzocaine|benzocaine|mesh-list
20489300|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
20489301|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
20489302|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489303|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489304|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
20489305|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489306|NCT01592227|Acetaminophen|acetaminophen|mesh-list
20489307|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20489308|NCT01592227|Analgesics|analgesics|mesh-ancestor
20489309|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
20489310|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489311|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489312|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
20489313|NCT01592253|Sirolimus|sirolimus|mesh-list
20489314|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20489315|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489316|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20489317|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489318|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
20489319|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489320|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
20489321|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489322|NCT01592279|Liraglutide|liraglutide|mesh-list
20489323|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20489324|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489325|NCT01592279|Incretins|incretins|mesh-ancestor
19414522|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489326|NCT01592279|Hormones|hormones|mesh-ancestor
20489327|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489328|NCT01592305|Ritonavir|ritonavir|mesh-list
20489329|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20489330|NCT01592305|Tenofovir|tenofovir|mesh-list
20489331|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20489332|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20489333|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
20489334|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489335|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489336|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20489337|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20489338|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
20489339|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489340|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20489341|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20489342|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20489343|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20489344|NCT01592318|Ritonavir|ritonavir|mesh-list
20489345|NCT01592318|Lactams|lactams|mesh-list
20489346|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20489347|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20489348|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
20489349|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489350|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489351|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20489352|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20489353|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
20489354|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489355|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20489356|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20489357|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20489358|NCT01592526|Nicotine|nicotine|mesh-list
20489359|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20489360|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
20489361|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489362|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489363|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20489364|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20489365|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
20489366|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489367|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489368|NCT01592630|Ropivacaine|ropivacaine|mesh-list
20489369|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
20489370|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
20489371|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489372|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489373|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
20489374|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489375|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
20489376|NCT01592981|Rituximab|rituximab|mesh-list
20489377|NCT01592981|Fludarabine|fludarabine|mesh-list
20489378|NCT01592981|Bortezomib|bortezomib|mesh-list
20489379|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489380|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
20489381|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489382|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489383|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20489384|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
20489385|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489386|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489387|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20489388|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20489389|NCT01593033|Micronutrients|micronutrients|mesh-list
20489390|NCT01593033|Trace Elements|trace elements|mesh-list
20489391|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489392|NCT01593046|Cabotegravir|cabotegravir|mesh-list
20489393|NCT01593046|Rilpivirine|rilpivirine|mesh-list
20489394|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20489395|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20489396|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489397|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489398|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20489399|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20489400|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
20489401|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489402|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20489403|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20528517|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528518|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
20528519|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20528520|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20528521|NCT01774474|Analgesics|analgesics|mesh-ancestor
20528522|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
20528523|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528524|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
20528525|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20528526|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528527|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528528|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20528529|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20528530|NCT01774487|Protective Agents|protective agents|mesh-ancestor
20528531|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528532|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
20528533|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20528534|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
20528535|NCT01774565|Insulin|insulin|mesh-list
20528536|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20528537|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20528538|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489404|NCT01593124|Imiquimod|imiquimod|mesh-list
20489405|NCT01593124|Nonoxynol|nonoxynol|mesh-list
20489406|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20489407|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
20489408|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489409|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489410|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
20489411|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20489412|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20489413|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20489414|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
20489415|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489416|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20489417|NCT01593137|Metformin|metformin|mesh-list
20489418|NCT01593137|Liraglutide|liraglutide|mesh-list
20489419|NCT01593137|Glimepiride|glimepiride|mesh-list
20489420|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20489421|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489422|NCT01593137|Incretins|incretins|mesh-ancestor
20489423|NCT01593137|Hormones|hormones|mesh-ancestor
20489424|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489425|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20489426|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489427|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
20489428|NCT01593150|Dabigatran|dabigatran|mesh-list
20489429|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
20489430|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20489431|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
20489432|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489433|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489434|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
20489435|NCT01593163|Ibuprofen|ibuprofen|mesh-list
20489436|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20489437|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20489438|NCT01593163|Analgesics|analgesics|mesh-ancestor
20489439|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
20489440|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489441|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489442|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20489443|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489444|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20489445|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489446|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489447|NCT01593280|Morphine|morphine|mesh-list
20489448|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20489449|NCT01593280|Narcotics|narcotics|mesh-ancestor
20489450|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489451|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489452|NCT01593280|Analgesics|analgesics|mesh-ancestor
20489453|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
20489454|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699739|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
20489455|NCT01593293|Pemetrexed|pemetrexed|mesh-list
19699740|NCT04900129|Diclofenac|diclofenac|mesh-list
19699741|NCT04900129|Salicylates|salicylates|mesh-list
19699742|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
19699743|NCT04900129|Menthol|menthol|mesh-list
19699744|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19699745|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19699746|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20241854|NCT00409526|Iloprost|iloprost|mesh-list
20489456|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241855|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20241856|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
20241857|NCT00409591|Ritonavir|ritonavir|mesh-list
20241858|NCT00409591|Lopinavir|lopinavir|mesh-list
20241859|NCT00409591|Zidovudine|zidovudine|mesh-list
20241860|NCT00409591|Nevirapine|nevirapine|mesh-list
20241861|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20241862|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20241863|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
20241864|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20241865|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241866|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20241867|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20241868|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
20489457|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489458|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489459|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20489460|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20489461|NCT01593306|Paclitaxel|paclitaxel|mesh-list
20489462|NCT01593306|Cisplatin|cisplatin|mesh-list
20489463|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20489464|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489465|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
20489466|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
20489467|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
20489468|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489469|NCT01593319|Ropivacaine|ropivacaine|mesh-list
20489470|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
20489471|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
20528539|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
20241869|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241870|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19699747|NCT04900129|Analgesics|analgesics|mesh-ancestor
19699748|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
20241871|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20241872|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
20489472|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489473|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489474|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
20489475|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489476|NCT01593332|Rituximab|rituximab|mesh-list
20489477|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20489478|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489479|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
20489480|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489481|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489482|NCT01593371|Metformin|metformin|mesh-list
20489483|NCT01593371|Pioglitazone|pioglitazone|mesh-list
20489484|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20489485|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489486|NCT01593397|Fentanyl|fentanyl|mesh-list
20489487|NCT01593397|Propofol|propofol|mesh-list
20489488|NCT01593397|Anesthetics|anesthetics|mesh-list
20489489|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20489490|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489491|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489492|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20489493|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
20489494|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20241873|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20241874|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20241875|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19852864|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241876|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20241877|NCT00409630|Fluticasone|fluticasone|mesh-list
20241878|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20241879|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20241880|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
20241881|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241882|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489495|NCT01593397|Narcotics|narcotics|mesh-ancestor
20489496|NCT01593397|Analgesics|analgesics|mesh-ancestor
20489497|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
20489498|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489499|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20489500|NCT01593410|Dexamethasone|dexamethasone|mesh-list
20489501|NCT01593410|Lenalidomide|lenalidomide|mesh-list
20489502|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20489503|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
20489504|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
20489505|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489506|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489507|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20489508|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
20489509|NCT01593410|Hormones|hormones|mesh-ancestor
20489510|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489511|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20489512|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489513|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
20489514|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20489515|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20489516|NCT01593410|Growth Substances|growth substances|mesh-ancestor
20489517|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
20489518|NCT01593488|Cytarabine|cytarabine|mesh-list
20489519|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20489520|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
20489521|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489522|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489523|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
20489524|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489525|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489526|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
20489527|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489528|NCT01593501|Vitamin D|vitamin d|mesh-list
20489529|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
20489530|NCT01593501|Vitamins|vitamins|mesh-ancestor
20489531|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
20489532|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489533|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20489534|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20489535|NCT01593514|Lactitol|lactitol|mesh-list
20489536|NCT01593514|Vaccines|vaccines|mesh-list
20489537|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
20489538|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489539|NCT01593514|Cathartics|cathartics|mesh-ancestor
20489540|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699749|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489541|NCT01593566|Bupivacaine|bupivacaine|mesh-list
20489542|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
19699750|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489543|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
20489544|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489545|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489546|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
20489547|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489548|NCT01593605|Resveratrol|resveratrol|mesh-list
20489549|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
20489550|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489551|NCT01593605|Protective Agents|protective agents|mesh-ancestor
20489552|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489553|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489554|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20489555|NCT01593644|Adenosine|adenosine|mesh-list
20489556|NCT01593644|Dipyridamole|dipyridamole|mesh-list
20489557|NCT01593644|Analgesics|analgesics|mesh-ancestor
20489558|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
20489559|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489560|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489561|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20489562|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
20489563|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20489564|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
20489565|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
20489566|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489567|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489568|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20489569|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489570|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20489571|NCT01593774|Melatonin|melatonin|mesh-list
20489572|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
20489573|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489574|NCT01593774|Protective Agents|protective agents|mesh-ancestor
20489575|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489576|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489577|NCT01593826|Budesonide|budesonide|mesh-list
20489578|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
20489579|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20489580|NCT01593826|Charcoal|charcoal|mesh-list
20489581|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20489582|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20489583|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
20489584|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489585|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489586|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20489587|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
20489588|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
20489589|NCT01593826|Hormones|hormones|mesh-ancestor
20489590|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489591|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20489592|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20489593|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20489594|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
20489595|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489596|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489597|NCT01593826|Antidotes|antidotes|mesh-ancestor
19414523|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19414524|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19414525|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414526|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414527|NCT03541655|Celecoxib|celecoxib|mesh-list
20241883|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20241884|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
20241885|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
20241886|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20241887|NCT00409643|Amlodipine|amlodipine|mesh-list
20241888|NCT00409643|Valsartan|valsartan|mesh-list
20241889|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19414528|NCT03541655|Bupivacaine|bupivacaine|mesh-list
19414529|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
19414530|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
19414531|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414532|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489598|NCT01593826|Protective Agents|protective agents|mesh-ancestor
20489599|NCT01593930|Lidocaine|lidocaine|mesh-list
20489600|NCT01593930|Carticaine|carticaine|mesh-list
20489601|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
19852865|NCT00727961|Doxorubicin|doxorubicin|mesh-list
19852866|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20241890|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19414533|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
19414534|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241891|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241892|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241893|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20241894|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241895|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
20241896|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20489602|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
19852867|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20489603|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489604|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489605|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
20489606|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489607|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20489608|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20489609|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20489610|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20489611|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699751|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699752|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19699753|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19699754|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699755|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699756|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
19699757|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
19699758|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
19699759|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699760|NCT04900129|Expectorants|expectorants|mesh-ancestor
19699761|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
20241897|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20241898|NCT00409656|Basiliximab|basiliximab|mesh-list
20241899|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241900|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
20241901|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241902|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
20241903|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20241904|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
19852868|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852869|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19852870|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19852871|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852872|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852873|NCT00728481|Budesonide|budesonide|mesh-list
19852874|NCT00728481|Esomeprazole|esomeprazole|mesh-list
19852875|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19852876|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19852877|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
19852878|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852879|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852880|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19852881|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
19852882|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
19852883|NCT00728481|Hormones|hormones|mesh-ancestor
19852884|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852885|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19852886|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852887|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19852888|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852889|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852890|NCT00728494|Ribavirin|ribavirin|mesh-list
19852891|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19852892|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
19852893|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
19852894|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241905|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241906|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241907|NCT00409721|Memantine|memantine|mesh-list
20241908|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20241909|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20489612|NCT01593995|Mitogens|mitogens|mesh-list
20489613|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
20489614|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489615|NCT01594047|Ketamine|ketamine|mesh-list
20489616|NCT01594047|Methadone|methadone|mesh-list
20489617|NCT01594047|Analgesics|analgesics|mesh-ancestor
20489618|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
20489619|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489620|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241910|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
20241911|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489621|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20489622|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20489623|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
20489624|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
20489625|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489626|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20489627|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20489628|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489629|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489630|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20241912|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241913|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241914|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20241915|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20241916|NCT00409760|Amlodipine|amlodipine|mesh-list
20241917|NCT00409760|Valsartan|valsartan|mesh-list
20241918|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20241919|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20489631|NCT01594047|Narcotics|narcotics|mesh-ancestor
20489632|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
20489633|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
20241920|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241921|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241922|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20241923|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241924|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
20489634|NCT01594060|Insulin|insulin|mesh-list
20489635|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20489636|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
20489637|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
20489638|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20489639|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489640|NCT01594099|Paclitaxel|paclitaxel|mesh-list
19699762|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20489641|NCT01594099|Cisplatin|cisplatin|mesh-list
20489642|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20489643|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489644|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
19699763|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
19699764|NCT04900129|Protective Agents|protective agents|mesh-ancestor
19699765|NCT04900129|Antidotes|antidotes|mesh-ancestor
19699766|NCT04899765|Vaccines|vaccines|mesh-list
19699767|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
19699768|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
19699769|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699770|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20489645|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
20489646|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
20489647|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489648|NCT01594177|Paclitaxel|paclitaxel|mesh-list
20489649|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
20489650|NCT01594177|Trastuzumab|trastuzumab|mesh-list
20489651|NCT01594177|Epirubicin|epirubicin|mesh-list
20489652|NCT01594177|Afatinib|afatinib|mesh-list
20489653|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20489654|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489655|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
20489656|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
20489657|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
20489658|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489659|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489660|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
20489661|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489662|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489663|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19699771|NCT04899570|Prednisone|prednisone|mesh-list
19699772|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
19699773|NCT04899570|Rituximab|rituximab|mesh-list
19699774|NCT04899570|Epirubicin|epirubicin|mesh-list
20489664|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
20489665|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20489666|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20489667|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20489668|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19414535|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19414536|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414537|NCT03541655|Analgesics|analgesics|mesh-ancestor
19414538|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414539|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414540|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19414541|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19414542|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414543|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414544|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19414545|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19699775|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
19414546|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414547|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414548|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414549|NCT03515044|Rifaximin|rifaximin|mesh-list
19414550|NCT03515044|Lactulose|lactulose|mesh-list
19699776|NCT04899570|Vindesine|vindesine|mesh-list
19699777|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489669|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20489670|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489671|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20489672|NCT01594229|Rituximab|rituximab|mesh-list
20489673|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20489674|NCT01594229|Venetoclax|venetoclax|mesh-list
20489675|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20489676|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489677|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
20489678|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489679|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489680|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20489681|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
20489682|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489683|NCT01594242|Bortezomib|bortezomib|mesh-list
20489684|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489685|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
20489686|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20489687|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528540|NCT01774812|Vitamin D|vitamin d|mesh-list
20489688|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20489689|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20489690|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489691|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489692|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489693|NCT01594268|Everolimus|everolimus|mesh-list
20489694|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489695|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489696|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
20489697|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489698|NCT01594346|Vitamin E|vitamin e|mesh-list
20489699|NCT01594346|Tocopherols|tocopherols|mesh-list
20489700|NCT01594346|Tocotrienols|tocotrienols|mesh-list
20489701|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
20489702|NCT01594346|Vitamins|vitamins|mesh-ancestor
20489703|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
20489704|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489705|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
20489706|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489707|NCT01594346|Protective Agents|protective agents|mesh-ancestor
20489708|NCT01594489|Aminophylline|aminophylline|mesh-list
20489709|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20489710|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
20489711|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489712|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489713|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20489714|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
20489715|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20489716|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20489717|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489718|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489719|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20489720|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20489721|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
19699778|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
20489722|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489723|NCT01594489|Protective Agents|protective agents|mesh-ancestor
20489724|NCT01594502|Dutasteride|dutasteride|mesh-list
20489725|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20489726|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20489727|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489728|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489729|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
20489730|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489731|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489732|NCT01594619|Diltiazem|diltiazem|mesh-list
20489733|NCT01594619|Naloxegol|naloxegol|mesh-list
20489734|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20489735|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20489736|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20489737|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489738|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20489739|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489740|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
20489741|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20489742|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
20489743|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489744|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
20489745|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20489746|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20489747|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489748|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
20489749|NCT01594671|Coagulants|coagulants|mesh-ancestor
20489750|NCT01594697|Metformin|metformin|mesh-list
20489751|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20241925|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20241926|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20241927|NCT00409851|Amlodipine|amlodipine|mesh-list
20241928|NCT00409851|Valsartan|valsartan|mesh-list
20241929|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20241930|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20241931|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241932|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241933|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20241934|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241935|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
19699779|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699780|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19699781|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20489752|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528541|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
20528542|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20528543|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20528544|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528545|NCT01774812|Vitamins|vitamins|mesh-ancestor
20528546|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
20528547|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20528548|NCT01774838|Clopidogrel|clopidogrel|mesh-list
20528549|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20528550|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20528551|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20528552|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19699782|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
19699783|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489753|NCT01594775|Oxytocin|oxytocin|mesh-list
20489754|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
20489755|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489756|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489757|NCT01594866|Dexetimide|dexetimide|mesh-list
20489758|NCT01594866|Citalopram|citalopram|mesh-list
20489759|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20489760|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20489761|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20489762|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489763|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19852895|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
20241936|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20241937|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20241938|NCT00409890|Scopolamine|scopolamine|mesh-list
19852896|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241939|NCT00409890|Bromides|bromides|mesh-list
20241940|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20241941|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
20241942|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20241943|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
20241944|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
20241945|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20241946|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241947|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20241948|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
20241949|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20241950|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
20241951|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20241952|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241953|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20241954|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
20241955|NCT00409903|Eprosartan|eprosartan|mesh-list
20241956|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20241957|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
20241958|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20241959|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489764|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
20489765|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489766|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20489767|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
20489768|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20489769|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20489770|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20489771|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
20489772|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
20489773|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489774|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20489775|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20489776|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
20489777|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
20489778|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20489779|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
20489780|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489781|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489782|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20489783|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20489784|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20489785|NCT01594905|Tenofovir|tenofovir|mesh-list
20489786|NCT01594905|Entecavir|entecavir|mesh-list
20489787|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
20489788|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489789|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20489790|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20489791|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489792|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489793|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20489794|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20489795|NCT01594918|Prednisone|prednisone|mesh-list
20489796|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
20489797|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20489798|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
20489799|NCT01594918|Hormones|hormones|mesh-ancestor
20489800|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489801|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489802|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20489803|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489804|NCT01594918|Analgesics|analgesics|mesh-ancestor
20489805|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
20489806|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489807|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20489808|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20489809|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489810|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489811|NCT01595009|Everolimus|everolimus|mesh-list
20489812|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489813|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489814|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
20489815|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489816|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
20489817|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
20489818|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489819|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489820|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20489821|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20489822|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20489823|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20489824|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
20489825|NCT01595152|Fesoterodine|fesoterodine|mesh-list
20489826|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20489827|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20489828|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
20489829|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489830|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489831|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489832|NCT01595152|Urological Agents|urological agents|mesh-ancestor
20489833|NCT01595334|Cetrorelix|cetrorelix|mesh-list
20489834|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20489835|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
20489836|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489837|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489838|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
20489839|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489840|NCT01595399|Atropine|atropine|mesh-list
20489841|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20489842|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20489843|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20489844|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
20489845|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489846|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489847|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20489848|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
20489849|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
20489850|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
20489851|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20489852|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20489853|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
20489854|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20489855|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489856|NCT01595425|Esomeprazole|esomeprazole|mesh-list
20489857|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20489858|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20489859|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20489860|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489861|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489862|NCT01595594|Doxycycline|doxycycline|mesh-list
20489863|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20489864|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699784|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489865|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
20489866|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20489867|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20489868|NCT01595633|Tenofovir|tenofovir|mesh-list
19699785|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19699786|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699787|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699788|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
19699789|NCT04899570|Hormones|hormones|mesh-ancestor
19699790|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699791|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19699792|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19699793|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19699794|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19699795|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489869|NCT01595633|Adefovir|adefovir|mesh-list
20489870|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
20489871|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489872|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20489873|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20489874|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489875|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489876|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20489877|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20489878|NCT01595685|Entecavir|entecavir|mesh-list
20489879|NCT01595685|Telbivudine|telbivudine|mesh-list
20489880|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
20489881|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489882|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20489883|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489884|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489885|NCT01595724|Dienogest|dienogest|mesh-list
20489886|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20489887|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
20489888|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489889|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489890|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20489891|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20489892|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20489893|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20489894|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
20489895|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489896|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20489897|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489898|NCT01595737|Simendan|simendan|mesh-list
20489899|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20489900|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
20489901|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20489902|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20489903|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489904|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489905|NCT01595737|Protective Agents|protective agents|mesh-ancestor
20489906|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489907|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
20489908|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20489909|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20489910|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489911|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
20489912|NCT01595763|Coagulants|coagulants|mesh-ancestor
20489913|NCT01595789|Liraglutide|liraglutide|mesh-list
20489914|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20489915|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699796|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19699797|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20489916|NCT01595789|Incretins|incretins|mesh-ancestor
20489917|NCT01595789|Hormones|hormones|mesh-ancestor
20489918|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489919|NCT01595815|Calcium|calcium|mesh-list
20489920|NCT01595815|Ionophores|ionophores|mesh-list
20489921|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
20489922|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20489923|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489924|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20489925|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489926|NCT01595828|Pitavastatin|pitavastatin|mesh-list
20489927|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20489928|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20489929|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20489930|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
20489931|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489932|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489933|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20489934|NCT01595867|Naltrexone|naltrexone|mesh-list
20489935|NCT01595867|Morphine|morphine|mesh-list
20489936|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20489937|NCT01595867|Narcotics|narcotics|mesh-ancestor
20489938|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20489939|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489940|NCT01595867|Analgesics|analgesics|mesh-ancestor
19852897|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
19852898|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489941|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
20489942|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20489943|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20489944|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20489945|NCT01595880|Metformin|metformin|mesh-list
20489946|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20489947|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489948|NCT01595893|Vitamin D|vitamin d|mesh-list
20489949|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
20489950|NCT01595893|Vitamins|vitamins|mesh-ancestor
20489951|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
20489952|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489953|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20489954|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20489955|NCT01595958|Cyclosporine|cyclosporine|mesh-list
20489956|NCT01595958|Cyclosporins|cyclosporins|mesh-list
20489957|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489958|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489959|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489960|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
20489961|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489962|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
20489963|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489964|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
20489965|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489966|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20489967|NCT01595984|Cyclosporine|cyclosporine|mesh-list
20489968|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
20489969|NCT01595984|Everolimus|everolimus|mesh-list
20489970|NCT01595984|Cyclosporins|cyclosporins|mesh-list
20489971|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20489972|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20489973|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20489974|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
20489975|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489976|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
20489977|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20489978|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
20489979|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20489980|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20489981|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20489982|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20489983|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20489984|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
20489985|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20489986|NCT01596010|Norethindrone|norethindrone|mesh-list
20489987|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
20489988|NCT01596010|Estradiol|estradiol|mesh-list
20489989|NCT01596010|Estrogens|estrogens|mesh-ancestor
20489990|NCT01596010|Hormones|hormones|mesh-ancestor
20489991|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20489992|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20489993|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20489994|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
20489995|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20489996|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20489997|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20489998|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20489999|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20490000|NCT01596075|Cannabidiol|cannabidiol|mesh-list
20490001|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
20490002|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
20490003|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
20490004|NCT01596114|Protective Agents|protective agents|mesh-ancestor
20490005|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490006|NCT01596140|Sirolimus|sirolimus|mesh-list
20490007|NCT01596140|Everolimus|everolimus|mesh-list
20490008|NCT01596140|Vemurafenib|vemurafenib|mesh-list
20490009|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490010|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20490011|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
20490012|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490013|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490014|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490015|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490016|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20490017|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
20490018|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20490019|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490020|NCT01596166|Ketorolac|ketorolac|mesh-list
20490021|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20490022|NCT01596166|Metoclopramide|metoclopramide|mesh-list
20490023|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20490024|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20490025|NCT01596166|Analgesics|analgesics|mesh-ancestor
20490026|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
20490027|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490028|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490029|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490030|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490031|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20490032|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490033|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490034|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
20490035|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
20490036|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490037|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20490038|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20490039|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
20490040|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490041|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20490042|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20490043|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490044|NCT01596296|Dinoprostone|dinoprostone|mesh-list
20490045|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
20490046|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490047|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490048|NCT01596387|Propofol|propofol|mesh-list
20490049|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20241960|NCT00409942|Torsemide|torsemide|mesh-list
20241961|NCT00409942|Furosemide|furosemide|mesh-list
20241962|NCT00409942|Diuretics|diuretics|mesh-ancestor
20241963|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
20241964|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241965|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20241966|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20241967|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241968|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20241969|NCT00409981|Paclitaxel|paclitaxel|mesh-list
20490050|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490051|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490052|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20490053|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
20490054|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
20490055|NCT01596400|Granisetron|granisetron|mesh-list
20490056|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
20490057|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
20490058|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490059|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490060|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490061|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20490062|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
20490063|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490064|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528553|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20528554|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
20528555|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528556|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528557|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528558|NCT01774864|Udenafil|udenafil|mesh-list
20528559|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20528560|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20528561|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528562|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528563|NCT01774877|Leflunomide|leflunomide|mesh-list
20528564|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528565|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490065|NCT01596413|Granisetron|granisetron|mesh-list
20490066|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
20490067|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
20490068|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490069|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490070|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490071|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20490072|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
20490073|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490074|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490075|NCT01596426|Granisetron|granisetron|mesh-list
20490076|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
20490077|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
20490078|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490079|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490080|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490081|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20490082|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
20490083|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490084|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490085|NCT01596517|Ribavirin|ribavirin|mesh-list
20490086|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20490087|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
20490088|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
20490089|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490090|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
20490091|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490092|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
20490093|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490094|NCT01596556|Nicotine|nicotine|mesh-list
20490095|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20490096|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
20490097|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490098|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490099|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20490100|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20490101|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
20490102|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490103|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490104|NCT01596634|Lactoferrin|lactoferrin|mesh-list
20490105|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490106|NCT01596647|Diclofenac|diclofenac|mesh-list
20490107|NCT01596647|Midazolam|midazolam|mesh-list
20490108|NCT01596647|Caffeine|caffeine|mesh-list
20490109|NCT01596647|Omeprazole|omeprazole|mesh-list
20490110|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20490111|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20490112|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490113|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490114|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20490115|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20490116|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20490117|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20490118|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
20490119|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
20490120|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
20490121|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
20490122|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490123|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490124|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20490125|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490126|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20490127|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490128|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20490129|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20490130|NCT01596647|Analgesics|analgesics|mesh-ancestor
20490131|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
20490132|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490133|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490134|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490135|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20490136|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20490137|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20490138|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20490139|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20490140|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
20490141|NCT01596660|Bupivacaine|bupivacaine|mesh-list
20490142|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
20490143|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
20490144|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490145|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490146|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
20490147|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490148|NCT01596673|Hydrocodone|hydrocodone|mesh-list
20490149|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20490150|NCT01596673|Narcotics|narcotics|mesh-ancestor
19852899|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
19852900|NCT00728507|Rifampin|rifampin|mesh-list
19852901|NCT00728507|Isoniazid|isoniazid|mesh-list
19852902|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
19852903|NCT00728507|Ethambutol|ethambutol|mesh-list
19852904|NCT00728507|Rifapentine|rifapentine|mesh-list
19852905|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490151|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852906|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490152|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852907|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19852908|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20490153|NCT01596673|Analgesics|analgesics|mesh-ancestor
20490154|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
20490155|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490156|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
20490157|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
20490158|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
20490159|NCT01596686|Cathartics|cathartics|mesh-ancestor
20490160|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490161|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
20490162|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20490163|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20490164|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490165|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
20490166|NCT01596738|Coagulants|coagulants|mesh-ancestor
20490167|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
20490168|NCT01596764|Naloxone|naloxone|mesh-list
20490169|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
20490170|NCT01596764|Loperamide|loperamide|mesh-list
20490171|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
20490172|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20490173|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490174|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
20490175|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490176|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490177|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490178|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20490179|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20490180|NCT01596764|Analgesics|analgesics|mesh-ancestor
20490181|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490182|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490183|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
20490184|NCT01596777|Naltrexone|naltrexone|mesh-list
20490185|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
20490186|NCT01596777|Loperamide|loperamide|mesh-list
19414551|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414552|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414553|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490187|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
20490188|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490189|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20490190|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699798|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
20490191|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
20490192|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490193|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20490194|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490195|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20490196|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20490197|NCT01596777|Analgesics|analgesics|mesh-ancestor
20490198|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490199|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490200|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
20490201|NCT01596803|Vitamin E|vitamin e|mesh-list
20490202|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
20490203|NCT01596803|Tocopherols|tocopherols|mesh-list
20490204|NCT01596803|Antioxidants|antioxidants|mesh-list
20490205|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490206|NCT01596803|Protective Agents|protective agents|mesh-ancestor
20490207|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490208|NCT01596803|Vitamins|vitamins|mesh-ancestor
20490209|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
20490210|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
20490211|NCT01596855|Hematinics|hematinics|mesh-ancestor
20490212|NCT01596868|Gemcitabine|gemcitabine|mesh-list
20490213|NCT01596868|Cisplatin|cisplatin|mesh-list
20490214|NCT01596868|Docetaxel|docetaxel|mesh-list
20490215|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490216|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20490217|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
20490218|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490219|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
20490220|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490221|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490222|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20490223|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
20490224|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490225|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
20490226|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
20490227|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699799|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
19699800|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
20490228|NCT01596894|Azithromycin|azithromycin|mesh-list
20490229|NCT01596894|Metronidazole|metronidazole|mesh-list
20490230|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490231|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490232|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20490233|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20490234|NCT01596907|Ephedrine|ephedrine|mesh-list
20490235|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
20490236|NCT01596907|Caffeine|caffeine|mesh-list
20490237|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20490238|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490239|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20490240|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490241|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490242|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20490243|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20490244|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
20490245|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490246|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
20490247|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
20490248|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490249|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20490250|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
20490251|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20490252|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20490253|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
20490254|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
20490255|NCT01596998|Epinephrine|epinephrine|mesh-list
20490256|NCT01596998|Racepinephrine|racepinephrine|mesh-list
20490257|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
20490258|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
20490259|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20490260|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20490261|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
20490262|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490263|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490264|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490265|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20490266|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19699801|NCT04899453|Rituximab|rituximab|mesh-list
19699802|NCT04899453|Methotrexate|methotrexate|mesh-list
19699803|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
19699804|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699805|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699806|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
19699807|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490267|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
19699808|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490268|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490269|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20490270|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
20490271|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
20490272|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
20490273|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20490274|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
20490275|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
20490276|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490277|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
20490278|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20490279|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
20490280|NCT01597011|Coagulants|coagulants|mesh-ancestor
20490281|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
20490282|NCT01597167|Analgesics|analgesics|mesh-ancestor
20490283|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
20490284|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490285|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490286|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
20490287|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490288|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20490289|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
20490290|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20490291|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20490292|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490293|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20490294|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
20490295|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490296|NCT01597206|Cobalt|cobalt|mesh-list
20490297|NCT01597206|Trace Elements|trace elements|mesh-ancestor
20490298|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
20490299|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490300|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
20241970|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20490301|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20490302|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20490303|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490304|NCT01597310|Pramipexole|pramipexole|mesh-list
20490305|NCT01597310|Warfarin|warfarin|mesh-list
20490306|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
20490307|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
20490308|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490309|NCT01597310|Protective Agents|protective agents|mesh-ancestor
20490310|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490311|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20490312|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20490313|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
20490314|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
20490315|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490316|NCT01597336|Plasminogen|plasminogen|mesh-list
20490317|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20490318|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20490319|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20490320|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490321|NCT01597427|Clonidine|clonidine|mesh-list
20490322|NCT01597427|Analgesics|analgesics|mesh-ancestor
20490323|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
20490324|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490325|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490326|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20490327|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
20241971|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241972|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
20241973|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
20241974|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
20241975|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20241976|NCT00409994|Sirolimus|sirolimus|mesh-list
20241977|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490328|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
20490329|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19699809|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19699810|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
19699811|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19699812|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699813|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
19699814|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699815|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
19699816|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699817|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19699818|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20490330|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20490331|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20490332|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
20490333|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490334|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490335|NCT01597518|Riluzole|riluzole|mesh-list
20490336|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
20490337|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20490338|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20490339|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490340|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490341|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490342|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20490343|NCT01597518|Protective Agents|protective agents|mesh-ancestor
20490344|NCT01597531|Liraglutide|liraglutide|mesh-list
20490345|NCT01597531|Orlistat|orlistat|mesh-list
20490346|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20490347|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490348|NCT01597531|Incretins|incretins|mesh-ancestor
20490349|NCT01597531|Hormones|hormones|mesh-ancestor
20490350|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20490351|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490352|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490353|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20490354|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20490355|NCT01597609|Sibutramine|sibutramine|mesh-list
20490356|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
20490357|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20490358|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
20490359|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20490360|NCT01597648|Maraviroc|maraviroc|mesh-list
20490361|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20490362|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20490363|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20490364|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490365|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20490366|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20490367|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
20490368|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490369|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20490370|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20490371|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20490372|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490373|NCT01597661|Bupropion|bupropion|mesh-list
19699819|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19699820|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19699821|NCT04899817|Granisetron|granisetron|mesh-list
19699822|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
19699823|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
19699824|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699825|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699826|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699827|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20490374|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
19699828|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
20490375|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20490376|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20490377|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20490378|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20490379|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20490380|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490381|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
20490382|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699829|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708008|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20241978|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490383|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490384|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20490385|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20241979|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20241980|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20241981|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
20241982|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20241983|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
20241984|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241985|NCT00410033|Insulin|insulin|mesh-list
19414554|NCT03512964|Dolutegravir|dolutegravir|mesh-list
19414555|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19414556|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19414557|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19414558|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414559|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414560|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19414561|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19414562|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
19414563|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20241986|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20241987|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
20241988|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
20241989|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
20241990|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
20490386|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490387|NCT01597700|Ezetimibe|ezetimibe|mesh-list
20490388|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20490389|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20490390|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
20490391|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490392|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20490393|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
20490394|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20490395|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490396|NCT01597726|Misoprostol|misoprostol|mesh-list
20490397|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20241991|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20241992|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20241993|NCT00410215|Bisacodyl|bisacodyl|mesh-list
20241994|NCT00410215|Cathartics|cathartics|mesh-ancestor
20241995|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20241996|NCT00410215|Laxatives|laxatives|mesh-ancestor
20241997|NCT00410254|Midazolam|midazolam|mesh-list
20241998|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20241999|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20490398|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
20242000|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242001|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852909|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852910|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852911|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490399|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490400|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490401|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20490402|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490403|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
20490404|NCT01597765|Vitamins|vitamins|mesh-list
20490405|NCT01597765|Vitamin E|vitamin e|mesh-list
20490406|NCT01597765|Tocopherols|tocopherols|mesh-list
20490407|NCT01597765|Tocotrienols|tocotrienols|mesh-list
20490408|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
20490409|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
20490410|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20490411|NCT01597765|Deferiprone|deferiprone|mesh-list
20490412|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
20490413|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490414|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
20490415|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490416|NCT01597765|Expectorants|expectorants|mesh-ancestor
20490417|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
20490418|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20490419|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
20490420|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490421|NCT01597765|Protective Agents|protective agents|mesh-ancestor
20490422|NCT01597765|Antidotes|antidotes|mesh-ancestor
19852912|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19852913|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
20242002|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20242003|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20242004|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19852914|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
19852915|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19852916|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20242005|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20242006|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
20242007|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
20242008|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
20242009|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
20242010|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242011|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242012|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
20242013|NCT00410306|Testosterone|testosterone|mesh-list
20242014|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
20242015|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
20242016|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20242017|NCT00410306|Androgens|androgens|mesh-ancestor
20242018|NCT00410306|Hormones|hormones|mesh-ancestor
20242019|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242020|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242021|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20242022|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242023|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
20242024|NCT00410345|Mifepristone|mifepristone|mesh-list
20242025|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20490423|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20490424|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
20490425|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
20490426|NCT01597817|Chitosan|chitosan|mesh-list
20490427|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20242026|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
20490428|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20490429|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
20490430|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490431|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20490432|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
20490433|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
20490434|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
20490435|NCT01597817|Coagulants|coagulants|mesh-ancestor
20490436|NCT01597895|Maraviroc|maraviroc|mesh-list
20490437|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20490438|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20490439|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490440|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20490441|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20490442|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
20490443|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490444|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20490445|NCT01597934|Tenofovir|tenofovir|mesh-list
20490446|NCT01597934|Entecavir|entecavir|mesh-list
20490447|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20490448|NCT01597934|Adefovir|adefovir|mesh-list
20490449|NCT01597934|Lamivudine|lamivudine|mesh-list
20242027|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20242028|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242029|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20242030|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20490450|NCT01597934|Telbivudine|telbivudine|mesh-list
20490451|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
20490452|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490453|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20490454|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20490455|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490456|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490457|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20490458|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20490459|NCT01597986|Isavuconazole|isavuconazole|mesh-list
20242031|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20242032|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
20242033|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20242034|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20242035|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
20242036|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242037|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
20242038|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20242039|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20490460|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19699830|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490461|NCT01597986|Norethindrone|norethindrone|mesh-list
20490462|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
20490463|NCT01597986|Norinyl|norinyl|mesh-list
20490464|NCT01597986|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20490465|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
20490466|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
20490467|NCT01597986|Estradiol|estradiol|mesh-list
20490468|NCT01597986|Estrogens|estrogens|mesh-ancestor
20490469|NCT01597986|Hormones|hormones|mesh-ancestor
20490470|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20490471|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699831|NCT04899674|Bupropion|bupropion|mesh-list
20490472|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20490473|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490474|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20490475|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20490476|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20490477|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
20490478|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490479|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20490480|NCT01597986|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20490481|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
20490482|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20490483|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414564|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19414565|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19414566|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
19414567|NCT03510884|Niacin|niacin|mesh-list
19414568|NCT03510884|Niacinamide|niacinamide|mesh-list
19414569|NCT03510884|Atorvastatin|atorvastatin|mesh-list
19414570|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19414571|NCT03510884|Simvastatin|simvastatin|mesh-list
19414572|NCT03510884|Ezetimibe|ezetimibe|mesh-list
19414573|NCT03510884|Pravastatin|pravastatin|mesh-list
19414574|NCT03510884|Lovastatin|lovastatin|mesh-list
19414575|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
19414576|NCT03510884|Fenofibrate|fenofibrate|mesh-list
19414577|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19414578|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19414579|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
20490484|NCT01598012|Analgesics|analgesics|mesh-ancestor
20490485|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
20490486|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490487|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490488|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490489|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490490|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20490491|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490492|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490493|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
20490494|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20490495|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
20490496|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20490497|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
20490498|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490499|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490500|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
20490501|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
20490502|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20490503|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
20490504|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20490505|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
20490506|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490507|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490508|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
20528566|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528567|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
20528568|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528569|NCT01775098|Allopurinol|allopurinol|mesh-list
20528570|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
20528571|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528572|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414580|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414581|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19414582|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19414583|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414584|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
19699832|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19414585|NCT03510884|Vitamins|vitamins|mesh-ancestor
19414586|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
20490509|NCT01598259|Melatonin|melatonin|mesh-list
20490510|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
20490511|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490512|NCT01598259|Protective Agents|protective agents|mesh-ancestor
20490513|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490514|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490515|NCT01598337|Aspirin|aspirin|mesh-list
20490516|NCT01598337|Tirofiban|tirofiban|mesh-list
20490517|NCT01598337|Clopidogrel|clopidogrel|mesh-list
20490518|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20490519|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20490520|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20490521|NCT01598337|Analgesics|analgesics|mesh-ancestor
20490522|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
20490523|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490524|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490525|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490526|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490527|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20490528|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20490529|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699833|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
20490530|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20490531|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20490532|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490533|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
20490534|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20490535|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20490536|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20490537|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
20490538|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490539|NCT01598363|Digoxin|digoxin|mesh-list
20490540|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20490541|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20490542|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20490543|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
20490544|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490545|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20490546|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19414587|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414588|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
20490547|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490548|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20490549|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20490550|NCT01598363|Protective Agents|protective agents|mesh-ancestor
20490551|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490552|NCT01598402|Amoxicillin|amoxicillin|mesh-list
20490553|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
20490554|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
20490555|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528573|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
19699834|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19699835|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19699836|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19699837|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19699838|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699839|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
19699840|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699841|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852917|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19852918|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20490556|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490557|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490558|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490559|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20490560|NCT01598441|Iloprost|iloprost|mesh-list
20490561|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20490562|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
20490563|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
20490564|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20490565|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20490566|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20490567|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
20490568|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20490569|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20490570|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20490571|NCT01598558|Rituximab|rituximab|mesh-list
20490572|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20490573|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490574|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
20490575|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490576|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490577|NCT01598584|Gemcitabine|gemcitabine|mesh-list
20490578|NCT01598584|Mirtazapine|mirtazapine|mesh-list
20490579|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20490580|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
20490581|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490582|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490583|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
20490584|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490585|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490586|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20490587|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
20528574|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490588|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490589|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
20490590|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20490591|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20490592|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
20490593|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
20490594|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490595|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20490596|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20490597|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19699842|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19699843|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19699844|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708009|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20242040|NCT00410371|Lamotrigine|lamotrigine|mesh-list
20490598|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20490599|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20490600|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20490601|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
20490602|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20490603|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20490604|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
20490605|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20490606|NCT01598623|Oxytocin|oxytocin|mesh-list
20490607|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
20490608|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490609|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490610|NCT01598649|Mannitol|mannitol|mesh-list
20490611|NCT01598649|Caseins|caseins|mesh-list
20490612|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20490613|NCT01598649|Diuretics|diuretics|mesh-ancestor
20490614|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
20490615|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490616|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
20490617|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
20490618|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490619|NCT01598675|Methamphetamine|methamphetamine|mesh-list
20490620|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20490621|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490622|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
20490623|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
20490624|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242041|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
20242042|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20242043|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20242044|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242045|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20242046|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242047|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20242048|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20242049|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242050|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20242051|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20242052|NCT00410449|Tocopherols|tocopherols|mesh-list
20242053|NCT00410449|Vitamin E|vitamin e|mesh-list
20242054|NCT00410449|Tocotrienols|tocotrienols|mesh-list
20242055|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
20242056|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
20242057|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490625|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
20490626|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490627|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490628|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
20490629|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20490630|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20490631|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20490632|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20490633|NCT01598883|Heparin|heparin|mesh-list
20490634|NCT01598883|Calcium heparin|calcium heparin|mesh-list
20490635|NCT01598883|Antithrombins|antithrombins|mesh-list
20490636|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
20490637|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20490638|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20490639|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490640|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20490641|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
20490642|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490643|NCT01598948|Mipomersen|mipomersen|mesh-list
20490644|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20490645|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20490646|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
20490647|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490648|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20490649|NCT01599000|Lumefantrine|lumefantrine|mesh-list
20490650|NCT01599000|Artemether|artemether|mesh-list
20490651|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20490652|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
20490653|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20490654|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20490655|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490656|NCT01599013|Gemcitabine|gemcitabine|mesh-list
20490657|NCT01599013|Carboplatin|carboplatin|mesh-list
20490658|NCT01599013|Vinblastine|vinblastine|mesh-list
20490659|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490660|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20490661|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
20490662|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490663|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
20490664|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490665|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490666|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20490667|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
20490668|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490669|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20490670|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
20490671|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
20490672|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
20490673|NCT01599078|Paclitaxel|paclitaxel|mesh-list
19699845|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19699846|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699847|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19699848|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699849|NCT04899414|Dexamethasone|dexamethasone|mesh-list
19699850|NCT04899414|Azacitidine|azacitidine|mesh-list
19699851|NCT04899414|Pegaspargase|pegaspargase|mesh-list
19699852|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699853|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
20490674|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20490675|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490676|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
20490677|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
20490678|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
20490679|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490680|NCT01599117|Udenafil|udenafil|mesh-list
19699854|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
20490681|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20490682|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20490683|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490684|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490685|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20490686|NCT01599130|Entecavir|entecavir|mesh-list
20490687|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
20490688|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490689|NCT01599273|Triamcinolone|triamcinolone|mesh-list
20490690|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490691|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
20490692|NCT01599273|Hormones|hormones|mesh-ancestor
20490693|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20490694|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490695|NCT01599312|Cobalt|cobalt|mesh-list
20490696|NCT01599312|Trace Elements|trace elements|mesh-ancestor
20490697|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
20490698|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490699|NCT01599338|Liraglutide|liraglutide|mesh-list
20490700|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20490701|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490702|NCT01599338|Incretins|incretins|mesh-ancestor
20490703|NCT01599338|Hormones|hormones|mesh-ancestor
20490704|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20490705|NCT01599364|Ritonavir|ritonavir|mesh-list
20490706|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20490707|NCT01599364|Lamivudine|lamivudine|mesh-list
20490708|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20490709|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20490710|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
20490711|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490712|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490713|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20490714|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20490715|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
20490716|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490717|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20490718|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20490719|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20490720|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20490721|NCT01599377|Tofacitinib|tofacitinib|mesh-list
20490722|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20490723|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490724|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490725|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
20490726|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20490727|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20490728|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490729|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
19699855|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699856|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699857|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699858|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
19699859|NCT04899414|Hormones|hormones|mesh-ancestor
19699860|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699861|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19699862|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699863|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699864|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
19699865|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699866|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699867|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
19699868|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
19699869|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19699870|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19699871|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699872|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19699873|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19699874|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19699875|NCT04899115|Vancomycin|vancomycin|mesh-list
19699876|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19852919|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20490730|NCT01599468|Coagulants|coagulants|mesh-ancestor
20490731|NCT01599572|Zinc|zinc|mesh-list
20490732|NCT01599572|Trace Elements|trace elements|mesh-ancestor
20490733|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
20490734|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490735|NCT01599598|Imidacloprid|imidacloprid|mesh-list
20490736|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
20490737|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490738|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490739|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490740|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20490741|NCT01599702|Hematinics|hematinics|mesh-ancestor
20490742|NCT01599728|Substance P|substance p|mesh-list
20490743|NCT01599728|Neurokinin A|neurokinin a|mesh-list
20490744|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490745|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490746|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490747|NCT01599819|Factor VIII|factor viii|mesh-list
20490748|NCT01599819|BAX 855|bax 855|mesh-list
20490749|NCT01599819|Coagulants|coagulants|mesh-ancestor
20490750|NCT01599858|Omeprazole|omeprazole|mesh-list
20490751|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20490752|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20490753|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20490754|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699877|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699878|NCT04898920|Dexamethasone|dexamethasone|mesh-list
20490755|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490756|NCT01599871|Theophylline|theophylline|mesh-list
20490757|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20490758|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
20490759|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490760|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490761|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20490762|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
20490763|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20490764|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490765|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490766|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
20490767|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20490768|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20490769|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
20490770|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490771|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
20490772|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20490773|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
20490774|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490775|NCT01599884|Expectorants|expectorants|mesh-ancestor
20490776|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
19699879|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19699880|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
20490777|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20490778|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
20490779|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490780|NCT01599884|Protective Agents|protective agents|mesh-ancestor
20490781|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490782|NCT01599884|Antidotes|antidotes|mesh-ancestor
20490783|NCT01599923|Antivenins|antivenins|mesh-list
20490784|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
20490785|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490786|NCT01599936|Antivenins|antivenins|mesh-list
20490787|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
20490788|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490789|NCT01599962|Cinacalcet|cinacalcet|mesh-list
20490790|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20490791|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490792|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20490793|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
20490794|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528575|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20528576|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
20528577|NCT01775098|Protective Agents|protective agents|mesh-ancestor
20528578|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528579|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20528580|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
20528581|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528582|NCT01775397|Vancomycin|vancomycin|mesh-list
20528583|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
20528584|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528585|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528586|NCT01775475|Prednisone|prednisone|mesh-list
20528587|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
20528588|NCT01775475|Lomustine|lomustine|mesh-list
20528589|NCT01775475|Doxorubicin|doxorubicin|mesh-list
20528590|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20528591|NCT01775475|Etoposide|etoposide|mesh-list
20528592|NCT01775475|Vincristine|vincristine|mesh-list
19699881|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
19699882|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242058|NCT00410449|Protective Agents|protective agents|mesh-ancestor
20242059|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242060|NCT00410449|Vitamins|vitamins|mesh-ancestor
20242061|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
20242062|NCT00410462|Doxorubicin|doxorubicin|mesh-list
20242063|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20242064|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20242065|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242066|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20242067|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20242068|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242069|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242070|NCT00410527|Meropenem|meropenem|mesh-list
20242071|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20242072|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528593|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
20528594|NCT01775475|Procarbazine|procarbazine|mesh-list
20490795|NCT01599975|Methylphenidate|methylphenidate|mesh-list
20490796|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20490797|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490798|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19414589|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19414590|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19414591|NCT03493932|Nivolumab|nivolumab|mesh-list
19414592|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19414593|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414594|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19414595|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414596|NCT03475706|Solabegron|solabegron|mesh-list
19414597|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19414598|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19414599|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20490799|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20490800|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20490801|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490802|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
20490803|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490804|NCT01599988|Caseins|caseins|mesh-list
20490805|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
20490806|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
20490807|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490808|NCT01600079|Vaccines|vaccines|mesh-list
20490809|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
20490810|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490811|NCT01600235|Phenylephrine|phenylephrine|mesh-list
20490812|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
20490813|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20490814|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
20490815|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
20490816|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490817|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490818|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
20490819|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20490820|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
20490821|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
20490822|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20490823|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20490824|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20490825|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
20490826|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490827|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490828|NCT01600235|Protective Agents|protective agents|mesh-ancestor
20490829|NCT01600274|Dienogest|dienogest|mesh-list
20490830|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20490831|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20490832|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20490833|NCT01600274|Estradiol|estradiol|mesh-list
20490834|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20490835|NCT01600274|Nandrolone|nandrolone|mesh-list
20490836|NCT01600274|Estrogens|estrogens|mesh-ancestor
20490837|NCT01600274|Hormones|hormones|mesh-ancestor
20490838|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20490839|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490840|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20490841|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
20490842|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490843|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20490844|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20490845|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20490846|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20490847|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
20490848|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20490849|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490850|NCT01600274|Androgens|androgens|mesh-ancestor
20490851|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
20490852|NCT01600365|Ganciclovir|ganciclovir|mesh-list
20490853|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20490854|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
20490855|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
20490856|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490857|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20490858|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490859|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490860|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20490861|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20490862|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
20490863|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20490864|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
20490865|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490866|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699883|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699884|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19699885|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
19699886|NCT04898920|Hormones|hormones|mesh-ancestor
19699887|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699888|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19699889|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699890|NCT04898946|Vaccines|vaccines|mesh-list
19699891|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
20490867|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490868|NCT01600430|Vitamin D|vitamin d|mesh-list
20490869|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
20490870|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
20490871|NCT01600430|Vitamins|vitamins|mesh-list
20490872|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
20490873|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490874|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20490875|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20490876|NCT01600456|Sertraline|sertraline|mesh-list
20490877|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
20490878|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20490879|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20490880|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20490881|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20490882|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490883|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490884|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
20490885|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490886|NCT01600573|Topotecan|topotecan|mesh-list
20490887|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19699892|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490888|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20490889|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490890|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490891|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490892|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
20490893|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20490894|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20490895|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490896|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
20490897|NCT01600599|Coagulants|coagulants|mesh-ancestor
20242073|NCT00410540|Morphine|morphine|mesh-list
20242074|NCT00410540|Hydromorphone|hydromorphone|mesh-list
20242075|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20490898|NCT01600612|Oxytocin|oxytocin|mesh-list
20490899|NCT01600612|Carbetocin|carbetocin|mesh-list
20490900|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
20490901|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490902|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490903|NCT01600625|Minocycline|minocycline|mesh-list
20490904|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490905|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490906|NCT01600742|Vorinostat|vorinostat|mesh-list
20490907|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490908|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20490909|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490910|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490911|NCT01600768|Lactams|lactams|mesh-list
20490912|NCT01600768|beta-Lactams|beta-lactams|mesh-list
19414600|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
20242076|NCT00410540|Narcotics|narcotics|mesh-ancestor
20242077|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242078|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242079|NCT00410540|Analgesics|analgesics|mesh-ancestor
20242080|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
20242081|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242082|NCT00410553|Gemcitabine|gemcitabine|mesh-list
20242083|NCT00410553|Halichondrin B|halichondrin b|mesh-list
20242084|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242085|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
20247987|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20490913|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490914|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490915|NCT01600807|Gemcitabine|gemcitabine|mesh-list
20490916|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20490917|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20490918|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
20490919|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490920|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490921|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
20490922|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490923|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490924|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20490925|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
20490926|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490927|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20490928|NCT01600963|Bedaquiline|bedaquiline|mesh-list
20490929|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
20490930|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
20490931|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490932|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490933|NCT01601002|Mirtazapine|mirtazapine|mesh-list
20490934|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
20490935|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20490936|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20490937|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
20490938|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
20490939|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20490940|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490941|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490942|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20490943|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20490944|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490945|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20490946|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20490947|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20490948|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
20490949|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20490950|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20490951|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
20490952|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20490953|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
20490954|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
20490955|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20490956|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19699893|NCT04899050|Cannabidiol|cannabidiol|mesh-list
20490957|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490958|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490959|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490960|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20490961|NCT01601093|Sulbactam|sulbactam|mesh-list
20490962|NCT01601093|Cefoperazone|cefoperazone|mesh-list
20490963|NCT01601093|Sulperazone|sulperazone|mesh-list
20490964|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20490965|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20490966|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20490967|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20490968|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490969|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20490970|NCT01601093|Renal Agents|renal agents|mesh-ancestor
20490971|NCT01601106|Prednisolone|prednisolone|mesh-list
20490972|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20490973|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
20490974|NCT01601106|Hormones|hormones|mesh-ancestor
20490975|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20490976|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699894|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
19699895|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
19699896|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20490977|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20490978|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699897|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699898|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
20490979|NCT01601184|Temozolomide|temozolomide|mesh-list
20490980|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20490981|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
20490982|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490983|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20490984|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
20490985|NCT01601314|Analgesics|analgesics|mesh-ancestor
20490986|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
20490987|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20490988|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20490989|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
20490990|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20490991|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20490992|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
20490993|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20490994|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20490995|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20490996|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20490997|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
20490998|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20490999|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
20491000|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20491001|NCT01601327|Testosterone|testosterone|mesh-list
20491002|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
20491003|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
20491004|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20491005|NCT01601327|Androgens|androgens|mesh-ancestor
20491006|NCT01601327|Hormones|hormones|mesh-ancestor
20491007|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491008|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491009|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20491010|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491011|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
20491012|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20491013|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
20491014|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
20491015|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20491016|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20491017|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491018|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20491019|NCT01601509|Tramazoline|tramazoline|mesh-list
20491020|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
20491021|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
20491022|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491023|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491024|NCT01601561|Insulin|insulin|mesh-list
20491025|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20491026|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20491027|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491028|NCT01601730|Dexetimide|dexetimide|mesh-list
19414601|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414602|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491029|NCT01601730|Modafinil|modafinil|mesh-list
20491030|NCT01601730|Citalopram|citalopram|mesh-list
20491031|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20491032|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20491033|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20491034|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491035|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491036|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
20491037|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491038|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20491039|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
20491040|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491041|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20491042|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20491043|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
20491044|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
20491045|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491046|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20491047|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20491048|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
19852920|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19852921|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19852922|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20491049|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20491050|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19414603|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414604|NCT03472885|Eculizumab|eculizumab|mesh-list
19414605|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19414606|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414607|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
19414608|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414609|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
19414610|NCT03471767|Bupropion|bupropion|mesh-list
19414611|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19414612|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
19414613|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19414614|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19414615|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19852923|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20491051|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20491052|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20491053|NCT01601795|Sevoflurane|sevoflurane|mesh-list
20491054|NCT01601795|Isoflurane|isoflurane|mesh-list
20491055|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20491056|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20491057|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
20491058|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
20491059|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491060|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491061|NCT01601899|Tenofovir|tenofovir|mesh-list
20491062|NCT01601899|Lamivudine|lamivudine|mesh-list
20491063|NCT01601899|Efavirenz|efavirenz|mesh-list
20491064|NCT01601899|Stavudine|stavudine|mesh-list
20491065|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
20491066|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491067|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20491068|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20491069|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491070|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491071|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20491072|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20491073|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20491074|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20491075|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20491076|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20491077|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20491078|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20491079|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
20491080|NCT01601912|Dexetimide|dexetimide|mesh-list
20491081|NCT01601912|Citalopram|citalopram|mesh-list
20491082|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20491083|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20491084|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20491085|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20491086|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491087|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491088|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
20491089|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491090|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20491091|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
20491092|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491093|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20491094|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20491095|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
20491096|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
20491097|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491098|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20491099|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20491100|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
20491101|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20491102|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
20491103|NCT01601938|Selenium|selenium|mesh-list
20491104|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
20491105|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491106|NCT01601938|Protective Agents|protective agents|mesh-ancestor
20491107|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242086|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242087|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242088|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
20242089|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242090|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242091|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242092|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
20242093|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242094|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
20242095|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
20242096|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
20242097|NCT00410592|Esomeprazole|esomeprazole|mesh-list
20242098|NCT00410592|Pantoprazole|pantoprazole|mesh-list
20242099|NCT00410592|Lansoprazole|lansoprazole|mesh-list
20242100|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
20242101|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20242102|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20242103|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20242104|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242105|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242106|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
20242107|NCT00410631|Melphalan|melphalan|mesh-list
20242108|NCT00410631|Ifosfamide|ifosfamide|mesh-list
20242109|NCT00410631|Dacarbazine|dacarbazine|mesh-list
20242110|NCT00410631|Carboplatin|carboplatin|mesh-list
20491108|NCT01601938|Trace Elements|trace elements|mesh-ancestor
20491109|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
20491110|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20491111|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20491112|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491113|NCT01602003|Incretins|incretins|mesh-ancestor
20491114|NCT01602003|Hormones|hormones|mesh-ancestor
20491115|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491116|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20491117|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
20491118|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491119|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491120|NCT01602029|Ondansetron|ondansetron|mesh-list
19699899|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
19699900|NCT04898751|Nivolumab|nivolumab|mesh-list
19699901|NCT04898751|Ipilimumab|ipilimumab|mesh-list
20491121|NCT01602029|Simvastatin|simvastatin|mesh-list
20491122|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20491123|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20491124|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
20491125|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491126|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19699902|NCT04898751|Durvalumab|durvalumab|mesh-list
19699903|NCT04898751|Avelumab|avelumab|mesh-list
20491127|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20491128|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491129|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
20491130|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
20491131|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491132|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491133|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491134|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
20491135|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
20491136|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20491137|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
20491138|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491139|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20491140|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20491141|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491142|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491143|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20491144|NCT01602055|Azithromycin|azithromycin|mesh-list
19852924|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
19852925|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20491145|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20491146|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491147|NCT01602185|Memantine|memantine|mesh-list
20491148|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
19852926|NCT00728910|Niacin|niacin|mesh-list
19852927|NCT00728910|Atorvastatin|atorvastatin|mesh-list
20491149|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
20491150|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20491151|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20491152|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
20491153|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491154|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491155|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491156|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20491157|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20491158|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
20491159|NCT01602250|Ropivacaine|ropivacaine|mesh-list
20491160|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
20491161|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20491162|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
20491163|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
20491164|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491165|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491166|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
20491167|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491168|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20491169|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20491170|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19414616|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20491171|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20491172|NCT01602289|Gefitinib|gefitinib|mesh-list
20491173|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491174|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20491175|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491176|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491177|NCT01602302|Adalimumab|adalimumab|mesh-list
20491178|NCT01602302|Etanercept|etanercept|mesh-list
20491179|NCT01602302|Golimumab|golimumab|mesh-list
20491180|NCT01602302|Abatacept|abatacept|mesh-list
20491181|NCT01602302|Infliximab|infliximab|mesh-list
20491182|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
20491183|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491184|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491185|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
20491186|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491187|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20491188|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20491189|NCT01602302|Analgesics|analgesics|mesh-ancestor
20491190|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
20491191|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491192|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491193|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414617|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491194|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
20491195|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19699904|NCT04898751|Cemiplimab|cemiplimab|mesh-list
19699905|NCT04898751|Atezolizumab|atezolizumab|mesh-list
19699906|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20491196|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491197|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491198|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20491199|NCT01602406|Trastuzumab|trastuzumab|mesh-list
20491200|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20491201|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491202|NCT01602523|Budesonide|budesonide|mesh-list
20491203|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
19699907|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19699908|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699909|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699910|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
20491204|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491205|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20491206|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
20491207|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699911|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19699912|NCT04898907|Mitogens|mitogens|mesh-list
19699913|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19699914|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699915|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19699916|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19852928|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19852929|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19852930|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
19852931|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852932|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19852933|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20242111|NCT00410631|Doxorubicin|doxorubicin|mesh-list
20242112|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20491208|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491209|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20491210|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
20491211|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
20491212|NCT01602523|Hormones|hormones|mesh-ancestor
20491213|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491214|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20491215|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20242113|NCT00410631|Etoposide|etoposide|mesh-list
20242114|NCT00410631|Vincristine|vincristine|mesh-list
20242115|NCT00410631|Topotecan|topotecan|mesh-list
20242116|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
20242117|NCT00410631|Vindesine|vindesine|mesh-list
20242118|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20242119|NCT00410631|Isotretinoin|isotretinoin|mesh-list
20242120|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242121|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
20491216|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19414618|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
19414619|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242122|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491217|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
20491218|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491219|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491220|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
20491221|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
20491222|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20491223|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20491224|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491225|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242123|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242124|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20242125|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
20242126|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242127|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242128|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19699917|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699918|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699919|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699920|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19699921|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
19699922|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19699923|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699924|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20242129|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20242130|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20242131|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20242132|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242133|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20242134|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
20242135|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
19699925|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19699926|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20242136|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
20491226|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699927|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
19699928|NCT04898699|Tenofovir|tenofovir|mesh-list
19699929|NCT04898699|Emtricitabine|emtricitabine|mesh-list
19699930|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19699931|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
19699932|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699933|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20242137|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20242138|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
20242139|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20242140|NCT00410644|Hydromorphone|hydromorphone|mesh-list
20242141|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20491227|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491228|NCT01602640|Fentanyl|fentanyl|mesh-list
20491229|NCT01602640|Midazolam|midazolam|mesh-list
20242142|NCT00410644|Narcotics|narcotics|mesh-ancestor
20242143|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242144|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491230|NCT01602640|Morphine|morphine|mesh-list
19699934|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19699935|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699936|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699937|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19699938|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19699939|NCT04898725|Vitamin D|vitamin d|mesh-list
20491231|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242145|NCT00410644|Analgesics|analgesics|mesh-ancestor
20491232|NCT01602640|Narcotics|narcotics|mesh-ancestor
20491233|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491234|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491235|NCT01602640|Analgesics|analgesics|mesh-ancestor
20491236|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
20491237|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491238|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20491239|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20491240|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
20491241|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
20491242|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20491243|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20491244|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20491245|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491246|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
20491247|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
20491248|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491249|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491250|NCT01602757|Lidocaine|lidocaine|mesh-list
20491251|NCT01602757|Tetracaine|tetracaine|mesh-list
20491252|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
20491253|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
20491254|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491255|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491256|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
20491257|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491258|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20491259|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20491260|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20491261|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20491262|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491263|NCT01602822|Ritonavir|ritonavir|mesh-list
20491264|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20491265|NCT01602822|Tenofovir|tenofovir|mesh-list
20491266|NCT01602822|Emtricitabine|emtricitabine|mesh-list
20491267|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20491268|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20491269|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20491270|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
20491271|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491272|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491273|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20491274|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20491275|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
20491276|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491277|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20491278|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20491279|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20491280|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20491281|NCT01602861|Spironolactone|spironolactone|mesh-list
20491282|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20491283|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
20491284|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491285|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491286|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20491287|NCT01602861|Diuretics|diuretics|mesh-ancestor
20491288|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
20491289|NCT01602874|Metronidazole|metronidazole|mesh-list
20491290|NCT01602874|Clarithromycin|clarithromycin|mesh-list
20491291|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
20491292|NCT01602874|Tigecycline|tigecycline|mesh-list
20491293|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699940|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
20491294|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20491295|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20491296|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20491297|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20491298|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491299|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491300|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20491301|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20491302|NCT01602887|Palbociclib|palbociclib|mesh-list
19414620|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414621|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20491303|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414622|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19414623|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414624|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
19414625|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
19414626|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19414627|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19852934|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852935|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
19852936|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
19852937|NCT00728910|Vitamins|vitamins|mesh-ancestor
20491304|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20491305|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491306|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491307|NCT01602900|Rolipram|rolipram|mesh-list
20491308|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
20491309|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491310|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20491311|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20491312|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491313|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491314|NCT01602913|Paroxetine|paroxetine|mesh-list
20491315|NCT01602913|Pravastatin|pravastatin|mesh-list
20491316|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20491317|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20491318|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20491319|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491320|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491321|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
20491322|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491323|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20491324|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
20491325|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491326|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20491327|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20491328|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491329|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20491330|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20491331|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
20491332|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20491333|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20491334|NCT01602939|Cladribine|cladribine|mesh-list
20491335|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491336|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20491337|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
20491338|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491339|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
20491340|NCT01603030|Prednisolone|prednisolone|mesh-list
20491341|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20491342|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
20491343|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20491344|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
20491345|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20491346|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20491347|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
20491348|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491349|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
20491350|NCT01603030|Hormones|hormones|mesh-ancestor
20491351|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491352|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491353|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20491354|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491355|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
20491356|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
20491357|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491358|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491359|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20491360|NCT01603030|Protective Agents|protective agents|mesh-ancestor
20491361|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20491362|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491363|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20491364|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491365|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491366|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491367|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20491368|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
20491369|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20491370|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20491371|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20491372|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20491373|NCT01603108|Rifaximin|rifaximin|mesh-list
20491374|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20491375|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491376|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491377|NCT01603134|Allopurinol|allopurinol|mesh-list
20491378|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
20491379|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491380|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491381|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
20491382|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491383|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20491384|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
20491385|NCT01603134|Protective Agents|protective agents|mesh-ancestor
19699941|NCT04898725|Vitamins|vitamins|mesh-ancestor
19414628|NCT03460756|Ganaxolone|ganaxolone|mesh-list
19699942|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
20491386|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491387|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20491388|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
20491389|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491390|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20491391|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20491392|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491393|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491394|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20491395|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
20491396|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491397|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20491398|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20491399|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491400|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491401|NCT01603212|Interferons|interferons|mesh-list
20491402|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
20491403|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
20491404|NCT01603212|Aldesleukin|aldesleukin|mesh-list
19852938|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
20491405|NCT01603212|Interleukin-2|interleukin-2|mesh-list
20491406|NCT01603212|Vemurafenib|vemurafenib|mesh-list
20491407|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491408|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
20491409|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491410|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
20491411|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491412|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20491413|NCT01603212|Analgesics|analgesics|mesh-ancestor
20491414|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
20491415|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491416|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20491417|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20491418|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20491419|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491420|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491421|NCT01603251|Ivermectin|ivermectin|mesh-list
20491422|NCT01603251|Lumefantrine|lumefantrine|mesh-list
20491423|NCT01603251|Artemether|artemether|mesh-list
20491424|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20491425|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20491426|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491427|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
20491428|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20491429|NCT01603264|Trastuzumab|trastuzumab|mesh-list
20491430|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20491431|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491432|NCT01603342|Clopidogrel|clopidogrel|mesh-list
20491433|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20491434|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20491435|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19699943|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491436|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20491437|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
20491438|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491439|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491440|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491441|NCT01603498|Dexamethasone|dexamethasone|mesh-list
20491442|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
20491443|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20242146|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
20491444|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20491445|NCT01603498|Prednisolone|prednisolone|mesh-list
20491446|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
20491447|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20491448|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
20491449|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491450|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
20491451|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
20491452|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491453|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242147|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242148|NCT00410657|Prednisone|prednisone|mesh-list
20242149|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
20242150|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20242151|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20242152|NCT00410657|Prednisolone|prednisolone|mesh-list
20491454|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491455|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
20491456|NCT01603498|Hormones|hormones|mesh-ancestor
20491457|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19699944|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20242153|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
20491458|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20491459|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491460|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20491461|NCT01603498|Protective Agents|protective agents|mesh-ancestor
20491462|NCT01603511|Charcoal|charcoal|mesh-list
20491463|NCT01603511|Antidotes|antidotes|mesh-ancestor
20491464|NCT01603511|Protective Agents|protective agents|mesh-ancestor
20491465|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528595|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528596|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
20528597|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528598|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528599|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20528600|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
20528601|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528602|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528603|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20528604|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20528605|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20528606|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491466|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
20491467|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
20491468|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
20491469|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491470|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
20491471|NCT01603654|Protective Agents|protective agents|mesh-ancestor
20491472|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414629|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
19414630|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491473|NCT01603654|Vitamins|vitamins|mesh-ancestor
20491474|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
20491475|NCT01603654|Cathartics|cathartics|mesh-ancestor
20491476|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491477|NCT01603680|Anesthetics|anesthetics|mesh-list
20491478|NCT01603680|Mepivacaine|mepivacaine|mesh-list
20491479|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
20491480|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491481|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491482|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
20491483|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491484|NCT01603693|Calcium|calcium|mesh-list
20491485|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20491486|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491487|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20491488|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20491489|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491490|NCT01603758|Ezetimibe|ezetimibe|mesh-list
20491491|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20491492|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20491493|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
20491494|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491495|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20491496|NCT01604031|Lenalidomide|lenalidomide|mesh-list
20491497|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
20491498|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708010|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242154|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
20242155|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20242156|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
20242157|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242158|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
20242159|NCT00410657|Hormones|hormones|mesh-ancestor
20242160|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242161|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242162|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20242163|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528607|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491499|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20491500|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20491501|NCT01604031|Growth Substances|growth substances|mesh-ancestor
20491502|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
20491503|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491504|NCT01604057|Teriparatide|teriparatide|mesh-list
20491505|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20491506|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491507|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20491508|NCT01604135|Riboflavin|riboflavin|mesh-list
20491509|NCT01604135|Dextrans|dextrans|mesh-list
20491510|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
20491511|NCT01604135|Vitamins|vitamins|mesh-ancestor
20491512|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
20491513|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491514|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20491515|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
20491516|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
20491517|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
20491518|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
20491519|NCT01604187|Fentanyl|fentanyl|mesh-list
20491520|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20491521|NCT01604187|Narcotics|narcotics|mesh-ancestor
20491522|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491523|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491524|NCT01604187|Analgesics|analgesics|mesh-ancestor
20491525|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
20491526|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491527|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20491528|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20491529|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
20491530|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
20491531|NCT01604213|Metformin|metformin|mesh-list
20491532|NCT01604213|Vildagliptin|vildagliptin|mesh-list
20491533|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20491534|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491535|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20491536|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
20491537|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491538|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491539|NCT01604330|Baclofen|baclofen|mesh-list
20491540|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20491541|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491542|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20491543|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242164|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
20242165|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
20242166|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242167|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20242168|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20242169|NCT00410657|Protective Agents|protective agents|mesh-ancestor
20242170|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20242171|NCT00410696|Lenograstim|lenograstim|mesh-list
20242172|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20242173|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
20242174|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491544|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20491545|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
20491546|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
20491547|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491548|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491549|NCT01604382|Remifentanil|remifentanil|mesh-list
20491550|NCT01604382|Bupivacaine|bupivacaine|mesh-list
20491551|NCT01604382|Anesthetics|anesthetics|mesh-list
20491552|NCT01604382|Propofol|propofol|mesh-list
20491553|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
20491554|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242175|NCT00410735|Pranlukast|pranlukast|mesh-list
20242176|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20242177|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
20242178|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20242179|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
20242180|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708513|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20242181|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491555|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491556|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
20491557|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491558|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20491559|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20491560|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
20242182|NCT00410748|Hydromorphone|hydromorphone|mesh-list
20242183|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242184|NCT00410748|Narcotics|narcotics|mesh-ancestor
20242185|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242186|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491561|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20491562|NCT01604382|Narcotics|narcotics|mesh-ancestor
19699945|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19699946|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
19699947|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19699948|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19699949|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699950|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
20242187|NCT00410748|Analgesics|analgesics|mesh-ancestor
20491563|NCT01604382|Analgesics|analgesics|mesh-ancestor
20491564|NCT01604629|Adalimumab|adalimumab|mesh-list
20491565|NCT01604629|Etanercept|etanercept|mesh-list
20491566|NCT01604629|Golimumab|golimumab|mesh-list
20491567|NCT01604629|Infliximab|infliximab|mesh-list
20491568|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20491569|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242188|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
20242189|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242190|NCT00410774|Gemcitabine|gemcitabine|mesh-list
20242191|NCT00410774|Bevacizumab|bevacizumab|mesh-list
20242192|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20242193|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242194|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20242195|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20491570|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491571|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
20491572|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491573|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20491574|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20491575|NCT01604629|Analgesics|analgesics|mesh-ancestor
20491576|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
20491577|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491578|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491579|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20491580|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
20491581|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20491582|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
20491583|NCT01604811|Tamsulosin|tamsulosin|mesh-list
20491584|NCT01604811|Urological Agents|urological agents|mesh-ancestor
20491585|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20491586|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20491587|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20491588|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
20491589|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491590|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491591|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491592|NCT01604863|Paclitaxel|paclitaxel|mesh-list
20491593|NCT01604863|Etoposide|etoposide|mesh-list
20491594|NCT01604863|Docetaxel|docetaxel|mesh-list
20491595|NCT01604863|Carboplatin|carboplatin|mesh-list
20491596|NCT01604863|Immunoglobulin G|immunoglobulin g|mesh-list
20491597|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20491598|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699951|NCT04898712|Coagulants|coagulants|mesh-ancestor
19699952|NCT04898387|Timolol|timolol|mesh-list
19699953|NCT04898387|Bimatoprost|bimatoprost|mesh-list
19699954|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19699955|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19699956|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
19699957|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19699958|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699959|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491599|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
20491600|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
20491601|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
19414631|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699960|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20491602|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491603|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20491604|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491605|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491606|NCT01604863|Immunologic Factors|immunologic factors|mesh-ancestor
19699961|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19699962|NCT04898374|Gemcitabine|gemcitabine|mesh-list
19699963|NCT04898374|Cisplatin|cisplatin|mesh-list
20491607|NCT01604863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491608|NCT01604928|Mirabegron|mirabegron|mesh-list
20491609|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20491610|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20491611|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20491612|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20491613|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
20491614|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491615|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491616|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491617|NCT01604928|Urological Agents|urological agents|mesh-ancestor
20491618|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20491619|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20491620|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
20491621|NCT01605084|Ritonavir|ritonavir|mesh-list
20491622|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20491623|NCT01605084|Darunavir|darunavir|mesh-list
20491624|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20491625|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20491626|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
20491627|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491628|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491629|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20491630|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20491631|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
20491632|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491633|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20491634|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20491635|NCT01605240|Acetaminophen|acetaminophen|mesh-list
20491636|NCT01605240|Ibuprofen|ibuprofen|mesh-list
20491637|NCT01605240|Codeine|codeine|mesh-list
20491638|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20491639|NCT01605240|Analgesics|analgesics|mesh-ancestor
20491640|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
20491641|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491642|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491643|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
20491644|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20491645|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491646|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491647|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20491648|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491649|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491650|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20491651|NCT01605240|Narcotics|narcotics|mesh-ancestor
20491652|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491653|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
20491654|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
20491655|NCT01605253|Eszopiclone|eszopiclone|mesh-list
20491656|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20491657|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491658|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491659|NCT01605279|Dobutamine|dobutamine|mesh-list
20491660|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20491661|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
20491662|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
20491663|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491664|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491665|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20491666|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20491667|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20491668|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
20242196|NCT00410774|Growth Substances|growth substances|mesh-ancestor
20242197|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242198|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
20242199|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242200|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
20491669|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491670|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491671|NCT01605279|Protective Agents|protective agents|mesh-ancestor
20491672|NCT01605318|Irinotecan|irinotecan|mesh-list
20491673|NCT01605318|Labetuzumab|labetuzumab|mesh-list
20491674|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
20491675|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
20491676|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699964|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242201|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242202|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
20242203|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242204|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242205|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242206|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
20242207|NCT00410787|Hydromorphone|hydromorphone|mesh-list
20242208|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242209|NCT00410787|Narcotics|narcotics|mesh-ancestor
20242210|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242211|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242212|NCT00410787|Analgesics|analgesics|mesh-ancestor
20242213|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
20242214|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491677|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20491678|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491679|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491680|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491681|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491682|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20491683|NCT01605344|Leucovorin|leucovorin|mesh-list
20491684|NCT01605344|Fluorouracil|fluorouracil|mesh-list
20491685|NCT01605344|Irinotecan|irinotecan|mesh-list
20491686|NCT01605344|Atorvastatin|atorvastatin|mesh-list
20491687|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
20491688|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491689|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242215|NCT00410852|Insulin|insulin|mesh-list
20242216|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20491690|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491691|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20491692|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
20491693|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491694|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20491695|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491696|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491697|NCT01605344|Antidotes|antidotes|mesh-ancestor
20491698|NCT01605344|Protective Agents|protective agents|mesh-ancestor
19414632|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414633|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
19414634|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
19414635|NCT03455504|Venetoclax|venetoclax|mesh-list
19414636|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414637|NCT03448081|Calcipotriene|calcipotriene|mesh-list
19414638|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414639|NCT03446807|Droxidopa|droxidopa|mesh-list
20242217|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20242218|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242219|NCT00410878|Hydromorphone|hydromorphone|mesh-list
20242220|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242221|NCT00410878|Narcotics|narcotics|mesh-ancestor
20242222|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242223|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242224|NCT00410878|Analgesics|analgesics|mesh-ancestor
20242225|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
20242226|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491699|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
20491700|NCT01605344|Vitamins|vitamins|mesh-ancestor
20491701|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
20491702|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20491703|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20491704|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20491705|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20491706|NCT01605357|Mannitol|mannitol|mesh-list
20491707|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20491708|NCT01605357|Diuretics|diuretics|mesh-ancestor
20491709|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
20491710|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491711|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
20491712|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
20491713|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
20491714|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491715|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20491716|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
20491717|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
20491718|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491719|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414640|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19414641|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20242227|NCT00410943|Hydromorphone|hydromorphone|mesh-list
20491720|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491721|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20491722|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
20491723|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20491724|NCT01605513|Interferons|interferons|mesh-list
20491725|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491726|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
20491727|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491728|NCT01605526|Doxorubicin|doxorubicin|mesh-list
20491729|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20491730|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491731|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20491732|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491733|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491734|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491735|NCT01605721|Everolimus|everolimus|mesh-list
20491736|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491737|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20491738|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
20491739|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491740|NCT01605734|Sorafenib|sorafenib|mesh-list
20491741|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
20242228|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242229|NCT00410943|Narcotics|narcotics|mesh-ancestor
20242230|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242231|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242232|NCT00410943|Analgesics|analgesics|mesh-ancestor
20242233|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
20242234|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242235|NCT00410956|Dexamethasone|dexamethasone|mesh-list
20242236|NCT00410956|Bevacizumab|bevacizumab|mesh-list
20242237|NCT00410956|Floxuridine|floxuridine|mesh-list
20491742|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491743|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20491744|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491745|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491746|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20491747|NCT01605734|Estrogens|estrogens|mesh-ancestor
20491748|NCT01605734|Hormones|hormones|mesh-ancestor
20491749|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491750|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491751|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20491752|NCT01605773|Glyburide|glyburide|mesh-list
20491753|NCT01605773|Repaglinide|repaglinide|mesh-list
20491754|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20491755|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491756|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20491757|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20491758|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491759|NCT01605929|Mepivacaine|mepivacaine|mesh-list
20491760|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
20491761|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
20491762|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491763|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491764|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
20491765|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491766|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20491767|NCT01605968|Laxatives|laxatives|mesh-ancestor
20491768|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491769|NCT01605994|Antacids|antacids|mesh-list
20491770|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491771|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491772|NCT01606046|Anesthetics|anesthetics|mesh-list
20491773|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
20491774|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20491775|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
20491776|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491777|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491778|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
20491779|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491780|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20491781|NCT01606059|Acetaminophen|acetaminophen|mesh-list
20491782|NCT01606059|Tramadol|tramadol|mesh-list
20491783|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20491784|NCT01606059|Analgesics|analgesics|mesh-ancestor
20491785|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
20491786|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491787|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491788|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
20491789|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20491790|NCT01606059|Narcotics|narcotics|mesh-ancestor
20491791|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491792|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20491793|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
20491794|NCT01606072|Coagulants|coagulants|mesh-ancestor
20491795|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20491796|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
20491797|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491798|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
20491799|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20491800|NCT01606111|Protective Agents|protective agents|mesh-ancestor
20491801|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491802|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
20491803|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
20491804|NCT01606241|Vaccines|vaccines|mesh-list
20491805|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
20491806|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491807|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20491808|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491809|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20491810|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
20491811|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491812|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491813|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20491814|NCT01606345|Valrubicin|valrubicin|mesh-list
20491815|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491816|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20491817|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491818|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491819|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491820|NCT01606358|Carboplatin|carboplatin|mesh-list
20491821|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491822|NCT01606384|Vasopressins|vasopressins|mesh-list
20491823|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
20491824|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
20491825|NCT01606384|Coagulants|coagulants|mesh-ancestor
20491826|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20491827|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20491828|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
20491829|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491830|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
20491831|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20491832|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242238|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20242239|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491833|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20491834|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491835|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491836|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491837|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491838|NCT01606462|Oxytocin|oxytocin|mesh-list
20491839|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
20491840|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20242240|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20242241|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20242242|NCT00410956|Growth Substances|growth substances|mesh-ancestor
20242243|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242244|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
20242245|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242246|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
20242247|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
20242248|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242249|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20242250|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
20242251|NCT00410956|Hormones|hormones|mesh-ancestor
20242252|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491841|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491842|NCT01606527|Ibuprofen|ibuprofen|mesh-list
20491843|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20491844|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20491845|NCT01606527|Analgesics|analgesics|mesh-ancestor
20491846|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
20491847|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491848|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491849|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491850|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491851|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20491852|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491853|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491854|NCT01606540|Ibuprofen|ibuprofen|mesh-list
20491855|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20491856|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20491857|NCT01606540|Analgesics|analgesics|mesh-ancestor
20491858|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
20491859|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491860|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491861|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491862|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491863|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20491864|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491865|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491866|NCT01606722|Ritonavir|ritonavir|mesh-list
20491867|NCT01606722|Darunavir|darunavir|mesh-list
20491868|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20491869|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20491870|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
20491871|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491872|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491873|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20491874|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20491875|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
20491876|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491877|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20491878|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20491879|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
20491880|NCT01606878|Doxorubicin|doxorubicin|mesh-list
20491881|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20491882|NCT01606878|Vincristine|vincristine|mesh-list
20491883|NCT01606878|Topotecan|topotecan|mesh-list
20491884|NCT01606878|Crizotinib|crizotinib|mesh-list
20491885|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
20491886|NCT01606878|Razoxane|razoxane|mesh-list
20491887|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20491888|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
20491889|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491890|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20491891|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20491892|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
20491893|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491894|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491895|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20491896|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20491897|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20491898|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20491899|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242253|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20242254|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242255|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
20242256|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242257|NCT00410982|Gemcitabine|gemcitabine|mesh-list
20242258|NCT00410982|Rituximab|rituximab|mesh-list
20242259|NCT00410982|Melphalan|melphalan|mesh-list
20242260|NCT00410982|Busulfan|busulfan|mesh-list
20491900|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20491901|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
20491902|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
20491903|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
20491904|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20491905|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20491906|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20491907|NCT01606878|Protective Agents|protective agents|mesh-ancestor
20491908|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20491909|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
20491910|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20491911|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
20491912|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19699965|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699966|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
19699967|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491913|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
20491914|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20491915|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491916|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
20528608|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528609|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
20528610|NCT01775475|Hormones|hormones|mesh-ancestor
20528611|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528612|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20528613|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20528614|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
20528615|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
19699968|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
20528616|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
20528617|NCT01775540|Dexamethasone|dexamethasone|mesh-list
20528618|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
20528619|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528620|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
20528621|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
19699969|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19699970|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528622|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20491917|NCT01607034|Pramipexole|pramipexole|mesh-list
20491918|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
20242261|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20242262|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491919|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491920|NCT01607034|Protective Agents|protective agents|mesh-ancestor
20491921|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242263|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
20242264|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242265|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242266|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242267|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
20242268|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242269|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
20242270|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20491922|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20491923|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20491924|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
20491925|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
20491926|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491927|NCT01607086|Lamotrigine|lamotrigine|mesh-list
20491928|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
20491929|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19699971|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19699972|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
19699973|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699974|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
19699975|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699976|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19699977|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19699978|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
19699979|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699980|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
19699981|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
19699982|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699983|NCT04898023|Protective Agents|protective agents|mesh-ancestor
20491930|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20491931|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491932|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20491933|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491934|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20491935|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20491936|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491937|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20242271|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19699984|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699985|NCT04898023|Vitamins|vitamins|mesh-ancestor
20491938|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20242272|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242273|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20242274|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
20242275|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20242276|NCT00410995|Naproxen|naproxen|mesh-list
20242277|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20491939|NCT01607125|Vortioxetine|vortioxetine|mesh-list
20491940|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
20491941|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20491942|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20491943|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20491944|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19852939|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852940|NCT00728949|Tamoxifen|tamoxifen|mesh-list
19852941|NCT00728949|Letrozole|letrozole|mesh-list
19852942|NCT00728949|Fulvestrant|fulvestrant|mesh-list
19852943|NCT00728949|Anastrozole|anastrozole|mesh-list
20242278|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20242279|NCT00410995|Analgesics|analgesics|mesh-ancestor
20242280|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
20242281|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242282|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242283|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242284|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242285|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
20242286|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20242287|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242288|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242289|NCT00411034|Hydromorphone|hydromorphone|mesh-list
20242290|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20491945|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491946|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20491947|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20491948|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20242291|NCT00411034|Narcotics|narcotics|mesh-ancestor
20242292|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242293|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852944|NCT00728949|Exemestane|exemestane|mesh-list
19852945|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20491949|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491950|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491951|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
20491952|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20491953|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20491954|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20491955|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20491956|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20491957|NCT01607333|Lamotrigine|lamotrigine|mesh-list
20491958|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
20491959|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20491960|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20491961|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491962|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20491963|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491964|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20491965|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20491966|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20491967|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19699986|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
19699987|NCT04898504|Floxuridine|floxuridine|mesh-list
19699988|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19699989|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
19699990|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19699991|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19699992|NCT04898075|Nicotine|nicotine|mesh-list
19699993|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19699994|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
19699995|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19699996|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19699997|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19699998|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19699999|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
19700000|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700001|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242294|NCT00411034|Analgesics|analgesics|mesh-ancestor
20242295|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
20242296|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242297|NCT00411047|Gefitinib|gefitinib|mesh-list
20242298|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242299|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20242300|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700002|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
19700003|NCT04898478|Narcotics|narcotics|mesh-ancestor
19700004|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700005|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700006|NCT04898478|Analgesics|analgesics|mesh-ancestor
19700007|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
19700008|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700009|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
19700010|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
19700011|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852946|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852947|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19852948|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19852949|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852950|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852951|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19852952|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
20242301|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242302|NCT00411073|Darapladib|darapladib|mesh-list
19700012|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
20491968|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20491969|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
20491970|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20491971|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20491972|NCT01607580|Prednisolone|prednisolone|mesh-list
20491973|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
20491974|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20491975|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
20491976|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
20491977|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20491978|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
20491979|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
20491980|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700013|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20242303|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20242304|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242305|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242306|NCT00411125|Calcitonin|calcitonin|mesh-list
20242307|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
20242308|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20242309|NCT00411125|Katacalcin|katacalcin|mesh-list
20242310|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20242311|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242312|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20491981|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491982|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20491983|NCT01607580|Hormones|hormones|mesh-ancestor
20491984|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20491985|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20491986|NCT01607580|Protective Agents|protective agents|mesh-ancestor
20491987|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20491988|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20491989|NCT01607671|Timolol|timolol|mesh-list
20491990|NCT01607671|Maleic acid|maleic acid|mesh-list
20491991|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20491992|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20491993|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
20491994|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20491995|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20491996|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20491997|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20491998|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20491999|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492000|NCT01607762|Olanzapine|olanzapine|mesh-list
20492001|NCT01607762|Risperidone|risperidone|mesh-list
20492002|NCT01607762|Aripiprazole|aripiprazole|mesh-list
20492003|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20492004|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20492005|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20492006|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
20492007|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492008|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492009|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492010|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20492011|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20492012|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492013|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20492014|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20492015|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
20492016|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
20492017|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
20492018|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492019|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492020|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20492021|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20492022|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20492023|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
20492024|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
20492025|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20492026|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20492027|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20492028|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20492029|NCT01607879|Androgens|androgens|mesh-list
20492030|NCT01607879|Hormones|hormones|mesh-ancestor
20492031|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492032|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492033|NCT01607918|Amoxicillin|amoxicillin|mesh-list
20492034|NCT01607918|Metronidazole|metronidazole|mesh-list
20492035|NCT01607918|Clarithromycin|clarithromycin|mesh-list
20492036|NCT01607918|Lansoprazole|lansoprazole|mesh-list
20492037|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
20492038|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20492039|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492040|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20492041|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20492042|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20492043|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492044|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492045|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20492046|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20492047|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20492048|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492049|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20492050|NCT01607970|Oxytocin|oxytocin|mesh-list
20492051|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
20492052|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20492053|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492054|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
20492055|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20492056|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
20492057|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492058|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492059|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20492060|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
20492061|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20492062|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
20492063|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492064|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492065|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20492066|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
20492067|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
20492068|NCT01607983|Protective Agents|protective agents|mesh-ancestor
20492069|NCT01607996|Anesthetics|anesthetics|mesh-list
20492070|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492071|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492072|NCT01608009|Paclitaxel|paclitaxel|mesh-list
20492073|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20492074|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492075|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
20492076|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
20492077|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
20492078|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492079|NCT01608139|Curcumin|curcumin|mesh-list
20492080|NCT01608139|Sorafenib|sorafenib|mesh-list
20492081|NCT01608139|Vorinostat|vorinostat|mesh-list
20492082|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492083|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20492084|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492085|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492086|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20492087|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20492088|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20492089|NCT01608139|Analgesics|analgesics|mesh-ancestor
20242313|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
20242314|NCT00411164|Hydromorphone|hydromorphone|mesh-list
20242315|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242316|NCT00411164|Narcotics|narcotics|mesh-ancestor
20242317|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242318|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242319|NCT00411164|Analgesics|analgesics|mesh-ancestor
20242320|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
20242321|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242322|NCT00411190|Acetaminophen|acetaminophen|mesh-list
20242323|NCT00411190|Ibuprofen|ibuprofen|mesh-list
20492090|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
20492091|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492092|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492093|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20492094|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492095|NCT01608217|Acetaminophen|acetaminophen|mesh-list
20492096|NCT01608217|Dronabinol|dronabinol|mesh-list
20492097|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20492098|NCT01608217|Analgesics|analgesics|mesh-ancestor
20492099|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
20492100|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492101|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492102|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
20492103|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
20492104|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20492105|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20492106|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20492107|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492108|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492109|NCT01608217|Hormones|hormones|mesh-ancestor
20492110|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492111|NCT01608269|Lamivudine|lamivudine|mesh-list
20492112|NCT01608269|Abacavir|abacavir|mesh-list
20492113|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20492114|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20492115|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492116|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492117|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
20492118|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492119|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20492120|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20492121|NCT01608334|Fentanyl|fentanyl|mesh-list
19700014|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20492122|NCT01608334|Sufentanil|sufentanil|mesh-list
20492123|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20492124|NCT01608334|Narcotics|narcotics|mesh-ancestor
20492125|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492126|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492127|NCT01608334|Analgesics|analgesics|mesh-ancestor
20492128|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
20242324|NCT00411190|Atorvastatin|atorvastatin|mesh-list
20242325|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20242326|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20242327|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
20242328|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242329|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20492129|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492130|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20492131|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20492132|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
20492133|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
20492134|NCT01608347|Folic Acid|folic acid|mesh-list
20492135|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
20492136|NCT01608347|Hematinics|hematinics|mesh-ancestor
20492137|NCT01608347|Vitamins|vitamins|mesh-ancestor
20492138|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
20492139|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492140|NCT01608360|Lidocaine|lidocaine|mesh-list
20492141|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
20242330|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20242331|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242332|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20242333|NCT00411190|Analgesics|analgesics|mesh-ancestor
20492142|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
20492143|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492144|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492145|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
20492146|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492147|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20492148|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20492149|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20492150|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20492151|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492152|NCT01608373|Lidocaine|lidocaine|mesh-list
20492153|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
20492154|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
20492155|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492156|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492157|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
20242334|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
20492158|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492159|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20492160|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20492161|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20492162|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20492163|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492164|NCT01608412|Everolimus|everolimus|mesh-list
20492165|NCT01608412|Tacrolimus|tacrolimus|mesh-list
20492166|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492167|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
19700015|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242335|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242336|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242337|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
20242338|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20242339|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242340|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242341|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20242342|NCT00411203|Tamoxifen|tamoxifen|mesh-list
20492168|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492169|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20492170|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492171|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492172|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492173|NCT01608464|Cisplatin|cisplatin|mesh-list
20492174|NCT01608464|Docetaxel|docetaxel|mesh-list
20492175|NCT01608464|Fluorouracil|fluorouracil|mesh-list
20492176|NCT01608464|Irinotecan|irinotecan|mesh-list
20492177|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492178|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
20492179|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
20492180|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
20492181|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492182|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
20492183|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20492184|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492185|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
20492186|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492187|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20492188|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20492189|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700016|NCT04898114|Urological Agents|urological agents|mesh-ancestor
19700017|NCT04898114|Analgesics|analgesics|mesh-ancestor
20492190|NCT01608555|Tobramycin|tobramycin|mesh-list
20492191|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20492192|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700018|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
20492193|NCT01608594|Ipilimumab|ipilimumab|mesh-list
20492194|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20492195|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492196|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20492197|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492198|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
20492199|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492200|NCT01608698|Drospirenone|drospirenone|mesh-list
20492201|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20492202|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
20492203|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20492204|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19852953|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19852954|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852955|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19852956|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19852957|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20492205|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20492206|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
20492207|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20492208|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492209|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20492210|NCT01608698|Estrogens|estrogens|mesh-ancestor
20492211|NCT01608698|Hormones|hormones|mesh-ancestor
20492212|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492213|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20492214|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
20492215|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20492216|NCT01608698|Diuretics|diuretics|mesh-ancestor
20492217|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
20492218|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
20492219|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20492220|NCT01608711|Gemcitabine|gemcitabine|mesh-list
20492221|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20492222|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
20492223|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492224|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492225|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
20492226|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492227|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492228|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492229|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
20492230|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528623|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528624|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528625|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
20528626|NCT01775540|Hormones|hormones|mesh-ancestor
20528627|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528628|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20528629|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528630|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20528631|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20528632|NCT01775579|Metformin|metformin|mesh-list
20528633|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20528634|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20528635|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528636|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20528637|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20528638|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
20528639|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852958|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19852959|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19852960|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
19852961|NCT00728988|Atorvastatin|atorvastatin|mesh-list
20528640|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20492231|NCT01608750|Folic Acid|folic acid|mesh-list
20492232|NCT01608750|Hematinics|hematinics|mesh-ancestor
20492233|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
20492234|NCT01608750|Vitamins|vitamins|mesh-ancestor
20492235|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
20492236|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492237|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20492238|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492239|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20492240|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492241|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492242|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20492243|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492244|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
20492245|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
20492246|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
20492247|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20492248|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20492249|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20492250|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20492251|NCT01608958|Oxytocin|oxytocin|mesh-list
20492252|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
20492253|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20492254|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492255|NCT01608984|Sufentanil|sufentanil|mesh-list
20492256|NCT01608984|Isoflurane|isoflurane|mesh-list
20492257|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20492258|NCT01608984|Narcotics|narcotics|mesh-ancestor
20242343|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20242344|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
20242345|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242346|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242347|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20242348|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242349|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20242350|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20492259|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242351|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20242352|NCT00411229|Capecitabine|capecitabine|mesh-list
20242353|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
20242354|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242355|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
20242356|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242357|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242358|NCT00411268|Hydromorphone|hydromorphone|mesh-list
20242359|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20492260|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492261|NCT01608984|Analgesics|analgesics|mesh-ancestor
20492262|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
20242360|NCT00411268|Narcotics|narcotics|mesh-ancestor
20242361|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242362|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242363|NCT00411268|Analgesics|analgesics|mesh-ancestor
20242364|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
20242365|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242366|NCT00411281|Cytarabine|cytarabine|mesh-list
20492263|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492264|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20492265|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20492266|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
20492267|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
20492268|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20492269|NCT01609049|Ribavirin|ribavirin|mesh-list
20492270|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20492271|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
20492272|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492273|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
20492274|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492275|NCT01609088|Erythritol|erythritol|mesh-list
20492276|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
20492277|NCT01609101|Cobalt|cobalt|mesh-list
20492278|NCT01609101|Trace Elements|trace elements|mesh-ancestor
20492279|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
20492280|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492281|NCT01609127|Capecitabine|capecitabine|mesh-list
20492282|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242367|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242368|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
20492283|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
20492284|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492285|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492286|NCT01609153|Olanzapine|olanzapine|mesh-list
20492287|NCT01609153|Amisulpride|amisulpride|mesh-list
20492288|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
20492289|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
20492290|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492291|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492292|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492293|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20492294|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20492295|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492296|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20492297|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20492298|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20492299|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20492300|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492301|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492302|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
20492303|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20492304|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
20492305|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20492306|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
20492307|NCT01609166|Allopurinol|allopurinol|mesh-list
20492308|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
20492309|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492310|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492311|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
20492312|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492313|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20492314|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
20492315|NCT01609166|Protective Agents|protective agents|mesh-ancestor
20492316|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492317|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
20492318|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492319|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
20492320|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492321|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492322|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20242369|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242370|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242371|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
20242372|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242373|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242374|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
20242375|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242376|NCT00411307|Hydromorphone|hydromorphone|mesh-list
20242377|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20492323|NCT01609205|Adalimumab|adalimumab|mesh-list
20492324|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700019|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700020|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700021|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
19700022|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700023|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19700024|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
19700025|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19700026|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19708514|NCT04813913|Bevacizumab|bevacizumab|mesh-list
20242378|NCT00411307|Narcotics|narcotics|mesh-ancestor
20242379|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242380|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242381|NCT00411307|Analgesics|analgesics|mesh-ancestor
20242382|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
20242383|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492325|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492326|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20492327|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20492328|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492329|NCT01609387|Tocopherols|tocopherols|mesh-list
20492330|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
20492331|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492332|NCT01609387|Protective Agents|protective agents|mesh-ancestor
20492333|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492334|NCT01609387|Vitamins|vitamins|mesh-ancestor
20492335|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
20492336|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
20492337|NCT01609413|Antacids|antacids|mesh-ancestor
20492338|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492339|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492340|NCT01609439|Vitamin D|vitamin d|mesh-list
20492341|NCT01609439|Vitamins|vitamins|mesh-ancestor
20492342|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
20242384|NCT00411320|Dexamethasone|dexamethasone|mesh-list
20242385|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242386|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
20242387|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
20242388|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492343|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492344|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20492345|NCT01609491|Phenylephrine|phenylephrine|mesh-list
20492346|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
20492347|NCT01609491|Norepinephrine|norepinephrine|mesh-list
20492348|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20492349|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
20492350|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
20492351|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492352|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492353|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
20492354|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20492355|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
20492356|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
20492357|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20242389|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242390|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20242391|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
20242392|NCT00411320|Hormones|hormones|mesh-ancestor
20242393|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242394|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20242395|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492358|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20492359|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20492360|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
20492361|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492362|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492363|NCT01609491|Protective Agents|protective agents|mesh-ancestor
20492364|NCT01609517|Bupivacaine|bupivacaine|mesh-list
20492365|NCT01609517|Anesthetics|anesthetics|mesh-list
20492366|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
20492367|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492368|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492369|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
20492370|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492371|NCT01609647|Clopidogrel|clopidogrel|mesh-list
20492372|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20492373|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20492374|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20492375|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20492376|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20492377|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
20492378|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492379|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492380|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492381|NCT01609673|Everolimus|everolimus|mesh-list
20492382|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414651|NCT03430843|Paclitaxel|paclitaxel|mesh-list
19700027|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20492383|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492384|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
20492385|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492386|NCT01609816|Dasatinib|dasatinib|mesh-list
20492387|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492388|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20492389|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492390|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700028|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
19700029|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19700030|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
19700031|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20492391|NCT01609855|Scopolamine|scopolamine|mesh-list
20492392|NCT01609855|Bromides|bromides|mesh-list
20492393|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20242396|NCT00411333|Triamcinolone|triamcinolone|mesh-list
20242397|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20242398|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20242399|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20242400|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242401|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
20242402|NCT00411333|Hormones|hormones|mesh-ancestor
20242403|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242404|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242405|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242406|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
20242407|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242408|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242409|NCT00411372|Fluticasone|fluticasone|mesh-list
20242410|NCT00411372|Xhance|xhance|mesh-list
20242411|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20492394|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
20492395|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20492396|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
20492397|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
20492398|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492399|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492400|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492401|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
20492402|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20492403|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
20492404|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492405|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492406|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20492407|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
20492408|NCT01609881|Ketorolac|ketorolac|mesh-list
20492409|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20492410|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20492411|NCT01609881|Analgesics|analgesics|mesh-ancestor
20492412|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
20492413|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492414|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492415|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20492416|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492417|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20492418|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492419|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492420|NCT01609907|Valsartan|valsartan|mesh-list
20492421|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20492422|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20492423|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20492424|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
20492425|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492426|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20492427|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20492428|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492429|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20492430|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20492431|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20492432|NCT01609959|Valsartan|valsartan|mesh-list
20492433|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20492434|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20492435|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20492436|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20492437|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492438|NCT01609998|Vaccines|vaccines|mesh-list
20492439|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
20492440|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492441|NCT01610141|Warfarin|warfarin|mesh-list
20492442|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
20492443|NCT01610310|Interferon-beta|interferon-beta|mesh-list
20492444|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492445|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
20492446|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492447|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
20492448|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852962|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20492449|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
20492450|NCT01610362|Antibodies|antibodies|mesh-list
20492451|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
20242412|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20242413|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242414|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20242415|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
20242416|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242417|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242418|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20492452|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20492453|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20492454|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
20492455|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
20492456|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492457|NCT01610401|Metformin|metformin|mesh-list
20492458|NCT01610401|Caffeine|caffeine|mesh-list
20492459|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492460|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492461|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20492462|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20492463|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492464|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492465|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20492466|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19700032|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19414652|NCT03430843|Docetaxel|docetaxel|mesh-list
20242419|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
20242420|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
20242421|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20242422|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20242423|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20242424|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20492467|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
20492468|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528641|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20528642|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528643|NCT01775618|Factor VIII|factor viii|mesh-list
20528644|NCT01775618|Coagulants|coagulants|mesh-ancestor
20528645|NCT01775631|Rituximab|rituximab|mesh-list
20528646|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20528647|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528648|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
20528649|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528650|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530753|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414653|NCT03430843|Irinotecan|irinotecan|mesh-list
19414654|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19414655|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414656|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
19414657|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
20530754|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530755|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
20530756|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492469|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
20492470|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492471|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20492472|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20492473|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
20492474|NCT01610869|Nintedanib|nintedanib|mesh-list
20492475|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492476|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20492477|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492478|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492479|NCT01610921|Adenosine|adenosine|mesh-list
20242425|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
20242426|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242427|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242428|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
20242429|NCT00411372|Hormones|hormones|mesh-ancestor
20242430|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242431|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
20242432|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20242433|NCT00411437|Oxybutynin|oxybutynin|mesh-list
20242434|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20242435|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20242436|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
20242437|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242438|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242439|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242440|NCT00411437|Urological Agents|urological agents|mesh-ancestor
20242441|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
20242442|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
20242443|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242444|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
20242445|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20242446|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492480|NCT01610921|Analgesics|analgesics|mesh-ancestor
20492481|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
20492482|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492483|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492484|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20492485|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
20492486|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20492487|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
20492488|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
20492489|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492490|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492491|NCT01610934|Liraglutide|liraglutide|mesh-list
20492492|NCT01610934|Glimepiride|glimepiride|mesh-list
20492493|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492494|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492495|NCT01610934|Incretins|incretins|mesh-ancestor
20492496|NCT01610934|Hormones|hormones|mesh-ancestor
19414658|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
20528651|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
20492497|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492498|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20492499|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492500|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
20492501|NCT01610947|Adalimumab|adalimumab|mesh-list
20492502|NCT01610947|Etanercept|etanercept|mesh-list
20492503|NCT01610947|Golimumab|golimumab|mesh-list
20492504|NCT01610947|Infliximab|infliximab|mesh-list
20492505|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20492506|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414659|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700033|NCT04898231|Prednisolone|prednisolone|mesh-list
20492507|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492508|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
20492509|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492510|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20492511|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20492512|NCT01610947|Analgesics|analgesics|mesh-ancestor
20492513|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
20492514|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492515|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492516|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492517|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
20492518|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20492519|NCT01610999|Plerixafor|plerixafor|mesh-list
20492520|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20492521|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20492522|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
20492523|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492524|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
20492525|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20492526|NCT01611038|Protective Agents|protective agents|mesh-ancestor
20492527|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492528|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492529|NCT01611077|Amlodipine|amlodipine|mesh-list
20492530|NCT01611077|Candesartan|candesartan|mesh-list
20492531|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
20492532|NCT01611077|Olmesartan|olmesartan|mesh-list
20492533|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20492534|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20492535|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20492536|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20492537|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492538|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20492539|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492540|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
20492541|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20492542|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20492543|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
20492544|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492545|NCT01611311|BI 409306|bi 409306|mesh-list
20492546|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20492547|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492548|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492549|NCT01611324|Epinephrine|epinephrine|mesh-list
20492550|NCT01611324|Mepivacaine|mepivacaine|mesh-list
20492551|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20492552|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20492553|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
20492554|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492555|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492556|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492557|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20492558|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20492559|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
20492560|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492561|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20492562|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
20492563|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
20492564|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
20492565|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20492566|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
20492567|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
20492568|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492569|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
20492570|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
20492571|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20492572|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492573|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492574|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492575|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
20492576|NCT01611415|Furosemide|furosemide|mesh-list
20492577|NCT01611415|Diuretics|diuretics|mesh-ancestor
20492578|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
20492579|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492580|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20492581|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20492582|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492583|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20492584|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492585|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
20492586|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20492587|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492588|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492589|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492590|NCT01611480|Imiquimod|imiquimod|mesh-list
19852963|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19852964|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
20492591|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20492592|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
20492593|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492594|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492595|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
20492596|NCT01611506|Capecitabine|capecitabine|mesh-list
20492597|NCT01611506|Cetuximab|cetuximab|mesh-list
20492598|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492599|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20492600|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
20492601|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492602|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20492603|NCT01611675|Vemurafenib|vemurafenib|mesh-list
20492604|NCT01611675|Leflunomide|leflunomide|mesh-list
20492605|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492606|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20492607|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492608|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492609|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492610|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
20492611|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492612|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20492613|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
20492614|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700034|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
20492615|NCT01611727|Cisplatin|cisplatin|mesh-list
20492616|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492617|NCT01611896|Selenium|selenium|mesh-list
20492618|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
20492619|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492620|NCT01611896|Protective Agents|protective agents|mesh-ancestor
20492621|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492622|NCT01611896|Trace Elements|trace elements|mesh-ancestor
20242447|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20242448|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
20242449|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20242450|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242451|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242452|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242453|NCT00411541|Dexamethasone|dexamethasone|mesh-list
20242454|NCT00411541|Vincristine|vincristine|mesh-list
20242455|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242456|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
20242457|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
20242458|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492623|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
20242459|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242460|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20242461|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
20242462|NCT00411541|Hormones|hormones|mesh-ancestor
19700035|NCT04898231|Infliximab|infliximab|mesh-list
19700036|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19700037|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19700038|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
19700039|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700040|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
19700041|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
19700042|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700043|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700044|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700045|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
19700046|NCT04898231|Hormones|hormones|mesh-ancestor
20242463|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242464|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20242465|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242466|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20242467|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
19700047|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700048|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19700049|NCT04898231|Protective Agents|protective agents|mesh-ancestor
19700050|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19700051|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700052|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700053|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19700054|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
19700055|NCT04898270|Flupenthixol|flupenthixol|mesh-list
19700056|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
20492624|NCT01611909|Terpin|terpin|mesh-list
20492625|NCT01611909|Expectorants|expectorants|mesh-ancestor
20492626|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
20492627|NCT01611961|Docetaxel|docetaxel|mesh-list
20492628|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492629|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
19852965|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19852966|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19852967|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20492630|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
20492631|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
20492632|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492633|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20492634|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492635|NCT01612065|Misoprostol|misoprostol|mesh-list
20492636|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20492637|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
20492638|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20492639|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492640|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20492641|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492642|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
20492643|NCT01612078|Droxidopa|droxidopa|mesh-list
20492644|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20492645|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20528652|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528653|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528654|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20528655|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20528656|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528657|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414660|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19852968|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19852969|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
19852970|NCT00729157|Aflibercept|aflibercept|mesh-list
19852971|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
19852972|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19852973|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19852974|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19852975|NCT00729157|Growth Substances|growth substances|mesh-ancestor
19852976|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852977|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
19852978|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528658|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528659|NCT01775839|Aspirin|aspirin|mesh-list
20528660|NCT01775839|Digoxin|digoxin|mesh-list
19700057|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19700058|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700059|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700060|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19700061|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19700062|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
19700063|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700064|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700065|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
19700066|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19700067|NCT04897971|Antibodies|antibodies|mesh-list
19700068|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
19700069|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700070|NCT04897958|Leuprolide|leuprolide|mesh-list
19700071|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19700072|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
19700073|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19700074|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700075|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19700076|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700077|NCT04897854|Folfirinox|folfirinox|mesh-list
19700078|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700079|NCT04897880|Panobinostat|panobinostat|mesh-list
19700080|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19852979|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492646|NCT01612247|Aspirin|aspirin|mesh-list
20492647|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
20492648|NCT01612247|Methotrexate|methotrexate|mesh-list
20492649|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492650|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
20492651|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492652|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492653|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20492654|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
20492655|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492656|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492657|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20492658|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20492659|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
20492660|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20492661|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20492662|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
20492663|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
19852980|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19852981|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
19852982|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
19852983|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19852984|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
19852985|NCT00729183|Vitamin D|vitamin d|mesh-list
19852986|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
19852987|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
19852988|NCT00729183|Calcium|calcium|mesh-list
20492664|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492665|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20492666|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20492667|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20492668|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20492669|NCT01612247|Analgesics|analgesics|mesh-ancestor
20492670|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
20492671|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492672|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20492673|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20492674|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20492675|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20492676|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20492677|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
20492678|NCT01612273|Aspirin|aspirin|mesh-list
20492679|NCT01612273|Triflusal|triflusal|mesh-list
20492680|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20492681|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20492682|NCT01612273|Analgesics|analgesics|mesh-ancestor
20492683|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
20492684|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19852989|NCT00729183|Vitamins|vitamins|mesh-ancestor
19852990|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
19852991|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19852992|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19852993|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20492685|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492686|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20492687|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492688|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20492689|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20492690|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492691|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20492692|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20492693|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492694|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
20492695|NCT01612286|Endostatins|endostatins|mesh-list
19852994|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492696|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20492697|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20492698|NCT01612286|Growth Substances|growth substances|mesh-ancestor
20492699|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492700|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
20492701|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492702|NCT01612299|Everolimus|everolimus|mesh-list
20492703|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492704|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20492705|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
20492706|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492707|NCT01612377|Prednisone|prednisone|mesh-list
20492708|NCT01612377|Prednisolone|prednisolone|mesh-list
20492709|NCT01612377|Dipyridamole|dipyridamole|mesh-list
20492710|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20492711|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
20492712|NCT01612377|Hormones|hormones|mesh-ancestor
20492713|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492714|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492715|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20492716|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492717|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20492718|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492719|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492720|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20492721|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
20492722|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
20492723|NCT01612403|Astringents|astringents|mesh-ancestor
20492724|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492725|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
20492726|NCT01612468|Liraglutide|liraglutide|mesh-list
20492727|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492728|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492729|NCT01612468|Incretins|incretins|mesh-ancestor
20492730|NCT01612468|Hormones|hormones|mesh-ancestor
20492731|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492732|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20492733|NCT01612507|Cephalosporins|cephalosporins|mesh-list
20492734|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20492735|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492736|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20492737|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20492738|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492739|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492740|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20492741|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
20492742|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492743|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492744|NCT01612741|Acarbose|acarbose|mesh-list
20492745|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20492746|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492747|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492748|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492749|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492750|NCT01612832|Pregabalin|pregabalin|mesh-list
20492751|NCT01612832|Analgesics|analgesics|mesh-ancestor
20492752|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
20492753|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492754|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492755|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
20492756|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20492757|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528661|NCT01775839|Clopidogrel|clopidogrel|mesh-list
20492758|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492759|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20492760|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20492761|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20492762|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492763|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20492764|NCT01612871|Tamoxifen|tamoxifen|mesh-list
20492765|NCT01612871|Letrozole|letrozole|mesh-list
20492766|NCT01612871|Anastrozole|anastrozole|mesh-list
20492767|NCT01612871|Exemestane|exemestane|mesh-list
20492768|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492769|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20492770|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20492771|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492772|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492773|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20492774|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
20492775|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492776|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492777|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20492778|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20492779|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20492780|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20492781|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20492782|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20492783|NCT01612910|Protective Agents|protective agents|mesh-ancestor
20492784|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492785|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492786|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20492787|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20492788|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492789|NCT01612975|Naproxen|naproxen|mesh-list
20492790|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20492791|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20492792|NCT01612975|Analgesics|analgesics|mesh-ancestor
20492793|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
20492794|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492795|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492796|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20492797|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492798|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
20492799|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20492800|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492801|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492802|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
20492803|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20492804|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20492805|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492806|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20492807|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20492808|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492809|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492810|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492811|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20492812|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
20492813|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20492814|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492815|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20492816|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20492817|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20492818|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
20492819|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492820|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20492821|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492822|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492823|NCT01613079|Methotrexate|methotrexate|mesh-list
20492824|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20492825|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
20492826|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19414661|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20492827|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492828|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20492829|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
20492830|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492831|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492832|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
20492833|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492834|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20492835|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700081|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19700082|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492836|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
20492837|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19700083|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700084|NCT04897737|Tenofovir|tenofovir|mesh-list
19700085|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
20492838|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20492839|NCT01613092|Vancomycin|vancomycin|mesh-list
20492840|NCT01613092|Clindamycin|clindamycin|mesh-list
20492841|NCT01613092|Cefazolin|cefazolin|mesh-list
20492842|NCT01613092|Cephalexin|cephalexin|mesh-list
20492843|NCT01613092|Bacitracin|bacitracin|mesh-list
20492844|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20492845|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492846|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20492847|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492848|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492849|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20492850|NCT01613105|Acarbose|acarbose|mesh-list
20492851|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20492852|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492853|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492854|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492855|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492856|NCT01613170|Estrogens|estrogens|mesh-list
20492857|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20492858|NCT01613170|Hormones|hormones|mesh-ancestor
20492859|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492860|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492861|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
20492862|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
20492863|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492864|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
20492865|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492866|NCT01613209|Candesartan|candesartan|mesh-list
20492867|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
20492868|NCT01613209|Olmesartan|olmesartan|mesh-list
20492869|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20492870|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20492871|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20492872|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492873|NCT01613300|Ofatumumab|ofatumumab|mesh-list
20492874|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492875|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
20492876|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20492877|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20492878|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492879|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
20492880|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
20492881|NCT01613469|Leucovorin|leucovorin|mesh-list
20492882|NCT01613469|Antidotes|antidotes|mesh-ancestor
20492883|NCT01613469|Protective Agents|protective agents|mesh-ancestor
20492884|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492885|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
20492886|NCT01613469|Vitamins|vitamins|mesh-ancestor
20492887|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
20492888|NCT01613482|Trastuzumab|trastuzumab|mesh-list
20492889|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20492890|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492891|NCT01613495|Octreotide|octreotide|mesh-list
20492892|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492893|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20492894|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492895|NCT01613534|Sucralfate|sucralfate|mesh-list
20492896|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20492897|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492898|NCT01613547|Amoxicillin|amoxicillin|mesh-list
20492899|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20492900|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20492901|NCT01613573|Hormones|hormones|mesh-list
20492902|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20492903|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492904|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20492905|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
20492906|NCT01613664|Coagulants|coagulants|mesh-ancestor
20492907|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
20492908|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20492909|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20492910|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20492911|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
20492912|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492913|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492914|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492915|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20492916|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20492917|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20492918|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
20492919|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492920|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20492921|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20492922|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492923|NCT01613755|Metformin|metformin|mesh-list
20492924|NCT01613755|Dipyridamole|dipyridamole|mesh-list
20492925|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492926|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492927|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20492928|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492929|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492930|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20492931|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
20492932|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20492933|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20492934|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20492935|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
20492936|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492937|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20492938|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20492939|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492940|NCT01613807|Insulin|insulin|mesh-list
20492941|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20492942|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
20492943|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
20492944|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
20492945|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20492946|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492947|NCT01613820|Scopolamine|scopolamine|mesh-list
20492948|NCT01613820|Ketamine|ketamine|mesh-list
20492949|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20492950|NCT01613820|Analgesics|analgesics|mesh-ancestor
20492951|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
20492952|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20492953|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492954|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20492955|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20492956|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
20492957|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
20492958|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20492959|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20492960|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20492961|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20492962|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492963|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20492964|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
20492965|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
20492966|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20492967|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
20492968|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20492969|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
20492970|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20492971|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
20492972|NCT01613846|Sorafenib|sorafenib|mesh-list
20492973|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414662|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414663|NCT03427125|Sevelamer|sevelamer|mesh-list
20492974|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20492975|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20492976|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528662|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19414664|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
19414665|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
19414666|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414667|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
20492977|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20492978|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
20492979|NCT01613963|Cyclosporine|cyclosporine|mesh-list
20492980|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
20492981|NCT01613963|Prednisolone|prednisolone|mesh-list
20492982|NCT01613963|Adalimumab|adalimumab|mesh-list
20492983|NCT01613963|Etanercept|etanercept|mesh-list
20492984|NCT01613963|Methotrexate|methotrexate|mesh-list
20492985|NCT01613963|Azathioprine|azathioprine|mesh-list
19414668|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19414669|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19414670|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414671|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
19414672|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414673|NCT03416530|TIC10 compound|tic10 compound|mesh-list
19414674|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416910|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416911|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700086|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700087|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19700088|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19700089|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700090|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242468|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
20242469|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
20242470|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242471|NCT00411593|Bevacizumab|bevacizumab|mesh-list
20242472|NCT00411593|Bortezomib|bortezomib|mesh-list
20242473|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20242474|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242475|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20242476|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20242477|NCT00411593|Growth Substances|growth substances|mesh-ancestor
20492986|NCT01613963|Infliximab|infliximab|mesh-list
20492987|NCT01613963|Cyclosporins|cyclosporins|mesh-list
19416912|NCT02244606|Fluconazole|fluconazole|mesh-list
19416913|NCT02244606|Micafungin|micafungin|mesh-list
20492988|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20492989|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20492990|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
20492991|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20492992|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20492993|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20492994|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
20492995|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20492996|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20492997|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
20492998|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20492999|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
20493000|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493001|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20493002|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20493003|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
20493004|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493005|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20493006|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20493007|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20493008|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
20493009|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20493010|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493011|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
20493012|NCT01613963|Hormones|hormones|mesh-ancestor
20493013|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493014|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20493015|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493016|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20493017|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20493018|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493019|NCT01613963|Analgesics|analgesics|mesh-ancestor
20493020|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
20493021|NCT01613976|Panobinostat|panobinostat|mesh-list
20493022|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493023|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20493024|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493025|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493026|NCT01614041|Tandospirone|tandospirone|mesh-list
20493027|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20493028|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493029|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493030|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493031|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493032|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20493033|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
20493034|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493035|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493036|NCT01614132|Cisplatin|cisplatin|mesh-list
20493037|NCT01614132|Vincristine|vincristine|mesh-list
20493038|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493039|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493040|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20493041|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
20493042|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
20493043|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
20493044|NCT01614197|Cytarabine|cytarabine|mesh-list
20493045|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
20493046|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20493047|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20493048|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20493049|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
20493050|NCT01614197|Methotrexate|methotrexate|mesh-list
20493051|NCT01614197|Etoposide|etoposide|mesh-list
20493052|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
20493053|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493054|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
20493055|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493056|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20493057|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20493058|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
20493059|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493060|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493061|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20493062|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20493063|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
20493064|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493065|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20493066|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
20493067|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
20493068|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493069|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20493070|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20493071|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20493072|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20493073|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20493074|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
20493075|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493076|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493077|NCT01614223|Betamethasone|betamethasone|mesh-list
20493078|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493079|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
20493080|NCT01614223|Hormones|hormones|mesh-ancestor
20493081|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493082|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493083|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20493084|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
20493085|NCT01614236|Pregabalin|pregabalin|mesh-list
20493086|NCT01614236|Analgesics|analgesics|mesh-ancestor
20493087|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
20493088|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493089|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493090|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
20493091|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20493092|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493093|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493094|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20493095|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20493096|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493097|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493098|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493099|NCT01614301|Pioglitazone|pioglitazone|mesh-list
20493100|NCT01614301|Sirolimus|sirolimus|mesh-list
20493101|NCT01614301|Etoricoxib|etoricoxib|mesh-list
20493102|NCT01614301|Dacarbazine|dacarbazine|mesh-list
20493103|NCT01614301|Trofosfamide|trofosfamide|mesh-list
20493104|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20493105|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493106|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20493107|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493108|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20493109|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493110|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
20493111|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493112|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
20493113|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20493114|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
20493115|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493116|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20493117|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493118|NCT01614301|Analgesics|analgesics|mesh-ancestor
20493119|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
20493120|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493121|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493122|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20493123|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20493124|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20493125|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493126|NCT01614366|Amlodipine|amlodipine|mesh-list
20493127|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20493128|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20493129|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493130|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493131|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20493132|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493133|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
20493134|NCT01614405|Ritonavir|ritonavir|mesh-list
20493135|NCT01614405|Lopinavir|lopinavir|mesh-list
20493136|NCT01614405|Tenofovir|tenofovir|mesh-list
20493137|NCT01614405|Emtricitabine|emtricitabine|mesh-list
20493138|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20493139|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20493140|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20493141|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
20493142|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493143|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493144|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20493145|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20493146|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
20493147|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493148|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20493149|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20493150|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20493151|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20493152|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
20493153|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20493154|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
20493155|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493156|NCT01614431|Expectorants|expectorants|mesh-ancestor
20493157|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
20493158|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20493159|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
20493160|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493161|NCT01614431|Protective Agents|protective agents|mesh-ancestor
20493162|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493163|NCT01614431|Antidotes|antidotes|mesh-ancestor
20493164|NCT01614496|Insulin|insulin|mesh-list
20493165|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20493166|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493167|NCT01614535|Remifentanil|remifentanil|mesh-list
20493168|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20493169|NCT01614535|Narcotics|narcotics|mesh-ancestor
20493170|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493171|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493172|NCT01614535|Analgesics|analgesics|mesh-ancestor
20493173|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
20493174|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493175|NCT01614665|Tacrolimus|tacrolimus|mesh-list
20493176|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493177|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
20493178|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493179|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20493180|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493181|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493182|NCT01614938|Cisplatin|cisplatin|mesh-list
20493183|NCT01614938|Docetaxel|docetaxel|mesh-list
20493184|NCT01614938|Cetuximab|cetuximab|mesh-list
20493185|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493186|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
20493187|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
20493188|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
20493189|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493190|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20493191|NCT01614964|Lumefantrine|lumefantrine|mesh-list
20493192|NCT01614964|Artemether|artemether|mesh-list
20493193|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19852995|NCT00729183|Antacids|antacids|mesh-ancestor
19852996|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19852997|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19852998|NCT00729326|Exenatide|exenatide|mesh-list
19852999|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19853000|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853001|NCT00729326|Incretins|incretins|mesh-ancestor
20493194|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
20493195|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20493196|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20493197|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414675|NCT03412890|Norethindrone|norethindrone|mesh-list
19414676|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
19700091|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19700092|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19700093|NCT04897516|Benzonidazole|benzonidazole|mesh-list
19700094|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700095|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
19700096|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700097|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19414677|NCT03412890|Estradiol|estradiol|mesh-list
19414678|NCT03412890|Relugolix|relugolix|mesh-list
19414679|NCT03412890|Estrogens|estrogens|mesh-ancestor
19414680|NCT03412890|Hormones|hormones|mesh-ancestor
19414681|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700098|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19700099|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19700100|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700101|NCT04897503|Riboflavin|riboflavin|mesh-list
19700102|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
19700103|NCT04897503|Vitamins|vitamins|mesh-ancestor
19700104|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
20242478|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493198|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20493199|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20493200|NCT01615042|Lenalidomide|lenalidomide|mesh-list
20493201|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
20493202|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493203|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20493204|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20493205|NCT01615042|Growth Substances|growth substances|mesh-ancestor
20493206|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
20493207|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414682|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700105|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700106|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19700107|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
19853002|NCT00729326|Hormones|hormones|mesh-ancestor
20242479|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
20242480|NCT00411736|Azithromycin|azithromycin|mesh-list
20242481|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20242482|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242483|NCT00411866|Ketoconazole|ketoconazole|mesh-list
20242484|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
20242485|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493208|NCT01615055|Fluoxetine|fluoxetine|mesh-list
20493209|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20493210|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20493211|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493212|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493213|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493214|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
20493215|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493216|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20493217|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
20493218|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493219|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19700108|NCT04897386|Pemetrexed|pemetrexed|mesh-list
19700109|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700110|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700111|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700112|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19700113|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19700114|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
19700115|NCT04897321|Fludarabine|fludarabine|mesh-list
19700116|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700117|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
19700118|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700119|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19700120|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19700121|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
20493220|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20493221|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493222|NCT01615081|Insulin|insulin|mesh-list
20493223|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20493224|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493225|NCT01615107|Oxytocin|oxytocin|mesh-list
20493226|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
20493227|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493228|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493229|NCT01615185|Amisulpride|amisulpride|mesh-list
20493230|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20493231|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493232|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493233|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493234|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493235|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20493236|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
20493237|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493238|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493239|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20493240|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
20493241|NCT01615211|Letrozole|letrozole|mesh-list
20493242|NCT01615211|Trilostane|trilostane|mesh-list
20493243|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493244|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20493245|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20493246|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493247|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493248|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20493249|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
20493250|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493251|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493252|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20493253|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
20493254|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493255|NCT01615224|Misoprostol|misoprostol|mesh-list
20493256|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20493257|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
20493258|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493259|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493260|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20493261|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20493262|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
20493263|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20493264|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20493265|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
20493266|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20493267|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
19414683|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19414684|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
19700122|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242486|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20242487|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20242488|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242489|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242490|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20242491|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
20242492|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242493|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242494|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20242495|NCT00411879|Vasopressins|vasopressins|mesh-list
20242496|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
20242497|NCT00411879|Epinephrine|epinephrine|mesh-list
20242498|NCT00411879|Racepinephrine|racepinephrine|mesh-list
20242499|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
20242500|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20493268|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493269|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493270|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20493271|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20493272|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20493273|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20493274|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19700123|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700124|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19700125|NCT04897477|Azacitidine|azacitidine|mesh-list
19700126|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20493275|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19700127|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20493276|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20493277|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20493278|NCT01615393|Ribavirin|ribavirin|mesh-list
20493279|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
20493280|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493281|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
20493282|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493283|NCT01615445|Resveratrol|resveratrol|mesh-list
20493284|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
20493285|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493286|NCT01615445|Protective Agents|protective agents|mesh-ancestor
20493287|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493288|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493289|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20493290|NCT01615510|Tapentadol|tapentadol|mesh-list
20493291|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20493292|NCT01615510|Narcotics|narcotics|mesh-ancestor
20493293|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493294|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493295|NCT01615510|Analgesics|analgesics|mesh-ancestor
20493296|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
20493297|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493298|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20493299|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20493300|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493301|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493302|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
20493303|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528663|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20528664|NCT01775839|Analgesics|analgesics|mesh-ancestor
20528665|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
20493304|NCT01615601|Ritonavir|ritonavir|mesh-list
20493305|NCT01615601|Darunavir|darunavir|mesh-list
20493306|NCT01615601|Etravirine|etravirine|mesh-list
20493307|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20493308|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20493309|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20493310|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
20493311|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493312|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493313|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19700128|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
20493314|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
20493315|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493316|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20493317|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20493318|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20493319|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20493320|NCT01615614|Rilpivirine|rilpivirine|mesh-list
20493321|NCT01615614|Rifabutin|rifabutin|mesh-list
20493322|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20493323|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20493324|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493325|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493326|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
20493327|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493328|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20493329|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20493330|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20493331|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20493332|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
20493333|NCT01615627|Treprostinil|treprostinil|mesh-list
20493334|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20493335|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20493336|NCT01615757|Cytarabine|cytarabine|mesh-list
20493337|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20493338|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
20493339|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493340|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493341|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
20493342|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493343|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493344|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
20493345|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700129|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493346|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20493347|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20493348|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493349|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20493350|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20493351|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493352|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493353|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
20493354|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493355|NCT01615913|Ketoconazole|ketoconazole|mesh-list
20493356|NCT01615913|Terbinafine|terbinafine|mesh-list
20493357|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
20493358|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493359|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20493360|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20493361|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493362|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493363|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20493364|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
20493365|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493366|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493367|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20493368|NCT01615978|Liraglutide|liraglutide|mesh-list
20493369|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20493370|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493371|NCT01615978|Incretins|incretins|mesh-ancestor
20493372|NCT01615978|Hormones|hormones|mesh-ancestor
20493373|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493374|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
20493375|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20493376|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
20493377|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
20493378|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493379|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493380|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493381|NCT01616004|Analgesics|analgesics|mesh-ancestor
20493382|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
20493383|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493384|NCT01616069|Simendan|simendan|mesh-list
20493385|NCT01616069|Epinephrine|epinephrine|mesh-list
20493386|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20493387|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20493388|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
20493389|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493390|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493391|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493392|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20493393|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20493394|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
20493395|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493396|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20493397|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
20493398|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
20493399|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
20493400|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20493401|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20493402|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
20493403|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20493404|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20493405|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493406|NCT01616069|Protective Agents|protective agents|mesh-ancestor
20493407|NCT01616108|Bupivacaine|bupivacaine|mesh-list
20493408|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
20493409|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
20493410|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493411|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493412|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
20493413|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493414|NCT01616186|Everolimus|everolimus|mesh-list
20493415|NCT01616186|Sorafenib|sorafenib|mesh-list
20493416|NCT01616186|Sunitinib|sunitinib|mesh-list
20493417|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493418|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493419|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
20493420|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493421|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19700130|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700131|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700132|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19700133|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
20493422|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493423|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493424|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20493425|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20493426|NCT01616186|Growth Substances|growth substances|mesh-ancestor
20493427|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
20493428|NCT01616225|Hormones|hormones|mesh-list
20493429|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493430|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493431|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20493432|NCT01616355|Eusol|eusol|mesh-list
20493433|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
20493434|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493435|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
20493436|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
20493437|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20493438|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20493439|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493440|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700134|NCT04897269|Progesterone|progesterone|mesh-list
19700135|NCT04897269|Progestins|progestins|mesh-ancestor
19700136|NCT04897269|Hormones|hormones|mesh-ancestor
19700137|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700138|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700139|NCT04896359|Ascorbic Acid|ascorbic acid|mesh-list
19700140|NCT04896359|Vitamins|vitamins|mesh-ancestor
19700141|NCT04896359|Micronutrients|micronutrients|mesh-ancestor
19700142|NCT04896359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700143|NCT04896359|Antioxidants|antioxidants|mesh-ancestor
19700144|NCT04896359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700145|NCT04896359|Protective Agents|protective agents|mesh-ancestor
19700146|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
20493441|NCT01616381|Urological Agents|urological agents|mesh-ancestor
20493442|NCT01616407|Methylphenidate|methylphenidate|mesh-list
20493443|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19700147|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242501|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20242502|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
20242503|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242504|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242505|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242506|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20242507|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20242508|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
20242509|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242510|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20242511|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
19700148|NCT04896177|Sirolimus|sirolimus|mesh-list
20242512|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
20242513|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
20242514|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20242515|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
20242516|NCT00411879|Coagulants|coagulants|mesh-ancestor
20242517|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20493444|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20493445|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493446|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20493447|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20493448|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493449|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493450|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
20493451|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493452|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
20493453|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493454|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
20493455|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20493456|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
20242518|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
20493457|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
20493458|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
20493459|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493460|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
20493461|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20493462|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20493463|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493464|NCT01616485|Urological Agents|urological agents|mesh-ancestor
20493465|NCT01616615|Aspirin|aspirin|mesh-list
20493466|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20493467|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493468|NCT01616615|Analgesics|analgesics|mesh-ancestor
20493469|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
20493470|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493471|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493472|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242519|NCT00411905|Bortezomib|bortezomib|mesh-list
20242520|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242521|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20242522|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20242523|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20242524|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
20242525|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242526|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242527|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20242528|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20242529|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
20242530|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242531|NCT00411996|Ritonavir|ritonavir|mesh-list
20242532|NCT00411996|Indinavir|indinavir|mesh-list
20493473|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20493474|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20493475|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20493476|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493477|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20493478|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20493479|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242533|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20242534|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20242535|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
20242536|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242537|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242538|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20493480|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
20493481|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20493482|NCT01616680|Antibodies|antibodies|mesh-list
20493483|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
20493484|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20493485|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
20493486|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
20493487|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493488|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20493489|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493490|NCT01616732|Testosterone|testosterone|mesh-list
19700149|NCT04896177|Paclitaxel|paclitaxel|mesh-list
20242539|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20242540|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
20493491|NCT01616732|Androgens|androgens|mesh-ancestor
20493492|NCT01616732|Hormones|hormones|mesh-ancestor
20493493|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493494|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493495|NCT01616784|Insulin|insulin|mesh-list
20493496|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20493497|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
20493498|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20493499|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493500|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
20493501|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493502|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20493503|NCT01616875|Cisplatin|cisplatin|mesh-list
20493504|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493505|NCT01616888|Paclitaxel|paclitaxel|mesh-list
20493506|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20493507|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493508|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
20493509|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
20493510|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
20493511|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493512|NCT01616927|Lanreotide|lanreotide|mesh-list
20493513|NCT01616927|Somatostatin|somatostatin|mesh-list
20493514|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493515|NCT01616927|Hormones|hormones|mesh-ancestor
20493516|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493517|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493518|NCT01616966|Remifentanil|remifentanil|mesh-list
20493519|NCT01616966|Propofol|propofol|mesh-list
19855615|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493520|NCT01616966|Sevoflurane|sevoflurane|mesh-list
20493521|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20493522|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493523|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493524|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20493525|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
20493526|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
20493527|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20493528|NCT01616966|Narcotics|narcotics|mesh-ancestor
20493529|NCT01616966|Analgesics|analgesics|mesh-ancestor
20493530|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
20493531|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493532|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19853003|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853004|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19853005|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853006|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853007|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853008|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19853009|NCT00729482|Everolimus|everolimus|mesh-list
19853010|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853011|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853012|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
19853013|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853014|NCT00729586|Tamoxifen|tamoxifen|mesh-list
19853015|NCT00729586|Sirolimus|sirolimus|mesh-list
19853016|NCT00729586|Megestrol|megestrol|mesh-list
19853017|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
20242541|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493533|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20493534|NCT01616992|Bupivacaine|bupivacaine|mesh-list
20493535|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
20242542|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20242543|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20242544|NCT00412022|Tamoxifen|tamoxifen|mesh-list
20242545|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
20242546|NCT00412022|Letrozole|letrozole|mesh-list
20242547|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20242548|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242549|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20242550|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20242551|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242552|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242553|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20242554|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
20493536|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
20493537|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493538|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493539|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
20493540|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493541|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
20493542|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20493543|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493544|NCT01617135|Levodopa|levodopa|mesh-list
20493545|NCT01617135|Carbidopa|carbidopa|mesh-list
20493546|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20493547|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20493548|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20493549|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
20493550|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493551|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493552|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493553|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20493554|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493555|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20493556|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
20493557|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
20493558|NCT01617200|Olanzapine|olanzapine|mesh-list
20493559|NCT01617200|Asenapine|asenapine|mesh-list
20493560|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
19700150|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19700151|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493561|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
20493562|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493563|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700152|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
20493564|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20493565|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20493566|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493567|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493568|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493569|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20242555|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242556|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242557|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20242558|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20242559|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20242560|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20493570|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20493571|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493572|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493573|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493574|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
20528666|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528667|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528668|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528669|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528670|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20528671|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20528672|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528673|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20528674|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20528675|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528676|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
20528677|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20528678|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20528679|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20528680|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
20528681|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528682|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20528683|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20528684|NCT01775839|Protective Agents|protective agents|mesh-ancestor
20528685|NCT01775891|Flecainide|flecainide|mesh-list
20528686|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20528687|NCT01775891|Propafenone|propafenone|mesh-list
20528688|NCT01775891|Pilsicainide|pilsicainide|mesh-list
20528689|NCT01775891|Lidocaine|lidocaine|mesh-list
20528690|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20528691|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20528692|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528693|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528694|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
20528695|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
20528696|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528697|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528698|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
20528699|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528700|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20528701|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20528702|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20242561|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
20242562|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20242563|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
20242564|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493575|NCT01617213|Lenalidomide|lenalidomide|mesh-list
20493576|NCT01617213|Melphalan|melphalan|mesh-list
20493577|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
20493578|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493579|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20493580|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20493581|NCT01617213|Growth Substances|growth substances|mesh-ancestor
20493582|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
20493583|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493584|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20493585|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
19414685|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19414686|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19414687|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20493586|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493587|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20493588|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493589|NCT01617226|Azacitidine|azacitidine|mesh-list
20493590|NCT01617226|Vorinostat|vorinostat|mesh-list
20493591|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20493592|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
20493593|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493594|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493595|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493596|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20493597|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
20493598|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20493599|NCT01617317|Antibodies|antibodies|mesh-list
20493600|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
20493601|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20493602|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
20493603|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493604|NCT01617356|Lidocaine|lidocaine|mesh-list
20493605|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
20493606|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
20493607|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493608|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493609|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
20493610|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493611|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20493612|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20493613|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20493614|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493615|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242565|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20242566|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
20242567|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20242568|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20242569|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20242570|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20242571|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242572|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
20242573|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242574|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242575|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20242576|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242577|NCT00412100|Oxycodone|oxycodone|mesh-list
20242578|NCT00412100|Naloxone|naloxone|mesh-list
20242579|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242580|NCT00412100|Narcotics|narcotics|mesh-ancestor
20242581|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242582|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242583|NCT00412100|Analgesics|analgesics|mesh-ancestor
20242584|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
20242585|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242586|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19414688|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20493616|NCT01617538|Atorvastatin|atorvastatin|mesh-list
20493617|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20493618|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20493619|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
20493620|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493621|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20493622|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20493623|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493624|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20493625|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493626|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493627|NCT01617564|Bupivacaine|bupivacaine|mesh-list
20493628|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
20493629|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
20493630|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493631|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493632|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
20493633|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493634|NCT01617590|Methotrexate|methotrexate|mesh-list
20493635|NCT01617590|Leflunomide|leflunomide|mesh-list
20493636|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20493637|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
20493638|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493639|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493640|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20493641|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
20493642|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493643|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493644|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
20493645|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493646|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20493647|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493648|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
20493649|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20493650|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20493651|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
20493652|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20493653|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493654|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493655|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493656|NCT01617694|Analgesics|analgesics|mesh-ancestor
20493657|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
20493658|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493659|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20493660|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20493661|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20493662|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
20493663|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493664|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493665|NCT01617707|Midazolam|midazolam|mesh-list
20493666|NCT01617707|Propofol|propofol|mesh-list
20493667|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20493668|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493669|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493670|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20493671|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
20493672|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
20493673|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20493674|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20493675|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493676|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493677|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
20493678|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
20493679|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493680|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493681|NCT01617733|Pasireotide|pasireotide|mesh-list
20493682|NCT01617733|Hormones|hormones|mesh-ancestor
20493683|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493684|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493685|NCT01617746|Bosentan|bosentan|mesh-list
20493686|NCT01617746|Ambrisentan|ambrisentan|mesh-list
20493687|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20493688|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20493689|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493690|NCT01617772|Atorvastatin|atorvastatin|mesh-list
20493691|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20493692|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20493693|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
20493694|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493695|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20493696|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20493697|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493698|NCT01617798|Metolazone|metolazone|mesh-list
20493699|NCT01617798|Furosemide|furosemide|mesh-list
20493700|NCT01617798|Diuretics|diuretics|mesh-ancestor
20493701|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
20493702|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493703|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20493704|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493705|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493706|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20493707|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20493708|NCT01617811|Anesthetics|anesthetics|mesh-list
20493709|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493710|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493711|NCT01617824|Linagliptin|linagliptin|mesh-list
20493712|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20493713|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493714|NCT01617824|Incretins|incretins|mesh-ancestor
20493715|NCT01617824|Hormones|hormones|mesh-ancestor
20493716|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493717|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20493718|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
20493719|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493720|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493721|NCT01617928|Paclitaxel|paclitaxel|mesh-list
20493722|NCT01617928|Carboplatin|carboplatin|mesh-list
20493723|NCT01617928|Veliparib|veliparib|mesh-list
20493724|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20493725|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493726|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
20493727|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
20493728|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
20493729|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493730|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20493731|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493732|NCT01618006|Aspirin|aspirin|mesh-list
20493733|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20493734|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493735|NCT01618006|Analgesics|analgesics|mesh-ancestor
20493736|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
20493737|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493738|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493739|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493740|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20493741|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20493742|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20493743|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493744|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20493745|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20493746|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493747|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
20493748|NCT01618136|Paclitaxel|paclitaxel|mesh-list
20493749|NCT01618136|Carboplatin|carboplatin|mesh-list
20493750|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20493751|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493752|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
20493753|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
20493754|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
20493755|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493756|NCT01618188|Insulin|insulin|mesh-list
20493757|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20493758|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
20493759|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
20493760|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20493761|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20493762|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493763|NCT01618253|Sorafenib|sorafenib|mesh-list
19414689|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19414690|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
19414691|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
19414692|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19414693|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19414694|NCT03373435|Glucagon|glucagon|mesh-list
19414695|NCT03373435|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20493764|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493765|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20493766|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493767|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493768|NCT01618357|Veliparib|veliparib|mesh-list
20493769|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20493770|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493771|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493772|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493773|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20493774|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493775|NCT01618396|Midazolam|midazolam|mesh-list
20493776|NCT01618396|Propofol|propofol|mesh-list
20493777|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20493778|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493779|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493780|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20493781|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
20493782|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
20493783|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19855616|NCT00749944|Varenicline|varenicline|mesh-list
20493784|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20493785|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493786|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493787|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
20493788|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
20493789|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493790|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493791|NCT01618448|Tolvaptan|tolvaptan|mesh-list
20493792|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20493793|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493794|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
20493795|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493796|NCT01618474|Docetaxel|docetaxel|mesh-list
20493797|NCT01618474|Capecitabine|capecitabine|mesh-list
20493798|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493799|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
20493800|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
20493801|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
20493802|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493803|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20493804|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
20493805|NCT01618513|Octreotide|octreotide|mesh-list
20493806|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20493807|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20493808|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493809|NCT01618539|Propofol|propofol|mesh-list
20242587|NCT00412126|Insulin|insulin|mesh-list
20242588|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20242589|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242590|NCT00412152|Oxycodone|oxycodone|mesh-list
20242591|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20242592|NCT00412152|Narcotics|narcotics|mesh-ancestor
20242593|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700153|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
19700154|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
20242594|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242595|NCT00412152|Analgesics|analgesics|mesh-ancestor
20242596|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
20242597|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242598|NCT00412191|Lamotrigine|lamotrigine|mesh-list
20242599|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
20242600|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20242601|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20242602|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242603|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20242604|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242605|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20242606|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20242607|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242608|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493810|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20493811|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493812|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493813|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20493814|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
20493815|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
20493816|NCT01618591|Azithromycin|azithromycin|mesh-list
20493817|NCT01618591|Levofloxacin|levofloxacin|mesh-list
20493818|NCT01618591|Ofloxacin|ofloxacin|mesh-list
20493819|NCT01618591|Rifaximin|rifaximin|mesh-list
20493820|NCT01618591|Loperamide|loperamide|mesh-list
20493821|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
20493822|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20493823|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493824|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20493825|NCT01618591|Renal Agents|renal agents|mesh-ancestor
20493826|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20493827|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20493828|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493829|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493830|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493831|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20493832|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20493833|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20493834|NCT01618643|Acetic Acid|acetic acid|mesh-list
20493835|NCT01618643|Retinol acetate|retinol acetate|mesh-list
20493836|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20493837|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493838|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20493839|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
20493840|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493841|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19416914|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
20493842|NCT01618643|Protective Agents|protective agents|mesh-ancestor
20493843|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493844|NCT01618760|Risperidone|risperidone|mesh-list
20493845|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20493846|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
20493847|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493848|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493849|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493850|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20493851|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493852|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493853|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493854|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20493855|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
20493856|NCT01618773|Adapalene|adapalene|mesh-list
20493857|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20493858|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
20493859|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20493860|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493861|NCT01618773|Analgesics|analgesics|mesh-ancestor
20493862|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
20493863|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493864|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493865|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493866|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853018|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19853019|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493867|NCT01618799|Lamotrigine|lamotrigine|mesh-list
20493868|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
20493869|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20493870|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493871|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493872|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20493873|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493874|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20493875|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493876|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493877|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493878|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20493879|NCT01618825|Lamotrigine|lamotrigine|mesh-list
20493880|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
20493881|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20493882|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20493883|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493884|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20493885|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853020|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20493886|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20493887|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20493888|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20493889|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20493890|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20493891|NCT01618877|Levetiracetam|levetiracetam|mesh-list
20493892|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
20493893|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
20493894|NCT01618890|Propranolol|propranolol|mesh-list
20493895|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20493896|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20493897|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
20493898|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20493899|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493900|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700155|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700156|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19700157|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700158|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19700159|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
19700160|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700161|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
19700162|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700163|NCT04896125|Bimatoprost|bimatoprost|mesh-list
19700164|NCT04896125|Latanoprost|latanoprost|mesh-list
20493901|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20493902|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20493903|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
20493904|NCT01618903|Levetiracetam|levetiracetam|mesh-list
20493905|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
20493906|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
20528703|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
20528704|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20528705|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20528706|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20528707|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
20528708|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20528709|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700165|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19700166|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19700167|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19700168|NCT04896164|Curcumin|curcumin|mesh-list
19700169|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19700170|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19700171|NCT04896164|Analgesics|analgesics|mesh-ancestor
19700172|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
20528710|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20528711|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20528712|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20528713|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20528714|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528715|NCT01776320|Alprostadil|alprostadil|mesh-list
20528716|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20528717|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
20528718|NCT01776320|Urological Agents|urological agents|mesh-ancestor
20528719|NCT01776437|Talazoparib|talazoparib|mesh-list
20528720|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20528721|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528722|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528723|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528724|NCT01776515|Acetaminophen|acetaminophen|mesh-list
20528725|NCT01776515|Tramadol|tramadol|mesh-list
20528726|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20528727|NCT01776515|Analgesics|analgesics|mesh-ancestor
20528728|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
20528729|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528730|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528731|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
20528732|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20528733|NCT01776515|Narcotics|narcotics|mesh-ancestor
20528734|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528735|NCT01776567|Everolimus|everolimus|mesh-list
20528736|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528737|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528738|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
20528739|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528740|NCT01776671|Gabapentin|gabapentin|mesh-list
20528741|NCT01776671|Analgesics|analgesics|mesh-ancestor
20528742|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
20528743|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528744|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528745|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
20528746|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20528747|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20528748|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528749|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20528750|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20528751|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20528752|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242609|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20493907|NCT01618929|Montelukast|montelukast|mesh-list
20493908|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20493909|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
20493910|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20493911|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
20493912|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493913|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242610|NCT00412204|Bromides|bromides|mesh-list
20242611|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
20242612|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20242613|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
20493914|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20493915|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20493916|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493917|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
20493918|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20493919|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
20493920|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20493921|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
20493922|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493923|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493924|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
20493925|NCT01619046|Factor VIII|factor viii|mesh-list
20493926|NCT01619046|Coagulants|coagulants|mesh-ancestor
20493927|NCT01619072|Misoprostol|misoprostol|mesh-list
20493928|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20493929|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
20493930|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493931|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493932|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20493933|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20493934|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
20493935|NCT01619111|Lapatinib|lapatinib|mesh-list
20493936|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493937|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20493938|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493939|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493940|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
20493941|NCT01619137|Povidone|povidone|mesh-list
20493942|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
20493943|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
20493944|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20493945|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20493946|NCT01619150|Etoricoxib|etoricoxib|mesh-list
20493947|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20493948|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493949|NCT01619150|Analgesics|analgesics|mesh-ancestor
20493950|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
20493951|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493952|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493953|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493954|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20493955|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20493956|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20493957|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493958|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493959|NCT01619163|Prednisolone|prednisolone|mesh-list
20493960|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20493961|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
20493962|NCT01619163|Hormones|hormones|mesh-ancestor
20493963|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20493964|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493965|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20493966|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493967|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20493968|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20493969|NCT01619176|Methotrexate|methotrexate|mesh-list
20493970|NCT01619176|Leflunomide|leflunomide|mesh-list
20493971|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19700173|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493972|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
20493973|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20493974|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20493975|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19700174|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700175|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700176|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19700177|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700178|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855617|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20493976|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
20493977|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493978|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20493979|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
20493980|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20493981|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20493982|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20493983|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
20493984|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20493985|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20493986|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20493987|NCT01619176|Analgesics|analgesics|mesh-ancestor
20493988|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
20493989|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493990|NCT01619280|Nitroprusside|nitroprusside|mesh-list
20493991|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20493992|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
20493993|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20493994|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20493995|NCT01619436|Clonidine|clonidine|mesh-list
20493996|NCT01619436|Analgesics|analgesics|mesh-ancestor
20493997|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
20493998|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20493999|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494000|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20494001|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
20494002|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
20494003|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20494004|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20494005|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20494006|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
20494007|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494008|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494009|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20494010|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
20494011|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708515|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20494012|NCT01619527|Darunavir|darunavir|mesh-list
20494013|NCT01619527|Cobicistat|cobicistat|mesh-list
20494014|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20494015|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20494016|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
20494017|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494018|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494019|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20494020|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20494021|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
20494022|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494023|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20494024|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20494025|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20494026|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20494027|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20494028|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494029|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494030|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494031|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494032|NCT01619566|Analgesics|analgesics|mesh-ancestor
20494033|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
20494034|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494035|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
20494036|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19700179|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700180|NCT04895917|Daratumumab|daratumumab|mesh-list
19700181|NCT04895917|Pomalidomide|pomalidomide|mesh-list
19700182|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700183|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
20494037|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
20494038|NCT01619644|Valproic Acid|valproic acid|mesh-list
20494039|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
20494040|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494041|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494042|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
20494043|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494044|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494045|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
20494046|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20494047|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494048|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19414696|NCT03373435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20494049|NCT01619683|Enclomiphene|enclomiphene|mesh-list
20494050|NCT01619683|Clomiphene|clomiphene|mesh-list
20494051|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
20494052|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20494053|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
20494054|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414697|NCT03373435|Hormones|hormones|mesh-ancestor
19414698|NCT03373435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414699|NCT03373435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414700|NCT03373435|Incretins|incretins|mesh-ancestor
19414701|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
19414702|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494055|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494056|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20494057|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
20494058|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20494059|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20494060|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20494061|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
20494062|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
20494063|NCT01619761|Melphalan|melphalan|mesh-list
20494064|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
20494065|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20494066|NCT01619761|Rituximab|rituximab|mesh-list
20494067|NCT01619761|Fludarabine|fludarabine|mesh-list
20494068|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
20494069|NCT01619761|Lenalidomide|lenalidomide|mesh-list
20494070|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20494071|NCT01619761|Tacrolimus|tacrolimus|mesh-list
20242614|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242615|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242616|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20494072|NCT01619761|Antibodies|antibodies|mesh-list
20494073|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
20494074|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20242617|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
20242618|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
20242619|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20242620|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
20242621|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242622|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242623|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
20242624|NCT00412321|Siltuximab|siltuximab|mesh-list
20242625|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242626|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20242627|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
20242628|NCT00412334|Ribavirin|ribavirin|mesh-list
20494075|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700184|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700185|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19700186|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20494076|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
20494077|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494078|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20494079|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20494080|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
20494081|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494082|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494083|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19700187|NCT04895917|Growth Substances|growth substances|mesh-ancestor
19700188|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
19700189|NCT04895657|Tazobactam|tazobactam|mesh-list
19700190|NCT04895657|Piperacillin|piperacillin|mesh-list
19700191|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20494084|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20494085|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
20494086|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20494087|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494088|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20494089|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20494090|NCT01619761|Growth Substances|growth substances|mesh-ancestor
20494091|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
20494092|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494093|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20494094|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
20494095|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20494096|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494097|NCT01619813|Prednisone|prednisone|mesh-list
20494098|NCT01619813|Docetaxel|docetaxel|mesh-list
20494099|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494100|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
20242629|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
20494101|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
20494102|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
20494103|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494104|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20494105|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
20494106|NCT01619813|Hormones|hormones|mesh-ancestor
20494107|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494108|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494109|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20494110|NCT01619891|Vitamin D|vitamin d|mesh-list
20494111|NCT01619891|Vitamins|vitamins|mesh-ancestor
20494112|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
20494113|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494114|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20494115|NCT01620112|Lidocaine|lidocaine|mesh-list
20494116|NCT01620112|Clonidine|clonidine|mesh-list
20494117|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
20494118|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
20494119|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494120|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494121|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
20494122|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494123|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20494124|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19700192|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20494125|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20494126|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494127|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494128|NCT01620112|Analgesics|analgesics|mesh-ancestor
20494129|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20494130|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
20494131|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
20494132|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20494133|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20494134|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20494135|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
20494136|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700193|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414703|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414704|NCT03352427|Everolimus|everolimus|mesh-list
19414705|NCT03352427|Dasatinib|dasatinib|mesh-list
19414706|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414707|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414708|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
19414709|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414710|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19414711|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414712|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414713|NCT03350035|Ganaxolone|ganaxolone|mesh-list
19414714|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
19414715|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414716|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414717|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414718|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
19414719|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
19414720|NCT03345082|Ranibizumab|ranibizumab|mesh-list
19414721|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19855618|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20494137|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20494138|NCT01620229|Antibodies|antibodies|mesh-list
20494139|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
20494140|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20494141|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
20494142|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
20494143|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494144|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20494145|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494146|NCT01620268|Leflunomide|leflunomide|mesh-list
20494147|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494148|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494149|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494150|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
20494151|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494152|NCT01620307|Sirolimus|sirolimus|mesh-list
20494153|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20494154|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416915|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
20494155|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494156|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494157|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
20494158|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494159|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
20494160|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494161|NCT01620320|Dobutamine|dobutamine|mesh-list
20242630|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242631|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
20242632|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494162|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20494163|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
20494164|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
19700194|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19700195|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700196|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700197|NCT04895423|Cyclosporine|cyclosporine|mesh-list
19700198|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
19700199|NCT04895423|Methotrexate|methotrexate|mesh-list
19700200|NCT04895423|Cyclosporins|cyclosporins|mesh-list
19700201|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20242633|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
20494165|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700202|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
20242634|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494166|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494167|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20242635|NCT00412347|Insulin|insulin|mesh-list
20242636|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20242637|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242638|NCT00412412|Trastuzumab|trastuzumab|mesh-list
20494168|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20494169|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20494170|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
20494171|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494172|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494173|NCT01620320|Protective Agents|protective agents|mesh-ancestor
20494174|NCT01620333|Insulin|insulin|mesh-list
20494175|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20494176|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
20494177|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
20494178|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20494179|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
20494180|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494181|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494182|NCT01620424|Insulin|insulin|mesh-list
20494183|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19700203|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20494184|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
20494185|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
20494186|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20494187|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
20494188|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20494189|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494190|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494191|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
20494192|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
20494193|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494194|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494195|NCT01620450|Insulin|insulin|mesh-list
20494196|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20494197|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494198|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494199|NCT01620463|Liraglutide|liraglutide|mesh-list
20494200|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494201|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494202|NCT01620463|Incretins|incretins|mesh-ancestor
20494203|NCT01620463|Hormones|hormones|mesh-ancestor
20494204|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494205|NCT01620476|Liraglutide|liraglutide|mesh-list
20494206|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494207|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494208|NCT01620476|Incretins|incretins|mesh-ancestor
20494209|NCT01620476|Hormones|hormones|mesh-ancestor
20494210|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528753|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528754|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
20528755|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20528756|NCT01776684|Gefitinib|gefitinib|mesh-list
20528757|NCT01776684|Afatinib|afatinib|mesh-list
20528758|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528759|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20528760|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528761|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528762|NCT01776788|Insulin|insulin|mesh-list
20494211|NCT01620684|Metyrapone|metyrapone|mesh-list
20494212|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
20494213|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494214|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494215|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
20494216|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20494217|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20494218|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
20494219|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494220|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20494221|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20494222|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494223|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494224|NCT01620788|Losartan|losartan|mesh-list
20494225|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20494226|NCT01620788|Indapamide|indapamide|mesh-list
20494227|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20494228|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20494229|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20494230|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20494231|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494232|NCT01620788|Diuretics|diuretics|mesh-ancestor
20494233|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
20494234|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494235|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20494236|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494237|NCT01620814|Misoprostol|misoprostol|mesh-list
20494238|NCT01620814|Dinoprostone|dinoprostone|mesh-list
20494239|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20494240|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
20494241|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20494242|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494243|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20494244|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20494245|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
20494246|NCT01620840|Lacosamide|lacosamide|mesh-list
20494247|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
19855619|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
20494248|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20494249|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20494250|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494251|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494252|NCT01620944|Ritonavir|ritonavir|mesh-list
20494253|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20494254|NCT01620944|Tenofovir|tenofovir|mesh-list
20494255|NCT01620944|Lamivudine|lamivudine|mesh-list
20494256|NCT01620944|Emtricitabine|emtricitabine|mesh-list
20494257|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20494258|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20494259|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20494260|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494261|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494262|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20494263|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20494264|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
20494265|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494266|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20494267|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20494268|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20528763|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20494269|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20494270|NCT01621022|Bupropion|bupropion|mesh-list
20494271|NCT01621022|Nicotine|nicotine|mesh-list
20494272|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20494273|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
20494274|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494275|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494276|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19853021|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853022|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
19853023|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853024|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
19853025|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853026|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19853027|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
19853028|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853029|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19853030|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19853031|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19853032|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19853033|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19853034|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19853035|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19853036|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
19853037|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19853038|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19853039|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19853040|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
20494277|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20494278|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
20494279|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494280|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494281|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20494282|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
20494283|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20494284|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20494285|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20494286|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494287|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
20494288|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20494289|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20494290|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494291|NCT01621100|Hydromorphone|hydromorphone|mesh-list
20494292|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20494293|NCT01621100|Narcotics|narcotics|mesh-ancestor
20494294|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494295|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494296|NCT01621100|Analgesics|analgesics|mesh-ancestor
20494297|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
20494298|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700204|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700205|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19414722|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19414723|NCT03345082|Growth Substances|growth substances|mesh-ancestor
19414724|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414725|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
19414726|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700206|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
19700207|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494299|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
19414727|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
19414728|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
19414729|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414730|NCT03340974|Protective Agents|protective agents|mesh-ancestor
19700208|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242639|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20494300|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20242640|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242641|NCT00412503|Temozolomide|temozolomide|mesh-list
20242642|NCT00412503|Topotecan|topotecan|mesh-list
20242643|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20242644|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
20242645|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494301|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494302|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494303|NCT01621165|Prazosin|prazosin|mesh-list
20494304|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20494305|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20494306|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20494307|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20494308|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
20494309|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494310|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494311|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494312|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
20494313|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20494314|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
20494315|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20494316|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
20494317|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494318|NCT01621217|Cetuximab|cetuximab|mesh-list
20494319|NCT01621217|Mitomycins|mitomycins|mesh-list
20494320|NCT01621217|Mitomycin|mitomycin|mesh-list
20494321|NCT01621217|Fluorouracil|fluorouracil|mesh-list
20494322|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20494323|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494324|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494325|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
20494326|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494327|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20494328|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494329|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
20494330|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20494331|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494332|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
20494333|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494334|NCT01621256|Ancrod|ancrod|mesh-list
20494335|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
20494336|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20494337|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20494338|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494339|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20494340|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20494341|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494342|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494343|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
20494344|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494345|NCT01621308|Insulin|insulin|mesh-list
20494346|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494347|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494348|NCT01621321|Voriconazole|voriconazole|mesh-list
20494349|NCT01621321|Prednisolone|prednisolone|mesh-list
20494350|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20494351|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
20494352|NCT01621321|Hormones|hormones|mesh-ancestor
20494353|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494354|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494355|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20494356|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494357|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
20494358|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494359|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20494360|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20494361|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494362|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494363|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20494364|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
20494365|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20494366|NCT01621373|Propofol|propofol|mesh-list
20494367|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20494368|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494369|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700209|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700210|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700211|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19700212|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700213|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
19700214|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19700215|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19700216|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
19700217|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700218|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19700219|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494370|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20494371|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
20494372|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
20494373|NCT01621386|Prednisone|prednisone|mesh-list
20494374|NCT01621386|Montelukast|montelukast|mesh-list
20494375|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414731|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414732|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
19414733|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19700220|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19700221|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
19700222|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19700223|NCT04895800|Caffeine|caffeine|mesh-list
20494376|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
20494377|NCT01621386|Hormones|hormones|mesh-ancestor
20494378|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494379|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494380|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20494381|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494382|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20494383|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
20494384|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20494385|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
20494386|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20494387|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20494388|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494389|NCT01621451|Aspirin|aspirin|mesh-list
20494390|NCT01621451|Clopidogrel|clopidogrel|mesh-list
20494391|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20494392|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20494393|NCT01621451|Analgesics|analgesics|mesh-ancestor
20242646|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242647|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20242648|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20242649|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242650|NCT00412555|Oseltamivir|oseltamivir|mesh-list
20242651|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
20242652|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242653|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242654|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242655|NCT00412581|Lenalidomide|lenalidomide|mesh-list
20242656|NCT00412581|Dacarbazine|dacarbazine|mesh-list
20242657|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
20242658|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242659|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20242660|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20494394|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
20494395|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494396|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494397|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20494398|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20494399|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20494400|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20494401|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494402|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20494403|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20494404|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494405|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
20494406|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20494407|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20494408|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20494409|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
20494410|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494411|NCT01621568|Sunitinib|sunitinib|mesh-list
20494412|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700224|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19700225|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700226|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19700227|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494413|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20494414|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20494415|NCT01621568|Growth Substances|growth substances|mesh-ancestor
20494416|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494417|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
20494418|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20494419|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494420|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494421|NCT01621620|Yohimbine|yohimbine|mesh-list
20494422|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
20494423|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
20494424|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494425|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494426|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20494427|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20494428|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20242661|NCT00412581|Growth Substances|growth substances|mesh-ancestor
20242662|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
20242663|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494429|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
20494430|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494431|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494432|NCT01621620|Urological Agents|urological agents|mesh-ancestor
20494433|NCT01621698|Fentanyl|fentanyl|mesh-list
20494434|NCT01621698|Bupivacaine|bupivacaine|mesh-list
20494435|NCT01621698|Propofol|propofol|mesh-list
20494436|NCT01621698|Atracurium|atracurium|mesh-list
20494437|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
20494438|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
20494439|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494440|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494441|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
20494442|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494443|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20494444|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20494445|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
20494446|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20494447|NCT01621698|Narcotics|narcotics|mesh-ancestor
20494448|NCT01621698|Analgesics|analgesics|mesh-ancestor
20494449|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20494450|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20494451|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20494452|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20494453|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20494454|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20494455|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
20494456|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494457|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494458|NCT01621750|Clopidogrel|clopidogrel|mesh-list
20494459|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20494460|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20494461|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20494462|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20494463|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
20494464|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494465|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494466|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494467|NCT01621763|Clopidogrel|clopidogrel|mesh-list
20494468|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20494469|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20494470|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20494471|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20494472|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
20494473|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528764|NCT01776788|Exenatide|exenatide|mesh-list
20494474|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494475|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494476|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
20494477|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20494478|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20494479|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494480|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20494481|NCT01621893|Calcium|calcium|mesh-list
20494482|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20494483|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494484|NCT01621906|Alovudine|alovudine|mesh-list
20494485|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
20494486|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494487|NCT01621971|Milrinone|milrinone|mesh-list
20494488|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20494489|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20494490|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
20494491|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20494492|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20494493|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494494|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494495|NCT01621971|Protective Agents|protective agents|mesh-ancestor
20494496|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494497|NCT01622075|Paclitaxel|paclitaxel|mesh-list
20494498|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20494499|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20494500|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494501|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
20494502|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
20494503|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
20494504|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494505|NCT01622283|Cetirizine|cetirizine|mesh-list
20494506|NCT01622283|Levocetirizine|levocetirizine|mesh-list
20494507|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20494508|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20494509|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20242664|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20242665|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
20242666|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242667|NCT00412594|Rituximab|rituximab|mesh-list
20242668|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20242669|NCT00412594|Cladribine|cladribine|mesh-list
20242670|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
20242671|NCT00412594|Antibodies|antibodies|mesh-list
20242672|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
20242673|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20242674|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
20242675|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494510|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
20494511|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
20494512|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494513|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494514|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494515|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
20494516|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20494517|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
20494518|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
20494519|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494520|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494521|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20494522|NCT01622322|Analgesics|analgesics|mesh-ancestor
20494523|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
20494524|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494525|NCT01622361|Tamoxifen|tamoxifen|mesh-list
20242676|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494526|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
20494527|NCT01622361|Docetaxel|docetaxel|mesh-list
20494528|NCT01622361|Doxorubicin|doxorubicin|mesh-list
20494529|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20494530|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494531|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
20494532|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494533|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20494534|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20494535|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
20494536|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853041|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19853042|NCT00729612|Paclitaxel|paclitaxel|mesh-list
19853043|NCT00729612|Carboplatin|carboplatin|mesh-list
19853044|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19853045|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20494537|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494538|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20494539|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
20494540|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
20494541|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
20494542|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494543|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20494544|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20494545|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494546|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20494547|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
20494548|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494549|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20494550|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20494551|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20494552|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20528765|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
20528766|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20242677|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242678|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242679|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242680|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
20242681|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242682|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
20242683|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242684|NCT00412646|Etravirine|etravirine|mesh-list
20242685|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20242686|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20242687|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242688|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242689|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
20242690|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242691|NCT00412698|Rimonabant|rimonabant|mesh-list
20242692|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20242693|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20242694|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20242695|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242696|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242697|NCT00412698|Hormones|hormones|mesh-ancestor
20242698|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242699|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242700|NCT00412763|Silymarin|silymarin|mesh-list
20242701|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
20242702|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494553|NCT01622439|Prednisone|prednisone|mesh-list
20494554|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
20494555|NCT01622439|Rituximab|rituximab|mesh-list
20494556|NCT01622439|Doxorubicin|doxorubicin|mesh-list
20494557|NCT01622439|Vincristine|vincristine|mesh-list
20494558|NCT01622439|Valproic Acid|valproic acid|mesh-list
20494559|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494560|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
20494561|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494562|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20494563|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20494564|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
20494565|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494566|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494567|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20494568|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20494569|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494570|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20494571|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20494572|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494573|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20494574|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
20494575|NCT01622439|Hormones|hormones|mesh-ancestor
20494576|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494577|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20494578|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20494579|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
20494580|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
20494581|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
20494582|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
20494583|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
20494584|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494585|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
20494586|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20494587|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494588|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20494589|NCT01622504|Naloxone|naloxone|mesh-list
20494590|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20494591|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494592|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
20494593|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494594|NCT01622556|Fludarabine|fludarabine|mesh-list
20494595|NCT01622556|Busulfan|busulfan|mesh-list
20494596|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
20494597|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494598|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494599|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494600|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
20494601|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494602|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
20494603|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20494604|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20494605|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20494606|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20242703|NCT00412763|Protective Agents|protective agents|mesh-ancestor
20242704|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242705|NCT00412789|Epothilone B|epothilone b|mesh-list
20242706|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242707|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
20242708|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
20242709|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
20242710|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242711|NCT00412802|Enoxaparin|enoxaparin|mesh-list
20242712|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
20242713|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
20242714|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20242715|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20242716|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494607|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20494608|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
20494609|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494610|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20494611|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20494612|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494613|NCT01622790|Lamivudine|lamivudine|mesh-list
20494614|NCT01622790|Abacavir|abacavir|mesh-list
20494615|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
20494616|NCT01622790|Dolutegravir|dolutegravir|mesh-list
20494617|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20494618|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20494619|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494620|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494621|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
20494622|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494623|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20494624|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20494625|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
20494626|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20494627|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20494628|NCT01622881|Nefopam|nefopam|mesh-list
20494629|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20494630|NCT01622881|Analgesics|analgesics|mesh-ancestor
20494631|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
20494632|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494633|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494634|NCT01622933|Interferons|interferons|mesh-list
20494635|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
20494636|NCT01622933|Vaccines|vaccines|mesh-list
20494637|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494638|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
20494639|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494640|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
20494641|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494642|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
20494643|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20494644|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20494645|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494646|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
20494647|NCT01622946|Coagulants|coagulants|mesh-ancestor
20494648|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20494649|NCT01622972|Laxatives|laxatives|mesh-ancestor
20494650|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20494651|NCT01623024|Vitamin D|vitamin d|mesh-list
20494652|NCT01623024|Vitamins|vitamins|mesh-ancestor
20494653|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
20494654|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494655|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20494656|NCT01623102|Gemcitabine|gemcitabine|mesh-list
20494657|NCT01623102|Bevacizumab|bevacizumab|mesh-list
20494658|NCT01623102|Cisplatin|cisplatin|mesh-list
20494659|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20494660|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494661|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20494662|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20494663|NCT01623102|Growth Substances|growth substances|mesh-ancestor
20494664|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494665|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
20494666|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20494667|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
20494668|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494669|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
20494670|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494671|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494672|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494673|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
20494674|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20494675|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
20494676|NCT01623206|Coagulants|coagulants|mesh-ancestor
20494677|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20494678|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
20494679|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494680|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20494681|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20494682|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494683|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20494684|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20494685|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
20494686|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
20494687|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494688|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
20494689|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494690|NCT01623349|Olaparib|olaparib|mesh-list
20494691|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20494692|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494693|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494694|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494695|NCT01623362|Fluorides|fluorides|mesh-list
20494696|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
20494697|NCT01623362|Protective Agents|protective agents|mesh-ancestor
20494698|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494699|NCT01623375|Insulin|insulin|mesh-list
20494700|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20494701|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
20494702|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494703|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494704|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
20494705|NCT01623401|Tedizolid|tedizolid|mesh-list
20494706|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20494707|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494708|NCT01623440|Naltrexone|naltrexone|mesh-list
20494709|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20494710|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20494711|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494712|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
20494713|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494714|NCT01623505|Varenicline|varenicline|mesh-list
20494715|NCT01623505|Nicotine|nicotine|mesh-list
20494716|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20494717|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20494718|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
20494719|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494720|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494721|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494722|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20494723|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
20494724|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494725|NCT01623570|Menotropins|menotropins|mesh-list
20494726|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20494727|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
20494728|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20494729|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494730|NCT01623609|Naloxegol|naloxegol|mesh-list
20494731|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20494732|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494733|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
20494734|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494735|NCT01623635|Ropivacaine|ropivacaine|mesh-list
20494736|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
20494737|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
20494738|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494739|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494740|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
20494741|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494742|NCT01623713|Risperidone|risperidone|mesh-list
20494743|NCT01623713|Iloperidone|iloperidone|mesh-list
20494744|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20494745|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
20494746|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494747|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494748|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494749|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20494750|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20494751|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494752|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20494753|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20494754|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
20494755|NCT01623778|Interferons|interferons|mesh-list
20494756|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
20494757|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
20494758|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494759|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
20494760|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494761|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
20494762|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494763|NCT01623817|Vancomycin|vancomycin|mesh-list
20494764|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20494765|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494766|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
20494767|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20494768|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494769|NCT01623921|Celecoxib|celecoxib|mesh-list
20494770|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20494771|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20494772|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20494773|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
20494774|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494775|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20494776|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20494777|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494778|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20494779|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20494780|NCT01623921|Analgesics|analgesics|mesh-ancestor
20494781|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
20494782|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494783|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494784|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20494785|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20494786|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20494787|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20528767|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528768|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20528769|NCT01776788|Incretins|incretins|mesh-ancestor
20528770|NCT01776788|Hormones|hormones|mesh-ancestor
20528771|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20528772|NCT01776853|Levan|levan|mesh-list
20528773|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528774|NCT01776970|Nabiximols|nabiximols|mesh-list
20528775|NCT01776970|Analgesics|analgesics|mesh-ancestor
20528776|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
20528777|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528778|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528779|NCT01777087|Capsaicin|capsaicin|mesh-list
20528780|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
20528781|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
20528782|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
20528783|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528784|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528785|NCT01777100|Sufentanil|sufentanil|mesh-list
20528786|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20528787|NCT01777100|Narcotics|narcotics|mesh-ancestor
20528788|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528789|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528790|NCT01777100|Analgesics|analgesics|mesh-ancestor
20528791|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
20528792|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528793|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20528794|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20528795|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
20528796|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
20528797|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20494788|NCT01624025|Docetaxel|docetaxel|mesh-list
20494789|NCT01624025|Epirubicin|epirubicin|mesh-list
20494790|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494791|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
20494792|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
20494793|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
20494794|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494795|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494796|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20494797|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19700228|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700229|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19700230|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19700231|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
19700232|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700233|NCT04895592|Dexamethasone|dexamethasone|mesh-list
19700234|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
19700235|NCT04895592|Ichthammol|ichthammol|mesh-list
20494798|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494799|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
20494800|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494801|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
20494802|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494803|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494804|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20494805|NCT01624051|Cisplatin|cisplatin|mesh-list
20494806|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494807|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
20494808|NCT01624064|Enalapril|enalapril|mesh-list
20494809|NCT01624064|Calcium|calcium|mesh-list
20494810|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20494811|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20494812|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19700236|NCT04895592|BB 1101|bb 1101|mesh-list
19700237|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700238|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
20494813|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700239|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
20494814|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20494815|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
20494816|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494817|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20494818|NCT01624103|Lidocaine|lidocaine|mesh-list
20494819|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
20494820|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
20494821|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
20494822|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494823|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494824|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
20494825|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494826|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20494827|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20494828|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20494829|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494830|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494831|NCT01624116|Metformin|metformin|mesh-list
20494832|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20494833|NCT01624116|Acarbose|acarbose|mesh-list
20494834|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20494835|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494836|NCT01624116|Incretins|incretins|mesh-ancestor
19700240|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700241|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494837|NCT01624116|Hormones|hormones|mesh-ancestor
20494838|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494839|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20494840|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
20494841|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494842|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494843|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20494844|NCT01624129|Fluticasone|fluticasone|mesh-list
20494845|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20494846|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20494847|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
20494848|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494849|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494850|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19700242|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700243|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
19700244|NCT04895592|Hormones|hormones|mesh-ancestor
19700245|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700246|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19700247|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700248|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
19700249|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700250|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700251|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700252|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19700253|NCT04895566|Antibodies|antibodies|mesh-list
19700254|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
19700255|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19700256|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
19700257|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700258|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700259|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19700260|NCT04895059|Ezetimibe|ezetimibe|mesh-list
19700261|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20242717|NCT00412919|Azacitidine|azacitidine|mesh-list
20242718|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19700262|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19700263|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
19700264|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242719|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
20242720|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242721|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242722|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242723|NCT00412997|Panobinostat|panobinostat|mesh-list
20242724|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494851|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
20494852|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
20494853|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20494854|NCT01624207|Atorvastatin|atorvastatin|mesh-list
20494855|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20494856|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20494857|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
20494858|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494859|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20494860|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20494861|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700265|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20494862|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20494863|NCT01624246|Avibactam|avibactam|mesh-list
20494864|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20494865|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494866|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20494867|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494868|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494869|NCT01624285|Sorafenib|sorafenib|mesh-list
20494870|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494871|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20494872|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494873|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494874|NCT01624337|Piperaquine|piperaquine|mesh-list
20494875|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
20494876|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20494877|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20494878|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494879|NCT01624428|Varenicline|varenicline|mesh-list
20494880|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20494881|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20494882|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
20494883|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494884|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494885|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494886|NCT01624441|Epirubicin|epirubicin|mesh-list
20494887|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494888|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494889|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20494890|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20494891|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494892|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494893|NCT01624493|Gemcitabine|gemcitabine|mesh-list
20494894|NCT01624493|Carboplatin|carboplatin|mesh-list
20494895|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494896|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20494897|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
20494898|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494899|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
20494900|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494901|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494902|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494903|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
20494904|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494905|NCT01624649|Methylphenidate|methylphenidate|mesh-list
20494906|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20494907|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20494908|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494909|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20494910|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20494911|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20494912|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494913|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
20494914|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494915|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20494916|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20494917|NCT01624675|Risperidone|risperidone|mesh-list
20494918|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20494919|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
20494920|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20494921|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494922|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494923|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20494924|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20494925|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20494926|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20494927|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20494928|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
19414734|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414735|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
19414736|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414737|NCT03321526|Norepinephrine|norepinephrine|mesh-list
19414738|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19414739|NCT03321526|Serotonin|serotonin|mesh-list
19414740|NCT03321526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19414741|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
19414742|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19414743|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19414744|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19414745|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414746|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414747|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19414748|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20494929|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
19414749|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19414750|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414751|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414752|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
19414753|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
19414754|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414755|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19414756|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19414757|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
20494930|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20494931|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494932|NCT01624766|Denosumab|denosumab|mesh-list
20494933|NCT01624766|Everolimus|everolimus|mesh-list
20494934|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20494935|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494936|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494937|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
20494938|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494939|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20494940|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20494941|NCT01624805|Cyclosporine|cyclosporine|mesh-list
20494942|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
20494943|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20494944|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20494945|NCT01624805|Prednisolone|prednisolone|mesh-list
20494946|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
20494947|NCT01624805|Lenograstim|lenograstim|mesh-list
20494948|NCT01624805|Cyclosporins|cyclosporins|mesh-list
20494949|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
20494950|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20494951|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20494952|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
20494953|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20494954|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
20494955|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494956|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494957|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494958|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494959|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
20494960|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20494961|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
20494962|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20494963|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20494964|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20494965|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
20494966|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
20494967|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20494968|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20494969|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
20494970|NCT01624805|Hormones|hormones|mesh-ancestor
20494971|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20494972|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20494973|NCT01624805|Protective Agents|protective agents|mesh-ancestor
20494974|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708516|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494975|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494976|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20242725|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20242726|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242727|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242728|NCT00413023|Casopitant|casopitant|mesh-list
20242729|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
20242730|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
20242731|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242732|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242733|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20242734|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20494977|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20494978|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20494979|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
20494980|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20494981|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20494982|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20494983|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20494984|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20494985|NCT01625026|Cathartics|cathartics|mesh-ancestor
20494986|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20494987|NCT01625156|Sirolimus|sirolimus|mesh-list
20242735|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242736|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242737|NCT00413075|Belinostat|belinostat|mesh-list
20242738|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242739|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20242740|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242741|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242742|NCT00413088|Bemiparin|bemiparin|mesh-list
20242743|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
20494988|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20494989|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414758|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19414759|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414760|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
19414761|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19414762|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
19414763|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19414764|NCT03320434|Prednisolone|prednisolone|mesh-list
19414765|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20494990|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20494991|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20494992|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
20494993|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20494994|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
20494995|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20494996|NCT01625260|Gemcitabine|gemcitabine|mesh-list
20494997|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20494998|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
20494999|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495000|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495001|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
20495002|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495003|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700266|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20242744|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
20242745|NCT00413101|Hematinics|hematinics|mesh-ancestor
20242746|NCT00413127|Lidocaine|lidocaine|mesh-list
20242747|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
20242748|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
20242749|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242750|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242751|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
20242752|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242753|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20242754|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20242755|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20242756|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20242757|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242758|NCT00413179|Metformin|metformin|mesh-list
20242759|NCT00413179|Clomiphene|clomiphene|mesh-list
19700267|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700268|NCT04895007|Vaccines|vaccines|mesh-list
19700269|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
19700270|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700271|NCT04895137|Bevacizumab|bevacizumab|mesh-list
19700272|NCT04895137|Antibodies|antibodies|mesh-list
19700273|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20495004|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495005|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
20495006|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495007|NCT01625351|Sirolimus|sirolimus|mesh-list
20495008|NCT01625351|Fludarabine|fludarabine|mesh-list
20495009|NCT01625351|Melphalan|melphalan|mesh-list
20495010|NCT01625351|Busulfan|busulfan|mesh-list
19700274|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19700275|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700276|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19700277|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20495011|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
20495012|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
20495013|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495014|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242760|NCT00413179|Enclomiphene|enclomiphene|mesh-list
20242761|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
20242762|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19700278|NCT04895137|Growth Substances|growth substances|mesh-ancestor
20242763|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242764|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20242765|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
20242766|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495015|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495016|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
20495017|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495018|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20495019|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495020|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20495021|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
20495022|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20495023|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
20495024|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20495025|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20495026|NCT01625429|Paclitaxel|paclitaxel|mesh-list
20495027|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20495028|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495029|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
20495030|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
20495031|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
20495032|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495033|NCT01625494|Amlodipine|amlodipine|mesh-list
20495034|NCT01625494|Irbesartan|irbesartan|mesh-list
20495035|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20495036|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20495037|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495038|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495039|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495040|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495041|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
20495042|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20495043|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20495044|NCT01625520|Everolimus|everolimus|mesh-list
20495045|NCT01625520|Pasireotide|pasireotide|mesh-list
20495046|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495047|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495048|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
20495049|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495050|NCT01625520|Hormones|hormones|mesh-ancestor
19853046|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853047|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19853048|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853049|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19853050|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853051|NCT00729690|Pregabalin|pregabalin|mesh-list
19853052|NCT00729690|Analgesics|analgesics|mesh-ancestor
19853053|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
19853054|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853055|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853056|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
19853057|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19853058|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853059|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853060|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19853061|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19853062|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20495051|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495052|NCT01625572|Morphine|morphine|mesh-list
20495053|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20495054|NCT01625572|Narcotics|narcotics|mesh-ancestor
20495055|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495056|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495057|NCT01625572|Analgesics|analgesics|mesh-ancestor
20495058|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
20495059|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495060|NCT01625715|Ketotifen|ketotifen|mesh-list
20242767|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20242768|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
20242769|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20242770|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20242771|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20242772|NCT00413257|Nefopam|nefopam|mesh-list
20242773|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20242774|NCT00413257|Analgesics|analgesics|mesh-ancestor
20495061|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
20495062|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
20495063|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20495064|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
20495065|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
20495066|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495067|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528798|NCT01777464|Histamine|histamine|mesh-list
19700279|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700280|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
19700281|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
19708011|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495068|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495069|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20495070|NCT01625741|Rituximab|rituximab|mesh-list
20495071|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20495072|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495073|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
20495074|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495075|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528799|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
20528800|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
20528801|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528802|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528803|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528804|NCT01777477|Gemcitabine|gemcitabine|mesh-list
20528805|NCT01777477|Chloroquine|chloroquine|mesh-list
20528806|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20528807|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
20528808|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528809|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528810|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
20528811|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528812|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528813|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20528814|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
20528815|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528816|NCT01777477|Amebicides|amebicides|mesh-ancestor
20528817|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20528818|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20528819|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
20528820|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20528821|NCT01777503|Clopidogrel|clopidogrel|mesh-list
20528822|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20528823|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20528824|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20528825|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20528826|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20528827|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
20528828|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528829|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414766|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
19708012|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495076|NCT01625793|Interferons|interferons|mesh-list
20495077|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
20495078|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495079|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
20495080|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495081|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
20495082|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495083|NCT01625806|Ketoconazole|ketoconazole|mesh-list
20495084|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
20495085|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242775|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
20242776|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242777|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242778|NCT00413296|Levetiracetam|levetiracetam|mesh-list
19700282|NCT04894994|Ipilimumab|ipilimumab|mesh-list
20242779|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
20242780|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
20242781|NCT00413322|Fluorouracil|fluorouracil|mesh-list
20242782|NCT00413322|Belinostat|belinostat|mesh-list
20242783|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
20242784|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242785|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20242786|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242787|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242788|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
20242789|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242790|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20242791|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242792|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
20242793|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
20242794|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20495086|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20495087|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20495088|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495089|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495090|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20495091|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
20495092|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700283|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20495093|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495094|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20495095|NCT01625871|Lumefantrine|lumefantrine|mesh-list
20495096|NCT01625871|Artemether|artemether|mesh-list
20495097|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20495098|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
20495099|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20495100|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19700284|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700285|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19700286|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700287|NCT04894643|Gemcitabine|gemcitabine|mesh-list
19700288|NCT04894643|Paclitaxel|paclitaxel|mesh-list
19700289|NCT04894643|Capecitabine|capecitabine|mesh-list
19700290|NCT04894643|Pancrelipase|pancrelipase|mesh-list
19700291|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19700292|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700293|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
19700294|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
19700295|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
19700296|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700297|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19700298|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
19700299|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
20495101|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495102|NCT01625936|Bevacizumab|bevacizumab|mesh-list
20495103|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20495104|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495105|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20242795|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20495106|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20495107|NCT01625936|Growth Substances|growth substances|mesh-ancestor
20495108|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495109|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
20495110|NCT01626222|Everolimus|everolimus|mesh-list
20495111|NCT01626222|Exemestane|exemestane|mesh-list
20495112|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495113|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495114|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
20495115|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495116|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20495117|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20495118|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495119|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495120|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20242796|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242797|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242798|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242799|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242800|NCT00413387|Budesonide|budesonide|mesh-list
20242801|NCT00413387|Beclomethasone|beclomethasone|mesh-list
20242802|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
20242803|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495121|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
20495122|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495123|NCT01626339|Bevacizumab|bevacizumab|mesh-list
20495124|NCT01626339|Ranibizumab|ranibizumab|mesh-list
20495125|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20495126|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495127|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20495128|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20495129|NCT01626339|Growth Substances|growth substances|mesh-ancestor
20495130|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495131|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
20495132|NCT01626443|Folic Acid|folic acid|mesh-list
20495133|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
20495134|NCT01626443|Inositol|inositol|mesh-list
20242804|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20242805|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
20242806|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495135|NCT01626443|Hematinics|hematinics|mesh-ancestor
20495136|NCT01626443|Vitamins|vitamins|mesh-ancestor
20495137|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
20495138|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495139|NCT01626469|Captopril|captopril|mesh-list
20495140|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20495141|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
20495142|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495143|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495144|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20495145|NCT01626534|Clopidogrel|clopidogrel|mesh-list
20495146|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20495147|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20495148|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20495149|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20495150|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
20495151|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495152|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495153|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495154|NCT01626560|Vancomycin|vancomycin|mesh-list
20495155|NCT01626560|Daptomycin|daptomycin|mesh-list
20495156|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20495157|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495158|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
20495159|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20495160|NCT01626651|Ketoconazole|ketoconazole|mesh-list
20495161|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
20495162|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495163|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20495164|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20495165|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495166|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495167|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20495168|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
20495169|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495170|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495171|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20495172|NCT01626911|Heparin|heparin|mesh-list
20495173|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20495174|NCT01626911|Tinzaparin|tinzaparin|mesh-list
20495175|NCT01626911|Dalteparin|dalteparin|mesh-list
20495176|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
20495177|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20495178|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20495179|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495180|NCT01627041|Cytarabine|cytarabine|mesh-list
20495181|NCT01627041|Decitabine|decitabine|mesh-list
20495182|NCT01627041|Daunorubicin|daunorubicin|mesh-list
20495183|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495184|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
20495185|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495186|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495187|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
20495188|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495189|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495190|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
20495191|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495192|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495193|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20495194|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20495195|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20495196|NCT01627106|Amiodarone|amiodarone|mesh-list
20495197|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20495198|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
20495199|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20495200|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495201|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495202|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20495203|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20495204|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20495205|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495206|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20495207|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20495208|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20495209|NCT01627132|Dasatinib|dasatinib|mesh-list
20495210|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495211|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20495212|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495213|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495214|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
20495215|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20495216|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20495217|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
20495218|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495219|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495220|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495221|NCT01627145|Urological Agents|urological agents|mesh-ancestor
20495222|NCT01627158|Budesonide|budesonide|mesh-list
20495223|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
20495224|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20495225|NCT01627158|Charcoal|charcoal|mesh-list
20495226|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495227|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20495228|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
20495229|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495230|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495231|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20495232|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
20495233|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
20495234|NCT01627158|Hormones|hormones|mesh-ancestor
19700300|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700301|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495235|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495236|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20495237|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20495238|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20495239|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
20495240|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495241|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495242|NCT01627158|Antidotes|antidotes|mesh-ancestor
20495243|NCT01627158|Protective Agents|protective agents|mesh-ancestor
20495244|NCT01627171|Bisacodyl|bisacodyl|mesh-list
20495245|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
20495246|NCT01627171|Cathartics|cathartics|mesh-ancestor
20495247|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495248|NCT01627171|Laxatives|laxatives|mesh-ancestor
20495249|NCT01627223|Lamivudine|lamivudine|mesh-list
20495250|NCT01627223|Entecavir|entecavir|mesh-list
20495251|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20495252|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20495253|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495254|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495255|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
20495256|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495257|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20495258|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20495259|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
20495260|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20495261|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20495262|NCT01627236|Prednisolone|prednisolone|mesh-list
20495263|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
20495264|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20495265|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
20495266|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495267|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
20495268|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
20495269|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495270|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495271|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495272|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
20495273|NCT01627236|Hormones|hormones|mesh-ancestor
20495274|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495275|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20495276|NCT01627236|Protective Agents|protective agents|mesh-ancestor
20495277|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20495278|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495279|NCT01627262|Mesalamine|mesalamine|mesh-list
20495280|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20495281|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495282|NCT01627262|Analgesics|analgesics|mesh-ancestor
20495283|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
20495284|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495285|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495286|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495287|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20495288|NCT01627353|Dexamethasone|dexamethasone|mesh-list
20495289|NCT01627353|Lidocaine|lidocaine|mesh-list
20495290|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
20495291|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495292|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
20495293|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
20495294|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495295|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495296|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495297|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
20495298|NCT01627353|Hormones|hormones|mesh-ancestor
20495299|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495300|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20495301|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495302|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495303|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
20495304|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
20495305|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495306|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
20495307|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20495308|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20495309|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20495310|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495311|NCT01627353|Analgesics|analgesics|mesh-ancestor
20495312|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
20495313|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20495314|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495315|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
20495316|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20495317|NCT01627379|Panitumumab|panitumumab|mesh-list
20495318|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495319|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20495320|NCT01627431|Aspirin|aspirin|mesh-list
20495321|NCT01627431|Clopidogrel|clopidogrel|mesh-list
20495322|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20495323|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495324|NCT01627431|Analgesics|analgesics|mesh-ancestor
20495325|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
20495326|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495327|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495328|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495329|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20495330|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20495331|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20495332|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495333|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20495334|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20495335|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495336|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
20495337|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20495338|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20495339|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20495340|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
20495341|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528830|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530757|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20530758|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20530759|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20530760|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530761|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530762|NCT01790529|Metronidazole|metronidazole|mesh-list
20530763|NCT01790529|Cefuroxime|cefuroxime|mesh-list
20530764|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
20530765|NCT01790529|Anesthetics|anesthetics|mesh-list
20530766|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530767|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530768|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530769|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20530770|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20530771|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19700302|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700303|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
20530772|NCT01790542|Iron|iron|mesh-list
20242807|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242808|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20242809|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
20495342|NCT01627587|Ketoconazole|ketoconazole|mesh-list
20495343|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
20495344|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495345|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20495346|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20495347|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495348|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495349|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20495350|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
20495351|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495352|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495353|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20495354|NCT01627626|Pilocarpine|pilocarpine|mesh-list
20495355|NCT01627626|Miotics|miotics|mesh-ancestor
20495356|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
20495357|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495358|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495359|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20495360|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20495361|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
20495362|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495363|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495364|NCT01627639|Acetazolamide|acetazolamide|mesh-list
20495365|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
20495366|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20495367|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495368|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242810|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
19700304|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700305|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700306|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
19414767|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414768|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
19414769|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
20495369|NCT01627639|Diuretics|diuretics|mesh-ancestor
20495370|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
20495371|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495372|NCT01627678|Molgramostim|molgramostim|mesh-list
20495373|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20495374|NCT01627678|Sargramostim|sargramostim|mesh-list
20495375|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
20495376|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495377|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495378|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20495379|NCT01627678|Antacids|antacids|mesh-ancestor
20495380|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495381|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495382|NCT01627717|Maraviroc|maraviroc|mesh-list
20495383|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20495384|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19700307|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19414770|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495385|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495386|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20495387|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20495388|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
20495389|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495390|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20495391|NCT01627834|Ropinirole|ropinirole|mesh-list
20495392|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20495393|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20495394|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
20495395|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
20495396|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495397|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495398|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495399|NCT01627847|Ropinirole|ropinirole|mesh-list
20495400|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20495401|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20495402|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
20495403|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
20495404|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495405|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495406|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495407|NCT01627873|Fentanyl|fentanyl|mesh-list
20495408|NCT01627873|Remifentanil|remifentanil|mesh-list
20495409|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20495410|NCT01627873|Narcotics|narcotics|mesh-ancestor
20495411|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495412|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495413|NCT01627873|Analgesics|analgesics|mesh-ancestor
20495414|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
20495415|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495416|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20495417|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20495418|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
20495419|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
20495420|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
20495421|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20495422|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495423|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
20495424|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
20495425|NCT01627938|Razoxane|razoxane|mesh-list
20495426|NCT01627938|Analgesics|analgesics|mesh-ancestor
20495427|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
20495428|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495429|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495430|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495431|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20495432|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20495433|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495434|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495435|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20495436|NCT01627938|Protective Agents|protective agents|mesh-ancestor
20495437|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
20495438|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
20495439|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
20495440|NCT01628055|Antibodies|antibodies|mesh-list
20495441|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
20495442|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20495443|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20495444|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
20495445|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
20495446|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495447|NCT01628211|Leucovorin|leucovorin|mesh-list
20495448|NCT01628211|Folic Acid|folic acid|mesh-list
20495449|NCT01628211|Fluorouracil|fluorouracil|mesh-list
20495450|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
20495451|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
20495452|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
20495453|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495454|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495455|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495456|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495457|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
20495458|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495459|NCT01628211|Antidotes|antidotes|mesh-ancestor
20495460|NCT01628211|Protective Agents|protective agents|mesh-ancestor
20495461|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
20495462|NCT01628211|Vitamins|vitamins|mesh-ancestor
20495463|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
20495464|NCT01628211|Hematinics|hematinics|mesh-ancestor
20495465|NCT01628341|Insulin|insulin|mesh-list
20495466|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20495467|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495468|NCT01628354|Ranibizumab|ranibizumab|mesh-list
20495469|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20495470|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20495471|NCT01628354|Growth Substances|growth substances|mesh-ancestor
20495472|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495473|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
20495474|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495475|NCT01628445|Liraglutide|liraglutide|mesh-list
20495476|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20495477|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495478|NCT01628445|Incretins|incretins|mesh-ancestor
20495479|NCT01628445|Hormones|hormones|mesh-ancestor
20495480|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495481|NCT01628471|Decitabine|decitabine|mesh-list
20495482|NCT01628471|Genistein|genistein|mesh-list
20495483|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495484|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
20495485|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495486|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495487|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495488|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20495489|NCT01628471|Protective Agents|protective agents|mesh-ancestor
20495490|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495491|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20495492|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
20495493|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20495494|NCT01628471|Estrogens|estrogens|mesh-ancestor
20495495|NCT01628471|Hormones|hormones|mesh-ancestor
20495496|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495497|NCT01628562|Remifentanil|remifentanil|mesh-list
20495498|NCT01628562|Esmolol|esmolol|mesh-list
20495499|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20495500|NCT01628562|Narcotics|narcotics|mesh-ancestor
20495501|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495502|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495503|NCT01628562|Analgesics|analgesics|mesh-ancestor
20495504|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
20495505|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495506|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20495507|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20495508|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20495509|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
20495510|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495511|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495512|NCT01628640|Interferons|interferons|mesh-list
20495513|NCT01628640|Interferon-beta|interferon-beta|mesh-list
20242811|NCT00413387|Hormones|hormones|mesh-ancestor
20242812|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20242813|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20242814|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20495514|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495515|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
20495516|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495517|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
20495518|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495519|NCT01628666|Vancomycin|vancomycin|mesh-list
20495520|NCT01628666|Cefazolin|cefazolin|mesh-list
20495521|NCT01628666|Cephalexin|cephalexin|mesh-list
20495522|NCT01628666|Bacitracin|bacitracin|mesh-list
20242815|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20495523|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20495524|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495525|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20495526|NCT01628731|Furosemide|furosemide|mesh-list
20495527|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
20495528|NCT01628731|Diuretics|diuretics|mesh-ancestor
20495529|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
20495530|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495531|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20495532|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495533|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495534|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495535|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20495536|NCT01628770|Hematinics|hematinics|mesh-ancestor
20495537|NCT01628783|Citalopram|citalopram|mesh-list
20495538|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20495539|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20495540|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495541|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495542|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495543|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
20242816|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
20242817|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242818|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242819|NCT00413426|Darifenacin|darifenacin|mesh-list
20242820|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20242821|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20242822|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
20242823|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242824|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495544|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495545|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20495546|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
20242825|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495547|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20495548|NCT01628952|Curare|curare|mesh-list
20495549|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20495550|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20495551|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20495552|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495553|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495554|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20495555|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20242826|NCT00413426|Urological Agents|urological agents|mesh-ancestor
20242827|NCT00413439|Isavuconazole|isavuconazole|mesh-list
20242828|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
20242829|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242830|NCT00413452|Etanercept|etanercept|mesh-list
20242831|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20242832|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20242833|NCT00413452|Analgesics|analgesics|mesh-ancestor
20242834|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
20242835|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495556|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
20495557|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495558|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495559|NCT01629082|Lenalidomide|lenalidomide|mesh-list
20495560|NCT01629082|Clofarabine|clofarabine|mesh-list
20495561|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
20495562|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495563|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20495564|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20495565|NCT01629082|Growth Substances|growth substances|mesh-ancestor
20495566|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
20495567|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495568|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495569|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
20495570|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495571|NCT01629173|Ethylene|ethylene|mesh-list
20495572|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20495573|NCT01629173|Growth Substances|growth substances|mesh-ancestor
20495574|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528831|NCT01777685|Sulpiride|sulpiride|mesh-list
20528832|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20528833|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20528834|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528835|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528836|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20528837|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20528838|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
20528839|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528840|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528841|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20528842|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
20528843|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20528844|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20528845|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528846|NCT01777737|Renal Agents|renal agents|mesh-ancestor
20528847|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528848|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
20528849|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20528850|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19414771|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414772|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19414773|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
19414774|NCT03320434|Hormones|hormones|mesh-ancestor
19700308|NCT04894617|Amantadine|amantadine|mesh-list
19414775|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19414776|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19414777|NCT03320434|Protective Agents|protective agents|mesh-ancestor
19414778|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19414779|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414780|NCT03318393|Heparin|heparin|mesh-list
19414781|NCT03318393|Calcium heparin|calcium heparin|mesh-list
19414782|NCT03318393|Bivalirudin|bivalirudin|mesh-list
19414783|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
19414784|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19414785|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19414786|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414787|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
19414788|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19414789|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
19414790|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414791|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19414792|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19414793|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414794|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414795|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495575|NCT01629199|Mitogens|mitogens|mesh-list
20495576|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
20495577|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495578|NCT01629212|Octylonium|octylonium|mesh-list
20495579|NCT01629212|Bromides|bromides|mesh-list
20495580|NCT01629212|Tiropramide|tiropramide|mesh-list
20495581|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
20495582|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
20495583|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
20495584|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495585|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495586|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20495587|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495588|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495589|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19414796|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
19414797|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19414798|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19414799|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
19414800|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
20495590|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495591|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20495592|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20495593|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
20495594|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495595|NCT01629225|Candesartan|candesartan|mesh-list
20495596|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20495597|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20495598|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20495599|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495600|NCT01629251|Insulin|insulin|mesh-list
20495601|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20495602|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495603|NCT01629277|Insulin|insulin|mesh-list
20495604|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20495605|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495606|NCT01629368|Carbamazepine|carbamazepine|mesh-list
20495607|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
20495608|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
20495609|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20495610|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495611|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495612|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20495613|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495614|NCT01629368|Analgesics|analgesics|mesh-ancestor
20495615|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
20495616|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495617|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20495618|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495619|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495620|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20495621|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20495622|NCT01629394|Neostigmine|neostigmine|mesh-list
20495623|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20495624|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242836|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414801|NCT03301051|Vaccines|vaccines|mesh-list
19414802|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
20242837|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20242838|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242839|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495625|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495626|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
20495627|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495628|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495629|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20495630|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
19414803|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414804|NCT03295396|TIC10 compound|tic10 compound|mesh-list
20242840|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700309|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20242841|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
20242842|NCT00413504|PENTA|penta|mesh-list
20242843|NCT00413504|Fondaparinux|fondaparinux|mesh-list
20242844|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20495631|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495632|NCT01629446|Lofexidine|lofexidine|mesh-list
20495633|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20495634|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20495635|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495636|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
20495637|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495638|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20495639|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20495640|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20495641|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
20495642|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495643|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495644|NCT01629511|Gemcitabine|gemcitabine|mesh-list
20495645|NCT01629511|Methotrexate|methotrexate|mesh-list
20495646|NCT01629511|Clofarabine|clofarabine|mesh-list
20495647|NCT01629511|Busulfan|busulfan|mesh-list
20495648|NCT01629511|Tacrolimus|tacrolimus|mesh-list
20495649|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
20495650|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20495651|NCT01629511|Lenograstim|lenograstim|mesh-list
20495652|NCT01629511|Sargramostim|sargramostim|mesh-list
20495653|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495654|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
20495655|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495656|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495657|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
20495658|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495659|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495660|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495661|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
20495662|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495663|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20495664|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
20495665|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20495666|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
20495667|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20495668|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20495669|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20495670|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20495671|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20495672|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
20495673|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20495674|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20495675|NCT01629628|Adalimumab|adalimumab|mesh-list
20495676|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
20495677|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495678|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20495679|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
20495680|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495681|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495682|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495683|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495684|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
20495685|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495686|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20495687|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495688|NCT01629680|Moxaverine|moxaverine|mesh-list
20495689|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
20495690|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
20495691|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495692|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495693|NCT01629732|Ribavirin|ribavirin|mesh-list
20495694|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
20495695|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495696|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
20495697|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495698|NCT01629758|Nivolumab|nivolumab|mesh-list
20495699|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20495700|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495701|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20495702|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495703|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20495704|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20495705|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20495706|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495707|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495708|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20495709|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495710|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495711|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
20495712|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495713|NCT01630018|Topotecan|topotecan|mesh-list
20495714|NCT01630018|Belotecan|belotecan|mesh-list
20495715|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20495716|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20495717|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495718|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495719|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495720|NCT01630057|Zonisamide|zonisamide|mesh-list
20495721|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
20495722|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20495723|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495724|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495725|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495726|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495727|NCT01630070|Paclitaxel|paclitaxel|mesh-list
20495728|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20495729|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495730|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
20495731|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
20495732|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
20495733|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495734|NCT01630083|Capecitabine|capecitabine|mesh-list
20495735|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
20495736|NCT01630083|Epirubicin|epirubicin|mesh-list
20495737|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495738|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
20495739|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495740|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495741|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20495742|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20495743|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20495744|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495745|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20495746|NCT01630096|Laxatives|laxatives|mesh-ancestor
20495747|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495748|NCT01630148|Bemiparin|bemiparin|mesh-list
20495749|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
20495750|NCT01630187|Carbetocin|carbetocin|mesh-list
20495751|NCT01630187|Oxytocin|oxytocin|mesh-list
20495752|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
20495753|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20495754|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495755|NCT01630226|Cisplatin|cisplatin|mesh-list
20495756|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495757|NCT01630278|Ibuprofen|ibuprofen|mesh-list
20495758|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20495759|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495760|NCT01630278|Analgesics|analgesics|mesh-ancestor
20495761|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
20495762|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495763|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495764|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495765|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20495766|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20495767|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495768|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495769|NCT01630343|Acetaminophen|acetaminophen|mesh-list
20495770|NCT01630343|Tramadol|tramadol|mesh-list
20495771|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495772|NCT01630343|Analgesics|analgesics|mesh-ancestor
20495773|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
20495774|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495775|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495776|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
20495777|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20495778|NCT01630343|Narcotics|narcotics|mesh-ancestor
20495779|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495780|NCT01630369|Insulin|insulin|mesh-list
20495781|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20495782|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20495783|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495784|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
20242845|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
20242846|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20242847|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
20242848|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242849|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242850|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
20242851|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20242852|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20247988|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20247989|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
20247990|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247991|NCT00434096|Rimonabant|rimonabant|mesh-list
20247992|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20247993|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20495785|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495786|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
20495787|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495788|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20495789|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20495790|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
20495791|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495792|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495793|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20495794|NCT01630564|Aldesleukin|aldesleukin|mesh-list
20495795|NCT01630564|Interleukin-2|interleukin-2|mesh-list
20495796|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495797|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495798|NCT01630564|Analgesics|analgesics|mesh-ancestor
20495799|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
20495800|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495801|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495802|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20495803|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20495804|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
20495805|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495806|NCT01630642|Clopidogrel|clopidogrel|mesh-list
20495807|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20495808|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20495809|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20495810|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20495811|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
20495812|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495813|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495814|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495815|NCT01630655|Felodipine|felodipine|mesh-list
20495816|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20495817|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20495818|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20495819|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495820|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495821|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495822|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495823|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
20495824|NCT01630720|Vitamin D|vitamin d|mesh-list
20495825|NCT01630720|Vitamins|vitamins|mesh-list
20495826|NCT01630720|Ascorbic Acid|ascorbic acid|mesh-list
20495827|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
20495828|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495829|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20495830|NCT01630720|Antioxidants|antioxidants|mesh-ancestor
20495831|NCT01630720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495832|NCT01630720|Protective Agents|protective agents|mesh-ancestor
20495833|NCT01630733|Docetaxel|docetaxel|mesh-list
20495834|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495835|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
20495836|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
20495837|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
20495838|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528851|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
20528852|NCT01777867|Miotics|miotics|mesh-ancestor
20528853|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
20528854|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20528855|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528856|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20528857|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20528858|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
20528859|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20528860|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20528861|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
20528862|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528863|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528864|NCT01777919|Copper|copper|mesh-list
20528865|NCT01777919|Temozolomide|temozolomide|mesh-list
20528866|NCT01777919|Disulfiram|disulfiram|mesh-list
20528867|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20528868|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
20528869|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528870|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528871|NCT01777919|Trace Elements|trace elements|mesh-ancestor
20528872|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
20528873|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528874|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20528875|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20528876|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528877|NCT01778075|Acetaminophen|acetaminophen|mesh-list
20528878|NCT01778075|Tramadol|tramadol|mesh-list
20528879|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20528880|NCT01778075|Analgesics|analgesics|mesh-ancestor
20528881|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
20528882|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242853|NCT00413608|Clopidogrel|clopidogrel|mesh-list
20242854|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20242855|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20242856|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20242857|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20242858|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
20242859|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242860|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242861|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495839|NCT01630902|Felodipine|felodipine|mesh-list
20495840|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20495841|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20495842|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20495843|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495844|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495845|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495846|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495847|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
20495848|NCT01630915|Clopidogrel|clopidogrel|mesh-list
20495849|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20495850|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20495851|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20495852|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20495853|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
20495854|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495855|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495856|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495857|NCT01630941|Denosumab|denosumab|mesh-list
20495858|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20495859|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495860|NCT01631058|Prednisone|prednisone|mesh-list
20495861|NCT01631058|Everolimus|everolimus|mesh-list
20495862|NCT01631058|Lactitol|lactitol|mesh-list
20495863|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495864|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
20495865|NCT01631058|Hormones|hormones|mesh-ancestor
20495866|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20495867|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495868|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20495869|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495870|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495871|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
20495872|NCT01631058|Cathartics|cathartics|mesh-ancestor
20495873|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495874|NCT01631136|Gemcitabine|gemcitabine|mesh-list
20495875|NCT01631136|Cisplatin|cisplatin|mesh-list
20495876|NCT01631136|Pemetrexed|pemetrexed|mesh-list
20495877|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495878|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495879|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
20495880|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495881|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
20495882|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495883|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495884|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20495885|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
20495886|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495887|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20495888|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20495889|NCT01631201|Azithromycin|azithromycin|mesh-list
20495890|NCT01631201|KRM 1648|krm 1648|mesh-list
20495891|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20495892|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495893|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20495894|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
20495895|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
20495896|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
20495897|NCT01631305|Calcium|calcium|mesh-list
20495898|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495899|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495900|NCT01631305|Antacids|antacids|mesh-ancestor
20242862|NCT00413686|Gemcitabine|gemcitabine|mesh-list
20242863|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495901|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495902|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20495903|NCT01631357|Gemcitabine|gemcitabine|mesh-list
20495904|NCT01631357|Cisplatin|cisplatin|mesh-list
20495905|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20495906|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20495907|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
20495908|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495909|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
20495910|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495911|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495912|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242864|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
20242865|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242866|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242867|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
19414805|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242868|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242869|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495913|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
20242870|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242871|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
20242872|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242873|NCT00413699|Tofacitinib|tofacitinib|mesh-list
20242874|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20242875|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242876|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242877|NCT00413712|Adenosine|adenosine|mesh-list
20242878|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
20242879|NCT00413712|Calcium|calcium|mesh-list
20242880|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20242881|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242882|NCT00413712|Analgesics|analgesics|mesh-ancestor
20242883|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
20242884|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700310|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19700311|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
19700312|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20495914|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495915|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
20495916|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20495917|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19700313|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
19700314|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700315|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700316|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700317|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19700318|NCT04894617|Analgesics|analgesics|mesh-ancestor
19700319|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
19700320|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495918|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19700321|NCT04894682|Vaccines|vaccines|mesh-list
19700322|NCT04894682|Immunologic Factors|immunologic factors|mesh-ancestor
19700323|NCT04894682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495919|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495920|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495921|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495922|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495923|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20495924|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20495925|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495926|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20495927|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20495928|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
20495929|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495930|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
20495931|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495932|NCT01631383|Analgesics|analgesics|mesh-ancestor
20495933|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
20495934|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495935|NCT01631396|Neostigmine|neostigmine|mesh-list
20495936|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20495937|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495938|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495939|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
20495940|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495941|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495942|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20495943|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
20495944|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495945|NCT01631409|Aspirin|aspirin|mesh-list
20495946|NCT01631409|Atenolol|atenolol|mesh-list
20495947|NCT01631409|Enalapril|enalapril|mesh-list
20495948|NCT01631409|Enalaprilat|enalaprilat|mesh-list
20495949|NCT01631409|Amlodipine|amlodipine|mesh-list
20495950|NCT01631409|Isosorbide|isosorbide|mesh-list
20495951|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20495952|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20495953|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
20495954|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20495955|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20495956|NCT01631409|Analgesics|analgesics|mesh-ancestor
20495957|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
20495958|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495959|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495960|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20495961|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20495962|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20495963|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20495964|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20495965|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20495966|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20495967|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20495968|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
20495969|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20495970|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
20495971|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20495972|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20495973|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
20495974|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
20495975|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20495976|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20495977|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20495978|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
20495979|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20495980|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20495981|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20495982|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20495983|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
20495984|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20495985|NCT01631409|Diuretics|diuretics|mesh-ancestor
20495986|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
20495987|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20495988|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20495989|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
20495990|NCT01631448|Coagulants|coagulants|mesh-ancestor
20495991|NCT01631513|Tapentadol|tapentadol|mesh-list
20495992|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20495993|NCT01631513|Narcotics|narcotics|mesh-ancestor
20495994|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20495995|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20495996|NCT01631513|Analgesics|analgesics|mesh-ancestor
20495997|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
20495998|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20495999|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20496000|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20496001|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20496002|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496003|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700324|NCT04894253|Vaccines|vaccines|mesh-list
19700325|NCT04894253|Immunologic Factors|immunologic factors|mesh-ancestor
19700326|NCT04894253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700327|NCT04893993|Thiamine|thiamine|mesh-list
19700328|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
19700329|NCT04893993|Vitamins|vitamins|mesh-ancestor
19700330|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
19700331|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700332|NCT04893980|Aldesleukin|aldesleukin|mesh-list
20242885|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20242886|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
20242887|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20242888|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
20242889|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
20242890|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242891|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242892|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20242893|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20242894|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242895|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20242896|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20242897|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20242898|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20242899|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20496004|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496005|NCT01631526|Vitamin D|vitamin d|mesh-list
20496006|NCT01631526|Vitamins|vitamins|mesh-ancestor
20496007|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
20496008|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496009|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496010|NCT01631539|Irinotecan|irinotecan|mesh-list
20496011|NCT01631539|Cetuximab|cetuximab|mesh-list
20496012|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20496013|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20496014|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496015|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496016|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496017|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20496018|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
20496019|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20496020|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20496021|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496022|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
20496023|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496024|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496025|NCT01631669|Celecoxib|celecoxib|mesh-list
20496026|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20496027|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496028|NCT01631669|Analgesics|analgesics|mesh-ancestor
20496029|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
20496030|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496031|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496032|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20496033|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20496034|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20496035|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20496036|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496037|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496038|NCT01631838|Tocotrienols|tocotrienols|mesh-list
20496039|NCT01631838|Vitamin E|vitamin e|mesh-list
20496040|NCT01631838|Tocopherols|tocopherols|mesh-list
20496041|NCT01631838|Tocovid|tocovid|mesh-list
20496042|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
20496043|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496044|NCT01631838|Protective Agents|protective agents|mesh-ancestor
20496045|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496046|NCT01631838|Vitamins|vitamins|mesh-ancestor
20496047|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
20496048|NCT01631877|Enoxaparin|enoxaparin|mesh-list
20496049|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
20496050|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
20496051|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20496052|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20496053|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496054|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20496055|NCT01631968|Colistin|colistin|mesh-list
20496056|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496057|NCT01631994|Metoclopramide|metoclopramide|mesh-list
20496058|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
20496059|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
20496060|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496061|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496062|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20496063|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20496064|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20496065|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
20496066|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496067|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496068|NCT01632007|Alogliptin|alogliptin|mesh-list
20496069|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20496070|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496071|NCT01632007|Incretins|incretins|mesh-ancestor
20496072|NCT01632007|Hormones|hormones|mesh-ancestor
20530773|NCT01790542|Trace Elements|trace elements|mesh-ancestor
20496073|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20496074|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20496075|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
20496076|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496077|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496078|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
20496079|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20496080|NCT01632163|Lixisenatide|lixisenatide|mesh-list
20496081|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20496082|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496083|NCT01632189|Varenicline|varenicline|mesh-list
20496084|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20496085|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20496086|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
20496087|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496088|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496089|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496090|NCT01632371|Paclitaxel|paclitaxel|mesh-list
20496091|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20496092|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20496093|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496094|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
20496095|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
20496096|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
20496097|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496098|NCT01632436|Pixantrone|pixantrone|mesh-list
20496099|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20496100|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20496101|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496102|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496103|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496104|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
20496105|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496106|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496107|NCT01632514|Vitamins|vitamins|mesh-ancestor
20496108|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
20496109|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496110|NCT01632540|Beclomethasone|beclomethasone|mesh-list
20496111|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20496112|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
20496113|NCT01632540|Hormones|hormones|mesh-ancestor
20496114|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20496115|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496116|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20496117|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
20496118|NCT01632592|Tesamorelin|tesamorelin|mesh-list
20496119|NCT01632592|Growth Substances|growth substances|mesh-ancestor
20496120|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496121|NCT01632605|Sirolimus|sirolimus|mesh-list
20496122|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20496123|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496124|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20496125|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496126|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
20496127|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496128|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
20496129|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496130|NCT01632657|Sumatriptan|sumatriptan|mesh-list
20496131|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20496132|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20496133|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20496134|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
20496135|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496136|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496137|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528883|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528884|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
19700333|NCT04893980|Interleukin-2|interleukin-2|mesh-list
20528885|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20528886|NCT01778075|Narcotics|narcotics|mesh-ancestor
19700334|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496138|NCT01632722|Bevacizumab|bevacizumab|mesh-list
20496139|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20496140|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496141|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20496142|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20496143|NCT01632722|Growth Substances|growth substances|mesh-ancestor
20496144|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496145|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496146|NCT01632761|Vitamin D|vitamin d|mesh-list
20496147|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
20496148|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
20496149|NCT01632761|Vitamins|vitamins|mesh-list
20496150|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
20496151|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496152|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496153|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496154|NCT01632826|Pomalidomide|pomalidomide|mesh-list
20496155|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
20496156|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496157|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20496158|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20496159|NCT01632826|Growth Substances|growth substances|mesh-ancestor
20496160|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496161|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496162|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
20496163|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20496164|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
20496165|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496166|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496167|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20496168|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
20496169|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20496170|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
20496171|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496172|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496173|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20496174|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
20496175|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
20496176|NCT01633086|Protective Agents|protective agents|mesh-ancestor
20496177|NCT01633099|Decitabine|decitabine|mesh-list
20496178|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20496179|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
20496180|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496181|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496182|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496183|NCT01633177|Vitamin D|vitamin d|mesh-list
20496184|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
20496185|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
20496186|NCT01633177|Vitamins|vitamins|mesh-list
20496187|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
20496188|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496189|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496190|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496191|NCT01633203|Capecitabine|capecitabine|mesh-list
20496192|NCT01633203|Epirubicin|epirubicin|mesh-list
20496193|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496194|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20496195|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
20496196|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496197|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20496198|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20496199|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20496200|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496201|NCT01633294|Gentamicins|gentamicins|mesh-list
20496202|NCT01633294|Ampicillin|ampicillin|mesh-list
20496203|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20496204|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496205|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20496206|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496207|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496208|NCT01633359|Atorvastatin|atorvastatin|mesh-list
20496209|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20496210|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20496211|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20496212|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
19414806|NCT03288454|Apixaban|apixaban|mesh-list
19414807|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20496213|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414808|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
20496214|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19700335|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496215|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496216|NCT01633450|Zinc|zinc|mesh-list
20496217|NCT01633450|Trace Elements|trace elements|mesh-ancestor
20496218|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
20496219|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496220|NCT01633476|Valacyclovir|valacyclovir|mesh-list
20496221|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
20496222|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496223|NCT01633593|Donepezil|donepezil|mesh-list
20496224|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20496225|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496226|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496227|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
20496228|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496229|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496230|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
20496231|NCT01633645|Gemcitabine|gemcitabine|mesh-list
20496232|NCT01633645|Bortezomib|bortezomib|mesh-list
20496233|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496234|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20496235|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
20496236|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496237|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
20496238|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496239|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496240|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496241|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
20496242|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496243|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
20496244|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496245|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496246|NCT01633658|Vitamins|vitamins|mesh-ancestor
19414809|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19414810|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
19414811|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414812|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414813|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
19414814|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19414815|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19414816|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
19414817|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414818|NCT03284385|Adavosertib|adavosertib|mesh-list
20242900|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20242901|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20242902|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
20242903|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242904|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242905|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242906|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20242907|NCT00413790|Darifenacin|darifenacin|mesh-list
20242908|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20242909|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20242910|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
20242911|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242912|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242913|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242914|NCT00413790|Urological Agents|urological agents|mesh-ancestor
20242915|NCT00413829|Ranibizumab|ranibizumab|mesh-list
20242916|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20242917|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20242918|NCT00413829|Growth Substances|growth substances|mesh-ancestor
20496247|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
20496248|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496249|NCT01633749|Vaccines|vaccines|mesh-list
20496250|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
20496251|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496252|NCT01633762|Vancomycin|vancomycin|mesh-list
20496253|NCT01633762|Gentamicins|gentamicins|mesh-list
20496254|NCT01633762|Meropenem|meropenem|mesh-list
20496255|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20496256|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496257|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20496258|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496259|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496260|NCT01633957|Warfarin|warfarin|mesh-list
20496261|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
20496262|NCT01633970|Leucovorin|leucovorin|mesh-list
20496263|NCT01633970|Paclitaxel|paclitaxel|mesh-list
20496264|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20496265|NCT01633970|Bevacizumab|bevacizumab|mesh-list
20496266|NCT01633970|Carboplatin|carboplatin|mesh-list
20496267|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
20496268|NCT01633970|Pemetrexed|pemetrexed|mesh-list
20496269|NCT01633970|Atezolizumab|atezolizumab|mesh-list
20496270|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20496271|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496272|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20496273|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
20496274|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20496275|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496276|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20496277|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20496278|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20496279|NCT01633970|Growth Substances|growth substances|mesh-ancestor
20496280|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853063|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853064|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853065|NCT00729807|Pentamidine|pentamidine|mesh-list
20496281|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496282|NCT01633970|Antidotes|antidotes|mesh-ancestor
20496283|NCT01633970|Protective Agents|protective agents|mesh-ancestor
20496284|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
20496285|NCT01633970|Vitamins|vitamins|mesh-ancestor
20496286|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
20496287|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496288|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20496289|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20496290|NCT01633983|Methotrexate|methotrexate|mesh-list
20496291|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20496292|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
20496293|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20496294|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496295|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20496296|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
20496297|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496298|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496299|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
20496300|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414819|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414820|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414821|NCT03263273|Minocycline|minocycline|mesh-list
20496301|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20496302|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496303|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
20496304|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20496305|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20496306|NCT01634061|Dactolisib|dactolisib|mesh-list
20496307|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496308|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
20496309|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19414822|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414823|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496310|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
20496311|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496312|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496313|NCT01634295|Niacin|niacin|mesh-list
20496314|NCT01634295|Amlodipine|amlodipine|mesh-list
19414824|NCT03254485|Praliciguat|praliciguat|mesh-list
19414825|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20496315|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19414826|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
19414827|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414828|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19414829|NCT03250117|Ropinirole|ropinirole|mesh-list
19414830|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19414831|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19414832|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
19700336|NCT04893980|Analgesics|analgesics|mesh-ancestor
19700337|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
19700338|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700339|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700340|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19853066|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
19853067|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496316|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20496317|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20496318|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496319|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496320|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496321|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
20496322|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20496323|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
20496324|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20496325|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
20496326|NCT01634295|Vitamins|vitamins|mesh-ancestor
19414833|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
19700341|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19700342|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
19700343|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700344|NCT04893655|Dobutamine|dobutamine|mesh-list
19700345|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19700346|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
19700347|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
19700348|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700349|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414834|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414835|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414836|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414837|NCT03241173|Nivolumab|nivolumab|mesh-list
19414838|NCT03241173|Ipilimumab|ipilimumab|mesh-list
19700350|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20496327|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
20496328|NCT01634321|Leuprolide|leuprolide|mesh-list
20496329|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20496330|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
20496331|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20496332|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496333|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20496334|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496335|NCT01634347|Propranolol|propranolol|mesh-list
20496336|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20496337|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20496338|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
20496339|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496340|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496341|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496342|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20496343|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20496344|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
20496345|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20496346|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
20496347|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496348|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20496349|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20496350|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496351|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496352|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20496353|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
20496354|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496355|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20496356|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20496357|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496358|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496359|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20496360|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
20496361|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496362|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20496363|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20496364|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496365|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496366|NCT01634412|Amitriptyline|amitriptyline|mesh-list
20496367|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
20496368|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20496369|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
20496370|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496371|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20496372|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496373|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20496374|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496375|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20496376|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496377|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496378|NCT01634412|Analgesics|analgesics|mesh-ancestor
20496379|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
20496380|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20496381|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20496382|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20496383|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496384|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
20496385|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496386|NCT01634438|Heparin|heparin|mesh-list
20496387|NCT01634438|Calcium heparin|calcium heparin|mesh-list
20496388|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
20496389|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20496390|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20496391|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528887|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496392|NCT01634594|Nicardipine|nicardipine|mesh-list
20496393|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
20496394|NCT01634594|Remifentanil|remifentanil|mesh-list
20496395|NCT01634594|Sevoflurane|sevoflurane|mesh-list
20496396|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20496397|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700351|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19700352|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19700353|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700354|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700355|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496398|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496399|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496400|NCT01634594|Analgesics|analgesics|mesh-ancestor
20496401|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
20496402|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496403|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20496404|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20496405|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20496406|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
20496407|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496408|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496409|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20496410|NCT01634594|Narcotics|narcotics|mesh-ancestor
20496411|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20496412|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20496413|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
20496414|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
20496415|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20496416|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20496417|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20496418|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496419|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
20496420|NCT01634685|Capecitabine|capecitabine|mesh-list
20496421|NCT01634685|Bavituximab|bavituximab|mesh-list
20496422|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20496423|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
20496424|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496425|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496426|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20496427|NCT01634698|Vitamin A|vitamin a|mesh-list
20496428|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
20496429|NCT01634698|Vitamins|vitamins|mesh-ancestor
20496430|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
20496431|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496432|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
20496433|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496434|NCT01634698|Protective Agents|protective agents|mesh-ancestor
20496435|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20496436|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496437|NCT01634763|Ceritinib|ceritinib|mesh-list
20496438|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496439|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20496440|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496441|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496442|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
20496443|NCT01634789|Estrogens|estrogens|mesh-list
20496444|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20496445|NCT01634789|Hormones|hormones|mesh-ancestor
20496446|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20496447|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496448|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20496449|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20496450|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
20496451|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496452|NCT01634880|Panitumumab|panitumumab|mesh-list
20496453|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20496454|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496455|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
20496456|NCT01634893|Sorafenib|sorafenib|mesh-list
20496457|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496458|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20496459|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496460|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496461|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
20496462|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20496463|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20496464|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496465|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20496466|NCT01634906|Atorvastatin|atorvastatin|mesh-list
20496467|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20496468|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20496469|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20496470|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
20496471|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496472|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20496473|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20496474|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496475|NCT01634932|Iron|iron|mesh-list
20496476|NCT01634932|Trace Elements|trace elements|mesh-ancestor
20496477|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
20496478|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496479|NCT01634945|Amodiaquine|amodiaquine|mesh-list
20496480|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
20496481|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19700356|NCT04893655|Protective Agents|protective agents|mesh-ancestor
19700357|NCT04893616|Vaccines|vaccines|mesh-list
20496482|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20496483|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496484|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19700358|NCT04893616|Immunologic Factors|immunologic factors|mesh-ancestor
19700359|NCT04893616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700360|NCT04893733|Folic Acid|folic acid|mesh-list
19700361|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
19700362|NCT04893733|Vitamins|vitamins|mesh-ancestor
19700363|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
20496485|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20496486|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
20496487|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496488|NCT01634958|Antacids|antacids|mesh-ancestor
20496489|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496490|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20496491|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
20496492|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20496493|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
20496494|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20496495|NCT01635114|Resveratrol|resveratrol|mesh-list
20496496|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
20496497|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496498|NCT01635114|Protective Agents|protective agents|mesh-ancestor
20496499|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496500|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496501|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20496502|NCT01635205|Anesthetics|anesthetics|mesh-list
20496503|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496504|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496505|NCT01635296|Cytarabine|cytarabine|mesh-list
20496506|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20496507|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
20496508|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496509|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700364|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496510|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
20496511|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496512|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496513|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
20496514|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496515|NCT01635400|Irinotecan|irinotecan|mesh-list
20496516|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20496517|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20496518|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700365|NCT04893733|Hematinics|hematinics|mesh-ancestor
19700366|NCT04893629|Digoxin|digoxin|mesh-list
20496519|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496520|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496521|NCT01635426|Aspirin|aspirin|mesh-list
20496522|NCT01635426|Clopidogrel|clopidogrel|mesh-list
20496523|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20496524|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19853068|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19853069|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19700367|NCT04893629|Captopril|captopril|mesh-list
19700368|NCT04893629|Furosemide|furosemide|mesh-list
19700369|NCT04893629|Diuretics|diuretics|mesh-ancestor
19700370|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
19700371|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496525|NCT01635426|Analgesics|analgesics|mesh-ancestor
20496526|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
20496527|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496528|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496529|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20496530|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20496531|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20496532|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20496533|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496534|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20496535|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20496536|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496537|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
19700372|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19700373|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19700374|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700375|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19700376|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19700377|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700378|NCT04893629|Protective Agents|protective agents|mesh-ancestor
20496538|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20496539|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19700379|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19700380|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853070|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19853071|NCT00729833|Sunitinib|sunitinib|mesh-list
19853072|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853073|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853074|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19853075|NCT00729833|Growth Substances|growth substances|mesh-ancestor
20496540|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20496541|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
20528888|NCT01778101|Lansoprazole|lansoprazole|mesh-list
19853076|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496542|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496543|NCT01635530|Doxycycline|doxycycline|mesh-list
20496544|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
20496545|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20496546|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496547|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
20496548|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20496549|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20496550|NCT01635608|Acetaminophen|acetaminophen|mesh-list
20496551|NCT01635608|Amoxicillin|amoxicillin|mesh-list
20496552|NCT01635608|Talinolol|talinolol|mesh-list
20496553|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496554|NCT01635608|Analgesics|analgesics|mesh-ancestor
20496555|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
20496556|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496557|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496558|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
20496559|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20496560|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496561|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20496562|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20496563|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
20496564|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496565|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496566|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20496567|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20496568|NCT01635686|Etanercept|etanercept|mesh-list
20496569|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20496570|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496571|NCT01635686|Analgesics|analgesics|mesh-ancestor
20496572|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
20496573|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496574|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853077|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496575|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20496576|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20496577|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20496578|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496579|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
20496580|NCT01635751|Pregabalin|pregabalin|mesh-list
20496581|NCT01635751|Analgesics|analgesics|mesh-ancestor
20496582|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
20496583|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496584|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496585|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
20496586|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20496587|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19700381|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19700382|NCT04893525|Buprenorphine|buprenorphine|mesh-list
19700383|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19700384|NCT04893525|Naloxone|naloxone|mesh-list
19700385|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19700386|NCT04893525|Narcotics|narcotics|mesh-ancestor
19700387|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700388|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700389|NCT04893525|Analgesics|analgesics|mesh-ancestor
19700390|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
19700391|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700392|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19700393|NCT04893356|Dacarbazine|dacarbazine|mesh-list
20242919|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242920|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
20242921|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242922|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
20242923|NCT00413946|Hematinics|hematinics|mesh-ancestor
20242924|NCT00414024|Tegaserod|tegaserod|mesh-list
20242925|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20242926|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
20242927|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242928|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242929|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242930|NCT00414037|Eszopiclone|eszopiclone|mesh-list
20242931|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20496588|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496589|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496590|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20496591|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20496592|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496593|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496594|NCT01635777|Miltefosine|miltefosine|mesh-list
20496595|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
20496596|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496597|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496598|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20496599|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20496600|NCT01635790|Bevacizumab|bevacizumab|mesh-list
20496601|NCT01635790|Ranibizumab|ranibizumab|mesh-list
20496602|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20496603|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496604|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20496605|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20496606|NCT01635790|Growth Substances|growth substances|mesh-ancestor
20496607|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496608|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496609|NCT01635803|Bevacizumab|bevacizumab|mesh-list
20496610|NCT01635803|Ranibizumab|ranibizumab|mesh-list
20496611|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20496612|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496613|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20496614|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20496615|NCT01635803|Growth Substances|growth substances|mesh-ancestor
20496616|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496617|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496618|NCT01635816|Vaccines|vaccines|mesh-list
20496619|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
20496620|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496621|NCT01635829|Carbamazepine|carbamazepine|mesh-list
20496622|NCT01635829|Phenytoin|phenytoin|mesh-list
20496623|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
20496624|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
20496625|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20496626|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496627|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496628|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496629|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496630|NCT01635829|Analgesics|analgesics|mesh-ancestor
20496631|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
20496632|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496633|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20496634|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20496635|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496636|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20496637|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20496638|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20496639|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20496640|NCT01635946|Isavuconazole|isavuconazole|mesh-list
20496641|NCT01635946|Atorvastatin|atorvastatin|mesh-list
20496642|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20496643|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20496644|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
20496645|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496646|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20496647|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20496648|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496649|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
20496650|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496651|NCT01635972|Isavuconazole|isavuconazole|mesh-list
20496652|NCT01635972|Bupropion|bupropion|mesh-list
20496653|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20496654|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
20496655|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496656|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20496657|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20496658|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20496659|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496660|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
20496661|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496662|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496663|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20496664|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20496665|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496666|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
20496667|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496668|NCT01636037|Levodopa|levodopa|mesh-list
20242932|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20242933|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242934|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20242935|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
20242936|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496669|NCT01636037|Carbidopa|carbidopa|mesh-list
20242937|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
20242938|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
20242939|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20242940|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
20242941|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496670|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20496671|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20496672|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20496673|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
20496674|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496675|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496676|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496677|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20496678|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496679|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20496680|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
20496681|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
20528889|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
20528890|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20528891|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528892|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20528893|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528894|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528895|NCT01778114|Vitamin D|vitamin d|mesh-list
20496682|NCT01636128|Eflornithine|eflornithine|mesh-list
20496683|NCT01636128|Sulindac|sulindac|mesh-list
20496684|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496685|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20496686|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20496687|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20496688|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496689|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20496690|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700394|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19700395|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
19700396|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700397|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700398|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
19700399|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19700400|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
20496691|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496692|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20242942|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20242943|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20242944|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
20242945|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242946|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242947|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20242948|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20496693|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496694|NCT01636128|Analgesics|analgesics|mesh-ancestor
20496695|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
20496696|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496697|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496698|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700401|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700402|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
19700403|NCT04893174|Protective Agents|protective agents|mesh-ancestor
19700404|NCT04892953|Gemcitabine|gemcitabine|mesh-list
19700405|NCT04892953|Paclitaxel|paclitaxel|mesh-list
20496699|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20496700|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20496701|NCT01636141|Dapansutrile|dapansutrile|mesh-list
20496702|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20496703|NCT01636180|Clopidogrel|clopidogrel|mesh-list
20496704|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20496705|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20496706|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20496707|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20496708|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
20496709|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496710|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496711|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496712|NCT01636245|Vaccines|vaccines|mesh-list
20496713|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
19700406|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20496714|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496715|NCT01636271|Darapladib|darapladib|mesh-list
20496716|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20496717|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496718|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496719|NCT01636310|Nicotine|nicotine|mesh-list
20496720|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20496721|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
20496722|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496723|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496724|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20496725|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20496726|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
20496727|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496728|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496729|NCT01636323|Nicotine|nicotine|mesh-list
20496730|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20496731|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
19853078|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853079|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853080|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853081|NCT00729846|Bevacizumab|bevacizumab|mesh-list
19853082|NCT00729846|Verteporfin|verteporfin|mesh-list
19853083|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19853084|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20242949|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20242950|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
20242951|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20242952|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242953|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242954|NCT00414180|Bupropion|bupropion|mesh-list
20242955|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20242956|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
20242957|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20242958|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20242959|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20496732|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496733|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700407|NCT04892953|Carboplatin|carboplatin|mesh-list
19700408|NCT04892953|Pemetrexed|pemetrexed|mesh-list
19700409|NCT04892953|Durvalumab|durvalumab|mesh-list
19700410|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
19700411|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19700412|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
19700413|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19700414|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700415|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19700416|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853085|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853086|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20496734|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20496735|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20496736|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
20496737|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496738|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496739|NCT01636336|Nicotine|nicotine|mesh-list
20496740|NCT01636336|Progesterone|progesterone|mesh-list
20496741|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19700417|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20496742|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
20496743|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700418|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700419|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19700420|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
19700421|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
19700422|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700423|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700424|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496744|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496745|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20496746|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20496747|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
20496748|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496749|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496750|NCT01636336|Progestins|progestins|mesh-ancestor
20496751|NCT01636336|Hormones|hormones|mesh-ancestor
20496752|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20496753|NCT01636401|Bromides|bromides|mesh-list
20496754|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
19700425|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
20496755|NCT01636505|Cetrorelix|cetrorelix|mesh-list
20496756|NCT01636505|Buserelin|buserelin|mesh-list
20496757|NCT01636505|Ganirelix|ganirelix|mesh-list
20496758|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20496759|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
20496760|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20496761|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496762|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
20496763|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20496764|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20496765|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
20496766|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496767|NCT01636557|Vitamin K|vitamin k|mesh-list
19414839|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19414840|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414841|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19414842|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414843|NCT03234907|Vedolizumab|vedolizumab|mesh-list
19414844|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19414845|NCT03228394|Ganaxolone|ganaxolone|mesh-list
19414846|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
19414847|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414848|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700426|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700427|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19700428|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19700429|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19700430|NCT04893252|Durvalumab|durvalumab|mesh-list
19700431|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19700432|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700433|NCT04892732|Budesonide|budesonide|mesh-list
19700434|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
19700435|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20496768|NCT01636557|Midazolam|midazolam|mesh-list
19700436|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19700437|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
20496769|NCT01636557|Caffeine|caffeine|mesh-list
19414849|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496770|NCT01636557|Omeprazole|omeprazole|mesh-list
20496771|NCT01636557|Warfarin|warfarin|mesh-list
20496772|NCT01636557|Vitamins|vitamins|mesh-ancestor
20496773|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
20496774|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496775|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20496776|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20496777|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496778|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20496779|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20496780|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20496781|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20496782|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
20496783|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
20496784|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
20496785|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
20496786|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496787|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496788|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
20496789|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20496790|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20496791|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20496792|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496793|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20496794|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20496795|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20496796|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20496797|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
20528896|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
20496798|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20496799|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20496800|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
20496801|NCT01636557|Coagulants|coagulants|mesh-ancestor
20496802|NCT01636570|Vitamin D|vitamin d|mesh-list
20496803|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
20496804|NCT01636570|Vitamins|vitamins|mesh-ancestor
20496805|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
20496806|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496807|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496808|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496809|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
20496810|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20496811|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414850|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
19414851|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
19700438|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414852|NCT03219164|Aztreonam|aztreonam|mesh-list
20496812|NCT01636609|Cytarabine|cytarabine|mesh-list
20496813|NCT01636609|Azacitidine|azacitidine|mesh-list
20496814|NCT01636609|Tosedostat|tosedostat|mesh-list
20496815|NCT01636609|Glycine|glycine|mesh-list
20496816|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20496817|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
20496818|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414853|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414854|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414855|NCT03217591|Praliciguat|praliciguat|mesh-list
19700439|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496819|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496820|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
20496821|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496822|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496823|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
20496824|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496825|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496826|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
20496827|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496828|NCT01636622|Paclitaxel|paclitaxel|mesh-list
20496829|NCT01636622|Carboplatin|carboplatin|mesh-list
20496830|NCT01636622|Vemurafenib|vemurafenib|mesh-list
20496831|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20496832|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496833|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
20496834|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
20496835|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
20496836|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496837|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20496838|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496839|NCT01636700|Tramadol|tramadol|mesh-list
20496840|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20496841|NCT01636700|Narcotics|narcotics|mesh-ancestor
20496842|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496843|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496844|NCT01636700|Analgesics|analgesics|mesh-ancestor
20496845|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
20496846|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496847|NCT01636869|Bupivacaine|bupivacaine|mesh-list
20496848|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
20496849|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
20496850|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496851|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496852|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
20496853|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496854|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
20496855|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20496856|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
20496857|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
20496858|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20496859|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20496860|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496861|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20496862|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528897|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
20496863|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496864|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20496865|NCT01636895|Renal Agents|renal agents|mesh-ancestor
20496866|NCT01636908|Everolimus|everolimus|mesh-list
20496867|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20496868|NCT01636908|Sorafenib|sorafenib|mesh-list
20496869|NCT01636908|Sunitinib|sunitinib|mesh-list
20496870|NCT01636908|Dasatinib|dasatinib|mesh-list
20496871|NCT01636908|Lapatinib|lapatinib|mesh-list
20496872|NCT01636908|Vemurafenib|vemurafenib|mesh-list
20496873|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496874|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496875|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
19853087|NCT00729846|Growth Substances|growth substances|mesh-ancestor
19853088|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853089|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496876|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496877|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20496878|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496879|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496880|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20496881|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20496882|NCT01636908|Growth Substances|growth substances|mesh-ancestor
20496883|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
20496884|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
20496885|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20496886|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
20496887|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
20496888|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20496889|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496890|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20496891|NCT01636999|Analgesics|analgesics|mesh-ancestor
20496892|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
20496893|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496894|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
20496895|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
20496896|NCT01637025|Coagulants|coagulants|mesh-ancestor
20496897|NCT01637155|Vitamin D|vitamin d|mesh-list
20496898|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
20496899|NCT01637155|Vitamins|vitamins|mesh-ancestor
20496900|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
20496901|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496902|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20496903|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20496904|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20496905|NCT01637194|Cetuximab|cetuximab|mesh-list
20496906|NCT01637194|Everolimus|everolimus|mesh-list
20496907|NCT01637194|Antibodies|antibodies|mesh-list
20496908|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
20496909|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20496910|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
20496911|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496912|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496913|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20496914|NCT01637233|Ritonavir|ritonavir|mesh-list
20496915|NCT01637233|Lopinavir|lopinavir|mesh-list
20496916|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20496917|NCT01637233|Darunavir|darunavir|mesh-list
20496918|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
20496919|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20496920|NCT01637233|Tenofovir|tenofovir|mesh-list
20496921|NCT01637233|Lamivudine|lamivudine|mesh-list
20496922|NCT01637233|Zidovudine|zidovudine|mesh-list
20496923|NCT01637233|Emtricitabine|emtricitabine|mesh-list
20496924|NCT01637233|Maraviroc|maraviroc|mesh-list
20496925|NCT01637233|Abacavir|abacavir|mesh-list
20496926|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
20496927|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20496928|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
20496929|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20496930|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496931|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496932|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20496933|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20496934|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
20496935|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496936|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20496937|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20496938|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20496939|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
20496940|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20496941|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20496942|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20496943|NCT01637259|Ritonavir|ritonavir|mesh-list
20496944|NCT01637259|Lopinavir|lopinavir|mesh-list
20496945|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20496946|NCT01637259|Darunavir|darunavir|mesh-list
20496947|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
20496948|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20496949|NCT01637259|Tenofovir|tenofovir|mesh-list
20496950|NCT01637259|Lamivudine|lamivudine|mesh-list
20496951|NCT01637259|Zidovudine|zidovudine|mesh-list
20496952|NCT01637259|Emtricitabine|emtricitabine|mesh-list
20496953|NCT01637259|Maraviroc|maraviroc|mesh-list
19700440|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19700441|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
19700442|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
20496954|NCT01637259|Abacavir|abacavir|mesh-list
20496955|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
20496956|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20496957|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
20496958|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20496959|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496960|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496961|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19700443|NCT04892732|Hormones|hormones|mesh-ancestor
19700444|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20496962|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20496963|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
20496964|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20496965|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20496966|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20496967|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20496968|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
20496969|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20496970|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20496971|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20496972|NCT01637376|Temoporfin|temoporfin|mesh-list
20496973|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496974|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20496975|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
20496976|NCT01637454|Terlipressin|terlipressin|mesh-list
20496977|NCT01637454|Norepinephrine|norepinephrine|mesh-list
20496978|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20496979|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20496980|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20496981|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20496982|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
20496983|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20496984|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20496985|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20496986|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
20496987|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
20496988|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20496989|NCT01637532|Interferons|interferons|mesh-list
20496990|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
20496991|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
20496992|NCT01637532|Carboplatin|carboplatin|mesh-list
20496993|NCT01637532|Doxorubicin|doxorubicin|mesh-list
20496994|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20496995|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20496996|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20496997|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20496998|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20496999|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497000|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
20497001|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497002|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
20497003|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497004|NCT01637545|Ramosetron|ramosetron|mesh-list
20497005|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
20497006|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
20497007|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497008|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497009|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497010|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20497011|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
20497012|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497013|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497014|NCT01637558|Ritonavir|ritonavir|mesh-list
20497015|NCT01637558|Lopinavir|lopinavir|mesh-list
20497016|NCT01637558|Nevirapine|nevirapine|mesh-list
20497017|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20497018|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20497019|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
20497020|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497021|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700445|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19700446|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19700447|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19700448|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700449|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700450|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700451|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
19700452|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
20242960|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247994|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20497022|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497023|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20497024|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
20497025|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497026|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20497027|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20497028|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20497029|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20497030|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20497031|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20497032|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
20497033|NCT01637571|Lansoprazole|lansoprazole|mesh-list
20497034|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20497035|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497036|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20497037|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497038|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497039|NCT01637636|Rifampin|rifampin|mesh-list
20497040|NCT01637636|Ketoconazole|ketoconazole|mesh-list
20497041|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20497042|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
20497043|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20497044|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497045|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
20497046|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20497047|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242961|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242962|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
20242963|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242964|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242965|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20242966|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20497048|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497049|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20497050|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20497051|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20497052|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20497053|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20528898|NCT01778114|Vitamins|vitamins|mesh-list
20242967|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497054|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20497055|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
20497056|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20497057|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20497058|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20497059|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
20497060|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497061|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497062|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20497063|NCT01637675|Tanshinone|tanshinone|mesh-list
20497064|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
20497065|NCT01637675|Citric Acid|citric acid|mesh-list
20497066|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
20497067|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
19853090|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19853091|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
19853092|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
20497068|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20497069|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
20497070|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
20497071|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497072|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
20497073|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20497074|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20497075|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242968|NCT00414245|Metformin|metformin|mesh-list
20242969|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20242970|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242971|NCT00414284|Lopinavir|lopinavir|mesh-list
20242972|NCT00414284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20242973|NCT00414284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20242974|NCT00414284|Protease Inhibitors|protease inhibitors|mesh-ancestor
20242975|NCT00414284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20242976|NCT00414284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853093|NCT00729859|Anastrozole|anastrozole|mesh-list
19853094|NCT00729859|Testosterone|testosterone|mesh-list
20242977|NCT00414284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497076|NCT01637675|Urological Agents|urological agents|mesh-ancestor
20497077|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497078|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20497079|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20497080|NCT01637675|Analgesics|analgesics|mesh-ancestor
20497081|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
20497082|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497083|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497084|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20497085|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497086|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20497087|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497088|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497089|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
20497090|NCT01637753|Carmustine|carmustine|mesh-list
20497091|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20497092|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
20497093|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497094|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497095|NCT01637766|Melphalan|melphalan|mesh-list
20497096|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19853095|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
20242978|NCT00414284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20242979|NCT00414284|Antiviral Agents|antiviral agents|mesh-ancestor
20242980|NCT00414284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20242981|NCT00414284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20242982|NCT00414284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20242983|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20242984|NCT00414323|Citalopram|citalopram|mesh-list
20242985|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20242986|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20242987|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20242988|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20242989|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20242990|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
20242991|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20242992|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20242993|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
20242994|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20242995|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20242996|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20242997|NCT00414323|Analgesics|analgesics|mesh-ancestor
20497097|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
20497098|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497099|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497100|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20497101|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497102|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
20497103|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528899|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
20528900|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528901|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20528902|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20528903|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
20528904|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
20528905|NCT01778192|Citric Acid|citric acid|mesh-list
20528906|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
20528907|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
20528908|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20528909|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
20528910|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
20528911|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528912|NCT01778192|Cathartics|cathartics|mesh-ancestor
20528913|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20528914|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
20528915|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
20528916|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528917|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
20528918|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528919|NCT01778244|Metformin|metformin|mesh-list
20528920|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20528921|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528922|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
20528923|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20528924|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
20528925|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20528926|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
20528927|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528928|NCT01778309|Expectorants|expectorants|mesh-ancestor
20528929|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
20528930|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20528931|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
20528932|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528933|NCT01778309|Protective Agents|protective agents|mesh-ancestor
20242998|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
20242999|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
20243000|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20243001|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20243002|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
20243003|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243004|NCT00414336|Antacids|antacids|mesh-ancestor
20243005|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243006|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243007|NCT00414349|Analgesics|analgesics|mesh-list
20243008|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
20243009|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243010|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243011|NCT00414414|Prednisone|prednisone|mesh-list
20243012|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243013|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
20243014|NCT00414414|Hormones|hormones|mesh-ancestor
20243015|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243016|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243017|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243018|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497104|NCT01637818|Acetaminophen|acetaminophen|mesh-list
20243019|NCT00414531|Atorvastatin|atorvastatin|mesh-list
20243020|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20243021|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20243022|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
20243023|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243024|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20243025|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20243026|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243027|NCT00414648|Sirolimus|sirolimus|mesh-list
20243028|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19700453|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19700454|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
19700455|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700456|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700457|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19700458|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
19700459|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19700460|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19700461|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19700462|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700463|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700464|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700465|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243029|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243030|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20497105|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20497106|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20497107|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20497108|NCT01637818|Analgesics|analgesics|mesh-ancestor
20497109|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
20497110|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497111|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497112|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
20497113|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497114|NCT01637844|Telbivudine|telbivudine|mesh-list
20497115|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
20497116|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497117|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20497118|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497119|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497120|NCT01637883|Benzydamine|benzydamine|mesh-list
20497121|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414856|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19414857|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
19414858|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414859|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19414860|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
19414861|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414862|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
19414863|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414864|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414865|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
19700466|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
20497122|NCT01637948|Listerine|listerine|mesh-list
20497123|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20497124|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497125|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20497126|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
20497127|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19700467|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20497128|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
20497129|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20497130|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497131|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20497132|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20497133|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497134|NCT01638078|Thalidomide|thalidomide|mesh-list
20497135|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497136|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
20497137|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497138|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
20497139|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20497140|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497141|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20497142|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20497143|NCT01638078|Growth Substances|growth substances|mesh-ancestor
20497144|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
20497145|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497146|NCT01638182|Vitamins|vitamins|mesh-list
20497147|NCT01638182|Vitamin K|vitamin k|mesh-list
20497148|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
20497149|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
20497150|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
20497151|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497152|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20497153|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20497154|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497155|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
20497156|NCT01638182|Coagulants|coagulants|mesh-ancestor
20497157|NCT01638234|Melatonin|melatonin|mesh-list
20497158|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
20497159|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497160|NCT01638234|Protective Agents|protective agents|mesh-ancestor
20497161|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497162|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20497163|NCT01638247|Tamoxifen|tamoxifen|mesh-list
20497164|NCT01638247|Goserelin|goserelin|mesh-list
20497165|NCT01638247|Exemestane|exemestane|mesh-list
20497166|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20497167|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20497168|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
20497169|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497170|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497171|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20497172|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497173|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20497174|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20497175|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20497176|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20497177|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20497178|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497179|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700468|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20497180|NCT01638247|Hormones|hormones|mesh-ancestor
20497181|NCT01638260|Liraglutide|liraglutide|mesh-list
20497182|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497183|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497184|NCT01638260|Incretins|incretins|mesh-ancestor
20497185|NCT01638260|Hormones|hormones|mesh-ancestor
20497186|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497187|NCT01638273|Pregabalin|pregabalin|mesh-list
20497188|NCT01638273|Analgesics|analgesics|mesh-ancestor
20497189|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
20497190|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497191|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497192|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
20497193|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20497194|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20497195|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497196|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20497197|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20497198|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20497199|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20497200|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20497201|NCT01638299|Insulin|insulin|mesh-list
20497202|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497203|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497204|NCT01638325|Insulin|insulin|mesh-list
20497205|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20497206|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
20497207|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497208|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497209|NCT01638364|Ethanol|ethanol|mesh-list
20497210|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20497211|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497212|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20497213|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497214|NCT01638377|Naltrexone|naltrexone|mesh-list
20497215|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20497216|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20497217|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497218|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
20497219|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497220|NCT01638403|Modafinil|modafinil|mesh-list
20497221|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20497222|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497223|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20497224|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20497225|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20497226|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497227|NCT01638442|Tosedostat|tosedostat|mesh-list
20497228|NCT01638442|Glycine|glycine|mesh-list
20497229|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497230|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497231|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
20497232|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497233|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700469|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700470|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700471|NCT04892511|Nitroprusside|nitroprusside|mesh-list
19700472|NCT04892511|Labetalol|labetalol|mesh-list
19700473|NCT04892511|Urapidil|urapidil|mesh-list
19700474|NCT04892511|Phenylephrine|phenylephrine|mesh-list
19700475|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19700476|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
19700477|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
19700478|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853096|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
19700479|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497234|NCT01638624|Propofol|propofol|mesh-list
20497235|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19414866|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19414867|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
19414868|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19414869|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414870|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19414871|NCT03204396|Dulaglutide|dulaglutide|mesh-list
20497236|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20497237|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497238|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20497239|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
20497240|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
20497241|NCT01638650|Ritonavir|ritonavir|mesh-list
20497242|NCT01638650|Saquinavir|saquinavir|mesh-list
19414872|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414873|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497243|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20497244|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20497245|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20497246|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
20497247|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497248|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414874|NCT03198728|Testosterone|testosterone|mesh-list
19853097|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19853098|NCT00729859|Acyline|acyline|mesh-list
19853099|NCT00729859|Androgens|androgens|mesh-ancestor
19853100|NCT00729859|Hormones|hormones|mesh-ancestor
19853101|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853102|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853103|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19853104|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853105|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
19853106|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19853107|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19853108|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853109|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497249|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497250|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20497251|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
20497252|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497253|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20497254|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20497255|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20497256|NCT01638663|Tolvaptan|tolvaptan|mesh-list
20497257|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20530774|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
20497258|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497259|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
20497260|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497261|NCT01638676|Metformin|metformin|mesh-list
20497262|NCT01638676|Vemurafenib|vemurafenib|mesh-list
20497263|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497264|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497265|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497266|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20497267|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497268|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497269|NCT01638689|Citalopram|citalopram|mesh-list
20497270|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20497271|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20497272|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20497273|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497274|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497275|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
20497276|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497277|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20497278|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
20497279|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20497280|NCT01638715|Rituximab|rituximab|mesh-list
20497281|NCT01638715|Abatacept|abatacept|mesh-list
20497282|NCT01638715|Infliximab|infliximab|mesh-list
20497283|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20497284|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497285|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
20497286|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497287|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497288|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
20497289|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497290|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20497291|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497292|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497293|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
20497294|NCT01638767|NuvaRing|nuvaring|mesh-list
20497295|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
20497296|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20497297|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497298|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20497299|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20497300|NCT01638780|Resveratrol|resveratrol|mesh-list
20497301|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
20528934|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497302|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497303|NCT01638780|Protective Agents|protective agents|mesh-ancestor
20497304|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497305|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497306|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20497307|NCT01638858|Ranibizumab|ranibizumab|mesh-list
20497308|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20497309|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20497310|NCT01638858|Growth Substances|growth substances|mesh-ancestor
20497311|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497312|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
20497313|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700480|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
19700481|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19700482|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
19700483|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
19700484|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19700485|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19700486|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20497314|NCT01638936|Maytansine|maytansine|mesh-list
20497315|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20497316|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497317|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
20497318|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497319|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
20497320|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497321|NCT01638962|Acetaminophen|acetaminophen|mesh-list
20497322|NCT01638962|Aspirin|aspirin|mesh-list
20497323|NCT01638962|Ibuprofen|ibuprofen|mesh-list
20497324|NCT01638962|Celecoxib|celecoxib|mesh-list
20497325|NCT01638962|Diclofenac|diclofenac|mesh-list
20497326|NCT01638962|Naproxen|naproxen|mesh-list
20497327|NCT01638962|Indomethacin|indomethacin|mesh-list
20497328|NCT01638962|Etoricoxib|etoricoxib|mesh-list
20497329|NCT01638962|Meloxicam|meloxicam|mesh-list
20497330|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20497331|NCT01638962|Etodolac|etodolac|mesh-list
20497332|NCT01638962|Lornoxicam|lornoxicam|mesh-list
20497333|NCT01638962|Nabumetone|nabumetone|mesh-list
20497334|NCT01638962|Tenoxicam|tenoxicam|mesh-list
20497335|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
20497336|NCT01638962|Analgesics|analgesics|mesh-list
20497337|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20497338|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
20497339|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497340|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497341|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
20497342|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20497343|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20497344|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497345|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20497346|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497347|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497348|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20497349|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
19414875|NCT03198728|Androgens|androgens|mesh-ancestor
19414876|NCT03198728|Hormones|hormones|mesh-ancestor
19414877|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497350|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20497351|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20497352|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20497353|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
20497354|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20497355|NCT01638988|Metformin|metformin|mesh-list
20497356|NCT01638988|Clomiphene|clomiphene|mesh-list
20497357|NCT01638988|Enclomiphene|enclomiphene|mesh-list
20497358|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
20497359|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497360|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497361|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20497362|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
20497363|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497364|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20497365|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
20497366|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20497367|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20497368|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20497369|NCT01639027|Drotaverin|drotaverin|mesh-list
20497370|NCT01639027|Analgesics|analgesics|mesh-ancestor
20497371|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
20497372|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497373|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497374|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
20497375|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
20497376|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
20497377|NCT01639066|Tenofovir|tenofovir|mesh-list
20497378|NCT01639066|Entecavir|entecavir|mesh-list
20497379|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
20497380|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497381|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20497382|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20497383|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497384|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497385|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497386|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20497387|NCT01639092|Tenofovir|tenofovir|mesh-list
20497388|NCT01639092|Entecavir|entecavir|mesh-list
20497389|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
20497390|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497391|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20497392|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19700487|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700488|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700489|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700490|NCT04892511|Protective Agents|protective agents|mesh-ancestor
19700491|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19700492|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
19700493|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19700494|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19700495|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19700496|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19700497|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19700498|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19700499|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
19700500|NCT04892693|Talazoparib|talazoparib|mesh-list
19700501|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19700502|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700503|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700504|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243031|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243032|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
20243033|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243034|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
20243035|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243036|NCT00414687|Iloprost|iloprost|mesh-list
20243037|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20243038|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
20243039|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
20243040|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20243041|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243042|NCT00414921|Clonidine|clonidine|mesh-list
20243043|NCT00414921|Methylphenidate|methylphenidate|mesh-list
20243044|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20497393|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497394|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497395|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497396|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20497397|NCT01639131|Gemcitabine|gemcitabine|mesh-list
20497398|NCT01639131|Docetaxel|docetaxel|mesh-list
20497399|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497400|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
20497401|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497402|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497403|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
20497404|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497405|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497406|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497407|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
20497408|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497409|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
20497410|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497411|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
20497412|NCT01639261|Interferons|interferons|mesh-list
20497413|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
20497414|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497415|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
20497416|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497417|NCT01639326|Irinotecan|irinotecan|mesh-list
20497418|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20497419|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20497420|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497421|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497422|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528935|NCT01778309|Antidotes|antidotes|mesh-ancestor
20528936|NCT01778400|Ethanol|ethanol|mesh-list
20528937|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20528938|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528939|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20528940|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528941|NCT01778413|Tenofovir|tenofovir|mesh-list
20528942|NCT01778413|Emtricitabine|emtricitabine|mesh-list
20528943|NCT01778413|Efavirenz|efavirenz|mesh-list
20528944|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20528945|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
20528946|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20528947|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20528948|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20528949|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20528950|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528951|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497423|NCT01639456|Aldesleukin|aldesleukin|mesh-list
20497424|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
20497425|NCT01639456|Fludarabine|fludarabine|mesh-list
20497426|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497427|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
20497428|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497429|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497430|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20497431|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
20497432|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497433|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497434|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20497435|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497436|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20497437|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
20497438|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497439|NCT01639521|Gemcitabine|gemcitabine|mesh-list
20497440|NCT01639521|Doxorubicin|doxorubicin|mesh-list
20497441|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20497442|NCT01639521|Methotrexate|methotrexate|mesh-list
20497443|NCT01639521|Vinblastine|vinblastine|mesh-list
20497444|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497445|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497446|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
20497447|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497448|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
20497449|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497450|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497451|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497452|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
20497453|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497454|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20497455|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20497456|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20497457|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20497458|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
20497459|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20497460|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
20497461|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20497462|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19700505|NCT04892654|Dolutegravir|dolutegravir|mesh-list
20497463|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20497464|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20497465|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
20497466|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497467|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
20497468|NCT01639547|Ribavirin|ribavirin|mesh-list
20497469|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20497470|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
20497471|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497472|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
20497473|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497474|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
20497475|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20497476|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497477|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
20497478|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20497479|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20497480|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
20497481|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497482|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497483|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497484|NCT01639794|Urological Agents|urological agents|mesh-ancestor
20497485|NCT01639807|Latanoprost|latanoprost|mesh-list
20497486|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20497487|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20497488|NCT01639885|Interferons|interferons|mesh-list
20497489|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
19853110|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19853111|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
19853112|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
19853113|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19853114|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19853115|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
19853116|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497490|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
19853117|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19853118|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19853119|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853120|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853121|NCT00729937|Clindamycin|clindamycin|mesh-list
19853122|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
20497491|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497492|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
20497493|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497494|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
20497495|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497496|NCT01639898|Dexamethasone|dexamethasone|mesh-list
20497497|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
20497498|NCT01639898|Lenalidomide|lenalidomide|mesh-list
20497499|NCT01639898|BB 1101|bb 1101|mesh-list
20497500|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20497501|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
20497502|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
20497503|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497504|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497505|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497506|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
20497507|NCT01639898|Hormones|hormones|mesh-ancestor
20497508|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497509|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20497510|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497511|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
20497512|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497513|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497514|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
20497515|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20497516|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20497517|NCT01639898|Growth Substances|growth substances|mesh-ancestor
20497518|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
20497519|NCT01640002|Bromides|bromides|mesh-list
20497520|NCT01640002|Propantheline|propantheline|mesh-list
19414878|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414879|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
19414880|NCT03197064|Aprepitant|aprepitant|mesh-list
19414881|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
19414882|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
20497521|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
20497522|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20497523|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497524|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20497525|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20497526|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
20243045|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243046|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20243047|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20243048|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20243049|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243050|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
20243051|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243052|NCT00414921|Analgesics|analgesics|mesh-ancestor
20243053|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
20243054|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497527|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497528|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497529|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497530|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
20497531|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497532|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20497533|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497534|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243055|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20243056|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
20243057|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
20243058|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20243059|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20243060|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20243061|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
20497535|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19853123|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
19853124|NCT00729937|Cephalexin|cephalexin|mesh-list
19853125|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19853126|NCT00729937|Trimethoprim|trimethoprim|mesh-list
19853127|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
19853128|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19853129|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497536|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853130|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19853131|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853132|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853133|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19853134|NCT00729937|Renal Agents|renal agents|mesh-ancestor
20243062|NCT00414947|Vildagliptin|vildagliptin|mesh-list
20243063|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497537|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497538|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20497539|NCT01640210|Insulin|insulin|mesh-list
20497540|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497541|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700506|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19700507|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19700508|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700509|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700510|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497542|NCT01640275|Propofol|propofol|mesh-list
20497543|NCT01640275|Isoflurane|isoflurane|mesh-list
20497544|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20497545|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20497546|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497547|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20497548|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
20497549|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
20497550|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20497551|NCT01640301|Aldesleukin|aldesleukin|mesh-list
20497552|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
20497553|NCT01640301|Fludarabine|fludarabine|mesh-list
20497554|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
20497555|NCT01640301|Interleukin-2|interleukin-2|mesh-list
19700511|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19700512|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
19700513|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700514|NCT04892563|Morphine|morphine|mesh-list
19700515|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20497556|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497557|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
20497558|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497559|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497560|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20497561|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
20497562|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497563|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497564|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20497565|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497566|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
20497567|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20497568|NCT01640301|Analgesics|analgesics|mesh-ancestor
20497569|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
20497570|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497571|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20497572|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20497573|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
20497574|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497575|NCT01640405|Bevacizumab|bevacizumab|mesh-list
20497576|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20497577|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497578|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20497579|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20497580|NCT01640405|Growth Substances|growth substances|mesh-ancestor
19700516|NCT04892563|Narcotics|narcotics|mesh-ancestor
19853135|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
20497581|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497582|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
20497583|NCT01640444|Bevacizumab|bevacizumab|mesh-list
20497584|NCT01640444|Cetuximab|cetuximab|mesh-list
20497585|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20497586|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497587|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20497588|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20497589|NCT01640444|Growth Substances|growth substances|mesh-ancestor
20497590|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497591|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
20497592|NCT01640496|Vitamin D|vitamin d|mesh-list
20497593|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
20497594|NCT01640496|Vitamins|vitamins|mesh-ancestor
20497595|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
20497596|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497597|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20497598|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20497599|NCT01640535|Cetirizine|cetirizine|mesh-list
20497600|NCT01640535|Montelukast|montelukast|mesh-list
20497601|NCT01640535|Levocetirizine|levocetirizine|mesh-list
20497602|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20497603|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
20497604|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20497605|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
20497606|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497607|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497608|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20497609|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20497610|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497611|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20497612|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20497613|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
20497614|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
20497615|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497616|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20497617|NCT01640574|Chloroquine|chloroquine|mesh-list
20497618|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20497619|NCT01640574|Piperaquine|piperaquine|mesh-list
20497620|NCT01640574|Artenimol|artenimol|mesh-list
20497621|NCT01640574|Artemisinins|artemisinins|mesh-list
20497622|NCT01640574|Amebicides|amebicides|mesh-ancestor
20497623|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20497624|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20497625|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497626|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
20497627|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497628|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20243064|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243065|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20497629|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20497630|NCT01640574|Analgesics|analgesics|mesh-ancestor
20497631|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
20497632|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497633|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497634|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20497635|NCT01640574|Filaricides|filaricides|mesh-ancestor
20497636|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
20497637|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
20497638|NCT01640587|Artesunate|artesunate|mesh-list
20497639|NCT01640587|Piperaquine|piperaquine|mesh-list
20497640|NCT01640587|Artenimol|artenimol|mesh-list
20497641|NCT01640587|Mefloquine|mefloquine|mesh-list
20497642|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
20497643|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20497644|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20497645|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497646|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497647|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
20497648|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
20497649|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20497650|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
20497651|NCT01640639|Thalidomide|thalidomide|mesh-list
20497652|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497653|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
20497654|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497655|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
20497656|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20497657|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497658|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20497659|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20497660|NCT01640639|Growth Substances|growth substances|mesh-ancestor
20497661|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
20497662|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497663|NCT01640665|Capecitabine|capecitabine|mesh-list
20497664|NCT01640665|Sorafenib|sorafenib|mesh-list
20497665|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497666|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
20497667|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497668|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497669|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20497670|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497671|NCT01640691|Vaccines|vaccines|mesh-list
20497672|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
20497673|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497674|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
20497675|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20497676|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20497677|NCT01640743|Prednisolone|prednisolone|mesh-list
20497678|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
20497679|NCT01640743|Everolimus|everolimus|mesh-list
19700517|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20497680|NCT01640743|Tacrolimus|tacrolimus|mesh-list
20497681|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20497682|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
20497683|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497684|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
20497685|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497686|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20497687|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497688|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497689|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497690|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20497691|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
20497692|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
20497693|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497694|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497695|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
20497696|NCT01640743|Hormones|hormones|mesh-ancestor
20497697|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497698|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20497699|NCT01640743|Protective Agents|protective agents|mesh-ancestor
20497700|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20497701|NCT01640782|Leucovorin|leucovorin|mesh-list
20497702|NCT01640782|Docetaxel|docetaxel|mesh-list
20497703|NCT01640782|Fluorouracil|fluorouracil|mesh-list
19853136|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19853137|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19853138|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19853139|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19853140|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19853141|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19853142|NCT00730015|Linaclotide|linaclotide|mesh-list
19853143|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19853144|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
20497704|NCT01640782|Irinotecan|irinotecan|mesh-list
20497705|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
20497706|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497707|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
20497708|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497709|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
20497710|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497711|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
20497712|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497713|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497714|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
20497715|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497716|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20497717|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20497718|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497719|NCT01640782|Antidotes|antidotes|mesh-ancestor
20497720|NCT01640782|Protective Agents|protective agents|mesh-ancestor
20497721|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
20497722|NCT01640782|Vitamins|vitamins|mesh-ancestor
20497723|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
19853145|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497724|NCT01640990|GW 328267|gw 328267|mesh-list
20497725|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20497726|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20497727|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
19700518|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700519|NCT04892563|Analgesics|analgesics|mesh-ancestor
19700520|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
19700521|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497728|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
20497729|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497730|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497731|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497732|NCT01641016|Efavirenz|efavirenz|mesh-list
20497733|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20497734|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20497735|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497736|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497737|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
20497738|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497739|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20497740|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20497741|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20497742|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20497743|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20497744|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20497745|NCT01641224|Pinaverium|pinaverium|mesh-list
20497746|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20497747|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20497748|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497749|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20497750|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497751|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
19700522|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
20497752|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
20497753|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497754|NCT01641250|Cytarabine|cytarabine|mesh-list
20497755|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497756|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
20497757|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497758|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497759|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
20497760|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497761|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497762|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
20497763|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700523|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700524|NCT04892212|Sirolimus|sirolimus|mesh-list
19700525|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20497764|NCT01641289|Acetaminophen|acetaminophen|mesh-list
20497765|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20243066|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
20243067|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243068|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243069|NCT00415064|Dexamethasone|dexamethasone|mesh-list
20243070|NCT00415064|Lenalidomide|lenalidomide|mesh-list
20243071|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243072|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
20243073|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
20243074|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497766|NCT01641289|Analgesics|analgesics|mesh-ancestor
20497767|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
20497768|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497769|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497770|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
20497771|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
20497772|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
20497773|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497774|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
20497775|NCT01641341|Pancrelipase|pancrelipase|mesh-list
20497776|NCT01641341|Pancreatin|pancreatin|mesh-list
20497777|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20497778|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497779|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497780|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
20497781|NCT01641406|Bevacizumab|bevacizumab|mesh-list
20497782|NCT01641406|Docetaxel|docetaxel|mesh-list
20497783|NCT01641406|Capecitabine|capecitabine|mesh-list
20497784|NCT01641406|Trastuzumab|trastuzumab|mesh-list
20497785|NCT01641406|Epirubicin|epirubicin|mesh-list
20497786|NCT01641406|Vinorelbine|vinorelbine|mesh-list
20497787|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497788|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
20497789|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497790|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497791|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20497792|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
20497793|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497794|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700526|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700527|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19700528|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700529|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
19700530|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700531|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
20243075|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497795|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20497796|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20497797|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20497798|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20497799|NCT01641406|Growth Substances|growth substances|mesh-ancestor
20497800|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
20497801|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243076|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497802|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497803|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243077|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
20243078|NCT00415064|Hormones|hormones|mesh-ancestor
20497804|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497805|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
19853146|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19853147|NCT00730028|Clindamycin|clindamycin|mesh-list
19853148|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
19853149|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
19853150|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20243079|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243080|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243081|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243082|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
20243083|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20243084|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243085|NCT00415064|Growth Substances|growth substances|mesh-ancestor
20243086|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
20243087|NCT00415090|Nevirapine|nevirapine|mesh-list
20243088|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20243089|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20243090|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243091|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497806|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20497807|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20497808|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20497809|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497810|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20528952|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20528953|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20528954|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20528955|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20528956|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20528957|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20528958|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20528959|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
20528960|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528961|NCT01778686|Pindolol|pindolol|mesh-list
20528962|NCT01778686|Citalopram|citalopram|mesh-list
20528963|NCT01778686|Tryptophan|tryptophan|mesh-list
20528964|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20528965|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20528966|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20528967|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243092|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
20497811|NCT01641419|Dexamethasone|dexamethasone|mesh-list
20497812|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
20497813|NCT01641419|BB 1101|bb 1101|mesh-list
20497814|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20497815|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
20497816|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
20497817|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497818|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497819|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20497820|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
20497821|NCT01641419|Hormones|hormones|mesh-ancestor
20497822|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497823|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20497824|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497825|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
20497826|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497827|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497828|NCT01641458|Capecitabine|capecitabine|mesh-list
20497829|NCT01641458|Fluorouracil|fluorouracil|mesh-list
20497830|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497831|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
20497832|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497833|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497834|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853151|NCT00730028|Trimethoprim|trimethoprim|mesh-list
19853152|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
20243093|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243094|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20243095|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20243096|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20243097|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20243098|NCT00415103|Aprepitant|aprepitant|mesh-list
20243099|NCT00415103|Palonosetron|palonosetron|mesh-list
20243100|NCT00415103|Granisetron|granisetron|mesh-list
20243101|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
20243102|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
20243103|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243104|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243105|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243106|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20243107|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243108|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243109|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20243110|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20243111|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
20243112|NCT00415116|Carboplatin|carboplatin|mesh-list
20243113|NCT00415116|Docetaxel|docetaxel|mesh-list
20497835|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
20497836|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497837|NCT01641510|Clopidogrel|clopidogrel|mesh-list
20497838|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20497839|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20497840|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20497841|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20497842|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20497843|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
20497844|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497845|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497846|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497847|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20497848|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
20497849|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20497850|NCT01641523|Protective Agents|protective agents|mesh-ancestor
20497851|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497852|NCT01641536|Entecavir|entecavir|mesh-list
20243114|NCT00415116|Lenalidomide|lenalidomide|mesh-list
20243115|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243116|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243117|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497853|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
20497854|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497855|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
20497856|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20497857|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497858|NCT01641575|Gemcitabine|gemcitabine|mesh-list
20497859|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497860|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20497861|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
20497862|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497863|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
20497864|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497865|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497866|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497867|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
19414883|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414884|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414885|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243118|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243119|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243120|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
20243121|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243122|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20243123|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243124|NCT00415116|Growth Substances|growth substances|mesh-ancestor
20243125|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
19414886|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19414887|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19414888|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414889|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
19414890|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19414891|NCT03191864|Fluticasone|fluticasone|mesh-list
20497868|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497869|NCT01641666|Ribavirin|ribavirin|mesh-list
20497870|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20497871|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
20497872|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
20497873|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497874|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
19414892|NCT03191864|Xhance|xhance|mesh-list
19414893|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414894|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19700532|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497875|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497876|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
20497877|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497878|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20497879|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
20497880|NCT01641718|Coagulants|coagulants|mesh-ancestor
20497881|NCT01641783|Paclitaxel|paclitaxel|mesh-list
20497882|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20497883|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20497884|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497885|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
20497886|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497887|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
20497888|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497889|NCT01641796|Paromomycin|paromomycin|mesh-list
20497890|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19700533|NCT04892264|Dexamethasone|dexamethasone|mesh-list
19700534|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
20497891|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497892|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20497893|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20497894|NCT01642030|Buprenorphine|buprenorphine|mesh-list
20497895|NCT01642030|Hydromorphone|hydromorphone|mesh-list
20497896|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20497897|NCT01642030|Narcotics|narcotics|mesh-ancestor
20497898|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20497899|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497900|NCT01642030|Analgesics|analgesics|mesh-ancestor
20497901|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
20497902|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497903|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20497904|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20497905|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20497906|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497907|NCT01642108|Incretins|incretins|mesh-ancestor
20497908|NCT01642108|Hormones|hormones|mesh-ancestor
20497909|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497910|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20497911|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
20497912|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497913|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497914|NCT01642134|Aspirin|aspirin|mesh-list
20497915|NCT01642134|Clopidogrel|clopidogrel|mesh-list
20497916|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20497917|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20497918|NCT01642134|Analgesics|analgesics|mesh-ancestor
20497919|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
20497920|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497921|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497922|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20497923|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20497924|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20497925|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20497926|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497927|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20497928|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20497929|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497930|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
20497931|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20497932|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20497933|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20497934|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
20497935|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497936|NCT01642186|Everolimus|everolimus|mesh-list
20497937|NCT01642186|Letrozole|letrozole|mesh-list
20497938|NCT01642186|Leuprolide|leuprolide|mesh-list
20497939|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497940|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20497941|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
20497942|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497943|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20497944|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20497945|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20497946|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497947|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20497948|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
20497949|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20497950|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20497951|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
20497952|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20497953|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20497954|NCT01642433|Prazosin|prazosin|mesh-list
20497955|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20497956|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20497957|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20497958|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20497959|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
20497960|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497961|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497962|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497963|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
20497964|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19414895|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
20243126|NCT00415233|Hormones|hormones|mesh-list
20243127|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243128|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497965|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
20243129|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20497966|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243130|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
20243131|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20243132|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
20243133|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243134|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243135|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20243136|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243137|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243138|NCT00415285|Docetaxel|docetaxel|mesh-list
20243139|NCT00415285|Capecitabine|capecitabine|mesh-list
20243140|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243141|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243142|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
20497967|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497968|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20497969|NCT01642524|Dextrans|dextrans|mesh-list
20497970|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
20497971|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
20497972|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
20497973|NCT01642667|Saruplase|saruplase|mesh-list
20497974|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20497975|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20497976|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497977|NCT01642745|Mannitol|mannitol|mesh-list
20497978|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
20497979|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20497980|NCT01642745|Diuretics|diuretics|mesh-ancestor
20497981|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
20243143|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243144|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243145|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20243146|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
20243147|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
20243148|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243149|NCT00415311|Lectins|lectins|mesh-list
20243150|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
20243151|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
20243152|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243153|NCT00415311|Coagulants|coagulants|mesh-ancestor
20497982|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20497983|NCT01642745|Miotics|miotics|mesh-ancestor
20497984|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
20497985|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20497986|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20497987|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20497988|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
20497989|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20497990|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20243154|NCT00415324|Cisplatin|cisplatin|mesh-list
20243155|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243156|NCT00415350|Azithromycin|azithromycin|mesh-list
20243157|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20243158|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20497991|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
20243159|NCT00415376|Levetiracetam|levetiracetam|mesh-list
20497992|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20497993|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20497994|NCT01642771|Docetaxel|docetaxel|mesh-list
20497995|NCT01642771|Fluorouracil|fluorouracil|mesh-list
20497996|NCT01642771|Capecitabine|capecitabine|mesh-list
20497997|NCT01642771|Epirubicin|epirubicin|mesh-list
20497998|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20497999|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
20498000|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
20498001|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243160|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
20498002|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498003|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
20498004|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498005|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498006|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
20498007|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498008|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20498009|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20498010|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20498011|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498012|NCT01642862|Simvastatin|simvastatin|mesh-list
20498013|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20498014|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20498015|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
20498016|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498017|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20498018|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20498019|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498020|NCT01642940|Ticagrelor|ticagrelor|mesh-list
20498021|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20498022|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20498023|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20498024|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20498025|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20498026|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
20498027|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498028|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498029|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498030|NCT01642966|Ticagrelor|ticagrelor|mesh-list
19414896|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414897|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498031|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19414898|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20498032|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20498033|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20498034|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20498035|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20498036|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
20498037|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498038|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498039|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498040|NCT01642979|Cyclosporine|cyclosporine|mesh-list
20498041|NCT01642979|Levamisole|levamisole|mesh-list
20498042|NCT01642979|Cyclosporins|cyclosporins|mesh-list
20498043|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
20498044|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498045|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414899|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
19414900|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414901|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19414902|NCT03187834|Amoxicillin|amoxicillin|mesh-list
19414903|NCT03187834|Azithromycin|azithromycin|mesh-list
19414904|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19414905|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19414906|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700535|NCT04892264|Lenalidomide|lenalidomide|mesh-list
19700536|NCT04892264|Daratumumab|daratumumab|mesh-list
19700537|NCT04892264|Ichthammol|ichthammol|mesh-list
20498046|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414907|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19414908|NCT03187834|Renal Agents|renal agents|mesh-ancestor
19414909|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
19414910|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19414911|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19416916|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700538|NCT04892264|BB 1101|bb 1101|mesh-list
20498047|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
20498048|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498049|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
20498050|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498051|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
20498052|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20498053|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20498054|NCT01642979|Hormones|hormones|mesh-ancestor
20498055|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498056|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20498057|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
20498058|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
20498059|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20498060|NCT01643031|Clopidogrel|clopidogrel|mesh-list
20498061|NCT01643031|Ticagrelor|ticagrelor|mesh-list
20498062|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20498063|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20498064|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19416917|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19700539|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498065|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20498066|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
20498067|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498068|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498069|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498070|NCT01643070|Capecitabine|capecitabine|mesh-list
20498071|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
20498072|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498073|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
20498074|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498075|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498076|NCT01643083|Rifaximin|rifaximin|mesh-list
20498077|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498078|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498079|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20498080|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
20498081|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
20498082|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20498083|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20498084|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498085|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
20498086|NCT01643135|Coagulants|coagulants|mesh-ancestor
20498087|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
20498088|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20498089|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20498090|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498091|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20498092|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20498093|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20498094|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414912|NCT03180684|Imiquimod|imiquimod|mesh-list
19414913|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19414914|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
19414915|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414916|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414917|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
19414918|NCT03175432|Bevacizumab|bevacizumab|mesh-list
19414919|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19414920|NCT03175432|Atezolizumab|atezolizumab|mesh-list
19414921|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
19414922|NCT03175432|Antibodies|antibodies|mesh-list
19414923|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
19414924|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19414925|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
19414926|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414927|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853153|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498095|NCT01643187|Vitamins|vitamins|mesh-list
20498096|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
20498097|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498098|NCT01643252|Riboflavin|riboflavin|mesh-list
20498099|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20498100|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20498101|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
20498102|NCT01643252|Vitamins|vitamins|mesh-ancestor
20498103|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
20498104|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498105|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20498106|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
20498107|NCT01643265|Caseins|caseins|mesh-list
20498108|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
20498109|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
20498110|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498111|NCT01643278|Ipilimumab|ipilimumab|mesh-list
20498112|NCT01643278|Dasatinib|dasatinib|mesh-list
20498113|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20498114|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498115|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20498116|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498117|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20498118|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498119|NCT01643434|Clonidine|clonidine|mesh-list
20498120|NCT01643434|Spironolactone|spironolactone|mesh-list
20498121|NCT01643434|Analgesics|analgesics|mesh-ancestor
20498122|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
20498123|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414928|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19853154|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414929|NCT03175432|Growth Substances|growth substances|mesh-ancestor
20498124|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498125|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20498126|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
20498127|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
20498128|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20498129|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20498130|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20498131|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
20498132|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498133|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498134|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20498135|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
20498136|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498137|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20498138|NCT01643434|Diuretics|diuretics|mesh-ancestor
20498139|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
20498140|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
20498141|NCT01643447|Urinastatin|urinastatin|mesh-list
20498142|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20498143|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20498144|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
20498145|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498146|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498147|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498148|NCT01643499|Leucovorin|leucovorin|mesh-list
20498149|NCT01643499|Fluorouracil|fluorouracil|mesh-list
20498150|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
20498151|NCT01643499|Irinotecan|irinotecan|mesh-list
20498152|NCT01643499|Calcium|calcium|mesh-list
20498153|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
20498154|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498155|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498156|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
20498157|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498158|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498159|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498160|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498161|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
20498162|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20498163|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20498164|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498165|NCT01643499|Antidotes|antidotes|mesh-ancestor
20498166|NCT01643499|Protective Agents|protective agents|mesh-ancestor
20498167|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
20498168|NCT01643499|Vitamins|vitamins|mesh-ancestor
20498169|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
20498170|NCT01643603|Dasatinib|dasatinib|mesh-list
19700540|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
20498171|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498172|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20498173|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498174|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498175|NCT01643629|Minoxidil|minoxidil|mesh-list
20498176|NCT01643629|Finasteride|finasteride|mesh-list
20498177|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20498178|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
20498179|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20498180|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19700541|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
20498181|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498182|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498183|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
20498184|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498185|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498186|NCT01643629|Urological Agents|urological agents|mesh-ancestor
20498187|NCT01643759|Buprenorphine|buprenorphine|mesh-list
20498188|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20498189|NCT01643759|Narcotics|narcotics|mesh-ancestor
20498190|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20498191|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498192|NCT01643759|Analgesics|analgesics|mesh-ancestor
20498193|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
20498194|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498195|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20498196|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
20498197|NCT01643889|Domperidone|domperidone|mesh-list
20498198|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498199|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498200|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20498201|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19700542|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700543|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498202|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498203|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498204|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498205|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498206|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
20498207|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
20498208|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498209|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20498210|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20498211|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
20498212|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498213|NCT01643941|Vaccines|vaccines|mesh-list
20498214|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
20498215|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498216|NCT01643980|Progesterone|progesterone|mesh-list
20498217|NCT01643980|Progestins|progestins|mesh-ancestor
20498218|NCT01643980|Hormones|hormones|mesh-ancestor
20498219|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498220|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498221|NCT01644071|Dexetimide|dexetimide|mesh-list
20498222|NCT01644071|Citalopram|citalopram|mesh-list
20498223|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20498224|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20498225|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
20498226|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
19700544|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700545|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
19700546|NCT04892264|Hormones|hormones|mesh-ancestor
20498227|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498228|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498229|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20498230|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20498231|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
20498232|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498233|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498234|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20498235|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20498236|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498237|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
20498238|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20498239|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
20498240|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20498241|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20498242|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
20498243|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
20498244|NCT01644110|Pomalidomide|pomalidomide|mesh-list
20498245|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
20498246|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498247|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20498248|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20498249|NCT01644110|Growth Substances|growth substances|mesh-ancestor
20498250|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
20498251|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498252|NCT01644253|Rituximab|rituximab|mesh-list
20498253|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
20498254|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20498255|NCT01644253|Idelalisib|idelalisib|mesh-list
20498256|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
20498257|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20498258|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498259|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
20498260|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498261|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20498262|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20498263|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
20498264|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498265|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498266|NCT01644773|Dasatinib|dasatinib|mesh-list
20498267|NCT01644773|Crizotinib|crizotinib|mesh-list
20498268|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498269|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20498270|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700547|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498271|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700548|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19700549|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498272|NCT01644799|Lenalidomide|lenalidomide|mesh-list
20498273|NCT01644799|Idelalisib|idelalisib|mesh-list
20498274|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
20498275|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498276|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20498277|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20498278|NCT01644799|Growth Substances|growth substances|mesh-ancestor
20498279|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
20498280|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498281|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498282|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498283|NCT01644825|Paclitaxel|paclitaxel|mesh-list
20498284|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20498285|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498286|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
20498287|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
20498288|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20498289|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498290|NCT01644838|Promethazine|promethazine|mesh-list
20498291|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
20498292|NCT01644838|Scopolamine|scopolamine|mesh-list
20498293|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20498294|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
20498295|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
20498296|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498297|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498298|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20498299|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
20498300|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20498301|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
20498302|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498303|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498304|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20498305|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
20498306|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
20498307|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20498308|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
20498309|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
20498310|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20498311|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20498312|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20498313|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20498314|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
20498315|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
20498316|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
20498317|NCT01644864|Ropivacaine|ropivacaine|mesh-list
20498318|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
20498319|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
20498320|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20498321|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498322|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
20498323|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498324|NCT01644955|Carboplatin|carboplatin|mesh-list
20498325|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528968|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528969|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
20528970|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528971|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20528972|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
20528973|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20528974|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19700550|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
19700551|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700552|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700553|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
19700554|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20528975|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20528976|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
20528977|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20528978|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20498326|NCT01644994|Cisplatin|cisplatin|mesh-list
20498327|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498328|NCT01645085|Mannitol|mannitol|mesh-list
20243161|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
20243162|NCT00415402|Vitamin D|vitamin d|mesh-list
20243163|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
20498329|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20498330|NCT01645085|Diuretics|diuretics|mesh-ancestor
20498331|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
20498332|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498333|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
20498334|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498335|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
20498336|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498337|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498338|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20498339|NCT01645228|Calcium|calcium|mesh-list
20498340|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498341|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498342|NCT01645241|Ganirelix|ganirelix|mesh-list
20498343|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
20498344|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498345|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498346|NCT01645254|Antimalarials|antimalarials|mesh-list
20243164|NCT00415402|Vitamins|vitamins|mesh-ancestor
20243165|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
20243166|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243167|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20243168|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20247995|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247996|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498347|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20498348|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20498349|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498350|NCT01645384|Atorvastatin|atorvastatin|mesh-list
20498351|NCT01645384|Calcium|calcium|mesh-list
20498352|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498353|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498354|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20498355|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20498356|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
20498357|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498358|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20498359|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20498360|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498361|NCT01645410|Atorvastatin|atorvastatin|mesh-list
20498362|NCT01645410|Calcium|calcium|mesh-list
20498363|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498364|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498365|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20498366|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20498367|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
20498368|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498369|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20498370|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20498371|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498372|NCT01645423|Atorvastatin|atorvastatin|mesh-list
20498373|NCT01645423|Calcium|calcium|mesh-list
20498374|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498375|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498376|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20498377|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20498378|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
20498379|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498380|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19700555|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19700556|NCT04892264|Growth Substances|growth substances|mesh-ancestor
19700557|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
19700558|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
20528979|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
19700559|NCT04892069|Insulin|insulin|mesh-list
20243169|NCT00415584|Cinacalcet|cinacalcet|mesh-list
20243170|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20243171|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243172|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20243173|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
20243174|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243175|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
20243176|NCT00415701|Propofol|propofol|mesh-list
20243177|NCT00415701|Etomidate|etomidate|mesh-list
20498381|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20498382|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498383|NCT01645449|Atorvastatin|atorvastatin|mesh-list
20498384|NCT01645449|Calcium|calcium|mesh-list
20498385|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498386|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498387|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20498388|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20498389|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
20498390|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243178|NCT00415701|Cosyntropin|cosyntropin|mesh-list
20243179|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20243180|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20243181|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243182|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20243183|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
20498391|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20498392|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20498393|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498394|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20498395|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
20498396|NCT01645475|Coagulants|coagulants|mesh-ancestor
20498397|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20498398|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
20498399|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498400|NCT01645748|Cisplatin|cisplatin|mesh-list
20498401|NCT01645748|Docetaxel|docetaxel|mesh-list
20498402|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498403|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
20498404|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
20498405|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
20498406|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498407|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
20498408|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20498409|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20498410|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
20498411|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498412|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498413|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498414|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
20498415|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
20498416|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498417|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
20498418|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20498419|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
20498420|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
20498421|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20498422|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498423|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498424|NCT01645800|Muramidase|muramidase|mesh-list
20498425|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498426|NCT01645826|Diltiazem|diltiazem|mesh-list
20498427|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20498428|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20498429|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498430|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498431|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498432|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498433|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
20498434|NCT01645839|Cytarabine|cytarabine|mesh-list
20498435|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498436|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
20498437|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498438|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498439|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
20498440|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498441|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498442|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
20498443|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498444|NCT01646229|Polymyxins|polymyxins|mesh-list
20498445|NCT01646229|Polymyxin B|polymyxin b|mesh-list
20498446|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498447|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498448|NCT01646281|Flecainide|flecainide|mesh-list
20498449|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20498450|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20498451|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20498452|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498453|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498454|NCT01646294|Mirabegron|mirabegron|mesh-list
20498455|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20498456|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20498457|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20498458|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
20498459|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498460|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498461|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498462|NCT01646294|Urological Agents|urological agents|mesh-ancestor
20498463|NCT01646307|Atorvastatin|atorvastatin|mesh-list
20498464|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20498465|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20498466|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20498467|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
20498468|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498469|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20498470|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20498471|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498472|NCT01646437|Aspirin|aspirin|mesh-list
20498473|NCT01646437|Vitamin D|vitamin d|mesh-list
20498474|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
20498475|NCT01646437|Vitamins|vitamins|mesh-ancestor
20498476|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
20498477|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498478|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19700560|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
19700561|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19700562|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700568|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
19700569|NCT04891861|Apixaban|apixaban|mesh-list
20498479|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20498480|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19700570|NCT04891861|Edoxaban|edoxaban|mesh-list
20498481|NCT01646437|Analgesics|analgesics|mesh-ancestor
19700571|NCT04891861|Dabigatran|dabigatran|mesh-list
20498482|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
19700572|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19700573|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
20498483|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498484|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498485|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20498486|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20498487|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20498488|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853155|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19853156|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498489|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19700574|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19700575|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
19700576|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700577|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700578|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
19700579|NCT04891744|Thalidomide|thalidomide|mesh-list
19700580|NCT04891744|Dexamethasone|dexamethasone|mesh-list
19700581|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700582|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
19700583|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
19700584|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700585|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700586|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700587|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
19700588|NCT04891744|Hormones|hormones|mesh-ancestor
19700589|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700590|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19700591|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700592|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700593|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
19700594|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
19700595|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19700596|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700597|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19700598|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19700599|NCT04891744|Growth Substances|growth substances|mesh-ancestor
19700600|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
19853157|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498490|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20498491|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498492|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
20498493|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498494|NCT01646515|Udenafil|udenafil|mesh-list
20498495|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20498496|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20498497|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498498|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498499|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
20498500|NCT01646554|Aflibercept|aflibercept|mesh-list
19853158|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19853159|NCT00730028|Renal Agents|renal agents|mesh-ancestor
19853160|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
19853161|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19853162|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19853163|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19853164|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19853165|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20498501|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498502|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20498503|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20498504|NCT01646554|Growth Substances|growth substances|mesh-ancestor
20498505|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498506|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
20498507|NCT01646567|Betamethasone|betamethasone|mesh-list
20498508|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
20498509|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20498510|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
20498511|NCT01646567|Calcipotriene|calcipotriene|mesh-list
20498512|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20498513|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498514|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
20498515|NCT01646567|Hormones|hormones|mesh-ancestor
20498516|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498517|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498518|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20498519|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
20498520|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
20498521|NCT01646580|Ciclopirox|ciclopirox|mesh-list
20498522|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
20498523|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498524|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
20498525|NCT01646619|Analgesics|analgesics|mesh-ancestor
20498526|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
20498527|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498528|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498529|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
20498530|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20498531|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20498532|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
20498533|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20498534|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498535|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700601|NCT04891900|Capecitabine|capecitabine|mesh-list
19700602|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
19700603|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19700604|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498536|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498537|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
20498538|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20498539|NCT01646684|Pasireotide|pasireotide|mesh-list
20498540|NCT01646684|Hormones|hormones|mesh-ancestor
20498541|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498542|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498543|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
19700605|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
19700606|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700607|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700608|NCT04891588|Timolol|timolol|mesh-list
19700609|NCT04891588|Latanoprost|latanoprost|mesh-list
19700610|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19700611|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19700612|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20498544|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498545|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
20498546|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498547|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20498548|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20498549|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
20243184|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
20243185|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498550|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498551|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498552|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20498553|NCT01646775|Fentanyl|fentanyl|mesh-list
20498554|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20498555|NCT01646775|Narcotics|narcotics|mesh-ancestor
20498556|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20243186|NCT00415701|Hormones|hormones|mesh-ancestor
20243187|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243188|NCT00415740|Levodopa|levodopa|mesh-list
20243189|NCT00415740|Carbidopa|carbidopa|mesh-list
20243190|NCT00415740|Entacapone|entacapone|mesh-list
20243191|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20243192|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20243193|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20498557|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498558|NCT01646775|Analgesics|analgesics|mesh-ancestor
20498559|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
20498560|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498561|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20498562|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20498563|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
20498564|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
20498565|NCT01646788|Paclitaxel|paclitaxel|mesh-list
20498566|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20498567|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498568|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
20498569|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
20498570|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
20498571|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498572|NCT01646853|Fluorouracil|fluorouracil|mesh-list
19700613|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19700614|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700615|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498573|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498574|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
20498575|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498576|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498577|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498578|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
20498579|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498580|NCT01647152|Ustekinumab|ustekinumab|mesh-list
20498581|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
20498582|NCT01647165|Dexamethasone|dexamethasone|mesh-list
19700616|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700617|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700618|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19700619|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19700620|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20498583|NCT01647165|Lenalidomide|lenalidomide|mesh-list
20498584|NCT01647165|Bortezomib|bortezomib|mesh-list
20498585|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498586|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
20498587|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
20498588|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498589|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498590|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20498591|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
20498592|NCT01647165|Hormones|hormones|mesh-ancestor
20498593|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498594|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20498595|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498596|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
20498597|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20498598|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20498599|NCT01647165|Growth Substances|growth substances|mesh-ancestor
20498600|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
20528980|NCT01778803|Paclitaxel|paclitaxel|mesh-list
20528981|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20528982|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20528983|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
20528984|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
20528985|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
20528986|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528987|NCT01778842|Clopidogrel|clopidogrel|mesh-list
20528988|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20498601|NCT01647256|Nikkomycin|nikkomycin|mesh-list
20498602|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
20498603|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498604|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498605|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498606|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
20498607|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20498608|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498609|NCT01647412|Curcumin|curcumin|mesh-list
20498610|NCT01647412|Hormones|hormones|mesh-list
20498611|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498612|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498613|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20498614|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20498615|NCT01647412|Analgesics|analgesics|mesh-ancestor
20498616|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
19414930|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498617|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498618|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498619|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20498620|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498621|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498622|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498623|NCT01647529|Ganciclovir|ganciclovir|mesh-list
20498624|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20498625|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
20498626|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498627|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20498628|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498629|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498630|NCT01647555|Cetuximab|cetuximab|mesh-list
20498631|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20498632|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498633|NCT01647633|Calcium|calcium|mesh-list
20498634|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498635|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498636|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20498637|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20498638|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
20498639|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20498640|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
20498641|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498642|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498643|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
20498644|NCT01647646|Hormones|hormones|mesh-ancestor
20498645|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498646|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
20498647|NCT01647659|Trametinib|trametinib|mesh-list
20498648|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498649|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20498650|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498651|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498652|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20498653|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498654|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
20498655|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20498656|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20498657|NCT01647685|Prednisolone|prednisolone|mesh-list
20243194|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
20243195|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243196|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243197|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243198|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20243199|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243200|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20243201|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20243202|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
20243203|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
20243204|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20498658|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
20498659|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20498660|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
20498661|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498662|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
20498663|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
20498664|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498665|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498666|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20498667|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
20498668|NCT01647685|Hormones|hormones|mesh-ancestor
20498669|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498670|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20498671|NCT01647685|Protective Agents|protective agents|mesh-ancestor
20498672|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20498673|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498674|NCT01647828|Gemcitabine|gemcitabine|mesh-list
20498675|NCT01647828|Paclitaxel|paclitaxel|mesh-list
20498676|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20498677|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498678|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
20498679|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
20498680|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
20498681|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498682|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498683|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
20498684|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
20498685|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498686|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498687|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498688|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
19700621|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700622|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700623|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
19700624|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700625|NCT04891679|Misoprostol|misoprostol|mesh-list
19700626|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19700627|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
19700628|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19700629|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700630|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19700631|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700632|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
19700633|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
20498689|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498690|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20498691|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20498692|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498693|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498694|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
20498695|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498696|NCT01647893|Bivalirudin|bivalirudin|mesh-list
20498697|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
20498698|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20498699|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
20498700|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498701|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498702|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
20498703|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19700634|NCT04891458|Anesthetics|anesthetics|mesh-list
20498704|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20498705|NCT01647932|Diuretics|diuretics|mesh-ancestor
20498706|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
20498707|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498708|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20498709|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498710|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498711|NCT01647984|Vitamins|vitamins|mesh-list
20498712|NCT01647984|Vitamin E|vitamin e|mesh-list
20498713|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
20498714|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
20498715|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498716|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
20498717|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498718|NCT01647984|Protective Agents|protective agents|mesh-ancestor
20498719|NCT01648010|Mitomycins|mitomycins|mesh-list
20498720|NCT01648010|Mitomycin|mitomycin|mesh-list
20498721|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20498722|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498723|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
20498724|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498725|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20498726|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498727|NCT01648036|Heparin|heparin|mesh-list
20498728|NCT01648036|Calcium heparin|calcium heparin|mesh-list
20498729|NCT01648036|Dalteparin|dalteparin|mesh-list
20498730|NCT01648036|Tinzaparin|tinzaparin|mesh-list
20498731|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20498732|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
20498733|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20498734|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20498735|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498736|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20498737|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498738|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498739|NCT01648218|Insulin|insulin|mesh-list
20498740|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20498741|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
20498742|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
20498743|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
19414931|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
20498744|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
20498745|NCT01648218|Protamines|protamines|mesh-list
20498746|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19414932|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
19414933|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
19414934|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19414935|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
19414936|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19414937|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
19414938|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414939|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414940|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
19414941|NCT03163667|Everolimus|everolimus|mesh-list
19414942|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414943|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498747|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498748|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
19414944|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
19700635|NCT04891458|Propofol|propofol|mesh-list
20528989|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20243205|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243206|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20243207|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20498749|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498750|NCT01648218|Coagulants|coagulants|mesh-ancestor
20498751|NCT01648231|Losartan|losartan|mesh-list
20498752|NCT01648231|Amlodipine|amlodipine|mesh-list
20498753|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20498754|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20498755|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498756|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498757|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20498758|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498759|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
20498760|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20498761|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20498762|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20243208|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243209|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
20243210|NCT00415779|Docetaxel|docetaxel|mesh-list
20243211|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243212|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243213|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243214|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243215|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243216|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20243217|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243218|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20243219|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20498763|NCT01648257|Cabotegravir|cabotegravir|mesh-list
20498764|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20498765|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20498766|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498767|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498768|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20498769|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20498770|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
20498771|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498772|NCT01648465|Everolimus|everolimus|mesh-list
20498773|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498774|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498775|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
20498776|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498777|NCT01648517|Gemcitabine|gemcitabine|mesh-list
20498778|NCT01648517|Carboplatin|carboplatin|mesh-list
20498779|NCT01648517|Docetaxel|docetaxel|mesh-list
20498780|NCT01648517|Vinorelbine|vinorelbine|mesh-list
20498781|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498782|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20498783|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
20498784|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498785|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
20498786|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498787|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498788|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20498789|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
20498790|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498791|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
20498792|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
20498793|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
20498794|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20498795|NCT01648556|Prednisone|prednisone|mesh-list
20498796|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498797|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
20498798|NCT01648556|Hormones|hormones|mesh-ancestor
20498799|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498800|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498801|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20498802|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498803|NCT01648595|Fentanyl|fentanyl|mesh-list
20498804|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20498805|NCT01648595|Narcotics|narcotics|mesh-ancestor
20498806|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20498807|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498808|NCT01648595|Analgesics|analgesics|mesh-ancestor
20498809|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
20498810|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498811|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19853166|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19853167|NCT00730158|Irinotecan|irinotecan|mesh-list
19853168|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19853169|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19853170|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853171|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853172|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853173|NCT00730171|Linaclotide|linaclotide|mesh-list
20498812|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20498813|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
20498814|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
20498815|NCT01648608|Exemestane|exemestane|mesh-list
20498816|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498817|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20498818|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20498819|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498820|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498821|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20498822|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
20498823|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498824|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853174|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19853175|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
20498825|NCT01648634|Nebivolol|nebivolol|mesh-list
20498826|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20498827|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
20498828|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20498829|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20498830|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20498831|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
20498832|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498833|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498834|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498835|NCT01648712|Heparin|heparin|mesh-list
20498836|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
20498837|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20498838|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20498839|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498840|NCT01648777|Bupivacaine|bupivacaine|mesh-list
20498841|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
20498842|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
20498843|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20498844|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498845|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
20498846|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498847|NCT01648829|Atorvastatin|atorvastatin|mesh-list
20498848|NCT01648829|Pitavastatin|pitavastatin|mesh-list
20498849|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20498850|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20498851|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
20498852|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498853|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20498854|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20498855|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498856|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20498857|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20498858|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498859|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
20498860|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20528990|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20528991|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20528992|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20528993|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
20528994|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20528995|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20528996|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20528997|NCT01779089|Minocycline|minocycline|mesh-list
20528998|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20528999|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529000|NCT01779206|Paclitaxel|paclitaxel|mesh-list
20529001|NCT01779206|Docetaxel|docetaxel|mesh-list
19414945|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498861|NCT01649024|Tremelimumab|tremelimumab|mesh-list
20498862|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498863|NCT01649037|Terlipressin|terlipressin|mesh-list
20498864|NCT01649037|Epinephrine|epinephrine|mesh-list
20498865|NCT01649037|Racepinephrine|racepinephrine|mesh-list
20498866|NCT01649037|Norepinephrine|norepinephrine|mesh-list
20498867|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
20498868|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19700636|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700637|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700638|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20498869|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20498870|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
20498871|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498872|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498873|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498874|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20498875|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20498876|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
20498877|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498878|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20498879|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
20498880|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
20498881|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
20498882|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20498883|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20498884|NCT01649245|Interferons|interferons|mesh-list
20498885|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498886|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
20498887|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498888|NCT01649258|Granisetron|granisetron|mesh-list
20498889|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
20498890|NCT01649258|Aprepitant|aprepitant|mesh-list
20498891|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
20498892|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
20498893|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20498894|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498895|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20498896|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20498897|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
20498898|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20498899|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498900|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20498901|NCT01649284|Afatinib|afatinib|mesh-list
20498902|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498903|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20498904|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498905|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498906|NCT01649336|Paclitaxel|paclitaxel|mesh-list
19700639|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20498907|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
20498908|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20498909|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498910|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
20498911|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
20498912|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498913|NCT01649466|Insulin|insulin|mesh-list
20498914|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20498915|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20498916|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498917|NCT01649479|Antibodies|antibodies|mesh-list
20498918|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
20498919|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
20498920|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498921|NCT01649544|Amiodarone|amiodarone|mesh-list
20498922|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20498923|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
20498924|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20498925|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20498926|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498927|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20498928|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20498929|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20498930|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498931|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20498932|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20498933|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20498934|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
20498935|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20498936|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498937|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20498938|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20498939|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
20498940|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498941|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498942|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
20498943|NCT01649635|Prednisone|prednisone|mesh-list
20498944|NCT01649635|Sargramostim|sargramostim|mesh-list
20498945|NCT01649635|Lenograstim|lenograstim|mesh-list
19700640|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
20498946|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20498947|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
20498948|NCT01649635|Hormones|hormones|mesh-ancestor
20498949|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20498950|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498951|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20498952|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498953|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
20498954|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498955|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498956|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20498957|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20498958|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498959|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498960|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20498961|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20498962|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20498963|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
20498964|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
20498965|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20498966|NCT01649674|Cathartics|cathartics|mesh-ancestor
20498967|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20498968|NCT01649713|Vaccines|vaccines|mesh-list
20498969|NCT01649713|Immunologic Factors|immunologic factors|mesh-ancestor
20498970|NCT01649713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498971|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20498972|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
20498973|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20498974|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20498975|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20498976|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498977|NCT01649739|Urological Agents|urological agents|mesh-ancestor
20498978|NCT01649830|Temozolomide|temozolomide|mesh-list
20498979|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20498980|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
20498981|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498982|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498983|NCT01649895|Cycloserine|cycloserine|mesh-list
20498984|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20498985|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498986|NCT01649895|Renal Agents|renal agents|mesh-ancestor
20498987|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20498988|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
19414946|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19414947|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19414948|NCT03161093|Naproxen|naproxen|mesh-list
19414949|NCT03161093|Fasinumab|fasinumab|mesh-list
19414950|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20498989|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498990|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
20498991|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20498992|NCT01649921|Interferons|interferons|mesh-list
19853176|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853177|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19853178|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19853179|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19853180|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20498993|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
20498994|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20498995|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
20498996|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20498997|NCT01649960|Sirolimus|sirolimus|mesh-list
20498998|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20498999|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499000|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20499001|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499002|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
20499003|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499004|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
20499005|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499006|NCT01650012|Eplerenone|eplerenone|mesh-list
20499007|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20499008|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
20499009|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853181|NCT00730275|Incretins|incretins|mesh-ancestor
20499010|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499011|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20499012|NCT01650012|Diuretics|diuretics|mesh-ancestor
20499013|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
20499014|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20499015|NCT01650090|Cisplatin|cisplatin|mesh-list
20499016|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499017|NCT01650129|Insulin|insulin|mesh-list
20499018|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20499019|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
20499020|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
20499021|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20499022|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499023|NCT01650181|Selenium|selenium|mesh-list
20499024|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
20499025|NCT01650181|Metformin|metformin|mesh-list
20499026|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20499027|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499028|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
20499029|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499030|NCT01650181|Protective Agents|protective agents|mesh-ancestor
20499031|NCT01650181|Trace Elements|trace elements|mesh-ancestor
20499032|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
20499033|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
20499034|NCT01650181|Vitamins|vitamins|mesh-ancestor
20499035|NCT01650272|Minoxidil|minoxidil|mesh-list
20499036|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20499037|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20499038|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
20499039|NCT01650376|Paclitaxel|paclitaxel|mesh-list
20499040|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20499041|NCT01650376|Carboplatin|carboplatin|mesh-list
20499042|NCT01650376|Olaparib|olaparib|mesh-list
20499043|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20499044|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499045|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
20499046|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
20499047|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
20499048|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499049|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20499050|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499051|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
20499052|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20499053|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
20499054|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499055|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
20499056|NCT01650415|Hematinics|hematinics|mesh-ancestor
20499057|NCT01650428|Bevacizumab|bevacizumab|mesh-list
20499058|NCT01650428|Fluorouracil|fluorouracil|mesh-list
20499059|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
20499060|NCT01650428|Irinotecan|irinotecan|mesh-list
20499061|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20499062|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499063|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20499064|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20499065|NCT01650428|Growth Substances|growth substances|mesh-ancestor
20499066|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499067|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
20499068|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
20499069|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499070|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499071|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499072|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
20499073|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20499074|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20499075|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499076|NCT01650441|Beclomethasone|beclomethasone|mesh-list
20499077|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
20499078|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20499079|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
20499080|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499081|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499082|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20499083|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
20499084|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20499085|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20499086|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20499087|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
20499088|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499089|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499090|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20499091|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
20499092|NCT01650441|Hormones|hormones|mesh-ancestor
20499093|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499094|NCT01650493|Listerine|listerine|mesh-list
20499095|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
20499096|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
19700641|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19700642|NCT04891458|Analgesics|analgesics|mesh-ancestor
19700643|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
20499097|NCT01650493|Protective Agents|protective agents|mesh-ancestor
20499098|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499099|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20499100|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499101|NCT01650506|Metformin|metformin|mesh-list
20499102|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20499103|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20499104|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499105|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700644|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499106|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20499107|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499108|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499109|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
19700645|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19700646|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19700647|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19700648|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700649|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700650|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499110|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499111|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499112|NCT01650649|Lofexidine|lofexidine|mesh-list
20499113|NCT01650649|Clonidine|clonidine|mesh-list
20499114|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20499115|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20499116|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499117|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
20499118|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499119|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20499120|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20499121|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19414951|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19414952|NCT03161093|Analgesics|analgesics|mesh-ancestor
19414953|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
19414954|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19414955|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414956|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19414957|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414958|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
19414959|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19414960|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414961|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414962|NCT03150797|Melatonin|melatonin|mesh-list
19414963|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
19414964|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414965|NCT03150797|Protective Agents|protective agents|mesh-ancestor
19414966|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414967|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19414968|NCT03148860|Methotrexate|methotrexate|mesh-list
19414969|NCT03148860|Ustekinumab|ustekinumab|mesh-list
19414970|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19414971|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
19414972|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19414973|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414974|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19414975|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
19700651|NCT04891718|Nivolumab|nivolumab|mesh-list
19853182|NCT00730275|Hormones|hormones|mesh-ancestor
20499122|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
19414976|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414977|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19414978|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
19414979|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19414980|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19414981|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19414982|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
19414983|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19414984|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20499123|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499124|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499125|NCT01650649|Analgesics|analgesics|mesh-ancestor
20499126|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
20499127|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
20499128|NCT01650662|Cyclosporine|cyclosporine|mesh-list
20499129|NCT01650662|Cyclosporins|cyclosporins|mesh-list
20499130|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499131|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499132|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499133|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
20499134|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499135|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
20499136|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499137|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20499138|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499139|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20499140|NCT01650701|Rituximab|rituximab|mesh-list
20499141|NCT01650701|Lenalidomide|lenalidomide|mesh-list
20499142|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20499143|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20499144|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499145|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
20499146|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499147|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499148|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20499149|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20499150|NCT01650701|Growth Substances|growth substances|mesh-ancestor
20499151|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
20499152|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20499153|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
20499154|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499155|NCT01650727|Rituximab|rituximab|mesh-list
20499156|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20499157|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499158|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
20499159|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499160|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499161|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20499162|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20499163|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20499164|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20499165|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499166|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499167|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499168|NCT01650740|Analgesics|analgesics|mesh-ancestor
20499169|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
20499170|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499171|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
20499172|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20499173|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
20499174|NCT01650792|Aspirin|aspirin|mesh-list
20499175|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20499176|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20499177|NCT01650792|Analgesics|analgesics|mesh-ancestor
20499178|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
20499179|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499180|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499181|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20499182|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499183|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20499184|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20499185|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499186|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20499187|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20499188|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499189|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
20529002|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
20529003|NCT01779206|Epirubicin|epirubicin|mesh-list
20529004|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19700652|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19700653|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700654|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19700655|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700656|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
19700657|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19700658|NCT04891172|Antibodies|antibodies|mesh-list
19700659|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
19700660|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19700661|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
19700662|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700663|NCT04891302|Clevudine|clevudine|mesh-list
20499190|NCT01650870|Lactulose|lactulose|mesh-list
20499191|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499192|NCT01650883|Vitamin D|vitamin d|mesh-list
20499193|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
20499194|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
20499195|NCT01650883|Vitamins|vitamins|mesh-list
20499196|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
20499197|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499198|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20499199|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20499200|NCT01650961|Palonosetron|palonosetron|mesh-list
20499201|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
20499202|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
20499203|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499204|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499205|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499206|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20499207|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20499208|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
20499209|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499210|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499211|NCT01651130|Carbetocin|carbetocin|mesh-list
20499212|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
20499213|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20499214|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499215|NCT01651156|Tolvaptan|tolvaptan|mesh-list
20499216|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20499217|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499218|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
20499219|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499220|NCT01651169|Methylphenidate|methylphenidate|mesh-list
20499221|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20499222|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499223|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20499224|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20499225|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20499226|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499227|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
20499228|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499229|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
20499230|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20499231|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20499232|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499233|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
20499234|NCT01651182|Coagulants|coagulants|mesh-ancestor
20499235|NCT01651312|Mirabegron|mirabegron|mesh-list
20499236|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20499237|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20499238|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20499239|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
20499240|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499241|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499242|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499243|NCT01651312|Urological Agents|urological agents|mesh-ancestor
20499244|NCT01651325|Isavuconazole|isavuconazole|mesh-list
20499245|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
20499246|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
20499247|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
20499248|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20499249|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20499250|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499251|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499252|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499253|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
20499254|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499255|NCT01651364|Cabergoline|cabergoline|mesh-list
20499256|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20499257|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20499258|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
20499259|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
20499260|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499261|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499262|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499263|NCT01651377|Pramipexole|pramipexole|mesh-list
20499264|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
20499265|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499266|NCT01651377|Protective Agents|protective agents|mesh-ancestor
20499267|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499268|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20499269|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20499270|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
20499271|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
20499272|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499273|NCT01651390|Sirolimus|sirolimus|mesh-list
20499274|NCT01651390|Paclitaxel|paclitaxel|mesh-list
20499275|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20499276|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499277|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
20499278|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
20499279|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
20499280|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499281|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499282|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19414985|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
20499283|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20499284|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
20499285|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499286|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
20499287|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499288|NCT01651416|Lumefantrine|lumefantrine|mesh-list
20499289|NCT01651416|Artemether|artemether|mesh-list
20499290|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
20499291|NCT01651416|Piperaquine|piperaquine|mesh-list
20499292|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
20499293|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20499294|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20499295|NCT01651416|Amodiaquine|amodiaquine|mesh-list
20499296|NCT01651416|Artenimol|artenimol|mesh-list
20499297|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
20499298|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20499299|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20499300|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499301|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20499302|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499303|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499304|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20499305|NCT01651416|Renal Agents|renal agents|mesh-ancestor
20499306|NCT01651481|Montelukast|montelukast|mesh-list
20499307|NCT01651481|Levocetirizine|levocetirizine|mesh-list
20499308|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20499309|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
20499310|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19414986|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19414987|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19414988|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19414989|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19414990|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19414991|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
19414992|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499311|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
20529005|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499312|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499313|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499314|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20499315|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20499316|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499317|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20499318|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20499319|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
20499320|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
20499321|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499322|NCT01651520|Flumazenil|flumazenil|mesh-list
20499323|NCT01651520|Antidotes|antidotes|mesh-ancestor
20499324|NCT01651520|Protective Agents|protective agents|mesh-ancestor
20243220|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243221|NCT00415831|Levodopa|levodopa|mesh-list
20243222|NCT00415831|Carbidopa|carbidopa|mesh-list
20243223|NCT00415831|Entacapone|entacapone|mesh-list
20243224|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20243225|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20243226|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20243227|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
20243228|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499325|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499326|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
20499327|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
20499328|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499329|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499330|NCT01651572|Rocuronium|rocuronium|mesh-list
20499331|NCT01651572|Cisatracurium|cisatracurium|mesh-list
20499332|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20499333|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20499334|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20499335|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499336|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499337|NCT01651585|Valacyclovir|valacyclovir|mesh-list
20499338|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
20499339|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499340|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20499341|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
20499342|NCT01651715|Antibodies|antibodies|mesh-list
20499343|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
20499344|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499345|NCT01651728|Simvastatin|simvastatin|mesh-list
20499346|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20243229|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499347|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20499348|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
20499349|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499350|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20499351|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20499352|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499353|NCT01651754|Vaccines|vaccines|mesh-list
20499354|NCT01651754|Immunologic Factors|immunologic factors|mesh-ancestor
20499355|NCT01651754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499356|NCT01651923|Heparin|heparin|mesh-list
20499357|NCT01651923|Calcium heparin|calcium heparin|mesh-list
20499358|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
20499359|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20499360|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20499361|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499362|NCT01651962|Fentanyl|fentanyl|mesh-list
20499363|NCT01651962|Terbutaline|terbutaline|mesh-list
20499364|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20499365|NCT01651962|Narcotics|narcotics|mesh-ancestor
20499366|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20499367|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499368|NCT01651962|Analgesics|analgesics|mesh-ancestor
20499369|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
20499370|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499371|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20499372|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20499373|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
20499374|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
20499375|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20499376|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
20499377|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20499378|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
20499379|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
20499380|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
19700664|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
20499381|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20499382|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20499383|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20499384|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20499385|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
20499386|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499387|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499388|NCT01651988|Propofol|propofol|mesh-list
20499389|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20499390|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20499391|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499392|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20499393|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
20499394|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
20499395|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
20499396|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
20499397|NCT01652014|Fludarabine|fludarabine|mesh-list
20499398|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
20499399|NCT01652014|Tacrolimus|tacrolimus|mesh-list
20499400|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499401|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
20499402|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499403|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499404|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20499405|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
20499406|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499407|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499408|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20499409|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499410|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
20499411|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20499412|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499413|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20499414|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20499415|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
20499416|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499417|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499418|NCT01652118|Clarithromycin|clarithromycin|mesh-list
20499419|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499420|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529006|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
20499421|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20499422|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499423|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499424|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20499425|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20499426|NCT01652157|Pancrelipase|pancrelipase|mesh-list
20499427|NCT01652157|Pancreatin|pancreatin|mesh-list
20499428|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499429|NCT01652183|Acetaminophen|acetaminophen|mesh-list
20499430|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20499431|NCT01652183|Analgesics|analgesics|mesh-ancestor
20499432|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
20499433|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499434|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499435|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
20499436|NCT01652196|Leucovorin|leucovorin|mesh-list
20499437|NCT01652196|Fluorouracil|fluorouracil|mesh-list
20499438|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
20499439|NCT01652196|Aflibercept|aflibercept|mesh-list
20499440|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
20499441|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20499442|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
20499443|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499444|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499445|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499446|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499447|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
20499448|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499449|NCT01652196|Antidotes|antidotes|mesh-ancestor
20499450|NCT01652196|Protective Agents|protective agents|mesh-ancestor
20499451|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
20499452|NCT01652196|Vitamins|vitamins|mesh-ancestor
20499453|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
20499454|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20499455|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19700665|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700666|NCT04891211|Vitamin D|vitamin d|mesh-list
20499456|NCT01652196|Growth Substances|growth substances|mesh-ancestor
20499457|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
20499458|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20499459|NCT01652313|Rasagiline|rasagiline|mesh-list
20499460|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20499461|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499462|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499463|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20499464|NCT01652313|Protective Agents|protective agents|mesh-ancestor
20499465|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499466|NCT01652326|Diazepam|diazepam|mesh-list
20499467|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20499468|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
20499469|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
20499470|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
20499471|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499472|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499473|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499474|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20499475|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20499476|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20499477|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20499478|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20499479|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20499480|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20499481|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20499482|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
20499483|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
20499484|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
20499485|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
20499486|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499487|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499488|NCT01652339|Amlodipine|amlodipine|mesh-list
20499489|NCT01652339|Valsartan|valsartan|mesh-list
20499490|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20499491|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20499492|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20499493|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20499494|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499495|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20499496|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499497|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
20499498|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20499499|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20499500|NCT01652378|Lidocaine|lidocaine|mesh-list
20499501|NCT01652378|Ondansetron|ondansetron|mesh-list
20499502|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
20499503|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
20499504|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20499505|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499506|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
20499507|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499508|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20499509|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20499510|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20499511|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20499512|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499513|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
20499514|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
20499515|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499516|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
20499517|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
20499518|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20499519|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
20499520|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499521|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20499522|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20499523|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20499524|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20499525|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
20499526|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20499527|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20499528|NCT01652417|Prednisolone|prednisolone|mesh-list
20499529|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
19700667|NCT04891211|Vitamins|vitamins|mesh-ancestor
20499530|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20499531|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
20499532|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20499533|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
20499534|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
20499535|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499536|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499537|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499538|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
20499539|NCT01652417|Hormones|hormones|mesh-ancestor
20499540|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499541|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20499542|NCT01652417|Protective Agents|protective agents|mesh-ancestor
20499543|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20499544|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529007|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
20529008|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
20529009|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529010|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529011|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
20529012|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529013|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529014|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20529015|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
20529016|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20529017|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20529018|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20529019|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20529020|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529021|NCT01779232|Danazol|danazol|mesh-list
20529022|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20529023|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
20529024|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529025|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529026|NCT01779245|Calcium|calcium|mesh-list
20529027|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20529028|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529029|NCT01779258|Desonide|desonide|mesh-list
20529030|NCT01779258|Glycerol|glycerol|mesh-list
19700668|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
20529031|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20499545|NCT01652534|Amantadine|amantadine|mesh-list
20499546|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20499547|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20499548|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
20499549|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499550|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
20499551|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499552|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499553|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499554|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20499555|NCT01652534|Analgesics|analgesics|mesh-ancestor
20499556|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
20499557|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499558|NCT01652547|Pasireotide|pasireotide|mesh-list
20243230|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243231|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20243232|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243233|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20243234|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20243235|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
20243236|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
20243237|NCT00415844|Levodopa|levodopa|mesh-list
20243238|NCT00415844|Carbidopa|carbidopa|mesh-list
20243239|NCT00415844|Entacapone|entacapone|mesh-list
20243240|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20243241|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20243242|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20243243|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
20243244|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243245|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243246|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499559|NCT01652547|Somatostatin|somatostatin|mesh-list
20247997|NCT00434096|Hormones|hormones|mesh-ancestor
20499560|NCT01652547|Hormones|hormones|mesh-ancestor
20529032|NCT01779258|Protective Agents|protective agents|mesh-ancestor
19414993|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19414994|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19414995|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499561|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499562|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499563|NCT01652560|Bevacizumab|bevacizumab|mesh-list
20499564|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20499565|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499566|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20499567|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20499568|NCT01652560|Growth Substances|growth substances|mesh-ancestor
20499569|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499570|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
20499571|NCT01652586|Midazolam|midazolam|mesh-list
20499572|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
20499573|NCT01652586|Remifentanil|remifentanil|mesh-list
20499574|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20499575|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20499576|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499577|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20499578|NCT01652586|Analgesics|analgesics|mesh-ancestor
20499579|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
20499580|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499581|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20499582|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20499583|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20499584|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
20499585|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499586|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499587|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20499588|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20499589|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20499590|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20499591|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20499592|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
20499593|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
20499594|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
20499595|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
20499596|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20499597|NCT01652586|Narcotics|narcotics|mesh-ancestor
20499598|NCT01652599|Dexamethasone|dexamethasone|mesh-list
20499599|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20499600|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
20499601|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
20499602|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499603|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499604|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499605|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
20499606|NCT01652599|Hormones|hormones|mesh-ancestor
20499607|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499608|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20499609|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499610|NCT01652638|Heparin|heparin|mesh-list
20499611|NCT01652638|Calcium heparin|calcium heparin|mesh-list
20499612|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
20499613|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20499614|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20499615|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499616|NCT01652781|Azacitidine|azacitidine|mesh-list
20499617|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499618|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
20499619|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499620|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499621|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499622|NCT01652794|Gemcitabine|gemcitabine|mesh-list
20499623|NCT01652794|Carboplatin|carboplatin|mesh-list
20499624|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499625|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499626|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
20499627|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499628|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
20499629|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499630|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499631|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499632|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
20499633|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499634|NCT01652820|Gemcitabine|gemcitabine|mesh-list
20499635|NCT01652820|Carboplatin|carboplatin|mesh-list
20499636|NCT01652820|Docetaxel|docetaxel|mesh-list
20499637|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499638|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499639|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
20499640|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499641|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
20499642|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499643|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499644|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499645|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
20499646|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499647|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
20499648|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
20499649|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
20499650|NCT01652859|Amphotericin B|amphotericin b|mesh-list
20499651|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20499652|NCT01652859|Amebicides|amebicides|mesh-ancestor
20499653|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20499654|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20499655|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499656|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499657|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
20499658|NCT01652898|Esmolol|esmolol|mesh-list
20499659|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20499660|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20499661|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20499662|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
20499663|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499664|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499665|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499666|NCT01652924|Anesthetics|anesthetics|mesh-list
20499667|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20499668|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499669|NCT01653015|Vaccines|vaccines|mesh-list
20499670|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
20499671|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499672|NCT01653041|Everolimus|everolimus|mesh-list
20499673|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499674|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499675|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
20499676|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499677|NCT01653067|Cytarabine|cytarabine|mesh-list
20499678|NCT01653067|Sirolimus|sirolimus|mesh-list
20499679|NCT01653067|Dexamethasone|dexamethasone|mesh-list
20499680|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
20499681|NCT01653067|Rituximab|rituximab|mesh-list
20499682|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20499683|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499684|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
20499685|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499686|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499687|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20499688|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
20499689|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
20499690|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499691|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499692|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
20499693|NCT01653067|Hormones|hormones|mesh-ancestor
20499694|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499695|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20499696|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499697|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499698|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
20499699|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
20499700|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499701|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499702|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499703|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20499704|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
20499705|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20499706|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20499707|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20499708|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
20499709|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499710|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20499711|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20499712|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499713|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
20499714|NCT01653171|Simethicone|simethicone|mesh-list
20499715|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20499716|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
20499717|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499718|NCT01653171|Expectorants|expectorants|mesh-ancestor
20499719|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
20499720|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20499721|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
20499722|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499723|NCT01653171|Protective Agents|protective agents|mesh-ancestor
19853183|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853184|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19853185|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853186|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853187|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853188|NCT00730353|Paclitaxel|paclitaxel|mesh-list
19853189|NCT00730353|Sunitinib|sunitinib|mesh-list
19853190|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19853191|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853192|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
19853193|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853194|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
20499724|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499725|NCT01653171|Antidotes|antidotes|mesh-ancestor
20499726|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
20499727|NCT01653171|Emollients|emollients|mesh-ancestor
20499728|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
20499729|NCT01653236|Ribavirin|ribavirin|mesh-list
20499730|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20499731|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
20499732|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499733|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
20499734|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499735|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
20499736|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499737|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20499738|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499739|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499740|NCT01653457|Memantine|memantine|mesh-list
20499741|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20499742|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20499743|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
20499744|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499745|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499746|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499747|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20499748|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20499749|NCT01653470|Leucovorin|leucovorin|mesh-list
20499750|NCT01653470|Paclitaxel|paclitaxel|mesh-list
20499751|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20499752|NCT01653470|Carboplatin|carboplatin|mesh-list
20499753|NCT01653470|Fluorouracil|fluorouracil|mesh-list
20499754|NCT01653470|Irinotecan|irinotecan|mesh-list
20499755|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20499756|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499757|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20499758|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20499759|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20499760|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499761|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
20499762|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499763|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499764|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
20499765|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499766|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20499767|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20499768|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499769|NCT01653470|Antidotes|antidotes|mesh-ancestor
20499770|NCT01653470|Protective Agents|protective agents|mesh-ancestor
20499771|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
20499772|NCT01653470|Vitamins|vitamins|mesh-ancestor
20499773|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
20499774|NCT01653522|Doxycycline|doxycycline|mesh-list
20499775|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499776|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499777|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
20499778|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20499779|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20499780|NCT01653561|Apatinib|apatinib|mesh-list
20499781|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499782|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20499783|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499784|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499785|NCT01653639|Factor VIII|factor viii|mesh-list
20499786|NCT01653639|Coagulants|coagulants|mesh-ancestor
20499787|NCT01653665|Sargramostim|sargramostim|mesh-list
20499788|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
20499789|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499790|NCT01653678|Vitamin D|vitamin d|mesh-list
20499791|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
20499792|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
20499793|NCT01653678|Vitamins|vitamins|mesh-list
20499794|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
20499795|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499796|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20499797|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20499798|NCT01653717|Vidarabine|vidarabine|mesh-list
20499799|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
20499800|NCT01653717|Fludarabine|fludarabine|mesh-list
20499801|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
20499802|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499803|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
20499804|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499805|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499806|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20499807|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
20499808|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499809|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499810|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20499811|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499812|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
20499813|NCT01653717|Antiviral Agents|antiviral agents|mesh-ancestor
20499814|NCT01653717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499815|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20499816|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
20499817|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20499818|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499819|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499820|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20499821|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20499822|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499823|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499824|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499825|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20499826|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
20499827|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20499828|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499829|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20499830|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20499831|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20499832|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20499833|NCT01654081|Irinotecan|irinotecan|mesh-list
20499834|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20499835|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20499836|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499837|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499838|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499839|NCT01654120|Liraglutide|liraglutide|mesh-list
20499840|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20499841|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499842|NCT01654120|Incretins|incretins|mesh-ancestor
20499843|NCT01654120|Hormones|hormones|mesh-ancestor
20499844|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499845|NCT01654146|Paclitaxel|paclitaxel|mesh-list
20499846|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20499847|NCT01654146|Carboplatin|carboplatin|mesh-list
20499848|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20499849|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499850|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
20499851|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
20499852|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
20499853|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499854|NCT01654185|Letrozole|letrozole|mesh-list
20499855|NCT01654185|Exemestane|exemestane|mesh-list
20499856|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19700669|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700670|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19700671|NCT04890626|Tenofovir|tenofovir|mesh-list
19700672|NCT04890626|Emtricitabine|emtricitabine|mesh-list
20499857|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700673|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19700674|NCT04890626|Dexamethasone|dexamethasone|mesh-list
19700675|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
19700676|NCT04890626|BB 1101|bb 1101|mesh-list
19700677|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700678|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
19700679|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
20499858|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20499859|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499860|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499861|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20499862|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
20499863|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499864|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499865|NCT01654211|Ritonavir|ritonavir|mesh-list
20499866|NCT01654211|Lactams|lactams|mesh-list
20499867|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20499868|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20499869|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
20499870|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499871|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499872|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19700680|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499873|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20499874|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
20499875|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499876|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20499877|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20499878|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499879|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
20499880|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20499881|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20499882|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499883|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20499884|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499885|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499886|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20499887|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
20499888|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529033|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529034|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529035|NCT01779271|Loxoprofen|loxoprofen|mesh-list
20529036|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20529037|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20529038|NCT01779271|Analgesics|analgesics|mesh-ancestor
20529039|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
20529040|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529041|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529042|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529043|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529044|NCT01779284|Timolol|timolol|mesh-list
20529045|NCT01779284|Travoprost|travoprost|mesh-list
20529046|NCT01779284|Latanoprost|latanoprost|mesh-list
20529047|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20529048|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20529049|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
20499889|NCT01654497|HU 211|hu 211|mesh-list
20499890|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20499891|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
20499892|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
20499893|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499894|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499895|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499896|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19414996|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19414997|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19414998|NCT03123783|Nivolumab|nivolumab|mesh-list
19414999|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415000|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415001|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20499897|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20499898|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499899|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499900|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20499901|NCT01654497|Protective Agents|protective agents|mesh-ancestor
20499902|NCT01654562|Simvastatin|simvastatin|mesh-list
20499903|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20499904|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20499905|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
20499906|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499907|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20499908|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20499909|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499910|NCT01654575|Methotrexate|methotrexate|mesh-list
20499911|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20499912|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
20499913|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20499914|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499915|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20499916|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
20499917|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499918|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499919|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
20499920|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499921|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20499922|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20499923|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
20499924|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20499925|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20499926|NCT01654640|Metformin|metformin|mesh-list
20499927|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20499928|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499929|NCT01654692|Ipilimumab|ipilimumab|mesh-list
20499930|NCT01654692|Fotemustine|fotemustine|mesh-list
20499931|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20499932|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499933|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20499934|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499935|NCT01654705|Pantoprazole|pantoprazole|mesh-list
20499936|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20499937|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499938|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20499939|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499940|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499941|NCT01654718|Pantoprazole|pantoprazole|mesh-list
20499942|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20499943|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499944|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20499945|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499946|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499947|NCT01654731|Bezafibrate|bezafibrate|mesh-list
20499948|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20499949|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
20499950|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499951|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20499952|NCT01654809|Vaccines|vaccines|mesh-list
20499953|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
20499954|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499955|NCT01654939|Rifaximin|rifaximin|mesh-list
20499956|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20499957|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20499958|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20499959|NCT01654965|Topotecan|topotecan|mesh-list
20499960|NCT01654965|Lenograstim|lenograstim|mesh-list
20499961|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20499962|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
20499963|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499964|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20499965|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20499966|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499967|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499968|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499969|NCT01655004|Exemestane|exemestane|mesh-list
20499970|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20499971|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20499972|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20499973|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499974|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499975|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20499976|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
20499977|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20499978|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499979|NCT01655056|Darexaban|darexaban|mesh-list
20499980|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20499981|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
20499982|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20499983|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
20499984|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20499985|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499986|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
20499987|NCT01655082|Nicotine|nicotine|mesh-list
20499988|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20499989|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
20499990|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20499991|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20499992|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20499993|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20499994|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
20499995|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20499996|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20499997|NCT01655095|Prucalopride|prucalopride|mesh-list
20499998|NCT01655095|Bisacodyl|bisacodyl|mesh-list
20499999|NCT01655095|Laxatives|laxatives|mesh-ancestor
20500000|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700681|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700682|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700683|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
19700684|NCT04890626|Hormones|hormones|mesh-ancestor
20243247|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19700685|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243248|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243249|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20500001|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20500002|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20500003|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
20243250|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20243251|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
20243252|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
20243253|NCT00415883|Valsartan|valsartan|mesh-list
20243254|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20243255|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20500004|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500005|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500006|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500007|NCT01655095|Cathartics|cathartics|mesh-ancestor
20500008|NCT01655108|Minoxidil|minoxidil|mesh-list
20500009|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20500010|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
20500011|NCT01655147|Rifampin|rifampin|mesh-list
20500012|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
20500013|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500014|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20243256|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20243257|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243258|NCT00415922|Levodopa|levodopa|mesh-list
20500015|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500016|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500017|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
20500018|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500019|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500020|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20500021|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20500022|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
20500023|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20243259|NCT00415922|Carbidopa|carbidopa|mesh-list
20243260|NCT00415922|Entacapone|entacapone|mesh-list
20243261|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20243262|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20243263|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20243264|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
20243265|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243266|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243267|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243268|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20243269|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243270|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20243271|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20243272|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
20243273|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
20243274|NCT00415935|Methotrexate|methotrexate|mesh-list
20243275|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20243276|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
20243277|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20500024|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500025|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
20500026|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20500027|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20500028|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20500029|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20500030|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20500031|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20500032|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20500033|NCT01655199|Albuterol|albuterol|mesh-list
20500034|NCT01655199|Ipratropium|ipratropium|mesh-list
20500035|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20500036|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
20500037|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500038|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500039|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20500040|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
20500041|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
20500042|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20500043|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20500044|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20500045|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20500046|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500047|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500048|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500049|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20500050|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
20500051|NCT01655212|Valganciclovir|valganciclovir|mesh-list
20500052|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
20500053|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500054|NCT01655303|Propranolol|propranolol|mesh-list
20500055|NCT01655303|Metoprolol|metoprolol|mesh-list
20500056|NCT01655303|Verapamil|verapamil|mesh-list
20500057|NCT01655303|Diltiazem|diltiazem|mesh-list
20500058|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20500059|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20500060|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500061|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500062|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500063|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500064|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20500065|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20500066|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
20500067|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
20500068|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
20500069|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500070|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20500071|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20500072|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500073|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20500074|NCT01655316|Verapamil|verapamil|mesh-list
20500075|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20500076|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20500077|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500078|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500079|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20500080|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500081|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
20243278|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243279|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20243280|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
20243281|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243282|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243283|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
20243284|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243285|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20243286|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243287|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
20500082|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
20500083|NCT01655524|Aminophylline|aminophylline|mesh-list
20500084|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20500085|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
20500086|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500087|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500088|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20500089|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
20500090|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20500091|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20500092|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500093|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500094|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20500095|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20500096|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
20500097|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500098|NCT01655524|Protective Agents|protective agents|mesh-ancestor
20500099|NCT01655628|Gemcitabine|gemcitabine|mesh-list
20500100|NCT01655628|Cisplatin|cisplatin|mesh-list
20500101|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500102|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20500103|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
20500104|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500105|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
20500106|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500107|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415002|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415003|NCT03118570|Vitamin D|vitamin d|mesh-list
20500108|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500109|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
20500110|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500111|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
20500112|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20500113|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20500114|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500115|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
20500116|NCT01655641|Coagulants|coagulants|mesh-ancestor
19415004|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
19415005|NCT03118570|Calcium|calcium|mesh-list
19415006|NCT03118570|Vitamins|vitamins|mesh-ancestor
19415007|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
20243288|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500117|NCT01655706|Aripiprazole|aripiprazole|mesh-list
20500118|NCT01655706|Citalopram|citalopram|mesh-list
20500119|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20500120|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20500121|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500122|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500123|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243289|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20243290|NCT00415961|Paclitaxel|paclitaxel|mesh-list
20243291|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20243292|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243293|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243294|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243295|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243296|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243297|NCT00416039|Midazolam|midazolam|mesh-list
20243298|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20243299|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20243300|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20243301|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415008|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415009|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19415010|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19415011|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
19415012|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19415013|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
19415014|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415015|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19415016|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415017|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19415018|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415019|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19415020|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415021|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19700686|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243302|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20243303|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20243304|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20500124|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
20500125|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700687|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700688|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
20500126|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20500127|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
20500128|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20500129|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20500130|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20500131|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20500132|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
20500133|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
20500134|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20500135|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20500136|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20500137|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20500138|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20500139|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20500140|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20500141|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20500142|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500143|NCT01655758|Timolol|timolol|mesh-list
20500144|NCT01655758|Bimatoprost|bimatoprost|mesh-list
20500145|NCT01655758|Travoprost|travoprost|mesh-list
20500146|NCT01655758|Dorzolamide|dorzolamide|mesh-list
20500147|NCT01655758|Latanoprost|latanoprost|mesh-list
20500148|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20500149|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20500150|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500151|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500152|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500153|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500154|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20500155|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20500156|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20500157|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20500158|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20500159|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500160|NCT01655810|Vitamin D|vitamin d|mesh-list
20500161|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
20500162|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
20500163|NCT01655810|Vitamins|vitamins|mesh-list
20500164|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
20500165|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
20500166|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500167|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20500168|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20500169|NCT01655810|Antacids|antacids|mesh-ancestor
20500170|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500171|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20500172|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
20500173|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20500174|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20500175|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20500176|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500177|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500178|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
20500179|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500180|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500181|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20500182|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500183|NCT01655875|Plerixafor|plerixafor|mesh-list
20500184|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20500185|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20500186|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
20500187|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500188|NCT01655888|Tremelimumab|tremelimumab|mesh-list
20500189|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500190|NCT01655914|Flumazenil|flumazenil|mesh-list
20500191|NCT01655914|Antidotes|antidotes|mesh-ancestor
20500192|NCT01655914|Protective Agents|protective agents|mesh-ancestor
20500193|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500194|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
20500195|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
20500196|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500197|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500198|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
20500199|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20500200|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20500201|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500202|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
20500203|NCT01655927|Coagulants|coagulants|mesh-ancestor
20500204|NCT01655966|Vitamin D|vitamin d|mesh-list
20500205|NCT01655966|Interferons|interferons|mesh-list
20500206|NCT01655966|Ribavirin|ribavirin|mesh-list
20500207|NCT01655966|Vitamins|vitamins|mesh-ancestor
20500208|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
19415022|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
20500209|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500210|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20500211|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500212|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
20500213|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500214|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
20500215|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500216|NCT01655992|Capecitabine|capecitabine|mesh-list
20500217|NCT01655992|Tegafur|tegafur|mesh-list
20500218|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20500219|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
20500220|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500221|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500222|NCT01656005|Beclomethasone|beclomethasone|mesh-list
20500223|NCT01656005|Carvedilol|carvedilol|mesh-list
20500224|NCT01656005|Bisoprolol|bisoprolol|mesh-list
20500225|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
20500226|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
20500227|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20500228|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
20500229|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500230|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500231|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20500232|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
20500233|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20500234|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20500235|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20500236|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500237|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500238|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500239|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
20500240|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20243305|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20243306|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
20243307|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
20243308|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
20243309|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
20243310|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243311|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243312|NCT00416130|Vorinostat|vorinostat|mesh-list
20243313|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243314|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20243315|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243316|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243317|NCT00416143|Prednisone|prednisone|mesh-list
20243318|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243319|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
20500241|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
20500242|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20500243|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20500244|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20500245|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
20500246|NCT01656005|Protective Agents|protective agents|mesh-ancestor
20500247|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20500248|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500249|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20500250|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
20500251|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20500252|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20500253|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
20500254|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20500255|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500256|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
20500257|NCT01656005|Hormones|hormones|mesh-ancestor
20500258|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500259|NCT01656018|Rilpivirine|rilpivirine|mesh-list
20500260|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20500261|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20500262|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500263|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500264|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
20500265|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500266|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20500267|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20500268|NCT01656057|Acetaminophen|acetaminophen|mesh-list
19415023|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500269|NCT01656057|Metformin|metformin|mesh-list
20500270|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
20500271|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20500272|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20500273|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500274|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20500275|NCT01656057|Analgesics|analgesics|mesh-ancestor
20500276|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
20500277|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500278|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
20500279|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20500280|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20500281|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
20500282|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500283|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20500284|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20500285|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20529050|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529051|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529052|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529053|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20529054|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20529055|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20529056|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20529057|NCT01779362|Metformin|metformin|mesh-list
20529058|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
20529059|NCT01779362|Liraglutide|liraglutide|mesh-list
20529060|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20529061|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529062|NCT01779362|Incretins|incretins|mesh-ancestor
20529063|NCT01779362|Hormones|hormones|mesh-ancestor
20529064|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529065|NCT01779401|Aspirin|aspirin|mesh-list
20529066|NCT01779401|Cilostazol|cilostazol|mesh-list
20529067|NCT01779401|Clopidogrel|clopidogrel|mesh-list
20529068|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20529069|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20529070|NCT01779401|Analgesics|analgesics|mesh-ancestor
20529071|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
20529072|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529073|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529074|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529075|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529076|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20529077|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20529078|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529079|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20529080|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20500286|NCT01656070|Vitamin D|vitamin d|mesh-list
20500287|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
20500288|NCT01656070|Vitamins|vitamins|mesh-ancestor
20500289|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
20500290|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500291|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20500292|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20500293|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20500294|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20500295|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20500296|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
20500297|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500298|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500299|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20500300|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20500301|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
20500302|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500303|NCT01656122|Abacavir|abacavir|mesh-list
20500304|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19415024|NCT03104842|Dexamethasone|dexamethasone|mesh-list
20529081|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500305|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20500306|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500307|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500308|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
20500309|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500310|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20500311|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20500312|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
20500313|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20500314|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500315|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500316|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
20500317|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20500318|NCT01656226|Protective Agents|protective agents|mesh-ancestor
20500319|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500320|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
20500321|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
20500322|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20500323|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
20500324|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20500325|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
20500326|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500327|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500328|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
20500329|NCT01656343|Abatacept|abatacept|mesh-list
20500330|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20500331|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20500332|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500333|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500334|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500335|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
20500336|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500337|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500338|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500339|NCT01656512|Vitamin D|vitamin d|mesh-list
20500340|NCT01656512|Diphosphonates|diphosphonates|mesh-list
20500341|NCT01656512|Calcium|calcium|mesh-list
20500342|NCT01656512|Vitamins|vitamins|mesh-ancestor
20500343|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
20500344|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500345|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20529082|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
19415025|NCT03104842|Lenalidomide|lenalidomide|mesh-list
19415026|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415027|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
20500346|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20500347|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20500348|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
20500349|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500350|NCT01656538|Paclitaxel|paclitaxel|mesh-list
20500351|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20500352|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500353|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
20500354|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
20500355|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
20500356|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500357|NCT01656551|Gemcitabine|gemcitabine|mesh-list
20500358|NCT01656551|Pemetrexed|pemetrexed|mesh-list
20500359|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500360|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19853195|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853196|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853197|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19853198|NCT00730353|Growth Substances|growth substances|mesh-ancestor
19853199|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853200|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
19853201|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853202|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853203|NCT00730405|Albaconazole|albaconazole|mesh-list
19853204|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
19853205|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853206|NCT00730483|Doxorubicin|doxorubicin|mesh-list
20500361|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
20500362|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500363|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
20500364|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500365|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500366|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500367|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
20500368|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500369|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20500370|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20500371|NCT01656616|Antidotes|antidotes|mesh-list
20500372|NCT01656616|Protective Agents|protective agents|mesh-ancestor
20500373|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500374|NCT01656642|Atezolizumab|atezolizumab|mesh-list
20500375|NCT01656642|Vemurafenib|vemurafenib|mesh-list
20500376|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500377|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20500378|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500379|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500380|NCT01656668|Theobromine|theobromine|mesh-list
20500381|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20500382|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
20500383|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500384|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500385|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20500386|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
19700689|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500387|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
20500388|NCT01656720|Methoxamine|methoxamine|mesh-list
20500389|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
20500390|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
20500391|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500392|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500393|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20500394|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20500395|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20500396|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20500397|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500398|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500399|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500400|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
20500401|NCT01656798|Citric Acid|citric acid|mesh-list
20500402|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
20500403|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
20500404|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20500405|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
20500406|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
20500407|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700690|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500408|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
19700691|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
19700692|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700693|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19700694|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19700695|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19700696|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19700697|NCT04890522|Gemcitabine|gemcitabine|mesh-list
19700698|NCT04890522|Fluorouracil|fluorouracil|mesh-list
19700699|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700700|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19700701|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
19700702|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700703|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
19700704|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700705|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243320|NCT00416143|Hormones|hormones|mesh-ancestor
19700706|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243321|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243322|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243323|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243324|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243325|NCT00416169|Galantamine|galantamine|mesh-list
20243326|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20243327|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243328|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243329|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
20243330|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243331|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415028|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
19415029|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415030|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415031|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19415032|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
19415033|NCT03104842|Hormones|hormones|mesh-ancestor
19415034|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700707|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
20243332|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20243333|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
20243334|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243335|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
20243336|NCT00416208|Bortezomib|bortezomib|mesh-list
20243337|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853207|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20243338|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
20243339|NCT00416221|Citalopram|citalopram|mesh-list
20243340|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20243341|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20243342|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20243343|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20243344|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243345|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243346|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
20500409|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20500410|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20500411|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500412|NCT01656798|Urological Agents|urological agents|mesh-ancestor
20500413|NCT01656811|Albuterol|albuterol|mesh-list
20500414|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20500415|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
20500416|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500417|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500418|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20500419|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
20500420|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
20500421|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20500422|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20500423|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20500424|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20500425|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500426|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500427|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500428|NCT01656980|Carmustine|carmustine|mesh-list
20500429|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20500430|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
20500431|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500432|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500433|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
20500434|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
20243347|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500435|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
20500436|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500437|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500438|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20500439|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20500440|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
20500441|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
20500442|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500443|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500444|NCT01657071|Aspirin|aspirin|mesh-list
20500445|NCT01657071|Clopidogrel|clopidogrel|mesh-list
20500446|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20500447|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20500448|NCT01657071|Analgesics|analgesics|mesh-ancestor
20500449|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
20500450|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500451|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500452|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500453|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500454|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20243348|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20243349|NCT00416273|Bortezomib|bortezomib|mesh-list
20243350|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243351|NCT00416325|Lycopene|lycopene|mesh-list
20243352|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243353|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
20500455|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20500456|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500457|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20500458|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20243354|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500459|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500460|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
20500461|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20500462|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20500463|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20500464|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
20500465|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500466|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
20500467|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20500468|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500469|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20500470|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20500471|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500472|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500473|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243355|NCT00416325|Protective Agents|protective agents|mesh-ancestor
20243356|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243357|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20500474|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500475|NCT01657201|Voriconazole|voriconazole|mesh-list
20500476|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
20500477|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500478|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20500479|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20500480|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500481|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500482|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20500483|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
20500484|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500485|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500486|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20500487|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20500488|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20500489|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20500490|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20500491|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20500492|NCT01657240|Analgesics|analgesics|mesh-ancestor
20500493|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
20500494|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500495|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500496|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500497|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500498|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20500499|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20500500|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20500501|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
20500502|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
20500503|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500504|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529083|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20529084|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20500505|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20500506|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500507|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20500508|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20500509|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20500510|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
20500511|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500512|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500513|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20500514|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
20500515|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20243358|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20243359|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243360|NCT00416377|Prednisolone|prednisolone|mesh-list
20243361|NCT00416377|Doxorubicin|doxorubicin|mesh-list
20243362|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20243363|NCT00416377|Bleomycin|bleomycin|mesh-list
20243364|NCT00416377|Vincristine|vincristine|mesh-list
20243365|NCT00416377|Dacarbazine|dacarbazine|mesh-list
20243366|NCT00416377|Vinblastine|vinblastine|mesh-list
20243367|NCT00416377|Procarbazine|procarbazine|mesh-list
20243368|NCT00416377|Chlorambucil|chlorambucil|mesh-list
20243369|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20243370|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243371|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20243372|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243373|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243374|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243375|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20243376|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243377|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243378|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243379|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243380|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
20243381|NCT00416377|Hormones|hormones|mesh-ancestor
20500516|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700708|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708013|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20243382|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500517|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
20500518|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
20500519|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20500520|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20500521|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20500522|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20500523|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500524|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500525|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
20500526|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500527|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500528|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20500529|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500530|NCT01657448|Methenamine|methenamine|mesh-list
20500531|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
20500532|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
20500533|NCT01657448|Methylene Blue|methylene blue|mesh-list
20500534|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20500535|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500536|NCT01657448|Renal Agents|renal agents|mesh-ancestor
20500537|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20500538|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500539|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500540|NCT01657487|Fluticasone|fluticasone|mesh-list
20500541|NCT01657487|Xhance|xhance|mesh-list
20500542|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20500543|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20243383|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243384|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19700709|NCT04890561|Lemborexant|lemborexant|mesh-list
20243385|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20243386|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
20243387|NCT00416390|Lycopene|lycopene|mesh-list
20243388|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243389|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
20243390|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243391|NCT00416390|Protective Agents|protective agents|mesh-ancestor
20243392|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243393|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20500544|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500545|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20500546|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
20500547|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500548|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500549|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20500550|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
20500551|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
20500552|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20500553|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20500554|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20500555|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20500556|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500557|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500558|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500559|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
20500560|NCT01657487|Hormones|hormones|mesh-ancestor
20500561|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500562|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
20500563|NCT01657578|Omeprazole|omeprazole|mesh-list
20500564|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20500565|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20500566|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20500567|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500568|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500569|NCT01657656|Vitamin D|vitamin d|mesh-list
20500570|NCT01657656|Vitamins|vitamins|mesh-ancestor
20500571|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
20500572|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500573|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20500574|NCT01657669|Aflibercept|aflibercept|mesh-list
20500575|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20500576|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20500577|NCT01657669|Growth Substances|growth substances|mesh-ancestor
20500578|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500579|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
20500580|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500581|NCT01657682|Crenolanib|crenolanib|mesh-list
20500582|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500583|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20500584|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
19853208|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19853209|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853210|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19853211|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19853212|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853213|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853214|NCT00730522|Vigabatrin|vigabatrin|mesh-list
19853215|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
19853216|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855620|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500585|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
20500586|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500587|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500588|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20500589|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20500590|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
20500591|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500592|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500593|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
20500594|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20500595|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20500596|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500597|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20500598|NCT01657812|Analgesics|analgesics|mesh-ancestor
20500599|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
20500600|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500601|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20500602|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20500603|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20500604|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500605|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500606|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500607|NCT01657825|Isavuconazole|isavuconazole|mesh-list
20500608|NCT01657825|Warfarin|warfarin|mesh-list
20500609|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
20500610|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
19700710|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20500611|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500612|NCT01657838|Ketoconazole|ketoconazole|mesh-list
20500613|NCT01657838|Isavuconazole|isavuconazole|mesh-list
20500614|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
20500615|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700711|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700712|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700713|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19700714|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19700715|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700716|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700717|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19700718|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700719|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700720|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
19700721|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700722|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20243394|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20243395|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500616|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20500617|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20500618|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500619|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500620|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20500621|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
20500622|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500623|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500624|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20500625|NCT01657851|Tamsulosin|tamsulosin|mesh-list
20500626|NCT01657851|Dutasteride|dutasteride|mesh-list
20500627|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20500628|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20500629|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20500630|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500631|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500632|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500633|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500634|NCT01657851|Urological Agents|urological agents|mesh-ancestor
20243396|NCT00416429|Interferons|interferons|mesh-list
20243397|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
20243398|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
20243399|NCT00416429|Aldesleukin|aldesleukin|mesh-list
20243400|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20243401|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
20243402|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243403|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
20243404|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243405|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
20243406|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243407|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20243408|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20243409|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20243410|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20243411|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20500635|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20500636|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20500637|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500638|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
20500639|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529085|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20529086|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
20529087|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529088|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20529089|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
20529090|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20529091|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
20500640|NCT01657864|Lamotrigine|lamotrigine|mesh-list
20500641|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
20500642|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20500643|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500644|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500645|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20500646|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500647|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20500648|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20500649|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20500650|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20500651|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20500652|NCT01657890|Isavuconazole|isavuconazole|mesh-list
20500653|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
20500654|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500655|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20500656|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20500657|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
20500658|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500659|NCT01657929|Antacids|antacids|mesh-ancestor
20500660|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500661|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20500662|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20500663|NCT01657955|Chlorambucil|chlorambucil|mesh-list
20500664|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20500665|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
20500666|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500667|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500668|NCT01657513|Adalimumab|adalimumab|mesh-list
20500669|NCT01657513|Etanercept|etanercept|mesh-list
20500670|NCT01657513|Infliximab|infliximab|mesh-list
20500671|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500672|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500673|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
20500674|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20500675|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20500676|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19700723|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700724|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700725|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
19700726|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700727|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19700728|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700729|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700730|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
19700731|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700732|NCT04890418|Ketamine|ketamine|mesh-list
20243412|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
20500677|NCT01657513|Analgesics|analgesics|mesh-ancestor
20500678|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
20500679|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500680|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500681|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500682|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
20500683|NCT01657981|Darexaban|darexaban|mesh-list
20500684|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20500685|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
20500686|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20500687|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
20500688|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500689|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500690|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
20500691|NCT01658007|Sirolimus|sirolimus|mesh-list
20500692|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20500693|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500694|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20243413|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243414|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20243415|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20243416|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20243417|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243418|NCT00416468|Valsartan|valsartan|mesh-list
20243419|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20243420|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20243421|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20243422|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243423|NCT00416507|Gemcitabine|gemcitabine|mesh-list
20243424|NCT00416507|Fluorouracil|fluorouracil|mesh-list
20243425|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243426|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20243427|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
20500695|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500696|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
20243428|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243429|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
20500697|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500698|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
20500699|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500700|NCT01658033|Leucovorin|leucovorin|mesh-list
20500701|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
20500702|NCT01658033|Bevacizumab|bevacizumab|mesh-list
20500703|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500704|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20500705|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20500706|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20500707|NCT01658033|Growth Substances|growth substances|mesh-ancestor
20500708|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500709|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
20500710|NCT01658033|Antidotes|antidotes|mesh-ancestor
20500711|NCT01658033|Protective Agents|protective agents|mesh-ancestor
20500712|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
20500713|NCT01658033|Vitamins|vitamins|mesh-ancestor
20500714|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
20500715|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
20500716|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20500717|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20500718|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500719|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
20500720|NCT01658124|Coagulants|coagulants|mesh-ancestor
20500721|NCT01658176|Exemestane|exemestane|mesh-list
20500722|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500723|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20500724|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20500725|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700733|NCT04890418|Analgesics|analgesics|mesh-ancestor
20500726|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500727|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20500728|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
20500729|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500730|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500731|NCT01658202|Nicotine|nicotine|mesh-list
20500732|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20500733|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
20500734|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500735|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500736|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20500737|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20500738|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
20500739|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500740|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500741|NCT01658215|Nicotine|nicotine|mesh-list
20500742|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20500743|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
20500744|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500745|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500746|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20500747|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20500748|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
20500749|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500750|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500751|NCT01658319|Fludarabine|fludarabine|mesh-list
20500752|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
20500753|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500754|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20500755|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
20500756|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500757|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500758|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
20500759|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500760|NCT01658358|Doxorubicin|doxorubicin|mesh-list
20500761|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20500762|NCT01658358|Lapatinib|lapatinib|mesh-list
20500763|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20500764|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500765|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20500766|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20500767|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500768|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500769|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20500770|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20500771|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20500772|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20500773|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500774|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
20500775|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20500776|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
20500777|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500778|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
20500779|NCT01658449|Protective Agents|protective agents|mesh-ancestor
20500780|NCT01658462|Docetaxel|docetaxel|mesh-list
20500781|NCT01658462|Nintedanib|nintedanib|mesh-list
20500782|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500783|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
20500784|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
20500785|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
20500786|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500787|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20500788|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500789|NCT01658527|Bicalutamide|bicalutamide|mesh-list
20500790|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
20500791|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
20500792|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500793|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500794|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500795|NCT01658553|Trametinib|trametinib|mesh-list
20500796|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500797|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19700734|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
19700735|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700736|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700737|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19700738|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19700739|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
19700740|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
20243430|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243431|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243432|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243433|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
20243434|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500798|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500799|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500800|NCT01658774|Ascorbic Acid|ascorbic acid|mesh-list
20500801|NCT01658774|Albendazole|albendazole|mesh-list
20500802|NCT01658774|Vitamins|vitamins|mesh-ancestor
20500803|NCT01658774|Micronutrients|micronutrients|mesh-ancestor
20500804|NCT01658774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500805|NCT01658774|Antioxidants|antioxidants|mesh-ancestor
19700741|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20243435|NCT00416533|Prednisone|prednisone|mesh-list
20243436|NCT00416533|Docetaxel|docetaxel|mesh-list
20500806|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500807|NCT01658774|Protective Agents|protective agents|mesh-ancestor
20500808|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
20500809|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20500810|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500811|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
20243437|NCT00416533|Doxorubicin|doxorubicin|mesh-list
20243438|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20243439|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243440|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243441|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243442|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
19415035|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19415036|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415037|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
20500812|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20500813|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20500814|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
20500815|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
20500816|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
20500817|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500818|NCT01658852|Metronidazole|metronidazole|mesh-list
20500819|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500820|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20500821|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20500822|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20500823|NCT01658878|Nivolumab|nivolumab|mesh-list
20500824|NCT01658878|Ipilimumab|ipilimumab|mesh-list
20500825|NCT01658878|Sorafenib|sorafenib|mesh-list
19415038|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19415039|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243443|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243444|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20243445|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20243446|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243447|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243448|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500826|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20500827|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500828|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20500829|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243449|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
20243450|NCT00416533|Hormones|hormones|mesh-ancestor
20243451|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243452|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243453|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243454|NCT00416585|Isotretinoin|isotretinoin|mesh-list
20243455|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
20243456|NCT00416637|Bevacizumab|bevacizumab|mesh-list
20500830|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20500831|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500832|NCT01658891|Beclomethasone|beclomethasone|mesh-list
20500833|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
20500834|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20500835|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
19415040|NCT03104842|Growth Substances|growth substances|mesh-ancestor
20500836|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500837|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500838|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20500839|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
20500840|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20500841|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20500842|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20500843|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500844|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500845|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500846|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500847|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
20500848|NCT01658891|Hormones|hormones|mesh-ancestor
20500849|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500850|NCT01659008|Estradiol|estradiol|mesh-list
20500851|NCT01659008|Estrogens|estrogens|mesh-ancestor
20500852|NCT01659008|Hormones|hormones|mesh-ancestor
20500853|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500854|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500855|NCT01659047|Idelalisib|idelalisib|mesh-list
20500856|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500857|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500858|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500859|NCT01659086|Vaccines|vaccines|mesh-list
20500860|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
20500861|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500862|NCT01659099|Prednisone|prednisone|mesh-list
20500863|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
20500864|NCT01659099|Rituximab|rituximab|mesh-list
20500865|NCT01659099|Doxorubicin|doxorubicin|mesh-list
20500866|NCT01659099|Vincristine|vincristine|mesh-list
20500867|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
20500868|NCT01659099|Bleomycin|bleomycin|mesh-list
20500869|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500870|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
20500871|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500872|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500873|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20500874|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
20500875|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500876|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500877|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20500878|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20500879|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20500880|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20500881|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20500882|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500883|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500884|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
20500885|NCT01659099|Hormones|hormones|mesh-ancestor
20500886|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20500887|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20500888|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20500889|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
20500890|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
20500891|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
20500892|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
20500893|NCT01659190|Antacids|antacids|mesh-ancestor
20500894|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500895|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20500896|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
20500897|NCT01659242|Methotrexate|methotrexate|mesh-list
20500898|NCT01659242|Leflunomide|leflunomide|mesh-list
19415041|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
20500899|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20500900|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
20500901|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20500902|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500903|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20500904|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
20500905|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500906|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500907|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
20500908|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500909|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20500910|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20500911|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
20500912|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529092|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
20500913|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20500914|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500915|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20500916|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20500917|NCT01659242|Analgesics|analgesics|mesh-ancestor
20500918|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
20500919|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500920|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500921|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243457|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20243458|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243459|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20500922|NCT01659281|Artesunate|artesunate|mesh-list
20500923|NCT01659281|Mefloquine|mefloquine|mesh-list
20500924|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
20500925|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20500926|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20500927|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500928|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20500929|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
20500930|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
20500931|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20500932|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
20500933|NCT01659307|Aspirin|aspirin|mesh-list
20500934|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20500935|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20500936|NCT01659307|Analgesics|analgesics|mesh-ancestor
20500937|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
20500938|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500939|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500940|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500941|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500942|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20500943|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20500944|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500945|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20500946|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20500947|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500948|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
20500949|NCT01659346|Carvedilol|carvedilol|mesh-list
20500950|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20500951|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20500952|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
20500953|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20500954|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500955|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500956|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20500957|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
20500958|NCT01659346|Protective Agents|protective agents|mesh-ancestor
20500959|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20500960|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500961|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20500962|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
20500963|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20500964|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20500965|NCT01659359|Lidocaine|lidocaine|mesh-list
20500966|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
20500967|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
20500968|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20243460|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243461|NCT00416637|Growth Substances|growth substances|mesh-ancestor
20243462|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243463|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
20243464|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20243465|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243466|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20243467|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243468|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243469|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
20243470|NCT00416676|Carboplatin|carboplatin|mesh-list
20243471|NCT00416676|Etoposide|etoposide|mesh-list
20243472|NCT00416676|Vincristine|vincristine|mesh-list
20243473|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243474|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
20243475|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415042|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19415043|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
19415044|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500969|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500970|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
20500971|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500972|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20500973|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20500974|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20500975|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20500976|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500977|NCT01659372|Naproxen|naproxen|mesh-list
20500978|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20500979|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20500980|NCT01659372|Analgesics|analgesics|mesh-ancestor
20500981|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
20500982|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20500983|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20500984|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20500985|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20500986|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
20500987|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19415045|NCT03094416|Esomeprazole|esomeprazole|mesh-list
19415046|NCT03094416|Omeprazole|omeprazole|mesh-list
19415047|NCT03094416|Rabeprazole|rabeprazole|mesh-list
19415048|NCT03094416|Pantoprazole|pantoprazole|mesh-list
19415049|NCT03094416|Lansoprazole|lansoprazole|mesh-list
19415050|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
19415051|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19415052|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19415053|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19415054|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415055|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500988|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500989|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500990|NCT01659437|Clarithromycin|clarithromycin|mesh-list
20500991|NCT01659437|Streptomycin|streptomycin|mesh-list
20500992|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20500993|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20500994|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20500995|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20500996|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20500997|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20500998|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20500999|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
20501000|NCT01659476|Miotics|miotics|mesh-ancestor
20501001|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
19415056|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
19415057|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415058|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708014|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
19700742|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19700743|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19700744|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700745|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700746|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
20243476|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20243477|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20243478|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
20243479|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243480|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501002|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501003|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501004|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20501005|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20501006|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
20501007|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20501008|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20501009|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
20501010|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501011|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501012|NCT01659515|Arbekacin|arbekacin|mesh-list
20501013|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529093|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20529094|NCT01779401|Protective Agents|protective agents|mesh-ancestor
20529095|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20529096|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20529097|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20529098|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
20529099|NCT01779466|Coagulants|coagulants|mesh-ancestor
20529100|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20529101|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
20529102|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530775|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530776|NCT01790555|Diazepam|diazepam|mesh-list
20530777|NCT01790555|Dronabinol|dronabinol|mesh-list
20530778|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20530779|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
20530780|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
20530781|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
20530782|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530783|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530784|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530785|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20530786|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530787|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20530788|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20530789|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20530790|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20530791|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530792|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20530793|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
20530794|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
20530795|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
20530796|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
20530797|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530798|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530799|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
20530800|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530801|NCT01790555|Analgesics|analgesics|mesh-ancestor
20530802|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
20530803|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20530804|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20530805|NCT01790555|Hormones|hormones|mesh-ancestor
20530806|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530807|NCT01790672|Ethanol|ethanol|mesh-list
20530808|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20530809|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530810|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530811|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530812|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
20530813|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20530814|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
20530815|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501014|NCT01659619|Erythromycin|erythromycin|mesh-list
20501015|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
20501016|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20501017|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
20501018|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20501019|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501020|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501021|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20501022|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415059|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19415060|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20243481|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20501023|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501024|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
20501025|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20501026|NCT01659684|Antibodies|antibodies|mesh-list
20501027|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
20501028|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20501029|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
20501030|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501031|NCT01659775|Ondansetron|ondansetron|mesh-list
20501032|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
20501033|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
20501034|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501035|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501036|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501037|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
20501038|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
20501039|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20501040|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
20501041|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501042|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501043|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20501044|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20501045|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501046|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415061|NCT03082014|Losartan|losartan|mesh-list
19415062|NCT03082014|Atenolol|atenolol|mesh-list
19415063|NCT03082014|Amlodipine|amlodipine|mesh-list
19415064|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19415065|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19415066|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415067|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415068|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19415069|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415070|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
19415071|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20243482|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20243483|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20243484|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243485|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243486|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243487|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243488|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243489|NCT00416728|Valsartan|valsartan|mesh-list
20243490|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20243491|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20243492|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20243493|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501047|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20501048|NCT01659788|Ubiquinone|ubiquinone|mesh-list
20501049|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
20501050|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
20501051|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501052|NCT01659788|Vitamins|vitamins|mesh-ancestor
20501053|NCT01659827|Bupivacaine|bupivacaine|mesh-list
20501054|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
20501055|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
20501056|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501057|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501058|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
20501059|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501060|NCT01659892|Montelukast|montelukast|mesh-list
20243494|NCT00416767|Leucovorin|leucovorin|mesh-list
20243495|NCT00416767|Fluorouracil|fluorouracil|mesh-list
20243496|NCT00416767|Irinotecan|irinotecan|mesh-list
20243497|NCT00416767|Calcium|calcium|mesh-list
20243498|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
20243499|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20243500|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243501|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
20243502|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501061|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20501062|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
20501063|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20501064|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
20501065|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501066|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501067|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20501068|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20501069|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501070|NCT01659905|Montelukast|montelukast|mesh-list
20501071|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20501072|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
20501073|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20501074|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
20501075|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501076|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501077|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20501078|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20501079|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501080|NCT01659918|Montelukast|montelukast|mesh-list
20501081|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20501082|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
20501083|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20501084|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
20501085|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501086|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501087|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20501088|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20501089|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700747|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19700748|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700749|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700750|NCT04890470|Vasopressins|vasopressins|mesh-list
19700751|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
19700752|NCT04890470|Oxytocin|oxytocin|mesh-list
20501090|NCT01659931|Montelukast|montelukast|mesh-list
20501091|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20501092|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
20501093|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20501094|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
20501095|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700753|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
20501096|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501097|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20501098|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20501099|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501100|NCT01659944|Metoprolol|metoprolol|mesh-list
20501101|NCT01659944|Eliglustat|eliglustat|mesh-list
19853217|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853218|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
19853219|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853220|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853221|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19853222|NCT00730691|Vortioxetine|vortioxetine|mesh-list
19853223|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19853224|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19853225|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853226|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853227|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501102|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20501103|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20501104|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
20501105|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
20501106|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501107|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501108|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20501109|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20501110|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20501111|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
20501112|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529103|NCT01779479|Paclitaxel|paclitaxel|mesh-list
20501113|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501114|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501115|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20501116|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
20501117|NCT01660295|Certoparin|certoparin|mesh-list
20501118|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
20501119|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20501120|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20501121|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501122|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20501123|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
20501124|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
20501125|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501126|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501127|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501128|NCT01660295|Analgesics|analgesics|mesh-ancestor
20501129|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
20501130|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501131|NCT01660373|Tirofiban|tirofiban|mesh-list
20501132|NCT01660373|Ticagrelor|ticagrelor|mesh-list
20501133|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20501134|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20501135|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20501136|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20501137|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
20501138|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501139|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501140|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700754|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20501141|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20501142|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20501143|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20501144|NCT01660386|Glimepiride|glimepiride|mesh-list
20501145|NCT01660386|Saxagliptin|saxagliptin|mesh-list
20501146|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20501147|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501148|NCT01660386|Incretins|incretins|mesh-ancestor
19700755|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700756|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
19700757|NCT04890470|Coagulants|coagulants|mesh-ancestor
19700758|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19700759|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19700760|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
19700761|NCT04889768|Antibodies|antibodies|mesh-list
19700762|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
20501149|NCT01660386|Hormones|hormones|mesh-ancestor
20501150|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501151|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20501152|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
20501153|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501154|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501155|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20501156|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20501157|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
20501158|NCT01660399|Docetaxel|docetaxel|mesh-list
20501159|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501160|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
20501161|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
20501162|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
20501163|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501164|NCT01660477|Ritonavir|ritonavir|mesh-list
20501165|NCT01660477|Lopinavir|lopinavir|mesh-list
20501166|NCT01660477|Isavuconazole|isavuconazole|mesh-list
20501167|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20501168|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20501169|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
20501170|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501171|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501172|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20501173|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20501174|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
20501175|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501176|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20501177|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20501178|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
20501179|NCT01660542|Docetaxel|docetaxel|mesh-list
20501180|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501181|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
20501182|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
20501183|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
20501184|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501185|NCT01660594|Calcium|calcium|mesh-list
20501186|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20501187|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501188|NCT01660620|Betaxolol|betaxolol|mesh-list
20501189|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20501190|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
20501191|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
20501192|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501193|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501194|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20501195|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20501196|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20501197|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
20501198|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501199|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501200|NCT01660750|Dexamethasone|dexamethasone|mesh-list
20501201|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
20501202|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20501203|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
20501204|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501205|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530816|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20501206|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20501207|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
20501208|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501209|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501210|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20501211|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501212|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
20501213|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
20501214|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501215|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501216|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
20501217|NCT01660750|Hormones|hormones|mesh-ancestor
20501218|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501219|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20501220|NCT01660854|Proguanil|proguanil|mesh-list
20501221|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20501222|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
20501223|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20501224|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20501225|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501226|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
20501227|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501228|NCT01660867|Dexamethasone|dexamethasone|mesh-list
20501229|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501230|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
20501231|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
20501232|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415072|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19415073|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19415074|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
20501233|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415075|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
19415076|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501234|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501235|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
20501236|NCT01660867|Hormones|hormones|mesh-ancestor
20501237|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501238|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20501239|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501240|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20501241|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20501242|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20501243|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
20501244|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501245|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20501246|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19415077|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19415078|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19700763|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501247|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501248|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20501249|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20501250|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20501251|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
20501252|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501253|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20501254|NCT01660997|Dexamethasone|dexamethasone|mesh-list
20501255|NCT01660997|Ixazomib|ixazomib|mesh-list
20501256|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501257|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
20501258|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
20501259|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501260|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501261|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501262|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
20501263|NCT01660997|Hormones|hormones|mesh-ancestor
20501264|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501265|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20501266|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501267|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
20501268|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700764|NCT04889781|Dexamethasone|dexamethasone|mesh-list
20501269|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501270|NCT01661101|Omeprazole|omeprazole|mesh-list
20501271|NCT01661101|Dabigatran|dabigatran|mesh-list
20501272|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20501273|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501274|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20501275|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501276|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501277|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
20501278|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20501279|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
20501280|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
20501281|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20501282|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
19853228|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501283|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20501284|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19853229|NCT00730691|Analgesics|analgesics|mesh-ancestor
20501285|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
20501286|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501287|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501288|NCT01661257|Infliximab|infliximab|mesh-list
20501289|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
20501290|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501291|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20501292|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20501293|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20501294|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20501295|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501296|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
20501297|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20501298|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
20501299|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
20501300|NCT01661309|Vitamins|vitamins|mesh-ancestor
20501301|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
20501302|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501303|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
20501304|NCT01661322|Aspirin|aspirin|mesh-list
20501305|NCT01661322|Clopidogrel|clopidogrel|mesh-list
20501306|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20501307|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501308|NCT01661322|Analgesics|analgesics|mesh-ancestor
20501309|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
20501310|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501311|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415079|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19415080|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
19415081|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415082|NCT03075462|Apatinib|apatinib|mesh-list
19415083|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415084|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19415085|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415086|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415087|NCT03070951|OBE2109|obe2109|mesh-list
20501312|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501313|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20501314|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20501315|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20501316|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501317|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20501318|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20501319|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501320|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
20501321|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20501322|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20501323|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20501324|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
20501325|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501326|NCT01661335|Dexamethasone|dexamethasone|mesh-list
20501327|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
19415088|NCT03070951|Hormone Antagonists|hormone antagonists|mesh-ancestor
19415089|NCT03070951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501328|NCT01661335|Ondansetron|ondansetron|mesh-list
20501329|NCT01661335|Aprepitant|aprepitant|mesh-list
20501330|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
20501331|NCT01661335|BB 1101|bb 1101|mesh-list
20501332|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501333|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
20501334|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
20501335|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501336|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501337|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501338|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
20501339|NCT01661335|Hormones|hormones|mesh-ancestor
20501340|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501341|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20501342|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501343|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
20501344|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501345|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501346|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
20501347|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
20501348|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20501349|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
20501350|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501351|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19415090|NCT03070951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501352|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20501353|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501354|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20501355|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20501356|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20501357|NCT01661439|Heparin|heparin|mesh-list
20501358|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20501359|NCT01661439|Tinzaparin|tinzaparin|mesh-list
20501360|NCT01661439|Dalteparin|dalteparin|mesh-list
20501361|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
20501362|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20501363|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20501364|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529104|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20529105|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529106|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
20529107|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
20529108|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
20529109|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529110|NCT01779492|Oxycodone|oxycodone|mesh-list
20501365|NCT01661530|Vitamin E|vitamin e|mesh-list
20501366|NCT01661530|Vitamins|vitamins|mesh-ancestor
20501367|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
20501368|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501369|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
20501370|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501371|NCT01661530|Protective Agents|protective agents|mesh-ancestor
20501372|NCT01661556|Miconazole|miconazole|mesh-list
20501373|NCT01661556|Hydroquinone|hydroquinone|mesh-list
20501374|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
20501375|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501376|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20501377|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20501378|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501379|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501380|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20501381|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
20501382|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501383|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501384|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19700765|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
20501385|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20501386|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
20501387|NCT01661556|Protective Agents|protective agents|mesh-ancestor
20501388|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20501389|NCT01661647|Anesthetics|anesthetics|mesh-list
20501390|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501391|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501392|NCT01661751|Vaccines|vaccines|mesh-list
20501393|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
19415091|NCT03070899|OBE2109|obe2109|mesh-list
19415092|NCT03070899|Hormone Antagonists|hormone antagonists|mesh-ancestor
19415093|NCT03070899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529111|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20501394|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501395|NCT01661777|Diuretics|diuretics|mesh-list
20501396|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
20501397|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20501398|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
20501399|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501400|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
20501401|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501402|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501403|NCT01661855|Riluzole|riluzole|mesh-list
20501404|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
20501405|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20501406|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20501407|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501408|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501409|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501410|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20501411|NCT01661855|Protective Agents|protective agents|mesh-ancestor
20501412|NCT01661868|Olaparib|olaparib|mesh-list
20501413|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20501414|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501415|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501416|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501417|NCT01661985|Azithromycin|azithromycin|mesh-list
20501418|NCT01661985|Doxycycline|doxycycline|mesh-list
20501419|NCT01661985|Lymecycline|lymecycline|mesh-list
20501420|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20501421|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501422|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
20501423|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20501424|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20501425|NCT01662037|Bosentan|bosentan|mesh-list
20501426|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20501427|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20501428|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501429|NCT01662050|Cytarabine|cytarabine|mesh-list
20501430|NCT01662050|Rituximab|rituximab|mesh-list
20501431|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20501432|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20501433|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501434|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
20501435|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501436|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20501437|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20501438|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
20501439|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501440|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
20501441|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501442|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20501443|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20501444|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
20501445|NCT01662089|Zinc|zinc|mesh-list
20501446|NCT01662089|Trace Elements|trace elements|mesh-ancestor
20501447|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
20501448|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501449|NCT01662128|Capecitabine|capecitabine|mesh-list
20501450|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20243503|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20243504|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501451|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
20501452|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501453|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501454|NCT01662180|Hormones|hormones|mesh-list
20501455|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20501456|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501457|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501458|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
20501459|NCT01662193|Vitamin D|vitamin d|mesh-list
20501460|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
19700766|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700767|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
19700768|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
19700769|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700770|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700771|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700772|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
19700773|NCT04889781|Hormones|hormones|mesh-ancestor
19700774|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700775|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19700776|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700777|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
19700778|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700779|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19700780|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700781|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700782|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
19708015|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243505|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20501461|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
20501462|NCT01662193|Vitamins|vitamins|mesh-list
20501463|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
20501464|NCT01662193|Calcium|calcium|mesh-list
20501465|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
20501466|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501467|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20501468|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20501469|NCT01662193|Antacids|antacids|mesh-ancestor
20501470|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501471|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501472|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
20501473|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20501474|NCT01662401|Bupivacaine|bupivacaine|mesh-list
20501475|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
20501476|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
20243506|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
20243507|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20243508|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243509|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243510|NCT00416767|Antidotes|antidotes|mesh-ancestor
20243511|NCT00416767|Protective Agents|protective agents|mesh-ancestor
20243512|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
20243513|NCT00416767|Vitamins|vitamins|mesh-ancestor
20243514|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
20243515|NCT00416819|Leucovorin|leucovorin|mesh-list
20501477|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700783|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700784|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700785|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19700786|NCT04889664|Ketamine|ketamine|mesh-list
19700787|NCT04889664|Analgesics|analgesics|mesh-ancestor
19700788|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
19700789|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700790|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700791|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20501478|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501479|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
20501480|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501481|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
20501482|NCT01662466|Testosterone|testosterone|mesh-list
20501483|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
20501484|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
20243516|NCT00416819|Cytarabine|cytarabine|mesh-list
20243517|NCT00416819|Rituximab|rituximab|mesh-list
20243518|NCT00416819|Methotrexate|methotrexate|mesh-list
20243519|NCT00416819|Etoposide|etoposide|mesh-list
20243520|NCT00416819|Temozolomide|temozolomide|mesh-list
20243521|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
20243522|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
20243523|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20243524|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243525|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
20243526|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243527|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20243528|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20243529|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
20243530|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243531|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20243532|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
19700792|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19700793|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
20501485|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20501486|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20501487|NCT01662466|Androgens|androgens|mesh-ancestor
20501488|NCT01662466|Hormones|hormones|mesh-ancestor
20501489|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501490|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853230|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
19853231|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501491|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20501492|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501493|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
20501494|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20501495|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
20501496|NCT01662518|Dexamethasone|dexamethasone|mesh-list
20501497|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501498|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
20501499|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
20501500|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501501|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501502|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501503|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
19853232|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853233|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853234|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
20501504|NCT01662518|Hormones|hormones|mesh-ancestor
20501505|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501506|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20501507|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501508|NCT01662622|Sevoflurane|sevoflurane|mesh-list
19415094|NCT03070899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415095|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19415096|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
19415097|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19415098|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
19415099|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415100|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19415101|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415102|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19415103|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700794|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
19700795|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700796|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19700797|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19700798|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700799|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700803|NCT04889196|Fluorides|fluorides|mesh-list
19415104|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19415105|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700804|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
20501509|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19700805|NCT04889196|Protective Agents|protective agents|mesh-ancestor
19700806|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700807|NCT04888663|Paclitaxel|paclitaxel|mesh-list
19700808|NCT04888663|Trastuzumab|trastuzumab|mesh-list
19700809|NCT04888663|Ramucirumab|ramucirumab|mesh-list
20501510|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20501511|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
20501512|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
20501513|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501514|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501515|NCT01662674|Metformin|metformin|mesh-list
20501516|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20501517|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501518|NCT01662687|Granisetron|granisetron|mesh-list
20501519|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
20501520|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
20501521|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501522|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501523|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20501524|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20501525|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
20501526|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501527|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501528|NCT01662700|Artesunate|artesunate|mesh-list
20501529|NCT01662700|Chloroquine|chloroquine|mesh-list
20501530|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
20501531|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20501532|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20501533|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501534|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501535|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
20501536|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
20501537|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20501538|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
20501539|NCT01662700|Amebicides|amebicides|mesh-ancestor
20501540|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20501541|NCT01662804|Interleukin-2|interleukin-2|mesh-list
20501542|NCT01662804|Antibodies|antibodies|mesh-list
20501543|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20501544|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
20501545|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501546|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501547|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501548|NCT01662804|Analgesics|analgesics|mesh-ancestor
20501549|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
20501550|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501551|NCT01662869|Leucovorin|leucovorin|mesh-list
20501552|NCT01662869|Folic Acid|folic acid|mesh-list
20501553|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
20501554|NCT01662869|Fluorouracil|fluorouracil|mesh-list
20501555|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
20501556|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501557|NCT01662869|Antidotes|antidotes|mesh-ancestor
20501558|NCT01662869|Protective Agents|protective agents|mesh-ancestor
20501559|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700810|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19700811|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501560|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
20501561|NCT01662869|Vitamins|vitamins|mesh-ancestor
20501562|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
20501563|NCT01662869|Hematinics|hematinics|mesh-ancestor
19700812|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
20501564|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
20501565|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501566|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20501567|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20501568|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
20501569|NCT01662921|Insulin|insulin|mesh-list
20501570|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20501571|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
20501572|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
20501573|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
20501574|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20501575|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501576|NCT01663038|Aspirin|aspirin|mesh-list
20501577|NCT01663038|Clopidogrel|clopidogrel|mesh-list
20501578|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20501579|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501580|NCT01663038|Analgesics|analgesics|mesh-ancestor
20501581|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
20501582|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501583|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501584|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501585|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20501586|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20501587|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20501588|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501589|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20501590|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20501591|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501592|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
20501593|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20501594|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20501595|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20501596|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
20501597|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501598|NCT01663077|Clozapine|clozapine|mesh-list
20501599|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20501600|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
20501601|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501602|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501603|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501604|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20501605|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20501606|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501607|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20501608|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
20501609|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
20501610|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20501611|NCT01663090|Hematinics|hematinics|mesh-ancestor
20501612|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19700813|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
20501613|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20501614|NCT01663168|Rifabutin|rifabutin|mesh-list
20501615|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20501616|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501617|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20501618|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
20529112|NCT01779492|Narcotics|narcotics|mesh-ancestor
20529113|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700814|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
19700815|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700816|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19700817|NCT04888728|Nebivolol|nebivolol|mesh-list
20529114|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529115|NCT01779492|Analgesics|analgesics|mesh-ancestor
20529116|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
20529117|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529118|NCT01779518|Interferons|interferons|mesh-list
20529119|NCT01779518|Ribavirin|ribavirin|mesh-list
20529120|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
20529121|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529122|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
20529123|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529124|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
20529125|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529126|NCT01779596|Bosentan|bosentan|mesh-list
20529127|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19853235|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19853236|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19853237|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853238|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19853239|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
19853240|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19853241|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19853242|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19853243|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19855621|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855622|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855623|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
19855624|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
20243533|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243534|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
20243535|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243536|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20529128|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20529129|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529130|NCT01779609|Bosentan|bosentan|mesh-list
20529131|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20529132|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19700818|NCT04888728|Paroxetine|paroxetine|mesh-list
19700819|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19700820|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19700821|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19700822|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243537|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243538|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20243539|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20243540|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19853244|NCT00730756|Fluticasone|fluticasone|mesh-list
19853245|NCT00730756|Xhance|xhance|mesh-list
19853246|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853247|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19853248|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
19853249|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853250|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853251|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19853252|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
19853253|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
19853254|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19853255|NCT00730847|Vaccines|vaccines|mesh-list
20243541|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243542|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
20243543|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243544|NCT00416819|Antidotes|antidotes|mesh-ancestor
20243545|NCT00416819|Protective Agents|protective agents|mesh-ancestor
20243546|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
20243547|NCT00416819|Vitamins|vitamins|mesh-ancestor
20243548|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
20243549|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20243550|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
20243551|NCT00416832|Prednisone|prednisone|mesh-list
19853256|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
19853257|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853258|NCT00730912|Loratadine|loratadine|mesh-list
19853259|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
19853260|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19853261|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19853262|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19853263|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19853264|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
20243552|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
20243553|NCT00416832|Dacarbazine|dacarbazine|mesh-list
19853265|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
19855625|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20243554|NCT00416832|Doxorubicin|doxorubicin|mesh-list
19853266|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853267|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853268|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853269|NCT00730925|Paclitaxel|paclitaxel|mesh-list
20501619|NCT01663441|Oprelvekin|oprelvekin|mesh-list
20501620|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501621|NCT01663558|Imiquimod|imiquimod|mesh-list
20501622|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19853270|NCT00730925|Afatinib|afatinib|mesh-list
19853271|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19853272|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853273|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
19853274|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853275|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
19853276|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853277|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853278|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853279|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19853280|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19853281|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853282|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
19853283|NCT00731055|Varenicline|varenicline|mesh-list
19853284|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19853285|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19853286|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
19853287|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853288|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853289|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501623|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
20501624|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501625|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853290|NCT00731120|Vortioxetine|vortioxetine|mesh-list
19853291|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853292|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853293|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20243555|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20243556|NCT00416832|Etoposide|etoposide|mesh-list
20243557|NCT00416832|Vincristine|vincristine|mesh-list
20501626|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
19853294|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20243558|NCT00416832|Procarbazine|procarbazine|mesh-list
20501627|NCT01663662|Tolvaptan|tolvaptan|mesh-list
19415106|NCT03060980|Empagliflozin|empagliflozin|mesh-list
20501628|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20501629|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501630|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
20501631|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501632|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20501633|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20501634|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501635|NCT01663805|Everolimus|everolimus|mesh-list
20501636|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501637|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20501638|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
20501639|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501640|NCT01663961|Digoxin|digoxin|mesh-list
20501641|NCT01663961|Mirabegron|mirabegron|mesh-list
20501642|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20501643|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20501644|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501645|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501646|NCT01663961|Protective Agents|protective agents|mesh-ancestor
20501647|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501648|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20501649|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20501650|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20501651|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
20501652|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501653|NCT01663961|Urological Agents|urological agents|mesh-ancestor
20501654|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
20501655|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20501656|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20501657|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20501658|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20501659|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501660|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
20501661|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501662|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501663|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19415107|NCT03060980|Glimepiride|glimepiride|mesh-list
20501664|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501665|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20501666|NCT01664065|Cephalosporins|cephalosporins|mesh-list
20501667|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20501668|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501669|NCT01664182|Bevacizumab|bevacizumab|mesh-list
20501670|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20501671|NCT01664182|Sunitinib|sunitinib|mesh-list
20501672|NCT01664182|Trebananib|trebananib|mesh-list
20501673|NCT01664182|Sorafenib|sorafenib|mesh-list
20501674|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
20501675|NCT01664182|Antibodies|antibodies|mesh-list
20501676|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
20501677|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20501678|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
20501679|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501680|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20501681|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20501682|NCT01664182|Growth Substances|growth substances|mesh-ancestor
20501683|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501684|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
20501685|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
20501686|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20501687|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501688|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501689|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
20501690|NCT01664195|Hematinics|hematinics|mesh-ancestor
20501691|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
20501692|NCT01664221|Hematinics|hematinics|mesh-ancestor
20501693|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
20501694|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20501695|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
20501696|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501697|NCT01664260|Expectorants|expectorants|mesh-ancestor
20501698|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
20501699|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19700823|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700824|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
19700825|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700826|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19700827|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
19700828|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19700829|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19700830|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19700831|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501700|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
20501701|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501702|NCT01664260|Protective Agents|protective agents|mesh-ancestor
20501703|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501704|NCT01664260|Antidotes|antidotes|mesh-ancestor
20501705|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
20501706|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20501707|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501708|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501709|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501710|NCT01664520|Analgesics|analgesics|mesh-ancestor
20501711|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
19700832|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19700833|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
19700834|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20501712|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501713|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20501714|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19855626|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501715|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20501716|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
20501717|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501718|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501719|NCT01664650|Genistein|genistein|mesh-list
20501720|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20501721|NCT01664650|Protective Agents|protective agents|mesh-ancestor
20501722|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501723|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501724|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20501725|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501726|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501727|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
20501728|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20501729|NCT01664650|Estrogens|estrogens|mesh-ancestor
20501730|NCT01664650|Hormones|hormones|mesh-ancestor
20501731|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501732|NCT01664676|Liraglutide|liraglutide|mesh-list
20501733|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20501734|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501735|NCT01664676|Incretins|incretins|mesh-ancestor
20501736|NCT01664676|Hormones|hormones|mesh-ancestor
20501737|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501738|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
19700835|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19700836|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19700837|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
19700838|NCT04888741|Cyclosporine|cyclosporine|mesh-list
19700839|NCT04888741|Sirolimus|sirolimus|mesh-list
19700840|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
19700841|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
19700842|NCT04888741|Cyclosporins|cyclosporins|mesh-list
19700843|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
19853295|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853296|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501739|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
20501740|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501741|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20501742|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501743|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853297|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19853298|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19853299|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853300|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501744|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
20501745|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501746|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501747|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20501748|NCT01664728|Hormones|hormones|mesh-ancestor
20501749|NCT01664754|Carboplatin|carboplatin|mesh-list
20501750|NCT01664754|Pemetrexed|pemetrexed|mesh-list
20501751|NCT01664754|Exemestane|exemestane|mesh-list
20501752|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501753|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501754|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501755|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20501756|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19700844|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19700845|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
20501757|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20501758|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20501759|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20501760|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
20501761|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501762|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501763|NCT01664819|Antioxidants|antioxidants|mesh-list
20501764|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243559|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415108|NCT03060980|Exenatide|exenatide|mesh-list
19700846|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700847|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19700848|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19700849|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
20243560|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
20243561|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243562|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20243563|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20243564|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
20243565|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243566|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243567|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20243568|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20501765|NCT01664819|Protective Agents|protective agents|mesh-ancestor
20501766|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501767|NCT01664845|Metformin|metformin|mesh-list
20501768|NCT01664845|Ribavirin|ribavirin|mesh-list
20501769|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19700850|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700851|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700852|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19700853|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501770|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501771|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
20501772|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501773|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
20501774|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501775|NCT01664871|Fluorides|fluorides|mesh-list
20501776|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
20501777|NCT01664871|Protective Agents|protective agents|mesh-ancestor
20501778|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501779|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20501780|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20501781|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501782|NCT01665066|Nicotine|nicotine|mesh-list
20501783|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20501784|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
20501785|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501786|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501787|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20501788|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20501789|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
20501790|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501791|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501792|NCT01665079|Propofol|propofol|mesh-list
20501793|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20501794|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700854|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
19700855|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700856|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
19700857|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19700858|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19700859|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19700860|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
19700861|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19700862|NCT04888715|Pirfenidone|pirfenidone|mesh-list
19700863|NCT04888715|Nintedanib|nintedanib|mesh-list
19700864|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243569|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20243570|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243571|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243572|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243573|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
20243574|NCT00416832|Hormones|hormones|mesh-ancestor
20243575|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415109|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19415110|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415111|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415112|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415113|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19415114|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415115|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
19415116|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19415117|NCT03060980|Incretins|incretins|mesh-ancestor
19415118|NCT03060980|Hormones|hormones|mesh-ancestor
20501795|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501796|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20501797|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
20501798|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
20501799|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
20501800|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20501801|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20501802|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501803|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
20501804|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
20501805|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501806|NCT01665209|Morphine|morphine|mesh-list
20501807|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20501808|NCT01665209|Narcotics|narcotics|mesh-ancestor
20501809|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501810|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501811|NCT01665209|Analgesics|analgesics|mesh-ancestor
20501812|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
20501813|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501814|NCT01665222|Morphine|morphine|mesh-list
20501815|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20501816|NCT01665222|Narcotics|narcotics|mesh-ancestor
20501817|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501818|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501819|NCT01665222|Analgesics|analgesics|mesh-ancestor
19415119|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415120|NCT03060772|Pioglitazone|pioglitazone|mesh-list
19415121|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415122|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415123|NCT03057600|Paclitaxel|paclitaxel|mesh-list
19700865|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20501820|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
19700866|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501821|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501822|NCT01665235|Aspirin|aspirin|mesh-list
20501823|NCT01665235|Amlodipine|amlodipine|mesh-list
20501824|NCT01665235|Clopidogrel|clopidogrel|mesh-list
20501825|NCT01665235|Atorvastatin|atorvastatin|mesh-list
20501826|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20501827|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501828|NCT01665235|Analgesics|analgesics|mesh-ancestor
20501829|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
20501830|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501831|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501832|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243576|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243577|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20501833|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20501834|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20501835|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20501836|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501837|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20501838|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20501839|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501840|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
20501841|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20243578|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
20501842|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20501843|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
20501844|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20501845|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20501846|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20501847|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20501848|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20501849|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
20243579|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243580|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243581|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20243582|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20243583|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243584|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20501850|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501851|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20501852|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20501853|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20501854|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20501855|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
20243585|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
19853301|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853302|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
19853303|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20501856|NCT01665248|Listerine|listerine|mesh-list
20501857|NCT01665248|Fluorides|fluorides|mesh-list
20501858|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
20501859|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
20501860|NCT01665248|Protective Agents|protective agents|mesh-ancestor
20501861|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501862|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20501863|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20501864|NCT01665274|Capecitabine|capecitabine|mesh-list
20501865|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
20501866|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20501867|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
20530817|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19853304|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19853305|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19853306|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19853307|NCT00731133|Disulfiram|disulfiram|mesh-list
19853308|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19853309|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19853310|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853311|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853312|NCT00731198|Drotaverin|drotaverin|mesh-list
19853313|NCT00731198|Scopolamine|scopolamine|mesh-list
19853314|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20243586|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243587|NCT00416858|Fluorouracil|fluorouracil|mesh-list
20243588|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243589|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
20243590|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243591|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20243592|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243593|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
20243594|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243595|NCT00416871|Interferons|interferons|mesh-list
20243596|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
20243597|NCT00416871|Aldesleukin|aldesleukin|mesh-list
20501868|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501869|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501870|NCT01665378|Folic Acid|folic acid|mesh-list
20501871|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
20501872|NCT01665378|Micronutrients|micronutrients|mesh-list
20501873|NCT01665378|Trace Elements|trace elements|mesh-list
20501874|NCT01665378|Hematinics|hematinics|mesh-ancestor
20501875|NCT01665378|Vitamins|vitamins|mesh-ancestor
20501876|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501877|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
20501878|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20501879|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20501880|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501881|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501882|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20501883|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20501884|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20501885|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853315|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19853316|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
19853317|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
20243598|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243599|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
20501886|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501887|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501888|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
20501889|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20501890|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
20501891|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20501892|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19853318|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243600|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243601|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
20243602|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243603|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20243604|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20243605|NCT00416897|Dexamethasone|dexamethasone|mesh-list
20501893|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501894|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20501895|NCT01665417|Docetaxel|docetaxel|mesh-list
20501896|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501897|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
20501898|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
20501899|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
20501900|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501901|NCT01665469|Lycopene|lycopene|mesh-list
20501902|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501903|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
20501904|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501905|NCT01665469|Protective Agents|protective agents|mesh-ancestor
20501906|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501907|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20501908|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20501909|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853319|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853320|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19853321|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
19853322|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19853323|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
19853324|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853325|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853326|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19853327|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
20529133|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529134|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
20501910|NCT01664507|Epinephrine|epinephrine|mesh-list
20501911|NCT01664507|Racepinephrine|racepinephrine|mesh-list
20501912|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
20501913|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20501914|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20501915|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
20501916|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700867|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700868|NCT04888715|Analgesics|analgesics|mesh-ancestor
19700869|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
20501917|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501918|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501919|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20501920|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20501921|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
20501922|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415124|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19700870|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700871|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700872|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19700873|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501923|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20501924|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
20501925|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
20501926|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
20501927|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20501928|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
20501929|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20501930|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20501931|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501932|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20501933|NCT01665586|Analgesics|analgesics|mesh-ancestor
20501934|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
20501935|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20501936|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20501937|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20501938|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20501939|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
20501940|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20501941|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501942|NCT01665638|Canagliflozin|canagliflozin|mesh-list
20501943|NCT01665638|Somatostatin|somatostatin|mesh-list
20501944|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20501945|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501946|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20501947|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501948|NCT01665638|Hormones|hormones|mesh-ancestor
20501949|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20501950|NCT01665677|Atorvastatin|atorvastatin|mesh-list
20501951|NCT01665677|Calcium|calcium|mesh-list
20501952|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20501953|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501954|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20501955|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20501956|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
20501957|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501958|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20501959|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20501960|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501961|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20501962|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20501963|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501964|NCT01665742|Tocopherols|tocopherols|mesh-list
20501965|NCT01665742|Vitamin E|vitamin e|mesh-list
20501966|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
20501967|NCT01665742|Lycopene|lycopene|mesh-list
20501968|NCT01665742|Vitamins|vitamins|mesh-ancestor
20501969|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
20501970|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20501971|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
20501972|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501973|NCT01665742|Protective Agents|protective agents|mesh-ancestor
20501974|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20501975|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20501976|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20501977|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20501978|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
20501979|NCT01665781|Hematinics|hematinics|mesh-ancestor
20501980|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20501981|NCT01665846|Hematinics|hematinics|mesh-ancestor
20501982|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20501983|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20501984|NCT01666041|Fenofibrate|fenofibrate|mesh-list
20501985|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20501986|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
20501987|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501988|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20501989|NCT01666067|Simvastatin|simvastatin|mesh-list
20501990|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20501991|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20501992|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20501993|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
20501994|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20501995|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20501996|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20501997|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20501998|NCT01666080|Fludarabine|fludarabine|mesh-list
20501999|NCT01666080|Busulfan|busulfan|mesh-list
20502000|NCT01666080|Levetiracetam|levetiracetam|mesh-list
20502001|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502002|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502003|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502004|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
20502005|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502006|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
20502007|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20502008|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20502009|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
20502010|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
19700874|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502011|NCT01666171|Metformin|metformin|mesh-list
20502012|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20502013|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502014|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20502015|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20502016|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20502017|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20502018|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
20502019|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502020|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20502021|NCT01666223|Cathartics|cathartics|mesh-ancestor
20502022|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502023|NCT01666236|Triamcinolone|triamcinolone|mesh-list
20502024|NCT01666236|Ranibizumab|ranibizumab|mesh-list
20502025|NCT01666236|Verteporfin|verteporfin|mesh-list
20502026|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20502027|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20502028|NCT01666236|Growth Substances|growth substances|mesh-ancestor
20502029|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502030|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
20502031|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502032|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502033|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
20502034|NCT01666236|Hormones|hormones|mesh-ancestor
20502035|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502036|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20502037|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502038|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
20502039|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20502040|NCT01666249|Antibodies|antibodies|mesh-list
20502041|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
20502042|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502043|NCT01666262|Vaccines|vaccines|mesh-list
20502044|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
20502045|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502046|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
20502047|NCT01666301|Hematinics|hematinics|mesh-ancestor
20502048|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20502049|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20502050|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502051|NCT01666379|Fentanyl|fentanyl|mesh-list
20502052|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20502053|NCT01666379|Narcotics|narcotics|mesh-ancestor
20502054|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502055|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502056|NCT01666379|Analgesics|analgesics|mesh-ancestor
20529135|NCT01779687|Atorvastatin|atorvastatin|mesh-list
20502057|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
20502058|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502059|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20502060|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20502061|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
20502062|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
20502063|NCT01666418|Paclitaxel|paclitaxel|mesh-list
20502064|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20502065|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502066|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
20502067|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
20502068|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
20502069|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502070|NCT01666431|Lapatinib|lapatinib|mesh-list
20502071|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502072|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20502073|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502074|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502075|NCT01666522|Vitamin D|vitamin d|mesh-list
20502076|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
20502077|NCT01666522|Vitamins|vitamins|mesh-ancestor
20502078|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
20502079|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502080|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20502081|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20502082|NCT01666535|Vaccines|vaccines|mesh-list
20502083|NCT01666535|Immunologic Factors|immunologic factors|mesh-ancestor
20502084|NCT01666535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502085|NCT01666587|Ibuprofen|ibuprofen|mesh-list
20502086|NCT01666587|Antioxidants|antioxidants|mesh-list
20502087|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
20502088|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502089|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502090|NCT01666587|Analgesics|analgesics|mesh-ancestor
20502091|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
20502092|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502093|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502094|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502095|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502096|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502097|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502098|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243606|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243607|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
20243608|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
20243609|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243610|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243611|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243612|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
20243613|NCT00416897|Hormones|hormones|mesh-ancestor
20243614|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243615|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20502099|NCT01666587|Protective Agents|protective agents|mesh-ancestor
20502100|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
20502101|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502102|NCT01666600|Nintedanib|nintedanib|mesh-list
20502103|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502104|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20502105|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415125|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415126|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
19415127|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
19415128|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
20502106|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502107|NCT01666665|Metformin|metformin|mesh-list
20502108|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20502109|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502110|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
20502111|NCT01666678|Promethazine|promethazine|mesh-list
19853328|NCT00731198|Analgesics|analgesics|mesh-ancestor
19853329|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
19853330|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
20502112|NCT01666678|Naproxen|naproxen|mesh-list
20502113|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502114|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19853331|NCT00731549|Aripiprazole|aripiprazole|mesh-list
19853332|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853333|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853334|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20243616|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415129|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243617|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
20243618|NCT00416910|Fludarabine|fludarabine|mesh-list
20243619|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
20243620|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243621|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
20243622|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243623|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20243624|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20243625|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
20243626|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243627|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243628|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20502115|NCT01666678|Analgesics|analgesics|mesh-ancestor
20502116|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
20502117|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502118|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502119|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502120|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502121|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
20502122|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502123|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502124|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502125|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20502126|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20502127|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502128|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
20502129|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
20502130|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
20502131|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
20502132|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502133|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20502134|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
20502135|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
20502136|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502137|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20502138|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
19415130|NCT03050060|Nelfinavir|nelfinavir|mesh-list
20502139|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502140|NCT01666691|CKD732|ckd732|mesh-list
20502141|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20502142|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20502143|NCT01666691|Growth Substances|growth substances|mesh-ancestor
20502144|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502145|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
20502146|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502147|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20502148|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502149|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853335|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20502150|NCT01666756|Sorafenib|sorafenib|mesh-list
20502151|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502152|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20502153|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853336|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853337|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853338|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
19853339|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
19853340|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853341|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853342|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19853343|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19853344|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
19853345|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19853346|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19853347|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20530818|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
19853348|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19853349|NCT00731588|Biotin|biotin|mesh-list
19853350|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
19853351|NCT00731588|Vitamins|vitamins|mesh-ancestor
19853352|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
19853353|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502154|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502155|NCT01666769|Micafungin|micafungin|mesh-list
20502156|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
20502157|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502158|NCT01666925|Vaccines|vaccines|mesh-list
20502159|NCT01666925|Immunologic Factors|immunologic factors|mesh-ancestor
20502160|NCT01666925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502161|NCT01667081|Grazoprevir|grazoprevir|mesh-list
20502162|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
20502163|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502164|NCT01667094|Meropenem|meropenem|mesh-list
20502165|NCT01667094|Tazobactam|tazobactam|mesh-list
19853354|NCT00731679|Rifaximin|rifaximin|mesh-list
19853355|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19853356|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853357|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19853358|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19853359|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19853360|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415131|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
19415132|NCT03050060|Nivolumab|nivolumab|mesh-list
19415133|NCT03050060|Atezolizumab|atezolizumab|mesh-list
19700875|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708016|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708017|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19708018|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19708019|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19708020|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19708021|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
19853361|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853362|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
19853363|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853364|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
19853365|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20502166|NCT01667094|Piperacillin|piperacillin|mesh-list
19415134|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19415135|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415136|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415137|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19415138|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415139|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
19708022|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19708023|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19708024|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708025|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853366|NCT00731783|Mupirocin|mupirocin|mesh-list
20502167|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
20502168|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
20502169|NCT01667094|Ceftazidime|ceftazidime|mesh-list
20502170|NCT01667094|Cefepime|cefepime|mesh-list
20243629|NCT00416910|Analgesics|analgesics|mesh-ancestor
20502171|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20502172|NCT01667094|Ticarcillin|ticarcillin|mesh-list
20502173|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
20502174|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502175|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502176|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20502177|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502178|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502179|NCT01667120|Ketorolac|ketorolac|mesh-list
20502180|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502181|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502182|NCT01667120|Analgesics|analgesics|mesh-ancestor
20502183|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
20502184|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502185|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502186|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502187|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502188|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502189|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502190|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502191|NCT01667133|Ponatinib|ponatinib|mesh-list
20502192|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502193|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20502194|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502195|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529136|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20529137|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20529138|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
20529139|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529140|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20529141|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20529142|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529143|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19415140|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243630|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
20243631|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243632|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20243633|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243634|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243635|NCT00416923|Rituximab|rituximab|mesh-list
20243636|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20243637|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243638|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
20243639|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243640|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502196|NCT01667211|Paclitaxel|paclitaxel|mesh-list
20502197|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20502198|NCT01667211|Nedaplatin|nedaplatin|mesh-list
20502199|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20502200|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502201|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
20502202|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
20502203|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
20502204|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502205|NCT01667263|Tretinoin|tretinoin|mesh-list
20502206|NCT01667263|Danazol|danazol|mesh-list
20502207|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502208|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
20502209|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502210|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20502211|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
20502212|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502213|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502214|NCT01667315|Bupivacaine|bupivacaine|mesh-list
19700876|NCT04888403|Paclitaxel|paclitaxel|mesh-list
19700877|NCT04888403|Nedaplatin|nedaplatin|mesh-list
19700878|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19700879|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700880|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
19700881|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
19700882|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
19700883|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502215|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
20502216|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
20502217|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502218|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502219|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
20502220|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502221|NCT01667445|Morphine|morphine|mesh-list
20502222|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20502223|NCT01667445|Narcotics|narcotics|mesh-ancestor
20502224|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502225|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502226|NCT01667445|Analgesics|analgesics|mesh-ancestor
20502227|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
20502228|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502229|NCT01667484|Adderall|adderall|mesh-list
20502230|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20502231|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502232|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
20502233|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20502234|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20502235|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502236|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
20243641|NCT00416962|Oseltamivir|oseltamivir|mesh-list
20243642|NCT00416962|Amantadine|amantadine|mesh-list
20243643|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
20243644|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243645|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243646|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700884|NCT04887818|Lidocaine|lidocaine|mesh-list
19700885|NCT04887818|Diltiazem|diltiazem|mesh-list
19700886|NCT04887818|Nifedipine|nifedipine|mesh-list
19700887|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
19700888|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
20502237|NCT01667523|Capsaicin|capsaicin|mesh-list
20502238|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
20502239|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502240|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
20502241|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853367|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19700889|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700890|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243647|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19700891|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
19853368|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243648|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20243649|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
19853369|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
19853370|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
19853371|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19853372|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19853373|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243650|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243651|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243652|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20243653|NCT00416962|Analgesics|analgesics|mesh-ancestor
20243654|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
20243655|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243656|NCT00417014|Prednisolone|prednisolone|mesh-list
20243657|NCT00417014|Vinblastine|vinblastine|mesh-list
20243658|NCT00417014|Procarbazine|procarbazine|mesh-list
20243659|NCT00417014|Chlorambucil|chlorambucil|mesh-list
20243660|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243661|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
20243662|NCT00417014|Hormones|hormones|mesh-ancestor
20243663|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502242|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502243|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20502244|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502245|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20502246|NCT01667523|Protective Agents|protective agents|mesh-ancestor
20502247|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20502248|NCT01667575|Amoxicillin|amoxicillin|mesh-list
20502249|NCT01667575|Clarithromycin|clarithromycin|mesh-list
20502250|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20502251|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
20502252|NCT01667575|Esomeprazole|esomeprazole|mesh-list
20502253|NCT01667575|Bismuth|bismuth|mesh-list
20502254|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20502255|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502256|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502257|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
20502258|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20502259|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502260|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502261|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20502262|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20502263|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20502264|NCT01667575|Antacids|antacids|mesh-ancestor
20502265|NCT01667575|Diuretics|diuretics|mesh-ancestor
20502266|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
20502267|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502268|NCT01667575|Expectorants|expectorants|mesh-ancestor
20502269|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
20502270|NCT01667614|Losartan|losartan|mesh-list
20502271|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20243664|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243665|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243666|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243667|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20243668|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243669|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243670|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243671|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243672|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20502272|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20502273|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20502274|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20502275|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502276|NCT01667692|Azithromycin|azithromycin|mesh-list
20502277|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502278|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502279|NCT01667718|Amoxicillin|amoxicillin|mesh-list
20502280|NCT01667718|Levofloxacin|levofloxacin|mesh-list
20502281|NCT01667718|Ofloxacin|ofloxacin|mesh-list
20502282|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
20502283|NCT01667718|Lansoprazole|lansoprazole|mesh-list
20502284|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
20502285|NCT01667718|Bismuth|bismuth|mesh-list
20502286|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20502287|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853374|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853375|NCT00731874|Tacrolimus|tacrolimus|mesh-list
19853376|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502288|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502289|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502290|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20502291|NCT01667718|Renal Agents|renal agents|mesh-ancestor
20502292|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20502293|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20502294|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502295|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502296|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20502297|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20502298|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20502299|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502300|NCT01667718|Antacids|antacids|mesh-ancestor
20502301|NCT01667718|Diuretics|diuretics|mesh-ancestor
20502302|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
20502303|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502304|NCT01667718|Expectorants|expectorants|mesh-ancestor
20502305|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
20502306|NCT01667744|Citalopram|citalopram|mesh-list
20502307|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20502308|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20502309|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20502310|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502311|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502312|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
20502313|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502314|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20502315|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
20502316|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20502317|NCT01667874|Gentamicins|gentamicins|mesh-list
20502318|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502319|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502320|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20502321|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502322|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502323|NCT01668043|UB-421|ub-421|mesh-list
20502324|NCT01668043|Antibodies|antibodies|mesh-list
20502325|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
20502326|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502327|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20502328|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
20502329|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502330|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20502331|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20502332|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502333|NCT01668069|Ondansetron|ondansetron|mesh-list
20502334|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
20502335|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
20502336|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502337|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502338|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502339|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
20502340|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502341|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20502342|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
20502343|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502344|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502345|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20502346|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20502347|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502348|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20502349|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20502350|NCT01668121|Budesonide|budesonide|mesh-list
20502351|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
20502352|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20502353|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502354|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20502355|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
20502356|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502357|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502358|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20502359|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
20502360|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
20502361|NCT01668121|Hormones|hormones|mesh-ancestor
20502362|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502363|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20502364|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20502365|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20502366|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
20502367|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502368|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502369|NCT01668433|Primaquine|primaquine|mesh-list
20502370|NCT01668433|Methylene Blue|methylene blue|mesh-list
20502371|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
20502372|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20502373|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20502374|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502375|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502376|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502377|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
20502378|NCT01668446|Estradiol|estradiol|mesh-list
20502379|NCT01668446|Estrogens|estrogens|mesh-ancestor
20502380|NCT01668446|Hormones|hormones|mesh-ancestor
20502381|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502382|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502383|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
20502384|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20502385|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20502386|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502387|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502388|NCT01668446|Urological Agents|urological agents|mesh-ancestor
20502389|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20502390|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502391|NCT01668498|Doxycycline|doxycycline|mesh-list
20502392|NCT01668498|Erythromycin|erythromycin|mesh-list
20502393|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
20502394|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20502395|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
20502396|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502397|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502398|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
20502399|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20502400|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20502401|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502402|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20502403|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502404|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243673|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
20243674|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
20243675|NCT00417053|Melphalan|melphalan|mesh-list
20243676|NCT00417053|Busulfan|busulfan|mesh-list
20243677|NCT00417053|Carboplatin|carboplatin|mesh-list
20243678|NCT00417053|Doxorubicin|doxorubicin|mesh-list
20243679|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20243680|NCT00417053|Etoposide|etoposide|mesh-list
20243681|NCT00417053|Vincristine|vincristine|mesh-list
20243682|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
20243683|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243684|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
20243685|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243686|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20243687|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20243688|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
20243689|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243690|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243691|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20243692|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20243693|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20502405|NCT01668550|AZD-0424|azd-0424|mesh-list
20502406|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20502407|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502408|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502409|NCT01668615|Tretinoin|tretinoin|mesh-list
20502410|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502411|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
20502412|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502413|NCT01668680|Celecoxib|celecoxib|mesh-list
20502414|NCT01668680|Capecitabine|capecitabine|mesh-list
20502415|NCT01668680|Methotrexate|methotrexate|mesh-list
20502416|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20502417|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
20502418|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502419|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502420|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20502421|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
20502422|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243694|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20243695|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243696|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20243697|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243698|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243699|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243700|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20243701|NCT00417066|Ganirelix|ganirelix|mesh-list
20502423|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502424|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20243702|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
20243703|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20243704|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
20502425|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502426|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20502427|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502428|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
20502429|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502430|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20502431|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502432|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502433|NCT01668680|Analgesics|analgesics|mesh-ancestor
20502434|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
20502435|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502436|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502437|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20502438|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502439|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20502440|NCT01668849|Fentanyl|fentanyl|mesh-list
20502441|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20502442|NCT01668849|Narcotics|narcotics|mesh-ancestor
20502443|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502444|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502445|NCT01668849|Analgesics|analgesics|mesh-ancestor
20502446|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
20502447|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502448|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20502449|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20502450|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
20502451|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
20502452|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502453|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19700892|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243705|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243706|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502454|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502455|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502456|NCT01668901|Aspirin|aspirin|mesh-list
20502457|NCT01668901|Warfarin|warfarin|mesh-list
20502458|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502459|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502460|NCT01668901|Analgesics|analgesics|mesh-ancestor
20502461|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
20502462|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502463|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700893|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20502464|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19700894|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19700895|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20502465|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502466|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20502467|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20502468|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502469|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20502470|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502471|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502472|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
20502473|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
20529144|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20529145|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
20529146|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529147|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20529148|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20529149|NCT01779830|Zolpidem|zolpidem|mesh-list
20529150|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20529151|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20529152|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529153|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529154|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20529155|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
20529156|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
20529157|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529158|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529159|NCT01779843|Cytarabine|cytarabine|mesh-list
20529160|NCT01779843|Idarubicin|idarubicin|mesh-list
20529161|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20529162|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
20529163|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529164|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529165|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
20529166|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529167|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529168|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
20529169|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529170|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19700896|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19700897|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700898|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20243707|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20243708|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243709|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243710|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
20243711|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247998|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247999|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248000|NCT00434135|Gemcitabine|gemcitabine|mesh-list
20502474|NCT01668927|Amoxicillin|amoxicillin|mesh-list
20502475|NCT01668927|Metronidazole|metronidazole|mesh-list
20502476|NCT01668927|Tetracycline|tetracycline|mesh-list
20502477|NCT01668927|Furazolidone|furazolidone|mesh-list
20502478|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
20502479|NCT01668927|Lansoprazole|lansoprazole|mesh-list
20502480|NCT01668927|Bismuth|bismuth|mesh-list
20502481|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20502482|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502483|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502484|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243712|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20502485|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20502486|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20502487|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20502488|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502489|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502490|NCT01668927|Antacids|antacids|mesh-ancestor
20502491|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20502492|NCT01668927|Diuretics|diuretics|mesh-ancestor
20502493|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
20502494|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502495|NCT01668927|Expectorants|expectorants|mesh-ancestor
20502496|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
20502497|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20243713|NCT00417144|Ganirelix|ganirelix|mesh-list
20243714|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
20243715|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20243716|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
20243717|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243718|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243719|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20243720|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20502498|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20502499|NCT01668927|Renal Agents|renal agents|mesh-ancestor
20502500|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20502501|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20502502|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
19700899|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19700900|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
19700901|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
20502503|NCT01669044|Propofol|propofol|mesh-list
20502504|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20502505|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502506|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502507|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20502508|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
20502509|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
20502510|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502511|NCT01669044|Analgesics|analgesics|mesh-ancestor
20502512|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
20502513|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502514|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20502515|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20502516|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20502517|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
20502518|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502519|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415141|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19415142|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19415143|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
20502520|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
20502521|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502522|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502523|NCT01669135|Anesthetics|anesthetics|mesh-list
20502524|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502525|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502526|NCT01669213|Ondansetron|ondansetron|mesh-list
20502527|NCT01669213|Ramosetron|ramosetron|mesh-list
20502528|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
20502529|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
20502530|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502531|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502532|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502533|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
20502534|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502535|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20502536|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
20502537|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502538|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502539|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20502540|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20502541|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502542|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20502543|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20502544|NCT01669226|Taxane|taxane|mesh-list
20502545|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502546|NCT01669239|Doxorubicin|doxorubicin|mesh-list
20502547|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20502548|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20502549|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502550|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20502551|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20502552|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502553|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502554|NCT01669291|Leuprolide|leuprolide|mesh-list
20502555|NCT01669291|Cetrorelix|cetrorelix|mesh-list
20502556|NCT01669291|Menotropins|menotropins|mesh-list
20502557|NCT01669291|Ganirelix|ganirelix|mesh-list
20502558|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20502559|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
20502560|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20502561|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502562|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20502563|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502564|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
20502565|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415144|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415145|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19853377|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
20502566|NCT01669304|Verapamil|verapamil|mesh-list
20502567|NCT01669304|Sertraline|sertraline|mesh-list
20502568|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
20502569|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20502570|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20502571|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20502572|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20502573|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502574|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502575|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
20502576|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502577|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20502578|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20502579|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20502580|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
20502581|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
20502582|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
20502583|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20502584|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502585|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502586|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
20502587|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20502588|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502589|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415146|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20502590|NCT01669447|Ranibizumab|ranibizumab|mesh-list
20243721|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243722|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
20243723|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243724|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20243725|NCT00417157|Ganirelix|ganirelix|mesh-list
20243726|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
20243727|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243728|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243729|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243730|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20502591|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20502592|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20502593|NCT01669447|Growth Substances|growth substances|mesh-ancestor
20502594|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502595|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
20502596|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502597|NCT01669499|Dexamethasone|dexamethasone|mesh-list
20502598|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
20502599|NCT01669499|BB 1101|bb 1101|mesh-list
20502600|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502601|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
20502602|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
20502603|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502604|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243731|NCT00417183|Ganirelix|ganirelix|mesh-list
20243732|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
20243733|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20243734|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
20243735|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20502605|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502606|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
20502607|NCT01669499|Hormones|hormones|mesh-ancestor
19700902|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19700903|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19700904|NCT04887961|Trabectedin|trabectedin|mesh-list
19700905|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20502608|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502609|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20502610|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502611|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
20502612|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502613|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502614|NCT01669707|Endostar protein|endostar protein|mesh-list
20502615|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20502616|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20502617|NCT01669707|Growth Substances|growth substances|mesh-ancestor
19700906|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
20502618|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502619|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
19700907|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502620|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502621|NCT01669824|Aspirin|aspirin|mesh-list
20502622|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502623|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502624|NCT01669824|Analgesics|analgesics|mesh-ancestor
20502625|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
20502626|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502627|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502628|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502629|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502630|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20502631|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20502632|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502633|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20502634|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502635|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502636|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
20502637|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20502638|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
20502639|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20502640|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20502641|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502642|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
20502643|NCT01669967|Promethazine|promethazine|mesh-list
20502644|NCT01669967|Lidocaine|lidocaine|mesh-list
20502645|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
20502646|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
20502647|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502648|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502649|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
20502650|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502651|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20502652|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20502653|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20502654|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20502655|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502656|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20502657|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20502658|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
20502659|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
20243736|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243737|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20243738|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243739|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243740|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
20243741|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243742|NCT00417222|Olmesartan|olmesartan|mesh-list
20243743|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20243744|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20243745|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20243746|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20243747|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502660|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243748|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
20243749|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20243750|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243751|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
20243752|NCT00417326|Sivelestat|sivelestat|mesh-list
20243753|NCT00417326|Glycine|glycine|mesh-list
19700908|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700909|NCT04887649|Morphine|morphine|mesh-list
19700910|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19700911|NCT04887649|Narcotics|narcotics|mesh-ancestor
20502661|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20502662|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
20502663|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
19700912|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19700913|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700914|NCT04887649|Analgesics|analgesics|mesh-ancestor
19700915|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
19700916|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700917|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
19700918|NCT04887805|Lenvatinib|lenvatinib|mesh-list
19700919|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19700920|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19700921|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19700922|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502664|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502665|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20502666|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
20502667|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502668|NCT01670071|Risperidone|risperidone|mesh-list
20502669|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19700923|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243754|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20502670|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20502671|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
20502672|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502673|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502674|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502675|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20502676|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20502677|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502678|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20502679|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20502680|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
20502681|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20502682|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20502683|NCT01670084|Leucovorin|leucovorin|mesh-list
20502684|NCT01670084|Cytarabine|cytarabine|mesh-list
20502685|NCT01670084|Dexamethasone|dexamethasone|mesh-list
20502686|NCT01670084|Prednisone|prednisone|mesh-list
20502687|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
20502688|NCT01670084|Rituximab|rituximab|mesh-list
20502689|NCT01670084|Doxorubicin|doxorubicin|mesh-list
20502690|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20502691|NCT01670084|Methotrexate|methotrexate|mesh-list
20502692|NCT01670084|Vincristine|vincristine|mesh-list
20502693|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
20502694|NCT01670084|Mesna|mesna|mesh-list
20502695|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502696|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
20502697|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502698|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415147|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
20502699|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20502700|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
20502701|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415148|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243755|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
20243756|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243757|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243758|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
20243759|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243760|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243761|NCT00417404|Vitamins|vitamins|mesh-list
20243762|NCT00417404|Vitamin A|vitamin a|mesh-list
20243763|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
20243764|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
20243765|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243766|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
20243767|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502702|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502703|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20502704|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20502705|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502706|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
20502707|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
20502708|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502709|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502710|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
20502711|NCT01670084|Hormones|hormones|mesh-ancestor
20502712|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502713|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20502714|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20502715|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20502716|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20502717|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502718|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20502719|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
20502720|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20502721|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20502722|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
20502723|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502724|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20502725|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20502726|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
20502727|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502728|NCT01670084|Antidotes|antidotes|mesh-ancestor
20502729|NCT01670084|Protective Agents|protective agents|mesh-ancestor
20502730|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
20502731|NCT01670084|Vitamins|vitamins|mesh-ancestor
20502732|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
20502733|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20502734|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
20502735|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
20502736|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
20502737|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
20502738|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
20502739|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20502740|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20502741|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502742|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502743|NCT01670136|Urological Agents|urological agents|mesh-ancestor
20502744|NCT01670149|Rifaximin|rifaximin|mesh-list
20502745|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502746|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502747|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700924|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
20502748|NCT01670162|Aflibercept|aflibercept|mesh-list
19415149|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
19415150|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19415151|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
19415152|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415153|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415154|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19415155|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
20502749|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19415156|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19415157|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
19415158|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415159|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502750|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20502751|NCT01670162|Growth Substances|growth substances|mesh-ancestor
20502752|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502753|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
20502754|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502755|NCT01670175|Sirolimus|sirolimus|mesh-list
20502756|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
20502757|NCT01670175|Topotecan|topotecan|mesh-list
20502758|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502759|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
20502760|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502761|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502762|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20502763|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
20502764|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502765|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502766|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20502767|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502768|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502769|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20502770|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
20502771|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20502772|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20502773|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502774|NCT01670240|Adalimumab|adalimumab|mesh-list
20502775|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502776|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502777|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
20502778|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502779|NCT01670318|Chromium|chromium|mesh-list
20502780|NCT01670318|Everolimus|everolimus|mesh-list
19853378|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853379|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19853380|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853381|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853382|NCT00732069|Valsartan|valsartan|mesh-list
19853383|NCT00732069|Ramipril|ramipril|mesh-list
19853384|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19853385|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19853386|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19853387|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853388|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19853389|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853390|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502781|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502782|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502783|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
20502784|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502785|NCT01670318|Trace Elements|trace elements|mesh-ancestor
19415160|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20502786|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
20502787|NCT01670370|Gemcitabine|gemcitabine|mesh-list
20502788|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
20502789|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502790|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
20502791|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502792|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20502793|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
20243768|NCT00417404|Protective Agents|protective agents|mesh-ancestor
20243769|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20243770|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243771|NCT00417430|Fulvestrant|fulvestrant|mesh-list
20243772|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19415161|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
19853391|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
19853392|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19853393|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
19853394|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853395|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
19853396|NCT00732225|Protective Agents|protective agents|mesh-ancestor
19853397|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20502794|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502795|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
20502796|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502797|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243773|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243774|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20502798|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502799|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
20502800|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502801|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502802|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20502803|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20502804|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502805|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502806|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502807|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20502808|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20502809|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20502810|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20502811|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20502812|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243775|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20243776|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
20243777|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243778|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243779|NCT00417443|Clonidine|clonidine|mesh-list
20243780|NCT00417443|Analgesics|analgesics|mesh-ancestor
20502813|NCT01670552|Naproxen|naproxen|mesh-list
20502814|NCT01670552|Nimesulide|nimesulide|mesh-list
20502815|NCT01670552|Esomeprazole|esomeprazole|mesh-list
20502816|NCT01670552|Pantoprazole|pantoprazole|mesh-list
20502817|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20502818|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502819|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20502820|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502821|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502822|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502823|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502824|NCT01670552|Analgesics|analgesics|mesh-ancestor
20502825|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
20502826|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502827|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502828|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502829|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502830|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
20502831|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502832|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
20502833|NCT01670565|Belimumab|belimumab|mesh-list
20502834|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20502835|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502836|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20502837|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
20502838|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502839|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502840|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502841|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502842|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20502843|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
19415162|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
19415163|NCT03044314|Protective Agents|protective agents|mesh-ancestor
19415164|NCT03040973|Gefitinib|gefitinib|mesh-list
19415165|NCT03040973|Nazartinib|nazartinib|mesh-list
19415166|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415167|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19415168|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243781|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
20243782|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243783|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243784|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20243785|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
20243786|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
20243787|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20243788|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20243789|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20243790|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
20243791|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243792|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243793|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20502844|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502845|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
20502846|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20502847|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
20502848|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243794|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
19415169|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502849|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
20502850|NCT01670578|Protective Agents|protective agents|mesh-ancestor
20502851|NCT01670669|Prucalopride|prucalopride|mesh-list
20502852|NCT01670669|Laxatives|laxatives|mesh-ancestor
20502853|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502854|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20502855|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20502856|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
20502857|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502858|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502859|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529171|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20529172|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20529173|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529174|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
20529175|NCT01779882|Busulfan|busulfan|mesh-list
20529176|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529177|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
20529178|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529179|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529180|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20529181|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
20529182|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529183|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529184|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20529185|NCT01779908|Vitamin D|vitamin d|mesh-list
20529186|NCT01779908|Vitamins|vitamins|mesh-ancestor
20529187|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
20529188|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529189|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20529190|NCT01779921|Thrombin|thrombin|mesh-list
20529191|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
20529192|NCT01779921|Coagulants|coagulants|mesh-ancestor
20529193|NCT01780051|Metformin|metformin|mesh-list
20529194|NCT01780051|Repaglinide|repaglinide|mesh-list
20529195|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20529196|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529197|NCT01780181|Gemcitabine|gemcitabine|mesh-list
20502860|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20502861|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502862|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502863|NCT01670773|Analgesics|analgesics|mesh-ancestor
20502864|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
20502865|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502866|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502867|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502868|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502869|NCT01670799|Ketorolac|ketorolac|mesh-list
20502870|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20502871|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20502872|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502873|NCT01670799|Analgesics|analgesics|mesh-ancestor
20502874|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
20502875|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502876|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502877|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502878|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502879|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20502880|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502881|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502882|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
20502883|NCT01670812|Rituximab|rituximab|mesh-list
20502884|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20502885|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502886|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
20502887|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502888|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502889|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502890|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
20502891|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
20502892|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502893|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20502894|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
20502895|NCT01670812|Hormones|hormones|mesh-ancestor
20502896|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502897|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20502898|NCT01670812|Protective Agents|protective agents|mesh-ancestor
20502899|NCT01670890|Cisplatin|cisplatin|mesh-list
20502900|NCT01670890|Temozolomide|temozolomide|mesh-list
19415170|NCT03022578|Lomustine|lomustine|mesh-list
20502901|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502902|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20502903|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
20529198|NCT01780181|Docetaxel|docetaxel|mesh-list
20243795|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243796|NCT00417677|Sirolimus|sirolimus|mesh-list
20243797|NCT00417677|Sunitinib|sunitinib|mesh-list
20243798|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243799|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20243800|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243801|NCT00417677|Growth Substances|growth substances|mesh-ancestor
20243802|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243803|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
20243804|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20243805|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243806|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243807|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20243808|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243809|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20243810|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
20243811|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243812|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
20243813|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
20243814|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
20243815|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20243816|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243817|NCT00417716|Bevacizumab|bevacizumab|mesh-list
19700925|NCT04887844|Lidocaine|lidocaine|mesh-list
19700926|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
20502904|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502905|NCT01670929|Progesterone|progesterone|mesh-list
20502906|NCT01670929|Progestins|progestins|mesh-ancestor
20502907|NCT01670929|Hormones|hormones|mesh-ancestor
20502908|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502909|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502910|NCT01670955|Folic Acid|folic acid|mesh-list
20502911|NCT01670955|Hematinics|hematinics|mesh-ancestor
20502912|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
20502913|NCT01670955|Vitamins|vitamins|mesh-ancestor
20502914|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
20502915|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502916|NCT01671384|Valproic Acid|valproic acid|mesh-list
20502917|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
20502918|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502919|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502920|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
19700927|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
19700928|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502921|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700929|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853398|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853399|NCT00732251|Allopurinol|allopurinol|mesh-list
19853400|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
19853401|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853402|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853403|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
19853404|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20502922|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502923|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
20502924|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20502925|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502926|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20502927|NCT01671410|Morphine|morphine|mesh-list
20502928|NCT01671410|Buprenorphine|buprenorphine|mesh-list
20502929|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20502930|NCT01671410|Narcotics|narcotics|mesh-ancestor
20502931|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20502932|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502933|NCT01671410|Analgesics|analgesics|mesh-ancestor
20502934|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
20502935|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853405|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19853406|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
19853407|NCT00732251|Protective Agents|protective agents|mesh-ancestor
20243818|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19853408|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853409|NCT00732303|Pemetrexed|pemetrexed|mesh-list
19853410|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853411|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853412|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853413|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19853414|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19853415|NCT00732498|Cytarabine|cytarabine|mesh-list
19853416|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
19853417|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20243819|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243820|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20243821|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243822|NCT00417716|Growth Substances|growth substances|mesh-ancestor
20243823|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243824|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
20243825|NCT00417729|Acarbose|acarbose|mesh-list
20243826|NCT00417729|Glyburide|glyburide|mesh-list
20243827|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20243828|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243829|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502936|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20502937|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
20502938|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502939|NCT01671709|Montelukast|montelukast|mesh-list
20502940|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20502941|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
20502942|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20502943|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
20502944|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502945|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502946|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20502947|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20502948|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502949|NCT01671722|Montelukast|montelukast|mesh-list
20502950|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20502951|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
20502952|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20502953|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
20502954|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20502955|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529199|NCT01780181|Vinorelbine|vinorelbine|mesh-list
20243830|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20243831|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243832|NCT00417768|Plasminogen|plasminogen|mesh-list
20243833|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20243834|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20243835|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20243836|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243837|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20243838|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20243839|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20243840|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20243841|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243842|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
20243843|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243844|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243845|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
20243846|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243847|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20243848|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243849|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243850|NCT00417833|Bevacizumab|bevacizumab|mesh-list
20243851|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20243852|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243853|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20243854|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243855|NCT00417833|Growth Substances|growth substances|mesh-ancestor
20243856|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243857|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
20243858|NCT00417872|Metronidazole|metronidazole|mesh-list
20243859|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
20243860|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243861|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20502956|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20502957|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20502958|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502959|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
20502960|NCT01671774|Interleukin-2|interleukin-2|mesh-list
20502961|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502962|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20502963|NCT01671774|Analgesics|analgesics|mesh-ancestor
20502964|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
20502965|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20502966|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502967|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20502968|NCT01671787|Tenofovir|tenofovir|mesh-list
20502969|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
20502970|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20502971|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20502972|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20502973|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20502974|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502975|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20502976|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20502977|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
20502978|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20502979|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20502980|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20502981|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20502982|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
20502983|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20502984|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502985|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20502986|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
20502987|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20502988|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20502989|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
20502990|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20502991|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
20502992|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20502993|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
20502994|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20502995|NCT01671891|Capecitabine|capecitabine|mesh-list
20502996|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
20502997|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20502998|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
20502999|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503000|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503001|NCT01671904|Rituximab|rituximab|mesh-list
20503002|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
20503003|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20503004|NCT01671904|Venetoclax|venetoclax|mesh-list
20503005|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503006|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503007|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
20503008|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503009|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20503010|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20503011|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
20503012|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503013|NCT01671982|Tenofovir|tenofovir|mesh-list
20503014|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
20503015|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503016|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20503017|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20503018|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503019|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503020|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20503021|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20503022|NCT01672047|Vitamin D|vitamin d|mesh-list
20503023|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
20503024|NCT01672047|Vitamins|vitamins|mesh-ancestor
20503025|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
20503026|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503027|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20503028|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20503029|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
20503030|NCT01672086|Antacids|antacids|mesh-ancestor
20503031|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503032|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503033|NCT01672112|Oxycodone|oxycodone|mesh-list
20503034|NCT01672112|Codeine|codeine|mesh-list
20503035|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20503036|NCT01672112|Narcotics|narcotics|mesh-ancestor
20503037|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503038|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503039|NCT01672112|Analgesics|analgesics|mesh-ancestor
20503040|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
20503041|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503042|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
20503043|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
20503044|NCT01672151|Sirolimus|sirolimus|mesh-list
20503045|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19700930|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
19700931|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503046|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503047|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20503048|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503049|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
20503050|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503051|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
20503052|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503053|NCT01672229|Bortezomib|bortezomib|mesh-list
20503054|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503055|NCT01672307|Minoxidil|minoxidil|mesh-list
20503056|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20503057|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
20503058|NCT01672346|Adenosine|adenosine|mesh-list
20503059|NCT01672346|Analgesics|analgesics|mesh-ancestor
20503060|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
20503061|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503062|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503063|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20503064|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
20503065|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20503066|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
20503067|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
20503068|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503069|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503070|NCT01672359|Choline|choline|mesh-list
20503071|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
20503072|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20503073|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
20503074|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503075|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503076|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20503077|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
20529200|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20529201|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
20529202|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529203|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529204|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
20529205|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529206|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529207|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529208|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
20529209|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529210|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
20529211|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
20529212|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
20529213|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20529214|NCT01780233|Fentanyl|fentanyl|mesh-list
20529215|NCT01780233|Naltrexone|naltrexone|mesh-list
20529216|NCT01780233|Citric Acid|citric acid|mesh-list
20503078|NCT01672450|Ipilimumab|ipilimumab|mesh-list
20503079|NCT01672450|Interleukin-2|interleukin-2|mesh-list
20503080|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503081|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503082|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20503083|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503084|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20503085|NCT01672450|Analgesics|analgesics|mesh-ancestor
20503086|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
20503087|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503088|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503089|NCT01672476|Valsartan|valsartan|mesh-list
20503090|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20503091|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20243862|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20503092|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20503093|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503094|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20503095|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
20503096|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20503097|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20503098|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20503099|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503100|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503101|NCT01672580|Vitamins|vitamins|mesh-list
20503102|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
20503103|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503104|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20503105|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503106|NCT01672606|Rocuronium|rocuronium|mesh-list
20503107|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20503108|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20503109|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20503110|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503111|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503112|NCT01672671|Paclitaxel|paclitaxel|mesh-list
20503113|NCT01672671|Doxorubicin|doxorubicin|mesh-list
20503114|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20503115|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503116|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
20503117|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
20503118|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
20503119|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503120|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20503121|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20503122|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20503123|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503124|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
20503125|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20503126|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503127|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503128|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503129|NCT01672814|Riboflavin|riboflavin|mesh-list
20503130|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20503131|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20503132|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
20503133|NCT01672814|Vitamins|vitamins|mesh-ancestor
20503134|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
20503135|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503136|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20503137|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
20503138|NCT01673087|Dexamethasone|dexamethasone|mesh-list
20503139|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20503140|NCT01673087|Cosyntropin|cosyntropin|mesh-list
20503141|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20503142|NCT01673087|Metyrapone|metyrapone|mesh-list
20503143|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20503144|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
20503145|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
20503146|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503147|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503148|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503149|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
20503150|NCT01673087|Hormones|hormones|mesh-ancestor
20529217|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
20243863|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20243864|NCT00417898|Aspirin|aspirin|mesh-list
20243865|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20503151|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503152|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20503153|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503154|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
20503155|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503156|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503157|NCT01673204|Calcitriol|calcitriol|mesh-list
20503158|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20503159|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503160|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20503161|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503162|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503163|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20503164|NCT01673204|Vitamins|vitamins|mesh-ancestor
20503165|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
20503166|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20503167|NCT01673217|Doxorubicin|doxorubicin|mesh-list
20503168|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20503169|NCT01673217|Decitabine|decitabine|mesh-list
20503170|NCT01673217|Azacitidine|azacitidine|mesh-list
20503171|NCT01673217|Vaccines|vaccines|mesh-list
20503172|NCT01673217|Sargramostim|sargramostim|mesh-list
20503173|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
20503174|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
20503175|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503176|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20503177|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503178|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20503179|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20503180|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503181|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503182|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20503183|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
20503184|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20503185|NCT01673308|Lenalidomide|lenalidomide|mesh-list
20503186|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
20503187|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503188|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20503189|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20503190|NCT01673308|Growth Substances|growth substances|mesh-ancestor
20503191|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
20503192|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503193|NCT01673399|Atosiban|atosiban|mesh-list
20503194|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
20503195|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503196|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503197|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
20503198|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20503199|NCT01673542|Lidocaine|lidocaine|mesh-list
20503200|NCT01673542|Prilocaine|prilocaine|mesh-list
20503201|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20503202|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20503203|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
20503204|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503205|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503206|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
20503207|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503208|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20503209|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20503210|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20503211|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503212|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503213|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20503214|NCT01673724|Pramipexole|pramipexole|mesh-list
20503215|NCT01673724|Bromocriptine|bromocriptine|mesh-list
20503216|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
20503217|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503218|NCT01673724|Protective Agents|protective agents|mesh-ancestor
20503219|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503220|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20503221|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20503222|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
20503223|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
20503224|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503225|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
20503226|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503227|NCT01673737|Vemurafenib|vemurafenib|mesh-list
20503228|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503229|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20243866|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20243867|NCT00417898|Analgesics|analgesics|mesh-ancestor
20243868|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
20503230|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503231|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503232|NCT01673997|Metoprolol|metoprolol|mesh-list
20503233|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20503234|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20503235|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
20503236|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
20503237|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503238|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503239|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20503240|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20503241|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20503242|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
20503243|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503244|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503245|NCT01674127|Methyldopa|methyldopa|mesh-list
20503246|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20503247|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
20503248|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
20503249|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503250|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503251|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20503252|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20503253|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20503254|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
20503255|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503256|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503257|NCT01674140|Tamoxifen|tamoxifen|mesh-list
20503258|NCT01674140|Everolimus|everolimus|mesh-list
20503259|NCT01674140|Letrozole|letrozole|mesh-list
20503260|NCT01674140|Anastrozole|anastrozole|mesh-list
20503261|NCT01674140|Leuprolide|leuprolide|mesh-list
20503262|NCT01674140|Exemestane|exemestane|mesh-list
20503263|NCT01674140|Goserelin|goserelin|mesh-list
20503264|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700932|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19700933|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19700934|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19700935|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19700936|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700937|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20503265|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503266|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503267|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
20503268|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503269|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20503270|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20503271|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503272|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20503273|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
20503274|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503275|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20503276|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19700938|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
19700939|NCT04887844|Hormones|hormones|mesh-ancestor
19700940|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19700941|NCT04887467|Apomorphine|apomorphine|mesh-list
19700942|NCT04887467|Emetics|emetics|mesh-ancestor
19700943|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700944|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
19700945|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700946|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700947|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
19700948|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
19700949|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700950|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700951|NCT04887493|Alprostadil|alprostadil|mesh-list
19700952|NCT04887493|Misoprostol|misoprostol|mesh-list
19700953|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19700954|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
19700955|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708026|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
20243869|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243870|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243871|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243872|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20243873|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20243874|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20243875|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243876|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20243877|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20243878|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243879|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
20243880|NCT00417911|Bortezomib|bortezomib|mesh-list
20503277|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20503278|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20503279|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20503280|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
20503281|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20503282|NCT01674166|Prucalopride|prucalopride|mesh-list
20503283|NCT01674166|Laxatives|laxatives|mesh-ancestor
20503284|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503285|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20503286|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20503287|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
20503288|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503289|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503290|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503291|NCT01674192|Prucalopride|prucalopride|mesh-list
20503292|NCT01674192|Laxatives|laxatives|mesh-ancestor
20503293|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503294|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20503295|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20503296|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
20503297|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503298|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503299|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503300|NCT01674205|Vaccines|vaccines|mesh-list
20503301|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
20503302|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503303|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
20503304|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20503305|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503306|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20503307|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20503308|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503309|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503310|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503311|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20503312|NCT01674257|Fluorides|fluorides|mesh-list
20503313|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
20503314|NCT01674257|Protective Agents|protective agents|mesh-ancestor
20503315|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503316|NCT01674257|Hematinics|hematinics|mesh-ancestor
20503317|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20503318|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20529218|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20529219|NCT01780233|Narcotics|narcotics|mesh-ancestor
20529220|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529221|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529222|NCT01780233|Analgesics|analgesics|mesh-ancestor
20529223|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
20529224|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529225|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20248001|NCT00434135|Paclitaxel|paclitaxel|mesh-list
20248002|NCT00434135|Pemetrexed|pemetrexed|mesh-list
20248003|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20248004|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248005|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
20248006|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
20248007|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
20248008|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248009|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20248010|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
20503319|NCT01674270|Bicalutamide|bicalutamide|mesh-list
20503320|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
20503321|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
20503322|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503323|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415171|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19415172|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
20503324|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503325|NCT01674283|Glucagon|glucagon|mesh-list
20503326|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503327|NCT01674283|Hormones|hormones|mesh-ancestor
20503328|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503329|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503330|NCT01674413|Adalimumab|adalimumab|mesh-list
19700956|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700957|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19700958|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19700959|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
19700960|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19700961|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
19700962|NCT04887493|Urological Agents|urological agents|mesh-ancestor
19700963|NCT04887389|Listerine|listerine|mesh-list
19700964|NCT04887389|Fluorides|fluorides|mesh-list
19700965|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
19700966|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
19700967|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
19700968|NCT04887389|Protective Agents|protective agents|mesh-ancestor
19700969|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700970|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19700971|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19700972|NCT04887311|Tempol|tempol|mesh-list
19700973|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
19700974|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700975|NCT04887311|Protective Agents|protective agents|mesh-ancestor
20503331|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20503332|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20503333|NCT01674504|Montelukast|montelukast|mesh-list
20503334|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20503335|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
20503336|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20503337|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
20503338|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503339|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503340|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19700976|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700977|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19700978|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700979|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20503341|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20503342|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700980|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19700981|NCT04886986|Edetic Acid|edetic acid|mesh-list
19853418|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19853419|NCT00732498|Prednisolone|prednisolone|mesh-list
19700982|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19700983|NCT04886986|Anticoagulants|anticoagulants|mesh-ancestor
20503343|NCT01674517|Montelukast|montelukast|mesh-list
20503344|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20503345|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
20503346|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20503347|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
20503348|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503349|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503350|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20503351|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20503352|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503353|NCT01674530|Lubiprostone|lubiprostone|mesh-list
19853420|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
19853421|NCT00732498|Rituximab|rituximab|mesh-list
20503354|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20503355|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503356|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503357|NCT01674556|Gemcitabine|gemcitabine|mesh-list
20503358|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19853422|NCT00732498|Etoposide|etoposide|mesh-list
19853423|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19853424|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19853425|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
19853426|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853427|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503359|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
20503360|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503361|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503362|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
20503363|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503364|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503365|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503366|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
20503367|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503368|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
20503369|NCT01674686|Atorvastatin|atorvastatin|mesh-list
20503370|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20503371|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20503372|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
20503373|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503374|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20503375|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20503376|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503377|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20503378|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20503379|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20503380|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20503381|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
20503382|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503383|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503384|NCT01674738|Bevacizumab|bevacizumab|mesh-list
20503385|NCT01674738|Pemetrexed|pemetrexed|mesh-list
20503386|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503387|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503388|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20503389|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20503390|NCT01674738|Growth Substances|growth substances|mesh-ancestor
20503391|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503392|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
20503393|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503394|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503395|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20503396|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19853428|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
19853429|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503397|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
20503398|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20503399|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503400|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503401|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503402|NCT01674842|Cisplatin|cisplatin|mesh-list
20503403|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503404|NCT01674855|Lenograstim|lenograstim|mesh-list
20503405|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20503406|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
20503407|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503408|NCT01674868|Fluoxetine|fluoxetine|mesh-list
19415173|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415174|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415175|NCT03015259|Budesonide|budesonide|mesh-list
19415176|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
19415177|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19415178|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415179|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19415180|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
19415181|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19700984|NCT04886986|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20503409|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20503410|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20503411|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503412|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503413|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503414|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
20503415|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503416|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20503417|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
20503418|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20503419|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20503420|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20503421|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503422|NCT01674933|Listerine|listerine|mesh-list
20503423|NCT01674933|Fluorides|fluorides|mesh-list
20503424|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
20503425|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
20503426|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
20503427|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
20503428|NCT01674933|Protective Agents|protective agents|mesh-ancestor
20503429|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503430|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20503431|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503432|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20503433|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
20503434|NCT01674946|Cathartics|cathartics|mesh-ancestor
20503435|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503436|NCT01675024|Rotigotine|rotigotine|mesh-list
20503437|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
20503438|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
20503439|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503440|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503441|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503442|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
20503443|NCT01675076|Apixaban|apixaban|mesh-list
20503444|NCT01675076|Dabigatran|dabigatran|mesh-list
20503445|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20503446|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
20503447|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20503448|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
20503449|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503450|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503451|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
20503452|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
20503453|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20503454|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503455|NCT01675115|Aspirin|aspirin|mesh-list
20503456|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20503457|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20503458|NCT01675115|Analgesics|analgesics|mesh-ancestor
20503459|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
20503460|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503461|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503462|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20503463|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20503464|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20503465|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20503466|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503467|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20503468|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20503469|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503470|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
20503471|NCT01675206|Vitamin K|vitamin k|mesh-list
20503472|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
20503473|NCT01675206|Vitamins|vitamins|mesh-ancestor
20503474|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
20503475|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503476|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20503477|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20503478|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503479|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
20503480|NCT01675206|Coagulants|coagulants|mesh-ancestor
20503481|NCT01675219|Mitomycins|mitomycins|mesh-list
20503482|NCT01675219|Mitomycin|mitomycin|mesh-list
20503483|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20503484|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503485|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
20503486|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503487|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20503488|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503489|NCT01675310|Metformin|metformin|mesh-list
20503490|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503491|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503492|NCT01675362|Selenium|selenium|mesh-list
20503493|NCT01675362|Losartan|losartan|mesh-list
20503494|NCT01675362|Verapamil|verapamil|mesh-list
20503495|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
20503496|NCT01675362|Calcium|calcium|mesh-list
20503497|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20503498|NCT01675362|Antioxidants|antioxidants|mesh-list
20503499|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20503500|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503501|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20503502|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20503503|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20503504|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503505|NCT01675362|Protective Agents|protective agents|mesh-ancestor
20503506|NCT01675362|Trace Elements|trace elements|mesh-ancestor
20503507|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
20503508|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503509|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
19415182|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503510|NCT01675466|Anesthetics|anesthetics|mesh-list
20503511|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503512|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503513|NCT01675518|ASP7991|asp7991|mesh-list
20503514|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20503515|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
20503516|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503517|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503518|NCT01675557|Vitamin D|vitamin d|mesh-list
20503519|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
20503520|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
20503521|NCT01675557|Vitamins|vitamins|mesh-list
20503522|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
20503523|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503524|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20503525|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20503526|NCT01675648|Lofexidine|lofexidine|mesh-list
20503527|NCT01675648|Clonidine|clonidine|mesh-list
20503528|NCT01675648|Diazepam|diazepam|mesh-list
20503529|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20503530|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
20503531|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
20503532|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
20503533|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503534|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503535|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503536|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20503537|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503538|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20503539|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19700985|NCT04886986|Chelating Agents|chelating agents|mesh-ancestor
19700986|NCT04886986|Sequestering Agents|sequestering agents|mesh-ancestor
19700987|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19700988|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19700989|NCT04886869|Caffeine|caffeine|mesh-list
19700990|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19700991|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19700992|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19700993|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19700994|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503540|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20503541|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20503542|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20503543|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20503544|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
20503545|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
19700995|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20503546|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
20503547|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
20503548|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503549|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503550|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20503551|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20503552|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
20503553|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20503554|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20503555|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20503556|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
20503557|NCT01675648|Analgesics|analgesics|mesh-ancestor
20503558|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
20503559|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
19700996|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19700997|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
20503560|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
20503561|NCT01675804|Methylphenidate|methylphenidate|mesh-list
20503562|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20503563|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503564|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19415183|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19415184|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
19415185|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
19415186|NCT03015259|Hormones|hormones|mesh-ancestor
19415187|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503565|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20503566|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503567|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503568|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
20503569|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503570|NCT01675895|Lidocaine|lidocaine|mesh-list
20503571|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
20503572|NCT01675895|Anesthetics|anesthetics|mesh-list
19415188|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19415189|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20503573|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
20503574|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503575|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503576|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
20503577|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503578|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19700998|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19700999|NCT04886752|Vitamins|vitamins|mesh-list
19701000|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
19701001|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
19701002|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
19701003|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701004|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
19701005|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701006|NCT04886752|Protective Agents|protective agents|mesh-ancestor
19701007|NCT04886323|Ketoconazole|ketoconazole|mesh-list
20503579|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20503580|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20503581|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503582|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503583|NCT01675947|Sirolimus|sirolimus|mesh-list
20503584|NCT01675947|Lidocaine|lidocaine|mesh-list
20503585|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
20503586|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
20503587|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503588|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701008|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
19701009|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503589|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
20503590|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503591|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20503592|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20503593|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20503594|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503595|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503596|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20503597|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503598|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20503599|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503600|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
20503601|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503602|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
19701010|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20503603|NCT01675973|Ranolazine|ranolazine|mesh-list
20503604|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20503605|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503606|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503607|NCT01675986|Pregabalin|pregabalin|mesh-list
20503608|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
20503609|NCT01675986|Analgesics|analgesics|mesh-ancestor
20503610|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
20503611|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503612|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503613|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
19415190|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19853430|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20503614|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20503615|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503616|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503617|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20503618|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20503619|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20503620|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503621|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20503622|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
20503623|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
20503624|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20503625|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
20503626|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
20503627|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529226|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20529227|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
20529228|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
20529229|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
20529230|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20529231|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
20529232|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
20529233|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529234|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20529235|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20529236|NCT01780259|Triazolam|triazolam|mesh-list
20529237|NCT01780259|Esketamine|esketamine|mesh-list
20529238|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
20529239|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20529240|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20529241|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20529242|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20529243|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529244|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529245|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
20529246|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
20529247|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529248|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529249|NCT01780311|Sotalol|sotalol|mesh-list
20529250|NCT01780311|Flecainide|flecainide|mesh-list
20529251|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20529252|NCT01780311|Propafenone|propafenone|mesh-list
20529253|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20529254|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20529255|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
20529256|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415191|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
19415192|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503628|NCT01675999|Leucovorin|leucovorin|mesh-list
20503629|NCT01675999|Cetuximab|cetuximab|mesh-list
20503630|NCT01675999|Fluorouracil|fluorouracil|mesh-list
20503631|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
20503632|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503633|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503634|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
20503635|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503636|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20503637|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503638|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
20503639|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503640|NCT01675999|Antidotes|antidotes|mesh-ancestor
20503641|NCT01675999|Protective Agents|protective agents|mesh-ancestor
20503642|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
20503643|NCT01675999|Vitamins|vitamins|mesh-ancestor
20503644|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
20503645|NCT01676233|Insulin|insulin|mesh-list
20503646|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20503647|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
20503648|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503649|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503650|NCT01676246|Flupirtine|flupirtine|mesh-list
20503651|NCT01676246|Analgesics|analgesics|mesh-ancestor
20503652|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
20503653|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503654|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503655|NCT01676259|Gemcitabine|gemcitabine|mesh-list
20503656|NCT01676259|Paclitaxel|paclitaxel|mesh-list
20503657|NCT01676259|Folfirinox|folfirinox|mesh-list
20503658|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20503659|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503660|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
20503661|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
20503662|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
20503663|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503664|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20503665|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
20503666|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
20503667|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503668|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503669|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503670|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
20503671|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503672|NCT01676285|Metoprolol|metoprolol|mesh-list
20503673|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20503674|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19853431|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20503675|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
20503676|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
20503677|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503678|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503679|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20503680|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20503681|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20503682|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
19853432|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19853433|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19853434|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853435|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853436|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20503683|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503684|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503685|NCT01676363|Diflunisal|diflunisal|mesh-list
20503686|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20503687|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20503688|NCT01676363|Analgesics|analgesics|mesh-ancestor
20503689|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
20503690|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503691|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503692|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20503693|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853437|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
19853438|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
19853439|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853440|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853441|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853442|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
19853443|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
20503694|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20503695|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503696|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503697|NCT01676402|Vaccines|vaccines|mesh-list
20503698|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
20503699|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503700|NCT01676493|Codeine|codeine|mesh-list
20503701|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20503702|NCT01676493|Narcotics|narcotics|mesh-ancestor
20503703|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503704|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853444|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853445|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19853446|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
19853447|NCT00732498|Hormones|hormones|mesh-ancestor
19853448|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853449|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19853450|NCT00732498|Protective Agents|protective agents|mesh-ancestor
20503705|NCT01676493|Analgesics|analgesics|mesh-ancestor
20503706|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
20503707|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503708|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
19853451|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20503709|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
20503710|NCT01676506|Ranibizumab|ranibizumab|mesh-list
20503711|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20503712|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20503713|NCT01676506|Growth Substances|growth substances|mesh-ancestor
20503714|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503715|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
20503716|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503717|NCT01676558|Rituximab|rituximab|mesh-list
20503718|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503719|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503720|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
20503721|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503722|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20503723|NCT01676571|Vortioxetine|vortioxetine|mesh-list
20503724|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
20503725|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20503726|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20503727|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20503728|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503729|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503730|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20503731|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20503732|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503733|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503734|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503735|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
20503736|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20503737|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20503738|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20503739|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20503740|NCT01676597|Rifaximin|rifaximin|mesh-list
20503741|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
20503742|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20503743|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503744|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503745|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20503746|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701011|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19701012|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701013|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701014|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19701015|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
19701016|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701017|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701018|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20503747|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503748|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20503749|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20503750|NCT01676597|Protective Agents|protective agents|mesh-ancestor
20503751|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503752|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
20503753|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20503754|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
20503755|NCT01676649|Paclitaxel|paclitaxel|mesh-list
20503756|NCT01676649|Carboplatin|carboplatin|mesh-list
20503757|NCT01676649|Ipilimumab|ipilimumab|mesh-list
20503758|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20503759|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503760|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
20503761|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
20503762|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
20503763|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701019|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
20503764|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503765|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20503766|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
20503767|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503768|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701020|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19701021|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701022|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
20503769|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20503770|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
20503771|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
20503772|NCT01676844|Protective Agents|protective agents|mesh-ancestor
20503773|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503774|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20503775|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
20503776|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503777|NCT01676987|Budesonide|budesonide|mesh-list
20503778|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
20503779|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20503780|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20503781|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
20503782|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503783|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503784|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20503785|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
20503786|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
20503787|NCT01676987|Hormones|hormones|mesh-ancestor
20503788|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503789|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20503790|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20503791|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20503792|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
19415193|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415194|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
19415195|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19415196|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19415197|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20503793|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503794|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503795|NCT01677039|Ethanol|ethanol|mesh-list
20503796|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20503797|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503798|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503799|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503800|NCT01677065|Oxycodone|oxycodone|mesh-list
20503801|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20503802|NCT01677065|Narcotics|narcotics|mesh-ancestor
20503803|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503804|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503805|NCT01677065|Analgesics|analgesics|mesh-ancestor
20503806|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
20503807|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503808|NCT01677104|Liraglutide|liraglutide|mesh-list
20503809|NCT01677104|Exenatide|exenatide|mesh-list
20503810|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20503811|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503812|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503813|NCT01677104|Incretins|incretins|mesh-ancestor
20503814|NCT01677104|Hormones|hormones|mesh-ancestor
20503815|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20503816|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20503817|NCT01677143|Bupivacaine|bupivacaine|mesh-list
20503818|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
20503819|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
20503820|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503821|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503822|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
20503823|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503824|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20503825|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
20503826|NCT01677247|Glimepiride|glimepiride|mesh-list
20503827|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20503828|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503829|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503830|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503831|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
20503832|NCT01677260|Metformin|metformin|mesh-list
20503833|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503834|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503835|NCT01677273|Caseins|caseins|mesh-list
20503836|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
20503837|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
20503838|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503839|NCT01677351|Clonidine|clonidine|mesh-list
20503840|NCT01677351|Analgesics|analgesics|mesh-ancestor
20503841|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
20503842|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503843|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503844|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20503845|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
20503846|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
20503847|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20503848|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20503849|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20503850|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
20503851|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503852|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503853|NCT01677364|Oxytocin|oxytocin|mesh-list
20503854|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
20503855|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20503856|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503857|NCT01677390|Everolimus|everolimus|mesh-list
20503858|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503859|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503860|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
20503861|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503862|NCT01677403|Tobramycin|tobramycin|mesh-list
20503863|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20503864|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503865|NCT01677442|Anesthetics|anesthetics|mesh-list
20503866|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503867|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503868|NCT01677468|Doxorubicin|doxorubicin|mesh-list
20503869|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20503870|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
20503871|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20503872|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503873|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20503874|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20503875|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503876|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503877|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
20503878|NCT01677468|Coagulants|coagulants|mesh-ancestor
20503879|NCT01677546|Insulin|insulin|mesh-list
20503880|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20503881|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503882|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503883|NCT01677559|Paclitaxel|paclitaxel|mesh-list
20503884|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20503885|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503886|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
20503887|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
20503888|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
20503889|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503890|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
20503891|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
20503892|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503893|NCT01677598|Ustekinumab|ustekinumab|mesh-list
20503894|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
20503895|NCT01677611|Resveratrol|resveratrol|mesh-list
20503896|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
20503897|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503898|NCT01677611|Protective Agents|protective agents|mesh-ancestor
20503899|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503900|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503901|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20503902|NCT01677650|Methadone|methadone|mesh-list
20503903|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20503904|NCT01677650|Narcotics|narcotics|mesh-ancestor
20503905|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20503906|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503907|NCT01677650|Analgesics|analgesics|mesh-ancestor
20503908|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
20503909|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503910|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
20503911|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
20529257|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529258|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529259|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
20529260|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
20529261|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415198|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20529262|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20503912|NCT01677702|Lactoferrin|lactoferrin|mesh-list
20503913|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20503914|NCT01677884|Bevacizumab|bevacizumab|mesh-list
20503915|NCT01677884|Capecitabine|capecitabine|mesh-list
20503916|NCT01677884|Irinotecan|irinotecan|mesh-list
20503917|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20503918|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503919|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20503920|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20503921|NCT01677884|Growth Substances|growth substances|mesh-ancestor
20503922|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503923|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
20503924|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20503925|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
20503926|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503927|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20503928|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20503929|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503930|NCT01677897|Metformin|metformin|mesh-list
19701023|NCT04886297|Resveratrol|resveratrol|mesh-list
19701024|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
19701025|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701026|NCT04886297|Protective Agents|protective agents|mesh-ancestor
19701027|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701028|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701029|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19701030|NCT04886362|Ivermectin|ivermectin|mesh-list
19701031|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19701032|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708027|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19708028|NCT04821193|Disinfectants|disinfectants|mesh-list
19708029|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19708030|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19708031|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708032|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708517|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19708518|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19708519|NCT04813913|Growth Substances|growth substances|mesh-ancestor
20503931|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503932|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503933|NCT01677923|Metformin|metformin|mesh-list
20503934|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503935|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503936|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
20503937|NCT01677949|Etoposide|etoposide|mesh-list
20503938|NCT01677949|Clofarabine|clofarabine|mesh-list
20503939|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20503940|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
20503941|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503942|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20503943|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20503944|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
20503945|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503946|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20503947|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20503948|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20503949|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20503950|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20503951|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503952|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20503953|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
20503954|NCT01677962|Poly ICLC|poly iclc|mesh-list
20503955|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
20503956|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
20503957|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503958|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20503959|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20503960|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503961|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503962|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20503963|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503964|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503965|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
20503966|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503967|NCT01678053|Omeprazole|omeprazole|mesh-list
20503968|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
20503969|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20503970|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20503971|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20503972|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20503973|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20503974|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20503975|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
20503976|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20503977|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503978|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20503979|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20503980|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20503981|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20503982|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20503983|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
20503984|NCT01678079|Calcium|calcium|mesh-list
20503985|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20503986|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503987|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20503988|NCT01678092|Omalizumab|omalizumab|mesh-list
20503989|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19701033|NCT04886193|Leucovorin|leucovorin|mesh-list
19701034|NCT04886193|Docetaxel|docetaxel|mesh-list
19701035|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
19701036|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701037|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701038|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
19701039|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701040|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701041|NCT04886193|Antidotes|antidotes|mesh-ancestor
19701042|NCT04886193|Protective Agents|protective agents|mesh-ancestor
19701043|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503990|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20503991|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
20503992|NCT01678235|Insulin|insulin|mesh-list
20503993|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20503994|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
20503995|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
20503996|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20503997|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20503998|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
20503999|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20504000|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504001|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504002|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504003|NCT01678352|Imiquimod|imiquimod|mesh-list
20504004|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20504005|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
20504006|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504007|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504008|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
20504009|NCT01678365|Metronidazole|metronidazole|mesh-list
20504010|NCT01678365|Gentamicins|gentamicins|mesh-list
20504011|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
20504012|NCT01678365|Ampicillin|ampicillin|mesh-list
20504013|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504014|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504015|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20504016|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20504017|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20504018|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504019|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504020|NCT01678404|Rituximab|rituximab|mesh-list
20504021|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504022|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504023|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
20504024|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504025|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504026|NCT01678417|Rituximab|rituximab|mesh-list
20504027|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504028|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504029|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
20504030|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504031|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504032|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20504033|NCT01678430|Chlorambucil|chlorambucil|mesh-list
20504034|NCT01678430|Ofatumumab|ofatumumab|mesh-list
20504035|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20504036|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
20504037|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504038|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504039|NCT01678495|Plasminogen|plasminogen|mesh-list
20504040|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20504041|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20504042|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20504043|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504044|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
20504045|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504046|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20504047|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504048|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504049|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
20504050|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504051|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504052|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20504053|NCT01678599|Benzonidazole|benzonidazole|mesh-list
20504054|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504055|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
20504056|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504057|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20504058|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20504059|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20504060|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504061|NCT01678612|Copper|copper|mesh-list
20504062|NCT01678612|Trace Elements|trace elements|mesh-ancestor
20504063|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
20504064|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504065|NCT01678664|Doxorubicin|doxorubicin|mesh-list
20504066|NCT01678664|Everolimus|everolimus|mesh-list
20504067|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19701044|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
19701045|NCT04886193|Vitamins|vitamins|mesh-ancestor
19701046|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
19701047|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19701048|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19701049|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19701050|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19701051|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701052|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
19853452|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
20504068|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504069|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20504070|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20504071|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504072|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504073|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701053|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853453|NCT00732654|Caseins|caseins|mesh-list
19701054|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853454|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853455|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
19853456|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
20504074|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
20504075|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504076|NCT01678677|Vaccines|vaccines|mesh-list
20504077|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
20504078|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504079|NCT01678690|Gemcitabine|gemcitabine|mesh-list
20504080|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20504081|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
20504082|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504083|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504084|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
20504085|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504086|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504087|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504088|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
20504089|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504090|NCT01678703|Misoprostol|misoprostol|mesh-list
20504091|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20504092|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
20504093|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20504094|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504095|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20504096|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504097|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
20504098|NCT01678716|Micronutrients|micronutrients|mesh-list
20504099|NCT01678716|Trace Elements|trace elements|mesh-list
20504100|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853457|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853458|NCT00732758|Vitamin D|vitamin d|mesh-list
19853459|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
19853460|NCT00732758|Vitamins|vitamins|mesh-ancestor
20504101|NCT01678937|Cyclosporine|cyclosporine|mesh-list
20504102|NCT01678937|Sirolimus|sirolimus|mesh-list
20504103|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
20504104|NCT01678937|Tacrolimus|tacrolimus|mesh-list
20504105|NCT01678937|Cyclosporins|cyclosporins|mesh-list
20504106|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504107|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
20504108|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504109|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20504110|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504111|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504112|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
20504113|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504114|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
20504115|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853461|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
20504116|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20504117|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504118|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20504119|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
20504120|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504121|NCT01678963|Squalamine|squalamine|mesh-list
19853462|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504122|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504123|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504124|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20504125|NCT01678963|Protective Agents|protective agents|mesh-ancestor
20504126|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504127|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504128|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20504129|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20504130|NCT01678963|Growth Substances|growth substances|mesh-ancestor
20504131|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
20504132|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
20504133|NCT01679041|Fludarabine|fludarabine|mesh-list
20504134|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
20504135|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504136|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
20504137|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504138|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504139|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20504140|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
20504141|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504142|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504143|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20504144|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504145|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
20504146|NCT01679080|Teriparatide|teriparatide|mesh-list
20504147|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20504148|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504149|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20504150|NCT01679093|Dexamethasone|dexamethasone|mesh-list
20504151|NCT01679093|Droperidol|droperidol|mesh-list
20504152|NCT01679093|Ondansetron|ondansetron|mesh-list
20504153|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20504154|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
20504155|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
20504156|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504157|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504158|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504159|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
20504160|NCT01679093|Hormones|hormones|mesh-ancestor
20504161|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504162|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20504163|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504164|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
20504165|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
20504166|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20504167|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
20504168|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504169|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504170|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20504171|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20504172|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504173|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20504174|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20504175|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20504176|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20504177|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20504178|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
20504179|NCT01679106|Fentanyl|fentanyl|mesh-list
20504180|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20504181|NCT01679106|Narcotics|narcotics|mesh-ancestor
20504182|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416918|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20504183|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504184|NCT01679106|Analgesics|analgesics|mesh-ancestor
20504185|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
20504186|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504187|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20504188|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20504189|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
20504190|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
20504191|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
20504192|NCT01679327|Leucovorin|leucovorin|mesh-list
20504193|NCT01679327|Bevacizumab|bevacizumab|mesh-list
20504194|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
20504195|NCT01679327|Calcium|calcium|mesh-list
20504196|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
19701055|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20504197|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504198|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504199|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20504200|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20504201|NCT01679327|Growth Substances|growth substances|mesh-ancestor
20504202|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504203|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
20504204|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20504205|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20504206|NCT01679327|Antidotes|antidotes|mesh-ancestor
20504207|NCT01679327|Protective Agents|protective agents|mesh-ancestor
20504208|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
20504209|NCT01679327|Vitamins|vitamins|mesh-ancestor
20504210|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
20504211|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
20243881|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243882|NCT00417937|Azelaic acid|azelaic acid|mesh-list
20243883|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243884|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
20243885|NCT00417950|Acarbose|acarbose|mesh-list
20243886|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20504212|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504213|NCT01679392|Ropivacaine|ropivacaine|mesh-list
20504214|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
20504215|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
20504216|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504217|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504218|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
20504219|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529263|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20529264|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20529265|NCT01780467|Dopamine|dopamine|mesh-list
20529266|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20529267|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
20529268|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
20529269|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529270|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529271|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
20529272|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701056|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701057|NCT04885907|Vaccines|vaccines|mesh-list
19701058|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
19701059|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504220|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20504221|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20504222|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20504223|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20504224|NCT01679574|Metformin|metformin|mesh-list
20504225|NCT01679574|Letrozole|letrozole|mesh-list
20504226|NCT01679574|Clomiphene|clomiphene|mesh-list
20504227|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504228|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504229|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504230|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20504231|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20504232|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504233|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504234|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20504235|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
20504236|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504237|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20504238|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
20504239|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20504240|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20504241|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19701060|NCT04885764|Vaccines|vaccines|mesh-list
20504242|NCT01679639|Rifampin|rifampin|mesh-list
20504243|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20504244|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
20504245|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504246|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504247|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
19415199|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415200|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
19415201|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415202|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415203|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19415204|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415205|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
19415206|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19415207|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19415208|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20504248|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20504249|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504250|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504251|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20504252|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19415209|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19701061|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
19708033|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
20504253|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20504254|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20504255|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20504256|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20504257|NCT01679652|Nebivolol|nebivolol|mesh-list
20504258|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20504259|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
20504260|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20504261|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20504262|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20504263|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
20504264|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504265|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504266|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504267|NCT01679691|Anesthetics|anesthetics|mesh-list
20243887|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248011|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
20248012|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248013|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248014|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248015|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
20248016|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248017|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20248018|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20243888|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243889|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20243890|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243891|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19416919|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504268|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504269|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504270|NCT01679743|Trastuzumab|trastuzumab|mesh-list
20504271|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504272|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504273|NCT01679795|Tibolone|tibolone|mesh-list
20504274|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
20504275|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
20504276|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415210|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504277|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415211|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
19415212|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504278|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20504279|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20504280|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504281|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20504282|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
20504283|NCT01679795|Hormones|hormones|mesh-ancestor
20504284|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
20504285|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
19708034|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
20504286|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504287|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504288|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504289|NCT01679899|Vildagliptin|vildagliptin|mesh-list
20504290|NCT01679899|Gliclazide|gliclazide|mesh-list
20504291|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504292|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504293|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20504294|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
20504295|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504296|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504297|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
20504298|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20504299|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20504300|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
20504301|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504302|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20504303|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20504304|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504305|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504306|NCT01680042|Phenytoin|phenytoin|mesh-list
20504307|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
20504308|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20504309|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20504310|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20504311|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504312|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20504313|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20504314|NCT01680081|Adenosine|adenosine|mesh-list
20504315|NCT01680081|Analgesics|analgesics|mesh-ancestor
20504316|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
20504317|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701062|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504318|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504319|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20504320|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
20504321|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20504322|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
20504323|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
20504324|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504325|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504326|NCT01680094|Panobinostat|panobinostat|mesh-list
20504327|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504328|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20504329|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504330|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504331|NCT01680107|Cycloserine|cycloserine|mesh-list
20504332|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20504333|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504334|NCT01680107|Renal Agents|renal agents|mesh-ancestor
20504335|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20504336|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
20504337|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504338|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
20504339|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504340|NCT01680120|Anesthetics|anesthetics|mesh-list
20504341|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504342|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504343|NCT01680146|Caseins|caseins|mesh-list
20504344|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
20504345|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
20504346|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504347|NCT01680185|Insulin|insulin|mesh-list
20504348|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20504349|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
20504350|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
20504351|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
20504352|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
20504353|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
20504354|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504355|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504356|NCT01680198|Vitamin D|vitamin d|mesh-list
20504357|NCT01680198|Vitamins|vitamins|mesh-ancestor
20504358|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
20504359|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504360|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20504361|NCT01680250|Sirolimus|sirolimus|mesh-list
20504362|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504363|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504364|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20504365|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504366|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
20504367|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504368|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
20504369|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243892|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
20243893|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
20243894|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
20243895|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243896|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
20243897|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243898|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20243899|NCT00418067|Sirolimus|sirolimus|mesh-list
20243900|NCT00418067|Paclitaxel|paclitaxel|mesh-list
20243901|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20243902|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243903|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
20243904|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
20243905|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
20243906|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504370|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20504371|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20504372|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20504373|NCT01680263|Analgesics|analgesics|mesh-ancestor
20504374|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
20504375|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504376|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504377|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504378|NCT01680406|Chloroquine|chloroquine|mesh-list
20504379|NCT01680406|Lumefantrine|lumefantrine|mesh-list
20504380|NCT01680406|Artemether|artemether|mesh-list
20504381|NCT01680406|Primaquine|primaquine|mesh-list
20504382|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20504383|NCT01680406|Amebicides|amebicides|mesh-ancestor
20504384|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20504385|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20504386|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504387|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
20504388|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504389|NCT01680471|Midazolam|midazolam|mesh-list
20504390|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20504391|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20504392|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504393|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504394|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20504395|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20504396|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20504397|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20504398|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
20504399|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
20504400|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
20504401|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
20504402|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504403|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504404|NCT01680536|Maraviroc|maraviroc|mesh-list
20504405|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20504406|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20504407|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504408|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20504409|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20504410|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
20504411|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504412|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20504413|NCT01680679|Vaccines|vaccines|mesh-list
20504414|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
20504415|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504416|NCT01680718|Vasopressins|vasopressins|mesh-list
20504417|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
20504418|NCT01680718|Oxytocin|oxytocin|mesh-list
20504419|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
20504420|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20504421|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504422|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
20504423|NCT01680718|Coagulants|coagulants|mesh-ancestor
20504424|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20504425|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20504426|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
20504427|NCT01680796|Dexamethasone|dexamethasone|mesh-list
20504428|NCT01680796|Bortezomib|bortezomib|mesh-list
20504429|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20504430|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
20504431|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
20504432|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504433|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504434|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504435|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
20504436|NCT01680796|Hormones|hormones|mesh-ancestor
20504437|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504438|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20504439|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504440|NCT01680913|Anesthetics|anesthetics|mesh-list
20504441|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504442|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504443|NCT01680939|Ibuprofen|ibuprofen|mesh-list
20504444|NCT01680939|Morphine|morphine|mesh-list
20504445|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20504446|NCT01680939|Narcotics|narcotics|mesh-ancestor
20504447|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504448|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504449|NCT01680939|Analgesics|analgesics|mesh-ancestor
20504450|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
20504451|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504452|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20504453|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20504454|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20504455|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504456|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20504457|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504458|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504459|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
20504460|NCT01680952|Sirolimus|sirolimus|mesh-list
20504461|NCT01680952|Tacrolimus|tacrolimus|mesh-list
20504462|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504463|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
20504464|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504465|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20504466|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504467|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504468|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20504469|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504470|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20504471|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
20504472|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504473|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504474|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
20529273|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504475|NCT01681134|Tacrolimus|tacrolimus|mesh-list
20504476|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504477|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
20504478|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504479|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20504480|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504481|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504482|NCT01681446|Interferons|interferons|mesh-list
20504483|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
20504484|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504485|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
20504486|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504487|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
20504488|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504489|NCT01681537|Cytarabine|cytarabine|mesh-list
20504490|NCT01681537|Etoposide|etoposide|mesh-list
20504491|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
20504492|NCT01681537|Lenalidomide|lenalidomide|mesh-list
20504493|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20504494|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504495|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20504496|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20504497|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504498|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504499|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20504500|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
20504501|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
20504502|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504503|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504504|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
20504505|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504506|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20504507|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20504508|NCT01681537|Growth Substances|growth substances|mesh-ancestor
20504509|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
20504510|NCT01681537|Analgesics|analgesics|mesh-ancestor
20504511|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
20504512|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504513|NCT01681550|Incretins|incretins|mesh-list
20504514|NCT01681550|Hormones|hormones|mesh-ancestor
20504515|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504516|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504517|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
20504518|NCT01681563|Ofatumumab|ofatumumab|mesh-list
20504519|NCT01681563|Pentostatin|pentostatin|mesh-list
20504520|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504521|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
20504522|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504523|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504524|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20504525|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
20504526|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504527|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504528|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20504529|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20504530|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504531|NCT01681667|Ibuprofen|ibuprofen|mesh-list
20504532|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20504533|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20504534|NCT01681667|Analgesics|analgesics|mesh-ancestor
20504535|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
20504536|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504537|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504538|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20504539|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504540|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20504541|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504542|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504543|NCT01681680|Metformin|metformin|mesh-list
20504544|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504545|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504546|NCT01681693|Metformin|metformin|mesh-list
20504547|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504548|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504549|NCT01681875|Nicotine|nicotine|mesh-list
20504550|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20504551|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
20504552|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504553|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504554|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20504555|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20504556|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
20504557|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504558|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504559|NCT01681966|Ropivacaine|ropivacaine|mesh-list
20504560|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20504561|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
20504562|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
20504563|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504564|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504565|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
20504566|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504567|NCT01681979|Fluticasone|fluticasone|mesh-list
20504568|NCT01681979|Xhance|xhance|mesh-list
20504569|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20504570|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20504571|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20504572|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
20504573|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504574|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504575|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20504576|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
20504577|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
20504578|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20504579|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20504580|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20504581|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20504582|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
20504583|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504584|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504585|NCT01682109|Valacyclovir|valacyclovir|mesh-list
20504586|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
20504587|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504588|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20504589|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20504590|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20504591|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504592|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504593|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20504594|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20504595|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20504596|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
20504597|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504598|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504599|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20504600|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20504601|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
20504602|NCT01682187|Lomustine|lomustine|mesh-list
20504603|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20504604|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
20504605|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504606|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504607|NCT01682343|Calcium|calcium|mesh-list
20504608|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20504609|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504610|NCT01682408|Mannitol|mannitol|mesh-list
20504611|NCT01682408|Ranitidine|ranitidine|mesh-list
20504612|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20504613|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20504614|NCT01682408|Diuretics|diuretics|mesh-ancestor
20504615|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
20504616|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504617|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20504618|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504619|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20504620|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
20504621|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
20504622|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504623|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504624|NCT01682421|Dexamethasone|dexamethasone|mesh-list
20504625|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
20504626|NCT01682421|BB 1101|bb 1101|mesh-list
20504627|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504628|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504629|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20504630|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
20504631|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
20504632|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504633|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504634|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
20504635|NCT01682421|Hormones|hormones|mesh-ancestor
20504636|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504637|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20504638|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504639|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
20504640|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504641|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
20504642|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
20504643|NCT01682499|Calcium|calcium|mesh-list
20504644|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20504645|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504646|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20504647|NCT01682499|Analgesics|analgesics|mesh-ancestor
20504648|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
20504649|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415213|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415214|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20504650|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
20504651|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504652|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20504653|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
20504654|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20504655|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20504656|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504657|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
20504658|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20504659|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
20504660|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20504661|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20504662|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20504663|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504664|NCT01682577|Perindopril|perindopril|mesh-list
20504665|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20504666|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
20504667|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504668|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504669|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19701063|NCT04885777|Lidocaine|lidocaine|mesh-list
20504670|NCT01682616|Rituximab|rituximab|mesh-list
20504671|NCT01682616|Venetoclax|venetoclax|mesh-list
20504672|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504673|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504674|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
20504675|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504676|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504677|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
20504678|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20504679|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20504680|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504681|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
20504682|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504683|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701064|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
20504684|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20504685|NCT01682746|Trioxsalen|trioxsalen|mesh-list
20504686|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504687|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
20504688|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20504689|NCT01682772|Olaparib|olaparib|mesh-list
20504690|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20504691|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504692|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504693|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529274|NCT01780467|Protective Agents|protective agents|mesh-ancestor
20529275|NCT01780519|Lorazepam|lorazepam|mesh-list
20529276|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
20529277|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
20529278|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
20529279|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529280|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853463|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19853464|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19853465|NCT00732875|Methotrexate|methotrexate|mesh-list
19853466|NCT00732875|Infliximab|infliximab|mesh-list
19853467|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19701065|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
19701066|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701067|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701068|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
19701069|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701070|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19701071|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19701072|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19701073|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19701074|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701075|NCT04885660|Lisinopril|lisinopril|mesh-list
19853468|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
19853469|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20243907|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20243908|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529281|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701076|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19701077|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
19701078|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701079|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504694|NCT01682902|Insulin|insulin|mesh-list
20504695|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20504696|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
20504697|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
20504698|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20504699|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504700|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504701|NCT01683006|Rocuronium|rocuronium|mesh-list
20504702|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20504703|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20504704|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20504705|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504706|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504707|NCT01683032|Methylphenidate|methylphenidate|mesh-list
20504708|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19701080|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19701081|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19701082|NCT04885660|Protective Agents|protective agents|mesh-ancestor
19701083|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701084|NCT04885686|Formaldehyde|formaldehyde|mesh-list
19701085|NCT04885686|Thymol|thymol|mesh-list
19701086|NCT04885686|Dexamethasone|dexamethasone|mesh-list
20504709|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504710|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20504711|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20504712|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20504713|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504714|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
20504715|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248019|NCT00434174|Pemetrexed|pemetrexed|mesh-list
20504716|NCT01683149|Sorafenib|sorafenib|mesh-list
20504717|NCT01683149|Topotecan|topotecan|mesh-list
20504718|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
20504719|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504720|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20504721|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504722|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504723|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20504724|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20504725|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20504726|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20504727|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20504728|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20504729|NCT01683175|Cisplatin|cisplatin|mesh-list
20504730|NCT01683175|Vinorelbine|vinorelbine|mesh-list
20504731|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504732|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20504733|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248020|NCT00434174|Everolimus|everolimus|mesh-list
20248021|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248022|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248023|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248024|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20248025|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20248026|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248027|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
20248028|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248029|NCT00434239|Lenalidomide|lenalidomide|mesh-list
20248030|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
20248031|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248032|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20248033|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20248034|NCT00434239|Growth Substances|growth substances|mesh-ancestor
20248035|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
20504734|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504735|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20504736|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
20504737|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
20504738|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
20504739|NCT01683188|Vemurafenib|vemurafenib|mesh-list
20504740|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504741|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20504742|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504743|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504744|NCT01683253|Dopamine|dopamine|mesh-list
20504745|NCT01683253|Levodopa|levodopa|mesh-list
20504746|NCT01683253|Carbidopa|carbidopa|mesh-list
20504747|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
20504748|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20504749|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20504750|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
20504751|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504752|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504753|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504754|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20504755|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504756|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19701087|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
19701088|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701089|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
19701090|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
19701091|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701092|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701093|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504757|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
20504758|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
20504759|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504760|NCT01683253|Protective Agents|protective agents|mesh-ancestor
20504761|NCT01683292|Apomorphine|apomorphine|mesh-list
20504762|NCT01683292|Emetics|emetics|mesh-ancestor
20504763|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504764|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
20504765|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504766|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504767|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
20504768|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
19701094|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
19701095|NCT04885686|Hormones|hormones|mesh-ancestor
19701096|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701097|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20243909|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20504769|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701098|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415215|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701099|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
19701100|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415216|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19415217|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19415218|NCT03011450|Fenofibrate|fenofibrate|mesh-list
19415219|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19415220|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
19415221|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415222|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19415223|NCT03009019|Celecoxib|celecoxib|mesh-list
19415224|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19701101|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20504770|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504771|NCT01683552|Fexofenadine|fexofenadine|mesh-list
20504772|NCT01683552|Prednisone|prednisone|mesh-list
20504773|NCT01683552|Aprepitant|aprepitant|mesh-list
20504774|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20504775|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
20504776|NCT01683552|Hormones|hormones|mesh-ancestor
20504777|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504778|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504779|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20504780|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504781|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
19701102|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
19701103|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
19701104|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
19415225|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415226|NCT03009019|Analgesics|analgesics|mesh-ancestor
19415227|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
19701105|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504782|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
20504783|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504784|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504785|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20504786|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504787|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504788|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20504789|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20504790|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20504791|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
20504792|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
20504793|NCT01683656|Niacin|niacin|mesh-list
20504794|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20504795|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
20504796|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504797|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20504798|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
19415228|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504799|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
20504800|NCT01683656|Vitamins|vitamins|mesh-ancestor
20504801|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
20504802|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504803|NCT01683682|Carboplatin|carboplatin|mesh-list
20504804|NCT01683682|Vinorelbine|vinorelbine|mesh-list
20504805|NCT01683682|Nintedanib|nintedanib|mesh-list
20504806|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504807|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20504808|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
20504809|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
20504810|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
19415229|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701106|NCT04885751|Rebamipide|rebamipide|mesh-list
19701107|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19701108|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701109|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
19701110|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701111|NCT04885751|Protective Agents|protective agents|mesh-ancestor
19701112|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701113|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701114|NCT04885803|Vitamin D|vitamin d|mesh-list
19701115|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
19701116|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
19701117|NCT04885803|Vitamins|vitamins|mesh-list
19701118|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
19701119|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504811|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504812|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20504813|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504814|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
20504815|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20504816|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20504817|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504818|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
20504819|NCT01683747|Coagulants|coagulants|mesh-ancestor
20504820|NCT01683760|Fluconazole|fluconazole|mesh-list
19701120|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20504821|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
20504822|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504823|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20504824|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20504825|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504826|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504827|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20504828|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
20504829|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20504830|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504831|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20504832|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20504833|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20504834|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
20504835|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504836|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
20504837|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20504838|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20504839|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504840|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
20504841|NCT01683955|Coagulants|coagulants|mesh-ancestor
20504842|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
20504843|NCT01684059|Astringents|astringents|mesh-ancestor
20504844|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504845|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
20504846|NCT01684072|Vaccines|vaccines|mesh-list
20504847|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
20504848|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504849|NCT01684085|Lorazepam|lorazepam|mesh-list
20504850|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
20504851|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
20504852|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
20504853|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504854|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504855|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504856|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20504857|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504858|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20504859|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20504860|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20504861|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
20504862|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
20504863|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504864|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504865|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
20504866|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20504867|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504868|NCT01684111|Vinorelbine|vinorelbine|mesh-list
20504869|NCT01684111|Nintedanib|nintedanib|mesh-list
20504870|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20504871|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504872|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
20504873|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
20504874|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
20504875|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504876|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20504877|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504878|NCT01684241|Vaccines|vaccines|mesh-list
20504879|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
20504880|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504881|NCT01684306|Modafinil|modafinil|mesh-list
20504882|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20504883|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504884|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20504885|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20504886|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20504887|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504888|NCT01684319|Caseins|caseins|mesh-list
20504889|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
20504890|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
20504891|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504892|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
19853470|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504893|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20504894|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20504895|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504896|NCT01684449|Gemcitabine|gemcitabine|mesh-list
20504897|NCT01684449|Sirolimus|sirolimus|mesh-list
20504898|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20504899|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
20504900|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504901|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504902|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
20504903|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504904|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504905|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504906|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
20504907|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504908|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20504909|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20504910|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
20504911|NCT01684657|Asenapine|asenapine|mesh-list
20504912|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20504913|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20504914|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504915|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504916|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20529282|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20529283|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529284|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20529285|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20529286|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20529287|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
20529288|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
20529289|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529290|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529291|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20529292|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20529293|NCT01780558|Hormones|hormones|mesh-list
20529294|NCT01780558|Estradiol|estradiol|mesh-list
20529295|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20529296|NCT01780558|Progesterone|progesterone|mesh-list
20504917|NCT01684683|Theophylline|theophylline|mesh-list
20504918|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20504919|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
20504920|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504921|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504922|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20504923|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
20504924|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20504925|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20504926|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504927|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
20504928|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20504929|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20504930|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
20504931|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504932|NCT01684774|Bupivacaine|bupivacaine|mesh-list
20504933|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
20504934|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
20504935|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504936|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504937|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
20504938|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20504939|NCT01684787|Ribavirin|ribavirin|mesh-list
20504940|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20504941|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
20504942|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
20504943|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504944|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
20504945|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504946|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
20504947|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504948|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20504949|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
20504950|NCT01684800|Coagulants|coagulants|mesh-ancestor
20504951|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20504952|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
20504953|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504954|NCT01684813|Clopidogrel|clopidogrel|mesh-list
20504955|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19701121|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19701122|NCT04885270|Cisplatin|cisplatin|mesh-list
20504956|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20504957|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20504958|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20504959|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19701123|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504960|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
20504961|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504962|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504963|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504964|NCT01684865|Rituximab|rituximab|mesh-list
20504965|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20504966|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504967|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
20504968|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504969|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20504970|NCT01684969|Haloperidol|haloperidol|mesh-list
20504971|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
20504972|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
20504973|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
20504974|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701124|NCT04885426|Metformin|metformin|mesh-list
19701125|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20504975|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701126|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504976|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20504977|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20504978|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20504979|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20504980|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20504981|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20504982|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
20504983|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20504984|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504985|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20504986|NCT01684982|Sirolimus|sirolimus|mesh-list
20504987|NCT01684982|Everolimus|everolimus|mesh-list
20504988|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20504989|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20504990|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
20504991|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20504992|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701127|NCT04885413|Niraparib|niraparib|mesh-list
19701128|NCT04885413|Antibodies|antibodies|mesh-list
19701129|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
19701130|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701131|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19701132|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701133|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701134|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701135|NCT04885153|Fenofibrate|fenofibrate|mesh-list
19701136|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19701137|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
19701138|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20504993|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20504994|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20504995|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
20504996|NCT01684995|Nicotine|nicotine|mesh-list
20504997|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20504998|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
19701139|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20504999|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505000|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505001|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20505002|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20505003|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
20505004|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505005|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505006|NCT01685125|Prednisone|prednisone|mesh-list
20505007|NCT01685125|Dasatinib|dasatinib|mesh-list
20505008|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
20505009|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505010|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
20505011|NCT01685125|Hormones|hormones|mesh-ancestor
20505012|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505013|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505014|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20505015|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505016|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19701140|NCT04884997|Temozolomide|temozolomide|mesh-list
19701141|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19701142|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
20505017|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505018|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505019|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20505020|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
20505021|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20505022|NCT01685281|Metadoxine|metadoxine|mesh-list
20505023|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20505024|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
20505025|NCT01685333|Hematinics|hematinics|mesh-ancestor
20505026|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
20505027|NCT01685359|Hematinics|hematinics|mesh-ancestor
20505028|NCT01685398|Timolol|timolol|mesh-list
20505029|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20505030|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20505031|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20505032|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20505033|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
20505034|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505035|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505036|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505037|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20505038|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20505039|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
20505040|NCT01685489|Docetaxel|docetaxel|mesh-list
20505041|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505042|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
20505043|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
20505044|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
20505045|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505046|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20505047|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
20505048|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415230|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415231|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415232|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19415233|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20505049|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20505050|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
20505051|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505052|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
20505053|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20505054|NCT01685489|Protective Agents|protective agents|mesh-ancestor
20505055|NCT01685502|Acarbose|acarbose|mesh-list
20505056|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20505057|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505058|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505059|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20505060|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505061|NCT01685515|Decitabine|decitabine|mesh-list
20505062|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
20505063|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20505064|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
20505065|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505066|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505067|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505068|NCT01685658|Acetaminophen|acetaminophen|mesh-list
20505069|NCT01685658|Ketoprofen|ketoprofen|mesh-list
20505070|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20505071|NCT01685658|Analgesics|analgesics|mesh-ancestor
20505072|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
20505073|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505074|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505075|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
20505076|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20505077|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505078|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20505079|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20505080|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505081|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505082|NCT01685762|Metformin|metformin|mesh-list
20505083|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20505084|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505085|NCT01685827|Eflornithine|eflornithine|mesh-list
20505086|NCT01685827|Nifurtimox|nifurtimox|mesh-list
20505087|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505088|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20505089|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20505090|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20505091|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505092|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20505093|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505094|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505095|NCT01685853|Bisacodyl|bisacodyl|mesh-list
20505096|NCT01685853|Cathartics|cathartics|mesh-ancestor
20505097|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505098|NCT01685853|Laxatives|laxatives|mesh-ancestor
20505099|NCT01685892|Venetoclax|venetoclax|mesh-list
20505100|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
20505101|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505102|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20505103|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20505104|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20505105|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20505106|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505107|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505108|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20505109|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20505110|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20505111|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
20505112|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505113|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505114|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20505115|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20505116|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
20505117|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
20505118|NCT01685970|Cathartics|cathartics|mesh-ancestor
20505119|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505120|NCT01686009|Ketamine|ketamine|mesh-list
20505121|NCT01686009|Analgesics|analgesics|mesh-ancestor
20505122|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
20505123|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505124|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505125|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19701143|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701144|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505126|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20505127|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
20505128|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
20505129|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505130|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20505131|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20505132|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505133|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505134|NCT01686126|Metformin|metformin|mesh-list
20505135|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
20505136|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20505137|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505138|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20505139|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
20505140|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20505141|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20505142|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20505143|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20505144|NCT01686217|Niacinamide|niacinamide|mesh-list
20505145|NCT01686217|Peficitinib|peficitinib|mesh-list
20505146|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505147|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505148|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20505149|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
20505150|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505151|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
19701145|NCT04884906|Paclitaxel|paclitaxel|mesh-list
20505152|NCT01686217|Vitamins|vitamins|mesh-ancestor
20505153|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
19415234|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701146|NCT04884906|Cisplatin|cisplatin|mesh-list
19701147|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19701148|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701149|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701150|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
19701151|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
19708035|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
20505154|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
20505155|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20505156|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505157|NCT01686321|Rituximab|rituximab|mesh-list
20505158|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20505159|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20505160|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505161|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
20505162|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505163|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20505164|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20505165|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
20505166|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505167|NCT01686347|Ropivacaine|ropivacaine|mesh-list
20505168|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
20505169|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
20505170|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505171|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505172|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
20505173|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505174|NCT01686386|Dexamethasone|dexamethasone|mesh-list
20505175|NCT01686386|Lenalidomide|lenalidomide|mesh-list
20505176|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20505177|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505178|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
20505179|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
20505180|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505181|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505182|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505183|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
20505184|NCT01686386|Hormones|hormones|mesh-ancestor
20505185|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505186|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20505187|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505188|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
20505189|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20505190|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20505191|NCT01686386|Growth Substances|growth substances|mesh-ancestor
20505192|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
20505193|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20505194|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
20505195|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505196|NCT01686464|Valacyclovir|valacyclovir|mesh-list
20505197|NCT01686464|Prednisone|prednisone|mesh-list
20505198|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505199|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
20505200|NCT01686464|Hormones|hormones|mesh-ancestor
20505201|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505202|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505203|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20505204|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505205|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
20505206|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505207|NCT01686529|Bevacizumab|bevacizumab|mesh-list
20505208|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20505209|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505210|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20505211|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20505212|NCT01686529|Growth Substances|growth substances|mesh-ancestor
20505213|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505214|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
20529297|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529298|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529299|NCT01780558|Estrogens|estrogens|mesh-ancestor
20529300|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20505215|NCT01686555|Venetoclax|venetoclax|mesh-list
20505216|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243910|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
20243911|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243912|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
20243913|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243914|NCT00418080|Bicalutamide|bicalutamide|mesh-list
20243915|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
20243916|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
20505217|NCT01686594|Methoxsalen|methoxsalen|mesh-list
20505218|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20505219|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
20505220|NCT01686607|Itraconazole|itraconazole|mesh-list
20505221|NCT01686607|Fluconazole|fluconazole|mesh-list
20505222|NCT01686607|Voriconazole|voriconazole|mesh-list
20505223|NCT01686607|Amphotericin B|amphotericin b|mesh-list
20505224|NCT01686607|Caspofungin|caspofungin|mesh-list
20505225|NCT01686607|Micafungin|micafungin|mesh-list
20505226|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
20505227|NCT01686607|Clotrimazole|clotrimazole|mesh-list
20505228|NCT01686607|Miconazole|miconazole|mesh-list
20505229|NCT01686607|Anidulafungin|anidulafungin|mesh-list
20505230|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505231|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20505232|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20505233|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505234|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505235|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20505236|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
20505237|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505238|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243917|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243918|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243919|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243920|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
20243921|NCT00418119|Hematinics|hematinics|mesh-ancestor
20505239|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20505240|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20505241|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20505242|NCT01686607|Amebicides|amebicides|mesh-ancestor
20505243|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20505244|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20505245|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505246|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19701152|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701153|NCT04885075|Midazolam|midazolam|mesh-list
19701154|NCT04885075|Diazepam|diazepam|mesh-list
20505247|NCT01686711|Pioglitazone|pioglitazone|mesh-list
20505248|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701155|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20243922|NCT00418132|Thalidomide|thalidomide|mesh-list
20505249|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505250|NCT01686789|Interferons|interferons|mesh-list
20505251|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
20505252|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
19701156|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19701157|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505253|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20505254|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505255|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
20505256|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505257|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
20505258|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505259|NCT01686802|Ibuprofen|ibuprofen|mesh-list
20505260|NCT01686802|Morphine|morphine|mesh-list
20505261|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20505262|NCT01686802|Narcotics|narcotics|mesh-ancestor
20505263|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505264|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505265|NCT01686802|Analgesics|analgesics|mesh-ancestor
20505266|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
20505267|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505268|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20505269|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20505270|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505271|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20505272|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19701158|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505273|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529301|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
20505274|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505275|NCT01687049|Red yeast rice|red yeast rice|mesh-list
20505276|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20505277|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20505278|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20505279|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
20505280|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505281|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505282|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20505283|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
20505284|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20505285|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
20505286|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
20505287|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505288|NCT01687127|Folic Acid|folic acid|mesh-list
20505289|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
20505290|NCT01687127|Calcium|calcium|mesh-list
20505291|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20505292|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505293|NCT01687127|Hematinics|hematinics|mesh-ancestor
20505294|NCT01687127|Vitamins|vitamins|mesh-ancestor
20505295|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
20505296|NCT01687140|Cycloserine|cycloserine|mesh-list
20505297|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20505298|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505299|NCT01687140|Renal Agents|renal agents|mesh-ancestor
20505300|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20505301|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
20505302|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505303|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
20505304|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505305|NCT01687205|Tenofovir|tenofovir|mesh-list
20505306|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
20505307|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505308|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20505309|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20505310|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505311|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505312|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20505313|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20505314|NCT01687348|Lidocaine|lidocaine|mesh-list
20505315|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
20505316|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
20505317|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505318|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505319|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
20505320|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505321|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20505322|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20505323|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20505324|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20505325|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505326|NCT01687374|Hormones|hormones|mesh-list
20505327|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
20505328|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505329|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505330|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20505331|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20505332|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20505333|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20505334|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20505335|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20505336|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
20505337|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505338|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505339|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505340|NCT01687439|Vinorelbine|vinorelbine|mesh-list
20505341|NCT01687439|Endostar protein|endostar protein|mesh-list
20505342|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415235|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505343|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20505344|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
20505345|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
20505346|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
20505347|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505348|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20505349|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20505350|NCT01687439|Growth Substances|growth substances|mesh-ancestor
20505351|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505352|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
20505353|NCT01687491|Enoxaparin|enoxaparin|mesh-list
20505354|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
20505355|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20505356|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20505357|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505358|NCT01687517|Vaccines|vaccines|mesh-list
20505359|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
20505360|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505361|NCT01687582|Liraglutide|liraglutide|mesh-list
20505362|NCT01687582|Exenatide|exenatide|mesh-list
20505363|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20505364|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505365|NCT01687582|Incretins|incretins|mesh-ancestor
20505366|NCT01687582|Hormones|hormones|mesh-ancestor
20505367|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505368|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20505369|NCT01687699|Spironolactone|spironolactone|mesh-list
20505370|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20505371|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
20505372|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505373|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415236|NCT03006276|Celecoxib|celecoxib|mesh-list
19701159|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20505374|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20505375|NCT01687699|Diuretics|diuretics|mesh-ancestor
20505376|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
20505377|NCT01687751|Midazolam|midazolam|mesh-list
20505378|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
20505379|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20505380|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505381|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505382|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20505383|NCT01687751|Analgesics|analgesics|mesh-ancestor
20505384|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
20505385|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505386|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20505387|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20505388|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20505389|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
20505390|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505391|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505392|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20505393|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20505394|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20505395|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20505396|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20505397|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
20505398|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
20505399|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
20505400|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
20505401|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
20505402|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20505403|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505404|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505405|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20505406|NCT01687868|Analgesics|analgesics|mesh-ancestor
20505407|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
20505408|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505409|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20505410|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20505411|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20505412|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
20505413|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505414|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505415|NCT01687894|Vasopressins|vasopressins|mesh-list
20505416|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
20505417|NCT01687894|Propofol|propofol|mesh-list
20505418|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
20505419|NCT01687894|Sevoflurane|sevoflurane|mesh-list
20505420|NCT01687894|Anesthetics|anesthetics|mesh-list
20505421|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
20505422|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20505423|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505424|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505425|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20505426|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20505427|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
20505428|NCT01687894|Coagulants|coagulants|mesh-ancestor
20505429|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20505430|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20505431|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
20505432|NCT01688024|Mitomycins|mitomycins|mesh-list
20505433|NCT01688024|Mitomycin|mitomycin|mesh-list
20505434|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20505435|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505436|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
20505437|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505438|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20505439|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505440|NCT01688089|Levodopa|levodopa|mesh-list
20505441|NCT01688089|Carbidopa|carbidopa|mesh-list
20505442|NCT01688089|Entacapone|entacapone|mesh-list
20505443|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20505444|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20505445|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
20505446|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505447|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505448|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505449|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20505450|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505451|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20505452|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
20505453|NCT01688154|Procyanidin|procyanidin|mesh-list
20505454|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
20505455|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505456|NCT01688154|Protective Agents|protective agents|mesh-ancestor
20505457|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505458|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20505459|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20505460|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505461|NCT01688206|Atezolizumab|atezolizumab|mesh-list
20505462|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505463|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
20505464|NCT01688349|Hormones|hormones|mesh-ancestor
20505465|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505466|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505467|NCT01688362|Dexamethasone|dexamethasone|mesh-list
20505468|NCT01688362|Bupivacaine|bupivacaine|mesh-list
20505469|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505470|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
20505471|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
20505472|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505473|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505474|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505475|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
20505476|NCT01688362|Hormones|hormones|mesh-ancestor
20505477|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505478|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20505479|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505480|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
20505481|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
20505482|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505483|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
20505484|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20505485|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20505486|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505487|NCT01688401|Melphalan|melphalan|mesh-list
20505488|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20505489|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
20505490|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505491|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505492|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20505493|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20505494|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
20505495|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529302|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20529303|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20529304|NCT01780558|Progestins|progestins|mesh-ancestor
20529305|NCT01780610|Letrozole|letrozole|mesh-list
20529306|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20529307|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20529308|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20529309|NCT01780610|Hormones|hormones|mesh-list
20529310|NCT01780610|Estradiol|estradiol|mesh-list
20529311|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20529312|NCT01780610|Progesterone|progesterone|mesh-list
20529313|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529314|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529315|NCT01780610|Estrogens|estrogens|mesh-ancestor
20529316|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20505496|NCT01688492|Ipilimumab|ipilimumab|mesh-list
20505497|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20505498|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505499|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20505500|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505501|NCT01688518|Lidocaine|lidocaine|mesh-list
20505502|NCT01688518|Tetracaine|tetracaine|mesh-list
20505503|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
20505504|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
20505505|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505506|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505507|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
20505508|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505509|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20505510|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20505511|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20505512|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20505513|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505514|NCT01688544|Benzimidazole|benzimidazole|mesh-list
20505515|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
20505516|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20505517|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505518|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
19415237|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20505519|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20505520|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20505521|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20505522|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20505523|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505524|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505525|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505526|NCT01688570|Analgesics|analgesics|mesh-ancestor
20505527|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
20505528|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505529|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
20505530|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20505531|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
20505532|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
20505533|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
20505534|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505535|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20505536|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
20505537|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
20505538|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20505539|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
20505540|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20505541|NCT01688583|Fentanyl|fentanyl|mesh-list
20505542|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20505543|NCT01688583|Narcotics|narcotics|mesh-ancestor
20505544|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505545|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505546|NCT01688583|Analgesics|analgesics|mesh-ancestor
20505547|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
20505548|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505549|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20505550|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20505551|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
20505552|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
20505553|NCT01688648|Lidocaine|lidocaine|mesh-list
20505554|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
20505555|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
20505556|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
20505557|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505558|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505559|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
19415238|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415239|NCT03006276|Analgesics|analgesics|mesh-ancestor
20505560|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505561|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20505562|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20505563|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20505564|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20505565|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415240|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
19415241|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415242|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415243|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701160|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19701161|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20505566|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20505567|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20505568|NCT01688648|Analgesics|analgesics|mesh-ancestor
20505569|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20505570|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20505571|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20505572|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
20505573|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505574|NCT01688700|Paclitaxel|paclitaxel|mesh-list
20505575|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
20505576|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20505577|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505578|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
20505579|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
20505580|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701162|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19415244|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415245|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19701163|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
19701164|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
20505581|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505582|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20505583|NCT01688791|Paclitaxel|paclitaxel|mesh-list
20505584|NCT01688791|Carboplatin|carboplatin|mesh-list
20505585|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20505586|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505587|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
20505588|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
20505589|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
20505590|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505591|NCT01688934|Naproxen|naproxen|mesh-list
20505592|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20505593|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20505594|NCT01688934|Analgesics|analgesics|mesh-ancestor
19415246|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19415247|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505595|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
20505596|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505597|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505598|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505599|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415248|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415249|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
20505600|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
20505601|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20505602|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505603|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505604|NCT01688947|Pregabalin|pregabalin|mesh-list
20505605|NCT01688947|Analgesics|analgesics|mesh-ancestor
20505606|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
20505607|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505608|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505609|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
20505610|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20505611|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20529317|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
20505612|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505613|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20505614|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20505615|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20505616|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505617|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20505618|NCT01688960|Aflibercept|aflibercept|mesh-list
20505619|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20505620|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20505621|NCT01688960|Growth Substances|growth substances|mesh-ancestor
20505622|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505623|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
20243923|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20243924|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
20243925|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243926|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
20243927|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20243928|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243929|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20505624|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505625|NCT01689051|Glucagon|glucagon|mesh-list
20505626|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20505627|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505628|NCT01689051|Hormones|hormones|mesh-ancestor
20505629|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505630|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505631|NCT01689051|Incretins|incretins|mesh-ancestor
20243930|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20243931|NCT00418132|Growth Substances|growth substances|mesh-ancestor
20505632|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
20505633|NCT01689090|Citric Acid|citric acid|mesh-list
20505634|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
20505635|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20505636|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
20505637|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20505638|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
20505639|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
20505640|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505641|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20505642|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20505643|NCT01689090|Analgesics|analgesics|mesh-ancestor
20505644|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
20505645|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505646|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505647|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505648|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20505649|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505650|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
20505651|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20505652|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505653|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505654|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20505655|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20505656|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505657|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505658|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505659|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20505660|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
20505661|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20505662|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505663|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20505664|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20505665|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20505666|NCT01689129|Insulin|insulin|mesh-list
20505667|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20505668|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
20505669|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20505670|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505671|NCT01689142|Insulin|insulin|mesh-list
20505672|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20505673|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
20505674|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20505675|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505676|NCT01689194|Cisplatin|cisplatin|mesh-list
20505677|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505678|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
20505679|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20505680|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853471|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19853472|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
19853473|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853474|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243932|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
20505681|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20505682|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20505683|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505684|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20505685|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505686|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20505687|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505688|NCT01689285|Valacyclovir|valacyclovir|mesh-list
20505689|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
20505690|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505691|NCT01689298|Oxytocin|oxytocin|mesh-list
20505692|NCT01689298|Carbetocin|carbetocin|mesh-list
20505693|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
19415250|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19415251|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19415252|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19415253|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415254|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415255|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
19415256|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243933|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243934|NCT00418171|Olanzapine|olanzapine|mesh-list
20243935|NCT00418171|Ziprasidone|ziprasidone|mesh-list
20243936|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
20243937|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
20243938|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505694|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20505695|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701165|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
19701166|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
19701167|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701168|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505696|NCT01689311|Alprostadil|alprostadil|mesh-list
20505697|NCT01689311|Misoprostol|misoprostol|mesh-list
20505698|NCT01689311|Oxytocin|oxytocin|mesh-list
20505699|NCT01689311|Ergonovine|ergonovine|mesh-list
20505700|NCT01689311|Dinoprost|dinoprost|mesh-list
20505701|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
20505702|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
20505703|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20505704|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505705|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20505706|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
20505707|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20505708|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505709|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20505710|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
20505711|NCT01689311|Urological Agents|urological agents|mesh-ancestor
20505712|NCT01689558|Endostatins|endostatins|mesh-list
20505713|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505714|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20505715|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20505716|NCT01689558|Growth Substances|growth substances|mesh-ancestor
20505717|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505718|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
20505719|NCT01689597|Morphine|morphine|mesh-list
19701169|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
20505720|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20505721|NCT01689597|Narcotics|narcotics|mesh-ancestor
20505722|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505723|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505724|NCT01689597|Analgesics|analgesics|mesh-ancestor
20505725|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
20505726|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505727|NCT01689623|Simeprevir|simeprevir|mesh-list
20505728|NCT01689623|Atorvastatin|atorvastatin|mesh-list
20505729|NCT01689623|Simvastatin|simvastatin|mesh-list
20505730|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20505731|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20505732|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
20505733|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505734|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20505735|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20505736|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505737|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
20505738|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505739|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
20505740|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
20505741|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20505742|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505743|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
20505744|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20505745|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505746|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
20505747|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20505748|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505749|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
20505750|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19415257|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701170|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
19701171|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
20505751|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505752|NCT01689753|Citric Acid|citric acid|mesh-list
20505753|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
20505754|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
20505755|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20505756|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
20505757|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
20505758|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505759|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
20505760|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20505761|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505762|NCT01689870|Ipilimumab|ipilimumab|mesh-list
20505763|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20505764|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505765|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20505766|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505767|NCT01689896|Testosterone|testosterone|mesh-list
20505768|NCT01689896|Androgens|androgens|mesh-ancestor
20505769|NCT01689896|Hormones|hormones|mesh-ancestor
20505770|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505771|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505772|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20505773|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20505774|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
20505775|NCT01689987|Sirolimus|sirolimus|mesh-list
20505776|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
20505777|NCT01689987|Dexamethasone|dexamethasone|mesh-list
20505778|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
20505779|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
20505780|NCT01689987|Ichthammol|ichthammol|mesh-list
20505781|NCT01689987|BB 1101|bb 1101|mesh-list
20505782|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20505783|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
20505784|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505785|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20505786|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20505787|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
20505788|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505789|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505790|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20505791|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505792|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
20505793|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
20505794|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505795|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20505796|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
20505797|NCT01689987|Hormones|hormones|mesh-ancestor
20505798|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505799|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20505800|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505801|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415258|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19415259|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505802|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20505803|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
20505804|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
20505805|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20505806|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20505807|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505808|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
20505809|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
20505810|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
20505811|NCT01690039|Furosemide|furosemide|mesh-list
20505812|NCT01690039|Diuretics|diuretics|mesh-ancestor
20505813|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
20505814|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505815|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20505816|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20505817|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505818|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20505819|NCT01690091|Metformin|metformin|mesh-list
20505820|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20505821|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505822|NCT01690104|Rifampin|rifampin|mesh-list
20505823|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20505824|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
20505825|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505826|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505827|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
20505828|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20505829|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505830|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505831|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20505832|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20505833|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20505834|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20505835|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20505836|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20505837|NCT01690221|Diltiazem|diltiazem|mesh-list
20505838|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20505839|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20505840|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20505841|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505842|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20505843|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505844|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
20529318|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20529319|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20529320|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529321|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20529322|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20529323|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529324|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415260|NCT03001817|Fenofibrate|fenofibrate|mesh-list
19415261|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19415262|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
19415263|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415264|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19415265|NCT02999984|Busulfan|busulfan|mesh-list
19415266|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
19415267|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415268|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415269|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
19415270|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415271|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19415272|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415273|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19415274|NCT02997657|Nicotine|nicotine|mesh-list
20529325|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20529326|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
20529327|NCT01780610|Progestins|progestins|mesh-ancestor
20529328|NCT01780740|Atorvastatin|atorvastatin|mesh-list
20529329|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20529330|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20529331|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
20529332|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529333|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19415275|NCT02997657|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19701172|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701173|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701174|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19701175|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20505845|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20505846|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
20505847|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505848|NCT01690286|Ketoconazole|ketoconazole|mesh-list
20505849|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
20505850|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505851|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20505852|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20505853|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505854|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505855|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20505856|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
20505857|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20505858|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505859|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20505860|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
20505861|NCT01690325|Bevacizumab|bevacizumab|mesh-list
20505862|NCT01690325|Docetaxel|docetaxel|mesh-list
20505863|NCT01690325|Trastuzumab|trastuzumab|mesh-list
20505864|NCT01690325|Epirubicin|epirubicin|mesh-list
20505865|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20505866|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
20505867|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505868|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20505869|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20505870|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
20505871|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505872|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505873|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20505874|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20505875|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20505876|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19415276|NCT02997657|Autonomic Agents|autonomic agents|mesh-ancestor
19701176|NCT04884919|Chitosan|chitosan|mesh-list
19701177|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19701178|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19701179|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
19701180|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701181|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19701182|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
19701183|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
19701184|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
19701185|NCT04884919|Coagulants|coagulants|mesh-ancestor
19701186|NCT04885049|Racecadotril|racecadotril|mesh-list
19701187|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
19701188|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701189|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
19701190|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505877|NCT01690325|Growth Substances|growth substances|mesh-ancestor
19415277|NCT02997657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415278|NCT02997657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415279|NCT02997657|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20505878|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
20505879|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
20505880|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
20505881|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
20505882|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20505883|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20505884|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20505885|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505886|NCT01690338|Bromides|bromides|mesh-list
19701191|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701192|NCT04884802|Phenylephrine|phenylephrine|mesh-list
20505887|NCT01690338|Rocuronium|rocuronium|mesh-list
20505888|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
20505889|NCT01690338|Cisatracurium|cisatracurium|mesh-list
20505890|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
20505891|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20505892|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20505893|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20505894|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505895|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505896|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20505897|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20505898|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
20505899|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505900|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505901|NCT01690364|Anesthetics|anesthetics|mesh-list
20505902|NCT01690364|Cisatracurium|cisatracurium|mesh-list
20505903|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
20505904|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20505905|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505906|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20505907|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20505908|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20505909|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20505910|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20505911|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20505912|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
20505913|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20505914|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505915|NCT01690403|Rifapentine|rifapentine|mesh-list
20505916|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20505917|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
20505918|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505919|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505920|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
20505921|NCT01690468|Carboplatin|carboplatin|mesh-list
20505922|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505923|NCT01690507|Cytarabine|cytarabine|mesh-list
20505924|NCT01690507|Decitabine|decitabine|mesh-list
20505925|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
20505926|NCT01690507|Sargramostim|sargramostim|mesh-list
20505927|NCT01690507|Lenograstim|lenograstim|mesh-list
20505928|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20505929|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
20505930|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505931|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505932|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
20505933|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505934|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20505935|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
20505936|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505937|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505938|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20505939|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20505940|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
20505941|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20505942|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505943|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505944|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20505945|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20505946|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505947|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505948|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505949|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20505950|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
20505951|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20505952|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505953|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20505954|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20505955|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20505956|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
20505957|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20505958|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505959|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20505960|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20505961|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505962|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505963|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505964|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20505965|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20505966|NCT01690572|Paclitaxel|paclitaxel|mesh-list
20505967|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
20505968|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20505969|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505970|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
20505971|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
20505972|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
20505973|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505974|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20505975|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
20505976|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20505977|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
20505978|NCT01690572|Protective Agents|protective agents|mesh-ancestor
20505979|NCT01690598|Topotecan|topotecan|mesh-list
20505980|NCT01690598|Veliparib|veliparib|mesh-list
20505981|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20505982|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20505983|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505984|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505985|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505986|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20505987|NCT01690637|Oseltamivir|oseltamivir|mesh-list
20505988|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
20505989|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20505990|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20505991|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20505992|NCT01690702|Paclitaxel|paclitaxel|mesh-list
20505993|NCT01690702|Docetaxel|docetaxel|mesh-list
20505994|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
20505995|NCT01690702|Epirubicin|epirubicin|mesh-list
20505996|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20505997|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20505998|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
20505999|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
20506000|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
20506001|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506002|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701193|NCT04884802|Norepinephrine|norepinephrine|mesh-list
19701194|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19701195|NCT04884802|Propofol|propofol|mesh-list
19701196|NCT04884802|Etomidate|etomidate|mesh-list
19701197|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19701198|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506003|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
20506004|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506005|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506006|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20506007|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
20506008|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20506009|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20506010|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20506011|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20506012|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506013|NCT01690767|Lidocaine|lidocaine|mesh-list
20506014|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
20506015|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
20506016|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506017|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506018|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
20506019|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506020|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20506021|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20506022|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20506023|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506024|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506025|NCT01690780|Ibuprofen|ibuprofen|mesh-list
20506026|NCT01690780|Morphine|morphine|mesh-list
20506027|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20506028|NCT01690780|Narcotics|narcotics|mesh-ancestor
19415280|NCT02997657|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20506029|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506030|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506031|NCT01690780|Analgesics|analgesics|mesh-ancestor
20506032|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
20506033|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506034|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20506035|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506036|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506037|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506038|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20506039|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506040|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506041|NCT01690832|Fenoldopam|fenoldopam|mesh-list
20506042|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20506043|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
20243939|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243940|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506044|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
20506045|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
20506046|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506047|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506048|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506049|NCT01690871|Dactolisib|dactolisib|mesh-list
20506050|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506051|NCT01690884|Adenosine|adenosine|mesh-list
20506052|NCT01690884|Analgesics|analgesics|mesh-ancestor
20506053|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
20506054|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506055|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506056|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20506057|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
20506058|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20506059|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
20506060|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
20506061|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506062|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506063|NCT01690962|Vitamins|vitamins|mesh-list
20506064|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
20506065|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
20506066|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
20506067|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
20506068|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506069|NCT01690962|Hematinics|hematinics|mesh-ancestor
20506070|NCT01690975|Benzonatate|benzonatate|mesh-list
20506071|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
20506072|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
20506073|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
20506074|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20506075|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506076|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506077|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506078|NCT01691001|Analgesics|analgesics|mesh-ancestor
20506079|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
20506080|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506081|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20506082|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20506083|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20506084|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506085|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506086|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506087|NCT01691053|Spironolactone|spironolactone|mesh-list
20506088|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20506089|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
20506090|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506091|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506092|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20506093|NCT01691053|Diuretics|diuretics|mesh-ancestor
20506094|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
20506095|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
20506096|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
20506097|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506098|NCT01691365|Vitamins|vitamins|mesh-list
20506099|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
20506100|NCT01691365|Antioxidants|antioxidants|mesh-list
20506101|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
20506102|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506103|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506104|NCT01691365|Protective Agents|protective agents|mesh-ancestor
20506105|NCT01691404|Quercetin|quercetin|mesh-list
20506106|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
20506107|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506108|NCT01691404|Protective Agents|protective agents|mesh-ancestor
20506109|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506110|NCT01691456|Montelukast|montelukast|mesh-list
20506111|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20506112|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
20506113|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20506114|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
20506115|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506116|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506117|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20506118|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20506119|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506120|NCT01691469|Montelukast|montelukast|mesh-list
20506121|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20506122|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
20506123|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20506124|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
20506125|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506126|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506127|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20506128|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20506129|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506130|NCT01691495|PENTA|penta|mesh-list
20506131|NCT01691495|Fondaparinux|fondaparinux|mesh-list
20506132|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20506133|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
20506134|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20506135|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
20506136|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506137|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506138|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
20506139|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20506140|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20506141|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
20506142|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20506143|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20506144|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20506145|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506146|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506147|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
20506148|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506149|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506150|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20506151|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506152|NCT01691677|Beclomethasone|beclomethasone|mesh-list
20506153|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506154|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
20506155|NCT01691677|Hormones|hormones|mesh-ancestor
20506156|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506157|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506158|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20506159|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
20506160|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20506161|NCT01691742|Laxatives|laxatives|mesh-list
20506162|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506163|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20506164|NCT01691807|Ofatumumab|ofatumumab|mesh-list
20506165|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20506166|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
20506167|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506168|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506169|NCT01691872|Ezogabine|ezogabine|mesh-list
20506170|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
19415281|NCT02997657|Cholinergic Agents|cholinergic agents|mesh-ancestor
19415282|NCT02997657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415283|NCT02997657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415284|NCT02997501|Osimertinib|osimertinib|mesh-list
19415285|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415286|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19415287|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701199|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701200|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20506171|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506172|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506173|NCT01691937|Sufentanil|sufentanil|mesh-list
20506174|NCT01691937|Ropivacaine|ropivacaine|mesh-list
20506175|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
20506176|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
20506177|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506178|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506179|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
20506180|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506181|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20506182|NCT01691937|Narcotics|narcotics|mesh-ancestor
20506183|NCT01691937|Analgesics|analgesics|mesh-ancestor
20506184|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20506185|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20506186|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
20506187|NCT01691976|Estrogens|estrogens|mesh-list
20506188|NCT01691976|Hormones|hormones|mesh-ancestor
20506189|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506190|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529334|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20529335|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529336|NCT01780753|Primaquine|primaquine|mesh-list
20529337|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
20529338|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20529339|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20529340|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529341|NCT01780883|Melatonin|melatonin|mesh-list
20529342|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
20529343|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529344|NCT01780883|Protective Agents|protective agents|mesh-ancestor
20529345|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529346|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529347|NCT01780909|Paromomycin|paromomycin|mesh-list
20529348|NCT01780909|Domperidone|domperidone|mesh-list
20529349|NCT01780909|Loperamide|loperamide|mesh-list
20506191|NCT01692132|Prucalopride|prucalopride|mesh-list
20506192|NCT01692132|Laxatives|laxatives|mesh-ancestor
20506193|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506194|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20506195|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20506196|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
20506197|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506198|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506199|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506200|NCT01692158|Heparin|heparin|mesh-list
19701201|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
19701202|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
20506201|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20506202|NCT01692158|Tinzaparin|tinzaparin|mesh-list
20506203|NCT01692158|Dalteparin|dalteparin|mesh-list
20506204|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
20506205|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20506206|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20506207|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506208|NCT01692171|Heparin|heparin|mesh-list
20506209|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20506210|NCT01692171|Tinzaparin|tinzaparin|mesh-list
20506211|NCT01692171|Dalteparin|dalteparin|mesh-list
20506212|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
20506213|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20506214|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20506215|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506216|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
20506217|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20506218|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506219|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506220|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506221|NCT01692210|Analgesics|analgesics|mesh-ancestor
20506222|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
20506223|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506224|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20506225|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20506226|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20506227|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506228|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506229|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506230|NCT01692457|Golimumab|golimumab|mesh-list
20506231|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20506232|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506233|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506234|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
20506235|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506236|NCT01692483|Prednisone|prednisone|mesh-list
20506237|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
20506238|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506239|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
20506240|NCT01692483|Hormones|hormones|mesh-ancestor
20506241|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506242|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506243|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20506244|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506245|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20506246|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506247|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506248|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
20506249|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20506250|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20506251|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20506252|NCT01692678|Dacarbazine|dacarbazine|mesh-list
20506253|NCT01692678|Trabectedin|trabectedin|mesh-list
20506254|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20506255|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
20506256|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506257|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506258|NCT01692704|Gemcitabine|gemcitabine|mesh-list
20506259|NCT01692704|Floxuridine|floxuridine|mesh-list
20506260|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506261|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20506262|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
20506263|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506264|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
20506265|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506266|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506267|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506268|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
20506269|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506270|NCT01692717|Losartan|losartan|mesh-list
20506271|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20506272|NCT01692717|Atorvastatin|atorvastatin|mesh-list
20506273|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20506274|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20506275|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
20506276|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506277|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20506278|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20506279|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506280|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20506281|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19415288|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415289|NCT02990806|Infliximab|infliximab|mesh-list
19415290|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
20506282|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20506283|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20506284|NCT01692717|Diuretics|diuretics|mesh-ancestor
20506285|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
20506286|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506287|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20506288|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506289|NCT01692808|Vitamin D|vitamin d|mesh-list
20506290|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
20506291|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
20506292|NCT01692808|Vitamins|vitamins|mesh-list
20506293|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
20506294|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506295|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20506296|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20506297|NCT01692834|Cyclosporine|cyclosporine|mesh-list
20506298|NCT01692834|Cyclosporins|cyclosporins|mesh-list
20506299|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506300|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506301|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506302|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
19415291|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20529350|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
20506303|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506304|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
20506305|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506306|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
20506307|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506308|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20506309|NCT01692886|Vaccines|vaccines|mesh-list
20506310|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20506311|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
20506312|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506313|NCT01692925|Factor VIII|factor viii|mesh-list
20506314|NCT01692925|Coagulants|coagulants|mesh-ancestor
20506315|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
20506316|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20506317|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
20506318|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506319|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506320|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20506321|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
20506322|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
20506323|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20506324|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
20506325|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506326|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506327|NCT01693081|Apomorphine|apomorphine|mesh-list
20506328|NCT01693081|Emetics|emetics|mesh-ancestor
20506329|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506330|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
20506331|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506332|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506333|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
20506334|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
20506335|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506336|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506337|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
20506338|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
20506339|NCT01693159|Coagulants|coagulants|mesh-ancestor
20506340|NCT01693276|Gemcitabine|gemcitabine|mesh-list
20506341|NCT01693276|Paclitaxel|paclitaxel|mesh-list
20506342|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20506343|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20506344|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506345|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
20506346|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
20506347|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
20506348|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506349|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20506350|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
20506351|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
20506352|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506353|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506354|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506355|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
20506356|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506357|NCT01693289|Metformin|metformin|mesh-list
20506358|NCT01693289|Letrozole|letrozole|mesh-list
20506359|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20506360|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506361|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506362|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20506363|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20506364|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506365|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506366|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20506367|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
20506368|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506369|NCT01693302|Insulin|insulin|mesh-list
20506370|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20506371|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20506372|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506373|NCT01693328|Fentanyl|fentanyl|mesh-list
20506374|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20506375|NCT01693328|Narcotics|narcotics|mesh-ancestor
20506376|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506377|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506378|NCT01693328|Analgesics|analgesics|mesh-ancestor
20506379|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
20506380|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506381|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20506382|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20506383|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
20506384|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
20506385|NCT01693380|Vaccines|vaccines|mesh-list
20506386|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
20506387|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506388|NCT01693393|Cyclosporine|cyclosporine|mesh-list
20506389|NCT01693393|Cyclosporins|cyclosporins|mesh-list
20506390|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506391|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506392|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506393|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
20506394|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506395|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
20506396|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506397|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
20506398|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506399|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20506400|NCT01693419|Gemcitabine|gemcitabine|mesh-list
20506401|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20506402|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20506403|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
20506404|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506405|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506406|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
20506407|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506408|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506409|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506410|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
20506411|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506412|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20506413|NCT01693432|Docetaxel|docetaxel|mesh-list
20506414|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506415|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
20506416|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
20506417|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
20506418|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506419|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
20506420|NCT01693445|Irinotecan|irinotecan|mesh-list
20506421|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506422|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20506423|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20506424|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506425|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506426|NCT01693601|Panobinostat|panobinostat|mesh-list
20506427|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506428|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19701203|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19701204|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
19701205|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
19701206|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506429|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701207|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
20506430|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506431|NCT01693640|Abatacept|abatacept|mesh-list
20506432|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20506433|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506434|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506435|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506436|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
20506437|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506438|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506439|NCT01693679|Lamivudine|lamivudine|mesh-list
20506440|NCT01693679|Adefovir|adefovir|mesh-list
20506441|NCT01693679|Telbivudine|telbivudine|mesh-list
20506442|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20506443|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20506444|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506445|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506446|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
20506447|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506448|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20506449|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20529351|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20529352|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
20529353|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
20529354|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529355|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529356|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20529357|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
20529358|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529359|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529360|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20529361|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529362|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20529363|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20529364|NCT01780948|Everolimus|everolimus|mesh-list
20529365|NCT01780948|Atorvastatin|atorvastatin|mesh-list
20529366|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20529367|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20529368|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
20529369|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529370|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20243941|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20243942|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20243943|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20243944|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20506450|NCT01693718|Fluorouracil|fluorouracil|mesh-list
20506451|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
20506452|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243945|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20243946|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20243947|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20243948|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243949|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20243950|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
20243951|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20243952|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20243953|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
20243954|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20243955|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20243956|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
20243957|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243958|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243959|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20243960|NCT00418249|Protective Agents|protective agents|mesh-ancestor
20243961|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20243962|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20243963|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243964|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243965|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
20243966|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20243967|NCT00418275|Plasminogen|plasminogen|mesh-list
20243968|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20243969|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20243970|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243971|NCT00418288|Glucagon|glucagon|mesh-list
20243972|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20243973|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243974|NCT00418288|Hormones|hormones|mesh-ancestor
20243975|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243976|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243977|NCT00418288|Incretins|incretins|mesh-ancestor
20506453|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
20506454|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701208|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
19701209|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
19701210|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20506455|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20506456|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506457|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
20506458|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506459|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
20506460|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506461|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20506462|NCT01693809|Caffeine|caffeine|mesh-list
19701211|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19701212|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20243978|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20243979|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20243980|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20243981|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20243982|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243983|NCT00418353|Dexamethasone|dexamethasone|mesh-list
20506463|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20506464|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506465|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20506466|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506467|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506468|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20506469|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20506470|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
20506471|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506472|NCT01693822|Axitinib|axitinib|mesh-list
20506473|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506474|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20506475|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506476|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506477|NCT01694017|Tenofovir|tenofovir|mesh-list
20506478|NCT01694017|Zidovudine|zidovudine|mesh-list
20506479|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
20506480|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506481|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20506482|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20506483|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506484|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506485|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20506486|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20506487|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
20506488|NCT05289687|Daratumumab|daratumumab|mesh-list
20506489|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20506490|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506491|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
20506492|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506493|NCT05289648|Niraparib|niraparib|mesh-list
20506494|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20506495|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530903|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20243984|NCT00418353|Betamethasone|betamethasone|mesh-list
20506496|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506497|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506498|NCT05289492|Dexamethasone|dexamethasone|mesh-list
20506499|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506500|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
20506501|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
20506502|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506503|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506504|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506505|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
20506506|NCT05289492|Hormones|hormones|mesh-ancestor
20506507|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506508|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20506509|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506510|NCT05289063|Atorvastatin|atorvastatin|mesh-list
20506511|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20506512|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20506513|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
20506514|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506515|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20506516|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20506517|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506518|NCT05288907|Lidocaine|lidocaine|mesh-list
20506519|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
20506520|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
20506521|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506522|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506523|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
20506524|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506525|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20506526|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20506527|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20506528|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506529|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506530|NCT05288829|Ravulizumab|ravulizumab|mesh-list
19415292|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415293|NCT02989597|Dexamethasone|dexamethasone|mesh-list
20506531|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20506532|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506533|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
20506534|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506535|NCT05288816|Ravulizumab|ravulizumab|mesh-list
20506536|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20506537|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506538|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
20506539|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506540|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
20506541|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20506542|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506543|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506544|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506545|NCT05288738|Analgesics|analgesics|mesh-ancestor
20506546|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
20506547|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506548|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20243985|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
20506549|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20506550|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20506551|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506552|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506553|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506554|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20506555|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506556|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
20506557|NCT05288725|Hormones|hormones|mesh-ancestor
20506558|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701213|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
19701214|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701215|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506559|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701216|NCT04884802|Protective Agents|protective agents|mesh-ancestor
19701217|NCT04884750|Vaccines|vaccines|mesh-list
19701218|NCT04884750|Immunologic Factors|immunologic factors|mesh-ancestor
19415294|NCT02989597|Sufentanil|sufentanil|mesh-list
20506560|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506561|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
20506562|NCT05288673|Ravulizumab|ravulizumab|mesh-list
20506563|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20506564|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506565|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
20506566|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506567|NCT05288660|Ravulizumab|ravulizumab|mesh-list
20506568|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20506569|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506570|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
20506571|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506572|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
20506573|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20506574|NCT05288465|Protective Agents|protective agents|mesh-ancestor
20506575|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506576|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
20506577|NCT05288400|Amlodipine|amlodipine|mesh-list
20506578|NCT05288400|Bisoprolol|bisoprolol|mesh-list
20506579|NCT05288400|Perindopril|perindopril|mesh-list
20506580|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20506581|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20506582|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506583|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506584|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20506585|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506586|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
20506587|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
20506588|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
20506589|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506590|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20506591|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20506592|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20506593|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506594|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506595|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20506596|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
19701219|NCT04884750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701220|NCT04884503|Clonazepam|clonazepam|mesh-list
19701221|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
19701222|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
19701223|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
19701224|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701225|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506597|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506598|NCT05288374|Celecoxib|celecoxib|mesh-list
20506599|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20506600|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506601|NCT05288374|Analgesics|analgesics|mesh-ancestor
20506602|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
20506603|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506604|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506605|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506606|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506607|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20506608|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20506609|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506610|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243986|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19701226|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506611|NCT05288335|Methamphetamine|methamphetamine|mesh-list
19701227|NCT04884516|Vitamin A|vitamin a|mesh-list
20506612|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20506613|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506614|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
20506615|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
20506616|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506617|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
20506618|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506619|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701228|NCT04884516|Vitamins|vitamins|mesh-ancestor
19701229|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
19701230|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701231|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19701232|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19701233|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701234|NCT04884490|Renal Agents|renal agents|mesh-ancestor
19701235|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701236|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
19701237|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20243987|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
20506620|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506621|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20506622|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20506623|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506624|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20506625|NCT05288283|Cannabidiol|cannabidiol|mesh-list
20506626|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
20506627|NCT05288192|Triamcinolone|triamcinolone|mesh-list
20506628|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20506629|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20506630|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20506631|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506632|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
20506633|NCT05288192|Hormones|hormones|mesh-ancestor
20530904|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19701238|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20506634|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506635|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506636|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506637|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
20506638|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415295|NCT02989597|Ketamine|ketamine|mesh-list
20506639|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529371|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20529372|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529373|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529374|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529375|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
20529376|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529377|NCT01781052|Iloprost|iloprost|mesh-list
20529378|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20529379|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
20530819|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530820|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530821|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19415296|NCT02989597|Remifentanil|remifentanil|mesh-list
19415297|NCT02989597|Methadone|methadone|mesh-list
20506640|NCT05288179|Pirfenidone|pirfenidone|mesh-list
20506641|NCT05288179|Analgesics|analgesics|mesh-ancestor
20506642|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
20506643|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506644|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506645|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20506646|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506647|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506648|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506649|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506650|NCT05288153|Metformin|metformin|mesh-list
20506651|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20506652|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506653|NCT05288127|Talazoparib|talazoparib|mesh-list
20506654|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20506655|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506656|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701239|NCT04884399|Ranibizumab|ranibizumab|mesh-list
19701240|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19701241|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19701242|NCT04884399|Growth Substances|growth substances|mesh-ancestor
20506657|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506658|NCT05291455|Lacosamide|lacosamide|mesh-list
20506659|NCT05291455|Phenobarbital|phenobarbital|mesh-list
20506660|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
20506661|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20506662|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20506663|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506664|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506665|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20506666|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506667|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506668|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20506669|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20506670|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506671|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
20506672|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
20506673|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20506674|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20506675|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20506676|NCT05291364|Ethanol|ethanol|mesh-list
20506677|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
20506678|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20506679|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506680|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701243|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506681|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506682|NCT05291364|Analgesics|analgesics|mesh-ancestor
20506683|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
20506684|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506685|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20506686|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20506687|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20506688|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506689|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506690|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506691|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20506692|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506693|NCT05291338|Doxorubicin|doxorubicin|mesh-list
20506694|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
20506695|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20506696|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506697|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20506698|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20506699|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506700|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506701|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19701244|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
20506702|NCT05291221|Lidocaine|lidocaine|mesh-list
20506703|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
20506704|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
20506705|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
20506706|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506707|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506708|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
20506709|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506710|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20506711|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20506712|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20506713|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506714|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506715|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20506716|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20506717|NCT05291221|Analgesics|analgesics|mesh-ancestor
20506718|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20506719|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20506720|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20506721|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506722|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506723|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20506724|NCT05291195|Eusol|eusol|mesh-list
20506725|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
20506726|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506727|NCT05291130|Vitamin E|vitamin e|mesh-list
20506728|NCT05291130|Vitamins|vitamins|mesh-ancestor
20506729|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
20506730|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506731|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
20506732|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506733|NCT05291130|Protective Agents|protective agents|mesh-ancestor
20506734|NCT05291104|Folic Acid|folic acid|mesh-list
20506735|NCT05291104|Choline|choline|mesh-list
20506736|NCT05291104|Hematinics|hematinics|mesh-ancestor
20506737|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
20506738|NCT05291104|Vitamins|vitamins|mesh-ancestor
20506739|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
20506740|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506741|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
20506742|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20506743|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
20506744|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506745|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506746|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20506747|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
20506748|NCT05291052|Capecitabine|capecitabine|mesh-list
20506749|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
20506750|NCT05291052|Lenvatinib|lenvatinib|mesh-list
20506751|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20506752|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
20506753|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506754|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506755|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20506756|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853475|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
20506757|NCT05291039|Adalimumab|adalimumab|mesh-list
20506758|NCT05291039|Infliximab|infliximab|mesh-list
20506759|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506760|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506761|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
20506762|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506763|NCT05290948|Bevacizumab|bevacizumab|mesh-list
20506764|NCT05290948|Acetazolamide|acetazolamide|mesh-list
20506765|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20506766|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506767|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20506768|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20506769|NCT05290948|Growth Substances|growth substances|mesh-ancestor
20506770|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506771|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
20506772|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
20506773|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19853476|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853477|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19853478|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853479|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
19853480|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506774|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506775|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506776|NCT05290948|Diuretics|diuretics|mesh-ancestor
20506777|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
20506778|NCT05290935|Paclitaxel|paclitaxel|mesh-list
20506779|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20506780|NCT05290935|Antibodies|antibodies|mesh-list
20506781|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20506782|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506783|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
20506784|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
20506785|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
20506786|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506787|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
20506788|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506789|NCT05290857|Hemostatics|hemostatics|mesh-list
20506790|NCT05290857|Coagulants|coagulants|mesh-ancestor
20506791|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
20506792|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19415298|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415299|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
19853481|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20506793|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
20506794|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506795|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
20506796|NCT05290727|Protective Agents|protective agents|mesh-ancestor
20506797|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
20506798|NCT05290662|Fludarabine|fludarabine|mesh-list
20506799|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506800|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
20506801|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506802|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506803|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20506804|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
20506805|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506806|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506807|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20506808|NCT05290506|Linagliptin|linagliptin|mesh-list
20506809|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20506810|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20506811|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506812|NCT05290506|Incretins|incretins|mesh-ancestor
20506813|NCT05290506|Hormones|hormones|mesh-ancestor
20506814|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506815|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
20506816|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415300|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
20506817|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20243988|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
20243989|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20243990|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20243991|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
20243992|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
20243993|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20243994|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243995|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20243996|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
20506818|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
20506819|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
20506820|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506821|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506822|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
20506823|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506824|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20506825|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506826|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506827|NCT05290324|Midazolam|midazolam|mesh-list
20506828|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20529380|NCT01781273|Ethanol|ethanol|mesh-list
20243997|NCT00418353|Hormones|hormones|mesh-ancestor
20506829|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19701245|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708036|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708037|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19708038|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
19708039|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
19708040|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708041|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708042|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708043|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19708044|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
19708045|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19708046|NCT04820933|Tenofovir|tenofovir|mesh-list
20506830|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506831|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506832|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20506833|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20506834|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20506835|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20506836|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
20506837|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
20506838|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
20506839|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
19415301|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415302|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415303|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19415304|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
19415305|NCT02989597|Hormones|hormones|mesh-ancestor
19415306|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415307|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19415308|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708047|NCT04820933|Emtricitabine|emtricitabine|mesh-list
19708048|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
19708049|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506840|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506841|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506842|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20506843|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506844|NCT05290129|Oxytocin|oxytocin|mesh-list
20506845|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
20506846|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20506847|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506848|NCT05290116|Apatinib|apatinib|mesh-list
20506849|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506850|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20506851|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506852|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506853|NCT05290090|Rituximab|rituximab|mesh-list
20506854|NCT05290090|Lenalidomide|lenalidomide|mesh-list
20506855|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
20506856|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20506857|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506858|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
20506859|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506860|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506861|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20506862|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20506863|NCT05290090|Growth Substances|growth substances|mesh-ancestor
20506864|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
20506865|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20506866|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506867|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506868|NCT05290025|Nicotine|nicotine|mesh-list
20506869|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20506870|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
20506871|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506872|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506873|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20506874|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20506875|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
20506876|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506877|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529381|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20529382|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529383|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529384|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529385|NCT01781377|Metoclopramide|metoclopramide|mesh-list
20529386|NCT01781377|Propofol|propofol|mesh-list
20529387|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20529388|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506878|NCT05292742|Capecitabine|capecitabine|mesh-list
20506879|NCT05292742|Trastuzumab|trastuzumab|mesh-list
20506880|NCT05292742|Pertuzumab|pertuzumab|mesh-list
20506881|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20506882|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
20506883|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506884|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506885|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20506886|NCT05292690|Caffeine|caffeine|mesh-list
20506887|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20506888|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506889|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20506890|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506891|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506892|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20506893|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20506894|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
20506895|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506896|NCT05292677|Anesthetics|anesthetics|mesh-list
20506897|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506898|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506899|NCT05292664|Leucovorin|leucovorin|mesh-list
20506900|NCT05292664|Cytarabine|cytarabine|mesh-list
20506901|NCT05292664|Dexamethasone|dexamethasone|mesh-list
20506902|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
20506903|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
20506904|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20506905|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20506906|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20506907|NCT05292664|Cortisone|cortisone|mesh-list
20506908|NCT05292664|Doxorubicin|doxorubicin|mesh-list
20506909|NCT05292664|Methotrexate|methotrexate|mesh-list
20506910|NCT05292664|Vincristine|vincristine|mesh-list
20506911|NCT05292664|Azacitidine|azacitidine|mesh-list
20506912|NCT05292664|Venetoclax|venetoclax|mesh-list
20506913|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
20506914|NCT05292664|Razoxane|razoxane|mesh-list
20506915|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20506916|NCT05292664|BB 1101|bb 1101|mesh-list
20506917|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
20506918|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506919|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
20506920|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
20506921|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506922|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506923|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20506924|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
20506925|NCT05292664|Hormones|hormones|mesh-ancestor
20506926|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506927|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20506928|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20506929|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
20506930|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20506931|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506932|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20506933|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20506934|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20506935|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20506936|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
20506937|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20506938|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20506939|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
20506940|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
20506941|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20506942|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20506943|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
20506944|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20506945|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20506946|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
20506947|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506948|NCT05292664|Antidotes|antidotes|mesh-ancestor
20506949|NCT05292664|Protective Agents|protective agents|mesh-ancestor
20506950|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
20506951|NCT05292664|Vitamins|vitamins|mesh-ancestor
20506952|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
20506953|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20506954|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
20506955|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
20506956|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
20506957|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20506958|NCT05292586|Beclomethasone|beclomethasone|mesh-list
20506959|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
20506960|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20506961|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
20506962|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20506963|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506964|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20506965|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
20506966|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20506967|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20506968|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20506969|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
20506970|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506971|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506972|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20506973|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
20506974|NCT05292586|Hormones|hormones|mesh-ancestor
20506975|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20506976|NCT05292573|Metformin|metformin|mesh-list
20506977|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20506978|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506979|NCT05292066|Pregabalin|pregabalin|mesh-list
20506980|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20506981|NCT05292066|Analgesics|analgesics|mesh-ancestor
20506982|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
20506983|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701246|NCT04884139|Tenofovir|tenofovir|mesh-list
19701247|NCT04884139|Lamivudine|lamivudine|mesh-list
19701248|NCT04884139|Emtricitabine|emtricitabine|mesh-list
19701249|NCT04884139|Dolutegravir|dolutegravir|mesh-list
19701250|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
20506984|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20506985|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
20506986|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20506987|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20506988|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20506989|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20506990|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20506991|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20530905|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
19701251|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20506992|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20506993|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20506994|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20506995|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20506996|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20506997|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
20506998|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
20506999|NCT05291910|Paclitaxel|paclitaxel|mesh-list
20507000|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20507001|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20507002|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507003|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
20507004|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
20507005|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
20507006|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507007|NCT05291845|Vaccines|vaccines|mesh-list
20507008|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
20507009|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507010|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
20507011|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20507012|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20507013|NCT05291793|Prednisolone|prednisolone|mesh-list
20507014|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
20507015|NCT05291793|Tenoxicam|tenoxicam|mesh-list
20507016|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20507017|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
20507018|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507019|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
20507020|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
20507021|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507022|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507023|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507024|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
20507025|NCT05291793|Hormones|hormones|mesh-ancestor
20507026|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507027|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20507028|NCT05291793|Protective Agents|protective agents|mesh-ancestor
20507029|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20507030|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507031|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20507032|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507033|NCT05291793|Analgesics|analgesics|mesh-ancestor
20507034|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
20507035|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507036|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20507037|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507038|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507039|NCT05294926|Rocuronium|rocuronium|mesh-list
20507040|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20507041|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20507042|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20507043|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507044|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507045|NCT05294887|Diltiazem|diltiazem|mesh-list
20507046|NCT05294887|Bisoprolol|bisoprolol|mesh-list
20507047|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20507048|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20507049|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507050|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507051|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507052|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507053|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20507054|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20507055|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507056|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20507057|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
20507058|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
20507059|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
20507060|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507061|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20507062|NCT05294822|Insulin|insulin|mesh-list
20507063|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20507064|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507065|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
20507066|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20507067|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
20507068|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507069|NCT05294744|Expectorants|expectorants|mesh-ancestor
20507070|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507071|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20507072|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
20507073|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507074|NCT05294744|Protective Agents|protective agents|mesh-ancestor
20507075|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507076|NCT05294744|Antidotes|antidotes|mesh-ancestor
20507077|NCT05294679|Propofol|propofol|mesh-list
20507078|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20507079|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507080|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20243998|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20243999|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20244000|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244001|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20244002|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
20244003|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20244004|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20244005|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20244006|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244007|NCT00418366|Incretins|incretins|mesh-ancestor
20244008|NCT00418366|Hormones|hormones|mesh-ancestor
20244009|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507081|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20507082|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
20507083|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
20507084|NCT05294666|Cyclosporine|cyclosporine|mesh-list
20507085|NCT05294666|Tacrolimus|tacrolimus|mesh-list
20507086|NCT05294666|Cyclosporins|cyclosporins|mesh-list
20507087|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507088|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
20507089|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507090|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20507091|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507092|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507093|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
20507094|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507095|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
20507096|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507097|NCT05294640|Lidocaine|lidocaine|mesh-list
20507098|NCT05294640|Epinephrine|epinephrine|mesh-list
20507099|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
20507100|NCT05294640|Anesthetics|anesthetics|mesh-list
20507101|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507102|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507103|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
20507104|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507105|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20507106|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20507107|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20507108|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507109|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507110|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20507111|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20507112|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507113|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507114|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20507115|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20507116|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
20507117|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20507118|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507119|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
20507120|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
20507121|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20529389|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529390|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20507122|NCT05294536|Liraglutide|liraglutide|mesh-list
20507123|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20507124|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507125|NCT05294536|Incretins|incretins|mesh-ancestor
20507126|NCT05294536|Hormones|hormones|mesh-ancestor
20507127|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507128|NCT05294523|Rocuronium|rocuronium|mesh-list
20507129|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20507130|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20507131|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20507132|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507133|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507134|NCT05294484|Indapamide|indapamide|mesh-list
20507135|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20507136|NCT05294484|Diuretics|diuretics|mesh-ancestor
20507137|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
20507138|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507139|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20529391|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
20507140|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507141|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507142|NCT05294406|Piperaquine|piperaquine|mesh-list
20507143|NCT05294406|Artenimol|artenimol|mesh-list
20507144|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
20507145|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20507146|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20507147|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507148|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
20507149|NCT05294393|Ropivacaine|ropivacaine|mesh-list
20507150|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
20507151|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
20507152|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507153|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507154|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
20507155|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507156|NCT05294393|Analgesics|analgesics|mesh-ancestor
20507157|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20507158|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
20507159|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20507160|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507161|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507162|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20507163|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
20507164|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20507165|NCT05294263|Varenicline|varenicline|mesh-list
20507166|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20507167|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20507168|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
20507169|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507170|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507171|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507172|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
20507173|NCT05294055|Etoposide|etoposide|mesh-list
20507174|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507175|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
20507176|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507177|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507178|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20507179|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
20507180|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507181|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415309|NCT02989597|Analgesics|analgesics|mesh-ancestor
19415310|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
19415311|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20507182|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20507183|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19415312|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19415313|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
20507184|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19415314|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
19415315|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507185|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20507186|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507187|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20507188|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507189|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20507190|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
20507191|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507192|NCT05293808|Aspirin|aspirin|mesh-list
20507193|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20507194|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507195|NCT05293808|Analgesics|analgesics|mesh-ancestor
20507196|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
20507197|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507198|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507199|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507200|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507201|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20507202|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20507203|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507204|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20507205|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20507206|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507207|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
20507208|NCT05293704|Mizoribine|mizoribine|mesh-list
20507209|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20507210|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507211|NCT05293704|Analgesics|analgesics|mesh-ancestor
20507212|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
20507213|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507214|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507215|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507216|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507217|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20507218|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507219|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20507220|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507221|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
20507222|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20507223|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20507224|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507225|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507226|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507227|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
20507228|NCT05293665|Vaccines|vaccines|mesh-list
20507229|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
20507230|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507231|NCT05293600|Acetazolamide|acetazolamide|mesh-list
20507232|NCT05293600|Eszopiclone|eszopiclone|mesh-list
20507233|NCT05293600|Trazodone|trazodone|mesh-list
20507234|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20507235|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20507236|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20507237|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507238|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507239|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507240|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507241|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507242|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
19415316|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20507243|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20507244|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507245|NCT05293600|Diuretics|diuretics|mesh-ancestor
20507246|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
20507247|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20507248|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507249|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20507250|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20507251|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20507252|NCT05293600|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20507253|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
20507254|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20507255|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
20507256|NCT05293574|Norethindrone|norethindrone|mesh-list
20507257|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
20507258|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20507259|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20507260|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20507261|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
20507262|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20507263|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507264|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20507265|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20507266|NCT05293288|Anesthetics|anesthetics|mesh-list
20507267|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507268|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507269|NCT05293210|Dexamethasone|dexamethasone|mesh-list
20507270|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507271|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
20507272|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
20507273|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507274|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507275|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507276|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
20507277|NCT05293210|Hormones|hormones|mesh-ancestor
20507278|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507279|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20507280|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507281|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
20507282|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20507283|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507284|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20507285|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20507286|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507287|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507288|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507289|NCT05293132|Ubiquinone|ubiquinone|mesh-list
20507290|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
20507291|NCT05293132|Montelukast|montelukast|mesh-list
20507292|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20507293|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507294|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20507295|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
20507296|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507297|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507298|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20507299|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20507300|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507301|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
20507302|NCT05293132|Vitamins|vitamins|mesh-ancestor
20507303|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
20507304|NCT05293119|Tofacitinib|tofacitinib|mesh-list
20507305|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853482|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507306|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
20507307|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20507308|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20507309|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507310|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507311|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20507312|NCT05296863|Minoxidil|minoxidil|mesh-list
20507313|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20507314|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
19701252|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19701253|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19701254|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701255|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701256|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19701257|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19701258|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19701259|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19701260|NCT04884282|Docetaxel|docetaxel|mesh-list
20507315|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
20507316|NCT05296772|Antibodies|antibodies|mesh-list
20507317|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
20507318|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
20507319|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507320|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20507321|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507322|NCT05296564|Aldesleukin|aldesleukin|mesh-list
20507323|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
20507324|NCT05296564|Interleukin-2|interleukin-2|mesh-list
20507325|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507326|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
20507327|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507328|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507329|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20507330|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
20507331|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507332|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507333|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20507334|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507335|NCT05296564|Analgesics|analgesics|mesh-ancestor
20507336|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
20507337|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507338|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20507339|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20507340|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
20244010|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20507341|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507342|NCT05296369|Folic Acid|folic acid|mesh-list
20507343|NCT05296369|Hematinics|hematinics|mesh-ancestor
20507344|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
20507345|NCT05296369|Vitamins|vitamins|mesh-ancestor
20507346|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
20507347|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507348|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
20507349|NCT05296317|Epirubicin|epirubicin|mesh-list
20507350|NCT05296317|Lenograstim|lenograstim|mesh-list
20507351|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507352|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
20507353|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507354|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507355|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19701261|NCT04884282|Nivolumab|nivolumab|mesh-list
20507356|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
20507357|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507358|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507359|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20507360|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20507361|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20507362|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20507363|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20507364|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507365|NCT05296304|Bexarotene|bexarotene|mesh-list
20507366|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507367|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20507368|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20507369|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529392|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
20529393|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
20529394|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
20529395|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529396|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20529397|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20529398|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20529399|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
20529400|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529401|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529402|NCT01781442|Sirolimus|sirolimus|mesh-list
20529403|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20529404|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529405|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20529406|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529407|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
20529408|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507370|NCT05296005|Leucovorin|leucovorin|mesh-list
20507371|NCT05296005|Docetaxel|docetaxel|mesh-list
20507372|NCT05296005|Fluorouracil|fluorouracil|mesh-list
20507373|NCT05296005|Capecitabine|capecitabine|mesh-list
20507374|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
20507375|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507376|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
20507377|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20507378|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
20507379|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701262|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701263|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701264|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
19701265|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701266|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701267|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19701268|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19701269|NCT04883996|Pilocarpine|pilocarpine|mesh-list
19701270|NCT04883996|Miotics|miotics|mesh-ancestor
19701271|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
19701272|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701273|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701274|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19701275|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19701276|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
19701277|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701278|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701279|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
19701280|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20507380|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
20507381|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20507382|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507383|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
20507384|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507385|NCT05296005|Antidotes|antidotes|mesh-ancestor
20507386|NCT05296005|Protective Agents|protective agents|mesh-ancestor
20507387|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
20507388|NCT05296005|Vitamins|vitamins|mesh-ancestor
20507389|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
20507390|NCT05295836|Glycerol|glycerol|mesh-list
20507391|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20507392|NCT05295836|Protective Agents|protective agents|mesh-ancestor
20507393|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701281|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
19853483|NCT00732901|Citalopram|citalopram|mesh-list
20507394|NCT05295537|Liver Extracts|liver extracts|mesh-list
20507395|NCT05295537|Hematinics|hematinics|mesh-ancestor
20507396|NCT05295355|Bromides|bromides|mesh-list
20507397|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
20507398|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20507399|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
20507400|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507401|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507402|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20507403|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507404|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
20507405|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20507406|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
20507407|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507408|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507409|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
20507410|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20507411|NCT05295173|Plasminogen|plasminogen|mesh-list
20507412|NCT05295173|Reteplase|reteplase|mesh-list
20507413|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20507414|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20507415|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507416|NCT05294900|Paclitaxel|paclitaxel|mesh-list
20507417|NCT05294900|Carboplatin|carboplatin|mesh-list
19701282|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19701283|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701284|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
19701285|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
19701286|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20507418|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20507419|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507420|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
20507421|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20507422|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701287|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
19701288|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701289|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
19701290|NCT04884464|Protective Agents|protective agents|mesh-ancestor
19701291|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19701292|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19701293|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19701294|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
19701295|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701296|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19701297|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19701298|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507423|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507424|NCT05289349|Propofol|propofol|mesh-list
20507425|NCT05289349|Sevoflurane|sevoflurane|mesh-list
20507426|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20507427|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507428|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507429|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20507430|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
20507431|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
20507432|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20507433|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19701299|NCT04883736|Tretinoin|tretinoin|mesh-list
19701300|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701301|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
19701302|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
19701303|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
19701304|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19853484|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19853485|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19853486|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507434|NCT05288062|Dexamethasone|dexamethasone|mesh-list
19701305|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
20244011|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
20507435|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
20507436|NCT05288062|Lenalidomide|lenalidomide|mesh-list
20507437|NCT05288062|Pomalidomide|pomalidomide|mesh-list
20507438|NCT05288062|Ichthammol|ichthammol|mesh-list
20507439|NCT05288062|BB 1101|bb 1101|mesh-list
20507440|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507441|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
20507442|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
20507443|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507444|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415317|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19415318|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415319|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415320|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19415321|NCT02989597|Narcotics|narcotics|mesh-ancestor
19415322|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19415323|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
20244012|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244013|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507445|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507446|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
20507447|NCT05288062|Hormones|hormones|mesh-ancestor
20507448|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507449|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20507450|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507451|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
20507452|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507453|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507454|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
20507455|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20507456|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20507457|NCT05288062|Growth Substances|growth substances|mesh-ancestor
20507458|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
20507459|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
20507460|NCT05280405|Infliximab|infliximab|mesh-list
20507461|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
20507462|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507463|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507464|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19701306|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701307|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
20507465|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20244014|NCT00418392|Minocycline|minocycline|mesh-list
20244015|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244016|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507466|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507467|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507468|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20507469|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507470|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507471|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
20507472|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244017|NCT00418431|Bevacizumab|bevacizumab|mesh-list
20244018|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20244019|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244020|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20244021|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20244022|NCT00418431|Growth Substances|growth substances|mesh-ancestor
20507473|NCT05275491|Calcium|calcium|mesh-list
20507474|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
20507475|NCT05275491|Hormones|hormones|mesh-list
20507476|NCT05275491|Mitogens|mitogens|mesh-list
20507477|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20507478|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507479|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507480|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
20507481|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507482|NCT05275374|Trametinib|trametinib|mesh-list
20507483|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507484|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20507485|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507486|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507487|NCT05274243|Phenol|phenol|mesh-list
20507488|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20507489|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507490|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
20507491|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20507492|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20507493|NCT05273996|Bupropion|bupropion|mesh-list
20507494|NCT05273996|Sertraline|sertraline|mesh-list
20507495|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20507496|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20507497|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
20507498|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20507499|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20507500|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20507501|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507502|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507503|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
20507504|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507505|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507506|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20507507|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20507508|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507509|NCT05273996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20507510|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
20507511|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20507512|NCT05273242|Artesunate|artesunate|mesh-list
20507513|NCT05273242|Infliximab|infliximab|mesh-list
20507514|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507515|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
20507516|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507517|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507518|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
20507519|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20507520|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20507521|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507522|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
20507523|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
20507524|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20507525|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
20507526|NCT05272826|Dexamethasone|dexamethasone|mesh-list
20507527|NCT05272826|Bortezomib|bortezomib|mesh-list
20507528|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507529|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
20507530|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
20507531|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507532|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507533|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507534|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
20507535|NCT05272826|Hormones|hormones|mesh-ancestor
20507536|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507537|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20507538|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507539|NCT05272202|Propofol|propofol|mesh-list
20507540|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20507541|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507542|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507543|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20507544|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
20507545|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
20507546|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20507547|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507548|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507549|NCT05269095|Anesthetics|anesthetics|mesh-list
20507550|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507551|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529409|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
20507552|NCT05267938|Lidocaine|lidocaine|mesh-list
20507553|NCT05267938|Epinephrine|epinephrine|mesh-list
20507554|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
20507555|NCT05267938|Anesthetics|anesthetics|mesh-list
20507556|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507557|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507558|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
20507559|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507560|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20507561|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20507562|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20507563|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507564|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507565|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20507566|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20507567|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507568|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507569|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20507570|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20507571|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
20507572|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20507573|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507574|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
20507575|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
20507576|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19415324|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
19415325|NCT02986659|Metformin|metformin|mesh-list
19415326|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415327|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415328|NCT02978456|Sirolimus|sirolimus|mesh-list
19415329|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19415330|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415331|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19415332|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415333|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
19415334|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415335|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
20244023|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244024|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
20244025|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20244026|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20244027|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244028|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
20244029|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
20244030|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20244031|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20244032|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244033|NCT00418496|Aldesleukin|aldesleukin|mesh-list
20244034|NCT00418496|Sorafenib|sorafenib|mesh-list
20244035|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244036|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20244037|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244038|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244039|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20244040|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20244041|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
20244042|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244043|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
20244044|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
20244045|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20244046|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
20244047|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244048|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244049|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19415336|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507577|NCT05267431|Methotrexate|methotrexate|mesh-list
20507578|NCT05267431|Hydroquinone|hydroquinone|mesh-list
20507579|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20507580|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
19415337|NCT02975271|Serlopitant|serlopitant|mesh-list
19415338|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19415339|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415340|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415341|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415342|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20507581|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20507582|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507583|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20507584|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
20507585|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507586|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507587|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
20507588|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507589|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20507590|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507591|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
20507592|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507593|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20507594|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
20507595|NCT05267431|Protective Agents|protective agents|mesh-ancestor
20507596|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20507597|NCT05266248|Caffeine|caffeine|mesh-list
19415343|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
20507598|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20507599|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507600|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20507601|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507602|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507603|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20507604|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20507605|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
20507606|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507607|NCT05264896|Leucovorin|leucovorin|mesh-list
20507608|NCT05264896|Docetaxel|docetaxel|mesh-list
20507609|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
20507610|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507611|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
20507612|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
20507613|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
20507614|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507615|NCT05264896|Antidotes|antidotes|mesh-ancestor
20507616|NCT05264896|Protective Agents|protective agents|mesh-ancestor
20507617|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507618|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
20507619|NCT05264896|Vitamins|vitamins|mesh-ancestor
20507620|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
20244050|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
20244051|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20244052|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20244053|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20244054|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244055|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244056|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244057|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244058|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
20244059|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19701308|NCT04883892|Protective Agents|protective agents|mesh-ancestor
19701309|NCT04883528|Valsartan|valsartan|mesh-list
19701310|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19701311|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19701312|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19701313|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19701314|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701315|NCT04883632|Lidocaine|lidocaine|mesh-list
19701316|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
19701317|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
19701318|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701319|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701320|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
20244060|NCT00418535|Cisplatin|cisplatin|mesh-list
20244061|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507621|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
20507622|NCT05264584|Febuxostat|febuxostat|mesh-list
19701321|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701322|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19701323|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19701324|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19853487|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244062|NCT00418548|Etanercept|etanercept|mesh-list
20244063|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244064|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244065|NCT00418548|Analgesics|analgesics|mesh-ancestor
20244066|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
20244067|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244068|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853488|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701325|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19701326|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701327|NCT04883164|Antibodies|antibodies|mesh-list
19701328|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
19701329|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701330|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19853489|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
19853490|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853491|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19853492|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853493|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853494|NCT00732940|Belimumab|belimumab|mesh-list
19853495|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853496|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
19853497|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244069|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244070|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244071|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701331|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
19701332|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19701333|NCT04883034|Analgesics|analgesics|mesh-list
19701334|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
20244072|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244073|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
20244074|NCT00418587|Vitamin D|vitamin d|mesh-list
20244075|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
20244076|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
20244077|NCT00418587|Vitamins|vitamins|mesh-list
20244078|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
20244079|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244080|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20244081|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20507623|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20507624|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
20507625|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507626|NCT05264584|Expectorants|expectorants|mesh-ancestor
20507627|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507628|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20507629|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
20507630|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507631|NCT05264584|Protective Agents|protective agents|mesh-ancestor
20507632|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507633|NCT05264584|Antidotes|antidotes|mesh-ancestor
20507634|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
19701335|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853498|NCT00732992|Pemetrexed|pemetrexed|mesh-list
20507635|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507636|NCT05262686|Aldesleukin|aldesleukin|mesh-list
20244082|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20507637|NCT05262686|Interleukin-2|interleukin-2|mesh-list
20507638|NCT05262686|Belimumab|belimumab|mesh-list
20507639|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507640|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507641|NCT05262686|Analgesics|analgesics|mesh-ancestor
20507642|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
20507643|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507644|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507645|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507646|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
20507647|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20507648|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20507649|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
20507650|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507651|NCT05261386|Betadex|betadex|mesh-list
20507652|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
20507653|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507654|NCT05260008|Epinephrine|epinephrine|mesh-list
20507655|NCT05260008|Bupivacaine|bupivacaine|mesh-list
20507656|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
20507657|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
20507658|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507659|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507660|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
20507661|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507662|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20507663|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20507664|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
19415344|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
19415345|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415346|NCT02971891|Furosemide|furosemide|mesh-list
19415347|NCT02971891|Diuretics|diuretics|mesh-ancestor
19415348|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
19415349|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415350|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19415351|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415352|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415353|NCT02968940|Avelumab|avelumab|mesh-list
19415354|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415355|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415356|NCT02964273|Tolvaptan|tolvaptan|mesh-list
19415357|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19415358|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701336|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507665|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507666|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507667|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20507668|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20244083|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
20244084|NCT00418600|Vitamins|vitamins|mesh-ancestor
20244085|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
20244086|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244087|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20507669|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
20507670|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20507671|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507672|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
20507673|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
20507674|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20507675|NCT05259566|Menthol|menthol|mesh-list
20507676|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
20244088|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20244089|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
20507677|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
20507678|NCT05257447|Baclofen|baclofen|mesh-list
20507679|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
20507680|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20507681|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507682|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20507683|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507684|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20507685|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
20507686|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
20507687|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507688|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507689|NCT05256823|Celecoxib|celecoxib|mesh-list
20507690|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20507691|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507692|NCT05256823|Analgesics|analgesics|mesh-ancestor
20507693|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
20507694|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507695|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507696|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507697|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507698|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20507699|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20507700|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507701|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507702|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20507703|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20507704|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507705|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507706|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507707|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507708|NCT05249920|Edaravone|edaravone|mesh-list
19415359|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
19415360|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416920|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416921|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19416922|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
19701337|NCT04882839|Psilocybin|psilocybin|mesh-list
20507709|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20507710|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
20507711|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507712|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20507713|NCT05249920|Protective Agents|protective agents|mesh-ancestor
20507714|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507715|NCT05245669|Denosumab|denosumab|mesh-list
20507716|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20507717|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507718|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
20507719|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
20507720|NCT05243147|Coagulants|coagulants|mesh-ancestor
20507721|NCT05242029|Psilocybin|psilocybin|mesh-list
19701338|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
19701339|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701340|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19701341|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
19701342|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
20507722|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
20507723|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507724|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20507725|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20507726|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20507727|NCT05238506|Lidocaine|lidocaine|mesh-list
20507728|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
20507729|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
20507730|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507731|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507732|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
20507733|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507734|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20507735|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20507736|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20507737|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20507738|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507739|NCT05236608|Nivolumab|nivolumab|mesh-list
20507740|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20507741|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507742|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20507743|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507744|NCT05225402|Norepinephrine|norepinephrine|mesh-list
20507745|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20507746|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20507747|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507748|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507749|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507750|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507751|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
20507752|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
20507753|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507754|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20507755|NCT05225116|Lenvatinib|lenvatinib|mesh-list
20507756|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507757|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20507758|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507759|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507760|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
20507761|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
20507762|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20507763|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20507764|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507765|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507766|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507767|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529410|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529411|NCT01781507|Cetirizine|cetirizine|mesh-list
20529412|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20529413|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20529414|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20529415|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
20529416|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
20529417|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529418|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529419|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529420|NCT01781663|Petrolatum|petrolatum|mesh-list
20529421|NCT01781663|Emollients|emollients|mesh-ancestor
20529422|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
20529423|NCT01781702|Celecoxib|celecoxib|mesh-list
20529424|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20529425|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20529426|NCT01781702|Analgesics|analgesics|mesh-ancestor
20529427|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
20529428|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529429|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529430|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529431|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529432|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19701343|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19701344|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19701345|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853499|NCT00732992|Sunitinib|sunitinib|mesh-list
20507768|NCT05221229|Liraglutide|liraglutide|mesh-list
20507769|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20507770|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507771|NCT05221229|Incretins|incretins|mesh-ancestor
20507772|NCT05221229|Hormones|hormones|mesh-ancestor
20507773|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507774|NCT05220826|Ethanol|ethanol|mesh-list
20507775|NCT05220826|Ethylene|ethylene|mesh-list
20507776|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20507777|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507778|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507779|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507780|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20507781|NCT05220826|Growth Substances|growth substances|mesh-ancestor
20507782|NCT05219799|Propranolol|propranolol|mesh-list
20507783|NCT05219799|Nitroprusside|nitroprusside|mesh-list
20507784|NCT05219799|Isoproterenol|isoproterenol|mesh-list
20507785|NCT05219799|Norepinephrine|norepinephrine|mesh-list
20507786|NCT05219799|Acetylcholine|acetylcholine|mesh-list
20507787|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20507788|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20507789|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507790|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507791|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507792|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507793|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20244090|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20244091|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244092|NCT00418678|Nabilone|nabilone|mesh-list
20244093|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
20507794|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20507795|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
20244094|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
20244095|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244096|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244097|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244098|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20244099|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20244100|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507796|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20244101|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244102|NCT00418704|Docetaxel|docetaxel|mesh-list
20244103|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20507797|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20507798|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
20507799|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
20507800|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507801|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20507802|NCT05219799|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20507803|NCT05219799|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20507804|NCT05219799|Cholinergic Agents|cholinergic agents|mesh-ancestor
20507805|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20507806|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20507807|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20507808|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507809|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20507810|NCT05219799|Protective Agents|protective agents|mesh-ancestor
20507811|NCT05216055|Dexamethasone|dexamethasone|mesh-list
20507812|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
20507813|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
20507814|NCT05216055|Bupivacaine|bupivacaine|mesh-list
20507815|NCT05216055|Ropivacaine|ropivacaine|mesh-list
20507816|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20507817|NCT05216055|BB 1101|bb 1101|mesh-list
20507818|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507819|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
20507820|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
20507821|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507822|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507823|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507824|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
20507825|NCT05216055|Hormones|hormones|mesh-ancestor
20507826|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20507827|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20507828|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507829|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
20507830|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
20507831|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507832|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
20507833|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20507834|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507835|NCT05216055|Analgesics|analgesics|mesh-ancestor
20507836|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20507837|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20507838|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20507839|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507840|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507841|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701346|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701347|NCT04882826|Urological Agents|urological agents|mesh-ancestor
19701348|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20507842|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
19415361|NCT02946125|Phenylephrine|phenylephrine|mesh-list
19415362|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
19415363|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19415364|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19415365|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
20507843|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507844|NCT05215548|Afatinib|afatinib|mesh-list
20507845|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507846|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20507847|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415366|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
19415367|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415368|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415369|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
19701349|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
20507848|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507849|NCT05215327|Vaccines|vaccines|mesh-list
19415370|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19415371|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
19415372|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
19415373|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19415374|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19415375|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19415376|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
19415377|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415378|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415379|NCT02946125|Protective Agents|protective agents|mesh-ancestor
19415380|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19415381|NCT02933671|Ropivacaine|ropivacaine|mesh-list
19415382|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
19415383|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
19415384|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415385|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415386|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
19415387|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507850|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
20507851|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507852|NCT05210413|Spartalizumab|spartalizumab|mesh-list
20507853|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20507854|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507855|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507856|NCT05203705|Enoxaparin|enoxaparin|mesh-list
20507857|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
20507858|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19415388|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19415389|NCT02924389|Dolutegravir|dolutegravir|mesh-list
19415390|NCT02924389|Triumeq|triumeq|mesh-list
19415391|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19415392|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19415393|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701350|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20507859|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20507860|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507861|NCT05202561|Vaccines|vaccines|mesh-list
20507862|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
20507863|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507864|NCT05200364|Bevacizumab|bevacizumab|mesh-list
19415394|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415395|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
19415396|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415397|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19415398|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19415399|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19415400|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19415401|NCT02923531|Nivolumab|nivolumab|mesh-list
19415402|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415403|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415404|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19415405|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415406|NCT02920008|Guadecitabine|guadecitabine|mesh-list
19415407|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415408|NCT02918006|Vaccines|vaccines|mesh-list
20507865|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20507866|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507867|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20507868|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20507869|NCT05200364|Growth Substances|growth substances|mesh-ancestor
20507870|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507871|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
20507872|NCT05199818|Palonosetron|palonosetron|mesh-list
20507873|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
20507874|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
20507875|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507876|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507877|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507878|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20507879|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20507880|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
20507881|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507882|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507883|NCT05192629|Midazolam|midazolam|mesh-list
20507884|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
20244104|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244105|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
20244106|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244107|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
20244108|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244109|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20244110|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244111|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
20244112|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244113|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244114|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244115|NCT00418782|Naproxen|naproxen|mesh-list
20244116|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244117|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244118|NCT00418782|Analgesics|analgesics|mesh-ancestor
20244119|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
20244120|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244121|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244122|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20507885|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20244123|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244124|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
20244125|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20244126|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244127|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507886|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507887|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507888|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20507889|NCT05192629|Analgesics|analgesics|mesh-ancestor
20507890|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
20507891|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20507892|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20507893|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20507894|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20507895|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
20507896|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20507897|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507898|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19853500|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853501|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853502|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853503|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19853504|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19853505|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20507899|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20507900|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20507901|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20507902|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20507903|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
20507904|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
20507905|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
20507906|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
20507907|NCT05189444|Amoxicillin|amoxicillin|mesh-list
20507908|NCT05189444|Clarithromycin|clarithromycin|mesh-list
19853506|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19853507|NCT00732992|Growth Substances|growth substances|mesh-ancestor
20507909|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
20507910|NCT05189444|Esomeprazole|esomeprazole|mesh-list
20507911|NCT05189444|Bismuth|bismuth|mesh-list
20507912|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507913|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20507914|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20507915|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20507916|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20507917|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20507918|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507919|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20507920|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20507921|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20507922|NCT05189444|Antacids|antacids|mesh-ancestor
20507923|NCT05189444|Diuretics|diuretics|mesh-ancestor
20244128|NCT00418847|Miglustat|miglustat|mesh-list
20507924|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
20507925|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853508|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853509|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19853510|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853511|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
19853512|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19853513|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20507926|NCT05189444|Expectorants|expectorants|mesh-ancestor
20507927|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
20507928|NCT05180006|Bevacizumab|bevacizumab|mesh-list
19853514|NCT00733096|Prednisolone|prednisolone|mesh-list
19853515|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
19853516|NCT00733096|Etanercept|etanercept|mesh-list
20507929|NCT05180006|Trastuzumab|trastuzumab|mesh-list
20507930|NCT05180006|Pertuzumab|pertuzumab|mesh-list
20507931|NCT05180006|Atezolizumab|atezolizumab|mesh-list
20507932|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20507933|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507934|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20507935|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20507936|NCT05180006|Growth Substances|growth substances|mesh-ancestor
20507937|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507938|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
20507939|NCT05177796|Paclitaxel|paclitaxel|mesh-list
20507940|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
19853517|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19853518|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
19853519|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853520|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
19853521|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
19701351|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701352|NCT04882813|Incretins|incretins|mesh-ancestor
20507941|NCT05177796|Carboplatin|carboplatin|mesh-list
20507942|NCT05177796|Doxorubicin|doxorubicin|mesh-list
20507943|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20507944|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
20507945|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20507946|NCT05177796|Daunorubicin|daunorubicin|mesh-list
20507947|NCT05177796|Panitumumab|panitumumab|mesh-list
20507948|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20507949|NCT05177796|Antibodies|antibodies|mesh-list
20507950|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
20507951|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20507952|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20507953|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701353|NCT04882813|Hormones|hormones|mesh-ancestor
19701354|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701355|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19701356|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853522|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853523|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853524|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701357|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701358|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701359|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19701360|NCT04883125|Pioglitazone|pioglitazone|mesh-list
19701361|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701362|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701363|NCT04882540|Brivaracetam|brivaracetam|mesh-list
19701364|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
19701365|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
19853525|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
20507954|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
20507955|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
20507956|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
20507957|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507958|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20507959|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
20507960|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507961|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507962|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20507963|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
19701366|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19853526|NCT00733096|Hormones|hormones|mesh-ancestor
20507964|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19855627|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507965|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20507966|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20507967|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20507968|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20507969|NCT05175274|Colchicine|colchicine|mesh-list
20507970|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
20507971|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20507972|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
20507973|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
20507974|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
20507975|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20507976|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507977|NCT05174611|Vitamin D|vitamin d|mesh-list
20507978|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
20507979|NCT05174611|Vitamins|vitamins|mesh-ancestor
20507980|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
20507981|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507982|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20507983|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20507984|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20507985|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
20507986|NCT05174585|Antibodies|antibodies|mesh-list
20507987|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
20507988|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20507989|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
20507990|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20507991|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20507992|NCT05169268|Aripiprazole|aripiprazole|mesh-list
20507993|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
20507994|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
20507995|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20507996|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20507997|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20507998|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20507999|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508000|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
20508001|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
20508002|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508003|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508004|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20508005|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20508006|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
20508007|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20508008|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20508009|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20508010|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20508011|NCT05166876|Brequinar|brequinar|mesh-list
20508012|NCT05166876|Dipyridamole|dipyridamole|mesh-list
20508013|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20508014|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508015|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508016|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20508017|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
20508018|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508019|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20508020|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
20508021|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529433|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20529434|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529435|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529436|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20529437|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
20529438|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244129|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244130|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244131|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20244132|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20244133|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
20244134|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244135|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20244136|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20244137|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244138|NCT00418860|Aspirin|aspirin|mesh-list
20244139|NCT00418860|Clopidogrel|clopidogrel|mesh-list
20244140|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244141|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244142|NCT00418860|Analgesics|analgesics|mesh-ancestor
19701367|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701368|NCT04882683|Prednisone|prednisone|mesh-list
19701369|NCT04882683|Adalimumab|adalimumab|mesh-list
19701370|NCT04882683|Azathioprine|azathioprine|mesh-list
19701371|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701372|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
19701373|NCT04882683|Hormones|hormones|mesh-ancestor
19701374|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701375|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701376|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19701377|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508022|NCT05217706|Ketamine|ketamine|mesh-list
20508023|NCT05217706|Analgesics|analgesics|mesh-ancestor
20508024|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
20508025|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508026|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508027|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20508028|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508029|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
20508030|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
20508031|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508032|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20508033|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20508034|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508035|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508036|NCT05159427|Glipizide|glipizide|mesh-list
20508037|NCT05159427|Rifaximin|rifaximin|mesh-list
20508038|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508039|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701378|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701379|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
19701380|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701381|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20508040|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508041|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508042|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508043|NCT05157126|Gentamicins|gentamicins|mesh-list
20508044|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508045|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508046|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20508047|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508048|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508049|NCT05150795|Pregabalin|pregabalin|mesh-list
20508050|NCT05150795|Fentanyl|fentanyl|mesh-list
20508051|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20508052|NCT05150795|Narcotics|narcotics|mesh-ancestor
20508053|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508054|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855628|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
20508055|NCT05150795|Analgesics|analgesics|mesh-ancestor
20508056|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
20508057|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508058|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20508059|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508060|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
20508061|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
20508062|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
20508063|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20508064|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508065|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508066|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20508067|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20508068|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20508069|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20508070|NCT05150756|Lidocaine|lidocaine|mesh-list
20508071|NCT05150756|Morphine|morphine|mesh-list
20508072|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
20508073|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
20508074|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508075|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508076|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
20508077|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508078|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20508079|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20508080|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20508081|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508082|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508083|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20508084|NCT05150756|Narcotics|narcotics|mesh-ancestor
20508085|NCT05150756|Analgesics|analgesics|mesh-ancestor
20508086|NCT05148078|Anesthetics|anesthetics|mesh-list
20508087|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508088|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508089|NCT05146778|Lidocaine|lidocaine|mesh-list
20508090|NCT05146778|Fentanyl|fentanyl|mesh-list
20508091|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
20508092|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
20508093|NCT05146778|Anesthetics|anesthetics|mesh-list
20508094|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
20508095|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508096|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508097|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
20508098|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508099|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20508100|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20508101|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20508102|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508103|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508104|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20508105|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508106|NCT05146778|Analgesics|analgesics|mesh-ancestor
20508107|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20508108|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20508109|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20508110|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
20508111|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508112|NCT05146778|Narcotics|narcotics|mesh-ancestor
20508113|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20508114|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508115|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
20508116|NCT05141344|Melatonin|melatonin|mesh-list
20508117|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
20508118|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508119|NCT05141344|Protective Agents|protective agents|mesh-ancestor
20508120|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508121|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508122|NCT05140278|Artesunate|artesunate|mesh-list
20508123|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
20508124|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20508125|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20508126|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508127|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508128|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
20508129|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
20508130|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20508131|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
20508132|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
20508133|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20508134|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508135|NCT05138822|Renal Agents|renal agents|mesh-ancestor
20508136|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508137|NCT05138549|Beta Carotene|beta carotene|mesh-list
20508138|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508139|NCT05138549|Provitamins|provitamins|mesh-ancestor
20508140|NCT05138549|Vitamins|vitamins|mesh-ancestor
20508141|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
20508142|NCT05132439|Metformin|metformin|mesh-list
20508143|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508144|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508145|NCT05132114|Lugol's solution|lugol's solution|mesh-list
20508146|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
20508147|NCT05132114|Coagulants|coagulants|mesh-ancestor
20508148|NCT05129137|Acetaminophen|acetaminophen|mesh-list
20508149|NCT05129137|Nefopam|nefopam|mesh-list
20508150|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508151|NCT05129137|Analgesics|analgesics|mesh-ancestor
20508152|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
20508153|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508154|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508155|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
20508156|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
20508157|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20508158|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508159|NCT05111314|Edetic Acid|edetic acid|mesh-list
20508160|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20508161|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
20508162|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
20508163|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508164|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
20508165|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20508166|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20508167|NCT05110898|Olmesartan|olmesartan|mesh-list
20508168|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20508169|NCT05110898|Indapamide|indapamide|mesh-list
20508170|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20508171|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20508172|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20508173|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508174|NCT05110898|Diuretics|diuretics|mesh-ancestor
20508175|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
20508176|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508177|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20508178|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19701382|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701383|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
19708050|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19708051|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19708052|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708053|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708054|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19708055|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19708056|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
19708057|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19855629|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20508179|NCT05110638|Luliconazole|luliconazole|mesh-list
20508180|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
20508181|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508182|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
20508183|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20508184|NCT05110001|Natamycin|natamycin|mesh-list
20508185|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
20508186|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20508187|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508188|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
20508189|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
20508190|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508191|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20508192|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20508193|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508194|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508195|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508196|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
20508197|NCT05108428|Capecitabine|capecitabine|mesh-list
20508198|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20508199|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
20508200|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508201|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508202|NCT05107427|Avelumab|avelumab|mesh-list
20508203|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508204|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508205|NCT05103696|Propofol|propofol|mesh-list
19853527|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853528|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19853529|NCT00733096|Protective Agents|protective agents|mesh-ancestor
20508206|NCT05103696|Etomidate|etomidate|mesh-list
20508207|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20508208|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508209|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508210|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508211|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
20508212|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
20508213|NCT05098041|Rifampin|rifampin|mesh-list
20508214|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20508215|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
20508216|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508217|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853530|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19853531|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508218|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
20508219|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20508220|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508221|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508222|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20508223|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20508224|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20508225|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20508226|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20508227|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20508228|NCT05096325|Insulin|insulin|mesh-list
20508229|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508230|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508231|NCT05096065|Leuprolide|leuprolide|mesh-list
20508232|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20508233|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
20508234|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20508235|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508236|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20508237|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508238|NCT05094427|Anesthetics|anesthetics|mesh-list
20508239|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
20508240|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508241|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508242|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
19701384|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
20508243|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508244|NCT05093608|Bevacizumab|bevacizumab|mesh-list
20508245|NCT05093608|Atezolizumab|atezolizumab|mesh-list
20508246|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508247|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508248|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20508249|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20508250|NCT05093608|Growth Substances|growth substances|mesh-ancestor
20508251|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508252|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
20529439|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
20529440|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
20529441|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529442|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529443|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529444|NCT01781897|Mosapride|mosapride|mesh-list
20529445|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508253|NCT05090384|Prednisone|prednisone|mesh-list
20508254|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508255|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
20508256|NCT05090384|Hormones|hormones|mesh-ancestor
20508257|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508258|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508259|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20508260|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508261|NCT05085574|Celecoxib|celecoxib|mesh-list
20508262|NCT05085574|Famotidine|famotidine|mesh-list
20508263|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20508264|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508265|NCT05085574|Analgesics|analgesics|mesh-ancestor
20508266|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
20508267|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508268|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508269|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508270|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508271|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20508272|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20508273|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508274|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508275|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20508276|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508277|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20508278|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
20508279|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
20508280|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508281|NCT05084248|Vitamin D|vitamin d|mesh-list
20508282|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
20508283|NCT05084248|Vitamins|vitamins|mesh-ancestor
20508284|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
20508285|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508286|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20508287|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20508288|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20508289|NCT05083572|Rifaximin|rifaximin|mesh-list
19415409|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
19415410|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415411|NCT02917629|Pioglitazone|pioglitazone|mesh-list
19415412|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415413|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415414|NCT02913612|Timolol|timolol|mesh-list
20508290|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508291|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508292|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20508293|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20508294|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20508295|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415415|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20529446|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20508296|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508297|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
20508298|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853532|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20508299|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508300|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
20508301|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20508302|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508303|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508304|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508305|NCT05057273|Adalimumab|adalimumab|mesh-list
20508306|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508307|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508308|NCT05039476|Vitamin A|vitamin a|mesh-list
20508309|NCT05039476|Vitamins|vitamins|mesh-ancestor
20508310|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
20508311|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508312|NCT05036018|Anesthetics|anesthetics|mesh-list
20508313|NCT05036018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508314|NCT05036018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508315|NCT05035680|Vaccines|vaccines|mesh-list
20508316|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
20508317|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508318|NCT05033743|Secnidazole|secnidazole|mesh-list
20508319|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20508320|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20508321|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508322|NCT05030025|Lamivudine|lamivudine|mesh-list
20508323|NCT05030025|Abacavir|abacavir|mesh-list
20508324|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
20508325|NCT05030025|Dolutegravir|dolutegravir|mesh-list
19701385|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19701386|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701387|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701388|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701389|NCT04882163|Gemcitabine|gemcitabine|mesh-list
19701390|NCT04882163|Dexamethasone|dexamethasone|mesh-list
19701391|NCT04882163|Rituximab|rituximab|mesh-list
19701392|NCT04882163|Lenalidomide|lenalidomide|mesh-list
19701393|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19701394|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701395|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19701396|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
19701397|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701398|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701399|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701400|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
19701401|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
20508326|NCT05030025|Triumeq|triumeq|mesh-list
20508327|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20508328|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20508329|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508330|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508331|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
20508332|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508333|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20508334|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20508335|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
20508336|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20508337|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20508338|NCT05027646|Granisetron|granisetron|mesh-list
20508339|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
20508340|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
20508341|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508342|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853533|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508343|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508344|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19415416|NCT02913612|Maleic acid|maleic acid|mesh-list
19415417|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19415418|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20508345|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
20508346|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508347|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508348|NCT05022901|Melphalan|melphalan|mesh-list
20508349|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20508350|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
20508351|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508352|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508353|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20508354|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20508355|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
20508356|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508357|NCT05022524|Acetic Acid|acetic acid|mesh-list
20508358|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508359|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508360|NCT05021809|Calcium|calcium|mesh-list
20508361|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20508362|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508363|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
20508364|NCT05014776|Ipilimumab|ipilimumab|mesh-list
20508365|NCT05014776|Tadalafil|tadalafil|mesh-list
20508366|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508367|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508368|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20508369|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508370|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
20508371|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19415419|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
19415420|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415421|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415422|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415423|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19415424|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19415425|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415426|NCT02907359|Guadecitabine|guadecitabine|mesh-list
19415427|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415428|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
20244143|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
19415429|NCT02905188|Fludarabine|fludarabine|mesh-list
19415430|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415431|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
19415432|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415433|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508372|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20508373|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508374|NCT05014776|Urological Agents|urological agents|mesh-ancestor
19415434|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20508375|NCT05013567|Ibuprofen|ibuprofen|mesh-list
20508376|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20508377|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508378|NCT05013567|Analgesics|analgesics|mesh-ancestor
20508379|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
20508380|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415435|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
20508381|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508382|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508383|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508384|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20508385|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508386|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508387|NCT05013502|Empagliflozin|empagliflozin|mesh-list
20508388|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20508389|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508390|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508391|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529447|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
20529448|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529449|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529450|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529451|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20529452|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529453|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
20529454|NCT01781936|Hormones|hormones|mesh-ancestor
20529455|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529456|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529457|NCT01781988|Gemcitabine|gemcitabine|mesh-list
20529458|NCT01781988|Carboplatin|carboplatin|mesh-list
20529459|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529460|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20529461|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
20529462|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529463|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
20529464|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529465|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508392|NCT05013229|Insulin|insulin|mesh-list
20508393|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20508394|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
20508395|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
20508396|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508397|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508398|NCT05008926|Naloxegol|naloxegol|mesh-list
20508399|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20508400|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508401|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
19853534|NCT00733096|Analgesics|analgesics|mesh-ancestor
19853535|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
19853536|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853537|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853538|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
19853539|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
19853540|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19853541|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
20508402|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508403|NCT05007821|Linezolid|linezolid|mesh-list
20508404|NCT05007821|Bedaquiline|bedaquiline|mesh-list
20508405|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
20508406|NCT05007821|Clofazimine|clofazimine|mesh-list
20508407|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508408|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508409|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20508410|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508411|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508412|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
20508413|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508414|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
20508415|NCT05001373|Vaccines|vaccines|mesh-list
20508416|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
20508417|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508418|NCT04999644|Nicotine|nicotine|mesh-list
20508419|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20508420|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
19853542|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853543|NCT00733278|Copper|copper|mesh-list
19853544|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
19853545|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19853546|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853547|NCT00733278|Trace Elements|trace elements|mesh-ancestor
19853548|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
19853549|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19853550|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19853551|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19853552|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853553|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19853554|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19853555|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853556|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853557|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
19853558|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853559|NCT00733408|Paclitaxel|paclitaxel|mesh-list
19853560|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19853561|NCT00733408|Bevacizumab|bevacizumab|mesh-list
20508421|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853562|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19853563|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20508422|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508423|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20508424|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20508425|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
20508426|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508427|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508428|NCT04992065|Evolocumab|evolocumab|mesh-list
20508429|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20508430|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20508431|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
20508432|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508433|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20508434|NCT04989621|Rituximab|rituximab|mesh-list
20508435|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508436|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508437|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
20508438|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508439|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508440|NCT04989049|Folic Acid|folic acid|mesh-list
20508441|NCT04989049|Hematinics|hematinics|mesh-ancestor
20508442|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
20508443|NCT04989049|Vitamins|vitamins|mesh-ancestor
20508444|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
20508445|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508446|NCT04984993|Tadalafil|tadalafil|mesh-list
20508447|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
20508448|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20508449|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20508450|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508451|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508452|NCT04984993|Urological Agents|urological agents|mesh-ancestor
20508453|NCT04984044|Vitamin D|vitamin d|mesh-list
20508454|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
20508455|NCT04984044|Vitamins|vitamins|mesh-ancestor
20508456|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
20508457|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508458|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20508459|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20508460|NCT04981912|Rituximab|rituximab|mesh-list
20508461|NCT04981912|Venetoclax|venetoclax|mesh-list
20508462|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508463|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508464|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
20508465|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508466|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508467|NCT04979442|Trabectedin|trabectedin|mesh-list
20508468|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20508469|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
20508470|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508471|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508472|NCT04979065|Vitamin D|vitamin d|mesh-list
20508473|NCT04979065|Vitamins|vitamins|mesh-ancestor
20508474|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
20508475|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508476|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20508477|NCT04976036|Nintedanib|nintedanib|mesh-list
20508478|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508479|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20508480|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508481|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508482|NCT04975802|Caffeine|caffeine|mesh-list
20508483|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20508484|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508485|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20508486|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508487|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508488|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20508489|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20508490|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
20508491|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508492|NCT04973930|Citalopram|citalopram|mesh-list
20508493|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20508494|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20508495|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20508496|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508497|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508498|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508499|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
20508500|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508501|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20508502|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
20508503|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20508504|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20508505|NCT04972552|Ubiquinone|ubiquinone|mesh-list
20508506|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
20508507|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
20508508|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508509|NCT04972552|Vitamins|vitamins|mesh-ancestor
20508510|NCT04971499|Dapansutrile|dapansutrile|mesh-list
20508511|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
20508512|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508513|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508514|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508515|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
20508516|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20508517|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20508518|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20508519|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20508520|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508521|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508522|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
20508523|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508524|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508525|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20508526|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508527|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
20508528|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20508529|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508530|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508531|NCT04966585|Posaconazole|posaconazole|mesh-list
20508532|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
20508533|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508534|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20508535|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20508536|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20508537|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20508538|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20508539|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508540|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508541|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20508542|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
20508543|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508544|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508545|NCT04964700|Natalizumab|natalizumab|mesh-list
20508546|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
20508547|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508548|NCT04952779|Insulin|insulin|mesh-list
20508549|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20508550|NCT04952779|Liraglutide|liraglutide|mesh-list
20508551|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
20508552|NCT04952779|Xultophy|xultophy|mesh-list
20508553|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508554|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508555|NCT04952779|Incretins|incretins|mesh-ancestor
20508556|NCT04952779|Hormones|hormones|mesh-ancestor
20508557|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508558|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20508559|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
20508560|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20508561|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20508562|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20508563|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508564|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529466|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529467|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
19853564|NCT00733408|Antibodies|antibodies|mesh-list
19853565|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
19853566|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19853567|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19853568|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529468|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529469|NCT01782001|Vitamins|vitamins|mesh-list
20529470|NCT01782001|Vitamin A|vitamin a|mesh-list
20529471|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
20529472|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
20529473|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529474|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
20508565|NCT04941521|Exenatide|exenatide|mesh-list
20508566|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701402|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701403|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701404|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
19701405|NCT04882163|Hormones|hormones|mesh-ancestor
19701406|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701407|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20508567|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508568|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20508569|NCT04941521|Incretins|incretins|mesh-ancestor
20508570|NCT04941521|Hormones|hormones|mesh-ancestor
20508571|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508572|NCT04940767|Minocycline|minocycline|mesh-list
20244144|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244145|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244146|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244147|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244148|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20508573|NCT04940767|Isotretinoin|isotretinoin|mesh-list
20508574|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19415436|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415437|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415438|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19415439|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
19415440|NCT02892149|Hematinics|hematinics|mesh-ancestor
20508575|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508576|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
20508577|NCT04939597|Memantine|memantine|mesh-list
20508578|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20508579|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20508580|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
20508581|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508582|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508583|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508584|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20508585|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20508586|NCT04936854|Sirolimus|sirolimus|mesh-list
20508587|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
20508588|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20508589|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20508590|NCT04936854|Prednisolone|prednisolone|mesh-list
20508591|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
20508592|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20508593|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
20508594|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508595|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508596|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20508597|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508598|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
20508599|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20508600|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
20508601|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508602|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415441|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
19415442|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19415443|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415444|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19415445|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19701408|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20244149|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20508603|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
20508604|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
20508605|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508606|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508607|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
20508608|NCT04936854|Hormones|hormones|mesh-ancestor
20508609|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508610|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20508611|NCT04936854|Protective Agents|protective agents|mesh-ancestor
19415446|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415447|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415448|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
20508612|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20508613|NCT04926181|Androgens|androgens|mesh-list
20508614|NCT04926181|Hormones|hormones|mesh-ancestor
20508615|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508616|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508617|NCT04921527|Paclitaxel|paclitaxel|mesh-list
20508618|NCT04921527|Chiauranib|chiauranib|mesh-list
20508619|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20508620|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508621|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
20508622|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
20508623|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
20508624|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508625|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20508626|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415449|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701409|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
20508627|NCT04908176|Midazolam|midazolam|mesh-list
20508628|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19701410|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701411|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
19701412|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701413|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701414|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701415|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19701416|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19701417|NCT04882163|Growth Substances|growth substances|mesh-ancestor
19701418|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
19701419|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19701420|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
19701421|NCT04881942|Menthol|menthol|mesh-list
19701422|NCT04881942|Nicotine|nicotine|mesh-list
19701423|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19701424|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
19701425|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701426|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701427|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19701428|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19701429|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
19701430|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701431|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508629|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20508630|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508631|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508632|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20508633|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20508634|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415450|NCT02880956|Tilavonemab|tilavonemab|mesh-list
20508635|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508636|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
20508637|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
20508638|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
19415451|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
19415452|NCT02872116|Leucovorin|leucovorin|mesh-list
19415453|NCT02872116|Fluorouracil|fluorouracil|mesh-list
19415454|NCT02872116|Capecitabine|capecitabine|mesh-list
19415455|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
19415456|NCT02872116|Nivolumab|nivolumab|mesh-list
19415457|NCT02872116|Ipilimumab|ipilimumab|mesh-list
19415458|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
20508639|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
20508640|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508641|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508642|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
20508643|NCT04899843|Astringents|astringents|mesh-ancestor
20508644|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508645|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
20508646|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
20508647|NCT04899687|Fluoxetine|fluoxetine|mesh-list
20508648|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20508649|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20508650|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508651|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508652|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508653|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
20508654|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508655|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20508656|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
20508657|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20508658|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20508659|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19701432|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
20508660|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508661|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
20508662|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
20508663|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20508664|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20508665|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
20508666|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19701433|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
19701434|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
19701435|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701436|NCT04881929|Docetaxel|docetaxel|mesh-list
19701437|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701438|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701439|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
20508667|NCT04897802|Exenatide|exenatide|mesh-list
20508668|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508669|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508670|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20508671|NCT04897802|Incretins|incretins|mesh-ancestor
20508672|NCT04897802|Hormones|hormones|mesh-ancestor
20508673|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508674|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20508675|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
20508676|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508677|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
20508678|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508679|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
20508680|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
20508681|NCT04882332|Vitamins|vitamins|mesh-ancestor
20508682|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
20508683|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508684|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
20508685|NCT04882332|Hematinics|hematinics|mesh-ancestor
20508686|NCT04882202|Acetaminophen|acetaminophen|mesh-list
20508687|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508688|NCT04882202|Analgesics|analgesics|mesh-ancestor
20508689|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
20508690|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508691|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508692|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
20508693|NCT04877288|Cyclosporine|cyclosporine|mesh-list
20508694|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
20508695|NCT04877288|Abatacept|abatacept|mesh-list
20508696|NCT04877288|Tacrolimus|tacrolimus|mesh-list
20508697|NCT04877288|Cyclosporins|cyclosporins|mesh-list
20508698|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20508699|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
19853569|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
19853570|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853571|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
19853572|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853573|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853574|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19853575|NCT00733408|Growth Substances|growth substances|mesh-ancestor
19853576|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853577|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
20508700|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508701|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20508702|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508703|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508704|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
20508705|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508706|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
20508707|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508708|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20508709|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508710|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20508711|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
20508712|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20508713|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20508714|NCT04871607|Cytarabine|cytarabine|mesh-list
20508715|NCT04871607|Etoposide|etoposide|mesh-list
20508716|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
20508717|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
20508718|NCT04871607|Carmustine|carmustine|mesh-list
20508719|NCT04871607|Basiliximab|basiliximab|mesh-list
20508720|NCT04871607|Sargramostim|sargramostim|mesh-list
20508721|NCT04871607|Lenograstim|lenograstim|mesh-list
20508722|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20508723|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508724|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20508725|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20508726|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508727|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508728|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20508729|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
20508730|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
20508731|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508732|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20508733|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
20508734|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508735|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20508736|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20508737|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
20508738|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
20508739|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
20508740|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
20508741|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
20508742|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
20508743|NCT04871425|Fentanyl|fentanyl|mesh-list
20508744|NCT04871425|Ketamine|ketamine|mesh-list
20508745|NCT04871425|Analgesics|analgesics|mesh-ancestor
20508746|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
20508747|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508748|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508749|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20508750|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508751|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
20508752|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
20508753|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508754|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20508755|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20508756|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508757|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508758|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20508759|NCT04871425|Narcotics|narcotics|mesh-ancestor
20508760|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20508761|NCT04862975|Tenofovir|tenofovir|mesh-list
20508762|NCT04862975|Emtricitabine|emtricitabine|mesh-list
20508763|NCT04862975|Efavirenz|efavirenz|mesh-list
20508764|NCT04862975|Dolutegravir|dolutegravir|mesh-list
20508765|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
20508766|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508767|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20508768|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20508769|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508770|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508771|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20508772|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20508773|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20508774|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20508775|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20508776|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20508777|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20508778|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20508779|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20508780|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19701440|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
19853578|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
20508781|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
20508782|NCT04848337|Lenvatinib|lenvatinib|mesh-list
20508783|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508784|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508785|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20508786|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508787|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508788|NCT04847193|Xanthohumol|xanthohumol|mesh-list
20508789|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508790|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20508791|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20508792|NCT04847193|Growth Substances|growth substances|mesh-ancestor
20508793|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508794|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
20508795|NCT04843631|Ustekinumab|ustekinumab|mesh-list
20508796|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
20508797|NCT04838743|Xultophy|xultophy|mesh-list
20508798|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508799|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508800|NCT04838743|Incretins|incretins|mesh-ancestor
20508801|NCT04838743|Hormones|hormones|mesh-ancestor
20508802|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508803|NCT04835584|Dasatinib|dasatinib|mesh-list
20508804|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508805|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20508806|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508807|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508808|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
20508809|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508810|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508811|NCT04826393|Cemiplimab|cemiplimab|mesh-list
20508812|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20508813|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508814|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
20508815|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20508816|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701441|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701442|NCT04881747|Lasmiditan|lasmiditan|mesh-list
19701443|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19701444|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
20508817|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508818|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508819|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
20508820|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
20508821|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20508822|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20508823|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20508824|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508825|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508826|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
20508827|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508828|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508829|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20508830|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508831|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20508832|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20508833|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20508834|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20508835|NCT04800107|Curcumin|curcumin|mesh-list
20508836|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20508837|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508838|NCT04800107|Analgesics|analgesics|mesh-ancestor
20508839|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
20508840|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508841|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415459|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415460|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19415461|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508842|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508843|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508844|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508845|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508846|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508847|NCT04793867|Xenon|xenon|mesh-list
20508848|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20508849|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
20508850|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
20508851|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508852|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508853|NCT04791969|Naltrexone|naltrexone|mesh-list
20508854|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20508855|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20508856|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508857|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
20508858|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508859|NCT04790474|Dexamethasone|dexamethasone|mesh-list
20508860|NCT04790474|Pomalidomide|pomalidomide|mesh-list
20508861|NCT04790474|Ixazomib|ixazomib|mesh-list
20508862|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20508863|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
20508864|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
20508865|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508866|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508867|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508868|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
20508869|NCT04790474|Hormones|hormones|mesh-ancestor
20508870|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508871|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19701445|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701446|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701447|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701448|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
19701449|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19701450|NCT04881682|Antibodies|antibodies|mesh-list
19701451|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
19701452|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701453|NCT04881474|Ibuprofen|ibuprofen|mesh-list
19701454|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19701455|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19701456|NCT04881474|Analgesics|analgesics|mesh-ancestor
19701457|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
19701458|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701459|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701460|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701461|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20508872|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508873|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
20508874|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20508875|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20508876|NCT04790474|Growth Substances|growth substances|mesh-ancestor
20508877|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
20508878|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
20508879|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508880|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529475|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529476|NCT01782001|Protective Agents|protective agents|mesh-ancestor
20529477|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20508881|NCT04781647|Interferons|interferons|mesh-list
20508882|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
20508883|NCT04781647|Entecavir|entecavir|mesh-list
20508884|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508885|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
20508886|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20508887|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
20508888|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508889|NCT04779320|Vedolizumab|vedolizumab|mesh-list
20508890|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20508891|NCT04777539|Natalizumab|natalizumab|mesh-list
20508892|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
20508893|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508894|NCT04774315|Omalizumab|omalizumab|mesh-list
20508895|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20508896|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20508897|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
20508898|NCT04767503|Propofol|propofol|mesh-list
20508899|NCT04767503|Desflurane|desflurane|mesh-list
20508900|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20508901|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508902|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508903|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508904|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
20508905|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
20508906|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20508907|NCT04763564|Liraglutide|liraglutide|mesh-list
20508908|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20508909|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508910|NCT04763564|Incretins|incretins|mesh-ancestor
20508911|NCT04763564|Hormones|hormones|mesh-ancestor
20508912|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20508913|NCT04763252|Coal Tar|coal tar|mesh-list
20508914|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
20508915|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
20508916|NCT04762888|Edetic Acid|edetic acid|mesh-list
20508917|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20508918|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
20508919|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
20508920|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508921|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
20508922|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20508923|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20508924|NCT04762199|Osimertinib|osimertinib|mesh-list
20508925|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508926|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20508927|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508928|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508929|NCT04761159|Ketamine|ketamine|mesh-list
20508930|NCT04761159|Analgesics|analgesics|mesh-ancestor
20508931|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
20508932|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508933|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508934|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20508935|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20508936|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
20508937|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
20508938|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508939|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20508940|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20508941|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508942|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508943|NCT04760496|Oxytocin|oxytocin|mesh-list
20508944|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
20508945|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20508946|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508947|NCT04753216|Bevacizumab|bevacizumab|mesh-list
20508948|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20508949|NCT04753216|Irinotecan|irinotecan|mesh-list
20508950|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
20508951|NCT04753216|Antibodies|antibodies|mesh-list
20508952|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
20508953|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20508954|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
20508955|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20508956|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20508957|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20508958|NCT04753216|Growth Substances|growth substances|mesh-ancestor
20508959|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508960|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
20508961|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
20508962|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20508963|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20508964|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20508965|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508966|NCT04752033|Morphine|morphine|mesh-list
20508967|NCT04752033|Hydromorphone|hydromorphone|mesh-list
20508968|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20508969|NCT04752033|Narcotics|narcotics|mesh-ancestor
20508970|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508971|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508972|NCT04752033|Analgesics|analgesics|mesh-ancestor
20508973|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
20508974|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508975|NCT04750967|Lidocaine|lidocaine|mesh-list
20508976|NCT04750967|Amitriptyline|amitriptyline|mesh-list
20508977|NCT04750967|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20508978|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
20508979|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
20508980|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20508981|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20508982|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
20508983|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20508984|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20508985|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20508986|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20508987|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20508988|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20508989|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20508990|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
20508991|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20508992|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20508993|NCT04750967|Analgesics|analgesics|mesh-ancestor
20508994|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20508995|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20508996|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
20508997|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20508998|NCT04750967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20508999|NCT04750967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20509000|NCT04741698|Propranolol|propranolol|mesh-list
20509001|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20509002|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20509003|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
20509004|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509005|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509006|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509007|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20509008|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20509009|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
20509010|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20509011|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
20509012|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20509013|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
20509014|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20509015|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509016|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20509017|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20509018|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509019|NCT04733547|Furosemide|furosemide|mesh-list
20509020|NCT04733547|Diuretics|diuretics|mesh-ancestor
20509021|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
20244150|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509022|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509023|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20509024|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20509025|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509026|NCT04731480|Propofol|propofol|mesh-list
20509027|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20509028|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509029|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509030|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20509031|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
20509032|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
20509033|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
20509034|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20509035|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509036|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20244151|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20244152|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20244153|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244154|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
20244155|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20244156|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20244157|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20244158|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
20244159|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244160|NCT00418873|Risperidone|risperidone|mesh-list
20244161|NCT00418873|Zotepine|zotepine|mesh-list
20244162|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20244163|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
20244164|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244165|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244166|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509037|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509038|NCT04722679|Anticoagulants|anticoagulants|mesh-list
20509039|NCT04718961|Volixibat|volixibat|mesh-list
20509040|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20509041|NCT04716712|Azithromycin|azithromycin|mesh-list
20509042|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20509043|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509044|NCT04707794|Sevoflurane|sevoflurane|mesh-list
20509045|NCT04707794|Desflurane|desflurane|mesh-list
20509046|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20509047|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20509048|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
20509049|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
20509050|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509051|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509052|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
20509053|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509054|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
20509055|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509056|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509057|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20509058|NCT04706507|Ganciclovir|ganciclovir|mesh-list
20509059|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
20509060|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
20509061|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509062|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20509063|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244167|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20244168|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20244169|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244170|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244171|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20244172|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
20248036|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509064|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509065|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
20509066|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20509067|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
20509068|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509069|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
20509070|NCT04704518|Protective Agents|protective agents|mesh-ancestor
20509071|NCT04699461|Idelalisib|idelalisib|mesh-list
20509072|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
20248037|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
20248038|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20509073|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509074|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509075|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509076|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509077|NCT04696380|Nicotine|nicotine|mesh-list
20509078|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20509079|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
20509080|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509081|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509082|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20509083|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20509084|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
20509085|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509086|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529478|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529479|NCT01782261|Liraglutide|liraglutide|mesh-list
20529480|NCT01782261|Saxagliptin|saxagliptin|mesh-list
20529481|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20529482|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529483|NCT01782261|Incretins|incretins|mesh-ancestor
20529484|NCT01782261|Hormones|hormones|mesh-ancestor
20529485|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529486|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20529487|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
20529488|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529489|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529490|NCT01782274|Vaccines|vaccines|mesh-list
20529491|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
20529492|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529493|NCT01782287|Vaccines|vaccines|mesh-list
20529494|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
20529495|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529496|NCT01782300|Vaccines|vaccines|mesh-list
20529497|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
20529498|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529499|NCT01782352|Vitamin D|vitamin d|mesh-list
20529500|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
20529501|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
20529502|NCT01782352|Vitamins|vitamins|mesh-list
20529503|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
20529504|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529505|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20529506|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20529507|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
20529508|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20529509|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529510|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
20529511|NCT01782443|Aflibercept|aflibercept|mesh-list
20509087|NCT04690855|Atezolizumab|atezolizumab|mesh-list
20509088|NCT04690855|Talazoparib|talazoparib|mesh-list
20509089|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509090|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20509091|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509092|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509093|NCT04672772|Paclitaxel|paclitaxel|mesh-list
20509094|NCT04672772|Cetuximab|cetuximab|mesh-list
20509095|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20509096|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509097|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
20509098|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
20509099|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
20509100|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509101|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509102|NCT04671082|Tolperisone|tolperisone|mesh-list
20509103|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20509104|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509105|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20244173|NCT00418925|Dronabinol|dronabinol|mesh-list
20244174|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
20244175|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244176|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244177|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244178|NCT00418925|Analgesics|analgesics|mesh-ancestor
20509106|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509107|NCT04669587|Palbociclib|palbociclib|mesh-list
20509108|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509109|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509110|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509111|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509112|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
20509113|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20509114|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
20509115|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509116|NCT04659382|Bevacizumab|bevacizumab|mesh-list
20509117|NCT04659382|Atezolizumab|atezolizumab|mesh-list
19415462|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509118|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509119|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509120|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20509121|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20509122|NCT04659382|Growth Substances|growth substances|mesh-ancestor
20509123|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509124|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
20509125|NCT04658823|Vitamin E|vitamin e|mesh-list
20509126|NCT04658823|Tocopherols|tocopherols|mesh-list
20509127|NCT04658823|Tocotrienols|tocotrienols|mesh-list
20509128|NCT04658823|Tocovid|tocovid|mesh-list
20509129|NCT04658823|Vitamins|vitamins|mesh-ancestor
20509130|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
20509131|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509132|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
19415463|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
20509133|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509134|NCT04658823|Protective Agents|protective agents|mesh-ancestor
20509135|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
20509136|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509137|NCT04657016|Tirzepatide|tirzepatide|mesh-list
20244179|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
20244180|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244181|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20244182|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19701462|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19701463|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701464|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701465|NCT04881851|Folic Acid|folic acid|mesh-list
20244183|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244184|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244185|NCT00418925|Hormones|hormones|mesh-ancestor
20244186|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244187|NCT00419042|Gemcitabine|gemcitabine|mesh-list
20244188|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20244189|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20509138|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20509139|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701466|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
19701467|NCT04881851|Inositol|inositol|mesh-list
19701468|NCT04881851|Hematinics|hematinics|mesh-ancestor
19701469|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
19701470|NCT04881851|Vitamins|vitamins|mesh-ancestor
19701471|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
20509140|NCT04657016|Incretins|incretins|mesh-ancestor
20509141|NCT04657016|Hormones|hormones|mesh-ancestor
20509142|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509143|NCT04655144|Dexamethasone|dexamethasone|mesh-list
20509144|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509145|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
20509146|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
20509147|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509148|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701472|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701473|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
20509149|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20509150|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
20509151|NCT04655144|Hormones|hormones|mesh-ancestor
20509152|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509153|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20509154|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509155|NCT04649476|Cisplatin|cisplatin|mesh-list
20509156|NCT04649476|Docetaxel|docetaxel|mesh-list
20509157|NCT04649476|Fluorouracil|fluorouracil|mesh-list
20509158|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509159|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
20509160|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
20509161|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
20509162|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509163|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
20509164|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20509165|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509166|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
20509167|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509168|NCT04648241|Vaccines|vaccines|mesh-list
20509169|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
20509170|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509171|NCT04640818|Rituximab|rituximab|mesh-list
20509172|NCT04640818|Cladribine|cladribine|mesh-list
20509173|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
20509174|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509175|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509176|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
20509177|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509178|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509179|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509180|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
20509181|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20509182|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509183|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20509184|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509185|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
20509186|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20509187|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509188|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509189|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20509190|NCT04635098|Analgesics|analgesics|mesh-ancestor
20509191|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
20509192|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509193|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20509194|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20509195|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20509196|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
20509197|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509198|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244190|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
20244191|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509199|NCT04626791|Cytarabine|cytarabine|mesh-list
20509200|NCT04626791|Prednisone|prednisone|mesh-list
20509201|NCT04626791|Cortisone|cortisone|mesh-list
20509202|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
20509203|NCT04626791|Rituximab|rituximab|mesh-list
20509204|NCT04626791|Doxorubicin|doxorubicin|mesh-list
20509205|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20509206|NCT04626791|Bortezomib|bortezomib|mesh-list
20509207|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
20509208|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20509209|NCT04626791|Antibodies|antibodies|mesh-list
20509210|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
20509211|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20509212|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509213|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
20509214|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509215|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415464|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415465|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415466|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19415467|NCT02872116|Antidotes|antidotes|mesh-ancestor
19415468|NCT02872116|Protective Agents|protective agents|mesh-ancestor
19415469|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
19415470|NCT02872116|Vitamins|vitamins|mesh-ancestor
19415471|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
19415472|NCT02866227|TOL-463|tol-463|mesh-list
19415473|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415474|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
19415475|NCT02865850|Hematinics|hematinics|mesh-ancestor
19415476|NCT02863991|TIC10 compound|tic10 compound|mesh-list
19415477|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415478|NCT02858895|Interleukin-4|interleukin-4|mesh-list
19701474|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415479|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20509216|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20509217|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
20509218|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509219|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509220|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20509221|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20509222|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20509223|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20509224|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509225|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509226|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
20509227|NCT04626791|Hormones|hormones|mesh-ancestor
20509228|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509229|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20509230|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20509231|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
20509232|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
20509233|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509234|NCT04626635|Cemiplimab|cemiplimab|mesh-list
20509235|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509236|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509237|NCT04625777|Vaccines|vaccines|mesh-list
20509238|NCT04625777|Immunologic Factors|immunologic factors|mesh-ancestor
20509239|NCT04625777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509240|NCT04623775|Paclitaxel|paclitaxel|mesh-list
20509241|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20509242|NCT04623775|Carboplatin|carboplatin|mesh-list
20509243|NCT04623775|Nivolumab|nivolumab|mesh-list
20509244|NCT04623775|Pemetrexed|pemetrexed|mesh-list
20509245|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20509246|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853579|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853580|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853581|NCT00733421|Etoricoxib|etoricoxib|mesh-list
20509247|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
20509248|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
20509249|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
20509250|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509251|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509252|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20509253|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509254|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20509255|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20509256|NCT04613830|Tramadol|tramadol|mesh-list
20509257|NCT04613830|Bupivacaine|bupivacaine|mesh-list
20509258|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
20509259|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
20509260|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509261|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509262|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
20509263|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509264|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20509265|NCT04613830|Narcotics|narcotics|mesh-ancestor
20509266|NCT04613830|Analgesics|analgesics|mesh-ancestor
20509267|NCT04606797|Nicotine|nicotine|mesh-list
20509268|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20509269|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
20509270|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509271|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509272|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20509273|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20509274|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
20509275|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509276|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509277|NCT04602078|Gemcitabine|gemcitabine|mesh-list
20509278|NCT04602078|Atezolizumab|atezolizumab|mesh-list
20509279|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509280|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20509281|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
20509282|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509283|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
19701475|NCT04881851|Protective Agents|protective agents|mesh-ancestor
20509284|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509285|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509286|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509287|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
20509288|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509289|NCT04597697|Insulin|insulin|mesh-list
20509290|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20509291|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509292|NCT04594811|Nivolumab|nivolumab|mesh-list
20509293|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509294|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509295|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20509296|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529512|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20529513|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20529514|NCT01782443|Growth Substances|growth substances|mesh-ancestor
20529515|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529516|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
20529517|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529518|NCT01782508|Interferons|interferons|mesh-list
20529519|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
20529520|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529521|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
20529522|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529523|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20529524|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529525|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529526|NCT01782560|Omeprazole|omeprazole|mesh-list
20529527|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20529528|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20529529|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20529530|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529531|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529532|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
20529533|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20529534|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20529535|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529536|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
20529537|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
20529538|NCT01782599|Nicotine|nicotine|mesh-list
20529539|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20529540|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
20529541|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529542|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529543|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20529544|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20529545|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
20529546|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529547|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529548|NCT01782612|Analgesics|analgesics|mesh-list
20529549|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
20529550|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529551|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529552|NCT01782651|Capecitabine|capecitabine|mesh-list
20529553|NCT01782651|Lapatinib|lapatinib|mesh-list
20529554|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20529555|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
20529556|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529557|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529558|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20529559|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529560|NCT01782781|Epinephrine|epinephrine|mesh-list
20529561|NCT01782781|Ropivacaine|ropivacaine|mesh-list
20529562|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
20529563|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
20529564|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529565|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529566|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
20529567|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529568|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20529569|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20529570|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
20529571|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509297|NCT04590326|Cemiplimab|cemiplimab|mesh-list
20509298|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509299|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509300|NCT04589611|Amobarbital|amobarbital|mesh-list
20509301|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
20509302|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19415480|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
19415481|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701476|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
20509303|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
20509304|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509305|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
20509306|NCT04589611|Protective Agents|protective agents|mesh-ancestor
20509307|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20509308|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509309|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
20509310|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
20509311|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509312|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509313|NCT04588857|Dexamethasone|dexamethasone|mesh-list
20509314|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509315|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
20509316|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
20509317|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509318|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509319|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19853582|NCT00733421|Tramadol|tramadol|mesh-list
20509320|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
20509321|NCT04588857|Hormones|hormones|mesh-ancestor
19853583|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19853584|NCT00733421|Narcotics|narcotics|mesh-ancestor
19853585|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853586|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853587|NCT00733421|Analgesics|analgesics|mesh-ancestor
19853588|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
19853589|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853590|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19853591|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20509322|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509323|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20509324|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509325|NCT04584684|Ethanol|ethanol|mesh-list
20509326|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20509327|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
20509328|NCT04584684|Povidone|povidone|mesh-list
20509329|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20509330|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509331|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509332|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509333|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
20509334|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
20509335|NCT04582435|Insulin|insulin|mesh-list
20509336|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20509337|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509338|NCT04578639|Rituximab|rituximab|mesh-list
20509339|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
20509340|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509341|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509342|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
20509343|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509344|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509345|NCT04577001|Letrozole|letrozole|mesh-list
20509346|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509347|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20509348|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20509349|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509350|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509351|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20509352|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
20509353|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509354|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509355|NCT04570436|Diazepam|diazepam|mesh-list
20509356|NCT04570436|Gabapentin|gabapentin|mesh-list
20509357|NCT04570436|Analgesics|analgesics|mesh-ancestor
20509358|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
20509359|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509360|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509361|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
20509362|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20509363|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20509364|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509365|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20509366|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20509367|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20509368|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509369|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509370|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
20509371|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20509372|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
20509373|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
20509374|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20509375|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20509376|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20509377|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20509378|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20509379|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
20509380|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
19415482|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415483|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415484|NCT02846545|Golimumab|golimumab|mesh-list
19415485|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19415486|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415487|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415488|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
19415489|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415490|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19415491|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
19415492|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19415493|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
19415494|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415495|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19701477|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19708058|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509381|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
20509382|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
20509383|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
20509384|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
20509385|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509386|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509387|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509388|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
20509389|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
20509390|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
20509391|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509392|NCT04564885|Meloxicam|meloxicam|mesh-list
20509393|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20509394|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20509395|NCT04564885|Analgesics|analgesics|mesh-ancestor
20509396|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
20509397|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415496|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509398|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415497|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20509399|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509400|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509401|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20509402|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20509403|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509404|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509405|NCT04564443|Calcium|calcium|mesh-list
20509406|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20509407|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509408|NCT04562831|Niacinamide|niacinamide|mesh-list
20509409|NCT04562831|Niacin|niacin|mesh-list
20509410|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
20509411|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
20509412|NCT04562831|Vitamins|vitamins|mesh-ancestor
20509413|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
20509414|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509415|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20509416|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
20509417|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509418|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20509419|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
20509420|NCT04561375|Fentanyl|fentanyl|mesh-list
20509421|NCT04561375|Sufentanil|sufentanil|mesh-list
20509422|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20509423|NCT04561375|Narcotics|narcotics|mesh-ancestor
20509424|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509425|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509426|NCT04561375|Analgesics|analgesics|mesh-ancestor
20509427|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
20509428|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509429|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20509430|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20509431|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
20509432|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
20509433|NCT04560972|Carboplatin|carboplatin|mesh-list
20509434|NCT04560972|Etoposide|etoposide|mesh-list
20509435|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
20509436|NCT04560972|Atezolizumab|atezolizumab|mesh-list
20509437|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
20509438|NCT04560972|LB100|lb100|mesh-list
20509439|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20509440|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509441|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20509442|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20509443|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20509444|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509445|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509446|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
20509447|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509448|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
20509449|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
20509450|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
20509451|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
20509452|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
20509453|NCT04551521|Trastuzumab|trastuzumab|mesh-list
20509454|NCT04551521|Pertuzumab|pertuzumab|mesh-list
20509455|NCT04551521|Atezolizumab|atezolizumab|mesh-list
20509456|NCT04551521|Vemurafenib|vemurafenib|mesh-list
20509457|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20509458|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509459|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509460|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
20509461|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509462|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509463|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509464|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509465|NCT04551300|Sevelamer|sevelamer|mesh-list
20509466|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
20509467|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
20509468|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509469|NCT04548648|Isavuconazole|isavuconazole|mesh-list
20509470|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
20509471|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509472|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
20509473|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509474|NCT04545242|Dexamethasone|dexamethasone|mesh-list
20509475|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509476|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
20509477|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
20509478|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509479|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509480|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20509481|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
20509482|NCT04545242|Hormones|hormones|mesh-ancestor
20509483|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509484|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20509485|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509486|NCT04543409|Benralizumab|benralizumab|mesh-list
20509487|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20509488|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
20509489|NCT04542980|Autoantibodies|autoantibodies|mesh-list
20509490|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
20509491|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509492|NCT04540133|Dexamethasone|dexamethasone|mesh-list
20509493|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
20509494|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20509495|NCT04540133|BB 1101|bb 1101|mesh-list
20509496|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509497|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
20509498|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
20509499|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509500|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509501|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20509502|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
20509503|NCT04540133|Hormones|hormones|mesh-ancestor
20509504|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509505|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20509506|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509507|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
20509508|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509509|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509510|NCT04539938|Trastuzumab|trastuzumab|mesh-list
20509511|NCT04539938|Tucatinib|tucatinib|mesh-list
20509512|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509513|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509514|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509515|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509516|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509517|NCT04534153|Fexofenadine|fexofenadine|mesh-list
20509518|NCT04534153|Terfenadine|terfenadine|mesh-list
20509519|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20509520|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20509521|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20509522|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
20509523|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
20509524|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509525|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509526|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509527|NCT04529499|Favipiravir|favipiravir|mesh-list
20509528|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
20509529|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509530|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
20509531|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20509532|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20509533|NCT04526132|Analgesics|analgesics|mesh-ancestor
20509534|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
20509535|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509536|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509537|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509538|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509539|NCT04525014|Irinotecan|irinotecan|mesh-list
20509540|NCT04525014|Temozolomide|temozolomide|mesh-list
20509541|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19415498|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509542|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20509543|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509544|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509545|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509546|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19701478|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509547|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
20509548|NCT04523428|Venetoclax|venetoclax|mesh-list
20509549|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
20509550|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509551|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20509552|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20509553|NCT04521920|Narcotics|narcotics|mesh-ancestor
20509554|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509555|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509556|NCT04521920|Analgesics|analgesics|mesh-ancestor
20509557|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
20509558|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509559|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20509560|NCT04520776|Meloxicam|meloxicam|mesh-list
20509561|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20509562|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20509563|NCT04520776|Analgesics|analgesics|mesh-ancestor
20509564|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
20509565|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509566|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509567|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509568|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509569|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20509570|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20509571|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509572|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509573|NCT04519944|Edoxaban|edoxaban|mesh-list
20509574|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20509575|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
20509576|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20509577|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
20509578|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509579|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509580|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
20509581|NCT04516317|Artesunate|artesunate|mesh-list
20509582|NCT04516317|Quinine|quinine|mesh-list
20509583|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
20509584|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20509585|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20509586|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509587|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509588|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
20509589|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
20509590|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20509591|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
20509592|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20509593|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701479|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701480|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701481|NCT04881110|Liraglutide|liraglutide|mesh-list
19701482|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701483|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701484|NCT04881110|Incretins|incretins|mesh-ancestor
19415499|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20509594|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19701485|NCT04881110|Hormones|hormones|mesh-ancestor
19701486|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509595|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509596|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20509597|NCT04516317|Analgesics|analgesics|mesh-ancestor
20509598|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
20509599|NCT04515147|Vaccines|vaccines|mesh-list
20509600|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20509601|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
20509602|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509603|NCT04508504|Ropivacaine|ropivacaine|mesh-list
20509604|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
20509605|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
20509606|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509607|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509608|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
20509609|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509610|NCT04505280|Lidocaine|lidocaine|mesh-list
20509611|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
19701487|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
19701488|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19701489|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509612|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
20509613|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20509614|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509615|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
20509616|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509617|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20509618|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20509619|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19701490|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701491|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701492|NCT04880746|Cladribine|cladribine|mesh-list
19701493|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701494|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701495|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
19701496|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701497|NCT04880811|Afatinib|afatinib|mesh-list
19853592|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509620|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853593|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853594|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19853595|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19701498|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701499|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19701500|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701501|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701502|NCT04880785|Lamivudine|lamivudine|mesh-list
19701503|NCT04880785|Dolutegravir|dolutegravir|mesh-list
19701504|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19701505|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19701506|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701507|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853596|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509621|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509622|NCT04504825|Dexamethasone|dexamethasone|mesh-list
20509623|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
20509624|NCT04504825|Bortezomib|bortezomib|mesh-list
20509625|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509626|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
20509627|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509628|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509629|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20509630|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
20509631|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509632|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509633|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20509634|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509635|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
20509636|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
20509637|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509638|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20509639|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
20509640|NCT04504825|Hormones|hormones|mesh-ancestor
20509641|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509642|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20529572|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529573|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19853597|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853598|NCT00733746|Gemcitabine|gemcitabine|mesh-list
19853599|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19853600|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19853601|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
19853602|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853603|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853604|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
19853605|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701508|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
19701509|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701510|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19701511|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19701512|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19701513|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19701514|NCT04880655|Bacitracin|bacitracin|mesh-list
19701515|NCT04880655|Petrolatum|petrolatum|mesh-list
19701516|NCT04880655|Emollients|emollients|mesh-ancestor
19701517|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
19701518|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19701519|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701520|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701521|NCT04880499|Folic Acid|folic acid|mesh-list
19701522|NCT04880499|Riboflavin|riboflavin|mesh-list
19701523|NCT04880499|Vitamins|vitamins|mesh-ancestor
19701524|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
19701525|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701526|NCT04880499|Hematinics|hematinics|mesh-ancestor
20509643|NCT04495179|Durvalumab|durvalumab|mesh-list
20509644|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509645|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701527|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
19701528|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19701529|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
19701530|NCT04880395|Lamivudine|lamivudine|mesh-list
19701531|NCT04880395|Emtricitabine|emtricitabine|mesh-list
19701532|NCT04880395|Dolutegravir|dolutegravir|mesh-list
19701533|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19701534|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19701535|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701536|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701537|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
20509646|NCT04490707|Lenalidomide|lenalidomide|mesh-list
20509647|NCT04490707|Azacitidine|azacitidine|mesh-list
20509648|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
20509649|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509650|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20509651|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20509652|NCT04490707|Growth Substances|growth substances|mesh-ancestor
20509653|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
20509654|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509655|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20509656|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
20509657|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701538|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701539|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19701540|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19701541|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19701542|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20509658|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509659|NCT04489732|Interferons|interferons|mesh-list
20509660|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
20509661|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509662|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
19701543|NCT04879992|Amoxicillin|amoxicillin|mesh-list
19701544|NCT04879992|Metronidazole|metronidazole|mesh-list
19701545|NCT04879992|Tetracycline|tetracycline|mesh-list
19701546|NCT04879992|Rifabutin|rifabutin|mesh-list
20509663|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509664|NCT04486716|Ofatumumab|ofatumumab|mesh-list
20509665|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509666|NCT04484350|Enalapril|enalapril|mesh-list
20509667|NCT04484350|Hydralazine|hydralazine|mesh-list
20509668|NCT04484350|Labetalol|labetalol|mesh-list
20509669|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20509670|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
20509671|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509672|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509673|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20509674|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
20509675|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20509676|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20509677|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
20509678|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509679|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509680|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
20509681|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
20509682|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509683|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20509684|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20509685|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
20509686|NCT04469842|Prednisone|prednisone|mesh-list
20509687|NCT04469842|Azathioprine|azathioprine|mesh-list
20509688|NCT04469842|Tacrolimus|tacrolimus|mesh-list
20509689|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20509690|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
20509691|NCT04469842|Hormones|hormones|mesh-ancestor
20509692|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509693|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509694|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20509695|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509696|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509697|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
20509698|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20509699|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509700|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509701|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20509702|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20509703|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
20509704|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20509705|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509706|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
20509707|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19701547|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
19701548|NCT04879992|Esomeprazole|esomeprazole|mesh-list
19701549|NCT04879992|Bismuth|bismuth|mesh-list
20509708|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708059|NCT04820439|Pertuzumab|pertuzumab|mesh-list
20509709|NCT04464577|Itraconazole|itraconazole|mesh-list
20509710|NCT04464577|Fluconazole|fluconazole|mesh-list
20509711|NCT04464577|Bupropion|bupropion|mesh-list
20509712|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20509713|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
20509714|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20509715|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20509716|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20509717|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20509718|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509719|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
20509720|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509721|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509722|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20509723|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20509724|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509725|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
20509726|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509727|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20509728|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20509729|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
20509730|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509731|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20509732|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20509733|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20509734|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
20509735|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509736|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509737|NCT04454229|Penicillins|penicillins|mesh-list
20509738|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20509739|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509740|NCT04430855|Upadacitinib|upadacitinib|mesh-list
20509741|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20509742|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509743|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701550|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701551|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701552|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701553|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19701554|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19701555|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19701556|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20509744|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509745|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509746|NCT04430738|Leucovorin|leucovorin|mesh-list
20509747|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
19701557|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19701558|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701559|NCT04879992|Antacids|antacids|mesh-ancestor
19701560|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19701561|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19701562|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
19701563|NCT04879992|Diuretics|diuretics|mesh-ancestor
19701564|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
19701565|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701566|NCT04879992|Expectorants|expectorants|mesh-ancestor
19701567|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
19701568|NCT04879966|Infliximab|infliximab|mesh-list
19701569|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
19701570|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20509748|NCT04430738|Trastuzumab|trastuzumab|mesh-list
20509749|NCT04430738|Fluorouracil|fluorouracil|mesh-list
20509750|NCT04430738|Capecitabine|capecitabine|mesh-list
20509751|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
20509752|NCT04430738|Tucatinib|tucatinib|mesh-list
20509753|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509754|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509755|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
20509756|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509757|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20509758|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509759|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
20509760|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509761|NCT04430738|Antidotes|antidotes|mesh-ancestor
20509762|NCT04430738|Protective Agents|protective agents|mesh-ancestor
20509763|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
20509764|NCT04430738|Vitamins|vitamins|mesh-ancestor
20509765|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
20509766|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509767|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509768|NCT04430517|Niacinamide|niacinamide|mesh-list
20509769|NCT04430517|Niacin|niacin|mesh-list
20509770|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
20509771|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
20509772|NCT04430517|Vitamins|vitamins|mesh-ancestor
20509773|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
20509774|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509775|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20509776|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
20509777|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509778|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20509779|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
20509780|NCT04417361|Erenumab|erenumab|mesh-list
20529574|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19701571|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708060|NCT04820439|Antibodies|antibodies|mesh-list
19708061|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20509781|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20509782|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509783|NCT04417361|Analgesics|analgesics|mesh-ancestor
20509784|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
20509785|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509786|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509787|NCT04402658|Albuterol|albuterol|mesh-list
20509788|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20509789|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
20509790|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509791|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509792|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20509793|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
20509794|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
20509795|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20509796|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19415500|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701572|NCT04879446|Mitogens|mitogens|mesh-list
19701573|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701574|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701575|NCT04879511|Metformin|metformin|mesh-list
19701576|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701577|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701578|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
19701579|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19701580|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19701581|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415501|NCT02822508|Laxatives|laxatives|mesh-list
19415502|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19415503|NCT02820714|Laxatives|laxatives|mesh-list
19415504|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244192|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244193|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
20244194|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244195|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244196|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701582|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
19701583|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701584|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509797|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20509798|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20509799|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
20509800|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509801|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244197|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
20244198|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415512|NCT02818894|Lidocaine|lidocaine|mesh-list
19415513|NCT02818894|Bupivacaine|bupivacaine|mesh-list
20509802|NCT04391179|Dipyridamole|dipyridamole|mesh-list
20509803|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20509804|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509805|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509806|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20509807|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
20509808|NCT04387227|Carboplatin|carboplatin|mesh-list
20509809|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
19415514|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
19415515|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
19415516|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415517|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701585|NCT04879420|Teriparatide|teriparatide|mesh-list
20509810|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509811|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509812|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
20509813|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
20509814|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509815|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
20509816|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509817|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509818|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509819|NCT04375631|Cytarabine|cytarabine|mesh-list
20509820|NCT04375631|Cyclosporine|cyclosporine|mesh-list
20509821|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
20509822|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
20509823|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
20509824|NCT04375631|Cladribine|cladribine|mesh-list
20509825|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
20509826|NCT04375631|Cyclosporins|cyclosporins|mesh-list
20509827|NCT04375631|Lenograstim|lenograstim|mesh-list
20509828|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509829|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
20509830|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509831|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509832|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20509833|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
20509834|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509835|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509836|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20509837|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20509838|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
20509839|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
20509840|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509841|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20509842|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509843|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
20509844|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
20509845|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20509846|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20509847|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20509848|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
20509849|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20509850|NCT04375631|Analgesics|analgesics|mesh-ancestor
20509851|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
20509852|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509853|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20509854|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20509855|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
20509856|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
20509857|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20509858|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20509859|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509860|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
20509861|NCT04373603|Coagulants|coagulants|mesh-ancestor
20509862|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20509863|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
20509864|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509865|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
20509866|NCT04373603|Protective Agents|protective agents|mesh-ancestor
20529575|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
20529576|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20529577|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
20529578|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
20529579|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
20529580|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20529581|NCT01782846|Codeine|codeine|mesh-list
20529582|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20529583|NCT01782846|Narcotics|narcotics|mesh-ancestor
20529584|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529585|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529586|NCT01782846|Analgesics|analgesics|mesh-ancestor
20529587|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
20529588|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529589|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
20529590|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
20529591|NCT01782911|Resveratrol|resveratrol|mesh-list
20529592|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
20529593|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529594|NCT01782911|Protective Agents|protective agents|mesh-ancestor
20529595|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529596|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529597|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20529598|NCT01782924|Brodalumab|brodalumab|mesh-list
20529599|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
20529600|NCT01782937|Brodalumab|brodalumab|mesh-list
20529601|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
20529602|NCT01782950|Rifampin|rifampin|mesh-list
20529603|NCT01782950|Isoniazid|isoniazid|mesh-list
20529604|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
20529605|NCT01782950|Ethambutol|ethambutol|mesh-list
20509867|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
20509868|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20509869|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20509870|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509871|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
20509872|NCT04372940|Coagulants|coagulants|mesh-ancestor
20509873|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20509874|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509875|NCT04356742|Metformin|metformin|mesh-list
20509876|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
20509877|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20509878|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509879|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20509880|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509881|NCT04353284|Gabexate|gabexate|mesh-list
20509882|NCT04353284|Camostat|camostat|mesh-list
20509883|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
20509884|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529606|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20509885|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509886|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20509887|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20509888|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
20509889|NCT04348864|Antibodies|antibodies|mesh-list
20509890|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
20509891|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509892|NCT04345367|Abrocitinib|abrocitinib|mesh-list
20509893|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853606|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853607|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853608|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
19853609|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509894|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853610|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509895|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509896|NCT04344262|Atracurium|atracurium|mesh-list
19701586|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
20509897|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20509898|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20509899|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20509900|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509901|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509902|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20509903|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20509904|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
20509905|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509906|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509907|NCT04328012|Losartan|losartan|mesh-list
20509908|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20509909|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20509910|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20509911|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20509912|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509913|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
20509914|NCT04321993|Remdesivir|remdesivir|mesh-list
20509915|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
20509916|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509917|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
20509918|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509919|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20509920|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509921|NCT04315948|Interferons|interferons|mesh-list
20509922|NCT04315948|Ritonavir|ritonavir|mesh-list
20509923|NCT04315948|Lopinavir|lopinavir|mesh-list
20509924|NCT04315948|Interferon-beta|interferon-beta|mesh-list
20509925|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
20509926|NCT04315948|Remdesivir|remdesivir|mesh-list
20509927|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
20509928|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509929|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
20509930|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509931|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20509932|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20509933|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
20509934|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509935|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509936|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20509937|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20509938|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20509939|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20509940|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
20509941|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20509942|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20509943|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20509944|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
20509945|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509946|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20509947|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
20509948|NCT04310150|Hemostatics|hemostatics|mesh-list
20509949|NCT04310150|Coagulants|coagulants|mesh-ancestor
20509950|NCT04307329|Trastuzumab|trastuzumab|mesh-list
20509951|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20509952|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509953|NCT04305444|Everolimus|everolimus|mesh-list
20509954|NCT04305444|Pomalidomide|pomalidomide|mesh-list
20509955|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20509956|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20509957|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
20509958|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509959|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20509960|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20509961|NCT04305444|Growth Substances|growth substances|mesh-ancestor
20509962|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
20509963|NCT04299438|Propranolol|propranolol|mesh-list
20509964|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20509965|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20509966|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
20509967|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20509968|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509969|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509970|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20509971|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20509972|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
20509973|NCT04298983|Androgens|androgens|mesh-list
20509974|NCT04298983|Hormones|hormones|mesh-ancestor
20509975|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20509976|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509977|NCT04295772|Islatravir|islatravir|mesh-list
20509978|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
20509979|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20509980|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20509981|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509982|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20509983|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20509984|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20509985|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20509986|NCT04294147|Erenumab|erenumab|mesh-list
20509987|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20509988|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20509989|NCT04294147|Analgesics|analgesics|mesh-ancestor
20509990|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
20509991|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20509992|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509993|NCT04292873|Vitamin D|vitamin d|mesh-list
20509994|NCT04292873|Vitamins|vitamins|mesh-ancestor
20509995|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
20509996|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20509997|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20509998|NCT04291079|Antibodies|antibodies|mesh-list
19853611|NCT00733824|Plerixafor|plerixafor|mesh-list
20509999|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
20510000|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510001|NCT04290624|Listerine|listerine|mesh-list
20510002|NCT04290624|Fluorides|fluorides|mesh-list
20510003|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
20510004|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
20510005|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
20510006|NCT04290624|Protective Agents|protective agents|mesh-ancestor
20510007|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510008|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20510009|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510010|NCT04285866|Durvalumab|durvalumab|mesh-list
20510011|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510012|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510013|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
20510014|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
20510015|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20510016|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510017|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510018|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
20510019|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20510020|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510021|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510022|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
20510023|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20510024|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20510025|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510026|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
20510027|NCT04272606|Coagulants|coagulants|mesh-ancestor
20510028|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
20510029|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20510030|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510031|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510032|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20510033|NCT04266145|Analgesics|analgesics|mesh-ancestor
20510034|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
20510035|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510036|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20510037|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20510038|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20510039|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
20510040|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510041|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510042|NCT04265534|Folic Acid|folic acid|mesh-list
20510043|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
20510044|NCT04265534|Hydroxocobalamin|hydroxocobalamin|mesh-list
20510045|NCT04265534|Dexamethasone|dexamethasone|mesh-list
20510046|NCT04265534|Carboplatin|carboplatin|mesh-list
20510047|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
20510048|NCT04265534|Pemetrexed|pemetrexed|mesh-list
20510049|NCT04265534|Vitamins|vitamins|mesh-ancestor
20510050|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
20510051|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510052|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510053|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
20510054|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
20510055|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510056|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510057|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
19415518|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
19853612|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20510058|NCT04265534|Hormones|hormones|mesh-ancestor
20510059|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510060|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20510061|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510062|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510063|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510064|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510065|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20510066|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20510067|NCT04265534|Hematinics|hematinics|mesh-ancestor
20510068|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
20510069|NCT04264637|Azelastine|azelastine|mesh-list
20510070|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20510071|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
20510072|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510073|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510074|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20510075|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
20510076|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20510077|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510078|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510079|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20510080|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20510081|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20510082|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
20510083|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
20510084|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510085|NCT04262687|Bevacizumab|bevacizumab|mesh-list
20510086|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
20510087|NCT04262687|Capecitabine|capecitabine|mesh-list
20510088|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
20510089|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510090|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510091|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20510092|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20510093|NCT04262687|Growth Substances|growth substances|mesh-ancestor
19853613|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20244199|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20510094|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510095|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
20510096|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20510097|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
20510098|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510099|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
20510100|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
20510101|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20510102|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
20244200|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
20510103|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510104|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
19853614|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
19853615|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853616|NCT00733902|Tanezumab|tanezumab|mesh-list
19853617|NCT00733902|Analgesics|analgesics|mesh-ancestor
19853618|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
19853619|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853620|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510105|NCT04262336|Protective Agents|protective agents|mesh-ancestor
20510106|NCT04262336|Antidotes|antidotes|mesh-ancestor
20510107|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
20510108|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510109|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
20510110|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20510111|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510112|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
20510113|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
20510114|NCT04262206|Atorvastatin|atorvastatin|mesh-list
20510115|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20510116|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20510117|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
20510118|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510119|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20510120|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20510121|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510122|NCT04261439|Spartalizumab|spartalizumab|mesh-list
20510123|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510124|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510125|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529607|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
20529608|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20529609|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529610|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
20529611|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20529612|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529613|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529614|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20529615|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20529616|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20529617|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20529618|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20529619|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20510126|NCT04241562|Mitogens|mitogens|mesh-list
20510127|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510128|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510129|NCT04239703|Antibodies|antibodies|mesh-list
20510130|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
20510131|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510132|NCT04239313|Vaccines|vaccines|mesh-list
20510133|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
20510134|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510135|NCT04238546|Sirolimus|sirolimus|mesh-list
20510136|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20510137|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510138|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20510139|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510140|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
20510141|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20510142|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
20510143|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510144|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20510145|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510146|NCT04233801|Empagliflozin|empagliflozin|mesh-list
20510147|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20510148|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510149|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20510150|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510151|NCT04233190|Budesonide|budesonide|mesh-list
20510152|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
20510153|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20510154|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
20510155|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510156|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510157|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20510158|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
20510159|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20510160|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20510161|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20510162|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
20510163|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510164|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510165|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510166|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
20510167|NCT04233190|Hormones|hormones|mesh-ancestor
20510168|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510169|NCT04233112|Melatonin|melatonin|mesh-list
20510170|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
20510171|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510172|NCT04233112|Protective Agents|protective agents|mesh-ancestor
20510173|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510174|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510175|NCT04233034|Verapamil|verapamil|mesh-list
20510176|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20510177|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20510178|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20510179|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510180|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20510181|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510182|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
20510183|NCT04230304|Daratumumab|daratumumab|mesh-list
20510184|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510185|NCT04224558|Acetaminophen|acetaminophen|mesh-list
20510186|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
20510187|NCT04224558|Promethazine|promethazine|mesh-list
20510188|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
20510189|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20510190|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
20510191|NCT04224558|Fludarabine|fludarabine|mesh-list
20510192|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
20510193|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20510194|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
20510195|NCT04224558|Antibodies|antibodies|mesh-list
20510196|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
20244201|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20244202|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244203|NCT00419068|Vitamins|vitamins|mesh-ancestor
20244204|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
20244205|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20244206|NCT00419146|Vitamins|vitamins|mesh-list
20244207|NCT00419146|Vitamin E|vitamin e|mesh-list
20244208|NCT00419146|Tocopherols|tocopherols|mesh-list
20244209|NCT00419146|Tocotrienols|tocotrienols|mesh-list
20244210|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
20244211|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20510197|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20510198|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20510199|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20510200|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
20510201|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244212|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
20244213|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244214|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
20244215|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244216|NCT00419146|Protective Agents|protective agents|mesh-ancestor
20244217|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20244218|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20244219|NCT00419172|Rifampin|rifampin|mesh-list
20510202|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510203|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20510204|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
20510205|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510206|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510207|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20510208|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20510209|NCT04224558|Analgesics|analgesics|mesh-ancestor
20510210|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
20510211|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510212|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
20510213|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244220|NCT00419172|Deferasirox|deferasirox|mesh-list
20510214|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
20510215|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
20510216|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510217|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
20510218|NCT04224558|Hormones|hormones|mesh-ancestor
20510219|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510220|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20510221|NCT04224558|Protective Agents|protective agents|mesh-ancestor
20510222|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20510223|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20510224|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20510225|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510226|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
20510227|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
20510228|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20510229|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
20510230|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
20510231|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510232|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20510233|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
20510234|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
20510235|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
20510236|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20510237|NCT04223570|Levulinic acid|levulinic acid|mesh-list
20510238|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20510239|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
20510240|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510241|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510242|NCT04219774|Aspirin|aspirin|mesh-list
20510243|NCT04219774|Clopidogrel|clopidogrel|mesh-list
20510244|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20510245|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20510246|NCT04219774|Analgesics|analgesics|mesh-ancestor
20510247|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
20510248|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510249|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510250|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510251|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510252|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20510253|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20510254|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510255|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20510256|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20510257|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510258|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
20510259|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20510260|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20510261|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20510262|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
20510263|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510264|NCT04201197|Dronabinol|dronabinol|mesh-list
20510265|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
20510266|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510267|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20510268|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20510269|NCT04201197|Analgesics|analgesics|mesh-ancestor
20510270|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
20510271|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510272|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20510273|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20510274|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510275|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510276|NCT04201197|Hormones|hormones|mesh-ancestor
20510277|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510278|NCT04200651|Dexamethasone|dexamethasone|mesh-list
20510279|NCT04200651|Prednisolone|prednisolone|mesh-list
20510280|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20510281|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
20510282|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20510283|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
20510284|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20510285|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
20510286|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510287|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
20244221|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20244222|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
20244223|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244224|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244225|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
20244226|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20244227|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244228|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244229|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20510288|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
20510289|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244230|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20244231|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20244232|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20244233|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20244234|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20244235|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20244236|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
20244237|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
20244238|NCT00419250|Lenalidomide|lenalidomide|mesh-list
20244239|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
20244240|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244241|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20244242|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20244243|NCT00419250|Growth Substances|growth substances|mesh-ancestor
20244244|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
20244245|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244246|NCT00419302|Insulin|insulin|mesh-list
20244247|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20244248|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244249|NCT00419367|Vorinostat|vorinostat|mesh-list
20244250|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244251|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20244252|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244253|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244254|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
20244255|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
20244256|NCT00419471|Citalopram|citalopram|mesh-list
20244257|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20244258|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20244259|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20244260|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244261|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244262|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
20510290|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510291|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510292|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
20510293|NCT04200651|Hormones|hormones|mesh-ancestor
20510294|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510295|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20510296|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510297|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20510298|NCT04200651|Protective Agents|protective agents|mesh-ancestor
20510299|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
20510300|NCT04198428|Narcotics|narcotics|mesh-ancestor
20244263|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244264|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20510301|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510302|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510303|NCT04198428|Analgesics|analgesics|mesh-ancestor
20510304|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
20510305|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510306|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
20510307|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20510308|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
20510309|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510310|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
20510311|NCT04192630|Protective Agents|protective agents|mesh-ancestor
20510312|NCT04187833|Nivolumab|nivolumab|mesh-list
20510313|NCT04187833|Talazoparib|talazoparib|mesh-list
20510314|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510315|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510316|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510317|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510318|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20510319|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510320|NCT04183205|Sertraline|sertraline|mesh-list
20510321|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
20510322|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20510323|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20510324|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20510325|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20510326|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510327|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510328|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
20510329|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510330|NCT04180085|Abatacept|abatacept|mesh-list
20510331|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510332|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510333|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510334|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20510335|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
20510336|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510337|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510338|NCT04171141|Bevacizumab|bevacizumab|mesh-list
20510339|NCT04171141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510340|NCT04171141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510341|NCT04171141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20510342|NCT04171141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20510343|NCT04171141|Growth Substances|growth substances|mesh-ancestor
20510344|NCT04171141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510345|NCT04171141|Growth Inhibitors|growth inhibitors|mesh-ancestor
20510346|NCT04169451|Letrozole|letrozole|mesh-list
20510347|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510348|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20510349|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20510350|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510351|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510352|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20244265|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
20244266|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244267|NCT00419484|Pioglitazone|pioglitazone|mesh-list
20510353|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
20510354|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510355|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510356|NCT04169438|Petrolatum|petrolatum|mesh-list
20510357|NCT04169438|Emollients|emollients|mesh-ancestor
20510358|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
20510359|NCT04160494|Atezolizumab|atezolizumab|mesh-list
20510360|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
20510361|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510362|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
20510363|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510364|NCT04159818|Doxorubicin|doxorubicin|mesh-list
20510365|NCT04159818|Nivolumab|nivolumab|mesh-list
20510366|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510367|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20510368|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20510369|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20510370|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510371|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510372|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510373|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510374|NCT04157881|Rabeprazole|rabeprazole|mesh-list
20510375|NCT04157881|Dabigatran|dabigatran|mesh-list
20510376|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
20510377|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20510378|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
20510379|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244268|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20510380|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701587|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20510381|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
20510382|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20244269|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244270|NCT00419536|Panobinostat|panobinostat|mesh-list
20244271|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510383|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510384|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20529620|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20529621|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20529622|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
20529623|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20529624|NCT01782976|Bevacizumab|bevacizumab|mesh-list
20529625|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20529626|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529627|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20529628|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20529629|NCT01782976|Growth Substances|growth substances|mesh-ancestor
20529630|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529631|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
20529632|NCT01782989|Doxycycline|doxycycline|mesh-list
20529633|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20529634|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529635|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
20529636|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20529637|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20530822|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20530823|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20530824|NCT01790893|Aflibercept|aflibercept|mesh-list
20530825|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20530826|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20530827|NCT01790893|Growth Substances|growth substances|mesh-ancestor
20530828|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530829|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
20530830|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530831|NCT01790971|Morphine|morphine|mesh-list
20530832|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20530833|NCT01790971|Narcotics|narcotics|mesh-ancestor
20530834|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530835|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530836|NCT01790971|Analgesics|analgesics|mesh-ancestor
20530837|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
20530838|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530839|NCT01790997|Aspirin|aspirin|mesh-list
20530840|NCT01790997|Clopidogrel|clopidogrel|mesh-list
20530841|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20530842|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530843|NCT01790997|Analgesics|analgesics|mesh-ancestor
20530844|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
20530845|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530846|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530847|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530848|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530849|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20530850|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20530851|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530852|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20530853|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20530854|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530855|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
20530856|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20530857|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20530858|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20530859|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
20530860|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530861|NCT01791088|Sirolimus|sirolimus|mesh-list
20530862|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20530863|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530864|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20530865|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530866|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
20530867|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20530868|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
20530869|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530870|NCT01791114|Propranolol|propranolol|mesh-list
20530871|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20530872|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20530873|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
20530874|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510385|NCT04151563|Docetaxel|docetaxel|mesh-list
20510386|NCT04151563|Nivolumab|nivolumab|mesh-list
20510387|NCT04151563|Ipilimumab|ipilimumab|mesh-list
20510388|NCT04151563|Ramucirumab|ramucirumab|mesh-list
20510389|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510390|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
20510391|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
20510392|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510393|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510394|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510395|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510396|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
20510397|NCT04150900|Bavituximab|bavituximab|mesh-list
20510398|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510399|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510400|NCT04143711|Paclitaxel|paclitaxel|mesh-list
20510401|NCT04143711|Nivolumab|nivolumab|mesh-list
20510402|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20510403|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510404|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
20510405|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
20510406|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510407|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510408|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510409|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510410|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
20510411|NCT04138394|Vitamins|vitamins|mesh-ancestor
20510412|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
20510413|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510414|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
20510415|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510416|NCT04138394|Protective Agents|protective agents|mesh-ancestor
20510417|NCT04136756|Rituximab|rituximab|mesh-list
20510418|NCT04136756|Daratumumab|daratumumab|mesh-list
20510419|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510420|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510421|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
20510422|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510423|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510424|NCT04136262|Methotrexate|methotrexate|mesh-list
20510425|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20510426|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
20510427|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20510428|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510429|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20510430|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
20510431|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510432|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510433|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
20510434|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510435|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20510436|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20510437|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
20510438|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510439|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20510440|NCT04133922|Insulin|insulin|mesh-list
20510441|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20510442|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510443|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
20510444|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
20529638|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
20510445|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510446|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
20510447|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510448|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510449|NCT04129151|Palbociclib|palbociclib|mesh-list
20510450|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510451|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20510452|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510453|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510454|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
20510455|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20510456|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510457|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510458|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510459|NCT04124497|Dexamethasone|dexamethasone|mesh-list
20510460|NCT04124497|Daratumumab|daratumumab|mesh-list
20510461|NCT04124497|Pomalidomide|pomalidomide|mesh-list
20510462|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510463|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
20510464|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
20510465|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510466|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510467|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510468|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
20510469|NCT04124497|Hormones|hormones|mesh-ancestor
20510470|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510471|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20510472|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510473|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
20510474|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20510475|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20510476|NCT04124497|Growth Substances|growth substances|mesh-ancestor
20510477|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
20510478|NCT04123314|Psilocybin|psilocybin|mesh-list
20510479|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
20510480|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510481|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20510482|NCT04115059|Dasatinib|dasatinib|mesh-list
20510483|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510484|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20510485|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529639|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20510486|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510487|NCT04114890|Tenofovir|tenofovir|mesh-list
20510488|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
20510489|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510490|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20510491|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20510492|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510493|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510494|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20510495|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19415519|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415520|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19415521|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19701588|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415522|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19415523|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415524|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415525|NCT02814019|Idebenone|idebenone|mesh-list
19415526|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
19415527|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415528|NCT02814019|Protective Agents|protective agents|mesh-ancestor
19701589|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19701590|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19701591|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19701592|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701593|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19701594|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20510496|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19415529|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415530|NCT02813447|Sertraline|sertraline|mesh-list
19701595|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19701596|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701597|NCT04879407|Warfarin|warfarin|mesh-list
19701598|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
19701599|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
19701600|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19415531|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
19415532|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415533|NCT02813447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19415534|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19415535|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415536|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701601|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
19701602|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20510497|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
20510498|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20510499|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20510500|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19701603|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
19701604|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510501|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20510502|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510503|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
20510504|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510505|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415537|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701605|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701606|NCT04879004|Ropivacaine|ropivacaine|mesh-list
19701607|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
19701608|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
20244272|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20244273|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244274|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244275|NCT00419549|Valdecoxib|valdecoxib|mesh-list
20244276|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20244277|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20244278|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244279|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244280|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244281|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244282|NCT00419549|Analgesics|analgesics|mesh-ancestor
20244283|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
20244284|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244285|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244286|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510506|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20510507|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510508|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20510509|NCT04096066|Dexamethasone|dexamethasone|mesh-list
20510510|NCT04096066|Lenalidomide|lenalidomide|mesh-list
20510511|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510512|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
20510513|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
20510514|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510515|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510516|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510517|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
20510518|NCT04096066|Hormones|hormones|mesh-ancestor
20510519|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510520|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20510521|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510522|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
20510523|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20510524|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20510525|NCT04096066|Growth Substances|growth substances|mesh-ancestor
20510526|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
20510527|NCT04084548|Lidocaine|lidocaine|mesh-list
20510528|NCT04084548|Ketamine|ketamine|mesh-list
20510529|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
20510530|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
20510531|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510532|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510533|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
20510534|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510535|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20510536|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20510537|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20510538|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20510539|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510540|NCT04084548|Analgesics|analgesics|mesh-ancestor
20510541|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20510542|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20510543|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
20510544|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20510545|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20510546|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510547|NCT04084210|Nicotine|nicotine|mesh-list
20510548|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20510549|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
20510550|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510551|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510552|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20510553|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20510554|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
20510555|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510556|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510557|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
20510558|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20510559|NCT04083495|Fludarabine|fludarabine|mesh-list
20510560|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20510561|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
20510562|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510563|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510564|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20510565|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
20510566|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510567|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510568|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20510569|NCT04082676|Bupivacaine|bupivacaine|mesh-list
20510570|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
20510571|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
20510572|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510573|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510574|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
20510575|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510576|NCT04080895|Lumefantrine|lumefantrine|mesh-list
20510577|NCT04080895|Artemether|artemether|mesh-list
20510578|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19415538|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
19415539|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415540|NCT02811939|Dronabinol|dronabinol|mesh-list
20510579|NCT04080895|Amodiaquine|amodiaquine|mesh-list
20510580|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
20510581|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20510582|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20510583|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510584|NCT04075747|Venetoclax|venetoclax|mesh-list
20510585|NCT04075747|Midostaurin|midostaurin|mesh-list
20510586|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510587|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20510588|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510589|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510590|NCT04069156|Aspirin|aspirin|mesh-list
20510591|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20510592|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20510593|NCT04069156|Analgesics|analgesics|mesh-ancestor
19415541|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
19701609|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510594|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
20510595|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510596|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510597|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510598|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510599|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20510600|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20510601|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701610|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701611|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
19701612|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701613|NCT04878926|Midazolam|midazolam|mesh-list
19701614|NCT04878926|Propofol|propofol|mesh-list
20510602|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20510603|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19701615|NCT04878926|Anesthetics|anesthetics|mesh-list
19701616|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
20510604|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510605|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
20510606|NCT04067648|Sufentanil|sufentanil|mesh-list
19415542|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415543|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415544|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415545|NCT02811939|Analgesics|analgesics|mesh-ancestor
19415546|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
19701617|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19701618|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510607|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20510608|NCT04067648|Narcotics|narcotics|mesh-ancestor
20510609|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510610|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510611|NCT04067648|Analgesics|analgesics|mesh-ancestor
20510612|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
20510613|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510614|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20510615|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20510616|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
20510617|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
20510618|NCT04060862|Fulvestrant|fulvestrant|mesh-list
20510619|NCT04060862|Palbociclib|palbociclib|mesh-list
20510620|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20510621|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510622|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20510623|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20510624|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
20510625|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510626|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510627|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20510628|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510629|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510630|NCT04060849|Ethanol|ethanol|mesh-list
20510631|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19853621|NCT00733954|Clobetasol|clobetasol|mesh-list
19853622|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853623|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
19701619|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701620|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19701621|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
19701622|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19701623|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19701624|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19701625|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19701626|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
19701627|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
19701628|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853624|NCT00733954|Hormones|hormones|mesh-ancestor
19701629|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701630|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
19701631|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701632|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
19855630|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510632|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20510633|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510634|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510635|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510636|NCT04058756|Spartalizumab|spartalizumab|mesh-list
20510637|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510638|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510639|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510640|NCT04055818|Niacinamide|niacinamide|mesh-list
20510641|NCT04055818|Niacin|niacin|mesh-list
20510642|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
20510643|NCT04055818|Decitabine|decitabine|mesh-list
20510644|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
20510645|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20510646|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
20510647|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510648|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510649|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510650|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
20510651|NCT04055818|Vitamins|vitamins|mesh-ancestor
20510652|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
20510653|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510654|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20510655|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20510656|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
20510657|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
20510658|NCT04049669|Temozolomide|temozolomide|mesh-list
20510659|NCT04049669|Lomustine|lomustine|mesh-list
19853625|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853626|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853627|NCT00733993|Caffeine|caffeine|mesh-list
19853628|NCT00733993|Amphetamine|amphetamine|mesh-list
19853629|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19853630|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510660|NCT04049669|Etoposide|etoposide|mesh-list
20510661|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20510662|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
20510663|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510664|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510665|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20510666|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
20510667|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510668|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510669|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20510670|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19853631|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20510671|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20510672|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20510673|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529640|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529641|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
20510674|NCT04038502|Carboplatin|carboplatin|mesh-list
20510675|NCT04038502|Olaparib|olaparib|mesh-list
20510676|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510677|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20510678|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510679|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510680|NCT04022200|Paclitaxel|paclitaxel|mesh-list
20510681|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20510682|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510683|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
20510684|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
20510685|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510686|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510687|NCT04020848|Melatonin|melatonin|mesh-list
20510688|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
20510689|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510690|NCT04020848|Protective Agents|protective agents|mesh-ancestor
20510691|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510692|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510693|NCT04012177|Niacinamide|niacinamide|mesh-list
20510694|NCT04012177|Niacin|niacin|mesh-list
20510695|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
20510696|NCT04012177|Azithromycin|azithromycin|mesh-list
20510697|NCT04012177|Choline|choline|mesh-list
20510698|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20510699|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510700|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
20510701|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20510702|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
20510703|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510704|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510705|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20510706|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
20510707|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
20510708|NCT04012177|Vitamins|vitamins|mesh-ancestor
20510709|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
20510710|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510711|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
20510712|NCT04009109|Dexamethasone|dexamethasone|mesh-list
20510713|NCT04009109|Lenalidomide|lenalidomide|mesh-list
20510714|NCT04009109|Daratumumab|daratumumab|mesh-list
20510715|NCT04009109|Ixazomib|ixazomib|mesh-list
20510716|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20510717|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
20510718|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
20510719|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510720|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510721|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510722|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
20510723|NCT04009109|Hormones|hormones|mesh-ancestor
20510724|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510725|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20510726|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510727|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
20510728|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20510729|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20510730|NCT04009109|Growth Substances|growth substances|mesh-ancestor
20510731|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
20510732|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
20510733|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510734|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510735|NCT04007289|Apixaban|apixaban|mesh-list
20510736|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20510737|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
20510738|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20510739|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
20510740|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510741|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510742|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
20510743|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
20510744|NCT04004416|Lorazepam|lorazepam|mesh-list
20510745|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
20510746|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
20510747|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
20510748|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510749|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510750|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510751|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20510752|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510753|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20510754|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20510755|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20510756|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
20510757|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
20510758|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510759|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510760|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
20510761|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20510762|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20510763|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
20510764|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20510765|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510766|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20510767|NCT04002518|Cimetidine|cimetidine|mesh-list
20510768|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20510769|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20510770|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20510771|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
20510772|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
20510773|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510774|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510775|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510776|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20510777|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20510778|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510779|NCT04000529|Spartalizumab|spartalizumab|mesh-list
20510780|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20529642|NCT01783106|Doxycycline|doxycycline|mesh-list
19701633|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
19701634|NCT04879030|Levofloxacin|levofloxacin|mesh-list
20510781|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510782|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510783|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20510784|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20510785|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510786|NCT03993249|Nivolumab|nivolumab|mesh-list
20510787|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19701635|NCT04879030|Meropenem|meropenem|mesh-list
19701636|NCT04879030|Tazobactam|tazobactam|mesh-list
19701637|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
19701638|NCT04879030|Piperacillin|piperacillin|mesh-list
19701639|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
19701640|NCT04879030|Imipenem|imipenem|mesh-list
19701641|NCT04879030|Ceftazidime|ceftazidime|mesh-list
19701642|NCT04879030|Ertapenem|ertapenem|mesh-list
19701643|NCT04879030|Lactams|lactams|mesh-list
19701644|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19701645|NCT04879030|Cefotaxime|cefotaxime|mesh-list
19701646|NCT04879030|Cefixime|cefixime|mesh-list
19701647|NCT04879030|beta-Lactams|beta-lactams|mesh-list
19415547|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853632|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853633|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510788|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510789|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510790|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510791|NCT03990883|Lidocaine|lidocaine|mesh-list
20510792|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
20510793|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
20510794|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510795|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510796|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
20510797|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510798|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20510799|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20510800|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20510801|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20510802|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510803|NCT03988634|Valsartan|valsartan|mesh-list
20510804|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20510805|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20510806|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20510807|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510808|NCT03984890|Vitamin D|vitamin d|mesh-list
20510809|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
20510810|NCT03984890|Vitamins|vitamins|mesh-ancestor
20510811|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
20510812|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510813|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20510814|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20510815|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20510816|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20510817|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510818|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
20510819|NCT03969446|Decitabine|decitabine|mesh-list
20510820|NCT03969446|Venetoclax|venetoclax|mesh-list
20510821|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510822|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510823|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20510824|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
20510825|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510826|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510827|NCT03960008|Doxorubicin|doxorubicin|mesh-list
20510828|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20510829|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20510830|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510831|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20510832|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20510833|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510834|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510835|NCT03944941|Cetuximab|cetuximab|mesh-list
20510836|NCT03944941|Avelumab|avelumab|mesh-list
20510837|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510838|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510839|NCT03940352|Venetoclax|venetoclax|mesh-list
20510840|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510841|NCT03931551|Trastuzumab|trastuzumab|mesh-list
20510842|NCT03931551|Olaparib|olaparib|mesh-list
20510843|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510844|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510845|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20510846|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510847|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510848|NCT03930615|Letermovir|letermovir|mesh-list
20510849|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20510850|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510851|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510852|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510853|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
20510854|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510855|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19701648|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
19701649|NCT04879030|Ticarcillin|ticarcillin|mesh-list
20510856|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
20510857|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510858|NCT03928847|Protective Agents|protective agents|mesh-ancestor
20510859|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510860|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20510861|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20510862|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510863|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20510864|NCT03928600|Misoprostol|misoprostol|mesh-list
20510865|NCT03928600|Dinoprostone|dinoprostone|mesh-list
20510866|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20510867|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
20510868|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20510869|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510870|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20510871|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244287|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510872|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
20510873|NCT03928314|Paclitaxel|paclitaxel|mesh-list
20510874|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20510875|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510876|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
20510877|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
20510878|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510879|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510880|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
20510881|NCT03926091|Docetaxel|docetaxel|mesh-list
20510882|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20510883|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
20510884|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510885|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510886|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20510887|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
20510888|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510889|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510890|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20510891|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701650|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701651|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510892|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
20510893|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510894|NCT03924427|BMS-986165|bms-986165|mesh-list
20510895|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
20510896|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20510897|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510898|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510899|NCT03922451|Cefazolin|cefazolin|mesh-list
20510900|NCT03922451|Tazobactam|tazobactam|mesh-list
20510901|NCT03922451|Piperacillin|piperacillin|mesh-list
20510902|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20510903|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20510904|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20510905|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20510906|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510907|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510908|NCT03916419|Paclitaxel|paclitaxel|mesh-list
20510909|NCT03916419|Carboplatin|carboplatin|mesh-list
20510910|NCT03916419|Durvalumab|durvalumab|mesh-list
20510911|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20510912|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510913|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
20510914|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
20510915|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510916|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510917|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510918|NCT03913442|Colchicine|colchicine|mesh-list
20510919|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
20510920|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20510921|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
20510922|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
20510923|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510924|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510925|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510926|NCT03910244|Pomalidomide|pomalidomide|mesh-list
20510927|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
20510928|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510929|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20510930|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20510931|NCT03910244|Growth Substances|growth substances|mesh-ancestor
20510932|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
20510933|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529643|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
20529644|NCT01783106|Budesonide|budesonide|mesh-list
20529645|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529646|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20244288|NCT00419601|Fentanyl|fentanyl|mesh-list
20529647|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
20529648|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510934|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20510935|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
20510936|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510937|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20510938|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20510939|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20510940|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
20510941|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510942|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20510943|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20510944|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510945|NCT03884998|Nivolumab|nivolumab|mesh-list
19701652|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19701653|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19701654|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701655|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701656|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701657|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19701658|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19701659|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19701660|NCT04879030|Renal Agents|renal agents|mesh-ancestor
19701661|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19701662|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19701663|NCT04878835|Ranibizumab|ranibizumab|mesh-list
20510946|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510947|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510948|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20510949|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510950|NCT03874052|Venetoclax|venetoclax|mesh-list
20510951|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
20510952|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510953|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20510954|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510955|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510956|NCT03873857|Venetoclax|venetoclax|mesh-list
20510957|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510958|NCT03870880|Risperidone|risperidone|mesh-list
20510959|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20510960|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
20510961|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20510962|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510963|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510964|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19701664|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19701665|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19701666|NCT04878835|Growth Substances|growth substances|mesh-ancestor
19701667|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701668|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
19701669|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701670|NCT04878770|Cyclosporine|cyclosporine|mesh-list
19701671|NCT04878770|Cyclosporins|cyclosporins|mesh-list
19701672|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701673|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701674|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701675|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
20510965|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20510966|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510967|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20510968|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20510969|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
20510970|NCT03861377|Remifentanil|remifentanil|mesh-list
20510971|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20510972|NCT03861377|Narcotics|narcotics|mesh-ancestor
19701676|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510973|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20510974|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20510975|NCT03861377|Analgesics|analgesics|mesh-ancestor
20510976|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
20510977|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20510978|NCT03852992|Minoxidil|minoxidil|mesh-list
20510979|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20510980|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
20510981|NCT03850444|Paclitaxel|paclitaxel|mesh-list
20510982|NCT03850444|Carboplatin|carboplatin|mesh-list
20510983|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
20510984|NCT03850444|Pemetrexed|pemetrexed|mesh-list
20510985|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20510986|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20510987|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
20510988|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
19415548|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19415549|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19415550|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415551|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415552|NCT02811939|Hormones|hormones|mesh-ancestor
19415553|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415554|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
19415555|NCT02811861|Everolimus|everolimus|mesh-list
20510989|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
20510990|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20510991|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20510992|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20510993|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20510994|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20510995|NCT03846570|Beclomethasone|beclomethasone|mesh-list
20510996|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
20510997|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19415556|NCT02811861|Sunitinib|sunitinib|mesh-list
20510998|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
20510999|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511000|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511001|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20511002|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
20511003|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20511004|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20511005|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20511006|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
20511007|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511008|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511009|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511010|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
20511011|NCT03846570|Hormones|hormones|mesh-ancestor
20511012|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511013|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20511014|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20511015|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511016|NCT03838367|Leronlimab|leronlimab|mesh-list
20511017|NCT03838367|Carboplatin|carboplatin|mesh-list
20511018|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
20511019|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511020|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20511021|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20511022|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511023|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20511024|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20511025|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
20511026|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511027|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
20511028|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511029|NCT03837925|Atorvastatin|atorvastatin|mesh-list
20511030|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20511031|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20511032|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
20511033|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511034|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19701677|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
19701678|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701679|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
19701680|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701681|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19701682|NCT04878718|Vancomycin|vancomycin|mesh-list
19701683|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701684|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701685|NCT04878497|Warfarin|warfarin|mesh-list
19701686|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
19701687|NCT04878497|Dabigatran|dabigatran|mesh-list
19701688|NCT04878497|Apixaban|apixaban|mesh-list
19701689|NCT04878497|Edoxaban|edoxaban|mesh-list
19701690|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
19701691|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19701692|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
19701693|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20511035|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20511036|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511037|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
20511038|NCT03836144|Diuretics|diuretics|mesh-ancestor
20511039|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
19701694|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
19701695|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701696|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511040|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511041|NCT03836144|Expectorants|expectorants|mesh-ancestor
20511042|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
20511043|NCT03836066|Bevacizumab|bevacizumab|mesh-list
20511044|NCT03836066|Atezolizumab|atezolizumab|mesh-list
20511045|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511046|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511047|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511048|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511049|NCT03836066|Growth Substances|growth substances|mesh-ancestor
20511050|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511051|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511052|NCT03826628|Sirolimus|sirolimus|mesh-list
20511053|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20511054|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511055|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20511056|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511057|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
20511058|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511059|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
20511060|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511061|NCT03826563|Melatonin|melatonin|mesh-list
20511062|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
20511063|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511064|NCT03826563|Protective Agents|protective agents|mesh-ancestor
20511065|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511066|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20511067|NCT03825536|Methamphetamine|methamphetamine|mesh-list
20511068|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20511069|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511070|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
20511071|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
20511072|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511073|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
20511074|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511075|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511076|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
20511077|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20511078|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20511079|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511080|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20511081|NCT03816397|Adalimumab|adalimumab|mesh-list
20511082|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511083|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511084|NCT03815643|Avelumab|avelumab|mesh-list
20511085|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511086|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511087|NCT03814590|Vaccines|vaccines|mesh-list
20511088|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
20511089|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511090|NCT03809923|Lidocaine|lidocaine|mesh-list
20511091|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
20511092|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
20511093|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
20511094|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20511095|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511096|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
20511097|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511098|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20511099|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20511100|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20511101|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511102|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511103|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20511104|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20511105|NCT03809923|Analgesics|analgesics|mesh-ancestor
20511106|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20511107|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20511108|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20511109|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
20511110|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511111|NCT03808961|Vitamins|vitamins|mesh-list
20511112|NCT03808961|Niacin|niacin|mesh-list
19701697|NCT04878198|Melatonin|melatonin|mesh-list
19701698|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
19701699|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511113|NCT03808961|Niacinamide|niacinamide|mesh-list
20511114|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
20511115|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
20511116|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
20511117|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511118|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19701700|NCT04878198|Protective Agents|protective agents|mesh-ancestor
19701701|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701702|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701703|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19701704|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19701705|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701706|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
19701707|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
19701708|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701709|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
19701710|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19701711|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701712|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511119|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
19415557|NCT02811861|Lenvatinib|lenvatinib|mesh-list
20511120|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511121|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20511122|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
20511123|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
20511124|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511125|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
20511126|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511127|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511128|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511129|NCT03804138|Vaccines|vaccines|mesh-list
20511130|NCT03804138|Immunologic Factors|immunologic factors|mesh-ancestor
20511131|NCT03804138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511132|NCT03796416|Misoprostol|misoprostol|mesh-list
20511133|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20511134|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
20511135|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20511136|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511137|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20511138|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511139|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
20511140|NCT03785106|Vitamins|vitamins|mesh-list
20511141|NCT03785106|Pyridoxine|pyridoxine|mesh-list
20511142|NCT03785106|Pyridoxal|pyridoxal|mesh-list
20511143|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
20511144|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
20511145|NCT03785106|Isoniazid|isoniazid|mesh-list
20511146|NCT03785106|Rifapentine|rifapentine|mesh-list
20511147|NCT03785106|Rifampin|rifampin|mesh-list
20511148|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
20511149|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511150|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
20511151|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20511152|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511153|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20511154|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20511155|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
20511156|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415558|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511157|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20511158|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20511159|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
20511160|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511161|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511162|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20511163|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20511164|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20511165|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20511166|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20511167|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20511168|NCT03782142|Tenofovir|tenofovir|mesh-list
20511169|NCT03782142|Dolutegravir|dolutegravir|mesh-list
20511170|NCT03782142|Rilpivirine|rilpivirine|mesh-list
20511171|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
20511172|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
20511173|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511174|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20511175|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511176|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511177|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511178|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20511179|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19708062|NCT04820439|Mitogens|mitogens|mesh-list
20511180|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20511181|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20511182|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
20511183|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20511184|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20511185|NCT03778931|Fulvestrant|fulvestrant|mesh-list
20511186|NCT03778931|Anastrozole|anastrozole|mesh-list
20511187|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19701713|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20511188|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511189|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20511190|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20511191|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
20511192|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511193|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511194|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20511195|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20511196|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511197|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511198|NCT03770299|Gemcitabine|gemcitabine|mesh-list
20511199|NCT03770299|Paclitaxel|paclitaxel|mesh-list
20511200|NCT03770299|Vinorelbine|vinorelbine|mesh-list
20511201|NCT03770299|Docetaxel|docetaxel|mesh-list
20511202|NCT03770299|Carboplatin|carboplatin|mesh-list
20511203|NCT03770299|Nivolumab|nivolumab|mesh-list
20511204|NCT03770299|Pemetrexed|pemetrexed|mesh-list
19701714|NCT04877639|Analgesics|analgesics|mesh-ancestor
19701715|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
20511205|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511206|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708063|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
19701716|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701717|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19701718|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19701719|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19701720|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
19701721|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701722|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701723|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
19701724|NCT04877613|Fludarabine|fludarabine|mesh-list
19701725|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701726|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
19701727|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701728|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701729|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19701730|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
19701731|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701732|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701733|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19708064|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708065|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511207|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511208|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
20511209|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511210|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511211|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20511212|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
20511213|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
20511214|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511215|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511216|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511217|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
19708066|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708067|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19708068|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708069|NCT04820036|Insulin|insulin|mesh-list
19708070|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19708071|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708072|NCT04819971|Docetaxel|docetaxel|mesh-list
19708073|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
20244289|NCT00419601|Remifentanil|remifentanil|mesh-list
20244290|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20511218|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511219|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511220|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511221|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20511222|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511223|NCT03762473|Tacrolimus|tacrolimus|mesh-list
19708074|NCT04819971|Trastuzumab|trastuzumab|mesh-list
19708075|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244291|NCT00419601|Narcotics|narcotics|mesh-ancestor
20511224|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511225|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
20511226|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511227|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20511228|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511229|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529649|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529650|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20529651|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
20529652|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
20529653|NCT01783106|Hormones|hormones|mesh-ancestor
20529654|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529655|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
20529656|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20529657|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20529658|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529659|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529660|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529661|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529662|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20529663|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20529664|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20529665|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529666|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20529667|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20529668|NCT01783197|Paclitaxel|paclitaxel|mesh-list
20529669|NCT01783197|Carboplatin|carboplatin|mesh-list
20529670|NCT01783197|Pemetrexed|pemetrexed|mesh-list
20529671|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20529672|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511230|NCT03760835|Dexamethasone|dexamethasone|mesh-list
20511231|NCT03760835|Prednisone|prednisone|mesh-list
20511232|NCT03760835|Prednisolone|prednisolone|mesh-list
20511233|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
20511234|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20511235|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20511236|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20511237|NCT03760835|Cortisone|cortisone|mesh-list
20511238|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
20511239|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511240|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
20511241|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
20511242|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511243|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511244|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511245|NCT03760835|Hormones|hormones|mesh-ancestor
20511246|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511247|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511248|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511249|NCT03759496|Durvalumab|durvalumab|mesh-list
20511250|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511251|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511252|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
20511253|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511254|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511255|NCT03754725|Deferiprone|deferiprone|mesh-list
20511256|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20511257|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
20511258|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
20511259|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511260|NCT03750968|Carotenoids|carotenoids|mesh-list
20511261|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
20511262|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511263|NCT03750968|Protective Agents|protective agents|mesh-ancestor
20511264|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511265|NCT03748784|Aflibercept|aflibercept|mesh-list
20511266|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511267|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511268|NCT03748784|Growth Substances|growth substances|mesh-ancestor
20511269|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511270|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511271|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511272|NCT03744026|Carboplatin|carboplatin|mesh-list
20511273|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511274|NCT03737240|Insulin|insulin|mesh-list
20511275|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20511276|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
20511277|NCT03737240|Liraglutide|liraglutide|mesh-list
20511278|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
19853634|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19853635|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19853636|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
19853637|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853638|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
19853639|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
19853640|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853641|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
19853642|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244292|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244293|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511279|NCT03737240|Xultophy|xultophy|mesh-list
20244294|NCT00419601|Analgesics|analgesics|mesh-ancestor
20244295|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
20244296|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244297|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20244298|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20244299|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
20244300|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
20244301|NCT00419653|Haloperidol|haloperidol|mesh-list
20244302|NCT00419653|Olanzapine|olanzapine|mesh-list
20244303|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
19853643|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20511280|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20244304|NCT00419653|Amisulpride|amisulpride|mesh-list
20244305|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
20511281|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511282|NCT03737240|Incretins|incretins|mesh-ancestor
20511283|NCT03737240|Hormones|hormones|mesh-ancestor
20511284|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511285|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
20511286|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511287|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511288|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
20511289|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511290|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511291|NCT03726879|Paclitaxel|paclitaxel|mesh-list
20511292|NCT03726879|Maytansine|maytansine|mesh-list
20511293|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20511294|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
20511295|NCT03726879|Doxorubicin|doxorubicin|mesh-list
20511296|NCT03726879|Trastuzumab|trastuzumab|mesh-list
20511297|NCT03726879|Atezolizumab|atezolizumab|mesh-list
20511298|NCT03726879|Pertuzumab|pertuzumab|mesh-list
20511299|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511300|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511301|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511302|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
20511303|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511304|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511305|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511306|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
20511307|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511308|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511309|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20511310|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
20511311|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20511312|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20511313|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20511314|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20511315|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511316|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511317|NCT03724409|Octreotide|octreotide|mesh-list
20511318|NCT03724409|Edotreotide|edotreotide|mesh-list
20511319|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244306|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
20511320|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511321|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511322|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20511323|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511324|NCT03715829|PF-06700841|pf-06700841|mesh-list
20511325|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20511326|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511327|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511328|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
20511329|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
20511330|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20511331|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511332|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511333|NCT03710642|Prazosin|prazosin|mesh-list
20511334|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20511335|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20511336|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20511337|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20511338|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
20511339|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511340|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511341|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511342|NCT03704441|Bupivacaine|bupivacaine|mesh-list
20511343|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
20511344|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
20511345|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415559|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415560|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415561|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
19415562|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415563|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511346|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701734|NCT04878016|Carboplatin|carboplatin|mesh-list
19701735|NCT04878016|Etoposide|etoposide|mesh-list
19701736|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415564|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19701737|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19701738|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19701739|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20511347|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
20511348|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511349|NCT03702725|Dexamethasone|dexamethasone|mesh-list
20511350|NCT03702725|Lenalidomide|lenalidomide|mesh-list
20511351|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511352|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
20511353|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
20511354|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511355|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511356|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511357|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
20511358|NCT03702725|Hormones|hormones|mesh-ancestor
19701740|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511359|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511360|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511361|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511362|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
20511363|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511364|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511365|NCT03702725|Growth Substances|growth substances|mesh-ancestor
20511366|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511367|NCT03701308|Cytarabine|cytarabine|mesh-list
20511368|NCT03701308|Daunorubicin|daunorubicin|mesh-list
20511369|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20511370|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
20511371|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511372|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511373|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
20511374|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511375|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511376|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
19701741|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701742|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
19701743|NCT04877834|Lansoprazole|lansoprazole|mesh-list
19701744|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19701745|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701746|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20511377|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701747|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511378|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20511379|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20511380|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20511381|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511382|NCT03696355|GDC-0084|gdc-0084|mesh-list
20511383|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511384|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511385|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
20511386|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511387|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511388|NCT03693677|Gemcitabine|gemcitabine|mesh-list
20511389|NCT03693677|Paclitaxel|paclitaxel|mesh-list
20511390|NCT03693677|Irinotecan|irinotecan|mesh-list
20511391|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511392|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511393|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511394|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
20511395|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511396|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244307|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244308|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244309|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244310|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20244311|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20244312|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244313|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244314|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20244315|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20511397|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20511398|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
20511399|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
20511400|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511401|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511402|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511403|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
20511404|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511405|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20511406|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20511407|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20511408|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
20511409|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511410|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
20511411|NCT03680092|Methotrexate|methotrexate|mesh-list
20511412|NCT03680092|Abatacept|abatacept|mesh-list
20511413|NCT03680092|Tacrolimus|tacrolimus|mesh-list
20511414|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511415|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
20511416|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511417|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511418|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20511419|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
20511420|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511421|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511422|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20511423|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20511424|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
20511425|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20511426|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20511427|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
20511428|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
20511429|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511430|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20511431|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511432|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20511433|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511434|NCT03677934|Ranibizumab|ranibizumab|mesh-list
20511435|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511436|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511437|NCT03677934|Growth Substances|growth substances|mesh-ancestor
20511438|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511439|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511440|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511441|NCT03677817|Lidocaine|lidocaine|mesh-list
20511442|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
20511443|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
20511444|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20511445|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511446|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
20511447|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511448|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19415565|NCT02811861|Growth Substances|growth substances|mesh-ancestor
19415566|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
19415567|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19415568|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415569|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415570|NCT02811679|Blinatumomab|blinatumomab|mesh-list
19415571|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415572|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
19415573|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
19415574|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19701748|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511449|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20511450|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20511451|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511452|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511453|NCT03673826|Dexamethasone|dexamethasone|mesh-list
20511454|NCT03673826|Lenalidomide|lenalidomide|mesh-list
20511455|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511456|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
20511457|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
20511458|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511459|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511460|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511461|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
20511462|NCT03673826|Hormones|hormones|mesh-ancestor
20511463|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511464|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511465|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511466|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
19701749|NCT05257993|Gemcitabine|gemcitabine|mesh-list
20511467|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511468|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511469|NCT03673826|Growth Substances|growth substances|mesh-ancestor
20511470|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511471|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20511472|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511473|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511474|NCT03662919|Adalimumab|adalimumab|mesh-list
20511475|NCT03662919|Infliximab|infliximab|mesh-list
20511476|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511477|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511478|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
20511479|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511480|NCT03662685|Coal Tar|coal tar|mesh-list
20511481|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
20511482|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
20511483|NCT03660839|Artefenomel|artefenomel|mesh-list
20511484|NCT03660839|Ferroquine|ferroquine|mesh-list
20511485|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
20511486|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19415575|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19701750|NCT05257993|Paclitaxel|paclitaxel|mesh-list
20511487|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20529673|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511488|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511489|NCT03660241|Abrocitinib|abrocitinib|mesh-list
20511490|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20511491|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511492|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511493|NCT03651102|Thalidomide|thalidomide|mesh-list
20511494|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
20511495|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511496|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
20511497|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511498|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
20511499|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20511500|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511501|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511502|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511503|NCT03651102|Growth Substances|growth substances|mesh-ancestor
20511504|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511505|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511506|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
20511507|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511508|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511509|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511510|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
20511511|NCT03649841|Prednisone|prednisone|mesh-list
20511512|NCT03649841|Cortisone|cortisone|mesh-list
20511513|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
20511514|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
20511515|NCT03649841|Hormones|hormones|mesh-list
20511516|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20511517|NCT03649841|Androgens|androgens|mesh-list
20511518|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
20511519|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511520|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
20511521|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511522|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511523|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511524|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511525|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19701751|NCT05257993|Folfirinox|folfirinox|mesh-list
19701752|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511526|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511527|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511528|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
19415576|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
20511529|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20511530|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
20511531|NCT03649841|Protective Agents|protective agents|mesh-ancestor
20511532|NCT03649841|Vitamins|vitamins|mesh-ancestor
20511533|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
20511534|NCT03649841|Estrogens|estrogens|mesh-ancestor
20511535|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
20511536|NCT03649802|Vitamin D|vitamin d|mesh-list
20511537|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
20511538|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
20511539|NCT03649802|Vitamins|vitamins|mesh-list
20511540|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
20511541|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511542|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20511543|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20511544|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
20511545|NCT03645928|Nivolumab|nivolumab|mesh-list
20511546|NCT03645928|Ipilimumab|ipilimumab|mesh-list
20511547|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511548|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511549|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511550|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511551|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20511552|NCT03643198|Metronidazole|metronidazole|mesh-list
20511553|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
20511554|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511555|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20511556|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20511557|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20511558|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20511559|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511560|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511561|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511562|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20511563|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20511564|NCT03623243|Siponimod|siponimod|mesh-list
20511565|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20511566|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511567|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511568|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
20511569|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529674|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
20529675|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
20529676|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529677|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529678|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20529679|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20529680|NCT01783340|Azithromycin|azithromycin|mesh-list
20529681|NCT01783340|Vaccines|vaccines|mesh-list
20244316|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20244317|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244318|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244319|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
20244320|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20244321|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
20244322|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20244323|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20529682|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701753|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701754|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701755|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
19701756|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701757|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701758|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19701759|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
19701760|NCT05257993|Antiviral Agents|antiviral agents|mesh-ancestor
20244324|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
20244325|NCT00419692|Ropinirole|ropinirole|mesh-list
20244326|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20244327|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20244328|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
20244329|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
20244330|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511570|NCT03620578|Nivolumab|nivolumab|mesh-list
20511571|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511572|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511573|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511574|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511584|NCT03611556|Leucovorin|leucovorin|mesh-list
20511585|NCT03611556|Gemcitabine|gemcitabine|mesh-list
20511586|NCT03611556|Paclitaxel|paclitaxel|mesh-list
20511587|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
20511588|NCT03611556|Fluorouracil|fluorouracil|mesh-list
20511589|NCT03611556|Durvalumab|durvalumab|mesh-list
20511590|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
19701761|NCT05257993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244331|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511591|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511592|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511593|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
20244332|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244333|NCT00419718|Insulin|insulin|mesh-list
20244334|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20511594|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20511595|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511596|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511597|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20511598|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
20511599|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
20511600|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701762|NCT05257993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701763|NCT05257993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701764|NCT05257993|Immunologic Factors|immunologic factors|mesh-ancestor
19701765|NCT05257993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701766|NCT05257902|Choline|choline|mesh-list
19701767|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
19701768|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19701769|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
19701770|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701771|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701772|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19701773|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
19701774|NCT05257824|Aspirin|aspirin|mesh-list
19701775|NCT05257824|Clopidogrel|clopidogrel|mesh-list
20511601|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511602|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511603|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
20511604|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511605|NCT03611556|Antidotes|antidotes|mesh-ancestor
20511606|NCT03611556|Protective Agents|protective agents|mesh-ancestor
20511607|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
20511608|NCT03611556|Vitamins|vitamins|mesh-ancestor
20511609|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
20244335|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20244336|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244337|NCT00419731|Naltrexone|naltrexone|mesh-list
20244338|NCT00419731|Bupropion|bupropion|mesh-list
20244339|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20244340|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19701776|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244341|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511610|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511611|NCT03606980|Dexamethasone|dexamethasone|mesh-list
20511612|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
20511613|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20511614|NCT03606980|BB 1101|bb 1101|mesh-list
20511615|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511616|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
20511617|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
20511618|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511619|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511620|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511621|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
20511622|NCT03606980|Hormones|hormones|mesh-ancestor
20511623|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511624|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511625|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511626|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
20511627|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511628|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511629|NCT03596385|Metoprolol|metoprolol|mesh-list
20511630|NCT03596385|Atenolol|atenolol|mesh-list
20511631|NCT03596385|Carvedilol|carvedilol|mesh-list
20511632|NCT03596385|Bisoprolol|bisoprolol|mesh-list
20511633|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20511634|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20511635|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20511636|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
20511637|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
20511638|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511639|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511640|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20511641|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20511642|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
20511643|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511644|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511645|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
20511646|NCT03596385|Protective Agents|protective agents|mesh-ancestor
20511647|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20511648|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511649|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20511650|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
20511651|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20511652|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20511653|NCT03591731|Nivolumab|nivolumab|mesh-list
20511654|NCT03591731|Ipilimumab|ipilimumab|mesh-list
20511655|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511656|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511657|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511658|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511659|NCT03590652|Dexamethasone|dexamethasone|mesh-list
19701777|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19701778|NCT05257824|Analgesics|analgesics|mesh-ancestor
19701779|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
19853644|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19853645|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853646|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19853647|NCT00734032|Darapladib|darapladib|mesh-list
19853648|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19853649|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853650|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853651|NCT00734071|Vortioxetine|vortioxetine|mesh-list
19853652|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853653|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853654|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19853655|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19853656|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853657|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853658|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19853659|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20511660|NCT03590652|Daratumumab|daratumumab|mesh-list
20511661|NCT03590652|Pomalidomide|pomalidomide|mesh-list
19853660|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855631|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511662|NCT03590652|Ixazomib|ixazomib|mesh-list
20511663|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511664|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
20511665|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
20511666|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511667|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511668|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511669|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
20511670|NCT03590652|Hormones|hormones|mesh-ancestor
20511671|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511672|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511673|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511674|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
20511675|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511676|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511677|NCT03590652|Growth Substances|growth substances|mesh-ancestor
20511678|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511679|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
20511680|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511681|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511682|NCT03584711|Panitumumab|panitumumab|mesh-list
20511683|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511684|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511685|NCT03582475|Cisplatin|cisplatin|mesh-list
20511686|NCT03582475|Carboplatin|carboplatin|mesh-list
20511687|NCT03582475|Docetaxel|docetaxel|mesh-list
20511688|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
20511689|NCT03582475|Etoposide|etoposide|mesh-list
20511690|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
20511691|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
20511692|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511693|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511694|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
20511695|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511696|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511697|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511698|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511699|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20511700|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20511701|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511702|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
20511703|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
20511704|NCT03579316|Olaparib|olaparib|mesh-list
20511705|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20511706|NCT03579316|Adavosertib|adavosertib|mesh-list
20511707|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511708|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511709|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511710|NCT03576417|Nivolumab|nivolumab|mesh-list
20511711|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511712|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511713|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511714|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511715|NCT03573115|Adapalene|adapalene|mesh-list
20511716|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20511717|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
20511718|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20511719|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20511720|NCT03573115|Analgesics|analgesics|mesh-ancestor
20511721|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
20511722|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511723|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511724|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511725|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511726|NCT03569475|Milnacipran|milnacipran|mesh-list
20511727|NCT03569475|Fluoxetine|fluoxetine|mesh-list
20511728|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
20511729|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20511730|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20511731|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511732|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511733|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511734|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
20511735|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511736|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20511737|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
20511738|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20511739|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20511740|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20511741|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511742|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20511743|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20511744|NCT03569475|Analgesics|analgesics|mesh-ancestor
20511745|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
20511746|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511747|NCT03546556|Alovudine|alovudine|mesh-list
20511748|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
20511749|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
20511750|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511751|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
20511752|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511753|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20511754|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511755|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511756|NCT03544281|Dexamethasone|dexamethasone|mesh-list
20511757|NCT03544281|Lenalidomide|lenalidomide|mesh-list
20511758|NCT03544281|Bortezomib|bortezomib|mesh-list
20511759|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511760|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
20511761|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
20511762|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511763|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511764|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511765|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
20511766|NCT03544281|Hormones|hormones|mesh-ancestor
20511767|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511768|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20511769|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511770|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
20511771|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20511772|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20511773|NCT03544281|Growth Substances|growth substances|mesh-ancestor
20511774|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
20511775|NCT03542175|Rucaparib|rucaparib|mesh-list
20511776|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20511777|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511778|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511779|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511780|NCT03533712|Folic Acid|folic acid|mesh-list
20511781|NCT03533712|Hematinics|hematinics|mesh-ancestor
20511782|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
20511783|NCT03533712|Vitamins|vitamins|mesh-ancestor
20511784|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
20511785|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511786|NCT03529396|Chloroquine|chloroquine|mesh-list
20511787|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20511788|NCT03529396|Primaquine|primaquine|mesh-list
20511789|NCT03529396|Amebicides|amebicides|mesh-ancestor
20511790|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20511791|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20511792|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511793|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
20511794|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511795|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20511796|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20511797|NCT03529396|Analgesics|analgesics|mesh-ancestor
20511798|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
20511799|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511800|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511801|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20511802|NCT03529396|Filaricides|filaricides|mesh-ancestor
20511803|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
20511804|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
20511805|NCT03523520|Naltrexone|naltrexone|mesh-list
20511806|NCT03523520|Bromides|bromides|mesh-list
20511807|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
20511808|NCT03523520|Naloxegol|naloxegol|mesh-list
20511809|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
20511810|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20511811|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511812|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
20511813|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511814|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20511815|NCT03521830|Nivolumab|nivolumab|mesh-list
20511816|NCT03521830|Ipilimumab|ipilimumab|mesh-list
20511817|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511818|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511819|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511820|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511821|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
20511822|NCT03518242|Capecitabine|capecitabine|mesh-list
20511823|NCT03518242|Methotrexate|methotrexate|mesh-list
20511824|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511825|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
20511826|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511827|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511828|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20511829|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
20511830|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511831|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511832|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20511833|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20511834|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
20511835|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20511836|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
20511837|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20511838|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
20511839|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511840|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20511841|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20511842|NCT03508570|Nivolumab|nivolumab|mesh-list
20511843|NCT03508570|Ipilimumab|ipilimumab|mesh-list
20511844|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511845|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511846|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511847|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511848|NCT03500549|Eculizumab|eculizumab|mesh-list
20511849|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20511850|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511851|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
20511852|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511853|NCT03498001|Liraglutide|liraglutide|mesh-list
20511854|NCT03498001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20511855|NCT03498001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511856|NCT03498001|Incretins|incretins|mesh-ancestor
20511857|NCT03498001|Hormones|hormones|mesh-ancestor
20511858|NCT03498001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511859|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
20511860|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
20511861|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511862|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
20511863|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415577|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511864|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511865|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20511866|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
19708076|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511867|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511868|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511869|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20511870|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511871|NCT03475186|Ramipril|ramipril|mesh-list
20511872|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20511873|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
20511874|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511875|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511876|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20511877|NCT03469960|Nivolumab|nivolumab|mesh-list
20511878|NCT03469960|Ipilimumab|ipilimumab|mesh-list
20511879|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20511880|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511881|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20511882|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511883|NCT03460379|Citalopram|citalopram|mesh-list
20511884|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20511885|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20511886|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511887|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511888|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511889|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
20511890|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511891|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20511892|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
20511893|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20511894|NCT03460366|Enalapril|enalapril|mesh-list
20511895|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20511896|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
20511897|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511898|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511899|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20511900|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
20511901|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20511902|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511903|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20511904|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20511905|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511906|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511907|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
20511908|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511909|NCT03460327|Candesartan|candesartan|mesh-list
20511910|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20511911|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20511912|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20511913|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511914|NCT03460314|Buprenorphine|buprenorphine|mesh-list
20511915|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20511916|NCT03460314|Narcotics|narcotics|mesh-ancestor
20511917|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20511918|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511919|NCT03460314|Analgesics|analgesics|mesh-ancestor
20511920|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
20511921|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511922|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20511923|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19701780|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708077|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244342|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
20511924|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20511925|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20511926|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511927|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511928|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
20511929|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20511930|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511931|NCT03456700|Sirolimus|sirolimus|mesh-list
20511932|NCT03456700|Auranofin|auranofin|mesh-list
20511933|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20511934|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511935|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20511936|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511937|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
20511938|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511939|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
20244343|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244344|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20244345|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
20244346|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244347|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20244348|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20244349|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248039|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701781|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701782|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701783|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701784|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19701785|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19701786|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701787|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19701788|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19701789|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701790|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
19701791|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19701792|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19701793|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19701794|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
19701795|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701796|NCT05257460|Insulin|insulin|mesh-list
19701797|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19701798|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
19701799|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19701800|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701801|NCT05257408|Paclitaxel|paclitaxel|mesh-list
19701802|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19701803|NCT05257408|Doxorubicin|doxorubicin|mesh-list
19701804|NCT05257408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19701805|NCT05257408|Topotecan|topotecan|mesh-list
19701806|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19701807|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244350|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244351|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
20244352|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244353|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20244354|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20244355|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244356|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
20244357|NCT00419783|Ketoconazole|ketoconazole|mesh-list
19701808|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701809|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244358|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244359|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511940|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511941|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20511942|NCT03455270|Palbociclib|palbociclib|mesh-list
20511943|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511944|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20511945|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511946|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511947|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19701810|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701811|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701812|NCT05257408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19701813|NCT05257408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19701814|NCT05257408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19701815|NCT05257408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701816|NCT05257408|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19701817|NCT05257395|Letrozole|letrozole|mesh-list
19701818|NCT05257395|Anastrozole|anastrozole|mesh-list
19701819|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701820|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19701821|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19701822|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701823|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701824|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19701825|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
19701826|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701827|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511948|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
20511949|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20511950|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20511951|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20511952|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20511953|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511954|NCT03435185|Lidocaine|lidocaine|mesh-list
20511955|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
20511956|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
20511957|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20511958|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20511959|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
19701828|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19701829|NCT05257291|Melatonin|melatonin|mesh-list
19701830|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
19701831|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701832|NCT05257291|Protective Agents|protective agents|mesh-ancestor
20511960|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20511961|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19701833|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853661|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853662|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853663|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
19853664|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19853665|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19853666|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19853667|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19853668|NCT00734097|Esomeprazole|esomeprazole|mesh-list
19853669|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19701834|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701835|NCT05257083|Dexamethasone|dexamethasone|mesh-list
19701836|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
19701837|NCT05257083|Fludarabine|fludarabine|mesh-list
19701838|NCT05257083|Lenalidomide|lenalidomide|mesh-list
19701839|NCT05257083|Bortezomib|bortezomib|mesh-list
19701840|NCT05257083|Daratumumab|daratumumab|mesh-list
19701841|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701842|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
19701843|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701844|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701845|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19701846|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
19701847|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701848|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701849|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19701850|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701851|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
19701852|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
19701853|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701854|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701855|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
19701856|NCT05257083|Hormones|hormones|mesh-ancestor
19853670|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20511962|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20511963|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20511964|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20511965|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511966|NCT03430882|Paclitaxel|paclitaxel|mesh-list
20511967|NCT03430882|Carboplatin|carboplatin|mesh-list
20511968|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20511969|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511970|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511971|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511972|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
20511973|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511974|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511975|NCT03430219|Calcium|calcium|mesh-list
19701857|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20511976|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20511977|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529683|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529684|NCT01783340|Immunologic Factors|immunologic factors|mesh-ancestor
20529685|NCT01783340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529686|NCT01783379|Micafungin|micafungin|mesh-list
20529687|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
20529688|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529689|NCT01783431|Poly ICLC|poly iclc|mesh-list
20529690|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
20529691|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
20529692|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529693|NCT01783587|Docetaxel|docetaxel|mesh-list
20529694|NCT01783587|Afatinib|afatinib|mesh-list
20529695|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511978|NCT03426293|Heparin|heparin|mesh-list
20511979|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
20511980|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20511981|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20511982|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511983|NCT03421353|Gemcitabine|gemcitabine|mesh-list
20511984|NCT03421353|Paclitaxel|paclitaxel|mesh-list
20511985|NCT03421353|Carboplatin|carboplatin|mesh-list
20511986|NCT03421353|Durvalumab|durvalumab|mesh-list
20511987|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20511988|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20511989|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
20511990|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
20511991|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
20511992|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20511993|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20511994|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
20511995|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
20511996|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20511997|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20511998|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20511999|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
20512000|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512001|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512002|NCT03414684|Carboplatin|carboplatin|mesh-list
20512003|NCT03414684|Nivolumab|nivolumab|mesh-list
20512004|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512005|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512006|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512007|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512008|NCT03408574|Mecamylamine|mecamylamine|mesh-list
20512009|NCT03408574|Nicotine|nicotine|mesh-list
20512010|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20512011|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
20512012|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512013|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512014|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20512015|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20512016|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
20512017|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529696|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
19853671|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19853672|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853673|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853674|NCT00734149|Prednisone|prednisone|mesh-list
20512018|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512019|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20512020|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19701858|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19701859|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19701860|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19701861|NCT05257083|Growth Substances|growth substances|mesh-ancestor
19701862|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
20512021|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20512022|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20512023|NCT03408119|Vitamin D|vitamin d|mesh-list
20512024|NCT03408119|Calcium|calcium|mesh-list
20512025|NCT03408119|Vitamins|vitamins|mesh-ancestor
20512026|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
19701863|NCT05257018|Doxorubicin|doxorubicin|mesh-list
19701864|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19701865|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701866|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19701867|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19853675|NCT00734149|Bortezomib|bortezomib|mesh-list
19853676|NCT00734149|Melphalan|melphalan|mesh-list
19853677|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853678|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
19853679|NCT00734149|Hormones|hormones|mesh-ancestor
19853680|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853681|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853682|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19853683|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853684|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19853685|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
19853686|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853687|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19853688|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19853689|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
19853690|NCT00734162|Tenofovir|tenofovir|mesh-list
19853691|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
19853692|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853693|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19853694|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19853695|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853696|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853697|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19853698|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19853699|NCT00734344|Tenofovir|tenofovir|mesh-list
19853700|NCT00734344|Efavirenz|efavirenz|mesh-list
19853701|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
20512027|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529697|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512028|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20512029|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20512030|NCT03402945|Vancomycin|vancomycin|mesh-list
20512031|NCT03402945|Cefazolin|cefazolin|mesh-list
19853702|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
19853703|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853704|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19853705|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19853706|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512032|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20512033|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512034|NCT03398655|Paclitaxel|paclitaxel|mesh-list
20512035|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20512036|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20512037|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512038|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512039|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512040|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512041|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512042|NCT03383380|Sirolimus|sirolimus|mesh-list
20512043|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20512044|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512045|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20512046|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512047|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
20512048|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512049|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
20512050|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512051|NCT03370133|Ustekinumab|ustekinumab|mesh-list
20512052|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
20512053|NCT03369041|Irinotecan|irinotecan|mesh-list
20512054|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20512055|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20512056|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512057|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512058|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512059|NCT03358030|Riboflavin|riboflavin|mesh-list
20512060|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
20512061|NCT03358030|Vitamins|vitamins|mesh-ancestor
20512062|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
20512063|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512064|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20512065|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
20512066|NCT03331341|Doxorubicin|doxorubicin|mesh-list
20512067|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20512068|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
20512069|NCT03331341|Dacarbazine|dacarbazine|mesh-list
20512070|NCT03331341|Vinblastine|vinblastine|mesh-list
20512071|NCT03331341|Imidazole|imidazole|mesh-list
20512072|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20512073|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512074|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20512075|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20512076|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512077|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512078|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512079|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512080|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
20512081|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20512082|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512083|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512084|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512085|NCT03330847|Olaparib|olaparib|mesh-list
20512086|NCT03330847|Adavosertib|adavosertib|mesh-list
20512087|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20512088|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512089|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512090|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512091|NCT03325439|Brivaracetam|brivaracetam|mesh-list
20512092|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
20512093|NCT03323034|Irinotecan|irinotecan|mesh-list
20512094|NCT03323034|Temozolomide|temozolomide|mesh-list
20512095|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20512096|NCT03323034|Pevonedistat|pevonedistat|mesh-list
20512097|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20512098|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20512099|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512100|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512101|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512102|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
20512103|NCT03300544|Leucovorin|leucovorin|mesh-list
20512104|NCT03300544|Fluorouracil|fluorouracil|mesh-list
20512105|NCT03300544|Capecitabine|capecitabine|mesh-list
20512106|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
20512107|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20512108|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
20512109|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512110|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512111|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512112|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512113|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
20512114|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512115|NCT03300544|Antidotes|antidotes|mesh-ancestor
20512116|NCT03300544|Protective Agents|protective agents|mesh-ancestor
20512117|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
20512118|NCT03300544|Vitamins|vitamins|mesh-ancestor
20512119|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
20512120|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512121|NCT03260504|Aldesleukin|aldesleukin|mesh-list
20512122|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
20512123|NCT03260504|Interleukin-2|interleukin-2|mesh-list
20512124|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
20512125|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
20512126|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512127|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512128|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
20512129|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512130|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20512131|NCT03260504|Analgesics|analgesics|mesh-ancestor
20512132|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
20512133|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512134|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20512135|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20512136|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
20512137|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512138|NCT03251924|Nivolumab|nivolumab|mesh-list
20512139|NCT03251924|Ipilimumab|ipilimumab|mesh-list
20512140|NCT03251924|Antibodies|antibodies|mesh-list
20512141|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
20512142|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
20512143|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
20512144|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512145|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512146|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512147|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512148|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512149|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
20512150|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20512151|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
20512152|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512153|NCT03242772|Amphetamine|amphetamine|mesh-list
20512154|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20512155|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512156|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
20512157|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
20512158|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512159|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
20512160|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20512161|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512162|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
20512163|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20512164|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20512165|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20512166|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20512167|NCT03237702|Carotenoids|carotenoids|mesh-list
20512168|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
20512169|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512170|NCT03237702|Protective Agents|protective agents|mesh-ancestor
20512171|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512172|NCT03236311|Adenosine|adenosine|mesh-list
20512173|NCT03236311|Regadenoson|regadenoson|mesh-list
20512174|NCT03236311|Analgesics|analgesics|mesh-ancestor
20512175|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
20529698|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512176|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512177|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512178|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20512179|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
20512180|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20512181|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
20512182|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
20512183|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20512184|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512185|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20512186|NCT03234686|Deferiprone|deferiprone|mesh-list
20512187|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20512188|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
20512189|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
20512190|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512191|NCT03233204|Olaparib|olaparib|mesh-list
20512192|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20512193|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512194|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512195|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512196|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
20512197|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20512198|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20512199|NCT03229538|Prednisolone|prednisolone|mesh-list
20512200|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
20512201|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20512202|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
20512203|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20512204|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
20512205|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
20512206|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512207|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512208|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19701868|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701869|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701870|NCT05256953|Anesthetics|anesthetics|mesh-list
19701871|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701872|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701873|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
19701874|NCT05256901|Neostigmine|neostigmine|mesh-list
19701875|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20512209|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
20512210|NCT03229538|Hormones|hormones|mesh-ancestor
20512211|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512212|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20512213|NCT03229538|Protective Agents|protective agents|mesh-ancestor
20512214|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20512215|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512216|NCT03229057|Metformin|metformin|mesh-list
20512217|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20512218|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512219|NCT03224767|Vemurafenib|vemurafenib|mesh-list
20512220|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512221|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512222|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512223|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512224|NCT03223974|Paclitaxel|paclitaxel|mesh-list
20512225|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20512226|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512227|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512228|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512229|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512230|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512231|NCT03220035|Vemurafenib|vemurafenib|mesh-list
20512232|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512233|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512234|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512235|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512236|NCT03216343|Chiauranib|chiauranib|mesh-list
20512237|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512238|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512239|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512240|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512241|NCT03201939|Lisinopril|lisinopril|mesh-list
20512242|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20512243|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
20512244|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512245|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512246|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19415578|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
20512247|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20512248|NCT03201939|Protective Agents|protective agents|mesh-ancestor
20512249|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512250|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
20512251|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20512252|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512253|NCT03190369|Hylan|hylan|mesh-list
20512254|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
20512255|NCT03190369|Protective Agents|protective agents|mesh-ancestor
20512256|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512257|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
20512258|NCT03190265|Nivolumab|nivolumab|mesh-list
20512259|NCT03190265|Ipilimumab|ipilimumab|mesh-list
20512260|NCT03190265|Pancrelipase|pancrelipase|mesh-list
20512261|NCT03190265|Vaccines|vaccines|mesh-list
20512262|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
20512263|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512264|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512265|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20512266|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512267|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
20512268|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512269|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512270|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20512271|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512272|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512273|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20512274|NCT03188432|Carboplatin|carboplatin|mesh-list
20512275|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512276|NCT03186209|Benralizumab|benralizumab|mesh-list
20512277|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20512278|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
20529699|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529700|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20529701|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529702|NCT01783717|Exenatide|exenatide|mesh-list
20529703|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20529704|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529705|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20529706|NCT01783717|Incretins|incretins|mesh-ancestor
20529707|NCT01783717|Hormones|hormones|mesh-ancestor
20529708|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529709|NCT01783756|Capecitabine|capecitabine|mesh-list
20529710|NCT01783756|Everolimus|everolimus|mesh-list
20529711|NCT01783756|Lapatinib|lapatinib|mesh-list
20529712|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20529713|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
20529714|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415579|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
20529715|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529716|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529717|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
20529718|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512279|NCT03178487|Upadacitinib|upadacitinib|mesh-list
20512280|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20512281|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512282|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512283|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512284|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20512285|NCT03172975|Albendazole|albendazole|mesh-list
20512286|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20512287|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
20512288|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20512289|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512290|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
20512291|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20512292|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20512293|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512294|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512295|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512296|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512297|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512298|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20512299|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
20512300|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512301|NCT03172975|Antacids|antacids|mesh-ancestor
20512302|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20512303|NCT03164889|Entecavir|entecavir|mesh-list
20512304|NCT03164889|Molgramostim|molgramostim|mesh-list
20512305|NCT03164889|Sargramostim|sargramostim|mesh-list
20512306|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
20512307|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512308|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
20512309|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512310|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512311|NCT03147287|Fulvestrant|fulvestrant|mesh-list
20512312|NCT03147287|Palbociclib|palbociclib|mesh-list
20512313|NCT03147287|Avelumab|avelumab|mesh-list
20512314|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20512315|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512316|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20512317|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20512318|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
19853707|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512319|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512320|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512321|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512322|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512323|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512324|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512325|NCT03147040|Carboplatin|carboplatin|mesh-list
20512326|NCT03147040|Atezolizumab|atezolizumab|mesh-list
20512327|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512328|NCT03133260|Aspirin|aspirin|mesh-list
20244360|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20244361|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20244362|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244363|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244364|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244365|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244366|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
20512329|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20512330|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20512331|NCT03133260|Analgesics|analgesics|mesh-ancestor
20512332|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
20512333|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512334|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512335|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20512336|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701876|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708078|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512337|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20512338|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20512339|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512340|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20512341|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20512342|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512343|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
20512344|NCT03132636|Cemiplimab|cemiplimab|mesh-list
20512345|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512346|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512347|NCT03126812|Paclitaxel|paclitaxel|mesh-list
20512348|NCT03126812|Carboplatin|carboplatin|mesh-list
20512349|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
20512350|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20512351|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512352|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512353|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512354|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512355|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512356|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512357|NCT03114319|Nazartinib|nazartinib|mesh-list
20512358|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512359|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
20512360|NCT03110432|Niacin|niacin|mesh-list
20512361|NCT03110432|Ezetimibe|ezetimibe|mesh-list
20512362|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20512363|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20512364|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20512365|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
20512366|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512367|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20512368|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
20512369|NCT03110432|Vitamins|vitamins|mesh-ancestor
20512370|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
20512371|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512372|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
20512373|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
20512374|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512375|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512376|NCT03096834|Erenumab|erenumab|mesh-list
20512377|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20512378|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512379|NCT03096834|Analgesics|analgesics|mesh-ancestor
20512380|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
20512381|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512382|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512383|NCT03095612|Docetaxel|docetaxel|mesh-list
20512384|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512385|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512386|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512387|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512388|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512389|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
20512390|NCT03089203|Fludarabine|fludarabine|mesh-list
20512391|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512392|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
20512393|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512394|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20512395|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512396|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
20512397|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512398|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512399|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20512400|NCT03088813|Irinotecan|irinotecan|mesh-list
20512401|NCT03088813|Topotecan|topotecan|mesh-list
20512402|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20512403|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20512404|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512405|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512406|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512407|NCT03086993|Gemcitabine|gemcitabine|mesh-list
20512408|NCT03086993|Melphalan|melphalan|mesh-list
20512409|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512410|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512411|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
20512412|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512413|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
20512414|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512415|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512416|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512417|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
20512418|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512419|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512420|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
20512421|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20512422|NCT03085485|Ivacaftor|ivacaftor|mesh-list
20512423|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20512424|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20512425|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512426|NCT03083197|Azithromycin|azithromycin|mesh-list
20512427|NCT03083197|Doxycycline|doxycycline|mesh-list
20512428|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20512429|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512430|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
20512431|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20512432|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20512433|NCT03082209|Bevacizumab|bevacizumab|mesh-list
20512434|NCT03082209|Venetoclax|venetoclax|mesh-list
20512435|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512436|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512437|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20512438|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20512439|NCT03082209|Growth Substances|growth substances|mesh-ancestor
20512440|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512441|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
20512442|NCT03078010|Tazobactam|tazobactam|mesh-list
20512443|NCT03078010|Piperacillin|piperacillin|mesh-list
20512444|NCT03078010|Cefepime|cefepime|mesh-list
20512445|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20512446|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20512447|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512448|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20512449|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512450|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512451|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
20512452|NCT03070392|Ipilimumab|ipilimumab|mesh-list
20512453|NCT03070392|Dacarbazine|dacarbazine|mesh-list
20512454|NCT03070392|Imidazole|imidazole|mesh-list
20512455|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512456|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512457|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512458|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512459|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512460|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
20512461|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512462|NCT03064854|Gemcitabine|gemcitabine|mesh-list
20512463|NCT03064854|Paclitaxel|paclitaxel|mesh-list
20512464|NCT03064854|Carboplatin|carboplatin|mesh-list
20512465|NCT03064854|Pemetrexed|pemetrexed|mesh-list
20512466|NCT03064854|Spartalizumab|spartalizumab|mesh-list
20512467|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20512468|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512469|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512470|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512471|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512472|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512473|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512474|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
20512475|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
20512476|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512477|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512478|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512479|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
20512480|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512481|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20512482|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20512483|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512484|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
20512485|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512486|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512487|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
20512488|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20512489|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
20512490|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512491|NCT03056014|Expectorants|expectorants|mesh-ancestor
20512492|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
20512493|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20512494|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
20512495|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512496|NCT03056014|Protective Agents|protective agents|mesh-ancestor
20512497|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512498|NCT03056014|Antidotes|antidotes|mesh-ancestor
20512499|NCT03054363|Letrozole|letrozole|mesh-list
20512500|NCT03054363|Palbociclib|palbociclib|mesh-list
20512501|NCT03054363|Tucatinib|tucatinib|mesh-list
20512502|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512503|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20512504|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20512505|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512506|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512507|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20512508|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
20512509|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512510|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512511|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512512|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
20512513|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
20512514|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512515|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
20512516|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512517|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
20512518|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512519|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853708|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20244367|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20512520|NCT03048578|Liraglutide|liraglutide|mesh-list
20512521|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20512522|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512523|NCT03048578|Incretins|incretins|mesh-ancestor
20512524|NCT03048578|Hormones|hormones|mesh-ancestor
20512525|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512526|NCT03026972|Vaccines|vaccines|mesh-list
20512527|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
20512528|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512529|NCT03017833|Metformin|metformin|mesh-list
20512530|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20512531|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512532|NCT03015792|Dexamethasone|dexamethasone|mesh-list
20512533|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
20512534|NCT03015792|Lenalidomide|lenalidomide|mesh-list
20512535|NCT03015792|Ichthammol|ichthammol|mesh-list
20512536|NCT03015792|BB 1101|bb 1101|mesh-list
20512537|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20512538|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
20512539|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
20512540|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512541|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512542|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20512543|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
20512544|NCT03015792|Hormones|hormones|mesh-ancestor
20512545|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512546|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20512547|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512548|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
20512549|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20244368|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20512550|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20244369|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20244370|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
20244371|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244372|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20244373|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
20244374|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20244375|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20244376|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244377|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244378|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244379|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415588|NCT02804282|Furosemide|furosemide|mesh-list
19415589|NCT02804282|Diuretics|diuretics|mesh-ancestor
19415590|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
19415591|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415592|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19853709|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20244380|NCT00419796|Analgesics|analgesics|mesh-ancestor
20244381|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
20244382|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248040|NCT00434382|Fentanyl|fentanyl|mesh-list
20512551|NCT03015792|Growth Substances|growth substances|mesh-ancestor
20512552|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
20512553|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
20512554|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512555|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512556|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
20512557|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
20512558|NCT03012815|Gabapentin|gabapentin|mesh-list
20512559|NCT03012815|Lorazepam|lorazepam|mesh-list
20512560|NCT03012815|Valproic Acid|valproic acid|mesh-list
20512561|NCT03012815|Analgesics|analgesics|mesh-ancestor
20512562|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
20512563|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512564|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512565|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
20512566|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20512567|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20512568|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20512569|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20512570|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20512571|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20512572|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20512573|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512574|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
20512575|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
20512576|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
20512577|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20512578|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20512579|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
20512580|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
20512581|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512582|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19415593|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20512583|NCT03006432|Leucovorin|leucovorin|mesh-list
20512584|NCT03006432|Folic Acid|folic acid|mesh-list
20512585|NCT03006432|Docetaxel|docetaxel|mesh-list
20512586|NCT03006432|Fluorouracil|fluorouracil|mesh-list
20512587|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
20512588|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
20512589|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512590|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701877|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701878|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
19701879|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701880|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701881|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19701882|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
19701883|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701884|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20512591|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512592|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512593|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512594|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
20512595|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512596|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512597|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
20512598|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512599|NCT03006432|Antidotes|antidotes|mesh-ancestor
20512600|NCT03006432|Protective Agents|protective agents|mesh-ancestor
20512601|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
20512602|NCT03006432|Vitamins|vitamins|mesh-ancestor
20512603|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
19853710|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20512604|NCT03006432|Hematinics|hematinics|mesh-ancestor
20512605|NCT03003065|Temoporfin|temoporfin|mesh-list
20512606|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512607|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20512608|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
20512609|NCT03001011|Sevelamer|sevelamer|mesh-list
20512610|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
20512611|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
20512612|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512613|NCT02999633|Acetaminophen|acetaminophen|mesh-list
20512614|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
20512615|NCT02999633|Promethazine|promethazine|mesh-list
20512616|NCT02999633|Dexamethasone|dexamethasone|mesh-list
20512617|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
20512618|NCT02999633|Ranitidine|ranitidine|mesh-list
20512619|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20512620|NCT02999633|BB 1101|bb 1101|mesh-list
20512621|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20512622|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
20512623|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
20512624|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512625|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512626|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20512627|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
20512628|NCT02999633|Hormones|hormones|mesh-ancestor
20512629|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512630|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20512631|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512632|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
20512633|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853711|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19853712|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19853713|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19853714|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20512634|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512635|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20512636|NCT02999633|Analgesics|analgesics|mesh-ancestor
20512637|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
20512638|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
20512639|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20512640|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20512641|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20512642|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
20512643|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
20512644|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20512645|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
20512646|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
20512647|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20512648|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20512649|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
20512650|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
20512651|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20512652|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20512653|NCT02993757|Vaccines|vaccines|mesh-list
20512654|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
20512655|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512656|NCT02992418|Vaccines|vaccines|mesh-list
20512657|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
20512658|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512659|NCT02979535|Vaccines|vaccines|mesh-list
20512660|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
20512661|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512662|NCT02978716|Gemcitabine|gemcitabine|mesh-list
20512663|NCT02978716|Carboplatin|carboplatin|mesh-list
20512664|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512665|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512666|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
20512667|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512668|NCT02978716|Antiviral Agents|antiviral agents|mesh-ancestor
20512669|NCT02978716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512670|NCT02978716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512671|NCT02978716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512672|NCT02978716|Immunologic Factors|immunologic factors|mesh-ancestor
20512673|NCT02978716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512674|NCT02977156|Ipilimumab|ipilimumab|mesh-list
20512675|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512676|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512677|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512678|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512679|NCT02975934|Docetaxel|docetaxel|mesh-list
20512680|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
20512681|NCT02975934|Rucaparib|rucaparib|mesh-list
20512682|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512683|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512684|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512685|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512686|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512687|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20512688|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512689|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
20512690|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244383|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244384|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244385|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244386|NCT00419835|Losartan|losartan|mesh-list
20244387|NCT00419835|Enalapril|enalapril|mesh-list
20244388|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20244389|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20248041|NCT00434382|Sufentanil|sufentanil|mesh-list
20512691|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244390|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20244391|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20244392|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244393|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20244394|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244395|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415594|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244396|NCT00419848|Azithromycin|azithromycin|mesh-list
19415595|NCT02804035|Furosemide|furosemide|mesh-list
19415596|NCT02804035|Diuretics|diuretics|mesh-ancestor
19415597|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
19415598|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701885|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19701886|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19701887|NCT05256758|Fenofibrate|fenofibrate|mesh-list
20244397|NCT00419848|Doxycycline|doxycycline|mesh-list
20244398|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244399|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244400|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
20244401|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19701888|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19701889|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
19701890|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701891|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19701892|NCT05256745|Paclitaxel|paclitaxel|mesh-list
20244402|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20244403|NCT00419887|Vildagliptin|vildagliptin|mesh-list
20244404|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20244405|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244406|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20244407|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244408|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244409|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244410|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20244411|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20244412|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
20248042|NCT00434382|Remifentanil|remifentanil|mesh-list
20512692|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20512693|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20512694|NCT02973321|Metformin|metformin|mesh-list
20512695|NCT02973321|Liraglutide|liraglutide|mesh-list
20512696|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20512697|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512698|NCT02973321|Incretins|incretins|mesh-ancestor
20512699|NCT02973321|Hormones|hormones|mesh-ancestor
20512700|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19701893|NCT05256745|Docetaxel|docetaxel|mesh-list
20512701|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20512702|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20512703|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20512704|NCT02964585|Canagliflozin|canagliflozin|mesh-list
19701894|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
20512705|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20529719|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19701895|NCT05256745|Carboplatin|carboplatin|mesh-list
20512706|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512707|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20512708|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529720|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529721|NCT01783834|Pemetrexed|pemetrexed|mesh-list
20529722|NCT01783834|Gefitinib|gefitinib|mesh-list
20529723|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529724|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529725|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529726|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20529727|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20529728|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20529729|NCT01783925|Aflibercept|aflibercept|mesh-list
20529730|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20529731|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20529732|NCT01783925|Growth Substances|growth substances|mesh-ancestor
20529733|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529734|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
20529735|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701896|NCT05256745|Doxorubicin|doxorubicin|mesh-list
19701897|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19701898|NCT05256745|Trastuzumab|trastuzumab|mesh-list
19701899|NCT05256745|Pertuzumab|pertuzumab|mesh-list
20529736|NCT01783951|Cisplatin|cisplatin|mesh-list
20529737|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529738|NCT01783964|Cytarabine|cytarabine|mesh-list
20529739|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20529740|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
20529741|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701900|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20529742|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529743|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
20529744|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529745|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701901|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529746|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
20529747|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701902|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701903|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
19701904|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
19701905|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701906|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512709|NCT02950766|Ipilimumab|ipilimumab|mesh-list
20512710|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512711|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512712|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512713|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512714|NCT02943785|Edoxaban|edoxaban|mesh-list
20512715|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20512716|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
20512717|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20512718|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
20512719|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512720|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512721|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
20512722|NCT02937818|Carboplatin|carboplatin|mesh-list
20512723|NCT02937818|Durvalumab|durvalumab|mesh-list
20512724|NCT02937818|Olaparib|olaparib|mesh-list
20512725|NCT02937818|Tremelimumab|tremelimumab|mesh-list
20512726|NCT02937818|Adavosertib|adavosertib|mesh-list
20512727|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701907|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
19701908|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701909|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853715|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19853716|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19853717|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19853718|NCT00734474|Metformin|metformin|mesh-list
19853719|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19853720|NCT00734474|Dulaglutide|dulaglutide|mesh-list
19853721|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20512728|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19701910|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19701911|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
19701912|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19701913|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19701914|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19701915|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19701916|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701917|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19701918|NCT05256719|Abatacept|abatacept|mesh-list
19701919|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19701920|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701921|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853722|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512729|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20512730|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512731|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853723|NCT00734474|Incretins|incretins|mesh-ancestor
20512732|NCT02908685|Risdiplam|risdiplam|mesh-list
20512733|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20512734|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512735|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512736|NCT02908334|Sertraline|sertraline|mesh-list
20512737|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
20512738|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20512739|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20512740|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20512741|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20512742|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512743|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20512744|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
20512745|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512746|NCT02901067|Aspirin|aspirin|mesh-list
20512747|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20512748|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20512749|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20512750|NCT02901067|Analgesics|analgesics|mesh-ancestor
20512751|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
20512752|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853724|NCT00734474|Hormones|hormones|mesh-ancestor
19853725|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853726|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19853727|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853728|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853729|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853730|NCT00734500|Anidulafungin|anidulafungin|mesh-list
19853731|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
19853732|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853733|NCT00734539|Fluconazole|fluconazole|mesh-list
19853734|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
19853735|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853736|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20512753|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853737|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19853738|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853739|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512754|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20512755|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20512756|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20512757|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20512758|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512759|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20512760|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20512761|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512762|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
20512763|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20512764|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20512765|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
20512766|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20512767|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20512768|NCT02890329|Ipilimumab|ipilimumab|mesh-list
20512769|NCT02890329|Decitabine|decitabine|mesh-list
20512770|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512771|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512772|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512773|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512774|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512775|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
20512776|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512777|NCT02886286|Fentanyl|fentanyl|mesh-list
20512778|NCT02886286|Morphine|morphine|mesh-list
20512779|NCT02886286|Hydromorphone|hydromorphone|mesh-list
20512780|NCT02886286|Bupivacaine|bupivacaine|mesh-list
20512781|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
20512782|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
20512783|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20512784|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512785|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
20512786|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512787|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20512788|NCT02886286|Narcotics|narcotics|mesh-ancestor
20512789|NCT02886286|Analgesics|analgesics|mesh-ancestor
20512790|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20512791|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20512792|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
20512793|NCT02874742|Dexamethasone|dexamethasone|mesh-list
20512794|NCT02874742|Lenalidomide|lenalidomide|mesh-list
20512795|NCT02874742|Bortezomib|bortezomib|mesh-list
20512796|NCT02874742|Daratumumab|daratumumab|mesh-list
20512797|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20512798|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
20512799|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
20512800|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20512801|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512802|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244413|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244414|NCT00419991|Tigecycline|tigecycline|mesh-list
20244415|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244416|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244417|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20244418|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244419|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244420|NCT00420030|Abciximab|abciximab|mesh-list
20244421|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
20244422|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20244423|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
20244424|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512803|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
20512804|NCT02874742|Hormones|hormones|mesh-ancestor
20512805|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512806|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20512807|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512808|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
20512809|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20512810|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20512811|NCT02874742|Growth Substances|growth substances|mesh-ancestor
20512812|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
20512813|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
20512814|NCT02872259|Trametinib|trametinib|mesh-list
20512815|NCT02872259|Dabrafenib|dabrafenib|mesh-list
20512816|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512817|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512818|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512819|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512820|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512821|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
20512822|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512823|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512824|NCT02865187|Vitamin D|vitamin d|mesh-list
20512825|NCT02865187|Vitamins|vitamins|mesh-ancestor
20512826|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
20512827|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512828|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20512829|NCT02829931|Bevacizumab|bevacizumab|mesh-list
20512830|NCT02829931|Nivolumab|nivolumab|mesh-list
20512831|NCT02829931|Ipilimumab|ipilimumab|mesh-list
20512832|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512833|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512834|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20512835|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20512836|NCT02829931|Growth Substances|growth substances|mesh-ancestor
19701922|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19701923|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
20512837|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512838|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
20512839|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512840|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512841|NCT02829918|Nivolumab|nivolumab|mesh-list
20512842|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512843|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855632|NCT00750308|Ramipril|ramipril|mesh-list
20512844|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512845|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512846|NCT02826512|Niraparib|niraparib|mesh-list
20512847|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20512848|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512849|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512850|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512851|NCT02821754|Durvalumab|durvalumab|mesh-list
20512852|NCT02821754|Tremelimumab|tremelimumab|mesh-list
20512853|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512854|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512855|NCT02810743|Olaparib|olaparib|mesh-list
20512856|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20512857|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512858|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512859|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512860|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
20512861|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512862|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
20512863|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512864|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20512865|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512866|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
20512867|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512868|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512869|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20512870|NCT02787551|Metformin|metformin|mesh-list
20512871|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
20512872|NCT02787551|Pioglitazone|pioglitazone|mesh-list
20512873|NCT02787551|Liraglutide|liraglutide|mesh-list
20512874|NCT02787551|Exenatide|exenatide|mesh-list
20512875|NCT02787551|Dulaglutide|dulaglutide|mesh-list
20512876|NCT02787551|Lixisenatide|lixisenatide|mesh-list
20512877|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20512878|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20512879|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
20512880|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512881|NCT02787551|Incretins|incretins|mesh-ancestor
20512882|NCT02787551|Hormones|hormones|mesh-ancestor
20512883|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512884|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20512885|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512886|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
20512887|NCT02778685|Letrozole|letrozole|mesh-list
20512888|NCT02778685|Fulvestrant|fulvestrant|mesh-list
20512889|NCT02778685|Palbociclib|palbociclib|mesh-list
20512890|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512891|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512892|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20512893|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20512894|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512895|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512896|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20512897|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
20512898|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512899|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512900|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20512901|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20512902|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20512903|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
20512904|NCT02757885|Thiotepa|thiotepa|mesh-list
19855633|NCT00750308|Tadalafil|tadalafil|mesh-list
20512905|NCT02757885|Fludarabine|fludarabine|mesh-list
19701924|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244425|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20244426|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244427|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244428|NCT00420082|Cetirizine|cetirizine|mesh-list
20244429|NCT00420082|Fexofenadine|fexofenadine|mesh-list
20244430|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20244431|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20244432|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20244433|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
20244434|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
20512906|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
20512907|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
20512908|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20512909|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
20512910|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20512911|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
20512912|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512913|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20512914|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512915|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
20512916|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512917|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512918|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20512919|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19701925|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244435|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20512920|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
20512921|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
20512922|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512923|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20512924|NCT02754011|Capecitabine|capecitabine|mesh-list
20512925|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512926|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
20512927|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512928|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512929|NCT02753998|Paclitaxel|paclitaxel|mesh-list
20512930|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20512931|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512932|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
20512933|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
20512934|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
20512935|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512936|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
20512937|NCT02750319|Amiodarone|amiodarone|mesh-list
20512938|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20512939|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
20512940|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512941|NCT02750319|Expectorants|expectorants|mesh-ancestor
20512942|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
20512943|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20512944|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
20512945|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512946|NCT02750319|Protective Agents|protective agents|mesh-ancestor
20512947|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512948|NCT02750319|Antidotes|antidotes|mesh-ancestor
20512949|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19701926|NCT05256693|Vancomycin|vancomycin|mesh-list
20512950|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
20512951|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20512952|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20512953|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20512954|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20512955|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20512956|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20512957|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20512958|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20512959|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20512960|NCT02736656|Viloxazine|viloxazine|mesh-list
20512961|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20512962|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
20512963|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20512964|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20512965|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20512966|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20512967|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512968|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
20512969|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20512970|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512971|NCT02735044|Insulin|insulin|mesh-list
19701927|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19701928|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19701929|NCT05256472|Axitinib|axitinib|mesh-list
19701930|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19701931|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19701932|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701933|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701934|NCT05256342|Etoricoxib|etoricoxib|mesh-list
19701935|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19701936|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19701937|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19853740|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20512972|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20512973|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
20512974|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20512975|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512976|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20512977|NCT02725177|Hormones|hormones|mesh-ancestor
20512978|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20512979|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20512980|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
20512981|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20512982|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
20512983|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512984|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512985|NCT02713867|Nivolumab|nivolumab|mesh-list
20512986|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20512987|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20512988|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20512989|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512990|NCT02692651|Vancomycin|vancomycin|mesh-list
20512991|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
20512992|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20512993|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20512994|NCT02688712|Fluorouracil|fluorouracil|mesh-list
20512995|NCT02688712|Capecitabine|capecitabine|mesh-list
20512996|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
20512997|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20512998|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20512999|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513000|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513001|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
20513002|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513003|NCT02688140|Cytarabine|cytarabine|mesh-list
20513004|NCT02688140|Methotrexate|methotrexate|mesh-list
20513005|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
20513006|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
20513007|NCT02688140|Idarubicin|idarubicin|mesh-list
20513008|NCT02688140|Tretinoin|tretinoin|mesh-list
20513009|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
20513010|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20513011|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
20513012|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20513013|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513014|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513015|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
20513016|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513017|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513018|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
20513019|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513020|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20513021|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513022|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
20513023|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513024|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20513025|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
20513026|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513027|NCT02688140|Analgesics|analgesics|mesh-ancestor
20513028|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
20513029|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513030|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20513031|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20244436|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244437|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244438|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20244439|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20244440|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
20244441|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
20244442|NCT00420355|Ritonavir|ritonavir|mesh-list
20244443|NCT00420355|Lopinavir|lopinavir|mesh-list
20513032|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20513033|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
20513034|NCT02678572|Melphalan|melphalan|mesh-list
20513035|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513036|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
20513037|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513038|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513039|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513040|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513041|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
20513042|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529748|NCT01783977|Vaccines|vaccines|mesh-list
20529749|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
20529750|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529751|NCT01784107|Ifosfamide|ifosfamide|mesh-list
20529752|NCT01784107|Belotecan|belotecan|mesh-list
20529753|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20529754|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
20529755|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529756|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529757|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20529758|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20244444|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20244445|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20244446|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20244447|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244448|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244449|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244450|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20244451|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20244452|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
20244453|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244454|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20244455|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20529759|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529760|NCT01784120|Doxorubicin|doxorubicin|mesh-list
20529761|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20513043|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
20513044|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513045|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513046|NCT02656706|Nivolumab|nivolumab|mesh-list
19701938|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20513047|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513048|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513049|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19701939|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701940|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701941|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701942|NCT05256342|Analgesics|analgesics|mesh-ancestor
20513050|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513051|NCT02654314|Melatonin|melatonin|mesh-list
20513052|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
20513053|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513054|NCT02654314|Protective Agents|protective agents|mesh-ancestor
20513055|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513056|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513057|NCT02642042|Docetaxel|docetaxel|mesh-list
20244456|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
20244457|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19701943|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
20513058|NCT02642042|Trametinib|trametinib|mesh-list
19701944|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244458|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244459|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20513059|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513060|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
20244460|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
20244461|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244462|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244463|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244464|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513061|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513062|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513063|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513064|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513065|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513066|NCT02626962|Nivolumab|nivolumab|mesh-list
20513067|NCT02626962|Ipilimumab|ipilimumab|mesh-list
20513068|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513069|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513070|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20513071|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513072|NCT02623998|Metformin|metformin|mesh-list
20513073|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
20513074|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20513075|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20513076|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513077|NCT02623998|Incretins|incretins|mesh-ancestor
20513078|NCT02623998|Hormones|hormones|mesh-ancestor
20513079|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513080|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20513081|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
20513082|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513083|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513084|NCT02608684|Gemcitabine|gemcitabine|mesh-list
20513085|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
20513086|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513087|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513088|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
20513089|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513090|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
20513091|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244465|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20244466|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20244467|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20244468|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20244469|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244470|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244471|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244472|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244473|NCT00420524|Epothilone B|epothilone b|mesh-list
20244474|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244475|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701945|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
19701946|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19701947|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
19701948|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19701949|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19701950|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701951|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701952|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19701953|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19415599|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19415600|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415601|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415602|NCT02802813|Piperaquine|piperaquine|mesh-list
19415603|NCT02802813|Primaquine|primaquine|mesh-list
19415604|NCT02802813|Artenimol|artenimol|mesh-list
19415605|NCT02802813|Artemisinins|artemisinins|mesh-list
19415606|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
19415607|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19415608|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19415609|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415610|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
19701954|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701955|NCT05256264|Ketamine|ketamine|mesh-list
19701956|NCT05256264|Analgesics|analgesics|mesh-ancestor
19701957|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
19701958|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701959|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701960|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19701961|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19701962|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
19701963|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
19701964|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244476|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244477|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
20244478|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244479|NCT00420537|Cyclosporine|cyclosporine|mesh-list
20244480|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
20244481|NCT00420537|Everolimus|everolimus|mesh-list
20244482|NCT00420537|Cyclosporins|cyclosporins|mesh-list
20244483|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244484|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415611|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20513092|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513093|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513094|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
20513095|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513096|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513097|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
20513098|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513099|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513100|NCT02599324|Paclitaxel|paclitaxel|mesh-list
20513101|NCT02599324|Docetaxel|docetaxel|mesh-list
20513102|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
20513103|NCT02599324|Cetuximab|cetuximab|mesh-list
20513104|NCT02599324|Everolimus|everolimus|mesh-list
20513105|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513106|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513107|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
20513108|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513109|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513110|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513111|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513112|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513113|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
20513114|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513115|NCT02595892|Gemcitabine|gemcitabine|mesh-list
20513116|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513117|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
20513118|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513119|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415612|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244485|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244486|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
20244487|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244488|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
20244489|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244490|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
20244491|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244492|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20244493|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244494|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20244495|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20244496|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
20244497|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20513120|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
20513121|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513122|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513123|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513124|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
20513125|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853741|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
20513126|NCT02587520|Vaccines|vaccines|mesh-list
20513127|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
20513128|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513129|NCT02584829|Interferons|interferons|mesh-list
20513130|NCT02584829|Interferon-beta|interferon-beta|mesh-list
20513131|NCT02584829|Avelumab|avelumab|mesh-list
20513132|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20513133|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513134|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
20513135|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513136|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513137|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
20513138|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513139|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
20513140|NCT02559856|Apixaban|apixaban|mesh-list
20513141|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20513142|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
20513143|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20513144|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
20513145|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513146|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513147|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
20513148|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
20513149|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513150|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513151|NCT02516241|Gemcitabine|gemcitabine|mesh-list
20513152|NCT02516241|Carboplatin|carboplatin|mesh-list
20513153|NCT02516241|Durvalumab|durvalumab|mesh-list
20513154|NCT02516241|Tremelimumab|tremelimumab|mesh-list
20513155|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513156|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513157|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
20513158|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513159|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
20513160|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513161|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513162|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513163|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
20513164|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513165|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513166|NCT02514083|Fludarabine|fludarabine|mesh-list
20513167|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513168|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
20513169|NCT02512172|Azacitidine|azacitidine|mesh-list
20513170|NCT02512172|Romidepsin|romidepsin|mesh-list
20513171|NCT02512172|Cc-486|cc-486|mesh-list
20513172|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513173|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513174|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513175|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
20513176|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513177|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513178|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20513179|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
20513180|NCT02499367|Doxorubicin|doxorubicin|mesh-list
20513181|NCT02499367|Nivolumab|nivolumab|mesh-list
20513182|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513183|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
19701965|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20513184|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513185|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513186|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513187|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
20513188|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513189|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513190|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513191|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20513192|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20513193|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20513194|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513195|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513196|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20513197|NCT02497612|Artefenomel|artefenomel|mesh-list
20513198|NCT02497612|Ferroquine|ferroquine|mesh-list
20513199|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
20513200|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20513201|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20513202|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513203|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20513204|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513205|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513206|NCT02491333|Metformin|metformin|mesh-list
20513207|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20513208|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513209|NCT02469987|Bevacizumab|bevacizumab|mesh-list
20244498|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
20244499|NCT00420563|Megestrol|megestrol|mesh-list
20244500|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513210|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513211|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513212|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513213|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19855634|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
20513214|NCT02469987|Growth Substances|growth substances|mesh-ancestor
20513215|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513216|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
20513217|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
20513218|NCT02453373|Plasminogen|plasminogen|mesh-list
20513219|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20513220|NCT02453373|Propofol|propofol|mesh-list
20513221|NCT02453373|Etomidate|etomidate|mesh-list
20513222|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20513223|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513224|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513225|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20513226|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
20513227|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
20513228|NCT02453373|Analgesics|analgesics|mesh-ancestor
20513229|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
20513230|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513231|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20513232|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
20513233|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20513234|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20513235|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513236|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20513237|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
19701966|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19701967|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701968|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701969|NCT05256173|Melatonin|melatonin|mesh-list
19701970|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
19701971|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701972|NCT05256173|Protective Agents|protective agents|mesh-ancestor
19701973|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701974|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19701975|NCT05256147|Ibuprofen|ibuprofen|mesh-list
19701976|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19701977|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19853742|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853743|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853744|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20244501|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
20513238|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19853745|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19853746|NCT00734578|Guanfacine|guanfacine|mesh-list
20513239|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20513240|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20513241|NCT02452268|Spartalizumab|spartalizumab|mesh-list
20513242|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20513243|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513244|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513245|NCT02449031|Tobramycin|tobramycin|mesh-list
20513246|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20513247|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513248|NCT02442349|Osimertinib|osimertinib|mesh-list
19853747|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19853748|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19853749|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19853750|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19853751|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
19853752|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513249|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513250|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513251|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513252|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701978|NCT05256147|Analgesics|analgesics|mesh-ancestor
20244502|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244503|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244504|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513253|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20513254|NCT02439307|Rifaximin|rifaximin|mesh-list
20513255|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513256|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513257|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
20513258|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513259|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513260|NCT02404935|Cetuximab|cetuximab|mesh-list
20513261|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513262|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513263|NCT02392572|TIC10 compound|tic10 compound|mesh-list
20513264|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513265|NCT02381652|Triamcinolone|triamcinolone|mesh-list
20513266|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20513267|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20513268|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
20513269|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20513270|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513271|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
20513272|NCT02381652|Hormones|hormones|mesh-ancestor
20513273|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513274|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513275|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513276|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
20513277|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513278|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513279|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20513280|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
20244505|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
20244506|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244507|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244508|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20244509|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20244510|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20244511|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20513281|NCT02381652|Protective Agents|protective agents|mesh-ancestor
20513282|NCT02368301|Dexamethasone|dexamethasone|mesh-list
20513283|NCT02368301|Lenalidomide|lenalidomide|mesh-list
20513284|NCT02368301|Elotuzumab|elotuzumab|mesh-list
20513285|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513286|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
20513287|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
20513288|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513289|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513290|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513291|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
20513292|NCT02368301|Hormones|hormones|mesh-ancestor
20513293|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513294|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513295|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513296|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
20513297|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513298|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20513299|NCT02368301|Growth Substances|growth substances|mesh-ancestor
20513300|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
20513301|NCT02367794|Paclitaxel|paclitaxel|mesh-list
20513302|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20513303|NCT02367794|Carboplatin|carboplatin|mesh-list
20513304|NCT02367794|Atezolizumab|atezolizumab|mesh-list
20513305|NCT02367794|Antibodies|antibodies|mesh-list
20513306|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513307|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513308|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
19701979|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
19701980|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19701981|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701982|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19701983|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19701984|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19701985|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19701986|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513309|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513310|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513311|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701987|NCT05256069|Propranolol|propranolol|mesh-list
19701988|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20513312|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
20513313|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513320|NCT02363998|Lofexidine|lofexidine|mesh-list
20513321|NCT02363998|Clonidine|clonidine|mesh-list
20513322|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20513323|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20513324|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513325|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
20513326|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244512|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
20244513|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20513327|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20513328|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20513329|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20513330|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
20513331|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513332|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513333|NCT02363998|Analgesics|analgesics|mesh-ancestor
20513334|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
20513335|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
20513336|NCT02358031|Carboplatin|carboplatin|mesh-list
20513337|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
19415613|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415614|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415615|NCT02784288|Paclitaxel|paclitaxel|mesh-list
19415616|NCT02784288|Carboplatin|carboplatin|mesh-list
19415617|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19415618|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415619|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
19415620|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244514|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20513338|NCT02358031|Cetuximab|cetuximab|mesh-list
20513339|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513340|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513341|NCT02355379|Capecitabine|capecitabine|mesh-list
20513342|NCT02355379|Fluorouracil|fluorouracil|mesh-list
20513343|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513344|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
20513345|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244515|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20244516|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20248043|NCT00434382|Alfentanil|alfentanil|mesh-list
20513346|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513347|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513348|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
20513349|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513350|NCT02332928|Melatonin|melatonin|mesh-list
20513351|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
20513352|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513353|NCT02332928|Protective Agents|protective agents|mesh-ancestor
20513354|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513355|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513356|NCT02325466|Aspirin|aspirin|mesh-list
20513357|NCT02325466|Ticagrelor|ticagrelor|mesh-list
20513358|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20513359|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20513360|NCT02325466|Analgesics|analgesics|mesh-ancestor
20513361|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
20513362|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513363|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513364|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513365|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513366|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20513367|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20513368|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513369|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20513370|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20513371|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513372|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
20513373|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20513374|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20513375|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20513376|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
20513377|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513378|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20513379|NCT02323100|Glycerol|glycerol|mesh-list
20513380|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20513381|NCT02323100|Protective Agents|protective agents|mesh-ancestor
20513382|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513383|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513384|NCT02322710|Petrolatum|petrolatum|mesh-list
19701989|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19701990|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
19701991|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19701992|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19701993|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701994|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19701995|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19701996|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
19701997|NCT05255991|Treprostinil|treprostinil|mesh-list
19701998|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19708079|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708080|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19708081|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
19708082|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20513385|NCT02322710|Emollients|emollients|mesh-ancestor
20513386|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
20513387|NCT02285179|Tamoxifen|tamoxifen|mesh-list
20513388|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20513389|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
20513390|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513391|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513392|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513393|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513394|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20513395|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20513396|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20513397|NCT02283281|Dronabinol|dronabinol|mesh-list
20513398|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
20513399|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19701999|NCT05255913|Fluorides|fluorides|mesh-list
20244517|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20244518|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20244519|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20244520|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244521|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244522|NCT00420589|Hormones|hormones|mesh-ancestor
20244523|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244524|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244525|NCT00420615|Epothilone B|epothilone b|mesh-list
20244526|NCT00420615|Epothilones|epothilones|mesh-list
20244527|NCT00420615|Omeprazole|omeprazole|mesh-list
20513400|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20513401|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20513402|NCT02283281|Analgesics|analgesics|mesh-ancestor
20513403|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
20513404|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513405|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20513406|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20513407|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513408|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513409|NCT02283281|Hormones|hormones|mesh-ancestor
20513410|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702000|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
19702001|NCT05255913|Protective Agents|protective agents|mesh-ancestor
20244528|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20244529|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244530|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20513411|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
20513412|NCT02251548|Rituximab|rituximab|mesh-list
20513413|NCT02251548|Fludarabine|fludarabine|mesh-list
20513414|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513415|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
20513416|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513417|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513418|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513419|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
20513420|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513421|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513422|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513423|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513424|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20513425|NCT02240498|Methylene Blue|methylene blue|mesh-list
20513426|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20513427|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20513428|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20513429|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513430|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513431|NCT02215980|Dexamethasone|dexamethasone|mesh-list
20513432|NCT02215980|Lenalidomide|lenalidomide|mesh-list
20513433|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513434|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
20513435|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
20513436|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513437|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702002|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702003|NCT05255848|Heparin|heparin|mesh-list
19702004|NCT05255848|Calcium heparin|calcium heparin|mesh-list
19702005|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
19702006|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19702007|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19702008|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513438|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513439|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
20513440|NCT02215980|Hormones|hormones|mesh-ancestor
20513441|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513442|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513443|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513444|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
20513445|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513446|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20513447|NCT02215980|Growth Substances|growth substances|mesh-ancestor
20513448|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
20513449|NCT02212015|Paclitaxel|paclitaxel|mesh-list
20513450|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513451|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513452|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
20513453|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513454|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513455|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513456|NCT02204241|Dexamethasone|dexamethasone|mesh-list
20513457|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
20513458|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513459|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
20513460|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513461|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513462|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513463|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
20513464|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513465|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513466|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513467|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513468|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
20513469|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
20513470|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513471|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513472|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
20513473|NCT02204241|Hormones|hormones|mesh-ancestor
20513474|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513475|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513476|NCT02185820|Dexamethasone|dexamethasone|mesh-list
20513477|NCT02185820|Pomalidomide|pomalidomide|mesh-list
20513478|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513479|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
20513480|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
20513481|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513482|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513483|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513484|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
20513485|NCT02185820|Hormones|hormones|mesh-ancestor
20513486|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853753|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853754|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853755|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
19853756|NCT00734604|Tadalafil|tadalafil|mesh-list
20513487|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513488|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513489|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
20513490|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513491|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20513492|NCT02185820|Growth Substances|growth substances|mesh-ancestor
20513493|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
20513494|NCT02168829|Aspirin|aspirin|mesh-list
20513495|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
20513496|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20513497|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20513498|NCT02168829|Analgesics|analgesics|mesh-ancestor
20513499|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
20513500|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513501|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513502|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513503|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513504|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20513505|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20513506|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513507|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20513508|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20513509|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513510|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
20513511|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20513512|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
20513513|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20513514|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
20513515|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
20513516|NCT02162563|Leucovorin|leucovorin|mesh-list
20513517|NCT02162563|Bevacizumab|bevacizumab|mesh-list
20513518|NCT02162563|Panitumumab|panitumumab|mesh-list
20513519|NCT02162563|Fluorouracil|fluorouracil|mesh-list
20513520|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
20513521|NCT02162563|Irinotecan|irinotecan|mesh-list
20513522|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
20513523|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513524|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513525|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513526|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20513527|NCT02162563|Growth Substances|growth substances|mesh-ancestor
20513528|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513529|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
20513530|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
20513531|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513532|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513533|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513534|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
20513535|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19702009|NCT05255770|Benzocaine|benzocaine|mesh-list
19702010|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
19702011|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
20513536|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702012|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513537|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513538|NCT02162563|Antidotes|antidotes|mesh-ancestor
19853757|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853758|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
19853759|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19853760|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19853761|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513539|NCT02162563|Protective Agents|protective agents|mesh-ancestor
20513540|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
20513541|NCT02162563|Vitamins|vitamins|mesh-ancestor
20513542|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
20513543|NCT02158234|Cisplatin|cisplatin|mesh-list
20513544|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
20513545|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513546|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513547|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
20513548|NCT02158091|Rituximab|rituximab|mesh-list
19702013|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702014|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
19702015|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702016|NCT05238831|Paclitaxel|paclitaxel|mesh-list
19702017|NCT05238831|Vinorelbine|vinorelbine|mesh-list
19702018|NCT05238831|Maytansine|maytansine|mesh-list
19702019|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19702020|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19702021|NCT05238831|Bevacizumab|bevacizumab|mesh-list
19702022|NCT05238831|Carboplatin|carboplatin|mesh-list
19702023|NCT05238831|Capecitabine|capecitabine|mesh-list
19702024|NCT05238831|Trastuzumab|trastuzumab|mesh-list
19702025|NCT05238831|Irinotecan|irinotecan|mesh-list
19702026|NCT05238831|Atezolizumab|atezolizumab|mesh-list
19702027|NCT05238831|Letrozole|letrozole|mesh-list
19702028|NCT05238831|Olaparib|olaparib|mesh-list
19702029|NCT05238831|Fulvestrant|fulvestrant|mesh-list
19702030|NCT05238831|Palbociclib|palbociclib|mesh-list
19702031|NCT05238831|Anastrozole|anastrozole|mesh-list
20513549|NCT02158091|Fludarabine|fludarabine|mesh-list
19702032|NCT05238831|Pertuzumab|pertuzumab|mesh-list
19702033|NCT05238831|Niraparib|niraparib|mesh-list
19702034|NCT05238831|Vemurafenib|vemurafenib|mesh-list
19702035|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20513550|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513551|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
20513552|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513553|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513554|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513555|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
20513556|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513557|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513558|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513559|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513560|NCT02141542|Tremelimumab|tremelimumab|mesh-list
20513561|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513562|NCT02127086|Analgesics|analgesics|mesh-list
20513563|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
20513564|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513565|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513566|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20513567|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20513568|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
20513569|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20513570|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20513571|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
20513572|NCT02114229|Carboplatin|carboplatin|mesh-list
20513573|NCT02114229|Methotrexate|methotrexate|mesh-list
20513574|NCT02114229|Etoposide|etoposide|mesh-list
20513575|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
20513576|NCT02114229|Vincristine|vincristine|mesh-list
20513577|NCT02114229|Topotecan|topotecan|mesh-list
20513578|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513579|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
20513580|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513581|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513582|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513583|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
20513584|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513585|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513586|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513587|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20513588|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
20513589|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20513590|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513591|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
20513592|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
20513593|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513594|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20513595|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20513596|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513597|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20513598|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20513599|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
20513600|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513601|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513602|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20513603|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
20513604|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513605|NCT02102243|Insulin|insulin|mesh-list
20513606|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20244531|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244532|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244533|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244534|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
20244535|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244536|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
20244537|NCT00420654|Hormones|hormones|mesh-list
20244538|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513607|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20513608|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513609|NCT02075840|Crizotinib|crizotinib|mesh-list
20513610|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513611|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513612|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513613|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513614|NCT02075177|Ketoconazole|ketoconazole|mesh-list
19702036|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
19702037|NCT05238831|Antibodies|antibodies|mesh-list
19702038|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
19702039|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19702040|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20244539|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513615|NCT02075177|Fenretinide|fenretinide|mesh-list
20513616|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
20513617|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513618|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20513619|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20513620|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513621|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513622|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20513623|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
19702041|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
20513624|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513625|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513626|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20513627|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513628|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20513629|NCT02075177|Protective Agents|protective agents|mesh-ancestor
20513630|NCT02066181|Sorafenib|sorafenib|mesh-list
20513631|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513632|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513633|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513634|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513635|NCT02050919|Sorafenib|sorafenib|mesh-list
20513636|NCT02050919|Epirubicin|epirubicin|mesh-list
20513637|NCT02050919|Ifosfamide|ifosfamide|mesh-list
20513638|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
20513639|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513640|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513641|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513642|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513643|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20513644|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20513645|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20513646|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20244540|NCT00420667|Enoxaparin|enoxaparin|mesh-list
20244541|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
20244542|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20244543|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20244544|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244545|NCT00420693|Sevoflurane|sevoflurane|mesh-list
20513647|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
20513648|NCT02040857|Tamoxifen|tamoxifen|mesh-list
20513649|NCT02040857|Letrozole|letrozole|mesh-list
20513650|NCT02040857|Palbociclib|palbociclib|mesh-list
20513651|NCT02040857|Anastrozole|anastrozole|mesh-list
20513652|NCT02040857|Exemestane|exemestane|mesh-list
20513653|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20513654|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513655|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20513656|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513657|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513658|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20513659|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
20513660|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513661|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513662|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513663|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20513664|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20513665|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20513666|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20244546|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20244547|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20244548|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
20244549|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
20244550|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244551|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244552|NCT00420797|Phenylephrine|phenylephrine|mesh-list
20513667|NCT01997463|Albuterol|albuterol|mesh-list
19702042|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
19702043|NCT05238831|Entrectinib|entrectinib|mesh-list
20244553|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
20513668|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20513669|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
20513670|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513671|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244554|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20513672|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20513673|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20513674|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
20513675|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20513676|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20513677|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20513678|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20513679|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
20513680|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513681|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513682|NCT01996267|Paclitaxel|paclitaxel|mesh-list
20513683|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
20513684|NCT01996267|Carboplatin|carboplatin|mesh-list
20513685|NCT01996267|Fluorouracil|fluorouracil|mesh-list
20513686|NCT01996267|Trastuzumab|trastuzumab|mesh-list
20513687|NCT01996267|Pertuzumab|pertuzumab|mesh-list
20513688|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513689|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513690|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
20513691|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
19415621|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513692|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513693|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513694|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513695|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
20513696|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513697|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513698|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513699|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
20513700|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513701|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
20513702|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513703|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513704|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
20513705|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20513706|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513707|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244555|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
20244556|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
20244557|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244558|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513708|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20513709|NCT01976754|Analgesics|analgesics|mesh-ancestor
19415622|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415623|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
19415624|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19415625|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702044|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
20244559|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
20513710|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
20513711|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513712|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20513713|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20244560|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20244561|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
20244562|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
20244563|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20244564|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20244565|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20244566|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244567|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513714|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20513715|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
20513716|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513717|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513718|NCT01950390|Bevacizumab|bevacizumab|mesh-list
20513719|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20513720|NCT01950390|Ipilimumab|ipilimumab|mesh-list
20513721|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
20513722|NCT01950390|Antibodies|antibodies|mesh-list
20513723|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
20513724|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20513725|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
20513726|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513727|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513728|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20513729|NCT01950390|Growth Substances|growth substances|mesh-ancestor
20513730|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513731|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
20513732|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
20513733|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19853762|NCT00734604|Urological Agents|urological agents|mesh-ancestor
19853763|NCT00734617|Nicotine|nicotine|mesh-list
19853764|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20513734|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513735|NCT01943825|Vaccines|vaccines|mesh-list
20513736|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
20513737|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702045|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702046|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702047|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702048|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513738|NCT01916317|Lidocaine|lidocaine|mesh-list
20513739|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
20513740|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
20513741|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513742|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513743|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
20513744|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513745|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20513746|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20513747|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20513748|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20513749|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513750|NCT01913951|Azacitidine|azacitidine|mesh-list
20513751|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513752|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
20513753|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513754|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513755|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513756|NCT01913730|Dexamethasone|dexamethasone|mesh-list
20513757|NCT01913730|Bortezomib|bortezomib|mesh-list
20513758|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513759|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
20513760|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
20513761|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513762|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513763|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513764|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
20513765|NCT01913730|Hormones|hormones|mesh-ancestor
19702049|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
19702050|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702051|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19702052|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19702053|NCT05238831|Growth Substances|growth substances|mesh-ancestor
20513766|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853765|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
19853766|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513767|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513768|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513769|NCT01904123|Tyrphostins|tyrphostins|mesh-list
20513770|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513771|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513772|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513773|NCT01898117|Paclitaxel|paclitaxel|mesh-list
20513774|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20513775|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
20513776|NCT01898117|Carboplatin|carboplatin|mesh-list
20513777|NCT01898117|Atezolizumab|atezolizumab|mesh-list
20513778|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20513779|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513780|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513781|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
20513782|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513783|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513784|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513785|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513786|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
20513787|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513788|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513789|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513790|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
20513791|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513792|NCT01892371|Cytarabine|cytarabine|mesh-list
20513793|NCT01892371|Azacitidine|azacitidine|mesh-list
20513794|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513795|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
20513796|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513797|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513798|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
20513799|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702054|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702055|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
19702056|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
19702057|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19702058|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
19702059|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19702060|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702061|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702062|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19702063|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19702064|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19702065|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
19702066|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244568|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244569|NCT00420797|Protective Agents|protective agents|mesh-ancestor
20513800|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513801|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
20513802|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702067|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19702068|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702069|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19702070|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19702071|NCT05231941|Lidocaine|lidocaine|mesh-list
19702072|NCT05231941|Ropivacaine|ropivacaine|mesh-list
20513803|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513804|NCT01874353|Olaparib|olaparib|mesh-list
20513805|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20513806|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513807|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513808|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513809|NCT01863186|Lofexidine|lofexidine|mesh-list
20513810|NCT01863186|Clonidine|clonidine|mesh-list
20513811|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20513812|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20513813|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513814|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
20513815|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513816|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20513817|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20513818|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20513819|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
20513820|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513821|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513822|NCT01863186|Analgesics|analgesics|mesh-ancestor
20513823|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
20513824|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
20513825|NCT01857115|Dexamethasone|dexamethasone|mesh-list
20513826|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
20513827|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513828|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
20513829|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513830|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244570|NCT00420836|Tobramycin|tobramycin|mesh-list
20244571|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244572|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244573|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
20244574|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
20244575|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20244576|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20244577|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244578|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513831|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19853767|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853768|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19853769|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19853770|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
19853771|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853772|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853773|NCT00734630|Losartan|losartan|mesh-list
20513832|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
20513833|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513834|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853774|NCT00734630|Lisinopril|lisinopril|mesh-list
19853775|NCT00734630|Nebivolol|nebivolol|mesh-list
20244579|NCT00420901|Urological Agents|urological agents|mesh-ancestor
20513835|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513836|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513837|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
20513838|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
20513839|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513840|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513841|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
20513842|NCT01857115|Hormones|hormones|mesh-ancestor
20513843|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513844|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20513845|NCT01853748|Paclitaxel|paclitaxel|mesh-list
20513846|NCT01853748|Maytansine|maytansine|mesh-list
20513847|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20513848|NCT01853748|Trastuzumab|trastuzumab|mesh-list
20513849|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513850|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513851|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
20513852|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513853|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513854|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513855|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513856|NCT01843374|Tremelimumab|tremelimumab|mesh-list
20513857|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244580|NCT00420953|Amiodarone|amiodarone|mesh-list
20248044|NCT00434382|Propofol|propofol|mesh-list
20513858|NCT01828840|Fentanyl|fentanyl|mesh-list
20513859|NCT01828840|Morphine|morphine|mesh-list
20513860|NCT01828840|Methadone|methadone|mesh-list
20513861|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20513862|NCT01828840|Narcotics|narcotics|mesh-ancestor
20513863|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513864|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513865|NCT01828840|Analgesics|analgesics|mesh-ancestor
20513866|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
20513867|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513868|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20513869|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20513870|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
20513871|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
20513872|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
20513873|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
20513874|NCT01817751|Sorafenib|sorafenib|mesh-list
20513875|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
20513876|NCT01817751|Valproic Acid|valproic acid|mesh-list
20513877|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513878|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513879|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513880|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513881|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
20513882|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20513883|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20513884|NCT01817751|Urological Agents|urological agents|mesh-ancestor
20513885|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
20513886|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
20513887|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20513888|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513889|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
20244581|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20244582|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
20244583|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20244584|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20244585|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244586|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20513890|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20513891|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20513892|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20513893|NCT01817426|Infliximab|infliximab|mesh-list
20513894|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
20513895|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513896|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513897|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20513898|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20513899|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513900|NCT01741103|Incretins|incretins|mesh-ancestor
20513901|NCT01741103|Hormones|hormones|mesh-ancestor
20513902|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513903|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20513904|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
20513905|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513906|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513907|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20513908|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
20513909|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513910|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
20513911|NCT01716117|Antacids|antacids|mesh-ancestor
20513912|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513913|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513914|NCT01657591|Vemurafenib|vemurafenib|mesh-list
20513915|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513916|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513917|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513918|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513919|NCT01646034|Gemcitabine|gemcitabine|mesh-list
20513920|NCT01646034|Paclitaxel|paclitaxel|mesh-list
20513921|NCT01646034|Docetaxel|docetaxel|mesh-list
20513922|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
20513923|NCT01646034|Carboplatin|carboplatin|mesh-list
20513924|NCT01646034|Doxorubicin|doxorubicin|mesh-list
20513925|NCT01646034|Thiotepa|thiotepa|mesh-list
20513926|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20513927|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513928|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
20513929|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
20513930|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
20513931|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513932|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20513933|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
20513934|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513935|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20513936|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20513937|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
19702073|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
20513938|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20513939|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20513940|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
20513941|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
20513942|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20513943|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513944|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20513945|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20513946|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20513947|NCT01630590|Androgens|androgens|mesh-list
20513948|NCT01630590|Hormones|hormones|mesh-ancestor
20513949|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513950|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513951|NCT01619085|Nintedanib|nintedanib|mesh-list
20513952|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513953|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20513954|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20513955|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20513956|NCT01606098|Bevacizumab|bevacizumab|mesh-list
20513957|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20513958|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513959|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513960|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20513961|NCT01606098|Growth Substances|growth substances|mesh-ancestor
20513962|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513963|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
20529762|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529763|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20529764|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20529765|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529766|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529767|NCT01784250|Propranolol|propranolol|mesh-list
20529768|NCT01784250|Clonidine|clonidine|mesh-list
20529769|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20529770|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20529771|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
20529772|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529773|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529774|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529775|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20529776|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20529777|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
20529778|NCT01784250|Analgesics|analgesics|mesh-ancestor
20529779|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
20529780|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529781|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
20529782|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
20529783|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20529784|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20529785|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20529786|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
20529787|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20529788|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20529789|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
20529790|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529791|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20529792|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20529793|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529794|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529795|NCT01784315|Chloroquine|chloroquine|mesh-list
20529796|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20529797|NCT01784315|Primaquine|primaquine|mesh-list
20529798|NCT01784315|Artemisinins|artemisinins|mesh-list
20529799|NCT01784315|Artemisinin|artemisinin|mesh-list
20513964|NCT01499095|Insulin|insulin|mesh-list
20513965|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20513966|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
20513967|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20513968|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513969|NCT01499082|Insulin|insulin|mesh-list
20513970|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20513971|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
20513972|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20513973|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513974|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
20513975|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20513976|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20513977|NCT01496976|Prednisolone|prednisolone|mesh-list
20513978|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
20513979|NCT01496976|Lenalidomide|lenalidomide|mesh-list
20513980|NCT01496976|Ofatumumab|ofatumumab|mesh-list
20513981|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20513982|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
20513983|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
20513984|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20513985|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20513986|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19702074|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
19702075|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702076|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702077|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
19702078|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702079|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19702080|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19702081|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19702082|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19702083|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702084|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
19702085|NCT05231590|Paraproteins|paraproteins|mesh-list
20513987|NCT01496976|Growth Substances|growth substances|mesh-ancestor
20513988|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
20513989|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20513990|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20513991|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
20513992|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
20513993|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20513994|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20513995|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
20513996|NCT01496976|Hormones|hormones|mesh-ancestor
20513997|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20513998|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20513999|NCT01496976|Protective Agents|protective agents|mesh-ancestor
20514000|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514001|NCT01488890|Vaccines|vaccines|mesh-list
20514002|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
20514003|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514004|NCT01436396|Vaccines|vaccines|mesh-list
20514005|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
20514006|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514007|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
20514008|NCT01428973|Sirolimus|sirolimus|mesh-list
20514009|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514010|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514011|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20514012|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
20514013|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20514014|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244587|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20244588|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20244589|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244590|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20244591|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20244592|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20514015|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514016|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514017|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
20514018|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514019|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
20514020|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514052|NCT01414777|Ondansetron|ondansetron|mesh-list
20514053|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
20514054|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
20514055|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514056|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514057|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514058|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
20514059|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
20514060|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20514061|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
20514062|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20514063|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514064|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20514065|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20514066|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20514067|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20514068|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20514069|NCT01411241|Vaccines|vaccines|mesh-list
20514070|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20514071|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
20514072|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514073|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20514074|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514075|NCT01396408|Sirolimus|sirolimus|mesh-list
20514076|NCT01396408|Sunitinib|sunitinib|mesh-list
20244593|NCT00421018|Montelukast|montelukast|mesh-list
20244594|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20244595|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
20244596|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20244597|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
20514077|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514078|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20514079|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20514080|NCT01396408|Growth Substances|growth substances|mesh-ancestor
20514081|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514082|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
20514083|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20514084|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514085|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514086|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20514087|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514088|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514089|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
20514090|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514091|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
20514092|NCT01380938|Ribavirin|ribavirin|mesh-list
20514093|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20514094|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
20514095|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
20514096|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514097|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
20514098|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514099|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
20514100|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514101|NCT01374516|Vaccines|vaccines|mesh-list
20248045|NCT00434382|Sevoflurane|sevoflurane|mesh-list
20514102|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
20514103|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514104|NCT01373281|Vaccines|vaccines|mesh-list
20514105|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
20514106|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514107|NCT01346787|Dexamethasone|dexamethasone|mesh-list
20514108|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
20514109|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514110|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
20514111|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514112|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244598|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244599|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244600|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20514113|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514114|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
20514115|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514116|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514117|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514118|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514119|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
20514120|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
20514121|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514122|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514123|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
20514124|NCT01346787|Hormones|hormones|mesh-ancestor
20514125|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514126|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20244601|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20244602|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244603|NCT00421044|Epothilone B|epothilone b|mesh-list
20244604|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244605|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
20244606|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244607|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
20248046|NCT00434382|Desflurane|desflurane|mesh-list
20244608|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244609|NCT00421083|Tadalafil|tadalafil|mesh-list
20244610|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
20244611|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20514157|NCT01254422|Vaccines|vaccines|mesh-list
20514158|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
20514159|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514160|NCT01229878|Vitamin D|vitamin d|mesh-list
20514161|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
20514162|NCT01229878|Vitamins|vitamins|mesh-ancestor
20514163|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
20514164|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514165|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20514166|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20514167|NCT01204242|Lidocaine|lidocaine|mesh-list
20514168|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
20514169|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
20514170|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20514171|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514172|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
20514173|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514174|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20514175|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20514176|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20514177|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20514178|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514179|NCT01190787|Prednisone|prednisone|mesh-list
20514180|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
20514181|NCT01190787|Melphalan|melphalan|mesh-list
20514182|NCT01190787|Bortezomib|bortezomib|mesh-list
20514183|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514184|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
20514185|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514186|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514187|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514188|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
20514189|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514190|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514191|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514192|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514193|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
20514194|NCT01190787|Hormones|hormones|mesh-ancestor
20514195|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514196|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514197|NCT01187433|Vaccines|vaccines|mesh-list
20514198|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
20514199|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244612|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20244613|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244614|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244615|NCT00421083|Urological Agents|urological agents|mesh-ancestor
20244616|NCT00421096|Gemcitabine|gemcitabine|mesh-list
20244617|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244618|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20514200|NCT01166113|Prednisone|prednisone|mesh-list
20514201|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
20514202|NCT01166113|Pomalidomide|pomalidomide|mesh-list
20514203|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514204|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
20514205|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514206|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514207|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514208|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
20514209|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514210|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514211|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514212|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514213|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
20514214|NCT01166113|Hormones|hormones|mesh-ancestor
20244619|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
20244620|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244621|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
20244622|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514215|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514216|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514217|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20514218|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20514219|NCT01166113|Growth Substances|growth substances|mesh-ancestor
20514220|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
20514221|NCT01160107|Prednisone|prednisone|mesh-list
20514222|NCT01160107|Melphalan|melphalan|mesh-list
20514223|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514224|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
20514225|NCT01160107|Hormones|hormones|mesh-ancestor
20514226|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514227|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514228|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514229|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514230|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514231|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
20514232|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514233|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514234|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514235|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
20514236|NCT01150045|Leucovorin|leucovorin|mesh-list
20514237|NCT01150045|Celecoxib|celecoxib|mesh-list
20514238|NCT01150045|Fluorouracil|fluorouracil|mesh-list
20514239|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
20514240|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
20514241|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514242|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20514243|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514244|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514245|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
20514246|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514247|NCT01150045|Antidotes|antidotes|mesh-ancestor
20514248|NCT01150045|Protective Agents|protective agents|mesh-ancestor
20514249|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
20514250|NCT01150045|Vitamins|vitamins|mesh-ancestor
20514251|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
20514252|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20514253|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20514254|NCT01150045|Analgesics|analgesics|mesh-ancestor
20514255|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
20514256|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514257|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514258|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514259|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20514260|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20514261|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514262|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
20514263|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
20514264|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514265|NCT01098032|Expectorants|expectorants|mesh-ancestor
20514266|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
20514267|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20514268|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
20514269|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514270|NCT01098032|Protective Agents|protective agents|mesh-ancestor
20244623|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244624|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244625|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
20244626|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244627|NCT00421109|Levocetirizine|levocetirizine|mesh-list
20244628|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20514271|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514272|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
20514273|NCT01096368|Cisplatin|cisplatin|mesh-list
20514274|NCT01096368|Carboplatin|carboplatin|mesh-list
20514275|NCT01096368|Etoposide|etoposide|mesh-list
20514276|NCT01096368|Vincristine|vincristine|mesh-list
20514277|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
20514278|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
20514279|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514280|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
20514281|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514282|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514283|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514284|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
20514285|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514286|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514287|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514288|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20514289|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20514290|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20514291|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244629|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20244630|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
20244631|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
20244632|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244633|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244634|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244635|NCT00421122|Budesonide|budesonide|mesh-list
20514292|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
20514293|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244636|NCT00421122|Terbutaline|terbutaline|mesh-list
20244637|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
20244638|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20244639|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244640|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20244641|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
20244642|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244643|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514294|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
20514295|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
20514296|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
20514297|NCT01093196|Dexamethasone|dexamethasone|mesh-list
20514298|NCT01093196|Prednisone|prednisone|mesh-list
20514299|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
20514300|NCT01093196|Melphalan|melphalan|mesh-list
20514301|NCT01093196|Lenalidomide|lenalidomide|mesh-list
20514302|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514303|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
20514304|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514305|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514306|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514307|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
20529800|NCT01784315|Amebicides|amebicides|mesh-ancestor
20514308|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514309|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514310|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514311|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514312|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
20514313|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
20514314|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514315|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514316|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
20514317|NCT01093196|Hormones|hormones|mesh-ancestor
20514318|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514319|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514320|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20514321|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20514322|NCT01093196|Growth Substances|growth substances|mesh-ancestor
20514323|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
20514324|NCT01054248|Artesunate|artesunate|mesh-list
20514325|NCT01054248|Piperaquine|piperaquine|mesh-list
20514326|NCT01054248|Artenimol|artenimol|mesh-list
20514327|NCT01054248|Mefloquine|mefloquine|mesh-list
20514328|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
20514329|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20514330|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20514331|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514332|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514333|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
20514334|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
20514335|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20514336|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
20514337|NCT01050855|Busulfan|busulfan|mesh-list
20514338|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
20244644|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20244645|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
20244646|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
20244647|NCT00421122|Hormones|hormones|mesh-ancestor
20244648|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244649|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20244650|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20244651|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20244652|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244653|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244654|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244655|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
20244656|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
20244657|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20244658|NCT00421187|Amphotericin B|amphotericin b|mesh-list
20244659|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20244660|NCT00421187|Amebicides|amebicides|mesh-ancestor
20244661|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20244662|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20244663|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514339|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
20514340|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514341|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514342|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
19702086|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
19702087|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702088|NCT05216575|Almitrine|almitrine|mesh-list
19702089|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
19702090|NCT05214417|Ketamine|ketamine|mesh-list
19702091|NCT05214417|Analgesics|analgesics|mesh-ancestor
19702092|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
20514343|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702093|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702094|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702095|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19702096|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19702097|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
19702098|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
19702099|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702100|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19702101|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20514344|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514345|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514346|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514347|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20514348|NCT01005745|Aldesleukin|aldesleukin|mesh-list
20514349|NCT01005745|Interleukin-2|interleukin-2|mesh-list
20514350|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514351|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244664|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20244665|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
20244666|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20244667|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20244668|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
20244669|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
20244670|NCT00421252|Clopidogrel|clopidogrel|mesh-list
20244671|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20244672|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20244673|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20244674|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20514352|NCT01005745|Analgesics|analgesics|mesh-ancestor
20244675|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
20244676|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244677|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244678|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514353|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
20514354|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514355|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514356|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20514357|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20514358|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
20514359|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514360|NCT00945009|Dactinomycin|dactinomycin|mesh-list
20514361|NCT00945009|Cactinomycin|cactinomycin|mesh-list
20244679|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
20244680|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244681|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20244682|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244683|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244684|NCT00421369|Sertraline|sertraline|mesh-list
20244685|NCT00421369|Reboxetine|reboxetine|mesh-list
20244686|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
20244687|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20514362|NCT00945009|Doxorubicin|doxorubicin|mesh-list
20514363|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20514364|NCT00945009|Vincristine|vincristine|mesh-list
20514365|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514366|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514367|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20514368|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20514369|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514370|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514371|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20514372|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
20514373|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
20514374|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
20514375|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20514376|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514377|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20514378|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20244688|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20514379|NCT00942877|Cediranib|cediranib|mesh-list
20514380|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514381|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20514382|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514383|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514384|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20514385|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20514386|NCT00896389|Diuretics|diuretics|mesh-ancestor
20514387|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
20514388|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514389|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20514390|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20514391|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514392|NCT00887146|Vincristine|vincristine|mesh-list
20514393|NCT00887146|Temozolomide|temozolomide|mesh-list
20514394|NCT00887146|Procarbazine|procarbazine|mesh-list
20514395|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20514396|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514397|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
20514398|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
20514399|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
20514400|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514401|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514402|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
20514403|NCT00880893|Vaccines|vaccines|mesh-list
20514404|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
20514405|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514406|NCT00866918|Cytarabine|cytarabine|mesh-list
20514407|NCT00866918|Methotrexate|methotrexate|mesh-list
20514408|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
20514409|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
20514410|NCT00866918|Idarubicin|idarubicin|mesh-list
20514411|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
20514412|NCT00866918|Tretinoin|tretinoin|mesh-list
20514413|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20514414|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
20514415|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20514416|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514417|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20514418|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
20514419|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514420|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514421|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
20514422|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514423|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20514424|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514425|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
20514426|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514427|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19853776|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19853777|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19853778|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19853779|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19853780|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853781|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19853782|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853783|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514428|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
20514429|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514430|NCT00866918|Analgesics|analgesics|mesh-ancestor
20514431|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
20514432|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514433|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20514434|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19853784|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19853785|NCT00734630|Protective Agents|protective agents|mesh-ancestor
19853786|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853787|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
19853788|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19853789|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19853790|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19853791|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
19853792|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853793|NCT00734656|Ethanol|ethanol|mesh-list
20514435|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514436|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
20514437|NCT00782574|Olaparib|olaparib|mesh-list
20514438|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514439|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19853794|NCT00734656|Dutasteride|dutasteride|mesh-list
20244689|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20244690|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20244691|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244692|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244693|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
20244694|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244695|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20244696|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244697|NCT00421395|Epratuzumab|epratuzumab|mesh-list
20244698|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20244699|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244700|NCT00421421|Dutasteride|dutasteride|mesh-list
20244701|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20244702|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20244703|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244704|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244705|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
20244706|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248047|NCT00434382|Isoflurane|isoflurane|mesh-list
20514440|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853795|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19853796|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244707|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244708|NCT00421434|Ribavirin|ribavirin|mesh-list
20514441|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514442|NCT00753545|Olaparib|olaparib|mesh-list
20514443|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20514444|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514445|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514446|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514447|NCT00750841|Cediranib|cediranib|mesh-list
20514448|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514449|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20514450|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514451|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702102|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19702103|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702104|NCT05205252|Dexamethasone|dexamethasone|mesh-list
19702105|NCT05205252|Dexamethasone acetate|dexamethasone acetate|mesh-list
19702106|NCT05205252|Lenalidomide|lenalidomide|mesh-list
19702107|NCT05205252|Daratumumab|daratumumab|mesh-list
19702108|NCT05205252|Pomalidomide|pomalidomide|mesh-list
19702109|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
19702110|NCT05205252|BB 1101|bb 1101|mesh-list
19702111|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19702112|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702113|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
19702114|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
19702115|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702116|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702117|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514477|NCT00579527|Cyclosporine|cyclosporine|mesh-list
20514478|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
20514479|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
19702118|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
20514480|NCT00579527|Prednisolone|prednisolone|mesh-list
19702119|NCT05205252|Hormones|hormones|mesh-ancestor
20514481|NCT00579527|Tacrolimus|tacrolimus|mesh-list
20514482|NCT00579527|Cyclosporins|cyclosporins|mesh-list
20514483|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
20514484|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20514485|NCT00579527|Daclizumab|daclizumab|mesh-list
20514486|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
20514487|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514488|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
20514489|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514490|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20514491|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514492|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514493|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
20514494|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514495|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
20514496|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514497|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514498|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514499|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20514500|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
20514501|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20514502|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853797|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853798|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853799|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20514503|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
20514504|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
20514505|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514506|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514507|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
20514508|NCT00579527|Hormones|hormones|mesh-ancestor
20514509|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514510|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20514511|NCT00579527|Protective Agents|protective agents|mesh-ancestor
20514512|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514513|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20514514|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
20514515|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20514516|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514517|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
20514518|NCT00557193|Leucovorin|leucovorin|mesh-list
20514519|NCT00557193|Folic Acid|folic acid|mesh-list
20514520|NCT00557193|Cytarabine|cytarabine|mesh-list
20514521|NCT00557193|Dexamethasone|dexamethasone|mesh-list
20514522|NCT00557193|Prednisone|prednisone|mesh-list
20514523|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
20514524|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20514525|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20514526|NCT00557193|Prednisolone|prednisolone|mesh-list
20514527|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
20514528|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
20514529|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20514530|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20514531|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20244709|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20244710|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
20244711|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
20244712|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
20244713|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244714|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
20244715|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244716|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
20244717|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514532|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
20514533|NCT00557193|Cortisone|cortisone|mesh-list
20514534|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
20514535|NCT00557193|Methotrexate|methotrexate|mesh-list
20514536|NCT00557193|Etoposide|etoposide|mesh-list
20514537|NCT00557193|Vincristine|vincristine|mesh-list
20514538|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
20514539|NCT00557193|Daunorubicin|daunorubicin|mesh-list
20244718|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20244719|NCT00421447|Anastrozole|anastrozole|mesh-list
20244720|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20244721|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244722|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20244723|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20244724|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514540|NCT00557193|Asparaginase|asparaginase|mesh-list
20514541|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
20514542|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
20514543|NCT00557193|Pegaspargase|pegaspargase|mesh-list
20514544|NCT00557193|Lenograstim|lenograstim|mesh-list
19415626|NCT02778399|OBE2109|obe2109|mesh-list
20514545|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20514546|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
20514547|NCT00557193|Calcium|calcium|mesh-list
20514548|NCT00557193|BB 1101|bb 1101|mesh-list
20514549|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
20514550|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514551|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
20514552|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514553|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514554|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514555|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
20514556|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514557|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514558|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514559|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514560|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
20514561|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
20514562|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514563|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514564|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
20514565|NCT00557193|Hormones|hormones|mesh-ancestor
20514566|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514567|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514568|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20514569|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20514570|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20514571|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
20514572|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20514573|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20514574|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
20514575|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
20514576|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514577|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20514578|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20514579|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20514580|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20514581|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20514582|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
20514583|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514584|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20514585|NCT00557193|Antidotes|antidotes|mesh-ancestor
20514586|NCT00557193|Protective Agents|protective agents|mesh-ancestor
20514587|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
20514588|NCT00557193|Vitamins|vitamins|mesh-ancestor
20514589|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
20514590|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
20514591|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
20514592|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
20514593|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20514594|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514595|NCT00557193|Hematinics|hematinics|mesh-ancestor
20514596|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
20514597|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
20514598|NCT00551928|Prednisone|prednisone|mesh-list
20514599|NCT00551928|Lenalidomide|lenalidomide|mesh-list
20514600|NCT00551928|Melphalan|melphalan|mesh-list
20514601|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514602|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
20514603|NCT00551928|Hormones|hormones|mesh-ancestor
20514604|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514605|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514606|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514607|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514608|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
20514609|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20514610|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20514611|NCT00551928|Growth Substances|growth substances|mesh-ancestor
20514612|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
20514613|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20514614|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
20514615|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514616|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514617|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514618|NCT00531232|Clofarabine|clofarabine|mesh-list
20514619|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20514620|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
20514621|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514622|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514623|NCT00476606|Ritonavir|ritonavir|mesh-list
20514624|NCT00476606|Nelfinavir|nelfinavir|mesh-list
20514625|NCT00476606|Indinavir|indinavir|mesh-list
20514626|NCT00476606|Saquinavir|saquinavir|mesh-list
20514627|NCT00476606|Lamivudine|lamivudine|mesh-list
20514628|NCT00476606|Zidovudine|zidovudine|mesh-list
20514629|NCT00476606|Nevirapine|nevirapine|mesh-list
20514630|NCT00476606|Stavudine|stavudine|mesh-list
20514631|NCT00476606|Didanosine|didanosine|mesh-list
20514632|NCT00476606|Efavirenz|efavirenz|mesh-list
20514633|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20514634|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20514635|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
20514636|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514637|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514638|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20514639|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20514640|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
20514641|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514642|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20514643|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20514644|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20514645|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20514646|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
20244725|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244726|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20244727|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
20244728|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244729|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244730|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
20244731|NCT00421460|Testosterone|testosterone|mesh-list
20514647|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20514648|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20514649|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20514650|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20514651|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20514652|NCT00379340|Dactinomycin|dactinomycin|mesh-list
20514653|NCT00379340|Cactinomycin|cactinomycin|mesh-list
20514654|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
20514655|NCT00379340|Doxorubicin|doxorubicin|mesh-list
20514656|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20514657|NCT00379340|Etoposide|etoposide|mesh-list
20514658|NCT00379340|Vincristine|vincristine|mesh-list
20514659|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
20514660|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514661|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
20514662|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514663|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514664|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19853800|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19853801|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514665|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
20529801|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20514666|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514667|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514668|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20514669|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514670|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20514671|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20514672|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514673|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20514674|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
20514675|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
20514676|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
20514677|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20514678|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514679|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20514680|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20514681|NCT00304070|Doxorubicin|doxorubicin|mesh-list
20514682|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20514683|NCT00304070|Etoposide|etoposide|mesh-list
20514684|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
20514685|NCT00304070|Mitotane|mitotane|mesh-list
20514686|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514687|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20514688|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20514689|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20514690|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514691|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514692|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20514693|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514694|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
20514695|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20514696|NCT00066950|Fluorides|fluorides|mesh-list
20514697|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
20514698|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
20514699|NCT00066950|Protective Agents|protective agents|mesh-ancestor
20514700|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514701|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20514702|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514703|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
20514704|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
20514705|NCT00004935|Trastuzumab|trastuzumab|mesh-list
20514706|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20514707|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529802|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20529803|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529804|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
20529805|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529806|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20529807|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20529808|NCT01784315|Analgesics|analgesics|mesh-ancestor
20529809|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
20529810|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529811|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529812|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529813|NCT01784315|Filaricides|filaricides|mesh-ancestor
20529814|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
20529815|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
20529816|NCT01784380|Metformin|metformin|mesh-list
20529817|NCT01784380|Clomiphene|clomiphene|mesh-list
20529818|NCT01784380|Enclomiphene|enclomiphene|mesh-list
20529819|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
20529820|NCT01784380|Menotropins|menotropins|mesh-list
20529821|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
20529822|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20529823|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529824|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20529825|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
20529826|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20529827|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20529828|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
20529829|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20529830|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20529831|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20529832|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
20529833|NCT01784445|Ceftazidime|ceftazidime|mesh-list
19415627|NCT02778399|Hormone Antagonists|hormone antagonists|mesh-ancestor
20514708|NCT00001322|Leuprolide|leuprolide|mesh-list
20514709|NCT00001322|Estradiol|estradiol|mesh-list
20514710|NCT00001322|Progesterone|progesterone|mesh-list
20514711|NCT00001322|Estrogens|estrogens|mesh-ancestor
20514712|NCT00001322|Hormones|hormones|mesh-ancestor
20514713|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514714|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514715|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20514716|NCT00001322|Progestins|progestins|mesh-ancestor
20514717|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20514718|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
20514719|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514720|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514721|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20514722|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
20514723|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20514724|NCT01694134|Prednisolone|prednisolone|mesh-list
19702120|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702121|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702122|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244732|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
20514725|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
20514726|NCT01694134|Lidocaine|lidocaine|mesh-list
20514727|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20514728|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
20514729|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
20514730|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
20514731|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20514732|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514733|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
20514734|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514735|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20514736|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20514737|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20514738|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20514739|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514740|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514741|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
20514742|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
20514743|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514744|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
20514745|NCT01694134|Hormones|hormones|mesh-ancestor
20514746|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514747|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20514748|NCT01694134|Protective Agents|protective agents|mesh-ancestor
20514749|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514750|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514751|NCT01694212|Diclofenac|diclofenac|mesh-list
20514752|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20514753|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20514754|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20514755|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20514756|NCT01694212|Analgesics|analgesics|mesh-ancestor
20514757|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
20514758|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514759|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514760|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514761|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514762|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20514763|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244733|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
20514764|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514765|NCT01694264|Entecavir|entecavir|mesh-list
20514766|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
19702123|NCT05205252|Protease Inhibitors|protease inhibitors|mesh-ancestor
19702124|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702125|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702126|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
19702127|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19702128|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20514767|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514768|NCT01694355|Vitamin D|vitamin d|mesh-list
20514769|NCT01694355|Vitamins|vitamins|mesh-ancestor
20514770|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
20514771|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514772|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20514773|NCT01694407|Tenofovir|tenofovir|mesh-list
20514774|NCT01694407|Emtricitabine|emtricitabine|mesh-list
20514775|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
20514776|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514777|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19702129|NCT05205252|Growth Substances|growth substances|mesh-ancestor
19702130|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
19702131|NCT05197842|Prednisone|prednisone|mesh-list
19702132|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
19702133|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
19702134|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514778|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20514779|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514780|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514781|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20514782|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20514783|NCT01694459|Heparin|heparin|mesh-list
20514784|NCT01694459|Calcium heparin|calcium heparin|mesh-list
20514785|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
20514786|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20514787|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20514788|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514789|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20514790|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
20514791|NCT01694498|Coagulants|coagulants|mesh-ancestor
20514792|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20514793|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
20514794|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514795|NCT01694576|Paclitaxel|paclitaxel|mesh-list
20514796|NCT01694576|Nedaplatin|nedaplatin|mesh-list
20514797|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20514798|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514799|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
20514800|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
20514801|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
20514802|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514803|NCT01694693|Abatacept|abatacept|mesh-list
20514804|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19702135|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
20514805|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514806|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514807|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20514808|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
20514809|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514810|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20514811|NCT01694732|Varenicline|varenicline|mesh-list
20514812|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20514813|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20514814|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
20514815|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20514816|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514817|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514818|NCT01694797|Metoprolol|metoprolol|mesh-list
20514819|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20514820|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20514821|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
20514822|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
20514823|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514824|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514825|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20514826|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20514827|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20514828|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
20514829|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20514830|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514831|NCT01695005|Prednisone|prednisone|mesh-list
20514832|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514833|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
20514834|NCT01695005|Hormones|hormones|mesh-ancestor
20514835|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514836|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514837|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20514838|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514839|NCT01695057|Vorinostat|vorinostat|mesh-list
20514840|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514841|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20514842|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514843|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514844|NCT01695070|Melatonin|melatonin|mesh-list
20514845|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
20514846|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514847|NCT01695070|Protective Agents|protective agents|mesh-ancestor
20514848|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514849|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20514850|NCT01695109|Liraglutide|liraglutide|mesh-list
20514851|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20514852|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514853|NCT01695109|Incretins|incretins|mesh-ancestor
20514854|NCT01695109|Hormones|hormones|mesh-ancestor
20514855|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20514856|NCT01695122|Valproic Acid|valproic acid|mesh-list
20514857|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
20514858|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514859|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514860|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
20514861|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20514862|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514863|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
20514864|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20514865|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20514866|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20514867|NCT01695148|Carotenoids|carotenoids|mesh-list
20514868|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
20514869|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514870|NCT01695148|Protective Agents|protective agents|mesh-ancestor
20514871|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514872|NCT01695174|Rifaximin|rifaximin|mesh-list
20514873|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20514874|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514875|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514876|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
20514877|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
20514878|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514879|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514880|NCT01695226|Celecoxib|celecoxib|mesh-list
20514881|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19415628|NCT02778399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415629|NCT02778399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415630|NCT02771626|Nivolumab|nivolumab|mesh-list
19415631|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415632|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415633|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19415634|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415635|NCT02770716|Terlipressin|terlipressin|mesh-list
19415636|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19415637|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19415638|NCT02770391|Leuprolide|leuprolide|mesh-list
19415639|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20514882|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20514883|NCT01695226|Analgesics|analgesics|mesh-ancestor
20514884|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
20514885|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20514886|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514887|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20514888|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415640|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
20514889|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20514890|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20514891|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514892|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514893|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
20514894|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
20514895|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
20514896|NCT01695356|Avobenzone|avobenzone|mesh-list
20514897|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
20514898|NCT01695356|Benzophenone|benzophenone|mesh-list
20514899|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20514900|NCT01695356|Protective Agents|protective agents|mesh-ancestor
20514901|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514902|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
20514903|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20514904|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
20514905|NCT01695460|Vitamins|vitamins|mesh-list
20514906|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
20514907|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514908|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20514909|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20529834|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20514910|NCT01695707|Pioglitazone|pioglitazone|mesh-list
20514911|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20514912|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514913|NCT01695733|Vaccines|vaccines|mesh-list
20514914|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
20514915|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514916|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
20514917|NCT01695759|Hematinics|hematinics|mesh-ancestor
20514918|NCT01695798|Vaccines|vaccines|mesh-list
20514919|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
19853802|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514920|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514921|NCT01695824|Warfarin|warfarin|mesh-list
20514922|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
20514923|NCT01695850|Sennosides|sennosides|mesh-list
20514924|NCT01695850|Laxatives|laxatives|mesh-ancestor
20514925|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20514926|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
20514927|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20514928|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
20514929|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20514930|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514931|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20514932|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20514933|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20514934|NCT01696110|Heparin|heparin|mesh-list
20514935|NCT01696110|Calcium heparin|calcium heparin|mesh-list
20514936|NCT01696110|Tirofiban|tirofiban|mesh-list
20514937|NCT01696110|Bivalirudin|bivalirudin|mesh-list
20514938|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
19853803|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
20514939|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20514940|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20514941|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514942|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
20514943|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20514944|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
20514945|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514946|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20514947|NCT01696240|Udenafil|udenafil|mesh-list
20514948|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20514949|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20514950|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20514951|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514952|NCT01696370|Trimetazidine|trimetazidine|mesh-list
20514953|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
20514954|NCT01696383|Timolol|timolol|mesh-list
20514955|NCT01696383|Travoprost|travoprost|mesh-list
20514956|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20514957|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20514958|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
20514959|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20514960|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514961|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514962|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20514963|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20514964|NCT01696409|Vitamin D|vitamin d|mesh-list
20514965|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
20514966|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
20514967|NCT01696409|Vitamins|vitamins|mesh-list
20514968|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
20514969|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514970|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20514971|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20514972|NCT01696422|Vaccines|vaccines|mesh-list
20244734|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20514973|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
20514974|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514975|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
20514976|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
20514977|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20514978|NCT01696448|Protective Agents|protective agents|mesh-ancestor
20514979|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514980|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
20514981|NCT01696448|Vitamins|vitamins|mesh-ancestor
20514982|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
20514983|NCT01696461|Plerixafor|plerixafor|mesh-list
20514984|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20514985|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20514986|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
20514987|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20514988|NCT01696474|Bortezomib|bortezomib|mesh-list
20514989|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20514990|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
20514991|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20514992|NCT01696500|Antibodies|antibodies|mesh-list
20514993|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
20514994|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20514995|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
20514996|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20514997|NCT01696526|Vitamin D|vitamin d|mesh-list
20514998|NCT01696526|Vitamins|vitamins|mesh-ancestor
20514999|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
20515000|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515001|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20515002|NCT01696552|Cimetidine|cimetidine|mesh-list
20515003|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20515004|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515005|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20515006|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
20515007|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
20515008|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515009|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515010|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515011|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20515012|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20515013|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515014|NCT01696617|Aripiprazole|aripiprazole|mesh-list
20515015|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
20515016|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515017|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20515018|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20515019|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515020|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515021|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
20515022|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
20515023|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515024|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515025|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20515026|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20515027|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
20515028|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20515029|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20515030|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20515031|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20515032|NCT01696630|Desflurane|desflurane|mesh-list
20515033|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20515034|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
20515035|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
20515036|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515037|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515038|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20515039|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
20515040|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515041|NCT01696799|Econazole|econazole|mesh-list
20515042|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
20515043|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515044|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20515045|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20515046|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515047|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515048|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20515049|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
20515050|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515051|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515052|NCT01696825|Diazepam|diazepam|mesh-list
20515053|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20515054|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
20515055|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
20515056|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
20515057|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244735|NCT00421460|Androgens|androgens|mesh-ancestor
20515058|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515059|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515060|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20515061|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515062|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20515063|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20515064|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20515065|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20515066|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515067|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20515068|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
20515069|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
20515070|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
20515071|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
20515072|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515073|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515074|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
20515075|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
20515076|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515077|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20515078|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515079|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515080|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
20515081|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515082|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20515083|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515084|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20515085|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
20515086|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20515087|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20515088|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515089|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855635|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20515090|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
20515091|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244736|NCT00421460|Hormones|hormones|mesh-ancestor
20244737|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244738|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244739|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20244740|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244741|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
20244742|NCT00421473|Atovaquone|atovaquone|mesh-list
20244743|NCT00421473|Proguanil|proguanil|mesh-list
20515092|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20515093|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20515094|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20515095|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20515096|NCT01697059|Amoxicillin|amoxicillin|mesh-list
20515097|NCT01697059|Piperacillin|piperacillin|mesh-list
20515098|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20515099|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20515100|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515101|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20515102|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515103|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515104|NCT01697098|Dexamethasone|dexamethasone|mesh-list
20515105|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
20515106|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
20515107|NCT01697098|BB 1101|bb 1101|mesh-list
20515108|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515109|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
20515110|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
20515111|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515112|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515113|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515114|NCT01697098|Hormones|hormones|mesh-ancestor
20515115|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515116|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515117|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515118|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
20515119|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515120|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515121|NCT01697111|Dienogest|dienogest|mesh-list
20515122|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20515123|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
20515124|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20515125|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515126|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20515127|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20515128|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20515129|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20515130|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
20515131|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515132|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515133|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515134|NCT01697150|Pancrelipase|pancrelipase|mesh-list
20515135|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515136|NCT01697228|Vitamin D|vitamin d|mesh-list
20515137|NCT01697228|Vitamins|vitamins|mesh-ancestor
20515138|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
20515139|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515140|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20515141|NCT01697280|Vaccines|vaccines|mesh-list
20515142|NCT01697280|Immunologic Factors|immunologic factors|mesh-ancestor
20515143|NCT01697280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515144|NCT01697293|Paclitaxel|paclitaxel|mesh-list
20515145|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
20515146|NCT01697293|Doxorubicin|doxorubicin|mesh-list
20515147|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20515148|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20515149|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20515150|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515151|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
20515152|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
20515153|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
20515154|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515155|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515156|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
20515157|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515158|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20515159|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20515160|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
20515161|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20515162|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20515163|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20515164|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20515165|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515166|NCT01697306|Gemcitabine|gemcitabine|mesh-list
20515167|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
20515168|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20515169|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
20515170|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244744|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20515171|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515172|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
20515173|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515174|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515175|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515176|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
20515177|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515178|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20515179|NCT01697410|Terlipressin|terlipressin|mesh-list
20515180|NCT01697410|Norepinephrine|norepinephrine|mesh-list
20515181|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20515182|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20515183|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
20515184|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515185|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515186|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515187|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
20515188|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
20515189|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515190|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20515191|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20515192|NCT01697436|Ribavirin|ribavirin|mesh-list
20515193|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
20515194|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515195|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
20515196|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529835|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529836|NCT01784536|Oritavancin|oritavancin|mesh-list
20529837|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20529838|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529839|NCT01784549|Gemcitabine|gemcitabine|mesh-list
20529840|NCT01784549|Docetaxel|docetaxel|mesh-list
20529841|NCT01784549|Pemetrexed|pemetrexed|mesh-list
20529842|NCT01784549|Vinorelbine|vinorelbine|mesh-list
20529843|NCT01784549|Gefitinib|gefitinib|mesh-list
20529844|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529845|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20529846|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
20529847|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529848|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
20529849|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20529850|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529851|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20529852|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
20529853|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529854|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
20529855|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
20529856|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
20529857|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20515197|NCT01697566|Metformin|metformin|mesh-list
20515198|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20515199|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515200|NCT01697605|Infigratinib|infigratinib|mesh-list
20515201|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515202|NCT01697618|Insulin|insulin|mesh-list
20515203|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20515204|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
20244745|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244746|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
20244747|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20244748|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20244749|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244750|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244751|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
20244752|NCT00421512|Bevacizumab|bevacizumab|mesh-list
20244753|NCT00421512|Sunitinib|sunitinib|mesh-list
20244754|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20244755|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244756|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20244757|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20244758|NCT00421512|Growth Substances|growth substances|mesh-ancestor
20515205|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
20515206|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20515207|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20515208|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515209|NCT01697631|Insulin|insulin|mesh-list
20515210|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20515211|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
20515212|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
20515213|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20515214|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
20515215|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20244759|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244760|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
20515216|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20515217|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515218|NCT01697657|Insulin|insulin|mesh-list
20515219|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20515220|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
20515221|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
20515222|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
20515223|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
20515224|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
20515225|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20515226|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515227|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19702136|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702137|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702138|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19702139|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
19702140|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702141|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702142|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19702143|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702144|NCT05197842|Hormones|hormones|mesh-ancestor
20515228|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20515229|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
20515230|NCT01697722|Beclomethasone|beclomethasone|mesh-list
20515231|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515232|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
20515233|NCT01697722|Hormones|hormones|mesh-ancestor
20515234|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515235|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515236|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20515237|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
20515238|NCT01697735|Atorvastatin|atorvastatin|mesh-list
20515239|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20515240|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20515241|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20515242|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
20515243|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515244|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20515245|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20515246|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515247|NCT01697787|Artesunate|artesunate|mesh-list
20515248|NCT01697787|Lumefantrine|lumefantrine|mesh-list
20515249|NCT01697787|Artemether|artemether|mesh-list
20515250|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20515251|NCT01697787|Amodiaquine|amodiaquine|mesh-list
19702145|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515252|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
20515253|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20515254|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20515255|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515256|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702146|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702147|NCT05189730|Paclitaxel|paclitaxel|mesh-list
19702148|NCT05189730|Carboplatin|carboplatin|mesh-list
20515257|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
20515258|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
20515259|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20515260|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
20515261|NCT01697826|Clindamycin|clindamycin|mesh-list
19702149|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702150|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702151|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702152|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
19702153|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
20515262|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
20515263|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
19708083|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515264|NCT01697826|Clotrimazole|clotrimazole|mesh-list
20515265|NCT01697826|Miconazole|miconazole|mesh-list
20515266|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20515267|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515268|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20515269|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515270|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515271|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20515272|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
20515273|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20515274|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20515275|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20244761|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20244762|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244763|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244764|NCT00421538|Nadroparin|nadroparin|mesh-list
20515276|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
20515277|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515278|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515279|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20515280|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20515281|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20515282|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20515283|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20515284|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515285|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515286|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20515287|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20515288|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515289|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
20515290|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515291|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20515292|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20515293|NCT01698164|Estradiol|estradiol|mesh-list
20515294|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20515295|NCT01698164|Progesterone|progesterone|mesh-list
20515296|NCT01698164|Estrogens|estrogens|mesh-ancestor
20515297|NCT01698164|Hormones|hormones|mesh-ancestor
20515298|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515299|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515300|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20515301|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
20515302|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20515303|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20515304|NCT01698164|Progestins|progestins|mesh-ancestor
20515305|NCT01698177|Vaccines|vaccines|mesh-list
20515306|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
20515307|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515308|NCT01698203|Ropivacaine|ropivacaine|mesh-list
20515309|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
20515310|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
20515311|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515312|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515313|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
20244765|NCT00421538|Calcium|calcium|mesh-list
20515314|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515315|NCT01698476|Vitamin D|vitamin d|mesh-list
20515316|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
20515317|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20515318|NCT01698476|Vitamins|vitamins|mesh-ancestor
20515319|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
20515320|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515321|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20515322|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20515323|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515324|NCT01698541|Tacrolimus|tacrolimus|mesh-list
20515325|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515326|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
20515327|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515328|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20515329|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515330|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515331|NCT01698567|Antithrombins|antithrombins|mesh-list
20515332|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
20515333|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20515334|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244766|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20244767|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244768|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
20244769|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20244770|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20244771|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244772|NCT00421551|Ritonavir|ritonavir|mesh-list
20244773|NCT00421551|Darunavir|darunavir|mesh-list
20244774|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20244775|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20244776|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244777|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515335|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515336|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515337|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
20515338|NCT01698593|Epinephrine|epinephrine|mesh-list
20515339|NCT01698593|Bupivacaine|bupivacaine|mesh-list
19702154|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515340|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
19415641|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19415642|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415643|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19415644|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415645|NCT02762929|Bupivacaine|bupivacaine|mesh-list
19415646|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
19415647|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
19415648|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415649|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415650|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
19415651|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515341|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
20515342|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515343|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515344|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
20515345|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515346|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20515347|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20515348|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
20515349|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515350|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515351|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20515352|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20515353|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
20515354|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20515355|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
20515356|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
19415652|NCT02755597|Dexamethasone|dexamethasone|mesh-list
19415653|NCT02755597|Bortezomib|bortezomib|mesh-list
19415654|NCT02755597|Venetoclax|venetoclax|mesh-list
20515357|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
20515358|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20515359|NCT01698645|Fentanyl|fentanyl|mesh-list
20515360|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20515361|NCT01698645|Narcotics|narcotics|mesh-ancestor
20515362|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515363|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515364|NCT01698645|Analgesics|analgesics|mesh-ancestor
20515365|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
20515366|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515367|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20515368|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20515369|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
20515370|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
20515371|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
20515372|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20515373|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515374|NCT01698723|Ribavirin|ribavirin|mesh-list
20515375|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
20515376|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515377|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
20515378|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515379|NCT01698749|Dexamethasone|dexamethasone|mesh-list
20515380|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515381|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
20515382|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
20515383|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515384|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515385|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515386|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
20515387|NCT01698749|Hormones|hormones|mesh-ancestor
20515388|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515389|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515390|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515391|NCT01698788|Dexamethasone|dexamethasone|mesh-list
20515392|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
20515393|NCT01698788|BB 1101|bb 1101|mesh-list
20515394|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515395|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
20515396|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
20515397|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515398|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515399|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515400|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
20515401|NCT01698788|Hormones|hormones|mesh-ancestor
20515402|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515403|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19415655|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515404|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515405|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
20515406|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515407|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515408|NCT01698931|Glyburide|glyburide|mesh-list
20515409|NCT01698931|Repaglinide|repaglinide|mesh-list
20515410|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20515411|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515412|NCT01699113|Rabeprazole|rabeprazole|mesh-list
20515413|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20515414|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515415|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20515416|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515417|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515418|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20515419|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20515420|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20515421|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
20515422|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515423|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20515424|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20515425|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515426|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
20515427|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20515428|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
20515429|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515430|NCT01699204|Expectorants|expectorants|mesh-ancestor
20515431|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
20515432|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20515433|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
20515434|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515435|NCT01699204|Protective Agents|protective agents|mesh-ancestor
20515436|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515437|NCT01699204|Antidotes|antidotes|mesh-ancestor
20515438|NCT01699282|Antivitamins K|antivitamins k|mesh-list
20515439|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
20529858|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20529859|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19415656|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
19415657|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
20515440|NCT01699347|Picibanil|picibanil|mesh-list
20515441|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515442|NCT01699360|Cyclosporine|cyclosporine|mesh-list
20515443|NCT01699360|Sirolimus|sirolimus|mesh-list
20515444|NCT01699360|Tacrolimus|tacrolimus|mesh-list
20515445|NCT01699360|Cyclosporins|cyclosporins|mesh-list
20515446|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515447|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
19415658|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515448|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515449|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20515450|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515451|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415659|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415660|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244778|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244779|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20244780|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20515452|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
20515453|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515454|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
20515455|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20515456|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20515457|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20515458|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515459|NCT01699412|Dexamethasone|dexamethasone|mesh-list
20515460|NCT01699412|Clobetasol|clobetasol|mesh-list
20515461|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515462|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
20515463|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
20515464|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515465|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515466|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515467|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
20515468|NCT01699412|Hormones|hormones|mesh-ancestor
20515469|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515470|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515471|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515472|NCT01699438|Mesalamine|mesalamine|mesh-list
20515473|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20515474|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20515475|NCT01699438|Analgesics|analgesics|mesh-ancestor
20515476|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
20515477|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515478|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515479|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515480|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20515481|NCT01699490|Valsartan|valsartan|mesh-list
20515482|NCT01699490|Fluoxetine|fluoxetine|mesh-list
20515483|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20515484|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20515485|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20515486|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515487|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20515488|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20515489|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20515490|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515491|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
20515492|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515493|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20515494|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
20515495|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515496|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20515497|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20515498|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515499|NCT01699594|Mannitol|mannitol|mesh-list
20515500|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
20515501|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20515502|NCT01699594|Diuretics|diuretics|mesh-ancestor
20515503|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
20515504|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515505|NCT01699594|Miotics|miotics|mesh-ancestor
20515506|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
20515507|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515508|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20515509|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20515510|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
20515511|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20515512|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20515513|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
20515514|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515515|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515516|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20515517|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
20515518|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515519|NCT01699711|Protective Agents|protective agents|mesh-ancestor
20515520|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515521|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20515522|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20515523|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515524|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20515525|NCT01699724|Sertraline|sertraline|mesh-list
20515526|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
20515527|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515528|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20515529|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20515530|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20515531|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415661|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
20244781|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
20244782|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244783|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20244784|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20244785|NCT00421642|Adalimumab|adalimumab|mesh-list
20244786|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244787|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244788|NCT00421694|Bicalutamide|bicalutamide|mesh-list
20244789|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
20244790|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
20515532|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515533|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
19415662|NCT02755597|Hormones|hormones|mesh-ancestor
19415663|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415664|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515534|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248048|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20515535|NCT01699776|Digoxin|digoxin|mesh-list
20515536|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20515537|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20515538|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515539|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515540|NCT01699776|Protective Agents|protective agents|mesh-ancestor
20515541|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515542|NCT01699802|Anesthetics|anesthetics|mesh-list
20515543|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515544|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515545|NCT01699828|Buspirone|buspirone|mesh-list
20515546|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20515547|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20515548|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515549|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515550|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515551|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20515552|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
20515553|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515554|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515555|NCT01699854|Capsaicin|capsaicin|mesh-list
20515556|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
20515557|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
20515558|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
20515559|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515560|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515561|NCT01699919|Lidocaine|lidocaine|mesh-list
20515562|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
20515563|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
20515564|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515565|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515566|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
20515567|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515568|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20515569|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20515570|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20515571|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20515572|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515573|NCT01699932|Metformin|metformin|mesh-list
20515574|NCT01699932|Glimepiride|glimepiride|mesh-list
20515575|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20515576|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515577|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20515578|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702155|NCT05168709|Vaccines|vaccines|mesh-list
20515579|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
20515580|NCT01699997|Oxytocin|oxytocin|mesh-list
20515581|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
20515582|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20515583|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515584|NCT01700010|Paclitaxel|paclitaxel|mesh-list
20515585|NCT01700010|Lapatinib|lapatinib|mesh-list
20515586|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20515587|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515588|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
20515589|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
20515590|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
20515591|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515592|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20515593|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515594|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
20515595|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20515596|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20515597|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515598|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515599|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515600|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20515601|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20515602|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415665|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415666|NCT02744833|Enoxaparin|enoxaparin|mesh-list
19415667|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
19415668|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
19415669|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20515603|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515604|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515605|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
20515606|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20515607|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
20515608|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20515609|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20515610|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515611|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20515612|NCT01700322|Clopidogrel|clopidogrel|mesh-list
20515613|NCT01700322|Ticagrelor|ticagrelor|mesh-list
20515614|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20515615|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20515616|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20515617|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20515618|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20515619|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
20515620|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515621|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515622|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515623|NCT01700400|Bevacizumab|bevacizumab|mesh-list
20515624|NCT01700400|Carboplatin|carboplatin|mesh-list
20515625|NCT01700400|Pemetrexed|pemetrexed|mesh-list
20515626|NCT01700400|Everolimus|everolimus|mesh-list
20515627|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20515628|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515629|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20515630|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20515631|NCT01700400|Growth Substances|growth substances|mesh-ancestor
20515632|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515633|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
20515634|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515635|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515636|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19415670|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19702156|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
20515637|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20515638|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515639|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
20515640|NCT01700413|Idarubicin|idarubicin|mesh-list
20515641|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20515642|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515643|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20515644|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20515645|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515646|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515647|NCT01700426|Vitamins|vitamins|mesh-list
20515648|NCT01700426|Vitamin E|vitamin e|mesh-list
20515649|NCT01700426|Tocopherols|tocopherols|mesh-list
20515650|NCT01700426|Tocotrienols|tocotrienols|mesh-list
20515651|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
20515652|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
20515653|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515654|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
20515655|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515656|NCT01700426|Protective Agents|protective agents|mesh-ancestor
20515657|NCT01700478|Vasopressins|vasopressins|mesh-list
20515658|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
20515659|NCT01700478|Misoprostol|misoprostol|mesh-list
19702157|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702158|NCT05163106|Letrozole|letrozole|mesh-list
20515660|NCT01700478|Diuretics|diuretics|mesh-list
20515661|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515662|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20515663|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
20515664|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20515665|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20515666|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515667|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
20515668|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
20515669|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
20515670|NCT01700478|Coagulants|coagulants|mesh-ancestor
20515671|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20515672|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20515673|NCT01700491|Ropivacaine|ropivacaine|mesh-list
20515674|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
20515675|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
20515676|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515677|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515678|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
20515679|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515680|NCT01700504|Gentamicins|gentamicins|mesh-list
20515681|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20515682|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515683|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20515684|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515685|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515686|NCT01700569|Leucovorin|leucovorin|mesh-list
20515687|NCT01700569|Folic Acid|folic acid|mesh-list
20515688|NCT01700569|Temozolomide|temozolomide|mesh-list
20515689|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
20515690|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515691|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20515692|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
20515693|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515694|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515695|NCT01700569|Antidotes|antidotes|mesh-ancestor
20515696|NCT01700569|Protective Agents|protective agents|mesh-ancestor
20515697|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
20515698|NCT01700569|Vitamins|vitamins|mesh-ancestor
20515699|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
20515700|NCT01700569|Hematinics|hematinics|mesh-ancestor
20515701|NCT01700608|Plerixafor|plerixafor|mesh-list
20515702|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20515703|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20515704|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
20515705|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515706|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20515707|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702159|NCT05163106|Goserelin|goserelin|mesh-list
20515708|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515709|NCT01700790|Ritonavir|ritonavir|mesh-list
20515710|NCT01700790|Lopinavir|lopinavir|mesh-list
20515711|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20515712|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20515713|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
19702160|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702161|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19702162|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19702163|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702164|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702165|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19702166|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
19702167|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515714|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515715|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515716|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20515717|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20515718|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
20515719|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515720|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20515721|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20515722|NCT01700803|Iodine|iodine|mesh-list
20515723|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
20515724|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
20515725|NCT01700803|Povidone|povidone|mesh-list
20515726|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20515727|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515728|NCT01700803|Trace Elements|trace elements|mesh-ancestor
20515729|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
20515730|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515731|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
20515732|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
20515733|NCT01700881|Vitamin E|vitamin e|mesh-list
20515734|NCT01700881|Vitamins|vitamins|mesh-ancestor
20515735|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
20515736|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515737|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
20515738|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515739|NCT01700881|Protective Agents|protective agents|mesh-ancestor
20515740|NCT01700946|Cytarabine|cytarabine|mesh-list
20515741|NCT01700946|Aldesleukin|aldesleukin|mesh-list
20515742|NCT01700946|Dexamethasone|dexamethasone|mesh-list
20515743|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
20515744|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20515745|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20515746|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20244791|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244792|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244793|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515747|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
20515748|NCT01700946|Rituximab|rituximab|mesh-list
20515749|NCT01700946|Methotrexate|methotrexate|mesh-list
20515750|NCT01700946|Etoposide|etoposide|mesh-list
20515751|NCT01700946|Vincristine|vincristine|mesh-list
20515752|NCT01700946|Interleukin-2|interleukin-2|mesh-list
20515753|NCT01700946|Asparaginase|asparaginase|mesh-list
20515754|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
20515755|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
20515756|NCT01700946|Clofarabine|clofarabine|mesh-list
20515757|NCT01700946|Vinblastine|vinblastine|mesh-list
20515758|NCT01700946|Pegaspargase|pegaspargase|mesh-list
20515759|NCT01700946|Teniposide|teniposide|mesh-list
20515760|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515761|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
20515762|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515763|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20515764|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20515765|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
20515766|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515767|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515768|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20515769|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20515770|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515771|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
20515772|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
20244794|NCT00421720|Sufentanil|sufentanil|mesh-list
20515773|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515774|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515775|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
20515776|NCT01700946|Hormones|hormones|mesh-ancestor
20515777|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515778|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515779|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20515780|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
20515781|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20515782|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20515783|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
20515784|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
20515785|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515786|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20515787|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20515788|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20515789|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20515790|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20515791|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
20515792|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515793|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
20515794|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
20515795|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
20515796|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20515797|NCT01700946|Analgesics|analgesics|mesh-ancestor
20515798|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
20515799|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20515800|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20515801|NCT01701076|Dexamethasone|dexamethasone|mesh-list
20515802|NCT01701076|Lenalidomide|lenalidomide|mesh-list
20515803|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20515804|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515805|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
20515806|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
20515807|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515808|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515809|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515810|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
20515811|NCT01701076|Hormones|hormones|mesh-ancestor
20515812|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515813|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515814|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515815|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515816|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
20515817|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20515818|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20515819|NCT01701076|Growth Substances|growth substances|mesh-ancestor
20515820|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
20515821|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20515822|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
20515823|NCT01701089|Selegiline|selegiline|mesh-list
20515824|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
20515825|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515826|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20515827|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20515828|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20515829|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515830|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515831|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20515832|NCT01701089|Protective Agents|protective agents|mesh-ancestor
20515833|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529860|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20529861|NCT01784562|Riociguat|riociguat|mesh-list
20529862|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
20529863|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529864|NCT01784640|Pemetrexed|pemetrexed|mesh-list
20529865|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529866|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529867|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529868|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20529869|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20529870|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20529871|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530875|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530876|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702168|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515834|NCT01701180|Oxytocin|oxytocin|mesh-list
20515835|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
20515836|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20515837|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515838|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20515839|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20515840|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515841|NCT01701232|Rituximab|rituximab|mesh-list
20515842|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20515843|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515844|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
20515845|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702169|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702170|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19702171|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19702172|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19702173|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
19702174|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702175|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19702176|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20515846|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702177|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702178|NCT05048264|Dexamethasone|dexamethasone|mesh-list
20515847|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20515848|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20515849|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515850|NCT01701297|Renal Agents|renal agents|mesh-ancestor
20515851|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20515852|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
20515853|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20515854|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20515855|NCT01701323|Cytarabine|cytarabine|mesh-list
20515856|NCT01701323|Fludarabine|fludarabine|mesh-list
20515857|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
20515858|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515859|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20515860|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
20515861|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515862|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20515863|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
20515864|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515865|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
20515866|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515867|NCT01701336|Cloricromen|cloricromen|mesh-list
20515868|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20515869|NCT01701349|Paclitaxel|paclitaxel|mesh-list
20515870|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
20515871|NCT01701349|Combretastatin|combretastatin|mesh-list
20515872|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20515873|NCT01701349|Carboplatin|carboplatin|mesh-list
20515874|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20515875|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515876|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
20244795|NCT00421720|Remifentanil|remifentanil|mesh-list
20244796|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20244797|NCT00421720|Narcotics|narcotics|mesh-ancestor
20244798|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244799|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244800|NCT00421720|Analgesics|analgesics|mesh-ancestor
20244801|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
20244802|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244803|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20515877|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
20515878|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
20515879|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515880|NCT01701453|Clopidogrel|clopidogrel|mesh-list
20515881|NCT01701453|Ticagrelor|ticagrelor|mesh-list
20515882|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20515883|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20515884|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20515885|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20515886|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20515887|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
20515888|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515889|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515890|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515891|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20515892|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20515893|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515894|NCT01701479|Aldesleukin|aldesleukin|mesh-list
20515895|NCT01701479|Interleukin-2|interleukin-2|mesh-list
20515896|NCT01701479|Dinutuximab|dinutuximab|mesh-list
20515897|NCT01701479|Isotretinoin|isotretinoin|mesh-list
20515898|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515899|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20515900|NCT01701479|Analgesics|analgesics|mesh-ancestor
20515901|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
20515902|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515903|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515904|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20515905|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19702179|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
19702180|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19702181|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19702182|NCT05048264|Prednisolone|prednisolone|mesh-list
19702183|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
19702184|NCT05048264|Triamcinolone|triamcinolone|mesh-list
19702185|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19702186|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20515906|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
20515907|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515908|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
20515909|NCT01701518|Dexamethasone|dexamethasone|mesh-list
20515910|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515911|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
20515912|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
20515913|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515914|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515915|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20515916|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
20515917|NCT01701518|Hormones|hormones|mesh-ancestor
20515918|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515919|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20515920|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515921|NCT01701583|Omalizumab|omalizumab|mesh-list
20515922|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20515923|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20515924|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
20515925|NCT01701739|Digoxin|digoxin|mesh-list
20515926|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20515927|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20515928|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515929|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515930|NCT01701739|Protective Agents|protective agents|mesh-ancestor
20515931|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515932|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
20515933|NCT01701778|Sevoflurane|sevoflurane|mesh-list
20515934|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
20515935|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20515936|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515937|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515938|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244804|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20244805|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
20244806|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
20515939|NCT01701778|Analgesics|analgesics|mesh-ancestor
20515940|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
20515941|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853804|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853805|NCT00734851|Docetaxel|docetaxel|mesh-list
19853806|NCT00734851|Sunitinib|sunitinib|mesh-list
19853807|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853808|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
20515942|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20515943|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19853809|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853810|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
20515944|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20515945|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
20515946|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20515947|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515948|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20515949|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20244807|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
20244808|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20244809|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
19702187|NCT05048264|Betamethasone|betamethasone|mesh-list
19702188|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19702189|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
19702190|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19702191|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702192|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
19702193|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
19702194|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244810|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702195|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702196|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702197|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
19853811|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244811|NCT00421785|Expectorants|expectorants|mesh-ancestor
20515950|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
19702198|NCT05048264|Hormones|hormones|mesh-ancestor
20244812|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
20244813|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20244814|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
20244815|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244816|NCT00421785|Protective Agents|protective agents|mesh-ancestor
20244817|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244818|NCT00421785|Antidotes|antidotes|mesh-ancestor
20244819|NCT00421811|Melphalan|melphalan|mesh-list
20244820|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20244821|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
20244822|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244823|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244824|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20244825|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244826|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
20244827|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244828|NCT00421824|Capecitabine|capecitabine|mesh-list
20244829|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
20244830|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20244831|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
20244832|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244833|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244834|NCT00421863|Amlodipine|amlodipine|mesh-list
20244835|NCT00421863|Telmisartan|telmisartan|mesh-list
20515951|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
20515952|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
20515953|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
20515954|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
20515955|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
20515956|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515957|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20515958|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20515959|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
20515960|NCT01701856|Interferons|interferons|mesh-list
20244836|NCT00421863|Clonidine|clonidine|mesh-list
20515961|NCT01701856|Interferon-beta|interferon-beta|mesh-list
20515962|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
20515963|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515964|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
20515965|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515966|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
20515967|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853812|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853813|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19853814|NCT00734851|Growth Substances|growth substances|mesh-ancestor
19853815|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853816|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
19853817|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853818|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515968|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20515969|NCT01701882|Tenofovir|tenofovir|mesh-list
20515970|NCT01701882|Emtricitabine|emtricitabine|mesh-list
20515971|NCT01701882|Rilpivirine|rilpivirine|mesh-list
20515972|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
20515973|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20515974|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20515975|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20515976|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20515977|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515978|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20515979|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20515980|NCT01701921|Pregabalin|pregabalin|mesh-list
20515981|NCT01701921|Analgesics|analgesics|mesh-ancestor
19853819|NCT00734929|Dexamethasone|dexamethasone|mesh-list
19853820|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
19853821|NCT00734929|Ondansetron|ondansetron|mesh-list
19853822|NCT00734929|Aprepitant|aprepitant|mesh-list
19853823|NCT00734929|BB 1101|bb 1101|mesh-list
19853824|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853825|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
19853826|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
19853827|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853828|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853829|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19853830|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
19853831|NCT00734929|Hormones|hormones|mesh-ancestor
20515982|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
20515983|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20515984|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515985|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
20515986|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20515987|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20515988|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20515989|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20515990|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20515991|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20515992|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20515993|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20515994|NCT01702038|Rituximab|rituximab|mesh-list
20515995|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20515996|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20515997|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
19853832|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20515998|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20515999|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20516000|NCT01702090|Ritonavir|ritonavir|mesh-list
20516001|NCT01702090|Darunavir|darunavir|mesh-list
20516002|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20516003|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20516004|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244837|NCT00421863|Ramipril|ramipril|mesh-list
20244838|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20244839|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20244840|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20244841|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244842|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20244843|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516005|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516006|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516007|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20516008|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20516009|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
20516010|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516011|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20516012|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20516013|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
20516014|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20516015|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
20516016|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20516017|NCT01702129|Doxorubicin|doxorubicin|mesh-list
20516018|NCT01702129|Cetuximab|cetuximab|mesh-list
20516019|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20516020|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516021|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20516022|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20516023|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516024|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516025|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516026|NCT01702181|Tacrolimus|tacrolimus|mesh-list
20516027|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516028|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
20516029|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516030|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20516031|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516032|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244844|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
20244845|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20516033|NCT01702207|Tacrolimus|tacrolimus|mesh-list
20516034|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516035|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
20516036|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516037|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20516038|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516039|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516040|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
20516041|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20516042|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415671|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415672|NCT02741791|Bupropion|bupropion|mesh-list
19415673|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19415674|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
19415675|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19415676|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19415677|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19415678|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19702199|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19853833|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702200|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702201|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702202|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19702203|NCT05048264|Protective Agents|protective agents|mesh-ancestor
19702204|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702205|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
19702206|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702207|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702208|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19853834|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853835|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
19853836|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516043|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20516044|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20516045|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244846|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20244847|NCT00421863|Analgesics|analgesics|mesh-ancestor
20244848|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
20244849|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244850|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
20244851|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
20244852|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20244853|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20244854|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20244855|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244856|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244857|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20516046|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516047|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516048|NCT01702389|Remifentanil|remifentanil|mesh-list
20516049|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20516050|NCT01702389|Narcotics|narcotics|mesh-ancestor
20516051|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516052|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516053|NCT01702389|Analgesics|analgesics|mesh-ancestor
20516054|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
20516055|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516056|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
20516057|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20516058|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516059|NCT01702506|Antacids|antacids|mesh-list
20516060|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702209|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
19702210|NCT05028608|Carbamazepine|carbamazepine|mesh-list
19702211|NCT05028608|Midazolam|midazolam|mesh-list
19702212|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19702213|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19702214|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702215|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702216|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19702217|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19702218|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19702219|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19702220|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
19702221|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
19702222|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
19702223|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
19702224|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244858|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
20244859|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244860|NCT00421915|Etanercept|etanercept|mesh-list
20244861|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244862|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244863|NCT00421915|Analgesics|analgesics|mesh-ancestor
20244864|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
20244865|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244866|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244867|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244868|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244869|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244870|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244871|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
20244872|NCT00421967|Ketorolac|ketorolac|mesh-list
20244873|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20244874|NCT00421967|Epinephrine|epinephrine|mesh-list
20244875|NCT00421967|Racepinephrine|racepinephrine|mesh-list
20244876|NCT00421967|Ropivacaine|ropivacaine|mesh-list
20244877|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
19415679|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702225|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702226|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
19702227|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
19702228|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19702229|NCT05028608|Analgesics|analgesics|mesh-ancestor
19702230|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
19702231|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516061|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702232|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19415680|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
19415681|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415682|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702233|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516062|NCT01702610|Temozolomide|temozolomide|mesh-list
20516063|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20516064|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
20516065|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516066|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516067|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
20516068|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
20516069|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20516070|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20516071|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516072|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516073|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20516074|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20516075|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
20516076|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20244878|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
20244879|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
20244880|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516077|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20516078|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516079|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
20516080|NCT01702636|Coagulants|coagulants|mesh-ancestor
20516081|NCT01702649|Biapenem|biapenem|mesh-list
20516082|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516083|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
20516084|NCT01702688|Giapreza|giapreza|mesh-list
19415683|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19415684|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19415685|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415686|NCT02736968|Auranofin|auranofin|mesh-list
19415687|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415688|NCT02736149|Ubenimex|ubenimex|mesh-list
19415689|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19415690|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
19415691|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516085|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
20516086|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20516087|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20516088|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
20516089|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516090|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516091|NCT01702701|Fluticasone|fluticasone|mesh-list
20516092|NCT01702701|Montelukast|montelukast|mesh-list
20516093|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20516094|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20516095|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
20516096|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516097|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516098|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20516099|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
19415692|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19415693|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516100|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20516101|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19415694|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19415695|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415696|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
19415697|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415698|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516102|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20516103|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
20516104|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516105|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20516106|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20516107|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415699|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20516108|NCT01702714|Gemcitabine|gemcitabine|mesh-list
20516109|NCT01702714|Paclitaxel|paclitaxel|mesh-list
20516110|NCT01702714|Carboplatin|carboplatin|mesh-list
20516111|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20516112|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516113|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516114|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
20516115|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
20516116|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516117|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20516118|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
20516119|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
20516120|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516121|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516122|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415700|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20516123|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
20516124|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529872|NCT01784900|Catumaxomab|catumaxomab|mesh-list
20529873|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20529874|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20529875|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
20529876|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529877|NCT01784913|Sargramostim|sargramostim|mesh-list
20529878|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
20529879|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529880|NCT01784978|Everolimus|everolimus|mesh-list
20529881|NCT01784978|Sunitinib|sunitinib|mesh-list
20529882|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20529883|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415701|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
19415702|NCT02735122|Acetaminophen|acetaminophen|mesh-list
19415703|NCT02735122|Ibuprofen|ibuprofen|mesh-list
19415704|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415705|NCT02735122|Analgesics|analgesics|mesh-ancestor
19415706|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
19415707|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415708|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853837|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516125|NCT01702831|Lenalidomide|lenalidomide|mesh-list
20516126|NCT01702831|Melphalan|melphalan|mesh-list
20516127|NCT01702831|Busulfan|busulfan|mesh-list
20516128|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
20516129|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516130|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516131|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516132|NCT01702831|Growth Substances|growth substances|mesh-ancestor
20516133|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516134|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516135|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20516136|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
20516137|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516138|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20516139|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516140|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20516141|NCT01702857|Vaccines|vaccines|mesh-list
20516142|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
20516143|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
20516144|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516145|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20516146|NCT01702857|Antacids|antacids|mesh-ancestor
20516147|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516148|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20516149|NCT01702974|Vitamin D|vitamin d|mesh-list
20516150|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
20516151|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20516152|NCT01702974|Vitamins|vitamins|mesh-ancestor
20516153|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
20516154|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516155|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20516156|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20516157|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516158|NCT01703104|Folic Acid|folic acid|mesh-list
20516159|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
19853838|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
20516160|NCT01703104|Proguanil|proguanil|mesh-list
20516161|NCT01703104|Hematinics|hematinics|mesh-ancestor
20516162|NCT01703104|Vitamins|vitamins|mesh-ancestor
20516163|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
20516164|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516165|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
20516166|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19415709|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
19415710|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19702234|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20244881|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244882|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
20244883|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244884|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244885|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244886|NCT00421967|Analgesics|analgesics|mesh-ancestor
20244887|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244888|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244889|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19702235|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19702236|NCT05020899|Nicotine|nicotine|mesh-list
19702237|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19702238|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
19702239|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702240|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516167|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20244890|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244891|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244892|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20244893|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20516168|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244894|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
20244895|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244896|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20244897|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20244898|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
20244899|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20244900|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
20516169|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
19702241|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19702242|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20516170|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516171|NCT01703130|Ropivacaine|ropivacaine|mesh-list
20516172|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
20516173|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
20516174|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516175|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516176|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
20516177|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516178|NCT01703234|Ramipril|ramipril|mesh-list
20516179|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20516180|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
20516181|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516182|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516183|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20516184|NCT01703312|Omalizumab|omalizumab|mesh-list
20516185|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20516186|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20516187|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
20516188|NCT01703325|Triamcinolone|triamcinolone|mesh-list
20516189|NCT01703325|Clobetasol|clobetasol|mesh-list
20516190|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20516191|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
20516192|NCT01703325|Hormones|hormones|mesh-ancestor
20516193|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516194|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516195|NCT01703351|Fentanyl|fentanyl|mesh-list
20516196|NCT01703351|Ropivacaine|ropivacaine|mesh-list
20516197|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
20516198|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
20516199|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516200|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516201|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
20516202|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516203|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20516204|NCT01703351|Narcotics|narcotics|mesh-ancestor
20516205|NCT01703351|Analgesics|analgesics|mesh-ancestor
20516206|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20516207|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20516208|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
20516209|NCT01703364|Lenalidomide|lenalidomide|mesh-list
20516210|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
20516211|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516212|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516213|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516214|NCT01703364|Growth Substances|growth substances|mesh-ancestor
20516215|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516216|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516217|NCT01703390|Cetuximab|cetuximab|mesh-list
20516218|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516219|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516220|NCT01703455|Sorafenib|sorafenib|mesh-list
20516221|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516222|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20516223|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516224|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516225|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
20516226|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
20516227|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20516228|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20516229|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516230|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516231|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20516232|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20516233|NCT01703559|Phentolamine|phentolamine|mesh-list
19415711|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20516234|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20516235|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20516236|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20516237|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20516238|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
20516239|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415712|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415713|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19415714|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415715|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415716|NCT02733432|Fluconazole|fluconazole|mesh-list
19415717|NCT02733432|Rezafungin|rezafungin|mesh-list
19702243|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
20516240|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516241|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516242|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20516243|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
20516244|NCT01703624|Bromides|bromides|mesh-list
20516245|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
20516246|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20516247|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20516248|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20516249|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
20516250|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516251|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516252|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516253|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20516254|NCT01703637|Vildagliptin|vildagliptin|mesh-list
20516255|NCT01703637|Saxagliptin|saxagliptin|mesh-list
20516256|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516257|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516258|NCT01703637|Incretins|incretins|mesh-ancestor
20516259|NCT01703637|Hormones|hormones|mesh-ancestor
20516260|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516261|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20516262|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
20516263|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516264|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516265|NCT01703728|Menotropins|menotropins|mesh-list
20516266|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20516267|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
20516268|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20516269|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516270|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
20516271|NCT01703754|Ifosfamide|ifosfamide|mesh-list
20516272|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20516273|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
20244901|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
20244902|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
20244903|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20244904|NCT00421980|Etanercept|etanercept|mesh-list
20244905|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244906|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244907|NCT00421980|Analgesics|analgesics|mesh-ancestor
20244908|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
20244909|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244910|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529884|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
20516274|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516275|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516276|NCT01703910|Gemcitabine|gemcitabine|mesh-list
20516277|NCT01703910|Paclitaxel|paclitaxel|mesh-list
20516278|NCT01703910|Etoposide|etoposide|mesh-list
20516279|NCT01703910|Vinorelbine|vinorelbine|mesh-list
20516280|NCT01703910|Docetaxel|docetaxel|mesh-list
20516281|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20516282|NCT01703910|Cisplatin|cisplatin|mesh-list
20516283|NCT01703910|Doxorubicin|doxorubicin|mesh-list
20516284|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20516285|NCT01703910|Fluorouracil|fluorouracil|mesh-list
20516286|NCT01703910|Capecitabine|capecitabine|mesh-list
20516287|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
20516288|NCT01703910|Irinotecan|irinotecan|mesh-list
20516289|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
19702244|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516290|NCT01703910|Pemetrexed|pemetrexed|mesh-list
20516291|NCT01703910|Cetuximab|cetuximab|mesh-list
20516292|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20516293|NCT01703910|Sorafenib|sorafenib|mesh-list
20516294|NCT01703910|Topotecan|topotecan|mesh-list
20516295|NCT01703910|Dasatinib|dasatinib|mesh-list
20516296|NCT01703910|Mitomycins|mitomycins|mesh-list
20516297|NCT01703910|Mitomycin|mitomycin|mesh-list
20516298|NCT01703910|Raltitrexed|raltitrexed|mesh-list
20516299|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20516300|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516301|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516302|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
20516303|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
20516304|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516305|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20516306|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
19415718|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
20516307|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
20516308|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516309|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516310|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516311|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
20516312|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516313|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20516314|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20516315|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20516316|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20516317|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20516318|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20516319|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516320|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20516321|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
20516322|NCT01704027|Androgens|androgens|mesh-list
20516323|NCT01704027|Hormones|hormones|mesh-ancestor
20516324|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516325|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516326|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
20516327|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20516328|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244911|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244912|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244913|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244914|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244915|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
20244916|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20244917|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
20244918|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244919|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20244920|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20244921|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244922|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244923|NCT00422175|Siponimod|siponimod|mesh-list
20244924|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20244925|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244926|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244927|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
20244928|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244929|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
20244930|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20244931|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20244932|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20244933|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
20244934|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20516329|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244935|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20244936|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20244937|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20244938|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244939|NCT00422240|Adapalene|adapalene|mesh-list
20244940|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20244941|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20244942|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
20244943|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20244944|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20244945|NCT00422240|Analgesics|analgesics|mesh-ancestor
20244946|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
20244947|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20244948|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244949|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20244950|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244951|NCT00422318|Benzbromarone|benzbromarone|mesh-list
20244952|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
19702245|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702246|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20244953|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
20244954|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20244955|NCT00422318|Renal Agents|renal agents|mesh-ancestor
20244956|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
20244957|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
20244958|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20244959|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244960|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244961|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
20244962|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20516330|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20516331|NCT01704092|Analgesics|analgesics|mesh-ancestor
20516332|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
20516333|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516334|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20516335|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20516336|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20516337|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
20516338|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516339|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516340|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20516341|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20516342|NCT01704339|Capsaicin|capsaicin|mesh-list
20516343|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
20516344|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
20516345|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
20516346|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19853839|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
19853840|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19853841|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
19853842|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853843|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19853844|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19853845|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853846|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853847|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19853848|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20516347|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516348|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
19853849|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
19853850|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19853851|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244963|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702247|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19702248|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19702249|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702250|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702251|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19702252|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19702253|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702254|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
19702255|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19702256|NCT04873596|Midazolam|midazolam|mesh-list
19702257|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
20244964|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244965|NCT00422344|Sunitinib|sunitinib|mesh-list
20516349|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
20516350|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516351|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516352|NCT01704417|Insulin|insulin|mesh-list
20516353|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20516354|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
20516355|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516356|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702258|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19415719|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20244966|NCT00422344|Everolimus|everolimus|mesh-list
20244967|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244968|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20244969|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20244970|NCT00422344|Growth Substances|growth substances|mesh-ancestor
20244971|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244972|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
20244973|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20244974|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20244975|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244976|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20244977|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
20244978|NCT00422396|Fenofibrate|fenofibrate|mesh-list
20244979|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20244980|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
20516357|NCT01704469|Anesthetics|anesthetics|mesh-list
20516358|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
20516359|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516360|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516361|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
20516362|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516363|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
20516364|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20516365|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
20516366|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516367|NCT01704482|Expectorants|expectorants|mesh-ancestor
20516368|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
20244981|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516369|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20244982|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20244983|NCT00422435|Paclitaxel|paclitaxel|mesh-list
19702259|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702260|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702261|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19702262|NCT04873596|Analgesics|analgesics|mesh-ancestor
19702263|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
19702264|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702265|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19702266|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19702267|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19702268|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
19702269|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19702270|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702271|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19702272|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19702273|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19702274|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19702275|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19702276|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
19702277|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
19702278|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
19702279|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
19853852|NCT00734968|Renal Agents|renal agents|mesh-ancestor
19853853|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19853854|NCT00734994|Mitomycins|mitomycins|mesh-list
19853855|NCT00734994|Mitomycin|mitomycin|mesh-list
20244984|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20244985|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244986|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516370|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
20516371|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516372|NCT01704482|Protective Agents|protective agents|mesh-ancestor
20516373|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516374|NCT01704482|Antidotes|antidotes|mesh-ancestor
20516375|NCT01704508|Lumefantrine|lumefantrine|mesh-list
20516376|NCT01704508|Artemether|artemether|mesh-list
20516377|NCT01704508|Piperaquine|piperaquine|mesh-list
20516378|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20516379|NCT01704508|Artenimol|artenimol|mesh-list
20516380|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
20516381|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20516382|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20516383|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516384|NCT01704534|Ustekinumab|ustekinumab|mesh-list
20516385|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
20516386|NCT01704612|Ropivacaine|ropivacaine|mesh-list
19853856|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20516387|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
20244987|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
20244988|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
20244989|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20244990|NCT00422526|Progesterone|progesterone|mesh-list
20244991|NCT00422526|Progestins|progestins|mesh-ancestor
20244992|NCT00422526|Hormones|hormones|mesh-ancestor
20244993|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20244994|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248049|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248050|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516388|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
20516389|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516390|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516391|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
20516392|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516393|NCT01704638|Digoxin|digoxin|mesh-list
20516394|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
20516395|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20516396|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20516397|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516398|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702280|NCT04854434|Trifluridine|trifluridine|mesh-list
19702281|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
20516399|NCT01704638|Protective Agents|protective agents|mesh-ancestor
20516400|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516401|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20516402|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20516403|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516404|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20516405|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20516406|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20516407|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516408|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516409|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
20516410|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20516411|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
19702282|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702283|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702284|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
19702285|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702286|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
19702287|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702288|NCT04795336|Melatonin|melatonin|mesh-list
19702289|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
19702290|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702291|NCT04795336|Protective Agents|protective agents|mesh-ancestor
19702292|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702293|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702294|NCT04685876|Bupivacaine|bupivacaine|mesh-list
19702295|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
19702296|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
19702297|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702298|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702299|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
20516412|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20516413|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20516414|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20529885|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529886|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20529887|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19702300|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702301|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20529888|NCT01784978|Growth Substances|growth substances|mesh-ancestor
20529889|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
20529890|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20529891|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529892|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529893|NCT01785004|Vitamin D|vitamin d|mesh-list
20529894|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
20529895|NCT01785004|Vitamins|vitamins|mesh-ancestor
20529896|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
19702302|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19702303|NCT04676399|Diuretics|diuretics|mesh-ancestor
19702304|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
19702305|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529897|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529898|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20529899|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20529900|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
20529901|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20529902|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
20529903|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
20529904|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529905|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529906|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20529907|NCT01785030|Analgesics|analgesics|mesh-ancestor
20529908|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
19702306|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19702307|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19702308|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702309|NCT04659603|Maytansine|maytansine|mesh-list
19702310|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702311|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702312|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702313|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
19702314|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
19702315|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708084|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19708085|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19708086|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708087|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708088|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708089|NCT04820010|Insulin|insulin|mesh-list
19708090|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19708091|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708092|NCT04819776|Iloperidone|iloperidone|mesh-list
20516415|NCT01704690|Paclitaxel|paclitaxel|mesh-list
20516416|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20516417|NCT01704690|Cisplatin|cisplatin|mesh-list
20516418|NCT01704690|Fluorouracil|fluorouracil|mesh-list
20516419|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20516420|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516421|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516422|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
20516423|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
20516424|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516425|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
20516426|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20516427|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516428|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
20516429|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516430|NCT01704703|Panitumumab|panitumumab|mesh-list
19708093|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19708094|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19708095|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708096|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708097|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19708098|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
19708099|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19708100|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708101|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708102|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19708103|NCT04820101|Analgesics|analgesics|mesh-ancestor
19708104|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
19708105|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708106|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19708107|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19708108|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19708109|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
19708110|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708111|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708112|NCT04819867|Propolis|propolis|mesh-list
19708113|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708114|NCT04819503|Anesthetics|anesthetics|mesh-list
19708115|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708116|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708117|NCT04819438|Riluzole|riluzole|mesh-list
19708118|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
19708119|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19708120|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19708121|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708122|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708123|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20244995|NCT00422565|Sirolimus|sirolimus|mesh-list
20516431|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516432|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516433|NCT01704716|Aldesleukin|aldesleukin|mesh-list
20516434|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
20516435|NCT01704716|Melphalan|melphalan|mesh-list
20516436|NCT01704716|Busulfan|busulfan|mesh-list
20516437|NCT01704716|Carboplatin|carboplatin|mesh-list
20516438|NCT01704716|Doxorubicin|doxorubicin|mesh-list
20516439|NCT01704716|Etoposide|etoposide|mesh-list
20516440|NCT01704716|Vincristine|vincristine|mesh-list
20516441|NCT01704716|Interleukin-2|interleukin-2|mesh-list
20516442|NCT01704716|Dinutuximab|dinutuximab|mesh-list
20516443|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516444|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
20516445|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516446|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20516447|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20516448|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
20516449|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516450|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702316|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
19702317|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19702318|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702319|NCT04576962|Vaccines|vaccines|mesh-list
20516451|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20516452|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20516453|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20516454|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20516455|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516456|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20516457|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516458|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
20516459|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
19702320|NCT04576962|Immunologic Factors|immunologic factors|mesh-ancestor
19702321|NCT04576962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702322|NCT04569045|Lidocaine|lidocaine|mesh-list
19702323|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
19702324|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
19702325|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702326|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702327|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
19702328|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516460|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20516461|NCT01704716|Analgesics|analgesics|mesh-ancestor
20516462|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
20516463|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516464|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20516465|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20516466|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
20516467|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516468|NCT01704794|Folic Acid|folic acid|mesh-list
20516469|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
20516470|NCT01704794|Proguanil|proguanil|mesh-list
20516471|NCT01704794|Hematinics|hematinics|mesh-ancestor
20516472|NCT01704794|Vitamins|vitamins|mesh-ancestor
20516473|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
20516474|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516475|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
20516476|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20516477|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20516478|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516479|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
20516480|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516481|NCT01704872|Dinutuximab|dinutuximab|mesh-list
20516482|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516483|NCT01704898|Efavirenz|efavirenz|mesh-list
20516484|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20516485|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20516486|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516487|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516488|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
20516489|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516490|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20516491|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20516492|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20516493|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20516494|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20516495|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20516496|NCT01705002|Bevacizumab|bevacizumab|mesh-list
20516497|NCT01705002|Capecitabine|capecitabine|mesh-list
20516498|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516499|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516500|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516501|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516502|NCT01705002|Growth Substances|growth substances|mesh-ancestor
20516503|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516504|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516505|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20516506|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
20516507|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516508|NCT01705041|Liver Extracts|liver extracts|mesh-list
20516509|NCT01705041|Hematinics|hematinics|mesh-ancestor
20516510|NCT01705158|Carboplatin|carboplatin|mesh-list
20516511|NCT01705158|Doxorubicin|doxorubicin|mesh-list
20516512|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20516513|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516514|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20516515|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20516516|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20516517|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516518|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516519|NCT01705184|Bevacizumab|bevacizumab|mesh-list
19702329|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19702330|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19702331|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19702332|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19702333|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702334|NCT04550195|Famotidine|famotidine|mesh-list
19702335|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19702336|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20516520|NCT01705184|Pemetrexed|pemetrexed|mesh-list
20516521|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516522|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702337|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20516523|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516524|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516525|NCT01705184|Growth Substances|growth substances|mesh-ancestor
20516526|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516527|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516528|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516529|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516530|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20516531|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20516532|NCT01705223|Vaccines|vaccines|mesh-list
20516533|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
20516534|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516535|NCT01705249|Norethindrone|norethindrone|mesh-list
20516536|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
20516537|NCT01705249|Estradiol|estradiol|mesh-list
20244996|NCT00422565|Paclitaxel|paclitaxel|mesh-list
20516538|NCT01705249|Estrogens|estrogens|mesh-ancestor
20516539|NCT01705249|Hormones|hormones|mesh-ancestor
20516540|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516541|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516542|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20516543|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
20516544|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20516545|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20516546|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20516547|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20516548|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20516549|NCT01705314|Vitamin D|vitamin d|mesh-list
20516550|NCT01705314|Vitamins|vitamins|mesh-ancestor
20516551|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
20516552|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516553|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20516554|NCT01705340|Trastuzumab|trastuzumab|mesh-list
20516555|NCT01705340|Lapatinib|lapatinib|mesh-list
20516556|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516557|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516558|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19702338|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
19702339|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
19702340|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19702341|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702342|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702343|NCT04537962|Listerine|listerine|mesh-list
19702344|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
19702345|NCT04537962|Fluorides|fluorides|mesh-list
20516559|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516560|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516561|NCT01705379|Lactitol|lactitol|mesh-list
20516562|NCT01705379|Cathartics|cathartics|mesh-ancestor
20516563|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20516564|NCT01705392|Bevacizumab|bevacizumab|mesh-list
19702346|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
20516565|NCT01705392|Dacarbazine|dacarbazine|mesh-list
20516566|NCT01705392|Propranolol|propranolol|mesh-list
20516567|NCT01705392|Enalapril|enalapril|mesh-list
20516568|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516569|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516570|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516571|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516572|NCT01705392|Growth Substances|growth substances|mesh-ancestor
20516573|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516574|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516575|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20516576|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20516577|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
20516578|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516579|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516580|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20516581|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20516582|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
20516583|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20516584|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
20516585|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20516586|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
20516587|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516588|NCT01705457|Vitamin A|vitamin a|mesh-list
19702347|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
19702348|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
20516589|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
20516590|NCT01705457|Vitamins|vitamins|mesh-ancestor
20516591|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
20516592|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516593|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
20516594|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516595|NCT01705457|Protective Agents|protective agents|mesh-ancestor
20516596|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20516597|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516598|NCT01705470|Furosemide|furosemide|mesh-list
20516599|NCT01705470|Diuretics|diuretics|mesh-ancestor
20516600|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
20516601|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516602|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20516603|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516604|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516605|NCT01705483|Paclitaxel|paclitaxel|mesh-list
20516606|NCT01705483|Docetaxel|docetaxel|mesh-list
19702349|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
19702350|NCT04537962|Protective Agents|protective agents|mesh-ancestor
19702351|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702352|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19702353|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702354|NCT04525391|Durvalumab|durvalumab|mesh-list
19702355|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702356|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516607|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20516608|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516609|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516610|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
20516611|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
20516612|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516613|NCT01705639|Melatonin|melatonin|mesh-list
20516614|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
20516615|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516616|NCT01705639|Protective Agents|protective agents|mesh-ancestor
20516617|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516618|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516619|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
20516620|NCT01705743|Sevoflurane|sevoflurane|mesh-list
20516621|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20516622|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20516623|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
20516624|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
20516625|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516626|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516627|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20516628|NCT01705743|Analgesics|analgesics|mesh-ancestor
20516629|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
20516630|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516631|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20516632|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20516633|NCT01705769|Micronutrients|micronutrients|mesh-list
20516634|NCT01705769|Trace Elements|trace elements|mesh-list
19853857|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853858|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
19853859|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853860|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19853861|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516635|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516636|NCT01705795|Antibodies|antibodies|mesh-list
20516637|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
20516638|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516639|NCT01705808|Protein C|protein c|mesh-list
20516640|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
20516641|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20516642|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20516643|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516644|NCT01705938|Dolcanatide|dolcanatide|mesh-list
20516645|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20516646|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
20516647|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516648|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20516649|NCT01705951|Nicotine|nicotine|mesh-list
20516650|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20516651|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
20516652|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516653|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516654|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20516655|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20516656|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
20516657|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20244997|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20244998|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20244999|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516658|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516659|NCT01706055|Interferons|interferons|mesh-list
20516660|NCT01706055|Interferon-beta|interferon-beta|mesh-list
20516661|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
20516662|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516663|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
19853862|NCT00735072|Maraviroc|maraviroc|mesh-list
19853863|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19853864|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19853865|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853866|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19853867|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19853868|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
19853869|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19853870|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20516664|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516665|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
20516666|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516667|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20516668|NCT01706120|Paclitaxel|paclitaxel|mesh-list
20516669|NCT01706120|Bevacizumab|bevacizumab|mesh-list
20516670|NCT01706120|Carboplatin|carboplatin|mesh-list
20516671|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20516672|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516673|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
20516674|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
20516675|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
20516676|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516677|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516678|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516679|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516680|NCT01706120|Growth Substances|growth substances|mesh-ancestor
20516681|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516682|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516683|NCT01706172|Lidocaine|lidocaine|mesh-list
20516684|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
20516685|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
20516686|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516687|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516688|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
20516689|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516690|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20516691|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20516692|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20516693|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516694|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516695|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
20516696|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516697|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516698|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19853871|NCT00735306|Bevacizumab|bevacizumab|mesh-list
19702357|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
19702358|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19702359|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
19702360|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702361|NCT04481048|Expectorants|expectorants|mesh-ancestor
19702362|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
19702363|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19702364|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
19702365|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702366|NCT04481048|Protective Agents|protective agents|mesh-ancestor
19702367|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702368|NCT04481048|Antidotes|antidotes|mesh-ancestor
19702369|NCT04469530|Sirolimus|sirolimus|mesh-list
20516699|NCT01706354|Anesthetics|anesthetics|mesh-list
20516700|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
19702370|NCT04469530|Celecoxib|celecoxib|mesh-list
20516701|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516702|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516703|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
20516704|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516705|NCT01706367|Vaccines|vaccines|mesh-list
20516706|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
20516707|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529909|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529910|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20529911|NCT01785043|Liraglutide|liraglutide|mesh-list
20529912|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20529913|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529914|NCT01785043|Incretins|incretins|mesh-ancestor
20529915|NCT01785043|Hormones|hormones|mesh-ancestor
20529916|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702371|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
20529917|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20529918|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
20529919|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529920|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529921|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20529922|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
20529923|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529924|NCT01785108|Vitamin D|vitamin d|mesh-list
20529925|NCT01785108|Ibuprofen|ibuprofen|mesh-list
20529926|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
19702372|NCT04469530|Etoposide|etoposide|mesh-list
19702373|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702374|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
19702375|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702376|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702377|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19702378|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
19702379|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702380|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702381|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19702382|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702383|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19702384|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702385|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702386|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19702387|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702388|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19702389|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
20529927|NCT01785108|Vitamins|vitamins|mesh-ancestor
20529928|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
20529929|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516708|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
20516709|NCT01706471|Everolimus|everolimus|mesh-list
20516710|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516711|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516712|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
20516713|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516714|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20516715|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20516716|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
20516717|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20516718|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516719|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516720|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516721|NCT01706510|Clopidogrel|clopidogrel|mesh-list
20516722|NCT01706510|Ticagrelor|ticagrelor|mesh-list
20516723|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20516724|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20516725|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20516726|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20516727|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
20516728|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516729|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702390|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19702391|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19702392|NCT04469530|Analgesics|analgesics|mesh-ancestor
19702393|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
19702394|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702395|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20516730|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516731|NCT01706562|Itraconazole|itraconazole|mesh-list
20516732|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
20516733|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516734|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20516735|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20516736|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516737|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516738|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20516739|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
20516740|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516741|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516742|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20516743|NCT01706627|Melatonin|melatonin|mesh-list
20516744|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
20516745|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516746|NCT01706627|Protective Agents|protective agents|mesh-ancestor
20516747|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516748|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516749|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
20516750|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20516751|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516752|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20516753|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20516754|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516755|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516756|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516757|NCT01706874|Listerine|listerine|mesh-list
20516758|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20516759|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516760|NCT01706887|Amiloride|amiloride|mesh-list
19415720|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19415721|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19415722|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415723|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415724|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19415725|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
19415726|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415727|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415728|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19415729|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19415730|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
19415731|NCT02723162|Varenicline|varenicline|mesh-list
19415732|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19415733|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19415734|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19415735|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
19415736|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415737|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415738|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516761|NCT01706887|Diuretics|diuretics|mesh-ancestor
19415739|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
20516762|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
20516763|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516764|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20516765|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20516766|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516767|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516768|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20516769|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20516770|NCT01707082|Midazolam|midazolam|mesh-list
20516771|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20516772|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20516773|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415740|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516774|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516775|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20516776|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20516777|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20516778|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20516779|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
20516780|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
20516781|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
20516782|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
20516783|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516784|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516785|NCT01707134|Insulin|insulin|mesh-list
20516786|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20516787|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
20516788|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
20516789|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
20516790|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
20516791|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516792|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516793|NCT01707160|Insulin|insulin|mesh-list
20516794|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20516795|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
20516796|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
20516797|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20516798|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516799|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516800|NCT01707199|Artesunate|artesunate|mesh-list
20516801|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
20516802|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
20516803|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20516804|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
20516805|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20516806|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20516807|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516808|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516809|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
20516810|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
20516811|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20516812|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
20516813|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19702396|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19702397|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19702398|NCT04425291|Vaccines|vaccines|mesh-list
19702399|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
19702400|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702401|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
19702402|NCT04423055|Etonogestrel|etonogestrel|mesh-list
19702403|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19702404|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702405|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19702406|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20516814|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516815|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516816|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20516817|NCT01707199|Renal Agents|renal agents|mesh-ancestor
20516818|NCT01707251|Ibuprofen|ibuprofen|mesh-list
20516819|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20516820|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20516821|NCT01707251|Analgesics|analgesics|mesh-ancestor
19702407|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
20516822|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
20516823|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516824|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516825|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20516826|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20516827|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20516828|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516829|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516830|NCT01707316|Canagliflozin|canagliflozin|mesh-list
19702408|NCT04389073|Bevacizumab|bevacizumab|mesh-list
19702409|NCT04389073|Capecitabine|capecitabine|mesh-list
19702410|NCT04389073|Vinorelbine|vinorelbine|mesh-list
19702411|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702412|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
20516831|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20516832|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516833|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516834|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516835|NCT01707342|Simeprevir|simeprevir|mesh-list
20516836|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
20516837|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516838|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
20516839|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516840|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516841|NCT01707394|Apixaban|apixaban|mesh-list
20516842|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20516843|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
20516844|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20245000|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245001|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
20245002|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245003|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20245004|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516845|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
20516846|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516847|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516848|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
20516849|NCT01707407|Ketoconazole|ketoconazole|mesh-list
20516850|NCT01707407|Pomalidomide|pomalidomide|mesh-list
20516851|NCT01707407|Carbamazepine|carbamazepine|mesh-list
20516852|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
20245005|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20245006|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
20245007|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245008|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
20245009|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516853|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
20516854|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516855|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516856|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516857|NCT01707407|Growth Substances|growth substances|mesh-ancestor
20516858|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516859|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516860|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
19702413|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245010|NCT00422578|Tadalafil|tadalafil|mesh-list
20516861|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516862|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20516863|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20516864|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516865|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516866|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20245011|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
20245012|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20245013|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20516867|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
20516868|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516869|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20516870|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
20516871|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
20516872|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20516873|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516874|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20516875|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20516876|NCT01707407|Analgesics|analgesics|mesh-ancestor
20516877|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
20516878|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516879|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20516880|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516881|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20516882|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20516883|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20516884|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20516885|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20516886|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516887|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
20516888|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20516889|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
20516890|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20516891|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20516892|NCT01707537|Vaccines|vaccines|mesh-list
20516893|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
20516894|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516895|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
20516896|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
20516897|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516898|NCT01707615|Protective Agents|protective agents|mesh-ancestor
20516899|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245014|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245015|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516900|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20516901|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20516902|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516903|NCT01707628|Vaccines|vaccines|mesh-list
20516904|NCT01707628|Immunologic Factors|immunologic factors|mesh-ancestor
20516905|NCT01707628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516906|NCT01707732|Enoxaparin|enoxaparin|mesh-list
20516907|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
20516908|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20245016|NCT00422578|Urological Agents|urological agents|mesh-ancestor
20245017|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
20516909|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20516910|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516911|NCT01707745|Bevacizumab|bevacizumab|mesh-list
20516912|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20516913|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516914|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20516915|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516916|NCT01707745|Growth Substances|growth substances|mesh-ancestor
20245018|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20245019|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20245020|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
20245021|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516917|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702414|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702415|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19702416|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
19702417|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702418|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702419|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19702420|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702421|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19702422|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19702423|NCT04389073|Growth Substances|growth substances|mesh-ancestor
19702424|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
19702425|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19702426|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
19702427|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702428|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702429|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245022|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245023|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20245024|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
20245025|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
20245026|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20245027|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
20245028|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248051|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20516918|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516919|NCT01707823|Aspirin|aspirin|mesh-list
20516920|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19853872|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19853873|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19853874|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853875|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853876|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19853877|NCT00735306|Growth Substances|growth substances|mesh-ancestor
19853878|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516921|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20516922|NCT01707823|Analgesics|analgesics|mesh-ancestor
20516923|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
20516924|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516925|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516926|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20516927|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20516928|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20516929|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20516930|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516931|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20516932|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20516933|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516934|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
20516935|NCT01707849|Everolimus|everolimus|mesh-list
20516936|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20516937|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20516938|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
20516939|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516940|NCT01707940|Ketoconazole|ketoconazole|mesh-list
20516941|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
20516942|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20516943|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20516944|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20516945|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20516946|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516947|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20516948|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
20516949|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20516950|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516951|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20516952|NCT01707953|Midodrine|midodrine|mesh-list
20516953|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
20516954|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
20516955|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516956|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516957|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20516958|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20516959|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20516960|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20516961|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
19853879|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
20516962|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20516963|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516964|NCT01708005|Vitamin D|vitamin d|mesh-list
20516965|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
20516966|NCT01708005|Vitamins|vitamins|mesh-ancestor
20516967|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
20516968|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516969|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20516970|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20516971|NCT01708044|Pramlintide|pramlintide|mesh-list
19853880|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853881|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853882|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853883|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19853884|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19853885|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853886|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19853887|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20516972|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20516973|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529930|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20529931|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20529932|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20529933|NCT01785108|Analgesics|analgesics|mesh-ancestor
20529934|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
20529935|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529936|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20529937|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529938|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20529939|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529940|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529941|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20529942|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
20529943|NCT01785290|Haloperidol|haloperidol|mesh-list
20529944|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
20529945|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
20529946|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
20529947|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529948|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853888|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853889|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853890|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
19853891|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853892|NCT00735436|Bevacizumab|bevacizumab|mesh-list
19853893|NCT00735436|Irinotecan|irinotecan|mesh-list
19853894|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20529949|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20516974|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
20516975|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20516976|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20516977|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516978|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
19853895|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853896|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19853897|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20516979|NCT01708239|Coagulants|coagulants|mesh-ancestor
20516980|NCT01708330|Lidocaine|lidocaine|mesh-list
20516981|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
20516982|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
20516983|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20516984|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20516985|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
20516986|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20516987|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20516988|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20516989|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20516990|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20516991|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20516992|NCT01708369|Aspirin|aspirin|mesh-list
20516993|NCT01708369|Ethanol|ethanol|mesh-list
20516994|NCT01708369|Oseltamivir|oseltamivir|mesh-list
20516995|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20516996|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20516997|NCT01708369|Analgesics|analgesics|mesh-ancestor
20516998|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
20516999|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517000|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517001|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517002|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517003|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20517004|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20517005|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517006|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20517007|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20517008|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517009|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
20517010|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20517011|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517012|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517013|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
20517014|NCT01708447|Lidocaine|lidocaine|mesh-list
20517015|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
20517016|NCT01708447|Anesthetics|anesthetics|mesh-list
20517017|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517018|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517019|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
20517020|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517021|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20517022|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20517023|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20517024|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517025|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517026|NCT01708616|Risperidone|risperidone|mesh-list
20517027|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20517028|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
20517029|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517030|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517031|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853898|NCT00735436|Growth Substances|growth substances|mesh-ancestor
20517032|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20517033|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20517034|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517035|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20517036|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20517037|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
20517038|NCT01708642|Epinephrine|epinephrine|mesh-list
20517039|NCT01708642|Racepinephrine|racepinephrine|mesh-list
20517040|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
20517041|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20517042|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20517043|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
20517044|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517045|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517046|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517047|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20517048|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20517049|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
20517050|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517051|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20517052|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
20517053|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
20517054|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
20517055|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20517056|NCT01708707|Morphine|morphine|mesh-list
20517057|NCT01708707|Buprenorphine|buprenorphine|mesh-list
20517058|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20517059|NCT01708707|Narcotics|narcotics|mesh-ancestor
20517060|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517061|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517062|NCT01708707|Analgesics|analgesics|mesh-ancestor
20517063|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
20517064|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517065|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20517066|NCT01708720|Vaccines|vaccines|mesh-list
20517067|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
20517068|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517069|NCT01708798|Eplerenone|eplerenone|mesh-list
20517070|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20517071|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
20517072|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702430|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
19702431|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
19702432|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702433|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702434|NCT04371445|Dexamethasone|dexamethasone|mesh-list
19702435|NCT04371445|Prednisolone|prednisolone|mesh-list
19702436|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19702437|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
19702438|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19702439|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
19702440|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19702441|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
19702442|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853899|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853900|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
19853901|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19853902|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19853903|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853904|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853905|NCT00735449|Timolol|timolol|mesh-list
19853906|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19853907|NCT00735449|Latanoprost|latanoprost|mesh-list
19853908|NCT00735449|Maleic acid|maleic acid|mesh-list
19853909|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19853910|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19853911|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
19853912|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853913|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853914|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853915|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19853916|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517073|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702443|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
19702444|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
20517074|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20517075|NCT01708798|Diuretics|diuretics|mesh-ancestor
20517076|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
20517077|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517078|NCT01708837|Propofol|propofol|mesh-list
20517079|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20517080|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517081|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517082|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20517083|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
20517084|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
20517085|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
20517086|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20517087|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
20517088|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20517089|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
20517090|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517091|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517092|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
20517093|NCT01708876|Artesunate|artesunate|mesh-list
20517094|NCT01708876|Chloroquine|chloroquine|mesh-list
20517095|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20517096|NCT01708876|Primaquine|primaquine|mesh-list
20517097|NCT01708876|Mefloquine|mefloquine|mesh-list
20517098|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
20517099|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19702445|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702446|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702447|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702448|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
19702449|NCT04371445|Hormones|hormones|mesh-ancestor
19702450|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702451|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702452|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702453|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19702454|NCT04371445|Protective Agents|protective agents|mesh-ancestor
20517100|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20517101|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517102|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702455|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
19702456|NCT04357782|Vitamins|vitamins|mesh-ancestor
19702457|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
19702458|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517103|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
20517104|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
20517105|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20517106|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
20517107|NCT01708876|Amebicides|amebicides|mesh-ancestor
20517108|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517109|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20517110|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19853917|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853918|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19853919|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20517111|NCT01708876|Analgesics|analgesics|mesh-ancestor
20517112|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
20245029|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245030|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20517113|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517114|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517115|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517116|NCT01708876|Filaricides|filaricides|mesh-ancestor
20517117|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
19702459|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
19702460|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702461|NCT04357782|Protective Agents|protective agents|mesh-ancestor
19702462|NCT04337073|Propofol|propofol|mesh-list
19702463|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19853920|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20245031|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20245032|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20245033|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
20245034|NCT00422617|Alefacept|alefacept|mesh-list
20245035|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
20245036|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
20245037|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517118|NCT01708993|Docetaxel|docetaxel|mesh-list
20517119|NCT01708993|Pemetrexed|pemetrexed|mesh-list
20517120|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517121|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
20517122|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
20517123|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
20517124|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517125|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517126|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20517127|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20517128|NCT01709019|Vaccines|vaccines|mesh-list
20517129|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
20517130|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517131|NCT01709071|Vaccines|vaccines|mesh-list
20517132|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
20517133|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517134|NCT01709123|Chromium|chromium|mesh-list
20517135|NCT01709123|Trace Elements|trace elements|mesh-ancestor
20517136|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
20245038|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
20517137|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517138|NCT01709292|Vemurafenib|vemurafenib|mesh-list
20517139|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517140|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20517141|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517142|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517143|NCT01709370|Letrozole|letrozole|mesh-list
20517144|NCT01709370|Palbociclib|palbociclib|mesh-list
20517145|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517146|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20517147|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20517148|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517149|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517150|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20517151|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
20517152|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517153|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517154|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20245039|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20245040|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
20245041|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245042|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
20245043|NCT00422643|Protective Agents|protective agents|mesh-ancestor
20245044|NCT00422682|Gemcitabine|gemcitabine|mesh-list
20245045|NCT00422682|Paclitaxel|paclitaxel|mesh-list
20517155|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
20517156|NCT01709630|Analgesics|analgesics|mesh-ancestor
20517157|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
20245046|NCT00422682|Carboplatin|carboplatin|mesh-list
20245047|NCT00422682|Temozolomide|temozolomide|mesh-list
20245048|NCT00422682|Topotecan|topotecan|mesh-list
20245049|NCT00422682|Iniparib|iniparib|mesh-list
20245050|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20245051|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245052|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
20245053|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245054|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
20517158|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702464|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19702465|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517159|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517160|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
20517161|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517162|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20517163|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
20517164|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20517165|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517166|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517167|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20517168|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
20517169|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517170|NCT01709656|Celecoxib|celecoxib|mesh-list
20517171|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20517172|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20517173|NCT01709656|Analgesics|analgesics|mesh-ancestor
20517174|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
20517175|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517176|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517177|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517178|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517179|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20517180|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20517181|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245055|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245056|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20517182|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517183|NCT01709682|Amiodarone|amiodarone|mesh-list
20517184|NCT01709682|Sotalol|sotalol|mesh-list
20517185|NCT01709682|Flecainide|flecainide|mesh-list
20517186|NCT01709682|Propafenone|propafenone|mesh-list
20517187|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20517188|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
20517189|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20517190|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19702466|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19702467|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
19702468|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
20245057|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
20245058|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
20245059|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245060|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245061|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245062|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
20245063|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517191|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517192|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20517193|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20517194|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20517195|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517196|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20517197|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20517198|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20517199|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20517200|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20517201|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
20517202|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517203|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517204|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
20517205|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
20517206|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517207|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20517208|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
20517209|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517210|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517211|NCT01709760|Methotrexate|methotrexate|mesh-list
20517212|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20517213|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
20517214|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20245064|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19702469|NCT04316806|Rifaximin|rifaximin|mesh-list
19702470|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19702471|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702472|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702473|NCT04311606|Aflibercept|aflibercept|mesh-list
19702474|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20517215|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517216|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20517217|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
20517218|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517219|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517220|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
19702475|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19702476|NCT04311606|Growth Substances|growth substances|mesh-ancestor
20517221|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517222|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20517223|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517224|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
19702477|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702478|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
19702479|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702480|NCT04309916|Esomeprazole|esomeprazole|mesh-list
19702481|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19853921|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19853922|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19853923|NCT00735462|Imiquimod|imiquimod|mesh-list
19853924|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19853925|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
19853926|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853927|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853928|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
19853929|NCT00735475|Vaccines|vaccines|mesh-list
19853930|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
19853931|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415741|NCT02723162|Expectorants|expectorants|mesh-ancestor
19855636|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19415742|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
19415743|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19415744|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
19415745|NCT02723162|Protective Agents|protective agents|mesh-ancestor
19415746|NCT02723162|Antidotes|antidotes|mesh-ancestor
19415747|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19415748|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19415749|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19415750|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415751|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415752|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20517225|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517226|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20517227|NCT01709825|Sulfalene|sulfalene|mesh-list
20517228|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517229|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20517230|NCT01709825|Renal Agents|renal agents|mesh-ancestor
20517231|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
19415753|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415754|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415755|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
19415756|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415757|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
20517232|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19415758|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20517233|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20517234|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
20517235|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20517236|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517237|NCT01709942|Cetrorelix|cetrorelix|mesh-list
20517238|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20517239|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
20517240|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517241|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517242|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
20517243|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517244|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20517245|NCT01709955|Cathartics|cathartics|mesh-ancestor
20517246|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517247|NCT01709994|Aspirin|aspirin|mesh-list
20517248|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20517249|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20517250|NCT01709994|Analgesics|analgesics|mesh-ancestor
20517251|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
20517252|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517253|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517254|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517255|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517256|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20517257|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19415759|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517258|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517259|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20517260|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20517261|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517262|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
20517263|NCT01710007|Atorvastatin|atorvastatin|mesh-list
20517264|NCT01710007|Pitavastatin|pitavastatin|mesh-list
20517265|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20517266|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20517267|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
20517268|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517269|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20517270|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20517271|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517272|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
20517273|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
20517274|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517275|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517276|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517277|NCT01710072|Aspirin|aspirin|mesh-list
20517278|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19702482|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702483|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19702484|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702485|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702486|NCT04284397|Aspirin|aspirin|mesh-list
19702487|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20517279|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20517280|NCT01710072|Analgesics|analgesics|mesh-ancestor
20517281|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
20517282|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517283|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517284|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517285|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517286|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20517287|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20517288|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517289|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20517290|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20517291|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517292|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
20529950|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20529951|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20529952|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529953|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20529954|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20529955|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
20529956|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529957|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529958|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20529959|NCT01785446|Sufentanil|sufentanil|mesh-list
20529960|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
20529961|NCT01785446|Dsuvia|dsuvia|mesh-list
20529962|NCT01785446|Atracurium|atracurium|mesh-list
20529963|NCT01785446|Cisatracurium|cisatracurium|mesh-list
20529964|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20529965|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20529966|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529967|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20529968|NCT01785446|Analgesics|analgesics|mesh-ancestor
20529969|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
20529970|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529971|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19702488|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19702489|NCT04284397|Analgesics|analgesics|mesh-ancestor
20517293|NCT01710163|Aripiprazole|aripiprazole|mesh-list
20517294|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
20517295|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20517296|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20517297|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19702490|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
19702491|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702492|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702493|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517298|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517299|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517300|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
20517301|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
20517302|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517303|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517304|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20517305|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20517306|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
19702494|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517307|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20517308|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20517309|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20517310|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20517311|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
20517312|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517313|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
20517314|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20517315|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20517316|NCT01710228|Prednisolone|prednisolone|mesh-list
20517317|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
20517318|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20517319|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
19415760|NCT02700529|Ubenimex|ubenimex|mesh-list
20517320|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517321|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
20245065|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
20245066|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20245067|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20245068|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20245069|NCT00422708|Anesthetics|anesthetics|mesh-list
20245070|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245071|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517322|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
19853932|NCT00735644|Vaccines|vaccines|mesh-list
19853933|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
19853934|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853935|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19853936|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19853937|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20245072|NCT00422773|Cetuximab|cetuximab|mesh-list
20517323|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517324|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517325|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517326|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
20517327|NCT01710228|Hormones|hormones|mesh-ancestor
20517328|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517329|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20517330|NCT01710228|Protective Agents|protective agents|mesh-ancestor
20517331|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20517332|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517333|NCT01710384|Betamethasone|betamethasone|mesh-list
20517334|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415761|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19415762|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
19415763|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415764|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19415765|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415766|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19415767|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517335|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
20517336|NCT01710384|Hormones|hormones|mesh-ancestor
20517337|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517338|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517339|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20517340|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
20517341|NCT01710462|Domperidone|domperidone|mesh-list
20517342|NCT01710462|Pantoprazole|pantoprazole|mesh-list
20517343|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20517344|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517345|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20517346|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517347|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517348|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
20517349|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
20517350|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517351|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517352|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20517353|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
20517354|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517355|NCT01710488|Levofloxacin|levofloxacin|mesh-list
20517356|NCT01710488|Ofloxacin|ofloxacin|mesh-list
20517357|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
20517358|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20517359|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517360|NCT01710488|Renal Agents|renal agents|mesh-ancestor
20517361|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20517362|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20517363|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20517364|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517365|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517366|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517367|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20517368|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20517369|NCT01710540|Metformin|metformin|mesh-list
20517370|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20517371|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517372|NCT01710553|Metformin|metformin|mesh-list
20517373|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20517374|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517375|NCT01710566|Misoprostol|misoprostol|mesh-list
20517376|NCT01710566|Oxytocin|oxytocin|mesh-list
20517377|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
20517378|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517379|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517380|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20517381|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
20517382|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20517383|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517384|NCT01710592|Docetaxel|docetaxel|mesh-list
20517385|NCT01710592|Capecitabine|capecitabine|mesh-list
20517386|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
20517387|NCT01710592|Epirubicin|epirubicin|mesh-list
20517388|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517389|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
20517390|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
20517391|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
20517392|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517393|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20517394|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
20517395|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20517396|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20517397|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20517398|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517399|NCT01710631|Eszopiclone|eszopiclone|mesh-list
19702495|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19702496|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19708124|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20517400|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20517401|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517402|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517403|NCT01710670|Ethanol|ethanol|mesh-list
20517404|NCT01710670|Brivaracetam|brivaracetam|mesh-list
20517405|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20517406|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517407|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517408|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517409|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
20517410|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20517411|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20517412|NCT01710696|Estradiol|estradiol|mesh-list
19702497|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517413|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20517414|NCT01710696|Estrogens|estrogens|mesh-ancestor
20517415|NCT01710696|Hormones|hormones|mesh-ancestor
20517416|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517417|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517418|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20517419|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
20517420|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517421|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20517422|NCT01710722|Ephedrine|ephedrine|mesh-list
20517423|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
20517424|NCT01710722|Caffeine|caffeine|mesh-list
20517425|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20517426|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517427|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20517428|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517429|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517430|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20517431|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20517432|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
20517433|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517434|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
20517435|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
20517436|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517437|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20517438|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
20517439|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20517440|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20517441|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
20517442|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
20517443|NCT01710748|Everolimus|everolimus|mesh-list
20517444|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517445|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517446|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
20517447|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517448|NCT01710761|Caffeine|caffeine|mesh-list
20517449|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20517450|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517451|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20517452|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517453|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517454|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20517455|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20517456|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
20517457|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517458|NCT01710904|Oxycodone|oxycodone|mesh-list
20517459|NCT01710904|Naloxone|naloxone|mesh-list
20517460|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20517461|NCT01710904|Narcotics|narcotics|mesh-ancestor
20517462|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517463|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517464|NCT01710904|Analgesics|analgesics|mesh-ancestor
20517465|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
20517466|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517467|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20517468|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
20517469|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20517470|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517471|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517472|NCT01711060|Oxytocin|oxytocin|mesh-list
20517473|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
20517474|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517475|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517476|NCT01711073|Plerixafor|plerixafor|mesh-list
20517477|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20517478|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20517479|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
20517480|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517481|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
20517482|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19702498|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20517483|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
20517484|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702499|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20517485|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517486|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20517487|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
20517488|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20517489|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20517490|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20517491|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
20517492|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517493|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517494|NCT01711112|Docetaxel|docetaxel|mesh-list
20517495|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517496|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
20517497|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
20517498|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
20517499|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517500|NCT01711125|Baclofen|baclofen|mesh-list
20517501|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20517502|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517503|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19702500|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702501|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
19702502|NCT04275999|Ivermectin|ivermectin|mesh-list
19702503|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19702504|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517504|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517505|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20517506|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
20517507|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
20517508|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517509|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517510|NCT01711229|Acetaminophen|acetaminophen|mesh-list
20517511|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20517512|NCT01711229|Analgesics|analgesics|mesh-ancestor
20517513|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
20517514|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517515|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517516|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
20517517|NCT01711320|Omeprazole|omeprazole|mesh-list
20517518|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20517519|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517520|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20517521|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517522|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517523|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
20517524|NCT01711437|Simethicone|simethicone|mesh-list
20517525|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
20517526|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
20517527|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20517528|NCT01711437|Citric Acid|citric acid|mesh-list
20517529|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
19702505|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19702506|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
19702507|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19702508|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702509|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702510|NCT04245215|Ustekinumab|ustekinumab|mesh-list
19702511|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
19702512|NCT04189107|Dexamethasone|dexamethasone|mesh-list
20517530|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20517531|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
20517532|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20517533|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
20517534|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
20517535|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517536|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
20517537|NCT01711437|Protective Agents|protective agents|mesh-ancestor
20517538|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517539|NCT01711437|Vitamins|vitamins|mesh-ancestor
20517540|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
20517541|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
20517542|NCT01711437|Emollients|emollients|mesh-ancestor
20517543|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
20517544|NCT01711437|Cathartics|cathartics|mesh-ancestor
20517545|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517546|NCT01711437|Antacids|antacids|mesh-ancestor
20517547|NCT01711437|Laxatives|laxatives|mesh-ancestor
20517548|NCT01711463|Fluticasone|fluticasone|mesh-list
20517549|NCT01711463|Xhance|xhance|mesh-list
20517550|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517551|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20517552|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
20517553|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517554|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517555|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20517556|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20517557|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
20517558|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20517559|NCT01711476|Complement Factor H|complement factor h|mesh-list
19702513|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
19702514|NCT04189107|BB 1101|bb 1101|mesh-list
20517560|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20517561|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517562|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
20517563|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517564|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
20517565|NCT01711489|Isavuconazole|isavuconazole|mesh-list
20517566|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20517567|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517568|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20517569|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
20517570|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20517571|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517572|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517573|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517574|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
20517575|NCT01711515|Cisplatin|cisplatin|mesh-list
20517576|NCT01711515|Ipilimumab|ipilimumab|mesh-list
20517577|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517578|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20517579|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20517580|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517581|NCT01711528|Dexamethasone|dexamethasone|mesh-list
20517582|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
20517583|NCT01711528|Bortezomib|bortezomib|mesh-list
20517584|NCT01711528|Ichthammol|ichthammol|mesh-list
20517585|NCT01711528|BB 1101|bb 1101|mesh-list
20517586|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517587|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
20517588|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
20517589|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517590|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517591|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702515|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702516|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
19702517|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
19702518|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702519|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702520|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702521|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
19853938|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517592|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
20517593|NCT01711528|Hormones|hormones|mesh-ancestor
20517594|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517595|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20517596|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517597|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
20517598|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517599|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517600|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
20245073|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245074|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517601|NCT01711567|Tenofovir|tenofovir|mesh-list
20517602|NCT01711567|Entecavir|entecavir|mesh-list
20245075|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
20517603|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
20517604|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702522|NCT04189107|Hormones|hormones|mesh-ancestor
20517605|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20517606|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20517607|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517608|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517609|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20517610|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20517611|NCT01711671|Dexamethasone|dexamethasone|mesh-list
20517612|NCT01711671|Lenalidomide|lenalidomide|mesh-list
19702523|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245076|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517613|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517614|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
20517615|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
20517616|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517617|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517618|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517619|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
20517620|NCT01711671|Hormones|hormones|mesh-ancestor
19702524|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702525|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702526|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
19702527|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702528|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702529|NCT04112095|Norgestrel|norgestrel|mesh-list
20529972|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20517621|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517622|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20517623|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517624|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
20517625|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20517626|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20517627|NCT01711671|Growth Substances|growth substances|mesh-ancestor
20517628|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
19702530|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19702531|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19702532|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19702533|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
20517629|NCT01711697|Paclitaxel|paclitaxel|mesh-list
20517630|NCT01711697|Carboplatin|carboplatin|mesh-list
20517631|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20517632|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517633|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
20517634|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
20517635|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
20517636|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517637|NCT01711723|Darapladib|darapladib|mesh-list
20517638|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20517639|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20529973|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19702534|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19702535|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702536|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19702537|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20245077|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20245078|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245079|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245080|NCT00422864|Leucovorin|leucovorin|mesh-list
20245081|NCT00422864|Fluorouracil|fluorouracil|mesh-list
20245082|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
20245083|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
20517640|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517641|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20517642|NCT01711749|Calcium|calcium|mesh-list
20517643|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20517644|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517645|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20517646|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20517647|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
20517648|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245084|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245085|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245086|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245087|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245088|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
20245089|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245090|NCT00422864|Antidotes|antidotes|mesh-ancestor
20517649|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20517650|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20517651|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517652|NCT01711814|Peficitinib|peficitinib|mesh-list
20517653|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517654|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517655|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517656|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
20517657|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517658|NCT01711827|Isavuconazole|isavuconazole|mesh-list
20517659|NCT01711827|Prednisone|prednisone|mesh-list
20517660|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517661|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
20517662|NCT01711827|Hormones|hormones|mesh-ancestor
20517663|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517664|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517665|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20517666|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517667|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
19702538|NCT04050553|Tirzepatide|tirzepatide|mesh-list
19702539|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19702540|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245091|NCT00422864|Protective Agents|protective agents|mesh-ancestor
20245092|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
20245093|NCT00422864|Vitamins|vitamins|mesh-ancestor
20245094|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
20245095|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
20245096|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245097|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517668|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517669|NCT01711905|Vitamin D|vitamin d|mesh-list
20517670|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
20517671|NCT01711905|Vitamins|vitamins|mesh-ancestor
20517672|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
20517673|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517674|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20517675|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20517676|NCT01711931|Everolimus|everolimus|mesh-list
20517677|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517678|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517679|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
20517680|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529974|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
20529975|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20529976|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20529977|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20529978|NCT01785446|Narcotics|narcotics|mesh-ancestor
20529979|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20529980|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20529981|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
20529982|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
20245098|NCT00422994|Ropinirole|ropinirole|mesh-list
20529983|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20245099|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20529984|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20529985|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20517681|NCT01711957|Liver Extracts|liver extracts|mesh-list
20517682|NCT01711957|Hematinics|hematinics|mesh-ancestor
20517683|NCT01711970|Paclitaxel|paclitaxel|mesh-list
20517684|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20517685|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517686|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20517687|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
20517688|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20517689|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517690|NCT01712100|Irbesartan|irbesartan|mesh-list
20517691|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517692|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20517693|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20517694|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517695|NCT01712113|Irbesartan|irbesartan|mesh-list
20517696|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517697|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20517698|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20517699|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517700|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20517701|NCT01712126|Irbesartan|irbesartan|mesh-list
20517702|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19702541|NCT04050553|Incretins|incretins|mesh-ancestor
19702542|NCT04050553|Hormones|hormones|mesh-ancestor
20517703|NCT01712126|Diuretics|diuretics|mesh-ancestor
20517704|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
20517705|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517706|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20517707|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517708|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415768|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
19415769|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702543|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20517709|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20517710|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20517711|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19853939|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853940|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853941|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853942|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19853943|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853944|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19853945|NCT00735696|Paclitaxel|paclitaxel|mesh-list
19853946|NCT00735696|Carboplatin|carboplatin|mesh-list
19853947|NCT00735696|Ramucirumab|ramucirumab|mesh-list
19853948|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20517712|NCT01712139|Irbesartan|irbesartan|mesh-list
20517713|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517714|NCT01712139|Diuretics|diuretics|mesh-ancestor
20517715|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
20517716|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517717|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20517718|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517719|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517720|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20517721|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20517722|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
20517723|NCT01712295|Salicylates|salicylates|mesh-list
20517724|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19702544|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
19702545|NCT04049331|Testosterone|testosterone|mesh-list
19702546|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
19702547|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
19702548|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19702549|NCT04049331|Androgens|androgens|mesh-ancestor
19702550|NCT04049331|Hormones|hormones|mesh-ancestor
19702551|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702552|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702553|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702554|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702555|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
19702556|NCT03955471|Niraparib|niraparib|mesh-list
19702557|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19702558|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702559|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702560|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702561|NCT03946891|Furosemide|furosemide|mesh-list
19702562|NCT03946891|Diuretics|diuretics|mesh-ancestor
20517725|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19702563|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
19702564|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702565|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19702566|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19702567|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517726|NCT01712295|Analgesics|analgesics|mesh-ancestor
20517727|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
20517728|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517729|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517730|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20517731|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20517732|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20517733|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517734|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517735|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517736|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
20517737|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
20517738|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
20517739|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19702568|NCT03934684|Dexamethasone|dexamethasone|mesh-list
20517740|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
20517741|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20517742|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20517743|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20517744|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517745|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517746|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517747|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
20517748|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517749|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20517750|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20517751|NCT01712347|Bevacizumab|bevacizumab|mesh-list
20517752|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20517753|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415770|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415771|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19415772|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19415773|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
19415774|NCT02689258|Bupivacaine|bupivacaine|mesh-list
20517754|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20517755|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20517756|NCT01712347|Growth Substances|growth substances|mesh-ancestor
19415775|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
19415776|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
19415777|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415778|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415779|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
19415780|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415781|NCT02683239|Fasinumab|fasinumab|mesh-list
19415782|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415783|NCT02683239|Analgesics|analgesics|mesh-ancestor
19415784|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
19415785|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415786|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415787|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
19415788|NCT02680574|Hematinics|hematinics|mesh-ancestor
19415789|NCT02677545|Aspirin|aspirin|mesh-list
20517757|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517758|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
20517759|NCT01712464|Oxytocin|oxytocin|mesh-list
20517760|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
20517761|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517762|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517763|NCT01712477|Midazolam|midazolam|mesh-list
20517764|NCT01712477|Propofol|propofol|mesh-list
20517765|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20517766|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517767|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517768|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20517769|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
20517770|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
20517771|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20517772|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20517773|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20517774|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20517775|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
20517776|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
20517777|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517778|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517779|NCT01712568|Ropinirole|ropinirole|mesh-list
20517780|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20517781|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20517782|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
20517783|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
20517784|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517785|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517786|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517787|NCT01712646|Oxytocin|oxytocin|mesh-list
20517788|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
20517789|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517790|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517791|NCT01712815|Clevudine|clevudine|mesh-list
20517792|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
20517793|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517794|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
20517795|NCT01712828|Promethazine|promethazine|mesh-list
20517796|NCT01712828|Sirolimus|sirolimus|mesh-list
19415790|NCT02677545|Clopidogrel|clopidogrel|mesh-list
19702569|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
20517797|NCT01712828|Quinidine|quinidine|mesh-list
20517798|NCT01712828|Lenalidomide|lenalidomide|mesh-list
19415791|NCT02677545|Ticagrelor|ticagrelor|mesh-list
20517799|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
20517800|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517801|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20517802|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20517803|NCT01712828|Growth Substances|growth substances|mesh-ancestor
19853949|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853950|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
19853951|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853952|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
19855637|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517804|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
20517805|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517806|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20517807|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517808|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20517809|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
20517810|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517811|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20517812|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20517813|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517814|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
20517815|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
20517816|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
20517817|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517818|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
20517819|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
20517820|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517821|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20517822|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
20517823|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
20517824|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517825|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517826|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20517827|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
20517828|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
20517829|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20517830|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20517831|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
20517832|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20517833|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
20517834|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20517835|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20517836|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517837|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20517838|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20517839|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
20517840|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20517841|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20517842|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517843|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20517844|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20517845|NCT01712893|Goserelin|goserelin|mesh-list
20517846|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20517847|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517848|NCT01712919|Paclitaxel|paclitaxel|mesh-list
20517849|NCT01712919|Cetuximab|cetuximab|mesh-list
20517850|NCT01712919|Nedaplatin|nedaplatin|mesh-list
20517851|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20517852|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517853|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
20517854|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
20517855|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
20517856|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517857|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20517858|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
20517859|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20517860|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517861|NCT01712997|Bosentan|bosentan|mesh-list
20517862|NCT01712997|Iloprost|iloprost|mesh-list
20517863|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517864|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20517865|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517866|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20517867|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
20517868|NCT01713049|Alovudine|alovudine|mesh-list
20517869|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
20517870|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517871|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
20517872|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
20517873|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
20517874|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20517875|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517876|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
20517877|NCT01713101|Coagulants|coagulants|mesh-ancestor
20517878|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
20517879|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20245100|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20245101|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
20245102|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
20245103|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245104|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245105|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245106|NCT00423007|Bromfenac|bromfenac|mesh-list
20245107|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20245108|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20245109|NCT00423007|Analgesics|analgesics|mesh-ancestor
20245110|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
20245111|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517880|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20517881|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517882|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20517883|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20517884|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517885|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517886|NCT01713127|Remifentanil|remifentanil|mesh-list
20517887|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20517888|NCT01713127|Narcotics|narcotics|mesh-ancestor
20517889|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517890|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517891|NCT01713127|Analgesics|analgesics|mesh-ancestor
20517892|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
20517893|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415792|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19415793|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415794|NCT02677545|Analgesics|analgesics|mesh-ancestor
20517894|NCT01713153|Misoprostol|misoprostol|mesh-list
20517895|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20517896|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
20517897|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20517898|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517899|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20517900|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20517901|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
20517902|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
20517903|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20517904|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20517905|NCT01713179|Ambroxol|ambroxol|mesh-list
20517906|NCT01713179|Expectorants|expectorants|mesh-ancestor
20517907|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
20517908|NCT01713218|Gemcitabine|gemcitabine|mesh-list
20517909|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20517910|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
20517911|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517912|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517913|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
20517914|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517915|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517916|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517917|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
20517918|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517919|NCT01713231|Vitamin D|vitamin d|mesh-list
20517920|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
20517921|NCT01713231|Vitamins|vitamins|mesh-list
20517922|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
19415795|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
20517923|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517924|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20517925|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20517926|NCT01713309|Lenograstim|lenograstim|mesh-list
20517927|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20517928|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
20517929|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517930|NCT01713361|Enoxaparin|enoxaparin|mesh-list
20517931|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
20517932|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20517933|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20517934|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415796|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702570|NCT03934684|Lenalidomide|lenalidomide|mesh-list
19702571|NCT03934684|BB 1101|bb 1101|mesh-list
20517935|NCT01713387|Gemcitabine|gemcitabine|mesh-list
20517936|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20517937|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
20517938|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517939|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517940|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
20517941|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20517942|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20517943|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20517944|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
20517945|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517946|NCT01713426|Pregabalin|pregabalin|mesh-list
20517947|NCT01713426|Capsaicin|capsaicin|mesh-list
20517948|NCT01713426|Analgesics|analgesics|mesh-ancestor
20517949|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
20517950|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20517951|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517952|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
20517953|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20517954|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517955|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517956|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20517957|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20517958|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20517959|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517960|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20517961|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
20517962|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
20517963|NCT01713556|Propranolol|propranolol|mesh-list
20517964|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20517965|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20517966|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
20517967|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20517968|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517969|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517970|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20517971|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517972|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
20517973|NCT01713647|Losartan|losartan|mesh-list
20517974|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20517975|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20517976|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20517977|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20517978|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517979|NCT01713725|Omalizumab|omalizumab|mesh-list
20517980|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20517981|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20517982|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
20517983|NCT01713738|Rituximab|rituximab|mesh-list
20517984|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20517985|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20517986|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
20517987|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517988|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20529986|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20529987|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20529988|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
20529989|NCT01785589|Adenosine|adenosine|mesh-list
20529990|NCT01785589|Analgesics|analgesics|mesh-ancestor
20529991|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
20529992|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20529993|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20529994|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20529995|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
20529996|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20529997|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
20529998|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
20529999|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530000|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530001|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20530002|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
20530003|NCT01785641|Gentamicins|gentamicins|mesh-list
20530004|NCT01785641|Cefazolin|cefazolin|mesh-list
20530005|NCT01785641|Ceftazidime|ceftazidime|mesh-list
20530006|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20530007|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530008|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
20530009|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20530010|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20530011|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530012|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530013|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530014|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20530015|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20530016|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20530017|NCT01785693|Clonidine|clonidine|mesh-list
20530018|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
20530019|NCT01785693|Analgesics|analgesics|mesh-ancestor
20530020|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
20517989|NCT01713777|Lamotrigine|lamotrigine|mesh-list
20517990|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
20517991|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20517992|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20517993|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20517994|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20517995|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20517996|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20517997|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20517998|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20517999|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20518000|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20518001|NCT01713803|Buprenorphine|buprenorphine|mesh-list
20518002|NCT01713803|Naloxone|naloxone|mesh-list
20518003|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20518004|NCT01713803|Narcotics|narcotics|mesh-ancestor
20518005|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518006|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518007|NCT01713803|Analgesics|analgesics|mesh-ancestor
20518008|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
20518009|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518010|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20518011|NCT01713920|Amlodipine|amlodipine|mesh-list
20518012|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20518013|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20518014|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518015|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518016|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20518017|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518018|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
20518019|NCT01713972|Dabrafenib|dabrafenib|mesh-list
20518020|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518021|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20518022|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518023|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518024|NCT01714011|Aripiprazole|aripiprazole|mesh-list
20518025|NCT01714011|Ziprasidone|ziprasidone|mesh-list
20518026|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
20518027|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20518028|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20518029|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20518030|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518031|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518032|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
20518033|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
20518034|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518035|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518036|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20518037|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20518038|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
20518039|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20518040|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20518041|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20518042|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20518043|NCT01714037|Gemcitabine|gemcitabine|mesh-list
20518044|NCT01714037|Docetaxel|docetaxel|mesh-list
20518045|NCT01714037|Pemetrexed|pemetrexed|mesh-list
20518046|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518047|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20518048|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
20518049|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518050|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
20518051|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518052|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518053|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518054|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
20518055|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518056|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
20518057|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
20518058|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
20518059|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20518060|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19415797|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853953|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518061|NCT01714089|Interferons|interferons|mesh-list
20518062|NCT01714089|Interferon-beta|interferon-beta|mesh-list
20518063|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
20518064|NCT01714089|RNS60|rns60|mesh-list
20518065|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518066|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
20518067|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518068|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
20518069|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518070|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20518071|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20518072|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20518073|NCT01714089|Analgesics|analgesics|mesh-ancestor
20518074|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
20518075|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518076|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518077|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518078|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20518079|NCT01714102|Resveratrol|resveratrol|mesh-list
20518080|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
20518081|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853954|NCT00735709|Vortioxetine|vortioxetine|mesh-list
19853955|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
19853956|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20518082|NCT01714102|Protective Agents|protective agents|mesh-ancestor
20518083|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853957|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19853958|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19853959|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853960|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518084|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518085|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20518086|NCT01714115|Aflibercept|aflibercept|mesh-list
20518087|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20518088|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20518089|NCT01714115|Growth Substances|growth substances|mesh-ancestor
20518090|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518091|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
20518092|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518093|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20518094|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20518095|NCT01714128|Estradiol|estradiol|mesh-list
20518096|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20518097|NCT01714128|Estrogens|estrogens|mesh-ancestor
20518098|NCT01714128|Hormones|hormones|mesh-ancestor
20518099|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518100|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518101|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20518102|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
20518103|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20518104|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20518105|NCT01714154|Ritonavir|ritonavir|mesh-list
20518106|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20518107|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20518108|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
20518109|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518110|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518111|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20518112|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20518113|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
19853961|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20518114|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518115|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20518116|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20518117|NCT01714193|Canagliflozin|canagliflozin|mesh-list
20518118|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
20518119|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
20518120|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20518121|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518122|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20518123|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518124|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518125|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20518126|NCT01714206|Canagliflozin|canagliflozin|mesh-list
20518127|NCT01714206|Digoxin|digoxin|mesh-list
20518128|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20518129|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20518130|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518131|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518132|NCT01714206|Protective Agents|protective agents|mesh-ancestor
20518133|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518134|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20518135|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518136|NCT01714297|Dalteparin|dalteparin|mesh-list
20518137|NCT01714297|Tinzaparin|tinzaparin|mesh-list
20518138|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20518139|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
20518140|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20518141|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20518142|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518143|NCT01714388|Remifentanil|remifentanil|mesh-list
20518144|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20518145|NCT01714388|Narcotics|narcotics|mesh-ancestor
20518146|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518147|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518148|NCT01714388|Analgesics|analgesics|mesh-ancestor
20518149|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
20518150|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518151|NCT01714401|Albuterol|albuterol|mesh-list
20518152|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20518153|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
20518154|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518155|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518156|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20518157|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
20518158|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
20518159|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20518160|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20518161|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20518162|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20518163|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
20518164|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518165|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518166|NCT01714414|Lamivudine|lamivudine|mesh-list
20518167|NCT01714414|Zidovudine|zidovudine|mesh-list
20518168|NCT01714414|Efavirenz|efavirenz|mesh-list
20518169|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20518170|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20518171|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518172|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518173|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
20518174|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518175|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20518176|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20518177|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
20245112|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245113|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20245114|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245115|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
20245116|NCT00423020|Hematinics|hematinics|mesh-ancestor
20245117|NCT00423059|Bevacizumab|bevacizumab|mesh-list
20245118|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245119|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248052|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
20518178|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20518179|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20518180|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20518181|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20518182|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20518183|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20518184|NCT01714427|Dexamethasone|dexamethasone|mesh-list
20518185|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518186|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
20518187|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
20518188|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518189|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518190|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20518191|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
20518192|NCT01714427|Hormones|hormones|mesh-ancestor
20518193|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518194|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20518195|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518196|NCT01714557|Tazobactam|tazobactam|mesh-list
20518197|NCT01714557|Piperacillin|piperacillin|mesh-list
20518198|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20518199|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20518200|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518201|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20518202|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518203|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518204|NCT01714570|Tazobactam|tazobactam|mesh-list
20518205|NCT01714570|Piperacillin|piperacillin|mesh-list
20518206|NCT01714570|Imipenem|imipenem|mesh-list
20518207|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20518208|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20518209|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518210|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20518211|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518212|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518213|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20518214|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518215|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20518216|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
20518217|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20518218|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
20518219|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20518220|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518221|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20518222|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20518223|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518224|NCT01714765|Everolimus|everolimus|mesh-list
20518225|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518226|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518227|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
20518228|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518229|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
20518230|NCT01714817|Prednisone|prednisone|mesh-list
19702572|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20245120|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20245121|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20245122|NCT00423059|Growth Substances|growth substances|mesh-ancestor
20245123|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245124|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
20245125|NCT00423163|Voriconazole|voriconazole|mesh-list
20245126|NCT00423163|Micafungin|micafungin|mesh-list
20518231|NCT01714817|Abatacept|abatacept|mesh-list
20518232|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518233|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
20518234|NCT01714817|Hormones|hormones|mesh-ancestor
20518235|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518236|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518237|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20518238|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245127|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
20245128|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245129|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20245130|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20245131|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245132|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518239|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20518240|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20518241|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
20518242|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20518243|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518244|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518245|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518246|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19702573|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
20245133|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19702574|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
19702575|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702576|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702577|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702578|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
19702579|NCT03934684|Hormones|hormones|mesh-ancestor
19702580|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702581|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702582|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702583|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
20518247|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518248|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
20518249|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518250|NCT01714843|Linaclotide|linaclotide|mesh-list
20518251|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20518252|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
20518253|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518254|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702584|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518255|NCT01714856|Ropinirole|ropinirole|mesh-list
20518256|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20518257|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20518258|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
20518259|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
20518260|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518261|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518262|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518263|NCT01714895|Insulin|insulin|mesh-list
20518264|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20518265|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20518266|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518267|NCT01714908|Etoposide|etoposide|mesh-list
20518268|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20518269|NCT01714908|Cisplatin|cisplatin|mesh-list
20518270|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20518271|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518272|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20518273|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20518274|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518275|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518276|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20518277|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20518278|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20518279|NCT01715077|Ipilimumab|ipilimumab|mesh-list
20518280|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20518281|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518282|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19702585|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518283|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518284|NCT01715090|Insulin|insulin|mesh-list
20518285|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518286|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518287|NCT01715142|Gemcitabine|gemcitabine|mesh-list
20518288|NCT01715142|Paclitaxel|paclitaxel|mesh-list
20518289|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20518290|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20518291|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518292|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
20518293|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
20518294|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
20518295|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518296|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20518297|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
20518298|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
20518299|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518300|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518301|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518302|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
20518303|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518304|NCT01715168|Doxorubicin|doxorubicin|mesh-list
20518305|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20518306|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20518307|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518308|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20518309|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20518310|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518311|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518312|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
20518313|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
20518314|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
20518315|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518316|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20518317|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702586|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
19702587|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20518318|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518319|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
20518320|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702588|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20518321|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518322|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20518323|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
20518324|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20518325|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
20518326|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518327|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518328|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20518329|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
20518330|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
20518331|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20518332|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
20518333|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518334|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518335|NCT01715363|Leucovorin|leucovorin|mesh-list
20518336|NCT01715363|Folic Acid|folic acid|mesh-list
20518337|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
20518338|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
20518339|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518340|NCT01715363|Antidotes|antidotes|mesh-ancestor
20518341|NCT01715363|Protective Agents|protective agents|mesh-ancestor
20518342|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518343|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
19702589|NCT03934684|Growth Substances|growth substances|mesh-ancestor
20518344|NCT01715363|Vitamins|vitamins|mesh-ancestor
20518345|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
20518346|NCT01715363|Hematinics|hematinics|mesh-ancestor
20518347|NCT01715441|Irinotecan|irinotecan|mesh-list
20518348|NCT01715441|Sorafenib|sorafenib|mesh-list
20518349|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19702590|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
20518350|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702591|NCT03911453|Rucaparib|rucaparib|mesh-list
20518351|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518352|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518353|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518354|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20518355|NCT01715493|Muramidase|muramidase|mesh-list
20518356|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530021|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530022|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530023|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20530024|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
20530025|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
20530026|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20530027|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20530028|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20530029|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
20530030|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530031|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530032|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
20530033|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
20530034|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530035|NCT01785797|Silicon|silicon|mesh-list
20530036|NCT01785797|Trace Elements|trace elements|mesh-ancestor
20530037|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
20530038|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530039|NCT01785836|Dapsone|dapsone|mesh-list
20530040|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518357|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20518358|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
20518359|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20518360|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20518361|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20518362|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518363|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530041|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
20245134|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
19702592|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20245135|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245136|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245137|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20245138|NCT00423202|Ambrisentan|ambrisentan|mesh-list
20245139|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20245140|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
20245141|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19702593|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702594|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702595|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702596|NCT03871049|Dexamethasone|dexamethasone|mesh-list
19702597|NCT03871049|Bupivacaine|bupivacaine|mesh-list
20245142|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518364|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518365|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
20518366|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518367|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20518368|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20518369|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
20518370|NCT01715584|Sevoflurane|sevoflurane|mesh-list
20518371|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20518372|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20518373|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
20518374|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
20518375|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518376|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518377|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20518378|NCT01715584|Analgesics|analgesics|mesh-ancestor
20518379|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
20518380|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518381|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
20518382|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
20518383|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518384|NCT01715597|Protective Agents|protective agents|mesh-ancestor
20518385|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518386|NCT01715597|Vitamins|vitamins|mesh-ancestor
20518387|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
20518388|NCT01715610|Clindamycin|clindamycin|mesh-list
20518389|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
20518390|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
20518391|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20518392|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20518393|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518394|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20518395|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518396|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518397|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20518398|NCT01715636|Tenofovir|tenofovir|mesh-list
20518399|NCT01715636|Emtricitabine|emtricitabine|mesh-list
20518400|NCT01715636|Rilpivirine|rilpivirine|mesh-list
20245143|NCT00423228|Donepezil|donepezil|mesh-list
20245144|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20245145|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245146|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245147|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
20245148|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245149|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245150|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
20245151|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
20245152|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20518401|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
20518402|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518403|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20530042|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20518404|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20518405|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518406|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518407|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20518408|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20518409|NCT01715688|Lidocaine|lidocaine|mesh-list
20518410|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
20518411|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
20518412|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518413|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518414|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
20518415|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245153|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
20245154|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245155|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
20245156|NCT00423371|Protective Agents|protective agents|mesh-ancestor
20245157|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
20245158|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20518416|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20518417|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20518418|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20518419|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518420|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518421|NCT01715701|Iodine|iodine|mesh-list
20518422|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20518423|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518424|NCT01715701|Trace Elements|trace elements|mesh-ancestor
20518425|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
20518426|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518427|NCT01715714|Atorvastatin|atorvastatin|mesh-list
20518428|NCT01715714|Simvastatin|simvastatin|mesh-list
20518429|NCT01715714|Pravastatin|pravastatin|mesh-list
20518430|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20518431|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20518432|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
20518433|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518434|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20518435|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20518436|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518437|NCT01715909|Oseltamivir|oseltamivir|mesh-list
20518438|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
20518439|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518440|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518441|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518442|NCT01715922|Fluconazole|fluconazole|mesh-list
20518443|NCT01715922|Flucytosine|flucytosine|mesh-list
20518444|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
20518445|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518446|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20518447|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20518448|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518449|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518450|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20518451|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
20518452|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518453|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518454|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20518455|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20518456|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
20518457|NCT01715935|Everolimus|everolimus|mesh-list
20518458|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530043|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19702598|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702599|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
19702600|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
19702601|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702602|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518459|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518460|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
20518461|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518462|NCT01715974|Lenograstim|lenograstim|mesh-list
20518463|NCT01715974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20518464|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
20518465|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518466|NCT01715987|Tenofovir|tenofovir|mesh-list
20518467|NCT01715987|Entecavir|entecavir|mesh-list
20518468|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
20518469|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518470|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20518471|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20518472|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518473|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518474|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20518475|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20518476|NCT01716260|Chloroquine|chloroquine|mesh-list
20518477|NCT01716260|Primaquine|primaquine|mesh-list
20518478|NCT01716260|Amebicides|amebicides|mesh-ancestor
20518479|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20518480|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20518481|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518482|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
20518483|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518484|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20518485|NCT01716273|Laxatives|laxatives|mesh-ancestor
20518486|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20518487|NCT01716338|Glyburide|glyburide|mesh-list
20518488|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518489|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518490|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20518491|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20518492|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20518493|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518494|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518495|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518496|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518497|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20518498|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
20518499|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20518500|NCT01716416|Cetuximab|cetuximab|mesh-list
19702603|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702604|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
20518501|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20518502|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518503|NCT01716442|Rituximab|rituximab|mesh-list
20518504|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20518505|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518506|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
20518507|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518508|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518509|NCT01716572|Erythromycin|erythromycin|mesh-list
20518510|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
20518511|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20518512|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
20518513|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20518514|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518515|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20518516|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20518517|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518518|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518519|NCT01716611|Tolvaptan|tolvaptan|mesh-list
20518520|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20518521|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518522|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
20518523|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518524|NCT01716624|Oxybutynin|oxybutynin|mesh-list
20518525|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
20518526|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20518527|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20518528|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20518529|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518530|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518531|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
20518532|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518533|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702605|NCT03871049|Hormones|hormones|mesh-ancestor
19702606|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702607|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702608|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702609|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
19702610|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
19702611|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245159|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245160|NCT00423397|Interferons|interferons|mesh-list
20245161|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
20245162|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
20245163|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20245164|NCT00423397|Gefitinib|gefitinib|mesh-list
20245165|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245166|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
20245167|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245168|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
20245169|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245170|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20245171|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245172|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245173|NCT00423475|Goserelin|goserelin|mesh-list
20245174|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20245175|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245176|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20245177|NCT00423501|Incretins|incretins|mesh-ancestor
20245178|NCT00423501|Hormones|hormones|mesh-ancestor
20245179|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518534|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19702612|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
19702613|NCT03849625|Aspirin|aspirin|mesh-list
19702614|NCT03849625|Acetaminophen|acetaminophen|mesh-list
19702615|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19702616|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19702617|NCT03849625|Analgesics|analgesics|mesh-ancestor
19702618|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
19702619|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702620|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518535|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518536|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
20518537|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
20518538|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20518539|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20518540|NCT01716624|Urological Agents|urological agents|mesh-ancestor
20518541|NCT01716637|Etanercept|etanercept|mesh-list
20518542|NCT01716637|Curcumin|curcumin|mesh-list
20518543|NCT01716637|Resveratrol|resveratrol|mesh-list
20518544|NCT01716637|Quercetin|quercetin|mesh-list
20518545|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20518546|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20518547|NCT01716637|Analgesics|analgesics|mesh-ancestor
20518548|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
20518549|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245180|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245181|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
20245182|NCT00423514|Melphalan|melphalan|mesh-list
19702621|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702622|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702623|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19702624|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19702625|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702626|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19702627|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19702628|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702629|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
19708125|NCT04819438|Protective Agents|protective agents|mesh-ancestor
20245183|NCT00423514|Thiotepa|thiotepa|mesh-list
20245184|NCT00423514|Clofarabine|clofarabine|mesh-list
20245185|NCT00423514|Tacrolimus|tacrolimus|mesh-list
20245186|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
20245187|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245188|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245189|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19708126|NCT04819828|Diclofenac|diclofenac|mesh-list
20245190|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708127|NCT04819828|Tamsulosin|tamsulosin|mesh-list
20245191|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245192|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20245193|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245194|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20518550|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518551|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518552|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518553|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20518554|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518555|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
20518556|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518557|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518558|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245195|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
20245196|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20245197|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245198|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20245199|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
20245200|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20245201|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245202|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
20245203|NCT00423527|Levetiracetam|levetiracetam|mesh-list
20518559|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
20518560|NCT01716637|Protective Agents|protective agents|mesh-ancestor
20518561|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20518562|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
20518563|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518564|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
20245204|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
20245205|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
20245206|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
20245207|NCT00423540|Analgesics|analgesics|mesh-ancestor
20245208|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
20245209|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245210|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245211|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
20245212|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245213|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20245214|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
20245215|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20245216|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20245217|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245218|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20518565|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518566|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518567|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20518568|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
20518569|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518570|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415798|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20245219|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
20518571|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20518572|NCT01716767|Analgesics|analgesics|mesh-list
19702630|NCT03769844|Molgramostim|molgramostim|mesh-list
19702631|NCT03769844|Sargramostim|sargramostim|mesh-list
19702632|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
19702633|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702634|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702635|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
19702636|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19702637|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702638|NCT03755804|Prednisone|prednisone|mesh-list
19702639|NCT03755804|Prednisolone|prednisolone|mesh-list
19702640|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
19702641|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19702642|NCT03755804|Dacarbazine|dacarbazine|mesh-list
19702643|NCT03755804|Doxorubicin|doxorubicin|mesh-list
19702644|NCT03755804|Etoposide|etoposide|mesh-list
19702645|NCT03755804|Vincristine|vincristine|mesh-list
19702646|NCT03755804|Bleomycin|bleomycin|mesh-list
19702647|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19702648|NCT03755804|Vinblastine|vinblastine|mesh-list
20518573|NCT01716767|Menthol|menthol|mesh-list
20518574|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
20518575|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518576|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518577|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
20518578|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
20518579|NCT01716858|Sulforaphane|sulforaphane|mesh-list
19702649|NCT03755804|Imidazole|imidazole|mesh-list
19702650|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702651|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
19702652|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702653|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702654|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19702655|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
19702656|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702657|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702658|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19702659|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19702660|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20518580|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20518581|NCT01716858|Protective Agents|protective agents|mesh-ancestor
20518582|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415799|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19415800|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19415801|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19415802|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415803|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19415804|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19415805|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415806|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
19415807|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19415808|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19415809|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19415810|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
19415811|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415812|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
20245220|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19702661|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702662|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518583|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518584|NCT01716949|Fluorouracil|fluorouracil|mesh-list
20518585|NCT01716949|Capecitabine|capecitabine|mesh-list
20518586|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
20518587|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
20518588|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518589|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20518590|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518591|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518592|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
20518593|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518594|NCT01717027|Oxycodone|oxycodone|mesh-list
20518595|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20518596|NCT01717027|Narcotics|narcotics|mesh-ancestor
20518597|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518598|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518599|NCT01717027|Analgesics|analgesics|mesh-ancestor
20518600|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
20518601|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518602|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
20518603|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20518604|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518605|NCT01717118|Vaccines|vaccines|mesh-list
20518606|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
20518607|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518608|NCT01717157|Fentanyl|fentanyl|mesh-list
20518609|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20518610|NCT01717157|Narcotics|narcotics|mesh-ancestor
20518611|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518612|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518613|NCT01717157|Analgesics|analgesics|mesh-ancestor
20518614|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
20518615|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518616|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20518617|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20518618|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
20518619|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
20518620|NCT01717222|Lidocaine|lidocaine|mesh-list
20518621|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
20518622|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
20518623|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518624|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518625|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
19702663|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702664|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
19702665|NCT03755804|Hormones|hormones|mesh-ancestor
19702666|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702667|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702668|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702669|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702670|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
19702671|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
20518626|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518627|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20518628|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20518629|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20518630|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518631|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518632|NCT01717235|Ropinirole|ropinirole|mesh-list
20518633|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20518634|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20518635|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
20518636|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
20518637|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518638|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518639|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530044|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20530045|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530046|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530047|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
20530048|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20530049|NCT01785862|Ibuprofen|ibuprofen|mesh-list
20530050|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19702672|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20530051|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530052|NCT01785862|Analgesics|analgesics|mesh-ancestor
20530053|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
20530054|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702673|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
20518640|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
20518641|NCT01717300|Anacetrapib|anacetrapib|mesh-list
20518642|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20518643|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20518644|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
20518645|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518646|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20518647|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518648|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20518649|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518650|NCT01717404|Mexiletine|mexiletine|mesh-list
20518651|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20518652|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20518653|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20518654|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518655|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518656|NCT01717599|Diclofenac|diclofenac|mesh-list
20518657|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20518658|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20518659|NCT01717599|Analgesics|analgesics|mesh-ancestor
20518660|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
20518661|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518662|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518663|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518664|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518665|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20518666|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518667|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518668|NCT01717612|Thrombin|thrombin|mesh-list
20518669|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
20518670|NCT01717612|Coagulants|coagulants|mesh-ancestor
20518671|NCT01717625|Montelukast|montelukast|mesh-list
20518672|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20518673|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
20518674|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20518675|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
20518676|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518677|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702674|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702675|NCT03742986|Paclitaxel|paclitaxel|mesh-list
19702676|NCT03742986|Docetaxel|docetaxel|mesh-list
19702677|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19702678|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
19702679|NCT03742986|Doxorubicin|doxorubicin|mesh-list
19702680|NCT03742986|Nivolumab|nivolumab|mesh-list
19702681|NCT03742986|Trastuzumab|trastuzumab|mesh-list
19702682|NCT03742986|Pertuzumab|pertuzumab|mesh-list
20518678|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19702683|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702684|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702685|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
20518679|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20518680|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518681|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
20518682|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20518683|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20518684|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518685|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
20518686|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
20518687|NCT01717729|Iodine|iodine|mesh-list
20518688|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20518689|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518690|NCT01717729|Trace Elements|trace elements|mesh-ancestor
20518691|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
20518692|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518693|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20518694|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518695|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20518696|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518697|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518698|NCT01717846|Abatacept|abatacept|mesh-list
20518699|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20518700|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518701|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518702|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518703|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
20518704|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702686|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
19702687|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
20518705|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518706|NCT01717911|Metformin|metformin|mesh-list
20518707|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19415813|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19702688|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518708|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
20518709|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19702689|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702690|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
19702691|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518710|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518711|NCT01717911|Incretins|incretins|mesh-ancestor
20518712|NCT01717911|Hormones|hormones|mesh-ancestor
20518713|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518714|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20518715|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
20518716|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518717|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702692|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702693|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19702694|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
19702695|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19702696|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20518718|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20518719|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20518720|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
20518721|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518722|NCT01717950|Antacids|antacids|mesh-ancestor
20518723|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518724|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20518725|NCT01717963|Naltrexone|naltrexone|mesh-list
20518726|NCT01717963|Buprenorphine|buprenorphine|mesh-list
20518727|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20518728|NCT01717963|Naloxone|naloxone|mesh-list
20518729|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20518730|NCT01717963|Narcotics|narcotics|mesh-ancestor
20518731|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518732|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518733|NCT01717963|Analgesics|analgesics|mesh-ancestor
20518734|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
20518735|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518736|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20518737|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20518738|NCT01718054|Chloroquine|chloroquine|mesh-list
20518739|NCT01718054|Amebicides|amebicides|mesh-ancestor
20518740|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20518741|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20518742|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518743|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
20518744|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518745|NCT01718093|Metformin|metformin|mesh-list
20518746|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20518747|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518748|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518749|NCT01718093|Incretins|incretins|mesh-ancestor
20518750|NCT01718093|Hormones|hormones|mesh-ancestor
20518751|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20518752|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20518753|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
20518754|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518755|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518756|NCT01718223|Temoporfin|temoporfin|mesh-list
20518757|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245221|NCT00423696|Leucovorin|leucovorin|mesh-list
20245222|NCT00423696|Bevacizumab|bevacizumab|mesh-list
20245223|NCT00423696|Fluorouracil|fluorouracil|mesh-list
20245224|NCT00423696|Capecitabine|capecitabine|mesh-list
20245225|NCT00423696|Irinotecan|irinotecan|mesh-list
19702697|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20245226|NCT00423696|Calcium|calcium|mesh-list
20245227|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
20518758|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20518759|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
20518760|NCT01718236|Rocuronium|rocuronium|mesh-list
20518761|NCT01718236|Succinylcholine|succinylcholine|mesh-list
20518762|NCT01718236|Neostigmine|neostigmine|mesh-list
20518763|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20518764|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20518765|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20518766|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518767|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518768|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20518769|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518770|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518771|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
20518772|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518773|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20518774|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
20518775|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20518776|NCT01718288|Aspirin|aspirin|mesh-list
20518777|NCT01718288|Iloprost|iloprost|mesh-list
20518778|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20518779|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20518780|NCT01718288|Analgesics|analgesics|mesh-ancestor
20518781|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
20518782|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518783|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518784|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518785|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20518786|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20518787|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20518788|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518789|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20518790|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20518791|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518792|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
20518793|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
20518794|NCT01718301|Ribavirin|ribavirin|mesh-list
20518795|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20518796|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20518797|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
20518798|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518799|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
20518800|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518801|NCT01718314|Lidocaine|lidocaine|mesh-list
20518802|NCT01718314|Misoprostol|misoprostol|mesh-list
20518803|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
20518804|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
20518805|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518806|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245228|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245229|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245230|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20245231|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20245232|NCT00423696|Growth Substances|growth substances|mesh-ancestor
20245233|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245234|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
20245235|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20245236|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
20245237|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518807|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
20518808|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518809|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20518810|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20518811|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20518812|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518813|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518814|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20518815|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
20518816|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20518817|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20518818|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20518819|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
20518820|NCT01718327|Sunitinib|sunitinib|mesh-list
20518821|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518822|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20245238|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245239|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245240|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
20245241|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20245242|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20245243|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245244|NCT00423696|Antidotes|antidotes|mesh-ancestor
20245245|NCT00423696|Protective Agents|protective agents|mesh-ancestor
20245246|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
20245247|NCT00423696|Vitamins|vitamins|mesh-ancestor
20245248|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
20245249|NCT00423709|Fludarabine|fludarabine|mesh-list
20245250|NCT00423709|Melphalan|melphalan|mesh-list
20245251|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245252|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245253|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245254|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
20245255|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245256|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20245257|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
20245258|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19415814|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20518823|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20518824|NCT01718327|Growth Substances|growth substances|mesh-ancestor
20518825|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518826|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
20518827|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20518828|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518829|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518830|NCT01718340|Metformin|metformin|mesh-list
20518831|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518832|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518833|NCT01718366|Vitamin D|vitamin d|mesh-list
20518834|NCT01718366|Azacitidine|azacitidine|mesh-list
20518835|NCT01718366|Deferasirox|deferasirox|mesh-list
20518836|NCT01718366|Vitamins|vitamins|mesh-ancestor
20518837|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
20518838|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518839|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19415815|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20245259|NCT00423748|Ambrisentan|ambrisentan|mesh-list
20518840|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19702698|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702699|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702700|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702701|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19702702|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
19702703|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702704|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702705|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
19702706|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20518841|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
20518842|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518843|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518844|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518845|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20518846|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
20518847|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
20518848|NCT01718379|Lenalidomide|lenalidomide|mesh-list
20518849|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
20518850|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518851|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20518852|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20518853|NCT01718379|Growth Substances|growth substances|mesh-ancestor
20518854|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
20518855|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518856|NCT01718496|Morphine|morphine|mesh-list
20518857|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20518858|NCT01718496|Narcotics|narcotics|mesh-ancestor
20518859|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518860|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518861|NCT01718496|Analgesics|analgesics|mesh-ancestor
20518862|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
20518863|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518864|NCT01718587|Lamivudine|lamivudine|mesh-list
20518865|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
20518866|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20518867|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20518868|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518869|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518870|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518871|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19702707|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702708|NCT03612973|Insulin|insulin|mesh-list
19702709|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518872|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20518873|NCT01718613|Vasopressins|vasopressins|mesh-list
19702710|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702711|NCT03589014|Propranolol|propranolol|mesh-list
20518874|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
20518875|NCT01718613|Norepinephrine|norepinephrine|mesh-list
20518876|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20518877|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20518878|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
20518879|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20518880|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518881|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518882|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
20518883|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
20518884|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518885|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20518886|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
20518887|NCT01718613|Coagulants|coagulants|mesh-ancestor
20518888|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20518889|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
20518890|NCT01718626|Docetaxel|docetaxel|mesh-list
20518891|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518892|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702712|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19702713|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20518893|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
20518894|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
20518895|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518896|NCT01718652|Canagliflozin|canagliflozin|mesh-list
20518897|NCT01718652|Cyclosporine|cyclosporine|mesh-list
20518898|NCT01718652|Cyclosporins|cyclosporins|mesh-list
20518899|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20518900|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518901|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518902|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
20518903|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518904|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
20518905|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518906|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
20518907|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853962|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19853963|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19853964|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853965|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19853966|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
19853967|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19853968|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19853969|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19853970|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19853971|NCT00735787|Adalimumab|adalimumab|mesh-list
19853972|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19853973|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19853974|NCT00735826|Vorinostat|vorinostat|mesh-list
20518908|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20518909|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20518910|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20518911|NCT01718678|Melatonin|melatonin|mesh-list
20518912|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
20518913|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518914|NCT01718678|Protective Agents|protective agents|mesh-ancestor
20518915|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518916|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518917|NCT01718717|Morphine|morphine|mesh-list
20518918|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20518919|NCT01718717|Narcotics|narcotics|mesh-ancestor
20518920|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20518921|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518922|NCT01718717|Analgesics|analgesics|mesh-ancestor
19853975|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853976|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19853977|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19853978|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853979|NCT00735878|Carboplatin|carboplatin|mesh-list
19853980|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518923|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
20518924|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518925|NCT01718808|Capecitabine|capecitabine|mesh-list
20518926|NCT01718808|Cetuximab|cetuximab|mesh-list
19853981|NCT00735904|Gemcitabine|gemcitabine|mesh-list
19853982|NCT00735904|Axitinib|axitinib|mesh-list
19853983|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853984|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19853985|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
19853986|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245260|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20518927|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19415816|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19415817|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415818|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
19415819|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415820|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518928|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
20518929|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518930|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518931|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20518932|NCT01718834|Vaccines|vaccines|mesh-list
20518933|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
20518934|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518935|NCT01718873|Leucovorin|leucovorin|mesh-list
20518936|NCT01718873|Folic Acid|folic acid|mesh-list
20518937|NCT01718873|Bevacizumab|bevacizumab|mesh-list
20518938|NCT01718873|Fluorouracil|fluorouracil|mesh-list
19702714|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
20518939|NCT01718873|Capecitabine|capecitabine|mesh-list
20518940|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
20518941|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
20518942|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20518943|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20518944|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20518945|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20518946|NCT01718873|Growth Substances|growth substances|mesh-ancestor
20518947|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518948|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
20518949|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
20518950|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518951|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20518952|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518953|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
20518954|NCT01718873|Antidotes|antidotes|mesh-ancestor
20518955|NCT01718873|Protective Agents|protective agents|mesh-ancestor
20518956|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
20518957|NCT01718873|Vitamins|vitamins|mesh-ancestor
20518958|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
19702715|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19702716|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702717|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702718|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19702719|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19702720|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
19702721|NCT03583255|Dexamethasone|dexamethasone|mesh-list
19702722|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
19702723|NCT03583255|Ichthammol|ichthammol|mesh-list
19702724|NCT03583255|BB 1101|bb 1101|mesh-list
19702725|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702726|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
20518959|NCT01718873|Hematinics|hematinics|mesh-ancestor
20518960|NCT01718899|Lenalidomide|lenalidomide|mesh-list
20518961|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
20518962|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518963|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20518964|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20518965|NCT01718899|Growth Substances|growth substances|mesh-ancestor
20518966|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
20518967|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702727|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
19702728|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702729|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530055|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530056|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530057|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530058|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20530059|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530060|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530061|NCT01785979|Chloroquine|chloroquine|mesh-list
20530062|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20530063|NCT01785979|Prednisone|prednisone|mesh-list
20530064|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530065|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
20530066|NCT01785979|Hormones|hormones|mesh-ancestor
20530067|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530068|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702730|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702731|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
19702732|NCT03583255|Hormones|hormones|mesh-ancestor
19702733|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702734|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20518968|NCT01718912|Metronidazole|metronidazole|mesh-list
20518969|NCT01718912|Nystatin|nystatin|mesh-list
20518970|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20518971|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20518972|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20518973|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20518974|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
20518975|NCT01718912|Ionophores|ionophores|mesh-ancestor
20518976|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20518977|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20518978|NCT01718951|Pamidronate|pamidronate|mesh-list
20518979|NCT01718951|Golimumab|golimumab|mesh-list
20518980|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20518981|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518982|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20518983|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
20518984|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518985|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20518986|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
20518987|NCT01718964|Mannitol|mannitol|mesh-list
20518988|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20518989|NCT01718964|Diuretics|diuretics|mesh-ancestor
20518990|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
20518991|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702735|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702736|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
19702737|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702738|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702739|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
19702740|NCT03557918|Tremelimumab|tremelimumab|mesh-list
19702741|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702742|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
19702743|NCT03456843|Docetaxel|docetaxel|mesh-list
19702744|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
19702745|NCT03456843|Hormones|hormones|mesh-list
19702746|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19702747|NCT03456843|Androgens|androgens|mesh-list
19702748|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
19702749|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702750|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702751|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
19853987|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
20518992|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20518993|NCT01719016|Adenosine|adenosine|mesh-list
20518994|NCT01719016|Analgesics|analgesics|mesh-ancestor
20518995|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
20518996|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20518997|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20518998|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20518999|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519000|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20519001|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
20519002|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
20519003|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519004|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519005|NCT01719042|Ondansetron|ondansetron|mesh-list
20519006|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
20519007|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
20519008|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519009|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519010|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20519011|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
20519012|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
20519013|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20519014|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
20519015|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519016|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519017|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20519018|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20519019|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519020|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20519021|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20519022|NCT01719133|Histamine|histamine|mesh-list
20519023|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
20519024|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
20519025|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
20519026|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519027|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519028|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519029|NCT01719159|Rituximab|rituximab|mesh-list
20519030|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20519031|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519032|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
20519033|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519034|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20519035|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
20519036|NCT01719185|Phentermine|phentermine|mesh-list
20519037|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20519038|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519039|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
20519040|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20519041|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
20519042|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
20519043|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519044|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519045|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519046|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519047|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
20519048|NCT01719185|Vitamins|vitamins|mesh-ancestor
20519049|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
20519050|NCT01719237|Ropivacaine|ropivacaine|mesh-list
20519051|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
20519052|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
20245261|NCT00423761|Midazolam|midazolam|mesh-list
20245262|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20245263|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20245264|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245265|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245266|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20245267|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20245268|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20245269|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20245270|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
20245271|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
20245272|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
20245273|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
20245274|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245275|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245276|NCT00423826|Cytarabine|cytarabine|mesh-list
20519053|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
20519054|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519055|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519056|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
20519057|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519058|NCT01719302|Gemcitabine|gemcitabine|mesh-list
20519059|NCT01719302|Docetaxel|docetaxel|mesh-list
20519060|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20519061|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
20519062|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519063|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519064|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
20519065|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519066|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519067|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20519068|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
20519069|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245277|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
20519070|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
20519071|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
20519072|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
20519073|NCT01719419|Orlistat|orlistat|mesh-list
20519074|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702752|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
19702753|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702754|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702755|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702756|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
20519075|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519076|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20519077|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20519078|NCT01719588|Tapentadol|tapentadol|mesh-list
20519079|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20519080|NCT01719588|Narcotics|narcotics|mesh-ancestor
19702757|NCT03456843|Protective Agents|protective agents|mesh-ancestor
19702758|NCT03456843|Vitamins|vitamins|mesh-ancestor
19702759|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
19702760|NCT03456843|Estrogens|estrogens|mesh-ancestor
20519081|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519082|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519083|NCT01719588|Analgesics|analgesics|mesh-ancestor
20519084|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
20519085|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519086|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20519087|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20519088|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519089|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519090|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519091|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519092|NCT01719601|Tapentadol|tapentadol|mesh-list
20519093|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19702761|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702762|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
19702763|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
19415821|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19415822|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415823|NCT02677038|Olaparib|olaparib|mesh-list
19415824|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19415825|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415826|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519094|NCT01719601|Narcotics|narcotics|mesh-ancestor
20519095|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519096|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519097|NCT01719601|Analgesics|analgesics|mesh-ancestor
20519098|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
20519099|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519100|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20519101|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20519102|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519103|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519104|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519105|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519106|NCT01719614|Metformin|metformin|mesh-list
20519107|NCT01719614|Rilpivirine|rilpivirine|mesh-list
20519108|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519109|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519110|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20519111|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20519112|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519113|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519114|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
20519115|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519116|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20519117|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20519118|NCT01719627|Maraviroc|maraviroc|mesh-list
20519119|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20519120|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20519121|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519122|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20519123|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20519124|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
20519125|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519126|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20519127|NCT01719640|Insulin|insulin|mesh-list
20519128|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519129|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519130|NCT01719692|Rituximab|rituximab|mesh-list
20519131|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20519132|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519133|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
20519134|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519135|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20519136|NCT01719705|Pregabalin|pregabalin|mesh-list
20519137|NCT01719705|Analgesics|analgesics|mesh-ancestor
20519138|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
20519139|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519140|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519141|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
20519142|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20519143|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519144|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519145|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20519146|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20519147|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20519148|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519149|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20519150|NCT01719770|Rocuronium|rocuronium|mesh-list
20519151|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20519152|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20519153|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20519154|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519155|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519156|NCT01719835|Gemcitabine|gemcitabine|mesh-list
20519157|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
20519158|NCT01719835|Prednisolone|prednisolone|mesh-list
20519159|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
20519160|NCT01719835|Doxorubicin|doxorubicin|mesh-list
20519161|NCT01719835|Vincristine|vincristine|mesh-list
20519162|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20519163|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
20519164|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519165|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20519166|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20519167|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
20519168|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519169|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519170|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20519171|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20519172|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
20245278|NCT00423826|Fludarabine|fludarabine|mesh-list
20245279|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
20245280|NCT00423826|Busulfan|busulfan|mesh-list
20519173|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
20519174|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519175|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519176|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20519177|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20519178|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20519179|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20519180|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
20519181|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
20519182|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
20519183|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519184|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
20519185|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
20519186|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519187|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20519188|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
20519189|NCT01719835|Hormones|hormones|mesh-ancestor
20519190|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519191|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19415827|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415828|NCT02675829|Trastuzumab|trastuzumab|mesh-list
19702764|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
19702765|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519192|NCT01719835|Protective Agents|protective agents|mesh-ancestor
20519193|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20519194|NCT01719926|Indomethacin|indomethacin|mesh-list
20519195|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20519196|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20519197|NCT01719926|Analgesics|analgesics|mesh-ancestor
20519198|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
20519199|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519200|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519201|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519202|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20519203|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
20519204|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
20519205|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20519206|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20519207|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415829|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19415830|NCT02675829|Maytansine|maytansine|mesh-list
19415831|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415832|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415833|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20245281|NCT00423826|Tacrolimus|tacrolimus|mesh-list
20245282|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702766|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
19702767|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702768|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519208|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519209|NCT01719952|Oxytocin|oxytocin|mesh-list
20519210|NCT01719952|Carbetocin|carbetocin|mesh-list
20519211|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
20519212|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20519213|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519214|NCT01719978|Epinephrine|epinephrine|mesh-list
19702769|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19702770|NCT03352934|Avelumab|avelumab|mesh-list
19702771|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702772|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702773|NCT03341689|Psilocybin|psilocybin|mesh-list
19853988|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519215|NCT01719978|Racepinephrine|racepinephrine|mesh-list
20519216|NCT01719978|Mepivacaine|mepivacaine|mesh-list
20519217|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
20519218|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20519219|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20519220|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519221|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519222|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519223|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519224|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20519225|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20519226|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
20519227|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519228|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20519229|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
20519230|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
20519231|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
20519232|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20519233|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
19702774|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
19853989|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519234|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
20519235|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19853990|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20519236|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
19853991|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
19853992|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19853993|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19853994|NCT00735917|Saracatinib|saracatinib|mesh-list
19853995|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19853996|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19853997|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19853998|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19853999|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854000|NCT00735969|Ribavirin|ribavirin|mesh-list
19854001|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
19854002|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854003|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
20519237|NCT01720030|Simendan|simendan|mesh-list
20519238|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20519239|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519240|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20519241|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20519242|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519243|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519244|NCT01720030|Protective Agents|protective agents|mesh-ancestor
20519245|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519246|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20519247|NCT01720056|Verapamil|verapamil|mesh-list
19854004|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519248|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519249|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
20519250|NCT01720056|Hormones|hormones|mesh-ancestor
20519251|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519252|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519253|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20519254|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
20519255|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519256|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20519257|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20519258|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519259|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20519260|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519261|NCT01720095|Niacin|niacin|mesh-list
20519262|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
20519263|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20519264|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
20519265|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519266|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20519267|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519268|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
20519269|NCT01720095|Vitamins|vitamins|mesh-ancestor
20519270|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
20519271|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519272|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
20519273|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20519274|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
20519275|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20519276|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
20519277|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519278|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519279|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
20519280|NCT01720212|Mirabegron|mirabegron|mesh-list
20519281|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20519282|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20519283|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19702775|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702776|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20519284|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519285|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519286|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519287|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519288|NCT01720212|Urological Agents|urological agents|mesh-ancestor
20519289|NCT01720238|Lamivudine|lamivudine|mesh-list
20519290|NCT01720238|Adefovir|adefovir|mesh-list
20519291|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20519292|NCT01720238|Entecavir|entecavir|mesh-list
20519293|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20519294|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20519295|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519296|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519297|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
19702777|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
19702778|NCT03340766|Blinatumomab|blinatumomab|mesh-list
19702779|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20519298|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519299|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20519300|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20519301|NCT01720290|Metformin|metformin|mesh-list
20519302|NCT01720290|Repaglinide|repaglinide|mesh-list
20519303|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519304|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519305|NCT01720303|Insulin|insulin|mesh-list
20519306|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20519307|NCT01720303|Repaglinide|repaglinide|mesh-list
20519308|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
20519309|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
20519310|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
20519311|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519312|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519313|NCT01720394|Dinoprostone|dinoprostone|mesh-list
20519314|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
20519315|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20519316|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519317|NCT01720407|Imiquimod|imiquimod|mesh-list
20519318|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20519319|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
19702780|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702781|NCT03300817|Poly ICLC|poly iclc|mesh-list
19702782|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
19702783|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
19702784|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702785|NCT03257033|Gemcitabine|gemcitabine|mesh-list
19702786|NCT03257033|Paclitaxel|paclitaxel|mesh-list
20519320|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519321|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519322|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
19702787|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20519323|NCT01720459|Resveratrol|resveratrol|mesh-list
19702788|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702789|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
19702790|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
19702791|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19702792|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702793|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19702794|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
19702795|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
19702796|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702797|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702798|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702799|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
19702800|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702801|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
19702802|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702803|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702804|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
19702805|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19702806|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
19702807|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702808|NCT03154580|Expectorants|expectorants|mesh-ancestor
20519324|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
20519325|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519326|NCT01720459|Protective Agents|protective agents|mesh-ancestor
20519327|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519328|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519329|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20519330|NCT01720485|Prednisolone|prednisolone|mesh-list
20519331|NCT01720485|Betamethasone|betamethasone|mesh-list
20519332|NCT01720485|Desloratadine|desloratadine|mesh-list
20519333|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
20519334|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519335|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
20519336|NCT01720485|Hormones|hormones|mesh-ancestor
20519337|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415834|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20519338|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519339|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19415835|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
19415836|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
19415837|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415838|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19415839|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19415840|NCT02664558|Ubenimex|ubenimex|mesh-list
20519340|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702809|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
19702810|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19702811|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
19415841|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20519341|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20519342|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
20519343|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20519344|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
20519345|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519346|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519347|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20519348|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20519349|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
19702812|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702813|NCT03154580|Protective Agents|protective agents|mesh-ancestor
19702814|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702815|NCT03154580|Antidotes|antidotes|mesh-ancestor
19702816|NCT03123978|Niclosamide|niclosamide|mesh-list
19702817|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
19702818|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19702819|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
20245283|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245284|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
20245285|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245286|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245287|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
20245288|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245289|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
20245290|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245291|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20245292|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245293|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20245294|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20245295|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
20245296|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20245297|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
20245298|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20519350|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
20519351|NCT01720498|Remifentanil|remifentanil|mesh-list
20519352|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20519353|NCT01720498|Narcotics|narcotics|mesh-ancestor
20519354|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519355|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519356|NCT01720498|Analgesics|analgesics|mesh-ancestor
20519357|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
20519358|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519359|NCT01720537|Bococizumab|bococizumab|mesh-list
20519360|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20519361|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20519362|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20519363|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
20519364|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519365|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20519366|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
20519367|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519368|NCT01720563|Leucovorin|leucovorin|mesh-list
20519369|NCT01720563|Tegafur|tegafur|mesh-list
20519370|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519371|NCT01720563|Antidotes|antidotes|mesh-ancestor
20519372|NCT01720563|Protective Agents|protective agents|mesh-ancestor
20519373|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519374|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
20519375|NCT01720563|Vitamins|vitamins|mesh-ancestor
20519376|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
20519377|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20519378|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
20519379|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530069|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20530070|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530071|NCT01785979|Amebicides|amebicides|mesh-ancestor
20530072|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20530073|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20530074|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530075|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
20530076|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530077|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20530078|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530079|NCT01785979|Analgesics|analgesics|mesh-ancestor
20530080|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
20530081|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519380|NCT01720615|Remifentanil|remifentanil|mesh-list
20519381|NCT01720615|Propofol|propofol|mesh-list
20519382|NCT01720615|Sevoflurane|sevoflurane|mesh-list
20519383|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20519384|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519385|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519386|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20519387|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
20519388|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
20519389|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20519390|NCT01720615|Narcotics|narcotics|mesh-ancestor
20519391|NCT01720615|Analgesics|analgesics|mesh-ancestor
20519392|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
20519393|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519394|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20519395|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20519396|NCT01720628|Angiogenin|angiogenin|mesh-list
20519397|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20519398|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20519399|NCT01720628|Growth Substances|growth substances|mesh-ancestor
20519400|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519401|NCT01720719|Vitamin E|vitamin e|mesh-list
19702820|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19702821|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702822|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
19702823|NCT03043599|Nivolumab|nivolumab|mesh-list
19702824|NCT03043599|Ipilimumab|ipilimumab|mesh-list
19702825|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20519402|NCT01720719|Atorvastatin|atorvastatin|mesh-list
20519403|NCT01720719|Vitamins|vitamins|mesh-ancestor
20519404|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
20519405|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519406|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20519407|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19415842|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
20519408|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
20519409|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519410|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20519411|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19702826|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702827|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19702828|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702829|NCT02877550|Venetoclax|venetoclax|mesh-list
19702830|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
19702831|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245299|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20245300|NCT00423865|Everolimus|everolimus|mesh-list
20245301|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245302|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702832|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19702833|NCT02720185|Dasatinib|dasatinib|mesh-list
19702834|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702835|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19702836|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702837|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702838|NCT02706847|Upadacitinib|upadacitinib|mesh-list
19702839|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20245303|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
20245304|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702840|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19702841|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245305|NCT00423969|Galantamine|galantamine|mesh-list
20245306|NCT00423969|Citalopram|citalopram|mesh-list
20519412|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519413|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
20519414|NCT01720719|Protective Agents|protective agents|mesh-ancestor
19854005|NCT00736073|Aprepitant|aprepitant|mesh-list
19854006|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
19854007|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
19854008|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854009|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854010|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854011|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20519419|NCT01720875|Dexamethasone|dexamethasone|mesh-list
20519420|NCT01720875|Bortezomib|bortezomib|mesh-list
20519421|NCT01720875|Vorinostat|vorinostat|mesh-list
20519422|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519423|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
20245307|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20245308|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20245309|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20245310|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245311|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854012|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519424|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
20519425|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519426|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519427|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20519428|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
20519429|NCT01720875|Hormones|hormones|mesh-ancestor
20519430|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519431|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20519432|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519433|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20519434|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519435|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519436|NCT01720940|Vancomycin|vancomycin|mesh-list
20519437|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20519438|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519439|NCT01721031|Tramadol|tramadol|mesh-list
20519440|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20245312|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
20245313|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248053|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
20519441|NCT01721031|Narcotics|narcotics|mesh-ancestor
20530082|NCT01785979|Filaricides|filaricides|mesh-ancestor
20245314|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20519442|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519443|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519444|NCT01721031|Analgesics|analgesics|mesh-ancestor
20519445|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
20519446|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519447|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
20519448|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20519449|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20519450|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519451|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20519452|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20519453|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519454|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519455|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519456|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20519457|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
20519458|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20519459|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519460|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20519461|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20519462|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20519463|NCT01721291|Albuterol|albuterol|mesh-list
20519464|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20519465|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
20519466|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519467|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519468|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20519469|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
20519470|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
20519471|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20519472|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20519473|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20519474|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20519475|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519476|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519477|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245315|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
20519478|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20519479|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519480|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519481|NCT01721382|Incretins|incretins|mesh-ancestor
20519482|NCT01721382|Hormones|hormones|mesh-ancestor
20519483|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245316|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20519484|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20519485|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
20519486|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519487|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519488|NCT01721434|Simendan|simendan|mesh-list
20519489|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20519490|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519491|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20519492|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20519493|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519494|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854013|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854014|NCT00736099|Pioglitazone|pioglitazone|mesh-list
19854015|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19854016|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519495|NCT01721434|Protective Agents|protective agents|mesh-ancestor
20519496|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519497|NCT01721525|Ribavirin|ribavirin|mesh-list
20519498|NCT01721525|Paclitaxel|paclitaxel|mesh-list
20519499|NCT01721525|Carboplatin|carboplatin|mesh-list
20519500|NCT01721525|Afatinib|afatinib|mesh-list
20519501|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20519502|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519503|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
20519504|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
20519505|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
20519506|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519507|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
20519508|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
20519509|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519510|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20519511|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519512|NCT01721616|Azithromycin|azithromycin|mesh-list
20519513|NCT01721616|Cefazolin|cefazolin|mesh-list
20519514|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20519515|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519516|NCT01721655|Spironolactone|spironolactone|mesh-list
20519517|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20519518|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
20519519|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519520|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519521|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20519522|NCT01721655|Diuretics|diuretics|mesh-ancestor
20519523|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
20519524|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20519525|NCT01721694|Azithromycin|azithromycin|mesh-list
20519526|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20519527|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519528|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20519529|NCT01721707|Latanoprost|latanoprost|mesh-list
20519530|NCT01721707|Brinzolamide|brinzolamide|mesh-list
20519531|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20519532|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20519533|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20519534|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245317|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
20245318|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519535|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519536|NCT01721798|Copper|copper|mesh-list
20519537|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
20519538|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20519539|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
20519540|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20519541|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519542|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20519543|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20245319|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
20245320|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20245321|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245322|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20245323|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
20245324|NCT00423982|Vancomycin|vancomycin|mesh-list
20245325|NCT00423982|Rifampin|rifampin|mesh-list
20519544|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20519545|NCT01721798|Trace Elements|trace elements|mesh-ancestor
20245326|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20245327|NCT00423982|Cloxacillin|cloxacillin|mesh-list
19854017|NCT00736190|Tenofovir|tenofovir|mesh-list
20519546|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
20519547|NCT01721915|Vitamin D|vitamin d|mesh-list
20519548|NCT01721915|Vitamins|vitamins|mesh-ancestor
20519549|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
20519550|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519551|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20519552|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
20519553|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20519554|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519555|NCT01722110|Indomethacin|indomethacin|mesh-list
20519556|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20519557|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20519558|NCT01722110|Analgesics|analgesics|mesh-ancestor
20519559|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
20519560|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519561|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519562|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519563|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20519564|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
20519565|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
20519566|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19854018|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
20519567|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19702842|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702843|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702844|NCT02564900|Camptothecin|camptothecin|mesh-list
19702845|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
19702846|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19702847|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702848|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19702849|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702850|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702851|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702852|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
19702853|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702854|NCT02496780|Insulin|insulin|mesh-list
19702855|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19702856|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
19702857|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
19702858|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519568|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519569|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519570|NCT01722201|Risperidone|risperidone|mesh-list
20519571|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20519572|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
20519573|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519574|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519575|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519576|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20519577|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20519578|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519579|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20519580|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20519581|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
20519582|NCT01722214|Adalimumab|adalimumab|mesh-list
20519583|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519584|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702859|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702860|NCT02393859|Dexamethasone|dexamethasone|mesh-list
20519585|NCT01722227|Liraglutide|liraglutide|mesh-list
19702861|NCT02393859|Methotrexate|methotrexate|mesh-list
19702862|NCT02393859|Daunorubicin|daunorubicin|mesh-list
19702863|NCT02393859|Asparaginase|asparaginase|mesh-list
19702864|NCT02393859|Ifosfamide|ifosfamide|mesh-list
19702865|NCT02393859|Blinatumomab|blinatumomab|mesh-list
19702866|NCT02393859|Pegaspargase|pegaspargase|mesh-list
19702867|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702868|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
19702869|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
19702870|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702871|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702872|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702873|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
19702874|NCT02393859|Hormones|hormones|mesh-ancestor
19702875|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702876|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702877|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702878|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19702879|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
19702880|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19702881|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19702882|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
19702883|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702884|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
19702885|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702886|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19702887|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702888|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
20519586|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519587|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519588|NCT01722227|Incretins|incretins|mesh-ancestor
20519589|NCT01722227|Hormones|hormones|mesh-ancestor
20519590|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519591|NCT01722240|Liraglutide|liraglutide|mesh-list
19702889|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19702890|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19702891|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19702892|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19702893|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19702894|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19702895|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
19702896|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19702897|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702898|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20519592|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20519593|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519594|NCT01722240|Incretins|incretins|mesh-ancestor
20519595|NCT01722240|Hormones|hormones|mesh-ancestor
20519596|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519597|NCT01722305|Dexamethasone|dexamethasone|mesh-list
20519598|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
20519599|NCT01722305|Pomalidomide|pomalidomide|mesh-list
20519600|NCT01722305|Ichthammol|ichthammol|mesh-list
20519601|NCT01722305|BB 1101|bb 1101|mesh-list
20519602|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519603|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
20519604|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
20519605|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519606|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702899|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702900|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519607|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20519608|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
20519609|NCT01722305|Hormones|hormones|mesh-ancestor
20519610|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519611|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20519612|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519613|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
20519614|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519615|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519616|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
20519617|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20519618|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20519619|NCT01722305|Growth Substances|growth substances|mesh-ancestor
20519620|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
20519621|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
20519622|NCT01722396|Vitamin D|vitamin d|mesh-list
20519623|NCT01722396|Vitamins|vitamins|mesh-ancestor
19702901|NCT02178358|Sorafenib|sorafenib|mesh-list
19702902|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519624|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
19702903|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19702904|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530083|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
20519625|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519626|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20519627|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
20519628|NCT01722409|Sevoflurane|sevoflurane|mesh-list
20519629|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20519630|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519631|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519632|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20519633|NCT01722409|Analgesics|analgesics|mesh-ancestor
20519634|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
20519635|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519636|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20519637|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20519638|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20519639|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519640|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519641|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519642|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20519643|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20519644|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
20519645|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
20530084|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
20530085|NCT01786018|Cyclosporine|cyclosporine|mesh-list
20530086|NCT01786018|Methotrexate|methotrexate|mesh-list
20530087|NCT01786018|Busulfan|busulfan|mesh-list
20530088|NCT01786018|Thiotepa|thiotepa|mesh-list
20245328|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
20530089|NCT01786018|Cyclosporins|cyclosporins|mesh-list
20530090|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20530091|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
20530092|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20530093|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530094|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20530095|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
20530096|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530097|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530098|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
20530099|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530100|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20530101|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20530102|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
20530103|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530104|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20530105|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
20530106|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519646|NCT01722448|Choline|choline|mesh-list
20519647|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
20519648|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20519649|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
20519650|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519651|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20519652|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20519653|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
20519654|NCT01722513|Alprostadil|alprostadil|mesh-list
20519655|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20519656|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519657|NCT01722513|Urological Agents|urological agents|mesh-ancestor
20519658|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
20519659|NCT01722539|Piperaquine|piperaquine|mesh-list
20519660|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
20519661|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20519662|NCT01722539|Albendazole|albendazole|mesh-list
20519663|NCT01722539|Praziquantel|praziquantel|mesh-list
20519664|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
20248054|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20519665|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20519666|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20519667|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519668|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20519669|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519670|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519671|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20519672|NCT01722539|Renal Agents|renal agents|mesh-ancestor
20519673|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
20519674|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
20519675|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20519676|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
20519677|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
20519678|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
20519679|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519680|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
20519681|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20519682|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20519683|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519684|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519685|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519686|NCT01722630|Dopamine|dopamine|mesh-list
20519687|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20519688|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
20519689|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
20519690|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519691|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519692|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
20519693|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519694|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519695|NCT01722630|Protective Agents|protective agents|mesh-ancestor
20519696|NCT01722656|Aflibercept|aflibercept|mesh-list
20519697|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20519698|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20519699|NCT01722656|Growth Substances|growth substances|mesh-ancestor
20519700|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519701|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
20519702|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519703|NCT01722708|Metronidazole|metronidazole|mesh-list
20519704|NCT01722708|Clindamycin|clindamycin|mesh-list
20519705|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
20519706|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
20519707|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519708|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20519709|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20519710|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20519711|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20519712|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519713|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519714|NCT01722799|Paclitaxel|paclitaxel|mesh-list
20519715|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20519716|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519717|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
20519718|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
20519719|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
20519720|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519721|NCT01722942|Amiodarone|amiodarone|mesh-list
20519722|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20519723|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519724|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20519725|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519726|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519727|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20519728|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20519729|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20519730|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519731|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20519732|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20519733|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20519734|NCT01722968|Paclitaxel|paclitaxel|mesh-list
20519735|NCT01722968|Bevacizumab|bevacizumab|mesh-list
19702905|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702906|NCT02157610|Nicotine|nicotine|mesh-list
19702907|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20519736|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20519737|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519738|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
20519739|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
20519740|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
20519741|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519742|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20519743|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20519744|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20519745|NCT01722968|Growth Substances|growth substances|mesh-ancestor
20519746|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519747|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
20519748|NCT01723059|Amoxicillin|amoxicillin|mesh-list
20519749|NCT01723059|Metronidazole|metronidazole|mesh-list
20519750|NCT01723059|Clarithromycin|clarithromycin|mesh-list
20519751|NCT01723059|Omeprazole|omeprazole|mesh-list
20519752|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20519753|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519754|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20519755|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20519756|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20519757|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20519758|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20519759|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519760|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519761|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20519762|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20519763|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20519764|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
20519765|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
20519766|NCT01723150|Ertapenem|ertapenem|mesh-list
20519767|NCT01723150|Trimethoprim|trimethoprim|mesh-list
20519768|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
20519769|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20519770|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519771|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20519772|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20519773|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519774|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519775|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519776|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20519777|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20519778|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20519779|NCT01723150|Renal Agents|renal agents|mesh-ancestor
20519780|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
20519781|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20519782|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20519783|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20519784|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20519785|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20519786|NCT01723371|Carvedilol|carvedilol|mesh-list
20519787|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20519788|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20519789|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519790|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519791|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519792|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519793|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20519794|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
20519795|NCT01723371|Protective Agents|protective agents|mesh-ancestor
20519796|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20519797|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519798|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20519799|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
20519800|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20519801|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20519802|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
20519803|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20519804|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519805|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
20519806|NCT01723527|Buprenorphine|buprenorphine|mesh-list
20519807|NCT01723527|Methadone|methadone|mesh-list
20519808|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20519809|NCT01723527|Narcotics|narcotics|mesh-ancestor
20519810|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519811|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519812|NCT01723527|Analgesics|analgesics|mesh-ancestor
20519813|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
20519814|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519815|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19702908|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
19702909|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519816|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
20519817|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
20519818|NCT01723553|Corticosterone|corticosterone|mesh-list
20519819|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519820|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
20519821|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20248055|NCT00434382|Narcotics|narcotics|mesh-ancestor
20519822|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519823|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
19702910|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702911|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19702912|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19702913|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
19702914|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519824|NCT01723670|Analgesics|analgesics|mesh-ancestor
20519825|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
20519826|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519827|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519828|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20519829|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20519830|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519831|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20519832|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20519833|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519834|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519835|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20519836|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
20519837|NCT01723735|Ezetimibe|ezetimibe|mesh-list
20519838|NCT01723735|Fenofibrate|fenofibrate|mesh-list
20519839|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20519840|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20519841|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
20519842|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519843|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20519844|NCT01723748|Hormones|hormones|mesh-list
20519845|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519846|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519847|NCT01723774|Anastrozole|anastrozole|mesh-list
20519848|NCT01723774|Goserelin|goserelin|mesh-list
20519849|NCT01723774|Palbociclib|palbociclib|mesh-list
19854019|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854020|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19854021|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19854022|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854023|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702915|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854024|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19854025|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19854026|NCT00736229|Exenatide|exenatide|mesh-list
20519850|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20519851|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519852|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20519853|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20519854|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519855|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519856|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20519857|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
20519858|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519859|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519860|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20519861|NCT01723800|Carboplatin|carboplatin|mesh-list
20519862|NCT01723800|Pemetrexed|pemetrexed|mesh-list
20519863|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702916|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
19702917|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19702918|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19702919|NCT01838174|Prednisolone|prednisolone|mesh-list
19702920|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
19702921|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19702922|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
19702923|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19702924|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
19702925|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
19702926|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702927|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702928|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19702929|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
19702930|NCT01838174|Hormones|hormones|mesh-ancestor
20519864|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519865|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519866|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20519867|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20519868|NCT01723852|Vitamin D|vitamin d|mesh-list
20519869|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
20519870|NCT01723852|Vitamins|vitamins|mesh-list
20519871|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
20519872|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519873|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19702931|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519874|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20519875|NCT01724086|Interferons|interferons|mesh-list
20519876|NCT01724086|Ritonavir|ritonavir|mesh-list
20519877|NCT01724086|Ribavirin|ribavirin|mesh-list
20519878|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
20519879|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
20519880|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20519881|NCT01724086|Simeprevir|simeprevir|mesh-list
20519882|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519883|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
20519884|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519885|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20519886|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20519887|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
20519888|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519889|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519890|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20519891|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20519892|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20519893|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20519894|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
20519895|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
20519896|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519897|NCT01724138|Deferasirox|deferasirox|mesh-list
20519898|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20519899|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
20519900|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
20519901|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530107|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20530108|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
20530109|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20530110|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20530111|NCT01786070|Budesonide|budesonide|mesh-list
20530112|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530113|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20530114|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
20530115|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530116|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530117|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20530118|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
20530119|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
20530120|NCT01786070|Hormones|hormones|mesh-ancestor
20530121|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530122|NCT01786200|Aspirin|aspirin|mesh-list
20530123|NCT01786200|Ibuprofen|ibuprofen|mesh-list
20530124|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20530125|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530126|NCT01786200|Analgesics|analgesics|mesh-ancestor
20519902|NCT01724190|Vitamin D|vitamin d|mesh-list
20519903|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
20519904|NCT01724190|Vitamins|vitamins|mesh-ancestor
20519905|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
20519906|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519907|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20519908|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20519909|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
20519910|NCT01724229|Clotrimazole|clotrimazole|mesh-list
20519911|NCT01724229|Miconazole|miconazole|mesh-list
20519912|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20519913|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20519914|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20519915|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20519916|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519917|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519918|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20519919|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
20519920|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519921|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519922|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20519923|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20519924|NCT01724268|Prednisolone|prednisolone|mesh-list
20519925|NCT01724268|Methotrexate|methotrexate|mesh-list
20519926|NCT01724268|Methamphetamine|methamphetamine|mesh-list
20519927|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20519928|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
20519929|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20519930|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519931|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20519932|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
20519933|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519934|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519935|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
20519936|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519937|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20519938|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20519939|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
20519940|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20519941|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20519942|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20519943|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
20519944|NCT01724268|Hormones|hormones|mesh-ancestor
20519945|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20519946|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20519947|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
20519948|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20519949|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20519950|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
20519951|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
20519952|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519953|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
20519954|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20519955|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20519956|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519957|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20519958|NCT01724346|Chlorambucil|chlorambucil|mesh-list
20519959|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20519960|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
20519961|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519962|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519963|NCT01724372|Aripiprazole|aripiprazole|mesh-list
20519964|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
20519965|NCT01724372|Fluoxetine|fluoxetine|mesh-list
20519966|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
20519967|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20519968|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20519969|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20519970|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519971|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
20519972|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
20519973|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20519974|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20519975|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20519976|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20519977|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
20519978|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20519979|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20519980|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20519981|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20519982|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20519983|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20245329|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20245330|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
20519984|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20519985|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20519986|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20519987|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20519988|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20519989|NCT01724385|Bevacizumab|bevacizumab|mesh-list
20519990|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19854027|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245331|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
20519991|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20519992|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20519993|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20519994|NCT01724385|Growth Substances|growth substances|mesh-ancestor
20519995|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20519996|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
20519997|NCT01724424|Melatonin|melatonin|mesh-list
20519998|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
20519999|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520000|NCT01724424|Protective Agents|protective agents|mesh-ancestor
20520001|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520002|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520003|NCT01724450|Carvedilol|carvedilol|mesh-list
20520004|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20520005|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20520006|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
20520007|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520008|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520009|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520010|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20520011|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
20520012|NCT01724450|Protective Agents|protective agents|mesh-ancestor
20520013|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20520014|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520015|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20520016|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
20520017|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20520018|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20520019|NCT01724554|Aflibercept|aflibercept|mesh-list
20520020|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20520021|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20520022|NCT01724554|Growth Substances|growth substances|mesh-ancestor
20520023|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520024|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
20520025|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520026|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
20520027|NCT01724619|Androgens|androgens|mesh-ancestor
20520028|NCT01724619|Hormones|hormones|mesh-ancestor
20520029|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20520030|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520031|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
20520032|NCT01724658|Testosterone|testosterone|mesh-list
20520033|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
20520034|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
20520035|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20520036|NCT01724658|Androgens|androgens|mesh-ancestor
20520037|NCT01724658|Hormones|hormones|mesh-ancestor
20520038|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20520039|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520040|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20520041|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520042|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
20520043|NCT01724723|Entecavir|entecavir|mesh-list
20520044|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
20520045|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520046|NCT01724788|Furosemide|furosemide|mesh-list
20520047|NCT01724788|Diuretics|diuretics|mesh-ancestor
20520048|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
20520049|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520050|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20520051|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520052|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520053|NCT01724814|Insulin|insulin|mesh-list
20520054|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20248056|NCT00434382|Analgesics|analgesics|mesh-ancestor
20520055|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520056|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20520057|NCT01724892|Dexamethasone|dexamethasone|mesh-list
20520058|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520059|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
20520060|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
20520061|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520062|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520063|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20520064|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
20520065|NCT01724892|Hormones|hormones|mesh-ancestor
20520066|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20520067|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20520068|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520069|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20520070|NCT01724918|Lacosamide|lacosamide|mesh-list
20520071|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
20520072|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20520073|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20520074|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520075|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520076|NCT01724931|Aminopterin|aminopterin|mesh-list
20520077|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20520078|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520079|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520080|NCT01724983|Fentanyl|fentanyl|mesh-list
20520081|NCT01724983|Ketamine|ketamine|mesh-list
20520082|NCT01724983|Analgesics|analgesics|mesh-ancestor
20520083|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
20520084|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520085|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520086|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20520087|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20520088|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
20520089|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
20520090|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520091|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20520092|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20520093|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520094|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520095|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20520096|NCT01724983|Narcotics|narcotics|mesh-ancestor
20520097|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20520098|NCT01725009|Levetiracetam|levetiracetam|mesh-list
20520099|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
20520100|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
20520101|NCT01725048|Mirtazapine|mirtazapine|mesh-list
20520102|NCT01725048|Citalopram|citalopram|mesh-list
20520103|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20520104|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20520105|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520106|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520107|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520108|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
20520109|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520110|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20520111|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
20520112|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20520113|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20520114|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
20520115|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
20520116|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20520117|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20520118|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520119|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20520120|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20520121|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20520122|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20520123|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20520124|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20520125|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20520126|NCT01725087|Tapentadol|tapentadol|mesh-list
20520127|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20520128|NCT01725087|Narcotics|narcotics|mesh-ancestor
20520129|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520130|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520131|NCT01725087|Analgesics|analgesics|mesh-ancestor
20520132|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
20520133|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520134|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20520135|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20520136|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520137|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520138|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
20520139|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520140|NCT01725100|Trametinib|trametinib|mesh-list
20520141|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20520142|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520143|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20520144|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520145|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520146|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20520147|NCT01725100|Protective Agents|protective agents|mesh-ancestor
20520148|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520149|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20520150|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
20520151|NCT01725113|Calcitriol|calcitriol|mesh-list
20520152|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20520153|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520154|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20520155|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520156|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520157|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20520158|NCT01725113|Vitamins|vitamins|mesh-ancestor
20520159|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
20520160|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20520161|NCT01725204|Dasatinib|dasatinib|mesh-list
20520162|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520163|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20520164|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520165|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520166|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20520167|NCT01725230|Simvastatin|simvastatin|mesh-list
20520168|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20520169|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20520170|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
20520171|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520172|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20520173|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20520174|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520175|NCT01725243|Carbetocin|carbetocin|mesh-list
20520176|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
20520177|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20520178|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520179|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20520180|NCT01725360|Montelukast|montelukast|mesh-list
20520181|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20520182|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
20520183|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20520184|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
20520185|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20520186|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520187|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20520188|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20520189|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520190|NCT01725412|Thiamine|thiamine|mesh-list
20520191|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
19415843|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415844|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20520192|NCT01725412|Vitamins|vitamins|mesh-ancestor
20520193|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
20520194|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520195|NCT01725477|Methylene Blue|methylene blue|mesh-list
20520196|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520197|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520198|NCT01725490|Metformin|metformin|mesh-list
20520199|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20520200|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520201|NCT01725542|Ribavirin|ribavirin|mesh-list
20520202|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20520203|NCT01725542|Asunaprevir|asunaprevir|mesh-list
20520204|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
20520205|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520206|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
20520207|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520208|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
20520209|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520210|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
20520211|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20520212|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520213|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
20520214|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
20520215|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
20520216|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
20520217|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
20520218|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520219|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
20520220|NCT01725607|Anesthetics|anesthetics|mesh-list
20520221|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520222|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520223|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20520224|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20520225|NCT01725607|Analgesics|analgesics|mesh-ancestor
20520226|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
20520227|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520228|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20520229|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20520230|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20520231|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
20520232|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520233|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702932|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20520234|NCT01725620|Etanercept|etanercept|mesh-list
19702933|NCT01838174|Protective Agents|protective agents|mesh-ancestor
19702934|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19702935|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702936|NCT01532310|Belimumab|belimumab|mesh-list
19702937|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702938|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
19702939|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520235|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20520236|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20520237|NCT01725620|Analgesics|analgesics|mesh-ancestor
20520238|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
20520239|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520240|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520241|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520242|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520243|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20520244|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245332|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20245333|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245334|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245335|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20245336|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20245337|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20245338|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20245339|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20245340|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19702940|NCT01495637|Sargramostim|sargramostim|mesh-list
19702941|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
19702942|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702943|NCT01243190|Ofatumumab|ofatumumab|mesh-list
19702944|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702945|NCT00806390|Metoprolol|metoprolol|mesh-list
19702946|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19702947|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19702948|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
19702949|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
19702950|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19702951|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245341|NCT00424060|Sagopilone|sagopilone|mesh-list
20245342|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245343|NCT00424086|Vaccines|vaccines|mesh-list
20245344|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
20245345|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245346|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20245347|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20520245|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
20520246|NCT01725672|Metformin|metformin|mesh-list
20520247|NCT01725672|Glimepiride|glimepiride|mesh-list
20520248|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20520249|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520250|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20520251|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520252|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
20530127|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
19702952|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19702953|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20530128|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245348|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245349|NCT00424151|Rituximab|rituximab|mesh-list
20245350|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245351|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520253|NCT01725776|Milrinone|milrinone|mesh-list
20520254|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20520255|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20520256|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
20520257|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20520258|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20520259|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520260|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520261|NCT01725776|Protective Agents|protective agents|mesh-ancestor
20520262|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520263|NCT01725802|Levodopa|levodopa|mesh-list
20520264|NCT01725802|Carbidopa|carbidopa|mesh-list
20520265|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20520266|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20520267|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
20520268|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520269|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520270|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520271|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20245352|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
20245353|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245354|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245355|NCT00424164|Tamoxifen|tamoxifen|mesh-list
20245356|NCT00424164|Lapatinib|lapatinib|mesh-list
20245357|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245358|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20245359|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
20245360|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245361|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245362|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20245363|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245364|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20520272|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520273|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20520274|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20520275|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520276|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
20520277|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20520278|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20520279|NCT01726075|Somatostatin|somatostatin|mesh-list
20520280|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20520281|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20520282|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20520283|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20520284|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20520285|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
20520286|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520287|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520288|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520289|NCT01726075|Hormones|hormones|mesh-ancestor
20520290|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20520291|NCT01726088|Modafinil|modafinil|mesh-list
20520292|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19702954|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19702955|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
19702956|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520293|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520294|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20520295|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20520296|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20520297|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520298|NCT01726192|Ropivacaine|ropivacaine|mesh-list
20520299|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
20520300|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
20520301|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520302|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520303|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
20520304|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520305|NCT01726205|Pregabalin|pregabalin|mesh-list
20520306|NCT01726205|Ropivacaine|ropivacaine|mesh-list
20520307|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
20520308|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
20520309|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520310|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520311|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
20520312|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520313|NCT01726205|Analgesics|analgesics|mesh-ancestor
20520314|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
20520315|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20520316|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520317|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520318|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20520319|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20520320|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20520321|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20520322|NCT01726283|Riboflavin|riboflavin|mesh-list
20520323|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
20520324|NCT01726283|Vitamins|vitamins|mesh-ancestor
20520325|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
20520326|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520327|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20520328|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
20520329|NCT01726400|Interferons|interferons|mesh-list
20520330|NCT01726400|Ribavirin|ribavirin|mesh-list
20520331|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
20520332|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520333|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
20520334|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520335|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
20520336|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520337|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
20520338|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520339|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
20520340|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
20520341|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20520342|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20520343|NCT01726465|Prednisolone|prednisolone|mesh-list
20520344|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
20520345|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20520346|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
20520347|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20520348|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520349|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
19702957|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702958|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
20520350|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
20520351|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520352|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520353|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20520354|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
20520355|NCT01726465|Hormones|hormones|mesh-ancestor
20520356|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20520357|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20520358|NCT01726465|Protective Agents|protective agents|mesh-ancestor
20520359|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20520360|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520361|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
20520362|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520363|NCT01726465|Expectorants|expectorants|mesh-ancestor
20520364|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
20520365|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20520366|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
20520367|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520368|NCT01726465|Antidotes|antidotes|mesh-ancestor
20520369|NCT01726478|Oxytocin|oxytocin|mesh-list
20520370|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
20520371|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20520372|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520373|NCT01726530|Fentanyl|fentanyl|mesh-list
20520374|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20520375|NCT01726530|Narcotics|narcotics|mesh-ancestor
20520376|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520377|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520378|NCT01726530|Analgesics|analgesics|mesh-ancestor
20520379|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
20520380|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520381|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20520382|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20520383|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
20520384|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
20520385|NCT01726582|Leucovorin|leucovorin|mesh-list
20520386|NCT01726582|Gemcitabine|gemcitabine|mesh-list
20520387|NCT01726582|Paclitaxel|paclitaxel|mesh-list
20520388|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20520389|NCT01726582|Capecitabine|capecitabine|mesh-list
20520390|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
20520391|NCT01726582|Irinotecan|irinotecan|mesh-list
20520392|NCT01726582|Cisplatin|cisplatin|mesh-list
20520393|NCT01726582|Folfirinox|folfirinox|mesh-list
20520394|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20520395|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520396|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20520397|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20520398|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20520399|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520400|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20520401|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
19415845|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415846|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19415847|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702959|NCT00566618|Dasatinib|dasatinib|mesh-list
20520402|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
20520403|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520404|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520405|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520406|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
20520407|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520408|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20520409|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20520410|NCT01726582|Antidotes|antidotes|mesh-ancestor
20520411|NCT01726582|Protective Agents|protective agents|mesh-ancestor
20520412|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
20520413|NCT01726582|Vitamins|vitamins|mesh-ancestor
20520414|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
20520415|NCT01726686|Ropivacaine|ropivacaine|mesh-list
20520416|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
19702960|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245365|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20520417|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
20520418|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520419|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520420|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
20520421|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520422|NCT01726725|Desflurane|desflurane|mesh-list
20520423|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20520424|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
20520425|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
20245366|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20245367|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20245368|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245369|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
20245370|NCT00424203|Doxorubicin|doxorubicin|mesh-list
20245371|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20245372|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245373|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
20245374|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245375|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245376|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20245377|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
20245378|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520426|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520427|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520428|NCT01726764|Metformin|metformin|mesh-list
20520429|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245379|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245380|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20245381|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20520430|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520431|NCT01726777|Vitamin D|vitamin d|mesh-list
20520432|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
20520433|NCT01726777|Vitamins|vitamins|mesh-list
20520434|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
20520435|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520436|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20520437|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20520438|NCT01726816|Probucol|probucol|mesh-list
20520439|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20520440|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20520441|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
20520442|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520443|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20520444|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
20520445|NCT01726816|Protective Agents|protective agents|mesh-ancestor
20520446|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520447|NCT01726829|Pancrelipase|pancrelipase|mesh-list
20520448|NCT01726829|Pancreatin|pancreatin|mesh-list
20520449|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20520450|NCT01726920|Naproxen|naproxen|mesh-list
20520451|NCT01726920|Naratriptan|naratriptan|mesh-list
20520452|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20520453|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20520454|NCT01726920|Analgesics|analgesics|mesh-ancestor
20520455|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
20520456|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520457|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520458|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520459|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520460|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
20520461|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20245382|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20245383|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20245384|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245385|NCT00424229|Lenalidomide|lenalidomide|mesh-list
20245386|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
20520462|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520463|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520464|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20520465|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20520466|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20520467|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
20520468|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520469|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20520470|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
20520471|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19702961|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19702962|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19702963|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702964|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19702965|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702966|NCT00442559|Montelukast|montelukast|mesh-list
19702967|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19702968|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
20520472|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
20520473|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520474|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20520475|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
20520476|NCT01727050|Coagulants|coagulants|mesh-ancestor
20520477|NCT01727271|Interferons|interferons|mesh-list
20520478|NCT01727271|Tenofovir|tenofovir|mesh-list
20520479|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
20520480|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
20520481|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20520482|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520483|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
20520484|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520485|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20520486|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20520487|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520488|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520489|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20520490|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20520491|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
20520492|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520493|NCT01727401|PENTA|penta|mesh-list
20520494|NCT01727401|Fondaparinux|fondaparinux|mesh-list
20520495|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20520496|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
20520497|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20520498|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
20520499|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520500|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520501|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
20520502|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20520503|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20520504|NCT01727427|Aspirin|aspirin|mesh-list
20520505|NCT01727427|Vitamin K|vitamin k|mesh-list
20520506|NCT01727427|Heparin|heparin|mesh-list
20520507|NCT01727427|Enoxaparin|enoxaparin|mesh-list
20520508|NCT01727427|Dalteparin|dalteparin|mesh-list
20520509|NCT01727427|Tinzaparin|tinzaparin|mesh-list
20520510|NCT01727427|PENTA|penta|mesh-list
20520511|NCT01727427|Nadroparin|nadroparin|mesh-list
20520512|NCT01727427|Warfarin|warfarin|mesh-list
20520513|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
20520514|NCT01727427|Dabigatran|dabigatran|mesh-list
20520515|NCT01727427|Apixaban|apixaban|mesh-list
20520516|NCT01727427|Fondaparinux|fondaparinux|mesh-list
20520517|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
20520518|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
20520519|NCT01727427|Bemiparin|bemiparin|mesh-list
20520520|NCT01727427|Vitamins|vitamins|mesh-ancestor
20520521|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
20520522|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520523|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20520524|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20520525|NCT01727427|Analgesics|analgesics|mesh-ancestor
20520526|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
20520527|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520528|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520529|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520530|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20520531|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20520532|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520533|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20520534|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20520535|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415848|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
20520536|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
20520537|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
20520538|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20520539|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
20520540|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20520541|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
20520542|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20520543|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
20520544|NCT01727427|Coagulants|coagulants|mesh-ancestor
20520545|NCT01727453|Warfarin|warfarin|mesh-list
20520546|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
20530129|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530130|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20530131|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530132|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19415849|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415850|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415851|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19415852|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19415853|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
20530133|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20530134|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530135|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20530136|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20530137|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530138|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
20530139|NCT01786226|Mifepristone|mifepristone|mesh-list
20530140|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20530141|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
20530142|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20530143|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530144|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20530145|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20530146|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20530147|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
20530148|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20530149|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20530150|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
20530151|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20530152|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
20530153|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20530154|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20530155|NCT01786382|Midazolam|midazolam|mesh-list
20530156|NCT01786382|Omeprazole|omeprazole|mesh-list
20530157|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20530158|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20245387|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245388|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20245389|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19415857|NCT02661282|Temozolomide|temozolomide|mesh-list
20245390|NCT00424229|Growth Substances|growth substances|mesh-ancestor
20245391|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
20245392|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530159|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530160|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530161|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20530162|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20530163|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530164|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20530165|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
20530166|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
20530167|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
20530168|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
20530169|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530170|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530171|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20530172|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530173|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20530174|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530175|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
19415858|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20530176|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20530177|NCT01786538|Leucovorin|leucovorin|mesh-list
20530178|NCT01786538|Fluorouracil|fluorouracil|mesh-list
20530179|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
20530180|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
19415859|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
19415860|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520547|NCT01727531|Chloroquine|chloroquine|mesh-list
20520548|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20520549|NCT01727531|Amebicides|amebicides|mesh-ancestor
20520550|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20520551|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20520552|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520553|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
20520554|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520555|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20520556|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19415861|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415862|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19415863|NCT02659397|Atorvastatin|atorvastatin|mesh-list
19415864|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19415865|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19702969|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20520557|NCT01727531|Analgesics|analgesics|mesh-ancestor
19415866|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
20520558|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
20520559|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520560|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520561|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520562|NCT01727531|Filaricides|filaricides|mesh-ancestor
20520563|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
20520564|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
20520565|NCT01727557|Anesthetics|anesthetics|mesh-list
20520566|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520567|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520568|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20245393|NCT00424242|Pemetrexed|pemetrexed|mesh-list
20245394|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245395|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245396|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245397|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20245398|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20520569|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20520570|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520571|NCT01727778|Antibodies|antibodies|mesh-list
20520572|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
20520573|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
20520574|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702970|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
19708520|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520575|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
20520576|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20520577|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20520578|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520579|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
20520580|NCT01727843|Coagulants|coagulants|mesh-ancestor
20520581|NCT01727869|Cetuximab|cetuximab|mesh-list
20520582|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20520583|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20520584|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520585|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20520586|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520587|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520588|NCT01727973|Doxycycline|doxycycline|mesh-list
20520589|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20520590|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520591|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
20520592|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20520593|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19854028|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520594|NCT01728025|Ranolazine|ranolazine|mesh-list
20520595|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20520596|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520597|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520598|NCT01728051|Melphalan|melphalan|mesh-list
20520599|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20520600|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
20520601|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520602|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520603|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20520604|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520605|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
20520606|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415867|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415868|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19415869|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19415870|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415871|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415872|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415873|NCT02654990|Dexamethasone|dexamethasone|mesh-list
19415874|NCT02654990|Bortezomib|bortezomib|mesh-list
19415875|NCT02654990|Panobinostat|panobinostat|mesh-list
19415876|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19415877|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
19415878|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
19415879|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415880|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415881|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19415882|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
19415883|NCT02654990|Hormones|hormones|mesh-ancestor
19415884|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19415885|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19415886|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415887|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19415888|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415889|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415890|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
19415891|NCT02650804|Gemcitabine|gemcitabine|mesh-list
19415892|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19415893|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
19415894|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415895|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415896|NCT02650804|Antiviral Agents|antiviral agents|mesh-ancestor
20245399|NCT00424281|PENTA|penta|mesh-list
20520607|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
20520608|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20520609|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520610|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
20520611|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20520612|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520613|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20520614|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520615|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520616|NCT01728272|Metoprolol|metoprolol|mesh-list
20520617|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20520618|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20520619|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
19415897|NCT02650804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415898|NCT02650804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415899|NCT02650804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415900|NCT02650804|Immunologic Factors|immunologic factors|mesh-ancestor
19415901|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415902|NCT02650804|Vitamins|vitamins|mesh-ancestor
19415903|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
19415904|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
19415905|NCT02648347|Hematinics|hematinics|mesh-ancestor
19415906|NCT02646982|Candesartan|candesartan|mesh-list
19415907|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19415908|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19415909|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19415910|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245400|NCT00424281|Fondaparinux|fondaparinux|mesh-list
20245401|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20245402|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
20245403|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20520620|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
20245404|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
20520621|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245405|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520622|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520623|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20520624|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20520625|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20520626|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
20520627|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520628|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520629|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20520630|NCT01728363|Rifampin|rifampin|mesh-list
20520631|NCT01728363|Clindamycin|clindamycin|mesh-list
20520632|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
20520633|NCT01728363|Ticarcillin|ticarcillin|mesh-list
20520634|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
20520635|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520636|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20520637|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
20520638|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
20520639|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20520640|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520641|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520642|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20520643|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20520644|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20520645|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20520646|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20520647|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20520648|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19702971|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702972|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708521|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
20245406|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245407|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
20245408|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20245409|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20245410|NCT00424333|Insulin|insulin|mesh-list
20245411|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20245412|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245413|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245414|NCT00424411|Insulin|insulin|mesh-list
20245415|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20245416|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245417|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245418|NCT00424437|Insulin|insulin|mesh-list
19702973|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19702974|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19702975|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19702976|NCT00117338|Montelukast|montelukast|mesh-list
19702977|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19702978|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
19702979|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19702980|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
19702981|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19702982|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19702983|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19702984|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19702985|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245419|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20245420|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245421|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245422|NCT00424580|Montelukast|montelukast|mesh-list
20245423|NCT00424580|Desloratadine|desloratadine|mesh-list
20245424|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20245425|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
20245426|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20245427|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
20245428|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245429|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245430|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19702986|NCT04877626|Artesunate|artesunate|mesh-list
19702987|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
19702988|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19702989|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19702990|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19702991|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19702992|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
19854029|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19854030|NCT00736229|Incretins|incretins|mesh-ancestor
20245431|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19702993|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
19702994|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19702995|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
19702996|NCT04877509|Vitamin D|vitamin d|mesh-list
19702997|NCT04877509|Vitamin A|vitamin a|mesh-list
19702998|NCT04877509|Selenium|selenium|mesh-list
19702999|NCT04877509|Copper|copper|mesh-list
19703000|NCT04877509|Vitamins|vitamins|mesh-ancestor
19703001|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
19703002|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703003|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
19703004|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703005|NCT04877509|Protective Agents|protective agents|mesh-ancestor
19703006|NCT04877509|Trace Elements|trace elements|mesh-ancestor
20248057|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
19703007|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19708128|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19708129|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19708130|NCT04819828|Analgesics|analgesics|mesh-ancestor
19703008|NCT04877275|Dexamethasone|dexamethasone|mesh-list
19703009|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
19703010|NCT04877275|Doxorubicin|doxorubicin|mesh-list
19703011|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19703012|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703013|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
19703014|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703015|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703016|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19703017|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
19703018|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703019|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703020|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19703021|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703022|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
19703023|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
19703024|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703025|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703026|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
19703027|NCT04877275|Hormones|hormones|mesh-ancestor
19703028|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703029|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703030|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19703031|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20248058|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520649|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20520650|NCT01728441|Paclitaxel|paclitaxel|mesh-list
20520651|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20520652|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20520653|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520654|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
20520655|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
20520656|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
20520657|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520658|NCT01728480|Cisplatin|cisplatin|mesh-list
19854031|NCT00736229|Hormones|hormones|mesh-ancestor
19854032|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854033|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19854034|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
19854035|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
19854036|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854037|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854038|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19854039|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
19854040|NCT00736255|Nicotine|nicotine|mesh-list
19703032|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19703033|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703034|NCT04877210|Insulin|insulin|mesh-list
19703035|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19703036|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19703037|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703038|NCT04877106|Metformin|metformin|mesh-list
19703039|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19703040|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19703041|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703042|NCT04877106|Incretins|incretins|mesh-ancestor
20245432|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415916|NCT02638805|Metformin|metformin|mesh-list
19415917|NCT02638805|Liraglutide|liraglutide|mesh-list
19415918|NCT02638805|Exenatide|exenatide|mesh-list
19415919|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415920|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415921|NCT02638805|Incretins|incretins|mesh-ancestor
19415922|NCT02638805|Hormones|hormones|mesh-ancestor
19703043|NCT04877106|Hormones|hormones|mesh-ancestor
19854041|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19415923|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703044|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854042|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
19703045|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19703046|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
19703047|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703048|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703049|NCT04876716|Voriconazole|voriconazole|mesh-list
20245433|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20245434|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
20245435|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245436|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20520659|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520660|NCT01728571|Vitamin D|vitamin d|mesh-list
20245437|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20520661|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
20520662|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
20520663|NCT01728571|Vitamins|vitamins|mesh-list
20520664|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
20520665|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520666|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20520667|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20520668|NCT01728740|Metformin|metformin|mesh-list
20520669|NCT01728740|Acarbose|acarbose|mesh-list
20520670|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20520671|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520672|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20520673|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415924|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19415925|NCT02636582|Molgramostim|molgramostim|mesh-list
20245438|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
19415926|NCT02636582|Vaccines|vaccines|mesh-list
19415927|NCT02636582|Sargramostim|sargramostim|mesh-list
19415928|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
19415929|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703050|NCT04876716|Posaconazole|posaconazole|mesh-list
19703051|NCT04876716|Isavuconazole|isavuconazole|mesh-list
19703052|NCT04876716|Anidulafungin|anidulafungin|mesh-list
19415930|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415931|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19415932|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19415933|NCT02627274|Trastuzumab|trastuzumab|mesh-list
19415934|NCT02627274|Cetuximab|cetuximab|mesh-list
19415935|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415936|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415937|NCT02626338|Vidarabine|vidarabine|mesh-list
19415938|NCT02626338|Cytarabine|cytarabine|mesh-list
19415939|NCT02626338|Fludarabine|fludarabine|mesh-list
19703053|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
19415940|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
19703054|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245439|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
20245440|NCT00424606|Docetaxel|docetaxel|mesh-list
20245441|NCT00424606|Epirubicin|epirubicin|mesh-list
20245442|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245443|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
20245444|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245445|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
20245446|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245447|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20245448|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20245449|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20245450|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245451|NCT00424710|Ranibizumab|ranibizumab|mesh-list
20245452|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20245453|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20245454|NCT00424710|Growth Substances|growth substances|mesh-ancestor
20245455|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703055|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19703056|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19703057|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703058|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703059|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19703060|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
19708131|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
20245456|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
19703061|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703062|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703063|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19703064|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19703065|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19703066|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19703067|NCT04876638|Minocycline|minocycline|mesh-list
19703068|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703069|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703070|NCT04876859|Anesthetics|anesthetics|mesh-list
19703071|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703072|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703073|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
19703074|NCT04876807|Omeprazole|omeprazole|mesh-list
19703075|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19703076|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703077|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19703078|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703079|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703080|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703081|NCT04876430|Meropenem|meropenem|mesh-list
19703082|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703083|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703084|NCT04876313|Paclitaxel|paclitaxel|mesh-list
19703085|NCT04876313|Nivolumab|nivolumab|mesh-list
19703086|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19703087|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703088|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
19703089|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
19703090|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
19703091|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703092|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703093|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19703094|NCT04876755|TEMPO|tempo|mesh-list
19703095|NCT04876755|TEMPOL-H|tempol-h|mesh-list
19703096|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
19703097|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703098|NCT04876755|Protective Agents|protective agents|mesh-ancestor
19703099|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703100|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19703101|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
19703102|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
19703103|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
19703104|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703105|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19703106|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
19703107|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
19703108|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703109|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703110|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703111|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19703112|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
19703113|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19703114|NCT04876521|Olanzapine|olanzapine|mesh-list
19703115|NCT04876521|Amisulpride|amisulpride|mesh-list
19703116|NCT04876521|Fluoxetine|fluoxetine|mesh-list
19703117|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
19703118|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
19703119|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703120|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245457|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245458|NCT00424723|Pemetrexed|pemetrexed|mesh-list
19703121|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703122|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20245459|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703123|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19703124|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245460|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245461|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245462|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19703125|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19703126|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19708522|NCT04813952|Sevoflurane|sevoflurane|mesh-list
20245463|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19703127|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19703128|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19703129|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245464|NCT00424788|Natalizumab|natalizumab|mesh-list
19703130|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703131|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
19703132|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19703133|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
19703134|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19703135|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19703136|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703137|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19703138|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
19703139|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
19703140|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19703141|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19703142|NCT04876534|Prednisolone|prednisolone|mesh-list
19703143|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
19703144|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19703145|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19703146|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
19703147|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703148|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
19703149|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
19703150|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703151|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703152|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703153|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
19703154|NCT04876534|Hormones|hormones|mesh-ancestor
19703155|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703156|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19703157|NCT04876534|Protective Agents|protective agents|mesh-ancestor
19703158|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703159|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703160|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
19703161|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703162|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
19703163|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703164|NCT04876261|Protective Agents|protective agents|mesh-ancestor
19703165|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703166|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19703167|NCT04875819|Vaccines|vaccines|mesh-list
19703168|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19703169|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
19703170|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703171|NCT04876079|Insulin|insulin|mesh-list
19703172|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19703173|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703174|NCT04876027|Dulaglutide|dulaglutide|mesh-list
19703175|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19703176|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703177|NCT04875767|Coal Tar|coal tar|mesh-list
19703178|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
19703179|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
19703180|NCT04875728|Cefazolin|cefazolin|mesh-list
19703181|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703182|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703183|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19703184|NCT04875702|Allopurinol|allopurinol|mesh-list
19703185|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
19703186|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703187|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415941|NCT02626338|Etoposide|etoposide|mesh-list
19703188|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
19703189|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703190|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19703191|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
19703192|NCT04875702|Protective Agents|protective agents|mesh-ancestor
19703193|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703194|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
19703195|NCT04875585|Lenvatinib|lenvatinib|mesh-list
19703196|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703197|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703198|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19703199|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703200|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703201|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19703202|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
19703203|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703204|NCT04875611|Nivolumab|nivolumab|mesh-list
19703205|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703206|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703207|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19703208|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708132|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708133|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708134|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708135|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708136|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19703209|NCT04875026|Fluorouracil|fluorouracil|mesh-list
19703210|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
19703211|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703212|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19703213|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703214|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703215|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
19703216|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703217|NCT04874844|Antibodies|antibodies|mesh-list
19703218|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19703219|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
19703220|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703221|NCT04875039|Dexamethasone|dexamethasone|mesh-list
19703222|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
19703223|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
19703224|NCT04875039|BB 1101|bb 1101|mesh-list
19703225|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703226|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
19703227|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
19703228|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703229|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703230|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703231|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
19703232|NCT04875039|Hormones|hormones|mesh-ancestor
19703233|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854043|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854044|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854045|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19703234|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703235|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703236|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
19703237|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703238|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703239|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19703240|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703241|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703242|NCT04875039|Analgesics|analgesics|mesh-ancestor
19703243|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
19703244|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19708137|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703245|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19703246|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19703247|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
19415942|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
19703248|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703249|NCT04874688|Provitamins|provitamins|mesh-list
19703250|NCT04874688|Beta Carotene|beta carotene|mesh-list
19854046|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19703251|NCT04874688|Vitamins|vitamins|mesh-ancestor
19703252|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
19703253|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703254|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
19703255|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19703256|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19703257|NCT04874610|Prednisolone|prednisolone|mesh-list
19703258|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
19703259|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19703260|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
19703261|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703262|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
19703263|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
19703264|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703265|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703266|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703267|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
19703268|NCT04874610|Hormones|hormones|mesh-ancestor
19703269|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703270|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19703271|NCT04874610|Protective Agents|protective agents|mesh-ancestor
19703272|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703273|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703274|NCT04874675|Acetaminophen|acetaminophen|mesh-list
19703275|NCT04874675|Ibuprofen|ibuprofen|mesh-list
19703276|NCT04874675|Diclofenac|diclofenac|mesh-list
19703277|NCT04874675|Codeine|codeine|mesh-list
19703278|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703279|NCT04874675|Analgesics|analgesics|mesh-ancestor
19854047|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
19703280|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
19703281|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703282|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703283|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
19854048|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854049|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854050|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19854051|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19854052|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19854053|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19854054|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
19854055|NCT00736333|Doxorubicin|doxorubicin|mesh-list
19854056|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19854057|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854058|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854059|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20245465|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
20245466|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245467|NCT00424801|Nicorandil|nicorandil|mesh-list
20245468|NCT00424801|Valsartan|valsartan|mesh-list
20245469|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20245470|NCT00424801|Doxazosin|doxazosin|mesh-list
20245471|NCT00424801|Lercanidipine|lercanidipine|mesh-list
20245472|NCT00424801|Pindolol|pindolol|mesh-list
20245473|NCT00424801|Moxonidine|moxonidine|mesh-list
20245474|NCT00424801|Amiloride|amiloride|mesh-list
20245475|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20245476|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20245477|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20245478|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245479|NCT00424801|Diuretics|diuretics|mesh-ancestor
20245480|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
20245481|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245482|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20245483|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20245484|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20245485|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20245486|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20245487|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
20245488|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19415943|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
19703284|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703285|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854060|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19854061|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854062|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854063|NCT00736450|Prednisone|prednisone|mesh-list
19854064|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
19854065|NCT00736450|Rituximab|rituximab|mesh-list
19854066|NCT00736450|Doxorubicin|doxorubicin|mesh-list
19854067|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19854068|NCT00736450|Vincristine|vincristine|mesh-list
19854069|NCT00736450|Oblimersen|oblimersen|mesh-list
19854070|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854071|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
19854072|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854073|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854074|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19854075|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
19854076|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703286|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703287|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19703288|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703289|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703290|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19703291|NCT04874675|Narcotics|narcotics|mesh-ancestor
19703292|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703293|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
19703294|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
19703295|NCT04874506|TEMPO|tempo|mesh-list
19703296|NCT04874506|TEMPOL-H|tempol-h|mesh-list
19703297|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
19703298|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703299|NCT04874506|Protective Agents|protective agents|mesh-ancestor
19703300|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703301|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19703302|NCT04874246|Vasopressins|vasopressins|mesh-list
19703303|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
19703304|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
19703305|NCT04874246|Coagulants|coagulants|mesh-ancestor
19703306|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19703307|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19854077|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854078|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19854079|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19854080|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854081|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19854082|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19854083|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854084|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854085|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
19854086|NCT00736450|Hormones|hormones|mesh-ancestor
19854087|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854088|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19854089|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19854090|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
19854091|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
19854092|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
19854093|NCT00736476|Vaccines|vaccines|mesh-list
20245489|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19854094|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
19854095|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854096|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
19854097|NCT00736489|AZD-3199|azd-3199|mesh-list
19854098|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19854099|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
19854100|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854101|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854102|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19854103|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
19854104|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19854105|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19854106|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19854107|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
19854108|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854109|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854110|NCT00736632|Vitamin D|vitamin d|mesh-list
19854111|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
19854112|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
19854113|NCT00736632|Vitamins|vitamins|mesh-list
20245490|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20245491|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19703308|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
19703309|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245492|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19703310|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
19703311|NCT04874428|Apixaban|apixaban|mesh-list
19703312|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19703313|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
19703314|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19703315|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
19703316|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703317|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703318|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
19703319|NCT04873531|Neostigmine|neostigmine|mesh-list
19703320|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20245493|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19854114|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
19854115|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854116|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19854117|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19854118|NCT00736645|Selenium|selenium|mesh-list
19854119|NCT00736645|Finasteride|finasteride|mesh-list
19854120|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19854121|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19854122|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854123|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854124|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
20245494|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
20245495|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
20245496|NCT00424801|Vitamins|vitamins|mesh-ancestor
20245497|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
20245498|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20245499|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20245500|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20245501|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20245502|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
20245503|NCT00424814|Ritonavir|ritonavir|mesh-list
19703321|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703322|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703323|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
19703324|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703325|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703326|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19703327|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
19703328|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703329|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
19703330|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
19703331|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703332|NCT04873440|Manganese|manganese|mesh-list
19703333|NCT04873440|Trace Elements|trace elements|mesh-ancestor
19703334|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
19703335|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245504|NCT00424814|Lopinavir|lopinavir|mesh-list
19703336|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
19703337|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20245505|NCT00424814|Lamivudine|lamivudine|mesh-list
20245506|NCT00424814|Zidovudine|zidovudine|mesh-list
20245507|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20245508|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19703338|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703339|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19703340|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19703341|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703342|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703343|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703344|NCT04873479|Ketamine|ketamine|mesh-list
19703345|NCT04873479|Esketamine|esketamine|mesh-list
19703346|NCT04873479|Analgesics|analgesics|mesh-ancestor
19703347|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
19703348|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703349|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703350|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19703351|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19703352|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
19703353|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
19703354|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245509|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20245510|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
20245511|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854125|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854126|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854127|NCT00736645|Urological Agents|urological agents|mesh-ancestor
19854128|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
19854129|NCT00736645|Protective Agents|protective agents|mesh-ancestor
19854130|NCT00736645|Trace Elements|trace elements|mesh-ancestor
19854131|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
19854132|NCT00736853|Acetaminophen|acetaminophen|mesh-list
19854133|NCT00736853|Tramadol|tramadol|mesh-list
19854134|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854135|NCT00736853|Analgesics|analgesics|mesh-ancestor
19854136|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
19854137|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854138|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854139|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
19854140|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19854141|NCT00736853|Narcotics|narcotics|mesh-ancestor
19854142|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19854143|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
19854144|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19854145|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854146|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19854147|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854148|NCT00736944|Cisplatin|cisplatin|mesh-list
19854149|NCT00736944|Cetuximab|cetuximab|mesh-list
19854150|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19854151|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703355|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19703356|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19703357|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703358|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703359|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
19703360|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19854152|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19854153|NCT00736957|Acetaminophen|acetaminophen|mesh-list
20520674|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520675|NCT01728818|Gemcitabine|gemcitabine|mesh-list
20520676|NCT01728818|Afatinib|afatinib|mesh-list
20520677|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19703361|NCT04873349|Oleuropein|oleuropein|mesh-list
19703362|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854154|NCT00736957|Tramadol|tramadol|mesh-list
20520678|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
20520679|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520680|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520681|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
20520682|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520683|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520684|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520685|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
20520686|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520687|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20520688|NCT01728909|Oxytocin|oxytocin|mesh-list
20520689|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
20520690|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20520691|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520692|NCT01728922|Vitamin D|vitamin d|mesh-list
20520693|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
20520694|NCT01728922|Vitamins|vitamins|mesh-list
20520695|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
20520696|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520697|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20520698|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20520699|NCT01728935|Tenofovir|tenofovir|mesh-list
20520700|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
20520701|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520702|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19854155|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854156|NCT00736957|Analgesics|analgesics|mesh-ancestor
20245512|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245513|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20245514|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20245515|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
20245516|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245517|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20245518|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20245519|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20245520|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20245521|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
19854157|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
19854158|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245522|NCT00424853|Gemcitabine|gemcitabine|mesh-list
20245523|NCT00424853|Cisplatin|cisplatin|mesh-list
20245524|NCT00424853|Docetaxel|docetaxel|mesh-list
20245525|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245526|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245527|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
20245528|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245529|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
19703363|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19703364|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
19703365|NCT04873284|Dexamethasone|dexamethasone|mesh-list
19703366|NCT04873284|Aprepitant|aprepitant|mesh-list
19703367|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
19703368|NCT04873284|Granisetron|granisetron|mesh-list
19703369|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703370|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
19703371|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
19703372|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703373|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703374|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703375|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
19703376|NCT04873284|Hormones|hormones|mesh-ancestor
19703377|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245530|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245531|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520703|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20520704|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703378|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703379|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854159|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854160|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
19854161|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20245532|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520705|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520706|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20520707|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20520708|NCT01728948|Sorafenib|sorafenib|mesh-list
20520709|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520710|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20520711|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520712|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520713|NCT01728961|Lumefantrine|lumefantrine|mesh-list
20520714|NCT01728961|Artemether|artemether|mesh-list
20520715|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20520716|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
20520717|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20520718|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20520719|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520720|NCT01728974|Anesthetics|anesthetics|mesh-list
20520721|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520722|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520723|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
20520724|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19703380|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20245533|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
20245534|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245535|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
20245536|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245537|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
20245538|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20245539|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20245540|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20245541|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20245542|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245543|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245544|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245545|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
20245546|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20245547|NCT00424931|Modafinil|modafinil|mesh-list
20245548|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20245549|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245550|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20245551|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20245552|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20245553|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245554|NCT00424944|Vaccines|vaccines|mesh-list
20245555|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
20245556|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245557|NCT00424970|Acetazolamide|acetazolamide|mesh-list
20245558|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
20245559|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20245560|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245561|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245562|NCT00424970|Diuretics|diuretics|mesh-ancestor
20520725|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520726|NCT01728987|Vitamins|vitamins|mesh-ancestor
20520727|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
20520728|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20520729|NCT01729104|Rituximab|rituximab|mesh-list
20520730|NCT01729104|Lenalidomide|lenalidomide|mesh-list
20520731|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20520732|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520733|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
20520734|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703381|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703382|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703383|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19703384|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
19708138|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708139|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19708140|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19708141|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19708142|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
19708143|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708144|NCT04819828|Urological Agents|urological agents|mesh-ancestor
19708145|NCT04818931|Cefazolin|cefazolin|mesh-list
19708146|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19708147|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708148|NCT04819204|Cetrorelix|cetrorelix|mesh-list
19708149|NCT04819204|Testosterone|testosterone|mesh-list
19708150|NCT04819204|Androgens|androgens|mesh-ancestor
19708151|NCT04819204|Hormones|hormones|mesh-ancestor
19708152|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708153|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708154|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19708155|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
19708156|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708157|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
19708158|NCT04819217|Charcoal|charcoal|mesh-list
19854162|NCT00736957|Narcotics|narcotics|mesh-ancestor
19854163|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19854164|NCT00736996|Pioglitazone|pioglitazone|mesh-list
19854165|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19854166|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854167|NCT00737048|Acetaminophen|acetaminophen|mesh-list
19854168|NCT00737048|Tramadol|tramadol|mesh-list
19854169|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854170|NCT00737048|Analgesics|analgesics|mesh-ancestor
19854171|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
19854172|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854173|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854174|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
19854175|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19854176|NCT00737048|Narcotics|narcotics|mesh-ancestor
19854177|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19854178|NCT00737100|Bromides|bromides|mesh-list
19854179|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
19854180|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19854181|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
19854182|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708159|NCT04819217|Antidotes|antidotes|mesh-ancestor
19708160|NCT04819217|Protective Agents|protective agents|mesh-ancestor
20520735|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520736|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20520737|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20520738|NCT01729104|Growth Substances|growth substances|mesh-ancestor
20520739|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
20520740|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
20520741|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20520742|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520743|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20520744|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20520745|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520746|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520747|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520748|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20520749|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20530181|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854183|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245563|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
20245564|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245565|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
20245566|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20245567|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245568|NCT00425009|Metformin|metformin|mesh-list
20245569|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245570|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245571|NCT00425035|Panitumumab|panitumumab|mesh-list
20520750|NCT01729260|Mebendazole|mebendazole|mesh-list
20520751|NCT01729260|Piperazine|piperazine|mesh-list
20520752|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
20520753|NCT01729260|DMP 777|dmp 777|mesh-list
20520754|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
20245572|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245573|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245574|NCT00425074|Aspirin|aspirin|mesh-list
20245575|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
20245576|NCT00425074|Salicylates|salicylates|mesh-list
20245577|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245578|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
20245579|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
20245580|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
20245581|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20520755|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
20520756|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20520757|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520758|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
19703385|NCT04873102|Danazol|danazol|mesh-list
19703386|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20245582|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20520759|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
19703387|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
19703388|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703389|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703390|NCT04873011|Quinine|quinine|mesh-list
19703391|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
19703392|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19703393|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19703394|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703395|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19703396|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703397|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19703398|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703399|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854184|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19854185|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
19854186|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
19854187|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19854188|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
19854189|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854190|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854191|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
19854192|NCT00737178|Copper|copper|mesh-list
19854193|NCT00737178|Trace Elements|trace elements|mesh-ancestor
19854194|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
19854195|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854196|NCT00737204|Modafinil|modafinil|mesh-list
19854197|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19854198|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415944|NCT02626338|Idarubicin|idarubicin|mesh-list
19854199|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19854200|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20245583|NCT00425074|Analgesics|analgesics|mesh-ancestor
20520760|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
20520761|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520762|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520763|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520764|NCT01729468|Aspirin|aspirin|mesh-list
20520765|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20520766|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20245584|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
20245585|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245586|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520767|NCT01729468|Analgesics|analgesics|mesh-ancestor
20520768|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
20520769|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520770|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245587|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20245588|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245589|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19415945|NCT02626338|Crenolanib|crenolanib|mesh-list
19703400|NCT04873011|Analgesics|analgesics|mesh-ancestor
19703401|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
19703402|NCT04872985|Paclitaxel|paclitaxel|mesh-list
19703403|NCT04872985|Docetaxel|docetaxel|mesh-list
19703404|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
19703405|NCT04872985|Doxorubicin|doxorubicin|mesh-list
19703406|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19703407|NCT04872985|Epirubicin|epirubicin|mesh-list
19703408|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19703409|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245590|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245591|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245592|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20245593|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20245594|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20245595|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
20245596|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
20245597|NCT00425126|Hematinics|hematinics|mesh-ancestor
20245598|NCT00425152|Leucovorin|leucovorin|mesh-list
20245599|NCT00425152|Levamisole|levamisole|mesh-list
20245600|NCT00425152|Fluorouracil|fluorouracil|mesh-list
20245601|NCT00425152|Calcium|calcium|mesh-list
20245602|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
20245603|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20245604|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245605|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
20245606|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245607|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245608|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245609|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245610|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
20245611|NCT00425152|Antidotes|antidotes|mesh-ancestor
20520771|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520772|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520773|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20520774|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20520775|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520776|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20520777|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20520778|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520779|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
20520780|NCT01729481|Leucovorin|leucovorin|mesh-list
20520781|NCT01729481|Folic Acid|folic acid|mesh-list
20520782|NCT01729481|Gemcitabine|gemcitabine|mesh-list
20520783|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
20520784|NCT01729481|Irinotecan|irinotecan|mesh-list
20520785|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
20520786|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20520787|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
20520788|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520789|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520790|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
20520791|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520792|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520793|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520794|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
20245612|NCT00425152|Protective Agents|protective agents|mesh-ancestor
20245613|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
20245614|NCT00425152|Vitamins|vitamins|mesh-ancestor
20245615|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
20245616|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20245617|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
20245618|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
20245619|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20245620|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245621|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245622|NCT00425191|Gemcitabine|gemcitabine|mesh-list
20245623|NCT00425191|Docetaxel|docetaxel|mesh-list
20245624|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245625|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245626|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
20245627|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245628|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
20245629|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520795|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703410|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
19703411|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
19703412|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
20245630|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520796|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20520797|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20520798|NCT01729481|Antidotes|antidotes|mesh-ancestor
20520799|NCT01729481|Protective Agents|protective agents|mesh-ancestor
20520800|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
20520801|NCT01729481|Vitamins|vitamins|mesh-ancestor
20520802|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
20520803|NCT01729481|Hematinics|hematinics|mesh-ancestor
20520804|NCT01729663|Interferons|interferons|mesh-list
20520805|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
19708161|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245631|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520806|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
20245632|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
20245633|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245634|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
20245635|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245636|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
20245637|NCT00425204|Panitumumab|panitumumab|mesh-list
19415946|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415947|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19415948|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
19415949|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415950|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19415951|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
19415952|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415953|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
19703413|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703414|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703415|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
19415954|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415955|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19415956|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19415957|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19415958|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415959|NCT02626338|Analgesics|analgesics|mesh-ancestor
19415960|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
19415961|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703416|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703417|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703418|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19703419|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
19854201|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19854202|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854203|NCT00737243|Paclitaxel|paclitaxel|mesh-list
19854204|NCT00737243|Bevacizumab|bevacizumab|mesh-list
19854205|NCT00737243|Carboplatin|carboplatin|mesh-list
19854206|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19854207|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19854208|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703420|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19703421|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19703422|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19703423|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19703424|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703425|NCT04872907|Fluorides|fluorides|mesh-list
19703426|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
19703427|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
19703428|NCT04872907|Protective Agents|protective agents|mesh-ancestor
19703429|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703430|NCT04872608|Letrozole|letrozole|mesh-list
19703431|NCT04872608|Palbociclib|palbociclib|mesh-list
19703432|NCT04872608|Onapristone|onapristone|mesh-list
19703433|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703434|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19703435|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19703436|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245638|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703437|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854209|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19854210|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
19854211|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19854212|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854213|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19854214|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19854215|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19854216|NCT00737243|Growth Substances|growth substances|mesh-ancestor
19854217|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854218|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
19854219|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19854220|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854221|NCT00737438|Bevacizumab|bevacizumab|mesh-list
19854222|NCT00737438|Docetaxel|docetaxel|mesh-list
19703438|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19854223|NCT00737438|Capecitabine|capecitabine|mesh-list
19854224|NCT00737438|Irinotecan|irinotecan|mesh-list
19854225|NCT00737438|Epirubicin|epirubicin|mesh-list
19854226|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703439|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
19703440|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703441|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703442|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19703443|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19703444|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
19703445|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19703446|NCT04872881|Fentanyl|fentanyl|mesh-list
19703447|NCT04872881|Propofol|propofol|mesh-list
19703448|NCT04872881|Rocuronium|rocuronium|mesh-list
19703449|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19703450|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703451|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703452|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19703453|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
19703454|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
19703455|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19703456|NCT04872881|Narcotics|narcotics|mesh-ancestor
19703457|NCT04872881|Analgesics|analgesics|mesh-ancestor
19703458|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
19703459|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703460|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19703461|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19703462|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19703463|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19854227|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854228|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19703464|NCT04872634|Cetuximab|cetuximab|mesh-list
20520807|NCT01729663|Molgramostim|molgramostim|mesh-list
20520808|NCT01729663|Sargramostim|sargramostim|mesh-list
20520809|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
20520810|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520811|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
20520812|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520813|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
20520814|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703465|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703466|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703467|NCT04872270|Caffeine|caffeine|mesh-list
19703468|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19703469|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703470|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19703471|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703472|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703473|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19703474|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19703475|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
19703476|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703477|NCT04872400|Vancomycin|vancomycin|mesh-list
19703478|NCT04872400|Tobramycin|tobramycin|mesh-list
19703479|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703480|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703481|NCT04872192|Anesthetics|anesthetics|mesh-list
19703482|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703483|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520815|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20520816|NCT01729767|Acyclovir|acyclovir|mesh-list
20520817|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
20520818|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520819|NCT01729806|Rituximab|rituximab|mesh-list
20520820|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20520821|NCT01729806|Ipilimumab|ipilimumab|mesh-list
20520822|NCT01729806|Antibodies|antibodies|mesh-list
20520823|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
20520824|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20520825|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
20520826|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245639|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245640|NCT00425217|Rituximab|rituximab|mesh-list
20245641|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245642|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245643|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
20245644|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245645|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245646|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20245647|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20245648|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20245649|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248059|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20520827|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520828|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520829|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20520830|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520831|NCT01729897|Fentanyl|fentanyl|mesh-list
20520832|NCT01729897|Propofol|propofol|mesh-list
20520833|NCT01729897|Etomidate|etomidate|mesh-list
19703484|NCT04872231|Voriconazole|voriconazole|mesh-list
19415962|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19703485|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
19703486|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703487|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19703488|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19703489|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520834|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20520835|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520836|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520837|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20520838|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
19854229|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19854230|NCT00737438|Growth Substances|growth substances|mesh-ancestor
19854231|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854232|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
19854233|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
20245650|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245651|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245652|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245653|NCT00425230|Analgesics|analgesics|mesh-ancestor
20245654|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
20245655|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245656|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
20245657|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20245658|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
20245659|NCT00425243|Zolpidem|zolpidem|mesh-list
20245660|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20245661|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20245662|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245663|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245664|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20245665|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
20245666|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
20245667|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245668|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245669|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20245670|NCT00425347|Elotuzumab|elotuzumab|mesh-list
19703490|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703491|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19703492|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
19703493|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703494|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703495|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19703496|NCT04872283|Aspirin|aspirin|mesh-list
19703497|NCT04872283|Acetaminophen|acetaminophen|mesh-list
19854234|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
19854235|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
19854236|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854237|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19703498|NCT04872283|Ketorolac|ketorolac|mesh-list
19703499|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19703500|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19703501|NCT04872283|Oxycodone|oxycodone|mesh-list
19703502|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703503|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703504|NCT04872283|Analgesics|analgesics|mesh-ancestor
19854238|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
19854239|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19854240|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19854241|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854242|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854243|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19703505|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
19703506|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703507|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520839|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
19703508|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520840|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20520841|NCT01729897|Narcotics|narcotics|mesh-ancestor
20520842|NCT01729897|Analgesics|analgesics|mesh-ancestor
20520843|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
20520844|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520845|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20520846|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
20520847|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20520848|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520849|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20520850|NCT01730157|Ipilimumab|ipilimumab|mesh-list
20520851|NCT01730157|Antibodies|antibodies|mesh-list
20520852|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
20520853|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20520854|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
20520855|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520856|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520857|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20245671|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245672|NCT00425360|Gemcitabine|gemcitabine|mesh-list
19703509|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703510|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19703511|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19703512|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703513|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19703514|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19703515|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703516|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
20245673|NCT00425360|Capecitabine|capecitabine|mesh-list
19703517|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19703518|NCT04872283|Narcotics|narcotics|mesh-ancestor
19703519|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703520|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
19703521|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19703522|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
19703523|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19703524|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245674|NCT00425360|Sargramostim|sargramostim|mesh-list
20245675|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19703525|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19703526|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20245676|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
20245677|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520858|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520859|NCT01730209|Everolimus|everolimus|mesh-list
20520860|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520861|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520862|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
20520863|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703527|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19703528|NCT04872322|Ropivacaine|ropivacaine|mesh-list
19703529|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19703530|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
19703531|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
19703532|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703533|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703534|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
20520864|NCT01730222|Gemcitabine|gemcitabine|mesh-list
20520865|NCT01730222|Paclitaxel|paclitaxel|mesh-list
20520866|NCT01730222|Capecitabine|capecitabine|mesh-list
20520867|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20520868|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520869|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
19708162|NCT04819243|Atezolizumab|atezolizumab|mesh-list
20520870|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
19703535|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703536|NCT04871958|Insulin|insulin|mesh-list
19703537|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19703538|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703539|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
19703540|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
19703541|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703542|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703543|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19703544|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
19703545|NCT04871724|Fluconazole|fluconazole|mesh-list
19703546|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
19703547|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703548|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19703549|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19703550|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245678|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245679|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
20245680|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520871|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
20520872|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520873|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20520874|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
20520875|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
20520876|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520877|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520878|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520879|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
20245681|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245682|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245683|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
20245684|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245685|NCT00425425|Fluorouracil|fluorouracil|mesh-list
20245686|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
20245687|NCT00425425|Cetuximab|cetuximab|mesh-list
20245688|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
20245689|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245690|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245691|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245692|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703551|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703552|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19703553|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
19703554|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703555|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703556|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19703557|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19703558|NCT04871802|Taxifolin|taxifolin|mesh-list
19703559|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703560|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703561|NCT04871802|Analgesics|analgesics|mesh-ancestor
19703562|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
19703563|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703564|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703565|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703566|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854244|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
19854245|NCT00737464|Hematinics|hematinics|mesh-ancestor
19854246|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
19854247|NCT00737477|Hematinics|hematinics|mesh-ancestor
19854248|NCT00737529|Lenalidomide|lenalidomide|mesh-list
20520880|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520881|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
20520882|NCT01730287|Calcium|calcium|mesh-list
20520883|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20520884|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520885|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19703567|NCT04871633|Azithromycin|azithromycin|mesh-list
19703568|NCT04871633|Remdesivir|remdesivir|mesh-list
19703569|NCT04871633|Dexamethasone|dexamethasone|mesh-list
19703570|NCT04871633|Prednisolone|prednisolone|mesh-list
19703571|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19703572|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703573|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
19703574|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
19703575|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703576|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703577|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854249|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
19854250|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854251|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20520886|NCT01730326|Acetaminophen|acetaminophen|mesh-list
20520887|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19854252|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19854253|NCT00737529|Growth Substances|growth substances|mesh-ancestor
19854254|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
20245693|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
20245694|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245695|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245696|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
20245697|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20245698|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
20245699|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20245700|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245701|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
20245702|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
20245703|NCT00425451|Analgesics|analgesics|mesh-ancestor
20245704|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
20245705|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245706|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854255|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854256|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19854257|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19854258|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19854259|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854260|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854261|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
19415963|NCT02626130|Tremelimumab|tremelimumab|mesh-list
19703578|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
19703579|NCT04871633|Hormones|hormones|mesh-ancestor
19703580|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703581|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703582|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708163|NCT04819243|Talazoparib|talazoparib|mesh-list
20245707|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20245708|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20245709|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20245710|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245711|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20245712|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520888|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20520889|NCT01730326|Analgesics|analgesics|mesh-ancestor
20520890|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
20520891|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520892|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520893|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
20520894|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20245713|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245714|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20245715|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245716|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245717|NCT00425490|Incretins|incretins|mesh-ancestor
20245718|NCT00425490|Hormones|hormones|mesh-ancestor
20245719|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245720|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20245721|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
20245722|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245723|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245724|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
20245725|NCT00425516|Docetaxel|docetaxel|mesh-list
20245726|NCT00425516|Fluorouracil|fluorouracil|mesh-list
20245727|NCT00425516|Epirubicin|epirubicin|mesh-list
20520895|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520896|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520897|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20520898|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520899|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520900|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520901|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19854262|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854263|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19854264|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19854265|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
19854266|NCT00737711|Hematinics|hematinics|mesh-ancestor
19854267|NCT00737737|Morphine|morphine|mesh-list
19854268|NCT00737737|Oxycodone|oxycodone|mesh-list
19854269|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19415964|NCT02626130|Ipilimumab|ipilimumab|mesh-list
19415965|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19415966|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19415967|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19415968|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415969|NCT02620553|Insulin|insulin|mesh-list
19415970|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19415971|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19415972|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415973|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
19415974|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19415975|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19415976|NCT02609828|Tanezumab|tanezumab|mesh-list
19415977|NCT02609828|Analgesics|analgesics|mesh-ancestor
19415978|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
19415979|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19415980|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19415981|NCT02609048|Seladelpar|seladelpar|mesh-list
19415982|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19415983|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
19415984|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415985|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19415986|NCT02608697|Atorvastatin|atorvastatin|mesh-list
19415987|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19415988|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19415989|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
19854270|NCT00737737|Narcotics|narcotics|mesh-ancestor
19854271|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19415990|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854272|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703583|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703584|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19703585|NCT04871633|Protective Agents|protective agents|mesh-ancestor
19703586|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703587|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703588|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
19703589|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
19703590|NCT04871750|Caseins|caseins|mesh-list
19703591|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
19703592|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
19703593|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703594|NCT04871932|Vaccines|vaccines|mesh-list
19703595|NCT04871932|Immunologic Factors|immunologic factors|mesh-ancestor
19703596|NCT04871932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703597|NCT04871321|Gemcitabine|gemcitabine|mesh-list
19703598|NCT04871321|Paclitaxel|paclitaxel|mesh-list
19703599|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19703600|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703601|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
19703602|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
19703603|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
19703604|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703605|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19703606|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
19703607|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
19703608|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703609|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703610|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703611|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
19703612|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703613|NCT04871191|Rituximab|rituximab|mesh-list
19703614|NCT04871191|Abatacept|abatacept|mesh-list
19703615|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703616|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703617|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
19703618|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703619|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703620|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19703621|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703622|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703623|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
19703624|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19703625|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520902|NCT01730495|Etanercept|etanercept|mesh-list
20520903|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20520904|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20520905|NCT01730495|Analgesics|analgesics|mesh-ancestor
20520906|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
20520907|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20520908|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520909|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520910|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20520911|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20520912|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20520913|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
20520914|NCT01730508|Interferons|interferons|mesh-list
20520915|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
20520916|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520917|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
19703626|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854273|NCT00737737|Analgesics|analgesics|mesh-ancestor
20520918|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520919|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
19703627|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703628|NCT04871308|Analgesics|analgesics|mesh-ancestor
19703629|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
19703630|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703631|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19703632|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19703633|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19703634|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
19703635|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703636|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245728|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245729|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
20245730|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245731|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703637|NCT04871204|Octreotide|octreotide|mesh-list
19703638|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703639|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703640|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703641|NCT04871269|Dronabinol|dronabinol|mesh-list
19703642|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
19703643|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703644|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19703645|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703646|NCT04871269|Analgesics|analgesics|mesh-ancestor
19703647|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
19703648|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703649|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19703650|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19703651|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703652|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703653|NCT04871269|Hormones|hormones|mesh-ancestor
19703654|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708164|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708165|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19708166|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708167|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708168|NCT04818723|Montelukast|montelukast|mesh-list
19708169|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19708170|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
19708171|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19854274|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
19854275|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854276|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
19854277|NCT00737893|Hematinics|hematinics|mesh-ancestor
19854278|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
19854279|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19854280|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19854281|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854282|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19703655|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19703656|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19703657|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19703658|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19703659|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703660|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703661|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703662|NCT04870957|Analgesics|analgesics|mesh-ancestor
19703663|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
19703664|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854283|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19854284|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19854285|NCT00738049|Darusentan|darusentan|mesh-list
19854286|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19703665|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
19703666|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19703667|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
19703668|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19703669|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20245732|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20245733|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
20245734|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245735|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245736|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20245737|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
20245738|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245739|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
20245740|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
20245741|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245742|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20245743|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19703670|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19703671|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703672|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703673|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19703674|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19703675|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703676|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
19703677|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703678|NCT04870372|Selegiline|selegiline|mesh-list
20245744|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19703679|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
19703680|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19703681|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19703682|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19703683|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19703684|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703685|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703686|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19703687|NCT04870372|Protective Agents|protective agents|mesh-ancestor
19703688|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703689|NCT04870671|Tenofovir|tenofovir|mesh-list
19703690|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
19703691|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703692|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19703693|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19703694|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703695|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703696|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19703697|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19703698|NCT04870866|Niacinamide|niacinamide|mesh-list
19703699|NCT04870866|Niacin|niacin|mesh-list
19703700|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
19703701|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
19854287|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854288|NCT00738062|Droxidopa|droxidopa|mesh-list
19854289|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19854290|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19854291|NCT00738361|Paclitaxel|paclitaxel|mesh-list
20520920|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520921|NCT01730612|Histamine|histamine|mesh-list
20520922|NCT01730612|Glycine|glycine|mesh-list
20520923|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
20520924|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
20520925|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520926|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520927|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520928|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
20520929|NCT01730638|Histamine|histamine|mesh-list
20520930|NCT01730638|Glycine|glycine|mesh-list
20520931|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
20520932|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
19854292|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20520933|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245745|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245746|NCT00425568|Testosterone|testosterone|mesh-list
20245747|NCT00425568|Androgens|androgens|mesh-ancestor
20245748|NCT00425568|Hormones|hormones|mesh-ancestor
20245749|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245750|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245751|NCT00425594|Bisacodyl|bisacodyl|mesh-list
20245752|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20245753|NCT00425594|Cathartics|cathartics|mesh-ancestor
20245754|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854293|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19854294|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703702|NCT04870866|Vitamins|vitamins|mesh-ancestor
19854295|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
19854296|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
19854297|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
19854298|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703703|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
19703704|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703705|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19703706|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
19703707|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703708|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19703709|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
19703710|NCT04870489|Isotretinoin|isotretinoin|mesh-list
19703711|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
19703712|NCT04870541|Nefopam|nefopam|mesh-list
19854299|NCT00738374|Rituximab|rituximab|mesh-list
19854300|NCT00738374|Chlorambucil|chlorambucil|mesh-list
19854301|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19854302|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854303|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
19854304|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854305|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854306|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19854307|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
19854308|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854309|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20245755|NCT00425594|Laxatives|laxatives|mesh-ancestor
19703713|NCT04870541|Ondansetron|ondansetron|mesh-list
19703714|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
19854310|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
19854311|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19854312|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19854313|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854314|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854315|NCT00738400|Urological Agents|urological agents|mesh-ancestor
19854316|NCT00738530|Interferons|interferons|mesh-list
19854317|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
19854318|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
19854319|NCT00738530|Bevacizumab|bevacizumab|mesh-list
19854320|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19854321|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854322|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20245756|NCT00425620|Amphotericin B|amphotericin b|mesh-list
20245757|NCT00425620|Amebicides|amebicides|mesh-ancestor
20245758|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19415991|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19415992|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20245759|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20245760|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703715|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
19703716|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703717|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703718|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703719|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
19703720|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
19703721|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19703722|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
19708172|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
20245761|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703723|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703724|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703725|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19703726|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19703727|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703728|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19703729|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19703730|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703731|NCT04870541|Analgesics|analgesics|mesh-ancestor
19703732|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
19703733|NCT04870502|Clomiphene|clomiphene|mesh-list
19703734|NCT04870502|Enclomiphene|enclomiphene|mesh-list
19703735|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
19703736|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19703737|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
19703738|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703739|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703740|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19703741|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
20245762|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
20245763|NCT00425646|Bevacizumab|bevacizumab|mesh-list
20245764|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
20245765|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245766|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520934|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520935|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520936|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
20520937|NCT01730664|Ertapenem|ertapenem|mesh-list
20520938|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20520939|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20520940|NCT01730677|Vinorelbine|vinorelbine|mesh-list
20520941|NCT01730677|Lapatinib|lapatinib|mesh-list
20520942|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20520943|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703742|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19703743|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19703744|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19703745|NCT04870359|Prednisolone|prednisolone|mesh-list
19703746|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19703747|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703748|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
19703749|NCT04870359|Hormones|hormones|mesh-ancestor
19703750|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703751|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703752|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19703753|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703754|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
19703755|NCT04870203|Adalimumab|adalimumab|mesh-list
19703756|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20520944|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
20520945|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
20520946|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
20520947|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520948|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20520949|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520950|NCT01730976|Vitamin D|vitamin d|mesh-list
20520951|NCT01730976|Vitamins|vitamins|mesh-list
20520952|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
20520953|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520954|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20530182|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20530183|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245767|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20245768|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20245769|NCT00425646|Growth Substances|growth substances|mesh-ancestor
19703757|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245770|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703758|NCT04870190|Osimertinib|osimertinib|mesh-list
19703759|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703760|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19703761|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703762|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703763|NCT04870021|Vaccines|vaccines|mesh-list
19703764|NCT04870021|Immunologic Factors|immunologic factors|mesh-ancestor
19703765|NCT04870021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703766|NCT04870060|Curcumin|curcumin|mesh-list
19703767|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703768|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703769|NCT04870060|Analgesics|analgesics|mesh-ancestor
19703770|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
19854323|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19854324|NCT00738530|Growth Substances|growth substances|mesh-ancestor
19703771|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703772|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703773|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703774|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703775|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703776|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703777|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703778|NCT04870073|Mannitol|mannitol|mesh-list
19703779|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19703780|NCT04870073|Diuretics|diuretics|mesh-ancestor
20245771|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
20245772|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20245773|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245774|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245775|NCT00425711|Acamprosate|acamprosate|mesh-list
20245776|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19703781|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
19703782|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703783|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19703784|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
19703785|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703786|NCT04869592|Vaccines|vaccines|mesh-list
19703787|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
19854325|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854326|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
19854327|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
19854328|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854329|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
19854330|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
19854331|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19854332|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854333|NCT00738699|Paclitaxel|paclitaxel|mesh-list
19854334|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19854335|NCT00738699|Farletuzumab|farletuzumab|mesh-list
19854336|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19854337|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854338|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
19854339|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
19854340|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
19854341|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854342|NCT00738881|Pemetrexed|pemetrexed|mesh-list
19854343|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19854344|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854345|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854346|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854347|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19854348|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19854349|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19415993|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703788|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703789|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
19854350|NCT00738894|Aspirin|aspirin|mesh-list
19854351|NCT00738894|Dipyridamole|dipyridamole|mesh-list
20245777|NCT00425724|Cyclosporine|cyclosporine|mesh-list
20520955|NCT01731067|Fexofenadine|fexofenadine|mesh-list
20520956|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
20520957|NCT01731067|Midazolam|midazolam|mesh-list
20520958|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
20520959|NCT01731067|Caffeine|caffeine|mesh-list
20520960|NCT01731067|Bupropion|bupropion|mesh-list
20520961|NCT01731067|Omeprazole|omeprazole|mesh-list
20520962|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20520963|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20520964|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20520965|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520966|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19703790|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703791|NCT04869501|Atezolizumab|atezolizumab|mesh-list
19703792|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20520967|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20520968|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20520969|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20520970|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
20520971|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
20520972|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
20520973|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
20520974|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20520975|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20520976|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20520977|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19703793|NCT04869579|Selenium|selenium|mesh-list
19703794|NCT04869579|Selenious Acid|selenious acid|mesh-list
19703795|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
19703796|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703797|NCT04869579|Protective Agents|protective agents|mesh-ancestor
19703798|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520978|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20520979|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20520980|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20520981|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20520982|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20520983|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20520984|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
20520985|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20520986|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
20520987|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20520988|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20520989|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20520990|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
20520991|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20520992|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20520993|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
20520994|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
20520995|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19703799|NCT04869579|Trace Elements|trace elements|mesh-ancestor
19703800|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
19703801|NCT04869709|Betamethasone|betamethasone|mesh-list
19703802|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
19703803|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19703804|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
19703805|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19703806|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703807|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
19703808|NCT04869709|Hormones|hormones|mesh-ancestor
19703809|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703810|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520996|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19703811|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19854352|NCT00738894|Clopidogrel|clopidogrel|mesh-list
20245778|NCT00425724|Prednisone|prednisone|mesh-list
19703812|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
19703813|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
19703814|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19703815|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
19703816|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20520997|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20520998|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20520999|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20521000|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
20521001|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
20521002|NCT01731067|Analgesics|analgesics|mesh-ancestor
20521003|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
20521004|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245779|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
20245780|NCT00425724|Cyclosporins|cyclosporins|mesh-list
20245781|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703817|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
19703818|NCT04869306|Protective Agents|protective agents|mesh-ancestor
19703819|NCT04869176|Caffeine|caffeine|mesh-list
19703820|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
19703821|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703822|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19703823|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703824|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20521005|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703825|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703826|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19703827|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19703828|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
19703829|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703830|NCT04869046|Acetaminophen|acetaminophen|mesh-list
19703831|NCT04869046|Ibuprofen|ibuprofen|mesh-list
19703832|NCT04869046|Analgesics|analgesics|mesh-list
19703833|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
19703834|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19703835|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
19703836|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703837|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703838|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
19703839|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703840|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19703841|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703842|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19703843|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703844|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703845|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
19703846|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
19703847|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708173|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708174|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708175|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19708176|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19708177|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708523|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19708524|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19708525|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
19708526|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
20245782|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
20521006|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521007|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521008|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521009|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20521010|NCT01731132|Copper|copper|mesh-list
20521011|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
20521012|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20521013|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
20521014|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20521015|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521016|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20521017|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20521018|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20521019|NCT01731132|Trace Elements|trace elements|mesh-ancestor
19703848|NCT04868903|Vitamin D|vitamin d|mesh-list
19703849|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
19703850|NCT04868903|Vitamins|vitamins|mesh-ancestor
19703851|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
19703852|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703853|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19703854|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19703855|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
19703856|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19703857|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703858|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19703859|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
19703860|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703861|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703862|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703863|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703864|NCT04868760|Ipilimumab|ipilimumab|mesh-list
19703865|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19703866|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703867|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19703868|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703869|NCT04868747|Lidocaine|lidocaine|mesh-list
19703870|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
20245783|NCT00425724|Hormones|hormones|mesh-ancestor
20245784|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245785|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245786|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20245787|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245788|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245789|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245790|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245791|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
19703871|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
19703872|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703873|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703874|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
19703875|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703876|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19703877|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19703878|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19703879|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19703880|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703881|NCT04868552|Naloxone|naloxone|mesh-list
19703882|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19703883|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703884|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
19703885|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245792|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
20245793|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245794|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
20245795|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245796|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20245797|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
20245798|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
20245799|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245800|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20245801|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20245802|NCT00425724|Protective Agents|protective agents|mesh-ancestor
20245803|NCT00425841|Gemcitabine|gemcitabine|mesh-list
20245804|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
20245805|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20245806|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
20245807|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245808|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245809|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
20245810|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245811|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245812|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245813|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
20245814|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245815|NCT00425906|Nicotine|nicotine|mesh-list
20245816|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20245817|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
20245818|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245819|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245820|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20245821|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20245822|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
20245823|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521020|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
20521021|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
20521022|NCT01731158|Bevacizumab|bevacizumab|mesh-list
20521023|NCT01731158|Sunitinib|sunitinib|mesh-list
20521024|NCT01731158|Everolimus|everolimus|mesh-list
20521025|NCT01731158|Sorafenib|sorafenib|mesh-list
20521026|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521027|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521028|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20521029|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20521030|NCT01731158|Growth Substances|growth substances|mesh-ancestor
20521031|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521032|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
20245824|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245825|NCT00425932|Rituximab|rituximab|mesh-list
20521033|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20521034|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
19854353|NCT00738894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19854354|NCT00738894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854355|NCT00738894|Analgesics|analgesics|mesh-ancestor
19854356|NCT00738894|Sensory System Agents|sensory system agents|mesh-ancestor
19854357|NCT00738894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854358|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854359|NCT00738894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854360|NCT00738894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854361|NCT00738894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19854362|NCT00738894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19854363|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854364|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19854365|NCT00738894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19854366|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854367|NCT00738894|Antipyretics|antipyretics|mesh-ancestor
19854368|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19854369|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19854370|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19854371|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
19854372|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521035|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20521036|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521037|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521038|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
20521039|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521040|NCT01731184|Midazolam|midazolam|mesh-list
20521041|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20521042|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19854373|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19854374|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
19854375|NCT00739297|Montelukast|montelukast|mesh-list
19854376|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19854377|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
19854378|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19854379|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
19854380|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854381|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854382|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19854383|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19854384|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854385|NCT00739596|Amlodipine|amlodipine|mesh-list
19854386|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19854387|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19854388|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19854389|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19854390|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854391|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19854392|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854393|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
19854394|NCT00739596|Diuretics|diuretics|mesh-ancestor
20521043|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521044|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521045|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20521046|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20521047|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20521048|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20521049|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
20521050|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
20521051|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
20521052|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
20521053|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521054|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521055|NCT01731236|Aspirin|aspirin|mesh-list
20521056|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20521057|NCT01731236|Vancomycin|vancomycin|mesh-list
20521058|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
20521059|NCT01731236|Neomycin|neomycin|mesh-list
20521060|NCT01731236|Choline|choline|mesh-list
19703886|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
19703887|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19703888|NCT04868513|Fluorides|fluorides|mesh-list
19703889|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
19703890|NCT04868513|Protective Agents|protective agents|mesh-ancestor
19703891|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703892|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19703893|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703894|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
19703895|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
19703896|NCT04868773|Trifluridine|trifluridine|mesh-list
19854395|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
19854396|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19854397|NCT00739648|Levofloxacin|levofloxacin|mesh-list
19854398|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19854399|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703897|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
19703898|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703899|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
19703900|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703901|NCT04868175|Timolol|timolol|mesh-list
19854400|NCT00739648|Renal Agents|renal agents|mesh-ancestor
19854401|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19854402|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19854403|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19854404|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703902|NCT04868175|Travoprost|travoprost|mesh-list
19703903|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19703904|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19703905|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
19703906|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245826|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20245827|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245828|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
20521061|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703907|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703908|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703909|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19703910|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19703911|NCT04868227|Vitamin D|vitamin d|mesh-list
19703912|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
19703913|NCT04868227|Vitamins|vitamins|mesh-ancestor
19703914|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
19703915|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703916|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19703917|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19703918|NCT04868461|Caseins|caseins|mesh-list
19703919|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
19703920|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
19703921|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703922|NCT04868019|Fenofibrate|fenofibrate|mesh-list
19703923|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19703924|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
19703925|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703926|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19703927|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
19703928|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
19703929|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703930|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521062|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521063|NCT01731236|Analgesics|analgesics|mesh-ancestor
20521064|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
20521065|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521066|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521067|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521068|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521069|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20521070|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20521071|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521072|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19703931|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20521073|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20521074|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521075|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
20521076|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521077|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20521078|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20521079|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521080|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20521081|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20521082|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
20521083|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20521084|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
20521085|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521086|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19703932|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19703933|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19703934|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703935|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703936|NCT04868253|Oxazepam|oxazepam|mesh-list
19703937|NCT04868253|Metyrapone|metyrapone|mesh-list
19703938|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
19703939|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703940|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854405|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854406|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854407|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19854408|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19854409|NCT00739934|Voriconazole|voriconazole|mesh-list
19854410|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
19854411|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854412|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19854413|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19854414|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854415|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854416|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19854417|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
19854418|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521087|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
20521088|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20521089|NCT01731275|Quetmolimab|quetmolimab|mesh-list
19415994|NCT02607930|Lamivudine|lamivudine|mesh-list
19703941|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19703942|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703943|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521090|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20521091|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521092|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
20521093|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521094|NCT01731301|Ribavirin|ribavirin|mesh-list
20521095|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
20521096|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521097|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
20521098|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521099|NCT01731327|Tofacitinib|tofacitinib|mesh-list
20521100|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20521101|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521102|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521103|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
20521104|NCT01731340|Calcium|calcium|mesh-list
20521105|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20521106|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521107|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20521108|NCT01731431|Glyburide|glyburide|mesh-list
20521109|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19703944|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19703945|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19703946|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19703947|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
19703948|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
19703949|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19703950|NCT04867993|Amikacin|amikacin|mesh-list
19703951|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19703952|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19703953|NCT04868058|Ropivacaine|ropivacaine|mesh-list
19703954|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
19703955|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
19703956|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703957|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854419|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854420|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19854421|NCT00739960|Abatacept|abatacept|mesh-list
19854422|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19854423|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19415995|NCT02607930|Triumeq|triumeq|mesh-list
19415996|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19415997|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19415998|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19415999|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416000|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
19416001|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416002|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19416003|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19416004|NCT02606305|Bevacizumab|bevacizumab|mesh-list
19416005|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
19416006|NCT02606305|Carboplatin|carboplatin|mesh-list
19416007|NCT02606305|Doxorubicin|doxorubicin|mesh-list
19416008|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19416009|NCT02606305|Maytansine|maytansine|mesh-list
19416010|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416011|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416012|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19416013|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19416014|NCT02606305|Growth Substances|growth substances|mesh-ancestor
19416015|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416016|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
19416017|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19416018|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19416019|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19416020|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416021|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416022|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19416023|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
19416024|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
19416025|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
19416026|NCT02602353|Loxoprofen|loxoprofen|mesh-list
19416027|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416028|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416029|NCT02602353|Analgesics|analgesics|mesh-ancestor
19854424|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854425|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703958|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
19854426|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
19854427|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854428|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854429|NCT00739973|Amlodipine|amlodipine|mesh-list
19854430|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19854431|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19854432|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19854433|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854434|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20245829|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245830|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245831|NCT00425997|Amlodipine|amlodipine|mesh-list
20245832|NCT00425997|Valsartan|valsartan|mesh-list
20245833|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20245834|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19854435|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854436|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
19854437|NCT00739999|Atorvastatin|atorvastatin|mesh-list
19854438|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19854439|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19854440|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
19854441|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854442|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20245835|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20245836|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20245837|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245838|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20245839|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245840|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
20245841|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19703959|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703960|NCT04868045|Hormones|hormones|mesh-list
19703961|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
19703962|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19703963|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416030|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
19416031|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416032|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416033|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416034|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416035|NCT02598960|Nivolumab|nivolumab|mesh-list
19416036|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416037|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416038|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19416039|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703964|NCT04867720|Everolimus|everolimus|mesh-list
19703965|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703966|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703967|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
19703968|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703969|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
19703970|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703971|NCT04867343|Fentanyl|fentanyl|mesh-list
19703972|NCT04867343|Remifentanil|remifentanil|mesh-list
19703973|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19703974|NCT04867343|Narcotics|narcotics|mesh-ancestor
19703975|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19703976|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703977|NCT04867343|Analgesics|analgesics|mesh-ancestor
19703978|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
19703979|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19703980|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20521110|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521111|NCT01731457|Etanercept|etanercept|mesh-list
20521112|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19703981|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19703982|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
19703983|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
19703984|NCT04867226|Colchicine|colchicine|mesh-list
19703985|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
19703986|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19703987|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
20521113|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521114|NCT01731457|Analgesics|analgesics|mesh-ancestor
20521115|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
20521116|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521117|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521118|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521119|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521120|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521121|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19703988|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
20521122|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
20521123|NCT01731561|Rituximab|rituximab|mesh-list
20521124|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521125|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521126|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
20521127|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521128|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521129|NCT01731574|Dapivirine|dapivirine|mesh-list
20521130|NCT01731574|Miconazole|miconazole|mesh-list
20521131|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19703989|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
19703990|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19703991|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19703992|NCT04867252|Inositol|inositol|mesh-list
19703993|NCT04867252|Metformin|metformin|mesh-list
19703994|NCT04867252|Pioglitazone|pioglitazone|mesh-list
19703995|NCT04867252|Resveratrol|resveratrol|mesh-list
19703996|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19703997|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19703998|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
19703999|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704000|NCT04867252|Protective Agents|protective agents|mesh-ancestor
19704001|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704002|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19704003|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
19704004|NCT04867252|Vitamins|vitamins|mesh-ancestor
20245842|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20245843|NCT00425997|Diuretics|diuretics|mesh-ancestor
19704005|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
19854443|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19854444|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854445|NCT00740051|Glimepiride|glimepiride|mesh-list
19854446|NCT00740051|Linagliptin|linagliptin|mesh-list
19854447|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19854448|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19854449|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854450|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854451|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
19854452|NCT00740051|Incretins|incretins|mesh-ancestor
19854453|NCT00740051|Hormones|hormones|mesh-ancestor
19854454|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854455|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19854456|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
19854457|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854458|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854459|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
19854460|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19854461|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854462|NCT00740636|Temozolomide|temozolomide|mesh-list
19704006|NCT04866498|Analgesics|analgesics|mesh-list
19704007|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
19704008|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704009|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704010|NCT04866654|Nivolumab|nivolumab|mesh-list
19704011|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19854463|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19854464|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
19854465|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854466|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521132|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19704012|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704013|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19704014|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521133|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
20521134|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521135|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
20521136|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20521137|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20521138|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521139|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521140|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20521141|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
20521142|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521143|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521144|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20521145|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20521146|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
20521147|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20521148|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
20521149|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521150|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521151|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20521152|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
20521153|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521154|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521155|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20521156|NCT01731652|Imiquimod|imiquimod|mesh-list
20521157|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20521158|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
20521159|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521160|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521161|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
20521162|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
20521163|NCT01731756|Salicylates|salicylates|mesh-list
20521164|NCT01731756|Petrolatum|petrolatum|mesh-list
20521165|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521166|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
20521167|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
20521168|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
20521169|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20521170|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521171|NCT01731756|Analgesics|analgesics|mesh-ancestor
20521172|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
20521173|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521174|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521175|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521176|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854467|NCT00740714|Vitamins|vitamins|mesh-list
20521177|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20521178|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521179|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521180|NCT01731756|Emollients|emollients|mesh-ancestor
20521181|NCT01731782|Bupivacaine|bupivacaine|mesh-list
20521182|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
20521183|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
20521184|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521185|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521186|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
20521187|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521188|NCT01731795|Dexamethasone|dexamethasone|mesh-list
20521189|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
20521190|NCT01731795|BB 1101|bb 1101|mesh-list
20521191|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521192|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
20521193|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
20521194|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521195|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521196|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521197|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
20521198|NCT01731795|Hormones|hormones|mesh-ancestor
20521199|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521200|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20521201|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521202|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
19416040|NCT02598557|Exemestane|exemestane|mesh-list
19416041|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521203|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521204|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854468|NCT00740714|Vitamin E|vitamin e|mesh-list
19854469|NCT00740714|Tocopherols|tocopherols|mesh-list
19854470|NCT00740714|Tocotrienols|tocotrienols|mesh-list
19854471|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
19854472|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
19854473|NCT00740714|Ubiquinone|ubiquinone|mesh-list
19854474|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
19854475|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854476|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
19854477|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854478|NCT00740714|Protective Agents|protective agents|mesh-ancestor
19854479|NCT00740779|Silodosin|silodosin|mesh-list
20245844|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
20521205|NCT01731899|S 20098|s 20098|mesh-list
19854480|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19854481|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19854482|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19854483|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
19854484|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854485|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854486|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854487|NCT00740779|Urological Agents|urological agents|mesh-ancestor
19854488|NCT00740792|Fluticasone|fluticasone|mesh-list
19854489|NCT00740792|Xhance|xhance|mesh-list
19854490|NCT00740792|Azelastine|azelastine|mesh-list
19854491|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854492|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19854493|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
19854494|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854495|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854496|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19854497|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
19854498|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
19854499|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19854500|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19854501|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521206|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20245845|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20245846|NCT00426010|Caffeine|caffeine|mesh-list
20245847|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20245848|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245849|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20245850|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245851|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245852|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20245853|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20521207|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521208|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521209|NCT01731925|Sunitinib|sunitinib|mesh-list
20521210|NCT01731925|Lanreotide|lanreotide|mesh-list
20521211|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521212|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20521213|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20521214|NCT01731925|Growth Substances|growth substances|mesh-ancestor
20521215|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521216|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
20521217|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20521218|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521219|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521220|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
20521221|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20521222|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20521223|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
20521224|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20521225|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
20521226|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20521227|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704015|NCT04866355|Ibuprofen|ibuprofen|mesh-list
19704016|NCT04866355|Scopolamine|scopolamine|mesh-list
19704017|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20245854|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
20245855|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416042|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19416043|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19416044|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416045|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416046|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19416047|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
19416048|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521228|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20521229|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20521230|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521231|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20521232|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
20521233|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20521234|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
20521235|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20521236|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521237|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20521238|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20521239|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521240|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
20521241|NCT01732146|Hematinics|hematinics|mesh-ancestor
20245856|NCT00426023|Ketotifen|ketotifen|mesh-list
20245857|NCT00426023|Cyclosporine|cyclosporine|mesh-list
19854502|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854503|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19854504|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19854505|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
19854506|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
19854507|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854508|NCT00740831|Leuprolide|leuprolide|mesh-list
19854509|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
19854510|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19854511|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
19854512|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19854513|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854514|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19854515|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854516|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20245858|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20245859|NCT00426023|Cyclosporins|cyclosporins|mesh-list
20245860|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245861|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245862|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245863|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
20245864|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245865|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
20245866|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245867|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
20245868|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245869|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20245870|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20245871|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
20245872|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20245873|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
20245874|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
20245875|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245876|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20245877|NCT00426049|Everolimus|everolimus|mesh-list
19854517|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
19854518|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19854519|NCT00740857|Ibuprofen|ibuprofen|mesh-list
19854520|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19854521|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854522|NCT00740857|Analgesics|analgesics|mesh-ancestor
19854523|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
19854524|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854525|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854526|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854527|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854528|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19854529|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245878|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245879|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20521242|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20521243|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
20521244|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521245|NCT01732224|Tenofovir|tenofovir|mesh-list
20521246|NCT01732224|Telbivudine|telbivudine|mesh-list
20521247|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
20521248|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521249|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20521250|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20521251|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521252|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521253|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20521254|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20521255|NCT01732250|Meropenem|meropenem|mesh-list
20521256|NCT01732250|Colistin|colistin|mesh-list
20521257|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20521258|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521259|NCT01732276|Gefitinib|gefitinib|mesh-list
20521260|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521261|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20521262|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521263|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521264|NCT01732328|Vitamin D|vitamin d|mesh-list
20521265|NCT01732328|Calcium|calcium|mesh-list
20521266|NCT01732328|Vitamins|vitamins|mesh-ancestor
20521267|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
20521268|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521269|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20521270|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20521271|NCT01732367|Tenofovir|tenofovir|mesh-list
20521272|NCT01732367|Lamivudine|lamivudine|mesh-list
20521273|NCT01732367|Adefovir|adefovir|mesh-list
20521274|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
20521275|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521276|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20521277|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20521278|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521279|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521280|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20521281|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20521282|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
20521283|NCT01732380|Raltitrexed|raltitrexed|mesh-list
20521284|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521285|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20521286|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
20521287|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521288|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20521289|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521290|NCT01732393|Quercetin|quercetin|mesh-list
20521291|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
20521292|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521293|NCT01732393|Protective Agents|protective agents|mesh-ancestor
20521294|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521295|NCT01732666|Remifentanil|remifentanil|mesh-list
20521296|NCT01732666|Nefopam|nefopam|mesh-list
20521297|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20245880|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
20245881|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245882|NCT00426101|Cyclosporine|cyclosporine|mesh-list
20245883|NCT00426101|Dexamethasone|dexamethasone|mesh-list
20245884|NCT00426101|Etoposide|etoposide|mesh-list
20245885|NCT00426101|Cyclosporins|cyclosporins|mesh-list
20245886|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521298|NCT01732666|Narcotics|narcotics|mesh-ancestor
20245887|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
20245888|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
20245889|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20245890|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704018|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19704019|NCT04866355|Analgesics|analgesics|mesh-ancestor
19704020|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
19704021|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704022|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704023|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854530|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854531|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
19854532|NCT00741013|Protein C|protein c|mesh-list
19854533|NCT00741013|Lovastatin|lovastatin|mesh-list
19854534|NCT00741013|L 647318|l 647318|mesh-list
20521299|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521300|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521301|NCT01732666|Analgesics|analgesics|mesh-ancestor
20521302|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
20521303|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854535|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
20521304|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20530184|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854536|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20530185|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
20530186|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530187|NCT01786538|Antidotes|antidotes|mesh-ancestor
20530188|NCT01786538|Protective Agents|protective agents|mesh-ancestor
19854537|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19854538|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
20245891|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854539|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854540|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19854541|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19854542|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854543|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
20245892|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
20245893|NCT00426101|Hormones|hormones|mesh-ancestor
20245894|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20245895|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20245896|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245897|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20245898|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20245899|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20245900|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245901|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245902|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245903|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
20245904|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
20245905|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245906|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
20245907|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245908|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20245909|NCT00426140|Epothilone B|epothilone b|mesh-list
20245910|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245911|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
20245912|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
20245913|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
20245914|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245915|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
20245916|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521305|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20521306|NCT01732744|Eusol|eusol|mesh-list
20521307|NCT01732744|Castor Oil|castor oil|mesh-list
20521308|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20521309|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
20521310|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521311|NCT01732744|Cathartics|cathartics|mesh-ancestor
20521312|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521313|NCT01732861|Lenalidomide|lenalidomide|mesh-list
20521314|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
20521315|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521316|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20521317|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20521318|NCT01732861|Growth Substances|growth substances|mesh-ancestor
20521319|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
20521320|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521321|NCT01733017|Lycopene|lycopene|mesh-list
20521322|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521323|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
20521324|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521325|NCT01733017|Protective Agents|protective agents|mesh-ancestor
20521326|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521327|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20521328|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20521329|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521330|NCT01733030|Cycloserine|cycloserine|mesh-list
20521331|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20521332|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521333|NCT01733030|Renal Agents|renal agents|mesh-ancestor
20521334|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20521335|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
20521336|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20521337|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
20521338|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521339|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
20521340|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20521341|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521342|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521343|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521344|NCT01733043|Analgesics|analgesics|mesh-ancestor
20521345|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
20521346|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521347|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20521348|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20521349|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20521350|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
20521351|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521352|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521353|NCT01733095|Ambrisentan|ambrisentan|mesh-list
20521354|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20521355|NCT01733108|Canagliflozin|canagliflozin|mesh-list
19854544|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19854545|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19854546|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854547|NCT00741026|Olanzapine|olanzapine|mesh-list
19704024|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19704025|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19704026|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704027|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854548|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
19854549|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
19854550|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854551|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854552|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854553|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19854554|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19854555|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19854556|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19854557|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19854558|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19854559|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20521356|NCT01733108|Glyburide|glyburide|mesh-list
20521357|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20521358|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521359|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20521360|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521361|NCT01733134|Tolvaptan|tolvaptan|mesh-list
20521362|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20521363|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521364|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
20521365|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521366|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
20521367|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19704028|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19704029|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
19704030|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
19704031|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19704032|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
19704033|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19704034|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
19704035|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854560|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854561|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854562|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
19854563|NCT00741039|Vaccines|vaccines|mesh-list
19854564|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19854565|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
19854566|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855638|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855639|NCT00750308|Urological Agents|urological agents|mesh-ancestor
19855640|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19855641|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
19855642|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19855643|NCT00750737|Amphotericin B|amphotericin b|mesh-list
19855644|NCT00750737|Posaconazole|posaconazole|mesh-list
19704036|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19704037|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
19704038|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704039|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704040|NCT04866108|Capecitabine|capecitabine|mesh-list
19704041|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19704042|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
19704043|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704044|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704045|NCT04866056|Azacitidine|azacitidine|mesh-list
19704046|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19855645|NCT00750737|Amebicides|amebicides|mesh-ancestor
19855646|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20521368|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19704047|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
19704048|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521369|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20521370|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20521371|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521372|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
20521373|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704049|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704050|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704051|NCT04865900|Antibodies|antibodies|mesh-list
19704052|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
20521374|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521375|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19704053|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704054|NCT04865848|Anesthetics|anesthetics|mesh-list
19704055|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704056|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704057|NCT04865705|Paclitaxel|paclitaxel|mesh-list
19704058|NCT04865705|Cisplatin|cisplatin|mesh-list
19704059|NCT04865705|Carboplatin|carboplatin|mesh-list
19704060|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19704061|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704062|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
19704063|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
19855647|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19704064|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
19708178|NCT04818736|Vaccines|vaccines|mesh-list
19854567|NCT00741104|Infliximab|infliximab|mesh-list
19854568|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
19854569|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854570|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854571|NCT00741156|Enalaprilat|enalaprilat|mesh-list
19854572|NCT00741156|Enalapril|enalapril|mesh-list
19854573|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19854574|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
19854575|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521376|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521377|NCT01733342|Anesthetics|anesthetics|mesh-list
20521378|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521379|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521380|NCT01733394|Lamotrigine|lamotrigine|mesh-list
20521381|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
20521382|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20521383|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20521384|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530189|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
19855648|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704065|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704066|NCT04865991|Propofol|propofol|mesh-list
19704067|NCT04865991|Sevoflurane|sevoflurane|mesh-list
19704068|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19704069|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704070|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704071|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19704072|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
19704073|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
19704074|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19704075|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19704076|NCT04865510|Heparin|heparin|mesh-list
19704077|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
19704078|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704079|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19704080|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19704081|NCT04865211|Bupivacaine|bupivacaine|mesh-list
19704082|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
19704083|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
19704084|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704085|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704086|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
19704087|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521385|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20521386|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521387|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20521388|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20521389|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521390|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20521391|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20521392|NCT01733459|Metformin|metformin|mesh-list
20521393|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20521394|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521395|NCT01733485|Aspirin|aspirin|mesh-list
20521396|NCT01733485|Indomethacin|indomethacin|mesh-list
20521397|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20521398|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19704088|NCT04865445|Midazolam|midazolam|mesh-list
19854576|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854577|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19854578|NCT00741260|Capecitabine|capecitabine|mesh-list
19854579|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19704089|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19704090|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19704091|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704092|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704093|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19704094|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19704095|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19704096|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20245917|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20245918|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245919|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245920|NCT00426192|Mannitol|mannitol|mesh-list
20245921|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20245922|NCT00426192|Diuretics|diuretics|mesh-ancestor
20245923|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
20245924|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245925|NCT00426296|Ritonavir|ritonavir|mesh-list
20245926|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20245927|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20245928|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20245929|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
19854580|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
19854581|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854582|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854583|NCT00741286|Aspirin|aspirin|mesh-list
19854584|NCT00741286|Cilostazol|cilostazol|mesh-list
19854585|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19854586|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854587|NCT00741286|Analgesics|analgesics|mesh-ancestor
19854588|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
19854589|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854590|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854591|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854592|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854593|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19854594|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19854595|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854596|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19854597|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19854598|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854599|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
19854600|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19854601|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
19854602|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19854603|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
19854604|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
19704097|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
19704098|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
19704099|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
19704100|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
19704101|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704102|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704103|NCT04865250|Paclitaxel|paclitaxel|mesh-list
19704104|NCT04865250|Carboplatin|carboplatin|mesh-list
19704105|NCT04865250|Atezolizumab|atezolizumab|mesh-list
19704106|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19704107|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704108|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
19704109|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
19704110|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
19704111|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704112|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
19704113|NCT04865562|Testosterone|testosterone|mesh-list
19704114|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
19704115|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
19854605|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19704116|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19704117|NCT04865562|Androgens|androgens|mesh-ancestor
20245930|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854606|NCT00741286|Protective Agents|protective agents|mesh-ancestor
20245931|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245932|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19704118|NCT04865562|Hormones|hormones|mesh-ancestor
19704119|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704120|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704121|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20245933|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20245934|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
20245935|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245936|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20245937|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20245938|NCT00426348|Valsartan|valsartan|mesh-list
20245939|NCT00426348|Probucol|probucol|mesh-list
20245940|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20245941|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19704122|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704123|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
19704124|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
19704125|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19704126|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19704127|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704128|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
19704129|NCT04865380|Coagulants|coagulants|mesh-ancestor
19704130|NCT04865185|Ethanol|ethanol|mesh-list
19704131|NCT04865185|Lidocaine|lidocaine|mesh-list
19704132|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19704133|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704134|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704135|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704136|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
19704137|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
19854607|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19416049|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416050|NCT02597634|Ibuprofen|ibuprofen|mesh-list
19416051|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20245942|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19704138|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
20245943|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245944|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20245945|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20245946|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
20245947|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20245948|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
20245949|NCT00426348|Protective Agents|protective agents|mesh-ancestor
20245950|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245951|NCT00426413|Pioglitazone|pioglitazone|mesh-list
20245952|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20245953|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245954|NCT00426439|Chloroquine|chloroquine|mesh-list
20245955|NCT00426439|Lumefantrine|lumefantrine|mesh-list
20245956|NCT00426439|Artemether|artemether|mesh-list
20245957|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20245958|NCT00426439|Amebicides|amebicides|mesh-ancestor
20521399|NCT01733485|Analgesics|analgesics|mesh-ancestor
20521400|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
20521401|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521402|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521403|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704139|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521404|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521405|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20521406|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20521407|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521408|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20521409|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20521410|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521411|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
20521412|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
20521413|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
20521414|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19704140|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19704141|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19704142|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19704143|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19704144|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704145|NCT04865159|Tipifarnib|tipifarnib|mesh-list
19704146|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704147|NCT04864977|Insulin|insulin|mesh-list
19704148|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19704149|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704150|NCT04864782|Paclitaxel|paclitaxel|mesh-list
19704151|NCT04864782|Carboplatin|carboplatin|mesh-list
19704152|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19704153|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704154|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
19704155|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
19704156|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
20521415|NCT01733589|Etoposide|etoposide|mesh-list
20521416|NCT01733589|Cisplatin|cisplatin|mesh-list
20245959|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20245960|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20245961|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20245962|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
20245963|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20245964|NCT00426452|Vatalanib|vatalanib|mesh-list
20245965|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20245966|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245967|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245968|NCT00426478|Amlodipine|amlodipine|mesh-list
20245969|NCT00426478|Valsartan|valsartan|mesh-list
20245970|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20245971|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20245972|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20245973|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20245974|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20245975|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20245976|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521417|NCT01733589|Endostatins|endostatins|mesh-list
20521418|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20521419|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521420|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20521421|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20521422|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521423|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521424|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20521425|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20521426|NCT01733589|Growth Substances|growth substances|mesh-ancestor
20521427|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521428|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
20521429|NCT01733706|Nicotine|nicotine|mesh-list
20521430|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20521431|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
20521432|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521433|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521434|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20521435|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20521436|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
20521437|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521438|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521439|NCT01733823|Nimorazole|nimorazole|mesh-list
20521440|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20521441|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20521442|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20521443|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521444|NCT01733836|Metformin|metformin|mesh-list
20521445|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20521446|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521447|NCT01733966|Amoxicillin|amoxicillin|mesh-list
20521448|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
20521449|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
20521450|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20521451|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
20521452|NCT01733966|Secnidazole|secnidazole|mesh-list
20521453|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20521454|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521455|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521456|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521457|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20521458|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20521459|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20521460|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20521461|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20521462|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521463|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19704157|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704158|NCT04864717|Doxycycline|doxycycline|mesh-list
19704159|NCT04864717|Isotretinoin|isotretinoin|mesh-list
19704160|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19704161|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704162|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
19704163|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19854608|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19854609|NCT00741338|Cyclosporine|cyclosporine|mesh-list
19854610|NCT00741338|Azathioprine|azathioprine|mesh-list
19854611|NCT00741338|Cyclosporins|cyclosporins|mesh-list
19854612|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20245977|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
19704164|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19704165|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
19704166|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19704167|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19704168|NCT04865029|Estradiol|estradiol|mesh-list
19704169|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19704170|NCT04865029|Progesterone|progesterone|mesh-list
19704171|NCT04865029|Estrogens|estrogens|mesh-ancestor
19704172|NCT04865029|Hormones|hormones|mesh-ancestor
19704173|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704174|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704175|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19704176|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
19704177|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19704178|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19854613|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854614|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854615|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
19854616|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854617|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
19704179|NCT04865029|Progestins|progestins|mesh-ancestor
19708179|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
19854618|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704180|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19704181|NCT04864379|Molgramostim|molgramostim|mesh-list
19704182|NCT04864379|Sargramostim|sargramostim|mesh-list
19704183|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
19704184|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704185|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704186|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704187|NCT04864431|Vitamin D|vitamin d|mesh-list
19704188|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
19704189|NCT04864431|Vitamins|vitamins|mesh-ancestor
19704190|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
19704191|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854619|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
19854620|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854621|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19854622|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
20521464|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19704192|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19704193|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19704194|NCT04864210|Bupivacaine|bupivacaine|mesh-list
20521465|NCT01733979|Iron|iron|mesh-list
20521466|NCT01733979|Trace Elements|trace elements|mesh-ancestor
20521467|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
20521468|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521469|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20521470|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20521471|NCT01734044|Dexamethasone|dexamethasone|mesh-list
20521472|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
19704195|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
20521473|NCT01734044|BB 1101|bb 1101|mesh-list
20521474|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521475|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
19704196|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
19704197|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20245978|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20245979|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20245980|NCT00426478|Diuretics|diuretics|mesh-ancestor
20245981|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
20245982|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20245983|NCT00426491|Misoprostol|misoprostol|mesh-list
20245984|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20245985|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
20245986|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19416052|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416053|NCT02597634|Analgesics|analgesics|mesh-ancestor
19416054|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
19416055|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416056|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416057|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416058|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416059|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416060|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416061|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416062|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
19416063|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19416064|NCT02591199|Lidocaine|lidocaine|mesh-list
19416065|NCT02591199|Heparin|heparin|mesh-list
19416066|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
19416067|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
19416068|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416069|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416070|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
19416071|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416072|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19416073|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19416074|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19416075|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416076|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416077|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
19416078|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19416079|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19416080|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
19416081|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19416082|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
19854623|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19854624|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854625|NCT00741455|Cyclosporine|cyclosporine|mesh-list
19854626|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
19854627|NCT00741455|Methotrexate|methotrexate|mesh-list
19854628|NCT00741455|Fludarabine|fludarabine|mesh-list
19854629|NCT00741455|Cyclosporins|cyclosporins|mesh-list
19854630|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854631|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
19854632|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854633|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19704198|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704199|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
19854634|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19854635|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
19854636|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854637|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854638|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19854639|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19854640|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
19854641|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19854642|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19854643|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
19704200|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704201|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
19704202|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19704203|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
19704204|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704205|NCT04864314|Protective Agents|protective agents|mesh-ancestor
19704206|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704207|NCT04864366|Tenofovir|tenofovir|mesh-list
19704208|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
19704209|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704210|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19704211|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19704212|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704213|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704214|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19704215|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19704216|NCT04864444|Piperaquine|piperaquine|mesh-list
19704217|NCT04864444|Primaquine|primaquine|mesh-list
19854644|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
19704218|NCT04864444|Artenimol|artenimol|mesh-list
19704219|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
19704220|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19704221|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19704222|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704223|NCT04864067|Leucovorin|leucovorin|mesh-list
19704224|NCT04864067|Capecitabine|capecitabine|mesh-list
19704225|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
19704226|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19704227|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
19704228|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704229|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704230|NCT04864067|Antidotes|antidotes|mesh-ancestor
19704231|NCT04864067|Protective Agents|protective agents|mesh-ancestor
19704232|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704233|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
19704234|NCT04864067|Vitamins|vitamins|mesh-ancestor
19704235|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
19704236|NCT04864509|Melatonin|melatonin|mesh-list
19704237|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
19704238|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704239|NCT04864509|Protective Agents|protective agents|mesh-ancestor
19704240|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704241|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704242|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
19704243|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19704244|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
19704245|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704246|NCT04864496|Expectorants|expectorants|mesh-ancestor
19704247|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
19704248|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19704249|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
19704250|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704251|NCT04864496|Protective Agents|protective agents|mesh-ancestor
19704252|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704253|NCT04864496|Antidotes|antidotes|mesh-ancestor
19704254|NCT04863742|Prednisolone|prednisolone|mesh-list
19704255|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19704256|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
19704257|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19704258|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
19704259|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19704260|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
19704261|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704262|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
19704263|NCT04863742|Hormones|hormones|mesh-ancestor
19704264|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704265|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704266|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19704267|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704268|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
19704269|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
19416083|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19416084|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19416085|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416086|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19416087|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416088|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19416089|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416090|NCT02588677|Riluzole|riluzole|mesh-list
19416091|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
19416092|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19416093|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19416094|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20245987|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245988|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20245989|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20245990|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
20245991|NCT00426530|Everolimus|everolimus|mesh-list
20521476|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
20521477|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521478|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521479|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521480|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
20521481|NCT01734044|Hormones|hormones|mesh-ancestor
20521482|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521483|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20521484|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521485|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
20521486|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521487|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521488|NCT01734057|Dexamethasone|dexamethasone|mesh-list
20521489|NCT01734057|Rituximab|rituximab|mesh-list
19704270|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704271|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19704272|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19704273|NCT04863742|Protective Agents|protective agents|mesh-ancestor
19704274|NCT04863807|Anesthetics|anesthetics|mesh-list
20521490|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521491|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521492|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
20521493|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521494|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20530190|NCT01786538|Vitamins|vitamins|mesh-ancestor
19854645|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521495|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521496|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
20521497|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
20521498|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521499|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521500|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
20521501|NCT01734057|Hormones|hormones|mesh-ancestor
20521502|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521503|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20521504|NCT01734096|Candesartan|candesartan|mesh-list
20521505|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
20521506|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19704275|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704276|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704277|NCT04863638|Vaccines|vaccines|mesh-list
19704278|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
19704279|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704280|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
19704281|NCT04863430|Apatinib|apatinib|mesh-list
19704282|NCT04863430|Tegafur|tegafur|mesh-list
19704283|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704284|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19704285|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704286|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704287|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19854646|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19854647|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19704288|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
19704289|NCT04863183|Triamcinolone|triamcinolone|mesh-list
19704290|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19704291|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19704292|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19704293|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704294|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
20521507|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20521508|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20521509|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521510|NCT01734252|Argatroban|argatroban|mesh-list
20521511|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
20521512|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20521513|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
20521514|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521515|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521516|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
20521517|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20521518|NCT01734304|Vaccines|vaccines|mesh-list
20521519|NCT01734304|Immunologic Factors|immunologic factors|mesh-ancestor
20521520|NCT01734304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521521|NCT01734330|Nicotine|nicotine|mesh-list
19704295|NCT04863183|Hormones|hormones|mesh-ancestor
19704296|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704297|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704298|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19704299|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
19704300|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704301|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704302|NCT04863274|Atorvastatin|atorvastatin|mesh-list
19704303|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19704304|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19704305|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
19854648|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
20521522|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19704306|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704307|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19704308|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19704309|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704310|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19704311|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19704312|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
19704313|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704314|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704315|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19704316|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
19704317|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704318|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19704319|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704320|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704321|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
19704322|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704323|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245992|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245993|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20245994|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
20245995|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245996|NCT00426543|Rituximab|rituximab|mesh-list
20245997|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704324|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19704325|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
19704326|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704327|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704328|NCT04862767|Aldesleukin|aldesleukin|mesh-list
19704329|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704330|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19704331|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19704332|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
19704333|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708180|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708181|NCT04818749|Dexamethasone|dexamethasone|mesh-list
19708182|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
19708183|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
19708184|NCT04818749|BB 1101|bb 1101|mesh-list
19708185|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708186|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
19708187|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
19708188|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708189|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708190|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521523|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
20521524|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521525|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521526|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20521527|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20521528|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
20521529|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521530|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521531|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20521532|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
20521533|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20521534|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
20521535|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521536|NCT01734408|Antacids|antacids|mesh-ancestor
20521537|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521538|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521539|NCT01734473|Caseins|caseins|mesh-list
19708191|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
19704334|NCT04862845|Pregabalin|pregabalin|mesh-list
19704335|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19704336|NCT04862845|Analgesics|analgesics|mesh-ancestor
19704337|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
19704338|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704339|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704340|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
19704341|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19704342|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19704343|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704344|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19704345|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19704346|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19704347|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704348|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19704349|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19704350|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19704351|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704352|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
19704353|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
19704354|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
19704355|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704356|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19704357|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704358|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704359|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
19704360|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704361|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704362|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19704363|NCT04862377|Budesonide|budesonide|mesh-list
19704364|NCT04862377|Poractant alfa|poractant alfa|mesh-list
19704365|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704366|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19704367|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
19704368|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704369|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704370|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19704371|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
19704372|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
19704373|NCT04862377|Hormones|hormones|mesh-ancestor
19704374|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704375|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19704376|NCT04862234|Dulaglutide|dulaglutide|mesh-list
19704377|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19704378|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854649|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854650|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19854651|NCT00741468|Tolbutamide|tolbutamide|mesh-list
19854652|NCT00741468|Midazolam|midazolam|mesh-list
19704379|NCT04861948|Bevacizumab|bevacizumab|mesh-list
19704380|NCT04861948|Carboplatin|carboplatin|mesh-list
19704381|NCT04861948|Pemetrexed|pemetrexed|mesh-list
19704382|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704383|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704384|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19704385|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19704386|NCT04861948|Growth Substances|growth substances|mesh-ancestor
19704387|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704388|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
19704389|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704390|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704391|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19704392|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19704393|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19704394|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
19704395|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704396|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704397|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704398|NCT04861922|Heparin|heparin|mesh-list
19704399|NCT04861922|Calcium heparin|calcium heparin|mesh-list
19704400|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
19704401|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19854653|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
19854654|NCT00741468|Caffeine|caffeine|mesh-list
19854655|NCT00741468|Omeprazole|omeprazole|mesh-list
19854656|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19854657|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19854658|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19854659|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20245998|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20245999|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
19704402|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19704403|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704404|NCT04861142|Denosumab|denosumab|mesh-list
19704405|NCT04861142|Alendronate|alendronate|mesh-list
19704406|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19704407|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704408|NCT04861051|Ketamine|ketamine|mesh-list
19704409|NCT04861051|Analgesics|analgesics|mesh-ancestor
19704410|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
20246000|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246001|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246002|NCT00426582|Epothilone B|epothilone b|mesh-list
20246003|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704411|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704412|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704413|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19704414|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19704415|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
19704416|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
19704417|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704418|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19704419|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19704420|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704421|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704422|NCT04861103|Enoxaparin|enoxaparin|mesh-list
19704423|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
19704424|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20246004|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20246005|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20246006|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246007|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248060|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20248061|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20248062|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
20248063|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20248064|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248065|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
19704425|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19704426|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704427|NCT04860674|Carboplatin|carboplatin|mesh-list
19704428|NCT04860674|Etoposide|etoposide|mesh-list
19704429|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19704430|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704431|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19704432|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19704433|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19704434|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704435|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704436|NCT04860856|Ropivacaine|ropivacaine|mesh-list
19704437|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
19704438|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
19704439|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704440|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704441|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
19704442|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704443|NCT04860505|Doxycycline|doxycycline|mesh-list
19704444|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19704445|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704446|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
19704447|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19704448|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19704449|NCT04861207|Cladribine|cladribine|mesh-list
19704450|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704451|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19704452|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
19704453|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704454|NCT04860531|Betamethasone|betamethasone|mesh-list
19704455|NCT04860531|Lidocaine|lidocaine|mesh-list
19704456|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
19704457|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
19704458|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704459|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704460|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
19704461|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704462|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19704463|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19704464|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19704465|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19704466|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704467|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704468|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
19704469|NCT04860531|Hormones|hormones|mesh-ancestor
19704470|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704471|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19704472|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
19704473|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
19704474|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
19704475|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19704476|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19704477|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704478|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704479|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704480|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708192|NCT04818749|Hormones|hormones|mesh-ancestor
19708193|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708194|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708195|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708196|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
19708197|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708198|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704481|NCT04860141|Gabapentin|gabapentin|mesh-list
19704482|NCT04860141|Analgesics|analgesics|mesh-ancestor
19704483|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
19704484|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704485|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704486|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
19704487|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19704488|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19704489|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704490|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19704491|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19704492|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19704493|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704494|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704495|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
19704496|NCT04860167|Diclofenac|diclofenac|mesh-list
19704497|NCT04860167|Lidocaine|lidocaine|mesh-list
19704498|NCT04860167|Propofol|propofol|mesh-list
19704499|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19704500|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704501|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704502|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19704503|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
19704504|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
19704505|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19704506|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19704507|NCT04860167|Analgesics|analgesics|mesh-ancestor
19704508|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
19704509|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704510|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704511|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19704512|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19704513|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704514|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704515|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
19704516|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19704517|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19704518|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19704519|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19704520|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
19704521|NCT04860076|Nivolumab|nivolumab|mesh-list
19704522|NCT04860076|Ipilimumab|ipilimumab|mesh-list
19704523|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704524|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704525|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19704526|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704527|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
19704528|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19704529|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
19704530|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
19704531|NCT04860011|Metolazone|metolazone|mesh-list
19704532|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19704533|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704534|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19704535|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704536|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19704537|NCT04860011|Diuretics|diuretics|mesh-ancestor
19704538|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
19704539|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19704540|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19704541|NCT04859738|Lidocaine|lidocaine|mesh-list
19854660|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20521540|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
20521541|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
19704542|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
19704543|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
19704544|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704545|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704546|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
19704547|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704548|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20521542|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521543|NCT01734564|Poly I-C|poly i-c|mesh-list
20521544|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20521545|NCT01734564|Poly ICLC|poly iclc|mesh-list
20521546|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
19704549|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19704550|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19704551|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19704552|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704553|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
19704554|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704555|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704556|NCT04860219|Lactoferrin|lactoferrin|mesh-list
19704557|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704558|NCT04859621|Vitamin D|vitamin d|mesh-list
19704559|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
19704560|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
19704561|NCT04859621|Vitamins|vitamins|mesh-list
19704562|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19704563|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
19704564|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704565|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19704566|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19704567|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704568|NCT04859556|Dipivefrin|dipivefrin|mesh-list
19704569|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19704570|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
19704571|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708199|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20521547|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
19704572|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704573|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704574|NCT04859569|Denosumab|denosumab|mesh-list
19704575|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19704576|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704577|NCT04859530|Lugol's solution|lugol's solution|mesh-list
19704578|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
19704579|NCT04859530|Coagulants|coagulants|mesh-ancestor
19704580|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
19704581|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19704582|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704583|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704584|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19704585|NCT04859283|Analgesics|analgesics|mesh-ancestor
19704586|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
19704587|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704588|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19704589|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19704590|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19704591|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
19704592|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704593|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704594|NCT04859452|Metformin|metformin|mesh-list
19704595|NCT04859452|Glyburide|glyburide|mesh-list
19704596|NCT04859452|Valsartan|valsartan|mesh-list
19704597|NCT04859452|Simvastatin|simvastatin|mesh-list
19704598|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19704599|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704600|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19704601|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19704602|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
19704603|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704604|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20246008|NCT00426595|Omeprazole|omeprazole|mesh-list
20246009|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20246010|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19704605|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19704606|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704607|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19704608|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19704609|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19704610|NCT04859361|Imiquimod|imiquimod|mesh-list
19704611|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19704612|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
19704613|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704614|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704615|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
19704616|NCT04859322|Glucagon|glucagon|mesh-list
19704617|NCT04859322|Somatostatin|somatostatin|mesh-list
19704618|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704619|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19704620|NCT04859322|Hormones|hormones|mesh-ancestor
20246011|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19704621|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704622|NCT04859244|Remdesivir|remdesivir|mesh-list
19704623|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
19708200|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416095|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416096|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416097|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19416098|NCT02588677|Protective Agents|protective agents|mesh-ancestor
19416099|NCT02580708|Trametinib|trametinib|mesh-list
19416100|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416101|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19416102|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416103|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416104|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
19416105|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19416106|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19416107|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19416108|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416109|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416110|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
19416111|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416112|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416113|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19416114|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416115|NCT02580305|Memantine|memantine|mesh-list
19416116|NCT02580305|Donepezil|donepezil|mesh-list
19416117|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
19416118|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19416119|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416120|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416121|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
19854661|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19854662|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19854663|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19704624|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704625|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
19704626|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704627|NCT04858997|Palbociclib|palbociclib|mesh-list
19704628|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704629|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19704630|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704631|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246012|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246013|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246014|NCT00426608|Alprazolam|alprazolam|mesh-list
20246015|NCT00426608|Metyrapone|metyrapone|mesh-list
20246016|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20246017|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20246018|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246019|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20246020|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20246021|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20246022|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
19704632|NCT04858841|Levetiracetam|levetiracetam|mesh-list
19704633|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
19704634|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
19704635|NCT04858529|Carboplatin|carboplatin|mesh-list
19704636|NCT04858529|Docetaxel|docetaxel|mesh-list
19704637|NCT04858529|Trastuzumab|trastuzumab|mesh-list
19704638|NCT04858529|Pertuzumab|pertuzumab|mesh-list
19704639|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704640|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
19854664|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
19704641|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
19704642|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
19704643|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704644|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704645|NCT04858516|Trastuzumab|trastuzumab|mesh-list
19704646|NCT04858516|Palbociclib|palbociclib|mesh-list
19704647|NCT04858516|Exemestane|exemestane|mesh-list
19704648|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704649|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704650|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19854665|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
19854666|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
19704651|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854667|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
20246023|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
20246024|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246025|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246026|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
20246027|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246028|NCT00426621|Diclofenac|diclofenac|mesh-list
20246029|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20246030|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246031|NCT00426621|Analgesics|analgesics|mesh-ancestor
20246032|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
20246033|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246034|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246035|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246036|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246037|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20246038|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246039|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246040|NCT00426647|Buprenorphine|buprenorphine|mesh-list
20246041|NCT00426647|Tramadol|tramadol|mesh-list
20246042|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20246043|NCT00426647|Narcotics|narcotics|mesh-ancestor
20246044|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20246045|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246046|NCT00426647|Analgesics|analgesics|mesh-ancestor
20246047|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
20246048|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246049|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20246050|NCT00426673|Brivaracetam|brivaracetam|mesh-list
20246051|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
20246052|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
20246053|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20246054|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
20246055|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246056|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
20246057|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
20246058|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19704652|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704653|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19704654|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20246059|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20246060|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246061|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20246062|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246063|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20246064|NCT00426829|Bevacizumab|bevacizumab|mesh-list
20246065|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521548|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521549|NCT01734564|Laxatives|laxatives|mesh-ancestor
20521550|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521551|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
20521552|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530191|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
20530192|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
20530193|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20530194|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
20530195|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530196|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530197|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20530198|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
20530199|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20530200|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19704655|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20521553|NCT01734694|Vancomycin|vancomycin|mesh-list
20521554|NCT01734694|Linezolid|linezolid|mesh-list
20521555|NCT01734694|Daptomycin|daptomycin|mesh-list
20521556|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20521557|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20521558|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521559|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20521560|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521561|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521562|NCT01734798|Gemcitabine|gemcitabine|mesh-list
20521563|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521564|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20521565|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
20521566|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521567|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
20521568|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521569|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521570|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20521571|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
20521572|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521573|NCT01734824|Denosumab|denosumab|mesh-list
20521574|NCT01734824|Teriparatide|teriparatide|mesh-list
20521575|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
20521576|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20521577|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521578|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20521579|NCT01734915|Iproplatin|iproplatin|mesh-list
20521580|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521581|NCT01734954|Midazolam|midazolam|mesh-list
19704656|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
19704657|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704658|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704659|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
19704660|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
19704661|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20521582|NCT01734954|Analgesics|analgesics|mesh-list
20521583|NCT01734954|Anesthetics|anesthetics|mesh-list
20521584|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
20521585|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
20521586|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521587|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521588|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20521589|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20521590|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19704662|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20521591|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20521592|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20521593|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20521594|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
20521595|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
20521596|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
20521597|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521598|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521599|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
20521600|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521601|NCT01735006|Vaccines|vaccines|mesh-list
20521602|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
20521603|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521604|NCT01735019|Remifentanil|remifentanil|mesh-list
20521605|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20521606|NCT01735019|Narcotics|narcotics|mesh-ancestor
20521607|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521608|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521609|NCT01735019|Analgesics|analgesics|mesh-ancestor
20521610|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
20521611|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246066|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246067|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20246068|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20246069|NCT00426829|Growth Substances|growth substances|mesh-ancestor
20246070|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246071|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
20521612|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
19416122|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416123|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416124|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
19416125|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19416126|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19416127|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
19416128|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19416129|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19416130|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19416131|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
19416132|NCT02580058|Doxorubicin|doxorubicin|mesh-list
19416133|NCT02580058|Avelumab|avelumab|mesh-list
19416134|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19416135|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416136|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19416137|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19416138|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416139|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416140|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416141|NCT02578771|Methylene Blue|methylene blue|mesh-list
20521613|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20521614|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
20521615|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521616|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
20521617|NCT01735058|Protective Agents|protective agents|mesh-ancestor
19704663|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704664|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704665|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704666|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708201|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19708202|NCT04818749|Analgesics|analgesics|mesh-ancestor
19708203|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
19708204|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19708205|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20521618|NCT01735071|Bevacizumab|bevacizumab|mesh-list
20521619|NCT01735071|Carboplatin|carboplatin|mesh-list
20521620|NCT01735071|Trabectedin|trabectedin|mesh-list
20521621|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521622|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521623|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19708206|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19704667|NCT04858087|Lumefantrine|lumefantrine|mesh-list
19704668|NCT04858087|Artemether|artemether|mesh-list
19704669|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19704670|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
19704671|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19704672|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19704673|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704674|NCT04858048|Anesthetics|anesthetics|mesh-list
19704675|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704676|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704677|NCT04857983|Memantine|memantine|mesh-list
19704678|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19704679|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19704680|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
19854668|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854669|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854670|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19854671|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854672|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19704681|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704682|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704683|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416142|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416143|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416144|NCT02578680|Folic Acid|folic acid|mesh-list
19416145|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
19416146|NCT02578680|Hydroxocobalamin|hydroxocobalamin|mesh-list
19416147|NCT02578680|Dexamethasone|dexamethasone|mesh-list
19704684|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19704685|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19704686|NCT04857801|Teduglutide|teduglutide|mesh-list
19704687|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19704688|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19704689|NCT04857801|Protective Agents|protective agents|mesh-ancestor
20246072|NCT00426920|Insulin|insulin|mesh-list
20246073|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20246074|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246075|NCT00426933|Vancomycin|vancomycin|mesh-list
20246076|NCT00426933|Daptomycin|daptomycin|mesh-list
20246077|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20246078|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246079|NCT00426946|Reboxetine|reboxetine|mesh-list
20246080|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
20246081|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20246082|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20246083|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19704690|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704691|NCT04857840|Firibastat|firibastat|mesh-list
19704692|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20246084|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20246085|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246086|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
20246087|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246088|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246089|NCT00426972|Estradiol|estradiol|mesh-list
20246090|NCT00426972|Estrogens|estrogens|mesh-ancestor
20246091|NCT00426972|Hormones|hormones|mesh-ancestor
20246092|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246093|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246094|NCT00426985|Ketoprofen|ketoprofen|mesh-list
20246095|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19704693|NCT04857320|Insulin|insulin|mesh-list
19704694|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19704695|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20246096|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246097|NCT00426985|Analgesics|analgesics|mesh-ancestor
19704696|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704697|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19704698|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704699|NCT04857450|Ketamine|ketamine|mesh-list
19704700|NCT04857450|Etomidate|etomidate|mesh-list
19704701|NCT04857450|Analgesics|analgesics|mesh-ancestor
19704702|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
19416148|NCT02578680|Carboplatin|carboplatin|mesh-list
19416149|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
19416150|NCT02578680|Pemetrexed|pemetrexed|mesh-list
19416151|NCT02578680|Vitamins|vitamins|mesh-ancestor
19416152|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
19416153|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416154|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416155|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416156|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
19416157|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
19416158|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246098|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
19416159|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19416160|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
19416161|NCT02578680|Hormones|hormones|mesh-ancestor
19704703|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704704|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704705|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19704706|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19704707|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
19704708|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
19704709|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704710|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19704711|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19704712|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704713|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704714|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19704715|NCT04857177|Ranibizumab|ranibizumab|mesh-list
19704716|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19704717|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19704718|NCT04857177|Growth Substances|growth substances|mesh-ancestor
19704719|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704720|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
19704721|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704722|NCT04857203|Vitamin D|vitamin d|mesh-list
19704723|NCT04857203|Vitamins|vitamins|mesh-ancestor
19704724|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
19704725|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704726|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19704727|NCT04856761|Capecitabine|capecitabine|mesh-list
19704728|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19704729|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
19704730|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704731|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704732|NCT04856852|Iodine|iodine|mesh-list
19704733|NCT04856852|Temozolomide|temozolomide|mesh-list
19704734|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19704735|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
20246099|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416162|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416163|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19416164|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416165|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246100|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246101|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246102|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246103|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20246104|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246105|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704736|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704737|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704738|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19704739|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704740|NCT04856852|Trace Elements|trace elements|mesh-ancestor
20246106|NCT00426998|Bevacizumab|bevacizumab|mesh-list
20246107|NCT00426998|Verteporfin|verteporfin|mesh-list
20246108|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20246109|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246110|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19854673|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854674|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19854675|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19854676|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19854677|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19854678|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
20530201|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19704741|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
19704742|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704743|NCT04856878|Vancomycin|vancomycin|mesh-list
19704744|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19704745|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704746|NCT04856787|Fluorouracil|fluorouracil|mesh-list
19704747|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
19704748|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704749|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19704750|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530202|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
20530203|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530204|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530205|NCT01786655|Epinephrine|epinephrine|mesh-list
20530206|NCT01786655|Bupivacaine|bupivacaine|mesh-list
20530207|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
20530208|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
20530209|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
20530210|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530211|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530212|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
20530213|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530214|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20530215|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20530216|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
20530217|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704751|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19704752|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
19704753|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704754|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
19704755|NCT04856969|Olmesartan|olmesartan|mesh-list
19704756|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19704757|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704758|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19704759|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704760|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19704761|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19704762|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19704763|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
19704764|NCT04856644|Rifapentine|rifapentine|mesh-list
19704765|NCT04856644|Rifampin|rifampin|mesh-list
19704766|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19704767|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704768|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19704769|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19704770|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704771|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704772|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854679|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
19854680|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
19704773|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19704774|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
19704775|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
19704776|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19704777|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19704778|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19704779|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19704780|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19704781|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19704782|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19704783|NCT04856371|Letrozole|letrozole|mesh-list
19704784|NCT04856371|Fulvestrant|fulvestrant|mesh-list
19704785|NCT04856371|Palbociclib|palbociclib|mesh-list
19704786|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704787|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19704788|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19704789|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704790|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704791|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19704792|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
19704793|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704794|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704795|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19704796|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19704797|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19704798|NCT04856137|Paclitaxel|paclitaxel|mesh-list
19704799|NCT04856137|Rituximab|rituximab|mesh-list
19704800|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19704801|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704802|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
19704803|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19704804|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19704805|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704806|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704807|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
19704808|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704809|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19704810|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
19704811|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20246111|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20246112|NCT00426998|Growth Substances|growth substances|mesh-ancestor
20246113|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246114|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
20246115|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20246116|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
20246117|NCT00427076|Vancomycin|vancomycin|mesh-list
20246118|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20246119|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20521624|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20521625|NCT01735071|Growth Substances|growth substances|mesh-ancestor
20521626|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521627|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
20521628|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20521629|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
20521630|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521631|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20521632|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
20521633|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521634|NCT01735097|Vitamin E|vitamin e|mesh-list
20521635|NCT01735097|Vitamins|vitamins|mesh-ancestor
20521636|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
20521637|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521638|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
20521639|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521640|NCT01735097|Protective Agents|protective agents|mesh-ancestor
19854681|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19854682|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19854683|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19854684|NCT00741598|Galantamine|galantamine|mesh-list
20521641|NCT01735123|Caseins|caseins|mesh-list
19416166|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416167|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19416168|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19416169|NCT02578680|Hematinics|hematinics|mesh-ancestor
19416170|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
19416171|NCT02570490|Linezolid|linezolid|mesh-list
19416172|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
19416173|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19416174|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416175|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19416176|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416177|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416178|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
19416179|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19416180|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19704812|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704813|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
19704814|NCT04856098|Bromides|bromides|mesh-list
19704815|NCT04856098|Maleic acid|maleic acid|mesh-list
19704816|NCT04856098|Charcoal|charcoal|mesh-list
19854685|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19854686|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854687|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854688|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
19854689|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246120|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246121|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20246122|NCT00427076|Renal Agents|renal agents|mesh-ancestor
20246123|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
19704817|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
19704818|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704819|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704820|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19704821|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19704822|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19704823|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
19704824|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704825|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704826|NCT04856098|Antidotes|antidotes|mesh-ancestor
19704827|NCT04856098|Protective Agents|protective agents|mesh-ancestor
19704828|NCT04856111|Pirfenidone|pirfenidone|mesh-list
19704829|NCT04856111|Nintedanib|nintedanib|mesh-list
19704830|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704831|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19704832|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704833|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704834|NCT04856111|Analgesics|analgesics|mesh-ancestor
19704835|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
19704836|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704837|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704838|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19704839|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19704840|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704841|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19704842|NCT04855968|Analgesics|analgesics|mesh-list
19704843|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
19704844|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704845|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704846|NCT04856124|Ketamine|ketamine|mesh-list
19854690|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854691|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19704847|NCT04856124|Esketamine|esketamine|mesh-list
19704848|NCT04856124|Analgesics|analgesics|mesh-ancestor
19704849|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
19704850|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704851|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704852|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19704853|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19704854|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
19704855|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
19704856|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708207|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
20246124|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20246125|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20246126|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
20246127|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20246128|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
20246129|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246130|NCT00427089|Protective Agents|protective agents|mesh-ancestor
20246131|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246132|NCT00427089|Vitamins|vitamins|mesh-ancestor
20246133|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
20246134|NCT00427089|Laxatives|laxatives|mesh-ancestor
20246135|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20246136|NCT00427102|Cisplatin|cisplatin|mesh-list
19854692|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
19854693|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854694|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
19854695|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19854696|NCT00741819|Treprostinil|treprostinil|mesh-list
19854697|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19854698|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19854699|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20246137|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246138|NCT00427128|Fluoxetine|fluoxetine|mesh-list
19854700|NCT00741858|Estradiol|estradiol|mesh-list
19854701|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19854702|NCT00741858|Estrogens|estrogens|mesh-ancestor
19854703|NCT00741858|Hormones|hormones|mesh-ancestor
19854704|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246139|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20246140|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20246141|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19704857|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19704858|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19704859|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704860|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704861|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
19704862|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19708208|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708209|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19708210|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19708211|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19708212|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
19854705|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854706|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19854707|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
19854708|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708213|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708214|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19708215|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19708216|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708217|NCT04817826|Durvalumab|durvalumab|mesh-list
19708218|NCT04817826|Tremelimumab|tremelimumab|mesh-list
19708219|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19708220|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708221|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19708222|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708223|NCT04817982|Dexamethasone|dexamethasone|mesh-list
19708224|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
19708225|NCT04817982|Lidocaine|lidocaine|mesh-list
19708226|NCT04817982|BB 1101|bb 1101|mesh-list
19708227|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708228|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
19708229|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
19708230|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708231|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708232|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708233|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
19708234|NCT04817982|Hormones|hormones|mesh-ancestor
19708235|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521642|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
20521643|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
20521644|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521645|NCT01735227|Omeprazole|omeprazole|mesh-list
20521646|NCT01735227|Pantoprazole|pantoprazole|mesh-list
20521647|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20521648|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521649|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20521650|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521651|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521652|NCT01735240|Ketoconazole|ketoconazole|mesh-list
20521653|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
20521654|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521655|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20521656|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20521657|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521658|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521659|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20521660|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
20521661|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521662|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521663|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20521664|NCT01735318|Lisinopril|lisinopril|mesh-list
20521665|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20521666|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
20521667|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854709|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19854710|NCT00742027|Panobinostat|panobinostat|mesh-list
19854711|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854712|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19854713|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854714|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854715|NCT00742079|Cycloserine|cycloserine|mesh-list
19854716|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19854717|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854718|NCT00742079|Renal Agents|renal agents|mesh-ancestor
19854719|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19854720|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
19854721|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19854722|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
19854723|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854724|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19854725|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19854726|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854727|NCT00742235|Vitamin D|vitamin d|mesh-list
19854728|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
19854729|NCT00742235|Vitamins|vitamins|mesh-ancestor
19854730|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
19854731|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854732|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20246142|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246143|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246144|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
20246145|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246146|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20246147|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
20246148|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20246149|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20246150|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20246151|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246152|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20246153|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20246154|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
20246155|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704863|NCT04855279|Listerine|listerine|mesh-list
19854733|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19854734|NCT00742313|Hemostatics|hemostatics|mesh-list
19854735|NCT00742313|Coagulants|coagulants|mesh-ancestor
19854736|NCT00742326|Pioglitazone|pioglitazone|mesh-list
19854737|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19854738|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521668|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704864|NCT04855279|Fluorides|fluorides|mesh-list
19704865|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
19704866|NCT04855279|Glycerol|glycerol|mesh-list
19704867|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
19704868|NCT04855279|Protective Agents|protective agents|mesh-ancestor
19704869|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704870|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19704871|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704872|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19704873|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19704874|NCT04855266|Hematinics|hematinics|mesh-ancestor
19704875|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19704876|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19704877|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704878|NCT04855695|Venetoclax|venetoclax|mesh-list
19704879|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
19704880|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
19704881|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704882|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704883|NCT04855110|Warfarin|warfarin|mesh-list
19704884|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
19704885|NCT04854837|Remdesivir|remdesivir|mesh-list
19704886|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
19704887|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704888|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
19704889|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19704890|NCT04854889|Decitabine|decitabine|mesh-list
19704891|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19704892|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
20521669|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20521670|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20521671|NCT01735318|Protective Agents|protective agents|mesh-ancestor
20521672|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521673|NCT01735344|Lisinopril|lisinopril|mesh-list
20521674|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20521675|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
20521676|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521677|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521678|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20521679|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20521680|NCT01735344|Protective Agents|protective agents|mesh-ancestor
19704893|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704894|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704895|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19704896|NCT04854759|Amantadine|amantadine|mesh-list
19854739|NCT00742469|Rifaximin|rifaximin|mesh-list
19704897|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19704898|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19704899|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
19704900|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246156|NCT00427167|Antacids|antacids|mesh-ancestor
20246157|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246158|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19416181|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19416182|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416183|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416184|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
19416185|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704901|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
19704902|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19704903|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704904|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704905|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19704906|NCT04854759|Analgesics|analgesics|mesh-ancestor
19704907|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
19704908|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704909|NCT04855136|Dexamethasone|dexamethasone|mesh-list
19704910|NCT04855136|Bortezomib|bortezomib|mesh-list
19704911|NCT04855136|Pomalidomide|pomalidomide|mesh-list
19704912|NCT04855136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704913|NCT04855136|Antiemetics|antiemetics|mesh-ancestor
19704914|NCT04855136|Autonomic Agents|autonomic agents|mesh-ancestor
19704915|NCT04855136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704916|NCT04855136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704917|NCT04855136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19704918|NCT04855136|Glucocorticoids|glucocorticoids|mesh-ancestor
19704919|NCT04855136|Hormones|hormones|mesh-ancestor
19704920|NCT04855136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704921|NCT04855136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19704922|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704923|NCT04855136|Immunologic Factors|immunologic factors|mesh-ancestor
19704924|NCT04855136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19704925|NCT04855136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19704926|NCT04855136|Growth Substances|growth substances|mesh-ancestor
19704927|NCT04855136|Growth Inhibitors|growth inhibitors|mesh-ancestor
20246159|NCT00427206|Acetaminophen|acetaminophen|mesh-list
20246160|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416186|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416187|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19416188|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416189|NCT02564744|Rituximab|rituximab|mesh-list
19416190|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416191|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704928|NCT04854668|Bevacizumab|bevacizumab|mesh-list
19704929|NCT04854668|Capecitabine|capecitabine|mesh-list
19704930|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
19704931|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19704932|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704933|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20246161|NCT00427206|Analgesics|analgesics|mesh-ancestor
20246162|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
19854740|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19854741|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854742|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854743|NCT00742508|Carvedilol|carvedilol|mesh-list
19854744|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19854745|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19854746|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19854747|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854748|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854749|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854750|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19854751|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
19704934|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19704935|NCT04854668|Growth Substances|growth substances|mesh-ancestor
19704936|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704937|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
19704938|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19704939|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
19704940|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704941|NCT04854460|Ivermectin|ivermectin|mesh-list
19704942|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19704943|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246163|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246164|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246165|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
20246166|NCT00427232|BQ 788|bq 788|mesh-list
20246167|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20246168|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20246169|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246170|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20246171|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
20246172|NCT00427245|Goserelin|goserelin|mesh-list
20246173|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246174|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
20246175|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246176|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19704944|NCT04854551|Naltrexone|naltrexone|mesh-list
19704945|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19704946|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19704947|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704948|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
19704949|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704950|NCT04854577|Anesthetics|anesthetics|mesh-list
19704951|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704952|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704953|NCT04854538|Budesonide|budesonide|mesh-list
19704954|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19704955|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19704956|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
19704957|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704958|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704959|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19704960|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
19704961|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
19704962|NCT04854538|Hormones|hormones|mesh-ancestor
19854752|NCT00742508|Protective Agents|protective agents|mesh-ancestor
19704963|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19704964|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19704965|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19704966|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704967|NCT04854044|TIC10 compound|tic10 compound|mesh-list
19854753|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19854754|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19854755|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19854756|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
19854757|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19854758|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19704968|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19704969|NCT04854252|Fentanyl|fentanyl|mesh-list
19704970|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19704971|NCT04854252|Narcotics|narcotics|mesh-ancestor
19704972|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19704973|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704974|NCT04854252|Analgesics|analgesics|mesh-ancestor
19704975|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
19704976|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19704977|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19704978|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19704979|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
19704980|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
19704981|NCT04853758|Valsartan|valsartan|mesh-list
19704982|NCT04853758|Enalapril|enalapril|mesh-list
19704983|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19704984|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19704985|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19704986|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19704987|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19704988|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19704989|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19704990|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
19704991|NCT04853797|Calcium|calcium|mesh-list
19704992|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19704993|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19704994|NCT04853875|Amoxicillin|amoxicillin|mesh-list
19704995|NCT04853875|Metronidazole|metronidazole|mesh-list
19704996|NCT04853875|Clarithromycin|clarithromycin|mesh-list
19704997|NCT04853875|Tetracycline|tetracycline|mesh-list
19704998|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19704999|NCT04853875|Bismuth|bismuth|mesh-list
19705000|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19705001|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705002|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19705003|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19705004|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19705005|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705006|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705007|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19705008|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19705009|NCT04853875|Antacids|antacids|mesh-ancestor
19705010|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705011|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19705012|NCT04853615|Empagliflozin|empagliflozin|mesh-list
19705013|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19708236|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20246177|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20246178|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
20246179|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246180|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246181|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20246182|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20246183|NCT00427271|Aspirin|aspirin|mesh-list
20246184|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20246185|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246186|NCT00427271|Analgesics|analgesics|mesh-ancestor
20246187|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
20246188|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416192|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
19416193|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416194|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416195|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
19416196|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19416197|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416923|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416924|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416925|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19416926|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19416960|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416961|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19416962|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
19416963|NCT02230891|Protective Agents|protective agents|mesh-ancestor
19416964|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19416965|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416966|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19416967|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
19416968|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19416969|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20246189|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246190|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246191|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246192|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20246193|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20246194|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246195|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20246196|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20246197|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246198|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
20246199|NCT00427310|Fluorouracil|fluorouracil|mesh-list
20521681|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705014|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705015|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19705016|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705017|NCT04853446|Dexamethasone|dexamethasone|mesh-list
19705018|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
19705019|NCT04853446|BB 1101|bb 1101|mesh-list
19705020|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705021|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
19705022|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
19854759|NCT00742560|Dexamethasone|dexamethasone|mesh-list
20246200|NCT00427310|Heparin|heparin|mesh-list
20521682|NCT01735370|Etodolac|etodolac|mesh-list
20521683|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20521684|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521685|NCT01735370|Analgesics|analgesics|mesh-ancestor
20521686|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
20521687|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521688|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521689|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521690|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521691|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20521692|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20521693|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521694|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521695|NCT01735383|Etodolac|etodolac|mesh-list
20521696|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20521697|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521698|NCT01735383|Analgesics|analgesics|mesh-ancestor
20521699|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
19705023|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705024|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705025|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705026|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
19705027|NCT04853446|Hormones|hormones|mesh-ancestor
20246201|NCT00427310|Calcium heparin|calcium heparin|mesh-list
19705028|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705029|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19705030|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705031|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
19705032|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705033|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705034|NCT04853719|Aspirin|aspirin|mesh-list
19705035|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
19705036|NCT04853719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19705037|NCT04853719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19705038|NCT04853719|Analgesics|analgesics|mesh-ancestor
19705039|NCT04853719|Sensory System Agents|sensory system agents|mesh-ancestor
19705040|NCT04853719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705041|NCT04853719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705042|NCT04853719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416198|NCT02553343|Vaccines|vaccines|mesh-list
19416199|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
19416200|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416201|NCT02551237|Capecitabine|capecitabine|mesh-list
19416202|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19416203|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
19416204|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416205|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416206|NCT02547818|Ibuprofen|ibuprofen|mesh-list
19416207|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416208|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416209|NCT02547818|Analgesics|analgesics|mesh-ancestor
19416210|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
19705043|NCT04853719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705044|NCT04853719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19705045|NCT04853719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19705046|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705047|NCT04853719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19705048|NCT04853719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19705049|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705050|NCT04853719|Antipyretics|antipyretics|mesh-ancestor
19705051|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19705052|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
19705053|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19705054|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
19854760|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
19854761|NCT00742560|Lenalidomide|lenalidomide|mesh-list
19854762|NCT00742560|Elotuzumab|elotuzumab|mesh-list
19854763|NCT00742560|BB 1101|bb 1101|mesh-list
19854764|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705055|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
19705056|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
19705057|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19705058|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
19705059|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705060|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
19705061|NCT04853589|Protective Agents|protective agents|mesh-ancestor
19705062|NCT04853628|Ethanol|ethanol|mesh-list
19705063|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19705064|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705065|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705066|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705067|NCT04853524|Tenofovir|tenofovir|mesh-list
19705068|NCT04853524|Emtricitabine|emtricitabine|mesh-list
19705069|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
19705070|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705071|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19705072|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19705073|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705074|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705075|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19705076|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19705077|NCT04853901|Remdesivir|remdesivir|mesh-list
19705078|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705079|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705080|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
19854765|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
19854766|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
19854767|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854768|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521700|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854769|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854770|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
20246202|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
20246203|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246204|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20246205|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246206|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246207|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
20246208|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521701|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521702|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521703|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521704|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20521705|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20521706|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521707|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521708|NCT01735487|Nicotine|nicotine|mesh-list
20521709|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20521710|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
20521711|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521712|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521713|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20521714|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20521715|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
19705081|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
19854771|NCT00742560|Hormones|hormones|mesh-ancestor
19855649|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20521716|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705082|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19705083|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19705084|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705085|NCT04853199|Quercetin|quercetin|mesh-list
19705086|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
19705087|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705088|NCT04853199|Protective Agents|protective agents|mesh-ancestor
19705089|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705090|NCT04853069|Estradiol|estradiol|mesh-list
19705091|NCT04853069|Estrogens|estrogens|mesh-ancestor
19705092|NCT04853069|Hormones|hormones|mesh-ancestor
19705093|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705094|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705095|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
19705096|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19705097|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705098|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
19705099|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19705100|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705101|NCT04852510|Metformin|metformin|mesh-list
19705102|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19705103|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705104|NCT04852315|Caffeine|caffeine|mesh-list
19705105|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19705106|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705107|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19705108|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705109|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705110|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19705111|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19705112|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
19705113|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705114|NCT04852484|Ketamine|ketamine|mesh-list
19705115|NCT04852484|Morphine|morphine|mesh-list
19705116|NCT04852484|Anesthetics|anesthetics|mesh-list
19705117|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
19705118|NCT04852484|Analgesics|analgesics|mesh-ancestor
19705119|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
19705120|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705121|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705122|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19705123|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19705124|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
19705125|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705126|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19705127|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19705128|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705129|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705130|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19705131|NCT04852484|Narcotics|narcotics|mesh-ancestor
19705132|NCT04852068|Vaccines|vaccines|mesh-list
19705133|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
19705134|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705135|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19705136|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19705137|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19705138|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
19705139|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854772|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854773|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20521717|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521718|NCT01735669|Remifentanil|remifentanil|mesh-list
20521719|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
20521720|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20521721|NCT01735669|Narcotics|narcotics|mesh-ancestor
20521722|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521723|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521724|NCT01735669|Analgesics|analgesics|mesh-ancestor
19705140|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705141|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19705142|NCT04851821|Quercetin|quercetin|mesh-list
19705143|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
19705144|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705145|NCT04851821|Protective Agents|protective agents|mesh-ancestor
20246209|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
20246210|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20246211|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20246212|NCT00427362|Adalimumab|adalimumab|mesh-list
20246213|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246214|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246215|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
20246216|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20246217|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20246218|NCT00427388|Prednisolone|prednisolone|mesh-list
20521725|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
20521726|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521727|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19705146|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705147|NCT04851977|Vaccines|vaccines|mesh-list
19705148|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
20246219|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
20246220|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20246221|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
20246222|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246223|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
20246224|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
20521728|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
20521729|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
19416211|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416212|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416213|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521730|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521731|NCT01735747|Vincristine|vincristine|mesh-list
20521732|NCT01735747|Temozolomide|temozolomide|mesh-list
20521733|NCT01735747|Nedaplatin|nedaplatin|mesh-list
20521734|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20521735|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521736|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
20521737|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
20521738|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
19416214|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416215|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416216|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416217|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416218|NCT02539537|Leucovorin|leucovorin|mesh-list
19416219|NCT02539537|Folic Acid|folic acid|mesh-list
19416220|NCT02539537|Gemcitabine|gemcitabine|mesh-list
19416221|NCT02539537|Fluorouracil|fluorouracil|mesh-list
19416222|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
19416223|NCT02539537|Irinotecan|irinotecan|mesh-list
19416224|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
19416225|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19416226|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
19416227|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416228|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416229|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
19416230|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416231|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705149|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705150|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
19705151|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19705152|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
19705153|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705154|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
19705155|NCT04851548|Protective Agents|protective agents|mesh-ancestor
19705156|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19705157|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705158|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705159|NCT04852081|Tamoxifen|tamoxifen|mesh-list
19705160|NCT04852081|Letrozole|letrozole|mesh-list
19705161|NCT04852081|Fulvestrant|fulvestrant|mesh-list
19705162|NCT04852081|Palbociclib|palbociclib|mesh-list
19705163|NCT04852081|Anastrozole|anastrozole|mesh-list
19705164|NCT04852081|Exemestane|exemestane|mesh-list
19705165|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705166|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19705167|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19705168|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705169|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705170|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19705171|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
19705172|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705173|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705174|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19705175|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19705176|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19705177|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19705178|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19705179|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19705180|NCT04851457|Tirofiban|tirofiban|mesh-list
19705181|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19705182|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19705183|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705184|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19705185|NCT04851392|Dronabinol|dronabinol|mesh-list
19705186|NCT04851392|Cannabidiol|cannabidiol|mesh-list
19705187|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
19705188|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
19705189|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705190|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705191|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19705192|NCT04851392|Analgesics|analgesics|mesh-ancestor
19705193|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
19705194|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705195|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19705196|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19705197|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705198|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854774|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416927|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
19416928|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19416929|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19416930|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19416931|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19416932|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416933|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19416934|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416935|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416936|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19416937|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416938|NCT02236195|Mocetinostat|mocetinostat|mesh-list
19416939|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19705199|NCT04851392|Hormones|hormones|mesh-ancestor
19705200|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705201|NCT04851015|Trimethoprim|trimethoprim|mesh-list
19705202|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19705203|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
19705204|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20246225|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246226|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246227|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705205|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705206|NCT04851015|Renal Agents|renal agents|mesh-ancestor
19705207|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
19854775|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
19854776|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854777|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854778|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
19854779|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19854780|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19854781|NCT00742560|Growth Substances|growth substances|mesh-ancestor
19854782|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
19854783|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
19854784|NCT00742573|Bupropion|bupropion|mesh-list
19854785|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19854786|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19705208|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19705209|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19705210|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19705211|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705212|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705213|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19854787|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19854788|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854789|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854790|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854791|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19854792|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
19854793|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20246228|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
20246229|NCT00427388|Hormones|hormones|mesh-ancestor
20246230|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416940|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416941|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416942|NCT02236156|Metronidazole|metronidazole|mesh-list
19416943|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416944|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19416945|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19416946|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19416947|NCT02230891|Carvedilol|carvedilol|mesh-list
19416948|NCT02230891|Spironolactone|spironolactone|mesh-list
19416949|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19416950|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
19416951|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416952|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416953|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19416954|NCT02230891|Diuretics|diuretics|mesh-ancestor
19416955|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
19416956|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19416957|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19416958|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
19705214|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19705215|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20246231|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20246232|NCT00427388|Protective Agents|protective agents|mesh-ancestor
19705216|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19705217|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19705218|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19705219|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705220|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
19708237|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708238|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
19708239|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708240|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854794|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19854795|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19854796|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854797|NCT00742625|Cytarabine|cytarabine|mesh-list
19854798|NCT00742625|Bortezomib|bortezomib|mesh-list
19854799|NCT00742625|Daunorubicin|daunorubicin|mesh-list
19854800|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19854801|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
19854802|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854803|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854804|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
19854805|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854806|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854807|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
19854808|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854809|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854810|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19708241|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19708242|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
19708243|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708244|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
19708245|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19708246|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19708247|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19708248|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19708249|NCT04818099|Vortioxetine|vortioxetine|mesh-list
19708250|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
19708251|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19708252|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19708253|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19708254|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708255|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854811|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19854812|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705221|NCT04851002|Mitogens|mitogens|mesh-list
19705222|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
19705223|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705224|NCT04850911|Ketamine|ketamine|mesh-list
19705225|NCT04850911|Analgesics|analgesics|mesh-ancestor
19705226|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
19705227|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705228|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705229|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19705230|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19705231|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
19705232|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
19705233|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705234|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19705235|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19705236|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705237|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705238|NCT04851132|Durvalumab|durvalumab|mesh-list
19705239|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19705240|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705241|NCT04850885|Dexamethasone|dexamethasone|mesh-list
19705242|NCT04850885|Lidocaine|lidocaine|mesh-list
19705243|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705244|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
19705245|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
19705246|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705247|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705248|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705249|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
19705250|NCT04850885|Hormones|hormones|mesh-ancestor
19705251|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705252|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19705253|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705254|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
19705255|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
19705256|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705257|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
19705258|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19705259|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19705260|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19705261|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705262|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705263|NCT04850950|Tenofovir|tenofovir|mesh-list
19705264|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
19705265|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705266|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19705267|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19705268|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705269|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705270|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19705271|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19705272|NCT04850937|Esketamine|esketamine|mesh-list
19705273|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
19705274|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705275|NCT04850638|Furosemide|furosemide|mesh-list
19705276|NCT04850638|Diuretics|diuretics|mesh-ancestor
19705277|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
20246233|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20246234|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246235|NCT00427414|Daunorubicin|daunorubicin|mesh-list
20246236|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246237|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246238|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705278|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246239|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19705279|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19705280|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705281|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705282|NCT04850755|Nivolumab|nivolumab|mesh-list
19705283|NCT04850755|Ipilimumab|ipilimumab|mesh-list
19705284|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19705285|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705286|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19705287|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705288|NCT04850560|Decitabine|decitabine|mesh-list
19705289|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19705290|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
19705291|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705292|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705293|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705294|NCT04850404|Ropivacaine|ropivacaine|mesh-list
19705295|NCT04850404|Rocuronium|rocuronium|mesh-list
19705296|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
19705297|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
19854813|NCT00742781|Vitamin D|vitamin d|mesh-list
19416232|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19416233|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
19416234|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416235|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19416236|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19416237|NCT02539537|Antidotes|antidotes|mesh-ancestor
19416238|NCT02539537|Protective Agents|protective agents|mesh-ancestor
19416239|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
19416240|NCT02539537|Vitamins|vitamins|mesh-ancestor
19416241|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
19416242|NCT02539537|Hematinics|hematinics|mesh-ancestor
19416243|NCT02527707|Ritonavir|ritonavir|mesh-list
19416244|NCT02527707|Lonafarnib|lonafarnib|mesh-list
19416245|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19416246|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19416247|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
19416248|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416959|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705298|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705299|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705300|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
19705301|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705302|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19705303|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19705304|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19854814|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
19854815|NCT00742781|Vitamins|vitamins|mesh-ancestor
19854816|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
19854817|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854818|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19854819|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19854820|NCT00742859|Warfarin|warfarin|mesh-list
19854821|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
19854822|NCT00742859|Betrixaban|betrixaban|mesh-list
19854823|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
19854824|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19854825|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
19854826|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19854827|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
19854828|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854829|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854830|NCT00742872|Mosapride|mosapride|mesh-list
19854831|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854832|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854833|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19854834|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
19854835|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854836|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854837|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
19854838|NCT00742924|Leucovorin|leucovorin|mesh-list
19854839|NCT00742924|Cisplatin|cisplatin|mesh-list
19854840|NCT00742924|Doxorubicin|doxorubicin|mesh-list
19854841|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19854842|NCT00742924|Methotrexate|methotrexate|mesh-list
19854843|NCT00742924|Etoposide|etoposide|mesh-list
19854844|NCT00742924|Ifosfamide|ifosfamide|mesh-list
20246240|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20246241|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246242|NCT00427427|Trastuzumab|trastuzumab|mesh-list
20246243|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20246244|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705305|NCT04850417|Aspirin|aspirin|mesh-list
19705306|NCT04850417|Clopidogrel|clopidogrel|mesh-list
19705307|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19705308|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19705309|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19705310|NCT04850417|Analgesics|analgesics|mesh-ancestor
19705311|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
20246245|NCT00427466|Pemetrexed|pemetrexed|mesh-list
20246246|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246247|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246248|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246249|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20246250|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20246251|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
20246252|NCT00427492|Antacids|antacids|mesh-ancestor
20521739|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521740|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20521741|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
20521742|NCT01735825|Paclitaxel|paclitaxel|mesh-list
20246253|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246254|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20246255|NCT00427505|Deferasirox|deferasirox|mesh-list
20246256|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20521743|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19705312|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705313|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705314|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705315|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705316|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19705317|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19705318|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705319|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19705320|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19705321|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705322|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
19705323|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19705324|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19705325|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19705326|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
19705327|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705328|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19705329|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
20521744|NCT01735825|Everolimus|everolimus|mesh-list
20521745|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20521746|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521747|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
20521748|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
20521749|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
20521750|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521751|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20521752|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
20521753|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521754|NCT01735864|Indirubin|indirubin|mesh-list
19705330|NCT04850235|Paclitaxel|paclitaxel|mesh-list
19705331|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19705332|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705333|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
19705334|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
19705335|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246257|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
20246258|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
19705336|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705337|NCT04850261|Nafarelin|nafarelin|mesh-list
19705338|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19705339|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
19705340|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19705341|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705342|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
19705343|NCT04850040|Apatinib|apatinib|mesh-list
19705344|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854845|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
19854846|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
19854847|NCT00742924|Razoxane|razoxane|mesh-list
19854848|NCT00742924|Imidazole|imidazole|mesh-list
20246259|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521755|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20521756|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521757|NCT01735890|Amlodipine|amlodipine|mesh-list
20521758|NCT01735890|Valsartan|valsartan|mesh-list
20521759|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20521760|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20521761|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20521762|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20521763|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416970|NCT02224235|Aspirin|aspirin|mesh-list
20530877|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19416971|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416972|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416973|NCT02224235|Analgesics|analgesics|mesh-ancestor
19416974|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
19416975|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416976|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416977|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416978|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416979|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19416980|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19705345|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19705346|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705347|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705348|NCT04850001|Aspirin|aspirin|mesh-list
19705349|NCT04850001|Clopidogrel|clopidogrel|mesh-list
19705350|NCT04850001|Atorvastatin|atorvastatin|mesh-list
19705351|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19705352|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19705353|NCT04850001|Analgesics|analgesics|mesh-ancestor
19705354|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
19705355|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705356|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705357|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705358|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705359|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19705360|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19705361|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705362|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19705363|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19705364|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705365|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
19705366|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19705367|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19705368|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
19705369|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19705370|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19705371|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19705372|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19705373|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19705374|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
19705375|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705376|NCT04849845|Insulin|insulin|mesh-list
19705377|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19705378|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19705379|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705380|NCT04849858|Bupivacaine|bupivacaine|mesh-list
19705381|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
19705382|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
19705383|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705384|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705385|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
19705386|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705387|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
19705388|NCT04849533|Prednisone|prednisone|mesh-list
19705389|NCT04849533|Everolimus|everolimus|mesh-list
19705390|NCT04849533|Abatacept|abatacept|mesh-list
19705391|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
19705392|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19705393|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705394|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
19705395|NCT04849533|Hormones|hormones|mesh-ancestor
19705396|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705397|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705398|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19705399|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705400|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19705401|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
19705402|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19705403|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19705404|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
19705405|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19705406|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705407|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705408|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705409|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19705410|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705411|NCT04849377|Cisplatin|cisplatin|mesh-list
19705412|NCT04849377|Carboplatin|carboplatin|mesh-list
19705413|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705414|NCT04849455|Morphine|morphine|mesh-list
19705415|NCT04849455|Ropivacaine|ropivacaine|mesh-list
19705416|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
19705417|NCT04849455|Anesthetics|anesthetics|mesh-list
19705418|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19705419|NCT04849455|Narcotics|narcotics|mesh-ancestor
19705420|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705421|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705422|NCT04849455|Analgesics|analgesics|mesh-ancestor
19705423|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
19705424|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705425|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
19705426|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705427|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
19705428|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19705429|NCT04849013|Ketanserin|ketanserin|mesh-list
19705430|NCT04849013|Mescaline|mescaline|mesh-list
19705431|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19705432|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19705433|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19705434|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
19705435|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705436|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705437|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705438|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
19705439|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705440|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19705441|NCT04849026|Clozapine|clozapine|mesh-list
19705442|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19705443|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
19705444|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705445|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705446|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705447|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19705448|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19705449|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705450|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705451|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
19705452|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
19705453|NCT04849299|Cyclosporine|cyclosporine|mesh-list
19705454|NCT04849299|Cyclosporins|cyclosporins|mesh-list
19705455|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705456|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705457|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19705458|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
19705459|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705460|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
19705461|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705462|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
19705463|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705464|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19708256|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19708257|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19708258|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19708259|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708260|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708261|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
19708262|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19708263|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19708264|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20521764|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20521765|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521766|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
20521767|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20521768|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20521769|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
19708265|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19708266|NCT04817969|Cimetidine|cimetidine|mesh-list
19708267|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19708268|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708269|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19708270|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
19708271|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
20246260|NCT00427570|Fluorouracil|fluorouracil|mesh-list
20246261|NCT00427570|Vincristine|vincristine|mesh-list
20246262|NCT00427570|Semustine|semustine|mesh-list
20521770|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
19708272|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708273|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708274|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708275|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19708276|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19708277|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708278|NCT04818151|Warfarin|warfarin|mesh-list
19708279|NCT04818151|Apixaban|apixaban|mesh-list
19708280|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
19708281|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19708282|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
19708283|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19708284|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
19708285|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708286|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708287|NCT04817800|Azelastine|azelastine|mesh-list
19708288|NCT04817800|Beclomethasone|beclomethasone|mesh-list
19708289|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708290|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
19708291|NCT04817800|Hormones|hormones|mesh-ancestor
19708292|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708293|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708294|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19708295|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
20521771|NCT01736020|Ketamine|ketamine|mesh-list
19708296|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19708297|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
19708298|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708299|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19708300|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708301|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708302|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19708303|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19708304|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19708305|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
20521772|NCT01736020|Propofol|propofol|mesh-list
19708306|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
20246263|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
19705465|NCT04848974|Cytarabine|cytarabine|mesh-list
19705466|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19705467|NCT04848974|Cladribine|cladribine|mesh-list
19705468|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19705469|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
19705470|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705471|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705472|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
19705473|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705474|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19705475|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
19705476|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705477|NCT04848857|Colchicine|colchicine|mesh-list
19705478|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
19705479|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705480|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
19705481|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
19705482|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19705483|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705484|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705485|NCT04848792|Sulforaphane|sulforaphane|mesh-list
19705486|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19705487|NCT04848792|Protective Agents|protective agents|mesh-ancestor
19705488|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705489|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705490|NCT04848467|Vaccines|vaccines|mesh-list
19705491|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
19705492|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705493|NCT04848259|Dexamethasone|dexamethasone|mesh-list
19705494|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
19705495|NCT04848259|BB 1101|bb 1101|mesh-list
19705496|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705497|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
19705498|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
19705499|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705500|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705501|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854849|NCT00742924|Lenograstim|lenograstim|mesh-list
19854850|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
19854851|NCT00742924|Mesna|mesna|mesh-list
19705502|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
19705503|NCT04848259|Hormones|hormones|mesh-ancestor
19705504|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246264|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
20246265|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705505|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19705506|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705507|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
19705508|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854852|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854853|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854854|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19854855|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19854856|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854857|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705509|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705510|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
19705511|NCT04848519|Propranolol|propranolol|mesh-list
19705512|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19705513|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705514|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19705515|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19705516|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
19705517|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705518|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705519|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705520|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19705521|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19705522|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
19705523|NCT04848246|Bupropion|bupropion|mesh-list
19705524|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19705525|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
19705526|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705527|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19705528|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20521773|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20521774|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521775|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521776|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20521777|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
20521778|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
20521779|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20521780|NCT01736020|Analgesics|analgesics|mesh-ancestor
20521781|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
19705529|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705530|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705531|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
19705532|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705533|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705534|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19705535|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19705536|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705537|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
19705538|NCT04848181|Finasteride|finasteride|mesh-list
19705539|NCT04848181|Cyproterone|cyproterone|mesh-list
19705540|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19705541|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19705542|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705543|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705544|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
19705545|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705546|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705547|NCT04848181|Urological Agents|urological agents|mesh-ancestor
19705548|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
19705549|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705550|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19705551|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
19705552|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19705553|NCT04848116|Nivolumab|nivolumab|mesh-list
19705554|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19705555|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705556|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19705557|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705558|NCT04847791|Lactoferrin|lactoferrin|mesh-list
19705559|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705560|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
19705561|NCT04848064|Fludarabine|fludarabine|mesh-list
19705562|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
19705563|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
19705564|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
19705565|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19705566|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
19855650|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
19705567|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705568|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705569|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19705570|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
19705571|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705572|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705573|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19705574|NCT04847921|Dalbavancin|dalbavancin|mesh-list
19705575|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19705576|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705577|NCT04847895|Ranibizumab|ranibizumab|mesh-list
19705578|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19705579|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19705580|NCT04847895|Growth Substances|growth substances|mesh-ancestor
19705581|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705582|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
19705583|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705584|NCT04847947|Vitamin D|vitamin d|mesh-list
19705585|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
19705586|NCT04847947|Vitamins|vitamins|mesh-ancestor
19705587|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
19705588|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705589|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19705590|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19705591|NCT04847752|Aspirin|aspirin|mesh-list
19705592|NCT04847752|Warfarin|warfarin|mesh-list
19705593|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
19705594|NCT04847752|Dabigatran|dabigatran|mesh-list
19705595|NCT04847752|Anticoagulants|anticoagulants|mesh-list
19705596|NCT04847752|Clopidogrel|clopidogrel|mesh-list
19705597|NCT04847752|Atorvastatin|atorvastatin|mesh-list
19705598|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19705599|NCT04847752|Evolocumab|evolocumab|mesh-list
19705600|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19854858|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854859|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19854860|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
19854861|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19854862|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19854863|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
19705601|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19705602|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19705603|NCT04847752|Analgesics|analgesics|mesh-ancestor
19705604|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
19705605|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705606|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705607|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705608|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705609|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20246266|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20246267|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246268|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246269|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
20246270|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246271|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20246272|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
20246273|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
20246274|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246275|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20246276|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20246277|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
20521782|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705610|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19705611|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705612|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19705613|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19705614|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705615|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
19705616|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19705617|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19705618|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
19705619|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19705620|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19705621|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19705622|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19705623|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
19705624|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705625|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19705626|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
19705627|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19705628|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
19705629|NCT04847622|Remdesivir|remdesivir|mesh-list
19705630|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
19705631|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705632|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
19705633|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705634|NCT04847661|Mefloquine|mefloquine|mesh-list
19705635|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
19705636|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19705637|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19705638|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705639|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
19705640|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19705641|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19705642|NCT04847687|Prednisolone|prednisolone|mesh-list
19705643|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
19705644|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19705645|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
19705646|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705647|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
19705648|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
19705649|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705650|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854864|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
19854865|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20521783|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20521784|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20521785|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20521786|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
20521787|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521788|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521789|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20521790|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20521791|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20521792|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20521793|NCT01736033|Tamsulosin|tamsulosin|mesh-list
19705651|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705652|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
20246278|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
20521794|NCT01736033|Finasteride|finasteride|mesh-list
19705653|NCT04847687|Hormones|hormones|mesh-ancestor
19705654|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705655|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19705656|NCT04847687|Protective Agents|protective agents|mesh-ancestor
19705657|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19705658|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705659|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19705660|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
19705661|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19705662|NCT04847024|Parecoxib|parecoxib|mesh-list
19705663|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19854866|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19705664|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19705665|NCT04847024|Analgesics|analgesics|mesh-ancestor
19705666|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
19705667|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705668|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705669|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705670|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705671|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19705672|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19705673|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705674|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705675|NCT04847245|Pregabalin|pregabalin|mesh-list
19705676|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19705677|NCT04847245|Esketamine|esketamine|mesh-list
19705678|NCT04847245|Analgesics|analgesics|mesh-ancestor
19705679|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
19705680|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705681|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705682|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
19705683|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19705684|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705685|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705686|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19705687|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19705688|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19705689|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705690|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705691|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19705692|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19705693|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19705694|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
19705695|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
19705696|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
19705697|NCT04846673|Pregabalin|pregabalin|mesh-list
19705698|NCT04846673|Analgesics|analgesics|mesh-ancestor
19705699|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
19705700|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705701|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705702|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
19705703|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19705704|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705705|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705706|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19705707|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19705708|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19705709|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705710|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705711|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
19705712|NCT04846673|Protective Agents|protective agents|mesh-ancestor
19705713|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
19705714|NCT04846673|Vitamins|vitamins|mesh-ancestor
19705715|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
19705716|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
19705717|NCT04846621|Calcium|calcium|mesh-list
19705718|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19705719|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705720|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705721|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705722|NCT04846855|Anesthetics|anesthetics|mesh-list
19705723|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
19705724|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705725|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705726|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
19705727|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708307|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708308|NCT04817527|Edaravone|edaravone|mesh-list
19708309|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19708310|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
19708311|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708312|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19708313|NCT04817527|Protective Agents|protective agents|mesh-ancestor
19708314|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708315|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19708316|NCT04817202|Antibodies|antibodies|mesh-list
19708317|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
19708318|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19708319|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
19708320|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708321|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708322|NCT04816968|Vancomycin|vancomycin|mesh-list
19708323|NCT04816968|Meropenem|meropenem|mesh-list
19708324|NCT04816968|Tazobactam|tazobactam|mesh-list
19708325|NCT04816968|Piperacillin|piperacillin|mesh-list
19708326|NCT04816968|Cefepime|cefepime|mesh-list
19708327|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19708328|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19708329|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708330|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19708331|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708332|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708333|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
19708334|NCT04816877|Narcotics|narcotics|mesh-ancestor
19708335|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708336|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708337|NCT04816877|Analgesics|analgesics|mesh-ancestor
19708338|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
19708339|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708340|NCT04816838|Osimertinib|osimertinib|mesh-list
19708341|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708342|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19708343|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708344|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708345|NCT04816682|Silymarin|silymarin|mesh-list
19708346|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
19708347|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708348|NCT04816682|Protective Agents|protective agents|mesh-ancestor
19708349|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708350|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
19708351|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19708352|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708353|NCT04816344|Anesthetics|anesthetics|mesh-list
19708354|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708355|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708356|NCT04816461|Piperaquine|piperaquine|mesh-list
19708357|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
19708358|NCT04816461|Amodiaquine|amodiaquine|mesh-list
19708359|NCT04816461|Artenimol|artenimol|mesh-list
19708360|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
19708361|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19708362|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19708363|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708364|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19708365|NCT04816461|Renal Agents|renal agents|mesh-ancestor
19705728|NCT04846634|Gemcitabine|gemcitabine|mesh-list
19705729|NCT04846634|Paclitaxel|paclitaxel|mesh-list
19705730|NCT04846634|Docetaxel|docetaxel|mesh-list
19705731|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19705732|NCT04846634|Cisplatin|cisplatin|mesh-list
19705733|NCT04846634|Carboplatin|carboplatin|mesh-list
19705734|NCT04846634|Pemetrexed|pemetrexed|mesh-list
19705735|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19705736|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705737|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
19705738|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
19705739|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
19705740|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705741|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19705742|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
19705743|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
19705744|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705745|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705746|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19705747|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
19705748|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705749|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19705750|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19705751|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19705752|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
19705753|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
19705754|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705755|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
19705756|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705757|NCT04846452|Paclitaxel|paclitaxel|mesh-list
19705758|NCT04846452|Carboplatin|carboplatin|mesh-list
19705759|NCT04846452|Pemetrexed|pemetrexed|mesh-list
19705760|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19705761|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705762|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
19705763|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
19705764|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
19705765|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705766|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705767|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19705768|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19705769|NCT04846478|Talazoparib|talazoparib|mesh-list
19705770|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19705771|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705772|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705773|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705774|NCT04846335|Doxycycline|doxycycline|mesh-list
19705775|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19705776|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705777|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
19705778|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19705779|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19705780|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
19705781|NCT04845880|Paraproteins|paraproteins|mesh-list
19705782|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
19705783|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854867|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
19854868|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854869|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19854870|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19854871|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19854872|NCT00742924|Antidotes|antidotes|mesh-ancestor
19854873|NCT00742924|Protective Agents|protective agents|mesh-ancestor
19854874|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
19854875|NCT00742924|Vitamins|vitamins|mesh-ancestor
19854876|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
19854877|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19854878|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
19854879|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19854880|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19854881|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
19854882|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
19854883|NCT00743093|Acetaminophen|acetaminophen|mesh-list
19854884|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854885|NCT00743093|Analgesics|analgesics|mesh-ancestor
20246279|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705784|NCT04845737|Vitamin D|vitamin d|mesh-list
19705785|NCT04845737|Vitamins|vitamins|mesh-ancestor
19705786|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
19705787|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705788|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19705789|NCT04845607|Amiodarone|amiodarone|mesh-list
19705790|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19705791|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
19705792|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19705793|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705794|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705795|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19705796|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19854886|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
19855651|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20246280|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20246281|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246282|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246283|NCT00427596|Solabegron|solabegron|mesh-list
20246284|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20246285|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20246286|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20246287|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
20246288|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246289|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246290|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246291|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
20246292|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20246293|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246294|NCT00427713|Capecitabine|capecitabine|mesh-list
20246295|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
20246296|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20246297|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
20246298|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246299|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246300|NCT00427882|Alfuzosin|alfuzosin|mesh-list
19416249|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416250|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19416251|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19416252|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
19416253|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416254|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19416255|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19416256|NCT02521285|Aspirin|aspirin|mesh-list
19416257|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19416258|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416259|NCT02521285|Analgesics|analgesics|mesh-ancestor
19416260|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
19416261|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416262|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416263|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416264|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416265|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19705797|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19854887|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854888|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854889|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
19854890|NCT00743106|Fenoldopam|fenoldopam|mesh-list
19854891|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19854892|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
19854893|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
19705798|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705799|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19705800|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19705801|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19705802|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
19705803|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19705804|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19705805|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705806|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
19705807|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
19705808|NCT04845646|Itraconazole|itraconazole|mesh-list
19705809|NCT04845646|Phenytoin|phenytoin|mesh-list
19705810|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
19705811|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705812|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19705813|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19705814|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705815|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705816|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19705817|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
19705818|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705819|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705820|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19705821|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
19705822|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19705823|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19705824|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19705825|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19705826|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19705827|NCT04845399|Factor VIII|factor viii|mesh-list
19705828|NCT04845399|Coagulants|coagulants|mesh-ancestor
19705829|NCT04845217|Peppermint oil|peppermint oil|mesh-list
19705830|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
19705831|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
19705832|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705833|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705834|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705835|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
19705836|NCT04845139|Nivolumab|nivolumab|mesh-list
19705837|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19705838|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705839|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19705840|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705841|NCT04844996|Ezetimibe|ezetimibe|mesh-list
19705842|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19705843|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19705844|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
19705845|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705846|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19705847|NCT04845061|Nebivolol|nebivolol|mesh-list
19705848|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19705849|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
19705850|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19705851|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19705852|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19705853|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
19705854|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708366|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
19854894|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
19705855|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705856|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705857|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
19705858|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19705859|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
19705860|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705861|NCT04844385|Paclitaxel|paclitaxel|mesh-list
19705862|NCT04844385|Capecitabine|capecitabine|mesh-list
19705863|NCT04844385|Nedaplatin|nedaplatin|mesh-list
19705864|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19705865|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705866|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
19705867|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
19705868|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
19705869|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705870|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19705871|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
19705872|NCT04844489|Vaccines|vaccines|mesh-list
19705873|NCT04844489|Immunologic Factors|immunologic factors|mesh-ancestor
19705874|NCT04844489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854895|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854896|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854897|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854898|NCT00743119|Dronabinol|dronabinol|mesh-list
19854899|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
19854900|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854901|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19854902|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19854903|NCT00743119|Analgesics|analgesics|mesh-ancestor
19854904|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
19854905|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19854906|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19708367|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19708368|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19708369|NCT04816253|Prednisolone|prednisolone|mesh-list
19708370|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
19708371|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19708372|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
19708373|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
19708374|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708375|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
19708376|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
19708377|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708378|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708379|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708380|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
19708381|NCT04816253|Hormones|hormones|mesh-ancestor
19708382|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708383|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19708384|NCT04816253|Protective Agents|protective agents|mesh-ancestor
19708385|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708386|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708387|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19708388|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
19708389|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
19708390|NCT04816097|Dexamethasone|dexamethasone|mesh-list
19708391|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19708392|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708393|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
19708394|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
19708395|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708396|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708397|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705875|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
19705876|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19705877|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705878|NCT04844164|Vitamins|vitamins|mesh-ancestor
19705879|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
19705880|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19705881|NCT04844333|Anesthetics|anesthetics|mesh-list
19705882|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19705883|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705884|NCT04844099|Piperaquine|piperaquine|mesh-list
19705885|NCT04844099|Artenimol|artenimol|mesh-list
19705886|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
19705887|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19705888|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19705889|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705890|NCT04843982|Esketamine|esketamine|mesh-list
19705891|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
19705892|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19705893|NCT04843943|Bevacizumab|bevacizumab|mesh-list
19705894|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19705895|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705896|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19705897|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19705898|NCT04843943|Growth Substances|growth substances|mesh-ancestor
19705899|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705900|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
19705901|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
19705902|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19705903|NCT04843917|Antibodies|antibodies|mesh-list
19705904|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
19705905|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
19705906|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705907|NCT04843904|Rituximab|rituximab|mesh-list
19705908|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
19705909|NCT04843904|Venetoclax|venetoclax|mesh-list
19705910|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19705911|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705912|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
19705913|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705914|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705915|NCT04843839|Nepafenac|nepafenac|mesh-list
19705916|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19705917|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19705918|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
19705919|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19705920|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19705921|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19705922|NCT04843839|Analgesics|analgesics|mesh-ancestor
19705923|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
19708398|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
19705924|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19705925|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705926|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19705927|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19705928|NCT04843839|Laxatives|laxatives|mesh-ancestor
19705929|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19705930|NCT04843553|Niacinamide|niacinamide|mesh-list
19705931|NCT04843553|Niacin|niacin|mesh-list
19705932|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
19705933|NCT04843553|Vitamins|vitamins|mesh-ancestor
19705934|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
19705935|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705936|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
19705937|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19705938|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
20246301|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20246302|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19705939|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705940|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19705941|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
19705942|NCT04843449|Itraconazole|itraconazole|mesh-list
19705943|NCT04843449|Rifampin|rifampin|mesh-list
19705944|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
19705945|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705946|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19705947|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19705948|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705949|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705950|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19705951|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
19705952|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705953|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705954|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19705955|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19705956|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
19705957|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19705958|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
19705959|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19705960|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19705961|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19705962|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19705963|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19705964|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19705965|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19705966|NCT04843644|Propolis|propolis|mesh-list
19705967|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19705968|NCT04843280|Coal Tar|coal tar|mesh-list
19705969|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
19705970|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
19705971|NCT04843098|Paclitaxel|paclitaxel|mesh-list
19705972|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19705973|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705974|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
19705975|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
19705976|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
19705977|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705978|NCT04842825|Cetrorelix|cetrorelix|mesh-list
19705979|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19705980|NCT04842825|Hormones|hormones|mesh-ancestor
19705981|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19705982|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705983|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19705984|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
19705985|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19705986|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
19705987|NCT04843046|Pioglitazone|pioglitazone|mesh-list
19705988|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19705989|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19705990|NCT04843007|Pemetrexed|pemetrexed|mesh-list
19705991|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705992|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19705993|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19705994|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19705995|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19705996|NCT04842838|Paclitaxel|paclitaxel|mesh-list
19705997|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19705998|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19705999|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706000|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706001|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
19706002|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706003|NCT04842968|Methylene Blue|methylene blue|mesh-list
19706004|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706005|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706006|NCT04842682|Diazepam|diazepam|mesh-list
19706007|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19706008|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
19706009|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
19706010|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
19706011|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706012|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706013|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706014|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19706015|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706016|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19706017|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19706018|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19706019|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19706020|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19706021|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19706022|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
19706023|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
19706024|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
19706025|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
19706026|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706027|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706028|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
19706029|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19706030|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
19706031|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708399|NCT04816097|Hormones|hormones|mesh-ancestor
19708400|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708401|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708402|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708403|NCT04816240|Midodrine|midodrine|mesh-list
19708404|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
19708405|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
19708406|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708407|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708408|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19708409|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19708410|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19708411|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19708412|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19708413|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708414|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708415|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
19708416|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19708417|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708418|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708419|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19708420|NCT04815265|Analgesics|analgesics|mesh-ancestor
19708421|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
19708422|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708423|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19708424|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19708425|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19708426|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
19708427|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706032|NCT04842487|Prednisone|prednisone|mesh-list
19706033|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
19706034|NCT04842487|Rituximab|rituximab|mesh-list
19706035|NCT04842487|Vincristine|vincristine|mesh-list
19706036|NCT04842487|Lenalidomide|lenalidomide|mesh-list
19706037|NCT04842487|Doxorubicin|doxorubicin|mesh-list
19706038|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19706039|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706040|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
19706041|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706042|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706043|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706044|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
19706045|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706046|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706047|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19706048|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706049|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706050|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
19706051|NCT04842487|Hormones|hormones|mesh-ancestor
19706052|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706053|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706054|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19706055|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706056|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706057|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
19706058|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19706059|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19706060|NCT04842487|Growth Substances|growth substances|mesh-ancestor
19706061|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
19706062|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19706063|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19706064|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19706065|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706066|NCT04842292|Heparin|heparin|mesh-list
19706067|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
19706068|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19706069|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19706070|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706071|NCT04842383|Peppermint oil|peppermint oil|mesh-list
19706072|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
19706073|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
19706074|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706075|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706076|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706077|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
19706078|NCT04842526|Irinotecan|irinotecan|mesh-list
19706079|NCT04842526|Temozolomide|temozolomide|mesh-list
19706080|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19706081|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19706082|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706083|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706084|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706085|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706086|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
19706087|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
19706088|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19706089|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
19706090|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706091|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706092|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19706093|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
19706094|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19706095|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
19706096|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706097|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706098|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19706099|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
19706100|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
19706101|NCT04842331|Protective Agents|protective agents|mesh-ancestor
19706102|NCT04841980|Rifaximin|rifaximin|mesh-list
19706103|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19706104|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706105|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706106|NCT04841720|Metformin|metformin|mesh-list
19706107|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19706108|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706109|NCT04841668|Metformin|metformin|mesh-list
19706110|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19706111|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706112|NCT04842071|Listerine|listerine|mesh-list
19706113|NCT04842071|Fluorides|fluorides|mesh-list
19706114|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
19706115|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
19706116|NCT04842071|Protective Agents|protective agents|mesh-ancestor
19706117|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706118|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19706119|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706120|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
19706121|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19706122|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706123|NCT04841096|Metformin|metformin|mesh-list
19706124|NCT04841096|Glimepiride|glimepiride|mesh-list
19706125|NCT04841096|Vildagliptin|vildagliptin|mesh-list
19706126|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19706127|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706128|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19706129|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706130|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
19706131|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19706132|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
19706133|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706134|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706135|NCT04841369|Vaccines|vaccines|mesh-list
19706136|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
19706137|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706138|NCT04841343|Triamcinolone|triamcinolone|mesh-list
19706139|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706140|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
19706141|NCT04841343|Hormones|hormones|mesh-ancestor
19706142|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706143|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706144|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
19706145|NCT04841148|Palbociclib|palbociclib|mesh-list
19706146|NCT04841148|Avelumab|avelumab|mesh-list
19706147|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
19706148|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19706149|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19706150|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706151|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706152|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706153|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706154|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706155|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19706156|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706157|NCT04841434|Methotrexate|methotrexate|mesh-list
19706158|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19706159|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
19706160|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19706161|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706162|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19706163|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
19706164|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706165|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854907|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19854908|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854909|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854910|NCT00743119|Hormones|hormones|mesh-ancestor
19706166|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
19706167|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706168|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19706169|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706170|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
19706171|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706172|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19706173|NCT04841265|Vitamin D|vitamin d|mesh-list
19706174|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
19706175|NCT04841265|Vitamins|vitamins|mesh-ancestor
19706176|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
19706177|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706178|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19706179|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19706180|NCT04841018|Dexamethasone|dexamethasone|mesh-list
19706181|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
19706182|NCT04841018|BB 1101|bb 1101|mesh-list
19706183|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706184|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
19706185|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
19706186|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706187|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706188|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706189|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
19706190|NCT04841018|Hormones|hormones|mesh-ancestor
19706191|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706192|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706193|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706194|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
19706195|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706196|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706197|NCT04840992|Vaccines|vaccines|mesh-list
19706198|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
19706199|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706200|NCT04840550|Lansoprazole|lansoprazole|mesh-list
19706201|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
19706202|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19706203|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706204|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19706205|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706206|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706207|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
19706208|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706209|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706210|NCT04840511|Lidocaine|lidocaine|mesh-list
19706211|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
19706212|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
19854911|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706213|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706214|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706215|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
19706216|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706217|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19706218|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19706219|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19706220|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20246303|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20246304|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
19706221|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706222|NCT04840745|Leuprolide|leuprolide|mesh-list
19706223|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19706224|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
19706225|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19706226|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706227|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706228|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708428|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708429|NCT04815408|Paclitaxel|paclitaxel|mesh-list
19708430|NCT04815408|Carboplatin|carboplatin|mesh-list
19708431|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19708432|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19708433|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708434|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
19708435|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
19708436|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
19708437|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708438|NCT04815395|Oxytocin|oxytocin|mesh-list
19708439|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
19708440|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708441|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708442|NCT04815187|Montelukast|montelukast|mesh-list
19708443|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19708444|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
19708445|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19708446|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
19854912|NCT00743145|Naltrexone|naltrexone|mesh-list
19854913|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19854914|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19854915|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854916|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
20246305|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521795|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20521796|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20521797|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20521798|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
20521799|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521800|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521801|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521802|NCT01736033|Urological Agents|urological agents|mesh-ancestor
20521803|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20521804|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20521805|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521806|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
19854917|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706229|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
19706230|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19706231|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706232|NCT04840238|Vitamins|vitamins|mesh-ancestor
19706233|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
19706234|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19706235|NCT04840290|Paclitaxel|paclitaxel|mesh-list
19706236|NCT04840290|Carboplatin|carboplatin|mesh-list
19706237|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19706238|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706239|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706240|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706241|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
19706242|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706243|NCT04840342|Amlodipine|amlodipine|mesh-list
19706244|NCT04840342|Eplerenone|eplerenone|mesh-list
19706245|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19706246|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19706247|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19706248|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706249|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19706250|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706251|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
19706252|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19706253|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
19706254|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706255|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19706256|NCT04840342|Diuretics|diuretics|mesh-ancestor
19706257|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
19706258|NCT04839913|Antibodies|antibodies|mesh-list
19706259|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
19706260|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706261|NCT04839666|Propofol|propofol|mesh-list
19706262|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19706263|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706264|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706265|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19706266|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
19706267|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
19706268|NCT04839731|Fluorouracil|fluorouracil|mesh-list
19706269|NCT04839731|Calcipotriene|calcipotriene|mesh-list
19706270|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
19706271|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706272|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19706273|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706274|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706275|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
19706276|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706277|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
19706278|NCT04839653|Vancomycin|vancomycin|mesh-list
19706279|NCT04839653|Gentamicins|gentamicins|mesh-list
19706280|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
19706281|NCT04839653|Polymyxins|polymyxins|mesh-list
19706282|NCT04839653|Cefotaxime|cefotaxime|mesh-list
19706283|NCT04839653|Cefoxitin|cefoxitin|mesh-list
19854918|NCT00743288|Melphalan|melphalan|mesh-list
19854919|NCT00743288|Panobinostat|panobinostat|mesh-list
19854920|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706284|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19706285|NCT04839653|Polymyxin B|polymyxin b|mesh-list
19706286|NCT04839653|Amphotericin B|amphotericin b|mesh-list
19706287|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19706288|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706289|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19706290|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706291|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706292|NCT04839653|Amebicides|amebicides|mesh-ancestor
19706293|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19706294|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19706295|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
19706296|NCT04839536|Sevoflurane|sevoflurane|mesh-list
19706297|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19706298|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19706299|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
19706300|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
19854921|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
19706301|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706302|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706303|NCT04839549|Fluorometholone|fluorometholone|mesh-list
19706304|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706305|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706306|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
19706307|NCT04839549|Hormones|hormones|mesh-ancestor
19706308|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706309|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19706310|NCT04839627|Progesterone|progesterone|mesh-list
19706311|NCT04839627|Progestins|progestins|mesh-ancestor
19706312|NCT04839627|Hormones|hormones|mesh-ancestor
19706313|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706314|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706315|NCT04839445|Anesthetics|anesthetics|mesh-list
19706316|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19854922|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854923|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854924|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19854925|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854926|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
19854927|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854928|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19854929|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854930|NCT00743340|Emtricitabine|emtricitabine|mesh-list
19854931|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
19854932|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854933|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19706317|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706318|NCT04839224|Phenylephrine|phenylephrine|mesh-list
19706319|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
19706320|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19706321|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
19706322|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
19706323|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706324|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706325|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
19706326|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19706327|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
19706328|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
19706329|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19706330|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19706331|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19706332|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
19706333|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706334|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706335|NCT04839224|Protective Agents|protective agents|mesh-ancestor
19706336|NCT04839471|Afatinib|afatinib|mesh-list
19706337|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706338|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19706339|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706340|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706341|NCT04839328|Hemay005|hemay005|mesh-list
19706342|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
19706343|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19706344|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19706345|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706346|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706347|NCT04839198|Nicotine|nicotine|mesh-list
19706348|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19706349|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
19706350|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706351|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706352|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19706353|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19706354|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
19706355|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706356|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706357|NCT04839237|Metformin|metformin|mesh-list
19706358|NCT04839237|Liraglutide|liraglutide|mesh-list
19706359|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19706360|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706361|NCT04839237|Incretins|incretins|mesh-ancestor
19706362|NCT04839237|Hormones|hormones|mesh-ancestor
19706363|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706364|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
19706365|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706366|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706367|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
19706368|NCT04838704|Methotrexate|methotrexate|mesh-list
19706369|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19706370|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
19706371|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19706372|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706373|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19706374|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
19706375|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706376|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706377|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
19706378|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706379|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19706380|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706381|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
19706382|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706383|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19706384|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19706385|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19706386|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
19706387|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19706388|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706389|NCT04838665|Phenylephrine|phenylephrine|mesh-list
19706390|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
19706391|NCT04838665|Tropicamide|tropicamide|mesh-list
19706392|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
19706393|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19706394|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
19706395|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
19706396|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706397|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706398|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
19706399|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19706400|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
19706401|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
19706402|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19706403|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19706404|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19706405|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
19706406|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706407|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706408|NCT04838665|Protective Agents|protective agents|mesh-ancestor
19706409|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19706410|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19706411|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
19706412|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
19706413|NCT04838860|Siltuximab|siltuximab|mesh-list
19706414|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706415|NCT04838288|Tacrolimus|tacrolimus|mesh-list
19706416|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706417|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
20246306|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246307|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246308|NCT00427882|Urological Agents|urological agents|mesh-ancestor
20246309|NCT00427947|Ropivacaine|ropivacaine|mesh-list
20246310|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
20246311|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
20246312|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706418|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706419|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19706420|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708527|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706421|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708447|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708448|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708449|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19708450|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19708451|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708452|NCT04815200|Copper|copper|mesh-list
19708453|NCT04815200|Nickel|nickel|mesh-list
19708454|NCT04815200|Trace Elements|trace elements|mesh-ancestor
19708455|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
19708456|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708457|NCT04814875|Carboplatin|carboplatin|mesh-list
19708458|NCT04814875|Doxorubicin|doxorubicin|mesh-list
19708459|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19708460|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708461|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854934|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19854935|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854936|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854937|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19854938|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19854939|NCT00743366|Riboflavin|riboflavin|mesh-list
19854940|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19854941|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
19854942|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19854943|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19854944|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20521807|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521808|NCT01736150|Sevelamer|sevelamer|mesh-list
20521809|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
20521810|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
20521811|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521812|NCT01736163|Hormones|hormones|mesh-list
20521813|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521814|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521815|NCT01736371|Propofol|propofol|mesh-list
20521816|NCT01736371|Sevoflurane|sevoflurane|mesh-list
19708462|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19708463|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19708464|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706422|NCT04838145|Ribavirin|ribavirin|mesh-list
19706423|NCT04838145|Pleconaril|pleconaril|mesh-list
19706424|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
19706425|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706426|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
19706427|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706428|NCT04838132|Ropivacaine|ropivacaine|mesh-list
19706429|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
19706430|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
19706431|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706432|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706433|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
19706434|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706435|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19706436|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19706437|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706438|NCT04837924|Acetaminophen|acetaminophen|mesh-list
19706439|NCT04837924|Tramadol|tramadol|mesh-list
19706440|NCT04837924|Analgesics|analgesics|mesh-list
19706441|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
19706442|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19706443|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
19706444|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521817|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
20521818|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521819|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521820|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20521821|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20521822|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
20521823|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19706445|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706446|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
19706447|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19706448|NCT04837924|Narcotics|narcotics|mesh-ancestor
19706449|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706450|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
19706451|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
19706452|NCT04838080|Vaccines|vaccines|mesh-list
19706453|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
19706454|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706455|NCT04837664|Nystatin|nystatin|mesh-list
19706456|NCT04837664|Curcumin|curcumin|mesh-list
19706457|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19706458|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19706459|NCT04837664|Analgesics|analgesics|mesh-ancestor
19706460|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
19706461|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706462|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706463|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706464|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706465|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706466|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706467|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706468|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19706469|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706470|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
19706471|NCT04837664|Ionophores|ionophores|mesh-ancestor
19706472|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19706473|NCT04837651|Antibodies|antibodies|mesh-list
19706474|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
19706475|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706476|NCT04837131|Ixazomib|ixazomib|mesh-list
19706477|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706478|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
19706479|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706480|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706481|NCT04837014|Acetaminophen|acetaminophen|mesh-list
19706482|NCT04837014|Naproxen|naproxen|mesh-list
19854945|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19854946|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854947|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
19854948|NCT00743366|Vitamins|vitamins|mesh-ancestor
20521824|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19854949|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
19706483|NCT04837014|Hydromorphone|hydromorphone|mesh-list
19706484|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19706485|NCT04837014|Analgesics|analgesics|mesh-ancestor
19854950|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19854951|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
19854952|NCT00743431|Doxorubicin|doxorubicin|mesh-list
19854953|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854954|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854955|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19854956|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19854957|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19854958|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854959|NCT00743444|Lesogaberan|lesogaberan|mesh-list
19854960|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19854961|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19854962|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
19706486|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
19706487|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706488|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706489|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
19706490|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19706491|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19854963|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
19854964|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19854965|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854966|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854967|NCT00743509|Sirolimus|sirolimus|mesh-list
19854968|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
19854969|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19854970|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
19854971|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854972|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19854973|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706492|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706493|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
19706494|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19706495|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706496|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706497|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19706498|NCT04837014|Narcotics|narcotics|mesh-ancestor
19706499|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706500|NCT04837170|Ketamine|ketamine|mesh-list
19706501|NCT04837170|Esketamine|esketamine|mesh-list
19706502|NCT04837170|Analgesics|analgesics|mesh-ancestor
19706503|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
19706504|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706505|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706506|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19706507|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19706508|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
19706509|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
19706510|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706511|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19706512|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19706513|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706514|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706515|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
19854974|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
19854975|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19854976|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19854977|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19854978|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19854979|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19854980|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19854981|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
19854982|NCT00743574|Vitamin D|vitamin d|mesh-list
19706516|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20521825|NCT01736410|Trastuzumab|trastuzumab|mesh-list
20521826|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521827|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521828|NCT01736423|Ramosetron|ramosetron|mesh-list
20521829|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
20521830|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
20521831|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521832|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521833|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20521834|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19706517|NCT04837261|Propranolol|propranolol|mesh-list
19706518|NCT04837261|Amiodarone|amiodarone|mesh-list
19706519|NCT04837261|Flecainide|flecainide|mesh-list
19706520|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19706521|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19706522|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
19706523|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706524|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706525|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706526|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19706527|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19706528|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
19706529|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19706530|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19706531|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19706532|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19706533|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19706534|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706535|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20246313|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246314|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
20246315|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246316|NCT00428025|Diclofenac|diclofenac|mesh-list
20246317|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20246318|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246319|NCT00428025|Analgesics|analgesics|mesh-ancestor
19706536|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19706537|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19706538|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19706539|NCT04836962|Dexamethasone|dexamethasone|mesh-list
19706540|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706541|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
19706542|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
19706543|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706544|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706545|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706546|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
19706547|NCT04836962|Hormones|hormones|mesh-ancestor
19706548|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706549|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706550|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706551|NCT04836806|Cetirizine|cetirizine|mesh-list
19706552|NCT04836806|Famotidine|famotidine|mesh-list
19706553|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19706554|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706555|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19706556|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
19706557|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
19706558|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706559|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706560|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706561|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19706562|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19706563|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19706564|NCT04836728|Paclitaxel|paclitaxel|mesh-list
19706565|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19706566|NCT04836728|Carboplatin|carboplatin|mesh-list
19706567|NCT04836728|Pemetrexed|pemetrexed|mesh-list
19706568|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19706569|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19706570|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706571|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706572|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706573|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246320|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
19706574|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706575|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706576|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19706577|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19706578|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
19706579|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19706580|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
19706581|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
19706582|NCT04836637|Calcium|calcium|mesh-list
19706583|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19706584|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706585|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19706586|NCT04836637|Antacids|antacids|mesh-ancestor
19706587|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706588|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706589|NCT04836819|Lidocaine|lidocaine|mesh-list
19706590|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
19706591|NCT04836819|Ketamine|ketamine|mesh-list
19706592|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
19706593|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
19706594|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706595|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706596|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
19706597|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706598|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19706599|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19706600|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19706601|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19706602|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706603|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19706604|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19706605|NCT04836819|Analgesics|analgesics|mesh-ancestor
19706606|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19706607|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19706608|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19706609|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
19706610|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706611|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19706612|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19706613|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
19706614|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19706615|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19706616|NCT04836780|Dexamethasone|dexamethasone|mesh-list
19706617|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706618|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
19706619|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
19706620|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706621|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706622|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706623|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
20521835|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
20521836|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521837|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521838|NCT01736449|Bevacizumab|bevacizumab|mesh-list
20521839|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521840|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521841|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20521842|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20521843|NCT01736449|Growth Substances|growth substances|mesh-ancestor
20521844|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521845|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
20521846|NCT01736488|Atenolol|atenolol|mesh-list
20521847|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20521848|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20521849|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
20521850|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
20521851|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521852|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521853|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20521854|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19706624|NCT04836780|Hormones|hormones|mesh-ancestor
19706625|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19854983|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
19706626|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706627|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706628|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
19706629|NCT04836507|Fludarabine|fludarabine|mesh-list
19706630|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706631|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
19706632|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706633|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706634|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706635|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
19706636|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706637|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706638|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19706639|NCT04836078|Chitosan|chitosan|mesh-list
19706640|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19706641|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19706642|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
19706643|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706644|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19706645|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
19706646|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
19706647|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
19706648|NCT04836078|Coagulants|coagulants|mesh-ancestor
19706649|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
19706650|NCT04836156|Carboplatin|carboplatin|mesh-list
19706651|NCT04836156|Docetaxel|docetaxel|mesh-list
19706652|NCT04836156|Epirubicin|epirubicin|mesh-list
19706653|NCT04836156|Phenobarbital|phenobarbital|mesh-list
19706654|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706655|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
19706656|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706657|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706658|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706659|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
19706660|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706661|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706662|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19706663|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706664|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706665|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246321|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246322|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246323|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246324|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246325|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20246326|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246327|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246328|NCT00428064|Cyclosporine|cyclosporine|mesh-list
20246329|NCT00428064|Sirolimus|sirolimus|mesh-list
20246330|NCT00428064|Cyclosporins|cyclosporins|mesh-list
19706666|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246331|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246332|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246333|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246334|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
20246335|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246336|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
20246337|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246338|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
20246339|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246340|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20246341|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20246342|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246343|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246344|NCT00428129|Plasminogen|plasminogen|mesh-list
20246345|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20521855|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19706667|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20246346|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20521856|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
20521857|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20521858|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521859|NCT01736514|Allopurinol|allopurinol|mesh-list
20521860|NCT01736514|Febuxostat|febuxostat|mesh-list
20521861|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
20521862|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521863|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521864|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
20521865|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521866|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20521867|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
20521868|NCT01736514|Protective Agents|protective agents|mesh-ancestor
20521869|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521870|NCT01736670|Triamcinolone|triamcinolone|mesh-list
19854984|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
19854985|NCT00743574|Vitamins|vitamins|mesh-list
19854986|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19854987|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
19854988|NCT00743574|Calcium|calcium|mesh-list
19854989|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
19854990|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19854991|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19854992|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19854993|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19854994|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19854995|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19854996|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
19854997|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19854998|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19854999|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19855000|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19855001|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19855002|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706668|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19706669|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706670|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
19706671|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19706672|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706673|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19706674|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19706675|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706676|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
19706677|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
19855003|NCT00743652|Vaccines|vaccines|mesh-list
19855004|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19855005|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
19855006|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855007|NCT00743717|Cobalt|cobalt|mesh-list
19855008|NCT00743717|Trace Elements|trace elements|mesh-ancestor
19855009|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
19855010|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855011|NCT00743730|Morphine|morphine|mesh-list
19855012|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19855013|NCT00743730|Narcotics|narcotics|mesh-ancestor
19855014|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855015|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855016|NCT00743730|Analgesics|analgesics|mesh-ancestor
19855017|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
19855018|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855019|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
19855020|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
19855021|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855022|NCT00744055|Prazosin|prazosin|mesh-list
19855023|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19855024|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19855025|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19855026|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19855027|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
19855028|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855029|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855030|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855031|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
19855032|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19855033|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855034|NCT00744237|Metoprolol|metoprolol|mesh-list
19855035|NCT00744237|Nebivolol|nebivolol|mesh-list
19855036|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19855037|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19855038|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
19855039|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
19855040|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855041|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855042|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19855043|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19855044|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19855045|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
19855046|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855047|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855048|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
19855049|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19855050|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19855051|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19855052|NCT00744263|Vaccines|vaccines|mesh-list
19855053|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19855054|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
19855055|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855056|NCT00744328|Sertraline|sertraline|mesh-list
19855057|NCT00744328|Estradiol|estradiol|mesh-list
19855058|NCT00744328|Estrogens|estrogens|mesh-ancestor
19416266|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19706678|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19706679|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19706680|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19706681|NCT04836143|Mitogens|mitogens|mesh-list
19706682|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
19706683|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
19706684|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706685|NCT04836143|Growth Substances|growth substances|mesh-ancestor
19706686|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706687|NCT04836299|Ivermectin|ivermectin|mesh-list
19706688|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19706689|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708465|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708466|NCT04814537|Bupivacaine|bupivacaine|mesh-list
19708467|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
19708468|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
19708469|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708470|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708471|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
19708472|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708473|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
19708474|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
19708475|NCT04814615|Daratumumab|daratumumab|mesh-list
19708476|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708477|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19708478|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19708479|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708480|NCT04814303|Morphine|morphine|mesh-list
19706690|NCT04835870|Prednisone|prednisone|mesh-list
19706691|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
19706692|NCT04835870|Rituximab|rituximab|mesh-list
19706693|NCT04835870|Doxorubicin|doxorubicin|mesh-list
19706694|NCT04835870|Vincristine|vincristine|mesh-list
19706695|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
19706696|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706697|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
19706698|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706699|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706700|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706701|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
19706702|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706703|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706704|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19706705|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706706|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19706707|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19706708|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19706709|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706710|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246347|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246348|NCT00428142|Prednisone|prednisone|mesh-list
20246349|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
20246350|NCT00428142|Rituximab|rituximab|mesh-list
20246351|NCT00428142|Vincristine|vincristine|mesh-list
20246352|NCT00428142|Bortezomib|bortezomib|mesh-list
20246353|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246354|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
20246355|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521871|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20521872|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20521873|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20521874|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20521875|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
20521876|NCT01736670|Hormones|hormones|mesh-ancestor
20521877|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20521878|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521879|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20521880|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
20521881|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521882|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521883|NCT01736761|Ritonavir|ritonavir|mesh-list
19706711|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
19706712|NCT04835870|Hormones|hormones|mesh-ancestor
20246356|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521884|NCT01736761|Darunavir|darunavir|mesh-list
20246357|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706713|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706714|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706715|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19706716|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706717|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706718|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
19706719|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19706720|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19706721|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
19706722|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706723|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706724|NCT04835623|Cyclosporine|cyclosporine|mesh-list
19706725|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19706726|NCT04835623|Cyclosporins|cyclosporins|mesh-list
19706727|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706728|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706729|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706730|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
19706731|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706732|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
19706733|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706734|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
19706735|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706736|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19706737|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19706738|NCT04835922|Anesthetics|anesthetics|mesh-list
19706739|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706740|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706741|NCT04835896|Paclitaxel|paclitaxel|mesh-list
19855059|NCT00744328|Hormones|hormones|mesh-ancestor
19708481|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19706742|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19706743|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521885|NCT01736761|Rilpivirine|rilpivirine|mesh-list
20521886|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20521887|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20521888|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
20521889|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521890|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521891|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20521892|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20521893|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
20521894|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521895|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20521896|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20521897|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20521898|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20521899|NCT01736800|Temozolomide|temozolomide|mesh-list
20521900|NCT01736800|Topotecan|topotecan|mesh-list
20521901|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20521902|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
20521903|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521904|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521905|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20521906|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20521907|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521908|NCT01736813|Maraviroc|maraviroc|mesh-list
20521909|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20521910|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20246358|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
20246359|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246360|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246361|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20246362|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20246363|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246364|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
20246365|NCT00428142|Hormones|hormones|mesh-ancestor
20246366|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246367|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20246368|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20246369|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
20246370|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
20521911|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521912|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20521913|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20521914|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
20521915|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521916|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20521917|NCT01736878|Sorafenib|sorafenib|mesh-list
20521918|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521919|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20521920|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521921|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521922|NCT01736891|Rasagiline|rasagiline|mesh-list
20521923|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19706744|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706745|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706746|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
19706747|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706748|NCT04835350|Pancrelipase|pancrelipase|mesh-list
19706749|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706750|NCT04835259|Selenium|selenium|mesh-list
19706751|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
19706752|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706753|NCT04835259|Protective Agents|protective agents|mesh-ancestor
19706754|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706755|NCT04835259|Trace Elements|trace elements|mesh-ancestor
19855060|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855061|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855062|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
19855063|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855064|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19855065|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19855066|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855067|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855068|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855069|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
19855070|NCT00744380|Midazolam|midazolam|mesh-list
19855071|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
19855072|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19855073|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855074|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855075|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19855076|NCT00744380|Analgesics|analgesics|mesh-ancestor
19855077|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
19855078|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855079|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19855080|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19855081|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19855082|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
20246371|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
19855083|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855084|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855085|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20246372|NCT00428168|Betahistine|betahistine|mesh-list
20246373|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
20246374|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
20246375|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
20246376|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246377|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246378|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246379|NCT00428181|Ethanol|ethanol|mesh-list
20246380|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20246381|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246382|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521924|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521925|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521926|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20521927|NCT01736891|Protective Agents|protective agents|mesh-ancestor
20521928|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521929|NCT01737008|Cisplatin|cisplatin|mesh-list
20521930|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521931|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
20521932|NCT01737073|Narcotics|narcotics|mesh-ancestor
20521933|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20521934|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521935|NCT01737073|Analgesics|analgesics|mesh-ancestor
20521936|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
20521937|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521938|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
20521939|NCT01737086|Astringents|astringents|mesh-ancestor
20521940|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521941|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
20521942|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
20521943|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20521944|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855086|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19855087|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855088|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855089|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19855090|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
19855091|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
19855092|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
19855093|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
19855094|NCT00744471|Tanezumab|tanezumab|mesh-list
19855095|NCT00744471|Analgesics|analgesics|mesh-ancestor
19855096|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
19855097|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855098|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855099|NCT00744497|Prednisone|prednisone|mesh-list
19706756|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
19706757|NCT04835233|Methyldopa|methyldopa|mesh-list
19706758|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19706759|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
19706760|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
19706761|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706762|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706763|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19706764|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19706765|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19706766|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
19706767|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706768|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706769|NCT04834986|Lenvatinib|lenvatinib|mesh-list
19706770|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706771|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19416267|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416268|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19416269|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416270|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416271|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
19416272|NCT02519439|Ganaxolone|ganaxolone|mesh-list
19416273|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
19416274|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416275|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416276|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416277|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
19416278|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
19416279|NCT02515175|Vaccines|vaccines|mesh-list
19416280|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
20246383|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246384|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19855100|NCT00744497|Docetaxel|docetaxel|mesh-list
19855101|NCT00744497|Dasatinib|dasatinib|mesh-list
19855102|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855103|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
19855104|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
19855105|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
19855106|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855107|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855108|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
19855109|NCT00744497|Hormones|hormones|mesh-ancestor
19855110|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855111|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855112|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19855113|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19855114|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855115|NCT00744627|Vortioxetine|vortioxetine|mesh-list
19855116|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
19855117|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855118|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19855119|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855120|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855121|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855122|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19855123|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19855124|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855652|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20246385|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855125|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855126|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855127|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
19855128|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19855129|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19855130|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19855131|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19855132|NCT00744653|Bleomycin|bleomycin|mesh-list
19706772|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706773|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706774|NCT04835064|Gemcitabine|gemcitabine|mesh-list
19706775|NCT04835064|Paclitaxel|paclitaxel|mesh-list
19706776|NCT04835064|Folfirinox|folfirinox|mesh-list
19706777|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19706778|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706779|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
19706780|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706781|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
19706782|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706783|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19706784|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
19706785|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
19706786|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706787|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706788|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706789|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
19855133|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19855134|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855135|NCT00744692|Fludarabine|fludarabine|mesh-list
19855136|NCT00744692|Melphalan|melphalan|mesh-list
19855137|NCT00744692|Thiotepa|thiotepa|mesh-list
19855138|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
19855139|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855140|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521945|NCT01737177|Rituximab|rituximab|mesh-list
20521946|NCT01737177|Lenalidomide|lenalidomide|mesh-list
20521947|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20521948|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20521949|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521950|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
20521951|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521952|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20521953|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20521954|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20521955|NCT01737177|Growth Substances|growth substances|mesh-ancestor
20521956|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
20521957|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20521958|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
20521959|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521960|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
20521961|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521962|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
20521963|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20521964|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20521965|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521966|NCT01737203|Urological Agents|urological agents|mesh-ancestor
20521967|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
20521968|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20521969|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521970|NCT01737294|Capsaicin|capsaicin|mesh-list
20521971|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
20246386|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20246387|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246388|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246389|NCT00428272|Interferons|interferons|mesh-list
20246390|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
20246391|NCT00428272|Lexatumumab|lexatumumab|mesh-list
20246392|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20246393|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246394|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
20246395|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246396|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
20246397|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246398|NCT00428311|Metformin|metformin|mesh-list
20246399|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
20246400|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20246401|NCT00428311|Estradiol|estradiol|mesh-list
20246402|NCT00428311|Cyproterone|cyproterone|mesh-list
20246403|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20246404|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246405|NCT00428311|Estrogens|estrogens|mesh-ancestor
20246406|NCT00428311|Hormones|hormones|mesh-ancestor
20246407|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246408|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20246409|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
20246410|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20521972|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
20521973|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
20521974|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20521975|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20521976|NCT01737307|Fluorides|fluorides|mesh-list
20521977|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
20521978|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
20521979|NCT01737307|Protective Agents|protective agents|mesh-ancestor
20521980|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416281|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416282|NCT02514447|Topotecan|topotecan|mesh-list
19706790|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706791|NCT04835116|Acetaminophen|acetaminophen|mesh-list
19706792|NCT04835116|Tramadol|tramadol|mesh-list
19706793|NCT04835116|Analgesics|analgesics|mesh-list
19706794|NCT04835116|Orphenadrine|orphenadrine|mesh-list
19706795|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
19706796|NCT04835116|Bupivacaine|bupivacaine|mesh-list
19706797|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
19706798|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
19706799|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708482|NCT04814303|Narcotics|narcotics|mesh-ancestor
20246411|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20246412|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20246413|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20246414|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
20246415|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
20246416|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246417|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20246418|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20246419|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
20246420|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20246421|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20246422|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20246423|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20246424|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246425|NCT00428428|Isoproterenol|isoproterenol|mesh-list
19706800|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706801|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
19706802|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706803|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19706804|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
19706805|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19706806|NCT04835116|Narcotics|narcotics|mesh-ancestor
19706807|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19706808|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19855141|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855142|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
19855143|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706809|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19855144|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19706810|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19706811|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
19706812|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
19706813|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19706814|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19706815|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
19416283|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19706816|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706817|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706818|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
19706819|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19706820|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706821|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
20521981|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20521982|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20521983|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521984|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
20521985|NCT01737346|Lomustine|lomustine|mesh-list
20521986|NCT01737346|Procarbazine|procarbazine|mesh-list
20521987|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20521988|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
20521989|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521990|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20521991|NCT01737359|Tenofovir|tenofovir|mesh-list
20521992|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
20521993|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20521994|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20521995|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20521996|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20521997|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20521998|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20521999|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20522000|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
20522001|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20522002|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20522003|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
20522004|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522005|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522006|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522007|NCT01737411|Urological Agents|urological agents|mesh-ancestor
20522008|NCT01737541|Fluoxetine|fluoxetine|mesh-list
20522009|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20522010|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20522011|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20522012|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246426|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20246427|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20246428|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
20246429|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246430|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246431|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706822|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706823|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19706824|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
19706825|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
19706826|NCT04834908|Immune Sera|immune sera|mesh-list
20246432|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20246433|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
20246434|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246435|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20246436|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
20246437|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20246438|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
20246439|NCT00428428|Protective Agents|protective agents|mesh-ancestor
20246440|NCT00428454|Sirolimus|sirolimus|mesh-list
19706827|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
19706828|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706829|NCT04834791|Letrozole|letrozole|mesh-list
19706830|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706831|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19706832|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19706833|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706834|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706835|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19706836|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
19706837|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706838|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706839|NCT04834960|Vaccines|vaccines|mesh-list
19706840|NCT04834960|Immunologic Factors|immunologic factors|mesh-ancestor
19706841|NCT04834960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706842|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19706843|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706844|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706845|NCT04834440|Ropivacaine|ropivacaine|mesh-list
19706846|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
19706847|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
19706848|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706849|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706850|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
19706851|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706852|NCT04834752|Esomeprazole|esomeprazole|mesh-list
19706853|NCT04834752|Omeprazole|omeprazole|mesh-list
19706854|NCT04834752|Rabeprazole|rabeprazole|mesh-list
19706855|NCT04834752|Pantoprazole|pantoprazole|mesh-list
19706856|NCT04834752|Lansoprazole|lansoprazole|mesh-list
19706857|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
19706858|NCT04834752|Famotidine|famotidine|mesh-list
19706859|NCT04834752|Ranitidine|ranitidine|mesh-list
19706860|NCT04834752|Cimetidine|cimetidine|mesh-list
19706861|NCT04834752|Nizatidine|nizatidine|mesh-list
19706862|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19706863|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706864|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19706865|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855145|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
19706866|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706867|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19706868|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
19706869|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
19706870|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416284|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19416285|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416286|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416287|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246441|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20246442|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246443|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246444|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246445|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
20246446|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246447|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
19416288|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
19416289|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19416290|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19706871|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416291|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416292|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
19416293|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
19416294|NCT02513485|Levodopa|levodopa|mesh-list
19416295|NCT02513485|Carbidopa|carbidopa|mesh-list
19416296|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20246448|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248066|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248067|NCT00434668|Cisplatin|cisplatin|mesh-list
20248068|NCT00434668|Docetaxel|docetaxel|mesh-list
19706872|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20248069|NCT00434668|Vinorelbine|vinorelbine|mesh-list
20248070|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706873|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20248071|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
20246449|NCT00428480|Methamphetamine|methamphetamine|mesh-list
20246450|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20246451|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246452|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
20246453|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
20246454|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246455|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
20246456|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246457|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246458|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
20246459|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20246460|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20246461|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20246462|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20246463|NCT00428519|Aprepitant|aprepitant|mesh-list
20246464|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
20246465|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
20246466|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
20246467|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248072|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
19706874|NCT04834674|Apatinib|apatinib|mesh-list
20522013|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522014|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
20522015|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522016|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20522017|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
20522018|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522019|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20522020|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20522021|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522022|NCT01737671|Leucovorin|leucovorin|mesh-list
20522023|NCT01737671|Methotrexate|methotrexate|mesh-list
20246468|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246469|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20246470|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20246471|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246472|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246473|NCT00428545|Bevacizumab|bevacizumab|mesh-list
20246474|NCT00428545|Bortezomib|bortezomib|mesh-list
20246475|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20246476|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522024|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20522025|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
20522026|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522027|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522028|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20522029|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
20522030|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522031|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522032|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522033|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706875|NCT04834674|Antibodies|antibodies|mesh-list
20246477|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20246478|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20246479|NCT00428545|Growth Substances|growth substances|mesh-ancestor
20246480|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246481|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
20246482|NCT00428558|Cytarabine|cytarabine|mesh-list
20246483|NCT00428558|Daunorubicin|daunorubicin|mesh-list
20246484|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20246485|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
20248073|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
20522034|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20522035|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20522036|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
20522037|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522038|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20522039|NCT01737671|Antidotes|antidotes|mesh-ancestor
20522040|NCT01737671|Protective Agents|protective agents|mesh-ancestor
20522041|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
20522042|NCT01737671|Vitamins|vitamins|mesh-ancestor
20522043|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
20522044|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
20522045|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20522046|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20522047|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
20522048|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522049|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522050|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522051|NCT01737918|Urological Agents|urological agents|mesh-ancestor
20522052|NCT01738035|Budesonide|budesonide|mesh-list
20522053|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522054|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20522055|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
20522056|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522057|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522058|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19706876|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
19706877|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706878|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706879|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20522059|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
20522060|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
20522061|NCT01738035|Hormones|hormones|mesh-ancestor
20522062|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522063|NCT01738087|Fluticasone|fluticasone|mesh-list
20522064|NCT01738087|Xhance|xhance|mesh-list
20522065|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
20522066|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522067|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20522068|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
20522069|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522070|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522071|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20522072|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
19706880|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706881|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706882|NCT04834427|Ketamine|ketamine|mesh-list
19706883|NCT04834427|Esketamine|esketamine|mesh-list
19706884|NCT04834427|Analgesics|analgesics|mesh-ancestor
19706885|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
19706886|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706887|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706888|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20246486|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706889|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19706890|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
20246487|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246488|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
20246489|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246490|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246491|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
20246492|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246493|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246494|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20246495|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20246496|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246497|NCT00428649|Selenium|selenium|mesh-list
20246498|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
19706891|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
20248129|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20246499|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246500|NCT00428649|Protective Agents|protective agents|mesh-ancestor
19855146|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19855147|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
19855148|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855149|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19855150|NCT00744757|Decitabine|decitabine|mesh-list
20246501|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246502|NCT00428649|Trace Elements|trace elements|mesh-ancestor
20246503|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
20246504|NCT00428701|Esomeprazole|esomeprazole|mesh-list
20246505|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20246506|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706892|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19706893|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19706894|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19706895|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706896|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706897|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
19706898|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19706899|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19706900|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19706901|NCT04834375|Dexamethasone|dexamethasone|mesh-list
19706902|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
19855151|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20522073|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522074|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20522075|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20522076|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20522077|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20522078|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
20522079|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522080|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522081|NCT01738100|Morphine|morphine|mesh-list
20522082|NCT01738100|Clopidogrel|clopidogrel|mesh-list
20522083|NCT01738100|Ticagrelor|ticagrelor|mesh-list
20522084|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20522085|NCT01738100|Narcotics|narcotics|mesh-ancestor
20522086|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522087|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522088|NCT01738100|Analgesics|analgesics|mesh-ancestor
20522089|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
20522090|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522091|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20522092|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20522093|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20246507|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20246508|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246509|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246510|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
20246511|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19706903|NCT04834375|BB 1101|bb 1101|mesh-list
19706904|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706905|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
19706906|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
19706907|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706908|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522094|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20522095|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
20522096|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522097|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522098|NCT01738139|Ipilimumab|ipilimumab|mesh-list
20522099|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
20522100|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20522101|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522102|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20522103|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522104|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20522105|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522106|NCT01738178|Caffeine|caffeine|mesh-list
20522107|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20246512|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
20522108|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522109|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20522110|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522111|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522112|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20522113|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20522114|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
20522115|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522116|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
20522117|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20522118|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
20522119|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522120|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
20522121|NCT01738243|Protective Agents|protective agents|mesh-ancestor
20530218|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530219|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20530220|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20530221|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
20530222|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20530223|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
20530224|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
20530225|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
19416297|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19416298|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
19416299|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416300|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416301|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416302|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19416303|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416304|NCT02513303|Sirolimus|sirolimus|mesh-list
19416305|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19416306|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416307|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19416308|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416309|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
19416310|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20530226|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20530227|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20530228|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20530878|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20530879|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
20246513|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522122|NCT01738282|Baclofen|baclofen|mesh-list
20522123|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20522124|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522125|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20522126|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522127|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20522128|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
20522129|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
20522130|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855152|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
19855153|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855154|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855155|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855156|NCT00744848|Epinephrine|epinephrine|mesh-list
19855157|NCT00744848|Bupivacaine|bupivacaine|mesh-list
19855158|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
19855159|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
19855160|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855161|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855162|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
19855163|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855164|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19416311|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
19855165|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19706909|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19706910|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
19706911|NCT04834375|Hormones|hormones|mesh-ancestor
19855166|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
19855167|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855168|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855169|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19855170|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19855171|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
19855172|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20522131|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522132|NCT01738295|Donepezil|donepezil|mesh-list
20522133|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20522134|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522135|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522136|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
20522137|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522138|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522139|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
20522140|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
20522141|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522142|NCT01738373|Plerixafor|plerixafor|mesh-list
20522143|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20530880|NCT01791166|Antibodies|antibodies|mesh-list
19855173|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
19855174|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
20246514|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246515|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20246516|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
20246517|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20246518|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
20246519|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246520|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246521|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20246522|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
20246523|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
20246524|NCT00428727|Protective Agents|protective agents|mesh-ancestor
20246525|NCT00428766|Farletuzumab|farletuzumab|mesh-list
20246526|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522144|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20522145|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
20522146|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522147|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
20522148|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
20246527|NCT00428818|Doxycycline|doxycycline|mesh-list
19706912|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706913|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706914|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706915|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
19706916|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706917|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706918|NCT04834310|Clindamycin|clindamycin|mesh-list
19706919|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
19706920|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
19706921|NCT04834310|Cefazolin|cefazolin|mesh-list
19706922|NCT04834310|Cephalexin|cephalexin|mesh-list
19706923|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20522149|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522150|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522151|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706924|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246528|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20522152|NCT01738451|Dabrafenib|dabrafenib|mesh-list
19706925|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19706926|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706927|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708483|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708484|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708485|NCT04814303|Analgesics|analgesics|mesh-ancestor
19708486|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
19708487|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708488|NCT04814511|Permethrin|permethrin|mesh-list
19708489|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855175|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
19708490|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708491|NCT04814485|Paclitaxel|paclitaxel|mesh-list
19708492|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19706928|NCT04833959|Panitumumab|panitumumab|mesh-list
19706929|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706930|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706931|NCT04834115|Ivermectin|ivermectin|mesh-list
20246529|NCT00428818|Trimethoprim|trimethoprim|mesh-list
20246530|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
20246531|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20246532|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246533|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
20246534|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20246535|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20246536|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20246537|NCT00428818|Renal Agents|renal agents|mesh-ancestor
20246538|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20246539|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246540|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246541|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20246542|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20246543|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19855176|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19855177|NCT00744965|Glyburide|glyburide|mesh-list
19855178|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19855179|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855180|NCT00744978|Varenicline|varenicline|mesh-list
19855181|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19855182|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19855183|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
19855184|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855185|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855186|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855187|NCT00745095|Neostigmine|neostigmine|mesh-list
19855188|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20246544|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
20522153|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522154|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20522155|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522156|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522157|NCT01738542|Bosentan|bosentan|mesh-list
20522158|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
20522159|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20522160|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522161|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20522162|NCT01738607|Psyllium|psyllium|mesh-list
20522163|NCT01738607|Laxatives|laxatives|mesh-ancestor
20522164|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20522165|NCT01738607|Cathartics|cathartics|mesh-ancestor
20522166|NCT01738724|Goserelin|goserelin|mesh-list
20522167|NCT01738724|Dienogest|dienogest|mesh-list
19855189|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246545|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20246546|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
19706932|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19706933|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706934|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
19706935|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706936|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706937|NCT04833907|Prednisolone|prednisolone|mesh-list
19706938|NCT04833907|Levetiracetam|levetiracetam|mesh-list
19706939|NCT04833907|Prednisolone phosphate|prednisolone phosphate|mesh-list
19706940|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706941|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
19855190|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855191|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
19855192|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855193|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855194|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19855195|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
19855196|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855197|NCT00745290|Bupivacaine|bupivacaine|mesh-list
19855198|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19855199|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
20522168|NCT01738724|Desogestrel|desogestrel|mesh-list
20522169|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20522170|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522171|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20522172|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
20522173|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522174|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522175|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20522176|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20522177|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20530881|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
20246547|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246548|NCT00428883|Expectorants|expectorants|mesh-ancestor
20246549|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
20246550|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20246551|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
20246552|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246553|NCT00428883|Protective Agents|protective agents|mesh-ancestor
20246554|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246555|NCT00428883|Antidotes|antidotes|mesh-ancestor
20246556|NCT00428896|Gefitinib|gefitinib|mesh-list
20246557|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246558|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20246559|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855200|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855201|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246560|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246561|NCT00428909|Acetaminophen|acetaminophen|mesh-list
20522178|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20522179|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
20522180|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522181|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20522182|NCT01738724|Progestins|progestins|mesh-ancestor
20522183|NCT01738724|Hormones|hormones|mesh-ancestor
20522184|NCT01738763|Inositol|inositol|mesh-list
20522185|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
20522186|NCT01738763|Vitamins|vitamins|mesh-ancestor
20522187|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
20522188|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416312|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416313|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
19416314|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19416315|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416316|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19416317|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246562|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
20246563|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246564|NCT00428909|Analgesics|analgesics|mesh-ancestor
20246565|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
20246566|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246567|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246568|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
20246569|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522189|NCT01738802|Micronutrients|micronutrients|mesh-list
20522190|NCT01738802|Trace Elements|trace elements|mesh-list
20522191|NCT01738802|Antioxidants|antioxidants|mesh-list
20522192|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522193|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522194|NCT01738802|Protective Agents|protective agents|mesh-ancestor
20522195|NCT01738815|Valproic Acid|valproic acid|mesh-list
20522196|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
20522197|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522198|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522199|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
20522200|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522201|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706942|NCT04833907|Hormones|hormones|mesh-ancestor
20246570|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19855202|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
19855203|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855204|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
19855205|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19855206|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19855207|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
19855208|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855209|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19855210|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19855211|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855212|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855213|NCT00745498|Bevacizumab|bevacizumab|mesh-list
19855214|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19855215|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855216|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19855217|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19855218|NCT00745498|Growth Substances|growth substances|mesh-ancestor
19855219|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855220|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
19855221|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
20246571|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706943|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706944|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706945|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19706946|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416318|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19706947|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
19706948|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
20522202|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
20522203|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20522204|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522205|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522206|NCT01738867|Naltrexone|naltrexone|mesh-list
20522207|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20522208|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20522209|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522210|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
20522211|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522212|NCT01738893|Gabapentin|gabapentin|mesh-list
19706949|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
19706950|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20522213|NCT01738893|Analgesics|analgesics|mesh-ancestor
20522214|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
20522215|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522216|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522217|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
20522218|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20522219|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20522220|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522221|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855222|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19416319|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
19855223|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19855224|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19855225|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
19855226|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855227|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19855228|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19855229|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855230|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855231|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19855232|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19855233|NCT00745849|Esomeprazole|esomeprazole|mesh-list
19855234|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19855235|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19855236|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19855237|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855238|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855239|NCT00745875|Pemetrexed|pemetrexed|mesh-list
20522222|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20522223|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19855240|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522224|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522225|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522226|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
20522227|NCT01738945|Amlodipine|amlodipine|mesh-list
20522228|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20522229|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20522230|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20522231|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522232|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20522233|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522234|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
20522235|NCT01739049|Liraglutide|liraglutide|mesh-list
20522236|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19855241|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855242|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855243|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19855244|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19855245|NCT00745901|Drospirenone|drospirenone|mesh-list
19855246|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19855247|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19855248|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19855249|NCT00745901|Norgestimate|norgestimate|mesh-list
19855250|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19855251|NCT00745901|Estradiol|estradiol|mesh-list
19855252|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19706951|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706952|NCT04833738|Triamcinolone|triamcinolone|mesh-list
19706953|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19706954|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19706955|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
19706956|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19416320|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
19855253|NCT00745901|Estrogens|estrogens|mesh-ancestor
19855254|NCT00745901|Hormones|hormones|mesh-ancestor
19855255|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855256|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246572|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246573|NCT00429065|Rituximab|rituximab|mesh-list
20246574|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20246575|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246576|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
20246577|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246578|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246579|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20246580|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20246581|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20246582|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20246583|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246584|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
19416321|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416322|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416323|NCT02510599|Solithromycin|solithromycin|mesh-list
19416324|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19416325|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416326|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
20246585|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246586|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246587|NCT00429208|Nicotine|nicotine|mesh-list
20246588|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20246589|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
20246590|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246591|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246592|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20246593|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19855257|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19416327|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19416328|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
19416329|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19416330|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416331|NCT02504580|Bupivacaine|bupivacaine|mesh-list
19416332|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
19855258|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
19855259|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19416333|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
19416334|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416335|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706957|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19706958|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
19706959|NCT04833738|Hormones|hormones|mesh-ancestor
19706960|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19706961|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706962|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19706963|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
19706964|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19706965|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706966|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19706967|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
19706968|NCT04833738|Protective Agents|protective agents|mesh-ancestor
19706969|NCT04833777|Lidocaine|lidocaine|mesh-list
19416336|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
19416337|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416338|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19416339|NCT02502669|Finasteride|finasteride|mesh-list
19416340|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19416341|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19416342|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416343|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416344|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
19416345|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416346|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416347|NCT02502669|Urological Agents|urological agents|mesh-ancestor
19416348|NCT02490488|Gemcitabine|gemcitabine|mesh-list
19706970|NCT04833777|Bupivacaine|bupivacaine|mesh-list
19706971|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
19706972|NCT04833777|Anesthetics|anesthetics|mesh-list
19416349|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19416350|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
19416351|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416352|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416353|NCT02490488|Antiviral Agents|antiviral agents|mesh-ancestor
19416354|NCT02490488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19706973|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416355|NCT02490488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855260|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19855261|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19855262|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19855263|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19855264|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
19855265|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19855266|NCT00745901|Diuretics|diuretics|mesh-ancestor
19855267|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
20246594|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
19416356|NCT02490488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19416357|NCT02490488|Immunologic Factors|immunologic factors|mesh-ancestor
20246595|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246596|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246597|NCT00429234|Gemcitabine|gemcitabine|mesh-list
20246598|NCT00429234|Dasatinib|dasatinib|mesh-list
20246599|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19855268|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19855269|NCT00746252|Risperidone|risperidone|mesh-list
19855270|NCT00746252|Aripiprazole|aripiprazole|mesh-list
19855271|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19855272|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
19855273|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706974|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855274|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855275|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855276|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19706975|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
19706976|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706977|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19706978|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19706979|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19706980|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19706981|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706982|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
19706983|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19706984|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19706985|NCT04833218|Propranolol|propranolol|mesh-list
19706986|NCT04833218|Clonidine|clonidine|mesh-list
19706987|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19706988|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19855277|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855278|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855279|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855280|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19855281|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
19855282|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
19855283|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
19855284|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19855285|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19855286|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20522237|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522238|NCT01739049|Incretins|incretins|mesh-ancestor
20522239|NCT01739049|Hormones|hormones|mesh-ancestor
20522240|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522241|NCT01739127|Risperidone|risperidone|mesh-list
20522242|NCT01739127|Aripiprazole|aripiprazole|mesh-list
20522243|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20522244|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20522245|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
20522246|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522247|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522248|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706989|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
19706990|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19706991|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19706992|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19706993|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19706994|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19706995|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
19706996|NCT04833218|Analgesics|analgesics|mesh-ancestor
19706997|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
20246600|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
20246601|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855287|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19855288|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
19855289|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
19855290|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19706998|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19706999|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
19707000|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
19707001|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19707002|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19707003|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19707004|NCT04833114|Carboplatin|carboplatin|mesh-list
19707005|NCT04833114|Etoposide|etoposide|mesh-list
19707006|NCT04833114|Rituximab|rituximab|mesh-list
19707007|NCT04833114|Ifosfamide|ifosfamide|mesh-list
19707008|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707009|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19707010|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19707011|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19707012|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707013|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707014|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707015|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
19707016|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707017|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707018|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19707019|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
19707020|NCT04833387|Antibodies|antibodies|mesh-list
19707021|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
20246602|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246603|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
20246604|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246605|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246606|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246607|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
20246608|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246609|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19707022|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707023|NCT04833374|Prednisone|prednisone|mesh-list
19855291|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
20246610|NCT00429247|Trastuzumab|trastuzumab|mesh-list
19707024|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
19707025|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19707026|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19707027|NCT04833374|Prednisolone|prednisolone|mesh-list
19707028|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
19707029|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19707030|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
19707031|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707032|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
19707033|NCT04833374|Hormones|hormones|mesh-ancestor
19707034|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707035|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707036|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20246611|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20246612|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246613|NCT00429377|Tacrolimus|tacrolimus|mesh-list
20246614|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246615|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
20246616|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246617|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19707037|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246618|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246619|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246620|NCT00429442|Simvastatin|simvastatin|mesh-list
20246621|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20246622|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20246623|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
20246624|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246625|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20246626|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20246627|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246628|NCT00429468|Acetaminophen|acetaminophen|mesh-list
20246629|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20246630|NCT00429468|Hydrocodone|hydrocodone|mesh-list
20246631|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246632|NCT00429468|Analgesics|analgesics|mesh-ancestor
20246633|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
20246634|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246635|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246636|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
20246637|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20246638|NCT00429468|Narcotics|narcotics|mesh-ancestor
20246639|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20246640|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
20246641|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
20246642|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20246643|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246644|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246645|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
20246646|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20246647|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
20246648|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246649|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
19416358|NCT02490488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246650|NCT00429520|Protective Agents|protective agents|mesh-ancestor
19416359|NCT02488408|Cytarabine|cytarabine|mesh-list
19707038|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
19707039|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
19707040|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707041|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707042|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19707043|NCT04833374|Protective Agents|protective agents|mesh-ancestor
19707044|NCT04833101|Vaccines|vaccines|mesh-list
19707045|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
19855292|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855293|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855294|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19855295|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
20246651|NCT00429533|Dapsone|dapsone|mesh-list
20246652|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246653|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
20246654|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20246655|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20246656|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20246657|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246658|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246659|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
20522249|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20522250|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20522251|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522252|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522253|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20522254|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
20522255|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
20522256|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
20522257|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20522258|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20522259|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20522260|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20522261|NCT01739192|Bupropion|bupropion|mesh-list
20522262|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20522263|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
20522264|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20246660|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20246661|NCT00429559|Gemcitabine|gemcitabine|mesh-list
20246662|NCT00429559|Topotecan|topotecan|mesh-list
20246663|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20246664|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
20246665|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246666|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246667|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
20246668|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246669|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246670|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246671|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
20246672|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246673|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20246674|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20246675|NCT00429624|Acetaminophen|acetaminophen|mesh-list
20246676|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246677|NCT00429624|Analgesics|analgesics|mesh-ancestor
20246678|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
20246679|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522265|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20522266|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20522267|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20522268|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522269|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
20522270|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522271|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522272|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20522273|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20522274|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522275|NCT01739218|Paclitaxel|paclitaxel|mesh-list
19707046|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707047|NCT04833036|Irinotecan|irinotecan|mesh-list
20522276|NCT01739218|Bevacizumab|bevacizumab|mesh-list
20522277|NCT01739218|Carboplatin|carboplatin|mesh-list
19855296|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20522278|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20522279|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522280|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
20522281|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
20522282|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
20522283|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522284|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707048|NCT04833036|Cetuximab|cetuximab|mesh-list
19707049|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19707050|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19707051|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522285|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20522286|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20522287|NCT01739218|Growth Substances|growth substances|mesh-ancestor
20522288|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522289|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
20522290|NCT01739413|Anesthetics|anesthetics|mesh-list
20522291|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522292|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522293|NCT01739439|Gemcitabine|gemcitabine|mesh-list
20522294|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20522295|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
20522296|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522297|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522298|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
19707052|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707053|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707054|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707055|NCT04833296|Ropivacaine|ropivacaine|mesh-list
19707056|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
19707057|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
19707058|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707059|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707060|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
19707061|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707062|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
19707063|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19707064|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
20246680|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246681|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
20246682|NCT00429676|Haloperidol|haloperidol|mesh-list
20246683|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
20246684|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
20246685|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
20246686|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246687|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246688|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20246689|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20246690|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20246691|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20246692|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20246693|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20246694|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
20246695|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246696|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246697|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20246698|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
20246699|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20246700|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
20246701|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246702|NCT00429754|Aprepitant|aprepitant|mesh-list
20246703|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
20246704|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
20246705|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707065|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20246706|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707066|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707067|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20246707|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20246708|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19855297|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19855298|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19855299|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
19855300|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855301|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855302|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855303|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
19855304|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19855305|NCT00746395|Lubiprostone|lubiprostone|mesh-list
19855306|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19855307|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855308|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707068|NCT04832880|Remdesivir|remdesivir|mesh-list
19707069|NCT04832880|Dexamethasone|dexamethasone|mesh-list
19707070|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707071|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
19707072|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
19707073|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707074|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707075|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20246709|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246710|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246711|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
20246712|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20246713|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
20246714|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246715|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20246716|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20246717|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
20246718|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246719|NCT00429832|Promethazine|promethazine|mesh-list
20246720|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
20246721|NCT00429832|Ondansetron|ondansetron|mesh-list
20246722|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
20246723|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
20246724|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246725|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246726|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20246727|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
20246728|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
20246729|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20246730|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
20246731|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246732|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246733|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20246734|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20246735|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20246736|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522299|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522300|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246737|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20522301|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20522302|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
20522303|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522304|NCT01739504|Anesthetics|anesthetics|mesh-list
20522305|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522306|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522307|NCT01739556|Aspirin|aspirin|mesh-list
20522308|NCT01739556|Ticagrelor|ticagrelor|mesh-list
20522309|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20522310|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20522311|NCT01739556|Analgesics|analgesics|mesh-ancestor
20522312|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
20522313|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522314|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246738|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20522315|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20246739|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
20246740|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
20246741|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20246742|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20246743|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20246744|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
20246745|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
20246746|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
20246747|NCT00429871|Docetaxel|docetaxel|mesh-list
20246748|NCT00429871|Capecitabine|capecitabine|mesh-list
20246749|NCT00429871|Epirubicin|epirubicin|mesh-list
20246750|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246751|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
20246752|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
20246753|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246754|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246755|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20246756|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
20246757|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246758|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20246759|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20246760|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522316|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522317|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20522318|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20522319|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522320|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20522321|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20522322|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522323|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
20522324|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20522325|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20522326|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20522327|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
20522328|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522329|NCT01739582|Enclomiphene|enclomiphene|mesh-list
20522330|NCT01739582|Clomiphene|clomiphene|mesh-list
20522331|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
20522332|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20246761|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
20246762|NCT00429897|Amiloride|amiloride|mesh-list
20522333|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
19707076|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
19707077|NCT04832880|Hormones|hormones|mesh-ancestor
19707078|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707079|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19707080|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707081|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
19707082|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707083|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
19707084|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707085|NCT04832945|Ivermectin|ivermectin|mesh-list
19707086|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19707087|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707088|NCT04832776|Bevacizumab|bevacizumab|mesh-list
19707089|NCT04832776|Cetuximab|cetuximab|mesh-list
19416360|NCT02488408|Decitabine|decitabine|mesh-list
19416361|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19416362|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
19416363|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416364|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416365|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
19416366|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416367|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19416368|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
19416369|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707090|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416370|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707091|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707092|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19707093|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19707094|NCT04832776|Growth Substances|growth substances|mesh-ancestor
19707095|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707096|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
19707097|NCT04832399|Natalizumab|natalizumab|mesh-list
19707098|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
19707099|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708493|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19708494|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708495|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
19708496|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
19708497|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246763|NCT00429897|Spironolactone|spironolactone|mesh-list
20246764|NCT00429897|Furosemide|furosemide|mesh-list
20246765|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20246766|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
20246767|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246768|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246769|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20246770|NCT00429897|Diuretics|diuretics|mesh-ancestor
20246771|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
20246772|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20246773|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20246774|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20246775|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855309|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19855310|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
19855311|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855312|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19855313|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855314|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855315|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246776|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20246777|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20246778|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20246779|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20246780|NCT00429936|Fenretinide|fenretinide|mesh-list
20246781|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246782|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20246783|NCT00429936|Protective Agents|protective agents|mesh-ancestor
19707100|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
19707101|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19707102|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19707103|NCT04832269|Prednisolone|prednisolone|mesh-list
19707104|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
19707105|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19707106|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
19707107|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707108|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
19707109|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
19707110|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707111|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707112|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707113|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
19707114|NCT04832269|Hormones|hormones|mesh-ancestor
19707115|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707116|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19707117|NCT04832269|Protective Agents|protective agents|mesh-ancestor
19707118|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19707119|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707120|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
19707121|NCT04832100|Pregabalin|pregabalin|mesh-list
19707122|NCT04832100|Imipramine|imipramine|mesh-list
19707123|NCT04832100|Analgesics|analgesics|mesh-ancestor
19707124|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
19707125|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707126|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707127|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
19707128|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19707129|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19707130|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707131|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20246784|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246785|NCT00429962|Ranibizumab|ranibizumab|mesh-list
20246786|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19707132|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20246787|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20246788|NCT00429962|Growth Substances|growth substances|mesh-ancestor
20246789|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707133|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19707134|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707135|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19707136|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19707137|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
19707138|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19707139|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19707140|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
19707141|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707142|NCT04832204|Apatinib|apatinib|mesh-list
19707143|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707144|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19707145|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707146|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707147|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19707148|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19707149|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707150|NCT04831593|Anesthetics|anesthetics|mesh-list
19707151|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707152|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707153|NCT04831736|Ketamine|ketamine|mesh-list
19707154|NCT04831736|Analgesics|analgesics|mesh-ancestor
19707155|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
19707156|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707157|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707158|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19707159|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20522334|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522335|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522336|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20522337|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
20522338|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522339|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20522340|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20522341|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
20522342|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
20522343|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20522344|NCT01739673|Riboflavin|riboflavin|mesh-list
20522345|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
20522346|NCT01739673|Vitamins|vitamins|mesh-ancestor
20522347|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
20522348|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522349|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20522350|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522351|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
20522352|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
20522353|NCT01739855|Calcium|calcium|mesh-list
20522354|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20522355|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522356|NCT01739855|Antacids|antacids|mesh-ancestor
20522357|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522358|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20522359|NCT01739855|Vitamins|vitamins|mesh-ancestor
20522360|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
20522361|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20530229|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20530230|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20530231|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19707160|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
19707161|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
19855316|NCT00746512|Prednisone|prednisone|mesh-list
20530232|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20530233|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
19707162|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707163|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20522362|NCT01739894|Paclitaxel|paclitaxel|mesh-list
20522363|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20522364|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522365|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
20522366|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
19855317|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522367|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
20522368|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522369|NCT01739907|Vitamin D|vitamin d|mesh-list
20522370|NCT01739907|Vitamins|vitamins|mesh-ancestor
20522371|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
20522372|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522373|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20522374|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
20522375|NCT01739920|Povidone|povidone|mesh-list
20522376|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
20522377|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
20522378|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19707164|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19707165|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855318|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
19855319|NCT00746512|Hormones|hormones|mesh-ancestor
19855320|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855321|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855322|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19855323|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855324|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19707166|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707167|NCT04831528|Bevacizumab|bevacizumab|mesh-list
19707168|NCT04831528|Trastuzumab|trastuzumab|mesh-list
19707169|NCT04831528|Cetuximab|cetuximab|mesh-list
19707170|NCT04831528|Pertuzumab|pertuzumab|mesh-list
19707171|NCT04831528|Lapatinib|lapatinib|mesh-list
19707172|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707173|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855325|NCT00746551|Hematinics|hematinics|mesh-ancestor
19855326|NCT00746733|Amphetamine|amphetamine|mesh-list
19855327|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19855328|NCT00746733|Adderall|adderall|mesh-list
19855329|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19855330|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855331|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
19855332|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
19855333|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855334|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
19855335|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855336|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855337|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
19855338|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19855339|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19855340|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855341|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19855342|NCT00746785|Olanzapine|olanzapine|mesh-list
19855343|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
19855344|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
19855345|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855346|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855347|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19855348|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19855349|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855350|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855351|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855352|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19855353|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19855354|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855355|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522379|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522380|NCT01739985|Dexamethasone|dexamethasone|mesh-list
19855356|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522381|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
20522382|NCT01739985|Droperidol|droperidol|mesh-list
20522383|NCT01739985|Ondansetron|ondansetron|mesh-list
20522384|NCT01739985|BB 1101|bb 1101|mesh-list
20522385|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522386|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
20522387|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
20522388|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522389|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522390|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20522391|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
20522392|NCT01739985|Hormones|hormones|mesh-ancestor
20522393|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855357|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
19855358|NCT00746798|Vaccines|vaccines|mesh-list
19855359|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
19855360|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855361|NCT00746863|Bupivacaine|bupivacaine|mesh-list
19855362|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
19855363|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
19855364|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855365|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855366|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
19855367|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855368|NCT00746889|Triamcinolone|triamcinolone|mesh-list
19855369|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19855370|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19855371|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19855372|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855373|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
19855374|NCT00746889|Hormones|hormones|mesh-ancestor
19855653|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20246790|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
20246791|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246792|NCT00429975|Levofloxacin|levofloxacin|mesh-list
20246793|NCT00429975|Ofloxacin|ofloxacin|mesh-list
20246794|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
20246795|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20246796|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246797|NCT00429975|Renal Agents|renal agents|mesh-ancestor
20246798|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20246799|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20246800|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20246801|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246802|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246803|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246804|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19855375|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246805|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20246806|NCT00430001|Docetaxel|docetaxel|mesh-list
20246807|NCT00430001|Trastuzumab|trastuzumab|mesh-list
20246808|NCT00430001|Vinorelbine|vinorelbine|mesh-list
20246809|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246810|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
19855376|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855377|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855378|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
20522394|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20522395|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707174|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19707175|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19707176|NCT04831528|Growth Substances|growth substances|mesh-ancestor
19707177|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707178|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
19707179|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19707180|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707181|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707182|NCT04831320|Paclitaxel|paclitaxel|mesh-list
19707183|NCT04831320|Nivolumab|nivolumab|mesh-list
19707184|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20522396|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
20522397|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522398|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522399|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
20522400|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522401|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20522402|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
20522403|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522404|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20522405|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19707185|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707186|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
19707187|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
19707188|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707189|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707190|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707191|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19707192|NCT04831255|Triamcinolone|triamcinolone|mesh-list
19707193|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19707194|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19707195|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19707196|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707197|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
19707198|NCT04831255|Hormones|hormones|mesh-ancestor
19707199|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522406|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522407|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522408|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20522409|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20522410|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20522411|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20522412|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
20522413|NCT01740245|Biguanides|biguanides|mesh-list
20522414|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
20522415|NCT01740245|Polihexanide|polihexanide|mesh-list
20522416|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20522417|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855379|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522418|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
20522419|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20522420|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522421|NCT01740271|Epirubicin|epirubicin|mesh-list
20522422|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20522423|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522424|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20522425|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20522426|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522427|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522428|NCT01740336|Paclitaxel|paclitaxel|mesh-list
20522429|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20522430|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522431|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
20522432|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
20522433|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
20522434|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522435|NCT01740453|Ropivacaine|ropivacaine|mesh-list
20522436|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
20522437|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
20522438|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707200|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707201|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19707202|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
19707203|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707204|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707205|NCT04831294|Cannabidiol|cannabidiol|mesh-list
19707206|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
19707207|NCT04830982|Diazoxide|diazoxide|mesh-list
19707208|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19707209|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
19707210|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
19707211|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19707212|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19707213|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707214|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
19707215|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
19707216|NCT04830878|Methotrexate|methotrexate|mesh-list
20522439|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522440|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
20522441|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522442|NCT01740492|Ketamine|ketamine|mesh-list
20522443|NCT01740492|Analgesics|analgesics|mesh-ancestor
20522444|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
20522445|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522446|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522447|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20522448|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20522449|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
20522450|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
20522451|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522452|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20522453|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20522454|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522455|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522456|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
20522457|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
20522458|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855380|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855381|NCT00746941|Mefloquine|mefloquine|mesh-list
19855382|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
19855383|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19855384|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19855385|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416371|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19416372|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19855386|NCT00746954|Acetazolamide|acetazolamide|mesh-list
19855387|NCT00746954|Buspirone|buspirone|mesh-list
19855388|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
20246811|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
20246812|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246813|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246814|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416373|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19416374|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19707217|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19707218|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
19707219|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20246815|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20246816|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
20246817|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707220|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707221|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19707222|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
19707223|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416375|NCT02471222|Amantadine|amantadine|mesh-list
19416376|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19416377|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19416378|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
20246818|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20246819|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246820|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246821|NCT00430079|Etanidazole|etanidazole|mesh-list
20246822|NCT00430079|Imidazole|imidazole|mesh-list
20246823|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246824|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246825|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246826|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
20246827|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246828|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
20246829|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246830|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246831|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20246832|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
20246833|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246834|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246835|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20246836|NCT00430118|Cytarabine|cytarabine|mesh-list
20246837|NCT00430118|Dexamethasone|dexamethasone|mesh-list
20246838|NCT00430118|Prednisone|prednisone|mesh-list
20246839|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
20246840|NCT00430118|Ifosfamide|ifosfamide|mesh-list
20246841|NCT00430118|Doxorubicin|doxorubicin|mesh-list
20246842|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20246843|NCT00430118|Methotrexate|methotrexate|mesh-list
19707224|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707225|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
19707226|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707227|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19707228|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246844|NCT00430118|Etoposide|etoposide|mesh-list
19707229|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
20246845|NCT00430118|Vincristine|vincristine|mesh-list
20246846|NCT00430118|Daunorubicin|daunorubicin|mesh-list
20246847|NCT00430118|Asparaginase|asparaginase|mesh-list
20246848|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
20246849|NCT00430118|Thioguanine|thioguanine|mesh-list
20246850|NCT00430118|Vindesine|vindesine|mesh-list
20246851|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20246852|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
20246853|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246854|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20246855|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20246856|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
20246857|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246858|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246859|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20246860|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522459|NCT01740518|Protective Agents|protective agents|mesh-ancestor
20522460|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522461|NCT01740518|Vitamins|vitamins|mesh-ancestor
20522462|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
20522463|NCT01740921|Aspirin|aspirin|mesh-list
20522464|NCT01740921|Liraglutide|liraglutide|mesh-list
20522465|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20522466|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246861|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
20522467|NCT01740921|Analgesics|analgesics|mesh-ancestor
19707230|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19416379|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246862|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
20246863|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246864|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707231|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19707232|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
19707233|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19707234|NCT04830943|Protective Agents|protective agents|mesh-ancestor
19707235|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707236|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
19707237|NCT04830579|Etoricoxib|etoricoxib|mesh-list
19707238|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19707239|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20246865|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
20246866|NCT00430118|Hormones|hormones|mesh-ancestor
20246867|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416380|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
19416381|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416382|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416383|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416384|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416385|NCT02471222|Analgesics|analgesics|mesh-ancestor
19416386|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
19416387|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416388|NCT02470039|Insulin|insulin|mesh-list
19416389|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19416390|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
19416391|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19416392|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416393|NCT02469155|Risperidone|risperidone|mesh-list
19416394|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19416395|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
19416396|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416397|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707240|NCT04830579|Analgesics|analgesics|mesh-ancestor
19707241|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
19707242|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707243|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246868|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20246869|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246870|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20246871|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20246872|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246873|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20246874|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
20246875|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20246876|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20522468|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
20522469|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522470|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522471|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522472|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522473|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20522474|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20522475|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522476|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20522477|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20522478|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522479|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
20246877|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
20246878|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
20246879|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20246880|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20246881|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20246882|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
20246883|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246884|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
20246885|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
20246886|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
20246887|NCT00430144|Belotecan|belotecan|mesh-list
19855389|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19855390|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855391|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855392|NCT00746954|Diuretics|diuretics|mesh-ancestor
19855393|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
19855394|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855395|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19855396|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855397|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20246888|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20522480|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20522481|NCT01740921|Incretins|incretins|mesh-ancestor
20522482|NCT01740921|Hormones|hormones|mesh-ancestor
20522483|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522484|NCT01740947|Amphotericin B|amphotericin b|mesh-list
20522485|NCT01740947|Tobramycin|tobramycin|mesh-list
20522486|NCT01740947|Colistin|colistin|mesh-list
20522487|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20522488|NCT01740947|Amebicides|amebicides|mesh-ancestor
20522489|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20522490|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20522491|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522492|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20522493|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
20522494|NCT01740960|Dronabinol|dronabinol|mesh-list
20522495|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
20522496|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522497|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522498|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20522499|NCT01740960|Analgesics|analgesics|mesh-ancestor
20522500|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
20522501|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522502|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20522503|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20522504|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522505|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522506|NCT01740960|Hormones|hormones|mesh-ancestor
20522507|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522508|NCT01741038|Cetuximab|cetuximab|mesh-list
20522509|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20522510|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522511|NCT01741077|Folic Acid|folic acid|mesh-list
20522512|NCT01741077|Hematinics|hematinics|mesh-ancestor
20522513|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
20522514|NCT01741077|Vitamins|vitamins|mesh-ancestor
20522515|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
20522516|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522517|NCT01741142|Citalopram|citalopram|mesh-list
20522518|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20522519|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20522520|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20522521|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522522|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522523|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
20522524|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522525|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20522526|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
20522527|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522528|NCT01741181|Vitamin D|vitamin d|mesh-list
20246889|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20246890|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246891|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246892|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246893|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
20246894|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20246895|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20246896|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522529|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
20522530|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
20522531|NCT01741181|Vitamins|vitamins|mesh-list
20522532|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
20522533|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522534|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20522535|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20522536|NCT01741285|Fluticasone|fluticasone|mesh-list
20522537|NCT01741285|Beclomethasone|beclomethasone|mesh-list
20522538|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522539|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19707244|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522540|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
20522541|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522542|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522543|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20522544|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
20522545|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522546|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20522547|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
20522548|NCT01741285|Hormones|hormones|mesh-ancestor
20522549|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522550|NCT01741324|Vitamin D|vitamin d|mesh-list
20522551|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
20522552|NCT01741324|Vitamins|vitamins|mesh-list
20246897|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246898|NCT00430170|Dipyridamole|dipyridamole|mesh-list
20246899|NCT00430170|Caffeine|caffeine|mesh-list
20246900|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20246901|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246902|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19855398|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855399|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19855400|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
19855401|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855402|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
19855403|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19855404|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855405|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19855406|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19855407|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19855408|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
19855409|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855410|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19855411|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19855412|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522553|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
20522554|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522555|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20522556|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20522557|NCT01741376|Progesterone|progesterone|mesh-list
20522558|NCT01741376|Progestins|progestins|mesh-ancestor
20522559|NCT01741376|Hormones|hormones|mesh-ancestor
20522560|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522561|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522562|NCT01741389|Melatonin|melatonin|mesh-list
20522563|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
20522564|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522565|NCT01741389|Protective Agents|protective agents|mesh-ancestor
19855413|NCT00747214|Prednisolone|prednisolone|mesh-list
20522566|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707245|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522567|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522568|NCT01741493|Upadacitinib|upadacitinib|mesh-list
20522569|NCT01741493|Tofacitinib|tofacitinib|mesh-list
20522570|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20522571|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522572|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522573|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20522574|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522575|NCT01741506|Dalteparin|dalteparin|mesh-list
20522576|NCT01741506|Tinzaparin|tinzaparin|mesh-list
19707246|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19707247|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20522577|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20522578|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
20522579|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20522580|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19855414|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
20246903|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246904|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246905|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20246906|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20246907|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
20246908|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246909|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20522581|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522582|NCT01741519|Landiolol|landiolol|mesh-list
20522583|NCT01741519|Esmolol|esmolol|mesh-list
20522584|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20522585|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20522586|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20522587|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
20522588|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522589|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522590|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522591|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20522592|NCT01741558|Riboflavin|riboflavin|mesh-list
20522593|NCT01741558|Methotrexate|methotrexate|mesh-list
20522594|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20522595|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
20522596|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522597|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522598|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20522599|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
19855415|NCT00747214|Dipyridamole|dipyridamole|mesh-list
19707248|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707249|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707250|NCT04830462|Rifampin|rifampin|mesh-list
20246910|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
20246911|NCT00430196|Tizanidine|tizanidine|mesh-list
20522600|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522601|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522602|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522603|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522604|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20522605|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20522606|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
20522607|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522608|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20522609|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
20522610|NCT01741558|Vitamins|vitamins|mesh-ancestor
19707251|NCT04830462|Isoniazid|isoniazid|mesh-list
20522611|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
20522612|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20530234|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20530235|NCT01787123|Protective Agents|protective agents|mesh-ancestor
19707252|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19707253|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
20530236|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530237|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
20530238|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
20530239|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
20530240|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
20530241|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20530242|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20530243|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530244|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530245|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530246|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
20530247|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20530248|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20530249|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20530250|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530251|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707254|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20522613|NCT01741623|Bisoprolol|bisoprolol|mesh-list
20522614|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20522615|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
19707255|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522616|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
20522617|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522618|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522619|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20522620|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20522621|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19855416|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855417|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
19855418|NCT00747214|Hormones|hormones|mesh-ancestor
19855419|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246912|NCT00430196|Analgesics|analgesics|mesh-ancestor
20246913|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
20246914|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246915|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246916|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
20246917|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20246918|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20246919|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
20246920|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
20246921|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20246922|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20246923|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20246924|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
20246925|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246926|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522622|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
20522623|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522624|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522625|NCT01741649|Povidone|povidone|mesh-list
20522626|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
20522627|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
20522628|NCT01741753|Prednisone|prednisone|mesh-list
20522629|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522630|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
20522631|NCT01741753|Hormones|hormones|mesh-ancestor
20522632|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522633|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522634|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20522635|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522636|NCT01741831|Darunavir|darunavir|mesh-list
20522637|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20522638|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20522639|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
20522640|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522641|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522642|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20522643|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20522644|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
20522645|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522646|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
20522647|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522648|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522649|NCT01742247|Palmidrol|palmidrol|mesh-list
20522650|NCT01742247|Analgesics|analgesics|mesh-ancestor
20522651|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
20522652|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522653|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522654|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20522655|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416398|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416399|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19416400|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19416401|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416402|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19416403|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19416404|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
19416405|NCT02466867|Naftifine|naftifine|mesh-list
19416406|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
19416407|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416408|NCT02465606|Triamcinolone|triamcinolone|mesh-list
20522656|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522657|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522658|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
20522659|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522660|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20522661|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20522662|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522663|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522664|NCT01742247|Hormones|hormones|mesh-ancestor
20522665|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522666|NCT01742273|Vitamin K|vitamin k|mesh-list
20522667|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
20522668|NCT01742273|Vitamins|vitamins|mesh-ancestor
20522669|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
20522670|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522671|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20522672|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20522673|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522674|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
19707256|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
19707257|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19707258|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707259|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707260|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19707261|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19707262|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19707263|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19707264|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19707265|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19707266|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19707267|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19707268|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
19707269|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19707270|NCT04831099|Testosterone|testosterone|mesh-list
19707271|NCT04831099|Androgens|androgens|mesh-ancestor
19707272|NCT04831099|Hormones|hormones|mesh-ancestor
19707273|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522675|NCT01742273|Coagulants|coagulants|mesh-ancestor
20522676|NCT01742338|Prednisone|prednisone|mesh-list
20522677|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
20522678|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20522679|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20522680|NCT01742338|Prednisolone|prednisolone|mesh-list
20522681|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
20522682|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20522683|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
20522684|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522685|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
20522686|NCT01742338|Hormones|hormones|mesh-ancestor
20522687|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522688|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522689|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20522690|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522691|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
20522692|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
20522693|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522694|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20522695|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20522696|NCT01742338|Protective Agents|protective agents|mesh-ancestor
20522697|NCT01742390|Risperidone|risperidone|mesh-list
20522698|NCT01742390|Aripiprazole|aripiprazole|mesh-list
20522699|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20522700|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20522701|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
20246927|NCT00430235|Sorafenib|sorafenib|mesh-list
20246928|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246929|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20246930|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246931|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246932|NCT00430261|Sunitinib|sunitinib|mesh-list
20246933|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707274|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855420|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416409|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19416410|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20246934|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20246935|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20246936|NCT00430261|Growth Substances|growth substances|mesh-ancestor
20246937|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246938|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
19416411|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
19416412|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19416413|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416414|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
19416415|NCT02465606|Hormones|hormones|mesh-ancestor
19416416|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19416417|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416418|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19416419|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
19416420|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416421|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416422|NCT02462811|Acetaminophen|acetaminophen|mesh-list
19855654|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707275|NCT04831229|Menthol|menthol|mesh-list
19707276|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
20246939|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20246940|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20246941|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248074|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248075|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20248076|NCT00434681|Acetaminophen|acetaminophen|mesh-list
20248077|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20248078|NCT00434681|Analgesics|analgesics|mesh-ancestor
20248079|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
20248080|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248081|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248082|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
20248083|NCT00434746|Fezakinumab|fezakinumab|mesh-list
20248084|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
20248085|NCT00434772|Glucagon|glucagon|mesh-list
20248086|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20248087|NCT00434772|Hormones|hormones|mesh-ancestor
20248088|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248089|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248090|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
20248091|NCT00434824|Testosterone|testosterone|mesh-list
20248092|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
20248093|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
20248094|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20248095|NCT00434824|Androgens|androgens|mesh-ancestor
20248096|NCT00434824|Hormones|hormones|mesh-ancestor
20248097|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248098|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416423|NCT02462811|Promethazine|promethazine|mesh-list
19707277|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
19707278|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19707279|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
20246942|NCT00430365|Lenalidomide|lenalidomide|mesh-list
20246943|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
20246944|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246945|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20246946|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20246947|NCT00430365|Growth Substances|growth substances|mesh-ancestor
20246948|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
20246949|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246950|NCT00430443|Annamycin|annamycin|mesh-list
20530252|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
20530253|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530254|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530255|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20530256|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530257|NCT01787357|Canagliflozin|canagliflozin|mesh-list
20530258|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
20530259|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20530260|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530261|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20530262|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20530263|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530264|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530265|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530266|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530267|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20530268|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20530269|NCT01787396|Metformin|metformin|mesh-list
20530270|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20530271|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522702|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522703|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522704|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522705|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20522706|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20522707|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522708|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522709|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20522710|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
20522711|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
20522712|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
20522713|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20522714|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20522715|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20522716|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20522717|NCT01742429|Amoxicillin|amoxicillin|mesh-list
20246951|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20246952|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246953|NCT00430469|Lactoferrin|lactoferrin|mesh-list
20246954|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246955|NCT00430547|Carbimazole|carbimazole|mesh-list
20246956|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
20246957|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
20246958|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246959|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246960|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20246961|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20246962|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
20246963|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20246964|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20246965|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20246966|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246967|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20246968|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20246969|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246970|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
20246971|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522718|NCT01742429|Metronidazole|metronidazole|mesh-list
20522719|NCT01742429|Levofloxacin|levofloxacin|mesh-list
20522720|NCT01742429|Ofloxacin|ofloxacin|mesh-list
20522721|NCT01742429|Tetracycline|tetracycline|mesh-list
20522722|NCT01742429|Bismuth|bismuth|mesh-list
20522723|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20522724|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20522725|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20522726|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522727|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20522728|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20522729|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20522730|NCT01742429|Renal Agents|renal agents|mesh-ancestor
20522731|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20522732|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20522733|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522734|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522735|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522736|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20522737|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20522738|NCT01742429|Antacids|antacids|mesh-ancestor
20522739|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20522740|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20246972|NCT00430651|Carboplatin|carboplatin|mesh-list
20246973|NCT00430651|Docetaxel|docetaxel|mesh-list
20246974|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20246975|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
20246976|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
20522741|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
20522742|NCT01742533|Hormones|hormones|mesh-list
20522743|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522744|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522745|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
20522746|NCT01742624|Tacrolimus|tacrolimus|mesh-list
20522747|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20522748|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
20522749|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522750|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20522751|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522752|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522753|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20522754|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522755|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20522756|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
20522757|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20522758|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522759|NCT01742637|Adapalene|adapalene|mesh-list
20522760|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20246977|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707280|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707281|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
19707282|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19707283|NCT04830410|Levan|levan|mesh-list
19707284|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707285|NCT04829799|Ketorolac|ketorolac|mesh-list
19707286|NCT04829799|Lidocaine|lidocaine|mesh-list
19707287|NCT04829799|Phenylephrine|phenylephrine|mesh-list
19707288|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
19707289|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
19707290|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
19707291|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707292|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707293|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
19707294|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707295|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19707296|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19707297|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19707298|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19707299|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707300|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19707301|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19707302|NCT04829799|Analgesics|analgesics|mesh-ancestor
19707303|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707304|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707305|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19707306|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707307|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19707308|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
19707309|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
19707310|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
19707311|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19707312|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
19707313|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
19416424|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
19416425|NCT02462811|Hydrocodone|hydrocodone|mesh-list
19707314|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20522761|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522762|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20522763|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20522764|NCT01742637|Analgesics|analgesics|mesh-ancestor
20522765|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
20522766|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522767|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522768|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522769|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522770|NCT01742663|Diclofenac|diclofenac|mesh-list
19707315|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20246978|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246979|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
20246980|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19707316|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19707317|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
19707318|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707319|NCT04829799|Protective Agents|protective agents|mesh-ancestor
19708498|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708528|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708529|NCT04814056|Afatinib|afatinib|mesh-list
19708530|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708531|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19708532|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522771|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20522772|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20522773|NCT01742663|Analgesics|analgesics|mesh-ancestor
20522774|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
20522775|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522776|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522777|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708533|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708534|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
19708535|NCT04814381|Ketamine|ketamine|mesh-list
19708536|NCT04814381|Analgesics|analgesics|mesh-ancestor
20522778|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20522779|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20522780|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522781|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522782|NCT01742676|Tacrolimus|tacrolimus|mesh-list
20522783|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20522784|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
20522785|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522786|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20522787|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522788|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522789|NCT01742689|Indomethacin|indomethacin|mesh-list
20522790|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19708537|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
19707320|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19707321|NCT04829773|Midazolam|midazolam|mesh-list
19707322|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19707323|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19707324|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707325|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707326|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19707327|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19707328|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19707329|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19707330|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
19707331|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
19707332|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
19707333|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
19707334|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707335|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707336|NCT04829760|Psyllium|psyllium|mesh-list
19707337|NCT04829760|Cathartics|cathartics|mesh-ancestor
19707338|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707339|NCT04829695|Artesunate|artesunate|mesh-list
19707340|NCT04829695|Lumefantrine|lumefantrine|mesh-list
19707341|NCT04829695|Artemether|artemether|mesh-list
19707342|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19707343|NCT04829695|Amodiaquine|amodiaquine|mesh-list
19707344|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
19707345|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19707346|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19707347|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707348|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707349|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
19707350|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
20246981|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20246982|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
20246983|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20246984|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20246985|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20246986|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20246987|NCT00430742|Hormones|hormones|mesh-ancestor
20246988|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246989|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20246990|NCT00430794|Spironolactone|spironolactone|mesh-list
20246991|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20246992|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
20246993|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20246994|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855421|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19855422|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855423|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19855424|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855425|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855426|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19855427|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
20246995|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19707351|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19707352|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
19707353|NCT04829435|Rasburicase|rasburicase|mesh-list
19707354|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
19707355|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707356|NCT04829487|Vitamin D|vitamin d|mesh-list
19707357|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
19707358|NCT04829487|Vitamins|vitamins|mesh-ancestor
19707359|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
19707360|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707361|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19707362|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19707363|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
19707364|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19855428|NCT00747344|Ustekinumab|ustekinumab|mesh-list
20246996|NCT00430794|Diuretics|diuretics|mesh-ancestor
20246997|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
20246998|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
20246999|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
20247000|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20247001|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20247002|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247003|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522791|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20522792|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20522793|NCT01742689|Analgesics|analgesics|mesh-ancestor
20522794|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
20522795|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522796|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522797|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522798|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855429|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
19855430|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19855431|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19855432|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522799|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
20522800|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
20522801|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522802|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20522803|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522804|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522805|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
20522806|NCT01742689|Coagulants|coagulants|mesh-ancestor
20522807|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20522808|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
20522809|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
20522810|NCT01742702|Bisoprolol|bisoprolol|mesh-list
20522811|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
20522812|NCT01742702|Albuterol|albuterol|mesh-list
20522813|NCT01742702|Caseins|caseins|mesh-list
20522814|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20522815|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
19707365|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19707366|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707367|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
19707368|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707369|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707370|NCT04829097|Temozolomide|temozolomide|mesh-list
19707371|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19855433|NCT00747643|Varenicline|varenicline|mesh-list
19855434|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20522816|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248099|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19707372|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
19707373|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707374|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707375|NCT04829019|Osimertinib|osimertinib|mesh-list
19707376|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707377|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19707378|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707379|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522817|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522818|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20522819|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
20522820|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
20522821|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19707380|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
20522822|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20522823|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20522824|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19855435|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20522825|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
20522826|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522827|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522828|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
20522829|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
20522830|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
20522831|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20522832|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
20522833|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20522834|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20522835|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20522836|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522837|NCT01742767|Pemetrexed|pemetrexed|mesh-list
20522838|NCT01742767|Cisplatin|cisplatin|mesh-list
20522839|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522840|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522841|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522842|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20522843|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20522844|NCT01742793|Lenalidomide|lenalidomide|mesh-list
20522845|NCT01742793|Romidepsin|romidepsin|mesh-list
20522846|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
20522847|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522848|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20522849|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20522850|NCT01742793|Growth Substances|growth substances|mesh-ancestor
20522851|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
20522852|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248100|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707381|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19707382|NCT04828824|Norgestimate|norgestimate|mesh-list
19707383|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20522853|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20522854|NCT01742845|Ropivacaine|ropivacaine|mesh-list
20522855|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
20522856|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
20522857|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522858|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522859|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
20522860|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522861|NCT01742988|Rituximab|rituximab|mesh-list
20522862|NCT01742988|Venetoclax|venetoclax|mesh-list
20522863|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20522864|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522865|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
20522866|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522867|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19707384|NCT04828824|Estradiol|estradiol|mesh-list
20522868|NCT01743014|Ramipril|ramipril|mesh-list
19707385|NCT04828824|Estrogens|estrogens|mesh-ancestor
19707386|NCT04828824|Hormones|hormones|mesh-ancestor
19707387|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707388|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707389|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19707390|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
19855436|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
20247004|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247005|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247006|NCT00430833|Candesartan|candesartan|mesh-list
20247007|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20247008|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20247009|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20247010|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855437|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855438|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855439|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855440|NCT00748072|Vasopressins|vasopressins|mesh-list
19855441|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
19855442|NCT00748072|Coagulants|coagulants|mesh-ancestor
19855443|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19855444|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19855445|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
20522869|NCT01743014|Clopidogrel|clopidogrel|mesh-list
20522870|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20522871|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20522872|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20522873|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20522874|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
20522875|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522876|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522877|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522878|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20522879|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
20522880|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522881|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20522882|NCT01743066|Vitamin E|vitamin e|mesh-list
20522883|NCT01743066|Vitamins|vitamins|mesh-ancestor
19855446|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247011|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20247012|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20247013|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247014|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
20247015|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20247016|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
20247017|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19707391|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20247018|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
20247019|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522884|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
20522885|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522886|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
20522887|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522888|NCT01743066|Protective Agents|protective agents|mesh-ancestor
20522889|NCT01743079|Lamivudine|lamivudine|mesh-list
20522890|NCT01743079|Telbivudine|telbivudine|mesh-list
20522891|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20522892|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20522893|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522894|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522895|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
20522896|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20522897|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20522898|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20247020|NCT00430898|Basiliximab|basiliximab|mesh-list
20247021|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247022|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
20247023|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247024|NCT00430924|Eplerenone|eplerenone|mesh-list
20247025|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20247026|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
20247027|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247028|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247029|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19707392|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19707393|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19707394|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19707395|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19707396|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19707397|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707398|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19707399|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19707400|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707401|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707402|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707403|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19707404|NCT04828525|Dexamethasone|dexamethasone|mesh-list
19707405|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707406|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
19707407|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
19707408|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707409|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707410|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707411|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
19707412|NCT04828525|Hormones|hormones|mesh-ancestor
19707413|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707414|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19707415|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707416|NCT04828642|Vitamins|vitamins|mesh-list
19707417|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
19707418|NCT04828642|Vitamin E|vitamin e|mesh-list
19707419|NCT04828642|Tocopherols|tocopherols|mesh-list
19707420|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
19707421|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707422|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
19707423|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707424|NCT04828642|Protective Agents|protective agents|mesh-ancestor
19707425|NCT04828564|Ribavirin|ribavirin|mesh-list
19707426|NCT04828564|Favipiravir|favipiravir|mesh-list
19707427|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
19707428|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707429|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
19416426|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416427|NCT02462811|Analgesics|analgesics|mesh-ancestor
19416428|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
19416429|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19416430|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416431|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
19416432|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19416433|NCT02462811|Narcotics|narcotics|mesh-ancestor
19416434|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416435|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
19416436|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
19416437|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
19416438|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19416439|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19707430|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416440|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
19707431|NCT04828135|Xenon|xenon|mesh-list
19707432|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19416441|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
19416442|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416443|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416444|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20522899|NCT01743118|Calcipotriene|calcipotriene|mesh-list
20522900|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
20522901|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
20522902|NCT01743144|Analgesics|analgesics|mesh-ancestor
20522903|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
20522904|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522905|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416445|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20522906|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
20522907|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522908|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20522909|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
20522910|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19707433|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
19707434|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
19707435|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707436|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707437|NCT04828031|Vitamin D|vitamin d|mesh-list
19707438|NCT04828031|Vitamins|vitamins|mesh-ancestor
19707439|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
19707440|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707441|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19707442|NCT04828057|Timolol|timolol|mesh-list
19707443|NCT04828057|Bimatoprost|bimatoprost|mesh-list
19707444|NCT04828057|Travoprost|travoprost|mesh-list
19707445|NCT04828057|Latanoprost|latanoprost|mesh-list
19707446|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19707447|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19707448|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
19707449|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707450|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707451|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707452|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19707453|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19707454|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20247030|NCT00430924|Diuretics|diuretics|mesh-ancestor
20247031|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
20247032|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20247033|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20247034|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20247035|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20247036|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707455|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19707456|NCT04828226|Clonidine|clonidine|mesh-list
20248101|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
20247037|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20247038|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20247039|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247040|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
20247041|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20247042|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
20247043|NCT00431028|Triamcinolone|triamcinolone|mesh-list
20247044|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20247045|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
20247046|NCT00431028|Hormones|hormones|mesh-ancestor
20247047|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247048|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247049|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247050|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707457|NCT04828226|Analgesics|analgesics|mesh-ancestor
19707458|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
19707459|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707460|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708499|NCT04814043|Lenvatinib|lenvatinib|mesh-list
20522911|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20522912|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522913|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20522914|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
19707461|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20522915|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522916|NCT01743157|Bevacizumab|bevacizumab|mesh-list
20522917|NCT01743157|Ipilimumab|ipilimumab|mesh-list
20522918|NCT01743157|Interleukin-2|interleukin-2|mesh-list
20522919|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20522920|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522921|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20530272|NCT01787474|Cytarabine|cytarabine|mesh-list
19416446|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19707462|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
19707463|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
20247051|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20522922|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20522923|NCT01743157|Growth Substances|growth substances|mesh-ancestor
20522924|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522925|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
20522926|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20522927|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522928|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20522929|NCT01743157|Analgesics|analgesics|mesh-ancestor
20522930|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
20522931|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530273|NCT01787474|Fludarabine|fludarabine|mesh-list
20530274|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
20530275|NCT01787474|Lenograstim|lenograstim|mesh-list
20530276|NCT01787474|Sargramostim|sargramostim|mesh-list
20530277|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530278|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20530279|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
20530280|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530281|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20530282|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
20530283|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530284|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
20530285|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20530286|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20530287|NCT01787487|Azacitidine|azacitidine|mesh-list
19707464|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19707465|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19707466|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19707467|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
19707468|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707469|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707470|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
19707471|NCT04827966|Listerine|listerine|mesh-list
19707472|NCT04827966|Calcium|calcium|mesh-list
19707473|NCT04827966|Fluorides|fluorides|mesh-list
19707474|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
19707475|NCT04827966|Caseins|caseins|mesh-list
19707476|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19707477|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707478|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19707479|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
19707480|NCT04827966|Protective Agents|protective agents|mesh-ancestor
19707481|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19707482|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707483|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
19707484|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
19707485|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707486|NCT04828395|Paclitaxel|paclitaxel|mesh-list
19707487|NCT04828395|Etoposide|etoposide|mesh-list
19707488|NCT04828395|Cisplatin|cisplatin|mesh-list
20247052|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707489|NCT04828395|Carboplatin|carboplatin|mesh-list
19707490|NCT04828395|Pemetrexed|pemetrexed|mesh-list
20247053|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20248102|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
19855447|NCT00748098|Gabapentin|gabapentin|mesh-list
19855448|NCT00748098|Analgesics|analgesics|mesh-ancestor
19855449|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
19855450|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522932|NCT01743235|Buspirone|buspirone|mesh-list
20522933|NCT01743235|Testosterone|testosterone|mesh-list
20522934|NCT01743235|Androgens|androgens|mesh-ancestor
20522935|NCT01743235|Hormones|hormones|mesh-ancestor
20522936|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20522937|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522938|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20522939|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20522940|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522941|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522942|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20522943|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
20522944|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522945|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522946|NCT01743300|Sunitinib|sunitinib|mesh-list
20522947|NCT01743300|Midazolam|midazolam|mesh-list
20522948|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20522949|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20522950|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522951|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855451|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855452|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
19855453|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19855454|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855455|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855456|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855457|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19855458|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19855459|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855460|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855461|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
19855462|NCT00748189|Ofatumumab|ofatumumab|mesh-list
19855463|NCT00748189|Chlorambucil|chlorambucil|mesh-list
19855464|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855465|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20522952|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20522953|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20522954|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20522955|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20522956|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
20522957|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
20522958|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
20522959|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
20522960|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20522961|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522962|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522963|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20522964|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20522965|NCT01743300|Growth Substances|growth substances|mesh-ancestor
20522966|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
20522967|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20522968|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522969|NCT01743326|Anesthetics|anesthetics|mesh-list
20522970|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522971|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522972|NCT01743365|Afatinib|afatinib|mesh-list
20522973|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20522974|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20522975|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20522976|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20522977|NCT01743378|Ropivacaine|ropivacaine|mesh-list
20522978|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
20522979|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
20522980|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522981|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522982|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
20522983|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20522984|NCT01743456|Anesthetics|anesthetics|mesh-list
20522985|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20522986|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707491|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20247054|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20522987|NCT01743508|Misoprostol|misoprostol|mesh-list
20522988|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20522989|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
20522990|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20522991|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707492|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707493|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
19707494|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
19707495|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707496|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707497|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19707498|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20522992|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20522993|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20522994|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
20522995|NCT01743690|Nystatin|nystatin|mesh-list
19707499|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707500|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19707501|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19707502|NCT04827784|Anesthetics|anesthetics|mesh-list
19707503|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
19855466|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
19855467|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855468|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
19855469|NCT00748215|Loperamide|loperamide|mesh-list
19855470|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
19855471|NCT00748215|Calcium|calcium|mesh-list
19855472|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20522996|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19707504|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707505|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707506|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
19707507|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855473|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20522997|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20522998|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
20522999|NCT01743690|Hormones|hormones|mesh-ancestor
20523000|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20523001|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523002|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20523003|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707508|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
19707509|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19707510|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707511|NCT04827446|Methamphetamine|methamphetamine|mesh-list
19707512|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19707513|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707514|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
19707515|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
19707516|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523004|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
20523005|NCT01743690|Ionophores|ionophores|mesh-ancestor
20523006|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523007|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523008|NCT01743742|Vitamins|vitamins|mesh-list
20523009|NCT01743742|Ascorbic Acid|ascorbic acid|mesh-list
20523010|NCT01743742|Vitamin E|vitamin e|mesh-list
20523011|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
20523012|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523013|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
20523014|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523015|NCT01743742|Protective Agents|protective agents|mesh-ancestor
20523016|NCT01743755|Dexamethasone|dexamethasone|mesh-list
20523017|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523018|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
20523019|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
20523020|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523021|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523022|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523023|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
20523024|NCT01743755|Hormones|hormones|mesh-ancestor
20523025|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20523026|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20523027|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707517|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
19707518|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707519|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707520|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
19707521|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19707522|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19707523|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19707524|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19707525|NCT04827134|Triumeq|triumeq|mesh-list
19707526|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19707527|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19707528|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
19707529|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707530|NCT04827147|Methamphetamine|methamphetamine|mesh-list
19707531|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19707532|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707533|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
19707534|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
19707535|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707536|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
19707537|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707538|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707539|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
19707540|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19707541|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19707542|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19707543|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19707544|NCT04826822|Dexamethasone|dexamethasone|mesh-list
19707545|NCT04826822|Spironolactone|spironolactone|mesh-list
19707546|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19416447|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
20247055|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247056|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20247057|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20247058|NCT00431054|Docetaxel|docetaxel|mesh-list
20247059|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247060|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247061|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
20247062|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
20247063|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247064|NCT00431080|Paclitaxel|paclitaxel|mesh-list
20247065|NCT00431080|Docetaxel|docetaxel|mesh-list
20247066|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
20247067|NCT00431080|Epirubicin|epirubicin|mesh-list
20523028|NCT01743794|Ropivacaine|ropivacaine|mesh-list
20523029|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
20523030|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
20523031|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523032|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523033|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
20523034|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523035|NCT01743820|Piperaquine|piperaquine|mesh-list
20523036|NCT01743820|Primaquine|primaquine|mesh-list
20523037|NCT01743820|Artenimol|artenimol|mesh-list
20523038|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
20523039|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20523040|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20523041|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20523042|NCT01743885|Propranolol|propranolol|mesh-list
20523043|NCT01743885|Acebutolol|acebutolol|mesh-list
20523044|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20523045|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20523046|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523047|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19416448|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
20247068|NCT00431080|Fluorouracil|fluorouracil|mesh-list
20523048|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523049|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247069|NCT00431080|Mitogens|mitogens|mesh-list
20247070|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20247071|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247072|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
19707547|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
19707548|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
19707549|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707550|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707551|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707552|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
19707553|NCT04826822|Hormones|hormones|mesh-ancestor
19707554|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707555|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19707556|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707557|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19707558|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
19707559|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19707560|NCT04826822|Diuretics|diuretics|mesh-ancestor
19707561|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
19707562|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19707563|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20523050|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20523051|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20523052|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
20523053|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
20523054|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
20523055|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523056|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20523057|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
20523058|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20247073|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
19416449|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
19416450|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
19416451|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19416452|NCT02454933|Durvalumab|durvalumab|mesh-list
20247074|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
20247075|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247076|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247077|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
20247078|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247079|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247080|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20247081|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
20247082|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19416453|NCT02454933|Osimertinib|osimertinib|mesh-list
19416454|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19416455|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19416456|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19416457|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416458|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19416459|NCT02447276|Fasinumab|fasinumab|mesh-list
19416460|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19416461|NCT02447276|Analgesics|analgesics|mesh-ancestor
19416462|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
20523059|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
20523060|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20523061|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
20523062|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523063|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523064|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
20523065|NCT01743911|Tadalafil|tadalafil|mesh-list
20523066|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
20523067|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20523068|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20523069|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523070|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523071|NCT01743911|Urological Agents|urological agents|mesh-ancestor
20523072|NCT01743950|Bevacizumab|bevacizumab|mesh-list
20523073|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20523074|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523075|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20523076|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19707564|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707565|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707566|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19707567|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20523077|NCT01743950|Growth Substances|growth substances|mesh-ancestor
20523078|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523079|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
20523080|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
19707568|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707569|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
19707570|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707571|NCT04826679|Paclitaxel|paclitaxel|mesh-list
19707572|NCT04826679|Cisplatin|cisplatin|mesh-list
19707573|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20247083|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20247084|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20247085|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20247086|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247087|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
20247088|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20247089|NCT00431106|Gemcitabine|gemcitabine|mesh-list
20247090|NCT00431106|Capecitabine|capecitabine|mesh-list
20247091|NCT00431106|Vinorelbine|vinorelbine|mesh-list
20247092|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20247093|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
20247094|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247095|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247096|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
20247097|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247098|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247099|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247100|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
20247101|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247102|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20247103|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247104|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
19707574|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707575|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247105|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707576|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
19855474|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19855475|NCT00748553|Paclitaxel|paclitaxel|mesh-list
19855476|NCT00748553|Azacitidine|azacitidine|mesh-list
19855477|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19855478|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19855479|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855480|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
19855481|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
19855482|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
19855483|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855484|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19855485|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
19855486|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855487|NCT00748566|Ziprasidone|ziprasidone|mesh-list
19855488|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19855489|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
19855490|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19707577|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707578|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707579|NCT04826198|Olaparib|olaparib|mesh-list
19707580|NCT04826198|Niraparib|niraparib|mesh-list
19707581|NCT04826198|Rucaparib|rucaparib|mesh-list
19707582|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19707583|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707584|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523081|NCT01744106|Ephedrine|ephedrine|mesh-list
20523082|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20523083|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
20523084|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523085|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523086|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19707585|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523087|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
20523088|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
20247106|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
20247107|NCT00431119|Azathioprine|azathioprine|mesh-list
19707586|NCT04826562|Lamivudine|lamivudine|mesh-list
19707587|NCT04826562|Dolutegravir|dolutegravir|mesh-list
19707588|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19707589|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19707590|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707591|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855491|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855492|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855493|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19855494|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855495|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855496|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855497|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19855498|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
19855499|NCT00748657|Bevacizumab|bevacizumab|mesh-list
19855500|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19855501|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
19855502|NCT00748657|Antibodies|antibodies|mesh-list
19855503|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
19855504|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19855505|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
19855506|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855507|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20247108|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20247109|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247110|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20247111|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
19855508|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19416463|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855509|NCT00748657|Growth Substances|growth substances|mesh-ancestor
19855510|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855511|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
19855512|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
19855513|NCT00748709|Afatinib|afatinib|mesh-list
19855514|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855515|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19855516|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855517|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855518|NCT00748826|Infliximab|infliximab|mesh-list
19855519|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
19416464|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416465|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
19855520|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523089|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20523090|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20523091|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
20523092|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
20523093|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523094|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523095|NCT01744184|Midazolam|midazolam|mesh-list
20523096|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
20523097|NCT01744184|Entonox|entonox|mesh-list
20523098|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20523099|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20523100|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523101|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523102|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19416466|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19416467|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707592|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
19707593|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19707594|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19707595|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19707596|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19707597|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19707598|NCT04826406|Apatinib|apatinib|mesh-list
19707599|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523103|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20523104|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523105|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20523106|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
20523107|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
20523108|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
20523109|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
20523110|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523111|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855521|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855522|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19855523|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
20523112|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19855524|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20523113|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523114|NCT01744184|Analgesics|analgesics|mesh-ancestor
20523115|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
20523116|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523117|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20523118|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20523119|NCT01744236|Liraglutide|liraglutide|mesh-list
20523120|NCT01744236|Exenatide|exenatide|mesh-list
20523121|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20523122|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523123|NCT01744236|Incretins|incretins|mesh-ancestor
20523124|NCT01744236|Hormones|hormones|mesh-ancestor
20523125|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20523126|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20523127|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
20523128|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523129|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855525|NCT00749125|Citalopram|citalopram|mesh-list
19707600|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19707601|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707602|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523130|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20523131|NCT01744249|Axitinib|axitinib|mesh-list
20523132|NCT01744249|Octreotide|octreotide|mesh-list
20523133|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523134|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20523135|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523136|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523137|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19707603|NCT04826432|Pasireotide|pasireotide|mesh-list
19707604|NCT04826432|Hormones|hormones|mesh-ancestor
19707605|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707606|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707607|NCT04826497|Nicorandil|nicorandil|mesh-list
19707608|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19707609|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19707610|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
19707611|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
19707612|NCT04826497|Vitamins|vitamins|mesh-ancestor
19707613|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
19707614|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707615|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
19707616|NCT04826510|Perospirone|perospirone|mesh-list
19707617|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
19855526|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19855527|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19855528|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855529|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855530|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855531|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
19855532|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855533|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19855534|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
19855535|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855536|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19855537|NCT00749190|Empagliflozin|empagliflozin|mesh-list
19855538|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19855539|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855540|NCT00749190|Incretins|incretins|mesh-ancestor
19855541|NCT00749190|Hormones|hormones|mesh-ancestor
19855542|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855543|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19855544|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
19855545|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707618|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19707619|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707620|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707621|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
19707622|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19707623|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707624|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707625|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19707626|NCT04825938|Paclitaxel|paclitaxel|mesh-list
19707627|NCT04825938|Carboplatin|carboplatin|mesh-list
20523138|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20523139|NCT01744262|Anesthetics|anesthetics|mesh-list
20523140|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523141|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523142|NCT01744288|Clopidogrel|clopidogrel|mesh-list
20523143|NCT01744288|Ticagrelor|ticagrelor|mesh-list
20523144|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20523145|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20523146|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20523147|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20523148|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
20523149|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523150|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523151|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523152|NCT01744314|Indomethacin|indomethacin|mesh-list
20523153|NCT01744314|Pantoprazole|pantoprazole|mesh-list
20523154|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20523155|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20523156|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20523157|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523158|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523159|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20523160|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20523161|NCT01744314|Analgesics|analgesics|mesh-ancestor
20523162|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
20523163|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523164|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523165|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20523166|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523167|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
20523168|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
20523169|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20523170|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20247112|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20247113|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247114|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247115|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247116|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
20247117|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20247118|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19707628|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19707629|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707630|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
20247119|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
20523171|NCT01744366|Goserelin|goserelin|mesh-list
20523172|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20523173|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523174|NCT01744379|Lesinurad|lesinurad|mesh-list
20523175|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
20523176|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523177|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
20523178|NCT01744379|Renal Agents|renal agents|mesh-ancestor
20523179|NCT01744444|Gabapentin|gabapentin|mesh-list
20523180|NCT01744444|Memantine|memantine|mesh-list
20523181|NCT01744444|Analgesics|analgesics|mesh-ancestor
20523182|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
20523183|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20523184|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523185|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
20523186|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20523187|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20523188|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20523189|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523190|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20247120|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247121|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20247122|NCT00431145|Niacin|niacin|mesh-list
20523191|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20523192|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20523193|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523194|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
20523195|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20523196|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19707631|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
20523197|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
20523198|NCT01744470|Tacrolimus|tacrolimus|mesh-list
20523199|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20247123|NCT00431145|Niacinamide|niacinamide|mesh-list
20247124|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
19707632|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707633|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707634|NCT04826016|Paclitaxel|paclitaxel|mesh-list
19707635|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19707636|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707637|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
19855546|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855547|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19707638|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
19707639|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
19707640|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707641|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19707642|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
19707643|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707644|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707645|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19707646|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707647|NCT04826133|Calcitriol|calcitriol|mesh-list
19707648|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19707649|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19707650|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707651|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19707652|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19707653|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707654|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19707655|NCT04826133|Vitamins|vitamins|mesh-ancestor
19707656|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
19855548|NCT00749203|Midazolam|midazolam|mesh-list
19707657|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19708500|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19708501|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708502|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19708503|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708504|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708505|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19708506|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708507|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708508|NCT04814589|Ezetimibe|ezetimibe|mesh-list
19708509|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19708510|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19855549|NCT00749203|Ketamine|ketamine|mesh-list
19855550|NCT00749203|Analgesics|analgesics|mesh-ancestor
19707658|NCT04824924|Venetoclax|venetoclax|mesh-list
19707659|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707660|NCT04825093|Vitamin D|vitamin d|mesh-list
19707661|NCT04825093|Vitamins|vitamins|mesh-ancestor
19707662|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
19707663|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707664|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19707665|NCT04824638|Vaccines|vaccines|mesh-list
19707666|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
19707667|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707668|NCT04824586|Insulin|insulin|mesh-list
19707669|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19707670|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19707671|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707672|NCT04824599|Ropivacaine|ropivacaine|mesh-list
19707673|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
20523200|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
20523201|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523202|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20523203|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523204|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523205|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20523206|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
20523207|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523208|NCT01744587|Protective Agents|protective agents|mesh-ancestor
20523209|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523210|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20523211|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20523212|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20247125|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20247126|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
20247127|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247128|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20247129|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
20247130|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
20247131|NCT00431145|Vitamins|vitamins|mesh-ancestor
20247132|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
20247133|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247134|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
20247135|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
20247136|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20523213|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19707674|NCT04824599|Anesthetics|anesthetics|mesh-list
19707675|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19707676|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707677|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
19707678|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19707679|NCT04824898|Simvastatin|simvastatin|mesh-list
19707680|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19707681|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19707682|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
19707683|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19707684|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19707685|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19707686|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707687|NCT04824937|Talazoparib|talazoparib|mesh-list
19707688|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19707689|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19707690|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855551|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
20523214|NCT01744626|Rituximab|rituximab|mesh-list
20523215|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20523216|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523217|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
20523218|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523219|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20523220|NCT01744652|Dasatinib|dasatinib|mesh-list
20523221|NCT01744652|Crizotinib|crizotinib|mesh-list
20523222|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20523223|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20523224|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20523225|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20523226|NCT01744678|Immunoconjugates|immunoconjugates|mesh-list
20523227|NCT01744678|Immunologic Factors|immunologic factors|mesh-ancestor
20523228|NCT01744678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20523229|NCT01744756|Bevacizumab|bevacizumab|mesh-list
20523230|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20523231|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707691|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19707692|NCT04824612|Triamcinolone|triamcinolone|mesh-list
19707693|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19707694|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19707695|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19707696|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19707697|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
19707698|NCT04824612|Hormones|hormones|mesh-ancestor
19707699|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19707700|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19707701|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19707702|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
19707703|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247137|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708511|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
19855552|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855553|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855554|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19855555|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19855556|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
19855557|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
19855558|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855559|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19855560|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19855561|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855562|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855563|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19855564|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19855565|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19855566|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855567|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855568|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
19855569|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
19855570|NCT00749398|Infliximab|infliximab|mesh-list
19855571|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
19855572|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19855573|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855574|NCT00749463|Nicotine|nicotine|mesh-list
20247138|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247139|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
20247140|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20247141|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20247142|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247143|NCT00431197|Ketoconazole|ketoconazole|mesh-list
20247144|NCT00431197|Testosterone|testosterone|mesh-list
20247145|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
20247146|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20247147|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20247148|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20247149|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20247150|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20247151|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20247152|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
20247153|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20247154|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20247155|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20247156|NCT00431197|Androgens|androgens|mesh-ancestor
20247157|NCT00431197|Hormones|hormones|mesh-ancestor
19855575|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19416981|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855655|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855656|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19855657|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
19855658|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855659|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855660|NCT00750815|Dexamethasone|dexamethasone|mesh-list
19855661|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
19855662|NCT00750815|Doxorubicin|doxorubicin|mesh-list
19855663|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19855664|NCT00750815|Bortezomib|bortezomib|mesh-list
19855665|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248135|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248136|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248137|NCT00435279|Eszopiclone|eszopiclone|mesh-list
20248138|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20248139|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20248140|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20248141|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248142|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708538|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708539|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733654|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
19708540|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19708541|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19708542|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
19708543|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
19708544|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708545|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19708546|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19855666|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
19855667|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855668|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855669|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19855670|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
19855671|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855672|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855673|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19855674|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855675|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
19855676|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
20248143|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248144|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248145|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20248146|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
20248147|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248148|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20248149|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708547|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855677|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248150|NCT00435292|Naproxen|naproxen|mesh-list
19416982|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19416983|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19416984|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19416985|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
19416986|NCT02221232|Ethanol|ethanol|mesh-list
19416987|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
19416988|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19416989|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19416990|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19416991|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19416992|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19416993|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
19416994|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
19416995|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19416996|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19416997|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19416998|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19416999|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
19417000|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19417001|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417002|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19417003|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19417004|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19417005|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19417006|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
19417007|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417008|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417009|NCT02210806|Albuterol|albuterol|mesh-list
19417010|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19417011|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
19417012|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417013|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417014|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19417015|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
19417016|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
19417017|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19417018|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19417019|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19708548|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708549|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19708550|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
19417020|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19417021|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
19417022|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417023|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248151|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20248152|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20248153|NCT00435292|Analgesics|analgesics|mesh-ancestor
20248154|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
20248155|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248156|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248157|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248158|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708551|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19708552|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248159|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
20248160|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20248161|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248162|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417024|NCT02207257|Edoxaban|edoxaban|mesh-list
19417025|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19417026|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
19417027|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19417028|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
19417029|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417030|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417031|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
19708553|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19855678|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19855679|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
19855680|NCT00750815|Hormones|hormones|mesh-ancestor
19855681|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855682|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19855683|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19855684|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19855685|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19855686|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855687|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
19855688|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19855689|NCT00750867|Antibodies|antibodies|mesh-list
19855690|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
19855691|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19855692|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
19855693|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855694|NCT00750919|Mirtazapine|mirtazapine|mesh-list
19855695|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
19855696|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19855697|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19855698|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
19855699|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
19855700|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855701|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855702|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855703|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19855704|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19855705|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855706|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19855707|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19855708|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19855709|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
19855710|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19855711|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19855712|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
19855713|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20248163|NCT00435305|Vancomycin|vancomycin|mesh-list
20248164|NCT00435305|Meropenem|meropenem|mesh-list
20248165|NCT00435305|Tazobactam|tazobactam|mesh-list
20248166|NCT00435305|Linezolid|linezolid|mesh-list
20248167|NCT00435305|Piperacillin|piperacillin|mesh-list
20248168|NCT00435305|Ceftazidime|ceftazidime|mesh-list
20248169|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20248170|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20248171|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855714|NCT00751023|Modafinil|modafinil|mesh-list
20248172|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20248173|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286492|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417032|NCT02206100|Enoxaparin|enoxaparin|mesh-list
19417033|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
19417034|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19417035|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19417036|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417037|NCT02206087|Heparin|heparin|mesh-list
19417038|NCT02206087|Calcium heparin|calcium heparin|mesh-list
19417039|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
19417040|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19855715|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19708554|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
19708555|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708556|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
19708557|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19708558|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
19708559|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
19708560|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19855716|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855717|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19855718|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19855719|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19855720|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417041|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19417042|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417043|NCT02205528|Metformin|metformin|mesh-list
19417044|NCT02205528|Liraglutide|liraglutide|mesh-list
19417045|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417046|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417047|NCT02205528|Incretins|incretins|mesh-ancestor
19417048|NCT02205528|Hormones|hormones|mesh-ancestor
19417049|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417050|NCT02204345|Paclitaxel|paclitaxel|mesh-list
19417051|NCT02204345|Carboplatin|carboplatin|mesh-list
19417052|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19417053|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417054|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
19417055|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417056|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417057|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417058|NCT02200380|Plerixafor|plerixafor|mesh-list
19417059|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19417060|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19417061|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
19417062|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417063|NCT02187302|Bevacizumab|bevacizumab|mesh-list
19417064|NCT02187302|Sunitinib|sunitinib|mesh-list
19417065|NCT02187302|Everolimus|everolimus|mesh-list
19417066|NCT02187302|Sorafenib|sorafenib|mesh-list
19417067|NCT02187302|Axitinib|axitinib|mesh-list
19417068|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417069|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417070|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417071|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417072|NCT02187302|Growth Substances|growth substances|mesh-ancestor
19417073|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417074|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417075|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417076|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
19417077|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19708561|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855721|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
19855722|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417078|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417079|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417080|NCT02179749|Mifepristone|mifepristone|mesh-list
19417081|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19708562|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19708563|NCT04813874|Analgesics|analgesics|mesh-ancestor
19708564|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
19708565|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708566|NCT04813848|Fluorides|fluorides|mesh-list
19708567|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
19708568|NCT04813848|Protective Agents|protective agents|mesh-ancestor
19708569|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708570|NCT04813523|Cisplatin|cisplatin|mesh-list
19855723|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19855724|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855725|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855726|NCT00751101|Nicotine|nicotine|mesh-list
19855727|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19855728|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
19855729|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855730|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855731|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19417082|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
19417083|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19417084|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417085|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19417086|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19417087|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19417088|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
19417089|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19417090|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19417091|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
19417092|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417093|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
19417094|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19417095|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19417096|NCT02179151|CKD732|ckd732|mesh-list
19417097|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417098|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417099|NCT02179151|Growth Substances|growth substances|mesh-ancestor
19417100|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417101|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417102|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417103|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19417104|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19417105|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
19417106|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417107|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19417108|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417109|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417110|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417111|NCT02160678|Tazarotene|tazarotene|mesh-list
19417112|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
19417113|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
19417114|NCT02160665|Tazarotene|tazarotene|mesh-list
19417115|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
19417116|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
19417117|NCT02153502|Quinidine|quinidine|mesh-list
19417118|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
19417119|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
19417120|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
19417121|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
19417122|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19417123|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19855732|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19855733|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
19417124|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417125|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417126|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417127|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19417128|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19417129|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
19855734|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855735|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417130|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19417131|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
19417132|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19708571|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
19708572|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708573|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19708574|NCT04813471|Folic Acid|folic acid|mesh-list
19708575|NCT04813471|Nicorandil|nicorandil|mesh-list
19708576|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
19708577|NCT04813471|Atorvastatin|atorvastatin|mesh-list
19708578|NCT04813471|Vitamins|vitamins|mesh-ancestor
19708579|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
19708580|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708581|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19708582|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19708583|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
19708584|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708585|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19708586|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19708587|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855736|NCT00751114|Metformin|metformin|mesh-list
19708588|NCT04813471|Hematinics|hematinics|mesh-ancestor
19855737|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
20248174|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248175|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19855738|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19855739|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19855740|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855741|NCT00751114|Incretins|incretins|mesh-ancestor
19855742|NCT00751114|Hormones|hormones|mesh-ancestor
19855743|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855744|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19855745|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
19855746|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855747|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855748|NCT00751179|Bromides|bromides|mesh-list
19855749|NCT00751179|Rocuronium|rocuronium|mesh-list
19855750|NCT00751179|Succinylcholine|succinylcholine|mesh-list
19855751|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
20248176|NCT00435331|Verapamil|verapamil|mesh-list
20248177|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19708589|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19708590|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19708591|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
19708592|NCT04813653|Cyclosporine|cyclosporine|mesh-list
19708593|NCT04813653|Dexamethasone|dexamethasone|mesh-list
19708594|NCT04813653|Cyclosporins|cyclosporins|mesh-list
20248178|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20248179|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248180|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248181|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20248182|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248183|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
20248184|NCT00435435|Disulfiram|disulfiram|mesh-list
20248185|NCT00435435|Acamprosate|acamprosate|mesh-list
20248186|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20248187|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19708595|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708596|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
19708597|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
19708598|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708599|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708600|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708601|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
19708602|NCT04813653|Hormones|hormones|mesh-ancestor
19708603|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417133|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19417134|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417135|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417136|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19417137|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19417138|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
19417139|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19417140|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19417141|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19417142|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19417143|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19417144|NCT02137343|Capecitabine|capecitabine|mesh-list
19417145|NCT02137343|Rilotumumab|rilotumumab|mesh-list
19417146|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417147|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417148|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
19417149|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417150|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417151|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19417152|NCT02130687|Aprepitant|aprepitant|mesh-list
19417153|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417154|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417155|NCT02130687|Incretins|incretins|mesh-ancestor
19417156|NCT02130687|Hormones|hormones|mesh-ancestor
19417157|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417158|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19417159|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
19417160|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708604|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708605|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708606|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708607|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708608|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19708609|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
19708610|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
19708611|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708612|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708613|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417161|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417162|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
19417163|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
19417164|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417165|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19417166|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19417167|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417168|NCT02125266|Methotrexate|methotrexate|mesh-list
19417169|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19417170|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
19417171|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19417172|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417173|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417174|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
19417175|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417176|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417177|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708614|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19417178|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417179|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19417180|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417181|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
19417182|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417183|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19417184|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
19417185|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19417186|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
19417187|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19417188|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19417189|NCT02116998|Vaccines|vaccines|mesh-list
19417190|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19417191|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
19417192|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417193|NCT02116998|Antacids|antacids|mesh-ancestor
19417194|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417195|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19417196|NCT02114060|Vaccines|vaccines|mesh-list
19417197|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
19417198|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417199|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
19708615|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
19708616|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19708617|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708618|NCT04812470|Melphalan|melphalan|mesh-list
20248188|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248189|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248190|NCT00435448|Lonidamine|lonidamine|mesh-list
20248191|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248192|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20248193|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248194|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20248195|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
20248196|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20248197|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20248198|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20248199|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19708619|NCT04812470|Interleukin-2|interleukin-2|mesh-list
19417200|NCT02110368|Testosterone|testosterone|mesh-list
19417201|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
19417202|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
19417203|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19417204|NCT02110368|Androgens|androgens|mesh-ancestor
19417205|NCT02110368|Hormones|hormones|mesh-ancestor
19417206|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417207|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417208|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19417209|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417210|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
19417211|NCT02106546|Paclitaxel|paclitaxel|mesh-list
19417212|NCT02106546|Carboplatin|carboplatin|mesh-list
19417213|NCT02106546|Veliparib|veliparib|mesh-list
19417214|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19417215|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417216|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
19417217|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417218|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417219|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417220|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19417221|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417222|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19417223|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19417224|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
19417225|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19417226|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417227|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19417228|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19417229|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417230|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417231|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417232|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19417233|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19417234|NCT02104050|Dapansutrile|dapansutrile|mesh-list
19708620|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19708621|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
19708622|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708623|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708624|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19708625|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19708626|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
19855752|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19855753|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19855754|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19855755|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855756|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855757|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19855758|NCT00751296|Lenalidomide|lenalidomide|mesh-list
19855759|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
19855760|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855761|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19855762|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19855763|NCT00751296|Growth Substances|growth substances|mesh-ancestor
19855764|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
20248200|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248201|NCT00435500|Fluorides|fluorides|mesh-list
20248202|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
20248203|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
20248204|NCT00435500|Protective Agents|protective agents|mesh-ancestor
20248205|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248206|NCT00435747|Parecoxib|parecoxib|mesh-list
19855765|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855766|NCT00751400|Naproxen|naproxen|mesh-list
20248207|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20248208|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19708627|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708628|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19708629|NCT04812470|Analgesics|analgesics|mesh-ancestor
19708630|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
19708631|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708632|NCT04812860|Tramadol|tramadol|mesh-list
19708633|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19708634|NCT04812860|Narcotics|narcotics|mesh-ancestor
19708635|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248209|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248210|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975495|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20286493|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19452882|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
19417235|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19417236|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
19417237|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417238|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417239|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417240|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417241|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19417242|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417243|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417244|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417245|NCT02092935|Vancomycin|vancomycin|mesh-list
19417246|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19417247|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417248|NCT02092922|Filanesib|filanesib|mesh-list
19417249|NCT02092922|Lenograstim|lenograstim|mesh-list
19417250|NCT02092922|Sargramostim|sargramostim|mesh-list
19417251|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19417252|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
19417253|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417254|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417255|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417256|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417257|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417258|NCT02092454|Benzocaine|benzocaine|mesh-list
19417259|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
19417260|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
19417261|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19417262|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417263|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
19417264|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417265|NCT02092077|Hormones|hormones|mesh-list
19417266|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417267|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417268|NCT02083289|Latanoprost|latanoprost|mesh-list
19417269|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19417270|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19417271|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
19417272|NCT02081300|Testosterone|testosterone|mesh-list
19417273|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
19417274|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
19417275|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19417276|NCT02081300|Androgens|androgens|mesh-ancestor
19417277|NCT02081300|Hormones|hormones|mesh-ancestor
19417278|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417279|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417280|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19417281|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417282|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
19417283|NCT02081118|Exenatide|exenatide|mesh-list
19417284|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417285|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417286|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19417287|NCT02081118|Incretins|incretins|mesh-ancestor
19417288|NCT02081118|Hormones|hormones|mesh-ancestor
19417289|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417290|NCT02077881|Gemcitabine|gemcitabine|mesh-list
19417291|NCT02077881|Paclitaxel|paclitaxel|mesh-list
19417292|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19417293|NCT02077881|Tryptophan|tryptophan|mesh-list
19417294|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19417295|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417296|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
19417297|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417298|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417299|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417300|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417301|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
19417302|NCT02077881|Antiviral Agents|antiviral agents|mesh-ancestor
19417303|NCT02077881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417304|NCT02077881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417305|NCT02077881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417306|NCT02077881|Immunologic Factors|immunologic factors|mesh-ancestor
19417307|NCT02077881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417308|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19417309|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
19417310|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19417311|NCT02074007|Benzocaine|benzocaine|mesh-list
19417312|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417313|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19417314|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
19417315|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19417316|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
19417317|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417318|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
19417319|NCT02073123|Nivolumab|nivolumab|mesh-list
19417320|NCT02073123|Ipilimumab|ipilimumab|mesh-list
20553271|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
19417321|NCT02073123|Tryptophan|tryptophan|mesh-list
19417322|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417323|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553272|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248211|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20248212|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20248213|NCT00435747|Analgesics|analgesics|mesh-ancestor
20248214|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
20248215|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248216|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248217|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248218|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20248219|NCT00435760|Bromides|bromides|mesh-list
20248220|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
19417324|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19417325|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417326|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19417327|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
19417328|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19417329|NCT02072954|Asenapine|asenapine|mesh-list
19417330|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19417331|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19417332|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19417333|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417334|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19417335|NCT02072863|Prednisone|prednisone|mesh-list
19417336|NCT02072863|Melphalan|melphalan|mesh-list
19417337|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19417338|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
19417339|NCT02072863|Hormones|hormones|mesh-ancestor
19417340|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417341|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417342|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19417343|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417344|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19417345|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
19417346|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417347|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19417348|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417349|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
19417350|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19417351|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19417352|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
19417353|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417354|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19417355|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417356|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417357|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450505|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19450506|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450507|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
19450508|NCT03427944|Coagulants|coagulants|mesh-ancestor
19450509|NCT03427801|Hematinics|hematinics|mesh-list
19450510|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19450511|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
19855767|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20248221|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20248222|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
20248223|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417358|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
19417359|NCT02064426|Hematinics|hematinics|mesh-ancestor
19708636|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708637|NCT04812860|Analgesics|analgesics|mesh-ancestor
19708638|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
19708639|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708640|NCT04812379|Aripiprazole|aripiprazole|mesh-list
19708641|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
19708642|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19708643|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19708644|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19708645|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708646|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417360|NCT02063997|Colchicine|colchicine|mesh-list
19417361|NCT02063997|Allopurinol|allopurinol|mesh-list
19417362|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
19417363|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417364|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
19417365|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417366|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417367|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417368|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417369|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
19417370|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417371|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19417372|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
19417373|NCT02063997|Protective Agents|protective agents|mesh-ancestor
19417374|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417375|NCT02063295|CKD732|ckd732|mesh-list
19417376|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417377|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417378|NCT02063295|Growth Substances|growth substances|mesh-ancestor
19417379|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417380|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417381|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417382|NCT02058420|Tocotrienols|tocotrienols|mesh-list
19417383|NCT02058420|Vitamin E|vitamin e|mesh-list
19417384|NCT02058420|Tocopherols|tocopherols|mesh-list
19417385|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
19417386|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417387|NCT02058420|Protective Agents|protective agents|mesh-ancestor
19417388|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417389|NCT02058420|Vitamins|vitamins|mesh-ancestor
19417390|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
19417391|NCT02057380|Dexamethasone|dexamethasone|mesh-list
19417392|NCT02057380|Paclitaxel|paclitaxel|mesh-list
19417393|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19417394|NCT02057380|Bortezomib|bortezomib|mesh-list
19417395|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19417396|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417397|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
19417398|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417399|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417400|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417401|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248224|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248225|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20248226|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
20248227|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
20248228|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20248229|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
20248230|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248231|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248232|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
20286494|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286495|NCT03432949|Dexamethasone|dexamethasone|mesh-list
20286496|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
20286497|NCT03432949|BB 1101|bb 1101|mesh-list
20286498|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286499|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
20286500|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
20286501|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286502|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286503|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20248233|NCT00435799|Riboflavin|riboflavin|mesh-list
20248234|NCT00435799|Dextrans|dextrans|mesh-list
20248235|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20248236|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
20248237|NCT00435799|Vitamins|vitamins|mesh-ancestor
20248238|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
20248239|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248240|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20248241|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
20248242|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
20248243|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
20248244|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
20248245|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20248246|NCT00435851|Hormones|hormones|mesh-list
20248247|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248248|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248249|NCT00435955|Rituximab|rituximab|mesh-list
20248250|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20248251|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248252|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
20248253|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248254|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20248255|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20248256|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20248257|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
20248258|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248259|NCT00435981|Antacids|antacids|mesh-ancestor
20248260|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248261|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20248262|NCT00436033|Milnacipran|milnacipran|mesh-list
20248263|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
20248264|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19417402|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
19417403|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
19855768|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19855769|NCT00751400|Analgesics|analgesics|mesh-ancestor
19855770|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
19855771|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855772|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855773|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855774|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855775|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
19855776|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19855777|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855778|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855779|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
19855780|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19855781|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19855782|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
19855783|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855784|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19855785|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19855786|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855787|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855788|NCT00751777|Vaccines|vaccines|mesh-list
19450512|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20248265|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20248266|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248267|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248268|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248269|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248270|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20248271|NCT00436033|Analgesics|analgesics|mesh-ancestor
20530907|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530908|NCT01791309|Panitumumab|panitumumab|mesh-list
20530909|NCT01791309|Vemurafenib|vemurafenib|mesh-list
20530910|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20530911|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530912|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20530913|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530914|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248272|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
20248273|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248274|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
20248275|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248276|NCT00436059|Bortezomib|bortezomib|mesh-list
20248277|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248278|NCT00436072|Irinotecan|irinotecan|mesh-list
20248279|NCT00436072|Cetuximab|cetuximab|mesh-list
20248280|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20248281|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20248282|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248283|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248284|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248285|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417404|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417405|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417406|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19417407|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
19417408|NCT02057380|Hormones|hormones|mesh-ancestor
19417409|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417410|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19450513|NCT03427632|Protective Agents|protective agents|mesh-ancestor
20248286|NCT00436124|Oseltamivir|oseltamivir|mesh-list
20248287|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
19708647|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
19708648|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
19855789|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
19855790|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855791|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19855792|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
19855793|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19855794|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
19855795|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20248288|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248289|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248290|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248291|NCT00436241|Capecitabine|capecitabine|mesh-list
20248292|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
20248293|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20248294|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
20248295|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417411|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417412|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417413|NCT02057315|Ketoprofen|ketoprofen|mesh-list
19417414|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19417415|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19417416|NCT02057315|Analgesics|analgesics|mesh-ancestor
20248296|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248297|NCT00436267|Fluorouracil|fluorouracil|mesh-list
20248298|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
20248299|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248300|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20248301|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248302|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248303|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
20248304|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248305|NCT00436293|Docetaxel|docetaxel|mesh-list
20248306|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248307|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
20248308|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
20248309|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
20248310|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417417|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
19452883|NCT03408847|Hormones|hormones|mesh-ancestor
19855796|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855797|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19855798|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19855799|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855800|NCT00751881|Teriflunomide|teriflunomide|mesh-list
19855801|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19855802|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19855803|NCT00751881|Analgesics|analgesics|mesh-ancestor
19855804|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
19855805|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417418|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417419|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417420|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19417421|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417422|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19417423|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417424|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417425|NCT02057172|Liraglutide|liraglutide|mesh-list
19417426|NCT02057172|Exenatide|exenatide|mesh-list
19417427|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417428|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417429|NCT02057172|Incretins|incretins|mesh-ancestor
19417430|NCT02057172|Hormones|hormones|mesh-ancestor
19417431|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417432|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19417433|NCT02052778|Futibatinib|futibatinib|mesh-list
19417434|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417435|NCT02052648|Bevacizumab|bevacizumab|mesh-list
19417436|NCT02052648|Temozolomide|temozolomide|mesh-list
19417437|NCT02052648|Tryptophan|tryptophan|mesh-list
19417438|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417439|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417440|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417441|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417442|NCT02052648|Growth Substances|growth substances|mesh-ancestor
19417443|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417444|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417445|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19417446|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
19417447|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417448|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19417449|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
19417450|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19417451|NCT02050828|Ranibizumab|ranibizumab|mesh-list
19417452|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417453|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417454|NCT02050828|Growth Substances|growth substances|mesh-ancestor
19417455|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417456|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417457|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417458|NCT02047214|Bevacizumab|bevacizumab|mesh-list
19417459|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417460|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417461|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417462|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417463|NCT02047214|Growth Substances|growth substances|mesh-ancestor
19417464|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417465|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417466|NCT02046395|Amlodipine|amlodipine|mesh-list
19417467|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19417468|NCT02046395|Hydralazine|hydralazine|mesh-list
19417469|NCT02046395|Terazosin|terazosin|mesh-list
19417470|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19417471|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19417472|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19417473|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417474|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19417475|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417476|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
19417477|NCT02046395|Diuretics|diuretics|mesh-ancestor
19417478|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
19417479|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19417480|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19417481|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19417482|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19417483|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
19417484|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417485|NCT02046395|Urological Agents|urological agents|mesh-ancestor
19417486|NCT02044341|Benzocaine|benzocaine|mesh-list
19417487|NCT02044341|Glycerol|glycerol|mesh-list
19417488|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19417489|NCT02044341|Protective Agents|protective agents|mesh-ancestor
19708649|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708650|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708651|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19708652|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19417490|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417491|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
19417492|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
19417493|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19417494|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
19417495|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417496|NCT02042378|Rucaparib|rucaparib|mesh-list
19417497|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19417498|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417499|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417500|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417501|NCT02032277|Paclitaxel|paclitaxel|mesh-list
19417502|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
19417503|NCT02032277|Carboplatin|carboplatin|mesh-list
19417504|NCT02032277|Doxorubicin|doxorubicin|mesh-list
19417505|NCT02032277|Veliparib|veliparib|mesh-list
19417506|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19417507|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417508|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
19417509|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417510|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417511|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417512|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417513|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
19417514|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417515|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417516|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19417517|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
19417518|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19417519|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19417520|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19417521|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19417522|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417523|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19417524|NCT02030860|Gemcitabine|gemcitabine|mesh-list
19417525|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19417526|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417527|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
19417528|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417529|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417530|NCT02030860|Antiviral Agents|antiviral agents|mesh-ancestor
19417531|NCT02030860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417532|NCT02030860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417533|NCT02030860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19708653|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
19708654|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19708655|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19708656|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19708657|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19708658|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
19708659|NCT04812535|Vilobelimab|vilobelimab|mesh-list
19708660|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19708661|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855806|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855807|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855808|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855809|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855810|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
19855811|NCT00752102|Calcitriol|calcitriol|mesh-list
20248311|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
19708662|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19855812|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20286504|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
19708663|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248312|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20248313|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248314|NCT00436371|Amisulpride|amisulpride|mesh-list
20248315|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20248316|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20248317|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248318|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248319|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248320|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20248321|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
20248322|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248323|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248324|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19708664|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
19708665|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708666|NCT04812509|Denosumab|denosumab|mesh-list
20248325|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
20248326|NCT00436423|Gemcitabine|gemcitabine|mesh-list
20248327|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20248328|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
20248329|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248330|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248331|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
20248332|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248333|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248334|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248335|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
19855813|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855814|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19855815|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248336|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248337|NCT00436527|Metronidazole|metronidazole|mesh-list
20248338|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248339|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20248340|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20248341|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20248342|NCT00436540|Clobetasol|clobetasol|mesh-list
20248343|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855816|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855817|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20248344|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
20248345|NCT00436540|Hormones|hormones|mesh-ancestor
20248346|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248347|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248348|NCT00436579|Sorafenib|sorafenib|mesh-list
20248349|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248350|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20248351|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248352|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248353|NCT00436657|Cisplatin|cisplatin|mesh-list
20248354|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248355|NCT00436709|Paclitaxel|paclitaxel|mesh-list
20248356|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
20248357|NCT00436709|Bevacizumab|bevacizumab|mesh-list
20248358|NCT00436709|Doxorubicin|doxorubicin|mesh-list
20248359|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20248360|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20530915|NCT01791374|Rilotumumab|rilotumumab|mesh-list
20530916|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20530917|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20530918|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530919|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
20530920|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530921|NCT01791400|Sumatriptan|sumatriptan|mesh-list
20530922|NCT01791400|Metoclopramide|metoclopramide|mesh-list
19708667|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19708668|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733655|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733656|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248361|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20248362|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20530923|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
19708669|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
19708670|NCT04812028|Analgesics|analgesics|mesh-ancestor
19708671|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
20530924|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
20530925|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530926|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530927|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20530928|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20530929|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20530930|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
20530931|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530932|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530933|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20530934|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20530935|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19417534|NCT02030860|Immunologic Factors|immunologic factors|mesh-ancestor
19417535|NCT02030860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417536|NCT02026349|Favipiravir|favipiravir|mesh-list
19417537|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
19417538|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417539|NCT02019589|Progesterone|progesterone|mesh-list
19417540|NCT02019589|Progestins|progestins|mesh-ancestor
19417541|NCT02019589|Hormones|hormones|mesh-ancestor
19417542|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417543|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417544|NCT02018926|Azacitidine|azacitidine|mesh-list
19417545|NCT02018926|Mocetinostat|mocetinostat|mesh-list
19417546|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417547|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
20248363|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
20248364|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
20248365|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
20248366|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248367|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248368|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
20248369|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248370|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20248371|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19417548|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417549|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708672|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708673|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708674|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
19708675|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708676|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19708677|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
19708678|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19708679|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248372|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
20248373|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20248374|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20248375|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20248376|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20248377|NCT00436709|Growth Substances|growth substances|mesh-ancestor
20248378|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
20248379|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20530936|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
19708680|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708681|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19708682|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
19708683|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708684|NCT04811573|Thalidomide|thalidomide|mesh-list
19708685|NCT04811573|Apremilast|apremilast|mesh-list
19708686|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19708687|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19417550|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248380|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20530937|NCT01791439|Lidocaine|lidocaine|mesh-list
20530938|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
20530939|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
20530940|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530941|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530942|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
20530943|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530944|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20530945|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20530946|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20530947|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20530948|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530949|NCT01791608|Zinc|zinc|mesh-list
20530950|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
20530951|NCT01791608|Trace Elements|trace elements|mesh-ancestor
20530952|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
20530953|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530954|NCT01791608|Astringents|astringents|mesh-ancestor
20530955|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
20530956|NCT01791647|Inositol|inositol|mesh-list
20530957|NCT01791647|Metformin|metformin|mesh-list
20530958|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20530959|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530960|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
20530961|NCT01791647|Vitamins|vitamins|mesh-ancestor
19417551|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19417552|NCT02017717|Bevacizumab|bevacizumab|mesh-list
19417553|NCT02017717|Nivolumab|nivolumab|mesh-list
19417554|NCT02017717|Ipilimumab|ipilimumab|mesh-list
19417555|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417556|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417557|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417558|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417559|NCT02017717|Growth Substances|growth substances|mesh-ancestor
19417560|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417561|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417562|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19417563|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417564|NCT02014649|Laninamivir|laninamivir|mesh-list
19417565|NCT02014649|Zanamivir|zanamivir|mesh-list
19417566|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
19417567|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417568|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417569|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417570|NCT02014142|Latanoprost|latanoprost|mesh-list
19417571|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19417572|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19417573|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
19417574|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
19417575|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
19417576|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19417577|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417578|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
19417579|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530962|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
19417580|NCT02009579|Nintedanib|nintedanib|mesh-list
20530963|NCT01791699|Moxonidine|moxonidine|mesh-list
20530964|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20530965|NCT01791751|Clomiphene|clomiphene|mesh-list
20530966|NCT01791751|Enclomiphene|enclomiphene|mesh-list
20530967|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
20530968|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20530969|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
20530970|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248381|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20248382|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248383|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
20248384|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20248385|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
20248386|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530971|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530972|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20530973|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
20530974|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20530975|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20530976|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20530977|NCT01791868|Valproic Acid|valproic acid|mesh-list
20530978|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
20530979|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20530980|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708688|NCT04811573|Analgesics|analgesics|mesh-ancestor
20248387|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248388|NCT00436761|Cyclosporine|cyclosporine|mesh-list
20248389|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
20248390|NCT00436761|Melphalan|melphalan|mesh-list
20248391|NCT00436761|Busulfan|busulfan|mesh-list
20248392|NCT00436761|Cyclosporins|cyclosporins|mesh-list
20248393|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20248394|NCT00436761|Sargramostim|sargramostim|mesh-list
20530981|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
19855818|NCT00752102|Vitamins|vitamins|mesh-ancestor
19417581|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417582|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417583|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417584|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417585|NCT02008344|Favipiravir|favipiravir|mesh-list
19417586|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
19417587|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417588|NCT01999764|Retinol acetate|retinol acetate|mesh-list
19417589|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19417590|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
20530982|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530983|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530984|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
20530985|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20530986|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20530987|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20530988|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
20530989|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20530990|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20530991|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20530992|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855819|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
19855820|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19417591|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417592|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19417593|NCT01999764|Protective Agents|protective agents|mesh-ancestor
19417594|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417595|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
19417596|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19417597|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417598|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19417599|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
19417600|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19417601|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417602|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708689|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
19708690|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708691|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708692|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708693|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708694|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19708695|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19708696|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708697|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708698|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19708699|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
19708700|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
19969565|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708701|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19417603|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417604|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19417605|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417606|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417607|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417608|NCT01998035|Azacitidine|azacitidine|mesh-list
19417609|NCT01998035|Romidepsin|romidepsin|mesh-list
19417610|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417611|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
19417612|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417613|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417614|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708702|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708703|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19708704|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19708705|NCT04811573|Growth Substances|growth substances|mesh-ancestor
19708706|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19708707|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708708|NCT04811911|Methotrexate|methotrexate|mesh-list
19708709|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19708710|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
19708711|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708712|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708713|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19708714|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
19708715|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708716|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708717|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708718|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708719|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19708720|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19708721|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
19708722|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708723|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19708724|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19708725|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
19708726|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708727|NCT04811326|Latanoprost|latanoprost|mesh-list
19708728|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19708729|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19708730|NCT04811209|Analgesics|analgesics|mesh-list
19708731|NCT04811209|Anesthetics|anesthetics|mesh-list
19708732|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708733|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708734|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
19708735|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708736|NCT04811313|Bupivacaine|bupivacaine|mesh-list
19708737|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
19708738|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
19708739|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
19708740|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708741|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708742|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
19708743|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855821|NCT00752206|Saracatinib|saracatinib|mesh-list
19708744|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19708745|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19855822|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855823|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855824|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855825|NCT00752219|Metronidazole|metronidazole|mesh-list
19855826|NCT00752219|Meropenem|meropenem|mesh-list
19708746|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855827|NCT00752219|Ceftazidime|ceftazidime|mesh-list
19855828|NCT00752219|Avibactam|avibactam|mesh-list
19855829|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855830|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19855831|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19855832|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19855833|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19708747|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
19708748|NCT04811313|Coagulants|coagulants|mesh-ancestor
19708749|NCT04811001|Osimertinib|osimertinib|mesh-list
19708750|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708751|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19708752|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708753|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708754|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
19708755|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19708756|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19708757|NCT04810819|Prednisolone|prednisolone|mesh-list
19855834|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248395|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286505|NCT03432949|Hormones|hormones|mesh-ancestor
20248396|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248397|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248398|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
20248399|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248400|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
20248401|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248402|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
20248403|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20248404|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20248405|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248406|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
20248407|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
20248408|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248409|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20248410|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
20248411|NCT00436761|Hormones|hormones|mesh-ancestor
20248412|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248413|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20248414|NCT00436761|Protective Agents|protective agents|mesh-ancestor
20248415|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708758|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
20248416|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20248417|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
19708759|NCT04810819|Dyphylline|dyphylline|mesh-list
19417615|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19417616|NCT01994382|Rituximab|rituximab|mesh-list
19417617|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417618|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417619|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
19417620|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417621|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417622|NCT01993641|Azacitidine|azacitidine|mesh-list
19417623|NCT01993641|Decitabine|decitabine|mesh-list
19417624|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417625|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
19417626|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417627|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417628|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417629|NCT01989429|Vitamin D|vitamin d|mesh-list
19417630|NCT01989429|Vitamins|vitamins|mesh-ancestor
19417631|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
19417632|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417633|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19417634|NCT01989325|Dexamethasone|dexamethasone|mesh-list
19417635|NCT01989325|Filanesib|filanesib|mesh-list
19417636|NCT01989325|Lenograstim|lenograstim|mesh-list
19417637|NCT01989325|Sargramostim|sargramostim|mesh-list
19417638|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19417639|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19417640|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
19417641|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
19417642|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417643|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417644|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19417645|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
19417646|NCT01989325|Hormones|hormones|mesh-ancestor
19417647|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417648|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19417649|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417650|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19417651|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
19417652|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
19417653|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417654|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417655|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417656|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417657|NCT01983306|Dolcanatide|dolcanatide|mesh-list
19417658|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19417659|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
19417660|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417661|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19417662|NCT01978366|Halofuginone|halofuginone|mesh-list
19417663|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417664|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
19417665|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19417666|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19417667|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417668|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19417669|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417670|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708760|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19417671|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19417672|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417673|NCT01978366|Growth Substances|growth substances|mesh-ancestor
19708761|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
19708762|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708763|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
19708764|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
19708765|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248418|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20248419|NCT00436787|PENTA|penta|mesh-list
20248420|NCT00436787|Fondaparinux|fondaparinux|mesh-list
20248421|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20248422|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
20248423|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20248424|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
20248425|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248426|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248427|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
20248428|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19708766|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708767|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19417674|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417675|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417676|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
19417677|NCT01975818|Hematinics|hematinics|mesh-ancestor
19417678|NCT01975610|Spebrutinib|spebrutinib|mesh-list
19417679|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417680|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417681|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417682|NCT01973049|Ribavirin|ribavirin|mesh-list
19417683|NCT01973049|Asunaprevir|asunaprevir|mesh-list
19417684|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
19855835|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855836|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
19855837|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19855838|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
19855839|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417685|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417686|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
19417687|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417688|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
19417689|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417690|NCT01972854|Riboflavin|riboflavin|mesh-list
19417691|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19417692|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
19417693|NCT01972854|Vitamins|vitamins|mesh-ancestor
19417694|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
19417695|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417696|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19417697|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
19417698|NCT01970501|Metoprolol|metoprolol|mesh-list
19417699|NCT01970501|Bucindolol|bucindolol|mesh-list
19417700|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19417701|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19417702|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
19417703|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
19417704|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417705|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417706|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19417707|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19417708|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19417709|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
19417710|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417711|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417712|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
19417713|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
19417714|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19417715|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19417716|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19417717|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417718|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417719|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417720|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
19417721|NCT01968733|Solithromycin|solithromycin|mesh-list
19417722|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19417723|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417724|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19417725|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19417726|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417727|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417728|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417729|NCT01967810|Bevacizumab|bevacizumab|mesh-list
19417730|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19417731|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417732|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19708768|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
19708769|NCT04810819|Hormones|hormones|mesh-ancestor
19708770|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708771|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19708772|NCT04810819|Protective Agents|protective agents|mesh-ancestor
19708773|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19855840|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
19855841|NCT00752557|Vitamin D|vitamin d|mesh-list
19855842|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
20248429|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20248430|NCT00436800|Gemcitabine|gemcitabine|mesh-list
20248431|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
20248432|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19708774|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708775|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19708776|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19708777|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
20248433|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
19417733|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19417734|NCT01967810|Growth Substances|growth substances|mesh-ancestor
19417735|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417736|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
19417737|NCT01964989|Vaccines|vaccines|mesh-list
19708778|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19708779|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248434|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248435|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248436|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
20248437|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248438|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248439|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248440|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
20248441|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248442|NCT00436826|Interferons|interferons|mesh-list
20248443|NCT00436826|Interferon-beta|interferon-beta|mesh-list
20248444|NCT00436826|Cladribine|cladribine|mesh-list
20248445|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
20248446|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248447|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
20248448|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248449|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
20248450|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248451|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248452|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20248453|NCT00436839|Prednisone|prednisone|mesh-list
20248454|NCT00436839|Docetaxel|docetaxel|mesh-list
20248455|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
20530993|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20530994|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
20530995|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20530996|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20530997|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20530998|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20530999|NCT01791985|Letrozole|letrozole|mesh-list
20531000|NCT01791985|Anastrozole|anastrozole|mesh-list
20531001|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531002|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20531003|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19855843|NCT00752557|Diphosphonates|diphosphonates|mesh-list
19855844|NCT00752557|Vitamins|vitamins|mesh-list
19855845|NCT00752557|Calcium|calcium|mesh-list
19855846|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
19417738|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
19855847|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531004|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531005|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531006|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20531007|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
20531008|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531009|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531010|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20531011|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
20531012|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20531013|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20531014|NCT01792037|Prednisolone|prednisolone|mesh-list
19417739|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531015|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
20531016|NCT01792037|Midazolam|midazolam|mesh-list
20531017|NCT01792037|Etomidate|etomidate|mesh-list
20531018|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20531019|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
20248456|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248457|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
20248458|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
20248459|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19855848|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20288551|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20248460|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417740|NCT01963208|Ganaxolone|ganaxolone|mesh-list
19417741|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
19417742|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417743|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417744|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417745|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
19417746|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
19417747|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20248461|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248462|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
20248463|NCT00436839|Hormones|hormones|mesh-ancestor
20248464|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248465|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248466|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19417748|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19417749|NCT01959282|Niacinamide|niacinamide|mesh-list
19417750|NCT01959282|Peficitinib|peficitinib|mesh-list
19417751|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417752|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417753|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417754|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
19417755|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417756|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
19417757|NCT01959282|Vitamins|vitamins|mesh-ancestor
19417758|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
19417759|NCT01956812|Gemcitabine|gemcitabine|mesh-list
19417760|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417761|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
19417762|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417763|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417764|NCT01956812|Antiviral Agents|antiviral agents|mesh-ancestor
19417765|NCT01956812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417766|NCT01956812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248467|NCT00436839|Analgesics|analgesics|mesh-ancestor
19708780|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708781|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
19708782|NCT04810754|Daratumumab|daratumumab|mesh-list
19708783|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417767|NCT01956812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417768|NCT01956812|Immunologic Factors|immunologic factors|mesh-ancestor
19417769|NCT01956812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417770|NCT01952990|Phenylephrine|phenylephrine|mesh-list
19417771|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
19417772|NCT01952990|Tetracaine|tetracaine|mesh-list
19417773|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
19417774|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
19417775|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19417776|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417777|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
19417778|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417779|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19417780|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19417781|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
19417782|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417783|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417784|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
19417785|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
19417786|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
19417787|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19417788|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
19417789|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19417790|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
19417791|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19417792|NCT01952990|Protective Agents|protective agents|mesh-ancestor
19450514|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452686|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19452687|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19855849|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19855850|NCT00752622|Infliximab|infliximab|mesh-list
19855851|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
19855852|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19855853|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855854|NCT00752726|Orlistat|orlistat|mesh-list
19855855|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855856|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855857|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19855858|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19855859|NCT00752856|Ritonavir|ritonavir|mesh-list
19855860|NCT00752856|Lopinavir|lopinavir|mesh-list
19855861|NCT00752856|Tenofovir|tenofovir|mesh-list
19855862|NCT00752856|Emtricitabine|emtricitabine|mesh-list
19417793|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19855863|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
20248468|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
20248469|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248470|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20248471|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20248472|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248473|NCT00436930|Sargramostim|sargramostim|mesh-list
20248474|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
20248475|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248476|NCT00436943|Bupropion|bupropion|mesh-list
20531020|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20531021|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20531022|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531023|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531024|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20531025|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20531026|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20531027|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20531028|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
20531029|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
20531030|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
20531031|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
20248477|NCT00436943|Nicotine|nicotine|mesh-list
20248478|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20248479|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
20248480|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417794|NCT01941836|Ezetimibe|ezetimibe|mesh-list
19417795|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19417796|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19417797|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
19417798|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417799|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19417800|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417801|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417802|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417803|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
19708784|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20248481|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248482|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20248483|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20248484|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
20248485|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248486|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248487|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20248488|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
20248489|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248490|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20248491|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20248492|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19417804|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19708785|NCT04810507|Anagliptin|anagliptin|mesh-list
20248493|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
20248494|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20248495|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19708786|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20248496|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248497|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
20248498|NCT00436995|Hematinics|hematinics|mesh-ancestor
20248499|NCT00437008|Benphothiamine|benphothiamine|mesh-list
20248500|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20248501|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
20248502|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248503|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
20248504|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
20248505|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248506|NCT00437086|Bortezomib|bortezomib|mesh-list
20248507|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248508|NCT00437164|Insulin|insulin|mesh-list
20248509|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20248510|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20248511|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248512|NCT00437177|Apomorphine|apomorphine|mesh-list
19969566|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
20248513|NCT00437177|Emetics|emetics|mesh-ancestor
20248514|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248515|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
19417805|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19417806|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19417807|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19417808|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417809|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
19417810|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417811|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417812|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19417813|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417814|NCT01930357|Vaccines|vaccines|mesh-list
19417815|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
19417816|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417817|NCT01927198|Verinurad|verinurad|mesh-list
19417818|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
19417819|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417820|NCT01922843|Calcitriol|calcitriol|mesh-list
19417821|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19417822|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417823|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19417824|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19417825|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417826|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19417827|NCT01922843|Vitamins|vitamins|mesh-ancestor
19417828|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
19417829|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19417830|NCT01917383|Timolol|timolol|mesh-list
19417831|NCT01917383|Latanoprost|latanoprost|mesh-list
19417832|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19417833|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19417834|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
19417835|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19417836|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417837|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417838|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19417839|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19417840|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19417841|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19417842|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
19417843|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19417844|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19417845|NCT01909427|Methotrexate|methotrexate|mesh-list
19417846|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19417847|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
19417848|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19417849|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417850|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417851|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
19417852|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417853|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417854|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
19417855|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417856|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19417857|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417858|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
19417859|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417860|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19417861|NCT01908738|Lidocaine|lidocaine|mesh-list
19417862|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
19417863|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
19417864|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708787|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708788|NCT04810507|Incretins|incretins|mesh-ancestor
20531032|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531033|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531034|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20531035|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
20531036|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
20531037|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531038|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531039|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
20531040|NCT01792037|Hormones|hormones|mesh-ancestor
20531041|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531042|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19417865|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708789|NCT04810507|Hormones|hormones|mesh-ancestor
20248516|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248517|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20248518|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
20248519|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
20248520|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248521|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248522|NCT00437216|Clobetasol|clobetasol|mesh-list
20248523|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248524|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
20248525|NCT00437216|Hormones|hormones|mesh-ancestor
20248526|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708790|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708791|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19708792|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
19708793|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248527|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248528|NCT00437229|Dexamethasone|dexamethasone|mesh-list
20248529|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
19708794|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248530|NCT00437229|Ondansetron|ondansetron|mesh-list
20248531|NCT00437229|Casopitant|casopitant|mesh-list
20248532|NCT00437229|BB 1101|bb 1101|mesh-list
20248533|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248534|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
19708795|NCT04810572|Silymarin|silymarin|mesh-list
19708796|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
20248535|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
20248536|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417866|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
19708797|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708798|NCT04810572|Protective Agents|protective agents|mesh-ancestor
19708799|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708800|NCT04810585|Aflibercept|aflibercept|mesh-list
19855864|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19855865|NCT00752856|Efavirenz|efavirenz|mesh-list
19855866|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19708801|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19708802|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19708803|NCT04810585|Growth Substances|growth substances|mesh-ancestor
19708804|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708805|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
19708806|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733657|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733658|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
19417867|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417868|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19417869|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19417870|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19417871|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19417872|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417873|NCT01904409|Rifaximin|rifaximin|mesh-list
19417874|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19417875|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417876|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19417877|NCT01903954|Ribavirin|ribavirin|mesh-list
19417878|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19417879|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
19417880|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733659|NCT04559425|Hormones|hormones|mesh-ancestor
19417881|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
19417882|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417883|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
19417884|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
19417885|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417886|NCT01902381|Protective Agents|protective agents|mesh-ancestor
19417887|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417888|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
19417889|NCT01902381|Vitamins|vitamins|mesh-ancestor
19417890|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
19417891|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19417892|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417893|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417894|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417895|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417896|NCT01896531|Leucovorin|leucovorin|mesh-list
19417897|NCT01896531|Fluorouracil|fluorouracil|mesh-list
19417898|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
19417899|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
19417900|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248537|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248538|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20248539|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
20248540|NCT00437229|Hormones|hormones|mesh-ancestor
20248541|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248542|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20248543|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417901|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417902|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417903|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417904|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
19417905|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417906|NCT01896531|Antidotes|antidotes|mesh-ancestor
19417907|NCT01896531|Protective Agents|protective agents|mesh-ancestor
19417908|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
19417909|NCT01896531|Vitamins|vitamins|mesh-ancestor
19417910|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
19417911|NCT01893190|Nimodipine|nimodipine|mesh-list
19417912|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19417913|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19417914|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19417915|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417916|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19417917|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417918|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
19417919|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19417920|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417921|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19417922|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417923|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417924|NCT01877395|Vaccines|vaccines|mesh-list
19417925|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
19417926|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417927|NCT01874626|Ibuprofen|ibuprofen|mesh-list
19417928|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19417929|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19417930|NCT01874626|Analgesics|analgesics|mesh-ancestor
19417931|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
19417932|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19417933|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417934|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19417935|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417936|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19417937|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417938|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417939|NCT01873703|Azacitidine|azacitidine|mesh-list
19417940|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417941|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
20248544|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
20248545|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248546|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248547|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
19417942|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450515|NCT03427554|Tretinoin|tretinoin|mesh-list
19708807|NCT04809818|Aspirin|aspirin|mesh-list
19708808|NCT04809818|Dabigatran|dabigatran|mesh-list
19708809|NCT04809818|Apixaban|apixaban|mesh-list
19708810|NCT04809818|Clopidogrel|clopidogrel|mesh-list
19417943|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417944|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417945|NCT01871415|Metformin|metformin|mesh-list
19417946|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19417947|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417948|NCT01870505|Letrozole|letrozole|mesh-list
19417949|NCT01870505|Exemestane|exemestane|mesh-list
19417950|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417951|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19417952|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19417953|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417954|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417955|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19417956|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
19417957|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19417958|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417959|NCT01866930|Interferons|interferons|mesh-list
19417960|NCT01866930|Ribavirin|ribavirin|mesh-list
19417961|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417962|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
19417963|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417964|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
19417965|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417966|NCT01862224|Methotrexate|methotrexate|mesh-list
19417967|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19417968|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
19417969|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19417970|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417971|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19417972|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
19417973|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417974|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417975|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
19417976|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19417977|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19417978|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19417979|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
19417980|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19417981|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19417982|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19417983|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19417984|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
19417985|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417986|NCT01859962|Ribavirin|ribavirin|mesh-list
19417987|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
19417988|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417989|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
19417990|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19417991|NCT01858883|Gemcitabine|gemcitabine|mesh-list
19417992|NCT01858883|Paclitaxel|paclitaxel|mesh-list
19417993|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19708811|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20248548|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
20248549|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20248550|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
20248551|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248552|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20248553|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20248554|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248555|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248556|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20248557|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20248558|NCT00437255|Betamethasone|betamethasone|mesh-list
20248559|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
20248560|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20248561|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
19708812|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19708813|NCT04809818|Analgesics|analgesics|mesh-ancestor
19708814|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
19708815|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708816|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708817|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248562|NCT00437255|Clobetasol|clobetasol|mesh-list
20248563|NCT00437255|Calcipotriene|calcipotriene|mesh-list
20248564|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20248565|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248566|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
20248567|NCT00437255|Hormones|hormones|mesh-ancestor
20248568|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855867|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20248569|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19417994|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19417995|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
19417996|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
19417997|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
19417998|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19417999|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418000|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
19418001|NCT01858883|Antiviral Agents|antiviral agents|mesh-ancestor
19418002|NCT01858883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418003|NCT01858883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418004|NCT01858883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418005|NCT01858883|Immunologic Factors|immunologic factors|mesh-ancestor
19418006|NCT01858883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418007|NCT01847573|Halofuginone|halofuginone|mesh-list
19418008|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418009|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
19418010|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19418011|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19418012|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418013|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19418014|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418015|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248570|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19418016|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20531043|NCT01792037|Protective Agents|protective agents|mesh-ancestor
20531044|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20531045|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248571|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
20248572|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
20248573|NCT00437307|Topotecan|topotecan|mesh-list
20248574|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20248575|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20248576|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248577|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248578|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248579|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20248580|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20248581|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708818|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708819|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19708820|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19708821|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708822|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19708823|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19708824|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708825|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
19708826|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20248582|NCT00437333|Metformin|metformin|mesh-list
19708827|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19708828|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19708829|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
19708830|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708831|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
19708832|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19708833|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19708834|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
19708835|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19708836|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
19708837|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
20248583|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20248584|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248585|NCT00437359|Toremifene|toremifene|mesh-list
20248586|NCT00437359|Anastrozole|anastrozole|mesh-list
20248587|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248588|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20248589|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248590|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20248591|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20248592|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248593|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20248594|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
19452688|NCT03411798|Analgesics|analgesics|mesh-ancestor
19855868|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
19855869|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855870|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855871|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19855872|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19855873|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
19855874|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855875|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19855876|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19855877|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19855878|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19855879|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19855880|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19855881|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19708838|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19708839|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19708840|NCT04810156|Prednisolone|prednisolone|mesh-list
19708841|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
19708842|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19708843|NCT04810156|Tacrolimus|tacrolimus|mesh-list
19708844|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19855882|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19855883|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19855884|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19855885|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19855886|NCT00752973|Malathion|malathion|mesh-list
19855887|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19855888|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855889|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855890|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
19855891|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855892|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855893|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19855894|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19855895|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855896|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19855897|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19855898|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855899|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418017|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19418018|NCT01847573|Growth Substances|growth substances|mesh-ancestor
19418019|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418020|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19418021|NCT01846481|Cocaine|cocaine|mesh-list
19418022|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
19418023|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
19418024|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19418025|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418026|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
19418027|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418028|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19418029|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19418030|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19418031|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19418032|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418033|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
19418034|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418035|NCT01836432|Leucovorin|leucovorin|mesh-list
19418036|NCT01836432|Gemcitabine|gemcitabine|mesh-list
19708845|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
19418037|NCT01836432|Paclitaxel|paclitaxel|mesh-list
19418038|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19418039|NCT01836432|Fluorouracil|fluorouracil|mesh-list
19418040|NCT01836432|Capecitabine|capecitabine|mesh-list
19418041|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
19418042|NCT01836432|Irinotecan|irinotecan|mesh-list
19418043|NCT01836432|Folfirinox|folfirinox|mesh-list
19418044|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19418045|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418046|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418047|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418048|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
19708846|NCT04810156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855900|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
19855901|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19855902|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19855903|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19855904|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19855905|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19855906|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
19855907|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855908|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
19855909|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855910|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855911|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19855912|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
19855913|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855914|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855915|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19855916|NCT00753337|Cobalt|cobalt|mesh-list
20248595|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855917|NCT00753337|Trace Elements|trace elements|mesh-ancestor
19418049|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418050|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418051|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
19418052|NCT01836432|Antiviral Agents|antiviral agents|mesh-ancestor
19418053|NCT01836432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418054|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418055|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418056|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
19418057|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418058|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19418059|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19418060|NCT01836432|Antidotes|antidotes|mesh-ancestor
19418061|NCT01836432|Protective Agents|protective agents|mesh-ancestor
19418062|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
19418063|NCT01836432|Vitamins|vitamins|mesh-ancestor
19418064|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
19418065|NCT01825980|Ritonavir|ritonavir|mesh-list
19418066|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19418067|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19418068|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
19418069|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418070|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418071|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19418072|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19418073|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
19418074|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418075|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19418076|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19418077|NCT01818921|CKD732|ckd732|mesh-list
19418078|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19418079|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19708847|NCT04810156|Immunologic Factors|immunologic factors|mesh-ancestor
19708848|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708849|NCT04810156|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19708850|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735804|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19418080|NCT01818921|Growth Substances|growth substances|mesh-ancestor
20248596|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418081|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418082|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
19418083|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418084|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
19418085|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19418086|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19418087|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19418088|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855918|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
19855919|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855920|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
19855921|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855922|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
19855923|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855924|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19855925|NCT00753506|Artemisinins|artemisinins|mesh-list
19855926|NCT00753506|Artemisinin|artemisinin|mesh-list
19855927|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
19855928|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19855929|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19855930|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248597|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20248598|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20248599|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20248600|NCT00437372|Sunitinib|sunitinib|mesh-list
20248601|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248602|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20248603|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19450516|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855931|NCT00753636|Isradipine|isradipine|mesh-list
19855932|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19855933|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19450517|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
19450518|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
19450519|NCT03427502|Epinephrine|epinephrine|mesh-list
19450520|NCT03427502|Bupivacaine|bupivacaine|mesh-list
19450521|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
19450522|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
19450523|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450524|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450525|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
19855934|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19855935|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418089|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418090|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
19418091|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418092|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418093|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19418094|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418095|NCT01811576|Hormones|hormones|mesh-list
19418096|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418097|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418098|NCT01810575|Alprostadil|alprostadil|mesh-list
19418099|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19418100|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
19418101|NCT01810575|Urological Agents|urological agents|mesh-ancestor
19450526|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450527|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19450528|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19450529|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
19450530|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450531|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450532|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19450533|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19450534|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
19450535|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19450536|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
19450537|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
19450538|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
19450539|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19450540|NCT03427437|Epinephrine|epinephrine|mesh-list
19450541|NCT03427437|Racepinephrine|racepinephrine|mesh-list
19450542|NCT03427437|Bupivacaine|bupivacaine|mesh-list
19450543|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
19450544|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
19450545|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
19450546|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450547|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450548|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
19450549|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450550|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19450551|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19450552|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
19450553|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450554|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450555|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19450556|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19450557|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
19450558|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19450559|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
19450560|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
19450561|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
19450562|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19450563|NCT03427385|Ropivacaine|ropivacaine|mesh-list
19450564|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
19450565|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
20248604|NCT00437372|Growth Substances|growth substances|mesh-ancestor
20248605|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708851|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708852|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19708853|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708854|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19708855|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
19708856|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19708857|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708858|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708859|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
20248606|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
20248607|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20248608|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248609|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248610|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
20248611|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
20248612|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248613|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248614|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248615|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
20248616|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20248617|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19418102|NCT01807546|ON 01910|on 01910|mesh-list
19418103|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418104|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19418105|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708860|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
19708861|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708862|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19708863|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
19708864|NCT04810156|Hormones|hormones|mesh-ancestor
19708865|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708866|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19708867|NCT04810156|Protective Agents|protective agents|mesh-ancestor
19708868|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708869|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19708870|NCT04809974|Niacinamide|niacinamide|mesh-list
19708871|NCT04809974|Vitamins|vitamins|mesh-ancestor
19708872|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
19708873|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708874|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
19708875|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
19708876|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708877|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
19855936|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19855937|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855938|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
19855939|NCT00753675|Gemcitabine|gemcitabine|mesh-list
19855940|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19855941|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
19855942|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855943|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855944|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
19855945|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855946|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708878|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
19855947|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855948|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
20531046|NCT01792063|Sevoflurane|sevoflurane|mesh-list
20531047|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20531048|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20531049|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
20531050|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
20531051|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531052|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531053|NCT01792102|Dexamethasone|dexamethasone|mesh-list
20531054|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20531055|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
20531056|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
19418106|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418107|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
19418108|NCT01804829|Antibodies|antibodies|mesh-list
19418109|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
19418110|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19418111|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19418112|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
19418113|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
19418114|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418115|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19418116|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19418117|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
19418118|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418119|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418120|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19418121|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418122|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19418123|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19418124|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19418125|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
19418126|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418127|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418128|NCT01795911|Interferons|interferons|mesh-list
19418129|NCT01795911|Ribavirin|ribavirin|mesh-list
19418130|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418131|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
19418132|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418133|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
19418134|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855949|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855950|NCT00753714|Gemcitabine|gemcitabine|mesh-list
19855951|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19855952|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
19855953|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855954|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19855955|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
19855956|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19855957|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855958|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19855959|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
19855960|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855961|NCT00753896|Exenatide|exenatide|mesh-list
19855962|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19708879|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708880|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
19708881|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708882|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19708883|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
19708884|NCT04809662|Imiquimod|imiquimod|mesh-list
19708885|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19708886|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
19855963|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708887|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855964|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19855965|NCT00753896|Incretins|incretins|mesh-ancestor
19855966|NCT00753896|Hormones|hormones|mesh-ancestor
19855967|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855968|NCT00753935|Aspirin|aspirin|mesh-list
19855969|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19855970|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19855971|NCT00753935|Analgesics|analgesics|mesh-ancestor
19855972|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
19855973|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19855974|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855975|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19855976|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19418135|NCT01792050|Paclitaxel|paclitaxel|mesh-list
19855977|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19418136|NCT01792050|Docetaxel|docetaxel|mesh-list
20248618|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248619|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
20248620|NCT00437450|Hematinics|hematinics|mesh-ancestor
20248621|NCT00437463|Ramipril|ramipril|mesh-list
20248622|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20248623|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
20248624|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288552|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708888|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708889|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
19708890|NCT04809649|Itraconazole|itraconazole|mesh-list
19708891|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
19418137|NCT01792050|Tryptophan|tryptophan|mesh-list
19418138|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19418139|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418140|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418141|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418142|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418143|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855978|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19855979|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19855980|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19855981|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19418144|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19418145|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
19418146|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19418147|NCT01790100|Ribavirin|ribavirin|mesh-list
19418148|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
19418149|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418150|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
19855982|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19855983|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
19855984|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
19855985|NCT00754065|Dienogest|dienogest|mesh-list
19855986|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19855987|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19855988|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19855989|NCT00754065|Estradiol|estradiol|mesh-list
19855990|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19855991|NCT00754065|Estrogens|estrogens|mesh-ancestor
19855992|NCT00754065|Hormones|hormones|mesh-ancestor
19855993|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19855994|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19855995|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19418151|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418152|NCT01789736|Travoprost|travoprost|mesh-list
19418153|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19855996|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
19855997|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19855998|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19855999|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19856000|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19856001|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19856002|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
19856003|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19856004|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856005|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19856006|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19856007|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856008|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19856009|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19856010|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418154|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19418155|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19418156|NCT01785771|Exenatide|exenatide|mesh-list
19418157|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418158|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418159|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19418160|NCT01785771|Incretins|incretins|mesh-ancestor
19418161|NCT01785771|Hormones|hormones|mesh-ancestor
19418162|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418163|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
19418164|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19418165|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
19418166|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418167|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418168|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19418169|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418170|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
19418171|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19418172|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
19418173|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418174|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418175|NCT01784874|Vaccines|vaccines|mesh-list
19418176|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
19418177|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418178|NCT01782729|Tacrolimus|tacrolimus|mesh-list
19418179|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418180|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
19418181|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418182|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19418183|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418184|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418185|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
19418186|NCT01780844|Prednisone|prednisone|mesh-list
19418187|NCT01780844|Tacrolimus|tacrolimus|mesh-list
19418188|NCT01780844|Basiliximab|basiliximab|mesh-list
19418189|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418190|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
19418191|NCT01780844|Hormones|hormones|mesh-ancestor
19418192|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418193|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418194|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19418195|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418196|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418197|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
19418198|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19418199|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418200|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418201|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19418202|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19418203|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
19418204|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19418205|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418206|NCT01780428|Acetaminophen|acetaminophen|mesh-list
19418207|NCT01780428|Promethazine|promethazine|mesh-list
19418208|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
19418209|NCT01780428|Hydrocodone|hydrocodone|mesh-list
19418210|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19418211|NCT01780428|Analgesics|analgesics|mesh-ancestor
19418212|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
19418213|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418214|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418215|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
19418216|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19418217|NCT01780428|Narcotics|narcotics|mesh-ancestor
19418218|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19418219|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
19418220|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418221|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
19418222|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
19418223|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19418224|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
19418225|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
19418226|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418227|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418228|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19418229|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19418230|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19418231|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
19418232|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
19418233|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
19418234|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
19418235|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19418236|NCT01779947|Estradiol|estradiol|mesh-list
19418237|NCT01779947|Estrogens|estrogens|mesh-ancestor
19418238|NCT01779947|Hormones|hormones|mesh-ancestor
19418239|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418240|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856011|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856012|NCT00754208|Methylphenidate|methylphenidate|mesh-list
19708892|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708893|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19708894|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19708895|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708896|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708897|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19708898|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
19708899|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248625|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248626|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20248627|NCT00437476|Ribavirin|ribavirin|mesh-list
20248628|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20248629|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20248630|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
20248631|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248632|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
20248633|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856013|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19856014|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856015|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19856016|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19856017|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248634|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20248635|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248636|NCT00437502|Vaccines|vaccines|mesh-list
20248637|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
20248638|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248639|NCT00437554|Glimepiride|glimepiride|mesh-list
20288553|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
20248640|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20248641|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20248642|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248643|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248644|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
20248645|NCT00437606|Ethanol|ethanol|mesh-list
20248646|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20248647|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708900|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708901|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19708902|NCT04809532|Tramadol|tramadol|mesh-list
19708903|NCT04809532|Bupivacaine|bupivacaine|mesh-list
19708904|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
19708905|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
19708906|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708907|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708908|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
19708909|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708910|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19708911|NCT04809532|Narcotics|narcotics|mesh-ancestor
19708912|NCT04809532|Analgesics|analgesics|mesh-ancestor
19708913|NCT04809116|Pimavanserin|pimavanserin|mesh-list
20248648|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708914|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19708915|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19708916|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20248649|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248650|NCT00437619|Calcipotriene|calcipotriene|mesh-list
20248651|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
20248652|NCT00437632|Caffeine|caffeine|mesh-list
20248653|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20248654|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248655|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20248656|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248657|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248658|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20248659|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20248660|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
20248661|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248662|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
20248663|NCT00437671|Antibodies|antibodies|mesh-list
20248664|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
20248665|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20248666|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20248667|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
20288554|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418241|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19418242|NCT01779453|Atorvastatin|atorvastatin|mesh-list
19418243|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20288555|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418244|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19418245|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
19418246|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418247|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19418248|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19418249|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418250|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418251|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418252|NCT01777555|Levodopa|levodopa|mesh-list
19418253|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19418254|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19418255|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
19418256|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418257|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418258|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418259|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
19418260|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19418261|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19418262|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19418263|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19418264|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418265|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
19418266|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418267|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418268|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19418269|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418270|NCT01774578|Gemcitabine|gemcitabine|mesh-list
19418271|NCT01774578|Docetaxel|docetaxel|mesh-list
19418272|NCT01774578|Pemetrexed|pemetrexed|mesh-list
19418273|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418274|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
20248668|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248669|NCT00437684|Ribavirin|ribavirin|mesh-list
20248670|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20248671|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
20248672|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248673|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
20248674|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286506|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286507|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286508|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286509|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
20286510|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286511|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286512|NCT03421288|Leucovorin|leucovorin|mesh-list
20286513|NCT03421288|Docetaxel|docetaxel|mesh-list
20286514|NCT03421288|Fluorouracil|fluorouracil|mesh-list
20286515|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
20286516|NCT03421288|Atezolizumab|atezolizumab|mesh-list
20286517|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286518|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286519|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286520|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418275|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418276|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418277|NCT01774578|Antiviral Agents|antiviral agents|mesh-ancestor
19418278|NCT01774578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418279|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418280|NCT01774578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418281|NCT01774578|Immunologic Factors|immunologic factors|mesh-ancestor
19418282|NCT01774578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418283|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418284|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418285|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418286|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19418287|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19418288|NCT01773928|Vaccines|vaccines|mesh-list
19418289|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
19418290|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418291|NCT01773785|Docetaxel|docetaxel|mesh-list
19418292|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418293|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418294|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418295|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418296|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418297|NCT01768975|Dapansutrile|dapansutrile|mesh-list
19418298|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418299|NCT01758458|Interferons|interferons|mesh-list
19418300|NCT01758458|Aldesleukin|aldesleukin|mesh-list
19418301|NCT01758458|Interferon-beta|interferon-beta|mesh-list
19418302|NCT01758458|Interleukin-2|interleukin-2|mesh-list
19418303|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418304|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
19418305|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418306|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19418307|NCT01758458|Analgesics|analgesics|mesh-ancestor
19418308|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
19418309|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418310|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418311|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19418312|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19418313|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
19418314|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19418315|NCT01756924|Vancomycin|vancomycin|mesh-list
19418316|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
19418317|NCT01756924|Levofloxacin|levofloxacin|mesh-list
19418318|NCT01756924|Rifampin|rifampin|mesh-list
19418319|NCT01756924|Cefazolin|cefazolin|mesh-list
19418320|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
19418321|NCT01756924|Linezolid|linezolid|mesh-list
19418322|NCT01756924|Daptomycin|daptomycin|mesh-list
19418323|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19418324|NCT01756924|Oxacillin|oxacillin|mesh-list
19418325|NCT01756924|Nafcillin|nafcillin|mesh-list
19418326|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
19418327|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418328|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19418329|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
19418330|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19418331|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19418332|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708917|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19708918|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708919|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708920|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19708921|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19708922|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19708923|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
19708924|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418333|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418334|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418335|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19418336|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19418337|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19418338|NCT01756924|Renal Agents|renal agents|mesh-ancestor
19418339|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
19418340|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19418341|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19418342|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19418343|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19418344|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19418345|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19418346|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19418347|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20248675|NCT00437697|Dalteparin|dalteparin|mesh-list
20248676|NCT00437697|Tinzaparin|tinzaparin|mesh-list
20248677|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19418348|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
19418349|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19418350|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19418351|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
19418352|NCT01756339|Solithromycin|solithromycin|mesh-list
19418353|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19418354|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418355|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19418356|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19418357|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418358|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418359|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418360|NCT01741155|Docetaxel|docetaxel|mesh-list
19418361|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418362|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418363|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418364|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418365|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418366|NCT01737905|Epinephrine|epinephrine|mesh-list
19418367|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19418368|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19418369|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
19418370|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418371|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418372|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418373|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19418374|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19418375|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
19418376|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418377|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19418378|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418379|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
19418380|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
19418381|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19418382|NCT01737892|Epinephrine|epinephrine|mesh-list
19418383|NCT01737892|Racepinephrine|racepinephrine|mesh-list
19418384|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
19418385|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19418386|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19418387|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
19418388|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418389|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418390|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418391|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19969567|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20248678|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
19856018|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856019|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
19856020|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856021|NCT00754247|Vitamin E|vitamin e|mesh-list
19856022|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
19856023|NCT00754247|Vitamins|vitamins|mesh-ancestor
19856024|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
19856025|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856026|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856027|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
19856028|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248679|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20248680|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20248681|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248682|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
20248683|NCT00437723|Hematinics|hematinics|mesh-ancestor
20531057|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418392|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19418393|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
19418394|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418395|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19418396|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418397|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
19418398|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
19418399|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19418400|NCT01730027|Montelukast|montelukast|mesh-list
19418401|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19418402|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418403|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19418404|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
19418405|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531058|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531059|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531060|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
20531061|NCT01792102|Hormones|hormones|mesh-ancestor
20531062|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531063|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20531064|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531065|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
19418406|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856029|NCT00754247|Protective Agents|protective agents|mesh-ancestor
19708925|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708926|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
19708927|NCT04809038|Analgesics|analgesics|mesh-ancestor
19708928|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
19708929|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708930|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708931|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
19708932|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19708933|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19708934|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
19708935|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19708936|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19708937|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708938|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19708939|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
19708940|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19708941|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
19708942|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19708943|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708944|NCT04808882|Tinzaparin|tinzaparin|mesh-list
19708945|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19708946|NCT04808882|Dalteparin|dalteparin|mesh-list
19708947|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
19708948|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20248684|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
19856030|NCT00754325|Dasatinib|dasatinib|mesh-list
19856031|NCT00754325|Fulvestrant|fulvestrant|mesh-list
19856032|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856033|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19856034|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856035|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856036|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19856037|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19856038|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19856039|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
19856040|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856041|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856042|NCT00754338|Dipivefrin|dipivefrin|mesh-list
19856043|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19856044|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
19856045|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856046|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856047|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856048|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
19856049|NCT00754390|Calcium|calcium|mesh-list
19856050|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19856051|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856052|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20248685|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20248686|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20248687|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19856053|NCT00754442|Teriparatide|teriparatide|mesh-list
19418407|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19418408|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19418409|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418410|NCT01729403|Metformin|metformin|mesh-list
19418411|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418412|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418413|NCT01728753|Favipiravir|favipiravir|mesh-list
19418414|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
19418415|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418416|NCT01728064|Ubiquinone|ubiquinone|mesh-list
19418417|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
19418418|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418419|NCT01726946|Ribavirin|ribavirin|mesh-list
19418420|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
19418421|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418422|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
19418423|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418424|NCT01725152|Ganaxolone|ganaxolone|mesh-list
19418425|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
19418426|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418427|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418428|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418429|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
19418430|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
19418431|NCT01721733|Ubiquinone|ubiquinone|mesh-list
19418432|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
19418433|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418434|NCT01718158|Ribavirin|ribavirin|mesh-list
19418435|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19418436|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
19418437|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418438|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
19418439|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418440|NCT01718145|Ribavirin|ribavirin|mesh-list
19418441|NCT01718145|Asunaprevir|asunaprevir|mesh-list
19418442|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
19418443|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418444|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
19418445|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418446|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
19418447|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418448|NCT01714739|Nivolumab|nivolumab|mesh-list
19418449|NCT01714739|Ipilimumab|ipilimumab|mesh-list
19708949|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19708950|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708951|NCT04809142|Gemcitabine|gemcitabine|mesh-list
19708952|NCT04809142|Capecitabine|capecitabine|mesh-list
19708953|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
19708954|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19708955|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
19708956|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708957|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708958|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
19856054|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19856055|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856056|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19856057|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19856058|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856059|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19856060|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856061|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856062|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
19856063|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19856064|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
19708959|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248688|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248689|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248690|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
20248691|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248692|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248693|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19708960|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708961|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418450|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
19418451|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19418452|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418453|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19418454|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418455|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
19418456|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418457|NCT01712451|Fluticasone|fluticasone|mesh-list
19418458|NCT01712451|Xhance|xhance|mesh-list
19418459|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19418460|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418461|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19418462|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
19418463|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418464|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418465|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19708962|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
20248694|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248695|NCT00437814|Ketamine|ketamine|mesh-list
20248696|NCT00437814|Analgesics|analgesics|mesh-ancestor
20248697|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
20248698|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248699|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248700|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20248701|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20248702|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
20248703|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
20248704|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531066|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531067|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531068|NCT01792375|Dinoprostone|dinoprostone|mesh-list
20531069|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
20531070|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20531071|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531072|NCT01792388|Vitamin D|vitamin d|mesh-list
20531073|NCT01792388|Vitamins|vitamins|mesh-ancestor
20531074|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
20531075|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531076|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20531077|NCT01792505|Imiquimod|imiquimod|mesh-list
20531078|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20531079|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
20248705|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20248706|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20248707|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248708|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856065|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248709|NCT00437853|Anastrozole|anastrozole|mesh-list
20248710|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20248711|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248712|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20248713|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20248714|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248715|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248716|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20248717|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
20248718|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248719|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248720|NCT00437892|Atorvastatin|atorvastatin|mesh-list
20248721|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20248722|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20248723|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
19856066|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856067|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19856068|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
19856069|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19856070|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19856071|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19856072|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
19856073|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248724|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248725|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20248726|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20248727|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418466|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418467|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
19418468|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19418469|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19418470|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19418471|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19418472|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
19418473|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418474|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418475|NCT01712217|Crizotinib|crizotinib|mesh-list
19418476|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418477|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19418478|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418479|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418480|NCT01709214|Oxycodone|oxycodone|mesh-list
19418481|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19418482|NCT01709214|Narcotics|narcotics|mesh-ancestor
19418483|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19418484|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418485|NCT01709214|Analgesics|analgesics|mesh-ancestor
19418486|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
19418487|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418488|NCT01704365|Vaccines|vaccines|mesh-list
19418489|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
19418490|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418491|NCT01699737|Glimepiride|glimepiride|mesh-list
19418492|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19418493|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418494|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418495|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418496|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
19418497|NCT01699464|Timolol|timolol|mesh-list
19418498|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19418499|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19418500|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19418501|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19418502|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
19418503|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418504|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418505|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418506|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19418507|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19418508|NCT01698281|Dexamethasone|dexamethasone|mesh-list
19418509|NCT01698281|Doxorubicin|doxorubicin|mesh-list
19418510|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418511|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
19418512|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
19418513|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418514|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418515|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19418516|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
19418517|NCT01698281|Hormones|hormones|mesh-ancestor
19418518|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418519|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19708963|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708964|NCT04809181|Azacitidine|azacitidine|mesh-list
19708965|NCT04809181|Venetoclax|venetoclax|mesh-list
19418520|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418521|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19708966|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19856074|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856075|NCT00754572|Methotrexate|methotrexate|mesh-list
19856076|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20248728|NCT00437918|Acarbose|acarbose|mesh-list
20248729|NCT00437918|Nateglinide|nateglinide|mesh-list
20248730|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20248731|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248732|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248733|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19856077|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
19856078|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20248734|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248735|NCT00437957|Temozolomide|temozolomide|mesh-list
20248736|NCT00437957|Valproic Acid|valproic acid|mesh-list
20248737|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20248738|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
19856079|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418522|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19418523|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19418524|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418525|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418526|NCT01697072|Cisplatin|cisplatin|mesh-list
19418527|NCT01697072|Capecitabine|capecitabine|mesh-list
19856080|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418528|NCT01697072|Epirubicin|epirubicin|mesh-list
19418529|NCT01697072|Rilotumumab|rilotumumab|mesh-list
19708967|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
19708968|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708969|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19708970|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708971|NCT04808739|Adalimumab|adalimumab|mesh-list
19856081|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
19856082|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708972|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856083|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856084|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19856085|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708973|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19708974|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
19708975|NCT04808856|Hormones|hormones|mesh-list
19708976|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19708977|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19856086|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19708978|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
19708979|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19708980|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708981|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19708982|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
19708983|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
19708984|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19708985|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856087|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19856088|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
19856089|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856090|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19856091|NCT00754624|Insulin|insulin|mesh-list
19856092|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418530|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418531|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418532|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
19418533|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418534|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19418535|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19418536|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19418537|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418538|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19418539|NCT01696435|Vitamin D|vitamin d|mesh-list
19418540|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
19418541|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
19418542|NCT01696435|Vitamins|vitamins|mesh-list
19418543|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
19418544|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418545|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19418546|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19418547|NCT01694277|Sunitinib|sunitinib|mesh-list
19418548|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418549|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19418550|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19708986|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
19418551|NCT01694277|Growth Substances|growth substances|mesh-ancestor
19969568|NCT01773473|Insulin|insulin|mesh-list
19418552|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418553|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
19418554|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19418555|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418556|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418557|NCT01691846|Metformin|metformin|mesh-list
19418558|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19708987|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19708988|NCT04808856|Protective Agents|protective agents|mesh-ancestor
19418559|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19708989|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19708990|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708991|NCT04808648|Itraconazole|itraconazole|mesh-list
19708992|NCT04808648|Rifampin|rifampin|mesh-list
19708993|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
19708994|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19708995|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19708996|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19708997|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19708998|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19708999|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19709000|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
19709001|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19709002|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709003|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19709004|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19709005|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
19709006|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19709007|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
19709008|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19709009|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19709010|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19418560|NCT01689246|Methylene Blue|methylene blue|mesh-list
19418561|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418562|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418563|NCT01687985|Laxatives|laxatives|mesh-list
19418564|NCT01687985|Cathartics|cathartics|mesh-list
19418565|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19418566|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
19418567|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418568|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418569|NCT01685268|Prednisone|prednisone|mesh-list
19418570|NCT01685268|Prednisolone|prednisolone|mesh-list
19418571|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
19418572|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418573|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
19418574|NCT01685268|Hormones|hormones|mesh-ancestor
19418575|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418576|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418577|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19418578|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418579|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19418580|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418581|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418582|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
19418583|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19418584|NCT01685255|Tamoxifen|tamoxifen|mesh-list
19418585|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19418586|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
19418587|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418588|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418589|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19418590|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418591|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19418592|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19418593|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19450566|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450567|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450568|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
19450569|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450570|NCT03427359|Capecitabine|capecitabine|mesh-list
19450571|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450572|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19450573|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
19450574|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450575|NCT03427242|Apatinib|apatinib|mesh-list
19450576|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450577|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19450578|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450579|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450580|NCT03427229|Vancomycin|vancomycin|mesh-list
19450581|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19450582|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450583|NCT03427216|Diazepam|diazepam|mesh-list
19450584|NCT03427216|Baclofen|baclofen|mesh-list
19450585|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19450586|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450587|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19450588|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450589|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19450590|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
19450591|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
19450592|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450593|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450594|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19450595|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
19450596|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
19450597|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
19856093|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856094|NCT00754650|Bevacizumab|bevacizumab|mesh-list
19856095|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19418594|NCT01683084|Telmisartan|telmisartan|mesh-list
19418595|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19418596|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19709011|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19709012|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19709013|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19709014|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19709015|NCT04808895|Aspirin|aspirin|mesh-list
19709016|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19709017|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709018|NCT04808895|Analgesics|analgesics|mesh-ancestor
19709019|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
19709020|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709021|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709022|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709023|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19709024|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19709025|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19709026|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709027|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19709028|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19709029|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709030|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
19418597|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19418598|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418599|NCT01679951|Methotrexate|methotrexate|mesh-list
19418600|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19418601|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
19418602|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19418603|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418604|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418605|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
19418606|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418607|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418608|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
19418609|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418610|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19418611|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418612|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
19418613|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19418614|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19418615|NCT01677754|Memantine|memantine|mesh-list
19418616|NCT01677754|Rivastigmine|rivastigmine|mesh-list
19418617|NCT01677754|Donepezil|donepezil|mesh-list
19418618|NCT01677754|Galantamine|galantamine|mesh-list
19418619|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19418620|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418621|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418622|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
19418623|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856096|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531080|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531081|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531082|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
20531083|NCT01792557|Phenol|phenol|mesh-list
20531084|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20531085|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531086|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
20531087|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20531088|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19856097|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19856098|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19856099|NCT00754650|Growth Substances|growth substances|mesh-ancestor
19856100|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856101|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
19856102|NCT00754845|Letrozole|letrozole|mesh-list
19856103|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856104|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19709031|NCT04808791|Trifluridine|trifluridine|mesh-list
19709032|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
19709033|NCT04808791|Irinotecan|irinotecan|mesh-list
19709034|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709035|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19418624|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418625|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
19418626|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19418627|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19418628|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
19418629|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19418630|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19418631|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19418632|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
19418633|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418634|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19418635|NCT01677754|Protective Agents|protective agents|mesh-ancestor
19418636|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19418637|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19418638|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418639|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19418640|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19418641|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19418642|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19418643|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19418644|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19418645|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418646|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418647|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418648|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
19418649|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418650|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
19418651|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19418652|NCT01669980|Vancomycin|vancomycin|mesh-list
19418653|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
19418654|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19418655|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19418656|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418657|NCT01666977|Carboplatin|carboplatin|mesh-list
19418658|NCT01666977|Pemetrexed|pemetrexed|mesh-list
19418659|NCT01666977|Trebananib|trebananib|mesh-list
19418660|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418661|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418662|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418663|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19418664|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19418665|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19418666|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19418667|NCT01666977|Growth Substances|growth substances|mesh-ancestor
19418668|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418669|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
19418670|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19418671|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
19418672|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418673|NCT01661634|Ularitide|ularitide|mesh-list
19418674|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19418675|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
19418676|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418677|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418678|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19418679|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
19418680|NCT01661634|Diuretics|diuretics|mesh-ancestor
19418681|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
19418682|NCT01661166|Fesoterodine|fesoterodine|mesh-list
19418683|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19418684|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19418685|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
19418686|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969569|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19709036|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19709037|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709038|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709039|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
19709040|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
19709041|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418687|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418688|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418689|NCT01661166|Urological Agents|urological agents|mesh-ancestor
19418690|NCT01660633|Melphalan|melphalan|mesh-list
19418691|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19418692|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
19418693|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418694|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418695|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19418696|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418697|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
19418698|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418699|NCT01658826|Valacyclovir|valacyclovir|mesh-list
19418700|NCT01658826|Pritelivir|pritelivir|mesh-list
19418701|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
19418702|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418703|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418704|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418705|NCT01658501|Metformin|metformin|mesh-list
19418706|NCT01658501|Liraglutide|liraglutide|mesh-list
19418707|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418708|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418709|NCT01658501|Incretins|incretins|mesh-ancestor
19418710|NCT01658501|Hormones|hormones|mesh-ancestor
19418711|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418712|NCT01652482|Leucovorin|leucovorin|mesh-list
19418713|NCT01652482|Fluorouracil|fluorouracil|mesh-list
19418714|NCT01652482|Irinotecan|irinotecan|mesh-list
19418715|NCT01652482|Cetuximab|cetuximab|mesh-list
19418716|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
19418717|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418718|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418719|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418720|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418721|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
19418722|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418723|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19418724|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19418725|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418726|NCT01652482|Antidotes|antidotes|mesh-ancestor
19418727|NCT01652482|Protective Agents|protective agents|mesh-ancestor
19418728|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
19418729|NCT01652482|Vitamins|vitamins|mesh-ancestor
19418730|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
19418731|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19418732|NCT01651871|Cetirizine|cetirizine|mesh-list
19418733|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19418734|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19418735|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19418736|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
19709042|NCT04808687|Paclitaxel|paclitaxel|mesh-list
19418737|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
19418738|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19418739|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709043|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20248739|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248740|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248741|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
20248742|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709044|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709045|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709046|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709047|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709048|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709049|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
19709050|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
19709051|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248743|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
20248744|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248745|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248746|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
20248747|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20248748|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248749|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248750|NCT00437970|Metformin|metformin|mesh-list
20248751|NCT00437970|Pioglitazone|pioglitazone|mesh-list
20248752|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20248753|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248754|NCT00437996|Clonidine|clonidine|mesh-list
20248755|NCT00437996|Sufentanil|sufentanil|mesh-list
20248756|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
20248757|NCT00437996|Analgesics|analgesics|mesh-ancestor
20248758|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
20248759|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248760|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531089|NCT01792570|Darunavir|darunavir|mesh-list
20531090|NCT01792570|Rilpivirine|rilpivirine|mesh-list
20531091|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20531092|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20531093|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
20531094|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248761|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20248762|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
20248763|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
20531095|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709052|NCT04808622|Protective Agents|protective agents|mesh-ancestor
20248764|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20531096|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20531097|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20531098|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
20531099|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531100|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20531101|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20248765|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20248766|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20248767|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
20248768|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248769|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248770|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
20248771|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
20248772|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248773|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20248774|NCT00437996|Narcotics|narcotics|mesh-ancestor
20248775|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20248776|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20248777|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
20248778|NCT00438048|Pilocarpine|pilocarpine|mesh-list
20248779|NCT00438048|Miotics|miotics|mesh-ancestor
19969570|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
19709053|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709054|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19856105|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19709055|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709056|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
19709057|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531102|NCT01792700|Amoxicillin|amoxicillin|mesh-list
20531103|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
20531104|NCT01792700|Metronidazole|metronidazole|mesh-list
20531105|NCT01792700|Tetracycline|tetracycline|mesh-list
20531106|NCT01792700|Esomeprazole|esomeprazole|mesh-list
20531107|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20531108|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709058|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
19709059|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709060|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709061|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19709062|NCT04808323|Capecitabine|capecitabine|mesh-list
19709063|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
19709064|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20531109|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20531110|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20531111|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531112|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709065|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
20531113|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531114|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19856106|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856107|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856108|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19709066|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709067|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733660|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733661|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733662|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733663|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
19733664|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733665|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733666|NCT04559607|Apatinib|apatinib|mesh-list
19733667|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733668|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19733669|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856109|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
19856110|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856111|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856112|NCT00754923|Sorafenib|sorafenib|mesh-list
19856113|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856114|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19856115|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856116|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856117|NCT00754936|Citalopram|citalopram|mesh-list
19856118|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19856119|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19856120|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19856121|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856122|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856123|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
19856124|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856125|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19856126|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
19856127|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856128|NCT00755040|Cyclosporine|cyclosporine|mesh-list
19856129|NCT00755040|Cyclosporins|cyclosporins|mesh-list
19856130|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856131|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856132|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19856133|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
19418740|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418741|NCT01649999|Peficitinib|peficitinib|mesh-list
19418742|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418743|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418744|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418745|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
19418746|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418747|NCT01643226|Riboflavin|riboflavin|mesh-list
19418748|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19418749|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
19418750|NCT01643226|Vitamins|vitamins|mesh-ancestor
19418751|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
19418752|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418753|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19418754|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
19418755|NCT01640080|Esketamine|esketamine|mesh-list
19418756|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
19418757|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19418758|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19418759|NCT01638533|Romidepsin|romidepsin|mesh-list
19418760|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248780|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
20248781|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248782|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248783|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20248784|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19418761|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19418762|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418763|NCT01632228|Bevacizumab|bevacizumab|mesh-list
19418764|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19418765|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418766|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19418767|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19418768|NCT01632228|Growth Substances|growth substances|mesh-ancestor
19418769|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418770|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
19418771|NCT01632137|Rebamipide|rebamipide|mesh-list
19418772|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19418773|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19418774|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
20248785|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
19418775|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418776|NCT01632137|Protective Agents|protective agents|mesh-ancestor
19418777|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418778|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418779|NCT01628094|Ritonavir|ritonavir|mesh-list
19418780|NCT01628094|Ribavirin|ribavirin|mesh-list
19418781|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19418782|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19418783|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
19418784|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418785|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418786|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20248786|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248787|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418787|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19418788|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
19418789|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418790|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19418791|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19418792|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
19418793|NCT01625234|Ensartinib|ensartinib|mesh-list
19418794|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418795|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19418796|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418797|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418798|NCT01621243|Gemcitabine|gemcitabine|mesh-list
19418799|NCT01621243|Paclitaxel|paclitaxel|mesh-list
19418800|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19418801|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19418802|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418803|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418804|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418805|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418806|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418807|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418808|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
19418809|NCT01621243|Antiviral Agents|antiviral agents|mesh-ancestor
19418810|NCT01621243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418811|NCT01621243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418812|NCT01621243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418813|NCT01621243|Immunologic Factors|immunologic factors|mesh-ancestor
19418814|NCT01621243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418815|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19418816|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418817|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418818|NCT01619332|Incretins|incretins|mesh-ancestor
19418819|NCT01619332|Hormones|hormones|mesh-ancestor
19418820|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418821|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19418822|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
19418823|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418824|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418825|NCT01616524|Interferons|interferons|mesh-list
19418826|NCT01616524|Ribavirin|ribavirin|mesh-list
19418827|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
19418828|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
19418829|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19418830|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418831|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
19418832|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418833|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
19418834|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418835|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
19418836|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856134|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856135|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
19856136|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856137|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
19856138|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856139|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19856140|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
19856141|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
19856142|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969571|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19709068|NCT04807816|Gemcitabine|gemcitabine|mesh-list
19418837|NCT01616303|Paclitaxel|paclitaxel|mesh-list
19418838|NCT01616303|Carboplatin|carboplatin|mesh-list
19418839|NCT01616303|Oregovomab|oregovomab|mesh-list
19418840|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19418841|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418842|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418843|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418844|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418845|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418846|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19418847|NCT01616199|Vemurafenib|vemurafenib|mesh-list
19418848|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418849|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19418850|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418851|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418852|NCT01610245|Oseltamivir|oseltamivir|mesh-list
19418853|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
19418854|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
19418855|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418856|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418857|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418858|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19418859|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19418860|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19418861|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
19418862|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418863|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19418864|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418865|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19418866|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418867|NCT01606566|Bleomycin|bleomycin|mesh-list
19418868|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19418869|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418870|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
19418871|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19418872|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418873|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418874|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418875|NCT01604889|Ipilimumab|ipilimumab|mesh-list
19418876|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19418877|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418878|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19418879|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418880|NCT01603407|Prednisone|prednisone|mesh-list
19418881|NCT01603407|Deflazacort|deflazacort|mesh-list
19418882|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418883|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
19418884|NCT01603407|Hormones|hormones|mesh-ancestor
19418885|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418886|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418887|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19418888|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418889|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418890|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
19418891|NCT01602393|Flurbiprofen|flurbiprofen|mesh-list
19418892|NCT01602393|Analgesics|analgesics|mesh-ancestor
19418893|NCT01602393|Sensory System Agents|sensory system agents|mesh-ancestor
19418894|NCT01602393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418895|NCT01602393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248788|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
20248789|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20248790|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20248791|NCT00438087|Prednisolone|prednisolone|mesh-list
20248792|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
20248793|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20248794|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
20248795|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248796|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
20248797|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
20248798|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248799|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248800|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531115|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20531116|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20531117|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531118|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20531119|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20531120|NCT01792713|Sertaconazole|sertaconazole|mesh-list
20531121|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
20531122|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531123|NCT01792804|Vancomycin|vancomycin|mesh-list
20531124|NCT01792804|Clindamycin|clindamycin|mesh-list
20531125|NCT01792804|Cefazolin|cefazolin|mesh-list
20531126|NCT01792804|Linezolid|linezolid|mesh-list
20531127|NCT01792804|Daptomycin|daptomycin|mesh-list
20531128|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20531129|NCT01792804|Floxacillin|floxacillin|mesh-list
20531130|NCT01792804|Cloxacillin|cloxacillin|mesh-list
20531131|NCT01792804|Trimethoprim|trimethoprim|mesh-list
20531132|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
20531133|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20531134|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531135|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20531136|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531137|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531138|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20531139|NCT01792804|Renal Agents|renal agents|mesh-ancestor
20531140|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
20531141|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20531142|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20531143|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20531144|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20531145|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20531146|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20531147|NCT01792934|Bevacizumab|bevacizumab|mesh-list
19418896|NCT01602393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20248801|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
20248802|NCT00438087|Hormones|hormones|mesh-ancestor
20531148|NCT01792934|Irinotecan|irinotecan|mesh-list
19709069|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19709070|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
19709071|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709072|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709073|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
19709074|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709075|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709076|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709077|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
19709078|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856143|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856144|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856145|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
19856146|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19856147|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19856148|NCT00755183|Testosterone|testosterone|mesh-list
19856149|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
19856150|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
19709079|NCT04807829|Nabilone|nabilone|mesh-list
19709080|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
19709081|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
19856151|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19856152|NCT00755183|Androgens|androgens|mesh-ancestor
19856153|NCT00755183|Hormones|hormones|mesh-ancestor
19418897|NCT01602393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19418898|NCT01602393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19418899|NCT01602393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19418900|NCT01602393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19418901|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418902|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418903|NCT01594983|Fenofibrate|fenofibrate|mesh-list
19418904|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19418905|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
19418906|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418907|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20248803|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248804|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20248805|NCT00438087|Protective Agents|protective agents|mesh-ancestor
20248806|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20248807|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248808|NCT00438113|Atenolol|atenolol|mesh-list
20248809|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19418908|NCT01594216|Exemestane|exemestane|mesh-list
19418909|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418910|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19418911|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19418912|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418913|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418914|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19418915|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
19418916|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19418917|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418918|NCT01593228|Gemcitabine|gemcitabine|mesh-list
19418919|NCT01593228|Paclitaxel|paclitaxel|mesh-list
19418920|NCT01593228|Carboplatin|carboplatin|mesh-list
19418921|NCT01593228|Doxorubicin|doxorubicin|mesh-list
19418922|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19418923|NCT01593228|Irinotecan|irinotecan|mesh-list
19418924|NCT01593228|Topotecan|topotecan|mesh-list
20248810|NCT00438113|Terazosin|terazosin|mesh-list
19856154|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856155|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856156|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19856157|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856158|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
19856159|NCT00755274|Vaccines|vaccines|mesh-list
19856160|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
19856161|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856162|NCT00755417|Gabapentin|gabapentin|mesh-list
19856163|NCT00755417|Analgesics|analgesics|mesh-ancestor
19856164|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
19856165|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856166|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856167|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
19856168|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19856169|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856170|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856171|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856172|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20248811|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20248812|NCT00438113|Diuretics|diuretics|mesh-ancestor
20248813|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
20248814|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248815|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20248816|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248817|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248818|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20248819|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
20248820|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
20248821|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248822|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20248823|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20248824|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20248825|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
20248826|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531149|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20531150|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531151|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20531152|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20531153|NCT01792934|Growth Substances|growth substances|mesh-ancestor
20531154|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531155|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
20531156|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20531157|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20531158|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531159|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531160|NCT01793038|Clomiphene|clomiphene|mesh-list
20531161|NCT01793038|Enclomiphene|enclomiphene|mesh-list
20531162|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
20531163|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20531164|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418925|NCT01593228|Iniparib|iniparib|mesh-list
19418926|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19418927|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418928|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
19418929|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
19418930|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
19418931|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418932|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418933|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
19418934|NCT01593228|Antiviral Agents|antiviral agents|mesh-ancestor
19418935|NCT01593228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418936|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19418937|NCT01593228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418938|NCT01593228|Immunologic Factors|immunologic factors|mesh-ancestor
19418939|NCT01593228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418940|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19418941|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19418942|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19418943|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19418944|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19418945|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19418946|NCT01591473|Poly I-C|poly i-c|mesh-list
19418947|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
19418948|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418949|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
19418950|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
19418951|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418952|NCT01591447|Solithromycin|solithromycin|mesh-list
19709082|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709083|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709084|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709085|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19709086|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856173|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19856174|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856175|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856176|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
19856177|NCT00755716|Topiramate|topiramate|mesh-list
19856178|NCT00755716|Nicotine|nicotine|mesh-list
19856179|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19856180|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
19856181|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856182|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856183|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19856184|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19418953|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19709087|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709088|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709089|NCT04807569|Tamsulosin|tamsulosin|mesh-list
19709090|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19709091|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19709092|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19709093|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
19418954|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418955|NCT01590719|Leucovorin|leucovorin|mesh-list
19709094|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856185|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
19418956|NCT01590719|Folic Acid|folic acid|mesh-list
19418957|NCT01590719|Fluorouracil|fluorouracil|mesh-list
19418958|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
19418959|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
19418960|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
19418961|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418962|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19418963|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418964|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19418965|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
19418966|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418967|NCT01590719|Antidotes|antidotes|mesh-ancestor
19418968|NCT01590719|Protective Agents|protective agents|mesh-ancestor
19418969|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
19418970|NCT01590719|Vitamins|vitamins|mesh-ancestor
19418971|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
19418972|NCT01590719|Hematinics|hematinics|mesh-ancestor
19418973|NCT01588535|Benzocaine|benzocaine|mesh-list
19418974|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
19418975|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
19418976|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19418977|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19418978|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
19418979|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19418980|NCT01587144|Lucanthone|lucanthone|mesh-list
19418981|NCT01587144|Temozolomide|temozolomide|mesh-list
19418982|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19418983|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
20248827|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20248828|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19418984|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19418985|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418986|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
19418987|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19418988|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
19418989|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19418990|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19418991|NCT01584531|ON 01910|on 01910|mesh-list
19418992|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19418993|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19418994|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856186|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856187|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856188|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
19856189|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19856190|NCT00755755|Iron|iron|mesh-list
19856191|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
19418995|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856192|NCT00755755|Trace Elements|trace elements|mesh-ancestor
19418996|NCT01582347|Buprenorphine|buprenorphine|mesh-list
19418997|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19418998|NCT01582347|Naloxone|naloxone|mesh-list
19418999|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19709095|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709096|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709097|NCT04807569|Urological Agents|urological agents|mesh-ancestor
19709098|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19709099|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19709100|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19709101|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19709102|NCT04807504|Ropivacaine|ropivacaine|mesh-list
19709103|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
19709104|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
19709105|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709106|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709107|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
19709108|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709109|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
19709110|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19709111|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
19709112|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709113|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709114|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19709115|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
19709116|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19709117|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
19856193|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
19856194|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419000|NCT01582347|Narcotics|narcotics|mesh-ancestor
19709118|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709119|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709120|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19709121|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
19709122|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
19709123|NCT04807413|Protective Agents|protective agents|mesh-ancestor
19709124|NCT04807673|Paclitaxel|paclitaxel|mesh-list
19709125|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
19709126|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709127|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856195|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19856196|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
19856197|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19856198|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19856199|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19856200|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19856201|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19856202|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19856203|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856204|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856205|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856206|NCT00755807|Analgesics|analgesics|mesh-ancestor
19856207|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
19856208|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856209|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
19856210|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856211|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
19856212|NCT00755846|Alogliptin|alogliptin|mesh-list
19856213|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19856214|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856215|NCT00755846|Incretins|incretins|mesh-ancestor
19856216|NCT00755846|Hormones|hormones|mesh-ancestor
19856217|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856218|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19856219|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
19856220|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856221|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856222|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19856223|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
19856224|NCT00755911|Coagulants|coagulants|mesh-ancestor
19709128|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
19419001|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19419002|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419003|NCT01582347|Analgesics|analgesics|mesh-ancestor
19419004|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
19419005|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419006|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19419007|NCT01582269|Lomustine|lomustine|mesh-list
19419008|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19419009|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
19419010|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419011|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419012|NCT01581203|Interferons|interferons|mesh-list
19419013|NCT01581203|Ribavirin|ribavirin|mesh-list
19419014|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
19419015|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
19419016|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19419017|NCT01581203|Asunaprevir|asunaprevir|mesh-list
19419018|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419019|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
19419020|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419021|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
19419022|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419023|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
19419024|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419025|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419026|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419027|NCT01581177|Albuterol|albuterol|mesh-list
19419028|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419029|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
19419030|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419031|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419032|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419033|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419034|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
19419035|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19419036|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19419037|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19419038|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19419039|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
19419040|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419041|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419042|NCT01581138|Ribavirin|ribavirin|mesh-list
19419043|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
19419044|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419045|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
19419046|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419047|NCT01580696|Molgramostim|molgramostim|mesh-list
19419048|NCT01580696|Vaccines|vaccines|mesh-list
19419049|NCT01580696|Sargramostim|sargramostim|mesh-list
19419050|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
19419051|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419052|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419053|NCT01578655|Prednisone|prednisone|mesh-list
19419054|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419055|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
19419056|NCT01578655|Hormones|hormones|mesh-ancestor
19419057|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419058|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419059|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19419060|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419061|NCT01577654|Folic Acid|folic acid|mesh-list
19419062|NCT01577654|Docetaxel|docetaxel|mesh-list
19419063|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
19419064|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419065|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
19419066|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419067|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
19419068|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419069|NCT01577654|Hematinics|hematinics|mesh-ancestor
19419070|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
19419071|NCT01577654|Vitamins|vitamins|mesh-ancestor
19419072|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
19419073|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419074|NCT01577173|Cetuximab|cetuximab|mesh-list
19709129|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709130|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709131|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709132|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19709133|NCT04807517|Buspirone|buspirone|mesh-list
19709134|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19709135|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709136|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709137|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709138|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709139|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19709140|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
19419075|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19419076|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419077|NCT01573351|Interferons|interferons|mesh-list
19419078|NCT01573351|Ribavirin|ribavirin|mesh-list
19419079|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
19419080|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
19419081|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19419082|NCT01573351|Asunaprevir|asunaprevir|mesh-list
19419083|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419084|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
19419085|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419086|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
19419087|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419088|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
19419089|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419090|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419091|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450598|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19450599|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450600|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450601|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19450602|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19450603|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19450604|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19450605|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
19450606|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
19450607|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
19450608|NCT03427086|Biotin|biotin|mesh-list
19450609|NCT03427086|Vitamins|vitamins|mesh-ancestor
19450610|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
19450611|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450612|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
19450613|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
19450614|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450615|NCT03426982|Heparin|heparin|mesh-list
19450616|NCT03426982|Calcium heparin|calcium heparin|mesh-list
19450617|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
20248829|NCT00438113|Urological Agents|urological agents|mesh-ancestor
20248830|NCT00438139|Dronabinol|dronabinol|mesh-list
20248831|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
20248832|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248833|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248834|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20248835|NCT00438139|Analgesics|analgesics|mesh-ancestor
20248836|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
20248837|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450618|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19450619|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19450620|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450621|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
19450622|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
19450623|NCT03426969|Melphalan|melphalan|mesh-list
20248838|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19419092|NCT01567904|Semuloparin|semuloparin|mesh-list
19419093|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19709141|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709142|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709143|NCT04807543|Castor Oil|castor oil|mesh-list
19709144|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19709145|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19709146|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19709147|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
19709148|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19709149|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709150|NCT04807543|Progestins|progestins|mesh-ancestor
19709151|NCT04807543|Hormones|hormones|mesh-ancestor
19856225|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19856226|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
19856227|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19856228|NCT00756106|Temozolomide|temozolomide|mesh-list
19856229|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19856230|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
19856231|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856232|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856233|NCT00756236|Metoprolol|metoprolol|mesh-list
19856234|NCT00756236|Esmolol|esmolol|mesh-list
19856235|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19856236|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19856237|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
19856238|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
19856239|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856240|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856241|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19856242|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19856243|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19856244|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
19856245|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419094|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19419095|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419096|NCT01567059|Cytarabine|cytarabine|mesh-list
19419097|NCT01567059|Decitabine|decitabine|mesh-list
19419098|NCT01567059|Azacitidine|azacitidine|mesh-list
19419099|NCT01567059|Tosedostat|tosedostat|mesh-list
19419100|NCT01567059|Glycine|glycine|mesh-list
19419101|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19419102|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
19419103|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419104|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419105|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
19419106|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419107|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419108|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
19419109|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419110|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419111|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
19419112|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419113|NCT01565655|Peficitinib|peficitinib|mesh-list
19419114|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419115|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419116|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419117|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
19419118|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419119|NCT01561768|Vaccines|vaccines|mesh-list
19419120|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
19419121|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419122|NCT01560104|Paclitaxel|paclitaxel|mesh-list
19419123|NCT01560104|Carboplatin|carboplatin|mesh-list
19419124|NCT01560104|Veliparib|veliparib|mesh-list
19419125|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19419126|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419127|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
19419128|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419129|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
19419130|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419131|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19419132|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248839|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20248840|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248841|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248842|NCT00438139|Hormones|hormones|mesh-ancestor
20248843|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419138|NCT01557777|Navitoclax|navitoclax|mesh-list
19419139|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419140|NCT01555554|Propranolol|propranolol|mesh-list
19419141|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19419142|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19419143|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
19419144|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419145|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419146|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419147|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19419148|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19419149|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
19419150|NCT01554696|Methotrexate|methotrexate|mesh-list
19419151|NCT01554696|Peficitinib|peficitinib|mesh-list
19419152|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19419153|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
19419154|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19419155|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419156|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19419157|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
19419158|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419159|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419160|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419161|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419162|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19419163|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419164|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
19419165|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419166|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19419167|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19419168|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
19419169|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419170|NCT01539226|Dapivirine|dapivirine|mesh-list
19419171|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19419172|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19419173|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
19419174|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419175|NCT01536041|Montelukast|montelukast|mesh-list
20248844|NCT00438152|Ritonavir|ritonavir|mesh-list
20248845|NCT00438152|Lopinavir|lopinavir|mesh-list
20248846|NCT00438152|Saquinavir|saquinavir|mesh-list
20248847|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20248848|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20248849|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
20248850|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248851|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248852|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20248853|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20248854|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
20248855|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248856|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20248857|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20248858|NCT00438178|Obatoclax|obatoclax|mesh-list
20248859|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709152|NCT04807543|Cathartics|cathartics|mesh-ancestor
19709153|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709154|NCT04807140|Paclitaxel|paclitaxel|mesh-list
19709155|NCT04807140|Carboplatin|carboplatin|mesh-list
19709156|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19419176|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19709157|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248860|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419177|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419178|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19419179|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
19419180|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419181|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419182|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19419183|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20248861|NCT00438217|Leuprolide|leuprolide|mesh-list
20248862|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20248863|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20248864|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20248865|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
20248866|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20248867|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248868|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20248869|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248870|NCT00438217|Hormones|hormones|mesh-ancestor
20248871|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419184|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419185|NCT01535508|Vitamin D|vitamin d|mesh-list
19419186|NCT01535508|Vitamins|vitamins|mesh-ancestor
19419187|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
19419188|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419189|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19419190|NCT01534403|Epratuzumab|epratuzumab|mesh-list
19419191|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19709158|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709159|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709160|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709161|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709162|NCT04807309|Danazol|danazol|mesh-list
19709163|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19419192|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419193|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
19419194|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19709164|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
19709165|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19709166|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709167|NCT04807166|Paclitaxel|paclitaxel|mesh-list
19709168|NCT04807166|Carboplatin|carboplatin|mesh-list
19709169|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709170|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709171|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709172|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709173|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709174|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709175|NCT04807335|Sufentanil|sufentanil|mesh-list
19709176|NCT04807335|Ketamine|ketamine|mesh-list
19709177|NCT04807335|Analgesics|analgesics|mesh-ancestor
19709178|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
19709179|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248872|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
20248873|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20248874|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
20248875|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19709180|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248876|NCT00438230|Warfarin|warfarin|mesh-list
20248877|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
20248878|NCT00438243|Bromfenac|bromfenac|mesh-list
20248879|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20248880|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20248881|NCT00438243|Analgesics|analgesics|mesh-ancestor
20248882|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
20248883|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419195|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19419196|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419197|NCT01527916|Donepezil|donepezil|mesh-list
20248884|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248885|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20248886|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20248887|NCT00438269|Metronidazole|metronidazole|mesh-list
20248888|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
19419198|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19419199|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419200|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419201|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
19419202|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419203|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419204|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
19419205|NCT01522469|Crenolanib|crenolanib|mesh-list
19419206|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419207|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
19419208|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19419209|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419210|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419211|NCT01520545|Baclofen|baclofen|mesh-list
20248889|NCT00438269|Meropenem|meropenem|mesh-list
20248890|NCT00438269|Cefazolin|cefazolin|mesh-list
20248891|NCT00438269|Tazobactam|tazobactam|mesh-list
20248892|NCT00438269|Piperacillin|piperacillin|mesh-list
20248893|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20248894|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20248895|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20248896|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20248897|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20248898|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20248899|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20248900|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20248901|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248902|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248903|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20248904|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20248905|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20248906|NCT00438321|Anastrozole|anastrozole|mesh-list
20248907|NCT00438321|Goserelin|goserelin|mesh-list
20248908|NCT00438321|Testosterone|testosterone|mesh-list
20248909|NCT00438321|Androgens|androgens|mesh-ancestor
20248910|NCT00438321|Hormones|hormones|mesh-ancestor
20248911|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20248912|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248913|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19419212|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19419213|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419214|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19419215|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419216|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19419217|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
19419218|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
19419219|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419220|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419221|NCT01519804|Paclitaxel|paclitaxel|mesh-list
19419222|NCT01519804|Carboplatin|carboplatin|mesh-list
19419223|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19419224|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419225|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
20248914|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248915|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19419226|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419227|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709181|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19709182|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19709183|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
19709184|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
19709185|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709186|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19709187|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19709188|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248916|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20248917|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419228|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709189|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709190|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19709191|NCT04807335|Narcotics|narcotics|mesh-ancestor
19709192|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19709193|NCT04807101|Midazolam|midazolam|mesh-list
19709194|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19709195|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19709196|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709197|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709198|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19709199|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709200|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709201|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19709202|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
19709203|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
19709204|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
19709205|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
19856246|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856247|NCT00756275|Nicotine|nicotine|mesh-list
19856248|NCT00756275|Varenicline|varenicline|mesh-list
19856249|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19856250|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
19856251|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856252|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856253|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19856254|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19856255|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
19856256|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856257|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856258|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
19856259|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19856260|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856261|NCT00756444|Panitumumab|panitumumab|mesh-list
19856262|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856263|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19856264|NCT00756470|Paclitaxel|paclitaxel|mesh-list
19856265|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
19856266|NCT00756470|Fluorouracil|fluorouracil|mesh-list
19856267|NCT00756470|Epirubicin|epirubicin|mesh-list
19856268|NCT00756470|Lapatinib|lapatinib|mesh-list
19856269|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19856270|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856271|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709206|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856272|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20248918|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248919|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19419229|NCT01517776|Temozolomide|temozolomide|mesh-list
19419230|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19419231|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
19419232|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419233|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419234|NCT01516918|Ribavirin|ribavirin|mesh-list
19419235|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19419236|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
19419237|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419238|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
19419239|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419240|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
19419241|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19419242|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19419243|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
19419244|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248920|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
20248921|NCT00438386|Aripiprazole|aripiprazole|mesh-list
20248922|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
20248923|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248924|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20248925|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20248926|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248927|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248928|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
19419245|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19419246|NCT01516476|Liraglutide|liraglutide|mesh-list
19419247|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419248|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419249|NCT01516476|Incretins|incretins|mesh-ancestor
19419250|NCT01516476|Hormones|hormones|mesh-ancestor
19419251|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419252|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
19419253|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419254|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
19419255|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419256|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419257|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19419258|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
19419259|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419260|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419261|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19419262|NCT01516203|Rifampin|rifampin|mesh-list
19709207|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419263|NCT01516203|Isoniazid|isoniazid|mesh-list
20248929|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
19419264|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
19419265|NCT01516203|Ethambutol|ethambutol|mesh-list
19419266|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19419267|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
19419268|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19419269|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419270|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
19419271|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19419272|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419273|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419274|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19419275|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19419276|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19419277|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19419278|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19419279|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19419280|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19419281|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19419282|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
19419283|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19419284|NCT01516086|Fluticasone|fluticasone|mesh-list
19419285|NCT01516086|Xhance|xhance|mesh-list
19419286|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419287|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419288|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
19419289|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419290|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419291|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419292|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419293|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419294|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19419295|NCT01516073|Fluticasone|fluticasone|mesh-list
19419296|NCT01516073|Xhance|xhance|mesh-list
19419297|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419298|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419299|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
19419300|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419301|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248930|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248931|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248932|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19419302|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20248933|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20248934|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
19419303|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419304|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419305|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19419306|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
19419307|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19419308|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419309|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19419310|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19419311|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419312|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419313|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709208|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
19709209|NCT04807127|Durvalumab|durvalumab|mesh-list
20531165|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20531166|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
20531167|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531168|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531169|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20531170|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
20531171|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20531172|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20531173|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20531174|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20248935|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20248936|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20248937|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20248938|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20248939|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20248940|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20248941|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248942|NCT00438568|Insulin|insulin|mesh-list
20248943|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20248944|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20248945|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248946|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20248947|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
20248948|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248949|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
20248950|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20248951|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20248952|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19709210|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19709211|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19709212|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709213|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248953|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
20248954|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419314|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19419315|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19419316|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
19419317|NCT01510119|Everolimus|everolimus|mesh-list
19419318|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419319|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419320|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
19419321|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419322|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
19419323|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19419324|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19419325|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419326|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419327|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419328|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419329|NCT01508026|Valsartan|valsartan|mesh-list
19419330|NCT01508026|Nebivolol|nebivolol|mesh-list
19419331|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19419332|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19419333|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19419334|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419335|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
19419336|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19419337|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19419338|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19419339|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
19419340|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419341|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419342|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19419343|NCT01501513|Laxatives|laxatives|mesh-ancestor
19419344|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19419345|NCT01499563|Risperidone|risperidone|mesh-list
19419346|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19419347|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
19419348|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419349|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419350|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419351|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19419352|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19419353|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19419354|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19419355|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19419356|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
19419357|NCT01498328|Bevacizumab|bevacizumab|mesh-list
19419358|NCT01498328|Rindopepimut|rindopepimut|mesh-list
19419359|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19419360|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419361|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19419362|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19419363|NCT01498328|Growth Substances|growth substances|mesh-ancestor
19419364|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419365|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
19419366|NCT01497834|Asunaprevir|asunaprevir|mesh-list
19419367|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419368|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419369|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709214|NCT04806945|Paclitaxel|paclitaxel|mesh-list
20248955|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248956|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248957|NCT00438737|Leucovorin|leucovorin|mesh-list
20248958|NCT00438737|Bevacizumab|bevacizumab|mesh-list
20248959|NCT00438737|Cetuximab|cetuximab|mesh-list
20248960|NCT00438737|Fluorouracil|fluorouracil|mesh-list
20248961|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
19709215|NCT04806945|Carboplatin|carboplatin|mesh-list
19709216|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709217|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709218|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709219|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709220|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709221|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709222|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
20248962|NCT00438737|Calcium|calcium|mesh-list
20248963|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
20248964|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20248965|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20248966|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19856273|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20248967|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19419370|NCT01497704|Apatinib|apatinib|mesh-list
20248968|NCT00438737|Growth Substances|growth substances|mesh-ancestor
20248969|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248970|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
20248971|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20248972|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
20248973|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248974|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20248975|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20248976|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
20248977|NCT00438737|Antidotes|antidotes|mesh-ancestor
20248978|NCT00438737|Protective Agents|protective agents|mesh-ancestor
20248979|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
20248980|NCT00438737|Vitamins|vitamins|mesh-ancestor
20248981|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
20248982|NCT00438776|Olanzapine|olanzapine|mesh-list
20248983|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
20248984|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
20248985|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20248986|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20248987|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20248988|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20248989|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20248990|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20248991|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20248992|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20248993|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20248994|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20248995|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20248996|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20248997|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
20248998|NCT00438789|Eculizumab|eculizumab|mesh-list
20248999|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20249000|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249001|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
20249002|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249003|NCT00438828|Dexamethasone|dexamethasone|mesh-list
20249004|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419371|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419372|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19419373|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419374|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419375|NCT01495247|Paclitaxel|paclitaxel|mesh-list
19419376|NCT01495247|Dactolisib|dactolisib|mesh-list
19419377|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19419378|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419379|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
19419380|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419381|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
19419382|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419383|NCT01495013|Glimepiride|glimepiride|mesh-list
19419384|NCT01495013|Atorvastatin|atorvastatin|mesh-list
19419385|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19419386|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20249005|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
19419387|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
19419388|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419389|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19450624|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
19450625|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19450626|NCT03426969|Fludarabine|fludarabine|mesh-list
19450627|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
19450628|NCT03426969|Tacrolimus|tacrolimus|mesh-list
19450629|NCT03426969|Lenograstim|lenograstim|mesh-list
19450630|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19450631|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
19450632|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419390|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19419391|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419392|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19419393|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419394|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419395|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419396|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
19419397|NCT01493505|Paclitaxel|paclitaxel|mesh-list
19419398|NCT01493505|Carboplatin|carboplatin|mesh-list
19419399|NCT01493505|Trebananib|trebananib|mesh-list
19419400|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19419401|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419402|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
20249006|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
20249007|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249008|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249009|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249010|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
20249011|NCT00438828|Hormones|hormones|mesh-ancestor
20249012|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249013|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20249014|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249015|NCT00438841|Thalidomide|thalidomide|mesh-list
20249016|NCT00438841|Dexamethasone|dexamethasone|mesh-list
20249017|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
20249018|NCT00438841|Bortezomib|bortezomib|mesh-list
20249019|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249020|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
20249021|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249022|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249023|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20249024|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
20249025|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249026|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249027|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20249028|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249029|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
20249030|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
20249031|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419403|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419404|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
19419405|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419406|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19419407|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19419408|NCT01493505|Growth Substances|growth substances|mesh-ancestor
19419409|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419410|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
19419411|NCT01489046|Tenofovir|tenofovir|mesh-list
19419412|NCT01489046|Lamivudine|lamivudine|mesh-list
19419413|NCT01489046|Efavirenz|efavirenz|mesh-list
19419414|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
19419415|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419416|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19419417|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19419418|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419419|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419420|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20249032|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249033|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
19419421|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19419422|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20249034|NCT00438841|Hormones|hormones|mesh-ancestor
20531175|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531176|NCT01793077|Leuprolide|leuprolide|mesh-list
20531177|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20531178|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
20531179|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20531180|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531181|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20531182|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531183|NCT01793259|Methotrexate|methotrexate|mesh-list
20531184|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20531185|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
20531186|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19419423|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19419424|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19419425|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19419426|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19419427|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19419428|NCT01486849|Riluzole|riluzole|mesh-list
19419429|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
19419430|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19419431|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19419432|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419433|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419434|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419435|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19419436|NCT01486849|Protective Agents|protective agents|mesh-ancestor
19419437|NCT01484119|Cetirizine|cetirizine|mesh-list
19419438|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19419439|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19419440|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19419441|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
19419442|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
19419443|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249035|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249036|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20249037|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
20249038|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20249039|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249040|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20249041|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20249042|NCT00438841|Growth Substances|growth substances|mesh-ancestor
20249043|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
20249044|NCT00438906|Secretin|secretin|mesh-list
20249045|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249046|NCT00438906|Hormones|hormones|mesh-ancestor
20249047|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249048|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249049|NCT00438945|Eprosartan|eprosartan|mesh-list
20249050|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20249051|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
20249052|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20249053|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419444|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419445|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419446|NCT01483742|Ritonavir|ritonavir|mesh-list
19419447|NCT01483742|Ribavirin|ribavirin|mesh-list
19419448|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19419449|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19419450|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19419451|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419452|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419453|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419454|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19419455|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19709223|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19709224|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19709225|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709226|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709227|NCT04806737|Teriflunomide|teriflunomide|mesh-list
19709228|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19709229|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709230|NCT04806737|Analgesics|analgesics|mesh-ancestor
19709231|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
19709232|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709233|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709234|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709235|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19709236|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709237|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
19709238|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
19709239|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19709240|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709241|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19709242|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709243|NCT04806906|Azacitidine|azacitidine|mesh-list
19709244|NCT04806906|Cc-486|cc-486|mesh-list
19709245|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19709246|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
19709247|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709248|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709249|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709250|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19709251|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19709252|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19709253|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19709254|NCT04806438|Lidocaine|lidocaine|mesh-list
19709255|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
19709256|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
19709257|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709258|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709259|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
19709260|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419456|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
19419457|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419458|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19419459|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19419460|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
19419461|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19419462|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
19419463|NCT01482403|Ribavirin|ribavirin|mesh-list
19419464|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
20249054|NCT00438958|Lenograstim|lenograstim|mesh-list
20249055|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19419465|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419466|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
19419467|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419468|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
19419469|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419470|NCT01482390|Ribavirin|ribavirin|mesh-list
19419471|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19419472|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
19450633|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419473|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419474|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
19419475|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419476|NCT01481077|Latanoprost|latanoprost|mesh-list
19419477|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19419478|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19419479|NCT01481051|Latanoprost|latanoprost|mesh-list
19419480|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19419481|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19419482|NCT01480583|Alovudine|alovudine|mesh-list
19419483|NCT01480583|Trastuzumab|trastuzumab|mesh-list
19419484|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19419485|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419486|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
19419487|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419488|NCT01480479|Temozolomide|temozolomide|mesh-list
19419489|NCT01480479|Molgramostim|molgramostim|mesh-list
19419490|NCT01480479|Rindopepimut|rindopepimut|mesh-list
19419491|NCT01480479|Sargramostim|sargramostim|mesh-list
19419492|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19419493|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
19419494|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419495|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419496|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
19419497|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709261|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19709262|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19709263|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19709264|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19709265|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709266|NCT04806230|Mirtazapine|mirtazapine|mesh-list
19709267|NCT04806230|Citalopram|citalopram|mesh-list
19709268|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19709269|NCT04806230|Sertraline|sertraline|mesh-list
19709270|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19709271|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19709272|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19709273|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709274|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856274|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856275|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19856276|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
19856277|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419498|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19856278|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856279|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20249056|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
20249057|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249058|NCT00438984|Aldesleukin|aldesleukin|mesh-list
20249059|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
20249060|NCT00438984|Interleukin-2|interleukin-2|mesh-list
20249061|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249062|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
20249063|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419499|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
19856280|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
19856281|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20249064|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419500|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19419501|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
19419502|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419503|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419504|NCT01476904|Epinephrine|epinephrine|mesh-list
19419505|NCT01476904|Racepinephrine|racepinephrine|mesh-list
19419506|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
19419507|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19419508|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19419509|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19419510|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419511|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419512|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419513|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19419514|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419515|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
19419516|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419517|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419518|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419519|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
19419520|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
19419521|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19450634|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19450635|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
19450636|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450637|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450638|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19450639|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19450640|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
19450641|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19450642|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19450643|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450644|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19450645|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19450646|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
19450647|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19856282|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
19856283|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19450648|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450649|NCT03426956|Canagliflozin|canagliflozin|mesh-list
19450650|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19450651|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450652|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19450653|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450654|NCT03426904|Leucovorin|leucovorin|mesh-list
19450655|NCT03426904|Fluorouracil|fluorouracil|mesh-list
19450656|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
19450657|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
19450658|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450659|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19450660|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450661|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19450662|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
19450663|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450664|NCT03426904|Antidotes|antidotes|mesh-ancestor
19856284|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19450665|NCT03426904|Protective Agents|protective agents|mesh-ancestor
19419522|NCT01474135|Travoprost|travoprost|mesh-list
19419523|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19419524|NCT01472198|Gemcitabine|gemcitabine|mesh-list
19419525|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19419526|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
19419527|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419528|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419529|NCT01472198|Antiviral Agents|antiviral agents|mesh-ancestor
19419530|NCT01472198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419531|NCT01472198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419532|NCT01472198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419533|NCT01472198|Immunologic Factors|immunologic factors|mesh-ancestor
19419534|NCT01472198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419535|NCT01470131|Dexamethasone|dexamethasone|mesh-list
19419536|NCT01470131|Bortezomib|bortezomib|mesh-list
19419537|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419538|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
19419539|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
19419540|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419541|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419542|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249065|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20249066|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
20249067|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249068|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249069|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20249070|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249071|NCT00438984|Analgesics|analgesics|mesh-ancestor
20249072|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
19419543|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
19419544|NCT01470131|Hormones|hormones|mesh-ancestor
19419545|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419546|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19419547|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419548|NCT01466374|Antibodies|antibodies|mesh-list
19419549|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
19419550|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19419551|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
19419552|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419553|NCT01466088|Donepezil|donepezil|mesh-list
19419554|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19419555|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419556|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419557|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
19419558|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709275|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
19709276|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709277|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19709278|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
19709279|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709280|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19709281|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19709282|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
19709283|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
19709284|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19709285|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709286|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709287|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19709288|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19709289|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19709290|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
19709291|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19709292|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19709293|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19709294|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19709295|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19709296|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19709297|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733670|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733671|NCT04559412|Etanercept|etanercept|mesh-list
19733672|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19733673|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19733674|NCT04559412|Analgesics|analgesics|mesh-ancestor
19733675|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
19733676|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733677|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856285|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19856286|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19419559|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419560|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
19419561|NCT01464437|Metformin|metformin|mesh-list
19419562|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419563|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419564|NCT01461915|Gemcitabine|gemcitabine|mesh-list
19419565|NCT01461915|Paclitaxel|paclitaxel|mesh-list
19709298|NCT04805775|Propofol|propofol|mesh-list
19709299|NCT04805775|Desflurane|desflurane|mesh-list
19709300|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19419566|NCT01461915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19419567|NCT01461915|Heparin|heparin|mesh-list
19419568|NCT01461915|Calcium heparin|calcium heparin|mesh-list
19419569|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19419570|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419571|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
19419572|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419573|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
19419574|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419575|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19419576|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
19419577|NCT01461915|Antiviral Agents|antiviral agents|mesh-ancestor
19419578|NCT01461915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419579|NCT01461915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419580|NCT01461915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419581|NCT01461915|Immunologic Factors|immunologic factors|mesh-ancestor
19419582|NCT01461915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419583|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
19419584|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19419585|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19419586|NCT01461317|Etrolizumab|etrolizumab|mesh-list
19419587|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19419588|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
19419589|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419590|NCT01460511|Epinephrine|epinephrine|mesh-list
19419591|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19419592|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19419593|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
19419594|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419595|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419596|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419597|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19419598|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419599|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
19419600|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419601|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419602|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419603|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
19419604|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
19419605|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19419606|NCT01459679|Riboflavin|riboflavin|mesh-list
19419607|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19419608|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19419609|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
19709301|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856287|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531187|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531188|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20531189|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
20531190|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531191|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531192|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
20531193|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709302|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709303|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19419610|NCT01459679|Vitamins|vitamins|mesh-ancestor
20531194|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20531195|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419611|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
19419612|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709304|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
19709305|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
19709306|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19709307|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19709308|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
19709309|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709310|NCT04805957|Sulforaphane|sulforaphane|mesh-list
19419613|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19419614|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419615|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
19419616|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419617|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
19419618|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419619|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419620|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419621|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419622|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19419623|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
19419624|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419625|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419626|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19419627|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
20249073|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249074|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20249075|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20249076|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
20249077|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249078|NCT00439049|Naltrexone|naltrexone|mesh-list
20249079|NCT00439049|Modafinil|modafinil|mesh-list
20249080|NCT00439049|Amphetamine|amphetamine|mesh-list
20249081|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
20249082|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19419628|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
19419629|NCT01457781|Protective Agents|protective agents|mesh-ancestor
19419630|NCT01455896|Exenatide|exenatide|mesh-list
19419631|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419632|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419633|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19419634|NCT01455896|Incretins|incretins|mesh-ancestor
19419635|NCT01455896|Hormones|hormones|mesh-ancestor
19419636|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419637|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19419638|NCT01455870|Exenatide|exenatide|mesh-list
19419639|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419640|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249083|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19856288|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20531196|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
20531197|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20531198|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20531199|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
20531200|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19419641|NCT01455870|Incretins|incretins|mesh-ancestor
19419642|NCT01455870|Hormones|hormones|mesh-ancestor
19419643|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419644|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19419645|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419646|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419647|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419648|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19419649|NCT01455857|Exenatide|exenatide|mesh-list
19419650|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419651|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419652|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19419653|NCT01455857|Incretins|incretins|mesh-ancestor
19419654|NCT01455857|Hormones|hormones|mesh-ancestor
19419655|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419656|NCT01455090|Ribavirin|ribavirin|mesh-list
19419657|NCT01455090|Asunaprevir|asunaprevir|mesh-list
19419658|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
19419659|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419660|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
19419661|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419662|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419663|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419664|NCT01454089|Gemcitabine|gemcitabine|mesh-list
19709311|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19709312|NCT04805957|Protective Agents|protective agents|mesh-ancestor
19709313|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709314|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709315|NCT04805944|Dolutegravir|dolutegravir|mesh-list
19709316|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19709317|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19709318|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709319|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709320|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20531201|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531202|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531203|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20531204|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20531205|NCT01793272|Protective Agents|protective agents|mesh-ancestor
20531206|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531207|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
20531208|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20531209|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
20531210|NCT01793350|Benphothiamine|benphothiamine|mesh-list
20531211|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20531212|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
20531213|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531214|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
19419665|NCT01454089|Carboplatin|carboplatin|mesh-list
19419666|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419667|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19419668|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
19419669|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419670|NCT01454089|Antiviral Agents|antiviral agents|mesh-ancestor
19419671|NCT01454089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419672|NCT01454089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419673|NCT01454089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709321|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19709322|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
19709323|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709324|NCT04805827|Gabapentin|gabapentin|mesh-list
19709325|NCT04805827|Analgesics|analgesics|mesh-ancestor
19709326|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
19709327|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709328|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709329|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
19419674|NCT01454089|Immunologic Factors|immunologic factors|mesh-ancestor
19419675|NCT01454089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419676|NCT01452451|Exenatide|exenatide|mesh-list
19419677|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419678|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419679|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19419680|NCT01452451|Incretins|incretins|mesh-ancestor
19419681|NCT01452451|Hormones|hormones|mesh-ancestor
19419682|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419683|NCT01449591|Metronidazole|metronidazole|mesh-list
19419684|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419685|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19419686|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19419687|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19419688|NCT01449071|Epratuzumab|epratuzumab|mesh-list
19419689|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19419690|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419691|NCT01445899|Ranibizumab|ranibizumab|mesh-list
19709330|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19709331|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709332|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709333|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709334|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19419692|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19419693|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19419694|NCT01445899|Growth Substances|growth substances|mesh-ancestor
19419695|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419696|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
19419697|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419698|NCT01445795|Ribavirin|ribavirin|mesh-list
19419699|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
19419700|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419701|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
19419702|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419703|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19419704|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19419705|NCT01444365|Analgesics|analgesics|mesh-ancestor
19419706|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
19419707|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419708|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419709|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709335|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19419710|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419711|NCT01443728|Vitamin D|vitamin d|mesh-list
19419712|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
19419713|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
19419714|NCT01443728|Vitamins|vitamins|mesh-list
19709336|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19419715|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
19419716|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419717|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19419718|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19419719|NCT01442090|Everolimus|everolimus|mesh-list
19419720|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419721|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419722|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
19419723|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419724|NCT01437735|Montelukast|montelukast|mesh-list
19419725|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419726|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419727|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19419728|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
19419729|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419730|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419731|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19419732|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19419733|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419734|NCT01436032|Ketorolac|ketorolac|mesh-list
19419735|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19419736|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19419737|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249084|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249085|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
20249086|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249087|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20249088|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19419738|NCT01436032|Analgesics|analgesics|mesh-ancestor
19419739|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
19419740|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419741|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419742|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419743|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419744|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19419745|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419746|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709337|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709338|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
19709339|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
19709340|NCT04805710|Clopidogrel|clopidogrel|mesh-list
19709341|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20249089|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20249090|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20249091|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249092|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
20249093|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
19419747|NCT01435369|Pidilizumab|pidilizumab|mesh-list
19419748|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19419749|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419750|NCT01435226|Ribavirin|ribavirin|mesh-list
19419751|NCT01435226|Ledipasvir|ledipasvir|mesh-list
19419752|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
19419753|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419754|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
19419755|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419756|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
19419757|NCT01435044|Ribavirin|ribavirin|mesh-list
19419758|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
19419759|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419760|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
19419761|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419762|NCT01434498|Ribavirin|ribavirin|mesh-list
19419763|NCT01434498|Ledipasvir|ledipasvir|mesh-list
19419764|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
19419765|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419766|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
19419767|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419768|NCT01431820|Luliconazole|luliconazole|mesh-list
19419769|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19419770|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
19419771|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419772|NCT01425970|Interferons|interferons|mesh-list
19419773|NCT01425970|Ribavirin|ribavirin|mesh-list
19419774|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
19419775|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
19419776|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19419777|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419778|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
19419779|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419780|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
19419781|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419782|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
19419783|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419784|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
19419785|NCT01423149|Combretastatin|combretastatin|mesh-list
19419786|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19419787|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419788|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
19419789|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419790|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
19419791|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419792|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19419793|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19419794|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419795|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419796|NCT01422148|Minocycline|minocycline|mesh-list
19419797|NCT01422148|Amiodarone|amiodarone|mesh-list
19419798|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19419799|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419800|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19419801|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
19419802|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19419803|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19419804|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419805|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19419806|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19419807|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19419808|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419809|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19419810|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19419811|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19419812|NCT01421056|Flurbiprofen|flurbiprofen|mesh-list
19419813|NCT01421056|Analgesics|analgesics|mesh-ancestor
19419814|NCT01421056|Sensory System Agents|sensory system agents|mesh-ancestor
19419815|NCT01421056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709342|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19709343|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19709344|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19709345|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
19709346|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709347|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709348|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709349|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19709350|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
19709351|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19709352|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
19709353|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709354|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
19856289|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19856290|NCT00756548|Laxatives|laxatives|mesh-ancestor
19856291|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856292|NCT00756600|Anesthetics|anesthetics|mesh-list
20249094|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
20249095|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249096|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
20249097|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20249098|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20249099|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249100|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20249101|NCT00439062|Roxithromycin|roxithromycin|mesh-list
20249102|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20249103|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249104|NCT00439166|Doxycycline|doxycycline|mesh-list
20249105|NCT00439166|Rifampin|rifampin|mesh-list
20249106|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20249107|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249108|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
20249109|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20531215|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
20531216|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531217|NCT01793480|Methadone|methadone|mesh-list
20531218|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20531219|NCT01793480|Narcotics|narcotics|mesh-ancestor
20531220|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531221|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531222|NCT01793480|Analgesics|analgesics|mesh-ancestor
20531223|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
20531224|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531225|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
20531226|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
20531227|NCT01793519|Adalimumab|adalimumab|mesh-list
20531228|NCT01793519|Etanercept|etanercept|mesh-list
20531229|NCT01793519|Infliximab|infliximab|mesh-list
20531230|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20531231|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20531232|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
20531233|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531234|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20531235|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20531236|NCT01793519|Analgesics|analgesics|mesh-ancestor
20531237|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
20531238|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249110|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20249111|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20249112|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
20249113|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
20249114|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20249115|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249116|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249117|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20531239|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531240|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531241|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
20553273|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553274|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709355|NCT04805515|Nicotine|nicotine|mesh-list
19419816|NCT01421056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419817|NCT01421056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19419818|NCT01421056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19419819|NCT01421056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419820|NCT01421056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419821|NCT01421056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19419822|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419823|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419824|NCT01418222|Leucovorin|leucovorin|mesh-list
19419825|NCT01418222|Bevacizumab|bevacizumab|mesh-list
19419826|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19709356|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19709357|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
19709358|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709359|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709360|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19709361|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19709362|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
19709363|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709364|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709365|NCT04805580|Anesthetics|anesthetics|mesh-list
19709366|NCT04805580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709367|NCT04805580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709368|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
19709369|NCT04805229|Narcotics|narcotics|mesh-ancestor
19709370|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709371|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709372|NCT04805229|Analgesics|analgesics|mesh-ancestor
19709373|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
19709374|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709375|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19709376|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19709377|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709378|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
19709379|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
19709380|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856293|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19419827|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709381|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856294|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419828|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19419829|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19419830|NCT01418222|Growth Substances|growth substances|mesh-ancestor
19419831|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419832|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
19419833|NCT01418222|Antidotes|antidotes|mesh-ancestor
19419834|NCT01418222|Protective Agents|protective agents|mesh-ancestor
19419835|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
19419836|NCT01418222|Vitamins|vitamins|mesh-ancestor
19419837|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
19419838|NCT01416402|Colchicine|colchicine|mesh-list
19419839|NCT01416402|Febuxostat|febuxostat|mesh-list
19419840|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
19419841|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419842|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
19419843|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
19419844|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
19419845|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419846|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419847|NCT01416064|Molindone|molindone|mesh-list
19419848|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19419849|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19419850|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19419851|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419852|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19419853|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19419854|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419855|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419856|NCT01414920|Incretins|incretins|mesh-ancestor
19419857|NCT01414920|Hormones|hormones|mesh-ancestor
19419858|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419859|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19419860|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419861|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419862|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419863|NCT01410695|Methotrexate|methotrexate|mesh-list
19419864|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19419865|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
19419866|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19419867|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419868|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19419869|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
19419870|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419871|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419872|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419873|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419874|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19419875|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709382|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419876|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
19419877|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19419878|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19419879|NCT01410188|Latanoprost|latanoprost|mesh-list
19419880|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19419881|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19419882|NCT01408082|Azithromycin|azithromycin|mesh-list
19419883|NCT01408082|Dexamethasone|dexamethasone|mesh-list
19419884|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
19419885|NCT01408082|BB 1101|bb 1101|mesh-list
19419886|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419887|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
19419888|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
19419889|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419890|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419891|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19419892|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
19419893|NCT01408082|Hormones|hormones|mesh-ancestor
19419894|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419895|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19419896|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419897|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419898|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419899|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419900|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19419901|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419902|NCT01407003|Licogliflozin|licogliflozin|mesh-list
19419903|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19419904|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419905|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19419906|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856295|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19856296|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
19856297|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19856298|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19856299|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19856300|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20249118|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20249119|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20249120|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20249121|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20249122|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20249123|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19419907|NCT01402401|Trastuzumab|trastuzumab|mesh-list
19419908|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19419909|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419910|NCT01399684|Leucovorin|leucovorin|mesh-list
19419911|NCT01399684|Folic Acid|folic acid|mesh-list
19419912|NCT01399684|Bevacizumab|bevacizumab|mesh-list
19419913|NCT01399684|Fluorouracil|fluorouracil|mesh-list
19419914|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
19419915|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
19419916|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19419917|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419918|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19419919|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19419920|NCT01399684|Growth Substances|growth substances|mesh-ancestor
19419921|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419922|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
19419923|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
19419924|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419925|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19856301|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
19419926|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19419927|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
19419928|NCT01399684|Antidotes|antidotes|mesh-ancestor
19419929|NCT01399684|Protective Agents|protective agents|mesh-ancestor
19419930|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
19419931|NCT01399684|Vitamins|vitamins|mesh-ancestor
19419932|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
19419933|NCT01399684|Hematinics|hematinics|mesh-ancestor
19419934|NCT01399580|Atrasentan|atrasentan|mesh-list
19419935|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419936|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19419937|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19419938|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19419939|NCT01397968|Cenobamate|cenobamate|mesh-list
19419940|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
19419941|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19419942|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
19419943|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419944|NCT01397201|Fluticasone|fluticasone|mesh-list
19419945|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419946|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419947|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
19419948|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419949|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419950|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419951|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419952|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419953|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19419954|NCT01397162|Fluticasone|fluticasone|mesh-list
19419955|NCT01397162|Xhance|xhance|mesh-list
19419956|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419957|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419958|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
19419959|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419960|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419961|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419962|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419963|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419964|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19709383|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
19709384|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709385|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709386|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709387|NCT04805073|Promethazine|promethazine|mesh-list
19709388|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
19709389|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
19709390|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
19709391|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19419965|NCT01396278|Fluticasone|fluticasone|mesh-list
19419966|NCT01396278|Xhance|xhance|mesh-list
19419967|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709392|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
19709393|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
19419968|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419969|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
19419970|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419971|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419972|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419973|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419974|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
19419975|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19450666|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
19450667|NCT03426904|Vitamins|vitamins|mesh-ancestor
19450668|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
19450669|NCT03426761|Vancomycin|vancomycin|mesh-list
19450670|NCT03426761|Cefazolin|cefazolin|mesh-list
19450671|NCT03426761|Daptomycin|daptomycin|mesh-list
19450672|NCT03426761|Dalbavancin|dalbavancin|mesh-list
19450673|NCT03426761|Nafcillin|nafcillin|mesh-list
19450674|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19450675|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450676|NCT03426657|Durvalumab|durvalumab|mesh-list
19450677|NCT03426657|Tremelimumab|tremelimumab|mesh-list
19450678|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19450679|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450680|NCT03426592|Vitamin D|vitamin d|mesh-list
19450681|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
19450682|NCT03426592|Vitamins|vitamins|mesh-ancestor
19450683|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
19450684|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450685|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19450686|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19709394|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249124|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20249125|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20249126|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
20249127|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249128|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249129|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249130|NCT00439192|Urological Agents|urological agents|mesh-ancestor
20249131|NCT00439283|Methotrexate|methotrexate|mesh-list
20249132|NCT00439283|Infliximab|infliximab|mesh-list
20249133|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20249134|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
20249135|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20249136|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249137|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249138|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
20249139|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249140|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249141|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
20249142|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733678|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19450687|NCT03426553|Riboflavin|riboflavin|mesh-list
19450688|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
19450689|NCT03426553|Vitamins|vitamins|mesh-ancestor
19450690|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
19450691|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249143|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20249144|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249145|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
20249146|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249147|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20249148|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249149|NCT00439361|Carboplatin|carboplatin|mesh-list
20249150|NCT00439361|Etoposide|etoposide|mesh-list
20249151|NCT00439361|Bortezomib|bortezomib|mesh-list
20249152|NCT00439361|Ifosfamide|ifosfamide|mesh-list
20249153|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249154|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20249155|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20249156|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20249157|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249158|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249159|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20249160|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
20249161|NCT00439400|Doxycycline|doxycycline|mesh-list
20249162|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20249163|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249164|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
20249165|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19419976|NCT01393639|Prednisone|prednisone|mesh-list
19419977|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19419978|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
19419979|NCT01393639|Hormones|hormones|mesh-ancestor
19419980|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19419981|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419982|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19419983|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419984|NCT01390545|Veltuzumab|veltuzumab|mesh-list
19419985|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19419986|NCT01384383|Ledipasvir|ledipasvir|mesh-list
19419987|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
19419988|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19419989|NCT01382654|Azelastine|azelastine|mesh-list
19419990|NCT01382654|Epinastine|epinastine|mesh-list
19419991|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19419992|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
19419993|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19419994|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19419995|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19419996|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
19419997|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19419998|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19419999|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420000|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19420001|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19420002|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19420003|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
19420004|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
19420005|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420006|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19420007|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19420008|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19420009|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
19420010|NCT01379209|Sirolimus|sirolimus|mesh-list
19420011|NCT01379209|Methotrexate|methotrexate|mesh-list
19420012|NCT01379209|KRN 7000|krn 7000|mesh-list
19420013|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19709395|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709396|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709397|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19709398|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19709399|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20531242|NCT01793636|Everolimus|everolimus|mesh-list
19420014|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19420015|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
19420016|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19420017|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420018|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420019|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
19420020|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420021|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420022|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
19420023|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420024|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19420025|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420026|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
19420027|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19420028|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19420029|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19420030|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19420031|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
19420032|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19420033|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420034|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
19709400|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709401|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
19709402|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
19709403|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
19709404|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709405|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
19709406|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
19709407|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709408|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
19709409|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709410|NCT04804696|Paclitaxel|paclitaxel|mesh-list
19709411|NCT04804696|Cisplatin|cisplatin|mesh-list
19709412|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709413|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709414|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709415|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709416|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709417|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709418|NCT04804423|Listerine|listerine|mesh-list
19709419|NCT04804423|Fluorides|fluorides|mesh-list
19709420|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
19709421|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
19709422|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
19709423|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
19856302|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420035|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19420036|NCT01378676|Riluzole|riluzole|mesh-list
19420037|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
19420038|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19420039|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19420040|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420041|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420042|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420043|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19420044|NCT01378676|Protective Agents|protective agents|mesh-ancestor
19420045|NCT01377662|Methylphenidate|methylphenidate|mesh-list
19420046|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19420047|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420048|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19420049|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19420050|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420051|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420052|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
19420053|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420054|NCT01373086|Eplerenone|eplerenone|mesh-list
19420055|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19420056|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
19420057|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19420058|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709424|NCT04804423|Protective Agents|protective agents|mesh-ancestor
19709425|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709426|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19709427|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709428|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
19709429|NCT04804072|Narcotics|narcotics|mesh-ancestor
19709430|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709431|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709432|NCT04804072|Analgesics|analgesics|mesh-ancestor
19709433|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
19709434|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709435|NCT04804267|Linaclotide|linaclotide|mesh-list
19709436|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19709437|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
19709438|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709439|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856303|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856304|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19856305|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19856306|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
19856307|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856308|NCT00756886|Atorvastatin|atorvastatin|mesh-list
19856309|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19856310|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19856311|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
19856312|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856313|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19856314|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19856315|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856316|NCT00756964|Rasburicase|rasburicase|mesh-list
19856317|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
19856318|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856319|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20249166|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19420059|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19420060|NCT01373086|Diuretics|diuretics|mesh-ancestor
19420061|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
19420062|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19420063|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
19420064|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19420065|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
19420066|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420067|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
19420068|NCT01372475|Protective Agents|protective agents|mesh-ancestor
19420069|NCT01371578|Ribavirin|ribavirin|mesh-list
19420070|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19420071|NCT01371578|Ledipasvir|ledipasvir|mesh-list
19420072|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
19420073|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420074|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
19420075|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709440|NCT04803539|Capecitabine|capecitabine|mesh-list
19856320|NCT00756977|Laxatives|laxatives|mesh-ancestor
19420076|NCT01370512|Droxidopa|droxidopa|mesh-list
19420077|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19420078|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19420079|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19420080|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19420081|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420082|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420083|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
19420084|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420085|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420086|NCT01369147|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19420087|NCT01369147|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19420088|NCT01369147|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19420089|NCT01369147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19420090|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19420091|NCT01369095|Citalopram|citalopram|mesh-list
19420092|NCT01369095|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19420093|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19420094|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420095|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420096|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420097|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
19856321|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856322|NCT00757172|Docetaxel|docetaxel|mesh-list
19420098|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420099|NCT01369095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19420100|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
19420101|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19420102|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420103|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19709441|NCT04803539|Apatinib|apatinib|mesh-list
19709442|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19709443|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
19709444|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709445|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709446|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19709447|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709448|NCT04803734|Albuterol|albuterol|mesh-list
19709449|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19709450|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
19856323|NCT00757172|Panitumumab|panitumumab|mesh-list
19420104|NCT01369095|Analgesics|analgesics|mesh-ancestor
19420105|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
19420106|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
19420107|NCT01366131|Paclitaxel|paclitaxel|mesh-list
19420108|NCT01366131|Bevacizumab|bevacizumab|mesh-list
19420109|NCT01366131|Carboplatin|carboplatin|mesh-list
19420110|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19420111|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420112|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420113|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420114|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420115|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420116|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19420117|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19420118|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19420119|NCT01366131|Growth Substances|growth substances|mesh-ancestor
19420120|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420121|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
19420122|NCT01366014|Oxycodone|oxycodone|mesh-list
19420123|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19420124|NCT01366014|Narcotics|narcotics|mesh-ancestor
19420125|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420126|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420127|NCT01366014|Analgesics|analgesics|mesh-ancestor
19420128|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
19420129|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420130|NCT01365195|Ketamine|ketamine|mesh-list
19420131|NCT01365195|Analgesics|analgesics|mesh-ancestor
19420132|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
19420133|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420134|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420135|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19420136|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19420137|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
19420138|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
19420139|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420140|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19420141|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19420142|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420143|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420144|NCT01361802|Ambroxol|ambroxol|mesh-list
19420145|NCT01361802|Expectorants|expectorants|mesh-ancestor
19420146|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
19420147|NCT01360853|Gemcitabine|gemcitabine|mesh-list
19420148|NCT01360853|ON 01910|on 01910|mesh-list
19420149|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420150|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
19420151|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420152|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420153|NCT01360853|Antiviral Agents|antiviral agents|mesh-ancestor
19420154|NCT01360853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420155|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709451|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420156|NCT01360853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420157|NCT01360853|Immunologic Factors|immunologic factors|mesh-ancestor
19420158|NCT01360853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733679|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19420159|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19420160|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
19420161|NCT01359566|Baclofen|baclofen|mesh-list
19420162|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19420163|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420164|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19420165|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420166|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19420167|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
19420168|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
19420169|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420170|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420171|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
19420172|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19420173|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19420174|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19420175|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420176|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420177|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
19420178|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420179|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420180|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19420181|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420182|NCT01357642|Epinephrine|epinephrine|mesh-list
19420183|NCT01357642|Racepinephrine|racepinephrine|mesh-list
19420184|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
19420185|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19420186|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19420187|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
19420188|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420189|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420190|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420191|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19420192|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19420193|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
19420194|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420195|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19420196|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
19420197|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
19420198|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
19420199|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19420200|NCT01356849|Atrasentan|atrasentan|mesh-list
19420201|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420202|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19420203|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19420204|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420205|NCT01356160|Ribavirin|ribavirin|mesh-list
19420206|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19420207|NCT01356160|Ledipasvir|ledipasvir|mesh-list
20249167|NCT00439426|Capecitabine|capecitabine|mesh-list
20249168|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
19420208|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
20249169|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420209|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420210|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
19420211|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420212|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19420213|NCT01355393|Sargramostim|sargramostim|mesh-list
19420214|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
19420215|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420216|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
19420217|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420218|NCT01354717|Fluorouracil|fluorouracil|mesh-list
19420219|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
19420220|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420221|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420222|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420223|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420224|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
19420225|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420226|NCT01353248|Ribavirin|ribavirin|mesh-list
19420227|NCT01353248|Ledipasvir|ledipasvir|mesh-list
19420228|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
20249170|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
20249171|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249172|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286521|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286522|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
20286523|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20286524|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286525|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
20286526|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286527|NCT03421288|Antidotes|antidotes|mesh-ancestor
20286528|NCT03421288|Protective Agents|protective agents|mesh-ancestor
20286529|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
19420229|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420230|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
19420231|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420232|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
19420233|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19420234|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
19420235|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420236|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420237|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19420238|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
19420239|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19420240|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19420241|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19420242|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
19420243|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420244|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420245|NCT01348919|Dexamethasone|dexamethasone|mesh-list
19420246|NCT01348919|Lenalidomide|lenalidomide|mesh-list
19420247|NCT01348919|Delanzomib|delanzomib|mesh-list
19420248|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19420249|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
19420250|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
19420251|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420252|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709452|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709453|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19709454|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
19709455|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
19709456|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19709457|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19709458|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19709459|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19709460|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
19709461|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709462|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733680|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733681|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733682|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
19733683|NCT04559568|Midazolam|midazolam|mesh-list
19856324|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420253|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19420254|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
20286530|NCT03421288|Vitamins|vitamins|mesh-ancestor
19420255|NCT01348919|Hormones|hormones|mesh-ancestor
19420256|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19420257|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19420258|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420259|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
19420260|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19420261|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19420262|NCT01348919|Growth Substances|growth substances|mesh-ancestor
19420263|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
19420264|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
19420265|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
19420266|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420267|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420268|NCT01345045|Pregabalin|pregabalin|mesh-list
19420269|NCT01345045|Analgesics|analgesics|mesh-ancestor
19420270|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
19420271|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420272|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420273|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
19420274|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19420275|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420276|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420277|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19420278|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19420279|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19420280|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420281|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19420282|NCT01344187|Riboflavin|riboflavin|mesh-list
19420283|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19420284|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
19420285|NCT01344187|Vitamins|vitamins|mesh-ancestor
19420286|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
19420287|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420288|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19420289|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
19420290|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19420291|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
19420292|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420293|NCT01339689|Ganaxolone|ganaxolone|mesh-list
19420294|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
19420295|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420296|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420297|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420298|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
19420299|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
19420300|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19420301|NCT01338883|Efavirenz|efavirenz|mesh-list
19420302|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
19420303|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19709463|NCT04803500|Simvastatin|simvastatin|mesh-list
20249173|NCT00439504|Lobeline|lobeline|mesh-list
20249174|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19709464|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19709465|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19709466|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
19856325|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
19856326|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
19856327|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
20249175|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
20249176|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709467|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709468|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19709469|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19709470|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709471|NCT04803318|Everolimus|everolimus|mesh-list
19709472|NCT04803318|Lenvatinib|lenvatinib|mesh-list
19709473|NCT04803318|Trametinib|trametinib|mesh-list
19709474|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709475|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709476|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
19709477|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709478|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19709479|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709480|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709481|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20249177|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249178|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20249179|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19420304|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20249180|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
19420305|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420306|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420307|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
19420308|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420309|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19420310|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19420311|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19420312|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19420313|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19420314|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19420315|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19420316|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19420317|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19420318|NCT01337752|Dexamethasone|dexamethasone|mesh-list
19420319|NCT01337752|Bortezomib|bortezomib|mesh-list
19420320|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19420321|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19420322|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
19420323|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
19420324|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420325|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420326|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19420327|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
19420328|NCT01337752|Hormones|hormones|mesh-ancestor
19420329|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19420330|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19420331|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420332|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
19420333|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
19420334|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19420335|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420336|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420337|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19420338|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19420339|NCT01337349|Protective Agents|protective agents|mesh-ancestor
19420340|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420341|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
19420342|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19420343|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
19420344|NCT01336686|Colchicine|colchicine|mesh-list
19420345|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
19420346|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19420347|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420348|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420349|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420350|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420351|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420352|NCT01336465|Etrolizumab|etrolizumab|mesh-list
19420353|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19420354|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
19709482|NCT04803422|Amoxicillin|amoxicillin|mesh-list
19709483|NCT04803422|Metronidazole|metronidazole|mesh-list
19709484|NCT04803422|Tazobactam|tazobactam|mesh-list
19709485|NCT04803422|Piperacillin|piperacillin|mesh-list
19709486|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
19709487|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
19709488|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20249181|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420355|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420356|NCT01332812|Dexamethasone|dexamethasone|mesh-list
19856328|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420357|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
19420358|NCT01332812|BB 1101|bb 1101|mesh-list
19420359|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19420360|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
19420361|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
19420362|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420363|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420364|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19420365|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
19420366|NCT01332812|Hormones|hormones|mesh-ancestor
19420367|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19420368|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19420369|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420370|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
19420371|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420372|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420373|NCT01332656|Paclitaxel|paclitaxel|mesh-list
19420374|NCT01332656|Carboplatin|carboplatin|mesh-list
19420375|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19420376|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420377|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420378|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420379|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420380|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420381|NCT01331850|Ritonavir|ritonavir|mesh-list
19420382|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19420383|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
19420384|NCT01331850|Ribavirin|ribavirin|mesh-list
19420385|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19420386|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19420387|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
19420388|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420389|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420390|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19420391|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19420392|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
19420393|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420394|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19420395|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19420396|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
19420397|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420398|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
19420399|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19420400|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19420401|NCT01328808|Acetaminophen|acetaminophen|mesh-list
19420402|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19420403|NCT01328808|Analgesics|analgesics|mesh-ancestor
19420404|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
19420405|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420406|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420407|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
19420408|NCT01328093|Aripiprazole|aripiprazole|mesh-list
19420409|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
19420410|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19420411|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20249182|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420412|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19420413|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420414|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420415|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
19420416|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
19420417|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420418|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420419|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19420420|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19420421|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
19420422|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19420423|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19420424|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19420425|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19420426|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
19420427|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
19420428|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420429|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420430|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
19420431|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19420432|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420433|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420434|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19420435|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
19420436|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
19420437|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420438|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420439|NCT01318642|Gemcitabine|gemcitabine|mesh-list
19420440|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420441|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
19420442|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420443|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420444|NCT01318642|Antiviral Agents|antiviral agents|mesh-ancestor
19420445|NCT01318642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420446|NCT01318642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420447|NCT01318642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420448|NCT01318642|Immunologic Factors|immunologic factors|mesh-ancestor
19420449|NCT01318642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420450|NCT01318252|Latanoprost|latanoprost|mesh-list
19420451|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19420452|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19420453|NCT01314222|Pregabalin|pregabalin|mesh-list
19420454|NCT01314222|Analgesics|analgesics|mesh-ancestor
19420455|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
19420456|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420457|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856329|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19420458|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
19420459|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19420460|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420461|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420462|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19420463|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19420464|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19420465|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420466|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709489|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709490|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19709491|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19709492|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19709493|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709494|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709495|NCT04803162|Omeprazole|omeprazole|mesh-list
19709496|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19709497|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709498|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19709499|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709500|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709501|NCT04803175|Valsartan|valsartan|mesh-list
19709502|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19709503|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19709504|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19709505|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19709506|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709507|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
19709508|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19709509|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
19709510|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709511|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
19709512|NCT04803240|Protective Agents|protective agents|mesh-ancestor
19709513|NCT04803474|Hormones|hormones|mesh-list
19709514|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19709515|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709516|NCT04803370|Antibodies|antibodies|mesh-list
19709517|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
19709518|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709519|NCT04802967|Ketoprofen|ketoprofen|mesh-list
19709520|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
19709521|NCT04802967|Gabapentin|gabapentin|mesh-list
19709522|NCT04802967|Analgesics|analgesics|mesh-ancestor
19709523|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
19709524|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709525|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709526|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
19709527|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19709528|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709529|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709530|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709531|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19709532|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19709533|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709534|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709535|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
19709536|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19709537|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709538|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709539|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19709540|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19709541|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709542|NCT04802928|Isoniazid|isoniazid|mesh-list
19709543|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
20249183|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
20249184|NCT00439530|Oseltamivir|oseltamivir|mesh-list
20249185|NCT00439530|Probenecid|probenecid|mesh-list
20249186|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
20249187|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249188|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249189|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531243|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249190|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
19420467|NCT01313572|Adenosine|adenosine|mesh-list
19420468|NCT01313572|Analgesics|analgesics|mesh-ancestor
19420469|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
19420470|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420471|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420472|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19420473|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
19420474|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19420475|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
19420476|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
19420477|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420478|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420479|NCT01312454|Travoprost|travoprost|mesh-list
19420480|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19420481|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19420482|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19420483|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420484|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420485|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420486|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19420487|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19420488|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19420489|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420490|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420491|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420492|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420493|NCT01309945|Analgesics|analgesics|mesh-ancestor
19420494|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
19420495|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420496|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
19420497|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19420498|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
19420499|NCT01309932|Interferons|interferons|mesh-list
19420500|NCT01309932|Ribavirin|ribavirin|mesh-list
19420501|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
19420502|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
19420503|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19420504|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19420505|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
19420506|NCT01309932|Asunaprevir|asunaprevir|mesh-list
19420507|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420508|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
19420509|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420510|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
19420511|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420512|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
19420513|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420514|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420515|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19420516|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19420517|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19420518|NCT01303783|Candesartan|candesartan|mesh-list
19420519|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
19420520|NCT01303783|Nifedipine|nifedipine|mesh-list
19420521|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19420522|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19420523|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19420524|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420525|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19420526|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420527|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19420528|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420529|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
19420530|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
19420531|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19420532|NCT01302249|Timolol|timolol|mesh-list
19420533|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19420534|NCT01302249|Latanoprost|latanoprost|mesh-list
19420535|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19420536|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19420537|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19420538|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
19420539|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420540|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420541|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420542|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19420543|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19420544|NCT01301157|Calcipotriene|calcipotriene|mesh-list
19420545|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
19450692|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19450693|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
19450694|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
19450695|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
19450696|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
19450697|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450698|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450699|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450700|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19420546|NCT01298687|Travoprost|travoprost|mesh-list
20249191|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
19420547|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19420548|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19420549|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19420550|NCT01297543|Sargramostim|sargramostim|mesh-list
19420551|NCT01297543|Lenograstim|lenograstim|mesh-list
19420552|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
19420553|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420554|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19420555|NCT01295060|Octreotide|octreotide|mesh-list
19420556|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19420557|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19420558|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420559|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
19420560|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420561|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19420562|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420563|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420564|NCT01283594|Levodopa|levodopa|mesh-list
19420565|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19420566|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19420567|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
19420568|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420569|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420570|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420571|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19420572|NCT01281462|Cephalosporins|cephalosporins|mesh-list
19420573|NCT01281462|Doripenem|doripenem|mesh-list
19420574|NCT01281462|Avibactam|avibactam|mesh-list
19420575|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19420576|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420577|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19420578|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420579|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249192|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249193|NCT00439530|Renal Agents|renal agents|mesh-ancestor
20249194|NCT00439543|Iloprost|iloprost|mesh-list
20249195|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20249196|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
20249197|NCT00439699|Memantine|memantine|mesh-list
20249198|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19420580|NCT01281254|Trebananib|trebananib|mesh-list
19420581|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19420582|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19420583|NCT01281254|Growth Substances|growth substances|mesh-ancestor
19420584|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420585|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
19420586|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420587|NCT01280565|Dacarbazine|dacarbazine|mesh-list
19420588|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20249199|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20249200|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
20249201|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249202|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249203|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249204|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20249205|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19420589|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
19420590|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249206|NCT00439712|Levocetirizine|levocetirizine|mesh-list
20249207|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20249208|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20249209|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
20249210|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
20249211|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420591|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420592|NCT01280331|Morphine|morphine|mesh-list
19420593|NCT01280331|Oxycodone|oxycodone|mesh-list
19420594|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19420595|NCT01280331|Narcotics|narcotics|mesh-ancestor
19420596|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420597|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420598|NCT01280331|Analgesics|analgesics|mesh-ancestor
19420599|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
19420600|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420601|NCT01279590|Atorvastatin|atorvastatin|mesh-list
19420602|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19420603|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19420604|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
19420605|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420606|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19420607|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19420608|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420609|NCT01278134|Ritonavir|ritonavir|mesh-list
19420610|NCT01278134|Ribavirin|ribavirin|mesh-list
19420611|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19420612|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19420613|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19420614|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
19420615|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420616|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420617|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20249212|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249213|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249214|NCT00439751|Goserelin|goserelin|mesh-list
20249215|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20249216|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249217|NCT00439829|Cetrorelix|cetrorelix|mesh-list
19420618|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19420619|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
19420620|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420621|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19420622|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19420623|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
19856330|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19856331|NCT00757237|Tobramycin|tobramycin|mesh-list
19856332|NCT00757237|Aztreonam|aztreonam|mesh-list
19856333|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19856334|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19856335|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856336|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
19856337|NCT00757588|Insulin|insulin|mesh-list
19856338|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19856339|NCT00757588|Saxagliptin|saxagliptin|mesh-list
19856340|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19420624|NCT01276587|Vitamin D|vitamin d|mesh-list
19420625|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
19420626|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
19420627|NCT01276587|Vitamins|vitamins|mesh-list
19420628|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
20249218|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20249219|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
20249220|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20249221|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249222|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
19709544|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19709545|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709546|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19709547|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19709548|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
19856341|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856342|NCT00757588|Incretins|incretins|mesh-ancestor
19856343|NCT00757588|Hormones|hormones|mesh-ancestor
19856344|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856345|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19856346|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
19856347|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856348|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969572|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969573|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
19969574|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
19969575|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969576|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
19969577|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969578|NCT01773954|Aflibercept|aflibercept|mesh-list
19969579|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19969580|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19969581|NCT01773954|Growth Substances|growth substances|mesh-ancestor
19969582|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969583|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
19969584|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969585|NCT01773993|Pregabalin|pregabalin|mesh-list
19969586|NCT01773993|Analgesics|analgesics|mesh-ancestor
19969587|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
19969588|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969589|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969590|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
19969591|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19969592|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19969593|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969594|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19969595|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19969596|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19969597|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19969598|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19969599|NCT01774149|Diazepam|diazepam|mesh-list
19969600|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19969601|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
19709549|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709550|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19709551|NCT04802785|Aspirin|aspirin|mesh-list
19709552|NCT04802785|Domperidone|domperidone|mesh-list
19709553|NCT04802785|Melatonin|melatonin|mesh-list
19709554|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19420629|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420630|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19420631|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19420632|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19420633|NCT01275105|Phenylephrine|phenylephrine|mesh-list
19420634|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
19420635|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19420636|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19420637|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19420638|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19420639|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
19420640|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420641|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420642|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420643|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
19420644|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
19420645|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420646|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
19420647|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19420648|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
19420649|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19420650|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
19420651|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19420652|NCT01275105|Protective Agents|protective agents|mesh-ancestor
19420653|NCT01272791|Gemcitabine|gemcitabine|mesh-list
19420654|NCT01272791|Bavituximab|bavituximab|mesh-list
19420655|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420656|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
19420657|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420658|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420659|NCT01272791|Antiviral Agents|antiviral agents|mesh-ancestor
19420660|NCT01272791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420661|NCT01272791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420662|NCT01272791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420663|NCT01272791|Immunologic Factors|immunologic factors|mesh-ancestor
19420664|NCT01272791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420665|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19420666|NCT01271920|Trastuzumab|trastuzumab|mesh-list
19420667|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19420668|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420669|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19420670|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
19420671|NCT01271790|Ribavirin|ribavirin|mesh-list
19420672|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
19420673|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420674|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
19420675|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420676|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
19420677|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420678|NCT01270347|Levofloxacin|levofloxacin|mesh-list
20249223|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249224|NCT00439855|Heparin|heparin|mesh-list
20249225|NCT00439855|Enoxaparin|enoxaparin|mesh-list
20249226|NCT00439855|Calcium heparin|calcium heparin|mesh-list
20249227|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
20249228|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20249229|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20249230|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249231|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
20249232|NCT00439972|Ortho Evra|ortho evra|mesh-list
20249233|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19420679|NCT01270347|Ofloxacin|ofloxacin|mesh-list
19420680|NCT01270347|Tobramycin|tobramycin|mesh-list
20249234|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19420681|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19420682|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19420683|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420684|NCT01270347|Renal Agents|renal agents|mesh-ancestor
19420685|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19420686|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19420687|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19420688|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420689|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420690|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709555|NCT04802785|Simethicone|simethicone|mesh-list
19709556|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19709557|NCT04802785|Citric Acid|citric acid|mesh-list
19709558|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
19709559|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
19709560|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19709561|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
19709562|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
19709563|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709564|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
19709565|NCT04802785|Protective Agents|protective agents|mesh-ancestor
19709566|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709567|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709568|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19709569|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709570|NCT04802785|Analgesics|analgesics|mesh-ancestor
19709571|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
19709572|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709573|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709574|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19709575|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19709576|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19709577|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19709578|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19709579|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709580|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
19709581|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
19709582|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
19709583|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709584|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19709585|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
19709586|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709587|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
19709588|NCT04802785|Emollients|emollients|mesh-ancestor
19709589|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19709590|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
19709591|NCT04802785|Antacids|antacids|mesh-ancestor
19709592|NCT04802876|Spartalizumab|spartalizumab|mesh-list
19709593|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19709594|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709595|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709596|NCT04802980|Gemcitabine|gemcitabine|mesh-list
19709597|NCT04802980|Paclitaxel|paclitaxel|mesh-list
19709598|NCT04802980|Carboplatin|carboplatin|mesh-list
19709599|NCT04802980|Capecitabine|capecitabine|mesh-list
19709600|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
19709601|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709602|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709603|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420691|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19709604|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709605|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709606|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709607|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420692|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19420693|NCT01269658|Azithromycin|azithromycin|mesh-list
19420694|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19420695|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19420696|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19420697|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420698|NCT01266525|Donepezil|donepezil|mesh-list
19420699|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19420700|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420701|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420702|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
19420703|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420704|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420705|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
19420706|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
19420707|NCT01265901|Sunitinib|sunitinib|mesh-list
19420708|NCT01265901|Molgramostim|molgramostim|mesh-list
19420709|NCT01265901|Sargramostim|sargramostim|mesh-list
19420710|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
19420711|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420712|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420713|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19420714|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19420715|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
19420716|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420717|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420718|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19420719|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19420720|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19420721|NCT01265901|Growth Substances|growth substances|mesh-ancestor
19420722|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
19420723|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19420724|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420725|NCT01262261|Buprenorphine|buprenorphine|mesh-list
19420726|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19420727|NCT01262261|Narcotics|narcotics|mesh-ancestor
19709608|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
20249235|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
20249236|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20249237|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249238|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20249239|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249240|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19709609|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
19420728|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420729|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420730|NCT01262261|Analgesics|analgesics|mesh-ancestor
19420731|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
19420732|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420733|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19420734|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19420735|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
19420736|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420737|NCT01261312|Guadecitabine|guadecitabine|mesh-list
19420738|NCT01261312|Azacitidine|azacitidine|mesh-list
19420739|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420740|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420741|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
19420742|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420743|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420744|NCT01260870|Paclitaxel|paclitaxel|mesh-list
19420745|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19420746|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420747|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420748|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420749|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420750|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420751|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19420752|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
19420753|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420754|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19420755|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19420756|NCT01256762|Paclitaxel|paclitaxel|mesh-list
19420757|NCT01256762|Bevacizumab|bevacizumab|mesh-list
19420758|NCT01256762|Imetelstat|imetelstat|mesh-list
19420759|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
19709610|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709611|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709612|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709613|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
19709614|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709615|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
19709616|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19709617|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19709618|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709619|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
19709620|NCT04802382|Coagulants|coagulants|mesh-ancestor
19709621|NCT04802122|Propofol|propofol|mesh-list
19709622|NCT04802122|Sevoflurane|sevoflurane|mesh-list
19709623|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19709624|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709625|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709626|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19709627|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
19709628|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
19709629|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19856349|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19856350|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19420760|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19420761|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420762|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709630|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19709631|NCT04802083|Eculizumab|eculizumab|mesh-list
19420763|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420764|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420765|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420766|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19420767|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19420768|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19420769|NCT01256762|Growth Substances|growth substances|mesh-ancestor
19420770|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420771|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
19420772|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420773|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19420774|NCT01255709|Epinephrine|epinephrine|mesh-list
19420775|NCT01255709|Racepinephrine|racepinephrine|mesh-list
19420776|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
19420777|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19420778|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19420779|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
19420780|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420781|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420782|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420783|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19420784|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19420785|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
19420786|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420787|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19420788|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
19420789|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
19420790|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
19420791|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19420792|NCT01254370|Travoprost|travoprost|mesh-list
19420793|NCT01254370|Latanoprost|latanoprost|mesh-list
19420794|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19420795|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19420796|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19420797|NCT01254136|Trastuzumab|trastuzumab|mesh-list
19420798|NCT01254136|Vinorelbine|vinorelbine|mesh-list
19420799|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19420800|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420801|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19420802|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420803|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420804|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420805|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420806|NCT01253603|Fluticasone|fluticasone|mesh-list
19420807|NCT01253603|Xhance|xhance|mesh-list
19420808|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
19420809|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19420810|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19420811|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
19450701|NCT03426527|Analgesics|analgesics|mesh-ancestor
19450702|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
19420812|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420813|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420814|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19420815|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
19420816|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
19420817|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19420818|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19420819|NCT01253603|Growth Substances|growth substances|mesh-ancestor
19420820|NCT01252693|Goserelin|goserelin|mesh-list
19420821|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19420822|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420823|NCT01252628|Cetuximab|cetuximab|mesh-list
19420824|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19420825|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420826|NCT01248975|Montelukast|montelukast|mesh-list
19420827|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19420828|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
19420829|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19420830|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
19420831|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19420832|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420833|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19420834|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19420835|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420836|NCT01243346|Crenolanib|crenolanib|mesh-list
19420837|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420838|NCT01243073|Imetelstat|imetelstat|mesh-list
19420839|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
19420840|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420841|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420842|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19420843|NCT01242930|Niacinamide|niacinamide|mesh-list
19420844|NCT01242930|Lenalidomide|lenalidomide|mesh-list
19420845|NCT01242930|Imetelstat|imetelstat|mesh-list
19420846|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
19420847|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
19420848|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420849|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19420850|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19420851|NCT01242930|Growth Substances|growth substances|mesh-ancestor
19420852|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
19420853|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420854|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420855|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420856|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19420857|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
19420858|NCT01242930|Vitamins|vitamins|mesh-ancestor
19420859|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
19420860|NCT01241214|Cetirizine|cetirizine|mesh-list
19420861|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19420862|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19420863|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19420864|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
19420865|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
19420866|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420867|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420868|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420869|NCT01240759|Metformin|metformin|mesh-list
19420870|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19420871|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420872|NCT01240512|Vitamin D|vitamin d|mesh-list
19420873|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
19420874|NCT01240512|Vitamins|vitamins|mesh-ancestor
19420875|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
19420876|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420877|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19420878|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19420879|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19420880|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19420881|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420882|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420883|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
19420884|NCT01235754|Testosterone|testosterone|mesh-list
19420885|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
19420886|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
19420887|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19420888|NCT01235754|Androgens|androgens|mesh-ancestor
19420889|NCT01235754|Hormones|hormones|mesh-ancestor
19420890|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19420891|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856351|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19420892|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19420893|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420894|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
19420895|NCT01235039|Insulin|insulin|mesh-list
19420896|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
19420897|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19420898|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19420899|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420900|NCT01234779|Olanzapine|olanzapine|mesh-list
19420901|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
19420902|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
19420903|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19420904|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420905|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19420906|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19420907|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19420908|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19420909|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19420910|NCT01234779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19420911|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19709632|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19709633|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709634|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
19709635|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709636|NCT04801953|Nimodipine|nimodipine|mesh-list
19709637|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19709638|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19709639|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19709640|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709641|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19709642|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709643|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
19709644|NCT04801888|Vaccines|vaccines|mesh-list
19709645|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
19709646|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709647|NCT04801940|Apixaban|apixaban|mesh-list
19420912|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19420913|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420914|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19420915|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
19420916|NCT01234519|Doxorubicin|doxorubicin|mesh-list
19420917|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19420918|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420919|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19420920|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19420921|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420922|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420923|NCT01234038|Paclitaxel|paclitaxel|mesh-list
19420924|NCT01234038|Carboplatin|carboplatin|mesh-list
19420925|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19420926|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420927|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420928|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420929|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420930|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420931|NCT01234025|Prednisone|prednisone|mesh-list
19420932|NCT01234025|Docetaxel|docetaxel|mesh-list
19420933|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420934|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
19420935|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
19420936|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
19420937|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420938|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19420939|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
19420940|NCT01234025|Hormones|hormones|mesh-ancestor
19420941|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19420942|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420943|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19420944|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
19420945|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19420946|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
19420947|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420948|NCT01232595|Vancomycin|vancomycin|mesh-list
19420949|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19420950|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420951|NCT01231347|Gemcitabine|gemcitabine|mesh-list
19420952|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19420953|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420954|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
19709648|NCT04801940|Atorvastatin|atorvastatin|mesh-list
19709649|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19709650|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19709651|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
19709652|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709653|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19709654|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19709655|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709656|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19709657|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
19709658|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19709659|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
19709660|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
19709661|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
19709662|NCT04801966|Nivolumab|nivolumab|mesh-list
19709663|NCT04801966|Atezolizumab|atezolizumab|mesh-list
19709664|NCT04801966|Olaparib|olaparib|mesh-list
19709665|NCT04801966|Palbociclib|palbociclib|mesh-list
19709666|NCT04801966|Trametinib|trametinib|mesh-list
19709667|NCT04801966|Vemurafenib|vemurafenib|mesh-list
19709668|NCT04801966|Dabrafenib|dabrafenib|mesh-list
19709669|NCT04801966|Talazoparib|talazoparib|mesh-list
19709670|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19709671|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709672|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19709673|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709674|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19709675|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420955|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420956|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420957|NCT01231347|Antiviral Agents|antiviral agents|mesh-ancestor
19709676|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19709677|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19420958|NCT01231347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420959|NCT01231347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420960|NCT01231347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420961|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
19420962|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420963|NCT01230957|Vaccines|vaccines|mesh-list
19420964|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
19420965|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420966|NCT01229982|Latanoprost|latanoprost|mesh-list
19420967|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19420968|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19420969|NCT01229644|Crenolanib|crenolanib|mesh-list
19420970|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450703|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450704|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19450705|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19450706|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19450707|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
19856352|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856353|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450708|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450709|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450710|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
19450711|NCT03426462|Propofol|propofol|mesh-list
19450712|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450713|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450714|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450715|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19450716|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
19856354|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19450717|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
19450718|NCT03426202|Modafinil|modafinil|mesh-list
19450719|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19450720|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709678|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
19709679|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733684|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19733685|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19733686|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733687|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733688|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19733689|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19733690|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19733691|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19733692|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
19733693|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
19733694|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
19733695|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
19733696|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733697|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733698|NCT04559308|Metformin|metformin|mesh-list
19733699|NCT04559308|Paclitaxel|paclitaxel|mesh-list
19733700|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
19733701|NCT04559308|Doxorubicin|doxorubicin|mesh-list
19733702|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19733703|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733704|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
19733705|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
19733706|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
19733707|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733708|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19420971|NCT01228383|Vaccines|vaccines|mesh-list
19420972|NCT01228383|Antibodies|antibodies|mesh-list
19420973|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19420974|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
19420975|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
19420976|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19420977|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19420978|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
19420979|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420980|NCT01226563|Calcium|calcium|mesh-list
19420981|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19420982|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19420983|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
19420984|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19420985|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19420986|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19420987|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420988|NCT01225393|Adalimumab|adalimumab|mesh-list
19420989|NCT01225393|Methotrexate|methotrexate|mesh-list
19420990|NCT01225393|Leflunomide|leflunomide|mesh-list
19420991|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19420992|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
19709680|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
19709681|NCT04801511|Vitamins|vitamins|mesh-ancestor
19709682|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
19709683|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709684|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
19709685|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709686|NCT04801511|Protective Agents|protective agents|mesh-ancestor
19709687|NCT04801303|Calcitriol|calcitriol|mesh-list
19709688|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19709689|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709690|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19709691|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19709692|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709693|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19709694|NCT04801303|Vitamins|vitamins|mesh-ancestor
19709695|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
19709696|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19709697|NCT04801589|Midazolam|midazolam|mesh-list
19709698|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
19709699|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19709700|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709701|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709702|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709703|NCT04801589|Analgesics|analgesics|mesh-ancestor
19709704|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
19709705|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709706|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19709707|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19856355|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19856356|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19856357|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
19856358|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856359|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856360|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19856361|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19856362|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
19856363|NCT00757783|Ritonavir|ritonavir|mesh-list
19856364|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19856365|NCT00757783|Darunavir|darunavir|mesh-list
19856366|NCT00757783|Tenofovir|tenofovir|mesh-list
19856367|NCT00757783|Emtricitabine|emtricitabine|mesh-list
19420993|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19420994|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856368|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19969602|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
19420995|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19420996|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
19420997|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19420998|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19420999|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
19421000|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421001|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19421002|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421003|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
19421004|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421005|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19421006|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19421007|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19421008|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
19421009|NCT01225380|Ribavirin|ribavirin|mesh-list
19421010|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
19421011|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856369|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19856370|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
19856371|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856372|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856373|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19856374|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19856375|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
19856376|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856377|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19856378|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19856379|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19421012|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
19421013|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421014|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
19421015|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421016|NCT01224795|Peramivir|peramivir|mesh-list
19421017|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
19421018|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421019|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421020|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421021|NCT01224262|Vaccines|vaccines|mesh-list
19421022|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
19856380|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19421023|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421024|NCT01222702|Vancomycin|vancomycin|mesh-list
19421025|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
19421026|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421027|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421028|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19421029|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421030|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421031|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19421032|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421033|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19421034|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421035|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421036|NCT01220947|Ritonavir|ritonavir|mesh-list
19421037|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19421038|NCT01220947|Lactams|lactams|mesh-list
19421039|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19421040|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19421041|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
19421042|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421043|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421044|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19421045|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19421046|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
19421047|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421048|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19421049|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19421050|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421051|NCT01220271|Temozolomide|temozolomide|mesh-list
19421052|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19421053|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
19421054|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421055|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421056|NCT01207115|Naproxen|naproxen|mesh-list
19421057|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19421058|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19421059|NCT01207115|Analgesics|analgesics|mesh-ancestor
19421060|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
19421061|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421062|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421063|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19421064|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421065|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
19421066|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19421067|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421068|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421069|NCT01205061|Lidocaine|lidocaine|mesh-list
19421070|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
19709708|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19709709|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
19709710|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709711|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709712|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19709713|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19709714|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709715|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709716|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19709717|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
19709718|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
19709719|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
19709720|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
19709721|NCT04801485|Inositol|inositol|mesh-list
19856381|NCT00757822|Dronabinol|dronabinol|mesh-list
19856382|NCT00757822|Ondansetron|ondansetron|mesh-list
19856383|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
19856384|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
19856385|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856386|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856387|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856388|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
19856389|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
19856390|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19856391|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
19856392|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856393|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856394|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19856395|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856396|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856397|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856398|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19856399|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
19856400|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19856401|NCT00757822|Analgesics|analgesics|mesh-ancestor
19856402|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
19856403|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19856404|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19856405|NCT00757822|Hormones|hormones|mesh-ancestor
19856406|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856407|NCT00758043|Ribavirin|ribavirin|mesh-list
19856408|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19856409|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
19856410|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856411|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
19856412|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709722|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
19421071|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
19421072|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421073|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421074|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
19421075|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421076|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19421077|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19421078|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19421079|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421080|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421081|NCT01205048|Lidocaine|lidocaine|mesh-list
19856413|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19856414|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19856415|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856416|NCT00758069|Incretins|incretins|mesh-ancestor
19856417|NCT00758069|Hormones|hormones|mesh-ancestor
19856418|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856419|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19856420|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
19856421|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856422|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856423|NCT00758160|Methylphenidate|methylphenidate|mesh-list
19856424|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19856425|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421082|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
19421083|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
19856426|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19856427|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19856428|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19856429|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856430|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
19856431|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856432|NCT00758264|Vaccines|vaccines|mesh-list
19421084|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421085|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421086|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
19421087|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421088|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19421089|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19421090|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19421091|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421092|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421093|NCT01204762|Entecavir|entecavir|mesh-list
19421094|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
19421095|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249241|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20249242|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249243|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249244|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421096|NCT01204749|Paclitaxel|paclitaxel|mesh-list
19421097|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19421098|NCT01204749|Trebananib|trebananib|mesh-list
19421099|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19421100|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19421101|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421102|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421103|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421104|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421105|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421106|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19421107|NCT01204749|Growth Substances|growth substances|mesh-ancestor
19421108|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709723|NCT04801485|Vitamins|vitamins|mesh-ancestor
19709724|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
20249245|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20249246|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20249247|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20249248|NCT00440024|Tazarotene|tazarotene|mesh-list
20249249|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
20249250|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
20249251|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
20249252|NCT00440063|Hematinics|hematinics|mesh-ancestor
20249253|NCT00440076|Bortezomib|bortezomib|mesh-list
20249254|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249255|NCT00440102|Ketamine|ketamine|mesh-list
20249256|NCT00440102|Etomidate|etomidate|mesh-list
20249257|NCT00440102|Analgesics|analgesics|mesh-ancestor
19709725|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709726|NCT04801342|Memantine|memantine|mesh-list
19709727|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19709728|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19709729|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
19709730|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709731|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709732|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709733|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19709734|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19709735|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19709736|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
19709737|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19709738|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709739|NCT04800978|Durvalumab|durvalumab|mesh-list
19709740|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19709741|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709742|NCT04801017|Artemisinins|artemisinins|mesh-list
19709743|NCT04801017|Artemisinin|artemisinin|mesh-list
19709744|NCT04801017|Trabedersen|trabedersen|mesh-list
19709745|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
19709746|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19709747|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19709748|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709749|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709750|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20249258|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
20249259|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249260|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249261|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20249262|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20249263|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
20249264|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
20249265|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249266|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20249267|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20249268|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249269|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249270|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20249271|NCT00440128|Docetaxel|docetaxel|mesh-list
20249272|NCT00440128|Casopitant|casopitant|mesh-list
19709751|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19709752|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709753|NCT04801199|Incretins|incretins|mesh-ancestor
19709754|NCT04801199|Hormones|hormones|mesh-ancestor
19709755|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249273|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421109|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
20249274|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
20249275|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421110|NCT01204099|Docetaxel|docetaxel|mesh-list
19421111|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421112|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421113|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421114|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421115|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421116|NCT01198834|Etodolac|etodolac|mesh-list
19421117|NCT01198834|Lidocaine|lidocaine|mesh-list
19421118|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
19421119|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
19421120|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421121|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421122|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
19421123|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421124|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19421125|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19421126|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19421127|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421128|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421129|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19421130|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19421131|NCT01198834|Analgesics|analgesics|mesh-ancestor
19421132|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19421133|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421134|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19421135|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19421136|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421137|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
19421138|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421139|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421140|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19421141|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421142|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421143|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421144|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531244|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531245|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
20531246|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531247|NCT01793753|Propofol|propofol|mesh-list
20531248|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20531249|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531250|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531251|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20531252|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
20531253|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
20531254|NCT01793870|Carvedilol|carvedilol|mesh-list
20531255|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20531256|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20531257|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531258|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421145|NCT01194960|Docetaxel|docetaxel|mesh-list
19421146|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421147|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421148|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421149|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421150|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421151|NCT01193361|Interferons|interferons|mesh-list
19421152|NCT01193361|Ribavirin|ribavirin|mesh-list
19421153|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
19421154|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
19421155|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19421156|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421157|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
19421158|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421159|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
19421160|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421161|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
19421162|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421163|NCT01193140|Temozolomide|temozolomide|mesh-list
19421164|NCT01193140|Veliparib|veliparib|mesh-list
19709756|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19709757|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
19709758|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709759|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709760|NCT04800471|Insulin|insulin|mesh-list
19709761|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19709762|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709763|NCT04800367|Denosumab|denosumab|mesh-list
19709764|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19709765|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709766|NCT04800081|Valsartan|valsartan|mesh-list
19856433|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19856434|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
19856435|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856436|NCT00758342|Travoprost|travoprost|mesh-list
19856437|NCT00758342|Brinzolamide|brinzolamide|mesh-list
19856438|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19856439|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19856440|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856441|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856442|NCT00758394|Listerine|listerine|mesh-list
19856443|NCT00758394|Triclosan|triclosan|mesh-list
19856444|NCT00758394|Fluorides|fluorides|mesh-list
19856445|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
19856446|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
19856447|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
19856448|NCT00758394|Protective Agents|protective agents|mesh-ancestor
19856449|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856450|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19856451|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856452|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19856453|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19856454|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
19856455|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856456|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19856457|NCT00758420|Polidocanol|polidocanol|mesh-list
19856458|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19856459|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19856460|NCT00758498|Modafinil|modafinil|mesh-list
19856461|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19856462|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856463|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19856464|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19856465|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19856466|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856467|NCT00758524|Eplerenone|eplerenone|mesh-list
19856468|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19856469|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
19856470|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856471|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856472|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19856473|NCT00758524|Diuretics|diuretics|mesh-ancestor
19421165|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19421166|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
19856474|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
19421167|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421168|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421169|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19421170|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421171|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
19421172|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19421173|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421174|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421175|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19421176|NCT01192035|Ritonavir|ritonavir|mesh-list
19421177|NCT01192035|Lopinavir|lopinavir|mesh-list
19421178|NCT01192035|Nevirapine|nevirapine|mesh-list
19421179|NCT01192035|Efavirenz|efavirenz|mesh-list
19421180|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19421181|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19709767|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19709768|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19709769|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19709770|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709771|NCT04799847|Catumaxomab|catumaxomab|mesh-list
19709772|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709773|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19709774|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
19709775|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19709776|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19709777|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
19709778|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709779|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709780|NCT04799925|Febuxostat|febuxostat|mesh-list
19856475|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20249276|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
20249277|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249278|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
20249279|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
20249280|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249281|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249282|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286531|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
20531259|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531260|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531261|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20531262|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
20531263|NCT01793870|Protective Agents|protective agents|mesh-ancestor
20531264|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20531265|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531266|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20531267|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
20553275|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19421182|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
19421183|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421184|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421185|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19421186|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19421187|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
19421188|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421189|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19421190|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19421191|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19421192|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19421193|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19421194|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19421195|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19421196|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19421197|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19421198|NCT01189396|Albuterol|albuterol|mesh-list
19421199|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19421200|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
19421201|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421202|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421203|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19421204|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
19421205|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
19421206|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19421207|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19421208|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19421209|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19421210|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
19421211|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421212|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421213|NCT01188187|Dexamethasone|dexamethasone|mesh-list
19421214|NCT01188187|Prednisone|prednisone|mesh-list
19421215|NCT01188187|Docetaxel|docetaxel|mesh-list
19421216|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19421217|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
19421218|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
19421219|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421220|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421221|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19421222|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
19421223|NCT01188187|Hormones|hormones|mesh-ancestor
19421224|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19421225|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19421226|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421227|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421228|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421229|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421230|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421231|NCT01186991|Paclitaxel|paclitaxel|mesh-list
19421232|NCT01186991|Bevacizumab|bevacizumab|mesh-list
19421233|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19421234|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19421235|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709781|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
19709782|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19709783|NCT04799782|Mirtazapine|mirtazapine|mesh-list
19709784|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
19421236|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421237|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421238|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421239|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421240|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421241|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19421242|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19421243|NCT01186991|Growth Substances|growth substances|mesh-ancestor
19421244|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421245|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
19421246|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
19421247|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19421248|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421249|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19421250|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421251|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421252|NCT01183949|Bortezomib|bortezomib|mesh-list
19421253|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421254|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19421255|NCT01180634|Levofloxacin|levofloxacin|mesh-list
19421256|NCT01180634|Ofloxacin|ofloxacin|mesh-list
19421257|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19421258|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421259|NCT01180634|Renal Agents|renal agents|mesh-ancestor
19709785|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19709786|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19709787|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
19709788|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
19709789|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19709790|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709791|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709792|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19421260|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421261|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19421262|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19709793|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19709794|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421263|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421264|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421265|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421266|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19421267|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19421268|NCT01175785|Cyclosporine|cyclosporine|mesh-list
19421269|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
19421270|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
19421271|NCT01175785|Fludarabine|fludarabine|mesh-list
19421272|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
19421273|NCT01175785|Cyclosporins|cyclosporins|mesh-list
19421274|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421275|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
19421276|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421277|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421278|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19421279|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
19421280|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421281|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421282|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19421283|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19421284|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
19421285|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421286|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
19421287|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421288|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19421289|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19421290|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19421291|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19421292|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
19421293|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421294|NCT01174732|Albuterol|albuterol|mesh-list
19421295|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19421296|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
19421297|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421298|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421299|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19421300|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
19421301|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
19421302|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19421303|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19421304|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19421305|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19421306|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
19421307|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421308|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421309|NCT01173497|Irinotecan|irinotecan|mesh-list
19421310|NCT01173497|Iniparib|iniparib|mesh-list
19421311|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19421312|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19709795|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19709796|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19709797|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19421313|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421314|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709798|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
19709799|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19709800|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19709801|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
19709802|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19709803|NCT04799743|Resveratrol|resveratrol|mesh-list
19709804|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
19709805|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709806|NCT04799743|Protective Agents|protective agents|mesh-ancestor
19856476|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
19856477|NCT00758602|Tacrolimus|tacrolimus|mesh-list
19856478|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19856479|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
19856480|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856481|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19856482|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856483|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856484|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19856485|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856486|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19856487|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
19856488|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19856489|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856490|NCT00758667|Mesna|mesna|mesh-list
19856491|NCT00758667|Protective Agents|protective agents|mesh-ancestor
19856492|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856493|NCT00758784|Bromfenac|bromfenac|mesh-list
19856494|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19856495|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19856496|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19856497|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19856498|NCT00758784|Analgesics|analgesics|mesh-ancestor
19856499|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
19856500|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856501|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856502|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856503|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856504|NCT00758836|Acetaminophen|acetaminophen|mesh-list
19856505|NCT00758836|Ibuprofen|ibuprofen|mesh-list
19856506|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19856507|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19856508|NCT00758836|Analgesics|analgesics|mesh-ancestor
19856509|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
19856510|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856511|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856512|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856513|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856514|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19709807|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421315|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421316|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19421317|NCT01171313|Carbidopa|carbidopa|mesh-list
19421318|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19421319|NCT01171313|Levodopa|levodopa|mesh-list
19421320|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19421321|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19421322|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
19421323|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421324|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421325|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421326|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19421327|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421328|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19421329|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
19421330|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
19421331|NCT01170650|Doxorubicin|doxorubicin|mesh-list
19421332|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19421333|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19421334|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421335|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19421336|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421337|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421338|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421339|NCT01168713|Levofloxacin|levofloxacin|mesh-list
19421340|NCT01168713|Ofloxacin|ofloxacin|mesh-list
19421341|NCT01168713|Solithromycin|solithromycin|mesh-list
19421342|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19421343|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421344|NCT01168713|Renal Agents|renal agents|mesh-ancestor
19421345|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421346|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19421347|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421348|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421349|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421350|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709808|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709809|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19709810|NCT04799626|Meropenem|meropenem|mesh-list
19709811|NCT04799626|Tazobactam|tazobactam|mesh-list
19709812|NCT04799626|Piperacillin|piperacillin|mesh-list
19709813|NCT04799626|Tigecycline|tigecycline|mesh-list
19856515|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856516|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856517|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
19856518|NCT00759031|Listerine|listerine|mesh-list
19856519|NCT00759031|Triclosan|triclosan|mesh-list
19856520|NCT00759031|Fluorides|fluorides|mesh-list
19856521|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
19856522|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
19856523|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
19856524|NCT00759031|Protective Agents|protective agents|mesh-ancestor
19856525|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856526|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19856527|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856528|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19856529|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19421351|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19709814|NCT04799626|Biapenem|biapenem|mesh-list
19709815|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19709816|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709817|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19709818|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709819|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709820|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19709821|NCT04799262|Prednisone|prednisone|mesh-list
19709822|NCT04799262|Tofacitinib|tofacitinib|mesh-list
19421352|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19421353|NCT01168310|Fluticasone|fluticasone|mesh-list
19421354|NCT01168310|Xhance|xhance|mesh-list
19421355|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
19421356|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19421357|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19421358|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
19421359|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421360|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421361|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19421362|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
19421363|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
19421364|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19421365|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19421366|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19421367|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19421368|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
19421369|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421370|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421371|NCT01167166|ON 01910|on 01910|mesh-list
19421372|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421373|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19421374|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421375|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421376|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
19421377|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19421378|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
19421379|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19421380|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709823|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709824|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
19709825|NCT04799262|Hormones|hormones|mesh-ancestor
19709826|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19709827|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709828|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19709829|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709830|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19709831|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709832|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733709|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
19733710|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733711|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733712|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19733713|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
19733714|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19733715|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19733716|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19733717|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19733718|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19733719|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733720|NCT04559165|Chitosan|chitosan|mesh-list
19733721|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19733722|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19733723|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
19733724|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733725|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19733726|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
19733727|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
19733728|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
19733729|NCT04559165|Coagulants|coagulants|mesh-ancestor
19733730|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
19733731|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19733732|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19733733|NCT04559113|Prednisolone|prednisolone|mesh-list
19733734|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
19733735|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19733736|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
19421381|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19733737|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733738|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
19421382|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19421383|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19421384|NCT01160601|Paclitaxel|paclitaxel|mesh-list
19421385|NCT01160601|Carboplatin|carboplatin|mesh-list
19421386|NCT01160601|Bavituximab|bavituximab|mesh-list
19421387|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709833|NCT04799639|Paclitaxel|paclitaxel|mesh-list
19709834|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709835|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709836|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709837|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
20249283|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20249284|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249285|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19709838|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709839|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709840|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19709841|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709842|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709843|NCT04799002|Melphalan|melphalan|mesh-list
19709844|NCT04799002|Topotecan|topotecan|mesh-list
19709845|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19709846|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
19709847|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709848|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709849|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19709850|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709851|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
19709852|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709853|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19709854|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19709855|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249286|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20249287|NCT00440141|Latanoprost|latanoprost|mesh-list
20249288|NCT00440141|Brinzolamide|brinzolamide|mesh-list
20249289|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20249290|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20249291|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20249292|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20249293|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20249294|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
20249295|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249296|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249297|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421388|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421389|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421390|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421391|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421392|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421393|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421394|NCT01159249|Vildagliptin|vildagliptin|mesh-list
19421395|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19709856|NCT04799184|Epinephrine|epinephrine|mesh-list
19709857|NCT04799184|Racepinephrine|racepinephrine|mesh-list
20249298|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20249299|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249300|NCT00440154|Ezetimibe|ezetimibe|mesh-list
20249301|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19421396|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421397|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19421398|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
19421399|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421400|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421401|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
19421402|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421403|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421404|NCT01156415|S 20098|s 20098|mesh-list
19421405|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19421406|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421407|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421408|NCT01150695|Vaccines|vaccines|mesh-list
19421409|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
19421410|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421411|NCT01143246|Terlipressin|terlipressin|mesh-list
19421412|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19421413|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19421414|NCT01143064|Progesterone|progesterone|mesh-list
19421415|NCT01143064|Progestins|progestins|mesh-ancestor
19421416|NCT01143064|Hormones|hormones|mesh-ancestor
19421417|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19421418|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421419|NCT01140217|Norethindrone|norethindrone|mesh-list
19421420|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
19421421|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19421422|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19421423|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19421424|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
19421425|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19421426|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421427|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19421428|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19421429|NCT01138163|Docetaxel|docetaxel|mesh-list
19421430|NCT01138163|Bavituximab|bavituximab|mesh-list
19421431|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421432|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19856530|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
19856531|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856532|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19856533|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19856534|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
19856535|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856536|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
19856537|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19856538|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19856539|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19856540|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19856541|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421433|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421434|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421435|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421436|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421437|NCT01137968|Bevacizumab|bevacizumab|mesh-list
19421438|NCT01137968|Imetelstat|imetelstat|mesh-list
19421439|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
19421440|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421441|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969603|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
19421442|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19421443|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19421444|NCT01137968|Growth Substances|growth substances|mesh-ancestor
19421445|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421446|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
19421447|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421448|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421449|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19421450|NCT01137526|Donepezil|donepezil|mesh-list
19421451|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19421452|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421453|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421454|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
19421455|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421456|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421457|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
19421458|NCT01133990|Leucovorin|leucovorin|mesh-list
19421459|NCT01133990|Bevacizumab|bevacizumab|mesh-list
19421460|NCT01133990|Fluorouracil|fluorouracil|mesh-list
19421461|NCT01133990|Irinotecan|irinotecan|mesh-list
19421462|NCT01133990|Calcium|calcium|mesh-list
19421463|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
19421464|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421465|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421466|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19421467|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19421468|NCT01133990|Growth Substances|growth substances|mesh-ancestor
19421469|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709858|NCT04799184|Bupivacaine|bupivacaine|mesh-list
19709859|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
19709860|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
19421470|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
19421471|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19421472|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
19421473|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421474|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19421475|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421476|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
19421477|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19421478|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421479|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421480|NCT01133990|Antidotes|antidotes|mesh-ancestor
19421481|NCT01133990|Protective Agents|protective agents|mesh-ancestor
19421482|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
19421483|NCT01133990|Vitamins|vitamins|mesh-ancestor
19421484|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
19421485|NCT01130142|Gemcitabine|gemcitabine|mesh-list
19421486|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19421487|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
19421488|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421489|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421490|NCT01130142|Antiviral Agents|antiviral agents|mesh-ancestor
19421491|NCT01130142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421492|NCT01130142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421493|NCT01130142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421494|NCT01130142|Immunologic Factors|immunologic factors|mesh-ancestor
19421495|NCT01130142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421496|NCT01129674|Olanzapine|olanzapine|mesh-list
19421497|NCT01129674|Risperidone|risperidone|mesh-list
19421498|NCT01129674|Aripiprazole|aripiprazole|mesh-list
19421499|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19421500|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19421501|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
19421502|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421503|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421504|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421505|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19421506|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19421507|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421508|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19421509|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19421510|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
19421511|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
19421512|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
19421513|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709861|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
19421514|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19421515|NCT01129674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19421516|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19421517|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19709862|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
19421518|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
19421519|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
19421520|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19421521|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19421522|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19421523|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19421524|NCT01129648|Allopurinol|allopurinol|mesh-list
19421525|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
19421526|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421527|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421528|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
19421529|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421530|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19421531|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
19421532|NCT01129648|Protective Agents|protective agents|mesh-ancestor
19421533|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421534|NCT01128530|Linezolid|linezolid|mesh-list
19421535|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421536|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421537|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19421538|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421539|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421540|NCT01128335|Tacrolimus|tacrolimus|mesh-list
19421541|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421542|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
19421543|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421544|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19421545|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421546|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450721|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19450722|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19450723|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19450724|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450725|NCT03426176|Oxytocin|oxytocin|mesh-list
19450726|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
19450727|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19709863|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709864|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709865|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
19709866|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709867|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19709868|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19709869|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
19709870|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733739|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
19856542|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19856543|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19856544|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450728|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450729|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19450730|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20531268|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20531269|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20531270|NCT01793948|Metformin|metformin|mesh-list
19450731|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450732|NCT03426085|Liraglutide|liraglutide|mesh-list
19450733|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19450734|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450735|NCT03426085|Incretins|incretins|mesh-ancestor
19450736|NCT03426085|Hormones|hormones|mesh-ancestor
19452689|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
20249302|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20531271|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531272|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531273|NCT01794078|Ambrisentan|ambrisentan|mesh-list
20531274|NCT01794078|Aminophylline|aminophylline|mesh-list
20531275|NCT01794078|Theophylline|theophylline|mesh-list
20531276|NCT01794078|Ethylene|ethylene|mesh-list
20531277|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19421547|NCT01126970|Orlistat|orlistat|mesh-list
19421548|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421549|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421550|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20531278|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
20531279|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531280|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531281|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20531282|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
20531283|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20531284|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531285|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531286|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
20531287|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20531288|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20531289|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
20531290|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421551|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19421552|NCT01126190|Docetaxel|docetaxel|mesh-list
19421553|NCT01126190|Doxorubicin|doxorubicin|mesh-list
19421554|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421555|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421556|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421557|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421558|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421559|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19421560|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19421561|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421562|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421563|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
19421564|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19421565|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19421566|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19421567|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421568|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709871|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856545|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856546|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709872|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19709873|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19709874|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
19709875|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19709876|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
19709877|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
19709878|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
20531291|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19421569|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
19421570|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421571|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421572|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19421573|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421574|NCT01122784|Vaccines|vaccines|mesh-list
19421575|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
19421576|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421577|NCT01120470|Prednisone|prednisone|mesh-list
19421578|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19421579|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
19421580|NCT01120470|Hormones|hormones|mesh-ancestor
19421581|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19421582|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421583|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19421584|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421585|NCT01117584|Metformin|metformin|mesh-list
19421586|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
19421587|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19421588|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421589|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19421590|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421591|NCT01116141|Folic Acid|folic acid|mesh-list
19421592|NCT01116141|Methotrexate|methotrexate|mesh-list
19421593|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19421594|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
19421595|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19421596|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421597|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19421598|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
19421599|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421600|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421601|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
19421602|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421603|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19421604|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421605|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
19421606|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421607|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19421608|NCT01116141|Hematinics|hematinics|mesh-ancestor
19421609|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
19421610|NCT01116141|Vitamins|vitamins|mesh-ancestor
19421611|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
19421612|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19421613|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19421614|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19421615|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421616|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421617|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421618|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421619|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19421620|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
19421621|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19421622|NCT01114308|Buprenorphine|buprenorphine|mesh-list
19421623|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19421624|NCT01114308|Narcotics|narcotics|mesh-ancestor
19421625|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421626|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421627|NCT01114308|Analgesics|analgesics|mesh-ancestor
19421628|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
19421629|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421630|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19421631|NCT01113957|Doxorubicin|doxorubicin|mesh-list
19421632|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19421633|NCT01113957|Temozolomide|temozolomide|mesh-list
19421634|NCT01113957|Veliparib|veliparib|mesh-list
19421635|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19421636|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421637|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19421638|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421639|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421640|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421641|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19421642|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
19421643|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19421644|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
19421645|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19421646|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
19421647|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421648|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421649|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19421650|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
19421651|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19421652|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19421653|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19421654|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19421655|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421656|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421657|NCT01111955|Metformin|metformin|mesh-list
19421658|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19421659|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421660|NCT01111773|Lidocaine|lidocaine|mesh-list
19421661|NCT01111773|Tetracaine|tetracaine|mesh-list
19421662|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
19421663|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
19421664|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421665|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421666|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
19421667|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421668|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19421669|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19421670|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19421671|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421672|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421673|NCT01110902|S 20098|s 20098|mesh-list
19421674|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19421675|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421676|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421677|NCT01110889|S 20098|s 20098|mesh-list
19421678|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19421679|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421680|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421681|NCT01110746|Insulin|insulin|mesh-list
19709879|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19709880|NCT04798703|Paclitaxel|paclitaxel|mesh-list
19709881|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
19709882|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19709883|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709884|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
19709885|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
19709886|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
19709887|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709888|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19421682|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19421683|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19421684|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421685|NCT01107496|Viloxazine|viloxazine|mesh-list
19421686|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19421687|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
19421688|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19421689|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19421690|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19421691|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421692|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421693|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
19421694|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421695|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709889|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
20249303|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
19421696|NCT01106989|Lidocaine|lidocaine|mesh-list
19421697|NCT01106989|Tetracaine|tetracaine|mesh-list
19421698|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
19421699|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
19421700|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421701|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421702|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
19421703|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421704|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19421705|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19421706|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19421707|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421708|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421709|NCT01106807|Adapalene|adapalene|mesh-list
19421710|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19421711|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19421712|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
19421713|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19421714|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19421715|NCT01106807|Analgesics|analgesics|mesh-ancestor
19421716|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
19421717|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421718|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421719|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19421720|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421721|NCT01105624|Azithromycin|azithromycin|mesh-list
19421722|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19421723|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19421724|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421725|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709890|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709891|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
19421736|NCT01102660|Naproxen|naproxen|mesh-list
19421737|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19421738|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19421739|NCT01102660|Analgesics|analgesics|mesh-ancestor
19421740|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
19421741|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421742|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421743|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709892|NCT04798703|Protective Agents|protective agents|mesh-ancestor
19709893|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
19709894|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709895|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
19709896|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
19709897|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
19709898|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19709899|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
19709900|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19709901|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
20286532|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
19709902|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19421744|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421745|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
19421746|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19421747|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421748|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709903|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
19709904|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709905|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
19709906|NCT04798443|Protective Agents|protective agents|mesh-ancestor
19709907|NCT04798313|Denosumab|denosumab|mesh-list
19709908|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19709909|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709910|NCT04798287|Adalimumab|adalimumab|mesh-list
19709911|NCT04798287|Etanercept|etanercept|mesh-list
19709912|NCT04798287|Golimumab|golimumab|mesh-list
19709913|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19709914|NCT04798287|Infliximab|infliximab|mesh-list
19709915|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
19856547|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19856548|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
19856549|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19856550|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856551|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19856552|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19856553|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19856554|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
19856555|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20249304|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249305|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20249306|NCT00440167|Gemcitabine|gemcitabine|mesh-list
20249307|NCT00440167|Capecitabine|capecitabine|mesh-list
20249308|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20531292|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20531293|NCT01794078|Protective Agents|protective agents|mesh-ancestor
20531294|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20531295|NCT01794078|Growth Substances|growth substances|mesh-ancestor
20531296|NCT01794091|Eplerenone|eplerenone|mesh-list
20531297|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20531298|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
20531299|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531300|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531301|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19421749|NCT01101594|Doxorubicin|doxorubicin|mesh-list
19421750|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19421751|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421752|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19856556|NCT00759187|Triclosan|triclosan|mesh-list
19856557|NCT00759187|Fluorides|fluorides|mesh-list
19856558|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
19856559|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
19856560|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
19856561|NCT00759187|Protective Agents|protective agents|mesh-ancestor
19856562|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856563|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19856564|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249309|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249310|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
19421753|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421754|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421755|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421756|NCT01098435|ALKS-33|alks-33|mesh-list
19421757|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19421758|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709916|NCT04798287|Tofacitinib|tofacitinib|mesh-list
19709917|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709918|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249311|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249312|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249313|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
19421759|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
19421760|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421761|NCT01097018|Capecitabine|capecitabine|mesh-list
19421762|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19421763|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
19421764|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421765|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421766|NCT01096966|Bupivacaine|bupivacaine|mesh-list
19421767|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
19421768|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
19421769|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421770|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421771|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
19421772|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421773|NCT01096862|Peficitinib|peficitinib|mesh-list
19421774|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421775|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421776|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421777|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
19421778|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421779|NCT01094262|Oxycodone|oxycodone|mesh-list
19421780|NCT01094262|Analgesics|analgesics|mesh-list
19421781|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19421782|NCT01094262|Narcotics|narcotics|mesh-ancestor
19421783|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421784|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421785|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
19421786|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421798|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
19421799|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19421800|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421801|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19421802|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19421803|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
19421804|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421805|NCT01092065|Levodopa|levodopa|mesh-list
19421806|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19421807|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19421808|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
19856565|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
19421809|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421810|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421811|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421812|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19421813|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19421814|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421815|NCT01089790|Incretins|incretins|mesh-ancestor
19421816|NCT01089790|Hormones|hormones|mesh-ancestor
19421817|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19421818|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19421819|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
19709919|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
19709920|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709921|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19709922|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709923|NCT04798287|Analgesics|analgesics|mesh-ancestor
19709924|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
19709925|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709926|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709927|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19709928|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
19709929|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19709930|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709931|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709932|NCT04798391|Dexamethasone|dexamethasone|mesh-list
19709933|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709934|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
19709935|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
19709936|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709937|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709938|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19709939|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
19709940|NCT04798391|Hormones|hormones|mesh-ancestor
19709941|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19709942|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19709943|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19709944|NCT04798001|Vaccines|vaccines|mesh-list
19709945|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
19709946|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709947|NCT04797949|Aspirin|aspirin|mesh-list
19709948|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19709949|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709950|NCT04797949|Analgesics|analgesics|mesh-ancestor
19709951|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
19709952|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709953|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709954|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709955|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19709956|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19709957|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19709958|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19709959|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19709960|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19709961|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709962|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
19709963|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
19709964|NCT04797832|Hematinics|hematinics|mesh-ancestor
19709965|NCT04797546|Morphine|morphine|mesh-list
19709966|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19709967|NCT04797546|Narcotics|narcotics|mesh-ancestor
19709968|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19709969|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709970|NCT04797546|Analgesics|analgesics|mesh-ancestor
19709971|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
19709972|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709973|NCT04797793|Adapalene|adapalene|mesh-list
19709974|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19709975|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19709976|NCT04797793|Analgesics|analgesics|mesh-ancestor
19709977|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
19709978|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19709979|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531302|NCT01794091|Diuretics|diuretics|mesh-ancestor
19421820|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19709980|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709981|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19709982|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
19421821|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421822|NCT01087151|Rituximab|rituximab|mesh-list
19421823|NCT01087151|Navitoclax|navitoclax|mesh-list
19421824|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421825|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421826|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
19421827|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421828|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421829|NCT01086748|Risperidone|risperidone|mesh-list
19421830|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19421831|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
19856566|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
19856567|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19421832|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421833|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421834|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421835|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19421836|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19421837|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421838|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19421839|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19421840|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
19421841|NCT01086267|Cetuximab|cetuximab|mesh-list
19421842|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19421843|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421844|NCT01084330|Docetaxel|docetaxel|mesh-list
19421845|NCT01084330|Irinotecan|irinotecan|mesh-list
19421846|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421847|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421848|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421849|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421850|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421851|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19421852|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421853|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421854|NCT01084161|Morphine|morphine|mesh-list
19421855|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19421856|NCT01084161|Narcotics|narcotics|mesh-ancestor
19421857|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19421858|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421859|NCT01084161|Analgesics|analgesics|mesh-ancestor
19421860|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
19421861|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421862|NCT01083615|Prednisone|prednisone|mesh-list
19421863|NCT01083615|Docetaxel|docetaxel|mesh-list
19421864|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421865|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
19421866|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19421867|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
19421868|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421869|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19709983|NCT04797338|Nafarelin|nafarelin|mesh-list
19709984|NCT04797338|Progesterone|progesterone|mesh-list
19709985|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19709986|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19709987|NCT04797338|Estradiol|estradiol|mesh-list
19709988|NCT04797338|Progestins|progestins|mesh-ancestor
19709989|NCT04797338|Hormones|hormones|mesh-ancestor
19709990|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19709991|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19709992|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19709993|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
19709994|NCT04797338|Estrogens|estrogens|mesh-ancestor
19709995|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19709996|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19856568|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19421870|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
19421871|NCT01083615|Hormones|hormones|mesh-ancestor
19421872|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19421873|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421874|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19421875|NCT01082549|Gemcitabine|gemcitabine|mesh-list
19421876|NCT01082549|Carboplatin|carboplatin|mesh-list
19421877|NCT01082549|Iniparib|iniparib|mesh-list
19421878|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421879|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19709997|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
19421880|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
19421881|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421882|NCT01082549|Antiviral Agents|antiviral agents|mesh-ancestor
19421883|NCT01082549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421884|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421885|NCT01082549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421886|NCT01082549|Immunologic Factors|immunologic factors|mesh-ancestor
19421887|NCT01082549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421888|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19709998|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
19709999|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
19710000|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19710001|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19710002|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710003|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710004|NCT04797286|Urological Agents|urological agents|mesh-ancestor
19710005|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19710006|NCT04797013|Plasminogen|plasminogen|mesh-list
19710007|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19856569|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
19856570|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856571|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19856572|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
19856573|NCT00759330|Analgesics|analgesics|mesh-ancestor
19856574|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
19856575|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856576|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856577|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19856578|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19856579|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856580|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856581|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19856582|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856583|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856584|NCT00759356|Morphine|morphine|mesh-list
19856585|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19856586|NCT00759356|Narcotics|narcotics|mesh-ancestor
19856587|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856588|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856589|NCT00759356|Analgesics|analgesics|mesh-ancestor
19856590|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
19856591|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856592|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
19856593|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19856594|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19856595|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856596|NCT00759473|Cycloserine|cycloserine|mesh-list
19421889|NCT01082068|Letrozole|letrozole|mesh-list
19421890|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421891|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19421892|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19421893|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421894|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421895|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19421896|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
19452690|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452691|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452692|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452693|NCT03411551|Anesthetics|anesthetics|mesh-list
19452694|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452695|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452696|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
19452697|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19452698|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452699|NCT03411434|Methylphenidate|methylphenidate|mesh-list
19452700|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19452701|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452702|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19452703|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19452704|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19421897|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19421898|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421899|NCT01081782|Ceralifimod|ceralifimod|mesh-list
19421900|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19421901|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421902|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421903|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
19421904|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421905|NCT01080222|Ribavirin|ribavirin|mesh-list
19421906|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19421907|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
19421908|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421909|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
19421910|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421911|NCT01077297|Tezosentan|tezosentan|mesh-list
19421912|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
19421913|NCT01076764|Heparin|heparin|mesh-list
19421914|NCT01076764|Calcium heparin|calcium heparin|mesh-list
19421915|NCT01076764|Otamixaban|otamixaban|mesh-list
19421916|NCT01076764|Eptifibatide|eptifibatide|mesh-list
19421917|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
19421918|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19421919|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19421920|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421921|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19421922|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19421923|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
19421924|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19421925|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
19421926|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421927|NCT01074294|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19421928|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421929|NCT01072981|Gemcitabine|gemcitabine|mesh-list
19421930|NCT01072981|Fluorouracil|fluorouracil|mesh-list
19421931|NCT01072981|Pancrelipase|pancrelipase|mesh-list
19421932|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
19421933|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19421934|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
19421935|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421936|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421937|NCT01072981|Antiviral Agents|antiviral agents|mesh-ancestor
19421938|NCT01072981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421939|NCT01072981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421940|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421941|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421942|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19421943|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
19421944|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19421945|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19421946|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19421947|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19421948|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19421949|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421950|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421951|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421952|NCT01071850|Metformin|metformin|mesh-list
19421953|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
19421954|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19421955|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421956|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19421957|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421958|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
19421959|NCT01071239|Busulfan|busulfan|mesh-list
19421960|NCT01071239|Fludarabine|fludarabine|mesh-list
19421961|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19421962|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
19421963|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421964|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19421965|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19421966|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
19421967|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421968|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421969|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19421970|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
19421971|NCT01069692|Hematinics|hematinics|mesh-ancestor
19421972|NCT01068704|Letrozole|letrozole|mesh-list
19421973|NCT01068704|Lapatinib|lapatinib|mesh-list
19421974|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19421975|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19421976|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19421977|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19421978|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421979|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19421980|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
19421981|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19421982|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421983|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19421984|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
19421985|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19421986|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
19421987|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19421988|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19421989|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19421990|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
19421991|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
19421992|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19710008|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19710009|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733740|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733741|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733742|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19421993|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
19421994|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19421995|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19421996|NCT01065012|Udenafil|udenafil|mesh-list
19421997|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19421998|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19421999|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422000|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422001|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
19422002|NCT01064791|Tacrolimus|tacrolimus|mesh-list
19422003|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19422004|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
19422005|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422006|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19422007|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422008|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422009|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19422010|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422011|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19422012|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
19422013|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422014|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422015|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
19422016|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19422017|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19422018|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19422019|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19422020|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422021|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
19422022|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422023|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422024|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19422025|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422026|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19710010|NCT04796857|Lenalidomide|lenalidomide|mesh-list
19710011|NCT04796857|Antibodies|antibodies|mesh-list
19710012|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
19710013|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710014|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19710015|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19710016|NCT04796857|Growth Substances|growth substances|mesh-ancestor
19710017|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
19710018|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710019|NCT04796623|Fulvestrant|fulvestrant|mesh-list
19710020|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710021|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710022|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19710023|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19710024|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
19710025|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710026|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422027|NCT01060579|Latanoprost|latanoprost|mesh-list
19422028|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19422029|NCT01057667|Ribavirin|ribavirin|mesh-list
19422030|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20249314|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422031|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
19422032|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422033|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
19422034|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422035|NCT01057147|Rebamipide|rebamipide|mesh-list
19422036|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19422037|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19422038|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19422039|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422040|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
19422041|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422042|NCT01057147|Protective Agents|protective agents|mesh-ancestor
19422043|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422044|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422045|NCT01056393|Ibalizumab|ibalizumab|mesh-list
19422046|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19422047|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19422048|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19856597|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19856598|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422049|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
19422050|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422051|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
19422052|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422053|NCT01055444|Lidocaine|lidocaine|mesh-list
19422054|NCT01055444|Tetracaine|tetracaine|mesh-list
19422055|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
19422056|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
19422057|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422058|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422059|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
19422060|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422061|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422062|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19422063|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19422064|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19422065|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422066|NCT01055106|Metronidazole|metronidazole|mesh-list
19422067|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422068|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422069|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19422070|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19422071|NCT01055015|Morphine|morphine|mesh-list
19422072|NCT01055015|Oxycodone|oxycodone|mesh-list
19422073|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19422074|NCT01055015|Narcotics|narcotics|mesh-ancestor
20249315|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249316|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249317|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
20249318|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856599|NCT00759473|Renal Agents|renal agents|mesh-ancestor
19856600|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19856601|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
19856602|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19856603|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
19856604|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856605|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
19856606|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856607|NCT00759564|Lactams|lactams|mesh-list
19856608|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19856609|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856610|NCT00759603|Rituximab|rituximab|mesh-list
19856611|NCT00759603|Lenalidomide|lenalidomide|mesh-list
19856612|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19856613|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856614|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
19856615|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249319|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19422075|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422076|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422077|NCT01055015|Analgesics|analgesics|mesh-ancestor
19422078|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
19422079|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422080|NCT01051414|Asunaprevir|asunaprevir|mesh-list
19422081|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422082|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422083|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856616|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856617|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19856618|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20249320|NCT00440219|Prednisone|prednisone|mesh-list
20249321|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249322|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
19856619|NCT00759603|Growth Substances|growth substances|mesh-ancestor
19856620|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
19856621|NCT00759642|Lapatinib|lapatinib|mesh-list
20249323|NCT00440219|Hormones|hormones|mesh-ancestor
19422084|NCT01046422|Metformin|metformin|mesh-list
19422085|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19422086|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422087|NCT01044381|Luliconazole|luliconazole|mesh-list
19422088|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
19422089|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422090|NCT01043029|Pioglitazone|pioglitazone|mesh-list
19422091|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19422092|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422093|NCT01042925|Paclitaxel|paclitaxel|mesh-list
19422094|NCT01042925|Trastuzumab|trastuzumab|mesh-list
19422095|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19422096|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422097|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
19422098|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422099|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
19422100|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422101|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19422102|NCT01038804|Docetaxel|docetaxel|mesh-list
19422103|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422104|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
19422105|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422106|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
19422107|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422108|NCT01038739|Mesalamine|mesalamine|mesh-list
19422109|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19422110|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422111|NCT01038739|Analgesics|analgesics|mesh-ancestor
19422112|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
19422113|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422114|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422115|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710027|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
19710028|NCT04796688|Fludarabine|fludarabine|mesh-list
19710029|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19710030|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
19710031|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710032|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19710033|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19710034|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
19710035|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710036|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710037|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19710038|NCT04796714|Aspirin|aspirin|mesh-list
19710039|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19710040|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19710041|NCT04796714|Analgesics|analgesics|mesh-ancestor
19710042|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
19710043|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249324|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249325|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249326|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20249327|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249328|NCT00440245|Albuterol|albuterol|mesh-list
20249329|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20249330|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
20249331|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249332|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249333|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20249334|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
19710044|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710045|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710046|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19710047|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19710048|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19710049|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710050|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19710051|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19710052|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710053|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
19710054|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
19710055|NCT04796428|Empagliflozin|empagliflozin|mesh-list
19710056|NCT04796428|Canagliflozin|canagliflozin|mesh-list
19710057|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19710058|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710059|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19710060|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710061|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
19710062|NCT04796675|Fludarabine|fludarabine|mesh-list
19710063|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19710064|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
19710065|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710066|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19710067|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19710068|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
19710069|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249335|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
20249336|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20249337|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20249338|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20249339|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20249340|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
20249341|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249342|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249343|NCT00440258|Cabergoline|cabergoline|mesh-list
19856622|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856623|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19856624|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856625|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856626|NCT00759655|Factor VIII|factor viii|mesh-list
19856627|NCT00759655|Coagulants|coagulants|mesh-ancestor
19856628|NCT00759681|Thrombin|thrombin|mesh-list
19856629|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19856630|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
19856631|NCT00759681|Coagulants|coagulants|mesh-ancestor
19856632|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19856633|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856634|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856635|NCT00759759|Morphine|morphine|mesh-list
19856636|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20249344|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20249345|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20249346|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
20249347|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
20249348|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422116|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422117|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19856637|NCT00759759|Narcotics|narcotics|mesh-ancestor
19856638|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422118|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19422119|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19422120|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19422121|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422122|NCT01037179|Analgesics|analgesics|mesh-ancestor
19422123|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
19422124|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422125|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422126|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422127|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422128|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19422129|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19422130|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19422131|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
19422132|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
19422133|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422134|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422135|NCT01037166|Entecavir|entecavir|mesh-list
19422136|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
19422137|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422138|NCT01037062|Entecavir|entecavir|mesh-list
19422139|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
19422140|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422141|NCT01037036|Latanoprost|latanoprost|mesh-list
19422142|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19710070|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710071|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19710072|NCT04796454|Gemcitabine|gemcitabine|mesh-list
19710073|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
19710074|NCT04796454|Temozolomide|temozolomide|mesh-list
19422143|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19710075|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710076|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19710077|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
19710078|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710079|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
19710080|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710081|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710082|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19710083|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
20249349|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249350|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249351|NCT00440284|Insulin|insulin|mesh-list
20249352|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20249353|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249354|NCT00440323|Zolpidem|zolpidem|mesh-list
20249355|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20531303|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
20531304|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20531305|NCT01794169|Cytarabine|cytarabine|mesh-list
20531306|NCT01794169|Azacitidine|azacitidine|mesh-list
19710084|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710085|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19856639|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531307|NCT01794169|Daunorubicin|daunorubicin|mesh-list
20531308|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20531309|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
20531310|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531311|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531312|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
19422144|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20531313|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422145|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19422146|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422147|NCT01035879|Incretins|incretins|mesh-ancestor
19422148|NCT01035879|Hormones|hormones|mesh-ancestor
19422149|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422150|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19422151|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422152|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422153|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422154|NCT01035502|Idarubicin|idarubicin|mesh-list
19422155|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19422156|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422157|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19422158|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19422159|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422160|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422161|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19422162|NCT01033292|Iniparib|iniparib|mesh-list
19422163|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422164|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422165|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422166|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19422167|NCT01033123|Iniparib|iniparib|mesh-list
19422168|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422169|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422170|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422171|NCT01030432|Ribavirin|ribavirin|mesh-list
19422172|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19422173|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
19422174|NCT01030432|Asunaprevir|asunaprevir|mesh-list
19422175|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
19422176|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422177|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
19422178|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422179|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
19422180|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422181|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422182|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422183|NCT01029873|Cisplatin|cisplatin|mesh-list
19422184|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422185|NCT01027013|Rebamipide|rebamipide|mesh-list
19422186|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19422187|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19422188|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19422189|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422190|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
19422191|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422192|NCT01027013|Protective Agents|protective agents|mesh-ancestor
19422193|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422194|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422195|NCT01025648|Epinephrine|epinephrine|mesh-list
19422196|NCT01025648|Racepinephrine|racepinephrine|mesh-list
19422197|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
19422198|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19422199|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19422200|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
19422201|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710086|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
19710087|NCT04796025|Bevacizumab|bevacizumab|mesh-list
19422202|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422203|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422204|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19422205|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19422206|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
19422207|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422208|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19422209|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
19422210|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
19422211|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
19422212|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20249356|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20249357|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249358|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249359|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20249360|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
20249361|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
20553276|NCT01928407|Darunavir|darunavir|mesh-list
19422213|NCT01024101|Paclitaxel|paclitaxel|mesh-list
19422214|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19422215|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422216|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
19422217|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422218|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
19422219|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422220|NCT01024062|Paclitaxel|paclitaxel|mesh-list
19422221|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19422222|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422223|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19422224|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422225|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19422226|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422227|NCT01023880|Delanzomib|delanzomib|mesh-list
19422228|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
19422229|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422230|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422231|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422232|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
19422233|NCT01023295|Combretastatin|combretastatin|mesh-list
19422234|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19422235|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422236|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
19422237|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422238|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
19422239|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422240|NCT01023204|Paclitaxel|paclitaxel|mesh-list
19710088|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710089|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710090|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19422241|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19422242|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422243|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
19422244|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422245|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
19422246|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422247|NCT01022801|Entecavir|entecavir|mesh-list
19422248|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
19422249|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422250|NCT01020565|Entecavir|entecavir|mesh-list
19422251|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
19422252|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422253|NCT01020097|Fluorides|fluorides|mesh-list
19422254|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
19733743|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
20553277|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20553278|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20553279|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
20553280|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553281|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553282|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20553283|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19422255|NCT01020097|Protective Agents|protective agents|mesh-ancestor
19422256|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422257|NCT01019187|Modafinil|modafinil|mesh-list
19422258|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19422259|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422260|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19422261|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19422262|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19422263|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422264|NCT01018875|Donepezil|donepezil|mesh-list
19422265|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19422266|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422267|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422268|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
19422269|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422270|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422271|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
19422272|NCT01016808|Morphine|morphine|mesh-list
19422273|NCT01016808|Oxycodone|oxycodone|mesh-list
19422274|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19422275|NCT01016808|Narcotics|narcotics|mesh-ancestor
19422276|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422277|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422278|NCT01016808|Analgesics|analgesics|mesh-ancestor
19422279|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
20531314|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531315|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
20531316|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422280|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422281|NCT01014078|Azithromycin|azithromycin|mesh-list
19422282|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19422283|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19422284|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422285|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422286|NCT01012895|Interferons|interferons|mesh-list
19422287|NCT01012895|Ribavirin|ribavirin|mesh-list
19422288|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
19422289|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
19422290|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19422291|NCT01012895|Asunaprevir|asunaprevir|mesh-list
19422292|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422293|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
19422294|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422295|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
19422296|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422297|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
19422298|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422299|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422300|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422301|NCT01009775|Docetaxel|docetaxel|mesh-list
19422302|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249362|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531317|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531318|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20531319|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20531320|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20531321|NCT01794182|Glyburide|glyburide|mesh-list
20531322|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19422303|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
19710091|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19710092|NCT04796025|Growth Substances|growth substances|mesh-ancestor
19710093|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710094|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
19710095|NCT04795752|Cyclosporine|cyclosporine|mesh-list
19710096|NCT04795752|Cyclosporins|cyclosporins|mesh-list
19710097|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710098|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710099|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19710100|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
19710101|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710102|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
19710103|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710104|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
19710105|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19710106|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19710107|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
19710108|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19710109|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710110|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19710111|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19710112|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710113|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710114|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710115|NCT04794738|Morphine|morphine|mesh-list
19710116|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19710117|NCT04794738|Narcotics|narcotics|mesh-ancestor
19710118|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710119|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710120|NCT04794738|Analgesics|analgesics|mesh-ancestor
20249363|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249364|NCT00440336|Latanoprost|latanoprost|mesh-list
20249365|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20249366|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20249367|NCT00440349|Tamoxifen|tamoxifen|mesh-list
20249368|NCT00440349|Prednisone|prednisone|mesh-list
20249369|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249370|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
20249371|NCT00440349|Hormones|hormones|mesh-ancestor
19422304|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422305|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
19710121|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
19733744|NCT04559113|Hormones|hormones|mesh-ancestor
20249372|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422306|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422307|NCT01009242|Methotrexate|methotrexate|mesh-list
19422308|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19422309|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
19422310|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19422311|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422312|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249373|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422313|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
19710122|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733745|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733746|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19733747|NCT04559113|Protective Agents|protective agents|mesh-ancestor
19733748|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733749|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733750|NCT04559074|Amlodipine|amlodipine|mesh-list
19733751|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19422314|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422315|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422316|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
19422317|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422318|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19422319|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19422320|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
19422321|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733752|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19733753|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19733754|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733755|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19733756|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733757|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
19733758|NCT04559048|Tacrolimus|tacrolimus|mesh-list
19733759|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733760|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
19733761|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733762|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19733763|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733764|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733765|NCT04558892|Enoxaparin|enoxaparin|mesh-list
19733766|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
19733767|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19733768|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19733769|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735805|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19735806|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
19735807|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19735808|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
19735809|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
19735810|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
19735811|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19735812|NCT04535960|Liraglutide|liraglutide|mesh-list
19735813|NCT04535960|Empagliflozin|empagliflozin|mesh-list
19735814|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19735815|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735816|NCT04535960|Incretins|incretins|mesh-ancestor
19735817|NCT04535960|Hormones|hormones|mesh-ancestor
19735818|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735819|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19735820|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735821|NCT04536181|Prednisone|prednisone|mesh-list
19735822|NCT04536181|Prednisolone|prednisolone|mesh-list
19735823|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856640|NCT00759759|Analgesics|analgesics|mesh-ancestor
19735824|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
19735825|NCT04536181|Hormones|hormones|mesh-ancestor
19735826|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856641|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
19856642|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422322|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19422323|NCT01007721|Fluticasone|fluticasone|mesh-list
19422324|NCT01007721|Xhance|xhance|mesh-list
19422325|NCT01007721|Montelukast|montelukast|mesh-list
19422326|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422327|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19422328|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
19422329|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422330|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422331|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19422332|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
19856643|NCT00759772|Teriparatide|teriparatide|mesh-list
19856644|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19856645|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856646|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19856647|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19856648|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
19856649|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856650|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
19856651|NCT00759798|Rituximab|rituximab|mesh-list
20531323|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531324|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20531325|NCT01794208|Hormones|hormones|mesh-ancestor
20531326|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531327|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531328|NCT01794247|Lidocaine|lidocaine|mesh-list
20531329|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
20531330|NCT01794247|Fentanyl|fentanyl|mesh-list
20531331|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
20531332|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
20531333|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531334|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531335|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
20531336|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422333|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19422334|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19422335|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19422336|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
19422337|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422338|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19422339|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19422340|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422341|NCT01007292|Rituximab|rituximab|mesh-list
19422342|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19422343|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422344|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
19422345|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422346|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422347|NCT01007097|Glimepiride|glimepiride|mesh-list
19422348|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422349|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19422350|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422351|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19422352|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
19422353|NCT01005108|Gabapentin|gabapentin|mesh-list
19422354|NCT01005108|Analgesics|analgesics|mesh-ancestor
19422355|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
19422356|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422357|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422358|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
19422359|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19422360|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856652|NCT00759798|Fludarabine|fludarabine|mesh-list
19422361|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422362|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19422363|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19422364|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19422365|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422366|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422367|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
19422368|NCT01004081|Exemestane|exemestane|mesh-list
19422369|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422370|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19422371|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19422372|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422373|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710123|NCT04794842|Phenol|phenol|mesh-list
19710124|NCT04794842|Tetracaine|tetracaine|mesh-list
19710125|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710126|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
19710127|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710128|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710129|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
19710130|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710131|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19710132|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710133|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
19710134|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19710135|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19710136|NCT04794426|Fluorides|fluorides|mesh-list
19710137|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
19710138|NCT04794426|Protective Agents|protective agents|mesh-ancestor
19710139|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710140|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
19710141|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19710142|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19710143|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710144|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
19710145|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
19710146|NCT04794413|Pimavanserin|pimavanserin|mesh-list
19710147|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19710148|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19710149|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19710150|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19710151|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710152|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710153|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19710154|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19710155|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19710156|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
19710157|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710158|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710159|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19710160|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19710161|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710162|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710163|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19710164|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710165|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710166|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
19710167|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710168|NCT04794049|Lactulose|lactulose|mesh-list
19856653|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19422374|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19422375|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
19422376|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422377|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422378|NCT01002820|Ganaxolone|ganaxolone|mesh-list
19422379|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
19422380|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422381|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422382|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710169|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710170|NCT04794127|Pioglitazone|pioglitazone|mesh-list
19710171|NCT04794127|Trabectedin|trabectedin|mesh-list
19710172|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19710173|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710174|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19710175|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
19856654|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
19856655|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856656|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856657|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19856658|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
19856659|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856660|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856661|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19856662|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19856663|NCT00759811|Methotrexate|methotrexate|mesh-list
19856664|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19856665|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
19856666|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19856667|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856668|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19856669|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
19856670|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856671|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856672|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19856673|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856674|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19856675|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249374|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20249375|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249376|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19710176|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710177|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710178|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
19710179|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710180|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19422383|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
19422384|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
19422385|NCT01002248|Dexamethasone|dexamethasone|mesh-list
19422386|NCT01002248|Bortezomib|bortezomib|mesh-list
19422387|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422388|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
19422389|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
19422390|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422391|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422392|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422393|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
19422394|NCT01002248|Hormones|hormones|mesh-ancestor
19422395|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422396|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19422397|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422398|NCT01001923|Fasinumab|fasinumab|mesh-list
19422399|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422400|NCT01001923|Analgesics|analgesics|mesh-ancestor
19422401|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
19422402|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422403|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422404|NCT01001715|Fasinumab|fasinumab|mesh-list
19422405|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422406|NCT01001715|Analgesics|analgesics|mesh-ancestor
19422407|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
19422408|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422409|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422410|NCT01001338|Allopurinol|allopurinol|mesh-list
19422411|NCT01001338|Lesinurad|lesinurad|mesh-list
19422412|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
19422413|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422414|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422415|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
19422416|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422417|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19422418|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
19422419|NCT01001338|Protective Agents|protective agents|mesh-ancestor
19422420|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422421|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
19422422|NCT01001338|Renal Agents|renal agents|mesh-ancestor
19422423|NCT01001091|Dexamethasone|dexamethasone|mesh-list
19710181|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710182|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710183|NCT04793919|Tretinoin|tretinoin|mesh-list
19710184|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
19710185|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
19710186|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710187|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
19710188|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
19422424|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19422425|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19422426|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422427|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
19422428|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
19422429|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422430|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422431|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422432|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
19422433|NCT01001091|Hormones|hormones|mesh-ancestor
19422434|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422435|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19422436|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422437|NCT01000922|Insulin|insulin|mesh-list
19710189|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19422438|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19422439|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
19422440|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19422441|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422442|NCT00994292|Darexaban|darexaban|mesh-list
19422443|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19422444|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
19422445|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19422446|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422447|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422448|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422449|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
19422450|NCT00993382|Amiodarone|amiodarone|mesh-list
19422451|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422452|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
19422453|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19422454|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19422455|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422456|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19422457|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19422458|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19422459|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422460|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19422461|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19422462|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19422463|NCT00992732|Valganciclovir|valganciclovir|mesh-list
19422464|NCT00992732|Ganciclovir|ganciclovir|mesh-list
19422465|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19422466|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
19422467|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
19422468|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422469|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19422470|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422471|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422472|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422473|NCT00992563|Ranibizumab|ranibizumab|mesh-list
19422474|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19422475|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19422476|NCT00992563|Growth Substances|growth substances|mesh-ancestor
19422477|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422478|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
19422479|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422480|NCT00991172|Fasinumab|fasinumab|mesh-list
19422481|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422482|NCT00991172|Analgesics|analgesics|mesh-ancestor
19422483|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
19422484|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422485|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422486|NCT00991068|Lidocaine|lidocaine|mesh-list
19422487|NCT00991068|Tetracaine|tetracaine|mesh-list
19422488|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
19422489|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
19422490|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422491|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422492|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
19422493|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422494|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422495|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19422496|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19422497|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19422498|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422499|NCT00990912|Carboplatin|carboplatin|mesh-list
19422500|NCT00990912|Irinotecan|irinotecan|mesh-list
20249377|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553284|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
20553285|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553286|NCT01928459|Infigratinib|infigratinib|mesh-list
20553287|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553288|NCT01928498|Paclitaxel|paclitaxel|mesh-list
20553289|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20553290|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553291|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
20553292|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
20553293|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
20553294|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553295|NCT01928511|Interferons|interferons|mesh-list
20249378|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20249379|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20249380|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20249381|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
19856676|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
19856677|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856678|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19856679|NCT00759902|Morphine|morphine|mesh-list
19856680|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19856681|NCT00759902|Narcotics|narcotics|mesh-ancestor
19856682|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856683|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856684|NCT00759902|Analgesics|analgesics|mesh-ancestor
19856685|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
19856686|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856687|NCT00759915|Morphine|morphine|mesh-list
19856688|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19856689|NCT00759915|Narcotics|narcotics|mesh-ancestor
19856690|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856691|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856692|NCT00759915|Analgesics|analgesics|mesh-ancestor
19856693|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
19856694|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856695|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19856696|NCT00759941|Latanoprost|latanoprost|mesh-list
19856697|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19856698|NCT00759941|Brinzolamide|brinzolamide|mesh-list
19856699|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19856700|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856701|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856702|NCT00759954|Morphine|morphine|mesh-list
19856703|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19856704|NCT00759954|Narcotics|narcotics|mesh-ancestor
19856705|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856706|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856707|NCT00759954|Analgesics|analgesics|mesh-ancestor
19856708|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
19856709|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856710|NCT00760006|Ampicillin|ampicillin|mesh-list
19856711|NCT00760006|Sulbactam|sulbactam|mesh-list
19856712|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19856713|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422501|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422502|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19422503|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19422504|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422505|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422506|NCT00990327|Adenosine|adenosine|mesh-list
19422507|NCT00990327|Analgesics|analgesics|mesh-ancestor
19422508|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
19422509|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422510|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856714|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856715|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19856716|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856717|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856718|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19856719|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19856720|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19856721|NCT00760019|Analgesics|analgesics|mesh-ancestor
20249382|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19422511|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422512|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
19422513|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19422514|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
19422515|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
19422516|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422517|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422518|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19422519|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19422520|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19422521|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19422522|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422523|NCT00987272|Analgesics|analgesics|mesh-ancestor
19422524|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
19422525|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422526|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422527|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422528|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422529|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19422530|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19422531|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19422532|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
19422533|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
19422534|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422535|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422536|NCT00986882|Ibuprofen|ibuprofen|mesh-list
19422537|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19422538|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422539|NCT00986882|Analgesics|analgesics|mesh-ancestor
19422540|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
19422541|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422542|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422543|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422544|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422545|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19422546|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422547|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422548|NCT00983814|Carbidopa|carbidopa|mesh-list
19422549|NCT00983814|Droxidopa|droxidopa|mesh-list
19422550|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19422551|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19422552|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
19422553|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422554|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422555|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422556|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19422557|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422558|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
19422559|NCT00982696|Mitogens|mitogens|mesh-list
19422560|NCT00982696|Enkephalin, Methionine|enkephalin, methionine|mesh-list
19422561|NCT00982696|Enkephalins|enkephalins|mesh-list
19422562|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
19422563|NCT00982696|Narcotics|narcotics|mesh-ancestor
19422564|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422565|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422566|NCT00982696|Analgesics|analgesics|mesh-ancestor
19422567|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
19422568|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422569|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
19710190|NCT04793711|Decanoic acid|decanoic acid|mesh-list
19710191|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
19710192|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710193|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
19710194|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19710195|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710196|NCT04793529|Vitamins|vitamins|mesh-ancestor
19710197|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
19710198|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19710199|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
19710200|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710201|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710202|NCT04793256|Listerine|listerine|mesh-list
19710203|NCT04793256|Fluorides|fluorides|mesh-list
20249383|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422570|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422571|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422572|NCT00981617|ALKS-33|alks-33|mesh-list
19422573|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19422574|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422575|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
19422576|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422577|NCT00981357|Naproxen|naproxen|mesh-list
19422578|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19422579|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422580|NCT00981357|Analgesics|analgesics|mesh-ancestor
19422581|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
19422582|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422583|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422584|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422585|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422586|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
19422587|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19422588|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422589|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422590|NCT00979251|Oseltamivir|oseltamivir|mesh-list
19422591|NCT00979251|Amantadine|amantadine|mesh-list
19710204|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
19710205|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
19710206|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
19710207|NCT04793256|Protective Agents|protective agents|mesh-ancestor
19710208|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710209|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19710210|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710211|NCT04793243|Vitamin D|vitamin d|mesh-list
19710212|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
19710213|NCT04793243|Vitamins|vitamins|mesh-ancestor
19710214|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
19710215|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710216|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19710217|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19710218|NCT04793399|Atezolizumab|atezolizumab|mesh-list
19710219|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710220|NCT04793152|Vancomycin|vancomycin|mesh-list
19710221|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19710222|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710223|NCT04793022|Anesthetics|anesthetics|mesh-list
19710224|NCT04793022|Propofol|propofol|mesh-list
19710225|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710226|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710227|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19710228|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19710229|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
19710230|NCT04792723|Aspirin|aspirin|mesh-list
19710231|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19710232|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19710233|NCT04792723|Analgesics|analgesics|mesh-ancestor
19710234|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
19710235|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710236|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710237|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710238|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19710239|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19422592|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
19710240|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19710241|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422593|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422594|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422595|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422596|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19422597|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19422598|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
19422599|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422600|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422601|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422602|NCT00979251|Analgesics|analgesics|mesh-ancestor
19422603|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
19422604|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450737|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19450738|NCT03426033|Warfarin|warfarin|mesh-list
19450739|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
19450740|NCT03426020|Midazolam|midazolam|mesh-list
19450741|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19450742|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450743|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450744|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450745|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19450746|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19450747|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19450748|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19450749|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
19450750|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
19450751|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
19450752|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
19450753|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450754|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450755|NCT03425994|Emtricitabine|emtricitabine|mesh-list
19450756|NCT03425994|Cobicistat|cobicistat|mesh-list
19450757|NCT03425994|Elvitegravir|elvitegravir|mesh-list
19450758|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
19450759|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450760|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19450761|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19450762|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450763|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450764|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19450765|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19450766|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19450767|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19450768|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19450769|NCT03425929|Oxytocin|oxytocin|mesh-list
19450770|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
19450771|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19450772|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452705|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452706|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
19452707|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452708|NCT03411369|Vitamins|vitamins|mesh-list
19452709|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
19452710|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452711|NCT03411330|Lidocaine|lidocaine|mesh-list
19452712|NCT03411330|Bupivacaine|bupivacaine|mesh-list
19452713|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
19452714|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
19452715|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452716|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452717|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
19452718|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452719|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452720|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19452721|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19452722|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452723|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452724|NCT03411252|Mirabegron|mirabegron|mesh-list
19452725|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19856722|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
19856723|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856724|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452726|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19452727|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19452728|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
19422605|NCT00978497|Ribavirin|ribavirin|mesh-list
19422606|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
19422607|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422608|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
19422609|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422610|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
19422611|NCT00978016|Baclofen|baclofen|mesh-list
19422612|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19422613|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422614|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422615|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19422616|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422617|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19422618|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422619|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19422620|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
19422621|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
19422622|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422623|NCT00975091|Entecavir|entecavir|mesh-list
19422624|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
19422625|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422626|NCT00973284|Mannitol|mannitol|mesh-list
19856725|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856726|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856727|NCT00760084|Decitabine|decitabine|mesh-list
19856728|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19856729|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
19856730|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710242|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19710243|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19856731|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710244|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710245|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
19710246|NCT04792645|Memantine|memantine|mesh-list
19710247|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19710248|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19710249|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
19710250|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710251|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710252|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710253|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19710254|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19733770|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
19856732|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422627|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19422628|NCT00973284|Diuretics|diuretics|mesh-ancestor
19422629|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
19422630|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422631|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19422632|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
19422633|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422634|NCT00969722|Tretinoin|tretinoin|mesh-list
19422635|NCT00969722|Molgramostim|molgramostim|mesh-list
19422636|NCT00969722|Isotretinoin|isotretinoin|mesh-list
19422637|NCT00969722|Sargramostim|sargramostim|mesh-list
19422638|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
19422639|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422640|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422641|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
19422642|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
19422643|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
19422644|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19422645|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19422646|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19422647|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19422648|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422649|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
19422650|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422651|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422652|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19422653|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422654|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
19422655|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19422656|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19422657|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19710255|NCT04792749|Metformin|metformin|mesh-list
19710256|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19710257|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710258|NCT04792710|Metronidazole|metronidazole|mesh-list
19710259|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710260|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19710261|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19710262|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19710263|NCT04792840|Letrozole|letrozole|mesh-list
19710264|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710265|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19710266|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19710267|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710268|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710269|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19710270|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
19422658|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19422659|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422660|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
19422661|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422662|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422663|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19422664|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422665|NCT00966953|Honokiol|honokiol|mesh-list
19422666|NCT00966953|Triclosan|triclosan|mesh-list
19422667|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19422668|NCT00966953|Fluorides|fluorides|mesh-list
19422669|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
19422670|NCT00966953|Protective Agents|protective agents|mesh-ancestor
19422671|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733771|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19422672|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19422673|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422674|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19422675|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19422676|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
19422677|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422678|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19422679|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422680|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19422681|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422682|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422683|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422684|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422685|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19422686|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19422687|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19422688|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19422689|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19422690|NCT00963885|Lactams|lactams|mesh-list
19422691|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
19422692|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422693|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422694|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
19422695|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
19422696|NCT00961675|Dexamethasone|dexamethasone|mesh-list
19422697|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
19422698|NCT00961675|Povidone|povidone|mesh-list
19422699|NCT00961675|BB 1101|bb 1101|mesh-list
19422700|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422701|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
19422702|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
19422703|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422704|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422705|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422706|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
19422707|NCT00961675|Hormones|hormones|mesh-ancestor
19422708|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422709|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19422710|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422711|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422712|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710271|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710272|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422713|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422714|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422715|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422716|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19422717|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19422718|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19422719|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19422720|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
19422721|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
19422722|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19422723|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19422724|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19422725|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
19422726|NCT00959036|Methotrexate|methotrexate|mesh-list
19422727|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19422728|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
19422729|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19422730|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422731|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19422732|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
19422733|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422734|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422735|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
20249384|NCT00440414|Pemetrexed|pemetrexed|mesh-list
20249385|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20531337|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422736|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422737|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19422738|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19422739|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
19422740|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422741|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19422742|NCT00957918|Nicotine|nicotine|mesh-list
19710273|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19710274|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19710275|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710276|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710277|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19710278|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531338|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20531339|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19422743|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19422744|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
19422745|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422746|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422747|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19422748|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19422749|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
19422750|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422751|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422752|NCT00955981|Lesinurad|lesinurad|mesh-list
19422753|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
19422754|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422755|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
19422756|NCT00955981|Renal Agents|renal agents|mesh-ancestor
19422757|NCT00953420|Dexamethasone|dexamethasone|mesh-list
19422758|NCT00953420|Carboplatin|carboplatin|mesh-list
19422759|NCT00953420|Docetaxel|docetaxel|mesh-list
19422760|NCT00953420|Lenograstim|lenograstim|mesh-list
19710279|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710280|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
19710281|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710282|NCT04792333|Firibastat|firibastat|mesh-list
19710283|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19710284|NCT04792385|Drospirenone|drospirenone|mesh-list
19710285|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
19710286|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
20531340|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531341|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531342|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20531343|NCT01794247|Narcotics|narcotics|mesh-ancestor
19422761|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422762|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
19422763|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
20249386|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422764|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422765|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422766|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422767|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
19422768|NCT00953420|Hormones|hormones|mesh-ancestor
19422769|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422770|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19422771|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422772|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19422773|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19422774|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19422775|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422776|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19422777|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
19710287|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19710288|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19710289|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710290|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19710291|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19710292|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
19710293|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710294|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19710295|NCT04792385|Diuretics|diuretics|mesh-ancestor
19710296|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
19856733|NCT00760214|Ramipril|ramipril|mesh-list
19856734|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19856735|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19856736|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
19856737|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856738|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856739|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19856740|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19856741|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19856742|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19856743|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19856744|NCT00760266|Diuretics|diuretics|mesh-ancestor
19856745|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
19856746|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856747|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19856748|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19856749|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856750|NCT00760435|Infliximab|infliximab|mesh-list
19856751|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
19856752|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856753|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856754|NCT00760474|Pregabalin|pregabalin|mesh-list
19856755|NCT00760474|Analgesics|analgesics|mesh-ancestor
19422778|NCT00950885|Melatonin|melatonin|mesh-list
19422779|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
19856756|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
20249387|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531344|NCT01794247|Analgesics|analgesics|mesh-ancestor
20531345|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20531346|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20531347|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
20531348|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
20531349|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20531350|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20531351|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
20553296|NCT01928511|Tenofovir|tenofovir|mesh-list
19710297|NCT04792320|Charcoal|charcoal|mesh-list
19856757|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422780|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422781|NCT00950885|Protective Agents|protective agents|mesh-ancestor
19422782|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422783|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422784|NCT00948961|Poly I-C|poly i-c|mesh-list
19422785|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19422786|NCT00948961|Poly ICLC|poly iclc|mesh-list
19422787|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
19422788|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
19422789|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422790|NCT00948961|Laxatives|laxatives|mesh-ancestor
19422791|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422792|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
19422793|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422794|NCT00948909|Donepezil|donepezil|mesh-list
19422795|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19422796|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422797|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422798|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
19422799|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422800|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422801|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
19422802|NCT00948753|Maraviroc|maraviroc|mesh-list
19422803|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19422804|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19422805|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422806|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19422807|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19422808|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
19422809|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422810|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19422811|NCT00948142|Linezolid|linezolid|mesh-list
19422812|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
19422813|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422814|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422815|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19422816|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422817|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422818|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
19422819|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19422820|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422821|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
19422822|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
19422823|NCT00945802|Dexamethasone|dexamethasone|mesh-list
19422824|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
19422825|NCT00945802|BB 1101|bb 1101|mesh-list
19422826|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422827|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
19422828|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
19422829|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710298|NCT04792320|Antidotes|antidotes|mesh-ancestor
20249388|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249389|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20249390|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20249391|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20249392|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20249393|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20249394|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20553297|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
19422830|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422831|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422832|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
19422833|NCT00945802|Hormones|hormones|mesh-ancestor
19422834|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422835|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19422836|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422837|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
19422838|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422839|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422840|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19710299|NCT04792320|Protective Agents|protective agents|mesh-ancestor
19710300|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710301|NCT04792138|Phenobarbital|phenobarbital|mesh-list
19710302|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
19710303|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19422841|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422842|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19422843|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19422844|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19422845|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19422846|NCT00945763|Ibuprofen|ibuprofen|mesh-list
19422847|NCT00945763|Meloxicam|meloxicam|mesh-list
19422848|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19422849|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422850|NCT00945763|Analgesics|analgesics|mesh-ancestor
19422851|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
19422852|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422853|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422854|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422855|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422856|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19422857|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422858|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422859|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19422860|NCT00945646|Dexamethasone|dexamethasone|mesh-list
19422861|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422862|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
19422863|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
19422864|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422865|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422866|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422867|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
19422868|NCT00945646|Hormones|hormones|mesh-ancestor
19422869|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422870|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19422871|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422872|NCT00945269|Aldesleukin|aldesleukin|mesh-list
19422873|NCT00945269|Interleukin-2|interleukin-2|mesh-list
19422874|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
19422875|NCT00945269|Immunotoxins|immunotoxins|mesh-list
19422876|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422877|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422878|NCT00945269|Analgesics|analgesics|mesh-ancestor
19422879|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
19422880|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422881|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422882|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19422883|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19422884|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
19422885|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422886|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
19422887|NCT00944970|Adenosine|adenosine|mesh-list
19422888|NCT00944970|Binodenoson|binodenoson|mesh-list
19422889|NCT00944970|Analgesics|analgesics|mesh-ancestor
19422890|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
19422891|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422892|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422893|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422894|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
19422895|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19422896|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
19422897|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
19422898|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422899|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422900|NCT00944892|Fasinumab|fasinumab|mesh-list
19422901|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422902|NCT00944892|Analgesics|analgesics|mesh-ancestor
20249395|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249396|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249397|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249398|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249399|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
20249400|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20249401|NCT00440440|Testosterone|testosterone|mesh-list
20249402|NCT00440440|Androgens|androgens|mesh-ancestor
19422903|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
19422904|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422905|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422906|NCT00944294|Adenosine|adenosine|mesh-list
19422907|NCT00944294|Binodenoson|binodenoson|mesh-list
19422908|NCT00944294|Analgesics|analgesics|mesh-ancestor
19422909|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
19710304|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710305|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710306|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19710307|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19710308|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710309|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710310|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
19710311|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
19710312|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19710313|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19710314|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19710315|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19710316|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19710317|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710318|NCT04792515|Apatinib|apatinib|mesh-list
19710319|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710320|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19710321|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710322|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710323|NCT04792034|Cocaine|cocaine|mesh-list
19710324|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710325|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
19710326|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710327|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710328|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
19710329|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710330|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19710331|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19710332|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19710333|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710334|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710335|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
19710336|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710337|NCT04791943|Melatonin|melatonin|mesh-list
19710338|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
19710339|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710340|NCT04791943|Protective Agents|protective agents|mesh-ancestor
19710341|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710342|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710343|NCT04791774|Caseins|caseins|mesh-list
19710344|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
19710345|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
19710346|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710347|NCT04791345|Dexamethasone|dexamethasone|mesh-list
19710348|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
19710349|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
19710350|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19422910|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422911|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422912|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19422913|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
19422914|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19422915|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
19422916|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
19422917|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422918|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422919|NCT00939276|Nepafenac|nepafenac|mesh-list
19422920|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19422921|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19422922|NCT00939276|Analgesics|analgesics|mesh-ancestor
19422923|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
19422924|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422925|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422926|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422927|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19422928|NCT00938652|Gemcitabine|gemcitabine|mesh-list
19422929|NCT00938652|Carboplatin|carboplatin|mesh-list
19422930|NCT00938652|Iniparib|iniparib|mesh-list
19422931|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422932|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19710351|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19710352|NCT04791345|Prednisolone|prednisolone|mesh-list
19710353|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
19710354|NCT04791345|Deflazacort|deflazacort|mesh-list
19710355|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19710356|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
19710357|NCT04791345|BB 1101|bb 1101|mesh-list
19710358|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710359|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
19710360|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
19710361|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710362|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710363|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856758|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856759|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
19856760|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19856761|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249403|NCT00440440|Hormones|hormones|mesh-ancestor
20249404|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422933|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
19422934|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422935|NCT00938652|Antiviral Agents|antiviral agents|mesh-ancestor
19422936|NCT00938652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422937|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422938|NCT00938652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19422939|NCT00938652|Immunologic Factors|immunologic factors|mesh-ancestor
19422940|NCT00938652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422941|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19422942|NCT00938587|Prednisone|prednisone|mesh-list
19422943|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422944|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
19422945|NCT00938587|Hormones|hormones|mesh-ancestor
19422946|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19422947|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422948|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19422949|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422950|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
19422951|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19422952|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19422953|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19422954|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19422955|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422956|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422957|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19422958|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19422959|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19422960|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19422961|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422962|NCT00934921|Ondansetron|ondansetron|mesh-list
19422963|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
19710364|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
19710365|NCT04791345|Hormones|hormones|mesh-ancestor
19856762|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856763|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19856764|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19856765|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856766|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856767|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856768|NCT00760578|Pioglitazone|pioglitazone|mesh-list
19856769|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19710366|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710367|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710368|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710369|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
19710370|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710371|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710372|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19710373|NCT04791345|Protective Agents|protective agents|mesh-ancestor
19710374|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19710375|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
19710386|NCT04791566|Dexamethasone|dexamethasone|mesh-list
19710387|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710388|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
19710389|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
19710390|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710391|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710392|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856770|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856771|NCT00760669|Methotrexate|methotrexate|mesh-list
19422964|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
19422965|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422966|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422967|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422968|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
19422969|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
19422970|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19422971|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
19422972|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422973|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422974|NCT00934921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19422975|NCT00934921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19422976|NCT00934921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422977|NCT00934921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19422978|NCT00934921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19422979|NCT00934180|Ondansetron|ondansetron|mesh-list
19422980|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
19422981|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
19422982|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19422983|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19422984|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19422985|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
19422986|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
19422987|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19422988|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
19422989|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19422990|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19422991|NCT00934180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19422992|NCT00934180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19422993|NCT00934180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19422994|NCT00934180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19422995|NCT00934180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19422996|NCT00929968|Fluticasone|fluticasone|mesh-list
19422997|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19422998|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19422999|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
19423000|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423001|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423002|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19423003|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
19423004|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
19423005|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19423006|NCT00928590|Timolol|timolol|mesh-list
19423007|NCT00928590|Travoprost|travoprost|mesh-list
19423008|NCT00928590|Cloprostenol|cloprostenol|mesh-list
19423009|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19423010|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19423011|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
19856772|NCT00760669|Infliximab|infliximab|mesh-list
19856773|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19423012|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423013|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423014|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423015|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19423016|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423017|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
19423018|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19423019|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
19423020|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19423021|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19423022|NCT00927914|Ranirestat|ranirestat|mesh-list
19423023|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423024|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423025|NCT00927641|Ketoprofen|ketoprofen|mesh-list
19423026|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19423027|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19423028|NCT00927641|Analgesics|analgesics|mesh-ancestor
19423029|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
19423030|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423031|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423032|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249405|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249406|NCT00440479|Bortezomib|bortezomib|mesh-list
20249407|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249408|NCT00440609|Ranibizumab|ranibizumab|mesh-list
20249409|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19423033|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19423034|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19423035|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423036|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423037|NCT00925535|Rifabutin|rifabutin|mesh-list
19423038|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423039|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423040|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19423041|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
19423042|NCT00924833|Carvedilol|carvedilol|mesh-list
19423043|NCT00924833|Nebivolol|nebivolol|mesh-list
19423044|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19423045|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19423046|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
19423047|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423048|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423049|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423050|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423051|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
19423052|NCT00924833|Protective Agents|protective agents|mesh-ancestor
19423053|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19423054|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423055|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423056|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
19423057|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19423058|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19423059|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19423060|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19423061|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19423062|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
19423063|NCT00920985|Gestodene|gestodene|mesh-list
19423064|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
19423065|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19423066|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423067|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19423068|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19710393|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
19710394|NCT04791566|Hormones|hormones|mesh-ancestor
19856774|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
19423069|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19423070|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19423071|NCT00920985|Progestins|progestins|mesh-ancestor
19423072|NCT00920985|Hormones|hormones|mesh-ancestor
19423073|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19423074|NCT00920764|Atrasentan|atrasentan|mesh-list
19423075|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423076|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19423077|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19423078|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423079|NCT00917826|Valganciclovir|valganciclovir|mesh-list
19423080|NCT00917826|Ganciclovir|ganciclovir|mesh-list
19423081|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19423082|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
19710395|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710396|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710397|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710398|NCT04791475|Dexamethasone|dexamethasone|mesh-list
19710399|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
19710400|NCT04791475|Bupivacaine|bupivacaine|mesh-list
19710401|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710402|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
19710403|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
19710404|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710405|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710406|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710407|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
19710408|NCT04791475|Hormones|hormones|mesh-ancestor
19710409|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710410|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710411|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710412|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710413|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
19710414|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710415|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
19710416|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19710417|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19710418|NCT04791475|Analgesics|analgesics|mesh-ancestor
19710419|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19710420|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19710421|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19710422|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
19710423|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710424|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423083|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
19423084|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423085|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19423086|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423087|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423088|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423089|NCT00917293|Pyridoxal|pyridoxal|mesh-list
19423090|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
19423091|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
19423092|NCT00917293|Vitamins|vitamins|mesh-ancestor
19423093|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
19423094|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423095|NCT00914602|Levodopa|levodopa|mesh-list
19423096|NCT00914602|Carbidopa|carbidopa|mesh-list
19423097|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19423098|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19423099|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19423100|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
19450773|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
19450774|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
19450775|NCT03425747|Calcium|calcium|mesh-list
19450776|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19450777|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450778|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19450779|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450780|NCT03425747|Antacids|antacids|mesh-ancestor
19450781|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19450782|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
19450783|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450784|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423101|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423102|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423103|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423104|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19423105|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423106|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19423107|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
19423108|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
19423109|NCT00914290|Baclofen|baclofen|mesh-list
19423110|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19423111|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423112|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19423113|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423114|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19423115|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
19423116|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
19423117|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423118|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423119|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19423120|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
19423121|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423122|NCT00911963|Ribavirin|ribavirin|mesh-list
19423123|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19423124|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
19423125|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423126|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
19423127|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423128|NCT00911443|Interferons|interferons|mesh-list
19423129|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
19423130|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
19423131|NCT00911443|Dacarbazine|dacarbazine|mesh-list
19423132|NCT00911443|Thymalfasin|thymalfasin|mesh-list
19423133|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423134|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
19423135|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423136|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
19423137|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423138|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19423139|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
19423140|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423141|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19423142|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
19423143|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19423144|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423145|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19423146|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
19423147|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423148|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423149|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450785|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710425|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
19710426|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19423150|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423151|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19423152|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19423153|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19423154|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19423155|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
19423156|NCT00909649|Coagulants|coagulants|mesh-ancestor
19423157|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19423158|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19423159|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249410|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20249411|NCT00440609|Growth Substances|growth substances|mesh-ancestor
20249412|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249413|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
20249414|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423160|NCT00909597|Pioglitazone|pioglitazone|mesh-list
19423161|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19423162|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423163|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423164|NCT00909597|Incretins|incretins|mesh-ancestor
19423165|NCT00909597|Hormones|hormones|mesh-ancestor
20249415|NCT00440622|Gemcitabine|gemcitabine|mesh-list
20249416|NCT00440622|Capecitabine|capecitabine|mesh-list
20249417|NCT00440622|Trastuzumab|trastuzumab|mesh-list
20249418|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249419|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
20249420|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249421|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531352|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19423166|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19450786|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19710427|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20531353|NCT01794273|Phenylephrine|phenylephrine|mesh-list
20531354|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
20531355|NCT01794273|Ephedrine|ephedrine|mesh-list
20531356|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20531357|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
20531358|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
20531359|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531360|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531361|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
20531362|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20249422|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
20249423|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531363|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
20531364|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
20531365|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20531366|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20531367|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20531368|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531369|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450787|NCT03425734|Analgesics|analgesics|mesh-ancestor
19710428|NCT04791202|Prednisolone|prednisolone|mesh-list
19710429|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
19710430|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20249424|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553298|NCT01928511|Lamivudine|lamivudine|mesh-list
19450788|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
19450789|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450790|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19450791|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19450792|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19423167|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
19423168|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19423169|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423170|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19423171|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
19423172|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423173|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423174|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531370|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531371|NCT01794273|Protective Agents|protective agents|mesh-ancestor
20531372|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20531373|NCT01794351|Resveratrol|resveratrol|mesh-list
20531374|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
20531375|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531376|NCT01794351|Protective Agents|protective agents|mesh-ancestor
20531377|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531378|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531379|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19710431|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
19710432|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710433|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
19710434|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
19710435|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710436|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710437|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710438|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
19710439|NCT04791202|Hormones|hormones|mesh-ancestor
19710440|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710441|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19710442|NCT04791202|Protective Agents|protective agents|mesh-ancestor
19856775|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19856776|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856777|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19856778|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
19856779|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856780|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856781|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
19856782|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856783|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19856784|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19856785|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
19856786|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856787|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19856788|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856789|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19856790|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19423175|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423176|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
19423177|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19423178|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423179|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19423180|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
19423181|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423182|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423183|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423184|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423185|NCT00906334|ON 01910|on 01910|mesh-list
19423186|NCT00906334|Glycine|glycine|mesh-list
19423187|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450793|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
19450794|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450795|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450796|NCT03425708|Febuxostat|febuxostat|mesh-list
19450797|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
19450798|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450799|NCT03425669|Methylphenidate|methylphenidate|mesh-list
19450800|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19450801|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450802|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19450803|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19710443|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710444|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423188|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19423189|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423190|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423191|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
19423192|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423193|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423194|NCT00905606|Topiramate|topiramate|mesh-list
19423195|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
19710445|NCT04790838|Fluticasone|fluticasone|mesh-list
19710446|NCT04790838|Xhance|xhance|mesh-list
19710447|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19710448|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19710449|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710450|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19710451|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
19710452|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710453|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710454|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19710455|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
19710456|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
19710457|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19710458|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19710459|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19710460|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19710461|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
19710462|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710463|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710464|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
19710465|NCT04790838|Hormones|hormones|mesh-ancestor
19710466|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710467|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
19710468|NCT04791020|Lidocaine|lidocaine|mesh-list
19710469|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710470|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
19710471|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710472|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710473|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
19423196|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423197|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710474|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710475|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19710476|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19710477|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19710478|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710479|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710480|NCT04790812|Acetaminophen|acetaminophen|mesh-list
19710481|NCT04790812|Celecoxib|celecoxib|mesh-list
20531380|NCT01794429|Exenatide|exenatide|mesh-list
20531381|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19710482|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19710483|NCT04790812|Analgesics|analgesics|mesh-ancestor
19710484|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
19710485|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710486|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710487|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
19710488|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19710489|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710490|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856791|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19856792|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19856793|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856794|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
19856795|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531382|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423198|NCT00905567|Topiramate|topiramate|mesh-list
20531383|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20531384|NCT01794429|Incretins|incretins|mesh-ancestor
20531385|NCT01794429|Hormones|hormones|mesh-ancestor
20531386|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531387|NCT01794507|Dexamethasone|dexamethasone|mesh-list
19423199|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
19423200|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531388|NCT01794507|Bortezomib|bortezomib|mesh-list
19423201|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423202|NCT00905346|Topiramate|topiramate|mesh-list
19423203|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
19423204|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423205|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423206|NCT00905164|Topiramate|topiramate|mesh-list
19423207|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
19423208|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423209|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423210|NCT00904943|Topiramate|topiramate|mesh-list
19423211|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
19423212|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423213|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423214|NCT00902928|Enoxaparin|enoxaparin|mesh-list
19423215|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
19423216|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19423217|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19423218|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423219|NCT00902291|Gemcitabine|gemcitabine|mesh-list
19423220|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19423221|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
19423222|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423223|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423224|NCT00902291|Antiviral Agents|antiviral agents|mesh-ancestor
19423225|NCT00902291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423226|NCT00902291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423227|NCT00902291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19423228|NCT00902291|Immunologic Factors|immunologic factors|mesh-ancestor
19423229|NCT00902291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423230|NCT00901979|Metformin|metformin|mesh-list
19423231|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19423232|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423233|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423234|NCT00901979|Incretins|incretins|mesh-ancestor
19423235|NCT00901979|Hormones|hormones|mesh-ancestor
19423236|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19423237|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19423238|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
19423239|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423240|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423241|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19423242|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19423243|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19423244|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19423245|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
19423246|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423247|NCT00900783|Valacyclovir|valacyclovir|mesh-list
19423248|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
19423249|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423250|NCT00894868|Vildagliptin|vildagliptin|mesh-list
19423251|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423252|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423253|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19423254|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
19423255|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423256|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423257|NCT00894530|Azithromycin|azithromycin|mesh-list
19423258|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19423259|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19423260|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423261|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423262|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19423263|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19423264|NCT00892970|Azithromycin|azithromycin|mesh-list
19423265|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19423266|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19423267|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423268|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423269|NCT00892762|Travoprost|travoprost|mesh-list
19423270|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19423271|NCT00892762|Latanoprost|latanoprost|mesh-list
19423272|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19423273|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423274|NCT00892203|Sumatriptan|sumatriptan|mesh-list
19423275|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19423276|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19423277|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19423278|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
19423279|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423280|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423281|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423282|NCT00890968|Triamcinolone|triamcinolone|mesh-list
19423283|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19423284|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19423285|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19423286|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19423287|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
19423288|NCT00890968|Hormones|hormones|mesh-ancestor
19423289|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19423290|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423291|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19856796|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423292|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
19423293|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423294|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423295|NCT00890591|Amlodipine|amlodipine|mesh-list
19423296|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19423297|NCT00890591|Olmesartan|olmesartan|mesh-list
19423298|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19423299|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423300|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19423301|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423302|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423303|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423304|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423305|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
19423306|NCT00890591|Diuretics|diuretics|mesh-ancestor
19423307|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
19423308|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19423309|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19423310|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19423311|NCT00890305|Pidilizumab|pidilizumab|mesh-list
19423312|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19423313|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423314|NCT00890149|Ondansetron|ondansetron|mesh-list
19423315|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
19423316|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
19423317|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423318|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423319|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19423320|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
19423321|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
19423322|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19423323|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
19423324|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423325|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423326|NCT00890149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19423327|NCT00890149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19423328|NCT00890149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423329|NCT00890149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423330|NCT00890149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19423331|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
19423332|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423333|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423334|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19423335|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19423336|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423337|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423338|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423339|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19423340|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19423341|NCT00889382|Paclitaxel|paclitaxel|mesh-list
19423342|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19423343|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423344|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
19423345|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
19423346|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
19423347|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423348|NCT00888355|Losartan|losartan|mesh-list
19423349|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19423350|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423351|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19423352|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19423353|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423354|NCT00887250|Losartan|losartan|mesh-list
19423355|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19423356|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423357|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19423358|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19423359|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423360|NCT00886600|Losartan|losartan|mesh-list
19423361|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19423362|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19423363|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423364|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19423365|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19710491|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19710492|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19710493|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710494|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710495|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
19733772|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733773|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
19733774|NCT04558736|Fludarabine|fludarabine|mesh-list
19733775|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
19733776|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19733777|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733778|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
19733779|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733780|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733781|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19733782|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
19733783|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733784|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733785|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19733786|NCT04558580|Rufinamide|rufinamide|mesh-list
19733787|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
19733788|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19733789|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19733790|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19733791|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733792|NCT04558463|Oseltamivir|oseltamivir|mesh-list
19733793|NCT04558463|Favipiravir|favipiravir|mesh-list
19733794|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
19733795|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733796|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733797|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733798|NCT04558268|Folic Acid|folic acid|mesh-list
19733799|NCT04558268|Prednisone|prednisone|mesh-list
19733800|NCT04558268|Progesterone|progesterone|mesh-list
19733801|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733802|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
19733803|NCT04558268|Hormones|hormones|mesh-ancestor
19733804|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733805|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733806|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733807|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733808|NCT04558268|Progestins|progestins|mesh-ancestor
19733809|NCT04558268|Hematinics|hematinics|mesh-ancestor
19733810|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
19733811|NCT04558268|Vitamins|vitamins|mesh-ancestor
19733812|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
19733813|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
19733814|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
19733815|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733816|NCT04558424|Protective Agents|protective agents|mesh-ancestor
19733817|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733818|NCT04558424|Vitamins|vitamins|mesh-ancestor
19733819|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
19733820|NCT04558281|Ropivacaine|ropivacaine|mesh-list
19733821|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
20531389|NCT01794507|Venetoclax|venetoclax|mesh-list
20531390|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20531391|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
20531392|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
20531393|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531394|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531395|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531396|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
20531397|NCT01794507|Hormones|hormones|mesh-ancestor
20531398|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531399|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20531400|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531401|NCT01794533|Lidocaine|lidocaine|mesh-list
19423366|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423367|NCT00886600|Diuretics|diuretics|mesh-ancestor
19423368|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
19423369|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423370|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19423371|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423372|NCT00884715|Octreotide|octreotide|mesh-list
19423373|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19423374|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19423375|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423376|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
19423377|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19423378|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19423379|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19423380|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423381|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423382|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
19423383|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423384|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423385|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19423386|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423387|NCT00883896|Fezakinumab|fezakinumab|mesh-list
19423388|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
19423389|NCT00882440|Losartan|losartan|mesh-list
19423390|NCT00882440|Enalapril|enalapril|mesh-list
19423391|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19423392|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423393|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19423394|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19423395|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710496|NCT04790734|Remifentanil|remifentanil|mesh-list
19710497|NCT04790734|Propofol|propofol|mesh-list
19710498|NCT04790734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19710499|NCT04790734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710500|NCT04790734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710501|NCT04790734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19710502|NCT04790734|Anesthetics, General|anesthetics, general|mesh-ancestor
19710503|NCT04790734|Anesthetics|anesthetics|mesh-ancestor
19710504|NCT04790734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19710505|NCT04790734|Narcotics|narcotics|mesh-ancestor
19710506|NCT04790734|Analgesics|analgesics|mesh-ancestor
19710507|NCT04790734|Sensory System Agents|sensory system agents|mesh-ancestor
19710508|NCT04790734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710509|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19710510|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
19710511|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19710512|NCT04790383|Protective Agents|protective agents|mesh-ancestor
19710513|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710514|NCT04790708|Octreotide|octreotide|mesh-list
19710515|NCT04790708|Edotreotide|edotreotide|mesh-list
19710516|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19710517|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710518|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710519|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710520|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710521|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
19710522|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
19710523|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
19710524|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19710525|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
19710526|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
19710527|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710528|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856797|NCT00760838|Azithromycin|azithromycin|mesh-list
19856798|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19856799|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423396|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19423397|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
19423398|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423399|NCT00881452|Citric Acid|citric acid|mesh-list
19423400|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
19423401|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19423402|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
19423403|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
19423404|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423405|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
19423406|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19423407|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
19423408|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423409|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423410|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19423411|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
19423412|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19423413|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19423414|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19423415|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19423416|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423417|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423418|NCT00880217|Methylphenidate|methylphenidate|mesh-list
19423419|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19423420|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19423421|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423422|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19423423|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19423424|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423425|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423426|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
19423427|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423428|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19423429|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
19423430|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
19423431|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19423432|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
19423433|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423434|NCT00875459|Insulin|insulin|mesh-list
19423435|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19423436|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423437|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423438|NCT00875108|Insulin|insulin|mesh-list
19423439|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19423440|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423441|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423442|NCT00872885|Morphine|morphine|mesh-list
19423443|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19423444|NCT00872885|Narcotics|narcotics|mesh-ancestor
19423445|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423446|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423447|NCT00872885|Analgesics|analgesics|mesh-ancestor
19423448|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
19423449|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423450|NCT00872430|Laxatives|laxatives|mesh-list
19423451|NCT00872430|Cathartics|cathartics|mesh-list
19423452|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19423453|NCT00872014|Sorafenib|sorafenib|mesh-list
19423454|NCT00872014|Trebananib|trebananib|mesh-list
19423455|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423456|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19423457|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423458|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423459|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19423460|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19423461|NCT00872014|Growth Substances|growth substances|mesh-ancestor
19423462|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423463|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
19423464|NCT00871936|Metformin|metformin|mesh-list
19423465|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423466|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423467|NCT00871481|Aldesleukin|aldesleukin|mesh-list
19423468|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
19423469|NCT00871481|Ipilimumab|ipilimumab|mesh-list
19423470|NCT00871481|Interleukin-2|interleukin-2|mesh-list
19423471|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19423472|NCT00871481|Antibodies|antibodies|mesh-list
19423473|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
19423474|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19423475|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19423476|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
19423477|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423478|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19423479|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19423480|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
19423481|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423482|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423483|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19423484|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19423485|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19423486|NCT00871481|Analgesics|analgesics|mesh-ancestor
19423487|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
19423488|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423489|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19423490|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19423491|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
19710529|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710530|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19710531|NCT04790448|Irinotecan|irinotecan|mesh-list
19856800|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
19856801|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856802|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19856803|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856804|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856805|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19856806|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19856807|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856808|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19856809|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856810|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856811|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
19856812|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856813|NCT00761085|Morphine|morphine|mesh-list
19856814|NCT00761085|Methadone|methadone|mesh-list
19856815|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20249425|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249426|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
20249427|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249428|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20249429|NCT00440635|Bortezomib|bortezomib|mesh-list
20249430|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249431|NCT00440648|Sevelamer|sevelamer|mesh-list
20249432|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
20531402|NCT01794533|Epinephrine|epinephrine|mesh-list
20531403|NCT01794533|Racepinephrine|racepinephrine|mesh-list
20531404|NCT01794533|Fentanyl|fentanyl|mesh-list
20531405|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
20531406|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710532|NCT04790448|Camptothecin|camptothecin|mesh-list
19710533|NCT04790448|Cetuximab|cetuximab|mesh-list
19710534|NCT04790448|Vemurafenib|vemurafenib|mesh-list
19710535|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19710536|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19710537|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531407|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
20531408|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531409|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531410|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
20531411|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531412|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20531413|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20553299|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
19423492|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423493|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
19423494|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19423495|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
19423496|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423497|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423498|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19423499|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
19423500|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
19423501|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19423502|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
19423503|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423504|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423505|NCT00870688|Valproic Acid|valproic acid|mesh-list
19423506|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
19423507|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423508|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423509|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
19423510|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423511|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423512|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
19423513|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19423514|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423515|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423516|NCT00870454|Pregabalin|pregabalin|mesh-list
19423517|NCT00870454|Analgesics|analgesics|mesh-ancestor
19423518|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
19423519|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423520|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423521|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
19423522|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19423523|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423524|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423525|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423526|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19423527|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19423528|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423529|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423530|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19423531|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
19423532|NCT00869661|Ribavirin|ribavirin|mesh-list
19423533|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
19423534|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423535|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
19423536|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423537|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
19423538|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423539|NCT00869336|Luliconazole|luliconazole|mesh-list
19423540|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
19423541|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423542|NCT00869128|Melatonin|melatonin|mesh-list
19423543|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
19423544|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423545|NCT00869128|Protective Agents|protective agents|mesh-ancestor
19423546|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733822|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
19423547|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423548|NCT00864175|Docetaxel|docetaxel|mesh-list
19423549|NCT00864175|Trastuzumab|trastuzumab|mesh-list
19423550|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423551|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
19423552|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
19423553|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
19423554|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423555|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19423556|NCT00863369|Gemcitabine|gemcitabine|mesh-list
19423557|NCT00863369|Rituximab|rituximab|mesh-list
19423558|NCT00863369|Bortezomib|bortezomib|mesh-list
19423559|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710538|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710539|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856816|NCT00761085|Narcotics|narcotics|mesh-ancestor
19710540|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710541|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19710542|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19710543|NCT04790331|Verapamil|verapamil|mesh-list
19710544|NCT04790331|Diltiazem|diltiazem|mesh-list
19710545|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19710546|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19710547|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710548|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710549|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19710550|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710551|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
19710552|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19710553|NCT04790136|Cannabidiol|cannabidiol|mesh-list
19710554|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
19710555|NCT04790279|Amlodipine|amlodipine|mesh-list
19710556|NCT04790279|Nifedipine|nifedipine|mesh-list
19710557|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19710558|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19710559|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710560|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710561|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423560|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710562|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710563|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
19423561|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
19423562|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423563|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19423564|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249433|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
20249434|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249435|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
20249436|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249437|NCT00440674|Paclitaxel|paclitaxel|mesh-list
20249438|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20249439|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249440|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
19423565|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
19423566|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423567|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
19423568|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423569|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423570|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19423571|NCT00862524|Gemcitabine|gemcitabine|mesh-list
19423572|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19423573|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
19423574|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423575|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423576|NCT00862524|Antiviral Agents|antiviral agents|mesh-ancestor
19423577|NCT00862524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423578|NCT00862524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423579|NCT00862524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19423580|NCT00862524|Immunologic Factors|immunologic factors|mesh-ancestor
19423581|NCT00862524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423582|NCT00861705|Paclitaxel|paclitaxel|mesh-list
19423583|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
19423584|NCT00861705|Bevacizumab|bevacizumab|mesh-list
19423585|NCT00861705|Carboplatin|carboplatin|mesh-list
19423586|NCT00861705|Doxorubicin|doxorubicin|mesh-list
19423587|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19423588|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19423589|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19423590|NCT00861705|Antibodies|antibodies|mesh-list
19423591|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
19423592|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19423593|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
19423594|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
19423595|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19423596|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423597|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
19423598|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
19423599|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
19423600|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423601|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19423602|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
19423603|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423604|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19423605|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19423606|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
19423607|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19423608|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19423609|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19423610|NCT00861705|Growth Substances|growth substances|mesh-ancestor
19423611|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
19423612|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19423613|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19710564|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
19710565|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19710566|NCT04789941|Irinotecan|irinotecan|mesh-list
19710567|NCT04789941|Cisplatin|cisplatin|mesh-list
19710568|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19710569|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19710570|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710571|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710572|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710573|NCT04789915|Memantine|memantine|mesh-list
19710574|NCT04789915|Amisulpride|amisulpride|mesh-list
19710575|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19710576|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19710577|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
19423614|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19423615|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423616|NCT00860288|Metformin|metformin|mesh-list
19423617|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19423618|NCT00860288|Vildagliptin|vildagliptin|mesh-list
19423619|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19423620|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423621|NCT00860288|Incretins|incretins|mesh-ancestor
19423622|NCT00860288|Hormones|hormones|mesh-ancestor
19423623|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19423624|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19423625|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
19423626|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423627|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423628|NCT00859521|Levetiracetam|levetiracetam|mesh-list
19423629|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
19423630|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
19423631|NCT00859430|Levetiracetam|levetiracetam|mesh-list
19423632|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
19423633|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
19450804|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19450805|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450806|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
19450807|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450808|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
19450809|NCT03425656|Docetaxel|docetaxel|mesh-list
19450810|NCT03425656|Doxorubicin|doxorubicin|mesh-list
19450811|NCT03425656|Trastuzumab|trastuzumab|mesh-list
19450812|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19450813|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
19450814|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450815|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450816|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19450817|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
19450818|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450819|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450820|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19450821|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
19450822|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
19450823|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
19450824|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19450825|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19450826|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19450827|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450828|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19450829|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
19450830|NCT03425617|Olodaterol|olodaterol|mesh-list
19450831|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19450832|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
19450833|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450834|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249441|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19450835|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19450836|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
19423634|NCT00858871|Sorafenib|sorafenib|mesh-list
19423635|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423636|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19423637|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423638|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423639|NCT00858702|Olmesartan|olmesartan|mesh-list
19423640|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19423641|NCT00858702|Diuretics|diuretics|mesh-list
20249442|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
20249443|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249444|NCT00440687|Fluticasone|fluticasone|mesh-list
20249445|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249446|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20249447|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
20249448|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249449|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249450|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20249451|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
20249452|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
20249453|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20249454|NCT00440713|Aripiprazole|aripiprazole|mesh-list
20249455|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
20249456|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20249457|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20249458|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20531414|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20531415|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710578|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710579|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710580|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710581|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19710582|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19710583|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19710584|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19710585|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710586|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19710587|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19710588|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19710589|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
19710590|NCT04789668|Atezolizumab|atezolizumab|mesh-list
19710591|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531416|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531417|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20531418|NCT01794533|Narcotics|narcotics|mesh-ancestor
20531419|NCT01794533|Analgesics|analgesics|mesh-ancestor
20531420|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20531421|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20531422|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
20531423|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20531424|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19423642|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19450837|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
19450838|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19450839|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
19450840|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450841|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450842|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19450843|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19450844|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19450845|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450846|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450847|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19450848|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19450849|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19423643|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19423644|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19423645|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423646|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
19423647|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423648|NCT00857285|Losartan|losartan|mesh-list
19423649|NCT00857285|Olmesartan|olmesartan|mesh-list
19423650|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19423651|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19423652|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423653|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19423654|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19710592|NCT04790032|Cangrelor|cangrelor|mesh-list
19710593|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19710594|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19710595|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19710596|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19710597|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
19710598|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710599|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710600|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710601|NCT04789005|Phenylephrine|phenylephrine|mesh-list
19710602|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
19710603|NCT04789005|Norepinephrine|norepinephrine|mesh-list
19710604|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20249459|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249460|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423655|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249461|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
20249462|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
20249463|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249464|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249465|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20249466|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20249467|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
20249468|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20249469|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20249470|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20249471|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19710605|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
19710606|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
19710607|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710608|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710609|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
19710610|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19710611|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
19710612|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
19710613|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19710614|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19710615|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19710616|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
19423656|NCT00855764|Paclitaxel|paclitaxel|mesh-list
19423657|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19423658|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423659|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
19423660|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
19423661|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
19423662|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423663|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
19423664|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19423665|NCT00854945|ON 01910|on 01910|mesh-list
19423666|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423667|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19423668|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423669|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423670|NCT00851045|Leucovorin|leucovorin|mesh-list
19423671|NCT00851045|Bevacizumab|bevacizumab|mesh-list
19423672|NCT00851045|Fluorouracil|fluorouracil|mesh-list
19423673|NCT00851045|Irinotecan|irinotecan|mesh-list
19423674|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19423675|NCT00851045|Calcium|calcium|mesh-list
19423676|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
19423677|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710617|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856817|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856818|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423678|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423679|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19423680|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19423681|NCT00851045|Growth Substances|growth substances|mesh-ancestor
19423682|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423683|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
19423684|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423685|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
19423686|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423687|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19423688|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19423689|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
19423690|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19423691|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19423692|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423693|NCT00851045|Antidotes|antidotes|mesh-ancestor
19423694|NCT00851045|Protective Agents|protective agents|mesh-ancestor
19423695|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
19423696|NCT00851045|Vitamins|vitamins|mesh-ancestor
19423697|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
19423698|NCT00850577|Paclitaxel|paclitaxel|mesh-list
19423699|NCT00850577|Bevacizumab|bevacizumab|mesh-list
19423700|NCT00850577|Carboplatin|carboplatin|mesh-list
19423701|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19423702|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19423703|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423704|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
19423705|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
19423706|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
19423707|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423708|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19423709|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19423710|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19423711|NCT00850577|Growth Substances|growth substances|mesh-ancestor
19423712|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423713|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
19423714|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
19423715|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
19423716|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19423717|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19423718|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423719|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423720|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19423721|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19423722|NCT00849862|Levetiracetam|levetiracetam|mesh-list
19423723|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
19423724|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
19423725|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
19423726|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
19423727|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19423728|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19423729|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423730|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423731|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19423732|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19423733|NCT00849667|Farletuzumab|farletuzumab|mesh-list
19423734|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423735|NCT00849576|Insulin|insulin|mesh-list
19423736|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19423737|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
19423738|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19710618|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710619|NCT04789005|Protective Agents|protective agents|mesh-ancestor
19710620|NCT04788979|Melatonin|melatonin|mesh-list
19423739|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710621|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
19733823|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423740|NCT00849485|Levetiracetam|levetiracetam|mesh-list
19423741|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
19423742|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
19423743|NCT00847405|Sumatriptan|sumatriptan|mesh-list
19423744|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19423745|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19423746|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19423747|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
19423748|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423749|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423750|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423751|NCT00847366|Tamoxifen|tamoxifen|mesh-list
19423752|NCT00847366|Trastuzumab|trastuzumab|mesh-list
19423753|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19423754|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19423755|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19423756|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
19423757|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19423758|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423759|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19423760|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19423761|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19423762|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19423763|NCT00846989|Latanoprost|latanoprost|mesh-list
19423764|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19423765|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19423766|NCT00846885|Sumatriptan|sumatriptan|mesh-list
19423767|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19423768|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19423769|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19423770|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
19423771|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423772|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423773|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423774|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19423775|NCT00845299|Latanoprost|latanoprost|mesh-list
19423776|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
19423777|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19423778|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19423779|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19423780|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710622|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710623|NCT04788979|Protective Agents|protective agents|mesh-ancestor
19710624|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710625|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710626|NCT04788823|Prednisone|prednisone|mesh-list
19710627|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710628|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
19710629|NCT04788823|Hormones|hormones|mesh-ancestor
19710630|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710631|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710632|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710633|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710634|NCT04788914|Charcoal|charcoal|mesh-list
19710635|NCT04788914|Antidotes|antidotes|mesh-ancestor
19710636|NCT04788914|Protective Agents|protective agents|mesh-ancestor
19710637|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710638|NCT04788654|Acetaminophen|acetaminophen|mesh-list
19710639|NCT04788654|Dexamethasone|dexamethasone|mesh-list
19710640|NCT04788654|Celecoxib|celecoxib|mesh-list
19710641|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710642|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
19710643|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
19710644|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710645|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710646|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710647|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
19710648|NCT04788654|Hormones|hormones|mesh-ancestor
19856819|NCT00761085|Analgesics|analgesics|mesh-ancestor
19856820|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
19856821|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423781|NCT00845026|Olanzapine|olanzapine|mesh-list
19423782|NCT00845026|Risperidone|risperidone|mesh-list
19856822|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
19710649|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19423783|NCT00845026|Aripiprazole|aripiprazole|mesh-list
19423784|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19423785|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
19710650|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19710651|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710652|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19710653|NCT04788654|Analgesics|analgesics|mesh-ancestor
19710654|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
19710655|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
19710656|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19710657|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19710658|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19710659|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19710660|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710661|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733824|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733825|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
19733826|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733827|NCT04558021|Niclosamide|niclosamide|mesh-list
19733828|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
19733829|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19733830|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
19733831|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19733832|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733833|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
19733834|NCT04557878|Mitogens|mitogens|mesh-list
19733835|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
19733836|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733837|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
19733838|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19733839|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
19733840|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450850|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
19450851|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450852|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450853|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19450854|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19450855|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
19450856|NCT03425474|Propofol|propofol|mesh-list
19450857|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450858|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450859|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450860|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19423786|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423787|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423788|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423789|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19423790|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19423791|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423792|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423793|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19423794|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
19423795|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
19423796|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
19423797|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423798|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19423799|NCT00845026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19423800|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19423801|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423802|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
19423803|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
19423804|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19423805|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19423806|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19423807|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19423808|NCT00843687|Risperidone|risperidone|mesh-list
19423809|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19423810|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
19423811|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423812|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423813|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423814|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19423815|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19423816|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423817|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423818|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19423819|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
19423820|NCT00841815|Amlodipine|amlodipine|mesh-list
19423821|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423822|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19423823|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19450861|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
19710662|NCT04789057|Atorvastatin|atorvastatin|mesh-list
19710663|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19710664|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19710665|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
19710666|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710667|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19710668|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19856823|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
19856824|NCT00761137|Tropicamide|tropicamide|mesh-list
19856825|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
19856826|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
19856827|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856828|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856829|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19856830|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19856831|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
19856832|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249472|NCT00440739|Etoricoxib|etoricoxib|mesh-list
20249473|NCT00440739|Flavoxate|flavoxate|mesh-list
19710669|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423824|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423825|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423826|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423827|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
19423828|NCT00841698|Paroxetine|paroxetine|mesh-list
19423829|NCT00841698|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19423830|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19423831|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423832|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423833|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423834|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
19423835|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423836|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19423837|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
19423838|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423839|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19423840|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19423841|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423842|NCT00841659|Paroxetine|paroxetine|mesh-list
19423843|NCT00841659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19423844|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19423845|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423846|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423847|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423848|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
19423849|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423850|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19423851|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
19423852|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423853|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19423854|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19423855|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423856|NCT00841542|Amlodipine|amlodipine|mesh-list
19423857|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423858|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19423859|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423860|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249474|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20249475|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249476|NCT00440739|Analgesics|analgesics|mesh-ancestor
20249477|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
20249478|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249479|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423861|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423862|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710670|NCT04788745|Trimetazidine|trimetazidine|mesh-list
19710671|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
19710672|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
19710673|NCT04788355|Apixaban|apixaban|mesh-list
19710674|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
19710675|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19710676|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19710677|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710678|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710679|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710680|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19710681|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19710682|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
20249480|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249481|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20531425|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19710683|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20531426|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19423863|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
19423864|NCT00840879|Meloxicam|meloxicam|mesh-list
19423865|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19423866|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19423867|NCT00840879|Analgesics|analgesics|mesh-ancestor
19423868|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
19423869|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423870|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423871|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249482|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20249483|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249484|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249485|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423872|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19423873|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19423874|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19423875|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423876|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423877|NCT00840866|Cefprozil|cefprozil|mesh-list
19423878|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423879|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423880|NCT00840840|Amoxicillin|amoxicillin|mesh-list
19423881|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
19423882|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
19423883|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19423884|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423885|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423886|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19423887|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423888|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423889|NCT00840632|Trandolapril|trandolapril|mesh-list
19423890|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19423891|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
19423892|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423893|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423894|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423895|NCT00840476|Meloxicam|meloxicam|mesh-list
19423896|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19423897|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19423898|NCT00840476|Analgesics|analgesics|mesh-ancestor
19423899|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
19423900|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423901|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423902|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19710684|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
19710685|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
19710686|NCT04788381|Bevacizumab|bevacizumab|mesh-list
19710687|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19423903|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19423904|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19423905|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19423906|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423907|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423908|NCT00840411|Clarithromycin|clarithromycin|mesh-list
19423909|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423910|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423911|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19423912|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423913|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423914|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19423915|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19423916|NCT00840281|Cefprozil|cefprozil|mesh-list
20249486|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
20249487|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
20249488|NCT00440739|Urological Agents|urological agents|mesh-ancestor
20249489|NCT00440765|Bortezomib|bortezomib|mesh-list
20249490|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249491|NCT00440778|Abciximab|abciximab|mesh-list
19423917|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423918|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423919|NCT00840216|Clarithromycin|clarithromycin|mesh-list
19423920|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423921|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423922|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19423923|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423924|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423925|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19423926|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19423927|NCT00840203|Mesalamine|mesalamine|mesh-list
19423928|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19423929|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19423930|NCT00840203|Analgesics|analgesics|mesh-ancestor
19423931|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
19423932|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423933|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423934|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19423935|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19423936|NCT00840099|Amoxicillin|amoxicillin|mesh-list
19423937|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
19423938|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
19423939|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19423940|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19423941|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19423942|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19423943|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423944|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423945|NCT00840073|Trandolapril|trandolapril|mesh-list
19423946|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19423947|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
19423948|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423949|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423950|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19423951|NCT00839930|Cilostazol|cilostazol|mesh-list
19423952|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19423953|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
19423954|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423955|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423956|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19423957|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
19423958|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19423959|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19423960|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423961|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19423962|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
19423963|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19423964|NCT00839930|Protective Agents|protective agents|mesh-ancestor
19423965|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19423966|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20249492|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
20249493|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19423967|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423968|NCT00838799|Pregabalin|pregabalin|mesh-list
19423969|NCT00838799|Analgesics|analgesics|mesh-ancestor
19423970|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
19423971|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423972|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423973|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
19423974|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19423975|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19423976|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423977|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19423978|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19423979|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19423980|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19423981|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19423982|NCT00838630|Cilostazol|cilostazol|mesh-list
19423983|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19423984|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
19423985|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19423986|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19423987|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19423988|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
20249494|NCT00440804|Ibuprofen|ibuprofen|mesh-list
19423989|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19423990|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19423991|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553300|NCT01928511|Entecavir|entecavir|mesh-list
20553301|NCT01928511|Adefovir|adefovir|mesh-list
20553302|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20553303|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553304|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
20553305|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553306|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20553307|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20553308|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553309|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19423992|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19423993|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
19423994|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19423995|NCT00838630|Protective Agents|protective agents|mesh-ancestor
19423996|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19423997|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19423998|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19423999|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
19424000|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19424001|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424002|NCT00838279|Lamotrigine|lamotrigine|mesh-list
19424003|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
19424004|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424005|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424006|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424007|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424008|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424009|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19424010|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424011|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424012|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424013|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19424014|NCT00838136|Lamotrigine|lamotrigine|mesh-list
19424015|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
19424016|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424017|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424018|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424019|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424020|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424021|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19424022|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424023|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424024|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424025|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19424026|NCT00837265|Docetaxel|docetaxel|mesh-list
19424027|NCT00837265|Doxorubicin|doxorubicin|mesh-list
19424028|NCT00837265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424029|NCT00837265|Tubulin Modulators|tubulin modulators|mesh-ancestor
19424030|NCT00837265|Antimitotic Agents|antimitotic agents|mesh-ancestor
19424031|NCT00837265|Mitosis Modulators|mitosis modulators|mesh-ancestor
19424032|NCT00837265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424033|NCT00837265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20531427|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19424034|NCT00837265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19424035|NCT00837265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19424036|NCT00837265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424037|NCT00836901|Amoxicillin|amoxicillin|mesh-list
19424038|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19710688|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531428|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20531429|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
20531430|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20531431|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
20531432|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
20531433|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
20531434|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20531435|NCT01794572|Melphalan|melphalan|mesh-list
19424039|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
19424040|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
19424041|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424042|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424043|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19424044|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424045|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424046|NCT00836706|Clarithromycin|clarithromycin|mesh-list
19424047|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424048|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424049|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19424050|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424051|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424052|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19424053|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19424054|NCT00836472|Metformin|metformin|mesh-list
19424055|NCT00836472|Glyburide|glyburide|mesh-list
19424056|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424057|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424058|NCT00836069|Paroxetine|paroxetine|mesh-list
19424059|NCT00836069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19424060|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19710689|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19710690|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19710691|NCT04788381|Growth Substances|growth substances|mesh-ancestor
19710692|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710693|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
19710694|NCT04788420|Sorafenib|sorafenib|mesh-list
19710695|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710696|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19424061|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19450862|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
19450863|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19450864|NCT03425461|Nivolumab|nivolumab|mesh-list
19450865|NCT03425461|Ipilimumab|ipilimumab|mesh-list
19450866|NCT03425461|Antibodies|antibodies|mesh-list
19450867|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
19450868|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19710697|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856833|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856834|NCT00761150|Acetaminophen|acetaminophen|mesh-list
19856835|NCT00761150|Hydrocodone|hydrocodone|mesh-list
19856836|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19856837|NCT00761150|Analgesics|analgesics|mesh-ancestor
19856838|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
19856839|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856840|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856841|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
19856842|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19856843|NCT00761150|Narcotics|narcotics|mesh-ancestor
19856844|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856845|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
19856846|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
19856847|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19856848|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19856849|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856850|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531436|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20531437|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
20531438|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733841|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
20531439|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531440|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20531441|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531442|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
20531443|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531444|NCT01794767|Heparin|heparin|mesh-list
20531445|NCT01794767|Calcium heparin|calcium heparin|mesh-list
20531446|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
20531447|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20531448|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20531449|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531450|NCT01794897|Valacyclovir|valacyclovir|mesh-list
19424062|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424063|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424064|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
19424065|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424066|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19424067|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
19424068|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424069|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19424070|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19424071|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424072|NCT00836056|Clindamycin|clindamycin|mesh-list
19424073|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
19710698|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710699|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
19710700|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19710701|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710702|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19710703|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
19710704|NCT04788043|Magrolimab|magrolimab|mesh-list
19710705|NCT04788043|Antibodies|antibodies|mesh-list
19710706|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
19710707|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19710708|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
19710709|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710710|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710711|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
19710712|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19710713|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19710714|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710715|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
19710716|NCT04788121|Coagulants|coagulants|mesh-ancestor
19710717|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19710718|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19710719|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
19710720|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710721|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710722|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710723|NCT04787848|Bromides|bromides|mesh-list
19710724|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
19710725|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
19710726|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19710727|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710728|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
19710729|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710730|NCT04787510|Heparin|heparin|mesh-list
19710731|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19710732|NCT04787510|Tinzaparin|tinzaparin|mesh-list
19710733|NCT04787510|Dalteparin|dalteparin|mesh-list
19710734|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
19710735|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19710736|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19710737|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710738|NCT04787341|Panitumumab|panitumumab|mesh-list
19710739|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710740|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710741|NCT04787471|Riboflavin|riboflavin|mesh-list
19710742|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
19710743|NCT04787471|Vitamins|vitamins|mesh-ancestor
19710744|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
19710745|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710746|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19710747|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
19710748|NCT04787731|Lidocaine|lidocaine|mesh-list
19710749|NCT04787731|Bupivacaine|bupivacaine|mesh-list
19710750|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
19710751|NCT04787731|Anesthetics|anesthetics|mesh-list
19710752|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710753|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710754|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
19710755|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710756|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19710757|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19710758|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19710759|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424074|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
19710760|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424075|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424076|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424077|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19424078|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424079|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424080|NCT00836004|Clindamycin|clindamycin|mesh-list
19424081|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
19424082|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
19424083|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424084|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424085|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19424086|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424087|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424088|NCT00835991|Metformin|metformin|mesh-list
19424089|NCT00835991|Glyburide|glyburide|mesh-list
19424090|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424091|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424092|NCT00835796|Finasteride|finasteride|mesh-list
19424093|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19424094|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19424095|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424096|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424097|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
19424098|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19424099|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424100|NCT00835796|Urological Agents|urological agents|mesh-ancestor
19424101|NCT00835705|Amoxicillin|amoxicillin|mesh-list
19424102|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19424103|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
19424104|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
19424105|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424106|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424107|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19424108|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424109|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424110|NCT00835692|Clarithromycin|clarithromycin|mesh-list
19424111|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424112|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424113|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19424114|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424115|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424116|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19424117|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19424118|NCT00835666|Finasteride|finasteride|mesh-list
19424119|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19424120|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19424121|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424122|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424123|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
19424124|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19424125|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424126|NCT00835666|Urological Agents|urological agents|mesh-ancestor
19424127|NCT00835640|Fexofenadine|fexofenadine|mesh-list
19424128|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19424129|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19424130|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19424131|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
19424132|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
19424133|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424134|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424135|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424136|NCT00835614|Cefprozil|cefprozil|mesh-list
19424137|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19450869|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
19424138|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424139|NCT00835588|Pantoprazole|pantoprazole|mesh-list
19424140|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19424141|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19424142|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19424143|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424144|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424145|NCT00835575|Mirtazapine|mirtazapine|mesh-list
19424146|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
19424147|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424148|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19424149|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
19424150|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
19424151|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424152|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424153|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424154|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19424155|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424156|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424157|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19424158|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19424159|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19424160|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
19424161|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19424162|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19424163|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
19424164|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19424165|NCT00835549|Cefdinir|cefdinir|mesh-list
19424166|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424167|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424168|NCT00835536|Ribavirin|ribavirin|mesh-list
19424169|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
19424170|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710761|NCT04787289|Bevacizumab|bevacizumab|mesh-list
19710762|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710763|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710764|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19710765|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19710766|NCT04787289|Growth Substances|growth substances|mesh-ancestor
19710767|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710768|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
19710769|NCT04787276|Rifaximin|rifaximin|mesh-list
19710770|NCT04787276|Lactulose|lactulose|mesh-list
19710771|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19710772|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710773|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710774|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19710775|NCT04786795|Pancreatin|pancreatin|mesh-list
19710776|NCT04786795|Pancrelipase|pancrelipase|mesh-list
19710777|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19710778|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710779|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
19710780|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19710781|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
19710782|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710783|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
19710784|NCT04786613|Protective Agents|protective agents|mesh-ancestor
19710785|NCT04786873|Clonidine|clonidine|mesh-list
19710786|NCT04786873|Analgesics|analgesics|mesh-ancestor
19710787|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
19424171|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
19710788|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710789|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424172|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424173|NCT00835497|Metformin|metformin|mesh-list
19424174|NCT00835497|Glipizide|glipizide|mesh-list
19424175|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424176|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424177|NCT00835484|Cefdinir|cefdinir|mesh-list
19424178|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424179|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424180|NCT00835406|Alendronate|alendronate|mesh-list
19424181|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19424182|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424183|NCT00835367|Amlodipine|amlodipine|mesh-list
19424184|NCT00835367|Benazepril|benazepril|mesh-list
19424185|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424186|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424187|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424188|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424189|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424190|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424191|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
19424192|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19424193|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424194|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424195|NCT00835354|Cefprozil|cefprozil|mesh-list
19424196|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424197|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424198|NCT00835276|Fexofenadine|fexofenadine|mesh-list
19424199|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19424200|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19424201|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19424202|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
19424203|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
19424204|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424205|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424206|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424207|NCT00835263|Lamotrigine|lamotrigine|mesh-list
19424208|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
19424209|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424210|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424211|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424212|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424213|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424214|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19424215|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424216|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424217|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424218|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19424219|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19424220|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
19424221|NCT00835211|Coagulants|coagulants|mesh-ancestor
19424222|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19424223|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
19424224|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424225|NCT00835172|Glimepiride|glimepiride|mesh-list
19424226|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19424227|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424228|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424229|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19424230|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
19424231|NCT00835146|Ribavirin|ribavirin|mesh-list
19424232|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
19424233|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424234|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
19424235|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424236|NCT00835081|Cefadroxil|cefadroxil|mesh-list
19424237|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424238|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424239|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19424240|NCT00835042|Moexipril|moexipril|mesh-list
19424241|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424242|NCT00835042|Diuretics|diuretics|mesh-ancestor
19424243|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
19424244|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424245|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19424246|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424247|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424248|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19424249|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424250|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424251|NCT00834990|Valproic Acid|valproic acid|mesh-list
19424252|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
19424253|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424254|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424255|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
19424256|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424257|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424258|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
19424259|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424260|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424261|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424262|NCT00834977|Amlodipine|amlodipine|mesh-list
19424263|NCT00834977|Benazepril|benazepril|mesh-list
19424264|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424265|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424266|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424267|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424268|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424269|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424270|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
19424271|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19424272|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424273|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424274|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19424275|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19424276|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19424277|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424278|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424279|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424280|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424281|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19710790|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19710791|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
19710792|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
19424282|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
19424283|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424284|NCT00834873|Carvedilol|carvedilol|mesh-list
19424285|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19424286|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19424287|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
19424288|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424289|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424290|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424291|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424292|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
19424293|NCT00834873|Protective Agents|protective agents|mesh-ancestor
19424294|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424295|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424296|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424297|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
19424298|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19424299|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19424300|NCT00834795|Carvedilol|carvedilol|mesh-list
19424301|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19424302|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19424303|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
19424304|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424305|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424306|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424307|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424308|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
19424309|NCT00834795|Protective Agents|protective agents|mesh-ancestor
19424310|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424311|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424312|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424313|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
19424314|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19424315|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19424316|NCT00834756|Azithromycin|azithromycin|mesh-list
19424317|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424318|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424319|NCT00834743|Metformin|metformin|mesh-list
19424320|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424321|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424322|NCT00834717|Granisetron|granisetron|mesh-list
19424323|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
19424324|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
19424325|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424326|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424327|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19424328|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19424329|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
19424330|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424331|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424332|NCT00834639|Valproic Acid|valproic acid|mesh-list
19424333|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
19424334|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424335|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424336|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
19424337|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424338|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424339|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
19424340|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424341|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424342|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424343|NCT00834613|Metformin|metformin|mesh-list
19424344|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424345|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424346|NCT00834587|Metformin|metformin|mesh-list
19424347|NCT00834587|Glipizide|glipizide|mesh-list
19424348|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424349|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424350|NCT00834574|Cefdinir|cefdinir|mesh-list
19424351|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424352|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424353|NCT00834561|Lamotrigine|lamotrigine|mesh-list
19424354|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
19424355|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424356|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424357|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424358|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424359|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424360|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19424361|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424362|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424363|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424364|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19424365|NCT00834535|Cefdinir|cefdinir|mesh-list
19424366|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424367|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424368|NCT00834522|Granisetron|granisetron|mesh-list
19424369|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
19424370|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
19424371|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424372|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424373|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19424374|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19424375|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
19424376|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424377|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450870|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450871|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450872|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19450873|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450874|NCT03425448|Heparin|heparin|mesh-list
19450875|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
19450876|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19450877|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19450878|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450879|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19450880|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450881|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450882|NCT03425162|Morphine|morphine|mesh-list
19450883|NCT03425162|Bupivacaine|bupivacaine|mesh-list
19450884|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
19450885|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
19450886|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450887|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450888|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
19450889|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710793|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19710794|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19710795|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19710796|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
19710797|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710798|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856851|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856852|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856853|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19856854|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19856855|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
19856856|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856857|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710799|NCT04786574|Tolvaptan|tolvaptan|mesh-list
19710800|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19710801|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710802|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
19710803|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733842|NCT04557943|Protective Agents|protective agents|mesh-ancestor
19733843|NCT04557475|Aspirin|aspirin|mesh-list
19733844|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19733845|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19733846|NCT04557475|Analgesics|analgesics|mesh-ancestor
19733847|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
19733848|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733849|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733850|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733851|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733852|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19424378|NCT00834444|Famciclovir|famciclovir|mesh-list
19424379|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
19424380|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424381|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19424382|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424383|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424384|NCT00834431|Famciclovir|famciclovir|mesh-list
19424385|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
19424386|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424387|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19424388|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424389|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424390|NCT00834418|Leflunomide|leflunomide|mesh-list
19424391|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424392|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424393|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19424394|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
19424395|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424396|NCT00834405|Leflunomide|leflunomide|mesh-list
19424397|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424398|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424399|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19424400|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
19424401|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424402|NCT00834340|Glimepiride|glimepiride|mesh-list
19424403|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19424404|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424405|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424406|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19424407|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
19424408|NCT00834275|Cefadroxil|cefadroxil|mesh-list
19424409|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424410|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424411|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19424412|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19424413|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19424414|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424415|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424416|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424417|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424418|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19424419|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
19424420|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424421|NCT00834197|Mirtazapine|mirtazapine|mesh-list
19424422|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
19424423|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424424|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19424425|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
19424426|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
19424427|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424428|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424429|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424430|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19710804|NCT04786158|Apomorphine|apomorphine|mesh-list
19424431|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424432|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424433|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19424434|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19424435|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19424436|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
19424437|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19424438|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19424439|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
19424440|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19424441|NCT00834132|Azithromycin|azithromycin|mesh-list
19424442|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424443|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424444|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19424445|NCT00834067|Moexipril|moexipril|mesh-list
19424446|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424447|NCT00834067|Diuretics|diuretics|mesh-ancestor
19424448|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
19424449|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424450|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19424451|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424452|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424453|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19424454|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424455|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424456|NCT00833937|Zolpidem|zolpidem|mesh-list
19424457|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19424458|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19424459|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710805|NCT04786158|Emetics|emetics|mesh-ancestor
19710806|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710807|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
19710808|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710809|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710810|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
19710811|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
19710812|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710813|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710814|NCT04786327|Edetic Acid|edetic acid|mesh-list
19710815|NCT04786327|Mitogens|mitogens|mesh-list
19710816|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
19710817|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
19710818|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710819|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
19710820|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19710821|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
19710822|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
19710823|NCT04786327|Antidotes|antidotes|mesh-ancestor
19710824|NCT04786327|Protective Agents|protective agents|mesh-ancestor
19710825|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710826|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19710827|NCT04786470|Ropivacaine|ropivacaine|mesh-list
19710828|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710829|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
19710830|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710831|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710832|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
19710833|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710834|NCT04785716|Niraparib|niraparib|mesh-list
19710835|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19710836|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710837|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710838|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710839|NCT04785755|Etilefrine|etilefrine|mesh-list
19710840|NCT04785755|Furosemide|furosemide|mesh-list
19710841|NCT04785755|Spironolactone|spironolactone|mesh-list
19710842|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19710843|NCT04785755|Diuretics|diuretics|mesh-list
19710844|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
19710845|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710846|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19710847|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710848|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424460|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710849|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19710850|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
19710851|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19710852|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19710853|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19710854|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19710855|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
19710856|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710857|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19710858|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
19710859|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
19710860|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710861|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19710862|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19710863|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19710864|NCT04785755|Protective Agents|protective agents|mesh-ancestor
19710865|NCT04786002|Busulfan|busulfan|mesh-list
19710866|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
19710867|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710868|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19710869|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
19710870|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710871|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19710872|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710873|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19710874|NCT04785911|Antiemetics|antiemetics|mesh-list
19710875|NCT04785911|Histamine|histamine|mesh-list
19710876|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
19710877|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
19710878|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710879|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424461|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19424462|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
19424463|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
19424464|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424465|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424466|NCT00833664|Terbinafine|terbinafine|mesh-list
19424467|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
19424468|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424469|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424470|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424471|NCT00833586|Terbinafine|terbinafine|mesh-list
19424472|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
19424473|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424474|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424475|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424476|NCT00833521|Zolpidem|zolpidem|mesh-list
19424477|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19424478|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19424479|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424480|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424481|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19424482|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
19424483|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
19424484|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424485|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424486|NCT00833495|Prednisolone|prednisolone|mesh-list
19424487|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19424488|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
19424489|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19424490|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
19424491|NCT00833495|Prednisone|prednisone|mesh-list
19424492|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19424493|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
19424494|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19424495|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
19424496|NCT00833495|Hormones|hormones|mesh-ancestor
19424497|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19424498|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424499|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19424500|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424501|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
19424502|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
19424503|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424504|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19424505|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19424506|NCT00833495|Protective Agents|protective agents|mesh-ancestor
19424507|NCT00832507|Cicletanine|cicletanine|mesh-list
19424508|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19424509|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424510|NCT00832507|Diuretics|diuretics|mesh-ancestor
19424511|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
19424512|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424513|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19424514|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19424515|NCT00831051|Morphine|morphine|mesh-list
19424516|NCT00831051|Oxycodone|oxycodone|mesh-list
19424517|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19424518|NCT00831051|Narcotics|narcotics|mesh-ancestor
19424519|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424520|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424521|NCT00831051|Analgesics|analgesics|mesh-ancestor
19424522|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
19424523|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424524|NCT00830336|Azithromycin|azithromycin|mesh-list
19424525|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20249495|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20249496|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249497|NCT00440804|Analgesics|analgesics|mesh-ancestor
20249498|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
20249499|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249500|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249501|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249502|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249503|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249504|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249505|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249506|NCT00440843|Olanzapine|olanzapine|mesh-list
20249507|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
20249508|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
20249509|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249510|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249511|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249512|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20249513|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20249514|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424526|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424527|NCT00830258|Pravastatin|pravastatin|mesh-list
19424528|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19424529|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19424530|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
19424531|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424532|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19424533|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19424534|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424535|NCT00830219|Ropinirole|ropinirole|mesh-list
19424536|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19424537|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19424538|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
19424539|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
19424540|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424541|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424542|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424543|NCT00830206|Azithromycin|azithromycin|mesh-list
19710880|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710881|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
19856858|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19856859|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19856860|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
19856861|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19856862|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
19856863|NCT00761202|Glycerol|glycerol|mesh-list
19856864|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19856865|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
19856866|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856867|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
19856868|NCT00761202|Protective Agents|protective agents|mesh-ancestor
19856869|NCT00761202|Laxatives|laxatives|mesh-ancestor
19856870|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19856871|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19856872|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
19856873|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424544|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424545|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424546|NCT00830102|Fluticasone|fluticasone|mesh-list
19424547|NCT00830102|Xhance|xhance|mesh-list
19710882|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710883|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710884|NCT04785768|Morphine|morphine|mesh-list
19710885|NCT04785768|Hydromorphone|hydromorphone|mesh-list
19710886|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19710887|NCT04785768|Narcotics|narcotics|mesh-ancestor
19710888|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710889|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710890|NCT04785768|Analgesics|analgesics|mesh-ancestor
19710891|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
19710892|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710893|NCT04785547|Blinatumomab|blinatumomab|mesh-list
19710894|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424548|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
19424549|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19424550|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19424551|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
19424552|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424553|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424554|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19424555|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
19424556|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
19424557|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19424558|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19424559|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19424560|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19424561|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
19424562|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424563|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424564|NCT00830024|Alprazolam|alprazolam|mesh-list
19424565|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19424566|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856874|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856875|NCT00761267|Fluconazole|fluconazole|mesh-list
19424567|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424568|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19424569|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424570|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424571|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
19424572|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
19424573|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424574|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424575|NCT00829998|Zaleplon|zaleplon|mesh-list
19424576|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
19424577|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19424578|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424579|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424580|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
19424581|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
19424582|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424583|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710895|NCT04785183|Melatonin|melatonin|mesh-list
19710896|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
19710897|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710898|NCT04785183|Protective Agents|protective agents|mesh-ancestor
19710899|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710900|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710901|NCT04785118|Scopolamine|scopolamine|mesh-list
19710902|NCT04785118|Ondansetron|ondansetron|mesh-list
19710903|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19710904|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
19710905|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
19710906|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710907|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710908|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710909|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
19710910|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
19710911|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19710912|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
19710913|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710914|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710915|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19710916|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19710917|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710918|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19710919|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19710920|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19710921|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
19710922|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19710923|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
19710924|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19710925|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
19710926|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
19710927|NCT04785222|Bupivacaine|bupivacaine|mesh-list
19710928|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
19856876|NCT00761267|Anidulafungin|anidulafungin|mesh-list
19424584|NCT00829868|Zaleplon|zaleplon|mesh-list
19424585|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
19424586|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19856877|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
19424587|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424588|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424589|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
19424590|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
19424591|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424592|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424593|NCT00829790|Doxycycline|doxycycline|mesh-list
19424594|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424595|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424596|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
19424597|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20531451|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
20531452|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531453|NCT01794975|Ketamine|ketamine|mesh-list
20531454|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20531455|NCT01794975|Analgesics|analgesics|mesh-ancestor
20531456|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
20531457|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424598|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19424599|NCT00829764|Doxycycline|doxycycline|mesh-list
19424600|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424601|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531458|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531459|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20531460|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20531461|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
20531462|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
20531463|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531464|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19424602|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
19424603|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19424604|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19424605|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19424606|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19424607|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424608|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19424609|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19424610|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424611|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424612|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
19424613|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424614|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19424615|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19424616|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424617|NCT00829686|Renal Agents|renal agents|mesh-ancestor
19424618|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424619|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
19710929|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
19710930|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710931|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710932|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
19710933|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710934|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19710935|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19710936|NCT04785222|Analgesics|analgesics|mesh-ancestor
19710937|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19710938|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19710939|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19710940|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
19710941|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19710942|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710943|NCT04784988|BAX 855|bax 855|mesh-list
19710944|NCT04784988|Coagulants|coagulants|mesh-ancestor
19710945|NCT04784728|Lidocaine|lidocaine|mesh-list
19710946|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710947|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
19710948|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19710949|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710950|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
19710951|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19710952|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19710953|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19856878|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424620|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19424621|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19424622|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19424623|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19424624|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424625|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19424626|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19424627|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424628|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424629|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
19424630|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424631|NCT00829530|Ramipril|ramipril|mesh-list
19424632|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19424633|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424634|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424635|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424636|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424637|NCT00829504|Ropinirole|ropinirole|mesh-list
19424638|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19424639|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19424640|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
19424641|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
19424642|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424643|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424644|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424645|NCT00829452|Ramipril|ramipril|mesh-list
19424646|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19424647|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424648|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424649|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424650|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424651|NCT00829426|Alprazolam|alprazolam|mesh-list
19424652|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19424653|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424654|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424655|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19424656|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19424657|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424658|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
19424659|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
19424660|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424661|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424662|NCT00829309|Pravastatin|pravastatin|mesh-list
19424663|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19424664|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19424665|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
19424666|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424667|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19424668|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19424669|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424670|NCT00828321|Ramipril|ramipril|mesh-list
19424671|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19424672|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424673|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450890|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19424674|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424675|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19424676|NCT00821977|Vildagliptin|vildagliptin|mesh-list
20531465|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20531466|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531467|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531468|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20531469|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20531470|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531471|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531472|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
20531473|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531474|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
20531475|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
20531476|NCT01795131|Vitamins|vitamins|mesh-ancestor
20531477|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
20531478|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424677|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424678|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424679|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19424680|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
19424681|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424682|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424683|NCT00821249|Dexamethasone|dexamethasone|mesh-list
19424684|NCT00821249|Filanesib|filanesib|mesh-list
19424685|NCT00821249|Lenograstim|lenograstim|mesh-list
19424686|NCT00821249|Sargramostim|sargramostim|mesh-list
19424687|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19424688|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
19424689|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
19424690|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424691|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424692|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19424693|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
19424694|NCT00821249|Hormones|hormones|mesh-ancestor
19424695|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19424696|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19424697|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424698|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19424699|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
19424700|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
19424701|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
19424702|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424703|NCT00821002|Latanoprost|latanoprost|mesh-list
19424704|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19424705|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19424706|NCT00820924|Lapatinib|lapatinib|mesh-list
19424707|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424708|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19424709|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424710|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424711|NCT00820846|Vaccines|vaccines|mesh-list
19424712|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
19424713|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424714|NCT00820300|Latanoprost|latanoprost|mesh-list
19424715|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19710954|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19710955|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19710956|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710957|NCT04784910|Lansoprazole|lansoprazole|mesh-list
19710958|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
19710959|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19710960|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19710961|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19710962|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710963|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710964|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
19710965|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19710966|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
19710967|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733853|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20249515|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19424716|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19424717|NCT00819169|Conatumumab|conatumumab|mesh-list
19424718|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19424719|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424720|NCT00818844|Nepafenac|nepafenac|mesh-list
19424721|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19424722|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19424723|NCT00818844|Analgesics|analgesics|mesh-ancestor
20249516|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20249517|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20249518|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424724|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
20249519|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249520|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249521|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
20249522|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
20249523|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20249524|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
20249525|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249526|NCT00440869|Expectorants|expectorants|mesh-ancestor
20249527|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
20249528|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20249529|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
20249530|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249531|NCT00440869|Protective Agents|protective agents|mesh-ancestor
20249532|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249533|NCT00440869|Antidotes|antidotes|mesh-ancestor
20249534|NCT00440895|Abciximab|abciximab|mesh-list
20249535|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
20249536|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20249537|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19710968|NCT04784481|Ivermectin|ivermectin|mesh-list
19710969|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19710970|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19710971|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19710972|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19710973|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
19710974|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710975|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19710976|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710977|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19710978|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19710979|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
19710980|NCT04784247|Lenvatinib|lenvatinib|mesh-list
19710981|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19710982|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19710983|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19710984|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19710985|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710986|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
19710987|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19710988|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19710989|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19710990|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
19710991|NCT04784039|Coagulants|coagulants|mesh-ancestor
19710992|NCT04784104|Epinephrine|epinephrine|mesh-list
19710993|NCT04784104|Racepinephrine|racepinephrine|mesh-list
19710994|NCT04784104|Bupivacaine|bupivacaine|mesh-list
19710995|NCT04784104|Prilocaine|prilocaine|mesh-list
19710996|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19710997|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
19710998|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
19710999|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
19711000|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711001|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711002|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
19711003|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711004|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19711005|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19711006|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
19711007|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711008|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711009|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19711010|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19711011|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
19711012|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20249538|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
20249539|NCT00440921|Coagulants|coagulants|mesh-ancestor
20249540|NCT00440960|Lidocaine|lidocaine|mesh-list
20249541|NCT00440960|Midazolam|midazolam|mesh-list
20249542|NCT00440960|Alfentanil|alfentanil|mesh-list
19424725|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424726|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424727|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19424728|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19424729|NCT00818571|Vildagliptin|vildagliptin|mesh-list
19424730|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424731|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711013|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
19711014|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
19711015|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
19711016|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19711017|NCT04784000|Carbamazepine|carbamazepine|mesh-list
19711018|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
19711019|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
19424732|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19424733|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
19856879|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19856880|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19856881|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856882|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856883|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19856884|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
19856885|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856886|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856887|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19856888|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19856889|NCT00761280|Temozolomide|temozolomide|mesh-list
19856890|NCT00761280|Carmustine|carmustine|mesh-list
19856891|NCT00761280|Lomustine|lomustine|mesh-list
19856892|NCT00761280|Trabedersen|trabedersen|mesh-list
19856893|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19856894|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
19856895|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856896|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856897|NCT00761306|Vortioxetine|vortioxetine|mesh-list
19856898|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
19856899|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856900|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19856901|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856902|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856903|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856904|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19856905|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19856906|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19856907|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856908|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856909|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
19856910|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19856911|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19856912|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19856913|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19856914|NCT00761319|Travoprost|travoprost|mesh-list
19856915|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20249543|NCT00440960|Propofol|propofol|mesh-list
19424734|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711020|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19711021|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249544|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
19424735|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424736|NCT00818493|Acetaminophen|acetaminophen|mesh-list
19424737|NCT00818493|Morphine|morphine|mesh-list
19424738|NCT00818493|Oxycodone|oxycodone|mesh-list
19424739|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19424740|NCT00818493|Narcotics|narcotics|mesh-ancestor
19424741|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424742|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424743|NCT00818493|Analgesics|analgesics|mesh-ancestor
19424744|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
19424745|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424746|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19424747|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
19424748|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
19424749|NCT00817986|Baclofen|baclofen|mesh-list
19424750|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19424751|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424752|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19424753|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424754|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19424755|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
19424756|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
19424757|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424758|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424759|NCT00817362|Trastuzumab|trastuzumab|mesh-list
19424760|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19424761|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424762|NCT00814372|Metformin|metformin|mesh-list
19424763|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424764|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424765|NCT00814294|Insulin|insulin|mesh-list
19424766|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19424767|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19424768|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424769|NCT00813956|Gemcitabine|gemcitabine|mesh-list
19424770|NCT00813956|Carboplatin|carboplatin|mesh-list
19424771|NCT00813956|Iniparib|iniparib|mesh-list
19424772|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424773|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19424774|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
19424775|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424776|NCT00813956|Antiviral Agents|antiviral agents|mesh-ancestor
19424777|NCT00813956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424778|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424779|NCT00813956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19424780|NCT00813956|Immunologic Factors|immunologic factors|mesh-ancestor
19424781|NCT00813956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424782|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19424783|NCT00813605|Conatumumab|conatumumab|mesh-list
19424784|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19424785|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424786|NCT00813163|Irinotecan|irinotecan|mesh-list
19424787|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19424788|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19424789|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424790|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424791|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424792|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
20249545|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
20249546|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249547|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249548|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
19424793|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424794|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19424795|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424796|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424797|NCT00810732|Nifedipine|nifedipine|mesh-list
19424798|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
19424799|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19424800|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19424801|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424802|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19424803|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424804|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
19424805|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
19424806|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19424807|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19424808|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19424809|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19424810|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
19424811|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424812|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424813|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19424814|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
19424815|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19424816|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19424817|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19424818|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
19424819|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424820|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424821|NCT00807612|Paclitaxel|paclitaxel|mesh-list
19424822|NCT00807612|Carboplatin|carboplatin|mesh-list
19424823|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19424824|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19424825|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424826|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19424827|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
19424828|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19424829|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424830|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
19424831|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424832|NCT00806403|Reteplase|reteplase|mesh-list
19424833|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19424834|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19424835|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424836|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19424837|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
19424838|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
19450891|NCT03425162|Narcotics|narcotics|mesh-ancestor
19711022|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531479|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
20531480|NCT01795131|Hematinics|hematinics|mesh-ancestor
20531481|NCT01795144|Glucagon|glucagon|mesh-list
20531482|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20531483|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531484|NCT01795144|Hormones|hormones|mesh-ancestor
20531485|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531486|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531487|NCT01795144|Incretins|incretins|mesh-ancestor
20531488|NCT01795170|Pyridoxine|pyridoxine|mesh-list
20531489|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
20531490|NCT01795170|Vitamins|vitamins|mesh-ancestor
20531491|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
20531492|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531493|NCT01795183|Amisulpride|amisulpride|mesh-list
20531494|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20531495|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20531496|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424839|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424840|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424841|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19424842|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19424843|NCT00805805|Growth Substances|growth substances|mesh-ancestor
19424844|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424845|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
19424846|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424847|NCT00805350|SR 46349B|sr 46349b|mesh-list
19424848|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19424849|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19424850|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424851|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19424852|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19424853|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
19424854|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424855|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424856|NCT00803114|Morphine|morphine|mesh-list
19424857|NCT00803114|Narcotics|narcotics|mesh-list
19424858|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19424859|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424860|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424861|NCT00803114|Analgesics|analgesics|mesh-ancestor
19424862|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
19424863|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424864|NCT00799292|Vasopressins|vasopressins|mesh-list
19424865|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
19424866|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
19424867|NCT00799292|Coagulants|coagulants|mesh-ancestor
19424868|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19424869|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19424870|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
19424871|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424872|NCT00796289|Citric Acid|citric acid|mesh-list
19424873|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
19424874|NCT00796289|Clomiphene|clomiphene|mesh-list
19424875|NCT00796289|Enclomiphene|enclomiphene|mesh-list
19424876|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
19424877|NCT00796289|Hormones|hormones|mesh-list
19424878|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19424879|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
19424880|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19424881|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
19424882|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
19424883|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424884|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19424885|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424886|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19424887|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
19424888|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19424889|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
19424890|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19424891|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19424892|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19424893|NCT00794677|Ezetimibe|ezetimibe|mesh-list
19424894|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19424895|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19424896|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
19424897|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424898|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19450892|NCT03425162|Analgesics|analgesics|mesh-ancestor
19450893|NCT03425084|Morphine|morphine|mesh-list
19450894|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19450895|NCT03425084|Narcotics|narcotics|mesh-ancestor
19450896|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19424899|NCT00792727|Ketoprofen|ketoprofen|mesh-list
19424900|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19711023|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711024|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19711025|NCT04784000|Analgesics|analgesics|mesh-ancestor
19711026|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
19711027|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711028|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19711029|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711030|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711031|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19711032|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19711033|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
19711034|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19711035|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711036|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711037|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711038|NCT04783935|Cladribine|cladribine|mesh-list
19711039|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711040|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19711041|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
19711042|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711043|NCT04783753|Itraconazole|itraconazole|mesh-list
19711044|NCT04783753|Quinidine|quinidine|mesh-list
19711045|NCT04783753|Carbamazepine|carbamazepine|mesh-list
19711046|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
19711047|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711048|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19711049|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19711050|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711051|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711052|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19711053|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
20249549|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249550|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20249551|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20249552|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20249553|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249554|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249555|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20249556|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20531497|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531498|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20531499|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20531500|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
20531501|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531502|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531503|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20531504|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
20531505|NCT01795209|Ranibizumab|ranibizumab|mesh-list
20531506|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20531507|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20531508|NCT01795209|Growth Substances|growth substances|mesh-ancestor
20531509|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531510|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
20531511|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424901|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19424902|NCT00792727|Analgesics|analgesics|mesh-ancestor
19424903|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
19424904|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424905|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424906|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19424907|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735827|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424908|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19424909|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424910|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424911|NCT00791154|Carboplatin|carboplatin|mesh-list
19424912|NCT00791154|Etoposide|etoposide|mesh-list
19424913|NCT00791154|Rilotumumab|rilotumumab|mesh-list
19424914|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424915|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19424916|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19424917|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19424918|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424919|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424920|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19424921|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
19424922|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19424923|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424924|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711054|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19711055|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711056|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19711057|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
19711058|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
19711059|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19711060|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711061|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711062|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19711063|NCT04783753|Analgesics|analgesics|mesh-ancestor
19711064|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
19711065|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711066|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19711067|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711068|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19711069|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19711070|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19711071|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19711072|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
19711073|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711074|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19711075|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
19711076|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19711077|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19711078|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19711079|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19711080|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
19711081|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19711082|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19711083|NCT04783636|Leuprolide|leuprolide|mesh-list
19711084|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19711085|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
19711086|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19711087|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711088|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19711089|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711090|NCT04783610|Ethanol|ethanol|mesh-list
19711091|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19711092|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711093|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711094|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711095|NCT04783194|Dexamethasone|dexamethasone|mesh-list
19711096|NCT04783194|Bupivacaine|bupivacaine|mesh-list
19711097|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19711098|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
19711099|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
19711100|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711101|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711102|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711103|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
19856916|NCT00761319|Latanoprost|latanoprost|mesh-list
19424925|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424926|NCT00789633|Gemcitabine|gemcitabine|mesh-list
19424927|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19424928|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
19424929|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424930|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424931|NCT00789633|Antiviral Agents|antiviral agents|mesh-ancestor
19424932|NCT00789633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424933|NCT00789633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424934|NCT00789633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19424935|NCT00789633|Immunologic Factors|immunologic factors|mesh-ancestor
19424936|NCT00789633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424937|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
19424938|NCT00788541|Anecortave|anecortave|mesh-list
19424939|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19424940|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19424941|NCT00788541|Growth Substances|growth substances|mesh-ancestor
19424942|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424943|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
19424944|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424945|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19424946|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19424947|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
19424948|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424949|NCT00785226|Sorafenib|sorafenib|mesh-list
19424950|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424951|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19424952|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424953|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424954|NCT00782431|Vaccines|vaccines|mesh-list
19424955|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
19424956|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424957|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19424958|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424959|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19424960|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424961|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424962|NCT00776373|Cytarabine|cytarabine|mesh-list
19424963|NCT00776373|Sirolimus|sirolimus|mesh-list
19424964|NCT00776373|Etoposide|etoposide|mesh-list
19424965|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19424966|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19424967|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19424968|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19424969|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19424970|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424971|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19424972|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
19424973|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
19424974|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19424975|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19424976|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
19424977|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19424978|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19424979|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19424980|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
19424981|NCT00774761|Fluticasone|fluticasone|mesh-list
19424982|NCT00774761|Xhance|xhance|mesh-list
19424983|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
19424984|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19424985|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19424986|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
19424987|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19424988|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856917|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19424989|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19424990|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
19424991|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
19424992|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19424993|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19424994|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19424995|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19424996|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
19424997|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19424998|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19424999|NCT00772785|Buprenorphine|buprenorphine|mesh-list
19425000|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19425001|NCT00772785|Narcotics|narcotics|mesh-ancestor
19425002|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19425003|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425004|NCT00772785|Analgesics|analgesics|mesh-ancestor
19425005|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
19425006|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425007|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19425008|NCT00772343|Vaccines|vaccines|mesh-list
19425009|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
19425010|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425011|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19425012|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
19425013|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19425014|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19425015|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19425016|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19425017|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425018|NCT00770848|Prednisone|prednisone|mesh-list
19425019|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
19425020|NCT00770848|Rilotumumab|rilotumumab|mesh-list
19425021|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19425022|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425023|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
19425024|NCT00770848|Hormones|hormones|mesh-ancestor
19425025|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425026|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425027|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425028|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425029|NCT00770848|Analgesics|analgesics|mesh-ancestor
19425030|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
19425031|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711104|NCT04783194|Hormones|hormones|mesh-ancestor
19711105|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19711106|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19711107|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711108|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711109|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
19711110|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711111|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
19711112|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
19711113|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856918|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19856919|NCT00761345|Gemcitabine|gemcitabine|mesh-list
19856920|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19856921|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19856922|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
19856923|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856924|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856925|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
19856926|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856927|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856928|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19856929|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
19856930|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856931|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19856932|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19425032|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19856933|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
19425033|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19425034|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425035|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425036|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19425037|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
19425038|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19425039|NCT00770081|Vildagliptin|vildagliptin|mesh-list
19425040|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425041|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425042|NCT00770081|Incretins|incretins|mesh-ancestor
19425043|NCT00770081|Hormones|hormones|mesh-ancestor
19425044|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425045|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19425046|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
19425047|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425048|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425049|NCT00769795|Goserelin|goserelin|mesh-list
19425050|NCT00769795|Bicalutamide|bicalutamide|mesh-list
19425051|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425052|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425053|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
19425054|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
19425055|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425056|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425057|NCT00768482|Buprenorphine|buprenorphine|mesh-list
19425058|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19425059|NCT00768482|Narcotics|narcotics|mesh-ancestor
19425060|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711114|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
19711115|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
19711116|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19711117|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
19711118|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19711119|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19711120|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711121|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19711122|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711123|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711124|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19711125|NCT04783051|Renal Agents|renal agents|mesh-ancestor
19711126|NCT04782622|Apatinib|apatinib|mesh-list
19711127|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249557|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
20249558|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20249559|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19856934|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19856935|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19856936|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19856937|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856938|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856939|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425061|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425062|NCT00768482|Analgesics|analgesics|mesh-ancestor
19425063|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
19425064|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425065|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19425066|NCT00765830|Vildagliptin|vildagliptin|mesh-list
19425067|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425068|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425069|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19425070|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
19425071|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425072|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425073|NCT00765804|Dexamethasone|dexamethasone|mesh-list
19425074|NCT00765804|Citric Acid|citric acid|mesh-list
19711128|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20249560|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19425075|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
19425076|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19425077|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19425078|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20249561|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20249562|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
20249563|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
20249564|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249565|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20249566|NCT00440960|Narcotics|narcotics|mesh-ancestor
20249567|NCT00440960|Analgesics|analgesics|mesh-ancestor
20249568|NCT00440973|Bevacizumab|bevacizumab|mesh-list
19425079|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425080|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
19425081|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
19425082|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425083|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425084|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425085|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
19425086|NCT00765804|Hormones|hormones|mesh-ancestor
19425087|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425088|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425089|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425090|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425091|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
19856940|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19856941|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19856942|NCT00761514|Adalimumab|adalimumab|mesh-list
19856943|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19856944|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425092|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19425093|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
19425094|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
19425095|NCT00765700|Ketoprofen|ketoprofen|mesh-list
19425096|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19425097|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19425098|NCT00765700|Analgesics|analgesics|mesh-ancestor
19425099|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
19425100|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425101|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425102|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425103|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19856945|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19425104|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19425105|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425106|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425107|NCT00765323|Octreotide|octreotide|mesh-list
19425108|NCT00765323|Somatostatin|somatostatin|mesh-list
19425109|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425110|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425111|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425112|NCT00765323|Hormones|hormones|mesh-ancestor
19425113|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425114|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425115|NCT00764634|Vaccines|vaccines|mesh-list
19425116|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
19425117|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425118|NCT00763555|Calcitriol|calcitriol|mesh-list
19425119|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20249569|NCT00440973|Interleukin-2|interleukin-2|mesh-list
20249570|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20531512|NCT01795222|Midazolam|midazolam|mesh-list
20531513|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20531514|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20531515|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531516|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531517|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20531518|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20531519|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20531520|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19425120|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425121|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19425122|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425123|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425124|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19425125|NCT00763555|Vitamins|vitamins|mesh-ancestor
19425126|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
19425127|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19425128|NCT00763503|Calcitriol|calcitriol|mesh-list
19425129|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19425130|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425131|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19425132|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425133|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425134|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19425135|NCT00763503|Vitamins|vitamins|mesh-ancestor
19425136|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
19425137|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19425138|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19425139|NCT00761709|Latanoprost|latanoprost|mesh-list
19425140|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19425141|NCT00760539|Timolol|timolol|mesh-list
19425142|NCT00760539|Travoprost|travoprost|mesh-list
19425143|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19425144|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19425145|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19425146|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19425147|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
19425148|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425149|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425150|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425151|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19425152|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19425153|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19425154|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711129|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425155|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425156|NCT00760344|Incretins|incretins|mesh-ancestor
19425157|NCT00760344|Hormones|hormones|mesh-ancestor
19425158|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425159|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19425160|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
19425161|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425162|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425163|NCT00759135|Finasteride|finasteride|mesh-list
19856946|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19856947|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856948|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856949|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856950|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856951|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19856952|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20249571|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249572|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20249573|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20249574|NCT00440973|Growth Substances|growth substances|mesh-ancestor
20249575|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249576|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
20249577|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249578|NCT00440973|Analgesics|analgesics|mesh-ancestor
20249579|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
20249580|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249581|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
20249582|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20249583|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531521|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
20531522|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
20531523|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
20531524|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
20531525|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531526|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531527|NCT01795235|Atenolol|atenolol|mesh-list
20531528|NCT01795235|Glucagon|glucagon|mesh-list
19425164|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19425165|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19425166|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425167|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425168|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
19425169|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425170|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425171|NCT00759135|Urological Agents|urological agents|mesh-ancestor
19425172|NCT00758966|Naltrexone|naltrexone|mesh-list
19425173|NCT00758966|Fluoxetine|fluoxetine|mesh-list
19425174|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19425175|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19425176|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425177|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
19425178|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425179|NCT00758966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19425180|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19425181|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425182|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425183|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425184|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
19425185|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19425186|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
19425187|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856953|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
20249584|NCT00441051|Diclofenac|diclofenac|mesh-list
19425188|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19425189|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19425190|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425191|NCT00758953|Danazol|danazol|mesh-list
19425192|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19425193|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
19425194|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425195|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425196|NCT00758563|Triclosan|triclosan|mesh-list
19425197|NCT00758563|Fluorides|fluorides|mesh-list
19711130|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711131|NCT04782960|Bupivacaine|bupivacaine|mesh-list
19711132|NCT04782960|Anesthetics|anesthetics|mesh-list
19711133|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711134|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711135|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711136|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
19711137|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711138|NCT04782804|Capecitabine|capecitabine|mesh-list
19711139|NCT04782804|Antibodies|antibodies|mesh-list
19711140|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
19711141|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711142|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19711143|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
19711144|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711145|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711146|NCT04782388|Alprazolam|alprazolam|mesh-list
19711147|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19711148|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711149|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711150|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19711151|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19711152|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711153|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
19711154|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
19711155|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711156|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711157|NCT04782076|Dabigatran|dabigatran|mesh-list
19711158|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
19711159|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19711160|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
19711161|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711162|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711163|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
19711164|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19711165|NCT04782089|Antibodies|antibodies|mesh-list
19425198|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
19425199|NCT00758563|Protective Agents|protective agents|mesh-ancestor
19425200|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425201|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19425202|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425203|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19425204|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19711166|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
20553310|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20553311|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20553312|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
20553313|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553314|NCT01928537|ON 01910|on 01910|mesh-list
20553315|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553316|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553317|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553318|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553319|NCT01928563|Udenafil|udenafil|mesh-list
19425205|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
19425206|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425207|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19425208|NCT00758290|Triclosan|triclosan|mesh-list
19425209|NCT00758290|Fluorides|fluorides|mesh-list
19425210|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
19425211|NCT00758290|Protective Agents|protective agents|mesh-ancestor
19425212|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425213|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19425214|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425215|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19425216|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19425217|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
19425218|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425219|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19425220|NCT00755287|Metformin|metformin|mesh-list
19425221|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
19425222|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19425223|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425224|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425225|NCT00755287|Incretins|incretins|mesh-ancestor
19425226|NCT00755287|Hormones|hormones|mesh-ancestor
19425227|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531529|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20531530|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531531|NCT01795235|Hormones|hormones|mesh-ancestor
20531532|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531533|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531534|NCT01795235|Incretins|incretins|mesh-ancestor
20531535|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20531536|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20531537|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
20531538|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
20531539|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531540|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19425228|NCT00754988|Metformin|metformin|mesh-list
20531541|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20249585|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20249586|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249587|NCT00441051|Analgesics|analgesics|mesh-ancestor
20249588|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
20249589|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249590|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249591|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249592|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249593|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20531542|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20531543|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531544|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531545|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531546|NCT01795248|Liraglutide|liraglutide|mesh-list
20531547|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531548|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531549|NCT01795248|Incretins|incretins|mesh-ancestor
20531550|NCT01795248|Hormones|hormones|mesh-ancestor
19425229|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19425230|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19425231|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425232|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425233|NCT00754988|Incretins|incretins|mesh-ancestor
19425234|NCT00754988|Hormones|hormones|mesh-ancestor
19425235|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425236|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19425237|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
19425238|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425239|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425240|NCT00754221|Reboxetine|reboxetine|mesh-list
19425241|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
19425242|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20249594|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425243|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19425244|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19425245|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425246|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425247|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
19425248|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425249|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425250|NCT00752570|Trebananib|trebananib|mesh-list
19425251|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19425252|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19425253|NCT00752570|Growth Substances|growth substances|mesh-ancestor
19425254|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425255|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
19425256|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425257|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
19425258|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19425259|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19425260|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19425261|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425262|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425263|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
19425264|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425265|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425266|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19425267|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425268|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
19425269|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19425270|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19425271|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19711167|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711168|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711169|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711170|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711171|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
19711172|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19711173|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711174|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711175|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733854|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733855|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19733856|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19733857|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733858|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
19733859|NCT04557397|Itraconazole|itraconazole|mesh-list
19733860|NCT04557397|Rifampin|rifampin|mesh-list
19733861|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
19733862|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733863|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19733864|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19733865|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733866|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733867|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19733868|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
19733869|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733870|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733871|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19733872|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19733873|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
19733874|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19733875|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
19856954|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425272|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19856955|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856956|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19856957|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19856958|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
19856959|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
19425273|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425274|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
19425275|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425276|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425277|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19425278|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425279|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
19425280|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19425281|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19425282|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19425283|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425284|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425285|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
19425286|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425287|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425288|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19425289|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425290|NCT00751803|Eletriptan|eletriptan|mesh-list
19425291|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19425292|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
19425293|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425294|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425295|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425296|NCT00751231|Clopidogrel|clopidogrel|mesh-list
19425297|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19425298|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19425299|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19425300|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19425301|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
19425302|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425303|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425304|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856960|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19856961|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19856962|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20531551|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531552|NCT01795287|Anesthetics|anesthetics|mesh-list
20531553|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20531554|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531555|NCT01795313|Imiquimod|imiquimod|mesh-list
20531556|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20531557|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
20531558|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531559|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531560|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
20553320|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19425305|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
19425306|NCT00750633|Dexamethasone|dexamethasone|mesh-list
19425307|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19425308|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19425309|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425310|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
19425311|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
19425312|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425313|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425314|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425315|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
19425316|NCT00750633|Hormones|hormones|mesh-ancestor
19425317|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425318|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425319|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425320|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19425321|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425322|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19425323|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19425324|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425325|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425326|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
19425327|NCT00750295|Hematinics|hematinics|mesh-ancestor
19425328|NCT00750243|Naproxen|naproxen|mesh-list
19425329|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19425330|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19425331|NCT00750243|Analgesics|analgesics|mesh-ancestor
19425332|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
19425333|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425334|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425335|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425336|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425337|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
19425338|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19425339|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425340|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425341|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
19425342|NCT00749632|Oxybutynin|oxybutynin|mesh-list
19425343|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
19425344|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
19425345|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711176|NCT04782258|Tolvaptan|tolvaptan|mesh-list
19711177|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19425346|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425347|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19425348|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19425349|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
19425350|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711178|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711179|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
19711180|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711181|NCT04782310|Pregabalin|pregabalin|mesh-list
19711182|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19711183|NCT04782310|Analgesics|analgesics|mesh-ancestor
19711184|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
19711185|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711186|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711187|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
19711188|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19711189|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711190|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711191|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19711192|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19711193|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19711194|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711195|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711196|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19711197|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19711198|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711199|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
19711200|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
19711201|NCT04781998|Liraglutide|liraglutide|mesh-list
19711202|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711203|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711204|NCT04781998|Incretins|incretins|mesh-ancestor
19711205|NCT04781998|Hormones|hormones|mesh-ancestor
19711206|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19856963|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531561|NCT01795430|Etoposide|etoposide|mesh-list
19425351|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425352|NCT00749632|Urological Agents|urological agents|mesh-ancestor
19425353|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19425354|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425355|NCT00749632|Renal Agents|renal agents|mesh-ancestor
19711207|NCT04781803|Cyclosporine|cyclosporine|mesh-list
19711208|NCT04781803|Cyclosporins|cyclosporins|mesh-list
19711209|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19856964|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531562|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
19425356|NCT00747318|Fluticasone|fluticasone|mesh-list
19425357|NCT00747318|Xhance|xhance|mesh-list
19425358|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
19425359|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425360|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19425361|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
19425362|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531563|NCT01795430|Melphalan|melphalan|mesh-list
20531564|NCT01795430|Busulfan|busulfan|mesh-list
20531565|NCT01795430|Topotecan|topotecan|mesh-list
20531566|NCT01795430|Ifosfamide|ifosfamide|mesh-list
20531567|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20531568|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531569|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20531570|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20531571|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531572|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531573|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20531574|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
20531575|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20531576|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531577|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
20531578|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531579|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20531580|NCT01795599|Mifepristone|mifepristone|mesh-list
20531581|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20531582|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
20531583|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19425363|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425364|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19425365|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
19425366|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
19425367|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19425368|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19425369|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19425370|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20249595|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249596|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
20249597|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249598|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20249599|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249600|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249601|NCT00441181|Travoprost|travoprost|mesh-list
20249602|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20249603|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
20249604|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
19425371|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
19425372|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425373|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425374|NCT00745316|Adenosine|adenosine|mesh-list
19425375|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
19425376|NCT00745316|Analgesics|analgesics|mesh-ancestor
19425377|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
19425378|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425379|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425380|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19425381|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
19425382|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19425383|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
19425384|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
19425385|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425386|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425387|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19425388|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19425389|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19425390|NCT00744926|Incretins|incretins|mesh-ancestor
19425391|NCT00744926|Hormones|hormones|mesh-ancestor
19425392|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425393|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425394|NCT00744367|Metformin|metformin|mesh-list
19425395|NCT00744367|Pioglitazone|pioglitazone|mesh-list
19425396|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19425397|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425398|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425399|NCT00744367|Incretins|incretins|mesh-ancestor
19425400|NCT00744367|Hormones|hormones|mesh-ancestor
19425401|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425402|NCT00744276|Danazol|danazol|mesh-list
19425403|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19425404|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
19425405|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425406|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425407|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19425408|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425409|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20249605|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425410|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425411|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425412|NCT00743925|Atorvastatin|atorvastatin|mesh-list
19425413|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
19425414|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19425415|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19425416|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
19425417|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425418|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19425419|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19425420|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425421|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19450897|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450898|NCT03425084|Analgesics|analgesics|mesh-ancestor
19450899|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
19450900|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450901|NCT03424928|Thalidomide|thalidomide|mesh-list
19450902|NCT03424928|Pomalidomide|pomalidomide|mesh-list
19450903|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
19450904|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450905|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19450906|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19450907|NCT03424928|Growth Substances|growth substances|mesh-ancestor
19450908|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
19450909|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450910|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19711210|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711211|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19711212|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
19711213|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711214|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
19711215|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711216|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
19711217|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711218|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19856965|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
19856966|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19856967|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856968|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19856969|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19856970|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19856971|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19856972|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19856973|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19856974|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19856975|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19856976|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19856977|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19450911|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
19450912|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19450913|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711219|NCT04781959|Lenograstim|lenograstim|mesh-list
19711220|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19711221|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
19856978|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
19856979|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450914|NCT03424889|Xylometazoline|xylometazoline|mesh-list
19450915|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
19450916|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19450917|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
19450918|NCT03424876|Sunitinib|sunitinib|mesh-list
19450919|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
19450920|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711222|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711223|NCT04781686|Docetaxel|docetaxel|mesh-list
19450921|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19425422|NCT00743795|Ribavirin|ribavirin|mesh-list
19425423|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19711224|NCT04781686|Apatinib|apatinib|mesh-list
19711225|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19856980|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856981|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19856982|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19856983|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
19856984|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20249606|NCT00441207|Protective Agents|protective agents|mesh-ancestor
20249607|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425424|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
19711226|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
19711227|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
19711228|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
19711229|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711230|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19711231|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711232|NCT04781777|Insulin|insulin|mesh-list
19711233|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711234|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711235|NCT04781751|Insulin|insulin|mesh-list
19711236|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711237|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711238|NCT04781270|Bevacizumab|bevacizumab|mesh-list
19711239|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19711240|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711241|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19711242|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19711243|NCT04781270|Growth Substances|growth substances|mesh-ancestor
19711244|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711245|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
19711246|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19711247|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711248|NCT04781075|Bupivacaine|bupivacaine|mesh-list
19711249|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711250|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
19711251|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711252|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711253|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
19711254|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711255|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
19711256|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19711257|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425425|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425426|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
19425427|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425428|NCT00743002|Metformin|metformin|mesh-list
19425429|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425430|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425431|NCT00741715|Atorvastatin|atorvastatin|mesh-list
19425432|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19425433|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19856985|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
19856986|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969604|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969605|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969606|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969607|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19969608|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19969609|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19969610|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19969611|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19969612|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19969613|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19969614|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19969615|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
19969616|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
19969617|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
19969618|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
19969619|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969620|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969621|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
19969622|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19969623|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19969624|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969625|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969626|NCT01774305|Analgesics|analgesics|mesh-ancestor
19969627|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
19969628|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249608|NCT00441207|Vitamins|vitamins|mesh-ancestor
19425434|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
19425435|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425436|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19425437|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19425438|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425439|NCT00739349|Cyclosporine|cyclosporine|mesh-list
19425440|NCT00739349|Cyclosporins|cyclosporins|mesh-list
19425441|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425442|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425443|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19425444|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
19425445|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425446|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
19425447|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425448|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
19425449|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425450|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19425451|NCT00738582|Pemetrexed|pemetrexed|mesh-list
19425452|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425453|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425454|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425455|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19425456|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19425457|NCT00738387|Docetaxel|docetaxel|mesh-list
19425458|NCT00738387|Vadimezan|vadimezan|mesh-list
19425459|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425460|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
19425461|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
19425462|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
19425463|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425464|NCT00734461|Naltrexone|naltrexone|mesh-list
19425465|NCT00734461|Oxycodone|oxycodone|mesh-list
19425466|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19425467|NCT00734461|Narcotics|narcotics|mesh-ancestor
19425468|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19425469|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425470|NCT00734461|Analgesics|analgesics|mesh-ancestor
19425471|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
19425472|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425473|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19425474|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20249609|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
20249610|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
20249611|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
20249612|NCT00441246|Ephedrine|ephedrine|mesh-list
20249613|NCT00441246|Guaifenesin|guaifenesin|mesh-list
20249614|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
20249615|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20249616|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
20249617|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249618|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249619|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20249620|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
20531584|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531585|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20531586|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20531587|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20531588|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
19425475|NCT00734435|Zonisamide|zonisamide|mesh-list
19425476|NCT00734435|Olanzapine|olanzapine|mesh-list
19425477|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
19425478|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
19425479|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425480|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425481|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425482|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19425483|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19425484|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19425485|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19425486|NCT00734435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19425487|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19425488|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425489|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425490|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425491|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
19425492|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
19425493|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19425494|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19425495|NCT00734292|Fluticasone|fluticasone|mesh-list
19425496|NCT00734292|Xhance|xhance|mesh-list
19425497|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
19425498|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425499|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19425500|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
19425501|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425502|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425503|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19425504|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
19425505|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
19425506|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19425507|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19425508|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19425509|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19425510|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
19425511|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425512|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425513|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
19425514|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
19425515|NCT00734253|Vitamins|vitamins|mesh-ancestor
19425516|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
19425517|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425518|NCT00730665|Esomeprazole|esomeprazole|mesh-list
19425519|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19425520|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425521|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19425522|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425523|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425524|NCT00728351|Metformin|metformin|mesh-list
20249621|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
20249622|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20531589|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20531590|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20531591|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
19425525|NCT00728351|Vildagliptin|vildagliptin|mesh-list
19425526|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425527|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425528|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19425529|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
19425530|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425531|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425532|NCT00728091|Satavaptan|satavaptan|mesh-list
19425533|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19425534|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425535|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
19425536|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425537|NCT00726336|Tenofovir|tenofovir|mesh-list
19425538|NCT00726336|Dolutegravir|dolutegravir|mesh-list
19425539|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
19425540|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425541|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19425542|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19425543|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425544|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425545|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19425546|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19425547|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19425548|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19425549|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
19425550|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
19425551|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425552|NCT00725881|Protective Agents|protective agents|mesh-ancestor
20249623|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20249624|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
20249625|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
20249626|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249627|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249628|NCT00441246|Expectorants|expectorants|mesh-ancestor
20531592|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425553|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425554|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19425555|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425556|NCT00724841|Temozolomide|temozolomide|mesh-list
19425557|NCT00724841|Obatoclax|obatoclax|mesh-list
19425558|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19425559|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
19425560|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425561|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425562|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425563|NCT00724698|Desloratadine|desloratadine|mesh-list
19425564|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19425565|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
19425566|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425567|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425568|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425569|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19425570|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19425571|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
19425572|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
19425573|NCT00722917|Pioglitazone|pioglitazone|mesh-list
19425574|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425575|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425576|NCT00722592|Doxorubicin|doxorubicin|mesh-list
19425577|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19425578|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19425579|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425580|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19425581|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19425582|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249629|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20249630|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20249631|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
20531593|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
20531594|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20531595|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20531596|NCT01795664|Fluticasone|fluticasone|mesh-list
19425583|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425584|NCT00722358|Asunaprevir|asunaprevir|mesh-list
19425585|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
19425586|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425587|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425588|NCT00721760|Enoxaparin|enoxaparin|mesh-list
19425589|NCT00721760|Semuloparin|semuloparin|mesh-list
19425590|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
19425591|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
19425592|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19425593|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19425594|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425595|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19425596|NCT00721695|Mydriatics|mydriatics|mesh-list
19425597|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
19425598|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425599|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425600|NCT00719550|Capecitabine|capecitabine|mesh-list
19425601|NCT00719550|Epirubicin|epirubicin|mesh-list
19425602|NCT00719550|Rilotumumab|rilotumumab|mesh-list
19425603|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425604|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19425605|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
19425606|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425607|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19425608|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19425609|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19425610|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425611|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19425612|NCT00718224|Enoxaparin|enoxaparin|mesh-list
19425613|NCT00718224|Semuloparin|semuloparin|mesh-list
19425614|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
19425615|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19425616|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19425617|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425618|NCT00717457|Exenatide|exenatide|mesh-list
19425619|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19425620|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425621|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425622|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19425623|NCT00717457|Incretins|incretins|mesh-ancestor
19425624|NCT00717457|Hormones|hormones|mesh-ancestor
19425625|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425626|NCT00716534|Paclitaxel|paclitaxel|mesh-list
19425627|NCT00716534|Carboplatin|carboplatin|mesh-list
19425628|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19425629|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425630|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
19425631|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
19425632|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
19425633|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425634|NCT00714597|Enoxaparin|enoxaparin|mesh-list
19425635|NCT00714597|Semuloparin|semuloparin|mesh-list
19425636|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
19425637|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
19425638|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19425639|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19425640|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425641|NCT00713518|Ranibizumab|ranibizumab|mesh-list
19425642|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19425643|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19425644|NCT00713518|Growth Substances|growth substances|mesh-ancestor
19425645|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425646|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
19425647|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711258|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
19711259|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19711260|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19711261|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711262|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19711263|NCT04780867|Vaccines|vaccines|mesh-list
19711264|NCT04780867|Immunologic Factors|immunologic factors|mesh-ancestor
19711265|NCT04780867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711266|NCT04780945|Olaparib|olaparib|mesh-list
19711267|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19711268|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711269|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711270|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711271|NCT04780659|Vaccines|vaccines|mesh-list
19711272|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
19711273|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711274|NCT04780750|Docetaxel|docetaxel|mesh-list
20249632|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20249633|NCT00441298|Tenofovir|tenofovir|mesh-list
20249634|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
20249635|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249636|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20249637|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20249638|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249639|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249640|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20249641|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20286533|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20286534|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20286535|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20531597|NCT01795664|Xhance|xhance|mesh-list
20531598|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20531599|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20531600|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425648|NCT00713401|Esmolol|esmolol|mesh-list
19425649|NCT00713401|Tecadenoson|tecadenoson|mesh-list
19425650|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19425651|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19425652|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19425653|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
19425654|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425655|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425656|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425657|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19425658|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
19425659|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
19425660|NCT00712699|Adderall|adderall|mesh-list
19425661|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19425662|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425663|NCT00711555|Dexamethasone|dexamethasone|mesh-list
19711275|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286536|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425664|NCT00711555|Ondansetron|ondansetron|mesh-list
20286537|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286538|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
20286539|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286540|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286541|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20286542|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286543|NCT03245892|Paclitaxel|paclitaxel|mesh-list
19425665|NCT00711555|Aprepitant|aprepitant|mesh-list
20531601|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20531602|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
20531603|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531604|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531605|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20531606|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
20531607|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
20531608|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20531609|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19425666|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425667|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
19425668|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
19425669|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425670|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425671|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425672|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
19425673|NCT00711555|Hormones|hormones|mesh-ancestor
19425674|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425675|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425676|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425677|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
19425678|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
19425679|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19425680|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
19425681|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425682|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425683|NCT00711555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19425684|NCT00711555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19425685|NCT00711555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19425686|NCT00711555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19425687|NCT00711555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19425688|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19425689|NCT00710580|Etanercept|etanercept|mesh-list
19425690|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19425691|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19425692|NCT00710580|Analgesics|analgesics|mesh-ancestor
19425693|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
19425694|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425695|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425696|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425697|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425698|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425699|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19425700|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
19425701|NCT00709904|Semuloparin|semuloparin|mesh-list
19425702|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19425703|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19425704|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19425705|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425706|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
19425707|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
19425708|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
19425709|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19425710|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19425711|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
19425712|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425713|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425714|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425715|NCT00709371|Zonisamide|zonisamide|mesh-list
19425716|NCT00709371|Bupropion|bupropion|mesh-list
19425717|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19425718|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
19425719|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19425720|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19425721|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19425722|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425723|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425724|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
19425725|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425726|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425727|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19425728|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19425729|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425730|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
19425731|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19425732|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19425733|NCT00708292|Dexamethasone|dexamethasone|mesh-list
19425734|NCT00708292|Bortezomib|bortezomib|mesh-list
19425735|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425736|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
19425737|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
19425738|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425739|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425740|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425741|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
19711276|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
19711277|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
19711278|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19711279|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711280|NCT04780854|Metformin|metformin|mesh-list
19711281|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711282|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711283|NCT04780581|Dexamethasone|dexamethasone|mesh-list
19711284|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
19711285|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20249642|NCT00441415|Adapalene|adapalene|mesh-list
19856987|NCT00761735|Ribavirin|ribavirin|mesh-list
19856988|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19856989|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
19856990|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19856991|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
19856992|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249643|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19856993|NCT00761774|Brivaracetam|brivaracetam|mesh-list
20249644|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249645|NCT00441415|Analgesics|analgesics|mesh-ancestor
20249646|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
20249647|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425742|NCT00708292|Hormones|hormones|mesh-ancestor
19425743|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425744|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425745|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425746|NCT00707889|Leucovorin|leucovorin|mesh-list
19856994|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
19856995|NCT00761891|Aspirin|aspirin|mesh-list
19856996|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19856997|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19856998|NCT00761891|Analgesics|analgesics|mesh-ancestor
19856999|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
19857000|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857001|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425747|NCT00707889|Folic Acid|folic acid|mesh-list
19425748|NCT00707889|Bevacizumab|bevacizumab|mesh-list
19425749|NCT00707889|Fluorouracil|fluorouracil|mesh-list
19425750|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
19425751|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
19425752|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19425753|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425754|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19425755|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19425756|NCT00707889|Growth Substances|growth substances|mesh-ancestor
19425757|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425758|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19425759|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
19425760|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711286|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19711287|NCT04780581|Prednisolone|prednisolone|mesh-list
19711288|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
19711289|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19711290|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
19711291|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19711292|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
19711293|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
19711294|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711295|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711296|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711297|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
19711298|NCT04780581|Hormones|hormones|mesh-ancestor
19711299|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19711300|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19711301|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711302|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19711303|NCT04780581|Protective Agents|protective agents|mesh-ancestor
19711304|NCT04780958|Vitamin A|vitamin a|mesh-list
19711305|NCT04780958|Vitamins|vitamins|mesh-ancestor
19711306|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
19711307|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711308|NCT04780568|Osimertinib|osimertinib|mesh-list
19711309|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711310|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19711311|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711312|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711313|NCT04780984|Bromides|bromides|mesh-list
19711314|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
20249648|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425761|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19711315|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19711316|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
19857002|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425762|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19425763|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
19425764|NCT00707889|Antidotes|antidotes|mesh-ancestor
19425765|NCT00707889|Protective Agents|protective agents|mesh-ancestor
19425766|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
19425767|NCT00707889|Vitamins|vitamins|mesh-ancestor
19425768|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
19425769|NCT00707889|Hematinics|hematinics|mesh-ancestor
19425770|NCT00707304|Lactoferrin|lactoferrin|mesh-list
19425771|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
19425772|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425773|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425774|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
19425775|NCT00704483|Sevelamer|sevelamer|mesh-list
19425776|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
19425777|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
19425778|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425779|NCT00704483|Hematinics|hematinics|mesh-ancestor
19711317|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711318|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711319|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19711320|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
19711321|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
19711322|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19711323|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
19711324|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711325|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711326|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
19711327|NCT04780412|Alprostadil|alprostadil|mesh-list
19711328|NCT04780412|Misoprostol|misoprostol|mesh-list
19711329|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19711330|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
19711331|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19711332|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711333|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19711334|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711335|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
19425780|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
19425781|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19425782|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425783|NCT00701883|Atorvastatin|atorvastatin|mesh-list
19711336|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19425784|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19425785|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19425786|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
19425787|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425788|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19425789|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19425790|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531610|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20531611|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20531612|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531613|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531614|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531615|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
20531616|NCT01795664|Hormones|hormones|mesh-ancestor
19425791|NCT00698789|Metformin|metformin|mesh-list
19425792|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425793|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425794|NCT00698230|Metformin|metformin|mesh-list
19425795|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425796|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425797|NCT00697099|Enoxaparin|enoxaparin|mesh-list
19425798|NCT00697099|Semuloparin|semuloparin|mesh-list
19425799|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
19425800|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
19425801|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19425802|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19425803|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425804|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
19425805|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19425806|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19425807|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425808|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425809|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425810|NCT00694928|Clindamycin|clindamycin|mesh-list
19425811|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
19425812|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
19425813|NCT00694928|Butoconazole|butoconazole|mesh-list
19425814|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19425815|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425816|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19425817|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857003|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857004|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19857005|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19857006|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857007|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19857008|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19857009|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857010|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
19425818|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425819|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
19857011|NCT00761930|Listerine|listerine|mesh-list
19425820|NCT00694382|Semuloparin|semuloparin|mesh-list
19425821|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19425822|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19425823|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19425824|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425825|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
19425826|NCT00694135|Dexamethasone|dexamethasone|mesh-list
19425827|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
19425828|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19425829|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19425830|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19425831|NCT00694135|BB 1101|bb 1101|mesh-list
19857012|NCT00761930|Triclosan|triclosan|mesh-list
20553321|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19425832|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425833|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
19425834|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
19425835|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425836|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425837|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425838|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
19425839|NCT00694135|Hormones|hormones|mesh-ancestor
19425840|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425841|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19425842|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425843|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
19425844|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425845|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425846|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
19425847|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19425848|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
20249649|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249650|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249651|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
20249652|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
20249653|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20249654|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20249655|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
20249656|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425849|NCT00692484|Povidone|povidone|mesh-list
19425850|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19425851|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425852|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
19425853|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
19425854|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
19425855|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
19425856|NCT00692445|Mecamylamine|mecamylamine|mesh-list
19425857|NCT00692445|Dexetimide|dexetimide|mesh-list
19425858|NCT00692445|Citalopram|citalopram|mesh-list
19425859|NCT00692445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19425860|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19425861|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19425862|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425863|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425864|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
19425865|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425866|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19425867|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
19425868|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20249657|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249658|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249659|NCT00441428|Urological Agents|urological agents|mesh-ancestor
20249660|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20249661|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249662|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249663|NCT00441519|Aspirin|aspirin|mesh-list
20249664|NCT00441519|Omeprazole|omeprazole|mesh-list
20249665|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19425869|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19425870|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19425871|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
19425872|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
19425873|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425874|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19425875|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19425876|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
19425877|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19425878|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19425879|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19425880|NCT00691964|Etanercept|etanercept|mesh-list
19425881|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19425882|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19425883|NCT00691964|Analgesics|analgesics|mesh-ancestor
19425884|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
19425885|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425886|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425887|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425888|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425889|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19425890|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19425891|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
19425892|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
19425893|NCT00691717|Anecortave|anecortave|mesh-list
19425894|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19425895|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19425896|NCT00691717|Growth Substances|growth substances|mesh-ancestor
19425897|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425898|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
19425899|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425900|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425901|NCT00690456|Metformin|metformin|mesh-list
19425902|NCT00690456|Rimonabant|rimonabant|mesh-list
19425903|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19425904|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425905|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19425906|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19425907|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19425908|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19425909|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425910|NCT00690456|Hormones|hormones|mesh-ancestor
19425911|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19425912|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
19425913|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425914|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
19425915|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19425916|NCT00687882|Anticoagulants|anticoagulants|mesh-list
19425917|NCT00687687|Paclitaxel|paclitaxel|mesh-list
19425918|NCT00687687|Carboplatin|carboplatin|mesh-list
19425919|NCT00687687|Iniparib|iniparib|mesh-list
19425920|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19711337|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
19711338|NCT04780412|Urological Agents|urological agents|mesh-ancestor
19711339|NCT04780347|Paclitaxel|paclitaxel|mesh-list
19711340|NCT04780347|Capecitabine|capecitabine|mesh-list
19711341|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19425921|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711342|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19711343|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425922|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
19425923|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
19425924|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
19425925|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425926|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19425927|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425928|NCT00684918|Obatoclax|obatoclax|mesh-list
19425929|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425930|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450922|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19450923|NCT03424876|Growth Substances|growth substances|mesh-ancestor
19450924|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450925|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
19450926|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19711344|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
19711345|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
19711346|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
19711347|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711348|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19711349|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
19711350|NCT04780269|Dinoprostone|dinoprostone|mesh-list
19711351|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
19711352|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19711353|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711354|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
19711355|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19711356|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711357|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711358|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733876|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19733877|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19857013|NCT00761930|Fluorides|fluorides|mesh-list
19857014|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
19857015|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857016|NCT00761930|Protective Agents|protective agents|mesh-ancestor
19857017|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857018|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857019|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857020|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857021|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857022|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
19857023|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857024|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20249666|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249667|NCT00441519|Analgesics|analgesics|mesh-ancestor
20531617|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531618|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
20531619|NCT01795703|Prednisolone|prednisolone|mesh-list
20531620|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20531621|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
20531622|NCT01795703|Hormones|hormones|mesh-ancestor
20531623|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531624|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531625|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20531626|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531627|NCT01795794|Omeprazole|omeprazole|mesh-list
19450927|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450928|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450929|NCT03424759|Osimertinib|osimertinib|mesh-list
19450930|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450931|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19450932|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450933|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450934|NCT03424746|Edetic Acid|edetic acid|mesh-list
19450935|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
19450936|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
19450937|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19425931|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
19425932|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425933|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
19425934|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711359|NCT04780217|Pembrolizumab|pembrolizumab|mesh-list
19711360|NCT04780217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19711361|NCT04780217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711362|NCT04779853|Antibodies|antibodies|mesh-list
19711363|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
19711364|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711365|NCT04779892|Infliximab|infliximab|mesh-list
19711366|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
19711367|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249668|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
20249669|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249670|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249671|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249672|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249673|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20249674|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20249675|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249676|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20249677|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249678|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249679|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
19425935|NCT00682981|Carboplatin|carboplatin|mesh-list
19425936|NCT00682981|Etoposide|etoposide|mesh-list
19425937|NCT00682981|Obatoclax|obatoclax|mesh-list
19425938|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425939|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19425940|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19425941|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19425942|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425943|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425944|NCT00680784|Ketoprofen|ketoprofen|mesh-list
19425945|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19425946|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19425947|NCT00680784|Analgesics|analgesics|mesh-ancestor
19425948|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
19425949|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425950|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425951|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425952|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425953|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19425954|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425955|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425956|NCT00680472|Ketoprofen|ketoprofen|mesh-list
19425957|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19425958|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19425959|NCT00680472|Analgesics|analgesics|mesh-ancestor
19425960|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
19425961|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19425962|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425963|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19425964|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425965|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19425966|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425967|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425968|NCT00680342|Silymarin|silymarin|mesh-list
19425969|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
19425970|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425971|NCT00680342|Protective Agents|protective agents|mesh-ancestor
19425972|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425973|NCT00679731|Methotrexate|methotrexate|mesh-list
19425974|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19425975|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
19425976|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19425977|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19425978|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19425979|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
19425980|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425981|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425982|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
20249680|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20249681|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249682|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20249683|NCT00441532|Lidocaine|lidocaine|mesh-list
19425983|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19425984|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19425985|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19425986|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
19425987|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19425988|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19425989|NCT00679588|Enoxaparin|enoxaparin|mesh-list
19425990|NCT00679588|Semuloparin|semuloparin|mesh-list
19425991|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
19425992|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
19425993|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19425994|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19425995|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19425996|NCT00678119|Sunitinib|sunitinib|mesh-list
19425997|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19425998|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19425999|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19426000|NCT00678119|Growth Substances|growth substances|mesh-ancestor
19426001|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426002|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
19426003|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19426004|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426005|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426006|NCT00677079|Iniparib|iniparib|mesh-list
19426007|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19426008|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426009|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426010|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426011|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
20249684|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
20249685|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
20249686|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249687|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249688|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
20249689|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249690|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20286544|NCT03245892|Carboplatin|carboplatin|mesh-list
19426012|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19426013|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
19426014|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19426015|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426016|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426017|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426018|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
19426019|NCT00676832|Prednisolone|prednisolone|mesh-list
19426020|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19426021|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
19426022|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19426023|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
19426024|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19426025|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
19426026|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19426027|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
19426028|NCT00676832|Hormones|hormones|mesh-ancestor
19426029|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426030|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426031|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19426032|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426033|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
19426034|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
19426035|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426036|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19426037|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19426038|NCT00676832|Protective Agents|protective agents|mesh-ancestor
19426039|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
19426040|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19426041|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19426042|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426043|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426044|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
19426045|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426046|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19426047|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19426048|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19426049|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
19426050|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426051|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426052|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249691|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20249692|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20249693|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249694|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249695|NCT00441597|Atorvastatin|atorvastatin|mesh-list
20249696|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20249697|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19426053|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
19426054|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19426055|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426056|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
19426057|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426058|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426059|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426060|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426061|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
19426062|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19426063|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
19711368|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711369|NCT04780152|Fluoxetine|fluoxetine|mesh-list
19711370|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
19711371|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19426064|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426065|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426066|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19426067|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426068|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19426069|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426070|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
19426071|NCT00673062|Ephedrine|ephedrine|mesh-list
19426072|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426073|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
20249698|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
20249699|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249700|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20249701|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20249702|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249703|NCT00441649|Methylphenidate|methylphenidate|mesh-list
20249704|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20249705|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249706|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20249707|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20249708|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249709|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249710|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
20249711|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249712|NCT00441662|Triamcinolone|triamcinolone|mesh-list
20531628|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20531629|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19426074|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426075|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426076|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426077|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426078|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
19426079|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19426080|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19426081|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
19426082|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426083|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426084|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426085|NCT00672997|Timolol|timolol|mesh-list
19426086|NCT00672997|Travoprost|travoprost|mesh-list
19711372|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19711373|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531630|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20531631|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531632|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531633|NCT01795820|Ticagrelor|ticagrelor|mesh-list
20531634|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20531635|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20553322|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426087|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19426088|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19426089|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19426090|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19426091|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426092|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426093|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426094|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426095|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19426096|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19426097|NCT00672412|Lamivudine|lamivudine|mesh-list
19426098|NCT00672412|Zidovudine|zidovudine|mesh-list
19426099|NCT00672412|Nevirapine|nevirapine|mesh-list
19426100|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19426101|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19426102|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426103|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426104|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
19426105|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426106|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19426107|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19426108|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
19426109|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19426110|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19426111|NCT00672386|Metformin|metformin|mesh-list
19426112|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19426113|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426114|NCT00670033|Travoprost|travoprost|mesh-list
19426115|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19426116|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19426117|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19426118|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
19426119|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19426120|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426121|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
19426122|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426123|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426124|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20249713|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19426125|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426126|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
19426127|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19711374|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711375|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711376|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
19711377|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426128|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
19426129|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426130|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426131|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20249714|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
20249715|NCT00441662|Hormones|hormones|mesh-ancestor
20249716|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249717|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249718|NCT00441740|Gemcitabine|gemcitabine|mesh-list
20249719|NCT00441740|Docetaxel|docetaxel|mesh-list
20249720|NCT00441740|Vinorelbine|vinorelbine|mesh-list
20249721|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249722|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
19426132|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426133|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19711378|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19711379|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19857025|NCT00762034|Paclitaxel|paclitaxel|mesh-list
20249723|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426134|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426135|NCT00667953|Temozolomide|temozolomide|mesh-list
19426136|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
19711380|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19711381|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19711382|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711383|NCT04779762|Ustekinumab|ustekinumab|mesh-list
19711384|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
19711385|NCT04779645|Volagidemab|volagidemab|mesh-list
19711386|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19711387|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711388|NCT04779255|Acetaminophen|acetaminophen|mesh-list
19711389|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711390|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19711391|NCT04779255|Analgesics|analgesics|mesh-ancestor
19711392|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
19711393|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711394|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
19711395|NCT04779567|Acetaminophen|acetaminophen|mesh-list
19711396|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19711397|NCT04779567|Analgesics|analgesics|mesh-ancestor
19711398|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
19711399|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711400|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711401|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
19711402|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
19711403|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19711404|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19711405|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711406|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
19711407|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
19711408|NCT04779580|Anesthetics|anesthetics|mesh-list
19711409|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
19711410|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711411|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711412|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
19711413|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711414|NCT04778982|Fulvestrant|fulvestrant|mesh-list
19711415|NCT04778982|Palbociclib|palbociclib|mesh-list
19711416|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19711417|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711418|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19711419|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19711420|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
19711421|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19711422|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711423|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19711424|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711425|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426137|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19426138|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
19711426|NCT04779151|Niraparib|niraparib|mesh-list
19711427|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20249724|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426139|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426140|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426141|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19426142|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426143|NCT00666497|Azacitidine|azacitidine|mesh-list
19426144|NCT00666497|Mocetinostat|mocetinostat|mesh-list
19426145|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19426146|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
19426147|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426148|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426149|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426150|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19426151|NCT00663767|Celecoxib|celecoxib|mesh-list
19426152|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19426153|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19426154|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19426155|NCT00663767|Analgesics|analgesics|mesh-ancestor
19426156|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
19426157|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426158|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426159|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19426160|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19426161|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19426162|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426163|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426164|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
19426165|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19426166|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426167|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
19426168|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426169|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426170|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19857026|NCT00762034|Bevacizumab|bevacizumab|mesh-list
19857027|NCT00762034|Carboplatin|carboplatin|mesh-list
19857028|NCT00762034|Pemetrexed|pemetrexed|mesh-list
19857029|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19857030|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857031|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
19857032|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
19426171|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
19857033|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
19711428|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711429|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711430|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711431|NCT04779060|Dexamethasone|dexamethasone|mesh-list
19711432|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19711433|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
19711434|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
19711435|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711436|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711437|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711438|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
19711439|NCT04779060|Hormones|hormones|mesh-ancestor
19711440|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19711441|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19711442|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711443|NCT04778917|Heparin|heparin|mesh-list
19711444|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19857034|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857035|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19857036|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19857037|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19857038|NCT00762034|Growth Substances|growth substances|mesh-ancestor
19857039|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857040|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
19857041|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426172|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
19426173|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19426174|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
19426175|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426176|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426177|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19426178|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426179|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19426180|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426181|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
19426182|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19426183|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426184|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
19426185|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426186|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426187|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426188|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
19711445|NCT04778917|Tinzaparin|tinzaparin|mesh-list
19711446|NCT04778917|Dalteparin|dalteparin|mesh-list
19711447|NCT04778917|Calcium heparin|calcium heparin|mesh-list
19711448|NCT04778917|Calcium|calcium|mesh-list
19711449|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19711450|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711451|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
19711452|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19711453|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19711454|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711455|NCT04778865|Vitamin D|vitamin d|mesh-list
19711456|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
19711457|NCT04778865|Vitamins|vitamins|mesh-list
19711458|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
19711459|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711460|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19711461|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19711462|NCT04778839|Paclitaxel|paclitaxel|mesh-list
19711463|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19711464|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19711465|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711466|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
19711467|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
19711468|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
19711469|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711470|NCT04778813|Artesunate|artesunate|mesh-list
19711471|NCT04778813|Lumefantrine|lumefantrine|mesh-list
19711472|NCT04778813|Artemether|artemether|mesh-list
19711473|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19711474|NCT04778813|Artenimol|artenimol|mesh-list
19711475|NCT04778813|Pyronaridine|pyronaridine|mesh-list
19711476|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
19711477|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19711478|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19711479|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711480|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711481|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
19711482|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
19711483|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19711484|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
19711485|NCT04779047|Ritonavir|ritonavir|mesh-list
19711486|NCT04779047|Lopinavir|lopinavir|mesh-list
19711487|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
19426189|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
19711488|NCT04779047|Ivermectin|ivermectin|mesh-list
19711489|NCT04779047|Remdesivir|remdesivir|mesh-list
19711490|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19711491|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19711492|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426190|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19426191|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
19426192|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426193|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249725|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
19426194|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19426195|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426196|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19711493|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711494|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711495|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19711496|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19711497|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
19711498|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711499|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19711500|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19711501|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
19711502|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19711503|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19711504|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711505|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
19711506|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
19711507|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
19711508|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19711509|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19711510|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711511|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19711512|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19711513|NCT04778358|Hormones|hormones|mesh-ancestor
19711514|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19711515|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711516|NCT04778176|Levodopa|levodopa|mesh-list
19711517|NCT04778176|Carbidopa|carbidopa|mesh-list
19711518|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19711519|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19711520|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
19711521|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711522|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711523|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711524|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19711525|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711526|NCT04778072|Iron|iron|mesh-list
19711527|NCT04778072|Trace Elements|trace elements|mesh-ancestor
19711528|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
19711529|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733878|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19426197|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733879|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20249726|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249727|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249728|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249729|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
20249730|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249731|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
20249732|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
20249733|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
20249734|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19426198|NCT00662597|Paclitaxel|paclitaxel|mesh-list
19426199|NCT00662597|Carboplatin|carboplatin|mesh-list
19426200|NCT00662597|Vadimezan|vadimezan|mesh-list
19426201|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19426202|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426203|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
19426204|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
19426205|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
19426206|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426207|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
19426208|NCT00662506|Temozolomide|temozolomide|mesh-list
19426209|NCT00662506|Cediranib|cediranib|mesh-list
19426210|NCT00662506|Maleic acid|maleic acid|mesh-list
19426211|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19426212|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19426213|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
19426214|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426215|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426216|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426217|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19426218|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19426219|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
19426220|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
19426221|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426222|NCT00660881|Epratuzumab|epratuzumab|mesh-list
19426223|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426224|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426225|NCT00659191|Cabotegravir|cabotegravir|mesh-list
19426226|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19426227|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19426228|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426229|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426230|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19426231|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19426232|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
19426233|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426234|NCT00659061|Micronutrients|micronutrients|mesh-list
19426235|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426236|NCT00658762|Paroxetine|paroxetine|mesh-list
19711530|NCT04778137|Omalizumab|omalizumab|mesh-list
19711531|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19711532|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19857042|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19857043|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19711533|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
19711534|NCT04777968|Fluorides|fluorides|mesh-list
19711535|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
19711536|NCT04777968|Protective Agents|protective agents|mesh-ancestor
19711537|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711538|NCT04777929|Progesterone|progesterone|mesh-list
19711539|NCT04777929|Estrogens|estrogens|mesh-list
19711540|NCT04777929|Progestins|progestins|mesh-ancestor
19711541|NCT04777929|Hormones|hormones|mesh-ancestor
19711542|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426237|NCT00658762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19426238|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19450938|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
19450939|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
19450940|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450941|NCT03424746|Antidotes|antidotes|mesh-ancestor
19450942|NCT03424746|Protective Agents|protective agents|mesh-ancestor
19450943|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450944|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19450945|NCT03424733|Acetaminophen|acetaminophen|mesh-list
19450946|NCT03424733|Interferons|interferons|mesh-list
19450947|NCT03424733|Interferon-beta|interferon-beta|mesh-list
19450948|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
19450949|NCT03424733|Prednisone|prednisone|mesh-list
19450950|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19450951|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
19450952|NCT03424733|Hormones|hormones|mesh-ancestor
19450953|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426239|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426240|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426241|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426242|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
19426243|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426244|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19426245|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426246|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426247|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19426248|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19426249|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426250|NCT00658372|Paroxetine|paroxetine|mesh-list
19426251|NCT00658372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19711543|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426252|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426253|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426254|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426255|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426256|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
19426257|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426258|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19426259|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426260|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426261|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19426262|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19426263|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426264|NCT00658047|Methotrexate|methotrexate|mesh-list
19426265|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19426266|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
19426267|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19426268|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426269|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19426270|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
19426271|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426272|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426273|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
19426274|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426275|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19426276|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19426277|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
19426278|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19426279|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19426280|NCT00658008|Paroxetine|paroxetine|mesh-list
19426281|NCT00658008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19426282|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426283|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711544|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19711545|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
19711546|NCT04777383|Atropine|atropine|mesh-list
19711547|NCT04777383|Phenylephrine|phenylephrine|mesh-list
19711548|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
19711549|NCT04777383|Norepinephrine|norepinephrine|mesh-list
19711550|NCT04777383|Acetylcholine|acetylcholine|mesh-list
19711551|NCT04777383|Neostigmine|neostigmine|mesh-list
19711552|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19711553|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
19711554|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
19711555|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711556|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711557|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
19711558|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19711559|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
19711560|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
19711561|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19711562|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19711563|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19711564|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
19711565|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711566|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711567|NCT04777383|Protective Agents|protective agents|mesh-ancestor
19711568|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19711569|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19711570|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19711571|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19857044|NCT00762073|Budesonide|budesonide|mesh-list
19857045|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19857046|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19857047|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
19857048|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857049|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857050|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19857051|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
19857052|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
19857053|NCT00762073|Hormones|hormones|mesh-ancestor
19857054|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857055|NCT00762164|Simvastatin|simvastatin|mesh-list
19857056|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19857057|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19857058|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857059|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
19857060|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857061|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857062|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19857063|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857064|NCT00762177|Triclosan|triclosan|mesh-list
19711572|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
19426284|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426285|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426286|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
19426287|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426288|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19426289|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426290|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426291|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19426292|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19426293|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426294|NCT00657501|Testosterone|testosterone|mesh-list
19426295|NCT00657501|Androgens|androgens|mesh-ancestor
19426296|NCT00657501|Hormones|hormones|mesh-ancestor
19426297|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426298|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426299|NCT00657189|Sifalimumab|sifalimumab|mesh-list
19426300|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19426301|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
19426302|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426303|NCT00656539|Azithromycin|azithromycin|mesh-list
19426304|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19426305|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531636|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20531637|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20531638|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
20531639|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531640|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531641|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531642|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
20531643|NCT01795976|Fludarabine|fludarabine|mesh-list
20531644|NCT01795976|Interleukin-2|interleukin-2|mesh-list
20531645|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19426306|NCT00656357|Cocaine|cocaine|mesh-list
19426307|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
19426308|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
19426309|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426310|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426311|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
19426312|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426313|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19426314|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19426315|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426316|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426317|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857065|NCT00762177|Fluorides|fluorides|mesh-list
19857066|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
19426318|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
19426319|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426320|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
19426321|NCT00654992|Hematinics|hematinics|mesh-ancestor
19426322|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19426323|NCT00654706|Sertindole|sertindole|mesh-list
20531646|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
20531647|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531648|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20531649|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20531650|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
20531651|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531652|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531653|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20531654|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19426324|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426325|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426326|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19426327|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19857067|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857068|NCT00762177|Protective Agents|protective agents|mesh-ancestor
19857069|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857070|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857071|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857072|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857073|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857074|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
19857075|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857076|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857077|NCT00762229|Ezetimibe|ezetimibe|mesh-list
19426328|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426329|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426330|NCT00650949|Carboplatin|carboplatin|mesh-list
19426331|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426332|NCT00650832|Darunavir|darunavir|mesh-list
19426333|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19426334|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19426335|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426336|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426337|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426338|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19426339|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19426340|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
19426341|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426342|NCT00650702|Latanoprost|latanoprost|mesh-list
19426343|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19426344|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19857078|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19857079|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857080|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
20249735|NCT00441844|Simvastatin|simvastatin|mesh-list
20249736|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20249737|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20531655|NCT01795976|Analgesics|analgesics|mesh-ancestor
19857081|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249738|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
19426345|NCT00649025|Fluticasone|fluticasone|mesh-list
19426346|NCT00649025|Xhance|xhance|mesh-list
19426347|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19426348|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426349|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
19426350|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426351|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426352|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426353|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426354|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
19426355|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19426356|NCT00647231|Ketoprofen|ketoprofen|mesh-list
19426357|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19426358|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19426359|NCT00647231|Analgesics|analgesics|mesh-ancestor
19426360|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
19426361|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426362|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426363|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19426364|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19426365|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19426366|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426367|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426368|NCT00646542|Vildagliptin|vildagliptin|mesh-list
19426369|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19426370|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426371|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19426372|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426373|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426374|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426375|NCT00645177|Paclitaxel|paclitaxel|mesh-list
19426376|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19426377|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426378|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
19426379|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
19426380|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
19426381|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426382|NCT00643383|Acetaminophen|acetaminophen|mesh-list
19426383|NCT00643383|Tramadol|tramadol|mesh-list
19426384|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19426385|NCT00643383|Analgesics|analgesics|mesh-ancestor
19426386|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
19426387|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426388|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426389|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
19426390|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19711573|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19711574|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19711575|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
19711576|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19711577|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711578|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19711579|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
19711580|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20286545|NCT03245892|Nivolumab|nivolumab|mesh-list
19711581|NCT04777838|Amitriptyline|amitriptyline|mesh-list
19426391|NCT00643383|Narcotics|narcotics|mesh-ancestor
19426392|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426393|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19426394|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426395|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
19426396|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426397|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426398|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426399|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426400|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
19426401|NCT00642148|Hormones|hormones|mesh-ancestor
19426402|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426403|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
19426404|NCT00641732|Enoxaparin|enoxaparin|mesh-list
19426405|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
19426406|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
19426407|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19426408|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19426409|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426410|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19426411|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
19426412|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19426413|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426414|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426415|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19426416|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426417|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
19426418|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426419|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426420|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426421|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426422|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19426423|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426424|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19426425|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426426|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426427|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426428|NCT00637130|Travoprost|travoprost|mesh-list
19426429|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19426430|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19426431|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19426432|NCT00637052|Filanesib|filanesib|mesh-list
19426433|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
19426434|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
19426435|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426436|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426437|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
19426438|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19426439|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19426440|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426441|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
19426442|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
19450954|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450955|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19450956|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450957|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
19450958|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450959|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19450960|NCT03424733|Analgesics|analgesics|mesh-ancestor
19450961|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
19450962|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450963|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
19450964|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
19450965|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19450966|NCT03424707|Eperisone|eperisone|mesh-list
19450967|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
19450968|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19450969|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711582|NCT04777838|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19711583|NCT04777838|Citalopram|citalopram|mesh-list
19711584|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19711585|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19711586|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426443|NCT00635505|Albuterol|albuterol|mesh-list
19426444|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426445|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
19426446|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426447|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426448|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426449|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426450|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
19426451|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19426452|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19426453|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426454|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19426455|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426456|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426457|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426458|NCT00635193|Doxorubicin|doxorubicin|mesh-list
19426459|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19426460|NCT00635193|Volociximab|volociximab|mesh-list
19426461|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19426462|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19426463|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426464|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19426465|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19426466|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426467|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426468|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19426469|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19426470|NCT00635193|Growth Substances|growth substances|mesh-ancestor
19426471|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426472|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
19426473|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
19426474|NCT00634829|Albuterol|albuterol|mesh-list
19426475|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426476|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
19426477|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426478|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426479|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426480|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426481|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
19426482|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19426483|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19426484|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426485|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19426486|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426487|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426488|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426489|NCT00634517|Albuterol|albuterol|mesh-list
19426490|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426491|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
19426492|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426493|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426494|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426495|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426496|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
19426497|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19426498|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19426499|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19426500|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19426501|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
19857082|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19426502|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426503|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426504|NCT00633997|Vildagliptin|vildagliptin|mesh-list
19426505|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19426506|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426507|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19426508|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426509|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426510|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426511|NCT00631111|Aspirin|aspirin|mesh-list
19426512|NCT00631111|Ascorbic Acid|ascorbic acid|mesh-list
19426513|NCT00631111|Ibuprofen|ibuprofen|mesh-list
19426514|NCT00631111|Vitamins|vitamins|mesh-ancestor
19426515|NCT00631111|Micronutrients|micronutrients|mesh-ancestor
19426516|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426517|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19426518|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19426519|NCT00631111|Analgesics|analgesics|mesh-ancestor
19426520|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
19426521|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426522|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19426523|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19426524|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19426525|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19426526|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426527|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19426528|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19426529|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426530|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
19426531|NCT00631111|Antioxidants|antioxidants|mesh-ancestor
19426532|NCT00631111|Protective Agents|protective agents|mesh-ancestor
19426533|NCT00630799|Leuprolide|leuprolide|mesh-list
19426534|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19426535|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
19426536|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19426537|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426538|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19426539|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711587|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711588|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711589|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
19711590|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711591|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19711592|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
19711593|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711594|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711595|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19711596|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19711597|NCT04777838|Analgesics|analgesics|mesh-ancestor
19711598|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
19711599|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19711600|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
19711601|NCT04777838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19711602|NCT04777838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19711603|NCT04777838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857083|NCT00762320|Ritonavir|ritonavir|mesh-list
19426540|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
19426541|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426542|NCT00630552|Conatumumab|conatumumab|mesh-list
19426543|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426544|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711604|NCT04777552|Diazepam|diazepam|mesh-list
19857084|NCT00762320|Lopinavir|lopinavir|mesh-list
19857085|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19857086|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19426545|NCT00630201|Buprenorphine|buprenorphine|mesh-list
19426546|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19426547|NCT00630201|Narcotics|narcotics|mesh-ancestor
19426548|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426549|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426550|NCT00630201|Analgesics|analgesics|mesh-ancestor
19426551|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
19426552|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426553|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19426554|NCT00629980|Azithromycin|azithromycin|mesh-list
19426555|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19857087|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
19857088|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426556|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426557|NCT00629941|Azithromycin|azithromycin|mesh-list
19426558|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19426559|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426560|NCT00629590|Azithromycin|azithromycin|mesh-list
19426561|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19426562|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426563|NCT00629551|Paroxetine|paroxetine|mesh-list
19426564|NCT00629551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19426565|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426566|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426567|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426568|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426569|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
19426570|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286546|NCT03245892|Ipilimumab|ipilimumab|mesh-list
19857089|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426571|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19426572|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426573|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426574|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19426575|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19426576|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426577|NCT00626704|Doxorubicin|doxorubicin|mesh-list
19711605|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19711606|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
19711607|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
19857090|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19857091|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19857092|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
19857093|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857094|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19857095|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19857096|NCT00762359|Lansoprazole|lansoprazole|mesh-list
19857097|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
19857098|NCT00762359|Gefarnate|gefarnate|mesh-list
19857099|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19857100|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19857101|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19857102|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857103|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857104|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
19857105|NCT00762372|Sevoflurane|sevoflurane|mesh-list
19857106|NCT00762372|Desflurane|desflurane|mesh-list
19857107|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19857108|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19857109|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
19857110|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
19857111|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857112|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857113|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857114|NCT00762372|Analgesics|analgesics|mesh-ancestor
19857115|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
19857116|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857117|NCT00762450|Triclosan|triclosan|mesh-list
19857118|NCT00762450|Fluorides|fluorides|mesh-list
19857119|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857120|NCT00762450|Protective Agents|protective agents|mesh-ancestor
19857121|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857122|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857123|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857124|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857125|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857126|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
19857127|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857128|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857129|NCT00762463|Celecoxib|celecoxib|mesh-list
19857130|NCT00762463|Diclofenac|diclofenac|mesh-list
19857131|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20249739|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426578|NCT00626704|Conatumumab|conatumumab|mesh-list
19426579|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19426580|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857132|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857133|NCT00762463|Analgesics|analgesics|mesh-ancestor
19857134|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
19857135|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857136|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857137|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19857138|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857139|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19857140|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249740|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19711608|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
19711609|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711610|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711611|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711612|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19711613|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711614|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19711615|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19711616|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19426581|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19426582|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19426583|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426584|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426585|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426586|NCT00626106|Fulvestrant|fulvestrant|mesh-list
19426587|NCT00626106|Exemestane|exemestane|mesh-list
19426588|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19426589|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19426590|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426591|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19426592|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19426593|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
19426594|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426595|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426596|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19426597|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19426598|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426599|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426600|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
19426601|NCT00625833|Reboxetine|reboxetine|mesh-list
19426602|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426603|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426604|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19426605|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426606|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426607|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426608|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426609|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426610|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426611|NCT00625664|Gemcitabine|gemcitabine|mesh-list
19426612|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426613|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19426614|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
19426615|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426616|NCT00625664|Antiviral Agents|antiviral agents|mesh-ancestor
19426617|NCT00625664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426618|NCT00625664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426619|NCT00625664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19426620|NCT00625664|Immunologic Factors|immunologic factors|mesh-ancestor
19426621|NCT00625664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426622|NCT00625651|Bevacizumab|bevacizumab|mesh-list
19426623|NCT00625651|Conatumumab|conatumumab|mesh-list
19426624|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426625|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426626|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19426627|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19426628|NCT00625651|Growth Substances|growth substances|mesh-ancestor
19426629|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426630|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
19426631|NCT00625326|Calcipotriene|calcipotriene|mesh-list
19426632|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
19426633|NCT00624858|Naltrexone|naltrexone|mesh-list
19426634|NCT00624858|Bupropion|bupropion|mesh-list
19426635|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19426636|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19426637|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426638|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
19426639|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426640|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19426641|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426642|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426643|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19426644|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426645|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426646|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426647|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
20531656|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
20531657|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531658|NCT01796002|Romidepsin|romidepsin|mesh-list
20531659|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20531660|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531661|NCT01796028|Metformin|metformin|mesh-list
19426648|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426649|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19426650|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19426651|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426652|NCT00624351|Epratuzumab|epratuzumab|mesh-list
19426653|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426654|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426655|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
19426656|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426657|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19426658|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19426659|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426660|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426661|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
19426662|NCT00620256|Timolol|timolol|mesh-list
19426663|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19711617|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19711618|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711619|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19711620|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
19711621|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
19711622|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
19711623|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
19857141|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426664|NCT00620256|Latanoprost|latanoprost|mesh-list
19711624|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711625|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711626|NCT04777591|Bupivacaine|bupivacaine|mesh-list
19711627|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711628|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
19857142|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857143|NCT00762515|Triclosan|triclosan|mesh-list
19857144|NCT00762515|Fluorides|fluorides|mesh-list
19857145|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857146|NCT00762515|Protective Agents|protective agents|mesh-ancestor
19857147|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531662|NCT01796028|Docetaxel|docetaxel|mesh-list
20531663|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531664|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426665|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19426666|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19426667|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20531665|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531666|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
20531667|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20531668|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
20531669|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531670|NCT01796093|Digoxin|digoxin|mesh-list
20531671|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20531672|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20531673|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711629|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426668|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426669|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426670|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426671|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426672|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19426673|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19426674|NCT00618098|Thrombin|thrombin|mesh-list
19426675|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
19857148|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857149|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857150|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857151|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857152|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
19857153|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857154|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857155|NCT00762528|Triclosan|triclosan|mesh-list
19426676|NCT00618098|Coagulants|coagulants|mesh-ancestor
19426677|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19711630|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711631|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
19711632|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711633|NCT04777045|Diltiazem|diltiazem|mesh-list
19711634|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19711635|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19857156|NCT00762528|Fluorides|fluorides|mesh-list
19857157|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
19857158|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857159|NCT00762528|Protective Agents|protective agents|mesh-ancestor
19857160|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857161|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857162|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857163|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857164|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857165|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
19857166|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857167|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857168|NCT00762619|Triclosan|triclosan|mesh-list
19857169|NCT00762619|Fluorides|fluorides|mesh-list
19857170|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857171|NCT00762619|Protective Agents|protective agents|mesh-ancestor
19857172|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857173|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857174|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857175|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857176|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857177|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
19426678|NCT00616811|Vildagliptin|vildagliptin|mesh-list
19711636|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711637|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711638|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19711639|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711640|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
19426679|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857178|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857179|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857180|NCT00762645|Travoprost|travoprost|mesh-list
19857181|NCT00762645|Pilocarpine|pilocarpine|mesh-list
19857182|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19857183|NCT00762645|Miotics|miotics|mesh-ancestor
19426680|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426681|NCT00616811|Incretins|incretins|mesh-ancestor
19426682|NCT00616811|Hormones|hormones|mesh-ancestor
19426683|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426684|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19426685|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426686|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426687|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426688|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
19426689|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19426690|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426691|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426692|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426693|NCT00616330|Clindamycin|clindamycin|mesh-list
19426694|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
19711641|NCT04777227|Lidocaine|lidocaine|mesh-list
19711642|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711643|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
19711644|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711645|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711646|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
19711647|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711648|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19711649|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19711650|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19711651|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711652|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711653|NCT04777110|Esketamine|esketamine|mesh-list
19711654|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
19711655|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711656|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19711657|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19711658|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19711659|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
19711660|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711661|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19711662|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19711663|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711664|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
19711665|NCT04776850|Dexamethasone|dexamethasone|mesh-list
19711666|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
19711667|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
19711668|NCT04776850|Busulfan|busulfan|mesh-list
19711669|NCT04776850|Rituximab|rituximab|mesh-list
19711670|NCT04776850|Fludarabine|fludarabine|mesh-list
19711671|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
19711672|NCT04776850|Bortezomib|bortezomib|mesh-list
19711673|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19711674|NCT04776850|Tacrolimus|tacrolimus|mesh-list
19711675|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
19711676|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19711677|NCT04776850|Antibodies|antibodies|mesh-list
19711678|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
19711679|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19711680|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
19857184|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
19426695|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
19426696|NCT00616330|Butoconazole|butoconazole|mesh-list
19426697|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19426698|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426699|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19426700|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426701|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426702|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
19426703|NCT00616148|Cenobamate|cenobamate|mesh-list
19426704|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
19426705|NCT00615251|Progesterone|progesterone|mesh-list
19426706|NCT00615251|Progestins|progestins|mesh-ancestor
19426707|NCT00615251|Hormones|hormones|mesh-ancestor
19426708|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426709|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426710|NCT00614601|Vaccines|vaccines|mesh-list
19426711|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
19426712|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426713|NCT00613002|Testosterone|testosterone|mesh-list
19426714|NCT00613002|Androgens|androgens|mesh-ancestor
19426715|NCT00613002|Hormones|hormones|mesh-ancestor
19426716|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426717|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426718|NCT00612820|Fluticasone|fluticasone|mesh-list
19426719|NCT00612820|Xhance|xhance|mesh-list
19426720|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
19426721|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19426722|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426723|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
19426724|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426725|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426726|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426727|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426728|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
19426729|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19426730|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19426731|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19426732|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426733|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426734|NCT00612742|Testosterone|testosterone|mesh-list
19426735|NCT00612742|Androgens|androgens|mesh-ancestor
19426736|NCT00612742|Hormones|hormones|mesh-ancestor
19426737|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19426738|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426739|NCT00612170|Reboxetine|reboxetine|mesh-list
19426740|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426741|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426742|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19426743|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426744|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426745|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426746|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426747|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426748|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426749|NCT00612118|Azelastine|azelastine|mesh-list
19426750|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
19426751|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19426752|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
19426753|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426754|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426755|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19426756|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
19426757|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19426758|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426759|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426760|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19426761|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19426762|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19426763|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
19711681|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19711682|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19711683|NCT04776850|BB 1101|bb 1101|mesh-list
19711684|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19711685|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
19711686|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711687|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711688|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19711689|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
19711690|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711691|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711692|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19711693|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19711694|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
19711695|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
19711696|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711697|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711698|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
19711699|NCT04776850|Hormones|hormones|mesh-ancestor
19711700|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249741|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20249742|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249743|NCT00441870|Folic Acid|folic acid|mesh-list
20249744|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
20249745|NCT00441870|Hematinics|hematinics|mesh-ancestor
20249746|NCT00441870|Vitamins|vitamins|mesh-ancestor
20249747|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
20249748|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711701|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19711702|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
19711703|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711704|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19711705|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
19711706|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19711707|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19711708|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19711709|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
19711710|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19711711|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711712|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
19711713|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
19711714|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711715|NCT04776512|Bupivacaine|bupivacaine|mesh-list
19711716|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711717|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
19711718|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711719|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711720|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
19711721|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711722|NCT04776525|Doxorubicin|doxorubicin|mesh-list
19711723|NCT04776525|Ifosfamide|ifosfamide|mesh-list
19711724|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19711725|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711726|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19711727|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20249749|NCT00441909|UC-781|uc-781|mesh-list
19426764|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
19426765|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426766|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19426767|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19426768|NCT00609323|Lidocaine|lidocaine|mesh-list
19426769|NCT00609323|Tetracaine|tetracaine|mesh-list
19426770|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
19426771|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
19426772|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426773|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426774|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
19426775|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426776|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19426777|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19426778|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19426779|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426780|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426781|NCT00607256|Reboxetine|reboxetine|mesh-list
19426782|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
20531674|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531675|NCT01796093|Protective Agents|protective agents|mesh-ancestor
20531676|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531677|NCT01796106|Fluorides|fluorides|mesh-list
20531678|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
20531679|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
20531680|NCT01796106|Protective Agents|protective agents|mesh-ancestor
20531681|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531682|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19711728|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531683|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
20531684|NCT01796132|Citalopram|citalopram|mesh-list
20531685|NCT01796132|Fluoxetine|fluoxetine|mesh-list
20531686|NCT01796132|Paroxetine|paroxetine|mesh-list
20531687|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20531688|NCT01796132|Sertraline|sertraline|mesh-list
20531689|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20531690|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20531691|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531692|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531693|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531694|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
20531695|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531696|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20531697|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426783|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19733880|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20531698|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20531699|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531700|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20531701|NCT01796132|Analgesics|analgesics|mesh-ancestor
19711729|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711730|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19711731|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
19711732|NCT04776655|Leucovorin|leucovorin|mesh-list
19711733|NCT04776655|Bevacizumab|bevacizumab|mesh-list
19711734|NCT04776655|Cetuximab|cetuximab|mesh-list
19711735|NCT04776655|Fluorouracil|fluorouracil|mesh-list
19711736|NCT04776655|Irinotecan|irinotecan|mesh-list
19711737|NCT04776655|Calcium|calcium|mesh-list
19711738|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
19711739|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19711740|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711741|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19711742|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19711743|NCT04776655|Growth Substances|growth substances|mesh-ancestor
19711744|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711745|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
19711746|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19711747|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
20531702|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
20531703|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
20531704|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19711748|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711749|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19711750|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19711751|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
19711752|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19711753|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19711754|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711755|NCT04776655|Antidotes|antidotes|mesh-ancestor
19711756|NCT04776655|Protective Agents|protective agents|mesh-ancestor
19711757|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
19711758|NCT04776655|Vitamins|vitamins|mesh-ancestor
19857185|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857186|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857187|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19857188|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19857189|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
19857190|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857191|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857192|NCT00762710|Prazosin|prazosin|mesh-list
19857193|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19857194|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19857195|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19857196|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19857197|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
19857198|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857199|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857200|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857201|NCT00762762|Triclosan|triclosan|mesh-list
19857202|NCT00762762|Fluorides|fluorides|mesh-list
19857203|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857204|NCT00762762|Protective Agents|protective agents|mesh-ancestor
19857205|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857206|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857207|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857208|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857209|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857210|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
19857211|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857212|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857213|NCT00762853|Triclosan|triclosan|mesh-list
19857214|NCT00762853|Fluorides|fluorides|mesh-list
19857215|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
20531705|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20531706|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531707|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20531708|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20531709|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711759|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
19711760|NCT04776369|Lidocaine|lidocaine|mesh-list
19711761|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
20531710|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19426784|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19426785|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426786|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426787|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426788|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19426789|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426790|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426791|NCT00606697|Vofopitant|vofopitant|mesh-list
19426792|NCT00606697|Vestipitant|vestipitant|mesh-list
19426793|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19426794|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426795|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426796|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426797|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
19426798|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
19426799|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19426800|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19426801|NCT00603616|Rifaximin|rifaximin|mesh-list
19426802|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19711762|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711763|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
19711764|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711765|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711766|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
19711767|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711768|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19857216|NCT00762853|Protective Agents|protective agents|mesh-ancestor
19857217|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857218|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857219|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857220|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857221|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857222|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
19857223|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857224|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857225|NCT00762892|Tenofovir|tenofovir|mesh-list
19857226|NCT00762892|Emtricitabine|emtricitabine|mesh-list
19857227|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
19857228|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19857229|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19857230|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
19857231|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857232|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19857233|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19857234|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857235|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857236|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19857237|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19857238|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19857239|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19426803|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426804|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19426805|NCT00603577|Xaliproden|xaliproden|mesh-list
19426806|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19711769|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19857240|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19857241|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20531711|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20531712|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20531713|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531714|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20531715|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531716|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531717|NCT01796366|Insulin|insulin|mesh-list
19426807|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19426808|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
20531718|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20531719|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
20531720|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531721|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531722|NCT01796405|Clofarabine|clofarabine|mesh-list
19426809|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426810|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426811|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426812|NCT00602745|Fluorouracil|fluorouracil|mesh-list
19426813|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
19426814|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426815|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19426816|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426817|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19426818|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
19426819|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426820|NCT00602602|Gemcitabine|gemcitabine|mesh-list
19426821|NCT00602602|Bevacizumab|bevacizumab|mesh-list
19426822|NCT00602602|Fluorouracil|fluorouracil|mesh-list
19426823|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
19426824|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426825|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426826|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19426827|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19426828|NCT00602602|Growth Substances|growth substances|mesh-ancestor
19426829|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426830|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
19426831|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19426832|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
19426833|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426834|NCT00602602|Antiviral Agents|antiviral agents|mesh-ancestor
19426835|NCT00602602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426836|NCT00602602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426837|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19426838|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
19426839|NCT00602576|Temozolomide|temozolomide|mesh-list
19426840|NCT00602576|Sorafenib|sorafenib|mesh-list
19426841|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19426842|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
19426843|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426844|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426845|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19426846|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426847|NCT00602329|Leucovorin|leucovorin|mesh-list
19426848|NCT00602329|Bevacizumab|bevacizumab|mesh-list
19426849|NCT00602329|Fluorouracil|fluorouracil|mesh-list
19426850|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
19426851|NCT00602329|Calcium|calcium|mesh-list
19426852|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
19426853|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426854|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426855|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19426856|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19426857|NCT00602329|Growth Substances|growth substances|mesh-ancestor
19426858|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426859|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
19426860|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19426861|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
19426862|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426863|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249750|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20249751|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
20249752|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531723|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19426864|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19426865|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
19426866|NCT00602329|Antidotes|antidotes|mesh-ancestor
19426867|NCT00602329|Protective Agents|protective agents|mesh-ancestor
19426868|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
19857242|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426869|NCT00602329|Vitamins|vitamins|mesh-ancestor
19426870|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
19857243|NCT00763035|Dobutamine|dobutamine|mesh-list
19857244|NCT00763035|Regadenoson|regadenoson|mesh-list
19426871|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19426872|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19426873|NCT00598312|Leuprolide|leuprolide|mesh-list
19426874|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19426875|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
19426876|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19426877|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426878|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19426879|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426880|NCT00595699|Citalopram|citalopram|mesh-list
19426881|NCT00595699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19426882|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426883|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426884|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426885|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426886|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
19426887|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426888|NCT00595699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19426889|NCT00595699|Antidepressive Agents|antidepressive agents|mesh-ancestor
20249753|NCT00441922|Docetaxel|docetaxel|mesh-list
20249754|NCT00441922|Vinorelbine|vinorelbine|mesh-list
20249755|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249756|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
20249757|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
20249758|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
20249759|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249760|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20249761|NCT00441961|Methotrexate|methotrexate|mesh-list
19426890|NCT00595699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426891|NCT00595426|Warfarin|warfarin|mesh-list
19426892|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
19426893|NCT00594984|Irinotecan|irinotecan|mesh-list
19426894|NCT00594984|Cetuximab|cetuximab|mesh-list
19426895|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19426896|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19426897|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426898|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426899|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426900|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19426901|NCT00589875|Valacyclovir|valacyclovir|mesh-list
19711770|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19711771|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711772|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711773|NCT04776369|Analgesics|analgesics|mesh-ancestor
19711774|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
19711775|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19711776|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19711777|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
19711778|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19733881|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19733882|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19733883|NCT04557384|Ramucirumab|ramucirumab|mesh-list
20249762|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19426902|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
19426903|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426904|NCT00589823|Fentanyl|fentanyl|mesh-list
19426905|NCT00589823|Morphine|morphine|mesh-list
19426906|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19426907|NCT00589823|Narcotics|narcotics|mesh-ancestor
19426908|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426909|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426910|NCT00589823|Analgesics|analgesics|mesh-ancestor
19426911|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
19426912|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711779|NCT04776135|Edaravone|edaravone|mesh-list
19711780|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19711781|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
19711782|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711783|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19711784|NCT04776135|Protective Agents|protective agents|mesh-ancestor
19711785|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711786|NCT04776226|Citalopram|citalopram|mesh-list
19711787|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19711788|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19711789|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711790|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711791|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19711792|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
19711793|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711794|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19711795|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
19711796|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711797|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19711798|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
19711799|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19711800|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19711801|NCT04776096|Analgesics|analgesics|mesh-ancestor
19711802|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
19711803|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711804|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711805|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19711806|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711807|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19711808|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19711809|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19711810|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
19711811|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
19711812|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857245|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19857246|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
19711813|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711814|NCT04775797|Tenofovir|tenofovir|mesh-list
20249763|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
19857247|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
19857248|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857249|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857250|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20249764|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20249765|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711815|NCT04775797|Antiviral Agents|antiviral agents|mesh-ancestor
19711816|NCT04775797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711817|NCT04775797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19857251|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20531724|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
20531725|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426913|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20531726|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531727|NCT01796418|Beraprost|beraprost|mesh-list
20531728|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20531729|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
19426914|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19426915|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
19426916|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
19426917|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19426918|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19426919|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19426920|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19426921|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426922|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19426923|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426924|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19426925|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426926|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426927|NCT00583830|Paclitaxel|paclitaxel|mesh-list
19426928|NCT00583830|Carboplatin|carboplatin|mesh-list
19426929|NCT00583830|Mapatumumab|mapatumumab|mesh-list
19426930|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19426931|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19426932|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426933|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
19426934|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
19426935|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
19426936|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426937|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
19426938|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711818|NCT04775797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19711819|NCT04775797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711820|NCT04775797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711821|NCT04775797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19857252|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19857253|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
19857254|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857255|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531730|NCT01796444|Hormones|hormones|mesh-list
20531731|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531732|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531733|NCT01796483|Clonidine|clonidine|mesh-list
20531734|NCT01796483|Analgesics|analgesics|mesh-ancestor
20531735|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
20531736|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531737|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426939|NCT00583674|Cisplatin|cisplatin|mesh-list
19426940|NCT00583674|Capecitabine|capecitabine|mesh-list
19426941|NCT00583674|Trebananib|trebananib|mesh-list
19426942|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711822|NCT04775797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19711823|NCT04775732|Infliximab|infliximab|mesh-list
19711824|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
19711825|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711826|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711827|NCT04775563|Vaccines|vaccines|mesh-list
19711828|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
19711829|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711830|NCT04775303|Cyclosporine|cyclosporine|mesh-list
19711831|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19711832|NCT04775303|Cyclosporins|cyclosporins|mesh-list
19711833|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711834|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426943|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19426944|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
19426945|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426946|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19426947|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19426948|NCT00583674|Growth Substances|growth substances|mesh-ancestor
19426949|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426950|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
19426951|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19426952|NCT00583609|Laxatives|laxatives|mesh-ancestor
19426953|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19450970|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450971|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19450972|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450973|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19450974|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19450975|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450976|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
19450977|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
19450978|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
19450979|NCT03424629|Methotrexate|methotrexate|mesh-list
19450980|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19450981|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
19450982|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19450983|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450984|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19450985|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
19450986|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450987|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450988|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
19450989|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450990|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19450991|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19450992|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
19450993|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450994|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19450995|NCT03424473|Tucatinib|tucatinib|mesh-list
19450996|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450997|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19450998|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450999|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451000|NCT03424408|Aspirin|aspirin|mesh-list
19451001|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19451002|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451003|NCT03424408|Analgesics|analgesics|mesh-ancestor
19451004|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
19451005|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451006|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451007|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451008|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451009|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19451010|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19451011|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451012|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19451013|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19451014|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711835|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19711836|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
19711837|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451015|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
19426954|NCT00581477|Droxidopa|droxidopa|mesh-list
19426955|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19426956|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19426957|NCT00580216|Biotin|biotin|mesh-list
19426958|NCT00580216|Warfarin|warfarin|mesh-list
19426959|NCT00580216|Idraparinux|idraparinux|mesh-list
19426960|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
19426961|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
19426962|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19426963|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
19426964|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19426965|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
19426966|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426967|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426968|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
19426969|NCT00580216|Vitamins|vitamins|mesh-ancestor
19426970|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
19426971|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426972|NCT00580125|Aripiprazole|aripiprazole|mesh-list
19426973|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
19426974|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19426975|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19426976|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19426977|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19426978|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426979|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
19426980|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
19426981|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857256|NCT00763035|Protective Agents|protective agents|mesh-ancestor
19857257|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19857258|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19857259|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
19857260|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
19857261|NCT00763048|Triclosan|triclosan|mesh-list
19857262|NCT00763048|Fluorides|fluorides|mesh-list
19857263|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857264|NCT00763048|Protective Agents|protective agents|mesh-ancestor
19857265|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857266|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857267|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857268|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857269|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19426982|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426983|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19426984|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19426985|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
19711838|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
19711839|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711840|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
19711841|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711842|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19711843|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19711844|NCT04775576|Anesthetics|anesthetics|mesh-list
19711845|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711846|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711847|NCT04775381|Vitamin D|vitamin d|mesh-list
19711848|NCT04775381|Vitamins|vitamins|mesh-ancestor
19711849|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
19711850|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711851|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19711852|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19711853|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
19711854|NCT04775212|Sevoflurane|sevoflurane|mesh-list
19711855|NCT04775212|Desflurane|desflurane|mesh-list
19711856|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19711857|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19711858|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
19711859|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
19711860|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711861|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711862|NCT04775238|Copper|copper|mesh-list
19426986|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19857270|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
19857271|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711863|NCT04775238|Trace Elements|trace elements|mesh-ancestor
19711864|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
19711865|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19426987|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19426988|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19426989|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19426990|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
19426991|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19426992|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19426993|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19426994|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19426995|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19426996|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19426997|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19426998|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19426999|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
19427000|NCT00579020|Dexamethasone|dexamethasone|mesh-list
19427001|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
19427002|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19427003|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19427004|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19427005|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19427006|NCT00579020|BB 1101|bb 1101|mesh-list
20531738|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20531739|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
20531740|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
20531741|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20531742|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20531743|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20531744|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531745|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531746|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427007|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427008|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
19427009|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
19427010|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427011|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427012|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427013|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
19427014|NCT00579020|Hormones|hormones|mesh-ancestor
19427015|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427016|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19427017|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427018|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
19427019|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427020|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427021|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19427022|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427023|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19427024|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19711866|NCT04774822|Mydriatics|mydriatics|mesh-list
19857272|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20531747|NCT01796522|Nifedipine|nifedipine|mesh-list
20531748|NCT01796522|Progesterone|progesterone|mesh-list
20531749|NCT01796522|Progestins|progestins|mesh-ancestor
20531750|NCT01796522|Hormones|hormones|mesh-ancestor
20531751|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531752|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531753|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20531754|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531755|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531756|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19427025|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19711867|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
19711868|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711869|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711870|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
19711871|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711872|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
19711873|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
19711874|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
19711875|NCT04774627|Olaparib|olaparib|mesh-list
19711876|NCT04774627|Niraparib|niraparib|mesh-list
19711877|NCT04774627|Veliparib|veliparib|mesh-list
19711878|NCT04774627|Talazoparib|talazoparib|mesh-list
19711879|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19857273|NCT00763061|Timolol|timolol|mesh-list
19711880|NCT04774627|Rucaparib|rucaparib|mesh-list
19857274|NCT00763061|Travoprost|travoprost|mesh-list
19857275|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19857276|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19857277|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19857278|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19857279|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
19857280|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857281|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857282|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857283|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19857284|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427026|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
19427027|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19427028|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19427029|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19427030|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19427031|NCT00578955|Azithromycin|azithromycin|mesh-list
19711881|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711882|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711883|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711884|NCT04775329|Rifaximin|rifaximin|mesh-list
19711885|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19711886|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711887|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427032|NCT00578955|Dexamethasone|dexamethasone|mesh-list
19427033|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
19427034|NCT00578955|BB 1101|bb 1101|mesh-list
19427035|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427036|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
19427037|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
19427038|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711888|NCT04774029|Lidocaine|lidocaine|mesh-list
19711889|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711890|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
19711891|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711892|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711893|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
19857285|NCT00763139|Pioglitazone|pioglitazone|mesh-list
19427039|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427040|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427041|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
19427042|NCT00578955|Hormones|hormones|mesh-ancestor
19427043|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427044|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19427045|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427046|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
19427047|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427048|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427049|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19427050|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427051|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
19427052|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19427053|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19427054|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427055|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19427056|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19427057|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427058|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427059|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711894|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711895|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19711896|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19711897|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19711898|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711899|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733884|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733885|NCT04557163|Itraconazole|itraconazole|mesh-list
19733886|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
19733887|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733888|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19733889|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19733890|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857286|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427060|NCT00578474|Ofloxacin|ofloxacin|mesh-list
19427061|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19427062|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19427063|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427064|NCT00578474|Renal Agents|renal agents|mesh-ancestor
19427065|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19427066|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19427067|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19427068|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427069|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427070|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427071|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19427072|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19427073|NCT00577148|Rimonabant|rimonabant|mesh-list
19427074|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19427075|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19427076|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19427077|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427078|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427079|NCT00577148|Hormones|hormones|mesh-ancestor
19427080|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427081|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427082|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
19427083|NCT00576810|Cathartics|cathartics|mesh-ancestor
19427084|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427085|NCT00576667|Rimonabant|rimonabant|mesh-list
19427086|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19427087|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19427088|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19427089|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427090|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427091|NCT00576667|Hormones|hormones|mesh-ancestor
19427092|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427093|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427094|NCT00576537|Vaccines|vaccines|mesh-list
19427095|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
19427096|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427097|NCT00576342|Timolol|timolol|mesh-list
19427098|NCT00576342|Dorzolamide|dorzolamide|mesh-list
19427099|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19427100|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19427101|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19427102|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19427103|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
19427104|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427105|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427106|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427107|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19427108|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427109|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19427110|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711900|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
20249766|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249767|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
20249768|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249769|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249770|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
20249771|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249772|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20249773|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249774|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
20249775|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20531757|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
20531758|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
20531759|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20531760|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20531761|NCT01796613|Desogestrel|desogestrel|mesh-list
20531762|NCT01796613|Etonogestrel|etonogestrel|mesh-list
20531763|NCT01796613|NuvaRing|nuvaring|mesh-list
20531764|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19427111|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19427112|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
19427113|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427114|NCT00570752|Atorvastatin|atorvastatin|mesh-list
19427115|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19427116|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19427117|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
19427118|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427119|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19427120|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19427121|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427122|NCT00569387|Vaccines|vaccines|mesh-list
19427123|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
19427124|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427125|NCT00566202|Citalopram|citalopram|mesh-list
19427126|NCT00566202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19427127|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19427128|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427129|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427130|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427131|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
19427132|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427133|NCT00566202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19427134|NCT00566202|Antidepressive Agents|antidepressive agents|mesh-ancestor
19427135|NCT00566202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19427136|NCT00564421|Epinastine|epinastine|mesh-list
19427137|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19427138|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
19427139|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
19427140|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427141|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427142|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427143|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19427144|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19427145|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19427146|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
19427147|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427148|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711901|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
19711902|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427149|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427150|NCT00564226|Urological Agents|urological agents|mesh-ancestor
19427151|NCT00563563|Naltrexone|naltrexone|mesh-list
19427152|NCT00563563|Bupropion|bupropion|mesh-list
19427153|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19427154|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19427155|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427156|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
19427157|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427158|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19427159|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
19427160|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711903|NCT04773951|Antibodies|antibodies|mesh-list
19711904|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19711905|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
19427161|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19427162|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19427163|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427164|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427165|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
19427166|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427167|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19427168|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19427169|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427170|NCT00563459|Topiramate|topiramate|mesh-list
19427171|NCT00563459|Levetiracetam|levetiracetam|mesh-list
19427172|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
19427173|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427174|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427175|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
19427176|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19427177|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
19427178|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427179|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
19427180|NCT00562497|Prednisone|prednisone|mesh-list
19427181|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
19427182|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427183|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
19427184|NCT00562497|Hormones|hormones|mesh-ancestor
19427185|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427186|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427187|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19427188|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427189|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
19427190|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
19427191|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427192|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19711906|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711907|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
19711908|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
19711909|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19711910|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711911|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711912|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
19711913|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19711914|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711915|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711916|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
19711917|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
19711918|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711919|NCT04773717|Protective Agents|protective agents|mesh-ancestor
19711920|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711921|NCT04773717|Vitamins|vitamins|mesh-ancestor
19711922|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
19711923|NCT04774159|Colchicine|colchicine|mesh-list
19711924|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
19857287|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857288|NCT00763256|Triclosan|triclosan|mesh-list
19857289|NCT00763256|Fluorides|fluorides|mesh-list
19427193|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19427194|NCT00562497|Protective Agents|protective agents|mesh-ancestor
19427195|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
19427196|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427197|NCT00561743|Dexamethasone|dexamethasone|mesh-list
19427198|NCT00561743|Doxorubicin|doxorubicin|mesh-list
19427199|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19427200|NCT00561743|Bortezomib|bortezomib|mesh-list
19711925|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19711926|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
19711927|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
19711928|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
19711929|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427201|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427202|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
19427203|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
19427204|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427205|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427206|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427207|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
19427208|NCT00561743|Hormones|hormones|mesh-ancestor
19427209|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427210|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19427211|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427212|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19427213|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19427214|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19427215|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427216|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427217|NCT00560183|Morphine|morphine|mesh-list
19427218|NCT00560183|Oxycodone|oxycodone|mesh-list
19711930|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711931|NCT04774406|Olaparib|olaparib|mesh-list
19711932|NCT04774406|Niraparib|niraparib|mesh-list
19711933|NCT04774406|Veliparib|veliparib|mesh-list
19711934|NCT04774406|Talazoparib|talazoparib|mesh-list
19711935|NCT04774406|Rucaparib|rucaparib|mesh-list
19711936|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19711937|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711938|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711939|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711940|NCT04773366|Cytarabine|cytarabine|mesh-list
19711941|NCT04773366|Prednisone|prednisone|mesh-list
19711942|NCT04773366|Vincristine|vincristine|mesh-list
19711943|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
19711944|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19711945|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
19711946|NCT04773366|Hormones|hormones|mesh-ancestor
19711947|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19711948|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711949|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19711950|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711951|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19711952|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
19711953|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711954|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
19711955|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19711956|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19711957|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
19711958|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19427219|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19427220|NCT00560183|Narcotics|narcotics|mesh-ancestor
19711959|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
19711960|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
19711961|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
19711962|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19711963|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711964|NCT04773301|Ropivacaine|ropivacaine|mesh-list
19711965|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
19711966|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711967|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
19711968|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711969|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857290|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857291|NCT00763256|Protective Agents|protective agents|mesh-ancestor
19857292|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857293|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857294|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857295|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857296|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857297|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
19857298|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857299|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20531765|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19857300|NCT00763269|Silicon|silicon|mesh-list
19857301|NCT00763269|Triclosan|triclosan|mesh-list
19857302|NCT00763269|Fluorides|fluorides|mesh-list
19857303|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
19857304|NCT00763269|Protective Agents|protective agents|mesh-ancestor
19857305|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857306|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857307|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857308|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857309|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857310|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
19857311|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857312|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857313|NCT00763269|Trace Elements|trace elements|mesh-ancestor
19857314|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
19857315|NCT00763321|Acetaminophen|acetaminophen|mesh-list
19857316|NCT00763321|Hydrocodone|hydrocodone|mesh-list
19857317|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857318|NCT00763321|Analgesics|analgesics|mesh-ancestor
19857319|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
19857320|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857321|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857322|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
19857323|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19857324|NCT00763321|Narcotics|narcotics|mesh-ancestor
19857325|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857326|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
20249776|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20249777|NCT00442026|Gemcitabine|gemcitabine|mesh-list
20249778|NCT00442026|Docetaxel|docetaxel|mesh-list
20249779|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249780|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
20249781|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249782|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249783|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
20249784|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249785|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249786|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249787|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
20531766|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19711970|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
19857327|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
19857328|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
20531767|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
20531768|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20531769|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531770|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20531771|NCT01796613|Estrogens|estrogens|mesh-ancestor
20531772|NCT01796613|Hormones|hormones|mesh-ancestor
19427221|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427222|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427223|NCT00560183|Analgesics|analgesics|mesh-ancestor
19427224|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
19427225|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427226|NCT00559247|Asunaprevir|asunaprevir|mesh-list
19427227|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
19711971|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711972|NCT04773236|Lidocaine|lidocaine|mesh-list
19711973|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
19711974|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
19711975|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19711976|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19711977|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
19711978|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19711979|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19711980|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19711981|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19711982|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19711983|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19711984|NCT04774393|Decitabine|decitabine|mesh-list
19711985|NCT04774393|Venetoclax|venetoclax|mesh-list
19711986|NCT04774393|Ivosidenib|ivosidenib|mesh-list
19711987|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19857329|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19857330|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
19857331|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857332|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
19857333|NCT00763360|Protective Agents|protective agents|mesh-ancestor
19857334|NCT00763412|Repaglinide|repaglinide|mesh-list
19857335|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857336|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857337|NCT00763451|Metformin|metformin|mesh-list
19857338|NCT00763451|Lixisenatide|lixisenatide|mesh-list
19857339|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857340|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857341|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
19857342|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19857343|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857344|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19857345|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
19857346|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19857347|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857348|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857349|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857350|NCT00763815|Metformin|metformin|mesh-list
19857351|NCT00763815|Pioglitazone|pioglitazone|mesh-list
19857352|NCT00763815|Lixisenatide|lixisenatide|mesh-list
19857353|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857354|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857355|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
19857356|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
19857357|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19857358|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19857359|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857360|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857361|NCT00763867|Urological Agents|urological agents|mesh-ancestor
19857362|NCT00763958|Buprenorphine|buprenorphine|mesh-list
19857363|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19857364|NCT00763958|Narcotics|narcotics|mesh-ancestor
19857365|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857366|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857367|NCT00763958|Analgesics|analgesics|mesh-ancestor
19857368|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
19857369|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857370|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19857371|NCT00763971|Methylphenidate|methylphenidate|mesh-list
19427228|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857372|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19711988|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
19427229|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427230|NCT00558207|Gemcitabine|gemcitabine|mesh-list
19427231|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19427232|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
19427233|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427234|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427235|NCT00558207|Antiviral Agents|antiviral agents|mesh-ancestor
19427236|NCT00558207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531773|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531774|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20531775|NCT01796613|Progestins|progestins|mesh-ancestor
20531776|NCT01796730|Bambuterol|bambuterol|mesh-list
20531777|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20531778|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
20531779|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531780|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531781|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19711989|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249788|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249789|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
20249790|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
20249791|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
20249792|NCT00442052|Aspirin|aspirin|mesh-list
20249793|NCT00442052|Omeprazole|omeprazole|mesh-list
20249794|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20249795|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249796|NCT00442052|Analgesics|analgesics|mesh-ancestor
20249797|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
20249798|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249799|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249800|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249801|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249802|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20531782|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
20249803|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20249804|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249805|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20249806|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249807|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249808|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
20249809|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20249810|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249811|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20249812|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
20249813|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20249814|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249815|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249816|NCT00442221|Naproxen|naproxen|mesh-list
20249817|NCT00442221|Sumatriptan|sumatriptan|mesh-list
20249818|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20249819|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249820|NCT00442221|Analgesics|analgesics|mesh-ancestor
20249821|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
20249822|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249823|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531783|NCT01796782|Capecitabine|capecitabine|mesh-list
20531784|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20531785|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
20531786|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531787|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531788|NCT01796808|Lidocaine|lidocaine|mesh-list
20531789|NCT01796808|Epinephrine|epinephrine|mesh-list
20531790|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
20531791|NCT01796808|Anesthetics|anesthetics|mesh-list
20531792|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427237|NCT00558207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427238|NCT00558207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427239|NCT00558207|Immunologic Factors|immunologic factors|mesh-ancestor
19427240|NCT00558207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427241|NCT00558038|Lactulose|lactulose|mesh-list
19427242|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427243|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
19427244|NCT00557973|Baclofen|baclofen|mesh-list
19711990|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19711991|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19711992|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
19711993|NCT04773392|Prednisone|prednisone|mesh-list
19711994|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
19711995|NCT04773392|Azathioprine|azathioprine|mesh-list
19711996|NCT04773392|Tacrolimus|tacrolimus|mesh-list
19711997|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
19711998|NCT04773392|Basiliximab|basiliximab|mesh-list
19711999|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19712000|NCT04773392|Antimetabolites|antimetabolites|mesh-list
19712001|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712002|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
19712003|NCT04773392|Hormones|hormones|mesh-ancestor
19712004|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19712005|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712006|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19712007|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712008|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712009|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
19712010|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19712011|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712012|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712013|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19712014|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19712015|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
19712016|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712017|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712018|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
19712019|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
19712020|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712021|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19712022|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19712023|NCT04773392|Protective Agents|protective agents|mesh-ancestor
19712024|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19712025|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712026|NCT04773093|Lidocaine|lidocaine|mesh-list
19712027|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712028|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
19712029|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712030|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712031|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
19712032|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712033|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19712034|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19712035|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19712036|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712037|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712038|NCT04772781|Ibuprofen|ibuprofen|mesh-list
19712039|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19712040|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19712041|NCT04772781|Analgesics|analgesics|mesh-ancestor
19712042|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
19712043|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712044|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427245|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19427246|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427247|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19427248|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427249|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19427250|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
19427251|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
19427252|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427253|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427254|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
19712045|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712046|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427255|NCT00557401|Baclofen|baclofen|mesh-list
19427256|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19427257|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427258|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19427259|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427260|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19427261|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
19427262|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
19427263|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427264|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427265|NCT00557128|Lisinopril|lisinopril|mesh-list
19427266|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19427267|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
19427268|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712047|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19712048|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712049|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712050|NCT04772729|Insulin|insulin|mesh-list
19712051|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19712052|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
19712053|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19712054|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712055|NCT04772521|Nicotine|nicotine|mesh-list
19712056|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19712057|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
19712058|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712059|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712060|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19712061|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19712062|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
19712063|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857373|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19712064|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712065|NCT04772287|Gemcitabine|gemcitabine|mesh-list
19712066|NCT04772287|Paclitaxel|paclitaxel|mesh-list
19712067|NCT04772287|Vinorelbine|vinorelbine|mesh-list
19712068|NCT04772287|Docetaxel|docetaxel|mesh-list
19712069|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19712070|NCT04772287|Cisplatin|cisplatin|mesh-list
19712071|NCT04772287|Carboplatin|carboplatin|mesh-list
19712072|NCT04772287|Pemetrexed|pemetrexed|mesh-list
19712073|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712074|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712075|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712076|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712077|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
19735828|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19451016|NCT03424356|Fentanyl|fentanyl|mesh-list
19451017|NCT03424356|Narcotics|narcotics|mesh-list
19451018|NCT03424356|Analgesics|analgesics|mesh-list
19451019|NCT03424356|Bromides|bromides|mesh-list
19451020|NCT03424356|Propofol|propofol|mesh-list
19451021|NCT03424356|Rocuronium|rocuronium|mesh-list
19451022|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19451023|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451024|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451025|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19451026|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
19451027|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
19451028|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19451029|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
19451030|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451031|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19451032|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
19451033|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19427269|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427270|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427271|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19427272|NCT00557128|Protective Agents|protective agents|mesh-ancestor
19427273|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427274|NCT00556920|Carvedilol|carvedilol|mesh-list
19427275|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19427276|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19427277|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
19712078|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712079|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19712080|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
19712081|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
19712082|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712083|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712084|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712085|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
19712086|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712087|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19712088|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19712089|NCT04772352|Febuxostat|febuxostat|mesh-list
19712090|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
19712091|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712092|NCT04772235|Osimertinib|osimertinib|mesh-list
19712093|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712094|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19712095|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712096|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733891|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733892|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19733893|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
19733894|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733895|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733896|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19733897|NCT04557137|Somatostatin|somatostatin|mesh-list
19733898|NCT04557137|Hormones|hormones|mesh-ancestor
19733899|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427278|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427279|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427280|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427281|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427282|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
19427283|NCT00556920|Protective Agents|protective agents|mesh-ancestor
19427284|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19427285|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427286|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19427287|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
19427288|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19427289|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19427290|NCT00555789|Tacrolimus|tacrolimus|mesh-list
19427291|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427292|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
19427293|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427294|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19427295|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427296|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427297|NCT00555035|Dolutegravir|dolutegravir|mesh-list
19427298|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19427299|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19427300|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427301|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427302|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19427303|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19427304|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
19427305|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427306|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19427307|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19427308|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19427309|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
19427310|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427311|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427312|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427313|NCT00553657|Urological Agents|urological agents|mesh-ancestor
19427314|NCT00553306|Aldesleukin|aldesleukin|mesh-list
19427315|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
19712097|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
19712098|NCT04771715|Nivolumab|nivolumab|mesh-list
19712099|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19712100|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712101|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19712102|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712103|NCT04771728|Metronidazole|metronidazole|mesh-list
19712104|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712105|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712106|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19712107|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19712108|NCT04771884|Vancomycin|vancomycin|mesh-list
19712109|NCT04771884|Meropenem|meropenem|mesh-list
19712110|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
19712111|NCT04771884|Linezolid|linezolid|mesh-list
19712112|NCT04771884|Ceftazidime|ceftazidime|mesh-list
19712113|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
19712114|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712115|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712116|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19712117|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712118|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712119|NCT04771754|Dolutegravir|dolutegravir|mesh-list
19712120|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19712121|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19857374|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857375|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20531793|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531794|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
20531795|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427316|NCT00553306|Interleukin-2|interleukin-2|mesh-list
19427317|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427318|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
19427319|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427320|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427321|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19427322|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
19427323|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427324|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427325|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19427326|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19427327|NCT00553306|Analgesics|analgesics|mesh-ancestor
19427328|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
19427329|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427330|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19712122|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712123|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427331|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19427332|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
19427333|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427334|NCT00552708|Lisinopril|lisinopril|mesh-list
19427335|NCT00552708|Carvedilol|carvedilol|mesh-list
19427336|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19427337|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
19427338|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427339|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427340|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427341|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19427342|NCT00552708|Protective Agents|protective agents|mesh-ancestor
19427343|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427344|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19427345|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19427346|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
19427347|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427348|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
19427349|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19427350|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427351|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19427352|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
19427353|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19427354|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19427355|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
19427356|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19427357|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19427358|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857376|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19857377|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857378|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857379|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
19427359|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427360|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
19427361|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19427362|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19427363|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427364|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427365|NCT00549510|Lisinopril|lisinopril|mesh-list
19427366|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19427367|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
19427368|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427369|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427370|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427371|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19427372|NCT00549510|Protective Agents|protective agents|mesh-ancestor
19427373|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427374|NCT00547651|Topotecan|topotecan|mesh-list
19427375|NCT00547651|Amrubicin|amrubicin|mesh-list
19427376|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19427377|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19427378|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427379|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427380|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427381|NCT00547066|Veltuzumab|veltuzumab|mesh-list
19427382|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427383|NCT00546793|Veltuzumab|veltuzumab|mesh-list
19427384|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427385|NCT00546780|Bortezomib|bortezomib|mesh-list
19427386|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427387|NCT00546273|Vaccines|vaccines|mesh-list
19427388|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
19427389|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427390|NCT00544960|Docetaxel|docetaxel|mesh-list
19712124|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19712125|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19712126|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
19857380|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857381|NCT00764309|Dasatinib|dasatinib|mesh-list
19857382|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857383|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19857384|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857385|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857386|NCT00764322|Tamoxifen|tamoxifen|mesh-list
19857387|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19857388|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
19857389|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857390|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857391|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19427391|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427392|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
19427393|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
19427394|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
19427395|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427396|NCT00544466|Fludarabine|fludarabine|mesh-list
19712127|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712128|NCT04771559|Antibodies|antibodies|mesh-list
19712129|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
19712130|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712131|NCT04771767|Ketamine|ketamine|mesh-list
19712132|NCT04771767|Analgesics|analgesics|mesh-ancestor
19712133|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
19712134|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712135|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712136|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19712137|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19712138|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
19427397|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
19427398|NCT00544466|Melphalan|melphalan|mesh-list
19427399|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427400|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19857392|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857393|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19857394|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19857395|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19857396|NCT00764361|Doxycycline|doxycycline|mesh-list
19857397|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19857398|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857399|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
19857400|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19857401|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19857402|NCT00764465|Ritonavir|ritonavir|mesh-list
19857403|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
19857404|NCT00764465|Maraviroc|maraviroc|mesh-list
19857405|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19857406|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19857407|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
19857408|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857409|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857410|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19857411|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19857412|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
19857413|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857414|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19857415|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19857416|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19857417|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19857418|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19857419|NCT00764517|Rituximab|rituximab|mesh-list
19857420|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19857421|NCT00764517|Vorinostat|vorinostat|mesh-list
19857422|NCT00764517|Cladribine|cladribine|mesh-list
19857423|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19857424|NCT00764517|Antibodies|antibodies|mesh-list
19857425|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
19857426|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19857427|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
19857428|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857429|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857430|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857431|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19857432|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857433|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857434|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19857435|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19857436|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
19857437|NCT00764738|Ranibizumab|ranibizumab|mesh-list
19857438|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19857439|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19857440|NCT00764738|Growth Substances|growth substances|mesh-ancestor
19857441|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857442|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
20531796|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19427401|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
19427402|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427403|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427404|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
19427405|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427406|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19427407|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
19427408|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20531797|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19857443|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857444|NCT00764751|Calcipotriene|calcipotriene|mesh-list
19857445|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
19857446|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19857447|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19857448|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427409|NCT00544115|Cyclosporine|cyclosporine|mesh-list
19427410|NCT00544115|Sirolimus|sirolimus|mesh-list
19857449|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19857450|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20531798|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20531799|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531800|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531801|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20531802|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19427411|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
19427412|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
19427413|NCT00544115|Melphalan|melphalan|mesh-list
19427414|NCT00544115|Busulfan|busulfan|mesh-list
19427415|NCT00544115|Methotrexate|methotrexate|mesh-list
19427416|NCT00544115|Fludarabine|fludarabine|mesh-list
19427417|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
19427418|NCT00544115|Etoposide|etoposide|mesh-list
19427419|NCT00544115|Tacrolimus|tacrolimus|mesh-list
19427420|NCT00544115|Cyclosporins|cyclosporins|mesh-list
19427421|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427422|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
19427423|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427424|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427425|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19427426|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
19427427|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427428|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427429|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19427430|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19427431|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
19427432|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19712139|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
19712140|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712141|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19712142|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19712143|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427433|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19427434|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
19427435|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
19427436|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427437|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19427438|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19427439|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19427440|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19427441|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19427442|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19427443|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
19427444|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427445|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19427446|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19427447|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
19712144|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531803|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531804|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20531805|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20531806|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20531807|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
20531808|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20531809|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
20531810|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
20531811|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
20531812|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20531813|NCT01796899|Brivaracetam|brivaracetam|mesh-list
20531814|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
20531815|NCT01796938|Lacosamide|lacosamide|mesh-list
19427448|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19427449|NCT00543582|Azacitidine|azacitidine|mesh-list
19427450|NCT00543582|Mocetinostat|mocetinostat|mesh-list
19427451|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19427452|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
19427453|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427454|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427455|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427456|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19427457|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
19427458|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427459|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
19427460|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427461|NCT00542724|Insulin|insulin|mesh-list
19427462|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19427463|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427464|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427465|NCT00542633|Insulin|insulin|mesh-list
19427466|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19427467|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427468|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857451|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857452|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857453|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
19857454|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857455|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19857456|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19857457|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19857458|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
19857459|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19857460|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857461|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19857462|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19857463|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19857464|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19857465|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19857466|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19857467|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19857468|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19857469|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
19857470|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19857471|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19427469|NCT00540358|Gemcitabine|gemcitabine|mesh-list
19427470|NCT00540358|Carboplatin|carboplatin|mesh-list
19427471|NCT00540358|Iniparib|iniparib|mesh-list
19712145|NCT04771520|Piperazine|piperazine|mesh-list
19712146|NCT04771520|Mebendazole|mebendazole|mesh-list
19712147|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
19712148|NCT04771520|DMP 777|dmp 777|mesh-list
19712149|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
19712150|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
19712151|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19712152|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712153|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712154|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712155|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712156|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712157|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427472|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427473|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19427474|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
19427475|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427476|NCT00540358|Antiviral Agents|antiviral agents|mesh-ancestor
19427477|NCT00540358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427478|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427479|NCT00540358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427480|NCT00540358|Immunologic Factors|immunologic factors|mesh-ancestor
19427481|NCT00540358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427482|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19427483|NCT00539721|Ondansetron|ondansetron|mesh-list
19427484|NCT00539721|Rolapitant|rolapitant|mesh-list
19427485|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
19712158|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531816|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
20531817|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20531818|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20531819|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531820|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531821|NCT01796951|Aspirin|aspirin|mesh-list
20531822|NCT01796951|Celecoxib|celecoxib|mesh-list
20531823|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20531824|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20531825|NCT01796951|Analgesics|analgesics|mesh-ancestor
20531826|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
20531827|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531828|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531829|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20531830|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20531831|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20531832|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20531833|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531834|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20531835|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20531836|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531837|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
20531838|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20553323|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553324|NCT01928576|Nivolumab|nivolumab|mesh-list
20531839|NCT01797107|Azithromycin|azithromycin|mesh-list
20531840|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712159|NCT04771390|Selitrectinib|selitrectinib|mesh-list
20531841|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531842|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20531843|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20531844|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531845|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
20531846|NCT01797198|Repaglinide|repaglinide|mesh-list
20531847|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
19427486|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
19427487|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427488|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427489|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427490|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
19427491|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19427492|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19427493|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
19427494|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427495|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427496|NCT00539721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19427497|NCT00539721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19427498|NCT00539721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427499|NCT00539721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19427500|NCT00539721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19427501|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19451034|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19451035|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19451036|NCT03424291|Apatinib|apatinib|mesh-list
19451037|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451038|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19451039|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451040|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451041|NCT03424226|Acetazolamide|acetazolamide|mesh-list
19451042|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
20531848|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427502|NCT00537043|Carvedilol|carvedilol|mesh-list
19427503|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19427504|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19427505|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
19427506|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427507|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427508|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427509|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427510|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
19427511|NCT00537043|Protective Agents|protective agents|mesh-ancestor
19427512|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19712160|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712161|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712162|NCT04771026|Dexamethasone|dexamethasone|mesh-list
19712163|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712164|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
19712165|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
19712166|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712167|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712168|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19712169|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
19712170|NCT04771026|Hormones|hormones|mesh-ancestor
19712171|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19712172|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19712173|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712174|NCT04771000|Ambrisentan|ambrisentan|mesh-list
19712175|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19712176|NCT04770740|Vitamin K|vitamin k|mesh-list
19712177|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
19857472|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
19857473|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857474|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19857475|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19857476|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857477|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857478|NCT00765063|Dalteparin|dalteparin|mesh-list
19857479|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
19857480|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19857481|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19857482|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857483|NCT00765102|Bortezomib|bortezomib|mesh-list
19857484|NCT00765102|Romidepsin|romidepsin|mesh-list
19857485|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857486|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19857487|NCT00765128|Ketorolac|ketorolac|mesh-list
19857488|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19857489|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857490|NCT00765128|Analgesics|analgesics|mesh-ancestor
19857491|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
19857492|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857493|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857494|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19857495|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857496|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19857497|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857498|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857499|NCT00765206|Omeprazole|omeprazole|mesh-list
19857500|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19857501|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19857502|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19857503|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857504|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857505|NCT00765232|Ketorolac|ketorolac|mesh-list
19857506|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19857507|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857508|NCT00765232|Analgesics|analgesics|mesh-ancestor
19857509|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
19857510|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712178|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
19712179|NCT04770740|Vitamins|vitamins|mesh-ancestor
20553325|NCT01928576|Azacitidine|azacitidine|mesh-list
20553326|NCT01928576|Entinostat|entinostat|mesh-list
20553327|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20553328|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712180|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
19712181|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712182|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19712183|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19712184|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712185|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
19712186|NCT04770740|Coagulants|coagulants|mesh-ancestor
19712187|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
19712188|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19712189|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19712190|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712191|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
19712192|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
19712193|NCT04770688|Osimertinib|osimertinib|mesh-list
19712194|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531849|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531850|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20531851|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
20531852|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531853|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20531854|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20531855|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20531856|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531857|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
20531858|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19712195|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19712196|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531859|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20531860|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531861|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
20531862|NCT01797289|Coagulants|coagulants|mesh-ancestor
20531863|NCT01797315|Sirolimus|sirolimus|mesh-list
20531864|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20531865|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531866|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20531867|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531868|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
20531869|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531870|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
20531871|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531872|NCT01797341|Tacrolimus|tacrolimus|mesh-list
20531873|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531874|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
20531875|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531876|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19427513|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427514|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20531877|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712197|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712198|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19712199|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19712200|NCT04770961|Ropivacaine|ropivacaine|mesh-list
19712201|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712202|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
19712203|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712204|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712205|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
19712206|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712207|NCT04770155|Bosentan|bosentan|mesh-list
19712208|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
19712209|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
19712210|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19712211|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19712212|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712213|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712214|NCT04770155|Urological Agents|urological agents|mesh-ancestor
19712215|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19712216|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19712217|NCT04770389|Ezetimibe|ezetimibe|mesh-list
19712218|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
19712219|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19712220|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
19712221|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712222|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19712223|NCT04769908|Lenvatinib|lenvatinib|mesh-list
19712224|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712225|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19712226|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712227|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712228|NCT04769557|Acetaminophen|acetaminophen|mesh-list
19712229|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857511|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857512|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19857513|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857514|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19857515|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857516|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857517|NCT00765245|Rituximab|rituximab|mesh-list
19857518|NCT00765245|Lenalidomide|lenalidomide|mesh-list
19857519|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19857520|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857521|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
19857522|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531878|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531879|NCT01797601|Insulin|insulin|mesh-list
20531880|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20531881|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531882|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531883|NCT01797666|Pioglitazone|pioglitazone|mesh-list
20531884|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20531885|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712230|NCT04769557|Analgesics|analgesics|mesh-ancestor
20531886|NCT01797718|Letrozole|letrozole|mesh-list
19427515|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
19427516|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19427517|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19427518|NCT00535366|Fluticasone|fluticasone|mesh-list
19427519|NCT00535366|Ciclesonide|ciclesonide|mesh-list
19427520|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
19427521|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19712231|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
19712232|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712233|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712234|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
19712235|NCT04769713|Ropivacaine|ropivacaine|mesh-list
20249824|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249825|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249826|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
19712236|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712237|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
19712238|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712239|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712240|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
19712241|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712242|NCT04769583|Metronidazole|metronidazole|mesh-list
19712243|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712244|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712245|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19712246|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19712247|NCT04769778|Valsartan|valsartan|mesh-list
19712248|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19712249|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19712250|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19712251|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733900|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733901|NCT04557202|Tamsulosin|tamsulosin|mesh-list
19733902|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19733903|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19733904|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19733905|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733906|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733907|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733908|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733909|NCT04557202|Urological Agents|urological agents|mesh-ancestor
19733910|NCT04557020|Gemcitabine|gemcitabine|mesh-list
19733911|NCT04557020|Cisplatin|cisplatin|mesh-list
19733912|NCT04557020|Antibodies|antibodies|mesh-list
19733913|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
19733914|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733915|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19733916|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
19733917|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733918|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733919|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
19733920|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733921|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733922|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733923|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20249827|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249828|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249829|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249830|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20531887|NCT01797718|Testosterone|testosterone|mesh-list
19427522|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427523|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19427524|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
19427525|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427526|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427527|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19427528|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
19427529|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
19427530|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19427531|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
19427532|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19427533|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
19427534|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427535|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427536|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19427537|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19427538|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19427539|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
19427540|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
19427541|NCT00535366|Hormones|hormones|mesh-ancestor
19427542|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427543|NCT00534027|Conatumumab|conatumumab|mesh-list
19427544|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19427545|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427546|NCT00532311|Atorvastatin|atorvastatin|mesh-list
19427547|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19427548|NCT00532311|Simvastatin|simvastatin|mesh-list
19427549|NCT00532311|Pravastatin|pravastatin|mesh-list
19427550|NCT00532311|Lovastatin|lovastatin|mesh-list
19427551|NCT00532311|L 647318|l 647318|mesh-list
19427552|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
19427553|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19427554|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19427555|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19427556|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
19427557|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427558|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19427559|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427560|NCT00532038|Ketoprofen|ketoprofen|mesh-list
19427561|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19427562|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19427563|NCT00532038|Analgesics|analgesics|mesh-ancestor
19427564|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
19427565|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427566|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427567|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427568|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427569|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19427570|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427571|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427572|NCT00531622|Citalopram|citalopram|mesh-list
19427573|NCT00531622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19427574|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19427575|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427576|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427577|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857523|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857524|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19857525|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19857526|NCT00765245|Growth Substances|growth substances|mesh-ancestor
19857527|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
19857528|NCT00765336|Minocycline|minocycline|mesh-list
19427578|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
19427579|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427580|NCT00531622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19427581|NCT00531622|Antidepressive Agents|antidepressive agents|mesh-ancestor
19427582|NCT00531622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19427583|NCT00530062|Albuterol|albuterol|mesh-list
19427584|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19427585|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
19427586|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712252|NCT04769258|Vaccines|vaccines|mesh-list
19712253|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
19712254|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712255|NCT04769297|Ketamine|ketamine|mesh-list
19712256|NCT04769297|Analgesics|analgesics|mesh-ancestor
19712257|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
19712258|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712259|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712260|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19712261|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19857529|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712262|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
19712263|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
19427587|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427588|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19427589|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
19427590|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
19427591|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19427592|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19427593|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19427594|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19427595|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
19427596|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427597|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427598|NCT00529503|Rituximab|rituximab|mesh-list
19427599|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
19427600|NCT00529503|Carboplatin|carboplatin|mesh-list
19427601|NCT00529503|Etoposide|etoposide|mesh-list
19427602|NCT00529503|Ifosfamide|ifosfamide|mesh-list
19427603|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19427604|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427605|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
19427606|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427607|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427608|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19427609|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19427610|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19427611|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427612|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427613|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19427614|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
19427615|NCT00529178|Pravastatin|pravastatin|mesh-list
19427616|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19427617|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19427618|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
19427619|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427620|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19427621|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19427622|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427623|NCT00529152|Deferiprone|deferiprone|mesh-list
19427624|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19427625|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
19427626|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
19427627|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427628|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19427629|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19427630|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19427631|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427632|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427633|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
19427634|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427635|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427636|NCT00528333|Cytarabine|cytarabine|mesh-list
19427637|NCT00528333|Lintuzumab|lintuzumab|mesh-list
19427638|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19427639|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
19427640|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427641|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427642|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
19427643|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427644|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427645|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
19427646|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427647|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19427648|NCT00526227|Clotrimazole|clotrimazole|mesh-list
19427649|NCT00526227|Miconazole|miconazole|mesh-list
19427650|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19427651|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427652|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
19427653|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19427654|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19427655|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427656|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427657|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19427658|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
19712264|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427659|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427660|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427661|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19427662|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19427663|NCT00525941|Indiplon|indiplon|mesh-list
19427664|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19427665|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427666|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427667|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
19427668|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
19427669|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427670|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427671|NCT00525330|Metformin|metformin|mesh-list
19427672|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427673|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427674|NCT00524277|Molgramostim|molgramostim|mesh-list
19427675|NCT00524277|Vaccines|vaccines|mesh-list
19427676|NCT00524277|Sargramostim|sargramostim|mesh-list
19427677|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
19427678|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427679|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427680|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19427681|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19427682|NCT00523042|Insulin|insulin|mesh-list
19427683|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19427684|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
19427685|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427686|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427687|NCT00522834|Paclitaxel|paclitaxel|mesh-list
19427688|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19427689|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427690|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
19427691|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
19427692|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
19427693|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427694|NCT00520923|Olanzapine|olanzapine|mesh-list
19427695|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
19427696|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
19427697|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427698|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427699|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427700|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19427701|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19427702|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427703|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19427704|NCT00520923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19427705|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19427706|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427707|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427708|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427709|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
19427710|NCT00519142|Mitiglinide|mitiglinide|mesh-list
19427711|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427712|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249831|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19427713|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20249832|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20249833|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
19427714|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
20249834|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249835|NCT00442234|Monteplase|monteplase|mesh-list
20249836|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20249837|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20249838|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249839|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20249840|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19427715|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
19712265|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19712266|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19712267|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712268|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712269|NCT04769076|Paclitaxel|paclitaxel|mesh-list
19712270|NCT04769076|Cisplatin|cisplatin|mesh-list
19712271|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19712272|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712273|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712274|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712275|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712276|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712277|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712278|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
19712279|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19712280|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712281|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
19712282|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712283|NCT04768764|Bupivacaine|bupivacaine|mesh-list
19712284|NCT04768764|Anesthetics|anesthetics|mesh-list
19712285|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712286|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712287|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712288|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
19712289|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712290|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
19857530|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857531|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
19857532|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19857533|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19857534|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19857535|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857536|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857537|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
19857538|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857539|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857540|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19857541|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857542|NCT00765648|Labetalol|labetalol|mesh-list
19857543|NCT00765648|Nicardipine|nicardipine|mesh-list
19857544|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19857545|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19857546|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
20531888|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531889|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20531890|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20531891|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531892|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531893|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20531894|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
19857547|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857548|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857549|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857550|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19427716|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427717|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
19427718|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427719|NCT00517153|Miglustat|miglustat|mesh-list
19427720|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427721|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427722|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19427723|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19427724|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
19427725|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427726|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19427727|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427728|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427729|NCT00517049|Rituximab|rituximab|mesh-list
19427730|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19427731|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427732|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
19427733|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427734|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427735|NCT00514371|Bortezomib|bortezomib|mesh-list
19427736|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427737|NCT00514267|Prednisone|prednisone|mesh-list
19427738|NCT00514267|Docetaxel|docetaxel|mesh-list
19427739|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427740|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
19427741|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
19427742|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
19427743|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427744|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427745|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
19427746|NCT00514267|Hormones|hormones|mesh-ancestor
19427747|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427748|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427749|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19427750|NCT00512317|Ganaxolone|ganaxolone|mesh-list
19712291|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19712292|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712293|NCT04768465|Prednisone|prednisone|mesh-list
19427751|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
19427752|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427753|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427754|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427755|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
19427756|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
19427757|NCT00511459|Paclitaxel|paclitaxel|mesh-list
19427758|NCT00511459|Bevacizumab|bevacizumab|mesh-list
19427759|NCT00511459|Trebananib|trebananib|mesh-list
19857551|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
19857552|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
19857553|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857554|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19857555|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19857556|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19857557|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857558|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20531895|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531896|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531897|NCT01797718|Androgens|androgens|mesh-ancestor
20531898|NCT01797718|Hormones|hormones|mesh-ancestor
20531899|NCT01797757|Orlistat|orlistat|mesh-list
20531900|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531901|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531902|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20531903|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20531904|NCT01797796|Capsaicin|capsaicin|mesh-list
20531905|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
20531906|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
20531907|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
20531908|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531909|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531910|NCT01797848|Ribavirin|ribavirin|mesh-list
20531911|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19712294|NCT04768465|Bromides|bromides|mesh-list
19712295|NCT04768465|Tacrolimus|tacrolimus|mesh-list
19712296|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19712297|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712298|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
19712299|NCT04768465|Hormones|hormones|mesh-ancestor
19712300|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19712301|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712302|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19712303|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712304|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712305|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
20531912|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
19427760|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19427761|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427762|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
19427763|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
19427764|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
19427765|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427766|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19427767|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19427768|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19427769|NCT00511459|Growth Substances|growth substances|mesh-ancestor
19427770|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427771|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
19427772|NCT00511043|Vatalanib|vatalanib|mesh-list
19427773|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19427774|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427775|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427776|NCT00508989|Niacin|niacin|mesh-list
19427777|NCT00508989|Acetylcholine|acetylcholine|mesh-list
19427778|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19427779|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
19427780|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427781|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19427782|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
19427783|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
19427784|NCT00508989|Vitamins|vitamins|mesh-ancestor
19427785|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
19427786|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427787|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19427788|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
19857559|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
19857560|NCT00765661|Tacrolimus|tacrolimus|mesh-list
19857561|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19857562|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
19857563|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857564|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19857565|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857566|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712306|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19712307|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712308|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712309|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
19712310|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19712311|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
19712312|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712313|NCT04768231|Rifampin|rifampin|mesh-list
19712314|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19712315|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
19712316|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712317|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712318|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
19712319|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19712320|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712321|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712322|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19712323|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19712324|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19712325|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19712326|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19712327|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19712328|NCT04768075|Paclitaxel|paclitaxel|mesh-list
19712329|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19857567|NCT00765674|Amlodipine|amlodipine|mesh-list
19427789|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427790|NCT00508625|Paclitaxel|paclitaxel|mesh-list
19427791|NCT00508625|Bevacizumab|bevacizumab|mesh-list
19427792|NCT00508625|Carboplatin|carboplatin|mesh-list
19427793|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19427794|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427795|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
19427796|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
19427797|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
19427798|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427799|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19427800|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19712330|NCT04768075|Carboplatin|carboplatin|mesh-list
19712331|NCT04768075|Pemetrexed|pemetrexed|mesh-list
19712332|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712333|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712334|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712335|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712336|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712337|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712338|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712339|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19712340|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19712341|NCT04768439|Vitamin D|vitamin d|mesh-list
19712342|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
19712343|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19712344|NCT04768439|Calcitriol|calcitriol|mesh-list
19712345|NCT04768439|Vitamins|vitamins|mesh-list
19712346|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
19712347|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712348|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19712349|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19712350|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19712351|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712352|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712353|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19712354|NCT04768023|Vitamin D|vitamin d|mesh-list
19712355|NCT04768023|Vitamins|vitamins|mesh-ancestor
19712356|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
19712357|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712358|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19712359|NCT04767828|Capecitabine|capecitabine|mesh-list
19712360|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19712361|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
19712362|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712363|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712364|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
19712365|NCT04767633|Analgesics|analgesics|mesh-ancestor
19857568|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19857569|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19857570|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19857571|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857572|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531913|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531914|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
19712366|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
19712367|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531915|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531916|NCT01797900|Paclitaxel|paclitaxel|mesh-list
20531917|NCT01797900|Cisplatin|cisplatin|mesh-list
20531918|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20531919|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531920|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
20531921|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20531922|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
20531923|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427801|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19427802|NCT00508625|Growth Substances|growth substances|mesh-ancestor
19427803|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427804|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
19427805|NCT00508066|Bupivacaine|bupivacaine|mesh-list
19427806|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
19427807|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
19427808|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427809|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427810|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
19427811|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427812|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19427813|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19427814|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19427815|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427816|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427817|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427818|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427819|NCT00507936|Analgesics|analgesics|mesh-ancestor
19427820|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
19427821|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427822|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
19427823|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19427824|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
19427825|NCT00501709|Abatacept|abatacept|mesh-list
19427826|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19427827|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19427828|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427829|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427830|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
19427831|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427832|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427833|NCT00498836|Sorafenib|sorafenib|mesh-list
19427834|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427835|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19427836|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427837|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427838|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
19427839|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19427840|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
19427841|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427842|NCT00495885|Volinanserin|volinanserin|mesh-list
19427843|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19427844|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
19427845|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427846|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427847|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427848|NCT00495131|Interferons|interferons|mesh-list
19427849|NCT00495131|Ribavirin|ribavirin|mesh-list
19427850|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
19427851|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
19427852|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19427853|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427854|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
19427855|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427856|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
19427857|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427858|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
19427859|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427860|NCT00491738|Bevacizumab|bevacizumab|mesh-list
19427861|NCT00491738|Sunitinib|sunitinib|mesh-list
19712368|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712369|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
19712370|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712371|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19712372|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
19427862|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19427863|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427864|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19427865|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19427866|NCT00491738|Growth Substances|growth substances|mesh-ancestor
19427867|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427868|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
19427869|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19427870|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427871|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427872|NCT00489203|Beclomethasone|beclomethasone|mesh-list
19427873|NCT00489203|Methotrexate|methotrexate|mesh-list
19427874|NCT00489203|Tacrolimus|tacrolimus|mesh-list
19427875|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19427876|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
19427877|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19427878|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427879|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19427880|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
19427881|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427882|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427883|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
19427884|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427885|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19427886|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19427887|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
19427888|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19427889|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19427890|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19427891|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427892|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
19427893|NCT00489203|Hormones|hormones|mesh-ancestor
19427894|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427895|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19427896|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
19427897|NCT00488839|Baclofen|baclofen|mesh-list
19427898|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19427899|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427900|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19427901|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427902|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19427903|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
19427904|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
19427905|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427906|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427907|NCT00488267|Ketoprofen|ketoprofen|mesh-list
19427908|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19427909|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19427910|NCT00488267|Analgesics|analgesics|mesh-ancestor
19427911|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
19427912|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427913|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427914|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427915|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712373|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19712374|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712375|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531924|NCT01797913|Gemcitabine|gemcitabine|mesh-list
20531925|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20531926|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
20531927|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531928|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531929|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
20531930|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20531931|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427916|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19427917|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249841|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
20249842|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20249843|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19427918|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427919|NCT00486512|Aspirin|aspirin|mesh-list
19427920|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
19427921|NCT00486512|Calcitriol|calcitriol|mesh-list
19427922|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19427923|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
19427924|NCT00486512|Calcium|calcium|mesh-list
19427925|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19427926|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427927|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19427928|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19427929|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19427930|NCT00486512|Analgesics|analgesics|mesh-ancestor
19427931|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
19427932|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427933|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427934|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712376|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19712377|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
19712378|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19712379|NCT04767243|Methamphetamine|methamphetamine|mesh-list
19712380|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19712381|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712382|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
19712383|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
19857573|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19857574|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857575|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
19857576|NCT00765674|Diuretics|diuretics|mesh-ancestor
19857577|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
19857578|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19857579|NCT00765726|Factor VIII|factor viii|mesh-list
19857580|NCT00765726|Coagulants|coagulants|mesh-ancestor
19857581|NCT00765817|Exenatide|exenatide|mesh-list
19857582|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857583|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857584|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19857585|NCT00765817|Incretins|incretins|mesh-ancestor
19857586|NCT00765817|Hormones|hormones|mesh-ancestor
19857587|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969629|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19969630|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20249844|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
20249845|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19427935|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19427936|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19427937|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427938|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19427939|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19427940|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427941|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
19427942|NCT00486512|Antacids|antacids|mesh-ancestor
19427943|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19427944|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19427945|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19427946|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19427947|NCT00486512|Vitamins|vitamins|mesh-ancestor
19427948|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
19427949|NCT00486200|Valacyclovir|valacyclovir|mesh-list
19427950|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
19427951|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427952|NCT00485563|Folic Acid|folic acid|mesh-list
19427953|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
19427954|NCT00485563|Interferons|interferons|mesh-list
19427955|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
19427956|NCT00485563|Interleukin-2|interleukin-2|mesh-list
19427957|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19427958|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19427959|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
19427960|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19427961|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
19427962|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427963|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19427964|NCT00485563|Analgesics|analgesics|mesh-ancestor
19427965|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
19427966|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19427967|NCT00485563|Hematinics|hematinics|mesh-ancestor
19427968|NCT00485563|Vitamins|vitamins|mesh-ancestor
19427969|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
19427970|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19427971|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19427972|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
19427973|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19427974|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19427975|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427976|NCT00484419|Incretins|incretins|mesh-ancestor
19427977|NCT00484419|Hormones|hormones|mesh-ancestor
19427978|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19427979|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19427980|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
19427981|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19427982|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19427983|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19427984|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19427985|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
19427986|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19427987|NCT00483977|Oxycodone|oxycodone|mesh-list
19427988|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19427989|NCT00483977|Narcotics|narcotics|mesh-ancestor
19427990|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19427991|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427992|NCT00483977|Analgesics|analgesics|mesh-ancestor
19427993|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
19427994|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451043|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19451044|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451045|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451046|NCT03424226|Diuretics|diuretics|mesh-ancestor
19451047|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
19451048|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452729|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452730|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452731|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452732|NCT03411252|Urological Agents|urological agents|mesh-ancestor
19452733|NCT03411161|Paclitaxel|paclitaxel|mesh-list
19452734|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19452735|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19452736|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452737|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
19452738|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
19452739|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
19452740|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452741|NCT03411109|Hydromorphone|hydromorphone|mesh-list
19452742|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19712384|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452743|NCT03411109|Narcotics|narcotics|mesh-ancestor
19452744|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452745|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531932|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20531933|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
20531934|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531935|NCT01797926|Losartan|losartan|mesh-list
20531936|NCT01797926|Amlodipine|amlodipine|mesh-list
20531937|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20531938|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20531939|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20531940|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531941|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20531942|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531943|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
20531944|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19427995|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
19427996|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19427997|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
19427998|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857588|NCT00765856|Oxymorphone|oxymorphone|mesh-list
19857589|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19857590|NCT00765856|Narcotics|narcotics|mesh-ancestor
19857591|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857592|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19427999|NCT00481325|Citalopram|citalopram|mesh-list
19428000|NCT00481325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19428001|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19428002|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428003|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428004|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428005|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
19428006|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428007|NCT00481325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19428008|NCT00481325|Antidepressive Agents|antidepressive agents|mesh-ancestor
19428009|NCT00481325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19428010|NCT00480831|Paclitaxel|paclitaxel|mesh-list
19428011|NCT00480831|Bevacizumab|bevacizumab|mesh-list
19428012|NCT00480831|Carboplatin|carboplatin|mesh-list
19428013|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19428014|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428015|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
19428016|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
19428017|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
19428018|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428019|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428020|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19857593|NCT00765856|Analgesics|analgesics|mesh-ancestor
19857594|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
19428021|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19428022|NCT00480831|Growth Substances|growth substances|mesh-ancestor
19428023|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428024|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428025|NCT00479817|Paclitaxel|paclitaxel|mesh-list
19428026|NCT00479817|Trebananib|trebananib|mesh-list
19428027|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19428028|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428029|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
19428030|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
19428031|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712385|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
19712386|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712387|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712388|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
19712389|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20531945|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20531946|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20531947|NCT01797978|Methylene Blue|methylene blue|mesh-list
20531948|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531949|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531950|NCT01797991|Dexamethasone|dexamethasone|mesh-list
20531951|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
20531952|NCT01797991|BB 1101|bb 1101|mesh-list
20531953|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20531954|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
19428032|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712390|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20531955|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
20531956|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20531957|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20531958|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531959|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
20531960|NCT01797991|Hormones|hormones|mesh-ancestor
20531961|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531962|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20531963|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428033|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19428034|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19428035|NCT00479817|Growth Substances|growth substances|mesh-ancestor
19428036|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428037|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428038|NCT00479258|Insulin|insulin|mesh-list
19428039|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19428040|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428041|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428042|NCT00478972|Rimonabant|rimonabant|mesh-list
19428043|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19428044|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19428045|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19428046|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428047|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428048|NCT00478972|Hormones|hormones|mesh-ancestor
19428049|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428050|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428051|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19428052|NCT00478595|Rimonabant|rimonabant|mesh-list
19428053|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19428054|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19428055|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19428056|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428057|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428058|NCT00478595|Hormones|hormones|mesh-ancestor
19428059|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428060|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428061|NCT00478179|Bupivacaine|bupivacaine|mesh-list
19428062|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
19428063|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
19428064|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19428065|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428066|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
19428067|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428068|NCT00477529|Docetaxel|docetaxel|mesh-list
19428069|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428070|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
19428071|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
19428072|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
19428073|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428074|NCT00474188|Dexamethasone|dexamethasone|mesh-list
19428075|NCT00474188|Lenalidomide|lenalidomide|mesh-list
19428076|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428077|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
19428078|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
19428079|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428080|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428081|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428082|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
19428083|NCT00474188|Hormones|hormones|mesh-ancestor
19428084|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428085|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19428086|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428087|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
19428088|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19428089|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19857595|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428090|NCT00474188|Growth Substances|growth substances|mesh-ancestor
19428091|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428092|NCT00472693|Bevacizumab|bevacizumab|mesh-list
19428093|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19428094|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428095|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428096|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19712391|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712392|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19712393|NCT04767295|Paclitaxel|paclitaxel|mesh-list
19712394|NCT04767295|Carboplatin|carboplatin|mesh-list
19712395|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712396|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712397|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712398|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712399|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712400|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428097|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19733924|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19733925|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
19733926|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
19733927|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19733928|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733929|NCT04556760|Prednisolone|prednisolone|mesh-list
19733930|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733931|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
19733932|NCT04556760|Hormones|hormones|mesh-ancestor
19733933|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733934|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733935|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733936|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733937|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
19733938|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19733939|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733940|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
20531964|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
20531965|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20531966|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20531967|NCT01798017|Misoprostol|misoprostol|mesh-list
20531968|NCT01798017|Mifepristone|mifepristone|mesh-list
20531969|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20531970|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
20531971|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20531972|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428098|NCT00472693|Growth Substances|growth substances|mesh-ancestor
19428099|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428100|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428101|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19428102|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19428103|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
19428104|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428105|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428106|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19428107|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
19428108|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19428109|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19428110|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19428111|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428112|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428113|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428114|NCT00468442|Sirolimus|sirolimus|mesh-list
19428115|NCT00468442|Rituximab|rituximab|mesh-list
19428116|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19428117|NCT00468442|Daclizumab|daclizumab|mesh-list
19428118|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428119|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428120|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
19428121|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428122|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428123|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19428124|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428125|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19428126|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
19428127|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428128|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
19428129|NCT00468403|Abatacept|abatacept|mesh-list
19428130|NCT00468403|Tacrolimus|tacrolimus|mesh-list
19428131|NCT00468403|Basiliximab|basiliximab|mesh-list
19428132|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428133|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
19428134|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428135|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19428136|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428137|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428138|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19428139|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428140|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19428141|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
19428142|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19428143|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428144|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19428145|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428146|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
19428147|NCT00468273|Antibodies|antibodies|mesh-list
19428148|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
19428149|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19428150|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19428151|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
19428152|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428153|NCT00468117|Etanercept|etanercept|mesh-list
19428154|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19428155|NCT00468117|Basiliximab|basiliximab|mesh-list
19428156|NCT00468117|Daclizumab|daclizumab|mesh-list
19428157|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19428158|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19428159|NCT00468117|Analgesics|analgesics|mesh-ancestor
19428160|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
19428161|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428162|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428163|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428164|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428165|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428166|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428167|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
19428168|NCT00468039|Metformin|metformin|mesh-list
19428169|NCT00468039|Vildagliptin|vildagliptin|mesh-list
20531973|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20531974|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20531975|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
20531976|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20531977|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20531978|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20531979|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20531980|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
20531981|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20531982|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20531983|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
20531984|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20531985|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
20531986|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20531987|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20531988|NCT01798030|Vitamin D|vitamin d|mesh-list
19428170|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428171|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428172|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20531989|NCT01798030|Vitamins|vitamins|mesh-ancestor
20531990|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
20531991|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428173|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
19428174|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428175|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428176|NCT00467402|S 20098|s 20098|mesh-list
19428177|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19428178|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19428179|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428180|NCT00467025|Sorafenib|sorafenib|mesh-list
19428181|NCT00467025|Trebananib|trebananib|mesh-list
19428182|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428183|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19428184|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428185|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428186|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19428187|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19428188|NCT00467025|Growth Substances|growth substances|mesh-ancestor
19428189|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428190|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428191|NCT00465959|Trospium chloride|trospium chloride|mesh-list
19428192|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
19428193|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
19428194|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428195|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428196|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19428197|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19428198|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
19428199|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428200|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428201|NCT00465959|Urological Agents|urological agents|mesh-ancestor
19428202|NCT00465803|Timolol|timolol|mesh-list
19428203|NCT00465803|Travoprost|travoprost|mesh-list
19428204|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19428205|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19428206|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19428207|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19428208|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428209|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428210|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428211|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428212|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19428213|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19428214|NCT00465517|Ganaxolone|ganaxolone|mesh-list
19428215|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
19428216|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428217|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428218|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428219|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
19428220|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
19428221|NCT00464633|Alvocidib|alvocidib|mesh-list
19428222|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428223|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428224|NCT00464633|Growth Substances|growth substances|mesh-ancestor
19428225|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428226|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19428227|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428228|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428229|NCT00464555|Sirolimus|sirolimus|mesh-list
19428230|NCT00464555|Lisofylline|lisofylline|mesh-list
19428231|NCT00464555|Tacrolimus|tacrolimus|mesh-list
19428232|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19428233|NCT00464555|Basiliximab|basiliximab|mesh-list
19428234|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428235|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
19428236|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428237|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19428238|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428239|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428240|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19428241|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428242|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19428243|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428244|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
19428245|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19428246|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19428247|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19428248|NCT00464555|Analgesics|analgesics|mesh-ancestor
19428249|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
19428250|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428251|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428252|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428253|NCT00464243|Volinanserin|volinanserin|mesh-list
19428254|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19428255|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
19428256|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428257|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428258|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428259|NCT00464061|Volinanserin|volinanserin|mesh-list
19428260|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19712401|NCT04767217|Lumefantrine|lumefantrine|mesh-list
19712402|NCT04767217|Artemether|artemether|mesh-list
19712403|NCT04767217|Piperaquine|piperaquine|mesh-list
19712404|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19712405|NCT04767217|Artenimol|artenimol|mesh-list
19712406|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
19712407|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19712408|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19712409|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428261|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
19428262|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428263|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428264|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428265|NCT00463242|S 20098|s 20098|mesh-list
19428266|NCT00463242|Paroxetine|paroxetine|mesh-list
19428267|NCT00463242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19428268|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19428269|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428270|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428271|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428272|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
19428273|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428274|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19428275|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
19428276|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19712410|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
19712411|NCT04767308|Fludarabine|fludarabine|mesh-list
19712412|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712413|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
19712414|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712415|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712416|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19712417|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
19712418|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712419|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712420|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19712421|NCT04767178|Acetaminophen|acetaminophen|mesh-list
19712422|NCT04767178|Ibuprofen|ibuprofen|mesh-list
19712423|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19712424|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19712425|NCT04767178|Analgesics|analgesics|mesh-ancestor
19712426|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
19712427|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712428|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712429|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712430|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712431|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19712432|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712433|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712434|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
19712435|NCT04767542|Acetaminophen|acetaminophen|mesh-list
19712436|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712437|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19712438|NCT04767542|Analgesics|analgesics|mesh-ancestor
19712439|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
19712440|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712441|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
19712442|NCT04766853|Dexamethasone|dexamethasone|mesh-list
19712443|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
19712444|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712445|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
19712446|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
19712447|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712448|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712449|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19712450|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
19712451|NCT04766853|Hormones|hormones|mesh-ancestor
19712452|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19712453|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19712454|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712455|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19712456|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
19712457|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
19712458|NCT04766853|Protective Agents|protective agents|mesh-ancestor
19712459|NCT04767035|Midazolam|midazolam|mesh-list
19712460|NCT04767035|Ketamine|ketamine|mesh-list
19712461|NCT04767035|Analgesics|analgesics|mesh-ancestor
19428277|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19428278|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19428279|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428280|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19428281|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712462|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
19712463|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428282|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19428283|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
19428284|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19428285|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
19428286|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428287|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19428288|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19428289|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19428290|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428291|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249846|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249847|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249848|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20249849|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20249850|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19428292|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20249851|NCT00442325|Atorvastatin|atorvastatin|mesh-list
20249852|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20249853|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19712464|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712465|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19712466|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19712467|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
19712468|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
19712469|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712470|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19712471|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19712472|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712473|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712474|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19712475|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19712476|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20249854|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
20249855|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249856|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20249857|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20249858|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249859|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
20249860|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20249861|NCT00442403|Chloroquine|chloroquine|mesh-list
20249862|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19428293|NCT00460941|Incretins|incretins|mesh-ancestor
19428294|NCT00460941|Hormones|hormones|mesh-ancestor
19451049|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
19451050|NCT03424135|Promethazine|promethazine|mesh-list
19451051|NCT03424135|Naproxen|naproxen|mesh-list
19451052|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19451053|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451054|NCT03424135|Analgesics|analgesics|mesh-ancestor
19451055|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
19451056|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451057|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451058|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451059|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451060|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
19451061|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19428295|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428296|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428297|NCT00460317|Paclitaxel|paclitaxel|mesh-list
19428298|NCT00460317|Carboplatin|carboplatin|mesh-list
19428299|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
19428300|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19428301|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428302|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
19428303|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
19428304|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
19428305|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428306|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19428307|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428308|NCT00459745|Fenofibrate|fenofibrate|mesh-list
19428309|NCT00459745|Pravastatin|pravastatin|mesh-list
19428310|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19428311|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
19428312|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428313|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19428314|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19428315|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19428316|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428317|NCT00459277|Fentanyl|fentanyl|mesh-list
19428318|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19428319|NCT00459277|Narcotics|narcotics|mesh-ancestor
19428320|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19428321|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428322|NCT00459277|Analgesics|analgesics|mesh-ancestor
19428323|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
19428324|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428325|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19428326|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19428327|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
19428328|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
19428329|NCT00458978|Cediranib|cediranib|mesh-list
19428330|NCT00458978|Maleic acid|maleic acid|mesh-list
19428331|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428332|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428333|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428334|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19428335|NCT00458601|Temozolomide|temozolomide|mesh-list
19428336|NCT00458601|Molgramostim|molgramostim|mesh-list
19712477|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19712478|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19712479|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
19712480|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
19712481|NCT04766827|Paclitaxel|paclitaxel|mesh-list
19712482|NCT04766827|Docetaxel|docetaxel|mesh-list
19857596|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19857597|NCT00765882|Linaclotide|linaclotide|mesh-list
19857598|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19857599|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
19428337|NCT00458601|Rindopepimut|rindopepimut|mesh-list
19428338|NCT00458601|Sargramostim|sargramostim|mesh-list
19428339|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19428340|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
19428341|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428342|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428343|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
19428344|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712483|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19712484|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712485|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712486|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712487|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712488|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712489|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428345|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428346|NCT00458276|Tezosentan|tezosentan|mesh-list
19428347|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
19428348|NCT00457457|Tamsulosin|tamsulosin|mesh-list
19428349|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19428350|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19428351|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19428352|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428353|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428354|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428355|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428356|NCT00457457|Urological Agents|urological agents|mesh-ancestor
19428357|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
19428358|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428359|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19428360|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428361|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712490|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
19712491|NCT04767074|Guaifenesin|guaifenesin|mesh-list
19857600|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857601|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19857602|NCT00765895|Nortriptyline|nortriptyline|mesh-list
19428362|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19428363|NCT00455156|ST 1435|st 1435|mesh-list
19428364|NCT00455156|Estradiol|estradiol|mesh-list
19428365|NCT00455156|Estrogens|estrogens|mesh-ancestor
19428366|NCT00455156|Hormones|hormones|mesh-ancestor
19857603|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19857604|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
19857605|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20531992|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20531993|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20531994|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20531995|NCT01798251|Capecitabine|capecitabine|mesh-list
20531996|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
19428367|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19712492|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19712493|NCT04767074|Expectorants|expectorants|mesh-ancestor
19712494|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
19712495|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20531997|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20531998|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
20531999|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532000|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857606|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19857607|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19857608|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857609|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857610|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
19857611|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857612|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857613|NCT00765947|Amlodipine|amlodipine|mesh-list
19857614|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19857615|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19857616|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19857617|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857618|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857619|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19857620|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857621|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
19857622|NCT00765947|Diuretics|diuretics|mesh-ancestor
19857623|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
19857624|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19857625|NCT00765999|Linaclotide|linaclotide|mesh-list
20532001|NCT01798277|Amiodarone|amiodarone|mesh-list
20532002|NCT01798277|Sotalol|sotalol|mesh-list
20532003|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19451062|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712496|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19712497|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
19712498|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712499|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712500|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712501|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
19712502|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19712503|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
19428368|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428369|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19428370|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
19428371|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19428372|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19428373|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19428374|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19428375|NCT00453531|Acetylcholine|acetylcholine|mesh-list
19428376|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
19428377|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19428378|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
19428379|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428380|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428381|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428382|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
19428383|NCT00451152|Anecortave|anecortave|mesh-list
19428384|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19428385|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19428386|NCT00451152|Growth Substances|growth substances|mesh-ancestor
19428387|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428388|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428389|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428390|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428391|NCT00450970|Satraplatin|satraplatin|mesh-list
19428392|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428393|NCT00449605|Metformin|metformin|mesh-list
19428394|NCT00449605|Glimepiride|glimepiride|mesh-list
19428395|NCT00449605|Rimonabant|rimonabant|mesh-list
19428396|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428397|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428398|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19428399|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428400|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
19428401|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19428402|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19428403|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19428404|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428405|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428406|NCT00449605|Hormones|hormones|mesh-ancestor
19428407|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428408|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
19428409|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19428410|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428411|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19428412|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19712504|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
19712505|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712506|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
19712507|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19712508|NCT04767113|Heparin|heparin|mesh-list
19712509|NCT04767113|Calcium heparin|calcium heparin|mesh-list
19712510|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
19712511|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19712512|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19712513|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712514|NCT04766775|Fluorides|fluorides|mesh-list
19712515|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
19712516|NCT04766775|Protective Agents|protective agents|mesh-ancestor
19712517|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712518|NCT04766762|Flunarizine|flunarizine|mesh-list
19857626|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19857627|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
19857628|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857629|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19857630|NCT00766038|Hormones|hormones|mesh-list
19428413|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712519|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
19428414|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428415|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428416|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19428417|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19428418|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19428419|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428420|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857631|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857632|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857633|NCT00766116|Azacitidine|azacitidine|mesh-list
19857634|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
19857635|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19857636|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
19857637|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857638|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857639|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857640|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19857641|NCT00766142|Leucovorin|leucovorin|mesh-list
19857642|NCT00766142|Fluorouracil|fluorouracil|mesh-list
19428421|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712520|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19712521|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712522|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712523|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19712524|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712525|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19712526|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
19712527|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
19712528|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712529|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
19712530|NCT04766736|Antibodies|antibodies|mesh-list
19712531|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
19712532|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712533|NCT04766307|Interleukin-2|interleukin-2|mesh-list
19712534|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712535|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19712536|NCT04766307|Analgesics|analgesics|mesh-ancestor
19712537|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
19712538|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712539|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712540|NCT04766359|Paclitaxel|paclitaxel|mesh-list
19712541|NCT04766359|Cisplatin|cisplatin|mesh-list
19712542|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19712543|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712544|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712545|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712546|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712547|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712548|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712549|NCT04766177|Bumetanide|bumetanide|mesh-list
19712550|NCT04766177|Diuretics|diuretics|mesh-ancestor
19712551|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
19857643|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
19428422|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428423|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19428424|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
19428425|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19428426|NCT00447564|Buprenorphine|buprenorphine|mesh-list
19428427|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19428428|NCT00447564|Narcotics|narcotics|mesh-ancestor
19428429|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19428430|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428431|NCT00447564|Analgesics|analgesics|mesh-ancestor
19428432|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
19428433|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428434|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19428435|NCT00445198|Navitoclax|navitoclax|mesh-list
19428436|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428437|NCT00443287|Cilostazol|cilostazol|mesh-list
19428438|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
19428439|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19428440|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
20249863|NCT00442403|Amebicides|amebicides|mesh-ancestor
20249864|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20249865|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20249866|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249867|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
19712552|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712553|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19712554|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712555|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712556|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
20249868|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712557|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
19712558|NCT04766684|Lidocaine|lidocaine|mesh-list
19712559|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712560|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
19712561|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857644|NCT00766142|Cetuximab|cetuximab|mesh-list
19428441|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428442|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712562|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857645|NCT00766142|Calcium|calcium|mesh-list
20249869|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249870|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20249871|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
20249872|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20249873|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249874|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20249875|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249876|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249877|NCT00442481|Citalopram|citalopram|mesh-list
19857646|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
19857647|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19857648|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857649|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
19857650|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857651|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19857652|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857653|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20249878|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19712563|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
20532004|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
20532005|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20532006|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20532007|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532008|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20532009|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19857654|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
19857655|NCT00766142|Antidotes|antidotes|mesh-ancestor
19857656|NCT00766142|Protective Agents|protective agents|mesh-ancestor
19857657|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
19857658|NCT00766142|Vitamins|vitamins|mesh-ancestor
19857659|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
19857660|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428443|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19428444|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
19428445|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19857661|NCT00766363|Rivastigmine|rivastigmine|mesh-list
19857662|NCT00766363|Donepezil|donepezil|mesh-list
19857663|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19857664|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857665|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857666|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
19857667|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428446|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19428447|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428448|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19428449|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
19428450|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19428451|NCT00443287|Protective Agents|protective agents|mesh-ancestor
19428452|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19428453|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19428454|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428455|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
19857668|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249879|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20532010|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20532011|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532012|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20532013|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20532014|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20532015|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20532016|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20532017|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
20532018|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532019|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532020|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
20532021|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
19428456|NCT00442104|Ganaxolone|ganaxolone|mesh-list
19428457|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
19428458|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428459|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428460|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428461|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
19428462|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
19428463|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
19428464|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
19428465|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19428466|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428467|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428468|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
19428469|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19428470|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19428471|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428472|NCT00441896|Ganaxolone|ganaxolone|mesh-list
19428473|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
19428474|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428475|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428476|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428477|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
19428478|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
19428479|NCT00440531|Vaccines|vaccines|mesh-list
19428480|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
19428481|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428482|NCT00440388|Rituximab|rituximab|mesh-list
19428483|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428484|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428485|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
19428486|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428487|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428488|NCT00439738|Amlodipine|amlodipine|mesh-list
19428489|NCT00439738|Valsartan|valsartan|mesh-list
19428490|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19428491|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19428492|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19428493|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428494|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428495|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19428496|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428497|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
19428498|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19428499|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19428500|NCT00439738|Diuretics|diuretics|mesh-ancestor
19428501|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
19428502|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19428503|NCT00437112|Insulin|insulin|mesh-list
19428504|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19428505|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
19428506|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428507|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428508|NCT00436683|Sevelamer|sevelamer|mesh-list
19428509|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
19428510|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
19428511|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428512|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19428513|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
19428514|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428515|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
19428516|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19712564|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428517|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428518|NCT00434850|Gusperimus|gusperimus|mesh-list
19428519|NCT00434850|Sirolimus|sirolimus|mesh-list
19428520|NCT00434850|Etanercept|etanercept|mesh-list
20249880|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249881|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249882|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249883|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
19428521|NCT00434850|Tacrolimus|tacrolimus|mesh-list
19428522|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19428523|NCT00434850|Basiliximab|basiliximab|mesh-list
19712565|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19712566|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19712567|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19712568|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712569|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712570|NCT04766463|Morphine|morphine|mesh-list
19712571|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19712572|NCT04766463|Narcotics|narcotics|mesh-ancestor
19712573|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712574|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712575|NCT04766463|Analgesics|analgesics|mesh-ancestor
19712576|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
19712577|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712578|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
19712579|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19712580|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
19712581|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712582|NCT04766450|Expectorants|expectorants|mesh-ancestor
19712583|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
19712584|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19712585|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
19712586|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712587|NCT04766450|Protective Agents|protective agents|mesh-ancestor
19712588|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712589|NCT04766450|Antidotes|antidotes|mesh-ancestor
19712590|NCT04766229|Gabapentin|gabapentin|mesh-list
19712591|NCT04766229|Citalopram|citalopram|mesh-list
19712592|NCT04766229|Analgesics|analgesics|mesh-ancestor
19712593|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
19857669|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
19969631|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19428524|NCT00434850|Daclizumab|daclizumab|mesh-list
19428525|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428526|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
19428527|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428528|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19428529|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428530|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428531|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19428532|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428533|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19428534|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428535|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
19428536|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19428537|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19428538|NCT00434850|Analgesics|analgesics|mesh-ancestor
19428539|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
19428540|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428541|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428542|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452746|NCT03411109|Analgesics|analgesics|mesh-ancestor
19452747|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
19452748|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452749|NCT03411096|Ropivacaine|ropivacaine|mesh-list
19452750|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
19452751|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
19452752|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452753|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452754|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
19452755|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428543|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428544|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428545|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19428546|NCT00434850|Protective Agents|protective agents|mesh-ancestor
19428547|NCT00434811|Sirolimus|sirolimus|mesh-list
19428548|NCT00434811|Etanercept|etanercept|mesh-list
19428549|NCT00434811|Tacrolimus|tacrolimus|mesh-list
20532022|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532023|NCT01798446|Axitinib|axitinib|mesh-list
20532024|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712594|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712595|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712596|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
19712597|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19712598|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19712599|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712600|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19712601|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19712602|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19857670|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19857671|NCT00766363|Protective Agents|protective agents|mesh-ancestor
19857672|NCT00766467|Modafinil|modafinil|mesh-list
19857673|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19857674|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857675|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19857676|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19857677|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19857678|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857679|NCT00766506|Fentanyl|fentanyl|mesh-list
19857680|NCT00766506|Morphine|morphine|mesh-list
19857681|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19857682|NCT00766506|Narcotics|narcotics|mesh-ancestor
19857683|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857684|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857685|NCT00766506|Analgesics|analgesics|mesh-ancestor
19857686|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
19857687|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857688|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19857689|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19857690|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
19857691|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
19857692|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19857693|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19857694|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857695|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857696|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19857697|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
19857698|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857699|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857700|NCT00766649|Sirolimus|sirolimus|mesh-list
19857701|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19857702|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857703|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19857704|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857705|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
19857706|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19857707|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
19857708|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857709|NCT00766675|Acetaminophen|acetaminophen|mesh-list
19857710|NCT00766675|Tramadol|tramadol|mesh-list
19857711|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857712|NCT00766675|Analgesics|analgesics|mesh-ancestor
19857713|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
19857714|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857715|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857716|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
19857717|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19857718|NCT00766675|Narcotics|narcotics|mesh-ancestor
19857719|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857720|NCT00766753|Vaccines|vaccines|mesh-list
19857721|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
19857722|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857723|NCT00766831|Hydromorphone|hydromorphone|mesh-list
19428550|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20532025|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20532026|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532027|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532028|NCT01798459|Methylphenidate|methylphenidate|mesh-list
20532029|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20532030|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532031|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20532032|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20532033|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20532034|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532035|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
20532036|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532037|NCT01798472|Cimetidine|cimetidine|mesh-list
20532038|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20532039|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428551|NCT00434811|Basiliximab|basiliximab|mesh-list
19428552|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428553|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
19428554|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428555|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19428556|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428557|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428558|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19428559|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428560|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19428561|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428562|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
19428563|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19428564|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19428565|NCT00434811|Analgesics|analgesics|mesh-ancestor
19428566|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
19428567|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428568|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428569|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428570|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428571|NCT00434226|Paclitaxel|paclitaxel|mesh-list
19428572|NCT00434226|Bevacizumab|bevacizumab|mesh-list
19428573|NCT00434226|Carboplatin|carboplatin|mesh-list
19428574|NCT00434226|Sunitinib|sunitinib|mesh-list
19428575|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19428576|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428577|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
19428578|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
19428579|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
19428580|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428581|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428582|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19428583|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19428584|NCT00434226|Growth Substances|growth substances|mesh-ancestor
19428585|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428586|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428587|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19428588|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428589|NCT00431873|Mocetinostat|mocetinostat|mesh-list
19428590|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19712603|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712604|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712605|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
19712606|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19712607|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19712608|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712609|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
19712610|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19712611|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
19712612|NCT04765904|Fluorides|fluorides|mesh-list
19712613|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
19428591|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428592|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428593|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19428594|NCT00430950|Olmesartan|olmesartan|mesh-list
19428595|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19712614|NCT04765904|Protective Agents|protective agents|mesh-ancestor
19712615|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428596|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19428597|NCT00430950|Diuretics|diuretics|mesh-ancestor
19428598|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
19428599|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428600|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19428601|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428602|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428603|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19428604|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19428605|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19428606|NCT00430508|Olmesartan|olmesartan|mesh-list
19428607|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19428608|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19428609|NCT00430508|Diuretics|diuretics|mesh-ancestor
19428610|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
19428611|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428612|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19428613|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428614|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428615|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19428616|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19428617|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
19428618|NCT00430092|Difluprednate|difluprednate|mesh-list
19428619|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
19428620|NCT00430092|Hormones|hormones|mesh-ancestor
19428621|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428622|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428623|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451063|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451064|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19451065|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19451066|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451067|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
19451068|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
19451069|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
19451070|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
19451071|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19451072|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19451073|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
19451074|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
19451075|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451076|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19451077|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
19451078|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
19451079|NCT03423979|Paclitaxel|paclitaxel|mesh-list
19451080|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19451081|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451082|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
19451083|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
19451084|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
19451085|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451086|NCT03423849|Gemcitabine|gemcitabine|mesh-list
19451087|NCT03423849|Capecitabine|capecitabine|mesh-list
19451088|NCT03423849|Vinorelbine|vinorelbine|mesh-list
19451089|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451090|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19451091|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
19451092|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451093|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
19451094|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451095|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451096|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19451097|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
19451098|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451099|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19451100|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
19451101|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
19451102|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
19451103|NCT03423823|Ranibizumab|ranibizumab|mesh-list
19451104|NCT03423823|Aflibercept|aflibercept|mesh-list
19451105|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451106|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19712616|NCT04765709|Carboplatin|carboplatin|mesh-list
19712617|NCT04765709|Pemetrexed|pemetrexed|mesh-list
19712618|NCT04765709|Durvalumab|durvalumab|mesh-list
19428624|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
19428625|NCT00429923|Difluprednate|difluprednate|mesh-list
19428626|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
19428627|NCT00429923|Hormones|hormones|mesh-ancestor
19428628|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428629|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428630|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428631|NCT00427856|Rituximab|rituximab|mesh-list
19428632|NCT00427856|Obatoclax|obatoclax|mesh-list
19428633|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428634|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428635|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
19428636|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428637|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428638|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428639|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428640|NCT00427440|Rilotumumab|rilotumumab|mesh-list
19428641|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19428642|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428643|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428644|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
19428645|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428646|NCT00427154|Insulin|insulin|mesh-list
19428647|NCT00427154|Metformin|metformin|mesh-list
19428648|NCT00427154|Glimepiride|glimepiride|mesh-list
19428649|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
19428650|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19428651|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428652|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249884|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249885|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20249886|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
20249887|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20249888|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
20249889|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428653|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19428654|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428655|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
19857724|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19857725|NCT00766831|Narcotics|narcotics|mesh-ancestor
19857726|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857727|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857728|NCT00766831|Analgesics|analgesics|mesh-ancestor
19857729|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
19857730|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249890|NCT00442546|Pregabalin|pregabalin|mesh-list
19428656|NCT00425100|Fesoterodine|fesoterodine|mesh-list
19428657|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19428658|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19428659|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
19428660|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428661|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428662|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428663|NCT00425100|Urological Agents|urological agents|mesh-ancestor
19428664|NCT00424697|Lorazepam|lorazepam|mesh-list
19428665|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
19857731|NCT00767000|Metformin|metformin|mesh-list
19857732|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
19857733|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857734|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857735|NCT00767039|Poractant alfa|poractant alfa|mesh-list
19428666|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
19428667|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
19428668|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428669|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428670|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428671|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19428672|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857736|NCT00767039|Beractant|beractant|mesh-list
19857737|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19857738|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
19857739|NCT00767325|Methotrexate|methotrexate|mesh-list
19857740|NCT00767325|Abatacept|abatacept|mesh-list
19857741|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19857742|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
19857743|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19857744|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857745|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532040|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20532041|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
20532042|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
20532043|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532044|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532045|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532046|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20532047|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20532048|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857746|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
19428673|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19428674|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19428675|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19712619|NCT04765709|Vinorelbine|vinorelbine|mesh-list
19712620|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19712621|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712622|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712623|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712624|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19712625|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19712626|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19712627|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
19712628|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712629|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712630|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712631|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712632|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712633|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
19712634|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19712635|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712636|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712637|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19712638|NCT04766047|Analgesics|analgesics|mesh-ancestor
19712639|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
19712640|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712641|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19712642|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19712643|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19712644|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
19712645|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712646|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712647|NCT04766021|Mirabegron|mirabegron|mesh-list
19712648|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19712649|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19712650|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19712651|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
19712652|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857747|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857748|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428676|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
19428677|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
19428678|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428679|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428680|NCT00422019|Rilotumumab|rilotumumab|mesh-list
19428681|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19428682|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428683|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428684|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
19428685|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428686|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19428687|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
19428688|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
19428689|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428690|NCT00417209|Fluorouracil|fluorouracil|mesh-list
19428691|NCT00417209|Capecitabine|capecitabine|mesh-list
19428692|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
19428693|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428694|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19428695|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428696|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428697|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
19428698|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428699|NCT00417118|Citalopram|citalopram|mesh-list
19428700|NCT00417118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19428701|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19428702|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428703|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428704|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428705|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
19428706|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428707|NCT00417118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19428708|NCT00417118|Antidepressive Agents|antidepressive agents|mesh-ancestor
19428709|NCT00417118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19428710|NCT00415623|Amlodipine|amlodipine|mesh-list
19428711|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19428712|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19428713|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428714|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428715|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19428716|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428717|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
19428718|NCT00415142|Citalopram|citalopram|mesh-list
19428719|NCT00415142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19428720|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19428721|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428722|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712653|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712654|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712655|NCT04766021|Urological Agents|urological agents|mesh-ancestor
19712656|NCT04765267|Vitamin D|vitamin d|mesh-list
19712657|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
19712658|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
19712659|NCT04765267|Vitamins|vitamins|mesh-ancestor
19712660|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
19712661|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712662|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19712663|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19712664|NCT04765267|Astringents|astringents|mesh-ancestor
19712665|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
19712666|NCT04765514|Temozolomide|temozolomide|mesh-list
19712667|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19712668|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
19712669|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712670|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733941|NCT04556110|Perindopril|perindopril|mesh-list
19733942|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19733943|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
19733944|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733945|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733946|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19733947|NCT04556136|Vitamin D|vitamin d|mesh-list
19733948|NCT04556136|Vitamins|vitamins|mesh-ancestor
20249891|NCT00442546|Analgesics|analgesics|mesh-ancestor
20249892|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
19428723|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428724|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
19428725|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428726|NCT00415142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19428727|NCT00415142|Antidepressive Agents|antidepressive agents|mesh-ancestor
19428728|NCT00415142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19428729|NCT00413114|Obatoclax|obatoclax|mesh-list
19428730|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428731|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428732|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19428733|NCT00412932|Olmesartan|olmesartan|mesh-list
19428734|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19428735|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19428736|NCT00412932|Diuretics|diuretics|mesh-ancestor
19428737|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
19428738|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428739|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19428740|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19428741|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428742|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19428743|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19428744|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
19428745|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19428746|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428747|NCT00411892|Insulin|insulin|mesh-list
19428748|NCT00411892|Pioglitazone|pioglitazone|mesh-list
19428749|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19428750|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428751|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428752|NCT00411528|Prednisone|prednisone|mesh-list
19428753|NCT00411528|Docetaxel|docetaxel|mesh-list
19428754|NCT00411528|Epothilone B|epothilone b|mesh-list
19428755|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712671|NCT04765527|Turmeric extract|turmeric extract|mesh-list
19712672|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
19712673|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712674|NCT04765527|Protective Agents|protective agents|mesh-ancestor
19712675|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712676|NCT04765228|Doxorubicin|doxorubicin|mesh-list
19712677|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19712678|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19712679|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712680|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19712681|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19712682|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712683|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712684|NCT04765085|Aripiprazole|aripiprazole|mesh-list
19712685|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
19712686|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19712687|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19712688|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19712689|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712690|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712691|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
19712692|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
19712693|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712694|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712695|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19712696|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19712697|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
19712698|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19712699|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19712700|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19712701|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19712702|NCT04765111|Rituximab|rituximab|mesh-list
19712703|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19712704|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
19712705|NCT04765111|Antibodies|antibodies|mesh-list
19712706|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
19712707|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19428756|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712708|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
19712709|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712710|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428757|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
19428758|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
19428759|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428760|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428761|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
19428762|NCT00411528|Hormones|hormones|mesh-ancestor
19428763|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428764|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428765|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19428766|NCT00411385|Interferons|interferons|mesh-list
19428767|NCT00411385|Ribavirin|ribavirin|mesh-list
19428768|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
19428769|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
19428770|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19428771|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428772|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
19428773|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428774|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
19428775|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428776|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
19428777|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428778|NCT00411242|S 20098|s 20098|mesh-list
19428779|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19428780|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19428781|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428782|NCT00411099|S 20098|s 20098|mesh-list
19428783|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19428784|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19428785|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428786|NCT00407303|Bortezomib|bortezomib|mesh-list
19428787|NCT00407303|Obatoclax|obatoclax|mesh-list
19428788|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428789|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428790|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428791|NCT00406809|Navitoclax|navitoclax|mesh-list
19428792|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428793|NCT00406588|Levodopa|levodopa|mesh-list
19428794|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19428795|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19428796|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
19428797|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428798|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428799|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428800|NCT00405951|Docetaxel|docetaxel|mesh-list
19428801|NCT00405951|Obatoclax|obatoclax|mesh-list
19428802|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428803|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
19428804|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
19428805|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
19428806|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857749|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
19428807|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428808|NCT00405743|Cytarabine|cytarabine|mesh-list
19428809|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19428810|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
19857750|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857751|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19857752|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19857753|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
19857754|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857755|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19857756|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19857757|NCT00767364|Vaccines|vaccines|mesh-list
19857758|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
19857759|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857760|NCT00767507|Cangrelor|cangrelor|mesh-list
19857761|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19428811|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428812|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428813|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
19428814|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428815|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19428816|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
19428817|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428818|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
19428819|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19428820|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428821|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19428822|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
19428823|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19428824|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428825|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428826|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428827|NCT00403169|Lenalidomide|lenalidomide|mesh-list
19428828|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
19428829|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428830|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19428831|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19428832|NCT00403169|Growth Substances|growth substances|mesh-ancestor
19428833|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428834|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428835|NCT00402428|Interferons|interferons|mesh-list
19428836|NCT00402428|Ribavirin|ribavirin|mesh-list
19428837|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
19428838|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
19428839|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19428840|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428841|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
19857762|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19428842|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428843|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
19428844|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428845|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
19428846|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857763|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19428847|NCT00401570|Gemcitabine|gemcitabine|mesh-list
19428848|NCT00401570|Volociximab|volociximab|mesh-list
19969632|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428849|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19428850|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
19428851|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428852|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428853|NCT00401570|Antiviral Agents|antiviral agents|mesh-ancestor
19428854|NCT00401570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19428855|NCT00401570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428856|NCT00401570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712711|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712712|NCT04764955|Vitamin D|vitamin d|mesh-list
19712713|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
19712714|NCT04764955|Vitamins|vitamins|mesh-ancestor
19712715|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
19712716|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712717|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19712718|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19712719|NCT04764825|Morphine|morphine|mesh-list
19712720|NCT04764825|Methadone|methadone|mesh-list
19712721|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19712722|NCT04764825|Narcotics|narcotics|mesh-ancestor
19712723|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712724|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712725|NCT04764825|Analgesics|analgesics|mesh-ancestor
19712726|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
19712727|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712728|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
19712729|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
19712730|NCT04765098|Tamoxifen|tamoxifen|mesh-list
19712731|NCT04765098|Etoposide|etoposide|mesh-list
19712732|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712733|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712734|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19712735|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19712736|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712737|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712738|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19712739|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
19712740|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19712741|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712742|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19857764|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19857765|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
19857766|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969633|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712743|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19712744|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19712745|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19712746|NCT04764916|Bupivacaine|bupivacaine|mesh-list
19712747|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712748|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
19712749|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712750|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712751|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
19712752|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712753|NCT04764851|Ecopipam|ecopipam|mesh-list
19712754|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19712755|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19712756|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712757|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712758|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19712759|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19428857|NCT00401570|Immunologic Factors|immunologic factors|mesh-ancestor
19428858|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428859|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19428860|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19428861|NCT00401570|Growth Substances|growth substances|mesh-ancestor
19428862|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
19428863|NCT00401388|Allopurinol|allopurinol|mesh-list
19428864|NCT00401388|Antiemetics|antiemetics|mesh-list
19428865|NCT00401388|Loperamide|loperamide|mesh-list
19428866|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
19428867|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
19428868|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428869|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428870|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
19428871|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19428872|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19428873|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
19428874|NCT00401388|Protective Agents|protective agents|mesh-ancestor
19428875|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428876|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428877|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
19428878|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428879|NCT00401011|Dexamethasone|dexamethasone|mesh-list
19428880|NCT00401011|Bortezomib|bortezomib|mesh-list
19428881|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428882|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
19428883|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
19428884|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428885|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428886|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19428887|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
19428888|NCT00401011|Hormones|hormones|mesh-ancestor
19428889|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19428890|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19428891|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428892|NCT00398879|Capecitabine|capecitabine|mesh-list
19428893|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19712760|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
19712761|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712762|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712763|NCT04764630|Naloxone|naloxone|mesh-list
19712764|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19712765|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712766|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
19712767|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712768|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
19428894|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
19428895|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428896|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428897|NCT00397293|Topotecan|topotecan|mesh-list
19428898|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19428899|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19428900|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428901|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428902|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19428903|NCT00397254|Rizatriptan|rizatriptan|mesh-list
19428904|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19857767|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857768|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857769|NCT00767520|Dasatinib|dasatinib|mesh-list
19428905|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
19428906|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428907|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428908|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428909|NCT00396357|Metformin|metformin|mesh-list
19428910|NCT00396357|Vildagliptin|vildagliptin|mesh-list
19428911|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19428912|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428913|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19428914|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
19428915|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19428916|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428917|NCT00394563|Tanezumab|tanezumab|mesh-list
19428918|NCT00394563|Analgesics|analgesics|mesh-ancestor
19428919|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
19428920|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428921|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428922|NCT00394199|Fluticasone|fluticasone|mesh-list
19428923|NCT00394199|Xhance|xhance|mesh-list
19428924|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
19428925|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428926|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19428927|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
19712769|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
19712770|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19712771|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19712772|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
19712773|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712774|NCT04764643|Expectorants|expectorants|mesh-ancestor
19712775|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
19712776|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19712777|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
19712778|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712779|NCT04764643|Protective Agents|protective agents|mesh-ancestor
19712780|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532049|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
19428928|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428929|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428930|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19428931|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
19428932|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
19428933|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19428934|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19428935|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19428936|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19428937|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428938|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428939|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428940|NCT00394121|Fluticasone|fluticasone|mesh-list
19428941|NCT00394121|Xhance|xhance|mesh-list
19712781|NCT04764643|Antidotes|antidotes|mesh-ancestor
19712782|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
19712783|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712784|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
19712785|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
19712786|NCT04764396|Heparin|heparin|mesh-list
19712787|NCT04764396|Calcium heparin|calcium heparin|mesh-list
19712788|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
19712789|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20532050|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20532051|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
20532052|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532053|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
20532054|NCT01798498|Protective Agents|protective agents|mesh-ancestor
20532055|NCT01798537|Vancomycin|vancomycin|mesh-list
20532056|NCT01798537|Colistin|colistin|mesh-list
20532057|NCT01798537|Nystatin|nystatin|mesh-list
20532058|NCT01798537|Neomycin|neomycin|mesh-list
20532059|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20532060|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532061|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
20532062|NCT01798537|Ionophores|ionophores|mesh-ancestor
20532063|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20532064|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532065|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20532066|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532067|NCT01798576|Interferons|interferons|mesh-list
20532068|NCT01798576|Ribavirin|ribavirin|mesh-list
20532069|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
20532070|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
20532071|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20532072|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532073|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
20532074|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532075|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
20532076|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532077|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
20532078|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428942|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
19428943|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428944|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19428945|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
19428946|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428947|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428948|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19428949|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
19428950|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
19428951|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19428952|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19428953|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19428954|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19428955|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428956|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428957|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428958|NCT00393991|Fluticasone|fluticasone|mesh-list
19428959|NCT00393991|Xhance|xhance|mesh-list
19428960|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
19428961|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428962|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19428963|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
19712790|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20532079|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20532080|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19428964|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428965|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428966|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19712791|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857770|NCT00767520|Exemestane|exemestane|mesh-list
19857771|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857772|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19857773|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857774|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857775|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19857776|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19857777|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19857778|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
19857779|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857780|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857781|NCT00767572|Atorvastatin|atorvastatin|mesh-list
19857782|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19857783|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857784|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
19857785|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857786|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857787|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19857788|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857789|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
19857790|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19857791|NCT00767767|Thiopental|thiopental|mesh-list
19857792|NCT00767767|Propofol|propofol|mesh-list
19857793|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19857794|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857795|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857796|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19857797|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
19857798|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
19428967|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
19428968|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
19428969|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19428970|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19428971|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19428972|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19428973|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428974|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19428975|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428976|NCT00393952|Fluticasone|fluticasone|mesh-list
19428977|NCT00393952|Xhance|xhance|mesh-list
19428978|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
19428979|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19428980|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19428981|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
19428982|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19428983|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428984|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19428985|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
19428986|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
19428987|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19428988|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19428989|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19428990|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19428991|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
19428992|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712792|NCT04764227|Paclitaxel|paclitaxel|mesh-list
19712793|NCT04764227|Carboplatin|carboplatin|mesh-list
19712794|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712795|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712796|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19712797|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712798|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712799|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712800|NCT04764344|Haloperidol|haloperidol|mesh-list
19712801|NCT04764344|Ondansetron|ondansetron|mesh-list
19712802|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
19712803|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
19712804|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
19712805|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712806|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19428993|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19428994|NCT00393068|Paclitaxel|paclitaxel|mesh-list
19428995|NCT00393068|Bevacizumab|bevacizumab|mesh-list
19428996|NCT00393068|Carboplatin|carboplatin|mesh-list
19428997|NCT00393068|Fluorouracil|fluorouracil|mesh-list
19428998|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19428999|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429000|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429001|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429002|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429003|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
19429004|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429005|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429006|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20532081|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19429007|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429008|NCT00393068|Growth Substances|growth substances|mesh-ancestor
19429009|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429010|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
19712807|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19712808|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
19712809|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
19712810|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19712811|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
19712812|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712813|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712814|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19712815|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19712816|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712817|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19712818|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19712819|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19712820|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
19712821|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19712822|NCT04764383|Histamine|histamine|mesh-list
19712823|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
19712824|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
19712825|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712826|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712827|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712828|NCT04764084|Niraparib|niraparib|mesh-list
19712829|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19712830|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712831|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712832|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712833|NCT04764214|Osimertinib|osimertinib|mesh-list
19712834|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712835|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19712836|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712837|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712838|NCT04764045|Ropivacaine|ropivacaine|mesh-list
19712839|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712840|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
19712841|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712842|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712843|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
19712844|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712845|NCT04763876|Ketorolac|ketorolac|mesh-list
19712846|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19712847|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19712848|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19712849|NCT04763876|Analgesics|analgesics|mesh-ancestor
19712850|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
20532082|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
20532083|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532084|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20532085|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20532086|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532087|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
20532088|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532089|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20532090|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429011|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
19429012|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429013|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429014|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
19429015|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429016|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429017|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
19429018|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19429019|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429020|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19429021|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19429022|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429023|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429024|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429025|NCT00391209|Insulin|insulin|mesh-list
19429026|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19429027|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429028|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429029|NCT00389779|Guanfacine|guanfacine|mesh-list
19429030|NCT00389779|Darusentan|darusentan|mesh-list
19429031|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429032|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19429033|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19429034|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19429035|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
19429036|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429037|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429038|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429039|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19429040|NCT00389675|Guanfacine|guanfacine|mesh-list
19429041|NCT00389675|Darusentan|darusentan|mesh-list
19429042|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429043|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19429044|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19429045|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19429046|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
19429047|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429048|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429049|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429050|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19712851|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857799|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
19857800|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
19857801|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
19857802|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857803|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712852|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712853|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712854|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712855|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19712856|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712857|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857804|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19712858|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
19712859|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19429051|NCT00389155|Gemcitabine|gemcitabine|mesh-list
19429052|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429053|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
19429054|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429055|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429056|NCT00389155|Antiviral Agents|antiviral agents|mesh-ancestor
19429057|NCT00389155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429058|NCT00389155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429059|NCT00389155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429060|NCT00389155|Immunologic Factors|immunologic factors|mesh-ancestor
19429061|NCT00389155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429062|NCT00388960|Etoposide|etoposide|mesh-list
19429063|NCT00388960|Amrubicin|amrubicin|mesh-list
19429064|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429065|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429066|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19429067|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19429068|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429069|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429070|NCT00387907|Trastuzumab|trastuzumab|mesh-list
19429071|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429072|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429073|NCT00385515|Meclocycline|meclocycline|mesh-list
19429074|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19429075|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429076|NCT00384904|Ritonavir|ritonavir|mesh-list
19429077|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19429078|NCT00384904|Tenofovir|tenofovir|mesh-list
19429079|NCT00384904|Famotidine|famotidine|mesh-list
19429080|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19429081|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19429082|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429083|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429084|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429085|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19429086|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19429087|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
19429088|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429089|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19429090|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19429091|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19429092|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19429093|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19429094|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19429095|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19429096|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
19429097|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
19429098|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429099|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429100|NCT00384150|Galiximab|galiximab|mesh-list
19429101|NCT00384150|Rituximab|rituximab|mesh-list
19429102|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429103|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429104|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
19429105|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429106|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19429107|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429108|NCT00383578|Metformin|metformin|mesh-list
19429109|NCT00383578|Vildagliptin|vildagliptin|mesh-list
19429110|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429111|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429112|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19429113|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429114|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429115|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429116|NCT00383513|Epratuzumab|epratuzumab|mesh-list
19429117|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429118|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429119|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19429120|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19712860|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429121|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
19712861|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
19857805|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19857806|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19712862|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712863|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712864|NCT04763434|Dexamethasone|dexamethasone|mesh-list
19712865|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
19712866|NCT04763434|Ropivacaine|ropivacaine|mesh-list
19712867|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429122|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429123|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429124|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19429125|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19429126|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19429127|NCT00382811|Carboplatin|carboplatin|mesh-list
19429128|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429129|NCT00382460|Pravastatin|pravastatin|mesh-list
19429130|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19429131|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19429132|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
19429133|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429134|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19429135|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19429136|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429137|NCT00382096|Metformin|metformin|mesh-list
19429138|NCT00382096|Vildagliptin|vildagliptin|mesh-list
19712868|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
19712869|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
19712870|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712871|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712872|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19712873|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
19712874|NCT04763434|Hormones|hormones|mesh-ancestor
19712875|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857807|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19429139|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429140|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429141|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19429142|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429143|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429144|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451107|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19451108|NCT03423823|Growth Substances|growth substances|mesh-ancestor
19451109|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451110|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
19451111|NCT03423810|Hydralazine|hydralazine|mesh-list
19451112|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19451113|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
19451114|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19451115|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
19451116|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19451117|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
19451118|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451119|NCT03423667|Expectorants|expectorants|mesh-ancestor
19451120|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
19451121|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19451122|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
19451123|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451124|NCT03423667|Protective Agents|protective agents|mesh-ancestor
19712876|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19451125|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429145|NCT00380159|Lamivudine|lamivudine|mesh-list
19429146|NCT00380159|Emtricitabine|emtricitabine|mesh-list
19429147|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
19429148|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19429149|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19429150|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429151|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429152|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
19429153|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429154|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19429155|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19429156|NCT00379990|Prednisolone|prednisolone|mesh-list
19429157|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429158|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
19429159|NCT00379990|Hormones|hormones|mesh-ancestor
19429160|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429161|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429162|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19429163|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429164|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19429165|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
19429166|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429167|NCT00375791|Dexamethasone|dexamethasone|mesh-list
19429168|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429169|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
19429170|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
19429171|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19429172|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429173|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19429174|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
19429175|NCT00375791|Hormones|hormones|mesh-ancestor
19429176|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429177|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19429178|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429179|NCT00375193|Amrubicin|amrubicin|mesh-list
19429180|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429181|NCT00374296|Mocetinostat|mocetinostat|mesh-list
19429182|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19429183|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429184|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429185|NCT00374166|Paroxetine|paroxetine|mesh-list
19429186|NCT00374166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19429187|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19429188|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19429189|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429190|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429191|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
19429192|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429193|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19429194|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
19429195|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19429196|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19429197|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19429198|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429199|NCT00372944|Capecitabine|capecitabine|mesh-list
19429200|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429201|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
19429202|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429203|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429204|NCT00372437|Gemcitabine|gemcitabine|mesh-list
19429205|NCT00372437|Mocetinostat|mocetinostat|mesh-list
19429206|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429207|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
19429208|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429209|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429210|NCT00372437|Antiviral Agents|antiviral agents|mesh-ancestor
19429211|NCT00372437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429212|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429213|NCT00372437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429214|NCT00372437|Immunologic Factors|immunologic factors|mesh-ancestor
19451126|NCT03423667|Antidotes|antidotes|mesh-ancestor
19429215|NCT00372437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429216|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19429217|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19429218|NCT00370383|Satraplatin|satraplatin|mesh-list
19429219|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429220|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429221|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429222|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429223|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19429224|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
19429225|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429226|NCT00369070|Paclitaxel|paclitaxel|mesh-list
19429227|NCT00369070|Bevacizumab|bevacizumab|mesh-list
19429228|NCT00369070|Carboplatin|carboplatin|mesh-list
19429229|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
19712877|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712878|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19712879|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19712880|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19712881|NCT04763434|Analgesics|analgesics|mesh-ancestor
19712882|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
19712883|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19712884|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19712885|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19712886|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
19712887|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712888|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712889|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
19712890|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
19712891|NCT04763486|Cefazolin|cefazolin|mesh-list
19712892|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712893|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19712894|NCT04763616|Cemiplimab|cemiplimab|mesh-list
19712895|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19712896|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712897|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
19712898|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19712899|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19712900|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19712901|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19712902|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712903|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
19712904|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19712905|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712906|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19712907|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249893|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249894|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249895|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
20249896|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20249897|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20249898|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249899|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20249900|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20249901|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20249902|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249903|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20249904|NCT00442585|Ibuprofen|ibuprofen|mesh-list
19712908|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
19712909|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712910|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429230|NCT00369070|Imetelstat|imetelstat|mesh-list
19429231|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429232|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429233|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429234|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429235|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
19429236|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429237|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429238|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429239|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429240|NCT00369070|Growth Substances|growth substances|mesh-ancestor
19429241|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429242|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429243|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429244|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429245|NCT00367887|Ribavirin|ribavirin|mesh-list
19429246|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
19429247|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19429248|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
19429249|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
19429250|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429251|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
19429252|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429253|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429254|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
19429255|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429256|NCT00366795|Satavaptan|satavaptan|mesh-list
19429257|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19429258|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429259|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
19429260|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429261|NCT00366704|Risperidone|risperidone|mesh-list
19429262|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19429263|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
19429264|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429265|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429266|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429267|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19429268|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19429269|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19429270|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19429271|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19429272|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
19429273|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
19429274|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429275|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
19429276|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429277|NCT00364546|Tapentadol|tapentadol|mesh-list
19429278|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19429279|NCT00364546|Narcotics|narcotics|mesh-ancestor
19429280|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19429281|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429282|NCT00364546|Analgesics|analgesics|mesh-ancestor
19429283|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
20532091|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532092|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
20532093|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20532094|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532095|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20532096|NCT01798680|Vitamin D|vitamin d|mesh-list
20532097|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
20532098|NCT01798680|Vitamins|vitamins|mesh-ancestor
20532099|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
20532100|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532101|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20532102|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20532103|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19429284|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19429285|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19429286|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19429287|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19429288|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429289|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
19429290|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429291|NCT00364247|Tapentadol|tapentadol|mesh-list
19429292|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19429293|NCT00364247|Narcotics|narcotics|mesh-ancestor
19429294|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451127|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19712911|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19712912|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19712913|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733949|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
20532104|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20532105|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532106|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20532107|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20532108|NCT01798836|Estradiol|estradiol|mesh-list
20532109|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20532110|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20532111|NCT01798836|Estrogens|estrogens|mesh-ancestor
20532112|NCT01798836|Hormones|hormones|mesh-ancestor
20532113|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429295|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429296|NCT00364247|Analgesics|analgesics|mesh-ancestor
19429297|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
19429298|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19429299|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19429300|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19429301|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19429302|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429303|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
19429304|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429305|NCT00363636|Galiximab|galiximab|mesh-list
19429306|NCT00363636|Rituximab|rituximab|mesh-list
19429307|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429308|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429309|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
19429310|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429311|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19429312|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429313|NCT00361582|Tapentadol|tapentadol|mesh-list
19429314|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19712914|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712915|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712916|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19712917|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19733950|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733951|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19733952|NCT04556058|Perindopril|perindopril|mesh-list
19733953|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19733954|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
19733955|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733956|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733957|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19733958|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19733959|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
19733960|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733961|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733962|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19733963|NCT04556279|Diuretics|diuretics|mesh-ancestor
19733964|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
19733965|NCT04556032|Ergothioneine|ergothioneine|mesh-list
19733966|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
19733967|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733968|NCT04556032|Protective Agents|protective agents|mesh-ancestor
19733969|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733970|NCT04556071|Bevacizumab|bevacizumab|mesh-list
19733971|NCT04556071|Niraparib|niraparib|mesh-list
19733972|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19733973|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733974|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19733975|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19733976|NCT04556071|Growth Substances|growth substances|mesh-ancestor
19733977|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733978|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
19733979|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19733980|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733981|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733982|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
19733983|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19733984|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733985|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19733986|NCT04555694|Cyclosporine|cyclosporine|mesh-list
19733987|NCT04555694|Dexamethasone|dexamethasone|mesh-list
19733988|NCT04555694|Cyclosporins|cyclosporins|mesh-list
19733989|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733990|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
19429315|NCT00361582|Narcotics|narcotics|mesh-ancestor
19429316|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19429317|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429318|NCT00361582|Analgesics|analgesics|mesh-ancestor
19429319|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
19429320|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19429321|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19429322|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19429323|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19429324|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429325|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
19429326|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429327|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
19429328|NCT00360867|Imetelstat|imetelstat|mesh-list
19429329|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429330|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429331|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429332|NCT00360035|Obatoclax|obatoclax|mesh-list
19429333|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429334|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429335|NCT00359450|Taxane|taxane|mesh-list
19429336|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429337|NCT00359437|Satavaptan|satavaptan|mesh-list
19429338|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19429339|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429340|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
19429341|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429342|NCT00359086|Mocetinostat|mocetinostat|mesh-list
19429343|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19429344|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429345|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429346|NCT00358982|Mocetinostat|mocetinostat|mesh-list
19429347|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19429348|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429349|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429350|NCT00358878|Satavaptan|satavaptan|mesh-list
19429351|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19429352|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429353|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
19429354|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429355|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20249905|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19429356|NCT00356681|Niacinamide|niacinamide|mesh-list
19429357|NCT00356681|Paclitaxel|paclitaxel|mesh-list
19429358|NCT00356681|Bevacizumab|bevacizumab|mesh-list
19429359|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
19429360|NCT00356681|Imetelstat|imetelstat|mesh-list
19429361|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429362|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429363|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429364|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429365|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
19429366|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429367|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429368|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429369|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429370|NCT00356681|Growth Substances|growth substances|mesh-ancestor
19429371|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429372|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429373|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429374|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429375|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
19429376|NCT00356681|Vitamins|vitamins|mesh-ancestor
19429377|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
19429378|NCT00356109|Insulin|insulin|mesh-list
19429379|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19429380|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
19429381|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429382|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429383|NCT00355849|Insulin|insulin|mesh-list
19429384|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19429385|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
19429386|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429387|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429388|NCT00355355|Talaporfin|talaporfin|mesh-list
19429389|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429390|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19429391|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
19429392|NCT00353574|Darusentan|darusentan|mesh-list
19429393|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19429394|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429395|NCT00353457|Capecitabine|capecitabine|mesh-list
19429396|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
19429397|NCT00353457|Cetuximab|cetuximab|mesh-list
19429398|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429399|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
19429400|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429401|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429402|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20249906|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249907|NCT00442585|Analgesics|analgesics|mesh-ancestor
20249908|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
20249909|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249910|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249911|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429403|NCT00352560|Irbesartan|irbesartan|mesh-list
19429404|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429405|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19429406|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19429407|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429408|NCT00345748|Abatacept|abatacept|mesh-list
19429409|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19857808|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857809|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857810|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857811|NCT00767806|Analgesics|analgesics|mesh-ancestor
19857812|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
19857813|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857814|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
19857815|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19857816|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
19857817|NCT00767819|Everolimus|everolimus|mesh-list
19857818|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857819|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19857820|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
19857821|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857822|NCT00768053|Etanercept|etanercept|mesh-list
19857823|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19857824|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857825|NCT00768053|Analgesics|analgesics|mesh-ancestor
19857826|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
19857827|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857828|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857829|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19857830|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857831|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19857832|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19857833|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
19857834|NCT00768079|Benralizumab|benralizumab|mesh-list
19857835|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19857836|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
19857837|NCT00768118|Curcumin|curcumin|mesh-list
19857838|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19857839|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857840|NCT00768118|Analgesics|analgesics|mesh-ancestor
19857841|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
19857842|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857843|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857844|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19857845|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19857846|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857847|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857848|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857849|NCT00768144|Sunitinib|sunitinib|mesh-list
19857850|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857851|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19857852|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19857853|NCT00768144|Growth Substances|growth substances|mesh-ancestor
19857854|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857855|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
19857856|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19857857|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857858|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857859|NCT00768222|Triclosan|triclosan|mesh-list
19857860|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19857861|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857862|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19857863|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857864|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
19857865|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857866|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19857867|NCT00768261|Memantine|memantine|mesh-list
19429410|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429411|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429412|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429413|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
19429414|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429415|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19429416|NCT00345618|Biotin|biotin|mesh-list
19429417|NCT00345618|Enoxaparin|enoxaparin|mesh-list
19429418|NCT00345618|Warfarin|warfarin|mesh-list
19429419|NCT00345618|Idraparinux|idraparinux|mesh-list
19429420|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
19712918|NCT04763057|Calcium|calcium|mesh-list
19712919|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19712920|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712921|NCT04763096|Tacrolimus|tacrolimus|mesh-list
19712922|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712923|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
19712924|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712925|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19712926|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712927|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712928|NCT04762953|Leucovorin|leucovorin|mesh-list
19712929|NCT04762953|Paclitaxel|paclitaxel|mesh-list
19712930|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19712931|NCT04762953|Fluorouracil|fluorouracil|mesh-list
19712932|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19712933|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712934|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19857868|NCT00768261|Donepezil|donepezil|mesh-list
19712935|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19712936|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712937|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712938|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
19712939|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19712940|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712941|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
19712942|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712943|NCT04762953|Antidotes|antidotes|mesh-ancestor
19712944|NCT04762953|Protective Agents|protective agents|mesh-ancestor
19857869|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19857870|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857871|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857872|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
19857873|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857874|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857875|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
19857876|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19857877|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19857878|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
19857879|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19857880|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19857881|NCT00768300|Ambrisentan|ambrisentan|mesh-list
19857882|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19712945|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
19857883|NCT00768430|Midazolam|midazolam|mesh-list
19857884|NCT00768430|Ketamine|ketamine|mesh-list
19429421|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
19429422|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19429423|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19429424|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429425|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19429426|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
19429427|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19429428|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429429|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429430|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
19429431|NCT00345618|Vitamins|vitamins|mesh-ancestor
19429432|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
19429433|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429434|NCT00344045|Acetaminophen|acetaminophen|mesh-list
19429435|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19429436|NCT00344045|Analgesics|analgesics|mesh-ancestor
19712946|NCT04762953|Vitamins|vitamins|mesh-ancestor
19712947|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
20249912|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20249913|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249914|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712948|NCT04762992|Enoxaparin|enoxaparin|mesh-list
19429437|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
19712949|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
19712950|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19712951|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19733991|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
20249915|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249916|NCT00442637|Bevacizumab|bevacizumab|mesh-list
20249917|NCT00442637|Capecitabine|capecitabine|mesh-list
20249918|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429438|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19429439|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429440|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
19429441|NCT00343109|Sargramostim|sargramostim|mesh-list
19429442|NCT00343109|Vaccines|vaccines|mesh-list
19429443|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
19429444|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429445|NCT00338104|Insulin|insulin|mesh-list
19429446|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19429447|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
19429448|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429449|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429450|NCT00337532|Paclitaxel|paclitaxel|mesh-list
19429451|NCT00337532|Cisplatin|cisplatin|mesh-list
20249919|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249920|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20249921|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20249922|NCT00442637|Growth Substances|growth substances|mesh-ancestor
20249923|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249924|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
20249925|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20249926|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
20249927|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249928|NCT00442676|Celecoxib|celecoxib|mesh-list
19429452|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429453|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429454|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429455|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429456|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712952|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249929|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19429457|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429458|NCT00337454|Dasatinib|dasatinib|mesh-list
19429459|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429460|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429461|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429462|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429463|NCT00333502|Camptothecin|camptothecin|mesh-list
19429464|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20249930|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20249931|NCT00442676|Analgesics|analgesics|mesh-ancestor
20249932|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
20249933|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249934|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249935|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429465|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429466|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19429467|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19429468|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429469|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429470|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
19429471|NCT00333216|Anecortave|anecortave|mesh-list
19429472|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429473|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429474|NCT00333216|Growth Substances|growth substances|mesh-ancestor
19429475|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429476|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429477|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429478|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429479|NCT00332956|Vaccines|vaccines|mesh-list
19712953|NCT04762966|Metformin|metformin|mesh-list
19429480|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
19712954|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429481|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429482|NCT00332748|Taxane|taxane|mesh-list
19429483|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429484|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
19429485|NCT00332657|Anecortave|anecortave|mesh-list
19429486|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429487|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429488|NCT00332657|Growth Substances|growth substances|mesh-ancestor
19429489|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429490|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429491|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429492|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429493|NCT00330473|Insulin|insulin|mesh-list
19429494|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19429495|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429496|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429497|NCT00330369|Darusentan|darusentan|mesh-list
19429498|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19429499|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429500|NCT00327743|Capecitabine|capecitabine|mesh-list
19429501|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429502|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
19429503|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429504|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429505|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
19429506|NCT00326287|Linezolid|linezolid|mesh-list
19429507|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
19429508|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19429509|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19429510|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429511|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19429512|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429513|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429514|NCT00325650|Rimonabant|rimonabant|mesh-list
19429515|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19429516|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19429517|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19429518|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429519|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429520|NCT00325650|Hormones|hormones|mesh-ancestor
19712955|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712956|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
19712957|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
19429521|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429522|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857885|NCT00768430|Analgesics|analgesics|mesh-ancestor
19857886|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
19857887|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857888|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857889|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19857890|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19857891|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
19429523|NCT00325364|Insulin|insulin|mesh-list
19429524|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19429525|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19712958|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712959|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
19712960|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712961|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19712962|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19712963|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
19712964|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712965|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712966|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19712967|NCT04762810|Hormones|hormones|mesh-ancestor
19712968|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19712969|NCT04762745|Thalidomide|thalidomide|mesh-list
19712970|NCT04762745|Dexamethasone|dexamethasone|mesh-list
19712971|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
19712972|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19712973|NCT04762745|Pomalidomide|pomalidomide|mesh-list
19712974|NCT04762745|BB 1101|bb 1101|mesh-list
19712975|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19712976|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
19712977|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
19712978|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19712979|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19712980|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19712981|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
19712982|NCT04762745|Hormones|hormones|mesh-ancestor
19712983|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857892|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
19857893|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19857894|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19857895|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19857896|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857897|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857898|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19429526|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857899|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19857900|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19857901|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19857902|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19857903|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
19857904|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
19857905|NCT00768469|Paclitaxel|paclitaxel|mesh-list
20249936|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19429527|NCT00324220|Mocetinostat|mocetinostat|mesh-list
19429528|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19429529|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429530|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429531|NCT00323037|Carvedilol|carvedilol|mesh-list
19429532|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19429533|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19712984|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19429534|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
19429535|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857906|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429536|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429537|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429538|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429539|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
19429540|NCT00323037|Protective Agents|protective agents|mesh-ancestor
19429541|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19429542|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19429543|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19429544|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
19429545|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19429546|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19429547|NCT00322257|Insulin|insulin|mesh-list
19429548|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19429549|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
19429550|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
19429551|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429552|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429553|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19429554|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429555|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429556|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429557|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429558|NCT00321308|Pemetrexed|pemetrexed|mesh-list
19429559|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429560|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429561|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429562|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19429563|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19429564|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
19429565|NCT00320203|Anecortave|anecortave|mesh-list
19429566|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429567|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429568|NCT00320203|Growth Substances|growth substances|mesh-ancestor
19429569|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429570|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429571|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429572|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429573|NCT00319969|Topotecan|topotecan|mesh-list
19429574|NCT00319969|Amrubicin|amrubicin|mesh-list
19429575|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19429576|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19429577|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429578|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429579|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429580|NCT00318656|Metformin|metformin|mesh-list
19429581|NCT00318656|Glimepiride|glimepiride|mesh-list
19429582|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
19429583|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19712985|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19712986|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
19712987|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19712988|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19712989|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19712990|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
19712991|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
19712992|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19712993|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19857907|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857908|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
19857909|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
19857910|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
19712994|NCT04762745|Growth Substances|growth substances|mesh-ancestor
19712995|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429584|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429585|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19429586|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429587|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
19429588|NCT00317486|Bosentan|bosentan|mesh-list
19429589|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429590|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19712996|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19712997|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
19712998|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19712999|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857911|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429591|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429592|NCT00317395|Heparin|heparin|mesh-list
19713000|NCT04762511|Vaccines|vaccines|mesh-list
19713001|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
19857912|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19429593|NCT00317395|Calcium heparin|calcium heparin|mesh-list
19429594|NCT00317395|Otamixaban|otamixaban|mesh-list
19429595|NCT00317395|Eptifibatide|eptifibatide|mesh-list
19429596|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
19429597|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19429598|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19429599|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429600|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19429601|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19429602|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
19429603|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19429604|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429605|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429606|NCT00315757|Bortezomib|bortezomib|mesh-list
19429607|NCT00315757|Mapatumumab|mapatumumab|mesh-list
19429608|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19429609|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429610|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
19429611|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429612|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
19429613|NCT00315640|Anecortave|anecortave|mesh-list
19429614|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429615|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19713002|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713003|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
19713004|NCT04762784|Hormones|hormones|mesh-ancestor
19713005|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713006|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713007|NCT04762901|Paclitaxel|paclitaxel|mesh-list
19713008|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
19713009|NCT04762901|Carboplatin|carboplatin|mesh-list
19713010|NCT04762901|Doxorubicin|doxorubicin|mesh-list
19713011|NCT04762901|Niraparib|niraparib|mesh-list
19713012|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19713013|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713014|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713015|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713016|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713017|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713018|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713019|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
19713020|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713021|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713022|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19713023|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
19713024|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19713025|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19713026|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19857913|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19429616|NCT00315640|Growth Substances|growth substances|mesh-ancestor
19429617|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429618|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429619|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429620|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429621|NCT00313794|Tremelimumab|tremelimumab|mesh-list
19429622|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429623|NCT00313768|Paclitaxel|paclitaxel|mesh-list
19429624|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19429625|NCT00313768|Bevacizumab|bevacizumab|mesh-list
19429626|NCT00313768|Carboplatin|carboplatin|mesh-list
19429627|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429628|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429629|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429630|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429631|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
19429632|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429633|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429634|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429635|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429636|NCT00313768|Growth Substances|growth substances|mesh-ancestor
19429637|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429638|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429639|NCT00313248|Sagopilone|sagopilone|mesh-list
19429640|NCT00313248|Epothilones|epothilones|mesh-list
19429641|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429642|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429643|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429644|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19429645|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429646|NCT00313222|Bosentan|bosentan|mesh-list
19429647|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429648|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19429649|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451128|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19451129|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451130|NCT03423472|Vitamin A|vitamin a|mesh-list
19451131|NCT03423472|Vitamins|vitamins|mesh-ancestor
19451132|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
19451133|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451134|NCT03423342|Niacinamide|niacinamide|mesh-list
19451135|NCT03423342|Niacin|niacin|mesh-list
19451136|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
19451137|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
19713027|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532114|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532115|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20532116|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
20532117|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20532118|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20553329|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20553330|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553331|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19713028|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713029|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19713030|NCT04761952|Azathioprine|azathioprine|mesh-list
19713031|NCT04761952|Infliximab|infliximab|mesh-list
19713032|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
19713033|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553332|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
20553333|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553334|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20553335|NCT01928628|Valsartan|valsartan|mesh-list
20553336|NCT01928628|Lercanidipine|lercanidipine|mesh-list
20553337|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19451138|NCT03423342|Vitamins|vitamins|mesh-ancestor
19713034|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713035|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
19713036|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713037|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19857914|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19429650|NCT00313196|Bosentan|bosentan|mesh-list
19429651|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429652|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19429653|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429654|NCT00312975|Tremelimumab|tremelimumab|mesh-list
19429655|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429656|NCT00312091|Lamivudine|lamivudine|mesh-list
19429657|NCT00312091|Nevirapine|nevirapine|mesh-list
19429658|NCT00312091|Stavudine|stavudine|mesh-list
19429659|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19429660|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19429661|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429662|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429663|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
19429664|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429665|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19429666|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19429667|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19429668|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19429669|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
19429670|NCT00311090|Idraparinux|idraparinux|mesh-list
19429671|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
19429672|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19429673|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
19429674|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19429675|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429676|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429677|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429678|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
19429679|NCT00310830|Bosentan|bosentan|mesh-list
19429680|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429681|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19429682|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249937|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20249938|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20249939|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249940|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249941|NCT00442741|Epothilone B|epothilone b|mesh-list
20249942|NCT00442741|Epothilones|epothilones|mesh-list
20532119|NCT01798875|Metformin|metformin|mesh-list
19429683|NCT00309179|Cetuximab|cetuximab|mesh-list
19429684|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429685|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429686|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
19429687|NCT00307398|Anecortave|anecortave|mesh-list
19429688|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429689|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429690|NCT00307398|Growth Substances|growth substances|mesh-ancestor
19429691|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857915|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
19857916|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19857917|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857918|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857919|NCT00768521|Urological Agents|urological agents|mesh-ancestor
19857920|NCT00768560|Nifedipine|nifedipine|mesh-list
19857921|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20249943|NCT00442741|Omeprazole|omeprazole|mesh-list
20249944|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20249945|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20249946|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20249947|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532120|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
20532121|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
20532122|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532123|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532124|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19429692|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429693|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429694|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429695|NCT00305656|Cediranib|cediranib|mesh-list
19429696|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429697|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429698|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429699|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429700|NCT00305188|Leucovorin|leucovorin|mesh-list
19429701|NCT00305188|Fluorouracil|fluorouracil|mesh-list
19429702|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
19429703|NCT00305188|Xaliproden|xaliproden|mesh-list
19429704|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
19429705|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429706|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429707|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429708|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429709|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
19429710|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429711|NCT00305188|Antidotes|antidotes|mesh-ancestor
19429712|NCT00305188|Protective Agents|protective agents|mesh-ancestor
19429713|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
19429714|NCT00305188|Vitamins|vitamins|mesh-ancestor
19429715|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
19429716|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19429717|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19429718|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
19429719|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429720|NCT00303498|Sitaxsentan|sitaxsentan|mesh-list
19429721|NCT00303498|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19429722|NCT00303498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429723|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
19429724|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429725|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
19429726|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19429727|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19429728|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429729|NCT00301262|Urological Agents|urological agents|mesh-ancestor
19429730|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19429731|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19429732|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19429733|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19429734|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713038|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713039|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713040|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
19713041|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713042|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
19713043|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19713044|NCT04762030|Paclitaxel|paclitaxel|mesh-list
20249948|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249949|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20249950|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
20249951|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
20249952|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
20249953|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
20249954|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
19429735|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19451139|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
19451140|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429736|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19429737|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20249955|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20249956|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20249957|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
20249958|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20249959|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429738|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
19429739|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429740|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429741|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19429742|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19429743|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
19857922|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857923|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857924|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19857925|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857926|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
19429744|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
19429745|NCT00299507|Anecortave|anecortave|mesh-list
19429746|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19429747|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19429748|NCT00299507|Growth Substances|growth substances|mesh-ancestor
19429749|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429750|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
19429751|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429752|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19429753|NCT00299325|Rimonabant|rimonabant|mesh-list
19429754|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19429755|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19429756|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19429757|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429758|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429759|NCT00299325|Hormones|hormones|mesh-ancestor
19429760|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429761|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532125|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20532126|NCT01798901|Decitabine|decitabine|mesh-list
20532127|NCT01798901|Azacitidine|azacitidine|mesh-list
20532128|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20532129|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532130|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
20532131|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532132|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429762|NCT00298987|Dasatinib|dasatinib|mesh-list
19429763|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429764|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19429765|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429766|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429767|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
19429768|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429769|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429770|NCT00297310|Tacrolimus|tacrolimus|mesh-list
19429771|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429772|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
19429773|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429774|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19429775|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429776|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713045|NCT04762030|Carboplatin|carboplatin|mesh-list
19713046|NCT04762030|Durvalumab|durvalumab|mesh-list
19713047|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19713048|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713049|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713050|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713051|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713052|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857927|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
19429777|NCT00297089|Pemetrexed|pemetrexed|mesh-list
19429778|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429779|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429780|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429781|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19429782|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19429783|NCT00292396|Antibodies|antibodies|mesh-list
19429784|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19429785|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
19429786|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429787|NCT00289640|Ipilimumab|ipilimumab|mesh-list
19429788|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19429789|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429790|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19429791|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429792|NCT00287547|Abatacept|abatacept|mesh-list
19429793|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19429794|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429795|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429796|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429797|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
19429798|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429799|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713053|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19713054|NCT04762134|Doxycycline|doxycycline|mesh-list
19713055|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19713056|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713057|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
20532133|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532134|NCT01798914|Insulin|insulin|mesh-list
20532135|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532136|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532137|NCT01798940|Pioglitazone|pioglitazone|mesh-list
20532138|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532139|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532140|NCT01798979|Midazolam|midazolam|mesh-list
20532141|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20532142|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20532143|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532144|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532145|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20532146|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20532147|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20532148|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20532149|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
19429800|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
19429801|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429802|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429803|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19429804|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
19429805|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19429806|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429807|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19429808|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19429809|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19429810|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
19429811|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429812|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429813|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19429814|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
19429815|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19429816|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429817|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19429818|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19429819|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19429820|NCT00284128|Losartan|losartan|mesh-list
19429821|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19429822|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19429823|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19429824|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19429825|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429826|NCT00282867|Insulin|insulin|mesh-list
19429827|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429828|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429829|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
19429830|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429831|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429832|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19857928|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19857929|NCT00768599|Econazole|econazole|mesh-list
20249960|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249961|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
20249962|NCT00442793|Hematinics|hematinics|mesh-ancestor
20249963|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20249964|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
20249965|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20249966|NCT00442819|Protective Agents|protective agents|mesh-ancestor
20249967|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249968|NCT00442832|Vancomycin|vancomycin|mesh-list
20249969|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20532150|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
20532151|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
20532152|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
20532153|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532154|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532155|NCT01799005|Micronutrients|micronutrients|mesh-list
20532156|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532157|NCT01799057|Metformin|metformin|mesh-list
20532158|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857930|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
19857931|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857932|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19857933|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19857934|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857935|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857936|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19857937|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
19857938|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857939|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249970|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20249971|NCT00442845|Atorvastatin|atorvastatin|mesh-list
20249972|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20249973|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20249974|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
20249975|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249976|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20532159|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532160|NCT01799083|Decitabine|decitabine|mesh-list
20532161|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532162|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
20532163|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532164|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532165|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532166|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
20532167|NCT01799109|Albuterol|albuterol|mesh-list
20532168|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20532169|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
20532170|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532171|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532172|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19429833|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
19429834|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19429835|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429836|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19429837|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19429838|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19429839|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
19429840|NCT00273650|Vitamins|vitamins|mesh-ancestor
19429841|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
19429842|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429843|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
19429844|NCT00267592|Temozolomide|temozolomide|mesh-list
19429845|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19429846|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
19429847|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429848|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429849|NCT00267280|Atorvastatin|atorvastatin|mesh-list
19429850|NCT00267280|Simvastatin|simvastatin|mesh-list
19429851|NCT00267280|Torcetrapib|torcetrapib|mesh-list
19429852|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19429853|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19429854|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
19429855|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429856|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19429857|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19429858|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429859|NCT00265655|Satraplatin|satraplatin|mesh-list
19429860|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429861|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
19429862|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19429863|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19429864|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429865|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19429866|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19429867|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19429868|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19429869|NCT00263341|Estrogens|estrogens|mesh-ancestor
19429870|NCT00263341|Hormones|hormones|mesh-ancestor
19429871|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429872|NCT00263042|Rimonabant|rimonabant|mesh-list
19429873|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19429874|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19429875|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19429876|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429877|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429878|NCT00263042|Hormones|hormones|mesh-ancestor
19429879|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19429880|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429881|NCT00262990|Doxorubicin|doxorubicin|mesh-list
19429882|NCT00262990|Epothilone B|epothilone b|mesh-list
19429883|NCT00262990|Epothilones|epothilones|mesh-list
19713058|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19713059|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19857940|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19857941|NCT00768651|Pantoprazole|pantoprazole|mesh-list
19857942|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857943|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857944|NCT00768651|Incretins|incretins|mesh-ancestor
19857945|NCT00768651|Hormones|hormones|mesh-ancestor
19857946|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19857947|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19857948|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
19857949|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857950|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857951|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19429884|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19713060|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19713061|NCT04761705|Latanoprost|latanoprost|mesh-list
19713062|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19713063|NCT04762147|Acetaminophen|acetaminophen|mesh-list
19713064|NCT04762147|Fentanyl|fentanyl|mesh-list
19713065|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19713066|NCT04762147|Narcotics|narcotics|mesh-ancestor
19713067|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713068|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429885|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429886|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19429887|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19429888|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429889|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429890|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429891|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429892|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
19429893|NCT00260156|Vildagliptin|vildagliptin|mesh-list
19429894|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19429895|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429896|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19429897|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429898|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429899|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429900|NCT00260078|Ritonavir|ritonavir|mesh-list
19429901|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19429902|NCT00260078|Darunavir|darunavir|mesh-list
19429903|NCT00260078|Tenofovir|tenofovir|mesh-list
19429904|NCT00260078|Nevirapine|nevirapine|mesh-list
19429905|NCT00260078|Efavirenz|efavirenz|mesh-list
19429906|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19429907|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19429908|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429909|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429910|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429911|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19429912|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19429913|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
19429914|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429915|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19429916|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19429917|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19429918|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19429919|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19429920|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19429921|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19429922|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19429923|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19429924|NCT00257205|Temozolomide|temozolomide|mesh-list
19429925|NCT00257205|Dacarbazine|dacarbazine|mesh-list
19429926|NCT00257205|Tremelimumab|tremelimumab|mesh-list
19451141|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19429927|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19429928|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
19429929|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429930|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429931|NCT00255099|Etravirine|etravirine|mesh-list
19429932|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19429933|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19429934|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429935|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713069|NCT04762147|Analgesics|analgesics|mesh-ancestor
19713070|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
19713071|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713072|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19713073|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19713074|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
19713075|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
19713076|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19713077|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
19713078|NCT04761744|Nivolumab|nivolumab|mesh-list
19713079|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19713080|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713081|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19713082|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713083|NCT04761731|Tacrolimus|tacrolimus|mesh-list
19713084|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713085|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
19713086|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713087|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19713088|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713089|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713090|NCT04761601|Gemcitabine|gemcitabine|mesh-list
19713091|NCT04761601|Paclitaxel|paclitaxel|mesh-list
19713092|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19713093|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713094|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713095|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713096|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713097|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713098|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19713099|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
19713100|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
19713101|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713102|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713103|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713104|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
19713105|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713106|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19713107|NCT04761185|Raltitrexed|raltitrexed|mesh-list
19713108|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429936|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
19429937|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713109|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
19713110|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429938|NCT00254904|Gemcitabine|gemcitabine|mesh-list
19429939|NCT00254904|Cisplatin|cisplatin|mesh-list
19429940|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429941|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429942|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
19429943|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429944|NCT00254904|Antiviral Agents|antiviral agents|mesh-ancestor
19429945|NCT00254904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429946|NCT00254904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429947|NCT00254904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429948|NCT00254904|Immunologic Factors|immunologic factors|mesh-ancestor
19429949|NCT00254904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429950|NCT00254891|Paclitaxel|paclitaxel|mesh-list
19429951|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19713111|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713112|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19713113|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713114|NCT04761393|Xenon|xenon|mesh-list
19713115|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19713116|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
19713117|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
19713118|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713119|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713120|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
19713121|NCT04761133|Povidone|povidone|mesh-list
19713122|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
19713123|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
19713124|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19713125|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713126|NCT04761198|Nivolumab|nivolumab|mesh-list
19713127|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19713128|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713129|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19713130|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713131|NCT04761029|Tramadol|tramadol|mesh-list
19713132|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19713133|NCT04761029|Narcotics|narcotics|mesh-ancestor
19713134|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713135|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713136|NCT04761029|Analgesics|analgesics|mesh-ancestor
19713137|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
19713138|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733992|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19429952|NCT00254891|Carboplatin|carboplatin|mesh-list
19429953|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19857952|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19857953|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19429954|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429955|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
19429956|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
19429957|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
19429958|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429959|NCT00254579|Tremelimumab|tremelimumab|mesh-list
19429960|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429961|NCT00253968|SR 46349B|sr 46349b|mesh-list
19429962|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20249977|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19429963|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19429964|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429965|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19429966|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19429967|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
19429968|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429969|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429970|NCT00252005|Apixaban|apixaban|mesh-list
19429971|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19429972|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
19429973|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19429974|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
19429975|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429976|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429977|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
19429978|NCT00250822|Gemcitabine|gemcitabine|mesh-list
19429979|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
19429980|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19429981|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
19429982|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429983|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19429984|NCT00250822|Antiviral Agents|antiviral agents|mesh-ancestor
19429985|NCT00250822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19429986|NCT00250822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19429987|NCT00250822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19429988|NCT00250822|Immunologic Factors|immunologic factors|mesh-ancestor
19429989|NCT00250822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19429990|NCT00243906|Plasminogen|plasminogen|mesh-list
19429991|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19429992|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19429993|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19429994|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19429995|NCT00243867|Paclitaxel|paclitaxel|mesh-list
19429996|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19429997|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713139|NCT04760821|Trimetazidine|trimetazidine|mesh-list
19713140|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
19713141|NCT04760860|Prazosin|prazosin|mesh-list
19713142|NCT04760860|Terazosin|terazosin|mesh-list
19713143|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19713144|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19713145|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19429998|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713146|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
19713147|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19429999|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
19430000|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
19430001|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430002|NCT00239694|Vaccines|vaccines|mesh-list
19430003|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19430004|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
19430005|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430006|NCT00232752|Sirolimus|sirolimus|mesh-list
19430007|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19430008|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430009|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19430010|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430011|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
19430012|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430013|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
19430014|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430015|NCT00232141|Pregabalin|pregabalin|mesh-list
19430016|NCT00232141|Analgesics|analgesics|mesh-ancestor
19430017|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
19430018|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430019|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430020|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
19430021|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19430022|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19430023|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713148|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713149|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249978|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249979|NCT00443105|Tacrolimus|tacrolimus|mesh-list
19430024|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19430025|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19430026|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19430027|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19430028|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19430029|NCT00231257|Sirolimus|sirolimus|mesh-list
19430030|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19430031|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430032|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19430033|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713150|NCT04760860|Urological Agents|urological agents|mesh-ancestor
19713151|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19713152|NCT04760704|Antibodies|antibodies|mesh-list
19713153|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
19713154|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713155|NCT04760574|Testosterone|testosterone|mesh-list
19713156|NCT04760574|Androgens|androgens|mesh-ancestor
19713157|NCT04760574|Hormones|hormones|mesh-ancestor
19713158|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713159|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713160|NCT04760327|Cisplatin|cisplatin|mesh-list
19713161|NCT04760327|Bleomycin|bleomycin|mesh-list
19430034|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
19430035|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430036|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
19430037|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430038|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
19430039|NCT00231153|Povidone|povidone|mesh-list
19713162|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430040|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
19857954|NCT00768716|Acetaminophen|acetaminophen|mesh-list
19430041|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
19430042|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19430043|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430044|NCT00229008|Linezolid|linezolid|mesh-list
19430045|NCT00229008|Ceftazidime|ceftazidime|mesh-list
19430046|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
19430047|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19430048|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19430049|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430050|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19430051|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430052|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430053|NCT00228176|Rimonabant|rimonabant|mesh-list
19430054|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19430055|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19430056|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19430057|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19430058|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430059|NCT00228176|Hormones|hormones|mesh-ancestor
19430060|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430061|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430062|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
19430063|NCT00224003|Hematinics|hematinics|mesh-ancestor
19430064|NCT00219297|Epothilone B|epothilone b|mesh-list
19430065|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430066|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
19430067|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
19430068|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
19430069|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430070|NCT00216593|Galantamine|galantamine|mesh-list
19430071|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19430072|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430073|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430074|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
19430075|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19430076|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430077|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19430078|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
19430079|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20249980|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430080|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
19430081|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
19430082|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
19430083|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430084|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
19430085|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430086|NCT00214968|Modafinil|modafinil|mesh-list
19430087|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19430088|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430089|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19430090|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430091|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430092|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430093|NCT00210964|Linezolid|linezolid|mesh-list
19430094|NCT00210964|Ceftazidime|ceftazidime|mesh-list
19430095|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
19430096|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19430097|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19430098|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430099|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20249981|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
20532173|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
19430100|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430101|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430102|NCT00198276|Bleomycin|bleomycin|mesh-list
19430103|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19430104|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430105|NCT00198263|Bleomycin|bleomycin|mesh-list
19430106|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19430107|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430108|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
19430109|NCT00196339|Cyproterone|cyproterone|mesh-list
19430110|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
19430111|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
19430112|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430113|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430114|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430115|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19430116|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
19430117|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19430118|NCT00179400|Pioglitazone|pioglitazone|mesh-list
19430119|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430120|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451142|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
19451143|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451144|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19451145|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
19451146|NCT03423329|Ibuprofen|ibuprofen|mesh-list
19451147|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19451148|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451149|NCT03423329|Analgesics|analgesics|mesh-ancestor
19451150|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
19451151|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451152|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451153|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451154|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451155|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19451156|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451157|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451158|NCT03423225|Tacrolimus|tacrolimus|mesh-list
19451159|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19451160|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
19451161|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451162|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19451163|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451164|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451165|NCT03423030|Macozinone|macozinone|mesh-list
19451166|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
19451167|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19451168|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451169|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
19451170|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19451171|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451172|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451173|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451174|NCT03422978|Analgesics|analgesics|mesh-ancestor
19451175|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
19451176|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451177|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20249982|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249983|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20249984|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20249985|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20249986|NCT00443144|Hormones|hormones|mesh-list
20249987|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20249988|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249989|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
20249990|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
20249991|NCT00443170|Midazolam|midazolam|mesh-list
20249992|NCT00443170|Caffeine|caffeine|mesh-list
20249993|NCT00443170|Omeprazole|omeprazole|mesh-list
19430121|NCT00174837|Tirapazamine|tirapazamine|mesh-list
19430122|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430123|NCT00162292|Methotrexate|methotrexate|mesh-list
19430124|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19430125|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
19430126|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19430127|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430128|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19430129|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
19430130|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430131|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430132|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
19430133|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430134|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19430135|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430136|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
19430137|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430138|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430139|NCT00162279|Abatacept|abatacept|mesh-list
19430140|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19430141|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430142|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430143|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430144|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
19430145|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430146|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430147|NCT00157339|Insulin|insulin|mesh-list
19430148|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19430149|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430150|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430151|NCT00145431|Atorvastatin|atorvastatin|mesh-list
19430152|NCT00145431|Torcetrapib|torcetrapib|mesh-list
19430153|NCT00145431|Fenofibrate|fenofibrate|mesh-list
19430154|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19430155|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19430156|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
19430157|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430158|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19430159|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19430160|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430161|NCT00141284|Lamivudine|lamivudine|mesh-list
19430162|NCT00141284|Zidovudine|zidovudine|mesh-list
19430163|NCT00141284|Nelfinavir|nelfinavir|mesh-list
19430164|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430165|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430166|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430167|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430168|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
19430169|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430170|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430171|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430172|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
19430173|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430174|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430175|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430176|NCT00138762|Atorvastatin|atorvastatin|mesh-list
19430177|NCT00138762|Torcetrapib|torcetrapib|mesh-list
19430178|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19430179|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19430180|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
19430181|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430182|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19430183|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19430184|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430185|NCT00135421|Citalopram|citalopram|mesh-list
19430186|NCT00135421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19430187|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19713163|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19713164|NCT04760431|Paclitaxel|paclitaxel|mesh-list
19713165|NCT04760431|Docetaxel|docetaxel|mesh-list
19713166|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19713167|NCT04760431|Trastuzumab|trastuzumab|mesh-list
19713168|NCT04760431|Pertuzumab|pertuzumab|mesh-list
19713169|NCT04760431|Taxane|taxane|mesh-list
19713170|NCT04760431|Tucatinib|tucatinib|mesh-list
19713171|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19713172|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713173|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713174|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713175|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713176|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713177|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19713178|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19713179|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713180|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
19713181|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19713182|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19713183|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713184|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
19713185|NCT04760301|Coagulants|coagulants|mesh-ancestor
19713186|NCT04759703|Pramipexole|pramipexole|mesh-list
19713187|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
19430188|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19430189|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430190|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19430191|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
19430192|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430193|NCT00135421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19430194|NCT00135421|Antidepressive Agents|antidepressive agents|mesh-ancestor
19430195|NCT00135421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19430196|NCT00135395|Ritonavir|ritonavir|mesh-list
19430197|NCT00135395|Lopinavir|lopinavir|mesh-list
19430198|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430199|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19713188|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713189|NCT04759703|Protective Agents|protective agents|mesh-ancestor
19430200|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430201|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430202|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430203|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430204|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430205|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430206|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
19430207|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430208|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19430209|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430210|NCT00135382|Efavirenz|efavirenz|mesh-list
20249994|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20249995|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20249996|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20249997|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20249998|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20249999|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20250000|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20250001|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20250002|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
20250003|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
20250004|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
19430211|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430212|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430213|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430214|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430215|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
19430216|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430217|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430218|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430219|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430220|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19430221|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430222|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430223|NCT00135369|Lamivudine|lamivudine|mesh-list
19430224|NCT00135369|Efavirenz|efavirenz|mesh-list
19430225|NCT00135369|Stavudine|stavudine|mesh-list
19430226|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430227|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430228|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430229|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430230|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
19430231|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430232|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430233|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430234|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430235|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19713190|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713191|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19713192|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19713193|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
19713194|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
19713195|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713196|NCT04759729|Vitamin D|vitamin d|mesh-list
19713197|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
19713198|NCT04759729|Vitamins|vitamins|mesh-list
19713199|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
19713200|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430236|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430237|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19430238|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430239|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430240|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
19430241|NCT00135343|Ritonavir|ritonavir|mesh-list
19713201|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19713202|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19857955|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19857956|NCT00768716|Analgesics|analgesics|mesh-ancestor
19857957|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
19857958|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19857959|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857960|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
19857961|NCT00768755|Pemetrexed|pemetrexed|mesh-list
20250005|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
19430242|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430243|NCT00135343|Efavirenz|efavirenz|mesh-list
19430244|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430245|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430246|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430247|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430248|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430249|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430250|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430251|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
19430252|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430253|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19430254|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430255|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430256|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430257|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430258|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430259|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19430260|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430261|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430262|NCT00134264|Atorvastatin|atorvastatin|mesh-list
19430263|NCT00134264|Torcetrapib|torcetrapib|mesh-list
19430264|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19430265|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19430266|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
19430267|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430268|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19430269|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19430270|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430271|NCT00134238|Atorvastatin|atorvastatin|mesh-list
19430272|NCT00134238|Torcetrapib|torcetrapib|mesh-list
19430273|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19430274|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19430275|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
19430276|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430277|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19430278|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20250006|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250007|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250008|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19430279|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430280|NCT00131924|Estrogens|estrogens|mesh-list
19430281|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
19430282|NCT00131924|Hormones|hormones|mesh-ancestor
19430283|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430284|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430285|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19430286|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
19430287|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19430288|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
19430289|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430290|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19430291|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19430292|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19430293|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430294|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430295|NCT00127634|Insulin|insulin|mesh-list
19430296|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19430297|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
19430298|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430299|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430300|NCT00126984|Vaccines|vaccines|mesh-list
19430301|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
19430302|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430303|NCT00125970|Vaccines|vaccines|mesh-list
19430304|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
19430305|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430306|NCT00120393|Ritonavir|ritonavir|mesh-list
19430307|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430308|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430309|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430310|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430311|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430312|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430313|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430314|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430315|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
19430316|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430317|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19430318|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430319|NCT00120042|Misoprostol|misoprostol|mesh-list
19430320|NCT00120042|Oxytocin|oxytocin|mesh-list
19430321|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
19430322|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19430323|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430324|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19430325|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
19430326|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19430327|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19430328|NCT00119366|Iodine|iodine|mesh-list
19430329|NCT00119366|Cyclosporine|cyclosporine|mesh-list
19430330|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
19430331|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19430332|NCT00119366|Fludarabine|fludarabine|mesh-list
19430333|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
19430334|NCT00119366|Antibodies|antibodies|mesh-list
19430335|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
19430336|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19430337|NCT00119366|Cyclosporins|cyclosporins|mesh-list
19430338|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
19430339|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430340|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430341|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19430342|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
19430343|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430344|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430345|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430346|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
19430347|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430348|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
19430349|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430350|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19430351|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19430352|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19430353|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
19430354|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19430355|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19430356|NCT00119366|Trace Elements|trace elements|mesh-ancestor
19430357|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
20532174|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
19430358|NCT00117650|Etoposide|etoposide|mesh-list
19430359|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
19430360|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19430361|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430362|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20532175|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20532176|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19430363|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19430364|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430365|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430366|NCT00116415|Lamivudine|lamivudine|mesh-list
19430367|NCT00116415|Efavirenz|efavirenz|mesh-list
19430368|NCT00116415|Didanosine|didanosine|mesh-list
19430369|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430370|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430371|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430372|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430373|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
19430374|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430375|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20250009|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250010|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20250011|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430376|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430377|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430378|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430379|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430380|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19430381|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430382|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430383|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
19713203|NCT04759742|Ropivacaine|ropivacaine|mesh-list
19713204|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
19713205|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
19713206|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713207|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713208|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
19713209|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713210|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19713211|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19713212|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713213|NCT04760262|Remifentanil|remifentanil|mesh-list
19713214|NCT04760262|Propofol|propofol|mesh-list
19713215|NCT04760262|Sevoflurane|sevoflurane|mesh-list
19713216|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19713217|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713218|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713219|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19713220|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
19713221|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
19713222|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19713223|NCT04760262|Narcotics|narcotics|mesh-ancestor
20250012|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20250013|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19430384|NCT00116298|Lamivudine|lamivudine|mesh-list
19713224|NCT04760262|Analgesics|analgesics|mesh-ancestor
19713225|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
19713226|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713227|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19713228|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19713229|NCT04758936|Clonidine|clonidine|mesh-list
19713230|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
19713231|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19713232|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713233|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713234|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19713235|NCT04758936|Analgesics|analgesics|mesh-ancestor
19713236|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
19713237|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713238|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19713239|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19713240|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19713241|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
19713242|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713243|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713244|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19713245|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
19713246|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
19857962|NCT00768755|Axitinib|axitinib|mesh-list
19713247|NCT04758871|Progesterone|progesterone|mesh-list
19713248|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
19713249|NCT04758871|Progestins|progestins|mesh-ancestor
19857963|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713250|NCT04758871|Hormones|hormones|mesh-ancestor
19713251|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430385|NCT00116298|Efavirenz|efavirenz|mesh-list
19430386|NCT00116298|Stavudine|stavudine|mesh-list
19430387|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430388|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430389|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430390|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430391|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
19430392|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430393|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430394|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430395|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430396|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430397|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430398|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19430399|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430400|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430401|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
19430402|NCT00116116|Lamivudine|lamivudine|mesh-list
19430403|NCT00116116|Efavirenz|efavirenz|mesh-list
19430404|NCT00116116|Stavudine|stavudine|mesh-list
19430405|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430406|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430407|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430408|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430409|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
19430410|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430411|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430412|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430413|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430414|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430415|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430416|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19430417|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19713252|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713253|NCT04758858|Glucagon|glucagon|mesh-list
19713254|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713255|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713256|NCT04758858|Hormones|hormones|mesh-ancestor
19713257|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713258|NCT04759079|Antiemetics|antiemetics|mesh-list
19430418|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430419|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
19430420|NCT00115050|Darunavir|darunavir|mesh-list
19430421|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430422|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430423|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430424|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430425|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430426|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430427|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430428|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
19430429|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430430|NCT00113438|Paclitaxel|paclitaxel|mesh-list
19430431|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
19430432|NCT00113438|Combretastatin|combretastatin|mesh-list
19430433|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19430434|NCT00113438|Carboplatin|carboplatin|mesh-list
19430435|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19430436|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430437|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
19430438|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
19430439|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
19430440|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430441|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19430442|NCT00110422|Irbesartan|irbesartan|mesh-list
19430443|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19430444|NCT00110422|Diuretics|diuretics|mesh-ancestor
19430445|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
19430446|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430447|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19430448|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19857964|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857965|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857966|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19857967|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19857968|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19430449|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430450|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19430451|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19430452|NCT00109681|Iloprost|iloprost|mesh-list
19430453|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19430454|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
19430455|NCT00109538|Lonafarnib|lonafarnib|mesh-list
19430456|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430457|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430458|NCT00108810|Ketoprofen|ketoprofen|mesh-list
19430459|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19430460|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19430461|NCT00108810|Analgesics|analgesics|mesh-ancestor
19430462|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
19430463|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430464|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430465|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19430466|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430467|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19430468|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430469|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430470|NCT00106808|Pioglitazone|pioglitazone|mesh-list
19430471|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430472|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430473|NCT00106626|Pemetrexed|pemetrexed|mesh-list
19430474|NCT00106626|Vorinostat|vorinostat|mesh-list
19430475|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430476|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430477|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430478|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19430479|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430480|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19430481|NCT00106340|Metformin|metformin|mesh-list
19430482|NCT00106340|Glimepiride|glimepiride|mesh-list
19430483|NCT00106340|Vildagliptin|vildagliptin|mesh-list
19430484|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430485|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430486|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19430487|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430488|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
19430489|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20250014|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20250015|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20250016|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
19430490|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430491|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430492|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250017|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20250018|NCT00443170|Analgesics|analgesics|mesh-ancestor
20250019|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
20250020|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430493|NCT00103831|Taxane|taxane|mesh-list
19430494|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430495|NCT00102466|Metformin|metformin|mesh-list
19430496|NCT00102466|Vildagliptin|vildagliptin|mesh-list
19430497|NCT00102466|Gliclazide|gliclazide|mesh-list
19430498|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19857969|NCT00768989|Ritonavir|ritonavir|mesh-list
20250021|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20250022|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20250023|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250024|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250025|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20250026|NCT00443222|Infliximab|infliximab|mesh-list
20250027|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
20250028|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250029|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286547|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20532177|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20532178|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20532179|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
19430499|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286548|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430500|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19430501|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430502|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430503|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430504|NCT00101595|Dasatinib|dasatinib|mesh-list
19430505|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430506|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19430507|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713259|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
19713260|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713261|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713262|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713263|NCT04759196|Topiramate|topiramate|mesh-list
19713264|NCT04759196|Levetiracetam|levetiracetam|mesh-list
19713265|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
19713266|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19713267|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713268|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
19733993|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733994|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733995|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
19733996|NCT04555694|Hormones|hormones|mesh-ancestor
19733997|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733998|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733999|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734000|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430508|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430509|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
19430510|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430511|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19430512|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
19430513|NCT00099853|Pioglitazone|pioglitazone|mesh-list
19430514|NCT00099853|Vildagliptin|vildagliptin|mesh-list
19430515|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430516|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452756|NCT03410836|Lidocaine|lidocaine|mesh-list
19452757|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
19452758|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
19452759|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452760|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452761|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
19452762|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452763|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452764|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19452765|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19452766|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452767|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452768|NCT03410784|Paclitaxel|paclitaxel|mesh-list
19452769|NCT03410784|Carboplatin|carboplatin|mesh-list
19452770|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
19452771|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19452772|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452773|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
19452774|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
19452775|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
19452776|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430517|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19430518|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430519|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430520|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430521|NCT00097357|Enoxaparin|enoxaparin|mesh-list
19430522|NCT00097357|Warfarin|warfarin|mesh-list
19430523|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
19430524|NCT00097357|Apixaban|apixaban|mesh-list
19430525|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
19430526|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19430527|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19430528|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250030|NCT00443235|Thalidomide|thalidomide|mesh-list
20250031|NCT00443235|Prednisone|prednisone|mesh-list
20250032|NCT00443235|Melphalan|melphalan|mesh-list
20250033|NCT00443235|Bortezomib|bortezomib|mesh-list
20250034|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19430529|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19430530|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
19430531|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19430532|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430533|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430534|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19430535|NCT00095550|Irbesartan|irbesartan|mesh-list
19430536|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19430537|NCT00095550|Diuretics|diuretics|mesh-ancestor
19430538|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
19430539|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430540|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19430541|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19430542|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430543|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19430544|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19430545|NCT00095394|Irbesartan|irbesartan|mesh-list
19430546|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19430547|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19430548|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19430549|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430550|NCT00095290|Ramipril|ramipril|mesh-list
19430551|NCT00095290|Irbesartan|irbesartan|mesh-list
19430552|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19430553|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430554|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430555|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430556|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19713269|NCT04758689|Methotrexate|methotrexate|mesh-list
19713270|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19713271|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
19713272|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19713273|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713274|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19713275|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
19713276|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713277|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713278|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
19713279|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857970|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20250035|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
20250036|NCT00443235|Hormones|hormones|mesh-ancestor
20250037|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250038|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532180|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532181|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532182|NCT01799109|Analgesics|analgesics|mesh-ancestor
19713280|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19857971|NCT00768989|Tenofovir|tenofovir|mesh-list
20286549|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286550|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286551|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286552|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286553|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19430557|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19430558|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19430559|NCT00093132|Satraplatin|satraplatin|mesh-list
19430560|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430561|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
19430562|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19430563|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430564|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19430565|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
19430566|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19430567|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430568|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430569|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430570|NCT00086723|Captopril|captopril|mesh-list
19430571|NCT00086723|Plasminogen|plasminogen|mesh-list
19430572|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19430573|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19430574|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19430575|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430576|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19430577|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430578|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430579|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19430580|NCT00086671|Antibodies|antibodies|mesh-list
19430581|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19713281|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250039|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20250040|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250041|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20250042|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
20250043|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532183|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
20532184|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
20532185|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532186|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20532187|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
20532188|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20532189|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20532190|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20532191|NCT01799161|Theophylline|theophylline|mesh-list
20532192|NCT01799161|Vaccines|vaccines|mesh-list
20250044|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20532193|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
19430582|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
19430583|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430584|NCT00084344|Afimoxifene|afimoxifene|mesh-list
19430585|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430586|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19430587|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
19430588|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430589|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430590|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19430591|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19430592|NCT00084253|Ritonavir|ritonavir|mesh-list
19430593|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430594|NCT00084253|Lamivudine|lamivudine|mesh-list
19430595|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430596|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430597|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430598|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532194|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19857972|NCT00768989|Emtricitabine|emtricitabine|mesh-list
19857973|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
19857974|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19857975|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19857976|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
19857977|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857978|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430599|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430600|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430601|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430602|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
19430603|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430604|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19430605|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430606|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430607|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430608|NCT00083941|Interleukin-2|interleukin-2|mesh-list
19430609|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430610|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19430611|NCT00083941|Analgesics|analgesics|mesh-ancestor
19430612|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
19430613|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430614|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430615|NCT00083759|Natalizumab|natalizumab|mesh-list
19430616|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
19430617|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430618|NCT00081510|Anastrozole|anastrozole|mesh-list
19430619|NCT00081510|Lonafarnib|lonafarnib|mesh-list
19430620|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19430621|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857979|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19857980|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19857981|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
19857982|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19857983|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19857984|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19857985|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19857986|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20250045|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250046|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
20250047|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
20250048|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250049|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250050|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20250051|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20250052|NCT00443235|Growth Substances|growth substances|mesh-ancestor
20250053|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
20250054|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
20250055|NCT00443339|Hematinics|hematinics|mesh-ancestor
20250056|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
20532195|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20532196|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
20532197|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532198|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20532199|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
19430622|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19430623|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20532200|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20532201|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532202|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430624|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430625|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430626|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19430627|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
19430628|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430629|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430630|NCT00080106|Vaccines|vaccines|mesh-list
19430631|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
19430632|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430633|NCT00079482|Cytarabine|cytarabine|mesh-list
19430634|NCT00079482|Etoposide|etoposide|mesh-list
19430635|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
19430636|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19430637|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430638|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19430639|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19430640|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430641|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430642|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19430643|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
19430644|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
19430645|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430646|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430647|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
19430648|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430649|NCT00079482|Analgesics|analgesics|mesh-ancestor
19430650|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
19430651|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430652|NCT00073866|Celecoxib|celecoxib|mesh-list
19430653|NCT00073866|Docetaxel|docetaxel|mesh-list
19430654|NCT00073866|Irinotecan|irinotecan|mesh-list
19430655|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430656|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
19430657|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
19430658|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
19430659|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430660|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19430661|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19430662|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430663|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19430664|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19430665|NCT00073866|Analgesics|analgesics|mesh-ancestor
19430666|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
19430667|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430668|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430669|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19430670|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430671|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19430672|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19857987|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19857988|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19857989|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19857990|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19857991|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19857992|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19857993|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19857994|NCT00769132|Niacin|niacin|mesh-list
19857995|NCT00769132|Niacinamide|niacinamide|mesh-list
19857996|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
19857997|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19857998|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
19857999|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858000|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19858001|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
19858002|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
19858003|NCT00769132|Vitamins|vitamins|mesh-ancestor
19858004|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
19858005|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858006|NCT00769184|Clobetasol|clobetasol|mesh-list
19430673|NCT00071461|Bosentan|bosentan|mesh-list
19430674|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19430675|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19430676|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430677|NCT00070590|Bosentan|bosentan|mesh-list
19430678|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19430679|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19430680|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430681|NCT00069745|Prednisone|prednisone|mesh-list
19430682|NCT00069745|Satraplatin|satraplatin|mesh-list
19430683|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19430684|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
19430685|NCT00069745|Hormones|hormones|mesh-ancestor
19858007|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858008|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
20250057|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20250058|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
20250059|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250060|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250061|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20250062|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
20250063|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20250064|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20250065|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20250066|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250067|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250068|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250069|NCT00443508|Everolimus|everolimus|mesh-list
20250070|NCT00443508|Tacrolimus|tacrolimus|mesh-list
20250071|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250072|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
20250073|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250074|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20250075|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250076|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250077|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250078|NCT00443521|Triamcinolone|triamcinolone|mesh-list
20250079|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20532203|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
20532204|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20532205|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20532206|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
20532207|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532208|NCT01799317|Vitamin D|vitamin d|mesh-list
20532209|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
20532210|NCT01799317|Vitamins|vitamins|mesh-ancestor
20532211|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
20532212|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532213|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20532214|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20532215|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19430686|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858009|NCT00769184|Hormones|hormones|mesh-ancestor
19858010|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430687|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430688|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19430689|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430690|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430691|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430692|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430693|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430694|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430695|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430696|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430697|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430698|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
19430699|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430700|NCT00065728|Anecortave|anecortave|mesh-list
19430701|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19430702|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19430703|NCT00065728|Growth Substances|growth substances|mesh-ancestor
19430704|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430705|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
19430706|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430707|NCT00064714|Exenatide|exenatide|mesh-list
19713282|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
19713283|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713284|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19713285|NCT04758728|Epinephrine|epinephrine|mesh-list
19713286|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19713287|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19713288|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
19713289|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713290|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713291|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713292|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19713293|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19713294|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
19713295|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858011|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532216|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
19713296|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19713297|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
19713298|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
19713299|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
19713300|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19713301|NCT04758260|Antioxidants|antioxidants|mesh-list
19713302|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713303|NCT04758260|Protective Agents|protective agents|mesh-ancestor
19713304|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713305|NCT04758286|Anesthetics|anesthetics|mesh-list
19713306|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713307|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713308|NCT04757883|Antibodies|antibodies|mesh-list
19713309|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
19713310|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713311|NCT04758273|Vaccines|vaccines|mesh-list
19713312|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
19713313|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713314|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
19713315|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19713316|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713317|NCT04758000|Metformin|metformin|mesh-list
19713318|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19713319|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713320|NCT04757974|Fostemsavir|fostemsavir|mesh-list
19713321|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19713322|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19713323|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
19713324|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713325|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19713326|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19713327|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713328|NCT04757779|Docetaxel|docetaxel|mesh-list
19713329|NCT04757779|Irinotecan|irinotecan|mesh-list
19430708|NCT00064714|Daclizumab|daclizumab|mesh-list
19713330|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430709|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19713331|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
19430710|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430711|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430712|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19430713|NCT00064714|Incretins|incretins|mesh-ancestor
19430714|NCT00064714|Hormones|hormones|mesh-ancestor
19430715|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713332|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713333|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713334|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713335|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19713336|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19713337|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713338|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
19713339|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19713340|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19713341|NCT04757740|Prednisolone|prednisolone|mesh-list
19713342|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
19713343|NCT04757740|Lidocaine|lidocaine|mesh-list
19713344|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19713345|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
19713346|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
19713347|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
19713348|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713349|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713350|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
19713351|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713352|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19713353|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19713354|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19713355|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19713356|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713357|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19713358|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
19713359|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
19713360|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713361|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
19713362|NCT04757740|Hormones|hormones|mesh-ancestor
19713363|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713364|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19713365|NCT04757740|Protective Agents|protective agents|mesh-ancestor
19713366|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19713367|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713368|NCT04757506|Naltrexone|naltrexone|mesh-list
19713369|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19713370|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19713371|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713372|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
19713373|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713374|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
19713375|NCT04757532|Anastrozole|anastrozole|mesh-list
19713376|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
19858012|NCT00769314|Acyclovir|acyclovir|mesh-list
19858013|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
19858014|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858015|NCT00769392|Lidocaine|lidocaine|mesh-list
19430716|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
19430717|NCT00058266|Genistein|genistein|mesh-list
19430718|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19430719|NCT00058266|Protective Agents|protective agents|mesh-ancestor
19430720|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430721|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713377|NCT04757532|Bupropion|bupropion|mesh-list
19858016|NCT00769392|Tetracaine|tetracaine|mesh-list
19713378|NCT04757532|Testosterone|testosterone|mesh-list
19713379|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
19858017|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
19430722|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19430723|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430724|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430725|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
19430726|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19430727|NCT00058266|Estrogens|estrogens|mesh-ancestor
19430728|NCT00058266|Hormones|hormones|mesh-ancestor
19430729|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430730|NCT00057993|Trastuzumab|trastuzumab|mesh-list
19430731|NCT00057993|Exemestane|exemestane|mesh-list
19430732|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19430733|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430734|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19430735|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19430736|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430737|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430738|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19430739|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
19430740|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430741|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430742|NCT00057980|Celecoxib|celecoxib|mesh-list
19430743|NCT00057980|Epirubicin|epirubicin|mesh-list
19430744|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19430745|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19430746|NCT00057980|Analgesics|analgesics|mesh-ancestor
19430747|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
19430748|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430749|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430750|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19430751|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430752|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19430753|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19430754|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430755|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430756|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19430757|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430758|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19430759|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19430760|NCT00057473|Carboplatin|carboplatin|mesh-list
19430761|NCT00057473|Irinotecan|irinotecan|mesh-list
19430762|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430763|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19430764|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19713380|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
19713381|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19713382|NCT04757532|Danazol|danazol|mesh-list
19713383|NCT04757532|Androgens|androgens|mesh-ancestor
19713384|NCT04757532|Hormones|hormones|mesh-ancestor
19713385|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713386|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713387|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19430765|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858018|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19858019|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
19858020|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19858021|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858022|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
19430766|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451178|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19451179|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19451180|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
19451181|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451182|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451183|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
19451184|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19451185|NCT03422887|Nalbuphine|nalbuphine|mesh-list
19451186|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19451187|NCT03422887|Narcotics|narcotics|mesh-ancestor
19451188|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451189|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451190|NCT03422887|Analgesics|analgesics|mesh-ancestor
19451191|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
20250080|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20250081|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19451192|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451193|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19451194|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19858023|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858024|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19858025|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19858026|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19858027|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858028|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858029|NCT00769483|Gemcitabine|gemcitabine|mesh-list
19858030|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19858031|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19858032|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
19430767|NCT00055575|Scopolamine|scopolamine|mesh-list
19430768|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19430769|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19430770|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
19430771|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
19430772|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430773|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430774|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19430775|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
19430776|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19430777|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
19430778|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19430779|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430780|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19430781|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
19430782|NCT00052598|Aldesleukin|aldesleukin|mesh-list
19858033|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430783|NCT00052598|Interleukin-2|interleukin-2|mesh-list
19430784|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430785|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19430786|NCT00052598|Analgesics|analgesics|mesh-ancestor
19430787|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
19430788|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430789|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430790|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430791|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430792|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
19430793|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430794|NCT00052520|Aldesleukin|aldesleukin|mesh-list
19430795|NCT00052520|Interleukin-2|interleukin-2|mesh-list
19430796|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430797|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19430798|NCT00052520|Analgesics|analgesics|mesh-ancestor
19430799|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
19430800|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19430801|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430802|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19858034|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858035|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
19858036|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858037|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858038|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858039|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
19858040|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532217|NCT01799356|Metronidazole|metronidazole|mesh-list
19430803|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430804|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
20532218|NCT01799356|Ofloxacin|ofloxacin|mesh-list
20532219|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20532220|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532221|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
20532222|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20532223|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532224|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532225|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532226|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430805|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858041|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19858042|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
20250082|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250083|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
20250084|NCT00443521|Hormones|hormones|mesh-ancestor
20250085|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250086|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250087|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430806|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
19713388|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713389|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
19713390|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19713391|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
19713392|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19713393|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19713394|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19713395|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19713396|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713397|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
19713398|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713399|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19713400|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19713401|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713402|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19713403|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19713404|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19713405|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
19713406|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19713407|NCT04757532|Diuretics|diuretics|mesh-ancestor
19858043|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858044|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
19858045|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
19858046|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
19858047|NCT00769600|Itraconazole|itraconazole|mesh-list
19858048|NCT00769600|Pemetrexed|pemetrexed|mesh-list
19858049|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858050|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858051|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858052|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20250088|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
20250089|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430807|NCT00051129|Anecortave|anecortave|mesh-list
19430808|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19430809|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19430810|NCT00051129|Growth Substances|growth substances|mesh-ancestor
19430811|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430812|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
19430813|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430814|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19430815|NCT00051038|Entecavir|entecavir|mesh-list
19430816|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
19430817|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430818|NCT00050102|Ipilimumab|ipilimumab|mesh-list
19430819|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858053|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430820|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430821|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19430822|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430823|NCT00049959|Verteporfin|verteporfin|mesh-list
19430824|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19430825|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
19430826|NCT00036608|Entecavir|entecavir|mesh-list
19430827|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
19430828|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430829|NCT00035789|Entecavir|entecavir|mesh-list
19430830|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
19430831|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430832|NCT00035633|Entecavir|entecavir|mesh-list
19430833|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
19430834|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430835|NCT00035568|Metformin|metformin|mesh-list
19430836|NCT00035568|Glyburide|glyburide|mesh-list
19430837|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430838|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430839|NCT00035542|Metformin|metformin|mesh-list
19430840|NCT00035542|Glyburide|glyburide|mesh-list
20250090|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250091|NCT00443573|Protein C|protein c|mesh-list
20250092|NCT00443573|Anticoagulants|anticoagulants|mesh-list
20250093|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20250094|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20250095|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430841|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19430842|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430843|NCT00035529|Abatacept|abatacept|mesh-list
19713408|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
19713409|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19713410|NCT04757376|Denosumab|denosumab|mesh-list
20250096|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19430844|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19713411|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19713412|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250097|NCT00443612|Irbesartan|irbesartan|mesh-list
19430845|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430846|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430847|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430848|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
19430849|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430850|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430851|NCT00031512|Pleconaril|pleconaril|mesh-list
19430852|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
19430853|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430854|NCT00028639|Bortezomib|bortezomib|mesh-list
19430855|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430856|NCT00028301|Ritonavir|ritonavir|mesh-list
19430857|NCT00028301|Lopinavir|lopinavir|mesh-list
19430858|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430859|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430860|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430861|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430862|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250098|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20250099|NCT00443612|Diuretics|diuretics|mesh-ancestor
20250100|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
19430863|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858054|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
19858055|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858056|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19858057|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19858058|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19858059|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
19858060|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858061|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858062|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19858063|NCT00769704|Molgramostim|molgramostim|mesh-list
19858064|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19858065|NCT00769704|Sargramostim|sargramostim|mesh-list
19858066|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
19858067|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858068|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858069|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20250101|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430864|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430865|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430866|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
19430867|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430868|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19430869|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430870|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430871|NCT00028067|Nelfinavir|nelfinavir|mesh-list
19430872|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430873|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430874|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430875|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430876|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430877|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430878|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430879|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
19430880|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430881|NCT00013897|Lamivudine|lamivudine|mesh-list
19430882|NCT00013897|Zidovudine|zidovudine|mesh-list
19430883|NCT00013897|Efavirenz|efavirenz|mesh-list
19430884|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
20532227|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19858070|NCT00769886|Ketotifen|ketotifen|mesh-list
19858071|NCT00769886|Naphazoline|naphazoline|mesh-list
19858072|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
19858073|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
19858074|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19858075|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
19858076|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
19430885|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19430886|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430887|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19430888|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430889|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430890|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
19430891|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430892|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430893|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430894|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
19430895|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430896|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430897|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430898|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19713413|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
19713414|NCT04757337|Doxorubicin|doxorubicin|mesh-list
19713415|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713416|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
19713417|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713418|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713419|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19713420|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
19713421|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713422|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713423|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20532228|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20532229|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20532230|NCT01799356|Renal Agents|renal agents|mesh-ancestor
20532231|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20532232|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20532233|NCT01799460|Cyclosporine|cyclosporine|mesh-list
20532234|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
20532235|NCT01799460|Tacrolimus|tacrolimus|mesh-list
20532236|NCT01799460|Cyclosporins|cyclosporins|mesh-list
20532237|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19430899|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430900|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430901|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19430902|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19430903|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
19430904|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
19430905|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19430906|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
19713424|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19713425|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19713426|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19713427|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713428|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19713429|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19713430|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19713431|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19713432|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713433|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
19713434|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713435|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713436|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19713437|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713438|NCT04756895|Vancomycin|vancomycin|mesh-list
19713439|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19713440|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713441|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
19713442|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19713443|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
19713444|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713445|NCT04756622|Expectorants|expectorants|mesh-ancestor
19713446|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
19713447|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19713448|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
19713449|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713450|NCT04756622|Protective Agents|protective agents|mesh-ancestor
19713451|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713452|NCT04756622|Antidotes|antidotes|mesh-ancestor
19734001|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734002|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19734003|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
19734004|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
19734005|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734006|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
19734007|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734008|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19734009|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19734010|NCT04555733|Lemborexant|lemborexant|mesh-list
19734011|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19734012|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734013|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734014|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19734015|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19734016|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734017|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734018|NCT04555707|Betamethasone|betamethasone|mesh-list
19858077|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250102|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20250103|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250104|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250105|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20250106|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20250107|NCT00443690|Rolofylline|rolofylline|mesh-list
20250108|NCT00443690|Diuretics|diuretics|mesh-ancestor
20250109|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
19430907|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430908|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19430909|NCT00006225|Protective Agents|protective agents|mesh-ancestor
19734019|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
19430910|NCT00005918|Lamivudine|lamivudine|mesh-list
19430911|NCT00005918|Efavirenz|efavirenz|mesh-list
19430912|NCT00005918|Stavudine|stavudine|mesh-list
19430913|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430914|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19713453|NCT04756492|Cyclosporine|cyclosporine|mesh-list
19713454|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
20250110|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250111|NCT00443716|Estrogens|estrogens|mesh-list
20250112|NCT00443716|Hormones|hormones|mesh-ancestor
20250113|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250114|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250115|NCT00443794|Aspirin|aspirin|mesh-list
20250116|NCT00443794|Atenolol|atenolol|mesh-list
20250117|NCT00443794|Ramipril|ramipril|mesh-list
20250118|NCT00443794|Simvastatin|simvastatin|mesh-list
20532238|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
20532239|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
20532240|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430915|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430916|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430917|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
19430918|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430919|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430920|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430921|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19430922|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19430923|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19430924|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19713455|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713456|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
19713457|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532241|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532242|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20532243|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
20532244|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532245|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532246|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20532247|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20532248|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532249|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
20532250|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532251|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532252|NCT01799460|Hormones|hormones|mesh-ancestor
20532253|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20532254|NCT01799486|Adefovir|adefovir|mesh-list
20532255|NCT01799486|Telbivudine|telbivudine|mesh-list
20532256|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
20532257|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532258|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19430925|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19430926|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19430927|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
19430928|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
19430929|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430930|NCT00005788|Aldesleukin|aldesleukin|mesh-list
19430931|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430932|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19430933|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19430934|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
19430935|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19430936|NCT00005608|Leucovorin|leucovorin|mesh-list
19430937|NCT00005608|Tegafur|tegafur|mesh-list
19430938|NCT00005608|Calcium|calcium|mesh-list
19430939|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
19430940|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19430941|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430942|NCT00005608|Antidotes|antidotes|mesh-ancestor
19430943|NCT00005608|Protective Agents|protective agents|mesh-ancestor
19430944|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
19430945|NCT00005608|Vitamins|vitamins|mesh-ancestor
19430946|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
19430947|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19430948|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
19430949|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430950|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430951|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
19430952|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430953|NCT00004916|Paclitaxel|paclitaxel|mesh-list
19713458|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713459|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713460|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
19713461|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713462|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713463|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19713464|NCT04756661|Misoprostol|misoprostol|mesh-list
19713465|NCT04756661|Oxytocin|oxytocin|mesh-list
19713466|NCT04756661|Carbetocin|carbetocin|mesh-list
19713467|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
19713468|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19713469|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713470|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19858078|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532259|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20532260|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532261|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532262|NCT01799603|Simeprevir|simeprevir|mesh-list
20532263|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
20532264|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532265|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
20532266|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532267|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250119|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20250120|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20250121|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20250122|NCT00443794|Analgesics|analgesics|mesh-ancestor
20250123|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
20250124|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250125|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532268|NCT01799616|Pamidronate|pamidronate|mesh-list
20532269|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20532270|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532271|NCT01799798|Denosumab|denosumab|mesh-list
20532272|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20532273|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532274|NCT01799850|Pioglitazone|pioglitazone|mesh-list
20250126|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20532275|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532276|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430954|NCT00004916|Ifosfamide|ifosfamide|mesh-list
19430955|NCT00004916|Teniposide|teniposide|mesh-list
19858079|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430956|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19713471|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
19858080|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19858081|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19430957|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430958|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
19430959|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
19430960|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
19430961|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430962|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19430963|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
19430964|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19430965|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19430966|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19430967|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19430968|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20250127|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250128|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20250129|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20250130|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250131|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20250132|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20250133|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250134|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
20250135|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20250136|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20250137|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
20250138|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20532277|NCT01799863|Ketorolac|ketorolac|mesh-list
19430969|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
19430970|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19430971|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430972|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19430973|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19430974|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19430975|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
19430976|NCT00004914|Hematinics|hematinics|mesh-ancestor
19430977|NCT00004912|Megestrol|megestrol|mesh-list
19430978|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
19430979|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19430980|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19430981|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19430982|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
19430983|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19430984|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532278|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20532279|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19430985|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19430986|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19430987|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19430988|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19430989|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
19430990|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19430991|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
19430992|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19430993|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
19430994|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19430995|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19430996|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19858082|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20532280|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
20532281|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20532282|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20532283|NCT01799863|Analgesics|analgesics|mesh-ancestor
20532284|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
19430997|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
19430998|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19430999|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431000|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431001|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
19431002|NCT00004907|Busulfan|busulfan|mesh-list
19431003|NCT00004907|Etoposide|etoposide|mesh-list
19431004|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431005|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
19431006|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431007|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431008|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431009|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
19431010|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431011|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431012|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431013|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19431014|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431015|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431016|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431017|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
19431018|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431019|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
19431020|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431021|NCT00004899|Etoposide|etoposide|mesh-list
19431022|NCT00004899|Busulfan|busulfan|mesh-list
19431023|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19431024|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431025|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431026|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431027|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431028|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431029|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
19858083|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858084|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
19858085|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19858086|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
19858087|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
19858088|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19858089|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19858090|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19858091|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19858092|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858093|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858094|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
19858095|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858096|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858097|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19858098|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858099|NCT00770120|Everolimus|everolimus|mesh-list
19431030|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431031|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
19431032|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431033|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431034|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431035|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
19431036|NCT00004898|Etoposide|etoposide|mesh-list
20532285|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532286|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532287|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20532288|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532289|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20532290|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532291|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532292|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19431037|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431038|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
19431039|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431040|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431041|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431042|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
19431043|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431044|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431045|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431046|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19431047|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431048|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431049|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713472|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20250139|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20250140|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20250141|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
20250142|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20250143|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20250144|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
20250145|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
20250146|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19713473|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713474|NCT04756323|Vaccines|vaccines|mesh-list
19713475|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
19713476|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713477|NCT04756557|Fluorides|fluorides|mesh-list
19713478|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
19713479|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
19713480|NCT04756557|Protective Agents|protective agents|mesh-ancestor
19713481|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713482|NCT04756206|Dutasteride|dutasteride|mesh-list
19713483|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19713484|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19713485|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858100|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858101|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250147|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20250148|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20250149|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250150|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250151|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250152|NCT00443794|Diuretics|diuretics|mesh-ancestor
20250153|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
20250154|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19431050|NCT00004897|Leucovorin|leucovorin|mesh-list
19431051|NCT00004897|Interferons|interferons|mesh-list
19431052|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
19431053|NCT00004897|Fluorouracil|fluorouracil|mesh-list
19431054|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
19431055|NCT00004897|Calcium|calcium|mesh-list
19431056|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
19431057|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431058|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19431059|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431060|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
19431061|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431062|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19431063|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431064|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
19431065|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
19431066|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431067|NCT00004897|Antidotes|antidotes|mesh-ancestor
19431068|NCT00004897|Protective Agents|protective agents|mesh-ancestor
20250155|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20250156|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
20250157|NCT00443937|Everolimus|everolimus|mesh-list
20250158|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250159|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250160|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
20250161|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250162|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20250163|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20250164|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
20250165|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250166|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250167|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250168|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250169|NCT00443950|Etanercept|etanercept|mesh-list
20250170|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19431069|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
19431070|NCT00004897|Vitamins|vitamins|mesh-ancestor
19431071|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
19431072|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
19431073|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431074|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20250171|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20250172|NCT00443950|Analgesics|analgesics|mesh-ancestor
20250173|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
19431075|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
19431076|NCT00004896|Busulfan|busulfan|mesh-list
19431077|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431078|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
19431079|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431080|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431081|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431082|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
19431083|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431084|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858102|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
19858103|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250174|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431085|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431086|NCT00004895|Octreotide|octreotide|mesh-list
19431087|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19431088|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19431089|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431090|NCT00004584|Ritonavir|ritonavir|mesh-list
19431091|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19431092|NCT00004584|Saquinavir|saquinavir|mesh-list
19858104|NCT00770133|Ketotifen|ketotifen|mesh-list
19858105|NCT00770133|Naphazoline|naphazoline|mesh-list
19858106|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
19858107|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
19431093|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19431094|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19431095|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431096|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431097|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431098|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431099|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431100|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
19431101|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431102|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19431103|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19431104|NCT00004231|Leucovorin|leucovorin|mesh-list
19431105|NCT00004231|Interferons|interferons|mesh-list
19713486|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713487|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
19713488|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713489|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713490|NCT04756128|Colchicine|colchicine|mesh-list
19713491|NCT04756128|Naltrexone|naltrexone|mesh-list
19713492|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19713493|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19713494|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713495|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
19713496|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713497|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
19713498|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713499|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713500|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713501|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713502|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713503|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713504|NCT04756089|Oxytocin|oxytocin|mesh-list
19713505|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
19713506|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19713507|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532293|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20532294|NCT01799863|Laxatives|laxatives|mesh-ancestor
20532295|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20532296|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
20532297|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19713508|NCT04755998|Vaccines|vaccines|mesh-list
19713509|NCT04755998|Immunologic Factors|immunologic factors|mesh-ancestor
19713510|NCT04755998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713511|NCT04755868|Talazoparib|talazoparib|mesh-list
19713512|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19713513|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713514|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713515|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858108|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19858109|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
19858110|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
19858111|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858112|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858113|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532298|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20532299|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
20532300|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532301|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532302|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532303|NCT01799902|Urological Agents|urological agents|mesh-ancestor
20532304|NCT01799954|Vaccines|vaccines|mesh-list
20532305|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
20532306|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532307|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
19431106|NCT00004231|Cytarabine|cytarabine|mesh-list
19431107|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
19431108|NCT00004231|Aldesleukin|aldesleukin|mesh-list
19431109|NCT00004231|Prednisone|prednisone|mesh-list
19431110|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
19431111|NCT00004231|Busulfan|busulfan|mesh-list
19431112|NCT00004231|Doxorubicin|doxorubicin|mesh-list
19431113|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19431114|NCT00004231|Methotrexate|methotrexate|mesh-list
19431115|NCT00004231|Vincristine|vincristine|mesh-list
19431116|NCT00004231|Teniposide|teniposide|mesh-list
19431117|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
19431118|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431119|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
19431120|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431121|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431122|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431123|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
19431124|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431125|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431126|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431127|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19431128|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431129|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431130|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431131|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431132|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
19431133|NCT00004231|Hormones|hormones|mesh-ancestor
19431134|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19431135|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19431136|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19431137|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
19431138|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19431139|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19431140|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
19431141|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
19858114|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19858115|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19858116|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19858117|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
20532308|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19431142|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19713516|NCT04756050|Epinephrine|epinephrine|mesh-list
19713517|NCT04756050|Racepinephrine|racepinephrine|mesh-list
19713518|NCT04756050|Bupivacaine|bupivacaine|mesh-list
19713519|NCT04756050|Prilocaine|prilocaine|mesh-list
19713520|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19431143|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431144|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
19431145|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431146|NCT00004231|Antidotes|antidotes|mesh-ancestor
19431147|NCT00004231|Protective Agents|protective agents|mesh-ancestor
19431148|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
19431149|NCT00004231|Vitamins|vitamins|mesh-ancestor
19713521|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
19713522|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
20532309|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
20532310|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19431150|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
19431151|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19713523|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
19713524|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532311|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
20532312|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532313|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532314|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
20532315|NCT01800019|Nicotine|nicotine|mesh-list
20532316|NCT01800019|Varenicline|varenicline|mesh-list
20532317|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20532318|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
20532319|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858118|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
20532320|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431152|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
19431153|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
19431154|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
19431155|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431156|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431157|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
20532321|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20532322|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19431158|NCT00004230|Captopril|captopril|mesh-list
19431159|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431160|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
19431161|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431162|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431163|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431164|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
19431165|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250175|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250176|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250177|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431166|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431167|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431168|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19431169|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431170|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431171|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19431172|NCT00004182|Irinotecan|irinotecan|mesh-list
19431173|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19431174|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19713525|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713526|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
19713527|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713528|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19713529|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19713530|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
19713531|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713532|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713533|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19713534|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19713535|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
19713536|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19713537|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
20532323|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
20532324|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532325|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532326|NCT01800097|Modafinil|modafinil|mesh-list
20532327|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20532328|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532329|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20532330|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19431175|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431176|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431177|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431178|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
19431179|NCT00004181|Busulfan|busulfan|mesh-list
19431180|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532331|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19431181|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
19431182|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431183|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431184|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431185|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
19431186|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431187|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431188|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431189|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
19431190|NCT00004175|Docetaxel|docetaxel|mesh-list
19431191|NCT00004175|Doxorubicin|doxorubicin|mesh-list
19431192|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19431193|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431194|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
19431195|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431196|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431197|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431198|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
19431199|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431200|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431201|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431202|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
19858119|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19858120|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
19858121|NCT00770146|Mipomersen|mipomersen|mesh-list
19858122|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19858123|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19858124|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
19431203|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
19431204|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
19431205|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19431206|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431207|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431208|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431209|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
19431210|NCT00004172|Ifosfamide|ifosfamide|mesh-list
19431211|NCT00004172|Thiotepa|thiotepa|mesh-list
19431212|NCT00004172|Carboplatin|carboplatin|mesh-list
19431213|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431214|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
19431215|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431216|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431217|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431218|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
19431219|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431220|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431221|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431222|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
19431223|NCT00004171|Busulfan|busulfan|mesh-list
19858125|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858126|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20532332|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532333|NCT01800227|Metformin|metformin|mesh-list
20532334|NCT01800227|Pioglitazone|pioglitazone|mesh-list
20532335|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532336|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532337|NCT01800240|Metformin|metformin|mesh-list
20532338|NCT01800240|Pioglitazone|pioglitazone|mesh-list
20532339|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532340|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532341|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
20532342|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532343|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
20532344|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19431224|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431225|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
19431226|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431227|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431228|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431229|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
19431230|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431231|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431232|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431233|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
19431234|NCT00004169|Carboplatin|carboplatin|mesh-list
19431235|NCT00004169|Etoposide|etoposide|mesh-list
19431236|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431237|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
19431238|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713538|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
19713539|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
19713540|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19713541|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19713542|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19713543|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19713544|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713545|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713546|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19713547|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19713548|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713549|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
19431239|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431240|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431241|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
19431242|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431243|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431244|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431245|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19431246|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431247|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431248|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431249|NCT00004166|Amifostine|amifostine|mesh-list
19431250|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19431251|NCT00004166|Protective Agents|protective agents|mesh-ancestor
19431252|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431253|NCT00004165|Melphalan|melphalan|mesh-list
19431254|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
19431255|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431256|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431257|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
19431258|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431259|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431260|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431261|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431262|NCT00004106|Temozolomide|temozolomide|mesh-list
20250178|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250179|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250180|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
20250181|NCT00443963|Esomeprazole|esomeprazole|mesh-list
20250182|NCT00443963|Ranitidine|ranitidine|mesh-list
20250183|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20250184|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19431263|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431264|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
19431265|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431266|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431267|NCT00004096|Carboplatin|carboplatin|mesh-list
19431268|NCT00004096|Vinorelbine|vinorelbine|mesh-list
19431269|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431270|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19431271|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
19431272|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
19431273|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713550|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713551|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
19713552|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19713553|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19713554|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
19713555|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713556|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713557|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19713558|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
19713559|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19713560|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
19713561|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713562|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713563|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19713564|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
19713565|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
19713566|NCT04755647|Protective Agents|protective agents|mesh-ancestor
20250185|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20250186|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431274|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431275|NCT00004093|Gemcitabine|gemcitabine|mesh-list
19431276|NCT00004093|Paclitaxel|paclitaxel|mesh-list
19431277|NCT00004093|Vinorelbine|vinorelbine|mesh-list
19431278|NCT00004093|Carboplatin|carboplatin|mesh-list
19431279|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19431280|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431281|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
19431282|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
19431283|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
19431284|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431285|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19431286|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
19431287|NCT00004093|Antiviral Agents|antiviral agents|mesh-ancestor
19431288|NCT00004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431289|NCT00004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431290|NCT00004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431291|NCT00004093|Immunologic Factors|immunologic factors|mesh-ancestor
19431292|NCT00004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431293|NCT00002479|Tretinoin|tretinoin|mesh-list
19431294|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431295|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
19431296|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
19431297|NCT00002429|Lamivudine|lamivudine|mesh-list
19431298|NCT00002429|Zidovudine|zidovudine|mesh-list
19431299|NCT00002429|Stavudine|stavudine|mesh-list
19431300|NCT00002429|Didanosine|didanosine|mesh-list
19431301|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19713567|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
19431302|NCT00002429|Nelfinavir|nelfinavir|mesh-list
19431303|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19431304|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431305|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431306|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431307|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
19431308|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431309|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431310|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431311|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
19431312|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19431313|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19431314|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431315|NCT00002411|Lamivudine|lamivudine|mesh-list
19431316|NCT00002411|Zidovudine|zidovudine|mesh-list
19431317|NCT00002411|Stavudine|stavudine|mesh-list
19431318|NCT00002411|Didanosine|didanosine|mesh-list
19713568|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19713569|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
19713570|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713571|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
19713572|NCT04755634|Protective Agents|protective agents|mesh-ancestor
19713573|NCT04755543|Fluorouracil|fluorouracil|mesh-list
19713574|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713575|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
19713576|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713577|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19713578|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713579|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
19713580|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713581|NCT04755322|Aspirin|aspirin|mesh-list
19713582|NCT04755322|Folic Acid|folic acid|mesh-list
19713583|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
19713584|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19713585|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19713586|NCT04755322|Analgesics|analgesics|mesh-ancestor
19713587|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
19713588|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713589|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713590|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19713591|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713592|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19713593|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19713594|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713595|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19713596|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19713597|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713598|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
19713599|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
19713600|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19713601|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19713602|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713603|NCT04755322|Hematinics|hematinics|mesh-ancestor
19713604|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
19713605|NCT04755322|Vitamins|vitamins|mesh-ancestor
19713606|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
19713607|NCT04755387|Ticagrelor|ticagrelor|mesh-list
19713608|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19713609|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19713610|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19713611|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19713612|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
19431319|NCT00002411|Nelfinavir|nelfinavir|mesh-list
19431320|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19713613|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858127|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
19431321|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431322|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431323|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431324|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
19431325|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431326|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431327|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431328|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
19431329|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19431330|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19431331|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431332|NCT00002371|Lamivudine|lamivudine|mesh-list
19431333|NCT00002371|Zidovudine|zidovudine|mesh-list
19431334|NCT00002371|Stavudine|stavudine|mesh-list
19431335|NCT00002371|Indinavir|indinavir|mesh-list
19431336|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19431337|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431338|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431339|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431340|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
19431341|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431342|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431343|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431344|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
19431345|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19431346|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19431347|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431348|NCT00002246|Stavudine|stavudine|mesh-list
19431349|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
19431350|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431351|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19431352|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431353|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431354|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
19431355|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431356|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431357|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431358|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19431359|NCT00002240|Nelfinavir|nelfinavir|mesh-list
19431360|NCT00002240|Stavudine|stavudine|mesh-list
19713614|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713615|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713616|NCT04755062|Micronutrients|micronutrients|mesh-list
19713617|NCT04755062|Trace Elements|trace elements|mesh-list
19713618|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713619|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19713620|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20532345|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20532346|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532347|NCT01800292|Urological Agents|urological agents|mesh-ancestor
20532348|NCT01800357|Aspirin|aspirin|mesh-list
20532349|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
20532350|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20532351|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20532352|NCT01800357|Analgesics|analgesics|mesh-ancestor
20532353|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
20532354|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532355|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532356|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431361|NCT00002240|Didanosine|didanosine|mesh-list
19431362|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19713621|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19713622|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19713623|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713624|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
19713625|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19431363|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20250187|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250188|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20250189|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
20250190|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
20250191|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250192|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250193|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20250194|NCT00444015|Dasatinib|dasatinib|mesh-list
20250195|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250196|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20250197|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250198|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250199|NCT00444041|Bevacizumab|bevacizumab|mesh-list
20250200|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20250201|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250202|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20250203|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20250204|NCT00444041|Growth Substances|growth substances|mesh-ancestor
20250205|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250206|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
19431364|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431365|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431366|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431367|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431368|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431369|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
19431370|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431371|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
19431372|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19431373|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431374|NCT00002224|Stavudine|stavudine|mesh-list
19431375|NCT00002224|Didanosine|didanosine|mesh-list
19431376|NCT00002224|Nelfinavir|nelfinavir|mesh-list
19431377|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
19431378|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431379|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19713626|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713627|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713628|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20250207|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
19431380|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431381|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431382|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
19431383|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431384|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431385|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431386|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19431387|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19431388|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431389|NCT00002207|Stavudine|stavudine|mesh-list
19431390|NCT00002207|Didanosine|didanosine|mesh-list
19431391|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
19431392|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431393|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19431394|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431395|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431396|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
19431397|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431398|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431399|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431400|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
19431401|NCT03532620|Atorvastatin|atorvastatin|mesh-list
19431402|NCT03532620|Pitavastatin|pitavastatin|mesh-list
19431403|NCT03532620|Calcium|calcium|mesh-list
19431404|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19431405|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431406|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19713629|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19713630|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713631|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
19713632|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713633|NCT04754763|Propolis|propolis|mesh-list
19713634|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713635|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19713636|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19713637|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19713638|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713639|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713640|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19713641|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19713642|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19713643|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
19713644|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713645|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713646|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19713647|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19713648|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
19713649|NCT04754789|Aspirin|aspirin|mesh-list
19713650|NCT04754789|Ticagrelor|ticagrelor|mesh-list
19713651|NCT04754789|Atorvastatin|atorvastatin|mesh-list
19713652|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19713653|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19713654|NCT04754789|Analgesics|analgesics|mesh-ancestor
19713655|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
19713656|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713657|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713658|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19713659|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713660|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19713661|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19713662|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431407|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19858128|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19431408|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19431409|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
19431410|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431411|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19431412|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19431413|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431414|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19431415|NCT03532516|Brivaracetam|brivaracetam|mesh-list
19431416|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
19431417|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19431418|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19431419|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19431420|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19431421|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431422|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431423|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713663|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19713664|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19713665|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713666|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
19713667|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19713668|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19713669|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
19713670|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19713671|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19713672|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19713673|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19713674|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19713675|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
19713676|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858129|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19431424|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19431425|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
19431426|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19431427|NCT03532464|Azithromycin|azithromycin|mesh-list
19431428|NCT03532464|Doxycycline|doxycycline|mesh-list
19431429|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19431430|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431431|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
19431432|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19431433|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19431434|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19431435|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19431436|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19431437|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431438|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431439|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
19431440|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431441|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431442|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431443|NCT03532399|Bivalirudin|bivalirudin|mesh-list
19431444|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
19431445|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19431446|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431447|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431448|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250208|NCT00444093|Loperamide|loperamide|mesh-list
20532357|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532358|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20532359|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20532360|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532361|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20532362|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20532363|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532364|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
20532365|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20532366|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
20532367|NCT01800396|Caseins|caseins|mesh-list
20532368|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
20532369|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
19431449|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
19431450|NCT03532178|Rocuronium|rocuronium|mesh-list
19431451|NCT03532178|Succinylcholine|succinylcholine|mesh-list
19431452|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19431453|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19431454|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19431455|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431456|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431457|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19451195|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451196|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451197|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19451198|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451199|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451200|NCT03422874|Nelfinavir|nelfinavir|mesh-list
19451201|NCT03422874|Ixazomib|ixazomib|mesh-list
19451202|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451203|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
19451204|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451205|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451206|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19451207|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19451208|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19451209|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19451210|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
19451211|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451212|NCT03422796|Cilostazol|cilostazol|mesh-list
19451213|NCT03422796|Sumatriptan|sumatriptan|mesh-list
19858130|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20532370|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532371|NCT01800422|Progesterone|progesterone|mesh-list
20532372|NCT01800422|Progestins|progestins|mesh-ancestor
20532373|NCT01800422|Hormones|hormones|mesh-ancestor
20532374|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19451214|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20532375|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532376|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
20532377|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
20532378|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20532379|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19451215|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
19451216|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451217|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451218|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19451219|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
19451220|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19451221|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19451222|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451223|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19451224|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
19713677|NCT04754399|Cannabidiol|cannabidiol|mesh-list
20532380|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532381|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
19713678|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
19713679|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
19713680|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19713681|NCT04753918|Trioxsalen|trioxsalen|mesh-list
19713682|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713683|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
19713684|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19713685|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
19713686|NCT04753723|Gentamicins|gentamicins|mesh-list
19431458|NCT03532087|Denosumab|denosumab|mesh-list
19431459|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19431460|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431461|NCT03532035|Brincidofovir|brincidofovir|mesh-list
19431462|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
19431463|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431464|NCT03531970|Dexamethasone|dexamethasone|mesh-list
19431465|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
19431466|NCT03531970|Lidocaine|lidocaine|mesh-list
19431467|NCT03531970|Epinephrine|epinephrine|mesh-list
19431468|NCT03531970|BB 1101|bb 1101|mesh-list
19431469|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431470|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
19431471|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
19431472|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431473|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431474|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19431475|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
19431476|NCT03531970|Hormones|hormones|mesh-ancestor
19431477|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19431478|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19431479|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431480|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431481|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431482|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431483|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
19431484|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
19431485|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431486|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
19431487|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19431488|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19431489|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19431490|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19431491|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19431492|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19431493|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
19431494|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431495|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19431496|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19431497|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19431498|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
19431499|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
19431500|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
19713687|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19713688|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713689|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19713690|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713691|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713692|NCT04753515|Midazolam|midazolam|mesh-list
19713693|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
19713694|NCT04753515|Remifentanil|remifentanil|mesh-list
19431501|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19431502|NCT03531931|Apatinib|apatinib|mesh-list
19431503|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431504|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19431505|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431506|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713695|NCT04753515|Propofol|propofol|mesh-list
19713696|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19713697|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713698|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713699|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19713700|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
19713701|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
19431507|NCT03531918|Cytarabine|cytarabine|mesh-list
19431508|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19431509|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
19431510|NCT03531918|Cladribine|cladribine|mesh-list
19431511|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
19431512|NCT03531918|Calicheamicins|calicheamicins|mesh-list
19431513|NCT03531918|Sargramostim|sargramostim|mesh-list
19713702|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19713703|NCT04753515|Analgesics|analgesics|mesh-ancestor
19713704|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
19713705|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713706|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19713707|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19713708|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19713709|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858131|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19858132|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19431514|NCT03531918|Lenograstim|lenograstim|mesh-list
19431515|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19431516|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
19431517|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431518|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431519|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
19431520|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431521|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431522|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
19431523|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431524|NCT03531918|Analgesics|analgesics|mesh-ancestor
19431525|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
19431526|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431527|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431528|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431529|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431530|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19431531|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19431532|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19431533|NCT03531762|Tepotinib|tepotinib|mesh-list
19431534|NCT03531762|Omeprazole|omeprazole|mesh-list
19431535|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20250209|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250210|NCT00444132|Clopidogrel|clopidogrel|mesh-list
20250211|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20250212|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20250213|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20250214|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20250215|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
20250216|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250217|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431536|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250218|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250219|NCT00444171|Insulin|insulin|mesh-list
19713710|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713711|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713712|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19713713|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19713714|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19713715|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19713716|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
19858133|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858134|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
19858135|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858136|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858137|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19858138|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858139|NCT00770224|Prednisone|prednisone|mesh-list
19858140|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
19858141|NCT00770224|Rituximab|rituximab|mesh-list
19858142|NCT00770224|Doxorubicin|doxorubicin|mesh-list
19858143|NCT00770224|Vincristine|vincristine|mesh-list
19858144|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
19858145|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858146|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
19858147|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858148|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858149|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19858150|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
19858151|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858152|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858153|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19858154|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858155|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19858156|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19858157|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19858158|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858159|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858160|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
19858161|NCT00770224|Hormones|hormones|mesh-ancestor
19858162|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858163|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19858164|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19858165|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
19858166|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
20250220|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20250221|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20250222|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250223|NCT00444184|Timolol|timolol|mesh-list
20250224|NCT00444184|Travoprost|travoprost|mesh-list
20250225|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20250226|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20250227|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250228|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250229|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250230|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250231|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20250232|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20250233|NCT00444223|Fluorides|fluorides|mesh-list
20250234|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
20250235|NCT00444223|Protective Agents|protective agents|mesh-ancestor
20250236|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250237|NCT00444236|Esomeprazole|esomeprazole|mesh-list
19431537|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19431538|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431539|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431540|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431541|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
19431542|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
19431543|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431544|NCT03531749|Protective Agents|protective agents|mesh-ancestor
19431545|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431546|NCT03531749|Vitamins|vitamins|mesh-ancestor
19431547|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
19713717|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
19713718|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19713719|NCT04753515|Narcotics|narcotics|mesh-ancestor
19431548|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19431549|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19431550|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19431551|NCT03531437|Gestodene|gestodene|mesh-list
19431552|NCT03531437|Estradiol|estradiol|mesh-list
19431553|NCT03531437|Estrogens|estrogens|mesh-ancestor
19431554|NCT03531437|Hormones|hormones|mesh-ancestor
19431555|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19431556|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431557|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19431558|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
19431559|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19431560|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19431561|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19431562|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19431563|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19431564|NCT03531437|Progestins|progestins|mesh-ancestor
19431565|NCT03531372|Antacids|antacids|mesh-list
19431566|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431567|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713720|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
19713721|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19713722|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
19713723|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19713724|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
19713725|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858167|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
19431568|NCT03531359|Midazolam|midazolam|mesh-list
19431569|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19431570|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19431571|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431572|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431573|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19431574|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19431575|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19431576|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19431577|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
19431578|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
19431579|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
19431580|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
19431581|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431582|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431583|NCT03531294|Aflibercept|aflibercept|mesh-list
19431584|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19431585|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19431586|NCT03531294|Growth Substances|growth substances|mesh-ancestor
19431587|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431588|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
19431589|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431590|NCT03531281|Sirolimus|sirolimus|mesh-list
19431591|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
19431592|NCT03531281|Etoposide|etoposide|mesh-list
19431593|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
19431594|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
19431595|NCT03531281|Tacrolimus|tacrolimus|mesh-list
19431596|NCT03531281|Mitogens|mitogens|mesh-list
19431597|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431598|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
19431599|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713726|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431600|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713727|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
19713728|NCT04753619|Niclosamide|niclosamide|mesh-list
19713729|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
19713730|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19713731|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
19713732|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19713733|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713734|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
19713735|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
19713736|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19713737|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19713738|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713739|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
19713740|NCT04753151|Coagulants|coagulants|mesh-ancestor
19713741|NCT04753112|Valsartan|valsartan|mesh-list
19713742|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19713743|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19713744|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19713745|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19713746|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713747|NCT04753203|Capecitabine|capecitabine|mesh-list
19713748|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19713749|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
19713750|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858168|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
19858169|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19858170|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858171|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858172|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19858173|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19858174|NCT00770328|Protective Agents|protective agents|mesh-ancestor
19858175|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532382|NCT01800435|Coagulants|coagulants|mesh-ancestor
20532383|NCT01800487|Silymarin|silymarin|mesh-list
20532384|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
20532385|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532386|NCT01800487|Protective Agents|protective agents|mesh-ancestor
20532387|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553338|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20553339|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20553340|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553341|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20553342|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20553343|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20553344|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553345|NCT01928823|Cycloserine|cycloserine|mesh-list
20553346|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20553347|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553348|NCT01928823|Renal Agents|renal agents|mesh-ancestor
20553349|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19431601|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431602|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
19431603|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431604|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431605|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431606|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19431607|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431608|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19431609|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431610|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19431611|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19431612|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431613|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19431614|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
19431615|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
19431616|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
19431617|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
19431618|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
19431619|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
19431620|NCT03531047|Riboflavin|riboflavin|mesh-list
19431621|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
19431622|NCT03531047|Vitamins|vitamins|mesh-ancestor
19431623|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
19431624|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431625|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19431626|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
19431627|NCT03530800|Dronabinol|dronabinol|mesh-list
19431628|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
19431629|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431630|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19431631|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19431632|NCT03530800|Analgesics|analgesics|mesh-ancestor
19431633|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
19431634|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431635|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19431636|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19431637|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431638|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431639|NCT03530800|Hormones|hormones|mesh-ancestor
19431640|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19431641|NCT03530670|Midazolam|midazolam|mesh-list
19431642|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19431643|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19431644|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431645|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431646|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19431647|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19431648|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19431649|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19431650|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
19431651|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
19431652|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
19431653|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
19431654|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431655|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431656|NCT03530488|Lidocaine|lidocaine|mesh-list
19431657|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
19431658|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
19431659|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431660|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431661|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
19431662|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431663|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19431664|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19431665|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19431666|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19431667|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431668|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
19431669|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
19431670|NCT03530462|Rituximab|rituximab|mesh-list
19431671|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
19431672|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19431673|NCT03530462|Antibodies|antibodies|mesh-list
19431674|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
19431675|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19431676|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431677|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
20250238|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20250239|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250240|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20250241|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532388|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
19431678|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431679|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532389|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20532390|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
20532391|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532392|NCT01800526|Expectorants|expectorants|mesh-ancestor
20532393|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
20532394|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20532395|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
20532396|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532397|NCT01800526|Protective Agents|protective agents|mesh-ancestor
19431680|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431681|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
19431682|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431683|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431684|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431685|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20250242|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250243|NCT00444249|Dipivefrin|dipivefrin|mesh-list
20250244|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20250245|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250246|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431686|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431687|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
19431688|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
19431689|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431690|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19431691|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
19431692|NCT03530462|Hormones|hormones|mesh-ancestor
19431693|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19431694|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19431695|NCT03530462|Protective Agents|protective agents|mesh-ancestor
19431696|NCT03530436|Curcumin|curcumin|mesh-list
19431697|NCT03530436|Turmeric extract|turmeric extract|mesh-list
19431698|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19431699|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19431700|NCT03530436|Analgesics|analgesics|mesh-ancestor
19431701|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
19431702|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431703|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431704|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431705|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431706|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431707|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431708|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431709|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
19431710|NCT03530436|Protective Agents|protective agents|mesh-ancestor
19451225|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19451226|NCT03422796|Protective Agents|protective agents|mesh-ancestor
19451227|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19451228|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19451229|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451230|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19451231|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19451232|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19451233|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
19451234|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451235|NCT03422705|Lisinopril|lisinopril|mesh-list
19451236|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19451237|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
19451238|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858176|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
19858177|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19858178|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
19858179|NCT00770341|Vancomycin|vancomycin|mesh-list
19858180|NCT00770341|Daptomycin|daptomycin|mesh-list
19858181|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19858182|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858183|NCT00770367|Pioglitazone|pioglitazone|mesh-list
19858184|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19858185|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858186|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19858187|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19858188|NCT00770432|Laxatives|laxatives|mesh-ancestor
19431711|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
19431712|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19431713|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431714|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431715|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19431716|NCT03530371|Analgesics|analgesics|mesh-ancestor
19431717|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
19431718|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431719|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19431720|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19431721|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19858189|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858190|NCT00770484|Propranolol|propranolol|mesh-list
19858191|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19858192|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19858193|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858194|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858195|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431722|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
19713751|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713752|NCT04753177|Paclitaxel|paclitaxel|mesh-list
19713753|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
19858196|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858197|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19858198|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19858199|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
19858200|NCT00770510|Zolpidem|zolpidem|mesh-list
19858201|NCT00770510|Eszopiclone|eszopiclone|mesh-list
19858202|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19858203|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20250247|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713754|NCT04753177|Doxorubicin|doxorubicin|mesh-list
19713755|NCT04753177|Fulvestrant|fulvestrant|mesh-list
19713756|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19713757|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19713758|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713759|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713760|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713761|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
19858204|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19858205|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858206|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19858207|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
19858208|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
19858209|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858210|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858211|NCT00770562|Dexamethasone|dexamethasone|mesh-list
19858212|NCT00770562|Rituximab|rituximab|mesh-list
19858213|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858214|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858215|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
19858216|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858217|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858218|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858219|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
19858220|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
19858221|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858222|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858223|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
19858224|NCT00770562|Hormones|hormones|mesh-ancestor
19858225|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858226|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19858227|NCT00770588|Gefitinib|gefitinib|mesh-list
19431723|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431724|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431725|NCT03530319|Azithromycin|azithromycin|mesh-list
19431726|NCT03530319|Doxycycline|doxycycline|mesh-list
19431727|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19431728|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431729|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
19431730|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19431731|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19431732|NCT03530280|Pregabalin|pregabalin|mesh-list
19431733|NCT03530280|Bupivacaine|bupivacaine|mesh-list
19431734|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
19431735|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
19431736|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431737|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431738|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
19431739|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431740|NCT03530280|Analgesics|analgesics|mesh-ancestor
19431741|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
19713762|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713763|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713764|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
19713765|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713766|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713767|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19713768|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
19713769|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19713770|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20250248|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431742|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19431743|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19431744|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431745|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19431746|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19431747|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19713771|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19431748|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19431749|NCT03530228|Esomeprazole|esomeprazole|mesh-list
19431750|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20532398|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532399|NCT01800526|Antidotes|antidotes|mesh-ancestor
20532400|NCT01800630|Gemcitabine|gemcitabine|mesh-list
20532401|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532402|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
20532403|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532404|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532405|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
20532406|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532407|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532408|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532409|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
20532410|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431751|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19431752|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19431753|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431754|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431755|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
19431756|NCT03530189|Insulin|insulin|mesh-list
19431757|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19431758|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431759|NCT03530176|Listerine|listerine|mesh-list
19431760|NCT03530176|Fluorides|fluorides|mesh-list
19431761|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
19431762|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
19431763|NCT03530176|Protective Agents|protective agents|mesh-ancestor
19431764|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431765|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19431766|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19431767|NCT03530150|Pirfenidone|pirfenidone|mesh-list
19431768|NCT03530150|Analgesics|analgesics|mesh-ancestor
20532411|NCT01800643|Busulfan|busulfan|mesh-list
20532412|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
20532413|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532414|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431769|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
19431770|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431771|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431772|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19431773|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19431774|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431775|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431776|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431777|NCT03530085|Fludarabine|fludarabine|mesh-list
19431778|NCT03530085|Busulfan|busulfan|mesh-list
19431779|NCT03530085|Decitabine|decitabine|mesh-list
19431780|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431781|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19431782|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
19431783|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431784|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431785|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
19431786|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431787|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
19431788|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431789|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19431790|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431791|NCT03530033|Lidocaine|lidocaine|mesh-list
19431792|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
19431793|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
19431794|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431795|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431796|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
19431797|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431798|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19431799|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19431800|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19431801|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19431802|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431803|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
19431804|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
19431805|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19431806|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431807|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431808|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
19431809|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19431810|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431811|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431812|NCT03530007|Ondansetron|ondansetron|mesh-list
19431813|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
19431814|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
19713772|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19713773|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713774|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19713775|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19431815|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431816|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431817|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19431818|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
19431819|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
19431820|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19431821|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
19431822|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431823|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431824|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19431825|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19431826|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431827|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19431828|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19431829|NCT03529955|Apremilast|apremilast|mesh-list
19431830|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19431831|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19431832|NCT03529955|Analgesics|analgesics|mesh-ancestor
19431833|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
19431834|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431835|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431836|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431837|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431838|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19431839|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20250249|NCT00444314|Sunitinib|sunitinib|mesh-list
20250250|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250251|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20250252|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20250253|NCT00444314|Growth Substances|growth substances|mesh-ancestor
20250254|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250255|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
20250256|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20250257|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250258|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250259|NCT00444340|Etanercept|etanercept|mesh-list
20250260|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20250261|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20250262|NCT00444340|Analgesics|analgesics|mesh-ancestor
20250263|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
20250264|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250265|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250266|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250267|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250268|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250269|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532415|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
20532416|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532417|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20532418|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532419|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20532420|NCT01800695|Temozolomide|temozolomide|mesh-list
20532421|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20532422|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
19431840|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431841|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431842|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
19431843|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19431844|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19431845|NCT03529929|Prednisolone|prednisolone|mesh-list
19431846|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
19431847|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19431848|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
19431849|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431850|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
19431851|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
19431852|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250270|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
20250271|NCT00444379|Ritonavir|ritonavir|mesh-list
20250272|NCT00444379|Lopinavir|lopinavir|mesh-list
19431853|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431854|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19431855|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
19431856|NCT03529929|Hormones|hormones|mesh-ancestor
19431857|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19431858|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19431859|NCT03529929|Protective Agents|protective agents|mesh-ancestor
19431860|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19431861|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431862|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
19431863|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19431864|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431865|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431866|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19431867|NCT03529643|Analgesics|analgesics|mesh-ancestor
19713776|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19713777|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
19713778|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713779|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
19713780|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19713781|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
19713782|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19713783|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19713784|NCT04753008|Dopamine|dopamine|mesh-list
19713785|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19713786|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
19713787|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
19713788|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713789|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713790|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
19713791|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713792|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713793|NCT04753008|Protective Agents|protective agents|mesh-ancestor
19713794|NCT04753294|Diazepam|diazepam|mesh-list
19713795|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19713796|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
19713797|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
19713798|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
19713799|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713800|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713801|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250273|NCT00444379|Tenofovir|tenofovir|mesh-list
20250274|NCT00444379|Emtricitabine|emtricitabine|mesh-list
20250275|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20250276|NCT00444379|Efavirenz|efavirenz|mesh-list
20250277|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20250278|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19431868|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
19431869|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431870|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19431871|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19431872|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19431873|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
19431874|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431875|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431876|NCT03529487|Phenylephrine|phenylephrine|mesh-list
19431877|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
19431878|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19431879|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19431880|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
19431881|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431882|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431883|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431884|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
19431885|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
19431886|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431887|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
19431888|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19431889|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
19431890|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19431891|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
19431892|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19431893|NCT03529487|Protective Agents|protective agents|mesh-ancestor
19431894|NCT03529448|Temozolomide|temozolomide|mesh-list
19431895|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19431896|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
19431897|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431898|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713802|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20250279|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
19431902|NCT03529331|Acetaminophen|acetaminophen|mesh-list
19431903|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19431904|NCT03529331|Morphine|morphine|mesh-list
19431905|NCT03529331|Oxycodone|oxycodone|mesh-list
19431906|NCT03529331|Hydrocodone|hydrocodone|mesh-list
19431907|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19431908|NCT03529331|Narcotics|narcotics|mesh-ancestor
19431909|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431910|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431911|NCT03529331|Analgesics|analgesics|mesh-ancestor
19431912|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
19431913|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431914|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19431915|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
19431916|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
19431917|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
19431918|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19431919|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19431920|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19431921|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19431922|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
19431923|NCT03529266|Coagulants|coagulants|mesh-ancestor
19431924|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20250280|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250281|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250282|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19431925|NCT03529253|Calcium|calcium|mesh-list
19431926|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19431927|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431928|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19431929|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19431930|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
19431931|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431932|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19431933|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19431934|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431935|NCT03529201|Fentanyl|fentanyl|mesh-list
19431936|NCT03529201|Oxycodone|oxycodone|mesh-list
19431937|NCT03529201|Sevoflurane|sevoflurane|mesh-list
19431938|NCT03529201|Rocuronium|rocuronium|mesh-list
19431939|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19431940|NCT03529201|Narcotics|narcotics|mesh-ancestor
19431941|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431942|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431943|NCT03529201|Analgesics|analgesics|mesh-ancestor
19431944|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
19431945|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431946|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19431947|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19431948|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
19431949|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
19431950|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19431951|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19431952|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19431953|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19431954|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19431955|NCT03529175|Gemcitabine|gemcitabine|mesh-list
20250283|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19431956|NCT03529175|Paclitaxel|paclitaxel|mesh-list
19431957|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19431958|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20250284|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
19431959|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19431960|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713803|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713804|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19713805|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19713806|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19713807|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19713808|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19713809|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19713810|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
19713811|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
19713812|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
19713813|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
19713814|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713815|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713816|NCT04752852|Dexamethasone|dexamethasone|mesh-list
19713817|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19713818|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
19713819|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
19713820|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713821|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713822|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713823|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
19713824|NCT04752852|Hormones|hormones|mesh-ancestor
19713825|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713826|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19713827|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713828|NCT04752813|Vitamin K|vitamin k|mesh-list
19713829|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
19713830|NCT04752813|Temozolomide|temozolomide|mesh-list
19713831|NCT04752813|Vitamins|vitamins|mesh-ancestor
19713832|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
19713833|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713834|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19713835|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
19713836|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713837|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713838|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19713839|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19713840|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
19713841|NCT04752813|Coagulants|coagulants|mesh-ancestor
19713842|NCT04752267|Clevudine|clevudine|mesh-list
19713843|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
19713844|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713845|NCT04752384|Buprenorphine|buprenorphine|mesh-list
19713846|NCT04752384|Tramadol|tramadol|mesh-list
19713847|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19713848|NCT04752384|Narcotics|narcotics|mesh-ancestor
19713849|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713850|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713851|NCT04752384|Analgesics|analgesics|mesh-ancestor
19713852|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
19713853|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713854|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19713855|NCT04752163|Leucovorin|leucovorin|mesh-list
19858228|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858229|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19431961|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
19431962|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
19431963|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431964|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19431965|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
19431966|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
19431967|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858230|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19431968|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713856|NCT04752163|Cytarabine|cytarabine|mesh-list
19713857|NCT04752163|Voriconazole|voriconazole|mesh-list
19431969|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19431970|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
19431971|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431972|NCT03529149|Diltiazem|diltiazem|mesh-list
19431973|NCT03529149|Urapidil|urapidil|mesh-list
19431974|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19431975|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19431976|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19431977|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19431978|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19431979|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431980|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
19431981|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19431982|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
19431983|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19431984|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19431985|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19431986|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19431987|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
19431988|NCT03529097|Dipyrone|dipyrone|mesh-list
19431989|NCT03529097|Diclofenac|diclofenac|mesh-list
19431990|NCT03529097|Morphine|morphine|mesh-list
19431991|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19431992|NCT03529097|Narcotics|narcotics|mesh-ancestor
19431993|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19431994|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19431995|NCT03529097|Analgesics|analgesics|mesh-ancestor
19431996|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
19431997|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19431998|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19431999|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432000|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432001|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432002|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19432003|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432004|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432005|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
19432006|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19432007|NCT03529084|Gefitinib|gefitinib|mesh-list
19432008|NCT03529084|Nazartinib|nazartinib|mesh-list
19432009|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432010|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19432011|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432012|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432013|NCT03529032|Methadone|methadone|mesh-list
19432014|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19432015|NCT03529032|Narcotics|narcotics|mesh-ancestor
19432016|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432017|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432018|NCT03529032|Analgesics|analgesics|mesh-ancestor
19432019|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
19432020|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432021|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
19432022|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
19432023|NCT03528967|Aspirin|aspirin|mesh-list
19432024|NCT03528967|Enoxaparin|enoxaparin|mesh-list
19432025|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19432026|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432027|NCT03528967|Analgesics|analgesics|mesh-ancestor
19432028|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
19432029|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432030|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432031|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432032|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432033|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19432034|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19432035|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432036|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19432037|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19432038|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713858|NCT04752163|Posaconazole|posaconazole|mesh-list
19432039|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
19432040|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
19432041|NCT03528954|Propofol|propofol|mesh-list
19432042|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19432043|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432044|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432045|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19432046|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
19432047|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
19432048|NCT03528915|Rifamycins|rifamycins|mesh-list
19432049|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
19432050|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19432051|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432052|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432053|NCT03528824|Diclofenac|diclofenac|mesh-list
19432054|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19432055|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432056|NCT03528824|Analgesics|analgesics|mesh-ancestor
19432057|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
19432058|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432059|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432060|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432061|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432062|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19432063|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432064|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432065|NCT03528785|Leucovorin|leucovorin|mesh-list
19432066|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
19432067|NCT03528785|Irinotecan|irinotecan|mesh-list
19432068|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
19432069|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432070|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19432071|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19432072|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432073|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432074|NCT03528785|Antidotes|antidotes|mesh-ancestor
19432075|NCT03528785|Protective Agents|protective agents|mesh-ancestor
19432076|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432077|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
19432078|NCT03528785|Vitamins|vitamins|mesh-ancestor
19713859|NCT04752163|Dexamethasone|dexamethasone|mesh-list
19432079|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
19432080|NCT03528772|Minoxidil|minoxidil|mesh-list
19432081|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
19432082|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19432083|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
19451239|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451240|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19451241|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19451242|NCT03422705|Protective Agents|protective agents|mesh-ancestor
19451243|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451244|NCT03422640|Apremilast|apremilast|mesh-list
19451245|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19451246|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451247|NCT03422640|Analgesics|analgesics|mesh-ancestor
19451248|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
19451249|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451250|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451251|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451252|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451253|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19451254|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19451255|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451256|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451257|NCT03422575|Etoricoxib|etoricoxib|mesh-list
19451258|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19451259|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451260|NCT03422575|Analgesics|analgesics|mesh-ancestor
19451261|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
19451262|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451263|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451264|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19713860|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
19713861|NCT04752163|Prednisone|prednisone|mesh-list
19713862|NCT04752163|Cortisone|cortisone|mesh-list
19713863|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
19713864|NCT04752163|Rituximab|rituximab|mesh-list
19713865|NCT04752163|Methotrexate|methotrexate|mesh-list
19713866|NCT04752163|Vincristine|vincristine|mesh-list
19713867|NCT04752163|Azacitidine|azacitidine|mesh-list
19713868|NCT04752163|Venetoclax|venetoclax|mesh-list
19713869|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19713870|NCT04752163|Antibodies|antibodies|mesh-list
19713871|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
19713872|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19713873|NCT04752163|Lenograstim|lenograstim|mesh-list
19713874|NCT04752163|BB 1101|bb 1101|mesh-list
19713875|NCT04752163|Mesna|mesna|mesh-list
19713876|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713877|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
19713878|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713879|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19713880|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19713881|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
19713882|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713883|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250285|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250286|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20250287|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20250288|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20250289|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19858231|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858232|NCT00770653|Metformin|metformin|mesh-list
19858233|NCT00770653|Pioglitazone|pioglitazone|mesh-list
19858234|NCT00770653|Glimepiride|glimepiride|mesh-list
19858235|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19858236|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858237|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19858238|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858239|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
19858240|NCT00770679|Atorvastatin|atorvastatin|mesh-list
19451265|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451266|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19858241|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19713884|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19713885|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19713886|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
20250290|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19432084|NCT03528616|Propranolol|propranolol|mesh-list
19432085|NCT03528616|Digoxin|digoxin|mesh-list
19432086|NCT03528616|Adenosine|adenosine|mesh-list
19432087|NCT03528616|Amiodarone|amiodarone|mesh-list
19432088|NCT03528616|Flecainide|flecainide|mesh-list
19432089|NCT03528616|Procainamide|procainamide|mesh-list
19432090|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19432091|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19432092|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
19432093|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432094|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432095|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432096|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19432097|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19432098|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
19432099|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19432100|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432101|NCT03528616|Protective Agents|protective agents|mesh-ancestor
19432102|NCT03528616|Analgesics|analgesics|mesh-ancestor
19432103|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
19432104|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432105|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19432106|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
19432107|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
19432108|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19432109|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432110|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19432111|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19432112|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20250291|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20250292|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20250293|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20250294|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20250295|NCT00444418|Naltrexone|naltrexone|mesh-list
20250296|NCT00444418|Naloxone|naloxone|mesh-list
20250297|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19713887|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
19713888|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713889|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713890|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
19713891|NCT04752163|Hormones|hormones|mesh-ancestor
19713892|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713893|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19713894|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
19713895|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713896|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19713897|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
19713898|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19713899|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19713900|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
19713901|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
19713902|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19713903|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19713904|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
19713905|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713906|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19713907|NCT04752163|Antidotes|antidotes|mesh-ancestor
19713908|NCT04752163|Protective Agents|protective agents|mesh-ancestor
19713909|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
19713910|NCT04752163|Vitamins|vitamins|mesh-ancestor
19713911|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
20250298|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19432113|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19432114|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19432115|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19432116|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19432117|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
19432118|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19432119|NCT03528564|Hematinics|hematinics|mesh-ancestor
19432120|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
19432121|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19432122|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432123|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
19432124|NCT03528421|Fludarabine|fludarabine|mesh-list
19432125|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19432126|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
19432127|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432128|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432129|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19432130|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
19432131|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432132|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432133|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19432134|NCT03528070|Tranilast|tranilast|mesh-list
19432135|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19432136|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432137|NCT03528070|Analgesics|analgesics|mesh-ancestor
19432138|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
19432139|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432140|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432141|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432142|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432143|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19432144|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432145|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432146|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19432147|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19432148|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
19432149|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
19432150|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432151|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19432152|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19432153|NCT03528057|Hemostatics|hemostatics|mesh-list
19432154|NCT03528057|Coagulants|coagulants|mesh-ancestor
19432155|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19432156|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
19432157|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432158|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432159|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432160|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19432161|NCT03527836|Lidocaine|lidocaine|mesh-list
19432162|NCT03527836|Bupivacaine|bupivacaine|mesh-list
19432163|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
19432164|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
19432165|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432166|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432167|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
19432168|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432169|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19432170|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19432171|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19432172|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432173|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432174|NCT03527732|Ivermectin|ivermectin|mesh-list
19432175|NCT03527732|Albendazole|albendazole|mesh-list
19432176|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19713912|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19432177|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432178|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
19432179|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
19432180|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19432181|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19432182|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
19432183|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
19432184|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
19432185|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432186|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432187|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
19432188|NCT03527628|Dacarbazine|dacarbazine|mesh-list
19432189|NCT03527628|Doxorubicin|doxorubicin|mesh-list
19432190|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19432191|NCT03527628|Bleomycin|bleomycin|mesh-list
19432192|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19432193|NCT03527628|Vinblastine|vinblastine|mesh-list
19432194|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19432195|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
19432196|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432197|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432198|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19432199|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
19432200|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432201|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713913|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19713914|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19713915|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19713916|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
19713917|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19713918|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19713919|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19713920|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
19713921|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19713922|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19713923|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19432202|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19432203|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19432204|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19432205|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19432206|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432207|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432208|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19432209|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
19432210|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
19432211|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
19432212|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
19432213|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19432214|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
19432215|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432216|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432217|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19432218|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
19432219|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19432220|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
19432221|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432222|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432223|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19432224|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
19432225|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
19432226|NCT03527381|Protective Agents|protective agents|mesh-ancestor
19432227|NCT03527355|Vaccines|vaccines|mesh-list
19432228|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
19432229|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432230|NCT03527251|Ipilimumab|ipilimumab|mesh-list
19432231|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432232|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432233|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19432234|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432235|NCT03527147|Rituximab|rituximab|mesh-list
19432236|NCT03527147|Magrolimab|magrolimab|mesh-list
19432237|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
20250299|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250300|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
20250301|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250302|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
20250303|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20250304|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20250305|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250306|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
20250307|NCT00444470|Coagulants|coagulants|mesh-ancestor
20250308|NCT00444522|Alprazolam|alprazolam|mesh-list
20250309|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20250310|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250311|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250312|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19713924|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19734020|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19734021|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
19734022|NCT04555707|Apremilast|apremilast|mesh-list
19734023|NCT04555707|Calcipotriene|calcipotriene|mesh-list
19734024|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19734025|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734026|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
19734027|NCT04555707|Hormones|hormones|mesh-ancestor
20250313|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19734028|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734029|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734030|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19734031|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
19734032|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20250314|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20250315|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
20250316|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
20250317|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250318|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250319|NCT00444548|Reboxetine|reboxetine|mesh-list
20250320|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
20250321|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20250322|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20250323|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20250324|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250325|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250326|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250327|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734033|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20250328|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250329|NCT00444561|Pramlintide|pramlintide|mesh-list
20250330|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20250331|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250332|NCT00444574|Methylphenidate|methylphenidate|mesh-list
20250333|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19432238|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432239|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432240|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
19432241|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432242|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432243|NCT03527134|Amantadine|amantadine|mesh-list
19432244|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19432245|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19432246|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
19432247|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432248|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
19432249|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432250|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432251|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432252|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19713925|NCT04752059|Trastuzumab|trastuzumab|mesh-list
19432253|NCT03527134|Analgesics|analgesics|mesh-ancestor
19432254|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
19713926|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19713927|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432255|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432256|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19432257|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19432258|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19432259|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
19432260|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432261|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19432262|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20250334|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250335|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20250336|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19432263|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713928|NCT04752111|Esmolol|esmolol|mesh-list
19713929|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19713930|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19713931|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19713932|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858242|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19713933|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713934|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713935|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713936|NCT04751955|Capecitabine|capecitabine|mesh-list
19451267|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19451268|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451269|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451270|NCT03422523|Gemcitabine|gemcitabine|mesh-list
19451271|NCT03422523|Rituximab|rituximab|mesh-list
19451272|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
19451273|NCT03422523|Atezolizumab|atezolizumab|mesh-list
19451274|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19451275|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713937|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19451276|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
19451277|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451278|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451279|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19451280|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
19451281|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451282|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
19451283|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451284|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451285|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19713938|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
19451286|NCT03422510|CXA-10|cxa-10|mesh-list
19451287|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451288|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19451289|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451290|NCT03422445|Temozolomide|temozolomide|mesh-list
19451291|NCT03422445|Apatinib|apatinib|mesh-list
19713939|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713940|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19713941|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
19713942|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19713943|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19713944|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
19713945|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19713946|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713947|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713948|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
19713949|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
19713950|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432264|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
19432265|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19432266|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432267|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
19432268|NCT03526575|Zaleplon|zaleplon|mesh-list
19432269|NCT03526575|Zolpidem|zolpidem|mesh-list
19432270|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19432271|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19713951|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
19713952|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19432272|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432273|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432274|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19432275|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
19713953|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
19713954|NCT04751929|Atezolizumab|atezolizumab|mesh-list
19713955|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858243|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
19432276|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
19713956|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19713957|NCT04751500|Metronidazole|metronidazole|mesh-list
19858244|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713958|NCT04751500|Clindamycin|clindamycin|mesh-list
19432277|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432278|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432279|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
19432280|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
19432281|NCT03526536|Insulin|insulin|mesh-list
19432282|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19432283|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19432284|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432285|NCT03526445|Glucagon|glucagon|mesh-list
19432286|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19432287|NCT03526445|Hormones|hormones|mesh-ancestor
19432288|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432289|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432290|NCT03526419|Bupivacaine|bupivacaine|mesh-list
19432291|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
19713959|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19713960|NCT04751500|Misoprostol|misoprostol|mesh-list
19713961|NCT04751500|Mifepristone|mifepristone|mesh-list
19713962|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19713963|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19713964|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19713965|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19713966|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
19713967|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19713968|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713969|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19713970|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19713971|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
19713972|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19713973|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19713974|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19713975|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19713976|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19713977|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19713978|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19713979|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
19713980|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19713981|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19713982|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
19713983|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19713984|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
19713985|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19713986|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19713987|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19713988|NCT04751669|Trace Elements|trace elements|mesh-list
19713989|NCT04751669|Micronutrients|micronutrients|mesh-list
19734034|NCT04555707|Analgesics|analgesics|mesh-ancestor
19858245|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19858246|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19858247|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858248|NCT00770692|Eszopiclone|eszopiclone|mesh-list
19858249|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19858250|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432292|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
19432293|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19858251|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432294|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432295|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
19432296|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432297|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19432298|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19432299|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19432300|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
19432301|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432302|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19432303|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19432304|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432305|NCT03526315|Fluorides|fluorides|mesh-list
19432306|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
19432307|NCT03526315|Protective Agents|protective agents|mesh-ancestor
19713990|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713991|NCT04751344|Bupivacaine|bupivacaine|mesh-list
19432308|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432309|NCT03526276|Fluorides|fluorides|mesh-list
19432310|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
19432311|NCT03526276|Protective Agents|protective agents|mesh-ancestor
19713992|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
19713993|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
19713994|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19713995|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19713996|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
19713997|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19713998|NCT04751227|Modafinil|modafinil|mesh-list
19713999|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19714000|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714001|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19714002|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19714003|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19432312|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432313|NCT03526224|Teriflunomide|teriflunomide|mesh-list
19432314|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19432315|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
19432316|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714004|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714005|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19714006|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19714007|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19714008|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19714009|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714010|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714011|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714012|NCT04751318|Analgesics|analgesics|mesh-ancestor
19714013|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
19714014|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714015|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
19714016|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19714017|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
19714018|NCT04751604|Niacinamide|niacinamide|mesh-list
19714019|NCT04751604|Niacin|niacin|mesh-list
19714020|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
19714021|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
19714022|NCT04751604|Vitamins|vitamins|mesh-ancestor
19714023|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
19714024|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432317|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
19432318|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432319|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19432320|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432321|NCT03526224|Analgesics|analgesics|mesh-ancestor
19432322|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
19432323|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858252|NCT00770757|Pomalidomide|pomalidomide|mesh-list
19432324|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432325|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432326|NCT03526185|Nivolumab|nivolumab|mesh-list
19432327|NCT03526185|Ipilimumab|ipilimumab|mesh-list
19432328|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432329|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432330|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19432331|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432332|NCT03526159|Gentamicins|gentamicins|mesh-list
19432333|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19432334|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714025|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19714026|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
19714027|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714028|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19432335|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19432336|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432337|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250337|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250338|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250339|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
19432338|NCT03526107|Theobromine|theobromine|mesh-list
19432339|NCT03526107|Caffeine|caffeine|mesh-list
19432340|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19432341|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432342|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19432343|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432344|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432345|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19432346|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19432347|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
19432348|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714029|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
19714030|NCT04751175|Dexamethasone|dexamethasone|mesh-list
19714031|NCT04751175|Ketamine|ketamine|mesh-list
19714032|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714033|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
19714034|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
19432349|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19714035|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858253|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
19858254|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432350|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
19432351|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432352|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19858255|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19858256|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19858257|NCT00770757|Growth Substances|growth substances|mesh-ancestor
19858258|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
20250340|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250341|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
20250342|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
20250343|NCT00444613|Vitamins|vitamins|mesh-ancestor
20250344|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
20250345|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250346|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20250347|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
20250348|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20250349|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
19858259|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858260|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19432353|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
19432354|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
19432355|NCT03526042|Losartan|losartan|mesh-list
19432356|NCT03526042|Enalapril|enalapril|mesh-list
19432357|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19432358|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19432359|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19432360|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19432361|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19432362|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19432363|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432364|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19432365|NCT03525925|Nivolumab|nivolumab|mesh-list
19432366|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432367|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432368|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19432369|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432370|NCT03525912|Ketamine|ketamine|mesh-list
19432371|NCT03525912|Analgesics|analgesics|mesh-list
19432372|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
19432373|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432374|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858261|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858262|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
19858263|NCT00770770|Hormones|hormones|mesh-ancestor
19858264|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858265|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858266|NCT00770861|Nebivolol|nebivolol|mesh-list
19858267|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19858268|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
20250350|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19432375|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19432376|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19432377|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
19432378|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
19432379|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432380|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19432381|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19432382|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432383|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432384|NCT03525821|Ketamine|ketamine|mesh-list
19432385|NCT03525821|Analgesics|analgesics|mesh-ancestor
19432386|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
19432387|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432388|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432389|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19432390|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19432391|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
19714036|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714037|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19714038|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
19714039|NCT04751175|Hormones|hormones|mesh-ancestor
19714040|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714041|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714042|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714043|NCT04751175|Analgesics|analgesics|mesh-ancestor
19714044|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
19714045|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19714046|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19714047|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
19714048|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
19714049|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714050|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19714051|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19714052|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714053|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714054|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19714055|NCT04751188|Bezafibrate|bezafibrate|mesh-list
19714056|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19714057|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858269|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19858270|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19858271|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19858272|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858273|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858274|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858275|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858276|NCT00770874|Cisplatin|cisplatin|mesh-list
19858277|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858278|NCT00770913|Rabeprazole|rabeprazole|mesh-list
19858279|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19858280|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858281|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19432392|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
19858282|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714058|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19714059|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
19858283|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858284|NCT00771030|Brodalumab|brodalumab|mesh-list
19858285|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
19858286|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
19858287|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
19858288|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19432393|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432394|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19432395|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19432396|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432397|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858289|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19858290|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858291|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432398|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
19432399|NCT03525730|Valproic Acid|valproic acid|mesh-list
19432400|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
19432401|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19432402|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19432403|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432404|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19432405|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432406|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432407|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
19432408|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
19432409|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432410|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432411|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
19432412|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432413|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432414|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432415|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19432416|NCT03525652|Vaccines|vaccines|mesh-list
19432417|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
19432418|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432419|NCT03525574|Ivacaftor|ivacaftor|mesh-list
19432420|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19432421|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432422|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432423|NCT03525561|Acetazolamide|acetazolamide|mesh-list
19432424|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
19432425|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19432426|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432427|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432428|NCT03525561|Diuretics|diuretics|mesh-ancestor
19432429|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
19432430|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432431|NCT03525522|Betamethasone|betamethasone|mesh-list
19432432|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19432433|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432434|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
19432435|NCT03525522|Hormones|hormones|mesh-ancestor
19714060|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714061|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19714062|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19714063|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
19714064|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
19432436|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432437|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432438|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19432439|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
19714065|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714066|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714067|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19432440|NCT03525509|Morphine|morphine|mesh-list
20250351|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250352|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20250353|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20250354|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250355|NCT00444652|Enoxaparin|enoxaparin|mesh-list
19432441|NCT03525509|Methadone|methadone|mesh-list
19432442|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19432443|NCT03525509|Narcotics|narcotics|mesh-ancestor
19432444|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432445|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432446|NCT03525509|Analgesics|analgesics|mesh-ancestor
19432447|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
19432448|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432449|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
19432450|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
19858292|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858293|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969634|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969635|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19714068|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19714069|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
19714070|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714071|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714072|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
19714073|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19714074|NCT04751136|Protective Agents|protective agents|mesh-ancestor
19714075|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714076|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
19714077|NCT04750902|Listerine|listerine|mesh-list
19714078|NCT04750902|Fluorides|fluorides|mesh-list
19714079|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
19714080|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
19714081|NCT04750902|Protective Agents|protective agents|mesh-ancestor
19714082|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714083|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19714084|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714085|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19714086|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19714087|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714088|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
19714089|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19714090|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714091|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19714092|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19714093|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250356|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
20250357|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19858294|NCT00771472|Vorinostat|vorinostat|mesh-list
19858295|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432458|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
19432459|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19451292|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19451293|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
19451294|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451295|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451296|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19451297|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451298|NCT03422419|Heparin|heparin|mesh-list
19451299|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
19451300|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19451301|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19451302|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451303|NCT03422406|Iodine|iodine|mesh-list
19451304|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19451305|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451306|NCT03422406|Trace Elements|trace elements|mesh-ancestor
19451307|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
19451308|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451309|NCT03422393|Venetoclax|venetoclax|mesh-list
19451310|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451311|NCT03422315|Propofol|propofol|mesh-list
19451312|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19451313|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451314|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451315|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19451316|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
19451317|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
19452777|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19452778|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19452779|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858296|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19858297|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858298|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858299|NCT00771667|Ustekinumab|ustekinumab|mesh-list
19858300|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
19858301|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
19858302|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19714094|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858303|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
19858304|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858305|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858306|NCT00771758|Oxycodone|oxycodone|mesh-list
19858307|NCT00771758|Tapentadol|tapentadol|mesh-list
19858308|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19858309|NCT00771758|Narcotics|narcotics|mesh-ancestor
19858310|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19858311|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858312|NCT00771758|Analgesics|analgesics|mesh-ancestor
20250358|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20250359|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250360|NCT00444665|Travoprost|travoprost|mesh-list
19452787|NCT03410524|Simethicone|simethicone|mesh-list
19452788|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
19452789|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714095|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714096|NCT04750603|Fluticasone|fluticasone|mesh-list
19714097|NCT04750603|Xhance|xhance|mesh-list
19714098|NCT04750603|Albuterol|albuterol|mesh-list
19714099|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714100|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19714101|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
19714102|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858313|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
19858314|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714103|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432460|NCT03525002|Bromocriptine|bromocriptine|mesh-list
19432461|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19432462|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19432463|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
19432464|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432465|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432466|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
19432467|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
19432468|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432469|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432470|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
19432471|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19432472|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432473|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432474|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432475|NCT03524950|Analgesics|analgesics|mesh-ancestor
19432476|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
19432477|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432478|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19432479|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19432480|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19432481|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19432482|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432483|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432484|NCT03524937|Melatonin|melatonin|mesh-list
19432485|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
19432486|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432487|NCT03524937|Protective Agents|protective agents|mesh-ancestor
19432488|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432489|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432490|NCT03524872|Analgesics|analgesics|mesh-list
19432491|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432492|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
19432493|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432494|NCT03524846|Vitamins|vitamins|mesh-list
19432495|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
19432496|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
19432497|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432498|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
19451318|NCT03422289|Folic Acid|folic acid|mesh-list
19451319|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
19451320|NCT03422289|Inositol|inositol|mesh-list
19451321|NCT03422289|Hematinics|hematinics|mesh-ancestor
19451322|NCT03422289|Vitamins|vitamins|mesh-ancestor
19451323|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
19451324|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451325|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
19451326|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19451327|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451328|NCT03422055|Fucoidan|fucoidan|mesh-list
19451329|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19451330|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19451331|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
19432499|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432500|NCT03524846|Protective Agents|protective agents|mesh-ancestor
19432501|NCT03524833|Amoxicillin|amoxicillin|mesh-list
19432502|NCT03524833|Metronidazole|metronidazole|mesh-list
19432503|NCT03524833|Lansoprazole|lansoprazole|mesh-list
19432504|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
19432505|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19432506|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432507|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19432508|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19432509|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19432510|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19432511|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19432512|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432513|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432514|NCT03524820|Cetuximab|cetuximab|mesh-list
19432515|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432516|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432517|NCT03524508|Fluorouracil|fluorouracil|mesh-list
19432518|NCT03524508|Irinotecan|irinotecan|mesh-list
19432519|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
19432520|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432521|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19432522|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432523|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19432524|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
19432525|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432526|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19432527|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19432528|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432529|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
19432530|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
19432531|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432532|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
19432533|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432534|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714104|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19714105|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
19714106|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
19714107|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19432535|NCT03524274|Antibodies|antibodies|mesh-list
19432536|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19432537|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
19432538|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532423|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532424|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532425|NCT01800708|Prednisolone|prednisolone|mesh-list
19432539|NCT03524261|Antibodies|antibodies|mesh-list
19432540|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19432541|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
19432542|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432543|NCT03524079|Ajmaline|ajmaline|mesh-list
20532426|NCT01800708|Triamcinolone|triamcinolone|mesh-list
20532427|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20532428|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20532429|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20532430|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20532431|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
20532432|NCT01800708|Hormones|hormones|mesh-ancestor
20532433|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20532434|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532435|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20532436|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532437|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19432544|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19432545|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19432546|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19432547|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432548|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714108|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
19714109|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19714110|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19714111|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19714112|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19714113|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714114|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432549|NCT03523832|Celecoxib|celecoxib|mesh-list
19432550|NCT03523832|Pregabalin|pregabalin|mesh-list
19432551|NCT03523832|Analgesics|analgesics|mesh-ancestor
19714115|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714116|NCT04750473|Edetic Acid|edetic acid|mesh-list
19714117|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19714118|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
19714119|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
19714120|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714121|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
19714122|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19714123|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19714124|NCT04750460|Teriparatide|teriparatide|mesh-list
19714125|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19714126|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432552|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
19432553|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714127|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19714128|NCT04750317|Tofacitinib|tofacitinib|mesh-list
19714129|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714130|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714131|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714132|NCT04750382|Gemcitabine|gemcitabine|mesh-list
19714133|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714134|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19714135|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
19714136|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714137|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
19714138|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714139|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714140|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714141|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
19714142|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714143|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19714144|NCT04749940|Laxatives|laxatives|mesh-ancestor
19714145|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19714146|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19714147|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
19858315|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20250361|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20250362|NCT00444717|Pitavastatin|pitavastatin|mesh-list
20250363|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20250364|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20250365|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20532438|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
20532439|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532440|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532441|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20532442|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532443|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
20532444|NCT01800799|Celecoxib|celecoxib|mesh-list
20532445|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20532446|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20532447|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20532448|NCT01800799|Analgesics|analgesics|mesh-ancestor
20532449|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
20532450|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532451|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532452|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532453|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20532454|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20532455|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532456|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532457|NCT01800825|Clindamycin|clindamycin|mesh-list
20532458|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
20532459|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
19432554|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432555|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
19432556|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19432557|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432558|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432559|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19432560|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19432561|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432562|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432563|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432564|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19432565|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432566|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432567|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432568|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19432569|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19432570|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432571|NCT03523754|Isosorbide|isosorbide|mesh-list
19432572|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19432573|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19432574|NCT03523754|Misoprostol|misoprostol|mesh-list
19432575|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19432576|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
19432577|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19714148|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19714149|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
19714150|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19714151|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714152|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19432578|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432579|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19432580|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19432581|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
19432582|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19432583|NCT03523754|Diuretics|diuretics|mesh-ancestor
19432584|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
19432585|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
19432586|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19432587|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432588|NCT03523741|Clozapine|clozapine|mesh-list
19432589|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19432590|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
19714153|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714154|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714155|NCT04749914|Dabigatran|dabigatran|mesh-list
19858316|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19858317|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858318|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858319|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858320|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858321|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19858322|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19858323|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
19858324|NCT00771875|Acetaminophen|acetaminophen|mesh-list
19858325|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
19858326|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
19858327|NCT00771875|Rituximab|rituximab|mesh-list
20250366|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
20250367|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250368|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250369|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20250370|NCT00444756|Lidocaine|lidocaine|mesh-list
20250371|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
19432591|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714156|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19714157|NCT04749914|Lasmiditan|lasmiditan|mesh-list
20250372|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
19432592|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432593|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432594|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19432595|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432596|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432597|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432598|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
19432599|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
19432600|NCT03523650|Propranolol|propranolol|mesh-list
19432601|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19432602|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19432603|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714158|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19714159|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19714160|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
19714161|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714162|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19714163|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19714164|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714165|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
19714166|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19714167|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
19714168|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
19714169|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19714170|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
19714171|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714172|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714173|NCT04750122|Carboplatin|carboplatin|mesh-list
19714174|NCT04750122|Docetaxel|docetaxel|mesh-list
19432604|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432605|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432606|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432607|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19432608|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19714175|NCT04750122|Trastuzumab|trastuzumab|mesh-list
19714176|NCT04750122|Pertuzumab|pertuzumab|mesh-list
19858328|NCT00771875|Bortezomib|bortezomib|mesh-list
19432609|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
19714177|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714178|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
19432610|NCT03523572|Nivolumab|nivolumab|mesh-list
19432611|NCT03523572|Trastuzumab|trastuzumab|mesh-list
19432612|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432613|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432614|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19432615|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432616|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
19432617|NCT03523455|Hematinics|hematinics|mesh-ancestor
19714179|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
19714180|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
19714181|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714182|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714183|NCT04750135|Metformin|metformin|mesh-list
20250373|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250374|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250375|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
20250376|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532460|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19714184|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19858329|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
19858330|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19858331|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19858332|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
19858333|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858334|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858335|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
19858336|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858337|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858338|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19858339|NCT00771875|Analgesics|analgesics|mesh-ancestor
19858340|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
19858341|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858342|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
19858343|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858344|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
19858345|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
19858346|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858347|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
19858348|NCT00771875|Hormones|hormones|mesh-ancestor
19858349|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858350|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19858351|NCT00771875|Protective Agents|protective agents|mesh-ancestor
19858352|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858353|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19858354|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20532461|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532462|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19858355|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19858356|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
19858357|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
19858358|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
19858359|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858360|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858361|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19858362|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19858363|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19858364|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858365|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
19858366|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532463|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532464|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532465|NCT01800942|Azithromycin|azithromycin|mesh-list
20532466|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20532467|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532468|NCT01801046|Cytarabine|cytarabine|mesh-list
20532469|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
20532470|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532471|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
19432618|NCT03523429|Blinatumomab|blinatumomab|mesh-list
19858367|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19858368|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19432619|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451332|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451333|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19451334|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19451335|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451336|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
19451337|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19451338|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19451339|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451340|NCT03421990|Anesthetics|anesthetics|mesh-list
19451341|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451342|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451343|NCT03421860|Phenylephrine|phenylephrine|mesh-list
19451344|NCT03421860|Epinephrine|epinephrine|mesh-list
19451345|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
19451346|NCT03421860|Ephedrine|ephedrine|mesh-list
19451347|NCT03421860|Norepinephrine|norepinephrine|mesh-list
19451348|NCT03421860|Ondansetron|ondansetron|mesh-list
19451349|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19451350|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19451351|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
19451352|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451353|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451354|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451355|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19451356|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19451357|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
19451358|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451359|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19451360|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
19451361|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
19451362|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
19451363|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19714185|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734035|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
19734036|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734037|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734038|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19734039|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19734040|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734041|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734042|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19734043|NCT04555525|Sarecycline|sarecycline|mesh-list
19734044|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734045|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734046|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532472|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532473|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532474|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
20532475|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532476|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532477|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
20532478|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532479|NCT01801046|Analgesics|analgesics|mesh-ancestor
20532480|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
20532481|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532482|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20532483|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532484|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532485|NCT01801072|Levetiracetam|levetiracetam|mesh-list
20532486|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
20532487|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
20532488|NCT01801137|Everolimus|everolimus|mesh-list
20532489|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532490|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19734047|NCT04555304|Paclitaxel|paclitaxel|mesh-list
19734048|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19734049|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19734050|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734051|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734052|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
19451364|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
19451365|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19451366|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
19451367|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
19734053|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
19432620|NCT03523390|Avelumab|avelumab|mesh-list
19432621|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432622|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432623|NCT03523273|Liraglutide|liraglutide|mesh-list
19432624|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19432625|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432626|NCT03523273|Incretins|incretins|mesh-ancestor
19432627|NCT03523273|Hormones|hormones|mesh-ancestor
19432628|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432629|NCT03523221|Dexamethasone|dexamethasone|mesh-list
19432630|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432631|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
19432632|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
19432633|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432634|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432635|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19432636|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
19432637|NCT03523221|Hormones|hormones|mesh-ancestor
19432638|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432639|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19432640|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432641|NCT03522987|Citalopram|citalopram|mesh-list
19432642|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19432643|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19432644|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432645|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432646|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432647|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
19432648|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432649|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19432650|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
19432651|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432652|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
19432653|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19432654|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432655|NCT03522961|Renal Agents|renal agents|mesh-ancestor
19432656|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19432657|NCT03522935|Elafin|elafin|mesh-list
19432658|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
19432659|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432660|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432661|NCT03522922|Ascorbic Acid|ascorbic acid|mesh-list
19432662|NCT03522922|Vitamins|vitamins|mesh-ancestor
19432663|NCT03522922|Micronutrients|micronutrients|mesh-ancestor
19432664|NCT03522922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432665|NCT03522922|Antioxidants|antioxidants|mesh-ancestor
19432666|NCT03522922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432667|NCT03522922|Protective Agents|protective agents|mesh-ancestor
19432668|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
19432669|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19432670|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432671|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432672|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432673|NCT03522688|Analgesics|analgesics|mesh-ancestor
19432674|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
19432675|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432676|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20250377|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20250378|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19432677|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19432678|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19432679|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19432680|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432681|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432682|NCT03522649|Leucovorin|leucovorin|mesh-list
19432683|NCT03522649|Fluorouracil|fluorouracil|mesh-list
19432684|NCT03522649|Irinotecan|irinotecan|mesh-list
19432685|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
19432686|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714186|NCT04750083|Carboplatin|carboplatin|mesh-list
19714187|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
19858369|NCT00771914|Aspirin|aspirin|mesh-list
19858370|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19858371|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19858372|NCT00771914|Analgesics|analgesics|mesh-ancestor
19858373|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
19858374|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858375|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858376|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858377|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858378|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20532491|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
20532492|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532493|NCT01801163|Sorafenib|sorafenib|mesh-list
20532494|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532495|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19432687|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19432688|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432689|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19432690|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
19432691|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432692|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20532496|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532497|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532498|NCT01801189|Pregabalin|pregabalin|mesh-list
19432693|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19432694|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432695|NCT03522649|Antidotes|antidotes|mesh-ancestor
19432696|NCT03522649|Protective Agents|protective agents|mesh-ancestor
19432697|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
19432698|NCT03522649|Vitamins|vitamins|mesh-ancestor
19432699|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
19432700|NCT03522532|Zinc|zinc|mesh-list
19432701|NCT03522532|Trace Elements|trace elements|mesh-ancestor
19432702|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
19432703|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432704|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
19432705|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
19432706|NCT03522428|Vitamins|vitamins|mesh-ancestor
19432707|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
19432708|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432709|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
19432710|NCT03522428|Hematinics|hematinics|mesh-ancestor
19432711|NCT03522402|Sevoflurane|sevoflurane|mesh-list
19432712|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19432713|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19432714|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
19432715|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
19432716|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714188|NCT04750083|Pemetrexed|pemetrexed|mesh-list
19714189|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714190|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714191|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714192|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714193|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19714194|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19714195|NCT04749797|Bupivacaine|bupivacaine|mesh-list
19714196|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
19714197|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
19714198|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432717|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432718|NCT03522298|GDC-0084|gdc-0084|mesh-list
19432719|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432720|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432721|NCT03522207|Trazodone|trazodone|mesh-list
19432722|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19432723|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432724|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432725|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432726|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432727|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19432728|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20250379|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20250380|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250381|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250382|NCT00444808|Calcitonin|calcitonin|mesh-list
20250383|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
20250384|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20250385|NCT00444808|Katacalcin|katacalcin|mesh-list
20250386|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250387|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250388|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20250389|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
20250390|NCT00444834|Carvedilol|carvedilol|mesh-list
20250391|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20250392|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20250393|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250394|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250395|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250396|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250397|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19432729|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19714199|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714200|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
19714201|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714202|NCT04749810|Eculizumab|eculizumab|mesh-list
19714203|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19714204|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250398|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
20250399|NCT00444834|Protective Agents|protective agents|mesh-ancestor
20250400|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20250401|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250402|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250403|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
20250404|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20250405|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20250406|NCT00444873|Lanreotide|lanreotide|mesh-list
20250407|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532499|NCT01801189|Analgesics|analgesics|mesh-ancestor
20532500|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
20532501|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532502|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532503|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
20532504|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20532505|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20532506|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250408|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
20250409|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20250410|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20250411|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20250412|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250413|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250414|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
19432730|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432731|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432732|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
19432733|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19432734|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
19432735|NCT03522194|Propofol|propofol|mesh-list
19432736|NCT03522194|Sevoflurane|sevoflurane|mesh-list
19432737|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19432738|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714205|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
19714206|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714207|NCT04749641|Vaccines|vaccines|mesh-list
20250415|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250416|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250417|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20250418|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250419|NCT00445016|Anesthetics|anesthetics|mesh-list
20250420|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250421|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250422|NCT00445042|Sorafenib|sorafenib|mesh-list
20250423|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714208|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
19714209|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714210|NCT04749394|Apatinib|apatinib|mesh-list
19714211|NCT04749394|Antibodies|antibodies|mesh-list
19714212|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
19714213|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19714214|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
19714215|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714216|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714217|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714218|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714219|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714220|NCT04749602|Nivolumab|nivolumab|mesh-list
19432739|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432740|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19432741|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
19432742|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
19432743|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19432744|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19432745|NCT03522181|Insulin|insulin|mesh-list
19432746|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19432747|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19432748|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432749|NCT03522168|Risperidone|risperidone|mesh-list
19432750|NCT03522168|Aripiprazole|aripiprazole|mesh-list
19432751|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19432752|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
19432753|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432754|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432755|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432756|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19432757|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432758|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432759|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432760|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19432761|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
19432762|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
20250424|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714221|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432763|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
19432764|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19432765|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19432766|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19432767|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19432768|NCT03522077|Hemostatics|hemostatics|mesh-list
19432769|NCT03522077|Coagulants|coagulants|mesh-ancestor
19432770|NCT03522051|Calcium|calcium|mesh-list
19432771|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19432772|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432773|NCT03521960|Buspirone|buspirone|mesh-list
19432774|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19432775|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432776|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714222|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714223|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20250425|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432777|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432778|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432779|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19432780|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
19432781|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432782|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432783|NCT03521895|Aflibercept|aflibercept|mesh-list
19432784|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19432785|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19432786|NCT03521895|Growth Substances|growth substances|mesh-ancestor
19432787|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432788|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
19432789|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432790|NCT03521726|Amoxicillin|amoxicillin|mesh-list
19432791|NCT03521726|Rabeprazole|rabeprazole|mesh-list
19432792|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250426|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250427|NCT00445055|Droperidol|droperidol|mesh-list
19432793|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432794|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19432795|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19714224|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714225|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19714226|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
20250428|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20250429|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
20250430|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
20250431|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250432|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250433|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250434|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20250435|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20250436|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250437|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20250438|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20250439|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20250440|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
20250441|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250442|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532507|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20532508|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20532509|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20532510|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532511|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20532512|NCT01801228|Eplerenone|eplerenone|mesh-list
20532513|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20532514|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
20250443|NCT00445081|Cyclosporine|cyclosporine|mesh-list
20250444|NCT00445081|Prednisolone|prednisolone|mesh-list
20250445|NCT00445081|Cyclosporins|cyclosporins|mesh-list
20250446|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250447|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
20250448|NCT00445081|Hormones|hormones|mesh-ancestor
20250449|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250450|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250451|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20250452|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250453|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250454|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432796|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19432797|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432798|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432799|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
19432800|NCT03521713|Hematinics|hematinics|mesh-ancestor
19432801|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19432802|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19432803|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19432804|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
19432805|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432806|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20250455|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250456|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
20250457|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
20250458|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250459|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
20250460|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432807|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19432808|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451368|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19451369|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
19451370|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19714227|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714228|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
19714229|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19714230|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
19714231|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
19714232|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714233|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714234|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19714235|NCT04749043|Analgesics|analgesics|mesh-ancestor
19714236|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
19714237|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451371|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19451372|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451373|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19451374|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19451375|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19451376|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
19451377|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19451378|NCT03421860|Protective Agents|protective agents|mesh-ancestor
19451379|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19451380|NCT03421821|Ropivacaine|ropivacaine|mesh-list
19432809|NCT03521492|Vitamin D|vitamin d|mesh-list
19432810|NCT03521492|Calcium|calcium|mesh-list
19432811|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
19432812|NCT03521492|Hormones|hormones|mesh-list
19432813|NCT03521492|Vitamins|vitamins|mesh-ancestor
19432814|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
19432815|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432816|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19432817|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19714238|NCT04749069|Remifentanil|remifentanil|mesh-list
19714239|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19714240|NCT04749069|Narcotics|narcotics|mesh-ancestor
19714241|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714242|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714243|NCT04749069|Analgesics|analgesics|mesh-ancestor
19714244|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
19714245|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714246|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
19858379|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19858380|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432818|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432819|NCT03521414|Sevoflurane|sevoflurane|mesh-list
19432820|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19432821|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19432822|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
19432823|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
19432824|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250461|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20250462|NCT00445094|Vancomycin|vancomycin|mesh-list
20250463|NCT00445094|Imipenem|imipenem|mesh-list
20250464|NCT00445094|Amikacin|amikacin|mesh-list
20250465|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20250466|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
20250467|NCT00445094|Cilastatin|cilastatin|mesh-list
20250468|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250469|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250470|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250471|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
20250472|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714247|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19858381|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19858382|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19858383|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858384|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
19714248|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
19714249|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714250|NCT04748887|Protective Agents|protective agents|mesh-ancestor
19714251|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714252|NCT04748562|Progesterone|progesterone|mesh-list
19714253|NCT04748562|Progestins|progestins|mesh-ancestor
19714254|NCT04748562|Hormones|hormones|mesh-ancestor
19714255|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714256|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714257|NCT04748822|Ethanol|ethanol|mesh-list
19714258|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19858385|NCT00771927|Lacosamide|lacosamide|mesh-list
19714259|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858386|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
20250473|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20250474|NCT00445159|Treprostinil|treprostinil|mesh-list
20250475|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19432825|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532515|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432826|NCT03521245|Trastuzumab|trastuzumab|mesh-list
19432827|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19432828|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714260|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714261|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714262|NCT04748757|Annexin A5|annexin a5|mesh-list
19714263|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714264|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714265|NCT04748796|Landiolol|landiolol|mesh-list
19714266|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19714267|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19714268|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714269|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714270|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714271|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714272|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19714273|NCT04748276|Norepinephrine|norepinephrine|mesh-list
19714274|NCT04748276|Serotonin|serotonin|mesh-list
19858387|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19432829|NCT03521219|Apatinib|apatinib|mesh-list
19432830|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714275|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19858388|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19858389|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858390|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858391|NCT00771953|Docetaxel|docetaxel|mesh-list
19858392|NCT00771953|Pemetrexed|pemetrexed|mesh-list
19858393|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858394|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19858395|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19858396|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
19858397|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858398|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858399|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19858400|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19858401|NCT00772005|Modafinil|modafinil|mesh-list
19858402|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19858403|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714276|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19858404|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19858405|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19858406|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19858407|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858408|NCT00772031|Topiramate|topiramate|mesh-list
19858409|NCT00772031|Propranolol|propranolol|mesh-list
19858410|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19858411|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19858412|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858413|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858414|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858415|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858416|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19858417|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19858418|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
19858419|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
19858420|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19858421|NCT00772070|Vaccines|vaccines|mesh-list
19858422|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
19858423|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858424|NCT00772109|Vaccines|vaccines|mesh-list
19858425|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
20250476|NCT00445185|Vaccines|vaccines|mesh-list
19714277|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19714278|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714279|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858426|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250477|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
20250478|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858427|NCT00772148|Tacrolimus|tacrolimus|mesh-list
20250479|NCT00445250|Calcipotriene|calcipotriene|mesh-list
19432831|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20250480|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
20250481|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
20250482|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432832|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432833|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432834|NCT03521167|Acetaminophen|acetaminophen|mesh-list
19432835|NCT03521167|Lidocaine|lidocaine|mesh-list
19432836|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
19432837|NCT03521167|Ketamine|ketamine|mesh-list
19432838|NCT03521167|Gabapentin|gabapentin|mesh-list
20532516|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532517|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20532518|NCT01801228|Diuretics|diuretics|mesh-ancestor
20532519|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
20532520|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20532521|NCT01801410|Misoprostol|misoprostol|mesh-list
20532522|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20532523|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
20532524|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20532525|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532526|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20532527|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20532528|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
20532529|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
20532530|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532531|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
19432839|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
19432840|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
19432841|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432842|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432843|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
19432844|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432845|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19432846|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19432847|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19432848|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19432849|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432850|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19432851|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432852|NCT03521167|Analgesics|analgesics|mesh-ancestor
19432853|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19432854|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19432855|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19432856|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
19432857|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714280|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714281|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714282|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
19714283|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
19714284|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714285|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19714286|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19714287|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
19714288|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19714289|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19714290|NCT04748341|Benzocaine|benzocaine|mesh-list
19714291|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
19714292|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
19714293|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714294|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714295|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
19714296|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714297|NCT04748419|Durvalumab|durvalumab|mesh-list
19714298|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714299|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714300|NCT04748042|Prednisone|prednisone|mesh-list
19714301|NCT04748042|Olaparib|olaparib|mesh-list
19714302|NCT04748042|Androgens|androgens|mesh-list
19714303|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714304|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
19714305|NCT04748042|Hormones|hormones|mesh-ancestor
19714306|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714307|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714308|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714309|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714310|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19714311|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714312|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734054|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734055|NCT04555291|Ropivacaine|ropivacaine|mesh-list
19734056|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
19734057|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
19734058|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734059|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734060|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
19734061|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432858|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19432859|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19432860|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
19432861|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19432862|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19432863|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
19432864|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19432865|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432866|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432867|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
19432868|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
19714313|NCT04747678|Ivermectin|ivermectin|mesh-list
19714314|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19714315|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714316|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
19858428|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19432869|NCT03521063|Budesonide|budesonide|mesh-list
19432870|NCT03521063|Poractant alfa|poractant alfa|mesh-list
19714317|NCT04747795|Vitamins|vitamins|mesh-ancestor
19714318|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
19432871|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714319|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714320|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
19714321|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714322|NCT04747795|Protective Agents|protective agents|mesh-ancestor
19714323|NCT04747392|Teriparatide|teriparatide|mesh-list
19714324|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19714325|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714326|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19714327|NCT04747301|Dinoprostone|dinoprostone|mesh-list
19714328|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
19714329|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19714330|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714331|NCT04747015|Oxytocin|oxytocin|mesh-list
19714332|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
19714333|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19432872|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19432873|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
19432874|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432875|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432876|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19432877|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
19432878|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
19432879|NCT03521063|Hormones|hormones|mesh-ancestor
19714334|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858429|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
20250483|NCT00445406|Bevacizumab|bevacizumab|mesh-list
19432880|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250484|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20250485|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250486|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20250487|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20250488|NCT00445406|Growth Substances|growth substances|mesh-ancestor
20250489|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250490|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
19714335|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
19714336|NCT04746937|Norfloxacin|norfloxacin|mesh-list
19714337|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19714338|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432881|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19432882|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
19432883|NCT03521024|Ether|ether|mesh-list
20250491|NCT00445497|Amoxicillin|amoxicillin|mesh-list
20250492|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
19432884|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
19432885|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19432886|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432887|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432888|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
19714339|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19714340|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19714341|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19714342|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532532|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432889|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19432890|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19432891|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432892|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19432893|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
19432894|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
19432895|NCT03520985|Dexamethasone|dexamethasone|mesh-list
19432896|NCT03520985|Pomalidomide|pomalidomide|mesh-list
19432897|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432898|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
19432899|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
19432900|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432901|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432902|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19432903|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
19432904|NCT03520985|Hormones|hormones|mesh-ancestor
19432905|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432906|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19432907|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432908|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
19432909|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19432910|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19432911|NCT03520985|Growth Substances|growth substances|mesh-ancestor
19432912|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
19432913|NCT03520946|Ramucirumab|ramucirumab|mesh-list
19432914|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432915|NCT03520595|Diclofenac|diclofenac|mesh-list
19432916|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19714343|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714344|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250493|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
19714345|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19714346|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19714347|NCT04747080|Dexamethasone|dexamethasone|mesh-list
19714348|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
19714349|NCT04747080|BB 1101|bb 1101|mesh-list
19714350|NCT04747080|Tacrolimus|tacrolimus|mesh-list
19714351|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714352|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
19432917|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19432918|NCT03520595|Analgesics|analgesics|mesh-ancestor
19432919|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
19432920|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432921|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432922|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19432923|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19432924|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19432925|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432926|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432927|NCT03520543|Clonidine|clonidine|mesh-list
19432928|NCT03520543|Yohimbine|yohimbine|mesh-list
19432929|NCT03520543|Analgesics|analgesics|mesh-ancestor
19432930|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
19432931|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19432932|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432933|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19432934|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
19432935|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
19432936|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19432937|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19432938|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19432939|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
19432940|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19432941|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432942|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
19432943|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19432944|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19432945|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19432946|NCT03520543|Urological Agents|urological agents|mesh-ancestor
19432947|NCT03520478|Bicalutamide|bicalutamide|mesh-list
19432948|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
19714353|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
19714354|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858430|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432949|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
19451381|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
19714355|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432950|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432951|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432952|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432953|NCT03520439|Mifepristone|mifepristone|mesh-list
20250494|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
19432954|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19432955|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
19432956|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19432957|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432958|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19432959|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20250495|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20250496|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250497|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250498|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20250499|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20250500|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432960|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19432961|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
19432962|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19432963|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19432964|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
19432965|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432966|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
19432967|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19432968|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19432969|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19432970|NCT03520257|Apatinib|apatinib|mesh-list
19432971|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19432972|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19432973|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432974|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19432975|NCT03520062|Liraglutide|liraglutide|mesh-list
19432976|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19432977|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19432978|NCT03520062|Incretins|incretins|mesh-ancestor
19432979|NCT03520062|Hormones|hormones|mesh-ancestor
19432980|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19432981|NCT03520049|Oseltamivir|oseltamivir|mesh-list
19432982|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
19432983|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19432984|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19432985|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858431|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19858432|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858433|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858434|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19858435|NCT00772304|Azelastine|azelastine|mesh-list
19858436|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19858437|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19858438|NCT00772304|Analgesics|analgesics|mesh-ancestor
19858439|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
19858440|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858441|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858442|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858443|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858444|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19858445|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19858446|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19858447|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
19858448|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
19858449|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433005|NCT03519776|Progesterone|progesterone|mesh-list
19433006|NCT03519776|Progestins|progestins|mesh-ancestor
19433007|NCT03519776|Hormones|hormones|mesh-ancestor
19433008|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433009|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433010|NCT03519750|Melatonin|melatonin|mesh-list
19433011|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
20250501|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250502|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250503|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19975496|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20250504|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19714356|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19714357|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
19714358|NCT04747080|Hormones|hormones|mesh-ancestor
19714359|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714360|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714361|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714362|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
19714363|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714364|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714365|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250505|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20250506|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
20250507|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20532533|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532534|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20532535|NCT01801644|Gemcitabine|gemcitabine|mesh-list
20532536|NCT01801644|Cisplatin|cisplatin|mesh-list
19714366|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
19714367|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19714368|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
19714369|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19714370|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532537|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532538|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532539|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
20532540|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532541|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
19714371|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532542|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433012|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433013|NCT03519750|Protective Agents|protective agents|mesh-ancestor
19433014|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433015|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433016|NCT03519724|Neostigmine|neostigmine|mesh-list
19433017|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19433018|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433019|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433020|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
20250508|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20250509|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250510|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250511|NCT00445523|Interferons|interferons|mesh-list
20250512|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
20250513|NCT00445523|Vaccines|vaccines|mesh-list
20250514|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532543|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532544|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532545|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
20532546|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532547|NCT01801774|Triamcinolone|triamcinolone|mesh-list
20532548|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20532549|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20532550|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20532551|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250515|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
20250516|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250517|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
20250518|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250519|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
20250520|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
20532552|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
20532553|NCT01801774|Hormones|hormones|mesh-ancestor
20532554|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20532555|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532556|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532557|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
20250521|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20250522|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250523|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250524|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250525|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250526|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20250527|NCT00445796|Artesunate|artesunate|mesh-list
20250528|NCT00445796|Amodiaquine|amodiaquine|mesh-list
20250529|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
20250530|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20250531|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20250532|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250533|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250534|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
20250535|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
20250536|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20250537|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
19714372|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19714373|NCT04747171|Analgesics|analgesics|mesh-ancestor
19714374|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
19714375|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250538|NCT00445861|Docetaxel|docetaxel|mesh-list
19714376|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19714377|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19714378|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19714379|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714380|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734062|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20250539|NCT00445861|Cetuximab|cetuximab|mesh-list
20250540|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250541|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
20250542|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
20250543|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
20250544|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250545|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20250546|NCT00445874|Ketotifen|ketotifen|mesh-list
20250547|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
20250548|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
20250549|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19975497|NCT01849692|Growth Substances|growth substances|mesh-ancestor
19433021|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433022|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433023|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19433024|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
19433025|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433026|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
19433027|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19433028|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451382|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
19451383|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451384|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451385|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
19451386|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451387|NCT03421743|Molgramostim|molgramostim|mesh-list
19451388|NCT03421743|Sargramostim|sargramostim|mesh-list
19451389|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451390|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
19451391|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451392|NCT03421717|Chitosan|chitosan|mesh-list
19714381|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714382|NCT04747145|Temozolomide|temozolomide|mesh-list
19714383|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19714384|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
19714385|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714386|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714387|NCT04746430|Dexamethasone|dexamethasone|mesh-list
19858450|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858451|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19858452|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
19858453|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19858454|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19714388|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714389|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
19714390|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
19714391|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714392|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714393|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19714394|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
19714395|NCT04746430|Hormones|hormones|mesh-ancestor
19734063|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
19858455|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20532558|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532559|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532560|NCT01801904|Panitumumab|panitumumab|mesh-list
20532561|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20532562|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553350|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
20553351|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553352|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
20553353|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553354|NCT01928875|Anesthetics|anesthetics|mesh-list
20553355|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553356|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553357|NCT01928888|Famotidine|famotidine|mesh-list
19451393|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19451394|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19714396|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714397|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714398|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858456|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858457|NCT00772447|Vancomycin|vancomycin|mesh-list
19858458|NCT00772447|Daptomycin|daptomycin|mesh-list
20250550|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
20250551|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
20250552|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250553|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250554|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250555|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20250556|NCT00445900|Thalidomide|thalidomide|mesh-list
20250557|NCT00445900|Prednisone|prednisone|mesh-list
20250558|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
20250559|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433029|NCT03519646|Eliglustat|eliglustat|mesh-list
19433030|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433031|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433032|NCT03519633|Neostigmine|neostigmine|mesh-list
19433033|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19433034|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433035|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433036|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
19433037|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250560|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
20250561|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714399|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
19858459|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19858460|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858461|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
19858462|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19858463|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
19858464|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858465|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858466|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19858467|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
19858468|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
19858469|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19858470|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
19858471|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858472|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858473|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19858474|NCT00772577|Ramipril|ramipril|mesh-list
19858475|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19858476|NCT00772577|Diuretics|diuretics|mesh-ancestor
19858477|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
19858478|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858479|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19858480|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858481|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858482|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19858483|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
19858484|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858485|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
19858486|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19858487|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19858488|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
19858489|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858490|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19858491|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19858492|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858493|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858494|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
19858495|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
19858496|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19858497|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19714400|NCT04746365|Ivermectin|ivermectin|mesh-list
19858498|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250562|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19714401|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
19714402|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19714403|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19734064|NCT04554979|Anticoagulants|anticoagulants|mesh-list
19714404|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433038|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433039|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19433040|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
19433041|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433042|NCT03519568|Vaccines|vaccines|mesh-list
19433043|NCT03519568|Immunologic Factors|immunologic factors|mesh-ancestor
19433044|NCT03519568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433045|NCT03519542|Sunitinib|sunitinib|mesh-list
19433046|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433047|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19433048|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19433049|NCT03519542|Growth Substances|growth substances|mesh-ancestor
19433050|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433051|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
19433052|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19433053|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433054|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433055|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
19433056|NCT03519412|Temozolomide|temozolomide|mesh-list
19433057|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19433058|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433059|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433060|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
19433061|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433062|NCT03519386|Travoprost|travoprost|mesh-list
19433063|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19433064|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19433065|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19433066|NCT03519152|Diclofenac|diclofenac|mesh-list
19714405|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714406|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714407|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19714408|NCT04746339|Apixaban|apixaban|mesh-list
19714409|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19714410|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
19714411|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20250563|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433067|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19433068|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19714412|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
19714413|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714414|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714415|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
19714416|NCT04746209|Blinatumomab|blinatumomab|mesh-list
19433069|NCT03519152|Analgesics|analgesics|mesh-ancestor
19433070|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
19433071|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433072|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433073|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19433074|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433075|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19433076|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433077|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433078|NCT03519061|Budesonide|budesonide|mesh-list
19433079|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714417|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714418|NCT04746040|Fluticasone|fluticasone|mesh-list
19714419|NCT04746040|Xhance|xhance|mesh-list
20532563|NCT01802255|Midazolam|midazolam|mesh-list
20532564|NCT01802255|Sevoflurane|sevoflurane|mesh-list
19433080|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19433081|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
19433082|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433083|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433084|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19433085|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
19433086|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
19433087|NCT03519061|Hormones|hormones|mesh-ancestor
19451395|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
19451396|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451397|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19451398|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
19714420|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19714421|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20250564|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
20532565|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20532566|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20532567|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532568|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532569|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20532570|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20532571|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20532572|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20532573|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
20532574|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
19451399|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
19451400|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
19451401|NCT03421717|Coagulants|coagulants|mesh-ancestor
19451402|NCT03421496|Cannabidiol|cannabidiol|mesh-list
19451403|NCT03421496|Vigabatrin|vigabatrin|mesh-list
19451404|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
19714422|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714423|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19714424|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
19714425|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714426|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714427|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19858499|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714428|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
19714429|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
19858500|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19858501|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19858502|NCT00772668|Prednisone|prednisone|mesh-list
19858503|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
19858504|NCT00772668|Rituximab|rituximab|mesh-list
20250565|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250566|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250567|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20250568|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250569|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
19714430|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20250570|NCT00445900|Hormones|hormones|mesh-ancestor
19714431|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19714432|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19714433|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19714434|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714435|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714436|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714437|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
19714438|NCT04746040|Hormones|hormones|mesh-ancestor
19714439|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714440|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
19433088|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433089|NCT03519022|Cocaine|cocaine|mesh-list
19714441|NCT04745780|Inositol|inositol|mesh-list
19858505|NCT00772668|Bortezomib|bortezomib|mesh-list
19858506|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858507|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
19858508|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858509|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858510|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19858511|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
19858512|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433090|NCT03519022|Methylphenidate|methylphenidate|mesh-list
19433091|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19433092|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433093|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19433094|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19433095|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19451405|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451406|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451407|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
19858513|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858514|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19858515|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858516|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858517|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
19858518|NCT00772668|Hormones|hormones|mesh-ancestor
19452790|NCT03410524|Emollients|emollients|mesh-ancestor
19714442|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
19714443|NCT04745780|Vitamins|vitamins|mesh-ancestor
19714444|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
19714445|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714446|NCT04745663|Iodine|iodine|mesh-list
19714447|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
19714448|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
19714449|NCT04745663|Povidone|povidone|mesh-list
19858519|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858520|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19858521|NCT00772772|Vitamin D|vitamin d|mesh-list
19858522|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
19858523|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
19858524|NCT00772772|Vitamins|vitamins|mesh-list
19858525|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
19714450|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19858526|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714451|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250571|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250572|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714452|NCT04745663|Trace Elements|trace elements|mesh-ancestor
19714453|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
20250573|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
20250574|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250575|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250576|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20250577|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20250578|NCT00445900|Growth Substances|growth substances|mesh-ancestor
20250579|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
20250580|NCT00445965|Antibodies|antibodies|mesh-list
20250581|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19433096|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433097|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
19433098|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433099|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
19433100|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
19433101|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433102|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
19433103|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433104|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19433105|NCT03518801|Cannabidiol|cannabidiol|mesh-list
19433106|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
19433107|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19433108|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19433109|NCT03518528|Estradiol|estradiol|mesh-list
19433110|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19433111|NCT03518528|Estrogens|estrogens|mesh-ancestor
19433112|NCT03518528|Hormones|hormones|mesh-ancestor
19714454|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433113|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433114|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433115|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19433116|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
19433117|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19433118|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19433119|NCT03518502|Sorafenib|sorafenib|mesh-list
19433120|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433121|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19433122|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433123|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433124|NCT03518489|Lappaconitine|lappaconitine|mesh-list
19433125|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19433126|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433127|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19433128|NCT03518489|Analgesics|analgesics|mesh-ancestor
19433129|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
19433130|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433131|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433132|NCT03518320|Gemcitabine|gemcitabine|mesh-list
19714455|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
19714456|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
19734065|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734066|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
19734067|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19734068|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19734069|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734070|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250582|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
19433133|NCT03518320|Nivolumab|nivolumab|mesh-list
19734071|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433134|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19714457|NCT04745260|Fentanyl|fentanyl|mesh-list
19714458|NCT04745260|Midazolam|midazolam|mesh-list
19714459|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19433135|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
19433136|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433137|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433138|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
19433139|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433140|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250583|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250584|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
19714460|NCT04745260|Narcotics|narcotics|mesh-ancestor
19714461|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714462|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714463|NCT04745260|Analgesics|analgesics|mesh-ancestor
20250585|NCT00446004|Omeprazole|omeprazole|mesh-list
20250586|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20250587|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250588|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20250589|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433141|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433142|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
19433143|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433144|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19433145|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19433146|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
19433147|NCT03518112|Leucovorin|leucovorin|mesh-list
19433148|NCT03518112|Folic Acid|folic acid|mesh-list
19433149|NCT03518112|Cytarabine|cytarabine|mesh-list
19433150|NCT03518112|Dexamethasone|dexamethasone|mesh-list
19433151|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
19433152|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
19433153|NCT03518112|Rituximab|rituximab|mesh-list
19433154|NCT03518112|Methotrexate|methotrexate|mesh-list
19433155|NCT03518112|Vincristine|vincristine|mesh-list
19433156|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
19433157|NCT03518112|Blinatumomab|blinatumomab|mesh-list
19433158|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19433159|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
19433160|NCT03518112|Antibodies|antibodies|mesh-list
19433161|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
19433162|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19433163|NCT03518112|Lenograstim|lenograstim|mesh-list
19433164|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19433165|NCT03518112|BB 1101|bb 1101|mesh-list
19433166|NCT03518112|Calcium|calcium|mesh-list
19433167|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
19433168|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433169|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
19433170|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714464|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
20250590|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250591|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19433171|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250592|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250593|NCT00446017|Milrinone|milrinone|mesh-list
20250594|NCT00446017|Epinephrine|epinephrine|mesh-list
19433172|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433173|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
19433174|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433175|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433176|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19433177|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19433178|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
19433179|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
19433180|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433181|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19433182|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
19433183|NCT03518112|Hormones|hormones|mesh-ancestor
20250595|NCT00446017|Racepinephrine|racepinephrine|mesh-list
20250596|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
20250597|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20250598|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20250599|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250600|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250601|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250602|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250603|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20250604|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20250605|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
19433184|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433185|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19433186|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19433187|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433188|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19433189|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19433190|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19433191|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
19433192|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19433193|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19714465|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714466|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19714467|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19714468|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
19714469|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
19714470|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19858527|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19858528|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19858529|NCT00772915|Dexamethasone|dexamethasone|mesh-list
19858530|NCT00772915|Lenalidomide|lenalidomide|mesh-list
19858531|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858532|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
19858533|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
19858534|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858535|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858536|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858537|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
19858538|NCT00772915|Hormones|hormones|mesh-ancestor
19858539|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858540|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19858541|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858542|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
19858543|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19858544|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19858545|NCT00772915|Growth Substances|growth substances|mesh-ancestor
20250606|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250607|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19714471|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19714472|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19714473|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19714474|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
19714475|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
19714476|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714477|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433194|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
19433195|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
19433196|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19433197|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19433198|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
19433199|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433200|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19433201|NCT03518112|Antidotes|antidotes|mesh-ancestor
19433202|NCT03518112|Protective Agents|protective agents|mesh-ancestor
20250608|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
20250609|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
20250610|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
20250611|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20250612|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20250613|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19433203|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
19433204|NCT03518112|Vitamins|vitamins|mesh-ancestor
19433205|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
19433206|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19433207|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
19433208|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
19433209|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
19433210|NCT03518112|Hematinics|hematinics|mesh-ancestor
19433211|NCT03518021|Naloxone|naloxone|mesh-list
19433212|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19433213|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433214|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
19433215|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433216|NCT03517995|Sulforaphane|sulforaphane|mesh-list
19433217|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19433218|NCT03517995|Protective Agents|protective agents|mesh-ancestor
19433219|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714478|NCT04745286|Ketamine|ketamine|mesh-list
19714479|NCT04745286|Esketamine|esketamine|mesh-list
19714480|NCT04745286|Analgesics|analgesics|mesh-ancestor
19714481|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
19433220|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433221|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
19433222|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19714482|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714483|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714484|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19714485|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19714486|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
19714487|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
19714488|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714489|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19714490|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19714491|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734072|NCT04554654|Progesterone|progesterone|mesh-list
20250614|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
19433223|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433224|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19433225|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
19433226|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19433227|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433228|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433229|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433230|NCT03517943|Loratadine|loratadine|mesh-list
19433231|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
19433232|NCT03517943|Ephedrine|ephedrine|mesh-list
19433233|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
19433234|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
19433235|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19433236|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19433237|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19433238|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
19433239|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
19433240|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433241|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433242|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714492|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714493|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
19714494|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19714495|NCT04745273|Ondansetron|ondansetron|mesh-list
19714496|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
19714497|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
19433243|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19433244|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
19433245|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250615|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19433246|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19433247|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
19433248|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
19433249|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19433250|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19433251|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
19433252|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
19433253|NCT03517930|Loratadine|loratadine|mesh-list
19433254|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
19714498|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714499|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714500|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19714501|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
19714502|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
19714503|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19714504|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
19714505|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714506|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714507|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19714508|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19714509|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714510|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19714511|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19714512|NCT04745442|Antithrombins|antithrombins|mesh-list
19714513|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
19714514|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19714515|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
19714516|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714517|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714518|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
19714519|NCT04745377|Antibodies|antibodies|mesh-list
19714520|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
19714521|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714522|NCT04744883|Naloxone|naloxone|mesh-list
19714523|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19714524|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714525|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
19714526|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714527|NCT04745130|Cetuximab|cetuximab|mesh-list
19714528|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858546|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
19858547|NCT00772928|Vaccines|vaccines|mesh-list
19858548|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19858549|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
19858550|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858551|NCT00772941|Varenicline|varenicline|mesh-list
19858552|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19858553|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19858554|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
19858555|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858556|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858557|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433255|NCT03517930|Ephedrine|ephedrine|mesh-list
19858558|NCT00772954|Vaccines|vaccines|mesh-list
19858559|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
19858560|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858561|NCT00772967|Naproxen|naproxen|mesh-list
19858562|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19858563|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19858564|NCT00772967|Analgesics|analgesics|mesh-ancestor
19858565|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
19858566|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433256|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
19433257|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
19433258|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19433259|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19433260|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19433261|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
19433262|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
19433263|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433264|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714529|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714530|NCT04744753|Calcium|calcium|mesh-list
19714531|NCT04744753|Ionophores|ionophores|mesh-list
19714532|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
19714533|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19714534|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433265|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433266|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19433267|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
19433268|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433269|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19433270|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
19433271|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
19433272|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19433273|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19433274|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
19433275|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
19451408|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451409|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451410|NCT03421483|Folic Acid|folic acid|mesh-list
19451411|NCT03421483|Hematinics|hematinics|mesh-ancestor
19451412|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
19451413|NCT03421483|Vitamins|vitamins|mesh-ancestor
19451414|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
19451415|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714535|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19714536|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451416|NCT03421366|Posaconazole|posaconazole|mesh-list
19451417|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
19451418|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451419|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19451420|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19451421|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19451422|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19451423|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19451424|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451425|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451426|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19451427|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
19451428|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19451429|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451430|NCT03421314|Selenium|selenium|mesh-list
19451431|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
19451432|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451433|NCT03421314|Protective Agents|protective agents|mesh-ancestor
19451434|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451435|NCT03421314|Trace Elements|trace elements|mesh-ancestor
19451436|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
19451437|NCT03421275|Fentanyl|fentanyl|mesh-list
19451438|NCT03421275|Esketamine|esketamine|mesh-list
19451439|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19451440|NCT03421275|Narcotics|narcotics|mesh-ancestor
19451441|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451442|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451443|NCT03421275|Analgesics|analgesics|mesh-ancestor
19451444|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
19451445|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451446|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19451447|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19451448|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
19451449|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
19451450|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
19451451|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433276|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19433277|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19714537|NCT04744727|Acetaminophen|acetaminophen|mesh-list
19714538|NCT04744727|Meperidine|meperidine|mesh-list
19714539|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19714540|NCT04744727|Analgesics|analgesics|mesh-ancestor
19714541|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
19714542|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714543|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714544|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
19714545|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19714546|NCT04744727|Narcotics|narcotics|mesh-ancestor
19714547|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714548|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19714549|NCT04744649|Fluorouracil|fluorouracil|mesh-list
19714550|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
19714551|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714552|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19714553|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714554|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714555|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
19858567|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433278|NCT03517683|Methamphetamine|methamphetamine|mesh-list
19433279|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19433280|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433281|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
19433282|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
19714556|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714557|NCT04744675|Triamcinolone|triamcinolone|mesh-list
19858568|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858569|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858570|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
19858571|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19858572|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858573|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858574|NCT00773097|Poly ICLC|poly iclc|mesh-list
19858575|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
19858576|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
19858577|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858578|NCT00773136|Bimatoprost|bimatoprost|mesh-list
19714558|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19858579|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19433283|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433284|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
19433285|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433286|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433287|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
19433288|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19433289|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19433290|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433291|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19433292|NCT03517670|Milrinone|milrinone|mesh-list
19433293|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19433294|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19433295|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
19433296|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19433297|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19433298|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433299|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433300|NCT03517670|Protective Agents|protective agents|mesh-ancestor
19433301|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433302|NCT03517631|Busulfan|busulfan|mesh-list
19433303|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
19433304|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433305|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433306|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
19433307|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433308|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433309|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433310|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19433311|NCT03517618|Leucovorin|leucovorin|mesh-list
20250616|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19858580|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
19858581|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20250617|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250618|NCT00446017|Protective Agents|protective agents|mesh-ancestor
20250619|NCT00446043|Adapalene|adapalene|mesh-list
20250620|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20250621|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20250622|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
20250623|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20250624|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20250625|NCT00446043|Analgesics|analgesics|mesh-ancestor
20250626|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
20250627|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250628|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250629|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250630|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250631|NCT00446069|Morphine|morphine|mesh-list
20250632|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20250633|NCT00446069|Narcotics|narcotics|mesh-ancestor
20250634|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433312|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433313|NCT03517618|Antidotes|antidotes|mesh-ancestor
19433314|NCT03517618|Protective Agents|protective agents|mesh-ancestor
20250635|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250636|NCT00446069|Analgesics|analgesics|mesh-ancestor
20250637|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
20250638|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433315|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
20250639|NCT00446082|Pasireotide|pasireotide|mesh-list
20250640|NCT00446082|Hormones|hormones|mesh-ancestor
20250641|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250642|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433316|NCT03517618|Vitamins|vitamins|mesh-ancestor
20250643|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
20250644|NCT00446173|Busulfan|busulfan|mesh-list
20250645|NCT00446173|Sargramostim|sargramostim|mesh-list
20250646|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250647|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
19433317|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
19433318|NCT03517462|Ivermectin|ivermectin|mesh-list
19433319|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19433320|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433321|NCT03517423|Brivaracetam|brivaracetam|mesh-list
19433322|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
19433323|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
19433324|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19433325|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19433326|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19433327|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433328|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433329|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
19433330|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433331|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433332|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19433333|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433334|NCT03517176|Gemcitabine|gemcitabine|mesh-list
19433335|NCT03517176|Paclitaxel|paclitaxel|mesh-list
19433336|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19433337|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433338|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
19433339|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
19433340|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
19714559|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19714560|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19714561|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714562|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
19714563|NCT04744675|Hormones|hormones|mesh-ancestor
19714564|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433341|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433342|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19433343|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
19433344|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
19433345|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714565|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714566|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714567|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
19714568|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714569|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714570|NCT04744480|Anesthetics|anesthetics|mesh-list
19714571|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714572|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858582|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19858583|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19858584|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858585|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858586|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
19858587|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858588|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858589|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19858590|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858591|NCT00773292|Cyclosporine|cyclosporine|mesh-list
19858592|NCT00773292|Cyclosporins|cyclosporins|mesh-list
20250648|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250649|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19714573|NCT04744545|Curcumin|curcumin|mesh-list
19714574|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19858593|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858594|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858595|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858596|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
19858597|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858598|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
19858599|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858600|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
19433346|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433347|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433348|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
19433349|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433350|NCT03517033|Nebivolol|nebivolol|mesh-list
19433351|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19433352|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
19433353|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19433354|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19714575|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19714576|NCT04744545|Analgesics|analgesics|mesh-ancestor
19714577|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
19714578|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714579|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714580|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714581|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19714582|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433355|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19433356|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
20250650|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20250651|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
20250652|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714583|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714584|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433357|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433358|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433359|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433360|NCT03517020|Nebivolol|nebivolol|mesh-list
19433361|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19433362|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
19433363|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19714585|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19714586|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433364|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19714587|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
19714588|NCT04744623|Dapsone|dapsone|mesh-list
19714589|NCT04744623|Prednisolone|prednisolone|mesh-list
19714590|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19714591|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
19714592|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19714593|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
19714594|NCT04744623|Triamcinolone|triamcinolone|mesh-list
19714595|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19714596|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19714597|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19714598|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19714599|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
19714600|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19714601|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714602|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19714603|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
19714604|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19714605|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714606|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714607|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714608|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714609|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
19714610|NCT04744623|Hormones|hormones|mesh-ancestor
19714611|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714612|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714613|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714614|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
19714615|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
19714616|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714617|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250653|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250654|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20250655|NCT00446212|Propofol|propofol|mesh-list
20250656|NCT00446212|Desflurane|desflurane|mesh-list
20250657|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20250658|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250659|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250660|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20250661|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
20250662|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
20250663|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20250664|NCT00446225|Gemcitabine|gemcitabine|mesh-list
20250665|NCT00446225|Carboplatin|carboplatin|mesh-list
20250666|NCT00446225|Docetaxel|docetaxel|mesh-list
20250667|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20250668|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250669|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19433365|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19433366|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
19433367|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433368|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433369|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433370|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
19433371|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250670|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
20532575|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
20532576|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
20532577|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532578|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532579|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20532580|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20532581|NCT01802268|Sirolimus|sirolimus|mesh-list
20532582|NCT01802268|Tacrolimus|tacrolimus|mesh-list
20532583|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532584|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
20532585|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532586|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20532587|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553358|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
20553359|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20553360|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553361|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20553362|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
20553363|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
20553364|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553365|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553366|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553367|NCT01928888|Antacids|antacids|mesh-ancestor
19714618|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19714619|NCT04744623|Protective Agents|protective agents|mesh-ancestor
19714620|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714621|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
19714622|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
19714623|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19714624|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19714625|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19714626|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
19714627|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19714628|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19714629|NCT04744571|Aspirin|aspirin|mesh-list
20250671|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250672|NCT00446225|Antiviral Agents|antiviral agents|mesh-ancestor
20250673|NCT00446225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250674|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250675|NCT00446225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250676|NCT00446225|Immunologic Factors|immunologic factors|mesh-ancestor
20250677|NCT00446225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250678|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
20250679|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
20250680|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
20250681|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20250682|NCT00446303|Azacitidine|azacitidine|mesh-list
20250683|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20250684|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
20250685|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250686|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714630|NCT04744571|Metoprolol|metoprolol|mesh-list
19714631|NCT04744571|Clopidogrel|clopidogrel|mesh-list
19714632|NCT04744571|Ticagrelor|ticagrelor|mesh-list
19714633|NCT04744571|Atorvastatin|atorvastatin|mesh-list
19714634|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20250687|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433372|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433373|NCT03516968|Vitamins|vitamins|mesh-ancestor
19433374|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
19433375|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19433376|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19433377|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19433378|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19433379|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
19433380|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433381|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19433382|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19433383|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714635|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19433384|NCT03516903|Folic Acid|folic acid|mesh-list
19433385|NCT03516903|Methotrexate|methotrexate|mesh-list
19433386|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19858601|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858602|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19858603|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19858604|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858605|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19858606|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858607|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858608|NCT00773422|Naltrexone|naltrexone|mesh-list
19858609|NCT00773422|Varenicline|varenicline|mesh-list
19858610|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19858611|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20250688|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
20250689|NCT00446316|Antacids|antacids|mesh-list
20250690|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250691|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19433387|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
19433388|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19433389|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433390|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19433391|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
19433392|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433393|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433394|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
19433395|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433396|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19714636|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19714637|NCT04744571|Analgesics|analgesics|mesh-ancestor
19714638|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
19714639|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714640|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714641|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714642|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19714643|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19714644|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19714645|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714646|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19714647|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19714648|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714649|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
19714650|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19714651|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19714652|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
19714653|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19734073|NCT04554654|Progestins|progestins|mesh-ancestor
19858612|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858613|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
19858614|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858615|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19858616|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19858617|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
19858618|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858619|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858620|NCT00773474|Lonafarnib|lonafarnib|mesh-list
19858621|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858622|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858623|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
19858624|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
19858625|NCT00773513|Hematinics|hematinics|mesh-ancestor
19858626|NCT00773734|Thalidomide|thalidomide|mesh-list
19858627|NCT00773734|Apremilast|apremilast|mesh-list
19858628|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19858629|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19858630|NCT00773734|Analgesics|analgesics|mesh-ancestor
19858631|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
19858632|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858633|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858634|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858635|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858636|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19858637|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20250692|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250693|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714654|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19714655|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19714656|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19714657|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19714658|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
19714659|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714660|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19714661|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19714662|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
19714663|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
19714664|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19714665|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19714666|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20250694|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250695|NCT00446329|Cinacalcet|cinacalcet|mesh-list
20250696|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250697|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250698|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20250699|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
20250700|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250701|NCT00446368|Everolimus|everolimus|mesh-list
20250702|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250703|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250704|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
20250705|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250706|NCT00446420|Fentanyl|fentanyl|mesh-list
20250707|NCT00446420|Midazolam|midazolam|mesh-list
20250708|NCT00446420|Propofol|propofol|mesh-list
20250709|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20250710|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250711|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553368|NCT01928901|Thymol|thymol|mesh-list
20553369|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553370|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20553371|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
20553372|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
20553373|NCT01928914|Tafenoquine|tafenoquine|mesh-list
20553374|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553375|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553376|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20553377|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20553378|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553379|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553380|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553381|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
20553382|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20553383|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20553384|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20553385|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20553386|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20553387|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
20553388|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553389|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20553390|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20553391|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553392|NCT01929096|Edaravone|edaravone|mesh-list
20553393|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20553394|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
20553395|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553396|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20553397|NCT01929096|Protective Agents|protective agents|mesh-ancestor
19714667|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714668|NCT04743934|Androgens|androgens|mesh-list
19714669|NCT04743934|Hormones|hormones|mesh-ancestor
19714670|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714671|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714672|NCT04743739|Cyclosporine|cyclosporine|mesh-list
19714673|NCT04743739|Rituximab|rituximab|mesh-list
19714674|NCT04743739|Cyclosporins|cyclosporins|mesh-list
19714675|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20250712|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20250713|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
20250714|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
20250715|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20250716|NCT00446420|Narcotics|narcotics|mesh-ancestor
20250717|NCT00446420|Analgesics|analgesics|mesh-ancestor
20250718|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
20250719|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250720|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20532588|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532589|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20532590|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532591|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20532592|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532593|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
20532594|NCT01802450|Dasatinib|dasatinib|mesh-list
19433397|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532595|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532596|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20532597|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532598|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433398|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
19433399|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433400|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19433401|NCT03516903|Hematinics|hematinics|mesh-ancestor
19433402|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
19433403|NCT03516903|Vitamins|vitamins|mesh-ancestor
19433404|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
19433405|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
19433406|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19433407|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433408|NCT03516747|Hormones|hormones|mesh-list
19433409|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
19433410|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433411|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433412|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19433413|NCT03516669|Amoxicillin|amoxicillin|mesh-list
19433414|NCT03516669|Clarithromycin|clarithromycin|mesh-list
19433415|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19433416|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433417|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19433418|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433419|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433420|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19433421|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19433422|NCT03516656|Heparin|heparin|mesh-list
19433423|NCT03516656|Calcium heparin|calcium heparin|mesh-list
19433424|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
19433425|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19433426|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19433427|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433428|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
19433429|NCT03516630|Trazodone|trazodone|mesh-list
19433430|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250721|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20250722|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20250723|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20250724|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
20250725|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
20250726|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250727|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250728|NCT00446433|Lenalidomide|lenalidomide|mesh-list
20250729|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
20250730|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250731|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20250732|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19433431|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250733|NCT00446433|Growth Substances|growth substances|mesh-ancestor
20250734|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
20250735|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250736|NCT00446472|Becaplermin|becaplermin|mesh-list
19714676|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714677|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
20250737|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
20250738|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20250739|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20250740|NCT00446472|Growth Substances|growth substances|mesh-ancestor
20250741|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250742|NCT00446524|Amlodipine|amlodipine|mesh-list
20250743|NCT00446524|Valsartan|valsartan|mesh-list
20250744|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20250745|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20250746|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250747|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433432|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19433433|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19433434|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433435|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433436|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250748|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250749|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250750|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
20250751|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20250752|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20250753|NCT00446537|Methylphenidate|methylphenidate|mesh-list
20250754|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20250755|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250756|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20250757|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20250758|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250759|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250760|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
20250761|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250762|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
20250763|NCT00446576|Hematinics|hematinics|mesh-ancestor
20250764|NCT00446589|Teriparatide|teriparatide|mesh-list
20250765|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
20250766|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250767|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250768|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20250769|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
20250770|NCT00446602|Hematinics|hematinics|mesh-ancestor
20250771|NCT00446667|Mannitol|mannitol|mesh-list
20250772|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20250773|NCT00446667|Diuretics|diuretics|mesh-ancestor
20250774|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
20250775|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433437|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433438|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19433439|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19433440|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433441|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433442|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19433443|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19714678|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714679|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19714680|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714681|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714682|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714683|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
19714684|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714685|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
19714686|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19714687|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
19714688|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714689|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714690|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714691|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734074|NCT04554654|Hormones|hormones|mesh-ancestor
19734075|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734076|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734077|NCT04554680|Trametinib|trametinib|mesh-list
19734078|NCT04554680|Dabrafenib|dabrafenib|mesh-list
19734079|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734080|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19734081|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734082|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734083|NCT04554615|Insulin|insulin|mesh-list
19734084|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19734085|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735829|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735830|NCT04536428|Hemostatics|hemostatics|mesh-list
19735831|NCT04536428|Coagulants|coagulants|mesh-ancestor
19735832|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19735833|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19735834|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
19735835|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
19735836|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735837|NCT04535817|Omalizumab|omalizumab|mesh-list
19735838|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19735839|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19735840|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19736031|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736032|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19736033|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
19736034|NCT04533867|Ondansetron|ondansetron|mesh-list
19736035|NCT04533867|Palonosetron|palonosetron|mesh-list
19736036|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
19736037|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
20250776|NCT00446680|Mannitol|mannitol|mesh-list
20250777|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20250778|NCT00446680|Diuretics|diuretics|mesh-ancestor
20250779|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
20250780|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433444|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433445|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250781|NCT00446771|Mannitol|mannitol|mesh-list
20250782|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19433446|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
19433447|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19714692|NCT04743544|Voriconazole|voriconazole|mesh-list
19433448|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
19433449|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
19433450|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
19433451|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714693|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
19714694|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433452|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433453|NCT03516604|Citalopram|citalopram|mesh-list
19433454|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19433455|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19433456|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433457|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433458|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433459|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
19433460|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433461|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19433462|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
19433463|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433464|NCT03516526|Natalizumab|natalizumab|mesh-list
19433465|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
19433466|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433467|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19433468|NCT03516500|Hematinics|hematinics|mesh-ancestor
19433469|NCT03516214|Trametinib|trametinib|mesh-list
19433470|NCT03516214|Nazartinib|nazartinib|mesh-list
19433471|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433472|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19433473|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433474|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451452|NCT03421119|Insulin|insulin|mesh-list
19451453|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19451454|NCT03421119|Metformin|metformin|mesh-list
19451455|NCT03421119|Liraglutide|liraglutide|mesh-list
19451456|NCT03421119|Secretagogues|secretagogues|mesh-list
19433475|NCT03516188|Antacids|antacids|mesh-list
19433476|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433477|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19433478|NCT03515837|Carboplatin|carboplatin|mesh-list
19433479|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
19433480|NCT03515837|Pemetrexed|pemetrexed|mesh-list
19433481|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19433482|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433483|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19433484|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433485|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433486|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19714695|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19714696|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19714697|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714698|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714699|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19714700|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
19714701|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714702|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433487|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19433488|NCT03515798|Paclitaxel|paclitaxel|mesh-list
19433489|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19433490|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
19433491|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
20250783|NCT00446771|Diuretics|diuretics|mesh-ancestor
20250784|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
20250785|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250786|NCT00446784|Methotrexate|methotrexate|mesh-list
19433492|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19433493|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433494|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
19433495|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
19433496|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
19433497|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433498|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433499|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
19433500|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433501|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433502|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433503|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
19433504|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19433505|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19433506|NCT03515772|Darunavir|darunavir|mesh-list
19714703|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19714704|NCT04743622|Latanoprost|latanoprost|mesh-list
19714705|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19714706|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19858638|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858639|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858640|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858641|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
19858642|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
19858643|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19858644|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858645|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19858646|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19858647|NCT00773734|Growth Substances|growth substances|mesh-ancestor
19858648|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19858649|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858650|NCT00773747|Bortezomib|bortezomib|mesh-list
19858651|NCT00773747|Vorinostat|vorinostat|mesh-list
19858652|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858653|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19858654|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858655|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858656|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
19858657|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19858658|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
19858659|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858660|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250787|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19433507|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19714707|NCT04743180|Paclitaxel|paclitaxel|mesh-list
19714708|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19714709|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714710|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
19714711|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
19714712|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
19714713|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714714|NCT04743011|Heparin|heparin|mesh-list
19714715|NCT04743011|Calcium heparin|calcium heparin|mesh-list
19714716|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19714717|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
19714718|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19714719|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19714720|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714721|NCT04743297|Dinoprostone|dinoprostone|mesh-list
19714722|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
19714723|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19714724|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714725|NCT04743063|Losartan|losartan|mesh-list
19714726|NCT04743063|Valsartan|valsartan|mesh-list
19714727|NCT04743063|Telmisartan|telmisartan|mesh-list
19714728|NCT04743063|Candesartan|candesartan|mesh-list
19433508|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19433509|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
20250788|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
20250789|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20250790|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250791|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20250792|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
20250793|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250794|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250795|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
20250796|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714729|NCT04743063|Olmesartan|olmesartan|mesh-list
20250797|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20250798|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20250799|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
20250800|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250801|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19714730|NCT04743063|Irbesartan|irbesartan|mesh-list
19714731|NCT04743063|Eprosartan|eprosartan|mesh-list
19714732|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
19714733|NCT04743063|Giapreza|giapreza|mesh-list
19714734|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20250802|NCT00446810|Benphothiamine|benphothiamine|mesh-list
20250803|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20250804|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
20250805|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250806|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
20250807|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
20250808|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250809|NCT00446836|Paclitaxel|paclitaxel|mesh-list
20250810|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20250811|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20250812|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250813|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
20250814|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
20250815|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
20250816|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250817|NCT00446862|Losartan|losartan|mesh-list
19714735|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
19714736|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19714737|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19714738|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714739|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19714740|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19714741|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19714742|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
19714743|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714744|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
19858661|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19858662|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
19858663|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19714745|NCT04743193|Sevoflurane|sevoflurane|mesh-list
19714746|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
19858664|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19858665|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19858666|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858667|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858668|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858669|NCT00773838|Dexamethasone|dexamethasone|mesh-list
19858670|NCT00773838|Bortezomib|bortezomib|mesh-list
19858671|NCT00773838|Vorinostat|vorinostat|mesh-list
20250818|NCT00446862|Enalapril|enalapril|mesh-list
20250819|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20250820|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20250821|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20250822|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20250823|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20250824|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20250825|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532599|NCT01802476|Palbociclib|palbociclib|mesh-list
19714747|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714748|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714749|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19714750|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19714751|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
19714752|NCT04742504|Benralizumab|benralizumab|mesh-list
19714753|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19714754|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
19714755|NCT04742699|Lemborexant|lemborexant|mesh-list
20532600|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532601|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20532602|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532603|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532604|NCT01802489|Amiloride|amiloride|mesh-list
20532605|NCT01802489|Diuretics|diuretics|mesh-ancestor
20532606|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
20532607|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532608|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20532609|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19433510|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433511|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433512|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19433513|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19714756|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19714757|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714758|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714759|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19714760|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19714761|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714762|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714763|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19714764|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19714765|NCT04742491|Emtricitabine|emtricitabine|mesh-list
20532610|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433514|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
19433515|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433516|NCT03515707|Etoposide|etoposide|mesh-list
19433517|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
19433518|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
19433519|NCT03515707|Busulfan|busulfan|mesh-list
19714766|NCT04742491|Tenofovir|tenofovir|mesh-list
20532611|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532612|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20532613|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20532614|NCT01802502|Rifampin|rifampin|mesh-list
20532615|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20532616|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
20532617|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20532618|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532619|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
20532620|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20532621|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532622|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532623|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20532624|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20532625|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19433520|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19433521|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433522|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19433523|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19433524|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433525|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433526|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
19433527|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433528|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
19433529|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433530|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433531|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19433532|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
19433533|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19714767|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19714768|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19714769|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714770|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714771|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
19714772|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714773|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19714774|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19714775|NCT04742101|Azacitidine|azacitidine|mesh-list
19714776|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19714777|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
19714778|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714779|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714780|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714781|NCT04742348|Levodopa|levodopa|mesh-list
19714782|NCT04742348|Carbidopa|carbidopa|mesh-list
19714783|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19714784|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19714785|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19714786|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
19714787|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714788|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714789|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714790|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19714791|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714792|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19714793|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
19714794|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
19714795|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
19714796|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19714797|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19714798|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714799|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
19714800|NCT04742205|Coagulants|coagulants|mesh-ancestor
19714801|NCT04741880|Lidocaine|lidocaine|mesh-list
19714802|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
19714803|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
19858672|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858673|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
19858674|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
19433534|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
19433535|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
19433536|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
19433537|NCT03515668|Methylphenidate|methylphenidate|mesh-list
19433538|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19858675|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858676|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714804|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714805|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714806|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
19714807|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714808|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19714809|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19714810|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19714811|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19714812|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714813|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
19714814|NCT04741620|Capsaicin|capsaicin|mesh-list
19714815|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
19714816|NCT04741620|Citric Acid|citric acid|mesh-list
19714817|NCT04741620|Piperine|piperine|mesh-list
19714818|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
19714819|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
19714820|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
19714821|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714822|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858677|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858678|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
19858679|NCT00773838|Hormones|hormones|mesh-ancestor
19858680|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858681|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19433539|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433540|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19433541|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19858682|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250826|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
20250827|NCT00446901|Selenium|selenium|mesh-list
20250828|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
20250829|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858683|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19858684|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858685|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858686|NCT00773955|Acetic Acid|acetic acid|mesh-list
19858687|NCT00773955|Retinol acetate|retinol acetate|mesh-list
19858688|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
19858689|NCT00773955|Gossypol|gossypol|mesh-list
19858690|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19858691|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858692|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19858693|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
19858694|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250830|NCT00446901|Protective Agents|protective agents|mesh-ancestor
20250831|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250832|NCT00446901|Trace Elements|trace elements|mesh-ancestor
19433542|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19714823|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
19714824|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19714825|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
19714826|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
19714827|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714828|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19714829|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714830|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19714831|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714832|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19714833|NCT04741620|Protective Agents|protective agents|mesh-ancestor
19858695|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19858696|NCT00773955|Protective Agents|protective agents|mesh-ancestor
19858697|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858698|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19858699|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
19858700|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19858701|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19858702|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19858703|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19858704|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19858705|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
19858706|NCT00773968|Hematinics|hematinics|mesh-ancestor
19858707|NCT00774046|Cytarabine|cytarabine|mesh-list
19858708|NCT00774046|Etoposide|etoposide|mesh-list
19858709|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
19858710|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19858711|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858712|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19858713|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19858714|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858715|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858716|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19858717|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
19858718|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
19858719|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858720|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858721|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
19858722|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714834|NCT04741464|Tinzaparin|tinzaparin|mesh-list
19734086|NCT04554862|Ketorolac|ketorolac|mesh-list
19858723|NCT00774046|Analgesics|analgesics|mesh-ancestor
19858724|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
20250833|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
19714835|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19714836|NCT04741464|Dalteparin|dalteparin|mesh-list
19714837|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
19714838|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19714839|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19714840|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433543|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433544|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
19433545|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433546|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
19734087|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19734088|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
19734089|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19734090|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19734091|NCT04554862|Analgesics|analgesics|mesh-ancestor
19734092|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
19734093|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734094|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734095|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734096|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734097|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19734098|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734099|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734100|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
19734101|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734102|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19734103|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
19734104|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19734105|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858725|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734106|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19734107|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
19734108|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19734109|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
19734110|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19734111|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19734112|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19734113|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
19734114|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734115|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734116|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734117|NCT04554433|Ethanol|ethanol|mesh-list
19734118|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19734119|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858726|NCT00774202|Prednisone|prednisone|mesh-list
19858727|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
19858728|NCT00774202|Rituximab|rituximab|mesh-list
19433547|NCT03515629|Cemiplimab|cemiplimab|mesh-list
19858729|NCT00774202|Vincristine|vincristine|mesh-list
19858730|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858731|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
19858732|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858733|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858734|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19735841|NCT04535804|Aspirin|aspirin|mesh-list
20250834|NCT00446940|Atorvastatin|atorvastatin|mesh-list
19433548|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19433549|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433550|NCT03515577|Edetic Acid|edetic acid|mesh-list
19433551|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19433552|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
19433553|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
19433554|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433555|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
19433556|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19433557|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19433558|NCT03515538|Cisplatin|cisplatin|mesh-list
19433559|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433560|NCT03515382|Itraconazole|itraconazole|mesh-list
19433561|NCT03515382|Voriconazole|voriconazole|mesh-list
19433562|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
19433563|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433564|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19714841|NCT04741438|Nivolumab|nivolumab|mesh-list
19714842|NCT04741438|Ipilimumab|ipilimumab|mesh-list
19714843|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714844|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714845|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19714846|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714847|NCT04741295|Heparin|heparin|mesh-list
19714848|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19714849|NCT04741295|Tinzaparin|tinzaparin|mesh-list
20250835|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20250836|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20250837|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20250838|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
20250839|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250840|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20250841|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20250842|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250843|NCT00446953|Betamethasone|betamethasone|mesh-list
20250844|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250845|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
20250846|NCT00446953|Hormones|hormones|mesh-ancestor
20250847|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250848|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433565|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19433566|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433567|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433568|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19433569|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
19433570|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433571|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451457|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19451458|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714850|NCT04741295|Dalteparin|dalteparin|mesh-list
19714851|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
19714852|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19714853|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19451459|NCT03421119|Incretins|incretins|mesh-ancestor
19714854|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451460|NCT03421119|Hormones|hormones|mesh-ancestor
19451461|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19451462|NCT03421002|Micafungin|micafungin|mesh-list
19451463|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
19451464|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451465|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
19714855|NCT04741165|Bevacizumab|bevacizumab|mesh-list
19714856|NCT04741165|Lenvatinib|lenvatinib|mesh-list
19714857|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714858|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714859|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19714860|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19714861|NCT04741165|Growth Substances|growth substances|mesh-ancestor
19714862|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714863|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
19858735|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
19858736|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858737|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858738|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19433572|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19433573|NCT03515369|Liver Extracts|liver extracts|mesh-list
19433574|NCT03515369|Hematinics|hematinics|mesh-ancestor
19433575|NCT03515213|Fenofibrate|fenofibrate|mesh-list
19433576|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19433577|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
19433578|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433579|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19433580|NCT03515200|Cytarabine|cytarabine|mesh-list
19433581|NCT03515200|Dexamethasone|dexamethasone|mesh-list
19433582|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
19433583|NCT03515200|Doxorubicin|doxorubicin|mesh-list
19433584|NCT03515200|Methotrexate|methotrexate|mesh-list
19433585|NCT03515200|Bortezomib|bortezomib|mesh-list
19433586|NCT03515200|Dasatinib|dasatinib|mesh-list
19433587|NCT03515200|Palbociclib|palbociclib|mesh-list
19433588|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19433589|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
19433590|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
19433591|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433592|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433593|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19433594|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
19433595|NCT03515200|Hormones|hormones|mesh-ancestor
19433596|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433597|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19433598|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433599|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19433600|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19433601|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19433602|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433603|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433604|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19433605|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
19433606|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19433607|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19433608|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
19433609|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
19433610|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19433611|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433612|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
19433613|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433614|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19433615|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
19714864|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714865|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714866|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858739|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858740|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858741|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
19858742|NCT00774202|Hormones|hormones|mesh-ancestor
19858743|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858744|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19433616|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433617|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714867|NCT04740840|Amlodipine|amlodipine|mesh-list
19714868|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19714869|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19714870|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433618|NCT03515187|Bromides|bromides|mesh-list
19433619|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19433620|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19433621|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
19433622|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
19433623|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19433624|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
19433625|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433626|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
19433627|NCT03515187|Protective Agents|protective agents|mesh-ancestor
19433628|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
19433629|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
19433630|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433631|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714871|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858745|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19433632|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433633|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433634|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
19433635|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19433636|NCT03514979|Vaccines|vaccines|mesh-list
19433637|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
19433638|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433639|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
19433640|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433641|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
19433642|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714872|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19714873|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714874|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
19714875|NCT04740593|Methamphetamine|methamphetamine|mesh-list
19714876|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19714877|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714878|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
19714879|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
19714880|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714881|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
19714882|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714883|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714884|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19714885|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19714886|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19858746|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19858747|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19858748|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19858749|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19858750|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19858751|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
19975498|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433643|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433644|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433645|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
19433646|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433647|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714887|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19714888|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19714889|NCT04740554|Prednisone|prednisone|mesh-list
19714890|NCT04740554|Deflazacort|deflazacort|mesh-list
19714891|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19714892|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
19714893|NCT04740554|Hormones|hormones|mesh-ancestor
19714894|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858752|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858753|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433648|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19858754|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19858755|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19858756|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19858757|NCT00774787|Imiquimod|imiquimod|mesh-list
19858758|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19858759|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
19858760|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858761|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858762|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
19858763|NCT00774800|Insulin|insulin|mesh-list
19433649|NCT03514810|Ketoprofen|ketoprofen|mesh-list
19433650|NCT03514810|Sertraline|sertraline|mesh-list
20250849|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20250850|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
20250851|NCT00446979|UC-781|uc-781|mesh-list
20250852|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20250853|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
20250854|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250855|NCT00447018|Mannitol|mannitol|mesh-list
19714895|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433651|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
19433652|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433653|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19433654|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19433655|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433656|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433657|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433658|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
19858764|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20250856|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20250857|NCT00447018|Diuretics|diuretics|mesh-ancestor
20250858|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
20250859|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250860|NCT00447031|Triamcinolone|triamcinolone|mesh-list
20250861|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19858765|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
19858766|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19858767|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858768|NCT00774852|Prednisone|prednisone|mesh-list
19858769|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
19858770|NCT00774852|Abatacept|abatacept|mesh-list
19858771|NCT00774852|Azathioprine|azathioprine|mesh-list
19858772|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858773|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
19858774|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858775|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858776|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19858777|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
19858778|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858779|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714896|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19714897|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714898|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714899|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
19714900|NCT04740190|Carboplatin|carboplatin|mesh-list
19714901|NCT04740190|Talazoparib|talazoparib|mesh-list
19714902|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714903|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19714904|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714905|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250862|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20250863|NCT00447031|Bevacizumab|bevacizumab|mesh-list
20250864|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20250865|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20250866|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250867|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19714906|NCT04740021|Carboplatin|carboplatin|mesh-list
19714907|NCT04740021|Etoposide|etoposide|mesh-list
19714908|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714909|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19714910|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19714911|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19714912|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714913|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714914|NCT04740099|Naloxone|naloxone|mesh-list
19714915|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19714916|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714917|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
19714918|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19714919|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
19714920|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20532626|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20250868|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19714921|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734120|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532627|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20532628|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20532629|NCT01802593|Methotrexate|methotrexate|mesh-list
20532630|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
20532631|NCT01802593|Azathioprine|azathioprine|mesh-list
20532632|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20532633|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
20532634|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20532635|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532636|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532637|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
19451466|NCT03420963|Etoposide|etoposide|mesh-list
19451467|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
19451468|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
19714922|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714923|NCT04739774|Itraconazole|itraconazole|mesh-list
19714924|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
20250869|NCT00447031|Growth Substances|growth substances|mesh-ancestor
20250870|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250871|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
19714925|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714926|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19714927|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19714928|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714929|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714930|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20250872|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250873|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
20250874|NCT00447031|Hormones|hormones|mesh-ancestor
20250875|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250876|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433659|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433660|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19433661|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19433662|NCT03514810|Analgesics|analgesics|mesh-ancestor
19433663|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
19433664|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433665|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19433666|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433667|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19433668|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250877|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
20250878|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250879|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250880|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20250881|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19714931|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
19433669|NCT03514771|Valacyclovir|valacyclovir|mesh-list
19433670|NCT03514771|Isotretinoin|isotretinoin|mesh-list
19433671|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
19433672|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433673|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
19451469|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19451470|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
19451471|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451472|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451473|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19451474|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
19451475|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451476|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451477|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19714932|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19714933|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714934|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19714935|NCT04740086|Calcium|calcium|mesh-list
20250882|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20250883|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20250884|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250885|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250886|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20250887|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20250888|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
20250889|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451478|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19451479|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19451480|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19451481|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451482|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
19451483|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
19451484|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
19451485|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
19451486|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
19451487|NCT03420937|Atropine|atropine|mesh-list
19451488|NCT03420937|Neostigmine|neostigmine|mesh-list
19451489|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19451490|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19451491|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20286554|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286555|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20286556|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286557|NCT03150810|Temozolomide|temozolomide|mesh-list
20286558|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20286559|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
20286560|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286561|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286562|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
20286563|NCT03112603|Sirolimus|sirolimus|mesh-list
20286564|NCT03112603|Rituximab|rituximab|mesh-list
19714936|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19714937|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714938|NCT04739670|Gemcitabine|gemcitabine|mesh-list
19714939|NCT04739670|Bevacizumab|bevacizumab|mesh-list
19714940|NCT04739670|Carboplatin|carboplatin|mesh-list
19714941|NCT04739670|Atezolizumab|atezolizumab|mesh-list
19714942|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714943|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286565|NCT03112603|Methotrexate|methotrexate|mesh-list
20532638|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433674|NCT03514667|Curcumin|curcumin|mesh-list
19433675|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19433676|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19433677|NCT03514667|Analgesics|analgesics|mesh-ancestor
19433678|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
19433679|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433680|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433681|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19433682|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433683|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433684|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433685|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433686|NCT03514589|Cosyntropin|cosyntropin|mesh-list
19433687|NCT03514589|Hormones|hormones|mesh-ancestor
19433688|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433689|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433690|NCT03514576|Pasireotide|pasireotide|mesh-list
19433691|NCT03514576|Hormones|hormones|mesh-ancestor
19433692|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19433693|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433694|NCT03514550|Propofol|propofol|mesh-list
20250890|NCT00447213|Insulin|insulin|mesh-list
20250891|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20250892|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
19433695|NCT03514550|Sevoflurane|sevoflurane|mesh-list
19433696|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19433697|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433698|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433699|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19433700|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
19433701|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
19433702|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19433703|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19433704|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19433705|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433706|NCT03514381|Doxorubicin|doxorubicin|mesh-list
19433707|NCT03514381|Ifosfamide|ifosfamide|mesh-list
19433708|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19433709|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714944|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19714945|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19714946|NCT04739670|Growth Substances|growth substances|mesh-ancestor
19714947|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532639|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532640|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532641|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714948|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
19714949|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19714950|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
20532642|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20532643|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532644|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
20532645|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532646|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20532647|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
20532648|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20532649|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
19433710|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19433711|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532650|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433712|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433713|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433714|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433715|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
19433716|NCT03514342|Ropivacaine|ropivacaine|mesh-list
20250893|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20250894|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433717|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
19433718|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
19433719|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433720|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433721|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
19433722|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433723|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
19433724|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19433725|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433726|NCT03514108|Metformin|metformin|mesh-list
19433727|NCT03514108|Hydralazine|hydralazine|mesh-list
19433728|NCT03514108|Isosorbide|isosorbide|mesh-list
19433729|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19433730|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19433731|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19433732|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433733|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19433734|NCT03514108|Diuretics|diuretics|mesh-ancestor
19433735|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
19433736|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
19433737|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19433738|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433739|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19433740|NCT03514030|Antibodies|antibodies|mesh-list
19433741|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
19433742|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433743|NCT03513874|Metformin|metformin|mesh-list
19433744|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19714951|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714952|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
19714953|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714954|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714955|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19714956|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
19714957|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
19714958|NCT04739618|Ipilimumab|ipilimumab|mesh-list
19714959|NCT04739618|Sargramostim|sargramostim|mesh-list
19714960|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714961|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714962|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19714963|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714964|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
19714965|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714966|NCT04739566|Trametinib|trametinib|mesh-list
19714967|NCT04739566|Dabrafenib|dabrafenib|mesh-list
19714968|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714969|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19714970|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714971|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858780|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19858781|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858782|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
19858783|NCT00774852|Hormones|hormones|mesh-ancestor
19975499|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
19433745|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433746|NCT03513822|Midazolam|midazolam|mesh-list
19433747|NCT03513822|Ketamine|ketamine|mesh-list
19433748|NCT03513822|Analgesics|analgesics|mesh-ancestor
19714972|NCT04739410|Ivermectin|ivermectin|mesh-list
19433749|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
19433750|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433751|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433752|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19433753|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19433754|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
19433755|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
19433756|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433757|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19433758|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19433759|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433760|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433761|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19433762|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19433763|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19433764|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19433765|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433766|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
19433767|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
19433768|NCT03513601|Rituximab|rituximab|mesh-list
19433769|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19433770|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433771|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
19433772|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433773|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433774|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
19433775|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19433776|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433777|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
19433778|NCT03513549|Loxapine|loxapine|mesh-list
19433779|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19714973|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19433780|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19433781|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19714974|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714975|NCT04739241|Insulin|insulin|mesh-list
19714976|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19714977|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19714978|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714979|NCT04739202|Bevacizumab|bevacizumab|mesh-list
19858784|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858785|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19858786|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19858787|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
19858788|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19858789|NCT00774930|Lanreotide|lanreotide|mesh-list
19858790|NCT00774930|Somatostatin|somatostatin|mesh-list
19858791|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858792|NCT00774930|Hormones|hormones|mesh-ancestor
19858793|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858794|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858795|NCT00775138|Amikacin|amikacin|mesh-list
19858796|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19433782|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433783|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433784|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19433785|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
19433786|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433787|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433788|NCT03513484|Azacitidine|azacitidine|mesh-list
19433789|NCT03513484|Nintedanib|nintedanib|mesh-list
19433790|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19433791|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
19433792|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433793|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433794|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433795|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19433796|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19433797|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19714980|NCT04739202|Atezolizumab|atezolizumab|mesh-list
20532651|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532652|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20532653|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
20532654|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20532655|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
20532656|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532657|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19714981|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20250895|NCT00447239|Insulin|insulin|mesh-list
20250896|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20250897|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250898|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
20250899|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250900|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250901|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20250902|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532658|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19714982|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19714983|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858797|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858798|NCT00775203|Trazodone|trazodone|mesh-list
20532659|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
20250903|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433798|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19433799|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433800|NCT03513432|Ethanol|ethanol|mesh-list
19433801|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19433802|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19714984|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19714985|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19714986|NCT04739202|Growth Substances|growth substances|mesh-ancestor
19714987|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19714988|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
19714989|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
19714990|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
19714991|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19714992|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19714993|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19714994|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734121|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734122|NCT04554524|Paclitaxel|paclitaxel|mesh-list
19734123|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
19734124|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19734125|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734126|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734127|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734128|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
19734129|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734130|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734131|NCT04554303|Amlodipine|amlodipine|mesh-list
19734132|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19734133|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19734134|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734135|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734136|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19858799|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19858800|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19858801|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19858802|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858803|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19858804|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19858805|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19858806|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858807|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858808|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858809|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
19858810|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19858811|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
19858812|NCT00775229|Naltrexone|naltrexone|mesh-list
19858813|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19858814|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19858815|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858816|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
19858817|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858818|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19858819|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19858820|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858821|NCT00775411|Dexamethasone|dexamethasone|mesh-list
19858822|NCT00775411|Ranibizumab|ranibizumab|mesh-list
19858823|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858824|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
19858825|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
19858826|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858827|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858828|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858829|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
19858830|NCT00775411|Hormones|hormones|mesh-ancestor
19858831|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858832|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19858833|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858834|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19858835|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19858836|NCT00775411|Growth Substances|growth substances|mesh-ancestor
19858837|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
19858838|NCT00775437|Adalimumab|adalimumab|mesh-list
20286566|NCT03112603|Everolimus|everolimus|mesh-list
19433803|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433804|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433805|NCT03513393|Velpatasvir|velpatasvir|mesh-list
19433806|NCT03513393|Omeprazole|omeprazole|mesh-list
19433807|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19433808|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250904|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250905|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250906|NCT00447356|Interferons|interferons|mesh-list
20250907|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
20250908|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433809|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19433810|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433811|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433812|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
19433813|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433814|NCT03513328|Thiotepa|thiotepa|mesh-list
19433815|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19433816|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
19433817|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433818|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433819|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19433820|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433821|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
19433822|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433823|NCT03513276|Epinephrine|epinephrine|mesh-list
19433824|NCT03513276|Racepinephrine|racepinephrine|mesh-list
19433825|NCT03513276|Ropivacaine|ropivacaine|mesh-list
19433826|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
19433827|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
19433828|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
19433829|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433830|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433831|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
19433832|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433833|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19433834|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19433835|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
19433836|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433837|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433838|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19433839|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19433840|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
20250909|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
19433841|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19433842|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
19433843|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
19433844|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
19433845|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19433846|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19433847|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19433848|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19433849|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19433850|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19433851|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
19433852|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433853|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433854|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433855|NCT03513055|Insulin|insulin|mesh-list
19433856|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19433857|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451492|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
19451493|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451494|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451495|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19451496|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19451497|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
19451498|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
19451499|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19451500|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19451501|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
19451502|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451503|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451504|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19451505|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451506|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19451507|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19451508|NCT03420911|Midazolam|midazolam|mesh-list
19451509|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19451510|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19451511|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451512|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451513|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19451514|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19451515|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19451516|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19451517|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
19451518|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
19451519|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
19451520|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
19451521|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433858|NCT03512990|Bupivacaine|bupivacaine|mesh-list
19433859|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
19433860|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
19433861|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433862|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433863|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
19433864|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433865|NCT03512873|Tranilast|tranilast|mesh-list
19433866|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19433867|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19433868|NCT03512873|Analgesics|analgesics|mesh-ancestor
19433869|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
19433870|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433871|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433872|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19433873|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19433874|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19433875|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433876|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433877|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19433878|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19433879|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
19433880|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
19433881|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433882|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19433883|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19433884|NCT03512860|Valproic Acid|valproic acid|mesh-list
19433885|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
20250910|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250911|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
20250912|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250913|NCT00447369|Pregabalin|pregabalin|mesh-list
20250914|NCT00447369|Valproic Acid|valproic acid|mesh-list
20250915|NCT00447369|Analgesics|analgesics|mesh-ancestor
20250916|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
20250917|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250918|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250919|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
20250920|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20250921|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20250922|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250923|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20250924|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20250925|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20250926|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20250927|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20250928|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250929|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
20250930|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20250931|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
20532660|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
20532661|NCT01802619|Protective Agents|protective agents|mesh-ancestor
20532662|NCT01802645|Leucovorin|leucovorin|mesh-list
20532663|NCT01802645|Folic Acid|folic acid|mesh-list
20532664|NCT01802645|Bevacizumab|bevacizumab|mesh-list
20532665|NCT01802645|Cetuximab|cetuximab|mesh-list
20532666|NCT01802645|Fluorouracil|fluorouracil|mesh-list
20532667|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
20532668|NCT01802645|Irinotecan|irinotecan|mesh-list
20532669|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
20532670|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20532671|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532672|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20532673|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20532674|NCT01802645|Growth Substances|growth substances|mesh-ancestor
20532675|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532676|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
20250932|NCT00447473|Ketoconazole|ketoconazole|mesh-list
20250933|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
19433886|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433887|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433888|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
19433889|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433890|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433891|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
19433892|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19433893|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433894|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433895|NCT03512834|Paclitaxel|paclitaxel|mesh-list
19714995|NCT04738955|Micafungin|micafungin|mesh-list
19433896|NCT03512834|Avelumab|avelumab|mesh-list
19433897|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19433898|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19714996|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
19714997|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433899|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
19433900|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
19433901|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
19433902|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433903|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19433904|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19433905|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19433906|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19433907|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19433908|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19433909|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19433910|NCT03512756|Gemcitabine|gemcitabine|mesh-list
19433911|NCT03512756|Sirolimus|sirolimus|mesh-list
19433912|NCT03512756|Capecitabine|capecitabine|mesh-list
19433913|NCT03512756|Phenytoin|phenytoin|mesh-list
19433914|NCT03512756|Methoxsalen|methoxsalen|mesh-list
19433915|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19433916|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
19433917|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433918|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433919|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
19433920|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433921|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19714998|NCT04739111|Antibodies|antibodies|mesh-list
20250934|NCT00447473|Analgesics|analgesics|mesh-ancestor
19714999|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
19715000|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19715001|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
19433922|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19433923|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
19715002|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715003|NCT04738981|Basiliximab|basiliximab|mesh-list
19715004|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715005|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
19715006|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433924|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433925|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19433926|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19433927|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
19433928|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
19433929|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19433930|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20250935|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
20250936|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250937|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250938|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20250939|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19433931|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433932|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19433933|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19433934|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19433935|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
19433936|NCT03512574|Pregabalin|pregabalin|mesh-list
19433937|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
19433938|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19715007|NCT04738838|Oxytocin|oxytocin|mesh-list
19715008|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
19715009|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19858839|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858840|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250940|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20250941|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250942|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250943|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
20250944|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250945|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19433939|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433940|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433941|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19433942|NCT03512574|Analgesics|analgesics|mesh-ancestor
19433943|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
19433944|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433945|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19433946|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19433947|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19433948|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715010|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715011|NCT04738773|Naltrexone|naltrexone|mesh-list
19715012|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19715013|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20250946|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20250947|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20250948|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
20250949|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286567|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
19715014|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715015|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
19715016|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715017|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
19715018|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
19715019|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715020|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715021|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433949|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433950|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433951|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
19433952|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19433953|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19433954|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19433955|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19433956|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19433957|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19433958|NCT03512548|Itraconazole|itraconazole|mesh-list
19433959|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
19433960|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19433961|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19433962|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19433963|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433964|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250950|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20250951|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20250952|NCT00447577|Tobramycin|tobramycin|mesh-list
20250953|NCT00447577|Dexamethasone|dexamethasone|mesh-list
20250954|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250955|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
20250956|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
20250957|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532677|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
20532678|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532679|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19433965|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19433966|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
19433967|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715022|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
19715023|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19715024|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19433968|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433969|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19433970|NCT03512496|Caffeine|caffeine|mesh-list
19433971|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19433972|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433973|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19433974|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19433975|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433976|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19433977|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19433978|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
20250958|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532680|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532681|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
20532682|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20532683|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532684|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532685|NCT01802645|Antidotes|antidotes|mesh-ancestor
20532686|NCT01802645|Protective Agents|protective agents|mesh-ancestor
20532687|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
20532688|NCT01802645|Vitamins|vitamins|mesh-ancestor
20532689|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
20532690|NCT01802645|Hematinics|hematinics|mesh-ancestor
20532691|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
20532692|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20532693|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532694|NCT01802684|Aflibercept|aflibercept|mesh-list
20532695|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20532696|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20532697|NCT01802684|Growth Substances|growth substances|mesh-ancestor
19715025|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715026|NCT04738058|Lactoferrin|lactoferrin|mesh-list
19715027|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715028|NCT04738188|Epirubicin|epirubicin|mesh-list
19715029|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715030|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715031|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19715032|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19715033|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715034|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715035|NCT04738097|Clopidogrel|clopidogrel|mesh-list
19715036|NCT04738097|Ticagrelor|ticagrelor|mesh-list
19715037|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19715038|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19715039|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19715040|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19858841|NCT00775450|Vaccines|vaccines|mesh-list
19858842|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
19433979|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433980|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
19433981|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19433982|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715041|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
19715042|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715043|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715044|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715045|NCT04738045|Ritonavir|ritonavir|mesh-list
19715046|NCT04738045|Lopinavir|lopinavir|mesh-list
19715047|NCT04738045|Remdesivir|remdesivir|mesh-list
19858843|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858844|NCT00775463|Treprostinil|treprostinil|mesh-list
19433983|NCT03512171|Amphetamine|amphetamine|mesh-list
19433984|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
19433985|NCT03512171|Fallypride|fallypride|mesh-list
19433986|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19433987|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19433988|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
19433989|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
19433990|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19433991|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
19433992|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19433993|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19433994|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
19433995|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19433996|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19433997|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19715048|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19858845|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19858846|NCT00775528|Pancrelipase|pancrelipase|mesh-list
19858847|NCT00775528|Pancreatin|pancreatin|mesh-list
19858848|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19858849|NCT00775593|Sirolimus|sirolimus|mesh-list
19858850|NCT00775593|Clofarabine|clofarabine|mesh-list
19858851|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19858852|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19858853|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715049|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19858854|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19433998|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19433999|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19434000|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19434001|NCT03511976|Methylphenidate|methylphenidate|mesh-list
19434002|NCT03511976|Amphetamine|amphetamine|mesh-list
19434003|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19715050|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
19715051|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715052|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434004|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434005|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19434006|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19434007|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434008|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434009|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
19434010|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434011|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
19434012|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
19434013|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434014|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
19434015|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19434016|NCT03511846|Capsaicin|capsaicin|mesh-list
19434017|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
19434018|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
19434019|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
19434020|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434021|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434022|NCT03511833|Ketamine|ketamine|mesh-list
19434023|NCT03511833|Morphine|morphine|mesh-list
19434024|NCT03511833|Analgesics|analgesics|mesh-ancestor
19434025|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
19434026|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434027|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434028|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19434029|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19434030|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
19434031|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
19434032|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434033|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19434034|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19434035|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434036|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434037|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19434038|NCT03511833|Narcotics|narcotics|mesh-ancestor
19434039|NCT03511820|Amphotericin B|amphotericin b|mesh-list
19434040|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19434041|NCT03511820|Amebicides|amebicides|mesh-ancestor
19434042|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19434043|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19434044|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434045|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434046|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
19434047|NCT03511768|Octreotide|octreotide|mesh-list
19434048|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19434049|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19434050|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434051|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
19434052|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434053|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434054|NCT03511703|Apatinib|apatinib|mesh-list
19434055|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434056|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19434057|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434058|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434059|NCT03511560|Tacrolimus|tacrolimus|mesh-list
19434060|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19434061|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
19434062|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434063|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19434064|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434065|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434066|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
19434067|NCT03511391|Nivolumab|nivolumab|mesh-list
19434068|NCT03511391|Atezolizumab|atezolizumab|mesh-list
19434069|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19434070|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19434071|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434072|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434073|NCT03511261|Curcumin|curcumin|mesh-list
19434074|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19434075|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19434076|NCT03511261|Analgesics|analgesics|mesh-ancestor
19434077|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
19434078|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434079|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434080|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19434081|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19434082|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434083|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434084|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451522|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451523|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19451524|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451525|NCT03420911|Analgesics|analgesics|mesh-ancestor
20250959|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20250960|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
20250961|NCT00447577|Hormones|hormones|mesh-ancestor
20250962|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250963|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20250964|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532698|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715053|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19715054|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19715055|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
19715056|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715057|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19715058|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19715059|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
19715060|NCT04737889|Rituximab|rituximab|mesh-list
19715061|NCT04737889|Methotrexate|methotrexate|mesh-list
19715062|NCT04737889|Lenalidomide|lenalidomide|mesh-list
19715063|NCT04737889|Temozolomide|temozolomide|mesh-list
19715064|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19715065|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715066|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
19715067|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715068|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19715069|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19715070|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
19715071|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19715072|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19715073|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
19715074|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715075|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
19715076|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532699|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
19451526|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
19451527|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451528|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19451529|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451530|NCT03420794|Analgesics|analgesics|mesh-list
19451531|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19451532|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
19434085|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
19434086|NCT03511222|Nivolumab|nivolumab|mesh-list
19434087|NCT03511222|Vorolanib|vorolanib|mesh-list
19434088|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19434089|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434090|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19434091|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434092|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19434093|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434094|NCT03511183|Bevacizumab|bevacizumab|mesh-list
19434095|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19434096|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434097|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19434098|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19434099|NCT03511183|Growth Substances|growth substances|mesh-ancestor
20250965|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20250966|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20250967|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20250968|NCT00447681|Fezakinumab|fezakinumab|mesh-list
19434100|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434101|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
19434102|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19434103|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
19434104|NCT03510975|Coagulants|coagulants|mesh-ancestor
19434105|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19434106|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
19715077|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20250969|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
20250970|NCT00447759|Ibuprofen|ibuprofen|mesh-list
20250971|NCT00447759|Celecoxib|celecoxib|mesh-list
20250972|NCT00447759|Diclofenac|diclofenac|mesh-list
20250973|NCT00447759|Naproxen|naproxen|mesh-list
20250974|NCT00447759|Meloxicam|meloxicam|mesh-list
20250975|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20250976|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20250977|NCT00447759|Analgesics|analgesics|mesh-ancestor
20250978|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
20250979|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250980|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20250981|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250982|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20250983|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20250984|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20250985|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250986|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20250987|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
20250988|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
20250989|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20250990|NCT00447863|Estradiol|estradiol|mesh-list
20250991|NCT00447863|Estrogens|estrogens|mesh-ancestor
19715078|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715079|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19715080|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19715081|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19715082|NCT04737889|Growth Substances|growth substances|mesh-ancestor
19715083|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19715084|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19715085|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
19715086|NCT04737928|Latanoprost|latanoprost|mesh-list
19715087|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19715088|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19715089|NCT04737980|Dexamethasone|dexamethasone|mesh-list
19715090|NCT04737980|Bupivacaine|bupivacaine|mesh-list
19715091|NCT04737980|Ropivacaine|ropivacaine|mesh-list
20250992|NCT00447863|Hormones|hormones|mesh-ancestor
19715092|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20250993|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20250994|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715093|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
19715094|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
19715095|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20250995|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20250996|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
19858855|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
19858856|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858857|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
19858858|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858859|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19858860|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
19858861|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20250997|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20250998|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20250999|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20251000|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20251001|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20251002|NCT00447915|Vitamin D|vitamin d|mesh-list
20251003|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
19858862|NCT00775606|Ritonavir|ritonavir|mesh-list
19858863|NCT00775606|Lopinavir|lopinavir|mesh-list
19858864|NCT00775606|Efavirenz|efavirenz|mesh-list
19858865|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19858866|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19858867|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
19858868|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858869|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858870|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19858871|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19715096|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715097|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715098|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
19715099|NCT04737980|Hormones|hormones|mesh-ancestor
19715100|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251004|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
20251005|NCT00447915|Calcium|calcium|mesh-list
20251006|NCT00447915|Vitamins|vitamins|mesh-ancestor
19434107|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434108|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
19434109|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20251007|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
20251008|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715101|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19715102|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715103|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
19715104|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
19715105|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251009|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20251010|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20251011|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
20251012|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
20251013|NCT00447967|Leucovorin|leucovorin|mesh-list
20251014|NCT00447967|Fluorouracil|fluorouracil|mesh-list
20251015|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
20251016|NCT00447967|Irinotecan|irinotecan|mesh-list
20251017|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
20251018|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434110|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715106|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
19715107|NCT04737967|Memantine|memantine|mesh-list
19715108|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19715109|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19715110|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19715111|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
19858872|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
19858873|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251019|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19858874|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19715112|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715113|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715114|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715115|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19715116|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19715117|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19715118|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19715119|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19715120|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19715121|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
19715122|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715123|NCT04737837|Lacosamide|lacosamide|mesh-list
19715124|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
19858875|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19858876|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19434111|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
19434112|NCT03510871|Nivolumab|nivolumab|mesh-list
19434113|NCT03510871|Ipilimumab|ipilimumab|mesh-list
19434114|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19434115|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434116|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19434117|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434118|NCT03510793|Anesthetics|anesthetics|mesh-list
19434119|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434120|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434121|NCT03510611|Ensartinib|ensartinib|mesh-list
19434122|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434123|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19434124|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434125|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434126|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19434127|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19434128|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434129|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434130|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
20251020|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251021|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251022|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
19434131|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434132|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434133|NCT03510533|Autoantibodies|autoantibodies|mesh-list
19434134|NCT03510533|alpha-MSH|alpha-msh|mesh-list
19434135|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
19434136|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434137|NCT03510533|Hormones|hormones|mesh-ancestor
19434138|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434139|NCT03510416|Apatinib|apatinib|mesh-list
19434140|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434141|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19434142|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434143|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434144|NCT03510351|Tazobactam|tazobactam|mesh-list
19434145|NCT03510351|Ceftolozane|ceftolozane|mesh-list
19434146|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19434147|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434148|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251023|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251024|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20251025|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20251026|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251027|NCT00447967|Antidotes|antidotes|mesh-ancestor
20251028|NCT00447967|Protective Agents|protective agents|mesh-ancestor
20251029|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
20251030|NCT00447967|Vitamins|vitamins|mesh-ancestor
20251031|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
20251032|NCT00448097|Docetaxel|docetaxel|mesh-list
20251033|NCT00448097|Cetuximab|cetuximab|mesh-list
20251034|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251035|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251036|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251037|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
20251038|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251039|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20251040|NCT00448110|Diclofenac|diclofenac|mesh-list
20251041|NCT00448110|Ketorolac|ketorolac|mesh-list
19715125|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19715126|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20251042|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20251043|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19715127|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19715128|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715129|NCT04737655|Beclomethasone|beclomethasone|mesh-list
19715130|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
19858877|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19858878|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19858879|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19858880|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19858881|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19858882|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19858883|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
19858884|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
19858885|NCT00775645|Vitamins|vitamins|mesh-ancestor
19858886|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
19858887|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858888|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
20251044|NCT00448110|Analgesics|analgesics|mesh-ancestor
20251045|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
20251046|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251047|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434149|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19715131|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
19715132|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19715133|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
19715134|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858889|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19858890|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19858891|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19858892|NCT00775658|Analgesics|analgesics|mesh-ancestor
19858893|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
19858894|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858895|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858896|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858897|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858898|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19858899|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19858900|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19858901|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
20532700|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532701|NCT01802749|Gemcitabine|gemcitabine|mesh-list
20532702|NCT01802749|Paclitaxel|paclitaxel|mesh-list
20532703|NCT01802749|Bevacizumab|bevacizumab|mesh-list
20532704|NCT01802749|Carboplatin|carboplatin|mesh-list
20532705|NCT01802749|Doxorubicin|doxorubicin|mesh-list
20532706|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20532707|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20532708|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434150|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434151|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434152|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19434153|NCT03510351|Renal Agents|renal agents|mesh-ancestor
19434154|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
19434155|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
19434156|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19434157|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19434158|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434159|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434160|NCT03510338|Urological Agents|urological agents|mesh-ancestor
19434161|NCT03510325|Olanzapine|olanzapine|mesh-list
19434162|NCT03510325|Risperidone|risperidone|mesh-list
19434163|NCT03510325|Aripiprazole|aripiprazole|mesh-list
19434164|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19434165|NCT03510325|Amisulpride|amisulpride|mesh-list
19434166|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19715135|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251048|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251049|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20251050|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20251051|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251052|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251053|NCT00448149|Everolimus|everolimus|mesh-list
20251054|NCT00448149|Sorafenib|sorafenib|mesh-list
20251055|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715136|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19715137|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
19715138|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19715139|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19715140|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19715141|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715142|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715143|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715144|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715145|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19715146|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19715147|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
19715148|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19858902|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
19858903|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858904|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858905|NCT00775671|Metoprolol|metoprolol|mesh-list
19858906|NCT00775671|Nebivolol|nebivolol|mesh-list
19858907|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19858908|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20251056|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251057|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
20251058|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251059|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251060|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251061|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715149|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
19858909|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
20251062|NCT00448214|Warfarin|warfarin|mesh-list
20251063|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
19434167|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
19434168|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251064|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20251065|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251066|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251067|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715150|NCT04737655|Hormones|hormones|mesh-ancestor
19715151|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715152|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19715153|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19715154|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19715155|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
19715156|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715157|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19715158|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19858910|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
19858911|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858912|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858913|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19858914|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19858915|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19858916|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
19858917|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858918|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858919|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
19858920|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19858921|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20251068|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251069|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
20251070|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
20251071|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251072|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
20251073|NCT00448266|Thiotepa|thiotepa|mesh-list
20251074|NCT00448266|Carboplatin|carboplatin|mesh-list
20532709|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
20532710|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
20532711|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
20532712|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532713|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20532714|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20532715|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20532716|NCT01802749|Growth Substances|growth substances|mesh-ancestor
20532717|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532718|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
20532719|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532720|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
20532721|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
19715159|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734137|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715160|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
19715161|NCT04737278|Niacin|niacin|mesh-list
19715162|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
19715163|NCT04737278|Vitamins|vitamins|mesh-ancestor
19715164|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
19715165|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715166|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20251075|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251076|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
20251077|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251078|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20251079|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20251080|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
20532722|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532723|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532724|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532725|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
20532726|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20532727|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20532728|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532729|NCT01802814|Epratuzumab|epratuzumab|mesh-list
20532730|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20532731|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532732|NCT01802892|Plerixafor|plerixafor|mesh-list
20532733|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19858922|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19858923|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19434169|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434170|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434171|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19434172|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19434173|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434174|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715167|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
19715168|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858924|NCT00775684|Exenatide|exenatide|mesh-list
19858925|NCT00775684|Glimepiride|glimepiride|mesh-list
19858926|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19858927|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858928|NCT00775684|Incretins|incretins|mesh-ancestor
19858929|NCT00775684|Hormones|hormones|mesh-ancestor
19858930|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858931|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19858932|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
20251081|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532734|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20532735|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
20532736|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532737|NCT01802918|Ritonavir|ritonavir|mesh-list
19715169|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20251082|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251083|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20251084|NCT00448292|Naluzotan|naluzotan|mesh-list
20251085|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20251086|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20251087|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
20251088|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251089|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251090|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251091|NCT00448305|Paclitaxel|paclitaxel|mesh-list
20251092|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20532738|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
20532739|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20532740|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20251093|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20532741|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
20532742|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434175|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19434176|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
19434177|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
19434178|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
19434179|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434180|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19434181|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19434182|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19434183|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434184|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
19434185|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
19434186|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19434187|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19434188|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19434189|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19434190|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19434191|NCT03510221|Antioxidants|antioxidants|mesh-list
19434192|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434193|NCT03510221|Protective Agents|protective agents|mesh-ancestor
19434194|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434195|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19434196|NCT03510208|Panitumumab|panitumumab|mesh-list
19434197|NCT03510208|Antibodies|antibodies|mesh-list
19434198|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
19434199|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19434200|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
19434201|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434202|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434203|NCT03510078|Insulin|insulin|mesh-list
19715170|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
19715171|NCT04737473|Anesthetics|anesthetics|mesh-list
19715172|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715173|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715174|NCT04736953|Sirolimus|sirolimus|mesh-list
19715175|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715176|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715177|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715178|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434204|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19858933|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19858934|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434205|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858935|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19434206|NCT03510013|Sevoflurane|sevoflurane|mesh-list
19434207|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
19434208|NCT03510013|Anesthetics|anesthetics|mesh-list
19434209|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19434210|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
19434211|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434212|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434213|NCT03510000|Empagliflozin|empagliflozin|mesh-list
19434214|NCT03510000|Pancrelipase|pancrelipase|mesh-list
19715179|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
19715180|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715181|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
19715182|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858936|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19858937|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858938|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
19715183|NCT04737057|Fluorides|fluorides|mesh-list
19858939|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
19858940|NCT00775931|Busulfan|busulfan|mesh-list
19858941|NCT00775931|Fludarabine|fludarabine|mesh-list
19858942|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
19858943|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
19858944|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19858945|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
19858946|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858947|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19858948|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19858949|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
19715184|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
19715185|NCT04737057|Protective Agents|protective agents|mesh-ancestor
19715186|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858950|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434215|NCT03510000|Hormones|hormones|mesh-list
19715187|NCT04736836|Rifaximin|rifaximin|mesh-list
19858951|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734138|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
19858952|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19715188|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715189|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715190|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715191|NCT04736823|Paclitaxel|paclitaxel|mesh-list
19715192|NCT04736823|Docetaxel|docetaxel|mesh-list
19858953|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19858954|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
19858955|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858956|NCT00775944|Nicotine|nicotine|mesh-list
19858957|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19434216|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434217|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434218|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19434219|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434220|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19434221|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19434222|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
19434223|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19434224|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19434225|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434226|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19434227|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19434228|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
19434229|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858958|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
19858959|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19858960|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858961|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19715193|NCT04736823|Carboplatin|carboplatin|mesh-list
19715194|NCT04736823|Pemetrexed|pemetrexed|mesh-list
19715195|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19715196|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715197|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
19715198|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
19715199|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
19715200|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715201|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715202|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19715203|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19715204|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
19715205|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715206|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19715207|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532743|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532744|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20532745|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20532746|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
20532747|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532748|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20532749|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20532750|NCT01802931|Ketoconazole|ketoconazole|mesh-list
20532751|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
20532752|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532753|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20532754|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20532755|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532756|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434230|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434231|NCT03509831|Irsogladine|irsogladine|mesh-list
19434232|NCT03509831|Nizatidine|nizatidine|mesh-list
19434233|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251094|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532757|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20532758|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
20532759|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434234|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19434235|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19434236|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19434237|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
19434238|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
19434239|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434240|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434241|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434242|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20532760|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532761|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20532762|NCT01802944|Insulin|insulin|mesh-list
20532763|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532764|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532765|NCT01802970|Paclitaxel|paclitaxel|mesh-list
19434243|NCT03509831|Protective Agents|protective agents|mesh-ancestor
19434244|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19434245|NCT03509740|Acetaminophen|acetaminophen|mesh-list
19434246|NCT03509740|Tramadol|tramadol|mesh-list
19434247|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19434248|NCT03509740|Analgesics|analgesics|mesh-ancestor
19434249|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
19434250|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434251|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434252|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
19434253|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19434254|NCT03509740|Narcotics|narcotics|mesh-ancestor
19434255|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434256|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
19434257|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
19434258|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434259|NCT03509714|Protective Agents|protective agents|mesh-ancestor
19434260|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434261|NCT03509714|Vitamins|vitamins|mesh-ancestor
19434262|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
19434263|NCT03509701|Antibodies|antibodies|mesh-list
19434264|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
19434265|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434266|NCT03509688|Entecavir|entecavir|mesh-list
19434267|NCT03509688|Resveratrol|resveratrol|mesh-list
19434268|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
19434269|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434270|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
19434271|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434272|NCT03509688|Protective Agents|protective agents|mesh-ancestor
19434273|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434274|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251095|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251096|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251097|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
20251098|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251099|NCT00448383|Adalimumab|adalimumab|mesh-list
20251100|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251101|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20251102|NCT00448396|Epothilone B|epothilone b|mesh-list
20251103|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251104|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251105|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
20532766|NCT01802970|Vinorelbine|vinorelbine|mesh-list
19434275|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19434276|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
19434277|NCT03509662|Thiamine|thiamine|mesh-list
19715208|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715209|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19715210|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
19715211|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434278|NCT03509662|Vitamins|vitamins|mesh-ancestor
19434279|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
19434280|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434281|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
19434282|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434283|NCT03509662|Protective Agents|protective agents|mesh-ancestor
19434284|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
19434285|NCT03509584|Nivolumab|nivolumab|mesh-list
19434286|NCT03509584|Ipilimumab|ipilimumab|mesh-list
19434287|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19434288|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434289|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19434290|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434291|NCT03509545|Torsemide|torsemide|mesh-list
19434292|NCT03509545|Furosemide|furosemide|mesh-list
19715212|NCT04736901|Enoxaparin|enoxaparin|mesh-list
19715213|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
19715214|NCT04736901|Apixaban|apixaban|mesh-list
19715215|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
19715216|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19715217|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
19715218|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19715219|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
19715220|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715221|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715222|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
19715223|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19715224|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19858962|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19858963|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
19858964|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858965|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858966|NCT00776009|Methylphenidate|methylphenidate|mesh-list
19858967|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
20251106|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
19434293|NCT03509545|Diuretics|diuretics|mesh-ancestor
19434294|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
19452791|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
19452792|NCT03410511|Nicotine|nicotine|mesh-list
19452793|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19452794|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
19452795|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452796|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434295|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434296|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19434297|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434298|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434299|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19451533|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715225|NCT04736927|Midazolam|midazolam|mesh-list
19715226|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715227|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19715228|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715229|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715230|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19715231|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19715232|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715233|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19715234|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
19715235|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
19715236|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
19715237|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
19451534|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451535|NCT03420742|Midazolam|midazolam|mesh-list
19715238|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715239|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715240|NCT04736524|Antibodies|antibodies|mesh-list
19715241|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
19715242|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858968|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19858969|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451536|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19451537|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19451538|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451539|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451540|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19451541|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19451542|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19451543|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19451544|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
19451545|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
19451546|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
19451547|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
19451548|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451549|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451550|NCT03420703|Morphine|morphine|mesh-list
19451551|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19451552|NCT03420703|Narcotics|narcotics|mesh-ancestor
19451553|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451554|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451555|NCT03420703|Analgesics|analgesics|mesh-ancestor
19451556|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
19451557|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451558|NCT03420638|Epinephrine|epinephrine|mesh-list
19451559|NCT03420638|Bupivacaine|bupivacaine|mesh-list
19715243|NCT04736810|Gemcitabine|gemcitabine|mesh-list
19434300|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
20251107|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251108|NCT00448409|Sargramostim|sargramostim|mesh-list
20251109|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
20251110|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434301|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19434302|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434303|NCT03509298|Antibodies|antibodies|mesh-list
19434304|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19434305|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
19434306|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434307|NCT03509285|Cenobamate|cenobamate|mesh-list
19434308|NCT03509285|Alprazolam|alprazolam|mesh-list
19434309|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19434310|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434311|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434312|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19434313|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19434314|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19434315|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
19434316|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
19858970|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19434317|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251111|NCT00448461|Heparin|heparin|mesh-list
20251112|NCT00448461|Bivalirudin|bivalirudin|mesh-list
20251113|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
20251114|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20251115|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20251116|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251117|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
20251118|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19434318|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434319|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
19434320|NCT03509246|Doxorubicin|doxorubicin|mesh-list
19434321|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19434322|NCT03509246|Bortezomib|bortezomib|mesh-list
19715244|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715245|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251119|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
20251120|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434323|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19434324|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434325|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19715246|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
19715247|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715248|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
19715249|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715250|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715251|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715252|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
19734139|NCT04554771|Paclitaxel|paclitaxel|mesh-list
20251121|NCT00448552|Capecitabine|capecitabine|mesh-list
20251122|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
20251123|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251124|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
20251125|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251126|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251127|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19434326|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19434327|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434328|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251128|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
20251129|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20251130|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20251131|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20251132|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251133|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251134|NCT00448643|Cisplatin|cisplatin|mesh-list
20251135|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251136|NCT00448734|Docetaxel|docetaxel|mesh-list
20251137|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251138|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251139|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251140|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19434329|NCT03509168|Misoprostol|misoprostol|mesh-list
19434330|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19434331|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
19434332|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19434333|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434334|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19434335|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19434336|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
19434337|NCT03509142|Sirolimus|sirolimus|mesh-list
19434338|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434339|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434340|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19434341|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434342|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
19434343|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19434344|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
19434345|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251141|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251142|NCT00448786|Niacinamide|niacinamide|mesh-list
19434346|NCT03509051|Vaccines|vaccines|mesh-list
19434347|NCT03509051|Immunologic Factors|immunologic factors|mesh-ancestor
19434348|NCT03509051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434349|NCT03508999|Metronidazole|metronidazole|mesh-list
19434350|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434351|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434352|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19434353|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19434354|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20251143|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
20251144|NCT00448786|Imetelstat|imetelstat|mesh-list
20251145|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251146|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434355|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19434356|NCT03508921|Trimethoprim|trimethoprim|mesh-list
19434357|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
19434358|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19434359|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19434360|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434361|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
19434362|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19434363|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434364|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434365|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19434366|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434367|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434368|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
19434369|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434370|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19434371|NCT03508921|Renal Agents|renal agents|mesh-ancestor
19434372|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
19434373|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19434374|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19434375|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19434376|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434377|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19434378|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19858971|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19858972|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19858973|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858974|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
19858975|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19858976|NCT00776230|Vaccines|vaccines|mesh-list
20251147|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434379|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19434380|NCT03508895|Caseins|caseins|mesh-list
19434381|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
19434382|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
19434383|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434384|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
19434385|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19434386|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19434387|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19434388|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434389|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434390|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
19434391|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434392|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434393|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19434394|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715253|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715254|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
19715255|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19715256|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19715257|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715258|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19715259|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
19434395|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19434396|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20251148|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
20251149|NCT00448786|Vitamins|vitamins|mesh-ancestor
20251150|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
20251151|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251152|NCT00448825|Topiramate|topiramate|mesh-list
20251153|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
20251154|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251155|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251156|NCT00448838|Gemcitabine|gemcitabine|mesh-list
20251157|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
20251158|NCT00448838|Cetuximab|cetuximab|mesh-list
20251159|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251160|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
20251161|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251162|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251163|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
20251164|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251165|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434397|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19434398|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19715260|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251166|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251167|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
19434399|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19434400|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19434401|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19434402|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
19434403|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434404|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434405|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434406|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19434407|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434408|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
19434409|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19434410|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434411|NCT03508817|Atropine|atropine|mesh-list
19434412|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19434413|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19434414|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19434415|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19434416|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19434417|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
19434418|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434419|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434420|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19434421|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19434422|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
19434423|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
19434424|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19715261|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19715262|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19715263|NCT04736719|Warfarin|warfarin|mesh-list
19715264|NCT04736719|Apixaban|apixaban|mesh-list
19715265|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
19715266|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20532767|NCT01802970|Capecitabine|capecitabine|mesh-list
20532768|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20532769|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20532770|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532771|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
20532772|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
20532773|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
20532774|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532775|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532776|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
20532777|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532778|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
19434425|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19434426|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
19434427|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434428|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434429|NCT03508804|Lidocaine|lidocaine|mesh-list
19434430|NCT03508804|Prilocaine|prilocaine|mesh-list
19434431|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19434432|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
19434433|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
19434434|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434435|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434436|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
19434437|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434438|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19715267|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
19715268|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19715269|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
19715270|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715271|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715272|NCT04736433|Valsartan|valsartan|mesh-list
19715273|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19715274|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19715275|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19715276|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19715277|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715278|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
19715279|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715280|NCT04736420|Warfarin|warfarin|mesh-list
19715281|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
19715282|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
19434439|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19434440|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19434441|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434442|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434443|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19434444|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
19434445|NCT03508726|Vitamins|vitamins|mesh-ancestor
19434446|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
19434447|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434448|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
19434449|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434450|NCT03508726|Protective Agents|protective agents|mesh-ancestor
19434451|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
19434452|NCT03508635|Prednisone|prednisone|mesh-list
19434453|NCT03508635|Cortisone|cortisone|mesh-list
19434454|NCT03508635|Mifepristone|mifepristone|mesh-list
19434455|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19434456|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
19434457|NCT03508635|Hormones|hormones|mesh-ancestor
19434458|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434459|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251168|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251169|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20251170|NCT00448903|Bemiparin|bemiparin|mesh-list
20251171|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
20251172|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
20251173|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20251174|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251175|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
20286568|NCT03112603|Pentostatin|pentostatin|mesh-list
20286569|NCT03112603|Infliximab|infliximab|mesh-list
20532779|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20532780|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
19434460|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19434461|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434462|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19434463|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
19434464|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19434465|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19434466|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20532781|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286570|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286571|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286572|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
20286573|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286574|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286575|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20286576|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
20286577|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20286578|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20286579|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
20286580|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286581|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532782|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434467|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19434468|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
19434469|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19434470|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19434471|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
19434472|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
19434473|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19434474|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19434475|NCT03508440|Prednisone|prednisone|mesh-list
19434476|NCT03508440|Prednisolone|prednisolone|mesh-list
20532783|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20532784|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
20532785|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20532786|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20532787|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20532788|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
20532789|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434477|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19434478|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
19434479|NCT03508440|Hormones|hormones|mesh-ancestor
19434480|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434481|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434482|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19434483|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434484|NCT03508102|Remifentanil|remifentanil|mesh-list
19434485|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19434486|NCT03508102|Narcotics|narcotics|mesh-ancestor
19434487|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434488|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434489|NCT03508102|Analgesics|analgesics|mesh-ancestor
19434490|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
19434491|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451560|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
19451561|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
19451562|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451563|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451564|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
19715283|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19715284|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
19451565|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451566|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19451567|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19451568|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
19451569|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451570|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451571|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19451572|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19451573|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
19452797|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19715285|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19715286|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
20532790|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532791|NCT01803152|Gemcitabine|gemcitabine|mesh-list
20532792|NCT01803152|Imiquimod|imiquimod|mesh-list
20532793|NCT01803152|Vaccines|vaccines|mesh-list
20532794|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
20532795|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532796|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20532797|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
20532798|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532799|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532800|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
20532801|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532802|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532803|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532804|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20532805|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
20532806|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
20532807|NCT01803191|Fosfomycin|fosfomycin|mesh-list
20532808|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20532809|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532810|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20532811|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532812|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532813|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532814|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532815|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20532816|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19434492|NCT03507842|Cytarabine|cytarabine|mesh-list
19434493|NCT03507842|Daunorubicin|daunorubicin|mesh-list
19434494|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19434495|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
19434496|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434497|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434498|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
19434499|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434500|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19434501|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
19434502|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434503|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715287|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715288|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858977|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
19858978|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858979|NCT00776594|Bevacizumab|bevacizumab|mesh-list
19858980|NCT00776594|Bicalutamide|bicalutamide|mesh-list
19858981|NCT00776594|Androgens|androgens|mesh-list
19858982|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19858983|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858984|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19858985|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19858986|NCT00776594|Growth Substances|growth substances|mesh-ancestor
19858987|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858988|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
19858989|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
19858990|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
19858991|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19858992|NCT00776594|Hormones|hormones|mesh-ancestor
19858993|NCT00776659|Exemestane|exemestane|mesh-list
19858994|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19858995|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19858996|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19858997|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434504|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19434505|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19434506|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434507|NCT03507829|Insulin|insulin|mesh-list
19715289|NCT04736589|Sirolimus|sirolimus|mesh-list
19715290|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715291|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715292|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715293|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715294|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
19434508|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19715295|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715296|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
19715297|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19858998|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19858999|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19859000|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
19859001|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19859002|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969636|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19969637|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19969638|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969639|NCT01774604|Indomethacin|indomethacin|mesh-list
19969640|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19434509|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
19434510|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
19434511|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
19434512|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
19434513|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19434514|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715298|NCT04736329|Telmisartan|telmisartan|mesh-list
19969641|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20532817|NCT01803321|Rilonacept|rilonacept|mesh-list
20532818|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715299|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19715300|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19715301|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19715302|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715303|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
19715304|NCT04736381|Abatacept|abatacept|mesh-list
19715305|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715306|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715307|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19715308|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
19715309|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715310|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715311|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532819|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20532820|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
20532821|NCT01803347|Coagulants|coagulants|mesh-ancestor
20532822|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
20532823|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20532824|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532825|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20532826|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19434515|NCT03507751|Meropenem|meropenem|mesh-list
19734140|NCT04554771|Carboplatin|carboplatin|mesh-list
19715312|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715313|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715314|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
19715315|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715316|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20251176|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
20251177|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20251178|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251179|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
20251180|NCT00449020|Carboplatin|carboplatin|mesh-list
19715317|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19715318|NCT04736108|Prednisolone|prednisolone|mesh-list
19715319|NCT04736108|Goserelin|goserelin|mesh-list
19715320|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
19434516|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434517|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434518|NCT03507634|Lidocaine|lidocaine|mesh-list
19434519|NCT03507634|Fentanyl|fentanyl|mesh-list
19434520|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
19434521|NCT03507634|Remifentanil|remifentanil|mesh-list
19434522|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
19434523|NCT03507634|Anesthetics|anesthetics|mesh-list
19434524|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
19434525|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434526|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434527|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
19715321|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715322|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
19715323|NCT04736108|Hormones|hormones|mesh-ancestor
19715324|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715325|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715326|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19715327|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715328|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19715329|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734141|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19859003|NCT00776919|Clindamycin|clindamycin|mesh-list
20251181|NCT00449020|Docetaxel|docetaxel|mesh-list
20251182|NCT00449020|Irinotecan|irinotecan|mesh-list
20251183|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251184|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251185|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251186|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
19434528|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286582|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434529|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19434530|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19434531|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19434532|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19715330|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715331|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
19715332|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19715333|NCT04736225|Insulin|insulin|mesh-list
19715334|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19715335|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715336|NCT04736186|Loperamide|loperamide|mesh-list
19434533|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434534|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19434535|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19434536|NCT03507634|Analgesics|analgesics|mesh-ancestor
19434537|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19434538|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19434539|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19434540|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19434541|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434542|NCT03507634|Narcotics|narcotics|mesh-ancestor
19434543|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715337|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
19434544|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19434545|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
19434546|NCT03507608|Flutamide|flutamide|mesh-list
19434547|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
19434548|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
19434549|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434550|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434551|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19434552|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434553|NCT03507556|Metronidazole|metronidazole|mesh-list
19434554|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
19434555|NCT03507556|Minocycline|minocycline|mesh-list
19434556|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
19434557|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434558|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434559|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20251187|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251188|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20251189|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20251190|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251191|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
20251192|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
20251193|NCT00449137|Leucovorin|leucovorin|mesh-list
20251194|NCT00449137|Fluorouracil|fluorouracil|mesh-list
20251195|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
20251196|NCT00449137|Calcium|calcium|mesh-list
20251197|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
20251198|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20251199|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251200|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
19715338|NCT04736186|Bentonite|bentonite|mesh-list
19715339|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715340|NCT04736186|Antidotes|antidotes|mesh-ancestor
19715341|NCT04736186|Protective Agents|protective agents|mesh-ancestor
19715342|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715343|NCT04735978|Antibodies|antibodies|mesh-list
19434560|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19715344|NCT04735978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19715345|NCT04735978|Immunologic Factors|immunologic factors|mesh-ancestor
19715346|NCT04735978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251201|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715347|NCT04735523|Warfarin|warfarin|mesh-list
19715348|NCT04735523|Dabigatran|dabigatran|mesh-list
19715349|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
19715350|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
20251202|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251203|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251204|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251205|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
20251206|NCT00449137|Antidotes|antidotes|mesh-ancestor
20251207|NCT00449137|Protective Agents|protective agents|mesh-ancestor
20251208|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
19434561|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19434562|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19434563|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434564|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434565|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434566|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19434567|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19434568|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
19434569|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
19434570|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19434571|NCT03507556|Protective Agents|protective agents|mesh-ancestor
19434572|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434573|NCT03507465|Capecitabine|capecitabine|mesh-list
19434574|NCT03507465|Letrozole|letrozole|mesh-list
19434575|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19434576|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
19434577|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434578|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434579|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19434580|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19434581|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434582|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19434583|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
19434584|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434585|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434586|NCT03507426|Ketamine|ketamine|mesh-list
19434587|NCT03507426|Analgesics|analgesics|mesh-ancestor
19434588|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
19434589|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715351|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19715352|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
20251209|NCT00449137|Vitamins|vitamins|mesh-ancestor
20251210|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
20251211|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
20251212|NCT00449202|Estrone|estrone|mesh-list
20251213|NCT00449202|Estrogens|estrogens|mesh-ancestor
20251214|NCT00449202|Hormones|hormones|mesh-ancestor
19715353|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715354|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251215|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251216|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251217|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19715355|NCT04735445|Liver Extracts|liver extracts|mesh-list
19859004|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
19859005|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
20251218|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
20251219|NCT00449254|Estrone|estrone|mesh-list
19715356|NCT04735445|Hematinics|hematinics|mesh-ancestor
19715357|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
19715358|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
19715359|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715360|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715361|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
19859006|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19859007|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715362|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
19715363|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715364|NCT04735510|Cyclosporine|cyclosporine|mesh-list
19715365|NCT04735510|Cyclosporins|cyclosporins|mesh-list
19859008|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859009|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19859010|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859011|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251220|NCT00449254|Estrogens|estrogens|mesh-ancestor
20251221|NCT00449254|Hormones|hormones|mesh-ancestor
20251222|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251223|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251224|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20251225|NCT00449280|Sirolimus|sirolimus|mesh-list
20251226|NCT00449280|Sorafenib|sorafenib|mesh-list
20251227|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251228|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19715366|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859012|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
19434590|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434591|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19434592|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19434593|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
19434594|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
19434595|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434596|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19434597|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19434598|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434599|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859013|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
19859014|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19859015|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
19859016|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859017|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859018|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20251229|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286583|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19434600|NCT03507413|Metformin|metformin|mesh-list
19715367|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715368|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715369|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
19715370|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715371|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
19715372|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715373|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
19715374|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19715375|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19715376|NCT04735549|Hormones|hormones|mesh-list
19715377|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715378|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734142|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734143|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734144|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734145|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
19734146|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734147|NCT04553705|Quinine|quinine|mesh-list
19734148|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
19734149|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19734150|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19734151|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734152|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19859019|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859020|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
19859021|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19859022|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
19859023|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859024|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859025|NCT00777023|Gabapentin|gabapentin|mesh-list
19859026|NCT00777023|Analgesics|analgesics|mesh-ancestor
19859027|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
20251230|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251231|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251232|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734153|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734154|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19734155|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734156|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19734157|NCT04553705|Analgesics|analgesics|mesh-ancestor
19734158|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
19734159|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19734160|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19734161|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734162|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
19734163|NCT04553263|Naltrexone|naltrexone|mesh-list
19734164|NCT04553263|Bupropion|bupropion|mesh-list
19734165|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19734166|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19734167|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734168|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
19734169|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734170|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19734171|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
19734172|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19734173|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19734174|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19734175|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734176|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734177|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
19734178|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734179|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20251233|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20251234|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
20251235|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19434601|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19434602|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434603|NCT03507387|Phenylephrine|phenylephrine|mesh-list
19434604|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
19434605|NCT03507387|Bupivacaine|bupivacaine|mesh-list
19434606|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
19434607|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
19434608|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434609|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434610|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
19434611|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434612|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19434613|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
19434614|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
19434615|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
19434616|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19434617|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
19434618|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
19434619|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19434620|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19434621|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19434622|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
19434623|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434624|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434625|NCT03507387|Protective Agents|protective agents|mesh-ancestor
19434626|NCT03507348|Rituximab|rituximab|mesh-list
19434627|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19434628|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434629|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
19434630|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434631|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19434632|NCT03507244|Dexamethasone|dexamethasone|mesh-list
19434633|NCT03507244|Pemetrexed|pemetrexed|mesh-list
19434634|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19434635|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
19434636|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
19434637|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434638|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434639|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19434640|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
19434641|NCT03507244|Hormones|hormones|mesh-ancestor
19434642|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434643|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19715379|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
20251236|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
20251237|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251238|NCT00449319|Daunorubicin|daunorubicin|mesh-list
20251239|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20251240|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251241|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20251242|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20532827|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532828|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532829|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532830|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20532831|NCT01803503|Docetaxel|docetaxel|mesh-list
20532832|NCT01803503|Sunitinib|sunitinib|mesh-list
20532833|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532834|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
20532835|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251243|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452798|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20532836|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
19715380|NCT04735042|Empagliflozin|empagliflozin|mesh-list
19715381|NCT04735042|Linagliptin|linagliptin|mesh-list
19715382|NCT04735042|Saxagliptin|saxagliptin|mesh-list
19434644|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434645|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434646|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434647|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19434648|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19434649|NCT03507231|Vaccines|vaccines|mesh-list
19434650|NCT03507231|Immunologic Factors|immunologic factors|mesh-ancestor
19434651|NCT03507231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434652|NCT03507166|Trastuzumab|trastuzumab|mesh-list
19715383|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19715384|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715385|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19434653|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20251244|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251245|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20532837|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715386|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715387|NCT04735042|Incretins|incretins|mesh-ancestor
19715388|NCT04735042|Hormones|hormones|mesh-ancestor
19715389|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715390|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19715391|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
19434654|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715392|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715393|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
19715394|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715395|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715396|NCT04734678|Infliximab|infliximab|mesh-list
19715397|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
19715398|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715399|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19715400|NCT04734730|Prednisone|prednisone|mesh-list
19715401|NCT04734730|Cortisone|cortisone|mesh-list
19715402|NCT04734730|Leuprolide|leuprolide|mesh-list
19715403|NCT04734730|Goserelin|goserelin|mesh-list
19715404|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
19715405|NCT04734730|Bicalutamide|bicalutamide|mesh-list
19715406|NCT04734730|Talazoparib|talazoparib|mesh-list
19715407|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715408|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
19715409|NCT04734730|Hormones|hormones|mesh-ancestor
19715410|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715411|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715412|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19715413|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715414|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19715415|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
19715416|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19859028|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859029|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859030|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
19859031|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19859032|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19859033|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859034|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19859035|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19859036|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19859037|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532838|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20532839|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20532840|NCT01803503|Growth Substances|growth substances|mesh-ancestor
20532841|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532842|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
20532843|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20532844|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532845|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
20532846|NCT01803594|Niacin|niacin|mesh-list
20532847|NCT01803594|Niacinamide|niacinamide|mesh-list
20532848|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
20532849|NCT01803594|Vitamins|vitamins|mesh-ancestor
20532850|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
20532851|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532852|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20532853|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
19434655|NCT03507127|Varenicline|varenicline|mesh-list
19434656|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19434657|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19434658|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
19434659|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434660|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434661|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434662|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
19434663|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19434664|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19434665|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
19434666|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19434667|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434668|NCT03506919|Allopurinol|allopurinol|mesh-list
19434669|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
19434670|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434671|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434672|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
19434673|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19434674|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19715417|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19715418|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715419|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859038|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859039|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
19715420|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
19715421|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19715422|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
19715423|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19715424|NCT04734782|Antibodies|antibodies|mesh-list
19859040|NCT00777049|Panobinostat|panobinostat|mesh-list
19859041|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859042|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19859043|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859044|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715425|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
19715426|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715427|NCT04734665|Bevacizumab|bevacizumab|mesh-list
19859045|NCT00777062|Naltrexone|naltrexone|mesh-list
19859046|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19859047|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19859048|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859049|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
19859050|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859051|NCT00777101|Capecitabine|capecitabine|mesh-list
19859052|NCT00777101|Lapatinib|lapatinib|mesh-list
20532854|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532855|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20532856|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
20532857|NCT01803659|Vitamin A|vitamin a|mesh-list
20532858|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
20532859|NCT01803659|Carotenoids|carotenoids|mesh-list
20532860|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
20532861|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532862|NCT01803659|Protective Agents|protective agents|mesh-ancestor
20532863|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532864|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20532865|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434675|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
19434676|NCT03506919|Protective Agents|protective agents|mesh-ancestor
20532866|NCT01803659|Vitamins|vitamins|mesh-ancestor
20532867|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
20251246|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
20251247|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20251248|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20251249|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20251250|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251251|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251252|NCT00449410|Atorvastatin|atorvastatin|mesh-list
19434677|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434678|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
19434679|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19434680|NCT03506841|Protective Agents|protective agents|mesh-ancestor
19434681|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434682|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
19434683|NCT03506828|Phenol|phenol|mesh-list
19715428|NCT04734665|Niraparib|niraparib|mesh-list
19715429|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19715430|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434684|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19434685|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434686|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
19434687|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19434688|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19434689|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
19434690|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19434691|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
19434692|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19434693|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
19434694|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434695|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434696|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
19434697|NCT03506802|Aldesleukin|aldesleukin|mesh-list
19434698|NCT03506802|Plerixafor|plerixafor|mesh-list
19434699|NCT03506802|Lenalidomide|lenalidomide|mesh-list
19715431|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19715432|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19715433|NCT04734665|Growth Substances|growth substances|mesh-ancestor
19715434|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715435|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
19715436|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19715437|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715438|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715439|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19715440|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859053|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859054|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
19859055|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859056|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434700|NCT03506802|Melphalan|melphalan|mesh-list
19434701|NCT03506802|Interleukin-2|interleukin-2|mesh-list
19434702|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
19715441|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19715442|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715443|NCT05314673|Bevacizumab|bevacizumab|mesh-list
19859057|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19859058|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859059|NCT00777153|Cediranib|cediranib|mesh-list
19859060|NCT00777153|Lomustine|lomustine|mesh-list
19859061|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859062|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19859063|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434703|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19434704|NCT03506802|Lenograstim|lenograstim|mesh-list
20251253|NCT00449410|Ezetimibe|ezetimibe|mesh-list
20251254|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19859064|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859065|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19859066|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
19859067|NCT00777296|Amikacin|amikacin|mesh-list
19715444|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19715445|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715446|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19715447|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19715448|NCT05314673|Growth Substances|growth substances|mesh-ancestor
19715449|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715450|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19715451|NCT05314621|Fluticasone|fluticasone|mesh-list
19715452|NCT05314621|Xhance|xhance|mesh-list
19859068|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434705|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19434706|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
19434707|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434708|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19715453|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19715454|NCT05314621|Dextrans|dextrans|mesh-list
19715455|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19715456|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715457|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19715458|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
19715459|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434709|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19434710|NCT03506802|Growth Substances|growth substances|mesh-ancestor
19434711|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
19434712|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434713|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19434714|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
20251255|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19859069|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251256|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
19434715|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434716|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19434717|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19434718|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19434719|NCT03506802|Analgesics|analgesics|mesh-ancestor
19434720|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
19434721|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434722|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19434723|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19715460|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715461|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19859070|NCT00777335|Panobinostat|panobinostat|mesh-list
19859071|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859072|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20532868|NCT01803763|Omalizumab|omalizumab|mesh-list
19434724|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
19434725|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434726|NCT03506789|Dexamethasone|dexamethasone|mesh-list
19434727|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19434728|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
19434729|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
19434730|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434731|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434732|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19434733|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
19434734|NCT03506789|Hormones|hormones|mesh-ancestor
19434735|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434736|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19434737|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434738|NCT03506763|Diclofenac|diclofenac|mesh-list
19434739|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19434740|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19434741|NCT03506763|Analgesics|analgesics|mesh-ancestor
19434742|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
19434743|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434744|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434745|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251257|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715462|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
19715463|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
19715464|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19715465|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20251258|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20251259|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20251260|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251261|NCT00449423|Acipimox|acipimox|mesh-list
19715466|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19715467|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19715468|NCT05314621|Analgesics|analgesics|mesh-ancestor
19715469|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
20251262|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20251263|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
20251264|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251265|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20251266|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20251267|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20251268|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
20251269|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20251270|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251271|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251272|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
20251273|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251274|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19434746|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20251275|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20251276|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20251277|NCT00449449|Lidocaine|lidocaine|mesh-list
20251278|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
20251279|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
20251280|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251281|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251282|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
20251283|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251284|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20251285|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20251286|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20251287|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20251288|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251289|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
20251290|NCT00449488|Hematinics|hematinics|mesh-ancestor
20251291|NCT00449501|Budesonide|budesonide|mesh-list
20251292|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
20251293|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251294|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20251295|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
20251296|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251297|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251298|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20532869|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20532870|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19715470|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19715471|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19715472|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19715473|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
19715474|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
19715475|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715476|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715477|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
19715478|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
19715479|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
19715480|NCT05314569|Fentanyl|fentanyl|mesh-list
19715481|NCT05314569|Midazolam|midazolam|mesh-list
19715482|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
19715483|NCT05314569|Ketamine|ketamine|mesh-list
19715484|NCT05314569|Isoflurane|isoflurane|mesh-list
19715485|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19715486|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715487|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715488|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19715489|NCT05314569|Analgesics|analgesics|mesh-ancestor
19715490|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
19715491|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715492|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19715493|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19715494|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19715495|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715496|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715497|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715498|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19715499|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19715500|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
19715501|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
19715502|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19715503|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19715504|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19715505|NCT05314569|Narcotics|narcotics|mesh-ancestor
19715506|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715507|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19715508|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19715509|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715510|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
19715511|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
19715512|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19715513|NCT05314400|Liver Extracts|liver extracts|mesh-list
19715514|NCT05314400|Hematinics|hematinics|mesh-ancestor
19715515|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
19715516|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859073|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532871|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
19715517|NCT05314270|Copper|copper|mesh-list
20251299|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
20251300|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
20251301|NCT00449501|Hormones|hormones|mesh-ancestor
20251302|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715518|NCT05314270|Trace Elements|trace elements|mesh-ancestor
20251303|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20251304|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20251305|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20251306|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
19434747|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19434748|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251307|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251308|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251309|NCT00449514|Tamoxifen|tamoxifen|mesh-list
20251310|NCT00449514|Clomiphene|clomiphene|mesh-list
20251311|NCT00449514|Enclomiphene|enclomiphene|mesh-list
20251312|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
20251313|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20251314|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
20251315|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251316|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251317|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20251318|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251319|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20251320|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20251321|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20251322|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20251323|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
20251324|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20532872|NCT01803828|Tadalafil|tadalafil|mesh-list
20532873|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
20532874|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20532875|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20532876|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532877|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532878|NCT01803828|Urological Agents|urological agents|mesh-ancestor
20553398|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553399|NCT01929161|Oxytocin|oxytocin|mesh-list
20553400|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
20553401|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553402|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553403|NCT01929187|Amorolfine|amorolfine|mesh-list
20553404|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
20553405|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554914|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20554915|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
20554916|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
20554917|NCT01937754|Protective Agents|protective agents|mesh-ancestor
20554918|NCT01937767|Fentanyl|fentanyl|mesh-list
19434749|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554919|NCT01937767|Remifentanil|remifentanil|mesh-list
20554920|NCT01937767|Propofol|propofol|mesh-list
20554921|NCT01937767|Sevoflurane|sevoflurane|mesh-list
20554922|NCT01937767|Rocuronium|rocuronium|mesh-list
20554923|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20554924|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554925|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554926|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19434750|NCT03506620|Ropivacaine|ropivacaine|mesh-list
19715519|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
20554927|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
20554928|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
20251325|NCT00449527|Budesonide|budesonide|mesh-list
20251326|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
20251327|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251328|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20251329|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
20251330|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251331|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251332|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20251333|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
20251334|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
19434751|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
19434752|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
19434753|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434754|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434755|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
19434756|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715520|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715521|NCT05314257|Granisetron|granisetron|mesh-list
19715522|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
19715523|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
19715524|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715525|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715526|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969642|NCT01774604|Analgesics|analgesics|mesh-ancestor
20532879|NCT01804127|Rituximab|rituximab|mesh-list
20532880|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20532881|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532882|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
20532883|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532884|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532885|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
20532886|NCT01804205|Analgesics|analgesics|mesh-ancestor
20532887|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
20251335|NCT00449527|Hormones|hormones|mesh-ancestor
20532888|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434757|NCT03506542|Mitomycins|mitomycins|mesh-list
19434758|NCT03506542|Mitomycin|mitomycin|mesh-list
19434759|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19434760|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434761|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
19434762|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434763|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19434764|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434765|NCT03506516|Ethanol|ethanol|mesh-list
19434766|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19434767|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434768|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434769|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434770|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
19434771|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19434772|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
19434773|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
19434774|NCT03506399|Estradiol|estradiol|mesh-list
19434775|NCT03506399|Estrogens|estrogens|mesh-ancestor
19434776|NCT03506399|Hormones|hormones|mesh-ancestor
19434777|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19434778|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715527|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19715528|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
19715529|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715530|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715531|NCT05314153|Brexanolone|brexanolone|mesh-list
19715532|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
19715533|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715534|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715535|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715536|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
19859074|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859075|NCT00777491|Gemcitabine|gemcitabine|mesh-list
19859076|NCT00777491|Cisplatin|cisplatin|mesh-list
19859077|NCT00777491|Fluorouracil|fluorouracil|mesh-list
19859078|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859079|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859080|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
19859081|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859082|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
19434779|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19434780|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19434781|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19434782|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19434783|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19434784|NCT03506373|Ixazomib|ixazomib|mesh-list
19434785|NCT03506373|Glycine|glycine|mesh-list
20251336|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251337|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20251338|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20251339|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20251340|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
20251341|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251342|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251343|NCT00449553|Metformin|metformin|mesh-list
20251344|NCT00449553|Pioglitazone|pioglitazone|mesh-list
20251345|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251346|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251347|NCT00449618|Aspirin|aspirin|mesh-list
20251348|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20251349|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20251350|NCT00449618|Analgesics|analgesics|mesh-ancestor
20251351|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
20251352|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553406|NCT01929213|Bosentan|bosentan|mesh-list
20553407|NCT01929213|Udenafil|udenafil|mesh-list
19452799|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
20553408|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20553409|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20554929|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20251353|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251354|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251355|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20251356|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20251357|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20251358|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434786|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434787|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434788|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
19434789|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434790|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
19434791|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434792|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434793|NCT03506256|Norfloxacin|norfloxacin|mesh-list
19434794|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19434795|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251359|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20251360|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20251361|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251362|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
20251363|NCT00449657|Gemcitabine|gemcitabine|mesh-list
20251364|NCT00449657|Paclitaxel|paclitaxel|mesh-list
20251365|NCT00449657|Carboplatin|carboplatin|mesh-list
20251366|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20251367|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251368|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251369|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
19859083|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859084|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859085|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251370|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
20251371|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251372|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251373|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
20251374|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
20251375|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251376|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251377|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19434796|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19434797|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19434798|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434799|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434800|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532889|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532890|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
20532891|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20532892|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20532893|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
20532894|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19434801|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19434802|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19451574|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20532895|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20532896|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532897|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20532898|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
19859086|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
19859087|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859088|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
19859089|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19859090|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
19859091|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20251378|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
20532899|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20532900|NCT01804218|Nadolol|nadolol|mesh-list
20532901|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20532902|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20532903|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
20532904|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532905|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532906|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532907|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20532908|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20532909|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
20532910|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
20532911|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20532912|NCT01804244|Rilpivirine|rilpivirine|mesh-list
20532913|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20532914|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20532915|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532916|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532917|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
20532918|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434803|NCT03506178|Phenylephrine|phenylephrine|mesh-list
19434804|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
19434805|NCT03506178|Menthol|menthol|mesh-list
19434806|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
19434807|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
19434808|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19434809|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19715537|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
19715538|NCT05314140|Calcium|calcium|mesh-list
19715539|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19715540|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715541|NCT05314101|Bevacizumab|bevacizumab|mesh-list
19715542|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19715543|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434810|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
19434811|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434812|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434813|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434814|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
19434815|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
19434816|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434817|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
19434818|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19434819|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
19434820|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19715544|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19715545|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19715546|NCT05314101|Growth Substances|growth substances|mesh-ancestor
19859092|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859093|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19859094|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19859095|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19434821|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
19434822|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19434823|NCT03506178|Protective Agents|protective agents|mesh-ancestor
19715547|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715548|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
19715549|NCT05313958|Cytarabine|cytarabine|mesh-list
19715550|NCT05313958|Sorafenib|sorafenib|mesh-list
19434824|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19434825|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19434826|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434827|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
19715551|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
19715552|NCT05313958|Idarubicin|idarubicin|mesh-list
19859096|NCT00777608|Donepezil|donepezil|mesh-list
19859097|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19715553|NCT05313958|Cladribine|cladribine|mesh-list
19434828|NCT03506061|Ivacaftor|ivacaftor|mesh-list
19434829|NCT03506061|Elexacaftor|elexacaftor|mesh-list
19434830|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19434831|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434832|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434833|NCT03506048|Lenvatinib|lenvatinib|mesh-list
19434834|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434835|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19434836|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434837|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434838|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19434839|NCT03506009|Argatroban|argatroban|mesh-list
19434840|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19434841|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19434842|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434843|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
19434844|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19434845|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
19434846|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434847|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
19434848|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19434849|NCT03505788|Acetazolamide|acetazolamide|mesh-list
19434850|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
19434851|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19434852|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434853|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434854|NCT03505788|Diuretics|diuretics|mesh-ancestor
19715554|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19715555|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
19715556|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715557|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715558|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
19715559|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715560|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715561|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
19715562|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715563|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19715564|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715565|NCT05313958|Analgesics|analgesics|mesh-ancestor
19715566|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
19715567|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715568|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19715569|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19715570|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715571|NCT05313906|Cisplatin|cisplatin|mesh-list
19715572|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715573|NCT05313828|Fluorometholone|fluorometholone|mesh-list
19859098|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715574|NCT05313828|Tobramycin|tobramycin|mesh-list
19715575|NCT05313828|Acyclovir|acyclovir|mesh-list
19715576|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
19715577|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715578|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434855|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
19434856|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434857|NCT03505736|Adenosine|adenosine|mesh-list
19434858|NCT03505736|Regadenoson|regadenoson|mesh-list
19434859|NCT03505736|Analgesics|analgesics|mesh-ancestor
19434860|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
19434861|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434862|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434863|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19434864|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
19434865|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19434866|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
19434867|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
19434868|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20532919|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20532920|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20532921|NCT01804335|Trifarotene|trifarotene|mesh-list
20532922|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532923|NCT01804361|Cyclosporine|cyclosporine|mesh-list
20532924|NCT01804361|Cyclosporins|cyclosporins|mesh-list
20251379|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251380|NCT00449683|Terazosin|terazosin|mesh-list
20251381|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20251382|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20251383|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20251384|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
20251385|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251386|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251387|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251388|NCT00449683|Urological Agents|urological agents|mesh-ancestor
20251389|NCT00449722|Mesalamine|mesalamine|mesh-list
20251390|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20251391|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20251392|NCT00449722|Analgesics|analgesics|mesh-ancestor
20251393|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
20251394|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251395|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251396|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251397|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19434869|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434870|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19434871|NCT03505528|Paclitaxel|paclitaxel|mesh-list
19434872|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19434873|NCT03505528|Phenelzine|phenelzine|mesh-list
19434874|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20251398|NCT00449774|Lamotrigine|lamotrigine|mesh-list
20251399|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
20251400|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20251401|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20251402|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251403|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20251404|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251405|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20251406|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20532925|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434875|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434876|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
19434877|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
20532926|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532927|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532928|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
20532929|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532930|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
19434878|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
20532931|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434879|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532932|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532933|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532934|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19434880|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
19434881|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19434882|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19434883|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434884|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
20532935|NCT01804374|Everolimus|everolimus|mesh-list
20532936|NCT01804374|Sorafenib|sorafenib|mesh-list
20532937|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532938|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20532939|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
20532940|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532941|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20532942|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532943|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532944|NCT01804387|Lamivudine|lamivudine|mesh-list
20532945|NCT01804387|Adefovir|adefovir|mesh-list
20532946|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20532947|NCT01804387|Telbivudine|telbivudine|mesh-list
20532948|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20532949|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20532950|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532951|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532952|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
20532953|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20532954|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20532955|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20532956|NCT01804400|Montelukast|montelukast|mesh-list
20532957|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20532958|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
20532959|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20532960|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
20532961|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715579|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19715580|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
19715581|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715582|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
19715583|NCT05313828|Protective Agents|protective agents|mesh-ancestor
19715584|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
20532962|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532963|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20532964|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20532965|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532966|NCT01804413|Insulin|insulin|mesh-list
20532967|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20532968|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532969|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434885|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19715585|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715586|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
19715587|NCT05313828|Hormones|hormones|mesh-ancestor
19715588|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715589|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19734180|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19859099|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532970|NCT01804543|Ranolazine|ranolazine|mesh-list
20532971|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20532972|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20532973|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532974|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
20532975|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20251407|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251408|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20251409|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20251410|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
20251411|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251412|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715590|NCT05313750|Levofloxacin|levofloxacin|mesh-list
19715591|NCT05313750|Ofloxacin|ofloxacin|mesh-list
19715592|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
19715593|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
19715594|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19715595|NCT05313750|Renal Agents|renal agents|mesh-ancestor
19715596|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715597|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19715598|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19715599|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715600|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715601|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434886|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19859100|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
19859101|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859102|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859103|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
19859104|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
19859105|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19859106|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19859107|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19859108|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19859109|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859110|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859111|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
19859112|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859113|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859114|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19859115|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859116|NCT00777829|Zolpidem|zolpidem|mesh-list
19859117|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19859118|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19859119|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859120|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859121|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19859122|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
19859123|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
19859124|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434887|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434888|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
19434889|NCT03505502|Coagulants|coagulants|mesh-ancestor
19434890|NCT03505489|Mannitol|mannitol|mesh-list
19434891|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
19434892|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19434893|NCT03505489|Diuretics|diuretics|mesh-ancestor
19434894|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
20251413|NCT00449813|Pantoprazole|pantoprazole|mesh-list
19434895|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715602|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19715603|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19715604|NCT05313620|Adalimumab|adalimumab|mesh-list
19715605|NCT05313620|Golimumab|golimumab|mesh-list
20251414|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20251415|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20251416|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20532976|NCT01804595|Protective Agents|protective agents|mesh-ancestor
20532977|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532978|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
20532979|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
20532980|NCT01804634|Melphalan|melphalan|mesh-list
20532981|NCT01804634|Fludarabine|fludarabine|mesh-list
19434896|NCT03505489|Miotics|miotics|mesh-ancestor
19715606|NCT05313620|Infliximab|infliximab|mesh-list
19715607|NCT05313620|Tofacitinib|tofacitinib|mesh-list
19434897|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
19434898|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434899|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19434900|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19434901|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
20251417|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251418|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251419|NCT00449839|Insulin|insulin|mesh-list
20251420|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20251421|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
20251422|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
20251423|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20251424|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251425|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251426|NCT00450008|Thalidomide|thalidomide|mesh-list
20251427|NCT00450008|Docetaxel|docetaxel|mesh-list
20251428|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251429|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251430|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251431|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
20251432|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251433|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251434|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
20251435|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251436|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
20251437|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251438|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251439|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20251440|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20532982|NCT01804634|Tacrolimus|tacrolimus|mesh-list
20532983|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251441|NCT00450008|Growth Substances|growth substances|mesh-ancestor
20251442|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
20251443|NCT00450086|Budesonide|budesonide|mesh-list
20251444|NCT00450086|Mesalamine|mesalamine|mesh-list
20251445|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251446|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20251447|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
20251448|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251449|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251450|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20251451|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
19434902|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19434903|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19434904|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
19434905|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434906|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434907|NCT03505411|Melatonin|melatonin|mesh-list
19434908|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
19434909|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434910|NCT03505411|Protective Agents|protective agents|mesh-ancestor
19434911|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434912|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434913|NCT03505255|Neostigmine|neostigmine|mesh-list
19434914|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19434915|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434916|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434917|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
20251452|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
20251453|NCT00450086|Hormones|hormones|mesh-ancestor
20251454|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20532984|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
20532985|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532986|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20532987|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20251455|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20251456|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20532988|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
20532989|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20532990|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554930|NCT01937767|Narcotics|narcotics|mesh-ancestor
20251457|NCT00450086|Analgesics|analgesics|mesh-ancestor
20251458|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
20251459|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20251460|NCT00450099|Bupivacaine|bupivacaine|mesh-list
20251461|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
19434918|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251462|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
20251463|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251464|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251465|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
20251466|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251467|NCT00450138|Cisplatin|cisplatin|mesh-list
20251468|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251469|NCT00450164|Nadolol|nadolol|mesh-list
20251470|NCT00450164|Prazosin|prazosin|mesh-list
20251471|NCT00450164|Isosorbide|isosorbide|mesh-list
19434919|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434920|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19434921|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
19434922|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434923|NCT03505151|BI 409306|bi 409306|mesh-list
20251472|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19434924|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19434925|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434926|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434927|NCT03505047|Copper|copper|mesh-list
19434928|NCT03505047|Trace Elements|trace elements|mesh-ancestor
19434929|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
19434930|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434931|NCT03505008|Adalimumab|adalimumab|mesh-list
19434932|NCT03505008|Methotrexate|methotrexate|mesh-list
20251473|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19715608|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715609|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19715610|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
19715611|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715612|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19715613|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715614|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715615|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19859125|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859126|NCT00777855|Rifampin|rifampin|mesh-list
20251474|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20251475|NCT00450164|Diuretics|diuretics|mesh-ancestor
20251476|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
20251477|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251478|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
20251479|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20251480|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251481|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20251482|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20251483|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20532991|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20532992|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20532993|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20532994|NCT01804712|Rituximab|rituximab|mesh-list
20532995|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20532996|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20532997|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
19434933|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19715616|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715617|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
19715618|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715619|NCT05313529|Metformin|metformin|mesh-list
19715620|NCT05313529|Liraglutide|liraglutide|mesh-list
19715621|NCT05313529|Empagliflozin|empagliflozin|mesh-list
19715622|NCT05313529|Linagliptin|linagliptin|mesh-list
19715623|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20532998|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20532999|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533000|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20533001|NCT01804777|Amiloride|amiloride|mesh-list
20533002|NCT01804777|Diuretics|diuretics|mesh-ancestor
20533003|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
20533004|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533005|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20533006|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19715624|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715625|NCT05313529|Incretins|incretins|mesh-ancestor
19715626|NCT05313529|Hormones|hormones|mesh-ancestor
19715627|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715628|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19715629|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715630|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20533007|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533008|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533009|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19715631|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
19715632|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715633|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
19715634|NCT05313477|Vitamin D|vitamin d|mesh-list
19715635|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
19715636|NCT05313477|Calcium|calcium|mesh-list
19715637|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19715638|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715639|NCT05313477|Antacids|antacids|mesh-ancestor
19715640|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715641|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859127|NCT00777855|Warfarin|warfarin|mesh-list
19859128|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
19859129|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19859130|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
19859131|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19859132|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859133|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
19859134|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20533010|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19434934|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
19434935|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19434936|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434937|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19434938|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
20533011|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20533012|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20533013|NCT01804790|Capecitabine|capecitabine|mesh-list
20533014|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859135|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434939|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434940|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434941|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
20533015|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
20554931|NCT01937767|Analgesics|analgesics|mesh-ancestor
19434942|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434943|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19434944|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19715642|NCT05313477|Vitamins|vitamins|mesh-ancestor
19715643|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
19715644|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19715645|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19715646|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19715647|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
19715648|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19715649|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715650|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715651|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19715652|NCT05313386|Analgesics|analgesics|mesh-ancestor
19715653|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
19715654|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715655|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19715656|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19715657|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19715658|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715659|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715660|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715661|NCT05313308|Midazolam|midazolam|mesh-list
19715662|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715663|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19715664|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715665|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859136|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859137|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19859138|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19859139|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19859140|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19859141|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19859142|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19859143|NCT00777920|Ambrisentan|ambrisentan|mesh-list
19859144|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19859145|NCT00777946|Amlodipine|amlodipine|mesh-list
19859146|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19715666|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19715667|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533016|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533017|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533018|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
20533019|NCT01804985|Dasatinib|dasatinib|mesh-list
20533020|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533021|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20533022|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533023|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533024|NCT01805115|Misoprostol|misoprostol|mesh-list
19715668|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715669|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19715670|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
19715671|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
19715672|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
19715673|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
19434945|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
19434946|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19434947|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19434948|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19434949|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
20251484|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20251485|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
20251486|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251487|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20251488|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20251489|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
20251490|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
19715674|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251491|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434950|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19715675|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715676|NCT05313282|Apatinib|apatinib|mesh-list
20251492|NCT00450203|Bevacizumab|bevacizumab|mesh-list
19434951|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19434952|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19434953|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19434954|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434955|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434956|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434957|NCT03504956|Metoprolol|metoprolol|mesh-list
19434958|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19434959|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19434960|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19434961|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
19434962|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
19434963|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434964|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434965|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19434966|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20251493|NCT00450203|Capecitabine|capecitabine|mesh-list
20251494|NCT00450203|Epirubicin|epirubicin|mesh-list
20251495|NCT00450203|Lapatinib|lapatinib|mesh-list
20251496|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20251497|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251498|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20251499|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19715677|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715678|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19715679|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715680|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715681|NCT05313256|Lidocaine|lidocaine|mesh-list
19715682|NCT05313256|Epinephrine|epinephrine|mesh-list
19715683|NCT05313256|Racepinephrine|racepinephrine|mesh-list
19715684|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
19715685|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
19859147|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19859148|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859149|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251500|NCT00450203|Growth Substances|growth substances|mesh-ancestor
20251501|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251502|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
20251503|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251504|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
20251505|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434967|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
19434968|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19434969|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434970|NCT03504865|Bupivacaine|bupivacaine|mesh-list
19434971|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
19434972|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
19434973|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19434974|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434975|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
19434976|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19434977|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19434978|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19434979|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19434980|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
19434981|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715686|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
19859150|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19859151|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859152|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
19859153|NCT00778102|Leucovorin|leucovorin|mesh-list
19859154|NCT00778102|Bevacizumab|bevacizumab|mesh-list
19859155|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
19859156|NCT00778102|Irinotecan|irinotecan|mesh-list
19859157|NCT00778102|Fluorouracil|fluorouracil|mesh-list
19859158|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
19859159|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859160|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859161|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20251506|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20251507|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20251508|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20251509|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251510|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251511|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20251512|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20251513|NCT00450229|Protective Agents|protective agents|mesh-ancestor
20251514|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434982|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19434983|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19434984|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19434985|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19434986|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19434987|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19434988|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19434989|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434990|NCT03504644|Vincristine|vincristine|mesh-list
19434991|NCT03504644|Venetoclax|venetoclax|mesh-list
19434992|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19434993|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19434994|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
19715687|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715688|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715689|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
19715690|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715691|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19715692|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19715693|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20251515|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715694|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19715695|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715696|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19715697|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19715698|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715699|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715700|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19715701|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19715702|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
19715703|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19734181|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19434995|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
19434996|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
19434997|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19434998|NCT03504566|Empagliflozin|empagliflozin|mesh-list
19434999|NCT03504566|Linagliptin|linagliptin|mesh-list
19435000|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19435001|NCT03504566|Telmisartan|telmisartan|mesh-list
19435002|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19435003|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19435004|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19435005|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435006|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19435007|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19435008|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435009|NCT03504566|Incretins|incretins|mesh-ancestor
19435010|NCT03504566|Hormones|hormones|mesh-ancestor
19435011|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19859162|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859163|NCT00778102|Growth Substances|growth substances|mesh-ancestor
19859164|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859165|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
19859166|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19859167|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19859168|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435012|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19859169|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859170|NCT00778102|Antidotes|antidotes|mesh-ancestor
19859171|NCT00778102|Protective Agents|protective agents|mesh-ancestor
19859172|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
20251516|NCT00450281|Antibodies|antibodies|mesh-list
20251517|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
20251518|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251519|NCT00450307|Antibodies|antibodies|mesh-list
20251520|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20251521|NCT00450307|Sargramostim|sargramostim|mesh-list
20251522|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
20251523|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251524|NCT00450320|Sirolimus|sirolimus|mesh-list
20251525|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19435013|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
19435014|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435015|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
19435016|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19435017|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
19435018|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19435019|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19435020|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19435021|NCT03504527|Budesonide|budesonide|mesh-list
19435022|NCT03504527|Bromides|bromides|mesh-list
19859173|NCT00778102|Vitamins|vitamins|mesh-ancestor
20251526|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435023|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
19435024|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435025|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19435026|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
19435027|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435028|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435029|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19435030|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
19435031|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
19435032|NCT03504527|Hormones|hormones|mesh-ancestor
19435033|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435034|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
19435035|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19435036|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
19435037|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435038|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435039|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
19435040|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19435041|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435042|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435043|NCT03504475|Paroxetine|paroxetine|mesh-list
19435044|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19435045|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19435046|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19435047|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435048|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435049|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
19435050|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435051|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19435052|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
19435053|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19435054|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19435055|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19435056|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451575|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
19451576|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
19451577|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
19451578|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19451579|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
19451580|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19451581|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
19451582|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
19451583|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451584|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251527|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20251528|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251529|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
20251530|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251531|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
20251532|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251533|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
20251534|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19435057|NCT03504345|Progesterone|progesterone|mesh-list
19435058|NCT03504345|Progestins|progestins|mesh-ancestor
19435059|NCT03504345|Hormones|hormones|mesh-ancestor
19435060|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435061|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715704|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
20251535|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
20251536|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251537|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20251538|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251539|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
20251540|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251541|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
20251542|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20533025|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20533026|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
19715705|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
19715706|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
19715707|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19715708|NCT05312970|Polidocanol|polidocanol|mesh-list
19715709|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19715710|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19715711|NCT05312866|Acetaminophen|acetaminophen|mesh-list
19715712|NCT05312866|Dexamethasone|dexamethasone|mesh-list
19715713|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
19715714|NCT05312866|Fentanyl|fentanyl|mesh-list
19715715|NCT05312866|Bupivacaine|bupivacaine|mesh-list
19715716|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715717|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
19715718|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
19715719|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715720|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715721|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715722|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
19715723|NCT05312866|Hormones|hormones|mesh-ancestor
19715724|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715725|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19715726|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715727|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
19715728|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
19715729|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715730|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
19715731|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19715732|NCT05312866|Narcotics|narcotics|mesh-ancestor
19715733|NCT05312866|Analgesics|analgesics|mesh-ancestor
19715734|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715735|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19715736|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
19715737|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19715738|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
19715739|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19715740|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
19715741|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19715742|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19715743|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715744|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19715745|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
19715746|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19715747|NCT05312840|Gemcitabine|gemcitabine|mesh-list
19715748|NCT05312840|Carboplatin|carboplatin|mesh-list
19715749|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715750|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19715751|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
19715752|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715753|NCT05312840|Antiviral Agents|antiviral agents|mesh-ancestor
19715754|NCT05312840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715755|NCT05312840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715756|NCT05312840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435062|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
19715757|NCT05312840|Immunologic Factors|immunologic factors|mesh-ancestor
19715758|NCT05312840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715759|NCT05296759|Gabapentin|gabapentin|mesh-list
19715760|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19715761|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
19715762|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19715763|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20251543|NCT00450398|Protective Agents|protective agents|mesh-ancestor
20251544|NCT00450515|Capecitabine|capecitabine|mesh-list
20251545|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435063|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19435064|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435065|NCT03504280|Vitamins|vitamins|mesh-ancestor
19435066|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
19435067|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19435068|NCT03504202|Trimetazidine|trimetazidine|mesh-list
19435069|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
19435070|NCT03504072|Etanercept|etanercept|mesh-list
19435071|NCT03504072|Tofacitinib|tofacitinib|mesh-list
19435072|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19435073|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435074|NCT03504072|Analgesics|analgesics|mesh-ancestor
19435075|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
19435076|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435077|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435078|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435079|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435080|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435081|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435082|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
19435083|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251546|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
20251547|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251548|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251549|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20251550|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20251551|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251552|NCT00450645|Heparin|heparin|mesh-list
20251553|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20251554|NCT00450645|Tinzaparin|tinzaparin|mesh-list
20251555|NCT00450645|Dalteparin|dalteparin|mesh-list
20251556|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
20251557|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20251558|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20251559|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251560|NCT00450736|Celecoxib|celecoxib|mesh-list
20251561|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20251562|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435084|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435085|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435086|NCT03504046|Pancrelipase|pancrelipase|mesh-list
19435087|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435088|NCT03504033|Desflurane|desflurane|mesh-list
19435089|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19715764|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19715765|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20251563|NCT00450736|Analgesics|analgesics|mesh-ancestor
20251564|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
20251565|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251566|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251567|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251568|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20251569|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20251570|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20251571|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251572|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251573|NCT00450762|Gemcitabine|gemcitabine|mesh-list
19734182|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20251574|NCT00450762|Carboplatin|carboplatin|mesh-list
19435090|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
20251575|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715766|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715767|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
19715768|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715769|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715770|NCT05296759|Analgesics|analgesics|mesh-ancestor
19715771|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
19715772|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715773|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
19715774|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19859174|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
19859175|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
19859176|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859177|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859178|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
19859179|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19859180|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19859181|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859182|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19859183|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859184|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859185|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
19859186|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859187|NCT00778310|Methylphenidate|methylphenidate|mesh-list
19859188|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19859189|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859190|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19859191|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19859192|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859193|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859194|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
19859195|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859196|NCT00778375|Cytarabine|cytarabine|mesh-list
19859197|NCT00778375|Decitabine|decitabine|mesh-list
19859198|NCT00778375|Clofarabine|clofarabine|mesh-list
19859199|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859200|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
19859201|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859202|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859203|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
20533027|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19859204|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859205|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859206|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
20251576|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251577|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
20533028|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533029|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20533030|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533031|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
20533032|NCT01805232|Artesunate|artesunate|mesh-list
20533033|NCT01805232|Quinine|quinine|mesh-list
20533034|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
20533035|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19859207|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251578|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251579|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
20251580|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251581|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251582|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251583|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
20251584|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251585|NCT00450827|Bevacizumab|bevacizumab|mesh-list
20251586|NCT00450827|Antibodies|antibodies|mesh-list
20251587|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20251588|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533036|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19715775|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19715776|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715777|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715778|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19715779|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19715780|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
19715781|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19715782|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19715783|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
19715784|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
19715785|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19715786|NCT05295589|Paclitaxel|paclitaxel|mesh-list
19715787|NCT05295589|Doxorubicin|doxorubicin|mesh-list
19715788|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19715789|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19715790|NCT05295589|Topotecan|topotecan|mesh-list
19715791|NCT05295589|Olaparib|olaparib|mesh-list
19715792|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19715793|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19715794|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715795|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
19715796|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
19715797|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
19715798|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715799|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19715800|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19715801|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19859208|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859209|NCT00778622|Metformin|metformin|mesh-list
19859210|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859211|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859212|NCT00778817|Mitotane|mitotane|mesh-list
19859213|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19715802|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251589|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251590|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20251591|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20251592|NCT00450827|Growth Substances|growth substances|mesh-ancestor
19435091|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
19435092|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435093|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435094|NCT03503994|Beclomethasone|beclomethasone|mesh-list
19435095|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435096|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
19435097|NCT03503994|Hormones|hormones|mesh-ancestor
19435098|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435099|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435100|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19715803|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19715804|NCT05292976|Albuterol|albuterol|mesh-list
19715805|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
19435101|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
19435102|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
19435103|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435104|NCT03503786|Paclitaxel|paclitaxel|mesh-list
19715806|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19715807|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
19715808|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859214|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859215|NCT00778830|Cetuximab|cetuximab|mesh-list
19859216|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859217|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859218|NCT00778869|Infliximab|infliximab|mesh-list
19859219|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
19859220|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859221|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859222|NCT00778921|Amlodipine|amlodipine|mesh-list
19859223|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19859224|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19859225|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859226|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859227|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19859228|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859229|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
19859230|NCT00779142|Methotrexate|methotrexate|mesh-list
19859231|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19859232|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
19859233|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19859234|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859235|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859236|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
19859237|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859238|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859239|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
19859240|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859241|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19859242|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859243|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
19859244|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859245|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19859246|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
19859247|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20251593|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435105|NCT03503786|Carboplatin|carboplatin|mesh-list
19715809|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715810|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19715811|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
19715812|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
19715813|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19715814|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19715815|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19715816|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19715817|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715818|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715819|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715820|NCT05292976|Miotics|miotics|mesh-ancestor
19715821|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19715822|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19715823|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19715824|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19715825|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
19715826|NCT05288348|Sufentanil|sufentanil|mesh-list
19715827|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19715828|NCT05288348|Narcotics|narcotics|mesh-ancestor
19715829|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715830|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715831|NCT05288348|Analgesics|analgesics|mesh-ancestor
19715832|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
19715833|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715834|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715835|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19715836|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
19715837|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
19715838|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19859248|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19715839|NCT05286554|Hormones|hormones|mesh-list
19715840|NCT05286554|Progesterone|progesterone|mesh-list
19734183|NCT04553380|Insulin|insulin|mesh-list
19435106|NCT03503786|Avelumab|avelumab|mesh-list
19435107|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19435108|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435109|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
19435110|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
19435111|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
19435112|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435113|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20251594|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
20251595|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
20251596|NCT00450840|Simvastatin|simvastatin|mesh-list
20251597|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20251598|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20251599|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
20251600|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251601|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20251602|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20251603|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251604|NCT00450853|Granisetron|granisetron|mesh-list
20251605|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
20251606|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
20251607|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251608|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251609|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20251610|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20251611|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
20251612|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251613|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251614|NCT00450892|Docetaxel|docetaxel|mesh-list
19435114|NCT03503604|Leucovorin|leucovorin|mesh-list
19435115|NCT03503604|Gemcitabine|gemcitabine|mesh-list
19715841|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19715842|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715843|NCT05286554|Progestins|progestins|mesh-ancestor
19715844|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
19715845|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19715846|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
19715847|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19715848|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19715849|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19715850|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715851|NCT05286190|Bupivacaine|bupivacaine|mesh-list
19715852|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
19715853|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
19715854|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715855|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715856|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
19435116|NCT03503604|Paclitaxel|paclitaxel|mesh-list
20251615|NCT00450892|Trastuzumab|trastuzumab|mesh-list
19435117|NCT03503604|Carboplatin|carboplatin|mesh-list
19435118|NCT03503604|Fluorouracil|fluorouracil|mesh-list
19435119|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
19435120|NCT03503604|Irinotecan|irinotecan|mesh-list
19435121|NCT03503604|Bevacizumab|bevacizumab|mesh-list
19435122|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19435123|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435124|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
19435125|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
19715857|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715858|NCT05277727|Fucoidan|fucoidan|mesh-list
19715859|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19715860|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715861|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
19715862|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715863|NCT05276973|Paclitaxel|paclitaxel|mesh-list
19715864|NCT05276973|Carboplatin|carboplatin|mesh-list
19715865|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19715866|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19715867|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715868|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
19715869|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
19715870|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
19715871|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251616|NCT00450892|Lapatinib|lapatinib|mesh-list
20251617|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533037|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533038|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251618|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251619|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251620|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
20251621|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533039|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
20533040|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
19435126|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
19435127|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715872|NCT05275907|Amlodipine|amlodipine|mesh-list
20533041|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20533042|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
20533043|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20533044|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533045|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20533046|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533047|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20533048|NCT01805232|Analgesics|analgesics|mesh-ancestor
20533049|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
20533050|NCT01805258|Efavirenz|efavirenz|mesh-list
20533051|NCT01805258|Nevirapine|nevirapine|mesh-list
20533052|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19715873|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
19715874|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19715875|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19715876|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19435128|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435129|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
19435130|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
19435131|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435132|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435133|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435134|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
19435135|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435136|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19435137|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19435138|NCT03503604|Antidotes|antidotes|mesh-ancestor
19715877|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715878|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19715879|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715880|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
19715881|NCT05275907|Diuretics|diuretics|mesh-ancestor
19715882|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
19715883|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19715884|NCT05269537|Ephedrine|ephedrine|mesh-list
19715885|NCT05269537|Fentanyl|fentanyl|mesh-list
19715886|NCT05269537|Bupivacaine|bupivacaine|mesh-list
19859249|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435139|NCT03503604|Protective Agents|protective agents|mesh-ancestor
19435140|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
19435141|NCT03503604|Vitamins|vitamins|mesh-ancestor
19435142|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
19435143|NCT03503604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19435144|NCT03503604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19435145|NCT03503604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19435146|NCT03503604|Growth Substances|growth substances|mesh-ancestor
19435147|NCT03503604|Growth Inhibitors|growth inhibitors|mesh-ancestor
19435148|NCT03503409|Ivosidenib|ivosidenib|mesh-list
19435149|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435150|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435151|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435152|NCT03503227|Aspirin|aspirin|mesh-list
19435153|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
19715887|NCT05269537|Oxytocin|oxytocin|mesh-list
19859250|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
19859251|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
19859252|NCT00779259|Quinine|quinine|mesh-list
19859253|NCT00779259|Theophylline|theophylline|mesh-list
19859254|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19859255|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
19859256|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859257|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859258|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19859259|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859260|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19859261|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859262|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859263|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
19859264|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19859265|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19859266|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
19435154|NCT03503227|Prednisolone|prednisolone|mesh-list
19435155|NCT03503227|Salicylates|salicylates|mesh-list
19435156|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19715888|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
19715889|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
19715890|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715891|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715892|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
19715893|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715894|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19435157|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
20251622|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20251623|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251624|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286584|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286585|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20286586|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19435158|NCT03503227|Hormones|hormones|mesh-ancestor
19435159|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435160|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435161|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19435162|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435163|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435164|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715895|NCT05269537|Narcotics|narcotics|mesh-ancestor
19715896|NCT05269537|Analgesics|analgesics|mesh-ancestor
19715897|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19715898|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19715899|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
20286587|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19435165|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
19435166|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
19435167|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
19435168|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19435169|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435170|NCT03503227|Analgesics|analgesics|mesh-ancestor
19435171|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
19435172|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435173|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19715900|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
19715901|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19715902|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19715903|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
19715904|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
19715905|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19715906|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715907|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251625|NCT00450944|Immunotoxins|immunotoxins|mesh-list
20251626|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
19715908|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734184|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
19734185|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19734186|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734187|NCT04553393|Decitabine|decitabine|mesh-list
19734188|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734189|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
19734190|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859267|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251627|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251628|NCT00450957|Lycopene|lycopene|mesh-list
20251629|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251630|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
20251631|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251632|NCT00450957|Protective Agents|protective agents|mesh-ancestor
20251633|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251634|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20251635|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20251636|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251637|NCT00451061|Tamsulosin|tamsulosin|mesh-list
20533053|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20533054|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533055|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533056|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
20533057|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533058|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20533059|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20533060|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20533061|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19859268|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
20251638|NCT00451061|Alfuzosin|alfuzosin|mesh-list
19715909|NCT05263895|Ritonavir|ritonavir|mesh-list
19715910|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19715911|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19715912|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
19715913|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19715914|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251639|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20251640|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20251641|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20251642|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
19715915|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19859269|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19859270|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19859271|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251643|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251644|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251645|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251646|NCT00451061|Urological Agents|urological agents|mesh-ancestor
19715916|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19715917|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
19715918|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19715919|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19715920|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19715921|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19715922|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715923|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715924|NCT05243628|Insulin|insulin|mesh-list
19715925|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19715926|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859272|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20251647|NCT00451074|Gentamicins|gentamicins|mesh-list
20251648|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251649|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435174|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435175|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435176|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19435177|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19435178|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19435179|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
19435180|NCT03503201|Chromium|chromium|mesh-list
19435181|NCT03503201|Trace Elements|trace elements|mesh-ancestor
19435182|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
19435183|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435184|NCT03503136|Cisplatin|cisplatin|mesh-list
19715927|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715928|NCT05240898|Adenosine|adenosine|mesh-list
19715929|NCT05240898|Analgesics|analgesics|mesh-ancestor
19715930|NCT05240898|Sensory System Agents|sensory system agents|mesh-ancestor
19715931|NCT05240898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715932|NCT05240898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715933|NCT05240898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19715934|NCT05240898|Vasodilator Agents|vasodilator agents|mesh-ancestor
19715935|NCT05240898|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19715936|NCT05240898|Purinergic Agonists|purinergic agonists|mesh-ancestor
19715937|NCT05240898|Purinergic Agents|purinergic agents|mesh-ancestor
19715938|NCT05240898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715939|NCT05240898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715940|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
19715941|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
19715942|NCT05222555|Lenalidomide|lenalidomide|mesh-list
19715943|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
19715944|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715945|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19715946|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19715947|NCT05222555|Growth Substances|growth substances|mesh-ancestor
19715948|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
19715949|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715950|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
19715951|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19715952|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
19715953|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715954|NCT05221151|Pregabalin|pregabalin|mesh-list
19715955|NCT05221151|Ondansetron|ondansetron|mesh-list
19715956|NCT05221151|Melatonin|melatonin|mesh-list
19715957|NCT05221151|Analgesics|analgesics|mesh-ancestor
19715958|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
19859273|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19859274|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19859275|NCT00779259|Analgesics|analgesics|mesh-ancestor
19859276|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
19859277|NCT00779285|Doxorubicin|doxorubicin|mesh-list
19859278|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19859279|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19859280|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859281|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19435185|NCT03503136|Docetaxel|docetaxel|mesh-list
19715959|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435186|NCT03503136|Fluorouracil|fluorouracil|mesh-list
19715960|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715961|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
19715962|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19715963|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734191|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251650|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19435187|NCT03503136|Capecitabine|capecitabine|mesh-list
19435188|NCT03503136|Nedaplatin|nedaplatin|mesh-list
19435189|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435190|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
19435191|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
19435192|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
19435193|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435194|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
20251651|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251652|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251653|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
20251654|NCT00451100|Neostigmine|neostigmine|mesh-list
20251655|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19435195|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251656|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435196|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435197|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
19435198|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435199|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19435200|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435201|NCT03502889|Ropivacaine|ropivacaine|mesh-list
19435202|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435203|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
19435204|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435205|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435206|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
19435207|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435208|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
19435209|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19435210|NCT03502746|Nivolumab|nivolumab|mesh-list
19435211|NCT03502746|Ramucirumab|ramucirumab|mesh-list
19435212|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19435213|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435214|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19435215|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451585|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19451586|NCT03420586|Analgesics|analgesics|mesh-ancestor
19451587|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
19451588|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451589|NCT03420534|Iloperidone|iloperidone|mesh-list
20251657|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251658|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
20251659|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251660|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251661|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20251662|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
20251663|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251664|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20251665|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20251666|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20251667|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20251668|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20251669|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251670|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251671|NCT00451113|Incretins|incretins|mesh-ancestor
20251672|NCT00451113|Hormones|hormones|mesh-ancestor
20251673|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435216|NCT03502642|Morphine|morphine|mesh-list
19435217|NCT03502642|Ropivacaine|ropivacaine|mesh-list
19435218|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
19435219|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435220|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435221|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19435222|NCT03502642|Narcotics|narcotics|mesh-ancestor
19435223|NCT03502642|Analgesics|analgesics|mesh-ancestor
19435224|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
19435225|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435226|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435227|NCT03502551|Ketamine|ketamine|mesh-list
19435228|NCT03502551|Analgesics|analgesics|mesh-ancestor
19435229|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
19435230|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435231|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251674|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
20251675|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251676|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251677|NCT00451139|Lumefantrine|lumefantrine|mesh-list
20251678|NCT00451139|Artemether|artemether|mesh-list
20251679|NCT00451139|Quinine|quinine|mesh-list
20251680|NCT00451139|Atovaquone|atovaquone|mesh-list
20251681|NCT00451139|Proguanil|proguanil|mesh-list
20251682|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20251683|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20251684|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
20251685|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20251686|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20251687|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251688|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19435232|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19715964|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715965|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19715966|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20251689|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251690|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20251691|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715967|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19715968|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715969|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19715970|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
19715971|NCT05221151|Protective Agents|protective agents|mesh-ancestor
19715972|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
19859282|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19435233|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19435234|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
19435235|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
19859283|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859284|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435236|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435237|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19435238|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19435239|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435240|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435241|NCT03502434|Petrolatum|petrolatum|mesh-list
19435242|NCT03502434|Emollients|emollients|mesh-ancestor
19435243|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
19435244|NCT03502421|Ketamine|ketamine|mesh-list
19435245|NCT03502421|Analgesics|analgesics|mesh-ancestor
19435246|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
19435247|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19715973|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
19859285|NCT00779311|Bevacizumab|bevacizumab|mesh-list
19859286|NCT00779311|Sorafenib|sorafenib|mesh-list
19859287|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859288|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859289|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20251692|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435248|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435249|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19435250|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19435251|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
19435252|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
19435253|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19715974|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19715975|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
19715976|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19715977|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19715978|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
19435254|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19715979|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19715980|NCT05221151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19715981|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
19715982|NCT05218148|Trastuzumab|trastuzumab|mesh-list
19715983|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19715984|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19715985|NCT05195996|Propranolol|propranolol|mesh-list
19715986|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19715987|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19715988|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
19435255|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19435256|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435257|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435258|NCT03502395|Lidocaine|lidocaine|mesh-list
19435259|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435260|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
19435261|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435262|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435263|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
19435264|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435265|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20251693|NCT00451139|Analgesics|analgesics|mesh-ancestor
20251694|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
20251695|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251696|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251697|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
20251698|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
20251699|NCT00451230|Cocaine|cocaine|mesh-list
20251700|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251701|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
20251702|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
20251703|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251704|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435266|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19435267|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19435268|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19715989|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734192|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251705|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
19451590|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19435269|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251706|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251707|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20251708|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20251709|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20251710|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20251711|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251712|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
19715990|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19715991|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19715992|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19859290|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859291|NCT00779311|Growth Substances|growth substances|mesh-ancestor
19859292|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859293|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
19859294|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19859295|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859296|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859297|NCT00779324|Amantadine|amantadine|mesh-list
19859298|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20251713|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251714|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
20251715|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251716|NCT00451373|Vancomycin|vancomycin|mesh-list
20251717|NCT00451373|Daptomycin|daptomycin|mesh-list
20251718|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251719|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251720|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
20251721|NCT00451386|Ertapenem|ertapenem|mesh-list
20251722|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251723|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435270|NCT03502356|Azithromycin|azithromycin|mesh-list
20251724|NCT00451399|Metformin|metformin|mesh-list
20251725|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251726|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251727|NCT00451412|Heparin|heparin|mesh-list
20251728|NCT00451412|Calcium heparin|calcium heparin|mesh-list
20251729|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20251730|NCT00451412|Tinzaparin|tinzaparin|mesh-list
19435271|NCT03502356|Cefazolin|cefazolin|mesh-list
19435272|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19435273|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435274|NCT03502343|Gemcitabine|gemcitabine|mesh-list
20251731|NCT00451412|Dalteparin|dalteparin|mesh-list
20251732|NCT00451412|Certoparin|certoparin|mesh-list
20251733|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
20251734|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20251735|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20251736|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251737|NCT00451490|S 20098|s 20098|mesh-list
20251738|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19715993|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19715994|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
19715995|NCT05161754|Hemostatics|hemostatics|mesh-list
19715996|NCT05161754|Coagulants|coagulants|mesh-ancestor
19715997|NCT05161195|Tamoxifen|tamoxifen|mesh-list
19715998|NCT05161195|Letrozole|letrozole|mesh-list
19715999|NCT05161195|Fulvestrant|fulvestrant|mesh-list
19716000|NCT05161195|Anastrozole|anastrozole|mesh-list
19716001|NCT05161195|Goserelin|goserelin|mesh-list
19716002|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716003|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19716004|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19716005|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716006|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251739|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859299|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19859300|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
19859301|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716007|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19716008|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
19716009|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19859302|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
19859303|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859304|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859305|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859306|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19859307|NCT00779324|Analgesics|analgesics|mesh-ancestor
19859308|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
19859309|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859310|NCT00779467|Fentanyl|fentanyl|mesh-list
19859311|NCT00779467|Bupivacaine|bupivacaine|mesh-list
19859312|NCT00779467|Neostigmine|neostigmine|mesh-list
19859313|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
19859314|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
19859315|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859316|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859317|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
19859318|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859319|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19859320|NCT00779467|Narcotics|narcotics|mesh-ancestor
19859321|NCT00779467|Analgesics|analgesics|mesh-ancestor
19859322|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19859323|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19859324|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
19859325|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19859326|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859327|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251740|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435275|NCT03502343|Paclitaxel|paclitaxel|mesh-list
19435276|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20251741|NCT00451568|Metformin|metformin|mesh-list
20251742|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251743|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251744|NCT00451594|Dexamethasone|dexamethasone|mesh-list
20251745|NCT00451594|Prednisolone|prednisolone|mesh-list
20251746|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251747|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
20251748|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
20251749|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435277|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716010|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859328|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
19859329|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435278|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
19435279|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
19435280|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
19435281|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435282|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435283|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
19435284|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
19435285|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435286|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435287|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435288|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
19716011|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716012|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19716013|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19716014|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716015|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19716016|NCT05142696|Carboplatin|carboplatin|mesh-list
19716017|NCT05142696|Etoposide|etoposide|mesh-list
19716018|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19716019|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19716020|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716021|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19716022|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19716023|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19716024|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716025|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716026|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
19716027|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
19716028|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19716029|NCT05136196|Nivolumab|nivolumab|mesh-list
19716030|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716031|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716032|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716033|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716034|NCT05129358|Furosemide|furosemide|mesh-list
19716035|NCT05129358|Diuretics|diuretics|mesh-ancestor
20251750|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251751|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20251752|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
20251753|NCT00451594|Hormones|hormones|mesh-ancestor
20251754|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435289|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435290|NCT03502291|Vaccines|vaccines|mesh-list
19435291|NCT03502291|Immunologic Factors|immunologic factors|mesh-ancestor
20251755|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19451591|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19451592|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451593|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451594|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20251756|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251757|NCT00451620|Glyburide|glyburide|mesh-list
20251758|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251759|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251760|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20251761|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20251762|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20251763|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20251764|NCT00451672|Bromocriptine|bromocriptine|mesh-list
20251765|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20251766|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20251767|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
20251768|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251769|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251770|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
20251771|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
20251772|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251773|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251774|NCT00451711|Amphotericin B|amphotericin b|mesh-list
20251775|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20251776|NCT00451711|Amebicides|amebicides|mesh-ancestor
20251777|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20251778|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20251779|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251780|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251781|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
20251782|NCT00451724|Ketamine|ketamine|mesh-list
20251783|NCT00451724|Analgesics|analgesics|mesh-ancestor
20251784|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
20251785|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435292|NCT03502291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435293|NCT03502135|Phenylephrine|phenylephrine|mesh-list
19435294|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
19435295|NCT03502135|Tetracaine|tetracaine|mesh-list
19435296|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
19716036|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
19734193|NCT04553510|Bevacizumab|bevacizumab|mesh-list
20251786|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435297|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
19435298|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435299|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435300|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
19435301|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435302|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19435303|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19435304|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
19435305|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435306|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435307|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
20251787|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20251788|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20251789|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
20251790|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
20251791|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251792|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20251793|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20251794|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251795|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251796|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
19435308|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
19435309|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
19435310|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19435311|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
20251797|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251798|NCT00451763|Bevacizumab|bevacizumab|mesh-list
20251799|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20251800|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251801|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20251802|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20251803|NCT00451763|Growth Substances|growth substances|mesh-ancestor
20251804|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251805|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
20251806|NCT00451776|Propofol|propofol|mesh-list
20251807|NCT00451776|Etomidate|etomidate|mesh-list
20251808|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20251809|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251810|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251811|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20251812|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
20251813|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
20251814|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
20251815|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20251816|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20251817|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19435312|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19716037|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716038|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19716039|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19716040|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251818|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
20251819|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251820|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251821|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251822|NCT00451828|Simvastatin|simvastatin|mesh-list
20251823|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20251824|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20251825|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
20251826|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251827|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20251828|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20251829|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251830|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
20251831|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20533062|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19716041|NCT05115838|Islatravir|islatravir|mesh-list
20533063|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20533064|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20533065|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19716042|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
19716043|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716044|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716045|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716046|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19716047|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20251832|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251833|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20251834|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
20251835|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251836|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251837|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716048|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20251838|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251839|NCT00451880|Famotidine|famotidine|mesh-list
20533066|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
20533067|NCT01805310|Cathartics|cathartics|mesh-ancestor
20533068|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533069|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20533070|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533071|NCT01805453|Losartan|losartan|mesh-list
20533072|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20533073|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20533074|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20533075|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20533076|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533077|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
20533078|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20533079|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
20533080|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20251840|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20533081|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
20251841|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435313|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
19435314|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19435315|NCT03502135|Protective Agents|protective agents|mesh-ancestor
19435316|NCT03502018|Bupivacaine|bupivacaine|mesh-list
19435317|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435318|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
19435319|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435320|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435321|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
19435322|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435323|NCT03502005|Tenofovir|tenofovir|mesh-list
19435324|NCT03502005|Emtricitabine|emtricitabine|mesh-list
19435325|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19435326|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
19435327|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435328|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19435329|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19435330|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435331|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716049|NCT05111145|Ivacaftor|ivacaftor|mesh-list
20251842|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20251843|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
20251844|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
20251845|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251846|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251847|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716050|NCT05111145|Elexacaftor|elexacaftor|mesh-list
19716051|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19716052|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19716053|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716054|NCT05098028|Rifaximin|rifaximin|mesh-list
19716055|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19716056|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716057|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859330|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19859331|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
19859332|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19859333|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
19859334|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19859335|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19859336|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19859337|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20251848|NCT00451971|Leflunomide|leflunomide|mesh-list
20251849|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251850|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251851|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251852|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
20251853|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251854|NCT00451984|Interleukin-2|interleukin-2|mesh-list
20251855|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533082|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533083|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533084|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
19435332|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19716058|NCT05095376|Temozolomide|temozolomide|mesh-list
19716059|NCT05095376|Lomustine|lomustine|mesh-list
20533085|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
20533086|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20533087|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
20533088|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20533089|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
20533090|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533091|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533092|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
20533093|NCT01805570|Ticagrelor|ticagrelor|mesh-list
20533094|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20533095|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19716060|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19716061|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
19716062|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716063|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716064|NCT05083975|Anesthetics|anesthetics|mesh-list
19716065|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
19859338|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859339|NCT00779558|Heparin|heparin|mesh-list
19859340|NCT00779558|Calcium heparin|calcium heparin|mesh-list
19716066|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716067|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716068|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
19859341|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
19859342|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19859343|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19859344|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859345|NCT00779584|Gemcitabine|gemcitabine|mesh-list
19859346|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859347|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
19859348|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859349|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859350|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
19859351|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859352|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859353|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859354|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
19859355|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859356|NCT00779675|Infliximab|infliximab|mesh-list
19859357|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
20251856|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20251857|NCT00451984|Analgesics|analgesics|mesh-ancestor
20251858|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
20251859|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251860|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251861|NCT00451997|Cytarabine|cytarabine|mesh-list
19716069|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716070|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
19716071|NCT05073237|Estrogens|estrogens|mesh-list
19716072|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20251862|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
20251863|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251864|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
20251865|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251866|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716073|NCT05073237|Hormones|hormones|mesh-ancestor
19716074|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716075|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716076|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19716077|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19716078|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
19716079|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716080|NCT05065424|Atropine|atropine|mesh-list
19716081|NCT05065424|Fentanyl|fentanyl|mesh-list
19716082|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19716083|NCT05065424|Narcotics|narcotics|mesh-ancestor
20251867|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
20251868|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533096|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19435333|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19435334|NCT03501966|Acetazolamide|acetazolamide|mesh-list
19435335|NCT03501966|Diuretics|diuretics|mesh-list
19435336|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
19435337|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435338|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
19435339|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19435340|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435341|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435342|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19435343|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435344|NCT03501680|Insulin|insulin|mesh-list
19435345|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19435346|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435347|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
19716084|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533097|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20533098|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20533099|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
20533100|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716085|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716086|NCT05065424|Analgesics|analgesics|mesh-ancestor
19716087|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
19716088|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716089|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19716090|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19716091|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
19859358|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533101|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533102|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533103|NCT01805596|Clopidogrel|clopidogrel|mesh-list
20533104|NCT01805596|Ticagrelor|ticagrelor|mesh-list
20533105|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20533106|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20533107|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19716092|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
19859359|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859360|NCT00779701|Insulin|insulin|mesh-list
19859361|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859362|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859363|NCT00779909|Vitamin D|vitamin d|mesh-list
19859364|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
19859365|NCT00779909|Vitamins|vitamins|mesh-ancestor
19859366|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
19859367|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859368|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19859369|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19859370|NCT00780026|Insulin|insulin|mesh-list
19859371|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19435348|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533108|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20533109|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
20533110|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533111|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533112|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553410|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553411|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19716093|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716094|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19716095|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19716096|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
19716097|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19716098|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
19716099|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
19716100|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
19716101|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20251869|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251870|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
20251871|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251872|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251873|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251874|NCT00452062|Dexamethasone|dexamethasone|mesh-list
20251875|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251876|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
20251877|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
20251878|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251879|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251880|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20251881|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
20251882|NCT00452062|Hormones|hormones|mesh-ancestor
20251883|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251884|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20251885|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251886|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20251887|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251888|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251889|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251890|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251891|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
20251892|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251893|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251894|NCT00452192|Telmisartan|telmisartan|mesh-list
20251895|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20251896|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20251897|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20553412|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19716102|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19716103|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
19716104|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716105|NCT05052957|Temozolomide|temozolomide|mesh-list
19716106|NCT05052957|Carmustine|carmustine|mesh-list
19716107|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19716108|NCT05052957|Lenograstim|lenograstim|mesh-list
19716109|NCT05052957|Sargramostim|sargramostim|mesh-list
19716110|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19716111|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
19716112|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716113|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19716114|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
19716115|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716116|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716117|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716118|NCT05034952|Acetaminophen|acetaminophen|mesh-list
19716119|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19716120|NCT05034952|Analgesics|analgesics|mesh-ancestor
19716121|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
19716122|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716123|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716124|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
19716125|NCT05030441|Ivosidenib|ivosidenib|mesh-list
19716126|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553413|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553414|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
20553415|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
19716127|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251898|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251899|NCT00452218|Sorafenib|sorafenib|mesh-list
20251900|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251901|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251902|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286588|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
20533113|NCT01805700|Caffeine|caffeine|mesh-list
20533114|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20533115|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533116|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20533117|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533118|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533119|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20533120|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20533121|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
20533122|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533123|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
20533124|NCT01805726|Alfentanil|alfentanil|mesh-list
20533125|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533126|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533127|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533128|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20533129|NCT01805726|Analgesics|analgesics|mesh-ancestor
20533130|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
19716128|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716129|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
19716130|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19716131|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
19716132|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734194|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734195|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734196|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19734197|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19734198|NCT04553510|Growth Substances|growth substances|mesh-ancestor
19734199|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734200|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
20533131|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533132|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20533133|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20533134|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20533135|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
20533136|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533137|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435349|NCT03501498|Loperamide|loperamide|mesh-list
19435350|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
19435351|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435352|NCT03501459|Rituximab|rituximab|mesh-list
19435353|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734201|NCT04553458|Ethanol|ethanol|mesh-list
19734202|NCT04553458|Sorafenib|sorafenib|mesh-list
19734203|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435354|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435355|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
19435356|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435357|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435358|NCT03501433|Niacinamide|niacinamide|mesh-list
19435359|NCT03501433|Niacin|niacin|mesh-list
19435360|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
19435361|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
19435362|NCT03501433|Vitamins|vitamins|mesh-ancestor
19435363|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
19435364|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435365|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19435366|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
19859372|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859373|NCT00780143|Cytarabine|cytarabine|mesh-list
20251903|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251904|NCT00452231|Cycloserine|cycloserine|mesh-list
20251905|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20251906|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251907|NCT00452231|Renal Agents|renal agents|mesh-ancestor
20251908|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20251909|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
20251910|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251911|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
20251912|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251913|NCT00452244|Gefitinib|gefitinib|mesh-list
20251914|NCT00452244|Simvastatin|simvastatin|mesh-list
20251915|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19435367|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435368|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19435369|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
19435370|NCT03501251|Albendazole|albendazole|mesh-list
19435371|NCT03501251|Moxidectin|moxidectin|mesh-list
19435372|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
19435373|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19435374|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435375|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
19435376|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19435377|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19435378|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19435379|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19435380|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19435381|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435382|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435383|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
19435384|NCT03501212|Anesthetics|anesthetics|mesh-list
19435385|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
19435386|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435387|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435388|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
19435389|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435390|NCT03501056|Antibodies|antibodies|mesh-list
19435391|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19435392|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
19435393|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716133|NCT04987203|Nivolumab|nivolumab|mesh-list
19716134|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716135|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716136|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716137|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716138|NCT04975256|Adagrasib|adagrasib|mesh-list
19716139|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716140|NCT04948892|Anesthetics|anesthetics|mesh-list
19716141|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716142|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716143|NCT04943783|Atorvastatin|atorvastatin|mesh-list
19716144|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19716145|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19451595|NCT03420469|Bupropion|bupropion|mesh-list
19451596|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19451597|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
19451598|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19451599|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19451600|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19451601|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19451602|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451603|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
19451604|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451605|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451606|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19716146|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
19734204|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251916|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20251917|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
20251918|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251919|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20251920|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20251921|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435394|NCT03500913|Hormones|hormones|mesh-list
19435395|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435396|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435397|NCT03500900|Vildagliptin|vildagliptin|mesh-list
19435398|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19435399|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435400|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19435401|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
19435402|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435403|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435404|NCT03500874|Leucovorin|leucovorin|mesh-list
19435405|NCT03500874|Fluorouracil|fluorouracil|mesh-list
19435406|NCT03500874|Floxuridine|floxuridine|mesh-list
19435407|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
19435408|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
19435409|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533138|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20533139|NCT01805726|Narcotics|narcotics|mesh-ancestor
20533140|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20533141|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
20533142|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
20533143|NCT01805804|Valsartan|valsartan|mesh-list
20533144|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20533145|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20533146|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20533147|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533148|NCT01805817|Copper|copper|mesh-list
20533149|NCT01805817|Drospirenone|drospirenone|mesh-list
20533150|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
20533151|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20533152|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20533153|NCT01805817|Estradiol|estradiol|mesh-list
20533154|NCT01805817|Estrogens|estrogens|mesh-ancestor
20533155|NCT01805817|Hormones|hormones|mesh-ancestor
20533156|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533157|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533158|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20533159|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
20533160|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20533161|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20251922|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251923|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20251924|NCT00452270|Xylometazoline|xylometazoline|mesh-list
20251925|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
20251926|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20251927|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
20251928|NCT00452296|Insulin|insulin|mesh-list
20251929|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20251930|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716147|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716148|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19716149|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19716150|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716151|NCT04918186|Durvalumab|durvalumab|mesh-list
19716152|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716153|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716154|NCT04912427|Dexamethasone|dexamethasone|mesh-list
19716155|NCT04912427|Bortezomib|bortezomib|mesh-list
19716156|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19716157|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
19716158|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
19716159|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716160|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716161|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716162|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
19716163|NCT04912427|Hormones|hormones|mesh-ancestor
19716164|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716165|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716166|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716167|NCT04905407|Azacitidine|azacitidine|mesh-list
19716168|NCT04905407|Venetoclax|venetoclax|mesh-list
20251931|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
20251932|NCT00452322|Testosterone|testosterone|mesh-list
20251933|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
20251934|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
20251935|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20251936|NCT00452322|Androgens|androgens|mesh-ancestor
20251937|NCT00452322|Hormones|hormones|mesh-ancestor
20251938|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251939|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251940|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20251941|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251942|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
20533162|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20533163|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20533164|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20533165|NCT01805817|Trace Elements|trace elements|mesh-ancestor
20533166|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
20533167|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20533168|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
20533169|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20533170|NCT01805817|Diuretics|diuretics|mesh-ancestor
20533171|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
20533172|NCT01805856|Cefazolin|cefazolin|mesh-list
20533173|NCT01805856|Piperacillin|piperacillin|mesh-list
20533174|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20533175|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533176|NCT01805908|Pertuzumab|pertuzumab|mesh-list
20533177|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533178|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533179|NCT01805999|Psyllium|psyllium|mesh-list
20533180|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
19716169|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716170|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
20533181|NCT01805999|Cathartics|cathartics|mesh-ancestor
19716171|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251943|NCT00452556|Docetaxel|docetaxel|mesh-list
20533182|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20251944|NCT00452556|Leuprolide|leuprolide|mesh-list
20251945|NCT00452556|Androgens|androgens|mesh-list
19716172|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716173|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716174|NCT04859062|Lidocaine|lidocaine|mesh-list
19716175|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
20251946|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435410|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435411|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435412|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716176|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
19716177|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716178|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716179|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
19859374|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20251947|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
20251948|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
20251949|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
20251950|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251951|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20251952|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
20251953|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19435413|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
19435414|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435415|NCT03500874|Antidotes|antidotes|mesh-ancestor
19435416|NCT03500874|Protective Agents|protective agents|mesh-ancestor
19435417|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
19435418|NCT03500874|Vitamins|vitamins|mesh-ancestor
19435419|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
19859375|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
19859376|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859377|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859378|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
19859379|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859380|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859381|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
19859382|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859383|NCT00780208|Methylphenidate|methylphenidate|mesh-list
19859384|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19859385|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859386|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19859387|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19859388|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859389|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859390|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
19859391|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859392|NCT00780234|Pioglitazone|pioglitazone|mesh-list
19859393|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859394|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859395|NCT00780273|Cimetidine|cimetidine|mesh-list
19435420|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
19435421|NCT03500848|Sirolimus|sirolimus|mesh-list
19435422|NCT03500848|Tacrolimus|tacrolimus|mesh-list
19435423|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435424|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
19435425|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435426|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19435427|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435428|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435429|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19435430|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435431|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19435432|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
19435433|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19435434|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435435|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
20251954|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251955|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20251956|NCT00452556|Hormones|hormones|mesh-ancestor
20251957|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251958|NCT00452569|Thalidomide|thalidomide|mesh-list
20251959|NCT00452569|Dexamethasone|dexamethasone|mesh-list
20251960|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20251961|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
20251962|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
20251963|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20251964|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251965|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20251966|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
20251967|NCT00452569|Hormones|hormones|mesh-ancestor
20251968|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20251969|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20251970|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20251971|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20251972|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
20251973|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
20251974|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20251975|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20251976|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20251977|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20251978|NCT00452569|Growth Substances|growth substances|mesh-ancestor
20251979|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
20251980|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
20251981|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
20251982|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20251983|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20251984|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20251985|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251986|NCT00452582|Urological Agents|urological agents|mesh-ancestor
20251987|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20251988|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20251989|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20251990|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20251991|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251992|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20251993|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20251994|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
20251995|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20251996|NCT00452608|Atorvastatin|atorvastatin|mesh-list
20251997|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20251998|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19435436|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
19435437|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19435438|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
19435439|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435440|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435441|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19435442|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
19734205|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859396|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19859397|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859398|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19859399|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
19859400|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
19859401|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859402|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859403|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859404|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19859405|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19859406|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859407|NCT00780416|Ribavirin|ribavirin|mesh-list
19859408|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19859409|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
19859410|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
19859411|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734206|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20251999|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
20252000|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252001|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20252002|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20252003|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252004|NCT00452634|Irinotecan|irinotecan|mesh-list
20252005|NCT00452634|Simvastatin|simvastatin|mesh-list
20252006|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252007|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20252008|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19716180|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716181|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19716182|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19716183|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19716184|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19716185|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716186|NCT04831450|Cemiplimab|cemiplimab|mesh-list
19716187|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716188|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716189|NCT04795531|Insulin|insulin|mesh-list
19716190|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19716191|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
19716192|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19716193|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716194|NCT04737187|Trifluridine|trifluridine|mesh-list
19716195|NCT04737187|Bevacizumab|bevacizumab|mesh-list
19716196|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20252009|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716197|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716198|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19716199|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19716200|NCT04737187|Growth Substances|growth substances|mesh-ancestor
19716201|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716202|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
19716203|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
19716204|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716205|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
19716206|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716207|NCT04729205|Mitomycins|mitomycins|mesh-list
19716208|NCT04729205|Mitomycin|mitomycin|mesh-list
19859412|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
19859413|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859414|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
20252010|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252011|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20252012|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20252013|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
20252014|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20252015|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20252016|NCT00452660|Deferasirox|deferasirox|mesh-list
20252017|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20252018|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
20252019|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
20252020|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286589|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20286590|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286591|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
20286592|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20286593|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286594|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
20286595|NCT03069937|Docetaxel|docetaxel|mesh-list
20286596|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435443|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19435444|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
19435445|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435446|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435447|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20286597|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286598|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286599|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286600|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286601|NCT03031730|Dexamethasone|dexamethasone|mesh-list
20286602|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
20286603|NCT03031730|Lenalidomide|lenalidomide|mesh-list
20286604|NCT03031730|Ichthammol|ichthammol|mesh-list
20286605|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20286606|NCT03031730|BB 1101|bb 1101|mesh-list
20286607|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286608|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
20286609|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
20286610|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286611|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286612|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286613|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
20286614|NCT03031730|Hormones|hormones|mesh-ancestor
20286615|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286616|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19435448|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
19435449|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
19435450|NCT03500783|Protective Agents|protective agents|mesh-ancestor
19435451|NCT03500653|Curcumin|curcumin|mesh-list
20286617|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286618|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
19435452|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19435453|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435454|NCT03500653|Analgesics|analgesics|mesh-ancestor
19435455|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
19435456|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435457|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435458|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20252021|NCT00452725|Hormones|hormones|mesh-list
20252022|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252023|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435459|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435460|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435461|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435462|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435463|NCT03500445|Dexamethasone|dexamethasone|mesh-list
19435464|NCT03500445|Lenalidomide|lenalidomide|mesh-list
19435465|NCT03500445|Daratumumab|daratumumab|mesh-list
19435466|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435467|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
19435468|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
19435469|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435470|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435471|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435472|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
19435473|NCT03500445|Hormones|hormones|mesh-ancestor
19435474|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435475|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19435476|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435477|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
19435478|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19435479|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19435480|NCT03500445|Growth Substances|growth substances|mesh-ancestor
19435481|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
19435482|NCT03500432|Lidocaine|lidocaine|mesh-list
19435483|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435484|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
19435485|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435486|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435487|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
19435488|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252024|NCT00452829|Folic Acid|folic acid|mesh-list
20252025|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
20252026|NCT00452829|Inositol|inositol|mesh-list
20252027|NCT00452829|Hematinics|hematinics|mesh-ancestor
20252028|NCT00452829|Vitamins|vitamins|mesh-ancestor
20252029|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
20252030|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252031|NCT00452855|Remifentanil|remifentanil|mesh-list
20533183|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
20533184|NCT01806090|Clopidogrel|clopidogrel|mesh-list
20533185|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20533186|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20533187|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20533188|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20533189|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
20533190|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533191|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533192|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533193|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
20533194|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20533195|NCT01806116|Decitabine|decitabine|mesh-list
20252032|NCT00452855|Sevoflurane|sevoflurane|mesh-list
19435489|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19435490|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19435491|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20252033|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
20252034|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252035|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252036|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20252037|NCT00452855|Narcotics|narcotics|mesh-ancestor
20252038|NCT00452855|Analgesics|analgesics|mesh-ancestor
20252039|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
20252040|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252041|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20252042|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20252043|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
20252044|NCT00452881|Gemcitabine|gemcitabine|mesh-list
20252045|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
20252046|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252047|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20252048|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
20252049|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252050|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
20252051|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252052|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252053|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252054|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
20252055|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252056|NCT00452894|Varenicline|varenicline|mesh-list
20252057|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20252058|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20252059|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
19435492|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19435493|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435494|NCT03500367|Sirolimus|sirolimus|mesh-list
19435495|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19435496|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435497|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19435498|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435499|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
20252060|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286619|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716209|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19716210|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716211|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
19716212|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716213|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19435500|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435501|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
19435502|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435503|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19435504|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
19435505|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435506|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435507|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435508|NCT03500133|Cytarabine|cytarabine|mesh-list
19435509|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
20252061|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252062|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252063|NCT00452907|Artesunate|artesunate|mesh-list
20252064|NCT00452907|Lumefantrine|lumefantrine|mesh-list
20252065|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
19435510|NCT03500133|Cisplatin|cisplatin|mesh-list
19435511|NCT03500133|Etoposide|etoposide|mesh-list
19435512|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435513|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435514|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
19435515|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435516|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
19435517|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435518|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435519|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
19435520|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435521|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19435522|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19435523|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19435524|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716214|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716215|NCT04716881|Naltrexone|naltrexone|mesh-list
19859415|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252066|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
20252067|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20252068|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
20252069|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20252070|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20252071|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252072|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252073|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
20252074|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
20252075|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20252076|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
20252077|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20252078|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252079|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252080|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20252081|NCT00452907|Renal Agents|renal agents|mesh-ancestor
20533196|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20533197|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
20533198|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533199|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533200|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533201|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
20533202|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
20533203|NCT01806272|Vitamins|vitamins|mesh-ancestor
20533204|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
20533205|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533206|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
20533207|NCT01806272|Hematinics|hematinics|mesh-ancestor
20533208|NCT01806311|Amlodipine|amlodipine|mesh-list
20533209|NCT01806311|Candesartan|candesartan|mesh-list
20533210|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20252082|NCT00452920|Docetaxel|docetaxel|mesh-list
19435525|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435526|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
19435527|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
19435528|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435529|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435530|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
19435531|NCT03500133|Hormones|hormones|mesh-ancestor
19435532|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435533|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19435534|NCT03500133|Protective Agents|protective agents|mesh-ancestor
19435535|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
19435536|NCT03500120|Captopril|captopril|mesh-list
19435537|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20252083|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252084|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
20252085|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
19435538|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
19435539|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252086|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
19859416|NCT00780442|Cycloserine|cycloserine|mesh-list
19716216|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19716217|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19716218|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716219|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
19716220|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716221|NCT04706013|Pyridoxal|pyridoxal|mesh-list
19716222|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
19716223|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
19859417|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19859418|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859419|NCT00780442|Renal Agents|renal agents|mesh-ancestor
19859420|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19859421|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
19859422|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19859423|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
19859424|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859425|NCT00780494|Bevacizumab|bevacizumab|mesh-list
19435540|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435541|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19435542|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435543|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
19435544|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19435545|NCT03499886|Ketamine|ketamine|mesh-list
19435546|NCT03499886|Analgesics|analgesics|mesh-ancestor
19435547|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
19435548|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435549|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435550|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19435551|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19435552|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
19859426|NCT00780494|Carboplatin|carboplatin|mesh-list
19435553|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
19716224|NCT04706013|Vitamins|vitamins|mesh-ancestor
19716225|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
20252087|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435554|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435555|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19435556|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19435557|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435558|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435559|NCT03499743|Celecoxib|celecoxib|mesh-list
19435560|NCT03499743|Scopolamine|scopolamine|mesh-list
19435561|NCT03499743|Bromides|bromides|mesh-list
19435562|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19435563|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19435564|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435565|NCT03499743|Analgesics|analgesics|mesh-ancestor
19435566|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
19435567|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435568|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435569|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20252088|NCT00452972|Anesthetics|anesthetics|mesh-list
20252089|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252090|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252091|NCT00452985|Carboplatin|carboplatin|mesh-list
19435570|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20252092|NCT00452985|Docetaxel|docetaxel|mesh-list
20252093|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252094|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
20252095|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
20252096|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
20252097|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252098|NCT00453050|Imiquimod|imiquimod|mesh-list
20252099|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20252100|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
20252101|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252102|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252103|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
20252104|NCT00453076|Paclitaxel|paclitaxel|mesh-list
20252105|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20252106|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252107|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
20252108|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
20252109|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
20252110|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252111|NCT00453115|Gemcitabine|gemcitabine|mesh-list
19435571|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19435572|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19435573|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435574|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435575|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
20252112|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
20533211|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20533212|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533213|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533214|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19716226|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533215|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533216|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
20533217|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20533218|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20533219|NCT01806324|Losartan|losartan|mesh-list
19716227|NCT04697498|Anesthetics|anesthetics|mesh-list
19716228|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716229|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716230|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
19716231|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716232|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716233|NCT04685421|Bupivacaine|bupivacaine|mesh-list
19716234|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
19716235|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
19716236|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716237|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859427|NCT00780494|Capecitabine|capecitabine|mesh-list
19859428|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859429|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533220|NCT01806324|Atorvastatin|atorvastatin|mesh-list
20533221|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20533222|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20533223|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
20533224|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533225|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19859430|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19859431|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859432|NCT00780494|Growth Substances|growth substances|mesh-ancestor
19716238|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
19716239|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716240|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
20533226|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20533227|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533228|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20533229|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20533230|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20533231|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20533232|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
19716241|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19859433|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859434|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
19859435|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859436|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
19859437|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859438|NCT00780676|Dasatinib|dasatinib|mesh-list
20533233|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533234|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533235|NCT01806363|Telmisartan|telmisartan|mesh-list
20533236|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
19859439|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533237|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19435576|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19435577|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
20533238|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19435578|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
19435579|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435580|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
19435581|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19716242|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
19716243|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19716244|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
19716245|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252113|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20252114|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
20252115|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252116|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252117|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
20252118|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252119|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252120|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252121|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
20252122|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252123|NCT00453141|Betamethasone|betamethasone|mesh-list
20252124|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20252125|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
20252126|NCT00453141|Hormones|hormones|mesh-ancestor
20252127|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252128|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252129|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20252130|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
20252131|NCT00453167|Gemcitabine|gemcitabine|mesh-list
20252132|NCT00453167|Paclitaxel|paclitaxel|mesh-list
20252133|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20252134|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252135|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
20252136|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
20252137|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
20252138|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252139|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20252140|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
19435582|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
19435583|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435584|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19435585|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
19435586|NCT03499730|Midazolam|midazolam|mesh-list
20252141|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
20252142|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435587|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19435588|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19435589|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435590|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435591|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20252143|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252144|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252145|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
20252146|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252147|NCT00453232|Etoposide|etoposide|mesh-list
19435592|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19435593|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19435594|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19435595|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
19435596|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
19435597|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
19435598|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
19435599|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435600|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435601|NCT03499639|Ritonavir|ritonavir|mesh-list
19435602|NCT03499639|Ribavirin|ribavirin|mesh-list
20252148|NCT00453232|Bleomycin|bleomycin|mesh-list
20252149|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252150|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20252151|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19435603|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19435604|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20252152|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20252153|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252154|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252155|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20252156|NCT00453323|Paclitaxel|paclitaxel|mesh-list
20252157|NCT00453323|Capecitabine|capecitabine|mesh-list
20252158|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20252159|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252160|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
20252161|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
20252162|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
20252163|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252164|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435605|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
19435606|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435607|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435608|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19435609|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19435610|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
19435611|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435612|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19435613|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20252165|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
20252166|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
20252167|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
20252168|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252169|NCT00453375|Protective Agents|protective agents|mesh-ancestor
20252170|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252171|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
20252172|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
20252173|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252174|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252175|NCT00453414|Iloprost|iloprost|mesh-list
20252176|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20252177|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
20252178|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
20252179|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20252180|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252181|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20252182|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
20252183|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435614|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
19435615|NCT03499457|Amoxicillin|amoxicillin|mesh-list
19716246|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716247|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
19716248|NCT04652960|Nivolumab|nivolumab|mesh-list
19716249|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716250|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716251|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716252|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716253|NCT04633239|Olaparib|olaparib|mesh-list
19716254|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19716255|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716256|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716257|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716258|NCT04614363|Edetic Acid|edetic acid|mesh-list
19716259|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19716260|NCT04614363|Anticoagulants|anticoagulants|mesh-ancestor
19716261|NCT04614363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19716262|NCT04614363|Chelating Agents|chelating agents|mesh-ancestor
19716263|NCT04614363|Sequestering Agents|sequestering agents|mesh-ancestor
19716264|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252184|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
19435616|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252185|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20252186|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252187|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252188|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20252189|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252190|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20252191|NCT00453609|Naltrexone|naltrexone|mesh-list
20252192|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19435617|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435618|NCT03499444|Rucaparib|rucaparib|mesh-list
19435619|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19435620|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435621|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435622|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435623|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
19435624|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19435625|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
19435626|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19435627|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435628|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19435629|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19435630|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19435631|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
19435632|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19435633|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
19435634|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252193|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20252194|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252195|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
20252196|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252197|NCT00453635|Carboplatin|carboplatin|mesh-list
20252198|NCT00453635|Docetaxel|docetaxel|mesh-list
20252199|NCT00453635|Trastuzumab|trastuzumab|mesh-list
20252200|NCT00453635|Vinorelbine|vinorelbine|mesh-list
20252201|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252202|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
20252203|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
20252204|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
20252205|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252206|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20252207|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20252208|NCT00453648|Vitamin A|vitamin a|mesh-list
19435635|NCT03499249|Expectorants|expectorants|mesh-ancestor
19435636|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
19435637|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20252209|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
20252210|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
19435638|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
19435639|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252211|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252212|NCT00453648|Protective Agents|protective agents|mesh-ancestor
19716265|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19716266|NCT04609423|Vitamin D|vitamin d|mesh-list
19716267|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
20252213|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252214|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20252215|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252216|NCT00453648|Vitamins|vitamins|mesh-ancestor
20252217|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
20252218|NCT00453765|Montelukast|montelukast|mesh-list
20252219|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20252220|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
20252221|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20252222|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
20252223|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252224|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716268|NCT04609423|Vitamins|vitamins|mesh-ancestor
19716269|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
19716270|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716271|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716272|NCT04593459|Metformin|metformin|mesh-list
19716273|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19716274|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716275|NCT04590495|Cannabidiol|cannabidiol|mesh-list
19716276|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
19716277|NCT04588246|Memantine|memantine|mesh-list
19716278|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19716279|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19716280|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
19716281|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716282|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716283|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716284|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19716285|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19716286|NCT04587947|Valsartan|valsartan|mesh-list
19716287|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19716288|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19716289|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19716290|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716291|NCT04579640|Vitamin D|vitamin d|mesh-list
19716292|NCT04579640|Vitamins|vitamins|mesh-ancestor
19716293|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
19716294|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716295|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716296|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
19716297|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716298|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716299|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
19716300|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19716301|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716302|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
19734207|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19734208|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734209|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734210|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734211|NCT04553328|Bupivacaine|bupivacaine|mesh-list
19734212|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
19734213|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
19734214|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734215|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734216|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
19734217|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734218|NCT04552977|Temozolomide|temozolomide|mesh-list
19734219|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19734220|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
19734221|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734222|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734223|NCT04552951|Vitamin D|vitamin d|mesh-list
19734224|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
19859440|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20252225|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20252226|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20252227|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859441|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859442|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859443|NCT00780715|Metformin|metformin|mesh-list
19859444|NCT00780715|Pioglitazone|pioglitazone|mesh-list
20252228|NCT00453778|Fluticasone|fluticasone|mesh-list
20252229|NCT00453778|Xhance|xhance|mesh-list
20252230|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20252231|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20252232|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
20252233|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252234|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252235|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20252236|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
20252237|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
20252238|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20252239|NCT00453804|Naltrexone|naltrexone|mesh-list
20252240|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20252241|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20252242|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252243|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
20252244|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252245|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
20252246|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
19859445|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19859446|NCT00780715|Gliclazide|gliclazide|mesh-list
19859447|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859448|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859449|NCT00780715|Incretins|incretins|mesh-ancestor
19859450|NCT00780715|Hormones|hormones|mesh-ancestor
19859451|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19859452|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19859453|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
19859454|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252247|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20252248|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
19859455|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859456|NCT00780910|Ribavirin|ribavirin|mesh-list
20252249|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20252250|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20252251|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252252|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20252253|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252254|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252255|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20252256|NCT00453856|Renal Agents|renal agents|mesh-ancestor
20252257|NCT00453908|Alfuzosin|alfuzosin|mesh-list
20252258|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20252259|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19859457|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19859458|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
19859459|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859460|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
19859461|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859462|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
19859463|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19859464|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
19859465|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716303|NCT04556773|Paclitaxel|paclitaxel|mesh-list
19716304|NCT04556773|Capecitabine|capecitabine|mesh-list
19716305|NCT04556773|Trastuzumab|trastuzumab|mesh-list
19716306|NCT04556773|Durvalumab|durvalumab|mesh-list
19716307|NCT04556773|Fulvestrant|fulvestrant|mesh-list
20252260|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20252261|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
20252262|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252263|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252264|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252265|NCT00453908|Urological Agents|urological agents|mesh-ancestor
19716308|NCT04556773|Anastrozole|anastrozole|mesh-list
19716309|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19716310|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716311|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
19716312|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
19716313|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
19716314|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716315|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716316|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
19859466|NCT00780962|Expectorants|expectorants|mesh-ancestor
19859467|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859468|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19859469|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
19859470|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859471|NCT00780962|Protective Agents|protective agents|mesh-ancestor
19859472|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859473|NCT00780962|Antidotes|antidotes|mesh-ancestor
19859474|NCT00781274|Ribavirin|ribavirin|mesh-list
19859475|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19859476|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
19859477|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859478|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
19859479|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859480|NCT00781326|Nimodipine|nimodipine|mesh-list
19859481|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19716317|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716318|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716319|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19716320|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19859482|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20252266|NCT00453960|Norethindrone|norethindrone|mesh-list
20252267|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
20252268|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20252269|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20252270|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20252271|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
20252272|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20252273|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252274|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20252275|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20252276|NCT00454168|Sargramostim|sargramostim|mesh-list
20252277|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
20252278|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252279|NCT00454233|Metformin|metformin|mesh-list
19435640|NCT03499249|Protective Agents|protective agents|mesh-ancestor
19435641|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435642|NCT03499249|Antidotes|antidotes|mesh-ancestor
19435643|NCT03499223|Ranibizumab|ranibizumab|mesh-list
19435644|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19435645|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19435646|NCT03499223|Growth Substances|growth substances|mesh-ancestor
19435647|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435648|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
19435649|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716321|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
19716322|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716323|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716324|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19716325|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19716326|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435650|NCT03499184|Metronidazole|metronidazole|mesh-list
19435651|NCT03499184|Amoxicillin|amoxicillin|mesh-list
19435652|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435653|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19435654|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19435655|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19435656|NCT03499171|Citalopram|citalopram|mesh-list
19716327|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
19716328|NCT04555603|Avelumab|avelumab|mesh-list
19716329|NCT04555603|Axitinib|axitinib|mesh-list
19716330|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859483|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252280|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19435657|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19435658|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19716331|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716332|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19435659|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19435660|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435661|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435662|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
19435663|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435664|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19435665|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
19435666|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19435667|NCT03499132|Anesthetics|anesthetics|mesh-list
19435668|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435669|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435670|NCT03499106|Itraconazole|itraconazole|mesh-list
19435671|NCT03499106|Praliciguat|praliciguat|mesh-list
19716333|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716334|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716335|NCT04542148|Insulin|insulin|mesh-list
19716336|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19716337|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
19859484|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859485|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19859486|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435672|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
19435673|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435674|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19859487|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
19859488|NCT00781391|Warfarin|warfarin|mesh-list
19859489|NCT00781391|Edoxaban|edoxaban|mesh-list
19859490|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
19859491|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19859492|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
19859493|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19859494|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
19435675|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19435676|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435677|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435678|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19435679|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
19435680|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435681|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435682|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19435683|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19435684|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
19435685|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20252281|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252282|NCT00454259|Fentanyl|fentanyl|mesh-list
20252283|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20533239|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20533240|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533241|NCT01806363|Diuretics|diuretics|mesh-ancestor
19451607|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19451608|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451609|NCT03420378|Vitamin D|vitamin d|mesh-list
19451610|NCT03420378|Vitamins|vitamins|mesh-ancestor
19451611|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
19451612|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451613|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716338|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
19716339|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19716340|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716341|NCT04502433|Poractant alfa|poractant alfa|mesh-list
19716342|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19716343|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
19716344|NCT04491032|Anesthetics|anesthetics|mesh-list
19734225|NCT04552951|Vitamins|vitamins|mesh-ancestor
19859495|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859496|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859497|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
19859498|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
19859499|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
19859500|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19859501|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859502|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19859503|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20252284|NCT00454259|Narcotics|narcotics|mesh-ancestor
20252285|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252286|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252287|NCT00454259|Analgesics|analgesics|mesh-ancestor
20252288|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
20252289|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252290|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20252291|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20252292|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
20252293|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
20252294|NCT00454272|Vancomycin|vancomycin|mesh-list
19716345|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716346|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716347|NCT04482959|Carbetocin|carbetocin|mesh-list
19716348|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
19716349|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19716350|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716351|NCT04472767|Nivolumab|nivolumab|mesh-list
19435686|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
20252295|NCT00454272|Teicoplanin|teicoplanin|mesh-list
20252296|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252297|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252298|NCT00454337|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20252299|NCT00454337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20252300|NCT00454337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20252301|NCT00454337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252302|NCT00454337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252303|NCT00454337|Antiviral Agents|antiviral agents|mesh-ancestor
20252304|NCT00454337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252305|NCT00454337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19716352|NCT04472767|Ipilimumab|ipilimumab|mesh-list
19716353|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716354|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716355|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716356|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859504|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19859505|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
19859506|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
19859507|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19859508|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19859509|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859510|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859511|NCT00781508|Urological Agents|urological agents|mesh-ancestor
19859512|NCT00781599|Varenicline|varenicline|mesh-list
19859513|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19859514|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19859515|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
19859516|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859517|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252306|NCT00454337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20252307|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20252308|NCT00454350|Vitamins|vitamins|mesh-ancestor
19435687|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859518|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435688|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435689|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435690|NCT03498820|Remifentanil|remifentanil|mesh-list
19435691|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19435692|NCT03498820|Narcotics|narcotics|mesh-ancestor
19435693|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435694|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435695|NCT03498820|Analgesics|analgesics|mesh-ancestor
19435696|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
19435697|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435698|NCT03498703|Azathioprine|azathioprine|mesh-list
20252309|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
19435699|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
19435700|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435701|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435702|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859519|NCT00781768|Ondansetron|ondansetron|mesh-list
19859520|NCT00781768|Aprepitant|aprepitant|mesh-list
19859521|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
19859522|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
19859523|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859524|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859525|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859526|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
19859527|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
19859528|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19859529|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
19859530|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859531|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252310|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252311|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20252312|NCT00454389|Ranibizumab|ranibizumab|mesh-list
20252313|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20252314|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20252315|NCT00454389|Growth Substances|growth substances|mesh-ancestor
20252316|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252317|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
20252318|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252319|NCT00454402|Alfuzosin|alfuzosin|mesh-list
20252320|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20252321|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20252322|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20252323|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
20252324|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252325|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252326|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252327|NCT00454402|Urological Agents|urological agents|mesh-ancestor
20286620|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286621|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
20286622|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20286623|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20286624|NCT03031730|Growth Substances|growth substances|mesh-ancestor
20286625|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
20286626|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
20286627|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
20286628|NCT03007329|Exenatide|exenatide|mesh-list
20286629|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20286630|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286631|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20286632|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286633|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20286634|NCT03007329|Incretins|incretins|mesh-ancestor
20286635|NCT03007329|Hormones|hormones|mesh-ancestor
20286636|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716357|NCT04438330|Nickel|nickel|mesh-list
20286637|NCT02987257|Cyclosporine|cyclosporine|mesh-list
20286638|NCT02987257|Etanercept|etanercept|mesh-list
19716358|NCT04438330|Trace Elements|trace elements|mesh-ancestor
19716359|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
19716360|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716361|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
19716362|NCT04429893|Bupivacaine|bupivacaine|mesh-list
19716363|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
19716364|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
19716365|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716366|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716367|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
19716368|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716369|NCT04429893|Analgesics|analgesics|mesh-ancestor
19716370|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19716371|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
19716372|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19716373|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19716374|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716375|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19716376|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
19716377|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19716378|NCT04410653|Afatinib|afatinib|mesh-list
19716379|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716380|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19716381|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716382|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716383|NCT04403516|Dexamethasone|dexamethasone|mesh-list
19716384|NCT04403516|Prednisolone|prednisolone|mesh-list
19716385|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19716386|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
19716387|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19716388|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
19716389|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19716390|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
19716391|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19859532|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19859533|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19859534|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859535|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19859536|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19859537|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19716392|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
19859538|NCT00781859|Plasminogen|plasminogen|mesh-list
19859539|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19859540|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19859541|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859542|NCT00781885|Beraprost|beraprost|mesh-list
19859543|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19859544|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
19859545|NCT00781898|Naltrexone|naltrexone|mesh-list
19859546|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19859547|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19859548|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859549|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
19859550|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859551|NCT00781911|Octreotide|octreotide|mesh-list
19859552|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859553|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19859554|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859555|NCT00781937|Liraglutide|liraglutide|mesh-list
19716393|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
20252328|NCT00454480|Cytarabine|cytarabine|mesh-list
20252329|NCT00454480|Fludarabine|fludarabine|mesh-list
20252330|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
20252331|NCT00454480|Azacitidine|azacitidine|mesh-list
20252332|NCT00454480|Melphalan|melphalan|mesh-list
19716394|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252333|NCT00454480|Busulfan|busulfan|mesh-list
20252334|NCT00454480|Daunorubicin|daunorubicin|mesh-list
20252335|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
20252336|NCT00454480|Clofarabine|clofarabine|mesh-list
20252337|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
19716395|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716396|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716397|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
20252338|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
20252339|NCT00454480|Tipifarnib|tipifarnib|mesh-list
20252340|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252341|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20252342|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
19716398|NCT04403516|Hormones|hormones|mesh-ancestor
19716399|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716400|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716401|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716402|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19716403|NCT04403516|Protective Agents|protective agents|mesh-ancestor
19716404|NCT04383639|Locust bean gum|locust bean gum|mesh-list
19716405|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
19716406|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716407|NCT04353492|Ofatumumab|ofatumumab|mesh-list
19716408|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716409|NCT04349722|Scopolamine|scopolamine|mesh-list
19859556|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859557|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859558|NCT00781937|Incretins|incretins|mesh-ancestor
19859559|NCT00781937|Hormones|hormones|mesh-ancestor
19859560|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19859561|NCT00782067|Midostaurin|midostaurin|mesh-list
19859562|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859563|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19859564|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859565|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859566|NCT00782210|Olodaterol|olodaterol|mesh-list
19859567|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19859568|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
19859569|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859570|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859571|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19859572|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859573|NCT00782275|Sirolimus|sirolimus|mesh-list
20252343|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435703|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435704|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
19435705|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435706|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435707|NCT03498534|Isoniazid|isoniazid|mesh-list
19435708|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
19435709|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19435710|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435711|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19435712|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19435713|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
19435714|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435715|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19435716|NCT03498456|Amoxicillin|amoxicillin|mesh-list
19716410|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20252344|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252345|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
20252346|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435717|NCT03498456|Clarithromycin|clarithromycin|mesh-list
19716411|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19716412|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
19716413|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
19716414|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716415|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716416|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716417|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
19716418|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19716419|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
19435718|NCT03498456|Lansoprazole|lansoprazole|mesh-list
19716420|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716421|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716422|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19716423|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
19716424|NCT04313972|Naltrexone|naltrexone|mesh-list
19716425|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19716426|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19716427|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716428|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
19716429|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716430|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
19435719|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
19435720|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19435721|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435722|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19716431|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19716432|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
19716433|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252347|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
20252348|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252349|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435723|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435724|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435725|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19716434|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716435|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20252350|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20252351|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
20252352|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20252353|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20252354|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20252355|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20252356|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533242|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
20533243|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533244|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20533245|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533246|NCT01806376|Maleic acid|maleic acid|mesh-list
20533247|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533248|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533249|NCT01806415|Imidazole|imidazole|mesh-list
20533250|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533251|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533252|NCT01806454|Calcium|calcium|mesh-list
20533253|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19716436|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
20533254|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252357|NCT00454519|Mitomycins|mitomycins|mesh-list
20252358|NCT00454519|Mitomycin|mitomycin|mesh-list
20286639|NCT02987257|Cyclosporins|cyclosporins|mesh-list
20286640|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286641|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286642|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286643|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
20286644|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286645|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
20286646|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286647|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
20286648|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286649|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20252359|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252360|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19716437|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19716438|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
20252361|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
19859574|NCT00782275|Bevacizumab|bevacizumab|mesh-list
20252362|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252363|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20252364|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252365|NCT00454545|Atorvastatin|atorvastatin|mesh-list
20252366|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20252367|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20252368|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
20252369|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252370|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20252371|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20252372|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252373|NCT00454558|Riociguat|riociguat|mesh-list
20252374|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
20252375|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252376|NCT00454662|Amlodipine|amlodipine|mesh-list
20252377|NCT00454662|Olmesartan|olmesartan|mesh-list
20533255|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20533256|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
19716439|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716440|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716441|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19716442|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
19716443|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
19716444|NCT04306393|Protective Agents|protective agents|mesh-ancestor
19716445|NCT04302454|Leuprolide|leuprolide|mesh-list
19716446|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19716447|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
19716448|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19716449|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716450|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716451|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859575|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859576|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859577|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19859578|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859579|NCT00782275|Growth Substances|growth substances|mesh-ancestor
19859580|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859581|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
19859582|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19859583|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859584|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19859585|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
19859586|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533257|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533258|NCT01806753|Midazolam|midazolam|mesh-list
20533259|NCT01806753|Propofol|propofol|mesh-list
20533260|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533261|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533262|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533263|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20533264|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
20533265|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
20533266|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19716452|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19716453|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
19859587|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
19859588|NCT00782340|Droxidopa|droxidopa|mesh-list
19859589|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19859590|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19859591|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
19859592|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
19859593|NCT00782379|Busulfan|busulfan|mesh-list
20252378|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20252379|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19859594|NCT00782379|Fludarabine|fludarabine|mesh-list
19859595|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
19859596|NCT00782379|Tacrolimus|tacrolimus|mesh-list
19859597|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859598|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
19859599|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859600|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859601|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19859602|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
19859603|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859604|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859605|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19859606|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859607|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
19859608|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19859609|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859610|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20252380|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20252381|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252382|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252383|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20252384|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252385|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
20252386|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19716454|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533267|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20533268|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533269|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533270|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
20533271|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
19716455|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19716456|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19716457|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716458|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716459|NCT04277442|Nivolumab|nivolumab|mesh-list
19716460|NCT04277442|Decitabine|decitabine|mesh-list
20533272|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533273|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533274|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
20533275|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
20533276|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
20533277|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20533278|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533279|NCT01806792|Vitamins|vitamins|mesh-ancestor
20533280|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
20252387|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20252388|NCT00454701|Alefacept|alefacept|mesh-list
20252389|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20252390|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
20252391|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252392|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
19435726|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19435727|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19435728|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435729|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19435730|NCT03498417|Antibodies|antibodies|mesh-list
19435731|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
19435732|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435733|NCT03498326|Gemcitabine|gemcitabine|mesh-list
19435734|NCT03498326|Celecoxib|celecoxib|mesh-list
19435735|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435736|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
19435737|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435738|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716461|NCT04277442|Venetoclax|venetoclax|mesh-list
20252393|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
20252394|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20252395|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20252396|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252397|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533281|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716462|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716463|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716464|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716465|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716466|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716467|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
19716468|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716469|NCT04275232|Plasminogen|plasminogen|mesh-list
19716470|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19716471|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19716472|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859611|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20252398|NCT00454714|Urological Agents|urological agents|mesh-ancestor
20533282|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20533283|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533284|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533285|NCT01806805|Zonisamide|zonisamide|mesh-list
20533286|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
20533287|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20533288|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533289|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533290|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20533291|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533292|NCT01806948|Ramosetron|ramosetron|mesh-list
20533293|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
20533294|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
20533295|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533296|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533297|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533298|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20533299|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
20533300|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533301|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533302|NCT01807078|Ezetimibe|ezetimibe|mesh-list
20533303|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20533304|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20533305|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
20553416|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19859612|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
20252399|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
20252400|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20252401|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20252402|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
20252403|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252404|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252405|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252406|NCT00454740|Urological Agents|urological agents|mesh-ancestor
20252407|NCT00454831|Chitosan|chitosan|mesh-list
20533306|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252408|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19716473|NCT04248712|Loratadine|loratadine|mesh-list
19716474|NCT04248712|Famotidine|famotidine|mesh-list
19716475|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19716476|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716477|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20533307|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20252409|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20533308|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20533309|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20533310|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533311|NCT01807286|Dexamethasone|dexamethasone|mesh-list
20533312|NCT01807286|Melphalan|melphalan|mesh-list
19435739|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
19435740|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435741|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716478|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
20533313|NCT01807286|Pomalidomide|pomalidomide|mesh-list
20533314|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19716479|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
19716480|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716481|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716482|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716483|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
19716484|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
19716485|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19716486|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19716487|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19716488|NCT04225819|Vitamin D|vitamin d|mesh-list
19716489|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
19716490|NCT04225819|Vitamins|vitamins|mesh-ancestor
19859613|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19859614|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859615|NCT00782418|Exenatide|exenatide|mesh-list
19859616|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859617|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859618|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19859619|NCT00782418|Incretins|incretins|mesh-ancestor
20533315|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
19716491|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
19716492|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859620|NCT00782418|Hormones|hormones|mesh-ancestor
19716493|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716494|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19734226|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
19734227|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734228|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19734229|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19734230|NCT04552808|Yimitasvir|yimitasvir|mesh-list
20252410|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
20252411|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252412|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20252413|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
20252414|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
19435742|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435743|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
19435744|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435745|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19435746|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435747|NCT03498326|Analgesics|analgesics|mesh-ancestor
19435748|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
19435749|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734231|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
19734232|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435750|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435751|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435752|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19435753|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19435754|NCT03498261|Gabapentin|gabapentin|mesh-list
19435755|NCT03498261|Analgesics|analgesics|mesh-ancestor
19435756|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
19435757|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734233|NCT04552743|Plerixafor|plerixafor|mesh-list
19734234|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19734235|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19734236|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
20252415|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
20252416|NCT00454831|Coagulants|coagulants|mesh-ancestor
19734237|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252417|NCT00454883|Ziprasidone|ziprasidone|mesh-list
20252418|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20252419|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
20252420|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252421|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252422|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252423|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20252424|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20252425|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252426|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252427|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20252428|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
20252429|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
20252430|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20252431|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20252432|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
20252433|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252434|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252435|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252436|NCT00454896|Urological Agents|urological agents|mesh-ancestor
20252437|NCT00454961|Lumefantrine|lumefantrine|mesh-list
20533316|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
20533317|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533318|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533319|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533320|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
20533321|NCT01807286|Hormones|hormones|mesh-ancestor
20533322|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252438|NCT00454961|Artemether|artemether|mesh-list
20252439|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20252440|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
20252441|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20252442|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20252443|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252444|NCT00455026|Remifentanil|remifentanil|mesh-list
20252445|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19716495|NCT04214249|Cytarabine|cytarabine|mesh-list
19716496|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
19716497|NCT04214249|Daunorubicin|daunorubicin|mesh-list
19716498|NCT04214249|Idarubicin|idarubicin|mesh-list
19716499|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20252446|NCT00455026|Narcotics|narcotics|mesh-ancestor
20252447|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252448|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252449|NCT00455026|Analgesics|analgesics|mesh-ancestor
20252450|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
20252451|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252452|NCT00455039|Lapatinib|lapatinib|mesh-list
20252453|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252454|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20252455|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252456|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252457|NCT00455091|Lamivudine|lamivudine|mesh-list
20252458|NCT00455091|Adefovir|adefovir|mesh-list
20252459|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20252460|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20252461|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20252462|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252463|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252464|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
20252465|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252466|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20252467|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20252468|NCT00455117|Parecoxib|parecoxib|mesh-list
20252469|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19435758|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435759|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
19435760|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19435761|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19435762|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435763|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19451614|NCT03420339|Adderall|adderall|mesh-list
20252470|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20252471|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451615|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19451616|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451617|NCT03420313|Buprenorphine|buprenorphine|mesh-list
19451618|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19716500|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716501|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716502|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
19716503|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716504|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
20252472|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252473|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20252474|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19716505|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716506|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716507|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
19716508|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716509|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19716510|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19716511|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19716512|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716513|NCT04201756|Afatinib|afatinib|mesh-list
19716514|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716515|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19435764|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19435765|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19435766|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435767|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435768|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
19435769|NCT03498248|Lenograstim|lenograstim|mesh-list
19435770|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19435771|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
19716516|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716517|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716518|NCT04199624|Ascorbic Acid|ascorbic acid|mesh-list
19716519|NCT04199624|Omeprazole|omeprazole|mesh-list
19716520|NCT04199624|Vitamins|vitamins|mesh-ancestor
19716521|NCT04199624|Micronutrients|micronutrients|mesh-ancestor
19716522|NCT04199624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716523|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19716524|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716525|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19716526|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716527|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716528|NCT04199624|Antioxidants|antioxidants|mesh-ancestor
19716529|NCT04199624|Protective Agents|protective agents|mesh-ancestor
19716530|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
19716531|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716532|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716533|NCT04154943|Cemiplimab|cemiplimab|mesh-list
19716534|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716535|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716536|NCT04138706|Vancomycin|vancomycin|mesh-list
19716537|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19716538|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859621|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969643|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
19716539|NCT04123470|Atezolizumab|atezolizumab|mesh-list
19969644|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969645|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969646|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969647|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969648|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
19969649|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
19969650|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20252475|NCT00455117|Analgesics|analgesics|mesh-ancestor
20252476|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
19716540|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716541|NCT04084769|Vaccines|vaccines|mesh-list
19716542|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
19716543|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716544|NCT04082754|Antibodies|antibodies|mesh-list
19716545|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19716546|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
19716547|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716548|NCT04074343|Irinotecan|irinotecan|mesh-list
19716549|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19716550|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19716551|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716552|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716553|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716554|NCT04069117|Letrozole|letrozole|mesh-list
19716555|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716556|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20252477|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252478|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252479|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20252480|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20252481|NCT00455130|Mannitol|mannitol|mesh-list
20252482|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20252483|NCT00455130|Diuretics|diuretics|mesh-ancestor
20252484|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
20252485|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252486|NCT00455234|Promethazine|promethazine|mesh-list
20252487|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
20252488|NCT00455234|Haloperidol|haloperidol|mesh-list
20252489|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
20252490|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
20252491|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
20252492|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252493|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252494|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716557|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19716558|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716559|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859622|NCT00782509|Olodaterol|olodaterol|mesh-list
19859623|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19859624|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
19859625|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859626|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859627|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19859628|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859629|NCT00782626|Everolimus|everolimus|mesh-list
19859630|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859631|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859632|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
19859633|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252495|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20252496|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20252497|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252498|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252499|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20252500|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
20252501|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252502|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252503|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20252504|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
19716560|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19859634|NCT00782717|Prednisolone|prednisolone|mesh-list
20252505|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
20252506|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20252507|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
20252508|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
19716561|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
19716562|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716563|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716564|NCT04061252|Brodalumab|brodalumab|mesh-list
19716565|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
19716566|NCT04041232|Glycerol|glycerol|mesh-list
19716567|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19716568|NCT04041232|Protective Agents|protective agents|mesh-ancestor
19716569|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716570|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
20252509|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19716571|NCT04040361|Ramucirumab|ramucirumab|mesh-list
19716572|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716573|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716574|NCT04024228|Vaccines|vaccines|mesh-list
19716575|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
19859635|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19859636|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
19859637|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19859638|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
19859639|NCT00782717|Nepafenac|nepafenac|mesh-list
19859640|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19859641|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
19859642|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19859643|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
19859644|NCT00782717|Hormones|hormones|mesh-ancestor
19859645|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19859646|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859647|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20252510|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20252511|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20252512|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
20252513|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
20252514|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
19859648|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859649|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
19859650|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
19859651|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859652|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859653|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19859654|NCT00782717|Protective Agents|protective agents|mesh-ancestor
19859655|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19859656|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19859657|NCT00782717|Analgesics|analgesics|mesh-ancestor
19859658|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
19859659|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859660|NCT00782756|Bevacizumab|bevacizumab|mesh-list
19859661|NCT00782756|Temozolomide|temozolomide|mesh-list
19859662|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859663|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859664|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19859665|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859666|NCT00782756|Growth Substances|growth substances|mesh-ancestor
20252515|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
20252516|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20252517|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20252518|NCT00455286|Prednisolone|prednisolone|mesh-list
20252519|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
19716576|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
19859667|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252520|NCT00455286|Methotrexate|methotrexate|mesh-list
20252521|NCT00455286|Temozolomide|temozolomide|mesh-list
20252522|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20252523|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
20252524|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20252525|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
20252526|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20252527|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252528|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20252529|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
20252530|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252531|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252532|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
20252533|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252534|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20252535|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252536|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
20252537|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20252538|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20252539|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19435772|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435773|NCT03498235|Propofol|propofol|mesh-list
19435774|NCT03498235|Sevoflurane|sevoflurane|mesh-list
19435775|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19435776|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435777|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435778|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19435779|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
19435780|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
19435781|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19435782|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19435783|NCT03498222|Carboplatin|carboplatin|mesh-list
19435784|NCT03498222|Pemetrexed|pemetrexed|mesh-list
19435785|NCT03498222|Atezolizumab|atezolizumab|mesh-list
20252540|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
20252541|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20252542|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
20252543|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
20252544|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252545|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435786|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252546|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
20252547|NCT00455286|Hormones|hormones|mesh-ancestor
20252548|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252549|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20252550|NCT00455286|Protective Agents|protective agents|mesh-ancestor
20252551|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20252552|NCT00455351|Vorinostat|vorinostat|mesh-list
20252553|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252554|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20252555|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252556|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435787|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435788|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435789|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19435790|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19435791|NCT03498170|Itraconazole|itraconazole|mesh-list
19435792|NCT03498170|Acumapimod|acumapimod|mesh-list
19435793|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
19435794|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435795|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19435796|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19716577|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716578|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
19716579|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19716580|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19716581|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19716582|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19716583|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19435797|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435798|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435799|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19435800|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
19435801|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435802|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435803|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19435804|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19435805|NCT03498118|Bupivacaine|bupivacaine|mesh-list
19435806|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435807|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
19435808|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435809|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435810|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
19435811|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716584|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19716585|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20252557|NCT00455364|Voriconazole|voriconazole|mesh-list
20252558|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
20252559|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252560|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20252561|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20252562|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252563|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252564|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20252565|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
20252566|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252567|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533323|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20533324|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533325|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20533326|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
20533327|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533328|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20533329|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533330|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
20533331|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20533332|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20533333|NCT01807286|Growth Substances|growth substances|mesh-ancestor
20252568|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20533334|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
20533335|NCT01807325|Pancrelipase|pancrelipase|mesh-list
20533336|NCT01807325|Pancreatin|pancreatin|mesh-list
19716586|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
19716587|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716588|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716589|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716590|NCT03997266|Gentamicins|gentamicins|mesh-list
19716591|NCT03997266|Ampicillin|ampicillin|mesh-list
19716592|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19716593|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716594|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19716595|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716596|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716597|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
19716598|NCT03996148|Remifentanil|remifentanil|mesh-list
20533337|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533338|NCT01807377|Midazolam|midazolam|mesh-list
20533339|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20533340|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533341|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533342|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533343|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20533344|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533345|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533346|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20533347|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
20533348|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
20533349|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
20533350|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
20533351|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533352|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533353|NCT01807429|Midazolam|midazolam|mesh-list
20533354|NCT01807429|Ketamine|ketamine|mesh-list
19716599|NCT03996148|Propofol|propofol|mesh-list
20252569|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
20252570|NCT00455416|Selenium|selenium|mesh-list
20252571|NCT00455416|Allicin|allicin|mesh-list
20252572|NCT00455416|Resveratrol|resveratrol|mesh-list
20252573|NCT00455416|Quercetin|quercetin|mesh-list
20252574|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
20252575|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252576|NCT00455416|Protective Agents|protective agents|mesh-ancestor
20533355|NCT01807429|Morphine|morphine|mesh-list
20533356|NCT01807429|Analgesics|analgesics|mesh-ancestor
20533357|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
19716600|NCT03996148|Desflurane|desflurane|mesh-list
19716601|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19716602|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716603|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716604|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19716605|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
19716606|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
20252577|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252578|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716607|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20252579|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20252580|NCT00455416|Trace Elements|trace elements|mesh-ancestor
20252581|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
19435812|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
19435813|NCT03498092|Bupivacaine|bupivacaine|mesh-list
19435814|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435815|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
19435816|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435817|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435818|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
19435819|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435820|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19435821|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19716608|NCT03996148|Analgesics|analgesics|mesh-ancestor
19716609|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
19435822|NCT03498092|Analgesics|analgesics|mesh-ancestor
19435823|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19435824|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19435825|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19435826|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
19435827|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435828|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435829|NCT03497988|Oxytocin|oxytocin|mesh-list
19435830|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
19435831|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19435832|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435833|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
19435834|NCT03497923|Analgesics|analgesics|mesh-ancestor
19435835|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
19435836|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435837|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435838|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
19435839|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435840|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19435841|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
19435842|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19435843|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19435844|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435845|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19435846|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
19435847|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19435848|NCT03497767|Osimertinib|osimertinib|mesh-list
19435849|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435850|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19435851|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435852|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435853|NCT03497715|Ibuprofen|ibuprofen|mesh-list
19435854|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19435855|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435856|NCT03497715|Analgesics|analgesics|mesh-ancestor
19435857|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
19435858|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435859|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435860|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435861|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435862|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19435863|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435864|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716610|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716611|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19716612|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19435865|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
19435866|NCT03497702|Docetaxel|docetaxel|mesh-list
19435867|NCT03497702|Doxorubicin|doxorubicin|mesh-list
19435868|NCT03497702|Letrozole|letrozole|mesh-list
19435869|NCT03497702|Leuprolide|leuprolide|mesh-list
19435870|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435871|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
19435872|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435873|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435874|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19435875|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
19435876|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435877|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716613|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19716614|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
19716615|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716616|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716617|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19716618|NCT03996148|Narcotics|narcotics|mesh-ancestor
19716619|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19716620|NCT03972280|Antibodies|antibodies|mesh-list
19716621|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19716622|NCT03972280|Sargramostim|sargramostim|mesh-list
19716623|NCT03972280|Lenograstim|lenograstim|mesh-list
19716624|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
19716625|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716626|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19859668|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
19716627|NCT03940131|Panitumumab|panitumumab|mesh-list
19716628|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859669|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19859670|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
19859671|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859672|NCT00782795|Pioglitazone|pioglitazone|mesh-list
19859673|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859674|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859675|NCT00782821|Rituximab|rituximab|mesh-list
19859676|NCT00782821|Bortezomib|bortezomib|mesh-list
19859677|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
19859678|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19859679|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859680|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435878|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19435879|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
19435880|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
19435881|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
19435882|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19435883|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19435884|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19435885|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435886|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19435887|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19435888|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19435889|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
19435890|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435891|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19716629|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252582|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252583|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20252584|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
19859681|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
19859682|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252585|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20252586|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20252587|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19716630|NCT03912818|Gemcitabine|gemcitabine|mesh-list
19716631|NCT03912818|Carboplatin|carboplatin|mesh-list
19716632|NCT03912818|Doxorubicin|doxorubicin|mesh-list
19716633|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19716634|NCT03912818|Methotrexate|methotrexate|mesh-list
19716635|NCT03912818|Durvalumab|durvalumab|mesh-list
19716636|NCT03912818|Daunorubicin|daunorubicin|mesh-list
19716637|NCT03912818|Vinblastine|vinblastine|mesh-list
19859683|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19716638|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252588|NCT00455442|Mifepristone|mifepristone|mesh-list
20252589|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20252590|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
20252591|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20252592|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252593|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20252594|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20252595|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20252596|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
20252597|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20252598|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20252599|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
20252600|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252601|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
20252602|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20252603|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20252604|NCT00455507|Istradefylline|istradefylline|mesh-list
20252605|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20252606|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20252607|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20252608|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
20252609|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252610|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716639|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716640|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
19716641|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716642|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
19716643|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716644|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716645|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716646|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
19716647|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716648|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19716649|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19716650|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19716651|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19716652|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
19716653|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19716654|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
19716655|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19716656|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19716657|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19716658|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716659|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19716660|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
19716661|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
19716662|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
19716663|NCT03906539|Atorvastatin|atorvastatin|mesh-list
19716664|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19716665|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19716666|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
19716667|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716668|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19716669|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19716670|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716671|NCT03889912|Cemiplimab|cemiplimab|mesh-list
19716672|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716673|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716674|NCT03887702|Tenofovir|tenofovir|mesh-list
19716675|NCT03887702|Entecavir|entecavir|mesh-list
19716676|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
19716677|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716678|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19859684|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859685|NCT00783094|Tadalafil|tadalafil|mesh-list
20252611|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252612|NCT00455572|Vinorelbine|vinorelbine|mesh-list
19435892|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
19435893|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19435894|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19435895|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19435896|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19435897|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19435898|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19435899|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19435900|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
19435901|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435902|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435903|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435904|NCT03497364|Bupivacaine|bupivacaine|mesh-list
19435905|NCT03497364|Ropivacaine|ropivacaine|mesh-list
19435906|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435907|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
19435908|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435909|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252613|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252614|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20252615|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
20252616|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
20252617|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
20252618|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252619|NCT00455585|Lamivudine|lamivudine|mesh-list
20252620|NCT00455585|Nevirapine|nevirapine|mesh-list
20252621|NCT00455585|Stavudine|stavudine|mesh-list
20252622|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20252623|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20252624|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252625|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252626|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
20252627|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716679|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19435910|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
19716680|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252628|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19734238|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
19435911|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435912|NCT03497351|Nicardipine|nicardipine|mesh-list
19435913|NCT03497351|Urapidil|urapidil|mesh-list
19435914|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20252629|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20252630|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20252631|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20252632|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
19435915|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20252633|NCT00455624|Androgens|androgens|mesh-list
20252634|NCT00455624|Hormones|hormones|mesh-ancestor
20252635|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435916|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19435917|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435918|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19435919|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435920|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
19435921|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19435922|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
19435923|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435924|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19435925|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19435926|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19435927|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
19451619|NCT03420313|Naloxone|naloxone|mesh-list
19451620|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20252636|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252637|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
20252638|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20252639|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20252640|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20252641|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533358|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533359|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533360|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19716681|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252642|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252643|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
20252644|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252645|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252646|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20252647|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252648|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
20533361|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19435928|NCT03496870|Levodopa|levodopa|mesh-list
19435929|NCT03496870|Carbidopa|carbidopa|mesh-list
19435930|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19716682|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19716683|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19716684|NCT03876262|Ivermectin|ivermectin|mesh-list
19716685|NCT03876262|Moxidectin|moxidectin|mesh-list
19716686|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20533362|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
20533363|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
20533364|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533365|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20533366|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20533367|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533368|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435931|NCT03496870|Opicapone|opicapone|mesh-list
19435932|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19435933|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19435934|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
19435935|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435936|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435937|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435938|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19435939|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435940|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19435941|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
19435942|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
19716687|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252649|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
20252650|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20252651|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19716688|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
19716689|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
19716690|NCT03834909|Tenofovir|tenofovir|mesh-list
19716691|NCT03834909|Emtricitabine|emtricitabine|mesh-list
19716692|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19716693|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
19859686|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
19859687|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19859688|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19859689|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859690|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859691|NCT00783094|Urological Agents|urological agents|mesh-ancestor
19859692|NCT00783289|Benralizumab|benralizumab|mesh-list
19859693|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19859694|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859695|NCT00783367|Dexamethasone|dexamethasone|mesh-list
19859696|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
19859697|NCT00783367|Rituximab|rituximab|mesh-list
19859698|NCT00783367|Lenalidomide|lenalidomide|mesh-list
19859699|NCT00783367|BB 1101|bb 1101|mesh-list
19859700|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859701|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859702|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
19716694|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716695|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19734239|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19859703|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435943|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20252652|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252653|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252654|NCT00455715|Urological Agents|urological agents|mesh-ancestor
19716696|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19859704|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859705|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19859706|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
19859707|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
20252655|NCT00455754|Esomeprazole|esomeprazole|mesh-list
20252656|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20252657|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20252658|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20533369|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20533370|NCT01807429|Narcotics|narcotics|mesh-ancestor
20533371|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20533372|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533373|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20533374|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533375|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533376|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
20533377|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
20553417|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553418|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553419|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19859708|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859709|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859710|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
19859711|NCT00783367|Hormones|hormones|mesh-ancestor
19859712|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19435944|NCT03496831|Adalimumab|adalimumab|mesh-list
19435945|NCT03496831|Etanercept|etanercept|mesh-list
19435946|NCT03496831|Golimumab|golimumab|mesh-list
19435947|NCT03496831|Abatacept|abatacept|mesh-list
19435948|NCT03496831|Infliximab|infliximab|mesh-list
19435949|NCT03496831|Ustekinumab|ustekinumab|mesh-list
19435950|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435951|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
19435952|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435953|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19435954|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19435955|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
19435956|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19435957|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19435958|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19435959|NCT03496831|Analgesics|analgesics|mesh-ancestor
19859713|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19859714|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
19859715|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859716|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859717|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20252659|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553420|NCT01929252|Analgesics|analgesics|mesh-ancestor
19716697|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716698|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716699|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19435960|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
19716700|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19716701|NCT03816332|Prednisone|prednisone|mesh-list
19716702|NCT03816332|Cortisone|cortisone|mesh-list
19716703|NCT03816332|Nivolumab|nivolumab|mesh-list
19716704|NCT03816332|Ipilimumab|ipilimumab|mesh-list
19716705|NCT03816332|Tacrolimus|tacrolimus|mesh-list
19716706|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19716707|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
20553421|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
19435961|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716708|NCT03816332|Hormones|hormones|mesh-ancestor
19734240|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553422|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553423|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20553424|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20553425|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20553426|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
20553427|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553428|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435962|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435963|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19435964|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435965|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19435966|NCT03496779|Gemcitabine|gemcitabine|mesh-list
19435967|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19435968|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19435969|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19435970|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
19435971|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435972|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435973|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
19435974|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19435975|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19435976|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19435977|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
19435978|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435979|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19435980|NCT03496766|Tipifarnib|tipifarnib|mesh-list
19435981|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19435982|NCT03496740|Bupivacaine|bupivacaine|mesh-list
19435983|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
19435984|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
19435985|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19435986|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435987|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
19435988|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19435989|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19435990|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19435991|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252660|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252661|NCT00455806|Amoxicillin|amoxicillin|mesh-list
19435992|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19435993|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
19435994|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19435995|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19435996|NCT03496519|Durvalumab|durvalumab|mesh-list
19435997|NCT03496519|Trabectedin|trabectedin|mesh-list
19859718|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859719|NCT00783367|Growth Substances|growth substances|mesh-ancestor
19435998|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19435999|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436000|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436001|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
19436002|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436003|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19436004|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
19436005|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436006|NCT03496506|Selexipag|selexipag|mesh-list
19436007|NCT03496506|Clopidogrel|clopidogrel|mesh-list
19436008|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19436009|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20252662|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
20252663|NCT00455806|Esomeprazole|esomeprazole|mesh-list
20252664|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252665|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252666|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20252667|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20252668|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252669|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252670|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252671|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20252672|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20252673|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20533378|NCT01807494|Cimetidine|cimetidine|mesh-list
19716709|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716710|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716711|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716712|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716713|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716714|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716715|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716716|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716717|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
19716718|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19716719|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734241|NCT04552444|Biapenem|biapenem|mesh-list
19859720|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
19859721|NCT00783432|Azelastine|azelastine|mesh-list
19859722|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19859723|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
19859724|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859725|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859726|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19859727|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859728|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19859729|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859730|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859731|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19859732|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19859733|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19859734|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
19859735|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
19859736|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859737|NCT00783614|Aspirin|aspirin|mesh-list
19859738|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19859739|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19859740|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19734242|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735842|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19735843|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19735844|NCT04535804|Analgesics|analgesics|mesh-ancestor
19735845|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
19735846|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735847|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735848|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735849|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735850|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19735851|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19735852|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859741|NCT00783614|Analgesics|analgesics|mesh-ancestor
20252674|NCT00455832|Ribavirin|ribavirin|mesh-list
20252675|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
19716720|NCT03808480|Nivolumab|nivolumab|mesh-list
19716721|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716722|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716723|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716724|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716725|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
19716726|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19716727|NCT03780790|Bupivacaine|bupivacaine|mesh-list
19716728|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
19716729|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
20252676|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252677|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
20252678|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436010|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19436011|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19436012|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
19436013|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436014|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436015|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436016|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19436017|NCT03496389|Acetaminophen|acetaminophen|mesh-list
19436018|NCT03496389|Gabapentin|gabapentin|mesh-list
19436019|NCT03496389|Tramadol|tramadol|mesh-list
19436020|NCT03496389|Analgesics|analgesics|mesh-ancestor
19436021|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
19436022|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436023|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436024|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
19436025|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19436026|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19436027|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436028|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19436029|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19436030|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19716730|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716731|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716732|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
19716733|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716734|NCT03769298|Tacrolimus|tacrolimus|mesh-list
19716735|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716736|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
19716737|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716738|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19716739|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716740|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716741|NCT03761953|Oritavancin|oritavancin|mesh-list
19716742|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19716743|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716744|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19716745|NCT03751800|Dienogest|dienogest|mesh-list
19716746|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
19716747|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
19716748|NCT03751800|Estradiol|estradiol|mesh-list
19716749|NCT03751800|Estrogens|estrogens|mesh-ancestor
19436031|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436032|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436033|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
19436034|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19436035|NCT03496389|Narcotics|narcotics|mesh-ancestor
19436036|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19436037|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
19436038|NCT03496246|Vitamin D|vitamin d|mesh-list
19436039|NCT03496246|Calcifediol|calcifediol|mesh-list
19436040|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19436041|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
19716750|NCT03751800|Hormones|hormones|mesh-ancestor
19436042|NCT03496246|Calcium|calcium|mesh-list
19436043|NCT03496246|Vitamins|vitamins|mesh-ancestor
19436044|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
19436045|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436046|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19436047|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19436048|NCT03496233|Grazoprevir|grazoprevir|mesh-list
19436049|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19436050|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
19436051|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252679|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
20252680|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20252681|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
20533379|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20533380|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533381|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20533382|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
20533383|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
20252682|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20252683|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252684|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20252685|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20252686|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20252687|NCT00455871|Ranibizumab|ranibizumab|mesh-list
20252688|NCT00455871|Verteporfin|verteporfin|mesh-list
20252689|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20533384|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533385|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533386|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716751|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716752|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716753|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19716754|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
19716755|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20252690|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20533387|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20533388|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20533389|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533390|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
20533391|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
20533392|NCT01807611|Melphalan|melphalan|mesh-list
20533393|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
20533394|NCT01807611|Thiotepa|thiotepa|mesh-list
20533395|NCT01807611|Fludarabine|fludarabine|mesh-list
19716756|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19716757|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19716758|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19716759|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19716760|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19716761|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716762|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716763|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
19716764|NCT03709888|Pregabalin|pregabalin|mesh-list
19859742|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
19859743|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859744|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859745|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19859746|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859747|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19859748|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19859749|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859750|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19859751|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19859752|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859753|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
19859754|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
19859755|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859756|NCT00783692|Vedolizumab|vedolizumab|mesh-list
19859757|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859758|NCT00783705|Inositol|inositol|mesh-list
19859759|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
19859760|NCT00783705|Vitamins|vitamins|mesh-ancestor
19859761|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
19859762|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859763|NCT00783718|Vedolizumab|vedolizumab|mesh-list
19859764|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859765|NCT00783796|Everolimus|everolimus|mesh-list
19859766|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859767|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716765|NCT03709888|Memantine|memantine|mesh-list
19716766|NCT03709888|Analgesics|analgesics|mesh-ancestor
20252691|NCT00455871|Growth Substances|growth substances|mesh-ancestor
20252692|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252693|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
20252694|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252695|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20252696|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
19716767|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
19716768|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716769|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252697|NCT00455897|Rituximab|rituximab|mesh-list
20252698|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20252699|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252700|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
20252701|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252702|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19716770|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
19716771|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19716772|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19716773|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716774|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19859768|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
19859769|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252703|NCT00455910|Thalidomide|thalidomide|mesh-list
20252704|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252705|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
20252706|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252707|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
20252708|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252709|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252710|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20252711|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20533396|NCT01807611|Sargramostim|sargramostim|mesh-list
19859770|NCT00783835|Methylphenidate|methylphenidate|mesh-list
19859771|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19859772|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859773|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19859774|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19859775|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859776|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859777|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
19859778|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859779|NCT00783965|Tazarotene|tazarotene|mesh-list
19859780|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
19859781|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
19859782|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19859783|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19859784|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19859785|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859786|NCT00784147|Ibalizumab|ibalizumab|mesh-list
19859787|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19859788|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19859789|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19859790|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
19859791|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859792|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
19859793|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859794|NCT00784225|Vitamins|vitamins|mesh-list
19859795|NCT00784225|Vitamin E|vitamin e|mesh-list
19859796|NCT00784225|Tocopherols|tocopherols|mesh-list
19859797|NCT00784225|Tocotrienols|tocotrienols|mesh-list
19859798|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
19859799|NCT00784225|Selenium|selenium|mesh-list
19859800|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
19859801|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859802|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
19859803|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859804|NCT00784225|Protective Agents|protective agents|mesh-ancestor
19859805|NCT00784225|Trace Elements|trace elements|mesh-ancestor
19859806|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19859807|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20252712|NCT00455910|Growth Substances|growth substances|mesh-ancestor
20533397|NCT01807611|Lenograstim|lenograstim|mesh-list
19716775|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19716776|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19716777|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716778|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19716779|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19716780|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19716781|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
19716782|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716783|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19716784|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19716785|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19716786|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716787|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716788|NCT03622593|Aflibercept|aflibercept|mesh-list
19716789|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20252713|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
20252714|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252715|NCT00455936|Gefitinib|gefitinib|mesh-list
20252716|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252717|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20252718|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252719|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716790|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859808|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19859809|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859810|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859811|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19859812|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19859813|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19859814|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
19859815|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859816|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859817|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19859818|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19859819|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
19859820|NCT00784277|Oxycodone|oxycodone|mesh-list
19859821|NCT00784277|Tapentadol|tapentadol|mesh-list
19859822|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19859823|NCT00784277|Narcotics|narcotics|mesh-ancestor
19716791|NCT03622593|Growth Substances|growth substances|mesh-ancestor
19716792|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716793|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
19716794|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716795|NCT03622580|Aflibercept|aflibercept|mesh-list
19716796|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19716797|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19716798|NCT03622580|Growth Substances|growth substances|mesh-ancestor
19716799|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252720|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19716800|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
20252721|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20252722|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
20252723|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252724|NCT00456027|Antacids|antacids|mesh-ancestor
20252725|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252726|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20252727|NCT00456144|Hormones|hormones|mesh-list
20252728|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252729|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252730|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
20252731|NCT00456235|Cyclosporine|cyclosporine|mesh-list
20252732|NCT00456235|Tacrolimus|tacrolimus|mesh-list
20252733|NCT00456235|Cyclosporins|cyclosporins|mesh-list
20252734|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252735|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
20252736|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252737|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20252738|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252739|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252740|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20252741|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252742|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19716801|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716802|NCT03616717|Modafinil|modafinil|mesh-list
19716803|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19716804|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716805|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19716806|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19716807|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19716808|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716809|NCT03606213|Vaccines|vaccines|mesh-list
19716810|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
19716811|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716812|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
19716813|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19716814|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
19716815|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716816|NCT03575208|Interferons|interferons|mesh-list
19716817|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
19716818|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
19716819|NCT03575208|Antibodies|antibodies|mesh-list
19716820|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
19716821|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19716822|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19716823|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716824|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
19716825|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716826|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
19716827|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716828|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20533398|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716829|NCT03534180|Venetoclax|venetoclax|mesh-list
19716830|NCT03534180|Romidepsin|romidepsin|mesh-list
19716831|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716832|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252743|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
20533399|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
20533400|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533401|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533402|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20533403|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
20533404|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533405|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533406|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19716833|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20252744|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252745|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252746|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
20252747|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
19716834|NCT03484819|Nivolumab|nivolumab|mesh-list
19716835|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20252748|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20252749|NCT00456248|Ribavirin|ribavirin|mesh-list
20252750|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
19716836|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716837|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19716838|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716839|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
19716840|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716841|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716842|NCT03423199|Tamoxifen|tamoxifen|mesh-list
19716843|NCT03423199|Goserelin|goserelin|mesh-list
19716844|NCT03423199|Palbociclib|palbociclib|mesh-list
19716845|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19716846|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
19716847|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19716848|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716849|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19716850|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716851|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19716852|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19716853|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19716854|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19716855|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716856|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716857|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
19716858|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716859|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716860|NCT03388749|Annamycin|annamycin|mesh-list
19716861|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19859824|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859825|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859826|NCT00784277|Analgesics|analgesics|mesh-ancestor
19859827|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
19859828|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859829|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19859830|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20252751|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
20252752|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252753|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
20252754|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252755|NCT00456313|Fluticasone|fluticasone|mesh-list
20252756|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20252757|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19436052|NCT03495804|Mannitol|mannitol|mesh-list
19436053|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19436054|NCT03495804|Diuretics|diuretics|mesh-ancestor
19436055|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
19436056|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436057|NCT03495765|Ranibizumab|ranibizumab|mesh-list
19436058|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19436059|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19436060|NCT03495765|Growth Substances|growth substances|mesh-ancestor
19436061|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436062|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
19436063|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436064|NCT03495739|Dabigatran|dabigatran|mesh-list
19436065|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
19436066|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19436067|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
19716862|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716863|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
19716864|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19716865|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716866|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436068|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436069|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436070|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
19436071|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19716867|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19716868|NCT03384563|Analgesics|analgesics|mesh-ancestor
19716869|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
19716870|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252758|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
20252759|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252760|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252761|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20252762|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
20252763|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
20252764|NCT00456313|Hormones|hormones|mesh-ancestor
19716871|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19716872|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19716873|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19716874|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
19716875|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716876|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716877|NCT03377049|Acetazolamide|acetazolamide|mesh-list
19716878|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
19716879|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20252765|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252766|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
19436072|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19451621|NCT03420313|Narcotics|narcotics|mesh-ancestor
19451622|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451623|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451624|NCT03420313|Analgesics|analgesics|mesh-ancestor
19451625|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
19451626|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451627|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19451628|NCT03420144|Hormones|hormones|mesh-list
19451629|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19451630|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436073|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436074|NCT03495466|Anesthetics|anesthetics|mesh-list
19436075|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436076|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451631|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
19451632|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19451633|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451634|NCT03419975|Latanoprost|latanoprost|mesh-list
19451635|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19451636|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19451637|NCT03419949|Pregabalin|pregabalin|mesh-list
19451638|NCT03419949|Lamotrigine|lamotrigine|mesh-list
19451639|NCT03419949|Analgesics|analgesics|mesh-ancestor
19451640|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
19451641|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451642|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451643|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
19451644|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19451645|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19451646|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451647|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19451648|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19451649|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19451650|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451651|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19451652|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19451653|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19451654|NCT03419923|Citric Acid|citric acid|mesh-list
19451655|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
19451656|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
19451657|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19451658|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
19451659|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
19451660|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451661|NCT03419910|Cyclosporine|cyclosporine|mesh-list
19451662|NCT03419910|BMS-986165|bms-986165|mesh-list
19451663|NCT03419910|Cyclosporins|cyclosporins|mesh-list
20252767|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20252768|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
19451664|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451665|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451666|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19451667|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
19451668|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451669|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
19451670|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716880|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252769|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19451671|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19451672|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19451673|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19451674|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19451675|NCT03419858|Naloxone|naloxone|mesh-list
19451676|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19451677|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451678|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
19451679|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451680|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19451681|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19451682|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
19451683|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451684|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19451685|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19451686|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
19451687|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
19451688|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436077|NCT03495232|Cimetidine|cimetidine|mesh-list
19436078|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19436079|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436080|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19436081|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
19436082|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
19436083|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436084|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436085|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436086|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19436087|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19436088|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436089|NCT03495206|Edaravone|edaravone|mesh-list
19436090|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19436091|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
19436092|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436093|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19436094|NCT03495206|Protective Agents|protective agents|mesh-ancestor
19436095|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436096|NCT03495063|Caffeine|caffeine|mesh-list
19436097|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19436098|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436099|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19436100|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436101|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436102|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19436103|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19436104|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
19436105|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436106|NCT03495024|Varenicline|varenicline|mesh-list
19436107|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19436108|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19436109|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
19436110|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436111|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436112|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436113|NCT03494972|Tetracycline|tetracycline|mesh-list
19436114|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436115|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436116|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19436117|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436118|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436119|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
19436120|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19436121|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436122|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436123|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19436124|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19436125|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436126|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436127|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436128|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19436129|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
19436130|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19716881|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716882|NCT03377049|Diuretics|diuretics|mesh-ancestor
19716883|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
19716884|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716885|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
20252770|NCT00456339|Amoxicillin|amoxicillin|mesh-list
20252771|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
19716886|NCT03342937|Capecitabine|capecitabine|mesh-list
20252772|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
19716887|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
19716888|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716889|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859831|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859832|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859833|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
19859834|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859835|NCT00784303|Lenvatinib|lenvatinib|mesh-list
19859836|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859837|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19859838|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859839|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859840|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19859841|NCT00784459|Abatacept|abatacept|mesh-list
19859842|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19859843|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859844|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859845|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436131|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436132|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19436133|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19436134|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19436135|NCT03494686|Anesthetics|anesthetics|mesh-list
19436136|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436137|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436138|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
19716890|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716891|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
19716892|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716893|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
19716894|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
19859846|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
19859847|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716895|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
19716896|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
19716897|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716898|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716899|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
19716900|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716901|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
19716902|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19716903|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716904|NCT03298984|Cytarabine|cytarabine|mesh-list
19716905|NCT03298984|Daunorubicin|daunorubicin|mesh-list
19716906|NCT03298984|Alvocidib|alvocidib|mesh-list
19716907|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716908|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
19716909|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716910|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716911|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
19716912|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716913|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716914|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
19716915|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716916|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19716917|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19716918|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19859848|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859849|NCT00784524|Aldesleukin|aldesleukin|mesh-list
19859850|NCT00784524|Interleukin-2|interleukin-2|mesh-list
20533407|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20533408|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20533409|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
20533410|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436139|NCT03494517|Analgesics|analgesics|mesh-ancestor
19436140|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
19436141|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533411|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533412|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533413|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20533414|NCT01807741|Asenapine|asenapine|mesh-list
20533415|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19436142|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436143|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
19436144|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436145|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19436146|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
19436147|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19436148|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19436149|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436150|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19436151|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
19436152|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19436153|NCT03494426|Pregabalin|pregabalin|mesh-list
19436154|NCT03494426|Tramadol|tramadol|mesh-list
19436155|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
19436156|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
19436157|NCT03494426|Analgesics|analgesics|mesh-ancestor
19436158|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
19436159|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436160|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436161|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
19436162|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19716919|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716920|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
19436163|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19436164|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436165|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19436166|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19436167|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19716921|NCT03298984|Growth Substances|growth substances|mesh-ancestor
19716922|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19716923|NCT03295747|Peppermint oil|peppermint oil|mesh-list
19716924|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
19716925|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
19716926|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716927|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716928|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19716929|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
19716930|NCT03295552|Carboplatin|carboplatin|mesh-list
19716931|NCT03295552|Decitabine|decitabine|mesh-list
19859851|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859852|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19859853|NCT00784524|Analgesics|analgesics|mesh-ancestor
19859854|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
19859855|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859856|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436168|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19716932|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859857|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19859858|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19859859|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
19859860|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859861|NCT00784550|Fluticasone|fluticasone|mesh-list
19859862|NCT00784550|Xhance|xhance|mesh-list
19859863|NCT00784550|Bromides|bromides|mesh-list
19859864|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
19859865|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19859866|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19859867|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19859868|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
19859869|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859870|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859871|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19859872|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
19859873|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
19859874|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19859875|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
19716933|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19859876|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19716934|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
19859877|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
19716935|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436169|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19436170|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19436171|NCT03494426|Narcotics|narcotics|mesh-ancestor
19436172|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
19436173|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
19436174|NCT03494387|Antioxidants|antioxidants|mesh-list
19436175|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
19436176|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436177|NCT03494387|Expectorants|expectorants|mesh-ancestor
19436178|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
19436179|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19436180|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436181|NCT03494387|Protective Agents|protective agents|mesh-ancestor
19436182|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436183|NCT03494387|Vitamins|vitamins|mesh-ancestor
19436184|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
19436185|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19436186|NCT03494257|Brinzolamide|brinzolamide|mesh-list
19436187|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19436188|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19436189|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19716936|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716937|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
19716938|NCT03294954|Fludarabine|fludarabine|mesh-list
19716939|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716940|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
19716941|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716942|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19716943|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19859878|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859879|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859880|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19859881|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19859882|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19859883|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
19859884|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
19859885|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19859886|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19859887|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859888|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19859889|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19859890|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19859891|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859892|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
19859893|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19859894|NCT00784693|Tanezumab|tanezumab|mesh-list
19859895|NCT00784693|Analgesics|analgesics|mesh-ancestor
19859896|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
19859897|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859898|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859899|NCT00784719|Cyclosporine|cyclosporine|mesh-list
19859900|NCT00784719|Cyclosporins|cyclosporins|mesh-list
19859901|NCT00784719|Tofacitinib|tofacitinib|mesh-list
19859902|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859903|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859904|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859905|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
19859906|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859907|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
20252773|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20252774|NCT00456339|Prednisolone|prednisolone|mesh-list
20252775|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252776|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436190|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19436191|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
19436192|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436193|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436194|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436195|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19436196|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436197|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
19436198|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
19436199|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436200|NCT03493841|Protective Agents|protective agents|mesh-ancestor
19436201|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436202|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
19436203|NCT03493841|Vitamins|vitamins|mesh-ancestor
19436204|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
19436205|NCT03493568|Dolutegravir|dolutegravir|mesh-list
19436206|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19436207|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19436208|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19436209|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436210|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436211|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19436212|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19436213|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
19436214|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436215|NCT03493503|Albuterol|albuterol|mesh-list
19436216|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19436217|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
19436218|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436219|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436220|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19436221|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
19436222|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
19436223|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19436224|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19436225|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19436226|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19436227|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
19436228|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436229|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436230|NCT03493490|Diclofenac|diclofenac|mesh-list
19436231|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19436232|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19436233|NCT03493490|Analgesics|analgesics|mesh-ancestor
19436234|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
19436235|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436236|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436237|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436238|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19436239|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19436240|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436241|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436242|NCT03493412|Verapamil|verapamil|mesh-list
19436243|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19436244|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19436245|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19436246|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436247|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19436248|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436249|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
19451689|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451690|NCT03419767|Melatonin|melatonin|mesh-list
19451691|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
19451692|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436250|NCT03493269|Midazolam|midazolam|mesh-list
19436251|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19436252|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19436253|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436254|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716944|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
19716945|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716946|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716947|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19734243|NCT04552613|Carboplatin|carboplatin|mesh-list
19734244|NCT04552613|Pemetrexed|pemetrexed|mesh-list
19734245|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734246|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734247|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734248|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19734249|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19734250|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19734251|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
19734252|NCT04552431|Tamsulosin|tamsulosin|mesh-list
19734253|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734254|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734255|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19734256|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19734257|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859908|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859909|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19859910|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859911|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19859912|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19859913|NCT00784784|Zanamivir|zanamivir|mesh-list
19859914|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
19859915|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859916|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859917|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436255|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19436256|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19436257|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19436258|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19436259|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
19436260|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
19436261|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
19436262|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
19436263|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436264|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859918|NCT00784810|Acetaminophen|acetaminophen|mesh-list
19859919|NCT00784810|Oxycodone|oxycodone|mesh-list
19859920|NCT00784810|Codeine|codeine|mesh-list
19859921|NCT00784810|Naloxone|naloxone|mesh-list
19859922|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19859923|NCT00784810|Analgesics|analgesics|mesh-ancestor
19859924|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
19859925|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436265|NCT03493165|Everolimus|everolimus|mesh-list
19859926|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859927|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
19859928|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20533416|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19436266|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859929|NCT00784810|Narcotics|narcotics|mesh-ancestor
20533417|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533418|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533419|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533420|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
20533421|NCT01807767|Everolimus|everolimus|mesh-list
20533422|NCT01807767|Tacrolimus|tacrolimus|mesh-list
20533423|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533424|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
20533425|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533426|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20533427|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533428|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533429|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533430|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19716948|NCT03278509|Metoprolol|metoprolol|mesh-list
19436267|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436268|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
19436269|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436270|NCT03493087|Vitamin K|vitamin k|mesh-list
19436271|NCT03493087|Vitamins|vitamins|mesh-ancestor
19436272|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
19436273|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436274|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19436275|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19716949|NCT03278509|Bisoprolol|bisoprolol|mesh-list
19716950|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19716951|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19716952|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
19716953|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
19716954|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19716955|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716956|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19716957|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19716958|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19716959|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
19716960|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19716961|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716962|NCT03262454|Atezolizumab|atezolizumab|mesh-list
19716963|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716964|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
19716965|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19716966|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19716967|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716968|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
19859930|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19859931|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19859932|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
19859933|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
19436276|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436277|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
19436278|NCT03493087|Coagulants|coagulants|mesh-ancestor
19436279|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
19436280|NCT03493061|Irinotecan|irinotecan|mesh-list
19436281|NCT03493061|Floxuridine|floxuridine|mesh-list
19436282|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436283|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19436284|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19436285|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436286|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436287|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436288|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
19436289|NCT03493048|Leucovorin|leucovorin|mesh-list
19436290|NCT03493048|Fluorouracil|fluorouracil|mesh-list
19436291|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
19436292|NCT03493048|Irinotecan|irinotecan|mesh-list
19436293|NCT03493048|Cetuximab|cetuximab|mesh-list
19436294|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
19436295|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436296|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436297|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436298|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436299|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
19436300|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436301|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19436302|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19436303|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436304|NCT03493048|Antidotes|antidotes|mesh-ancestor
19436305|NCT03493048|Protective Agents|protective agents|mesh-ancestor
19436306|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
19436307|NCT03493048|Vitamins|vitamins|mesh-ancestor
19436308|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
19436309|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436310|NCT03492996|Delpazolid|delpazolid|mesh-list
19436311|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436312|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436313|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19436314|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436315|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436316|NCT03492970|Melatonin|melatonin|mesh-list
19436317|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
19436318|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436319|NCT03492970|Protective Agents|protective agents|mesh-ancestor
19436320|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436321|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436322|NCT03492931|Ticagrelor|ticagrelor|mesh-list
19436323|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19436324|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19436325|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19436326|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19436327|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
19436328|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436329|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436330|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436331|NCT03492866|Gentamicins|gentamicins|mesh-list
19436332|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19716969|NCT03216083|Coagulants|coagulants|mesh-ancestor
19716970|NCT03194932|Cytarabine|cytarabine|mesh-list
19716971|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
19716972|NCT03194932|Methotrexate|methotrexate|mesh-list
19716973|NCT03194932|Azacitidine|azacitidine|mesh-list
19716974|NCT03194932|Venetoclax|venetoclax|mesh-list
19716975|NCT03194932|Idarubicin|idarubicin|mesh-list
19716976|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19716977|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
19716978|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19716979|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19716980|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19716981|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
19716982|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19716983|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19716984|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
19716985|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19716986|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19716987|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19716988|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
19716989|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19716990|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19716991|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
19716992|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19716993|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19716994|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19716995|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19716996|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19716997|NCT03192215|Aspirin|aspirin|mesh-list
19716998|NCT03192215|Apixaban|apixaban|mesh-list
19716999|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19717000|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19717001|NCT03192215|Analgesics|analgesics|mesh-ancestor
19717002|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
19717003|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717004|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717005|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717006|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717007|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19717008|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19717009|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717010|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19717011|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19717012|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717013|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
19717014|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19436333|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436334|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19436335|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436336|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717015|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
19717016|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19717017|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
19717018|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
19717019|NCT03175198|Dabigatran|dabigatran|mesh-list
19717020|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
19717021|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19717022|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
19717023|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717024|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717025|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
19717026|NCT03164980|Trabectedin|trabectedin|mesh-list
19717027|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19717028|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
19717029|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717030|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436337|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
19436338|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19436339|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19436340|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436341|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
19436342|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19436343|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19436344|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
19436345|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19436346|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
19436347|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436348|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436349|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436350|NCT03492736|Melatonin|melatonin|mesh-list
19436351|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
19436352|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436353|NCT03492736|Protective Agents|protective agents|mesh-ancestor
19436354|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436355|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436356|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
19436357|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19436358|NCT03492710|Antibodies|antibodies|mesh-list
19436359|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
19436360|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436361|NCT03492671|Gemcitabine|gemcitabine|mesh-list
19436362|NCT03492671|Paclitaxel|paclitaxel|mesh-list
19436363|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19436364|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436365|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
19436366|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
19436367|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
19436368|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436369|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436370|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
19436371|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
19436372|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436373|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436374|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436375|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
19436376|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436377|NCT03492658|Methotrexate|methotrexate|mesh-list
19436378|NCT03492658|Abatacept|abatacept|mesh-list
19436379|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19436380|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
19436381|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19436382|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436383|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436384|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
19436385|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436386|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436387|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
19436388|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717031|NCT03149003|Bevacizumab|bevacizumab|mesh-list
19436389|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19436390|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436391|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
19436392|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19436393|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19717032|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717033|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717034|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19436394|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19436395|NCT03492632|Hormones|hormones|mesh-list
19436396|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436397|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436398|NCT03492593|Beta Carotene|beta carotene|mesh-list
19436399|NCT03492593|Lycopene|lycopene|mesh-list
19436400|NCT03492593|Carotenoids|carotenoids|mesh-list
19436401|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436402|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
19436403|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436404|NCT03492593|Protective Agents|protective agents|mesh-ancestor
19436405|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436406|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19436407|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19436408|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436409|NCT03492593|Provitamins|provitamins|mesh-ancestor
19436410|NCT03492593|Vitamins|vitamins|mesh-ancestor
19436411|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
19436412|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
19436413|NCT03492580|Empagliflozin|empagliflozin|mesh-list
19436414|NCT03492580|Canagliflozin|canagliflozin|mesh-list
19436415|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19436416|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19436417|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19436418|NCT03492580|Glucagon|glucagon|mesh-list
19436419|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19436420|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436421|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19436422|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436423|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436424|NCT03492580|Hormones|hormones|mesh-ancestor
19436425|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436426|NCT03492580|Incretins|incretins|mesh-ancestor
19436427|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
19436428|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436429|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19436430|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19436431|NCT03492489|Cemiplimab|cemiplimab|mesh-list
19436432|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436433|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717035|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19436434|NCT03492463|Nicotine|nicotine|mesh-list
19717036|NCT03149003|Growth Substances|growth substances|mesh-ancestor
19436435|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19436436|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
19436437|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436438|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436439|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19436440|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19436441|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
19436442|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436443|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436444|NCT03492437|Tepotinib|tepotinib|mesh-list
19436445|NCT03492437|Dabigatran|dabigatran|mesh-list
19436446|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
19436447|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19436448|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
19436449|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436450|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436451|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
19436452|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436453|NCT03492385|Ticagrelor|ticagrelor|mesh-list
19436454|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19436455|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19436456|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19436457|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19436458|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
19436459|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436460|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436461|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436462|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
19436463|NCT03492255|Prednisone|prednisone|mesh-list
19436464|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
19436465|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
19436466|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436467|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
19436468|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436469|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19436470|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19436471|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
19436472|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436473|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436474|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19436475|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436476|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
19436477|NCT03492255|Hormones|hormones|mesh-ancestor
19436478|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436479|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19436480|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19436481|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19436482|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
19436483|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436484|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436485|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436486|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
19717037|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717038|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717039|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
19717040|NCT03139370|Fludarabine|fludarabine|mesh-list
19717041|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717042|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
19717043|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717044|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717045|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19717046|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
19859934|NCT00784836|Interferons|interferons|mesh-list
19859935|NCT00784836|Interferon-beta|interferon-beta|mesh-list
19859936|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
19859937|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859938|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
19859939|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436487|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
19436488|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436489|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19735853|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19859940|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
19859941|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859942|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19436490|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19717047|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717048|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717049|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19436491|NCT03492255|Protective Agents|protective agents|mesh-ancestor
19436492|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19436493|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436494|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436495|NCT03492138|Dexamethasone|dexamethasone|mesh-list
19436496|NCT03492138|Ixazomib|ixazomib|mesh-list
19436497|NCT03492138|TIC10 compound|tic10 compound|mesh-list
19436498|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436499|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
19436500|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
19436501|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436502|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436503|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19717050|NCT03126799|Bevacizumab|bevacizumab|mesh-list
19717051|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19717052|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859943|NCT00784849|Methylene Blue|methylene blue|mesh-list
19859944|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19859945|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859946|NCT00784875|Zolpidem|zolpidem|mesh-list
19859947|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19859948|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19859949|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252777|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436504|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
19436505|NCT03492138|Hormones|hormones|mesh-ancestor
19436506|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436507|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19436508|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436509|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
19436510|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436511|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436512|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
19436513|NCT03492047|Paclitaxel|paclitaxel|mesh-list
19436514|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19436515|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19436516|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436517|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
19436518|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717053|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717054|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19717055|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717056|NCT03126799|Growth Substances|growth substances|mesh-ancestor
19717057|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717058|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
19436519|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
19436520|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436521|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
19436522|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436523|NCT03492047|Expectorants|expectorants|mesh-ancestor
19717059|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717060|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717061|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436524|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
20252778|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
19436525|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19436526|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
19436527|NCT03492047|Protective Agents|protective agents|mesh-ancestor
19436528|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436529|NCT03492047|Antidotes|antidotes|mesh-ancestor
19436530|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
19436531|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
19436532|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436533|NCT03491969|Protective Agents|protective agents|mesh-ancestor
19436534|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436535|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
19436536|NCT03491969|Vitamins|vitamins|mesh-ancestor
19436537|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
19436538|NCT03491904|Fasinumab|fasinumab|mesh-list
19717062|NCT03075826|Guadecitabine|guadecitabine|mesh-list
19717063|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717064|NCT03072238|Prednisone|prednisone|mesh-list
19717065|NCT03072238|Prednisolone|prednisolone|mesh-list
19717066|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19859950|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859951|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19859952|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
19859953|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
19859954|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252779|NCT00456339|Hormones|hormones|mesh-ancestor
19436539|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19436540|NCT03491904|Analgesics|analgesics|mesh-ancestor
19436541|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
19436542|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436543|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436544|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
19436545|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19436546|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
19436547|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436548|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
19436549|NCT03491761|Protective Agents|protective agents|mesh-ancestor
19717067|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
19717068|NCT03072238|Hormones|hormones|mesh-ancestor
19717069|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19717070|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717071|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19717072|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717073|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
19717074|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717075|NCT03029702|Metformin|metformin|mesh-list
19717076|NCT03029702|Glyburide|glyburide|mesh-list
19717077|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19717078|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717079|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
19717080|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717081|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717082|NCT02993731|Gemcitabine|gemcitabine|mesh-list
19717083|NCT02993731|Paclitaxel|paclitaxel|mesh-list
19717084|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19717085|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717086|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
19717087|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717088|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
19436550|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
19436551|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
19436552|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19735854|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20533431|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20533432|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
20533433|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20533434|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533435|NCT01807832|Capsaicin|capsaicin|mesh-list
20533436|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
20533437|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
20533438|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
19717089|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717090|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436553|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436554|NCT03491709|Cetuximab|cetuximab|mesh-list
19436555|NCT03491709|Antibodies|antibodies|mesh-list
19436556|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19436557|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
19436558|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436559|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436560|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451693|NCT03419767|Protective Agents|protective agents|mesh-ancestor
19451694|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451695|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451696|NCT03419715|Bimatoprost|bimatoprost|mesh-list
19451697|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19451698|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19451699|NCT03419650|Hormones|hormones|mesh-ancestor
19451700|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19451701|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451702|NCT03419624|Metformin|metformin|mesh-list
19451703|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
19451704|NCT03419624|Exenatide|exenatide|mesh-list
19451705|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19451706|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451707|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19451708|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451709|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19717091|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
20252780|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252781|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252782|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20252783|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252784|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20252785|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252786|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252787|NCT00456430|Citalopram|citalopram|mesh-list
20252788|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20252789|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20252790|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19451710|NCT03419624|Incretins|incretins|mesh-ancestor
19451711|NCT03419624|Hormones|hormones|mesh-ancestor
19451712|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19451713|NCT03419559|Durvalumab|durvalumab|mesh-list
19451714|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19451715|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451716|NCT03419494|Doxorubicin|doxorubicin|mesh-list
19451717|NCT03419494|Daunorubicin|daunorubicin|mesh-list
19451718|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19717092|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
19717093|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717094|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717095|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717096|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
19717097|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717098|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
19859955|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859956|NCT00784927|Dexamethasone|dexamethasone|mesh-list
19436561|NCT03491696|Metyrapone|metyrapone|mesh-list
19436562|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
19436563|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436564|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436565|NCT03491631|Apatinib|apatinib|mesh-list
19436566|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436567|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19436568|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436569|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436570|NCT03491579|Cytarabine|cytarabine|mesh-list
19436571|NCT03491579|Cladribine|cladribine|mesh-list
19436572|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436573|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
19436574|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436575|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436576|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
19436577|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436578|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436579|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
19436580|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436581|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
19436582|NCT03491527|Pemetrexed|pemetrexed|mesh-list
19436583|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436584|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436585|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436586|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19436587|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19436588|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436589|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
19436590|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
19436591|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
19436592|NCT03491475|Ajmaline|ajmaline|mesh-list
19436593|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19436594|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19436595|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19859957|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
19717099|NCT02992743|Fludarabine|fludarabine|mesh-list
19436596|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19717100|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717101|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
19859958|NCT00784927|Rituximab|rituximab|mesh-list
19859959|NCT00784927|Lenalidomide|lenalidomide|mesh-list
19859960|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19859961|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
19859962|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859963|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19859964|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19436597|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436598|NCT03491410|Aspirin|aspirin|mesh-list
19436599|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19436600|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19436601|NCT03491410|Analgesics|analgesics|mesh-ancestor
19436602|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
19436603|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436604|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436605|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436606|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20252791|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252792|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252793|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
20252794|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252795|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20252796|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
19436607|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19436608|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19436609|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436610|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19436611|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19436612|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436613|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
19436614|NCT03491371|Apatinib|apatinib|mesh-list
19436615|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436616|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19436617|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436618|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436619|NCT03491345|Avelumab|avelumab|mesh-list
19436620|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436621|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717102|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717103|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717104|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19717105|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
19717106|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717107|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717108|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19717109|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
19859965|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
19859966|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19859967|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859968|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20533439|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533440|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533441|NCT01807910|Choline|choline|mesh-list
20533442|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
20533443|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20533444|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
20533445|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717110|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19717111|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436622|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
19436623|NCT03491098|Prednisolone|prednisolone|mesh-list
19436624|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19436625|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
19436626|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19436627|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
19436628|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19436629|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
19436630|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436631|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
19436632|NCT03491098|Hormones|hormones|mesh-ancestor
19436633|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436634|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436635|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19436636|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436637|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
19436638|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
19436639|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436640|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436641|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19436642|NCT03491098|Protective Agents|protective agents|mesh-ancestor
19436643|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
19436644|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19436645|NCT03491085|Amoxicillin|amoxicillin|mesh-list
19436646|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
19436647|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
19436648|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19436649|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436650|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436651|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19436652|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717112|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717113|NCT02965703|Aspirin|aspirin|mesh-list
19717114|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19717115|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19717116|NCT02965703|Analgesics|analgesics|mesh-ancestor
19717117|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
19717118|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717119|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436653|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533446|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436654|NCT03491072|Fentanyl|fentanyl|mesh-list
19436655|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19436656|NCT03491072|Narcotics|narcotics|mesh-ancestor
19436657|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436658|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436659|NCT03491072|Analgesics|analgesics|mesh-ancestor
19436660|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
19436661|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436662|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19436663|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19436664|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
19436665|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
19436666|NCT03490994|Warfarin|warfarin|mesh-list
19436667|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
19436668|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
19436669|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19436670|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
19436671|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19436672|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
19436673|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436674|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436675|NCT03490825|Melatonin|melatonin|mesh-list
19436676|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
19436677|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436678|NCT03490825|Protective Agents|protective agents|mesh-ancestor
19436679|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717120|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436680|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436681|NCT03490708|Tranilast|tranilast|mesh-list
19436682|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19436683|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19436684|NCT03490708|Analgesics|analgesics|mesh-ancestor
19436685|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
19436686|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436687|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436688|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436689|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19436690|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19436691|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19436692|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717121|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717122|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19717123|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19717124|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717125|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19717126|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19717127|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252797|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19436693|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19436694|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19436695|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
19436696|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
19436697|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436698|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19436699|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19436700|NCT03490617|Misoprostol|misoprostol|mesh-list
19436701|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19436702|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
19436703|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19436704|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436705|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19859969|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19436706|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436707|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
19436708|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
19436709|NCT03490539|Azathioprine|azathioprine|mesh-list
19436710|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19436711|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436712|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19436713|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
19436714|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436715|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436716|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436717|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717128|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
19436718|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
19436719|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436720|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436721|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
19436722|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436723|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19436724|NCT03490487|Prednisolone|prednisolone|mesh-list
19436725|NCT03490487|Carbamazepine|carbamazepine|mesh-list
19436726|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
19436727|NCT03490487|Levetiracetam|levetiracetam|mesh-list
19436728|NCT03490487|Valproic Acid|valproic acid|mesh-list
19436729|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
19436730|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717129|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
19717130|NCT02936752|Entinostat|entinostat|mesh-list
19717131|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19717132|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717133|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717134|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717135|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717136|NCT02888067|Bromides|bromides|mesh-list
19717137|NCT02888067|Rocuronium|rocuronium|mesh-list
19717138|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
19717139|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19717140|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19717141|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19717142|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717143|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717144|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
19717145|NCT02858921|Trametinib|trametinib|mesh-list
19717146|NCT02858921|Dabrafenib|dabrafenib|mesh-list
19717147|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717148|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252798|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19436731|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
19717149|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20252799|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717150|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717151|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717152|NCT02831764|Tenofovir|tenofovir|mesh-list
19717153|NCT02831764|Lamivudine|lamivudine|mesh-list
19717154|NCT02831764|Emtricitabine|emtricitabine|mesh-list
19717155|NCT02831764|Dolutegravir|dolutegravir|mesh-list
19717156|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
19717157|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717158|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19717159|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19717160|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717161|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717162|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19717163|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19717164|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19717165|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19717166|NCT02826161|Paclitaxel|paclitaxel|mesh-list
19717167|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19717168|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717169|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
19717170|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717171|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
19717172|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252800|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
19436732|NCT03490487|Hormones|hormones|mesh-ancestor
19436733|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436734|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436735|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19436736|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436737|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436738|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
19436739|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436740|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436741|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
19436742|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436743|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
19436744|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19436745|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436746|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19436747|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19436748|NCT03490487|Analgesics|analgesics|mesh-ancestor
19436749|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
19436750|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19436751|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19436752|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19717173|NCT02697474|Vaccines|vaccines|mesh-list
19717174|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
19717175|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717176|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
19717177|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717178|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717179|NCT02627443|Gemcitabine|gemcitabine|mesh-list
19717180|NCT02627443|Carboplatin|carboplatin|mesh-list
19717181|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717182|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19717183|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
19717184|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717185|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
19717186|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717187|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717188|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717189|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
19717190|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717191|NCT02586025|Docetaxel|docetaxel|mesh-list
19717192|NCT02586025|Trastuzumab|trastuzumab|mesh-list
19717193|NCT02586025|Pertuzumab|pertuzumab|mesh-list
19717194|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717195|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
19717196|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717197|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
19717198|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717199|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717200|NCT02520011|Cytarabine|cytarabine|mesh-list
19717201|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
19717202|NCT02520011|Alvocidib|alvocidib|mesh-list
19717203|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436753|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19436754|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19436755|NCT03490396|Povidone|povidone|mesh-list
19436756|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
19436757|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19436758|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
19436759|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436760|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
19436761|NCT03490396|Protective Agents|protective agents|mesh-ancestor
19436762|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
19436763|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
19436764|NCT03490279|Lactoferrin|lactoferrin|mesh-list
19436765|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436766|NCT03490123|Azithromycin|azithromycin|mesh-list
19436767|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436768|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436769|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
19436770|NCT03490097|Simvastatin|simvastatin|mesh-list
19436771|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19436772|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19436773|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
19436774|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717204|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
19717205|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717206|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717207|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
19717208|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717209|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717210|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
19717211|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717212|NCT02520011|Analgesics|analgesics|mesh-ancestor
19717213|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
19717214|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717215|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19717216|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19717217|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436775|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19436776|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19436777|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717218|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717219|NCT02520011|Growth Substances|growth substances|mesh-ancestor
19717220|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19436778|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
19717221|NCT02453620|Nivolumab|nivolumab|mesh-list
19436779|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717222|NCT02453620|Ipilimumab|ipilimumab|mesh-list
19717223|NCT02453620|Entinostat|entinostat|mesh-list
19717224|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19717225|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19859970|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19859971|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
19859972|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
19859973|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859974|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19859975|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
19859976|NCT00784927|Hormones|hormones|mesh-ancestor
19436780|NCT03490019|Metformin|metformin|mesh-list
19436781|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19436782|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436783|NCT03489928|Misoprostol|misoprostol|mesh-list
19436784|NCT03489928|Dinoprostone|dinoprostone|mesh-list
19436785|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19436786|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
19436787|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19436788|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436789|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19436790|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19717226|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19859977|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19859978|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19859979|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19859980|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19859981|NCT00784927|Growth Substances|growth substances|mesh-ancestor
19859982|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
19859983|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
19859984|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
19859985|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859986|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
19859987|NCT00785213|Quinine|quinine|mesh-list
19859988|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19859989|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19859990|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
19859991|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19859992|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19859993|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19859994|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19859995|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19859996|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19859997|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19859998|NCT00785213|Analgesics|analgesics|mesh-ancestor
19859999|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
19860000|NCT00785486|Quinine|quinine|mesh-list
19860001|NCT00785486|Midazolam|midazolam|mesh-list
19860002|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19860003|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19860004|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860005|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860006|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19860007|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860008|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860009|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19436791|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
19436792|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19717227|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19717228|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717229|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717230|NCT02345265|Olaparib|olaparib|mesh-list
19717231|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19717232|NCT02345265|Cediranib|cediranib|mesh-list
19717233|NCT02345265|Maleic acid|maleic acid|mesh-list
19717234|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436793|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19436794|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436795|NCT03489837|Dipropizine|dipropizine|mesh-list
19436796|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
19717235|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252801|NCT00456482|Hormones|hormones|mesh-ancestor
20252802|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20252803|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252804|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
20252805|NCT00456560|Paroxetine|paroxetine|mesh-list
20252806|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20252807|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20252808|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252809|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717236|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717237|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717238|NCT02315534|Temozolomide|temozolomide|mesh-list
19717239|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19717240|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
19717241|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717242|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717243|NCT02311920|Nivolumab|nivolumab|mesh-list
19717244|NCT02311920|Ipilimumab|ipilimumab|mesh-list
19717245|NCT02311920|Temozolomide|temozolomide|mesh-list
19717246|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717247|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717248|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19717249|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717250|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19717251|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
19860010|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
19860011|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
19860012|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
19860013|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
19860014|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860015|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860016|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
19436797|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
19436798|NCT03489798|Alprostadil|alprostadil|mesh-list
19436799|NCT03489798|Misoprostol|misoprostol|mesh-list
19436800|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19436801|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
19436802|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19436803|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436804|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19436805|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436806|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
19436807|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19436808|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
19436809|NCT03489798|Urological Agents|urological agents|mesh-ancestor
19451719|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19451720|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451721|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19451722|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19451723|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451724|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451725|NCT03419442|Docetaxel|docetaxel|mesh-list
19451726|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451727|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19451728|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19451729|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19451730|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451731|NCT03419429|Simvastatin|simvastatin|mesh-list
19451732|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19451733|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19451734|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
19451735|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451736|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19451737|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19451738|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451739|NCT03419364|Niacinamide|niacinamide|mesh-list
19436810|NCT03489668|Metformin|metformin|mesh-list
19436811|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19436812|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436813|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
19436814|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19436815|NCT03489629|Minocycline|minocycline|mesh-list
19436816|NCT03489629|Trimethoprim|trimethoprim|mesh-list
19436817|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
19436818|NCT03489629|Mupirocin|mupirocin|mesh-list
19436819|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19436820|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19436821|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436822|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
19436823|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
19436824|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436825|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19436826|NCT03489629|Renal Agents|renal agents|mesh-ancestor
19436827|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
19436828|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19436829|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19436830|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19436831|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436832|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436833|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19717252|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
19717253|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717254|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717255|NCT02310321|Cytarabine|cytarabine|mesh-list
19717256|NCT02310321|Idarubicin|idarubicin|mesh-list
19717257|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19717258|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
19717259|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717260|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717261|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
19436834|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19436835|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19436836|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19436837|NCT03489616|Pemetrexed|pemetrexed|mesh-list
19436838|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436839|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436840|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436841|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19436842|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19436843|NCT03489395|Edoxaban|edoxaban|mesh-list
19436844|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19436845|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
19436846|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19436847|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
19436848|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436849|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436850|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
19436851|NCT03489317|Metformin|metformin|mesh-list
19436852|NCT03489317|Amlodipine|amlodipine|mesh-list
19436853|NCT03489317|Simvastatin|simvastatin|mesh-list
19436854|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19436855|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436856|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19436857|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19436858|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19451740|NCT03419364|Niacin|niacin|mesh-list
19451741|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
19451742|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
19451743|NCT03419364|Vitamins|vitamins|mesh-ancestor
19451744|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
19436859|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436860|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19436861|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
19436862|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19436863|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19436864|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
19436865|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19436866|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20252810|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252811|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
20252812|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252813|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20252814|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
20252815|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252816|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19436867|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436868|NCT03489265|Eluxadoline|eluxadoline|mesh-list
19436869|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436870|NCT03489239|Tenofovir|tenofovir|mesh-list
19436871|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
19436872|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436873|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19436874|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19436875|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436876|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436877|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19436878|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19436879|NCT03489161|Buprenorphine|buprenorphine|mesh-list
19436880|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19436881|NCT03489161|Narcotics|narcotics|mesh-ancestor
19436882|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436883|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436884|NCT03489161|Analgesics|analgesics|mesh-ancestor
19436885|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
19436886|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436887|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19436888|NCT03489044|Levetiracetam|levetiracetam|mesh-list
19436889|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
19436890|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
19436891|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
19436892|NCT03489005|Zamicastat|zamicastat|mesh-list
19436893|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19436894|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436895|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19436896|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19436897|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436898|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436899|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436900|NCT03488888|Bupivacaine|bupivacaine|mesh-list
19860017|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19436901|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
19436902|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
20553429|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
20553430|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
20553431|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20553432|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19436903|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436904|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436905|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
19436906|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436907|NCT03488810|Hormones|hormones|mesh-list
19436908|NCT03488810|Androgens|androgens|mesh-list
19436909|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
19436910|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
19436911|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436912|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436913|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
19436914|NCT03488719|Metoprolol|metoprolol|mesh-list
19436915|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19436916|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19717262|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717263|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717264|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
19717265|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717266|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19717267|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19717268|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19717269|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717270|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
19717271|NCT02298959|Aflibercept|aflibercept|mesh-list
19717272|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
19717273|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717274|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717275|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19717276|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717277|NCT02298959|Growth Substances|growth substances|mesh-ancestor
19717278|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717279|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717280|NCT02279719|Sorafenib|sorafenib|mesh-list
19717281|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717282|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717283|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717284|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717285|NCT02235857|Dextrans|dextrans|mesh-list
19717286|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
19717287|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
19717288|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
19717289|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
19717290|NCT02230189|Miotics|miotics|mesh-ancestor
19717291|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
19717292|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717293|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717294|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19717295|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19717296|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
19860018|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19860019|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860020|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19860021|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19860022|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860023|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19717297|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19860024|NCT00785486|Analgesics|analgesics|mesh-ancestor
19860025|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
19436917|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
19436918|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
19436919|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436920|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436921|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19436922|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19436923|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19436924|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
19436925|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19436926|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436927|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
19436928|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
19436929|NCT03488485|Ledipasvir|ledipasvir|mesh-list
19860026|NCT00785512|Nebivolol|nebivolol|mesh-list
19860027|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19860028|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
19860029|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19860030|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19860031|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19860032|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
19860033|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252817|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19436930|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436931|NCT03488316|Calcium|calcium|mesh-list
19436932|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19436933|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436934|NCT03488251|Gemcitabine|gemcitabine|mesh-list
19436935|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436936|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
19436937|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436938|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436939|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
19436940|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19436941|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436942|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436943|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
19436944|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436945|NCT03488186|Lansoprazole|lansoprazole|mesh-list
19436946|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
19717298|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19717299|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
19717300|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717301|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717302|NCT02192398|Guanfacine|guanfacine|mesh-list
19717303|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19717304|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19717305|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19717306|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19717307|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
19717308|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252818|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436947|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19717309|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436948|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436949|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19436950|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436951|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436952|NCT03488173|Lansoprazole|lansoprazole|mesh-list
19436953|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
19436954|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19436955|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436956|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19436957|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436958|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436959|NCT03488147|Esomeprazole|esomeprazole|mesh-list
19436960|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19717310|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252819|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19436961|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19436962|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19436963|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436964|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451745|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451746|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19451747|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
19451748|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451749|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19451750|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
19451751|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
19451752|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19451753|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451754|NCT03418974|Atorvastatin|atorvastatin|mesh-list
19451755|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19451756|NCT03418974|Pitavastatin|pitavastatin|mesh-list
19451757|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19451758|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19451759|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
19451760|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451761|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19451762|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19451763|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451764|NCT03418935|Niacinamide|niacinamide|mesh-list
19451765|NCT03418935|Niacin|niacin|mesh-list
19451766|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
19451767|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
19451768|NCT03418935|Vitamins|vitamins|mesh-ancestor
19451769|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
19451770|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451771|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19451772|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
19451773|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451774|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19451775|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
19436965|NCT03487939|Fluorouracil|fluorouracil|mesh-list
19436966|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
19436967|NCT03487939|Irinotecan|irinotecan|mesh-list
19436968|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
19436969|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19436970|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19436971|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19436972|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19436973|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
19436974|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436975|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19436976|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19436977|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19436978|NCT03487874|Ropivacaine|ropivacaine|mesh-list
19436979|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
19436980|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
19436981|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19436982|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436983|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
19436984|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436985|NCT03487809|Budesonide|budesonide|mesh-list
19436986|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19436987|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19436988|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
19436989|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19436990|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19436991|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19436992|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
19436993|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
19436994|NCT03487809|Hormones|hormones|mesh-ancestor
19436995|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19436996|NCT03487783|Aripiprazole|aripiprazole|mesh-list
19436997|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19436998|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
19436999|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19437000|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19437001|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19437002|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437003|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437004|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
19437005|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
19437006|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437007|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437008|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19437009|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19437010|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
19437011|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19437012|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19437013|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19437014|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19437015|NCT03487770|Aripiprazole|aripiprazole|mesh-list
19437016|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19437017|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
19437018|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19437019|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19437020|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19437021|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437022|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437023|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
19437024|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
19437025|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437026|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437027|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19437028|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19437029|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
19437030|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19437031|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19437032|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19437033|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19437034|NCT03487562|Amoxicillin|amoxicillin|mesh-list
19437035|NCT03487562|Clarithromycin|clarithromycin|mesh-list
19437036|NCT03487562|Lansoprazole|lansoprazole|mesh-list
19437037|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
19437038|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19437039|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437040|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19437041|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717311|NCT02178956|Paclitaxel|paclitaxel|mesh-list
19717312|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19717313|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717314|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
19717315|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717316|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
19437042|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437043|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19437044|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19437045|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19437046|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437047|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19437048|NCT03487406|Aspirin|aspirin|mesh-list
19437049|NCT03487406|Ticagrelor|ticagrelor|mesh-list
19437050|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19437051|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437052|NCT03487406|Analgesics|analgesics|mesh-ancestor
19437053|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
19437054|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437055|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437056|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437057|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19437058|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19717317|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717318|NCT02167945|Ritonavir|ritonavir|mesh-list
19717319|NCT02167945|Ribavirin|ribavirin|mesh-list
19717320|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19717321|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19860034|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860035|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860036|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19860037|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
19860038|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860039|NCT00785577|Pregabalin|pregabalin|mesh-list
19437059|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19437060|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437061|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19437062|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19437063|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437064|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
19437065|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19437066|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19717322|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
19717323|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717324|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717325|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19717326|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19717327|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
19860040|NCT00785577|Analgesics|analgesics|mesh-ancestor
19860041|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
19860042|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860043|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860044|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
19860045|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19860046|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860047|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717328|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717329|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19717330|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19437067|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19437068|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
19437069|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437070|NCT03487354|Misoprostol|misoprostol|mesh-list
19437071|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19437072|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
19437073|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19437074|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437075|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19437076|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19717331|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
19717332|NCT02160015|Rituximab|rituximab|mesh-list
19717333|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19717334|NCT02160015|Lenalidomide|lenalidomide|mesh-list
19717335|NCT02160015|Antibodies|antibodies|mesh-list
19717336|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
19860048|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19860049|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19860050|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860051|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860052|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860053|NCT00785629|Calcium|calcium|mesh-list
19860054|NCT00785629|Sevelamer|sevelamer|mesh-list
19860055|NCT00785629|Calcium acetate|calcium acetate|mesh-list
19860056|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19860057|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860058|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
19860059|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
19860060|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860061|NCT00785772|Gabapentin|gabapentin|mesh-list
19860062|NCT00785772|Analgesics|analgesics|mesh-ancestor
19860063|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
19860064|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860065|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860066|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
19860067|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19860068|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860069|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860070|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860071|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19860072|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19860073|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860074|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252820|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20553433|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
20553434|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437077|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
19717337|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19717338|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
19717339|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717340|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717341|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553435|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553436|NCT01929278|Clindamycin|clindamycin|mesh-list
20553437|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
20553438|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
20553439|NCT01929278|Tretinoin|tretinoin|mesh-list
20553440|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553441|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553442|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20553443|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553444|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553445|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553446|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
20553447|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
20553448|NCT01929330|Dutasteride|dutasteride|mesh-list
19437078|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19437079|NCT03487211|Citalopram|citalopram|mesh-list
19437080|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19437081|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19437082|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437083|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437084|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717342|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19717343|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717344|NCT02160015|Growth Substances|growth substances|mesh-ancestor
19717345|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717346|NCT02159755|Palbociclib|palbociclib|mesh-list
19437085|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
19437086|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437087|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19437088|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
19437089|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19717347|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717348|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717349|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717350|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717351|NCT02152995|Iodine|iodine|mesh-list
19717352|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
19717353|NCT02152995|Trametinib|trametinib|mesh-list
19717354|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19717355|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717356|NCT02152995|Trace Elements|trace elements|mesh-ancestor
19717357|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
19717358|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717359|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717360|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717361|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717362|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717363|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19717364|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19717365|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
19717366|NCT02030028|Hormones|hormones|mesh-ancestor
19717367|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19717368|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717369|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717370|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717371|NCT02024607|Leucovorin|leucovorin|mesh-list
19717372|NCT02024607|Bevacizumab|bevacizumab|mesh-list
19717373|NCT02024607|Fluorouracil|fluorouracil|mesh-list
19717374|NCT02024607|Capecitabine|capecitabine|mesh-list
19717375|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
19717376|NCT02024607|Irinotecan|irinotecan|mesh-list
19717377|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717378|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717379|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19717380|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717381|NCT02024607|Growth Substances|growth substances|mesh-ancestor
19717382|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717383|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717384|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
19717385|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717386|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19717387|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717388|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
19717389|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19437090|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437091|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19437092|NCT03487211|Analgesics|analgesics|mesh-ancestor
19437093|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
19437094|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
19437095|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
19437096|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
19437097|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437098|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437099|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437100|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
19437101|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
19437102|NCT03487172|Mannitol|mannitol|mesh-list
19437103|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19437104|NCT03487172|Diuretics|diuretics|mesh-ancestor
19717390|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19717391|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717392|NCT02024607|Antidotes|antidotes|mesh-ancestor
19717393|NCT02024607|Protective Agents|protective agents|mesh-ancestor
19717394|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
19717395|NCT02024607|Vitamins|vitamins|mesh-ancestor
19717396|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
19717397|NCT01955499|Lenalidomide|lenalidomide|mesh-list
19437105|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
19437106|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437107|NCT03487133|Dexamethasone|dexamethasone|mesh-list
19437108|NCT03487133|Bortezomib|bortezomib|mesh-list
19437109|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437110|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
19437111|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
19437112|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437113|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437114|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437115|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
19437116|NCT03487133|Hormones|hormones|mesh-ancestor
19437117|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437118|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19437119|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437120|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
19437121|NCT03487107|Yimitasvir|yimitasvir|mesh-list
19437122|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
19437123|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437124|NCT03487042|Bimatoprost|bimatoprost|mesh-list
19437125|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19437126|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19437127|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19437128|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
19437129|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19437130|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19437131|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
19437132|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437133|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437134|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437135|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
19437136|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
19437137|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717398|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
19717399|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437138|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
19437139|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19717400|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19437140|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
19437141|NCT03487016|Gemcitabine|gemcitabine|mesh-list
19437142|NCT03487016|Paclitaxel|paclitaxel|mesh-list
19437143|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
19437144|NCT03487016|Irinotecan|irinotecan|mesh-list
19437145|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19437146|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437147|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
19437148|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
19437149|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
19437150|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437151|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19437152|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
19437153|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
19437154|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437155|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437156|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19437157|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
19437158|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437159|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19437160|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19437161|NCT03487003|Bromides|bromides|mesh-list
19437162|NCT03487003|Rocuronium|rocuronium|mesh-list
19437163|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
19437164|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19437165|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19437166|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19437167|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437168|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437169|NCT03486925|Oxytocin|oxytocin|mesh-list
19437170|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
19437171|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19437172|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437173|NCT03486626|Metformin|metformin|mesh-list
19437174|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19437175|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437176|NCT03486561|Ranolazine|ranolazine|mesh-list
19437177|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19437178|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735855|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735856|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
19735857|NCT04535518|Aspirin|aspirin|mesh-list
19437179|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437180|NCT03486548|Dexamethasone|dexamethasone|mesh-list
19437181|NCT03486548|Lidocaine|lidocaine|mesh-list
19437182|NCT03486548|Bupivacaine|bupivacaine|mesh-list
19437183|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437184|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
19437185|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
19437186|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437187|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437188|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437189|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
19437190|NCT03486548|Hormones|hormones|mesh-ancestor
19437191|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437192|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19437193|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437194|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437195|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
19437196|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437197|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
19437198|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19437199|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19437200|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19437201|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437202|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437203|NCT03486509|Afatinib|afatinib|mesh-list
19437204|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437205|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19437206|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437207|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437208|NCT03486496|Gefitinib|gefitinib|mesh-list
19437209|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437210|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19437211|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437212|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437213|NCT03486457|Tofacitinib|tofacitinib|mesh-list
19437214|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717401|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19437215|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437216|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437217|NCT03486353|Azacitidine|azacitidine|mesh-list
19437218|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19437219|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
19437220|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437221|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437222|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860075|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
19860076|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
19860077|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860078|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717402|NCT01955499|Growth Substances|growth substances|mesh-ancestor
19717403|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717404|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734258|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734259|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734260|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19735858|NCT04535518|Infliximab|infliximab|mesh-list
19437223|NCT03486236|Ivacaftor|ivacaftor|mesh-list
19437224|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19437225|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437226|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437227|NCT03486184|Cystatins|cystatins|mesh-list
19717405|NCT01929811|Metformin|metformin|mesh-list
19717406|NCT01929811|Docetaxel|docetaxel|mesh-list
19717407|NCT01929811|Epirubicin|epirubicin|mesh-list
19717408|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19717409|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717410|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717411|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
19717412|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717413|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
19717414|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717415|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19717416|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19717417|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19717418|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717419|NCT01925131|Prednisone|prednisone|mesh-list
19717420|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
19717421|NCT01925131|Vincristine|vincristine|mesh-list
19717422|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19717423|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717424|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
19717425|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717426|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717427|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19717428|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
19717429|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717430|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717431|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19717432|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717433|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
19717434|NCT01925131|Hormones|hormones|mesh-ancestor
19717435|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19717436|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19717437|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19717438|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
19860079|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860080|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860081|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
19860082|NCT00785980|Quinine|quinine|mesh-list
19860083|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19860084|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860085|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19860086|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19860087|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860088|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860089|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533447|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20533448|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
20533449|NCT01807962|Lidocaine|lidocaine|mesh-list
20533450|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
20533451|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
20533452|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533453|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533454|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
20533455|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437228|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19437229|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
19437230|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437231|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437232|NCT03486119|Nivolumab|nivolumab|mesh-list
19437233|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19437234|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437235|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19437236|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437237|NCT03486106|Propofol|propofol|mesh-list
19437238|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19437239|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437240|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717439|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
20533456|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19717440|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
19717441|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717442|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19717443|NCT01886859|Lenalidomide|lenalidomide|mesh-list
19717444|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
19717445|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717446|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19717447|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717448|NCT01886859|Growth Substances|growth substances|mesh-ancestor
19717449|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
19437241|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19437242|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
19437243|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
19437244|NCT03486080|Lenograstim|lenograstim|mesh-list
19437245|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19717450|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860090|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19860091|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19860092|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
19860093|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19860094|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19860095|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19860096|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860097|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19860098|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437246|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
19437247|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437248|NCT03485846|Ritonavir|ritonavir|mesh-list
19437249|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19437250|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19437251|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
19437252|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437253|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437254|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19437255|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19437256|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
19437257|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437258|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19437259|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19437260|NCT03485703|Azithromycin|azithromycin|mesh-list
19437261|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19437262|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437263|NCT03485625|Acetaminophen|acetaminophen|mesh-list
19437264|NCT03485625|Ketorolac|ketorolac|mesh-list
19437265|NCT03485625|Lidocaine|lidocaine|mesh-list
19437266|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
19860099|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19860100|NCT00785980|Analgesics|analgesics|mesh-ancestor
19860101|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
19860102|NCT00786019|Vitamins|vitamins|mesh-list
19860103|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
19860104|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
19860105|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860106|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
19860107|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860108|NCT00786019|Protective Agents|protective agents|mesh-ancestor
19860109|NCT00786188|Paroxetine|paroxetine|mesh-list
19860110|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19860111|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19860112|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860113|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860114|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860115|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
19437267|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
19437268|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717451|NCT01829568|Rituximab|rituximab|mesh-list
19717452|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19717453|NCT01829568|Lenalidomide|lenalidomide|mesh-list
19717454|NCT01829568|Antibodies|antibodies|mesh-list
19717455|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
19717456|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19717457|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
19717458|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717459|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252821|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252822|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20252823|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20252824|NCT00456586|Istradefylline|istradefylline|mesh-list
20252825|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20252826|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20252827|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20252828|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
20252829|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553449|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19717460|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717461|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20553450|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20553451|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553452|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553453|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553454|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553455|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553456|NCT01929382|Interferons|interferons|mesh-list
20553457|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
20553458|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553459|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
20553460|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553461|NCT01929421|Gemcitabine|gemcitabine|mesh-list
20553462|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20553463|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
20553464|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553465|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553466|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
20553467|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553468|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437269|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437270|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
19437271|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437272|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19437273|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19437274|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19437275|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437276|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437277|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437278|NCT03485625|Analgesics|analgesics|mesh-ancestor
19437279|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
19437280|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19437281|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437282|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717462|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717463|NCT01829568|Growth Substances|growth substances|mesh-ancestor
19717464|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717465|NCT01803555|Budesonide|budesonide|mesh-list
19717466|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
19717467|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19717468|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717469|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19437283|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19437284|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437285|NCT03485534|Tenofovir|tenofovir|mesh-list
19437286|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
19437287|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437288|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19437289|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19437290|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437291|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437292|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19437293|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19437294|NCT03485482|Bisoprolol|bisoprolol|mesh-list
19437295|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19437296|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
19437297|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
19437298|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437299|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437300|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19437301|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19437302|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19437303|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
19437304|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437305|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437306|NCT03485456|Tobramycin|tobramycin|mesh-list
19437307|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19437308|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437309|NCT03485417|Aripiprazole|aripiprazole|mesh-list
19437310|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19437311|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
19717470|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
19717471|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717472|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717473|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19717474|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
19717475|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
19717476|NCT01803555|Hormones|hormones|mesh-ancestor
19717477|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437312|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19717478|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20252830|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252831|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252832|NCT00456677|Minocycline|minocycline|mesh-list
20252833|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252834|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252835|NCT00456716|Sorafenib|sorafenib|mesh-list
20252836|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437313|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20533457|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20533458|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20533459|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533460|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533461|NCT01808014|Nefopam|nefopam|mesh-list
20533462|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20533463|NCT01808014|Analgesics|analgesics|mesh-ancestor
20533464|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
20533465|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252837|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20252838|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252839|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252840|NCT00456729|Metronidazole|metronidazole|mesh-list
20252841|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252842|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20252843|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20252844|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20252845|NCT00456794|Istradefylline|istradefylline|mesh-list
20252846|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20252847|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20252848|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20252849|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
19437314|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20252850|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437315|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437316|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437317|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
19437318|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
19717479|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19717480|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19717481|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
19717482|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717483|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717484|NCT01791816|Phenylephrine|phenylephrine|mesh-list
19717485|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
19717486|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19717487|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19717488|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
19717489|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
19437319|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717490|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717491|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717492|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
19437320|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437321|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19437322|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19437323|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
19437324|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19437325|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19717493|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19437326|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19437327|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19437328|NCT03485404|Vitamins|vitamins|mesh-list
19437329|NCT03485404|Folic Acid|folic acid|mesh-list
19437330|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
19437331|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
19437332|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
19437333|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437334|NCT03485404|Hematinics|hematinics|mesh-ancestor
19437335|NCT03485300|Warfarin|warfarin|mesh-list
19437336|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
19437337|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19717494|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
19437338|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19437339|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437340|NCT03485118|Rituximab|rituximab|mesh-list
19437341|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19437342|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437343|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
19717495|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
19717496|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19717497|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19717498|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19717499|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
19717500|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717501|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717502|NCT01791816|Protective Agents|protective agents|mesh-ancestor
19717503|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717504|NCT01786434|Fentanyl|fentanyl|mesh-list
19717505|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19717506|NCT01786434|Narcotics|narcotics|mesh-ancestor
19717507|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717508|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717509|NCT01786434|Analgesics|analgesics|mesh-ancestor
19717510|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
19717511|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717512|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19717513|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19717514|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
19437344|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437345|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19437346|NCT03485092|Empagliflozin|empagliflozin|mesh-list
19437347|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19437348|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437349|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19437350|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437351|NCT03484962|Antibodies|antibodies|mesh-list
19437352|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19437353|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
19437354|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437355|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
19437356|NCT03484845|Lactoferrin|lactoferrin|mesh-list
19437357|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437358|NCT03484845|Trace Elements|trace elements|mesh-ancestor
19437359|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
19437360|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437361|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19437362|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
19437363|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437364|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
19437365|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437366|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437367|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
19437368|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437369|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19437370|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
19437371|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19437372|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437373|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437374|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
19437375|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437376|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437377|NCT03484650|Lidocaine|lidocaine|mesh-list
19437378|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437379|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
19437380|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717515|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
19717516|NCT01784159|Aspirin|aspirin|mesh-list
20252851|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437381|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437382|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
19437383|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437384|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19437385|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19437386|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19437387|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437388|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437389|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19437390|NCT03484611|Cetrorelix|cetrorelix|mesh-list
19437391|NCT03484611|Menotropins|menotropins|mesh-list
19437392|NCT03484611|Progesterone|progesterone|mesh-list
19437393|NCT03484611|Progestins|progestins|mesh-ancestor
19437394|NCT03484611|Hormones|hormones|mesh-ancestor
19437395|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437396|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437397|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19437398|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19437399|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
19437400|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
19860116|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860117|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19860118|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
19717517|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19717518|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19717519|NCT01784159|Analgesics|analgesics|mesh-ancestor
19717520|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
19717521|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717522|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717523|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717524|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717525|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19717526|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19717527|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717528|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19717529|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19717530|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717531|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
19717532|NCT01776307|Capecitabine|capecitabine|mesh-list
19717533|NCT01776307|Cetuximab|cetuximab|mesh-list
19717534|NCT01776307|Panitumumab|panitumumab|mesh-list
19717535|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19717536|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
19717537|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717538|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717539|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717540|NCT01695941|Rituximab|rituximab|mesh-list
19717541|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19717542|NCT01695941|Bortezomib|bortezomib|mesh-list
19717543|NCT01695941|Antibodies|antibodies|mesh-list
19717544|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
19717545|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19717546|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
19717547|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717548|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717549|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717550|NCT01681264|Guanfacine|guanfacine|mesh-list
19717551|NCT01681264|Morphine|morphine|mesh-list
19717552|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19717553|NCT01681264|Narcotics|narcotics|mesh-ancestor
19717554|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717555|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717556|NCT01681264|Analgesics|analgesics|mesh-ancestor
19717557|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
19717558|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717559|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19860119|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860120|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19860121|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19860122|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717560|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19860123|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
19860124|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19860125|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
19717561|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19717562|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19437401|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
19437402|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
19717563|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
19717564|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717565|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717566|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
19717567|NCT01678586|Gabapentin|gabapentin|mesh-list
19437403|NCT03484507|Prednisolone|prednisolone|mesh-list
19437404|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19437405|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
19437406|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19437407|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
19437408|NCT03484507|Povidone|povidone|mesh-list
19437409|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19437410|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
19437411|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437412|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
19437413|NCT03484507|Hormones|hormones|mesh-ancestor
19437414|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437415|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437416|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19717568|NCT01678586|Analgesics|analgesics|mesh-ancestor
19717569|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
19717570|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717571|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717572|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
19717573|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19717574|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19717575|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717576|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19717577|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19717578|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19717579|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717580|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717581|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
19717582|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19717583|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19717584|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
19717585|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
19717586|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
19717587|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
19717588|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860126|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19437417|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437418|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
19437419|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
19451784|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19437420|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437421|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437422|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19437423|NCT03484507|Protective Agents|protective agents|mesh-ancestor
19437424|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19437425|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437426|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
19437427|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
19437428|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
19437429|NCT03484416|Vitamin D|vitamin d|mesh-list
19437430|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
19437431|NCT03484416|Calcium|calcium|mesh-list
19437432|NCT03484416|Vitamins|vitamins|mesh-ancestor
19437433|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
19437434|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437435|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19437436|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19437437|NCT03484416|Antacids|antacids|mesh-ancestor
19437438|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437439|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437440|NCT03484299|Gemcitabine|gemcitabine|mesh-list
19437441|NCT03484299|Folfirinox|folfirinox|mesh-list
19437442|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19437443|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
19437444|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437445|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437446|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
19437447|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437448|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437449|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19437450|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
19437451|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252852|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437452|NCT03484260|Testosterone|testosterone|mesh-list
19437453|NCT03484260|Androgens|androgens|mesh-ancestor
19437454|NCT03484260|Hormones|hormones|mesh-ancestor
19717589|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19717590|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
19717591|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
19717592|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19717593|NCT01630213|Vitamin D|vitamin d|mesh-list
19717594|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
19717595|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
19717596|NCT01630213|Vitamins|vitamins|mesh-list
19717597|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
19717598|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717599|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19717600|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19437455|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437456|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437457|NCT03484221|Fluorouracil|fluorouracil|mesh-list
19717601|NCT01623167|Cyclosporine|cyclosporine|mesh-list
19717602|NCT01623167|Cyclosporins|cyclosporins|mesh-list
19717603|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19717604|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717605|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717606|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717607|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
20252853|NCT00456820|Bupropion|bupropion|mesh-list
19437458|NCT03484221|Capecitabine|capecitabine|mesh-list
19437459|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
19437460|NCT03484221|Irinotecan|irinotecan|mesh-list
19437461|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
19735859|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
19437462|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437463|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19437464|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437465|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19437466|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
19437467|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437468|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19437469|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19437470|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437471|NCT03484195|Fluorouracil|fluorouracil|mesh-list
19437472|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
19437473|NCT03484195|Irinotecan|irinotecan|mesh-list
19437474|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
19437475|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437476|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19437477|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437478|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19437479|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
19437480|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437481|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19437482|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19437483|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437484|NCT03484091|Hylan|hylan|mesh-list
19437485|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
19437486|NCT03484091|Protective Agents|protective agents|mesh-ancestor
19437487|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437488|NCT03483948|Azacitidine|azacitidine|mesh-list
19437489|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19437490|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
19437491|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437492|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437493|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437494|NCT03483883|Gemcitabine|gemcitabine|mesh-list
19437495|NCT03483883|Avelumab|avelumab|mesh-list
19717608|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717609|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
19717610|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717611|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
19717612|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717613|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19717614|NCT01528046|Metformin|metformin|mesh-list
19717615|NCT01528046|Irinotecan|irinotecan|mesh-list
19717616|NCT01528046|Camptothecin|camptothecin|mesh-list
19717617|NCT01528046|Vincristine|vincristine|mesh-list
19717618|NCT01528046|Temozolomide|temozolomide|mesh-list
19860127|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
19860128|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860129|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860130|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
19860131|NCT00786474|Dalteparin|dalteparin|mesh-list
19860132|NCT00786474|Tinzaparin|tinzaparin|mesh-list
19860133|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19860134|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
19860135|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19717619|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19860136|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19437496|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20533466|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717620|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533467|NCT01808131|Lesinurad|lesinurad|mesh-list
20533468|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
20533469|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533470|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
20533471|NCT01808131|Renal Agents|renal agents|mesh-ancestor
20533472|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
20533473|NCT01808300|Pregabalin|pregabalin|mesh-list
19437497|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
19437498|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437499|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437500|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
19437501|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437502|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437503|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19437504|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
19437505|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437506|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19437507|NCT03483870|Morphine|morphine|mesh-list
19437508|NCT03483870|Granisetron|granisetron|mesh-list
19437509|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19437510|NCT03483870|Narcotics|narcotics|mesh-ancestor
19437511|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437512|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437513|NCT03483870|Analgesics|analgesics|mesh-ancestor
19437514|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
19437515|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437516|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
19437517|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
19437518|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437519|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19437520|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
19437521|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437522|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437523|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
19437524|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437525|NCT03483753|Vasopressins|vasopressins|mesh-list
19437526|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
19437527|NCT03483753|Norepinephrine|norepinephrine|mesh-list
19437528|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19437529|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19437530|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
19437531|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437532|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437533|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437534|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
19437535|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
19437536|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437537|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19437538|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
19437539|NCT03483753|Coagulants|coagulants|mesh-ancestor
19437540|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19437541|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
19717621|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19717622|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19437542|NCT03483636|Lemborexant|lemborexant|mesh-list
19437543|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19437544|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437545|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437546|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19437547|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19437548|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437549|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437550|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19717623|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717624|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717625|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717626|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19717627|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
19717628|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717629|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
19860137|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860138|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19860139|NCT00786487|Glycerol|glycerol|mesh-list
20252854|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20252855|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
20252856|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252857|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20252858|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19860140|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19860141|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19860142|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19860143|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19860144|NCT00786487|Protective Agents|protective agents|mesh-ancestor
19860145|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860146|NCT00786643|Leucovorin|leucovorin|mesh-list
19860147|NCT00786643|Interferons|interferons|mesh-list
19860148|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
19860149|NCT00786643|Bevacizumab|bevacizumab|mesh-list
19860150|NCT00786643|Fluorouracil|fluorouracil|mesh-list
19860151|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
19860152|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19860153|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860154|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19860155|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19860156|NCT00786643|Growth Substances|growth substances|mesh-ancestor
19860157|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860158|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
19860159|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
19860160|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860161|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19860162|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860163|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
19860164|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
19860165|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860166|NCT00786643|Antidotes|antidotes|mesh-ancestor
19860167|NCT00786643|Protective Agents|protective agents|mesh-ancestor
19860168|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
19860169|NCT00786643|Vitamins|vitamins|mesh-ancestor
19860170|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
19860171|NCT00786825|Somatostatin|somatostatin|mesh-list
19860172|NCT00786825|Hormones|hormones|mesh-ancestor
19860173|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860174|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860175|NCT00786838|Trabectedin|trabectedin|mesh-list
19860176|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860177|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
19860178|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252859|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437551|NCT03483545|Hormones|hormones|mesh-ancestor
19437552|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437553|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437554|NCT03483415|Morphine|morphine|mesh-list
19437555|NCT03483415|Bupivacaine|bupivacaine|mesh-list
19437556|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437557|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
19437558|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437559|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437560|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
19437561|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437562|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19437563|NCT03483415|Narcotics|narcotics|mesh-ancestor
19437564|NCT03483415|Analgesics|analgesics|mesh-ancestor
19437565|NCT03483389|Ethanol|ethanol|mesh-list
19437566|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19437567|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437568|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437569|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437570|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
19437571|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19437572|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19437573|NCT03483363|Bacitracin|bacitracin|mesh-list
19437574|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19437575|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437576|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
19437577|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19437578|NCT03483350|Midazolam|midazolam|mesh-list
19437579|NCT03483350|Granisetron|granisetron|mesh-list
19437580|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19437581|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19437582|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437583|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437584|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19717630|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20252860|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252861|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
20252862|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717631|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
19437585|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19437586|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19437587|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19437588|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
19437589|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
19437590|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
19437591|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
19437592|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437593|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437594|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
19437595|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
19437596|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437597|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437598|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19437599|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
19437600|NCT03483207|Heparin|heparin|mesh-list
19437601|NCT03483207|Warfarin|warfarin|mesh-list
19437602|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
19437603|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19437604|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19437605|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437606|NCT03483181|Enoxaparin|enoxaparin|mesh-list
19437607|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
19437608|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19437609|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
19437610|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19437611|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
19437612|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437613|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437614|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
19437615|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19437616|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19437617|NCT03483142|Misoprostol|misoprostol|mesh-list
19437618|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19437619|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
19437620|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19437621|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437622|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19437623|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437624|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
19437625|NCT03482960|Xenon|xenon|mesh-list
19437626|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19437627|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
19437628|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
19437629|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437630|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533474|NCT01808300|Analgesics|analgesics|mesh-ancestor
19451785|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19451786|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451787|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19451788|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19451789|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
20533475|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
20533476|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533477|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533478|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
20533479|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20533480|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533481|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533482|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20533483|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20533484|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533485|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533486|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533487|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
20533488|NCT01808300|Protective Agents|protective agents|mesh-ancestor
20533489|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
20533490|NCT01808300|Vitamins|vitamins|mesh-ancestor
20533491|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
20533492|NCT01808456|Vaccines|vaccines|mesh-list
20533493|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
19437631|NCT03482752|Molgramostim|molgramostim|mesh-list
19437632|NCT03482752|Sargramostim|sargramostim|mesh-list
19437633|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437634|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
19437635|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437636|NCT03482544|Pregabalin|pregabalin|mesh-list
19437637|NCT03482544|Analgesics|analgesics|mesh-ancestor
19437638|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
19437639|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437640|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437641|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
19437642|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19437643|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19437644|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437645|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19437646|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19437647|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19437648|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437649|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19437650|NCT03482492|Acetaminophen|acetaminophen|mesh-list
19437651|NCT03482492|Tramadol|tramadol|mesh-list
19437652|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437653|NCT03482492|Analgesics|analgesics|mesh-ancestor
19437654|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
19437655|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437656|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437657|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
19437658|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19437659|NCT03482492|Narcotics|narcotics|mesh-ancestor
19437660|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437661|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19437662|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19437663|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437664|NCT03482440|Analgesics|analgesics|mesh-ancestor
19437665|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
19437666|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437667|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437668|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437669|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19437670|NCT03482362|Vinorelbine|vinorelbine|mesh-list
19437671|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19437672|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437673|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
19437674|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
19437675|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
19437676|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437677|NCT03482336|Immunoconjugates|immunoconjugates|mesh-list
19437678|NCT03482336|Immunologic Factors|immunologic factors|mesh-ancestor
19437679|NCT03482336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437680|NCT03482232|Acetaminophen|acetaminophen|mesh-list
19437681|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19437682|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19437683|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
19437684|NCT03482232|Ibuprofen|ibuprofen|mesh-list
19437685|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19437686|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19437687|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
19437688|NCT03482232|Expectorants|expectorants|mesh-list
19437689|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
19437690|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437691|NCT03482232|Analgesics|analgesics|mesh-ancestor
19437692|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
19437693|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437694|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437695|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19437696|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19437697|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437698|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437699|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
19437700|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
19437701|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19437702|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
19437703|NCT03482180|Atorvastatin|atorvastatin|mesh-list
19437704|NCT03482180|Calcium|calcium|mesh-list
19437705|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19437706|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437707|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19437708|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19437709|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
19437710|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437711|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19437712|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19437713|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437714|NCT03482167|Niacinamide|niacinamide|mesh-list
19437715|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
19437716|NCT03482167|Vitamins|vitamins|mesh-ancestor
19717632|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19717633|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717634|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717635|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717636|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717637|NCT01441349|Simvastatin|simvastatin|mesh-list
19717638|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19717639|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19717640|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
19717641|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717642|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19717643|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19717644|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717645|NCT01156545|Afatinib|afatinib|mesh-list
19717646|NCT01156545|Simvastatin|simvastatin|mesh-list
20533494|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437717|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
19437718|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437719|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19717647|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20533495|NCT01808469|Antibodies|antibodies|mesh-list
20533496|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20533497|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
20533498|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533499|NCT01808495|Mitomycins|mitomycins|mesh-list
20533500|NCT01808495|Mitomycin|mitomycin|mesh-list
20533501|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20533502|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533503|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
20533504|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533505|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20533506|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533507|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
20533508|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19437720|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437721|NCT03482102|Durvalumab|durvalumab|mesh-list
19437722|NCT03482102|Tremelimumab|tremelimumab|mesh-list
19437723|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19437724|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437725|NCT03482024|Tirzepatide|tirzepatide|mesh-list
19437726|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19437727|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437728|NCT03482024|Incretins|incretins|mesh-ancestor
19437729|NCT03482024|Hormones|hormones|mesh-ancestor
19437730|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437731|NCT03481998|Letrozole|letrozole|mesh-list
19437732|NCT03481998|Fulvestrant|fulvestrant|mesh-list
19437733|NCT03481998|Anastrozole|anastrozole|mesh-list
19437734|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717648|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19717649|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
19717650|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717651|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19717652|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19717653|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717654|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717655|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717656|NCT01140516|Trimethoprim|trimethoprim|mesh-list
19717657|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19717658|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717659|NCT01140516|Renal Agents|renal agents|mesh-ancestor
19717660|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
19717661|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19717662|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19717663|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19860179|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860180|NCT00786916|Lidocaine|lidocaine|mesh-list
19860181|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
19860182|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
19860183|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860184|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860185|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
19860186|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860187|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19860188|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19860189|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19860190|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860191|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860192|NCT00786994|Petrolatum|petrolatum|mesh-list
19860193|NCT00786994|Emollients|emollients|mesh-ancestor
19860194|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
19860195|NCT00787150|Warfarin|warfarin|mesh-list
19860196|NCT00787150|Apixaban|apixaban|mesh-list
19860197|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
19860198|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19860199|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
19860200|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19860201|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
19860202|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860203|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860204|NCT00787254|Lansoprazole|lansoprazole|mesh-list
19860205|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
19860206|NCT00787254|Gefarnate|gefarnate|mesh-list
19860207|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19860208|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860209|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20533509|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
20533510|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533511|NCT01808521|Expectorants|expectorants|mesh-ancestor
20533512|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
20533513|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20533514|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
20533515|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533516|NCT01808521|Protective Agents|protective agents|mesh-ancestor
19437735|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19860210|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860211|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533517|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437736|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19860212|NCT00787267|Dasatinib|dasatinib|mesh-list
20533518|NCT01808521|Antidotes|antidotes|mesh-ancestor
19717664|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717665|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717666|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19717667|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19717668|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19717669|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
19717670|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717671|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717672|NCT00544830|Leuprolide|leuprolide|mesh-list
19717673|NCT00544830|Goserelin|goserelin|mesh-list
19860213|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860214|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19437737|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437738|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437739|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19437740|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
19437741|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437742|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437743|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19437744|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19437745|NCT03481920|Avelumab|avelumab|mesh-list
19437746|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19437747|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437748|NCT03481790|Folic Acid|folic acid|mesh-list
19437749|NCT03481790|Lactoferrin|lactoferrin|mesh-list
19437750|NCT03481790|Vitamins|vitamins|mesh-ancestor
19437751|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
19437752|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437753|NCT03481790|Hematinics|hematinics|mesh-ancestor
19437754|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
19437755|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437756|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
19437757|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
19437758|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19437759|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437760|NCT03481517|Bupivacaine|bupivacaine|mesh-list
19437761|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437762|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
19437763|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437764|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437765|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
19437766|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437767|NCT03481400|Calcitonin|calcitonin|mesh-list
19437768|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
19437769|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19437770|NCT03481400|Katacalcin|katacalcin|mesh-list
19437771|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19437772|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437773|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19437774|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
19451790|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19451791|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437775|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
19437776|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437777|NCT03480997|Bromides|bromides|mesh-list
19437778|NCT03480997|Albuterol|albuterol|mesh-list
19437779|NCT03480997|Ipratropium|ipratropium|mesh-list
19437780|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
19437781|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19437782|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
19437783|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437784|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437785|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19437786|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
19437787|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
19437788|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19437789|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19437790|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19437791|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19437792|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
19437793|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437794|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437795|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19437796|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
19437797|NCT03480958|Morphine|morphine|mesh-list
19437798|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19437799|NCT03480958|Narcotics|narcotics|mesh-ancestor
19437800|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437801|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437802|NCT03480958|Analgesics|analgesics|mesh-ancestor
19437803|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
19437804|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717674|NCT00544830|Bicalutamide|bicalutamide|mesh-list
19717675|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19717676|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
19717677|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19717678|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717679|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19717680|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717681|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
19717682|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
19717683|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19717684|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
19717685|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
19717686|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717687|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
19717688|NCT00371059|Memantine|memantine|mesh-list
19717689|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19860215|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860216|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860217|NCT00787332|Desirudin|desirudin|mesh-list
19437805|NCT03480945|Nitroprusside|nitroprusside|mesh-list
19437806|NCT03480945|Serotonin|serotonin|mesh-list
19437807|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19437808|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
19437809|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437810|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437811|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437812|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19437813|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
19437814|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19437815|NCT03480906|Latanoprost|latanoprost|mesh-list
19437816|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19437817|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19437818|NCT03480867|Temozolomide|temozolomide|mesh-list
19437819|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19437820|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
19717690|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19717691|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
19437821|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437822|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437823|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
19437824|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19437825|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252863|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252864|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19437826|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437827|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437828|NCT03480789|Analgesics|analgesics|mesh-ancestor
19437829|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
19437830|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437831|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19860218|NCT00787332|Argatroban|argatroban|mesh-list
19860219|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
19437832|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19437833|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19437834|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
19437835|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437836|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437837|NCT03480646|Prednisone|prednisone|mesh-list
19437838|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
19437839|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437840|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
19437841|NCT03480646|Hormones|hormones|mesh-ancestor
19437842|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437843|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437844|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19437845|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437846|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437847|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437848|NCT03480607|Dexamethasone|dexamethasone|mesh-list
19437849|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
19437850|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437851|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
19437852|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
19437853|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437854|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437855|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437856|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
19437857|NCT03480607|Hormones|hormones|mesh-ancestor
19437858|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437859|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19437860|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437861|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19437862|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437863|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437864|NCT03480607|Analgesics|analgesics|mesh-ancestor
19437865|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
19437866|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19437867|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19437868|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19437869|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
19437870|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437871|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437872|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19437873|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
19437874|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437875|NCT03480516|Fluorides|fluorides|mesh-list
19437876|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
19437877|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
19437878|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
19437879|NCT03480516|Protective Agents|protective agents|mesh-ancestor
19437880|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437881|NCT03480438|Blinatumomab|blinatumomab|mesh-list
19437882|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717692|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717693|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717694|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717695|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19717696|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19717697|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
19717698|NCT04734418|Remifentanil|remifentanil|mesh-list
19717699|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19717700|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717701|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717702|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19717703|NCT04734418|Analgesics|analgesics|mesh-ancestor
19717704|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
19717705|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717706|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19717707|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19717708|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19717709|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
19717710|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717711|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717712|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19717713|NCT04734418|Narcotics|narcotics|mesh-ancestor
19717714|NCT04734405|Fluconazole|fluconazole|mesh-list
19717715|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
19717716|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717717|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19717718|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19717719|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717720|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717721|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19717722|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
19734261|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19437883|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
19860220|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19860221|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
19437884|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
19437885|NCT03480360|Fludarabine|fludarabine|mesh-list
19437886|NCT03480360|Tacrolimus|tacrolimus|mesh-list
19437887|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19437888|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
19437889|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437890|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19437891|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19437892|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
19437893|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437894|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437895|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19437896|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19437897|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437898|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19437899|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19860222|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860223|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860224|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
19860225|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19860226|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19860227|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19860228|NCT00787527|Prednisone|prednisone|mesh-list
19860229|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
19860230|NCT00787527|Doxorubicin|doxorubicin|mesh-list
19860231|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19860232|NCT00787527|Vincristine|vincristine|mesh-list
19860233|NCT00787527|Vorinostat|vorinostat|mesh-list
19860234|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860235|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
19860236|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860237|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860238|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860239|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
19860240|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860241|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860242|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860243|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19860244|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19860245|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19860246|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437900|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
19437901|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19437902|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860247|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860248|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
19860249|NCT00787527|Hormones|hormones|mesh-ancestor
19860250|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860251|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19860252|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19860253|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
19860254|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
19860255|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
19860256|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20533519|NCT01808586|Dexamethasone|dexamethasone|mesh-list
19437903|NCT03480334|Nivolumab|nivolumab|mesh-list
19437904|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19437905|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437906|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19437907|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437908|NCT03480321|Cilostazol|cilostazol|mesh-list
19437909|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19437910|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
19437911|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437912|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437913|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19437914|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
19437915|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19860257|NCT00787566|Granisetron|granisetron|mesh-list
19860258|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
19437916|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19437917|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437918|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19437919|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
19437920|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19437921|NCT03480321|Protective Agents|protective agents|mesh-ancestor
19437922|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19437923|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19437924|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437925|NCT03480308|Dexamethasone|dexamethasone|mesh-list
19437926|NCT03480308|Fentanyl|fentanyl|mesh-list
19437927|NCT03480308|Bupivacaine|bupivacaine|mesh-list
19437928|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437929|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
19437930|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
19437931|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437932|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437933|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19437934|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
19437935|NCT03480308|Hormones|hormones|mesh-ancestor
19437936|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19437937|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19437938|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19437939|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437940|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
19437941|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437942|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
19437943|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19437944|NCT03480308|Narcotics|narcotics|mesh-ancestor
19437945|NCT03480308|Analgesics|analgesics|mesh-ancestor
19437946|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19437947|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19437948|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
19437949|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
19437950|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19437951|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
19437952|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717723|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19717724|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717725|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19717726|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19717727|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19717728|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717729|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717730|NCT04734353|Ticagrelor|ticagrelor|mesh-list
19717731|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19717732|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19717733|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19717734|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19717735|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19717736|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
19717737|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717738|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717739|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860259|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
20533520|NCT01808586|Betamethasone|betamethasone|mesh-list
20533521|NCT01808586|Lidocaine|lidocaine|mesh-list
20533522|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20533523|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
20533524|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
20533525|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533526|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533527|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533528|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
20533529|NCT01808586|Hormones|hormones|mesh-ancestor
20533530|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533531|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20533532|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533533|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437953|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
19437954|NCT03480295|Protective Agents|protective agents|mesh-ancestor
19437955|NCT03480191|Daptomycin|daptomycin|mesh-list
19437956|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19717740|NCT04734119|Anesthetics|anesthetics|mesh-list
19717741|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252865|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20252866|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252867|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20252868|NCT00456833|Everolimus|everolimus|mesh-list
20252869|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252870|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20252871|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252872|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252873|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533534|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
20533535|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533536|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
19437957|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19437958|NCT03480165|Parecoxib|parecoxib|mesh-list
19437959|NCT03480165|Ropivacaine|ropivacaine|mesh-list
19437960|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437961|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
19437962|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437963|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437964|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
20533537|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20533538|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20533539|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20533540|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533541|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437965|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437966|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19437967|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19437968|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19437969|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437970|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19437971|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437972|NCT03480165|Analgesics|analgesics|mesh-ancestor
19437973|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19437974|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19437975|NCT03480100|Xylometazoline|xylometazoline|mesh-list
19437976|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
19437977|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19437978|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
19437979|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
19437980|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19437981|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437982|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437983|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19437984|NCT03480061|Analgesics|analgesics|mesh-ancestor
19437985|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
19437986|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19437987|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19437988|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19437989|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19717742|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717743|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19717744|NCT04733781|Lidocaine|lidocaine|mesh-list
19717745|NCT04733781|Epinephrine|epinephrine|mesh-list
19717746|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
19717747|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
19717748|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717749|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717750|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
19717751|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717752|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19717753|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19860260|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860261|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860262|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860263|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19860264|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
19860265|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860266|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717754|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19437990|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
19437991|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19437992|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19437993|NCT03479996|Bupivacaine|bupivacaine|mesh-list
19437994|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
19437995|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
19717755|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19717756|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717757|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19437996|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19437997|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19437998|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
19437999|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438000|NCT03479918|Prednisone|prednisone|mesh-list
19438001|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
19438002|NCT03479918|Doxorubicin|doxorubicin|mesh-list
19438003|NCT03479918|Etoposide|etoposide|mesh-list
19438004|NCT03479918|Vincristine|vincristine|mesh-list
19438005|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19438006|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
19438007|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438008|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438009|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19438010|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
19438011|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438012|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438013|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19438014|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19438015|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19438016|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19438017|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438018|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19438019|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19717758|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19717759|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
19717760|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717761|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19717762|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19717763|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
19717764|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19717765|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
19717766|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
19717767|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
19717768|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19717769|NCT04733625|Vitamin D|vitamin d|mesh-list
19717770|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
19717771|NCT04733625|Vitamins|vitamins|mesh-ancestor
19717772|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
19717773|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717774|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19717775|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19717776|NCT04733326|Ketorolac|ketorolac|mesh-list
19717777|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19717778|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19717779|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19717780|NCT04733326|Analgesics|analgesics|mesh-ancestor
19717781|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
19717782|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252874|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
20252875|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252876|NCT00456872|Lidocaine|lidocaine|mesh-list
20252877|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
19438020|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
19438021|NCT03479918|Hormones|hormones|mesh-ancestor
19717783|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717784|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438022|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438023|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19438024|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
19438025|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
19438026|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
19438027|NCT03479879|Misoprostol|misoprostol|mesh-list
19438028|NCT03479879|Estradiol|estradiol|mesh-list
19438029|NCT03479879|Estrogens|estrogens|mesh-ancestor
19438030|NCT03479879|Hormones|hormones|mesh-ancestor
19438031|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438032|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438033|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19438034|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19438035|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
19438036|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19438037|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438038|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
19438039|NCT03479762|Liraglutide|liraglutide|mesh-list
19438040|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19438041|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438042|NCT03479762|Incretins|incretins|mesh-ancestor
19438043|NCT03479762|Hormones|hormones|mesh-ancestor
19438044|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438045|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19438046|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
19438047|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19438048|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438049|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
19438050|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19438051|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438052|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438053|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19438054|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
19438055|NCT03479411|Itraconazole|itraconazole|mesh-list
19438056|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19717785|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717786|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19717787|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717788|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717789|NCT04733963|Bevacizumab|bevacizumab|mesh-list
19717790|NCT04733963|Capecitabine|capecitabine|mesh-list
19717791|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20252878|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
19438057|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
19438058|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252879|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252880|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252881|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
20252882|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252883|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20252884|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20252885|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19438059|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19438060|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19438061|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438062|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438063|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19438064|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
19438065|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438066|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438067|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19438068|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19438069|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19438070|NCT03479320|Lidocaine|lidocaine|mesh-list
19438071|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
19438072|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
19438073|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438074|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438075|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
19717792|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717793|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19717794|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717795|NCT04733963|Growth Substances|growth substances|mesh-ancestor
19717796|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717797|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
19438076|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438077|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19438078|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19438079|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19438080|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19438081|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451792|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19451793|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19451794|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19451795|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19451796|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19451797|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19451798|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19451799|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19451800|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19451801|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19451802|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19451803|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
19451804|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451805|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451806|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451807|NCT03418727|Laxatives|laxatives|mesh-ancestor
19451808|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452800|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452801|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452802|NCT03410212|Ketorolac|ketorolac|mesh-list
19452803|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19452804|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19452805|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452806|NCT03410212|Analgesics|analgesics|mesh-ancestor
19452807|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
19452808|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452809|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452810|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452811|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452812|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19452813|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452911|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19717798|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19717799|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
19717800|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717801|NCT04733521|Cisplatin|cisplatin|mesh-list
19717802|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717803|NCT04733508|Exenatide|exenatide|mesh-list
19717804|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19717805|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717806|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19717807|NCT04733508|Incretins|incretins|mesh-ancestor
19717808|NCT04733508|Hormones|hormones|mesh-ancestor
19717809|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734262|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19734263|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19734264|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19734265|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
19734266|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734267|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734268|NCT04552431|Urological Agents|urological agents|mesh-ancestor
19734269|NCT04552093|Floxuridine|floxuridine|mesh-list
19734270|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734271|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
19734272|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734273|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734274|NCT04551924|Ropivacaine|ropivacaine|mesh-list
19734275|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
19734276|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
19734277|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734278|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734279|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
20533542|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19734280|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734281|NCT04552067|Enoxaparin|enoxaparin|mesh-list
19860267|NCT00787605|Amlodipine|amlodipine|mesh-list
19860268|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19860269|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19860270|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19860271|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860272|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860273|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20252886|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533543|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
20533544|NCT01808599|Rituximab|rituximab|mesh-list
20533545|NCT01808599|Chlorambucil|chlorambucil|mesh-list
20533546|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533547|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533548|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
20533549|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533550|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533551|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20533552|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
20533553|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533554|NCT01808638|Gemcitabine|gemcitabine|mesh-list
19734282|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
19717810|NCT04733235|Progesterone|progesterone|mesh-list
19717811|NCT04733235|Hormones|hormones|mesh-ancestor
19717812|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19717813|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717814|NCT04733235|Progestins|progestins|mesh-ancestor
19717815|NCT04733131|Abatacept|abatacept|mesh-list
19717816|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19717817|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717818|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717819|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19717820|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
19717821|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717822|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19717823|NCT04733066|Teduglutide|teduglutide|mesh-list
19717824|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19717825|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19860274|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860275|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
19860276|NCT00787605|Diuretics|diuretics|mesh-ancestor
19860277|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
19860278|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20252887|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252888|NCT00456898|Codeine|codeine|mesh-list
20252889|NCT00456898|Paroxetine|paroxetine|mesh-list
20252890|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19438082|NCT03479086|Topiramate|topiramate|mesh-list
19717826|NCT04733066|Protective Agents|protective agents|mesh-ancestor
20252891|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20252892|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20252893|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252894|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252895|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252896|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
20252897|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252898|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20252899|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
20252900|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252901|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19717827|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717828|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
19717829|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717830|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
19860279|NCT00787644|Pioglitazone|pioglitazone|mesh-list
19860280|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19860281|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860282|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
19860283|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19860284|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19860285|NCT00787722|Prednisolone|prednisolone|mesh-list
19860286|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
19860287|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
19860288|NCT00787722|Rituximab|rituximab|mesh-list
19860289|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
19860290|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19860291|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19860292|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
19860293|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860294|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
19860295|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860296|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860297|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860298|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
19860299|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860300|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860301|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860302|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19860303|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860304|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
19860305|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
19860306|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860307|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860308|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
19438083|NCT03479086|Naltrexone|naltrexone|mesh-list
19717831|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
19717832|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
19717833|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
19717834|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19717835|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19717836|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19717837|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717838|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
19717839|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
19717840|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
19717841|NCT04732390|Bupivacaine|bupivacaine|mesh-list
19717842|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
19717843|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
19717844|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717845|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717846|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
19860309|NCT00787722|Hormones|hormones|mesh-ancestor
19860310|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860311|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19860312|NCT00787722|Protective Agents|protective agents|mesh-ancestor
19860313|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19860314|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
19860315|NCT00787761|Busulfan|busulfan|mesh-list
19860316|NCT00787761|Methotrexate|methotrexate|mesh-list
19860317|NCT00787761|Fludarabine|fludarabine|mesh-list
19860318|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
19860319|NCT00787761|Tacrolimus|tacrolimus|mesh-list
19860320|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
20252902|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20252903|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252904|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20252905|NCT00456898|Narcotics|narcotics|mesh-ancestor
20252906|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438084|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19438085|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19438086|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438087|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
19438088|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438089|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
19438090|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19438091|NCT03478709|Norepinephrine|norepinephrine|mesh-list
19438092|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19438093|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19438094|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
19438095|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438096|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438097|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438098|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
19438099|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
19438100|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438101|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19438102|NCT03478605|Dexamethasone|dexamethasone|mesh-list
19438103|NCT03478605|Ondansetron|ondansetron|mesh-list
19438104|NCT03478605|Olanzapine|olanzapine|mesh-list
19438105|NCT03478605|Aprepitant|aprepitant|mesh-list
19438106|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438107|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
19438108|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
19438109|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438110|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438111|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19717847|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717848|NCT04732390|Analgesics|analgesics|mesh-ancestor
19717849|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19717850|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
19717851|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19717852|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19717853|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717854|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19717855|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
19717856|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19860321|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19860322|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860323|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
20252907|NCT00456898|Analgesics|analgesics|mesh-ancestor
19438112|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
19438113|NCT03478605|Hormones|hormones|mesh-ancestor
19451809|NCT03418610|Azelaic acid|azelaic acid|mesh-list
19717857|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
19717858|NCT04732377|Bupivacaine|bupivacaine|mesh-list
19717859|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
19717860|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
19717861|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717862|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717863|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
19717864|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717865|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19717866|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19717867|NCT04732377|Analgesics|analgesics|mesh-ancestor
19717868|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19717869|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19717870|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19717871|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
19717872|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717873|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717874|NCT04732455|Lidocaine|lidocaine|mesh-list
19717875|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19717876|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
19717877|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
19717878|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717879|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717880|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
19717881|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717882|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19717883|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19717884|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19717885|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19717886|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717887|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19717888|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19717889|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717890|NCT04732455|Analgesics|analgesics|mesh-ancestor
19717891|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
19717892|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19717893|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
19717894|NCT04732364|Bupivacaine|bupivacaine|mesh-list
19717895|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
19717896|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
19717897|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717898|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717899|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
19717900|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717901|NCT04732598|Paclitaxel|paclitaxel|mesh-list
19717902|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19717903|NCT04732598|Bevacizumab|bevacizumab|mesh-list
19717904|NCT04732598|Atezolizumab|atezolizumab|mesh-list
19717905|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19717906|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717907|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
19717908|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
19717909|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
19717910|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717911|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19717912|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19717913|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19717914|NCT04732598|Growth Substances|growth substances|mesh-ancestor
19717915|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717916|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
19717917|NCT04732507|Lidocaine|lidocaine|mesh-list
19717918|NCT04732507|Bupivacaine|bupivacaine|mesh-list
19717919|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
19717920|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
19717921|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717922|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717923|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
19717924|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717925|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19717926|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19717927|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19717928|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19717929|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717930|NCT04732247|Oxytocin|oxytocin|mesh-list
19717931|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
19717932|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19717933|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717934|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19717935|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19717936|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19717937|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717938|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717939|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19717940|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19717941|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717942|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
19717943|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19717944|NCT04732104|Lidocaine|lidocaine|mesh-list
19717945|NCT04732104|Xylometazoline|xylometazoline|mesh-list
19717946|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
19717947|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
19860324|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860325|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860326|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860327|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
19860328|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860329|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252908|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
19717948|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
19717949|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19717950|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717951|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
19717952|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19717953|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19717954|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19717955|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19717956|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19717957|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717958|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19717959|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
19717960|NCT04731727|Riboflavin|riboflavin|mesh-list
20252909|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252910|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
20252911|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
20252912|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20252913|NCT00456937|Citalopram|citalopram|mesh-list
20252914|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20252915|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19717961|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
20252916|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252917|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252918|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20252919|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
19717962|NCT04731727|Vitamins|vitamins|mesh-ancestor
19717963|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
19717964|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717965|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19717966|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
19717967|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
19717968|NCT04731740|Lenvatinib|lenvatinib|mesh-list
19860330|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860331|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19860332|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
19860333|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19860334|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19860335|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
19860336|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
19860337|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860338|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19860339|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19860340|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19860341|NCT00787787|Capecitabine|capecitabine|mesh-list
19860342|NCT00787787|Sunitinib|sunitinib|mesh-list
19860343|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19860344|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
19860345|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860346|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860347|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19860348|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19860349|NCT00787787|Growth Substances|growth substances|mesh-ancestor
19860350|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860351|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
19860352|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19860353|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860354|NCT00787852|Paclitaxel|paclitaxel|mesh-list
19860355|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19860356|NCT00787852|Dasatinib|dasatinib|mesh-list
19860357|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19860358|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860359|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
19860360|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
19860361|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
19860362|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860363|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19860364|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860365|NCT00787891|Rabeprazole|rabeprazole|mesh-list
19860366|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19860367|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860368|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19860369|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860370|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860371|NCT00787930|Valproic Acid|valproic acid|mesh-list
19860372|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
19860373|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860374|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860375|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
19860376|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860377|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860378|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
19860379|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860380|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860381|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860382|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19860383|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
19860384|NCT00788008|Propofol|propofol|mesh-list
19860385|NCT00788008|Isoflurane|isoflurane|mesh-list
19860386|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
19860387|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860388|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717969|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19860389|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19860390|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19717970|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717971|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19717972|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19717973|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19717974|NCT04731948|Vitamins|vitamins|mesh-list
19717975|NCT04731948|Folic Acid|folic acid|mesh-list
19717976|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
19717977|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
19717978|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
19717979|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
19717980|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717981|NCT04731948|Hematinics|hematinics|mesh-ancestor
19717982|NCT04731909|Cisplatin|cisplatin|mesh-list
19717983|NCT04731909|Carboplatin|carboplatin|mesh-list
19717984|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19717985|NCT04731766|Listerine|listerine|mesh-list
19717986|NCT04731766|Fluorides|fluorides|mesh-list
19717987|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
19717988|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
19717989|NCT04731766|Protective Agents|protective agents|mesh-ancestor
19717990|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19717991|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19717992|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19717993|NCT04731558|Enoxaparin|enoxaparin|mesh-list
19717994|NCT04731558|Dalteparin|dalteparin|mesh-list
19717995|NCT04731558|Tinzaparin|tinzaparin|mesh-list
19717996|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19717997|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
19717998|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19717999|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19718000|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718001|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
19718002|NCT04731376|Testosterone|testosterone|mesh-list
19718003|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
19718004|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
19718005|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19718006|NCT04731376|Androgens|androgens|mesh-ancestor
19718007|NCT04731376|Hormones|hormones|mesh-ancestor
19718008|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718009|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718010|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19718011|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718012|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
19718013|NCT04731116|Cannabidiol|cannabidiol|mesh-list
19860391|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
19860392|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19969651|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19969652|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969653|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969654|NCT01774786|Fluorouracil|fluorouracil|mesh-list
19969655|NCT01774786|Capecitabine|capecitabine|mesh-list
19969656|NCT01774786|Trastuzumab|trastuzumab|mesh-list
19969657|NCT01774786|Pertuzumab|pertuzumab|mesh-list
19969658|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969659|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
19969660|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718014|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
19718015|NCT04731038|Paclitaxel|paclitaxel|mesh-list
19718016|NCT04731038|Carboplatin|carboplatin|mesh-list
19718017|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19718018|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718019|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
19718020|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
19718021|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
19718022|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718023|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19718024|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
19718025|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19718026|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718027|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
19718028|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19718029|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718030|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718031|NCT04730973|Evolocumab|evolocumab|mesh-list
19718032|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19718033|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19718034|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
19718035|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718036|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19734283|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19734284|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19734285|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734286|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
19734287|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
19734288|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
19734289|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734290|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734291|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
19734292|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734293|NCT04551755|Doxycycline|doxycycline|mesh-list
19860393|NCT00788255|Oxytocin|oxytocin|mesh-list
19860394|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
19860395|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19860396|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860397|NCT00788372|Fentanyl|fentanyl|mesh-list
19734294|NCT04551755|Ivermectin|ivermectin|mesh-list
19734295|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734296|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734297|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
19734298|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19734299|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19734300|NCT04551703|Epinephrine|epinephrine|mesh-list
19734301|NCT04551703|Racepinephrine|racepinephrine|mesh-list
19734302|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
19860398|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19860399|NCT00788372|Narcotics|narcotics|mesh-ancestor
19860400|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734303|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19860401|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860402|NCT00788372|Analgesics|analgesics|mesh-ancestor
19860403|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
19860404|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860405|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19860406|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19860407|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
19860408|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
19860409|NCT00788593|Pancreatin|pancreatin|mesh-list
19860410|NCT00788593|Pancrelipase|pancrelipase|mesh-list
19860411|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860412|NCT00788892|Cytarabine|cytarabine|mesh-list
19860413|NCT00788892|Daunorubicin|daunorubicin|mesh-list
19860414|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19860415|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
19860416|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860417|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860418|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
19860419|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860420|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533555|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20533556|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
20533557|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533558|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533559|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
20533560|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533561|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718037|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19718038|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718039|NCT04730895|Tretinoin|tretinoin|mesh-list
19718040|NCT04730895|Isotretinoin|isotretinoin|mesh-list
19718041|NCT04730895|Vaccines|vaccines|mesh-list
19718042|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
19718043|NCT04730895|Paraproteins|paraproteins|mesh-list
19718044|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
19718045|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718046|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718047|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
19718048|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718049|NCT04730999|Bevacizumab|bevacizumab|mesh-list
19718050|NCT04730999|Carboplatin|carboplatin|mesh-list
19718051|NCT04730999|Etoposide|etoposide|mesh-list
19718052|NCT04730999|Atezolizumab|atezolizumab|mesh-list
19718053|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19718054|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718055|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19718056|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19718057|NCT04730999|Growth Substances|growth substances|mesh-ancestor
19718058|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718059|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
19718060|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19718061|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19718062|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19718063|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718064|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718065|NCT04730622|Mitogens|mitogens|mesh-list
19718066|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
19718067|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718068|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
19718069|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718070|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718071|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718072|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718073|NCT04730609|Analgesics|analgesics|mesh-ancestor
19718074|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
19718075|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718076|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19718077|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19718078|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19718079|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19718080|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718081|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718082|NCT04730544|Nivolumab|nivolumab|mesh-list
19718083|NCT04730544|Ipilimumab|ipilimumab|mesh-list
19718084|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19718085|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718086|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19718087|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718088|NCT04730531|Epinephrine|epinephrine|mesh-list
19718089|NCT04730531|Bupivacaine|bupivacaine|mesh-list
19718090|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
19718091|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
19718092|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718093|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718094|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
19718095|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718096|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19718097|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19718098|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
19718099|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718100|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718101|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19718102|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19718103|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
19718104|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19718105|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
19718106|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
19860421|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
19860422|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718107|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
19718108|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19860423|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19438114|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438115|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19438116|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438117|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
19438118|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
19438119|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19438120|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
19438121|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438122|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438123|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19438124|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19438125|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438126|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19438127|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19438128|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19438129|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19438130|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19438131|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19438132|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19438133|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
19438134|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438135|NCT03478514|Palbociclib|palbociclib|mesh-list
19438136|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438137|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19438138|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438139|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438140|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
19438141|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19438142|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438143|NCT03478475|Vitamins|vitamins|mesh-ancestor
19438144|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
19438145|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19438146|NCT03478436|Doxycycline|doxycycline|mesh-list
19438147|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19438148|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438149|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
19438150|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19438151|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19438152|NCT03478423|Oxycodone|oxycodone|mesh-list
19438153|NCT03478423|Hydromorphone|hydromorphone|mesh-list
19438154|NCT03478423|Codeine|codeine|mesh-list
19438155|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19438156|NCT03478423|Narcotics|narcotics|mesh-ancestor
19438157|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438158|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438159|NCT03478423|Analgesics|analgesics|mesh-ancestor
19438160|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
19438161|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438162|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
19438163|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
19438164|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19438165|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19438166|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
19438167|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
19718109|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
19718110|NCT04730596|Ketamine|ketamine|mesh-list
19718111|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718112|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718113|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718114|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718115|NCT04730596|Analgesics|analgesics|mesh-ancestor
19438168|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
19718116|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
19718117|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718118|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19718119|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19718120|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19718121|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
19718122|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718123|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718124|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19718125|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19718126|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
19718127|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
19718128|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19718129|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19718130|NCT04730674|Tetracycline|tetracycline|mesh-list
19718131|NCT04730674|Lidocaine|lidocaine|mesh-list
19718132|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
19718133|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
19718134|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718135|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718136|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
19718137|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718138|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19718139|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19718140|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19718141|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19718142|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718143|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19718144|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718145|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19718146|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718147|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
19718148|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19718149|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718150|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
19718151|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718152|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718153|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860424|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19860425|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19860426|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860427|NCT00788957|Panitumumab|panitumumab|mesh-list
19860428|NCT00788957|Rilotumumab|rilotumumab|mesh-list
19860429|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19860430|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860431|NCT00789035|Metformin|metformin|mesh-list
19860432|NCT00789035|Empagliflozin|empagliflozin|mesh-list
19860433|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19860434|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860435|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19860436|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860437|NCT00789074|Varenicline|varenicline|mesh-list
19860438|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19860439|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19860440|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
19860441|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860442|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860443|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860444|NCT00789113|Lamotrigine|lamotrigine|mesh-list
19860445|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
19860446|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19860447|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860448|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718154|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718155|NCT04730375|Analgesics|analgesics|mesh-ancestor
19718156|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
19718157|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718158|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19718159|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19718160|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19860449|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19860450|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533562|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533563|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
20533564|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252920|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252921|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20533565|NCT01808768|Alcaftadine|alcaftadine|mesh-list
20533566|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20533567|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
20533568|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
20533569|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533570|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533571|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718161|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
19718162|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718163|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718164|NCT04730245|Rifaximin|rifaximin|mesh-list
19718165|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19860451|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19860452|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860453|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860454|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860455|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19860456|NCT00789191|Metformin|metformin|mesh-list
19860457|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19860458|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
19860459|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19860460|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860461|NCT00789191|Incretins|incretins|mesh-ancestor
19860462|NCT00789191|Hormones|hormones|mesh-ancestor
19860463|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860464|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19860465|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
19860466|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860467|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860468|NCT00789256|Bortezomib|bortezomib|mesh-list
19860469|NCT00789256|Melphalan|melphalan|mesh-list
19860470|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860471|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860472|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
19860473|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860474|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860475|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860476|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
19860477|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860478|NCT00789321|Amlodipine|amlodipine|mesh-list
19860479|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19860480|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19860481|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860482|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533572|NCT01808898|Bupivacaine|bupivacaine|mesh-list
19718166|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718167|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718168|NCT04730219|Paclitaxel|paclitaxel|mesh-list
19718169|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19718170|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718171|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
19718172|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
19718173|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
19718174|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718175|NCT04730297|Acetaminophen|acetaminophen|mesh-list
19718176|NCT04730297|Ibuprofen|ibuprofen|mesh-list
19718177|NCT04730297|Codeine|codeine|mesh-list
19718178|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860483|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19860484|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860485|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
19860486|NCT00789360|Loxapine|loxapine|mesh-list
19860487|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19860488|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860489|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860490|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860491|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860492|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19860493|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
19860494|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860495|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860496|NCT00789373|Pemetrexed|pemetrexed|mesh-list
19860497|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860498|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860499|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860500|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19860501|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19860502|NCT00789477|Aflibercept|aflibercept|mesh-list
19860503|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19860504|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19860505|NCT00789477|Growth Substances|growth substances|mesh-ancestor
19860506|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860507|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
19860508|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860509|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19860510|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860511|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19860512|NCT00789555|Analgesics|analgesics|mesh-ancestor
19860513|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
19860514|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860515|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860516|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860517|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860518|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19860519|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19860520|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19860521|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
19860522|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
19860523|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860524|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860525|NCT00789581|Paclitaxel|paclitaxel|mesh-list
19860526|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
19860527|NCT00789581|Doxorubicin|doxorubicin|mesh-list
19860528|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19860529|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19860530|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860531|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
19860532|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
19860533|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
19860534|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860535|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860536|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
19860537|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860538|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860539|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860540|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
19718179|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718180|NCT04730297|Analgesics|analgesics|mesh-ancestor
19718181|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
19718182|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718183|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718184|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19718185|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19718186|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19718187|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718188|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718189|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
19718190|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19718191|NCT04730297|Narcotics|narcotics|mesh-ancestor
19718192|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718193|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
19718194|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
19718195|NCT04730258|Azacitidine|azacitidine|mesh-list
19438169|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438170|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19438171|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
19438172|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438173|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
19438174|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
19438175|NCT03478306|Melatonin|melatonin|mesh-list
19438176|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
19438177|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438178|NCT03478306|Protective Agents|protective agents|mesh-ancestor
19438179|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438180|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438181|NCT03478280|Brodalumab|brodalumab|mesh-list
19438182|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718196|NCT04730258|Decitabine|decitabine|mesh-list
19718197|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19718198|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
19718199|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860541|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860542|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19860543|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19860544|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19860545|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860546|NCT00789672|Levodopa|levodopa|mesh-list
19860547|NCT00789672|Carbidopa|carbidopa|mesh-list
19860548|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19860549|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19860550|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
19860551|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438183|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
19438184|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
19438185|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
19438186|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19718200|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718201|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718202|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
19718203|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19718204|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
19718205|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19718206|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
19718207|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718208|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718209|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
19718210|NCT04729556|Chitosan|chitosan|mesh-list
19718211|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19718212|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19718213|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
19718214|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718215|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19718216|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
19718217|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
19718218|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
19718219|NCT04729556|Coagulants|coagulants|mesh-ancestor
19860552|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718220|NCT04729543|Azacitidine|azacitidine|mesh-list
19718221|NCT04729543|Interleukin-2|interleukin-2|mesh-list
19718222|NCT04729543|Valproic Acid|valproic acid|mesh-list
19860553|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718223|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19718224|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
19718225|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718226|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718227|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718228|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718229|NCT04729543|Analgesics|analgesics|mesh-ancestor
19718230|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
19718231|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718232|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718233|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
19718234|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
19718235|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718236|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
19718237|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19718238|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718239|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19718240|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
19718241|NCT04729868|Bupivacaine|bupivacaine|mesh-list
19718242|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
19718243|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
19718244|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
19718245|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718246|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718247|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
19718248|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718249|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718250|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718251|NCT04729868|Analgesics|analgesics|mesh-ancestor
19718252|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19718253|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19718254|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19860554|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19860555|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860556|NCT00789685|Interferons|interferons|mesh-list
19860557|NCT00789685|Interferon-beta|interferon-beta|mesh-list
19860558|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860559|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
19860560|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860561|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
19860562|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860563|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19860564|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20533573|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
20533574|NCT01808898|Mepivacaine|mepivacaine|mesh-list
20533575|NCT01808898|Anesthetics|anesthetics|mesh-list
19718255|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
20533576|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533577|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533578|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
20533579|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533580|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
20533581|NCT01808911|Rituximab|rituximab|mesh-list
19718256|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860565|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
19860566|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860567|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19860568|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533582|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252922|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
20252923|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252924|NCT00456963|Losartan|losartan|mesh-list
20252925|NCT00456963|Enalapril|enalapril|mesh-list
20252926|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20252927|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20252928|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20252929|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20252930|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252931|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20252932|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
19438187|NCT03478150|Protective Agents|protective agents|mesh-ancestor
19718257|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860569|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860570|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860571|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19860572|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19860573|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19860574|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
19860575|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860576|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860577|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19860578|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19860579|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
19860580|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19860581|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19860582|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
20252933|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718258|NCT04729465|Propofol|propofol|mesh-list
19718259|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718260|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718261|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718262|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19718263|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
19718264|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
19718265|NCT04729491|Azithromycin|azithromycin|mesh-list
19718266|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
19718267|NCT04729491|Dutasteride|dutasteride|mesh-list
19718268|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19718269|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718270|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19718271|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19718272|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718273|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718274|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718275|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718276|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718277|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19718278|NCT04729322|Metronidazole|metronidazole|mesh-list
19718279|NCT04729322|Vancomycin|vancomycin|mesh-list
19718280|NCT04729322|Neomycin|neomycin|mesh-list
19718281|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
19718282|NCT04729322|Nivolumab|nivolumab|mesh-list
19718283|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19718284|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718285|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19718286|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718287|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718288|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19718289|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19718290|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19718291|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19718292|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718293|NCT04729179|Cannabidiol|cannabidiol|mesh-list
19718294|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
19718295|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
19718296|NCT04729348|Lenvatinib|lenvatinib|mesh-list
19718297|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19718298|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718299|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19718300|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718301|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718302|NCT04729101|Lansoprazole|lansoprazole|mesh-list
19718303|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
19718304|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19718305|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718306|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19718307|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718308|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718309|NCT04728932|Simendan|simendan|mesh-list
19718310|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19718311|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
19718312|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19718313|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19718314|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718315|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718316|NCT04728932|Protective Agents|protective agents|mesh-ancestor
19718317|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718318|NCT04728880|Remdesivir|remdesivir|mesh-list
19718319|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
19718320|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860583|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19860584|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860585|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19860586|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19860587|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19860588|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
19860589|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860590|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19860591|NCT00789750|Pioglitazone|pioglitazone|mesh-list
19860592|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19860593|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19860594|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860595|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19860596|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19860597|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
19860598|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718321|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
19718322|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718323|NCT04728971|Caspofungin|caspofungin|mesh-list
19718324|NCT04728971|Micafungin|micafungin|mesh-list
19718325|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
19718326|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718327|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718328|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718329|NCT04728750|Pancrelipase|pancrelipase|mesh-list
19718330|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718331|NCT04728516|Amoxicillin|amoxicillin|mesh-list
19718332|NCT04728516|Pantoprazole|pantoprazole|mesh-list
19718333|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19718334|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718335|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19718336|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718337|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19718338|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718339|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718340|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19718341|NCT04728581|Mirtazapine|mirtazapine|mesh-list
19718342|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
19718343|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19718344|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19860599|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19860600|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
19860601|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
19860602|NCT00789776|Fludarabine|fludarabine|mesh-list
19718345|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860603|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
19860604|NCT00789776|Tacrolimus|tacrolimus|mesh-list
19860605|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860606|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
19860607|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860608|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860609|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19718346|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718347|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718348|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19718349|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
19718350|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
19718351|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718352|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718353|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19860610|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
19860611|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860612|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860613|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860614|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19860615|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
19860616|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19860617|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860618|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19860619|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19860620|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
19860621|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19860622|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860623|NCT00789802|Naproxen|naproxen|mesh-list
19860624|NCT00789802|Estradiol|estradiol|mesh-list
19860625|NCT00789802|Estrogens|estrogens|mesh-ancestor
19860626|NCT00789802|Hormones|hormones|mesh-ancestor
19860627|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860628|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860629|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860630|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19860631|NCT00789802|Analgesics|analgesics|mesh-ancestor
19860632|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
19860633|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860634|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860635|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860636|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
19860637|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19860638|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860639|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860640|NCT00789815|Midazolam|midazolam|mesh-list
19860641|NCT00789815|Propofol|propofol|mesh-list
19860642|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19860643|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860644|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860645|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19860646|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
19860647|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
19860648|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19860649|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19860650|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860651|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860652|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
19860653|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
19860654|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860655|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860656|NCT00789828|Everolimus|everolimus|mesh-list
19860657|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860658|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860659|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
19860660|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860661|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19860662|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
19860663|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19860664|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
19438188|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438189|NCT03478111|Methotrexate|methotrexate|mesh-list
19438190|NCT03478111|Infliximab|infliximab|mesh-list
19438191|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19438192|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
19438193|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19438194|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438195|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19438196|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
19438197|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438198|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438199|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
19438200|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438201|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19438202|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19438203|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
19438204|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438205|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19438206|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438207|NCT03478033|Rifampin|rifampin|mesh-list
19438208|NCT03478033|Rifabutin|rifabutin|mesh-list
19438209|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19438210|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
19438211|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19438212|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438213|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
19438214|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19438215|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438216|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438217|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19438218|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19438219|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19438220|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19438221|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19438222|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19438223|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
19438224|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
19438225|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19438226|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19438227|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438228|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19438229|NCT03477994|Clonidine|clonidine|mesh-list
19438230|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
19438231|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718354|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19718355|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19718356|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19718357|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19718358|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19718359|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19718360|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
19718361|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19718362|NCT04728659|Desogestrel|desogestrel|mesh-list
19718363|NCT04728659|Ganirelix|ganirelix|mesh-list
19718364|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19718365|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19718366|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19718367|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
19718368|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718369|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718370|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19718371|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19718372|NCT04728659|Progestins|progestins|mesh-ancestor
19718373|NCT04728659|Hormones|hormones|mesh-ancestor
19718374|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718375|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718376|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19718377|NCT04728386|Eusol|eusol|mesh-list
19718378|NCT04728386|Curcumin|curcumin|mesh-list
19718379|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19718380|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718381|NCT04728386|Analgesics|analgesics|mesh-ancestor
19718382|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
19718383|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718384|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860665|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860666|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19860667|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860668|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860669|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860670|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860671|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860672|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
19860673|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19860674|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19860675|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860676|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860677|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19860678|NCT00789880|Vitamin D|vitamin d|mesh-list
19860679|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
19860680|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
19860681|NCT00789880|Vitamins|vitamins|mesh-list
19860682|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
19860683|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860684|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19860685|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19860686|NCT00789958|Gemcitabine|gemcitabine|mesh-list
19860687|NCT00789958|Capecitabine|capecitabine|mesh-list
19860688|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19860689|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
19860690|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860691|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860692|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
19860693|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860694|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860695|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860696|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
19860697|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860698|NCT00789997|Levofloxacin|levofloxacin|mesh-list
19860699|NCT00789997|Ofloxacin|ofloxacin|mesh-list
19860700|NCT00789997|Prednisone|prednisone|mesh-list
19860701|NCT00789997|Etanercept|etanercept|mesh-list
19860702|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860703|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
20533583|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
20533584|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533585|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19718385|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19718386|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19718387|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718388|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718389|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718390|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
19718391|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718392|NCT04729088|Isosorbide|isosorbide|mesh-list
19718393|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19718394|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19718395|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19718396|NCT04729088|Diuretics|diuretics|mesh-ancestor
19718397|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
19718398|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718399|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
19718400|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19718401|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718402|NCT04729140|Doxycycline|doxycycline|mesh-list
19718403|NCT04729140|Ivermectin|ivermectin|mesh-list
19718404|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19718405|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718406|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
19718407|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19718408|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19718409|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
19718410|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19718411|NCT04728425|Antibodies|antibodies|mesh-list
19718412|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
19718413|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19718414|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
19718415|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
19718416|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718417|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19718418|NCT04728321|Lenvatinib|lenvatinib|mesh-list
19718419|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718420|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19718421|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718422|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718423|NCT04728360|Ustekinumab|ustekinumab|mesh-list
19718424|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718425|NCT04728308|Bupivacaine|bupivacaine|mesh-list
19718426|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
19718427|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
19718428|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718429|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718430|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
19718431|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718432|NCT04728230|Carboplatin|carboplatin|mesh-list
19718433|NCT04728230|Etoposide|etoposide|mesh-list
19718434|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
19718435|NCT04728230|Durvalumab|durvalumab|mesh-list
19718436|NCT04728230|Olaparib|olaparib|mesh-list
19718437|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
19718438|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
19860704|NCT00789997|Hormones|hormones|mesh-ancestor
19718439|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19718440|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
19718441|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718442|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19718443|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19860705|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860706|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438232|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438233|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438234|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718444|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19438235|NCT03477994|Analgesics|analgesics|mesh-ancestor
19718445|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860707|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19860708|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860709|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860710|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19860711|NCT00789997|Analgesics|analgesics|mesh-ancestor
19860712|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
19860713|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860714|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860715|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860716|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860717|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
19438236|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
19438237|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438238|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19438239|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19438240|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19438241|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
19438242|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438243|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438244|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19438245|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
19438246|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
19438247|NCT03477955|Silicon|silicon|mesh-list
19438248|NCT03477955|Trace Elements|trace elements|mesh-ancestor
19438249|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
19438250|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438251|NCT03477929|Cetrorelix|cetrorelix|mesh-list
19438252|NCT03477929|Ganirelix|ganirelix|mesh-list
19438253|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
19438254|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438255|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438256|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19438257|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
19438258|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19438259|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19438260|NCT03477864|Ipilimumab|ipilimumab|mesh-list
19438261|NCT03477864|Cemiplimab|cemiplimab|mesh-list
19438262|NCT03477864|Antibodies|antibodies|mesh-list
19438263|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
19438264|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19438265|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
19438266|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438267|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438268|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19718446|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718447|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19718448|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
19718449|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718450|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19718451|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
19718452|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718453|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
19718454|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
19718455|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
19718456|NCT04728035|Irinotecan|irinotecan|mesh-list
19718457|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19718458|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19718459|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718460|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438269|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438270|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
19438271|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19438272|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
19438273|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438274|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
19438275|NCT03477630|Protective Agents|protective agents|mesh-ancestor
19438276|NCT03477461|Terlipressin|terlipressin|mesh-list
19438277|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19438278|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19438279|NCT03477448|Bleomycin|bleomycin|mesh-list
19438280|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19438281|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438282|NCT03477422|Meropenem|meropenem|mesh-list
19438283|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
19438284|NCT03477422|Sulbactam|sulbactam|mesh-list
19438285|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19438286|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438287|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19438288|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438289|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451810|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451811|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
19451812|NCT03418597|Anesthetics|anesthetics|mesh-list
19451813|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451814|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451815|NCT03418558|Trastuzumab|trastuzumab|mesh-list
19451816|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19451817|NCT03418558|Maytansine|maytansine|mesh-list
19451818|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19451819|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451820|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19451821|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
19451822|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
19451823|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
19451824|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451825|NCT03418532|Osimertinib|osimertinib|mesh-list
19451826|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451827|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19451828|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451829|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451830|NCT03418506|Lobeline|lobeline|mesh-list
19451831|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19451832|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
19451833|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19451834|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451835|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19451836|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19451837|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
19451838|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19451839|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451840|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
19451841|NCT03418337|Lansoprazole|lansoprazole|mesh-list
19451842|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
19451843|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19451844|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19451845|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19451846|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451847|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451848|NCT03418246|Calcium|calcium|mesh-list
19860718|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19860719|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451849|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19718461|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718462|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19718463|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19718464|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718465|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19718466|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19718467|NCT04727671|Cetrorelix|cetrorelix|mesh-list
19718468|NCT04727671|Menotropins|menotropins|mesh-list
19718469|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
19718470|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19718471|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
19718472|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718473|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718474|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19718475|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19718476|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718477|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19718478|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
19718479|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718480|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718481|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19718482|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19718483|NCT04727684|Cetrorelix|cetrorelix|mesh-list
19718484|NCT04727684|Menotropins|menotropins|mesh-list
19718485|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
19718486|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19718487|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
19718488|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718489|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718490|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19718491|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19718492|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718493|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19718494|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
19718495|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718496|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718497|NCT04727515|Fentanyl|fentanyl|mesh-list
19718498|NCT04727515|Isoflurane|isoflurane|mesh-list
19718499|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19718500|NCT04727515|Narcotics|narcotics|mesh-ancestor
19860720|NCT00789997|Renal Agents|renal agents|mesh-ancestor
19860721|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19860722|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19860723|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19860724|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860725|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860726|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19860727|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19860728|NCT00790023|Ciclesonide|ciclesonide|mesh-list
19860729|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
19860730|NCT00790023|Hormones|hormones|mesh-ancestor
19860731|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718501|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718502|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860732|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860733|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19718503|NCT04727515|Analgesics|analgesics|mesh-ancestor
19718504|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
19860734|NCT00790036|Everolimus|everolimus|mesh-list
19860735|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860736|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860737|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
19860738|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860739|NCT00790062|Oxytocin|oxytocin|mesh-list
19860740|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
19718505|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718506|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19718507|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19860741|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718508|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
19718509|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
19718510|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19718511|NCT04727775|Remdesivir|remdesivir|mesh-list
19718512|NCT04727775|Favipiravir|favipiravir|mesh-list
19718513|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
19718514|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860742|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860743|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19860744|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19860745|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
19860746|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860747|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19860748|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860749|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860750|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860751|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19860752|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19860753|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19860754|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
19860755|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860756|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860757|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19860758|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19860759|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
19860760|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19860761|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19860762|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
19860763|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19860764|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19860765|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860766|NCT00790205|Incretins|incretins|mesh-ancestor
19860767|NCT00790205|Hormones|hormones|mesh-ancestor
19860768|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860769|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19860770|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
19860771|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860772|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860773|NCT00790270|Ibuprofen|ibuprofen|mesh-list
19860774|NCT00790270|Amitriptyline|amitriptyline|mesh-list
19860775|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
19860776|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860777|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19860778|NCT00790270|Analgesics|analgesics|mesh-ancestor
19860779|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
19860780|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860781|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860782|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860783|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860784|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19860785|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860786|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860787|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19860788|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
19860789|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860790|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19860791|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19860792|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860793|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860794|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19860795|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19860796|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19860797|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
19860798|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860799|NCT00790296|Hormones|hormones|mesh-list
19860800|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
20533586|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20533587|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
20533588|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718515|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
19718516|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718517|NCT04727853|Irinotecan|irinotecan|mesh-list
19718518|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19718519|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19718520|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718521|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718522|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718523|NCT04727437|Heparin|heparin|mesh-list
19718524|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19718525|NCT04727437|Tinzaparin|tinzaparin|mesh-list
19718526|NCT04727437|Dalteparin|dalteparin|mesh-list
19718527|NCT04727437|Warfarin|warfarin|mesh-list
19718528|NCT04727437|Anticoagulants|anticoagulants|mesh-list
19718529|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19718530|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19718531|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718532|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19718533|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
19718534|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718535|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19718536|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718537|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19718538|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19718539|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19860801|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860802|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860803|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19860804|NCT00790335|Plasminogen|plasminogen|mesh-list
19718540|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19718541|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718542|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718543|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718544|NCT04727502|Analgesics|analgesics|mesh-ancestor
19718545|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
19718546|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718547|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
19718548|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860805|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19860806|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19860807|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718549|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
19718550|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19718551|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19718552|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718553|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19718554|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19718555|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19718556|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718557|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
19718558|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718559|NCT04727034|Propofol|propofol|mesh-list
19718560|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718561|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718562|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718563|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19718564|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
19718565|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
19734304|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19734305|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
19734306|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734307|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734308|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734309|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19734310|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19734311|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
19734312|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734313|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19734314|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
19734315|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
19734316|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
19734317|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19734318|NCT04551950|Paclitaxel|paclitaxel|mesh-list
19734319|NCT04551950|Bevacizumab|bevacizumab|mesh-list
19734320|NCT04551950|Carboplatin|carboplatin|mesh-list
19734321|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19734322|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734323|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734324|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734325|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
19438290|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
19438291|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19438292|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438293|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438294|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438295|NCT03477344|Analgesics|analgesics|mesh-ancestor
19438296|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
19438297|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734326|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860808|NCT00790400|Everolimus|everolimus|mesh-list
19860809|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860810|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533589|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718566|NCT04726982|Acetazolamide|acetazolamide|mesh-list
19718567|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
19718568|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19718569|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718570|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718571|NCT04726982|Diuretics|diuretics|mesh-ancestor
19718572|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
19718573|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718574|NCT04726657|Insulin|insulin|mesh-list
19718575|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19718576|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
19718577|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
19718578|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
19718579|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19718580|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718581|NCT04727073|Spironolactone|spironolactone|mesh-list
19860811|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
19860812|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860813|NCT00790569|Nicotine|nicotine|mesh-list
19860814|NCT00790569|Varenicline|varenicline|mesh-list
19860815|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19860816|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
19860817|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860818|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860819|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19860820|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19860821|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
19860822|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19860823|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860824|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
19860825|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
19860826|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19860827|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860828|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860829|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
19860830|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19860831|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860832|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860833|NCT00790647|Bortezomib|bortezomib|mesh-list
19860834|NCT00790647|Melphalan|melphalan|mesh-list
19860835|NCT00790647|Sargramostim|sargramostim|mesh-list
19860836|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
19860837|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860838|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860839|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860840|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
19860841|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860842|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860843|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860844|NCT00790842|Aspirin|aspirin|mesh-list
19860845|NCT00790842|Dexamethasone|dexamethasone|mesh-list
20533590|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20533591|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533592|NCT01809041|Remifentanil|remifentanil|mesh-list
20533593|NCT01809041|Propofol|propofol|mesh-list
20533594|NCT01809041|Sevoflurane|sevoflurane|mesh-list
20533595|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533596|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533597|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533598|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20533599|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
19718582|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19718583|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
19860846|NCT00790842|Lenalidomide|lenalidomide|mesh-list
19860847|NCT00790842|Heparin|heparin|mesh-list
19860848|NCT00790842|Calcium heparin|calcium heparin|mesh-list
20252934|NCT00456976|Selegiline|selegiline|mesh-list
20533600|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
19718584|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718585|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718586|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19718587|NCT04727073|Diuretics|diuretics|mesh-ancestor
19718588|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
19438298|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19718589|NCT04726631|Insulin|insulin|mesh-list
19718590|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19718591|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
19718592|NCT04726631|Protamines|protamines|mesh-list
19718593|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19718594|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718595|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
19718596|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718597|NCT04726631|Coagulants|coagulants|mesh-ancestor
19718598|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
19718599|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19718600|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
19718601|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19718602|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
19718603|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718604|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718605|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
19718606|NCT04726332|Prednisone|prednisone|mesh-list
19718607|NCT04726332|Fulvestrant|fulvestrant|mesh-list
19718608|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19718609|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
19718610|NCT04726332|Hormones|hormones|mesh-ancestor
19718611|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718612|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718613|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19718614|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718615|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19718616|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19718617|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718618|NCT04726345|Fexofenadine|fexofenadine|mesh-list
19718619|NCT04726345|Terfenadine|terfenadine|mesh-list
19718620|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19718621|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19718622|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19718623|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
19718624|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
19718625|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718626|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718627|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718628|NCT04726280|Ropivacaine|ropivacaine|mesh-list
19718629|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19718630|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
19718631|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
19718632|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19860849|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19718633|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718634|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
19718635|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860850|NCT00790842|Tinzaparin|tinzaparin|mesh-list
19860851|NCT00790842|Dalteparin|dalteparin|mesh-list
19860852|NCT00790842|Anticoagulants|anticoagulants|mesh-list
19860853|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860854|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
19860855|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
19718636|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
19718637|NCT04726553|Antimalarials|antimalarials|mesh-list
19718638|NCT04726553|Methotrexate|methotrexate|mesh-list
19718639|NCT04726553|Azathioprine|azathioprine|mesh-list
19718640|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19718641|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
19718642|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718643|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718644|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19718645|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
19718646|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718647|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718648|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718649|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718650|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19718651|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19718652|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
19718653|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19718654|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19718655|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19718656|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19718657|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
19718658|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19718659|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718660|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19718661|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19860856|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860857|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438299|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19438300|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19438301|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
19438302|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438303|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438304|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19438305|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438306|NCT03477266|Mosapride|mosapride|mesh-list
19438307|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438308|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19438309|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
19438310|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438311|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438312|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438313|NCT03477175|Sorafenib|sorafenib|mesh-list
19438314|NCT03477175|Lenvatinib|lenvatinib|mesh-list
19860858|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438315|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718662|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19860859|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
19718663|NCT04726046|Cefotetan|cefotetan|mesh-list
19718664|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718665|NCT04725747|Midazolam|midazolam|mesh-list
19718666|NCT04725747|Ketamine|ketamine|mesh-list
19718667|NCT04725747|Analgesics|analgesics|mesh-ancestor
19718668|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
19718669|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718670|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860860|NCT00790842|Hormones|hormones|mesh-ancestor
19860861|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860862|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19860863|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860864|NCT00790842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860865|NCT00790842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19860866|NCT00790842|Analgesics|analgesics|mesh-ancestor
19860867|NCT00790842|Sensory System Agents|sensory system agents|mesh-ancestor
19860868|NCT00790842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860869|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19860870|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19860871|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860872|NCT00790842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19860873|NCT00790842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19860874|NCT00790842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860875|NCT00790842|Antipyretics|antipyretics|mesh-ancestor
19860876|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
19860877|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19860878|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19860879|NCT00790842|Growth Substances|growth substances|mesh-ancestor
19860880|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
19860881|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19860882|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860883|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
20533601|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20533602|NCT01809041|Narcotics|narcotics|mesh-ancestor
20533603|NCT01809041|Analgesics|analgesics|mesh-ancestor
20533604|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
20533605|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533606|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20533607|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19718671|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20533608|NCT01809158|Minocycline|minocycline|mesh-list
20533609|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19860884|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860885|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860886|NCT00790868|Cycloserine|cycloserine|mesh-list
19860887|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19718672|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19718673|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
19718674|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
19718675|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718676|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19718677|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19718678|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718679|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718680|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19718681|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718682|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19718683|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19718684|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19718685|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
19718686|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
19718687|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19718688|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19718689|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718690|NCT04725812|Eculizumab|eculizumab|mesh-list
19718691|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19718692|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19718693|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
19718694|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718695|NCT04725942|Posaconazole|posaconazole|mesh-list
19718696|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
19718697|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718698|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19718699|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19718700|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19718701|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19718702|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19860888|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860889|NCT00790868|Renal Agents|renal agents|mesh-ancestor
19860890|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19860891|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
19860892|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19860893|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
19860894|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860895|NCT00790907|Heparin|heparin|mesh-list
19860896|NCT00790907|PENTA|penta|mesh-list
19860897|NCT00790907|Fondaparinux|fondaparinux|mesh-list
19860898|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
19860899|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19860900|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19860901|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860902|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19860903|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
19860904|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19860905|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19860906|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860907|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
19860908|NCT00791037|Sargramostim|sargramostim|mesh-list
19860909|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860910|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
19860911|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860912|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860913|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19860914|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
19860915|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860916|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19860917|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19860918|NCT00791219|Itraconazole|itraconazole|mesh-list
19860919|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19860920|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
19860921|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860922|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19860923|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19860924|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860925|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860926|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19860927|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718703|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718704|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718705|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19718706|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718707|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718708|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718709|NCT04725591|Insulin|insulin|mesh-list
19718710|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19718711|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718712|NCT04725682|Tacrolimus|tacrolimus|mesh-list
19718713|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19718714|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
19718715|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718716|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19718717|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718718|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718719|NCT04725617|Varenicline|varenicline|mesh-list
19718720|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19718721|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19718722|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
19718723|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718724|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718725|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718726|NCT04725448|Paclitaxel|paclitaxel|mesh-list
19718727|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19718728|NCT04725448|Bevacizumab|bevacizumab|mesh-list
19718729|NCT04725448|Carboplatin|carboplatin|mesh-list
19718730|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19718731|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718732|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
19718733|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
19718734|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
19860928|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19860929|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860930|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19860931|NCT00791258|Amlodipine|amlodipine|mesh-list
19860932|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19860933|NCT00791258|Olmesartan|olmesartan|mesh-list
19860934|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19860935|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19860936|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19860937|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19718735|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718736|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19718737|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19718738|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19718739|NCT04725448|Growth Substances|growth substances|mesh-ancestor
19718740|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718741|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
19718742|NCT04725253|Niacinamide|niacinamide|mesh-list
19718743|NCT04725253|Niacin|niacin|mesh-list
19718744|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
19718745|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
19718746|NCT04725253|Vitamins|vitamins|mesh-ancestor
19718747|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
19718748|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718749|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19718750|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
20252935|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
20252936|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252937|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20252938|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19718751|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718752|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19860938|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860939|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19860940|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860941|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
19860942|NCT00791258|Diuretics|diuretics|mesh-ancestor
19860943|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
20252939|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20252940|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718753|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
19718754|NCT04725383|Amitriptyline|amitriptyline|mesh-list
19718755|NCT04725383|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19718756|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19718757|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
19718758|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19718759|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718760|NCT04725383|Analgesics|analgesics|mesh-ancestor
19718761|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
19718762|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718763|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718764|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19718765|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19718766|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19718767|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718768|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
19718769|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718770|NCT04725383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19718771|NCT04725383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19718772|NCT04725383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718773|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20533610|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718774|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19718775|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19718776|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718777|NCT04725357|Meloxicam|meloxicam|mesh-list
19718778|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19718779|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718780|NCT04725357|Analgesics|analgesics|mesh-ancestor
19718781|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
19718782|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718783|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718784|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19718785|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19718786|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19718787|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19718788|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718789|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718790|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
19718791|NCT04725422|Pamidronate|pamidronate|mesh-list
19718792|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
19718793|NCT04725422|Adalimumab|adalimumab|mesh-list
19718794|NCT04725422|Etanercept|etanercept|mesh-list
19718795|NCT04725422|Golimumab|golimumab|mesh-list
19718796|NCT04725422|Methotrexate|methotrexate|mesh-list
19860944|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20533611|NCT01809171|Vitamin D|vitamin d|mesh-list
20533612|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
20533613|NCT01809171|Vitamins|vitamins|mesh-ancestor
20533614|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
20533615|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533616|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20533617|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20533618|NCT01809184|Insulin|insulin|mesh-list
20533619|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20533620|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
20533621|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20533622|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533623|NCT01809301|Niacin|niacin|mesh-list
20533624|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
20533625|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19718797|NCT04725422|Infliximab|infliximab|mesh-list
19718798|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
19718799|NCT04725422|Leflunomide|leflunomide|mesh-list
19718800|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19718801|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
19718802|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718803|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718804|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19718805|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
19718806|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718807|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718808|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718809|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718810|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19718811|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19718812|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
19718813|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860945|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19438316|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19438317|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438318|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438319|NCT03477136|Vitamin D|vitamin d|mesh-list
19438320|NCT03477136|Vitamins|vitamins|mesh-ancestor
19860946|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20252941|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252942|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20252943|NCT00456976|Protective Agents|protective agents|mesh-ancestor
20252944|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252945|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
20252946|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
20252947|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252948|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860947|NCT00791323|Ketorolac|ketorolac|mesh-list
19860948|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19860949|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
19860950|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19860951|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860952|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19860953|NCT00791323|Analgesics|analgesics|mesh-ancestor
19860954|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
19860955|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860956|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860957|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860958|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860959|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19860960|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860961|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860962|NCT00791479|Dulaglutide|dulaglutide|mesh-list
19860963|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19860964|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860965|NCT00791557|Infliximab|infliximab|mesh-list
19860966|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
19860967|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860968|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860969|NCT00791648|Atorvastatin|atorvastatin|mesh-list
19438321|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
19718814|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19718815|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19718816|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718817|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19718818|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718819|NCT04725422|Analgesics|analgesics|mesh-ancestor
19718820|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
19718821|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718822|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19718823|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19718824|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718825|NCT04725214|Temozolomide|temozolomide|mesh-list
19718826|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19718827|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
19718828|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438322|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438323|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19438324|NCT03477110|Temozolomide|temozolomide|mesh-list
19438325|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19438326|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
19438327|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438328|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438329|NCT03476941|Clindamycin|clindamycin|mesh-list
19718829|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718830|NCT04725201|Heparin|heparin|mesh-list
19718831|NCT04725201|Calcium heparin|calcium heparin|mesh-list
19718832|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
19718833|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19718834|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19718835|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734327|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734328|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19734329|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19734330|NCT04551950|Growth Substances|growth substances|mesh-ancestor
19734331|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860970|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19860971|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19860972|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
19438330|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
19438331|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
19438332|NCT03476941|Gentamicins|gentamicins|mesh-list
19438333|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19438334|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438335|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19438336|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438337|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860973|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860974|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19860975|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19860976|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19860977|NCT00791700|Maraviroc|maraviroc|mesh-list
19860978|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20533626|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
20533627|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438346|NCT03476772|Nalbuphine|nalbuphine|mesh-list
19438347|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19438348|NCT03476772|Narcotics|narcotics|mesh-ancestor
19438349|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533628|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20533629|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
20533630|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
20533631|NCT01809301|Vitamins|vitamins|mesh-ancestor
20533632|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
20533633|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533634|NCT01809340|Minocycline|minocycline|mesh-list
20533635|NCT01809340|Ketamine|ketamine|mesh-list
20533636|NCT01809340|Analgesics|analgesics|mesh-ancestor
20533637|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
20533638|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533639|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533640|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20533641|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20252949|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252950|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
19718836|NCT04724655|Mineral Oil|mineral oil|mesh-list
19718837|NCT04724655|Emollients|emollients|mesh-ancestor
19718838|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718839|NCT04724759|Lidocaine|lidocaine|mesh-list
19718840|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
19718841|NCT04724759|Ketamine|ketamine|mesh-list
19718842|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
19718843|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
19718844|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718845|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718846|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
19718847|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718848|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19718849|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19718850|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19718851|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19718852|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718853|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19718854|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718855|NCT04724759|Analgesics|analgesics|mesh-ancestor
19718856|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19718857|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19718858|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19718859|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
19718860|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19718861|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19718862|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19718863|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
19718864|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19718865|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19718866|NCT04724629|Aldesleukin|aldesleukin|mesh-list
19718867|NCT04724629|Colchicine|colchicine|mesh-list
19718868|NCT04724629|Ixekizumab|ixekizumab|mesh-list
19718869|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718870|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20252951|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20252952|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252953|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252954|NCT00457067|Ranibizumab|ranibizumab|mesh-list
20252955|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20252956|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20252957|NCT00457067|Growth Substances|growth substances|mesh-ancestor
20252958|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252959|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
20252960|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252961|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
20252962|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20252963|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252964|NCT00457106|Risperidone|risperidone|mesh-list
20252965|NCT00457106|Paroxetine|paroxetine|mesh-list
19718871|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19718872|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
19718873|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718874|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
19718875|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19718876|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
19718877|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
19718878|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
19718879|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860979|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19860980|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19860981|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19860982|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19860983|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
19860984|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19860985|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19860986|NCT00791765|Etanercept|etanercept|mesh-list
19860987|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19860988|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19718880|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718881|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19718882|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19718883|NCT04724486|Cetrorelix|cetrorelix|mesh-list
19718884|NCT04724486|Menotropins|menotropins|mesh-list
19718885|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
19860989|NCT00791765|Analgesics|analgesics|mesh-ancestor
19860990|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
19860991|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19860992|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19860993|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19860994|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19860995|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19860996|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19860997|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
19860998|NCT00791778|Sorafenib|sorafenib|mesh-list
19860999|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861000|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19861001|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861002|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861003|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
19861004|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861005|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
19861006|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861007|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861008|NCT00791973|Fluticasone|fluticasone|mesh-list
19861009|NCT00791973|Xhance|xhance|mesh-list
19861010|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861011|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19861012|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
19861013|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861014|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861015|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19861016|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
19861017|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
19861018|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19861019|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
19861020|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861021|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
19861022|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861023|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861024|NCT00792077|Lenalidomide|lenalidomide|mesh-list
19861025|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
19861026|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861027|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861028|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861029|NCT00792077|Growth Substances|growth substances|mesh-ancestor
19718886|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19718887|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
19718888|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718889|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718890|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19438350|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438351|NCT03476772|Analgesics|analgesics|mesh-ancestor
19438352|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
19438353|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438354|NCT03476616|Valsartan|valsartan|mesh-list
19438355|NCT03476616|Eplerenone|eplerenone|mesh-list
19438356|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19438357|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19438358|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19718891|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19718892|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718893|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19718894|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
19718895|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718896|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718897|NCT04724473|Tretinoin|tretinoin|mesh-list
19718898|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718899|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
19718900|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718901|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
19718902|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19718903|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718904|NCT04724187|Misoprostol|misoprostol|mesh-list
19718905|NCT04724187|Oxytocin|oxytocin|mesh-list
19718906|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
19718907|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718908|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718909|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19718910|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
19718911|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19718912|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19718913|NCT04724226|Apatinib|apatinib|mesh-list
19718914|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718915|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19718916|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718917|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718918|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19718919|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19718920|NCT04724343|Cetrorelix|cetrorelix|mesh-list
19718921|NCT04724343|Menotropins|menotropins|mesh-list
19718922|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
19718923|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19718924|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
19718925|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19718926|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718927|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19718928|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19718929|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718930|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19718931|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
19718932|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718933|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718934|NCT04724148|Fentanyl|fentanyl|mesh-list
19718935|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19861030|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861031|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451850|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718936|NCT04724148|Narcotics|narcotics|mesh-ancestor
19718937|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19718938|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718939|NCT04724148|Analgesics|analgesics|mesh-ancestor
19718940|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
19718941|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19718942|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19718943|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19718944|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
19718945|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
19718946|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19718947|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718948|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718949|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718950|NCT04723836|Riboflavin|riboflavin|mesh-list
19718951|NCT04723836|Vitamins|vitamins|mesh-ancestor
19718952|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
19718953|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718954|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
19718955|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19718956|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718957|NCT04723940|Doxycycline|doxycycline|mesh-list
19718958|NCT04723940|Clindamycin|clindamycin|mesh-list
19718959|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
19718960|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
19718961|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19718962|NCT04723940|Cefadroxil|cefadroxil|mesh-list
20252966|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20252967|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
19438359|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438360|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19438361|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
19438362|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438363|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438364|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19438365|NCT03476616|Diuretics|diuretics|mesh-ancestor
19438366|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
19438367|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
19438368|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19438369|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438370|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438371|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19438372|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19438373|NCT03476564|Protective Agents|protective agents|mesh-ancestor
19451851|NCT03418090|Xenon|xenon|mesh-list
19718963|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19718964|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438374|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438375|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
19438376|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19438377|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
19438378|NCT03476356|Clomiphene|clomiphene|mesh-list
19438379|NCT03476356|Enclomiphene|enclomiphene|mesh-list
19438380|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
19438381|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19438382|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
19438383|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438384|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438385|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19438386|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
19438387|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19438388|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19438389|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19438390|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
19438391|NCT03476174|Interleukin-2|interleukin-2|mesh-list
19438392|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19438393|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438394|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438395|NCT03476174|Analgesics|analgesics|mesh-ancestor
19438396|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
19438397|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438398|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438399|NCT03476109|Omalizumab|omalizumab|mesh-list
19438400|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19438401|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19438402|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
19438403|NCT03476083|Tenofovir|tenofovir|mesh-list
19438404|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
19438405|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438406|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19438407|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19438408|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438409|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438410|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19438411|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19438412|NCT03476044|Selenium|selenium|mesh-list
19438413|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
19438414|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438415|NCT03476044|Protective Agents|protective agents|mesh-ancestor
19438416|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438417|NCT03476044|Trace Elements|trace elements|mesh-ancestor
19438418|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
19438419|NCT03475862|Oxycodone|oxycodone|mesh-list
19438420|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19438421|NCT03475862|Narcotics|narcotics|mesh-ancestor
19438422|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438423|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438424|NCT03475862|Analgesics|analgesics|mesh-ancestor
19438425|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
19438426|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438427|NCT03475810|Midazolam|midazolam|mesh-list
19438428|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19438429|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19438430|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438431|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438432|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19438433|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19438434|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19438435|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19718965|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
19718966|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19718967|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19718968|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19718969|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19718970|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718971|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19718972|NCT04723940|Renal Agents|renal agents|mesh-ancestor
19718973|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
19718974|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19718975|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19718976|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19718977|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
19718978|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
19718979|NCT04723875|Paclitaxel|paclitaxel|mesh-list
19718980|NCT04723875|Docetaxel|docetaxel|mesh-list
19718981|NCT04723875|Carboplatin|carboplatin|mesh-list
19718982|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19718983|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19718984|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
19718985|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
19718986|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
19718987|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19718988|NCT04723862|Spironolactone|spironolactone|mesh-list
19718989|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19718990|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
19718991|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19718992|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19718993|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19861032|NCT00792142|Thalidomide|thalidomide|mesh-list
19861033|NCT00792142|Dexamethasone|dexamethasone|mesh-list
19861034|NCT00792142|Bortezomib|bortezomib|mesh-list
19861035|NCT00792142|Melphalan|melphalan|mesh-list
19861036|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861037|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
19861038|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
19861039|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861040|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861041|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861042|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
19861043|NCT00792142|Hormones|hormones|mesh-ancestor
19861044|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861045|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19861046|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861047|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861048|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
19861049|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861050|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19861051|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861052|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
19861053|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
19861054|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861055|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861056|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861057|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861058|NCT00792142|Growth Substances|growth substances|mesh-ancestor
19861059|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861060|NCT00792298|Suvorexant|suvorexant|mesh-list
19861061|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19861062|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19861063|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19861064|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861065|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19861066|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861067|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861068|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19861069|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19861070|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861071|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861072|NCT00792571|Epoprostenol|epoprostenol|mesh-list
19861073|NCT00792571|Beraprost|beraprost|mesh-list
19861074|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19861075|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
19861076|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19718994|NCT04723862|Diuretics|diuretics|mesh-ancestor
19718995|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
19718996|NCT04723563|Heparin|heparin|mesh-list
19718997|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
19718998|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19718999|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19719000|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719001|NCT04723472|Cefuroxime|cefuroxime|mesh-list
19719002|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
19719003|NCT04723472|Bismuth|bismuth|mesh-list
19719004|NCT04723472|Antacids|antacids|mesh-ancestor
19719005|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719006|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719007|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19719008|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719009|NCT04723147|Levodopa|levodopa|mesh-list
19719010|NCT04723147|Carbidopa|carbidopa|mesh-list
19719011|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19719012|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19719013|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19719014|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
19719015|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719016|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719017|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719018|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19719019|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719020|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19719021|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
19719022|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
19719023|NCT04723342|Blinatumomab|blinatumomab|mesh-list
19719024|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719025|NCT04723459|Ivermectin|ivermectin|mesh-list
19719026|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719027|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719028|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19719029|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19719030|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19719031|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19719032|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719033|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719034|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719035|NCT04723238|Analgesics|analgesics|mesh-ancestor
19719036|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
19719037|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719038|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
19719039|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719040|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
19719041|NCT04723069|Metronidazole|metronidazole|mesh-list
19719042|NCT04723069|Doxycycline|doxycycline|mesh-list
19719043|NCT04723069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719044|NCT04723069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19719045|NCT04723069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19719046|NCT04723069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719047|NCT04723069|Antimalarials|antimalarials|mesh-ancestor
19719048|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19719049|NCT04722822|Vaccines|vaccines|mesh-list
19719050|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
19719051|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734332|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
19734333|NCT04551768|Ribavirin|ribavirin|mesh-list
19734334|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
19734335|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734336|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
19734337|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734338|NCT04551781|Prednisone|prednisone|mesh-list
19734339|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734340|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
19734341|NCT04551781|Hormones|hormones|mesh-ancestor
19734342|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861077|NCT00792636|Naproxen|naproxen|mesh-list
19861078|NCT00792636|Sumatriptan|sumatriptan|mesh-list
19861079|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19861080|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19861081|NCT00792636|Analgesics|analgesics|mesh-ancestor
19734343|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734344|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19734345|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861082|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
19719052|NCT04723030|Paclitaxel|paclitaxel|mesh-list
19719053|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19719054|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719055|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
19719056|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
19719057|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
19719058|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719059|NCT04722835|Albuterol|albuterol|mesh-list
19719060|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19861083|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861084|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861085|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861086|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861087|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
19861088|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19861089|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861090|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861091|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19861092|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19861093|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19861094|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
19861095|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861096|NCT00792701|Gemcitabine|gemcitabine|mesh-list
19861097|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861098|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19861099|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
19861100|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861101|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
19861102|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861103|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861104|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861105|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
19861106|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861107|NCT00792909|Vaccines|vaccines|mesh-list
19861108|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19861109|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
19861110|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861111|NCT00792922|Azithromycin|azithromycin|mesh-list
19861112|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861113|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861114|NCT00792935|Metformin|metformin|mesh-list
19861115|NCT00792935|Glimepiride|glimepiride|mesh-list
19861116|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19861117|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861118|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19861119|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861120|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
19969661|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19969662|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969663|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
19969664|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969665|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969666|NCT01774851|Paclitaxel|paclitaxel|mesh-list
19969667|NCT01774851|Trastuzumab|trastuzumab|mesh-list
19969668|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19969669|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969670|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
19969671|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
19969672|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
19969673|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969674|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19719061|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
19969675|NCT01774903|Fentanyl|fentanyl|mesh-list
19969676|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19969677|NCT01774903|Narcotics|narcotics|mesh-ancestor
19969678|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19969679|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969680|NCT01774903|Analgesics|analgesics|mesh-ancestor
19969681|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
19969682|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969683|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19969684|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20533642|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
19861121|NCT00793546|Exemestane|exemestane|mesh-list
19861122|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861123|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19861124|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19861125|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861126|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861127|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19861128|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
19861129|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861130|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861131|NCT00793572|Cyclosporine|cyclosporine|mesh-list
19861132|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
19861133|NCT00793572|Fludarabine|fludarabine|mesh-list
19861134|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
19861135|NCT00793572|Bortezomib|bortezomib|mesh-list
19861136|NCT00793572|Melphalan|melphalan|mesh-list
19861137|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
19861138|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19861139|NCT00793572|Cyclosporins|cyclosporins|mesh-list
19861140|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861141|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19861142|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
19861143|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861144|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861145|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
19861146|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861147|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861148|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
19861149|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861150|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19861151|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438436|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
19438437|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
19438438|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
19438439|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
19438440|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438441|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438442|NCT03475758|Goserelin|goserelin|mesh-list
19438443|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19438444|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438445|NCT03475693|Acetaminophen|acetaminophen|mesh-list
19438446|NCT03475693|Ondansetron|ondansetron|mesh-list
19438447|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
19861152|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19861153|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19719062|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719063|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719064|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19719065|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
19719066|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
19719067|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19719068|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19719069|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19719070|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19719071|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
19719072|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719073|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719074|NCT04723004|Bevacizumab|bevacizumab|mesh-list
19719075|NCT04723004|Sorafenib|sorafenib|mesh-list
19719076|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19719077|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719078|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19719079|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19719080|NCT04723004|Growth Substances|growth substances|mesh-ancestor
19719081|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719082|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
19719083|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19719084|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719085|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719086|NCT04722523|Carboplatin|carboplatin|mesh-list
19719087|NCT04722523|Docetaxel|docetaxel|mesh-list
19719088|NCT04722523|Cetuximab|cetuximab|mesh-list
19719089|NCT04722523|Cemiplimab|cemiplimab|mesh-list
19719090|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719091|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
19719092|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
19719093|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
19719094|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719095|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19719096|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
19719097|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19719098|NCT04722354|Growth Substances|growth substances|mesh-ancestor
19719099|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719100|NCT04722471|Progesterone|progesterone|mesh-list
19719101|NCT04722471|Progestins|progestins|mesh-ancestor
19719102|NCT04722471|Hormones|hormones|mesh-ancestor
19719103|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719104|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719105|NCT04721873|Topiramate|topiramate|mesh-list
19719106|NCT04721873|Phentermine|phentermine|mesh-list
19719107|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
19719108|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19719109|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719110|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19719111|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
19719112|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19719113|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
19719114|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
19719115|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719116|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
19719117|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719118|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719119|NCT04721899|Vitamin D|vitamin d|mesh-list
19719120|NCT04721899|Vitamins|vitamins|mesh-ancestor
19719121|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
19719122|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719123|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19719124|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
19719125|NCT04721964|Trace Elements|trace elements|mesh-ancestor
19719126|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
19719127|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719128|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
19719129|NCT04721795|Atorvastatin|atorvastatin|mesh-list
19719130|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19719131|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19719132|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
19719133|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719134|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19719135|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19719136|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719137|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19719138|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719139|NCT04721704|Amoxicillin|amoxicillin|mesh-list
19719140|NCT04721704|Metronidazole|metronidazole|mesh-list
19719141|NCT04721704|Clarithromycin|clarithromycin|mesh-list
19719142|NCT04721704|Omeprazole|omeprazole|mesh-list
19719143|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19719144|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719145|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19719146|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719147|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19719148|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719149|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19719150|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719151|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719152|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19719153|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19719154|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19861154|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19861155|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
19861156|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861157|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861158|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
19861159|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19861160|NCT00793585|Allopurinol|allopurinol|mesh-list
19861161|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
19861162|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861163|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861164|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
19861165|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861166|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19861167|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
19861168|NCT00793585|Protective Agents|protective agents|mesh-ancestor
19861169|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533643|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
20533644|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19861170|NCT00793598|Brincidofovir|brincidofovir|mesh-list
19861171|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
19861172|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861173|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
19861174|NCT00793624|Olodaterol|olodaterol|mesh-list
19861175|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19861176|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
19861177|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861178|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861179|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19861180|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
19861181|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19861182|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19861183|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19861184|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
19861185|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861186|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861187|NCT00793650|Bortezomib|bortezomib|mesh-list
19861188|NCT00793650|Melphalan|melphalan|mesh-list
19861189|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861190|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861191|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
20533645|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20533646|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20533647|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533648|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533649|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20533650|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533651|NCT01809379|Cisplatin|cisplatin|mesh-list
20533652|NCT01809379|Doxorubicin|doxorubicin|mesh-list
19719155|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19969685|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
19734346|NCT04551573|Rifapentine|rifapentine|mesh-list
19719156|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719157|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719158|NCT04721054|Lidocaine|lidocaine|mesh-list
19719159|NCT04721054|Bupivacaine|bupivacaine|mesh-list
19719160|NCT04721054|Anesthetics|anesthetics|mesh-list
19719161|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
19719162|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719163|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719164|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
19719165|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861192|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861193|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19438448|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438449|NCT03475693|Analgesics|analgesics|mesh-ancestor
19438450|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
19438451|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438452|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438453|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
19438454|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
19438455|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
19438456|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438457|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
19438458|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
19438459|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19438460|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
19438461|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719166|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19719167|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19719168|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19719169|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734347|NCT04551573|Rifampin|rifampin|mesh-list
19438462|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438463|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19719170|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719171|NCT04721119|Anesthetics|anesthetics|mesh-list
19719172|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719173|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719174|NCT04721301|Maraviroc|maraviroc|mesh-list
19719175|NCT04721301|Nivolumab|nivolumab|mesh-list
19719176|NCT04721301|Ipilimumab|ipilimumab|mesh-list
19719177|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19719178|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719179|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19719180|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719181|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19861194|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861195|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
19719182|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19719183|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19719184|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19719185|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
19719186|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719187|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19719188|NCT04720807|Letrozole|letrozole|mesh-list
19719189|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719190|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19719191|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19719192|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719193|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719194|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19719195|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
19719196|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719197|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719198|NCT04720768|Palbociclib|palbociclib|mesh-list
19719199|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719200|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19719201|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719202|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861196|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861197|NCT00793780|Naltrexone|naltrexone|mesh-list
19861198|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19861199|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19861200|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861201|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
19861202|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861203|NCT00793819|Silodosin|silodosin|mesh-list
19861204|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19861205|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19861206|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19861207|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
19861208|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861209|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861210|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861211|NCT00793819|Urological Agents|urological agents|mesh-ancestor
19861212|NCT00793871|Sunitinib|sunitinib|mesh-list
19861213|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719203|NCT04720833|Vitamin D|vitamin d|mesh-list
19719204|NCT04720833|Calcium|calcium|mesh-list
19719205|NCT04720833|Vitamins|vitamins|mesh-ancestor
19719206|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
19719207|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861214|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861215|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861216|NCT00793871|Growth Substances|growth substances|mesh-ancestor
19861217|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861218|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861219|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19861220|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861221|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861222|NCT00793910|Gabapentin|gabapentin|mesh-list
19861223|NCT00793910|Analgesics|analgesics|mesh-ancestor
19861224|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
19861225|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20252968|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734348|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19969686|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
19719208|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19719209|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19719210|NCT04720859|Canagliflozin|canagliflozin|mesh-list
19719211|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19719212|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719213|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19719214|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734349|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
19734350|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734351|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734352|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
19734353|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19734354|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734355|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734356|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19734357|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19734358|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19734359|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19734360|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19734361|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19734362|NCT04551170|Theophylline|theophylline|mesh-list
19734363|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19734364|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
19734365|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734366|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734367|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19734368|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
19734369|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19734370|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734371|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734372|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
19734373|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19734374|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19734375|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
19734376|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734377|NCT04551248|Vaccines|vaccines|mesh-list
19734378|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19734379|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
19734380|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734381|NCT04550936|Isavuconazole|isavuconazole|mesh-list
19734382|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
19734383|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734384|NCT04550949|Denosumab|denosumab|mesh-list
19734385|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19734386|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734387|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
19734388|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19969687|NCT01774929|Fentanyl|fentanyl|mesh-list
19438464|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19719215|NCT04720573|Neostigmine|neostigmine|mesh-list
19719216|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19719217|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719218|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719219|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
19719220|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719221|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719222|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19719223|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
19719224|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719225|NCT04720287|Bupivacaine|bupivacaine|mesh-list
19719226|NCT04720287|Neostigmine|neostigmine|mesh-list
19719227|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
19861226|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861227|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
19861228|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19861229|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19861230|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19861231|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861232|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19861233|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19861234|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861235|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861236|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
19861237|NCT00794040|Methylphenidate|methylphenidate|mesh-list
19861238|NCT00794040|Citalopram|citalopram|mesh-list
19861239|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19861240|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861241|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19861242|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861243|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861244|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861245|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
19861246|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861247|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19861248|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
19861249|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19861250|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
19861251|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861252|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19861253|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19861254|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19861255|NCT00794144|Analgesics|analgesics|mesh-ancestor
19861256|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
19861257|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861258|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861259|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861260|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861261|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19861262|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19861263|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19861264|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
19861265|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
19861266|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861267|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861268|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
19861269|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861270|NCT00794313|Topiramate|topiramate|mesh-list
19861271|NCT00794313|Amantadine|amantadine|mesh-list
19861272|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
19861273|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19861274|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861275|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19861276|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19861277|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
19861278|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861279|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
19861280|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861281|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861282|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19861283|NCT00794313|Analgesics|analgesics|mesh-ancestor
19861284|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
19861285|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861286|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19861287|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19969688|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19719228|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
19719229|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719230|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719231|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
19719232|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719233|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19719234|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719235|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861288|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861289|NCT00794365|Varenicline|varenicline|mesh-list
19861290|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19861291|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19861292|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
19861293|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861294|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861295|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861296|NCT00794417|Pemetrexed|pemetrexed|mesh-list
19719236|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
19861297|NCT00794417|Aflibercept|aflibercept|mesh-list
19861298|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861299|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861300|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861301|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19861302|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19861303|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861304|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861305|NCT00794417|Growth Substances|growth substances|mesh-ancestor
19861306|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861307|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861308|NCT00794547|Calcitriol|calcitriol|mesh-list
19861309|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19861310|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861311|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19861312|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19719237|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719238|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19719239|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
19719240|NCT04720248|Dipyrone|dipyrone|mesh-list
19719241|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19719242|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19719243|NCT04720248|Analgesics|analgesics|mesh-ancestor
19719244|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
19719245|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719246|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719247|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19719248|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719249|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
19719250|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
19719251|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719252|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19719253|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19719254|NCT04720183|Analgesics|analgesics|mesh-ancestor
19719255|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
19719256|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719257|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861313|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861314|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19861315|NCT00794547|Vitamins|vitamins|mesh-ancestor
19861316|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
19861317|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19861318|NCT00794573|Varenicline|varenicline|mesh-list
19861319|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19861320|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19861321|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
19861322|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861323|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861324|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861325|NCT00794664|Mipomersen|mipomersen|mesh-list
20533653|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533654|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20533655|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20533656|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20533657|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533658|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553469|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553470|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
19719258|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19719259|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719260|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719261|NCT04720131|Capecitabine|capecitabine|mesh-list
19452912|NCT03408405|Hormones|hormones|mesh-ancestor
19719262|NCT04720131|Apatinib|apatinib|mesh-list
19719263|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19719264|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
19719265|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719266|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719267|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19719268|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719269|NCT04720105|Halobetasol|halobetasol|mesh-list
19719270|NCT04720105|Tazarotene|tazarotene|mesh-list
19719271|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
19719272|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
19719273|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19719274|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
19719275|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19719276|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
19719277|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19719278|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
19719279|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719280|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719281|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
19719282|NCT04719819|Anesthetics|anesthetics|mesh-list
19719283|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719284|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719285|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
19719286|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19719287|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719288|NCT04719507|Meperidine|meperidine|mesh-list
19719289|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19719290|NCT04719507|Narcotics|narcotics|mesh-ancestor
19719291|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719292|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719293|NCT04719507|Analgesics|analgesics|mesh-ancestor
19719294|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
19719295|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861326|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19861327|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19861328|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
19861329|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861330|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19861331|NCT00794820|Vidarabine|vidarabine|mesh-list
19861332|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
19861333|NCT00794820|Rituximab|rituximab|mesh-list
19861334|NCT00794820|Fludarabine|fludarabine|mesh-list
19861335|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
19861336|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861337|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
19861338|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861339|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861340|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861341|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
19719296|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19719297|NCT04719715|Antibodies|antibodies|mesh-list
19719298|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
19719299|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719300|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19719301|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719302|NCT04719585|Analgesics|analgesics|mesh-ancestor
19719303|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
19719304|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719305|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19719306|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19719307|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19719308|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719309|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719310|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
19719311|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719312|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
19719313|NCT04719481|Pravastatin|pravastatin|mesh-list
19719314|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19719315|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19719316|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
19719317|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719318|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19719319|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19719320|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719321|NCT04719104|Bilirubin|bilirubin|mesh-list
19861342|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861343|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533659|NCT01809392|Decitabine|decitabine|mesh-list
20533660|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20533661|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
20533662|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533663|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533664|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533665|NCT01809444|Doxycycline|doxycycline|mesh-list
20533666|NCT01809444|Prednisone|prednisone|mesh-list
20533667|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19719322|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
19719323|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861344|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19861345|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19861346|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19861347|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
19861348|NCT00794820|Antiviral Agents|antiviral agents|mesh-ancestor
19861349|NCT00794820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861350|NCT00794950|Sunitinib|sunitinib|mesh-list
19861351|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861352|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861353|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861354|NCT00794950|Growth Substances|growth substances|mesh-ancestor
19861355|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861356|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861357|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19861358|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861359|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861360|NCT00794963|Metformin|metformin|mesh-list
19861361|NCT00794963|Orlistat|orlistat|mesh-list
19861362|NCT00794963|Irbesartan|irbesartan|mesh-list
19861363|NCT00794963|Fenofibrate|fenofibrate|mesh-list
19861364|NCT00794963|Pravastatin|pravastatin|mesh-list
19861365|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19861366|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861367|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19861368|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
19861369|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861370|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19861371|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19861372|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19861373|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861374|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19861375|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19861376|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19861377|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19861378|NCT00795002|Cytarabine|cytarabine|mesh-list
19861379|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
19861380|NCT00795002|Alvocidib|alvocidib|mesh-list
19861381|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19861382|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
19861383|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861384|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861385|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
19861386|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719324|NCT04719104|Protective Agents|protective agents|mesh-ancestor
19719325|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719326|NCT04719273|Anastrozole|anastrozole|mesh-list
19719327|NCT04719273|Onapristone|onapristone|mesh-list
19719328|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19719329|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719330|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19719331|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19719332|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719333|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861387|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861388|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
19969689|NCT01774929|Narcotics|narcotics|mesh-ancestor
19719334|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19719335|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
19719336|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719337|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719338|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19719339|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
19719340|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19719341|NCT04718792|Psilocybin|psilocybin|mesh-list
19719342|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
19719343|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719344|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719345|NCT04718805|Darunavir|darunavir|mesh-list
19719346|NCT04718805|Cobicistat|cobicistat|mesh-list
19861389|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861390|NCT00795002|Analgesics|analgesics|mesh-ancestor
19861391|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
19861392|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861393|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19861394|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19861395|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861396|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861397|NCT00795002|Growth Substances|growth substances|mesh-ancestor
19861398|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19861399|NCT00795132|Cyclosporine|cyclosporine|mesh-list
19861400|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
19861401|NCT00795132|Fludarabine|fludarabine|mesh-list
19861402|NCT00795132|Busulfan|busulfan|mesh-list
19861403|NCT00795132|Cyclosporins|cyclosporins|mesh-list
19861404|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
19861405|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19861406|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861407|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861408|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533668|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
19861409|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
19861410|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861411|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861412|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
19861413|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861414|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
19861415|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861416|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19861417|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19861418|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19861419|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
19719347|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19719348|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19861420|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861421|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
20533669|NCT01809444|Hormones|hormones|mesh-ancestor
20533670|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533671|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533672|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20533673|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533674|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20533675|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533676|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
20533677|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20533678|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719349|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
19719350|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719351|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719352|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19719353|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19719354|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
19719355|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719356|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19719357|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19719358|NCT04718740|Vitamin K|vitamin k|mesh-list
19719359|NCT04718740|Repaglinide|repaglinide|mesh-list
19861422|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861423|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19861424|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
19861425|NCT00795145|Linezolid|linezolid|mesh-list
19861426|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861427|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861428|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19861429|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19861430|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861431|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861432|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861433|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19861434|NCT00795210|Hormones|hormones|mesh-list
19861435|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19861436|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861437|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861438|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19861439|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19438465|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438466|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19438467|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19438468|NCT03475693|Antacids|antacids|mesh-ancestor
19438469|NCT03475680|Gentamicins|gentamicins|mesh-list
19438470|NCT03475680|Ornidazole|ornidazole|mesh-list
19438471|NCT03475680|Sennosides|sennosides|mesh-list
19438472|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19438473|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438474|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19438475|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438476|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438477|NCT03475680|Laxatives|laxatives|mesh-ancestor
19438478|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438479|NCT03475680|Amebicides|amebicides|mesh-ancestor
19438480|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19438481|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19438482|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19451852|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19451853|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
19451854|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
19451855|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451856|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719360|NCT04718740|Midazolam|midazolam|mesh-list
19719361|NCT04718740|Caffeine|caffeine|mesh-list
19719362|NCT04718740|Bupropion|bupropion|mesh-list
19719363|NCT04718740|Omeprazole|omeprazole|mesh-list
19719364|NCT04718740|Warfarin|warfarin|mesh-list
19719365|NCT04718740|Vitamins|vitamins|mesh-ancestor
19719366|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
19719367|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719368|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19719369|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19719370|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719371|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19719372|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19719373|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719374|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19719375|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
19719376|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
19719377|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
19719378|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
19719379|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719380|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719381|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
19719382|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19719383|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719384|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20252969|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252970|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252971|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20252972|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533679|NCT01809626|Zolpidem|zolpidem|mesh-list
19719385|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719386|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19719387|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19719388|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19719389|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19719390|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
19719391|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19719392|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
19719393|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19719394|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19719395|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19719396|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
19719397|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19719398|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19719399|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19719400|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19719401|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
19719402|NCT04718740|Coagulants|coagulants|mesh-ancestor
19861440|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861441|NCT00795275|Incretins|incretins|mesh-ancestor
19861442|NCT00795275|Hormones|hormones|mesh-ancestor
19861443|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861444|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19861445|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
19861446|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861447|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861448|NCT00795288|Simvastatin|simvastatin|mesh-list
19861449|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19861450|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19861451|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
19719403|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19719404|NCT04718701|Paclitaxel|paclitaxel|mesh-list
19719405|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19719406|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719407|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
19719408|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
19719409|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
19719410|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719411|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
19719412|NCT04718402|Analgesics|analgesics|mesh-ancestor
19719413|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
19719414|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719415|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719416|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719417|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20533680|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20533681|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533682|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533683|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533684|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20533685|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
20533686|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
20533687|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533688|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533689|NCT01809691|Bicalutamide|bicalutamide|mesh-list
20533690|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
19438483|NCT03475628|Daratumumab|daratumumab|mesh-list
19438484|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438485|NCT03475615|Paclitaxel|paclitaxel|mesh-list
19438486|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
19438487|NCT03475615|Tegafur|tegafur|mesh-list
19438488|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19438489|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438490|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
19438491|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19438492|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
19438493|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438494|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19438495|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
19438496|NCT03475589|Apatinib|apatinib|mesh-list
19438497|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438498|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19438499|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438500|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438501|NCT03475524|Metformin|metformin|mesh-list
19438502|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19438503|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438504|NCT03475459|Melatonin|melatonin|mesh-list
19438505|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
19438506|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438507|NCT03475459|Protective Agents|protective agents|mesh-ancestor
19438508|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438509|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438510|NCT03475407|Dexamethasone|dexamethasone|mesh-list
19438511|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
19438512|NCT03475407|BB 1101|bb 1101|mesh-list
19438513|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438514|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
19438515|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
19438516|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438517|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252973|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20252974|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20252975|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20252976|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
20252977|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20252978|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20252979|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20252980|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20252981|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
19861452|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861453|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19861454|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19861455|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861456|NCT00795340|Paclitaxel|paclitaxel|mesh-list
19861457|NCT00795340|Carboplatin|carboplatin|mesh-list
19719418|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19719419|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719420|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734389|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734390|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734391|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
19734392|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734393|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734394|NCT04550858|Rebamipide|rebamipide|mesh-list
19734395|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19734396|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19734397|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
19734398|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734399|NCT04550858|Protective Agents|protective agents|mesh-ancestor
19734400|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734401|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734402|NCT04551196|Acetaminophen|acetaminophen|mesh-list
19734403|NCT04551196|Ibuprofen|ibuprofen|mesh-list
19734404|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19734405|NCT04551196|Analgesics|analgesics|mesh-ancestor
19734406|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
19734407|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734408|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438518|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438519|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
19438520|NCT03475407|Hormones|hormones|mesh-ancestor
19438521|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438522|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19438523|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438524|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
19438525|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438526|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438527|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
19438528|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19438529|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438530|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
19438531|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
19438532|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19438533|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438534|NCT03475225|Vitamins|vitamins|mesh-ancestor
19438535|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
19438536|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19438537|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
19438538|NCT03475160|Citric Acid|citric acid|mesh-list
19438539|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
19719421|NCT04718311|Tacrolimus|tacrolimus|mesh-list
19861458|NCT00795340|Cediranib|cediranib|mesh-list
19861459|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19438540|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
19438541|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19438542|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
19438543|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
19438544|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438545|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
19719422|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719423|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
19719424|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719425|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19719426|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719427|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719428|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
19719429|NCT04718376|Analgesics|analgesics|mesh-ancestor
19719430|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
19719431|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719432|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719433|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719434|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19719435|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19719436|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719437|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719438|NCT04718584|Antibodies|antibodies|mesh-list
19719439|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19719440|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
20533691|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
20533692|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533693|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533694|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533695|NCT01809743|Adenosine|adenosine|mesh-list
20533696|NCT01809743|Regadenoson|regadenoson|mesh-list
20533697|NCT01809743|Analgesics|analgesics|mesh-ancestor
20533698|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
20533699|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533700|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719441|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719442|NCT04718649|Celecoxib|celecoxib|mesh-list
19719443|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19719444|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19719445|NCT04718649|Analgesics|analgesics|mesh-ancestor
19719446|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
19719447|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719448|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719449|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19719450|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719451|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19861460|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861461|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
19861462|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
19861463|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
19861464|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861465|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861466|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19861467|NCT00795366|Vasopressins|vasopressins|mesh-list
19861468|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
19861469|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
19861470|NCT00795366|Coagulants|coagulants|mesh-ancestor
19861471|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19719452|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19719453|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719454|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719455|NCT04718714|Midazolam|midazolam|mesh-list
19719456|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
19719457|NCT04718714|Propofol|propofol|mesh-list
19719458|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19719459|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719460|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719461|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19719462|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
19719463|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
19719464|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19719465|NCT04718714|Analgesics|analgesics|mesh-ancestor
19719466|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
19719467|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719468|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19719469|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19719470|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19719471|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
19719472|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719473|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20252982|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19719474|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19719475|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19719476|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19719477|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719478|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
19719479|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
19719480|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
19719481|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19719482|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19719483|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19861472|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19861473|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
19861474|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533701|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20533702|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
20533703|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20533704|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
20533705|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
20533706|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533707|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533708|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20533709|NCT01809808|Hormones|hormones|mesh-list
19438546|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19438547|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19438548|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438549|NCT03475160|Urological Agents|urological agents|mesh-ancestor
19438550|NCT03475121|Topotecan|topotecan|mesh-list
19438551|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19438552|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19438553|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438554|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438555|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438556|NCT03475017|Curcumin|curcumin|mesh-list
19438557|NCT03475017|Piperine|piperine|mesh-list
19438558|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19438559|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19861475|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19861476|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19861477|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19861478|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
19861479|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533710|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533711|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533712|NCT01809847|Ofatumumab|ofatumumab|mesh-list
20533713|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533714|NCT01809860|Sirolimus|sirolimus|mesh-list
20533715|NCT01809860|Isavuconazole|isavuconazole|mesh-list
20533716|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20533717|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438560|NCT03475017|Analgesics|analgesics|mesh-ancestor
19719484|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533718|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19969690|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438561|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
19438562|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438563|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438564|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438565|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438566|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438567|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438568|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438569|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19438570|NCT03474939|Midazolam|midazolam|mesh-list
19438571|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19438572|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19438573|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438574|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719485|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719486|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19719487|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19719488|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19719489|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719490|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719491|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
19719492|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19719493|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
19719494|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19719495|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19719496|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719497|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19719498|NCT04718038|Cetuximab|cetuximab|mesh-list
19719499|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19719500|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719501|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
19719502|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
19719503|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19719504|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19719505|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438575|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19438576|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19438577|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19438578|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19438579|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
19719506|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438580|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
19438581|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
19438582|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
19438583|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438584|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719507|NCT04718233|Urological Agents|urological agents|mesh-ancestor
19719508|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19719509|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19719510|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719511|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719512|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
19719513|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719514|NCT04718259|Midazolam|midazolam|mesh-list
19719515|NCT04718259|Bupivacaine|bupivacaine|mesh-list
19719516|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
19719517|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
19719518|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719519|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719520|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
19719521|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719522|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19719523|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19719524|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19719525|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19719526|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719527|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20252983|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20252984|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20252985|NCT00457119|Everolimus|everolimus|mesh-list
20252986|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252987|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20252988|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
19438585|NCT03474770|Huperzine A|huperzine a|mesh-list
19438586|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19438587|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438588|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719528|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
19719529|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
19719530|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
19719531|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719532|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719533|NCT04717973|Vitamin D|vitamin d|mesh-list
19719534|NCT04717973|Vitamins|vitamins|mesh-list
19719535|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
19719536|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
19719537|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
19719538|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719539|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19719540|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
19719541|NCT04717973|Hematinics|hematinics|mesh-ancestor
19719542|NCT04717908|Linezolid|linezolid|mesh-list
19719543|NCT04717908|Cycloserine|cycloserine|mesh-list
20533719|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533720|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
20533721|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533722|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
20533723|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533724|NCT01809886|Neostigmine|neostigmine|mesh-list
20533725|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19719544|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
19719545|NCT04717908|Bedaquiline|bedaquiline|mesh-list
19719546|NCT04717908|Clofazimine|clofazimine|mesh-list
19719547|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19719548|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20252989|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252990|NCT00457145|Ranibizumab|ranibizumab|mesh-list
20252991|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20252992|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20533726|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533727|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533728|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
19734409|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
19719549|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19719550|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719551|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719552|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19719553|NCT04717908|Renal Agents|renal agents|mesh-ancestor
19719554|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19719555|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
19719556|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
19719557|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19719558|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
19438589|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
19438590|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438591|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438592|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19438593|NCT03474770|Protective Agents|protective agents|mesh-ancestor
19438594|NCT03474614|Propranolol|propranolol|mesh-list
19438595|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19438596|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19438597|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
19438598|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438599|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438600|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438601|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19438602|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19438603|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
19438604|NCT03474601|Hormones|hormones|mesh-list
19719559|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
19719560|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19719561|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719562|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19719563|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719564|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19719565|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19719566|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719567|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
19719568|NCT04717531|Docetaxel|docetaxel|mesh-list
19719569|NCT04717531|Trastuzumab|trastuzumab|mesh-list
19719570|NCT04717531|Epirubicin|epirubicin|mesh-list
19719571|NCT04717531|Pertuzumab|pertuzumab|mesh-list
19719572|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719573|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
19719574|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719575|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719576|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19719577|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
19719578|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719579|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719580|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19719581|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
19719582|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
19719583|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
19719584|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19719585|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19719586|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19719587|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19719588|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719589|NCT04717609|Ropivacaine|ropivacaine|mesh-list
19719590|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
19719591|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
19719592|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719593|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719594|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
19719595|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719596|NCT04717102|Desflurane|desflurane|mesh-list
19719597|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19719598|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
20533729|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719599|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
20533730|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533731|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20533732|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
20533733|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533734|NCT01809925|Psyllium|psyllium|mesh-list
20533735|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
20533736|NCT01809925|Cathartics|cathartics|mesh-ancestor
20533737|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533738|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
20533739|NCT01810185|Naltrexone|naltrexone|mesh-list
20533740|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20533741|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20533742|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533743|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
20533744|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533745|NCT01810237|Dabigatran|dabigatran|mesh-list
20533746|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
20533747|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20533748|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
19719600|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719601|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719602|NCT04717089|Anesthetics|anesthetics|mesh-list
19719603|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719604|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719605|NCT04716894|Itraconazole|itraconazole|mesh-list
19719606|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
19719607|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719608|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19719609|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19719610|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719611|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719612|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19719613|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
19719614|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719615|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719616|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19719617|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19719618|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19719619|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719620|NCT04717193|Epinephrine|epinephrine|mesh-list
19719621|NCT04717193|Racepinephrine|racepinephrine|mesh-list
19719622|NCT04717193|Bupivacaine|bupivacaine|mesh-list
19719623|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
19719624|NCT04717193|Anesthetics|anesthetics|mesh-list
19719625|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
19719626|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719627|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719628|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
19719629|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719630|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19719631|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19719632|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
19719633|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719634|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719635|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19719636|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19719637|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
19719638|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19719639|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19719640|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
19719641|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
19719642|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19719643|NCT04716569|Ivermectin|ivermectin|mesh-list
19719644|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719645|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719646|NCT04716868|Levan|levan|mesh-list
19719647|NCT04716868|Psyllium|psyllium|mesh-list
19719648|NCT04716868|Cathartics|cathartics|mesh-ancestor
19719649|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719650|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719651|NCT04716751|Paclitaxel|paclitaxel|mesh-list
19719652|NCT04716751|Carboplatin|carboplatin|mesh-list
19719653|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19719654|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719655|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
19719656|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
19719657|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
19719658|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719659|NCT04716686|Niraparib|niraparib|mesh-list
19719660|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19719661|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719662|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719663|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734410|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19734411|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734412|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734413|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19734414|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734415|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734416|NCT04550702|Mirabegron|mirabegron|mesh-list
19861480|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734417|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19734418|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19719664|NCT04716296|Ketamine|ketamine|mesh-list
19438605|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438606|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438607|NCT03474510|Bupivacaine|bupivacaine|mesh-list
19438608|NCT03474510|Ropivacaine|ropivacaine|mesh-list
19438609|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
19438610|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
19438611|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438612|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438613|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
19438614|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438615|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19719665|NCT04716296|Analgesics|analgesics|mesh-ancestor
19719666|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
19719667|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719668|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719669|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19719670|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19861481|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861482|NCT00795509|Urological Agents|urological agents|mesh-ancestor
19861483|NCT00795600|Insulin|insulin|mesh-list
19861484|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19861485|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
19719671|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
19719672|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
19719673|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719674|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19719675|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19719676|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719677|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719678|NCT04716413|Dsuvia|dsuvia|mesh-list
19719679|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19719680|NCT04716413|Narcotics|narcotics|mesh-ancestor
19719681|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719682|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719683|NCT04716413|Analgesics|analgesics|mesh-ancestor
19719684|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
19719685|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438616|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19719686|NCT04716426|Tetracycline|tetracycline|mesh-list
19719687|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861486|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
19861487|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
19861488|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
19861489|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20252993|NCT00457145|Growth Substances|growth substances|mesh-ancestor
20533749|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533750|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533751|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
20533752|NCT01810315|Estradiol|estradiol|mesh-list
20533753|NCT01810315|Estrogens|estrogens|mesh-ancestor
20533754|NCT01810315|Hormones|hormones|mesh-ancestor
20533755|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533756|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533757|NCT01810354|Cefazolin|cefazolin|mesh-list
20533758|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20533759|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438617|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438618|NCT03474263|Antibodies|antibodies|mesh-list
19438619|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19734419|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20252994|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20252995|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
20252996|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20252997|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20252998|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
20252999|NCT00457223|Coagulants|coagulants|mesh-ancestor
20253000|NCT00457340|Atorvastatin|atorvastatin|mesh-list
20253001|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19719688|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719689|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19719690|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719691|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719692|NCT04716179|Hormones|hormones|mesh-list
19719693|NCT04716179|Testosterone|testosterone|mesh-list
19719694|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719695|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719696|NCT04716179|Androgens|androgens|mesh-ancestor
19719697|NCT04715763|Telmisartan|telmisartan|mesh-list
19719698|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19719699|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19719700|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19719701|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719702|NCT04715737|Vasopressins|vasopressins|mesh-list
19719703|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
19719704|NCT04715737|Oxytocin|oxytocin|mesh-list
19719705|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
19719706|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19719707|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719708|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
19719709|NCT04715737|Coagulants|coagulants|mesh-ancestor
19861490|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861491|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
19861492|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19861493|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861494|NCT00795769|Ondansetron|ondansetron|mesh-list
19861495|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
19861496|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
19861497|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861498|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861499|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861500|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
19861501|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
19861502|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19861503|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
19861504|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861505|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861506|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19861507|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19861508|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19861509|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861510|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19861511|NCT00795886|Sirolimus|sirolimus|mesh-list
19861512|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861513|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861514|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19861515|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861516|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
19861517|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861518|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
19861519|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861520|NCT00796003|Decitabine|decitabine|mesh-list
19861521|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253002|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20253003|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
20253004|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253005|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20533760|NCT01810367|Gemcitabine|gemcitabine|mesh-list
20533761|NCT01810367|Cisplatin|cisplatin|mesh-list
20533762|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861522|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
19861523|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861524|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861525|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253006|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20253007|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253008|NCT00457405|Dipyridamole|dipyridamole|mesh-list
20253009|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20253010|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253011|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253012|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20253013|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
20253014|NCT00457470|Rucaparib|rucaparib|mesh-list
19719710|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19719711|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19719712|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
19719719|NCT04715620|Niraparib|niraparib|mesh-list
19719720|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19719721|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861526|NCT00796120|Doxorubicin|doxorubicin|mesh-list
19861527|NCT00796120|Ifosfamide|ifosfamide|mesh-list
19861528|NCT00796120|Trabectedin|trabectedin|mesh-list
19861529|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19861530|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861531|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19861532|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19861533|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861534|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861535|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861536|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
19861537|NCT00796224|Azithromycin|azithromycin|mesh-list
19861538|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861539|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861540|NCT00796302|Risperidone|risperidone|mesh-list
19861541|NCT00796302|Methylphenidate|methylphenidate|mesh-list
19861542|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19861543|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
19861544|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861545|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861546|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861547|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19861548|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533763|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19861549|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533764|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
20533765|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533766|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
20533767|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533768|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533769|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533770|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
19719722|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719723|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719724|NCT04715568|Losartan|losartan|mesh-list
19438620|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
19438621|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438622|NCT03474237|Hormones|hormones|mesh-list
19438623|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438624|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438625|NCT03474198|Levofloxacin|levofloxacin|mesh-list
19438626|NCT03474198|Rifampin|rifampin|mesh-list
19438627|NCT03474198|Isoniazid|isoniazid|mesh-list
19438628|NCT03474198|Linezolid|linezolid|mesh-list
19438629|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
19438630|NCT03474198|Ethambutol|ethambutol|mesh-list
19438631|NCT03474198|Rifapentine|rifapentine|mesh-list
19438632|NCT03474198|Bedaquiline|bedaquiline|mesh-list
19438633|NCT03474198|Clofazimine|clofazimine|mesh-list
19438634|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19438635|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438636|NCT03474198|Renal Agents|renal agents|mesh-ancestor
19438637|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19438638|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19438639|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19438640|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438641|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438642|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438643|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19438644|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19438645|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19438646|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
19438647|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
19438648|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19438649|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19438650|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19438651|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19438652|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19438653|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19719725|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
19719726|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
19719727|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19719728|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19719729|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19719730|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719731|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19719732|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
19719733|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719734|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
19719735|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719736|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719737|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19719738|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
19719739|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719740|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719741|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19719742|NCT04715269|Alprazolam|alprazolam|mesh-list
19719743|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19719744|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719745|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861550|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719746|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19719747|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19719748|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19719749|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
19719750|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
19719751|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719752|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719753|NCT04715152|Dexamethasone|dexamethasone|mesh-list
19719754|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
19719755|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
19719756|NCT04715152|BB 1101|bb 1101|mesh-list
19861551|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19861552|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
19861553|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19861554|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19861555|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861556|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861557|NCT00796315|Doxylamine|doxylamine|mesh-list
19861558|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
19861559|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19861560|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
19861561|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
19861562|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861563|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861564|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861565|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
19861566|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
19861567|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861568|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861569|NCT00796328|Phenylephrine|phenylephrine|mesh-list
19861570|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
19861571|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19861572|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
19861573|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
19861574|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861575|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861576|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
19861577|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19861578|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
19861579|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
19861580|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19861581|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19861582|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19861583|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
19861584|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861585|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861586|NCT00796328|Protective Agents|protective agents|mesh-ancestor
19861587|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19861588|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
19861589|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
19861590|NCT00796549|Afatinib|afatinib|mesh-list
19861591|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861592|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19861593|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861594|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861595|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
19861596|NCT00796562|Busulfan|busulfan|mesh-list
19861597|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861598|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
19861599|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861600|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861601|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861602|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
19861603|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861604|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861605|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19861606|NCT00796614|Tamsulosin|tamsulosin|mesh-list
19861607|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19861608|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19861609|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19861610|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
19861611|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861612|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861613|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719757|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19719758|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
19719759|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
19719760|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719761|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719762|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719763|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
19719764|NCT04715152|Hormones|hormones|mesh-ancestor
19438654|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19438655|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19438656|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19438657|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
19438658|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19438659|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19438660|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438661|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
19438662|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19438663|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19438664|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438665|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
19438666|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
19438667|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19438668|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19438669|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438670|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19438671|NCT03473964|Hormones|hormones|mesh-ancestor
19438672|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438673|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438674|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
19438675|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19438676|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719765|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719766|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19719767|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719768|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
19861614|NCT00796614|Urological Agents|urological agents|mesh-ancestor
19719769|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719770|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719771|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
19719772|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
19719773|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719774|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
19719775|NCT04715360|Favipiravir|favipiravir|mesh-list
19719776|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
19719777|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719778|NCT04715295|Azithromycin|azithromycin|mesh-list
19719779|NCT04715295|Doxycycline|doxycycline|mesh-list
19719780|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
19719781|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
19719782|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19719783|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719784|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
19719785|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19719786|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719787|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719788|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719789|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719790|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19719791|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
19719792|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19719793|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
19719794|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
19719795|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19719796|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19719797|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719798|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
19719799|NCT04715165|Bupivacaine|bupivacaine|mesh-list
19719800|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
19719801|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
19719802|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719803|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719804|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
19719805|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719806|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19719807|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19719808|NCT04715165|Analgesics|analgesics|mesh-ancestor
19719809|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19719810|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19861615|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
19861616|NCT00796653|Olodaterol|olodaterol|mesh-list
19861617|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19861618|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
19861619|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861620|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861621|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19861622|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
19861623|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19861624|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19861625|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19861626|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
19861627|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253015|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20253016|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253017|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253018|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253019|NCT00457483|Valsartan|valsartan|mesh-list
20253020|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20533771|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533772|NCT01810393|Trastuzumab|trastuzumab|mesh-list
20533773|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533774|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533775|NCT01810458|Acetaminophen|acetaminophen|mesh-list
20533776|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20533777|NCT01810458|Lidocaine|lidocaine|mesh-list
20533778|NCT01810458|Fentanyl|fentanyl|mesh-list
20533779|NCT01810458|Midazolam|midazolam|mesh-list
20533780|NCT01810458|Oxycodone|oxycodone|mesh-list
20533781|NCT01810458|Lorazepam|lorazepam|mesh-list
20533782|NCT01810458|Ondansetron|ondansetron|mesh-list
20533783|NCT01810458|Liver Extracts|liver extracts|mesh-list
20533784|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
20533785|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
19719811|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19719812|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
19719813|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719814|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719815|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
19719816|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
19719817|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19719818|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19719819|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719820|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719821|NCT04715113|Urological Agents|urological agents|mesh-ancestor
19719822|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
19719823|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719824|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
19719825|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719826|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719827|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19719828|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
19719829|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719830|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719831|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19734420|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
19734421|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734422|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734423|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734424|NCT04550702|Urological Agents|urological agents|mesh-ancestor
19734425|NCT04550442|Azacitidine|azacitidine|mesh-list
19734426|NCT04550442|Venetoclax|venetoclax|mesh-list
19734427|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734428|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
19734429|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734430|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734431|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734432|NCT04550351|Vaccines|vaccines|mesh-list
19734433|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
19734434|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734435|NCT04550637|Apixaban|apixaban|mesh-list
19734436|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19734437|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
19734438|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19734439|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
19734440|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734441|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734442|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
19734443|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
19734444|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19734445|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19734446|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734447|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
19734448|NCT04550338|Coagulants|coagulants|mesh-ancestor
19734449|NCT04550234|Allopurinol|allopurinol|mesh-list
19734450|NCT04550234|Verinurad|verinurad|mesh-list
19734451|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
19734452|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734453|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734454|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
19734455|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734456|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19734457|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
19734458|NCT04550234|Protective Agents|protective agents|mesh-ancestor
19734459|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735860|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19735861|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
19735862|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19735863|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19735864|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19735865|NCT04535518|Analgesics|analgesics|mesh-ancestor
19735866|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
19735867|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719832|NCT04714554|Erythromycin|erythromycin|mesh-list
19719833|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
19719834|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19719835|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
19719836|NCT04714554|Relugolix|relugolix|mesh-list
19719837|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19719838|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719839|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719840|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19719841|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719842|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719843|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
19719844|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
19719845|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719846|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719847|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
19719848|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719849|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
19719850|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719851|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719852|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19719853|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
19719854|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719855|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719856|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19719857|NCT04714242|Ranibizumab|ranibizumab|mesh-list
19861628|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861629|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
19861630|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
19861631|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
19861632|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19861633|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19861634|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861635|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861636|NCT00796666|Urological Agents|urological agents|mesh-ancestor
19861637|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19861638|NCT00796705|Adalimumab|adalimumab|mesh-list
19861639|NCT00796705|Etanercept|etanercept|mesh-list
19861640|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861641|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19861642|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19861643|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19861644|NCT00796705|Analgesics|analgesics|mesh-ancestor
19861645|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
19861646|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861647|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861648|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861649|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861650|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
19861651|NCT00796718|Capecitabine|capecitabine|mesh-list
19861652|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19861653|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
19861654|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861655|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861656|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19861657|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19861658|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
19861659|NCT00796757|Interferons|interferons|mesh-list
19861660|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
19861661|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
19861662|NCT00796757|Bevacizumab|bevacizumab|mesh-list
19861663|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19861664|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861665|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861666|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861667|NCT00796757|Growth Substances|growth substances|mesh-ancestor
19861668|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861669|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861670|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
19861671|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861672|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
19861673|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
19861674|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19719858|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861675|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719859|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19719860|NCT04714242|Growth Substances|growth substances|mesh-ancestor
19719861|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719862|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
19719863|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719864|NCT04714229|Vaccines|vaccines|mesh-list
19719865|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
19719866|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719867|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
19719868|NCT04714515|Ivermectin|ivermectin|mesh-list
19719869|NCT04714515|Montelukast|montelukast|mesh-list
19719870|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
19719871|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19719872|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719873|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719874|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719875|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719876|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719877|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19719878|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
19719879|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19719880|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
19719881|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719882|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719883|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19719884|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19719885|NCT04714541|Ketamine|ketamine|mesh-list
19719886|NCT04714541|Analgesics|analgesics|mesh-ancestor
19719887|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
19719888|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719889|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719890|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19719891|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19719892|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
19861676|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861677|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19861678|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19861679|NCT00796822|Protective Agents|protective agents|mesh-ancestor
19861680|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861681|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
19861682|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19861683|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
19861684|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19861685|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19861686|NCT00796978|Trastuzumab|trastuzumab|mesh-list
19861687|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19861688|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861689|NCT00796991|Paclitaxel|paclitaxel|mesh-list
19861690|NCT00796991|Carboplatin|carboplatin|mesh-list
19861691|NCT00796991|Ipilimumab|ipilimumab|mesh-list
19861692|NCT00796991|Dacarbazine|dacarbazine|mesh-list
19861693|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19861694|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861695|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19861696|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19861697|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19861698|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719893|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
19861699|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19861700|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19734460|NCT04550585|Insulin|insulin|mesh-list
19719894|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19719895|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19719896|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19719897|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19719898|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719899|NCT04714073|Itraconazole|itraconazole|mesh-list
19719900|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
19719901|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719902|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19719903|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19719904|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719905|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719906|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19719907|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
19719908|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719909|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719910|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19719911|NCT04714112|Dexamethasone|dexamethasone|mesh-list
19861701|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19861702|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
20253021|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20253022|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20253023|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20253024|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253025|NCT00457483|Diuretics|diuretics|mesh-ancestor
19861703|NCT00797108|Amoxicillin|amoxicillin|mesh-list
19861704|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
19861705|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
19861706|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
19861707|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19861708|NCT00797108|Lactams|lactams|mesh-list
19861709|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19861710|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861711|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19861712|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861713|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861714|NCT00797225|Leuprolide|leuprolide|mesh-list
19861715|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19861716|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
19861717|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19861718|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861719|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19861720|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861721|NCT00797277|Lorazepam|lorazepam|mesh-list
19861722|NCT00797277|Haloperidol|haloperidol|mesh-list
19861723|NCT00797277|Olanzapine|olanzapine|mesh-list
19861724|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
19861725|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
19861726|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
19861727|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861728|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861729|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861730|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19861731|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19861732|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19861733|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861734|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19861735|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861736|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861737|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861738|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861739|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
19861740|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19861741|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
19861742|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20253026|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
20253027|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253028|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20253029|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20253030|NCT00457509|Vaccines|vaccines|mesh-list
20253031|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
20253032|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253033|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20253034|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20253035|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20253036|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
20253037|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253038|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20253039|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20253040|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253041|NCT00457678|Dexamethasone|dexamethasone|mesh-list
20253042|NCT00457678|Ranibizumab|ranibizumab|mesh-list
19861743|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
19861744|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19861745|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19861746|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
19861747|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
19861748|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19861749|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19861750|NCT00797316|Diuretics|diuretics|mesh-ancestor
19861751|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
19861752|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861753|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19861754|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861755|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861756|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
19861757|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19861758|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
19861759|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861760|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
19861761|NCT00797459|Protective Agents|protective agents|mesh-ancestor
19861762|NCT00797797|Milnacipran|milnacipran|mesh-list
20253043|NCT00457678|Verteporfin|verteporfin|mesh-list
20253044|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20253045|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
20253046|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
20253047|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253048|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253049|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20253050|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
20253051|NCT00457678|Hormones|hormones|mesh-ancestor
20253052|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253053|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20253054|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253055|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19719912|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
19719913|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19719914|NCT04714112|BB 1101|bb 1101|mesh-list
19719915|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861763|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
19861764|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19861765|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861766|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861767|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719916|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
19719917|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
19719918|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19719919|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719920|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19719921|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
19719922|NCT04714112|Hormones|hormones|mesh-ancestor
19719923|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719924|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19719925|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719926|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19719927|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719928|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719929|NCT04714099|Cyclosporine|cyclosporine|mesh-list
19719930|NCT04714099|Cyclosporins|cyclosporins|mesh-list
19719931|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719932|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719933|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719934|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
19719935|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719936|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
19719937|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719938|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
19719939|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719940|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19719941|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
19719942|NCT04713956|Busulfan|busulfan|mesh-list
19719943|NCT04713956|Fludarabine|fludarabine|mesh-list
19861768|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861769|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861770|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19861771|NCT00797797|Analgesics|analgesics|mesh-ancestor
19861772|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
19861773|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861774|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
19861775|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861776|NCT00797823|Insulin|insulin|mesh-list
19861777|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19861778|NCT00797823|Glucagon|glucagon|mesh-list
19861779|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19861780|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861781|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861782|NCT00797823|Hormones|hormones|mesh-ancestor
19861783|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861784|NCT00797862|Amlodipine|amlodipine|mesh-list
19861785|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19861786|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19861787|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19861788|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861789|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861790|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19861791|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861792|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
19861793|NCT00797862|Diuretics|diuretics|mesh-ancestor
20253056|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19438677|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
19438678|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19438679|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438680|NCT03473639|Capecitabine|capecitabine|mesh-list
19438681|NCT03473639|Entinostat|entinostat|mesh-list
19438682|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19438683|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
19438684|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719944|NCT04713956|Decitabine|decitabine|mesh-list
19719945|NCT04713956|Sargramostim|sargramostim|mesh-list
19719946|NCT04713956|Lenograstim|lenograstim|mesh-list
19719947|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19719948|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
19719949|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719950|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19719951|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19719952|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
19719953|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719954|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719955|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19719956|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19719957|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
19719958|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19719959|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19719960|NCT04714177|Edaravone|edaravone|mesh-list
19719961|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19719962|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
19719963|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19719964|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19719965|NCT04714177|Protective Agents|protective agents|mesh-ancestor
19719966|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719967|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19719968|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19719969|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19719970|NCT04713904|Estradiol|estradiol|mesh-list
19719971|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19719972|NCT04713904|Estrogens|estrogens|mesh-ancestor
19719973|NCT04713904|Hormones|hormones|mesh-ancestor
19861794|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
19861795|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19861796|NCT00797966|Citalopram|citalopram|mesh-list
19861797|NCT00797966|Fluoxetine|fluoxetine|mesh-list
19861798|NCT00797966|Paroxetine|paroxetine|mesh-list
20253057|NCT00457678|Growth Substances|growth substances|mesh-ancestor
19719974|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19719975|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19719976|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19719977|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
19719978|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19719979|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19719980|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19719981|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19719982|NCT04713891|Atezolizumab|atezolizumab|mesh-list
19719983|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19719984|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19719985|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
20253058|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
20253059|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20253060|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
20253061|NCT00457717|Atropine|atropine|mesh-list
20253062|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20253063|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20253064|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20253065|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
19719986|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861799|NCT00797966|Sertraline|sertraline|mesh-list
19719987|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19861800|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20253066|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253067|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253068|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20253069|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
20253070|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
19719988|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719989|NCT04713787|Albendazole|albendazole|mesh-list
19719990|NCT04713787|Oxfendazole|oxfendazole|mesh-list
19719991|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
19719992|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19719993|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19719994|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
19719995|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19719996|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19719997|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
19719998|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
19719999|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
19720000|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720001|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720002|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
19720003|NCT04713644|Propofol|propofol|mesh-list
19720004|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19720005|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253071|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
20253072|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20253073|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20253074|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
20253075|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253076|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253077|NCT00457769|Donepezil|donepezil|mesh-list
20253078|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20253079|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720006|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861801|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
20253080|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253081|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
19438685|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438686|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19438687|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438688|NCT03473626|Alicaforsen|alicaforsen|mesh-list
19438689|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438690|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19438691|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
19438692|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438693|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
19438694|NCT03473613|Cabergoline|cabergoline|mesh-list
19438695|NCT03473613|Calcium|calcium|mesh-list
19438696|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19720007|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19861802|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19861803|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861804|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861805|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861806|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861807|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
19861808|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861809|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19720008|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
19720009|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
19861810|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
19861811|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861812|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19861813|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19861814|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861815|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19861816|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
19861817|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
19861818|NCT00798018|Lidocaine|lidocaine|mesh-list
19861819|NCT00798018|Tetracaine|tetracaine|mesh-list
19861820|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
19861821|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
19861822|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19861823|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861824|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
19861825|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19861826|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19861827|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19861828|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19861829|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861830|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861831|NCT00798135|Itraconazole|itraconazole|mesh-list
19861832|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
19861833|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19861834|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19861835|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19861836|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861837|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861838|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19861839|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
19861840|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861841|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861842|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19861843|NCT00798161|Metformin|metformin|mesh-list
19861844|NCT00798161|Linagliptin|linagliptin|mesh-list
19861845|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19861846|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861847|NCT00798161|Incretins|incretins|mesh-ancestor
19861848|NCT00798161|Hormones|hormones|mesh-ancestor
19861849|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861850|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20253082|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253083|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253084|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
20253085|NCT00457808|Sirolimus|sirolimus|mesh-list
20253086|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20253087|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253088|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19861851|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
19861852|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861853|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861854|NCT00798304|Vaccines|vaccines|mesh-list
19861855|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
19861856|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861857|NCT00798317|Plasminogen|plasminogen|mesh-list
19861858|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19861859|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20253089|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253090|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
19720010|NCT04713488|Vaccines|vaccines|mesh-list
19720011|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
19720012|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720013|NCT04713735|Lactoferrin|lactoferrin|mesh-list
19720014|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720015|NCT04713761|Carboplatin|carboplatin|mesh-list
19720016|NCT04713761|Pemetrexed|pemetrexed|mesh-list
19720017|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720018|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720019|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720020|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19720021|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19720022|NCT04713631|Artesunate|artesunate|mesh-list
19720023|NCT04713631|Curcumin|curcumin|mesh-list
19720024|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19720025|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19720026|NCT04713631|Analgesics|analgesics|mesh-ancestor
19720027|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
19720028|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720029|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720030|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720031|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720032|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720033|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720034|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720035|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
19720036|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19720037|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19720038|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720039|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
19720040|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
19720041|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19720042|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
19720043|NCT04713254|Metoprolol|metoprolol|mesh-list
19720044|NCT04713254|Midazolam|midazolam|mesh-list
19720045|NCT04713254|Bupropion|bupropion|mesh-list
19720046|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19720047|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19720048|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720049|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720050|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19720051|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19720052|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861860|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861861|NCT00798369|Triamcinolone|triamcinolone|mesh-list
19861862|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19861863|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19861864|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19861865|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19861866|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861867|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
19861868|NCT00798369|Hormones|hormones|mesh-ancestor
19861869|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861870|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861871|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19861872|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
19861873|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861874|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861875|NCT00798434|Fesoterodine|fesoterodine|mesh-list
19861876|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20253091|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720053|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19861877|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19720054|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
19720055|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
19720056|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
19720057|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
19720058|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720059|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720060|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19720061|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
19720062|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19720063|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19720064|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720065|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
19720066|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19720067|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19720068|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720069|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19720070|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19720071|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
19720072|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
19720073|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720074|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19720075|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19720076|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19720077|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
19720078|NCT04713176|Remdesivir|remdesivir|mesh-list
19720079|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
19720080|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720081|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
19720082|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720083|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
19720084|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
19720085|NCT04713371|Ipilimumab|ipilimumab|mesh-list
19720086|NCT04713371|Sargramostim|sargramostim|mesh-list
19720087|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720088|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
19720089|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861878|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
19861879|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861880|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861881|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861882|NCT00798434|Urological Agents|urological agents|mesh-ancestor
19969691|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969692|NCT01774929|Analgesics|analgesics|mesh-ancestor
19969693|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
19969694|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969695|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19969696|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19969697|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
19969698|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
19969699|NCT01774968|Insulin|insulin|mesh-list
19969700|NCT01774968|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19969701|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969702|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969703|NCT01775124|Ranibizumab|ranibizumab|mesh-list
19969704|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19969705|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19969706|NCT01775124|Growth Substances|growth substances|mesh-ancestor
19969707|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969708|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
19969709|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969710|NCT01775189|Naltrexone|naltrexone|mesh-list
19969711|NCT01775189|Oxycodone|oxycodone|mesh-list
19969712|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19969713|NCT01775189|Narcotics|narcotics|mesh-ancestor
20253092|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
19720090|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720091|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19720092|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
19720093|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720094|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720095|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19720096|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19720097|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19720098|NCT04713410|Prednisolone|prednisolone|mesh-list
19720099|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720100|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
19720101|NCT04713410|Hormones|hormones|mesh-ancestor
19720102|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720103|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720104|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720105|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720106|NCT04713189|Fentanyl|fentanyl|mesh-list
19720107|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19720108|NCT04713189|Narcotics|narcotics|mesh-ancestor
19720109|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720110|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720111|NCT04713189|Analgesics|analgesics|mesh-ancestor
19720112|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
19720113|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720114|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19720115|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19720116|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
19720117|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
19720118|NCT04713163|Vaccines|vaccines|mesh-list
19720119|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
19720120|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720121|NCT04713332|Vitamin E|vitamin e|mesh-list
19720122|NCT04713332|Tocopherols|tocopherols|mesh-list
19720123|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
19720124|NCT04713332|Vitamins|vitamins|mesh-ancestor
19720125|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
19861883|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19861884|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19861885|NCT00798603|Bevacizumab|bevacizumab|mesh-list
19861886|NCT00798603|Carboplatin|carboplatin|mesh-list
19861887|NCT00798603|Pemetrexed|pemetrexed|mesh-list
19861888|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19861889|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861890|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861891|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861892|NCT00798603|Growth Substances|growth substances|mesh-ancestor
19861893|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861894|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861895|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861896|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861897|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19861898|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19861899|NCT00798655|Cisplatin|cisplatin|mesh-list
19861900|NCT00798655|Panitumumab|panitumumab|mesh-list
19861901|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861902|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19861903|NCT00798694|Travoprost|travoprost|mesh-list
19861904|NCT00798694|Latanoprost|latanoprost|mesh-list
19861905|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19861906|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19861907|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19861908|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19861909|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19861910|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861911|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861912|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861913|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861914|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861915|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
19861916|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19861917|NCT00798720|Bortezomib|bortezomib|mesh-list
19861918|NCT00798720|Vorinostat|vorinostat|mesh-list
19861919|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720126|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861920|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19720127|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
19720128|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720129|NCT04713332|Protective Agents|protective agents|mesh-ancestor
19720130|NCT04712929|Fluconazole|fluconazole|mesh-list
19720131|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
19720132|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720133|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19720134|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19720135|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720136|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720137|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19720138|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
19720139|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720140|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720141|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19720142|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19720143|NCT04712734|Iloperidone|iloperidone|mesh-list
19720144|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19720145|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19720146|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720147|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720148|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19720149|NCT04712539|Oseltamivir|oseltamivir|mesh-list
19720150|NCT04712539|Baloxavir|baloxavir|mesh-list
19720151|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
19720152|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720153|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720154|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720155|NCT04712799|Xylometazoline|xylometazoline|mesh-list
19720156|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
19720157|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19720158|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
19720159|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
19720160|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19720161|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
19720162|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720163|NCT04712435|Expectorants|expectorants|mesh-ancestor
19720164|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
19720165|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19720166|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
19720167|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720168|NCT04712435|Protective Agents|protective agents|mesh-ancestor
19720169|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720170|NCT04712435|Antidotes|antidotes|mesh-ancestor
19720171|NCT04712357|Ascorbic Acid|ascorbic acid|mesh-list
19720172|NCT04712357|Tenofovir|tenofovir|mesh-list
19720173|NCT04712357|Emtricitabine|emtricitabine|mesh-list
19720174|NCT04712357|Vitamins|vitamins|mesh-ancestor
19720175|NCT04712357|Micronutrients|micronutrients|mesh-ancestor
19720176|NCT04712357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720177|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
19720178|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720179|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19720180|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19720181|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720182|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720183|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19720184|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19720185|NCT04712357|Antioxidants|antioxidants|mesh-ancestor
19720186|NCT04712357|Protective Agents|protective agents|mesh-ancestor
19734461|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19861921|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861922|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861923|NCT00798759|Travoprost|travoprost|mesh-list
19734462|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19734463|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734464|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
19734465|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19734466|NCT04550611|Antibodies|antibodies|mesh-list
19720187|NCT04712396|Itraconazole|itraconazole|mesh-list
19720188|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
19720189|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720190|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19720191|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19720192|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720193|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720194|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19861924|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19438697|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438698|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19438699|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19438700|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19438701|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
19438702|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
19438703|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438704|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438705|NCT03473600|Triamcinolone|triamcinolone|mesh-list
19438706|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19438707|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19438708|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19720195|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
19720196|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720197|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720198|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19720199|NCT04712266|Insulin|insulin|mesh-list
19720200|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19720201|NCT04712266|Glucagon|glucagon|mesh-list
19720202|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19720203|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720204|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19720205|NCT04712266|Hormones|hormones|mesh-ancestor
19720206|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720207|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
19720208|NCT04712279|Ivermectin|ivermectin|mesh-list
19720209|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
19720210|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19720211|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19720212|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720213|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720214|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720215|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720216|NCT04711889|Urinastatin|urinastatin|mesh-list
19720217|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19720218|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19720219|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
19720220|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720221|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720222|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
19720223|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19720224|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19720225|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720226|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720227|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19720228|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19720229|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19720230|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720231|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720232|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720233|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
19720234|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19720235|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
19720236|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19720237|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19720238|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720239|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19720240|NCT04712058|Tenofovir|tenofovir|mesh-list
19720241|NCT04712058|Emtricitabine|emtricitabine|mesh-list
19720242|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19720243|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
19720244|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720245|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19720246|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19720247|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720248|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720249|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19720250|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19720251|NCT04711668|Lidocaine|lidocaine|mesh-list
19720252|NCT04711668|Ketamine|ketamine|mesh-list
19720253|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
19720254|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
19720255|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720256|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720257|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
19720258|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720259|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19720260|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19720261|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19720262|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720263|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720264|NCT04711668|Analgesics|analgesics|mesh-ancestor
19720265|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19720266|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19720267|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
19720268|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19720269|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19720270|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720271|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
19720272|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19720273|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
19720274|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720275|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
19720276|NCT04711642|Protective Agents|protective agents|mesh-ancestor
19720277|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19720278|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19720279|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19720280|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19720281|NCT04711291|Tacrolimus|tacrolimus|mesh-list
19720282|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720283|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
19720284|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720285|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19720286|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720287|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720288|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
19720289|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19720290|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
19720291|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720292|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
19720293|NCT04711304|Protective Agents|protective agents|mesh-ancestor
19720294|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19720295|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
19720296|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720297|NCT04711265|Vaccines|vaccines|mesh-list
19720298|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
19720299|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720300|NCT04711434|Antibodies|antibodies|mesh-list
19720301|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
19720302|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720303|NCT04711213|Dexamethasone|dexamethasone|mesh-list
19720304|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
19720305|NCT04711213|BB 1101|bb 1101|mesh-list
19438709|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438710|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
19438711|NCT03473600|Hormones|hormones|mesh-ancestor
19438712|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438713|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438714|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19438715|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
19438716|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438717|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438718|NCT03473431|Ketamine|ketamine|mesh-list
19438719|NCT03473431|Analgesics|analgesics|mesh-ancestor
19438720|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
19438721|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438722|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438723|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19438724|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19438725|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
19438726|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
19720306|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720307|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
19720308|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
19438727|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438728|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19438729|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19438730|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438731|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438732|NCT03473418|Ketoconazole|ketoconazole|mesh-list
19861925|NCT00798759|Latanoprost|latanoprost|mesh-list
19861926|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19861927|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19861928|NCT00798889|Sunitinib|sunitinib|mesh-list
19861929|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861930|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19861931|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19861932|NCT00798889|Growth Substances|growth substances|mesh-ancestor
19861933|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861934|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
19861935|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19861936|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19861937|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861938|NCT00798967|Teduglutide|teduglutide|mesh-list
19438733|NCT03473418|Terconazole|terconazole|mesh-list
19438734|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
19438735|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438736|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19438737|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19438738|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438739|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438740|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19438741|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
19438742|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720309|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720310|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720311|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19720312|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
19720313|NCT04711213|Hormones|hormones|mesh-ancestor
19720314|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734467|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
19438743|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438744|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19438745|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
19438746|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19438747|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
19438748|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438749|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438750|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19438751|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
19438752|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19438753|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
19438754|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438755|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438756|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19438757|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
19438758|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
19438759|NCT03473314|Protective Agents|protective agents|mesh-ancestor
19438760|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19438761|NCT03473210|Erythromycin|erythromycin|mesh-list
19438762|NCT03473210|Ampicillin|ampicillin|mesh-list
19438763|NCT03473210|Dexamethasone|dexamethasone|mesh-list
19438764|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438765|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
19438766|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
19438767|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438768|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438769|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19438770|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
19438771|NCT03473210|Hormones|hormones|mesh-ancestor
19438772|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861939|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861940|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19861941|NCT00798967|Protective Agents|protective agents|mesh-ancestor
19861942|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861943|NCT00799227|Dexamethasone|dexamethasone|mesh-list
19861944|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19861945|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
19861946|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
19861947|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720315|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720316|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720317|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
19720318|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720319|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720320|NCT04711161|Paclitaxel|paclitaxel|mesh-list
19720321|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19720322|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720323|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
19720324|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
19720325|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
19720326|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720327|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19720328|NCT04711122|Cephalosporins|cephalosporins|mesh-list
19720329|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720330|NCT04711096|Bupivacaine|bupivacaine|mesh-list
19720331|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
19720332|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
19720333|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720334|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861948|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861949|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19861950|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
19861951|NCT00799227|Hormones|hormones|mesh-ancestor
19861952|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861953|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19861954|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19861955|NCT00799383|Vitamin D|vitamin d|mesh-list
19861956|NCT00799383|Calcium|calcium|mesh-list
19861957|NCT00799383|Vitamins|vitamins|mesh-ancestor
19861958|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
19861959|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861960|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19861961|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19861962|NCT00799409|Methylphenidate|methylphenidate|mesh-list
19861963|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19861964|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861965|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19861966|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861967|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861968|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861969|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
19861970|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861971|NCT00799435|Exenatide|exenatide|mesh-list
19861972|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19861973|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861974|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19861975|NCT00799435|Incretins|incretins|mesh-ancestor
19861976|NCT00799435|Hormones|hormones|mesh-ancestor
19861977|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19861978|NCT00799487|Methylphenidate|methylphenidate|mesh-list
19438773|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19438774|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438775|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438776|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438777|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438778|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19438779|NCT03473132|Thrombin|thrombin|mesh-list
19438780|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
19438781|NCT03473132|Coagulants|coagulants|mesh-ancestor
19438782|NCT03473093|Pregabalin|pregabalin|mesh-list
19438783|NCT03473093|Morphine|morphine|mesh-list
19438784|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19438785|NCT03473093|Narcotics|narcotics|mesh-ancestor
19438786|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720335|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
19734468|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19720336|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720337|NCT04710927|Fluorides|fluorides|mesh-list
19720338|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
19720339|NCT04710927|Protective Agents|protective agents|mesh-ancestor
19720340|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720341|NCT04710914|Midazolam|midazolam|mesh-list
19720342|NCT04710914|Isoflurane|isoflurane|mesh-list
19720343|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19720344|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19720345|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720346|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720347|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19720348|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19720349|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19720350|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19720351|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
19720352|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
19720353|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
19720354|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
19720355|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720356|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720357|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19720358|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19720359|NCT04711044|Menthol|menthol|mesh-list
19720360|NCT04711044|Histamine|histamine|mesh-list
19720361|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
19720362|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
19720363|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
19720364|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
19720365|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720366|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720367|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720368|NCT04710719|Triamcinolone|triamcinolone|mesh-list
19720369|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19720370|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19720371|NCT04710719|Fluorouracil|fluorouracil|mesh-list
19720372|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19720373|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
19720374|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720375|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19720376|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720377|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720378|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
19720379|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861979|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19861980|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861981|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19861982|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19861983|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861984|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861985|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
19861986|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19861987|NCT00799578|Cysteamine|cysteamine|mesh-list
19720380|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720381|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
19720382|NCT04710719|Hormones|hormones|mesh-ancestor
19720383|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720384|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720385|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
19720386|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
19720387|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720388|NCT04710329|Protective Agents|protective agents|mesh-ancestor
19720389|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720390|NCT04710329|Vitamins|vitamins|mesh-ancestor
19720391|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
19734469|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
19734470|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734471|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
19734472|NCT04550624|Lenvatinib|lenvatinib|mesh-list
19734473|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734474|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734475|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19734476|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734477|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734478|NCT04550104|Olaparib|olaparib|mesh-list
19438787|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438788|NCT03473093|Analgesics|analgesics|mesh-ancestor
19438789|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
19438790|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438791|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
19438792|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19438793|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19438794|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438795|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19438796|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19438797|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19438798|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19438799|NCT03472976|Imiquimod|imiquimod|mesh-list
19438800|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19438801|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
19438802|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438803|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438804|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
19438805|NCT03472963|Darunavir|darunavir|mesh-list
19438806|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19734479|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19720392|NCT04710498|Atezolizumab|atezolizumab|mesh-list
19720393|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720394|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19720395|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
19720396|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
19720397|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19720398|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19720399|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861988|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19861989|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861990|NCT00799604|Clevidipine|clevidipine|mesh-list
19861991|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19861992|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19861993|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19861994|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19861995|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19861996|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
19861997|NCT00799617|Testosterone|testosterone|mesh-list
19861998|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
19861999|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
19862000|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19862001|NCT00799617|Androgens|androgens|mesh-ancestor
19862002|NCT00799617|Hormones|hormones|mesh-ancestor
19862003|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862004|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862005|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19862006|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862007|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
19862008|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19862009|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
19862010|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19862011|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19862012|NCT00799643|Analgesics|analgesics|mesh-ancestor
19862013|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
19862014|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862015|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862016|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862017|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862018|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19862019|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862020|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862021|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19862022|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19862023|NCT00799708|Estradiol|estradiol|mesh-list
19862024|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19862025|NCT00799708|Estrogens|estrogens|mesh-ancestor
19862026|NCT00799708|Hormones|hormones|mesh-ancestor
19862027|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862028|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862029|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19862030|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
19720400|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
19720401|NCT04710017|Coagulants|coagulants|mesh-ancestor
19720402|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19720403|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19720404|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19720405|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
19720406|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19720407|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720408|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19862031|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19862032|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19862033|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19862034|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19862035|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862036|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
19862037|NCT00799903|Darapladib|darapladib|mesh-list
19862038|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19862039|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862040|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862041|NCT00800202|Paclitaxel|paclitaxel|mesh-list
19862042|NCT00800202|Bevacizumab|bevacizumab|mesh-list
19862043|NCT00800202|Carboplatin|carboplatin|mesh-list
19862044|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19862045|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19862046|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862047|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19862048|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19862049|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19862050|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862051|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19862052|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19862053|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19862054|NCT00800202|Growth Substances|growth substances|mesh-ancestor
19862055|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862056|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
19862057|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19862058|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862059|NCT00800345|Topotecan|topotecan|mesh-list
19862060|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19862061|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19862062|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862063|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862064|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862065|NCT00800436|Trastuzumab|trastuzumab|mesh-list
19862066|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19862067|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862068|NCT00800540|Timolol|timolol|mesh-list
19862069|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19862070|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19862071|NCT00800540|Brinzolamide|brinzolamide|mesh-list
19862072|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19862073|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19862074|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19862075|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
19862076|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862077|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862078|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862079|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19862080|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19862081|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19862082|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19862083|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19862084|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19862085|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862086|NCT00800683|Linagliptin|linagliptin|mesh-list
19862087|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19862088|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862089|NCT00800683|Incretins|incretins|mesh-ancestor
19862090|NCT00800683|Hormones|hormones|mesh-ancestor
19862091|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862092|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19862093|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
19862094|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862095|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862096|NCT00800735|Interferons|interferons|mesh-list
19720409|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19720410|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19720411|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720412|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720413|NCT04710160|Calcium|calcium|mesh-list
19720414|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19720415|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720416|NCT04709770|Simethicone|simethicone|mesh-list
19720417|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720418|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
19720419|NCT04709770|Emollients|emollients|mesh-ancestor
19720420|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
19720421|NCT04709731|Ponatinib|ponatinib|mesh-list
19720422|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720423|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19720424|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720425|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720426|NCT04709744|Vitamin D|vitamin d|mesh-list
19720427|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
19720428|NCT04709744|Vitamins|vitamins|mesh-list
19720429|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
19720430|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720431|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19720432|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19720433|NCT04709380|Sorafenib|sorafenib|mesh-list
19862097|NCT00800735|Ribavirin|ribavirin|mesh-list
19862098|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
19862099|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
19862100|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19862101|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862102|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
19862103|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862104|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
19862105|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862106|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
19720434|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720435|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19720436|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720437|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720438|NCT04709185|Dexamethasone|dexamethasone|mesh-list
19720439|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720440|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
19720441|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
19720442|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720443|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720444|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19720445|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
19720446|NCT04709185|Hormones|hormones|mesh-ancestor
19720447|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720448|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720449|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720450|NCT04709172|Cefditoren|cefditoren|mesh-list
19720451|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
19720452|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19720453|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720454|NCT04709315|Choline|choline|mesh-list
19720455|NCT04709315|Rocuronium|rocuronium|mesh-list
19720456|NCT04709315|Succinylcholine|succinylcholine|mesh-list
19720457|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19720458|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19720459|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19720460|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862107|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720461|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720462|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
19862108|NCT00800839|Vidarabine|vidarabine|mesh-list
19720463|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19720464|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
19720465|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720466|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19720467|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19720468|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
19720469|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19720470|NCT04709094|Bupropion|bupropion|mesh-list
19720471|NCT04709094|Warfarin|warfarin|mesh-list
19720472|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19720473|NCT04709094|Norethindrone|norethindrone|mesh-list
19720474|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
19720475|NCT04709094|Norinyl|norinyl|mesh-list
19720476|NCT04709094|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19720477|NCT04709094|Estradiol|estradiol|mesh-list
19720478|NCT04709094|Estrogens|estrogens|mesh-ancestor
19720479|NCT04709094|Hormones|hormones|mesh-ancestor
19720480|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720481|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720482|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19720483|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
19720484|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19720485|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19720486|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
19720487|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19720488|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
19720489|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19720490|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19720491|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19720492|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720493|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720494|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
19862109|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
19862110|NCT00800839|Busulfan|busulfan|mesh-list
19862111|NCT00800839|Fludarabine|fludarabine|mesh-list
19862112|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
19862113|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862114|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
19862115|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862116|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862117|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19862118|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
20253093|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253094|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
20253095|NCT00457860|Immunotoxins|immunotoxins|mesh-list
20253096|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
20253097|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253098|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253099|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20253100|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
20253101|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19862119|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253102|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20253103|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20253104|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253105|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253106|NCT00457964|Everolimus|everolimus|mesh-list
20253107|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253108|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253109|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
20253110|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253111|NCT00458003|Phenylephrine|phenylephrine|mesh-list
20253112|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
20253113|NCT00458003|Ephedrine|ephedrine|mesh-list
20253114|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20533786|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533787|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533788|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
20533789|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533790|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20533791|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20533792|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19720495|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720496|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19720497|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19720498|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720499|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19720500|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19720501|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19720502|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19720503|NCT04709094|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19720504|NCT04709211|Bupivacaine|bupivacaine|mesh-list
19862120|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862121|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20253115|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
20253116|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
20253117|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720505|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
19720506|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
19720507|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720508|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862122|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19862123|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
19862124|NCT00800839|Antiviral Agents|antiviral agents|mesh-ancestor
19862125|NCT00800839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862126|NCT00800982|Etanercept|etanercept|mesh-list
19862127|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19862128|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19862129|NCT00800982|Analgesics|analgesics|mesh-ancestor
19862130|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
19862131|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862132|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862133|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862134|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862135|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862136|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862137|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
19862138|NCT00801099|Amoxicillin|amoxicillin|mesh-list
19862139|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19862140|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
19862141|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
19862142|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19862143|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862144|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19862145|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862146|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862147|NCT00801138|Dexamethasone|dexamethasone|mesh-list
19862148|NCT00801138|Bupivacaine|bupivacaine|mesh-list
19862149|NCT00801138|Ropivacaine|ropivacaine|mesh-list
19862150|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862151|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
19862152|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
19862153|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720509|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
19720510|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720511|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19720512|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19720513|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
19720514|NCT04709081|Itraconazole|itraconazole|mesh-list
19720515|NCT04709081|Digoxin|digoxin|mesh-list
19720516|NCT04709081|Midazolam|midazolam|mesh-list
19720517|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19720518|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19720519|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720520|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720521|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19720522|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20253118|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253119|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
20253120|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20253121|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
20253122|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
20253123|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20253124|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20253125|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19720523|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19720524|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19720525|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
19862154|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862155|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862156|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
19862157|NCT00801138|Hormones|hormones|mesh-ancestor
19862158|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862159|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19862160|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862161|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
19862162|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
19862163|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862164|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
19862165|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19862166|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20253126|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
19720526|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
19720527|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
19720528|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
19720529|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720530|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720531|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
19720532|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720533|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19720534|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19720535|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720536|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19720537|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
19720538|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720539|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19720540|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19720541|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19720542|NCT04709081|Protective Agents|protective agents|mesh-ancestor
19720543|NCT04709276|Carboplatin|carboplatin|mesh-list
19720544|NCT04709276|Nivolumab|nivolumab|mesh-list
19720545|NCT04709276|Ipilimumab|ipilimumab|mesh-list
19720546|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720547|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19720548|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19720549|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720550|NCT04709029|Dexamethasone|dexamethasone|mesh-list
19720551|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
19720552|NCT04709029|BB 1101|bb 1101|mesh-list
19720553|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720554|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
19720555|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
19720556|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720557|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862167|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720558|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19720559|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
19720560|NCT04709029|Hormones|hormones|mesh-ancestor
19720561|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720562|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720563|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720564|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
19862168|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19862169|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19862170|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862171|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862172|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
19862173|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862174|NCT00801398|Oxymorphone|oxymorphone|mesh-list
19862175|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19862176|NCT00801398|Narcotics|narcotics|mesh-ancestor
19862177|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862178|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862179|NCT00801398|Analgesics|analgesics|mesh-ancestor
19862180|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
19862181|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862182|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19862183|NCT00801632|Prednisone|prednisone|mesh-list
19862184|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
19862185|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
19862186|NCT00801632|Rituximab|rituximab|mesh-list
19862187|NCT00801632|Tacrolimus|tacrolimus|mesh-list
19862188|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862189|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
19862190|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862191|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862192|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19862193|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
19862194|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862195|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862196|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19862197|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19862198|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862199|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
19862200|NCT00801632|Hormones|hormones|mesh-ancestor
19862201|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862202|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720565|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720566|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720567|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19720568|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19720569|NCT04708821|Dexamethasone|dexamethasone|mesh-list
19862203|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19862204|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862205|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
19862206|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
19862207|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862208|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862209|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19862210|NCT00801632|Protective Agents|protective agents|mesh-ancestor
19862211|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19862212|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
19862213|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19862214|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
19862215|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438807|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19862216|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862217|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19862218|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
19862219|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19862220|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19862221|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19862222|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
19862223|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862224|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862225|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
19862226|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19862227|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
19862228|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19862229|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19438808|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19438809|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
19438810|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438811|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438812|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19438813|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19438814|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
19438815|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438816|NCT03472950|Ranolazine|ranolazine|mesh-list
19438817|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19720570|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19720571|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720572|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
19720573|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
19720574|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720575|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720576|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19720577|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
19720578|NCT04708821|Hormones|hormones|mesh-ancestor
19720579|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734480|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720580|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720581|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720582|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19720583|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19720584|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19720585|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19720586|NCT04708821|Analgesics|analgesics|mesh-ancestor
19720587|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
19720588|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720589|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19720590|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19720591|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
19720592|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
19862230|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19862231|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862232|NCT00801723|Budesonide|budesonide|mesh-list
19862233|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862234|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19862235|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
19862236|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862237|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862238|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19862239|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
19862240|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
19862241|NCT00801723|Hormones|hormones|mesh-ancestor
19862242|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862243|NCT00801801|Docetaxel|docetaxel|mesh-list
19862244|NCT00801801|Sorafenib|sorafenib|mesh-list
19862245|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862246|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
19862247|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
19862248|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
19862249|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862250|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19862251|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862252|NCT00801827|Fallypride|fallypride|mesh-list
19862253|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19862254|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19862255|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
19862256|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862257|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862258|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862259|NCT00802074|Ritonavir|ritonavir|mesh-list
19862260|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
19862261|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
19862262|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19862263|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19862264|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
19862265|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862266|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862267|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19862268|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19862269|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
19862270|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862271|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19862272|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19862273|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19862274|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19862275|NCT00802100|Metformin|metformin|mesh-list
19862276|NCT00802100|Benztropine|benztropine|mesh-list
19862277|NCT00802100|Olanzapine|olanzapine|mesh-list
19862278|NCT00802100|Aripiprazole|aripiprazole|mesh-list
19862279|NCT00802100|Perphenazine|perphenazine|mesh-list
19862280|NCT00802100|Simvastatin|simvastatin|mesh-list
19862281|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19862282|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862283|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19862284|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19862285|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
19862286|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862287|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19862288|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19862289|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862290|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
19862291|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
19720593|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720594|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720595|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
19720596|NCT04708964|Analgesics|analgesics|mesh-ancestor
19720597|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
19720598|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720599|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720600|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19720601|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19720602|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720603|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720604|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19720605|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720606|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720607|NCT04708496|Efavirenz|efavirenz|mesh-list
19720608|NCT04708496|Lumefantrine|lumefantrine|mesh-list
19720609|NCT04708496|Dolutegravir|dolutegravir|mesh-list
19720610|NCT04708496|Artemether|artemether|mesh-list
19720611|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19720612|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19720613|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19720614|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720615|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720616|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
19720617|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720618|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19720619|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19720620|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19720621|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19720622|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19720623|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19720624|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
19720625|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19720626|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19720627|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19720628|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19862292|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862293|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862294|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19862295|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19862296|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862297|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19862298|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19862299|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19862300|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862301|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862302|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
19862303|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
19862304|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
19862305|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
19862306|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19862307|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19862308|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19862309|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19862310|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19862311|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19862312|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19862313|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19862314|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
19862315|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19862316|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19862317|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
19862318|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19862319|NCT00802113|Fludarabine|fludarabine|mesh-list
19862320|NCT00802113|Busulfan|busulfan|mesh-list
19862321|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19862322|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862323|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862324|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862325|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
19862326|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862327|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
19862328|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19862329|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19720629|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19720630|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19720631|NCT04708249|Inositol|inositol|mesh-list
19720632|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
19720633|NCT04708249|Vitamins|vitamins|mesh-ancestor
19720634|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
19720635|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734481|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734482|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734483|NCT04549935|Prednisolone|prednisolone|mesh-list
19734484|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734485|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
19734486|NCT04549935|Hormones|hormones|mesh-ancestor
19734487|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734488|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734489|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19734490|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734491|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
19734492|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
19734493|NCT04550078|Calcium|calcium|mesh-list
19734494|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19734495|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734496|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19734497|NCT04550078|Antacids|antacids|mesh-ancestor
19734498|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734499|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862330|NCT00802360|Menotropins|menotropins|mesh-list
19862331|NCT00802360|Progesterone|progesterone|mesh-list
19734500|NCT04549844|Bupivacaine|bupivacaine|mesh-list
19734501|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
19734502|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
19734503|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734504|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253127|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253128|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253129|NCT00458003|Protective Agents|protective agents|mesh-ancestor
20253130|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20253131|NCT00458042|Treprostinil|treprostinil|mesh-list
20253132|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20253133|NCT00458055|Niacin|niacin|mesh-list
20253134|NCT00458055|Atorvastatin|atorvastatin|mesh-list
20253135|NCT00458055|Fenofibrate|fenofibrate|mesh-list
20253136|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19734505|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
19862332|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19862333|NCT00802360|Ganirelix|ganirelix|mesh-list
19862334|NCT00802360|Progestins|progestins|mesh-ancestor
19862335|NCT00802360|Hormones|hormones|mesh-ancestor
19862336|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862337|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862338|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
19862339|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19862340|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
19862341|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19862342|NCT00802412|Topiramate|topiramate|mesh-list
19862343|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
19862344|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19862345|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862346|NCT00802529|Gentamicins|gentamicins|mesh-list
19862347|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
19862348|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19862349|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19862350|NCT00802529|Prednisolone|prednisolone|mesh-list
19862351|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
19862352|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19862353|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
19862354|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862355|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
19862356|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
20253137|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19862357|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862358|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862359|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862360|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
19862361|NCT00802529|Hormones|hormones|mesh-ancestor
19862362|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253138|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
19720636|NCT04708353|Ascorbic Acid|ascorbic acid|mesh-list
19720637|NCT04708353|Pregabalin|pregabalin|mesh-list
19720638|NCT04708353|Vitamins|vitamins|mesh-ancestor
19720639|NCT04708353|Micronutrients|micronutrients|mesh-ancestor
19720640|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720641|NCT04708353|Analgesics|analgesics|mesh-ancestor
19720642|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
19720643|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720644|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
19720645|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19720646|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720647|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720648|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19720649|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19720650|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19720651|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720652|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19862363|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19862364|NCT00802529|Protective Agents|protective agents|mesh-ancestor
19862365|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19862366|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862367|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19862368|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862369|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19862370|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862371|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862372|NCT00802672|Ciclopirox|ciclopirox|mesh-list
19862373|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
19862374|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862375|NCT00802685|Ibuprofen|ibuprofen|mesh-list
19862376|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19862377|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19862378|NCT00802685|Analgesics|analgesics|mesh-ancestor
19862379|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
19862380|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862381|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862382|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862383|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862384|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19862385|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862386|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862387|NCT00802737|Ofatumumab|ofatumumab|mesh-list
19862388|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862389|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
19862390|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862391|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19862392|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862393|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862394|NCT00802880|Dacarbazine|dacarbazine|mesh-list
19862395|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19862396|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
19862397|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862398|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862399|NCT00802919|Varenicline|varenicline|mesh-list
19862400|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19862401|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19862402|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
19862403|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862404|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862405|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862406|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
19862407|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862408|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19862409|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19862410|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862411|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862412|NCT00803010|Sirolimus|sirolimus|mesh-list
19862413|NCT00803010|Methotrexate|methotrexate|mesh-list
19862414|NCT00803010|Tacrolimus|tacrolimus|mesh-list
19862415|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19862416|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
19862417|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19720653|NCT04708353|Antioxidants|antioxidants|mesh-ancestor
19720654|NCT04708353|Protective Agents|protective agents|mesh-ancestor
19720655|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
19720656|NCT04707950|Oxytocin|oxytocin|mesh-list
19720657|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
19720658|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19720659|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720660|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19720661|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19720662|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720663|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
19720664|NCT04707950|Coagulants|coagulants|mesh-ancestor
19720665|NCT04708106|Menthol|menthol|mesh-list
19720666|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
19720667|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
19720668|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
19720669|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19720670|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
19720671|NCT04707742|Povidone|povidone|mesh-list
19720672|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
19720673|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
19720674|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19720675|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720676|NCT04707560|Heparin|heparin|mesh-list
19720677|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
19720678|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19720679|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19720680|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720681|NCT04707547|Nivolumab|nivolumab|mesh-list
19720682|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19720683|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720684|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19720685|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720686|NCT04707508|Metformin|metformin|mesh-list
19720687|NCT04707508|Valsartan|valsartan|mesh-list
19720688|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19720689|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720690|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19720691|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19720692|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19720693|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720694|NCT04707703|Isavuconazole|isavuconazole|mesh-list
19720695|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
19720696|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720697|NCT04707209|Sirolimus|sirolimus|mesh-list
19720698|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19720699|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720700|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19720701|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720702|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
19720703|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720704|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
19720705|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720706|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19720707|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720708|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
19720709|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19720710|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720711|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19720712|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720713|NCT04707118|Paclitaxel|paclitaxel|mesh-list
19720714|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19720715|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19720716|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720717|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19720718|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19720719|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19720720|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720721|NCT04707027|Aflibercept|aflibercept|mesh-list
19720722|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19720723|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19720724|NCT04707027|Growth Substances|growth substances|mesh-ancestor
19720725|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720726|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
19720727|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720728|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
19720729|NCT04706936|Fludarabine|fludarabine|mesh-list
19720730|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720731|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
19720732|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720733|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720734|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19720735|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
19720736|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720737|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720738|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19720739|NCT04706806|Acetic Acid|acetic acid|mesh-list
19720740|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19720741|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720742|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
19720743|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19720744|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720745|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19720746|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720747|NCT04706910|Furosemide|furosemide|mesh-list
19720748|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19720749|NCT04706910|Diuretics|diuretics|mesh-ancestor
19720750|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
19720751|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720752|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19720753|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720754|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720755|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
19720756|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720757|NCT04706949|Carboplatin|carboplatin|mesh-list
19720758|NCT04706949|Pemetrexed|pemetrexed|mesh-list
19720759|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720760|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720761|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720762|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19720763|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19720764|NCT04706897|Lidocaine|lidocaine|mesh-list
19720765|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
19720766|NCT04706897|Ketamine|ketamine|mesh-list
19720767|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
19720768|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
19720769|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720770|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862418|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720771|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
19720772|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720773|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19720774|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19720775|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19720776|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720777|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720778|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19720779|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19720780|NCT04706897|Analgesics|analgesics|mesh-ancestor
19720781|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19862419|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19862420|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
19862421|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862422|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862423|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
19862424|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862425|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19862426|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862427|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
19862428|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862429|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19862430|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19862431|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19862432|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862433|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19862434|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
19862435|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
19862436|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19862437|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19862438|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
19862439|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
19862440|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862441|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862442|NCT00803049|Teriflunomide|teriflunomide|mesh-list
19862443|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19862444|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19862445|NCT00803049|Analgesics|analgesics|mesh-ancestor
19862446|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
19862447|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862448|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862449|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862450|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862451|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862452|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
19862453|NCT00803062|Paclitaxel|paclitaxel|mesh-list
19862454|NCT00803062|Bevacizumab|bevacizumab|mesh-list
19862455|NCT00803062|Cisplatin|cisplatin|mesh-list
19862456|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20253139|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253140|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20253141|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20253142|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253143|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
20253144|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
20253145|NCT00458055|Vitamins|vitamins|mesh-ancestor
20253146|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
19862457|NCT00803062|Topotecan|topotecan|mesh-list
19862458|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19862459|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
19862460|NCT00803062|Antibodies|antibodies|mesh-list
19862461|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
19862462|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19862463|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
19862464|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19862465|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862466|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19862467|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
19862468|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19862469|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862470|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19862471|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19862472|NCT00803062|Growth Substances|growth substances|mesh-ancestor
19862473|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720782|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19720783|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19720784|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
19720785|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253147|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253148|NCT00458081|Rimonabant|rimonabant|mesh-list
20253149|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20253150|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20253151|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20253152|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253153|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720786|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19720787|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19720788|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
19720789|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19720790|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19720791|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
19720792|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19720793|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
19720794|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720795|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
19720796|NCT04706455|Protective Agents|protective agents|mesh-ancestor
19720797|NCT04706429|Trientine|trientine|mesh-list
19720798|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
19720799|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
19720800|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720801|NCT04706247|Anesthetics|anesthetics|mesh-list
19720802|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720803|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720804|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
19720805|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
19720806|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19720807|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19720808|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720809|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720810|NCT04706546|Urological Agents|urological agents|mesh-ancestor
19720811|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
19720812|NCT04706377|Vitamins|vitamins|mesh-ancestor
19720813|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
19720814|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720815|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
19734506|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734507|NCT04549467|Tenofovir|tenofovir|mesh-list
19734508|NCT04549467|Lamivudine|lamivudine|mesh-list
19734509|NCT04549467|Emtricitabine|emtricitabine|mesh-list
19734510|NCT04549467|Dolutegravir|dolutegravir|mesh-list
19734511|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
19734512|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734513|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19734514|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19734515|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734516|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734517|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19734518|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19734519|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19734520|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19734521|NCT04549415|Metformin|metformin|mesh-list
19734522|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19734523|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734524|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
19734525|NCT04549012|Oxytocin|oxytocin|mesh-list
19734526|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
19734527|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19862474|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
19862475|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
19862476|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19862477|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19862478|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862479|NCT00803101|Protein C|protein c|mesh-list
19862480|NCT00803101|Protein S|protein s|mesh-list
19734528|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734529|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19734530|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19734531|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720816|NCT04706091|Suvorexant|suvorexant|mesh-list
19720817|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19720818|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19720819|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720820|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720821|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19720822|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720823|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720824|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
19862481|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
19862482|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19862483|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19862484|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862485|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19862486|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19862487|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19862488|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862489|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862490|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862491|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862492|NCT00803361|Analgesics|analgesics|mesh-ancestor
19862493|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
19862494|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862495|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
19862496|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19862497|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
19862498|NCT00803400|Alprazolam|alprazolam|mesh-list
19862499|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19862500|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862501|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862502|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19862503|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19862504|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19862505|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
19862506|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
19862507|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862508|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862509|NCT00803452|Azithromycin|azithromycin|mesh-list
19862510|NCT00803452|Doxycycline|doxycycline|mesh-list
19720825|NCT04705948|Ketamine|ketamine|mesh-list
19720826|NCT04705948|Analgesics|analgesics|mesh-ancestor
19720827|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
19720828|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720829|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720830|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19720831|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19720832|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
19720833|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
19862511|NCT00803452|Minocycline|minocycline|mesh-list
19862512|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19720834|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720835|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19720836|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19720837|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720838|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720839|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19720840|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
19720841|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19720842|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720843|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19720844|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
19720845|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19720846|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19720847|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19720848|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720849|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
19720850|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720851|NCT04705987|Colchicine|colchicine|mesh-list
19720852|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
19862513|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720853|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720854|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
19720855|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
19720856|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
19720857|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720858|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720859|NCT04705909|Pitavastatin|pitavastatin|mesh-list
19720860|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19720861|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19720862|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19720863|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
19720864|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720865|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720866|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19720867|NCT04706026|Anesthetics|anesthetics|mesh-list
19720868|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720869|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720870|NCT04705727|Budesonide|budesonide|mesh-list
19720871|NCT04705727|Terbutaline|terbutaline|mesh-list
19720872|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
19720873|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19720874|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720875|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19720876|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
19720877|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720878|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720879|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19720880|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
19720881|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
19720882|NCT04705727|Hormones|hormones|mesh-ancestor
19720883|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862514|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
19862515|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19862516|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19862517|NCT00803543|Valacyclovir|valacyclovir|mesh-list
19862518|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
19862519|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862520|NCT00803569|Sargramostim|sargramostim|mesh-list
19862521|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
19862522|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862523|NCT00803595|Oseltamivir|oseltamivir|mesh-list
19862524|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
19862525|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862526|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720884|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19720885|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19720886|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19862527|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862528|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
19862529|NCT00803634|Diltiazem|diltiazem|mesh-list
19862530|NCT00803634|Nitroprusside|nitroprusside|mesh-list
19862531|NCT00803634|Nicardipine|nicardipine|mesh-list
19862532|NCT00803634|Clevidipine|clevidipine|mesh-list
19862533|NCT00803634|Isosorbide|isosorbide|mesh-list
19862534|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19862535|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
19862536|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
19862537|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19862538|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862539|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862540|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19862541|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862542|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19862543|NCT00803634|Diuretics|diuretics|mesh-ancestor
19862544|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
19862545|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19862546|NCT00803647|Leucovorin|leucovorin|mesh-list
19720887|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
19720888|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720889|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720890|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
19720891|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
19720892|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19720893|NCT04705584|Cyclosporine|cyclosporine|mesh-list
19720894|NCT04705584|Prednisolone|prednisolone|mesh-list
19720895|NCT04705584|Cyclosporins|cyclosporins|mesh-list
19720896|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720897|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720898|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19720899|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
19720900|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720901|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
19720902|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720903|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
19720904|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19720905|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19720906|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19720907|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
19720908|NCT04705584|Hormones|hormones|mesh-ancestor
19720909|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19720910|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19720911|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720912|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19720913|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19720914|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862547|NCT00803647|Fluorouracil|fluorouracil|mesh-list
19720915|NCT04705337|Simendan|simendan|mesh-list
19720916|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19720917|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
19720918|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19720919|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19720920|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720921|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720922|NCT04705337|Protective Agents|protective agents|mesh-ancestor
19720923|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720924|NCT04705480|Pregabalin|pregabalin|mesh-list
19720925|NCT04705480|Gabapentin|gabapentin|mesh-list
19720926|NCT04705480|Analgesics|analgesics|mesh-ancestor
19720927|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
19720928|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720929|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720930|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
19720931|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19720932|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19720933|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720934|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19720935|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19720936|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19720937|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720938|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19720939|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19720940|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19720941|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720942|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
19720943|NCT04705402|Mannitol|mannitol|mesh-list
19720944|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19720945|NCT04705402|Diuretics|diuretics|mesh-ancestor
19720946|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
19720947|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720948|NCT04705519|Paclitaxel|paclitaxel|mesh-list
19720949|NCT04705519|Bevacizumab|bevacizumab|mesh-list
19720950|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19720951|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720952|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
19720953|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
19720954|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
19720955|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720956|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19720957|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19720958|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19720959|NCT04705519|Growth Substances|growth substances|mesh-ancestor
19720960|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720961|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
19720962|NCT04705428|Fluorides|fluorides|mesh-list
19720963|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
19720964|NCT04705428|Protective Agents|protective agents|mesh-ancestor
19720965|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720966|NCT04705415|Niclosamide|niclosamide|mesh-list
19720967|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
19720968|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19720969|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
20533793|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533794|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533795|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20533796|NCT01810458|Narcotics|narcotics|mesh-ancestor
20533797|NCT01810458|Analgesics|analgesics|mesh-ancestor
19720970|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19720971|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19720972|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
19720973|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
19720974|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19720975|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19720976|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19720977|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720978|NCT04704947|Alendronate|alendronate|mesh-list
19720979|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19720980|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
19720981|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19720982|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720983|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19720984|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
19720985|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19720986|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19720987|NCT04704622|Midazolam|midazolam|mesh-list
19720988|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
19720989|NCT04704622|Ketamine|ketamine|mesh-list
19720990|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19720991|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19720992|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19720993|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19720994|NCT04704622|Analgesics|analgesics|mesh-ancestor
19720995|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
19720996|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19720997|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19720998|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19720999|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19721000|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721001|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721002|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862548|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
19862549|NCT00803647|Cetuximab|cetuximab|mesh-list
19862550|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
19862551|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862552|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19862553|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862554|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862555|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
19862556|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862557|NCT00803647|Antidotes|antidotes|mesh-ancestor
19862558|NCT00803647|Protective Agents|protective agents|mesh-ancestor
19862559|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
19862560|NCT00803647|Vitamins|vitamins|mesh-ancestor
19862561|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
19862562|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19862563|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
19862564|NCT00803686|Calcitonin|calcitonin|mesh-list
19862565|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19862566|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862567|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19862568|NCT00803712|Vitamin D|vitamin d|mesh-list
19862569|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
19862570|NCT00803712|Vitamins|vitamins|mesh-list
19862571|NCT00803712|Cinacalcet|cinacalcet|mesh-list
19862572|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
19862573|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862574|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19862575|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19862576|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19862577|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
19862578|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862579|NCT00803738|Terconazole|terconazole|mesh-list
19862580|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
19862581|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862582|NCT00804141|Bromides|bromides|mesh-list
19862583|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
19862584|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
19862585|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19862586|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862587|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
19862588|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862589|NCT00804193|Ciclopirox|ciclopirox|mesh-list
19862590|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
19862591|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862592|NCT00804609|Lidocaine|lidocaine|mesh-list
19862593|NCT00804609|Morphine|morphine|mesh-list
19862594|NCT00804609|Anesthetics|anesthetics|mesh-list
19862595|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
19862596|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862597|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862598|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
19862599|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862600|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19862601|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19862602|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19862603|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533798|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19969714|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721003|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19721004|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19721005|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
19721006|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
19721007|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19721008|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19721009|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19721010|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19721011|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721012|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721013|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
19721014|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
19721015|NCT04704596|Anesthetics|anesthetics|mesh-list
19721016|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721017|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862604|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862605|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19862606|NCT00804609|Narcotics|narcotics|mesh-ancestor
19862607|NCT00804609|Analgesics|analgesics|mesh-ancestor
19862608|NCT00804648|Timolol|timolol|mesh-list
19862609|NCT00804648|Maleic acid|maleic acid|mesh-list
19862610|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19862611|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19862612|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
19862613|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862614|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862615|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862616|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19862617|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19862618|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969715|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969716|NCT01775189|Analgesics|analgesics|mesh-ancestor
19969717|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
19969718|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969719|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19969720|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19969721|NCT01775501|Leucovorin|leucovorin|mesh-list
19969722|NCT01775501|Fluorouracil|fluorouracil|mesh-list
19969723|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
19969724|NCT01775501|Sorafenib|sorafenib|mesh-list
19969725|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
19969726|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969727|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19969728|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969729|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969730|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
19969731|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969732|NCT01775501|Antidotes|antidotes|mesh-ancestor
19969733|NCT01775501|Protective Agents|protective agents|mesh-ancestor
20253154|NCT00458081|Hormones|hormones|mesh-ancestor
20253155|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253156|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286650|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20286651|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20286652|NCT02987257|Analgesics|analgesics|mesh-ancestor
19969734|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
19969735|NCT01775501|Vitamins|vitamins|mesh-ancestor
19969736|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
20286653|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
19969737|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19969738|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969739|NCT01775787|Menthol|menthol|mesh-list
19969740|NCT01775787|Nicotine|nicotine|mesh-list
19969741|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19969742|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
19969743|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969744|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969745|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19969746|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19969747|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
19969748|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286654|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721018|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
19969749|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969750|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
19969751|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
19969752|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19721019|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721020|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19721021|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19721022|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721023|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721024|NCT04704440|Urological Agents|urological agents|mesh-ancestor
19721025|NCT04704713|Afamelanotide|afamelanotide|mesh-list
19721026|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
19721027|NCT04704297|Acetaminophen|acetaminophen|mesh-list
19721028|NCT04704297|Ibuprofen|ibuprofen|mesh-list
19721029|NCT04704297|Ketorolac|ketorolac|mesh-list
19721030|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19721031|NCT04704297|Amitriptyline|amitriptyline|mesh-list
19721032|NCT04704297|Bupivacaine|bupivacaine|mesh-list
19721033|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
19721034|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
19721035|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
19721036|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721037|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721038|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
19721039|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721040|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19721041|NCT04704297|Analgesics|analgesics|mesh-ancestor
19721042|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
19721043|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19721044|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19721045|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19721046|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19721047|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721048|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721049|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19721050|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
19721051|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721052|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19721053|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19721054|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721055|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19721056|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19721057|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721058|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721059|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721060|NCT04704453|Amitriptyline|amitriptyline|mesh-list
19721061|NCT04704453|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19721062|NCT04704453|Capsaicin|capsaicin|mesh-list
19721063|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
19721064|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
19721065|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
19721066|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721067|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721068|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19721069|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
19721070|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721071|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19721072|NCT04704453|Analgesics|analgesics|mesh-ancestor
19721073|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19721074|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19721075|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721076|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721077|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721078|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721079|NCT04704453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19721080|NCT04704453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721081|NCT04704453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862619|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
19862620|NCT00804687|Ephedrine|ephedrine|mesh-list
19862621|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19862622|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
19862623|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862624|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862625|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19862626|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
19862627|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
19862628|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19862629|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19862630|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
19862631|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
19862632|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862633|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862634|NCT00804843|Niacin|niacin|mesh-list
19862635|NCT00804843|Atorvastatin|atorvastatin|mesh-list
19862636|NCT00804843|Simvastatin|simvastatin|mesh-list
19862637|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19862638|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19862639|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
19862640|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862641|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19862642|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19862643|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862644|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
19862645|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
19862646|NCT00804843|Vitamins|vitamins|mesh-ancestor
19862647|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
19862648|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862649|NCT00804908|Temozolomide|temozolomide|mesh-list
19862650|NCT00804908|Veliparib|veliparib|mesh-list
19862651|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19862652|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
19862653|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862654|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862655|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19862656|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862657|NCT00804973|Sumatriptan|sumatriptan|mesh-list
19862658|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19862659|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19862660|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19862661|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
19862662|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862663|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862664|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862665|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19862666|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19862667|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721082|NCT04704245|Petrolatum|petrolatum|mesh-list
19721083|NCT04704245|Mitogens|mitogens|mesh-list
19721084|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
19721085|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721086|NCT04704245|Emollients|emollients|mesh-ancestor
19721087|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
19721088|NCT04704141|Hormones|hormones|mesh-list
19721089|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19721090|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734532|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
19734533|NCT04549012|Coagulants|coagulants|mesh-ancestor
19734534|NCT04548700|Prednisone|prednisone|mesh-list
19734535|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
19734536|NCT04548700|Vincristine|vincristine|mesh-list
19734537|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
19734538|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19734539|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
19862668|NCT00805142|Tapentadol|tapentadol|mesh-list
19862669|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19862670|NCT00805142|Narcotics|narcotics|mesh-ancestor
19862671|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862672|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862673|NCT00805142|Analgesics|analgesics|mesh-ancestor
19862674|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
19862675|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862676|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19862677|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19862678|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862679|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862680|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
19862681|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862682|NCT00805194|Docetaxel|docetaxel|mesh-list
19862683|NCT00805194|Nintedanib|nintedanib|mesh-list
19862684|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862685|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
19862686|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
19862687|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
19862688|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862689|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19862690|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862691|NCT00805207|Estradiol|estradiol|mesh-list
19862692|NCT00805207|Estrogens|estrogens|mesh-list
19862693|NCT00805207|Testosterone|testosterone|mesh-list
19862694|NCT00805207|Progesterone|progesterone|mesh-list
19862695|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
19862696|NCT00805207|Hormones|hormones|mesh-ancestor
19862697|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862698|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862699|NCT00805207|Androgens|androgens|mesh-ancestor
19862700|NCT00805207|Progestins|progestins|mesh-ancestor
19862701|NCT00805285|Budesonide|budesonide|mesh-list
19862702|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
19862703|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862704|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19862705|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
19862706|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862707|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862708|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19862709|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
19862710|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
19862711|NCT00805285|Hormones|hormones|mesh-ancestor
19862712|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862713|NCT00805493|Riluzole|riluzole|mesh-list
19862714|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
19862715|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19862716|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19862717|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734540|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734541|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734542|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19862718|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969753|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
19721091|NCT04703868|Rabeprazole|rabeprazole|mesh-list
19721092|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19721093|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721094|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19721095|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721096|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721097|NCT04703803|Lidocaine|lidocaine|mesh-list
19721098|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
19721099|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
19721100|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721101|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721102|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
19721103|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721104|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721105|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19721106|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19721107|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721108|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862719|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862720|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19862721|NCT00805493|Protective Agents|protective agents|mesh-ancestor
19862722|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19862723|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19862724|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862725|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
19862726|NCT00805675|Tenofovir|tenofovir|mesh-list
19862727|NCT00805675|Telbivudine|telbivudine|mesh-list
19862728|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
19862729|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862730|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19862731|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19862732|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862733|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862734|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19862735|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19862736|NCT00805740|Caspofungin|caspofungin|mesh-list
19862737|NCT00805740|Anidulafungin|anidulafungin|mesh-list
19862738|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
19862739|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862740|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253157|NCT00458185|Etanercept|etanercept|mesh-list
20533799|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19862741|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862742|NCT00805766|Infliximab|infliximab|mesh-list
20533800|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
19438818|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862743|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
19862744|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862745|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533801|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533802|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20533803|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533804|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533805|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
20533806|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
20533807|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20533808|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20533809|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
20533810|NCT01810458|Hematinics|hematinics|mesh-ancestor
20533811|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
19438819|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438820|NCT03472872|Acetaminophen|acetaminophen|mesh-list
19438821|NCT03472872|Ketorolac|ketorolac|mesh-list
19438822|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438823|NCT03472872|Analgesics|analgesics|mesh-ancestor
19438824|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
19438825|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438826|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438827|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
19862746|NCT00805792|Donepezil|donepezil|mesh-list
19862747|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19721109|NCT04704063|Vitamin E|vitamin e|mesh-list
19721110|NCT04704063|Tocopherols|tocopherols|mesh-list
19721111|NCT04704063|Tocotrienols|tocotrienols|mesh-list
19721112|NCT04704063|Tocovid|tocovid|mesh-list
19721113|NCT04704063|Vitamins|vitamins|mesh-ancestor
19721114|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
19721115|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721116|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
19721117|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721118|NCT04704063|Protective Agents|protective agents|mesh-ancestor
19721119|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
19721120|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721121|NCT04703465|Tenofovir|tenofovir|mesh-list
19721122|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
19721123|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721124|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19721125|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19721126|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721127|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721128|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19721129|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19721130|NCT04703608|Ivermectin|ivermectin|mesh-list
19721131|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19721132|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721133|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
19721134|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
19721135|NCT04703673|Ephedrine|ephedrine|mesh-list
19721136|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
19721137|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19721138|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
19721139|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19721140|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862748|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862749|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862750|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
19862751|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862752|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862753|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
19862754|NCT00805935|Leuprolide|leuprolide|mesh-list
19862755|NCT00805935|Menotropins|menotropins|mesh-list
19862756|NCT00805935|Progesterone|progesterone|mesh-list
19862757|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19862758|NCT00805935|Progestins|progestins|mesh-ancestor
19862759|NCT00805935|Hormones|hormones|mesh-ancestor
19862760|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862761|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862762|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19862763|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
19862764|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19862765|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19862766|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862767|NCT00806026|Pregabalin|pregabalin|mesh-list
19862768|NCT00806026|Pramipexole|pramipexole|mesh-list
19862769|NCT00806026|Analgesics|analgesics|mesh-ancestor
19862770|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
19862771|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862772|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862773|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
19862774|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19862775|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862776|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862777|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19862778|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19862779|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19862780|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862781|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19862782|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
19862783|NCT00806026|Protective Agents|protective agents|mesh-ancestor
19862784|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19862785|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19862786|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
19862787|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
19862788|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721141|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
19721142|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721143|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
19862789|NCT00806078|Quinine|quinine|mesh-list
19721144|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721145|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721146|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19721147|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19721148|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
19721149|NCT04703426|Sargramostim|sargramostim|mesh-list
19721150|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721151|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721152|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
19721153|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721154|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
19721155|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721156|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721157|NCT04702906|Trimetazidine|trimetazidine|mesh-list
19862790|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
19862791|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19862792|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19862793|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862794|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19862795|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862796|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19862797|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862798|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19862799|NCT00806078|Analgesics|analgesics|mesh-ancestor
19862800|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
19862801|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
19862802|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862803|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19862804|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19862805|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862806|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862807|NCT00806195|Vaccines|vaccines|mesh-list
19862808|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19862809|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
19862810|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862811|NCT00806221|Emollients|emollients|mesh-list
19862812|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
19862813|NCT00806234|Metformin|metformin|mesh-list
19862814|NCT00806234|Olanzapine|olanzapine|mesh-list
19862815|NCT00806234|Risperidone|risperidone|mesh-list
19862816|NCT00806234|Aripiprazole|aripiprazole|mesh-list
19862817|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19862818|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19862819|NCT00806234|Ziprasidone|ziprasidone|mesh-list
19862820|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19862821|NCT00806234|Asenapine|asenapine|mesh-list
19862822|NCT00806234|Iloperidone|iloperidone|mesh-list
19862823|NCT00806234|Perphenazine|perphenazine|mesh-list
19862824|NCT00806234|Fluoxetine|fluoxetine|mesh-list
19862825|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19862826|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862827|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19862828|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
19862829|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862830|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721158|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721159|NCT04703127|Lidocaine|lidocaine|mesh-list
19721160|NCT04703127|Tadalafil|tadalafil|mesh-list
19862831|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19862832|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721161|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
19721162|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
19721163|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721164|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721165|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
19721166|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721167|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721168|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19721169|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19721170|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721171|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721172|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721173|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19721174|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19721175|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721176|NCT04703127|Urological Agents|urological agents|mesh-ancestor
19721177|NCT04702971|Flunarizine|flunarizine|mesh-list
19721178|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
19721179|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19721180|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721181|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862833|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862834|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19862835|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19721182|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19721183|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721184|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19721185|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
19721186|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
19721187|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721188|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721189|NCT04703088|Ondansetron|ondansetron|mesh-list
19721190|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
19862836|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
19862837|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
19862838|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
19862839|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862840|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862841|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19862842|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19862843|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19862844|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
19862845|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
19862846|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19862847|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19862848|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19862849|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19862850|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19862851|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19862852|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19862853|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862854|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19862855|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19862856|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19862857|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
19862858|NCT00806260|Ethanol|ethanol|mesh-list
19862859|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19862860|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862861|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862862|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721191|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
19721192|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721193|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721194|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721195|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
19721196|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
19721197|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19721198|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
19721199|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721200|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721201|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19721202|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721203|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721204|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721205|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19721206|NCT04702698|Peposertib|peposertib|mesh-list
19721207|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19721208|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721209|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721210|NCT04702685|Ropivacaine|ropivacaine|mesh-list
19721211|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
19721212|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
19721213|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862863|NCT00806286|Paclitaxel|paclitaxel|mesh-list
19862864|NCT00806286|Carboplatin|carboplatin|mesh-list
19862865|NCT00806286|Efatutazone|efatutazone|mesh-list
19862866|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19862867|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862868|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
19862869|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
19862870|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
19862871|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862872|NCT00806351|Caspofungin|caspofungin|mesh-list
19862873|NCT00806351|Anidulafungin|anidulafungin|mesh-list
19862874|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
19862875|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862876|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862877|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862878|NCT00806442|Borage oil|borage oil|mesh-list
19862879|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862880|NCT00806494|Fesoterodine|fesoterodine|mesh-list
19862881|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19862882|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19862883|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
19862884|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19862885|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862886|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862887|NCT00806494|Urological Agents|urological agents|mesh-ancestor
19862888|NCT00806598|Cyclosporine|cyclosporine|mesh-list
19862889|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
19862890|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19862891|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19862892|NCT00806598|Prednisolone|prednisolone|mesh-list
19862893|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
19862894|NCT00806598|Cyclosporins|cyclosporins|mesh-list
19862895|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
19862896|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19862897|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19862898|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
19862899|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862900|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862901|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862902|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
19438828|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19438829|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438830|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438831|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19438832|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438833|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438834|NCT03472846|Teriparatide|teriparatide|mesh-list
19438835|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19438836|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734543|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
19862903|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862904|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
19721214|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721215|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
19721216|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721217|NCT04702490|Empagliflozin|empagliflozin|mesh-list
19721218|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19721219|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721220|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19721221|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721222|NCT04702048|Aflibercept|aflibercept|mesh-list
19721223|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19721224|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19721225|NCT04702048|Growth Substances|growth substances|mesh-ancestor
19721226|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721227|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
19721228|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721229|NCT04702061|Anesthetics|anesthetics|mesh-list
19721230|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862905|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19862906|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
19862907|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862908|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19862909|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862910|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
19862911|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
19862912|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862913|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862914|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
19862915|NCT00806598|Hormones|hormones|mesh-ancestor
19862916|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862917|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19862918|NCT00806598|Protective Agents|protective agents|mesh-ancestor
19438837|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19438838|NCT03472677|Capsaicin|capsaicin|mesh-list
19438839|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
19438840|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
19438841|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
19438842|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438843|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438844|NCT03472651|Flupenthixol|flupenthixol|mesh-list
19438845|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
19438846|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19438847|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19438848|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438849|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438850|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19438851|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19438852|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
19438853|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438854|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438855|NCT03472560|Avelumab|avelumab|mesh-list
19438856|NCT03472560|Axitinib|axitinib|mesh-list
19438857|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19438858|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438859|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19438860|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438861|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438862|NCT03472508|Folic Acid|folic acid|mesh-list
19862919|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19862920|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721231|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721232|NCT04702334|Lidocaine|lidocaine|mesh-list
19721233|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
19721234|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
19862921|NCT00806624|Warfarin|warfarin|mesh-list
19862922|NCT00806624|Edoxaban|edoxaban|mesh-list
19862923|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
19862924|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19862925|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
19862926|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19862927|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
19862928|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862929|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862930|NCT00806676|Vaccines|vaccines|mesh-list
19862931|NCT00806676|Immunologic Factors|immunologic factors|mesh-ancestor
19862932|NCT00806676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862933|NCT00806819|Folic Acid|folic acid|mesh-list
19862934|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
19862935|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
19862936|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
19862937|NCT00806819|Dexamethasone|dexamethasone|mesh-list
19862938|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
19862939|NCT00806819|Pemetrexed|pemetrexed|mesh-list
19862940|NCT00806819|Nintedanib|nintedanib|mesh-list
19862941|NCT00806819|BB 1101|bb 1101|mesh-list
19862942|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862943|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
19862944|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
19862945|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862946|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862947|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19862948|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
19862949|NCT00806819|Hormones|hormones|mesh-ancestor
19862950|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19862951|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19862952|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862953|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
19862954|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862955|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862956|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19862957|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19862958|NCT00806819|Hematinics|hematinics|mesh-ancestor
19862959|NCT00806819|Vitamins|vitamins|mesh-ancestor
19862960|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
19721235|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
19721236|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721237|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721238|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
19721239|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721240|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721241|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19721242|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19721243|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721244|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721245|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19721246|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
19721247|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
19721248|NCT04702334|Protective Agents|protective agents|mesh-ancestor
19721249|NCT04702360|Ivacaftor|ivacaftor|mesh-list
19721250|NCT04702360|Elexacaftor|elexacaftor|mesh-list
19721251|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19721252|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721253|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721254|NCT04702204|Denosumab|denosumab|mesh-list
19721255|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19721256|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721257|NCT04702009|Antibodies|antibodies|mesh-list
19721258|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19721259|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
19721260|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734544|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734545|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19862961|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19862962|NCT00807014|Adapalene|adapalene|mesh-list
19862963|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19862964|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19721261|NCT04701606|Artesunate|artesunate|mesh-list
19721262|NCT04701606|Pyronaridine|pyronaridine|mesh-list
19721263|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
19721264|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19721265|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19721266|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721267|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721268|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
19721269|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
19721270|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19721271|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
19721272|NCT04701710|Ivermectin|ivermectin|mesh-list
19721273|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19721274|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721275|NCT04701528|Tacrolimus|tacrolimus|mesh-list
19721276|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19721277|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
19721278|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721279|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19721280|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721281|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721282|NCT04701463|Calcium|calcium|mesh-list
19721283|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19721284|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721285|NCT04701307|Niraparib|niraparib|mesh-list
19721286|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
19721287|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
19721288|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
19721289|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721290|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19721291|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721292|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721293|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721294|NCT04701242|Ezetimibe|ezetimibe|mesh-list
19721295|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19721296|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19721297|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
19721298|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721299|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19721300|NCT04701320|Methamphetamine|methamphetamine|mesh-list
19721301|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19721302|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721303|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
19721304|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
19721305|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721306|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
20253158|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20253159|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20253160|NCT00458185|Analgesics|analgesics|mesh-ancestor
20253161|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
20253162|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862965|NCT00807014|Analgesics|analgesics|mesh-ancestor
19721307|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721308|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721309|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721310|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19721311|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19721312|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721313|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19721314|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
19721315|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19721316|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
19721317|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721318|NCT04701034|Prednisolone|prednisolone|mesh-list
19721319|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
19721320|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19721321|NCT04701034|Antibodies|antibodies|mesh-list
19721322|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
19721323|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19721324|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862966|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
19438863|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
19438864|NCT03472508|Enalapril|enalapril|mesh-list
19862967|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862968|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862969|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19862970|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19862971|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
19862972|NCT00807092|Insulin|insulin|mesh-list
19862973|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19862974|NCT00807092|Metformin|metformin|mesh-list
19862975|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
19862976|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
19862977|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19862978|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19862979|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862980|NCT00807144|Tacrolimus|tacrolimus|mesh-list
19862981|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19862982|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
19862983|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862984|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19862985|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19862986|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19862987|NCT00807209|Fentanyl|fentanyl|mesh-list
19862988|NCT00807209|Bupivacaine|bupivacaine|mesh-list
19438865|NCT03472508|Enalaprilat|enalaprilat|mesh-list
19438866|NCT03472508|Hematinics|hematinics|mesh-ancestor
19438867|NCT03472508|Vitamins|vitamins|mesh-ancestor
19438868|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
19438869|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438870|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438871|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438872|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19438873|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
19438874|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19438875|NCT03472456|Eugenol|eugenol|mesh-list
19438876|NCT03472456|Carticaine|carticaine|mesh-list
19438877|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
19438878|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
19438879|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19438880|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438881|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
19438882|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438883|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438884|NCT03472378|Celecoxib|celecoxib|mesh-list
19438885|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19438886|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438887|NCT03472378|Analgesics|analgesics|mesh-ancestor
19862989|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
19862990|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
19438888|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
20533812|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
19721325|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
19721326|NCT04701034|Hormones|hormones|mesh-ancestor
19721327|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19721328|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721329|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19721330|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721331|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
19721332|NCT04701008|Ketamine|ketamine|mesh-list
19721333|NCT04701008|Analgesics|analgesics|mesh-ancestor
19721334|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
19721335|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721336|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721337|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19721338|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19721339|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
19721340|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
19721341|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721342|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19721343|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19721344|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721345|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721346|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
19721347|NCT04700826|Apixaban|apixaban|mesh-list
19721348|NCT04700826|Edoxaban|edoxaban|mesh-list
19721349|NCT04700826|Dabigatran|dabigatran|mesh-list
19721350|NCT04700826|Anticoagulants|anticoagulants|mesh-list
19721351|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19721352|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
19721353|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19721354|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
19721355|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721356|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721357|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
19721358|NCT04700670|Coagulants|coagulants|mesh-ancestor
19721359|NCT04700592|Ketamine|ketamine|mesh-list
19721360|NCT04700592|Gabapentin|gabapentin|mesh-list
19721361|NCT04700592|Analgesics|analgesics|mesh-ancestor
19721362|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
19721363|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721364|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721365|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19721366|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19862991|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19862992|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19862993|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
19862994|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19862995|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19862996|NCT00807209|Narcotics|narcotics|mesh-ancestor
19862997|NCT00807209|Analgesics|analgesics|mesh-ancestor
19862998|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19862999|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19863000|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
19863001|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19863002|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
19863003|NCT00807248|Gaboxadol|gaboxadol|mesh-list
19863004|NCT00807248|Dexetimide|dexetimide|mesh-list
19863005|NCT00807248|Citalopram|citalopram|mesh-list
19863006|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19863007|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19863008|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19863009|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863010|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863011|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
19863012|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863013|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19721367|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
19721368|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
19721369|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721370|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19721371|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19721372|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863014|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
19721373|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721374|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
19721375|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19863015|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721376|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721377|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721378|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
19721379|NCT04700943|Anesthetics|anesthetics|mesh-list
19721380|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721381|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721382|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
19721383|NCT04700696|Narcotics|narcotics|mesh-ancestor
19721384|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721385|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721386|NCT04700696|Analgesics|analgesics|mesh-ancestor
19721387|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
19721388|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721389|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
19721390|NCT04700709|Sirolimus|sirolimus|mesh-list
19721391|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19721392|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721393|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19721394|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
19721395|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19721396|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721397|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721398|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721399|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
19721400|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19721401|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
19721402|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721403|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
19721404|NCT04700761|Anesthetics|anesthetics|mesh-list
19721405|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721406|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721407|NCT04700761|Narcotics|narcotics|mesh-ancestor
19721408|NCT04700761|Analgesics|analgesics|mesh-ancestor
19721409|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
19721410|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721411|NCT04700839|Metformin|metformin|mesh-list
19721412|NCT04700839|Canagliflozin|canagliflozin|mesh-list
19721413|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19721414|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19721415|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721416|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721417|NCT04700475|Citric Acid|citric acid|mesh-list
19721418|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
19721419|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
19721420|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19721421|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
19721422|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
19721423|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721424|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19721425|NCT04700436|Ezetimibe|ezetimibe|mesh-list
19721426|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19721427|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19721428|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
19721429|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721430|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19721431|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19721432|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721433|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
19721434|NCT04700228|Bupivacaine|bupivacaine|mesh-list
19721435|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
19721436|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
19721437|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721438|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721439|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
19721440|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533813|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533814|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
20533815|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
20533816|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20533817|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
20533818|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19721441|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19721442|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20533819|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
19721443|NCT04700228|Analgesics|analgesics|mesh-ancestor
19721444|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19721445|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19721446|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19721447|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721448|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721449|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721450|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
19721451|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721452|NCT04700046|Mexiletine|mexiletine|mesh-list
19863016|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19863017|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19863018|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
19863019|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
19863020|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863021|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19863022|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19863023|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
19863024|NCT00807248|Analgesics|analgesics|mesh-ancestor
19863025|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
19863026|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
19863027|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
19863028|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
19863029|NCT00807573|Paclitaxel|paclitaxel|mesh-list
19863030|NCT00807573|Bevacizumab|bevacizumab|mesh-list
19863031|NCT00807573|Pemetrexed|pemetrexed|mesh-list
19863032|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19863033|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863034|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
19863035|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
19863036|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
19863037|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863038|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19863039|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19863040|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19863041|NCT00807573|Growth Substances|growth substances|mesh-ancestor
19863042|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863043|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19863044|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863045|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19863046|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863047|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19863048|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19863049|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
19863050|NCT00807586|Prednisolone|prednisolone|mesh-list
19863051|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
19863052|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19863053|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
19863054|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863055|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
19863056|NCT00807586|Hormones|hormones|mesh-ancestor
19863057|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863058|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863059|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19863060|NCT00807586|Protective Agents|protective agents|mesh-ancestor
19863061|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19863062|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863063|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
19863064|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
19863065|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863066|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19863067|NCT00807599|Dexamethasone|dexamethasone|mesh-list
19863068|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
19863069|NCT00807599|Lenalidomide|lenalidomide|mesh-list
19863070|NCT00807599|Melphalan|melphalan|mesh-list
19863071|NCT00807599|BB 1101|bb 1101|mesh-list
19863072|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863073|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
19863074|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
19863075|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863076|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863077|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533820|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20533821|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863078|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
20533822|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863079|NCT00807599|Hormones|hormones|mesh-ancestor
19975500|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721453|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721454|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19721455|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19721456|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721457|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721458|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19721459|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19721460|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721461|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
19721462|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
19721463|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721464|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721465|NCT04699903|Antibodies|antibodies|mesh-list
19721466|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
19721467|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
19721468|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721469|NCT04699734|Lidocaine|lidocaine|mesh-list
19721470|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
19721471|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
19721472|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721473|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721474|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
19721475|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863080|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19721476|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721477|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19721478|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19721479|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721480|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721481|NCT04699721|Paclitaxel|paclitaxel|mesh-list
19721482|NCT04699721|Carboplatin|carboplatin|mesh-list
19721483|NCT04699721|Nivolumab|nivolumab|mesh-list
19721484|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19721485|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721486|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
19721487|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
19721488|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
19721489|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721490|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721491|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19734546|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19734547|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734548|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
19734549|NCT04548700|Hormones|hormones|mesh-ancestor
19734550|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734551|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19734552|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19734553|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734554|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734555|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
19734556|NCT04548700|Analgesics|analgesics|mesh-ancestor
19734557|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
19734558|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734559|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19734560|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19734561|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734562|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
19734563|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19734564|NCT04548557|Antibodies|antibodies|mesh-list
19734565|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
19734566|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19863081|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19721492|NCT04699214|Endostar protein|endostar protein|mesh-list
19721493|NCT04699214|Endostatins|endostatins|mesh-list
19721494|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19721495|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19721496|NCT04699214|Growth Substances|growth substances|mesh-ancestor
19721497|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721498|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
19721499|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721500|NCT04698850|Ranibizumab|ranibizumab|mesh-list
19721501|NCT04698850|Aflibercept|aflibercept|mesh-list
19721502|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19721503|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19721504|NCT04698850|Growth Substances|growth substances|mesh-ancestor
19721505|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721506|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
19721507|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721508|NCT04698941|Paclitaxel|paclitaxel|mesh-list
19721509|NCT04698941|Simvastatin|simvastatin|mesh-list
19721510|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19721511|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253163|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253164|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20253165|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20253166|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20253167|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253168|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
20253169|NCT00458250|Cyclosporine|cyclosporine|mesh-list
20253170|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
20253171|NCT00458250|Busulfan|busulfan|mesh-list
20253172|NCT00458250|Methotrexate|methotrexate|mesh-list
20253173|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
20253174|NCT00458250|Cyclosporins|cyclosporins|mesh-list
19863082|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863083|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
19863084|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721512|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
19721513|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
19721514|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
19721515|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721516|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19721517|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19863085|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863086|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
19863087|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19863088|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19863089|NCT00807599|Growth Substances|growth substances|mesh-ancestor
19863090|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
19863091|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19863092|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
19863093|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19863094|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863095|NCT00807742|Nicotine|nicotine|mesh-list
19863096|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19863097|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
19863098|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863099|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863100|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19863101|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19863102|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
19863103|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863104|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863105|NCT00807768|Paclitaxel|paclitaxel|mesh-list
19863106|NCT00807768|Carboplatin|carboplatin|mesh-list
19863107|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19863108|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19863109|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863110|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
19863111|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
19863112|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
19863113|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721518|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
20253175|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253176|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
19721519|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19721520|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19721521|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721522|NCT04699058|Antibodies|antibodies|mesh-list
19721523|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
19721524|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721525|NCT04699110|Adenosine|adenosine|mesh-list
19721526|NCT04699110|Epinephrine|epinephrine|mesh-list
19721527|NCT04699110|Racepinephrine|racepinephrine|mesh-list
19721528|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
19863114|NCT00807846|Celecoxib|celecoxib|mesh-list
19863115|NCT00807846|Naproxen|naproxen|mesh-list
19863116|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19863117|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19863118|NCT00807846|Analgesics|analgesics|mesh-ancestor
19863119|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
19863120|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863121|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863122|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863123|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863124|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19863125|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19863126|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863127|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863128|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
19863129|NCT00807937|Lorazepam|lorazepam|mesh-list
19863130|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
19863131|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
19863132|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
19863133|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863134|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863135|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19863136|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19863137|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863138|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19863139|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19863140|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19863141|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
19863142|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
19863143|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863144|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863145|NCT00807989|Lamotrigine|lamotrigine|mesh-list
19863146|NCT00807989|Carbamazepine|carbamazepine|mesh-list
19863147|NCT00807989|Valproic Acid|valproic acid|mesh-list
19863148|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
19863149|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19863150|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19863151|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863152|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19863153|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863154|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19863155|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19863156|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863157|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19863158|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19863159|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863160|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
19863161|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863162|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
19863163|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19863164|NCT00807989|Analgesics|analgesics|mesh-ancestor
19863165|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
19863166|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863167|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19863168|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19863169|NCT00808015|Varenicline|varenicline|mesh-list
19863170|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19863171|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19863172|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
19863173|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863174|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863175|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721529|NCT04699110|Analgesics|analgesics|mesh-ancestor
19721530|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
19863176|NCT00808028|Vaccines|vaccines|mesh-list
19863177|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
19975501|NCT01849770|Mexiletine|mexiletine|mesh-list
19721531|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721532|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721533|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721534|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721535|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19721536|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
19721537|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
19721538|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721539|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721540|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19863178|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863179|NCT00808067|Dabigatran|dabigatran|mesh-list
19863180|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
19863181|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19863182|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
19863183|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863184|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863185|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
19863186|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
19863187|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19863188|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
19863189|NCT00808132|Estrogens|estrogens|mesh-list
19863190|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19863191|NCT00808132|Hormones|hormones|mesh-ancestor
19863192|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863193|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863194|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19863195|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19863196|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19863197|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
19863198|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863199|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19863200|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19863201|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19863202|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19863203|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863204|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19863205|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19863206|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
19863207|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19863208|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
19863209|NCT00808210|Methotrexate|methotrexate|mesh-list
20253177|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253178|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20253179|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20253180|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
20253181|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863210|NCT00808210|Infliximab|infliximab|mesh-list
20253182|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863211|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
19721541|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19721542|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721543|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19721544|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19721545|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
19721546|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19721547|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19721548|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
19721549|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
19721550|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19721551|NCT04699097|Azithromycin|azithromycin|mesh-list
19721552|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19721553|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721554|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19721555|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19721556|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19721557|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
20253183|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20253184|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20253185|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
20253186|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20253187|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253188|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
20253189|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19863212|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19863213|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
19863214|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863215|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863216|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863217|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
19863218|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863219|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438889|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438890|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438891|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438892|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438893|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19863220|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
19863221|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863222|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19863223|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863224|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
19863225|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863226|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863227|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863228|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
19863229|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
19863230|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863231|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19863232|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
19863233|NCT00808210|Hormones|hormones|mesh-ancestor
19863234|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863235|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19863236|NCT00808210|Protective Agents|protective agents|mesh-ancestor
19438894|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19863237|NCT00808405|Acyclovir|acyclovir|mesh-list
19863238|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
19863239|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863240|NCT00808444|Vaccines|vaccines|mesh-list
19863241|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19863242|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
19863243|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863244|NCT00808470|Ascorbic Acid|ascorbic acid|mesh-list
19863245|NCT00808470|Beta Carotene|beta carotene|mesh-list
19863246|NCT00808470|Carotenoids|carotenoids|mesh-list
19863247|NCT00808470|Vitamins|vitamins|mesh-ancestor
19863248|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
19863249|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863250|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
19975502|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19438895|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438896|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721558|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721559|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19721560|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19721561|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721562|NCT04698746|Anesthetics|anesthetics|mesh-list
19721563|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
19721564|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721565|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721566|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
19721567|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721568|NCT04698772|Ketamine|ketamine|mesh-list
19863251|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863252|NCT00808470|Protective Agents|protective agents|mesh-ancestor
19863253|NCT00808470|Provitamins|provitamins|mesh-ancestor
19863254|NCT00808509|Adalimumab|adalimumab|mesh-list
19863255|NCT00808509|Methotrexate|methotrexate|mesh-list
19863256|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19863257|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
19863258|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863259|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863260|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863261|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
19863262|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863263|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863264|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
19863265|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863266|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19863267|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863268|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
19863269|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863270|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863271|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863272|NCT00808639|Doxorubicin|doxorubicin|mesh-list
19863273|NCT00808639|Methotrexate|methotrexate|mesh-list
19863274|NCT00808639|Vinblastine|vinblastine|mesh-list
19863275|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863276|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19863277|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19863278|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19863279|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863280|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863281|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19863282|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
19863283|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863284|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863285|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863286|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
19863287|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
19863288|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19863289|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863290|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
19863291|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863292|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863293|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19863294|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
19863295|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
19863296|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
19863297|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
19863298|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19863299|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863300|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863301|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19863302|NCT00808665|Analgesics|analgesics|mesh-ancestor
19721569|NCT04698772|Morphine|morphine|mesh-list
19721570|NCT04698772|Analgesics|analgesics|mesh-ancestor
19863303|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
20253190|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721571|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
19721572|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721573|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721574|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19721575|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19721576|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
19721577|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
19721578|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721579|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19721580|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19721581|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721582|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721583|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19721584|NCT04698772|Narcotics|narcotics|mesh-ancestor
19721585|NCT04698512|Sirolimus|sirolimus|mesh-list
19721586|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19721587|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721588|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19721589|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721590|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
19721591|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19721592|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
19721593|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721594|NCT04698226|Temazepam|temazepam|mesh-list
19721595|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19721596|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721597|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721598|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19721599|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721600|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721601|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
19721602|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
19734567|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
19863304|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863305|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19863306|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19863307|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19863308|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
19863309|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863310|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863311|NCT00809055|Caffeine|caffeine|mesh-list
19863312|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
19863313|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863314|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19863315|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863316|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19863317|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863318|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19863319|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19863320|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
19863321|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863322|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
19863323|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19863324|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
19863325|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863326|NCT00809094|Expectorants|expectorants|mesh-ancestor
19863327|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
19863328|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19863329|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
19863330|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863331|NCT00809094|Protective Agents|protective agents|mesh-ancestor
19863332|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863333|NCT00809094|Antidotes|antidotes|mesh-ancestor
19863334|NCT00809133|Paclitaxel|paclitaxel|mesh-list
19863335|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19863336|NCT00809133|Bevacizumab|bevacizumab|mesh-list
19863337|NCT00809133|Carboplatin|carboplatin|mesh-list
19863338|NCT00809133|Afatinib|afatinib|mesh-list
19863339|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19863340|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863341|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
19863342|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
19863343|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
19721603|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721604|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721605|NCT04698213|Avelumab|avelumab|mesh-list
19721606|NCT04698213|Axitinib|axitinib|mesh-list
19721607|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721608|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721609|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19721610|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721611|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721612|NCT04698317|Mitogens|mitogens|mesh-list
19721613|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
19721614|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721615|NCT04697992|Vitamins|vitamins|mesh-list
19721616|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
19721617|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
19721618|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
19721619|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721620|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19721621|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19721622|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721623|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
19721624|NCT04697992|Coagulants|coagulants|mesh-ancestor
19721625|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
19721626|NCT04697992|Protective Agents|protective agents|mesh-ancestor
19721627|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
19721628|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
19721629|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19721630|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19721631|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721632|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721633|NCT04697862|Urological Agents|urological agents|mesh-ancestor
19721634|NCT04697602|Colchicine|colchicine|mesh-list
19721635|NCT04697602|Febuxostat|febuxostat|mesh-list
19721636|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
19721637|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19721638|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
19721639|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
19721640|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
19721641|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253191|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20253192|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20553471|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721642|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721643|NCT04697641|Amoxicillin|amoxicillin|mesh-list
19721644|NCT04697641|Clarithromycin|clarithromycin|mesh-list
19721645|NCT04697641|Pantoprazole|pantoprazole|mesh-list
19721646|NCT04697641|Z 338|z 338|mesh-list
19721647|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19721648|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721649|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19721650|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721651|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721652|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19721653|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19721654|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19721655|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721656|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19721657|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19721658|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
19721659|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721660|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721661|NCT04697732|Anesthetics|anesthetics|mesh-list
19721662|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721663|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721664|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
19721665|NCT04697537|Ropivacaine|ropivacaine|mesh-list
19721666|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
19721667|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721668|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721669|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19863344|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721670|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20253193|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
19721671|NCT04697537|Analgesics|analgesics|mesh-ancestor
19721672|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
19721673|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721674|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19721675|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19721676|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19721677|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721678|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721679|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721680|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
20253194|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253195|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20253196|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721681|NCT04697745|Dexamethasone|dexamethasone|mesh-list
19721682|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
19721683|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19721684|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
19721685|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
19721686|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721687|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721688|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721689|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
19721690|NCT04697745|Hormones|hormones|mesh-ancestor
19721691|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19721692|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19721693|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721694|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19721695|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721696|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19721697|NCT04697745|Analgesics|analgesics|mesh-ancestor
19721698|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
19721699|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19721700|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19721701|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19721702|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
19721703|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721704|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721705|NCT04697511|Midazolam|midazolam|mesh-list
19721706|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19721707|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19721708|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721709|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721710|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19721711|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19721712|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19863345|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19863346|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19863347|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19863348|NCT00809133|Growth Substances|growth substances|mesh-ancestor
19863349|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863350|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
19863351|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19863352|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863353|NCT00809185|Everolimus|everolimus|mesh-list
19863354|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863355|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863356|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
19863357|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863358|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
19863359|NCT00809276|Busulfan|busulfan|mesh-list
19863360|NCT00809276|Fludarabine|fludarabine|mesh-list
19863361|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863362|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
19863363|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863364|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863365|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19863366|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
19863367|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863368|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863369|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19863370|NCT00809328|Azithromycin|azithromycin|mesh-list
19863371|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19721713|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19863372|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863373|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19721714|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
19721715|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
19721716|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
19721717|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
19721718|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721719|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721720|NCT04697355|Beta Carotene|beta carotene|mesh-list
19721721|NCT04697355|Naringenin|naringenin|mesh-list
19721722|NCT04697355|Carotenoids|carotenoids|mesh-list
19721723|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
19721724|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721725|NCT04697355|Protective Agents|protective agents|mesh-ancestor
19721726|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721727|NCT04697355|Provitamins|provitamins|mesh-ancestor
19721728|NCT04697355|Vitamins|vitamins|mesh-ancestor
19721729|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
19721730|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19721731|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721732|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19721733|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
19721734|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19721735|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19721736|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734568|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734569|NCT04548440|Paclitaxel|paclitaxel|mesh-list
19734570|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19734571|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19438897|NCT03472365|Capecitabine|capecitabine|mesh-list
19438898|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
19438899|NCT03472365|Apatinib|apatinib|mesh-list
19438900|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734572|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734573|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734574|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734575|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
19734576|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734577|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19735868|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735869|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735870|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735871|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19735872|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19735873|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735874|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19735875|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19735876|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735877|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
19735878|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
19735879|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
19735880|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19863374|NCT00809354|Tanezumab|tanezumab|mesh-list
19438901|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
19438902|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438903|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863375|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19863376|NCT00809354|Analgesics|analgesics|mesh-ancestor
19863377|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
20533823|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20533824|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533825|NCT01810588|Vidarabine|vidarabine|mesh-list
20533826|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
20533827|NCT01810588|Rituximab|rituximab|mesh-list
20533828|NCT01810588|Fludarabine|fludarabine|mesh-list
19438904|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19438905|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438906|NCT03472339|Diclofenac|diclofenac|mesh-list
19438907|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19438908|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438909|NCT03472339|Analgesics|analgesics|mesh-ancestor
20533829|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
20533830|NCT01810588|Melphalan|melphalan|mesh-list
20533831|NCT01810588|Tacrolimus|tacrolimus|mesh-list
19438910|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
19735881|NCT04535700|Pioglitazone|pioglitazone|mesh-list
19735882|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20533832|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20533833|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
20553472|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
19721737|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
19721738|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721739|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
19721740|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
19721741|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
19721742|NCT04696939|Carboplatin|carboplatin|mesh-list
19721743|NCT04696939|Etoposide|etoposide|mesh-list
19721744|NCT04696939|Atezolizumab|atezolizumab|mesh-list
19721745|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721746|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19721747|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19721748|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19721749|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721750|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721751|NCT04697186|Amoxicillin|amoxicillin|mesh-list
19721752|NCT04697186|Clarithromycin|clarithromycin|mesh-list
19438911|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721753|NCT04697186|Rabeprazole|rabeprazole|mesh-list
19721754|NCT04697186|Bismuth|bismuth|mesh-list
19721755|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19721756|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721757|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19721758|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721759|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721760|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19721761|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19721762|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19721763|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721764|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19721765|NCT04697186|Antacids|antacids|mesh-ancestor
19721766|NCT04696848|Durvalumab|durvalumab|mesh-list
19721767|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721768|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721769|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
19721770|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19721771|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
19721772|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721773|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
19863378|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863379|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721774|NCT04696666|Protective Agents|protective agents|mesh-ancestor
19721775|NCT04696783|Esomeprazole|esomeprazole|mesh-list
19721776|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19721777|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721778|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19863380|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20533834|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533835|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533836|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
20533837|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533838|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533839|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20533840|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
20533841|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533842|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533843|NCT01810588|Antiviral Agents|antiviral agents|mesh-ancestor
20533844|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533845|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20533846|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533847|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20533848|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20533849|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
20533850|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20533851|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19438912|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438913|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438914|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438915|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19438916|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438917|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438918|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
19721779|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721780|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721781|NCT04696523|Xenon|xenon|mesh-list
19721782|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19721783|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
19721784|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
19721785|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721786|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721787|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
19721788|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19721789|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19721790|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721791|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
19721792|NCT04696224|Coagulants|coagulants|mesh-ancestor
19721793|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
19721794|NCT04696536|Listerine|listerine|mesh-list
19721795|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19721796|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863381|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863382|NCT00809757|Albuterol|albuterol|mesh-list
19863383|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19863384|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
19863385|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863386|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863387|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19863388|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
19863389|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
19863390|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863391|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19863392|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19863393|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19863394|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
19863395|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863396|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863397|NCT00809783|Tanezumab|tanezumab|mesh-list
19863398|NCT00809783|Analgesics|analgesics|mesh-ancestor
19863399|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
19863400|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863401|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863402|NCT00809809|Zinc|zinc|mesh-list
19863403|NCT00809809|Trace Elements|trace elements|mesh-ancestor
19863404|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
19863405|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863406|NCT00809835|Galantamine|galantamine|mesh-list
19863407|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19863408|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863409|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863410|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
19863411|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863412|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863413|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19863414|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
19863415|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863416|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
19863417|NCT00809848|Bimatoprost|bimatoprost|mesh-list
19863418|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19863419|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19863420|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19969754|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19969755|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969756|NCT01775865|Analgesics|analgesics|mesh-ancestor
19969757|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
19969758|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969759|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721797|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
19721798|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19721799|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721800|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19721801|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721802|NCT04696042|Lanreotide|lanreotide|mesh-list
19721803|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721804|NCT04695925|Carboplatin|carboplatin|mesh-list
19721805|NCT04695925|Pemetrexed|pemetrexed|mesh-list
19721806|NCT04695925|Osimertinib|osimertinib|mesh-list
19721807|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721808|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721809|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721810|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19721811|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19721812|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19721813|NCT04696120|Apixaban|apixaban|mesh-list
19721814|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19721815|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
19721816|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19721817|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
19863421|NCT00809926|Valsartan|valsartan|mesh-list
19863422|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19863423|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19863424|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19863425|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863426|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
19863427|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19863428|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
19863429|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19863430|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
19863431|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863432|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863433|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
19863434|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19863435|NCT00810069|Citalopram|citalopram|mesh-list
19863436|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19863437|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19863438|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19863439|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721818|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721819|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721820|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
19721821|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
19721822|NCT04695613|Analgesics|analgesics|mesh-ancestor
19721823|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
19721824|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721825|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863440|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863441|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
19863442|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863443|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19863444|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
20533852|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
20533853|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20533854|NCT01810601|Progesterone|progesterone|mesh-list
20533855|NCT01810601|Progestins|progestins|mesh-ancestor
20533856|NCT01810601|Hormones|hormones|mesh-ancestor
20533857|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533858|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533859|NCT01810640|Liver Extracts|liver extracts|mesh-list
20533860|NCT01810640|Hematinics|hematinics|mesh-ancestor
19863445|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19863446|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863447|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19863448|NCT00810069|Analgesics|analgesics|mesh-ancestor
19863449|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
19863450|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
19863451|NCT00810108|Ritonavir|ritonavir|mesh-list
19863452|NCT00810108|Lopinavir|lopinavir|mesh-list
19863453|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19863454|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19721826|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
19863455|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
20533861|NCT01810731|Vaccines|vaccines|mesh-list
19721827|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721828|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721829|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
19721830|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19721831|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721832|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863456|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863457|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863458|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19863459|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19863460|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
19863461|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863462|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19863463|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19863464|NCT00810199|Methotrexate|methotrexate|mesh-list
19863465|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19863466|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
19863467|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863468|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863469|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863470|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
19863471|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863472|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863473|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
19863474|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863475|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19863476|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863477|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
19863478|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863479|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863480|NCT00810303|Efavirenz|efavirenz|mesh-list
19863481|NCT00810303|Ezetimibe|ezetimibe|mesh-list
19863482|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20533862|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
20533863|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533864|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20533865|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533866|NCT01810796|Ranolazine|ranolazine|mesh-list
20533867|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20533868|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20533869|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533870|NCT01810809|Hylan|hylan|mesh-list
19721833|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19721834|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
19721835|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19721836|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
19721837|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19721838|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19721839|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19721840|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721841|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721842|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
19721843|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721844|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721845|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19721846|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721847|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19721848|NCT04695483|Hormones|hormones|mesh-ancestor
19721849|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19721850|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721851|NCT04695509|Propofol|propofol|mesh-list
19721852|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20533871|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
19863483|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19863484|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
19863485|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863486|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19863487|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19863488|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863489|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863490|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
19863491|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863492|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19863493|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19863494|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19863495|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19721853|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721854|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721855|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19721856|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
19721857|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
19721858|NCT04695769|Ribavirin|ribavirin|mesh-list
19863496|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19863497|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19863498|NCT00810394|Sorafenib|sorafenib|mesh-list
19863499|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863500|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19863501|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863502|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863503|NCT00810407|Rifabutin|rifabutin|mesh-list
19863504|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19863505|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863506|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19863507|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
19863508|NCT00810576|Bortezomib|bortezomib|mesh-list
19863509|NCT00810576|Vorinostat|vorinostat|mesh-list
19863510|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863511|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19863512|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863513|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863514|NCT00810602|Vorinostat|vorinostat|mesh-list
19863515|NCT00810602|Tacrolimus|tacrolimus|mesh-list
19863516|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863517|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
19863518|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863519|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19863520|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863521|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863522|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863523|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19863524|NCT00810693|Riociguat|riociguat|mesh-list
19863525|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
19863526|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863527|NCT00810719|Gemcitabine|gemcitabine|mesh-list
19863528|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19863529|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863530|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
19863531|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863532|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863533|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
19863534|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863535|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863536|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863537|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
19863538|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863539|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19863540|NCT00810797|Exemestane|exemestane|mesh-list
19863541|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863542|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19721859|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
19721860|NCT04695769|Velpatasvir|velpatasvir|mesh-list
19721861|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19721862|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
19863543|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19863544|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721863|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721864|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
19721865|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721866|NCT04695704|Montelukast|montelukast|mesh-list
19721867|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19721868|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19721869|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
19721870|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
19721871|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19721872|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721873|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19721874|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19721875|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721876|NCT04695197|Artesunate|artesunate|mesh-list
19721877|NCT04695197|Lumefantrine|lumefantrine|mesh-list
19721878|NCT04695197|Artemether|artemether|mesh-list
19721879|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19721880|NCT04695197|Pyronaridine|pyronaridine|mesh-list
19721881|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
19721882|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19721883|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19721884|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721885|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721886|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
19721887|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
19721888|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19721889|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
19734578|NCT04548518|Vaccines|vaccines|mesh-list
19734579|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
19734580|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734581|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19734582|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
19734583|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
19734584|NCT04548284|Hormones|hormones|mesh-ancestor
19734585|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734586|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734587|NCT04548271|Apatinib|apatinib|mesh-list
19734588|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734589|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19734590|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734591|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734592|NCT04548219|Mirikizumab|mirikizumab|mesh-list
19734593|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19734594|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19734595|NCT04548219|Analgesics|analgesics|mesh-ancestor
19734596|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
19734597|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734598|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734599|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734600|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734601|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19734602|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19863545|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863546|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19863547|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
19863548|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863549|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863550|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
19863551|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19863552|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863553|NCT00811057|Indomethacin|indomethacin|mesh-list
19863554|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
19863555|NCT00811057|Nifedipine|nifedipine|mesh-list
19863556|NCT00811057|Analgesics|analgesics|mesh-ancestor
19863557|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
19863558|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863559|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863560|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
19863561|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863562|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19863563|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
19863564|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19863565|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734603|NCT04547829|Sargramostim|sargramostim|mesh-list
19734604|NCT04547829|Lenograstim|lenograstim|mesh-list
19734605|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
19721890|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
19721891|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721892|NCT04694612|Remdesivir|remdesivir|mesh-list
19721893|NCT04694612|Favipiravir|favipiravir|mesh-list
19721894|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
19721895|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721896|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
19721897|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721898|NCT04694586|Rifampin|rifampin|mesh-list
19721899|NCT04694586|Isoniazid|isoniazid|mesh-list
19721900|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
19721901|NCT04694586|Ethambutol|ethambutol|mesh-list
19721902|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19721903|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
19721904|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19721905|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19721906|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
19721907|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19721908|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721909|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721910|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19721911|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19721912|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19721913|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19721914|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19721915|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19721916|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19721917|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19721918|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
19721919|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19721920|NCT04694846|Bupropion|bupropion|mesh-list
19863566|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863567|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19863568|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
19863569|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863570|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
19863571|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19863572|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19863573|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863574|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863575|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
19863576|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19863577|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863578|NCT00811135|Bevacizumab|bevacizumab|mesh-list
19863579|NCT00811135|Trastuzumab|trastuzumab|mesh-list
19863580|NCT00811135|Capecitabine|capecitabine|mesh-list
19863581|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19863582|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863583|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19863584|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19863585|NCT00811135|Growth Substances|growth substances|mesh-ancestor
19863586|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863587|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
19863588|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863589|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
19863590|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863591|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
19863592|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19863593|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19863594|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
19863595|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863596|NCT00811187|Lidocaine|lidocaine|mesh-list
19863597|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
19863598|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
19863599|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863600|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863601|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
19863602|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863603|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19863604|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19863605|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19863606|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20253197|NCT00458263|Hormones|hormones|mesh-list
19721921|NCT04694846|Nicotine|nicotine|mesh-list
19721922|NCT04694846|Varenicline|varenicline|mesh-list
19721923|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19721924|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
19721925|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721926|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721927|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19721928|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19721929|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
19721930|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19721931|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863607|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863608|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19863609|NCT00811252|Vortioxetine|vortioxetine|mesh-list
19863610|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19863611|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19863612|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19863613|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863614|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863615|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863616|NCT00811252|Analgesics|analgesics|mesh-ancestor
19863617|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
19863618|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863619|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
19863620|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19863621|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
19863622|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19863623|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19863624|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863625|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19863626|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
19863627|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19863628|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19863629|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19863630|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20253198|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253199|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253200|NCT00458315|Gemcitabine|gemcitabine|mesh-list
20253201|NCT00458315|Paclitaxel|paclitaxel|mesh-list
20253202|NCT00458315|Bevacizumab|bevacizumab|mesh-list
20253203|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20253204|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253205|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
20253206|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
20253207|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
20253208|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863631|NCT00811395|Interferons|interferons|mesh-list
19863632|NCT00811395|Interferon-beta|interferon-beta|mesh-list
19863633|NCT00811395|Teriflunomide|teriflunomide|mesh-list
19863634|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
19863635|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
19863636|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
19863637|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863638|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
19863639|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863640|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19863641|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
19863642|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863643|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863644|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863645|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19863646|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19863647|NCT00811395|Analgesics|analgesics|mesh-ancestor
19863648|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
19863649|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863650|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863651|NCT00811434|Lactulose|lactulose|mesh-list
19863652|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19863653|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19863654|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
19863655|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19863656|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19863657|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19863658|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533872|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
19721932|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19721933|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
19721934|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19721935|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19721936|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19721937|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19721938|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
19721939|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19721940|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19721941|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721942|NCT04694677|Misoprostol|misoprostol|mesh-list
19721943|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
19721944|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19721945|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19721946|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721947|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
19721948|NCT04694677|Coagulants|coagulants|mesh-ancestor
19721949|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19721950|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
19721951|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19721952|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721953|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19721954|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19721955|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
19721956|NCT04694183|Paclitaxel|paclitaxel|mesh-list
19721957|NCT04694183|Antibodies|antibodies|mesh-list
19721958|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
19721959|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19721960|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721961|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
19721962|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
19721963|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
19721964|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721965|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
19721966|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721967|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
19721968|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19721969|NCT04694092|Landiolol|landiolol|mesh-list
19863659|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863660|NCT00811564|Timolol|timolol|mesh-list
19863661|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19863662|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19863663|NCT00811564|Latanoprost|latanoprost|mesh-list
19863664|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19863665|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19863666|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19863667|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
19863668|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863669|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863670|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863671|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19863672|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20533873|NCT01810809|Protective Agents|protective agents|mesh-ancestor
20533874|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533875|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20533876|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
20533877|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
20533878|NCT01810848|Hylan|hylan|mesh-list
20533879|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20533880|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
20533881|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533882|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
20533883|NCT01810848|Protective Agents|protective agents|mesh-ancestor
20533884|NCT01810887|Ritonavir|ritonavir|mesh-list
19863673|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19863674|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19863675|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19863676|NCT00811642|Posaconazole|posaconazole|mesh-list
19863677|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
19863678|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863679|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20533885|NCT01810887|Darunavir|darunavir|mesh-list
20533886|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19721970|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19721971|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19721972|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
19863680|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19863681|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19863682|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19863683|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19863684|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863685|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721973|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863686|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19863687|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
19863688|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863689|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863690|NCT00811720|Nalmefene|nalmefene|mesh-list
19863691|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19863692|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863693|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
19863694|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863695|NCT00811733|Ofatumumab|ofatumumab|mesh-list
20253209|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19721974|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721975|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721976|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19721977|NCT04694300|Acetaminophen|acetaminophen|mesh-list
19721978|NCT04694300|Naproxen|naproxen|mesh-list
19721979|NCT04694300|Tramadol|tramadol|mesh-list
19721980|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19721981|NCT04694300|Analgesics|analgesics|mesh-ancestor
19721982|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
19721983|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19721984|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19721985|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
19721986|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19721987|NCT04694300|Narcotics|narcotics|mesh-ancestor
19721988|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19721989|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19721990|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19721991|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19721992|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
19721993|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19721994|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19721995|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19721996|NCT04694105|Dexamethasone|dexamethasone|mesh-list
19721997|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
19721998|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19721999|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
19722000|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
19722001|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722002|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722003|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19722004|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
19722005|NCT04694105|Hormones|hormones|mesh-ancestor
19722006|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722007|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19722008|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722009|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19722010|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722011|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19722012|NCT04694105|Analgesics|analgesics|mesh-ancestor
19722013|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
19722014|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19722015|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19722016|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19722017|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722018|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722019|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722020|NCT04693910|Hormones|hormones|mesh-list
19722021|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722022|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722023|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
19722024|NCT04693897|Mirabegron|mirabegron|mesh-list
19722025|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19722026|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20253210|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20253211|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20253212|NCT00458315|Growth Substances|growth substances|mesh-ancestor
19722027|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
19722028|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722029|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722030|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722031|NCT04693897|Urological Agents|urological agents|mesh-ancestor
19722032|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19722033|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19722034|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19722035|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722036|NCT04693962|Mitogens|mitogens|mesh-list
19722037|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
19722038|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722039|NCT04693169|Choline|choline|mesh-list
19722040|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
19722041|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19722042|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
19722043|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722044|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19722045|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19722046|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
19722047|NCT04693156|Bupivacaine|bupivacaine|mesh-list
19722048|NCT04693156|Prilocaine|prilocaine|mesh-list
19722049|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
19722050|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
19722051|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722052|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722053|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
19722054|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734606|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734607|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20253213|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253214|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
20253215|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253216|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
20253217|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
20253218|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253219|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734608|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19734609|NCT04547764|Calcium|calcium|mesh-list
19863696|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253220|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863697|NCT00811850|Timolol|timolol|mesh-list
19863698|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19863699|NCT00811850|Dorzolamide|dorzolamide|mesh-list
19863700|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19863701|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19863702|NCT00811850|Maleic acid|maleic acid|mesh-list
19863703|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19863704|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19863705|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
19863706|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863707|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863708|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863709|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19863710|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19863711|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863712|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19863713|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19863714|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19863715|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20253221|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
19722055|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
19722056|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19722057|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19722058|NCT04693312|Prednisolone|prednisolone|mesh-list
19722059|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
19722060|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19722061|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
19722062|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722063|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
19722064|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
19722065|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722066|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722067|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19722068|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
19863716|NCT00811928|Fluconazole|fluconazole|mesh-list
19722069|NCT04693312|Hormones|hormones|mesh-ancestor
19722070|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253222|NCT00458328|Z 338|z 338|mesh-list
19722071|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19722072|NCT04693312|Protective Agents|protective agents|mesh-ancestor
19722073|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19722074|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722075|NCT04693026|Remdesivir|remdesivir|mesh-list
19722076|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
19722077|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722078|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
19722079|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722080|NCT04692623|Insulin|insulin|mesh-list
19722081|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19722082|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
19722083|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
19722084|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19722085|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722086|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19722087|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722088|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19722089|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19722090|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722091|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722092|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722093|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
19722094|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19722095|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
19722096|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722097|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
19722098|NCT04692558|Protective Agents|protective agents|mesh-ancestor
19722099|NCT04692844|Propranolol|propranolol|mesh-list
19863717|NCT00811928|Posaconazole|posaconazole|mesh-list
19863718|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
19863719|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722100|NCT04692844|Primidone|primidone|mesh-list
19722101|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19722102|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19722103|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722104|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722105|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722106|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722107|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19722108|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19722109|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
19722110|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
19722111|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
19722112|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
19722113|NCT04692896|Lidocaine|lidocaine|mesh-list
19722114|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
19722115|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
19722116|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722117|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722118|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
19722119|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722120|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19863720|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19722121|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19863721|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19722122|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19722123|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19722124|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722125|NCT04692740|Chlorambucil|chlorambucil|mesh-list
19722126|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19722127|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
19722128|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722129|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722130|NCT04692285|Zolpidem|zolpidem|mesh-list
19722131|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19722132|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19722133|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722134|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722135|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19722136|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
19722137|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
19863722|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863723|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863724|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19863725|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
19863726|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863727|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863728|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19863729|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19863730|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19863731|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19863732|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19863733|NCT00811941|Nalmefene|nalmefene|mesh-list
19863734|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19863735|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863736|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
19863737|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863738|NCT00811954|Ritonavir|ritonavir|mesh-list
19863739|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19863740|NCT00811954|Darunavir|darunavir|mesh-list
19863741|NCT00811954|Tenofovir|tenofovir|mesh-list
19863742|NCT00811954|Emtricitabine|emtricitabine|mesh-list
19863743|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
19863744|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19863745|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19863746|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19863747|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
19863748|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863749|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863750|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19863751|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19863752|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
19863753|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863754|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19863755|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19863756|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19863757|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863758|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20533887|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20533888|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
20533889|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722138|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722139|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722140|NCT04692376|Cyclosporine|cyclosporine|mesh-list
19722141|NCT04692376|Cyclosporins|cyclosporins|mesh-list
19722142|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
19722143|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722144|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533890|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533891|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20533892|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20533893|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
19722145|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722146|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
19722147|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722148|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
19722149|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722150|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
19722151|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722152|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19722153|NCT04692376|Hormones|hormones|mesh-ancestor
19722154|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722155|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
19722156|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19722157|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722158|NCT04692051|Gemcitabine|gemcitabine|mesh-list
19722159|NCT04692051|Paclitaxel|paclitaxel|mesh-list
19722160|NCT04692051|Cisplatin|cisplatin|mesh-list
19722161|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19722162|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722163|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
19722164|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
19722165|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
19722166|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722167|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19722168|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
19722169|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
19722170|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863759|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19863760|NCT00812253|Insulin|insulin|mesh-list
19863761|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19863762|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19863763|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863764|NCT00812331|Simeprevir|simeprevir|mesh-list
19863765|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
19863766|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863767|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
19863768|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863769|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863770|NCT00812461|Nalmefene|nalmefene|mesh-list
19863771|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19863772|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863773|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
19863774|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863775|NCT00812487|Insulin|insulin|mesh-list
19863776|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19863777|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19863778|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863779|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
19863780|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19863781|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20533894|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533895|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20533896|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20533897|NCT01810926|Cyclosporine|cyclosporine|mesh-list
20533898|NCT01810926|Rituximab|rituximab|mesh-list
19722171|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863782|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
19863783|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722172|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722173|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
19722174|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722175|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19722176|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722177|NCT04691687|Furosemide|furosemide|mesh-list
19722178|NCT04691687|Diuretics|diuretics|mesh-ancestor
19722179|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
19722180|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722181|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19722182|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19722183|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722184|NCT04691726|Dipyrone|dipyrone|mesh-list
19722185|NCT04691726|Lidocaine|lidocaine|mesh-list
19722186|NCT04691726|Morphine|morphine|mesh-list
19863784|NCT00812604|Analgesics|analgesics|mesh-list
19863785|NCT00812604|Petrolatum|petrolatum|mesh-list
19863786|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
19722187|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
19722188|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
19722189|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722190|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722191|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
19722192|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722193|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19722194|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19722195|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19722196|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19722197|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722198|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19722199|NCT04691726|Narcotics|narcotics|mesh-ancestor
19722200|NCT04691726|Analgesics|analgesics|mesh-ancestor
19722201|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19722202|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19722203|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722204|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722205|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
19722206|NCT04691817|Atezolizumab|atezolizumab|mesh-list
19722207|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722208|NCT04691934|Anesthetics|anesthetics|mesh-list
19722209|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863787|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863788|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863789|NCT00812604|Emollients|emollients|mesh-ancestor
19863790|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
19863791|NCT00812812|Paroxetine|paroxetine|mesh-list
19863792|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19863793|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19863794|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19863795|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863796|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863797|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
19863798|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722210|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722211|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
19722212|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19722213|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19863799|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20533899|NCT01810926|Methotrexate|methotrexate|mesh-list
19722214|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722215|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
19722216|NCT04691362|Coagulants|coagulants|mesh-ancestor
19734610|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19734611|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734612|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734613|NCT04547907|Paclitaxel|paclitaxel|mesh-list
19734614|NCT04547907|Docetaxel|docetaxel|mesh-list
19734615|NCT04547907|Carboplatin|carboplatin|mesh-list
19734616|NCT04547907|Trastuzumab|trastuzumab|mesh-list
19734617|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19734618|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734619|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734620|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734621|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
19722217|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19722218|NCT04690920|Remdesivir|remdesivir|mesh-list
19722219|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722220|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722221|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
19863800|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
19863801|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19863802|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19863803|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19863804|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863805|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
19863806|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19863807|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19863808|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19863809|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19863810|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863811|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
19863812|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863813|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863814|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19863815|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863816|NCT00812877|Calcium|calcium|mesh-list
19863817|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19863818|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863819|NCT00812955|Simvastatin|simvastatin|mesh-list
19863820|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19863821|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19863822|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
19863823|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863824|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19863825|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19863826|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863827|NCT00812968|Lenalidomide|lenalidomide|mesh-list
19863828|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
19863829|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863830|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19863831|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19863832|NCT00812968|Growth Substances|growth substances|mesh-ancestor
19863833|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
19863834|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863835|NCT00813111|Epinephrine|epinephrine|mesh-list
19863836|NCT00813111|Bupivacaine|bupivacaine|mesh-list
19863837|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
19863838|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
19863839|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863840|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863841|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
19863842|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863843|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19863844|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19863845|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
19863846|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863847|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863848|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19863849|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19863850|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
19863851|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19863852|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
19863853|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
19863854|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
19722222|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
19722223|NCT04691076|Fentanyl|fentanyl|mesh-list
19722224|NCT04691076|Propofol|propofol|mesh-list
19722225|NCT04691076|Esketamine|esketamine|mesh-list
19722226|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19722227|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722228|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722229|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19722230|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
19722231|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
19722232|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19722233|NCT04691076|Narcotics|narcotics|mesh-ancestor
19722234|NCT04691076|Analgesics|analgesics|mesh-ancestor
19722235|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
19722236|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722237|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19722238|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
19722239|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19722240|NCT04691063|Carboplatin|carboplatin|mesh-list
19722241|NCT04691063|Etoposide|etoposide|mesh-list
19722242|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
19722243|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722244|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19722245|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19722246|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19722247|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722248|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722249|NCT04690608|Triamcinolone|triamcinolone|mesh-list
19722250|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19722251|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19722252|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19722253|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722254|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
19722255|NCT04690608|Hormones|hormones|mesh-ancestor
19722256|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722257|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722258|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722259|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
19722260|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722261|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722262|NCT04690647|Dexamethasone|dexamethasone|mesh-list
19722263|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19722264|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722265|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
19722266|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
19722267|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722268|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722269|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19722270|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
19722271|NCT04690647|Hormones|hormones|mesh-ancestor
19722272|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722273|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19722274|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722275|NCT04690647|Analgesics|analgesics|mesh-ancestor
19722276|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
19722277|NCT04690751|Cenobamate|cenobamate|mesh-list
19722278|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
19722279|NCT04690556|Ranibizumab|ranibizumab|mesh-list
19722280|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19722281|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19722282|NCT04690556|Growth Substances|growth substances|mesh-ancestor
19722283|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722284|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
20253223|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20253224|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253225|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722285|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722286|NCT04690270|Sumatriptan|sumatriptan|mesh-list
19722287|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19722288|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19722289|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19722290|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
19722291|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722292|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722293|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722294|NCT04689958|Vitamin D|vitamin d|mesh-list
19722295|NCT04689958|Vitamins|vitamins|mesh-ancestor
19722296|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
19722297|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722298|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19722299|NCT04689971|Vitamins|vitamins|mesh-list
20253226|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
20253227|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253228|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722300|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
19722301|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
19722302|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253229|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20253230|NCT00458367|Risperidone|risperidone|mesh-list
20253231|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19863855|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19863856|NCT00813124|Vidarabine|vidarabine|mesh-list
19863857|NCT00813124|Fludarabine|fludarabine|mesh-list
19863858|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
19863859|NCT00813124|Azacitidine|azacitidine|mesh-list
19863860|NCT00813124|Busulfan|busulfan|mesh-list
19863861|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
19863862|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19863863|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863864|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253232|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
20253233|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253234|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253235|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253236|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19863865|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
19863866|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863867|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863868|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
19863869|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863870|NCT00813124|Antiviral Agents|antiviral agents|mesh-ancestor
19863871|NCT00813124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863872|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863873|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
19863874|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19863875|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19863876|NCT00813150|Dexamethasone|dexamethasone|mesh-list
19863877|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
19863878|NCT00813150|Bortezomib|bortezomib|mesh-list
19863879|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863880|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
19863881|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863882|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863883|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20253237|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20253238|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253239|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20253240|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20253241|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
20253242|NCT00458419|Naloxone|naloxone|mesh-list
20253243|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20253244|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722303|NCT04690309|Insulin|insulin|mesh-list
19722304|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19863884|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
19863885|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863886|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863887|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19863888|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19863889|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
19863890|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
19863891|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863892|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19863893|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
19863894|NCT00813150|Hormones|hormones|mesh-ancestor
19863895|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863896|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19863897|NCT00813293|Sorafenib|sorafenib|mesh-list
19863898|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863899|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19863900|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863901|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722305|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19722306|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722307|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
19722308|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722309|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19722310|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
19722311|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
19722312|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863902|NCT00813488|Fentanyl|fentanyl|mesh-list
19863903|NCT00813488|Oxycodone|oxycodone|mesh-list
19863904|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19863905|NCT00813488|Narcotics|narcotics|mesh-ancestor
19722313|NCT04689412|Resveratrol|resveratrol|mesh-list
19722314|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
19722315|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722316|NCT04689412|Protective Agents|protective agents|mesh-ancestor
19722317|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722318|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253245|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
20253246|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253247|NCT00458458|Leuprolide|leuprolide|mesh-list
19438919|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19438920|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19438921|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19438922|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19438923|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438924|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
19438925|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438926|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438927|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19438928|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438929|NCT03472170|Lactoferrin|lactoferrin|mesh-list
19438930|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438931|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19438932|NCT03472144|Levofloxacin|levofloxacin|mesh-list
19438933|NCT03472144|Ofloxacin|ofloxacin|mesh-list
19438934|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19438935|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438936|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
19438937|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19438938|NCT03472144|Renal Agents|renal agents|mesh-ancestor
19438939|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19438940|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19438941|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438942|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438943|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19438944|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19438945|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19438946|NCT03472040|Berotralstat|berotralstat|mesh-list
19438947|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438948|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438949|NCT03471988|Voriconazole|voriconazole|mesh-list
19438950|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
19438951|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19438952|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19438953|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19438954|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19438955|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438956|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19438957|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
19438958|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438959|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253248|NCT00458458|Norethindrone|norethindrone|mesh-list
19722319|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19722320|NCT04689191|Vaccines|vaccines|mesh-list
19722321|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
19722322|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734622|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734623|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734624|NCT04547855|Temozolomide|temozolomide|mesh-list
19734625|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19734626|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
19734627|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734628|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253249|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
20253250|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20253251|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
20253252|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20253253|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253254|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20253255|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253256|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20253257|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20253258|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20253259|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
20253260|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20253261|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20253262|NCT00458510|Fentanyl|fentanyl|mesh-list
20253263|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20253264|NCT00458510|Narcotics|narcotics|mesh-ancestor
20253265|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253266|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253267|NCT00458510|Analgesics|analgesics|mesh-ancestor
20253268|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
20253269|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253270|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20253271|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20253272|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
20253273|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
20253274|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
20253275|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20253276|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253277|NCT00458614|Lansoprazole|lansoprazole|mesh-list
20253278|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
20253279|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20253280|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20253281|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20253282|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253283|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253284|NCT00458718|Rimonabant|rimonabant|mesh-list
20253285|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20253286|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20253287|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20253288|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253289|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253290|NCT00458718|Hormones|hormones|mesh-ancestor
20253291|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253292|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253293|NCT00458731|Bevacizumab|bevacizumab|mesh-list
20253294|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20253295|NCT00458731|Cediranib|cediranib|mesh-list
20253296|NCT00458731|Antibodies|antibodies|mesh-list
20253297|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
19734629|NCT04547842|Dexamethasone|dexamethasone|mesh-list
19734630|NCT04547842|Mirtazapine|mirtazapine|mesh-list
19734631|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734632|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
19734633|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
19734634|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734635|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734636|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19734637|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
19734638|NCT04547842|Hormones|hormones|mesh-ancestor
20253298|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20253299|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734639|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533900|NCT01810926|Fludarabine|fludarabine|mesh-list
19722323|NCT04689100|Leucovorin|leucovorin|mesh-list
19722324|NCT04689100|Fluorouracil|fluorouracil|mesh-list
19722325|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
19722326|NCT04689100|Irinotecan|irinotecan|mesh-list
19722327|NCT04689100|Calcium|calcium|mesh-list
19438960|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19863906|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19863907|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863908|NCT00813488|Analgesics|analgesics|mesh-ancestor
19863909|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
19863910|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19863911|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19863912|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19863913|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
19863914|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
19863915|NCT00813592|Pasireotide|pasireotide|mesh-list
20253300|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19863916|NCT00813592|Hormones|hormones|mesh-ancestor
19863917|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863918|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863919|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
19863920|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19863921|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
19863922|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863923|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863924|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
19863925|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19863926|NCT00813748|Omalizumab|omalizumab|mesh-list
19863927|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19863928|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19863929|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
19863930|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19863931|NCT00813800|Varenicline|varenicline|mesh-list
19863932|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19863933|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19863934|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
19863935|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863936|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863937|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863938|NCT00813917|Varenicline|varenicline|mesh-list
19863939|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19863940|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19863941|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
19863942|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19863943|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863944|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863945|NCT00813943|Temozolomide|temozolomide|mesh-list
19863946|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19863947|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
19863948|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863949|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863950|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19863951|NCT00813995|Metformin|metformin|mesh-list
19863952|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19863953|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863954|NCT00813995|Incretins|incretins|mesh-ancestor
19863955|NCT00813995|Hormones|hormones|mesh-ancestor
19863956|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19863957|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20253301|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19722328|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
19722329|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19722330|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722331|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
19722332|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722333|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19722334|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722335|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722336|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
19863958|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
19863959|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863960|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863961|NCT00814138|Methotrexate|methotrexate|mesh-list
19863962|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19863963|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
19863964|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19863965|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19863966|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863967|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
19863968|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863969|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863970|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
19863971|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19863972|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19863973|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19863974|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
19863975|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19863976|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19863977|NCT00814164|Daunorubicin|daunorubicin|mesh-list
19863978|NCT00814164|Clofarabine|clofarabine|mesh-list
19863979|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19863980|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19863981|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19863982|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19863983|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533901|NCT01810926|Thiotepa|thiotepa|mesh-list
20533902|NCT01810926|Treosulfan|treosulfan|mesh-list
19863984|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863985|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19863986|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
19863987|NCT00814177|Warfarin|warfarin|mesh-list
19863988|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
19863989|NCT00814255|Adalimumab|adalimumab|mesh-list
19863990|NCT00814255|Losartan|losartan|mesh-list
19863991|NCT00814255|Lisinopril|lisinopril|mesh-list
19863992|NCT00814255|Atorvastatin|atorvastatin|mesh-list
19863993|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19863994|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19863995|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
19863996|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19863997|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19863998|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19863999|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864000|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864001|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864002|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19864003|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19864004|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19864005|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19864006|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19864007|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
19864008|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19864009|NCT00814255|Protective Agents|protective agents|mesh-ancestor
19864010|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864011|NCT00814307|Tofacitinib|tofacitinib|mesh-list
19864012|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19864013|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864014|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722337|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19722338|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19722339|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722340|NCT04689100|Antidotes|antidotes|mesh-ancestor
19722341|NCT04689100|Protective Agents|protective agents|mesh-ancestor
19722342|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
19722343|NCT04689100|Vitamins|vitamins|mesh-ancestor
19722344|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
19722345|NCT04689165|Vaccines|vaccines|mesh-list
19722346|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
19722347|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722348|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
19722349|NCT04688983|Blinatumomab|blinatumomab|mesh-list
19722350|NCT04688983|Ponatinib|ponatinib|mesh-list
19864015|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
19722351|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722352|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19722353|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722354|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722355|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
19722356|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
19864016|NCT00814320|Antibodies|antibodies|mesh-list
19864017|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
19864018|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19864019|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19864020|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
19864021|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
19864022|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864023|NCT00814502|Zolpidem|zolpidem|mesh-list
19864024|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19864025|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19864026|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864027|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864028|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19864029|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
19864030|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
19864031|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864032|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969760|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969761|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969762|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19969763|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969764|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969765|NCT01776008|Anastrozole|anastrozole|mesh-list
19969766|NCT01776008|Goserelin|goserelin|mesh-list
19969767|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19969768|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969769|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19969770|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19969771|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969772|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969773|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19969774|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
19969775|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969776|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969777|NCT01776424|Aspirin|aspirin|mesh-list
19969778|NCT01776424|Pantoprazole|pantoprazole|mesh-list
19969779|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
19969780|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19969781|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969782|NCT01776424|Analgesics|analgesics|mesh-ancestor
19969783|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
19969784|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969785|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969786|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969787|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969788|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19969789|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19969790|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969791|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19969792|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19969793|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969794|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
19969795|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19969796|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
19969797|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19969798|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
19969799|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
19969800|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19969801|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969802|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19969803|NCT01777139|Ezogabine|ezogabine|mesh-list
19969804|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
19722357|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
19722358|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
19722359|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19722360|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
19722361|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
19722362|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734640|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19722363|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722364|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722365|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19722366|NCT04688723|Dabigatran|dabigatran|mesh-list
19722367|NCT04688723|Clopidogrel|clopidogrel|mesh-list
19722368|NCT04688723|Ticagrelor|ticagrelor|mesh-list
19722369|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19722370|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19722371|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19722372|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19722373|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
19722374|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722375|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722376|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722377|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
19722378|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19722379|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
19722380|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722381|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
19722382|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19722383|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
19722384|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19722385|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19722386|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722387|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19722388|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19722389|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722390|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722391|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722392|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19722393|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
19722394|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19722395|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722396|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19722397|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19722398|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19722399|NCT04688346|Epinephrine|epinephrine|mesh-list
19722400|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19722401|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19722402|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722403|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722404|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722405|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722406|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19438961|NCT03471819|Serotonin|serotonin|mesh-list
19438962|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19722407|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19438963|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
19438964|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438965|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438966|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438967|NCT03471585|Dronabinol|dronabinol|mesh-list
19438968|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
19438969|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438970|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19438971|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438972|NCT03471585|Analgesics|analgesics|mesh-ancestor
19722408|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
19722409|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722410|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19722411|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
19722412|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
19722413|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
19722414|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19722415|NCT04688021|Cytarabine|cytarabine|mesh-list
19722416|NCT04688021|Cyclosporine|cyclosporine|mesh-list
19722417|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
19722418|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
19722419|NCT04688021|Busulfan|busulfan|mesh-list
19722420|NCT04688021|Cyclosporins|cyclosporins|mesh-list
19722421|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19864033|NCT00814580|Oxycodone|oxycodone|mesh-list
19864034|NCT00814580|Tapentadol|tapentadol|mesh-list
19864035|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19722422|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
19722423|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722424|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
19722425|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722426|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722427|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19722428|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
19722429|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722430|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722431|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19722432|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19722433|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
19722434|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
19722435|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722436|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722437|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
19722438|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
19722439|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19722440|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19722441|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19722442|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
19864036|NCT00814580|Narcotics|narcotics|mesh-ancestor
19864037|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864038|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864039|NCT00814580|Analgesics|analgesics|mesh-ancestor
19864040|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
19864041|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864042|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19864043|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19864044|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19864045|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864046|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
19864047|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864048|NCT00814632|Apremilast|apremilast|mesh-list
19864049|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19864050|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19864051|NCT00814632|Analgesics|analgesics|mesh-ancestor
19864052|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
19864053|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864054|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864055|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864056|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864057|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19864058|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19864059|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722443|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19722444|NCT04688151|Rituximab|rituximab|mesh-list
19722445|NCT04688151|Durvalumab|durvalumab|mesh-list
19722446|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
19722447|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722448|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722449|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
19722450|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722451|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722452|NCT04687878|Insulin|insulin|mesh-list
20253302|NCT00458731|Growth Substances|growth substances|mesh-ancestor
20533903|NCT01810926|Antibodies|antibodies|mesh-list
19722453|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19722454|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19722455|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722456|NCT04687566|Memantine|memantine|mesh-list
19722457|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
19722458|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19722459|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19722460|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
19722461|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722462|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722463|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722464|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19722465|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19722466|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
19722467|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
19722468|NCT04687631|Bevacizumab|bevacizumab|mesh-list
19722469|NCT04687631|Cetuximab|cetuximab|mesh-list
19722470|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722471|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722472|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19722473|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19722474|NCT04687631|Growth Substances|growth substances|mesh-ancestor
19722475|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722476|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
19722477|NCT04687761|Cytarabine|cytarabine|mesh-list
19722478|NCT04687761|Azacitidine|azacitidine|mesh-list
19722479|NCT04687761|Venetoclax|venetoclax|mesh-list
19722480|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19864060|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864061|NCT00814658|Nimodipine|nimodipine|mesh-list
19864062|NCT00814658|Galantamine|galantamine|mesh-list
19864063|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19864064|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722481|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
19722482|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722483|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722484|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
19722485|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722486|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722487|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
19722488|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722489|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722490|NCT04687514|Dulaglutide|dulaglutide|mesh-list
19722491|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19722492|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722493|NCT04687332|Tryptophan|tryptophan|mesh-list
19722494|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19722495|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
19864065|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864066|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
19864067|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864068|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864069|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19864070|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
19864071|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864072|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
19864073|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19864074|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19864075|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19864076|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19864077|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
19864078|NCT00814671|Rifampin|rifampin|mesh-list
19864079|NCT00814671|Rifapentine|rifapentine|mesh-list
19864080|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19864081|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
19864082|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19864083|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864084|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
19864085|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19864086|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864087|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864088|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19864089|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19864090|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19864091|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19864092|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19722496|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19722497|NCT04687449|Curcumin|curcumin|mesh-list
19864093|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19864094|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19864095|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
19864096|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864097|NCT00814788|Everolimus|everolimus|mesh-list
19864098|NCT00814788|Bicalutamide|bicalutamide|mesh-list
19864099|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864100|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19864101|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
19864102|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253303|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253304|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
19722498|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19722499|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19722500|NCT04687449|Analgesics|analgesics|mesh-ancestor
20253305|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
20253306|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533904|NCT01810926|Cyclosporins|cyclosporins|mesh-list
20533905|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
20533906|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533907|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20533908|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533909|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533910|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20533911|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
19722501|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
19722502|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722503|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722504|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722505|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722506|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722507|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722508|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722509|NCT04687111|Valsartan|valsartan|mesh-list
19722510|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19722511|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20533912|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20533913|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20533914|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
20533915|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533916|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
20533917|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533918|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20533919|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20533920|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20533921|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
20533922|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20533923|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20533924|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20533925|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
20533926|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20553473|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553474|NCT01929512|Metformin|metformin|mesh-list
20553475|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20553476|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20553477|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553478|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20553479|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20553480|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
20553481|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553482|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20553483|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20553484|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553485|NCT01929577|Peficitinib|peficitinib|mesh-list
20553486|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553487|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553488|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553489|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
20553490|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553491|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20553492|NCT01929590|Laxatives|laxatives|mesh-ancestor
19722512|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19722513|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19722514|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722515|NCT04686890|Acetaminophen|acetaminophen|mesh-list
19722516|NCT04686890|Tramadol|tramadol|mesh-list
19722517|NCT04686890|Analgesics|analgesics|mesh-list
19722518|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19722519|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
19722520|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722521|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722522|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
19722523|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19722524|NCT04686890|Narcotics|narcotics|mesh-ancestor
19722525|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722526|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
19722527|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734641|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734642|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
19734643|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19734644|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19734645|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
19734646|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
19734647|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734648|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734649|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19734650|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19734651|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734652|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19734653|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19734654|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19734655|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
19734656|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19734657|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19734658|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
19734659|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19734660|NCT04547621|Temozolomide|temozolomide|mesh-list
19734661|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19734662|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
19734663|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734664|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734665|NCT04547608|Propofol|propofol|mesh-list
19734666|NCT04547608|Rocuronium|rocuronium|mesh-list
19734667|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19734668|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734669|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734670|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19734671|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
19438973|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
19734672|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
19734673|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19734674|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19734675|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19734676|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734677|NCT04547348|Denosumab|denosumab|mesh-list
19734678|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19734679|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734680|NCT04547426|Nicotine|nicotine|mesh-list
19734681|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19734682|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
19734683|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734684|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734685|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19734686|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19734687|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
19734688|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438974|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438975|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19438976|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19438977|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438978|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19438979|NCT03471585|Hormones|hormones|mesh-ancestor
19438980|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19438981|NCT03471559|Cannabidiol|cannabidiol|mesh-list
19722528|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
19722529|NCT04687163|Fluorouracil|fluorouracil|mesh-list
19722530|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722531|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
19722532|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722533|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19722534|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722535|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
19722536|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253307|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253308|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20253309|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
20253310|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722537|NCT04686929|Abatacept|abatacept|mesh-list
20253311|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
20253312|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20253313|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253314|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20253315|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20253316|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253317|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253318|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253319|NCT00458913|Bortezomib|bortezomib|mesh-list
20253320|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253321|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
20253322|NCT00458991|Caffeine|caffeine|mesh-list
20253323|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19864103|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
19864104|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
19864105|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864106|NCT00814801|Galantamine|galantamine|mesh-list
19864107|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19864108|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864109|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864110|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
19864111|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864112|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864113|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19864114|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
19864115|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253324|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722538|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19722539|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722540|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722541|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722542|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
19722543|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864116|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
19864117|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
19722544|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722545|NCT04687098|Idarubicin|idarubicin|mesh-list
19722546|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19722547|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722548|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19722549|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19722550|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864118|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19864119|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19864120|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19864121|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
19864122|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864123|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19864124|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19864125|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864126|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864127|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19864128|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19864129|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
19864130|NCT00815295|Cetuximab|cetuximab|mesh-list
19864131|NCT00815295|Sorafenib|sorafenib|mesh-list
19864132|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864133|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864134|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19864135|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864136|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864137|NCT00815308|Paclitaxel|paclitaxel|mesh-list
19864138|NCT00815308|Cetuximab|cetuximab|mesh-list
19864139|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19864140|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864141|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
19864142|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
19864143|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
19864144|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864145|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864146|NCT00815347|Bosentan|bosentan|mesh-list
19864147|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19864148|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19864149|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864150|NCT00815360|Triamcinolone|triamcinolone|mesh-list
19864151|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19864152|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19864153|NCT00815360|Ranibizumab|ranibizumab|mesh-list
19864154|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19864155|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19864156|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19722551|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722552|NCT04686448|Fentanyl|fentanyl|mesh-list
19722553|NCT04686448|Ketamine|ketamine|mesh-list
19722554|NCT04686448|Propofol|propofol|mesh-list
19722555|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19722556|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722557|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722558|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19722559|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
19864157|NCT00815360|Growth Substances|growth substances|mesh-ancestor
19864158|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864159|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
19864160|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864161|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864162|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
19864163|NCT00815360|Hormones|hormones|mesh-ancestor
19864164|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864165|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19864166|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
19864167|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864168|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864169|NCT00815516|Amphotericin B|amphotericin b|mesh-list
19864170|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19864171|NCT00815516|Micafungin|micafungin|mesh-list
19864172|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
19864173|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
19722560|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
19722561|NCT04686448|Analgesics|analgesics|mesh-ancestor
19722562|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
19722563|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722564|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19722565|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19722566|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19722567|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722568|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722569|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19722570|NCT04686448|Narcotics|narcotics|mesh-ancestor
19722571|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19722572|NCT04686825|DA-8010|da-8010|mesh-list
19722573|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19722574|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19722575|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
19722576|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722577|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722578|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722579|NCT04686643|Niacin|niacin|mesh-list
19722580|NCT04686643|Amlodipine|amlodipine|mesh-list
19722581|NCT04686643|Valsartan|valsartan|mesh-list
19722582|NCT04686643|Indapamide|indapamide|mesh-list
19722583|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19722584|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19722585|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19722586|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722587|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19722588|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722589|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
19722590|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19722591|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19722592|NCT04686643|Diuretics|diuretics|mesh-ancestor
19722593|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
19864174|NCT00815516|Amebicides|amebicides|mesh-ancestor
19864175|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19864176|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19864177|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864178|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19864179|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
19864180|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19864181|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864182|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19864183|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19864184|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19864185|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
19864186|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864187|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19864188|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19864189|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864190|NCT00815919|Prednisone|prednisone|mesh-list
19864191|NCT00815919|Bortezomib|bortezomib|mesh-list
19864192|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864193|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
19864194|NCT00815919|Hormones|hormones|mesh-ancestor
19864195|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864196|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864197|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19864198|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864199|NCT00816023|Ecallantide|ecallantide|mesh-list
19864200|NCT00816023|Analgesics|analgesics|mesh-ancestor
19864201|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
19864202|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864203|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864204|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19864205|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19864206|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864207|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864208|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
20533927|NCT01811056|Mifepristone|mifepristone|mesh-list
20533928|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20533929|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
20533930|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20533931|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533932|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20533933|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20533934|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20533935|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
20533936|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19722594|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19722595|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19722596|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
19722597|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19722598|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
19722599|NCT04686643|Vitamins|vitamins|mesh-ancestor
19722600|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
19722601|NCT04685980|Morphine|morphine|mesh-list
19722602|NCT04685980|Anesthetics|anesthetics|mesh-list
19722603|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
19864209|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19864210|NCT00816166|Aspirin|aspirin|mesh-list
20533937|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20533938|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
20533939|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20533940|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
19722604|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722605|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722606|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19438982|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
19864211|NCT00816166|Clopidogrel|clopidogrel|mesh-list
19864212|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19864213|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19864214|NCT00816166|Analgesics|analgesics|mesh-ancestor
19722607|NCT04685980|Narcotics|narcotics|mesh-ancestor
19722608|NCT04685980|Analgesics|analgesics|mesh-ancestor
19864215|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
19864216|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864217|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864218|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864219|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864220|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19864221|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19864222|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864223|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19864224|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19864225|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864226|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
19864227|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19864228|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19722609|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
19722610|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722611|NCT04686058|Midazolam|midazolam|mesh-list
19722612|NCT04686058|Meperidine|meperidine|mesh-list
19722613|NCT04686058|Propofol|propofol|mesh-list
19722614|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19722615|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722616|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722617|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19864229|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19864230|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
19864231|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864232|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19864233|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19864234|NCT00816556|Estradiol|estradiol|mesh-list
19864235|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19864236|NCT00816556|Estrogens|estrogens|mesh-ancestor
19864237|NCT00816556|Hormones|hormones|mesh-ancestor
19864238|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864239|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722618|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
19722619|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
19722620|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19722621|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19722622|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19722623|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20253325|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20253326|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722624|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
19864240|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19722625|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
19722626|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722627|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722628|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19722629|NCT04686058|Narcotics|narcotics|mesh-ancestor
19722630|NCT04686058|Analgesics|analgesics|mesh-ancestor
19722631|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
19722632|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722633|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
19722634|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19722635|NCT04685512|Tenofovir|tenofovir|mesh-list
19722636|NCT04685512|Emtricitabine|emtricitabine|mesh-list
19722637|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
19722638|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722639|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19722640|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19722641|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722642|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722643|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19722644|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19722645|NCT04685642|Aspirin|aspirin|mesh-list
19722646|NCT04685642|Atorvastatin|atorvastatin|mesh-list
19722647|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19722648|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20253327|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253328|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20253329|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20253330|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
20253331|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253332|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
20253333|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
20253334|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20253335|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20253336|NCT00459004|Rimonabant|rimonabant|mesh-list
20253337|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20253338|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20533941|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19722649|NCT04685642|Analgesics|analgesics|mesh-ancestor
19722650|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
19722651|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722652|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722653|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722654|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19722655|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19722656|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19722657|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722658|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19722659|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19722660|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722661|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
19722662|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19722663|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19722664|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
19722665|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19722666|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19722667|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
19722668|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722669|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722670|NCT04685538|Tetracaine|tetracaine|mesh-list
19722671|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
19722672|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
19722673|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
19722674|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722675|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533942|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20533943|NCT01811160|Melatonin|melatonin|mesh-list
20533944|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
20533945|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533946|NCT01811160|Protective Agents|protective agents|mesh-ancestor
20533947|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533948|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253339|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19864241|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
19722676|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
19722677|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722678|NCT04685148|Estradiol|estradiol|mesh-list
19722679|NCT04685148|Estrogens|estrogens|mesh-ancestor
19722680|NCT04685148|Hormones|hormones|mesh-ancestor
19722681|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722682|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722683|NCT04685031|Clobetasol|clobetasol|mesh-list
19722684|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
19722685|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
19722686|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722687|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
19722688|NCT04685031|Hormones|hormones|mesh-ancestor
19722689|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722690|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722691|NCT04685005|Caffeine|caffeine|mesh-list
19722692|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19722693|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722694|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19722695|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722696|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722697|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19722698|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19722699|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
19722700|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734689|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734690|NCT04547452|Antibodies|antibodies|mesh-list
19734691|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
19734692|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734693|NCT04547335|Voriconazole|voriconazole|mesh-list
19734694|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
19734695|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864242|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19864243|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19864244|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
19864245|NCT00816595|Bevacizumab|bevacizumab|mesh-list
19864246|NCT00816595|Rituximab|rituximab|mesh-list
19864247|NCT00816595|Pentostatin|pentostatin|mesh-list
19864248|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19864249|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
19734696|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19734697|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19734698|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734699|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734700|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19734701|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
19864250|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864251|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864252|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19864253|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
19864254|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864255|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864256|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19864257|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864258|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19864259|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19864260|NCT00816595|Growth Substances|growth substances|mesh-ancestor
19864261|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
19864262|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19864263|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864264|NCT00816751|Lidocaine|lidocaine|mesh-list
20533949|NCT01811251|Dexamethasone|dexamethasone|mesh-list
20533950|NCT01811251|Pregabalin|pregabalin|mesh-list
20533951|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20533952|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
20533953|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
20533954|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533955|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533956|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533957|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
20533958|NCT01811251|Hormones|hormones|mesh-ancestor
19722701|NCT04684667|Propranolol|propranolol|mesh-list
19722702|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19722703|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19722704|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722705|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722706|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722707|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722708|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19722709|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19722710|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
19722711|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19722712|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19722713|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722714|NCT04684199|Melatonin|melatonin|mesh-list
19722715|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
19722716|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722717|NCT04684199|Protective Agents|protective agents|mesh-ancestor
19722718|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722719|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19722720|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
19722721|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19722722|NCT04684498|Oseltamivir|oseltamivir|mesh-list
19722723|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
19722724|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722725|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722726|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722727|NCT04683965|Bevacizumab|bevacizumab|mesh-list
19722728|NCT04683965|Pemetrexed|pemetrexed|mesh-list
19722729|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722730|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722731|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19722732|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19722733|NCT04683965|Growth Substances|growth substances|mesh-ancestor
19722734|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722735|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
19722736|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722737|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722738|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19722739|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19722740|NCT04684017|Carboplatin|carboplatin|mesh-list
19722741|NCT04684017|Etoposide|etoposide|mesh-list
19722742|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722743|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19722744|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19722745|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19722746|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722747|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722748|NCT04683458|Paclitaxel|paclitaxel|mesh-list
19722749|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19722750|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19722751|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722752|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
19722753|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
19722754|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
19722755|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722756|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
19722757|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
19722758|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722759|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722760|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722761|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
19722762|NCT04683445|Trastuzumab|trastuzumab|mesh-list
19864265|NCT00816751|Vasopressins|vasopressins|mesh-list
19864266|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
19864267|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
19864268|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
19864269|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864270|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864271|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
19864272|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864273|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19722763|NCT04683445|Pertuzumab|pertuzumab|mesh-list
19722764|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722765|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864274|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19864275|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19864276|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19864277|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864278|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
19722766|NCT04683406|Oseltamivir|oseltamivir|mesh-list
19722767|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
19722768|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722769|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722770|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722771|NCT04683341|Tenofovir|tenofovir|mesh-list
19722772|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
19722773|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722774|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19722775|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19722776|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722777|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722778|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19722779|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19722780|NCT04683315|Gemcitabine|gemcitabine|mesh-list
19722781|NCT04683315|Paclitaxel|paclitaxel|mesh-list
19722782|NCT04683315|Fluorouracil|fluorouracil|mesh-list
19864279|NCT00816751|Coagulants|coagulants|mesh-ancestor
19864280|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19864281|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19864282|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
19722783|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19722784|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722785|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
19722786|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
19722787|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
19722788|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722789|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19722790|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
19864283|NCT00816829|Fenofibrate|fenofibrate|mesh-list
19864284|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19864285|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
19864286|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864287|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19864288|NCT00816907|Metformin|metformin|mesh-list
19864289|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19864290|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864291|NCT00817063|Alitretinoin|alitretinoin|mesh-list
19864292|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864293|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864294|NCT00817089|Naltrexone|naltrexone|mesh-list
19864295|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19864296|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19864297|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864298|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
19864299|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864300|NCT00817206|Tacrolimus|tacrolimus|mesh-list
19864301|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19864302|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
19864303|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864304|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19864305|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864306|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864307|NCT00817219|Betamethasone|betamethasone|mesh-list
19864308|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
19864309|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19864310|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
19864311|NCT00817219|Calcipotriene|calcipotriene|mesh-list
19864312|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19864313|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864314|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
19864315|NCT00817219|Hormones|hormones|mesh-ancestor
19864316|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864317|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864318|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19864319|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
19864320|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864321|NCT00817479|Dexamethasone|dexamethasone|mesh-list
20253340|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253341|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253342|NCT00459004|Hormones|hormones|mesh-ancestor
20253343|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253344|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722791|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
19864322|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864323|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
19864324|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
19864325|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864326|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864327|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864328|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
19864329|NCT00817479|Hormones|hormones|mesh-ancestor
19864330|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864331|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19864332|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864333|NCT00817531|Dasatinib|dasatinib|mesh-list
19864334|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864335|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19864336|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864337|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864338|NCT00817635|Eplerenone|eplerenone|mesh-list
19864339|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19864340|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
19864341|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864342|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864343|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19864344|NCT00817635|Diuretics|diuretics|mesh-ancestor
19864345|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
19864346|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19864347|NCT00817843|Simvastatin|simvastatin|mesh-list
19864348|NCT00817843|Ezetimibe|ezetimibe|mesh-list
19864349|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19864350|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19864351|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
19864352|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864353|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19864354|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19864355|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864356|NCT00817999|Clopidogrel|clopidogrel|mesh-list
19438983|NCT03471507|Diclofenac|diclofenac|mesh-list
19438984|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19438985|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19438986|NCT03471507|Analgesics|analgesics|mesh-ancestor
19438987|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
19438988|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19438989|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19438990|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19438991|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19438992|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19438993|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722792|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722793|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722794|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722795|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
19722796|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722797|NCT04683198|Carboplatin|carboplatin|mesh-list
19722798|NCT04683198|Etoposide|etoposide|mesh-list
19722799|NCT04683198|Apatinib|apatinib|mesh-list
19722800|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722801|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19722802|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19722803|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19722804|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722805|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722806|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19722807|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19722808|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19722809|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19722810|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19722811|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19722812|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722813|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722814|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722815|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864357|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19864358|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19864359|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19864360|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19864361|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
20253345|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
20253346|NCT00459173|Rimonabant|rimonabant|mesh-list
19864362|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864363|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864364|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864365|NCT00818168|Infliximab|infliximab|mesh-list
19864366|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864367|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864368|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864369|NCT00818259|Dexamethasone|dexamethasone|mesh-list
19864370|NCT00818259|Ondansetron|ondansetron|mesh-list
19864371|NCT00818259|Aprepitant|aprepitant|mesh-list
19864372|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
19864373|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864374|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
19864375|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
19864376|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864377|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864378|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864379|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
19864380|NCT00818259|Hormones|hormones|mesh-ancestor
19864381|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864382|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19864383|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864384|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
19864385|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864386|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19864387|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
19864388|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864389|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864390|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19864391|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19864392|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864393|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19864394|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19864395|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19864396|NCT00818272|Infliximab|infliximab|mesh-list
19864397|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864398|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864399|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864400|NCT00818324|Rebamipide|rebamipide|mesh-list
19864401|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19864402|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864403|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
19864404|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864405|NCT00818324|Protective Agents|protective agents|mesh-ancestor
19864406|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864407|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864408|NCT00818337|Aspirin|aspirin|mesh-list
19864409|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19864410|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19864411|NCT00818337|Analgesics|analgesics|mesh-ancestor
19864412|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
19864413|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864414|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864415|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864416|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864417|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19864418|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20253347|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20253348|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19722816|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
19722817|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19722818|NCT04683146|Propranolol|propranolol|mesh-list
19722819|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19722820|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722821|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
19722822|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
19722823|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19722824|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19722825|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722826|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722827|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722828|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722829|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19722830|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19722831|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
19722832|NCT04683237|Liraglutide|liraglutide|mesh-list
19722833|NCT04683237|Megestrol|megestrol|mesh-list
19722834|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
19722835|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19722836|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722837|NCT04683237|Incretins|incretins|mesh-ancestor
19722838|NCT04683237|Hormones|hormones|mesh-ancestor
19722839|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722840|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19722841|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19722842|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19722843|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
19722844|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19722845|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19722846|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19722847|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19722848|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722849|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
19722850|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19734702|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734703|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734704|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19734705|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19734706|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
19734707|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734708|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734709|NCT04547530|Vitamin D|vitamin d|mesh-list
19734710|NCT04547530|Vitamins|vitamins|mesh-ancestor
19734711|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
19734712|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734713|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19734714|NCT04546802|Grazoprevir|grazoprevir|mesh-list
19734715|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
19734716|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734717|NCT04547153|Docetaxel|docetaxel|mesh-list
19734718|NCT04547153|Fluorouracil|fluorouracil|mesh-list
19734719|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734720|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734721|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734722|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
19734723|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734724|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
19734725|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734726|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19734727|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
19734728|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734729|NCT04546815|Daptomycin|daptomycin|mesh-list
19734730|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734731|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734732|NCT04547088|Apatinib|apatinib|mesh-list
19734733|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734734|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19734735|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734736|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734737|NCT04547179|Erenumab|erenumab|mesh-list
19734738|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19734739|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734740|NCT04547179|Analgesics|analgesics|mesh-ancestor
19734741|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
19734742|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734743|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734744|NCT04546828|Gemcitabine|gemcitabine|mesh-list
19734745|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722851|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
19722852|NCT04683679|Olaparib|olaparib|mesh-list
19722853|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722854|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722855|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19722856|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722857|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722858|NCT04682782|Esketamine|esketamine|mesh-list
19722859|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
19864419|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864420|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19864421|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19864422|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864423|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
19864424|NCT00818363|Bupivacaine|bupivacaine|mesh-list
19864425|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
19864426|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
19864427|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864428|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864429|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
19864430|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722860|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19722861|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19722862|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19722863|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19722864|NCT04682691|Erythromycin|erythromycin|mesh-list
19722865|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
19722866|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19722867|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
19722868|NCT04682691|Metoclopramide|metoclopramide|mesh-list
19722869|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
19722870|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
19722871|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722872|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722873|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19722874|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19722875|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19722876|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
19722877|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722878|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722879|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19722880|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722881|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19722882|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722883|NCT04682795|Insulin|insulin|mesh-list
19722884|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19722885|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722886|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19722887|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19722888|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722889|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
19722890|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
19722891|NCT04682587|Avelumab|avelumab|mesh-list
19722892|NCT04682587|Axitinib|axitinib|mesh-list
19722893|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722894|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722895|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19722896|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722897|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722898|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
19722899|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19722900|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19722901|NCT04681937|Prednisolone|prednisolone|mesh-list
19722902|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
19722903|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19722904|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
19722905|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
19722906|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19722907|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
19722908|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
19722909|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722910|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864431|NCT00818389|Riluzole|riluzole|mesh-list
19864432|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
19722911|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864433|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
19722912|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
19722913|NCT04681937|Hormones|hormones|mesh-ancestor
19722914|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722915|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19722916|NCT04681937|Protective Agents|protective agents|mesh-ancestor
19722917|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19722918|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722919|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19722920|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
19722921|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
19722922|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19722923|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722924|NCT04682249|Apatinib|apatinib|mesh-list
19722925|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722926|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19722927|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722928|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722929|NCT04682184|Propranolol|propranolol|mesh-list
19722930|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
19722931|NCT04682184|Ephedrine|ephedrine|mesh-list
19722932|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19722933|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19722934|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
19722935|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19722936|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722937|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722938|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19722939|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19722940|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
19864434|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19864435|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864436|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864437|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
19864438|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19438994|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864439|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864440|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864441|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
19864442|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19864443|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19864444|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864445|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19864446|NCT00818389|Protective Agents|protective agents|mesh-ancestor
19864447|NCT00818454|Albuterol|albuterol|mesh-list
19864448|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19864449|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
19864450|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864451|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864452|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19864453|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
19864454|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
19864455|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19864456|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19864457|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19864458|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19864459|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19864460|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19438995|NCT03471455|Itraconazole|itraconazole|mesh-list
19438996|NCT03471455|Terbinafine|terbinafine|mesh-list
19438997|NCT03471455|Isotretinoin|isotretinoin|mesh-list
19438998|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
19438999|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439000|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19722941|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19722942|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
19722943|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19722944|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19722945|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
19722946|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
19722947|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19722948|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19722949|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
19722950|NCT04682210|Bevacizumab|bevacizumab|mesh-list
19722951|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19722952|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722953|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19722954|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19722955|NCT04682210|Growth Substances|growth substances|mesh-ancestor
19722956|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722957|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
19722958|NCT04682132|Antibodies|antibodies|mesh-list
19722959|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
19722960|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722961|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
19722962|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19722963|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722964|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722965|NCT04681911|Gemcitabine|gemcitabine|mesh-list
19722966|NCT04681911|Paclitaxel|paclitaxel|mesh-list
19864461|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864462|NCT00818519|Drospirenone|drospirenone|mesh-list
19722967|NCT04681911|Vinorelbine|vinorelbine|mesh-list
19722968|NCT04681911|Carboplatin|carboplatin|mesh-list
19864463|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19864464|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
19864465|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864466|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864467|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19864468|NCT00818519|Diuretics|diuretics|mesh-ancestor
19864469|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
19864470|NCT00818649|Bortezomib|bortezomib|mesh-list
19864471|NCT00818649|Vorinostat|vorinostat|mesh-list
19864472|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864473|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19864474|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864475|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864476|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19864477|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
19864478|NCT00818662|Antibodies|antibodies|mesh-list
19864479|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
19864480|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19864481|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19864482|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
19864483|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
19864484|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864485|NCT00818753|Heparin|heparin|mesh-list
19864486|NCT00818753|Calcium heparin|calcium heparin|mesh-list
19864487|NCT00818753|Dabigatran|dabigatran|mesh-list
19864488|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
19864489|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19864490|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19864491|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864492|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
19864493|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19864494|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
19864495|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864496|NCT00818766|Vancomycin|vancomycin|mesh-list
19864497|NCT00818766|Cefazolin|cefazolin|mesh-list
19864498|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19864499|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864500|NCT00818779|Amlodipine|amlodipine|mesh-list
19864501|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19864502|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19864503|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19864504|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864505|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19864506|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722969|NCT04681911|Capecitabine|capecitabine|mesh-list
19864507|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
19864508|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19722970|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19722971|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722972|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
19722973|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
19722974|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
19722975|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864509|NCT00818805|Tranilast|tranilast|mesh-list
19864510|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19864511|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19864512|NCT00818805|Analgesics|analgesics|mesh-ancestor
19864513|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
19864514|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864515|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864516|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864517|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864518|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19864519|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19864520|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19864521|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
19864522|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
19864523|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864524|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864525|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19864526|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19864527|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19864528|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19864529|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19864530|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
19864531|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19864532|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19864533|NCT00818883|Diuretics|diuretics|mesh-ancestor
19864534|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
19864535|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864536|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19864537|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19864538|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864539|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19864540|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19864541|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
19864542|NCT00818961|Busulfan|busulfan|mesh-list
19864543|NCT00818961|Rituximab|rituximab|mesh-list
19864544|NCT00818961|Methotrexate|methotrexate|mesh-list
19864545|NCT00818961|Fludarabine|fludarabine|mesh-list
19864546|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
19864547|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
19864548|NCT00818961|Tacrolimus|tacrolimus|mesh-list
20533959|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19722976|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19722977|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
19722978|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
19722979|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19722980|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722981|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19722982|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
19722983|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722984|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
19722985|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19722986|NCT04682041|Antibodies|antibodies|mesh-list
19722987|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
19722988|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722989|NCT04681469|Niraparib|niraparib|mesh-list
19722990|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19722991|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19722992|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19722993|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19722994|NCT04681833|Vaccines|vaccines|mesh-list
19722995|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
19722996|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19722997|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
19722998|NCT04680884|Clotrimazole|clotrimazole|mesh-list
19722999|NCT04680884|Miconazole|miconazole|mesh-list
19723000|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864549|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19864550|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
19723001|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19723002|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19723003|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19723004|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723005|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723006|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19723007|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
19723008|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19723009|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723010|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19723011|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19723012|NCT04680962|Rituximab|rituximab|mesh-list
19723013|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723014|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723015|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
19723016|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723017|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723018|NCT04681027|Oxymorphone|oxymorphone|mesh-list
19723019|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19723020|NCT04681027|Narcotics|narcotics|mesh-ancestor
19723021|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723022|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864551|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864552|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864553|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19864554|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
19864555|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864556|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864557|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19864558|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864559|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19864560|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
19864561|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19864562|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19864563|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
19864564|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864565|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864566|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19864567|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19864568|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19864569|NCT00819013|Vaccines|vaccines|mesh-list
19864570|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
19864571|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253349|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19723023|NCT04681027|Analgesics|analgesics|mesh-ancestor
19723024|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
19723025|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723026|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19723027|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19723028|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723029|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723030|NCT04681053|Ivermectin|ivermectin|mesh-list
19723031|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19723032|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723033|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19723034|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723035|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723036|NCT04680923|Bupivacaine|bupivacaine|mesh-list
19723037|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
19723038|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
19723039|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723040|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723041|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
19723042|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723043|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19723044|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723045|NCT04680819|Propolis|propolis|mesh-list
19723046|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734746|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734747|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
19734748|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734749|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
19734750|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734751|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734752|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19734753|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
19734754|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734755|NCT04547049|Cytarabine|cytarabine|mesh-list
19734756|NCT04547049|Cyclosporine|cyclosporine|mesh-list
19734757|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
19734758|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
19734759|NCT04547049|Busulfan|busulfan|mesh-list
19734760|NCT04547049|Cyclosporins|cyclosporins|mesh-list
19734761|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19734762|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
19734763|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19734764|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
19734765|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734766|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734767|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19734768|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
19734769|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734770|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734771|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19734772|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734773|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
19734774|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
19734775|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734776|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734777|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
19864572|NCT00819039|Ondansetron|ondansetron|mesh-list
19864573|NCT00819039|Aprepitant|aprepitant|mesh-list
19864574|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
19864575|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
19864576|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864577|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864578|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864579|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
19864580|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
20253350|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734778|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864581|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19864582|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
19723047|NCT04680650|Anesthetics|anesthetics|mesh-list
19723048|NCT04680650|Propofol|propofol|mesh-list
19723049|NCT04680650|Sevoflurane|sevoflurane|mesh-list
19723050|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723051|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723052|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723053|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723054|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
19723055|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19723056|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19723057|NCT04680442|Trastuzumab|trastuzumab|mesh-list
19723058|NCT04680442|Pertuzumab|pertuzumab|mesh-list
19723059|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19723060|NCT04680442|Maytansine|maytansine|mesh-list
19723061|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723062|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723063|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723064|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19723065|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19723066|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19723067|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723068|NCT04680221|Bupivacaine|bupivacaine|mesh-list
19723069|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
19723070|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
19864583|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864584|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864585|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19864586|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19723071|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723072|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723073|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
19723074|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723075|NCT04680091|Efavirenz|efavirenz|mesh-list
19723076|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723077|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723078|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19864587|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864588|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19864589|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20253351|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253352|NCT00459173|Hormones|hormones|mesh-ancestor
19723079|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19723080|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
19723081|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723082|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19723083|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19723084|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19723085|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19723086|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19723087|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19723088|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
19723089|NCT04680143|Hematinics|hematinics|mesh-ancestor
19723090|NCT04680208|Anesthetics|anesthetics|mesh-list
19723091|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253353|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253354|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253355|NCT00459264|Folic Acid|folic acid|mesh-list
20253356|NCT00459264|Hematinics|hematinics|mesh-ancestor
20253357|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
19723092|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253358|NCT00459264|Vitamins|vitamins|mesh-ancestor
20253359|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
19864590|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19864591|NCT00819052|Nevirapine|nevirapine|mesh-list
20533960|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20533961|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533962|NCT01811251|Analgesics|analgesics|mesh-ancestor
20533963|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
20533964|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
20533965|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20533966|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19723093|NCT04679948|Midazolam|midazolam|mesh-list
19723094|NCT04679948|Caffeine|caffeine|mesh-list
19723095|NCT04679948|Omeprazole|omeprazole|mesh-list
19723096|NCT04679948|Warfarin|warfarin|mesh-list
19723097|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19723098|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723099|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723100|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723101|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19864592|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19864593|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19864594|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864595|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864596|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
19864597|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864598|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19723102|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19723103|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19723104|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723105|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
19723106|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
19723107|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
19723108|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
19723109|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723110|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723111|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
19723112|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19723113|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19723114|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19723115|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723116|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19723117|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19723118|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19723119|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19723120|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
19723121|NCT04680286|Methadone|methadone|mesh-list
19723122|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19723123|NCT04680286|Narcotics|narcotics|mesh-ancestor
19723124|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723125|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723126|NCT04680286|Analgesics|analgesics|mesh-ancestor
19723127|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
19723128|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723129|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
19723130|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
19723131|NCT04679831|Praziquantel|praziquantel|mesh-list
19864599|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19864600|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19864601|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19864602|NCT00819091|Linagliptin|linagliptin|mesh-list
19864603|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19864604|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864605|NCT00819091|Incretins|incretins|mesh-ancestor
19864606|NCT00819091|Hormones|hormones|mesh-ancestor
19864607|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864608|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19864609|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
19864610|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864611|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864612|NCT00819234|Pramlintide|pramlintide|mesh-list
19864613|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20533967|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723132|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
19723133|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19723134|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723135|NCT04679740|Sirolimus|sirolimus|mesh-list
19723136|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19723137|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723138|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19723139|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723140|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
19723141|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723142|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
19723143|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723144|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
19723145|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19723146|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723147|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
19864614|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723148|NCT04679389|Acetazolamide|acetazolamide|mesh-list
19723149|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
19723150|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19723151|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723152|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723153|NCT04679389|Diuretics|diuretics|mesh-ancestor
19723154|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
19723155|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723156|NCT04680195|Thalidomide|thalidomide|mesh-list
19723157|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723158|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
19723159|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723160|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
19723161|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19439001|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19439002|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439003|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723162|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723163|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19723164|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19723165|NCT04680195|Growth Substances|growth substances|mesh-ancestor
19723166|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
19723167|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723168|NCT04679597|Capecitabine|capecitabine|mesh-list
19723169|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
19723170|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19723171|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
19723172|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723173|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723174|NCT04679506|Cytarabine|cytarabine|mesh-list
19723175|NCT04679506|Etoposide|etoposide|mesh-list
19723176|NCT04679506|Cladribine|cladribine|mesh-list
19723177|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723178|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723179|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19723180|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19723181|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723182|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723183|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19723184|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
19723185|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
19723186|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723187|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723188|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
19723189|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723190|NCT04679480|Cemiplimab|cemiplimab|mesh-list
19723191|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723192|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723193|NCT04679376|Atorvastatin|atorvastatin|mesh-list
19723194|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19723195|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19723196|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
19723197|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723198|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19723199|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19439004|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19439005|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
19439006|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439007|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439008|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19439009|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
19864615|NCT00819390|Chloroquine|chloroquine|mesh-list
19723200|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723201|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19723202|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
19723203|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723204|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19723205|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19723206|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723207|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723208|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723209|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19723210|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19723211|NCT04679142|Baclofen|baclofen|mesh-list
19723212|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19723213|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723214|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19723215|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723216|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19723217|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
19723218|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
19723219|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723220|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723221|NCT04679064|Gemcitabine|gemcitabine|mesh-list
19723222|NCT04679064|Paclitaxel|paclitaxel|mesh-list
19723223|NCT04679064|Bevacizumab|bevacizumab|mesh-list
19723224|NCT04679064|Doxorubicin|doxorubicin|mesh-list
19723225|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19723226|NCT04679064|Topotecan|topotecan|mesh-list
19723227|NCT04679064|Niraparib|niraparib|mesh-list
19864616|NCT00819390|Amebicides|amebicides|mesh-ancestor
19864617|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19864618|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19864619|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864620|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
19864621|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864622|NCT00819403|Simvastatin|simvastatin|mesh-list
19864623|NCT00819403|Ezetimibe|ezetimibe|mesh-list
19864624|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
19864625|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19864626|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19864627|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
19864628|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864629|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19864630|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19864631|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864632|NCT00819507|Fluocinonide|fluocinonide|mesh-list
19864633|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864634|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
19864635|NCT00819507|Hormones|hormones|mesh-ancestor
19864636|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864637|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864638|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19864639|NCT00819585|Colchicine|colchicine|mesh-list
19864640|NCT00819585|Allopurinol|allopurinol|mesh-list
19864641|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19864642|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
19864643|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864644|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
19864645|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
19864646|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
19864647|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864648|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864649|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
19864650|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864651|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19864652|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
19864653|NCT00819585|Protective Agents|protective agents|mesh-ancestor
19864654|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864655|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
19864656|NCT00819637|Albuterol|albuterol|mesh-list
19864657|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
19723228|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723229|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723230|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
19723231|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
19864658|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19864659|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
19864660|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864661|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864662|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19864663|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
19864664|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19864665|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19864666|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19864667|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
19864668|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864669|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864670|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
19864671|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19864672|NCT00819741|Metformin|metformin|mesh-list
19864673|NCT00819741|Repaglinide|repaglinide|mesh-list
19864674|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19864675|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864676|NCT00819767|Valsartan|valsartan|mesh-list
19864677|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19864678|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19864679|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19864680|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864681|NCT00819780|Bevacizumab|bevacizumab|mesh-list
19864682|NCT00819780|Panitumumab|panitumumab|mesh-list
19864683|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864684|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864685|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19864686|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19864687|NCT00819780|Growth Substances|growth substances|mesh-ancestor
19864688|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864689|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
19864690|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
19864691|NCT00819910|Fenofibrate|fenofibrate|mesh-list
19864692|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19864693|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864694|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19864695|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
19864696|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864697|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19864698|NCT00820170|Paclitaxel|paclitaxel|mesh-list
19864699|NCT00820170|Dasatinib|dasatinib|mesh-list
19864700|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19864701|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864702|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
19864703|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
19864704|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
19864705|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864706|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19864707|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723232|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
19723233|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723234|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723235|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19723236|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19723237|NCT04679064|Growth Substances|growth substances|mesh-ancestor
19723238|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723239|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
19723240|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19723241|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
19723242|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
19723243|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864708|NCT00820222|Capecitabine|capecitabine|mesh-list
19864709|NCT00820222|Trastuzumab|trastuzumab|mesh-list
19864710|NCT00820222|Lapatinib|lapatinib|mesh-list
19864711|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19864712|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
19864713|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864714|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864715|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864716|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19864717|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864718|NCT00820248|Panitumumab|panitumumab|mesh-list
19864719|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864720|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969805|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19969806|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969807|NCT01777152|Prednisone|prednisone|mesh-list
19969808|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
19969809|NCT01777152|Doxorubicin|doxorubicin|mesh-list
19969810|NCT01777152|Vincristine|vincristine|mesh-list
19969811|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19969812|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969813|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
19969814|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969815|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969816|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19969817|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
19969818|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969819|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969820|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19969821|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19969822|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19969823|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19969824|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969825|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969826|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
19969827|NCT01777152|Hormones|hormones|mesh-ancestor
19969828|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969829|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19969830|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19969831|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
19969832|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
19969833|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
19969834|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969835|NCT01777191|Ixekizumab|ixekizumab|mesh-list
19969836|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19969837|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
19969838|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19969839|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19969840|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
19969841|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969842|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969843|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969844|NCT01777217|Urological Agents|urological agents|mesh-ancestor
19969845|NCT01777269|Tamsulosin|tamsulosin|mesh-list
19969846|NCT01777269|Dutasteride|dutasteride|mesh-list
19969847|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19969848|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19969849|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19969850|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
20253360|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723244|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723245|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723246|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
19723247|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19723248|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19723249|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19723250|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19723251|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19723252|NCT04679103|Eculizumab|eculizumab|mesh-list
19723253|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19723254|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723255|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
19723256|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864721|NCT00820534|Penciclovir|penciclovir|mesh-list
19864722|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
19864723|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864724|NCT00820573|Metformin|metformin|mesh-list
19864725|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19864726|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19864727|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864728|NCT00820573|Incretins|incretins|mesh-ancestor
19864729|NCT00820573|Hormones|hormones|mesh-ancestor
19864730|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864731|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19864732|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
19864733|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864734|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864735|NCT00820612|Indomethacin|indomethacin|mesh-list
19864736|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19864737|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19864738|NCT00820612|Analgesics|analgesics|mesh-ancestor
19864739|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
19864740|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864741|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864742|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864743|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19864744|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
19864745|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
19864746|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19864747|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19864748|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864749|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864750|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19864751|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19864752|NCT00820664|Estradiol|estradiol|mesh-list
19864753|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19864754|NCT00820664|Estrogens|estrogens|mesh-ancestor
19864755|NCT00820664|Hormones|hormones|mesh-ancestor
19864756|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864757|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864758|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19864759|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
19864760|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19864761|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19864762|NCT00820755|Cetuximab|cetuximab|mesh-list
19864763|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864764|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864765|NCT00820872|Carboplatin|carboplatin|mesh-list
19864766|NCT00820872|Docetaxel|docetaxel|mesh-list
19864767|NCT00820872|Trastuzumab|trastuzumab|mesh-list
19864768|NCT00820872|Lapatinib|lapatinib|mesh-list
19864769|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864770|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
19864771|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
19864772|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
19864773|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864774|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864775|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19864776|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864777|NCT00820898|Gemcitabine|gemcitabine|mesh-list
19864778|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19864779|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
19864780|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864781|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864782|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
19864783|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723257|NCT04678830|Leronlimab|leronlimab|mesh-list
19723258|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19723259|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19723260|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723261|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19723262|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19723263|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
19864784|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864785|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723264|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723265|NCT04678791|Cisplatin|cisplatin|mesh-list
19723266|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
19723267|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723268|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19734779|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19734780|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19734781|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19734782|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
19734783|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734784|NCT04546672|Neostigmine|neostigmine|mesh-list
19734785|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19734786|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734787|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734788|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
19734789|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734790|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734791|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19734792|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
19864786|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
19864787|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864788|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19864789|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19864790|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
19864791|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864792|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864793|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19864794|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
19864795|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19864796|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19864797|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19864798|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
19864799|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864800|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864801|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
19864802|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19864803|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19864804|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
19864805|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864806|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439010|NCT03471442|Bupivacaine|bupivacaine|mesh-list
19723269|NCT04678739|Remdesivir|remdesivir|mesh-list
19723270|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
19723271|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723272|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
19723273|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723274|NCT04678492|Amoxicillin|amoxicillin|mesh-list
19723275|NCT04678492|Tetracycline|tetracycline|mesh-list
19723276|NCT04678492|Furazolidone|furazolidone|mesh-list
19723277|NCT04678492|Esomeprazole|esomeprazole|mesh-list
19723278|NCT04678492|Bismuth|bismuth|mesh-list
19723279|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19723280|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723281|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19723282|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19723283|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19723284|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723285|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723286|NCT04678492|Antacids|antacids|mesh-ancestor
19723287|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19723288|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19723289|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19723290|NCT04678492|Renal Agents|renal agents|mesh-ancestor
19723291|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19439011|NCT03471442|Ropivacaine|ropivacaine|mesh-list
19439012|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
19723292|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19723293|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19723294|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19723295|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
19439013|NCT03471442|Anesthetics|anesthetics|mesh-list
19439014|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
19439015|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439016|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439017|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
19439018|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439019|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
19439020|NCT03471351|Tenalisib|tenalisib|mesh-list
19439021|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439022|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439023|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
19439024|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452928|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723296|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19723297|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723298|NCT04678154|Vancomycin|vancomycin|mesh-list
19723299|NCT04678154|Tobramycin|tobramycin|mesh-list
19723300|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19723301|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723302|NCT04678076|Ketoprofen|ketoprofen|mesh-list
19723303|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
19723304|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19723305|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723306|NCT04678076|Analgesics|analgesics|mesh-ancestor
19723307|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
19723308|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723309|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723310|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723311|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723312|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19723313|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723314|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723315|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
19723316|NCT04678050|Ketamine|ketamine|mesh-list
19723317|NCT04678050|Propofol|propofol|mesh-list
19723318|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723319|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723320|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723321|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723322|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
19723323|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
19723324|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723325|NCT04678050|Analgesics|analgesics|mesh-ancestor
19723326|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
19723327|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723328|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19723329|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19723330|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19723331|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
19723332|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723333|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723334|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19723335|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19723336|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19723337|NCT04678661|Insulin|insulin|mesh-list
19439025|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439026|NCT03471325|Methamphetamine|methamphetamine|mesh-list
19439027|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19439028|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439029|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
19439030|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
19439031|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439032|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
19439033|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439034|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439035|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439036|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19439037|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19439038|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439039|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19439040|NCT03471260|Azacitidine|azacitidine|mesh-list
19439041|NCT03471260|Venetoclax|venetoclax|mesh-list
19439042|NCT03471260|Ivosidenib|ivosidenib|mesh-list
19439043|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439044|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
19439045|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723338|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20253361|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20253362|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
19723339|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723340|NCT04677985|Analgesics|analgesics|mesh-list
19723341|NCT04677985|Menthol|menthol|mesh-list
19723342|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
19723343|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723344|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723345|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
19723346|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
19723347|NCT04677868|Methotrexate|methotrexate|mesh-list
19723348|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19723349|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
19723350|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19723351|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723352|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19723353|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
19723354|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723355|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723356|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
19723357|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723358|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19723359|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723360|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
19723361|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723362|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19723363|NCT04678362|Avelumab|avelumab|mesh-list
19723364|NCT04678362|Talazoparib|talazoparib|mesh-list
20533968|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19439046|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439047|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533969|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20533970|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533971|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533972|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20533973|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
20533974|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533975|NCT01811381|Curcumin|curcumin|mesh-list
20533976|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20533977|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20533978|NCT01811381|Analgesics|analgesics|mesh-ancestor
19439048|NCT03471182|Cocaine|cocaine|mesh-list
19439049|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
19439050|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
19439051|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439052|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439053|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
19439054|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439055|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19439056|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19439057|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19439058|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439059|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439060|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
20533979|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
19439061|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439062|NCT03471117|Pioglitazone|pioglitazone|mesh-list
19439063|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19439064|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439065|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
19439066|NCT03471039|Growth Substances|growth substances|mesh-ancestor
19439067|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723365|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723366|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723367|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19723368|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723369|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723370|NCT04677855|Prednisone|prednisone|mesh-list
19723371|NCT04677855|Dutasteride|dutasteride|mesh-list
19723372|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723373|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
19723374|NCT04677855|Hormones|hormones|mesh-ancestor
19723375|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19723376|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864807|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864808|NCT00821184|Urological Agents|urological agents|mesh-ancestor
19864809|NCT05237115|Amoxicillin|amoxicillin|mesh-list
19864810|NCT05237115|Clarithromycin|clarithromycin|mesh-list
19864811|NCT05237115|Esomeprazole|esomeprazole|mesh-list
19864812|NCT05237115|Bismuth|bismuth|mesh-list
19864813|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19864814|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864815|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19864816|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864817|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19864818|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864819|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864820|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19864821|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19864822|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19864823|NCT05237115|Antacids|antacids|mesh-ancestor
19864824|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19864825|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
19864826|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19864827|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864828|NCT05236998|Incretins|incretins|mesh-ancestor
19864829|NCT05236998|Hormones|hormones|mesh-ancestor
19864830|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864831|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19864832|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
19864833|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864834|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864835|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19864836|NCT05236972|Capecitabine|capecitabine|mesh-list
19864837|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
19864838|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19864839|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
19864840|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864841|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864842|NCT05236907|Midazolam|midazolam|mesh-list
19864843|NCT05236907|Melatonin|melatonin|mesh-list
19864844|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19864845|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19864846|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439068|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
19439069|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864847|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864848|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19864849|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19439070|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439071|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19439072|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
19439073|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439074|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19439075|NCT03470805|Olaparib|olaparib|mesh-list
19439076|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19439077|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439078|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439079|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439080|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
19439081|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19439082|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19864850|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19864851|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723377|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19723378|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723379|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19723380|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19723381|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723382|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723383|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
19723384|NCT04677335|Lovastatin|lovastatin|mesh-list
19723385|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19723386|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19723387|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
19723388|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723389|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19723390|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19723391|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723392|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
19723393|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723394|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723395|NCT04676958|Vitamin K|vitamin k|mesh-list
19723396|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
19723397|NCT04676958|Vitamins|vitamins|mesh-ancestor
19723398|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
19723399|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723400|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19723401|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19723402|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723403|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
19723404|NCT04676958|Coagulants|coagulants|mesh-ancestor
19723405|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19723406|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19723407|NCT04677114|Buprenorphine|buprenorphine|mesh-list
19723408|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19723409|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723410|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
19723411|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19723412|NCT04677114|Narcotics|narcotics|mesh-ancestor
19723413|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723414|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723415|NCT04677114|Analgesics|analgesics|mesh-ancestor
19723416|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
19723417|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723418|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19723419|NCT04677049|Niacin|niacin|mesh-list
19723420|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
19723421|NCT04677049|Vitamins|vitamins|mesh-ancestor
19723422|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
19723423|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723424|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
19723425|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19723426|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
19723427|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723428|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19723429|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
19723430|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
19723431|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19723432|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19723433|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
19723434|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723435|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19723436|NCT04676997|Paclitaxel|paclitaxel|mesh-list
19723437|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
19723438|NCT04676997|Epirubicin|epirubicin|mesh-list
19723439|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723440|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723441|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
19723442|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
19723443|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
19723444|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723445|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723446|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
19723447|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723448|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723449|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19723450|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
19723451|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19723452|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19723453|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19723454|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19723455|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723456|NCT04676763|Histamine|histamine|mesh-list
19723457|NCT04676763|Substance P|substance p|mesh-list
19723458|NCT04676763|Neurokinin A|neurokinin a|mesh-list
19723459|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
19723460|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
19723461|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723462|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723463|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723464|NCT04676789|Pegaspargase|pegaspargase|mesh-list
19723465|NCT04676789|Antibodies|antibodies|mesh-list
19723466|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19723467|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
19723468|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723469|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734793|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734794|NCT04546373|Niraparib|niraparib|mesh-list
19734795|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19734796|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734797|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734798|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734799|NCT04546282|Osimertinib|osimertinib|mesh-list
19734800|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734801|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19734802|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734803|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864852|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
19864853|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
19864854|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
19864855|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
19864856|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734804|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19734805|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
19734806|NCT04546334|Analgesics|analgesics|mesh-ancestor
19734807|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
19734808|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734809|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734810|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
19734811|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734812|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19734813|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
19734814|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19864857|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864858|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
19864859|NCT05236907|Protective Agents|protective agents|mesh-ancestor
19864860|NCT05236842|Sulthiame|sulthiame|mesh-list
19864861|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
19864862|NCT05236777|Natalizumab|natalizumab|mesh-list
19864863|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
19864864|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864865|NCT05236634|Tadalafil|tadalafil|mesh-list
19864866|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19864867|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
19864868|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
19864869|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19864870|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864871|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864872|NCT05236634|Urological Agents|urological agents|mesh-ancestor
19864873|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19864874|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19864875|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864876|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864877|NCT05236621|Dexamethasone|dexamethasone|mesh-list
19864878|NCT05236621|Pomalidomide|pomalidomide|mesh-list
19864879|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864880|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
19864881|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
19864882|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864883|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864884|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19864885|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
19864886|NCT05236621|Hormones|hormones|mesh-ancestor
19864887|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864888|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19723470|NCT04676659|Tenecteplase|tenecteplase|mesh-list
19723471|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19723472|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19723473|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723474|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
19723475|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723476|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723477|NCT04676204|Teriflunomide|teriflunomide|mesh-list
19723478|NCT04676204|Cladribine|cladribine|mesh-list
19723479|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19723480|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19723481|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723482|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723483|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
19723484|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723485|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19723486|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723487|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
19723488|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19723489|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723490|NCT04676204|Analgesics|analgesics|mesh-ancestor
19723491|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
19723492|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723493|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723494|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723495|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
19723496|NCT04676776|Mifepristone|mifepristone|mesh-list
19723497|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19723498|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
19723499|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19723500|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723501|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19723502|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19723503|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19723504|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19723505|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
19723506|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19723507|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19723508|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
19723509|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19723510|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
19723511|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19723512|NCT04676139|Fluoxetine|fluoxetine|mesh-list
19723513|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19723514|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19723515|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19723516|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723517|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723518|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
19723519|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864889|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864890|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
19864891|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19864892|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19864893|NCT05236621|Growth Substances|growth substances|mesh-ancestor
19864894|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
19864895|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
19864896|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19864897|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20253363|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253364|NCT00459407|Protective Agents|protective agents|mesh-ancestor
19439083|NCT03470649|Hematinics|hematinics|mesh-ancestor
19723520|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19723521|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
19723522|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19723523|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19723524|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19723525|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723526|NCT04676061|Norethindrone|norethindrone|mesh-list
19723527|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
19723528|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19723529|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19723530|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19723531|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
19723532|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19723533|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723534|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19723535|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19723536|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
19723537|NCT04676035|Vitamin K|vitamin k|mesh-list
19723538|NCT04676035|Midazolam|midazolam|mesh-list
19723539|NCT04676035|Omeprazole|omeprazole|mesh-list
19723540|NCT04676035|Warfarin|warfarin|mesh-list
20253365|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253366|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20253367|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19864898|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864899|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
19864900|NCT05236569|Coagulants|coagulants|mesh-ancestor
19864901|NCT05236504|Melatonin|melatonin|mesh-list
19864902|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
19864903|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864904|NCT05236504|Protective Agents|protective agents|mesh-ancestor
19864905|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864906|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864907|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
19864908|NCT05235542|Paclitaxel|paclitaxel|mesh-list
19864909|NCT05235542|Docetaxel|docetaxel|mesh-list
19864910|NCT05235542|Capecitabine|capecitabine|mesh-list
19864911|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
19864912|NCT05235542|Irinotecan|irinotecan|mesh-list
19864913|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19864914|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864915|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
19864916|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
19864917|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
19864918|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864919|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19864920|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
19864921|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19864922|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19864923|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864924|NCT05235516|Cisplatin|cisplatin|mesh-list
19864925|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864926|NCT05235256|Dexamethasone|dexamethasone|mesh-list
19864927|NCT05235256|Lidocaine|lidocaine|mesh-list
19864928|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19864929|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
19864930|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
19864931|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864932|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439084|NCT03470610|Estradiol|estradiol|mesh-list
19723541|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19864933|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19723542|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723543|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723544|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723545|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19723546|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19723547|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19723548|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723549|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
19723550|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
19723551|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
19723552|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
19723553|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723554|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723555|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
19723556|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19723557|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20533980|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533981|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533982|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20533983|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20533984|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20533985|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20533986|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533987|NCT01811459|Haloperidol|haloperidol|mesh-list
20533988|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20533989|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
20533990|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
19723558|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19723559|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723560|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19723561|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19723562|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
19723563|NCT04676035|Coagulants|coagulants|mesh-ancestor
19723564|NCT04676035|Vitamins|vitamins|mesh-ancestor
19723565|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
19723566|NCT04675944|Treprostinil|treprostinil|mesh-list
19723567|NCT04675944|Zamicastat|zamicastat|mesh-list
19723568|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19723569|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723570|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723571|NCT04675697|Etoposide|etoposide|mesh-list
19723572|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723573|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723574|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19723575|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19723576|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723577|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723578|NCT04676126|Dorzolamide|dorzolamide|mesh-list
19723579|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19723580|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19723581|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723582|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723583|NCT04675619|Pirfenidone|pirfenidone|mesh-list
19864934|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
19864935|NCT05235256|Hormones|hormones|mesh-ancestor
20253368|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253369|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20253370|NCT00459420|Caffeine|caffeine|mesh-list
20253371|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20253372|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253373|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20253374|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253375|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864936|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19864937|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19864938|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864939|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
19864940|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
19864941|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864942|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
19864943|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19864944|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19864945|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20533991|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19723584|NCT04675619|Analgesics|analgesics|mesh-ancestor
19723585|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
19723586|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723587|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723588|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19723589|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723590|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723591|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723592|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723593|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
19723594|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
19723595|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
19723596|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
19723597|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723598|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723599|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19723600|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19723601|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723602|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723603|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
19723604|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723605|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
19723606|NCT04675710|Trametinib|trametinib|mesh-list
19723607|NCT04675710|Dabrafenib|dabrafenib|mesh-list
19723608|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723609|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723610|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19723611|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723612|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723613|NCT04675528|Paclitaxel|paclitaxel|mesh-list
19723614|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723615|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723616|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
19723617|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
19723618|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
19723619|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723620|NCT04675983|Fluorouracil|fluorouracil|mesh-list
19723621|NCT04675983|Capecitabine|capecitabine|mesh-list
19723622|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
19723623|NCT04675983|Ramucirumab|ramucirumab|mesh-list
19723624|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723625|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
19723626|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723627|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19723628|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723629|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
19723630|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723631|NCT04675177|Polidocanol|polidocanol|mesh-list
19723632|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19723633|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19723634|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
19723635|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19723636|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
19723637|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723638|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
19723639|NCT04675385|Protective Agents|protective agents|mesh-ancestor
19723640|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
19723641|NCT04675086|Remdesivir|remdesivir|mesh-list
19723642|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
19723643|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19723644|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723645|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
19723646|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723647|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723648|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19723649|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19723650|NCT04675372|Midazolam|midazolam|mesh-list
19723651|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
19723652|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723653|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723654|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723655|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723656|NCT04675372|Analgesics|analgesics|mesh-ancestor
19864946|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19723657|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
19723658|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723659|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19723660|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19723661|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19723662|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
19723663|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723664|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723665|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19723666|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19723667|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19723668|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19723669|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723670|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
19723671|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
19723672|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
19723673|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
19864947|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864948|NCT05235191|Methadone|methadone|mesh-list
19864949|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19864950|NCT05235191|Narcotics|narcotics|mesh-ancestor
19864951|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864952|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864953|NCT05235191|Analgesics|analgesics|mesh-ancestor
19864954|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
19864955|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864956|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
19864957|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
19969851|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969852|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969853|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723674|NCT04674956|Gemcitabine|gemcitabine|mesh-list
19969854|NCT01777269|Urological Agents|urological agents|mesh-ancestor
19969855|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19969856|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19969857|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969858|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
19969859|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969860|NCT01777282|Biguanides|biguanides|mesh-list
19969861|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19969862|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
19969863|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
19969864|NCT01777282|Incretins|incretins|mesh-ancestor
19969865|NCT01777282|Hormones|hormones|mesh-ancestor
19969866|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969867|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969868|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969869|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969870|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969871|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
19969872|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19969873|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
19969874|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969875|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969876|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19969877|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
19969878|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
19969879|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19969880|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
19969881|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969882|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969883|NCT01777412|Bevacizumab|bevacizumab|mesh-list
19969884|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969885|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723675|NCT04674956|Paclitaxel|paclitaxel|mesh-list
19723676|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723677|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723678|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
19723679|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
19723680|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
19723681|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723682|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19723683|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
19723684|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
19723685|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723686|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723687|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19723688|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
19723689|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723690|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19723691|NCT04674423|Tenofovir|tenofovir|mesh-list
19723692|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
19723693|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723694|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19723695|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19723696|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723697|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723698|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19723699|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19723700|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
19723701|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19723702|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723703|NCT04674176|Rifaximin|rifaximin|mesh-list
19723704|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19723705|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864958|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
19864959|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19864960|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19864961|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864962|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19864963|NCT05215158|Analgesics|analgesics|mesh-ancestor
19864964|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
19864965|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19864966|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19864967|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19864968|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19864969|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
19864970|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19864971|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864972|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
19864973|NCT05214196|Povidone|povidone|mesh-list
19864974|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
19864975|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
19864976|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19864977|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19864978|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
19864979|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
19864980|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19864981|NCT05209620|Pemetrexed|pemetrexed|mesh-list
19864982|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864983|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864984|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864985|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19864986|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19864987|NCT05206812|Durvalumab|durvalumab|mesh-list
19864988|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19864989|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19864990|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
19864991|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
19864992|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19864993|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19864994|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19864995|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19864996|NCT05201144|Urological Agents|urological agents|mesh-ancestor
19864997|NCT05177198|Clindamycin|clindamycin|mesh-list
19864998|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
19864999|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
19865000|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19865001|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253376|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19723706|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19723707|NCT04674527|Temozolomide|temozolomide|mesh-list
19723708|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19723709|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
19723710|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723711|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734815|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734816|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734817|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19734818|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
19734819|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19734820|NCT04546256|Fluticasone|fluticasone|mesh-list
19734821|NCT04546256|Xhance|xhance|mesh-list
19734822|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19734823|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19734824|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734825|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19734826|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
19734827|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734828|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734829|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19734830|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
19734831|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
19734832|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19734833|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19734834|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19734835|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19734836|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19734837|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734838|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734839|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
19734840|NCT04546256|Hormones|hormones|mesh-ancestor
19734841|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734842|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
19735883|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735884|NCT04535362|Nicotine|nicotine|mesh-list
19735885|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19735886|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
19735887|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735888|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735889|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19735890|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19735891|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
19735892|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735893|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735894|NCT04535271|Gemcitabine|gemcitabine|mesh-list
19735895|NCT04535271|Dacarbazine|dacarbazine|mesh-list
19735896|NCT04535271|Trabectedin|trabectedin|mesh-list
19735897|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19735898|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
19735899|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735900|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735901|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
19735902|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865002|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19865003|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969886|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19439085|NCT03470610|Progesterone|progesterone|mesh-list
19723712|NCT04673877|Vancomycin|vancomycin|mesh-list
19723713|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19723714|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723715|NCT04673955|Cetuximab|cetuximab|mesh-list
19723716|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723717|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723718|NCT04673799|Denosumab|denosumab|mesh-list
19723719|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19723720|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723721|NCT04673812|Fentanyl|fentanyl|mesh-list
19723722|NCT04673812|Bupivacaine|bupivacaine|mesh-list
19723723|NCT04673812|Naloxone|naloxone|mesh-list
19723724|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
19723725|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
19723726|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723727|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723728|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
19723729|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723730|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19723731|NCT04673812|Narcotics|narcotics|mesh-ancestor
19723732|NCT04673812|Analgesics|analgesics|mesh-ancestor
19723733|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19723734|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723735|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
19723736|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19723737|NCT04674137|Histamine|histamine|mesh-list
19723738|NCT04674137|Glutarimide|glutarimide|mesh-list
19723739|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
19723740|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
19723741|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723742|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865004|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865005|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19865006|NCT05170841|Tramadol|tramadol|mesh-list
19865007|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19865008|NCT05170841|Narcotics|narcotics|mesh-ancestor
19865009|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865010|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723743|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723744|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19723745|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723746|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
19723747|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
19723748|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
19723749|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723750|NCT04673461|Xylometazoline|xylometazoline|mesh-list
19723751|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
19723752|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19723753|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
19723754|NCT04673500|Lidocaine|lidocaine|mesh-list
19723755|NCT04673500|Propofol|propofol|mesh-list
19723756|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
19723757|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
19723758|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723759|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723760|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
19723761|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723762|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19723763|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19723764|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19723765|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19734843|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19865011|NCT05170841|Analgesics|analgesics|mesh-ancestor
19865012|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
19865013|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865014|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19865015|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19865016|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19865017|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865018|NCT05131152|Cyclosporine|cyclosporine|mesh-list
19865019|NCT05131152|Cyclosporins|cyclosporins|mesh-list
19865020|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865021|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865022|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865023|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
19865024|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865025|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
19865026|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865027|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
19865028|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865029|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19865030|NCT05126784|Denosumab|denosumab|mesh-list
19865031|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19865032|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865033|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
19865034|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19865035|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19865036|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865037|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
19865038|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865039|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439086|NCT03470610|Estrogens|estrogens|mesh-ancestor
19723766|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723767|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723768|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723769|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
19723770|NCT04673578|Celecoxib|celecoxib|mesh-list
19723771|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19723772|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723773|NCT04673578|Analgesics|analgesics|mesh-ancestor
19865040|NCT05124704|Ropivacaine|ropivacaine|mesh-list
19865041|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
19865042|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
19865043|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865044|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865045|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
19865046|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865047|NCT05120505|Metformin|metformin|mesh-list
19865048|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19865049|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865050|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
19865051|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865052|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865053|NCT05063201|Cariprazine|cariprazine|mesh-list
19865054|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19865055|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19865056|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865057|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865058|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19865059|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19865060|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19865061|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19865062|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865063|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865064|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
19865065|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865066|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19865067|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19865068|NCT05039736|Nivolumab|nivolumab|mesh-list
19865069|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865070|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865071|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19865072|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20533992|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20533993|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20533994|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20533995|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20533996|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
20533997|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
20533998|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20533999|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534000|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20534001|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
20534002|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534003|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534004|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20534005|NCT01811498|Bevacizumab|bevacizumab|mesh-list
20534006|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865073|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19865074|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865075|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865076|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865077|NCT05003089|Prednisolone|prednisolone|mesh-list
19865078|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19865079|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
19865080|NCT05003089|Hormones|hormones|mesh-ancestor
19865081|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534007|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723774|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
19723775|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723776|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723777|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723778|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723779|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19723780|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19723781|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723782|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723783|NCT04673396|Norcantharidin|norcantharidin|mesh-list
19723784|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865082|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865083|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19865084|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865085|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
19865086|NCT05000450|Fludarabine|fludarabine|mesh-list
19865087|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865088|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
19865089|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865090|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865091|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19865092|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
19865093|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865094|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865095|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19865096|NCT04994431|Tamsulosin|tamsulosin|mesh-list
19865097|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19865098|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19865099|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19865100|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
19865101|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865102|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865103|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865104|NCT04994431|Urological Agents|urological agents|mesh-ancestor
19865105|NCT04964947|Tobramycin|tobramycin|mesh-list
19865106|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19865107|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969887|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19969888|NCT01777412|Growth Substances|growth substances|mesh-ancestor
19969889|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969890|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
19969891|NCT01777542|Insulin|insulin|mesh-list
19969892|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19969893|NCT01777542|Mitogens|mitogens|mesh-list
19969894|NCT01777542|Mecasermin|mecasermin|mesh-list
19969895|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969896|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969897|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
19969898|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969899|NCT01777542|Growth Substances|growth substances|mesh-ancestor
19969900|NCT01777581|Milnacipran|milnacipran|mesh-list
19969901|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
19969902|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19969903|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19969904|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19969905|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969906|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969907|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969908|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969909|NCT01777581|Analgesics|analgesics|mesh-ancestor
19969910|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
19969911|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969912|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
19969913|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19969914|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
19969915|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19969916|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19969917|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19969918|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19969919|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969920|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
20253377|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20253378|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
19723785|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723786|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723787|NCT04672928|Paclitaxel|paclitaxel|mesh-list
19723788|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19723789|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723790|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
19723791|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
19723792|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
19723793|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723794|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
19865108|NCT04918407|Empagliflozin|empagliflozin|mesh-list
19865109|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19865110|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865111|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19865112|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865113|NCT04900116|Bupivacaine|bupivacaine|mesh-list
19865114|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
19865115|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
19865116|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865117|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865118|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
19865119|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865120|NCT04894123|Trifluridine|trifluridine|mesh-list
19865121|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
19865122|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865123|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
19723795|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19723796|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19723797|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19723798|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19723799|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723800|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
19723801|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723802|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723803|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19723804|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723805|NCT04673214|Acetaminophen|acetaminophen|mesh-list
19723806|NCT04673214|Azithromycin|azithromycin|mesh-list
19723807|NCT04673214|Ivermectin|ivermectin|mesh-list
19723808|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723809|NCT04673214|Analgesics|analgesics|mesh-ancestor
19723810|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
19723811|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723812|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723813|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
19865124|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865125|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
19865126|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865127|NCT04857684|Bevacizumab|bevacizumab|mesh-list
19865128|NCT04857684|Atezolizumab|atezolizumab|mesh-list
19865129|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865130|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865131|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19865132|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19865133|NCT04857684|Growth Substances|growth substances|mesh-ancestor
19865134|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865135|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
19865136|NCT04825275|Posaconazole|posaconazole|mesh-list
19865137|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
19865138|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865139|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19865140|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20253379|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534008|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20534009|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19865141|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20534010|NCT01811498|Growth Substances|growth substances|mesh-ancestor
20534011|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534012|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
20534013|NCT01811615|Ethanol|ethanol|mesh-list
20534014|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20534015|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534016|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865142|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20253380|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
19723814|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19723815|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723816|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19723817|NCT04672759|Durvalumab|durvalumab|mesh-list
19723818|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19723819|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723820|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723821|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
19723822|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723823|NCT04672499|Cortisone|cortisone|mesh-list
19723824|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723825|NCT04672707|Bromhexine|bromhexine|mesh-list
19723826|NCT04672707|Expectorants|expectorants|mesh-ancestor
19723827|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
19723828|NCT04672213|Tranexamic Acid|tranexamic acid|mesh-list
20534017|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534018|NCT01811667|Sirolimus|sirolimus|mesh-list
20534019|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534020|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534021|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20534022|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534023|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
20534024|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534025|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
20534026|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534027|NCT01811810|Androgens|androgens|mesh-list
20534028|NCT01811810|Hormones|hormones|mesh-ancestor
20534029|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534030|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723829|NCT04672213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19723830|NCT04672213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19723831|NCT04672213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723832|NCT04672213|Hemostatics|hemostatics|mesh-ancestor
20534031|NCT01811836|Zinc|zinc|mesh-list
20253381|NCT00459485|Astringents|astringents|mesh-ancestor
20253382|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253383|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
20253384|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
20253385|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20253386|NCT00459563|Vitamin D|vitamin d|mesh-list
19723833|NCT04672213|Coagulants|coagulants|mesh-ancestor
19865143|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19865144|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865145|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865146|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19865147|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865148|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865149|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865150|NCT04787744|Prednisone|prednisone|mesh-list
19865151|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
19865152|NCT04787744|Docetaxel|docetaxel|mesh-list
19865153|NCT04787744|Leuprolide|leuprolide|mesh-list
19865154|NCT04787744|Goserelin|goserelin|mesh-list
19865155|NCT04787744|Bicalutamide|bicalutamide|mesh-list
19865156|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19865157|NCT04787744|Flutamide|flutamide|mesh-list
19865158|NCT04787744|Nilutamide|nilutamide|mesh-list
19865159|NCT04787744|Relugolix|relugolix|mesh-list
19865160|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253387|NCT00459563|Calcitriol|calcitriol|mesh-list
20253388|NCT00459563|Vitamins|vitamins|mesh-ancestor
20534032|NCT01811836|Trace Elements|trace elements|mesh-ancestor
20534033|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
20534034|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534035|NCT01811849|Insulin|insulin|mesh-list
20534036|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20253389|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
19865161|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
20534037|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
19865162|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
19865163|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
20253390|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534038|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20534039|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723834|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
19723835|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19723836|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
19723837|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723838|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
19723839|NCT04671914|Protective Agents|protective agents|mesh-ancestor
19723840|NCT04671836|Lorazepam|lorazepam|mesh-list
19723841|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
19723842|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
19723843|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
19723844|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723845|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723846|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19723847|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723848|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723849|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19723850|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19723851|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19723852|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
19723853|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
19723854|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723855|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723856|NCT04671589|Meropenem|meropenem|mesh-list
19723857|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19723858|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723859|NCT04671563|Tenofovir|tenofovir|mesh-list
19723860|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
19723861|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19723862|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19723863|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19723864|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723865|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723866|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19723867|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19723868|NCT04671446|Autoantibodies|autoantibodies|mesh-list
19723869|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
19723870|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723871|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19723872|NCT04671160|Dalteparin|dalteparin|mesh-list
19723873|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
19723874|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19723875|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19723876|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723877|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
19723878|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
19723879|NCT04671420|Rituximab|rituximab|mesh-list
19723880|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723881|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865164|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865165|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19865166|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
19865167|NCT04787744|Hormones|hormones|mesh-ancestor
19865168|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865169|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865170|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19865171|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
19865172|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
19865173|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865174|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19865175|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19865176|NCT04787744|Protective Agents|protective agents|mesh-ancestor
19865177|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19865178|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
19865179|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20253391|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20253392|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20253393|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20253394|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19723882|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
19865180|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
19865181|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865182|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
19865183|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19865184|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
19723883|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723884|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723885|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
19723886|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19723887|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
19723888|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723889|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
19723890|NCT04671108|Protective Agents|protective agents|mesh-ancestor
19723891|NCT04670978|Bevacizumab|bevacizumab|mesh-list
19723892|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723893|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723894|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19723895|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19723896|NCT04670978|Growth Substances|growth substances|mesh-ancestor
19723897|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723898|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
19723899|NCT04671056|Pioglitazone|pioglitazone|mesh-list
19723900|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19723901|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723902|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
19723903|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723904|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
19723905|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19723906|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
19723907|NCT04670601|Analgesics|analgesics|mesh-ancestor
19723908|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
19723909|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723910|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723911|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19723912|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19723913|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723914|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19723915|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19723916|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723917|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723918|NCT04670913|Apatinib|apatinib|mesh-list
19723919|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723920|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19723921|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723922|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723923|NCT04671069|Clopidogrel|clopidogrel|mesh-list
19723924|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19723925|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19723926|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19723927|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19723928|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
19865185|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19865186|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
19865187|NCT04767984|Atorvastatin|atorvastatin|mesh-list
19865188|NCT04767984|Calcium|calcium|mesh-list
19865189|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19865190|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865191|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19865192|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19865193|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19865194|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
19865195|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865196|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19865197|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19865198|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865199|NCT04760275|Fluoxetine|fluoxetine|mesh-list
19865200|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19865201|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19865202|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19865203|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865204|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865205|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
19865206|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865207|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19865208|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
19865209|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19865210|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19865211|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20534040|NCT01812018|Gemcitabine|gemcitabine|mesh-list
19723929|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723930|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723931|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723932|NCT04670796|Trastuzumab|trastuzumab|mesh-list
19723933|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19723934|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723935|NCT04670809|Clevidipine|clevidipine|mesh-list
19723936|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19865212|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865213|NCT04742283|Timolol|timolol|mesh-list
19865214|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19865215|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19865216|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19865217|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19865218|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
19865219|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865220|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865221|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865222|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19865223|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19865224|NCT04729725|Cemiplimab|cemiplimab|mesh-list
19865225|NCT04729725|Antibodies|antibodies|mesh-list
19865226|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19865227|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
19865228|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865229|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865230|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865231|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
19865232|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19865233|NCT04694976|Vitamin D|vitamin d|mesh-list
19865234|NCT04694976|Vitamins|vitamins|mesh-ancestor
19865235|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
19865236|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865237|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19865238|NCT04661280|Donepezil|donepezil|mesh-list
19865239|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20253395|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253396|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20253397|NCT00459615|Artesunate|artesunate|mesh-list
20253398|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
20253399|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20253400|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20253401|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253402|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253403|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
20253404|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
20253405|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20253406|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
20253407|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20534041|NCT01812018|Docetaxel|docetaxel|mesh-list
19865240|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865241|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865242|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
19865243|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865244|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865245|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
19865246|NCT04645550|Aspirin|aspirin|mesh-list
19865247|NCT04645550|Heparin|heparin|mesh-list
19865248|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19865249|NCT04645550|Tinzaparin|tinzaparin|mesh-list
19865250|NCT04645550|Dalteparin|dalteparin|mesh-list
19865251|NCT04645550|Dipyridamole|dipyridamole|mesh-list
19865252|NCT04645550|Warfarin|warfarin|mesh-list
19865253|NCT04645550|Apixaban|apixaban|mesh-list
19865254|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19865255|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19865256|NCT04645550|Analgesics|analgesics|mesh-ancestor
19865257|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
19865258|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865259|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865260|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19865261|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865262|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19865263|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19865264|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865265|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19865266|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19723937|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19723938|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723939|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19723940|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723941|NCT04670666|Metformin|metformin|mesh-list
19723942|NCT04670666|Empagliflozin|empagliflozin|mesh-list
19723943|NCT04670666|Linagliptin|linagliptin|mesh-list
19723944|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19723945|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723946|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19723947|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723948|NCT04670666|Incretins|incretins|mesh-ancestor
19723949|NCT04670666|Hormones|hormones|mesh-ancestor
19723950|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19723951|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19723952|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
19865267|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865268|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
19865269|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
19865270|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19865271|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
19865272|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19865273|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
19865274|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19865275|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
19865276|NCT04634071|Bupropion|bupropion|mesh-list
19865277|NCT04634071|Nicotine|nicotine|mesh-list
19865278|NCT04634071|Varenicline|varenicline|mesh-list
19865279|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19865280|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
19865281|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865282|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865283|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19865284|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19865285|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
19865286|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865287|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865288|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19865289|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
19865290|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19865291|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19865292|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19865293|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19865294|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
19865295|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19865296|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19865297|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865298|NCT04609514|Nicotine|nicotine|mesh-list
19865299|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19865300|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
19865301|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865302|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865303|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19865304|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19865305|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
19865306|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865307|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865308|NCT04608201|Nicotine|nicotine|mesh-list
19865309|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19865310|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
19865311|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865312|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865313|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19865314|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19865315|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
19865316|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534042|NCT01812018|Endostar protein|endostar protein|mesh-list
20534043|NCT01812018|Endostatins|endostatins|mesh-list
20534044|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534045|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
20534046|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534047|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19723953|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253408|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253409|NCT00459719|Tacrolimus|tacrolimus|mesh-list
20253410|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253411|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
20253412|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253413|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19723954|NCT04670432|Troxerutin|troxerutin|mesh-list
19723955|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
19723956|NCT04670497|Epinephrine|epinephrine|mesh-list
19723957|NCT04670497|Racepinephrine|racepinephrine|mesh-list
19865317|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865318|NCT04603248|Nivolumab|nivolumab|mesh-list
19865319|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865320|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865321|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19865322|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865323|NCT04591925|Insulin|insulin|mesh-list
19865324|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19865325|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19865326|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865327|NCT04572256|Montelukast|montelukast|mesh-list
19865328|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19865329|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
19865330|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19865331|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865332|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865333|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865334|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19865335|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19865336|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865337|NCT04565730|Anesthetics|anesthetics|mesh-list
19865338|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865339|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865340|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19865341|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19865342|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19865343|NCT04550481|Lisinopril|lisinopril|mesh-list
19865344|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19865345|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
19865346|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865347|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865348|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19865349|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19865350|NCT04550481|Protective Agents|protective agents|mesh-ancestor
19865351|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865352|NCT04537156|Vaccines|vaccines|mesh-list
19865353|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
19865354|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865355|NCT04526691|Carboplatin|carboplatin|mesh-list
19865356|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
19865357|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865358|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865359|NCT04501718|Etoposide|etoposide|mesh-list
19865360|NCT04501718|Temozolomide|temozolomide|mesh-list
19865361|NCT04501718|Apatinib|apatinib|mesh-list
19865362|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19865363|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865364|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19865365|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19865366|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865367|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865368|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19865369|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
20253414|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723958|NCT04670497|Bupivacaine|bupivacaine|mesh-list
19723959|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
19723960|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
19723961|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
19723962|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723963|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723964|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
19723965|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19723966|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19723967|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19723968|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
19723969|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19723970|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723971|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19723972|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19723973|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
19723974|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19723975|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
19723976|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
19723977|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
19723978|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19723979|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19723980|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19723981|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734844|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
19734845|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19734846|NCT04545970|Protective Agents|protective agents|mesh-ancestor
19734847|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734848|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
19734849|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19734850|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
19734851|NCT04545931|Coagulants|coagulants|mesh-ancestor
19734852|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19734853|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
19734854|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734855|NCT04545944|Midazolam|midazolam|mesh-list
19734856|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19734857|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19734858|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734859|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734860|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19734861|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19734862|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19734863|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19734864|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
19734865|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
19734866|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
19865370|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865371|NCT04501705|Apatinib|apatinib|mesh-list
19865372|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865373|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865374|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865375|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865376|NCT04410406|Ivermectin|ivermectin|mesh-list
19865377|NCT04410406|Albendazole|albendazole|mesh-list
19865378|NCT04410406|Moxidectin|moxidectin|mesh-list
19865379|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
19865380|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865381|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19865382|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865383|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
19865384|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
19865385|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19865386|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19865387|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
19865388|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
19865389|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
19865390|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865391|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
19865392|NCT04410406|Filaricides|filaricides|mesh-ancestor
19865393|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19865394|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969921|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969922|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969923|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19969924|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969925|NCT01777763|Posaconazole|posaconazole|mesh-list
19969926|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
19969927|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969928|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19969929|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19969930|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19969931|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19969932|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19969933|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286655|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19723982|NCT04670224|Anesthetics|anesthetics|mesh-list
19723983|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723984|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723985|NCT04669821|Propofol|propofol|mesh-list
19723986|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19723987|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19723988|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723989|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19723990|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
19723991|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
19723992|NCT04670081|Niacinamide|niacinamide|mesh-list
19865395|NCT04342975|Niacinamide|niacinamide|mesh-list
19865396|NCT04342975|Niacin|niacin|mesh-list
19865397|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
19865398|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
19865399|NCT04342975|Vitamins|vitamins|mesh-ancestor
19865400|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
19865401|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865402|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19865403|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
19865404|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865405|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19865406|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
19865407|NCT04294069|Azithromycin|azithromycin|mesh-list
19865408|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19865409|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865410|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
19865411|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19865412|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19865413|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19865414|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19865415|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865416|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
19865417|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865418|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865419|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19865420|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865421|NCT04271904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19865422|NCT04270747|Aflibercept|aflibercept|mesh-list
19865423|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19865424|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19865425|NCT04270747|Growth Substances|growth substances|mesh-ancestor
19865426|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865427|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
19865428|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865429|NCT04267978|Irinotecan|irinotecan|mesh-list
19865430|NCT04267978|Temozolomide|temozolomide|mesh-list
19865431|NCT04267978|Endostatins|endostatins|mesh-list
19865432|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19865433|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19865434|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865435|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865436|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865437|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19865438|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
19865439|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19865440|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19865441|NCT04267978|Growth Substances|growth substances|mesh-ancestor
19865442|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865443|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
19865444|NCT04260022|Blinatumomab|blinatumomab|mesh-list
19865445|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865446|NCT04203901|Nivolumab|nivolumab|mesh-list
19865447|NCT04203901|Ipilimumab|ipilimumab|mesh-list
19865448|NCT04203901|Everolimus|everolimus|mesh-list
19865449|NCT04203901|Lenvatinib|lenvatinib|mesh-list
19865450|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865451|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865452|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19865453|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865454|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865455|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
19865456|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19723993|NCT04670081|Niacin|niacin|mesh-list
19723994|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
19865457|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865458|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19723995|NCT04670081|Psilocybin|psilocybin|mesh-list
19723996|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
19723997|NCT04670081|Vitamins|vitamins|mesh-ancestor
19723998|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
19723999|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724000|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19724001|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
19724002|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724003|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19865459|NCT04178005|Cladribine|cladribine|mesh-list
19865460|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865461|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865462|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
19865463|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865464|NCT04173494|Danazol|danazol|mesh-list
19865465|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19865466|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19865467|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865468|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865469|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865470|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865471|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865472|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865473|NCT04155164|Metformin|metformin|mesh-list
19865474|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19865475|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865476|NCT04138316|Candesartan|candesartan|mesh-list
19865477|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19865478|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19865479|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19865480|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865481|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19865482|NCT04134663|Oxytocin|oxytocin|mesh-list
19865483|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
19865484|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19865485|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865486|NCT04131504|Adalimumab|adalimumab|mesh-list
19865487|NCT04131504|Infliximab|infliximab|mesh-list
19865488|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19865489|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865490|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
19865491|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19865492|NCT04095221|Irinotecan|irinotecan|mesh-list
19865493|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19865494|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19865495|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865496|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865497|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865498|NCT04037683|Misoprostol|misoprostol|mesh-list
19865499|NCT04037683|Oxytocin|oxytocin|mesh-list
19865500|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
19865501|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19865502|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865503|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19865504|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
19865505|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19865506|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19865507|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19865508|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19865509|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865510|NCT03969004|Cemiplimab|cemiplimab|mesh-list
19865511|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865512|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253415|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253416|NCT00459771|Candesartan|candesartan|mesh-list
20253417|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20253418|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20253419|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20253420|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253421|NCT00459836|Gemcitabine|gemcitabine|mesh-list
20253422|NCT00459836|Docetaxel|docetaxel|mesh-list
20253423|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19865513|NCT03958474|Remifentanil|remifentanil|mesh-list
19865514|NCT03958474|Oxycodone|oxycodone|mesh-list
19865515|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19724004|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
19724005|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
19724006|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19865516|NCT03958474|Narcotics|narcotics|mesh-ancestor
19865517|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253424|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
19724007|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
19724008|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724009|NCT04669717|Amoxicillin|amoxicillin|mesh-list
19724010|NCT04669717|Azithromycin|azithromycin|mesh-list
19724011|NCT04669717|Metronidazole|metronidazole|mesh-list
19724012|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19724013|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724014|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19724015|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19724016|NCT04669990|Remdesivir|remdesivir|mesh-list
19724017|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
19724018|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724019|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
19724020|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724021|NCT04669392|Ethanol|ethanol|mesh-list
19724022|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19724023|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253425|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253426|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253427|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
20253428|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253429|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724024|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724025|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724026|NCT04669457|Midazolam|midazolam|mesh-list
19724027|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
19724028|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19724029|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724030|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724031|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724032|NCT04669457|Analgesics|analgesics|mesh-ancestor
19724033|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
19724034|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724035|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19724036|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19724037|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19724038|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724039|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724040|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724041|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19724042|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19724043|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19724044|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19724045|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19724046|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
19724047|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
19724048|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
19724049|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
19724050|NCT04669158|Idebenone|idebenone|mesh-list
19724051|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
19724052|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724053|NCT04669158|Protective Agents|protective agents|mesh-ancestor
19724054|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724055|NCT04669171|Rituximab|rituximab|mesh-list
19724056|NCT04669171|Lenalidomide|lenalidomide|mesh-list
19724057|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19724058|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724059|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
19724060|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865518|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865519|NCT03958474|Analgesics|analgesics|mesh-ancestor
19865520|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
19865521|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865522|NCT03936270|Letrozole|letrozole|mesh-list
19865523|NCT03936270|Palbociclib|palbociclib|mesh-list
19865524|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253430|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253431|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
19724061|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865525|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19865526|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19724062|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19724063|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19724064|NCT04669171|Growth Substances|growth substances|mesh-ancestor
19724065|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
19724066|NCT04669145|Ropivacaine|ropivacaine|mesh-list
19724067|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
19724068|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
19724069|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724070|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724071|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
19865527|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724072|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724073|NCT04668976|Gemcitabine|gemcitabine|mesh-list
19724074|NCT04668976|Fluorouracil|fluorouracil|mesh-list
19724075|NCT04668976|Floxuridine|floxuridine|mesh-list
19724076|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
19724077|NCT04668976|Irinotecan|irinotecan|mesh-list
19724078|NCT04668976|Cetuximab|cetuximab|mesh-list
19724079|NCT04668976|Panitumumab|panitumumab|mesh-list
19724080|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19724081|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
19724082|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724083|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724084|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
19724085|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724086|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724087|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724088|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
19724089|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724090|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19724091|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19724092|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19724093|NCT04669366|Sunitinib|sunitinib|mesh-list
19724094|NCT04669366|Axitinib|axitinib|mesh-list
19724095|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724096|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19724097|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19724098|NCT04669366|Growth Substances|growth substances|mesh-ancestor
19724099|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724100|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
19724101|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19724102|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724103|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724104|NCT04668859|Midodrine|midodrine|mesh-list
19724105|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
19724106|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
19724107|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724108|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724109|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19724110|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19724111|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19724112|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19724113|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724114|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724115|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724116|NCT04668456|Lidocaine|lidocaine|mesh-list
19724117|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
19724118|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
19724119|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
19724120|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724121|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724122|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
19724123|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724124|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19724125|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19724126|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19865528|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253432|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253433|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
20253434|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
20253435|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
19724127|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20253436|NCT00459901|Capecitabine|capecitabine|mesh-list
19724128|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253437|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19724129|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19724130|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724131|NCT04668456|Analgesics|analgesics|mesh-ancestor
19724132|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19724133|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19724134|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19724135|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724136|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724137|NCT04668417|Vaccines|vaccines|mesh-list
19724138|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
19724139|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724140|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
19724141|NCT04668690|Analgesics|analgesics|mesh-ancestor
19724142|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
19724143|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724144|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724145|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724146|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19724147|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19724148|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724149|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724150|NCT04668469|Acetaminophen|acetaminophen|mesh-list
19724151|NCT04668469|Vitamins|vitamins|mesh-list
19724152|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
19724153|NCT04668469|Zinc|zinc|mesh-list
19724154|NCT04668469|Azithromycin|azithromycin|mesh-list
19724155|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
19724156|NCT04668469|Ivermectin|ivermectin|mesh-list
19724157|NCT04668469|Lactoferrin|lactoferrin|mesh-list
19724158|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
19724159|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
19724160|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724161|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724162|NCT04668469|Analgesics|analgesics|mesh-ancestor
19724163|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
19724164|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724165|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
20253438|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253439|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
20253440|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253441|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253442|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20253443|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253444|NCT00459940|Pioglitazone|pioglitazone|mesh-list
20253445|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20253446|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253447|NCT00459992|Betahistine|betahistine|mesh-list
20253448|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
20253449|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
20253450|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
20253451|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253452|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253453|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253454|NCT00460057|Alendronate|alendronate|mesh-list
20253455|NCT00460057|Diphosphonates|diphosphonates|mesh-list
20253456|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20253457|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253458|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
20253459|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20253460|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724166|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19865529|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19865530|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865531|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865532|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865533|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865534|NCT03934905|Sulforaphane|sulforaphane|mesh-list
19865535|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19865536|NCT03934905|Protective Agents|protective agents|mesh-ancestor
19865537|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865538|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724167|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724168|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
19865539|NCT03918850|Buprenorphine|buprenorphine|mesh-list
20253461|NCT00460083|Analgesics|analgesics|mesh-ancestor
20534048|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
19724169|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19724170|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19724171|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724172|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724173|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724174|NCT04668469|Trace Elements|trace elements|mesh-ancestor
19724175|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
19724176|NCT04668469|Protective Agents|protective agents|mesh-ancestor
19724177|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19724178|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19724179|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
19724180|NCT04668469|Coagulants|coagulants|mesh-ancestor
19724181|NCT04668352|Dactolisib|dactolisib|mesh-list
19724182|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724183|NCT04668300|Durvalumab|durvalumab|mesh-list
19724184|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
19724185|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19724186|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
19724187|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19724188|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724189|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
19724190|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724191|NCT04668274|Resveratrol|resveratrol|mesh-list
19724192|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
19724193|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724194|NCT04668274|Protective Agents|protective agents|mesh-ancestor
19724195|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724196|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724197|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19724198|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19724199|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
19724200|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19724201|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20534049|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534050|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534051|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534052|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
20534053|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534054|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
20534055|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19865540|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19865541|NCT03918850|Narcotics|narcotics|mesh-ancestor
19865542|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865543|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865544|NCT03918850|Analgesics|analgesics|mesh-ancestor
19865545|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
19724202|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
19724203|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724204|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
19724205|NCT04668131|Protective Agents|protective agents|mesh-ancestor
19734867|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
19734868|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734869|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734870|NCT04545879|Allicin|allicin|mesh-list
19734871|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734872|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19865546|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865547|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19865548|NCT03911739|Buprenorphine|buprenorphine|mesh-list
19865549|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19865550|NCT03911739|Narcotics|narcotics|mesh-ancestor
19865551|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865552|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865553|NCT03911739|Analgesics|analgesics|mesh-ancestor
19865554|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
19865555|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865556|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19734873|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
19734874|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734875|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19734876|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
19865557|NCT03911466|Buprenorphine|buprenorphine|mesh-list
19865558|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19865559|NCT03911466|Narcotics|narcotics|mesh-ancestor
19734877|NCT04545879|Protective Agents|protective agents|mesh-ancestor
19865560|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534056|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19734878|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865561|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724206|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19724207|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19724208|NCT04667663|Dexamethasone|dexamethasone|mesh-list
19724209|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
19724210|NCT04667663|Daratumumab|daratumumab|mesh-list
19724211|NCT04667663|Pomalidomide|pomalidomide|mesh-list
19724212|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724213|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
19724214|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724215|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724216|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19724217|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
19724218|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724219|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724220|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19724221|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724222|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
19724223|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
19724224|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724225|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19724226|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
19724227|NCT04667663|Hormones|hormones|mesh-ancestor
19724228|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724229|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19724230|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19724231|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19724232|NCT04667663|Growth Substances|growth substances|mesh-ancestor
19724233|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
19865562|NCT03911466|Analgesics|analgesics|mesh-ancestor
19865563|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
19865564|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865565|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19865566|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19865567|NCT03872180|Venetoclax|venetoclax|mesh-list
19865568|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
19865569|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19865570|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
19865571|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865572|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865573|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865574|NCT03857321|Insulin|insulin|mesh-list
19865575|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19865576|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
19865577|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19865578|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865579|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
19865580|NCT03846219|Calcium|calcium|mesh-list
19865581|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19865582|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724234|NCT04667910|Ranibizumab|ranibizumab|mesh-list
19724235|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19724236|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19724237|NCT04667910|Growth Substances|growth substances|mesh-ancestor
19724238|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724239|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
19724240|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724241|NCT04667897|Ranibizumab|ranibizumab|mesh-list
19724242|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19724243|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19724244|NCT04667897|Growth Substances|growth substances|mesh-ancestor
19724245|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724246|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
19724247|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724248|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
19724249|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19724250|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
19865583|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19865584|NCT03839446|Etoposide|etoposide|mesh-list
19865585|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
19865586|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
19865587|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19865588|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865589|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19865590|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19724251|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865591|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724252|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
19865592|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865593|NCT03839446|Analgesics|analgesics|mesh-ancestor
19865594|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
19865595|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865596|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865597|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865598|NCT03781986|Carboplatin|carboplatin|mesh-list
19865599|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865600|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
19865601|NCT03781934|Lenvatinib|lenvatinib|mesh-list
19865602|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865603|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865604|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865605|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865606|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865607|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
19865608|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865609|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
19865610|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865611|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865612|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19865613|NCT03713645|Tacrolimus|tacrolimus|mesh-list
19865614|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865615|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
19865616|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865617|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19865618|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865619|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865620|NCT03690869|Cemiplimab|cemiplimab|mesh-list
19865621|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865622|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969934|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969935|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19969936|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
19969937|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969938|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969939|NCT01777945|Docetaxel|docetaxel|mesh-list
19969940|NCT01777945|Capecitabine|capecitabine|mesh-list
19969941|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969942|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
19969943|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
19969944|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
19969945|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969946|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19969947|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
19969948|NCT01777997|Tenofovir|tenofovir|mesh-list
19724253|NCT04667819|Protective Agents|protective agents|mesh-ancestor
19724254|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19724255|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19724256|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19724257|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19969949|NCT01777997|Emtricitabine|emtricitabine|mesh-list
19969950|NCT01777997|Rilpivirine|rilpivirine|mesh-list
19724258|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724259|NCT04667351|Fluorouracil|fluorouracil|mesh-list
19724260|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
19969951|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
19969952|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969953|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19724261|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724262|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19724263|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724264|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724265|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
19724266|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724267|NCT04667507|Dexamethasone|dexamethasone|mesh-list
19724268|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724269|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
19724270|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
19724271|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724272|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724273|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19724274|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
19724275|NCT04667507|Hormones|hormones|mesh-ancestor
19724276|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724277|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19724278|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724279|NCT04667299|Amoxicillin|amoxicillin|mesh-list
19724280|NCT04667299|Metronidazole|metronidazole|mesh-list
19724281|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
19724282|NCT04667299|Rabeprazole|rabeprazole|mesh-list
19724283|NCT04667299|Bismuth|bismuth|mesh-list
19724284|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724285|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19724286|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724287|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19724288|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19724289|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19865623|NCT03641001|Micronutrients|micronutrients|mesh-list
19865624|NCT03641001|Trace Elements|trace elements|mesh-list
19865625|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865626|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
19865627|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
19865628|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865629|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865630|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865631|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
19865632|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
19865633|NCT03608696|Buprenorphine|buprenorphine|mesh-list
19865634|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19865635|NCT03608696|Narcotics|narcotics|mesh-ancestor
19865636|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865637|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865638|NCT03608696|Analgesics|analgesics|mesh-ancestor
19865639|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
19865640|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865641|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19865642|NCT03541486|Gemcitabine|gemcitabine|mesh-list
19865643|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865644|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19865645|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
19865646|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865647|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865648|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
19865649|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865650|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865651|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865652|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
19865653|NCT03500731|Rituximab|rituximab|mesh-list
19865654|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
19865655|NCT03500731|Fludarabine|fludarabine|mesh-list
19865656|NCT03500731|Thiotepa|thiotepa|mesh-list
19865657|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
19724290|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19724291|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19865658|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865659|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724292|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724293|NCT04667299|Antacids|antacids|mesh-ancestor
19724294|NCT04667299|Diuretics|diuretics|mesh-ancestor
19724295|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
19724296|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724297|NCT04667299|Expectorants|expectorants|mesh-ancestor
19724298|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
19724299|NCT04667143|Metformin|metformin|mesh-list
19724300|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724301|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724302|NCT04666987|Liraglutide|liraglutide|mesh-list
19724303|NCT04666987|Xultophy|xultophy|mesh-list
19724304|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724305|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724306|NCT04666987|Incretins|incretins|mesh-ancestor
19724307|NCT04666987|Hormones|hormones|mesh-ancestor
19865660|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
19865661|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865662|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865663|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865664|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865665|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19865666|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
19865667|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19865668|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
19865669|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865670|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19865671|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
19865672|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19865673|NCT03493178|Glycine|glycine|mesh-list
19865674|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
19865675|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865676|NCT03493178|Expectorants|expectorants|mesh-ancestor
19865677|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
19865678|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19865679|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
19865680|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865681|NCT03493178|Protective Agents|protective agents|mesh-ancestor
19724308|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724309|NCT04666805|Tamoxifen|tamoxifen|mesh-list
19724310|NCT04666805|Toremifene|toremifene|mesh-list
19724311|NCT04666805|Letrozole|letrozole|mesh-list
19724312|NCT04666805|Anastrozole|anastrozole|mesh-list
19724313|NCT04666805|Exemestane|exemestane|mesh-list
19724314|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724315|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19724316|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19724317|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724318|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724319|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19724320|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865682|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865683|NCT03493178|Antidotes|antidotes|mesh-ancestor
19865684|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
19865685|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724321|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724322|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724323|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19724324|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19865686|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
19865687|NCT03417193|Anesthetics|anesthetics|mesh-list
19865688|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724325|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19724326|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19724327|NCT04667117|Ofatumumab|ofatumumab|mesh-list
19724328|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724329|NCT04666675|Upadacitinib|upadacitinib|mesh-list
19724330|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19724331|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19724332|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724333|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724334|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724335|NCT04666701|Ketorolac|ketorolac|mesh-list
19724336|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19724337|NCT04666701|Scopolamine|scopolamine|mesh-list
19724338|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19724339|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19724340|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724341|NCT04666701|Analgesics|analgesics|mesh-ancestor
19724342|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
19724343|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724344|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724345|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724346|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724347|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19724348|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724349|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724350|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19724351|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
19724352|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
19724353|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19724354|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
19724355|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19724356|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
19724357|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724358|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19724359|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
19724360|NCT04666623|Esketamine|esketamine|mesh-list
19724361|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
19724362|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19724363|NCT04666714|Pregabalin|pregabalin|mesh-list
19724364|NCT04666714|Analgesics|analgesics|mesh-ancestor
19724365|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
19724366|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724367|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865689|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865690|NCT03417193|Narcotics|narcotics|mesh-ancestor
19865691|NCT03417193|Analgesics|analgesics|mesh-ancestor
19865692|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
19865693|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865694|NCT03414112|Oxytocin|oxytocin|mesh-list
19865695|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
19865696|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19865697|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865698|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
19865699|NCT03410030|Gemcitabine|gemcitabine|mesh-list
19865700|NCT03410030|Paclitaxel|paclitaxel|mesh-list
19865701|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19865702|NCT03410030|Cisplatin|cisplatin|mesh-list
19865703|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19865704|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865705|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
19865706|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
19865707|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
19865708|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865709|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19865710|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
19865711|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
19865712|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865713|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865714|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865715|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
19865716|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534057|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19865717|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
19439087|NCT03470610|Hormones|hormones|mesh-ancestor
19724368|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
19724369|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19865718|NCT03410030|Protective Agents|protective agents|mesh-ancestor
19865719|NCT03410030|Vitamins|vitamins|mesh-ancestor
19724370|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19724371|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724372|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19724373|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19724374|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19724375|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724376|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19724377|NCT04666324|Simethicone|simethicone|mesh-list
19724378|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
19724379|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724380|NCT04666324|Emollients|emollients|mesh-ancestor
19724381|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
19724382|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19724383|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
19724384|NCT04666051|Coagulants|coagulants|mesh-ancestor
19724385|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
19724386|NCT04666168|Fludarabine|fludarabine|mesh-list
19724387|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724388|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
19724389|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724390|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724391|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19724392|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
19724393|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724394|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724395|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19724396|NCT04665895|Fluticasone|fluticasone|mesh-list
19724397|NCT04665895|Xhance|xhance|mesh-list
19724398|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724399|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19724400|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
19724401|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724402|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724403|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19724404|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
19724405|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
19724406|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19724407|NCT04665986|Docetaxel|docetaxel|mesh-list
19724408|NCT04665986|Vinorelbine|vinorelbine|mesh-list
19724409|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724410|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
20253462|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
20253463|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724411|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
20253464|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724412|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
19724413|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724414|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19734879|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19734880|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19734881|NCT04545892|Capsaicin|capsaicin|mesh-list
19734882|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
19734883|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
19734884|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
19734885|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734886|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734887|NCT04545801|Ketamine|ketamine|mesh-list
19734888|NCT04545801|Analgesics|analgesics|mesh-ancestor
19734889|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
19734890|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734891|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734892|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19734893|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19734894|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
19734895|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
19734896|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19734897|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19734898|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19734899|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734900|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734901|NCT04545788|Linezolid|linezolid|mesh-list
19734902|NCT04545788|Cycloserine|cycloserine|mesh-list
19734903|NCT04545788|Bedaquiline|bedaquiline|mesh-list
19734904|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734905|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734906|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19734907|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734908|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734909|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19734910|NCT04545788|Renal Agents|renal agents|mesh-ancestor
19734911|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19734912|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
19734913|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
19734914|NCT04545463|Psyllium|psyllium|mesh-list
19734915|NCT04545463|Cathartics|cathartics|mesh-ancestor
19734916|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19865720|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
19865721|NCT03386240|Triclosan|triclosan|mesh-list
19865722|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19865723|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865724|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19865725|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19865726|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
19865727|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865728|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19865729|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19865730|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19865731|NCT03298802|Diuretics|diuretics|mesh-ancestor
19865732|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
19865733|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734917|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
19724415|NCT04665830|Evolocumab|evolocumab|mesh-list
19724416|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19724417|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19724418|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
19724419|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724420|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19724421|NCT04665791|Vaccines|vaccines|mesh-list
19724422|NCT04665791|Immunologic Factors|immunologic factors|mesh-ancestor
19724423|NCT04665791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724424|NCT04665765|Rituximab|rituximab|mesh-list
19724425|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19724426|NCT04665765|Carboplatin|carboplatin|mesh-list
19724427|NCT04665765|Etoposide|etoposide|mesh-list
19724428|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
19724429|NCT04665765|Ifosfamide|ifosfamide|mesh-list
19724430|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
19724431|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
19724432|NCT04665765|Antibodies|antibodies|mesh-list
19724433|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
19724434|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19724435|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
19724436|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
19724437|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724438|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724439|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724440|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19724441|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19724442|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19724443|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865734|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19865735|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19865736|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865737|NCT03240861|Aldesleukin|aldesleukin|mesh-list
19865738|NCT03240861|Plerixafor|plerixafor|mesh-list
19865739|NCT03240861|Fludarabine|fludarabine|mesh-list
19865740|NCT03240861|Busulfan|busulfan|mesh-list
19865741|NCT03240861|Interleukin-2|interleukin-2|mesh-list
19865742|NCT03240861|Lenograstim|lenograstim|mesh-list
19865743|NCT03240861|Sargramostim|sargramostim|mesh-list
19865744|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865745|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865746|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865747|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
19865748|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865749|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19865750|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
19865751|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19865752|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19865753|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20534058|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20534059|NCT01812018|Growth Substances|growth substances|mesh-ancestor
20534060|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
20534061|NCT01812096|Bortezomib|bortezomib|mesh-list
20534062|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534063|NCT01812122|Glimepiride|glimepiride|mesh-list
20534064|NCT01812122|Vildagliptin|vildagliptin|mesh-list
20534065|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20534066|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20534067|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534068|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865754|NCT03240861|Analgesics|analgesics|mesh-ancestor
19865755|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
19865756|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865757|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20253465|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20253466|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534069|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
19724444|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724445|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19724446|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
19724447|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
19724448|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
19724449|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
19724450|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
19724451|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
19724452|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19724453|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
19724454|NCT04665453|Melatonin|melatonin|mesh-list
19724455|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19724456|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724457|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724458|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724459|NCT04665453|Analgesics|analgesics|mesh-ancestor
19724460|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
19724461|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724462|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19724463|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19724464|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19724465|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724466|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724467|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724468|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
19724469|NCT04665453|Protective Agents|protective agents|mesh-ancestor
19724470|NCT04665362|Apatinib|apatinib|mesh-list
19724471|NCT04665362|Antibodies|antibodies|mesh-list
19865758|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19865759|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
19865760|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865761|NCT03149770|Naloxone|naloxone|mesh-list
19865762|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19865763|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865764|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
19865765|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865766|NCT03088930|Crizotinib|crizotinib|mesh-list
19865767|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865768|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865769|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865770|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865771|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
19865772|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865773|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865774|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865775|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865776|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
19865777|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
19865778|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
19439088|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439089|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439090|NCT03470610|Progestins|progestins|mesh-ancestor
19439091|NCT03470597|Iodine|iodine|mesh-list
19439092|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19439093|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439094|NCT03470597|Trace Elements|trace elements|mesh-ancestor
19439095|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
19439096|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439097|NCT03470532|Epinephrine|epinephrine|mesh-list
19865779|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
19865780|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865781|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865782|NCT02845596|Cyclosporine|cyclosporine|mesh-list
19865783|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
19865784|NCT02845596|Methotrexate|methotrexate|mesh-list
19865785|NCT02845596|Fludarabine|fludarabine|mesh-list
19865786|NCT02845596|Cyclosporins|cyclosporins|mesh-list
19865787|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
19865788|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20534070|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20534071|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
20534072|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439098|NCT03470532|Racepinephrine|racepinephrine|mesh-list
19724472|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
19724473|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865789|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19865790|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
19439099|NCT03470532|Mepivacaine|mepivacaine|mesh-list
19865791|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865792|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724474|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724475|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19724476|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724477|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724478|NCT04665648|Nicorandil|nicorandil|mesh-list
19724479|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20534073|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534074|NCT01812135|Vaccines|vaccines|mesh-list
20534075|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
20534076|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534077|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
19724480|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19724481|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
19724482|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
19724483|NCT04665648|Vitamins|vitamins|mesh-ancestor
19724484|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
19724485|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724486|NCT04665232|Progesterone|progesterone|mesh-list
19724487|NCT04665232|Progestins|progestins|mesh-ancestor
19724488|NCT04665232|Hormones|hormones|mesh-ancestor
19724489|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724490|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724491|NCT04665141|Omalizumab|omalizumab|mesh-list
19724492|NCT04665141|Benralizumab|benralizumab|mesh-list
19865793|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19865794|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
19865795|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865796|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865797|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19865798|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19865799|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
19865800|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19865801|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19865802|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
19865803|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
19865804|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865805|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19865806|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19865807|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
19865808|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865809|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19865810|NCT02815995|Durvalumab|durvalumab|mesh-list
19865811|NCT02815995|Tremelimumab|tremelimumab|mesh-list
19865812|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534078|NCT01812200|Dabigatran|dabigatran|mesh-list
20534079|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
20534080|NCT01812200|Ticagrelor|ticagrelor|mesh-list
20534081|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19865813|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534082|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20534083|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19724493|NCT04665141|Reslizumab|reslizumab|mesh-list
19865814|NCT02812615|Micronutrients|micronutrients|mesh-list
19865815|NCT02812615|Trace Elements|trace elements|mesh-list
19865816|NCT02812615|Albendazole|albendazole|mesh-list
19865817|NCT02812615|Pyrantel|pyrantel|mesh-list
20534084|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20534085|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
20534086|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865818|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
19865819|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
19865820|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19865821|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865822|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
19724494|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19865823|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20534087|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724495|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19724496|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
19724497|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
19724498|NCT04665063|Fludarabine|fludarabine|mesh-list
19724499|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724500|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
19724501|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724502|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724503|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19724504|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
19724505|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724506|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724507|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19724508|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
19724509|NCT04665076|Fludarabine|fludarabine|mesh-list
19724510|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724511|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
19865824|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19865825|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
19865826|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19865827|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
19865828|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865829|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865830|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865831|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
19865832|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19865833|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19865834|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19865835|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865836|NCT02807883|Blinatumomab|blinatumomab|mesh-list
19865837|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865838|NCT02807363|Leuprolide|leuprolide|mesh-list
19865839|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19865840|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
19724512|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865841|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19865842|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865843|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19865844|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865845|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19865846|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19865847|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865848|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724513|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724514|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19724515|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
19865849|NCT02756403|Azithromycin|azithromycin|mesh-list
19865850|NCT02756403|Metronidazole|metronidazole|mesh-list
19865851|NCT02756403|Doxycycline|doxycycline|mesh-list
19865852|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19865853|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865854|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19865855|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19865856|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
19865857|NCT02739035|Dexamethasone|dexamethasone|mesh-list
19865858|NCT02739035|Celecoxib|celecoxib|mesh-list
19865859|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19865860|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
19865861|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
19865862|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724516|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724517|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724518|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19724519|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19724520|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
19724521|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724522|NCT04665284|Empagliflozin|empagliflozin|mesh-list
19724523|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19724524|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724525|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724526|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724527|NCT04665310|Tacrolimus|tacrolimus|mesh-list
19724528|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724529|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
19724530|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865863|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865864|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19865865|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
19865866|NCT02739035|Hormones|hormones|mesh-ancestor
19865867|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865868|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19865869|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865870|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19865871|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19865872|NCT02739035|Analgesics|analgesics|mesh-ancestor
19865873|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
19865874|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534088|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534089|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20534090|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
20534091|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20534092|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
20534093|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534094|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
19865875|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19865876|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19865877|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865878|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865879|NCT02710851|Vaccines|vaccines|mesh-list
19865880|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
20534095|NCT01812239|Progesterone|progesterone|mesh-list
20534096|NCT01812239|Progestins|progestins|mesh-list
19724531|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19724532|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724533|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865881|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865882|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
19865883|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865884|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865885|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534097|NCT01812239|Hormones|hormones|mesh-ancestor
20534098|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534099|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865886|NCT02682888|Oxytocin|oxytocin|mesh-list
19865887|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
19865888|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19865889|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865890|NCT02675452|Itraconazole|itraconazole|mesh-list
19865891|NCT02675452|Azacitidine|azacitidine|mesh-list
19865892|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19865893|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
19865894|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865895|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865896|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865897|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
19865898|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865899|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19865900|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19865901|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20253467|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
20534100|NCT01812330|Clopidogrel|clopidogrel|mesh-list
19724534|NCT04664894|Ribavirin|ribavirin|mesh-list
19724535|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
19724536|NCT04664894|Velpatasvir|velpatasvir|mesh-list
19724537|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
19724538|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724539|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
19724540|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724541|NCT04664803|Cefdinir|cefdinir|mesh-list
19724542|NCT04664803|Cefetamet|cefetamet|mesh-list
19724543|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19724544|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724545|NCT04664725|Repaglinide|repaglinide|mesh-list
19724546|NCT04664725|Bupropion|bupropion|mesh-list
19724547|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19724548|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
19724549|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19724550|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19724551|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19724552|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19724553|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724554|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
19724555|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724556|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724557|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19724558|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19724559|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724560|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724561|NCT04664829|Capecitabine|capecitabine|mesh-list
19724562|NCT04664829|Bexarotene|bexarotene|mesh-list
19724563|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19724564|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
19724565|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724566|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865902|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865903|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865904|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865905|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19865906|NCT02669186|Fentanyl|fentanyl|mesh-list
19865907|NCT02669186|Bupivacaine|bupivacaine|mesh-list
19865908|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
19865909|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
19865910|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19865911|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865912|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
19865913|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19865914|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19865915|NCT02669186|Narcotics|narcotics|mesh-ancestor
19865916|NCT02669186|Analgesics|analgesics|mesh-ancestor
19865917|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19724567|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
19724568|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
19724569|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
19724570|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724571|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724572|NCT04664595|Propofol|propofol|mesh-list
19724573|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19724574|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724575|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724576|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19724577|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
19724578|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
19724579|NCT04664530|Esketamine|esketamine|mesh-list
19724580|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
19724581|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19724582|NCT04664361|Niacinamide|niacinamide|mesh-list
19724583|NCT04664361|Niacin|niacin|mesh-list
19724584|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
19724585|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
19724586|NCT04664361|Vitamins|vitamins|mesh-ancestor
19724587|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
19724588|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724589|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19724590|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
19724591|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724592|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19724593|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
19724594|NCT04664517|Anesthetics|anesthetics|mesh-list
19724595|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724596|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724597|NCT04664010|Vitamins|vitamins|mesh-list
19724598|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
19724599|NCT04664010|Interferons|interferons|mesh-list
19724600|NCT04664010|Ribavirin|ribavirin|mesh-list
19724601|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
19724602|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19724603|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
19724604|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724605|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724606|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
19724607|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724608|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
19724609|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724610|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
19724611|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
19724612|NCT04664010|Protective Agents|protective agents|mesh-ancestor
19724613|NCT04664127|Valacyclovir|valacyclovir|mesh-list
19724614|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
19865918|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19865919|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
19865920|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
19865921|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
19865922|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19865923|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19865924|NCT02665117|Diuretics|diuretics|mesh-ancestor
19865925|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
19865926|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865927|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19865928|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19865929|NCT02665117|Cathartics|cathartics|mesh-ancestor
19865930|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19865931|NCT02646839|Biotin|biotin|mesh-list
19865932|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
19865933|NCT02646839|Vitamins|vitamins|mesh-ancestor
19865934|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
19724615|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724616|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19724617|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19724618|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19724619|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19724620|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724621|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724622|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724623|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19724624|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
19724625|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19734918|NCT04545450|Testosterone|testosterone|mesh-list
19734919|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
19734920|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
19734921|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19734922|NCT04545450|Dutasteride|dutasteride|mesh-list
19734923|NCT04545450|Androgens|androgens|mesh-ancestor
19734924|NCT04545450|Hormones|hormones|mesh-ancestor
19734925|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19734926|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734927|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19734928|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734929|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
19734930|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19734931|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19734932|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734933|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734934|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
19734935|NCT04545710|Osimertinib|osimertinib|mesh-list
19734936|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734937|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19734938|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734939|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734940|NCT04545099|Neostigmine|neostigmine|mesh-list
19734941|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19734942|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734943|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734944|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
19734945|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19734946|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734947|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19734948|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
19734949|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734950|NCT04544943|Gentamicins|gentamicins|mesh-list
19735903|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865935|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865936|NCT02641236|Vancomycin|vancomycin|mesh-list
19865937|NCT02641236|Polymyxins|polymyxins|mesh-list
19865938|NCT02641236|Polymyxin B|polymyxin b|mesh-list
19865939|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19865940|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865941|NCT02487797|Oxytocin|oxytocin|mesh-list
19865942|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
19865943|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19865944|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865945|NCT02476786|Tamoxifen|tamoxifen|mesh-list
19865946|NCT02476786|Fulvestrant|fulvestrant|mesh-list
19865947|NCT02476786|Anastrozole|anastrozole|mesh-list
19865948|NCT02476786|Goserelin|goserelin|mesh-list
19865949|NCT02476786|Exemestane|exemestane|mesh-list
19865950|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19865951|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
19865952|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865953|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865954|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19865955|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865956|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19865957|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19865958|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19865959|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19865960|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19865961|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19865962|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19865963|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969954|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19724626|NCT04663763|Capecitabine|capecitabine|mesh-list
19724627|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
19724628|NCT04663763|Antibodies|antibodies|mesh-list
19724629|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
19724630|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724631|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19724632|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
19724633|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724634|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724635|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
19724636|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19724637|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724638|NCT04664023|Vaccines|vaccines|mesh-list
19724639|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
19724640|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724641|NCT04663386|Budesonide|budesonide|mesh-list
19724642|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
19865964|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
19865965|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19865966|NCT02348762|Glycine|glycine|mesh-list
19865967|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
19865968|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19865969|NCT02348762|Expectorants|expectorants|mesh-ancestor
19865970|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
19865971|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19865972|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
19439100|NCT03470532|Carticaine|carticaine|mesh-list
19724643|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724644|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19724645|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
19724646|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724647|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724648|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19724649|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
19724650|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
19724651|NCT04663386|Hormones|hormones|mesh-ancestor
19724652|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724653|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19724654|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19724655|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19724656|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724657|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724658|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724659|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
19724660|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
19724661|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19724662|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
19724663|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19724664|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724665|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19724666|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19724667|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19724668|NCT04663295|Insulin|insulin|mesh-list
19724669|NCT04663295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724670|NCT04663295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724671|NCT04663269|Dexamethasone|dexamethasone|mesh-list
19724672|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724673|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
19724674|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
19724675|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724676|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724677|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19439101|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
19724678|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
19724679|NCT04663269|Hormones|hormones|mesh-ancestor
19724680|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19865973|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724681|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19724682|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724683|NCT04662788|Antibodies|antibodies|mesh-list
19724684|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19724685|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
19724686|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724687|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19724688|NCT04662736|Tedizolid|tedizolid|mesh-list
19724689|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724690|NCT04662840|Anesthetics|anesthetics|mesh-list
19724691|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
19724692|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724693|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724694|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
19724695|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724696|NCT04662866|Metformin|metformin|mesh-list
19724697|NCT04662866|Pioglitazone|pioglitazone|mesh-list
19724698|NCT04662866|Empagliflozin|empagliflozin|mesh-list
19724699|NCT04662866|Linagliptin|linagliptin|mesh-list
19865974|NCT02348762|Protective Agents|protective agents|mesh-ancestor
19865975|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865976|NCT02348762|Antidotes|antidotes|mesh-ancestor
19865977|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
19865978|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19865979|NCT02348359|Bevacizumab|bevacizumab|mesh-list
19865980|NCT02348359|Ranibizumab|ranibizumab|mesh-list
19865981|NCT02348359|Aflibercept|aflibercept|mesh-list
19865982|NCT02348359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19865983|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19865984|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19865985|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19865986|NCT02348359|Growth Substances|growth substances|mesh-ancestor
19865987|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865988|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
19865989|NCT02285062|Prednisone|prednisone|mesh-list
19865990|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
20534101|NCT01812330|Ticagrelor|ticagrelor|mesh-list
20534102|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20534103|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19865991|NCT02285062|Rituximab|rituximab|mesh-list
19865992|NCT02285062|Doxorubicin|doxorubicin|mesh-list
19865993|NCT02285062|Vincristine|vincristine|mesh-list
19865994|NCT02285062|Lenalidomide|lenalidomide|mesh-list
19865995|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19865996|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
19865997|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19865998|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19865999|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866000|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
19866001|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866002|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866003|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19866004|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866005|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19866006|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19866007|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19866008|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866009|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19866010|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
19866011|NCT02285062|Hormones|hormones|mesh-ancestor
19866012|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534104|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20534105|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20534106|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
20534107|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534108|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724700|NCT04662866|Biguanides|biguanides|mesh-list
19724701|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
19724702|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724703|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724704|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19724705|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724706|NCT04662866|Incretins|incretins|mesh-ancestor
19866013|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19724707|NCT04662866|Hormones|hormones|mesh-ancestor
19724708|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724709|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19724710|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724711|NCT04662476|Vitamin D|vitamin d|mesh-list
19724712|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
19724713|NCT04662476|Vitamins|vitamins|mesh-ancestor
19724714|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
19724715|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724716|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19724717|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19724718|NCT04662567|Acetaminophen|acetaminophen|mesh-list
19724719|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724720|NCT04662567|Analgesics|analgesics|mesh-ancestor
19724721|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
19439102|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19439103|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19439104|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439105|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439106|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439107|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439108|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19439109|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19439110|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
19439111|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439112|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19439113|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439114|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
19439115|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
19439116|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19439117|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
19439118|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
19439119|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439120|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
19439121|NCT03470480|Methamphetamine|methamphetamine|mesh-list
19439122|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19439123|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439124|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
19439125|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
19439126|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439127|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
19439128|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439129|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439130|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724722|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724723|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724724|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
19724725|NCT04662658|Xenon|xenon|mesh-list
19724726|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19724727|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
19724728|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
19724729|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724730|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724731|NCT04662385|Listerine|listerine|mesh-list
19724732|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
19724733|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
19724734|NCT04662385|Protective Agents|protective agents|mesh-ancestor
19724735|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724736|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19724737|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724738|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
19866014|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19866015|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
19866016|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
19866017|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
19866018|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866019|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866020|NCT02285062|Growth Substances|growth substances|mesh-ancestor
19866021|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866022|NCT02252432|Ketamine|ketamine|mesh-list
19866023|NCT02252432|Methadone|methadone|mesh-list
19866024|NCT02252432|Analgesics|analgesics|mesh-ancestor
19866025|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
19866026|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866027|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866028|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19866029|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19866030|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
19866031|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
19866032|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19866033|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19866034|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19866035|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866036|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253468|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866037|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19866038|NCT02252432|Narcotics|narcotics|mesh-ancestor
19866039|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
19866040|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
19866041|NCT02230969|Interferons|interferons|mesh-list
19866042|NCT02230969|Interferon-beta|interferon-beta|mesh-list
19866043|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
19866044|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866045|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
19866046|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866047|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
19866048|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866049|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19866050|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
19866051|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
19866052|NCT02224872|Fludarabine|fludarabine|mesh-list
19866053|NCT02224872|Tacrolimus|tacrolimus|mesh-list
19866054|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
19866055|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866056|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
19866057|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253469|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
20253470|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20253471|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724739|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19724740|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724741|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724742|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724743|NCT04662177|Analgesics|analgesics|mesh-ancestor
19724744|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
19724745|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724746|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19724747|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19724748|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19724749|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724750|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866058|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19866059|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866060|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
19724751|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724752|NCT04662125|Acetaminophen|acetaminophen|mesh-list
19724753|NCT04662125|Prednisolone|prednisolone|mesh-list
19724754|NCT04662125|Pregabalin|pregabalin|mesh-list
19724755|NCT04662125|Caffeine|caffeine|mesh-list
19724756|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724757|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
19724758|NCT04662125|Hormones|hormones|mesh-ancestor
19724759|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724760|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724761|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19724762|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724763|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724764|NCT04662125|Analgesics|analgesics|mesh-ancestor
19724765|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
19724766|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
19724767|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19724768|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19724769|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724770|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20253472|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724771|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19724772|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19724773|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724774|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19724775|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724776|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
19724777|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19724778|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19724779|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724780|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19724781|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19866061|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866062|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866063|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19866064|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19866065|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866066|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20286656|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286657|NCT02977052|Nivolumab|nivolumab|mesh-list
20286658|NCT02977052|Ipilimumab|ipilimumab|mesh-list
20286659|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286660|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286661|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286662|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286663|NCT02973542|Ethosuximide|ethosuximide|mesh-list
20286664|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
20534109|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534110|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
20534111|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20534112|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
20534113|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
20534114|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534115|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534116|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20534117|NCT01812356|Analgesics|analgesics|mesh-ancestor
20534118|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
20534119|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286665|NCT02973386|Cisplatin|cisplatin|mesh-list
20286666|NCT02973386|Capecitabine|capecitabine|mesh-list
20286667|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724782|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
19724783|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724784|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
19724785|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724786|NCT04662242|Selenium|selenium|mesh-list
19724787|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
19724788|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534120|NCT01812369|Gemcitabine|gemcitabine|mesh-list
20534121|NCT01812369|Doxorubicin|doxorubicin|mesh-list
20534122|NCT01812369|Vinblastine|vinblastine|mesh-list
20253473|NCT00460148|Ropinirole|ropinirole|mesh-list
20253474|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20253475|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20253476|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
20253477|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
20253478|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253479|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253480|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253481|NCT00460174|Gemcitabine|gemcitabine|mesh-list
20253482|NCT00460174|Bevacizumab|bevacizumab|mesh-list
20253483|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20253484|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724789|NCT04662242|Protective Agents|protective agents|mesh-ancestor
19724790|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724791|NCT04662242|Trace Elements|trace elements|mesh-ancestor
19724792|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
19734951|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19734952|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734953|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19734954|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734955|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734956|NCT04544969|Gemcitabine|gemcitabine|mesh-list
19734957|NCT04544969|Cisplatin|cisplatin|mesh-list
19734958|NCT04544969|Docetaxel|docetaxel|mesh-list
19734959|NCT04544969|Fluorouracil|fluorouracil|mesh-list
19734960|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734961|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734962|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
19734963|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734964|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
19734965|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19734966|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734967|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19734968|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
19734969|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734970|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
19734971|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
19734972|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
19866067|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19866068|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
19866069|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19866070|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866071|NCT02187224|Progesterone|progesterone|mesh-list
19866072|NCT02187224|Progestins|progestins|mesh-ancestor
19866073|NCT02187224|Hormones|hormones|mesh-ancestor
19866074|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866075|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866076|NCT02059499|Fluorouracil|fluorouracil|mesh-list
19866077|NCT02059499|Imiquimod|imiquimod|mesh-list
19866078|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
19866079|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866080|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19866081|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866082|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866083|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
19866084|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866085|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19866086|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
19866087|NCT01995669|Lenalidomide|lenalidomide|mesh-list
19866088|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
19866089|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
19866090|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534123|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19734973|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19866091|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866092|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20534124|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
19724793|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
19724794|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724795|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
19724796|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
19724797|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19724798|NCT04661709|Aspirin|aspirin|mesh-list
19724799|NCT04661709|Metoprolol|metoprolol|mesh-list
19724800|NCT04661709|Isosorbide|isosorbide|mesh-list
19724801|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19724802|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19724803|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
19724804|NCT04661709|Trimetazidine|trimetazidine|mesh-list
19724805|NCT04661709|Clopidogrel|clopidogrel|mesh-list
19724806|NCT04661709|Atorvastatin|atorvastatin|mesh-list
19724807|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724808|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19724809|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724810|NCT04661709|Analgesics|analgesics|mesh-ancestor
19724811|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
19724812|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724813|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724814|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724815|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19724816|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19724817|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724818|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19724819|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19724820|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724821|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
19724822|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19724823|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19724824|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
19724825|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19724826|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19724827|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19724828|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19724829|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19724830|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
19724831|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724832|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19724833|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19724834|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
19866093|NCT01995669|Growth Substances|growth substances|mesh-ancestor
19866094|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866095|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866096|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866097|NCT01968109|Nivolumab|nivolumab|mesh-list
19724835|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
19724836|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19724837|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19724838|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19724839|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724840|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19724841|NCT04661709|Diuretics|diuretics|mesh-ancestor
19724842|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
19724843|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
19724844|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19724845|NCT04661696|Paclitaxel|paclitaxel|mesh-list
19724846|NCT04661696|Carboplatin|carboplatin|mesh-list
19724847|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19724848|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724849|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
19724850|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
20534125|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534126|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534127|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
20534128|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439131|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19866098|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866099|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866100|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19866101|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866102|NCT01935336|Ponatinib|ponatinib|mesh-list
19866103|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866104|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20253485|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20253486|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20253487|NCT00460174|Growth Substances|growth substances|mesh-ancestor
19724851|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
19724852|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253488|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253489|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
20253490|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253491|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
20253492|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253493|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
20253494|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253495|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724853|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
19724854|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19724855|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724856|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724857|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19724858|NCT04661475|Analgesics|analgesics|mesh-ancestor
20253496|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253497|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
20253498|NCT00460213|Valsartan|valsartan|mesh-list
20253499|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20253500|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20253501|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20253502|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253503|NCT00460226|Lamotrigine|lamotrigine|mesh-list
20253504|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
20253505|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20253506|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20253507|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253508|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20253509|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253510|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20253511|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20253512|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534129|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439132|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19439133|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439134|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19439135|NCT03470454|Linagliptin|linagliptin|mesh-list
19439136|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19439137|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439138|NCT03470454|Incretins|incretins|mesh-ancestor
19439139|NCT03470454|Hormones|hormones|mesh-ancestor
19866105|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866106|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866107|NCT01905436|Ivermectin|ivermectin|mesh-list
19866108|NCT01905436|Albendazole|albendazole|mesh-list
19866109|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19866110|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866111|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
19866112|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
19866113|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19866114|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19724859|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
19724860|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19724861|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19724862|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19724863|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19724864|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
19724865|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19724866|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724867|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
19724868|NCT04661852|Topotecan|topotecan|mesh-list
19724869|NCT04661852|Mitogens|mitogens|mesh-list
19724870|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724871|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
19724872|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253513|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20253514|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20253515|NCT00460252|Insulin|insulin|mesh-list
20253516|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20253517|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724873|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19724874|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19724875|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
19724876|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724877|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253518|NCT00460304|Pramlintide|pramlintide|mesh-list
19439140|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439141|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19439142|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
19439143|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439144|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439145|NCT03470363|Sufentanil|sufentanil|mesh-list
19439146|NCT03470363|Bupivacaine|bupivacaine|mesh-list
19439147|NCT03470363|Sevoflurane|sevoflurane|mesh-list
19724878|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19724879|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19724880|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19724881|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724882|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
19724883|NCT04661345|Coagulase|coagulase|mesh-list
19724884|NCT04661345|Coagulants|coagulants|mesh-ancestor
19724885|NCT04661397|Tenofovir|tenofovir|mesh-list
19724886|NCT04661397|Emtricitabine|emtricitabine|mesh-list
19724887|NCT04661397|Darunavir|darunavir|mesh-list
19724888|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19724889|NCT04661397|Cobicistat|cobicistat|mesh-list
19724890|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19724891|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
19724892|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19724893|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19724894|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19724895|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866115|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
19866116|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
19724896|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724897|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19866117|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
20253519|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19866118|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866119|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866120|NCT01885702|Vaccines|vaccines|mesh-list
19866121|NCT01885702|Immunologic Factors|immunologic factors|mesh-ancestor
19866122|NCT01885702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724898|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19724899|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19724900|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19724901|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
19439148|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
19439149|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
19724902|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19724903|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19724904|NCT04660773|Pregabalin|pregabalin|mesh-list
19724905|NCT04660773|Analgesics|analgesics|mesh-ancestor
19724906|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
19724907|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866123|NCT01797523|Metformin|metformin|mesh-list
19866124|NCT01797523|Everolimus|everolimus|mesh-list
19866125|NCT01797523|Letrozole|letrozole|mesh-list
19866126|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19866127|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866128|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866129|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866130|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
19866131|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19866132|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19866133|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866134|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866135|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19866136|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
19866137|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866138|NCT01733693|Buprenorphine|buprenorphine|mesh-list
19866139|NCT01733693|Methadone|methadone|mesh-list
19866140|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19866141|NCT01733693|Narcotics|narcotics|mesh-ancestor
19866142|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19866143|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866144|NCT01733693|Analgesics|analgesics|mesh-ancestor
19866145|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
19866146|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866147|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19866148|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
19866149|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
19866150|NCT01712490|Doxorubicin|doxorubicin|mesh-list
19866151|NCT01712490|Bleomycin|bleomycin|mesh-list
19866152|NCT01712490|Dacarbazine|dacarbazine|mesh-list
19439150|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439151|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439152|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
19439153|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439154|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19439155|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19439156|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
19439157|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19439158|NCT03470363|Narcotics|narcotics|mesh-ancestor
19439159|NCT03470363|Analgesics|analgesics|mesh-ancestor
19439160|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19724908|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866153|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19866154|NCT01712490|Vinblastine|vinblastine|mesh-list
19724909|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
19724910|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19724911|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19724912|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724913|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19724914|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19724915|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19724916|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19724917|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19724918|NCT04660916|Isotretinoin|isotretinoin|mesh-list
19724919|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
19724920|NCT04660786|Vitamin D|vitamin d|mesh-list
19724921|NCT04660786|Triamcinolone|triamcinolone|mesh-list
19724922|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19724923|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19724924|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19724925|NCT04660786|Vitamins|vitamins|mesh-ancestor
19724926|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
19724927|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724928|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19724929|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724930|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
19724931|NCT04660786|Hormones|hormones|mesh-ancestor
19724932|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724933|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724934|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
19724935|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724936|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724937|NCT04660643|Tirzepatide|tirzepatide|mesh-list
19724938|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724939|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724940|NCT04660643|Incretins|incretins|mesh-ancestor
19724941|NCT04660643|Hormones|hormones|mesh-ancestor
19724942|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724943|NCT04660461|Lansoprazole|lansoprazole|mesh-list
19724944|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
19724945|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19724946|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19724947|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19724948|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724949|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724950|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
19724951|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724952|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724953|NCT04660565|Prednisone|prednisone|mesh-list
19724954|NCT04660565|Belimumab|belimumab|mesh-list
19724955|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724956|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
19724957|NCT04660565|Hormones|hormones|mesh-ancestor
19724958|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724959|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724960|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19866155|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19866156|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866157|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19866158|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19866159|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866160|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866161|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866162|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
19866163|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969955|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724961|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724962|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19724963|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
19724964|NCT04660110|Piperaquine|piperaquine|mesh-list
19724965|NCT04660110|Artenimol|artenimol|mesh-list
19724966|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
19724967|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19724968|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19724969|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253520|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253521|NCT00460369|Artesunate|artesunate|mesh-list
20253522|NCT00460369|Lumefantrine|lumefantrine|mesh-list
20253523|NCT00460369|Artemether|artemether|mesh-list
20253524|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
20253525|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
20253526|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20253527|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20253528|NCT00460369|Amodiaquine|amodiaquine|mesh-list
19724970|NCT04659915|Metformin|metformin|mesh-list
19724971|NCT04659915|Prednisone|prednisone|mesh-list
19724972|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19724973|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19724974|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19724975|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
19724976|NCT04659915|Hormones|hormones|mesh-ancestor
19724977|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19724978|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19724979|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724980|NCT04660123|Bismuth|bismuth|mesh-list
19724981|NCT04660123|Antacids|antacids|mesh-ancestor
19724982|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724983|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19724984|NCT04659785|Apatinib|apatinib|mesh-list
19724985|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19724986|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19724987|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19724988|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724989|NCT04659525|Ezetimibe|ezetimibe|mesh-list
19724990|NCT04659525|Evolocumab|evolocumab|mesh-list
19724991|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19724992|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19724993|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
19724994|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19724995|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19734974|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19734975|NCT04544683|Dexamethasone|dexamethasone|mesh-list
19734976|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
19734977|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19734978|NCT04544683|BB 1101|bb 1101|mesh-list
19734979|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19734980|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
19734981|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
19734982|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19734983|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734984|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19734985|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
19734986|NCT04544683|Hormones|hormones|mesh-ancestor
19734987|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253529|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
19724996|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
19724997|NCT04659551|Nivolumab|nivolumab|mesh-list
19724998|NCT04659551|Epirubicin|epirubicin|mesh-list
19724999|NCT04659551|Exemestane|exemestane|mesh-list
19725000|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19725001|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725002|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
19725003|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725004|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725005|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19725006|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
19725007|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725008|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725009|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19725010|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19725011|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19725012|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19725013|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19725014|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19725015|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725016|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19725017|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19725018|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19725019|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
19725020|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725021|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
19725022|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19725023|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
19725024|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19725025|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19725026|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725027|NCT04659616|Cytarabine|cytarabine|mesh-list
19725028|NCT04659616|Daunorubicin|daunorubicin|mesh-list
19725029|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19725030|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
19725031|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725032|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725033|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
19725034|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725035|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725036|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
19725037|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725038|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19725039|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19725040|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19725041|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725042|NCT04659499|Paclitaxel|paclitaxel|mesh-list
19725043|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19725044|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725045|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
19725046|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
19725047|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
19725048|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866164|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19866165|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
19866166|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
19866167|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
19866168|NCT01499160|Everolimus|everolimus|mesh-list
19866169|NCT01499160|Letrozole|letrozole|mesh-list
19866170|NCT01499160|Lapatinib|lapatinib|mesh-list
19866171|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866172|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866173|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
19866174|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866175|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19725049|NCT04659642|Fentanyl|fentanyl|mesh-list
19725050|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
19725051|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19725052|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725053|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725054|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725055|NCT04659642|Analgesics|analgesics|mesh-ancestor
19725056|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
19725057|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725058|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19725059|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19725060|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19725061|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725062|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725063|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725064|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19725065|NCT04659642|Narcotics|narcotics|mesh-ancestor
19725066|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19725067|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19725068|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
19725069|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
19866176|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19866177|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866178|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866179|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19866180|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
19866181|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866182|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866183|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
19866184|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19866185|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
19866186|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866187|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866188|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19866189|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
19866190|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19866191|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19866192|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19866193|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
19866194|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866195|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866196|NCT01149850|Bevacizumab|bevacizumab|mesh-list
19866197|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19866198|NCT01149850|Temozolomide|temozolomide|mesh-list
19866199|NCT01149850|Antibodies|antibodies|mesh-list
19866200|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
19866201|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19866202|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866203|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866204|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866205|NCT01149850|Growth Substances|growth substances|mesh-ancestor
20534130|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866206|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866207|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866208|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
19866209|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866210|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
19866211|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866212|NCT01090089|Dexamethasone|dexamethasone|mesh-list
19866213|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
19866214|NCT01090089|Lenalidomide|lenalidomide|mesh-list
19866215|NCT01090089|BB 1101|bb 1101|mesh-list
19866216|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19866217|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
19866218|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
19866219|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866220|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866221|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19866222|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
19866223|NCT01090089|Hormones|hormones|mesh-ancestor
19866224|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866225|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19866226|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866227|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
19725070|NCT04659278|Peppermint oil|peppermint oil|mesh-list
19725071|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
19725072|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
20534131|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
19866228|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866229|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866230|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
19866231|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866232|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866233|NCT01090089|Growth Substances|growth substances|mesh-ancestor
19866234|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866235|NCT01061151|Ritonavir|ritonavir|mesh-list
19866236|NCT01061151|Lopinavir|lopinavir|mesh-list
19866237|NCT01061151|Tenofovir|tenofovir|mesh-list
19866238|NCT01061151|Lamivudine|lamivudine|mesh-list
19866239|NCT01061151|Zidovudine|zidovudine|mesh-list
19866240|NCT01061151|Emtricitabine|emtricitabine|mesh-list
19866241|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19866242|NCT01061151|Nevirapine|nevirapine|mesh-list
19866243|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19866244|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19866245|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19866246|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
19866247|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866248|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866249|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19866250|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19866251|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
19866252|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866253|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19866254|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19866255|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19725073|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725074|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725075|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725076|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
19725077|NCT04659109|Glenzocimab|glenzocimab|mesh-list
19725078|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
19866256|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19866257|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
19866258|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19866259|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19866260|NCT00981058|Gemcitabine|gemcitabine|mesh-list
19866261|NCT00981058|Necitumumab|necitumumab|mesh-list
19725079|NCT04659070|Telmisartan|telmisartan|mesh-list
19725080|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19725081|NCT04659070|Ezetimibe|ezetimibe|mesh-list
19725082|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19725083|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19725084|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
19725085|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725086|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19725087|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19725088|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725089|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19725090|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19725091|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19725092|NCT04658927|Dexamethasone|dexamethasone|mesh-list
19725093|NCT04658927|Prednisone|prednisone|mesh-list
19866262|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866263|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19866264|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
19866265|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866266|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
19866267|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866268|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866269|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866270|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
19866271|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866272|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534132|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866273|NCT00885495|Ritonavir|ritonavir|mesh-list
19725094|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725095|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
19725096|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
19725097|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725098|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725099|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725100|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
19725101|NCT04658927|Hormones|hormones|mesh-ancestor
19725102|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725103|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19866274|NCT00885495|Darunavir|darunavir|mesh-list
19866275|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19866276|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19866277|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19866278|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
19866279|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866280|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866281|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19866282|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19866283|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
19866284|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866285|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19866286|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19866287|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19866288|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19866289|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
19866290|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19866291|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19866292|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
19866293|NCT00692939|Melphalan|melphalan|mesh-list
19866294|NCT00692939|Thiotepa|thiotepa|mesh-list
19866295|NCT00692939|Rituximab|rituximab|mesh-list
19866296|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
19866297|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
19866298|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19866299|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725104|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725105|NCT04659057|Lidocaine|lidocaine|mesh-list
19725106|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
19725107|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
19725108|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
19866300|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
19866301|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866302|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19866303|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866304|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
19866305|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866306|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866307|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19866308|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19725109|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725110|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725111|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
19725112|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725113|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19725114|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19725115|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19725116|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19725117|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725118|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19866309|NCT00388921|Vitamin A|vitamin a|mesh-list
19866310|NCT00388921|Vitamins|vitamins|mesh-ancestor
19866311|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
19866312|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866313|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
19866314|NCT00142285|Astringents|astringents|mesh-ancestor
19866315|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866316|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
19866317|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
19866318|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19866319|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866320|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19866321|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19866322|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866323|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866324|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866325|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19866326|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19866327|NCT00084799|Antibodies|antibodies|mesh-list
19866328|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19866329|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
19866330|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866331|NCT00821327|Gemcitabine|gemcitabine|mesh-list
19866332|NCT00821327|Sunitinib|sunitinib|mesh-list
19866333|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866334|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19866335|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
19866336|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866337|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
19866338|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866339|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866340|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866341|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
19866342|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866343|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866344|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866345|NCT00821327|Growth Substances|growth substances|mesh-ancestor
19866346|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866347|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866348|NCT00821509|Disinfectants|disinfectants|mesh-list
19866349|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866350|NCT00821795|Insulin|insulin|mesh-list
19866351|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
19866352|NCT00821795|Protamines|protamines|mesh-list
19866353|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19866354|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866355|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
19866356|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866357|NCT00821795|Coagulants|coagulants|mesh-ancestor
19866358|NCT00821821|Edaravone|edaravone|mesh-list
19866359|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19866360|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
19866361|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866362|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19725119|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19866363|NCT00821821|Protective Agents|protective agents|mesh-ancestor
19866364|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866365|NCT00821886|Carboplatin|carboplatin|mesh-list
19866366|NCT00821886|Trastuzumab|trastuzumab|mesh-list
19866367|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866368|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866369|NCT00821951|Vorinostat|vorinostat|mesh-list
19866370|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866371|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19866372|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866373|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866374|NCT00821964|Paclitaxel|paclitaxel|mesh-list
19866375|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19866376|NCT00821964|Imiquimod|imiquimod|mesh-list
19866377|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19866378|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866379|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
19866380|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
19866381|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
19866382|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866383|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19866384|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
19866385|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866386|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
19866387|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19866388|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19866389|NCT00822107|Diuretics|diuretics|mesh-ancestor
19866390|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
19866391|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866392|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19866393|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19866394|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866395|NCT00822172|Cilostazol|cilostazol|mesh-list
19866396|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19866397|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
19866398|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866399|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534133|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20534134|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20534135|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19866400|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19866401|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
19866402|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19866403|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20534136|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20534137|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
20534138|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
20534139|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
20534140|NCT01812382|Retapamulin|retapamulin|mesh-list
20534141|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534142|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725120|NCT04659057|Analgesics|analgesics|mesh-ancestor
19725121|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19725122|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19725123|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19725124|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725125|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725126|NCT04658836|Triamcinolone|triamcinolone|mesh-list
19866404|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534143|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
19725127|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19725128|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19725129|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19725130|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725131|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
19725132|NCT04658836|Hormones|hormones|mesh-ancestor
19725133|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725134|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725135|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725136|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
19725137|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725138|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725139|NCT04658680|Vaccines|vaccines|mesh-list
19725140|NCT04658680|Immunologic Factors|immunologic factors|mesh-ancestor
19725141|NCT04658680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725142|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
19725143|NCT04658732|Gabapentin|gabapentin|mesh-list
19725144|NCT04658732|Alprazolam|alprazolam|mesh-list
19725145|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19725146|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725147|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725148|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725149|NCT04658732|Analgesics|analgesics|mesh-ancestor
19725150|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
19725151|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725152|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19725153|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19725154|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19725155|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725156|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725157|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725158|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
19725159|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19725160|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19725161|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19725162|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19725163|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19725164|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
19866405|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19866406|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
19866407|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19725165|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
19725166|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
19725167|NCT04658420|Ketamine|ketamine|mesh-list
19725168|NCT04658420|Analgesics|analgesics|mesh-ancestor
19725169|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
19866408|NCT00822172|Protective Agents|protective agents|mesh-ancestor
19866409|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19866410|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19866411|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866412|NCT00822237|Vaccines|vaccines|mesh-list
19866413|NCT00822237|Immunoglobulins|immunoglobulins|mesh-list
19866414|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
19866415|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866416|NCT00822354|Tadalafil|tadalafil|mesh-list
19866417|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
19866418|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19866419|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19866420|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725170|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866421|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725171|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725172|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19725173|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19725174|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
19725175|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
19725176|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725177|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19725178|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19725179|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725180|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725181|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19725182|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
19725183|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725184|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
19725185|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19725186|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
19725187|NCT04658355|Povidone|povidone|mesh-list
19725188|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19725189|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725190|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
19725191|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
19725192|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
19725193|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
19725194|NCT04658160|Imidacloprid|imidacloprid|mesh-list
19725195|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
19725196|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725197|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725198|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725199|NCT04658134|Glycine|glycine|mesh-list
19725200|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
19725201|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725202|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725203|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725204|NCT04657939|Pioglitazone|pioglitazone|mesh-list
19725205|NCT04657939|Liraglutide|liraglutide|mesh-list
19725206|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19725207|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725208|NCT04657939|Incretins|incretins|mesh-ancestor
19725209|NCT04657939|Hormones|hormones|mesh-ancestor
19725210|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725211|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
19725212|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20253530|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19725213|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725214|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
19725215|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19725216|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19725217|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725218|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725219|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
19725220|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19734988|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19734989|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19734990|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
19866422|NCT00822354|Urological Agents|urological agents|mesh-ancestor
19866423|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
19734991|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19734992|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19734993|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
19734994|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19734995|NCT04544228|Ketamine|ketamine|mesh-list
19734996|NCT04544228|Bupivacaine|bupivacaine|mesh-list
19734997|NCT04544228|Neostigmine|neostigmine|mesh-list
19734998|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
19734999|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
19735000|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735001|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735002|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
19735003|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735004|NCT04544228|Analgesics|analgesics|mesh-ancestor
19735005|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19735006|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19735007|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
19735008|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19735009|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19735010|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735011|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735012|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19735013|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735014|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
19735015|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19735016|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
19735017|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
19735018|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19866424|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19866425|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19866426|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19866427|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19866428|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866429|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
19866430|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866431|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866432|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19866433|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866434|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19866435|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19725221|NCT04657497|Camostat|camostat|mesh-list
19725222|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
19725223|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725224|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725225|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19725226|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19725227|NCT04657692|Anesthetics|anesthetics|mesh-list
19725228|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725229|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725230|NCT04657484|Prednisolone|prednisolone|mesh-list
19725231|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19725232|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
19725233|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19725234|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
19725235|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19725236|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
19725237|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725238|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
19725239|NCT04657484|Hormones|hormones|mesh-ancestor
19725240|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725241|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725242|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725243|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725244|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
19725245|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
19725246|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725247|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725248|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19725249|NCT04657484|Protective Agents|protective agents|mesh-ancestor
19725250|NCT04657107|Ketamine|ketamine|mesh-list
19725251|NCT04657107|Esketamine|esketamine|mesh-list
19725252|NCT04657107|Analgesics|analgesics|mesh-ancestor
19725253|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
19725254|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725255|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725256|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19725257|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19725258|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
19725259|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
19725260|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725261|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19725262|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19725263|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725264|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725265|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
19725266|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19866436|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866437|NCT00822692|Renal Agents|renal agents|mesh-ancestor
19866438|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19866439|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
19866440|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19866441|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19725267|NCT04657172|Pilocarpine|pilocarpine|mesh-list
19725268|NCT04657172|Miotics|miotics|mesh-ancestor
19725269|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
19866442|NCT00822770|Vidarabine|vidarabine|mesh-list
19866443|NCT00822770|Plerixafor|plerixafor|mesh-list
19866444|NCT00822770|Fludarabine|fludarabine|mesh-list
19866445|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
19866446|NCT00822770|Busulfan|busulfan|mesh-list
20534144|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
20534145|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20534146|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20534147|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534148|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534149|NCT01812434|Urological Agents|urological agents|mesh-ancestor
20534150|NCT01812538|Diclofenac|diclofenac|mesh-list
20534151|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20534152|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20534153|NCT01812538|Analgesics|analgesics|mesh-ancestor
20534154|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
20534155|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534156|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866447|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
19866448|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19866449|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534157|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725270|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725271|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725272|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19725273|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19725274|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
19725275|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725276|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725277|NCT04656665|Aspirin|aspirin|mesh-list
19725278|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19725279|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725280|NCT04656665|Analgesics|analgesics|mesh-ancestor
19725281|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
19725282|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725283|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725284|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725285|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725286|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19725287|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19725288|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725289|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19725290|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19725291|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725292|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
19725293|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
19725294|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19725295|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19725296|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725297|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
19725298|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
19725299|NCT04656041|Paclitaxel|paclitaxel|mesh-list
19725300|NCT04656041|Carboplatin|carboplatin|mesh-list
19725301|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19725302|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725303|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
19725304|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
19725305|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
19725306|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725307|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19725308|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19725309|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725310|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
19725311|NCT04656262|Doxorubicin|doxorubicin|mesh-list
19866450|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19725312|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725313|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
19725314|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725315|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725316|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19725317|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
19866451|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
19866452|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866453|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19439161|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19439162|NCT03470350|Capecitabine|capecitabine|mesh-list
19439163|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439164|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
19439165|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439166|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439167|NCT03470337|Wobenzym|wobenzym|mesh-list
19439168|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19725318|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725319|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725320|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19725321|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19725322|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19725323|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19725324|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725325|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19725326|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
19725327|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19725328|NCT04656184|Antibodies|antibodies|mesh-list
19725329|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
19725330|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19866454|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
19866455|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866456|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
19866457|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866458|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
19866459|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866460|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19866461|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19866462|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19866463|NCT00822900|Progesterone|progesterone|mesh-list
19866464|NCT00822900|Progestins|progestins|mesh-ancestor
19866465|NCT00822900|Hormones|hormones|mesh-ancestor
19866466|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866467|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866468|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
19866469|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19866470|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19866471|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19866472|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19866473|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866474|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
19866475|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866476|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866477|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19866478|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534158|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534159|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20534160|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534161|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534162|NCT01812551|Alendronate|alendronate|mesh-list
19866479|NCT00823043|Timolol|timolol|mesh-list
19866480|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19866481|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19866482|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
19866483|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866484|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866485|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866486|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19866487|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19866488|NCT00823082|Antithrombins|antithrombins|mesh-list
19866489|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
19866490|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19866491|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
19866492|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866493|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534163|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20534164|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534165|NCT01812603|Nabiximols|nabiximols|mesh-list
20534166|NCT01812603|Analgesics|analgesics|mesh-ancestor
19866494|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
19866495|NCT00823212|Aspirin|aspirin|mesh-list
19866496|NCT00823212|Ticlopidine|ticlopidine|mesh-list
20253531|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19725331|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
19725332|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725333|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725334|NCT04656249|Lenvatinib|lenvatinib|mesh-list
19725335|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866497|NCT00823212|Clopidogrel|clopidogrel|mesh-list
19866498|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19866499|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19866500|NCT00823212|Analgesics|analgesics|mesh-ancestor
19866501|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
19866502|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866503|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866504|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19866505|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19866506|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19866507|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19866508|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866509|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19866510|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19866511|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866512|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
19866513|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19866514|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19866515|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19866516|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
19866517|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866518|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19866519|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19866520|NCT00823264|Charcoal|charcoal|mesh-list
19866521|NCT00823264|Antidotes|antidotes|mesh-ancestor
19866522|NCT00823264|Protective Agents|protective agents|mesh-ancestor
19866523|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534167|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
20534168|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534169|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866524|NCT00823303|Calcitriol|calcitriol|mesh-list
19725336|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19725337|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725338|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866525|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19866526|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866527|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19866528|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19866529|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866530|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19866531|NCT00823303|Vitamins|vitamins|mesh-ancestor
20534170|NCT01812616|Nabiximols|nabiximols|mesh-list
20534171|NCT01812616|Analgesics|analgesics|mesh-ancestor
20534172|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
20534173|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534174|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534175|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
20534176|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19866532|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
19725339|NCT04655482|Aflibercept|aflibercept|mesh-list
19725340|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19725341|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19725342|NCT04655482|Growth Substances|growth substances|mesh-ancestor
19725343|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725344|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
19725345|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725346|NCT04655807|Adalimumab|adalimumab|mesh-list
19725347|NCT04655807|Ustekinumab|ustekinumab|mesh-list
19725348|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725349|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725350|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
19725351|NCT04655664|Vitamin D|vitamin d|mesh-list
19725352|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
19725353|NCT04655664|Vitamins|vitamins|mesh-list
19725354|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
19725355|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725356|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19725357|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19725358|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
19725359|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19725360|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19725361|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19725362|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19725363|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
19725364|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725365|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725366|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19866533|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19866534|NCT00823459|Everolimus|everolimus|mesh-list
19866535|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866536|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866537|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
19866538|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866539|NCT00823472|Ganirelix|ganirelix|mesh-list
19866540|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
19866541|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866542|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866543|NCT00823719|Ofatumumab|ofatumumab|mesh-list
19866544|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19866545|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866546|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
19866547|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866548|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19866549|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866550|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
19866551|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866552|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866553|NCT00823823|Calpastatin|calpastatin|mesh-list
19866554|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20534177|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20534178|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
19866555|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
20253532|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439169|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
19725367|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
20534179|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534180|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534181|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534182|NCT01812720|Dexamethasone|dexamethasone|mesh-list
20534183|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534184|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
20534185|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
19725368|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
19725369|NCT04655508|Hormones|hormones|mesh-ancestor
19725370|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725371|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
19725372|NCT04655729|Infliximab|infliximab|mesh-list
19725373|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
19725374|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725375|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735019|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735020|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19735021|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735022|NCT04544059|Lenalidomide|lenalidomide|mesh-list
19735023|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
19735024|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735025|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19735026|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19735027|NCT04544059|Growth Substances|growth substances|mesh-ancestor
19735028|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
19735029|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735904|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735905|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
19735906|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735907|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19735908|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
19735909|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
19735910|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19735911|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
19735912|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735913|NCT04534725|Interferons|interferons|mesh-list
19735914|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
19735915|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735916|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
19735917|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735918|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
19735919|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735920|NCT04534491|Oxybutynin|oxybutynin|mesh-list
19735921|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
19735922|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
19735923|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735924|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735925|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19735926|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19735927|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
19735928|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735929|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735930|NCT04534491|Urological Agents|urological agents|mesh-ancestor
19735931|NCT04534478|Prednisone|prednisone|mesh-list
19735932|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735933|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
19735934|NCT04534478|Hormones|hormones|mesh-ancestor
19735935|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735936|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735937|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19735938|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735939|NCT04534465|Mannitol|mannitol|mesh-list
19735940|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19735941|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19735942|NCT04534465|Diuretics|diuretics|mesh-ancestor
19735943|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
19866556|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735944|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735945|NCT04534465|Laxatives|laxatives|mesh-ancestor
20253533|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725376|NCT04655170|Albuterol|albuterol|mesh-list
19725377|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
19725378|NCT04655170|Ipratropium|ipratropium|mesh-list
19725379|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19725380|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19725381|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
19725382|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725383|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725384|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19725385|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
19725386|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19725387|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19725388|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19439170|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439171|NCT03470311|Benralizumab|benralizumab|mesh-list
19439172|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19439173|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
19451911|NCT03417947|Vitamin D|vitamin d|mesh-list
19451912|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
19451913|NCT03417947|Vitamins|vitamins|mesh-ancestor
19451914|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
19451915|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451916|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19451917|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19451918|NCT03417921|Gemcitabine|gemcitabine|mesh-list
19451919|NCT03417921|Paclitaxel|paclitaxel|mesh-list
19451920|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19451921|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451922|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
19451923|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
19725389|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725390|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725391|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725392|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
20253534|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
19451924|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
19725393|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19439174|NCT03470103|Aflibercept|aflibercept|mesh-list
19439175|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19439176|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19439177|NCT03470103|Growth Substances|growth substances|mesh-ancestor
19439178|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439179|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
19439180|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439181|NCT03470077|Nalbuphine|nalbuphine|mesh-list
19439182|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439183|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439184|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19439185|NCT03470077|Narcotics|narcotics|mesh-ancestor
19439186|NCT03470077|Analgesics|analgesics|mesh-ancestor
19439187|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
19439188|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439189|NCT03470038|Mitogens|mitogens|mesh-list
19439190|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
19439191|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439192|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
19439193|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19439194|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19439195|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439196|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
19439197|NCT03469947|Coagulants|coagulants|mesh-ancestor
19439198|NCT03469895|Idelalisib|idelalisib|mesh-list
19439199|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439200|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439201|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439202|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19439203|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19439204|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
19439205|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439206|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439207|NCT03469700|Anesthetics|anesthetics|mesh-list
19439208|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439209|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439210|NCT03469583|Entecavir|entecavir|mesh-list
19439211|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
19439212|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439213|NCT03469557|Capecitabine|capecitabine|mesh-list
19439214|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
19439215|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439216|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439217|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
19439218|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439219|NCT03469544|Hormones|hormones|mesh-list
19439220|NCT03469544|Antibodies|antibodies|mesh-list
19439221|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439222|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439223|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
19439224|NCT03469531|Cisplatin|cisplatin|mesh-list
19439225|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
19439226|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439227|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439228|NCT03469375|Folfirinox|folfirinox|mesh-list
19439229|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439230|NCT03469323|Succinylcholine|succinylcholine|mesh-list
19439231|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19439232|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19439233|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19439234|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439235|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439236|NCT03469310|Acetaminophen|acetaminophen|mesh-list
19439237|NCT03469310|Tramadol|tramadol|mesh-list
19439238|NCT03469310|Codeine|codeine|mesh-list
19725394|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
19725395|NCT04655183|Niraparib|niraparib|mesh-list
20253535|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
20253536|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20253537|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
20253538|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20253539|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253540|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253541|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20253542|NCT00460369|Renal Agents|renal agents|mesh-ancestor
20253543|NCT00460382|Ritonavir|ritonavir|mesh-list
20253544|NCT00460382|Darunavir|darunavir|mesh-list
20253545|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
20253546|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
20253547|NCT00460382|Etravirine|etravirine|mesh-list
20253548|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20253549|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20253550|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
20253551|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253552|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534186|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534187|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534188|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534189|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
20534190|NCT01812720|Hormones|hormones|mesh-ancestor
20534191|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534192|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20534193|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553493|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553494|NCT01929603|Rifampin|rifampin|mesh-list
20553495|NCT01929603|Olaparib|olaparib|mesh-list
20553496|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20553497|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553498|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553499|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553500|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20553501|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
20553502|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553503|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553504|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
20553505|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20553506|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20553507|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20553508|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20553509|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20553510|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20553511|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20553512|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20553513|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553514|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
20553515|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
20553516|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553517|NCT01929668|Protective Agents|protective agents|mesh-ancestor
20553518|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553519|NCT01929668|Vitamins|vitamins|mesh-ancestor
20553520|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
20553521|NCT01929746|Daclizumab|daclizumab|mesh-list
20553522|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553523|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
20553524|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553525|NCT01929798|Pancrelipase|pancrelipase|mesh-list
20553526|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553527|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
20553528|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19439239|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19439240|NCT03469310|Analgesics|analgesics|mesh-ancestor
19439241|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
19439242|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439243|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439244|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
19439245|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19439246|NCT03469310|Narcotics|narcotics|mesh-ancestor
19439247|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439248|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
19439249|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439250|NCT03469284|Methylene Blue|methylene blue|mesh-list
19439251|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439252|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439253|NCT03469271|Calcitriol|calcitriol|mesh-list
19439254|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19439255|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19725396|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19725397|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725398|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725399|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253553|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20253554|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20253555|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
20253556|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253557|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20253558|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20253559|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20253560|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19439256|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534194|NCT01812889|TOL-463|tol-463|mesh-list
20253561|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20253562|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20534195|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534196|NCT01812928|Diclofenac|diclofenac|mesh-list
20253563|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20253564|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20253565|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
20253566|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534197|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19725400|NCT04655040|Caffeine|caffeine|mesh-list
20534198|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20534199|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20534200|NCT01812928|Analgesics|analgesics|mesh-ancestor
20534201|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
20534202|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534203|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534204|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534205|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19725401|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19725402|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725403|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19725404|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725405|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725406|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19725407|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19725408|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
19725409|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725410|NCT04654962|Anesthetics|anesthetics|mesh-list
19725411|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735030|NCT04544163|Lidocaine|lidocaine|mesh-list
20534206|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534207|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534208|NCT01812954|Cyclosporine|cyclosporine|mesh-list
20534209|NCT01812954|Adalimumab|adalimumab|mesh-list
20534210|NCT01812954|Etanercept|etanercept|mesh-list
20534211|NCT01812954|Methotrexate|methotrexate|mesh-list
20534212|NCT01812954|Infliximab|infliximab|mesh-list
20534213|NCT01812954|Ustekinumab|ustekinumab|mesh-list
20534214|NCT01812954|Acitretin|acitretin|mesh-list
20534215|NCT01812954|Cyclosporins|cyclosporins|mesh-list
20534216|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20534217|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
20534218|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20534219|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534220|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534221|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
20534222|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534223|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534224|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
20534225|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534226|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20534227|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534228|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
20534229|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534230|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20253567|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253568|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
20253569|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20253570|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253571|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253572|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20253573|NCT00460473|Analgesics|analgesics|mesh-ancestor
20253574|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
20253575|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253576|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20253577|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20253578|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20253579|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
20253580|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253581|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253582|NCT00460486|Formaldehyde|formaldehyde|mesh-list
20253583|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
20253584|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253585|NCT00460499|Insulin|insulin|mesh-list
20253586|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20253587|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253588|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20253589|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20253590|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20253591|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253592|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253593|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20253594|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20253595|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20253596|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
20253597|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253598|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253599|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20253600|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20253601|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
20253602|NCT00460616|Cabergoline|cabergoline|mesh-list
20253603|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20253604|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19725412|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725413|NCT04654416|Colchicine|colchicine|mesh-list
20253605|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
20253606|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
20253607|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253608|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253609|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253610|NCT00460642|Cetrorelix|cetrorelix|mesh-list
20253611|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20534231|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
19439257|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19725414|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
19866557|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866558|NCT00823836|Ropinirole|ropinirole|mesh-list
20253612|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
19439258|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439259|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439260|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19439261|NCT03469271|Vitamins|vitamins|mesh-ancestor
19439262|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
19439263|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19439264|NCT03469167|Epinephrine|epinephrine|mesh-list
19439265|NCT03469167|CEGP-003|cegp-003|mesh-list
19439266|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19439267|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19439268|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439269|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439270|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439271|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439272|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19439273|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19439274|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
19439275|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439276|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19439277|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439278|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
19439279|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
19439280|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19439281|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
19439282|NCT03469167|Coagulants|coagulants|mesh-ancestor
19439283|NCT03469128|Sertraline|sertraline|mesh-list
19439284|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
19439285|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19439286|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19439287|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19439288|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439289|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439290|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439291|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
19439292|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439293|NCT03469089|Ketamine|ketamine|mesh-list
19439294|NCT03469089|Modafinil|modafinil|mesh-list
19439295|NCT03469089|Analgesics|analgesics|mesh-ancestor
19439296|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
19439297|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439298|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725415|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725416|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
19725417|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
19725418|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
19725419|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725420|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725421|NCT04654676|Vildagliptin|vildagliptin|mesh-list
19725422|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19725423|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725424|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19725425|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
19725426|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725427|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866559|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20534232|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534233|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20534234|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534235|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534236|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20534237|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20534238|NCT01812954|Analgesics|analgesics|mesh-ancestor
20534239|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
19439299|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19439300|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19439301|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
19439302|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
19439303|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439304|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19439305|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19439306|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439307|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439308|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19439309|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19439310|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19439311|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19439312|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
19439313|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439314|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19439315|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439316|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439317|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19439318|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
19439319|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439320|NCT03468946|Caffeine|caffeine|mesh-list
19439321|NCT03468946|Citric Acid|citric acid|mesh-list
19439322|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19439323|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439324|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19439325|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439326|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439327|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19439328|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19439329|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
19439330|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439331|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
19439332|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19439333|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
19439334|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
19439335|NCT03468907|Tenofovir|tenofovir|mesh-list
19439336|NCT03468907|Telbivudine|telbivudine|mesh-list
19439337|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
19439338|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439339|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19439340|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19439341|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439342|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439343|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19439344|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19439345|NCT03468829|Gontivimab|gontivimab|mesh-list
19439346|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
19439347|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439348|NCT03468790|Fluticasone|fluticasone|mesh-list
19439349|NCT03468790|Xhance|xhance|mesh-list
19439350|NCT03468790|Budesonide|budesonide|mesh-list
19439351|NCT03468790|Albuterol|albuterol|mesh-list
19439352|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
19439353|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19439354|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19439355|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19439356|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19439357|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19439358|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
19439359|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439360|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725428|NCT04654819|Anesthetics|anesthetics|mesh-list
20253613|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20253614|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253615|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
20253616|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253617|NCT00460681|Thymopentin|thymopentin|mesh-list
20253618|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20253619|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
20253620|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253621|NCT00460707|Ketoconazole|ketoconazole|mesh-list
20253622|NCT00460707|Casopitant|casopitant|mesh-list
20253623|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
20253624|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253625|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20253626|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20253627|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253628|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253629|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20253630|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
20253631|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253632|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253633|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20253634|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
20253635|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
20253636|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534240|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534241|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
20534242|NCT01812967|Caseins|caseins|mesh-list
20534243|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
20534244|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
20534245|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534246|NCT01813162|Tenofovir|tenofovir|mesh-list
20534247|NCT01813162|Metronidazole|metronidazole|mesh-list
20534248|NCT01813162|Terconazole|terconazole|mesh-list
20534249|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
20534250|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
20534251|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534252|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20534253|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20534254|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534255|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534256|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20253637|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20253638|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20253639|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253640|NCT00460733|Vitamin D|vitamin d|mesh-list
19725429|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253641|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
20253642|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
20253643|NCT00460733|Calcium|calcium|mesh-list
20253644|NCT00460733|Vitamins|vitamins|mesh-ancestor
20253645|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
20253646|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253647|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20253648|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20253649|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20253650|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20253651|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553529|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
20553530|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553531|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553532|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20553533|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
20553534|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20553535|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
20553536|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553537|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553538|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20553539|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
20553540|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
20553541|NCT01929824|Protective Agents|protective agents|mesh-ancestor
20553542|NCT01929941|Gemcitabine|gemcitabine|mesh-list
20553543|NCT01929941|Paclitaxel|paclitaxel|mesh-list
20553544|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19439361|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19439362|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439363|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
19439364|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19439365|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
19439366|NCT03468790|Hormones|hormones|mesh-ancestor
19439367|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439368|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19439369|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19439370|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19439371|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439372|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439373|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439374|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
19725430|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725431|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19725432|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
19725433|NCT04654741|Ganirelix|ganirelix|mesh-list
19725434|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19725435|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19725436|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19725437|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
19725438|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19725439|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725440|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19725441|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19725442|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19725443|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725444|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725445|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
19725446|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725447|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
19725448|NCT04654195|Doxorubicin|doxorubicin|mesh-list
19725449|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725450|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
19725451|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725452|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725453|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19725454|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
19725455|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725456|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725457|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19725458|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19725459|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19725460|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19725461|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725462|NCT04654208|Palbociclib|palbociclib|mesh-list
19725463|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725464|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19725465|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725466|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725467|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
19725468|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19725469|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19725470|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725471|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
19725472|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
19725473|NCT04654026|Aspirin|aspirin|mesh-list
19725474|NCT04654026|Clopidogrel|clopidogrel|mesh-list
19725475|NCT04654026|Ticagrelor|ticagrelor|mesh-list
19725476|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19725477|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725478|NCT04654026|Analgesics|analgesics|mesh-ancestor
19725479|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
19725480|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735031|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
19439375|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19439376|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
19439377|NCT03468777|Lansoprazole|lansoprazole|mesh-list
19439378|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
19439379|NCT03468777|Ranitidine|ranitidine|mesh-list
19439380|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19439381|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19439382|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19439383|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19439384|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439385|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439386|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19439387|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
19439388|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
19439389|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439390|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451925|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451926|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19451927|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
19451928|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
19451929|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451930|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451931|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19451932|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
19451933|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451934|NCT03417895|Apatinib|apatinib|mesh-list
19451935|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451936|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19451937|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451938|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451939|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
19451940|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19451941|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451942|NCT03417700|Vitamin D|vitamin d|mesh-list
19451943|NCT03417700|Vitamins|vitamins|mesh-ancestor
19451944|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
19451945|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451946|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19451947|NCT03417687|Xenon|xenon|mesh-list
19451948|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19451949|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
19451950|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
19451951|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451952|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451953|NCT03417648|Vitamin E|vitamin e|mesh-list
19451954|NCT03417648|Vitamins|vitamins|mesh-ancestor
19451955|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
19451956|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451957|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
19439391|NCT05391360|Entecavir|entecavir|mesh-list
19439392|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
20253652|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
20253653|NCT00460759|Rifapentine|rifapentine|mesh-list
20253654|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19735032|NCT04544163|Fentanyl|fentanyl|mesh-list
20534257|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20534258|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534259|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20534260|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20534261|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20534262|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534263|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
20534264|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
20534265|NCT01813201|Testosterone|testosterone|mesh-list
20534266|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
20534267|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
20534268|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20534269|NCT01813201|Androgens|androgens|mesh-ancestor
20534270|NCT01813201|Hormones|hormones|mesh-ancestor
20534271|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725481|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725482|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725483|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725484|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19725485|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19725486|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725487|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19725488|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19725489|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725490|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
19725491|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19439393|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439394|NCT05391230|Permethrin|permethrin|mesh-list
19439395|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439396|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439397|NCT05391126|Irinotecan|irinotecan|mesh-list
19439398|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19439399|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19439400|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439401|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439402|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439403|NCT05391074|Vitamins|vitamins|mesh-list
19439404|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
19439405|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439406|NCT05391061|Abrocitinib|abrocitinib|mesh-list
19439407|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19439408|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439409|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439410|NCT05390905|Tramadol|tramadol|mesh-list
19439411|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19439412|NCT05390905|Narcotics|narcotics|mesh-ancestor
19439413|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439414|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439415|NCT05390905|Analgesics|analgesics|mesh-ancestor
19439416|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
19439417|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439418|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19439419|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439420|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19439421|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439422|NCT05390749|Rituximab|rituximab|mesh-list
19439423|NCT05390749|Methotrexate|methotrexate|mesh-list
19439424|NCT05390749|Pomalidomide|pomalidomide|mesh-list
19439425|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439426|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439427|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
19439428|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439429|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19439430|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19439431|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
19439432|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19439433|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439434|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
19439435|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725492|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19725493|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19725494|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
19725495|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725496|NCT04653831|Pirfenidone|pirfenidone|mesh-list
19439436|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19439437|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534272|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534273|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20534274|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534275|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
20534276|NCT01813240|Minocycline|minocycline|mesh-list
20534277|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534278|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534279|NCT01813253|Irinotecan|irinotecan|mesh-list
20534280|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
20534281|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20534282|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20534283|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534284|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439438|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19439439|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19439440|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19439441|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19439442|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19439443|NCT05390749|Growth Substances|growth substances|mesh-ancestor
19439444|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
19439445|NCT05390736|Vitamin D|vitamin d|mesh-list
19725497|NCT04653831|Analgesics|analgesics|mesh-ancestor
19725498|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
19725499|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725500|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725501|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19725502|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725503|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19439446|NCT05390736|Vitamins|vitamins|mesh-ancestor
19439447|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
19439448|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439449|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19439450|NCT05390710|Paclitaxel|paclitaxel|mesh-list
19439451|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19439452|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19439453|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439454|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
19439455|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
19439456|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
19439457|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439461|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19439462|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
19439463|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439464|NCT05390476|Capecitabine|capecitabine|mesh-list
19439465|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439466|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
19439467|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439468|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439469|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
19439470|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19439471|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19439472|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439473|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439474|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439475|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439476|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
19439477|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
19439478|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439479|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
19439480|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19439481|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439482|NCT05390307|Liraglutide|liraglutide|mesh-list
19439483|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
19439484|NCT05390307|Glucagon|glucagon|mesh-list
19439485|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19439486|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19439487|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439488|NCT05390307|Incretins|incretins|mesh-ancestor
19725504|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19866560|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19725505|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725506|NCT04653506|Acetaminophen|acetaminophen|mesh-list
19725507|NCT04653506|Ibuprofen|ibuprofen|mesh-list
19725508|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19725509|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20253655|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253656|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20253657|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20253658|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253659|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253660|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253661|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20253662|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
20253663|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
20253664|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
20253665|NCT00460785|Narcotics|narcotics|mesh-ancestor
20253666|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20253667|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253668|NCT00460785|Analgesics|analgesics|mesh-ancestor
20253669|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
19439489|NCT05390307|Hormones|hormones|mesh-ancestor
19439490|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439491|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19439492|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439493|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19439494|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
19439495|NCT05390255|Omalizumab|omalizumab|mesh-list
19439496|NCT05390255|Hormones|hormones|mesh-list
19439497|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439498|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439499|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19439500|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
20253670|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253671|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
20253672|NCT00460837|Cathartics|cathartics|mesh-ancestor
20253673|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20253674|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20253675|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
20253676|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253677|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
20253678|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20253679|NCT00460876|Topotecan|topotecan|mesh-list
20253680|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20534285|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534286|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534287|NCT01813318|Acamprosate|acamprosate|mesh-list
20534288|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20534289|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
20534290|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534291|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534292|NCT01813461|Isavuconazole|isavuconazole|mesh-list
20534293|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
20534294|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534295|NCT01813487|Entecavir|entecavir|mesh-list
20534296|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
20534297|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534298|NCT01813513|Simeprevir|simeprevir|mesh-list
20534299|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
20534300|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534301|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
20534302|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534303|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534304|NCT01813552|Ritonavir|ritonavir|mesh-list
20534305|NCT01813552|Omeprazole|omeprazole|mesh-list
20534306|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20534307|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20253681|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20534308|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
20534309|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534310|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534311|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19866561|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
19866562|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
20534312|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20534313|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
20534314|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534315|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20534316|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20534317|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20534318|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534319|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20534320|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
20534321|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20534322|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
20534323|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534324|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
20534325|NCT01813565|Protective Agents|protective agents|mesh-ancestor
20534326|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20534327|NCT01813591|Hormones|hormones|mesh-ancestor
20534328|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534329|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534330|NCT01813604|Vaccines|vaccines|mesh-list
20534331|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
19866563|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253682|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534332|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534333|NCT01813617|Prednisone|prednisone|mesh-list
20534334|NCT01813617|Methotrexate|methotrexate|mesh-list
20534335|NCT01813617|Azathioprine|azathioprine|mesh-list
20534336|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20534337|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534338|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
20534339|NCT01813617|Hormones|hormones|mesh-ancestor
20534340|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534341|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534342|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20534343|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534344|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19439501|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19439502|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19439503|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439504|NCT05390203|Testosterone|testosterone|mesh-list
19439505|NCT05390203|Androgens|androgens|mesh-ancestor
19439506|NCT05390203|Hormones|hormones|mesh-ancestor
19439507|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439508|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439509|NCT05390073|Hormones|hormones|mesh-list
19439510|NCT05390073|Mitogens|mitogens|mesh-list
19439511|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439512|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439513|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
19439514|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439515|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19439516|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19439517|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439518|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
19439519|NCT05389995|Methamphetamine|methamphetamine|mesh-list
19439520|NCT05389995|Citric Acid|citric acid|mesh-list
19439521|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
19439522|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
19439523|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19439524|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
19439525|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
19439526|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439527|NCT05389995|Diuretics|diuretics|mesh-ancestor
19439528|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
19439529|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439530|NCT05389995|Expectorants|expectorants|mesh-ancestor
19439531|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439532|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19439533|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
19439534|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
19439535|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439536|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
19439537|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439538|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439539|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19439540|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19439541|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439542|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19439543|NCT05389943|Vitamin D|vitamin d|mesh-list
19439544|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
19439545|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
19439546|NCT05389943|Vitamins|vitamins|mesh-list
19439547|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
19439548|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439549|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19439550|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19439551|NCT05389930|Ethanol|ethanol|mesh-list
20534345|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
20534346|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20253683|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534347|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534348|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
20534349|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534350|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
20534351|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534352|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20534353|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
20534354|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534355|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20534356|NCT01813643|Risperidone|risperidone|mesh-list
20534357|NCT01813643|Aripiprazole|aripiprazole|mesh-list
20253684|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253685|NCT00460915|Amlodipine|amlodipine|mesh-list
20253686|NCT00460915|Lacidipine|lacidipine|mesh-list
20253687|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20253688|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20253689|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534358|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20534359|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
19439552|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19439553|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439554|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439555|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439556|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
19439557|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19439558|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439559|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439560|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19439561|NCT05389852|Analgesics|analgesics|mesh-ancestor
19439562|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
19439563|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439564|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19439565|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19439566|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19439567|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439568|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439569|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439570|NCT05389813|Pregabalin|pregabalin|mesh-list
19439571|NCT05389813|Oxycodone|oxycodone|mesh-list
19439572|NCT05389813|Analgesics|analgesics|mesh-ancestor
19439573|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
19439574|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439575|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439576|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
19439577|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19439578|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439579|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439580|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19439581|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19439582|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19439583|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439584|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19439585|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19439586|NCT05389813|Narcotics|narcotics|mesh-ancestor
19439587|NCT05389722|Itraconazole|itraconazole|mesh-list
19439588|NCT05389722|Rifampin|rifampin|mesh-list
19439589|NCT05389722|Digoxin|digoxin|mesh-list
19439590|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19439591|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19439592|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19439593|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
19439594|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439595|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19439596|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19439597|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439598|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
19439599|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439600|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19439601|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19439602|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19439603|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
19439604|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439605|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439606|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19439607|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19439608|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
19439609|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19439610|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
19439611|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19439612|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19439613|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19725510|NCT04653506|Analgesics|analgesics|mesh-ancestor
19725511|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
19725512|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725513|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725514|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725515|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725516|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19725517|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253690|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253691|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20253692|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253693|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
20253694|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
20253695|NCT00460928|Antibodies|antibodies|mesh-list
20253696|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
20253697|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20253698|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20253699|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
20253700|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253701|NCT00460954|Levodopa|levodopa|mesh-list
20253702|NCT00460954|Carbidopa|carbidopa|mesh-list
20253703|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20253704|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20253705|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20253706|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
20253707|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253708|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253709|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253710|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19439614|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19439615|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19439616|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19439617|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19439618|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19439619|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19439620|NCT05389722|Protective Agents|protective agents|mesh-ancestor
19439628|NCT05389514|Gemcitabine|gemcitabine|mesh-list
19439629|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
19439630|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
19439631|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19439632|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
19439633|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439634|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19439635|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19439636|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
19439637|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439638|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439639|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19439640|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439641|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
19439642|NCT05389514|Antiviral Agents|antiviral agents|mesh-ancestor
19439643|NCT05389514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439644|NCT05389514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439645|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439646|NCT05389462|Gemcitabine|gemcitabine|mesh-list
19439647|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439648|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
19439649|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439650|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439651|NCT05389462|Antiviral Agents|antiviral agents|mesh-ancestor
19439652|NCT05389462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439653|NCT05389462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439654|NCT05389462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19439655|NCT05389462|Immunologic Factors|immunologic factors|mesh-ancestor
19439656|NCT05389462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866564|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866565|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969956|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969957|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19969958|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19969959|NCT01778010|Cocaine|cocaine|mesh-list
19969960|NCT01778010|Modafinil|modafinil|mesh-list
19969961|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19969962|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969963|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19969964|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19969965|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19969966|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969967|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
19969968|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
19969969|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19969970|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
19969971|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969972|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19969973|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20534360|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534361|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534362|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534363|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20534364|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20534365|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534366|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20534367|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20534368|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
20534369|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
20534370|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
20534371|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20534372|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20534373|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19725518|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725519|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
19725520|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
19725521|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19725522|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19725523|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725524|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
19725525|NCT04653623|Coagulants|coagulants|mesh-ancestor
19725526|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
19725527|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19725528|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725529|NCT04653792|Pregabalin|pregabalin|mesh-list
19725530|NCT04653792|Analgesics|analgesics|mesh-ancestor
19725531|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
20253711|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253712|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20253713|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
20253714|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
20253715|NCT00461084|Clarithromycin|clarithromycin|mesh-list
20253716|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20253717|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253718|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20253719|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253720|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253721|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20253722|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20253723|NCT00461149|Octreotide|octreotide|mesh-list
20253724|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20253725|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20253726|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253727|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20253728|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
20253729|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
19725532|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725533|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725534|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
19725535|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19725536|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534374|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20534375|NCT01813656|Aripiprazole|aripiprazole|mesh-list
20534376|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
20534377|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20534378|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20534379|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20534380|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534381|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534382|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
19439691|NCT05389176|Esmolol|esmolol|mesh-list
19439692|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19439693|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19439694|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19439695|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19439696|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439697|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439698|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439699|NCT05389150|Pregabalin|pregabalin|mesh-list
19439700|NCT05389150|Tramadol|tramadol|mesh-list
19439701|NCT05389150|Analgesics|analgesics|mesh-ancestor
19439702|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
19439703|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439704|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439705|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
19439706|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19439707|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19439708|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439709|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19439710|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19439711|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19439712|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439713|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19439714|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19439715|NCT05389150|Narcotics|narcotics|mesh-ancestor
19439716|NCT05382806|Flumazenil|flumazenil|mesh-list
19439717|NCT05382806|Antidotes|antidotes|mesh-ancestor
19439718|NCT05382806|Protective Agents|protective agents|mesh-ancestor
19439719|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439720|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
19439721|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
19439722|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439723|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439724|NCT05379790|Irinotecan|irinotecan|mesh-list
19439725|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19439726|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19439727|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439728|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439729|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439730|NCT05378945|Varenicline|varenicline|mesh-list
19439731|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19439732|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19439733|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
19439734|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439735|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439736|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439737|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19439738|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439739|NCT05374512|Paclitaxel|paclitaxel|mesh-list
19439740|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19439741|NCT05374512|Carboplatin|carboplatin|mesh-list
19439742|NCT05374512|Capecitabine|capecitabine|mesh-list
19735033|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
19735034|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
19735035|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735036|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735037|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
19735038|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735039|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19735040|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19735041|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19735042|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735043|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253730|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253731|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20253732|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20253733|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253734|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20253735|NCT00461344|Docetaxel|docetaxel|mesh-list
20253736|NCT00461344|Doxorubicin|doxorubicin|mesh-list
20253737|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253738|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
20253739|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
20253740|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
20253741|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253742|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20253743|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20253744|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20253745|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253746|NCT00461396|Interferons|interferons|mesh-list
20253747|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
20253748|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253749|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
20253750|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253751|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19439743|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19439744|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253752|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
20253753|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253754|NCT00461422|Ganirelix|ganirelix|mesh-list
20253755|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
20253756|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253757|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253758|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
20253759|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20253760|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
19439745|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
19439746|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
19439747|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
19439748|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439749|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19439750|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
19866566|NCT00823901|Clindamycin|clindamycin|mesh-list
19866567|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
19866568|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
19866569|NCT00823901|Tretinoin|tretinoin|mesh-list
19866570|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19866571|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866572|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19866573|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866574|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439765|NCT05357989|Phenserine|phenserine|mesh-list
19439766|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19439767|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439768|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439769|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
19439770|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439771|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866575|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866576|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
19866577|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
19866578|NCT00823966|Delavirdine|delavirdine|mesh-list
19866579|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19866580|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19866581|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866582|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866583|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
19866584|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866585|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19866586|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19866587|NCT00823979|Etravirine|etravirine|mesh-list
19866588|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19866589|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19866590|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866591|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866592|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
19866593|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866594|NCT00824044|Citalopram|citalopram|mesh-list
19866595|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19866596|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19866597|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19866598|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866599|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866600|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
19866601|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866602|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19866603|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
19866604|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19866605|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
19866606|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
19866607|NCT00824070|Besifloxacin|besifloxacin|mesh-list
19866608|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19866609|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19866610|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534383|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
19439810|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19439811|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439812|NCT05345691|Denosumab|denosumab|mesh-list
19439813|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19439814|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439815|NCT05345171|Prednisolone|prednisolone|mesh-list
19439816|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19439817|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
19439818|NCT05345171|Hormones|hormones|mesh-ancestor
19439819|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439820|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439821|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19439822|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439823|NCT05342636|Paclitaxel|paclitaxel|mesh-list
19439824|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
19439825|NCT05342636|Irinotecan|irinotecan|mesh-list
19439826|NCT05342636|Lenvatinib|lenvatinib|mesh-list
19439827|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
20534384|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534385|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534386|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20534387|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20534388|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
20534389|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20534390|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20253761|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20253762|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20253763|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253764|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253765|NCT00461565|Urological Agents|urological agents|mesh-ancestor
19725537|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725538|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19725539|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20253766|NCT00461578|Artesunate|artesunate|mesh-list
20253767|NCT00461578|Dapsone|dapsone|mesh-list
20253768|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
20253769|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
20253770|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20253771|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20253772|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253773|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253774|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
20253775|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
20253776|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19725540|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20253777|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
20253778|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20253779|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253780|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253781|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
20253782|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20253783|NCT00461617|Mitiglinide|mitiglinide|mesh-list
20253784|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20253785|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253786|NCT00461643|Metformin|metformin|mesh-list
20253787|NCT00461643|Citric Acid|citric acid|mesh-list
20253788|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
20253789|NCT00461643|Clomiphene|clomiphene|mesh-list
20253790|NCT00461643|Enclomiphene|enclomiphene|mesh-list
20253791|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
20253792|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20253793|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253794|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
20253795|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20253796|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
20253797|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
20253798|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253799|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20253800|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
20253801|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253802|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20253803|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
20253804|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20253805|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20253806|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20253807|NCT00461695|Vaccines|vaccines|mesh-list
20253808|NCT00461695|Immunologic Factors|immunologic factors|mesh-ancestor
20253809|NCT00461695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725541|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725542|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19725543|NCT04653779|Metformin|metformin|mesh-list
19725544|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19725545|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725546|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
19725547|NCT04653493|Fludarabine|fludarabine|mesh-list
19725548|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19725549|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
19725550|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725551|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725552|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19725553|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
19725554|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725555|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725556|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19439828|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19439829|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439830|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
19439831|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
19439832|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
19439833|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439834|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439835|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19439836|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19439837|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439838|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
19439839|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439840|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19439841|NCT05335252|Dronabinol|dronabinol|mesh-list
19439842|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
19439843|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439844|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19439845|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19439846|NCT05335252|Analgesics|analgesics|mesh-ancestor
19439847|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
19439848|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439849|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19439850|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19439851|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19439852|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439853|NCT05335252|Hormones|hormones|mesh-ancestor
19439854|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866611|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19866612|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19866613|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866614|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866615|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866616|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19866617|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
19866618|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19866619|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866620|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19866621|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19866622|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19866623|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19866624|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19866625|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19866626|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19866627|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19866628|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19866629|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866630|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866631|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866632|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
19866633|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19866634|NCT00824382|Olodaterol|olodaterol|mesh-list
19439881|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
19439882|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19439883|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19439884|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725557|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
19725558|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19439885|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
19439886|NCT05323149|Coagulants|coagulants|mesh-ancestor
19439887|NCT05322954|Psilocybin|psilocybin|mesh-list
20253810|NCT00461747|Thalidomide|thalidomide|mesh-list
20253811|NCT00461747|Dexamethasone|dexamethasone|mesh-list
20253812|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
20253813|NCT00461747|Bortezomib|bortezomib|mesh-list
20253814|NCT00461747|BB 1101|bb 1101|mesh-list
20253815|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20253816|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
20253817|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
20253818|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253819|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534391|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20253820|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534392|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20534393|NCT01813773|Aflibercept|aflibercept|mesh-list
20534394|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20534395|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20534396|NCT01813773|Growth Substances|growth substances|mesh-ancestor
20534397|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439888|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
19439889|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439890|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19439891|NCT05319730|Paclitaxel|paclitaxel|mesh-list
19439892|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
19439893|NCT05319730|Irinotecan|irinotecan|mesh-list
19439894|NCT05319730|Lenvatinib|lenvatinib|mesh-list
19439895|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
19439896|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19439897|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439898|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
19439899|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
19439900|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
19439901|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439902|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439903|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19439904|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19439905|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439906|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
19439907|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439908|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19439909|NCT05311436|Iron|iron|mesh-list
19439910|NCT05311436|Folic Acid|folic acid|mesh-list
20534398|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
20534399|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534400|NCT01813812|Rebamipide|rebamipide|mesh-list
20534401|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20534402|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19439911|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439912|NCT05311436|Trace Elements|trace elements|mesh-ancestor
19439913|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
19439914|NCT05311436|Hematinics|hematinics|mesh-ancestor
19439915|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
19439916|NCT05311436|Vitamins|vitamins|mesh-ancestor
19439917|NCT05307770|Melatonin|melatonin|mesh-list
19439918|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
19439919|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439920|NCT05307770|Protective Agents|protective agents|mesh-ancestor
19439921|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439922|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439923|NCT05303805|Sevoflurane|sevoflurane|mesh-list
19439924|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19439925|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19439926|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
19439927|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
19439928|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19439929|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439930|NCT05295212|Atezolizumab|atezolizumab|mesh-list
19439931|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866635|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19866636|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
19866637|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866638|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866639|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19866640|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
19866641|NCT00824408|Pemetrexed|pemetrexed|mesh-list
19866642|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866643|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866644|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866645|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19866646|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19866647|NCT00824460|Iron|iron|mesh-list
19866648|NCT00824460|Sevelamer|sevelamer|mesh-list
19866649|NCT00824460|Trace Elements|trace elements|mesh-ancestor
19866650|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
19866651|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534403|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
20534404|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534405|NCT01813812|Protective Agents|protective agents|mesh-ancestor
20534406|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534407|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866652|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
19866653|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
19969974|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20534408|NCT01813955|Papaverine|papaverine|mesh-list
20253821|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
20253822|NCT00461747|Hormones|hormones|mesh-ancestor
20253823|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253824|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20253825|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253826|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
20253827|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253828|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253829|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735044|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20534409|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20534410|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534411|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534412|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
20534413|NCT01813955|Urological Agents|urological agents|mesh-ancestor
20534414|NCT01813981|Caffeine|caffeine|mesh-list
20534415|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20534416|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725559|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19725560|NCT04653415|Prednisolone|prednisolone|mesh-list
19725561|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
19725562|NCT04653415|Gabapentin|gabapentin|mesh-list
19725563|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20534417|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20534418|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725564|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
19725565|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725566|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
19725567|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
19725568|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725569|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725570|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725571|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
19725572|NCT04653415|Hormones|hormones|mesh-ancestor
19725573|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253830|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
20253831|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
20253832|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20253833|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253834|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20253835|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20253836|NCT00461747|Growth Substances|growth substances|mesh-ancestor
20253837|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
20253838|NCT00461799|Orlistat|orlistat|mesh-list
20253839|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253840|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253841|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20253842|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20253843|NCT00461825|Cyclosporine|cyclosporine|mesh-list
20253844|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
20253845|NCT00461825|Azathioprine|azathioprine|mesh-list
20253846|NCT00461825|Cyclosporins|cyclosporins|mesh-list
20253847|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253848|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253849|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253850|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
20253851|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253852|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
20253853|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253854|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
20253855|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20253856|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20253857|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20253858|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253859|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20253860|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
20253861|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20253862|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
20253863|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253864|NCT00461890|Naltrexone|naltrexone|mesh-list
20253865|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20253866|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20253867|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253868|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
20253869|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253870|NCT00461903|Perindopril|perindopril|mesh-list
20253871|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20253872|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
20253873|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253874|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253875|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20253876|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20253877|NCT00461916|Buserelin|buserelin|mesh-list
20253878|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
20253879|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20253880|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
20553545|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253881|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553546|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
20553547|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
20553548|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
20553549|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553550|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20553551|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
20553552|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
20553553|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866654|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866655|NCT00824473|Azelastine|azelastine|mesh-list
19866656|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19866657|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
19866658|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866659|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866660|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19866661|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
19439970|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
20253882|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253883|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20253884|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20253885|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725574|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19866662|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19866663|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866664|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553554|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439971|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19439972|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439973|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
19439974|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19439975|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
19439976|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439977|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439978|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19439979|NCT05282706|Peppermint oil|peppermint oil|mesh-list
19439980|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
19439981|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
19439982|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19439983|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439984|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19439985|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
19439986|NCT05272683|Itraconazole|itraconazole|mesh-list
19439987|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
19439988|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19439989|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19439990|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19439991|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19439992|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19439993|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19439994|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
19439995|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19439996|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19439997|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19439998|NCT05255900|Metyrapone|metyrapone|mesh-list
19439999|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
19440000|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440001|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440002|NCT05252754|Indomethacin|indomethacin|mesh-list
19440003|NCT05252754|Tacrolimus|tacrolimus|mesh-list
19440004|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19440005|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
19440006|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440007|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19440008|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440009|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440010|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19440011|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19440012|NCT05252754|Analgesics|analgesics|mesh-ancestor
19440013|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
19440014|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440015|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19440016|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19440017|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
19440018|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
19440019|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19440020|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19866665|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20553555|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553556|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
20553557|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553558|NCT01930019|Thiopental|thiopental|mesh-list
20553559|NCT01930019|Etomidate|etomidate|mesh-list
20553560|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
20553561|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553562|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553563|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20253886|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20253887|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
20286668|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20286669|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
20286670|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286671|NCT02949934|Tolcapone|tolcapone|mesh-list
20286672|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20286673|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20286674|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20286675|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253888|NCT00461968|Simvastatin|simvastatin|mesh-list
20253889|NCT00461968|Ezetimibe|ezetimibe|mesh-list
20253890|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20253891|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20253892|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
20253893|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253894|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20253895|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20253896|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440030|NCT05236231|Tadalafil|tadalafil|mesh-list
19440031|NCT05236231|Macitentan|macitentan|mesh-list
19440032|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
19440033|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19440034|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19440035|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440036|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725575|NCT04653415|Protective Agents|protective agents|mesh-ancestor
19725576|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725577|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725578|NCT04653415|Analgesics|analgesics|mesh-ancestor
19725579|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
19725580|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
19725581|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19725582|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19725583|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725584|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19725585|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19725586|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19725587|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725588|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725589|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
19735045|NCT04544163|Narcotics|narcotics|mesh-ancestor
19735046|NCT04544163|Analgesics|analgesics|mesh-ancestor
19735047|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19735048|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19735049|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
19735050|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
19735051|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19735052|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19735053|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
19735054|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19735055|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
19735056|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19735057|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735058|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
19735059|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
19735060|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735061|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
20534419|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534420|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20534421|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20534422|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
20534423|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534424|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20534425|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20534426|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20534427|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
20534428|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534429|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534430|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20534431|NCT01814059|Sirolimus|sirolimus|mesh-list
20534432|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534433|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534434|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20534435|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534436|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
20534437|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534438|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
20534439|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534440|NCT01814085|Citalopram|citalopram|mesh-list
20534441|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20534442|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20534443|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534444|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534445|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534446|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
20534447|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534448|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20534449|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
20534450|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19725590|NCT04653246|Dexamethasone|dexamethasone|mesh-list
20253897|NCT00462111|Indomethacin|indomethacin|mesh-list
20253898|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20253899|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725591|NCT04653246|Lenalidomide|lenalidomide|mesh-list
19725592|NCT04653246|Bortezomib|bortezomib|mesh-list
19725593|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725594|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
19725595|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
19725596|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725597|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725598|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725599|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
19725600|NCT04653246|Hormones|hormones|mesh-ancestor
19725601|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866666|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19866667|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19866668|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
19866669|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
20253900|NCT00462111|Analgesics|analgesics|mesh-ancestor
20253901|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
19725602|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19440037|NCT05236231|Urological Agents|urological agents|mesh-ancestor
19440038|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19440039|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19440040|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19440041|NCT05234697|Remifentanil|remifentanil|mesh-list
19440042|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19440043|NCT05234697|Narcotics|narcotics|mesh-ancestor
19440044|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19440045|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440046|NCT05234697|Analgesics|analgesics|mesh-ancestor
19440047|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
19440048|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440049|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
19440050|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440051|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440052|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
19440053|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440054|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866670|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866671|NCT00824538|Sunitinib|sunitinib|mesh-list
19866672|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866673|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866674|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866675|NCT00824538|Growth Substances|growth substances|mesh-ancestor
19866676|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866677|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866678|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866679|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866680|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866681|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
19866682|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19866683|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19866684|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866685|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
19866686|NCT00824564|Coagulants|coagulants|mesh-ancestor
19866687|NCT00824616|Insulin|insulin|mesh-list
19866688|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19866689|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440075|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
19440076|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440077|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866690|NCT00824733|Trastuzumab|trastuzumab|mesh-list
19866691|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866692|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866693|NCT00824746|Gefitinib|gefitinib|mesh-list
19866694|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866695|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866696|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440085|NCT05182931|Trametinib|trametinib|mesh-list
19440086|NCT05182931|Dabrafenib|dabrafenib|mesh-list
19440087|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440088|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19440089|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725603|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725604|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
19725605|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19725606|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19725607|NCT04653246|Growth Substances|growth substances|mesh-ancestor
19725608|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
20534451|NCT01814098|Citalopram|citalopram|mesh-list
20534452|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20534453|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20534454|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534455|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534456|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534457|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
20534458|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534459|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20534460|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
20534461|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20534462|NCT01814163|Paclitaxel|paclitaxel|mesh-list
20534463|NCT01814163|Bevacizumab|bevacizumab|mesh-list
20534464|NCT01814163|Carboplatin|carboplatin|mesh-list
20534465|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20534466|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534467|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
20534468|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
20534469|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
20534470|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534471|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534472|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20534473|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20534474|NCT01814163|Growth Substances|growth substances|mesh-ancestor
20534475|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534476|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
20534477|NCT01814189|Promethazine|promethazine|mesh-list
20534478|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
20534479|NCT01814189|Sumatriptan|sumatriptan|mesh-list
20534480|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20534481|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20534482|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20534483|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
20534484|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534485|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253902|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253903|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253904|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20253905|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20253906|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
20253907|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
20253908|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19866697|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866698|NCT00824824|Timolol|timolol|mesh-list
19866699|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19866700|NCT00824824|Dorzolamide|dorzolamide|mesh-list
19866701|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19866702|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19866703|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
19866704|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866705|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866706|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440090|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440091|NCT05177055|Methamphetamine|methamphetamine|mesh-list
19440092|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19440093|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440094|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
19440095|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
19440096|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440097|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
19440098|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19440099|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440100|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
19440101|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19440102|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19440103|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19440104|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19866707|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19866708|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19866709|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19440108|NCT05167825|Macitentan|macitentan|mesh-list
19440109|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19440110|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19440111|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440112|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19440113|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19440114|NCT05165290|Latanoprost|latanoprost|mesh-list
19440115|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19866710|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19866711|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19866712|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19866713|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866714|NCT00824850|Vaccines|vaccines|mesh-list
19866715|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19866716|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
19440130|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19440131|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
19440132|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19440133|NCT05133674|Tamoxifen|tamoxifen|mesh-list
19440134|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19440135|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
19440136|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19440137|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440138|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19440139|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725609|NCT04653337|Norepinephrine|norepinephrine|mesh-list
19725610|NCT04653337|Serotonin|serotonin|mesh-list
19725611|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
19725612|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19725613|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19725614|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725615|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725616|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534486|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534487|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
20534488|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
20534489|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20534490|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
20534491|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
20534492|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20534493|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20534494|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19440140|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20534495|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534496|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
20534497|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
20534498|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
20534499|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534500|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
20534501|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
20534502|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534503|NCT01814319|Probenecid|probenecid|mesh-list
20534504|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
20534505|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
20534506|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534507|NCT01814319|Renal Agents|renal agents|mesh-ancestor
20534508|NCT01814410|Ethanol|ethanol|mesh-list
20534509|NCT01814410|Nicotine|nicotine|mesh-list
20534510|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20534511|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
20534512|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440141|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20534513|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534514|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19440142|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19440143|NCT05131867|Nimodipine|nimodipine|mesh-list
19440144|NCT05131867|Milrinone|milrinone|mesh-list
19440145|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19440146|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19440147|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
19440148|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19440149|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19440150|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440151|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440152|NCT05131867|Protective Agents|protective agents|mesh-ancestor
19440153|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440154|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19440155|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19440156|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19440157|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19440158|NCT05130086|Islatravir|islatravir|mesh-list
19440159|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
19440160|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19440161|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440162|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440163|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19440164|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19440165|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19440166|NCT05128773|Tamoxifen|tamoxifen|mesh-list
19440167|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19440168|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
19440169|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19440170|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440171|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19440172|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440173|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19440174|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19440175|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19440176|NCT05112965|Atezolizumab|atezolizumab|mesh-list
19440177|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440178|NCT05111626|Nivolumab|nivolumab|mesh-list
19440179|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
19440180|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440181|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440182|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19440183|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866717|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866718|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
19866719|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866720|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19440188|NCT05085782|Propranolol|propranolol|mesh-list
19440189|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19440190|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19440191|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
19440192|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725617|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725618|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
19725619|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
19725620|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725621|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19725622|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19725623|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
19725624|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19866721|NCT00825162|Vaccines|vaccines|mesh-list
19866722|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
19866723|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866724|NCT00825266|Pioglitazone|pioglitazone|mesh-list
19866725|NCT00825266|Bosentan|bosentan|mesh-list
19866726|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20534515|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20534516|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
20534517|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534518|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534519|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20534520|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534521|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534522|NCT01814423|Chloroquine|chloroquine|mesh-list
20534523|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20534524|NCT01814423|Amebicides|amebicides|mesh-ancestor
20534525|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20534526|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20534527|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534528|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
20534529|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19440193|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440194|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440195|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19440196|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19440197|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
19866727|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866728|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19866729|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19866730|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725625|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19725626|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
19725627|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
19866731|NCT00825305|Vaccines|vaccines|mesh-list
20253909|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20253910|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253911|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440206|NCT05057819|Empagliflozin|empagliflozin|mesh-list
19440207|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19440208|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440209|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19440210|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440211|NCT05050942|Octreotide|octreotide|mesh-list
19440212|NCT05050942|Lanreotide|lanreotide|mesh-list
19440213|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19440214|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19440215|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725628|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19725629|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19725630|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725631|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725632|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866732|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
19866733|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866734|NCT00825344|Etanercept|etanercept|mesh-list
19866735|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20253912|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
20253913|NCT00462189|Immunotoxins|immunotoxins|mesh-list
20253914|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
20253915|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253916|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253917|NCT00462215|Vaccines|vaccines|mesh-list
19440228|NCT05038228|Vitamin K|vitamin k|mesh-list
20253918|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
19440229|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
19440230|NCT05038228|Apixaban|apixaban|mesh-list
19440231|NCT05038228|Dabigatran|dabigatran|mesh-list
19440232|NCT05038228|Vitamins|vitamins|mesh-ancestor
19440233|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
19440234|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440235|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19440236|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
19440237|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19440238|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
19440239|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440240|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440241|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
19440242|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19440243|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19440244|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
19440245|NCT05038228|Coagulants|coagulants|mesh-ancestor
19866736|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19866737|NCT00825344|Analgesics|analgesics|mesh-ancestor
19866738|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
20253919|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253920|NCT00462358|Filanesib|filanesib|mesh-list
20253921|NCT00462358|Lenograstim|lenograstim|mesh-list
20253922|NCT00462358|Sargramostim|sargramostim|mesh-list
19725633|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725634|NCT04652739|Prednisolone|prednisolone|mesh-list
19725635|NCT04652739|Lycopene|lycopene|mesh-list
19725636|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725637|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
19725638|NCT04652739|Hormones|hormones|mesh-ancestor
19725639|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725640|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725641|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725642|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725643|NCT04652739|Protective Agents|protective agents|mesh-ancestor
19725644|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
19725645|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725646|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19725647|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19725648|NCT04652661|Midazolam|midazolam|mesh-list
19725649|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
19725650|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19725651|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725652|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725653|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725654|NCT04652661|Analgesics|analgesics|mesh-ancestor
19725655|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
19725656|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725657|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19725658|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19725659|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19725660|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
19866739|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866740|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866741|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19866742|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19866743|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19866744|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866745|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
19866746|NCT00825370|Hydromorphone|hydromorphone|mesh-list
19866747|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19866748|NCT00825370|Narcotics|narcotics|mesh-ancestor
19866749|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19866750|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866751|NCT00825370|Analgesics|analgesics|mesh-ancestor
19866752|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
19866753|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866754|NCT00825500|Loxapine|loxapine|mesh-list
19866755|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19866756|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19866757|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19866758|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866759|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19866760|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19866761|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
19866762|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866763|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866764|NCT00825565|Allantoin|allantoin|mesh-list
19866765|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
19866766|NCT00825630|Esomeprazole|esomeprazole|mesh-list
19866767|NCT00825630|Pantoprazole|pantoprazole|mesh-list
19866768|NCT00825630|Lansoprazole|lansoprazole|mesh-list
19440299|NCT05012787|Vaccines|vaccines|mesh-list
19440300|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
19440301|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
19440302|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440303|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19725661|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725662|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725663|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19725664|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19725665|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19725666|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19725667|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19725668|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
19725669|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
19725670|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
19725671|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
19725672|NCT04652765|Bicalutamide|bicalutamide|mesh-list
19725673|NCT04652765|Camostat|camostat|mesh-list
19725674|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
19725675|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
19725676|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725677|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725678|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725679|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
19725680|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725681|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725682|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19725683|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19725684|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
19725685|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19725686|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725687|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725688|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725689|NCT04652427|Analgesics|analgesics|mesh-ancestor
19725690|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
19725691|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725692|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19866769|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
19725693|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19725694|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19866770|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19866771|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19866772|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19440307|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
19440308|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
19440309|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440310|NCT05009901|Protective Agents|protective agents|mesh-ancestor
20253923|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20253924|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
20253925|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440311|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440312|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
19725695|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
19866773|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253926|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
20253927|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
20253928|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253929|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253930|NCT00462371|Insulin|insulin|mesh-list
19440313|NCT05009901|Vitamins|vitamins|mesh-ancestor
19725696|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725697|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725698|NCT04652284|Amoxicillin|amoxicillin|mesh-list
19725699|NCT04652284|Clarithromycin|clarithromycin|mesh-list
19725700|NCT04652284|Rifabutin|rifabutin|mesh-list
19725701|NCT04652284|Tinidazole|tinidazole|mesh-list
19725702|NCT04652284|Esomeprazole|esomeprazole|mesh-list
19725703|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19725704|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725705|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19725706|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725707|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19725708|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725709|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725710|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19725711|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19725712|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19725713|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19725714|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
19725715|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
19725716|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19866774|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866775|NCT00825734|Sorafenib|sorafenib|mesh-list
19866776|NCT00825734|Epothilones|epothilones|mesh-list
19866777|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866778|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866779|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866780|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866781|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19866782|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
19866783|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
20253931|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20253932|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253933|NCT00462397|Paclitaxel|paclitaxel|mesh-list
20253934|NCT00462397|Carboplatin|carboplatin|mesh-list
20253935|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20253936|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20253937|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
20253938|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
20253939|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
20253940|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253941|NCT00462475|Hormones|hormones|mesh-list
19440314|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
19725717|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19725718|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19725719|NCT04652323|Calcium|calcium|mesh-list
19725720|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20253942|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253943|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253944|NCT00462540|Bromides|bromides|mesh-list
20253945|NCT00462540|Albuterol|albuterol|mesh-list
20253946|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
20253947|NCT00462540|Ipratropium|ipratropium|mesh-list
20253948|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20253949|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
20253950|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253951|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253952|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20253953|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
20253954|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20253955|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20253956|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20253957|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725721|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253958|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253959|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866784|NCT00825786|Ropivacaine|ropivacaine|mesh-list
19866785|NCT00825786|Mepivacaine|mepivacaine|mesh-list
19866786|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
19866787|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
19866788|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19866789|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866790|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
19866791|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866792|NCT00825812|Atropine|atropine|mesh-list
19866793|NCT00825812|Neostigmine|neostigmine|mesh-list
19866794|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19440326|NCT04997850|Lenvatinib|lenvatinib|mesh-list
19440327|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440328|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19440329|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440330|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440331|NCT04991324|Vitamin D|vitamin d|mesh-list
19440332|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
19440333|NCT04991324|Vitamins|vitamins|mesh-ancestor
19440334|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
19440335|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440336|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19440337|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19866795|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19440338|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
19440339|NCT04976634|Lenvatinib|lenvatinib|mesh-list
20253960|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
19440340|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440341|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440342|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19440343|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440344|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440345|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
19440346|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
19440347|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866796|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19866797|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
19866798|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866799|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866800|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19866801|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
19866802|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
19866803|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
19866804|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19866805|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19866806|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
19866807|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20253961|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
20253962|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20253963|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20253964|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
20253965|NCT00462553|Gemcitabine|gemcitabine|mesh-list
20253966|NCT00462553|Sunitinib|sunitinib|mesh-list
20253967|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20253968|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
19866808|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866809|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19866810|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866811|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19866812|NCT00825825|Citalopram|citalopram|mesh-list
19866813|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19866814|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20253969|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440368|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
19440369|NCT04956640|Cetuximab|cetuximab|mesh-list
19440370|NCT04956640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19440371|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440372|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440373|NCT04956640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19440374|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440375|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440376|NCT04936399|Nivolumab|nivolumab|mesh-list
19440377|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440378|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440379|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19452929|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20253970|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452930|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
19866815|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534530|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20534531|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20534532|NCT01814423|Analgesics|analgesics|mesh-ancestor
20534533|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
20534534|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534535|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534536|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534537|NCT01814423|Filaricides|filaricides|mesh-ancestor
20534538|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
20534539|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
20534540|NCT01814449|Letrozole|letrozole|mesh-list
20534541|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534542|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20534543|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20534544|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534545|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534546|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20534547|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
19440380|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440381|NCT04936230|Atezolizumab|atezolizumab|mesh-list
19440382|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19440383|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440384|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
19440385|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866816|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866817|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866818|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
19866819|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866820|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19866821|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
19866822|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19866823|NCT00826111|Eszopiclone|eszopiclone|mesh-list
19866824|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19866825|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19866826|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866827|NCT00826228|Teriparatide|teriparatide|mesh-list
19866828|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19866829|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866830|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19866831|NCT00826241|Temozolomide|temozolomide|mesh-list
20253971|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
20253972|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20253973|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20253974|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20253975|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
20253976|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253977|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20253978|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20253979|NCT00462553|Growth Substances|growth substances|mesh-ancestor
20253980|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
20253981|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19725722|NCT04651959|Favipiravir|favipiravir|mesh-list
20253982|NCT00462592|Budesonide|budesonide|mesh-list
20253983|NCT00462592|Montelukast|montelukast|mesh-list
20253984|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20253985|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20253986|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
20253987|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20253988|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20253989|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20253990|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
20253991|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
20253992|NCT00462592|Hormones|hormones|mesh-ancestor
19725723|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
20253993|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20253994|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20253995|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
20253996|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20253997|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20253998|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20253999|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20254000|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
20254001|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19725724|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725725|NCT04652011|Analgesics|analgesics|mesh-list
19725726|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
19725727|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725728|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725729|NCT04652193|Anesthetics|anesthetics|mesh-list
19725730|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725731|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725732|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
19725733|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19725734|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725735|NCT04652115|Defibrotide|defibrotide|mesh-list
19725736|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19725737|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19725738|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725739|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19725740|NCT04651842|Insulin|insulin|mesh-list
19725741|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19725742|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725743|NCT04652089|Simvastatin|simvastatin|mesh-list
19725744|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19725745|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19725746|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
19725747|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725748|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19866832|NCT00826241|Lapatinib|lapatinib|mesh-list
19866833|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866834|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
19866835|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866836|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866837|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866838|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866839|NCT00826267|Trastuzumab|trastuzumab|mesh-list
19866840|NCT00826267|Lapatinib|lapatinib|mesh-list
19866841|NCT00826267|Afatinib|afatinib|mesh-list
19866842|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866843|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866844|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866845|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866846|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866847|NCT00826280|Caffeine|caffeine|mesh-list
19866848|NCT00826280|Regadenoson|regadenoson|mesh-list
19866849|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19866850|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866851|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19866852|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866853|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866854|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19866855|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19440428|NCT04929028|Fluorouracil|fluorouracil|mesh-list
19440429|NCT04929028|Capecitabine|capecitabine|mesh-list
19440430|NCT04929028|Nivolumab|nivolumab|mesh-list
19440431|NCT04929028|Mitomycins|mitomycins|mesh-list
19440432|NCT04929028|Mitomycin|mitomycin|mesh-list
19440433|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
19440434|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440435|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19440436|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440437|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19440438|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
19440439|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440440|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440441|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19440442|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19440443|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
19440444|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19440445|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866856|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
19866857|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866858|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19866859|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19866860|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
20254002|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20254003|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20254004|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254005|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254006|NCT00462631|Paclitaxel|paclitaxel|mesh-list
20254007|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20254008|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20254009|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254010|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
20254011|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
20254012|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
19440452|NCT04928183|Nitroprusside|nitroprusside|mesh-list
19440453|NCT04928183|Phenylephrine|phenylephrine|mesh-list
19440454|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
19440455|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
19440456|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19440457|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
19440458|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
19440459|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440460|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440461|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
19866861|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19866862|NCT00826449|Dasatinib|dasatinib|mesh-list
19866863|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725749|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19725750|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725751|NCT04651595|Morphine|morphine|mesh-list
19725752|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19725753|NCT04651595|Narcotics|narcotics|mesh-ancestor
19725754|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725755|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725756|NCT04651595|Analgesics|analgesics|mesh-ancestor
19866864|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866865|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866866|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866867|NCT00826514|Tanezumab|tanezumab|mesh-list
19866868|NCT00826514|Analgesics|analgesics|mesh-ancestor
19866869|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
19866870|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866871|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866872|NCT00826540|Bevacizumab|bevacizumab|mesh-list
20254013|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254014|NCT00462696|Docetaxel|docetaxel|mesh-list
20254015|NCT00462696|Epirubicin|epirubicin|mesh-list
20254016|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725757|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
19725758|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725759|NCT04651556|Acetaminophen|acetaminophen|mesh-list
19725760|NCT04651556|Ketorolac|ketorolac|mesh-list
19725761|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
19725762|NCT04651556|Bupivacaine|bupivacaine|mesh-list
19725763|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
20254017|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
19725764|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
19440462|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19440463|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
20254018|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
20254019|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
20254020|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254021|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20254022|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20254023|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254024|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254025|NCT00462787|Dexamethasone|dexamethasone|mesh-list
20254026|NCT00462787|Topotecan|topotecan|mesh-list
20254027|NCT00462787|Vinorelbine|vinorelbine|mesh-list
19440464|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
19452931|NCT03408054|Oxytocin|oxytocin|mesh-list
20254028|NCT00462787|Thiotepa|thiotepa|mesh-list
20254029|NCT00462787|Clofarabine|clofarabine|mesh-list
20254030|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20254031|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
20254032|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
20254033|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254034|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254035|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254036|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
20254037|NCT00462787|Hormones|hormones|mesh-ancestor
20254038|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254039|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20254040|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254041|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
20254042|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20254043|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254044|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254045|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440465|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19440466|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19440467|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19440468|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
20534548|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534549|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553564|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19866873|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20553565|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
20553566|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
19440469|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19440470|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440471|NCT04928183|Protective Agents|protective agents|mesh-ancestor
19440472|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
19440473|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
19440474|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19440475|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
19440476|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19440477|NCT04923659|Nimodipine|nimodipine|mesh-list
19440478|NCT04923659|Carbamazepine|carbamazepine|mesh-list
19440479|NCT04923659|Lorazepam|lorazepam|mesh-list
19440480|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
19440481|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
19440482|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
19440483|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19440484|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19440485|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19440486|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440487|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440488|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
19440489|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
19440490|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
20553567|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
20553568|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
20553569|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553570|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440491|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440492|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19440493|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20254046|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19725765|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254047|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
20254048|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
20534550|NCT01814475|Vidarabine|vidarabine|mesh-list
20534551|NCT01814475|Fludarabine|fludarabine|mesh-list
20534552|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
20534553|NCT01814475|Busulfan|busulfan|mesh-list
20534554|NCT01814475|Thiotepa|thiotepa|mesh-list
20534555|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534556|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534557|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
20534558|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534559|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254049|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
20254050|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20534560|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
20254051|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
20254052|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20254053|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866874|NCT00826540|Sorafenib|sorafenib|mesh-list
19866875|NCT00826540|Antibodies|antibodies|mesh-list
19866876|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
19866877|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19866878|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866879|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866880|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866881|NCT00826540|Growth Substances|growth substances|mesh-ancestor
19440494|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19440495|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19440496|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19440497|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19440498|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
19440499|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
19440500|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
19440501|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19440502|NCT04923659|Analgesics|analgesics|mesh-ancestor
19440503|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
19440504|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19440505|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19440506|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19440507|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19440508|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19440509|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20254054|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254055|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
20254056|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20254057|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20254058|NCT00462813|Protective Agents|protective agents|mesh-ancestor
20534561|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534562|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
20534563|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534564|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
20534565|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20534566|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19440510|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19440511|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
19440512|NCT04916392|Bupivacaine|bupivacaine|mesh-list
19440513|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19440514|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
19440515|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725766|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725767|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
19725768|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725769|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725770|NCT04651556|Analgesics|analgesics|mesh-ancestor
19725771|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
19725772|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19725773|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725774|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725775|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19725776|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725777|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725778|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19725779|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
19725780|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19866882|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534567|NCT01814501|Leucovorin|leucovorin|mesh-list
20534568|NCT01814501|Fluorouracil|fluorouracil|mesh-list
19866883|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866884|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
19866885|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19866886|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534569|NCT01814501|Irinotecan|irinotecan|mesh-list
20534570|NCT01814501|Panitumumab|panitumumab|mesh-list
20534571|NCT01814501|Calcium|calcium|mesh-list
19866887|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866888|NCT00826618|Ranibizumab|ranibizumab|mesh-list
19866889|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866890|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866891|NCT00826618|Growth Substances|growth substances|mesh-ancestor
20254059|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254060|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254061|NCT00462852|Gemcitabine|gemcitabine|mesh-list
20254062|NCT00462852|Dalteparin|dalteparin|mesh-list
20254063|NCT00462852|Tinzaparin|tinzaparin|mesh-list
20254064|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20254065|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254066|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
19866892|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254067|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440516|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440517|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
19440518|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19866893|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866894|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866895|NCT00826748|Beclomethasone|beclomethasone|mesh-list
19866896|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19866897|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
19866898|NCT00826748|Hormones|hormones|mesh-ancestor
19866899|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19866900|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866901|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19866902|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
19866903|NCT00826800|Bevacizumab|bevacizumab|mesh-list
19866904|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866905|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866906|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19866907|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19866908|NCT00826800|Growth Substances|growth substances|mesh-ancestor
19866909|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866910|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19866911|NCT00826943|Cetirizine|cetirizine|mesh-list
19866912|NCT00826943|Levocetirizine|levocetirizine|mesh-list
19866913|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19866914|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19866915|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19866916|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
19866917|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
19866918|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866919|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866920|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866921|NCT00827073|Lidocaine|lidocaine|mesh-list
19866922|NCT00827073|Tetracaine|tetracaine|mesh-list
19866923|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
19866924|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
19866925|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19866926|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866927|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
20254068|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254069|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
20254070|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254071|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254072|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254073|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
20254074|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254075|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
20254076|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20534572|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
20534573|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19866928|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534574|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866929|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19866930|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19866931|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19866932|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19866933|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866934|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
19866935|NCT00827099|Fludarabine|fludarabine|mesh-list
19866936|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
19866937|NCT00827099|Melphalan|melphalan|mesh-list
19866938|NCT00827099|Tacrolimus|tacrolimus|mesh-list
19866939|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19866940|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19866941|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19866942|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
19866943|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866944|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19440544|NCT04895436|Venetoclax|venetoclax|mesh-list
19440545|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
19440546|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440547|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440548|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19440549|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
19440550|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19440551|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19440552|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19440553|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
19440554|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19440555|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440556|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19440557|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19440558|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19440559|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19440560|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440561|NCT04891419|Lidocaine|lidocaine|mesh-list
19440562|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
19440563|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
19440564|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19440565|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440566|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
19440567|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440568|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19440569|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19440570|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19866945|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
20254077|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20534575|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
20534576|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534577|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534578|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534579|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534580|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
20534581|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20534582|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20534583|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534584|NCT01814501|Antidotes|antidotes|mesh-ancestor
20534585|NCT01814501|Protective Agents|protective agents|mesh-ancestor
20534586|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
20534587|NCT01814501|Vitamins|vitamins|mesh-ancestor
20254078|NCT00462878|Vancomycin|vancomycin|mesh-list
20254079|NCT00462878|Meropenem|meropenem|mesh-list
20254080|NCT00462878|Teicoplanin|teicoplanin|mesh-list
20254081|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20254082|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254083|NCT00462956|Lapatinib|lapatinib|mesh-list
20254084|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254085|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20254086|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254087|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254088|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20254089|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254090|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20254091|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254092|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254093|NCT00463008|Methotrexate|methotrexate|mesh-list
20254094|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20254095|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
19440571|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19440572|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866946|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866947|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19866948|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866949|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19866950|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19866951|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
19866952|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19866953|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866954|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19866955|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
19866956|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19866957|NCT00827112|Ritonavir|ritonavir|mesh-list
19866958|NCT00827112|Lopinavir|lopinavir|mesh-list
19866959|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19866960|NCT00827112|Darunavir|darunavir|mesh-list
19866961|NCT00827112|Tenofovir|tenofovir|mesh-list
19440589|NCT04868838|Daratumumab|daratumumab|mesh-list
19440590|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440591|NCT04868565|Caffeine|caffeine|mesh-list
19725781|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19725782|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19725783|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
19725784|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19725785|NCT04651049|Propranolol|propranolol|mesh-list
19725786|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19725787|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19725788|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725789|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725790|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440592|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
19440593|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440594|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19440595|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440596|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19440597|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440598|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19440599|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19440600|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
19440601|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19866962|NCT00827112|Emtricitabine|emtricitabine|mesh-list
20534588|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
20534589|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534590|NCT01814514|Timolol|timolol|mesh-list
20534591|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20534592|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20534593|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
20534594|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534595|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534596|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534597|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20534598|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19440602|NCT04862650|Paclitaxel|paclitaxel|mesh-list
19866963|NCT00827112|Maraviroc|maraviroc|mesh-list
19866964|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20534599|NCT01814618|Budesonide|budesonide|mesh-list
20534600|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534601|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20534602|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
20534603|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534604|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534605|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20534606|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
20534607|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
20534608|NCT01814618|Hormones|hormones|mesh-ancestor
20534609|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534610|NCT01814657|Lidocaine|lidocaine|mesh-list
19440603|NCT04862650|Carboplatin|carboplatin|mesh-list
19440604|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19440605|NCT04862650|Cemiplimab|cemiplimab|mesh-list
19440606|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19440607|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440608|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
19440609|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
19440610|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
19440611|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440612|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19866965|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19866966|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19866967|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866968|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866969|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19866970|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19866971|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
19866972|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866973|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19866974|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19866975|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19866976|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19866977|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19866978|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19866979|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19866980|NCT00827242|Tadalafil|tadalafil|mesh-list
19866981|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
19866982|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19866983|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19866984|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866985|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866986|NCT00827242|Urological Agents|urological agents|mesh-ancestor
19866987|NCT00827255|Cyclosporine|cyclosporine|mesh-list
19866988|NCT00827255|Cyclosporins|cyclosporins|mesh-list
19866989|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19866990|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19866991|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19866992|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
19866993|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19866994|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
19866995|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19866996|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
19866997|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19866998|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19866999|NCT00827359|Everolimus|everolimus|mesh-list
19440648|NCT04838301|Pregnanolone|pregnanolone|mesh-list
19440649|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
19440650|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19440651|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440652|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
19440653|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440654|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867000|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867001|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867002|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
19867003|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440661|NCT04807972|Folfirinox|folfirinox|mesh-list
19440662|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440663|NCT04805541|Tropicamide|tropicamide|mesh-list
19440664|NCT04805541|Mydriatics|mydriatics|mesh-list
19440665|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
19440666|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19440667|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440668|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19440669|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19440670|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
19440671|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19440672|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534611|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
20534612|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
20534613|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534614|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534615|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
20534616|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534617|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20534618|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20534619|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20534620|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534621|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867004|NCT00827541|Tigecycline|tigecycline|mesh-list
19867005|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19867006|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867007|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19867008|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867009|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867010|NCT00827606|Atorvastatin|atorvastatin|mesh-list
19867011|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19867012|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19867013|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
19867014|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440684|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
19440685|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19440686|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
19440687|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19440688|NCT04793646|Expectorants|expectorants|mesh-ancestor
19440689|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
19440690|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19440691|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
19440692|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725791|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725792|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19725793|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19725794|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
19725795|NCT04651205|Thiamine|thiamine|mesh-list
19725796|NCT04651205|Vitamins|vitamins|mesh-ancestor
19725797|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
19725798|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725799|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
19735062|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735063|NCT04543968|Protective Agents|protective agents|mesh-ancestor
19735064|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254096|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20254097|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254098|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254099|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
20254100|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254101|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254102|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
20254103|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534622|NCT01814683|Primaquine|primaquine|mesh-list
20534623|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
20534624|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20534625|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20534626|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534627|NCT01814709|Itraconazole|itraconazole|mesh-list
20534628|NCT01814709|Rifampin|rifampin|mesh-list
20534629|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
20534630|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254104|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20254105|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254106|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
20254107|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20254108|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19440693|NCT04793646|Protective Agents|protective agents|mesh-ancestor
19440694|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440695|NCT04793646|Antidotes|antidotes|mesh-ancestor
19440696|NCT04752631|Tenecteplase|tenecteplase|mesh-list
19440697|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19440698|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19440699|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440700|NCT04742777|Sirolimus|sirolimus|mesh-list
19440701|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19440702|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19440703|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19440704|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440705|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
19440706|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19440707|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
19440708|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867015|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19867016|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19867017|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867018|NCT00827775|Carvedilol|carvedilol|mesh-list
20254109|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20254110|NCT00463021|Vitamins|vitamins|mesh-ancestor
20254111|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
20254112|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254113|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20254114|NCT00463073|Bevacizumab|bevacizumab|mesh-list
20254115|NCT00463073|Cetuximab|cetuximab|mesh-list
20254116|NCT00463073|Irinotecan|irinotecan|mesh-list
20254117|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254118|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553571|NCT01930201|Anesthetics|anesthetics|mesh-list
20553572|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553573|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553574|NCT01930292|Paclitaxel|paclitaxel|mesh-list
20553575|NCT01930292|Carboplatin|carboplatin|mesh-list
20553576|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20553577|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553578|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
20553579|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
20553580|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
20553581|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553582|NCT01930318|Parecoxib|parecoxib|mesh-list
20553583|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20553584|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20553585|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534631|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20534632|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20534633|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534634|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534635|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20534636|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
20534637|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534638|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534639|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20254119|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20254120|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20534640|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19867019|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19867020|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19867021|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
19725800|NCT04650893|Dexamethasone|dexamethasone|mesh-list
19725801|NCT04650893|Ketorolac|ketorolac|mesh-list
19725802|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725803|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
19725804|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
19725805|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725806|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725807|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725808|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
19725809|NCT04650893|Hormones|hormones|mesh-ancestor
19725810|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725811|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725812|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725813|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19725814|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19725815|NCT04650893|Analgesics|analgesics|mesh-ancestor
19725816|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
19725817|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19725818|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19867022|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867023|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867024|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867025|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19867026|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
20534641|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
20534642|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534643|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
20534644|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20534645|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20534646|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20534647|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20534648|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20534649|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20534650|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19725819|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254121|NCT00463073|Growth Substances|growth substances|mesh-ancestor
20254122|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254123|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
20254124|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20254125|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254126|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254127|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254128|NCT00463086|Isoniazid|isoniazid|mesh-list
20254129|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
19867027|NCT00827775|Protective Agents|protective agents|mesh-ancestor
19867028|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20254130|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534651|NCT01814826|Azacitidine|azacitidine|mesh-list
20534652|NCT01814826|Pevonedistat|pevonedistat|mesh-list
20534653|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534654|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
20534655|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534656|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254131|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867029|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867030|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19725820|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725821|NCT04650841|Naloxone|naloxone|mesh-list
19725822|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19725823|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725824|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
19725825|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725826|NCT04650880|Vitamin D|vitamin d|mesh-list
19725827|NCT04650880|Vitamins|vitamins|mesh-ancestor
19725828|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
19725829|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725830|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19867031|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
19867032|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19867033|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19867034|NCT00827918|Olanzapine|olanzapine|mesh-list
19867035|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
19867036|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
19452932|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
19725831|NCT04650828|Tenofovir|tenofovir|mesh-list
19867037|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867038|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867039|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867040|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19867041|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20534657|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534658|NCT01814865|Prednisone|prednisone|mesh-list
20534659|NCT01814865|Anastrozole|anastrozole|mesh-list
20534660|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
20534661|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20534662|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20254132|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20254133|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20254134|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
20254135|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254136|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20254137|NCT00463112|Sibutramine|sibutramine|mesh-list
20254138|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
20254139|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20254140|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
20254141|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20254142|NCT00463203|Bevacizumab|bevacizumab|mesh-list
20254143|NCT00463203|Irinotecan|irinotecan|mesh-list
20254144|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254145|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254146|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20254147|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20254148|NCT00463203|Growth Substances|growth substances|mesh-ancestor
20254149|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254150|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
20254151|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20254152|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19725832|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
19725833|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725834|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19725835|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19725836|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725837|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725838|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19725839|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19725840|NCT04650555|Genistein|genistein|mesh-list
19725841|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19725842|NCT04650555|Protective Agents|protective agents|mesh-ancestor
19725843|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725844|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725845|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20254153|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254154|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254155|NCT00463268|Vitamin D|vitamin d|mesh-list
20254156|NCT00463268|Alendronate|alendronate|mesh-list
20254157|NCT00463268|Calcium|calcium|mesh-list
20254158|NCT00463268|Vitamins|vitamins|mesh-ancestor
20254159|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
19725846|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725847|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254160|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534663|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
20534664|NCT01814865|Hormones|hormones|mesh-ancestor
20534665|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534666|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534667|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725848|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
19725849|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19725850|NCT04650555|Estrogens|estrogens|mesh-ancestor
19725851|NCT04650555|Hormones|hormones|mesh-ancestor
19725852|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725853|NCT04650542|Paroxetine|paroxetine|mesh-list
19725854|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19725855|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19725856|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19725857|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725858|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725859|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
20254161|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20254162|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19725860|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725861|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19725862|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
19725863|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20254163|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20254164|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20254165|NCT00463359|Imiquimod|imiquimod|mesh-list
20254166|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20254167|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
20254168|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254169|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254170|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
20254171|NCT00463502|Metformin|metformin|mesh-list
20254172|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254173|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254174|NCT00463515|Gemcitabine|gemcitabine|mesh-list
20254175|NCT00463515|Carboplatin|carboplatin|mesh-list
20254176|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254177|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19725864|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19725865|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19867042|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867043|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867044|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19867045|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19867046|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867047|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867048|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867049|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
19867050|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
19867051|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19867052|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19867053|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867054|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
19867055|NCT00827931|Coagulants|coagulants|mesh-ancestor
19867056|NCT00827983|Progesterone|progesterone|mesh-list
19867057|NCT00827983|Progestins|progestins|mesh-ancestor
19867058|NCT00827983|Hormones|hormones|mesh-ancestor
19867059|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254178|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
20254179|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254180|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
20254181|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254182|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254183|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254184|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
20254185|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254186|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
20254187|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20254188|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19725866|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725867|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
19725868|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
19725869|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725870|NCT04649892|Naltrexone|naltrexone|mesh-list
19725871|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19725872|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19725873|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254189|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254190|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254191|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254192|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254193|NCT00463541|Urological Agents|urological agents|mesh-ancestor
20254194|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
20254195|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20254196|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
20254197|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254198|NCT00463671|Expectorants|expectorants|mesh-ancestor
20254199|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
20254200|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20254201|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
20254202|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254203|NCT00463671|Protective Agents|protective agents|mesh-ancestor
20254204|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254205|NCT00463671|Antidotes|antidotes|mesh-ancestor
20254206|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
20254207|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20534668|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534669|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20534670|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534671|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534672|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20534673|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
20534674|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20534675|NCT01814891|Vitamin A|vitamin a|mesh-list
20534676|NCT01814891|Vitamins|vitamins|mesh-ancestor
20534677|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
20534678|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534679|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
20534680|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254208|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
19867060|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867061|NCT00828009|Paclitaxel|paclitaxel|mesh-list
19867062|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
19867063|NCT00828009|Bevacizumab|bevacizumab|mesh-list
19867064|NCT00828009|Carboplatin|carboplatin|mesh-list
19867065|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19867066|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867067|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867068|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
19867069|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867070|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867071|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867072|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
19867073|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867074|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867075|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19867076|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
19867077|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19867078|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19867079|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19867080|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19867081|NCT00828009|Growth Substances|growth substances|mesh-ancestor
19867082|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
19867083|NCT00828061|Prednisone|prednisone|mesh-list
19867084|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867085|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
19867086|NCT00828061|Hormones|hormones|mesh-ancestor
19867087|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867088|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440754|NCT04722146|Lenalidomide|lenalidomide|mesh-list
19440755|NCT04722146|Pomalidomide|pomalidomide|mesh-list
19440756|NCT04722146|Bortezomib|bortezomib|mesh-list
19440757|NCT04722146|Daratumumab|daratumumab|mesh-list
19440758|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
19440759|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440760|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19440761|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19440762|NCT04722146|Growth Substances|growth substances|mesh-ancestor
19440763|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
19440764|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440765|NCT04711109|Denosumab|denosumab|mesh-list
19440766|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19440767|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867089|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19867090|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867091|NCT00828074|Sorafenib|sorafenib|mesh-list
19867092|NCT00828074|Vinorelbine|vinorelbine|mesh-list
19867093|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440773|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
19440774|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440775|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440776|NCT04695080|Cladribine|cladribine|mesh-list
19440777|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440778|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19440779|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
19440780|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440781|NCT04685616|Doxorubicin|doxorubicin|mesh-list
19440782|NCT04685616|Bleomycin|bleomycin|mesh-list
19440783|NCT04685616|Dacarbazine|dacarbazine|mesh-list
19440784|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19440785|NCT04685616|Vinblastine|vinblastine|mesh-list
19440786|NCT04685616|Mitogens|mitogens|mesh-list
19440787|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19440788|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440789|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19440790|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19440791|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254209|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254210|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254211|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
20254212|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254213|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20254214|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20254215|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
20254216|NCT00463736|Analgesics|analgesics|mesh-ancestor
20254217|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
20254218|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254219|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254220|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
20254221|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254222|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20254223|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
20254224|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20254225|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534681|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
20534682|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20534683|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725874|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
19725875|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534684|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
20534685|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
20534686|NCT01815021|Calcium|calcium|mesh-list
20534687|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20534688|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534689|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20534690|NCT01815021|Antacids|antacids|mesh-ancestor
19725876|NCT04649723|Rifampin|rifampin|mesh-list
19725877|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19725878|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
19725879|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19725880|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725881|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
19725882|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19725883|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725884|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725885|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20534691|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534692|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534693|NCT01815047|Vitamin D|vitamin d|mesh-list
20534694|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
20534695|NCT01815047|Vitamins|vitamins|mesh-ancestor
20534696|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
20534697|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534698|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20534699|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20534700|NCT01815073|Vaccines|vaccines|mesh-list
20534701|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
20534702|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534703|NCT01815125|Ondansetron|ondansetron|mesh-list
20534704|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
20534705|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
20534706|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534707|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534708|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534709|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
20534710|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
19725886|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19725887|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20534711|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20534712|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
20534713|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19440792|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440793|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19440794|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19440795|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
19440796|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440797|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19440798|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19440799|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19440800|NCT04677569|Azithromycin|azithromycin|mesh-list
19440801|NCT04677569|Amikacin|amikacin|mesh-list
19440802|NCT04677569|Ethambutol|ethambutol|mesh-list
19440803|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19440804|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19440805|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
19440806|NCT04677543|Azithromycin|azithromycin|mesh-list
19440807|NCT04677543|Amikacin|amikacin|mesh-list
19440808|NCT04677543|Ethambutol|ethambutol|mesh-list
19440809|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19440810|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19440811|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
19440812|NCT04675788|Ibutilide|ibutilide|mesh-list
19440813|NCT04675788|Testosterone|testosterone|mesh-list
19440814|NCT04675788|Progesterone|progesterone|mesh-list
19440815|NCT04675788|Androgens|androgens|mesh-ancestor
19440816|NCT04675788|Hormones|hormones|mesh-ancestor
19440817|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19440818|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440819|NCT04675788|Progestins|progestins|mesh-ancestor
19725888|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19440820|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20254226|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254227|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20254228|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
20254229|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20254230|NCT00463762|Sulbactam|sulbactam|mesh-list
20254231|NCT00463762|Cefoperazone|cefoperazone|mesh-list
20254232|NCT00463762|Sulperazone|sulperazone|mesh-list
20254233|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20254234|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254235|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20254236|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254237|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867094|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20534714|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534715|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20534716|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20534717|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534718|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20534719|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20534720|NCT01815203|Caffeine|caffeine|mesh-list
20534721|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20534722|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534723|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20534724|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534725|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534726|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20534727|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20534728|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
19725889|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19725890|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19725891|NCT04649645|Nicotine|nicotine|mesh-list
19725892|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19725893|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
19725894|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725895|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725896|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19725897|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19725898|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
19725899|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725900|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725901|NCT04649229|Aprepitant|aprepitant|mesh-list
19725902|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19725903|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
19725904|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
19725905|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725906|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725907|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725908|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19725909|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725910|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725911|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19725912|NCT04649697|Clobetasol|clobetasol|mesh-list
19725913|NCT04649697|Rebamipide|rebamipide|mesh-list
19725914|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725915|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
19725916|NCT04649697|Hormones|hormones|mesh-ancestor
19725917|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725918|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725919|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19725920|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725921|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
19725922|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534729|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534730|NCT01815242|Gemcitabine|gemcitabine|mesh-list
20534731|NCT01815242|Paclitaxel|paclitaxel|mesh-list
20534732|NCT01815242|Carboplatin|carboplatin|mesh-list
20534733|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20534734|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534735|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
20534736|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
20254238|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20254239|NCT00463762|Renal Agents|renal agents|mesh-ancestor
20254240|NCT00463775|Topiramate|topiramate|mesh-list
20254241|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
20254242|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19725923|NCT04649697|Protective Agents|protective agents|mesh-ancestor
19725924|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725925|NCT04649502|Metformin|metformin|mesh-list
19725926|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19725927|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725928|NCT04649398|Nimodipine|nimodipine|mesh-list
19725929|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19725930|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19725931|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19725932|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725933|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19725934|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725935|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
19725936|NCT04648891|Lidocaine|lidocaine|mesh-list
19725937|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
19725938|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
19725939|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725940|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725941|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
20254243|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254244|NCT00463827|Atorvastatin|atorvastatin|mesh-list
20254245|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19440826|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19440827|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19440828|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19440829|NCT04642261|Empagliflozin|empagliflozin|mesh-list
19440830|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19440831|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440832|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19440833|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867095|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867096|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867097|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19867098|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867099|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
19867100|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
20254246|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20254247|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
20254248|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254249|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20254250|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20254251|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254252|NCT00463879|Galantamine|galantamine|mesh-list
20534737|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867101|NCT00828113|Varenicline|varenicline|mesh-list
19867102|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19867103|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19867104|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
19867105|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867106|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867107|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867108|NCT00828139|Aflibercept|aflibercept|mesh-list
19867109|NCT00828139|Topotecan|topotecan|mesh-list
19867110|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
19725942|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725943|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19725944|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19725945|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19725946|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19725947|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867111|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19867112|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19867113|NCT00828139|Growth Substances|growth substances|mesh-ancestor
19867114|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867115|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
19867116|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867117|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19867118|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19867119|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440859|NCT04619797|Carboplatin|carboplatin|mesh-list
19440860|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
19440861|NCT04619797|Pemetrexed|pemetrexed|mesh-list
19440862|NCT04619797|Atezolizumab|atezolizumab|mesh-list
19440863|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440864|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440865|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19725948|NCT04648969|Hormones|hormones|mesh-list
19725949|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725950|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735065|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19735066|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20254253|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20534738|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440866|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440867|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20534739|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534740|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
20534741|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
20534742|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19725951|NCT04648813|Bromides|bromides|mesh-list
19725952|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
19725953|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19725954|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
19725955|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725956|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725957|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19725958|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
19725959|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
19725960|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19725961|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
19725962|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254254|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440868|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19440869|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
19440870|NCT04614636|Fludarabine|fludarabine|mesh-list
19440871|NCT04614636|Daratumumab|daratumumab|mesh-list
19440872|NCT04614636|Elotuzumab|elotuzumab|mesh-list
19440873|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19440874|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
19440875|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440876|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19440877|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19440878|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
19440879|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254255|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867120|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867121|NCT00828191|Progesterone|progesterone|mesh-list
19867122|NCT00828191|Progestins|progestins|mesh-ancestor
19867123|NCT00828191|Hormones|hormones|mesh-ancestor
19867124|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867125|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867126|NCT00828204|Interferons|interferons|mesh-list
19867127|NCT00828204|Interferon-beta|interferon-beta|mesh-list
19867128|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
19867129|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254256|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254257|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19725963|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254258|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254259|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19725964|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
19725965|NCT04648358|Dexamethasone|dexamethasone|mesh-list
19725966|NCT04648358|Bupivacaine|bupivacaine|mesh-list
19725967|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19725968|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
19725969|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
19725970|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19725971|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725972|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19725973|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
19725974|NCT04648358|Hormones|hormones|mesh-ancestor
19725975|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19725976|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19725977|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19725978|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
19725979|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
19725980|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19725981|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
19725982|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
19725983|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19725984|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19725985|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
19725986|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
19725987|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867130|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
19867131|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254260|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
19725988|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725989|NCT04648917|Caffeic acid|caffeic acid|mesh-list
19725990|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
19725991|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19725992|NCT04648917|Protective Agents|protective agents|mesh-ancestor
19725993|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254261|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254262|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
19867132|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
19867133|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867134|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19867135|NCT00828295|Palonosetron|palonosetron|mesh-list
19867136|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
19867137|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
19867138|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867139|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867140|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867141|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20254263|NCT00463918|Varenicline|varenicline|mesh-list
20254264|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20254265|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20254266|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254267|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254268|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254269|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254270|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
20254271|NCT00463957|Tadalafil|tadalafil|mesh-list
19725994|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19725995|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
19725996|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19725997|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19725998|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
19725999|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726000|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867142|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19867143|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
20254272|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
20254273|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19867144|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19440880|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440881|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20254274|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20254275|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254276|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254277|NCT00463957|Urological Agents|urological agents|mesh-ancestor
20286676|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286677|NCT02908672|Atezolizumab|atezolizumab|mesh-list
20286678|NCT02908672|Vemurafenib|vemurafenib|mesh-list
20286679|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20286680|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286681|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
20286682|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286683|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20286684|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286685|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286686|NCT02879617|Durvalumab|durvalumab|mesh-list
20286687|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286688|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286689|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20286690|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286691|NCT02713386|Paclitaxel|paclitaxel|mesh-list
20286692|NCT02713386|Carboplatin|carboplatin|mesh-list
20286693|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20286694|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20286695|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286696|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286697|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286698|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286699|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286700|NCT02702180|Molgramostim|molgramostim|mesh-list
20286701|NCT02702180|Sargramostim|sargramostim|mesh-list
20286702|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286703|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
20286704|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286705|NCT02668653|Cytarabine|cytarabine|mesh-list
19440882|NCT04602533|Durvalumab|durvalumab|mesh-list
19440883|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19440884|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867145|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867146|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
19867147|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19867148|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19867149|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440890|NCT04594915|Edoxaban|edoxaban|mesh-list
19440891|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19440892|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
19440893|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19440894|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
19440895|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19440896|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440897|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
19440898|NCT04586062|Plasminogen|plasminogen|mesh-list
19440899|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19440900|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19440901|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440902|NCT04576117|Vinblastine|vinblastine|mesh-list
19440903|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19440904|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440905|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
19440906|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
19440907|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867150|NCT00828347|Vitamins|vitamins|mesh-ancestor
19440908|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286706|NCT02668653|Daunorubicin|daunorubicin|mesh-list
19726001|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19726002|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19726003|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867151|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
19867152|NCT00828412|Desonide|desonide|mesh-list
19867153|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867154|NCT00828464|Clobetasol|clobetasol|mesh-list
19726004|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
19726005|NCT04648332|Bupivacaine|bupivacaine|mesh-list
19726006|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
19726007|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
19726008|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726009|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726010|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
19726011|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726012|NCT04648020|Clonidine|clonidine|mesh-list
19726013|NCT04648020|Analgesics|analgesics|mesh-ancestor
19726014|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
19726015|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726016|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726017|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19867155|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867156|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
19867157|NCT00828464|Hormones|hormones|mesh-ancestor
19867158|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867159|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867160|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19867161|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
19867162|NCT00828542|Desogestrel|desogestrel|mesh-list
19440920|NCT04565990|Selexipag|selexipag|mesh-list
19440921|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19440922|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19440923|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440924|NCT04550520|Glucagon|glucagon|mesh-list
19440925|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19440926|NCT04550520|Hormones|hormones|mesh-ancestor
19440927|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19440928|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867163|NCT00828542|Etonogestrel|etonogestrel|mesh-list
19867164|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19726018|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
19726019|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
19726020|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19726021|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19726022|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19726023|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
19726024|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726025|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726026|NCT04648280|Fostemsavir|fostemsavir|mesh-list
19726027|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19726028|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19726029|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
19726030|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726031|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19726032|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19726033|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726034|NCT04647669|Interferons|interferons|mesh-list
19726035|NCT04647669|Interferon-beta|interferon-beta|mesh-list
19726036|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
19726037|NCT04647669|Remdesivir|remdesivir|mesh-list
19726038|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
19726039|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726040|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
19726041|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867165|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19867166|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19867167|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
19867168|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19867169|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867170|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19867171|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19867172|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19867173|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19867174|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726042|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
19726043|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726044|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19726045|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
19726046|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726047|NCT04647877|Phenytoin|phenytoin|mesh-list
19726048|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
19726049|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19726050|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19726051|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726052|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726053|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19726054|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19726055|NCT04647838|Tepotinib|tepotinib|mesh-list
19726056|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726057|NCT04647773|Pregabalin|pregabalin|mesh-list
19726058|NCT04647773|Analgesics|analgesics|mesh-ancestor
19726059|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
19726060|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726061|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726062|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
19726063|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19726064|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726065|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726066|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19867175|NCT00828542|Progestins|progestins|mesh-ancestor
20254278|NCT00463983|Octreotide|octreotide|mesh-list
20254279|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254280|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20254281|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867176|NCT00828542|Hormones|hormones|mesh-ancestor
19867177|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19440932|NCT04543617|Atezolizumab|atezolizumab|mesh-list
19440933|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19440934|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440935|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
19440936|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19440937|NCT04540211|Paclitaxel|paclitaxel|mesh-list
19440938|NCT04540211|Atezolizumab|atezolizumab|mesh-list
19440939|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19440940|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19440941|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19440942|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
19440943|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
19440944|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
19440945|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19440946|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
19440947|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867178|NCT00828568|Imiquimod|imiquimod|mesh-list
19867179|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19867180|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
19867181|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867182|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867183|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
19867184|NCT00828672|Bevacizumab|bevacizumab|mesh-list
19867185|NCT00828672|Capecitabine|capecitabine|mesh-list
19867186|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
20254282|NCT00464035|Calcium|calcium|mesh-list
20254283|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20254284|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254285|NCT00464165|Rimonabant|rimonabant|mesh-list
20254286|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20254287|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20254288|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20254289|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254290|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254291|NCT00464165|Hormones|hormones|mesh-ancestor
20254292|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254293|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254294|NCT00464191|Citalopram|citalopram|mesh-list
20254295|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20254296|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20254297|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20254298|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534743|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534744|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534745|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
19726067|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19726068|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19726069|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726070|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19726071|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19726072|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19726073|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19726074|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20534746|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534747|NCT01815255|Tenofovir|tenofovir|mesh-list
20534748|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
20534749|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726075|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19726076|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19726077|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19726078|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
19726079|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726080|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726081|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726082|NCT04647695|Interferons|interferons|mesh-list
19726083|NCT04647695|Interferon-beta|interferon-beta|mesh-list
19726084|NCT04647695|Remdesivir|remdesivir|mesh-list
19726085|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
19726086|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726087|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
19726088|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726089|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
19726090|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726091|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
19726092|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726093|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19726094|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
19726095|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726096|NCT04647344|Paclitaxel|paclitaxel|mesh-list
19726097|NCT04647344|Carboplatin|carboplatin|mesh-list
19726098|NCT04647344|Pemetrexed|pemetrexed|mesh-list
19726099|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19726100|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726101|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
19726102|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
19726103|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867187|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534750|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20534751|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20534752|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534753|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534754|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20534755|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19735067|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
19726104|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726105|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726106|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19726107|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19726108|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
19726109|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
19726110|NCT04646876|Analgesics|analgesics|mesh-ancestor
19726111|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
19726112|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726113|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726114|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
19726115|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726116|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19726117|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
19726118|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19726119|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726120|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726121|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19726122|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
19726123|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19867188|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867189|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19867190|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19867191|NCT00828672|Growth Substances|growth substances|mesh-ancestor
19867192|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867193|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
19867194|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19867195|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
19867196|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867197|NCT00828841|Gemcitabine|gemcitabine|mesh-list
19867198|NCT00828841|Paclitaxel|paclitaxel|mesh-list
19867199|NCT00828841|Carboplatin|carboplatin|mesh-list
19867200|NCT00828841|Cetuximab|cetuximab|mesh-list
19867201|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19867202|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867203|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867204|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
19867205|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867206|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867207|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19867208|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
19867209|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
19867210|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867211|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867212|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867213|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
19867214|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867215|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969975|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19969976|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
19969977|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969978|NCT01778049|Empagliflozin|empagliflozin|mesh-list
19969979|NCT01778049|Linagliptin|linagliptin|mesh-list
19969980|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19969981|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969982|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969983|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969984|NCT01778049|Incretins|incretins|mesh-ancestor
19969985|NCT01778049|Hormones|hormones|mesh-ancestor
19969986|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969987|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19969988|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
19969989|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969990|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
19969991|NCT01778465|Salicylates|salicylates|mesh-list
19969992|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19969993|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969994|NCT01778465|Analgesics|analgesics|mesh-ancestor
19969995|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
19969996|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969997|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726124|NCT04647110|Crizotinib|crizotinib|mesh-list
19969998|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969999|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726125|NCT04647110|Ceritinib|ceritinib|mesh-list
19726126|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726127|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19726128|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726129|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726130|NCT04646824|Pemetrexed|pemetrexed|mesh-list
19867216|NCT00828984|Laxatives|laxatives|mesh-list
19867217|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19867218|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867219|NCT00829010|Vaccines|vaccines|mesh-list
19867220|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19867221|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
19867222|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867223|NCT00829049|Adapalene|adapalene|mesh-list
19867224|NCT00829049|Tazarotene|tazarotene|mesh-list
19867225|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20254299|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254300|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
20254301|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254302|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20254303|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
20254304|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20254305|NCT00464217|Idarubicin|idarubicin|mesh-list
20254306|NCT00464217|Molgramostim|molgramostim|mesh-list
20254307|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20254308|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254309|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20254310|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254311|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254312|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726131|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726132|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726133|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726134|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19726135|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19726136|NCT04646707|Lidocaine|lidocaine|mesh-list
19726137|NCT04646707|Bupivacaine|bupivacaine|mesh-list
19726138|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
19726139|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
19726140|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726141|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726142|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
19726143|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254313|NCT00464256|Rimonabant|rimonabant|mesh-list
20254314|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20254315|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
19726144|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19726145|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19726146|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19726147|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726148|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726149|NCT04646759|Capecitabine|capecitabine|mesh-list
19726150|NCT04646759|Fulvestrant|fulvestrant|mesh-list
19726151|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19726152|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
19726153|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726154|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726155|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19726156|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19726157|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19726158|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
19726159|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726160|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735068|NCT04543916|Irinotecan|irinotecan|mesh-list
19735069|NCT04543916|Venetoclax|venetoclax|mesh-list
19735070|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19735071|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19735072|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735073|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735074|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735075|NCT04543890|Etoposide|etoposide|mesh-list
19735076|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735077|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19735078|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19735079|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19735080|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735081|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735082|NCT04543565|Tenofovir|tenofovir|mesh-list
19735083|NCT04543565|Pradefovir|pradefovir|mesh-list
19735084|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
19735085|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735086|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19735087|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19735088|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735089|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735090|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19735091|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19735092|NCT04543370|Deflazacort|deflazacort|mesh-list
19735093|NCT04543370|Midazolam|midazolam|mesh-list
19735094|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19735095|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19735096|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867226|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19867227|NCT00829049|Analgesics|analgesics|mesh-ancestor
19726161|NCT04646694|Ketamine|ketamine|mesh-list
19726162|NCT04646694|Analgesics|analgesics|mesh-ancestor
19726163|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
19726164|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726165|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726166|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19726167|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19867228|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
19867229|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867230|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441015|NCT04527991|Paclitaxel|paclitaxel|mesh-list
19441016|NCT04527991|Docetaxel|docetaxel|mesh-list
19441017|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19441018|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441019|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19441020|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19441021|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19441022|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441023|NCT04524910|Aflibercept|aflibercept|mesh-list
19441024|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19441025|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19441026|NCT04524910|Growth Substances|growth substances|mesh-ancestor
19441027|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441028|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
19441029|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441030|NCT04514484|Nivolumab|nivolumab|mesh-list
19441031|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19441032|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441033|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19441034|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441035|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
19441036|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19441037|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
19441038|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19441039|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
19441040|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441041|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441042|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
19726168|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
19726169|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
19726170|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726171|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19726172|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19726173|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726174|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726175|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
19726176|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19726177|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726178|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726179|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19726180|NCT04646317|Analgesics|analgesics|mesh-ancestor
19726181|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
19441043|NCT04502589|Disulfiram|disulfiram|mesh-list
19726182|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726183|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20254316|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20254317|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254318|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254319|NCT00464256|Hormones|hormones|mesh-ancestor
20254320|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254321|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254322|NCT00464295|Capecitabine|capecitabine|mesh-list
20254323|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254324|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
20254325|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254326|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254327|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19867231|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867232|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867233|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
19867234|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
19867235|NCT00829166|Capecitabine|capecitabine|mesh-list
19867236|NCT00829166|Trastuzumab|trastuzumab|mesh-list
19867237|NCT00829166|Lapatinib|lapatinib|mesh-list
19726184|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19726185|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19726186|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
19726187|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726188|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726189|NCT04646161|Misoprostol|misoprostol|mesh-list
19726190|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19726191|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
19726192|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19726193|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726194|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19726195|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726196|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
19726197|NCT04646135|Lorazepam|lorazepam|mesh-list
19726198|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
19726199|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
19867238|NCT00829166|Maytansine|maytansine|mesh-list
20254328|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
20254329|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254330|NCT00464347|Triamcinolone|triamcinolone|mesh-list
20254331|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20254332|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20254333|NCT00464347|Bevacizumab|bevacizumab|mesh-list
20254334|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20254335|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254336|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254337|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20254338|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20254339|NCT00464347|Growth Substances|growth substances|mesh-ancestor
20254340|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254341|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
20254342|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20254343|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
20254344|NCT00464347|Hormones|hormones|mesh-ancestor
20254345|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254346|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254347|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
20254348|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441044|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19441045|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19441046|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441047|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441048|NCT04497844|Prednisone|prednisone|mesh-list
19441049|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
19441050|NCT04497844|Niraparib|niraparib|mesh-list
19441051|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19441052|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
19441053|NCT04497844|Hormones|hormones|mesh-ancestor
19441054|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441055|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441056|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19441057|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726200|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
19867239|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20254349|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254350|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
20254351|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20254352|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20254353|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20254354|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20254355|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254356|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254357|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254358|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254359|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20254360|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254361|NCT00464399|Everolimus|everolimus|mesh-list
20254362|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726201|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726202|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726203|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726204|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20254363|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254364|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
20254365|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254366|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
20254367|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
20254368|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20254369|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254370|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254371|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20254372|NCT00464451|Analgesics|analgesics|mesh-ancestor
20254373|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
20254374|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254375|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20286707|NCT02668653|Idarubicin|idarubicin|mesh-list
20254376|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20254377|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20254378|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
20254379|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254380|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254381|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20254382|NCT00464503|Pravastatin|pravastatin|mesh-list
20254383|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20254384|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20254385|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
20254386|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254387|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20254388|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20254389|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254390|NCT00464594|Metformin|metformin|mesh-list
20254391|NCT00464594|Acarbose|acarbose|mesh-list
20254392|NCT00464594|Gliclazide|gliclazide|mesh-list
20254393|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254394|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254395|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20254396|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441058|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20254397|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254398|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
20254399|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20254400|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254401|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254402|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20254403|NCT00464763|Analgesics|analgesics|mesh-ancestor
20254404|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
20254405|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254406|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20254407|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20254408|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20254409|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
19441059|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441060|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441061|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
19441062|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19441063|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20254410|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726205|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726206|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19726207|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19726208|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19726209|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
19726210|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
19726211|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726212|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726213|NCT04645914|Nicotine|nicotine|mesh-list
19726214|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19726215|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
19726216|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726217|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726218|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19726219|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19726220|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254411|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254412|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
20254413|NCT00464789|Estrogens|estrogens|mesh-list
20254414|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20254415|NCT00464789|Hormones|hormones|mesh-ancestor
20254416|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254417|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254418|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20254419|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20254420|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
20254421|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20254422|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
20254423|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254424|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254425|NCT00464893|Catumaxomab|catumaxomab|mesh-list
20254426|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20254427|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254428|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
20254429|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254430|NCT00464919|Sorafenib|sorafenib|mesh-list
19867240|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19867241|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
20254431|NCT00464919|Tegafur|tegafur|mesh-list
19970000|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19726221|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254432|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254433|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19867242|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867243|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867244|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19867245|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19441068|NCT04481919|Diuretics|diuretics|mesh-list
19441069|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
19441070|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867246|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867247|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19867248|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867249|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
19867250|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
19441076|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
19441077|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19441078|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867251|NCT00829179|Omalizumab|omalizumab|mesh-list
19867252|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19867253|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19867254|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
19867255|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19867256|NCT00829244|Hormones|hormones|mesh-ancestor
19867257|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867258|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867259|NCT00829283|Orlistat|orlistat|mesh-list
19867260|NCT00829283|Sibutramine|sibutramine|mesh-list
19867261|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867262|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867263|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19867264|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19867265|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
20254434|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254435|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254436|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254437|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
20254438|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
20254439|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254440|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
20254441|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20254442|NCT00464932|Protective Agents|protective agents|mesh-ancestor
19867266|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867267|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
19867268|NCT00829296|Metoprolol|metoprolol|mesh-list
19867269|NCT00829296|Nebivolol|nebivolol|mesh-list
19867270|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19867271|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19867272|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
19867273|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
19867274|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867275|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867276|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19867277|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19867278|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19867279|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
19867280|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867281|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534756|NCT01815268|Vaccines|vaccines|mesh-list
20534757|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
20534758|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534759|NCT01815294|Doxorubicin|doxorubicin|mesh-list
20534760|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20534761|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20534762|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534763|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20254443|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254444|NCT00464958|Tizanidine|tizanidine|mesh-list
20254445|NCT00464958|Analgesics|analgesics|mesh-ancestor
20254446|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
20254447|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254448|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254449|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
20254450|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20254451|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20254452|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
20254453|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
20254454|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20254455|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20254456|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20534764|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20534765|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534766|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534767|NCT01815307|Gemcitabine|gemcitabine|mesh-list
20534768|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20534769|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
20534770|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534771|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534772|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
20534773|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534774|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534775|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534776|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
20534777|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534778|NCT01815437|Vitamin D|vitamin d|mesh-list
20254457|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
20534779|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
20534780|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
20254458|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254459|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726222|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726223|NCT04646109|Azithromycin|azithromycin|mesh-list
19726224|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
19726225|NCT04646109|Ivermectin|ivermectin|mesh-list
19726226|NCT04646109|Favipiravir|favipiravir|mesh-list
20254460|NCT00464971|Estradiol|estradiol|mesh-list
20254461|NCT00464971|Estrogens|estrogens|mesh-ancestor
20254462|NCT00464971|Hormones|hormones|mesh-ancestor
20254463|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254464|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726227|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19726228|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726229|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
19726230|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19726231|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19726232|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726233|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726234|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726235|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
20254465|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20254466|NCT00465036|Cathartics|cathartics|mesh-ancestor
20254467|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254468|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
20254469|NCT00465075|Estrogens|estrogens|mesh-list
20254470|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20254471|NCT00465075|Hormones|hormones|mesh-ancestor
20254472|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254473|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254474|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20254475|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20254476|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
20254477|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20254478|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20254479|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20254480|NCT00465192|Estradiol|estradiol|mesh-list
20254481|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20254482|NCT00465192|Estrogens|estrogens|mesh-ancestor
20254483|NCT00465192|Hormones|hormones|mesh-ancestor
20254484|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867282|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
20254485|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726236|NCT04645940|Rabeprazole|rabeprazole|mesh-list
20254486|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20254487|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
19726237|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19726238|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726239|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19726240|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726241|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726242|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
19726243|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19726244|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726245|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19726246|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
19726247|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19726248|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726249|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726250|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726251|NCT04645745|Folic Acid|folic acid|mesh-list
19726252|NCT04645745|Inositol|inositol|mesh-list
19726253|NCT04645745|Hematinics|hematinics|mesh-ancestor
19726254|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
19726255|NCT04645745|Vitamins|vitamins|mesh-ancestor
19726256|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
19726257|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254488|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20254489|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20254490|NCT00465205|Valacyclovir|valacyclovir|mesh-list
20254491|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
20254492|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254493|NCT00465231|Fentanyl|fentanyl|mesh-list
20254494|NCT00465231|Bupivacaine|bupivacaine|mesh-list
20254495|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
20254496|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
20254497|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254498|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254499|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
20254500|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254501|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20254502|NCT00465231|Narcotics|narcotics|mesh-ancestor
20254503|NCT00465231|Analgesics|analgesics|mesh-ancestor
20254504|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20254505|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20254506|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
20254507|NCT00465244|Levetiracetam|levetiracetam|mesh-list
20254508|NCT00465244|Lorazepam|lorazepam|mesh-list
20254509|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
20254510|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
20254511|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
20254512|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
20254513|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254514|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254515|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254516|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20254517|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254518|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20254519|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20254520|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20254521|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
20254522|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
20254523|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254524|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254525|NCT00465257|Artesunate|artesunate|mesh-list
20254526|NCT00465257|Amodiaquine|amodiaquine|mesh-list
20254527|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
20254528|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20254529|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20254530|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254531|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254532|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
20254533|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
20254534|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20254535|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
20254536|NCT00465283|Donepezil|donepezil|mesh-list
20254537|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20254538|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867283|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19867284|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19867285|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19867286|NCT00829439|Levodopa|levodopa|mesh-list
19867287|NCT00829439|Carbidopa|carbidopa|mesh-list
19867288|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19867289|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19867290|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
19867291|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867292|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867293|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867294|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19867295|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867296|NCT00829738|Pantoprazole|pantoprazole|mesh-list
19867297|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19867298|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867299|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19867300|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867301|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441124|NCT04435782|Selexipag|selexipag|mesh-list
19726274|NCT04645303|Triamcinolone|triamcinolone|mesh-list
19726275|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19726276|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19726277|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
19726278|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19726279|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726280|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
20286708|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254539|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254540|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254541|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726281|NCT04645303|Hormones|hormones|mesh-ancestor
19726282|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726283|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726284|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726285|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
19726286|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726287|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726288|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19726289|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
19726290|NCT04645303|Protective Agents|protective agents|mesh-ancestor
19726291|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
19867302|NCT00829829|Rilonacept|rilonacept|mesh-list
19867303|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867304|NCT00829933|Warfarin|warfarin|mesh-list
20534781|NCT01815437|Vitamins|vitamins|mesh-list
20534782|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
20534783|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534784|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20534785|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19867305|NCT00829933|Edoxaban|edoxaban|mesh-list
19867306|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
19867307|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19867308|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
20254542|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254543|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
20254544|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
20254545|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254546|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254547|NCT00465439|Lidocaine|lidocaine|mesh-list
20254548|NCT00465439|Epinephrine|epinephrine|mesh-list
20254549|NCT00465439|Racepinephrine|racepinephrine|mesh-list
20534786|NCT01815528|Catumaxomab|catumaxomab|mesh-list
20534787|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534788|NCT01815541|Teicoplanin|teicoplanin|mesh-list
20534789|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20534790|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534791|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20534792|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20534793|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20534794|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20534795|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534796|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534797|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
20534798|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534799|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20534800|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20534801|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
20534802|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20534803|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534804|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20534805|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
20534806|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20534807|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
20534808|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534809|NCT01815892|Furosemide|furosemide|mesh-list
20534810|NCT01815892|Diuretics|diuretics|mesh-ancestor
20534811|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
20534812|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726292|NCT04644484|Vaccines|vaccines|mesh-list
19726293|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
19726294|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
19726295|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726296|NCT04644354|Nifedipine|nifedipine|mesh-list
19726297|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19726298|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726299|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726300|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19726301|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726302|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
19726303|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
19726304|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19726305|NCT04644250|Paclitaxel|paclitaxel|mesh-list
19726306|NCT04644250|Carboplatin|carboplatin|mesh-list
19726307|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19726308|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726309|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
19726310|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
19726311|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
19726312|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726313|NCT04644094|Dexamethasone|dexamethasone|mesh-list
19726314|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726315|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
19726316|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
19726317|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726318|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726319|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726320|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
19726321|NCT04644094|Hormones|hormones|mesh-ancestor
19726322|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726323|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19726324|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726325|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
19726326|NCT04644185|Paraproteins|paraproteins|mesh-list
19726327|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
19726328|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726329|NCT04644406|Trastuzumab|trastuzumab|mesh-list
19726330|NCT04644406|Pertuzumab|pertuzumab|mesh-list
19726331|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19726332|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726333|NCT04643821|Calcitriol|calcitriol|mesh-list
19726334|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
19726335|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19726336|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
19726337|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726338|NCT04643821|Expectorants|expectorants|mesh-ancestor
19726339|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
20254550|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
20254551|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
20254552|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
20254553|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254554|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254555|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
20254556|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254557|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20534813|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20534814|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534815|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534816|NCT01815944|Ropivacaine|ropivacaine|mesh-list
20534817|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
20534818|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
20534819|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534820|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534821|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
20534822|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534823|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20534824|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534825|NCT01816035|Trastuzumab|trastuzumab|mesh-list
20534826|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20534827|NCT01816035|Maytansine|maytansine|mesh-list
20534828|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
20534829|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534830|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534831|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20534832|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
20534833|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
20534834|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
19726340|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19726341|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
19726342|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726343|NCT04643821|Protective Agents|protective agents|mesh-ancestor
19726344|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726345|NCT04643821|Antidotes|antidotes|mesh-ancestor
19726346|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19726347|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20554932|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
20554933|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554934|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20554935|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20554936|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20554937|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20554938|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20554939|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20554940|NCT01937806|Tenofovir|tenofovir|mesh-list
20554941|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
20554942|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554943|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20554944|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20554945|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554946|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554947|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20554948|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20554949|NCT01937832|Ertapenem|ertapenem|mesh-list
20554950|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20554951|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254558|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20254559|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20254560|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20254561|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254562|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20254563|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20254564|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
20254565|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254566|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20254567|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20254568|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
19726348|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20254569|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20254570|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
20254571|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
19441125|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19441126|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
19441127|NCT04428333|Fluorouracil|fluorouracil|mesh-list
19441128|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19441129|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441130|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
19441131|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441132|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19441133|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19441134|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
19441135|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254572|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
19726349|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19726350|NCT04643821|Vitamins|vitamins|mesh-ancestor
19726351|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
19726352|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19726353|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20254573|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20254574|NCT00465452|Dopamine|dopamine|mesh-list
20254575|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
19726354|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726355|NCT04643691|Losartan|losartan|mesh-list
19726356|NCT04643691|Spironolactone|spironolactone|mesh-list
19726357|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19726358|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19726359|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19726360|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19726361|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726362|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19726363|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
19726364|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726365|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726366|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19441136|NCT04421339|Melatonin|melatonin|mesh-list
19441137|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
19441138|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441139|NCT04421339|Protective Agents|protective agents|mesh-ancestor
19441140|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441141|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20254576|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20254577|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
20254578|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
20254579|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726367|NCT04643691|Diuretics|diuretics|mesh-ancestor
19726368|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
19726369|NCT04643483|Adalimumab|adalimumab|mesh-list
19726370|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
19726371|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726372|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726373|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726374|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
19726375|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726376|NCT04643327|Levetiracetam|levetiracetam|mesh-list
19726377|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
19726378|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
19726379|NCT04643132|Ketamine|ketamine|mesh-list
19726380|NCT04643132|Esketamine|esketamine|mesh-list
19867309|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19867310|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
20254580|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254581|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
20254582|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286709|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
20254583|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867311|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867312|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867313|NCT00830063|Naproxen|naproxen|mesh-list
19867314|NCT00830063|Tanezumab|tanezumab|mesh-list
19867315|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19867316|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19867317|NCT00830063|Analgesics|analgesics|mesh-ancestor
19867318|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
19867319|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867320|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867321|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20254584|NCT00465452|Protective Agents|protective agents|mesh-ancestor
20254585|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
19867322|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867323|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
19867324|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19867325|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867326|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867327|NCT00830076|Metformin|metformin|mesh-list
19867328|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19867329|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19441155|NCT04388163|Gentian Violet|gentian violet|mesh-list
19441156|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19441157|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867330|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254586|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20254587|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20254588|NCT00465543|Analgesics|analgesics|mesh-ancestor
20254589|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
20254590|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867331|NCT00830076|Incretins|incretins|mesh-ancestor
19867332|NCT00830076|Hormones|hormones|mesh-ancestor
19867333|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867334|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19867335|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867336|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867337|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867338|NCT00830115|Pantoprazole|pantoprazole|mesh-list
19867339|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19867340|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867341|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19867342|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970001|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441172|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
19441173|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
19441174|NCT04370301|Melphalan|melphalan|mesh-list
19441175|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
19441176|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19441177|NCT04370301|Fludarabine|fludarabine|mesh-list
19441178|NCT04370301|Tacrolimus|tacrolimus|mesh-list
19441179|NCT04370301|Sargramostim|sargramostim|mesh-list
19970002|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441180|NCT04370301|Lenograstim|lenograstim|mesh-list
19441181|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19441182|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726381|NCT04643132|Analgesics|analgesics|mesh-ancestor
19726382|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
19726383|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726384|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726385|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19726386|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19726387|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
19726388|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
19726389|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726390|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19726391|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19726392|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726393|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726394|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
19726395|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19726396|NCT04643301|Liraglutide|liraglutide|mesh-list
19726397|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19726398|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726399|NCT04643301|Incretins|incretins|mesh-ancestor
19726400|NCT04643301|Hormones|hormones|mesh-ancestor
19726401|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726402|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19726403|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726404|NCT04643106|Hemostatics|hemostatics|mesh-list
19726405|NCT04643106|Coagulants|coagulants|mesh-ancestor
19726406|NCT04642846|Fluorides|fluorides|mesh-list
19726407|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
19726408|NCT04642846|Protective Agents|protective agents|mesh-ancestor
19726409|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867343|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726410|NCT04642664|Apatinib|apatinib|mesh-list
19726411|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726412|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19726413|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726414|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726415|NCT04642547|Lenvatinib|lenvatinib|mesh-list
19726416|NCT04642547|Gefitinib|gefitinib|mesh-list
19726417|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726418|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19726419|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726420|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735097|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735098|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19735099|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19735100|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19735101|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19735102|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
19735103|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
19735104|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
19735105|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
20254591|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254592|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20254593|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20254594|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
20254595|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254596|NCT00465543|Protective Agents|protective agents|mesh-ancestor
20254597|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20254598|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19735106|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735107|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735108|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735109|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735110|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
19735111|NCT04543110|Durvalumab|durvalumab|mesh-list
20254599|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
20254600|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254601|NCT00465608|Propranolol|propranolol|mesh-list
20254602|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20254603|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20254604|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
20254605|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254606|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735112|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19735113|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867344|NCT00830128|Pregabalin|pregabalin|mesh-list
20254607|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254608|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20254609|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20254610|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
20254611|NCT00465621|Latanoprost|latanoprost|mesh-list
19726421|NCT04642391|Cosyntropin|cosyntropin|mesh-list
19726422|NCT04642391|Hormones|hormones|mesh-ancestor
19726423|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726424|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726425|NCT04642131|Caffeine|caffeine|mesh-list
19726426|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19726427|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726428|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20254612|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20254613|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20254614|NCT00465673|Doxorubicin|doxorubicin|mesh-list
20254615|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20254616|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20254617|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254618|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20254619|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254620|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254621|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254622|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20254623|NCT00465751|Cathartics|cathartics|mesh-ancestor
19441183|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
19441184|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441185|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19441186|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19441187|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
19441188|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441189|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441190|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19441191|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19441192|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441193|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19441194|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19441195|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
19441196|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19441197|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441198|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19441199|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19441200|NCT04354012|Gentian Violet|gentian violet|mesh-list
20254624|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286710|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286711|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441201|NCT04354012|Methylene Blue|methylene blue|mesh-list
19441202|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441203|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286712|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
19726429|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726430|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726431|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19726432|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19726433|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
19726434|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726435|NCT04642001|Listerine|listerine|mesh-list
19726436|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
19726437|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
19726438|NCT04642001|Protective Agents|protective agents|mesh-ancestor
19726439|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726440|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19726441|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726442|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
19726443|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
19726444|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726445|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726446|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726447|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
19726448|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
19726449|NCT04641104|Thiamine|thiamine|mesh-list
19726450|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
19726451|NCT04641104|Vitamins|vitamins|mesh-ancestor
19726452|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
19726453|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726454|NCT04641338|Dipyrone|dipyrone|mesh-list
19726455|NCT04641338|Codeine|codeine|mesh-list
19726456|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19726457|NCT04641338|Narcotics|narcotics|mesh-ancestor
19726458|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726459|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726460|NCT04641338|Analgesics|analgesics|mesh-ancestor
19726461|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
19726462|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726463|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
19726464|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
19726465|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19726466|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19726467|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726468|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867345|NCT00830128|Analgesics|analgesics|mesh-ancestor
20254625|NCT00465907|Paclitaxel|paclitaxel|mesh-list
20254626|NCT00465907|Carboplatin|carboplatin|mesh-list
20254627|NCT00465907|Irinotecan|irinotecan|mesh-list
20254628|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20254629|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726469|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
19726470|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
19726471|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726472|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19726473|NCT04641026|Protective Agents|protective agents|mesh-ancestor
19726474|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726475|NCT04641234|Aflibercept|aflibercept|mesh-list
19726476|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19726477|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19726478|NCT04641234|Growth Substances|growth substances|mesh-ancestor
19726479|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867346|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
19867347|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867348|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254630|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
20254631|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
20534835|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534836|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
20534837|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534838|NCT01816191|Diltiazem|diltiazem|mesh-list
20534839|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19441204|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19441205|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441206|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
19441207|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19441208|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19441209|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534840|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20534841|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534842|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534843|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20534844|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534845|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
19441210|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
19441211|NCT04347122|Coagulants|coagulants|mesh-ancestor
19867349|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
19867350|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19867351|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867352|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867353|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19867354|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19867355|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19867356|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867357|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20254632|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
20254633|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254634|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20254635|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254636|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254637|NCT00466063|Deferasirox|deferasirox|mesh-list
20254638|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20254639|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
20254640|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
20254641|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254642|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
20254643|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
20254644|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20254645|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
19726480|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
19726481|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726482|NCT04641351|Triamcinolone|triamcinolone|mesh-list
19867358|NCT00830167|Pregabalin|pregabalin|mesh-list
19867359|NCT00830167|Analgesics|analgesics|mesh-ancestor
19867360|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
19867361|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867362|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867363|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
19867364|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19867365|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867366|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867367|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19867368|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19867369|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19867370|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867371|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867372|NCT00830362|Propranolol|propranolol|mesh-list
19867373|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19867374|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19867375|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
19867376|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867377|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867378|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867379|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19867380|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19867381|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
19867382|NCT00830375|Memantine|memantine|mesh-list
19867383|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19867384|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19867385|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
19867386|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867387|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867388|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867389|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19867390|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19867391|NCT00830388|Ketoconazole|ketoconazole|mesh-list
19867392|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
19867393|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867394|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19867395|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19867396|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867397|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867398|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19867399|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
19867400|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867401|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867402|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19867403|NCT00830765|Progesterone|progesterone|mesh-list
19867404|NCT00830765|Progestins|progestins|mesh-ancestor
19867405|NCT00830765|Hormones|hormones|mesh-ancestor
19867406|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867407|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867408|NCT00830804|Ritonavir|ritonavir|mesh-list
19867409|NCT00830804|Darunavir|darunavir|mesh-list
19867410|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
19726483|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19726484|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19726485|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19726486|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726487|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
19726488|NCT04641351|Hormones|hormones|mesh-ancestor
19726489|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726490|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726491|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726492|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
19726493|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726494|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726495|NCT04641247|Niraparib|niraparib|mesh-list
19726496|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19726497|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726498|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867411|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19867412|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19867413|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867414|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867415|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867416|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19867417|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19867418|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
19867419|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867420|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19867421|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19867422|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19867423|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19867424|NCT00830869|Ixazomib|ixazomib|mesh-list
19867425|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867426|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867427|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867428|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867429|NCT00830960|Clopidogrel|clopidogrel|mesh-list
19867430|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19867431|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19867432|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19867433|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19867434|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19867435|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
19867436|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867437|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867438|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867439|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
20534846|NCT01816321|Ganirelix|ganirelix|mesh-list
20534847|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
20534848|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534849|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534850|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
20534851|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20534852|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19867440|NCT00831129|Simvastatin|simvastatin|mesh-list
19867441|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19867442|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19867443|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
19867444|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867445|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19867446|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19867447|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867448|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19867449|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867450|NCT00831181|Leucovorin|leucovorin|mesh-list
19867451|NCT00831181|Fluorouracil|fluorouracil|mesh-list
19867452|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
19867453|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
19867454|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867455|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19867456|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867457|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867458|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
19867459|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867460|NCT00831181|Antidotes|antidotes|mesh-ancestor
19867461|NCT00831181|Protective Agents|protective agents|mesh-ancestor
19867462|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
19867463|NCT00831181|Vitamins|vitamins|mesh-ancestor
19726499|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726500|NCT04640870|Afatinib|afatinib|mesh-list
19726501|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726502|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19726503|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726504|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726505|NCT04640896|Lidocaine|lidocaine|mesh-list
19726506|NCT04640896|Bupivacaine|bupivacaine|mesh-list
19726507|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
19726508|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
19726509|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726510|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726511|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
19726512|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726513|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19726514|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19726515|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19726516|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726517|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726518|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
19726519|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726520|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
19726521|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726522|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19726523|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
19726524|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726525|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19726526|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19726527|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
19726528|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726529|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726530|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19726531|NCT04640181|Enoxaparin|enoxaparin|mesh-list
19726532|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
19726533|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19726534|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
19726535|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19726536|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
19726537|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726538|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726539|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
19726540|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19726541|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19735114|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
19735115|NCT04543227|Narcotics|narcotics|mesh-ancestor
19735116|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735117|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735118|NCT04543227|Analgesics|analgesics|mesh-ancestor
19735119|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
19735120|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735121|NCT04543188|Midazolam|midazolam|mesh-list
19735122|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19735123|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19735124|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735125|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735126|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19735127|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19735128|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19735129|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19735130|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
19735131|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
19735132|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
19735133|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
19735134|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735135|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735136|NCT04543123|Citalopram|citalopram|mesh-list
20254646|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254647|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254648|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867464|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
19867465|NCT00831233|Goserelin|goserelin|mesh-list
19867466|NCT00831233|Bicalutamide|bicalutamide|mesh-list
19867467|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19867468|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867469|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
19867470|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
19867471|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867472|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867473|NCT00831272|Naltrexone|naltrexone|mesh-list
19867474|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19867475|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19867476|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254649|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19726542|NCT04640129|Interferons|interferons|mesh-list
19726543|NCT04640129|Tenofovir|tenofovir|mesh-list
19726544|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
19726545|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726546|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
19726547|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726548|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19867477|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
19867478|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867479|NCT00831311|Vaccines|vaccines|mesh-list
19867480|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
19867481|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867482|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19867483|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19867484|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19867485|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867486|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867487|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867488|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254650|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254651|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20254652|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254653|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254654|NCT00466102|Everolimus|everolimus|mesh-list
20254655|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254656|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254657|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
20254658|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254659|NCT00466128|Indomethacin|indomethacin|mesh-list
20254660|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20254661|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20254662|NCT00466128|Analgesics|analgesics|mesh-ancestor
19441240|NCT04339036|Capecitabine|capecitabine|mesh-list
19441241|NCT04339036|Temozolomide|temozolomide|mesh-list
19441242|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19441243|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
19441244|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441245|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441246|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19441247|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
19441248|NCT04317807|Levetiracetam|levetiracetam|mesh-list
19441249|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
19441250|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
19441251|NCT04311489|Ularitide|ularitide|mesh-list
19441252|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19441253|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
19441254|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19441255|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441256|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19441257|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
19441258|NCT04311489|Diuretics|diuretics|mesh-ancestor
19441259|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
19867489|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
19867490|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867491|NCT00831441|Apixaban|apixaban|mesh-list
19867492|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20254663|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
19441265|NCT04308304|Donepezil|donepezil|mesh-list
19441266|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19441267|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441268|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726549|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19726550|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441269|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
19726551|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726552|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19726553|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19726554|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
19726555|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726556|NCT04640324|Vitamin D|vitamin d|mesh-list
19726557|NCT04640324|Vitamins|vitamins|mesh-list
19726558|NCT04640324|Vitamin E|vitamin e|mesh-list
19726559|NCT04640324|Silybin|silybin|mesh-list
19726560|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
19726561|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726562|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19726563|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
19726564|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726565|NCT04640324|Protective Agents|protective agents|mesh-ancestor
19726566|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19726567|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726568|NCT04640285|Menthol|menthol|mesh-list
19726569|NCT04640285|Nicotine|nicotine|mesh-list
20254664|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254665|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726570|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19726571|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
19726572|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726573|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726574|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20534853|NCT01816334|Prednisolone|prednisolone|mesh-list
20534854|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
20534855|NCT01816334|Ketoprofen|ketoprofen|mesh-list
20534856|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20534857|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
20534858|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726575|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19726576|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
19726577|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867493|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
19867494|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19867495|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867496|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867497|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726578|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726579|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
19726580|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
19726581|NCT04639817|Levofloxacin|levofloxacin|mesh-list
19726582|NCT04639817|Ofloxacin|ofloxacin|mesh-list
19726583|NCT04639817|Trimethoprim|trimethoprim|mesh-list
19726584|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19726585|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
19726586|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19726587|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726588|NCT04639817|Renal Agents|renal agents|mesh-ancestor
19726589|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19726590|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19726591|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19867498|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
20534859|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
20534860|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
20534861|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534862|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534863|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726592|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735137|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
20254666|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20254667|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20254668|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
20254669|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
20254670|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20254671|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20254672|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254673|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254674|NCT00466154|Aspirin|aspirin|mesh-list
19726593|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726594|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726595|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19726596|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19726597|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
19726598|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19726599|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19726600|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19726601|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19726602|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19726603|NCT04639804|Celecoxib|celecoxib|mesh-list
19726604|NCT04639804|Naproxen|naproxen|mesh-list
19726605|NCT04639804|Aceclofenac|aceclofenac|mesh-list
19726606|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19726607|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19726608|NCT04639804|Analgesics|analgesics|mesh-ancestor
19726609|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
19726610|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726611|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726612|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726613|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726614|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19726615|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19726616|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726617|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726618|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
19726619|NCT04639362|Venetoclax|venetoclax|mesh-list
19726620|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
19726621|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726622|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19726623|NCT04639232|Probenecid|probenecid|mesh-list
19726624|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
19726625|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
19726626|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726627|NCT04639232|Renal Agents|renal agents|mesh-ancestor
19726628|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19726629|NCT04639284|Antibodies|antibodies|mesh-list
19726630|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
19726631|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726632|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19726633|NCT04639284|Growth Substances|growth substances|mesh-ancestor
19726634|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
19726635|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726636|NCT04639271|Trastuzumab|trastuzumab|mesh-list
19726637|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19726638|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19726639|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726640|NCT04639180|Apatinib|apatinib|mesh-list
19726641|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726642|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19726643|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726644|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726645|NCT04638816|Lidocaine|lidocaine|mesh-list
19726646|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
19726647|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
19726648|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
19726649|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726650|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726651|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
19726652|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726653|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19726654|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19726655|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19726656|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726657|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726658|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19726659|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
19726660|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
19726661|NCT04638816|Protective Agents|protective agents|mesh-ancestor
20254675|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20254676|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20254677|NCT00466154|Analgesics|analgesics|mesh-ancestor
20254678|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
20254679|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254680|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254681|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20254682|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20254683|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20254684|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20286713|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726662|NCT04639193|Acetazolamide|acetazolamide|mesh-list
19867499|NCT00831480|Everolimus|everolimus|mesh-list
19867500|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867501|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867502|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
19867503|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867504|NCT00831493|Vorinostat|vorinostat|mesh-list
19726663|NCT04639193|Eszopiclone|eszopiclone|mesh-list
19867505|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726664|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19726665|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19726666|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19726667|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726668|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726669|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726670|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726671|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19726672|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
19726673|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19726674|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
19726675|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20254685|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254686|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20254687|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20254688|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254689|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
20254690|NCT00466180|Nevirapine|nevirapine|mesh-list
20254691|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20254692|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20254693|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254694|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254695|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
20254696|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254697|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20254698|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20254699|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20254700|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20254701|NCT00466219|Interferons|interferons|mesh-list
20254702|NCT00466219|Ribavirin|ribavirin|mesh-list
20254703|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
20254704|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
20254705|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20254706|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254707|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
20254708|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254709|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
20254710|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254711|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
20254712|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254713|NCT00466232|Sorafenib|sorafenib|mesh-list
20254714|NCT00466232|Topotecan|topotecan|mesh-list
20254715|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254716|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19441270|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19441271|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726676|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441272|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
20254717|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254718|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254719|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20254720|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254721|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20254722|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
20254723|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254724|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20254725|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726677|NCT04639193|Diuretics|diuretics|mesh-ancestor
19726678|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
20254726|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20254727|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254728|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254729|NCT00466388|Cevimeline|cevimeline|mesh-list
20254730|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20254731|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
20254732|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254733|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254734|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20254735|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20254736|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254737|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254738|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254739|NCT00466401|Simvastatin|simvastatin|mesh-list
19726679|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19726680|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726681|NCT04638686|Lamivudine|lamivudine|mesh-list
19726682|NCT04638686|Dolutegravir|dolutegravir|mesh-list
19726683|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19726684|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19726685|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726686|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726687|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
19726688|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726689|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19726690|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19726691|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19726692|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19726693|NCT04638790|Dexamethasone|dexamethasone|mesh-list
19726694|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
19726695|NCT04638790|Dacarbazine|dacarbazine|mesh-list
19726696|NCT04638790|Doxorubicin|doxorubicin|mesh-list
19726697|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19726698|NCT04638790|Etoposide|etoposide|mesh-list
19726699|NCT04638790|Vincristine|vincristine|mesh-list
19726700|NCT04638790|Bleomycin|bleomycin|mesh-list
19726701|NCT04638790|Vinblastine|vinblastine|mesh-list
19726702|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726703|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
19726704|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726705|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726706|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19726707|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
19867506|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19867507|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867508|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867509|NCT00831675|Vaccines|vaccines|mesh-list
19867510|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
19726708|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254740|NCT00466401|Ezetimibe|ezetimibe|mesh-list
20254741|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20254742|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20254743|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
19867511|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867512|NCT00831701|Tamsulosin|tamsulosin|mesh-list
19867513|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20286714|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19441286|NCT04288778|Metformin|metformin|mesh-list
19441287|NCT04288778|Canagliflozin|canagliflozin|mesh-list
19441288|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19441289|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441290|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19441291|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441292|NCT04280848|Temozolomide|temozolomide|mesh-list
19441293|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19726709|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726710|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19441294|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
19726711|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726712|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
19726713|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
19726714|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726715|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726716|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
19726717|NCT04638790|Hormones|hormones|mesh-ancestor
19726718|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726719|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19726720|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19726721|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19726722|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19726723|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726724|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20254744|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254745|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20254746|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20254747|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254748|NCT00466466|Everolimus|everolimus|mesh-list
20254749|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254750|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254751|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
19441295|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441296|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441297|NCT04273945|Macitentan|macitentan|mesh-list
19441298|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19441299|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19441300|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441301|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19441302|NCT04271475|Macitentan|macitentan|mesh-list
19441303|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19441304|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19441305|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441306|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19441307|NCT04270877|Naltrexone|naltrexone|mesh-list
19441308|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19441309|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19441310|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441311|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
19441312|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867514|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19867515|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19867516|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
19867517|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867518|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726725|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
19726726|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
19726727|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
19726728|NCT04639115|Ozanimod|ozanimod|mesh-list
19867519|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867520|NCT00831701|Urological Agents|urological agents|mesh-ancestor
19867521|NCT00831766|Cytarabine|cytarabine|mesh-list
19867522|NCT00831766|Lenalidomide|lenalidomide|mesh-list
19867523|NCT00831766|Idarubicin|idarubicin|mesh-list
19867524|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
19867525|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19867526|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
19867527|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867528|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
19867529|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867530|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726729|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19726730|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726731|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726732|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
19726733|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254752|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254753|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20254754|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20254755|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20254756|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20254757|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20254758|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
19867531|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
19867532|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867533|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19867534|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19867535|NCT00831766|Growth Substances|growth substances|mesh-ancestor
19867536|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
19867537|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19867538|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19867539|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19867540|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867541|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
19867542|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19867543|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867544|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19867545|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867546|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19867547|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
19867548|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867549|NCT00831987|Vaccines|vaccines|mesh-list
19867550|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
19867551|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867552|NCT00832000|Mexiletine|mexiletine|mesh-list
19867553|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19867554|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19867555|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19867556|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867557|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867558|NCT00832117|Cisplatin|cisplatin|mesh-list
19867559|NCT00832117|Epothilones|epothilones|mesh-list
19867560|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867561|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867562|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
19867563|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867564|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867565|NCT00832338|Dexamethasone|dexamethasone|mesh-list
19867566|NCT00832338|Docetaxel|docetaxel|mesh-list
19867567|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
19867568|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726734|NCT04638582|Paclitaxel|paclitaxel|mesh-list
19726735|NCT04638582|Carboplatin|carboplatin|mesh-list
19726736|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
19726737|NCT04638582|Pemetrexed|pemetrexed|mesh-list
19726738|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19726739|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726740|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
19726741|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
19726742|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
19726743|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726744|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19726745|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867569|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
19867570|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
19867571|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867572|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867573|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534864|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
19726746|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20534865|NCT01816334|Hormones|hormones|mesh-ancestor
20534866|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534867|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20534868|NCT01816334|Protective Agents|protective agents|mesh-ancestor
20534869|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20534870|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534871|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20534872|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20534873|NCT01816334|Analgesics|analgesics|mesh-ancestor
20534874|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
20534875|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534876|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20534877|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534878|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534879|NCT01816412|Paclitaxel|paclitaxel|mesh-list
19726747|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19726748|NCT04638751|Pembrolizumab|pembrolizumab|mesh-list
19726749|NCT04638751|Nivolumab|nivolumab|mesh-list
19726750|NCT04638751|Ipilimumab|ipilimumab|mesh-list
19726751|NCT04638751|Durvalumab|durvalumab|mesh-list
19726752|NCT04638751|Avelumab|avelumab|mesh-list
19726753|NCT04638751|Cemiplimab|cemiplimab|mesh-list
19726754|NCT04638751|Atezolizumab|atezolizumab|mesh-list
19726755|NCT04638751|Antineoplastic Agents|antineoplastic agents|mesh-list
19726756|NCT04638751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19726757|NCT04638751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19726758|NCT04638751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726759|NCT04638517|Danazol|danazol|mesh-list
19726760|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19726761|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
19726762|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726763|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726764|NCT04638400|Simvastatin|simvastatin|mesh-list
19726765|NCT04638400|Ezetimibe|ezetimibe|mesh-list
19726766|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19726767|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19726768|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
19726769|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726770|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19726771|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19726772|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726773|NCT04638439|Entecavir|entecavir|mesh-list
19726774|NCT04638439|Nivolumab|nivolumab|mesh-list
19726775|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19726776|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726777|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20254759|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254760|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286715|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
20554952|NCT01938092|Diazepam|diazepam|mesh-list
20554953|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19726778|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726779|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
19726780|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554954|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
20554955|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
20554956|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
20554957|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554958|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554959|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554960|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20554961|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554962|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20554963|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20554964|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20554965|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20554966|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554967|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20554968|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
20554969|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
20554970|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
20554971|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
20554972|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554973|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554974|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
20554975|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20554976|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554977|NCT01938144|Acetaminophen|acetaminophen|mesh-list
20554978|NCT01938144|Ibuprofen|ibuprofen|mesh-list
20554979|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19726781|NCT04638036|Cetuximab|cetuximab|mesh-list
19726782|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20534880|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20534881|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726783|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726784|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
19726785|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19726786|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19726787|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20534882|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
20534883|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
20534884|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
20534885|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534886|NCT01816490|Silybin|silybin|mesh-list
20534887|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19726788|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726789|NCT04637152|Valsartan|valsartan|mesh-list
19726790|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19726791|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19726792|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19726793|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19726794|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726795|NCT04636918|Cyclosporine|cyclosporine|mesh-list
19726796|NCT04636918|Cyclosporins|cyclosporins|mesh-list
19726797|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726798|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726799|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19726800|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
19726801|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867574|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
19867575|NCT00832338|Hormones|hormones|mesh-ancestor
19867576|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867577|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19867578|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867579|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867580|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
19867581|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867582|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867583|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867584|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
19867585|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867586|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20254761|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867587|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
19867588|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19867589|NCT00832377|Timolol|timolol|mesh-list
19867590|NCT00832377|Dorzolamide|dorzolamide|mesh-list
19867591|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19867592|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19867593|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
19867594|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867595|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867596|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867597|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19867598|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19867599|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19867600|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867601|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19867602|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19867603|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867604|NCT00832390|Incretins|incretins|mesh-ancestor
19867605|NCT00832390|Hormones|hormones|mesh-ancestor
19867606|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867607|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19867608|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867609|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867610|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867611|NCT00832416|Tramadol|tramadol|mesh-list
19867612|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19867613|NCT00832416|Narcotics|narcotics|mesh-ancestor
19867614|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867615|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867616|NCT00832416|Analgesics|analgesics|mesh-ancestor
19867617|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
19867618|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19441357|NCT04231877|Prednisone|prednisone|mesh-list
19441358|NCT04231877|Cortisone|cortisone|mesh-list
19441359|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
19441360|NCT04231877|Rituximab|rituximab|mesh-list
19441361|NCT04231877|Doxorubicin|doxorubicin|mesh-list
19441362|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19441363|NCT04231877|Etoposide|etoposide|mesh-list
19441364|NCT04231877|Daunorubicin|daunorubicin|mesh-list
19441365|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
19441366|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19441367|NCT04231877|Antibodies|antibodies|mesh-list
19441368|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
19441369|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19867619|NCT00832585|Alefacept|alefacept|mesh-list
19867620|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
20254762|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19441370|NCT04231877|Lenograstim|lenograstim|mesh-list
19441371|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
19726802|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
19726803|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726804|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
19726805|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19726806|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19726807|NCT04637204|Axitinib|axitinib|mesh-list
19726808|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726809|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19726810|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726811|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726812|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
19726813|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19726814|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19726815|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19726816|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726817|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19726818|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19726819|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726820|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726821|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726822|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19726823|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19726824|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726825|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
19867621|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
19867622|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867623|NCT00832637|Gemcitabine|gemcitabine|mesh-list
19867624|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19867625|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867626|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19867627|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
19867628|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867629|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
19867630|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867631|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867632|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867633|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
19867634|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867635|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19867636|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
19867637|NCT00832650|Fesoterodine|fesoterodine|mesh-list
19867638|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19867639|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19867640|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
19867641|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867642|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867643|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867644|NCT00832650|Urological Agents|urological agents|mesh-ancestor
19867645|NCT00832819|Paclitaxel|paclitaxel|mesh-list
19867646|NCT00832819|Carboplatin|carboplatin|mesh-list
19867647|NCT00832819|Lenvatinib|lenvatinib|mesh-list
19867648|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19867649|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867650|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867651|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
19867652|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867653|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867654|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19867655|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867656|NCT00832871|Mifepristone|mifepristone|mesh-list
19867657|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19867658|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
19726826|NCT04636957|Hormones|hormones|mesh-ancestor
19726827|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726828|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726829|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
19726830|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19726831|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
19726832|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726833|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19726834|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19726835|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19726836|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867659|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19867660|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867661|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19867662|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19867663|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19867664|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
19867665|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19726837|NCT04637360|Calcitriol|calcitriol|mesh-list
19867666|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19867667|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
19726838|NCT04637360|Cinacalcet|cinacalcet|mesh-list
19726839|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19726840|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726841|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19726842|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726843|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726844|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19726845|NCT04637360|Vitamins|vitamins|mesh-ancestor
19726846|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
19726847|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19726848|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19726849|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
19726850|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726851|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
19726852|NCT04636632|Aprepitant|aprepitant|mesh-list
19726853|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
19726854|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
19726855|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726856|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726857|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726858|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19726859|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726860|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726861|NCT04636125|Doxycycline|doxycycline|mesh-list
19726862|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19726863|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726864|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
19726865|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20534888|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534889|NCT01816490|Protective Agents|protective agents|mesh-ancestor
19726866|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19726867|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19726868|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19726869|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
19735138|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19735139|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19735140|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534890|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735946|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534891|NCT01816529|Diltiazem|diltiazem|mesh-list
20534892|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20534893|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20534894|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20534895|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534896|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20534897|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726870|NCT04635852|Fentanyl|fentanyl|mesh-list
19726871|NCT04635852|Morphine|morphine|mesh-list
19726872|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19726873|NCT04635852|Narcotics|narcotics|mesh-ancestor
19726874|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726875|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726876|NCT04635852|Analgesics|analgesics|mesh-ancestor
19726877|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
19726878|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726879|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19726880|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19726881|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
19726882|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
19726883|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
19726884|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
19726885|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
19726886|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726887|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726888|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
19726889|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726890|NCT04635280|Pancrelipase|pancrelipase|mesh-list
19726891|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726892|NCT04635176|Dexamethasone|dexamethasone|mesh-list
19726893|NCT04635176|Epinephrine|epinephrine|mesh-list
19726894|NCT04635176|Bupivacaine|bupivacaine|mesh-list
19726895|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726896|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
19726897|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
19726898|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726899|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726900|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726901|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
19726902|NCT04635176|Hormones|hormones|mesh-ancestor
19726903|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726904|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20254763|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254764|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254765|NCT00466518|Incretins|incretins|mesh-ancestor
20254766|NCT00466518|Hormones|hormones|mesh-ancestor
20254767|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254768|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20254769|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
20254770|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534898|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
19726905|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726906|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
19726907|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
20254771|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534899|NCT01816555|Vitamin D|vitamin d|mesh-list
20534900|NCT01816555|Vitamins|vitamins|mesh-ancestor
20534901|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
20534902|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534903|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20534904|NCT01816581|Morphine|morphine|mesh-list
20534905|NCT01816581|Naloxone|naloxone|mesh-list
20534906|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20534907|NCT01816581|Narcotics|narcotics|mesh-ancestor
20534908|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20534909|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534910|NCT01816581|Analgesics|analgesics|mesh-ancestor
20534911|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
20534912|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534913|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20534914|NCT01816620|Dexamethasone|dexamethasone|mesh-list
20534915|NCT01816620|Lenalidomide|lenalidomide|mesh-list
20534916|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534917|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
20534918|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
19726908|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726909|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
19726910|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19726911|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19726912|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
19867668|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867669|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
19867670|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19867671|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19867672|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19867673|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19867674|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867675|NCT00833027|Incretins|incretins|mesh-ancestor
19867676|NCT00833027|Hormones|hormones|mesh-ancestor
19867677|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867678|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19867679|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867680|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867681|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867682|NCT00833040|Sufentanil|sufentanil|mesh-list
19867683|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19867684|NCT00833040|Narcotics|narcotics|mesh-ancestor
19867685|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867686|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867687|NCT00833040|Analgesics|analgesics|mesh-ancestor
19867688|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
19867689|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867690|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19867691|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19867692|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
19867693|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
19867694|NCT00833053|Methotrexate|methotrexate|mesh-list
19867695|NCT00833053|Infliximab|infliximab|mesh-list
19867696|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19867697|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
19867698|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19867699|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867700|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19867701|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
19867702|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867703|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867704|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
19867705|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867706|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19867707|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867708|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
19867709|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867710|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19867711|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867712|NCT00833248|Goserelin|goserelin|mesh-list
19867713|NCT00833248|Bicalutamide|bicalutamide|mesh-list
19867714|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19867715|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867716|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
19867717|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
19867718|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867719|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867720|NCT00833261|Paclitaxel|paclitaxel|mesh-list
19867721|NCT00833261|Cetuximab|cetuximab|mesh-list
19867722|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19867723|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867724|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
19867725|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
19726913|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19726914|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726915|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19726916|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19726917|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19726918|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
19726919|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
19867726|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867727|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867728|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19867729|NCT00833365|Ibuprofen|ibuprofen|mesh-list
19867730|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19867731|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19867732|NCT00833365|Analgesics|analgesics|mesh-ancestor
19867733|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
19867734|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867735|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867736|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867737|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867738|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19867739|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867740|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867741|NCT00833443|Bupropion|bupropion|mesh-list
19867742|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19867743|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
19867744|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867745|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19867746|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19867747|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20254772|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
20254773|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
20254774|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20254775|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254776|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20254777|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20254778|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254779|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254780|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254781|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20254782|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20254783|NCT00466596|Vitamins|vitamins|mesh-list
20254784|NCT00466596|Vitamin E|vitamin e|mesh-list
20254785|NCT00466596|Tocopherols|tocopherols|mesh-list
20254786|NCT00466596|Tocotrienols|tocotrienols|mesh-list
20254787|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
20254788|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
20254789|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
20254790|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254791|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
20254792|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254793|NCT00466596|Protective Agents|protective agents|mesh-ancestor
20254794|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20254795|NCT00466609|Fluoxetine|fluoxetine|mesh-list
20254796|NCT00466609|Clomipramine|clomipramine|mesh-list
20254797|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
19726920|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
19726921|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19726922|NCT04635566|Mebeverine|mebeverine|mesh-list
19726923|NCT04635566|Alverine|alverine|mesh-list
19726924|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
19726925|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
19726926|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
19726927|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726928|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726929|NCT04635293|Simendan|simendan|mesh-list
19726930|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19726931|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
19726932|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19726933|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19726934|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19726935|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726936|NCT04635293|Protective Agents|protective agents|mesh-ancestor
19726937|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726938|NCT04635007|Misoprostol|misoprostol|mesh-list
19726939|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
19726940|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19726941|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19726942|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726943|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
19726944|NCT04635007|Coagulants|coagulants|mesh-ancestor
19726945|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19726946|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
19726947|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19726948|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726949|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19726950|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726951|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
19726952|NCT04635553|Praziquantel|praziquantel|mesh-list
19726953|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
19726954|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19726955|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726956|NCT04635189|Dexamethasone|dexamethasone|mesh-list
19726957|NCT04635189|Lenalidomide|lenalidomide|mesh-list
19726958|NCT04635189|Daratumumab|daratumumab|mesh-list
19726959|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19726960|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
19726961|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
19726962|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726963|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726964|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19726965|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
19726966|NCT04635189|Hormones|hormones|mesh-ancestor
19726967|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19726968|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19726969|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19726970|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
19726971|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19726972|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19867748|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867749|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
19867750|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867751|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867752|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19867753|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19867754|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867755|NCT00833469|Citalopram|citalopram|mesh-list
19867756|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19867757|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20534919|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726973|NCT04635189|Growth Substances|growth substances|mesh-ancestor
19726974|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19726975|NCT04634838|Copper|copper|mesh-list
19726976|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19726977|NCT04634838|Trace Elements|trace elements|mesh-ancestor
19726978|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
19726979|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726980|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19726981|NCT04634981|Anesthetics|anesthetics|mesh-list
19726982|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726983|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726984|NCT04634656|Lidocaine|lidocaine|mesh-list
19726985|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
19726986|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
19726987|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19726988|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19726989|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
19726990|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19726991|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19726992|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19726993|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19726994|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19726995|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726996|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
19726997|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19726998|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19726999|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19727000|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727001|NCT04634721|Bupivacaine|bupivacaine|mesh-list
19727002|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
19727003|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
19727004|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727005|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727006|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
19727007|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727008|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
19727009|NCT04634669|Bupropion|bupropion|mesh-list
19727010|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19727011|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
19727012|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19727013|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19727014|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19727015|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19727016|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727017|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
19727018|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727019|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727020|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19727021|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19727022|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727023|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
19727024|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
19727025|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19727026|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19727027|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
19727028|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727029|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727030|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19727031|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19727032|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19727033|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19727034|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19727035|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
19727036|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727037|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727038|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727039|NCT04634058|Antibodies|antibodies|mesh-list
19727040|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
19727041|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
19727042|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727043|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
19727044|NCT04633902|Olaparib|olaparib|mesh-list
19867758|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867759|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867760|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867761|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
19867762|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867763|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19867764|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
19867765|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867766|NCT00833482|Ritonavir|ritonavir|mesh-list
19867767|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20254798|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20254799|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20254800|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19441372|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19441373|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
19441374|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441375|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19441376|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19441377|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
19441378|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441379|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441380|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19441381|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19441382|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19441383|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19441384|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441385|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19441386|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
19441387|NCT04231877|Hormones|hormones|mesh-ancestor
19441388|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441389|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19441390|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19441391|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19867768|NCT00833482|Voriconazole|voriconazole|mesh-list
19867769|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19867770|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19867771|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867772|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534920|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534921|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534922|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
20534923|NCT01816620|Hormones|hormones|mesh-ancestor
20534924|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534925|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20534926|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867773|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867774|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19867775|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20254801|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735947|NCT04534231|Nicotine|nicotine|mesh-list
19727045|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727046|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727047|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19727048|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727049|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727050|NCT04633850|Dexamethasone|dexamethasone|mesh-list
19727051|NCT04633850|Bupivacaine|bupivacaine|mesh-list
19727052|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727053|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
19727054|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
19727055|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727056|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727057|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19727058|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
19727059|NCT04633850|Hormones|hormones|mesh-ancestor
19727060|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867776|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
19867777|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867778|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19867779|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19867780|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
19867781|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19867782|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19867783|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
19867784|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867785|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867786|NCT00833547|Eszopiclone|eszopiclone|mesh-list
19867787|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19867788|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867789|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867790|NCT00833560|Dexamethasone|dexamethasone|mesh-list
19867791|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
19867792|NCT00833560|Bortezomib|bortezomib|mesh-list
19867793|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19867794|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
19867795|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441392|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
19867796|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867797|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19867798|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
19867799|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867800|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867801|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19867802|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867803|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
19867804|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
19867805|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867806|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867807|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
19867808|NCT00833560|Hormones|hormones|mesh-ancestor
19867809|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441393|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
19441394|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
19441395|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
19441396|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
19867810|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19867811|NCT00833638|Tadalafil|tadalafil|mesh-list
19867812|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
19867813|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19867814|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19867815|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867816|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867817|NCT00833638|Urological Agents|urological agents|mesh-ancestor
19867818|NCT00833703|Clopidogrel|clopidogrel|mesh-list
19867819|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19867820|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20534927|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
20534928|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20534929|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19727061|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19727062|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727063|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
19727064|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
19727065|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727066|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
19727067|NCT04633746|Endostatins|endostatins|mesh-list
19727068|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727069|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19727070|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19727071|NCT04633746|Growth Substances|growth substances|mesh-ancestor
19727072|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727073|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
19727074|NCT04633733|Tacrolimus|tacrolimus|mesh-list
19727075|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727076|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
19727077|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727078|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19727079|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727080|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735141|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735142|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735143|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
19735144|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735145|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20254802|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254803|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20254804|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20254805|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20254806|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254807|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735146|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19735147|NCT04542694|Favipiravir|favipiravir|mesh-list
19735148|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
19735149|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735150|NCT04542993|Zinc|zinc|mesh-list
19735151|NCT04542993|Resveratrol|resveratrol|mesh-list
19735152|NCT04542993|Picolinic acid|picolinic acid|mesh-list
19735153|NCT04542993|Trace Elements|trace elements|mesh-ancestor
19735154|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
19735155|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735156|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
19735157|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727081|NCT04633577|Lidocaine|lidocaine|mesh-list
19727082|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
19727083|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
19727084|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727085|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727086|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
19727087|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727088|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19727089|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19727090|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19727091|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19727092|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727093|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19727094|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19727095|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19727096|NCT04633044|Betaine|betaine|mesh-list
19727097|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19727098|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
19727099|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20254808|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
20254809|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20254810|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20254811|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20254812|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727100|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
19727101|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727102|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19727103|NCT04633122|Sunitinib|sunitinib|mesh-list
19727104|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727105|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19727106|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19727107|NCT04633122|Growth Substances|growth substances|mesh-ancestor
19727108|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727109|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
19727110|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19727111|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727112|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727113|NCT04632693|Ascorbic Acid|ascorbic acid|mesh-list
19727114|NCT04632693|Vitamins|vitamins|mesh-ancestor
19727115|NCT04632693|Micronutrients|micronutrients|mesh-ancestor
19727116|NCT04632693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727117|NCT04632693|Antioxidants|antioxidants|mesh-ancestor
19727118|NCT04632693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727119|NCT04632693|Protective Agents|protective agents|mesh-ancestor
19727120|NCT04632758|Crizotinib|crizotinib|mesh-list
19727121|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727122|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19727123|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727124|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727125|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
19727126|NCT04632316|Fludarabine|fludarabine|mesh-list
19727127|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727128|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
19727129|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727130|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727131|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19727132|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
19727133|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727134|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727135|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20254813|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20254814|NCT00466622|Metformin|metformin|mesh-list
20534930|NCT01816620|Growth Substances|growth substances|mesh-ancestor
20534931|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
19727136|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
19727137|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19727138|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
19727139|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727140|NCT04632433|Cemiplimab|cemiplimab|mesh-list
19727141|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727142|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727143|NCT04632238|Metronidazole|metronidazole|mesh-list
19727144|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735158|NCT04542993|Protective Agents|protective agents|mesh-ancestor
20534932|NCT01816646|Cidofovir|cidofovir|mesh-list
19727145|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727146|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19727147|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19727148|NCT04632121|Nicorandil|nicorandil|mesh-list
19727149|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19727150|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19727151|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
19727152|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
19727153|NCT04632121|Vitamins|vitamins|mesh-ancestor
19727154|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
19727155|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727156|NCT04631874|Varenicline|varenicline|mesh-list
19727157|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19727158|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19727159|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
19727160|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727161|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727162|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727163|NCT04631822|Dexamethasone|dexamethasone|mesh-list
19727164|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727165|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
19727166|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
19727167|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727168|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727169|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19727170|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
19867821|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19867822|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19867823|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
19867824|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867825|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867826|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867827|NCT00833755|Ketamine|ketamine|mesh-list
19867828|NCT00833755|Analgesics|analgesics|mesh-ancestor
19867829|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
19867830|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867831|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867832|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19867833|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19867834|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
19867835|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
19867836|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867837|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19867838|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19867839|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867840|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867841|NCT00833794|Tramadol|tramadol|mesh-list
19867842|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19867843|NCT00833794|Narcotics|narcotics|mesh-ancestor
19867844|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867845|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867846|NCT00833794|Analgesics|analgesics|mesh-ancestor
19867847|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
20534933|NCT01816646|Probenecid|probenecid|mesh-list
20534934|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
20534935|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
20534936|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20534937|NCT01816646|Renal Agents|renal agents|mesh-ancestor
20534938|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
20534939|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20534940|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534941|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534942|NCT01816659|Metformin|metformin|mesh-list
19727171|NCT04631822|Hormones|hormones|mesh-ancestor
19867848|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867849|NCT00833833|Aspirin|aspirin|mesh-list
19867850|NCT00833833|Dexamethasone|dexamethasone|mesh-list
19867851|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
19867852|NCT00833833|Pomalidomide|pomalidomide|mesh-list
19727172|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19727173|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19727174|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727175|NCT04631627|Aspirin|aspirin|mesh-list
19727176|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19727177|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19727178|NCT04631627|Analgesics|analgesics|mesh-ancestor
19727179|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
19727180|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727181|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727182|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727183|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727184|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19727185|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19727186|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727187|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19727188|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19727189|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867853|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19867854|NCT00833833|BB 1101|bb 1101|mesh-list
19867855|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19867856|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
19867857|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
19867858|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254815|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254816|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254817|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
20254818|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254819|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254820|NCT00466791|Methylphenidate|methylphenidate|mesh-list
20254821|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20254822|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441410|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
19441411|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19441412|NCT04211272|Macitentan|macitentan|mesh-list
19441413|NCT04211272|Riociguat|riociguat|mesh-list
19441414|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19441415|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19441416|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
19441417|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254823|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20254824|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20534943|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20534944|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534945|NCT01816789|Buserelin|buserelin|mesh-list
20534946|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20534947|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
20534948|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20534949|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534950|NCT01816958|Ketamine|ketamine|mesh-list
20534951|NCT01816958|Analgesics|analgesics|mesh-ancestor
20534952|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
20534953|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534954|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534955|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20534956|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20534957|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
20534958|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
20534959|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19441418|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19727190|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
19735159|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735160|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19735161|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19735162|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
19735163|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
19735164|NCT04542629|Trace Elements|trace elements|mesh-list
19735165|NCT04542629|Rituximab|rituximab|mesh-list
19735166|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19735167|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735168|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
19735169|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735170|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735171|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
19735172|NCT04542759|Besifloxacin|besifloxacin|mesh-list
19735173|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19735174|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20254825|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735175|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727191|NCT04631315|Prednisolone|prednisolone|mesh-list
19727192|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19727193|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
19727194|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19727195|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
19727196|NCT04631315|Phenylephrine|phenylephrine|mesh-list
19727197|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
19727198|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19727199|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19727200|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
19867859|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867860|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19867861|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
19867862|NCT00833833|Hormones|hormones|mesh-ancestor
20534960|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20534961|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20254826|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254827|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
20254828|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254829|NCT00466843|Prednisone|prednisone|mesh-list
20254830|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20254831|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534962|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20534963|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534964|NCT01816971|Dexamethasone|dexamethasone|mesh-list
20534965|NCT01816971|Lenalidomide|lenalidomide|mesh-list
20534966|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20534967|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
20534968|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
20534969|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20534970|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867863|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19867864|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20254832|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
20254833|NCT00466843|Hormones|hormones|mesh-ancestor
19441419|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19441420|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441421|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
19441422|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19441423|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19441424|NCT04211272|Urological Agents|urological agents|mesh-ancestor
19441425|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19441426|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19441427|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19441428|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
19727201|NCT04631315|Difluprednate|difluprednate|mesh-list
19727202|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19727203|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727204|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
19727205|NCT04631315|Hormones|hormones|mesh-ancestor
19727206|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19727207|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727208|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19727209|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727210|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
19727211|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
19727212|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727213|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19727214|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19727215|NCT04631315|Protective Agents|protective agents|mesh-ancestor
20254834|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254835|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867865|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867866|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
19867867|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867868|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867869|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19867870|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19867871|NCT00833833|Analgesics|analgesics|mesh-ancestor
19867872|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
19867873|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19867874|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19867875|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19867876|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19867877|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19867878|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
19867879|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
19867880|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19867881|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19867882|NCT00833833|Growth Substances|growth substances|mesh-ancestor
19441447|NCT04203160|Gemcitabine|gemcitabine|mesh-list
19441448|NCT04203160|Cisplatin|cisplatin|mesh-list
19727216|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19727217|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
19727218|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
19727219|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19727220|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
19727221|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
19727222|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19727223|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19727224|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19727225|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
19727226|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727227|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727228|NCT04631341|Melatonin|melatonin|mesh-list
19727229|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
19727230|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727231|NCT04631341|Protective Agents|protective agents|mesh-ancestor
19727232|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727233|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727234|NCT04631484|Riboflavin|riboflavin|mesh-list
19727235|NCT04631484|Niacinamide|niacinamide|mesh-list
19727236|NCT04631484|Niacin|niacin|mesh-list
19727237|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
19727238|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
19727239|NCT04631484|Vitamins|vitamins|mesh-ancestor
19727240|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
19727241|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727242|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19727243|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
19727244|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19727245|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
19727246|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727247|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19727248|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
19727249|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19727250|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19727251|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19727252|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
19727253|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19727254|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
19867883|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
19867884|NCT00833911|Tramadol|tramadol|mesh-list
19727255|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727256|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
19867885|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19727257|NCT04631263|Protective Agents|protective agents|mesh-ancestor
19727258|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19727259|NCT04630821|Eusol|eusol|mesh-list
19727260|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
19727261|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441449|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727262|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
19727263|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19727264|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19727265|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727266|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
19867886|NCT00833911|Narcotics|narcotics|mesh-ancestor
19867887|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867888|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867889|NCT00833911|Analgesics|analgesics|mesh-ancestor
19867890|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
19867891|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970003|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970004|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
19970005|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
19970006|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
19970007|NCT01778634|Azithromycin|azithromycin|mesh-list
19970008|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970009|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970010|NCT01778985|Estrogens|estrogens|mesh-list
19970011|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19970012|NCT01778985|Hormones|hormones|mesh-ancestor
19970013|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970014|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975334|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19975335|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441450|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19441451|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
19441452|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441453|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
19441454|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441455|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441456|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19441457|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
19441458|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441459|NCT04201964|Tenecteplase|tenecteplase|mesh-list
19441460|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19975336|NCT01847638|Nepafenac|nepafenac|mesh-list
19975337|NCT01847638|Bromfenac|bromfenac|mesh-list
20254836|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19441461|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19452933|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19975338|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19727267|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727268|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727269|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19727270|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19727271|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727272|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
19727273|NCT04630522|Vitamin D|vitamin d|mesh-list
19867892|NCT00834080|Naltrexone|naltrexone|mesh-list
19867893|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19867894|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19867895|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867896|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
19867897|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867898|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19867899|NCT00834171|Tobramycin|tobramycin|mesh-list
19867900|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19867901|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867902|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19867903|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
19867904|NCT00834210|Dapsone|dapsone|mesh-list
19867905|NCT00834210|Tazarotene|tazarotene|mesh-list
19867906|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19867907|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
19867908|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19867909|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19867910|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19867911|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867912|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867913|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
19867914|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19867915|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
19867916|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
19867917|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
19867918|NCT00834210|Vitamins|vitamins|mesh-ancestor
19867919|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
19867920|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867921|NCT00834288|Tramadol|tramadol|mesh-list
19867922|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19867923|NCT00834288|Narcotics|narcotics|mesh-ancestor
19867924|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867925|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867926|NCT00834288|Analgesics|analgesics|mesh-ancestor
19867927|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
19867928|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867929|NCT00834366|Tramadol|tramadol|mesh-list
19867930|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19867931|NCT00834366|Narcotics|narcotics|mesh-ancestor
19867932|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867933|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867934|NCT00834366|Analgesics|analgesics|mesh-ancestor
19867935|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
19867936|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867937|NCT00834652|Metformin|metformin|mesh-list
19867938|NCT00834652|Sertraline|sertraline|mesh-list
19867939|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19867940|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867941|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
19867942|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867943|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19867944|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19867945|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867946|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867947|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867948|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
19867949|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19867950|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19867951|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19867952|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19867953|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867954|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867955|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19867956|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
20254837|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727274|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
19727275|NCT04630522|Calcium|calcium|mesh-list
19727276|NCT04630522|Vitamins|vitamins|mesh-ancestor
19727277|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
19867957|NCT00834808|Tramadol|tramadol|mesh-list
19727278|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727279|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19727280|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19727281|NCT04630444|Riluzole|riluzole|mesh-list
19727282|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
19727283|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19727284|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19727285|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727286|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727287|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727288|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19727289|NCT04630444|Protective Agents|protective agents|mesh-ancestor
19727290|NCT04630548|Copper|copper|mesh-list
19727291|NCT04630548|Trace Elements|trace elements|mesh-ancestor
19727292|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
19727293|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727294|NCT04630288|Clopidogrel|clopidogrel|mesh-list
19727295|NCT04630288|Ticagrelor|ticagrelor|mesh-list
19727296|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20254838|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
20254839|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254840|NCT00466856|Octreotide|octreotide|mesh-list
20254841|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254842|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20254843|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254844|NCT00466869|Betahistine|betahistine|mesh-list
20534971|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20534972|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
20534973|NCT01816971|Hormones|hormones|mesh-ancestor
20534974|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20534975|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20534976|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441462|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441463|NCT04172675|Gemcitabine|gemcitabine|mesh-list
19727297|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19727298|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19727299|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19727300|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
19727301|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727302|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727303|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727304|NCT04630171|Anesthetics|anesthetics|mesh-list
19727305|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727306|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727307|NCT04629885|Oxytocin|oxytocin|mesh-list
19727308|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
19727309|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19727310|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727311|NCT04629976|Tenofovir|tenofovir|mesh-list
19727312|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
19727313|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441464|NCT04172675|Mitomycins|mitomycins|mesh-list
19441465|NCT04172675|Mitomycin|mitomycin|mesh-list
19441466|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19441467|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
19441468|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441469|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441470|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
19441471|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441472|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441473|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19441474|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
19441475|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441476|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19441477|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
19441478|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19867958|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19867959|NCT00834808|Narcotics|narcotics|mesh-ancestor
19727314|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19727315|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19727316|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727317|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727318|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20254845|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
19727319|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19727320|NCT04630210|Atezolizumab|atezolizumab|mesh-list
19727321|NCT04630210|Letrozole|letrozole|mesh-list
19727322|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727323|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19727324|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19727325|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727326|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727327|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19727328|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
19727329|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19727330|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727331|NCT04629495|Sirolimus|sirolimus|mesh-list
19727332|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727333|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727334|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19727335|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727336|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
19727337|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727338|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
19727339|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727340|NCT04629846|Docetaxel|docetaxel|mesh-list
19727341|NCT04629846|Trastuzumab|trastuzumab|mesh-list
19727342|NCT04629846|Pertuzumab|pertuzumab|mesh-list
19727343|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727344|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19727345|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19727346|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19727347|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727348|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727349|NCT04629573|Anesthetics|anesthetics|mesh-list
19727350|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727351|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727352|NCT04629612|Anesthetics|anesthetics|mesh-list
19727353|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727354|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727355|NCT04629144|Belimumab|belimumab|mesh-list
19727356|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727357|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
19727358|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735176|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735177|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19735178|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19735179|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735180|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735181|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735182|NCT04542733|Everolimus|everolimus|mesh-list
19735183|NCT04542733|Tacrolimus|tacrolimus|mesh-list
19735184|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735185|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
19735186|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735187|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19735188|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735189|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735190|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735191|NCT04542395|Vaccines|vaccines|mesh-list
19735192|NCT04542395|Immunologic Factors|immunologic factors|mesh-ancestor
19735193|NCT04542395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735194|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19735195|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19735196|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19735197|NCT04542226|Bromides|bromides|mesh-list
19735198|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
19735199|NCT04542213|Insulin|insulin|mesh-list
19735200|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19735201|NCT04542213|Linagliptin|linagliptin|mesh-list
19735202|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19735203|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735204|NCT04542213|Incretins|incretins|mesh-ancestor
19735205|NCT04542213|Hormones|hormones|mesh-ancestor
19735206|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735207|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19970015|NCT01779167|Thalidomide|thalidomide|mesh-list
19867960|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727359|NCT04629209|TIC10 compound|tic10 compound|mesh-list
19727360|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727361|NCT04629196|Ustekinumab|ustekinumab|mesh-list
19727362|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
19727363|NCT04628884|Heparin|heparin|mesh-list
19727364|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
19727365|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19727366|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19727367|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727368|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19727369|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727370|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727371|NCT04629118|Sirolimus|sirolimus|mesh-list
19727372|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727373|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727374|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19727375|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727376|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
19727377|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727378|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
19727379|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727380|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
19727381|NCT04628559|Ketamine|ketamine|mesh-list
19727382|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19727383|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727384|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727385|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19727386|NCT04628559|Analgesics|analgesics|mesh-ancestor
19727387|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
19727388|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727389|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19727390|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19727391|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19727392|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
19727393|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727394|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727395|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19727396|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19727397|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
19727398|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
19727399|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19727400|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19727401|NCT04628676|Epinephrine|epinephrine|mesh-list
19727402|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
19727403|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
19727404|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19727405|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19727406|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
19727407|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867961|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867962|NCT00834808|Analgesics|analgesics|mesh-ancestor
19727408|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441484|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
19441485|NCT04155203|Mupirocin|mupirocin|mesh-list
19441486|NCT04155203|Calcium|calcium|mesh-list
19441487|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19441488|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441489|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19441490|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727409|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727410|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19867963|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
19727411|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19727412|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
19727413|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727414|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19727415|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
19727416|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
19727417|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
19727418|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19727419|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19727420|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19727421|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
19727422|NCT04628676|Coagulants|coagulants|mesh-ancestor
19727423|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
19727424|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19727425|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19727426|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727427|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19727428|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19727429|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727430|NCT04628325|Furosemide|furosemide|mesh-list
19727431|NCT04628325|Diuretics|diuretics|mesh-ancestor
19727432|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
19727433|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727434|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19727435|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19727436|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727437|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
19727438|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19727439|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19727440|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19727441|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727442|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727443|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727444|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
19727445|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
19727446|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727447|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
19727448|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19727449|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
19727450|NCT04628624|Antioxidants|antioxidants|mesh-list
19727451|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727452|NCT04628624|Protective Agents|protective agents|mesh-ancestor
19727453|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727454|NCT04628000|Vitamin D|vitamin d|mesh-list
19727455|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
19727456|NCT04628000|Vitamins|vitamins|mesh-list
19727457|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
19727458|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727459|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19727460|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19727461|NCT04627870|Paclitaxel|paclitaxel|mesh-list
19727462|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19727463|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727464|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
19727465|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
19727466|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
19727467|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254846|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
20254847|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
20254848|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254849|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254850|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254851|NCT00466895|Lenalidomide|lenalidomide|mesh-list
20254852|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
20254853|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254854|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20254855|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20254856|NCT00466895|Growth Substances|growth substances|mesh-ancestor
20254857|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
20254858|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727468|NCT04628143|Nafamostat|nafamostat|mesh-list
19727469|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19727470|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19727471|NCT04628143|Analgesics|analgesics|mesh-ancestor
19727472|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
19727473|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867964|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867965|NCT00834834|Fluoxetine|fluoxetine|mesh-list
19867966|NCT00834834|Citalopram|citalopram|mesh-list
19867967|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19867968|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19867969|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19867970|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867971|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19867972|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
19867973|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867974|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19867975|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
19867976|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19867977|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19867978|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19867979|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19867980|NCT00834886|Melatonin|melatonin|mesh-list
19867981|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
19867982|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19867983|NCT00834886|Protective Agents|protective agents|mesh-ancestor
19867984|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867985|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867986|NCT00834899|Eptifibatide|eptifibatide|mesh-list
19867987|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19867988|NCT00834912|Tramadol|tramadol|mesh-list
19867989|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19867990|NCT00834912|Narcotics|narcotics|mesh-ancestor
19867991|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19867992|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867993|NCT00834912|Analgesics|analgesics|mesh-ancestor
19867994|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
19867995|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19867996|NCT00835120|Pioglitazone|pioglitazone|mesh-list
19867997|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19867998|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19867999|NCT00835159|Rivastigmine|rivastigmine|mesh-list
19727474|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727475|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868000|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19868001|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868002|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868003|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
19868004|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868005|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727476|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868006|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19868007|NCT00835159|Protective Agents|protective agents|mesh-ancestor
19868008|NCT00835185|Leucovorin|leucovorin|mesh-list
19868009|NCT00835185|Folic Acid|folic acid|mesh-list
19868010|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
19868011|NCT00835185|Necitumumab|necitumumab|mesh-list
20254859|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19868012|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
19868013|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19868014|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727477|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
19727478|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
19727479|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727480|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727481|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19727482|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19727483|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19727484|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727485|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
19727486|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
19727487|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19727488|NCT04627779|Analgesics|analgesics|mesh-ancestor
19727489|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
19727490|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727491|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727492|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19727493|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19727494|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727495|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727496|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19727497|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727498|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727499|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19727500|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19727501|NCT04627467|Chloroquine|chloroquine|mesh-list
19727502|NCT04627467|Amebicides|amebicides|mesh-ancestor
19727503|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19727504|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19727505|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727506|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
19727507|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727508|NCT04627623|Antibodies|antibodies|mesh-list
19727509|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
19727510|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
19727511|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727512|NCT04627363|Bevacizumab|bevacizumab|mesh-list
19727513|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727514|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727515|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19868015|NCT00835185|Antidotes|antidotes|mesh-ancestor
19727516|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19727517|NCT04627363|Growth Substances|growth substances|mesh-ancestor
19727518|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727519|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
19735208|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
19735209|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735210|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735211|NCT04542369|Etoposide|etoposide|mesh-list
19735212|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735213|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19735214|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19735215|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19735216|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735217|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735218|NCT04542304|Metolazone|metolazone|mesh-list
19735219|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19735220|NCT04542304|Diuretics|diuretics|mesh-ancestor
19735221|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
19735222|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735223|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19735224|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735225|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735226|NCT04542252|Cyclosporine|cyclosporine|mesh-list
19735227|NCT04542252|Cyclosporins|cyclosporins|mesh-list
19735228|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868016|NCT00835185|Protective Agents|protective agents|mesh-ancestor
19868017|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868018|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
19868019|NCT00835185|Vitamins|vitamins|mesh-ancestor
19868020|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
19868021|NCT00835185|Hematinics|hematinics|mesh-ancestor
19868022|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19868023|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
19868024|NCT00835198|Dapsone|dapsone|mesh-list
19868025|NCT00835198|Tretinoin|tretinoin|mesh-list
19868026|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868027|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
19868028|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
19868029|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868030|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
19868031|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19868032|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19868033|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19868034|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868035|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868036|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
19868037|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868038|NCT00835224|Midodrine|midodrine|mesh-list
19868039|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
19868040|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
19868041|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868042|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868043|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19868044|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19868045|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19735229|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735230|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735231|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
19735232|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735233|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
19735234|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735235|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
19735236|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735237|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19735238|NCT04541719|Remifentanil|remifentanil|mesh-list
19735239|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19735240|NCT04541719|Narcotics|narcotics|mesh-ancestor
19735241|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735242|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735243|NCT04541719|Analgesics|analgesics|mesh-ancestor
19868046|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19868047|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
19868048|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727520|NCT04627298|Vaccines|vaccines|mesh-list
19727521|NCT04627298|Immunologic Factors|immunologic factors|mesh-ancestor
19727522|NCT04627298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727523|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
19727524|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
19441491|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441492|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19441493|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441494|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868049|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868050|NCT00835510|Butenafine|butenafine|mesh-list
19868051|NCT00835510|Clotrimazole|clotrimazole|mesh-list
19868052|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
19868053|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868054|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20254860|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254861|NCT00466999|Misoprostol|misoprostol|mesh-list
20254862|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20254863|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
20254864|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20254865|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254866|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20254867|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254868|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
20254869|NCT00467012|Paclitaxel|paclitaxel|mesh-list
20254870|NCT00467012|Bevacizumab|bevacizumab|mesh-list
20254871|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20254872|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254873|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
19868055|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19868056|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19868057|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868058|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868059|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19868060|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
19868061|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868062|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254874|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
19441517|NCT04132388|Adalimumab|adalimumab|mesh-list
19441518|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19441519|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19441536|NCT04099836|Bevacizumab|bevacizumab|mesh-list
19441537|NCT04099836|Atezolizumab|atezolizumab|mesh-list
19441538|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19441539|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441540|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19441541|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19441542|NCT04099836|Growth Substances|growth substances|mesh-ancestor
19441543|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727525|NCT04627181|Hematinics|hematinics|mesh-ancestor
19727526|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
19727527|NCT04627181|Vitamins|vitamins|mesh-ancestor
19441544|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
19727528|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
19727529|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727530|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
19727531|NCT04627012|Lenvatinib|lenvatinib|mesh-list
19727532|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727533|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727534|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727535|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19727536|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727537|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
19727538|NCT04626739|Fludarabine|fludarabine|mesh-list
19727539|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727540|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
19727541|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727542|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727543|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19727544|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
19727545|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727546|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727547|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19727548|NCT04627129|Itraconazole|itraconazole|mesh-list
19727549|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
19727550|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441545|NCT04099355|Dronabinol|dronabinol|mesh-list
19441546|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
19441547|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441548|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19441549|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19441550|NCT04099355|Analgesics|analgesics|mesh-ancestor
19441551|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
19441552|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19441553|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19441554|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19441555|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19441556|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441557|NCT04099355|Hormones|hormones|mesh-ancestor
19441558|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441559|NCT04092894|Suvorexant|suvorexant|mesh-list
19441560|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19441561|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19441562|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19441563|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441564|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19441565|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19441566|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868063|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
19868064|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
19868065|NCT00835731|Misoprostol|misoprostol|mesh-list
19868066|NCT00835731|Vitamins|vitamins|mesh-ancestor
19868067|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
19868068|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868069|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19868070|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
19868071|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19868072|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19868073|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19868074|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
19868075|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
19868076|NCT00835731|Hematinics|hematinics|mesh-ancestor
19868077|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19868078|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
19868079|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868080|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
19868081|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868082|NCT00835861|Insulin|insulin|mesh-list
19868083|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19868084|NCT00835861|Metformin|metformin|mesh-list
19868085|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
19868086|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
19868087|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868088|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868089|NCT00835900|Varenicline|varenicline|mesh-list
19868090|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19868091|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19868092|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
19868093|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868094|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868095|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441600|NCT04073615|Trifluridine|trifluridine|mesh-list
19441601|NCT04073615|Apatinib|apatinib|mesh-list
19441602|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441603|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20254875|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
19727551|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19727552|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19727553|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727554|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727555|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19727556|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
19727557|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19727558|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727559|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19727560|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19868096|NCT00835926|Vaccines|vaccines|mesh-list
19441604|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452934|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534977|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
19727561|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19727562|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727563|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
19727564|NCT04626765|Fludarabine|fludarabine|mesh-list
19727565|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727566|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
19727567|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727568|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727569|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19727570|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
19727571|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727572|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727573|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19727574|NCT04626973|Ezetimibe|ezetimibe|mesh-list
19727575|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19727576|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19727577|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19727578|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
19727579|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727580|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19727581|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727582|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
19727583|NCT04626752|Fludarabine|fludarabine|mesh-list
19727584|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727585|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
19727586|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727587|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727588|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19727589|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
19727590|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727591|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727592|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19727593|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
19727594|NCT04626726|Fludarabine|fludarabine|mesh-list
19727595|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727596|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
19727597|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727598|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727599|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19727600|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
19727601|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727602|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727603|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19727604|NCT04626414|Ferric maltol|ferric maltol|mesh-list
19727605|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
19727606|NCT04626414|Hematinics|hematinics|mesh-ancestor
19727607|NCT04626089|Metformin|metformin|mesh-list
19727608|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19727609|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727610|NCT04626193|Amoxicillin|amoxicillin|mesh-list
19727611|NCT04626193|Doxycycline|doxycycline|mesh-list
19727612|NCT04626193|Levofloxacin|levofloxacin|mesh-list
19727613|NCT04626193|Ofloxacin|ofloxacin|mesh-list
20534978|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20534979|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20534980|NCT01816971|Growth Substances|growth substances|mesh-ancestor
19727614|NCT04626193|Esomeprazole|esomeprazole|mesh-list
20534981|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
20534982|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20534983|NCT01816997|Pravastatin|pravastatin|mesh-list
20534984|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20534985|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20534986|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
20534987|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20534988|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20534989|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20534990|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20534991|NCT01817023|Cisplatin|cisplatin|mesh-list
20534992|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20534993|NCT01817036|Vitamin D|vitamin d|mesh-list
20534994|NCT01817036|Vitamins|vitamins|mesh-ancestor
20534995|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
20534996|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20534997|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20534998|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
20534999|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20535000|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20535001|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20535002|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535003|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
20535004|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20535005|NCT01817257|Heparin|heparin|mesh-list
20535006|NCT01817257|Enoxaparin|enoxaparin|mesh-list
20535007|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20535008|NCT01817257|Tinzaparin|tinzaparin|mesh-list
20535009|NCT01817257|Dalteparin|dalteparin|mesh-list
20535010|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
20535011|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20535012|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20535013|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535014|NCT01817283|Triptolide|triptolide|mesh-list
20535015|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19868097|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
20535016|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535017|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20535018|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
20535019|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20535020|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535021|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
20535022|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20535023|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
20554980|NCT01938144|Analgesics|analgesics|mesh-ancestor
19441605|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254876|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254877|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254878|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20254879|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20254880|NCT00467012|Growth Substances|growth substances|mesh-ancestor
20254881|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254882|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
20254883|NCT00467116|Gemcitabine|gemcitabine|mesh-list
20254884|NCT00467116|Cetuximab|cetuximab|mesh-list
19441606|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
19441607|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
19441608|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19441609|NCT04072042|Apatinib|apatinib|mesh-list
19441610|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441611|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19441612|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441613|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868098|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727615|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727616|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727617|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19727618|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19727619|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19727620|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727621|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727622|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
19727623|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19727624|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19727625|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19727626|NCT04626193|Renal Agents|renal agents|mesh-ancestor
19727627|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19727628|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19727629|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254885|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254886|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
20254887|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254888|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727630|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19868099|NCT00835978|Axitinib|axitinib|mesh-list
19868100|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868101|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19868102|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868103|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868104|NCT00836277|Irinotecan|irinotecan|mesh-list
19868105|NCT00836277|Panitumumab|panitumumab|mesh-list
19868106|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19868107|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19868108|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868109|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868110|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868111|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19868112|NCT00836407|Ipilimumab|ipilimumab|mesh-list
19868113|NCT00836407|Vaccines|vaccines|mesh-list
19868114|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
19868115|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727631|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19727632|NCT04626258|Fluconazole|fluconazole|mesh-list
19727633|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
19727634|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868116|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254889|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
19868117|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868118|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19868119|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868120|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19868121|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
19868122|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868123|NCT00836693|Tadalafil|tadalafil|mesh-list
19868124|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19868125|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19868126|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19868127|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868128|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868129|NCT00836693|Urological Agents|urological agents|mesh-ancestor
19868130|NCT00836810|Prednisone|prednisone|mesh-list
19868131|NCT00836810|Prednisolone|prednisolone|mesh-list
19441630|NCT04026113|Linaclotide|linaclotide|mesh-list
19441631|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19441632|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
19441633|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441634|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19868132|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868133|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
19441637|NCT04024436|Fulvestrant|fulvestrant|mesh-list
19441638|NCT04024436|Futibatinib|futibatinib|mesh-list
19441639|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19441640|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441641|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19441642|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19441643|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
19441644|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441645|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868134|NCT00836810|Hormones|hormones|mesh-ancestor
19868135|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868136|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868137|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19868138|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868139|NCT00836875|Voriconazole|voriconazole|mesh-list
19441653|NCT03991884|Prednisone|prednisone|mesh-list
19441654|NCT03991884|Cortisone|cortisone|mesh-list
19441655|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
19441656|NCT03991884|Doxorubicin|doxorubicin|mesh-list
19441657|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19441658|NCT03991884|Etoposide|etoposide|mesh-list
19441659|NCT03991884|Vincristine|vincristine|mesh-list
19441660|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
19441661|NCT03991884|Daunorubicin|daunorubicin|mesh-list
19441662|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
19441663|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19441664|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19441665|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
19441666|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441667|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19441668|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19441669|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
19441670|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441671|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441672|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20254890|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254891|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254892|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254893|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
20254894|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254895|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254896|NCT00467181|Fenoldopam|fenoldopam|mesh-list
19441673|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20254897|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20254898|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
20254899|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
20254900|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
20254901|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535024|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535025|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535026|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
20535027|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
20535028|NCT01817322|Prednisolone|prednisolone|mesh-list
20535029|NCT01817322|Deflazacort|deflazacort|mesh-list
20535030|NCT01817322|Basiliximab|basiliximab|mesh-list
20535031|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535032|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
20535033|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
20535034|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535035|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535036|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20535037|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
20535038|NCT01817322|Hormones|hormones|mesh-ancestor
20535039|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441674|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19868140|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
19868141|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868142|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19868143|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19868144|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868145|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868146|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19868147|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
19868148|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868149|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868150|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19868151|NCT00836888|Nivolumab|nivolumab|mesh-list
19868152|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19868153|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868154|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19868155|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868156|NCT00836927|Sirolimus|sirolimus|mesh-list
19868157|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868158|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868159|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20254902|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441675|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19441676|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441677|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19441678|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
19441679|NCT03991884|Hormones|hormones|mesh-ancestor
19441680|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441681|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19441682|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19441683|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
19441684|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
19441685|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
19441686|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
19441687|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
19441688|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254903|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254904|NCT00467194|Sirolimus|sirolimus|mesh-list
20254905|NCT00467194|Bevacizumab|bevacizumab|mesh-list
20254906|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20254907|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254908|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20254909|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20254910|NCT00467194|Growth Substances|growth substances|mesh-ancestor
20254911|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254912|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
20254913|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20254914|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254915|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20254916|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
20254917|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20254918|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
20254919|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
19868160|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868161|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
19868162|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868163|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
19868164|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868165|NCT00837031|Gemcitabine|gemcitabine|mesh-list
19868166|NCT00837031|Lenalidomide|lenalidomide|mesh-list
19868167|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20254920|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20254921|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20254922|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20254923|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20254924|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535040|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20535041|NCT01817322|Protective Agents|protective agents|mesh-ancestor
20535042|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20535043|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535044|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20535045|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20535046|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
20535047|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20535048|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535049|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535050|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535051|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535052|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
20535053|NCT01817348|Lidocaine|lidocaine|mesh-list
20535054|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
19868168|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
19868169|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868170|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868171|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
19868172|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868173|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868174|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868175|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
19868176|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868177|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19868178|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19868179|NCT00837031|Growth Substances|growth substances|mesh-ancestor
20254925|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
20254926|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254927|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254928|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20254929|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254930|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
20254931|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254932|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254933|NCT00467376|Insulin|insulin|mesh-list
20254934|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20254935|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
20254936|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
20254937|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254938|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254939|NCT00467454|Naltrexone|naltrexone|mesh-list
20254940|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20254941|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20254942|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868180|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
19868181|NCT00837148|Sorafenib|sorafenib|mesh-list
19868182|NCT00837148|Dacarbazine|dacarbazine|mesh-list
19868183|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868184|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19868185|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868186|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868187|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19868188|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
19868189|NCT00837200|Doxorubicin|doxorubicin|mesh-list
19868190|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19868191|NCT00837200|Asparaginase|asparaginase|mesh-list
19868192|NCT00837200|Pegaspargase|pegaspargase|mesh-list
19868193|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19868194|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868195|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19868196|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19868197|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868198|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868199|NCT00837213|Doxycycline|doxycycline|mesh-list
19868200|NCT00837213|Clindamycin|clindamycin|mesh-list
19868201|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
19868202|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
19868203|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19868204|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868205|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868206|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
19868207|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19868208|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19868209|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19868210|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868211|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868212|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
19868213|NCT00837252|Finasteride|finasteride|mesh-list
19868214|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19868215|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19868216|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868217|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868218|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
19868219|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868220|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868221|NCT00837252|Urological Agents|urological agents|mesh-ancestor
19868222|NCT00837330|Ranibizumab|ranibizumab|mesh-list
19868223|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19868224|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19868225|NCT00837330|Growth Substances|growth substances|mesh-ancestor
19868226|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868227|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
20254943|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
20535055|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
20535056|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535057|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535058|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
20535059|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535060|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20535061|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19727635|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19727636|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19727637|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727638|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727639|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19727640|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
19727641|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535062|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20535063|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535064|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535065|NCT01817400|Aspirin|aspirin|mesh-list
20535066|NCT01817400|Pioglitazone|pioglitazone|mesh-list
20535067|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
20535068|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20535069|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20535070|NCT01817400|Analgesics|analgesics|mesh-ancestor
20535071|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
20535072|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535073|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535074|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535075|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20535076|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20535077|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19868228|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868229|NCT00837434|Adalimumab|adalimumab|mesh-list
19868230|NCT00837434|Etanercept|etanercept|mesh-list
19868231|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868232|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868233|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19868234|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19868235|NCT00837434|Analgesics|analgesics|mesh-ancestor
19868236|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
19868237|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868238|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868239|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19868240|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868241|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
19868242|NCT00837512|Insulin|insulin|mesh-list
19868243|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19441769|NCT03942211|Selexipag|selexipag|mesh-list
19441770|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19727642|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727643|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19727644|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19727645|NCT04626063|Acetaminophen|acetaminophen|mesh-list
19727646|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19727647|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19727648|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19727649|NCT04626063|Analgesics|analgesics|mesh-ancestor
19727650|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
19727651|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727652|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727653|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
19727654|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727655|NCT04625985|Metformin|metformin|mesh-list
19727656|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19727657|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727658|NCT04625907|Dactinomycin|dactinomycin|mesh-list
19727659|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
20254944|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20254945|NCT00467467|Alfuzosin|alfuzosin|mesh-list
20254946|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20254947|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20254948|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20254949|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
20254950|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20254951|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254952|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254953|NCT00467467|Urological Agents|urological agents|mesh-ancestor
20254954|NCT00467493|Anastrozole|anastrozole|mesh-list
20254955|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20254956|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20254957|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20254958|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20254959|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254960|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254961|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20254962|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
20254963|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254964|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254965|NCT00467506|Antibodies|antibodies|mesh-list
20254966|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20254967|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
20254968|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868244|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868245|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868246|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19868247|NCT00837577|Voglibose|voglibose|mesh-list
19868248|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868249|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868250|NCT00837577|Incretins|incretins|mesh-ancestor
19868251|NCT00837577|Hormones|hormones|mesh-ancestor
19868252|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868253|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19868254|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
19868255|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868256|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868257|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19868258|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19868259|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
19868260|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19441798|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
19441799|NCT03912831|Fludarabine|fludarabine|mesh-list
19441800|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19441801|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
19441802|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441803|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19441804|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19441805|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
20254969|NCT00467545|Telbivudine|telbivudine|mesh-list
20254970|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
19441806|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441807|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441808|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19868261|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19868262|NCT00837590|Analgesics|analgesics|mesh-ancestor
19868263|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
19868264|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868265|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868266|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868267|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868268|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19868269|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868270|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254971|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20254972|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20254973|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254974|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254975|NCT00467571|Amoxicillin|amoxicillin|mesh-list
20254976|NCT00467571|Clarithromycin|clarithromycin|mesh-list
20254977|NCT00467571|Lansoprazole|lansoprazole|mesh-list
20254978|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
19868271|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19868272|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19868273|NCT00837616|Estradiol|estradiol|mesh-list
19868274|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19868275|NCT00837616|Estrogens|estrogens|mesh-ancestor
19868276|NCT00837616|Hormones|hormones|mesh-ancestor
20254979|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868277|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20254980|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727660|NCT04625907|Temozolomide|temozolomide|mesh-list
19727661|NCT04625907|Ifosfamide|ifosfamide|mesh-list
19727662|NCT04625907|Doxorubicin|doxorubicin|mesh-list
19727663|NCT04625907|Irinotecan|irinotecan|mesh-list
19727664|NCT04625907|Vincristine|vincristine|mesh-list
19727665|NCT04625907|Vinorelbine|vinorelbine|mesh-list
19727666|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727667|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
19727668|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727669|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868278|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254981|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20254982|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727670|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19727671|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
19868279|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19727672|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727673|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727674|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19727675|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19727676|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19727677|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19727678|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727679|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19727680|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19727681|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
19727682|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
19727683|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
19727684|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727685|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727686|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19727687|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19727688|NCT04625699|Durvalumab|durvalumab|mesh-list
19727689|NCT04625699|Tremelimumab|tremelimumab|mesh-list
19727690|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727691|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727692|NCT04625608|Acetaminophen|acetaminophen|mesh-list
19727693|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19868280|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
19868281|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19868282|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20254983|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254984|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20254985|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20254986|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20254987|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20254988|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20254989|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
20254990|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20254991|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20254992|NCT00467662|Acyclovir|acyclovir|mesh-list
19868283|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19868284|NCT00837759|Lansoprazole|lansoprazole|mesh-list
19868285|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
19868286|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868287|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868288|NCT00837759|Incretins|incretins|mesh-ancestor
19868289|NCT00837759|Hormones|hormones|mesh-ancestor
19868290|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19441822|NCT03910621|Miglustat|miglustat|mesh-list
19441823|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254993|NCT00467662|Docosanol|docosanol|mesh-list
20254994|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
20254995|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286716|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286717|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20286718|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20286719|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20286720|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286721|NCT02652052|Dasatinib|dasatinib|mesh-list
20286722|NCT02652052|Quercetin|quercetin|mesh-list
20286723|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19441824|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441825|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19441826|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19441827|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
19727694|NCT04625608|Analgesics|analgesics|mesh-ancestor
20286724|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20286725|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286726|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286727|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
20286728|NCT02652052|Protective Agents|protective agents|mesh-ancestor
20286729|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286730|NCT02595931|Irinotecan|irinotecan|mesh-list
20286731|NCT02595931|Camptothecin|camptothecin|mesh-list
20286732|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19441828|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727695|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
19727696|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727697|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727698|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
19727699|NCT04625595|Methyldopa|methyldopa|mesh-list
19727700|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19727701|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
19727702|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
19727703|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727704|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727705|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19868291|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19868292|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
20286733|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20286734|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554981|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
19441829|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19441830|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19441831|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868293|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868294|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868295|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19868296|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19868297|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19868298|NCT00837876|Sorafenib|sorafenib|mesh-list
19868299|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868300|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19868301|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868302|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868303|NCT00837902|Atenolol|atenolol|mesh-list
19868304|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19868305|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19868306|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
19868307|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
19868308|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868309|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441850|NCT03909607|Ketamine|ketamine|mesh-list
19441851|NCT03909607|Analgesics|analgesics|mesh-ancestor
19441852|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
19441853|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19441854|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441855|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19441856|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19441857|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
19441858|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
19441859|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19441860|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19441861|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19441862|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452935|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
19441863|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20254996|NCT00467766|Donepezil|donepezil|mesh-list
20254997|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20254998|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20254999|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255000|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
20255001|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255002|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255003|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
20255004|NCT00467883|Amphotericin B|amphotericin b|mesh-list
20255005|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20255006|NCT00467883|Amebicides|amebicides|mesh-ancestor
20255007|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20255008|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20255009|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255010|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20255011|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
20255012|NCT00467909|Micronutrients|micronutrients|mesh-list
20255013|NCT00467909|Trace Elements|trace elements|mesh-list
20255014|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255015|NCT00467935|Ranibizumab|ranibizumab|mesh-list
20255016|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255017|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255018|NCT00467935|Growth Substances|growth substances|mesh-ancestor
20255019|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255020|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255021|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255022|NCT00467948|Cefazolin|cefazolin|mesh-list
19441893|NCT03904693|Tadalafil|tadalafil|mesh-list
19441894|NCT03904693|Macitentan|macitentan|mesh-list
19441895|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19441896|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19441897|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19441898|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19441899|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19441900|NCT03904693|Urological Agents|urological agents|mesh-ancestor
19441901|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19441902|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19441903|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19441904|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19441905|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
19441906|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19441907|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19441908|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19441909|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
19441910|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19441911|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255023|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20255024|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255025|NCT00467987|Testosterone|testosterone|mesh-list
20255026|NCT00467987|Androgens|androgens|mesh-ancestor
20255027|NCT00467987|Hormones|hormones|mesh-ancestor
20286735|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868310|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20535078|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535079|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20535080|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20535081|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535082|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
20535083|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535084|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20535085|NCT01817439|Amiodarone|amiodarone|mesh-list
20535086|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20255028|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255029|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255030|NCT00468091|Atropine|atropine|mesh-list
20255031|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19727706|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19727707|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19727708|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
19727709|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727710|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727711|NCT04625283|Ketamine|ketamine|mesh-list
19727712|NCT04625283|Analgesics|analgesics|mesh-ancestor
19727713|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
20255032|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20535087|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535088|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20535089|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535090|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535091|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20535092|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19441912|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19868311|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19868312|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19868313|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
19868314|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868315|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868316|NCT00837967|Terbutaline|terbutaline|mesh-list
19868317|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19868318|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19868319|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
19868320|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19868321|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
19868322|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868323|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868324|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
19868325|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
19868326|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19868327|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19868328|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19868329|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19868330|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
20255033|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20255034|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
20255035|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255036|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868331|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868332|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868333|NCT00838162|Ritonavir|ritonavir|mesh-list
19868334|NCT00838162|TMC-310911|tmc-310911|mesh-list
19868335|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19868336|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19868337|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
19868338|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868339|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868340|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19868341|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19868342|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
20255037|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20255038|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
20255039|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
20255040|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
20255041|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20255042|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20255043|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
20255044|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255045|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255046|NCT00468182|Interferons|interferons|mesh-list
20255047|NCT00468182|Interferon-beta|interferon-beta|mesh-list
20255048|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
19868343|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868344|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19868345|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19868346|NCT00838201|Denosumab|denosumab|mesh-list
19868347|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19868348|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868349|NCT00838435|Verapamil|verapamil|mesh-list
19868350|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19868351|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19868352|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19868353|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868354|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19868355|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868356|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
19868357|NCT00838513|Eculizumab|eculizumab|mesh-list
19868358|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19868359|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868360|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
19868361|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868362|NCT00838539|Sirolimus|sirolimus|mesh-list
19868363|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868364|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868365|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19868366|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868367|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
19868368|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868369|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
19868370|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868371|NCT00838578|Irinotecan|irinotecan|mesh-list
19868372|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19868373|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19868374|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868375|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868376|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868377|NCT00838682|Omeprazole|omeprazole|mesh-list
19868378|NCT00838682|Rabeprazole|rabeprazole|mesh-list
19868379|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19868380|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19868381|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19868382|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868383|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868384|NCT00838695|Phenylephrine|phenylephrine|mesh-list
19868385|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
19868386|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19868387|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
19868388|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
19868389|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868390|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868391|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
19868392|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19868393|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
19868394|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
19868395|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19868396|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19868397|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19868398|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
19868399|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868400|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868401|NCT00838695|Protective Agents|protective agents|mesh-ancestor
19868402|NCT00838903|Metformin|metformin|mesh-list
19868403|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19868404|NCT00838903|Glimepiride|glimepiride|mesh-list
19868405|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
19868406|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19868407|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868408|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868409|NCT00838903|Incretins|incretins|mesh-ancestor
19868410|NCT00838903|Hormones|hormones|mesh-ancestor
19868411|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868412|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19868413|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
19868414|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868415|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868416|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19868417|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868418|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
19868419|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
19868420|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
19868421|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868422|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868423|NCT00838916|Incretins|incretins|mesh-ancestor
19868424|NCT00838916|Hormones|hormones|mesh-ancestor
19868425|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868426|NCT00838929|Vorinostat|vorinostat|mesh-list
19868427|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868428|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19868429|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868430|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868431|NCT00839072|Trazodone|trazodone|mesh-list
19868432|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19868433|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19868434|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868435|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868436|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19868437|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20255049|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255050|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
20255051|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255052|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
19868438|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19868439|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19868440|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868441|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868442|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
20255053|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442049|NCT03738228|Cisplatin|cisplatin|mesh-list
19727714|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727715|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727716|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19727717|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19727718|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
20255054|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20255055|NCT00468234|Nicotine|nicotine|mesh-list
20255056|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19868443|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19868444|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
19868445|NCT00839254|Vaccines|vaccines|mesh-list
19868446|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19868447|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
19868448|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868449|NCT00839306|Rabeprazole|rabeprazole|mesh-list
19868450|NCT00839306|Ranitidine|ranitidine|mesh-list
19868451|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19868452|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19727719|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
19727720|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727721|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19727722|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19727723|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727724|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727725|NCT04625257|Antibodies|antibodies|mesh-list
19727726|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
19727727|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735244|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
19735245|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735246|NCT04541732|Anesthetics|anesthetics|mesh-list
19735247|NCT04541732|Propofol|propofol|mesh-list
19735248|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735249|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735250|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19868453|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19868454|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19727728|NCT04625543|Paclitaxel|paclitaxel|mesh-list
19727729|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19727730|NCT04625543|Cisplatin|cisplatin|mesh-list
19727731|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19727732|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727733|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
19727734|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
19727735|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
19868455|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868456|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868457|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19868458|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
19868459|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
19868460|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868461|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868462|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19868463|NCT00839319|Testosterone|testosterone|mesh-list
19868464|NCT00839319|Acyline|acyline|mesh-list
19868465|NCT00839319|Androgens|androgens|mesh-ancestor
19868466|NCT00839319|Hormones|hormones|mesh-ancestor
19868467|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868468|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868469|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19868470|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
19970016|NCT01779167|Rituximab|rituximab|mesh-list
19970017|NCT01779167|Lenalidomide|lenalidomide|mesh-list
19727736|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727737|NCT04625426|Protective Agents|protective agents|mesh-list
19727738|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727739|NCT04625179|Melatonin|melatonin|mesh-list
19727740|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
19727741|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
19727742|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868471|NCT00839332|Gemcitabine|gemcitabine|mesh-list
19727743|NCT04625179|Protective Agents|protective agents|mesh-ancestor
19727744|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727745|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19442050|NCT03738228|Atezolizumab|atezolizumab|mesh-list
19727746|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19727747|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
19727748|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
19727749|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19727750|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
19727751|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
19727752|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727753|NCT04624906|Rituximab|rituximab|mesh-list
19727754|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19727755|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
19727756|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727757|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727758|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
19727759|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727760|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727761|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19727762|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
19442051|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19442052|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442053|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
19442054|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868472|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19868473|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
19868474|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868475|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868476|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
19868477|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868478|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868479|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868480|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
19868481|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868482|NCT00839423|Vortioxetine|vortioxetine|mesh-list
19868483|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19868484|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19868485|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19868486|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19868487|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442071|NCT03687957|Temozolomide|temozolomide|mesh-list
19442072|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19442073|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
19442074|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442075|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442076|NCT03664024|Carboplatin|carboplatin|mesh-list
19442077|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
19442078|NCT03664024|Pemetrexed|pemetrexed|mesh-list
19442079|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442080|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442081|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442082|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442083|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19442084|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19868488|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868489|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868490|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19868491|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
19868492|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19868493|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19868494|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19868495|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868496|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19868497|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
19868498|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19868499|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20255057|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
20255058|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255059|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255060|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20255061|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20255062|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
20255063|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255064|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255065|NCT00468260|Epothilone B|epothilone b|mesh-list
20255066|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255067|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
20255068|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
20255069|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
20255070|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255071|NCT00468351|Triamcinolone|triamcinolone|mesh-list
20255072|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20255073|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20255074|NCT00468351|Bevacizumab|bevacizumab|mesh-list
20255075|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20255076|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20255077|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255078|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255079|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255080|NCT00468351|Growth Substances|growth substances|mesh-ancestor
20255081|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255082|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255083|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255084|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
20255085|NCT00468351|Hormones|hormones|mesh-ancestor
20255086|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255087|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255088|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
20255089|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535093|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20535094|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868500|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19868501|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19868502|NCT00839527|Metformin|metformin|mesh-list
19868503|NCT00839527|Pioglitazone|pioglitazone|mesh-list
19868504|NCT00839527|Glimepiride|glimepiride|mesh-list
19452936|NCT03408015|Lifitegrast|lifitegrast|mesh-list
20535095|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20535096|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20535097|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20535098|NCT01817452|Paclitaxel|paclitaxel|mesh-list
20535099|NCT01817452|Trastuzumab|trastuzumab|mesh-list
20535100|NCT01817452|Pertuzumab|pertuzumab|mesh-list
20535101|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20535102|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535103|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
20535104|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535105|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535106|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535107|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20535108|NCT01817699|Vitamin D|vitamin d|mesh-list
20535109|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
20535110|NCT01817699|Vitamins|vitamins|mesh-ancestor
20535111|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
20535112|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535113|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19727763|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727764|NCT04625114|Gabexate|gabexate|mesh-list
19727765|NCT04625114|Camostat|camostat|mesh-list
19727766|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
19727767|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727768|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727769|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19727770|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19868505|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
19868506|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19868507|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868508|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868509|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19868510|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868511|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
19868512|NCT00839527|Incretins|incretins|mesh-ancestor
19868513|NCT00839527|Hormones|hormones|mesh-ancestor
19868514|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868515|NCT00839540|Caspofungin|caspofungin|mesh-list
19868516|NCT00839540|Micafungin|micafungin|mesh-list
19868517|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
19868518|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868519|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868520|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727771|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
19727772|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
19727773|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727774|NCT04624750|Mexiletine|mexiletine|mesh-list
19727775|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19727776|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19727777|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20255090|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255091|NCT00468364|Insulin|insulin|mesh-list
19727778|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19727779|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727780|NCT04624399|Atezolizumab|atezolizumab|mesh-list
19727781|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727782|NCT04624178|Nivolumab|nivolumab|mesh-list
19727783|NCT04624178|Rucaparib|rucaparib|mesh-list
19727784|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727785|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727786|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19727787|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727788|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19727789|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727790|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
19727791|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
19727792|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19727793|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19727794|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727795|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727796|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727797|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727798|NCT04624360|Dexamethasone|dexamethasone|mesh-list
19727799|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727800|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
19868521|NCT00839800|Terbutaline|terbutaline|mesh-list
19868522|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19868523|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19727801|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
19727802|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727803|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868524|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
19868525|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19868526|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
19868527|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868528|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868529|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
19727804|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19727805|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
19727806|NCT04624360|Hormones|hormones|mesh-ancestor
19727807|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19727808|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19727809|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727810|NCT04623879|Ivacaftor|ivacaftor|mesh-list
19727811|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19727812|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19727813|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727814|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
19727815|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727816|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727817|NCT04624217|Gemcitabine|gemcitabine|mesh-list
19727818|NCT04624217|Paclitaxel|paclitaxel|mesh-list
19727819|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19727820|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727821|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
19727822|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
19727823|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
19727824|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868530|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
19868531|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19868532|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19868533|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19868534|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19727825|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19727826|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
19727827|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
19727828|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255092|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19868535|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
19868536|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868537|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868538|NCT00839852|Cariprazine|cariprazine|mesh-list
19868539|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19868540|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19868541|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19442112|NCT03647124|Lenalidomide|lenalidomide|mesh-list
19442113|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
19442114|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442115|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19442116|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19442117|NCT03647124|Growth Substances|growth substances|mesh-ancestor
19442118|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
19442119|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868542|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868543|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19868544|NCT00839956|Bortezomib|bortezomib|mesh-list
19868545|NCT00839956|Vorinostat|vorinostat|mesh-list
19868546|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868547|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19868548|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868549|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868550|NCT00839982|Cytarabine|cytarabine|mesh-list
19868551|NCT00839982|Clofarabine|clofarabine|mesh-list
19868552|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19868553|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
19868554|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868555|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868556|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
19868557|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868558|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868559|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
19868560|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868561|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
19868562|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868563|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868564|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19868565|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19868566|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868567|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868568|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868569|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19868570|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19442149|NCT03573297|Cariprazine|cariprazine|mesh-list
19442150|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19442151|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19442152|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19442153|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442154|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19868571|NCT00840450|Paclitaxel|paclitaxel|mesh-list
19868572|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19868573|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
19868574|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19868575|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868576|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
19868577|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
19868578|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
19868579|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442164|NCT03530995|Itraconazole|itraconazole|mesh-list
19442165|NCT03530995|Rifampin|rifampin|mesh-list
19442166|NCT03530995|Omeprazole|omeprazole|mesh-list
19442167|NCT03530995|Rabeprazole|rabeprazole|mesh-list
19442168|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19442169|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20255093|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
20255094|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
20255095|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
20255096|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
20255097|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20255098|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255099|NCT00468429|Bevacizumab|bevacizumab|mesh-list
19727829|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727830|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727831|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
19727832|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727833|NCT04623866|Valsartan|valsartan|mesh-list
19727834|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19727835|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19727836|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19727837|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727838|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
19727839|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
19727840|NCT04623619|Vitamins|vitamins|mesh-ancestor
19727841|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
19727842|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727843|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
20255100|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727844|NCT04623840|Tadalafil|tadalafil|mesh-list
19727845|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
19727846|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19727847|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19727848|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727849|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727850|NCT04623840|Urological Agents|urological agents|mesh-ancestor
19735251|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19735252|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
19735948|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19735949|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
19735950|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735951|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735952|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19735953|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19735954|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
19735955|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735956|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735957|NCT04534452|Phenylephrine|phenylephrine|mesh-list
19735958|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
19735959|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19735960|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
19735961|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
19735962|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735963|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735964|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
19735965|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19735966|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
19735967|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
19735968|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19735969|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19735970|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19735971|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
19735972|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735973|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735974|NCT04534452|Protective Agents|protective agents|mesh-ancestor
19735975|NCT04534322|Dexamethasone|dexamethasone|mesh-list
19735976|NCT04534322|Melphalan|melphalan|mesh-list
19735977|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735978|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
19735979|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
19735980|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735981|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735982|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19442170|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19442171|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442172|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442173|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
19442174|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442175|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19442176|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19442177|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19442178|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
19442179|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19442180|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442181|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19442182|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19442183|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
19442184|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19442185|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
19442186|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19442187|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19442188|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19442189|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19442190|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19442191|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19442192|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19442193|NCT03521232|Niclosamide|niclosamide|mesh-list
19442194|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
19442195|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19442196|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
19442197|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19442198|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442199|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
19868580|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19868581|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868582|NCT00840463|Ambrisentan|ambrisentan|mesh-list
19868583|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20255101|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255102|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19868584|NCT00840996|Lidocaine|lidocaine|mesh-list
19868585|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
19868586|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
19868587|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868588|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868589|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
19868590|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868591|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19868592|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19868593|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19868594|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452937|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19727851|NCT04623086|Insulin|insulin|mesh-list
19727852|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19727853|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
19727854|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19727855|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727856|NCT04623385|Tretinoin|tretinoin|mesh-list
19727857|NCT04623385|Isotretinoin|isotretinoin|mesh-list
19727858|NCT04623385|Testosterone|testosterone|mesh-list
19727859|NCT04623385|Androgens|androgens|mesh-ancestor
19727860|NCT04623385|Hormones|hormones|mesh-ancestor
19868595|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868596|NCT00841087|Insulin|insulin|mesh-list
19868597|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19868598|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
19868599|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
19868600|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868601|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868602|NCT00841204|Sulindac|sulindac|mesh-list
19868603|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19868604|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19868605|NCT00841204|Analgesics|analgesics|mesh-ancestor
19868606|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
19868607|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868608|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868609|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868610|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868611|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868612|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19868613|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727861|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19727862|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727863|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727864|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
19727865|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
19727866|NCT04623021|Nafamostat|nafamostat|mesh-list
19727867|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19727868|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19727869|NCT04623021|Analgesics|analgesics|mesh-ancestor
19727870|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
19727871|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727872|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727873|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727874|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868614|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868615|NCT00841555|Temozolomide|temozolomide|mesh-list
19868616|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19868617|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
19868618|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868619|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868620|NCT00841568|Tolvaptan|tolvaptan|mesh-list
19868621|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19868622|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868623|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
19868624|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868625|NCT00841672|Amlodipine|amlodipine|mesh-list
19868626|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19868627|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19868628|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19868629|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868630|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19868631|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868632|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
19868633|NCT00841763|Vaccines|vaccines|mesh-list
19868634|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
19868635|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868636|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
19868637|NCT00841828|Docetaxel|docetaxel|mesh-list
19868638|NCT00841828|Trastuzumab|trastuzumab|mesh-list
19868639|NCT00841828|Epirubicin|epirubicin|mesh-list
19868640|NCT00841828|Lapatinib|lapatinib|mesh-list
19868641|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535114|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535115|NCT01817803|Metolazone|metolazone|mesh-list
20535116|NCT01817803|Furosemide|furosemide|mesh-list
20535117|NCT01817803|Spironolactone|spironolactone|mesh-list
20535118|NCT01817803|Diuretics|diuretics|mesh-ancestor
19868642|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
19868643|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868644|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868645|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19868646|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
19970018|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20535119|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
20535120|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535121|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19868647|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868648|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727875|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
19727876|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
19727877|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727878|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727879|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19727880|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19727881|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19727882|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727883|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
19727884|NCT04622618|Gabapentin|gabapentin|mesh-list
19727885|NCT04622618|Analgesics|analgesics|mesh-ancestor
19727886|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
19727887|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727888|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727889|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
19727890|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19868649|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19868650|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
19868651|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
19868652|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
19868653|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19868654|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19868655|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19868656|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19868657|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442250|NCT03449901|Gemcitabine|gemcitabine|mesh-list
19442251|NCT03449901|Docetaxel|docetaxel|mesh-list
19442252|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19442253|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
19442254|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442255|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442256|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
19442257|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442258|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442259|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19442260|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
19442261|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442262|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
19442263|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
19442264|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
19868658|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19868659|NCT00841971|Fluconazole|fluconazole|mesh-list
19868660|NCT00841971|Anidulafungin|anidulafungin|mesh-list
19868661|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
19868662|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868663|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19868664|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19868665|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868666|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727891|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19868667|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19442276|NCT03442972|Teduglutide|teduglutide|mesh-list
19735253|NCT04541823|Propofol|propofol|mesh-list
19727892|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727893|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19727894|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19727895|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19727896|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727897|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727898|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
19727899|NCT04622865|Quercetin|quercetin|mesh-list
19727900|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
19727901|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727902|NCT04622865|Protective Agents|protective agents|mesh-ancestor
19727903|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727904|NCT04622995|Diazepam|diazepam|mesh-list
19727905|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19727906|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
19727907|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
19727908|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
19727909|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727910|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727911|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19727912|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19727913|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19727914|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19727915|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19727916|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19727917|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19727918|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19727919|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19727920|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
19727921|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
19727922|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
19727923|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
19727924|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19727925|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727926|NCT04622709|Furosemide|furosemide|mesh-list
19727927|NCT04622709|Diuretics|diuretics|mesh-list
19727928|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19727929|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
19727930|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727931|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19727932|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727933|NCT04622956|Methotrexate|methotrexate|mesh-list
19727934|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19727935|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
19727936|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19727937|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727938|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19727939|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
19727940|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727941|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727942|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
19727943|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727944|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19727945|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19727946|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
19727947|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727948|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19727949|NCT04622891|Azithromycin|azithromycin|mesh-list
19727950|NCT04622891|Clarithromycin|clarithromycin|mesh-list
19727951|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19727952|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19727953|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19727954|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727955|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727956|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19727957|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19727958|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
19727959|NCT04622566|Lenvatinib|lenvatinib|mesh-list
19868668|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
20255103|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255104|NCT00468429|Growth Substances|growth substances|mesh-ancestor
20255105|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255106|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255107|NCT00468520|Oxytocin|oxytocin|mesh-list
20255108|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
19442277|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19442278|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19442279|NCT03442972|Protective Agents|protective agents|mesh-ancestor
19442280|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442281|NCT03440216|Meropenem|meropenem|mesh-list
20255109|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20255110|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255111|NCT00468533|Aripiprazole|aripiprazole|mesh-list
20255112|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
20255113|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20255114|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20255115|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19442282|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
19442283|NCT03440216|Temocillin|temocillin|mesh-list
19442284|NCT03440216|Penicillins|penicillins|mesh-list
19442285|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19442286|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868669|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735254|NCT04541823|Desflurane|desflurane|mesh-list
20255116|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20255117|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255118|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
19727960|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727961|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727962|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19727963|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727964|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19727965|NCT04622813|Acetaminophen|acetaminophen|mesh-list
19727966|NCT04622813|Ketoprofen|ketoprofen|mesh-list
19727967|NCT04622813|Nefopam|nefopam|mesh-list
19727968|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19727969|NCT04622813|Analgesics|analgesics|mesh-ancestor
19727970|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
19727971|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19727972|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727973|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
19727974|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19727975|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727976|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727977|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19727978|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19727979|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255119|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
19727980|NCT04622579|Rituximab|rituximab|mesh-list
19727981|NCT04622579|Lenalidomide|lenalidomide|mesh-list
19727982|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19727983|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19727984|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
19727985|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19727986|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19727987|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19727988|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19727989|NCT04622579|Growth Substances|growth substances|mesh-ancestor
19727990|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
19727991|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
19727992|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19727993|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19727994|NCT04622917|Prednisolone|prednisolone|mesh-list
19727995|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
19727996|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19727997|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
19727998|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19727999|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
19728000|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
19728001|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728002|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728003|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728004|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
19728005|NCT04622917|Hormones|hormones|mesh-ancestor
19728006|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728007|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19728008|NCT04622917|Protective Agents|protective agents|mesh-ancestor
19728009|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19728010|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728011|NCT04622982|Vitamin D|vitamin d|mesh-list
19728012|NCT04622982|Vitamins|vitamins|mesh-ancestor
19728013|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
19728014|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728015|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19728016|NCT04622488|Diclofenac|diclofenac|mesh-list
19728017|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19728018|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19728019|NCT04622488|Analgesics|analgesics|mesh-ancestor
20255120|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255121|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255122|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20255123|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20255124|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
20255125|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20255126|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20255127|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20255128|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20255129|NCT00468689|Ketoconazole|ketoconazole|mesh-list
20255130|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
20255131|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255132|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20255133|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20255134|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868670|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868671|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19868672|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19868673|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19868674|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
19868675|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
19868676|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
19868677|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442297|NCT03428126|Durvalumab|durvalumab|mesh-list
19442298|NCT03428126|Trametinib|trametinib|mesh-list
19442299|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442300|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442301|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19442302|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442303|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442304|NCT03425292|Bevacizumab|bevacizumab|mesh-list
19442305|NCT03425292|Nivolumab|nivolumab|mesh-list
19442306|NCT03425292|Ipilimumab|ipilimumab|mesh-list
19442307|NCT03425292|Temozolomide|temozolomide|mesh-list
19442308|NCT03425292|Lomustine|lomustine|mesh-list
19442309|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442310|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442311|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19442312|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19728020|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
19728021|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728022|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728023|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728024|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19728025|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19728026|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728027|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442313|NCT03425292|Growth Substances|growth substances|mesh-ancestor
19442314|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442315|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
19442316|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19442317|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442318|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19442319|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
19442320|NCT03422666|Teduglutide|teduglutide|mesh-list
19442321|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19442322|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19442323|NCT03422666|Protective Agents|protective agents|mesh-ancestor
19728028|NCT04622202|Pregabalin|pregabalin|mesh-list
19442324|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728029|NCT04622202|Analgesics|analgesics|mesh-ancestor
19728030|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
19728031|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728032|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728033|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
19728034|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19728035|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19728036|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728037|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19728038|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19728039|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728040|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728041|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728042|NCT04622358|Rabeprazole|rabeprazole|mesh-list
19728043|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19728044|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728045|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19728046|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735255|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19728047|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728048|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
19728049|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19728050|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19728051|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728052|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
19728053|NCT04622397|Coagulants|coagulants|mesh-ancestor
19728054|NCT04622111|Metformin|metformin|mesh-list
19728055|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728056|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728057|NCT04621929|Topiramate|topiramate|mesh-list
19728058|NCT04621929|Phentermine|phentermine|mesh-list
19728059|NCT04621929|Allopurinol|allopurinol|mesh-list
19728060|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728061|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
19728062|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728063|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728064|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
19728065|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728066|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
19728067|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19728068|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19728069|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
19728070|NCT04621929|Protective Agents|protective agents|mesh-ancestor
19868678|NCT00842075|Pramlintide|pramlintide|mesh-list
19868679|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868680|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868681|NCT00842153|Clobetasol|clobetasol|mesh-list
19868682|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868683|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
19868684|NCT00842153|Hormones|hormones|mesh-ancestor
19868685|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19442325|NCT03422328|Macitentan|macitentan|mesh-list
19442326|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19442327|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19442328|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442329|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19868686|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868687|NCT00842244|Capecitabine|capecitabine|mesh-list
19868688|NCT00842244|Axitinib|axitinib|mesh-list
19868689|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868690|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19728071|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19728072|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
19728073|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19728074|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
19728075|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
19728076|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728077|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728078|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728079|NCT04622033|Brodalumab|brodalumab|mesh-list
19728080|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728081|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19728082|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
19728083|NCT04621799|Coagulants|coagulants|mesh-ancestor
20255135|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255136|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20255137|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
19728084|NCT04621370|Capecitabine|capecitabine|mesh-list
19728085|NCT04621370|Durvalumab|durvalumab|mesh-list
19728086|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19868691|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
19728087|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
19868692|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868693|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19868694|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868695|NCT00842257|Panitumumab|panitumumab|mesh-list
19868696|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19868697|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868698|NCT00842309|Cycloserine|cycloserine|mesh-list
19868699|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19868700|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868701|NCT00842309|Renal Agents|renal agents|mesh-ancestor
19868702|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19868703|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
19868704|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868705|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
19868706|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868707|NCT00842348|Lanreotide|lanreotide|mesh-list
19868708|NCT00842348|Somatostatin|somatostatin|mesh-list
19868709|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868710|NCT00842348|Hormones|hormones|mesh-ancestor
19868711|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868712|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868713|NCT00842361|Insulin|insulin|mesh-list
19868714|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19868715|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
19868716|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
19868717|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19868718|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
19868719|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19868720|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19868721|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868722|NCT00842608|Haloperidol|haloperidol|mesh-list
19442348|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19442349|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19442350|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728088|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728089|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728090|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19728091|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
19728092|NCT04621461|Astringents|astringents|mesh-ancestor
19728093|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728094|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728095|NCT04621487|Amoxicillin|amoxicillin|mesh-list
19728096|NCT04621487|Metronidazole|metronidazole|mesh-list
19728097|NCT04621487|Clarithromycin|clarithromycin|mesh-list
19728098|NCT04621487|Pantoprazole|pantoprazole|mesh-list
19728099|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728100|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728101|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19728102|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19728103|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19728104|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728105|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728106|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19728107|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19728108|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19728109|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728110|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19728111|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
19728112|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19728113|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19728114|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19728115|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728116|NCT04621617|Midodrine|midodrine|mesh-list
19728117|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
19728118|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
19728119|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728120|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728121|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19728122|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19728123|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19728124|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19728125|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728126|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728127|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728128|NCT04621669|Metformin|metformin|mesh-list
19728129|NCT04621669|Digoxin|digoxin|mesh-list
19728130|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19728131|NCT04621669|Calcium|calcium|mesh-list
19728132|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728133|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728134|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19728135|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19728136|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19728137|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
19728138|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728139|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19728140|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19728141|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728142|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19728143|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19728144|NCT04621669|Protective Agents|protective agents|mesh-ancestor
19728145|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
19728146|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19728147|NCT04621318|Denosumab|denosumab|mesh-list
19728148|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19728149|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728150|NCT04621227|Midazolam|midazolam|mesh-list
19728151|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19728152|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19728153|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19728154|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728155|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728156|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20255138|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255139|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255140|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20255141|NCT00468715|Bicalutamide|bicalutamide|mesh-list
20255142|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
20255143|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
20255144|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728157|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728158|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728159|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19728160|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
19728161|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
19728162|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
19728163|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
19728164|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728165|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728166|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19728167|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19728168|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
19728169|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19728170|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19728171|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735256|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735257|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735258|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19735259|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
19735260|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
19735261|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19735262|NCT04542005|Albuterol|albuterol|mesh-list
19735263|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19735264|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
19735265|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735266|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442351|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19442352|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728172|NCT04621513|Montelukast|montelukast|mesh-list
19728173|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19728174|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
19728175|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19728176|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
19728177|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728178|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728179|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19728180|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19728181|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728182|NCT04621149|Lactoferrin|lactoferrin|mesh-list
19868723|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
19442353|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19442354|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19442355|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19442356|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19442357|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
19442358|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19442359|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442360|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19442361|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19442362|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
19442363|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19442364|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19442365|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
19868724|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19868725|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
19868726|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
19868727|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868728|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442372|NCT03377491|Gemcitabine|gemcitabine|mesh-list
19442373|NCT03377491|Paclitaxel|paclitaxel|mesh-list
19442374|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19442375|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442376|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
19442377|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
19442378|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
19442379|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442380|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19442381|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
19442382|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
19442383|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442384|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442385|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19442386|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
19442387|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442388|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
19442389|NCT03367988|Anesthetics|anesthetics|mesh-list
19728183|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
19728184|NCT04621149|Famotidine|famotidine|mesh-list
19728185|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19728186|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728187|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19728188|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
19728189|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
19728190|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728191|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728192|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728193|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728194|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
19728195|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
19728196|NCT04620954|Nivolumab|nivolumab|mesh-list
19728197|NCT04620954|Oregovomab|oregovomab|mesh-list
19728198|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19728199|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728200|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19728201|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728202|NCT04621253|Dipyrone|dipyrone|mesh-list
19728203|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19728204|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19728205|NCT04621253|Analgesics|analgesics|mesh-ancestor
19442390|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19442391|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442392|NCT03367988|Narcotics|narcotics|mesh-ancestor
19442393|NCT03367988|Analgesics|analgesics|mesh-ancestor
19442394|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
19442395|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868729|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19868730|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19868731|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19868732|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868733|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19868734|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19868735|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
19868736|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868737|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868738|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19868739|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
19868740|NCT00842712|Gemcitabine|gemcitabine|mesh-list
19868741|NCT00842712|Cisplatin|cisplatin|mesh-list
19868742|NCT00842712|Cetuximab|cetuximab|mesh-list
19868743|NCT00842712|Vinorelbine|vinorelbine|mesh-list
19442411|NCT03343431|Tenofovir|tenofovir|mesh-list
19442412|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
19442413|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442414|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19442415|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19442416|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442417|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442418|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19442419|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19442420|NCT03339128|Eluxadoline|eluxadoline|mesh-list
19442421|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728206|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
19735983|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
19868744|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535122|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535123|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535124|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20535125|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
20535126|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535127|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20535128|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535129|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20535130|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20535131|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20535132|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20535133|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535134|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535135|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20535136|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535137|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535138|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
20535139|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535140|NCT01817829|Acetaminophen|acetaminophen|mesh-list
20535141|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20535142|NCT01817829|Analgesics|analgesics|mesh-ancestor
20535143|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
20535144|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535145|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535146|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
19728207|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728208|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728209|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728210|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19728211|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
19728212|NCT04621058|Vitamin D|vitamin d|mesh-list
19868745|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19868746|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
19868747|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868748|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
19868749|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868750|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868751|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868752|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
19868753|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728213|NCT04621058|Vitamins|vitamins|mesh-list
19728214|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
19735984|NCT04534322|Hormones|hormones|mesh-ancestor
19728215|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728216|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19728217|NCT04621110|Fentanyl|fentanyl|mesh-list
19728218|NCT04621110|Midazolam|midazolam|mesh-list
19728219|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
19728220|NCT04621110|Ketamine|ketamine|mesh-list
19728221|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19728222|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728223|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728224|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19728225|NCT04621110|Analgesics|analgesics|mesh-ancestor
19728226|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
19728227|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728228|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19728229|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19728230|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19728231|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728232|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728233|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728234|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19728235|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19728236|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
19728237|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
19728238|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19728239|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19728240|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19728241|NCT04621110|Narcotics|narcotics|mesh-ancestor
19728242|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19728243|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19728244|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728245|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728246|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
19728247|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
19728248|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19728249|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19728250|NCT04620967|Insulin|insulin|mesh-list
19728251|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19728252|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
19728253|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
19728254|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19728255|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728256|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728257|NCT04620785|Methylene Blue|methylene blue|mesh-list
19728258|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728259|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728260|NCT04620720|Gabapentin|gabapentin|mesh-list
19728261|NCT04620720|Analgesics|analgesics|mesh-ancestor
19868754|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19868755|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19868756|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
19868757|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
19868758|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
19868759|NCT00842751|Finasteride|finasteride|mesh-list
19868760|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19868761|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19868762|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868763|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868764|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
19868765|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868766|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868767|NCT00842751|Urological Agents|urological agents|mesh-ancestor
19728262|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
19728263|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868768|NCT00842829|Fentanyl|fentanyl|mesh-list
19868769|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19728264|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728265|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
19728266|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19728267|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728268|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728269|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728270|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19728271|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19728272|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728273|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728274|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
19728275|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
19728276|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19728277|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728278|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728279|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728280|NCT04620603|Nivolumab|nivolumab|mesh-list
19728281|NCT04620603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19728282|NCT04620603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728283|NCT04620603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19728284|NCT04620603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728285|NCT04620616|Menthol|menthol|mesh-list
19728286|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
19728287|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728288|NCT04620473|Oxaliplatin|oxaliplatin|mesh-list
19728289|NCT04620473|Capecitabine|capecitabine|mesh-list
19728290|NCT04620473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728291|NCT04620473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19728292|NCT04620473|Antimetabolites|antimetabolites|mesh-ancestor
19735267|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20255145|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255146|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255147|NCT00468754|Insulin|insulin|mesh-list
20255148|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20255149|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255150|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20255151|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20255152|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535147|NCT01817868|Factor VIII|factor viii|mesh-list
20535148|NCT01817868|Coagulants|coagulants|mesh-ancestor
19868770|NCT00842829|Narcotics|narcotics|mesh-ancestor
19868771|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868772|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868773|NCT00842829|Analgesics|analgesics|mesh-ancestor
19868774|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
19868775|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19442431|NCT03324984|Bupivacaine|bupivacaine|mesh-list
19442432|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
19442433|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
19442434|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
19442435|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19442436|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442437|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
19442438|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868776|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19868777|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19868778|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
19868779|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
19868780|NCT00842985|Dronabinol|dronabinol|mesh-list
19868781|NCT00842985|Modafinil|modafinil|mesh-list
20255153|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
20255154|NCT00468871|Hormones|hormones|mesh-ancestor
20535149|NCT01817894|Eflornithine|eflornithine|mesh-list
19728293|NCT04620473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728294|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
19728295|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19728296|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
19728297|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728298|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868782|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19868783|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868784|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19868785|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19868786|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19868787|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868788|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
19868789|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19442444|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
20255155|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255156|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255157|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
20255158|NCT00468923|Candesartan|candesartan|mesh-list
20255159|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20255160|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20255161|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19442445|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442446|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868790|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19868791|NCT00842985|Analgesics|analgesics|mesh-ancestor
19868792|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
19868793|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868794|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19442452|NCT03284957|Everolimus|everolimus|mesh-list
19442453|NCT03284957|Palbociclib|palbociclib|mesh-list
19442454|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442455|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19442456|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
19442457|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442458|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19442459|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442460|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728299|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19728300|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
19728301|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728302|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728303|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19728304|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19868795|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19868796|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868797|NCT00842985|Hormones|hormones|mesh-ancestor
19728305|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728306|NCT04620018|Amoxicillin|amoxicillin|mesh-list
19728307|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728308|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728309|NCT04620031|Propofol|propofol|mesh-list
19728310|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19728311|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728312|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728313|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19728314|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
19728315|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
19728316|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19728317|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19728318|NCT04620200|Nivolumab|nivolumab|mesh-list
19728319|NCT04620200|Ipilimumab|ipilimumab|mesh-list
19728320|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
19728321|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19728322|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728323|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19728324|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728325|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728326|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19728327|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19728328|NCT04620343|Anesthetics|anesthetics|mesh-list
19728329|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728330|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728331|NCT04620213|Phentolamine|phentolamine|mesh-list
19868798|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19868799|NCT00843024|Naproxen|naproxen|mesh-list
19728332|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19728333|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19868800|NCT00843024|Sumatriptan|sumatriptan|mesh-list
19868801|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19868802|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19868803|NCT00843024|Analgesics|analgesics|mesh-ancestor
19868804|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
19868805|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868806|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868807|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868808|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868809|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
19868810|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19868811|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868812|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868813|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19868814|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19868815|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19868816|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
19868817|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868818|NCT00843115|Donepezil|donepezil|mesh-list
19868819|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19868820|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728334|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19728335|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19728336|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728337|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728338|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728339|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728340|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19728341|NCT04619758|Emollients|emollients|mesh-list
19728342|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728343|NCT04619914|Letrozole|letrozole|mesh-list
19728344|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255162|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
20255163|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255164|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20255165|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20255166|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255167|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19728345|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19728346|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19728347|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728348|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728349|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19728350|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
19728351|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728352|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728353|NCT04619875|Lactulose|lactulose|mesh-list
19728354|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728355|NCT04619862|Gabapentin|gabapentin|mesh-list
19728356|NCT04619862|Analgesics|analgesics|mesh-ancestor
19728357|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
19728358|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728359|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728360|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
19728361|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19728362|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728363|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728364|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728365|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19728366|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19728367|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728368|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728369|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
19728370|NCT04619290|Methylene Blue|methylene blue|mesh-list
19728371|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728372|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728373|NCT04619303|Dexamethasone|dexamethasone|mesh-list
19728374|NCT04619303|Bevacizumab|bevacizumab|mesh-list
19728375|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19728376|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728377|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19728378|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19728379|NCT04619303|Growth Substances|growth substances|mesh-ancestor
19728380|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728381|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
19868821|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728382|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728383|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
19728384|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
19728385|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728386|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728387|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
19728388|NCT04619303|Hormones|hormones|mesh-ancestor
19728389|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728390|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19728391|NCT04619537|Docetaxel|docetaxel|mesh-list
20255168|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20255169|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20255170|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
20255171|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20255172|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255173|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20255174|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
20255175|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20255176|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255177|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255178|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728392|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255179|NCT00468988|Travoprost|travoprost|mesh-list
19868822|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
20255180|NCT00468988|Latanoprost|latanoprost|mesh-list
20255181|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20255182|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20255183|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20255184|NCT00469053|Buprenorphine|buprenorphine|mesh-list
20255185|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20255186|NCT00469053|Narcotics|narcotics|mesh-ancestor
20255187|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20255188|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255189|NCT00469053|Analgesics|analgesics|mesh-ancestor
20535150|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868823|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868824|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868825|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
19868826|NCT00843193|Fluticasone|fluticasone|mesh-list
19868827|NCT00843193|Xhance|xhance|mesh-list
19868828|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19868829|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19868830|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
19868831|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868832|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868833|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20255190|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
20535151|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19442480|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19442481|NCT03258554|Cetuximab|cetuximab|mesh-list
19442482|NCT03258554|Durvalumab|durvalumab|mesh-list
19442483|NCT03258554|Antibodies|antibodies|mesh-list
19442484|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
19442485|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19442486|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
19442487|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
19442488|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535152|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20535153|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20535154|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535155|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20535156|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535157|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535158|NCT01817972|Azathioprine|azathioprine|mesh-list
20535159|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
20535160|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
20535161|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535162|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19442489|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535163|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535164|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535165|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
19442493|NCT03247712|Nivolumab|nivolumab|mesh-list
19442494|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442495|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442496|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19442497|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728393|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19728394|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19728395|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19728396|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735268|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
19735269|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
19735270|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19735271|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19735272|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19735273|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19735274|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
19735275|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728397|NCT04619563|Docetaxel|docetaxel|mesh-list
19728398|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728399|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
19728400|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
19728401|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
19728402|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728403|NCT04619251|Itraconazole|itraconazole|mesh-list
19728404|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
19728405|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868834|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19868835|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
19868836|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19442501|NCT03237611|Dexamethasone|dexamethasone|mesh-list
19442502|NCT03237611|Ondansetron|ondansetron|mesh-list
19442503|NCT03237611|Aprepitant|aprepitant|mesh-list
19442504|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
19442505|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19442506|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
19442507|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
19442508|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19442509|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442510|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19442511|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
19442512|NCT03237611|Hormones|hormones|mesh-ancestor
19442513|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19442514|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19442515|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442516|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
19442517|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
19442518|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19442519|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
19442520|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19442521|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442522|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19442523|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19442524|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19442525|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19442526|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19442527|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19868837|NCT00843284|Pregabalin|pregabalin|mesh-list
19728406|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19728407|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19728408|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728409|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728410|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19728411|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
19728412|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728413|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728414|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19728415|NCT04619381|Clopidogrel|clopidogrel|mesh-list
19728416|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19728417|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19728418|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19728419|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19728420|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
19728421|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255191|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255192|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20255193|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
20255194|NCT00469131|Tacrolimus|tacrolimus|mesh-list
20255195|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255196|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
20255197|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255198|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20255199|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255200|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255201|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20255202|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255203|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20255204|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
20255205|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20255206|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255207|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20255208|NCT00469183|Tretinoin|tretinoin|mesh-list
20535166|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728422|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535167|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553586|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553587|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20553588|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20553589|NCT01930318|Analgesics|analgesics|mesh-ancestor
20553590|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
19728423|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728424|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
19728425|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19728426|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728427|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728428|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19728429|NCT04618965|Analgesics|analgesics|mesh-ancestor
19728430|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
19728431|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255209|NCT00469183|Hydroquinone|hydroquinone|mesh-list
19442528|NCT03234491|Insulin|insulin|mesh-list
20553591|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255210|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442529|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19442530|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19442531|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868838|NCT00843284|Analgesics|analgesics|mesh-ancestor
19868839|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
19868840|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868841|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868842|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
19868843|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19868844|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19868845|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868846|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19442541|NCT03232073|Ponesimod|ponesimod|mesh-list
19442542|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19442543|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442544|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19442545|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
19442546|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442547|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19442548|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19442549|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19442550|NCT03229408|Analgesics|analgesics|mesh-ancestor
19442551|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
19442552|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19442553|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442554|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19442555|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19442556|NCT03225417|Sirolimus|sirolimus|mesh-list
19442557|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
19442558|NCT03225417|Ixazomib|ixazomib|mesh-list
19442559|NCT03225417|Tacrolimus|tacrolimus|mesh-list
19442560|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19442561|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19442562|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
19442563|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442564|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19442565|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19442566|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
19442567|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442568|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442569|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19442570|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19442571|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442572|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19442573|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442574|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19442575|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
19442576|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
19868847|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19868848|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19868849|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868850|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728432|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19728433|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19728434|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19728435|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728436|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728437|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728438|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
19728439|NCT04618913|Apixaban|apixaban|mesh-list
19728440|NCT04618913|Edoxaban|edoxaban|mesh-list
19728441|NCT04618913|Dabigatran|dabigatran|mesh-list
19728442|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19728443|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
19728444|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19728445|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
19728446|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728447|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728448|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
19728449|NCT04618952|Calcium|calcium|mesh-list
19728450|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19728451|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728452|NCT04619433|Carboplatin|carboplatin|mesh-list
19728453|NCT04619433|Pemetrexed|pemetrexed|mesh-list
19728454|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728455|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255211|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
19868851|NCT00843492|PENTA|penta|mesh-list
19868852|NCT00843492|Nadroparin|nadroparin|mesh-list
19868853|NCT00843492|Fondaparinux|fondaparinux|mesh-list
19868854|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19728456|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728457|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19728458|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19728459|NCT04619160|Propofol|propofol|mesh-list
19728460|NCT04619160|Sevoflurane|sevoflurane|mesh-list
19728461|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19728462|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868855|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
19868856|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19868857|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
19868858|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868859|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868860|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
19868861|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19728463|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728464|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19728465|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
19728466|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
19728467|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19728468|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19728469|NCT04619069|Hormones|hormones|mesh-list
19728470|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728471|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728472|NCT04618497|Ketorolac|ketorolac|mesh-list
19728473|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
19728474|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19728475|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19728476|NCT04618497|Analgesics|analgesics|mesh-ancestor
19728477|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
19728478|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728479|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728480|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728481|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19728482|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19728483|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728484|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728485|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19728486|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
19728487|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
19728488|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728489|NCT04618367|Lenvatinib|lenvatinib|mesh-list
19728490|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728491|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19728492|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728493|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728494|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19728495|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19728496|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728497|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
19728498|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19728499|NCT04618536|Protective Agents|protective agents|mesh-ancestor
19728500|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728501|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
19868862|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19868863|NCT00843531|Everolimus|everolimus|mesh-list
19868864|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19868865|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868866|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868867|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
19868868|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728502|NCT04618601|Spironolactone|spironolactone|mesh-list
19728503|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20255212|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728504|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
19728505|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728506|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728507|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19728508|NCT04618601|Diuretics|diuretics|mesh-ancestor
19728509|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
19728510|NCT04618107|Anesthetics|anesthetics|mesh-list
19728511|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728512|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728513|NCT04618146|Morphine|morphine|mesh-list
19728514|NCT04618146|Bupivacaine|bupivacaine|mesh-list
19728515|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
19728516|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
19728517|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728518|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728519|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
19728520|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868869|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19868870|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868871|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868872|NCT00843635|Tadalafil|tadalafil|mesh-list
20535168|NCT01817985|Velpatasvir|velpatasvir|mesh-list
20535169|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
20535170|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535171|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19868873|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
19868874|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19868875|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19868876|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868877|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868878|NCT00843635|Urological Agents|urological agents|mesh-ancestor
19868879|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
19868880|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19868881|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19868882|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
19868883|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868884|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19868885|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19868886|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868887|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868888|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
19868889|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868890|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
19868891|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868892|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868893|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
19868894|NCT00843856|Tacrolimus|tacrolimus|mesh-list
19868895|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868896|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
19868897|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868898|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19868899|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868900|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868901|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19868902|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535172|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
19868903|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19868904|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
19868905|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19868906|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868907|NCT00844051|Vaccines|vaccines|mesh-list
19868908|NCT00844051|Immunologic Factors|immunologic factors|mesh-ancestor
19868909|NCT00844051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868910|NCT00844090|Methylphenidate|methylphenidate|mesh-list
20535173|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535174|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20535175|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20535176|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535177|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535178|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535179|NCT01818375|Anesthetics|anesthetics|mesh-list
19728521|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19728522|NCT04618146|Narcotics|narcotics|mesh-ancestor
19728523|NCT04618146|Analgesics|analgesics|mesh-ancestor
19728524|NCT04618289|Vitamin D|vitamin d|mesh-list
19728525|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
19728526|NCT04618289|Vitamins|vitamins|mesh-ancestor
19728527|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
19728528|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728529|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19728530|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19728531|NCT04618328|Tretinoin|tretinoin|mesh-list
19728532|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728533|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
19728534|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728535|NCT04617782|Donepezil|donepezil|mesh-list
19728536|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19728537|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728538|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728539|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
19728540|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728541|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728542|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
19728543|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
19728544|NCT04617938|Narcotics|narcotics|mesh-ancestor
19728545|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728546|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728547|NCT04617938|Analgesics|analgesics|mesh-ancestor
19728548|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
19728549|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728550|NCT04617613|Amoxicillin|amoxicillin|mesh-list
19728551|NCT04617613|Metronidazole|metronidazole|mesh-list
19728552|NCT04617613|Clarithromycin|clarithromycin|mesh-list
19728553|NCT04617613|Omeprazole|omeprazole|mesh-list
19728554|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728555|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728556|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19868911|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19868912|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868913|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19442594|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
19442595|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442596|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868914|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19868915|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19868916|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442600|NCT03204812|Durvalumab|durvalumab|mesh-list
19442601|NCT03204812|Ipilimumab|ipilimumab|mesh-list
19442602|NCT03204812|Tremelimumab|tremelimumab|mesh-list
19728557|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19728558|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19728559|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728560|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19728561|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728562|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728563|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19442603|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
19442604|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19442605|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
19442606|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442607|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442608|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
19442609|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442610|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19442611|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868917|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
19868918|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728564|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19728565|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19728566|NCT04617626|Azithromycin|azithromycin|mesh-list
19728567|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728568|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728569|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
19728570|NCT04617652|Analgesics|analgesics|mesh-ancestor
19728571|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
19728572|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728573|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728574|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
19728575|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728576|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19728577|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
19728578|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19728579|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19728580|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728581|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19728582|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
19728583|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19728584|NCT04617795|Insulin|insulin|mesh-list
19728585|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728586|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868919|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19868920|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19868921|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19868922|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19868923|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868924|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19868925|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868926|NCT00844194|Analgesics|analgesics|mesh-ancestor
19868927|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
19868928|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19868929|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
19868930|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19868931|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
19868932|NCT00844298|Cytarabine|cytarabine|mesh-list
19868933|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19868934|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
19868935|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868936|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868937|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
19868938|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728587|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
19728588|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19728589|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19728590|NCT04617561|Prednisolone|prednisolone|mesh-list
19728591|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
19728592|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19728593|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19728594|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
19728595|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
19728596|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728597|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
19728598|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
19728599|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728600|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728601|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728602|NCT04617561|Hormones|hormones|mesh-ancestor
19728603|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728604|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19728605|NCT04617561|Protective Agents|protective agents|mesh-ancestor
19728606|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19728607|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728608|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19728609|NCT04617483|Vaccines|vaccines|mesh-list
19728610|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
19728611|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735276|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735277|NCT04541147|Dexamethasone|dexamethasone|mesh-list
19735278|NCT04541147|Analgesics|analgesics|mesh-list
19735279|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735280|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
19735281|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
19735282|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735283|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735284|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19735285|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
19735286|NCT04541147|Hormones|hormones|mesh-ancestor
19735287|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735288|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19735289|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735290|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
19735291|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
19735292|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19735293|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19735294|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735295|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
19442616|NCT03199885|Paclitaxel|paclitaxel|mesh-list
19442617|NCT03199885|Docetaxel|docetaxel|mesh-list
19442618|NCT03199885|Trastuzumab|trastuzumab|mesh-list
19442619|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19442620|NCT03199885|Atezolizumab|atezolizumab|mesh-list
19442621|NCT03199885|Pertuzumab|pertuzumab|mesh-list
19442622|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19442623|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19442624|NCT03199885|Antibodies|antibodies|mesh-list
19442625|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
19442626|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19442627|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19442628|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442629|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
19442630|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
19442631|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
19442632|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442633|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
19735296|NCT04541303|Coagulants|coagulants|mesh-ancestor
20255213|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255214|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
20255215|NCT00469183|Hormones|hormones|mesh-ancestor
19728612|NCT04617249|Anesthetics|anesthetics|mesh-list
19728613|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728614|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728615|NCT04617171|Benralizumab|benralizumab|mesh-list
19728616|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19728617|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
19728618|NCT04616872|Methotrexate|methotrexate|mesh-list
20255216|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728619|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19728620|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
19728621|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19728622|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728623|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19728624|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
19728625|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728626|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728627|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728628|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728629|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19728630|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19728631|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
19728632|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19728633|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19728634|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19442634|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442635|NCT03193190|Leucovorin|leucovorin|mesh-list
19442636|NCT03193190|Gemcitabine|gemcitabine|mesh-list
19442637|NCT03193190|Paclitaxel|paclitaxel|mesh-list
19442638|NCT03193190|Bevacizumab|bevacizumab|mesh-list
19442639|NCT03193190|Fluorouracil|fluorouracil|mesh-list
19728635|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
19442640|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
19442641|NCT03193190|Atezolizumab|atezolizumab|mesh-list
19728636|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19728637|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
19728638|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19728639|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728640|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19728641|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19728642|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728643|NCT04616807|Mexiletine|mexiletine|mesh-list
19728644|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19728645|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19728646|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19728647|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19728648|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728649|NCT04617015|Bromides|bromides|mesh-list
19728650|NCT04617015|Ipratropium|ipratropium|mesh-list
19728651|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
19728652|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19728653|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
19728654|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728655|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728656|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19728657|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
19728658|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19728659|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
19728660|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728661|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728662|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
19728663|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728664|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
19728665|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728666|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728667|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19728668|NCT04616859|Ethanol|ethanol|mesh-list
19728669|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19728670|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728671|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728672|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728673|NCT04616586|Siltuximab|siltuximab|mesh-list
19728674|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728675|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
19728676|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19728677|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
19728678|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728679|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728680|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19728681|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
19728682|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19728683|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19728684|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19728685|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728686|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728687|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728688|NCT04616352|Cefuroxime|cefuroxime|mesh-list
19728689|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
19728690|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728691|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728692|NCT04616313|Xenon|xenon|mesh-list
19728693|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19728694|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
19728695|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
19728696|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19868939|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868940|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
19442642|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19728697|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728698|NCT04616391|Insulin|insulin|mesh-list
19728699|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728700|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728701|NCT04615910|Exenatide|exenatide|mesh-list
19728702|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728703|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728704|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19728705|NCT04615910|Incretins|incretins|mesh-ancestor
19728706|NCT04615910|Hormones|hormones|mesh-ancestor
19728707|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728708|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
20255217|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255218|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
20255219|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255220|NCT00469183|Protective Agents|protective agents|mesh-ancestor
20255221|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20255222|NCT00469261|Doxycycline|doxycycline|mesh-list
19728709|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
19728710|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19728711|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19728712|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19728713|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728714|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728715|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19728716|NCT04615767|Inositol|inositol|mesh-list
19728717|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
19728718|NCT04615767|Vitamins|vitamins|mesh-ancestor
19728719|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
19728720|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728721|NCT04615702|Acetaminophen|acetaminophen|mesh-list
19728722|NCT04615702|Metronidazole|metronidazole|mesh-list
19728723|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
19728724|NCT04615702|Imipenem|imipenem|mesh-list
19728725|NCT04615702|Diclofenac|diclofenac|mesh-list
19728726|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19728727|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
19728728|NCT04615702|Secretin|secretin|mesh-list
19728729|NCT04615702|Bilirubin|bilirubin|mesh-list
19728730|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728731|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19728732|NCT04615702|Analgesics|analgesics|mesh-ancestor
19728733|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
19728734|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728735|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
19728736|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728737|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728738|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19728739|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19728740|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728741|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19728742|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19728743|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728744|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728745|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19728746|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19728747|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728748|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19728749|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19728750|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19728751|NCT04615702|Narcotics|narcotics|mesh-ancestor
19728752|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728753|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19442643|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442644|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
19442645|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
19442646|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
19442647|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442648|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442649|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19442650|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19728754|NCT04615702|Hormones|hormones|mesh-ancestor
19728755|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728756|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
19728757|NCT04615702|Protective Agents|protective agents|mesh-ancestor
19728758|NCT04615611|Albuterol|albuterol|mesh-list
19728759|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19728760|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
19728761|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728762|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728763|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19728764|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
19728765|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
19442651|NCT03193190|Growth Substances|growth substances|mesh-ancestor
19442652|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442653|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
19442654|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19442655|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
19442656|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
19442657|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442658|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442659|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19442660|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
19442661|NCT03193190|Antidotes|antidotes|mesh-ancestor
19442662|NCT03193190|Protective Agents|protective agents|mesh-ancestor
19442663|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
19442664|NCT03193190|Vitamins|vitamins|mesh-ancestor
19442665|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
19868941|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868942|NCT00844376|Atorvastatin|atorvastatin|mesh-list
19868943|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19868944|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19868945|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
19868946|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868947|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19868948|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19868949|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868950|NCT00844415|Dabigatran|dabigatran|mesh-list
19868951|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
19868952|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19868953|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
19868954|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868955|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868956|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
19868957|NCT00844428|Eculizumab|eculizumab|mesh-list
19868958|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19868959|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868960|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
19728766|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19728767|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19868961|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868962|NCT00844519|Maraviroc|maraviroc|mesh-list
19868963|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19728768|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19728769|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19728770|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728771|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728772|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728773|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19728774|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728775|NCT04615481|Metronidazole|metronidazole|mesh-list
19728776|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728777|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728778|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19728779|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19728780|NCT04615403|Travoprost|travoprost|mesh-list
19728781|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19728782|NCT04615351|Metformin|metformin|mesh-list
19728783|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19728784|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728785|NCT04615013|Leucovorin|leucovorin|mesh-list
19728786|NCT04615013|Paclitaxel|paclitaxel|mesh-list
19728787|NCT04615013|Docetaxel|docetaxel|mesh-list
19728788|NCT04615013|Carboplatin|carboplatin|mesh-list
19728789|NCT04615013|Fluorouracil|fluorouracil|mesh-list
19728790|NCT04615013|Capecitabine|capecitabine|mesh-list
19728791|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
19728792|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19728793|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19728794|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728795|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
19728796|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
19868964|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19868965|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868966|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19868967|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19868968|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
19868969|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868970|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19868971|NCT00844545|Eculizumab|eculizumab|mesh-list
19868972|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19868973|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868974|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
19868975|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868976|NCT00844649|Gemcitabine|gemcitabine|mesh-list
19868977|NCT00844649|Paclitaxel|paclitaxel|mesh-list
19868978|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19868979|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19868980|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868981|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
19868982|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
19868983|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
19868984|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19868985|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19868986|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
19442692|NCT03188172|Dexamethasone|dexamethasone|mesh-list
19442693|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
19442694|NCT03188172|Melphalan|melphalan|mesh-list
19442695|NCT03188172|Lenalidomide|lenalidomide|mesh-list
19442696|NCT03188172|Bortezomib|bortezomib|mesh-list
19442697|NCT03188172|Daratumumab|daratumumab|mesh-list
19442698|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19442699|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
19442700|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442701|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19442702|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19442703|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
19442704|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442705|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728797|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
19728798|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728799|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
19728800|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19728801|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19728802|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
19728803|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728804|NCT04615013|Antidotes|antidotes|mesh-ancestor
19728805|NCT04615013|Protective Agents|protective agents|mesh-ancestor
19728806|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
19728807|NCT04615013|Vitamins|vitamins|mesh-ancestor
19728808|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
19728809|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
19728810|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19728811|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
19728812|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728813|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
19728814|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728815|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19735297|NCT04541277|Cytarabine|cytarabine|mesh-list
19735298|NCT04541277|Azacitidine|azacitidine|mesh-list
19735299|NCT04541277|Decitabine|decitabine|mesh-list
19735300|NCT04541277|Idarubicin|idarubicin|mesh-list
19735301|NCT04541277|Sargramostim|sargramostim|mesh-list
19735302|NCT04541277|Lenograstim|lenograstim|mesh-list
19735303|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19735304|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
19735305|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735306|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735307|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
19735308|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735309|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735310|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
19868987|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
19868988|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19868989|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19868990|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19868991|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
19868992|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868993|NCT00844714|Rituximab|rituximab|mesh-list
19868994|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19868995|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19868996|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
19868997|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19868998|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19868999|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19869000|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19869001|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19869002|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869003|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869004|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
19869005|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869006|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869007|NCT00844805|Naproxen|naproxen|mesh-list
19869008|NCT00844805|Infliximab|infliximab|mesh-list
19869009|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
19869010|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869011|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255223|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19735311|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735312|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735313|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20255224|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728816|NCT04614727|Calcium|calcium|mesh-list
19728817|NCT04614727|Fluorides|fluorides|mesh-list
19728818|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19728819|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728820|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
19728821|NCT04614727|Protective Agents|protective agents|mesh-ancestor
19728822|NCT04614610|Lidocaine|lidocaine|mesh-list
19728823|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
19728824|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
19728825|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728826|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728827|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
19728828|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728829|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19728830|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19728831|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19728832|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19728833|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728834|NCT04614584|Mirtazapine|mirtazapine|mesh-list
19728835|NCT04614584|Methamphetamine|methamphetamine|mesh-list
19728836|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
19728837|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728838|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19728839|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
19728840|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
19728841|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728842|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728843|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728844|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19728845|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728846|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728847|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20255225|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
20255226|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20255227|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20255228|NCT00469300|Acyclovir|acyclovir|mesh-list
20255229|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
19728848|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19728849|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19728850|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
19728851|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19728852|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19728853|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
19728854|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19728855|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19728856|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
19728857|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
19728858|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728859|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
19728860|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19728861|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19728862|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19728863|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19869012|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19869013|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19869014|NCT00844805|Analgesics|analgesics|mesh-ancestor
19869015|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
19869016|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869017|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869018|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869019|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
19869020|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19869021|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869022|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869023|NCT00844831|Lubiprostone|lubiprostone|mesh-list
19869024|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19869025|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869026|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869027|NCT00844844|Eculizumab|eculizumab|mesh-list
19869028|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19869029|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869030|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
19869031|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869032|NCT00844857|Olanzapine|olanzapine|mesh-list
19869033|NCT00844857|Fluoxetine|fluoxetine|mesh-list
20255230|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728864|NCT04614311|Triamcinolone|triamcinolone|mesh-list
19728865|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19728866|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19728867|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19728868|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19728869|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
19728870|NCT04614311|Hormones|hormones|mesh-ancestor
19728871|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728872|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728873|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19728874|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
19728875|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728876|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728877|NCT04614298|Brodalumab|brodalumab|mesh-list
19728878|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728879|NCT04614259|Bupivacaine|bupivacaine|mesh-list
19728880|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
19728881|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
19728882|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728883|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728884|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
19728885|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869034|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
19442706|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19442707|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19442708|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
19442709|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
19442710|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19442711|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19442712|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
19442713|NCT03188172|Hormones|hormones|mesh-ancestor
19442714|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19442715|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19442716|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19442717|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19442718|NCT03188172|Growth Substances|growth substances|mesh-ancestor
19442719|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
19869035|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
19869036|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869037|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869038|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869039|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19869040|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19869041|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869042|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19869043|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19869044|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19728886|NCT04614194|Letrozole|letrozole|mesh-list
19728887|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869045|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19728888|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19728889|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19728890|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728891|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728892|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19728893|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
19728894|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728895|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728896|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
19728897|NCT04613960|Analgesics|analgesics|mesh-ancestor
19728898|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
19728899|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728900|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728901|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
19728902|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728903|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19728904|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
19728905|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19728906|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19728907|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728908|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19728909|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
19728910|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19728911|NCT04613609|Nicotine|nicotine|mesh-list
19728912|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19728913|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
19728914|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728915|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728916|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19728917|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19728918|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
19728919|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728920|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728921|NCT04613700|Secretin|secretin|mesh-list
19728922|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728923|NCT04613700|Hormones|hormones|mesh-ancestor
19728924|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19728925|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728926|NCT04613869|Hydromorphone|hydromorphone|mesh-list
19728927|NCT04613869|Esketamine|esketamine|mesh-list
19728928|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19728929|NCT04613869|Narcotics|narcotics|mesh-ancestor
19728930|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728931|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728932|NCT04613869|Analgesics|analgesics|mesh-ancestor
19728933|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
19728934|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728935|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
19728936|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728937|NCT04613726|Ondansetron|ondansetron|mesh-list
19728938|NCT04613726|Granisetron|granisetron|mesh-list
19728939|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
19728940|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
19728941|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19728942|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728943|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19728944|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
19728945|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
19728946|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19728947|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
19728948|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19728949|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728950|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19728951|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19728952|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19728953|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19728954|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19728955|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
19728956|NCT04613557|Fludarabine|fludarabine|mesh-list
19728957|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
19728958|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19728959|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
19728960|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19728961|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19728962|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19728963|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
19728964|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728965|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728966|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19728967|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19728968|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
19728969|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19728970|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728971|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728972|NCT04613102|Cannabidiol|cannabidiol|mesh-list
19728973|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
19728974|NCT04613219|Tofacitinib|tofacitinib|mesh-list
19728975|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19728976|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19728977|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728978|NCT04613167|Evolocumab|evolocumab|mesh-list
19728979|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19728980|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19728981|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
19728982|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19728983|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19728984|NCT04613271|Azithromycin|azithromycin|mesh-list
19728985|NCT04613271|Favipiravir|favipiravir|mesh-list
19728986|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19728987|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19728988|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
19728992|NCT04613284|Durvalumab|durvalumab|mesh-list
19728993|NCT04613284|Endostar protein|endostar protein|mesh-list
19728994|NCT04613284|Endostatins|endostatins|mesh-list
20255231|NCT00469326|Atorvastatin|atorvastatin|mesh-list
20255232|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20255233|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20255234|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
20255235|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255236|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20255237|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20255238|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255239|NCT00469352|Ranibizumab|ranibizumab|mesh-list
20255240|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255241|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255242|NCT00469352|Growth Substances|growth substances|mesh-ancestor
20255243|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255244|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255245|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255246|NCT00469404|Buprenorphine|buprenorphine|mesh-list
19728995|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19728996|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19728997|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19728998|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19728999|NCT04613284|Growth Substances|growth substances|mesh-ancestor
19729000|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729001|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
19729002|NCT04612998|Atropine|atropine|mesh-list
19729003|NCT04612998|Ephedrine|ephedrine|mesh-list
19729004|NCT04612998|Metoclopramide|metoclopramide|mesh-list
19729005|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19729006|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19729007|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19729008|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
19729009|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729010|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729011|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19729012|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
19729013|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
19729014|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
19729015|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19729016|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19729017|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
19729018|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729019|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729020|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
19729021|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729022|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19729023|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19729024|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
19729025|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19729026|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
19729027|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19729028|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
19729029|NCT04613180|Montelukast|montelukast|mesh-list
19729030|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19729031|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
19729032|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20255247|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20255248|NCT00469404|Narcotics|narcotics|mesh-ancestor
20255249|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729033|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
19735314|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19729034|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729035|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729036|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19729037|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19729038|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869046|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869047|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869048|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
19869049|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19869050|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
19869051|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19869052|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19869053|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869054|NCT00844883|Sorafenib|sorafenib|mesh-list
19869055|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869056|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19869057|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869058|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869059|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
19869060|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869061|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869062|NCT00845000|Levodopa|levodopa|mesh-list
19869063|NCT00845000|Carbidopa|carbidopa|mesh-list
19869064|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19869065|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19869066|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
19869067|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869068|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869069|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869070|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19869071|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869072|NCT00845039|Irinotecan|irinotecan|mesh-list
19869073|NCT00845039|Cetuximab|cetuximab|mesh-list
19452938|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19729039|NCT04612894|Apatinib|apatinib|mesh-list
19729040|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729041|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19729042|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735315|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19729043|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735316|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19735317|NCT04540926|Cyclosporine|cyclosporine|mesh-list
19735318|NCT04540926|Cyclosporins|cyclosporins|mesh-list
19735319|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735320|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735321|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735322|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
19735323|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735324|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
19735325|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735326|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
19735327|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869074|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19442731|NCT03170518|Canagliflozin|canagliflozin|mesh-list
19442732|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19442733|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442734|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19442735|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869075|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19869076|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19869077|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869078|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869079|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869080|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869081|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
19442743|NCT03158805|Liraglutide|liraglutide|mesh-list
19442744|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19442745|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442746|NCT03158805|Incretins|incretins|mesh-ancestor
19442747|NCT03158805|Hormones|hormones|mesh-ancestor
19442748|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19442749|NCT03138512|Nivolumab|nivolumab|mesh-list
19442750|NCT03138512|Ipilimumab|ipilimumab|mesh-list
19442751|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442752|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442753|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19442754|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442755|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
19442756|NCT03112044|Velpatasvir|velpatasvir|mesh-list
19442757|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
19442758|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869082|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869083|NCT00845065|Ribavirin|ribavirin|mesh-list
19869084|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19869085|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
19869086|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869087|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
19869088|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869089|NCT00845130|Vitamins|vitamins|mesh-list
19869090|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
19869091|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
19869092|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869093|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
19869094|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869095|NCT00845130|Protective Agents|protective agents|mesh-ancestor
19869096|NCT00845182|Pioglitazone|pioglitazone|mesh-list
19869097|NCT00845182|Exenatide|exenatide|mesh-list
19869098|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19869099|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869100|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19869101|NCT00845182|Incretins|incretins|mesh-ancestor
19869102|NCT00845182|Hormones|hormones|mesh-ancestor
19970019|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729044|NCT04612634|Vaccines|vaccines|mesh-list
19729045|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
19729046|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729047|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
19729048|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19729049|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
19869103|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869104|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19869105|NCT00845195|Azelastine|azelastine|mesh-list
19869106|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19869107|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19869108|NCT00845195|Analgesics|analgesics|mesh-ancestor
19869109|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
19869110|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869111|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869112|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869113|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869114|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19869115|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19869116|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19869117|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
19869118|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
19869119|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869120|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869121|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19869122|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
19869123|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19442801|NCT03084471|Durvalumab|durvalumab|mesh-list
19442802|NCT03084471|Tremelimumab|tremelimumab|mesh-list
19442803|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19442804|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19442805|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442806|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
19442807|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869124|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
19869125|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19869126|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970020|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
19970021|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970022|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970023|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19970024|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19970025|NCT01779167|Growth Substances|growth substances|mesh-ancestor
19970026|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
19970027|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970028|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
19970029|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970030|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970031|NCT01779375|Metformin|metformin|mesh-list
19970032|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
19729050|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729051|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729052|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729053|NCT04612556|Vaccines|vaccines|mesh-list
19729054|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
19729055|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729056|NCT04612582|Thalidomide|thalidomide|mesh-list
19729057|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
19729058|NCT04612582|Bortezomib|bortezomib|mesh-list
19729059|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729060|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
19729061|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729062|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729063|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19729064|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
19729065|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729066|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729067|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19729068|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
19729069|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19729070|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729071|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19729072|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19729073|NCT04612582|Growth Substances|growth substances|mesh-ancestor
19729074|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
19729075|NCT04612530|Nivolumab|nivolumab|mesh-list
19729076|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19729077|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729078|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19729079|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729080|NCT04612504|Atezolizumab|atezolizumab|mesh-list
19729081|NCT04612504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729082|NCT04612179|Sirolimus|sirolimus|mesh-list
19729083|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19729084|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869127|NCT00845429|Vaccines|vaccines|mesh-list
19869128|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
19869129|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869130|NCT00845481|Calcitriol|calcitriol|mesh-list
19869131|NCT00845481|Betamethasone|betamethasone|mesh-list
19869132|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869133|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
19869134|NCT00845481|Hormones|hormones|mesh-ancestor
19869135|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869136|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869137|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19729085|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19729086|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729087|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
19729088|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729089|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
19729090|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729091|NCT04612257|Insulin|insulin|mesh-list
19869138|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
19869139|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19729092|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19729093|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869140|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19869141|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869142|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869143|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19869144|NCT00845481|Vitamins|vitamins|mesh-ancestor
19442834|NCT03073967|Foscarnet|foscarnet|mesh-list
19442835|NCT03073967|Pritelivir|pritelivir|mesh-list
19442836|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
19442837|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19442838|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19442839|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19442840|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442841|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869145|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
19869146|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19869147|NCT00845507|Exenatide|exenatide|mesh-list
19869148|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19869149|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869150|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19869151|NCT00845507|Incretins|incretins|mesh-ancestor
19729094|NCT04611958|Bupivacaine|bupivacaine|mesh-list
19729095|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
19729096|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
19729097|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729098|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729099|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
19729100|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729101|NCT04611971|Belimumab|belimumab|mesh-list
19729102|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729103|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
19729104|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729105|NCT04611724|Folfirinox|folfirinox|mesh-list
19729106|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729107|NCT04611438|Cannabidiol|cannabidiol|mesh-list
19729108|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
19729109|NCT04611711|Decitabine|decitabine|mesh-list
19729110|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19729111|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
19729112|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729113|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729114|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729115|NCT04611685|Parecoxib|parecoxib|mesh-list
19729116|NCT04611685|Loxoprofen|loxoprofen|mesh-list
19729117|NCT04611685|Tramadol|tramadol|mesh-list
19729118|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19729119|NCT04611685|Narcotics|narcotics|mesh-ancestor
19729120|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729121|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729122|NCT04611685|Analgesics|analgesics|mesh-ancestor
19729123|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
19729124|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729125|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19729126|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19729127|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729128|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729129|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19729130|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729131|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729132|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729133|NCT04611373|Levamisole|levamisole|mesh-list
19729134|NCT04611373|Acetazolamide|acetazolamide|mesh-list
19729135|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
19729136|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19729137|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729138|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729139|NCT04611373|Diuretics|diuretics|mesh-ancestor
19869152|NCT00845507|Hormones|hormones|mesh-ancestor
19869153|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869154|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
19869155|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
19869156|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19869157|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19869158|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
19869159|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869160|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
19869161|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869162|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
19869163|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869164|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869165|NCT00845676|Interferons|interferons|mesh-list
19869166|NCT00845676|Ribavirin|ribavirin|mesh-list
19729140|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
19729141|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729142|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19729143|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
19729144|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
19729145|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
19729146|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19729147|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729148|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729149|NCT04611464|Misoprostol|misoprostol|mesh-list
19729150|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19729151|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
19729152|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19729153|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729154|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19729155|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729156|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
19869167|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
19869168|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
19869169|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19869170|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869171|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
19869172|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869173|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
19869174|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869175|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
19869176|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869177|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
19869178|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19869179|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
19869180|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869181|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869182|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19869183|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
19869184|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
19869185|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19869186|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
19869187|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869188|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869189|NCT00845832|Rituximab|rituximab|mesh-list
19869190|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869191|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869192|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
19869193|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869194|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869195|NCT00845858|Metoclopramide|metoclopramide|mesh-list
19869196|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
19869197|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
19869198|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869199|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869200|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869201|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19869202|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19729157|NCT04611776|Gemcitabine|gemcitabine|mesh-list
19729158|NCT04611776|Paclitaxel|paclitaxel|mesh-list
19729159|NCT04611776|Carboplatin|carboplatin|mesh-list
19729160|NCT04611776|Pemetrexed|pemetrexed|mesh-list
19729161|NCT04611776|Atezolizumab|atezolizumab|mesh-list
19729162|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19729163|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729164|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
19729165|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
19729166|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
19729167|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729168|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19729169|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
19729170|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
19729171|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729172|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729173|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729174|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
20255250|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255251|NCT00469404|Analgesics|analgesics|mesh-ancestor
20255252|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
20255253|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255254|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20255255|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20255256|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20255257|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20255258|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255259|NCT00469430|Metronidazole|metronidazole|mesh-list
20255260|NCT00469430|Cefotaxime|cefotaxime|mesh-list
19729175|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729176|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19729177|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19729178|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
19729179|NCT04611126|Nivolumab|nivolumab|mesh-list
19729180|NCT04611126|Fludarabine|fludarabine|mesh-list
19729181|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
19729182|NCT04611126|Ipilimumab|ipilimumab|mesh-list
19729183|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729184|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
19729185|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729186|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729187|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19729188|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
19729189|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729190|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729191|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19729192|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19729193|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19729194|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19729195|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
19729196|NCT04611152|Aflibercept|aflibercept|mesh-list
19729197|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19729198|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19729199|NCT04611152|Growth Substances|growth substances|mesh-ancestor
19729200|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729201|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
19729202|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729203|NCT04611165|Nivolumab|nivolumab|mesh-list
19729204|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19729205|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729206|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19729207|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729208|NCT04610879|Carbamazepine|carbamazepine|mesh-list
19729209|NCT04610879|Levetiracetam|levetiracetam|mesh-list
19729210|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
19729211|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
19729212|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
19729213|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19729214|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729215|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729216|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19729217|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729218|NCT04610879|Analgesics|analgesics|mesh-ancestor
19729219|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
19729220|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729221|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20255261|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255262|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20255263|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19729222|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19729223|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729224|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19729225|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19735328|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19735329|NCT04541251|Paclitaxel|paclitaxel|mesh-list
19735330|NCT04541251|Carboplatin|carboplatin|mesh-list
19735331|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19735332|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735333|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19735334|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19735335|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19735336|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735337|NCT04540861|Siponimod|siponimod|mesh-list
19735338|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19735339|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735340|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735341|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
19735342|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735343|NCT04540965|Famotidine|famotidine|mesh-list
19735344|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19735345|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19735346|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19735347|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
19735348|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
19735349|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735350|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735351|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735352|NCT04540653|Vaccines|vaccines|mesh-list
19735353|NCT04540653|Immunologic Factors|immunologic factors|mesh-ancestor
19735354|NCT04540653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735355|NCT04540666|Propofol|propofol|mesh-list
19735356|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19735357|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735358|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735359|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19735360|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
19735361|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
19735362|NCT04540744|Tadalafil|tadalafil|mesh-list
19735363|NCT04540744|Macitentan|macitentan|mesh-list
19735364|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
19735365|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19735366|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19735367|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735368|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735369|NCT04540744|Urological Agents|urological agents|mesh-ancestor
19735370|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19735371|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19735372|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19735373|NCT04540692|Paclitaxel|paclitaxel|mesh-list
19735374|NCT04540692|Docetaxel|docetaxel|mesh-list
19735375|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
19735376|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19869203|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
19869204|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869205|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869206|NCT00845871|Deferasirox|deferasirox|mesh-list
19869207|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19869208|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
19869209|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
19869210|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869211|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
19869212|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19869213|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735377|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729226|NCT04610580|Choline|choline|mesh-list
19729227|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
19729228|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19729229|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
19729230|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729231|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729232|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19729233|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
19729234|NCT04611243|Vaccines|vaccines|mesh-list
19729235|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
19729236|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729237|NCT04610567|Methotrexate|methotrexate|mesh-list
19729238|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19729239|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
19729240|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19729241|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729242|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19729243|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
19729244|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729245|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729246|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
19729247|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729248|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19729249|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729250|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
19729251|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729252|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19729253|NCT04610541|Remdesivir|remdesivir|mesh-list
19729254|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
19729255|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729256|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
19729257|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729258|NCT04610320|Daratumumab|daratumumab|mesh-list
19729259|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729260|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
19729261|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19729262|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19729263|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729264|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
19729265|NCT04610164|Coagulants|coagulants|mesh-ancestor
19729266|NCT04610307|Anesthetics|anesthetics|mesh-list
19729267|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729268|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729269|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
19729270|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19729271|NCT04610502|Antibodies|antibodies|mesh-list
19729272|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
19729273|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729274|NCT04610398|Dexamethasone|dexamethasone|mesh-list
19729275|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
19729276|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729277|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
19729278|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
19729279|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729280|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729281|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729282|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
19729283|NCT04610398|Hormones|hormones|mesh-ancestor
19729284|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729285|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19729286|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729287|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
19729288|NCT04610125|Fludarabine|fludarabine|mesh-list
19729289|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729290|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
19729291|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869214|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869215|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
19729292|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729293|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19729294|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
19729295|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729296|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729297|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20255264|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19869216|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869217|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869218|NCT00846027|Gemcitabine|gemcitabine|mesh-list
19869219|NCT00846027|Paclitaxel|paclitaxel|mesh-list
19442870|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
19442871|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19442872|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19442873|NCT03029234|Dexamethasone|dexamethasone|mesh-list
19442874|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19442875|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
19442876|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
19442877|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19442878|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442879|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19442880|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
19442881|NCT03029234|Hormones|hormones|mesh-ancestor
19729298|NCT04609865|Lidocaine|lidocaine|mesh-list
19729299|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
19729300|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
19729301|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729302|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729303|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
19729304|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729305|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19729306|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19729307|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19729308|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19729309|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729310|NCT04609748|Nimesulide|nimesulide|mesh-list
19729311|NCT04609748|Cannabidiol|cannabidiol|mesh-list
19729312|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
19729313|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19729314|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729315|NCT04609748|Analgesics|analgesics|mesh-ancestor
19729316|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
19729317|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729318|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729319|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255265|NCT00469443|Leucovorin|leucovorin|mesh-list
20255266|NCT00469443|Bevacizumab|bevacizumab|mesh-list
20255267|NCT00469443|Fluorouracil|fluorouracil|mesh-list
20255268|NCT00469443|Capecitabine|capecitabine|mesh-list
20255269|NCT00469443|Irinotecan|irinotecan|mesh-list
19729320|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729321|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19729322|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729323|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729324|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19729325|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729326|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19729327|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
19729328|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19729329|NCT04609761|Antibodies|antibodies|mesh-list
19729330|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
19729331|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19729332|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
19442882|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729333|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729334|NCT04609540|Trastuzumab|trastuzumab|mesh-list
19729335|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19729336|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729337|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19729338|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
19729339|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19729340|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19729341|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729342|NCT04609254|Acetaminophen|acetaminophen|mesh-list
19729343|NCT04609254|Ibuprofen|ibuprofen|mesh-list
19729344|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19729345|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19729346|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729347|NCT04609254|Analgesics|analgesics|mesh-ancestor
19729348|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
19729349|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729350|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729351|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729352|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729353|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19729354|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729355|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729356|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
19729357|NCT04609293|Apatinib|apatinib|mesh-list
19729358|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729359|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19729360|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729361|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729362|NCT04609189|Vitamin D|vitamin d|mesh-list
19729363|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
19729364|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
19729365|NCT04609189|Calcium|calcium|mesh-list
19729366|NCT04609189|Vitamins|vitamins|mesh-ancestor
19729367|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
19729368|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729369|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19729370|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19729371|NCT04609189|Antacids|antacids|mesh-ancestor
19729372|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729373|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729374|NCT04609176|Apatinib|apatinib|mesh-list
19729375|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729376|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19729377|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729378|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729379|NCT04609397|Hemay005|hemay005|mesh-list
19729380|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
19729381|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19729382|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19729383|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729384|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729385|NCT04609098|Piperaquine|piperaquine|mesh-list
19729386|NCT04609098|Artenimol|artenimol|mesh-list
19729387|NCT04609098|Tafenoquine|tafenoquine|mesh-list
19729388|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
19729389|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19729390|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19729391|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729392|NCT04608734|Midazolam|midazolam|mesh-list
19729393|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19729394|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19729395|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729396|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442883|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19442884|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869220|NCT00846027|Bevacizumab|bevacizumab|mesh-list
19869221|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19869222|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869223|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
19869224|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
19869225|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
19869226|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970033|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19729397|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19452939|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
19729398|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19729399|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19729400|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19729401|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
19729402|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
19729403|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
19729404|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
19729405|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729406|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729407|NCT04609033|Ketamine|ketamine|mesh-list
19729408|NCT04609033|Morphine|morphine|mesh-list
19729409|NCT04609033|Bupivacaine|bupivacaine|mesh-list
19729410|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
19729411|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
19729412|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729413|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729414|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
19729415|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729416|NCT04609033|Analgesics|analgesics|mesh-ancestor
19729417|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19729418|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19729419|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
19729420|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19729421|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19729422|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729423|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729424|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19729425|NCT04609033|Narcotics|narcotics|mesh-ancestor
19729426|NCT04608981|Prednisolone|prednisolone|mesh-list
19729427|NCT04608981|Diclofenac|diclofenac|mesh-list
19729428|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729429|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
19729430|NCT04608981|Hormones|hormones|mesh-ancestor
19729431|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729432|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729433|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19729434|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729435|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729436|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19729437|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729438|NCT04608981|Analgesics|analgesics|mesh-ancestor
19729439|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
19729440|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729441|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19729442|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729443|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729444|NCT04608669|Acetaminophen|acetaminophen|mesh-list
19729445|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729446|NCT04608669|Analgesics|analgesics|mesh-ancestor
19729447|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
19729448|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729449|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729450|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
19735378|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
19735379|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
19735380|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
19735381|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735382|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535180|NCT01818375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535181|NCT01818375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535182|NCT01818648|Exenatide|exenatide|mesh-list
20535183|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535184|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535185|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20535186|NCT01818648|Incretins|incretins|mesh-ancestor
19869227|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19452940|NCT03407976|Apatinib|apatinib|mesh-list
20535187|NCT01818648|Hormones|hormones|mesh-ancestor
20535188|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535189|NCT01818713|Doxorubicin|doxorubicin|mesh-list
20535190|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20535191|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20535192|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535193|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20535194|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20255270|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20255271|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255272|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255273|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255274|NCT00469443|Growth Substances|growth substances|mesh-ancestor
20255275|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255276|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255277|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
20255278|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255279|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255280|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255281|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
20255282|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20255283|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19869228|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19869229|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19869230|NCT00846027|Growth Substances|growth substances|mesh-ancestor
20255284|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255285|NCT00469443|Antidotes|antidotes|mesh-ancestor
20255286|NCT00469443|Protective Agents|protective agents|mesh-ancestor
20255287|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
20255288|NCT00469443|Vitamins|vitamins|mesh-ancestor
20255289|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
20255290|NCT00469469|Bevacizumab|bevacizumab|mesh-list
20255291|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20255292|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255293|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255294|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255295|NCT00469469|Growth Substances|growth substances|mesh-ancestor
20255296|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255297|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255298|NCT00469495|Anthelmintics|anthelmintics|mesh-list
20255299|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20255300|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255301|NCT00469547|Ethanol|ethanol|mesh-list
19869231|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869232|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
19869233|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19869234|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
19869235|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
19869236|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869237|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869238|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869239|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
19869240|NCT00846040|Fallypride|fallypride|mesh-list
19869241|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19869242|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19869243|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
19869244|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869245|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869246|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442939|NCT02949284|Prednisone|prednisone|mesh-list
19442940|NCT02949284|Cortisone|cortisone|mesh-list
19442941|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
19442942|NCT02949284|Hormones|hormones|mesh-list
19442943|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19442944|NCT02949284|Androgens|androgens|mesh-list
19442945|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
19442946|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19442947|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
19442948|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19442949|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19442950|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19442951|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19442952|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19442953|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19442954|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19442955|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
19442956|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19442957|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
19869247|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19869248|NCT00846365|Olmesartan|olmesartan|mesh-list
19869249|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19869250|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
19869251|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20255302|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
20255303|NCT00469547|Emollients|emollients|mesh-list
20255304|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20255305|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20255306|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255307|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255308|NCT00469560|Deferasirox|deferasirox|mesh-list
20255309|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19869252|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20255310|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
19869253|NCT00846365|Diuretics|diuretics|mesh-ancestor
19869254|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
20255311|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
19729451|NCT04608474|Evolocumab|evolocumab|mesh-list
19729452|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19729453|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19869255|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869256|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19869257|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869258|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869259|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19869260|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19869261|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
19869262|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869263|NCT00846495|Topiramate|topiramate|mesh-list
19729454|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19729455|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
19729456|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729457|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19729458|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729459|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19729460|NCT04608539|Hematinics|hematinics|mesh-ancestor
19729461|NCT04608253|Choline|choline|mesh-list
19729462|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
19729463|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19729464|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
20535195|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535196|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535197|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
20535198|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
20535199|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535200|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
19729465|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869264|NCT00846495|Frovatriptan|frovatriptan|mesh-list
20535201|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535202|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535203|NCT01818856|Ritonavir|ritonavir|mesh-list
20535204|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20535205|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20535206|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20535207|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
20535208|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535209|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535210|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20535211|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20255312|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255313|NCT00469586|Insulin|insulin|mesh-list
20255314|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20255315|NCT00469586|Metformin|metformin|mesh-list
19869265|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
19869266|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20255316|NCT00469586|Glimepiride|glimepiride|mesh-list
19869267|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255317|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20255318|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255319|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20255320|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255321|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
20255322|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
20255323|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20255324|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20255325|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255326|NCT00469599|Vitamins|vitamins|mesh-ancestor
20255327|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
19869268|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19869269|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
19869270|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869271|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729466|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729467|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19729468|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
19729469|NCT04608500|Minocycline|minocycline|mesh-list
19729470|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19729471|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729472|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19729473|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19729474|NCT04607772|Gemcitabine|gemcitabine|mesh-list
19729475|NCT04607772|Rituximab|rituximab|mesh-list
19729476|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
19729477|NCT04607772|Lenalidomide|lenalidomide|mesh-list
19729478|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19729479|NCT04607772|Venetoclax|venetoclax|mesh-list
19729480|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19729481|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729482|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
19729483|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729484|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729485|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19729486|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
19729487|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729488|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
19729489|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729490|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735383|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
19869272|NCT00846521|Acarbose|acarbose|mesh-list
19869273|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19869274|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729491|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729492|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19729493|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19729494|NCT04607772|Growth Substances|growth substances|mesh-ancestor
19729495|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
19729496|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19729497|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
19729498|NCT04608006|Fentanyl|fentanyl|mesh-list
19729499|NCT04608006|Bupivacaine|bupivacaine|mesh-list
19729500|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
19729501|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
19869275|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869276|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19869277|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869278|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
19869279|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19869280|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
19869281|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869282|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869283|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19869284|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
19869285|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
19869286|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19869287|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
19869288|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869289|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869290|NCT00846651|Phenylephrine|phenylephrine|mesh-list
19869291|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
19869292|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19869293|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
19869294|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
19869295|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869296|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869297|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
19869298|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19869299|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
19869300|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
19869301|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19443020|NCT02889159|Imiquimod|imiquimod|mesh-list
19443021|NCT02889159|Histamine|histamine|mesh-list
19443022|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
19443023|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19443024|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
19443025|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443026|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443027|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
19443028|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
19443029|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
19443030|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19443031|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443032|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
19443033|NCT02874144|Fluticasone|fluticasone|mesh-list
19443034|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19443035|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
19443036|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19443037|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19443038|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
19443039|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19443040|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869302|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20535212|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
19869303|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20535213|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535214|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20535215|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20535216|NCT01818869|Adenosine|adenosine|mesh-list
20535217|NCT01818869|Analgesics|analgesics|mesh-ancestor
20535218|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
20535219|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535220|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535221|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20535222|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535223|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20535224|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
20535225|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
20535226|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535227|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535228|NCT01818908|Prednisone|prednisone|mesh-list
20535229|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
20255328|NCT00469651|Vaccines|vaccines|mesh-list
20255329|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
20255330|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255331|NCT00469664|Guanfacine|guanfacine|mesh-list
20255332|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20255333|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20255334|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20255335|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20255336|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
20255337|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255338|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255339|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255340|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20255341|NCT00469690|Bromfenac|bromfenac|mesh-list
20255342|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20255343|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255344|NCT00469690|Analgesics|analgesics|mesh-ancestor
20255345|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
20255346|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255347|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255348|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255349|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255350|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19443041|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19443042|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
19443043|NCT02862171|Dapivirine|dapivirine|mesh-list
20255351|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255352|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255353|NCT00469703|Thalidomide|thalidomide|mesh-list
20255354|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255355|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
20255356|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255357|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
20255358|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20255359|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535230|NCT01818908|Doxorubicin|doxorubicin|mesh-list
20535231|NCT01818908|Etoposide|etoposide|mesh-list
19443044|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19443045|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19443046|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
19443047|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869304|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
19869305|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869306|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869307|NCT00846651|Protective Agents|protective agents|mesh-ancestor
19869308|NCT00846768|Olodaterol|olodaterol|mesh-list
20535232|NCT01818908|Vincristine|vincristine|mesh-list
20535233|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535234|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
20535235|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535236|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20535237|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20535238|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
20535239|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535240|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535241|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20535242|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20535243|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19869309|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19869310|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
19869311|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869312|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869313|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19869314|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
19869315|NCT00847015|Gemcitabine|gemcitabine|mesh-list
20255360|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255361|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255362|NCT00469703|Growth Substances|growth substances|mesh-ancestor
20255363|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255364|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255365|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20255366|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
20255367|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
20255368|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
20255369|NCT00469755|Adapalene|adapalene|mesh-list
20255370|NCT00469755|Tazarotene|tazarotene|mesh-list
20255371|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20255372|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255373|NCT00469755|Analgesics|analgesics|mesh-ancestor
20255374|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
20255375|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255376|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255377|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255378|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255379|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255380|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
20255381|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
20255382|NCT00469755|Vitamins|vitamins|mesh-ancestor
20255383|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
20255384|NCT00469768|Dapivirine|dapivirine|mesh-list
20255385|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20255386|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20255387|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
20255388|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255389|NCT00469781|Bromfenac|bromfenac|mesh-list
20255390|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
20255391|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20255392|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
20535244|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20255393|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20255394|NCT00469781|Prednisolone|prednisolone|mesh-list
20255395|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20255396|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
19869316|NCT00847015|Sunitinib|sunitinib|mesh-list
20255397|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20255398|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255399|NCT00469781|Analgesics|analgesics|mesh-ancestor
20255400|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
20255401|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255402|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255403|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869317|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869318|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19869319|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
19869320|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869321|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
19869322|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869323|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443064|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19443065|NCT02835534|Plasminogen|plasminogen|mesh-list
19443066|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19443067|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19443068|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869324|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255404|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869325|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
19869326|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869327|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19869328|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19869329|NCT00847015|Growth Substances|growth substances|mesh-ancestor
19869330|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
19869331|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19869332|NCT00847145|Vaccines|vaccines|mesh-list
20255405|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
20255406|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
20255407|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20255408|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
20255409|NCT00469781|Hormones|hormones|mesh-ancestor
20255410|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255411|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20255412|NCT00469781|Protective Agents|protective agents|mesh-ancestor
20255413|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20255414|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535245|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535246|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535247|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
20535248|NCT01818908|Hormones|hormones|mesh-ancestor
19869333|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
19869334|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869335|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
19869336|NCT00847171|Trastuzumab|trastuzumab|mesh-list
19869337|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869338|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
19869339|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869340|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869341|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19729502|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869342|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
19869343|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869344|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869345|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19869346|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869347|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
19869348|NCT00847210|Lansoprazole|lansoprazole|mesh-list
19869349|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19869350|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869351|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19869352|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869353|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869354|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
19869355|NCT00847587|Etonogestrel|etonogestrel|mesh-list
19869356|NCT00847587|Desogestrel|desogestrel|mesh-list
19869357|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19869358|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869359|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19869360|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19869361|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19869362|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19869363|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19869364|NCT00847587|Progestins|progestins|mesh-ancestor
19869365|NCT00847587|Hormones|hormones|mesh-ancestor
19869366|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869367|NCT00847613|Tofacitinib|tofacitinib|mesh-list
19869368|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19869369|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869370|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869371|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
19869372|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19869373|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19869374|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19869375|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869376|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19869377|NCT00847626|Diuretics|diuretics|mesh-ancestor
19869378|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
19869379|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869380|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19869381|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869382|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
19869383|NCT00847808|Lansoprazole|lansoprazole|mesh-list
19869384|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19869385|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869386|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19869387|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869388|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869389|NCT00847886|Methotrexate|methotrexate|mesh-list
19729503|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729504|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
19729505|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729506|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19729507|NCT04608006|Narcotics|narcotics|mesh-ancestor
19729508|NCT04608006|Analgesics|analgesics|mesh-ancestor
19729509|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19729510|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19729511|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
19869390|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19869391|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
19869392|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19869393|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869394|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19869395|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
19869396|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255415|NCT00469846|Ascorbic Acid|ascorbic acid|mesh-list
20255416|NCT00469846|Vitamins|vitamins|mesh-ancestor
20255417|NCT00469846|Micronutrients|micronutrients|mesh-ancestor
20255418|NCT00469846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255419|NCT00469846|Antioxidants|antioxidants|mesh-ancestor
20255420|NCT00469846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255421|NCT00469846|Protective Agents|protective agents|mesh-ancestor
20255422|NCT00469885|Nicotine|nicotine|mesh-list
20255423|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20255424|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
20255425|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255426|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255427|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20255428|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20255429|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
20255430|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255431|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255432|NCT00469924|Caffeine|caffeine|mesh-list
20255433|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19869397|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869398|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
19869399|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869400|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19869401|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869402|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
19869403|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869404|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19869405|NCT00847912|Fluorouracil|fluorouracil|mesh-list
19869406|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
19869407|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869408|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19869409|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869410|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869411|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
19869412|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869413|NCT00847938|Neostigmine|neostigmine|mesh-list
19869414|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19869415|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869416|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869417|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
19869418|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869419|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869420|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19869421|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
19869422|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869423|NCT00848016|Acetic Acid|acetic acid|mesh-list
19869424|NCT00848016|Retinol acetate|retinol acetate|mesh-list
19869425|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
19869426|NCT00848016|Gossypol|gossypol|mesh-list
19869427|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19869428|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729512|NCT04607733|Mirikizumab|mirikizumab|mesh-list
19869429|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19869430|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
19869431|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869432|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19869433|NCT00848016|Protective Agents|protective agents|mesh-ancestor
19869434|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729513|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19729514|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729515|NCT04607733|Analgesics|analgesics|mesh-ancestor
19729516|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
19729517|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729518|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729519|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729520|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729521|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19869435|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19869436|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
19869437|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19869438|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19869439|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19869440|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19869441|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19869442|NCT00848081|Tadalafil|tadalafil|mesh-list
19869443|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
19869444|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19869445|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19869446|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869447|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869448|NCT00848081|Urological Agents|urological agents|mesh-ancestor
19869449|NCT00848107|Treprostinil|treprostinil|mesh-list
19869450|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535249|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535250|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20535251|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20535252|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
20535253|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535254|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535255|NCT01818973|Bevacizumab|bevacizumab|mesh-list
20535256|NCT01818973|Capecitabine|capecitabine|mesh-list
19869451|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19443165|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
19443166|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869452|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19869453|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
19869454|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869455|NCT00848354|Etanercept|etanercept|mesh-list
19869456|NCT00848354|Methotrexate|methotrexate|mesh-list
19869457|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19869458|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
19869459|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19869460|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869461|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19869462|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
19869463|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869464|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869465|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
19869466|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869467|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19869468|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869469|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
19869470|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869471|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19869472|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19869473|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19869474|NCT00848354|Analgesics|analgesics|mesh-ancestor
19869475|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
19443191|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
19443192|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443193|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869476|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869477|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869478|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869479|NCT00848393|Fentanyl|fentanyl|mesh-list
20535257|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
19869480|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
20255434|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869481|NCT00848393|Citric Acid|citric acid|mesh-list
19869482|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
19869483|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19869484|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869485|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869486|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19869487|NCT00848393|Analgesics|analgesics|mesh-ancestor
19869488|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
19869489|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869490|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19869491|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19869492|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20255435|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20255436|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255437|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255438|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20255439|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20255440|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
20255441|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255442|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
20255443|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
20255444|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20255445|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255446|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255447|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
20255448|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20255449|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20255450|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255451|NCT00469976|Gemcitabine|gemcitabine|mesh-list
20255452|NCT00469976|Bevacizumab|bevacizumab|mesh-list
20255453|NCT00469976|Carboplatin|carboplatin|mesh-list
20255454|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20255455|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255456|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255457|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255458|NCT00469976|Growth Substances|growth substances|mesh-ancestor
20255459|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255460|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255461|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255462|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
20255463|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255464|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
20255465|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255466|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255467|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255468|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
19869493|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
19869494|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869495|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869496|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19869497|NCT00848393|Narcotics|narcotics|mesh-ancestor
19869498|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19869499|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19869500|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
19869501|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
19869502|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
19869503|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19869504|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
19443212|NCT02620306|Losartan|losartan|mesh-list
19443213|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19443214|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19443215|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19443216|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19443217|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443218|NCT02616055|XL647|xl647|mesh-list
19443219|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443220|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19443221|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443222|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443223|NCT02611830|Vedolizumab|vedolizumab|mesh-list
19443224|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19443225|NCT02611817|Vedolizumab|vedolizumab|mesh-list
19443226|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19443227|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
19443228|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
19443229|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19443230|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19443231|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19443232|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443233|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443234|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869505|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
19869506|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
19869507|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
19443238|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
19443239|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
19443240|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869508|NCT00848497|Testosterone|testosterone|mesh-list
19869509|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
19869510|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
19869511|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19869512|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869513|NCT00848497|Androgens|androgens|mesh-ancestor
19869514|NCT00848497|Hormones|hormones|mesh-ancestor
19869515|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869516|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869517|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19869518|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869519|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
19869520|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
19869521|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19869522|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19869523|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255469|NCT00470015|Aldesleukin|aldesleukin|mesh-list
20255470|NCT00470015|Interleukin-2|interleukin-2|mesh-list
20255471|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255472|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255473|NCT00470015|Analgesics|analgesics|mesh-ancestor
20255474|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
20255475|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255476|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255477|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20255478|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20255479|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
19869524|NCT00848497|Urological Agents|urological agents|mesh-ancestor
19869525|NCT00848536|Travoprost|travoprost|mesh-list
19869526|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19443259|NCT02488759|Nivolumab|nivolumab|mesh-list
19443260|NCT02488759|Ipilimumab|ipilimumab|mesh-list
19443261|NCT02488759|Daratumumab|daratumumab|mesh-list
19443262|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443263|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443264|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19443265|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869527|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19869528|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19869529|NCT00848549|Carbamazepine|carbamazepine|mesh-list
19869530|NCT00848549|Zonisamide|zonisamide|mesh-list
19869531|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
19869532|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
19869533|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19869534|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869535|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443275|NCT02477826|Gemcitabine|gemcitabine|mesh-list
19443276|NCT02477826|Paclitaxel|paclitaxel|mesh-list
19443277|NCT02477826|Carboplatin|carboplatin|mesh-list
19443278|NCT02477826|Nivolumab|nivolumab|mesh-list
19443279|NCT02477826|Pemetrexed|pemetrexed|mesh-list
19443280|NCT02477826|Ipilimumab|ipilimumab|mesh-list
19443281|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19443282|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443283|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
19443284|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
19443285|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
19443286|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443287|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19443288|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
19443289|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
19443290|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19443291|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443292|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19443293|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
19443294|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443295|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443296|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19443297|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19443298|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20255480|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255481|NCT00470041|Lamivudine|lamivudine|mesh-list
19869536|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19869537|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19869538|NCT00848549|Analgesics|analgesics|mesh-ancestor
19869539|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
19869540|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869541|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19869542|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869543|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869544|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19869545|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19869546|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19869547|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19869548|NCT00848718|Paclitaxel|paclitaxel|mesh-list
19869549|NCT00848718|Docetaxel|docetaxel|mesh-list
19869550|NCT00848718|Carboplatin|carboplatin|mesh-list
19869551|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19869552|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19869553|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869554|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
19869555|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
19869556|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
19869557|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255482|NCT00470041|Zidovudine|zidovudine|mesh-list
20255483|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
19869558|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19869559|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869560|NCT00848783|Capecitabine|capecitabine|mesh-list
19869561|NCT00848783|Irinotecan|irinotecan|mesh-list
19729522|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729523|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
19729524|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19729525|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19729526|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729527|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
19729528|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19869562|NCT00848783|Floxuridine|floxuridine|mesh-list
19869563|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869564|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19869565|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
19869566|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869567|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19869568|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19869569|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869570|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19869571|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869572|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869573|NCT00848965|Fluticasone|fluticasone|mesh-list
19869574|NCT00848965|Xhance|xhance|mesh-list
19729529|NCT04607629|Omalizumab|omalizumab|mesh-list
19729530|NCT04607629|Budesonide|budesonide|mesh-list
19869575|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255484|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20255485|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20255486|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255487|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255488|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255489|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20255490|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20255491|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
20255492|NCT00470197|Cytarabine|cytarabine|mesh-list
20255493|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
20255494|NCT00470197|Alvocidib|alvocidib|mesh-list
20255495|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255496|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
20255497|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255498|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255499|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
20255500|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255501|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255502|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
20255503|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869576|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20255504|NCT00470197|Analgesics|analgesics|mesh-ancestor
19869577|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
19869578|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869579|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869580|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19869581|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
19869582|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
19869583|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19869584|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
19443338|NCT02457221|Prednisone|prednisone|mesh-list
19443339|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
19443340|NCT02457221|Tacrolimus|tacrolimus|mesh-list
19443341|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19443342|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
19443343|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443344|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19443345|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19443346|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
19443347|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443348|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443349|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19443350|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19443351|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
19443352|NCT02457221|Hormones|hormones|mesh-ancestor
19443353|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19443354|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19443355|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19443356|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869585|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19869586|NCT00849017|Incretins|incretins|mesh-ancestor
19869587|NCT00849017|Hormones|hormones|mesh-ancestor
19869588|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869589|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869590|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
19869591|NCT00849056|Incretins|incretins|mesh-ancestor
19869592|NCT00849056|Hormones|hormones|mesh-ancestor
19869593|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869594|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869595|NCT00849121|Vaccines|vaccines|mesh-list
19869596|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
19869597|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869598|NCT00849186|Sunitinib|sunitinib|mesh-list
19869599|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869600|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19869601|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19869602|NCT00849186|Growth Substances|growth substances|mesh-ancestor
19869603|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869604|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
19869605|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19869606|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869607|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869608|NCT00849251|Dexamethasone|dexamethasone|mesh-list
19869609|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
19869610|NCT00849251|Doxorubicin|doxorubicin|mesh-list
19869611|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19869612|NCT00849251|Bortezomib|bortezomib|mesh-list
19869613|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729531|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
19729532|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19729533|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19729534|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729535|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19729536|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
19729537|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869614|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
20535258|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869615|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452941|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19729538|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729539|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19729540|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
19729541|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
19729542|NCT04607629|Hormones|hormones|mesh-ancestor
19729543|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729544|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19729545|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20255505|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
20255506|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255507|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20255508|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20255509|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255510|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255511|NCT00470197|Growth Substances|growth substances|mesh-ancestor
20255512|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20255513|NCT00470210|Ribavirin|ribavirin|mesh-list
20255514|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20255515|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
20255516|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255517|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
20255518|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255519|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
20255520|NCT00470223|Doxorubicin|doxorubicin|mesh-list
20255521|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20255522|NCT00470223|Methotrexate|methotrexate|mesh-list
20255523|NCT00470223|Etoposide|etoposide|mesh-list
20255524|NCT00470223|Ifosfamide|ifosfamide|mesh-list
20255525|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255526|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20255527|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20255528|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20255529|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255530|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255531|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20255532|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
20255533|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20255534|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255535|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255536|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
19729546|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19729547|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
19729548|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729549|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729550|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19729551|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
19729552|NCT04607603|Cannabidiol|cannabidiol|mesh-list
19729553|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
19729554|NCT04607447|Dexamethasone|dexamethasone|mesh-list
19729555|NCT04607447|Atorvastatin|atorvastatin|mesh-list
20255537|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255538|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19729556|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869616|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869617|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20535259|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535260|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20535261|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20535262|NCT01818973|Growth Substances|growth substances|mesh-ancestor
19869618|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
19869619|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869620|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869621|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19869622|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19869623|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
19869624|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
19869625|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869626|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869627|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
19869628|NCT00849251|Hormones|hormones|mesh-ancestor
19869629|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869630|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19869631|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19869632|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19443404|NCT02264678|Carboplatin|carboplatin|mesh-list
19443405|NCT02264678|Durvalumab|durvalumab|mesh-list
19443406|NCT02264678|Olaparib|olaparib|mesh-list
19443407|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443408|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443409|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19443410|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443411|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869633|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19869634|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729557|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
19729558|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
19729559|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729560|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729561|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729562|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
19729563|NCT04607447|Hormones|hormones|mesh-ancestor
19729564|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729565|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19729566|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729567|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19729568|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19729569|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
19729570|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729571|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19729572|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19729573|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729574|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
19729575|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19729576|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729577|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729578|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729579|NCT04607525|Analgesics|analgesics|mesh-ancestor
19729580|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
19869635|NCT00849472|Paclitaxel|paclitaxel|mesh-list
20535263|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535264|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
20535265|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20535266|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
20535267|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869636|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
20255539|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255540|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
20255541|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255542|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20255543|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20255544|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20255545|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
20255546|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20255547|NCT00470249|Gemcitabine|gemcitabine|mesh-list
20255548|NCT00470249|Carboplatin|carboplatin|mesh-list
20255549|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255550|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255551|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
20255552|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255553|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
20255554|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255555|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255556|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729581|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729582|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19729583|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19729584|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19869637|NCT00849472|Doxorubicin|doxorubicin|mesh-list
19869638|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19869639|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869640|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19869641|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19869642|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
19869643|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869644|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869645|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
19869646|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443428|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19443429|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443430|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869647|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869648|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19869649|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
19869650|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19869651|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19869652|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19869653|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19869654|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869655|NCT00849680|Vaccines|vaccines|mesh-list
19869656|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
19869657|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729585|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
19729586|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729587|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729588|NCT04607642|Manganese|manganese|mesh-list
19729589|NCT04607642|Trace Elements|trace elements|mesh-ancestor
19729590|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
19729591|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729592|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
19729593|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19729594|NCT04606914|Maytansine|maytansine|mesh-list
19729595|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19729596|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729597|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
19729598|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
19729599|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
19729600|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729601|NCT04606836|Bupivacaine|bupivacaine|mesh-list
19869658|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19869659|NCT00849693|Fluoxetine|fluoxetine|mesh-list
19869660|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19869661|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19869662|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869663|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869664|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255557|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
19729602|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
19729603|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
20535268|NCT01819012|Isoflurane|isoflurane|mesh-list
20535269|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20535270|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
20535271|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
20535272|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535273|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535274|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
20535275|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20535276|NCT01819064|Atropine|atropine|mesh-list
20535277|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20535278|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19869665|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869666|NCT00849693|Analgesics|analgesics|mesh-ancestor
19869667|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
19869668|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869669|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
19869670|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19869671|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
19869672|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19869673|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
19869674|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19869675|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19869676|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19869677|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869678|NCT00849810|Metoprolol|metoprolol|mesh-list
19869679|NCT00849810|Nebivolol|nebivolol|mesh-list
19869680|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19869681|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19869682|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
19869683|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
19869684|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869685|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869686|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19869687|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19869688|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19869689|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
19869690|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869691|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869692|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
19869693|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19869694|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19869695|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19869696|NCT00849875|Dacarbazine|dacarbazine|mesh-list
19869697|NCT00849875|Imidazole|imidazole|mesh-list
19869698|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19869699|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
19869700|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869701|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869702|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869703|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19869704|NCT00849901|Fluoxetine|fluoxetine|mesh-list
19729604|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869705|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19443485|NCT02186847|Metformin|metformin|mesh-list
19443486|NCT02186847|Paclitaxel|paclitaxel|mesh-list
19443487|NCT02186847|Carboplatin|carboplatin|mesh-list
19443488|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19443489|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443490|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
19443491|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
19443492|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
19443493|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443494|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19443495|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869706|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19869707|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869708|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869709|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869710|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869711|NCT00849901|Analgesics|analgesics|mesh-ancestor
19869712|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
19869713|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869714|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
19869715|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19869716|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
19869717|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19869718|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
19869719|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19869720|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19869721|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19869722|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869723|NCT00850096|Insulin|insulin|mesh-list
19869724|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19869725|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869726|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
19869727|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869728|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
19869729|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255558|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255559|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
20255560|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
20255561|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20255562|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255563|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255564|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255565|NCT00470340|Gemcitabine|gemcitabine|mesh-list
20255566|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
19869730|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255567|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
19869731|NCT00850395|Maraviroc|maraviroc|mesh-list
19869732|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19869733|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19869734|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869735|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19869736|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19869737|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
19869738|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869739|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19869740|NCT00850460|Atorvastatin|atorvastatin|mesh-list
19869741|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19869742|NCT00850460|Simvastatin|simvastatin|mesh-list
19869743|NCT00850460|Pravastatin|pravastatin|mesh-list
19869744|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19869745|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19869746|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
19869747|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869748|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19869749|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19869750|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443549|NCT02101034|Cetuximab|cetuximab|mesh-list
19443550|NCT02101034|Palbociclib|palbociclib|mesh-list
19443551|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443552|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443553|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19443554|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443555|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443556|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
19443557|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19443558|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19443559|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19443560|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19443561|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443562|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
19443563|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19443564|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443565|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19443566|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19443567|NCT02041533|Gemcitabine|gemcitabine|mesh-list
19443568|NCT02041533|Paclitaxel|paclitaxel|mesh-list
19443569|NCT02041533|Carboplatin|carboplatin|mesh-list
19443570|NCT02041533|Nivolumab|nivolumab|mesh-list
19443571|NCT02041533|Pemetrexed|pemetrexed|mesh-list
19443572|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19443573|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443574|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
19443575|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
19443576|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
19443577|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443578|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19443579|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
19443580|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
19443581|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19443582|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729605|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729606|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
19729607|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729608|NCT04606563|Losartan|losartan|mesh-list
19729609|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19729610|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19729611|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19729612|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19729613|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729614|NCT04606537|Itraconazole|itraconazole|mesh-list
19869751|NCT00850499|Rituximab|rituximab|mesh-list
19869752|NCT00850499|Fludarabine|fludarabine|mesh-list
19869753|NCT00850499|Bortezomib|bortezomib|mesh-list
19869754|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869755|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869756|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
19869757|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869758|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869759|NCT00850564|Hormones|hormones|mesh-list
20255568|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535279|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19869760|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19869761|NCT00850564|Tesamorelin|tesamorelin|mesh-list
20535280|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
20535281|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535282|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535283|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20535284|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
20535285|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
20535286|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
20535287|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20535288|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19443583|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19443584|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
19443585|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443586|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443587|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19443588|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19443589|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19869762|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869763|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869764|NCT00850564|Growth Substances|growth substances|mesh-ancestor
19869765|NCT00850889|Lidocaine|lidocaine|mesh-list
19869766|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
19869767|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19869768|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
19869769|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869770|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869771|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
19443600|NCT01996865|Rituximab|rituximab|mesh-list
19443601|NCT01996865|Lenalidomide|lenalidomide|mesh-list
19443602|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443603|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443604|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
19443605|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443606|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19443607|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19443608|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19443609|NCT01996865|Growth Substances|growth substances|mesh-ancestor
19443610|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
19869772|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869773|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19869774|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19869775|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20255569|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255570|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
20255571|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255572|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
20255573|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255574|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255575|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255576|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
20255577|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255578|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
20255579|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
20255580|NCT00470353|Calcium|calcium|mesh-list
20255581|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20255582|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255583|NCT00470353|Vitamins|vitamins|mesh-ancestor
20255584|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
19869776|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869777|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869778|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19869779|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
20255585|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20255586|NCT00470353|Antacids|antacids|mesh-ancestor
20255587|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255588|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20255589|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
20255590|NCT00470405|Pemetrexed|pemetrexed|mesh-list
20255591|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255592|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255593|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869780|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
19869781|NCT00850889|Protective Agents|protective agents|mesh-ancestor
19869782|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
19869783|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869784|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869785|NCT00851084|Leucovorin|leucovorin|mesh-list
19869786|NCT00851084|Folic Acid|folic acid|mesh-list
19869787|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
19443629|NCT01968590|Vitamin D|vitamin d|mesh-list
19443630|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
19443631|NCT01968590|Vitamins|vitamins|mesh-ancestor
19443632|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
19443633|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443634|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19443635|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19869788|NCT00851084|Aflibercept|aflibercept|mesh-list
19869789|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
19869790|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869791|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19869792|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19869793|NCT00851084|Growth Substances|growth substances|mesh-ancestor
19869794|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869795|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
19869796|NCT00851084|Antidotes|antidotes|mesh-ancestor
19869797|NCT00851084|Protective Agents|protective agents|mesh-ancestor
19869798|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
19869799|NCT00851084|Vitamins|vitamins|mesh-ancestor
19869800|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
19869801|NCT00851084|Hematinics|hematinics|mesh-ancestor
19869802|NCT00851318|Methotrexate|methotrexate|mesh-list
19869803|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
19869804|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19869805|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
19869806|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19869807|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869808|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19869809|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
19869810|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869811|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869812|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
19869813|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869814|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19869815|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255594|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20255595|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20255596|NCT00470483|Paroxetine|paroxetine|mesh-list
20255597|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20255598|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20255599|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19869816|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
19869817|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869818|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20255600|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255601|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255602|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
20255603|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255604|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20255605|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
20255606|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20255607|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20255608|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20255609|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255610|NCT00470509|Adalimumab|adalimumab|mesh-list
20255611|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255612|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255613|NCT00470522|Folic Acid|folic acid|mesh-list
20255614|NCT00470522|Methotrexate|methotrexate|mesh-list
20255615|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20255616|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
20255617|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20255618|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255619|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255620|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
20255621|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255622|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255623|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255624|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255625|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20255626|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255627|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
20255628|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255629|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20255630|NCT00470522|Hematinics|hematinics|mesh-ancestor
20255631|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
20255632|NCT00470522|Vitamins|vitamins|mesh-ancestor
20255633|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
19869819|NCT00851357|Nicotine|nicotine|mesh-list
19869820|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19869821|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
19869822|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869823|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869824|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19869825|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19869826|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
19869827|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19869828|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869829|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19869830|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19869831|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19869832|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
19869833|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869834|NCT00851630|Lamivudine|lamivudine|mesh-list
19869835|NCT00851630|Zidovudine|zidovudine|mesh-list
19869836|NCT00851630|Abacavir|abacavir|mesh-list
19869837|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19869838|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19443686|NCT01938261|Acetaminophen|acetaminophen|mesh-list
19443687|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19443688|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19443689|NCT01938261|Analgesics|analgesics|mesh-ancestor
19443690|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
19443691|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19443692|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443693|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
19869839|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869840|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869841|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
19869842|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255634|NCT00470561|Aspirin|aspirin|mesh-list
19869843|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19869844|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19869845|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
19869846|NCT00851721|Factor VIII|factor viii|mesh-list
19869847|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
19869848|NCT00851721|Coagulants|coagulants|mesh-ancestor
19869849|NCT00851799|Ritonavir|ritonavir|mesh-list
19869850|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19869851|NCT00851799|Darunavir|darunavir|mesh-list
19869852|NCT00851799|Tenofovir|tenofovir|mesh-list
19869853|NCT00851799|Emtricitabine|emtricitabine|mesh-list
19869854|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
19869855|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19869856|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19869857|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19869858|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
19869859|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869860|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869861|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19869862|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19869863|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
19869864|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729615|NCT04606537|Rifampin|rifampin|mesh-list
19729616|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
19729617|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729618|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19729619|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19729620|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729621|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729622|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19729623|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
19729624|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729625|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729626|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19729627|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19729628|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
19729629|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19729630|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
19729631|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19729632|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19729633|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19869865|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19869866|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19729634|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19729635|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19729636|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19729637|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19735384|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735385|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735386|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19735387|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
19735388|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19735389|NCT04540627|Palivizumab|palivizumab|mesh-list
19735390|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
19735391|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735392|NCT04539977|Cisplatin|cisplatin|mesh-list
19735393|NCT04539977|Etoposide|etoposide|mesh-list
19735394|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
19735395|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735396|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19735397|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19735398|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19869867|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19869868|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19869869|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19869870|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19869871|NCT00851877|Paclitaxel|paclitaxel|mesh-list
19869872|NCT00851877|Cetuximab|cetuximab|mesh-list
19869873|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19869874|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869875|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
19869876|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
19869877|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
19735399|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255635|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20255636|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255637|NCT00470561|Analgesics|analgesics|mesh-ancestor
20535289|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
19869878|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869879|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869880|NCT00851890|Interferons|interferons|mesh-list
19869881|NCT00851890|Ribavirin|ribavirin|mesh-list
19869882|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869883|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
19869884|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869885|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
19869886|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869887|NCT00851903|Metformin|metformin|mesh-list
19869888|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
19869889|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19869890|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19869891|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869892|NCT00851903|Incretins|incretins|mesh-ancestor
19869893|NCT00851903|Hormones|hormones|mesh-ancestor
19869894|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869895|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19869896|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
19869897|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869898|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869899|NCT00852202|Cariprazine|cariprazine|mesh-list
20535290|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535291|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535292|NCT01819155|Vaccines|vaccines|mesh-list
19443759|NCT01828112|Docetaxel|docetaxel|mesh-list
19443760|NCT01828112|Pemetrexed|pemetrexed|mesh-list
19443761|NCT01828112|Ceritinib|ceritinib|mesh-list
19443762|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443763|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
19443764|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
19443765|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
19443766|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443767|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443768|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19443769|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19443770|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20535293|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
20535294|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535295|NCT01819220|Amlodipine|amlodipine|mesh-list
20535296|NCT01819220|Valsartan|valsartan|mesh-list
20535297|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20535298|NCT01819220|Telmisartan|telmisartan|mesh-list
19729638|NCT04606212|Losartan|losartan|mesh-list
19729639|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19729640|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19729641|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19729642|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19729643|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729644|NCT04606225|Losartan|losartan|mesh-list
19729645|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19729646|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19729647|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19729648|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19729649|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729650|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19729651|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19869900|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19869901|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19729652|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729653|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19729654|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729655|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729656|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
19729657|NCT04606017|Antacids|antacids|mesh-ancestor
19729658|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729659|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729660|NCT04605770|Pemetrexed|pemetrexed|mesh-list
19869902|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869903|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869904|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19869905|NCT00852397|Apixaban|apixaban|mesh-list
19869906|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19869907|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
19869908|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19869909|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
19869910|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869911|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869912|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
19869913|NCT00852540|Linezolid|linezolid|mesh-list
19869914|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19869915|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869916|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19869917|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869918|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869919|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19869920|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
19869921|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19869922|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19869923|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19869924|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869925|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869926|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19869927|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19869928|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869929|NCT00852761|Clobetasol|clobetasol|mesh-list
19869930|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729661|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869931|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
19869932|NCT00852761|Hormones|hormones|mesh-ancestor
19869933|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19869934|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869935|NCT00852917|Tramadol|tramadol|mesh-list
19869936|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19869937|NCT00852917|Narcotics|narcotics|mesh-ancestor
19443786|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19443787|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19443788|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19869938|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19869939|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869940|NCT00852917|Analgesics|analgesics|mesh-ancestor
19869941|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
19869942|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19869943|NCT00852969|Niacin|niacin|mesh-list
19869944|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19869945|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
19443797|NCT01709981|Colchicine|colchicine|mesh-list
19443798|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
19443799|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19443800|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
19443801|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
19443802|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
19443803|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443804|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443805|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
19443806|NCT01670500|Cisplatin|cisplatin|mesh-list
19443807|NCT01670500|Doxorubicin|doxorubicin|mesh-list
19443808|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19443809|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
19443810|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443811|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19443812|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19443813|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
19443814|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443815|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443816|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19443817|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19443818|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19443819|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19443820|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869946|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869947|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19869948|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
19869949|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
19869950|NCT00852969|Vitamins|vitamins|mesh-ancestor
19729662|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729663|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255638|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
19729664|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19729665|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19729666|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19729667|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19729668|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
19729669|NCT04605952|Antibodies|antibodies|mesh-list
19729670|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
19869951|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
19729671|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
20255639|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255640|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255641|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255642|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255643|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20255644|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20286736|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869952|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869953|NCT00853021|Aldesleukin|aldesleukin|mesh-list
19869954|NCT00853021|Bevacizumab|bevacizumab|mesh-list
19869955|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869956|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869957|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19869958|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19869959|NCT00853021|Growth Substances|growth substances|mesh-ancestor
19869960|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869961|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
19869962|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19869963|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19869964|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
19869965|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19443841|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
19443842|NCT01593254|Dasatinib|dasatinib|mesh-list
19443843|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443844|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19443845|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19443846|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869966|NCT00853047|Octreotide|octreotide|mesh-list
19869967|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19869968|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19869969|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869970|NCT00853073|Bevacizumab|bevacizumab|mesh-list
19869971|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19869972|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869973|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19869974|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19869975|NCT00853073|Growth Substances|growth substances|mesh-ancestor
19869976|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19869977|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255645|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255646|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19869978|NCT00853099|Adalimumab|adalimumab|mesh-list
19869979|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255647|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20255648|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255649|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
20255650|NCT00470665|Sirolimus|sirolimus|mesh-list
19869980|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19869981|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
19869982|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
19869983|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20255651|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19869984|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19443864|NCT01553032|Cetuximab|cetuximab|mesh-list
19443865|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19443866|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869985|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869986|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869987|NCT00853112|Urological Agents|urological agents|mesh-ancestor
19869988|NCT00853125|Sunitinib|sunitinib|mesh-list
19869989|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869990|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19869991|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19869992|NCT00853125|Growth Substances|growth substances|mesh-ancestor
19729672|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729673|NCT04605562|Palbociclib|palbociclib|mesh-list
19729674|NCT04605562|Antibodies|antibodies|mesh-list
19729675|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
19729676|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
19729677|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729678|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729679|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19729680|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729681|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729682|NCT04605419|Calcium|calcium|mesh-list
19729683|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19729684|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729685|NCT04605588|Ribavirin|ribavirin|mesh-list
19729686|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
19729687|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
19729688|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
19729689|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729690|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
19729691|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729692|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
19729693|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19729694|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19729695|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729696|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19729697|NCT04605575|Vinorelbine|vinorelbine|mesh-list
19729698|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19729699|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19869993|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729700|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
19869994|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
19443877|NCT01453101|Fludarabine|fludarabine|mesh-list
19443878|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
19443879|NCT01453101|Bortezomib|bortezomib|mesh-list
19443880|NCT01453101|Melphalan|melphalan|mesh-list
19443881|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19443882|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19443883|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
19443884|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443885|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19443886|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
19443887|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443888|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19443889|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
19443890|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19869995|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19869996|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19869997|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19869998|NCT00853242|Sevelamer|sevelamer|mesh-list
19869999|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
19870000|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
19870001|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870002|NCT00853333|Midazolam|midazolam|mesh-list
19870003|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
19870004|NCT00853333|Propofol|propofol|mesh-list
19870005|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19870006|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870007|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870008|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19870009|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
19870010|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
19870011|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19870012|NCT00853333|Analgesics|analgesics|mesh-ancestor
19870013|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
19870014|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870015|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19870016|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19870017|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19870018|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
19870019|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452942|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729701|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
20255652|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255653|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20255654|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255655|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
20255656|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255657|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
20255658|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255659|NCT00470678|Ranibizumab|ranibizumab|mesh-list
20255660|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255661|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255662|NCT00470678|Growth Substances|growth substances|mesh-ancestor
20255663|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255664|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255665|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255666|NCT00470743|Ibuprofen|ibuprofen|mesh-list
20255667|NCT00470743|Indomethacin|indomethacin|mesh-list
20255668|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19870020|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870021|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19870022|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19870023|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19870024|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19870025|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
19870026|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
19870027|NCT00853372|Sunitinib|sunitinib|mesh-list
19870028|NCT00853372|Trebananib|trebananib|mesh-list
19870029|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19870030|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870031|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19870032|NCT00853372|Growth Substances|growth substances|mesh-ancestor
19870033|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870034|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
19870035|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870036|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870037|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870038|NCT00853385|Adalimumab|adalimumab|mesh-list
19870039|NCT00853385|Tofacitinib|tofacitinib|mesh-list
19870040|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870041|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870042|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870043|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870044|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870045|NCT00853580|Lovastatin|lovastatin|mesh-list
19870046|NCT00853580|L 647318|l 647318|mesh-list
19870047|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
19870048|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19870049|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19870050|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
19870051|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870052|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19870053|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19870054|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870055|NCT00853658|Enalapril|enalapril|mesh-list
19870056|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19870057|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
19870058|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870059|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870060|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19870061|NCT00853671|Adenosine|adenosine|mesh-list
19870062|NCT00853671|Analgesics|analgesics|mesh-ancestor
19870063|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
19870064|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870065|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870066|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19870067|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
19870068|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20255669|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255670|NCT00470743|Analgesics|analgesics|mesh-ancestor
20255671|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
20255672|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255673|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255674|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255675|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255676|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20255677|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255678|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255679|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
20255680|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
20255681|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19870069|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
19870070|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
19870071|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870072|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870073|NCT00853723|Teriparatide|teriparatide|mesh-list
20255682|NCT00470821|Melatonin|melatonin|mesh-list
20255683|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
20255684|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255685|NCT00470821|Protective Agents|protective agents|mesh-ancestor
20255686|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255687|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870074|NCT00853723|Hormones|hormones|mesh-list
19870075|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
19870076|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
19870077|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870078|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870079|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19870080|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19870081|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19870082|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
19870083|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870084|NCT00853840|Maraviroc|maraviroc|mesh-list
19870085|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19870086|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19870087|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19870088|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870089|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19870090|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19870091|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
19870092|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870093|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19870094|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
19870095|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19443989|NCT01192568|Oxybutynin|oxybutynin|mesh-list
19443990|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
19443991|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
19443992|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19443993|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19443994|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19443995|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19443996|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
19443997|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19443998|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19443999|NCT01192568|Urological Agents|urological agents|mesh-ancestor
19870096|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19870097|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870098|NCT00853840|Urological Agents|urological agents|mesh-ancestor
19870099|NCT00853905|Triamcinolone|triamcinolone|mesh-list
19870100|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19870101|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19870102|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19870103|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19870104|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870105|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
19870106|NCT00853905|Hormones|hormones|mesh-ancestor
19870107|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255688|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20255689|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
20255690|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20255691|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20255692|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286737|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19870108|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870109|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255693|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255694|NCT00470873|Urological Agents|urological agents|mesh-ancestor
20255695|NCT00470886|Telmisartan|telmisartan|mesh-list
20255696|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20255697|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20255698|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20255699|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255700|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
20255701|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20255702|NCT00470912|Protective Agents|protective agents|mesh-ancestor
19870110|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
19870111|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870112|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870113|NCT00853957|Amlodipine|amlodipine|mesh-list
19870114|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19870115|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19870116|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19870117|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870118|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19870119|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870120|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
19870121|NCT00853970|Bromfenac|bromfenac|mesh-list
19870122|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19870123|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19870124|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19870125|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19870126|NCT00853970|Analgesics|analgesics|mesh-ancestor
19870127|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
19444045|NCT01093326|Ponesimod|ponesimod|mesh-list
19444046|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19444047|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444048|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444049|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
19444050|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729702|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
19729703|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729704|NCT04605393|Dronabinol|dronabinol|mesh-list
19729705|NCT04605393|Cannabidiol|cannabidiol|mesh-list
19729706|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
19729707|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
19729708|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729709|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19729710|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19729711|NCT04605393|Analgesics|analgesics|mesh-ancestor
19729712|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
19729713|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729714|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19729715|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19729716|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729717|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729718|NCT04605393|Hormones|hormones|mesh-ancestor
19729719|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729720|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20255703|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255704|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255705|NCT00470977|Ranibizumab|ranibizumab|mesh-list
20255706|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20255707|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20255708|NCT00470977|Growth Substances|growth substances|mesh-ancestor
20255709|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255710|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
20255711|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255712|NCT00470990|Acyline|acyline|mesh-list
20255713|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
20255714|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255715|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255716|NCT00471003|Telmisartan|telmisartan|mesh-list
20255717|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20255718|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20255719|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20255720|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255721|NCT00471029|Esomeprazole|esomeprazole|mesh-list
20255722|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20255723|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20255724|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20255725|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255726|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255727|NCT00471042|Buprenorphine|buprenorphine|mesh-list
20255728|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20255729|NCT00471042|Narcotics|narcotics|mesh-ancestor
19729721|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19729722|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729723|NCT04605731|Durvalumab|durvalumab|mesh-list
20255730|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20255731|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255732|NCT00471042|Analgesics|analgesics|mesh-ancestor
20255733|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
20255734|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255735|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20255736|NCT00471055|Capsaicin|capsaicin|mesh-list
20255737|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
20255738|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255739|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
20255740|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255741|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255742|NCT00471094|Lansoprazole|lansoprazole|mesh-list
20255743|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
20255744|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20255745|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20255746|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20255747|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255748|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255749|NCT00471159|Docetaxel|docetaxel|mesh-list
20255750|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729724|NCT04605731|Ipilimumab|ipilimumab|mesh-list
19729725|NCT04605731|Tremelimumab|tremelimumab|mesh-list
20255751|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
20255752|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
20255753|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
20255754|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870128|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870129|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870130|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870131|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870132|NCT00854061|Prednisone|prednisone|mesh-list
19870133|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
19870134|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19870135|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
19870136|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19870137|NCT00854061|Prednisolone|prednisolone|mesh-list
19870138|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19870139|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
19870140|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870141|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
19870142|NCT00854061|Hormones|hormones|mesh-ancestor
19870143|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870144|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870145|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19870146|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870147|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
19870148|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
19870149|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870150|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870151|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19870152|NCT00854061|Protective Agents|protective agents|mesh-ancestor
19870153|NCT00854100|Cariprazine|cariprazine|mesh-list
19870154|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
19870155|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19870156|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19870157|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19870158|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870159|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870160|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19870161|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870162|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19444101|NCT00753532|Vitamin E|vitamin e|mesh-list
19444102|NCT00753532|Tocopherols|tocopherols|mesh-list
19444103|NCT00753532|Tocotrienols|tocotrienols|mesh-list
19444104|NCT00753532|Tocovid|tocovid|mesh-list
19444105|NCT00753532|Vitamins|vitamins|mesh-ancestor
19444106|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
19444107|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444108|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
19444109|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444110|NCT00753532|Protective Agents|protective agents|mesh-ancestor
19729726|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
19729727|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19729728|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
19729729|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19729730|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729731|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
19729732|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729733|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19729734|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729735|NCT04604938|Losartan|losartan|mesh-list
19729736|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19729737|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19729738|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19729739|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19729740|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729741|NCT04604756|Losartan|losartan|mesh-list
19729742|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19729743|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19729744|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19729745|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20255755|NCT00471185|Acyline|acyline|mesh-list
20255756|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
20255757|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255758|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255759|NCT00471289|Paclitaxel|paclitaxel|mesh-list
20255760|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20255761|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255762|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
20255763|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
20255764|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
19870163|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870164|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19870165|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870166|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870167|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870168|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870169|NCT00854360|Beclomethasone|beclomethasone|mesh-list
19870170|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870171|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
19870172|NCT00854360|Hormones|hormones|mesh-ancestor
19870173|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870174|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870175|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19870176|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
19870177|NCT00854373|Hormones|hormones|mesh-list
19870178|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19870179|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870180|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870181|NCT00854581|Interferons|interferons|mesh-list
19870182|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
19870183|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
19870184|NCT00854581|Zidovudine|zidovudine|mesh-list
19870185|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19870186|NCT00854581|Valproic Acid|valproic acid|mesh-list
19870187|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870188|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
19870189|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870190|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
19870191|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870192|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
20255765|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255766|NCT00471341|Celecoxib|celecoxib|mesh-list
20255767|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20255768|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255769|NCT00471341|Analgesics|analgesics|mesh-ancestor
20255770|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
20255771|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255772|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255773|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535299|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20535300|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
19870193|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870194|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19870195|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19870196|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870197|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19870198|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20535301|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535302|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535303|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535304|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535305|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535306|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255774|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255775|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20255776|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20255777|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255778|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255779|NCT00471393|Diclofenac|diclofenac|mesh-list
20255780|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20255781|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20255782|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20255783|NCT00471393|Analgesics|analgesics|mesh-ancestor
20255784|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
20255785|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255786|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729746|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729747|NCT04604886|Dobutamine|dobutamine|mesh-list
19729748|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19729749|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
19729750|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
19729751|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729752|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729753|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19729754|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19729755|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19729756|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
19729757|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729758|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729759|NCT04604886|Protective Agents|protective agents|mesh-ancestor
19729760|NCT04604678|Metformin|metformin|mesh-list
19870199|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
19870200|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
19870201|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870202|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
19870203|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19870204|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870205|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19870206|NCT00854620|Sorafenib|sorafenib|mesh-list
19870207|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870208|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870209|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870210|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870211|NCT00854724|Puerarin|puerarin|mesh-list
19870212|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
19870213|NCT00855010|Pioglitazone|pioglitazone|mesh-list
19870214|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19870215|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870216|NCT00855062|Minocycline|minocycline|mesh-list
19870217|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19870218|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870219|NCT00855166|Metformin|metformin|mesh-list
19870220|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19870221|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
19870222|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19870223|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870224|NCT00855166|Incretins|incretins|mesh-ancestor
19870225|NCT00855166|Hormones|hormones|mesh-ancestor
19870226|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870227|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19870228|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
19870229|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870230|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870231|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19870232|NCT00855218|Sorafenib|sorafenib|mesh-list
19870233|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870234|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20255787|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255788|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20255789|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20255790|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255791|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255792|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20255793|NCT00471393|Protective Agents|protective agents|mesh-ancestor
20255794|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20255795|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
20255796|NCT00471406|Verteporfin|verteporfin|mesh-list
20255797|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20255798|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
20255799|NCT00471419|Rimexolone|rimexolone|mesh-list
20255800|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
20255801|NCT00471419|Hormones|hormones|mesh-ancestor
20255802|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255803|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255804|NCT00471432|Docetaxel|docetaxel|mesh-list
20255805|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255806|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
20255807|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
20255808|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
20255809|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255810|NCT00471471|Sargramostim|sargramostim|mesh-list
20255811|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
20255812|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255813|NCT00471484|Interferons|interferons|mesh-list
20255814|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
20255815|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
20255816|NCT00471484|Doxorubicin|doxorubicin|mesh-list
20255817|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20255818|NCT00471484|Fluorouracil|fluorouracil|mesh-list
20255819|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
19870235|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255820|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20255821|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255822|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20255823|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20255824|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255825|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255826|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
20255827|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255828|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255829|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
20255830|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255831|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
19729761|NCT04604678|Naltrexone|naltrexone|mesh-list
19729762|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19729763|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729764|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19729765|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19870236|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870237|NCT00855309|Acyclovir|acyclovir|mesh-list
19870238|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
19870239|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870240|NCT00855335|Ritonavir|ritonavir|mesh-list
19870241|NCT00855335|Darunavir|darunavir|mesh-list
19870242|NCT00855335|Cobicistat|cobicistat|mesh-list
19870243|NCT00855335|Rilpivirine|rilpivirine|mesh-list
19870244|NCT00855335|Etravirine|etravirine|mesh-list
19870245|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19870246|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19870247|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
19870248|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870249|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870250|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19870251|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19870252|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
19870253|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870254|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19870255|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19870256|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19870257|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19870258|NCT00855413|Ritonavir|ritonavir|mesh-list
19870259|NCT00855413|Darunavir|darunavir|mesh-list
19870260|NCT00855413|Etravirine|etravirine|mesh-list
19870261|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19870262|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19870263|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
19870264|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870265|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870266|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19870267|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19870268|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
19870269|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870270|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19870271|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19870272|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19444218|NCT00003857|Tamoxifen|tamoxifen|mesh-list
19444219|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19444220|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19444221|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19444222|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444223|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19444224|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444225|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19444226|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19444227|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19870273|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19729766|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
19729767|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729768|NCT04604795|Itraconazole|itraconazole|mesh-list
19729769|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
19729770|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729771|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19729772|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19729773|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729774|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870274|NCT00855439|Exenatide|exenatide|mesh-list
19870275|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20255832|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255833|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
20255834|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
20255835|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255836|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286738|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
20286739|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286740|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288556|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288557|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288558|NCT05311176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20288559|NCT05311176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19870276|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870277|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19870278|NCT00855439|Incretins|incretins|mesh-ancestor
19870279|NCT00855439|Hormones|hormones|mesh-ancestor
19870280|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870281|NCT00855465|Riociguat|riociguat|mesh-list
19870282|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
19870283|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870284|NCT00855582|Tadalafil|tadalafil|mesh-list
19870285|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
19870286|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19870287|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19870288|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870289|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870290|NCT00855582|Urological Agents|urological agents|mesh-ancestor
19870291|NCT00855595|Metronidazole|metronidazole|mesh-list
19870292|NCT00855595|Doxycycline|doxycycline|mesh-list
19870293|NCT00855595|Azelaic acid|azelaic acid|mesh-list
19870294|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870295|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19870296|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19870297|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19870298|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
19870299|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870300|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
19870301|NCT00855738|Topiramate|topiramate|mesh-list
19870302|NCT00855738|Pregabalin|pregabalin|mesh-list
19870303|NCT00855738|Lamotrigine|lamotrigine|mesh-list
19870304|NCT00855738|Zonisamide|zonisamide|mesh-list
19870305|NCT00855738|Gabapentin|gabapentin|mesh-list
19870306|NCT00855738|Levetiracetam|levetiracetam|mesh-list
19870307|NCT00855738|Tiagabine|tiagabine|mesh-list
19870308|NCT00855738|Analgesics|analgesics|mesh-ancestor
19870309|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
19870310|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870311|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870312|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
19451958|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451959|NCT03417648|Protective Agents|protective agents|mesh-ancestor
19451960|NCT03417518|Propofol|propofol|mesh-list
19451961|NCT03417518|Desflurane|desflurane|mesh-list
19451962|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19451963|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19451964|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451965|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19451966|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
19451967|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
19451968|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19451969|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
19451970|NCT03417492|Citric Acid|citric acid|mesh-list
19451971|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
19451972|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
19451973|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19451974|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
19451975|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
19451976|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451977|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
19451978|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19451979|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19870313|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19870314|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19451980|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870315|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870316|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20255837|NCT00471523|Metformin|metformin|mesh-list
20255838|NCT00471523|Clomiphene|clomiphene|mesh-list
20255839|NCT00471523|Enclomiphene|enclomiphene|mesh-list
20255840|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
20255841|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20255842|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255843|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20255844|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
20255845|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255846|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20255847|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
20255848|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20255849|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20255850|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20255851|NCT00471549|Simvastatin|simvastatin|mesh-list
20255852|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20255853|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20255854|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
20255855|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255856|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20255857|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20255858|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255859|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20255860|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20255861|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
20255862|NCT00471588|Pramipexole|pramipexole|mesh-list
20255863|NCT00471588|Amisulpride|amisulpride|mesh-list
20255864|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
19444266|NCT03468595|Listerine|listerine|mesh-list
19444267|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19444268|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444269|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
19444270|NCT03468478|Sirolimus|sirolimus|mesh-list
19444271|NCT03468478|Everolimus|everolimus|mesh-list
19444272|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444273|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444274|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
19444275|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729775|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19729776|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
19729777|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729778|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729779|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19729780|NCT04604704|Niacinamide|niacinamide|mesh-list
19729781|NCT04604704|Naltrexone|naltrexone|mesh-list
19729782|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19729783|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19729784|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729785|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
19729786|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729787|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
19729788|NCT04604704|Vitamins|vitamins|mesh-ancestor
19729789|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
19729790|NCT04604509|Bupropion|bupropion|mesh-list
19729791|NCT04604509|Nicotine|nicotine|mesh-list
19729792|NCT04604509|Varenicline|varenicline|mesh-list
19729793|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19729794|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
19729795|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729796|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729797|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19729798|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19729799|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
19729800|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729801|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729802|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19729803|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
19729804|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19729805|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19729806|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19729807|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19729808|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
19729809|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19729810|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19729811|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729812|NCT04604327|Bemiparin|bemiparin|mesh-list
19729813|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
19735400|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735401|NCT04540055|Anesthetics|anesthetics|mesh-list
19735402|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735403|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444276|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19444277|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19870317|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20255865|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255866|NCT00471588|Protective Agents|protective agents|mesh-ancestor
20255867|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255868|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20255869|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20255870|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
20255871|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
20255872|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255873|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20255874|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20255875|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20255876|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20255877|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20255878|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20255879|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
20255880|NCT00471627|Pancrelipase|pancrelipase|mesh-list
20255881|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20255882|NCT00471640|Dexamethasone|dexamethasone|mesh-list
20255883|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255884|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
20255885|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
20255886|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286741|NCT02543255|Prednisone|prednisone|mesh-list
19444278|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
20255887|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255888|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20255889|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
20255890|NCT00471640|Hormones|hormones|mesh-ancestor
20255891|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255892|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20255893|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255894|NCT00471653|Temozolomide|temozolomide|mesh-list
20286742|NCT02543255|Leuprolide|leuprolide|mesh-list
20255895|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20255896|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
20255897|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255898|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255899|NCT00471679|Ethanol|ethanol|mesh-list
20255900|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20255901|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444279|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19444280|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444281|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444282|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444283|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
19444284|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
19444285|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19444286|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19444287|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
19444288|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444289|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444290|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444291|NCT03468465|Urological Agents|urological agents|mesh-ancestor
19444292|NCT03468439|Phenol|phenol|mesh-list
19444293|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19444294|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444295|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
19444296|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19444297|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19444298|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19444299|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19444300|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19444301|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19444302|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444303|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444304|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444305|NCT03468348|Analgesics|analgesics|mesh-ancestor
19444306|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
19444307|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444308|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
19444309|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19444310|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
19444311|NCT03468335|Irinotecan|irinotecan|mesh-list
19451981|NCT03417492|Urological Agents|urological agents|mesh-ancestor
19729814|NCT04604223|Pioglitazone|pioglitazone|mesh-list
19729815|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19729816|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729817|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
19729818|NCT04604028|Lenalidomide|lenalidomide|mesh-list
19729819|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19729820|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
19729821|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255902|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20255903|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255904|NCT00471744|Levetiracetam|levetiracetam|mesh-list
20255905|NCT00471744|Sulthiame|sulthiame|mesh-list
20255906|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
20255907|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
20255908|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
20255909|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20255910|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255911|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
20255912|NCT00471809|Azithromycin|azithromycin|mesh-list
20255913|NCT00471809|Budesonide|budesonide|mesh-list
20255914|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20255915|NCT00471809|Montelukast|montelukast|mesh-list
20255916|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20255917|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20255918|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
20255919|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20255920|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255921|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20255922|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
20255923|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
20255924|NCT00471809|Hormones|hormones|mesh-ancestor
20255925|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255926|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20255927|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20255928|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20255929|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19444312|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19444313|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19444314|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444315|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444316|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444317|NCT03468296|Aflibercept|aflibercept|mesh-list
19444318|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19444319|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19444320|NCT03468296|Growth Substances|growth substances|mesh-ancestor
19444321|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444322|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
19444323|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444324|NCT03468231|Leucovorin|leucovorin|mesh-list
19444325|NCT03468231|Fluorouracil|fluorouracil|mesh-list
19444326|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
19444327|NCT03468231|Sorafenib|sorafenib|mesh-list
19444328|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
19444329|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444330|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19444331|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444332|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444333|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
20255930|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20255931|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
20255932|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20255933|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255934|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20255935|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
20255936|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20255937|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20255938|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20255939|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20255940|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
20255941|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535307|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
19444334|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444335|NCT03468231|Antidotes|antidotes|mesh-ancestor
19444336|NCT03468231|Protective Agents|protective agents|mesh-ancestor
19444337|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
19444338|NCT03468231|Vitamins|vitamins|mesh-ancestor
19444339|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
19444340|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19444341|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444342|NCT03468140|Eculizumab|eculizumab|mesh-list
19444343|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20255942|NCT00471952|Caffeine|caffeine|mesh-list
20255943|NCT00471952|Rizatriptan|rizatriptan|mesh-list
20255944|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20255945|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255946|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20255947|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255948|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255949|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20255950|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20255951|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
20255952|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553592|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553593|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20553594|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553595|NCT01930331|Piperaquine|piperaquine|mesh-list
20553596|NCT01930331|Artenimol|artenimol|mesh-list
20553597|NCT01930331|Artemisinins|artemisinins|mesh-list
20553598|NCT01930331|Artemisinin|artemisinin|mesh-list
20553599|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
20553600|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20553601|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20553602|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553603|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20553604|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
20255953|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20255954|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
20255955|NCT00471965|Leucovorin|leucovorin|mesh-list
20255956|NCT00471965|Doxorubicin|doxorubicin|mesh-list
20255957|NCT00471965|Fluorouracil|fluorouracil|mesh-list
20553605|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
20255958|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
20286743|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
20553606|NCT01930396|Heparin|heparin|mesh-list
20553607|NCT01930396|Calcium heparin|calcium heparin|mesh-list
20553608|NCT01930396|Tinzaparin|tinzaparin|mesh-list
20553609|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20553610|NCT01930396|Dalteparin|dalteparin|mesh-list
20553611|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
20553612|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20553613|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20554982|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554983|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554984|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
20554985|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20554986|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554987|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554988|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20554989|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554990|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554991|NCT01938183|Metronidazole|metronidazole|mesh-list
20554992|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554993|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20554994|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20554995|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20554996|NCT01938235|Exenatide|exenatide|mesh-list
20554997|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20554998|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554999|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20255959|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20255960|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255961|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20255962|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20255963|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20255964|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255965|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
20255966|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20255967|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20255968|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
20255969|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255970|NCT00471965|Antidotes|antidotes|mesh-ancestor
20255971|NCT00471965|Protective Agents|protective agents|mesh-ancestor
20255972|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
20255973|NCT00471965|Vitamins|vitamins|mesh-ancestor
20255974|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
19444344|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444345|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
19444346|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444347|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
19444348|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19444349|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444350|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444351|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444352|NCT03468062|Analgesics|analgesics|mesh-ancestor
19444353|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
19444354|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444355|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19444356|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19444357|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19444358|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
19444359|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444360|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444361|NCT03468023|Calpastatin|calpastatin|mesh-list
19444362|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19444363|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
19444364|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444365|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444366|NCT03468010|Paclitaxel|paclitaxel|mesh-list
19444367|NCT03468010|Cisplatin|cisplatin|mesh-list
19444368|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19444369|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444370|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
19444371|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
19444372|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
19444373|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444374|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20255975|NCT00471991|Dienogest|dienogest|mesh-list
20255976|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20255977|NCT00471991|Estradiol|estradiol|mesh-list
20255978|NCT00471991|Estrogens|estrogens|mesh-ancestor
20255979|NCT00471991|Hormones|hormones|mesh-ancestor
19444375|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
19444376|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444377|NCT03467932|Insulin|insulin|mesh-list
19444378|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19444379|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19444380|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444381|NCT03467893|Antacids|antacids|mesh-list
19444382|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20255980|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255981|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255982|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20255983|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
20255984|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20255985|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20255986|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20255987|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20255988|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20255989|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
20255990|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20255991|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20255992|NCT00472004|Tibolone|tibolone|mesh-list
20255993|NCT00472004|Estradiol|estradiol|mesh-list
20255994|NCT00472004|Estrogens|estrogens|mesh-ancestor
20255995|NCT00472004|Hormones|hormones|mesh-ancestor
20255996|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20255997|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20255998|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
20255999|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
20256000|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20256001|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20256002|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256003|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20555000|NCT01938235|Incretins|incretins|mesh-ancestor
20256004|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
20256005|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20256006|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20256007|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256008|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20256009|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20256010|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256011|NCT00472134|Bupivacaine|bupivacaine|mesh-list
19729822|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256012|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
20256013|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
20555001|NCT01938235|Hormones|hormones|mesh-ancestor
20555002|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555003|NCT01938248|Aspirin|aspirin|mesh-list
20555004|NCT01938248|Apixaban|apixaban|mesh-list
20555005|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20555006|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20555007|NCT01938248|Analgesics|analgesics|mesh-ancestor
20555008|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
20555009|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555010|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555011|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256014|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256015|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256016|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
20256017|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256018|NCT00472173|Calcium|calcium|mesh-list
20256019|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20256020|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256021|NCT00472225|Rituximab|rituximab|mesh-list
20256022|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256023|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256024|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
20256025|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256026|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256027|NCT00472329|Fludarabine|fludarabine|mesh-list
20256028|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256029|NCT00472355|Apomorphine|apomorphine|mesh-list
19444383|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19444384|NCT03467750|Ketorolac|ketorolac|mesh-list
19444385|NCT03467750|Morphine|morphine|mesh-list
19444386|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19444387|NCT03467750|Narcotics|narcotics|mesh-ancestor
19444388|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444389|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444390|NCT03467750|Analgesics|analgesics|mesh-ancestor
19444391|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
19444392|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444393|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19444394|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444395|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444396|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444397|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19444398|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444399|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444400|NCT03467620|Cannabidiol|cannabidiol|mesh-list
19444401|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
19444402|NCT03467438|Polaprezinc|polaprezinc|mesh-list
19444403|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19444404|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19444405|NCT03467334|Simethicone|simethicone|mesh-list
20256030|NCT00472355|Emetics|emetics|mesh-ancestor
20256031|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256032|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
20256033|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256034|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20256035|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
20256036|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
20256037|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256038|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256039|NCT00472368|Panobinostat|panobinostat|mesh-list
20256040|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256041|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20256042|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535308|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19444406|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
19444407|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444408|NCT03467334|Emollients|emollients|mesh-ancestor
19444409|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
19444410|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
19444411|NCT03467256|Fludarabine|fludarabine|mesh-list
19444412|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444413|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
19444414|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444415|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444416|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19444417|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
19444418|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444419|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444420|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19444421|NCT03467178|Gemcitabine|gemcitabine|mesh-list
19444422|NCT03467178|Paclitaxel|paclitaxel|mesh-list
19444423|NCT03467178|Carboplatin|carboplatin|mesh-list
19444424|NCT03467178|Doxorubicin|doxorubicin|mesh-list
19444425|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19444426|NCT03467178|Decitabine|decitabine|mesh-list
19444427|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19444428|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444429|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
19444430|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
19444431|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
19444432|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444433|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19444434|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
19444435|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
19444436|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444437|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444438|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444439|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
19444440|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444441|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19444442|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19444443|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19444444|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
19444445|NCT03467022|Vitamins|vitamins|mesh-ancestor
19444446|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
19444447|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444448|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
19444449|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444450|NCT03467022|Protective Agents|protective agents|mesh-ancestor
19444451|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19444452|NCT03466983|Hematinics|hematinics|mesh-ancestor
19451982|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19451983|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19451984|NCT03417427|Cytarabine|cytarabine|mesh-list
19451985|NCT03417427|Decitabine|decitabine|mesh-list
19451986|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19451987|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
19451988|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19451989|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451990|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
19451991|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19451992|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19451993|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
19451994|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19451995|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19451996|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19451997|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19451998|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19729823|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20256043|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256044|NCT00472381|Insulin|insulin|mesh-list
20256045|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20256046|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256047|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
20256048|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256049|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256050|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20555012|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555013|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20555014|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20555015|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555016|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20555017|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20555018|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555019|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
20555020|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20555021|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
20555022|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20555023|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
20555024|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
20555025|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
20555026|NCT01938300|Analgesics|analgesics|mesh-ancestor
20555027|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
20555028|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444453|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
19444454|NCT03466775|Giapreza|giapreza|mesh-list
19444455|NCT03466775|Antibodies|antibodies|mesh-list
19444456|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
19444457|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
19444458|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444459|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19444460|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20256051|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20256052|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256053|NCT00472472|Paclitaxel|paclitaxel|mesh-list
20256054|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20256055|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256056|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
20256057|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
20256058|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20256059|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256060|NCT00472550|Esomeprazole|esomeprazole|mesh-list
20256061|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20256062|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20256063|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20256064|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444461|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
19444462|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444463|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444464|NCT03466749|Paclitaxel|paclitaxel|mesh-list
19444465|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19444466|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444467|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
19444468|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
19444469|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
19444470|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444471|NCT03466736|Flutemetamol|flutemetamol|mesh-list
19444472|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19444473|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444474|NCT03466645|Vancomycin|vancomycin|mesh-list
19444475|NCT03466645|Cefazolin|cefazolin|mesh-list
19444476|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19444477|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444478|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
19444479|NCT03466632|Propofol|propofol|mesh-list
19444480|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19444481|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444482|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444483|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19444484|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
19444485|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
19444486|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444487|NCT03466632|Analgesics|analgesics|mesh-ancestor
19444488|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
19444489|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444490|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19444491|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19444492|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19444493|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
19444494|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444495|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444496|NCT03466567|Cyclosporine|cyclosporine|mesh-list
19444497|NCT03466567|Probenecid|probenecid|mesh-list
19444498|NCT03466567|Cyclosporins|cyclosporins|mesh-list
19444499|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452943|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20535309|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20286744|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256065|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256066|NCT00472758|Sifalimumab|sifalimumab|mesh-list
20256067|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
20256068|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256069|NCT00472810|Mitomycins|mitomycins|mesh-list
20256070|NCT00472810|Mitomycin|mitomycin|mesh-list
20256071|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19444500|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444501|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444502|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
19444503|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444504|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
19444505|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444506|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
19444507|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444508|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19444509|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
19444510|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
19444511|NCT03466567|Renal Agents|renal agents|mesh-ancestor
19444512|NCT03466528|Thiamine|thiamine|mesh-list
19444513|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
19444514|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
19444515|NCT03466528|Vitamins|vitamins|mesh-ancestor
19444516|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
19444517|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444518|NCT03466528|Analgesics|analgesics|mesh-ancestor
19444519|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
19444520|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444521|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
19444522|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444523|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19444524|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
19444525|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19444526|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19444527|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444528|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19444529|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
19444530|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19444531|NCT03466502|Vancomycin|vancomycin|mesh-list
19444532|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19444533|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444534|NCT03466437|Methamphetamine|methamphetamine|mesh-list
19444535|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19444536|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444537|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
19444538|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
19444539|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444540|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
19444541|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444542|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444543|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
19444544|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19444545|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19444546|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19444547|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19444548|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
19444549|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444550|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444551|NCT03466333|Enalapril|enalapril|mesh-list
19444552|NCT03466333|Enalaprilat|enalaprilat|mesh-list
19444553|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444554|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444555|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19444556|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
19444557|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19444558|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
19444559|NCT03466320|Fludarabine|fludarabine|mesh-list
19444560|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444561|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
19444562|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444563|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444564|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19444565|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
19452944|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256072|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256073|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
20256074|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256075|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20256076|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256077|NCT00472823|Vitamin D|vitamin d|mesh-list
20256078|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
20256079|NCT00472823|Calcium|calcium|mesh-list
20256080|NCT00472823|Vitamins|vitamins|mesh-ancestor
20256081|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
20256082|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256083|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20256084|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20256085|NCT00472875|Glyburide|glyburide|mesh-list
20256086|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20256087|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256088|NCT00472901|Afamelanotide|afamelanotide|mesh-list
20256089|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256090|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19444566|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444567|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444568|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19444569|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
19444570|NCT03466242|Ketamine|ketamine|mesh-list
19444571|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19444572|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444573|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444574|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444575|NCT03466242|Analgesics|analgesics|mesh-ancestor
19444576|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
19444577|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444578|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19444579|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19444580|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19444581|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
19444582|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444583|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256091|NCT00472927|Estrogens|estrogens|mesh-ancestor
20256092|NCT00472927|Hormones|hormones|mesh-ancestor
20256093|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19444584|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19444585|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19444586|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
20535310|NCT01819220|Diuretics|diuretics|mesh-ancestor
19444587|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
20256094|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256095|NCT00472953|Insulin|insulin|mesh-list
20256096|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20256097|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
20256098|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20256099|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256100|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20256101|NCT00472966|Tretinoin|tretinoin|mesh-list
20256102|NCT00472966|Glycolic acid|glycolic acid|mesh-list
20256103|NCT00472966|Hydroquinone|hydroquinone|mesh-list
20256104|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256105|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
20256106|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256107|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256108|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
20256109|NCT00472966|Hormones|hormones|mesh-ancestor
20256110|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20256111|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256112|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
20535311|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
20535312|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20535313|NCT01819259|Nicotine|nicotine|mesh-list
20535314|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20535315|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
20535316|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535317|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535318|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20535319|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20535320|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
20535321|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535322|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535323|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20535324|NCT01819285|Hormones|hormones|mesh-ancestor
20535325|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535326|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535327|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
20535328|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535329|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20535330|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535331|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535332|NCT01819402|Pioglitazone|pioglitazone|mesh-list
20286745|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
20286746|NCT02543255|Hormones|hormones|mesh-ancestor
20286747|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286748|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286749|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286750|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286751|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20286752|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
20286753|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20286754|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20286755|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535333|NCT01819402|Glimepiride|glimepiride|mesh-list
20535334|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535335|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535336|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19870318|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19870319|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870320|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19870321|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19870322|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19870323|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870324|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
19870325|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535337|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535338|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
20535339|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20535340|NCT01819441|Perindopril|perindopril|mesh-list
20535341|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535342|NCT01819441|Diuretics|diuretics|mesh-ancestor
20535343|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
20535344|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535345|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20535346|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20256113|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256114|NCT00472966|Protective Agents|protective agents|mesh-ancestor
20256115|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20256116|NCT00473005|Capecitabine|capecitabine|mesh-list
20256117|NCT00473005|Everolimus|everolimus|mesh-list
20256118|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20256119|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
20256120|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256121|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256122|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256123|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
20256124|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256125|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
20256126|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444588|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19444589|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19444590|NCT03466216|Octreotide|octreotide|mesh-list
19729824|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
19729825|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729826|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729827|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19729828|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19729829|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19729830|NCT04604028|Growth Substances|growth substances|mesh-ancestor
19729831|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
19729832|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20256127|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20256128|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256129|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
20256130|NCT00473070|Hormones|hormones|mesh-ancestor
20256131|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20256132|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256133|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20256134|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20256135|NCT00473174|Ramipril|ramipril|mesh-list
20256136|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20256137|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
20256138|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256139|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256140|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20286756|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286757|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
20286758|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19444591|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19444592|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19444593|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444594|NCT03466021|Liraglutide|liraglutide|mesh-list
19729833|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19729834|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729835|NCT04603729|Dexamethasone|dexamethasone|mesh-list
19729836|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
19729837|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19729838|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19729839|NCT04603729|Prednisolone|prednisolone|mesh-list
19729840|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
19729841|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19729842|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
19729843|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729844|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
19729845|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
19729846|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256141|NCT00473213|Interferons|interferons|mesh-list
20256142|NCT00473213|Interferon-beta|interferon-beta|mesh-list
20256143|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256144|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
20256145|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256146|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
20256147|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256148|NCT00473239|Vitamin D|vitamin d|mesh-list
20256149|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
20256150|NCT00473239|Vitamins|vitamins|mesh-ancestor
20256151|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
20256152|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256153|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20256154|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20256155|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20256156|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20256157|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256158|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
20256159|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19735404|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
19444595|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19444596|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444597|NCT03466021|Incretins|incretins|mesh-ancestor
19444598|NCT03466021|Hormones|hormones|mesh-ancestor
19444599|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19444600|NCT03465969|Tacrolimus|tacrolimus|mesh-list
19444601|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444602|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
19444603|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444604|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19870326|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
20256160|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20256161|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444605|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729847|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729848|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729849|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
19729850|NCT04603729|Hormones|hormones|mesh-ancestor
19729851|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19729852|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19729853|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729854|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19729855|NCT04603729|Protective Agents|protective agents|mesh-ancestor
19729856|NCT04603976|Erenumab|erenumab|mesh-list
19729857|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19735405|NCT04540185|Vaccines|vaccines|mesh-list
20256162|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19735406|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
20256163|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20256164|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256165|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256166|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256167|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20256168|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
20256169|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20256170|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256171|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20256172|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20256173|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20256174|NCT00473486|Carboplatin|carboplatin|mesh-list
20256175|NCT00473486|Pemetrexed|pemetrexed|mesh-list
20256176|NCT00473486|Sorafenib|sorafenib|mesh-list
20256177|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256178|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256179|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256180|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20256181|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20256182|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20256183|NCT00473551|Vidarabine|vidarabine|mesh-list
20256184|NCT00473551|Sirolimus|sirolimus|mesh-list
20256185|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
20256186|NCT00473551|Rituximab|rituximab|mesh-list
20535347|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870327|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19870328|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19870329|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
19870330|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19870331|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
19870332|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19870333|NCT00855894|Pertuzumab|pertuzumab|mesh-list
19870334|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870335|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870336|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870337|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870338|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19870339|NCT00855920|Indomethacin|indomethacin|mesh-list
19870340|NCT00855920|Rilonacept|rilonacept|mesh-list
19870341|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19870342|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19870343|NCT00855920|Analgesics|analgesics|mesh-ancestor
19870344|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
20256187|NCT00473551|Fludarabine|fludarabine|mesh-list
20256188|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
19735407|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735408|NCT04540185|Protective Agents|protective agents|mesh-ancestor
19735409|NCT04539951|Memantine|memantine|mesh-list
19735410|NCT04539951|Aripiprazole|aripiprazole|mesh-list
19735411|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
19444606|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444607|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20256189|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256190|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
20256191|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256192|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256193|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20256194|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
20256195|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256196|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256197|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20256198|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256199|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20256200|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
20256201|NCT00473551|Antiviral Agents|antiviral agents|mesh-ancestor
19444608|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19444609|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
19444610|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19444611|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19444612|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19444613|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444614|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444615|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19444616|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19729858|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729859|NCT04603976|Analgesics|analgesics|mesh-ancestor
19729860|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
19729861|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729862|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729863|NCT04603833|Docetaxel|docetaxel|mesh-list
19729864|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729865|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
19729866|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
19729867|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
19729868|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256202|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444617|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19444618|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
19444619|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444620|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444621|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19444622|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19444623|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
19444624|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19444625|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19444626|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
19444627|NCT03465774|Doxycycline|doxycycline|mesh-list
19444628|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19444629|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444630|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
19444631|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19444632|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19444633|NCT03465592|Nivolumab|nivolumab|mesh-list
19444634|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19444635|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444636|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19444637|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444638|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19444639|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19444640|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256203|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20256204|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20256205|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
20256206|NCT00473603|Heparin|heparin|mesh-list
19444641|NCT03465488|Albendazole|albendazole|mesh-list
19444642|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
19444643|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19444644|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444645|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
19444646|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19444647|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19444648|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
19444649|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
19444650|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
19444651|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444652|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444653|NCT03465423|Propofol|propofol|mesh-list
19444654|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
19444655|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444656|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444657|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19444658|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19444659|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
19444660|NCT03465410|Tacrolimus|tacrolimus|mesh-list
19444661|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444662|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
19729869|NCT04603872|Dasatinib|dasatinib|mesh-list
20256207|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
19444663|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256208|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19444664|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19735412|NCT04539951|Sertraline|sertraline|mesh-list
19444665|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444666|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444667|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19444668|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
19444669|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444670|NCT03465345|Metformin|metformin|mesh-list
19444671|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
19444672|NCT03465345|Procyanidin|procyanidin|mesh-list
19444673|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19444674|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444675|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
19444676|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444677|NCT03465345|Protective Agents|protective agents|mesh-ancestor
19444678|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19444679|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19444680|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444681|NCT03465202|Capecitabine|capecitabine|mesh-list
19444682|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19444683|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
19444684|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444685|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19451999|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452000|NCT03417388|Aspirin|aspirin|mesh-list
19452001|NCT03417388|Losartan|losartan|mesh-list
19452002|NCT03417388|Lisinopril|lisinopril|mesh-list
19452003|NCT03417388|Atorvastatin|atorvastatin|mesh-list
19452004|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19452005|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19452006|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452007|NCT03417388|Analgesics|analgesics|mesh-ancestor
19452008|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
19452009|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452010|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452011|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452012|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452013|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19452014|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19452015|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452016|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19444686|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19444687|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19444688|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444689|NCT03465085|Heparin|heparin|mesh-list
19444690|NCT03465085|Calcium heparin|calcium heparin|mesh-list
19444691|NCT03465085|Streptokinase|streptokinase|mesh-list
19444692|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
19444693|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19444694|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19444695|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444696|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
19444697|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444698|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19444699|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444700|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444701|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
19444702|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444703|NCT03464968|Leucovorin|leucovorin|mesh-list
19444704|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
19444705|NCT03464968|Irinotecan|irinotecan|mesh-list
19444706|NCT03464968|Fluorouracil|fluorouracil|mesh-list
19444707|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
19444708|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444709|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19444710|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19444711|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444712|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444713|NCT03464968|Antidotes|antidotes|mesh-ancestor
19444714|NCT03464968|Protective Agents|protective agents|mesh-ancestor
19444715|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444716|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
19444717|NCT03464968|Vitamins|vitamins|mesh-ancestor
19444718|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
19444719|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
19444720|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19444721|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444722|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
19870345|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444725|NCT03464864|Treprostinil|treprostinil|mesh-list
19444726|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19444727|NCT03464734|Paclitaxel|paclitaxel|mesh-list
19444728|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
19444729|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19444730|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19444731|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444732|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
19444733|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
19444734|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
19444735|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444736|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19444737|NCT03464682|Atorvastatin|atorvastatin|mesh-list
19444738|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19444739|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19444740|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
19444741|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444742|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19444743|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19444744|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444745|NCT03464656|Antioxidants|antioxidants|mesh-list
19444746|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444747|NCT03464656|Protective Agents|protective agents|mesh-ancestor
19444748|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444749|NCT03464552|Celecoxib|celecoxib|mesh-list
20256209|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20256210|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256211|NCT00473616|Irinotecan|irinotecan|mesh-list
20256212|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20256213|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20256214|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256215|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444750|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19444751|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444752|NCT03464552|Analgesics|analgesics|mesh-ancestor
19444753|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
19444754|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444755|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444756|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444757|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444758|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19444759|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19444760|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444761|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444762|NCT03464539|Chitosan|chitosan|mesh-list
19444763|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19444764|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19444765|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
19444766|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444767|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19444768|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
19444769|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
19444770|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
19444771|NCT03464539|Coagulants|coagulants|mesh-ancestor
19444772|NCT03464448|Teriflunomide|teriflunomide|mesh-list
19444773|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19444774|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444775|NCT03464448|Analgesics|analgesics|mesh-ancestor
19444776|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
19444777|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444778|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444779|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444780|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444781|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444782|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
19444783|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19444784|NCT03464435|Tobramycin|tobramycin|mesh-list
19444785|NCT03464435|Tacrolimus|tacrolimus|mesh-list
19444786|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444787|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
19444788|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444789|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19444790|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444791|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444792|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19444793|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444794|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19444795|NCT03464305|Aspirin|aspirin|mesh-list
19444796|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19444797|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444798|NCT03464305|Analgesics|analgesics|mesh-ancestor
19444799|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
20286759|NCT02448381|Hypericin|hypericin|mesh-list
19444800|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444801|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444802|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444803|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444804|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19444805|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19444806|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444807|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19444808|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19444809|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870346|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870347|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870348|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870349|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
19870350|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
19870351|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19870352|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19870353|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870354|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870355|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
19870356|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19870357|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870358|NCT00855959|Budesonide|budesonide|mesh-list
19870359|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870360|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19870361|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
19870362|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870363|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256216|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256217|NCT00473707|Oxytocin|oxytocin|mesh-list
19444810|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
19444811|NCT03464292|Capsaicin|capsaicin|mesh-list
19444812|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
19444813|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
19444814|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
19444815|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444816|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444817|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19444818|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444819|NCT03464266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19444820|NCT03464266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19444821|NCT03464266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19444822|NCT03464266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444823|NCT03464266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444824|NCT03464266|Antiviral Agents|antiviral agents|mesh-ancestor
19444825|NCT03464266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444826|NCT03464266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19444827|NCT03464266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19444828|NCT03464058|Rabeprazole|rabeprazole|mesh-list
19444829|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19444830|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19444831|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20256218|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
19444832|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444833|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444834|NCT03464019|Etripamil|etripamil|mesh-list
19444835|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19444836|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19444837|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444838|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19444839|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444840|NCT03463967|Lycopene|lycopene|mesh-list
19444841|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444842|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
19444843|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444844|NCT03463967|Protective Agents|protective agents|mesh-ancestor
19444845|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444846|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19444847|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19444848|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256219|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20256220|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444849|NCT03463876|Apatinib|apatinib|mesh-list
19444850|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444851|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19444852|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444853|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444854|NCT03463733|Temozolomide|temozolomide|mesh-list
19444855|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
19444856|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19444857|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
19444858|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444859|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444860|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
20256221|NCT00473720|Paclitaxel|paclitaxel|mesh-list
20256222|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20256223|NCT00473720|Satraplatin|satraplatin|mesh-list
20256224|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20256225|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256226|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
20256227|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
20256228|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
20256229|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256230|NCT00473915|Fluticasone|fluticasone|mesh-list
20256231|NCT00473915|Xhance|xhance|mesh-list
19444861|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444862|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19444863|NCT03463642|Vitamin D|vitamin d|mesh-list
19444864|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
19444865|NCT03463642|Mineral Oil|mineral oil|mesh-list
19444866|NCT03463642|Vitamins|vitamins|mesh-ancestor
19444867|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
19444868|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444869|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19444870|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19444871|NCT03463642|Emollients|emollients|mesh-ancestor
19444872|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
19452017|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19452018|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452019|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
19452020|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19452021|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19452022|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
19452023|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19452024|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19452025|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452026|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19452027|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19452028|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19452029|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19452030|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
19452031|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19452032|NCT03417388|Protective Agents|protective agents|mesh-ancestor
19452033|NCT03417284|Melphalan|melphalan|mesh-list
19452034|NCT03417284|Lenograstim|lenograstim|mesh-list
20256232|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20555029|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452035|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19444873|NCT03463564|Insulin|insulin|mesh-list
19444874|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19444875|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19444876|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444877|NCT03463525|Osimertinib|osimertinib|mesh-list
19444878|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444879|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19444880|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444881|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444882|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
19444883|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19444884|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
19444885|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444886|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
19444887|NCT03463499|Protective Agents|protective agents|mesh-ancestor
19444888|NCT03463382|Bupivacaine|bupivacaine|mesh-list
19444889|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
19444890|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
19444891|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444892|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444893|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
19444894|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444895|NCT03463317|Aspirin|aspirin|mesh-list
19729870|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729871|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19729872|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729873|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729874|NCT04603924|Niclosamide|niclosamide|mesh-list
19729875|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
19729876|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19729877|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
19729878|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19729879|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729880|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
19729881|NCT04603937|Aflibercept|aflibercept|mesh-list
19729882|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19729883|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19729884|NCT04603937|Growth Substances|growth substances|mesh-ancestor
19729885|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729886|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
19729887|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729888|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
19729889|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19729890|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
19729891|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19729892|NCT04603794|Povidone|povidone|mesh-list
19729893|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19729894|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729895|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
19729896|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
19729897|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
19729898|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
19729899|NCT04603664|Cystatins|cystatins|mesh-list
19729900|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19729901|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
19729902|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729903|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729904|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
19729905|NCT04603508|Empagliflozin|empagliflozin|mesh-list
19870364|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19870365|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
19870366|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
19870367|NCT00855959|Hormones|hormones|mesh-ancestor
19870368|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970034|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970035|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19970036|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19970037|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970038|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970039|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
19970040|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970041|NCT01779869|Regadenoson|regadenoson|mesh-list
19970042|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20555030|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
19444896|NCT03463317|Warfarin|warfarin|mesh-list
19729906|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19729907|NCT04603508|Calcium|calcium|mesh-list
19444897|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
19444898|NCT03463317|Dabigatran|dabigatran|mesh-list
19444899|NCT03463317|Apixaban|apixaban|mesh-list
19444900|NCT03463317|Edoxaban|edoxaban|mesh-list
19444901|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
19444902|NCT03463317|Clopidogrel|clopidogrel|mesh-list
19444903|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19444904|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19444905|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19444906|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19444907|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
19444908|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444909|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444910|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444911|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
19444912|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19444913|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
19444914|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19444915|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
19444916|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19444917|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19444918|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444919|NCT03463317|Analgesics|analgesics|mesh-ancestor
19444920|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
19444921|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444922|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444923|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19444924|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19444925|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19444926|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19444927|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
19444928|NCT03463265|Sirolimus|sirolimus|mesh-list
19444929|NCT03463265|Bevacizumab|bevacizumab|mesh-list
19444930|NCT03463265|Temozolomide|temozolomide|mesh-list
19444931|NCT03463265|Lomustine|lomustine|mesh-list
20256233|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20256234|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
20256235|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444932|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19444933|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19444934|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19444935|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19444936|NCT03463265|Growth Substances|growth substances|mesh-ancestor
19444937|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444938|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
19444939|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19444940|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
19444941|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444942|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19444943|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19444944|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19444945|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
19444946|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19444947|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
19444948|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19444949|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
19444950|NCT03463252|Progesterone|progesterone|mesh-list
19444951|NCT03463252|Progestins|progestins|mesh-ancestor
19444952|NCT03463252|Hormones|hormones|mesh-ancestor
19444953|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19444954|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444955|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19444956|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19444957|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19444958|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
19444959|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19444960|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19444961|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19444962|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19444963|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19444964|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256236|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256237|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19444965|NCT03463083|Fentanyl|fentanyl|mesh-list
19444966|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
19444967|NCT03463083|Bupivacaine|bupivacaine|mesh-list
19444968|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
19444969|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
19444970|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19444971|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444972|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
19444973|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19444974|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19444975|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19444976|NCT03463083|Analgesics|analgesics|mesh-ancestor
19444977|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19444978|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19444979|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19444980|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
19444981|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19444982|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19444983|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19444984|NCT03463083|Narcotics|narcotics|mesh-ancestor
19444985|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19444986|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19444987|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
19444988|NCT03463070|Misoprostol|misoprostol|mesh-list
19444989|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19444990|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
19444991|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19444992|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19444993|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19444994|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19444995|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
19444996|NCT03463044|Nangibotide|nangibotide|mesh-list
19444997|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19444998|NCT03463005|Propolis|propolis|mesh-list
19444999|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445000|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19445001|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
19445002|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445003|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19445004|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19445005|NCT03462836|Lidocaine|lidocaine|mesh-list
19445006|NCT03462836|Ketamine|ketamine|mesh-list
19445007|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
19445008|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
19729908|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19729909|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729910|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19445009|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445010|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445011|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
19445012|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445013|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445014|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19445015|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19445016|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445017|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445018|NCT03462836|Analgesics|analgesics|mesh-ancestor
19445019|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19445020|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19445021|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
19445022|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19445023|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19445024|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445025|NCT03462810|Cabotegravir|cabotegravir|mesh-list
19445026|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19445027|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19445028|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445029|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445030|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19445031|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19445032|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
19445033|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445034|NCT03462641|Flumazenil|flumazenil|mesh-list
19445035|NCT03462641|Antidotes|antidotes|mesh-ancestor
19445036|NCT03462641|Protective Agents|protective agents|mesh-ancestor
19445037|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445038|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
19445039|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
19729911|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19445040|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445041|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445042|NCT03462446|Vitamin K|vitamin k|mesh-list
19445043|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
19445044|NCT03462446|Vitamins|vitamins|mesh-ancestor
19445045|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
19445046|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445047|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19445048|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
19445049|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20256238|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256239|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256240|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20256241|NCT00473980|Celecoxib|celecoxib|mesh-list
20256242|NCT00473980|Indomethacin|indomethacin|mesh-list
20256243|NCT00473980|Esomeprazole|esomeprazole|mesh-list
20256244|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20256245|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20256246|NCT00473980|Analgesics|analgesics|mesh-ancestor
20256247|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
20256248|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256249|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256250|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256251|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256252|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20256253|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20256254|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256255|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256256|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20256257|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20256258|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20256259|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
20256260|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
20256261|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20256262|NCT00474006|Daunorubicin|daunorubicin|mesh-list
20256263|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20256264|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256265|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20256266|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20256267|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256268|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256269|NCT00474019|Esomeprazole|esomeprazole|mesh-list
19445050|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
19445051|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445052|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445053|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
19445054|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19445055|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19445056|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
19445057|NCT03462446|Coagulants|coagulants|mesh-ancestor
19445058|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
19445059|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19445060|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19445061|NCT03462329|Doxycycline|doxycycline|mesh-list
19445062|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445063|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
19445064|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19445065|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19445066|NCT03462212|Paclitaxel|paclitaxel|mesh-list
19445067|NCT03462212|Bevacizumab|bevacizumab|mesh-list
19445068|NCT03462212|Carboplatin|carboplatin|mesh-list
19445069|NCT03462212|Rucaparib|rucaparib|mesh-list
19445070|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19445071|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445072|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
19445073|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
19445074|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
19445075|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445076|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445077|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19445078|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19445079|NCT03462212|Growth Substances|growth substances|mesh-ancestor
19445080|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445081|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
19445082|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19445083|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445084|NCT03462173|Yimitasvir|yimitasvir|mesh-list
19445085|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
19445086|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445087|NCT03461783|Charcoal|charcoal|mesh-list
19445088|NCT03461783|Antidotes|antidotes|mesh-ancestor
19445089|NCT03461783|Protective Agents|protective agents|mesh-ancestor
19445090|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445091|NCT03461718|Fentanyl|fentanyl|mesh-list
19445092|NCT03461718|Midazolam|midazolam|mesh-list
20256270|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20256271|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20256272|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20256273|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256274|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256275|NCT00474071|Remifentanil|remifentanil|mesh-list
20256276|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20256277|NCT00474071|Narcotics|narcotics|mesh-ancestor
20256278|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256279|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256280|NCT00474071|Analgesics|analgesics|mesh-ancestor
20256281|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
20256282|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256283|NCT00474110|Ketamine|ketamine|mesh-list
20256284|NCT00474110|Hydromorphone|hydromorphone|mesh-list
20256285|NCT00474110|Analgesics|analgesics|mesh-ancestor
19445093|NCT03461718|Ketamine|ketamine|mesh-list
19445094|NCT03461718|Analgesics|analgesics|mesh-ancestor
19445095|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
19445096|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445097|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445098|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19445099|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19445100|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
19445101|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
19445102|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445103|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19445104|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19445105|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445106|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445107|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19445108|NCT03461718|Narcotics|narcotics|mesh-ancestor
19445109|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19445110|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19445111|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19445112|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19445113|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19445114|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
19445115|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
19452036|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
19452037|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452038|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19452039|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
19452040|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452041|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452042|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19452043|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19452044|NCT03417206|Remifentanil|remifentanil|mesh-list
19452045|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19452046|NCT03417206|Narcotics|narcotics|mesh-ancestor
19452047|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452048|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452049|NCT03417206|Analgesics|analgesics|mesh-ancestor
19452050|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
19452051|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452052|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
19452053|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19452054|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452055|NCT03417037|Nivolumab|nivolumab|mesh-list
19452056|NCT03417037|Linrodostat|linrodostat|mesh-list
19452057|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19452058|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452059|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19870369|NCT00856024|Ribavirin|ribavirin|mesh-list
20256286|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
19452060|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452061|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256287|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452062|NCT03416777|Tocopherols|tocopherols|mesh-list
19452063|NCT03416777|Vitamin E|vitamin e|mesh-list
19445116|NCT03461627|Fluticasone|fluticasone|mesh-list
19445117|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19445118|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19445119|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445120|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19445121|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
19445122|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445123|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445124|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19445125|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
19445126|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
19445127|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20256288|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256289|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20256290|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20256291|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
20256292|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
20256293|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256294|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20256295|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20256296|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256297|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256298|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20256299|NCT00474110|Narcotics|narcotics|mesh-ancestor
20256300|NCT00474136|Diclofenac|diclofenac|mesh-list
20256301|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20256302|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20256303|NCT00474136|Analgesics|analgesics|mesh-ancestor
20256304|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
20256305|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256306|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256307|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256308|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256309|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20256310|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445128|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19445129|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19445130|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19445131|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
19445132|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445133|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445134|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
19445135|NCT03461627|Hormones|hormones|mesh-ancestor
19445136|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445137|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
19445138|NCT03461575|Cyclosporine|cyclosporine|mesh-list
19445139|NCT03461575|Cyclosporins|cyclosporins|mesh-list
19445140|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445141|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445142|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19445143|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
19445144|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445145|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
19445146|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445147|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
19445148|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445149|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19445150|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
19445151|NCT03461328|Analgesics|analgesics|mesh-ancestor
19445152|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
19445153|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445154|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445155|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
19445156|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445157|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445158|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
19445159|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19445160|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445161|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445162|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19445163|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
20288560|NCT05311176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445164|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19445165|NCT03461302|Coal Tar|coal tar|mesh-list
19445166|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
19445167|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
19445168|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
19445169|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20256311|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256312|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20256313|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
20256314|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
20256315|NCT00474279|Hormones|hormones|mesh-list
20256316|NCT00474279|Secretagogues|secretagogues|mesh-list
20256317|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445170|NCT03461185|Growth Substances|growth substances|mesh-ancestor
19445171|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445172|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
19445173|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445174|NCT03461081|Amlodipine|amlodipine|mesh-list
19445175|NCT03461081|Telmisartan|telmisartan|mesh-list
19445176|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19445177|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19445178|NCT03461081|Atorvastatin|atorvastatin|mesh-list
19445179|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19445180|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19445181|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
19445182|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445183|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19445184|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19445185|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445186|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19445187|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19445188|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445189|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19445190|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445191|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
19445192|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19445193|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19445194|NCT03461003|Losartan|losartan|mesh-list
19445195|NCT03461003|Amlodipine|amlodipine|mesh-list
19445196|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19445197|NCT03461003|Lisinopril|lisinopril|mesh-list
19445198|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19445199|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19445200|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445201|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445202|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19445203|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445204|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
19445205|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445206|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19445207|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19445208|NCT03461003|Diuretics|diuretics|mesh-ancestor
19445209|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
19445210|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19445211|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19445212|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
19445213|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445214|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19445215|NCT03461003|Protective Agents|protective agents|mesh-ancestor
19445216|NCT03460964|Pilocarpine|pilocarpine|mesh-list
19445217|NCT03460964|Miotics|miotics|mesh-ancestor
19445218|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
19445219|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445220|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445221|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19445222|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19445223|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
19445224|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445225|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445226|NCT03460860|Tocopherols|tocopherols|mesh-list
19445227|NCT03460860|Vitamin E|vitamin e|mesh-list
19445228|NCT03460860|Tocotrienols|tocotrienols|mesh-list
19445229|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
19445230|NCT03460860|Lycopene|lycopene|mesh-list
19445231|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
19445232|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445233|NCT03460860|Protective Agents|protective agents|mesh-ancestor
19445234|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445235|NCT03460860|Vitamins|vitamins|mesh-ancestor
19445236|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
19445237|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445238|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19445239|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19445240|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445241|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
19445242|NCT03460808|Atorvastatin|atorvastatin|mesh-list
19445243|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19445244|NCT03460808|Danazol|danazol|mesh-list
19445245|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19445246|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19445247|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
19445248|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445249|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19445250|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19445251|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445252|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
19445253|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870370|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19870371|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
19870372|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870373|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
19870374|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445254|NCT03460808|Expectorants|expectorants|mesh-ancestor
19445255|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
19445256|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19445257|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
19445258|NCT03460808|Protective Agents|protective agents|mesh-ancestor
19445259|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445260|NCT03460808|Antidotes|antidotes|mesh-ancestor
19445261|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19445262|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
19445263|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445264|NCT03460782|Ipilimumab|ipilimumab|mesh-list
19445265|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445266|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445267|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19445268|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445269|NCT03460743|Vaccines|vaccines|mesh-list
19445270|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
19445271|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
19445272|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445273|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
19445274|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19445275|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
19445276|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445277|NCT03460678|Pemetrexed|pemetrexed|mesh-list
19445278|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19445279|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445280|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445281|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445282|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19445283|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19445284|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19445285|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19445286|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445287|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445288|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19445289|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
19445290|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
19445291|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19445292|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19445293|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445294|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445295|NCT03460470|Urological Agents|urological agents|mesh-ancestor
19445296|NCT03460405|Vaccines|vaccines|mesh-list
19445297|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
19445298|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445299|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19870375|NCT00856050|Letrozole|letrozole|mesh-list
20288561|NCT05306379|Simvastatin|simvastatin|mesh-list
19445300|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445301|NCT03460275|Osimertinib|osimertinib|mesh-list
19445302|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445303|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19445304|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445305|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445306|NCT03460145|Propofol|propofol|mesh-list
19445307|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19445308|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445309|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445310|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19445311|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
19445312|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
19445313|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
19445314|NCT03460041|Bupivacaine|bupivacaine|mesh-list
19445315|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
19445316|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
19445317|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445318|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729912|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19729913|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
19729914|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729915|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19729916|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19729917|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729918|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19729919|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19729920|NCT04603573|Listerine|listerine|mesh-list
19729921|NCT04603573|Fluorides|fluorides|mesh-list
19729922|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
19729923|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
19729924|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
19729925|NCT04603573|Protective Agents|protective agents|mesh-ancestor
19729926|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729927|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19729928|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19729929|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
19729930|NCT04603456|Antacids|antacids|mesh-ancestor
19729931|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729932|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729933|NCT04603131|Vaccines|vaccines|mesh-list
19729934|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
19729935|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729936|NCT04603066|Ondansetron|ondansetron|mesh-list
19729937|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
19729938|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
19729939|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729940|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729941|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19729942|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
19729943|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
19729944|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19729945|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
19729946|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729947|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729948|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19729949|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19729950|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19729951|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19729952|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19729953|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
19729954|NCT04602754|Empagliflozin|empagliflozin|mesh-list
19729955|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19729956|NCT04602754|Calcium|calcium|mesh-list
19729957|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19729958|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729959|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19729960|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19729961|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19729962|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
19729963|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729964|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19729965|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19729966|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729967|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19729968|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19729969|NCT04602767|Phenylephrine|phenylephrine|mesh-list
20256318|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256319|NCT00474435|Tenofovir|tenofovir|mesh-list
20256320|NCT00474435|Emtricitabine|emtricitabine|mesh-list
20256321|NCT00474435|Efavirenz|efavirenz|mesh-list
20256322|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
20256323|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256324|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20256325|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20256326|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256327|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256328|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20535348|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19445319|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
19445320|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445321|NCT03460041|Analgesics|analgesics|mesh-ancestor
19445322|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445323|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
19445324|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19445325|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445326|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445327|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19445328|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
19445329|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19452064|NCT03416777|Tocotrienols|tocotrienols|mesh-list
19452065|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
19452066|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
19452067|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452068|NCT03416777|Protective Agents|protective agents|mesh-ancestor
19452069|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452070|NCT03416777|Vitamins|vitamins|mesh-ancestor
19452071|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
19452814|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452884|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452885|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452886|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19452887|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
19452888|NCT03408756|Methotrexate|methotrexate|mesh-list
19452889|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19452890|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
19452891|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19452892|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452893|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19452894|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
19452895|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452896|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452897|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
19452898|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452899|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19452900|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19452901|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
19452902|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452903|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19452904|NCT03408587|Ipilimumab|ipilimumab|mesh-list
19452905|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19452906|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452907|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19452908|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452909|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19452910|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452913|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452914|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452915|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
19452916|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19452917|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
19452918|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452919|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
19452920|NCT03408145|Protective Agents|protective agents|mesh-ancestor
19452921|NCT03408093|Interferons|interferons|mesh-list
19452922|NCT03408093|Interferon-beta|interferon-beta|mesh-list
19452923|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
19452924|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452925|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
19452926|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445330|NCT03460002|Vaccines|vaccines|mesh-list
19445331|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
19445332|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445333|NCT03459911|Losartan|losartan|mesh-list
19445334|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445335|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19445336|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19445337|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19445338|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445339|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
19445340|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19445341|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
19445342|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445343|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
19445344|NCT03459833|Protective Agents|protective agents|mesh-ancestor
19445345|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
19445346|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19445347|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19445348|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445349|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19445350|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445351|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445352|NCT03459417|Morphine|morphine|mesh-list
19445353|NCT03459417|Sulpiride|sulpiride|mesh-list
19445354|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19445355|NCT03459417|Narcotics|narcotics|mesh-ancestor
19445356|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445357|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445358|NCT03459417|Analgesics|analgesics|mesh-ancestor
19445359|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
19445360|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445361|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19445362|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19445363|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19445364|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19445365|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
19445366|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445367|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445368|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19445369|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
20256329|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20256330|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20256331|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256332|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20256333|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20256334|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20256335|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20256336|NCT00474591|PENTA|penta|mesh-list
20256337|NCT00474591|Fondaparinux|fondaparinux|mesh-list
20256338|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20256339|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
19445370|NCT03459404|Sufentanil|sufentanil|mesh-list
19445371|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19445372|NCT03459404|Narcotics|narcotics|mesh-ancestor
19445373|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445374|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445375|NCT03459404|Analgesics|analgesics|mesh-ancestor
19445376|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
19445377|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445378|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19445379|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19445380|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
19445381|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
19445382|NCT03459248|Anesthetics|anesthetics|mesh-list
19445383|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445384|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445385|NCT03459144|Ranibizumab|ranibizumab|mesh-list
19445386|NCT03459144|Verteporfin|verteporfin|mesh-list
19445387|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19445388|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19445389|NCT03459144|Growth Substances|growth substances|mesh-ancestor
19445390|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445391|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
19445392|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256340|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19445393|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19445394|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
19445395|NCT03459105|Bupivacaine|bupivacaine|mesh-list
19445396|NCT03459105|Anesthetics|anesthetics|mesh-list
19445397|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
19445398|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445399|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445400|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
19445401|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445402|NCT03458923|Diclofenac|diclofenac|mesh-list
19445403|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19445404|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19445405|NCT03458923|Ranibizumab|ranibizumab|mesh-list
19445406|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
19445407|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19445408|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19445409|NCT03458923|Growth Substances|growth substances|mesh-ancestor
19445410|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445411|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
19445412|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445413|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445414|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445415|NCT03458923|Analgesics|analgesics|mesh-ancestor
19445416|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
19445417|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445418|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445419|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19445420|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445421|NCT03458715|Empagliflozin|empagliflozin|mesh-list
19445422|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19445423|NCT03458715|Linagliptin|linagliptin|mesh-list
19445424|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19445425|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445426|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19445427|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445428|NCT03458715|Incretins|incretins|mesh-ancestor
19445429|NCT03458715|Hormones|hormones|mesh-ancestor
19445430|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445431|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
19445432|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445433|NCT03458689|Analgesics|analgesics|mesh-list
19445434|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
19445435|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445436|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256341|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
20256342|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256343|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256344|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
20256345|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20256346|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19445437|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
19445438|NCT03458598|Narcotics|narcotics|mesh-ancestor
19445439|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445440|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445441|NCT03458598|Analgesics|analgesics|mesh-ancestor
19445442|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
19445443|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445444|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19445445|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445446|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
19445447|NCT03458481|Yimitasvir|yimitasvir|mesh-list
19445448|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
19445449|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445450|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
19445451|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19445452|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19445453|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445454|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
20256347|NCT00474669|Docetaxel|docetaxel|mesh-list
20256348|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256349|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
20256350|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
20256351|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19445455|NCT03458468|Coagulants|coagulants|mesh-ancestor
19445456|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
19445457|NCT03458455|Nivolumab|nivolumab|mesh-list
19445458|NCT03458455|Ipilimumab|ipilimumab|mesh-list
19445459|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445460|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445461|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19445462|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445463|NCT03458416|Cannabidiol|cannabidiol|mesh-list
19445464|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
19452072|NCT03416569|Prazosin|prazosin|mesh-list
19452073|NCT03416569|Nicotine|nicotine|mesh-list
19452074|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19452075|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
19452076|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452077|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452078|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19452079|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19452080|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
19452081|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452082|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452083|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19452084|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19452085|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19452086|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19452087|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
19452088|NCT03416517|Irinotecan|irinotecan|mesh-list
19452089|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19452090|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19452091|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452092|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452093|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452094|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
19452095|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
19452096|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452097|NCT03416374|Dexamethasone|dexamethasone|mesh-list
19452098|NCT03416374|Lenalidomide|lenalidomide|mesh-list
19452099|NCT03416374|Bortezomib|bortezomib|mesh-list
19452100|NCT03416374|Ixazomib|ixazomib|mesh-list
19452101|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452102|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
19452103|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
19452104|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452105|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452106|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452107|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
19452108|NCT03416374|Hormones|hormones|mesh-ancestor
19452109|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452110|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19452111|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452112|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
19452113|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19452114|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19452115|NCT03416374|Growth Substances|growth substances|mesh-ancestor
19452116|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
19452117|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
19452118|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452119|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452120|NCT03416361|Vitamin D|vitamin d|mesh-list
19452121|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
19452122|NCT03416361|Vitamins|vitamins|mesh-ancestor
19452123|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
19452124|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452125|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19452126|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19452127|NCT03416348|Ethanol|ethanol|mesh-list
19452128|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19452129|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452130|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452131|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452132|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
19452133|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19452134|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452135|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19870376|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452136|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452137|NCT03416231|Docetaxel|docetaxel|mesh-list
19452138|NCT03416231|Apatinib|apatinib|mesh-list
19452139|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445465|NCT03458260|Rituximab|rituximab|mesh-list
19445466|NCT03458260|Etoposide|etoposide|mesh-list
19445467|NCT03458260|Ifosfamide|ifosfamide|mesh-list
19445468|NCT03458260|Pixantrone|pixantrone|mesh-list
19445469|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445470|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445471|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
19445472|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445473|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445474|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19445475|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19445476|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19445477|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445478|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445479|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19445480|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
19445481|NCT03458221|Tamoxifen|tamoxifen|mesh-list
19445482|NCT03458221|Itraconazole|itraconazole|mesh-list
19445483|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19445484|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
19445485|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445486|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445487|NCT03458221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19445488|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445489|NCT03458221|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19445490|NCT03458221|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19445491|NCT03458221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19445492|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
19445493|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445494|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19445495|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19445496|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445497|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445498|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19445499|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19445500|NCT03458208|Metformin|metformin|mesh-list
19445501|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19445502|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445503|NCT03458143|Ketamine|ketamine|mesh-list
19445504|NCT03458143|Remifentanil|remifentanil|mesh-list
19445505|NCT03458143|Analgesics|analgesics|mesh-ancestor
19445506|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
19445507|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445508|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445509|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19445510|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19445511|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
19445512|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
19445513|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445514|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19445515|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19445516|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445517|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445518|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19445519|NCT03458143|Narcotics|narcotics|mesh-ancestor
19445520|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
19445521|NCT03458078|Midazolam|midazolam|mesh-list
19445522|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19445523|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19445524|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445525|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445526|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19445527|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19445528|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19445529|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19445530|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
19445531|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
19445532|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
19445533|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
19445534|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445535|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870377|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19445536|NCT03458078|Analgesics|analgesics|mesh-ancestor
19445537|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
19452140|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
19445538|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445539|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445540|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
19445541|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19445542|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445543|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19445544|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
19445545|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19445546|NCT03457753|Riluzole|riluzole|mesh-list
19445547|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
19445548|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19445549|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19445550|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445551|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445552|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870378|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19870379|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445553|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19445554|NCT03457753|Protective Agents|protective agents|mesh-ancestor
19445555|NCT03457597|Pioglitazone|pioglitazone|mesh-list
19445556|NCT03457597|Tolbutamide|tolbutamide|mesh-list
19445557|NCT03457597|Metoprolol|metoprolol|mesh-list
19445558|NCT03457597|Midazolam|midazolam|mesh-list
19445559|NCT03457597|Omeprazole|omeprazole|mesh-list
19445560|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19445561|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19445562|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445563|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445564|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19445565|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19445566|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19445567|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19445568|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
19445569|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
19445570|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
19445571|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
19445572|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445573|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445574|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20256352|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256353|NCT00474695|Ranibizumab|ranibizumab|mesh-list
20256354|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20256355|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20256356|NCT00474695|Growth Substances|growth substances|mesh-ancestor
20256357|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256358|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
20256359|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256360|NCT00474721|Acetaminophen|acetaminophen|mesh-list
20256361|NCT00474721|Ibuprofen|ibuprofen|mesh-list
20256362|NCT00474721|Codeine|codeine|mesh-list
20256363|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445575|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19445576|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19445577|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19445578|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445579|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445580|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20256364|NCT00474721|Analgesics|analgesics|mesh-ancestor
19870380|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870381|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19870382|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
19870383|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870384|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870385|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
19870386|NCT00856180|Bevacizumab|bevacizumab|mesh-list
19870387|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870388|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
19870389|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870390|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870391|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19870392|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
19870393|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256365|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
19445581|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
20256366|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445582|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
20256367|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445583|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445584|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19445585|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19445586|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19445587|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
19445588|NCT03457467|Apatinib|apatinib|mesh-list
19445589|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445590|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19445591|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445592|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445593|NCT03457389|Cabergoline|cabergoline|mesh-list
19445594|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19445595|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19445596|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
19445597|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
19445598|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445599|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445600|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445601|NCT03457337|Gefitinib|gefitinib|mesh-list
19445602|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445603|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19445604|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445605|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445606|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19445607|NCT03457233|Cetrorelix|cetrorelix|mesh-list
19445608|NCT03457233|Menotropins|menotropins|mesh-list
19445609|NCT03457233|Progesterone|progesterone|mesh-list
19445610|NCT03457233|Progestins|progestins|mesh-ancestor
19445611|NCT03457233|Hormones|hormones|mesh-ancestor
19445612|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445613|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445614|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19445615|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19445616|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
19445617|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
19445618|NCT03457194|Vaccines|vaccines|mesh-list
19445619|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
19445620|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445621|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
19445622|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445623|NCT03456947|Pregabalin|pregabalin|mesh-list
19445624|NCT03456947|Analgesics|analgesics|mesh-ancestor
19445625|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
19445626|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445627|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445628|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
19445629|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19445630|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445631|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445632|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19445633|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19445634|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19445635|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445636|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19445637|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
19445638|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445639|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445640|NCT03456752|Dexamethasone|dexamethasone|mesh-list
19445641|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256368|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
20256369|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19445642|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
19445643|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
19445644|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445645|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445646|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19445647|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
19445648|NCT03456752|Hormones|hormones|mesh-ancestor
19445649|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445650|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19445651|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256370|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445652|NCT03456713|Mirikizumab|mirikizumab|mesh-list
19452141|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
19445653|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19445654|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445655|NCT03456713|Analgesics|analgesics|mesh-ancestor
19445656|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
19445657|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445658|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445659|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19729970|NCT04602767|Vasopressins|vasopressins|mesh-list
19729971|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
19729972|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
19729973|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19729974|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
19729975|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
19729976|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19729977|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19729978|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
19729979|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20256371|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256372|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19729980|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
19729981|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
19729982|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19729983|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19729984|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19729985|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
19729986|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19729987|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729988|NCT04602767|Protective Agents|protective agents|mesh-ancestor
19729989|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
19729990|NCT04602767|Coagulants|coagulants|mesh-ancestor
19729991|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19729992|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
19729993|NCT04602273|Azacitidine|azacitidine|mesh-list
19729994|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19729995|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
19729996|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19729997|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19729998|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19729999|NCT04602247|Fesoterodine|fesoterodine|mesh-list
19730000|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19730001|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19730002|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
19730003|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730004|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730005|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730006|NCT04602247|Urological Agents|urological agents|mesh-ancestor
19730007|NCT04602026|Coal Tar|coal tar|mesh-list
19730008|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
19730009|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730010|NCT04602143|Testosterone|testosterone|mesh-list
19730011|NCT04602143|Androgens|androgens|mesh-ancestor
19730012|NCT04602143|Hormones|hormones|mesh-ancestor
19730013|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730014|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730015|NCT04601961|Propofol|propofol|mesh-list
19730016|NCT04601961|Sevoflurane|sevoflurane|mesh-list
19730017|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19730018|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730019|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730020|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19730021|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
19730022|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
19730023|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19730024|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19735413|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19735414|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
19735415|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19735416|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19735417|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19735418|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735419|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735420|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
19735421|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
20256373|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735422|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735423|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445660|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445661|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19445662|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19445663|NCT03456687|Exenatide|exenatide|mesh-list
19445664|NCT03456687|Glucagon|glucagon|mesh-list
19445665|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19445666|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19445667|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445668|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19445669|NCT03456687|Incretins|incretins|mesh-ancestor
19445670|NCT03456687|Hormones|hormones|mesh-ancestor
19445671|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445672|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19445673|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
19445674|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
19445675|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19445676|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445677|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445678|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445679|NCT03456661|Analgesics|analgesics|mesh-ancestor
19445680|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
19445681|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445682|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19445683|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19445684|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19445685|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
19445686|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445687|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445688|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
19445689|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
19445690|NCT03456648|Apixaban|apixaban|mesh-list
19445691|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19445692|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
19445693|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19445694|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
19445695|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445696|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445697|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
19452142|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
19452143|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452144|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19452145|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452146|NCT03416062|Niacinamide|niacinamide|mesh-list
19452147|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
19452148|NCT03416062|Vitamins|vitamins|mesh-ancestor
19452149|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
19452150|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452151|NCT03415906|Valsartan|valsartan|mesh-list
19452152|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19452153|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19452154|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19452155|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452156|NCT03415828|Ethanol|ethanol|mesh-list
19452157|NCT03415828|Prednisolone|prednisolone|mesh-list
19452158|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19452159|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
19452160|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19452161|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
19452162|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19452163|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
19452164|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452165|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
19452166|NCT03415828|Hormones|hormones|mesh-ancestor
19452167|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452168|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452169|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19452170|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452171|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
19452172|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
19452173|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452174|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452175|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19452176|NCT03415828|Protective Agents|protective agents|mesh-ancestor
19452177|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19452178|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730025|NCT04602065|Antibodies|antibodies|mesh-list
19445698|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
19445699|NCT03456570|Progestins|progestins|mesh-ancestor
19445700|NCT03456570|Hormones|hormones|mesh-ancestor
19445701|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445702|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445703|NCT03456544|Vancomycin|vancomycin|mesh-list
19445704|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19445705|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445706|NCT03456531|Aspirin|aspirin|mesh-list
19445707|NCT03456531|Analgesics|analgesics|mesh-list
19445708|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19445709|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445710|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
19445711|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445712|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445713|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445714|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445715|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19445716|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19445717|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445718|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19445719|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19445720|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445721|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
19445722|NCT03456466|Rituximab|rituximab|mesh-list
19445723|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445724|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445725|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
19445726|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445727|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445728|NCT03456401|Sorafenib|sorafenib|mesh-list
19445729|NCT03456401|Sunitinib|sunitinib|mesh-list
19445730|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445731|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19445732|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445733|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445734|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19445735|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19445736|NCT03456401|Growth Substances|growth substances|mesh-ancestor
19445737|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445738|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
19445739|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
19445740|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445741|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
19445742|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
19445743|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
19445744|NCT03456102|Pravastatin|pravastatin|mesh-list
19445745|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19445746|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19445747|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
19445748|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445749|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19445750|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19445751|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445752|NCT03455426|Letrozole|letrozole|mesh-list
19445753|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445754|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19445755|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19445756|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445757|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445758|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19445759|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
19445760|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445761|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445762|NCT03455322|Octreotide|octreotide|mesh-list
19445763|NCT03455322|Norepinephrine|norepinephrine|mesh-list
19445764|NCT03455322|Midodrine|midodrine|mesh-list
19445765|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19445766|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19445767|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445768|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19445769|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19445770|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
19445771|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445772|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445773|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445774|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
19445775|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
19445776|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445777|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19445778|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19445779|NCT03455179|Methamphetamine|methamphetamine|mesh-list
19445780|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19445781|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445782|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
19445783|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
19445784|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445785|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
19445786|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256374|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256375|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20256376|NCT00474721|Narcotics|narcotics|mesh-ancestor
20256377|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256378|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
20256379|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256380|NCT00474773|Celecoxib|celecoxib|mesh-list
20256381|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20256382|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20256383|NCT00474773|Analgesics|analgesics|mesh-ancestor
20256384|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
20256385|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256386|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256387|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256388|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445787|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445788|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
19445789|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19445790|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19445791|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445792|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19445793|NCT03455140|BCT-100|bct-100|mesh-list
19445794|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445795|NCT03455088|Fluoxetine|fluoxetine|mesh-list
19445796|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19445797|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19445798|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445799|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445800|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445801|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
19445802|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445803|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19445804|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
19445805|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19445806|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19445807|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19445808|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445809|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
19445810|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19445811|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
19445812|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19445813|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445814|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19445815|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19445816|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19445817|NCT03455049|Andrographolide|andrographolide|mesh-list
19445818|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445819|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19445820|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445821|NCT03455049|Analgesics|analgesics|mesh-ancestor
19445822|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
19445823|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445824|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445825|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445826|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19445827|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19445828|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730026|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20535349|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
19445829|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
19445830|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19445831|NCT03454984|Guadecitabine|guadecitabine|mesh-list
19445832|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445833|NCT03454945|Doxycycline|doxycycline|mesh-list
19445834|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19445835|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445836|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
19445837|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19870394|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870395|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19870396|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19870397|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19870398|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19870399|NCT00856180|Growth Substances|growth substances|mesh-ancestor
19870400|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
19870401|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
19870402|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19870403|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19870404|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19870405|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
19870406|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445838|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19445839|NCT03454919|Palbociclib|palbociclib|mesh-list
19445840|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445841|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19445842|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445843|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452179|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452180|NCT03415802|Paclitaxel|paclitaxel|mesh-list
19452181|NCT03415802|Tegafur|tegafur|mesh-list
19452182|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19452183|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452184|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
19452185|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
19452186|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
19452187|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452188|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19452189|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
19452190|NCT03415763|Leucovorin|leucovorin|mesh-list
19452191|NCT03415763|Capecitabine|capecitabine|mesh-list
19452192|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
19452193|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19452194|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
19452195|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452196|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452197|NCT03415763|Antidotes|antidotes|mesh-ancestor
19452198|NCT03415763|Protective Agents|protective agents|mesh-ancestor
19452199|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452200|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
19452201|NCT03415763|Vitamins|vitamins|mesh-ancestor
19452202|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
19452203|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
19452204|NCT03415750|Everolimus|everolimus|mesh-list
19452205|NCT03415750|Tacrolimus|tacrolimus|mesh-list
19452206|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19452207|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
19452208|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452209|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19452210|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452211|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452212|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730027|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
19730028|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730029|NCT04602013|Paclitaxel|paclitaxel|mesh-list
19730030|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19730031|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19730032|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730033|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
19730034|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
19730035|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
19730036|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730037|NCT04601688|Dexamethasone|dexamethasone|mesh-list
19445844|NCT03454841|Ticagrelor|ticagrelor|mesh-list
19445845|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19445846|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19445847|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19445848|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19445849|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19445850|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
19445851|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445852|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445853|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445854|NCT03454789|Lidocaine|lidocaine|mesh-list
19445855|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
19445856|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
19445857|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445858|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445859|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
19445860|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445861|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445862|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19445863|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19445864|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445865|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445866|NCT03454724|Sirolimus|sirolimus|mesh-list
19445867|NCT03454724|Everolimus|everolimus|mesh-list
19445868|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445869|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19445870|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
20256389|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20256390|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20256391|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256392|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256393|NCT00474838|Metformin|metformin|mesh-list
20256394|NCT00474838|Glimepiride|glimepiride|mesh-list
20256395|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20256396|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256397|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20256398|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256399|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
20256400|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
20256401|NCT00474890|Ephedrine|ephedrine|mesh-list
20256402|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20256403|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
20256404|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256405|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256406|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20256407|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256408|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
20256409|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20256410|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20256411|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
19445871|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445872|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19445873|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445874|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19445875|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
19445876|NCT03454646|Rivastigmine|rivastigmine|mesh-list
19445877|NCT03454646|Donepezil|donepezil|mesh-list
19445878|NCT03454646|Galantamine|galantamine|mesh-list
19445879|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
19445880|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445881|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445882|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
19445883|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445884|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445885|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
19445886|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19445887|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
19445888|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445889|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19445890|NCT03454646|Protective Agents|protective agents|mesh-ancestor
19445891|NCT03454620|Irinotecan|irinotecan|mesh-list
19445892|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19445893|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19730038|NCT04601688|Bevacizumab|bevacizumab|mesh-list
20256412|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
19445894|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445895|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445896|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445897|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
19445898|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445899|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19445900|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445901|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445902|NCT03454217|Oxycodone|oxycodone|mesh-list
19445903|NCT03454217|Tramadol|tramadol|mesh-list
19445904|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19445905|NCT03454217|Narcotics|narcotics|mesh-ancestor
19445906|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445907|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445908|NCT03454217|Analgesics|analgesics|mesh-ancestor
19445909|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
19445910|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445911|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19445912|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445913|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
19445914|NCT03453931|Hormones|hormones|mesh-ancestor
19445915|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19445916|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445917|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19445918|NCT03453931|Protective Agents|protective agents|mesh-ancestor
19445919|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19445920|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445921|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
19445922|NCT03453892|Nivolumab|nivolumab|mesh-list
19445923|NCT03453892|Ipilimumab|ipilimumab|mesh-list
19445924|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445925|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445926|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19445927|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445928|NCT03453840|Lumefantrine|lumefantrine|mesh-list
19445929|NCT03453840|Artemether|artemether|mesh-list
19445930|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19445931|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
19445932|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19445933|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19445934|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19445935|NCT03453723|Lidocaine|lidocaine|mesh-list
19445936|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
19445937|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
19445938|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19445939|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445940|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
19445941|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445942|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19445943|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19445944|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19445945|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445946|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445947|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19445948|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19445949|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19445950|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445951|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
19445952|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19445953|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445954|NCT03453541|Ketorolac|ketorolac|mesh-list
19445955|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19445956|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19445957|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445958|NCT03453541|Analgesics|analgesics|mesh-ancestor
19445959|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
20256413|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256414|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256415|NCT00474916|KRN 5500|krn 5500|mesh-list
20256416|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256417|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20256418|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256419|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445960|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445961|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445962|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445963|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445964|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19445965|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445966|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445967|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19445968|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19445969|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445970|NCT03453346|Ribavirin|ribavirin|mesh-list
19445971|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
19445972|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
19445973|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445974|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
19445975|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452213|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19452214|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19452215|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
19452216|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19452217|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452218|NCT03415711|Mesalamine|mesalamine|mesh-list
19452219|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19452220|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452221|NCT03415711|Analgesics|analgesics|mesh-ancestor
19452222|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
19452223|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452224|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452225|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452226|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452227|NCT03415646|Morphine|morphine|mesh-list
19452228|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19452229|NCT03415646|Narcotics|narcotics|mesh-ancestor
19452230|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452231|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452232|NCT03415646|Analgesics|analgesics|mesh-ancestor
19452233|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
19452234|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452235|NCT03415594|Glucagon|glucagon|mesh-list
19452236|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19452237|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452238|NCT03415594|Hormones|hormones|mesh-ancestor
19452239|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452240|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452241|NCT03415594|Incretins|incretins|mesh-ancestor
19452242|NCT03415555|Acetaminophen|acetaminophen|mesh-list
19452243|NCT03415555|Oxycodone|oxycodone|mesh-list
19452244|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452245|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452246|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452247|NCT03415555|Analgesics|analgesics|mesh-ancestor
19452248|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
19452249|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452250|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
19452251|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19452252|NCT03415555|Narcotics|narcotics|mesh-ancestor
19452253|NCT03415477|Denosumab|denosumab|mesh-list
19452254|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19452255|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452256|NCT03415386|Anticoagulants|anticoagulants|mesh-list
19452257|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19452258|NCT03415269|Ambroxol|ambroxol|mesh-list
19452259|NCT03415269|Expectorants|expectorants|mesh-ancestor
19452260|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
19452261|NCT03415191|Ketamine|ketamine|mesh-list
19452262|NCT03415191|Analgesics|analgesics|mesh-ancestor
19452263|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
19452264|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452265|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452266|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19730039|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19730040|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256420|NCT00475059|Cimetidine|cimetidine|mesh-list
20256421|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19452267|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19452268|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
19452269|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
19445976|NCT03453281|Bevacizumab|bevacizumab|mesh-list
19445977|NCT03453281|Aflibercept|aflibercept|mesh-list
19445978|NCT03453281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19445979|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19445980|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19445981|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19445982|NCT03453281|Growth Substances|growth substances|mesh-ancestor
19445983|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445984|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
19445985|NCT03453190|Apremilast|apremilast|mesh-list
19445986|NCT03453190|Clobetasol|clobetasol|mesh-list
19445987|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19445988|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19445989|NCT03453190|Analgesics|analgesics|mesh-ancestor
19445990|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
19445991|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19445992|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19445993|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19445994|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19445995|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19445996|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19445997|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19445998|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19445999|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
19446000|NCT03453190|Hormones|hormones|mesh-ancestor
19446001|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446002|NCT03453177|Fosfomycin|fosfomycin|mesh-list
19446003|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19446004|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446005|NCT03453164|Nivolumab|nivolumab|mesh-list
19446006|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446007|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446008|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19446009|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446010|NCT03452891|Simvastatin|simvastatin|mesh-list
19446011|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19446012|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19446013|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
19446014|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870407|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446015|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19446016|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19446017|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446018|NCT03452722|Plasminogen|plasminogen|mesh-list
19446019|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19446020|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19446021|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19446022|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446023|NCT03452696|Calcium|calcium|mesh-list
19446024|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19446025|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446026|NCT03452657|Ranibizumab|ranibizumab|mesh-list
19446027|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19446028|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19446029|NCT03452657|Growth Substances|growth substances|mesh-ancestor
19446030|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446031|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
19446032|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446033|NCT03452579|Bevacizumab|bevacizumab|mesh-list
19446034|NCT03452579|Nivolumab|nivolumab|mesh-list
19446035|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446036|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446037|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19446038|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19446039|NCT03452579|Growth Substances|growth substances|mesh-ancestor
19446040|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446041|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
19446042|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19446043|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446044|NCT03452553|Doxorubicin|doxorubicin|mesh-list
19446045|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19446046|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446047|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19446048|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19446049|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446050|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446051|NCT03452501|Infliximab|infliximab|mesh-list
19446052|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
19446053|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19446054|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446055|NCT03452475|Lumefantrine|lumefantrine|mesh-list
19446056|NCT03452475|Artemether|artemether|mesh-list
19446057|NCT03452475|Piperaquine|piperaquine|mesh-list
19446058|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19446059|NCT03452475|Mefloquine|mefloquine|mesh-list
19446060|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
19446061|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19446062|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19446063|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446064|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19446065|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19446066|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446067|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446068|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19446069|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19446070|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446071|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
19446072|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446073|NCT03452332|Durvalumab|durvalumab|mesh-list
19446074|NCT03452332|Ipilimumab|ipilimumab|mesh-list
19446075|NCT03452332|Tremelimumab|tremelimumab|mesh-list
19446076|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
19446077|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19446078|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
19446079|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446080|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446081|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
19446082|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446083|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19446084|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446085|NCT03452306|Metformin|metformin|mesh-list
19446086|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446087|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446088|NCT03452267|Metformin|metformin|mesh-list
19446089|NCT03452267|Pioglitazone|pioglitazone|mesh-list
19446090|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446091|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446092|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
19446093|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19446094|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446095|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
19446096|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19446097|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19446098|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19446099|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446100|NCT03451734|Metformin|metformin|mesh-list
19446101|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
19446102|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446103|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446104|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19446105|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446106|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446107|NCT03451695|Morphine|morphine|mesh-list
19446108|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19446109|NCT03451695|Narcotics|narcotics|mesh-ancestor
19446110|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446111|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446112|NCT03451695|Analgesics|analgesics|mesh-ancestor
19446113|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
19446114|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446115|NCT03451682|Procyanidin|procyanidin|mesh-list
19446116|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
19446117|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446118|NCT03451682|Protective Agents|protective agents|mesh-ancestor
20256422|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19446119|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870408|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446120|NCT03451591|Cilostazol|cilostazol|mesh-list
19446121|NCT03451591|Isosorbide|isosorbide|mesh-list
19446122|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19446123|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19446124|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19446125|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
19446126|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446127|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446128|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19446129|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
19446130|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19446131|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19446132|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446133|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19446134|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
19446135|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19446136|NCT03451591|Protective Agents|protective agents|mesh-ancestor
19446137|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19446138|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19446139|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446140|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19446141|NCT03451591|Diuretics|diuretics|mesh-ancestor
19446142|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
19446143|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19452270|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452271|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20535350|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535351|NCT01819610|Ketorolac|ketorolac|mesh-list
20535352|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19452272|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19452273|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452274|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452815|NCT03410043|Osimertinib|osimertinib|mesh-list
19452816|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452817|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19452818|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452819|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452820|NCT03409874|Diclofenac|diclofenac|mesh-list
19452821|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19452822|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452823|NCT03409874|Analgesics|analgesics|mesh-ancestor
19452824|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
19452825|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452826|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452827|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452828|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452829|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19452830|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452831|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452832|NCT03409835|Ramosetron|ramosetron|mesh-list
19452833|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
19452834|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
19452835|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452836|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452837|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20535353|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20535354|NCT01819610|Analgesics|analgesics|mesh-ancestor
20535355|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
20535356|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535357|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535358|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535359|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20535360|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19446144|NCT03451500|Levodopa|levodopa|mesh-list
19446145|NCT03451500|Carbidopa|carbidopa|mesh-list
19446146|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19446147|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19446148|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19446149|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
20256423|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20256424|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
20256425|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
20256426|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256427|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256428|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256429|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20256430|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256431|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256432|NCT00475072|Ribavirin|ribavirin|mesh-list
20256433|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20256434|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
20256435|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256436|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
20256437|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256438|NCT00475098|Tinzaparin|tinzaparin|mesh-list
20256439|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20256440|NCT00475098|Dalteparin|dalteparin|mesh-list
20256441|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
20256442|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20256443|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20256444|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256445|NCT00475137|Lamotrigine|lamotrigine|mesh-list
20256446|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
20256447|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20256448|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20256449|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256450|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20256451|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446150|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446151|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446152|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446153|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19446154|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446155|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19446156|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
19446157|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
19446158|NCT03451487|Acetaminophen|acetaminophen|mesh-list
19446159|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19870409|NCT00856206|Rilonacept|rilonacept|mesh-list
19870410|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870411|NCT00856245|Rituximab|rituximab|mesh-list
19870412|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19870413|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870414|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
19870415|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870416|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870417|NCT00856284|Metformin|metformin|mesh-list
20256452|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20256453|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20535361|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446160|NCT03451487|Analgesics|analgesics|mesh-ancestor
19446161|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
19870418|NCT00856284|Alogliptin|alogliptin|mesh-list
19446162|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446163|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446164|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
19446165|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
19446166|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19446167|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
19446168|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446169|NCT03451435|Expectorants|expectorants|mesh-ancestor
19446170|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
19446171|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19446172|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
19870419|NCT00856284|Glipizide|glipizide|mesh-list
19870420|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446173|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446174|NCT03451435|Protective Agents|protective agents|mesh-ancestor
19446175|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446176|NCT03451435|Antidotes|antidotes|mesh-ancestor
19446177|NCT03451396|Lifitegrast|lifitegrast|mesh-list
19446178|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19446179|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19446180|NCT03451331|Gemcitabine|gemcitabine|mesh-list
19446181|NCT03451331|Carboplatin|carboplatin|mesh-list
19446182|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
19446183|NCT03451331|Nivolumab|nivolumab|mesh-list
19446184|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446185|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19446186|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
19446187|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446188|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
19446189|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446190|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446191|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446192|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
19446193|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446194|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446195|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19446196|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
19446197|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446198|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
19446199|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19446200|NCT03451266|Ascorbic Acid|ascorbic acid|mesh-list
19446201|NCT03451266|Vitamins|vitamins|mesh-ancestor
19446202|NCT03451266|Micronutrients|micronutrients|mesh-ancestor
19446203|NCT03451266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446204|NCT03451266|Antioxidants|antioxidants|mesh-ancestor
19446205|NCT03451266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446206|NCT03451266|Protective Agents|protective agents|mesh-ancestor
19446207|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
19446208|NCT03451227|Remifentanil|remifentanil|mesh-list
19446209|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19446210|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446211|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446212|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446213|NCT03451227|Analgesics|analgesics|mesh-ancestor
19446214|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
19446215|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446216|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19446217|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19446218|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19446219|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
19446220|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446221|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446222|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19446223|NCT03451227|Narcotics|narcotics|mesh-ancestor
19446224|NCT03451110|Fluconazole|fluconazole|mesh-list
19446225|NCT03451110|Lemborexant|lemborexant|mesh-list
19446226|NCT03451110|Famotidine|famotidine|mesh-list
19446227|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19446228|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
19446229|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446230|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19446231|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19446232|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446233|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446234|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19446235|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
19446236|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446237|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446238|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19446239|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19446240|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19446241|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452275|NCT03415087|Fentanyl|fentanyl|mesh-list
19730041|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19730042|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19730043|NCT04601688|Growth Substances|growth substances|mesh-ancestor
19730044|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535362|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446242|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19446243|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
19446244|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
19446245|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446246|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19446247|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19446248|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19446249|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446250|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20535363|NCT01819649|Selenium|selenium|mesh-list
20535364|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
19446251|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19446252|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19446253|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
19446254|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19446255|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19446256|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19446257|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19446258|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19446259|NCT03451019|Sevelamer|sevelamer|mesh-list
19446260|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
19446261|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
19446262|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446263|NCT03450967|Durvalumab|durvalumab|mesh-list
19446264|NCT03450967|Tremelimumab|tremelimumab|mesh-list
19446265|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446266|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446267|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
19446268|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446269|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446270|NCT03450798|Anesthetics|anesthetics|mesh-list
19446271|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446272|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446273|NCT05322499|Paclitaxel|paclitaxel|mesh-list
19446274|NCT05322499|Docetaxel|docetaxel|mesh-list
19446275|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19446276|NCT05322499|Irinotecan|irinotecan|mesh-list
19446277|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19446278|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446279|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
19446280|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
19446281|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
19446282|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256454|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256455|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20256456|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20256457|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20256458|NCT00475189|Norinyl|norinyl|mesh-list
20256459|NCT00475189|Mestranol|mestranol|mesh-list
20256460|NCT00475189|Norethindrone|norethindrone|mesh-list
19446283|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19446284|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19446285|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446286|NCT05322473|Adalimumab|adalimumab|mesh-list
19446287|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446288|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446289|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
19446290|NCT05322330|Fludarabine|fludarabine|mesh-list
19446291|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446292|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
19446293|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446294|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446295|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19446296|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
19446297|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446298|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446299|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19446300|NCT05322265|Epinephrine|epinephrine|mesh-list
19446301|NCT05322265|Racepinephrine|racepinephrine|mesh-list
19446302|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
19446303|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19446304|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20256461|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20256462|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19446305|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
19446306|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446307|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446308|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446309|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19446310|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19446311|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
19446312|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446313|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19446314|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
19446315|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
19446316|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
19446317|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19446318|NCT05322252|Misoprostol|misoprostol|mesh-list
19730045|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
19446319|NCT05322252|Mifepristone|mifepristone|mesh-list
19446320|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19446321|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
19446322|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19446323|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446324|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19730046|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730047|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
19730048|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
19730049|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730050|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730051|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
19730052|NCT04601688|Hormones|hormones|mesh-ancestor
19730053|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730054|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19730055|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
19730056|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19730057|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19730058|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730059|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19730060|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19730061|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
19730062|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19730063|NCT04601701|Dexamethasone|dexamethasone|mesh-list
19730064|NCT04601701|Bevacizumab|bevacizumab|mesh-list
19730065|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19730066|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730067|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19730068|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19730069|NCT04601701|Growth Substances|growth substances|mesh-ancestor
19730070|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730071|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
19730072|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730073|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
19730074|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
19730075|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730076|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730077|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
19730078|NCT04601701|Hormones|hormones|mesh-ancestor
19730079|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730080|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19730081|NCT04601675|Dexamethasone|dexamethasone|mesh-list
19730082|NCT04601675|Ranibizumab|ranibizumab|mesh-list
19730083|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730084|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
19730085|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
19730086|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730087|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730088|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730089|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
19730090|NCT04601675|Hormones|hormones|mesh-ancestor
19730091|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730092|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19730093|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730094|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19730095|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19730096|NCT04601675|Growth Substances|growth substances|mesh-ancestor
20535365|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730097|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
19730098|NCT04601402|Avelumab|avelumab|mesh-list
19730099|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446325|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19446326|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
19446327|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19446328|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19446329|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19446330|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19446331|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
19446332|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19446333|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19446334|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
19446335|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446336|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
19446337|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19446338|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19446339|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
19446340|NCT05322187|Lenvatinib|lenvatinib|mesh-list
19446341|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19446342|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446343|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446344|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19446345|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446346|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446347|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19446348|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19446349|NCT05321940|Interferons|interferons|mesh-list
19446350|NCT05321940|Vaccines|vaccines|mesh-list
19446351|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
19446352|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446353|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446354|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
19446355|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870421|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870422|NCT00856284|Incretins|incretins|mesh-ancestor
19870423|NCT00856284|Hormones|hormones|mesh-ancestor
19870424|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870425|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19870426|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
19870427|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446356|NCT05321810|Warfarin|warfarin|mesh-list
19446357|NCT05321810|Apixaban|apixaban|mesh-list
19446358|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
19446359|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19446360|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
19446361|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19446362|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
19446363|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446364|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452276|NCT03415087|Bupivacaine|bupivacaine|mesh-list
19452277|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
19452278|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
19452279|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452280|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452281|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
19452282|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452283|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19452284|NCT03415087|Narcotics|narcotics|mesh-ancestor
19452285|NCT03415087|Analgesics|analgesics|mesh-ancestor
19452286|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19452287|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19452288|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
19452289|NCT03414931|Sertraline|sertraline|mesh-list
19452290|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
19452291|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19452292|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19452293|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19452294|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452295|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452296|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452297|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
19452298|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452299|NCT03414918|Clarithromycin|clarithromycin|mesh-list
19452300|NCT03414918|Roxithromycin|roxithromycin|mesh-list
19452301|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19452302|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452303|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19452304|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446365|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
19446366|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19446367|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446368|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446369|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446370|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19446371|NCT05321524|Cathartics|cathartics|mesh-ancestor
19446372|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19446373|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19446374|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19446375|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19446376|NCT05321511|Hormones|hormones|mesh-ancestor
19446377|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446378|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446379|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
19446380|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19446381|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
19446382|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19446383|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19446384|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19446385|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446386|NCT05321420|Pirfenidone|pirfenidone|mesh-list
19446387|NCT05321420|Analgesics|analgesics|mesh-ancestor
20256463|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20256464|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
20256465|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20256466|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256467|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20535366|NCT01819649|Protective Agents|protective agents|mesh-ancestor
19446388|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
19446389|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446390|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446391|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19446392|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446393|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446394|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446395|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446396|NCT05321329|Capecitabine|capecitabine|mesh-list
19446397|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19446398|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
19446399|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446400|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446401|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19446402|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19446403|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446404|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
19446405|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19446406|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446407|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446408|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446409|NCT05321121|Analgesics|analgesics|mesh-ancestor
19446410|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
19446411|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446412|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19446413|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19446414|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19446415|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19446416|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446417|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446418|NCT05320926|Aspirin|aspirin|mesh-list
19446419|NCT05320926|Clopidogrel|clopidogrel|mesh-list
19446420|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19446421|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446422|NCT05320926|Analgesics|analgesics|mesh-ancestor
19446423|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
19446424|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446425|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446426|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446427|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446428|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19446429|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19452838|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19446430|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446431|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19446432|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19446433|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446434|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
19446435|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19446436|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19446437|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19446438|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
19446439|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446440|NCT05320874|Antibodies|antibodies|mesh-list
19446441|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19446442|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
19446443|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446444|NCT05320757|Olaparib|olaparib|mesh-list
19446445|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19446446|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446447|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256468|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20256469|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20256470|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19446448|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446449|NCT05320692|Apatinib|apatinib|mesh-list
19446450|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
19446451|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446452|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19446453|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446454|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446455|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19446456|NCT05320692|Estrogens|estrogens|mesh-ancestor
19446457|NCT05320692|Hormones|hormones|mesh-ancestor
19446458|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446459|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446460|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19446461|NCT05320640|Decitabine|decitabine|mesh-list
19446462|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19446463|NCT05320640|Antibodies|antibodies|mesh-list
19446464|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
19446465|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446466|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19446467|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
19446468|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446469|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446470|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446471|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
19446472|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446473|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446474|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
19446475|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446476|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19446477|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446478|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446479|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19446480|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19446481|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19446482|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446483|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446484|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19446485|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19446486|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446487|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
19446488|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446489|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19446490|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19446491|NCT05320120|Esketamine|esketamine|mesh-list
20256471|NCT00475189|Estrogens|estrogens|mesh-ancestor
20256472|NCT00475189|Hormones|hormones|mesh-ancestor
20256473|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20256474|NCT00475293|Panitumumab|panitumumab|mesh-list
20256475|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256476|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256477|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19446492|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
19446493|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446494|NCT05320107|Ketamine|ketamine|mesh-list
19446495|NCT05320107|Analgesics|analgesics|mesh-ancestor
19446496|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
20256478|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20256479|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20256480|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20256481|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256482|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256483|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256484|NCT00475358|Analgesics|analgesics|mesh-ancestor
20256485|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
20256486|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256487|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
20256488|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20256489|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
19870428|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870429|NCT00856297|Vaccines|vaccines|mesh-list
19870430|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
19870431|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870432|NCT00856323|Tenofovir|tenofovir|mesh-list
19870433|NCT00856323|Emtricitabine|emtricitabine|mesh-list
19870434|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19870435|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
19870436|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446497|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446498|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446499|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19446500|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19446501|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
19870437|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19870438|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19446502|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
19446503|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446504|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19446505|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19446506|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446507|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446508|NCT05320094|Sorbitol|sorbitol|mesh-list
19446509|NCT05320094|Charcoal|charcoal|mesh-list
19446510|NCT05320094|Antidotes|antidotes|mesh-ancestor
19446511|NCT05320094|Protective Agents|protective agents|mesh-ancestor
19446512|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446513|NCT05320094|Cathartics|cathartics|mesh-ancestor
19446514|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19446515|NCT05320068|Vancomycin|vancomycin|mesh-list
19446516|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19446517|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446518|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
19446519|NCT05311813|Enoxaparin|enoxaparin|mesh-list
19446520|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
19446521|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19446522|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19446523|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446524|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446525|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446526|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446527|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
19446528|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19446529|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19452305|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452306|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19452307|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19452308|NCT03414879|Lidocaine|lidocaine|mesh-list
19452309|NCT03414879|Ketamine|ketamine|mesh-list
19452310|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
20286760|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
20286761|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19452311|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
19452312|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452313|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452314|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
19452315|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446530|NCT05308030|Aspirin|aspirin|mesh-list
19446531|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
19446532|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19446533|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446534|NCT05308030|Analgesics|analgesics|mesh-ancestor
19446535|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
19446536|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446537|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446538|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446539|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446540|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19446541|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19446542|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446543|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19446544|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19446545|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446546|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
20256490|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20256491|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19870439|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870440|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446547|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19446548|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
19446549|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19446550|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
19446551|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
19446552|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19446553|NCT05306704|Calcifediol|calcifediol|mesh-list
19446554|NCT05306704|Vitamins|vitamins|mesh-ancestor
19446555|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
19446556|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446557|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19446558|NCT05306548|Triamcinolone|triamcinolone|mesh-list
19446559|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19446560|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19446561|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19446562|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446563|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
19446564|NCT05306548|Hormones|hormones|mesh-ancestor
19446565|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446566|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446567|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446568|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
19446569|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446570|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446571|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
19446572|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446573|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
19446574|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
19446575|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
19446576|NCT05303636|Drospirenone|drospirenone|mesh-list
19446577|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19446578|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
19446579|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446580|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446581|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19446582|NCT05303636|Diuretics|diuretics|mesh-ancestor
19446583|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
19446584|NCT05303311|Dexamethasone|dexamethasone|mesh-list
19446585|NCT05303311|Meperidine|meperidine|mesh-list
19446586|NCT05303311|Bupivacaine|bupivacaine|mesh-list
19446587|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446588|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
19446589|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
19446590|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446591|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446592|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19446593|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
19446594|NCT05303311|Hormones|hormones|mesh-ancestor
19446595|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446596|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19446597|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870441|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19446598|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
19446599|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
19446600|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446601|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
19446602|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19446603|NCT05303311|Narcotics|narcotics|mesh-ancestor
19446604|NCT05303311|Analgesics|analgesics|mesh-ancestor
19446605|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19446606|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
19446607|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19446608|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19446609|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446610|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
19446611|NCT05302986|Coagulants|coagulants|mesh-ancestor
19446612|NCT05302284|Gemcitabine|gemcitabine|mesh-list
19446613|NCT05302284|Carboplatin|carboplatin|mesh-list
19446614|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446615|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19446616|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
19446617|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446618|NCT05302284|Antiviral Agents|antiviral agents|mesh-ancestor
19446619|NCT05302284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446620|NCT05302284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446621|NCT05302284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446622|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
19446623|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446624|NCT05289908|Folic Acid|folic acid|mesh-list
19446625|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
19446626|NCT05289908|Hydroxocobalamin|hydroxocobalamin|mesh-list
19446627|NCT05289908|Dexamethasone|dexamethasone|mesh-list
19446628|NCT05289908|Pemetrexed|pemetrexed|mesh-list
19446629|NCT05289908|Vitamins|vitamins|mesh-ancestor
19446630|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
19446631|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446632|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446633|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
19446634|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
19446635|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446636|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19446637|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
19446638|NCT05289908|Hormones|hormones|mesh-ancestor
19446639|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446640|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19446641|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446642|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446643|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446644|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19446645|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19446646|NCT05289908|Hematinics|hematinics|mesh-ancestor
19446647|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
19446648|NCT05289050|Ketamine|ketamine|mesh-list
19446649|NCT05289050|Esketamine|esketamine|mesh-list
19446650|NCT05289050|Analgesics|analgesics|mesh-ancestor
19446651|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
19446652|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446653|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446654|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19446655|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19446656|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
19446657|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
19446658|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446659|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19446660|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19446661|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446662|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446663|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
19446664|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446665|NCT05283161|Dronabinol|dronabinol|mesh-list
19446666|NCT05283161|Cannabidiol|cannabidiol|mesh-list
19446667|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
19446668|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
19446669|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446670|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20535367|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446671|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446672|NCT05283161|Analgesics|analgesics|mesh-ancestor
19446673|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
19446674|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446675|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19446676|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19446677|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446678|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446679|NCT05283161|Hormones|hormones|mesh-ancestor
19446680|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446681|NCT05278858|Triamcinolone|triamcinolone|mesh-list
19446682|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446683|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
19446684|NCT05278858|Hormones|hormones|mesh-ancestor
19446685|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446686|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730100|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730101|NCT04601324|Fluticasone|fluticasone|mesh-list
19730102|NCT04601324|Xhance|xhance|mesh-list
19730103|NCT04601324|Azelastine|azelastine|mesh-list
19730104|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730105|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19730106|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
19730107|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730108|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730109|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19730110|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
19730111|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730112|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20256492|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20535368|NCT01819649|Trace Elements|trace elements|mesh-ancestor
19730113|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19730114|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730115|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730116|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19870442|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19870443|NCT00856375|Irinotecan|irinotecan|mesh-list
19870444|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
19870445|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19870446|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19870447|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870448|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870449|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870450|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19870451|NCT00856388|Fludarabine|fludarabine|mesh-list
19870452|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
19870453|NCT00856388|Melphalan|melphalan|mesh-list
19870454|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
19870455|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19870456|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
19870457|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870458|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19870459|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
19870460|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870461|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870462|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
19870463|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870464|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19870465|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
19870466|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19870467|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
19870468|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19870469|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19870470|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19870471|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19870472|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870473|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
19870474|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870475|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870476|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19870477|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870478|NCT00856492|Paclitaxel|paclitaxel|mesh-list
19870479|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
19870480|NCT00856492|Bevacizumab|bevacizumab|mesh-list
19870481|NCT00856492|Doxorubicin|doxorubicin|mesh-list
19870482|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19870483|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19870484|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19870485|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870486|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
19446687|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
19446688|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
19446689|NCT05269381|Sargramostim|sargramostim|mesh-list
19446690|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446691|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
19446692|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446693|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446694|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19446695|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
19446696|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446697|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446698|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19446699|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446700|NCT05265728|Natalizumab|natalizumab|mesh-list
19446701|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
19446702|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446703|NCT05260528|Cytarabine|cytarabine|mesh-list
19446704|NCT05260528|Idarubicin|idarubicin|mesh-list
19446705|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19446706|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
19446707|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446708|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446709|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
19446710|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446711|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446712|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
19446713|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446714|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19446715|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19446716|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19446717|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446718|NCT05231603|Ivermectin|ivermectin|mesh-list
19446719|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19446720|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446721|NCT05211635|Vitamin D|vitamin d|mesh-list
19446722|NCT05211635|Vitamins|vitamins|mesh-ancestor
19446723|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
19446724|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446725|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19446726|NCT05202145|Cyclosporine|cyclosporine|mesh-list
19446727|NCT05202145|Tacrolimus|tacrolimus|mesh-list
19446728|NCT05202145|Cyclosporins|cyclosporins|mesh-list
19446729|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446730|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
19446731|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446732|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19446733|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446734|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446735|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
19446736|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446737|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
19446738|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446739|NCT05198362|Metoprolol|metoprolol|mesh-list
19446740|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19446741|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19446742|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
19446743|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
19446744|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446745|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256493|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20256494|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256495|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256496|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256497|NCT00475397|Analgesics|analgesics|mesh-ancestor
20256498|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
20535369|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
19446746|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19446747|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19446748|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19446749|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
19446750|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446751|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870487|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
19446752|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
19446753|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
20256499|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446754|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446755|NCT05184335|RP5063|rp5063|mesh-list
19446756|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19446757|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19446758|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446759|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446760|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446761|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
19446762|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446763|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446764|NCT05147415|Metoprolol|metoprolol|mesh-list
19446765|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19446766|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19446767|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
19446768|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
19446769|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446770|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446771|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19446772|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19446773|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19446774|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
19446775|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446776|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446777|NCT05140499|Bupivacaine|bupivacaine|mesh-list
19446778|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
19446779|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
19446780|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446781|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446782|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
19446783|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446784|NCT05132075|Docetaxel|docetaxel|mesh-list
19446785|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446786|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
19446787|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
19446788|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
19446789|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452316|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452317|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19452318|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19452319|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452320|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452321|NCT03414879|Analgesics|analgesics|mesh-ancestor
19452322|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19452323|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19452324|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
19452325|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19452326|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19452327|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452328|NCT03414840|Atorvastatin|atorvastatin|mesh-list
19452329|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19452330|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19452331|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
19452332|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452333|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19452334|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19452335|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452336|NCT03414814|Osimertinib|osimertinib|mesh-list
19452337|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452338|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20256500|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
20256501|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20256502|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
20256503|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20256504|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
20256505|NCT00475410|Coagulants|coagulants|mesh-ancestor
20256506|NCT00475462|Metoprolol|metoprolol|mesh-list
20256507|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20256508|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20256509|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
19452339|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452340|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452341|NCT03414450|Dasatinib|dasatinib|mesh-list
19452342|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256510|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
20535370|NCT01819701|Ubiquinone|ubiquinone|mesh-list
19446790|NCT05108259|Adalimumab|adalimumab|mesh-list
19446791|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446792|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446793|NCT05102071|Metformin|metformin|mesh-list
19446794|NCT05102071|Empagliflozin|empagliflozin|mesh-list
19446795|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446796|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446797|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19446798|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446799|NCT05063734|Aflibercept|aflibercept|mesh-list
19446800|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19446801|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19446802|NCT05063734|Growth Substances|growth substances|mesh-ancestor
19446803|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446804|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19446805|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446806|NCT05062577|Buprenorphine|buprenorphine|mesh-list
19446807|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19446808|NCT05062577|Naloxone|naloxone|mesh-list
19446809|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19446810|NCT05062577|Narcotics|narcotics|mesh-ancestor
19446811|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446812|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446813|NCT05062577|Analgesics|analgesics|mesh-ancestor
19446814|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
19446815|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446816|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19446817|NCT05049226|Vaccines|vaccines|mesh-list
19446818|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
19446819|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446820|NCT05047770|Vaccines|vaccines|mesh-list
19446821|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
19446822|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446823|NCT05045703|Vitamin A|vitamin a|mesh-list
19446824|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
19446825|NCT05045703|Vitamins|vitamins|mesh-ancestor
19446826|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
19446827|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446828|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
19446829|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446830|NCT05045703|Protective Agents|protective agents|mesh-ancestor
19446831|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19446832|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446833|NCT05045378|Midazolam|midazolam|mesh-list
19446834|NCT05045378|Ketamine|ketamine|mesh-list
19446835|NCT05045378|Analgesics|analgesics|mesh-ancestor
19446836|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
19446837|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446838|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446839|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19446840|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19446841|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
19446842|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
19446843|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446844|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19446845|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19446846|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446847|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446848|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19446849|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19446850|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19446851|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19446852|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446853|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
19446854|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
19446855|NCT04998279|Sargramostim|sargramostim|mesh-list
19446856|NCT04998279|Lenograstim|lenograstim|mesh-list
19446857|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
19446858|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446859|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19446860|NCT04984889|Protein C|protein c|mesh-list
19446861|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
19446862|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19446863|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19446864|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446865|NCT04977830|Xenon|xenon|mesh-list
19446866|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19446867|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
19446868|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
19446869|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446870|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446871|NCT04966481|Cetuximab|cetuximab|mesh-list
19446872|NCT04966481|Palbociclib|palbociclib|mesh-list
19446873|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446874|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446875|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19446876|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446877|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446878|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19446879|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19446880|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
19446881|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446882|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446883|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19446884|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
19446885|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
19446886|NCT04946630|Hormones|hormones|mesh-ancestor
19446887|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19446888|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
19446889|NCT04915950|APD791|apd791|mesh-list
19446890|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19446891|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19446892|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
19446893|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446894|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446895|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446896|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
19446897|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446898|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446899|NCT04905121|Psilocybin|psilocybin|mesh-list
19446900|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
19446901|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446902|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446903|NCT04818632|Everolimus|everolimus|mesh-list
19446904|NCT04818632|Palbociclib|palbociclib|mesh-list
19446905|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446906|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19446907|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
19446908|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446909|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19446910|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446911|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446912|NCT04796363|Anesthetics|anesthetics|mesh-list
19446913|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446914|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446915|NCT04768166|Miglustat|miglustat|mesh-list
19446916|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446917|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446918|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19446919|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19446920|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
19446921|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19446922|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19446923|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19446924|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446925|NCT04760041|Midazolam|midazolam|mesh-list
19446926|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19446927|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19446928|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19446929|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446930|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19446931|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19446932|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446933|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19446934|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
19446935|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
20256511|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256512|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256513|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20535371|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
20535372|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
19446936|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
19446937|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
20256514|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19730117|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19730118|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
19730119|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
19730120|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730121|NCT04600999|Favipiravir|favipiravir|mesh-list
19730122|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
19730123|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730124|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
20256515|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20256516|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
20256517|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256518|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256519|NCT00475514|Frovatriptan|frovatriptan|mesh-list
20256520|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20256521|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
19446938|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446939|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446940|NCT04754035|Venetoclax|venetoclax|mesh-list
19446941|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446942|NCT04746235|Decitabine|decitabine|mesh-list
19446943|NCT04746235|Venetoclax|venetoclax|mesh-list
19446944|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19446945|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
19446946|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446947|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446948|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446949|NCT04734080|Dronabinol|dronabinol|mesh-list
19446950|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
19446951|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446952|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19446953|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446954|NCT04734080|Analgesics|analgesics|mesh-ancestor
19446955|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
19446956|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446957|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19446958|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19446959|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19446960|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446961|NCT04734080|Hormones|hormones|mesh-ancestor
19446962|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452343|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19452344|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452345|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452346|NCT03414333|Hormones|hormones|mesh-list
19452347|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452348|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452349|NCT03414164|Procyanidin|procyanidin|mesh-list
19452350|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
19452351|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452352|NCT03414164|Protective Agents|protective agents|mesh-ancestor
19452353|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452354|NCT03414034|Prednisone|prednisone|mesh-list
19452355|NCT03414034|Onvansertib|onvansertib|mesh-list
19452356|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452357|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
19452358|NCT03414034|Hormones|hormones|mesh-ancestor
19452359|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452360|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452361|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19452362|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452363|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19452364|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452365|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452366|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
19452367|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19452368|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19452369|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730125|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19730126|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19730127|NCT04601142|Prednisolone|prednisolone|mesh-list
19730128|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
19730129|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19446963|NCT04684511|Rofecoxib|rofecoxib|mesh-list
19446964|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19446965|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19446966|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446967|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446968|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19446969|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19446970|NCT04684511|Analgesics|analgesics|mesh-ancestor
19446971|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
19446972|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446973|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446974|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19446975|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19446976|NCT04650984|Doxorubicin|doxorubicin|mesh-list
19446977|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19446978|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19446979|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19446980|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19446981|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19446982|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446983|NCT04642404|Cannabidiol|cannabidiol|mesh-list
19446984|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
19446985|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
19446986|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19446987|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
19446988|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446989|NCT04628429|Erenumab|erenumab|mesh-list
19446990|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19446991|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19446992|NCT04628429|Analgesics|analgesics|mesh-ancestor
19446993|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
19446994|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19446995|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19446996|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
19446997|NCT04622007|Pemetrexed|pemetrexed|mesh-list
19446998|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19446999|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447000|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447001|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447002|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19447003|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19447004|NCT04614714|Niacinamide|niacinamide|mesh-list
19447005|NCT04614714|Niacin|niacin|mesh-list
19447006|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
19447007|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
19447008|NCT04614714|Vitamins|vitamins|mesh-ancestor
19447009|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
19447010|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447011|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19447012|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
19447013|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447014|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19447015|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
19447016|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
19447017|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447018|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447019|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
19447020|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19447021|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
19447022|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447023|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
19447024|NCT04557527|Protective Agents|protective agents|mesh-ancestor
19447025|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
19447026|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19447027|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19447028|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447029|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19447030|NCT04527107|Aflibercept|aflibercept|mesh-list
19447031|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19447032|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19447033|NCT04527107|Growth Substances|growth substances|mesh-ancestor
19447034|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447035|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
19447036|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447037|NCT04524871|Bevacizumab|bevacizumab|mesh-list
19447038|NCT04524871|Atezolizumab|atezolizumab|mesh-list
19447039|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447040|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447041|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19447042|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19447043|NCT04524871|Growth Substances|growth substances|mesh-ancestor
19447044|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447045|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
19447046|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
19447047|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19447048|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
19447049|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447050|NCT04477486|Venetoclax|venetoclax|mesh-list
19447051|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447052|NCT04450173|Venetoclax|venetoclax|mesh-list
19447053|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
19447054|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447055|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447056|NCT04430699|Cisplatin|cisplatin|mesh-list
19447057|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
19447058|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447059|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447060|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
19447061|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19447062|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
19447063|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447064|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447065|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19447066|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
19447067|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19447068|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
19447069|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447070|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447071|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19447072|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
19447073|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
19447074|NCT04383002|Protective Agents|protective agents|mesh-ancestor
19447075|NCT04375228|Rituximab|rituximab|mesh-list
19447076|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447077|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447078|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
19447079|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447080|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447081|NCT04370145|Meropenem|meropenem|mesh-list
19447082|NCT04370145|Tinidazole|tinidazole|mesh-list
19447083|NCT04370145|Teicoplanin|teicoplanin|mesh-list
19447084|NCT04370145|Sulperazone|sulperazone|mesh-list
19447085|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19447086|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447087|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
19447088|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447089|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19447090|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19447091|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19447092|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19447093|NCT04370145|Renal Agents|renal agents|mesh-ancestor
19447094|NCT04368429|Vaccines|vaccines|mesh-list
19447095|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
19447096|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447097|NCT04366908|Calcifediol|calcifediol|mesh-list
19447098|NCT04366908|Vitamins|vitamins|mesh-ancestor
19447099|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
19447100|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447101|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19447102|NCT04358003|Coal Tar|coal tar|mesh-list
19447103|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
19447104|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
19447105|NCT04331067|Paclitaxel|paclitaxel|mesh-list
19447106|NCT04331067|Carboplatin|carboplatin|mesh-list
19447107|NCT04331067|Nivolumab|nivolumab|mesh-list
19447108|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20256522|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447109|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447110|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
20256523|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447111|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447112|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447113|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447114|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447115|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19447116|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
19447117|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19447118|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19447119|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447120|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
19447121|NCT04311073|Coagulants|coagulants|mesh-ancestor
19447122|NCT04300790|Metformin|metformin|mesh-list
19447123|NCT04300790|Fulvestrant|fulvestrant|mesh-list
19447124|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19447125|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447126|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447127|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447128|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19447129|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19447130|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
19447131|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447132|NCT04298606|Vaccines|vaccines|mesh-list
19447133|NCT04298606|Mitogens|mitogens|mesh-list
19447134|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
19447135|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447136|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447137|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447138|NCT04283890|Nivolumab|nivolumab|mesh-list
19447139|NCT04283890|Ipilimumab|ipilimumab|mesh-list
19447140|NCT04283890|Melphalan|melphalan|mesh-list
19447141|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447142|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447143|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19447144|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447145|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19447146|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
19447147|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19447148|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447149|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
19447150|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447151|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19447152|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
19447153|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19447154|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19447155|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447156|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447157|NCT04266197|Urological Agents|urological agents|mesh-ancestor
19452370|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
19452371|NCT03413891|Coagulants|coagulants|mesh-ancestor
19452372|NCT03413800|Dexamethasone|dexamethasone|mesh-list
19452373|NCT03413800|Lenalidomide|lenalidomide|mesh-list
19452374|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452375|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
19452376|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
19452377|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452378|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452379|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452380|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
19452381|NCT03413800|Hormones|hormones|mesh-ancestor
19452382|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452383|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19452384|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452385|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
19452386|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19452387|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19452388|NCT03413800|Growth Substances|growth substances|mesh-ancestor
19452389|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
19452390|NCT03413722|Everolimus|everolimus|mesh-list
19452391|NCT03413722|Tacrolimus|tacrolimus|mesh-list
19452392|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19452393|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
19452394|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452395|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19452396|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452397|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730130|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
19452398|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452399|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
19447158|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19447159|NCT04238143|Complement Factor H|complement factor h|mesh-list
19447160|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19447161|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447162|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
19447163|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447164|NCT04221087|Dexamethasone|dexamethasone|mesh-list
19447165|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447166|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
19447167|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
19447168|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447169|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447170|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447171|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
19447172|NCT04221087|Hormones|hormones|mesh-ancestor
19447173|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447174|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447175|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447176|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
19447177|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
19447178|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19447179|NCT04205786|Vitamins|vitamins|mesh-ancestor
19447180|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
19447181|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447182|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
19447183|NCT04205786|Hematinics|hematinics|mesh-ancestor
19447184|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19447185|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447186|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447187|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19447188|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
19447189|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447190|NCT04197713|Olaparib|olaparib|mesh-list
19447191|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19447192|NCT04197713|Adavosertib|adavosertib|mesh-list
19447193|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447194|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447195|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447196|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
19447197|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19447198|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447199|NCT04187144|Renal Agents|renal agents|mesh-ancestor
19447200|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19447201|NCT04179032|Belimumab|belimumab|mesh-list
19447202|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447203|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
19447204|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447205|NCT04169100|Prednisone|prednisone|mesh-list
19447206|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447207|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
19447208|NCT04169100|Hormones|hormones|mesh-ancestor
19447209|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447210|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447211|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447212|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447213|NCT04155840|Rituximab|rituximab|mesh-list
19447214|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19447215|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19447216|NCT04155840|Antibodies|antibodies|mesh-list
19447217|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
19447218|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19447219|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
19447220|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447221|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447222|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447223|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19447224|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
19447225|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447226|NCT04142125|Aspirin|aspirin|mesh-list
19447227|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
19447228|NCT04142125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19447229|NCT04142125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19447230|NCT04142125|Analgesics|analgesics|mesh-ancestor
19447231|NCT04142125|Sensory System Agents|sensory system agents|mesh-ancestor
19447232|NCT04142125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447233|NCT04142125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447234|NCT04142125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447235|NCT04142125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447236|NCT04142125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19447237|NCT04142125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19447238|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447239|NCT04142125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19447240|NCT04142125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19447241|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447242|NCT04142125|Antipyretics|antipyretics|mesh-ancestor
19447243|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19447244|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
19447245|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19447246|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
19447247|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
19447248|NCT04119453|Apatinib|apatinib|mesh-list
19447249|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447250|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19447251|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447252|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447253|NCT04113317|Lenograstim|lenograstim|mesh-list
19730131|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730132|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
19730133|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
19730134|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730135|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730136|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730137|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
19730138|NCT04601142|Hormones|hormones|mesh-ancestor
19730139|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730140|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19730141|NCT04601142|Protective Agents|protective agents|mesh-ancestor
19730142|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20256524|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256525|NCT00475527|Amoxicillin|amoxicillin|mesh-list
20256526|NCT00475527|Metronidazole|metronidazole|mesh-list
20256527|NCT00475527|Clarithromycin|clarithromycin|mesh-list
20256528|NCT00475527|Omeprazole|omeprazole|mesh-list
20256529|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20256530|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256531|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20256532|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19447254|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19730143|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730144|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
19730145|NCT04601259|Salicylates|salicylates|mesh-list
19730146|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730147|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
19730148|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
19730149|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730150|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19730151|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730152|NCT04601259|Analgesics|analgesics|mesh-ancestor
19730153|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
19730154|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730155|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730156|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730157|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730158|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19730159|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730160|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730161|NCT04601389|Omalizumab|omalizumab|mesh-list
19730162|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19730163|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19730164|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19730165|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
19730166|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
19730167|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730168|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
19730169|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19730170|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
19730171|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730172|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730173|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19447255|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
19730174|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256533|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19447256|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447257|NCT04092673|Trastuzumab|trastuzumab|mesh-list
19447258|NCT04092673|Fulvestrant|fulvestrant|mesh-list
19447259|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447260|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447261|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447262|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19447263|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19447264|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
19447265|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447266|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447267|NCT04078152|Durvalumab|durvalumab|mesh-list
19447268|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447269|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447270|NCT04060628|Docetaxel|docetaxel|mesh-list
19447271|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447272|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447273|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447274|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447275|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447276|NCT04044534|Insulin|insulin|mesh-list
19447277|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19447278|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447279|NCT04037072|Mitomycins|mitomycins|mesh-list
19447280|NCT04037072|Mitomycin|mitomycin|mesh-list
19447281|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19447282|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447283|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
19447284|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447285|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19447286|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447287|NCT04033237|Nicotine|nicotine|mesh-list
19447288|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19447289|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
19447290|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447291|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447292|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19447293|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19447294|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
19447295|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447296|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447297|NCT04019873|Lamivudine|lamivudine|mesh-list
19730175|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19730176|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
19730177|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730178|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730179|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19730180|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
19730181|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
19730182|NCT04601077|Protective Agents|protective agents|mesh-ancestor
19730183|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19730184|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19730185|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730186|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19730187|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730188|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730189|NCT04601116|Atorvastatin|atorvastatin|mesh-list
19730190|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19730191|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19730192|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
19730193|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730194|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19730195|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19730196|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730197|NCT04600648|Insulin|insulin|mesh-list
19730198|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19730199|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730200|NCT04600167|Isoniazid|isoniazid|mesh-list
19730201|NCT04600167|Rifapentine|rifapentine|mesh-list
19730202|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
19730203|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19870488|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447298|NCT04019873|Rilpivirine|rilpivirine|mesh-list
19447299|NCT04019873|Dolutegravir|dolutegravir|mesh-list
19447300|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19447301|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19447302|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447303|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447304|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
19447305|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447306|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19447307|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19447308|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19447309|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19447310|NCT03961256|Exenatide|exenatide|mesh-list
19447311|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19447312|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447313|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19447314|NCT03961256|Incretins|incretins|mesh-ancestor
19447315|NCT03961256|Hormones|hormones|mesh-ancestor
19447316|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447317|NCT03819088|Zinc|zinc|mesh-list
19447318|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
19447319|NCT03819088|Trace Elements|trace elements|mesh-ancestor
19447320|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
19447321|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447322|NCT03819088|Astringents|astringents|mesh-ancestor
19447323|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
19447324|NCT03802604|Atezolizumab|atezolizumab|mesh-list
19447325|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19447326|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447327|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447328|NCT03791398|Nivolumab|nivolumab|mesh-list
19447329|NCT03791398|TIC10 compound|tic10 compound|mesh-list
19447330|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447331|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447332|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19447333|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447334|NCT03786081|Bevacizumab|bevacizumab|mesh-list
19447335|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
19447336|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
19447337|NCT03786081|Carboplatin|carboplatin|mesh-list
19447338|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447339|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447340|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19447341|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19447342|NCT03786081|Growth Substances|growth substances|mesh-ancestor
19447343|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447344|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
19447345|NCT03756311|Paclitaxel|paclitaxel|mesh-list
19447346|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19447347|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19447348|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447349|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447350|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447351|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447352|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447353|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20256534|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20256535|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20256536|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256537|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447354|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19447355|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447356|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
19447357|NCT03721068|Fludarabine|fludarabine|mesh-list
19447358|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447359|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
19447360|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447361|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447362|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19447363|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
19447364|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447365|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447366|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19447367|NCT03707028|Paclitaxel|paclitaxel|mesh-list
19447368|NCT03707028|Apatinib|apatinib|mesh-list
19447369|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19447370|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447371|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447372|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447373|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447374|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447375|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19447376|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447377|NCT03634228|Cytarabine|cytarabine|mesh-list
19447378|NCT03634228|Venetoclax|venetoclax|mesh-list
19447379|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19447380|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
19447381|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447382|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447383|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
19447384|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447385|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447386|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
19447387|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447388|NCT03620669|Durvalumab|durvalumab|mesh-list
19447389|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447390|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447391|NCT03604978|Nivolumab|nivolumab|mesh-list
19447392|NCT03604978|Ipilimumab|ipilimumab|mesh-list
19447393|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447394|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447395|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19447396|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447397|NCT03593213|Cariprazine|cariprazine|mesh-list
19447398|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19447399|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19447400|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19447401|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447402|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19447403|NCT03557619|Venetoclax|venetoclax|mesh-list
19447404|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
19447405|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19447406|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19447407|NCT03557619|Estradiol|estradiol|mesh-list
19447408|NCT03557619|Estrogens|estrogens|mesh-ancestor
19447409|NCT03557619|Hormones|hormones|mesh-ancestor
19447410|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447411|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447412|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19447413|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
19447414|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19447415|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19447416|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447417|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19447418|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19447419|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19447420|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19447421|NCT03507452|BAY 2287411|bay 2287411|mesh-list
19447422|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19447423|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447424|NCT03499704|Metformin|metformin|mesh-list
19447425|NCT03499704|Pioglitazone|pioglitazone|mesh-list
20256538|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19447426|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
19447427|NCT03499704|Alogliptin|alogliptin|mesh-list
19447428|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19447429|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447430|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19447431|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447432|NCT03499704|Incretins|incretins|mesh-ancestor
19447433|NCT03499704|Hormones|hormones|mesh-ancestor
19447434|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447435|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19447436|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
19447437|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447438|NCT03443869|Valganciclovir|valganciclovir|mesh-list
19447439|NCT03443869|Acyclovir|acyclovir|mesh-list
19447440|NCT03443869|Letermovir|letermovir|mesh-list
19447441|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
19447442|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447443|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19447444|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447445|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447446|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447447|NCT03406247|Nivolumab|nivolumab|mesh-list
19447448|NCT03406247|Ipilimumab|ipilimumab|mesh-list
19447449|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447450|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447451|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19447452|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447453|NCT03399539|Dexamethasone|dexamethasone|mesh-list
19447454|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
19447455|NCT03399539|Venetoclax|venetoclax|mesh-list
19447456|NCT03399539|Ixazomib|ixazomib|mesh-list
19447457|NCT03399539|Ichthammol|ichthammol|mesh-list
19447458|NCT03399539|BB 1101|bb 1101|mesh-list
19447459|NCT03399539|Glycine|glycine|mesh-list
19447460|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447461|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
19447462|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
19447463|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447464|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447465|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447466|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
19447467|NCT03399539|Hormones|hormones|mesh-ancestor
19447468|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447469|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447470|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447471|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447472|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
19447473|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447474|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
19447475|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
19447476|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447477|NCT03298061|Prednisolone|prednisolone|mesh-list
19447478|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447479|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
19447480|NCT03298061|Hormones|hormones|mesh-ancestor
19447481|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447482|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447483|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447484|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452400|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19452401|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452839|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
19452840|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452841|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452842|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19452843|NCT03409679|Murepavadin|murepavadin|mesh-list
19452844|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452845|NCT03409588|Riociguat|riociguat|mesh-list
19452846|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
19452847|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452848|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19452849|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19452850|NCT03409432|Lenalidomide|lenalidomide|mesh-list
19452851|NCT03409432|Antibodies|antibodies|mesh-list
19452852|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
19452853|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19452854|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
19452855|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
19452856|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452857|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452858|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19452859|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19452860|NCT03409432|Growth Substances|growth substances|mesh-ancestor
19452861|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
19452862|NCT03409367|Emollients|emollients|mesh-list
19452863|NCT03409367|Petrolatum|petrolatum|mesh-list
19452864|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
19452865|NCT03409250|Ranibizumab|ranibizumab|mesh-list
19452866|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19452867|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19452868|NCT03409250|Growth Substances|growth substances|mesh-ancestor
19452869|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452870|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
19452871|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452872|NCT03409237|Mannitol|mannitol|mesh-list
19452873|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19452874|NCT03409237|Diuretics|diuretics|mesh-ancestor
19452875|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
19870489|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870490|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870491|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
19870492|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870493|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870494|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19870495|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
19870496|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19870497|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19870498|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19870499|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19870500|NCT00856492|Growth Substances|growth substances|mesh-ancestor
19870501|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
19870502|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19870503|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19870504|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19870505|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870506|NCT00856544|Tofacitinib|tofacitinib|mesh-list
19870507|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870508|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870509|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870510|NCT00856583|Risperidone|risperidone|mesh-list
19870511|NCT00856583|Sertindole|sertindole|mesh-list
19870512|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19870513|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
19870514|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870515|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870516|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870517|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19447485|NCT03280563|Tamoxifen|tamoxifen|mesh-list
19447486|NCT03280563|Bevacizumab|bevacizumab|mesh-list
19447487|NCT03280563|Atezolizumab|atezolizumab|mesh-list
19447488|NCT03280563|Fulvestrant|fulvestrant|mesh-list
19447489|NCT03280563|Exemestane|exemestane|mesh-list
19447490|NCT03280563|Entinostat|entinostat|mesh-list
19447491|NCT03280563|Antibodies|antibodies|mesh-list
19447492|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447493|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447494|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19447495|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19447496|NCT03280563|Growth Substances|growth substances|mesh-ancestor
19447497|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447498|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
19447499|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
19447500|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19447501|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
19447502|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447503|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447504|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19447505|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19447506|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19447507|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19447508|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19447509|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19447510|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447511|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447512|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19447513|NCT03248531|Adalimumab|adalimumab|mesh-list
19447514|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447515|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447516|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19447517|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19447518|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730204|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730205|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19730206|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19730207|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
19730208|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730209|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19730210|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19730211|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
19730212|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19730213|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
19447519|NCT03245918|Aprepitant|aprepitant|mesh-list
19447520|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
19447521|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
19447522|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
19447523|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447524|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447525|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447526|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19447527|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447528|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447529|NCT03215511|Selitrectinib|selitrectinib|mesh-list
19447530|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447531|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447532|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
19447533|NCT03205605|Oxybutynin|oxybutynin|mesh-list
19447534|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
19447535|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
19447536|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447537|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447538|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19447539|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19447540|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
19447541|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447542|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447543|NCT03205605|Urological Agents|urological agents|mesh-ancestor
19447544|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19447545|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447546|NCT03205605|Renal Agents|renal agents|mesh-ancestor
19447547|NCT03193866|Interferons|interferons|mesh-list
19447548|NCT03193866|Interferon-beta|interferon-beta|mesh-list
19447549|NCT03193866|Rituximab|rituximab|mesh-list
19447550|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
19447551|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
19447552|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20535373|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535374|NCT01819701|Vitamins|vitamins|mesh-ancestor
20553614|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553615|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
20553616|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553617|NCT01930552|Leucovorin|leucovorin|mesh-list
20553618|NCT01930552|Fluorouracil|fluorouracil|mesh-list
20553619|NCT01930552|Irinotecan|irinotecan|mesh-list
20553620|NCT01930552|Aflibercept|aflibercept|mesh-list
20553621|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
20553622|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447553|NCT03193866|Natalizumab|natalizumab|mesh-list
20256539|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20256540|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256541|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20256542|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20256543|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20256544|NCT00475553|Etonogestrel|etonogestrel|mesh-list
20256545|NCT00475553|Desogestrel|desogestrel|mesh-list
19447554|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19447555|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
19447556|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447557|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447558|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
19447559|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447560|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447561|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
19447562|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447563|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19447564|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447565|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447566|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19447567|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
19447568|NCT03128619|Letrozole|letrozole|mesh-list
19447569|NCT03128619|Palbociclib|palbociclib|mesh-list
19447570|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256546|NCT00475553|NuvaRing|nuvaring|mesh-list
20256547|NCT00475553|Estradiol|estradiol|mesh-list
19447571|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19447572|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19447573|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452402|NCT03413436|Cisplatin|cisplatin|mesh-list
20256548|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20553623|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19447574|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447575|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19447576|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
19447577|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447578|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447579|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19447580|NCT03119584|Linaclotide|linaclotide|mesh-list
19447581|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19447582|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
19447583|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447584|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447585|NCT03118986|Olanzapine|olanzapine|mesh-list
19447586|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
19447587|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
19447588|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447589|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447590|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447591|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19447592|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19447593|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19447594|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19447595|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19447596|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19447597|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19447598|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447599|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447600|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
19447601|NCT03047330|Leuprolide|leuprolide|mesh-list
19447602|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19447603|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
19447604|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19447605|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447606|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447607|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447608|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
19447609|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
19447610|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447611|NCT03019588|Paclitaxel|paclitaxel|mesh-list
19447612|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
19447613|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19447614|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447615|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447616|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447617|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447618|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447619|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19447620|NCT02951377|Dexamethasone|dexamethasone|mesh-list
19447621|NCT02951377|Lidocaine|lidocaine|mesh-list
19447622|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447623|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
19447624|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
19447625|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447626|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447627|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447628|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
19447629|NCT02951377|Hormones|hormones|mesh-ancestor
19447630|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447631|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447632|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447633|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
19447634|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
19447635|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19447636|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
19447637|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19447638|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19447639|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19447640|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19447641|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447642|NCT02844907|Dexamethasone|dexamethasone|mesh-list
19447643|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447644|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
19447645|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
19447646|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447647|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447648|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447649|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
19447650|NCT02844907|Hormones|hormones|mesh-ancestor
19447651|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447652|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447653|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447654|NCT02811523|Doxorubicin|doxorubicin|mesh-list
19447655|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19447656|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447657|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19447658|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19447659|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447660|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447661|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19447662|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19447663|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447664|NCT02717455|Panobinostat|panobinostat|mesh-list
19447665|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447666|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19447667|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447668|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447669|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
19447670|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
19447671|NCT02700451|Acetaminophen|acetaminophen|mesh-list
19447672|NCT02700451|Ketorolac|ketorolac|mesh-list
19447673|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19447674|NCT02700451|Analgesics|analgesics|mesh-ancestor
19447675|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
19447676|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447677|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447678|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
19447679|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19447680|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447681|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447682|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19447683|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447684|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447685|NCT02525692|TIC10 compound|tic10 compound|mesh-list
19447686|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447687|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
19447688|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19447689|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447690|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447691|NCT02496208|Nivolumab|nivolumab|mesh-list
19447692|NCT02496208|Ipilimumab|ipilimumab|mesh-list
19447693|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20535375|NCT01819779|Amlodipine|amlodipine|mesh-list
20535376|NCT01819779|Valsartan|valsartan|mesh-list
20535377|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
20535378|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535379|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535380|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535381|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535382|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19447694|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447695|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19447696|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447697|NCT02481830|Nivolumab|nivolumab|mesh-list
19447698|NCT02481830|Topotecan|topotecan|mesh-list
19447699|NCT02481830|Amrubicin|amrubicin|mesh-list
19447700|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256549|NCT00475553|Estrogens|estrogens|mesh-ancestor
19447701|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256550|NCT00475553|Hormones|hormones|mesh-ancestor
20256551|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20256552|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256553|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20256554|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
20256555|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20256556|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20256557|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19447702|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19447703|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447704|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19447705|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19447706|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447707|NCT02366494|Docetaxel|docetaxel|mesh-list
19447708|NCT02366494|Leuprolide|leuprolide|mesh-list
19447709|NCT02366494|Goserelin|goserelin|mesh-list
19447710|NCT02366494|Bicalutamide|bicalutamide|mesh-list
19447711|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19447712|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447713|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447714|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447715|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447716|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447717|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19447718|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
19447719|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19447720|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447721|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447722|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
19447723|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
19447724|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447725|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
19447726|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19447727|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
19447728|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19447729|NCT02312245|Gemcitabine|gemcitabine|mesh-list
19447730|NCT02312245|Paclitaxel|paclitaxel|mesh-list
19447731|NCT02312245|Bevacizumab|bevacizumab|mesh-list
19447732|NCT02312245|Doxorubicin|doxorubicin|mesh-list
19447733|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19447734|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19447735|NCT02312245|Topotecan|topotecan|mesh-list
19447736|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19447737|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
19447738|NCT02312245|Antibodies|antibodies|mesh-list
19447739|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
19447740|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19447741|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
19447742|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19447743|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447744|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447745|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447746|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447747|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447748|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19447749|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19447750|NCT02312245|Growth Substances|growth substances|mesh-ancestor
19447751|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447752|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
19447753|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
19447754|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19447755|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
19447756|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
19447757|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19447758|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447759|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447760|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19447761|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19447762|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19447763|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19447764|NCT02262923|Metoclopramide|metoclopramide|mesh-list
19447765|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
19447766|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
19447767|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447768|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447769|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19447770|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19447771|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19447772|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
19447773|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447774|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447775|NCT02234323|Factor VIII|factor viii|mesh-list
19447776|NCT02234323|Coagulants|coagulants|mesh-ancestor
19447777|NCT02206984|Tamoxifen|tamoxifen|mesh-list
19447778|NCT02206984|Fulvestrant|fulvestrant|mesh-list
19447779|NCT02206984|Anastrozole|anastrozole|mesh-list
19447780|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19447781|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
19447782|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447783|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447784|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19447785|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447786|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19447787|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19447788|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19447789|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19447790|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19447791|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19447792|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447793|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256558|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20256559|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19447794|NCT02194595|Insulin|insulin|mesh-list
19447795|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19447796|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
19447797|NCT02194595|Exenatide|exenatide|mesh-list
19447798|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
19447799|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19447800|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447801|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19447802|NCT02194595|Incretins|incretins|mesh-ancestor
19447803|NCT02194595|Hormones|hormones|mesh-ancestor
19447804|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19447805|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
19447806|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19447807|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19447808|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
19447809|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447810|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447811|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
19447812|NCT02168140|Protective Agents|protective agents|mesh-ancestor
19447813|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447814|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
19447815|NCT02168140|Vitamins|vitamins|mesh-ancestor
19447816|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
19447817|NCT02099188|Leucovorin|leucovorin|mesh-list
19447818|NCT02099188|Docetaxel|docetaxel|mesh-list
19447819|NCT02099188|Fluorouracil|fluorouracil|mesh-list
19447820|NCT02099188|Etoposide|etoposide|mesh-list
19447821|NCT02099188|Doxorubicin|doxorubicin|mesh-list
19447822|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19447823|NCT02099188|Ifosfamide|ifosfamide|mesh-list
19447824|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447825|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447826|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447827|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447828|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447829|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
19447830|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19447831|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447832|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
19447833|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447834|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19447835|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19447836|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19447837|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447838|NCT02099188|Antidotes|antidotes|mesh-ancestor
19447839|NCT02099188|Protective Agents|protective agents|mesh-ancestor
19447840|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
19447841|NCT02099188|Vitamins|vitamins|mesh-ancestor
19447842|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
19447843|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19447844|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19447845|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
19447846|NCT02099175|Leucovorin|leucovorin|mesh-list
19447847|NCT02099175|Docetaxel|docetaxel|mesh-list
19447848|NCT02099175|Fluorouracil|fluorouracil|mesh-list
19447849|NCT02099175|Etoposide|etoposide|mesh-list
19447850|NCT02099175|Doxorubicin|doxorubicin|mesh-list
19447851|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19447852|NCT02099175|Ifosfamide|ifosfamide|mesh-list
19447853|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447854|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
19447855|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
19447856|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
19447857|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447858|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
19447859|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19447860|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447861|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
19447862|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447863|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19447864|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19447865|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19447866|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447867|NCT02099175|Antidotes|antidotes|mesh-ancestor
19447868|NCT02099175|Protective Agents|protective agents|mesh-ancestor
19447869|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
19447870|NCT02099175|Vitamins|vitamins|mesh-ancestor
19447871|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
19447872|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19447873|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19447874|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
19447875|NCT02087826|Metformin|metformin|mesh-list
19447876|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19447877|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447878|NCT02015117|Trametinib|trametinib|mesh-list
19447879|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447880|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19447881|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447882|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452403|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452404|NCT03413410|Metoprolol|metoprolol|mesh-list
19452405|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452406|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19452407|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
19452408|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
19452409|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452410|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452411|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19452412|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19730214|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730215|NCT04600427|Anesthetics|anesthetics|mesh-list
19730216|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730217|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730218|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19730219|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19730220|NCT04600271|Norepinephrine|norepinephrine|mesh-list
19730221|NCT04600271|Analgesics|analgesics|mesh-list
19730222|NCT04600271|Diuretics|diuretics|mesh-list
19730223|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
19730224|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730225|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730226|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
19730227|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19730228|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19730229|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
19730230|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730231|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730232|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
19730233|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
19730234|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19730235|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730236|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730237|NCT04600089|Ketamine|ketamine|mesh-list
19730238|NCT04600089|Analgesics|analgesics|mesh-ancestor
19730239|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
19730240|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730241|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730242|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19730243|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19730244|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
19730245|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
19730246|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730247|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19452413|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19730248|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19730249|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447883|NCT01451736|Risperidone|risperidone|mesh-list
19447884|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19447885|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19447886|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
19447887|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447888|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447889|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447890|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19447891|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19447892|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19447893|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19447894|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19447895|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
19447896|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19447897|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19447898|NCT01333046|Azacitidine|azacitidine|mesh-list
19447899|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19447900|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
19447901|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447902|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447903|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447904|NCT01166633|Atorvastatin|atorvastatin|mesh-list
19447905|NCT01166633|Pitavastatin|pitavastatin|mesh-list
19447906|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19447907|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19447908|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
19447909|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447910|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19447911|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19447912|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447913|NCT01030575|Inositol|inositol|mesh-list
19447914|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
19447915|NCT01030575|Vitamins|vitamins|mesh-ancestor
19447916|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
19447917|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447918|NCT00872950|Amifampridine|amifampridine|mesh-list
19447919|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19447920|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447921|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447922|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19447923|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19447924|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447925|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
19447926|NCT00740805|Doxorubicin|doxorubicin|mesh-list
19447927|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19447928|NCT00740805|Veliparib|veliparib|mesh-list
19447929|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19447930|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
19447931|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447932|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447933|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19447934|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
19447935|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447936|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19447937|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19447938|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19447939|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19447940|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19447941|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447942|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19447943|NCT00493896|Enoxaparin|enoxaparin|mesh-list
19447944|NCT00493896|PENTA|penta|mesh-list
19447945|NCT00493896|Fondaparinux|fondaparinux|mesh-list
19447946|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
19447947|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19447948|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19447949|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447950|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19447951|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
19447952|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19447953|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
19447954|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730250|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447955|NCT00089791|Denosumab|denosumab|mesh-list
19447956|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19447957|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447958|NCT03450499|Ketamine|ketamine|mesh-list
19447959|NCT03450499|Analgesics|analgesics|mesh-ancestor
19447960|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
19447961|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447962|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447963|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19447964|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19447965|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
19447966|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
19447967|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19447968|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19447969|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19447970|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447971|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447972|NCT03450434|Histamine|histamine|mesh-list
19447973|NCT03450434|Glutarimide|glutarimide|mesh-list
19447974|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
19447975|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
19447976|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19447977|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447978|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447979|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19447980|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447981|NCT03450317|Aspirin|aspirin|mesh-list
19447982|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19447983|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19447984|NCT03450317|Analgesics|analgesics|mesh-ancestor
19447985|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
19447986|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19447987|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19447988|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19447989|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19447990|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19447991|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19447992|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19447993|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19447994|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19447995|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19447996|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
19447997|NCT03450226|Bupivacaine|bupivacaine|mesh-list
19447998|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
19447999|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
19448000|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448001|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448002|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
19448003|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448004|NCT03450161|Fentanyl|fentanyl|mesh-list
19448005|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19448006|NCT03450161|Narcotics|narcotics|mesh-ancestor
19448007|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448008|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448009|NCT03450161|Analgesics|analgesics|mesh-ancestor
19448010|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
19448011|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448012|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19448013|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19448014|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
19448015|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
19448016|NCT03450109|Goserelin|goserelin|mesh-list
19448017|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448018|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448019|NCT03450057|Daratumumab|daratumumab|mesh-list
19448020|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448021|NCT03450018|Gemcitabine|gemcitabine|mesh-list
19448022|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19448023|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
19448024|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448025|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448026|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
19448027|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448028|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448029|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19448030|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
19448031|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448032|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19448033|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
19448034|NCT03449940|Diclofenac|diclofenac|mesh-list
19448035|NCT03449940|Lidocaine|lidocaine|mesh-list
19448036|NCT03449940|Analgesics|analgesics|mesh-list
19448037|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448038|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
19448039|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448040|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448041|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
19448042|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448043|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19448044|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19448045|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19448046|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19448047|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448048|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448049|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19448050|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19448051|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448052|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19448053|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19448054|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448055|NCT03449836|Fluticasone|fluticasone|mesh-list
19448056|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
19448057|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448058|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19448059|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
19448060|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448061|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448062|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19448063|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448064|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
19448065|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19448066|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
19448067|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19448068|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19448069|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19448070|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448071|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
19448072|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448073|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19448074|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448075|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448076|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
19448077|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448078|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448079|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19448080|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
19448081|NCT03449693|Antacids|antacids|mesh-ancestor
19448082|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448083|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448084|NCT03449654|Liraglutide|liraglutide|mesh-list
19448085|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19448086|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448087|NCT03449654|Incretins|incretins|mesh-ancestor
19448088|NCT03449654|Hormones|hormones|mesh-ancestor
19448089|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448090|NCT03449537|Caseins|caseins|mesh-list
19448091|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
19448092|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
19448093|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448094|NCT03449524|CXA-10|cxa-10|mesh-list
19448095|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448096|NCT03449459|Amikacin|amikacin|mesh-list
19448097|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19448098|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448099|NCT03449251|Verapamil|verapamil|mesh-list
19448100|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
19448101|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19448102|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19448103|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19448104|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448105|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19448106|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448107|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
19448108|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448109|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
19448110|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448111|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448112|NCT03449173|Sunitinib|sunitinib|mesh-list
19448113|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448114|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19448115|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19448116|NCT03449173|Growth Substances|growth substances|mesh-ancestor
19448117|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448118|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
19448119|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19448120|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448121|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448122|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19448123|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
19448124|NCT03449082|Coagulants|coagulants|mesh-ancestor
19448125|NCT03449056|Albuterol|albuterol|mesh-list
19448126|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19448127|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
19448128|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448129|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448130|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19448131|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448132|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
19448133|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19448134|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19448135|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19448136|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19448137|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
19448138|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448139|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452414|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
19452415|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452416|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452417|NCT03413371|Acetaminophen|acetaminophen|mesh-list
19452418|NCT03413371|Lidocaine|lidocaine|mesh-list
19452419|NCT03413371|Bupivacaine|bupivacaine|mesh-list
19452420|NCT03413371|Ropivacaine|ropivacaine|mesh-list
19452421|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
19452422|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
19452423|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452424|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452425|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
19452426|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452427|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452428|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19452429|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19452430|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452431|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452432|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452433|NCT03413371|Analgesics|analgesics|mesh-ancestor
19452434|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
19452435|NCT03413358|Carboplatin|carboplatin|mesh-list
19452436|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452437|NCT03413319|Tilavonemab|tilavonemab|mesh-list
19452438|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
20256560|NCT00475553|Progestins|progestins|mesh-ancestor
20256561|NCT00475566|Everolimus|everolimus|mesh-list
20256562|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256563|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256564|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
19452444|NCT03413150|Amiodarone|amiodarone|mesh-list
19452445|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452446|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
19452447|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19452448|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452449|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452450|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19452451|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19452452|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19452453|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452927|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
19448140|NCT03448835|Docetaxel|docetaxel|mesh-list
19448141|NCT03448835|Capecitabine|capecitabine|mesh-list
19448142|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
19448143|NCT03448835|Atezolizumab|atezolizumab|mesh-list
19448144|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448145|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
19448146|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
19448147|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
19448148|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448149|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19448150|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
19448151|NCT03448770|Lactulose|lactulose|mesh-list
19448152|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448153|NCT03448744|Entecavir|entecavir|mesh-list
19448154|NCT03448744|Thymalfasin|thymalfasin|mesh-list
19448155|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
19448156|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448157|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19448158|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
19448159|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448160|NCT03448731|Doxycycline|doxycycline|mesh-list
19448161|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19448162|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448163|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
19448164|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19448165|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19448166|NCT03448705|Vaccines|vaccines|mesh-list
19448167|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
19448168|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448169|NCT03448640|Tropicamide|tropicamide|mesh-list
19448170|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
19448171|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
19448172|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448173|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448174|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19448175|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19448176|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
19448177|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448178|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448179|NCT03448588|Selenium|selenium|mesh-list
19448180|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
19448181|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448182|NCT03448588|Protective Agents|protective agents|mesh-ancestor
19448183|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448184|NCT03448588|Trace Elements|trace elements|mesh-ancestor
19448185|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
19448186|NCT03448549|Capecitabine|capecitabine|mesh-list
19448187|NCT03448549|Tegafur|tegafur|mesh-list
19448188|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
19730251|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
19730252|NCT04600414|Narcotics|narcotics|mesh-ancestor
19730253|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870518|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20256565|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448189|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19730254|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730255|NCT04600414|Analgesics|analgesics|mesh-ancestor
19730256|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
19730257|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730258|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
19730259|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730260|NCT04600115|Adenosine|adenosine|mesh-list
19730261|NCT04600115|Regadenoson|regadenoson|mesh-list
19730262|NCT04600115|Analgesics|analgesics|mesh-ancestor
19730263|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
19730264|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730265|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730266|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19730267|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
19730268|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19730269|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
19730270|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
19730271|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730272|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448190|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
19448191|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448192|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448193|NCT03448107|Fluorides|fluorides|mesh-list
19448194|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
19448195|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
19448196|NCT03448107|Protective Agents|protective agents|mesh-ancestor
19448197|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448198|NCT03448094|Resveratrol|resveratrol|mesh-list
19448199|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
19448200|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448201|NCT03448094|Protective Agents|protective agents|mesh-ancestor
19448202|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448203|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448204|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19448205|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
19448206|NCT03447925|Salicylates|salicylates|mesh-list
19448207|NCT03447925|Petrolatum|petrolatum|mesh-list
19448208|NCT03447925|Emollients|emollients|mesh-ancestor
19448209|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
19448210|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19448211|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19448212|NCT03447925|Analgesics|analgesics|mesh-ancestor
19448213|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
19448214|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448215|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448216|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448217|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19448218|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19448219|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448220|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448221|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448222|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
19448223|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
19448224|NCT03447873|Lamivudine|lamivudine|mesh-list
19448225|NCT03447873|Cobicistat|cobicistat|mesh-list
19448226|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19448227|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19448228|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448229|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448230|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
19448231|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448232|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19448233|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19448234|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19448235|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19448236|NCT03447691|Remifentanil|remifentanil|mesh-list
19448237|NCT03447691|Anesthetics|anesthetics|mesh-list
19448238|NCT03447691|Propofol|propofol|mesh-list
19448239|NCT03447691|Desflurane|desflurane|mesh-list
19448240|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448241|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448242|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19448243|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19448244|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
19448245|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19448246|NCT03447691|Narcotics|narcotics|mesh-ancestor
19448247|NCT03447691|Analgesics|analgesics|mesh-ancestor
19448248|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
19448249|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448250|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19448251|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
19448252|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448253|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448254|NCT03447470|Nivolumab|nivolumab|mesh-list
19448255|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448256|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448257|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19448258|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452454|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19452455|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19452456|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19452457|NCT03413059|Triamcinolone|triamcinolone|mesh-list
19452458|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19452459|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19452460|NCT03413059|Morphine|morphine|mesh-list
19452461|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19452462|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19452463|NCT03413059|Narcotics|narcotics|mesh-ancestor
19452464|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448259|NCT03447184|Androgens|androgens|mesh-list
19448260|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19448261|NCT03447184|Hormones|hormones|mesh-ancestor
19448262|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448263|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448264|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19448265|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448266|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448267|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19448268|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
19448269|NCT03447132|Fulvestrant|fulvestrant|mesh-list
19448270|NCT03447132|Goserelin|goserelin|mesh-list
19448271|NCT03447132|Palbociclib|palbociclib|mesh-list
19448272|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448273|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448274|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19448275|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19448276|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
19448277|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448278|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448279|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19448280|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448281|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448282|NCT03447093|Methimazole|methimazole|mesh-list
19448283|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
19448284|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
19448285|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19448286|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448287|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448288|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
19448289|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448290|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19448291|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
19448292|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256566|NCT00475618|Fluorides|fluorides|mesh-list
20256567|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
19448293|NCT03446937|Dexamethasone|dexamethasone|mesh-list
20256568|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
20535383|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535384|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
19448294|NCT03446937|Betamethasone|betamethasone|mesh-list
19448295|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
19448296|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19448297|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
19448298|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
19448299|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19448300|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19448301|NCT03446937|BB 1101|bb 1101|mesh-list
19448302|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448303|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
19448304|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
19448305|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448306|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448307|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448308|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
19448309|NCT03446937|Hormones|hormones|mesh-ancestor
19448310|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448311|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448312|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448313|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19448314|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448315|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
19448316|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448317|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448318|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
19448319|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448320|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448321|NCT03446872|Leucovorin|leucovorin|mesh-list
19448322|NCT03446872|Fluorouracil|fluorouracil|mesh-list
19448323|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
19448324|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448325|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19448326|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448327|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19448328|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
19448329|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448330|NCT03446872|Antidotes|antidotes|mesh-ancestor
19448331|NCT03446872|Protective Agents|protective agents|mesh-ancestor
19448332|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
19448333|NCT03446872|Vitamins|vitamins|mesh-ancestor
19448334|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
19448335|NCT03446638|Cytarabine|cytarabine|mesh-list
19448336|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19448337|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
19448338|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448339|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448340|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
19448341|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448342|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19448343|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
19448344|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448345|NCT03446625|Resveratrol|resveratrol|mesh-list
19448346|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
19448347|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448348|NCT03446625|Protective Agents|protective agents|mesh-ancestor
19448349|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448350|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448351|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19448352|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
19448353|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
19448354|NCT03446599|Methylene Blue|methylene blue|mesh-list
19448355|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448356|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448357|NCT03446599|Hematinics|hematinics|mesh-ancestor
19448358|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
19448359|NCT03446599|Vitamins|vitamins|mesh-ancestor
19448360|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
19448361|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448362|NCT03446547|Durvalumab|durvalumab|mesh-list
19448363|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448364|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448365|NCT03446534|Amoxicillin|amoxicillin|mesh-list
19448366|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19448367|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448368|NCT03446495|Trabectedin|trabectedin|mesh-list
19448369|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19448370|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
19448371|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448372|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448373|NCT03446443|Metronidazole|metronidazole|mesh-list
19448374|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448375|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19448376|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19448377|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19448378|NCT03446001|Methylene Blue|methylene blue|mesh-list
19448379|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448380|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448381|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19448382|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19448383|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448384|NCT03445897|Miltefosine|miltefosine|mesh-list
19448385|NCT03445897|Pentamidine|pentamidine|mesh-list
19448386|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
19448387|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448388|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730273|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19735424|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19735425|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19735426|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
19735427|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19735428|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20256569|NCT00475618|Protective Agents|protective agents|mesh-ancestor
19448389|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19448390|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19448391|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19448392|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19448393|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448394|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
19448395|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448396|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
19448397|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448398|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448399|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
19448400|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448401|NCT03445702|Metformin|metformin|mesh-list
19448402|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19448403|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448404|NCT03445624|Infliximab|infliximab|mesh-list
19448405|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
19448406|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448407|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19448408|NCT03445611|Lidocaine|lidocaine|mesh-list
19448409|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19448410|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448411|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
19448412|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448413|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448414|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
19448415|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448416|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19448417|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19448418|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19448419|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19448420|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452465|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452466|NCT03413059|Analgesics|analgesics|mesh-ancestor
19452467|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
19452468|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452469|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452470|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
19452471|NCT03413059|Hormones|hormones|mesh-ancestor
19452472|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452473|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19452474|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
19452475|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452476|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452477|NCT03413020|Amoxicillin|amoxicillin|mesh-list
19452478|NCT03413020|Metronidazole|metronidazole|mesh-list
19452479|NCT03413020|Clarithromycin|clarithromycin|mesh-list
19452480|NCT03413020|Levofloxacin|levofloxacin|mesh-list
19452481|NCT03413020|Ofloxacin|ofloxacin|mesh-list
19452482|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
19452483|NCT03413020|Esomeprazole|esomeprazole|mesh-list
19452484|NCT03413020|Bismuth|bismuth|mesh-list
19452485|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452486|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19452487|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452488|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19452489|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19452490|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19452491|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452492|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19452493|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452494|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19452495|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19452496|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19452497|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19452498|NCT03413020|Renal Agents|renal agents|mesh-ancestor
19452499|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19452500|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19452501|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452502|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19730274|NCT04600492|Riociguat|riociguat|mesh-list
19730275|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
19730276|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730277|NCT04600037|Pregabalin|pregabalin|mesh-list
19730278|NCT04600037|Analgesics|analgesics|mesh-ancestor
19730279|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
19730280|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730281|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553624|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452503|NCT03413020|Antacids|antacids|mesh-ancestor
19452504|NCT03413020|Diuretics|diuretics|mesh-ancestor
19730282|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
19448421|NCT03445533|Ipilimumab|ipilimumab|mesh-list
19448422|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448423|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448424|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19448425|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448426|NCT03445468|Vaccines|vaccines|mesh-list
19448427|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
19448428|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448429|NCT03445286|Fluorides|fluorides|mesh-list
19448430|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
19448431|NCT03445286|Protective Agents|protective agents|mesh-ancestor
19448432|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448433|NCT03445182|Anesthetics|anesthetics|mesh-list
19448434|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448435|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448436|NCT03445104|Huperzine A|huperzine a|mesh-list
19448437|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19448438|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448439|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448440|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
19448441|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448442|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448443|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19448444|NCT03445104|Protective Agents|protective agents|mesh-ancestor
19448445|NCT03445078|Selenium|selenium|mesh-list
19448446|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
19448447|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448448|NCT03445078|Protective Agents|protective agents|mesh-ancestor
19448449|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448450|NCT03445078|Trace Elements|trace elements|mesh-ancestor
19448451|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
19448452|NCT03444831|Buspirone|buspirone|mesh-list
19448453|NCT03444831|Omeprazole|omeprazole|mesh-list
19448454|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19448455|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448456|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19448457|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448458|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448459|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19448460|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19448461|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448462|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448463|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19448464|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19448465|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
19448466|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448467|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19448468|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
19448469|NCT03444649|Cytarabine|cytarabine|mesh-list
19448470|NCT03444649|Daunorubicin|daunorubicin|mesh-list
20256570|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256571|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20256572|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19448471|NCT03444649|Idarubicin|idarubicin|mesh-list
19448472|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19448473|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
19448474|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448475|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448476|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
19448477|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448478|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19448479|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
19448480|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448481|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19448482|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19730283|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19448483|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19448484|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730284|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19730285|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730286|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19730287|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19730288|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19730289|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448485|NCT03444636|Fentanyl|fentanyl|mesh-list
19448486|NCT03444636|Bupivacaine|bupivacaine|mesh-list
19448487|NCT03444636|Ropivacaine|ropivacaine|mesh-list
19448488|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448489|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
19448490|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448491|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448492|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
19448493|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448494|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19448495|NCT03444636|Narcotics|narcotics|mesh-ancestor
19448496|NCT03444636|Analgesics|analgesics|mesh-ancestor
19448497|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19448498|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19448499|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
19448500|NCT03444519|Mannitol|mannitol|mesh-list
19448501|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19448502|NCT03444519|Diuretics|diuretics|mesh-ancestor
19448503|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
19448504|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448505|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19448506|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19448507|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19448508|NCT03444506|Analgesics|analgesics|mesh-ancestor
19448509|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
19448510|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448511|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448512|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448513|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19448514|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19448515|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19448516|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19448517|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
19448518|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
19448519|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448520|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448521|NCT03444467|Glucagon|glucagon|mesh-list
19448522|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448523|NCT03444467|Hormones|hormones|mesh-ancestor
19448524|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448525|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448526|NCT03444402|Esomeprazole|esomeprazole|mesh-list
19448527|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19448528|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448529|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19448530|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448531|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448532|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
19448533|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
19448534|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448535|NCT03444246|Iodine|iodine|mesh-list
19448536|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
19448537|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19448538|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448539|NCT03444246|Trace Elements|trace elements|mesh-ancestor
19448540|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
19448541|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448542|NCT03444142|Exenatide|exenatide|mesh-list
19448543|NCT03444142|Dulaglutide|dulaglutide|mesh-list
19448544|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19448545|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448546|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19448547|NCT03444142|Incretins|incretins|mesh-ancestor
19448548|NCT03444142|Hormones|hormones|mesh-ancestor
19448549|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448550|NCT03444025|Goserelin|goserelin|mesh-list
19448551|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448552|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448553|NCT03444012|Ticagrelor|ticagrelor|mesh-list
19448554|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19448555|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19448556|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19448557|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19448558|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
19448559|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448560|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452505|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
19448561|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448562|NCT03443999|Sirolimus|sirolimus|mesh-list
19448563|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19448564|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448565|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19448566|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448567|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
19448568|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19448569|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
19448570|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448571|NCT03443960|Amitriptyline|amitriptyline|mesh-list
19448572|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
19448573|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19448574|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
19448575|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19448576|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19448577|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448578|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19448579|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448580|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19448581|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448582|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19448583|NCT03443960|Analgesics|analgesics|mesh-ancestor
19448584|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
19448585|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19448586|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19448587|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19448588|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448589|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
19448590|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448591|NCT03443921|Paclitaxel|paclitaxel|mesh-list
19448592|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19448593|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448594|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
19448595|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
19448596|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
19448597|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870519|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870520|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19870521|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19870522|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
19448604|NCT03443843|Fluticasone|fluticasone|mesh-list
19448605|NCT03443843|Xhance|xhance|mesh-list
19448606|NCT03443843|Loratadine|loratadine|mesh-list
19448607|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
19448608|NCT03443843|Ephedrine|ephedrine|mesh-list
19448609|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448610|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19448611|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
19448612|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448613|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448614|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19448615|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448616|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
19448617|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19448618|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
19448619|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19448620|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19448621|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
19448622|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
19448623|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448624|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448625|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
19448626|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19448627|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19870523|NCT00856609|Exenatide|exenatide|mesh-list
19870524|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19870525|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448628|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
19448629|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
19452506|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452507|NCT03413020|Expectorants|expectorants|mesh-ancestor
19452508|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
19452509|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
19452510|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
19452511|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452512|NCT03412994|Apatinib|apatinib|mesh-list
19452513|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452514|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19452515|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452516|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452517|NCT03412773|Sorafenib|sorafenib|mesh-list
19452518|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452519|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19452520|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452521|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452522|NCT03412721|Analgesics|analgesics|mesh-list
19452523|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
19452524|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452525|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452526|NCT03412682|Budesonide|budesonide|mesh-list
19452527|NCT03412682|Mesalamine|mesalamine|mesh-list
19452528|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19452529|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20256573|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20256574|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20256575|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256576|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256577|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256578|NCT00475696|Analgesics|analgesics|mesh-ancestor
20256579|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
20256580|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256581|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
20256582|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20256583|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
20256584|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
20256585|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19452530|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
19452531|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452532|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452533|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19452534|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
19452535|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
19452536|NCT03412682|Hormones|hormones|mesh-ancestor
19452537|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19452538|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19452539|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452540|NCT03412682|Analgesics|analgesics|mesh-ancestor
19452541|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
19452542|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452543|NCT03412591|Suvorexant|suvorexant|mesh-list
20256586|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20256587|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452544|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19452545|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19452546|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452547|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452548|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19452549|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730290|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19730291|NCT04599894|Pregabalin|pregabalin|mesh-list
19730292|NCT04599894|Analgesics|analgesics|mesh-ancestor
19730293|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
19730294|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730295|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730296|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
19730297|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19730298|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19730299|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730300|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19730301|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19730302|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19448630|NCT03443778|Dexamethasone|dexamethasone|mesh-list
19448631|NCT03443778|Bupivacaine|bupivacaine|mesh-list
19448632|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448633|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
19448634|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
19448635|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448636|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448637|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448638|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
19448639|NCT03443778|Hormones|hormones|mesh-ancestor
19448640|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448641|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448642|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448643|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448644|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
19448645|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448646|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
19448647|NCT03443765|Vitamin D|vitamin d|mesh-list
19448648|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
19448649|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19448650|NCT03443765|Antibodies|antibodies|mesh-list
19448651|NCT03443765|Vitamins|vitamins|mesh-ancestor
19448652|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
19448653|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448654|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19448655|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
19448656|NCT03443726|Epinephrine|epinephrine|mesh-list
19448657|NCT03443726|Carticaine|carticaine|mesh-list
19448658|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19448659|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19448660|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
19448661|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448662|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448663|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448664|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19448665|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19448666|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
19448667|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448668|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19448669|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448670|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
19448671|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
19448672|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19448673|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448674|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
19448675|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448676|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
19448677|NCT03443570|Rituximab|rituximab|mesh-list
19448678|NCT03443570|Bortezomib|bortezomib|mesh-list
19448679|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448680|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448681|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
19448682|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448683|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19448684|NCT03443518|Remifentanil|remifentanil|mesh-list
19448685|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448686|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448687|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19448688|NCT03443518|Narcotics|narcotics|mesh-ancestor
19448689|NCT03443518|Analgesics|analgesics|mesh-ancestor
19448690|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
19448691|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448692|NCT03443492|Leucovorin|leucovorin|mesh-list
19448693|NCT03443492|Gemcitabine|gemcitabine|mesh-list
19448694|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
19448695|NCT03443492|Irinotecan|irinotecan|mesh-list
19448696|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
19448697|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19448698|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
19448699|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448700|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448701|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
20535385|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19448702|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448703|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448704|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19448705|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
19870526|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19448706|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448707|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19448708|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19448709|NCT03443492|Antidotes|antidotes|mesh-ancestor
19448710|NCT03443492|Protective Agents|protective agents|mesh-ancestor
19448711|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
19448712|NCT03443492|Vitamins|vitamins|mesh-ancestor
19448713|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
19448714|NCT03443271|Bupivacaine|bupivacaine|mesh-list
19448715|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448716|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
19448717|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448718|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448719|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
19448720|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448721|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
19870527|NCT00856609|Incretins|incretins|mesh-ancestor
19870528|NCT00856609|Hormones|hormones|mesh-ancestor
19870529|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870530|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
19870531|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
20256588|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448722|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19448723|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
19448724|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448725|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448726|NCT03443141|Vitamin E|vitamin e|mesh-list
19448727|NCT03443141|Vitamins|vitamins|mesh-ancestor
19448728|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
19448729|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448730|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
19448731|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448732|NCT03443141|Protective Agents|protective agents|mesh-ancestor
19448733|NCT03443128|Vinorelbine|vinorelbine|mesh-list
19448734|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19448735|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448736|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
19448737|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
19448738|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
19448739|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448740|NCT03443037|Amantadine|amantadine|mesh-list
19730303|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730304|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19730305|NCT04599478|Naltrexone|naltrexone|mesh-list
19730306|NCT04599478|Bupropion|bupropion|mesh-list
19730307|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19730308|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19730309|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730310|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
19730311|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730312|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19730313|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
19730314|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19730315|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19730316|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19730317|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19730318|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730319|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
19730320|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730321|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19730322|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19730323|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730324|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
19730325|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19730326|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730327|NCT04599621|Uric Acid|uric acid|mesh-list
19730328|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
19730329|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730330|NCT04599621|Protective Agents|protective agents|mesh-ancestor
19730331|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730332|NCT04599699|Androgens|androgens|mesh-list
19730333|NCT04599699|Hormones|hormones|mesh-ancestor
19730334|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870532|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19448741|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19448742|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19448743|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
19448744|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448745|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
19448746|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448747|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448748|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448749|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19448750|NCT03443037|Analgesics|analgesics|mesh-ancestor
19448751|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
19448752|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448753|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19448754|NCT03442673|Gemcitabine|gemcitabine|mesh-list
19448755|NCT03442673|Vinorelbine|vinorelbine|mesh-list
19448756|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19448757|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
19448758|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448759|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448760|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
19448761|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448762|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448763|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19448764|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
19448765|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448766|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19448767|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
19448768|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
19448769|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
19448770|NCT03442621|Cortisone|cortisone|mesh-list
19448771|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448772|NCT03442491|Hemostatics|hemostatics|mesh-list
19448773|NCT03442491|Coagulants|coagulants|mesh-ancestor
19448774|NCT03442309|Fluorides|fluorides|mesh-list
19448775|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
19448776|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
20256589|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20256590|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20256591|NCT00475800|Analgesics|analgesics|mesh-ancestor
20535386|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20535387|NCT01819857|Ondansetron|ondansetron|mesh-list
19448777|NCT03442309|Protective Agents|protective agents|mesh-ancestor
19448778|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448779|NCT03442283|Vitamins|vitamins|mesh-list
19448780|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
19448781|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452550|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452551|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
19452552|NCT03412552|Analgesics|analgesics|mesh-ancestor
19452553|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
19452554|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452555|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452556|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
19452557|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452558|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19452559|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
19452560|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19452561|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19452562|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452563|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19452564|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
19452565|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19452566|NCT03412526|Fludarabine|fludarabine|mesh-list
19452567|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452568|NCT03412513|Mirabegron|mirabegron|mesh-list
19452569|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19452570|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19452571|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19452572|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
19452573|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452574|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452575|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452576|NCT03412513|Urological Agents|urological agents|mesh-ancestor
19452577|NCT03412500|Vancomycin|vancomycin|mesh-list
19452578|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19452579|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535388|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
19448782|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
19448783|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19448784|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448785|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448786|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19448787|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
19448788|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19448789|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19448790|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448791|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
19448792|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
19448793|NCT03441841|Lidocaine|lidocaine|mesh-list
19448794|NCT03441841|Prilocaine|prilocaine|mesh-list
20256592|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
20256593|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256594|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256595|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256596|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256597|NCT00475813|Fluticasone|fluticasone|mesh-list
20256598|NCT00475813|Xhance|xhance|mesh-list
19448795|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19448796|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448797|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
19448798|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448799|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448800|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
19448801|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448802|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19448803|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19448804|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19448805|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19448806|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448807|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19448808|NCT03441815|Histamine|histamine|mesh-list
19448809|NCT03441815|Glutarimide|glutarimide|mesh-list
20256599|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
20256600|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256601|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20256602|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
20256603|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256604|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448810|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
19448811|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
19448812|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448813|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448814|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448815|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19448816|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448817|NCT03441529|Tazobactam|tazobactam|mesh-list
19448818|NCT03441529|Piperacillin|piperacillin|mesh-list
19448819|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19448820|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19448821|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448822|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19448823|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448824|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448825|NCT03441412|Metoprolol|metoprolol|mesh-list
19448826|NCT03441412|Epinephrine|epinephrine|mesh-list
19448827|NCT03441412|Ticagrelor|ticagrelor|mesh-list
19448828|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19448829|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19448830|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
19448831|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448832|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448833|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448834|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19448835|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19448836|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
19448837|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448838|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19448839|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448840|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
19448841|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
19448842|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20535389|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
19452580|NCT03412474|Acetaminophen|acetaminophen|mesh-list
19448843|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19448844|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19448845|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19448846|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19448847|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
19448848|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19448849|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19448850|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
19448851|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19448852|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19448853|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19448854|NCT03441373|Histamine|histamine|mesh-list
19448855|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
19448856|NCT03441373|Glutarimide|glutarimide|mesh-list
19448857|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
19448858|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
19448859|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448860|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256605|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20256606|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256607|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256608|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20256609|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20256610|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20256611|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20256612|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
20256613|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256614|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256615|NCT00475826|Ezetimibe|ezetimibe|mesh-list
20256616|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20256617|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20256618|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
20256619|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256620|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20256621|NCT00475917|Gemcitabine|gemcitabine|mesh-list
19448861|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448862|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19448863|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448864|NCT03441217|Scopolamine|scopolamine|mesh-list
19448865|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19448866|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19448867|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
19448868|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
19448869|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448870|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448871|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19448872|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
19448873|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19448874|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
19448875|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448876|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448877|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19448878|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
19448879|NCT03441035|Anesthetics|anesthetics|mesh-list
19448880|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448881|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448882|NCT03440996|Listerine|listerine|mesh-list
19448883|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
19448884|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
19448885|NCT03440996|Protective Agents|protective agents|mesh-ancestor
19448886|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448887|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19448888|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448889|NCT03440879|Goserelin|goserelin|mesh-list
19448890|NCT03440879|Androgens|androgens|mesh-list
19448891|NCT03440879|Hormones|hormones|mesh-ancestor
19448892|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448893|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448894|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448895|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448896|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19448897|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256622|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20256623|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
19448898|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448899|NCT03440515|Prednisone|prednisone|mesh-list
19448900|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448901|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
19448902|NCT03440515|Hormones|hormones|mesh-ancestor
19448903|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448904|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448905|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448906|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448907|NCT03440502|Anesthetics|anesthetics|mesh-list
19448908|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448909|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448910|NCT03440359|Letrozole|letrozole|mesh-list
19448911|NCT03440359|Progesterone|progesterone|mesh-list
19448912|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448913|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19448914|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19448915|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448916|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448917|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19448918|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
19448919|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448920|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448921|NCT03440359|Progestins|progestins|mesh-ancestor
19448922|NCT03440359|Hormones|hormones|mesh-ancestor
19448923|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19448924|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448925|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
19448926|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19448927|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
19448928|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19448929|NCT03440268|Expectorants|expectorants|mesh-ancestor
19448930|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448931|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19448932|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
19448933|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448934|NCT03440268|Protective Agents|protective agents|mesh-ancestor
19448935|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448936|NCT03440268|Antidotes|antidotes|mesh-ancestor
19448937|NCT03440177|Ramipril|ramipril|mesh-list
19448938|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19448939|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
19448940|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19448941|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448942|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19452581|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
19452582|NCT03412474|Bupivacaine|bupivacaine|mesh-list
19452583|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
19452584|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
19452585|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452586|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452587|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
19452588|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452589|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19452590|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19452591|NCT03412474|Analgesics|analgesics|mesh-ancestor
19452592|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19452593|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19452594|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19452595|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
19452596|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452597|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452598|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
19452599|NCT03412409|Cytarabine|cytarabine|mesh-list
19452600|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
19452601|NCT03412409|Busulfan|busulfan|mesh-list
19452602|NCT03412409|Semustine|semustine|mesh-list
19452603|NCT03412409|Fludarabine|fludarabine|mesh-list
19452604|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19452605|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19452606|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
20256624|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452607|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452608|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870533|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
19870534|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256625|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256626|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
20256627|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256628|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256629|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256630|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
20256631|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448943|NCT03440034|Pioglitazone|pioglitazone|mesh-list
19448944|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19448945|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448946|NCT03439943|Lixisenatide|lixisenatide|mesh-list
19448947|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19448948|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448949|NCT03439787|Epinephrine|epinephrine|mesh-list
19448950|NCT03439787|Bupivacaine|bupivacaine|mesh-list
19448951|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
19448952|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
19448953|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448954|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448955|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
19448956|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448957|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19448958|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19448959|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
19448960|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19448961|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448962|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19448963|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19448964|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
19448965|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19448966|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
19448967|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
19448968|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
19448969|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19448970|NCT03439709|Lanreotide|lanreotide|mesh-list
19448971|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448972|NCT03439670|Prednisone|prednisone|mesh-list
19448973|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19448974|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
19448975|NCT03439670|Hormones|hormones|mesh-ancestor
19448976|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19448977|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448978|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19448979|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448980|NCT03439501|Avelumab|avelumab|mesh-list
19448981|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19448982|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19448983|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
19448984|NCT03439358|Analgesics|analgesics|mesh-ancestor
19448985|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
19448986|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19448987|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19448988|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
19448989|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19448990|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19448991|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
19448992|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19448993|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19448994|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19448995|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19448996|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
19448997|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19448998|NCT03439345|Fenofibrate|fenofibrate|mesh-list
19448999|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19449000|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
19449001|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449002|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19449003|NCT03439267|Calcium|calcium|mesh-list
19449004|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20256632|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
20256633|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20256634|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20256635|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730335|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256636|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
20256637|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730336|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
19730337|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19730338|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19730339|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256638|NCT00475956|Cediranib|cediranib|mesh-list
20256639|NCT00475956|Saracatinib|saracatinib|mesh-list
20256640|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256641|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20256642|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256643|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256644|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20256645|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20256646|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20256647|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20256648|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256649|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449005|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449006|NCT03438955|Telmisartan|telmisartan|mesh-list
19449007|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19449008|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19449009|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19449010|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449011|NCT03438942|Folic Acid|folic acid|mesh-list
19449012|NCT03438942|Hematinics|hematinics|mesh-ancestor
19449013|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
19449014|NCT03438942|Vitamins|vitamins|mesh-ancestor
19449015|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
19449016|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449017|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
19449018|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19449019|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449020|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
19449021|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19449022|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19449023|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
19449024|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449025|NCT03438773|Tacrolimus|tacrolimus|mesh-list
19449026|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449027|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
19449028|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449029|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19449030|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449031|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449032|NCT03438708|Axitinib|axitinib|mesh-list
19449033|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449034|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19449035|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449036|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449037|NCT03438604|Donepezil|donepezil|mesh-list
19449038|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19449039|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449040|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449041|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
19449042|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449043|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449044|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
19449045|NCT03438487|Vaccines|vaccines|mesh-list
19449046|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
19449047|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449048|NCT03438344|Vaccines|vaccines|mesh-list
19449049|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
19449050|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452609|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19452610|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
19452611|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452612|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452613|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19452614|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19452615|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
19452616|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
19452617|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452618|NCT03412305|Amoxicillin|amoxicillin|mesh-list
19452619|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19452620|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449051|NCT03438253|Anesthetics|anesthetics|mesh-list
19449052|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449053|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449054|NCT03438240|Fentanyl|fentanyl|mesh-list
19449055|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
19449056|NCT03438240|Bupivacaine|bupivacaine|mesh-list
19449057|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
19449058|NCT03438240|Anesthetics|anesthetics|mesh-list
19449059|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
19449060|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449061|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449062|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
19449063|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449064|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19449065|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449066|NCT03438240|Analgesics|analgesics|mesh-ancestor
19449067|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19449068|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19449069|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19449070|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19449071|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449072|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449073|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19449074|NCT03438240|Narcotics|narcotics|mesh-ancestor
19449075|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19449076|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19449077|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
19449078|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
19449079|NCT03438227|Dextrans|dextrans|mesh-list
19449080|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
19449081|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
19449082|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
19449083|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
19449084|NCT03438227|Hematinics|hematinics|mesh-ancestor
19449085|NCT03438214|Vancomycin|vancomycin|mesh-list
19449086|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19449087|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449088|NCT03437980|Propofol|propofol|mesh-list
19449089|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19449090|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449091|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449092|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19449093|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
19449094|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
19449095|NCT03437902|Vitamins|vitamins|mesh-list
19449096|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
19449097|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
19449098|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449099|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
19449100|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449101|NCT03437902|Protective Agents|protective agents|mesh-ancestor
19449102|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
19449103|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
19449104|NCT03437824|Vitamins|vitamins|mesh-ancestor
19449105|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
19449106|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449107|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
19449108|NCT03437824|Hematinics|hematinics|mesh-ancestor
19730340|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
19730341|NCT04599205|Coagulants|coagulants|mesh-ancestor
19730342|NCT04599140|Nivolumab|nivolumab|mesh-list
19730343|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19730344|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730345|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19730346|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730347|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
19730348|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
19730349|NCT04598880|Cathartics|cathartics|mesh-ancestor
19730350|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730351|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
19730352|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
20535390|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449109|NCT03437785|Ethanol|ethanol|mesh-list
19730353|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20535391|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449110|NCT03437785|Rebamipide|rebamipide|mesh-list
19449111|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19449112|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452621|NCT03412071|Metronidazole|metronidazole|mesh-list
19730354|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449113|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449114|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449115|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19449116|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19449117|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
19449118|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449119|NCT03437785|Protective Agents|protective agents|mesh-ancestor
19449120|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449121|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
19449122|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19449123|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19449124|NCT03437746|Prednisolone|prednisolone|mesh-list
19449125|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
19449126|NCT03437746|Anesthetics|anesthetics|mesh-list
19449127|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19449128|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
19449129|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449130|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
19449131|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
19449132|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449133|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449134|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19449135|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
19449136|NCT03437746|Hormones|hormones|mesh-ancestor
19449137|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449138|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19449139|NCT03437746|Protective Agents|protective agents|mesh-ancestor
19449140|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19449141|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449142|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449143|NCT03437707|Acetaminophen|acetaminophen|mesh-list
19449144|NCT03437707|Ibuprofen|ibuprofen|mesh-list
19449145|NCT03437707|Morphine|morphine|mesh-list
19449146|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19449147|NCT03437707|Narcotics|narcotics|mesh-ancestor
19449148|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449149|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449150|NCT03437707|Analgesics|analgesics|mesh-ancestor
19449151|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
19449152|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449153|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19449154|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449155|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256650|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256651|NCT00475969|Analgesics|analgesics|mesh-ancestor
20256652|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
20256653|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256654|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
20256655|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20256656|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
19449156|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19449157|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20256657|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
19870535|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870536|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19449158|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449159|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449160|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
19449161|NCT03437655|Eugenol|eugenol|mesh-list
19449162|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
19449163|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
19449164|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
19449165|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19449166|NCT03437655|Protective Agents|protective agents|mesh-ancestor
19449167|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256658|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20256659|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20256660|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449168|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449169|NCT03437629|Calcium|calcium|mesh-list
19449170|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19449171|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449172|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
19449173|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
19449174|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19449175|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19449176|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
19449177|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449178|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449179|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449180|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19449181|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
19449182|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449183|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449184|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449185|NCT03437460|Ibuprofen|ibuprofen|mesh-list
19449186|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449187|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19449188|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449189|NCT03437460|Analgesics|analgesics|mesh-ancestor
19449190|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
19449191|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449192|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449193|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19449194|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19449195|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449196|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449197|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19449198|NCT03437226|Simendan|simendan|mesh-list
19449199|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19449200|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
19449201|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19449202|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19449203|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449204|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449205|NCT03437226|Protective Agents|protective agents|mesh-ancestor
19449206|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449207|NCT03437213|Anesthetics|anesthetics|mesh-list
19449208|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449209|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449210|NCT03437200|Nivolumab|nivolumab|mesh-list
19449211|NCT03437200|Ipilimumab|ipilimumab|mesh-list
19449212|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19449213|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449214|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19449215|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449216|NCT03437187|Analgesics|analgesics|mesh-list
19452622|NCT03412071|Clindamycin|clindamycin|mesh-list
19449217|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449218|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
19449219|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449220|NCT03437070|Doxorubicin|doxorubicin|mesh-list
19449221|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19449222|NCT03437070|Trabectedin|trabectedin|mesh-list
19449223|NCT03437070|Olaratumab|olaratumab|mesh-list
19449224|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19449225|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449226|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19449227|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19449228|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449229|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449230|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19449231|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
19449232|NCT03437057|Aspirin|aspirin|mesh-list
19449233|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19449234|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449235|NCT03437057|Analgesics|analgesics|mesh-ancestor
19449236|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
19449237|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449238|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449239|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449240|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19449241|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19449242|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19449243|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449244|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19449245|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19449246|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449247|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
19449248|NCT03437005|Ketoconazole|ketoconazole|mesh-list
19449249|NCT03437005|Desonide|desonide|mesh-list
19449250|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
19449251|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449252|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19449253|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19449254|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449255|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449256|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19449257|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
19449258|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449259|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449260|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19449261|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449262|NCT03436992|Resveratrol|resveratrol|mesh-list
19449263|NCT03436992|Antioxidants|antioxidants|mesh-list
19449264|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449265|NCT03436992|Protective Agents|protective agents|mesh-ancestor
19449266|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449267|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449268|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19449269|NCT03436836|Lidocaine|lidocaine|mesh-list
19449270|NCT03436836|Nalbuphine|nalbuphine|mesh-list
19449271|NCT03436836|Bupivacaine|bupivacaine|mesh-list
19449272|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
19449273|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
19449274|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449275|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449276|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
19449277|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449278|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19449279|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19449280|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19449281|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19449282|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449283|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19449284|NCT03436836|Narcotics|narcotics|mesh-ancestor
19449285|NCT03436836|Analgesics|analgesics|mesh-ancestor
19449286|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19449287|NCT03436719|Metronidazole|metronidazole|mesh-list
19449288|NCT03436719|Erythromycin|erythromycin|mesh-list
19449289|NCT03436719|Cefoperazone|cefoperazone|mesh-list
19449290|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19449291|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449292|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
19449293|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19449294|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19449295|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19449296|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19449297|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449298|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449299|NCT03436693|Canagliflozin|canagliflozin|mesh-list
19449300|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19449301|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449302|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19449303|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449304|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
19449305|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19449306|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449307|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449308|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449309|NCT03436472|Analgesics|analgesics|mesh-ancestor
19449310|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
19449311|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449312|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19449313|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19449314|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19449315|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
19449316|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449317|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452623|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
19452624|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
19452625|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19452626|NCT03412071|Tinidazole|tinidazole|mesh-list
19452627|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452628|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19452629|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19452630|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19452631|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19452632|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452633|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452634|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19452635|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
19452636|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19452637|NCT03412006|Fulacimstat|fulacimstat|mesh-list
19452638|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452639|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452640|NCT03411967|Docetaxel|docetaxel|mesh-list
19452641|NCT03411967|Apatinib|apatinib|mesh-list
19452642|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452643|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
19452644|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
19452645|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
19452646|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452647|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19452648|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452649|NCT03411941|Aflibercept|aflibercept|mesh-list
19452650|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19452651|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19452652|NCT03411941|Growth Substances|growth substances|mesh-ancestor
19452653|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452654|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
19452655|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452656|NCT03411850|Abatacept|abatacept|mesh-list
19452657|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19452658|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452659|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452660|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19452661|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
19452662|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452663|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452876|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452877|NCT03409068|Anesthetics|anesthetics|mesh-list
19452878|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452879|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452880|NCT03408847|Beclomethasone|beclomethasone|mesh-list
19449318|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
19449319|NCT03436303|Progestins|progestins|mesh-ancestor
19449320|NCT03436303|Hormones|hormones|mesh-ancestor
19449321|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449322|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449323|NCT03436225|Dexamethasone|dexamethasone|mesh-list
19449324|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
19449325|NCT03436225|Budesonide|budesonide|mesh-list
19449326|NCT03436225|Albuterol|albuterol|mesh-list
19449327|NCT03436225|BB 1101|bb 1101|mesh-list
19449328|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449329|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
19449330|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
19449331|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449332|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870537|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
19870538|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19870539|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19870540|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870541|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
19870542|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19870543|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870544|NCT00856791|ON 01910|on 01910|mesh-list
19870545|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449333|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19449334|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
19449335|NCT03436225|Hormones|hormones|mesh-ancestor
19449336|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449337|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19449338|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449339|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
19449340|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449341|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449342|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19449343|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19449344|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
19449345|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
19449346|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19449347|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19449348|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19870546|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870547|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870548|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870549|NCT00856830|Carboplatin|carboplatin|mesh-list
19449349|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19449350|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
19449351|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449352|NCT03436173|Fluoxetine|fluoxetine|mesh-list
19449353|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19449354|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19449355|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19449356|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730355|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730356|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
19730357|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19730358|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730359|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730360|NCT04598542|Triamcinolone|triamcinolone|mesh-list
19730361|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19730362|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19449357|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449358|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
19449359|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449360|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19449361|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
19449362|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19449363|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19449364|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19449365|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449366|NCT03436121|Midazolam|midazolam|mesh-list
19449367|NCT03436121|Ketamine|ketamine|mesh-list
19730363|NCT04598542|Lorecivivint|lorecivivint|mesh-list
19449368|NCT03436121|Analgesics|analgesics|mesh-ancestor
19730364|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19449369|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
19449370|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449371|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449372|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19449373|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19449374|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
19449375|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
19449376|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449377|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19449378|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19449379|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449380|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449381|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19449382|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19449383|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19449384|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19449385|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19449386|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
19449387|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
19449388|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
19449389|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19449390|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449391|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19449392|NCT03435900|Metronidazole|metronidazole|mesh-list
19449393|NCT03435900|Fosfomycin|fosfomycin|mesh-list
19449394|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19449395|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449396|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
19730365|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730366|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
19730367|NCT04598542|Hormones|hormones|mesh-ancestor
19730368|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730369|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730370|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19730371|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
19730372|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730373|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730374|NCT04598594|Nicotine|nicotine|mesh-list
19730375|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19730376|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
19730377|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730378|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730379|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19730380|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19730381|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
19730382|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730383|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730384|NCT04598191|Iloprost|iloprost|mesh-list
19730385|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19730386|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
19730387|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
19730388|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19730389|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730390|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730391|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730392|NCT04598061|Analgesics|analgesics|mesh-ancestor
19730393|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
19730394|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730395|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19730396|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19730397|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19730398|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
19730399|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730400|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735429|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19735430|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19735431|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19735432|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19735433|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735434|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19735435|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19735436|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20256661|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730401|NCT04597762|Cyclosporine|cyclosporine|mesh-list
19730402|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
19730403|NCT04597762|Cyclosporins|cyclosporins|mesh-list
19730404|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730405|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730406|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19730407|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
19730408|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730409|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
19730410|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730411|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730412|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730413|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19730414|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730415|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
19730416|NCT04597619|Analgesics|analgesics|mesh-ancestor
19730417|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
19730418|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730419|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730420|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
19730421|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19730422|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730423|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
19730424|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
19730425|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19730426|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19730427|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730428|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730429|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730430|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730431|NCT04597424|Doxycycline|doxycycline|mesh-list
19730432|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19730433|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730434|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
19730435|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19730436|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19730437|NCT04597203|Hydroquinone|hydroquinone|mesh-list
19730438|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
19730439|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730440|NCT04597203|Protective Agents|protective agents|mesh-ancestor
19730441|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730442|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19730443|NCT04597190|Norepinephrine|norepinephrine|mesh-list
19730444|NCT04597190|Serotonin|serotonin|mesh-list
19730445|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19730446|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19730447|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19730448|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
19730449|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730450|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730451|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730452|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
19730453|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
19730454|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730455|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19730456|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19730457|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
19730458|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19730459|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19730460|NCT04596826|Dronabinol|dronabinol|mesh-list
19730461|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
19730462|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730463|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19730464|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730465|NCT04596826|Analgesics|analgesics|mesh-ancestor
19730466|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
19730467|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730468|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19730469|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19730470|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730471|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730472|NCT04596826|Hormones|hormones|mesh-ancestor
20535392|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730473|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730474|NCT04596839|Remdesivir|remdesivir|mesh-list
19730475|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
19730476|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730477|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
19730478|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730479|NCT04596488|Efavirenz|efavirenz|mesh-list
19730480|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19730481|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19730482|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730483|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730484|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
19730485|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730486|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19870550|NCT00856830|Irinotecan|irinotecan|mesh-list
19870551|NCT00856830|Etoposide|etoposide|mesh-list
19870552|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19870553|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870554|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19870555|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19870556|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870557|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870558|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19870559|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19870560|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19870561|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
19870562|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19870563|NCT00856843|Laxatives|laxatives|mesh-ancestor
19870564|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870565|NCT00856856|Everolimus|everolimus|mesh-list
19870566|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870567|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870568|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
19870569|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870570|NCT00856973|Eszopiclone|eszopiclone|mesh-list
19870571|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19870572|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870573|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870574|NCT00856986|Metformin|metformin|mesh-list
19870575|NCT00856986|Liraglutide|liraglutide|mesh-list
19870576|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
19870577|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19870578|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870579|NCT00856986|Incretins|incretins|mesh-ancestor
19870580|NCT00856986|Hormones|hormones|mesh-ancestor
19870581|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870582|NCT00857220|Eszopiclone|eszopiclone|mesh-list
19870583|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19870584|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870585|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870586|NCT00857233|Memantine|memantine|mesh-list
19870587|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19870588|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19870589|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
19870590|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870591|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870592|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256662|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20256663|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20256664|NCT00476034|Analgesics|analgesics|mesh-ancestor
19870593|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19870594|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19870595|NCT00857246|Irinotecan|irinotecan|mesh-list
19870596|NCT00857246|Cetuximab|cetuximab|mesh-list
19870597|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870598|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19870599|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19870600|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870601|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870602|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19870603|NCT00857259|Everolimus|everolimus|mesh-list
19870604|NCT00857259|Ranibizumab|ranibizumab|mesh-list
19870605|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870606|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870607|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
19870608|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256665|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
19730487|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19730488|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19730489|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19730490|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19730491|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19730492|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
20256666|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256667|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256668|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256669|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256670|NCT00476073|Fluticasone|fluticasone|mesh-list
20256671|NCT00476073|Xhance|xhance|mesh-list
20256672|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
20256673|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256674|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20256675|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
20535393|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
20535394|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730493|NCT04595942|Midodrine|midodrine|mesh-list
19730494|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
19730495|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
19730496|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730497|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730498|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19730499|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19730500|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19730501|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19730502|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
19730503|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730504|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730505|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730506|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
19730507|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19730508|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
19730509|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730510|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19730511|NCT04595929|Leucovorin|leucovorin|mesh-list
19730512|NCT04595929|Docetaxel|docetaxel|mesh-list
19730513|NCT04595929|Fluorouracil|fluorouracil|mesh-list
19730514|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
19730515|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730516|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
19730517|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
19730518|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
19730519|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730520|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
19730521|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19730522|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19730523|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
19730524|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730525|NCT04595929|Antidotes|antidotes|mesh-ancestor
19730526|NCT04595929|Protective Agents|protective agents|mesh-ancestor
19730527|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
19730528|NCT04595929|Vitamins|vitamins|mesh-ancestor
19730529|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
19730530|NCT04595812|Misoprostol|misoprostol|mesh-list
19730531|NCT04595812|Hemostatics|hemostatics|mesh-list
19730532|NCT04595812|Oxytocin|oxytocin|mesh-list
19730533|NCT04595812|Carbetocin|carbetocin|mesh-list
19730534|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
19730535|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19730536|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730537|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19730538|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
19730539|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19730540|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730541|NCT04595812|Coagulants|coagulants|mesh-ancestor
19730544|NCT04595877|Dipyrone|dipyrone|mesh-list
19730545|NCT04595877|Endorphins|endorphins|mesh-list
19730546|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
19730547|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19730548|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730549|NCT04595877|Analgesics|analgesics|mesh-ancestor
20256676|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535395|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19730550|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
19730551|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730552|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730553|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730554|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730555|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
19730556|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730557|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735437|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19735438|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19735439|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19735440|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19735441|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19735442|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19735443|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735444|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19735445|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19735446|NCT04539626|Estradiol|estradiol|mesh-list
19735447|NCT04539626|Estrogens|estrogens|mesh-list
19735448|NCT04539626|Hormones|hormones|mesh-ancestor
19735449|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735450|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735451|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19735452|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
19735453|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19735454|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19735455|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19735456|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19735985|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735986|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19735987|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735988|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19735989|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
19735990|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735991|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19735992|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735993|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
19735994|NCT04534582|Denosumab|denosumab|mesh-list
19735995|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19735996|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735997|NCT04533646|Insulin|insulin|mesh-list
19735998|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19735999|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736000|NCT04533841|Propranolol|propranolol|mesh-list
19736001|NCT04533841|Misoprostol|misoprostol|mesh-list
19736002|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19870609|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19870610|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19870611|NCT00857259|Growth Substances|growth substances|mesh-ancestor
19870612|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
19870613|NCT00857272|Bisacodyl|bisacodyl|mesh-list
19870614|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19870615|NCT00857272|Cathartics|cathartics|mesh-ancestor
19870616|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870617|NCT00857272|Laxatives|laxatives|mesh-ancestor
19870618|NCT00857311|Vaccines|vaccines|mesh-list
19870619|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
19870620|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870621|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
19870622|NCT00857389|Busulfan|busulfan|mesh-list
19870623|NCT00857389|Thiotepa|thiotepa|mesh-list
19870624|NCT00857389|Methotrexate|methotrexate|mesh-list
19870625|NCT00857389|Clofarabine|clofarabine|mesh-list
19870626|NCT00857389|Tacrolimus|tacrolimus|mesh-list
19870627|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
19870628|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19870629|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870630|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
19870631|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870632|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870633|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19870634|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
19870635|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870636|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870637|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20535396|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
19730558|NCT04595617|Antibodies|antibodies|mesh-list
19730559|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
19730560|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730561|NCT04595318|Varenicline|varenicline|mesh-list
19730562|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19730563|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19730564|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
19730565|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730566|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730567|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730568|NCT04595591|Remifentanil|remifentanil|mesh-list
19730569|NCT04595591|Rocuronium|rocuronium|mesh-list
19730570|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19730571|NCT04595591|Narcotics|narcotics|mesh-ancestor
19730572|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730573|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730574|NCT04595591|Analgesics|analgesics|mesh-ancestor
19730575|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
19730576|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730577|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19730578|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19730579|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19730580|NCT04595409|Ustekinumab|ustekinumab|mesh-list
19730581|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730582|NCT04594772|Gemcitabine|gemcitabine|mesh-list
19730583|NCT04594772|Paclitaxel|paclitaxel|mesh-list
19730584|NCT04594772|Fluorouracil|fluorouracil|mesh-list
19730585|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
19730586|NCT04594772|Irinotecan|irinotecan|mesh-list
19730587|NCT04594772|Folfirinox|folfirinox|mesh-list
19730588|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19730589|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730590|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
19730591|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
19730592|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
19730593|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730594|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19730595|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
19730596|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
19730597|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730598|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730599|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19730600|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
19730601|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730602|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19730603|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19730604|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
19730605|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
19730606|NCT04594018|Minoxidil|minoxidil|mesh-list
19730607|NCT04594018|Finasteride|finasteride|mesh-list
19730608|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19730609|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
19730610|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19730611|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19730612|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730613|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730614|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
19730615|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730616|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730617|NCT04594018|Urological Agents|urological agents|mesh-ancestor
19730618|NCT04594005|Paclitaxel|paclitaxel|mesh-list
19730619|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19730620|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730621|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19730622|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
19730623|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19730624|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730625|NCT04594343|Disulfiram|disulfiram|mesh-list
19730626|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19730627|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19730628|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730629|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730630|NCT04593706|Dexamethasone|dexamethasone|mesh-list
19870638|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19730631|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
19730632|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19730633|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19730634|NCT04593706|Prednisolone|prednisolone|mesh-list
19730635|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
19730636|NCT04593706|Triamcinolone|triamcinolone|mesh-list
19730637|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19730638|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19730639|NCT04593706|Betamethasone|betamethasone|mesh-list
19730640|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
19730641|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19730642|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
19730643|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
19730644|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
19730645|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19730646|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
19730647|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19730648|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19730649|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19730650|NCT04593706|BB 1101|bb 1101|mesh-list
19730651|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730652|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
19730653|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
19730654|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730655|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730656|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870639|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
19870640|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19870641|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19870642|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
19870643|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
19870644|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870645|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19870646|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19870647|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19870648|NCT00857454|Testosterone|testosterone|mesh-list
19870649|NCT00857454|Androgens|androgens|mesh-ancestor
19870650|NCT00857454|Hormones|hormones|mesh-ancestor
19870651|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870652|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256677|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256678|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20256679|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256680|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256681|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20256682|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19870653|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
19870654|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
19870655|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870656|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19870657|NCT00857584|Sertraline|sertraline|mesh-list
19870658|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
19870659|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19870660|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19870661|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19870662|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870663|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870664|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19870665|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19870666|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19870667|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870668|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870669|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
19870670|NCT00857649|Memantine|memantine|mesh-list
19870671|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19870672|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19870673|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
19870674|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870675|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870676|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870677|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19870678|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19870679|NCT00857714|Lapatinib|lapatinib|mesh-list
19870680|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870681|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19730657|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
19730658|NCT04593706|Hormones|hormones|mesh-ancestor
19730659|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730660|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19730661|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730662|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19730663|NCT04593706|Protective Agents|protective agents|mesh-ancestor
19730664|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19730665|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
19730666|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730667|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730668|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19730669|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
19730670|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
19735457|NCT04539301|Anticoagulants|anticoagulants|mesh-list
19735458|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
19735459|NCT04539314|Bupivacaine|bupivacaine|mesh-list
19735460|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
19735461|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
19735462|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735463|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735464|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
19735465|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735466|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19735467|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19735468|NCT04539314|Analgesics|analgesics|mesh-ancestor
19735469|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19735470|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19735471|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19735472|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
19735473|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735474|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735475|NCT04539405|Sevoflurane|sevoflurane|mesh-list
19735476|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19735477|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19735478|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
19735479|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
19735480|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735481|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735482|NCT04539327|Rucaparib|rucaparib|mesh-list
19735483|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19735484|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735485|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735486|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735487|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
19735488|NCT04539249|Pentazocine|pentazocine|mesh-list
19735489|NCT04539249|Analgesics|analgesics|mesh-ancestor
19735490|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
19735491|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735492|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735493|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
19735494|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735495|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19735496|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
19735497|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19735498|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735499|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735500|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19735501|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
19735502|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19735503|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19735504|NCT04539249|Narcotics|narcotics|mesh-ancestor
19735505|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19735506|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19735507|NCT04539119|Tenofovir|tenofovir|mesh-list
19735508|NCT04539119|Entecavir|entecavir|mesh-list
19735509|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
19735510|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735511|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19735512|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19735513|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735514|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735515|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19735516|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19735517|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
19735518|NCT04539379|Analgesics|analgesics|mesh-ancestor
19730671|NCT04593836|Peppermint oil|peppermint oil|mesh-list
19730672|NCT04593836|Menthol|menthol|mesh-list
19730673|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
19730674|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730675|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
19730676|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
19730677|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730678|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730679|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730680|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
19730681|NCT04593654|Dalteparin|dalteparin|mesh-list
19730682|NCT04593654|Tinzaparin|tinzaparin|mesh-list
19730683|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19730684|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
19730685|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19730686|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19730687|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730688|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19730689|NCT04593238|Calcium|calcium|mesh-list
19730690|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19730691|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730692|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730693|NCT04593524|Vitamin D|vitamin d|mesh-list
19730694|NCT04593524|Vitamins|vitamins|mesh-ancestor
19730695|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
19730696|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730697|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19730698|NCT04593329|Dipyrone|dipyrone|mesh-list
19730699|NCT04593329|Tramadol|tramadol|mesh-list
19730700|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19730701|NCT04593329|Narcotics|narcotics|mesh-ancestor
19730702|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730703|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730704|NCT04593329|Analgesics|analgesics|mesh-ancestor
19730705|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
19730706|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730707|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19730708|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730709|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730710|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730711|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
19730712|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
19730713|NCT04593446|Cathartics|cathartics|mesh-ancestor
19730714|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730715|NCT04593160|Acetaminophen|acetaminophen|mesh-list
19730716|NCT04593160|Diclofenac|diclofenac|mesh-list
19730717|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730718|NCT04593160|Analgesics|analgesics|mesh-ancestor
19730719|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
19730720|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730721|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730722|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
19730723|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19730724|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730725|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730726|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19730727|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730728|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730729|NCT04593108|Letrozole|letrozole|mesh-list
19730730|NCT04593108|Misoprostol|misoprostol|mesh-list
19730731|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730732|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19730733|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19730734|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730735|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730736|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19730737|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
19730738|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730739|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730740|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19730741|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
19730742|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19730743|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19730744|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730745|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
19730746|NCT04592952|Calcitonin|calcitonin|mesh-list
19730747|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
19730748|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19730749|NCT04592952|Erenumab|erenumab|mesh-list
19730750|NCT04592952|Katacalcin|katacalcin|mesh-list
19730751|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19870682|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870683|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870684|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
19870685|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19870686|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870687|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870688|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19870689|NCT00857727|Analgesics|analgesics|mesh-ancestor
19870690|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
19870691|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870692|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19870693|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19870694|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19870695|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
19870696|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870697|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870698|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19870699|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19870700|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
19870701|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870702|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870703|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19870704|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
19870705|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
19870706|NCT00857766|Hormones|hormones|mesh-ancestor
19870707|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870708|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
19870709|NCT00857792|Regadenoson|regadenoson|mesh-list
19870710|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19870711|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19870712|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
19870713|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
19870714|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870715|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870716|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870717|NCT00857818|Risperidone|risperidone|mesh-list
19870718|NCT00857818|Aripiprazole|aripiprazole|mesh-list
19870719|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19870720|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19870721|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
19870722|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870723|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870724|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870725|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19870726|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19870727|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870728|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19870729|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19870730|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
19870731|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
19870732|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
19870733|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19870734|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19870735|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19870736|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19870737|NCT00857896|Fesoterodine|fesoterodine|mesh-list
19870738|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19870739|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19870740|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
19730752|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730753|NCT04592952|Analgesics|analgesics|mesh-ancestor
19730754|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
19730755|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730756|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730757|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19730758|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19730759|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
19730760|NCT04593030|Warfarin|warfarin|mesh-list
19730761|NCT04593030|Apixaban|apixaban|mesh-list
19730762|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
19730763|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19730764|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
19730765|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19730766|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
19730767|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730768|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730769|NCT04592822|Dabigatran|dabigatran|mesh-list
19730770|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
19730771|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19730772|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
19730773|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730774|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730775|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
19730776|NCT04592744|Vasopressins|vasopressins|mesh-list
19730777|NCT04592744|Epinephrine|epinephrine|mesh-list
19730778|NCT04592744|Norepinephrine|norepinephrine|mesh-list
19730779|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
19730780|NCT04592744|Giapreza|giapreza|mesh-list
19730781|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
19730782|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19730783|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19730784|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
19730785|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730786|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730787|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730788|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19730789|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19730790|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
19730791|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730792|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19730793|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
19730794|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
19730795|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
19730796|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19730797|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
19730798|NCT04592744|Coagulants|coagulants|mesh-ancestor
19730799|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19730800|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
19730801|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19730802|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
19730803|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730804|NCT04592666|Carboplatin|carboplatin|mesh-list
19730805|NCT04592666|Pemetrexed|pemetrexed|mesh-list
19730806|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730807|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870741|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870742|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870743|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870744|NCT00857896|Urological Agents|urological agents|mesh-ancestor
19870745|NCT00857948|Ivermectin|ivermectin|mesh-list
19870746|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19870747|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870748|NCT00857961|Testosterone|testosterone|mesh-list
19870749|NCT00857961|Androgens|androgens|mesh-ancestor
19870750|NCT00857961|Hormones|hormones|mesh-ancestor
19870751|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870752|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870753|NCT00858013|Glimepiride|glimepiride|mesh-list
19870754|NCT00858013|Nateglinide|nateglinide|mesh-list
19870755|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19870756|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20256683|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20256684|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20256685|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
20256686|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256687|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256688|NCT00476099|Budesonide|budesonide|mesh-list
20256689|NCT00476099|Beclomethasone|beclomethasone|mesh-list
20256690|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
20256691|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256692|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20256693|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
20256694|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256695|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256696|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19730808|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730809|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19730810|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19730811|NCT04593056|Warfarin|warfarin|mesh-list
19730812|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
19730813|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
19730814|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19730815|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
19730816|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19730817|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
19730818|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870757|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870758|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870759|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
19870760|NCT00858117|Rituximab|rituximab|mesh-list
19870761|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
19870762|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19870763|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870764|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
19870765|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870766|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870767|NCT00858234|Bortezomib|bortezomib|mesh-list
19870768|NCT00858234|Vorinostat|vorinostat|mesh-list
19870769|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870770|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19870771|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870772|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870773|NCT00858247|Vitamin D|vitamin d|mesh-list
19870774|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
19870775|NCT00858247|Vitamins|vitamins|mesh-ancestor
19870776|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
19870777|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870778|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19870779|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19870780|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
19870781|NCT00858364|Hematinics|hematinics|mesh-ancestor
19870782|NCT00858403|Dasatinib|dasatinib|mesh-list
19870783|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870784|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870785|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870786|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870787|NCT00858468|Vaccines|vaccines|mesh-list
19870788|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
19870789|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870790|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
19870791|NCT00858637|Simvastatin|simvastatin|mesh-list
19870792|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19870793|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19870794|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
19870795|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870796|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19870797|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19870798|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870799|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870800|NCT00858689|Minocycline|minocycline|mesh-list
19870801|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19870802|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870803|NCT00858780|Etanercept|etanercept|mesh-list
19870804|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19870805|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19870806|NCT00858780|Analgesics|analgesics|mesh-ancestor
19870807|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
19870808|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870809|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870810|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19870811|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19870812|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870813|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870814|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
19870815|NCT00858832|Methylergonovine|methylergonovine|mesh-list
19870816|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
19870817|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19870818|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870819|NCT00858845|Clonidine|clonidine|mesh-list
19870820|NCT00858845|Analgesics|analgesics|mesh-ancestor
19870821|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
19735519|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
19870822|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730819|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730820|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
19730821|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19730822|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730823|NCT04593043|Warfarin|warfarin|mesh-list
19730824|NCT04593043|Dabigatran|dabigatran|mesh-list
19730825|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
19730826|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
19730827|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19730828|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
19730829|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730830|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730831|NCT04592211|Paclitaxel|paclitaxel|mesh-list
19730832|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
19730833|NCT04592211|Olaparib|olaparib|mesh-list
19730834|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19730835|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730836|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
19730837|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
19730838|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
19730839|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730840|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19730841|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19730842|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730843|NCT04592159|Nabiximols|nabiximols|mesh-list
19730844|NCT04592159|Analgesics|analgesics|mesh-ancestor
19730845|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
19730846|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730847|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730848|NCT04592419|Aflibercept|aflibercept|mesh-list
19730849|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19730850|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19730851|NCT04592419|Growth Substances|growth substances|mesh-ancestor
19730852|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730853|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
19730854|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730855|NCT04592380|Clevidipine|clevidipine|mesh-list
19730856|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19730857|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19730858|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19730859|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19730860|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19730861|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19730862|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730863|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19730864|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730865|NCT04592198|Palonosetron|palonosetron|mesh-list
19730866|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
19730867|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
19730868|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730869|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730870|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730871|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19730872|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19730873|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
19730874|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730875|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730876|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
19730877|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19730878|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19730879|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19730880|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730881|NCT04592081|Dexamethasone|dexamethasone|mesh-list
19730882|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
19730883|NCT04592081|BB 1101|bb 1101|mesh-list
19730884|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730885|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
19730886|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
19730887|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730888|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730889|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19730890|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
19730891|NCT04592081|Hormones|hormones|mesh-ancestor
19735520|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870823|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730892|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19730893|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19730894|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256697|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256698|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
20256699|NCT00476099|Hormones|hormones|mesh-ancestor
20256700|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20256701|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20256702|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20256703|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20256704|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
19730895|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
19730896|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730897|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730898|NCT04591795|Diclofenac|diclofenac|mesh-list
19730899|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19730900|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449397|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19449398|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19449399|NCT03435744|Simvastatin|simvastatin|mesh-list
19449400|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19449401|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19449402|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
19449403|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449404|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19449405|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19449406|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730901|NCT04591795|Analgesics|analgesics|mesh-ancestor
19730902|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
19730903|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730904|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730905|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730906|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730907|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19730908|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730909|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730910|NCT04591743|Nicotine|nicotine|mesh-list
19730911|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19730912|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
19730913|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730914|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730915|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19730916|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19730917|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
19730918|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730919|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730920|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
19730921|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19730922|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730923|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19730924|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730925|NCT04592016|Diclofenac|diclofenac|mesh-list
19730926|NCT04592016|Coal Tar|coal tar|mesh-list
19730927|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19730928|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19730929|NCT04592016|Analgesics|analgesics|mesh-ancestor
19730930|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
19730931|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19730932|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730933|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19730934|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19730935|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19730936|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730937|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730938|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
19730939|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
19730940|NCT04592029|Bevacizumab|bevacizumab|mesh-list
19730941|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19730942|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19730943|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19730944|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19449407|NCT03435718|Albendazole|albendazole|mesh-list
19730945|NCT04592029|Growth Substances|growth substances|mesh-ancestor
19730946|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730947|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
19730948|NCT04591847|Vitamin D|vitamin d|mesh-list
19730949|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
19730950|NCT04591847|Vitamins|vitamins|mesh-ancestor
19730951|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
19730952|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730953|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19730954|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19735521|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735522|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
19735523|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735524|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19735525|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
19735526|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19735527|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735528|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735529|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19735530|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
19735531|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19735532|NCT04539106|Ranibizumab|ranibizumab|mesh-list
19735533|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19735534|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19735535|NCT04539106|Growth Substances|growth substances|mesh-ancestor
19736003|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
19870824|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19870825|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
19870826|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
19870827|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19870828|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19870829|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19870830|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
19870831|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19870832|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870833|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19870834|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19870835|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870836|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
19870837|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19870838|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19870839|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
19870840|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870841|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19870842|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19870843|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870844|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870845|NCT00858988|Rifaximin|rifaximin|mesh-list
19870846|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19870847|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870848|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19870849|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
19870850|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
19870851|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19870852|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19870853|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870854|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19870855|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870856|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19870857|NCT00859040|Pasireotide|pasireotide|mesh-list
19870858|NCT00859040|Hormones|hormones|mesh-ancestor
19870859|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870860|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870861|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
19870862|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19870863|NCT00859131|Daclizumab|daclizumab|mesh-list
19870864|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
19870865|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870866|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870867|NCT00859222|Bevacizumab|bevacizumab|mesh-list
19870868|NCT00859222|Panobinostat|panobinostat|mesh-list
19870869|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19870870|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870871|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19730955|NCT04591535|Levodopa|levodopa|mesh-list
19730956|NCT04591535|Carbidopa|carbidopa|mesh-list
19730957|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19730958|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19730959|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19730960|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
19730961|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19730962|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730963|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730964|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19730965|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19730966|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19730967|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
19730968|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
19730969|NCT04591444|Fluorides|fluorides|mesh-list
19730970|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
19730971|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
19730972|NCT04591444|Protective Agents|protective agents|mesh-ancestor
19730973|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730974|NCT04591457|Insulin|insulin|mesh-list
19730975|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19730976|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
19730977|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20256705|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256706|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256707|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19730978|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730979|NCT04591327|Anesthetics|anesthetics|mesh-list
19730980|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19730981|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730982|NCT04591275|Denosumab|denosumab|mesh-list
19730983|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19730984|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730985|NCT04591600|Ivermectin|ivermectin|mesh-list
19730986|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19730987|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19730988|NCT04591405|Vaccines|vaccines|mesh-list
19730989|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
19730990|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19730991|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
19730992|NCT04591210|Giapreza|giapreza|mesh-list
19730993|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19730994|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
19730995|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19730996|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19730997|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19730998|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19730999|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19731000|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
19731001|NCT04590742|Melatonin|melatonin|mesh-list
19731002|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
19731003|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731004|NCT04590742|Protective Agents|protective agents|mesh-ancestor
19731005|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731006|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731007|NCT04590638|Epinephrine|epinephrine|mesh-list
19731008|NCT04590638|Racepinephrine|racepinephrine|mesh-list
19731009|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
19731010|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19731011|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19731012|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
19731013|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731014|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731015|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731016|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19731017|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19731018|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
19731019|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731020|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19731021|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
19731022|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
19731023|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
19731024|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19731025|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19870872|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19731026|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19731027|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19731028|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
19731029|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870873|NCT00859222|Growth Substances|growth substances|mesh-ancestor
19870874|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870875|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
19870876|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19870877|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870878|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870879|NCT00859313|Sufentanil|sufentanil|mesh-list
19870880|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19870881|NCT00859313|Narcotics|narcotics|mesh-ancestor
19870882|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870883|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870884|NCT00859313|Analgesics|analgesics|mesh-ancestor
19870885|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
19870886|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870887|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19870888|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19870889|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
19870890|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
19870891|NCT00859339|Gemcitabine|gemcitabine|mesh-list
19870892|NCT00859339|Sunitinib|sunitinib|mesh-list
19870893|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870894|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19870895|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
19870896|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870897|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
19870898|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870899|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870900|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870901|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
19870902|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870903|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19870904|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19870905|NCT00859339|Growth Substances|growth substances|mesh-ancestor
19870906|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
19870907|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870908|NCT00859456|Sunitinib|sunitinib|mesh-list
19870909|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870910|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19870911|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19870912|NCT00859456|Growth Substances|growth substances|mesh-ancestor
19870913|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870914|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
19870915|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870916|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870917|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870918|NCT00859469|Gemcitabine|gemcitabine|mesh-list
20256708|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
20256709|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256710|NCT00476138|Protective Agents|protective agents|mesh-ancestor
20256711|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731030|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19870919|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
19870920|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19870921|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
19870922|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870923|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870924|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
19870925|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870926|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870927|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19870928|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
19870929|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731031|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19731032|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731033|NCT04590820|Rituximab|rituximab|mesh-list
19731034|NCT04590820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19731035|NCT04590820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731036|NCT04590820|Immunologic Factors|immunologic factors|mesh-ancestor
19731037|NCT04590820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731038|NCT04590820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731039|NCT04590612|Levodopa|levodopa|mesh-list
19731040|NCT04590612|Carbidopa|carbidopa|mesh-list
19731041|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19731042|NCT04590612|Citalopram|citalopram|mesh-list
19731043|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19731044|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19731045|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19731046|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
19731047|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731048|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731049|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731050|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19731051|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731052|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19731053|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19731054|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731055|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
19731056|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19731057|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
19731058|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731059|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19731060|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
19731061|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
19731062|NCT04590625|Carboplatin|carboplatin|mesh-list
19731063|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19731064|NCT04590625|Apatinib|apatinib|mesh-list
19731065|NCT04590625|Cisplatin|cisplatin|mesh-list
19731066|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731067|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731068|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19731069|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731070|NCT04590183|Prednisolone|prednisolone|mesh-list
19731071|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19731072|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
19731073|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19731074|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
19731075|NCT04590183|Tacrolimus|tacrolimus|mesh-list
19731076|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19731077|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
19731078|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19731079|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
19731080|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731081|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19731082|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731083|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731084|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731085|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
19731086|NCT04590183|Hormones|hormones|mesh-ancestor
19731087|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19731088|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19731089|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731090|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
19731091|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
19731092|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731093|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19731094|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19731095|NCT04590183|Protective Agents|protective agents|mesh-ancestor
19731096|NCT04590508|Xanthohumol|xanthohumol|mesh-list
19731097|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731098|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19731099|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19731100|NCT04590508|Growth Substances|growth substances|mesh-ancestor
19731101|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731102|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
19731103|NCT04590482|Letrozole|letrozole|mesh-list
19731104|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731105|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19731106|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19731107|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731108|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731109|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19731110|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
19731111|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19731112|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731113|NCT04590196|Curcumin|curcumin|mesh-list
19731114|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19731115|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19731116|NCT04590196|Analgesics|analgesics|mesh-ancestor
19731117|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
19731118|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731119|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731120|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731121|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731122|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731123|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731124|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731125|NCT04589819|Teriparatide|teriparatide|mesh-list
19870930|NCT00859495|Doxorubicin|doxorubicin|mesh-list
19870931|NCT00859495|Pemetrexed|pemetrexed|mesh-list
19731126|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19731127|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731128|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19731129|NCT04589728|Venetoclax|venetoclax|mesh-list
19731130|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731131|NCT04589429|Morphine|morphine|mesh-list
19731132|NCT04589429|Nalbuphine|nalbuphine|mesh-list
19731133|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19731134|NCT04589429|Narcotics|narcotics|mesh-ancestor
19731135|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731136|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731137|NCT04589429|Analgesics|analgesics|mesh-ancestor
19731138|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
19731139|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735536|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735537|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
19735538|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735539|NCT04538820|Dexamethasone|dexamethasone|mesh-list
19735540|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
19735541|NCT04538820|BB 1101|bb 1101|mesh-list
19735542|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735543|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
19735544|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
19735545|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735546|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735547|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19735548|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
19735549|NCT04538820|Hormones|hormones|mesh-ancestor
19735550|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735551|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19735552|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735553|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
19735554|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735555|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735556|NCT04539054|Caffeine|caffeine|mesh-list
19735557|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19735558|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735559|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19735560|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256712|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20256713|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20256714|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256715|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20256716|NCT00476164|Rituximab|rituximab|mesh-list
20256717|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256718|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256719|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
20256720|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256721|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256722|NCT00476190|Cytarabine|cytarabine|mesh-list
20256723|NCT00476190|Dexamethasone|dexamethasone|mesh-list
20256724|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
20256725|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20256726|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20256727|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20256728|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
20256729|NCT00476190|Doxorubicin|doxorubicin|mesh-list
20256730|NCT00476190|Methotrexate|methotrexate|mesh-list
20256731|NCT00476190|Etoposide|etoposide|mesh-list
20256732|NCT00476190|Vincristine|vincristine|mesh-list
20256733|NCT00476190|Asparaginase|asparaginase|mesh-list
20256734|NCT00476190|Pegaspargase|pegaspargase|mesh-list
20256735|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19731140|NCT04589390|Selexipag|selexipag|mesh-list
19731141|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19731142|NCT04589546|Niacinamide|niacinamide|mesh-list
19731143|NCT04589546|Niacin|niacin|mesh-list
19731144|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
19731145|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
19870932|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870933|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19870934|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19870935|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19870936|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870937|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870938|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19870939|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19870940|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19870941|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20535397|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535398|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535399|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20535400|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20535401|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19870942|NCT00859508|Estradiol|estradiol|mesh-list
19870943|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19870944|NCT00859508|Estrogens|estrogens|mesh-ancestor
19870945|NCT00859508|Hormones|hormones|mesh-ancestor
19870946|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19870947|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870948|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19870949|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
19870950|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19870951|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19870952|NCT00859573|Modafinil|modafinil|mesh-list
19870953|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19870954|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870955|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19870956|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19870957|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19870958|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870959|NCT00859651|Vitamin D|vitamin d|mesh-list
19870960|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
19870961|NCT00859651|Vitamins|vitamins|mesh-ancestor
19870962|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
19870963|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870964|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19870965|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19731146|NCT04589546|Vitamins|vitamins|mesh-ancestor
19731147|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
19731148|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731149|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19731150|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
19731151|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731152|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19731153|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
19731154|NCT04589494|Morphine|morphine|mesh-list
19870966|NCT00859833|Adenosine|adenosine|mesh-list
19870967|NCT00859833|Regadenoson|regadenoson|mesh-list
19870968|NCT00859833|Analgesics|analgesics|mesh-ancestor
19870969|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
19870970|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870971|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870972|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19870973|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535402|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731155|NCT04589494|Tramadol|tramadol|mesh-list
19731156|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19731157|NCT04589494|Narcotics|narcotics|mesh-ancestor
19731158|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731159|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731160|NCT04589494|Analgesics|analgesics|mesh-ancestor
19870974|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19870975|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
19870976|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
19870977|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256736|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
19731161|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
19731162|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19870978|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870979|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19870980|NCT00859898|Metformin|metformin|mesh-list
19870981|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
19870982|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19870983|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19870984|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19870985|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970043|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19970044|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
19970045|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
19970046|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731163|NCT04589325|Ixekizumab|ixekizumab|mesh-list
19731164|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
19731165|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
19731166|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19731167|NCT04589299|Antibodies|antibodies|mesh-list
19731168|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
19731169|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731170|NCT04589143|S 20098|s 20098|mesh-list
19731171|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19731172|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731173|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731174|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
19731175|NCT04589130|Naltrexone|naltrexone|mesh-list
19731176|NCT04589130|Bupropion|bupropion|mesh-list
19731177|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19731178|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19731179|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731180|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
19731181|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731182|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19731183|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
19731184|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731185|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19731186|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19731187|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731188|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731189|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
19731190|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731191|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19731192|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19731193|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731194|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19731195|NCT04589234|Gemcitabine|gemcitabine|mesh-list
19731196|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19731197|NCT04589234|Folfirinox|folfirinox|mesh-list
19731198|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19731199|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
19731200|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731201|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731202|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
19731203|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731204|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731205|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19731206|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
19731207|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731208|NCT04588935|Bisoprolol|bisoprolol|mesh-list
19731209|NCT04588935|Perindopril|perindopril|mesh-list
19731210|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19731211|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
19731212|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
19731213|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731214|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731215|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19731216|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19731217|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19731218|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
19970047|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970048|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970049|NCT01780324|Lidocaine|lidocaine|mesh-list
19449408|NCT03435718|Oxfendazole|oxfendazole|mesh-list
19731219|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731220|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731221|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19731222|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
19731223|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731224|NCT04588987|Apatinib|apatinib|mesh-list
19731225|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731226|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19731227|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870986|NCT00859937|Dasatinib|dasatinib|mesh-list
19870987|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870988|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19870989|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19870990|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870991|NCT00860015|Gemcitabine|gemcitabine|mesh-list
19870992|NCT00860015|Pemetrexed|pemetrexed|mesh-list
19870993|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19870994|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
19870995|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19870996|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19870997|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
19870998|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19870999|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871000|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871001|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
19871002|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871003|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19871004|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871005|NCT00860028|Varenicline|varenicline|mesh-list
19871006|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19871007|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19871008|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
19871009|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871010|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871011|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871012|NCT00860171|Iodine|iodine|mesh-list
19871013|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
19871014|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19871015|NCT00860171|Antibodies|antibodies|mesh-list
19871016|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
19871017|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19871018|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
19871019|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871020|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871021|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19871022|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871023|NCT00860171|Trace Elements|trace elements|mesh-ancestor
19871024|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
19871025|NCT00860262|Amlodipine|amlodipine|mesh-list
19871026|NCT00860262|Telmisartan|telmisartan|mesh-list
19871027|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19871028|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19871029|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19871030|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871031|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871032|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19871033|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871034|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
19871035|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19871036|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19871037|NCT00860379|Selenium|selenium|mesh-list
19871038|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
19871039|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871040|NCT00860379|Protective Agents|protective agents|mesh-ancestor
19871041|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871042|NCT00860379|Trace Elements|trace elements|mesh-ancestor
19871043|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
19871044|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19871045|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
19871046|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
19871047|NCT00860457|Rituximab|rituximab|mesh-list
19871048|NCT00860457|Fludarabine|fludarabine|mesh-list
19871049|NCT00860457|Lenalidomide|lenalidomide|mesh-list
19871050|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871051|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871052|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
19731228|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731229|NCT04588532|Doxepin|doxepin|mesh-list
19731230|NCT04588532|Histamine|histamine|mesh-list
19871053|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871054|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871055|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19871056|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19871057|NCT00860457|Growth Substances|growth substances|mesh-ancestor
19871058|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
20256737|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256738|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256739|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20256740|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
20256741|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256742|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256743|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20256744|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256745|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
19871059|NCT00860470|Iron|iron|mesh-list
19871060|NCT00860470|Trace Elements|trace elements|mesh-list
19871061|NCT00860470|Folic Acid|folic acid|mesh-list
19871062|NCT00860470|Micronutrients|micronutrients|mesh-list
19731231|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
20535403|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20535404|NCT01819870|Carvedilol|carvedilol|mesh-list
20535405|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20535406|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19731232|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
19731233|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731234|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731235|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871063|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871064|NCT00860470|Hematinics|hematinics|mesh-ancestor
19871065|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
19871066|NCT00860470|Vitamins|vitamins|mesh-ancestor
19871067|NCT00860574|Methotrexate|methotrexate|mesh-list
19871068|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
19871069|NCT00860574|Fludarabine|fludarabine|mesh-list
19871070|NCT00860574|Treosulfan|treosulfan|mesh-list
19871071|NCT00860574|Tacrolimus|tacrolimus|mesh-list
19871072|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19871073|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
19871074|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19871075|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871076|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19871077|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
19871078|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871079|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871080|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
19871081|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871082|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19871083|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871084|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
19871085|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871086|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871087|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20535407|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
20535408|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535409|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871088|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19871089|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
19871090|NCT00860743|Antioxidants|antioxidants|mesh-list
19871091|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871092|NCT00860743|Protective Agents|protective agents|mesh-ancestor
19871093|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871094|NCT00860847|Ubiquinone|ubiquinone|mesh-list
19871095|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
19871096|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
19871097|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871098|NCT00860847|Vitamins|vitamins|mesh-ancestor
19871099|NCT00860938|Budesonide|budesonide|mesh-list
19871100|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256746|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
20535410|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871101|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19871102|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
19871103|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731236|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19731237|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19731238|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731239|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19731240|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
19731241|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731242|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
19731243|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
19731244|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731245|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
19731246|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
19731247|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
19731248|NCT04588792|Furosemide|furosemide|mesh-list
19731249|NCT04588792|Diuretics|diuretics|mesh-ancestor
19731250|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
19731251|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731252|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19731253|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731254|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731255|NCT04588441|Adenosine|adenosine|mesh-list
19731256|NCT04588441|Analgesics|analgesics|mesh-ancestor
19731257|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
19731258|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731259|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731260|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19731261|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
19731262|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19731263|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
19731264|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
19731265|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731266|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731267|NCT04588389|Lidocaine|lidocaine|mesh-list
19731268|NCT04588389|Ropivacaine|ropivacaine|mesh-list
19731269|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
19731270|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
19731271|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731272|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731273|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
19731274|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731275|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19731276|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19731277|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19731278|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731279|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731280|NCT04588233|Melatonin|melatonin|mesh-list
19731281|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
19731282|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731283|NCT04588233|Protective Agents|protective agents|mesh-ancestor
19731284|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731285|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731286|NCT04588220|Plasminogen|plasminogen|mesh-list
19731287|NCT04588220|Melatonin|melatonin|mesh-list
19731288|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
19731289|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731290|NCT04588220|Protective Agents|protective agents|mesh-ancestor
19731291|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731292|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731293|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19731294|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19731295|NCT04588194|Dexamethasone|dexamethasone|mesh-list
19731296|NCT04588194|Rituximab|rituximab|mesh-list
19731297|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19731298|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731299|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
19731300|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731301|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731302|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731303|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
19731304|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
19731305|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731306|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19731307|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
19731308|NCT04588194|Hormones|hormones|mesh-ancestor
19871104|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731309|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19731310|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19731311|NCT04588090|Cisplatin|cisplatin|mesh-list
19731312|NCT04588090|Paclitaxel|paclitaxel|mesh-list
19731313|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731314|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19731315|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
19731316|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
19731317|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
19731318|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731319|NCT04588285|Ambroxol|ambroxol|mesh-list
19731320|NCT04588285|Expectorants|expectorants|mesh-ancestor
19731321|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
19731322|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
19731323|NCT04587973|Ropivacaine|ropivacaine|mesh-list
19731324|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19731325|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535411|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535412|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
19871105|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19871106|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
19871107|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
19871108|NCT00860938|Hormones|hormones|mesh-ancestor
19871109|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871110|NCT00861341|Aspirin|aspirin|mesh-list
19871111|NCT00861341|Pioglitazone|pioglitazone|mesh-list
19871112|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19871113|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19871114|NCT00861341|Analgesics|analgesics|mesh-ancestor
19871115|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
19871116|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535413|NCT01819870|Protective Agents|protective agents|mesh-ancestor
19731326|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731327|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19731328|NCT04587973|Analgesics|analgesics|mesh-ancestor
19731329|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
19731330|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731331|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19731332|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19731333|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19731334|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
19731335|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731336|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731337|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
19731338|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
19731339|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
19731340|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
19731341|NCT04587843|Naltrexone|naltrexone|mesh-list
19731342|NCT04587843|Bupropion|bupropion|mesh-list
19731343|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19731344|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19731345|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731346|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
19731347|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731348|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19731349|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
19731350|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731351|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19731352|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19731353|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731354|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731355|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
19731356|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731357|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19731358|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19731359|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731360|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19731361|NCT04587778|Ketamine|ketamine|mesh-list
19731362|NCT04587778|Esketamine|esketamine|mesh-list
19731363|NCT04587778|Analgesics|analgesics|mesh-ancestor
19731364|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
19731365|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871117|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871118|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731366|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731367|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19731368|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19731369|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
19731370|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
19731371|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731372|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19731373|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19871119|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871120|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19871121|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19871122|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871123|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19871124|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19871125|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256747|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256748|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20256749|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
20256750|NCT00476190|Hormones|hormones|mesh-ancestor
20256751|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19731374|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731375|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731376|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
19731377|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731378|NCT04587505|Morphine|morphine|mesh-list
19731379|NCT04587505|Tramadol|tramadol|mesh-list
19731380|NCT04587505|Anesthetics|anesthetics|mesh-list
19731381|NCT04587505|Ropivacaine|ropivacaine|mesh-list
19731382|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731383|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731384|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19731385|NCT04587505|Narcotics|narcotics|mesh-ancestor
19731386|NCT04587505|Analgesics|analgesics|mesh-ancestor
19731387|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
19731388|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731389|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
19735561|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735562|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19735563|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19735564|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
19735565|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735566|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19735567|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735568|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735569|NCT04539418|Vitamin K|vitamin k|mesh-list
19735570|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
19735571|NCT04539418|Vitamins|vitamins|mesh-ancestor
19735572|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
19735573|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735574|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19735575|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19735576|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735577|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
19735578|NCT04539418|Coagulants|coagulants|mesh-ancestor
19735579|NCT04538521|Niacin|niacin|mesh-list
19735580|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
19735581|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19735582|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
19735583|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735584|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19735585|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
19735586|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
19735587|NCT04538521|Vitamins|vitamins|mesh-ancestor
19735588|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
19735589|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735590|NCT04538391|Bupivacaine|bupivacaine|mesh-list
19735591|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
20256752|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20256753|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20256754|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20256755|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20256756|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735592|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
19871126|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
19735593|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731390|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
19731391|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19731392|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
19731393|NCT04587141|Hematinics|hematinics|mesh-ancestor
19731394|NCT04587115|Oxycodone|oxycodone|mesh-list
19731395|NCT04587115|Risperidone|risperidone|mesh-list
19731396|NCT04587115|Ziprasidone|ziprasidone|mesh-list
19731397|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19731398|NCT04587115|Narcotics|narcotics|mesh-ancestor
19731399|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731400|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731401|NCT04587115|Analgesics|analgesics|mesh-ancestor
19731402|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
19731403|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731404|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19731405|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
19731406|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731407|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731408|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19731409|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19731410|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731411|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19731412|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
19731413|NCT04586543|Docetaxel|docetaxel|mesh-list
19871127|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19871128|NCT00861380|Vaccines|vaccines|mesh-list
19871129|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19871130|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
19871131|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731414|NCT04586543|Selegiline|selegiline|mesh-list
19731415|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731416|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
19731417|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
19731418|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
19731419|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731420|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
19731421|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731422|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19731423|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19731424|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19731425|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731426|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19731427|NCT04586543|Protective Agents|protective agents|mesh-ancestor
19731428|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731429|NCT04586504|Midazolam|midazolam|mesh-list
19731430|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19731431|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19731432|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731433|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731434|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19731435|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19871132|NCT00861471|Docetaxel|docetaxel|mesh-list
19871133|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
19871134|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871135|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
19871136|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
19871137|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
19871138|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871139|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871140|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871141|NCT00861614|Ipilimumab|ipilimumab|mesh-list
19871142|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871143|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731436|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731437|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19731438|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
19731439|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
19731440|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
19731441|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
19731442|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871144|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19871145|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731443|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731444|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19449409|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
19731445|NCT04586790|Epinephrine|epinephrine|mesh-list
19731446|NCT04586790|Racepinephrine|racepinephrine|mesh-list
19731447|NCT04586790|Midodrine|midodrine|mesh-list
19731448|NCT04586790|Norepinephrine|norepinephrine|mesh-list
19731449|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
19731450|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19731451|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19731452|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
19731453|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731454|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731455|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731456|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19731457|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19731458|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
19731459|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731460|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19731461|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
19731462|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
19731463|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
19731464|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19731465|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19731466|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
19731467|NCT04586790|Coagulants|coagulants|mesh-ancestor
19731468|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19731469|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
19731470|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19731471|NCT04586465|Gemcitabine|gemcitabine|mesh-list
19871146|NCT00861692|Argatroban|argatroban|mesh-list
19871147|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
19871148|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19871149|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19871150|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871151|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871152|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
19731472|NCT04586465|Carboplatin|carboplatin|mesh-list
19731473|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
19731474|NCT04586465|Pemetrexed|pemetrexed|mesh-list
19731475|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731476|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19731477|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
19731478|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731479|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
19731480|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731481|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731482|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19731483|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
19731484|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731485|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19731486|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19731487|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19731488|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19731489|NCT04586335|Olaparib|olaparib|mesh-list
19731490|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19731491|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871153|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19871154|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19731492|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731493|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731494|NCT04586088|Apatinib|apatinib|mesh-list
19871155|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
19871156|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871157|NCT00861757|Tadalafil|tadalafil|mesh-list
19731495|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731496|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19731497|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731498|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731499|NCT04586166|Imidacloprid|imidacloprid|mesh-list
19731500|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
19731501|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731502|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731503|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871158|NCT00861757|Tamsulosin|tamsulosin|mesh-list
19871159|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
19871160|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19871161|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19871162|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970050|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
19731504|NCT04586348|Iodine|iodine|mesh-list
19731505|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
19731506|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19731507|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731508|NCT04586348|Trace Elements|trace elements|mesh-ancestor
19731509|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
19731510|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731511|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
19731512|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19731513|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
19731514|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731515|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
19731516|NCT04586361|Protective Agents|protective agents|mesh-ancestor
19731517|NCT04585997|Omalizumab|omalizumab|mesh-list
19731518|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19731519|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19731520|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
19731521|NCT04585737|Tenofovir|tenofovir|mesh-list
19731522|NCT04585737|Lamivudine|lamivudine|mesh-list
19731523|NCT04585737|Emtricitabine|emtricitabine|mesh-list
19731524|NCT04585737|Dolutegravir|dolutegravir|mesh-list
19731525|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19731526|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
19731527|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731528|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19731529|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19731530|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731531|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731532|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19731533|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19731534|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19731535|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19731536|NCT04585867|Bupivacaine|bupivacaine|mesh-list
19731537|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
19731538|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
19731539|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731540|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731541|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
19871163|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871164|NCT00861757|Urological Agents|urological agents|mesh-ancestor
19871165|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19871166|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19871167|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19871168|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
19871169|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871170|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871171|NCT00862082|Sorafenib|sorafenib|mesh-list
19871172|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19871173|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871174|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871175|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871176|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871177|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19871178|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
19871179|NCT00862121|Mesalamine|mesalamine|mesh-list
19871180|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19871181|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19871182|NCT00862121|Analgesics|analgesics|mesh-ancestor
19871183|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
19871184|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871185|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871186|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19871187|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871188|NCT00862134|Docetaxel|docetaxel|mesh-list
19871189|NCT00862134|Sargramostim|sargramostim|mesh-list
19871190|NCT00862134|Lenograstim|lenograstim|mesh-list
19871191|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871192|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
19871193|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
19871194|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
19871195|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871196|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
19871197|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871198|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19731542|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731543|NCT04585932|Leuprolide|leuprolide|mesh-list
19731544|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19731545|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
19731546|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19731547|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731548|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19731549|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731550|NCT04585776|Insulin|insulin|mesh-list
19731551|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19731552|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731553|NCT04585490|Paclitaxel|paclitaxel|mesh-list
19731554|NCT04585490|Cisplatin|cisplatin|mesh-list
19731555|NCT04585490|Carboplatin|carboplatin|mesh-list
19731556|NCT04585490|Pemetrexed|pemetrexed|mesh-list
19731557|NCT04585490|Durvalumab|durvalumab|mesh-list
19731558|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19731559|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19731560|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731561|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
19731562|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
19871199|NCT00862563|Topiramate|topiramate|mesh-list
19871200|NCT00862563|Zonisamide|zonisamide|mesh-list
19871201|NCT00862563|Levetiracetam|levetiracetam|mesh-list
19871202|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
19871203|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19871204|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871205|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
19871206|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19871207|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871208|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871209|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19871210|NCT00862641|Regadenoson|regadenoson|mesh-list
19871211|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19871212|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19871213|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
19871214|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
19871215|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871216|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871217|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871218|NCT00862654|Ketoconazole|ketoconazole|mesh-list
19871219|NCT00862654|Clobetasol|clobetasol|mesh-list
19871220|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
19871221|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871222|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19871223|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19871224|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871225|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871226|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19871227|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
19871228|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871229|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871230|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19871231|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19871232|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
19871233|NCT00862654|Hormones|hormones|mesh-ancestor
19871234|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19871235|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19871236|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871237|NCT00862719|Incretins|incretins|mesh-ancestor
19871238|NCT00862719|Hormones|hormones|mesh-ancestor
19871239|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871240|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19871241|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
19871242|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871243|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871244|NCT00862745|Fesoterodine|fesoterodine|mesh-list
19871245|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19871246|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19871247|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
19871248|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871249|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871250|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871251|NCT00862745|Urological Agents|urological agents|mesh-ancestor
19871252|NCT00862784|Leucovorin|leucovorin|mesh-list
19871253|NCT00862784|Folic Acid|folic acid|mesh-list
19731563|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
19731564|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731565|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731566|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19731567|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19731568|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19731569|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
19731570|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731571|NCT04585334|Diclofenac|diclofenac|mesh-list
19731572|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19731573|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19731574|NCT04585334|Analgesics|analgesics|mesh-ancestor
19731575|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
19731576|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731577|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731578|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731579|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731580|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19731581|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731582|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731583|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19731584|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
19731585|NCT04585542|Laxatives|laxatives|mesh-ancestor
19731586|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19731587|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
19871254|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
19871255|NCT00862784|Fluorouracil|fluorouracil|mesh-list
19871256|NCT00862784|Ramucirumab|ramucirumab|mesh-list
19871257|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19731588|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
19731589|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731590|NCT04585412|Palonosetron|palonosetron|mesh-list
19731591|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
19731592|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
19731593|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731594|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731595|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19731596|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19731597|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19731598|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
19731599|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731600|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731601|NCT04585438|Diclofenac|diclofenac|mesh-list
19731602|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19731603|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19731604|NCT04585438|Analgesics|analgesics|mesh-ancestor
19731605|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
19731606|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731607|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731608|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731609|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731610|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19731611|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731612|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731613|NCT04585321|Diclofenac|diclofenac|mesh-list
19731614|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
19731615|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19731616|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19731617|NCT04585321|Analgesics|analgesics|mesh-ancestor
19731618|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
19731619|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731620|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731621|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731622|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731623|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19731624|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731625|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735594|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735595|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
19735596|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735597|NCT04538365|Triclosan|triclosan|mesh-list
19735598|NCT04538365|Propranolol|propranolol|mesh-list
19735599|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19871258|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
19871259|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871260|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
19731626|NCT04585230|Mineral Oil|mineral oil|mesh-list
19731627|NCT04585230|Emollients|emollients|mesh-ancestor
19731628|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
19731629|NCT04585152|Rituximab|rituximab|mesh-list
19731630|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19731631|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731632|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
19731633|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731634|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731635|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19731636|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19731637|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19731638|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19731639|NCT04585022|Cimetidine|cimetidine|mesh-list
19731640|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19731641|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19871261|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871262|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19871263|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871264|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
19871265|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871266|NCT00862784|Antidotes|antidotes|mesh-ancestor
19871267|NCT00862784|Protective Agents|protective agents|mesh-ancestor
19871268|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
20256757|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19731642|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19731643|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
19731644|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
19731645|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731646|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731647|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731648|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19731649|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19731650|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731651|NCT04584515|Itraconazole|itraconazole|mesh-list
19731652|NCT04584515|Rifampin|rifampin|mesh-list
19731653|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
19731654|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731655|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19731656|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256758|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
20256759|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20256760|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20256761|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
20256762|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256763|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20256764|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20256765|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20256766|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
20256767|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256768|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
20256769|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
20256770|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
20256771|NCT00476216|Fondaparinux|fondaparinux|mesh-list
20256772|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20256773|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
20256774|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20256775|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
20256776|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256777|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256778|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
20256779|NCT00476268|Beclomethasone|beclomethasone|mesh-list
20256780|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
20256781|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20256782|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
20256783|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256784|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256785|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20256786|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
20256787|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20256788|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20256789|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19731657|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871269|NCT00862784|Vitamins|vitamins|mesh-ancestor
20535414|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535415|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731658|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731659|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19731660|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
19731661|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19731662|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731663|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19731664|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19731665|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
19731666|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19731667|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
19731668|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19731669|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19731670|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19731671|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19731672|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19731673|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19731674|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19731675|NCT04584580|Heparin|heparin|mesh-list
19731676|NCT04584580|Enoxaparin|enoxaparin|mesh-list
19731677|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19731678|NCT04584580|Tinzaparin|tinzaparin|mesh-list
19731679|NCT04584580|Dalteparin|dalteparin|mesh-list
19731680|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
19731681|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19731682|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19731683|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731684|NCT04584749|Lidocaine|lidocaine|mesh-list
19731685|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
19731686|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
19731687|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731688|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731689|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
19731690|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731691|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19731692|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19731693|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19731694|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731695|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731696|NCT04584710|Dactolisib|dactolisib|mesh-list
19731697|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731698|NCT04584671|Xenon|xenon|mesh-list
19731699|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19731700|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
19731701|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
19731702|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731703|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731704|NCT04584736|Ezetimibe|ezetimibe|mesh-list
19731705|NCT04584736|Pitavastatin|pitavastatin|mesh-list
19731706|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19731707|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19871270|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
19871271|NCT00862784|Hematinics|hematinics|mesh-ancestor
19871272|NCT00862810|Vaccines|vaccines|mesh-list
19871273|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
19871274|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871275|NCT00862823|Tenofovir|tenofovir|mesh-list
19871276|NCT00862823|Emtricitabine|emtricitabine|mesh-list
19871277|NCT00862823|Efavirenz|efavirenz|mesh-list
19871278|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
19871279|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871280|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19871281|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871282|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871283|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871284|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19871285|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19871286|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19871287|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19871288|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19871289|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19871290|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19731708|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
19731709|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731710|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19731711|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19731712|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731713|NCT04584125|Riboflavin|riboflavin|mesh-list
19731714|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
19731715|NCT04584125|Dextrans|dextrans|mesh-list
19731716|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19731717|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19731718|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
19731719|NCT04584125|Vitamins|vitamins|mesh-ancestor
19731720|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
19731721|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731722|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19731723|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
20535416|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535417|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535418|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19731724|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
19731725|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
19731726|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
19731727|NCT04584307|Pomalidomide|pomalidomide|mesh-list
19731728|NCT04584307|Elotuzumab|elotuzumab|mesh-list
19731729|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
19731730|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731731|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19731732|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19731733|NCT04584307|Growth Substances|growth substances|mesh-ancestor
19731734|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
19731735|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731736|NCT04584034|Albuterol|albuterol|mesh-list
19731737|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
19731738|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
19731739|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731740|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731741|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19731742|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
19731743|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
19731744|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19731745|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19731746|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19731747|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19731748|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
19731749|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731750|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731751|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19731752|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731753|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731754|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731755|NCT04583813|Empagliflozin|empagliflozin|mesh-list
19731756|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19731757|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731758|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19731759|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731760|NCT04583410|Nicotine|nicotine|mesh-list
19731761|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19731762|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
19731763|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731764|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731765|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19731766|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19731767|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
19731768|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731769|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731770|NCT04583267|Tenofovir|tenofovir|mesh-list
19731771|NCT04583267|Emtricitabine|emtricitabine|mesh-list
19731772|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
19731773|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731774|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19731775|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19731776|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731777|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535419|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19731778|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19731779|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19731780|NCT04583111|Domperidone|domperidone|mesh-list
19731781|NCT04583111|Sulpiride|sulpiride|mesh-list
19731782|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
19731783|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
19731784|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731785|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731786|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19731787|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19731788|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
19731789|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731790|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731791|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19731792|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19731793|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731794|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19731795|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19731796|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
19731797|NCT04582968|Capecitabine|capecitabine|mesh-list
19731798|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20535420|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20535421|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20535422|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19871291|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19871292|NCT00862849|Insulin|insulin|mesh-list
19871293|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19871294|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
19871295|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19871296|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871297|NCT00862940|Memantine|memantine|mesh-list
19871298|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19871299|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19871300|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
19871301|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871302|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871303|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871304|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19731799|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
19731800|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731801|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731802|NCT04583046|Iloprost|iloprost|mesh-list
19731803|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19731804|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
19871305|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19871306|NCT00862979|Cyclosporine|cyclosporine|mesh-list
19871307|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
19871308|NCT00862979|Everolimus|everolimus|mesh-list
19871309|NCT00862979|Tacrolimus|tacrolimus|mesh-list
19871310|NCT00862979|Cyclosporins|cyclosporins|mesh-list
19871311|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871312|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
19871313|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871314|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19871315|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256790|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
20256791|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256792|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256793|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20256794|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
20256795|NCT00476268|Hormones|hormones|mesh-ancestor
20256796|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535423|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20535424|NCT01820026|Amoxicillin|amoxicillin|mesh-list
20535425|NCT01820026|Azithromycin|azithromycin|mesh-list
20535426|NCT01820026|Vancomycin|vancomycin|mesh-list
20535427|NCT01820026|Imipenem|imipenem|mesh-list
20535428|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20256797|NCT00476346|Vitamin D|vitamin d|mesh-list
20256798|NCT00476346|Calcium|calcium|mesh-list
20256799|NCT00476346|Vitamins|vitamins|mesh-ancestor
19731805|NCT04583137|Lidocaine|lidocaine|mesh-list
19871316|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256800|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
20535429|NCT01820026|Cefotaxime|cefotaxime|mesh-list
19731806|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
20256801|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535430|NCT01820026|Cefoxitin|cefoxitin|mesh-list
19731807|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
19731808|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731809|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731810|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
19731811|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731812|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19731813|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19731814|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19731815|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871317|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
19871318|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731816|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731817|NCT04583020|Temozolomide|temozolomide|mesh-list
19731818|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19731819|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
19731820|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731821|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735600|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19735601|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871319|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
19871320|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871321|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871322|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19735602|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19735603|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19735604|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
19735605|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735606|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19735607|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19735608|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19735609|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
19735610|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735611|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735612|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19735613|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19735614|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
19735615|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
19735616|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
19735617|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19735618|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19735619|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735620|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735621|NCT04538976|Urological Agents|urological agents|mesh-ancestor
19735622|NCT04538053|Cefazolin|cefazolin|mesh-list
19735623|NCT04538053|Cephalexin|cephalexin|mesh-list
19735624|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19735625|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735626|NCT04537780|Montelukast|montelukast|mesh-list
19735627|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20256802|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20256803|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19735628|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
19735629|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19735630|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
19735631|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735632|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735633|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19735634|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19735635|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735636|NCT04537767|Esmolol|esmolol|mesh-list
19735637|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19735638|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19735639|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19871323|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19871324|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
19871325|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19871326|NCT00862992|Cariprazine|cariprazine|mesh-list
19871327|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19871328|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19871329|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256804|NCT00476359|Lopinavir|lopinavir|mesh-list
20256805|NCT00476359|Saquinavir|saquinavir|mesh-list
19731822|NCT04582942|Lactulose|lactulose|mesh-list
19731823|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19731824|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19731825|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19731826|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731827|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731828|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19731829|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731830|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731831|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
19731832|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731833|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19731834|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731835|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731836|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731837|NCT04582604|Decitabine|decitabine|mesh-list
19731838|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19731839|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
19731840|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731841|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731842|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731843|NCT04582786|Morphine|morphine|mesh-list
19731844|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19731845|NCT04582786|Narcotics|narcotics|mesh-ancestor
20256806|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19731846|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731847|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731848|NCT04582786|Analgesics|analgesics|mesh-ancestor
19731849|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
19871330|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871331|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19871332|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19871333|NCT00863057|Methadone|methadone|mesh-list
19871334|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19871335|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19871336|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871337|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871338|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871339|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871340|NCT00863057|Analgesics|analgesics|mesh-ancestor
19871341|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
19871342|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871343|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
19871344|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19871345|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
19871346|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19871347|NCT00863057|Narcotics|narcotics|mesh-ancestor
19871348|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19871349|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
19871350|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
19871351|NCT00863109|Ribavirin|ribavirin|mesh-list
19871352|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19871353|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
19871354|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871355|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
19871356|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871357|NCT00863122|Lapatinib|lapatinib|mesh-list
20256807|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20256808|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
19449410|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19449411|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449412|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
19449413|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19449414|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19449415|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
19449416|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
19449417|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
19449418|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449419|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449420|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
19449421|NCT03435666|Capecitabine|capecitabine|mesh-list
19449422|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19449423|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
20256809|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731850|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731851|NCT04582084|Etanercept|etanercept|mesh-list
19731852|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19731853|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19731854|NCT04582084|Analgesics|analgesics|mesh-ancestor
19731855|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
19731856|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731857|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731858|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731859|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731860|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19731861|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535431|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20535432|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535433|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20535434|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535435|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731862|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
19731863|NCT04582305|Bleomycin|bleomycin|mesh-list
19731864|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19731865|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731866|NCT04582136|Sirolimus|sirolimus|mesh-list
19731867|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19731868|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871358|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871359|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871360|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871361|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871362|NCT00863265|Ezetimibe|ezetimibe|mesh-list
19871363|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19871364|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19871365|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
19871366|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731869|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19731870|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731871|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
19731872|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19731873|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
19731874|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731875|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19731876|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19731877|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19731878|NCT04582032|Analgesics|analgesics|mesh-ancestor
19731879|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
19731880|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731881|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731882|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19731883|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731884|NCT04582097|Ramipril|ramipril|mesh-list
19731885|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19731886|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
19731887|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731888|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731889|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19731890|NCT04581876|Paclitaxel|paclitaxel|mesh-list
19731891|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19731892|NCT04581876|Raltitrexed|raltitrexed|mesh-list
19731893|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19731894|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731895|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
19731896|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
19731897|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
19731898|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731899|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19731900|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
19731901|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19731902|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731903|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
19871367|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19871368|NCT00863304|Naproxen|naproxen|mesh-list
19871369|NCT00863304|Tanezumab|tanezumab|mesh-list
19871370|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20535436|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
20535437|NCT01820091|Antidotes|antidotes|mesh-ancestor
20535438|NCT01820091|Protective Agents|protective agents|mesh-ancestor
19731904|NCT04581967|Doxorubicin|doxorubicin|mesh-list
19731905|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19731906|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
19731907|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731908|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19731909|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19731910|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
19731911|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731912|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731913|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19731914|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19731915|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19731916|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19731917|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731918|NCT04581603|Topiramate|topiramate|mesh-list
19731919|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
19731920|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19731921|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731922|NCT04581213|Anesthetics|anesthetics|mesh-list
19731923|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731924|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731925|NCT04581408|Ivacaftor|ivacaftor|mesh-list
19731926|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19731927|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19731928|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731929|NCT04581265|Paclitaxel|paclitaxel|mesh-list
19731930|NCT04581265|Ifosfamide|ifosfamide|mesh-list
19731931|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19731932|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19731933|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731934|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
19731935|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
19731936|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
19731937|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731938|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19731939|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
19731940|NCT04580797|PF-06700841|pf-06700841|mesh-list
19731941|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19731942|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731943|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735640|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
19735641|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735642|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735643|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736004|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19736005|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736006|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19736007|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736008|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
19736009|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19736010|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19736011|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
19736012|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736013|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736014|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19736015|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19736016|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
19736017|NCT04533984|Teriparatide|teriparatide|mesh-list
19736018|NCT04533984|Calcium|calcium|mesh-list
19736019|NCT04533984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19736020|NCT04533984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736021|NCT04533984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19736022|NCT04533724|Amisulpride|amisulpride|mesh-list
19736023|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19871371|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19871372|NCT00863304|Analgesics|analgesics|mesh-ancestor
19871373|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
19871374|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736024|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19736025|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736026|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736027|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19871375|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731944|NCT04580355|Amoxicillin|amoxicillin|mesh-list
19731945|NCT04580355|Metronidazole|metronidazole|mesh-list
20256810|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256811|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20256812|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20256813|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
20256814|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256815|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20256816|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256817|NCT00476424|Efavirenz|efavirenz|mesh-list
20256818|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20256819|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20535439|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535440|NCT01820104|Lansoprazole|lansoprazole|mesh-list
20535441|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
20535442|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20535443|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20535444|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20535445|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535446|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535447|NCT01820143|Esomeprazole|esomeprazole|mesh-list
20535448|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20535449|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20535450|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20535451|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535452|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535453|NCT01820299|Vitamin D|vitamin d|mesh-list
20535454|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
20535455|NCT01820299|Vitamins|vitamins|mesh-ancestor
20535456|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
20535457|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731946|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19731947|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731948|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19731949|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19731950|NCT04580342|Propranolol|propranolol|mesh-list
19731951|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19731952|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19731953|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
19731954|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731955|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731956|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731957|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19731958|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19731959|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
19731960|NCT04580472|Clindamycin|clindamycin|mesh-list
20535458|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20535459|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20535460|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535461|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
20535462|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535463|NCT01820299|Protective Agents|protective agents|mesh-ancestor
20535464|NCT01820312|Paclitaxel|paclitaxel|mesh-list
20535465|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19731961|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
20535466|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535467|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
20535468|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535469|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535470|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731962|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
19731963|NCT04580472|Cephalexin|cephalexin|mesh-list
19731964|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19731965|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731966|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19731967|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19731968|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731969|NCT04580394|Oxybutynin|oxybutynin|mesh-list
19731970|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19731971|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19731972|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20535471|NCT01820325|Paclitaxel|paclitaxel|mesh-list
20535472|NCT01820325|Carboplatin|carboplatin|mesh-list
19731973|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535473|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19871376|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19871377|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871378|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
19871379|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19871380|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871381|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871382|NCT00863317|Montelukast|montelukast|mesh-list
19871383|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19871384|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
19731974|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731975|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
19731976|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19731977|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731978|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
19731979|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
19731980|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19731981|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19871385|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19871386|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
19871387|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19731982|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19731983|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
19731984|NCT04580394|Urological Agents|urological agents|mesh-ancestor
19731985|NCT04580199|Ethanol|ethanol|mesh-list
19731986|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19731987|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19731988|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19731989|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19731990|NCT04580498|Paclitaxel|paclitaxel|mesh-list
19731991|NCT04580498|Carboplatin|carboplatin|mesh-list
19731992|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19731993|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19731994|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
19731995|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
19731996|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
19871388|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871389|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19871390|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19871391|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871392|NCT00863356|Hemostatics|hemostatics|mesh-list
19871393|NCT00863356|Chitosan|chitosan|mesh-list
19871394|NCT00863356|Coagulants|coagulants|mesh-ancestor
19871395|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19871396|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19871397|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
19871398|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871399|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19871400|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
19871401|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
19871402|NCT00863434|Cytarabine|cytarabine|mesh-list
19871403|NCT00863434|Clofarabine|clofarabine|mesh-list
19871404|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19871405|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
19871406|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871407|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871408|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
19731997|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19731998|NCT04580277|Tofacitinib|tofacitinib|mesh-list
19731999|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19732000|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732001|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732002|NCT04579614|Vaccines|vaccines|mesh-list
19871409|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732003|NCT04579614|Immunologic Factors|immunologic factors|mesh-ancestor
19732004|NCT04579614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732005|NCT04579731|Lactitol|lactitol|mesh-list
19732006|NCT04579731|Cathartics|cathartics|mesh-ancestor
19449424|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449425|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449426|NCT03435302|Temozolomide|temozolomide|mesh-list
19449427|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449428|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19449429|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
19735644|NCT04537689|Cyclosporine|cyclosporine|mesh-list
19732007|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732008|NCT04579302|Bupivacaine|bupivacaine|mesh-list
19732009|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
19732010|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
19732011|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732012|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732013|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
19732014|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732015|NCT04578938|Ketamine|ketamine|mesh-list
19871410|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871411|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
19871412|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871413|NCT00863551|Trospium chloride|trospium chloride|mesh-list
19871414|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
19871415|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
19871416|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871417|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871418|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19871419|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19871420|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
19871421|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871422|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871423|NCT00863551|Urological Agents|urological agents|mesh-ancestor
19871424|NCT00863655|Everolimus|everolimus|mesh-list
19871425|NCT00863655|Exemestane|exemestane|mesh-list
19871426|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871427|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871428|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
19871429|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871430|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19871431|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19871432|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871433|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871434|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19871435|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
19871436|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871437|NCT00863681|Riociguat|riociguat|mesh-list
19871438|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
19871439|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871440|NCT00863707|Regadenoson|regadenoson|mesh-list
19871441|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19871442|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19871443|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
19871444|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
19871445|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871446|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871447|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871448|NCT00863746|Sorafenib|sorafenib|mesh-list
19871449|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871450|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871451|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871452|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871453|NCT00863772|Tanezumab|tanezumab|mesh-list
19871454|NCT00863772|Analgesics|analgesics|mesh-ancestor
19871455|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
19871456|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871457|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871458|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19871459|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19871460|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19871461|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871462|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871463|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871464|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871465|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
19871466|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19871467|NCT00864032|Sorafenib|sorafenib|mesh-list
19871468|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256820|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871469|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871470|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970051|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
19732016|NCT04578938|Analgesics|analgesics|mesh-ancestor
19871471|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871472|NCT00864097|Diclofenac|diclofenac|mesh-list
19871473|NCT00864097|Tanezumab|tanezumab|mesh-list
19732017|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
19732018|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732019|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732020|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19732021|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19732022|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
19732023|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
19732024|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732025|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19732026|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19732027|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732028|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732029|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19732030|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19732031|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19732032|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732033|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732034|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19732035|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732036|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732037|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
19732038|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732039|NCT04579133|Durvalumab|durvalumab|mesh-list
19732040|NCT04579133|Olaparib|olaparib|mesh-list
19871474|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19871475|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19871476|NCT00864097|Analgesics|analgesics|mesh-ancestor
19871477|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
19871478|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871479|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871480|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19871481|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871482|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19871483|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871484|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871485|NCT00864123|Cycloserine|cycloserine|mesh-list
19871486|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19871487|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871488|NCT00864123|Renal Agents|renal agents|mesh-ancestor
19871489|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19871490|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
19871491|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19871492|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
19871493|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871494|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19871495|NCT00864253|Dacarbazine|dacarbazine|mesh-list
19871496|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871497|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19871498|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
19871499|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871500|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
19871501|NCT00864383|Rifampin|rifampin|mesh-list
19871502|NCT00864383|Isoniazid|isoniazid|mesh-list
19871503|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
19871504|NCT00864383|Ethambutol|ethambutol|mesh-list
19871505|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19871506|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871507|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19871508|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19871509|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871510|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871511|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871512|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20256821|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871513|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
19871514|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
19871515|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871516|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19871517|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20256822|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
19871518|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19871519|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19871520|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19871521|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19871522|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19871523|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19871524|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
19871525|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19871526|NCT00864513|Pemetrexed|pemetrexed|mesh-list
19871527|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871528|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871529|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871530|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19871531|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871532|NCT00864539|Vitamin D|vitamin d|mesh-list
19871533|NCT00864539|Calcium|calcium|mesh-list
19871534|NCT00864539|Vitamins|vitamins|mesh-ancestor
19871535|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
19871536|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871537|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19871538|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19871539|NCT00864682|Lidocaine|lidocaine|mesh-list
19871540|NCT00864682|Propofol|propofol|mesh-list
19871541|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
19871542|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
19871543|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19871544|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871545|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
19871546|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871547|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19871548|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19871549|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19871550|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871551|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871552|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19871553|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19871554|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
19871555|NCT00864721|Sunitinib|sunitinib|mesh-list
19871556|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871557|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19871558|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19871559|NCT00864721|Growth Substances|growth substances|mesh-ancestor
19871560|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871561|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
19871562|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871563|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871564|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871565|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19871566|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
19871567|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19871568|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256823|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256824|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20256825|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19449430|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449431|NCT03435289|Gemcitabine|gemcitabine|mesh-list
19449432|NCT03435289|Paclitaxel|paclitaxel|mesh-list
19449433|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19732041|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19732042|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732043|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19449434|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19449435|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449436|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
19449437|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
19449438|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
19449439|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732044|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732045|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732046|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
19732047|NCT04578847|Dasatinib|dasatinib|mesh-list
19732048|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871569|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732049|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19732050|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732051|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735645|NCT04537689|Methotrexate|methotrexate|mesh-list
19735646|NCT04537689|Ixekizumab|ixekizumab|mesh-list
19735647|NCT04537689|Acitretin|acitretin|mesh-list
19735648|NCT04537689|Cyclosporins|cyclosporins|mesh-list
19735649|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19735650|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
19735651|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19735652|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735653|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19735654|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
19735655|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735656|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735657|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
19735658|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735659|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19735660|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735661|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
19735662|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735663|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19735664|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
19735665|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735666|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19735667|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
19735668|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
19735669|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19735670|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19735671|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735672|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
19735673|NCT04537533|Coagulants|coagulants|mesh-ancestor
19735674|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19735675|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
19735676|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
19735677|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735678|NCT04537065|Mydriatics|mydriatics|mesh-list
19735679|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
19735680|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871570|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19871571|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19871572|NCT00864916|Protective Agents|protective agents|mesh-ancestor
19871573|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871574|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
19871575|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19871576|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
19871577|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
19871578|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871579|NCT00865020|Telmisartan|telmisartan|mesh-list
19871580|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19871581|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19871582|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19871583|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871584|NCT00865098|Cetuximab|cetuximab|mesh-list
19871585|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871586|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871587|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19871588|NCT00865124|Spironolactone|spironolactone|mesh-list
19871589|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19871590|NCT00865124|Diuretics|diuretics|mesh-ancestor
19871591|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
19871592|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871593|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20256826|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19871594|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871595|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871596|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19871597|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
19871598|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871599|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19871600|NCT00865189|Leucovorin|leucovorin|mesh-list
19871601|NCT00865189|Folic Acid|folic acid|mesh-list
19732052|NCT04578470|Vitamin D|vitamin d|mesh-list
19732053|NCT04578470|Vitamins|vitamins|mesh-ancestor
19732054|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
19732055|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732056|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19732057|NCT04578496|Afamelanotide|afamelanotide|mesh-list
19732058|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732059|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
19732060|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
19871602|NCT00865189|Bevacizumab|bevacizumab|mesh-list
19871603|NCT00865189|Fluorouracil|fluorouracil|mesh-list
19871604|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
19871605|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
19871606|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871607|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871608|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19871609|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19871610|NCT00865189|Growth Substances|growth substances|mesh-ancestor
19871611|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871612|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19871613|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
19871614|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871615|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19871616|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871617|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
19871618|NCT00865189|Antidotes|antidotes|mesh-ancestor
19871619|NCT00865189|Protective Agents|protective agents|mesh-ancestor
19871620|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
19871621|NCT00865189|Vitamins|vitamins|mesh-ancestor
19871622|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
19871623|NCT00865189|Hematinics|hematinics|mesh-ancestor
19871624|NCT00865202|Tryptophan|tryptophan|mesh-list
19871625|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19871626|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
19871627|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19871628|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
19871629|NCT00865280|Linezolid|linezolid|mesh-list
19871630|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19871631|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871632|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19871633|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19871634|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871635|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871636|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871637|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19871638|NCT00865566|Vaccines|vaccines|mesh-list
19871639|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
19871640|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871641|NCT00865709|Leucovorin|leucovorin|mesh-list
19871642|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
19871643|NCT00865709|Fluorouracil|fluorouracil|mesh-list
19871644|NCT00865709|Sorafenib|sorafenib|mesh-list
19871645|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
19871646|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871647|NCT00865709|Antidotes|antidotes|mesh-ancestor
19871648|NCT00865709|Protective Agents|protective agents|mesh-ancestor
19871649|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871650|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
19871651|NCT00865709|Vitamins|vitamins|mesh-ancestor
19871652|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
19871653|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
19871654|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871655|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19871656|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871657|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
19871658|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871659|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871660|NCT00865969|Belinostat|belinostat|mesh-list
19871661|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871662|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19871663|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871664|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871665|NCT00866034|Cetrorelix|cetrorelix|mesh-list
19871666|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19871667|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
19871668|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19871669|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871670|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
19732061|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19871671|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871672|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19871673|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871674|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871675|NCT00866281|Midostaurin|midostaurin|mesh-list
19871676|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871677|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871678|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871679|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970052|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19970053|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970054|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
19970055|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970056|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19970057|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19970058|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19970059|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19970060|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970061|NCT01780337|Oxytocin|oxytocin|mesh-list
19970062|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
19970063|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19970064|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970065|NCT01780389|Milnacipran|milnacipran|mesh-list
19970066|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
19970067|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19970068|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19970069|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19970070|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970071|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970072|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970073|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19970074|NCT01780389|Analgesics|analgesics|mesh-ancestor
19970075|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
19970076|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970077|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
19970078|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19970079|NCT01780454|Rituximab|rituximab|mesh-list
19970080|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19970081|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970082|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
19970083|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970084|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970085|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19970086|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19970087|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19970088|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
19970089|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970090|NCT01780545|Docetaxel|docetaxel|mesh-list
19970091|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970092|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
19970093|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
19970094|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
19970095|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970096|NCT01780662|Gemcitabine|gemcitabine|mesh-list
19970097|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19970098|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19970099|NCT01780662|Antibodies|antibodies|mesh-list
19970100|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
19970101|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19970102|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
19970103|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
19970104|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970105|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970106|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
19970107|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970108|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970109|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
19970110|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970111|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970112|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970113|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
19970114|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20535474|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535475|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
20535476|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535477|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535478|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535479|NCT01820442|Lofexidine|lofexidine|mesh-list
20535480|NCT01820442|Clonidine|clonidine|mesh-list
20535481|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535482|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20535483|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871680|NCT00866294|Paroxetine|paroxetine|mesh-list
19871681|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19871682|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19871683|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871684|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871685|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871686|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
19871687|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871688|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19871689|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
19871690|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19871691|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19871692|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19871693|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871694|NCT00866307|Cytarabine|cytarabine|mesh-list
19871695|NCT00866307|Dexamethasone|dexamethasone|mesh-list
19871696|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
19871697|NCT00866307|Prednisone|prednisone|mesh-list
19871698|NCT00866307|Cortisone|cortisone|mesh-list
19871699|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
19871700|NCT00866307|Doxorubicin|doxorubicin|mesh-list
19871701|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19871702|NCT00866307|Methotrexate|methotrexate|mesh-list
19871703|NCT00866307|Vincristine|vincristine|mesh-list
19871704|NCT00866307|Daunorubicin|daunorubicin|mesh-list
19871705|NCT00866307|Asparaginase|asparaginase|mesh-list
19871706|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
19871707|NCT00866307|Pegaspargase|pegaspargase|mesh-list
19871708|NCT00866307|Thioguanine|thioguanine|mesh-list
19871709|NCT00866307|BB 1101|bb 1101|mesh-list
19871710|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
19871711|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871712|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
19871713|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871714|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871715|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19871716|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
19871717|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871718|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871719|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19871720|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19871721|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
19871722|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
19871723|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871724|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19871725|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
19871726|NCT00866307|Hormones|hormones|mesh-ancestor
19871727|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871728|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19871729|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
19871730|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535484|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
19871731|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19871732|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19871733|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19871734|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19871735|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
19871736|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19871737|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19871738|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
19871739|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
19871740|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19871741|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871742|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
19871743|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871744|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19871745|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
19871746|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
19871747|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
19871748|NCT00866320|Sorafenib|sorafenib|mesh-list
19871749|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871750|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871751|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871752|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871753|NCT00866333|Entinostat|entinostat|mesh-list
19871754|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871755|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19871756|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871757|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871758|NCT00866359|Apremilast|apremilast|mesh-list
19871759|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19871760|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19871761|NCT00866359|Analgesics|analgesics|mesh-ancestor
19871762|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
19871763|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871764|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871765|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19871766|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871767|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19871768|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19871769|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871770|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871771|NCT00866619|Vaccines|vaccines|mesh-list
19871772|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
19871773|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871774|NCT00866658|Lixisenatide|lixisenatide|mesh-list
19871775|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19871776|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871777|NCT00866723|Bevacizumab|bevacizumab|mesh-list
19871778|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871779|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871780|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19871781|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19871782|NCT00866723|Growth Substances|growth substances|mesh-ancestor
19871783|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871784|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
19871785|NCT00866749|Cytarabine|cytarabine|mesh-list
19871786|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
19871787|NCT00866749|Doxorubicin|doxorubicin|mesh-list
19871788|NCT00866749|Methotrexate|methotrexate|mesh-list
19871789|NCT00866749|Vincristine|vincristine|mesh-list
19871790|NCT00866749|Daunorubicin|daunorubicin|mesh-list
19871791|NCT00866749|Asparaginase|asparaginase|mesh-list
19871792|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
19871793|NCT00866749|Thioguanine|thioguanine|mesh-list
19871794|NCT00866749|Pegaspargase|pegaspargase|mesh-list
19871795|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871796|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
19871797|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871798|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871799|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19871800|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
19871801|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871802|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871803|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19871804|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19871805|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19871806|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19871807|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871808|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19871809|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
19871810|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19871811|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19871812|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
19871813|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19871814|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19871815|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871816|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
19871817|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871818|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19871819|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
19871820|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
19871821|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
19871822|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19871823|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
19871824|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19871825|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19871826|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871827|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871828|NCT00866788|Omalizumab|omalizumab|mesh-list
19871829|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
19871830|NCT00866788|Promethazine|promethazine|mesh-list
19871831|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19871832|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
19871833|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19871834|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19871835|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
19871836|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19871837|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19871838|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19871839|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871840|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
19871841|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
19871842|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
19871843|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871844|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
19871845|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
19871846|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19871847|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
19871848|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871849|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871850|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
19871851|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
19871852|NCT00866879|Sirolimus|sirolimus|mesh-list
19871853|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19871854|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871855|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19871856|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871857|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
19871858|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871859|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
19871860|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871861|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
19871862|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871863|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
19871864|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871865|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871866|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20535485|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871867|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
19871868|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871869|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871870|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19871871|NCT00867009|Pemetrexed|pemetrexed|mesh-list
19871872|NCT00867009|Cetuximab|cetuximab|mesh-list
19871873|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871874|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871875|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871876|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19871877|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19871878|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871879|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
19871880|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19871881|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
19871882|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19871883|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871884|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
19871885|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
19871886|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
19871887|NCT00867087|Rituximab|rituximab|mesh-list
19871888|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19871889|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871890|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871891|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
19871892|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871893|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871894|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19871895|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
19871896|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871897|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871898|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871899|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871900|NCT00867139|Oseltamivir|oseltamivir|mesh-list
19871901|NCT00867139|Ribavirin|ribavirin|mesh-list
19871902|NCT00867139|Zanamivir|zanamivir|mesh-list
19871903|NCT00867139|Amantadine|amantadine|mesh-list
19871904|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
19871905|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
19871906|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19871907|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871908|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871909|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
19871910|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19871911|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19871912|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
19871913|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19871914|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871915|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19871916|NCT00867139|Analgesics|analgesics|mesh-ancestor
19871917|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
19871918|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19871919|NCT00867217|Vitamin D|vitamin d|mesh-list
20535486|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20535487|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20535488|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20535489|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
19871920|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
19871921|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
19871922|NCT00867217|Vitamins|vitamins|mesh-list
19871923|NCT00867217|Letrozole|letrozole|mesh-list
19871924|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
19871925|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871926|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19871927|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19871928|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871929|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19871930|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19871931|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871932|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871933|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19871934|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
19871935|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19871936|NCT00867308|Lenalidomide|lenalidomide|mesh-list
19871937|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
19871938|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871939|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19871940|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19871941|NCT00867308|Growth Substances|growth substances|mesh-ancestor
19871942|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
19871943|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871944|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
19871945|NCT00867334|Panitumumab|panitumumab|mesh-list
19871946|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871947|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19871948|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19871949|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871950|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871951|NCT00867360|Mifepristone|mifepristone|mesh-list
19871952|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19871953|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
19871954|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19871955|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871956|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19871957|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19871958|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19871959|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
19871960|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19871961|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19871962|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
19871963|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535490|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553625|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19871964|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
19871965|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19871966|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19871967|NCT00867451|Melatonin|melatonin|mesh-list
19871968|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
19871969|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871970|NCT00867451|Protective Agents|protective agents|mesh-ancestor
19871971|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871972|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19871973|NCT00867490|Amlodipine|amlodipine|mesh-list
19871974|NCT00867490|Candesartan|candesartan|mesh-list
19871975|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19871976|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19871977|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19871978|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19871979|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871980|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19871981|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871982|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
19871983|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19871984|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19871985|NCT00867490|Diuretics|diuretics|mesh-ancestor
19871986|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
19871987|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19871988|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19871989|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19871990|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
19871991|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19871992|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871993|NCT00867529|Rituximab|rituximab|mesh-list
19871994|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19871995|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19871996|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
19871997|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19871998|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19871999|NCT00867659|Cetrorelix|cetrorelix|mesh-list
19872000|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19872001|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
19872002|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19872003|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872004|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
19872005|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19872006|NCT00867789|Trimethoprim|trimethoprim|mesh-list
19872007|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19872008|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
19872009|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19872010|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872011|NCT00867789|Renal Agents|renal agents|mesh-ancestor
19872012|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
19872013|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19872014|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19872015|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19872016|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872017|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872018|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19872019|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19872020|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19872021|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19872022|NCT00867932|Eculizumab|eculizumab|mesh-list
19872023|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19872024|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872025|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
19872026|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872027|NCT00868140|Pioglitazone|pioglitazone|mesh-list
19872028|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19872029|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872030|NCT00868166|Riluzole|riluzole|mesh-list
19872031|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
19872032|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19872033|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19872034|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872035|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872036|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872037|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19872038|NCT00868166|Protective Agents|protective agents|mesh-ancestor
19872039|NCT00868192|Bevacizumab|bevacizumab|mesh-list
19872040|NCT00868192|Pemetrexed|pemetrexed|mesh-list
19872041|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872042|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872043|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19872044|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19872045|NCT00868192|Growth Substances|growth substances|mesh-ancestor
19872046|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872047|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
19872048|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872049|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872050|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19872051|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19872052|NCT00868231|Bromides|bromides|mesh-list
19872053|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
19872054|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19872055|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
19872056|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872057|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872058|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19872059|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
19872060|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
19872061|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19872062|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
19872063|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872064|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872065|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
19872066|NCT00868296|Pantoprazole|pantoprazole|mesh-list
19872067|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19872068|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19872069|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19872070|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872071|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872072|NCT00868309|Antivenins|antivenins|mesh-list
19872073|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
19872074|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872075|NCT00868348|Ketorolac|ketorolac|mesh-list
19872076|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19872077|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872078|NCT00868348|Analgesics|analgesics|mesh-ancestor
19872079|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
19872080|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872081|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535491|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872082|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872083|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872084|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19872085|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872086|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872087|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19872088|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
19872089|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872090|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19872091|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872092|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872093|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872094|NCT00868452|Valproic Acid|valproic acid|mesh-list
19872095|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
19872096|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19872097|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
19872098|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872099|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872100|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872101|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
19872102|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872103|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449440|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19449441|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
19449442|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
19449443|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872104|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872105|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
19872106|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
19872107|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449444|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449445|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449446|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
19449447|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449448|NCT03435250|Gemcitabine|gemcitabine|mesh-list
19449449|NCT03435250|Paclitaxel|paclitaxel|mesh-list
19449450|NCT03435250|Docetaxel|docetaxel|mesh-list
19449451|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19449452|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449453|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872108|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19872109|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19872110|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19872111|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19872112|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872113|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19872114|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19872115|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
19872116|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19872117|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19872118|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
19872119|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19872120|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872121|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872122|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19872123|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19872124|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19872125|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872126|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872127|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872128|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872129|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19872130|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19872131|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19872132|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872133|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872134|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872135|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19872136|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19872137|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
19872138|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20256827|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20256828|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20256829|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20256830|NCT00476437|Insulin|insulin|mesh-list
20256831|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20256832|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
20256833|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
20256834|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20256835|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256836|NCT00476463|Emtricitabine|emtricitabine|mesh-list
20256837|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
19449454|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
19449455|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
19449456|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449457|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19449458|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
19449459|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
19449460|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449461|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449462|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449463|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
19449464|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449465|NCT03435133|Ticagrelor|ticagrelor|mesh-list
19449466|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19449467|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19449468|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19449469|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19449470|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19449471|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
19449472|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872139|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19872140|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
19872141|NCT00868790|Metformin|metformin|mesh-list
19872142|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19872143|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872144|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19872145|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19872146|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872147|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872148|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872149|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872150|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20535492|NCT01820442|Analgesics|analgesics|mesh-ancestor
20535493|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
20535494|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
19872151|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19872152|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19872153|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872154|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872155|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872156|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19872157|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19872158|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
19872159|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19872160|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19872161|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
19872162|NCT00869050|Capecitabine|capecitabine|mesh-list
19872163|NCT00869050|Temozolomide|temozolomide|mesh-list
19872164|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19872165|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
19872166|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872167|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872168|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19872169|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
19872170|NCT00869089|Apremilast|apremilast|mesh-list
19872171|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19872172|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872173|NCT00869089|Analgesics|analgesics|mesh-ancestor
19872174|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
19872175|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872176|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872177|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872178|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872179|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19872180|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19872181|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872182|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872183|NCT00869141|Timolol|timolol|mesh-list
19872184|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19872185|NCT00869141|Dorzolamide|dorzolamide|mesh-list
19872186|NCT00869141|Brinzolamide|brinzolamide|mesh-list
19872187|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19872188|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19872189|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872190|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872191|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872192|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872193|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19872194|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19872195|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19872196|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19872197|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19872198|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19872199|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872200|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
19872201|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19872202|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872203|NCT00869323|Rituximab|rituximab|mesh-list
19872204|NCT00869323|Bortezomib|bortezomib|mesh-list
19872205|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872206|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872207|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
19872208|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535495|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
20535496|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19872209|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872210|NCT00869401|Temozolomide|temozolomide|mesh-list
19872211|NCT00869401|Dasatinib|dasatinib|mesh-list
19872212|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19872213|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
19872214|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872215|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872216|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19872217|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872218|NCT00869440|Midazolam|midazolam|mesh-list
19872219|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19872220|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19872221|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872222|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872223|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19872224|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872225|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872226|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19872227|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
19872228|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
19872229|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
19872230|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
19872231|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872232|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872233|NCT00869518|Trimethoprim|trimethoprim|mesh-list
19872234|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19872235|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
19872236|NCT00869518|Rifabutin|rifabutin|mesh-list
19872237|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19872238|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872239|NCT00869518|Renal Agents|renal agents|mesh-ancestor
19872240|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
19872241|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19872242|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19872243|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19872244|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872245|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872246|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19872247|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19872248|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19872249|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19872250|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19872251|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
19872252|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19872253|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19872254|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19872255|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19872256|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872257|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872258|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
19872259|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872260|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19872261|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19872262|NCT00869622|Vitamin D|vitamin d|mesh-list
19872263|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
19872264|NCT00869622|Calcium|calcium|mesh-list
19872265|NCT00869622|Vitamins|vitamins|mesh-ancestor
19872266|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
19872267|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872268|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19872269|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19872270|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19872271|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19872272|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872273|NCT00869778|Vaccines|vaccines|mesh-list
19872274|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
19872275|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872276|NCT00869791|Levodopa|levodopa|mesh-list
19872277|NCT00869791|Carbidopa|carbidopa|mesh-list
19872278|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19872279|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19872280|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19872281|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
19872282|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872283|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872284|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872285|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19872286|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872287|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19872288|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
19872289|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
19872290|NCT00869960|Ritonavir|ritonavir|mesh-list
19872291|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19872292|NCT00869960|Tenofovir|tenofovir|mesh-list
19872293|NCT00869960|Emtricitabine|emtricitabine|mesh-list
19872294|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19872295|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19872296|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
19872297|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872298|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872299|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19872300|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19872301|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
19872302|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872303|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19872304|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19872305|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19872306|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19872307|NCT00869999|Rituximab|rituximab|mesh-list
19872308|NCT00869999|Everolimus|everolimus|mesh-list
19872309|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872310|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872311|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
19872312|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872313|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872314|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872315|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
19872316|NCT00870103|Dexamethasone|dexamethasone|mesh-list
19872317|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19872318|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872319|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
19872320|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
19872321|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872322|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872323|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19872324|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
19872325|NCT00870103|Hormones|hormones|mesh-ancestor
19872326|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19872327|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19872328|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872329|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19872330|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872331|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19872332|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19872333|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872334|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872335|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19872336|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19872337|NCT00870194|Exenatide|exenatide|mesh-list
19872338|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19872339|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872340|NCT00870194|Incretins|incretins|mesh-ancestor
19872341|NCT00870194|Hormones|hormones|mesh-ancestor
19872342|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19872343|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19872344|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
19872345|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872346|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872347|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19872348|NCT00870363|Efavirenz|efavirenz|mesh-list
19872349|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19872350|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
19872351|NCT00870363|Maraviroc|maraviroc|mesh-list
19872352|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19872353|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872354|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872355|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
19872356|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872357|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19872358|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19872359|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19872360|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19872361|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19872362|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19872363|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19872364|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19872365|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19872366|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19872367|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19872368|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19872369|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19872370|NCT00870467|Adalimumab|adalimumab|mesh-list
19872371|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872372|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872373|NCT00870584|Omalizumab|omalizumab|mesh-list
19872374|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19872375|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19872376|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
19872377|NCT00870727|Aripiprazole|aripiprazole|mesh-list
19872378|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
19872379|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872380|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19872381|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872382|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872383|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872384|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
19872385|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
19872386|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872387|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872388|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19872389|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19872390|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
19872391|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19872392|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19872393|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19872394|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19872395|NCT00870740|Daclizumab|daclizumab|mesh-list
19872396|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872397|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
19872398|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872399|NCT00870870|Gemcitabine|gemcitabine|mesh-list
19872400|NCT00870870|Carboplatin|carboplatin|mesh-list
19872401|NCT00870870|Cetuximab|cetuximab|mesh-list
19872402|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19872403|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872404|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19872405|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
19872406|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872407|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
19872408|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872409|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872410|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872411|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
19872412|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872413|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872414|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
19872415|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19872416|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
19872417|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872418|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872419|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19872420|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
19872421|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
19872422|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19872423|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
19872424|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872425|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872426|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
19872427|NCT00871000|Antidotes|antidotes|mesh-ancestor
19872428|NCT00871000|Protective Agents|protective agents|mesh-ancestor
19872429|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872430|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
19872431|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
19872432|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872433|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19872434|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
19872435|NCT00871169|Irinotecan|irinotecan|mesh-list
19872436|NCT00871169|Cetuximab|cetuximab|mesh-list
19872437|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872438|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19872439|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19872440|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872441|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872442|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872443|NCT00871234|Etravirine|etravirine|mesh-list
19872444|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19872445|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19872446|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872447|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872448|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
19872449|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872450|NCT00871260|Regadenoson|regadenoson|mesh-list
19872451|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19872452|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19872453|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
19872454|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
19872455|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872456|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872457|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872458|NCT00871338|Vaccines|vaccines|mesh-list
19872459|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19872460|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
19872461|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872462|NCT00871403|Pemetrexed|pemetrexed|mesh-list
19872463|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872464|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872465|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872466|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19872467|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19872468|NCT00871494|Azithromycin|azithromycin|mesh-list
19872469|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19872470|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872471|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
19872472|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19872473|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872474|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872475|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872476|NCT00871624|Analgesics|analgesics|mesh-ancestor
19872477|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
19872478|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872479|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19872480|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19872481|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19872482|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872483|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872484|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970115|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19970116|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
19970117|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970118|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19970119|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19970120|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970121|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970122|NCT01780935|Ranibizumab|ranibizumab|mesh-list
19970123|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19970124|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19970125|NCT01780935|Growth Substances|growth substances|mesh-ancestor
19970126|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970127|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
19970128|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970129|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
19970130|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
19970131|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970132|NCT01780974|Protective Agents|protective agents|mesh-ancestor
19872485|NCT00871689|Vidarabine|vidarabine|mesh-list
19872486|NCT00871689|Aldesleukin|aldesleukin|mesh-list
19872487|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
19872488|NCT00871689|Fludarabine|fludarabine|mesh-list
19872489|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
19872490|NCT00871689|Interleukin-2|interleukin-2|mesh-list
19872491|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872492|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
19872493|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872494|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872495|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19872496|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
19872497|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872498|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872499|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19872500|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19872501|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
19872502|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
19872503|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872504|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872505|NCT00871689|Analgesics|analgesics|mesh-ancestor
19872506|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
19872507|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872508|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19872509|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19872510|NCT00871728|Itraconazole|itraconazole|mesh-list
19872511|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
19872512|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872513|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19872514|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19872515|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872516|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872517|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19872518|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
19872519|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19872520|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872521|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19872522|NCT00871780|Natalizumab|natalizumab|mesh-list
19872523|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
19872524|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872525|NCT00871858|Fulvestrant|fulvestrant|mesh-list
19872526|NCT00871858|Anastrozole|anastrozole|mesh-list
19872527|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19872528|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872529|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19872530|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19872531|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
19872532|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19872533|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732062|NCT04578691|Protective Agents|protective agents|mesh-ancestor
19732063|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732064|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732065|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19732066|NCT04578236|Tretinoin|tretinoin|mesh-list
19732067|NCT04578236|Captopril|captopril|mesh-list
19732068|NCT04578236|Isotretinoin|isotretinoin|mesh-list
19732069|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732070|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
19732071|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732072|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19732073|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
19732074|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732075|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872534|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19872535|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19872536|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872537|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872538|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19872539|NCT00871871|Isosorbide|isosorbide|mesh-list
19872540|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19872541|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19872542|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19872543|NCT00871871|Diuretics|diuretics|mesh-ancestor
19736028|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19872544|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
19872545|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872546|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19872547|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19872548|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872549|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19872550|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
19872551|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19872552|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19872553|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872554|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19872555|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872556|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872557|NCT00872027|Citalopram|citalopram|mesh-list
19872558|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19872559|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19872560|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19872561|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872562|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872563|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
19872564|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872565|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19872566|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
19872567|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872568|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
19872569|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
19872570|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19872571|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19872572|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872573|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872574|NCT00872170|Urological Agents|urological agents|mesh-ancestor
19872575|NCT00872534|Aspirin|aspirin|mesh-list
19872576|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19872577|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872578|NCT00872534|Analgesics|analgesics|mesh-ancestor
19872579|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
19872580|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872581|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872582|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872583|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872584|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19872585|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19872586|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872587|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19872588|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19872589|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872590|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
19872591|NCT00872599|Fenofibrate|fenofibrate|mesh-list
19872592|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19872593|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
19872594|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872595|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19872596|NCT00872729|Cysteamine|cysteamine|mesh-list
19872597|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19872598|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872599|NCT00872898|Memantine|memantine|mesh-list
19872600|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19872601|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19872602|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
19872603|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872604|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872605|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872606|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19872607|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19872608|NCT00872989|Docetaxel|docetaxel|mesh-list
19872609|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872610|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872611|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
19872612|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
19872613|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872614|NCT00873041|Deferasirox|deferasirox|mesh-list
19872615|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20535497|NCT01820455|Mupirocin|mupirocin|mesh-list
19872616|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
19872617|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
19872618|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872619|NCT00873093|Leucovorin|leucovorin|mesh-list
19872620|NCT00873093|Cytarabine|cytarabine|mesh-list
19872621|NCT00873093|Prednisone|prednisone|mesh-list
19872622|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
19872623|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19872624|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19872625|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19872626|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
19872627|NCT00873093|Doxorubicin|doxorubicin|mesh-list
19872628|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19872629|NCT00873093|Methotrexate|methotrexate|mesh-list
19872630|NCT00873093|Etoposide|etoposide|mesh-list
19872631|NCT00873093|Vincristine|vincristine|mesh-list
19872632|NCT00873093|Bortezomib|bortezomib|mesh-list
19872633|NCT00873093|Asparaginase|asparaginase|mesh-list
19872634|NCT00873093|Pegaspargase|pegaspargase|mesh-list
19872635|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
19872636|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
19872637|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872638|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
19872639|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872640|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872641|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19872642|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
19872643|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872644|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872645|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19872646|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19872647|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19872648|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19872649|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872650|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872651|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
19872652|NCT00873093|Hormones|hormones|mesh-ancestor
19872653|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19872654|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19872655|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19872656|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
19872657|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19872658|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19872659|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
19872660|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
19872661|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19872662|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19872663|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20256838|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535498|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19872664|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
19872665|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872666|NCT00873093|Antidotes|antidotes|mesh-ancestor
19872667|NCT00873093|Protective Agents|protective agents|mesh-ancestor
19872668|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
19872669|NCT00873093|Vitamins|vitamins|mesh-ancestor
19872670|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
19872671|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872672|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
19872673|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
19872674|NCT00873119|Paclitaxel|paclitaxel|mesh-list
19872675|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20256839|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20256840|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20256841|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256842|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256843|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20256844|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20256845|NCT00476515|Rituximab|rituximab|mesh-list
20256846|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256847|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256848|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
20256849|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256850|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256851|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
19872676|NCT00873119|Carboplatin|carboplatin|mesh-list
19872677|NCT00873119|Belinostat|belinostat|mesh-list
19872678|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19872679|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872680|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872681|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
19872682|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
19872683|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872684|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19872685|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872686|NCT00873327|Tazobactam|tazobactam|mesh-list
19872687|NCT00873327|Piperacillin|piperacillin|mesh-list
19872688|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19872689|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20256852|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20256853|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256854|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
20256855|NCT00476619|Hematinics|hematinics|mesh-ancestor
20256856|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20256857|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20256858|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19872690|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872691|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20535499|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535500|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
20535501|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
19872692|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872693|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872694|NCT00873730|Etanercept|etanercept|mesh-list
19872695|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19872696|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872697|NCT00873730|Analgesics|analgesics|mesh-ancestor
19872698|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
19872699|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872700|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872701|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872702|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872703|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19872704|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872705|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
20535502|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20535503|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20535504|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535505|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535506|NCT01820624|Tretinoin|tretinoin|mesh-list
20535507|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
20535508|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
20535509|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20535510|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535511|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872706|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19872707|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
20535512|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
20535513|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20535514|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535515|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872708|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872709|NCT00874120|Phenylephrine|phenylephrine|mesh-list
19872710|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
19872711|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19872712|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
19872713|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
19872714|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872715|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872716|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
19872717|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19872718|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
19872719|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
19872720|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19872721|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19872722|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19872723|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872724|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872725|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535516|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872726|NCT00874120|Protective Agents|protective agents|mesh-ancestor
20256859|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
19872727|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
19872728|NCT00874237|Loxapine|loxapine|mesh-list
19872729|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19872730|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872731|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19872732|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19872733|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872734|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872735|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872736|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872737|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19872738|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872739|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872740|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872741|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19872742|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
20535517|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
20535518|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
19872743|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872744|NCT00874432|Lisinopril|lisinopril|mesh-list
19872745|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19872746|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
19872747|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
19872748|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872749|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19872750|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19872751|NCT00874432|Protective Agents|protective agents|mesh-ancestor
19872752|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872753|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19872754|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872755|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872756|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872757|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19872758|NCT00874731|Sirolimus|sirolimus|mesh-list
20535519|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
20535520|NCT01820767|Atorvastatin|atorvastatin|mesh-list
19872759|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19872760|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872761|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19872762|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872763|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
19872764|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872765|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
19872766|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872767|NCT00874770|Ribavirin|ribavirin|mesh-list
19872768|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19872769|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
19872770|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872771|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
19872772|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872773|NCT00874848|Paclitaxel|paclitaxel|mesh-list
19872774|NCT00874848|Carboplatin|carboplatin|mesh-list
20535521|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20535522|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20535523|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
19872775|NCT00874848|Cetuximab|cetuximab|mesh-list
19872776|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19872777|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19872778|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872779|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872780|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
19872781|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
19872782|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872783|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872784|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
19872785|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
19872786|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19872787|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19872788|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19872789|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19872790|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19872791|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19872792|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872793|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872794|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535524|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872795|NCT00875017|Sevelamer|sevelamer|mesh-list
19872796|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
19872797|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
19872798|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872799|NCT00875056|Vorinostat|vorinostat|mesh-list
19872800|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872801|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19872802|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872803|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872804|NCT00875212|Calcium|calcium|mesh-list
19872805|NCT00875212|Fluorides|fluorides|mesh-list
19872806|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
19872807|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19872808|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872809|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
19872810|NCT00875212|Protective Agents|protective agents|mesh-ancestor
19872811|NCT00875277|Betamethasone|betamethasone|mesh-list
19872812|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
19872813|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19872814|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
19872815|NCT00875277|Calcipotriene|calcipotriene|mesh-list
19872816|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19872817|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872818|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
19872819|NCT00875277|Hormones|hormones|mesh-ancestor
19872820|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19872821|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872822|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19872823|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
19872824|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
19872825|NCT00875433|Afatinib|afatinib|mesh-list
19872826|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872827|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19872828|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872829|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872830|NCT00875550|Fentanyl|fentanyl|mesh-list
19872831|NCT00875550|Midazolam|midazolam|mesh-list
19872832|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
19872833|NCT00875550|Morphine|morphine|mesh-list
19872834|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19872835|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872836|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872837|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872838|NCT00875550|Analgesics|analgesics|mesh-ancestor
19872839|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
19872840|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872841|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19872842|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19872843|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19872844|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872845|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872846|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872847|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19872848|NCT00875550|Narcotics|narcotics|mesh-ancestor
19872849|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19872850|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19872851|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
19872852|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
19872853|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19872854|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20256860|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872855|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872856|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
19872857|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
19872858|NCT00875615|Carboplatin|carboplatin|mesh-list
19872859|NCT00875615|Sorafenib|sorafenib|mesh-list
19872860|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872861|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19872862|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872863|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872864|NCT00875667|Fludarabine|fludarabine|mesh-list
19872865|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
19872866|NCT00875667|Lenalidomide|lenalidomide|mesh-list
19872867|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872868|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19872869|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
19970133|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872870|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872871|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872872|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
19872873|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872874|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19872875|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19872876|NCT00875667|Growth Substances|growth substances|mesh-ancestor
19872877|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
19872878|NCT00875836|Buspirone|buspirone|mesh-list
19872879|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19872880|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872881|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872882|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872883|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872884|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19872885|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
19872886|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872887|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872888|NCT00875979|Trastuzumab|trastuzumab|mesh-list
19872889|NCT00875979|Pertuzumab|pertuzumab|mesh-list
19872890|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19872891|NCT00875979|Maytansine|maytansine|mesh-list
19872892|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872893|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872894|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19872895|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872896|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
19872897|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
19872898|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872899|NCT00876187|Naproxen|naproxen|mesh-list
19872900|NCT00876187|Tanezumab|tanezumab|mesh-list
19872901|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19872902|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19872903|NCT00876187|Analgesics|analgesics|mesh-ancestor
19872904|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
19872905|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872906|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872907|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19872908|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19872909|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
19872910|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19872911|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872912|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872913|NCT00876200|Minoxidil|minoxidil|mesh-list
19872914|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19872915|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
19872916|NCT00876343|Aripiprazole|aripiprazole|mesh-list
19872917|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
19872918|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19872919|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19872920|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19872921|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19872922|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872923|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
19872924|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
19872925|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872926|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872927|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19872928|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19872929|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
19872930|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19872931|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19872932|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19872933|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19872934|NCT00876395|Paclitaxel|paclitaxel|mesh-list
19872935|NCT00876395|Trastuzumab|trastuzumab|mesh-list
19872936|NCT00876395|Everolimus|everolimus|mesh-list
19872937|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19872938|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872939|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872940|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
19872941|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
19872942|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872943|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872944|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19872945|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
19872946|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872947|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
19872948|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19872949|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19872950|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19872951|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19872952|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872953|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
19872954|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872955|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872956|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19872957|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872958|NCT00876460|Docetaxel|docetaxel|mesh-list
19872959|NCT00876460|Nintedanib|nintedanib|mesh-list
19872960|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872961|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
19872962|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
19872963|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
19872964|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872965|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19872966|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19872967|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19872968|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19872969|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
19872970|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19872971|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872972|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19872973|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
19872974|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19872975|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19872976|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19872977|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
19872978|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19872979|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872980|NCT00876915|Dalteparin|dalteparin|mesh-list
19872981|NCT00876915|Tinzaparin|tinzaparin|mesh-list
19872982|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19872983|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
19872984|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19872985|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19872986|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19872987|NCT00876928|Vitamin D|vitamin d|mesh-list
19872988|NCT00876928|Vitamins|vitamins|mesh-ancestor
19872989|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
19872990|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19872991|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19872992|NCT00876993|Bevacizumab|bevacizumab|mesh-list
19872993|NCT00876993|Irinotecan|irinotecan|mesh-list
19872994|NCT00876993|Temozolomide|temozolomide|mesh-list
19872995|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19872996|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19872997|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19872998|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19872999|NCT00876993|Growth Substances|growth substances|mesh-ancestor
19873000|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873001|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873002|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19873003|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19873004|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873005|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873006|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19873007|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
19873008|NCT00877006|Prednisone|prednisone|mesh-list
19873009|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
19873010|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19873011|NCT00877006|Rituximab|rituximab|mesh-list
19873012|NCT00877006|Doxorubicin|doxorubicin|mesh-list
19873013|NCT00877006|Vincristine|vincristine|mesh-list
19873014|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873015|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
19873016|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873017|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19873018|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19873019|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
19873020|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873021|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873022|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19873023|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873024|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19873025|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19873026|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19873027|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873028|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873029|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
19873030|NCT00877006|Hormones|hormones|mesh-ancestor
19873031|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873032|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19873033|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19873034|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873035|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
19873036|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873037|NCT00877370|Ertapenem|ertapenem|mesh-list
19873038|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873039|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873040|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
19873041|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19873042|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
19873043|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873044|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873045|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19873046|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
19873047|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
19873048|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20256861|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19873049|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
19873050|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873051|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873052|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19873053|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19873054|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873055|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19873056|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19873057|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19873058|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873059|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
19873060|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873061|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19873062|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19873063|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19873064|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
19873065|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873066|NCT00877773|Sirolimus|sirolimus|mesh-list
19873067|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873068|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873069|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20256862|NCT00476853|Nevirapine|nevirapine|mesh-list
20256863|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19873070|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873071|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
20256864|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19873072|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873073|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
19873074|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873075|NCT00877890|Exenatide|exenatide|mesh-list
19873076|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873077|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873078|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19873079|NCT00877890|Incretins|incretins|mesh-ancestor
19873080|NCT00877890|Hormones|hormones|mesh-ancestor
19873081|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873082|NCT00877929|Amlodipine|amlodipine|mesh-list
19873083|NCT00877929|Telmisartan|telmisartan|mesh-list
19873084|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19873085|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19873086|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19873087|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873088|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19873089|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873090|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
19873091|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19873092|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19873093|NCT00878072|Famciclovir|famciclovir|mesh-list
19873094|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
19873095|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873096|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19873097|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873098|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873099|NCT00878215|Liver Extracts|liver extracts|mesh-list
19873100|NCT00878215|Hematinics|hematinics|mesh-ancestor
19970134|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
19970135|NCT01780974|Vitamins|vitamins|mesh-ancestor
19970136|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
19970137|NCT01780987|Heparin|heparin|mesh-list
19970138|NCT01780987|Calcium heparin|calcium heparin|mesh-list
19970139|NCT01780987|Warfarin|warfarin|mesh-list
19970140|NCT01780987|Apixaban|apixaban|mesh-list
19970141|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
19970142|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19970143|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19970144|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970145|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19970146|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
19970147|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19970148|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
19970149|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970150|NCT01781169|Vitamin D|vitamin d|mesh-list
19970151|NCT01781169|Vitamins|vitamins|mesh-ancestor
19970152|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
19970153|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970154|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20535525|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19970155|NCT01781234|Insulin|insulin|mesh-list
19970156|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535526|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20535527|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535528|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535529|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535530|NCT01820767|Vitamins|vitamins|mesh-ancestor
20535531|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
20535532|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20535533|NCT01820793|Cefoxitin|cefoxitin|mesh-list
20535534|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970157|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970158|NCT01781403|Capecitabine|capecitabine|mesh-list
19970159|NCT01781403|Temozolomide|temozolomide|mesh-list
19970160|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970161|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
19970162|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970163|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970164|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19970165|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
19970166|NCT01781468|Modafinil|modafinil|mesh-list
19970167|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19970168|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970169|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19970170|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19970171|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19970172|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970173|NCT01781611|Aspirin|aspirin|mesh-list
19970174|NCT01781611|Dipyridamole|dipyridamole|mesh-list
19970175|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19970176|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19970177|NCT01781611|Analgesics|analgesics|mesh-ancestor
19970178|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
19970179|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970180|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970181|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970182|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970183|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19970184|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20553626|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
19975339|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19873101|NCT00878228|Ondansetron|ondansetron|mesh-list
19873102|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
19873103|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
19873104|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873105|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873106|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19873107|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
19873108|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
19873109|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19873110|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
19873111|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873112|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256865|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256866|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256867|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
20256868|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256869|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20256870|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20256871|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20256872|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20535535|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535536|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
20535537|NCT01820832|Calcitriol|calcitriol|mesh-list
20256873|NCT00476918|Triamcinolone|triamcinolone|mesh-list
20256874|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20256875|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20256876|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20256877|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873113|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19873114|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873115|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873116|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873117|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19873118|NCT00878436|Bicalutamide|bicalutamide|mesh-list
19873119|NCT00878436|Panobinostat|panobinostat|mesh-list
20535538|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535539|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535540|NCT01820832|Vitamins|vitamins|mesh-ancestor
19873120|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
19873121|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
19873122|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873123|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873124|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873125|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19873126|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873127|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873128|NCT00878553|Zaleplon|zaleplon|mesh-list
19873129|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
19873130|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19873131|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873132|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873133|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
19873134|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
19873135|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873136|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873137|NCT00878722|Idarubicin|idarubicin|mesh-list
19873138|NCT00878722|Belinostat|belinostat|mesh-list
19873139|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19873140|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873141|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19873142|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19873143|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873144|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873145|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19873146|NCT00878800|Doxorubicin|doxorubicin|mesh-list
19873147|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19873148|NCT00878800|Belinostat|belinostat|mesh-list
19873149|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19873150|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873151|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19873152|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19873153|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873154|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873155|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19873156|NCT00878826|Enoxaparin|enoxaparin|mesh-list
19873157|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
19873158|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19873159|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19873160|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873161|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
19873162|NCT00878995|Testosterone|testosterone|mesh-list
19873163|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
19873164|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
19873165|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19873166|NCT00878995|Androgens|androgens|mesh-ancestor
19873167|NCT00878995|Hormones|hormones|mesh-ancestor
19873168|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873169|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873170|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19873171|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873172|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
19873173|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
19873174|NCT00879034|Pravastatin|pravastatin|mesh-list
19873175|NCT00879034|Lonafarnib|lonafarnib|mesh-list
19873176|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19873177|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873178|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19873179|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19873180|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
19873181|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873182|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19873183|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19873184|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873185|NCT00879060|Spironolactone|spironolactone|mesh-list
19873186|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20256878|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
20256879|NCT00476918|Hormones|hormones|mesh-ancestor
20256880|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20256881|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256882|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256883|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
20256884|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873187|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
19873188|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873189|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873190|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19873191|NCT00879060|Diuretics|diuretics|mesh-ancestor
19873192|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
19873193|NCT00879190|Gentamicins|gentamicins|mesh-list
19873194|NCT00879190|Ampicillin|ampicillin|mesh-list
19873195|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873196|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873197|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19873198|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873199|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873200|NCT00879229|Ambrisentan|ambrisentan|mesh-list
19873201|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19873202|NCT00879333|Everolimus|everolimus|mesh-list
19873203|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873204|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873205|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
19873206|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873207|NCT00879359|Paclitaxel|paclitaxel|mesh-list
19873208|NCT00879359|Bevacizumab|bevacizumab|mesh-list
19873209|NCT00879359|Carboplatin|carboplatin|mesh-list
19873210|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19873211|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873212|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873213|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
19873214|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873215|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535541|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
19732076|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19732077|NCT04578158|Quercetin|quercetin|mesh-list
19732078|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
19732079|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732080|NCT04578158|Protective Agents|protective agents|mesh-ancestor
19732081|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732082|NCT04577846|Cephalexin|cephalexin|mesh-list
19732083|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19732084|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732085|NCT04577885|Rifampin|rifampin|mesh-list
19732086|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19732087|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
19732088|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873216|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873217|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19873218|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19873219|NCT00879359|Growth Substances|growth substances|mesh-ancestor
19873220|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873221|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873222|NCT00879398|Fesoterodine|fesoterodine|mesh-list
19873223|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19873224|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19873225|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
19873226|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873227|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873228|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873229|NCT00879398|Urological Agents|urological agents|mesh-ancestor
19873230|NCT00879411|Telmisartan|telmisartan|mesh-list
19873231|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19873232|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20256885|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256886|NCT00476983|Ritonavir|ritonavir|mesh-list
20256887|NCT00476983|Saquinavir|saquinavir|mesh-list
20256888|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20256889|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20256890|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19873233|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19873234|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873235|NCT00879437|Bevacizumab|bevacizumab|mesh-list
19873236|NCT00879437|Valproic Acid|valproic acid|mesh-list
19873237|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873238|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873239|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19873240|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19873241|NCT00879437|Growth Substances|growth substances|mesh-ancestor
19873242|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873243|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873244|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
19873245|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873246|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873247|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
19873248|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873249|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
19873250|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873251|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873252|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873253|NCT00879658|Siponimod|siponimod|mesh-list
19873254|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19873255|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873256|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873257|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
19873258|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873259|NCT00879710|Simvastatin|simvastatin|mesh-list
19873260|NCT00879710|Ezetimibe|ezetimibe|mesh-list
19873261|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19873262|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19873263|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
19873264|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873265|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19873266|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19873267|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873268|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
19873269|NCT00879775|Caffeine|caffeine|mesh-list
19873270|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19732089|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732090|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
19732091|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19732092|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732093|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732094|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20535542|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19873271|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873272|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19873273|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873274|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873275|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19873276|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19873277|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
19873278|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873279|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
19873280|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873281|NCT00879814|Vaccines|vaccines|mesh-list
19873282|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
19873283|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873284|NCT00879879|Losartan|losartan|mesh-list
19873285|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19873286|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19873287|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19873288|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19873289|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873290|NCT00879970|Vitamin D|vitamin d|mesh-list
19873291|NCT00879970|Pioglitazone|pioglitazone|mesh-list
19873292|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
19873293|NCT00879970|Vitamins|vitamins|mesh-ancestor
19873294|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
19873295|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873296|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19873297|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873298|NCT00879996|Buprenorphine|buprenorphine|mesh-list
19873299|NCT00879996|Methadone|methadone|mesh-list
19873300|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19873301|NCT00879996|Naloxone|naloxone|mesh-list
19873302|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19873303|NCT00879996|Narcotics|narcotics|mesh-ancestor
19873304|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873305|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873306|NCT00879996|Analgesics|analgesics|mesh-ancestor
19873307|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
20535543|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20535544|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19873308|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873309|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19873310|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
19873311|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
19873312|NCT00880009|Letrozole|letrozole|mesh-list
19873313|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873314|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19873315|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19873316|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873317|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873318|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19873319|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
19873320|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873321|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873322|NCT00880100|Pancrelipase|pancrelipase|mesh-list
19873323|NCT00880100|Pancreatin|pancreatin|mesh-list
19873324|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19873325|NCT00880191|Dexamethasone|dexamethasone|mesh-list
19873326|NCT00880191|Gabapentin|gabapentin|mesh-list
19873327|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873328|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
19873329|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
19873330|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873331|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873332|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19873333|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
19873334|NCT00880191|Hormones|hormones|mesh-ancestor
19873335|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873336|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19873337|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873338|NCT00880191|Analgesics|analgesics|mesh-ancestor
19873339|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
19873340|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
19873341|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19873342|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873343|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873344|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873345|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19873346|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19873347|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873348|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873349|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
19873350|NCT00880269|Panobinostat|panobinostat|mesh-list
19873351|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873352|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19732095|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19732096|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19732097|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19732098|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19732099|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19732100|NCT04577443|Adenosine|adenosine|mesh-list
19732101|NCT04577443|Analgesics|analgesics|mesh-ancestor
19873353|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873354|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873355|NCT00880334|Docetaxel|docetaxel|mesh-list
19873356|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873357|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873358|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
19873359|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873360|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873361|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
19873362|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873363|NCT00880607|Morphine|morphine|mesh-list
19873364|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19873365|NCT00880607|Narcotics|narcotics|mesh-ancestor
19873366|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873367|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873368|NCT00880607|Analgesics|analgesics|mesh-ancestor
19873369|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
19873370|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873371|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19873372|NCT00880620|Carbidopa|carbidopa|mesh-list
19873373|NCT00880620|Levodopa|levodopa|mesh-list
19873374|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19873375|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
19873376|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535545|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873377|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19873378|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19873379|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
19873380|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
19873381|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873382|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873383|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19873384|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873385|NCT00880685|Memantine|memantine|mesh-list
19873386|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19873387|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19873388|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
19873389|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873390|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873391|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873392|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19873393|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19873394|NCT00880763|Interferons|interferons|mesh-list
19873395|NCT00880763|Ribavirin|ribavirin|mesh-list
19873396|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873397|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
19732102|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
19732103|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732104|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732105|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19732106|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
19732107|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19732108|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
19732109|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
19732110|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735681|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256891|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
20256892|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256893|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256894|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20256895|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20256896|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
20256897|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873398|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873399|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
19873400|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873401|NCT00880906|Fluticasone|fluticasone|mesh-list
19873402|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20256898|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20256899|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256900|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20256901|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20256902|NCT00477035|Gemcitabine|gemcitabine|mesh-list
20256903|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
20256904|NCT00477035|Melphalan|melphalan|mesh-list
20256905|NCT00477035|Carmustine|carmustine|mesh-list
20256906|NCT00477035|Etoposide|etoposide|mesh-list
20256907|NCT00477035|Vinorelbine|vinorelbine|mesh-list
20256908|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256909|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
20256910|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256911|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20256912|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19873403|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873404|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19873405|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
19873406|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873407|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256913|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
20286762|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873408|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19873409|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
19873410|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19873411|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19873412|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873413|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873414|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19873415|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
19873416|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873417|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19873418|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873419|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873420|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873421|NCT00880997|Doxazosin|doxazosin|mesh-list
19873422|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19873423|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19873424|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19873425|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19873426|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
19873427|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873428|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873429|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873430|NCT00881504|Bevacizumab|bevacizumab|mesh-list
19873431|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873432|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873433|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19873434|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19873435|NCT00881504|Growth Substances|growth substances|mesh-ancestor
19873436|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873437|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873438|NCT00881530|Metformin|metformin|mesh-list
19873439|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19873440|NCT00881530|Empagliflozin|empagliflozin|mesh-list
19873441|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873442|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873443|NCT00881530|Incretins|incretins|mesh-ancestor
19873444|NCT00881530|Hormones|hormones|mesh-ancestor
19873445|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873446|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20535546|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19873447|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873448|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873449|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873450|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19873451|NCT00881569|Efatutazone|efatutazone|mesh-list
19873452|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873453|NCT00881621|Capecitabine|capecitabine|mesh-list
19873454|NCT00881621|Lapatinib|lapatinib|mesh-list
19873455|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19873456|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
19873457|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873458|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873459|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19873460|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873461|NCT00881751|Bevacizumab|bevacizumab|mesh-list
19873462|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19873463|NCT00881751|Sorafenib|sorafenib|mesh-list
19873464|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873465|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873466|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19873467|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19873468|NCT00881751|Growth Substances|growth substances|mesh-ancestor
19873469|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873470|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873471|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19873472|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873473|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873474|NCT00881868|Clobetasol|clobetasol|mesh-list
19873475|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873476|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
19873477|NCT00881868|Hormones|hormones|mesh-ancestor
19873478|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873479|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873480|NCT00881894|Rotigotine|rotigotine|mesh-list
19873481|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
19873482|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
19873483|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873484|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873485|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873486|NCT00882102|Decitabine|decitabine|mesh-list
19873487|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
19873488|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19873489|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
19873490|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873491|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873492|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873493|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873494|NCT00882115|Sulforaphane|sulforaphane|mesh-list
19873495|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19873496|NCT00882115|Protective Agents|protective agents|mesh-ancestor
19873497|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873498|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873499|NCT00882206|Cytarabine|cytarabine|mesh-list
19873500|NCT00882206|Prednisone|prednisone|mesh-list
19873501|NCT00882206|Doxorubicin|doxorubicin|mesh-list
19873502|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19873503|NCT00882206|Methotrexate|methotrexate|mesh-list
19873504|NCT00882206|Vincristine|vincristine|mesh-list
19873505|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
19873506|NCT00882206|Decitabine|decitabine|mesh-list
19873507|NCT00882206|Asparaginase|asparaginase|mesh-list
19873508|NCT00882206|Vorinostat|vorinostat|mesh-list
19873509|NCT00882206|Pegaspargase|pegaspargase|mesh-list
19873510|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20256914|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256915|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256916|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19873511|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873512|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19449473|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449474|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449475|NCT03435107|Durvalumab|durvalumab|mesh-list
19449476|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873513|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19873514|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256917|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19449477|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449478|NCT03435094|Alendronate|alendronate|mesh-list
19449479|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19449480|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449481|NCT03434951|Morphine|morphine|mesh-list
19449482|NCT03434951|Bupivacaine|bupivacaine|mesh-list
19449483|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
19449484|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
19449485|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449486|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449487|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
19449488|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449489|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19449490|NCT03434951|Narcotics|narcotics|mesh-ancestor
19449491|NCT03434951|Analgesics|analgesics|mesh-ancestor
19449492|NCT03434782|Listerine|listerine|mesh-list
19449493|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19449494|NCT03434782|Fluorides|fluorides|mesh-list
19449495|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
19449496|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
19449497|NCT03434782|Protective Agents|protective agents|mesh-ancestor
19449498|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449499|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19449500|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449501|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
19449502|NCT03434704|Clotrimazole|clotrimazole|mesh-list
19449503|NCT03434704|Miconazole|miconazole|mesh-list
19449504|NCT03434704|Fludarabine|fludarabine|mesh-list
19873515|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873516|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873517|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
19873518|NCT00882206|Hormones|hormones|mesh-ancestor
19873519|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873520|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873521|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19873522|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19873523|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
19873524|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19873525|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19873526|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
19873527|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
19873528|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19873529|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873530|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
19873531|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19873532|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19873533|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
19873534|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873535|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19873536|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873537|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
19873538|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873539|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19873540|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19873541|NCT00882362|Aripiprazole|aripiprazole|mesh-list
19873542|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
19873543|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873544|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19873545|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873546|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873547|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873548|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
19873549|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
19873550|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873551|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873552|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19873553|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19873554|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
19873555|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19873556|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19873557|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19873558|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19873559|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
19449505|NCT03434704|Thiotepa|thiotepa|mesh-list
19449506|NCT03434704|Treosulfan|treosulfan|mesh-list
19449507|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873560|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19873561|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
19873562|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873563|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19873564|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873565|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873566|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873567|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
19873568|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
19873569|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873570|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19873571|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19873572|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
19873573|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873574|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873575|NCT00882557|Daptomycin|daptomycin|mesh-list
19873576|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873577|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873578|NCT00882583|Cisplatin|cisplatin|mesh-list
19873579|NCT00882583|Cetuximab|cetuximab|mesh-list
19873580|NCT00882583|Dasatinib|dasatinib|mesh-list
19873581|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873582|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873583|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19873584|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873585|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873586|NCT00882687|Lifitegrast|lifitegrast|mesh-list
19873587|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19873588|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19873589|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
19873590|NCT00882713|Hematinics|hematinics|mesh-ancestor
19873591|NCT00882908|Ribavirin|ribavirin|mesh-list
19873592|NCT00882908|Simeprevir|simeprevir|mesh-list
19873593|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
19873594|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873595|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
19873596|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873597|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873598|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873599|NCT00883051|Lasmiditan|lasmiditan|mesh-list
19873600|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19873601|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
19873602|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873603|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873604|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873605|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
20256918|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
20256919|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
19873606|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19873607|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19873608|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873609|NCT00883103|Lidocaine|lidocaine|mesh-list
19873610|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
19873611|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
19873612|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873613|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873614|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
19873615|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873616|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19873617|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19873618|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19873619|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19873620|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873621|NCT00883116|Paclitaxel|paclitaxel|mesh-list
19873622|NCT00883116|Doxorubicin|doxorubicin|mesh-list
19873623|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19873624|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19873625|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873626|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873627|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
19873628|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873629|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873630|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19873631|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19873632|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19873633|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873634|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
19873635|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
19873636|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873637|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
19873638|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873639|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19873640|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19873641|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
19873642|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873643|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873644|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19873645|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19873646|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19873647|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
19873648|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873649|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873650|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873651|NCT00883168|Fluticasone|fluticasone|mesh-list
19873652|NCT00883168|Xhance|xhance|mesh-list
19873653|NCT00883168|Azelastine|azelastine|mesh-list
19873654|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873655|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19873656|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
19873657|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873658|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873659|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19873660|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
19873661|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
19873662|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19873663|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19873664|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873665|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873666|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19873667|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19873668|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
19873669|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
19873670|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873671|NCT00883233|Adapalene|adapalene|mesh-list
19873672|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19873673|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19873674|NCT00883233|Analgesics|analgesics|mesh-ancestor
19873675|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
19873676|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873677|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873678|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873679|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19873680|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
19873681|NCT00883337|Interferons|interferons|mesh-list
19873682|NCT00883337|Interferon-beta|interferon-beta|mesh-list
19873683|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
19873684|NCT00883337|Teriflunomide|teriflunomide|mesh-list
19873685|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873686|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
20256920|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873687|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873688|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19873689|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19873690|NCT00883337|Analgesics|analgesics|mesh-ancestor
19873691|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
19873692|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873693|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873694|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873695|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19873696|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873697|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
19873698|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19873699|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
19873700|NCT00883415|Hematinics|hematinics|mesh-ancestor
19873701|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19873702|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
19873703|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
19873704|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873705|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19873706|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873707|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873708|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873709|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873710|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873711|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
19873712|NCT00883558|Insulin|insulin|mesh-list
19873713|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19873714|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
19873715|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
19873716|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873717|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873718|NCT00883675|Carboplatin|carboplatin|mesh-list
19873719|NCT00883675|Docetaxel|docetaxel|mesh-list
19873720|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873721|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873722|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
19873723|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873724|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970185|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970186|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19970187|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19732111|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732112|NCT04577378|Itraconazole|itraconazole|mesh-list
19732113|NCT04577378|Tretinoin|tretinoin|mesh-list
19732114|NCT04577378|Isotretinoin|isotretinoin|mesh-list
19732115|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
19732116|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732117|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19732118|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19732119|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735682|NCT04536922|Aldesleukin|aldesleukin|mesh-list
19970188|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970189|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
19970190|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19970191|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
19970192|NCT01781806|Tenofovir|tenofovir|mesh-list
19970193|NCT01781806|Emtricitabine|emtricitabine|mesh-list
19970194|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
19970195|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970196|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19970197|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19970198|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970199|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970200|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19970201|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19970202|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
19970203|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970204|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19970205|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970206|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970207|NCT01782131|Voriconazole|voriconazole|mesh-list
19970208|NCT01782131|Posaconazole|posaconazole|mesh-list
19970209|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
19970210|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970211|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19970212|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19970213|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970214|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970215|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19970216|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
19970217|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970218|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970219|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19970220|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19970221|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19970222|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19970223|NCT01782222|Rotigotine|rotigotine|mesh-list
19970224|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
19970225|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
19970226|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970227|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970228|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970229|NCT01782495|Ritonavir|ritonavir|mesh-list
19970230|NCT01782495|Ribavirin|ribavirin|mesh-list
19970231|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19970232|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19970233|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873725|NCT00883688|Bevacizumab|bevacizumab|mesh-list
19873726|NCT00883688|Lapatinib|lapatinib|mesh-list
19873727|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19873728|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873729|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19873730|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19873731|NCT00883688|Growth Substances|growth substances|mesh-ancestor
19873732|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873733|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873734|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19873735|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873736|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873737|NCT00883740|Pregabalin|pregabalin|mesh-list
19873738|NCT00883740|Analgesics|analgesics|mesh-ancestor
19873739|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
19873740|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873741|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873742|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
19873743|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19873744|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19873745|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873746|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19873747|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19873748|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19873749|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19873750|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19873751|NCT00883779|Gemcitabine|gemcitabine|mesh-list
19873752|NCT00883779|Carboplatin|carboplatin|mesh-list
19873753|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19873754|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873755|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19873756|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
19873757|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873758|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
19873759|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873760|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873761|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873762|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
19873763|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873764|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19873765|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
19873766|NCT00884039|Anecortave|anecortave|mesh-list
19873767|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19873768|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19873769|NCT00884039|Growth Substances|growth substances|mesh-ancestor
19873770|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873771|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873772|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873773|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19873774|NCT00884052|Levetiracetam|levetiracetam|mesh-list
19873775|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
19873776|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
19873777|NCT00884117|Oseltamivir|oseltamivir|mesh-list
19873778|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
19873779|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873780|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873781|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873782|NCT00884221|Menotropins|menotropins|mesh-list
19873783|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19873784|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
19873785|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19873786|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873787|NCT00884273|Goserelin|goserelin|mesh-list
19873788|NCT00884273|Bicalutamide|bicalutamide|mesh-list
19873789|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19873790|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873791|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
19873792|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
19873793|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873794|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873795|NCT00884325|Levocetirizine|levocetirizine|mesh-list
19873796|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19873797|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19873798|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
19873799|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
20256921|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256922|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20256923|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20256924|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19873800|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873801|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873802|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873803|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19873804|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19873805|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19873806|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873807|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
19873808|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19873809|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
19873810|NCT00884390|Factor VIII|factor viii|mesh-list
19873811|NCT00884390|Coagulants|coagulants|mesh-ancestor
19873812|NCT00884585|Cyclosporine|cyclosporine|mesh-list
19873813|NCT00884585|Cyclosporins|cyclosporins|mesh-list
19873814|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873815|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873816|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19873817|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
19873818|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873819|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
19873820|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873821|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
19873822|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19873823|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19873824|NCT00884650|Analgesics|analgesics|mesh-list
19873825|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
19873826|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873827|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873828|NCT00884741|Bevacizumab|bevacizumab|mesh-list
19873829|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19873830|NCT00884741|Temozolomide|temozolomide|mesh-list
19873831|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
19873832|NCT00884741|Antibodies|antibodies|mesh-list
19873833|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
19873834|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19873835|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
19873836|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873837|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19873838|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19873839|NCT00884741|Growth Substances|growth substances|mesh-ancestor
19873840|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873841|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
19873842|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
19873843|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19873844|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
19873845|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256925|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873846|NCT00884793|Ritonavir|ritonavir|mesh-list
19873847|NCT00884793|Lopinavir|lopinavir|mesh-list
19873848|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19873849|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
19873850|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
19873851|NCT00884793|Efavirenz|efavirenz|mesh-list
19873852|NCT00884793|Etravirine|etravirine|mesh-list
19873853|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19873854|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19873855|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873856|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873857|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873858|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19873859|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19873860|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
19873861|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873862|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19873863|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19873864|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19873865|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19873866|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19873867|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19873868|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19873869|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19873870|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19873871|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19873872|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19873873|NCT00884832|Clonidine|clonidine|mesh-list
19873874|NCT00884832|Analgesics|analgesics|mesh-ancestor
19873875|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
19873876|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19873877|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873878|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19873879|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
19873880|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
19873881|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19873882|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19873883|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19873884|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
19873885|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19873886|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873887|NCT00884897|Oxytocin|oxytocin|mesh-list
19873888|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
19873889|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19873890|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873891|NCT00885079|Rebamipide|rebamipide|mesh-list
19873892|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19873893|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19873894|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19873895|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19873896|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
19873897|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873898|NCT00885079|Protective Agents|protective agents|mesh-ancestor
19873899|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873900|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873901|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19873902|NCT00885105|Vaccines|vaccines|mesh-list
19873903|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
19873904|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873905|NCT00885118|Empagliflozin|empagliflozin|mesh-list
19873906|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19873907|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873908|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873909|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873910|NCT00885170|Vitamin D|vitamin d|mesh-list
19873911|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
19873912|NCT00885170|Calcium|calcium|mesh-list
19873913|NCT00885170|Vitamins|vitamins|mesh-ancestor
19873914|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
19873915|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873916|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19873917|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19873918|NCT00885352|Metformin|metformin|mesh-list
19873919|NCT00885352|Pioglitazone|pioglitazone|mesh-list
19873920|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19873921|NCT00885352|Glipizide|glipizide|mesh-list
19873922|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873923|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873924|NCT00885352|Incretins|incretins|mesh-ancestor
19873925|NCT00885352|Hormones|hormones|mesh-ancestor
19873926|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873927|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19873928|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873929|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873930|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873931|NCT00885365|Tobramycin|tobramycin|mesh-list
19873932|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873933|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873934|NCT00885378|Metformin|metformin|mesh-list
19873935|NCT00885378|Saxagliptin|saxagliptin|mesh-list
19873936|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873937|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873938|NCT00885378|Incretins|incretins|mesh-ancestor
19873939|NCT00885378|Hormones|hormones|mesh-ancestor
20256926|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
20256927|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873940|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873941|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19873942|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873943|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256928|NCT00477048|Saquinavir|saquinavir|mesh-list
19873944|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873945|NCT00885482|Ritonavir|ritonavir|mesh-list
19873946|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19873947|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19873948|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19873949|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873950|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873951|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873952|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20535547|NCT01820858|Paclitaxel|paclitaxel|mesh-list
20535548|NCT01820858|Carboplatin|carboplatin|mesh-list
20535549|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19873953|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19873954|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
19873955|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873956|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19873957|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19873958|NCT00885534|Temozolomide|temozolomide|mesh-list
19873959|NCT00885534|Vinblastine|vinblastine|mesh-list
19873960|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19873961|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19873962|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
19873963|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873964|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19873965|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
19873966|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
19873967|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
19873968|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19873969|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19873970|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873971|NCT00885638|Incretins|incretins|mesh-ancestor
19873972|NCT00885638|Hormones|hormones|mesh-ancestor
19873973|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873974|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19873975|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
19873976|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873977|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873978|NCT00885703|Fluconazole|fluconazole|mesh-list
19873979|NCT00885703|Amphotericin B|amphotericin b|mesh-list
19873980|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19873981|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
19873982|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
19873983|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
19873984|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19873985|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19873986|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19873987|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19873988|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19873989|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19873990|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
19873991|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19873992|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19873993|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19873994|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19873995|NCT00885703|Amebicides|amebicides|mesh-ancestor
19873996|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19873997|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19873998|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19873999|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19874000|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19874001|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
19874002|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19874003|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19874004|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874005|NCT00885755|Capecitabine|capecitabine|mesh-list
19874006|NCT00885755|Trastuzumab|trastuzumab|mesh-list
19874007|NCT00885755|Taxane|taxane|mesh-list
19874008|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874009|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
19874010|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874011|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874012|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20535550|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874013|NCT00886236|Gabapentin|gabapentin|mesh-list
19874014|NCT00886236|Analgesics|analgesics|mesh-ancestor
19874015|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
19874016|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874017|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874018|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
20256929|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20256930|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20256931|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
20256932|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256933|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874019|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19874020|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19874021|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874022|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874023|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19874024|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20256934|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20256935|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20535551|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
19874025|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874026|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874027|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
19874028|NCT00886262|Vasopressins|vasopressins|mesh-list
19874029|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
19874030|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
19874031|NCT00886262|Coagulants|coagulants|mesh-ancestor
19874032|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19874033|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19874034|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
19874035|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874036|NCT00886379|Vitamin D|vitamin d|mesh-list
19874037|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
19874038|NCT00886379|Vitamins|vitamins|mesh-list
19874039|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
19874040|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874041|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19874042|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19874043|NCT00886613|Vaccines|vaccines|mesh-list
19874044|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
19874045|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874046|NCT00886626|Exenatide|exenatide|mesh-list
20535552|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535553|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535554|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874047|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19874048|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874049|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19874050|NCT00886626|Incretins|incretins|mesh-ancestor
19874051|NCT00886626|Hormones|hormones|mesh-ancestor
19874052|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874053|NCT00886743|Oprelvekin|oprelvekin|mesh-list
19874054|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874055|NCT00886795|Abatacept|abatacept|mesh-list
19874056|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19874057|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874058|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874059|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19874060|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
19874061|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874062|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874063|NCT00886834|Misoprostol|misoprostol|mesh-list
19874064|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19874065|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
19874066|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19874067|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874068|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19874069|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19874070|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
19874071|NCT00887068|Azacitidine|azacitidine|mesh-list
19874072|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20256936|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
19874073|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
20535555|NCT01820897|Trimethoprim|trimethoprim|mesh-list
20535556|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19874074|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874075|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874076|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874077|NCT00887159|Cisplatin|cisplatin|mesh-list
19874078|NCT00887159|Etoposide|etoposide|mesh-list
19874079|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
19874080|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
19874081|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19874082|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874083|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19874084|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19874085|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19874086|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874087|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874088|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
19874089|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
19874090|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
19874091|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
19874092|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
19874093|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
19874094|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874095|NCT00887198|Prednisone|prednisone|mesh-list
19874096|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
19874097|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874098|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
19874099|NCT00887198|Hormones|hormones|mesh-ancestor
19874100|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874101|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874102|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19874103|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874104|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19874105|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874106|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874107|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
19874108|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19874109|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19874110|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19874111|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19874112|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874113|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874114|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874115|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874116|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
19874117|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874118|NCT00887354|Vitamin D|vitamin d|mesh-list
19874119|NCT00887354|Teriparatide|teriparatide|mesh-list
19874120|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
19874121|NCT00887354|Calcium|calcium|mesh-list
19874122|NCT00887354|Vitamins|vitamins|mesh-ancestor
19874123|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
19874124|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874125|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19874126|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19874127|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19874128|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874129|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874130|NCT00887432|Vitamin D|vitamin d|mesh-list
19874131|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
19874132|NCT00887432|Vitamins|vitamins|mesh-ancestor
19874133|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
19874134|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874135|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19874136|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19874137|NCT00887458|Itraconazole|itraconazole|mesh-list
19874138|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
19874139|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
19874140|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874141|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19874142|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19874143|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874144|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874145|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19874146|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
19874147|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874148|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874149|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19874150|NCT00887484|Clindamycin|clindamycin|mesh-list
19874151|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
19874152|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
19874153|NCT00887484|Adapalene|adapalene|mesh-list
19874154|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19874155|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19874156|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874157|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19874158|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874159|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874160|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
19874161|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19874162|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19874163|NCT00887484|Analgesics|analgesics|mesh-ancestor
19874164|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
19874165|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874166|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874167|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874168|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874169|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19874170|NCT00887510|Trandolapril|trandolapril|mesh-list
19874171|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19874172|NCT00887510|Diuretics|diuretics|mesh-ancestor
19874173|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
19874174|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874175|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19874176|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874177|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874178|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19874179|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
19874180|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874181|NCT00887549|Pemetrexed|pemetrexed|mesh-list
19874182|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874183|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874184|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874185|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19874186|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19874187|NCT00887562|Ubiquinone|ubiquinone|mesh-list
19874188|NCT00887562|Idebenone|idebenone|mesh-list
19874189|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
19874190|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874191|NCT00887562|Protective Agents|protective agents|mesh-ancestor
19874192|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874193|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
19874194|NCT00887575|Paclitaxel|paclitaxel|mesh-list
19874195|NCT00887575|Carboplatin|carboplatin|mesh-list
19874196|NCT00887575|Sunitinib|sunitinib|mesh-list
19874197|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19874198|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874199|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
19874200|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
19874201|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
19874202|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874203|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874204|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874205|NCT00887575|Growth Substances|growth substances|mesh-ancestor
19874206|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874207|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874208|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19874209|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874210|NCT00887588|Valsartan|valsartan|mesh-list
19874211|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19874212|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19874213|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19874214|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19874215|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874216|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
19874217|NCT00887640|Promethazine|promethazine|mesh-list
19874218|NCT00887640|Sirolimus|sirolimus|mesh-list
19874219|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19874220|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452664|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
19874221|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19874222|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874223|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
19874224|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19874225|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
19874226|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874227|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19874228|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19874229|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874230|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
19874231|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
19874232|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
19874233|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874234|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
19874235|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
19874236|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19874237|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19874238|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
19874239|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
19874240|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874241|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874242|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19874243|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
19874244|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
20256937|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20256938|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20256939|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256940|NCT00477061|Morphine|morphine|mesh-list
20256941|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19874245|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
19874246|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19874247|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19874248|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
19874249|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874250|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20256942|NCT00477061|Narcotics|narcotics|mesh-ancestor
20256943|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256944|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256945|NCT00477061|Analgesics|analgesics|mesh-ancestor
20256946|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
20256947|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256948|NCT00477126|Ritonavir|ritonavir|mesh-list
19874251|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19874252|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874253|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874254|NCT00887679|Citalopram|citalopram|mesh-list
19874255|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19874256|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19874257|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20256949|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19874258|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874259|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874260|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
19874261|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874262|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19874263|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
19874264|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874265|NCT00887809|Gemcitabine|gemcitabine|mesh-list
19874266|NCT00887809|Bevacizumab|bevacizumab|mesh-list
19874267|NCT00887809|Docetaxel|docetaxel|mesh-list
19874268|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874269|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874270|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874271|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20256950|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20256951|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
20256952|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256953|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256954|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20256955|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19874272|NCT00887809|Growth Substances|growth substances|mesh-ancestor
19874273|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256956|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
20256957|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874274|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874275|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874276|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
19874277|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874278|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
19874279|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874280|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874281|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19874282|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
19874283|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
19874284|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
19874285|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
19874286|NCT00887822|Bevacizumab|bevacizumab|mesh-list
19874287|NCT00887822|Capecitabine|capecitabine|mesh-list
19874288|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874289|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874290|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874291|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874292|NCT00887822|Growth Substances|growth substances|mesh-ancestor
19874293|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874294|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874295|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874296|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
19874297|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874298|NCT00887965|Denosumab|denosumab|mesh-list
19874299|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19874300|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874301|NCT00887978|Treprostinil|treprostinil|mesh-list
19874302|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535557|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
19874303|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19874304|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19874305|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874306|NCT00888238|Incretins|incretins|mesh-ancestor
19874307|NCT00888238|Hormones|hormones|mesh-ancestor
19874308|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874309|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19874310|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
19874311|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874312|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874313|NCT00888329|Aprepitant|aprepitant|mesh-list
19874314|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
19874315|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
19874316|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874317|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874318|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19874319|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19874320|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874321|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874322|NCT00888381|Vaccines|vaccines|mesh-list
20256958|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20256959|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20256960|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
19874323|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
19874324|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874325|NCT00888459|Nicotine|nicotine|mesh-list
19874326|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19874327|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
19874328|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535558|NCT01820897|Fosfomycin|fosfomycin|mesh-list
19874329|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874330|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19874331|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19874332|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
19874333|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874334|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874335|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19874336|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874337|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19874338|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874339|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874340|NCT00888615|Paclitaxel|paclitaxel|mesh-list
20256961|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20535559|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19874341|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19874342|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19874343|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535560|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535561|NCT01820897|Renal Agents|renal agents|mesh-ancestor
20535562|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
20535563|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20535564|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19874344|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
19874345|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19874346|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535565|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20535566|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535567|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535568|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20535569|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20535570|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20535571|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19874347|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874348|NCT00888628|Etanercept|etanercept|mesh-list
19874349|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19874350|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19874351|NCT00888628|Analgesics|analgesics|mesh-ancestor
19874352|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
19874353|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874354|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874355|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874356|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874357|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19874358|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19874359|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
19970234|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970235|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970236|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19970237|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19970238|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
19970239|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970240|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19970241|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19970242|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
19970243|NCT01782690|Gemcitabine|gemcitabine|mesh-list
19970244|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19970245|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970246|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
19970247|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970248|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970249|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
19970250|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970251|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970252|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970253|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
19970254|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970255|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19970256|NCT01782742|Bexarotene|bexarotene|mesh-list
19970257|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970258|NCT01782859|Prednisone|prednisone|mesh-list
19970259|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
19970260|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19970261|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19970262|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19970263|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970264|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
19970265|NCT01782859|Hormones|hormones|mesh-ancestor
19970266|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286763|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
19452665|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
20286764|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286765|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286766|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286767|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286768|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
20286769|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286770|NCT02437279|Nivolumab|nivolumab|mesh-list
20286771|NCT02437279|Ipilimumab|ipilimumab|mesh-list
20535572|NCT01820910|Doxycycline|doxycycline|mesh-list
20535573|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20535574|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535575|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
20535576|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19874360|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
19874361|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19874362|NCT00888654|Protective Agents|protective agents|mesh-ancestor
19874363|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874364|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874365|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
19874366|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874367|NCT00888940|Ecallantide|ecallantide|mesh-list
19874368|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
20256962|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535577|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20535578|NCT01820962|Heparin|heparin|mesh-list
20535579|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
19874369|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19874370|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19874371|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874372|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
19874373|NCT00888940|Coagulants|coagulants|mesh-ancestor
19874374|NCT00888940|Analgesics|analgesics|mesh-ancestor
19874375|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
19874376|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874377|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535580|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874378|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19874379|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19874380|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874381|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874382|NCT00888979|Nicotine|nicotine|mesh-list
19874383|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19874384|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
19874385|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874386|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874387|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19874388|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19874389|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
19874390|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874391|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874392|NCT00889187|Capecitabine|capecitabine|mesh-list
19874393|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874394|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
19874395|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874396|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874397|NCT00889200|Eszopiclone|eszopiclone|mesh-list
19874398|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19874399|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874400|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874401|NCT00889226|Atorvastatin|atorvastatin|mesh-list
19874402|NCT00889226|Pitavastatin|pitavastatin|mesh-list
19874403|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20286772|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286773|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286774|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286775|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286776|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
20286777|NCT02278887|Fludarabine|fludarabine|mesh-list
20286778|NCT02278887|Ipilimumab|ipilimumab|mesh-list
20286779|NCT02278887|Interleukin-2|interleukin-2|mesh-list
19874404|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19874405|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
19874406|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286780|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286781|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
20286782|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286783|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874407|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19874408|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19874409|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874410|NCT00889252|Ketotifen|ketotifen|mesh-list
19874411|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
20535581|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20535582|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19874412|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
19874413|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20256963|NCT00477282|Topotecan|topotecan|mesh-list
20256964|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20256965|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20256966|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20256967|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256968|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20256969|NCT00477347|Anesthetics|anesthetics|mesh-list
20256970|NCT00477347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20256971|NCT00477347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256972|NCT00477373|Valproic Acid|valproic acid|mesh-list
20256973|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
20535583|NCT01821001|Bromocriptine|bromocriptine|mesh-list
19874414|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
19874415|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
19874416|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874417|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874418|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874419|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19874420|NCT00889330|Alcaftadine|alcaftadine|mesh-list
19874421|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19874422|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
19874423|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
19874424|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874425|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874426|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874427|NCT00889603|Donepezil|donepezil|mesh-list
19874428|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19874429|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874430|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874431|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
19874432|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874433|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874434|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
19874435|NCT00889720|Varenicline|varenicline|mesh-list
19874436|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19874437|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19874438|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
19874439|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874440|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874441|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874442|NCT00889915|Methylphenidate|methylphenidate|mesh-list
19874443|NCT00889915|Amphetamine|amphetamine|mesh-list
19874444|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19874445|NCT00889915|Adderall|adderall|mesh-list
19874446|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19874447|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874448|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19874449|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19874450|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874451|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874452|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
19874453|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874454|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
19874455|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
19874456|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874457|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
19874458|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19874459|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19874460|NCT00890084|Telmisartan|telmisartan|mesh-list
19874461|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
19874462|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19874463|NCT00890084|Diuretics|diuretics|mesh-ancestor
19874464|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
19874465|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874466|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19874467|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874468|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874469|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19874470|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19874471|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19874472|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19874473|NCT00890162|Omalizumab|omalizumab|mesh-list
19874474|NCT00890162|Epinephrine|epinephrine|mesh-list
19874475|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20256974|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874476|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19874477|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
19874478|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874479|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874480|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874481|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19874482|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19874483|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
19874484|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874485|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19874486|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
19874487|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
19874488|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
19874489|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19874490|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19874491|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
19874492|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874493|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
19874494|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874495|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874496|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19874497|NCT00890552|Dexamethasone|dexamethasone|mesh-list
19874498|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
19874499|NCT00890552|Lenalidomide|lenalidomide|mesh-list
19874500|NCT00890552|Melphalan|melphalan|mesh-list
19874501|NCT00890552|BB 1101|bb 1101|mesh-list
19874502|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874503|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
19874504|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
19874505|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874506|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874507|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19874508|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
19874509|NCT00890552|Hormones|hormones|mesh-ancestor
19874510|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874511|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19874512|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874513|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
19874514|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874515|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874516|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
19874517|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874518|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874519|NCT00890552|Growth Substances|growth substances|mesh-ancestor
19874520|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874521|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19874522|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
19874523|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19874524|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19874525|NCT00890617|Prednisone|prednisone|mesh-list
19874526|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874527|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
19874528|NCT00890617|Hormones|hormones|mesh-ancestor
19874529|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874530|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874531|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19874532|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874533|NCT00890656|Dexamethasone|dexamethasone|mesh-list
19874534|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
19874535|NCT00890656|Doxorubicin|doxorubicin|mesh-list
19874536|NCT00890656|Methotrexate|methotrexate|mesh-list
19874537|NCT00890656|Vincristine|vincristine|mesh-list
19874538|NCT00890656|Asparaginase|asparaginase|mesh-list
19874539|NCT00890656|Pegaspargase|pegaspargase|mesh-list
19874540|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20256975|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20256976|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
20256977|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20256978|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256979|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
20256980|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19874541|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
19874542|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874543|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874544|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19874545|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
19874546|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874547|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874548|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19874549|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874550|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
19874551|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
19874552|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874553|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19874554|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
19874555|NCT00890656|Hormones|hormones|mesh-ancestor
19874556|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874557|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19874558|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874559|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19874560|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19874561|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19874562|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19874563|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
19874564|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19874565|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874566|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
19874567|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
19874568|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19874569|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19874570|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19874571|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
19874572|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
19874573|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
19874574|NCT00890825|Docetaxel|docetaxel|mesh-list
19874575|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874576|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
19874577|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19874578|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
19874579|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874580|NCT00890929|Lenalidomide|lenalidomide|mesh-list
19874581|NCT00890929|Azacitidine|azacitidine|mesh-list
19874582|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
19874583|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874584|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874585|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874586|NCT00890929|Growth Substances|growth substances|mesh-ancestor
19874587|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874588|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874589|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874590|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
19874591|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874592|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874593|NCT00890981|Denosumab|denosumab|mesh-list
19874594|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19874595|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874596|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19874597|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
19874598|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874599|NCT00891202|Eliglustat|eliglustat|mesh-list
19874600|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874601|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874602|NCT00891228|ST 1435|st 1435|mesh-list
19874603|NCT00891228|Testosterone|testosterone|mesh-list
19874604|NCT00891228|Androgens|androgens|mesh-ancestor
19874605|NCT00891228|Hormones|hormones|mesh-ancestor
19874606|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874607|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874608|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19874609|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
19874610|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19874611|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19874612|NCT00891293|Fenofibrate|fenofibrate|mesh-list
19874613|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19874614|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
19874615|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874616|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19874617|NCT00891371|Lanreotide|lanreotide|mesh-list
19874618|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874619|NCT00891436|Fluticasone|fluticasone|mesh-list
19874620|NCT00891436|Xhance|xhance|mesh-list
19874621|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874622|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19874623|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
19874624|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874625|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874626|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19874627|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
19874628|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
19874629|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19874630|NCT00891462|Bromides|bromides|mesh-list
19874631|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
19874632|NCT00891527|Bevacizumab|bevacizumab|mesh-list
19874633|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
19874634|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874635|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874636|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874637|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874638|NCT00891527|Growth Substances|growth substances|mesh-ancestor
19874639|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874640|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874641|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19874642|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874643|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874644|NCT00891735|Ranibizumab|ranibizumab|mesh-list
19874645|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874646|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874647|NCT00891735|Growth Substances|growth substances|mesh-ancestor
19874648|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874649|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874650|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874651|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
19874652|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19874653|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874654|NCT00891813|Vitamins|vitamins|mesh-ancestor
19874655|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
19874656|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19874657|NCT00891839|Rituximab|rituximab|mesh-list
19874658|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19874659|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874660|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874661|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
19874662|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874663|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874664|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19874665|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
19874666|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874667|NCT00891878|Capecitabine|capecitabine|mesh-list
19874668|NCT00891878|Sunitinib|sunitinib|mesh-list
19874669|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874670|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
19874671|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874672|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874673|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874674|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874675|NCT00891878|Growth Substances|growth substances|mesh-ancestor
19874676|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874677|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874678|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19874679|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874680|NCT00891930|Irinotecan|irinotecan|mesh-list
19874681|NCT00891930|Panitumumab|panitumumab|mesh-list
19874682|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19874683|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19874684|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874685|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874686|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874687|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874688|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
19874689|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
19874690|NCT00891995|Insulin|insulin|mesh-list
19874691|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19874692|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874693|NCT00892008|Pregabalin|pregabalin|mesh-list
19874694|NCT00892008|Analgesics|analgesics|mesh-ancestor
19874695|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
19874696|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874697|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874698|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
19874699|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19874700|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874701|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874702|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19874703|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19874704|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19874705|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874706|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19449508|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874707|NCT00892047|Aripiprazole|aripiprazole|mesh-list
19874708|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19874709|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
19874710|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874711|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19874712|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19874713|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874714|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874715|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
19874716|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
19874717|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874718|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874719|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19874720|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19874721|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
19874722|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19874723|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19874724|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19874725|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19874726|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19874727|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19874728|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874729|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19874730|NCT00892099|Vitamin D|vitamin d|mesh-list
19874731|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
19874732|NCT00892099|Vitamins|vitamins|mesh-list
19874733|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
19874734|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874735|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19874736|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19874737|NCT00892177|Bevacizumab|bevacizumab|mesh-list
19874738|NCT00892177|Dasatinib|dasatinib|mesh-list
19874739|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874740|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874741|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874742|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874743|NCT00892177|Growth Substances|growth substances|mesh-ancestor
19874744|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874745|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874746|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19874747|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874748|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874749|NCT00892281|Doxycycline|doxycycline|mesh-list
19874750|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19874751|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874752|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
19874753|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19874754|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19874755|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19874756|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19874757|NCT00892437|Cobicistat|cobicistat|mesh-list
19874758|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19874759|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19874760|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874761|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874762|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
19874763|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874764|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19874765|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19874766|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19874767|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19874768|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
19874769|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19874770|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19874771|NCT00892606|Morphine|morphine|mesh-list
19874772|NCT00892606|Methadone|methadone|mesh-list
19874773|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19874774|NCT00892606|Narcotics|narcotics|mesh-ancestor
19874775|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874776|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874777|NCT00892606|Analgesics|analgesics|mesh-ancestor
19874778|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
19874779|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874780|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
19874781|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
19874782|NCT00892697|Ribavirin|ribavirin|mesh-list
19874783|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19874784|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
19874785|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874786|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
19874787|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874788|NCT00892710|Bevacizumab|bevacizumab|mesh-list
19874789|NCT00892710|Carboplatin|carboplatin|mesh-list
19874790|NCT00892710|Pemetrexed|pemetrexed|mesh-list
19874791|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874792|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874793|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19874794|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19874795|NCT00892710|Growth Substances|growth substances|mesh-ancestor
19874796|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874797|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
19874798|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874799|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874800|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19874801|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19874802|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19874803|NCT00892957|Thrombin|thrombin|mesh-list
19874804|NCT00892957|Aprotinin|aprotinin|mesh-list
19874805|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
20256981|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874806|NCT00892957|Coagulants|coagulants|mesh-ancestor
19874807|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19874808|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19874809|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
19874810|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874811|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874812|NCT00893074|Dronabinol|dronabinol|mesh-list
20256982|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20256983|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
20256984|NCT00477503|Gallium citrate|gallium citrate|mesh-list
20256985|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
20256986|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
20256987|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874813|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
20256988|NCT00477503|Antidotes|antidotes|mesh-ancestor
20256989|NCT00477503|Protective Agents|protective agents|mesh-ancestor
20535584|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20256990|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256991|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20256992|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20256993|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
20256994|NCT00477516|Calcium|calcium|mesh-list
19874814|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874815|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874816|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19874817|NCT00893074|Analgesics|analgesics|mesh-ancestor
19874818|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
19874819|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874820|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19874821|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19874822|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874823|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874824|NCT00893074|Hormones|hormones|mesh-ancestor
19874825|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874826|NCT00893113|Alfuzosin|alfuzosin|mesh-list
19874827|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19874828|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19874829|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19874830|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19874831|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874832|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874833|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874834|NCT00893113|Urological Agents|urological agents|mesh-ancestor
19874835|NCT00893464|Ixazomib|ixazomib|mesh-list
19874836|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535585|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20535586|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
19874837|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
19874838|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874839|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874840|NCT00893737|Naproxen|naproxen|mesh-list
19874841|NCT00893737|Sumatriptan|sumatriptan|mesh-list
19874842|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19874843|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19874844|NCT00893737|Analgesics|analgesics|mesh-ancestor
19874845|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
19874846|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20256995|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20256996|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20256997|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20256998|NCT00477542|Clofarabine|clofarabine|mesh-list
20256999|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20257000|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
20257001|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874847|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257002|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874848|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19874849|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19874850|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
19874851|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19874852|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874853|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874854|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19874855|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19874856|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20257003|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19874857|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
19874858|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874859|NCT00893984|Nebivolol|nebivolol|mesh-list
19874860|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19874861|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
19874862|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19874863|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19874864|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19874865|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
19874866|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874867|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874868|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874869|NCT00893997|Vaccines|vaccines|mesh-list
19874870|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
19874871|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874872|NCT00894166|Bupropion|bupropion|mesh-list
19874873|NCT00894166|Nicotine|nicotine|mesh-list
19874874|NCT00894166|Varenicline|varenicline|mesh-list
19874875|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19874876|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
19874877|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874878|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874879|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19874880|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19874881|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
19874882|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874883|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874884|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19874885|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
19874886|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874887|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19874888|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19874889|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874890|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
19874891|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19874892|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19874893|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874894|NCT00894322|Exenatide|exenatide|mesh-list
19874895|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19874896|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874897|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19874898|NCT00894322|Incretins|incretins|mesh-ancestor
19874899|NCT00894322|Hormones|hormones|mesh-ancestor
19874900|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874901|NCT00894413|Tadalafil|tadalafil|mesh-list
19874902|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
19874903|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19874904|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19874905|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874906|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874907|NCT00894413|Urological Agents|urological agents|mesh-ancestor
19874908|NCT00894465|Midazolam|midazolam|mesh-list
19874909|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19874910|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19874911|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874912|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874913|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19874914|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19874915|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874916|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19874917|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
19874918|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
19874919|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
19874920|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
19874921|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874922|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874923|NCT00894504|Gemcitabine|gemcitabine|mesh-list
19874924|NCT00894504|Carboplatin|carboplatin|mesh-list
19874925|NCT00894504|Panitumumab|panitumumab|mesh-list
19874926|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874927|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19874928|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
19874929|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874930|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
19874931|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19874932|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19874933|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19874934|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
19874935|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874936|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19874937|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
19874938|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19874939|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19874940|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19874941|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874942|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874943|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
19874944|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874945|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874946|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19874947|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874948|NCT00894543|Citalopram|citalopram|mesh-list
19874949|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19874950|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19874951|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19874952|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874953|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874954|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
19874955|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874956|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19874957|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
19874958|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874959|NCT00894647|Imiquimod|imiquimod|mesh-list
19874960|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19874961|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
19874962|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874963|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19874964|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
19874965|NCT00894699|Sufentanil|sufentanil|mesh-list
19874966|NCT00894699|Triazolam|triazolam|mesh-list
19874967|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19874968|NCT00894699|Narcotics|narcotics|mesh-ancestor
19874969|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19874970|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874971|NCT00894699|Analgesics|analgesics|mesh-ancestor
19874972|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
19874973|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874974|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19874975|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19874976|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
19874977|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
19874978|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19874979|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19874980|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19874981|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
19874982|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
19874983|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19874984|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19874985|NCT00894803|Eptifibatide|eptifibatide|mesh-list
19874986|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19874987|NCT00895037|Factor VIII|factor viii|mesh-list
19874988|NCT00895037|Coagulants|coagulants|mesh-ancestor
19874989|NCT00895180|Ramucirumab|ramucirumab|mesh-list
19874990|NCT00895180|Olaratumab|olaratumab|mesh-list
19874991|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970267|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970268|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19970269|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970270|NCT01782872|Ropivacaine|ropivacaine|mesh-list
19970271|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
19449509|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449510|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
19449511|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449512|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19449513|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
19449514|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19449515|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449516|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19449517|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19970272|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
19970273|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449518|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19970274|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874992|NCT00895193|Aspirin|aspirin|mesh-list
19874993|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19874994|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19874995|NCT00895193|Analgesics|analgesics|mesh-ancestor
19449519|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449520|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19449521|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
19449522|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19874996|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
19874997|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19874998|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19874999|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875000|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875001|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19875002|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19875003|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875004|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19875005|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19875006|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875007|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
19875008|NCT00895232|Iron|iron|mesh-list
19875009|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19875010|NCT00895232|Trace Elements|trace elements|mesh-ancestor
19875011|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
19875012|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875013|NCT00895232|Hematinics|hematinics|mesh-ancestor
19875014|NCT00895245|Dexamethasone|dexamethasone|mesh-list
19875015|NCT00895245|Palonosetron|palonosetron|mesh-list
19875016|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
19875017|NCT00895245|Aprepitant|aprepitant|mesh-list
19875018|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875019|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875020|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
19875021|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
19875022|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875023|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875024|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875025|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
19875026|NCT00895245|Hormones|hormones|mesh-ancestor
19875027|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875028|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19875029|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19875030|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19875031|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
19875032|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875033|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875034|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19875035|NCT00895310|Ketoconazole|ketoconazole|mesh-list
19875036|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
19875037|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875038|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
19875039|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875040|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19875041|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19875042|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875043|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875044|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19875045|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
19875046|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875047|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875048|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19875049|NCT00895414|Doxorubicin|doxorubicin|mesh-list
19875050|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19875051|NCT00895414|Enalapril|enalapril|mesh-list
19875052|NCT00895414|Enalaprilat|enalaprilat|mesh-list
19875053|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19875054|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875055|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19875056|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19875057|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449523|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19449524|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19449525|NCT03434691|Remifentanil|remifentanil|mesh-list
19970275|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
19875058|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875059|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19875060|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
19875061|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19875062|NCT00895453|Iron|iron|mesh-list
19875063|NCT00895453|Itraconazole|itraconazole|mesh-list
19875064|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
19875065|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875066|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19875067|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19875068|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875069|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875070|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19875071|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
19875072|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875073|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875074|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19875075|NCT00895453|Trace Elements|trace elements|mesh-ancestor
19875076|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
19875077|NCT00895531|Morphine|morphine|mesh-list
19875078|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19875079|NCT00895531|Narcotics|narcotics|mesh-ancestor
19875080|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875081|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875082|NCT00895531|Analgesics|analgesics|mesh-ancestor
19875083|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
19875084|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875085|NCT00895583|Sirolimus|sirolimus|mesh-list
19875086|NCT00895583|Tacrolimus|tacrolimus|mesh-list
19875087|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875088|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
19875089|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875090|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19875091|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875092|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875093|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19875094|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875095|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19875096|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875097|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
19875098|NCT00895661|Rituximab|rituximab|mesh-list
19875099|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875100|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875101|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
19875102|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875103|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875104|NCT00895752|Riluzole|riluzole|mesh-list
19875105|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
19875106|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19875107|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19875108|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875109|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875110|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875111|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19875112|NCT00895752|Protective Agents|protective agents|mesh-ancestor
19875113|NCT00895817|Fluticasone|fluticasone|mesh-list
19875114|NCT00895817|Esomeprazole|esomeprazole|mesh-list
19875115|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875116|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19875117|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
19875118|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875119|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875120|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19875121|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19875122|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
19875123|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19875124|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19875125|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875126|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19875127|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875128|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875129|NCT00895843|Ibuprofen|ibuprofen|mesh-list
19875130|NCT00895843|Epinephrine|epinephrine|mesh-list
19875131|NCT00895843|Bupivacaine|bupivacaine|mesh-list
19875132|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
19875133|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
19875134|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257004|NCT00477581|Exenatide|exenatide|mesh-list
19875135|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875136|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
19875137|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875138|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19875139|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20257005|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20257006|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257007|NCT00477581|Incretins|incretins|mesh-ancestor
19875140|NCT00895843|Analgesics|analgesics|mesh-ancestor
19875141|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875142|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875143|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19875144|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875145|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257008|NCT00477581|Hormones|hormones|mesh-ancestor
20257009|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257010|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20553627|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875146|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19875147|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19875148|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
19875149|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875150|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19875151|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19875152|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
19875153|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19875154|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
19875155|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
19875156|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
19875157|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19875158|NCT00895895|Donepezil|donepezil|mesh-list
19875159|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19875160|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875161|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875162|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
19875163|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875164|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875165|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
19875166|NCT00895921|Olanzapine|olanzapine|mesh-list
19875167|NCT00895921|Aripiprazole|aripiprazole|mesh-list
19875168|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
19875169|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
19875170|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875171|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875172|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875173|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19875174|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19875175|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875176|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19875177|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19875178|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19875179|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875180|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875181|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875182|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
19875183|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
19875184|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
19875185|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
19875186|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19875187|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19875188|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19875189|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19875190|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19875191|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19875192|NCT00895934|Azacitidine|azacitidine|mesh-list
19875193|NCT00895934|Vorinostat|vorinostat|mesh-list
19875194|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
19875195|NCT00895934|Calicheamicins|calicheamicins|mesh-list
19875196|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19875197|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
20257011|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
20257012|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257013|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257014|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19875198|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875199|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875200|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875201|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19875202|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875203|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19875204|NCT00895947|Interferons|interferons|mesh-list
19875205|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
19875206|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875207|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
19875208|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875209|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
19875210|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875211|NCT00896012|Sirolimus|sirolimus|mesh-list
19875212|NCT00896012|Tacrolimus|tacrolimus|mesh-list
19875213|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875214|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
19875215|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875216|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19875217|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875218|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875219|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19875220|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875221|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19875222|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875223|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
19875224|NCT00896038|Aprepitant|aprepitant|mesh-list
19875225|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
19875226|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
19875227|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875228|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875229|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875230|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19875231|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875232|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875233|NCT00896051|Ritonavir|ritonavir|mesh-list
19875234|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19875235|NCT00896051|Tenofovir|tenofovir|mesh-list
19875236|NCT00896051|Etravirine|etravirine|mesh-list
19875237|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19875238|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19875239|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19875240|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
19875241|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875242|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875243|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19875244|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19875245|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
19875246|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875247|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19875248|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19875249|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19875250|NCT00896064|Vaccines|vaccines|mesh-list
20535587|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875251|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19875252|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
19875253|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875254|NCT00896168|Methotrexate|methotrexate|mesh-list
19875255|NCT00896168|Infliximab|infliximab|mesh-list
19875256|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19875257|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
19875258|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19875259|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875260|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19875261|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
19875262|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875263|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535588|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875264|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
19875265|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257015|NCT00477711|Capecitabine|capecitabine|mesh-list
19875266|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19875267|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875268|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
19875269|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875270|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20535589|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
20535590|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
20535591|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535592|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875271|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875272|NCT00896181|Carboplatin|carboplatin|mesh-list
19875273|NCT00896181|Docetaxel|docetaxel|mesh-list
19875274|NCT00896181|Fluorouracil|fluorouracil|mesh-list
19875275|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875276|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
19875277|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
19875278|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
19875279|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875280|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
19875281|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19875282|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875283|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
19875284|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875285|NCT00896441|Citalopram|citalopram|mesh-list
19875286|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19875287|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19875288|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875289|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875290|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875291|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
19875292|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875293|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19875294|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
19875295|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19875296|NCT00896454|Denosumab|denosumab|mesh-list
19875297|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19875298|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875299|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
19875300|NCT00896532|Denosumab|denosumab|mesh-list
19875301|NCT00896532|Alendronate|alendronate|mesh-list
19875302|NCT00896532|Teriparatide|teriparatide|mesh-list
19875303|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19875304|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19449526|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19449527|NCT03434691|Narcotics|narcotics|mesh-ancestor
19449528|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875305|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875306|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19875307|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
19875308|NCT00896779|Ranibizumab|ranibizumab|mesh-list
19875309|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19875310|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19875311|NCT00896779|Growth Substances|growth substances|mesh-ancestor
19875312|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875313|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
19875314|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875315|NCT00897390|Metformin|metformin|mesh-list
19875316|NCT00897390|Saxagliptin|saxagliptin|mesh-list
19875317|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19875318|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875319|NCT00897390|Incretins|incretins|mesh-ancestor
19449529|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449530|NCT03434691|Analgesics|analgesics|mesh-ancestor
19449531|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
19449532|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449533|NCT03434678|Fentanyl|fentanyl|mesh-list
19449534|NCT03434678|Bupivacaine|bupivacaine|mesh-list
19449535|NCT03434678|Propofol|propofol|mesh-list
19449536|NCT03434678|Rocuronium|rocuronium|mesh-list
19449537|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
19875320|NCT00897390|Hormones|hormones|mesh-ancestor
19875321|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875322|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19875323|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
19875324|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875325|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875326|NCT00897715|Rilonacept|rilonacept|mesh-list
19875327|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875328|NCT00898222|Aspirin|aspirin|mesh-list
19875329|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19875330|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19875331|NCT00898222|Analgesics|analgesics|mesh-ancestor
19875332|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
19875333|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875334|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875335|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875336|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875337|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19875338|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19875339|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875340|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19875341|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19875342|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875343|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
19875344|NCT00898443|Anesthetics|anesthetics|mesh-list
19875345|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875346|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875347|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19875348|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
19875349|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19875350|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19875351|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875352|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875353|NCT00898807|Citalopram|citalopram|mesh-list
19875354|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19875355|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19875356|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875357|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875358|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875359|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
19875360|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875361|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19875362|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
19875363|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19875364|NCT00899431|Vidarabine|vidarabine|mesh-list
19875365|NCT00899431|Rituximab|rituximab|mesh-list
19875366|NCT00899431|Fludarabine|fludarabine|mesh-list
19875367|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
19875368|NCT00899431|Lenalidomide|lenalidomide|mesh-list
19875369|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19875370|NCT00899431|Allopurinol|allopurinol|mesh-list
19875371|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
19875372|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19875373|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875374|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875375|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
19875376|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875377|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20535593|NCT01821027|Canagliflozin|canagliflozin|mesh-list
20535594|NCT01821027|Simvastatin|simvastatin|mesh-list
20535595|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19875378|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19875379|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
19875380|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875381|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875382|NCT00899431|Antiviral Agents|antiviral agents|mesh-ancestor
19875383|NCT00899431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875384|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19875385|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19875386|NCT00899431|Growth Substances|growth substances|mesh-ancestor
19875387|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
19875388|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19875389|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
19875390|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875391|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
19875392|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19875393|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
19875394|NCT00899431|Protective Agents|protective agents|mesh-ancestor
20535596|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19875395|NCT00899470|Metformin|metformin|mesh-list
20535597|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
19875396|NCT00899470|Saxagliptin|saxagliptin|mesh-list
19875397|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19875398|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875399|NCT00899470|Incretins|incretins|mesh-ancestor
19875400|NCT00899470|Hormones|hormones|mesh-ancestor
19875401|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875402|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19875403|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
20535598|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535599|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20535600|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20535601|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535602|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20535603|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535604|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535605|NCT01821040|Prednisone|prednisone|mesh-list
20535606|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535607|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
20535608|NCT01821040|Hormones|hormones|mesh-ancestor
20535609|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535610|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535611|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20535612|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535613|NCT01821066|Tamoxifen|tamoxifen|mesh-list
20535614|NCT01821066|Palbociclib|palbociclib|mesh-list
19875404|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875405|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875406|NCT00899574|Imiquimod|imiquimod|mesh-list
19875407|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19875408|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
19875409|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875410|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875411|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
19875412|NCT00899600|Ketamine|ketamine|mesh-list
19875413|NCT00899600|Analgesics|analgesics|mesh-ancestor
19875414|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
19875415|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875416|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875417|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19875418|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19875419|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
19875420|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
19875421|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875422|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19875423|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19875424|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875425|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875426|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
19875427|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875428|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
19875429|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257016|NCT00477711|Cetuximab|cetuximab|mesh-list
20257017|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257018|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20257019|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
20257020|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257021|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20257022|NCT00477737|Propofol|propofol|mesh-list
20257023|NCT00477737|Sevoflurane|sevoflurane|mesh-list
20257024|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20257025|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257026|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257027|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20257028|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
20257029|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
20257030|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20257031|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20257032|NCT00477763|Cyclosporine|cyclosporine|mesh-list
20257033|NCT00477763|Cyclosporins|cyclosporins|mesh-list
20535615|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20535616|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
20535617|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257034|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875430|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875431|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
19875432|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875433|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
19875434|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
19875435|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
19875436|NCT00899847|Acetaminophen|acetaminophen|mesh-list
19875437|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
19875438|NCT00899847|Promethazine|promethazine|mesh-list
19875439|NCT00899847|Cyclosporine|cyclosporine|mesh-list
19875440|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
19875441|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
19875442|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19875443|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
19875444|NCT00899847|Melphalan|melphalan|mesh-list
19875445|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
19875446|NCT00899847|Cyclosporins|cyclosporins|mesh-list
19875447|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
19875448|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19875449|NCT00899847|Lenograstim|lenograstim|mesh-list
19875450|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875451|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
19875452|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875453|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875454|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19875455|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
19875456|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875457|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875458|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19875459|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19875460|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875461|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
20535618|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535619|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20535620|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535621|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20535622|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20535623|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19875462|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875463|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
19875464|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19875465|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19875466|NCT00899847|Analgesics|analgesics|mesh-ancestor
19875467|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
19875468|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875469|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
19875470|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19875471|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19875472|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
19875473|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19875474|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875475|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19875476|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19875477|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875478|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
19875479|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
19875480|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
19875481|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
19875482|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875483|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19875484|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
19875485|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
19875486|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875487|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19875488|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
19875489|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
19875490|NCT00899847|Hormones|hormones|mesh-ancestor
19875491|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875492|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19875493|NCT00899847|Protective Agents|protective agents|mesh-ancestor
19875494|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19875495|NCT00900146|Metformin|metformin|mesh-list
19875496|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19875497|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875498|NCT00900159|Eszopiclone|eszopiclone|mesh-list
19875499|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19875500|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875501|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875502|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19875503|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
19875504|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
19875505|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19875506|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19875507|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875508|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875509|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19875510|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19875511|NCT00900627|Paclitaxel|paclitaxel|mesh-list
19875512|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19875513|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875514|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
19875515|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
19875516|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
19875517|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875518|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
19875519|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19875520|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19875521|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19875522|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875523|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875524|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
19875525|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875526|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875527|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19875528|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875529|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
19875530|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19875531|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
19875532|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875533|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875534|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19875535|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
19875536|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
19875537|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19875538|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
19875539|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875540|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875541|NCT00900757|Palonosetron|palonosetron|mesh-list
19875542|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
19875543|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
19875544|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875545|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875546|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875547|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19875548|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19875549|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
19875550|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875551|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875552|NCT00901186|Ranibizumab|ranibizumab|mesh-list
19875553|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19875554|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19875555|NCT00901186|Growth Substances|growth substances|mesh-ancestor
19875556|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875557|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
19875558|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875559|NCT00901199|Deferasirox|deferasirox|mesh-list
19875560|NCT00901199|Deferoxamine|deferoxamine|mesh-list
19875561|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19875562|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
19875563|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
19875564|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875565|NCT00901199|Siderophores|siderophores|mesh-ancestor
19875566|NCT00901225|Plerixafor|plerixafor|mesh-list
19875567|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19875568|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19875569|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
19875570|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875571|NCT00901394|Folic Acid|folic acid|mesh-list
19875572|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
19875573|NCT00901394|Hematinics|hematinics|mesh-ancestor
19875574|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
19875575|NCT00901394|Vitamins|vitamins|mesh-ancestor
19875576|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
19875577|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875578|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19875579|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
19875580|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
19875581|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875582|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19875583|NCT00901394|Analgesics|analgesics|mesh-ancestor
19875584|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
19875585|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875586|NCT00901576|Methylphenidate|methylphenidate|mesh-list
19875587|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20535624|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20535625|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535626|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535627|NCT01821170|Methylphenidate|methylphenidate|mesh-list
20535628|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19875588|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875589|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19875590|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19875591|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875592|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875593|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
19875594|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875595|NCT00901628|Cefuroxime|cefuroxime|mesh-list
19875596|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
19875597|NCT00901628|Ketorolac|ketorolac|mesh-list
19875598|NCT00901628|Epinephrine|epinephrine|mesh-list
19875599|NCT00901628|Morphine|morphine|mesh-list
19875600|NCT00901628|Ropivacaine|ropivacaine|mesh-list
19875601|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19875602|NCT00901628|Narcotics|narcotics|mesh-ancestor
19875603|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875604|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875605|NCT00901628|Analgesics|analgesics|mesh-ancestor
19875606|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
19875607|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875608|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
19875609|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
19875610|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19875611|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19875612|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
19875613|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875614|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875615|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19875616|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19875617|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
19875618|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19875619|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
19875620|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
19875621|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
19875622|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19875623|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19875624|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19875625|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875626|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257035|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257036|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875627|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19875628|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875629|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19875630|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875631|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19875632|NCT00901901|Sorafenib|sorafenib|mesh-list
19875633|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875634|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19875635|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875636|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875637|NCT00901927|Rituximab|rituximab|mesh-list
19875638|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19875639|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
19449538|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
19875640|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875641|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875642|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
19875643|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257037|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
20257038|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257039|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
20257040|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257041|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
20257042|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257043|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20257044|NCT00477776|Metoclopramide|metoclopramide|mesh-list
20257045|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
19875644|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875645|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19875646|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
19875647|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875648|NCT00901927|Analgesics|analgesics|mesh-ancestor
19875649|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
19875650|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875651|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19875652|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19875653|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875654|NCT00902161|Propranolol|propranolol|mesh-list
19875655|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19875656|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19875657|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
19875658|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257046|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
20257047|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257048|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257049|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20257050|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20257051|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20257052|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
20257053|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875659|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875660|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875661|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19875662|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19875663|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
19875664|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
19875665|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875666|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19875667|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875668|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875669|NCT00902226|Citalopram|citalopram|mesh-list
19875670|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19875671|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19875672|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875673|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875674|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875675|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
19875676|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875677|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19875678|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
19875679|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19875680|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19875681|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
19875682|NCT00902265|Coagulants|coagulants|mesh-ancestor
19875683|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19875684|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
19875685|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875686|NCT00902304|Amlodipine|amlodipine|mesh-list
19875687|NCT00902304|Valsartan|valsartan|mesh-list
19875688|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19875689|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19875690|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20257054|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875691|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19875692|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875693|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875694|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19875695|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875696|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
19875697|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19875698|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19875699|NCT00902304|Diuretics|diuretics|mesh-ancestor
19875700|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
19875701|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19875702|NCT00902538|Amlodipine|amlodipine|mesh-list
19875703|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19875704|NCT00902538|Olmesartan|olmesartan|mesh-list
19875705|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19875706|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19875707|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19875708|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875709|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875710|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19875711|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875712|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
19875713|NCT00902538|Diuretics|diuretics|mesh-ancestor
19875714|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
19875715|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19875716|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19875717|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19875718|NCT00902564|Citalopram|citalopram|mesh-list
19875719|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19875720|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19875721|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875722|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875723|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875724|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
19875725|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875726|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19875727|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
19875728|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19875729|NCT00902577|Misonidazole|misonidazole|mesh-list
19875730|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875731|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19875732|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19875733|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875734|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
19875735|NCT00903162|Letrozole|letrozole|mesh-list
19875736|NCT00903162|Leuprolide|leuprolide|mesh-list
19875737|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875738|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19875739|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19875740|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875741|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875742|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19875743|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
19875744|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875745|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875746|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19875747|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19875748|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
19875749|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19875750|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19875751|NCT00903175|Everolimus|everolimus|mesh-list
19875752|NCT00903175|Sunitinib|sunitinib|mesh-list
19875753|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875754|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875755|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
20257055|NCT00477789|Allopurinol|allopurinol|mesh-list
19875756|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875757|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19875758|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19875759|NCT00903175|Growth Substances|growth substances|mesh-ancestor
19875760|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
19875761|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257056|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
19875762|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875763|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875764|NCT00903331|Macitentan|macitentan|mesh-list
19875765|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19875766|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19875767|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875768|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19875769|NCT00903344|Vitamin D|vitamin d|mesh-list
19875770|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
19875771|NCT00903344|Vitamins|vitamins|mesh-ancestor
19875772|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
19875773|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875774|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19875775|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19875776|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
19875777|NCT00903357|Montelukast|montelukast|mesh-list
19875778|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19875779|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
19875780|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19875781|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
19875782|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875783|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875784|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19875785|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19875786|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875787|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
19875788|NCT00903357|Protective Agents|protective agents|mesh-ancestor
19875789|NCT00903357|Vitamins|vitamins|mesh-ancestor
19875790|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
19970276|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970277|NCT01782885|Acetaminophen|acetaminophen|mesh-list
19970278|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19970279|NCT01782885|Analgesics|analgesics|mesh-ancestor
19970280|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
19970281|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970282|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970283|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
19970284|NCT01782898|Esmolol|esmolol|mesh-list
19970285|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19970286|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19970287|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19970288|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
19970289|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970290|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970291|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970292|NCT01782963|Dexamethasone|dexamethasone|mesh-list
19970293|NCT01782963|Lenalidomide|lenalidomide|mesh-list
19970294|NCT01782963|Bortezomib|bortezomib|mesh-list
19970295|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970296|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
19970297|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
19970298|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970299|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970300|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19970301|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
19970302|NCT01782963|Hormones|hormones|mesh-ancestor
19970303|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970304|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19970305|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970306|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
19970307|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19970308|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19970309|NCT01782963|Growth Substances|growth substances|mesh-ancestor
19970310|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
19970311|NCT01783054|Gemcitabine|gemcitabine|mesh-list
19970312|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970313|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
19970314|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970315|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970316|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
19970317|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970318|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970319|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970320|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
19875791|NCT00903409|Simvastatin|simvastatin|mesh-list
19875792|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19875793|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19875794|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
19875795|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875796|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19875797|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19875798|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875799|NCT00903448|Omeprazole|omeprazole|mesh-list
19875800|NCT00903448|Lansoprazole|lansoprazole|mesh-list
19875801|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19875802|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875803|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19875804|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875805|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875806|NCT00903617|Niacin|niacin|mesh-list
19875807|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
19875808|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19875809|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
19875810|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875811|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19875812|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
19875813|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
19875814|NCT00903617|Vitamins|vitamins|mesh-ancestor
19875815|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
19875816|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875817|NCT00903630|Doxorubicin|doxorubicin|mesh-list
19875818|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19875819|NCT00903630|Lenalidomide|lenalidomide|mesh-list
19875820|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20257057|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257058|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257059|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
20257060|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257061|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20257062|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
20257063|NCT00477789|Protective Agents|protective agents|mesh-ancestor
20257064|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257065|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
20257066|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20257067|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20257068|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20257069|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20257070|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257071|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
20257072|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257073|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257074|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20257075|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257076|NCT00477815|Rituximab|rituximab|mesh-list
20257077|NCT00477815|Melphalan|melphalan|mesh-list
20257078|NCT00477815|Sargramostim|sargramostim|mesh-list
20257079|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20257080|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20257081|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875821|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875822|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19875823|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19875824|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875825|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875826|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
19875827|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875828|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19875829|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19875830|NCT00903630|Growth Substances|growth substances|mesh-ancestor
19875831|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
19875832|NCT00903682|Efavirenz|efavirenz|mesh-list
19875833|NCT00903682|Etravirine|etravirine|mesh-list
19875834|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19875835|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19875836|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875837|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875838|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
19875839|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875840|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19875841|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19875842|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19875843|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19875844|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19875845|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19875846|NCT00903760|Decitabine|decitabine|mesh-list
19875847|NCT00903760|Clofarabine|clofarabine|mesh-list
19875848|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19875849|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
19875850|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875851|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875852|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875853|NCT00903968|Plerixafor|plerixafor|mesh-list
19875854|NCT00903968|Dexamethasone|dexamethasone|mesh-list
19875855|NCT00903968|Bortezomib|bortezomib|mesh-list
19875856|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19875857|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
19875858|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
19875859|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875860|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875861|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19875862|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
19875863|NCT00903968|Hormones|hormones|mesh-ancestor
19875864|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875865|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19875866|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875867|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19875868|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19875869|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
19875870|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875871|NCT00904033|Calcitriol|calcitriol|mesh-list
19875872|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19875873|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875874|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19875875|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875876|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875877|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19875878|NCT00904033|Vitamins|vitamins|mesh-ancestor
19875879|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
19875880|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19875881|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19875882|NCT00904215|Telmisartan|telmisartan|mesh-list
19875883|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19875884|NCT00904215|Diuretics|diuretics|mesh-ancestor
19875885|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
19875886|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875887|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19875888|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875889|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875890|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19875891|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19875892|NCT00904345|Cetuximab|cetuximab|mesh-list
19875893|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875894|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875895|NCT00904488|Metolazone|metolazone|mesh-list
19875896|NCT00904488|Furosemide|furosemide|mesh-list
19875897|NCT00904488|Diuretics|diuretics|mesh-ancestor
19875898|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
19875899|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875900|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19875901|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875902|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875903|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19875904|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19875905|NCT00904618|Lidocaine|lidocaine|mesh-list
19875906|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
19875907|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
19875908|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19875909|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875910|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
19875911|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19875912|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19875913|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19875914|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19875915|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875916|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875917|NCT00904670|Methylphenidate|methylphenidate|mesh-list
19875918|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19875919|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875920|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19875921|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19875922|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875923|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875924|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
19875925|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19875926|NCT00904722|Rituximab|rituximab|mesh-list
19875927|NCT00904722|Pidilizumab|pidilizumab|mesh-list
19875928|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875929|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875930|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
19875931|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875932|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19875933|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
19875934|NCT00904748|Citric Acid|citric acid|mesh-list
19875935|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
19875936|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
19875937|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19875938|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
19875939|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
19875940|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875941|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
19875942|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19875943|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19875944|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875945|NCT00904748|Urological Agents|urological agents|mesh-ancestor
19875946|NCT00904826|Eculizumab|eculizumab|mesh-list
19875947|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19875948|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19875949|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
19875950|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875951|NCT00904839|Bevacizumab|bevacizumab|mesh-list
19875952|NCT00904839|Nintedanib|nintedanib|mesh-list
19875953|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875954|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875955|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19875956|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19875957|NCT00904839|Growth Substances|growth substances|mesh-ancestor
19875958|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875959|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
19875960|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19875961|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875962|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875963|NCT00904995|Voriconazole|voriconazole|mesh-list
19875964|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
19875965|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19875966|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19875967|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19875968|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875969|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875970|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19875971|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
19875972|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875973|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535629|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535630|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20535631|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20535632|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19875974|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19875975|NCT00905021|Sunitinib|sunitinib|mesh-list
19875976|NCT00905021|Exemestane|exemestane|mesh-list
19875977|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875978|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19875979|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19875980|NCT00905021|Growth Substances|growth substances|mesh-ancestor
19875981|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19875982|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
19875983|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19875984|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19875985|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19875986|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19875987|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19875988|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20535633|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535634|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
20535635|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553628|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20553629|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19875989|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
19875990|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19875991|NCT00905034|Dexamethasone|dexamethasone|mesh-list
19875992|NCT00905034|Rituximab|rituximab|mesh-list
19875993|NCT00905034|Methotrexate|methotrexate|mesh-list
19875994|NCT00905034|Vincristine|vincristine|mesh-list
19875995|NCT00905034|Asparaginase|asparaginase|mesh-list
19875996|NCT00905034|Pegaspargase|pegaspargase|mesh-list
19875997|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19875998|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19875999|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
19876000|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876001|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876002|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876003|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
19876004|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
19876005|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876006|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876007|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
19876008|NCT00905034|Hormones|hormones|mesh-ancestor
19876009|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876010|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876011|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19876012|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
19876013|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19876014|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19876015|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
19876016|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876017|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
19876018|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876019|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19876020|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876021|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19876022|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19876023|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
19876024|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
19876025|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
19876026|NCT00905060|Temozolomide|temozolomide|mesh-list
19876027|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19876028|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
19876029|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876030|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876031|NCT00905255|Lixisenatide|lixisenatide|mesh-list
19876032|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19876033|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876034|NCT00905268|Idebenone|idebenone|mesh-list
19876035|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
19876036|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876037|NCT00905268|Protective Agents|protective agents|mesh-ancestor
19876038|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876039|NCT00905307|Aripiprazole|aripiprazole|mesh-list
19876040|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
19876041|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19876042|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19876043|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19876044|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876045|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876046|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
19876047|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
19876048|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876049|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876050|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19876051|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19876052|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
19876053|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20535636|NCT01821235|Gabapentin|gabapentin|mesh-list
20535637|NCT01821235|Analgesics|analgesics|mesh-ancestor
20535638|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
20535639|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535640|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535641|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
19876054|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19876055|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19876056|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19876057|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19876058|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
19876059|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19876060|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19876061|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876062|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19876063|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19876064|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876065|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876066|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
19876067|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876068|NCT00905437|Pregabalin|pregabalin|mesh-list
19876069|NCT00905437|Analgesics|analgesics|mesh-ancestor
19876070|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
19876071|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876072|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876073|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
19876074|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19876075|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876076|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876077|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19876078|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19876079|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19876080|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876081|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19876082|NCT00905489|Nevirapine|nevirapine|mesh-list
19876083|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19876084|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19876085|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876086|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876087|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
19876088|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876089|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19876090|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19876091|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19876092|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19876093|NCT00905515|Cyclosporine|cyclosporine|mesh-list
19876094|NCT00905515|Tacrolimus|tacrolimus|mesh-list
19876095|NCT00905515|Cyclosporins|cyclosporins|mesh-list
19876096|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876097|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
19876098|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876099|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19876100|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876101|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876102|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
19876103|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876104|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
19876105|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876106|NCT00905580|Pregabalin|pregabalin|mesh-list
19876107|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876108|NCT00905580|Analgesics|analgesics|mesh-ancestor
19876109|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
19876110|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876111|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
19876112|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19876113|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876114|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535642|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20535643|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19876115|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19876116|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19876117|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19876118|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876119|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19876120|NCT00906087|Timolol|timolol|mesh-list
19876121|NCT00906087|Dorzolamide|dorzolamide|mesh-list
19876122|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19876123|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19876124|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19876125|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
19876126|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876127|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876128|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876129|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19876130|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19876131|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19876132|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876133|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19876134|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
19876135|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19876136|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
19876137|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876138|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876139|NCT00906282|Carboplatin|carboplatin|mesh-list
19876140|NCT00906282|Pemetrexed|pemetrexed|mesh-list
19876141|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876142|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452666|NCT03411798|Methotrexate|methotrexate|mesh-list
19876143|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876144|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19876145|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19876146|NCT00906347|Misoprostol|misoprostol|mesh-list
19876147|NCT00906347|Oxytocin|oxytocin|mesh-list
19876148|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
19876149|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19876150|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876151|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19876152|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
19876153|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19876154|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876155|NCT00906373|Sorafenib|sorafenib|mesh-list
19876156|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19876157|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876158|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19876159|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876160|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876161|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
19876162|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876163|NCT00906399|Interferons|interferons|mesh-list
19876164|NCT00906399|Interferon-beta|interferon-beta|mesh-list
19876165|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
19876166|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876167|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
19876168|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876169|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
19876170|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876171|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19876172|NCT00906503|Dexamethasone|dexamethasone|mesh-list
19876173|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19876174|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876175|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
19876176|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
19876177|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876178|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876179|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876180|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
19876181|NCT00906503|Hormones|hormones|mesh-ancestor
19876182|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876183|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876184|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876185|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19876186|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257082|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
19876187|NCT00906698|Vinorelbine|vinorelbine|mesh-list
19876188|NCT00906698|Afatinib|afatinib|mesh-list
19876189|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19876190|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876191|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
19876192|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
19876193|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
19876194|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876195|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19876196|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876197|NCT00906945|Cytarabine|cytarabine|mesh-list
19876198|NCT00906945|Plerixafor|plerixafor|mesh-list
19876199|NCT00906945|Etoposide|etoposide|mesh-list
19876200|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
19876201|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19876202|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876203|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19876204|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19876205|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876206|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876207|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19876208|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
19876209|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
19876210|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876211|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876212|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
19876213|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876214|NCT00906945|Analgesics|analgesics|mesh-ancestor
19876215|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
19876216|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876217|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19876218|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19876219|NCT00907101|Adapalene|adapalene|mesh-list
19876220|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19876221|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19876222|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
19876223|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19876224|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19876225|NCT00907101|Analgesics|analgesics|mesh-ancestor
19876226|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
19876227|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876228|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876229|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876230|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876231|NCT00907153|Vitamin D|vitamin d|mesh-list
19876232|NCT00907153|Vitamins|vitamins|mesh-ancestor
19876233|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
19876234|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876235|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19876236|NCT00907257|Tretinoin|tretinoin|mesh-list
19876237|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19876238|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
19876239|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876240|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
19876241|NCT00907335|Tretinoin|tretinoin|mesh-list
19876242|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19876243|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876244|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
19876245|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
19876246|NCT00907374|Benazepril|benazepril|mesh-list
19876247|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19876248|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
19876249|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876250|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876251|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19876252|NCT00907426|Bimatoprost|bimatoprost|mesh-list
19876253|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19876254|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19876255|NCT00907517|Cytarabine|cytarabine|mesh-list
19876256|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19876257|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
19876258|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257083|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257084|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876259|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876260|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
19876261|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876262|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876263|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
19876264|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876265|NCT00907738|Vorinostat|vorinostat|mesh-list
19876266|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876267|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19876268|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876269|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876270|NCT00907777|Vaccines|vaccines|mesh-list
19876271|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19876272|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
19876273|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876274|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19876275|NCT00908011|Ezetimibe|ezetimibe|mesh-list
19876276|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19876277|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19876278|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
19876279|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876280|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19876281|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19876282|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876283|NCT00908076|Lubiprostone|lubiprostone|mesh-list
19876284|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19876285|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876286|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876287|NCT00908141|Sargramostim|sargramostim|mesh-list
19876288|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
19876289|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876290|NCT00908232|Dexamethasone|dexamethasone|mesh-list
19876291|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
19876292|NCT00908232|Lenalidomide|lenalidomide|mesh-list
19876293|NCT00908232|Bortezomib|bortezomib|mesh-list
19876294|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876295|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
19876296|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876297|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876298|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19876299|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
19876300|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876301|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876302|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19876303|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20535644|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535645|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20535646|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19876304|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
19876305|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
19876306|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876307|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876308|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
19876309|NCT00908232|Hormones|hormones|mesh-ancestor
20535647|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20535648|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876310|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876311|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876312|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19876313|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19876314|NCT00908232|Growth Substances|growth substances|mesh-ancestor
19876315|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
19876316|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
19876317|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
19876318|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19876319|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19876320|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876321|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876322|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19876323|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19876324|NCT00908375|Pregabalin|pregabalin|mesh-list
19876325|NCT00908375|Analgesics|analgesics|mesh-ancestor
19876326|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
19876327|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876328|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876329|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
19876330|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19876331|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876332|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876333|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19876334|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19876335|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19876336|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876337|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19876338|NCT00908466|Sirolimus|sirolimus|mesh-list
19876339|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19876340|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876341|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19876342|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876343|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
19876344|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876345|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
19876346|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876347|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
19876348|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19876349|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19876350|NCT00908583|Prednisolone|prednisolone|mesh-list
19876351|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
19876352|NCT00908583|Rituximab|rituximab|mesh-list
19876353|NCT00908583|Bortezomib|bortezomib|mesh-list
19876354|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19876355|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
19876356|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19876357|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876358|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
19876359|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876360|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876361|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876362|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
19876363|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
19876364|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876365|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876366|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
19876367|NCT00908583|Hormones|hormones|mesh-ancestor
19876368|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876369|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19876370|NCT00908583|Protective Agents|protective agents|mesh-ancestor
19876371|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19970321|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970322|NCT01783236|Acetaminophen|acetaminophen|mesh-list
19970323|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19970324|NCT01783236|Analgesics|analgesics|mesh-ancestor
19970325|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
19970326|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970327|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970328|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
19970329|NCT01783444|Capecitabine|capecitabine|mesh-list
19970330|NCT01783444|Everolimus|everolimus|mesh-list
19970331|NCT01783444|Exemestane|exemestane|mesh-list
19970332|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970333|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
19970334|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970335|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970336|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970337|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
19970338|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970339|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19970340|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19970341|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970342|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19970343|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
19970344|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970345|NCT01783470|Mirabegron|mirabegron|mesh-list
19970346|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
19970347|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
19970348|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19970349|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19970350|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970351|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970352|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970353|NCT01783470|Urological Agents|urological agents|mesh-ancestor
19970354|NCT01783548|Beclomethasone|beclomethasone|mesh-list
19876372|NCT00908960|Enoxaparin|enoxaparin|mesh-list
19876373|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
19876374|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19876375|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19876376|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876377|NCT00909064|PENTA|penta|mesh-list
19876378|NCT00909064|Fondaparinux|fondaparinux|mesh-list
19876379|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19876380|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
19876381|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19876382|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
19876383|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876384|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876385|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
20535649|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535650|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
20535651|NCT01821248|Gemcitabine|gemcitabine|mesh-list
20535652|NCT01821248|Cisplatin|cisplatin|mesh-list
20535653|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535654|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19876386|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19876387|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19876388|NCT00909155|Fluoxetine|fluoxetine|mesh-list
19876389|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19876390|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19876391|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19876392|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876393|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876394|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876395|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
19876396|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876397|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19876398|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
19876399|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19876400|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19876401|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19876402|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876403|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19876404|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
19876405|NCT00909181|Oxybutynin|oxybutynin|mesh-list
19876406|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
19876407|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
19876408|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876409|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876410|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19876411|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19876412|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876413|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876414|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876415|NCT00909181|Urological Agents|urological agents|mesh-ancestor
19876416|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19876417|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876418|NCT00909181|Renal Agents|renal agents|mesh-ancestor
19876419|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
19876420|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19876421|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19876422|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876423|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876424|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876425|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876426|NCT00909428|Urological Agents|urological agents|mesh-ancestor
19876427|NCT00909480|Insulin|insulin|mesh-list
19876428|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19876429|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
19876430|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
19876431|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19876432|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876433|NCT00909532|Ivacaftor|ivacaftor|mesh-list
19876434|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19876435|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876436|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876437|NCT00909545|Isradipine|isradipine|mesh-list
19876438|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19876439|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535655|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
19876440|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876441|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876442|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19876443|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876444|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
19876445|NCT00909727|Ivacaftor|ivacaftor|mesh-list
19876446|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19876447|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876448|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876449|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
19876450|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19876451|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
19876452|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876453|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876454|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19876455|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
19876456|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19876457|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19876458|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19876459|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
19876460|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876461|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876462|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19876463|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
19876464|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19876465|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
19876466|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19876467|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876468|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19876469|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876470|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876471|NCT00909857|Dienogest|dienogest|mesh-list
19876472|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19876473|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20257085|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20257086|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
20257087|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257088|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20257089|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257090|NCT00477854|Chromium|chromium|mesh-list
20257091|NCT00477854|Picolinic acid|picolinic acid|mesh-list
20257092|NCT00477854|Trace Elements|trace elements|mesh-ancestor
20535656|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535657|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
19876474|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
19876475|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19876476|NCT00909857|Estradiol|estradiol|mesh-list
19876477|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19876478|NCT00909857|Estrogens|estrogens|mesh-ancestor
19876479|NCT00909857|Hormones|hormones|mesh-ancestor
19876480|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876481|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876482|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19876483|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
19876484|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19876485|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19876486|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19876487|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19876488|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19876489|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19876490|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
20535658|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876491|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876492|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876493|NCT00910000|Gemcitabine|gemcitabine|mesh-list
19876494|NCT00910000|Carboplatin|carboplatin|mesh-list
19876495|NCT00910000|Vorinostat|vorinostat|mesh-list
19876496|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876497|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19876498|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
20257093|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
20257094|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876499|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876500|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
19876501|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876502|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876503|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876504|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
19876505|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876506|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19876507|NCT00910039|Sunitinib|sunitinib|mesh-list
19876508|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876509|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19876510|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19876511|NCT00910039|Growth Substances|growth substances|mesh-ancestor
19876512|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876513|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
19876514|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19876515|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876516|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876517|NCT00910091|Megestrol|megestrol|mesh-list
19876518|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
19876519|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19876520|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19876521|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19876522|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
19876523|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19876524|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257095|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20257096|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
20535659|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535660|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535661|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
20535662|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535663|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
20535664|NCT01821261|Fluorides|fluorides|mesh-list
20535665|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
19876525|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19876526|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19876527|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876528|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876529|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
19876530|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19876531|NCT00910208|Morphine|morphine|mesh-list
19876532|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19876533|NCT00910208|Narcotics|narcotics|mesh-ancestor
19876534|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876535|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876536|NCT00910208|Analgesics|analgesics|mesh-ancestor
19876537|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
19876538|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876539|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19876540|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
19876541|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19876542|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19876543|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876544|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876545|NCT00910273|Etanercept|etanercept|mesh-list
19876546|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19876547|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19876548|NCT00910273|Analgesics|analgesics|mesh-ancestor
20535666|NCT01821261|Protective Agents|protective agents|mesh-ancestor
19876549|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
19876550|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876551|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876552|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876553|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876554|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876555|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876556|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
19876557|NCT00910299|Clopidogrel|clopidogrel|mesh-list
19876558|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19876559|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19876560|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19876561|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19876562|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19876563|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
19876564|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876565|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876566|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876567|NCT00910429|Riociguat|riociguat|mesh-list
19876568|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
19876569|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876570|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
19876571|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19876572|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19876573|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19876574|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876575|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876576|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876577|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876578|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876579|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19876580|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876581|NCT00910624|Ribavirin|ribavirin|mesh-list
19876582|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19876583|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
19876584|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876585|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
19876586|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876587|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
19876588|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19876589|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876590|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19876591|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
19876592|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19876593|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876594|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876595|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876596|NCT00910689|Propranolol|propranolol|mesh-list
19876597|NCT00910689|Nadolol|nadolol|mesh-list
19876598|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19876599|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19876600|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
19876601|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876602|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876603|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876604|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19876605|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20257097|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
19876606|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
19876607|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
19876608|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
19876609|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876610|NCT00910715|Doxycycline|doxycycline|mesh-list
19876611|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19876612|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876613|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
19876614|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19876615|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19876616|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
19876617|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20257098|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876618|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19876619|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20257099|NCT00477880|Cetuximab|cetuximab|mesh-list
20535667|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535668|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20535669|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535670|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
20535671|NCT01821274|Diltiazem|diltiazem|mesh-list
20535672|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535673|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535674|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876620|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876621|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876622|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876623|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876624|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876625|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19876626|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876627|NCT00910858|Lenalidomide|lenalidomide|mesh-list
19876628|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
19876629|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
19876630|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876631|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19876632|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19876633|NCT00910858|Growth Substances|growth substances|mesh-ancestor
19876634|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
19876635|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876636|NCT00910858|Hematinics|hematinics|mesh-ancestor
19876637|NCT00910871|Bedaquiline|bedaquiline|mesh-list
19876638|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
19876639|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19876640|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19876641|NCT00910910|Lenalidomide|lenalidomide|mesh-list
19876642|NCT00910910|Chlorambucil|chlorambucil|mesh-list
19876643|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
19876644|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876645|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19876646|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20535675|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535676|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535677|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535678|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535679|NCT01821404|Atorvastatin|atorvastatin|mesh-list
20535680|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20535681|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20535682|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
20535683|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535684|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20535685|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20535686|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876647|NCT00910910|Growth Substances|growth substances|mesh-ancestor
19876648|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
19876649|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876650|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19876651|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
19876652|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876653|NCT00910988|Olanzapine|olanzapine|mesh-list
19876654|NCT00910988|Ziprasidone|ziprasidone|mesh-list
19876655|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
19876656|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
19876657|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876658|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876659|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876660|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19876661|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19876662|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257100|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20257101|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257102|NCT00477893|Adalimumab|adalimumab|mesh-list
20257103|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257104|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257105|NCT00477945|Clofarabine|clofarabine|mesh-list
20257106|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20535687|NCT01821430|Pregabalin|pregabalin|mesh-list
19876663|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19876664|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20257107|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
19876665|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20257108|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257109|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257110|NCT00477984|Ethanol|ethanol|mesh-list
19876666|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876667|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876668|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876669|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
19876670|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19876671|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19876672|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
19876673|NCT00911144|Vaccines|vaccines|mesh-list
19876674|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19876675|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
19876676|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876677|NCT00911157|Heparin|heparin|mesh-list
19876678|NCT00911157|Calcium heparin|calcium heparin|mesh-list
19876679|NCT00911157|PENTA|penta|mesh-list
20535688|NCT01821430|Analgesics|analgesics|mesh-ancestor
20535689|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
20535690|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535691|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876680|NCT00911157|Fondaparinux|fondaparinux|mesh-list
19876681|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
20535692|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
20535693|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535694|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535695|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535696|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19876682|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19876683|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19876684|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876685|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19876686|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
19876687|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19876688|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
19876689|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876690|NCT00911170|Bevacizumab|bevacizumab|mesh-list
19876691|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19876692|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876693|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19876694|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19876695|NCT00911170|Growth Substances|growth substances|mesh-ancestor
19876696|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876697|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
19876698|NCT00911300|Vitamin K|vitamin k|mesh-list
19876699|NCT00911300|Heparin|heparin|mesh-list
19876700|NCT00911300|Calcium heparin|calcium heparin|mesh-list
19876701|NCT00911300|PENTA|penta|mesh-list
19876702|NCT00911300|Fondaparinux|fondaparinux|mesh-list
19876703|NCT00911300|Vitamins|vitamins|mesh-ancestor
19876704|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
19876705|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876706|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
19876707|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19876708|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19876709|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876710|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19876711|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
19876712|NCT00911300|Coagulants|coagulants|mesh-ancestor
19876713|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20257111|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20257112|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257113|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257114|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257115|NCT00477997|Hormones|hormones|mesh-list
20257116|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257117|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876714|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
19876715|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19876716|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
19876717|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876718|NCT00911326|Dextrans|dextrans|mesh-list
19876719|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
19876720|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
19876721|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
19876722|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
19876723|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
19876724|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
19876725|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876726|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19876727|NCT00911534|Rabeprazole|rabeprazole|mesh-list
19876728|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19876729|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876730|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19876731|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876732|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876733|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
19876734|NCT00911586|Testosterone|testosterone|mesh-list
19876735|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
19876736|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
19876737|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19876738|NCT00911586|Androgens|androgens|mesh-ancestor
19876739|NCT00911586|Hormones|hormones|mesh-ancestor
19876740|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876741|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876742|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876743|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876744|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
19876745|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19876746|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19876747|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19876748|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
19876749|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876750|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19876751|NCT00911625|Insulin|insulin|mesh-list
19876752|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19876753|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
19876754|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
19876755|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19876756|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876757|NCT00911742|Tramadol|tramadol|mesh-list
19876758|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19876759|NCT00911742|Narcotics|narcotics|mesh-ancestor
19876760|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876761|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876762|NCT00911742|Analgesics|analgesics|mesh-ancestor
19876763|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
19876764|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876765|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
19876766|NCT00911807|Donepezil|donepezil|mesh-list
19876767|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19876768|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876769|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876770|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876771|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876772|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876773|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
19876774|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19876775|NCT00911807|Protective Agents|protective agents|mesh-ancestor
19876776|NCT00911820|Bevacizumab|bevacizumab|mesh-list
19876777|NCT00911820|Cisplatin|cisplatin|mesh-list
19876778|NCT00911820|Docetaxel|docetaxel|mesh-list
19876779|NCT00911820|Irinotecan|irinotecan|mesh-list
19876780|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19876781|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876782|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19876783|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19876784|NCT00911820|Growth Substances|growth substances|mesh-ancestor
19876785|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876786|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
19876787|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
19876788|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
19876789|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
19876790|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876791|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19876792|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19876793|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535697|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20535698|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20535699|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535700|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20535701|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
20535702|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
20535703|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
20535704|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20535705|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20535706|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20535707|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876794|NCT00911859|Prednisone|prednisone|mesh-list
19876795|NCT00911859|Bortezomib|bortezomib|mesh-list
19876796|NCT00911859|Melphalan|melphalan|mesh-list
19876797|NCT00911859|Siltuximab|siltuximab|mesh-list
19876798|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19876799|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876800|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
19876801|NCT00911859|Hormones|hormones|mesh-ancestor
19876802|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876803|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876804|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876805|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876806|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19876807|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
19876808|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876809|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19876810|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876811|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
19876812|NCT00911937|Fesoterodine|fesoterodine|mesh-list
19876813|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19876814|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19876815|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876816|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876817|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876818|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876819|NCT00911937|Urological Agents|urological agents|mesh-ancestor
19876820|NCT00912015|Tramadol|tramadol|mesh-list
19876821|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19876822|NCT00912015|Narcotics|narcotics|mesh-ancestor
19876823|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876824|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876825|NCT00912015|Analgesics|analgesics|mesh-ancestor
19876826|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
19876827|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876828|NCT00912093|Icatibant|icatibant|mesh-list
19876829|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19876830|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19876831|NCT00912093|Analgesics|analgesics|mesh-ancestor
19876832|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
19876833|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876834|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876835|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876836|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876837|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19876838|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19876839|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876840|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19876841|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876842|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
19876843|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19876844|NCT00912301|Cathartics|cathartics|mesh-ancestor
19876845|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876846|NCT00912340|Trastuzumab|trastuzumab|mesh-list
19876847|NCT00912340|Everolimus|everolimus|mesh-list
19876848|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19876849|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876850|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876851|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
19876852|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876853|NCT00912509|Riboflavin|riboflavin|mesh-list
19876854|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
19876855|NCT00912509|Vitamins|vitamins|mesh-ancestor
19876856|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
19876857|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553630|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876858|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19876859|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
19876860|NCT00912743|Olaparib|olaparib|mesh-list
19876861|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19876862|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876863|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876864|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876865|NCT00912782|Vitamin D|vitamin d|mesh-list
19876866|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
19876867|NCT00912782|Vitamins|vitamins|mesh-ancestor
19876868|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
19876869|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876870|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19876871|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19876872|NCT00912808|Donepezil|donepezil|mesh-list
19876873|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19876874|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876875|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876876|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876877|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876878|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876879|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
19876880|NCT00912873|Ropivacaine|ropivacaine|mesh-list
19876881|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
19876882|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
19876883|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876884|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876885|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
19876886|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876887|NCT00912912|Sunitinib|sunitinib|mesh-list
19876888|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876889|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19876890|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19876891|NCT00912912|Growth Substances|growth substances|mesh-ancestor
19876892|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876893|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
19876894|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19876895|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876896|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876897|NCT00912964|Mirabegron|mirabegron|mesh-list
19876898|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19876899|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19876900|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19876901|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
20535708|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535709|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
20535710|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535711|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876902|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535712|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20535713|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535714|NCT01821612|Leucovorin|leucovorin|mesh-list
19876903|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876904|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876905|NCT00912964|Urological Agents|urological agents|mesh-ancestor
19876906|NCT00912990|Cisatracurium|cisatracurium|mesh-list
19876907|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19876908|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19876909|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876910|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876911|NCT00913003|Lidocaine|lidocaine|mesh-list
19876912|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
19876913|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
19876914|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876915|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876916|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
19876917|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876918|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19876919|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19876920|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19876921|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876922|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876923|NCT00913068|Lidocaine|lidocaine|mesh-list
19876924|NCT00913068|Ropivacaine|ropivacaine|mesh-list
19876925|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
19876926|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
19876927|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876928|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876929|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
19876930|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876931|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19876932|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19876933|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19876934|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19876935|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876936|NCT00913081|Quercetin|quercetin|mesh-list
19876937|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
19876938|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876939|NCT00913081|Protective Agents|protective agents|mesh-ancestor
19876940|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257118|NCT00478049|Docetaxel|docetaxel|mesh-list
20257119|NCT00478049|Gefitinib|gefitinib|mesh-list
19876941|NCT00913133|Desirudin|desirudin|mesh-list
19876942|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
19876943|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19876944|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19876945|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876946|NCT00913263|Flutamide|flutamide|mesh-list
19876947|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
19876948|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
19876949|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
19876950|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19876951|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876952|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19876953|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876954|NCT00913458|Etanercept|etanercept|mesh-list
19876955|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19876956|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19876957|NCT00913458|Analgesics|analgesics|mesh-ancestor
19876958|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
19876959|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876960|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876961|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876962|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876963|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19876964|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19876965|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
19876966|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19876967|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
19876968|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19876969|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876970|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876971|NCT00913627|Ibuprofen|ibuprofen|mesh-list
19876972|NCT00913627|Naproxen|naproxen|mesh-list
19876973|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19876974|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19876975|NCT00913627|Analgesics|analgesics|mesh-ancestor
19876976|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
19876977|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876978|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876979|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19876980|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19876981|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19876982|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19876983|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19876984|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
19876985|NCT00913770|Buprenorphine|buprenorphine|mesh-list
19876986|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19876987|NCT00913770|Narcotics|narcotics|mesh-ancestor
19876988|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19876989|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19876990|NCT00913770|Analgesics|analgesics|mesh-ancestor
19876991|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
19876992|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19876993|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19876994|NCT00913835|Doxorubicin|doxorubicin|mesh-list
19876995|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19876996|NCT00913835|Olaratumab|olaratumab|mesh-list
19876997|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19876998|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19876999|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19877000|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19877001|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877002|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877003|NCT00913913|Bevacizumab|bevacizumab|mesh-list
19877004|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877005|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877006|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19877007|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19877008|NCT00913913|Growth Substances|growth substances|mesh-ancestor
19877009|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877010|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
19877011|NCT00914316|Ranolazine|ranolazine|mesh-list
19877012|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19877013|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877014|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877015|NCT00914459|Factor VIII|factor viii|mesh-list
19877016|NCT00914459|Coagulants|coagulants|mesh-ancestor
19970355|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970356|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
19970357|NCT01783548|Hormones|hormones|mesh-ancestor
19970358|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970359|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970360|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19970361|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
19970362|NCT01783561|Caffeine|caffeine|mesh-list
19970363|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
19970364|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970365|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19970366|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970367|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19970368|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970369|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19970370|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19970371|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
19970372|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970373|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
19970374|NCT01783574|Testosterone|testosterone|mesh-list
19970375|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
19970376|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
19970377|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19970378|NCT01783574|Androgens|androgens|mesh-ancestor
19970379|NCT01783574|Hormones|hormones|mesh-ancestor
19970380|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970381|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970382|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19970383|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970384|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
19970385|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
19970386|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
19970387|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970388|NCT01783821|Budesonide|budesonide|mesh-list
19970389|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
19970390|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970391|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19970392|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
19970393|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970394|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970395|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19970396|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
19970397|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
19970398|NCT01783821|Hormones|hormones|mesh-ancestor
19970399|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970400|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19970401|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19970402|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19970403|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
19970404|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970405|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970406|NCT01783847|Prednisolone|prednisolone|mesh-list
19970407|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19877017|NCT00914732|Vaccines|vaccines|mesh-list
19877018|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
19877019|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877020|NCT00914810|Vitamin D|vitamin d|mesh-list
19877021|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
19877022|NCT00914810|Vitamins|vitamins|mesh-ancestor
19877023|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
19877024|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877025|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19877026|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19877027|NCT00914849|Plerixafor|plerixafor|mesh-list
19877028|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19877029|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19877030|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
19877031|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877032|NCT00914940|Fludarabine|fludarabine|mesh-list
19877033|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
19877034|NCT00914940|Thiotepa|thiotepa|mesh-list
19877035|NCT00914940|Tacrolimus|tacrolimus|mesh-list
19877036|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877037|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877038|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
19877039|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877040|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877041|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
19877042|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877043|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19877044|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877045|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877046|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
19877047|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877048|NCT00914966|Complement C1s|complement c1s|mesh-list
19877049|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19877050|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19877051|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
19877052|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877053|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19877054|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877055|NCT00915005|Paclitaxel|paclitaxel|mesh-list
19877056|NCT00915005|Carboplatin|carboplatin|mesh-list
19877057|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19877058|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877059|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19877060|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
19877061|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19877062|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877063|NCT00915018|Paclitaxel|paclitaxel|mesh-list
20257120|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257121|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
20257122|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
20257123|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
20257124|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257125|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257126|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877064|NCT00915018|Trastuzumab|trastuzumab|mesh-list
19877065|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19877066|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19877067|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257127|NCT00478075|Bortezomib|bortezomib|mesh-list
20257128|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
20257129|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877068|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19877069|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19877070|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19877071|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877072|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877073|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
19877074|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19877075|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19877076|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19877077|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877078|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
19877079|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19877080|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20535715|NCT01821612|Gemcitabine|gemcitabine|mesh-list
19877081|NCT00915473|Prednisolone|prednisolone|mesh-list
19877082|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
20535716|NCT01821612|Fluorouracil|fluorouracil|mesh-list
20535717|NCT01821612|Capecitabine|capecitabine|mesh-list
20535718|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
19877083|NCT00915473|Lidocaine|lidocaine|mesh-list
19877084|NCT00915473|Bupivacaine|bupivacaine|mesh-list
19877085|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19877086|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
19877087|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
19877088|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
19877089|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19877090|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877091|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
19877092|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877093|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19877094|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19877095|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19877096|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877097|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877098|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877099|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
19877100|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
19877101|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19877102|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
19877103|NCT00915473|Hormones|hormones|mesh-ancestor
19877104|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877105|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19877106|NCT00915473|Protective Agents|protective agents|mesh-ancestor
19877107|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19877108|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877109|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
19877110|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19877111|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19877112|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19877113|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877114|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877115|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
19877116|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877117|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257130|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20257131|NCT00478075|Analgesics|analgesics|mesh-ancestor
20257132|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
20535719|NCT01821612|Irinotecan|irinotecan|mesh-list
20535720|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20535721|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
20535722|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877118|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19877119|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877120|NCT00915538|Budesonide|budesonide|mesh-list
19877121|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19877122|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877123|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19877124|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
19877125|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877126|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877127|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19877128|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
19877129|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
19877130|NCT00915538|Hormones|hormones|mesh-ancestor
19877131|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877132|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19877133|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20535723|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877134|NCT00915603|Paclitaxel|paclitaxel|mesh-list
19877135|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19877136|NCT00915603|Bevacizumab|bevacizumab|mesh-list
19877137|NCT00915603|Everolimus|everolimus|mesh-list
19877138|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19877139|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257133|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257134|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877140|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
19877141|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
19877142|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535724|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
19877143|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877144|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877145|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19877146|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19877147|NCT00915603|Growth Substances|growth substances|mesh-ancestor
19877148|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877149|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
19877150|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877151|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
19877152|NCT00915655|Ritonavir|ritonavir|mesh-list
19877153|NCT00915655|Darunavir|darunavir|mesh-list
19877154|NCT00915655|Lamivudine|lamivudine|mesh-list
19877155|NCT00915655|Zidovudine|zidovudine|mesh-list
19877156|NCT00915655|Abacavir|abacavir|mesh-list
19877157|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19877158|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19877159|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877160|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877161|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877162|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19877163|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19877164|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
19877165|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877166|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19877167|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19877168|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19877169|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19877170|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
19877171|NCT00915772|Metformin|metformin|mesh-list
19877172|NCT00915772|Linagliptin|linagliptin|mesh-list
19877173|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877174|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877175|NCT00915772|Incretins|incretins|mesh-ancestor
19877176|NCT00915772|Hormones|hormones|mesh-ancestor
19877177|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877178|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19877179|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877180|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877181|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877182|NCT00915928|Perindopril|perindopril|mesh-list
19877183|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19877184|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877185|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877186|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877187|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19877188|NCT00915967|Vancomycin|vancomycin|mesh-list
19877189|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877190|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877191|NCT00916032|Factor VIII|factor viii|mesh-list
19877192|NCT00916032|Coagulants|coagulants|mesh-ancestor
19877193|NCT00916058|Melphalan|melphalan|mesh-list
19877194|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19877195|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877196|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
20553631|NCT01930552|Antidotes|antidotes|mesh-ancestor
19877197|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877198|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877199|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877200|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877201|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
19877202|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877203|NCT00916149|Lamotrigine|lamotrigine|mesh-list
19877204|NCT00916149|Levetiracetam|levetiracetam|mesh-list
19877205|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
19877206|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
19877207|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19877208|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877209|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877210|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19877211|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877212|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19877213|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19877214|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19877215|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20553632|NCT01930552|Protective Agents|protective agents|mesh-ancestor
19877216|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19877217|NCT00916279|Paclitaxel|paclitaxel|mesh-list
19877218|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19877219|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877220|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
19877221|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
19877222|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
19877223|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877224|NCT00916357|Insulin|insulin|mesh-list
19877225|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19877226|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
19877227|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877228|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877229|NCT00916383|Donepezil|donepezil|mesh-list
19877230|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20535725|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535726|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535727|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535728|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
20535729|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535730|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20535731|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20535732|NCT01821612|Antidotes|antidotes|mesh-ancestor
20257135|NCT00478101|Fentanyl|fentanyl|mesh-list
20257136|NCT00478101|Oxycodone|oxycodone|mesh-list
20257137|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20257138|NCT00478101|Narcotics|narcotics|mesh-ancestor
20257139|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257140|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535733|NCT01821612|Protective Agents|protective agents|mesh-ancestor
20535734|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
20535735|NCT01821612|Vitamins|vitamins|mesh-ancestor
20535736|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
19877231|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877232|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877233|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
20257141|NCT00478101|Analgesics|analgesics|mesh-ancestor
20257142|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
20257143|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257144|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20257145|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20257146|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
20257147|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
19877234|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257148|NCT00478114|Sorafenib|sorafenib|mesh-list
20257149|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257150|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257151|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257152|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257153|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
20257154|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20257155|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257156|NCT00478374|Doxorubicin|doxorubicin|mesh-list
20257157|NCT00478374|Sorafenib|sorafenib|mesh-list
19877235|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877236|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
19877237|NCT00916539|Calpastatin|calpastatin|mesh-list
19877238|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19877239|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877240|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877241|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877242|NCT00916578|Capecitabine|capecitabine|mesh-list
19877243|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877244|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
19877245|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877246|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877247|NCT00916721|Propranolol|propranolol|mesh-list
19877248|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19877249|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19877250|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
20257158|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20257159|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257160|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20257161|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20257162|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535737|NCT01821664|Heparin|heparin|mesh-list
20535738|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
19877251|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877252|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877253|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877254|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19877255|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19877256|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
19877257|NCT00917267|Exenatide|exenatide|mesh-list
19877258|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877259|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877260|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19877261|NCT00917267|Incretins|incretins|mesh-ancestor
19877262|NCT00917267|Hormones|hormones|mesh-ancestor
19877263|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877264|NCT00917384|Ramucirumab|ramucirumab|mesh-list
19877265|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877266|NCT00917462|Sorafenib|sorafenib|mesh-list
19877267|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877268|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19877269|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877270|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877271|NCT00917553|Doxycycline|doxycycline|mesh-list
19877272|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877273|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877274|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
19877275|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19877276|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19877277|NCT00917579|Atorvastatin|atorvastatin|mesh-list
19877278|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19877279|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19877280|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
19877281|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877282|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19877283|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19877284|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877285|NCT00917644|Atorvastatin|atorvastatin|mesh-list
19877286|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19877287|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19877288|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
19877289|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877290|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19877291|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19877292|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877293|NCT00918138|Metformin|metformin|mesh-list
19877294|NCT00918138|Saxagliptin|saxagliptin|mesh-list
19877295|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877296|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877297|NCT00918138|Incretins|incretins|mesh-ancestor
19877298|NCT00918138|Hormones|hormones|mesh-ancestor
19877299|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877300|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19877301|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877302|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877303|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877304|NCT00918203|Paclitaxel|paclitaxel|mesh-list
19877305|NCT00918203|Carboplatin|carboplatin|mesh-list
19877306|NCT00918203|Olaratumab|olaratumab|mesh-list
19877307|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19877308|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877309|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
19877310|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
19877311|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
19877312|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877313|NCT00918255|Adalimumab|adalimumab|mesh-list
19877314|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877315|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970408|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
19970409|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19970410|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
19970411|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
19970412|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19970413|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
19970414|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970415|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
19970416|NCT01783847|Hormones|hormones|mesh-ancestor
19970417|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877316|NCT00918333|Everolimus|everolimus|mesh-list
19877317|NCT00918333|Panobinostat|panobinostat|mesh-list
19877318|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19877319|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877320|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877321|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
19877322|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877323|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877324|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877325|NCT00918385|Dasatinib|dasatinib|mesh-list
19877326|NCT00918385|Nilutamide|nilutamide|mesh-list
19877327|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877328|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19877329|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877330|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877331|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
19877332|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
19877333|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877334|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877335|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19877336|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19877337|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19877338|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877339|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877340|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
19877341|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877342|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877343|NCT00918684|Citalopram|citalopram|mesh-list
19877344|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19877345|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19877346|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877347|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877348|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877349|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
19877350|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877351|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19877352|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
19877353|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19877354|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
19877355|NCT00918723|Rituximab|rituximab|mesh-list
19877356|NCT00918723|Fludarabine|fludarabine|mesh-list
19877357|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
19877358|NCT00918723|Vorinostat|vorinostat|mesh-list
19877359|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877360|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
19877361|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877362|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877363|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877364|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
19877365|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877366|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877367|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877368|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877369|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877370|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
19877371|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19877372|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877373|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
19877374|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19877375|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
19877376|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877377|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
19877378|NCT00918736|Protective Agents|protective agents|mesh-ancestor
19877379|NCT00918879|Saxagliptin|saxagliptin|mesh-list
19877380|NCT00918879|Incretins|incretins|mesh-ancestor
19877381|NCT00918879|Hormones|hormones|mesh-ancestor
19877382|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877383|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877384|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19877385|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877386|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877387|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877388|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877389|NCT00918931|Obatoclax|obatoclax|mesh-list
19877390|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877391|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877392|NCT00918957|Tobramycin|tobramycin|mesh-list
19877393|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877394|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877395|NCT00919035|Sirolimus|sirolimus|mesh-list
19877396|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877397|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877398|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19877399|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877400|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
19877401|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877402|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
19877403|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877404|NCT00919061|Gemcitabine|gemcitabine|mesh-list
19877405|NCT00919061|Sorafenib|sorafenib|mesh-list
19877406|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877407|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877408|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
19877409|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877410|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
19877411|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877412|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877413|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877414|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
19877415|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877416|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19877417|NCT00919126|Xenon|xenon|mesh-list
19877418|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19877419|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
19877420|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
19877421|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19877422|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877423|NCT00919191|Adapalene|adapalene|mesh-list
19877424|NCT00919191|Tretinoin|tretinoin|mesh-list
19877425|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19877426|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19877427|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19877428|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19877429|NCT00919191|Analgesics|analgesics|mesh-ancestor
19877430|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
19877431|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877432|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877433|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877434|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877435|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877436|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
19877437|NCT00919503|Cyclosporine|cyclosporine|mesh-list
19877438|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
19877439|NCT00919503|Methotrexate|methotrexate|mesh-list
19877440|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
19877441|NCT00919503|Fludarabine|fludarabine|mesh-list
19877442|NCT00919503|Treosulfan|treosulfan|mesh-list
19877443|NCT00919503|Busulfan|busulfan|mesh-list
19877444|NCT00919503|Tacrolimus|tacrolimus|mesh-list
19877445|NCT00919503|Cyclosporins|cyclosporins|mesh-list
19877446|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
19877447|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19877448|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19877449|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
19877450|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19877451|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877452|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877453|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
19877454|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877455|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877456|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
19877457|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877458|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19877459|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877460|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
19877461|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257163|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877462|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19877463|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19877464|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
19877465|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877466|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19877467|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19877468|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
19877469|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877470|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877471|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
19877472|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877473|NCT00919633|Interferons|interferons|mesh-list
19877474|NCT00919633|Ribavirin|ribavirin|mesh-list
19877475|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
19877476|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
19877477|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19877478|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877479|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877480|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
19877481|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877482|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
19877483|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877484|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
19877485|NCT00919711|Denosumab|denosumab|mesh-list
19877486|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
19877487|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19877488|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877489|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19877490|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877491|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877492|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19877493|NCT00919802|Oxytocin|oxytocin|mesh-list
19877494|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
19877495|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19877496|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877497|NCT00919854|Ritonavir|ritonavir|mesh-list
19877498|NCT00919854|Darunavir|darunavir|mesh-list
19877499|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19877500|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19877501|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877502|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877503|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877504|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19877505|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19877506|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
19877507|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877508|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19877509|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19877510|NCT00919867|Guanfacine|guanfacine|mesh-list
19877511|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19877512|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19877513|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877514|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19877515|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19877516|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877517|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877518|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
19877519|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877520|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19877521|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19877522|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19877523|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19877524|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
19877525|NCT00920075|Alendronate|alendronate|mesh-list
19877526|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19877527|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877528|NCT00920140|Trametinib|trametinib|mesh-list
19877529|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877530|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19877531|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877532|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877533|NCT00920218|Vaccines|vaccines|mesh-list
19877534|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
19877535|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970418|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970419|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19970420|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970421|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
19877536|NCT00920426|Cabotegravir|cabotegravir|mesh-list
19877537|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19877538|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19877539|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877540|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877541|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19877542|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19877543|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
19877544|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535739|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20535740|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20535741|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535742|NCT01821677|Danazol|danazol|mesh-list
19877545|NCT00920556|Bortezomib|bortezomib|mesh-list
19877546|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877547|NCT00920686|Sumatriptan|sumatriptan|mesh-list
19877548|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19877549|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19877550|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19877551|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
19877552|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877553|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877554|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877555|NCT00920699|Ubiquinone|ubiquinone|mesh-list
19877556|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
19877557|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
19877558|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877559|NCT00920699|Vitamins|vitamins|mesh-ancestor
19877560|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
19877561|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877562|NCT00920829|Naltrexone|naltrexone|mesh-list
19877563|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19877564|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19877565|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877566|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
19877567|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877568|NCT00920855|Bortezomib|bortezomib|mesh-list
19877569|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20257164|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257165|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
20257166|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257167|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
20257168|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257169|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257170|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20257171|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
20257172|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257173|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257174|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20257175|NCT00478504|Letrozole|letrozole|mesh-list
20257176|NCT00478504|Clomiphene|clomiphene|mesh-list
20257177|NCT00478504|Enclomiphene|enclomiphene|mesh-list
20257178|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
20257179|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257180|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257181|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20257182|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20257183|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257184|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20257185|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
20257186|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535743|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19877570|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877571|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877572|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
19877573|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877574|NCT00920907|Ipilimumab|ipilimumab|mesh-list
19877575|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877576|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877577|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19877578|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877579|NCT00921024|Ceftazidime|ceftazidime|mesh-list
19877580|NCT00921024|Ceftolozane|ceftolozane|mesh-list
19877581|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20257187|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877582|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877583|NCT00921115|Fulvestrant|fulvestrant|mesh-list
19877584|NCT00921115|Anastrozole|anastrozole|mesh-list
19877585|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19877586|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877587|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19877588|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19877589|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
19877590|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877591|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877592|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19877593|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19877594|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877595|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877596|NCT00921310|Sirolimus|sirolimus|mesh-list
19877597|NCT00921310|Pemetrexed|pemetrexed|mesh-list
19877598|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877599|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877600|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535744|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
19877601|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19877602|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19877603|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877604|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877605|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19877606|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
19877607|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877608|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
19877609|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877610|NCT00921557|Vitamin D|vitamin d|mesh-list
19877611|NCT00921557|Alendronate|alendronate|mesh-list
19877612|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
19877613|NCT00921557|Calcium|calcium|mesh-list
19877614|NCT00921557|Vitamins|vitamins|mesh-ancestor
19877615|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
19877616|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877617|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19877618|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19877619|NCT00921557|Antacids|antacids|mesh-ancestor
19877620|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877621|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19877622|NCT00921843|Methadone|methadone|mesh-list
19877623|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19877624|NCT00921843|Narcotics|narcotics|mesh-ancestor
19877625|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19877626|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877627|NCT00921843|Analgesics|analgesics|mesh-ancestor
19877628|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
19877629|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877630|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
19877631|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
19877632|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
19877633|NCT00922116|Hematinics|hematinics|mesh-ancestor
19877634|NCT00922194|Metformin|metformin|mesh-list
19877635|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877636|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877637|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19877638|NCT00922207|Entecavir|entecavir|mesh-list
19877639|NCT00922207|Adefovir|adefovir|mesh-list
19877640|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
19877641|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877642|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19877643|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19877644|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877645|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877646|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
19877647|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19877648|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
19877649|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19877650|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877651|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19877652|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19877653|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19877654|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19877655|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20257188|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20257189|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
20257190|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20257191|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20257192|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20257193|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
20257194|NCT00478517|Hematinics|hematinics|mesh-ancestor
20257195|NCT00478543|Furosemide|furosemide|mesh-list
20257196|NCT00478543|Diuretics|diuretics|mesh-ancestor
20257197|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
20257198|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257199|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20257200|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20257201|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257202|NCT00478621|Vaccines|vaccines|mesh-list
20257203|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
20257204|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257205|NCT00478634|Irinotecan|irinotecan|mesh-list
19877656|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877657|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19877658|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19877659|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877660|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877661|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
19877662|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877663|NCT00922441|Valsartan|valsartan|mesh-list
19877664|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19877665|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19877666|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19877667|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877668|NCT00922480|Losartan|losartan|mesh-list
19877669|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19877670|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19877671|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19877672|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19877673|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877674|NCT00922636|Methylphenidate|methylphenidate|mesh-list
19877675|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19877676|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877677|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19877678|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19877679|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877680|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877681|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
19877682|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877683|NCT00922766|Dalteparin|dalteparin|mesh-list
19877684|NCT00922766|Tinzaparin|tinzaparin|mesh-list
19877685|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19877686|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
19877687|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19877688|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19877689|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877690|NCT00922779|Ribavirin|ribavirin|mesh-list
19877691|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19877692|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
19877693|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877694|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
19877695|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877696|NCT00922987|Pregabalin|pregabalin|mesh-list
19877697|NCT00922987|Analgesics|analgesics|mesh-ancestor
19877698|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
19877699|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877700|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877701|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
19877702|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19877703|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877704|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877705|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19877706|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19877707|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19877708|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19877709|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19877710|NCT00923091|Amlodipine|amlodipine|mesh-list
19877711|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19877712|NCT00923091|Olmesartan|olmesartan|mesh-list
19877713|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19877714|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
19877715|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19877716|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19877717|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19877718|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877719|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19877720|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877721|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
19877722|NCT00923091|Diuretics|diuretics|mesh-ancestor
19877723|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
19877724|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19877725|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19877726|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19877727|NCT00923117|Sunitinib|sunitinib|mesh-list
19877728|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877729|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19877730|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19877731|NCT00923117|Growth Substances|growth substances|mesh-ancestor
19877732|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877733|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
19877734|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19877735|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877736|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877737|NCT00923130|Bevacizumab|bevacizumab|mesh-list
19877738|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877739|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877740|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19877741|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19877742|NCT00923130|Growth Substances|growth substances|mesh-ancestor
19877743|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877744|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
19877745|NCT00923156|Ramipril|ramipril|mesh-list
19877746|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19877747|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
19877748|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877749|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877750|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19877751|NCT00923195|Aldesleukin|aldesleukin|mesh-list
19877752|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
19877753|NCT00923195|Fludarabine|fludarabine|mesh-list
19877754|NCT00923195|Interleukin-2|interleukin-2|mesh-list
19877755|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877756|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
19877757|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877758|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877759|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877760|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
19877761|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877762|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877763|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877764|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19877765|NCT00923195|Analgesics|analgesics|mesh-ancestor
19877766|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
19877767|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877768|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19877769|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19877770|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
19877771|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877772|NCT00923273|Folic Acid|folic acid|mesh-list
19877773|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
19877774|NCT00923273|Hydroxocobalamin|hydroxocobalamin|mesh-list
19877775|NCT00923273|Sirolimus|sirolimus|mesh-list
19877776|NCT00923273|Dexamethasone|dexamethasone|mesh-list
19877777|NCT00923273|Pemetrexed|pemetrexed|mesh-list
19877778|NCT00923273|Vitamins|vitamins|mesh-ancestor
19877779|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
19877780|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877781|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877782|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
19877783|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
19877784|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877785|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19877786|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
19877787|NCT00923273|Hormones|hormones|mesh-ancestor
19877788|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877789|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19877790|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877791|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877792|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877793|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19877794|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19877795|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877796|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877797|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19877798|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
19877799|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877800|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
19877801|NCT00923273|Hematinics|hematinics|mesh-ancestor
19877802|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
19877803|NCT00923351|Vaccines|vaccines|mesh-list
19877804|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
19877805|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877806|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
19877807|NCT00923364|Fludarabine|fludarabine|mesh-list
19877808|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
19877809|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19877810|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877811|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
19877812|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877813|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877814|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877815|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
19877816|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877817|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877818|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877819|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877820|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
19877821|NCT00923845|Sirolimus|sirolimus|mesh-list
19877822|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
19877823|NCT00923845|Pentostatin|pentostatin|mesh-list
19877824|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877825|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
19877826|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877827|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877828|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877829|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
19877830|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877831|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877832|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877833|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19877834|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877835|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19877836|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
19877837|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19877838|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877839|NCT00923910|Acetaminophen|acetaminophen|mesh-list
19877840|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
19877841|NCT00923910|Promethazine|promethazine|mesh-list
19877842|NCT00923910|Interleukin-4|interleukin-4|mesh-list
19877843|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19877844|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19877845|NCT00923910|Analgesics|analgesics|mesh-ancestor
19877846|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
19877847|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877848|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877849|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
19877850|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19877851|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19877852|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19877853|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
19877854|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
19877855|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
19877856|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
19877857|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19877858|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19877859|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
19877860|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
19877861|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19877862|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877863|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19877864|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
19877865|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19877866|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19877867|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
19877868|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877869|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877870|NCT00923936|Bevacizumab|bevacizumab|mesh-list
19877871|NCT00923936|Doxorubicin|doxorubicin|mesh-list
19877872|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19877873|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877874|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877875|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19877876|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19877877|NCT00923936|Growth Substances|growth substances|mesh-ancestor
19877878|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877879|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
19877880|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19877881|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19877882|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19877883|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877884|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877885|NCT00923949|Pioglitazone|pioglitazone|mesh-list
19877886|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877887|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877888|NCT00924001|Aldesleukin|aldesleukin|mesh-list
19877889|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
19877890|NCT00924001|Fludarabine|fludarabine|mesh-list
19877891|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877892|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
19877893|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877894|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877895|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877896|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
19877897|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877898|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877899|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877900|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19877901|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19877902|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
19877903|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877904|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19877905|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877906|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19877907|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877908|NCT00924066|Epothilones|epothilones|mesh-list
19877909|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
19877910|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
19877911|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
19877912|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877913|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877914|NCT00924209|Gemcitabine|gemcitabine|mesh-list
19877915|NCT00924209|Bevacizumab|bevacizumab|mesh-list
19877916|NCT00924209|Etoposide|etoposide|mesh-list
19877917|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19877918|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877919|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19877920|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19877921|NCT00924209|Growth Substances|growth substances|mesh-ancestor
19877922|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877923|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
19877924|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877925|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
19877926|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877927|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
19877928|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877929|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877930|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877931|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
19877932|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19877933|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19877934|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19877935|NCT00924287|Aldesleukin|aldesleukin|mesh-list
19877936|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
19877937|NCT00924287|Fludarabine|fludarabine|mesh-list
19877938|NCT00924287|Interleukin-2|interleukin-2|mesh-list
19877939|NCT00924287|Mesna|mesna|mesh-list
19877940|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877941|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
19877942|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877943|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19877944|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19877945|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
19877946|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877947|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877948|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19877949|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19877950|NCT00924287|Analgesics|analgesics|mesh-ancestor
19877951|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
19877952|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19877953|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19877954|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19877955|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
19877956|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19877957|NCT00924287|Protective Agents|protective agents|mesh-ancestor
19877958|NCT00924352|Dasatinib|dasatinib|mesh-list
19877959|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877960|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19877961|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877962|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877963|NCT00924443|Clofarabine|clofarabine|mesh-list
19877964|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19877965|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
19877966|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877967|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877968|NCT00924469|Prednisone|prednisone|mesh-list
19877969|NCT00924469|Leuprolide|leuprolide|mesh-list
19877970|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877971|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
19877972|NCT00924469|Hormones|hormones|mesh-ancestor
19877973|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877974|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877975|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19877976|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19877977|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19877978|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
19877979|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19877980|NCT00924508|Triamcinolone|triamcinolone|mesh-list
19877981|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19877982|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19877983|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19877984|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19877985|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
19877986|NCT00924508|Hormones|hormones|mesh-ancestor
19877987|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19877988|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19877989|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19877990|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
19877991|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19877992|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19877993|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19877994|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19877995|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
19877996|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19877997|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
19877998|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
19877999|NCT00924560|Estradiol|estradiol|mesh-list
19878000|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20257206|NCT00478634|Cetuximab|cetuximab|mesh-list
19878001|NCT00924560|Estrogens|estrogens|mesh-ancestor
19878002|NCT00924560|Hormones|hormones|mesh-ancestor
19878003|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878004|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878005|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19878006|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19878007|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19878008|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20257207|NCT00478634|Everolimus|everolimus|mesh-list
20257208|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19878009|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19878010|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
19878011|NCT00924612|Testosterone|testosterone|mesh-list
19878012|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
19878013|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
19878014|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19878015|NCT00924612|Androgens|androgens|mesh-ancestor
19878016|NCT00924612|Hormones|hormones|mesh-ancestor
19878017|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878018|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878019|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19878020|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878021|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
19878022|NCT00924664|Tanezumab|tanezumab|mesh-list
19878023|NCT00924664|Analgesics|analgesics|mesh-ancestor
19878024|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
19878025|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878026|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878027|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
19878028|NCT00924729|Besifloxacin|besifloxacin|mesh-list
19878029|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19878030|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19878031|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19878032|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878033|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19878034|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19878035|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878036|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878037|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878038|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
19878039|NCT00924781|Hematinics|hematinics|mesh-ancestor
19878040|NCT00924820|Bevacizumab|bevacizumab|mesh-list
19878041|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19878042|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878043|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19878044|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19878045|NCT00924820|Growth Substances|growth substances|mesh-ancestor
19878046|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878047|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
19878048|NCT00924898|Tenofovir|tenofovir|mesh-list
19878049|NCT00924898|Emtricitabine|emtricitabine|mesh-list
19878050|NCT00924898|Efavirenz|efavirenz|mesh-list
19878051|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
19878052|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878053|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19878054|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19878055|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878056|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878057|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19878058|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19878059|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19878060|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19878061|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19878062|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19878063|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19878064|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19878065|NCT00924950|Calcitriol|calcitriol|mesh-list
19878066|NCT00924950|Betamethasone|betamethasone|mesh-list
19878067|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878068|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
19878069|NCT00924950|Hormones|hormones|mesh-ancestor
19878070|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878071|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878072|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878073|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878074|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19878075|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19878076|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878077|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878078|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19878079|NCT00924950|Vitamins|vitamins|mesh-ancestor
19878080|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
19878081|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19878082|NCT00925015|Irinotecan|irinotecan|mesh-list
19878083|NCT00925015|Cetuximab|cetuximab|mesh-list
19878084|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19878085|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19878086|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19878087|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878088|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878089|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878090|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19878091|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
19878092|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878093|NCT00925119|Atenolol|atenolol|mesh-list
19878094|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19878095|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19878096|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
19878097|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
19878098|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878099|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878100|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19878101|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19878102|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19878103|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
19878104|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878105|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878106|NCT00925132|Temozolomide|temozolomide|mesh-list
19878107|NCT00925132|Decitabine|decitabine|mesh-list
19878108|NCT00925132|Panobinostat|panobinostat|mesh-list
19878109|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19878110|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
19878111|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878112|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878113|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878114|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
19878115|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878116|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19878117|NCT00925288|Vaccines|vaccines|mesh-list
19878118|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
19878119|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878120|NCT00925353|Lidocaine|lidocaine|mesh-list
19878121|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
19878122|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
19878123|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878124|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878125|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
19878126|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878127|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19878128|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19878129|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19878130|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878131|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878132|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
19878133|NCT00925587|Hematinics|hematinics|mesh-ancestor
19878134|NCT00925600|Denosumab|denosumab|mesh-list
19878135|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19878136|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878137|NCT00925704|Calcitriol|calcitriol|mesh-list
19878138|NCT00925704|Sevelamer|sevelamer|mesh-list
19878139|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19878140|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878141|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19878142|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878143|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878144|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19878145|NCT00925704|Vitamins|vitamins|mesh-ancestor
19878146|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
19878147|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19878148|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
19878149|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
19878150|NCT00925756|Maraviroc|maraviroc|mesh-list
19878151|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19878152|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19878153|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878154|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19878155|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19878156|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
19878157|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878158|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19878159|NCT00925769|Bevacizumab|bevacizumab|mesh-list
19878160|NCT00925769|Capecitabine|capecitabine|mesh-list
19878161|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19878162|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19878163|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878164|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19878165|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19878166|NCT00925769|Growth Substances|growth substances|mesh-ancestor
19878167|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878168|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
19878169|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878170|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
19878171|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878172|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19878173|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878174|NCT00925782|Melphalan|melphalan|mesh-list
19878175|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19878176|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
19878177|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878178|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878179|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19878180|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878181|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
19878182|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878183|NCT00925899|Melatonin|melatonin|mesh-list
19878184|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
19878185|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878186|NCT00925899|Protective Agents|protective agents|mesh-ancestor
19878187|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878188|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878189|NCT00925938|Misoprostol|misoprostol|mesh-list
19878190|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19878191|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
19878192|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19878193|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878194|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19878195|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19878196|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
19970422|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
19970423|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970424|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19970425|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19970426|NCT01783847|Protective Agents|protective agents|mesh-ancestor
19970427|NCT01783847|Hematinics|hematinics|mesh-ancestor
19970428|NCT01783860|Azithromycin|azithromycin|mesh-list
19970429|NCT01783860|Doxycycline|doxycycline|mesh-list
19970430|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970431|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970432|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
19970433|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19970434|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19970435|NCT01783886|Aflibercept|aflibercept|mesh-list
19970436|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19970437|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19970438|NCT01783886|Growth Substances|growth substances|mesh-ancestor
19970439|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970440|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
19970441|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970442|NCT01783912|Nicotine|nicotine|mesh-list
19970443|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19970444|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
19970445|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970446|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970447|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19970448|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20535745|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535746|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535747|NCT01821703|Spironolactone|spironolactone|mesh-list
20535748|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20535749|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
20535750|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970449|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
19970450|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878197|NCT00925990|Ribavirin|ribavirin|mesh-list
19878198|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
19878199|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878200|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
19878201|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878202|NCT00926029|Listerine|listerine|mesh-list
19878203|NCT00926029|Triclosan|triclosan|mesh-list
19878204|NCT00926029|Fluorides|fluorides|mesh-list
19878205|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
19878206|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
19878207|NCT00926029|Protective Agents|protective agents|mesh-ancestor
19878208|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878209|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19878210|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878211|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19878212|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19878213|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
19878214|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878215|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19878216|NCT00926185|Lifitegrast|lifitegrast|mesh-list
19878217|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19878218|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19878219|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
20257209|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19878220|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19878221|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19878222|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878223|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19878224|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19878225|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878226|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878227|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878228|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878229|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
19878230|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19878231|NCT00926289|Telmisartan|telmisartan|mesh-list
19878232|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19878233|NCT00926289|Diuretics|diuretics|mesh-ancestor
20257210|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257211|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878234|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
19878235|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878236|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19878237|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878238|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878239|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19878240|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19878241|NCT00926328|Triclosan|triclosan|mesh-list
19878242|NCT00926328|Fluorides|fluorides|mesh-list
19878243|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
19878244|NCT00926328|Protective Agents|protective agents|mesh-ancestor
19878245|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878246|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19878247|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878248|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19878249|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19878250|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
19878251|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878252|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19878253|NCT00926367|Clindamycin|clindamycin|mesh-list
20257212|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257213|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20257214|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878254|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
19878255|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
19878256|NCT00926367|Adapalene|adapalene|mesh-list
19878257|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19878258|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19878259|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878260|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19878261|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878262|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878263|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
19878264|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20257215|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
20257216|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257217|NCT00478660|Adalimumab|adalimumab|mesh-list
19878265|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19878266|NCT00926367|Analgesics|analgesics|mesh-ancestor
20257218|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257219|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257220|NCT00478699|Gemcitabine|gemcitabine|mesh-list
20257221|NCT00478699|Cisplatin|cisplatin|mesh-list
20257222|NCT00478699|Docetaxel|docetaxel|mesh-list
20257223|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257224|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878267|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
19878268|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878269|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878270|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878271|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19878272|NCT00926380|Denosumab|denosumab|mesh-list
19878273|NCT00926380|Teriparatide|teriparatide|mesh-list
19878274|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19878275|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878276|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19878277|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19878278|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
19878279|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19878280|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19878281|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19878282|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878283|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257225|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
19878284|NCT00926588|Analgesics|analgesics|mesh-list
19878285|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
19878286|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878287|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878288|NCT00926796|Azithromycin|azithromycin|mesh-list
19878289|NCT00926796|Gentamicins|gentamicins|mesh-list
19878290|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
19878291|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19878292|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878293|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19878294|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878295|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878296|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19878297|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19878298|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878299|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19878300|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19878301|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
20257226|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257227|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
20257228|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535751|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535752|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20535753|NCT01821703|Diuretics|diuretics|mesh-ancestor
20535754|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
20535755|NCT01821846|Liraglutide|liraglutide|mesh-list
20535756|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535757|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535758|NCT01821846|Incretins|incretins|mesh-ancestor
20535759|NCT01821846|Hormones|hormones|mesh-ancestor
19878302|NCT00927069|Adalimumab|adalimumab|mesh-list
19878303|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878304|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19878305|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19878306|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
19878307|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878308|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19878309|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19878310|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878311|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
19878312|NCT00927186|Teriparatide|teriparatide|mesh-list
19878313|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19878314|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878315|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19878316|NCT00927355|Pioglitazone|pioglitazone|mesh-list
20535760|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535761|NCT01821872|Acetaminophen|acetaminophen|mesh-list
20535762|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20535763|NCT01821872|Analgesics|analgesics|mesh-ancestor
20535764|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
20535765|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535766|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535767|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
19878317|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19878318|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878319|NCT00927394|Valsartan|valsartan|mesh-list
19878320|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19878321|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20535768|NCT01821989|Lactoferrin|lactoferrin|mesh-list
20535769|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535770|NCT01822015|Cytarabine|cytarabine|mesh-list
20535771|NCT01822015|Sirolimus|sirolimus|mesh-list
20257229|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878322|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19878323|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878324|NCT00927472|Permethrin|permethrin|mesh-list
19878325|NCT00927472|Malathion|malathion|mesh-list
19878326|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878327|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878328|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19878329|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
19878330|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878331|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878332|NCT00927485|Curcumin|curcumin|mesh-list
19878333|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19878334|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19878335|NCT00927485|Analgesics|analgesics|mesh-ancestor
19878336|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
19878337|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878338|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878339|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878340|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19878341|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878342|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878343|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878344|NCT00927563|Tolcapone|tolcapone|mesh-list
19878345|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19878346|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19878347|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19878348|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878349|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878350|NCT00927589|Carboplatin|carboplatin|mesh-list
19878351|NCT00927589|Docetaxel|docetaxel|mesh-list
19878352|NCT00927589|Trastuzumab|trastuzumab|mesh-list
19878353|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878354|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
20257230|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257231|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
20257232|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535772|NCT01822015|Idarubicin|idarubicin|mesh-list
19878355|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
19878356|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
19878357|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878358|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19878359|NCT00927758|Fluticasone|fluticasone|mesh-list
19878360|NCT00927758|Xhance|xhance|mesh-list
19878361|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19878362|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20535773|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878363|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878364|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19878365|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
19878366|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878367|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878368|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878369|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878370|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
19878371|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19878372|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20257233|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
20257234|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535774|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
19878373|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19878374|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19878375|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19878376|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878377|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878378|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
19878379|NCT00927758|Hormones|hormones|mesh-ancestor
19878380|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878381|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
19878382|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
19878383|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
19878384|NCT00927849|Glycerol|glycerol|mesh-list
19878385|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19878386|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878387|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878388|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
19878389|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878390|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878391|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19878392|NCT00927849|Protective Agents|protective agents|mesh-ancestor
19878393|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
19878394|NCT00927862|Warfarin|warfarin|mesh-list
19878395|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
19878396|NCT00927888|Bupivacaine|bupivacaine|mesh-list
19878397|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
19878398|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
19878399|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878400|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878401|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
19878402|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535775|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535776|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535777|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
20535778|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535779|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535780|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
20535781|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535782|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20535783|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20535784|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
20535785|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20535786|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20535787|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535788|NCT01822028|Miglustat|miglustat|mesh-list
20535789|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
20535790|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535791|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535792|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19878403|NCT00927901|Maleic acid|maleic acid|mesh-list
19878404|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878405|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878406|NCT00928018|Cyclosporine|cyclosporine|mesh-list
19878407|NCT00928018|Sirolimus|sirolimus|mesh-list
19878408|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
19878409|NCT00928018|Methotrexate|methotrexate|mesh-list
19878410|NCT00928018|Tacrolimus|tacrolimus|mesh-list
19878411|NCT00928018|Cyclosporins|cyclosporins|mesh-list
19878412|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19878413|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
19878414|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19878415|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878416|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878417|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
19878418|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878419|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878420|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
19878421|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878422|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19878423|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878424|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
20535793|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20535794|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
20535795|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535796|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19878425|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20535797|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20535798|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535799|NCT01822080|Dienogest|dienogest|mesh-list
20535800|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20535801|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
20535802|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20535803|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535804|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20535805|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20535806|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20535807|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20535808|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
19878426|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19878427|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19878428|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
19878429|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878430|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19878431|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19878432|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
19878433|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19878434|NCT00928070|Fesoterodine|fesoterodine|mesh-list
19878435|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19878436|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19878437|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
19878438|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878439|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878440|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878441|NCT00928070|Urological Agents|urological agents|mesh-ancestor
19878442|NCT00928083|Artefenomel|artefenomel|mesh-list
19878443|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
19878444|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19878445|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19878446|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878447|NCT00928174|Fluorides|fluorides|mesh-list
19878448|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
19878449|NCT00928174|Protective Agents|protective agents|mesh-ancestor
19878450|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878451|NCT00928187|Ritonavir|ritonavir|mesh-list
19878452|NCT00928187|Lopinavir|lopinavir|mesh-list
19878453|NCT00928187|Darunavir|darunavir|mesh-list
19878454|NCT00928187|Tenofovir|tenofovir|mesh-list
19878455|NCT00928187|Emtricitabine|emtricitabine|mesh-list
19878456|NCT00928187|Abacavir|abacavir|mesh-list
19878457|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19878458|NCT00928187|Didanosine|didanosine|mesh-list
19878459|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19878460|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19878461|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
19878462|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878463|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878464|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19878465|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19878466|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
19878467|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878468|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19878469|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19878470|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19878471|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19878472|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
19878473|NCT00928200|Cytarabine|cytarabine|mesh-list
19878474|NCT00928200|Dexamethasone|dexamethasone|mesh-list
19878475|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
19878476|NCT00928200|Doxorubicin|doxorubicin|mesh-list
19878477|NCT00928200|Methotrexate|methotrexate|mesh-list
19878478|NCT00928200|Vincristine|vincristine|mesh-list
19878479|NCT00928200|Asparaginase|asparaginase|mesh-list
19878480|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
19878481|NCT00928200|Razoxane|razoxane|mesh-list
19878482|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19878483|NCT00928200|BB 1101|bb 1101|mesh-list
19878484|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878485|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
19878486|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
19878487|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878488|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878489|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19878490|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
19878491|NCT00928200|Hormones|hormones|mesh-ancestor
20257235|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
19878492|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878493|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19878494|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878495|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
19878496|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878497|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878498|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19878499|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19878500|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19878501|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19878502|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
19878503|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19878504|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878505|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
19878506|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
19878507|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19878508|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878509|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
19878510|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19878511|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19878512|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
19878513|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878514|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19878515|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
19878516|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
19878517|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
19878518|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19878519|NCT00928200|Protective Agents|protective agents|mesh-ancestor
19878520|NCT00928252|Fluorides|fluorides|mesh-list
19878521|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
19878522|NCT00928252|Protective Agents|protective agents|mesh-ancestor
19878523|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878524|NCT00928408|Cinacalcet|cinacalcet|mesh-list
19878525|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19878526|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878527|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19878528|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
19878529|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878530|NCT00928421|Polidocanol|polidocanol|mesh-list
19878531|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19878532|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19878533|NCT00928434|Leuprolide|leuprolide|mesh-list
19878534|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19878535|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
19878536|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19878537|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878538|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19878539|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878540|NCT00928486|Dexamethasone|dexamethasone|mesh-list
19878541|NCT00928486|Lenalidomide|lenalidomide|mesh-list
19878542|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878543|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
20257236|NCT00478764|Triamcinolone|triamcinolone|mesh-list
20257237|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257238|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
20257239|NCT00478764|Hormones|hormones|mesh-ancestor
20257240|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878544|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
19878545|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878546|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878547|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19878548|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
19878549|NCT00928486|Hormones|hormones|mesh-ancestor
19878550|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878551|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19878552|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878553|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
19878554|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19878555|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19878556|NCT00928486|Growth Substances|growth substances|mesh-ancestor
19878557|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
19878558|NCT00928564|Anesthetics|anesthetics|mesh-list
19878559|NCT00928564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257241|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878560|NCT00928564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878561|NCT00928642|Gemcitabine|gemcitabine|mesh-list
19878562|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
19878563|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878564|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
19878565|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878566|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878567|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
19878568|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878569|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878570|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878571|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
19878572|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878573|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19878574|NCT00928668|Olodaterol|olodaterol|mesh-list
19878575|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19878576|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
19878577|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878578|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878579|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878580|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878581|NCT00928694|Fenofibrate|fenofibrate|mesh-list
19878582|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19878583|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
19878584|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878585|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19878586|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
19878587|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19878588|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878589|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
19878590|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878591|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878592|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19878593|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19878594|NCT00928746|Bromides|bromides|mesh-list
19878595|NCT00928746|Ipratropium|ipratropium|mesh-list
19878596|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
19878597|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19878598|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
19878599|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878600|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878601|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878602|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878603|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19878604|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
19878605|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878606|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878607|NCT00928772|Midazolam|midazolam|mesh-list
19878608|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19878609|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19878610|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878611|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878612|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19878613|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19878614|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19878615|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19878616|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
19878617|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
19878618|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
19878619|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
19878620|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878621|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878622|NCT00928889|Acarbose|acarbose|mesh-list
19878623|NCT00928889|Nateglinide|nateglinide|mesh-list
19878624|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19878625|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878626|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878627|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19878628|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878629|NCT00928954|Gabapentin|gabapentin|mesh-list
19878630|NCT00928954|Memantine|memantine|mesh-list
19878631|NCT00928954|Analgesics|analgesics|mesh-ancestor
19878632|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
19878633|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878634|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878635|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
19878636|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19878637|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19878638|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878639|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19878640|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19878641|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19878642|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878643|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878644|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
19878645|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19878646|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19878647|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
19878648|NCT00929071|Lidocaine|lidocaine|mesh-list
19878649|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
19878650|NCT00929071|Anesthetics|anesthetics|mesh-list
20535809|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20535810|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20535811|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878651|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878652|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878653|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
19878654|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878655|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19878656|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19878657|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19878658|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878659|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878660|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
19878661|NCT00929110|Bromides|bromides|mesh-list
19878662|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
19878663|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19878664|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
19878665|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878666|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878667|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878668|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878669|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
20535812|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
20535813|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20535814|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535815|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535816|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
20535817|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535818|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535819|NCT01822275|Temozolomide|temozolomide|mesh-list
20535820|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20535821|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
20535822|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553633|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
19878670|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19878671|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
19878672|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878673|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878674|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
19878675|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19878676|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19878677|NCT00929162|Paclitaxel|paclitaxel|mesh-list
19878678|NCT00929162|Carboplatin|carboplatin|mesh-list
19878679|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19878680|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878681|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
19878682|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
19878683|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
19878684|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878685|NCT00929201|Metformin|metformin|mesh-list
19878686|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19878687|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19878688|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878689|NCT00929201|Incretins|incretins|mesh-ancestor
19878690|NCT00929201|Hormones|hormones|mesh-ancestor
19878691|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878692|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19878693|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
19878694|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878695|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878696|NCT00929240|Bevacizumab|bevacizumab|mesh-list
19878697|NCT00929240|Capecitabine|capecitabine|mesh-list
19878698|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19878699|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878700|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19878701|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19878702|NCT00929240|Growth Substances|growth substances|mesh-ancestor
19878703|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878704|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
19878705|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19878706|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
19878707|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878708|NCT00929344|Pregabalin|pregabalin|mesh-list
19878709|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19878710|NCT00929344|Analgesics|analgesics|mesh-ancestor
19878711|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
19878712|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878713|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878714|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
19878715|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19878716|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878717|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878718|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19878719|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20535823|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535824|NCT01822314|Paclitaxel|paclitaxel|mesh-list
20535825|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19878720|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19878721|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878722|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19878723|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19878724|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19878725|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878726|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
19878727|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
19878728|NCT00929383|Hemostatics|hemostatics|mesh-list
19878729|NCT00929383|Coagulants|coagulants|mesh-ancestor
19878730|NCT00929578|Fluphenazine|fluphenazine|mesh-list
19878731|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
19878732|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
19878733|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19878734|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19878735|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878736|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878737|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19878738|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19878739|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
19878740|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878741|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878742|NCT00929669|Pasireotide|pasireotide|mesh-list
19878743|NCT00929669|Hormones|hormones|mesh-ancestor
19878744|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878745|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878746|NCT00929695|Prednisone|prednisone|mesh-list
19878747|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
19878748|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19878749|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19878750|NCT00929695|Prednisolone|prednisolone|mesh-list
19878751|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
19878752|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19878753|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
19878754|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878755|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
19878756|NCT00929695|Hormones|hormones|mesh-ancestor
19878757|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878758|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878759|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19878760|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878761|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
19878762|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
20535826|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19878763|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878764|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19878765|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19878766|NCT00929695|Protective Agents|protective agents|mesh-ancestor
19878767|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
19878768|NCT00929708|AZD-3199|azd-3199|mesh-list
19878769|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19878770|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
19878771|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878772|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878773|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878774|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878775|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19878776|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19878777|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19878778|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
19878779|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878780|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878781|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19878782|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19878783|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19878784|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19878785|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
19878786|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878787|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19878788|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878789|NCT00929864|Adalimumab|adalimumab|mesh-list
19878790|NCT00929864|Abatacept|abatacept|mesh-list
19878791|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878792|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19878793|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19878794|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878795|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878796|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878797|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
19878798|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878799|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
19878800|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19878801|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19878802|NCT00929981|Prednisolone|prednisolone|mesh-list
19878803|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
19878804|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19878805|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
19878806|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878807|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
19878808|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
19878809|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878810|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878811|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19878812|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
19878813|NCT00929981|Hormones|hormones|mesh-ancestor
19878814|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19878815|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19878816|NCT00929981|Protective Agents|protective agents|mesh-ancestor
19878817|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19878818|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878819|NCT00930046|Ropivacaine|ropivacaine|mesh-list
19878820|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
19878821|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
19878822|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878823|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878824|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
19878825|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878826|NCT00930293|Dexetimide|dexetimide|mesh-list
19878827|NCT00930293|Citalopram|citalopram|mesh-list
19878828|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19878829|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19878830|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878831|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878832|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878833|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
19878834|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535827|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878835|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19878836|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
19878837|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19878838|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19878839|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19878840|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
19878841|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
19878842|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878843|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19878844|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19878845|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
19970451|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970452|NCT01783938|Nivolumab|nivolumab|mesh-list
19970453|NCT01783938|Ipilimumab|ipilimumab|mesh-list
19970454|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19970455|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970456|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19970457|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970458|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
19970459|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970460|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
19970461|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970462|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970463|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19970464|NCT01784029|Vitamin D|vitamin d|mesh-list
19970465|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
19970466|NCT01784029|Vitamins|vitamins|mesh-ancestor
19970467|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
19970468|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970469|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19970470|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19970471|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
19970472|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19970473|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970474|NCT01784419|Ivacaftor|ivacaftor|mesh-list
19970475|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19970476|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19970477|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970478|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
19970479|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
19970480|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19970481|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19970482|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970483|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970484|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970485|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970486|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19970487|NCT01784666|Isradipine|isradipine|mesh-list
19970488|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19970489|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19970490|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19970491|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970492|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19970493|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970494|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
19970495|NCT01784770|Azithromycin|azithromycin|mesh-list
19970496|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970497|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970498|NCT01784861|Everolimus|everolimus|mesh-list
19970499|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970500|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970501|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
19970502|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970503|NCT01784965|Liraglutide|liraglutide|mesh-list
19970504|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19970505|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970506|NCT01784965|Incretins|incretins|mesh-ancestor
19970507|NCT01784965|Hormones|hormones|mesh-ancestor
19970508|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970509|NCT01785095|Hormones|hormones|mesh-list
19970510|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19970511|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970512|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970513|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
19878846|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
19878847|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19878848|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878849|NCT00930644|Teduglutide|teduglutide|mesh-list
19878850|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19878851|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19878852|NCT00930644|Protective Agents|protective agents|mesh-ancestor
19878853|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878854|NCT00930930|Paclitaxel|paclitaxel|mesh-list
19878855|NCT00930930|Everolimus|everolimus|mesh-list
19878856|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19878857|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878858|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
19878859|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
19878860|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
19878861|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878862|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878863|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
19878864|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878865|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
19878866|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19878867|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878868|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19878869|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19878870|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878871|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878872|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878873|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19878874|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19878875|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
19878876|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19878877|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19878878|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
19878879|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
19878880|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878881|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878882|NCT00931242|Thalidomide|thalidomide|mesh-list
19878883|NCT00931242|Apremilast|apremilast|mesh-list
19878884|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19878885|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19878886|NCT00931242|Analgesics|analgesics|mesh-ancestor
19878887|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
19878888|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878889|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878890|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19878891|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19878892|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19878893|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19878894|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878895|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878896|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19878897|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
19878898|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
19878899|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19878900|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878901|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19878902|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19878903|NCT00931242|Growth Substances|growth substances|mesh-ancestor
19878904|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
19878905|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878906|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
19878907|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19878908|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
19878909|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878910|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878911|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878912|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878913|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19878914|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19878915|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19878916|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
19878917|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878918|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878919|NCT00931463|Ritonavir|ritonavir|mesh-list
19878920|NCT00931463|Lopinavir|lopinavir|mesh-list
19878921|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
19878922|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19878923|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19878924|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
19878925|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878926|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878927|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19878928|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19878929|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
19878930|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878931|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19878932|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19878933|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19878934|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19878935|NCT00931489|Ranibizumab|ranibizumab|mesh-list
19878936|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19878937|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19878938|NCT00931489|Growth Substances|growth substances|mesh-ancestor
19878939|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878940|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
19878941|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878942|NCT00931528|Tadalafil|tadalafil|mesh-list
19878943|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
19878944|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19878945|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19878946|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878947|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878948|NCT00931528|Urological Agents|urological agents|mesh-ancestor
19878949|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
19878950|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19878951|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
19878952|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19878953|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878954|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19878955|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
19878956|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19878957|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
19878958|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878959|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19878960|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19878961|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
19878962|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
19878963|NCT00931632|Protective Agents|protective agents|mesh-ancestor
19878964|NCT00931710|Losartan|losartan|mesh-list
19878965|NCT00931710|Amlodipine|amlodipine|mesh-list
19878966|NCT00931710|Valsartan|valsartan|mesh-list
19878967|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19878968|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19878969|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19878970|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19878971|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878972|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19878973|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878974|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
19878975|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19878976|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19878977|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19878978|NCT00931710|Diuretics|diuretics|mesh-ancestor
19878979|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
19878980|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19878981|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19878982|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
19878983|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19878984|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19878985|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19878986|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19878987|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19878988|NCT00931762|Panobinostat|panobinostat|mesh-list
19878989|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19878990|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19878991|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19878992|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19878993|NCT00931801|Tenofovir|tenofovir|mesh-list
19878994|NCT00931801|Emtricitabine|emtricitabine|mesh-list
19878995|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
19878996|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19878997|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
19878998|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19878999|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19879000|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19879001|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879002|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879003|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19879004|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19879005|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19879006|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19879007|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19879008|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19879009|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
19879010|NCT00931918|Prednisone|prednisone|mesh-list
19879011|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
19879012|NCT00931918|Rituximab|rituximab|mesh-list
19879013|NCT00931918|Doxorubicin|doxorubicin|mesh-list
19879014|NCT00931918|Vincristine|vincristine|mesh-list
19879015|NCT00931918|Bortezomib|bortezomib|mesh-list
19879016|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879017|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
19879018|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879019|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879020|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19879021|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
19879022|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879023|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879024|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19879025|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879026|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19879027|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19879028|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19879029|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535828|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
20535829|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535830|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535831|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535832|NCT01822405|Tocopherols|tocopherols|mesh-list
20535833|NCT01822405|Vitamin E|vitamin e|mesh-list
19879030|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19879031|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
19879032|NCT00931918|Hormones|hormones|mesh-ancestor
19879033|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879034|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19879035|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19879036|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879037|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
19879038|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
19879039|NCT00931944|Pramipexole|pramipexole|mesh-list
20535834|NCT01822405|Tocotrienols|tocotrienols|mesh-list
20535835|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
20535836|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
20535837|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20535838|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879040|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
19879041|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879042|NCT00931944|Protective Agents|protective agents|mesh-ancestor
19879043|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879044|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19879045|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19879046|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
19879047|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
20535839|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535840|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20535841|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20535842|NCT01822405|Protective Agents|protective agents|mesh-ancestor
20535843|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879048|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879049|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
19879050|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20535844|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
19879051|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535845|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20535846|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
20535847|NCT01822405|Vitamins|vitamins|mesh-ancestor
20535848|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
20535849|NCT01822418|S 20098|s 20098|mesh-list
20535850|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20535851|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535852|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535853|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20535854|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879052|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879053|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19879054|NCT00932022|Trospium chloride|trospium chloride|mesh-list
19879055|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
19879056|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
19879057|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879058|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879059|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19879060|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19879061|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879062|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879063|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879064|NCT00932022|Urological Agents|urological agents|mesh-ancestor
19879065|NCT00932113|Folic Acid|folic acid|mesh-list
19879066|NCT00932113|Adalimumab|adalimumab|mesh-list
19879067|NCT00932113|Methotrexate|methotrexate|mesh-list
19879068|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19879069|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
19879070|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19879071|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879072|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19879073|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
19879074|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879075|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879076|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
19879077|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879078|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19879079|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535855|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535856|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535857|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20257242|NCT00478816|Vaccines|vaccines|mesh-list
19879080|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
19879081|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879082|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19879083|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19879084|NCT00932113|Hematinics|hematinics|mesh-ancestor
19879085|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
19879086|NCT00932113|Vitamins|vitamins|mesh-ancestor
19879087|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
19879088|NCT00932165|Exemestane|exemestane|mesh-list
19879089|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879090|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19879091|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19879092|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879093|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879094|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19879095|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
19879096|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879097|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879098|NCT00932282|Omalizumab|omalizumab|mesh-list
19879099|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19879100|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19879101|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
19879102|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19879103|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19879104|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19879105|NCT00932321|Norethindrone|norethindrone|mesh-list
19879106|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
19879107|NCT00932321|Estradiol|estradiol|mesh-list
19879108|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19879109|NCT00932321|Estrogens|estrogens|mesh-ancestor
19879110|NCT00932321|Hormones|hormones|mesh-ancestor
20257243|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
19879111|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879112|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970514|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20535858|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
19879113|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19879114|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
19879115|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19879116|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19879117|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19879118|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19879119|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19879120|NCT00932373|Trastuzumab|trastuzumab|mesh-list
19879121|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20257244|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257245|NCT00478855|Piperacillin|piperacillin|mesh-list
20257246|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20257247|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19879122|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879123|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879124|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879125|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
19879126|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
19879127|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879128|NCT00932438|Leucovorin|leucovorin|mesh-list
19879129|NCT00932438|Bevacizumab|bevacizumab|mesh-list
19879130|NCT00932438|Fluorouracil|fluorouracil|mesh-list
19879131|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
19879132|NCT00932438|Irinotecan|irinotecan|mesh-list
19879133|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879134|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879135|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19879136|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19879137|NCT00932438|Growth Substances|growth substances|mesh-ancestor
19879138|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879139|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
19879140|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
19879141|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879142|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19879143|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879144|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
20257248|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257249|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20257250|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257251|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257252|NCT00478907|Ketamine|ketamine|mesh-list
20257253|NCT00478907|Thiopental|thiopental|mesh-list
20257254|NCT00478907|Propofol|propofol|mesh-list
20257255|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20257256|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257257|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257258|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20257259|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
20257260|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
20257261|NCT00478907|Analgesics|analgesics|mesh-ancestor
19449539|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449540|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449541|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
19449542|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449543|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19449544|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19449545|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
19449546|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19449547|NCT03434678|Narcotics|narcotics|mesh-ancestor
19449548|NCT03434678|Analgesics|analgesics|mesh-ancestor
19449549|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19449550|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19449551|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19449552|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19879145|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19879146|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19879147|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879148|NCT00932438|Antidotes|antidotes|mesh-ancestor
19879149|NCT00932438|Protective Agents|protective agents|mesh-ancestor
19879150|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
19879151|NCT00932438|Vitamins|vitamins|mesh-ancestor
19879152|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
19879153|NCT00932451|Crizotinib|crizotinib|mesh-list
19879154|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879155|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19879156|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879157|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879158|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19879159|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
19879160|NCT00932477|Glycerol|glycerol|mesh-list
19879161|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19879162|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19879163|NCT00932477|Laxatives|laxatives|mesh-ancestor
19879164|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19879165|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19879166|NCT00932477|Protective Agents|protective agents|mesh-ancestor
19879167|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879168|NCT00932620|Simvastatin|simvastatin|mesh-list
19879169|NCT00932620|Ezetimibe|ezetimibe|mesh-list
19879170|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19879171|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19879172|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
19879173|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879174|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19879175|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19879176|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879177|NCT00932646|Olodaterol|olodaterol|mesh-list
19879178|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
19879179|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19879180|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
19879181|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879182|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879183|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19879184|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
19879185|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19879186|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19879187|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19879188|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
19879189|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879190|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879191|NCT00932698|Ixazomib|ixazomib|mesh-list
19879192|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879193|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
19879194|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879195|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879196|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
19879197|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879198|NCT00932893|Docetaxel|docetaxel|mesh-list
19879199|NCT00932893|Pemetrexed|pemetrexed|mesh-list
19879200|NCT00932893|Crizotinib|crizotinib|mesh-list
19879201|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879202|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879203|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
19879204|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
19879205|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879206|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879207|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19879208|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19879209|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19879210|NCT00933244|Vitamin D|vitamin d|mesh-list
19879211|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
19879212|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
19879213|NCT00933244|Vitamins|vitamins|mesh-list
19879214|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
19879215|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879216|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19879217|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19879218|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
19879219|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879220|NCT00933608|Memantine|memantine|mesh-list
19879221|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19879222|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19879223|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
19879224|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879225|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879226|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879227|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19879228|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19879229|NCT00934024|Varenicline|varenicline|mesh-list
19879230|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19879231|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19879232|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879233|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879234|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879235|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879236|NCT00934050|Inositol|inositol|mesh-list
19879237|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
19879238|NCT00934050|Vitamins|vitamins|mesh-ancestor
19879239|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
19879240|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879241|NCT00934089|Latanoprost|latanoprost|mesh-list
19879242|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19879243|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19879244|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19879245|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
19879246|NCT00934375|Donepezil|donepezil|mesh-list
19879247|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19879248|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879249|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879250|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879251|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879252|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879253|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
19879254|NCT00934440|Bevacizumab|bevacizumab|mesh-list
19879255|NCT00934440|Azacitidine|azacitidine|mesh-list
19879256|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879257|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879258|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19879259|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19879260|NCT00934440|Growth Substances|growth substances|mesh-ancestor
19879261|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879262|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
19879263|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19879264|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
19879265|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879266|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879267|NCT00934635|Risperidone|risperidone|mesh-list
19879268|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19879269|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19879270|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
19879271|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879272|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879273|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879274|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19879275|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19879276|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879277|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19879278|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19879279|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
19879280|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19879281|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19879282|NCT00934648|Rituximab|rituximab|mesh-list
19879283|NCT00934648|Methotrexate|methotrexate|mesh-list
19879284|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879285|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879286|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
19879287|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879288|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879289|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19879290|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
19879291|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19879292|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19879293|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
19879294|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879295|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
19879296|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879297|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19879298|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879299|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19879300|NCT00934661|Morphine|morphine|mesh-list
19879301|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19879302|NCT00934661|Narcotics|narcotics|mesh-ancestor
19879303|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879304|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879305|NCT00934661|Analgesics|analgesics|mesh-ancestor
19879306|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
19879307|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879308|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
19879309|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19879310|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19879311|NCT00934843|Prednisolone|prednisolone|mesh-list
19879312|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
19879313|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19879314|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
19879315|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
19879316|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19879317|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
19879318|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
19879319|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879320|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879321|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732120|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732121|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19732122|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
19732123|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732124|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732125|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19732126|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879322|NCT00934843|Hormones|hormones|mesh-ancestor
19879323|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879324|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19879325|NCT00934843|Protective Agents|protective agents|mesh-ancestor
19879326|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19879327|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879328|NCT00934856|Docetaxel|docetaxel|mesh-list
19879329|NCT00934856|Trastuzumab|trastuzumab|mesh-list
19879330|NCT00934856|Pertuzumab|pertuzumab|mesh-list
19879331|NCT00934856|Maytansine|maytansine|mesh-list
19879332|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19879333|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879334|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879335|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
19879336|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
19879337|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879338|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879339|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19879340|NCT00934934|Anidulafungin|anidulafungin|mesh-list
19879341|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
19879342|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879343|NCT00934947|Propranolol|propranolol|mesh-list
19879344|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19879345|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19879346|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
19879347|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879348|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879349|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879350|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20257262|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
19879351|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19879352|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
19879353|NCT00935220|Linagliptin|linagliptin|mesh-list
19879354|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19879355|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879356|NCT00935220|Incretins|incretins|mesh-ancestor
19879357|NCT00935220|Hormones|hormones|mesh-ancestor
19879358|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879359|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19879360|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
19879361|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535859|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20535860|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732127|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
19732128|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732129|NCT04577417|Methylphenidate|methylphenidate|mesh-list
19732130|NCT04577417|Amphetamine|amphetamine|mesh-list
19732131|NCT04577417|Adderall|adderall|mesh-list
19732132|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
19879362|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879363|NCT00935259|Simvastatin|simvastatin|mesh-list
19879364|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19879365|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19879366|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
19879367|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879368|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19879369|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19879370|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879371|NCT00935311|Acetaminophen|acetaminophen|mesh-list
19879372|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19879373|NCT00935311|Hydrocodone|hydrocodone|mesh-list
19879374|NCT00935311|Oxycodone|oxycodone|mesh-list
19879375|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19879376|NCT00935311|Analgesics|analgesics|mesh-ancestor
19879377|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
19879378|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879379|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879380|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
19879381|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19879382|NCT00935311|Narcotics|narcotics|mesh-ancestor
19879383|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879384|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
19879385|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
19879386|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19879387|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19879388|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879389|NCT00935493|Guanfacine|guanfacine|mesh-list
19879390|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19879391|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19879392|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19879393|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19879394|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
19879395|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879396|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879397|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879398|NCT00935532|Insulin|insulin|mesh-list
19879399|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19879400|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
19879401|NCT00935532|Exenatide|exenatide|mesh-list
19879402|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19879403|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879404|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19879405|NCT00935532|Incretins|incretins|mesh-ancestor
19879406|NCT00935532|Hormones|hormones|mesh-ancestor
19879407|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879408|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19879409|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
19879410|NCT00935792|Everolimus|everolimus|mesh-list
19879411|NCT00935792|Antibodies|antibodies|mesh-list
19879412|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
19879413|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19879414|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
19879415|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879416|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879417|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879418|NCT00935818|Bupropion|bupropion|mesh-list
19879419|NCT00935818|Varenicline|varenicline|mesh-list
19879420|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19879421|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
19879422|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19879423|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19879424|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19879425|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19879426|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879427|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
19879428|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879429|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879430|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19879431|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19879432|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879433|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19879434|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19879435|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879436|NCT00935883|Eculizumab|eculizumab|mesh-list
19879437|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19879438|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879439|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
19879440|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879441|NCT00936065|Etanercept|etanercept|mesh-list
19879442|NCT00936065|Acitretin|acitretin|mesh-list
19879443|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19879444|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19879445|NCT00936065|Analgesics|analgesics|mesh-ancestor
19879446|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
19879447|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879448|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879449|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19879450|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879451|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19879452|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879453|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
19879454|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
19879455|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
19879456|NCT00936117|Posaconazole|posaconazole|mesh-list
19879457|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
19879458|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879459|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19879460|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19879461|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19879462|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19879463|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19879464|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879465|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879466|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19879467|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
19879468|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879469|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879470|NCT00936221|Dacarbazine|dacarbazine|mesh-list
19879471|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19879472|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
19879473|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879474|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879475|NCT00936299|Bupropion|bupropion|mesh-list
19879476|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19879477|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
19879478|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19879479|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19879480|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19879481|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19879482|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879483|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
19879484|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879485|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879486|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19879487|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19879488|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879489|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
19879490|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19879491|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879492|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879493|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19879494|NCT00936377|Analgesics|analgesics|mesh-ancestor
19879495|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
19879496|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879497|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19879498|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19879499|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19879500|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
19879501|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879502|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970515|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19970516|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
19970517|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970518|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19970519|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19970520|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879503|NCT00936611|Panobinostat|panobinostat|mesh-list
19879504|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879505|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19879506|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879507|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879508|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19879509|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19879510|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879511|NCT00936663|Incretins|incretins|mesh-ancestor
19879512|NCT00936663|Hormones|hormones|mesh-ancestor
19879513|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879514|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19879515|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
19879516|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879517|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879518|NCT00936702|Paclitaxel|paclitaxel|mesh-list
19879519|NCT00936702|Carboplatin|carboplatin|mesh-list
19879520|NCT00936702|Everolimus|everolimus|mesh-list
19879521|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19879522|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879523|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879524|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
19879525|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
19879526|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879527|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879528|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
19879529|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879530|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19879531|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19879532|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19879533|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879534|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879535|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
19879536|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879537|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19879538|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19879539|NCT00936741|Mifepristone|mifepristone|mesh-list
19879540|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19879541|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
19879542|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19879543|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879544|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19879545|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19879546|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19879547|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
19879548|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19879549|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19879550|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
19879551|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879552|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
19879553|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19879554|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19879555|NCT00936858|Everolimus|everolimus|mesh-list
19879556|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879557|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879558|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
19879559|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879560|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
19879561|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19879562|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879563|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
19879564|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879565|NCT00936897|Denosumab|denosumab|mesh-list
19879566|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
19879567|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19879568|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879569|NCT00936910|Amphotericin B|amphotericin b|mesh-list
19879570|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19879571|NCT00936910|Amebicides|amebicides|mesh-ancestor
19879572|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19879573|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19879574|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879575|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19879576|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
19879577|NCT00936975|Listerine|listerine|mesh-list
19879578|NCT00936975|Fluorides|fluorides|mesh-list
19879579|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
19879580|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
19879581|NCT00936975|Protective Agents|protective agents|mesh-ancestor
20535861|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20535862|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
20535863|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20535864|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20535865|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879582|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879583|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19879584|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879585|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
19879586|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
19879587|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19879588|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
19879589|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879590|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879591|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879592|NCT00937235|Varenicline|varenicline|mesh-list
19879593|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19879594|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19879595|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879596|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879597|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879598|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879599|NCT00937495|Bortezomib|bortezomib|mesh-list
19879600|NCT00937495|Vorinostat|vorinostat|mesh-list
20535866|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535867|NCT01822509|Nivolumab|nivolumab|mesh-list
20535868|NCT01822509|Ipilimumab|ipilimumab|mesh-list
19879601|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879602|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19879603|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879604|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879605|NCT00937521|Antipyretics|antipyretics|mesh-list
19879606|NCT00937521|Vaccines|vaccines|mesh-list
19879607|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
19879608|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879609|NCT00937560|Paclitaxel|paclitaxel|mesh-list
19879610|NCT00937560|Bevacizumab|bevacizumab|mesh-list
19879611|NCT00937560|Carboplatin|carboplatin|mesh-list
19879612|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19879613|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879614|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879615|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
19879616|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
19879617|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879618|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879619|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19879620|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19879621|NCT00937560|Growth Substances|growth substances|mesh-ancestor
19879622|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879623|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
19879624|NCT00937768|Leuprolide|leuprolide|mesh-list
19879625|NCT00937768|Goserelin|goserelin|mesh-list
19879626|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19879627|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
19879628|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19879629|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879630|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19879631|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879632|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
19879633|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553634|NCT01930552|Vitamins|vitamins|mesh-ancestor
20553635|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
20553636|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20553637|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20553638|NCT01930552|Growth Substances|growth substances|mesh-ancestor
20553639|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
20553640|NCT01930591|Clopidogrel|clopidogrel|mesh-list
20553641|NCT01930591|Ticagrelor|ticagrelor|mesh-list
20553642|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19879634|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
19879635|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19879636|NCT00938314|Hematinics|hematinics|mesh-ancestor
19879637|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19879638|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879639|NCT00938366|Cladribine|cladribine|mesh-list
19879640|NCT00938366|Pantoprazole|pantoprazole|mesh-list
19879641|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19879642|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19879643|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19879644|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879645|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879646|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879647|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879648|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
19879649|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879650|NCT00938392|Vaccines|vaccines|mesh-list
19879651|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
19879652|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879653|NCT00938431|Lacosamide|lacosamide|mesh-list
19879654|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
19879655|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19879656|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19879657|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19879658|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879659|NCT00938470|Docetaxel|docetaxel|mesh-list
19879660|NCT00938470|Fluorouracil|fluorouracil|mesh-list
19879661|NCT00938470|Capecitabine|capecitabine|mesh-list
19879662|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
19879663|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879664|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879665|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
19879666|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
19879667|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879668|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
19879669|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19879670|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879671|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
19879672|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879673|NCT00938548|Pregabalin|pregabalin|mesh-list
19879674|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879675|NCT00938548|Analgesics|analgesics|mesh-ancestor
19879676|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
19879677|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879678|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
19879679|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19879680|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19879681|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879682|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19879683|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19879684|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19879685|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879686|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19879687|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19879688|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
19879689|NCT00938704|Glycerol|glycerol|mesh-list
19879690|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19879691|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
19879692|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879693|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
19879694|NCT00938704|Protective Agents|protective agents|mesh-ancestor
19879695|NCT00938704|Laxatives|laxatives|mesh-ancestor
19879696|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19879697|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19879698|NCT00938717|Linaclotide|linaclotide|mesh-list
19879699|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19879700|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
19879701|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879702|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19879703|NCT00938860|Cyclosporine|cyclosporine|mesh-list
19879704|NCT00938860|Tacrolimus|tacrolimus|mesh-list
19879705|NCT00938860|Cyclosporins|cyclosporins|mesh-list
19879706|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879707|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
19879708|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879709|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19879710|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879711|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879712|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
19879713|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879714|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
19879715|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879716|NCT00938886|Naltrexone|naltrexone|mesh-list
19879717|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19879718|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19879719|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535869|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20535870|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535871|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20535872|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535873|NCT01822600|Omeprazole|omeprazole|mesh-list
20535874|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20535875|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19879720|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
19879721|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879722|NCT00938964|Lidocaine|lidocaine|mesh-list
19879723|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
19879724|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
19879725|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535876|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20535877|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879726|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879727|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
19879728|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879729|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19879730|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19879731|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19879732|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19879733|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879734|NCT00939003|Adalimumab|adalimumab|mesh-list
19879735|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19879736|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879737|NCT00939029|Nicotine|nicotine|mesh-list
19879738|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19879739|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
19879740|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879741|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879742|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19879743|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19879744|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879745|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879746|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879747|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19879748|NCT00939120|Dutasteride|dutasteride|mesh-list
19879749|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19879750|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19879751|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879752|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879753|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
19879754|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879755|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879756|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19879757|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19879758|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879759|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879760|NCT00939120|Urological Agents|urological agents|mesh-ancestor
19879761|NCT00939159|Panobinostat|panobinostat|mesh-list
19879762|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879763|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20535878|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535879|NCT01822613|Paclitaxel|paclitaxel|mesh-list
19879764|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879765|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879766|NCT00939185|Azithromycin|azithromycin|mesh-list
19879767|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19879768|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879769|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
19879770|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19879771|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
19879772|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20535880|NCT01822613|Docetaxel|docetaxel|mesh-list
19449553|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19449554|NCT03434613|Ezetimibe|ezetimibe|mesh-list
19449555|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19879773|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879774|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19879775|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
19879776|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
19879777|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19879778|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
19879779|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879780|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879781|NCT00939341|Budesonide|budesonide|mesh-list
19879782|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
19879783|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19879784|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19879785|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19879786|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
19879787|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19879788|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879789|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19879790|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
19879791|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
19879792|NCT00939341|Hormones|hormones|mesh-ancestor
19879793|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879794|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19879795|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19879796|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19879797|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
19879798|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879799|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879800|NCT00939367|Zolpidem|zolpidem|mesh-list
19879801|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19879802|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19879803|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879804|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879805|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19879806|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
19879807|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
19879808|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879809|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535881|NCT01822613|Irinotecan|irinotecan|mesh-list
20535882|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20535883|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879810|NCT00939510|Lenalidomide|lenalidomide|mesh-list
19879811|NCT00939510|Sargramostim|sargramostim|mesh-list
19879812|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
19879813|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879814|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19879815|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19879816|NCT00939510|Growth Substances|growth substances|mesh-ancestor
19879817|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
19879818|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879819|NCT00939523|Lapatinib|lapatinib|mesh-list
19879820|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879821|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19879822|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879823|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879824|NCT00939536|Zolpidem|zolpidem|mesh-list
19879825|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19879826|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19879827|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879828|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879829|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19879830|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
19879831|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
19879832|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19879833|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879834|NCT00939562|Doxycycline|doxycycline|mesh-list
19879835|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19879836|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879837|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
19879838|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19879839|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19449556|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19879840|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19879841|NCT00939627|Cetuximab|cetuximab|mesh-list
19879842|NCT00939627|Sorafenib|sorafenib|mesh-list
19879843|NCT00939627|Antibodies|antibodies|mesh-list
19879844|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
19879845|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19879846|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
19879847|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879848|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879849|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19879850|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879851|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879852|NCT00939653|Cytarabine|cytarabine|mesh-list
19879853|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
19879854|NCT00939653|Etoposide|etoposide|mesh-list
19879855|NCT00939653|Clofarabine|clofarabine|mesh-list
19879856|NCT00939653|Lenograstim|lenograstim|mesh-list
19879857|NCT00939653|Sargramostim|sargramostim|mesh-list
19879858|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879859|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
19879860|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879861|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879862|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19879863|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
19879864|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879865|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879866|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19879867|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19879868|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19879869|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19879870|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879871|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19879872|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
19879873|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
19879874|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879875|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19879876|NCT00939692|Topiramate|topiramate|mesh-list
19879877|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
19879878|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19879879|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879880|NCT00939705|Topiramate|topiramate|mesh-list
19879881|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
19879882|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19879883|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879884|NCT00939731|Crizotinib|crizotinib|mesh-list
19879885|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879886|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19879887|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879888|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879889|NCT00939770|Crizotinib|crizotinib|mesh-list
19879890|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879891|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19879892|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449557|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
19879893|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879894|NCT00939822|Simvastatin|simvastatin|mesh-list
19879895|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19879896|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19879897|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
19879898|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879899|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19879900|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19879901|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879902|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
19879903|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19879904|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19879905|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
19879906|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879907|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19879908|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19449558|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449559|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19879909|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879910|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535884|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
19879911|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
19879912|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19879913|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879914|NCT00939952|Ertapenem|ertapenem|mesh-list
19879915|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19879916|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879917|NCT00939991|Bevacizumab|bevacizumab|mesh-list
19879918|NCT00939991|Temozolomide|temozolomide|mesh-list
19879919|NCT00939991|Vorinostat|vorinostat|mesh-list
19879920|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879921|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879922|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19879923|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19879924|NCT00939991|Growth Substances|growth substances|mesh-ancestor
19879925|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879926|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
19879927|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19879928|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
19879929|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879930|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19879931|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879932|NCT00940017|Voriconazole|voriconazole|mesh-list
19879933|NCT00940017|Anidulafungin|anidulafungin|mesh-list
19879934|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
19879935|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879936|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19879937|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19879938|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879939|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879940|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19879941|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
19879942|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19879943|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879944|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19879945|NCT00940316|Irinotecan|irinotecan|mesh-list
19879946|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19879947|NCT00940316|Panitumumab|panitumumab|mesh-list
19879948|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19879949|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19879950|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879951|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879952|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879953|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19879954|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879955|NCT00940342|Rituximab|rituximab|mesh-list
19879956|NCT00940342|Molgramostim|molgramostim|mesh-list
19879957|NCT00940342|Sargramostim|sargramostim|mesh-list
19879958|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19879959|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879960|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
19879961|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879962|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19879963|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19879964|NCT00940485|Entecavir|entecavir|mesh-list
19879965|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
19879966|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879967|NCT00940589|Melatonin|melatonin|mesh-list
19879968|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
19879969|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879970|NCT00940589|Protective Agents|protective agents|mesh-ancestor
19879971|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19879972|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19879973|NCT00940602|Deferasirox|deferasirox|mesh-list
19879974|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19879975|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
19879976|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
19879977|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879978|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19879979|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19879980|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19879981|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
19879982|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879983|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879984|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19879985|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19879986|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
19879987|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879988|NCT00940875|Gemcitabine|gemcitabine|mesh-list
19879989|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19879990|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19879991|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
19879992|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19879993|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19879994|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
19879995|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19879996|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19879997|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19879998|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
19879999|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880000|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19880001|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
19880002|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
19880003|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19880004|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19880005|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880006|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880007|NCT00940901|Urological Agents|urological agents|mesh-ancestor
19880008|NCT00940927|Albuterol|albuterol|mesh-list
19880009|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19880010|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
19880011|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880012|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880013|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19880014|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
19880015|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
19880016|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19880017|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19880018|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19880019|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19880020|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
19880021|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880022|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970521|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970522|NCT01785186|Pyridoxine|pyridoxine|mesh-list
19970523|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
19970524|NCT01785186|Rifampin|rifampin|mesh-list
19970525|NCT01785186|Isoniazid|isoniazid|mesh-list
19970526|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
19970527|NCT01785186|Ethambutol|ethambutol|mesh-list
19970528|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970529|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970530|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20535885|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
20535886|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
20535887|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535888|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20535889|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20535890|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535891|NCT01822639|Amlodipine|amlodipine|mesh-list
20535892|NCT01822639|Enalapril|enalapril|mesh-list
20535893|NCT01822639|Enalaprilat|enalaprilat|mesh-list
20535894|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535895|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535896|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535897|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535898|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535899|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535900|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535901|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535902|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19970531|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19970532|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970533|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970534|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970535|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970536|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19970537|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
19452667|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19880023|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19880024|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
19880025|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880026|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19880027|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19880028|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880029|NCT00941304|Oxycodone|oxycodone|mesh-list
19880030|NCT00941304|Buprenorphine|buprenorphine|mesh-list
19880031|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19880032|NCT00941304|Narcotics|narcotics|mesh-ancestor
19880033|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19880034|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880035|NCT00941304|Analgesics|analgesics|mesh-ancestor
19880036|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
19880037|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880038|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19880039|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
19880040|NCT00941330|Docetaxel|docetaxel|mesh-list
19880041|NCT00941330|Exemestane|exemestane|mesh-list
19880042|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880043|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
19880044|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880045|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880046|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880047|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
19880048|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880049|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880050|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19880051|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880052|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880053|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880054|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19880055|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19880056|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880057|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19880058|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
19880059|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880060|NCT00941655|Leucovorin|leucovorin|mesh-list
19880061|NCT00941655|Fluorouracil|fluorouracil|mesh-list
19880062|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
19880063|NCT00941655|Irinotecan|irinotecan|mesh-list
19880064|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
19880065|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880066|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880067|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880068|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880069|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
19880070|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880071|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19880072|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19880073|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880074|NCT00941655|Antidotes|antidotes|mesh-ancestor
19880075|NCT00941655|Protective Agents|protective agents|mesh-ancestor
19880076|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
19880077|NCT00941655|Vitamins|vitamins|mesh-ancestor
19880078|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
19880079|NCT00941668|Triclosan|triclosan|mesh-list
19880080|NCT00941668|Fluorides|fluorides|mesh-list
19880081|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
19880082|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
19880083|NCT00941668|Protective Agents|protective agents|mesh-ancestor
19880084|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880085|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19880086|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880087|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19880088|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19880089|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
19880090|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880091|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19880092|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
19880093|NCT00941720|Busulfan|busulfan|mesh-list
19880094|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880095|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
19880096|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880097|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880098|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880099|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
19880100|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880101|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880102|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19880103|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
19880104|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880105|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
19880106|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19880107|NCT00941863|Sorafenib|sorafenib|mesh-list
19880108|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880109|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19880110|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535903|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
20535904|NCT01822730|Risperidone|risperidone|mesh-list
20535905|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20535906|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20535907|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
20535908|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880111|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880112|NCT00942084|Acyclovir|acyclovir|mesh-list
19880113|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
19880114|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880115|NCT00942149|Daptomycin|daptomycin|mesh-list
19880116|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19880117|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880118|NCT00942175|Esomeprazole|esomeprazole|mesh-list
19880119|NCT00942175|Omeprazole|omeprazole|mesh-list
19880120|NCT00942175|Lansoprazole|lansoprazole|mesh-list
19880121|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
19880122|NCT00942175|Clopidogrel|clopidogrel|mesh-list
19880123|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19880124|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19880125|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19880126|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19880127|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
19880128|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880129|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880130|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880131|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19880132|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880133|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19880134|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880135|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
19880136|NCT00942266|Leucovorin|leucovorin|mesh-list
19880137|NCT00942266|Fluorouracil|fluorouracil|mesh-list
19880138|NCT00942266|Vorinostat|vorinostat|mesh-list
19880139|NCT00942266|Calcium|calcium|mesh-list
19880140|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
19880141|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19880142|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880143|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19880144|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
20535909|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535910|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535911|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19880145|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880146|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880147|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880148|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880149|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
19880150|NCT00942266|Antidotes|antidotes|mesh-ancestor
19880151|NCT00942266|Protective Agents|protective agents|mesh-ancestor
19880152|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
19880153|NCT00942266|Vitamins|vitamins|mesh-ancestor
19880154|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
19880155|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19880156|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880157|NCT00942305|Brincidofovir|brincidofovir|mesh-list
19880158|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
19880159|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880160|NCT00942357|Paclitaxel|paclitaxel|mesh-list
19880161|NCT00942357|Cisplatin|cisplatin|mesh-list
20535912|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19880162|NCT00942357|Carboplatin|carboplatin|mesh-list
19880163|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19880164|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19880165|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880166|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880167|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880168|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880169|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880170|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19880171|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
19880172|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880173|NCT00942422|Protective Agents|protective agents|mesh-ancestor
19880174|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880175|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19880176|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19880177|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880178|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19880179|NCT00942448|Diclofenac|diclofenac|mesh-list
19880180|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19880181|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19880182|NCT00942448|Analgesics|analgesics|mesh-ancestor
19880183|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
19880184|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880185|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535913|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535914|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20535915|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20535916|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
20535917|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19880186|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880187|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880188|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19880189|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880190|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880191|NCT00942578|Prednisone|prednisone|mesh-list
19880192|NCT00942578|Bevacizumab|bevacizumab|mesh-list
19880193|NCT00942578|Lenalidomide|lenalidomide|mesh-list
19880194|NCT00942578|Docetaxel|docetaxel|mesh-list
19880195|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880196|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880197|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20535918|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20535919|NCT01822808|Hydralazine|hydralazine|mesh-list
20535920|NCT01822808|Isosorbide|isosorbide|mesh-list
20535921|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20535922|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20535923|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20535924|NCT01822808|Diuretics|diuretics|mesh-ancestor
20535925|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
20535926|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880198|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19880199|NCT00942578|Growth Substances|growth substances|mesh-ancestor
19880200|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880201|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
19880202|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880203|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880204|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880205|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880206|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880207|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
19880208|NCT00942578|Hormones|hormones|mesh-ancestor
19732133|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19732134|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19880209|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880210|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19880211|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
19880212|NCT00942708|Fluoxetine|fluoxetine|mesh-list
19880213|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19880214|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19880215|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19880216|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535927|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535928|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19732135|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732136|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19732137|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19732138|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732139|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732140|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
20535929|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535930|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535931|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20535932|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
20535933|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20535934|NCT01822860|Diuretics|diuretics|mesh-ancestor
20535935|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
20535936|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535937|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20535938|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535939|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535940|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
20535941|NCT01822951|Donepezil|donepezil|mesh-list
20535942|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20535943|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535944|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880217|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880218|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
19880219|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880220|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19880221|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
19880222|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19880223|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19880224|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19880225|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880226|NCT00942734|Everolimus|everolimus|mesh-list
19880227|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19880228|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880229|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880230|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
19880231|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880232|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19880233|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880234|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880235|NCT00942825|Cisplatin|cisplatin|mesh-list
19880236|NCT00942825|Pemetrexed|pemetrexed|mesh-list
19880237|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880238|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880239|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880240|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19880241|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19880242|NCT00942968|Dalteparin|dalteparin|mesh-list
19880243|NCT00942968|Tinzaparin|tinzaparin|mesh-list
19449560|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19880244|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19880245|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
19880246|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19880247|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19880248|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880249|NCT00942994|Amlodipine|amlodipine|mesh-list
19449561|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449562|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
19449563|NCT03434340|Dexamethasone|dexamethasone|mesh-list
19449564|NCT03434340|Granisetron|granisetron|mesh-list
19880250|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19880251|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19880252|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19880253|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19880254|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880255|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19880256|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880257|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
19880258|NCT00942994|Diuretics|diuretics|mesh-ancestor
19880259|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
19880260|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19880261|NCT00943072|Aflibercept|aflibercept|mesh-list
19880262|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19880263|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19880264|NCT00943072|Growth Substances|growth substances|mesh-ancestor
19880265|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880266|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
20535945|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
19880267|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880268|NCT00943098|Diclofenac|diclofenac|mesh-list
19880269|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19880270|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19880271|NCT00943098|Analgesics|analgesics|mesh-ancestor
19880272|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
19880273|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880274|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880275|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880276|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880277|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19880278|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880279|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880280|NCT00943111|Eliglustat|eliglustat|mesh-list
19880281|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880282|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880283|NCT00943124|Niacin|niacin|mesh-list
19880284|NCT00943124|Niacinamide|niacinamide|mesh-list
19880285|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
19880286|NCT00943124|Simvastatin|simvastatin|mesh-list
19880287|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19880288|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19880289|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
19880290|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880291|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19880292|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19880293|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880294|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
19880295|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
19880296|NCT00943124|Vitamins|vitamins|mesh-ancestor
19880297|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
19880298|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880299|NCT00943202|Vaccines|vaccines|mesh-list
19880300|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
19880301|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880302|NCT00943319|Fludarabine|fludarabine|mesh-list
19880303|NCT00943319|Busulfan|busulfan|mesh-list
19880304|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
19880305|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880306|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880307|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880308|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
19880309|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880310|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
19880311|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880312|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19880313|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880314|NCT00943592|Melphalan|melphalan|mesh-list
19880315|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
19880316|NCT00943592|Clofarabine|clofarabine|mesh-list
19880317|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880318|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
19880319|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880320|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880321|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19880322|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880323|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
19880324|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880325|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880326|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880327|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
19880328|NCT00943670|Trastuzumab|trastuzumab|mesh-list
19880329|NCT00943670|Pertuzumab|pertuzumab|mesh-list
19880330|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19880331|NCT00943670|Maytansine|maytansine|mesh-list
19880332|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880333|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880334|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19880335|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880336|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880337|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880338|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880339|NCT00943735|Fesoterodine|fesoterodine|mesh-list
19880340|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19880341|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19880342|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
19880343|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880344|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880345|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880346|NCT00943735|Urological Agents|urological agents|mesh-ancestor
19880347|NCT00943761|Interferons|interferons|mesh-list
19880348|NCT00943761|Ribavirin|ribavirin|mesh-list
19880349|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880350|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
19880351|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880352|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
19880353|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880354|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19880355|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880356|NCT00943800|Vidarabine|vidarabine|mesh-list
19880357|NCT00943800|Fludarabine|fludarabine|mesh-list
19880358|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
19880359|NCT00943800|Melphalan|melphalan|mesh-list
19880360|NCT00943800|Busulfan|busulfan|mesh-list
19880361|NCT00943800|Thiotepa|thiotepa|mesh-list
19880362|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19880363|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
19880364|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880365|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880366|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
19880367|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880368|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880369|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
19880370|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880371|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
19880372|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880373|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880374|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
19880375|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19880376|NCT00943826|Bevacizumab|bevacizumab|mesh-list
19880377|NCT00943826|Temozolomide|temozolomide|mesh-list
19880378|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880379|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880380|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19880381|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19880382|NCT00943826|Growth Substances|growth substances|mesh-ancestor
19880383|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880384|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
19880385|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880386|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
19880387|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880388|NCT00943878|Vaccines|vaccines|mesh-list
19880389|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
19880390|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880391|NCT00943917|Exenatide|exenatide|mesh-list
19880392|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19880393|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880394|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19880395|NCT00943917|Incretins|incretins|mesh-ancestor
19880396|NCT00943917|Hormones|hormones|mesh-ancestor
19880397|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880398|NCT00944034|Vaccines|vaccines|mesh-list
19880399|NCT00944034|Immunologic Factors|immunologic factors|mesh-ancestor
19880400|NCT00944034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880401|NCT00944047|Paclitaxel|paclitaxel|mesh-list
19880402|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
19880403|NCT00944047|Doxorubicin|doxorubicin|mesh-list
19880404|NCT00944047|Trastuzumab|trastuzumab|mesh-list
19880405|NCT00944047|Mitogens|mitogens|mesh-list
19880406|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19880407|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880408|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880409|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880410|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880411|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880412|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880413|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
19880414|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880415|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880416|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880417|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
19880418|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19970538|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
19880419|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19880420|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19880421|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19880422|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880423|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880424|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19880425|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19880426|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880427|NCT00944450|Incretins|incretins|mesh-ancestor
19880428|NCT00944450|Hormones|hormones|mesh-ancestor
19880429|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880430|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19880431|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
19880432|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880433|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880434|NCT00944554|Varenicline|varenicline|mesh-list
19880435|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19880436|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19880437|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
19880438|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880439|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880440|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880441|NCT00944645|Niacin|niacin|mesh-list
19880442|NCT00944645|Niacinamide|niacinamide|mesh-list
19880443|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
19880444|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19880445|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
19880446|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880447|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19880448|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
19880449|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
19880450|NCT00944645|Vitamins|vitamins|mesh-ancestor
19880451|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
19880452|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880453|NCT00944658|Apremilast|apremilast|mesh-list
19880454|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19880455|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19880456|NCT00944658|Analgesics|analgesics|mesh-ancestor
19880457|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
19880458|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880459|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880460|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880461|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880462|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19880463|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19880464|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880465|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880466|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
19880467|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
19880468|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19880469|NCT00944671|Famotidine|famotidine|mesh-list
19880470|NCT00944671|Calcium|calcium|mesh-list
19880471|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19880472|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880473|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19880474|NCT00944671|Antacids|antacids|mesh-ancestor
19880475|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880476|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880477|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19880478|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19880479|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
19880480|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
19880481|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880482|NCT00944697|Oxycodone|oxycodone|mesh-list
19880483|NCT00944697|Naloxone|naloxone|mesh-list
19880484|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19880485|NCT00944697|Narcotics|narcotics|mesh-ancestor
19880486|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19880487|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880488|NCT00944697|Analgesics|analgesics|mesh-ancestor
19880489|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
19880490|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880491|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19880492|NCT00944710|Atropine|atropine|mesh-list
19880493|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19880494|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19880495|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19880496|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
19880497|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880498|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880499|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19880500|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
19880501|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
19880502|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
19880503|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19880504|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19880505|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
19880506|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880507|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880508|NCT00944749|Cyclosporine|cyclosporine|mesh-list
19880509|NCT00944749|Cyclosporins|cyclosporins|mesh-list
19880510|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880511|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880512|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880513|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
19880514|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880515|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
19880516|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880517|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19880518|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880519|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19880520|NCT00945139|Bevacizumab|bevacizumab|mesh-list
19880521|NCT00945139|Doxorubicin|doxorubicin|mesh-list
19880522|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880523|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880524|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19880525|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19880526|NCT00945139|Growth Substances|growth substances|mesh-ancestor
19880527|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880528|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
19880529|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19880530|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19880531|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19880532|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880533|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880534|NCT00945191|Paclitaxel|paclitaxel|mesh-list
19880535|NCT00945191|Carboplatin|carboplatin|mesh-list
19880536|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19880537|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880538|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880539|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880540|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880541|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880542|NCT00945256|Nitroprusside|nitroprusside|mesh-list
19880543|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19880544|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
19880545|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19880546|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880547|NCT00945282|Ritonavir|ritonavir|mesh-list
19880548|NCT00945282|Lopinavir|lopinavir|mesh-list
19880549|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19880550|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19880551|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
19880552|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880553|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880554|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19880555|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19880556|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
19880557|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880558|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19880559|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19880560|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
19880561|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19880562|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19880563|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19880564|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19880565|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880566|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
19880567|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880568|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880569|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19880570|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880571|NCT00945321|Aprepitant|aprepitant|mesh-list
19880572|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
19880573|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
19880574|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
19880575|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880576|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880577|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880578|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19880579|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880580|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880581|NCT00945334|Rifaximin|rifaximin|mesh-list
19880582|NCT00945334|Neomycin|neomycin|mesh-list
19880583|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19880584|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880585|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880586|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19880587|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880588|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880589|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19880590|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880591|NCT00945750|Famotidine|famotidine|mesh-list
19880592|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19880593|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880594|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19880595|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
19880596|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
19880597|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880598|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880599|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880600|NCT00945815|Cytarabine|cytarabine|mesh-list
19880601|NCT00945815|Clofarabine|clofarabine|mesh-list
19880602|NCT00945815|Epratuzumab|epratuzumab|mesh-list
19880603|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880604|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
19880605|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880606|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880607|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
19880608|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880609|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880610|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
19880611|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880612|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880613|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
19880614|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19880615|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19880616|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880617|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19880618|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19880619|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19880620|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19880621|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880622|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880623|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880624|NCT00945945|Analgesics|analgesics|mesh-ancestor
19880625|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
19880626|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880627|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
19880628|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19880629|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
19880630|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
19880631|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
19880632|NCT00946023|Rituximab|rituximab|mesh-list
19880633|NCT00946023|Fludarabine|fludarabine|mesh-list
19880634|NCT00946023|Tacrolimus|tacrolimus|mesh-list
19880635|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880636|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
19880637|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880638|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880639|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880640|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
19880641|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880642|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880643|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19880644|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880645|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19880646|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880647|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19880648|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19880649|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
19880650|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19880651|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880652|NCT00946088|Progesterone|progesterone|mesh-list
19880653|NCT00946088|Progestins|progestins|mesh-ancestor
19880654|NCT00946088|Hormones|hormones|mesh-ancestor
19880655|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880656|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880657|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
19880658|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
19880659|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19880660|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19880661|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880662|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880663|NCT00946114|Urological Agents|urological agents|mesh-ancestor
19880664|NCT00946153|Lenvatinib|lenvatinib|mesh-list
19880665|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880666|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19880667|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880668|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880669|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19880670|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19880671|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19880672|NCT00946192|Desogestrel|desogestrel|mesh-list
19880673|NCT00946192|Estradiol|estradiol|mesh-list
19880674|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19880675|NCT00946192|Progesterone|progesterone|mesh-list
19880676|NCT00946192|Estrogens|estrogens|mesh-ancestor
19880677|NCT00946192|Hormones|hormones|mesh-ancestor
19880678|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880679|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880680|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19880681|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
19880682|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19880683|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19880684|NCT00946192|Progestins|progestins|mesh-ancestor
19880685|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19880686|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19880687|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19880688|NCT00946270|Thalidomide|thalidomide|mesh-list
19880689|NCT00946270|Prednisone|prednisone|mesh-list
19880690|NCT00946270|Pomalidomide|pomalidomide|mesh-list
19880691|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880692|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
19880693|NCT00946270|Hormones|hormones|mesh-ancestor
19880694|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880695|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880696|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19880697|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880698|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
19880699|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19880700|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19880701|NCT00946270|Growth Substances|growth substances|mesh-ancestor
19880702|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
19880703|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880704|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
19880705|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19880706|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970539|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19970540|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19970541|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19970542|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19970543|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19970544|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19970545|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19970546|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19970547|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19880707|NCT00946309|Sulforaphane|sulforaphane|mesh-list
19880708|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19880709|NCT00946309|Protective Agents|protective agents|mesh-ancestor
19880710|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880711|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880712|NCT00946348|Dronabinol|dronabinol|mesh-list
19880713|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
19880714|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880715|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19880716|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19880717|NCT00946348|Analgesics|analgesics|mesh-ancestor
19880718|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
19880719|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880720|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19880721|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19880722|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880723|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880724|NCT00946348|Hormones|hormones|mesh-ancestor
19880725|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880726|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
19880727|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19880728|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19880729|NCT00946478|Analgesics|analgesics|mesh-ancestor
19880730|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
19880731|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880732|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880733|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880734|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880735|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19880736|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880737|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
19880738|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19880739|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880740|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880741|NCT00946647|Azacitidine|azacitidine|mesh-list
19880742|NCT00946647|Panobinostat|panobinostat|mesh-list
19880743|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880744|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
19880745|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880746|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880747|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880748|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19880749|NCT00946712|Paclitaxel|paclitaxel|mesh-list
19880750|NCT00946712|Bevacizumab|bevacizumab|mesh-list
19880751|NCT00946712|Carboplatin|carboplatin|mesh-list
19880752|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19880753|NCT00946712|Cetuximab|cetuximab|mesh-list
19880754|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19880755|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
19880756|NCT00946712|Antibodies|antibodies|mesh-list
19880757|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
19880758|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19880759|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
19880760|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19880761|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880762|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880763|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880764|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880765|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880766|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19880767|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19880768|NCT00946712|Growth Substances|growth substances|mesh-ancestor
19880769|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880770|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
19880771|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
19880772|NCT00946920|Goserelin|goserelin|mesh-list
19880773|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19880774|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880775|NCT00946998|Sertraline|sertraline|mesh-list
19880776|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
19880777|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19880778|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19880779|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19880780|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19970548|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
19880781|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880782|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880783|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
19880784|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880785|NCT00947154|Aripiprazole|aripiprazole|mesh-list
19880786|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
19880787|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19880788|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19880789|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19880790|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19880791|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880792|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
19880793|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
19880794|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880795|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880796|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19880797|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19880798|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
19880799|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19880800|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19880801|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19880802|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19880803|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19880804|NCT00947167|Pertuzumab|pertuzumab|mesh-list
19880805|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880806|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19880807|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880808|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880809|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880810|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19880811|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880812|NCT00947349|Interferons|interferons|mesh-list
19880813|NCT00947349|Ribavirin|ribavirin|mesh-list
19880814|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880815|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
19880816|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880817|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
19880818|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880819|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19880820|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
19880821|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880822|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
19880823|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19880824|NCT00947531|Protective Agents|protective agents|mesh-ancestor
19880825|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880826|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
19880827|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19880828|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880829|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
19880830|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
19880831|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19880832|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
19880833|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880834|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880835|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880836|NCT00947765|Prednisolone|prednisolone|mesh-list
19880837|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19880838|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
19880839|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19880840|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
19880841|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19880842|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
19880843|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19880844|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
19880845|NCT00947765|Hormones|hormones|mesh-ancestor
19880846|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19880847|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880848|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19880849|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880850|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
19880851|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
19880852|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19880853|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880854|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19880855|NCT00947765|Protective Agents|protective agents|mesh-ancestor
19880856|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19880857|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880858|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880859|NCT00948064|Azacitidine|azacitidine|mesh-list
19880860|NCT00948064|Vorinostat|vorinostat|mesh-list
19880861|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880862|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
19880863|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880864|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880865|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880866|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19880867|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
19880868|NCT00948090|Busulfan|busulfan|mesh-list
19880869|NCT00948090|Etoposide|etoposide|mesh-list
19880870|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880871|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
19880872|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880873|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880874|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880875|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
19880876|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880877|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880878|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19880879|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19880880|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19880881|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19880882|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880883|NCT00948155|Varenicline|varenicline|mesh-list
19880884|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19880885|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19880886|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
19880887|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880888|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880889|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880890|NCT00948298|Vitamin D|vitamin d|mesh-list
19880891|NCT00948298|Vitamins|vitamins|mesh-ancestor
19880892|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
19880893|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880894|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19880895|NCT00948389|Dasatinib|dasatinib|mesh-list
19880896|NCT00948389|Lomustine|lomustine|mesh-list
19880897|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880898|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19880899|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880900|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880901|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19880902|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
19880903|NCT00948428|Imiquimod|imiquimod|mesh-list
19880904|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19880905|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
19880906|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880907|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880908|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
19880909|NCT00948441|Ethanol|ethanol|mesh-list
19880910|NCT00948441|Heparin|heparin|mesh-list
19880911|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
19880912|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19880913|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19880914|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880915|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19880916|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880917|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19880918|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880919|NCT00948506|Cidofovir|cidofovir|mesh-list
19880920|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
19880921|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880922|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880923|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880924|NCT00948610|Infliximab|infliximab|mesh-list
19880925|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
19880926|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880927|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19880928|NCT00948675|Paclitaxel|paclitaxel|mesh-list
19880929|NCT00948675|Bevacizumab|bevacizumab|mesh-list
19880930|NCT00948675|Carboplatin|carboplatin|mesh-list
19880931|NCT00948675|Pemetrexed|pemetrexed|mesh-list
19880932|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19880933|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880934|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
19880935|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
19880936|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
19880937|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880938|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19880939|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19880940|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19880941|NCT00948675|Growth Substances|growth substances|mesh-ancestor
19880942|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880943|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
19880944|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880945|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19880946|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19880947|NCT00948688|Vorinostat|vorinostat|mesh-list
19880948|NCT00948688|Fluorouracil|fluorouracil|mesh-list
19880949|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19880950|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19880951|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880952|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880953|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
19880954|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19880955|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19880956|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
19880957|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880958|NCT00948766|Rivastigmine|rivastigmine|mesh-list
19880959|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19880960|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880961|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880962|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
19880963|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19880964|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880965|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19880966|NCT00948766|Protective Agents|protective agents|mesh-ancestor
19880967|NCT00948818|Linaclotide|linaclotide|mesh-list
19880968|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19880969|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
19880970|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880971|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19880972|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19880973|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19880974|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
19880975|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19880976|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
19880977|NCT00948896|Piperaquine|piperaquine|mesh-list
19880978|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
19880979|NCT00948896|Trimethoprim|trimethoprim|mesh-list
19880980|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19880981|NCT00948896|Artenimol|artenimol|mesh-list
19880982|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19880983|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
19880984|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
19880985|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19880986|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19880987|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19880988|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19449565|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449566|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
19449567|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
19449568|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449569|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449570|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19449571|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
19449572|NCT03434340|Hormones|hormones|mesh-ancestor
19449573|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449574|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19449575|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449576|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19449577|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
19449578|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449579|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449580|NCT03434275|Meloxicam|meloxicam|mesh-list
19880989|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19880990|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19880991|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19880992|NCT00948896|Renal Agents|renal agents|mesh-ancestor
19880993|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19880994|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19880995|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19880996|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19880997|NCT00948922|Fludarabine|fludarabine|mesh-list
19880998|NCT00948922|Bortezomib|bortezomib|mesh-list
19880999|NCT00948922|Melphalan|melphalan|mesh-list
19881000|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881001|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881002|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881003|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
19881004|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881005|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19881006|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
19881007|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19881008|NCT00948935|Gemcitabine|gemcitabine|mesh-list
19881009|NCT00948935|Irinotecan|irinotecan|mesh-list
19881010|NCT00948935|Panitumumab|panitumumab|mesh-list
19881011|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19881012|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
19881013|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881014|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881015|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
19881016|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881017|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881018|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881019|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
19881020|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881021|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19881022|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19881023|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19881024|NCT00949078|Omalizumab|omalizumab|mesh-list
19881025|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19881026|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19881027|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
19881028|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
19881029|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
19881030|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
19881031|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19881032|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19881033|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
19881034|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
19881035|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881036|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881037|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881038|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19881039|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
20535946|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20535947|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535948|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
20535949|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20535950|NCT01822951|Protective Agents|protective agents|mesh-ancestor
20535951|NCT01822977|Omeprazole|omeprazole|mesh-list
20535952|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19449581|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19449582|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19881040|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19881041|NCT00949234|Ritonavir|ritonavir|mesh-list
19881042|NCT00949234|Lopinavir|lopinavir|mesh-list
19881043|NCT00949234|Tenofovir|tenofovir|mesh-list
19881044|NCT00949234|Emtricitabine|emtricitabine|mesh-list
19881045|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19881046|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19881047|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
19449583|NCT03434275|Analgesics|analgesics|mesh-ancestor
19449584|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
19449585|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449586|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449587|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449588|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19449589|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19881048|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535953|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19881049|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881050|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19881051|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19881052|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
19881053|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881054|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19881055|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19881056|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19881057|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19881058|NCT00949325|Sirolimus|sirolimus|mesh-list
19881059|NCT00949325|Doxorubicin|doxorubicin|mesh-list
19881060|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19881061|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19881062|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881063|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19881064|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19881065|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881066|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881067|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19881068|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881069|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
19881070|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881071|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
19881072|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881073|NCT00949533|Oseltamivir|oseltamivir|mesh-list
19881074|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
19881075|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881076|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881077|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881078|NCT00949650|Pemetrexed|pemetrexed|mesh-list
19881079|NCT00949650|Afatinib|afatinib|mesh-list
19881080|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881081|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881082|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881083|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19881084|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19881085|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881086|NCT00949702|Vemurafenib|vemurafenib|mesh-list
19881087|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881088|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881089|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881090|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881091|NCT00949884|Losartan|losartan|mesh-list
19881092|NCT00949884|Olmesartan|olmesartan|mesh-list
19881093|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19881094|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19881095|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19881096|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19881097|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19881098|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881099|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19881100|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881101|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881102|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881103|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881104|NCT00950170|Factor VIII|factor viii|mesh-list
19449590|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19449591|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881105|NCT00950170|Coagulants|coagulants|mesh-ancestor
19881106|NCT00950248|Idebenone|idebenone|mesh-list
19449592|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449593|NCT03434197|Diclofenac|diclofenac|mesh-list
19449594|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19449595|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449596|NCT03434197|Analgesics|analgesics|mesh-ancestor
19449597|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
19449598|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449599|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449600|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449601|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19449602|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19449603|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452668|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
19881107|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
19881108|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881109|NCT00950248|Protective Agents|protective agents|mesh-ancestor
19881110|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881111|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
19881112|NCT00950300|Docetaxel|docetaxel|mesh-list
19881113|NCT00950300|Fluorouracil|fluorouracil|mesh-list
19881114|NCT00950300|Trastuzumab|trastuzumab|mesh-list
19881115|NCT00950300|Epirubicin|epirubicin|mesh-list
19881116|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881117|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
19881118|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881119|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19881120|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19881121|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
19881122|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881123|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881124|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19881125|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
19881126|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
19881127|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
19881128|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
19881129|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19881130|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19881131|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19881132|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19881133|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19881134|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881135|NCT00950352|Choline|choline|mesh-list
19881136|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19881137|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
19881138|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19881139|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
19881140|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881141|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19881142|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19881143|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
19881144|NCT00950365|Pemetrexed|pemetrexed|mesh-list
19881145|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19881146|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881147|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881148|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881149|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19881150|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19881151|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881152|NCT00950599|Saxagliptin|saxagliptin|mesh-list
19881153|NCT00950599|Incretins|incretins|mesh-ancestor
19881154|NCT00950599|Hormones|hormones|mesh-ancestor
19881155|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881156|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881157|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19881158|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
19881159|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881160|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881161|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19881162|NCT00950651|Tramadol|tramadol|mesh-list
19881163|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19881164|NCT00950651|Narcotics|narcotics|mesh-ancestor
19881165|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20535954|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20535955|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535956|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535957|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
19881166|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881167|NCT00950651|Analgesics|analgesics|mesh-ancestor
19881168|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
19881169|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881170|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19881171|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19881172|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19881173|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881174|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881175|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19881176|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535958|NCT01823029|Hematinics|hematinics|mesh-ancestor
19881177|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881178|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
19881179|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881180|NCT00950742|Trastuzumab|trastuzumab|mesh-list
19881181|NCT00950742|Afatinib|afatinib|mesh-list
19881182|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19881183|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881184|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881185|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881186|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881187|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
19881188|NCT00950755|Antibodies|antibodies|mesh-list
19881189|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
19881190|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881191|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881192|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
19881193|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19881194|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
19881195|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881196|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881197|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19881198|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
19881199|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
19881200|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19881201|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
19881202|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881203|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881204|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19881205|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
19881206|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881207|NCT00950859|Dolutegravir|dolutegravir|mesh-list
19881208|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19881209|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19449604|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257263|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257264|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19881210|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881211|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881212|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19881213|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19881214|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
19881215|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881216|NCT00950911|Denosumab|denosumab|mesh-list
19881217|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19881218|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881219|NCT00951015|Efavirenz|efavirenz|mesh-list
19881220|NCT00951015|Dolutegravir|dolutegravir|mesh-list
19881221|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19881222|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19881223|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881224|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881225|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
19881226|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881227|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19881228|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19881229|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19881230|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19881231|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19881232|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19881233|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19881234|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19881235|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19881236|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19881237|NCT00951041|Vaccines|vaccines|mesh-list
19881238|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
20257265|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20257266|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20257267|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257268|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257269|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
20257270|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
20257271|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
20257272|NCT00478946|Leucovorin|leucovorin|mesh-list
19881239|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881240|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
19881241|NCT00951379|Pioglitazone|pioglitazone|mesh-list
19881242|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19881243|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881244|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19881245|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
19881246|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19881247|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19881248|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19881249|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881250|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881251|NCT00951496|Paclitaxel|paclitaxel|mesh-list
19881252|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19881253|NCT00951496|Bevacizumab|bevacizumab|mesh-list
19881254|NCT00951496|Cisplatin|cisplatin|mesh-list
19881255|NCT00951496|Carboplatin|carboplatin|mesh-list
19881256|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19881257|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
19881258|NCT00951496|Antibodies|antibodies|mesh-list
19881259|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
19881260|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19881261|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
19881262|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19881263|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881264|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
19881265|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
19881266|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
19881267|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881268|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19881269|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19881270|NCT00951496|Growth Substances|growth substances|mesh-ancestor
19881271|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881272|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
19881273|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
19881274|NCT00951561|Ibuprofen|ibuprofen|mesh-list
19881275|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19881276|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19881277|NCT00951561|Analgesics|analgesics|mesh-ancestor
19881278|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
19881279|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881280|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881281|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881282|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19881283|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19881284|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881285|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881286|NCT00951665|Paclitaxel|paclitaxel|mesh-list
19881287|NCT00951665|Maytansine|maytansine|mesh-list
19881288|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19881289|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19881290|NCT00951665|Trastuzumab|trastuzumab|mesh-list
19881291|NCT00951665|Pertuzumab|pertuzumab|mesh-list
19881292|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19881293|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881294|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
19881295|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
19881296|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
19881297|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881298|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19881299|NCT00951899|Metformin|metformin|mesh-list
19881300|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19881301|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19881302|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881303|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19881304|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19881305|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
19881306|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881307|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19881308|NCT00951912|Genistein|genistein|mesh-list
19881309|NCT00951912|Daidzein|daidzein|mesh-list
19881310|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19881311|NCT00951912|Protective Agents|protective agents|mesh-ancestor
19881312|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881313|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881314|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881315|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881316|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257273|NCT00478946|Antidotes|antidotes|mesh-ancestor
20257274|NCT00478946|Protective Agents|protective agents|mesh-ancestor
19881317|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
19881318|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19881319|NCT00951912|Estrogens|estrogens|mesh-ancestor
19881320|NCT00951912|Hormones|hormones|mesh-ancestor
19881321|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881322|NCT00952068|Tramadol|tramadol|mesh-list
19881323|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19881324|NCT00952068|Narcotics|narcotics|mesh-ancestor
19881325|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881326|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881327|NCT00952068|Analgesics|analgesics|mesh-ancestor
19881328|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
20257275|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257276|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
20257277|NCT00478946|Vitamins|vitamins|mesh-ancestor
20257278|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
20257279|NCT00478959|Lenalidomide|lenalidomide|mesh-list
20257280|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
20257281|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257282|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20257283|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20257284|NCT00478959|Growth Substances|growth substances|mesh-ancestor
20257285|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
20257286|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257287|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
20257288|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257289|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257290|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257291|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449605|NCT03434106|Dextrans|dextrans|mesh-list
19449606|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
19449607|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
19449608|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
19449609|NCT03434054|Losartan|losartan|mesh-list
19449610|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19449611|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19881329|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257292|NCT00478998|Tamsulosin|tamsulosin|mesh-list
20257293|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20257294|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20257295|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20257296|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
20257297|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257298|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257299|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257300|NCT00478998|Urological Agents|urological agents|mesh-ancestor
20257301|NCT00479076|Aflibercept|aflibercept|mesh-list
20257302|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19881330|NCT00952081|Clevidipine|clevidipine|mesh-list
19881331|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19881332|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881333|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881334|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20257303|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20257304|NCT00479076|Growth Substances|growth substances|mesh-ancestor
20257305|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257306|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
20257307|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257308|NCT00479128|Gemcitabine|gemcitabine|mesh-list
20257309|NCT00479128|Doxorubicin|doxorubicin|mesh-list
20257310|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20257311|NCT00479128|Bortezomib|bortezomib|mesh-list
20257312|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20257313|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
20257314|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257315|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881335|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257316|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
19449612|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20257317|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257318|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881336|NCT00952133|Dexamethasone|dexamethasone|mesh-list
19881337|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
19881338|NCT00952133|Palonosetron|palonosetron|mesh-list
19881339|NCT00952133|BB 1101|bb 1101|mesh-list
19881340|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881341|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
19881342|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
20535959|NCT01823042|Azathioprine|azathioprine|mesh-list
20535960|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
20535961|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535962|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20535963|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881343|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881344|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881345|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19881346|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
19881347|NCT00952133|Hormones|hormones|mesh-ancestor
19881348|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881349|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19881350|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881351|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
19881352|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881353|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881354|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19881355|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19881356|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
19881357|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881358|NCT00952276|Vaccines|vaccines|mesh-list
19881359|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
19881360|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881361|NCT00952341|Dexamethasone|dexamethasone|mesh-list
19881362|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
19881363|NCT00952341|Aprepitant|aprepitant|mesh-list
19881364|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
19881365|NCT00952341|Granisetron|granisetron|mesh-list
19881366|NCT00952341|BB 1101|bb 1101|mesh-list
19881367|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881368|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
19881369|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
19881370|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881371|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881372|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19881373|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
19881374|NCT00952341|Hormones|hormones|mesh-ancestor
19881375|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881376|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19881377|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881378|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
19881379|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881380|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881381|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19881382|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881383|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19881384|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
19881385|NCT00952380|Dalteparin|dalteparin|mesh-list
19881386|NCT00952380|Tinzaparin|tinzaparin|mesh-list
19881387|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19881388|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
19881389|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19881390|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19881391|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881392|NCT00952419|Vaccines|vaccines|mesh-list
19881393|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
19881394|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535964|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20535965|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
20535966|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535967|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20535968|NCT01823081|Bevacizumab|bevacizumab|mesh-list
20535969|NCT01823081|Fasudil|fasudil|mesh-list
20535970|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20535971|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20535972|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19881395|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
19881396|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
19881397|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881398|NCT00952523|Adapalene|adapalene|mesh-list
19881399|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19881400|NCT00952523|Tretinoin|tretinoin|mesh-list
19881401|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19881402|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
19881403|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19881404|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19881405|NCT00952523|Analgesics|analgesics|mesh-ancestor
19881406|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
19881407|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881408|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881409|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881410|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19881411|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881412|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
19881413|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19881414|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881415|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
20535973|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20535974|NCT01823081|Growth Substances|growth substances|mesh-ancestor
20535975|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20535976|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
20535977|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20535978|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535979|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535980|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20535981|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
20535982|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20535983|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535984|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19881416|NCT00952614|Hormones|hormones|mesh-ancestor
19881417|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881418|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881419|NCT00952653|Midazolam|midazolam|mesh-list
19881420|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19881421|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19881422|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19881423|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881424|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881425|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19881426|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19881427|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19881428|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19881429|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
19881430|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
19881431|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
19881432|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
19881433|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881434|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881435|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19881436|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19881437|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881438|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
19881439|NCT00952731|Tamoxifen|tamoxifen|mesh-list
19881440|NCT00952731|Afimoxifene|afimoxifene|mesh-list
19881441|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20535985|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20535986|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20535987|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
20535988|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20535989|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20535990|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20535991|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535992|NCT01823159|Ezogabine|ezogabine|mesh-list
20535993|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
20535994|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20535995|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881442|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
19881443|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881444|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881445|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20535996|NCT01823172|Methylene Blue|methylene blue|mesh-list
20535997|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20535998|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553643|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20553644|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20553645|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20553646|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
20553647|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553648|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553649|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553650|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
20553651|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20553652|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20553653|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20553654|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553655|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553656|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20553657|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20553658|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553659|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
20553660|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553661|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20553662|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20553663|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20553664|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20553665|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553666|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20553667|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
20553668|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553669|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
20553670|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553671|NCT01930734|Dobutamine|dobutamine|mesh-list
20553672|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20553673|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
20553674|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
20553675|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553676|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553677|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20553678|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20553679|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20553680|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
20553681|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553682|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257319|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553683|NCT01930734|Protective Agents|protective agents|mesh-ancestor
20553684|NCT01930773|Clopidogrel|clopidogrel|mesh-list
20553685|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20553686|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20553687|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20553688|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20553689|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
20553690|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553691|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881446|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881447|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19881448|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19881449|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19881450|NCT00952822|Factor VIII|factor viii|mesh-list
19881451|NCT00952822|Coagulants|coagulants|mesh-ancestor
19881452|NCT00953017|Bisacodyl|bisacodyl|mesh-list
19881453|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19881454|NCT00953017|Lubiprostone|lubiprostone|mesh-list
19881455|NCT00953017|Cathartics|cathartics|mesh-ancestor
20257320|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
20257321|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257322|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20257323|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20257324|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20257325|NCT00479193|Bacitracin|bacitracin|mesh-list
20257326|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19881456|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19881457|NCT00953017|Laxatives|laxatives|mesh-ancestor
19881458|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19881459|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881460|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881461|NCT00953043|Lubiprostone|lubiprostone|mesh-list
19881462|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19881463|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881464|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881465|NCT00953056|Vaccines|vaccines|mesh-list
19881466|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
19881467|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881468|NCT00953121|Bevacizumab|bevacizumab|mesh-list
19881469|NCT00953121|Carboplatin|carboplatin|mesh-list
19881470|NCT00953121|Irinotecan|irinotecan|mesh-list
19881471|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19881472|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881473|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19881474|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19881475|NCT00953121|Growth Substances|growth substances|mesh-ancestor
19881476|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881477|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
19881478|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20535999|NCT01823185|Clopidogrel|clopidogrel|mesh-list
19881479|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19881480|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881481|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881482|NCT00953147|Ciclesonide|ciclesonide|mesh-list
19881483|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
19881484|NCT00953147|Hormones|hormones|mesh-ancestor
19881485|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881486|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881487|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19881488|NCT00953199|Lidocaine|lidocaine|mesh-list
19881489|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
19881490|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
19881491|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536000|NCT01823185|Ticagrelor|ticagrelor|mesh-list
20536001|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20536002|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20536003|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19881492|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881493|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
19881494|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881495|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19881496|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19881497|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19881498|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536004|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20536005|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20536006|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
20536007|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536008|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536009|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881499|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881500|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
19881501|NCT00953212|Amiodarone|amiodarone|mesh-list
19881502|NCT00953212|Metoprolol|metoprolol|mesh-list
19881503|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19881504|NCT00953212|Vitamins|vitamins|mesh-ancestor
19881505|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
19881506|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881507|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
19881508|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881509|NCT00953212|Protective Agents|protective agents|mesh-ancestor
19881510|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19881511|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
19881512|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19881513|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881514|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19881515|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19881516|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19881517|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881518|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19881519|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19881520|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19881521|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19881522|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
19881523|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881524|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19881525|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
19881526|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
19881527|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881528|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19881529|NCT00953225|Vitamin D|vitamin d|mesh-list
19881530|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
19881531|NCT00953225|Vitamins|vitamins|mesh-ancestor
19881532|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
19881533|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881534|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19881535|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19881536|NCT00953524|Vaccines|vaccines|mesh-list
19881537|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
19881538|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881539|NCT00953576|Ketoconazole|ketoconazole|mesh-list
19881540|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
19881541|NCT00953576|Lapatinib|lapatinib|mesh-list
19881542|NCT00953576|Dutasteride|dutasteride|mesh-list
19881543|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881544|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881545|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881546|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881547|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881548|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
19881549|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881550|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19881551|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19881552|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19881553|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
19881554|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881555|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881556|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19881557|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19881558|NCT00953667|Niacin|niacin|mesh-list
19881559|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19881560|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
19881561|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881562|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19881563|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
19881564|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
19881565|NCT00953667|Vitamins|vitamins|mesh-ancestor
19881566|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
19881567|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881568|NCT00953706|Ivacaftor|ivacaftor|mesh-list
19881569|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19881570|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881571|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881572|NCT00953745|Aripiprazole|aripiprazole|mesh-list
19881573|NCT00953745|Citalopram|citalopram|mesh-list
19881574|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19881575|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19881576|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881577|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881578|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881579|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
19881580|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881581|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19881582|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
19881583|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19881584|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19881585|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19881586|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881587|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
19881588|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
19881589|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19881590|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19881591|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19881592|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19881593|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19881594|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20257327|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881595|NCT00953849|Calcitriol|calcitriol|mesh-list
19881596|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19881597|NCT00953849|Vitamin D|vitamin d|mesh-list
19881598|NCT00953849|Celecoxib|celecoxib|mesh-list
19881599|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19881600|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19881601|NCT00953849|Analgesics|analgesics|mesh-ancestor
19881602|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
20257328|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20257329|NCT00479206|Artesunate|artesunate|mesh-list
19881603|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881604|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881605|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881606|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19881607|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19881608|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19881609|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881610|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881611|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19881612|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19881613|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881614|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19881615|NCT00953849|Vitamins|vitamins|mesh-ancestor
19881616|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
19881617|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19881618|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19881619|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19881620|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19881621|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881622|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881623|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
19881624|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881625|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881626|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19881627|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
19881628|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19881629|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19881630|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20257330|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
20257331|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20257332|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20257333|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257334|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257335|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
20257336|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
20257337|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20257338|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
20257339|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20257340|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
20257341|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286784|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20286785|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
20286786|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881631|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881632|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881633|NCT00954174|Paclitaxel|paclitaxel|mesh-list
19881634|NCT00954174|Carboplatin|carboplatin|mesh-list
19881635|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19881636|NCT00954174|Ifosfamide|ifosfamide|mesh-list
19881637|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
19881638|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19881639|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881640|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
19881641|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
19881642|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
19881643|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881644|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19881645|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
19881646|NCT00954447|Linagliptin|linagliptin|mesh-list
19881647|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19881648|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881649|NCT00954447|Incretins|incretins|mesh-ancestor
19881650|NCT00954447|Hormones|hormones|mesh-ancestor
19881651|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881652|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19881653|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
19881654|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881655|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257342|NCT00479362|Aspirin|aspirin|mesh-list
20257343|NCT00479362|Warfarin|warfarin|mesh-list
19881656|NCT00954512|Leucovorin|leucovorin|mesh-list
19881657|NCT00954512|Folic Acid|folic acid|mesh-list
19881658|NCT00954512|Gemcitabine|gemcitabine|mesh-list
19881659|NCT00954512|Carboplatin|carboplatin|mesh-list
19881660|NCT00954512|Trastuzumab|trastuzumab|mesh-list
19881661|NCT00954512|Irinotecan|irinotecan|mesh-list
19881662|NCT00954512|Cetuximab|cetuximab|mesh-list
20257344|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20257345|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20257346|NCT00479362|Analgesics|analgesics|mesh-ancestor
20257347|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
19881663|NCT00954512|Everolimus|everolimus|mesh-list
19881664|NCT00954512|Epirubicin|epirubicin|mesh-list
19881665|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
19881666|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881667|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881668|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19881669|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
19881670|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
19881671|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881672|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881673|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257348|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257349|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257350|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257351|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257352|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20257353|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20257354|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257355|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20257356|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20257357|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257358|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
20257359|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
20257360|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
20257361|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
20257362|NCT00479479|Vitamins|vitamins|mesh-ancestor
20257363|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
20257364|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257365|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
20257366|NCT00479479|Hematinics|hematinics|mesh-ancestor
20257367|NCT00479609|Testosterone|testosterone|mesh-list
20257368|NCT00479609|Androgens|androgens|mesh-ancestor
20257369|NCT00479609|Hormones|hormones|mesh-ancestor
19881674|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
19881675|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257370|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257371|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257372|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
19881676|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19881677|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19881678|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19881679|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19881680|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19881681|NCT00954512|Antidotes|antidotes|mesh-ancestor
19881682|NCT00954512|Protective Agents|protective agents|mesh-ancestor
19881683|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
19881684|NCT00954512|Vitamins|vitamins|mesh-ancestor
19881685|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
19881686|NCT00954512|Hematinics|hematinics|mesh-ancestor
19881687|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19881688|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
19881689|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19881690|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19881691|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19881692|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881693|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881694|NCT00954707|Aspirin|aspirin|mesh-list
19881695|NCT00954707|Clopidogrel|clopidogrel|mesh-list
19881696|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19881697|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19881698|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19881699|NCT00954707|Analgesics|analgesics|mesh-ancestor
19881700|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
19881701|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881702|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881703|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881704|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19881705|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19881706|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19881707|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536033|NCT01823393|Heparin|heparin|mesh-list
19881708|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19881709|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19881710|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881711|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
19881712|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19881713|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19881714|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19881715|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
19881716|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881717|NCT00954941|Ondansetron|ondansetron|mesh-list
19881718|NCT00954941|Aprepitant|aprepitant|mesh-list
19881719|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
19881720|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
19881721|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881722|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881723|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19881724|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
19881725|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
20257373|NCT00479661|Propofol|propofol|mesh-list
20257374|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20257375|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257376|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257377|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20257378|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
20257379|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
20257380|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20257381|NCT00479661|Analgesics|analgesics|mesh-ancestor
20257382|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
20257383|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257384|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20257385|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20257386|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20257387|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
20257388|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257389|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881726|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19881727|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
19881728|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536034|NCT01823393|Calcium heparin|calcium heparin|mesh-list
19881729|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881730|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19881731|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19881732|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881733|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19881734|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19881735|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19881736|NCT00955110|Oxymorphone|oxymorphone|mesh-list
19881737|NCT00955110|Oxycodone|oxycodone|mesh-list
19881738|NCT00955110|Hydromorphone|hydromorphone|mesh-list
19881739|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19881740|NCT00955110|Narcotics|narcotics|mesh-ancestor
19881741|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881742|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881743|NCT00955110|Analgesics|analgesics|mesh-ancestor
19881744|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
19881745|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881746|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19881747|NCT00955253|Guanfacine|guanfacine|mesh-list
19881748|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19881749|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19881750|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19881751|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19881752|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
20536035|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
20536036|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20536037|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20536038|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536039|NCT01823523|Clindamycin|clindamycin|mesh-list
20536040|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
20536041|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
20536042|NCT01823523|Cefazolin|cefazolin|mesh-list
20536043|NCT01823523|Cephalexin|cephalexin|mesh-list
20536044|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20536045|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536046|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20536047|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536048|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536049|NCT01823744|Micronutrients|micronutrients|mesh-list
20536050|NCT01823744|Trace Elements|trace elements|mesh-list
20536051|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536052|NCT01823770|Rotigotine|rotigotine|mesh-list
20536053|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
20536054|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
20536055|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536056|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536057|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536058|NCT01823809|Adenosine|adenosine|mesh-list
19881753|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881754|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881755|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881756|NCT00955266|Calcium|calcium|mesh-list
19881757|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19881758|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881759|NCT00955279|Golimumab|golimumab|mesh-list
19881760|NCT00955279|Ustekinumab|ustekinumab|mesh-list
19881761|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
19881762|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19881763|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881764|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881765|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
19881766|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881767|NCT00955305|Paclitaxel|paclitaxel|mesh-list
19881768|NCT00955305|Bevacizumab|bevacizumab|mesh-list
19881769|NCT00955305|Carboplatin|carboplatin|mesh-list
19881770|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19881771|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881772|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
19881773|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
19881774|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
19881775|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881776|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19881777|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20536059|NCT01823809|Analgesics|analgesics|mesh-ancestor
20536060|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
19881778|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19881779|NCT00955305|Growth Substances|growth substances|mesh-ancestor
19881780|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881781|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
19881782|NCT00955357|Lacosamide|lacosamide|mesh-list
19881783|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
19881784|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19881785|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19881786|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881787|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881788|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
19881789|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19881790|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
19881791|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881792|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19881793|NCT00955474|Citalopram|citalopram|mesh-list
19881794|NCT00955474|Sertraline|sertraline|mesh-list
19881795|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19881796|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19881797|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881798|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881799|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881800|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
19881801|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881802|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19881803|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
19881804|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19881805|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19881806|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19881807|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881808|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
19881809|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19881810|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
19881811|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881812|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881813|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19881814|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
19881815|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19881816|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
19881817|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881818|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881819|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19881820|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
19881821|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
19881822|NCT00955487|Protective Agents|protective agents|mesh-ancestor
19881823|NCT00955513|Diclofenac|diclofenac|mesh-list
19881824|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19881825|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19881826|NCT00955513|Analgesics|analgesics|mesh-ancestor
19881827|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
19881828|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881829|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881830|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19881831|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19881832|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19881833|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881834|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881835|NCT00955721|Gemcitabine|gemcitabine|mesh-list
19881836|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
19881837|NCT00955721|Sorafenib|sorafenib|mesh-list
19881838|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19881839|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
20536061|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536062|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536063|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20536064|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
20536065|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20536066|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
20536067|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
19881840|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881841|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881842|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
19881843|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881844|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881845|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881846|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
19881847|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881848|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881849|NCT00955747|Tagatose|tagatose|mesh-list
19881850|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19881851|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
19881852|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
19881853|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881854|NCT00955877|Morphine|morphine|mesh-list
19881855|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19881856|NCT00955877|Narcotics|narcotics|mesh-ancestor
19881857|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881858|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881859|NCT00955877|Analgesics|analgesics|mesh-ancestor
19881860|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
19881861|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881862|NCT00955916|Cytarabine|cytarabine|mesh-list
19881863|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
19881864|NCT00955916|Cladribine|cladribine|mesh-list
19881865|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19881866|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
19881867|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881868|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881869|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
19881870|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881871|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881872|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
19881873|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881874|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19881875|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881876|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19881877|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
19881878|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881879|NCT00956085|Memantine|memantine|mesh-list
19881880|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19881881|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19881882|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
19881883|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881884|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881885|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881886|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19881887|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19881888|NCT00956254|Fentanyl|fentanyl|mesh-list
19881889|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19881890|NCT00956254|Narcotics|narcotics|mesh-ancestor
19881891|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881892|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881893|NCT00956254|Analgesics|analgesics|mesh-ancestor
19881894|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
19881895|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881896|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19881897|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19881898|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
19881899|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
19881900|NCT00956293|Cyclosporine|cyclosporine|mesh-list
19881901|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
19881902|NCT00956293|Everolimus|everolimus|mesh-list
19881903|NCT00956293|Cyclosporins|cyclosporins|mesh-list
19881904|NCT00956293|Basiliximab|basiliximab|mesh-list
19881905|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881906|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881907|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19881908|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
19881909|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881910|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
19881911|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19881912|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
19881913|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19881914|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19881915|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881916|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19881917|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19881918|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
19881919|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19881920|NCT00956709|Ropivacaine|ropivacaine|mesh-list
19881921|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
19881922|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
19881923|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
19881924|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881925|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881926|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
19881927|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881928|NCT00956839|Vitamin D|vitamin d|mesh-list
19881929|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
19881930|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
19881931|NCT00956839|Vitamins|vitamins|mesh-list
19881932|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
19881933|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881934|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19881935|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19881936|NCT00956930|Doxorubicin|doxorubicin|mesh-list
19881937|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19881938|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19881939|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19881940|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19881941|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19881942|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881943|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881944|NCT00956943|Nicotine|nicotine|mesh-list
19881945|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19881946|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
19881947|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881948|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881949|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19881950|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19881951|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
19881952|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881953|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881954|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19881955|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
19881956|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19881957|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19881958|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19881959|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881960|NCT00957242|Warfarin|warfarin|mesh-list
19881961|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
19881962|NCT00957268|Alogliptin|alogliptin|mesh-list
19881963|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19881964|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881965|NCT00957268|Incretins|incretins|mesh-ancestor
19881966|NCT00957268|Hormones|hormones|mesh-ancestor
19881967|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19881968|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19881969|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
19881970|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19881971|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881972|NCT00957333|Ketamine|ketamine|mesh-list
19881973|NCT00957333|Analgesics|analgesics|mesh-ancestor
19881974|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
19881975|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19881976|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881977|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19881978|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19881979|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
19881980|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
19881981|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19881982|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19881983|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19881984|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19881985|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970549|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19970550|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
20257390|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20257391|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20257392|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19881986|NCT00957359|Niacin|niacin|mesh-list
19881987|NCT00957359|Psilocybin|psilocybin|mesh-list
19881988|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
19881989|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19881990|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
19881991|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19881992|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19881993|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
19881994|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
19881995|NCT00957359|Vitamins|vitamins|mesh-ancestor
19881996|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
19881997|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19881998|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
19881999|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882000|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19882001|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
19882002|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882003|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19882004|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19882005|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
19882006|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19882007|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19882008|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882009|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882010|NCT00957424|Nicotine|nicotine|mesh-list
19882011|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19882012|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
19882013|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882014|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882015|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19882016|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19882017|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
19882018|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882019|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882020|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
19882021|NCT00957528|Testosterone|testosterone|mesh-list
19882022|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
19882023|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
19882024|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19882025|NCT00957528|Androgens|androgens|mesh-ancestor
19882026|NCT00957528|Hormones|hormones|mesh-ancestor
19882027|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882028|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882029|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19882030|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882031|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
19882032|NCT00957580|Niacinamide|niacinamide|mesh-list
19882033|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
20536068|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536069|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536070|NCT01823848|Mineral Oil|mineral oil|mesh-list
20536071|NCT01823848|Emollients|emollients|mesh-ancestor
20536072|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
20536073|NCT01823965|Ranibizumab|ranibizumab|mesh-list
20536074|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20536075|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19882034|NCT00957580|Vitamins|vitamins|mesh-ancestor
19882035|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
19882036|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882037|NCT00957593|Oxytocin|oxytocin|mesh-list
19882038|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
19882039|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19882040|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882041|NCT00957671|Hormones|hormones|mesh-list
19882042|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882043|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882044|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19882045|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
19882046|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19882047|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19882048|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882049|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882050|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
19882051|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19882052|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19882053|NCT00957801|Prednisolone|prednisolone|mesh-list
19882054|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
19882055|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
19882056|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19882057|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
19882058|NCT00957801|Testosterone|testosterone|mesh-list
19882059|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
19882060|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
19882061|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19882062|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882063|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
19882064|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
19882065|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882066|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882067|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19882068|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
19882069|NCT00957801|Hormones|hormones|mesh-ancestor
19882070|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882071|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19882072|NCT00957801|Protective Agents|protective agents|mesh-ancestor
19882073|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19882074|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882075|NCT00957801|Androgens|androgens|mesh-ancestor
19882076|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
19882077|NCT00957853|Cetuximab|cetuximab|mesh-list
19882078|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19882079|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882080|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
19882081|NCT00957905|Leucovorin|leucovorin|mesh-list
19882082|NCT00957905|Folic Acid|folic acid|mesh-list
19882083|NCT00957905|Fluorouracil|fluorouracil|mesh-list
19882084|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
20536076|NCT01823965|Growth Substances|growth substances|mesh-ancestor
20536077|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536078|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
20536079|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536080|NCT01824043|Ranibizumab|ranibizumab|mesh-list
19882085|NCT00957905|Alvocidib|alvocidib|mesh-list
19882086|NCT00957905|Calcium|calcium|mesh-list
19882087|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
19882088|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19882089|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882090|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19882091|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
19882092|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882093|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19882094|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882095|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882096|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
19882097|NCT00957905|Antidotes|antidotes|mesh-ancestor
19882098|NCT00957905|Protective Agents|protective agents|mesh-ancestor
19882099|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
19882100|NCT00957905|Vitamins|vitamins|mesh-ancestor
19882101|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
19882102|NCT00957905|Hematinics|hematinics|mesh-ancestor
19882103|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
20536081|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20536082|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20536083|NCT01824043|Growth Substances|growth substances|mesh-ancestor
20536084|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882104|NCT00957905|Growth Substances|growth substances|mesh-ancestor
19882105|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19882106|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882107|NCT00957944|Rotigotine|rotigotine|mesh-list
19882108|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
19882109|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
19882110|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882111|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882112|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882113|NCT00957996|Peramivir|peramivir|mesh-list
19882114|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
20536085|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
19882115|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882116|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536086|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882117|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882118|NCT00958035|Bimatoprost|bimatoprost|mesh-list
19882119|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19882120|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19882121|NCT00958074|Vorinostat|vorinostat|mesh-list
19882122|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882123|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19882124|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882125|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882126|NCT00958243|Vaccines|vaccines|mesh-list
19882127|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
19882128|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882129|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
19882130|NCT00958256|Rituximab|rituximab|mesh-list
19882131|NCT00958256|Bortezomib|bortezomib|mesh-list
19882132|NCT00958256|Sargramostim|sargramostim|mesh-list
19882133|NCT00958256|Lenograstim|lenograstim|mesh-list
19882134|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882135|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
19882136|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882137|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882138|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19882139|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
19882140|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882141|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882142|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19882143|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19882144|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19882145|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19882146|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19882147|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882148|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19882149|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882150|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882151|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882152|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
19882153|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882154|NCT00958438|Rilonacept|rilonacept|mesh-list
19882155|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882156|NCT00958568|Olanzapine|olanzapine|mesh-list
19882157|NCT00958568|Fluoxetine|fluoxetine|mesh-list
19882158|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
19882159|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
19882160|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882161|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882162|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19882163|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19882164|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19882165|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19882166|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882167|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19882168|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882169|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882170|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882171|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882172|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
19882173|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19882174|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
19882175|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19882176|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19882177|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882178|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
19882179|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
19882180|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19882181|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19882182|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882183|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
19882184|NCT00958581|Coagulants|coagulants|mesh-ancestor
19882185|NCT00958724|Vinorelbine|vinorelbine|mesh-list
19882186|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19882187|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882188|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
20257393|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882189|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
19882190|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
19882191|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882192|NCT00958776|Peramivir|peramivir|mesh-list
19882193|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
19882194|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882195|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882196|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882197|NCT00958841|Pasireotide|pasireotide|mesh-list
20257394|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257395|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257396|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257397|NCT00479726|Analgesics|analgesics|mesh-ancestor
20257398|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
20257399|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257400|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
20257401|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20257402|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
20257403|NCT00479739|Fluticasone|fluticasone|mesh-list
20257404|NCT00479739|Xhance|xhance|mesh-list
20257405|NCT00479739|Budesonide|budesonide|mesh-list
20257406|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
20257407|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20257408|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257409|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20257410|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
19449613|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19449614|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449615|NCT03433976|Anesthetics|anesthetics|mesh-list
19449616|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449617|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449618|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19449619|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19449620|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19449621|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449622|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257411|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257412|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882198|NCT00958841|Hormones|hormones|mesh-ancestor
19882199|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882200|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882201|NCT00958880|Yohimbine|yohimbine|mesh-list
19882202|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
19882203|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
19882204|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882205|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882206|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19882207|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19882208|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19882209|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
19882210|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882211|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882212|NCT00958880|Urological Agents|urological agents|mesh-ancestor
19882213|NCT00958919|Naloxone|naloxone|mesh-list
19882214|NCT00958919|Endorphins|endorphins|mesh-list
19882215|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19882216|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882217|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
19970551|NCT01785186|Vitamins|vitamins|mesh-ancestor
20257413|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19735683|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
19735684|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
19735685|NCT04536922|Fludarabine|fludarabine|mesh-list
19735686|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19735687|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
19735688|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735689|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735690|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19735691|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
19735692|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735693|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736029|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
19882218|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882219|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882220|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882221|NCT00959049|Vaccines|vaccines|mesh-list
19882222|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
19882223|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882224|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
19882225|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20536087|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20536088|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20536089|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536090|NCT01824199|Omeprazole|omeprazole|mesh-list
20536091|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20536092|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20536093|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20536094|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536095|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536096|NCT01824225|Aflibercept|aflibercept|mesh-list
19882226|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
19882227|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882228|NCT00959647|Bevacizumab|bevacizumab|mesh-list
19882229|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19882230|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882231|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19882232|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19882233|NCT00959647|Growth Substances|growth substances|mesh-ancestor
19882234|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882235|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
19882236|NCT00959699|Interferons|interferons|mesh-list
19882237|NCT00959699|Ribavirin|ribavirin|mesh-list
19882238|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
19882239|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
19882240|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19882241|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882242|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
19882243|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882244|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
19882245|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882246|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
19882247|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882248|NCT00959764|Calcitonin|calcitonin|mesh-list
19882249|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
19882250|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19882251|NCT00959764|Katacalcin|katacalcin|mesh-list
19882252|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20257414|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
20257415|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
20257416|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20257417|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
20257418|NCT00479739|Hormones|hormones|mesh-ancestor
20257419|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257420|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20536097|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19882253|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882254|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19882255|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
19882256|NCT00959894|Tenofovir|tenofovir|mesh-list
19882257|NCT00959894|Emtricitabine|emtricitabine|mesh-list
19882258|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19882259|NCT00959894|Etravirine|etravirine|mesh-list
19882260|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
19882261|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882262|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19882263|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20536098|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20536099|NCT01824225|Growth Substances|growth substances|mesh-ancestor
20536100|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536101|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
20536102|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536103|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
20536104|NCT01824238|Anacetrapib|anacetrapib|mesh-list
20536105|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20536106|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20536107|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
19882264|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882265|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882266|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19882267|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19882268|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
19882269|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19882270|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19882271|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19882272|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19882273|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882274|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882275|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
19882276|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882277|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882278|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19882279|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536108|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536109|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20536110|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882280|NCT00959946|Capecitabine|capecitabine|mesh-list
19882281|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19882282|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
19882283|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882284|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882285|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
20257421|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20257422|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20257423|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
19882286|NCT00960063|Temozolomide|temozolomide|mesh-list
19882287|NCT00960063|Ifosfamide|ifosfamide|mesh-list
19882288|NCT00960063|Doxorubicin|doxorubicin|mesh-list
19882289|NCT00960063|Irinotecan|irinotecan|mesh-list
19882290|NCT00960063|Etoposide|etoposide|mesh-list
19882291|NCT00960063|Vincristine|vincristine|mesh-list
19882292|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882293|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
19882294|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882295|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882296|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19882297|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
19882298|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882299|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882300|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19882301|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19882302|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19882303|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19882304|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882305|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19882306|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19882307|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19882308|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19882309|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19882310|NCT00960076|Metformin|metformin|mesh-list
19882311|NCT00960076|Saxagliptin|saxagliptin|mesh-list
19882312|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19882313|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536111|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19882314|NCT00960076|Incretins|incretins|mesh-ancestor
19882315|NCT00960076|Hormones|hormones|mesh-ancestor
19882316|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882317|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19882318|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
19882319|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882320|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882321|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
19882322|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
19882323|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882324|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882325|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882326|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19882327|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
19882328|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882329|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882330|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19882331|NCT00960193|Colchicine|colchicine|mesh-list
19882332|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
19882333|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882334|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
19882335|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
19882336|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
19882337|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882338|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882339|NCT00960323|Colchicine|colchicine|mesh-list
19882340|NCT00960323|Atorvastatin|atorvastatin|mesh-list
19882341|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19882342|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19882343|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
19882344|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882345|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882346|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19882347|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882348|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
19882349|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882350|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
19882351|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
19882352|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
19882353|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882354|NCT00960440|Tofacitinib|tofacitinib|mesh-list
19882355|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19882356|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882357|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257424|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257425|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257426|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
19882358|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
19882359|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19882360|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
19882361|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882362|NCT00960570|Efavirenz|efavirenz|mesh-list
19882363|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
19882364|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19882365|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19882366|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882367|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882368|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
19882369|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882370|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19882371|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19882372|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19882373|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19882374|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19882375|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19882376|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19882377|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19882378|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
19882379|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882380|NCT00960622|Tenofovir|tenofovir|mesh-list
19882381|NCT00960622|Lamivudine|lamivudine|mesh-list
19882382|NCT00960622|Zidovudine|zidovudine|mesh-list
19882383|NCT00960622|Emtricitabine|emtricitabine|mesh-list
20257427|NCT00479752|Cetuximab|cetuximab|mesh-list
20257428|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536112|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536113|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
20536114|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20536115|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
19882384|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19882385|NCT00960622|Abacavir|abacavir|mesh-list
19882386|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
19882387|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19882388|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
19882389|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882390|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19882391|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19882392|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882393|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882394|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19882395|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19882396|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
20536116|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20536117|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
20536118|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882397|NCT00960661|Insulin|insulin|mesh-list
19882398|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19882399|NCT00960661|Metformin|metformin|mesh-list
20536119|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20536120|NCT01824264|Licogliflozin|licogliflozin|mesh-list
20536121|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20536122|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536123|NCT01824264|Incretins|incretins|mesh-ancestor
20536124|NCT01824264|Hormones|hormones|mesh-ancestor
19882400|NCT00960661|Exenatide|exenatide|mesh-list
19882401|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
19882402|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19882403|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882404|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19882405|NCT00960661|Incretins|incretins|mesh-ancestor
19882406|NCT00960661|Hormones|hormones|mesh-ancestor
19882407|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882408|NCT00960687|Fenofibrate|fenofibrate|mesh-list
19882409|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
19882410|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19882411|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
19882412|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882413|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882414|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19882415|NCT00960778|Nicotine|nicotine|mesh-list
19882416|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19882417|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
19882418|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882419|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882420|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19882421|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19882422|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
19882423|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882424|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882425|NCT00960804|Tanezumab|tanezumab|mesh-list
19882426|NCT00960804|Analgesics|analgesics|mesh-ancestor
20553692|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553693|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
20553694|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20553695|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20553696|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20553697|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20553698|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882427|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
19882428|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882429|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882430|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
19882431|NCT00960856|Fenofibrate|fenofibrate|mesh-list
19882432|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19882433|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19882434|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
19882435|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882436|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882437|NCT00960869|Aspirin|aspirin|mesh-list
20257429|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20257430|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
20257431|NCT00479778|Estrogens|estrogens|mesh-list
20257432|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20257433|NCT00479778|Hormones|hormones|mesh-ancestor
20257434|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882438|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19882439|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19882440|NCT00960869|Analgesics|analgesics|mesh-ancestor
19882441|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
19882442|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882443|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882444|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882445|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882446|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19882447|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19882448|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882449|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19882450|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19882451|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882452|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
19882453|NCT00960934|Vitamin D|vitamin d|mesh-list
19882454|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
19882455|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
19882456|NCT00960934|Calcium|calcium|mesh-list
19882457|NCT00960934|Vitamins|vitamins|mesh-ancestor
19882458|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
19882459|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882460|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19882461|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19882462|NCT00960934|Antacids|antacids|mesh-ancestor
19882463|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882464|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19882465|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19882466|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19882467|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882468|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882469|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882470|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882471|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882472|NCT00960986|Analgesics|analgesics|mesh-ancestor
19882473|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
19882474|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882475|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
19882476|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882477|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
19882478|NCT00961116|Fenofibrate|fenofibrate|mesh-list
19882479|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
19882480|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20257435|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882481|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
19970552|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
20257436|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20257437|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19882482|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882483|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882484|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19882485|NCT00961181|Paclitaxel|paclitaxel|mesh-list
19882486|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19882487|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882488|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
19882489|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
19882490|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
19882491|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882492|NCT00961220|Carmustine|carmustine|mesh-list
19882493|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
19882494|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19882495|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
19882496|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882497|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882498|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882499|NCT00961233|Budesonide|budesonide|mesh-list
19882500|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882501|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19882502|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
19882503|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882504|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882505|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19882506|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
19882507|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
19882508|NCT00961233|Hormones|hormones|mesh-ancestor
19882509|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882510|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
19882511|NCT00961259|Fenofibrate|fenofibrate|mesh-list
20536125|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536126|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19882512|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19882513|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19882514|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
19882515|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882516|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882517|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19882518|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19882519|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20536127|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
20536128|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536129|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536130|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19882520|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882521|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882522|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882523|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882524|NCT00961298|Analgesics|analgesics|mesh-ancestor
19882525|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
19882526|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882527|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
19882528|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882529|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
19882530|NCT00961350|Aspirin|aspirin|mesh-list
19882531|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19882532|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19882533|NCT00961350|Analgesics|analgesics|mesh-ancestor
19882534|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
19882535|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882536|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882537|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882538|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882539|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19882540|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19882541|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882542|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19882543|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19882544|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882545|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
19882546|NCT00961415|Bevacizumab|bevacizumab|mesh-list
19882547|NCT00961415|Pemetrexed|pemetrexed|mesh-list
19882548|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19882549|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882550|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19882551|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19882552|NCT00961415|Growth Substances|growth substances|mesh-ancestor
19882553|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882554|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
19882555|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882556|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882557|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19882558|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19882559|NCT00961441|Levetiracetam|levetiracetam|mesh-list
19882560|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
19882561|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
19882562|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19882563|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
19882564|NCT00961532|Coagulants|coagulants|mesh-ancestor
19882565|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19882566|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
19882567|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882568|NCT00961571|Capecitabine|capecitabine|mesh-list
19882569|NCT00961571|Sunitinib|sunitinib|mesh-list
19882570|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19882571|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
19882572|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882573|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882574|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19882575|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19882576|NCT00961571|Growth Substances|growth substances|mesh-ancestor
19882577|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882578|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
19882579|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19882580|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882581|NCT00961636|Niacin|niacin|mesh-list
19882582|NCT00961636|Niacinamide|niacinamide|mesh-list
19882583|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
20536131|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
20536132|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20536133|NCT01824420|Oxybutynin|oxybutynin|mesh-list
20536134|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20536135|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20536136|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
20536137|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536138|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536139|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882584|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19882585|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
19882586|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882587|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882588|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
19882589|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
19882590|NCT00961636|Vitamins|vitamins|mesh-ancestor
19882591|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
19882592|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882593|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19882594|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19882595|NCT00961649|Brinzolamide|brinzolamide|mesh-list
19882596|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19882597|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19882598|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19882599|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19882600|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19882601|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
19882602|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882603|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882604|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882605|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19882606|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536140|NCT01824420|Urological Agents|urological agents|mesh-ancestor
20536141|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
20536142|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
20536143|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536144|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19882607|NCT00961662|Tagatose|tagatose|mesh-list
19882608|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19882609|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
19882610|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
19882611|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882612|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
19882613|NCT00961961|Fluoxetine|fluoxetine|mesh-list
19882614|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19882615|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882616|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882617|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882618|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882619|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
19882620|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882621|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19882622|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
19882623|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882624|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19882625|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19882626|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882627|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
19882628|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19882629|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19970553|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
19970554|NCT01785459|Bupivacaine|bupivacaine|mesh-list
19970555|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
19970556|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
19970557|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19970558|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970559|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
19970560|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970561|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
19970562|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
19970563|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19970564|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19970565|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19970566|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19970567|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19970568|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
19970569|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970570|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970571|NCT01785472|Olmesartan|olmesartan|mesh-list
19970572|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19970573|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20536145|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536146|NCT01824420|Renal Agents|renal agents|mesh-ancestor
20536147|NCT01824433|Fluoxetine|fluoxetine|mesh-list
20536148|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20536149|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20536150|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20536151|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20257438|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
20257439|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20257440|NCT00479895|HBOC 201|hboc 201|mesh-list
19970574|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19970575|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19970576|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19970577|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970578|NCT01785615|Atorvastatin|atorvastatin|mesh-list
19970579|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19970580|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19970581|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
20257441|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
20257442|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
20257443|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
20257444|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882630|NCT00962039|Citalopram|citalopram|mesh-list
19882631|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19882632|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882633|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882634|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882635|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882636|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
19882637|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882638|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19882639|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
19882640|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882641|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19882642|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19882643|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882644|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19882645|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882646|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19882647|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19882648|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882649|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882650|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882651|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
19882652|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882653|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882654|NCT00962390|Equol|equol|mesh-list
19882655|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
19882656|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19882657|NCT00962390|Estrogens|estrogens|mesh-ancestor
19882658|NCT00962390|Hormones|hormones|mesh-ancestor
19882659|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882660|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882661|NCT00962585|Equol|equol|mesh-list
19882662|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
19882663|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19882664|NCT00962585|Estrogens|estrogens|mesh-ancestor
19882665|NCT00962585|Hormones|hormones|mesh-ancestor
19882666|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882667|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882668|NCT00962741|Etanercept|etanercept|mesh-list
19882669|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19882670|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19882671|NCT00962741|Analgesics|analgesics|mesh-ancestor
19882672|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
19882673|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882674|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882675|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882676|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882677|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19882678|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882679|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
19882680|NCT00962780|Vaccines|vaccines|mesh-list
19882681|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19882682|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
19882683|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882684|NCT00962871|Tenofovir|tenofovir|mesh-list
19882685|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19882686|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
19882687|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882688|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19882689|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19882690|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882691|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882692|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19882693|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19882694|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
19882695|NCT00962949|Giapreza|giapreza|mesh-list
19882696|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
19882697|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19882698|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19882699|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
19882700|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882701|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882702|NCT00963105|Lenalidomide|lenalidomide|mesh-list
19882703|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
19882704|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882705|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19882706|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19882707|NCT00963105|Growth Substances|growth substances|mesh-ancestor
19882708|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
19882709|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882710|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19882711|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
19882712|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882713|NCT00963508|Permethrin|permethrin|mesh-list
19882714|NCT00963508|Malathion|malathion|mesh-list
19882715|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882716|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882717|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19882718|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
19882719|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882720|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882721|NCT00963547|Trastuzumab|trastuzumab|mesh-list
19882722|NCT00963547|Lapatinib|lapatinib|mesh-list
19882723|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19882724|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882725|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19882726|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882727|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882728|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
19882729|NCT00963807|Alovudine|alovudine|mesh-list
19882730|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
19882731|NCT00963807|Cisplatin|cisplatin|mesh-list
19882732|NCT00963807|Docetaxel|docetaxel|mesh-list
19882733|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19882734|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882735|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
19882736|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
19882737|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
19882738|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882739|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19882740|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
19882741|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
19882742|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882743|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19882744|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19882745|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882746|NCT00963820|Ixazomib|ixazomib|mesh-list
19882747|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882748|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882749|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
19882750|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882751|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
19882752|NCT00963872|Fludarabine|fludarabine|mesh-list
19882753|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
19882754|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882755|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
19882756|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882757|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882758|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19882759|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
19882760|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882761|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882762|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19882763|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19882764|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
19882765|NCT00963924|Cycloserine|cycloserine|mesh-list
19882766|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19882767|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882768|NCT00963924|Renal Agents|renal agents|mesh-ancestor
19882769|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19882770|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
19882771|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19882772|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
19882773|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882774|NCT00963937|Sumatriptan|sumatriptan|mesh-list
20257445|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
20257446|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19882775|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19882776|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19882777|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19882778|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
19882779|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882780|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882781|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882782|NCT00964223|Clindamycin|clindamycin|mesh-list
19882783|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
19882784|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
19882785|NCT00964223|Adapalene|adapalene|mesh-list
19882786|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19882787|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19882788|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19882789|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882790|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19882791|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882792|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882793|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
19882794|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19882795|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19882796|NCT00964223|Analgesics|analgesics|mesh-ancestor
19882797|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
19882798|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882799|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882800|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882801|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882802|NCT00964353|Warfarin|warfarin|mesh-list
19882803|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
19882804|NCT00964366|Clindamycin|clindamycin|mesh-list
19882805|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
19882806|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
19882807|NCT00964366|Dapsone|dapsone|mesh-list
19882808|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19882809|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19882810|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882811|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19882812|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882813|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882814|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
19882815|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
19882816|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19882817|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19882818|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19882819|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
19882820|NCT00964431|Celecoxib|celecoxib|mesh-list
19882821|NCT00964431|Indomethacin|indomethacin|mesh-list
19882822|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19882823|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19882824|NCT00964431|Analgesics|analgesics|mesh-ancestor
19882825|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
19882826|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882827|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882828|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19882829|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19882830|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19882831|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19882832|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882833|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882834|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
19882835|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
19882836|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19882837|NCT00964496|Thalidomide|thalidomide|mesh-list
19882838|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
19882839|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882840|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
19882841|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882842|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
19882843|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19882844|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882845|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19882846|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19882847|NCT00964496|Growth Substances|growth substances|mesh-ancestor
19882848|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
19882849|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882850|NCT00964496|Hematinics|hematinics|mesh-ancestor
19882851|NCT00964548|Dantrolene|dantrolene|mesh-list
19882852|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19882853|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882854|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19882855|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882856|NCT00964678|Carvedilol|carvedilol|mesh-list
19882857|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19882858|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19882859|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
19882860|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882861|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882862|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882863|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19882864|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
19882865|NCT00964678|Protective Agents|protective agents|mesh-ancestor
19882866|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19882867|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882868|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19882869|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
19882870|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19882871|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19882872|NCT00964743|Cytarabine|cytarabine|mesh-list
19882873|NCT00964743|Sorafenib|sorafenib|mesh-list
19882874|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19882875|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
19882876|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882877|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882878|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
19882879|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882880|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882881|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
19882882|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882883|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19882884|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882885|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
19882886|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
19882887|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19882888|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19882889|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882890|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882891|NCT00964782|Urological Agents|urological agents|mesh-ancestor
19882892|NCT00964795|Aflibercept|aflibercept|mesh-list
19882893|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19882894|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19882895|NCT00964795|Growth Substances|growth substances|mesh-ancestor
19882896|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882897|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19882898|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882899|NCT00964886|Benztropine|benztropine|mesh-list
19882900|NCT00964886|Desipramine|desipramine|mesh-list
19882901|NCT00964886|Clomipramine|clomipramine|mesh-list
19882902|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19882903|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
19882904|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882905|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882906|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882907|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19882908|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882909|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882910|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
19882911|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882912|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882913|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19882914|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19882915|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
19882916|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
19882917|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882918|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19882919|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19882920|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
19882921|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19882922|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
19882923|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19882924|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
19882925|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19882926|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19882927|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882928|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882929|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882930|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882931|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882932|NCT00965081|Analgesics|analgesics|mesh-ancestor
19882933|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
19882934|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882935|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
19882936|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19882937|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
19882938|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
19882939|NCT00965094|Everolimus|everolimus|mesh-list
19882940|NCT00965094|Tacrolimus|tacrolimus|mesh-list
19882941|NCT00965094|Basiliximab|basiliximab|mesh-list
19882942|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19882943|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
19882944|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882945|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19882946|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882947|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882948|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882949|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19882950|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19882951|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
19882952|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19882953|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19882954|NCT00965185|Atorvastatin|atorvastatin|mesh-list
19882955|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19882956|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19882957|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
19882958|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882959|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19882960|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19882961|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19882962|NCT00965263|Cocaine|cocaine|mesh-list
19882963|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
19882964|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
19882965|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19882966|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882967|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
19882968|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19882969|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19882970|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19882971|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882972|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882973|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882974|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
19882975|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882976|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
19882977|NCT00965341|Testosterone|testosterone|mesh-list
19882978|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
19882979|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
19882980|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19882981|NCT00965341|Androgens|androgens|mesh-ancestor
19882982|NCT00965341|Hormones|hormones|mesh-ancestor
19882983|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19882984|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882985|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19882986|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19882987|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
19882988|NCT00965458|Alefacept|alefacept|mesh-list
19882989|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
19882990|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
19882991|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19882992|NCT00965497|Citalopram|citalopram|mesh-list
19882993|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19882994|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19882995|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19882996|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19882997|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19882998|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
19882999|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883000|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19883001|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
19883002|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883003|NCT00965562|Fluoxetine|fluoxetine|mesh-list
19883004|NCT00965562|Calcium|calcium|mesh-list
19883005|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19883006|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883007|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19883008|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19883009|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19883010|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883011|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883012|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
19883013|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19883014|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
19883015|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883016|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19883017|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19883018|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883019|NCT00965575|Melatonin|melatonin|mesh-list
19883020|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
19883021|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883022|NCT00965575|Protective Agents|protective agents|mesh-ancestor
19883023|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883024|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883025|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19883026|NCT00965731|Crizotinib|crizotinib|mesh-list
19883027|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883028|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19883029|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883030|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883031|NCT00965848|Doripenem|doripenem|mesh-list
19883032|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19883033|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883034|NCT00966277|Dalteparin|dalteparin|mesh-list
19883035|NCT00966277|Tinzaparin|tinzaparin|mesh-list
19883036|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19883037|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
19883038|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19883039|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19883040|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883041|NCT00966355|Octreotide|octreotide|mesh-list
19883042|NCT00966355|Terlipressin|terlipressin|mesh-list
19883043|NCT00966355|Somatostatin|somatostatin|mesh-list
19883044|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883045|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19883046|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883047|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19883048|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19883049|NCT00966355|Hormones|hormones|mesh-ancestor
19883050|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883051|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883052|NCT00966641|Naproxen|naproxen|mesh-list
19883053|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19883054|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19883055|NCT00966641|Analgesics|analgesics|mesh-ancestor
19883056|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
20536152|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883057|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883058|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883059|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883060|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883061|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
19883062|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19883063|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883064|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883065|NCT00966693|Thalidomide|thalidomide|mesh-list
19883066|NCT00966693|Dexamethasone|dexamethasone|mesh-list
19883067|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
19883068|NCT00966693|Lenalidomide|lenalidomide|mesh-list
19883069|NCT00966693|Ichthammol|ichthammol|mesh-list
19883070|NCT00966693|BB 1101|bb 1101|mesh-list
19883071|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883072|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
19883073|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
19883074|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883075|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883076|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883077|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
19883078|NCT00966693|Hormones|hormones|mesh-ancestor
19883079|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883080|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19883081|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883082|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
19883083|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19883084|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19883085|NCT00966693|Growth Substances|growth substances|mesh-ancestor
19883086|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
19883087|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883088|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
19883089|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19883090|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883091|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
19883092|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883093|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883094|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883095|NCT00966875|Ixekizumab|ixekizumab|mesh-list
19883096|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883097|NCT00966940|Travoprost|travoprost|mesh-list
19883098|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19883099|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19883100|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19883101|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
19883102|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19883103|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
19883104|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883105|NCT00967005|Expectorants|expectorants|mesh-ancestor
19883106|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
19883107|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19883108|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
19883109|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883110|NCT00967005|Protective Agents|protective agents|mesh-ancestor
19883111|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883112|NCT00967005|Antidotes|antidotes|mesh-ancestor
19883113|NCT00967044|Everolimus|everolimus|mesh-list
19883114|NCT00967044|Panobinostat|panobinostat|mesh-list
19883115|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883116|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883117|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
19883118|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883119|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19883120|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883121|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883122|NCT00967226|Prednisolone|prednisolone|mesh-list
19883123|NCT00967226|Propranolol|propranolol|mesh-list
19883124|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
19883125|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883126|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
19883127|NCT00967226|Hormones|hormones|mesh-ancestor
19883128|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883129|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883130|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19883131|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883132|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19883133|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19883134|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
19883135|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883136|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883137|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19883138|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19883139|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
19883140|NCT00967330|Bevacizumab|bevacizumab|mesh-list
19883141|NCT00967330|Irinotecan|irinotecan|mesh-list
19883142|NCT00967330|Temozolomide|temozolomide|mesh-list
19883143|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883144|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883145|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19883146|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19883147|NCT00967330|Growth Substances|growth substances|mesh-ancestor
19883148|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883149|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
19883150|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19883151|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19883152|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883153|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883154|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19883155|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
19883156|NCT00967369|Carboplatin|carboplatin|mesh-list
19883157|NCT00967369|Etoposide|etoposide|mesh-list
19883158|NCT00967369|Bortezomib|bortezomib|mesh-list
19883159|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
19883160|NCT00967369|Ifosfamide|ifosfamide|mesh-list
20257447|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20257448|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257449|NCT00479908|Urological Agents|urological agents|mesh-ancestor
19883161|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
19883162|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
20257450|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
19883163|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883164|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19883165|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19883166|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19883167|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883168|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883169|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19883170|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
19883171|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
19883172|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883173|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
19883174|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
19883175|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
19883176|NCT00967499|Ondansetron|ondansetron|mesh-list
19883177|NCT00967499|Palonosetron|palonosetron|mesh-list
19883178|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
19883179|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
19883180|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883181|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883182|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883183|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
19883184|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883185|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19883186|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
19883187|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883188|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883189|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19883190|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19883191|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883192|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883193|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19883194|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19883195|NCT00967551|Zinc|zinc|mesh-list
19883196|NCT00967551|Trace Elements|trace elements|mesh-list
19883197|NCT00967551|Micronutrients|micronutrients|mesh-list
19883198|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883199|NCT00967616|Leucovorin|leucovorin|mesh-list
19883200|NCT00967616|Fluorouracil|fluorouracil|mesh-list
19883201|NCT00967616|Irinotecan|irinotecan|mesh-list
19883202|NCT00967616|Efatutazone|efatutazone|mesh-list
19883203|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
19883204|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
19883205|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883206|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883207|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883208|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883209|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
19883210|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883211|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19883212|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19883213|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883214|NCT00967616|Antidotes|antidotes|mesh-ancestor
19883215|NCT00967616|Protective Agents|protective agents|mesh-ancestor
19883216|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
19883217|NCT00967616|Vitamins|vitamins|mesh-ancestor
19883218|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
19883219|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
19883220|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19883221|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
19883222|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
19883223|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883224|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883225|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19883226|NCT00967694|Analgesics|analgesics|mesh-ancestor
19883227|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
19883228|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883229|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19883230|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883231|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883232|NCT00967798|Incretins|incretins|mesh-ancestor
19883233|NCT00967798|Hormones|hormones|mesh-ancestor
19883234|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883235|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19883236|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
19883237|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883238|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970582|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970583|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19970584|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19970585|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970586|NCT01785810|Maraviroc|maraviroc|mesh-list
19970587|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19970588|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19970589|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970590|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19970591|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19970592|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
20257451|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257452|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19970593|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970594|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19970595|NCT01786109|Dronabinol|dronabinol|mesh-list
19970596|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
19970597|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970598|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19970599|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19970600|NCT01786109|Analgesics|analgesics|mesh-ancestor
19970601|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
19970602|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970603|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19970604|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19970605|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970606|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970607|NCT01786109|Hormones|hormones|mesh-ancestor
19970608|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970609|NCT01786161|Vancomycin|vancomycin|mesh-list
19970610|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970611|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970612|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19970613|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19970614|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970615|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970616|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
19970617|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970618|NCT01786239|Risperidone|risperidone|mesh-list
19970619|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19970620|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
19970621|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970622|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970623|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970624|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19970625|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19970626|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19970627|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19970628|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19970629|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
19970630|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19970631|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19970632|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970633|NCT01786343|Decitabine|decitabine|mesh-list
19970634|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970635|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
19970636|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970637|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970638|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970639|NCT01786551|Eplerenone|eplerenone|mesh-list
20257453|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257454|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883239|NCT00968071|Decitabine|decitabine|mesh-list
19883240|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
19883241|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883242|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
19883243|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883244|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883245|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883246|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883247|NCT00968253|Cytarabine|cytarabine|mesh-list
19883248|NCT00968253|Dexamethasone|dexamethasone|mesh-list
19883249|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
19883250|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19883251|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19883252|NCT00968253|Prednisolone|prednisolone|mesh-list
19883253|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
19883254|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
19883255|NCT00968253|Doxorubicin|doxorubicin|mesh-list
19883256|NCT00968253|Methotrexate|methotrexate|mesh-list
19883257|NCT00968253|Vincristine|vincristine|mesh-list
19883258|NCT00968253|Everolimus|everolimus|mesh-list
19883259|NCT00968253|Lenograstim|lenograstim|mesh-list
19883260|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19883261|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
19883262|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883263|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
19883264|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883265|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883266|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19883267|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
19883268|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883269|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883270|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19883271|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883272|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
19883273|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
19883274|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883275|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883276|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
19883277|NCT00968253|Hormones|hormones|mesh-ancestor
19883278|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553699|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
19883279|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19883280|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19883281|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19883282|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20553700|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553701|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553702|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20553703|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553704|NCT01930812|Listerine|listerine|mesh-list
20553705|NCT01930812|Fluorides|fluorides|mesh-list
20553706|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
20553707|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
20553708|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
20553709|NCT01930812|Protective Agents|protective agents|mesh-ancestor
20553710|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553711|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19883283|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883284|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19883285|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
19883286|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19883287|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883288|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
19883289|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883290|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19883291|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19883292|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
19883293|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883294|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19883295|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
19883296|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
19883297|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
19883298|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19883299|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19883300|NCT00968253|Protective Agents|protective agents|mesh-ancestor
19883301|NCT00968539|Vaccines|vaccines|mesh-list
19883302|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
19883303|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883304|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
19883305|NCT00968617|Hematinics|hematinics|mesh-ancestor
19883306|NCT00968708|Alogliptin|alogliptin|mesh-list
19883307|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883308|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883309|NCT00968708|Incretins|incretins|mesh-ancestor
19883310|NCT00968708|Hormones|hormones|mesh-ancestor
19883311|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883312|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19883313|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
19883314|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883315|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883316|NCT00968799|Cisplatin|cisplatin|mesh-list
19883317|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883318|NCT00968812|Metformin|metformin|mesh-list
19883319|NCT00968812|Glimepiride|glimepiride|mesh-list
19883320|NCT00968812|Canagliflozin|canagliflozin|mesh-list
19883321|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883322|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883323|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19883324|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883325|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
19883326|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19883327|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883328|NCT00968890|Vaccines|vaccines|mesh-list
19883329|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
19883330|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883331|NCT00968968|Trastuzumab|trastuzumab|mesh-list
19883332|NCT00968968|Lapatinib|lapatinib|mesh-list
19883333|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883334|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883335|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19883336|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883337|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883338|NCT00969150|Milnacipran|milnacipran|mesh-list
19883339|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
19883340|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19883341|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19883342|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19883343|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883344|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883345|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883346|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
19883347|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883348|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19883349|NCT00969150|Analgesics|analgesics|mesh-ancestor
20257455|NCT00479986|Pioglitazone|pioglitazone|mesh-list
19883350|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
19883351|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883352|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19883353|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19883354|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19883355|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19883356|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883357|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
19883358|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883359|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883360|NCT00969709|Milnacipran|milnacipran|mesh-list
19883361|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
19883362|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19883363|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19883364|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19883365|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883366|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883367|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883368|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
19883369|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883370|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19883371|NCT00969709|Analgesics|analgesics|mesh-ancestor
19883372|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
19883373|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883374|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19883375|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19883376|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
19883377|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883378|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19883379|NCT00969878|Antacids|antacids|mesh-ancestor
19883380|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883381|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883382|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
19883383|NCT00970073|Tacrolimus|tacrolimus|mesh-list
19883384|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
19883385|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19883386|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883387|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
19883388|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883389|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19883390|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883391|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883392|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19883393|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883394|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19883395|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
19883396|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19883397|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883398|NCT00970203|Vaccines|vaccines|mesh-list
19883399|NCT00970203|Androgens|androgens|mesh-list
19883400|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
19883401|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883402|NCT00970203|Hormones|hormones|mesh-ancestor
19883403|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883404|NCT00970216|Telbivudine|telbivudine|mesh-list
19883405|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
19883406|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883407|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19883408|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883409|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883410|NCT00970268|Bromides|bromides|mesh-list
19883411|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
19883412|NCT00970281|Olanzapine|olanzapine|mesh-list
19883413|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
19883414|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
19883415|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883416|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883417|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883418|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19883419|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19883420|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883421|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883422|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19883423|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19883424|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19883425|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883426|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883427|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
19883428|NCT00970307|Vaccines|vaccines|mesh-list
19883429|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19883430|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
19883431|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883432|NCT00970502|Celecoxib|celecoxib|mesh-list
19883433|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19883434|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883435|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19883436|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883437|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883438|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19883439|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19883440|NCT00970502|Analgesics|analgesics|mesh-ancestor
19883441|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
19883442|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883443|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883444|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883445|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883446|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19883447|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19883448|NCT00970632|Tadalafil|tadalafil|mesh-list
19883449|NCT00970632|Tamsulosin|tamsulosin|mesh-list
19883450|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
19883451|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19883452|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19883453|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883454|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883455|NCT00970632|Urological Agents|urological agents|mesh-ancestor
19883456|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19883457|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19883458|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19883459|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
19883460|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883461|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883462|NCT00970684|Gemcitabine|gemcitabine|mesh-list
19883463|NCT00970684|Bevacizumab|bevacizumab|mesh-list
19883464|NCT00970684|Docetaxel|docetaxel|mesh-list
19883465|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883466|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883467|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19883468|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19883469|NCT00970684|Growth Substances|growth substances|mesh-ancestor
19883470|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883471|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
19883472|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883473|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
19883474|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883475|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
19883476|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883477|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883478|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883479|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
19883480|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
19883481|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
19883482|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
19883483|NCT00970814|Levetiracetam|levetiracetam|mesh-list
19883484|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
19883485|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
19883486|NCT00970944|Amantadine|amantadine|mesh-list
19883487|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19883488|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19883489|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
19883490|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883491|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
19883492|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883493|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883494|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883495|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19883496|NCT00970944|Analgesics|analgesics|mesh-ancestor
19883497|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
19883498|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883499|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
19883500|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19883501|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883502|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883503|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19883504|NCT00971178|Analgesics|analgesics|mesh-ancestor
19883505|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
19883506|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883507|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19883508|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19883509|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19883510|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
19883511|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883512|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883513|NCT00971243|Metformin|metformin|mesh-list
19883514|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883515|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883516|NCT00971295|Metformin|metformin|mesh-list
19883517|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19883518|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883519|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883520|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
19883521|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19883522|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19883523|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19883524|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883525|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
19883526|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19883527|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19883528|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19883529|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19883530|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883531|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
19883532|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883533|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883534|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19883535|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883536|NCT00971633|Ondansetron|ondansetron|mesh-list
19883537|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
19883538|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
19883539|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883540|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883541|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883542|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
19883543|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883544|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19883545|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
19883546|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883547|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883548|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19883549|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19883550|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883551|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883552|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19883553|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
19883554|NCT00971737|Trastuzumab|trastuzumab|mesh-list
19883555|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883556|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
19883557|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883558|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883559|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19883560|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
19883561|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883562|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883563|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19883564|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883565|NCT00971789|Sirolimus|sirolimus|mesh-list
19883566|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19883567|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19883568|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883569|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19883570|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883571|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
19883572|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883573|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
19883574|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883575|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19883576|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883577|NCT00971841|Paclitaxel|paclitaxel|mesh-list
19883578|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19883579|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883580|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
19883581|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
19883582|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
19883583|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883584|NCT00971932|Carboplatin|carboplatin|mesh-list
19883585|NCT00971932|Fluorouracil|fluorouracil|mesh-list
19883586|NCT00971932|Cetuximab|cetuximab|mesh-list
19883587|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883588|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
19883589|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883590|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883591|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883592|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
19883593|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883594|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883595|NCT00971945|Paclitaxel|paclitaxel|mesh-list
19883596|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19883597|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883598|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
19883599|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
19883600|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
19883601|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883602|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
19883603|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883604|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883605|NCT00972205|Paclitaxel|paclitaxel|mesh-list
19883606|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19883607|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19883608|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883609|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
19883610|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
19883611|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
19883612|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883613|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19883614|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
19883615|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19883616|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883617|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883618|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883619|NCT00972283|Insulin|insulin|mesh-list
19883620|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19883621|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
19883622|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
19883623|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883624|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883625|NCT00972335|Bevacizumab|bevacizumab|mesh-list
19883626|NCT00972335|Everolimus|everolimus|mesh-list
19883627|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883628|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883629|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19883630|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19883631|NCT00972335|Growth Substances|growth substances|mesh-ancestor
19883632|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883633|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
19883634|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883635|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
19883636|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19883637|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19883638|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19883639|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19883640|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19883641|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
19883642|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883643|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883644|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883645|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
19883646|NCT00972439|Norinyl|norinyl|mesh-list
19883647|NCT00972439|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19883648|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
19883649|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19883650|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883651|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19883652|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19883653|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19883654|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19883655|NCT00972439|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19883656|NCT00972439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19883657|NCT00972504|Cetirizine|cetirizine|mesh-list
19883658|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19883659|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19883660|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19883661|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
19883662|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
19883663|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883664|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883665|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883666|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19883667|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
19883668|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883669|NCT00972595|Ondansetron|ondansetron|mesh-list
19883670|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
19883671|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
19883672|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883673|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883674|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883675|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
19883676|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883677|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19883678|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
19883679|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883680|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883681|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19883682|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19883683|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883684|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883685|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19883686|NCT00972725|Chloroquine|chloroquine|mesh-list
19883687|NCT00972725|Amebicides|amebicides|mesh-ancestor
19883688|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19883689|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19883690|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883691|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
19883692|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883693|NCT00972777|Besifloxacin|besifloxacin|mesh-list
19883694|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19883695|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883696|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19883697|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19883698|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883699|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883700|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883701|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
19883702|NCT00972959|Dexamethasone|dexamethasone|mesh-list
19883703|NCT00972959|Bortezomib|bortezomib|mesh-list
19883704|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20536153|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536154|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
20536155|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536156|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20536157|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
20536158|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20536159|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19883705|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
19883706|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
19883707|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883708|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883709|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19883710|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
19883711|NCT00972959|Hormones|hormones|mesh-ancestor
19883712|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883713|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19883714|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883715|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19883716|NCT00973102|Estrogens|estrogens|mesh-list
19883717|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19883718|NCT00973102|Hormones|hormones|mesh-ancestor
19883719|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883720|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883721|NCT00973479|Golimumab|golimumab|mesh-list
19883722|NCT00973479|Methotrexate|methotrexate|mesh-list
19883723|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19883724|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
19883725|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19883726|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883727|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883728|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
19883729|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883730|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883731|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883732|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883733|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19883734|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883735|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
19883736|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883737|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19883738|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19883739|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883740|NCT00973674|Estrogens|estrogens|mesh-list
19883741|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19883742|NCT00973674|Hormones|hormones|mesh-ancestor
19883743|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883744|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883745|NCT00973739|Lapatinib|lapatinib|mesh-list
19883746|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883747|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19883748|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883749|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883750|NCT00973752|Cytarabine|cytarabine|mesh-list
19883751|NCT00973752|Prednisone|prednisone|mesh-list
19883752|NCT00973752|Doxorubicin|doxorubicin|mesh-list
19883753|NCT00973752|Methotrexate|methotrexate|mesh-list
19883754|NCT00973752|Vincristine|vincristine|mesh-list
19883755|NCT00973752|Asparaginase|asparaginase|mesh-list
19883756|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
19883757|NCT00973752|Clofarabine|clofarabine|mesh-list
19883758|NCT00973752|Pegaspargase|pegaspargase|mesh-list
19883759|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19883760|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883761|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19883762|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19883763|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883764|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883765|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883766|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
19883767|NCT00973752|Hormones|hormones|mesh-ancestor
19883768|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883769|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883770|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19883771|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19883772|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
19883773|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19883774|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883775|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
19883776|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883777|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19883778|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883779|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
19883780|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883781|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19883782|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
19883783|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883784|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19883785|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
19883786|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
19883787|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
19883788|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19883789|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19883790|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883791|NCT00973765|Renal Agents|renal agents|mesh-ancestor
19883792|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19883793|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
19883794|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19883795|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19883796|NCT00974051|Insulin|insulin|mesh-list
19883797|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19883798|NCT00974051|Terbutaline|terbutaline|mesh-list
19883799|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
19883800|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883801|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257456|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20257457|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257458|NCT00480064|Cytarabine|cytarabine|mesh-list
20257459|NCT00480064|Lomustine|lomustine|mesh-list
20257460|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20257461|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
20257462|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257463|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257464|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
20257465|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257466|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257467|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
20257468|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257469|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20257470|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
20257471|NCT00480090|Cytarabine|cytarabine|mesh-list
19883802|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19883803|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
19883804|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883805|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19883806|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
19883807|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
19883808|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
19883809|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19883810|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19883811|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20257472|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19883812|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
19883813|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883814|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883815|NCT00974090|Glimepiride|glimepiride|mesh-list
19883816|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19883817|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883818|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883819|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883820|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
19883821|NCT00974142|Cyclosporine|cyclosporine|mesh-list
19883822|NCT00974142|Cyclosporins|cyclosporins|mesh-list
19883823|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883824|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883825|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883826|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
19883827|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883828|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
19883829|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883830|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883831|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883832|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19883833|NCT00974220|Fentanyl|fentanyl|mesh-list
19883834|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19883835|NCT00974220|Narcotics|narcotics|mesh-ancestor
19883836|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883837|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883838|NCT00974220|Analgesics|analgesics|mesh-ancestor
19883839|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
19883840|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883841|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19883842|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19883843|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
19883844|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
19970640|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19970641|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
19970642|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970643|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970644|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19970645|NCT01786551|Diuretics|diuretics|mesh-ancestor
19970646|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
19970647|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19970648|NCT01786603|Rasagiline|rasagiline|mesh-list
19970649|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19970650|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970651|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970652|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19970653|NCT01786603|Protective Agents|protective agents|mesh-ancestor
19970654|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970655|NCT01786668|Tofacitinib|tofacitinib|mesh-list
19970656|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19970657|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970658|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970659|NCT01786707|Metformin|metformin|mesh-list
19970660|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19970661|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970662|NCT01786902|Hormones|hormones|mesh-list
19970663|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970664|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970665|NCT01786967|Fesoterodine|fesoterodine|mesh-list
19970666|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19970667|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19970668|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
19970669|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970670|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970671|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970672|NCT01786967|Urological Agents|urological agents|mesh-ancestor
19970673|NCT01787006|Fluorouracil|fluorouracil|mesh-list
19970674|NCT01787006|Cetuximab|cetuximab|mesh-list
19970675|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970676|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
19970677|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970678|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970679|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970680|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
19970681|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970682|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19970683|NCT01787032|Ketoconazole|ketoconazole|mesh-list
19970684|NCT01787032|Voriconazole|voriconazole|mesh-list
19970685|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
19970686|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970687|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19970688|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19970689|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970690|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970691|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19970692|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
19883845|NCT00974233|Rituximab|rituximab|mesh-list
19883846|NCT00974233|Lenalidomide|lenalidomide|mesh-list
19883847|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19883848|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19883849|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883850|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
19883851|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883852|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19883853|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19883854|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19883855|NCT00974233|Growth Substances|growth substances|mesh-ancestor
19883856|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
19883857|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19883858|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
19883859|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883860|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19883861|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19883862|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
19883863|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883864|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883865|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19883866|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
19883867|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
19883868|NCT00974246|Hormones|hormones|mesh-ancestor
19883869|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883870|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
19883871|NCT00974350|Bupivacaine|bupivacaine|mesh-list
19883872|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
19883873|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
19883874|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883875|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883876|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
19883877|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883878|NCT00974376|Gabapentin|gabapentin|mesh-list
19883879|NCT00974376|Analgesics|analgesics|mesh-ancestor
19883880|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
19883881|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883882|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883883|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
19883884|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19883885|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19883886|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883887|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883888|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19883889|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19883890|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883891|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883892|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
19883893|NCT00974480|Tretinoin|tretinoin|mesh-list
19883894|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883895|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
19883896|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883897|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19883898|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19883899|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19883900|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
19883901|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19883902|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
19883903|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257473|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
20257474|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257475|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257476|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
19883904|NCT00974818|Mitomycins|mitomycins|mesh-list
19883905|NCT00974818|Mitomycin|mitomycin|mesh-list
19883906|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
19883907|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19883908|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19883909|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
19883910|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883911|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19883912|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883913|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19883914|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
19883915|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883916|NCT00974974|Levodopa|levodopa|mesh-list
19883917|NCT00974974|Carbidopa|carbidopa|mesh-list
19883918|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19883919|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19883920|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19883921|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
19883922|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883923|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883924|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883925|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19883926|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19883927|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19883928|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
19883929|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
19883930|NCT00975000|Cinacalcet|cinacalcet|mesh-list
19883931|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19883932|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883933|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19883934|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
19883935|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883936|NCT00975130|Golimumab|golimumab|mesh-list
19883937|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19883938|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19883939|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883940|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19883941|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
19883942|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883943|NCT00975143|Isotretinoin|isotretinoin|mesh-list
19883944|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883945|NCT00975195|Fluticasone|fluticasone|mesh-list
19883946|NCT00975195|Xhance|xhance|mesh-list
19883947|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
19883948|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19883949|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19883950|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19883951|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
19883952|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19883953|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883954|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19883955|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
19883956|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883957|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19883958|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
19883959|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19883960|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
19883961|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883962|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883963|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19883964|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19883965|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19883966|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
19883967|NCT00975221|Cinacalcet|cinacalcet|mesh-list
19883968|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19883969|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883970|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19883971|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
19883972|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19883973|NCT00975286|Metformin|metformin|mesh-list
19883974|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
19883975|NCT00975286|Lixisenatide|lixisenatide|mesh-list
19883976|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19883977|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19883978|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883979|NCT00975416|Oxytocin|oxytocin|mesh-list
19883980|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
19883981|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19883982|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883983|NCT00975481|Alprazolam|alprazolam|mesh-list
19883984|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19883985|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19883986|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883987|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19883988|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19883989|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19883990|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
19883991|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
19883992|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19883993|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19883994|NCT00975637|Brodalumab|brodalumab|mesh-list
19883995|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19883996|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
19883997|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
19883998|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19883999|NCT00975650|Testosterone|testosterone|mesh-list
19884000|NCT00975650|Androgens|androgens|mesh-ancestor
19884001|NCT00975650|Hormones|hormones|mesh-ancestor
19884002|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19884003|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884004|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
19884005|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19884006|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
19884007|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884008|NCT00975689|Expectorants|expectorants|mesh-ancestor
19884009|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
19884010|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19884011|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
19884012|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884013|NCT00975689|Protective Agents|protective agents|mesh-ancestor
19884014|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884015|NCT00975689|Antidotes|antidotes|mesh-ancestor
19884016|NCT00975806|Lenalidomide|lenalidomide|mesh-list
19884017|NCT00975806|Sunitinib|sunitinib|mesh-list
19884018|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
19884019|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884020|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884021|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884022|NCT00975806|Growth Substances|growth substances|mesh-ancestor
19884023|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884024|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884025|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884026|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884027|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884028|NCT00975975|Basiliximab|basiliximab|mesh-list
19884029|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884030|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
19884031|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884032|NCT00976027|Vaccines|vaccines|mesh-list
19884033|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
19884034|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884035|NCT00976183|Vorinostat|vorinostat|mesh-list
19884036|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884037|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19884038|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884039|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884040|NCT00976209|Phenylephrine|phenylephrine|mesh-list
19884041|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
19884042|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19884043|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
19884044|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
19884045|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884046|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884047|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
19884048|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19884049|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
19884050|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
19884051|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19884052|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19884053|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19884054|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
19884055|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884056|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884057|NCT00976209|Protective Agents|protective agents|mesh-ancestor
19884058|NCT00976248|Everolimus|everolimus|mesh-list
19884059|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884060|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884061|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
19884062|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884063|NCT00976391|Insulin|insulin|mesh-list
19884064|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19884065|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
19884066|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
19884067|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
19884068|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19884069|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884070|NCT00976391|Incretins|incretins|mesh-ancestor
19884071|NCT00976391|Hormones|hormones|mesh-ancestor
19884072|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19884073|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
19884074|NCT00976404|Maraviroc|maraviroc|mesh-list
19884075|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19884076|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19884077|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
19884078|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884079|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19884080|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19884081|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884082|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884083|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19884084|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19884085|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19884086|NCT00976456|Bevacizumab|bevacizumab|mesh-list
19884087|NCT00976456|Carboplatin|carboplatin|mesh-list
19884088|NCT00976456|Pemetrexed|pemetrexed|mesh-list
19884089|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19884090|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884091|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884092|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884093|NCT00976456|Growth Substances|growth substances|mesh-ancestor
19884094|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884095|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884096|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884097|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884098|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19884099|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19884100|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
19884101|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19884102|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19884103|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884104|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19884105|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884106|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19884107|NCT00976495|Diuretics|diuretics|mesh-ancestor
19884108|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
19884109|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19884110|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884111|NCT00976521|Abciximab|abciximab|mesh-list
19884112|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
19884113|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19884114|NCT00976573|Paclitaxel|paclitaxel|mesh-list
19884115|NCT00976573|Bevacizumab|bevacizumab|mesh-list
19884116|NCT00976573|Carboplatin|carboplatin|mesh-list
19884117|NCT00976573|Everolimus|everolimus|mesh-list
19884118|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19884119|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884120|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884121|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884122|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884123|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884124|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19884125|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884126|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884127|NCT00976573|Growth Substances|growth substances|mesh-ancestor
19884128|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884129|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884130|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884131|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
19884132|NCT00976599|Methotrexate|methotrexate|mesh-list
19884133|NCT00976599|Tofacitinib|tofacitinib|mesh-list
19884134|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19884135|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
19884136|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19884137|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884138|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19884139|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
19884140|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884141|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884142|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
19884143|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884144|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19884145|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884146|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
19884147|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884148|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19884149|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257477|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257478|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257479|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
20257480|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257481|NCT00480103|Mineral Oil|mineral oil|mesh-list
20257482|NCT00480103|Emollients|emollients|mesh-ancestor
20257483|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
20536160|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20536161|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536162|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20536163|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
20536164|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536165|NCT01824524|Hydromorphone|hydromorphone|mesh-list
19884150|NCT00976677|Paclitaxel|paclitaxel|mesh-list
20257484|NCT00480116|Vaccines|vaccines|mesh-list
20257485|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
20257486|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257487|NCT00480142|Oxycodone|oxycodone|mesh-list
19884151|NCT00976677|Bevacizumab|bevacizumab|mesh-list
20257488|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884152|NCT00976677|Carboplatin|carboplatin|mesh-list
19884153|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19884154|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19884155|NCT00976677|Antibodies|antibodies|mesh-list
19884156|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
19884157|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19884158|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19884159|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884160|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884161|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884162|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884163|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884164|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884165|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884166|NCT00976677|Growth Substances|growth substances|mesh-ancestor
19884167|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884168|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884169|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
19884170|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884171|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884172|NCT00976716|Celecoxib|celecoxib|mesh-list
19884173|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19884174|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19884175|NCT00976716|Analgesics|analgesics|mesh-ancestor
19884176|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
19884177|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884178|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884179|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19884180|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884181|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19884182|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19884183|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884184|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884185|NCT00976911|Paclitaxel|paclitaxel|mesh-list
19884186|NCT00976911|Bevacizumab|bevacizumab|mesh-list
19884187|NCT00976911|Doxorubicin|doxorubicin|mesh-list
19884188|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19884189|NCT00976911|Topotecan|topotecan|mesh-list
19884190|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19884191|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884192|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884193|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884194|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884195|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884196|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19884197|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884198|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884199|NCT00976911|Growth Substances|growth substances|mesh-ancestor
19884200|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884201|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884202|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19884203|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19884204|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19884205|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884206|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19884207|NCT00976937|Metformin|metformin|mesh-list
19884208|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19884209|NCT00976937|Lixisenatide|lixisenatide|mesh-list
19884210|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19884211|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884212|NCT00976937|Incretins|incretins|mesh-ancestor
19884213|NCT00976937|Hormones|hormones|mesh-ancestor
19884214|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257489|NCT00480142|Narcotics|narcotics|mesh-ancestor
20257490|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536166|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884215|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19884216|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
19884217|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884218|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884219|NCT00976950|Ritonavir|ritonavir|mesh-list
19884220|NCT00976950|Tipranavir|tipranavir|mesh-list
19884221|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19884222|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19884223|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
19884224|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884225|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884226|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19884227|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19884228|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
19884229|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884230|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19884231|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19884232|NCT00976989|Docetaxel|docetaxel|mesh-list
19884233|NCT00976989|Trastuzumab|trastuzumab|mesh-list
19884234|NCT00976989|Pertuzumab|pertuzumab|mesh-list
19884235|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884236|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884237|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884238|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884239|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884240|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19884241|NCT00977080|Cinacalcet|cinacalcet|mesh-list
19884242|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19884243|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884244|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19884245|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
19884246|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19884247|NCT00977171|Droxidopa|droxidopa|mesh-list
19884248|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19884249|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19884250|NCT00977197|Pregabalin|pregabalin|mesh-list
19884251|NCT00977197|Analgesics|analgesics|mesh-ancestor
19884252|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
19884253|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884254|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884255|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
19884256|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19884257|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884258|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884259|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19884260|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19884261|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19884262|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884263|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19884264|NCT00977379|Capecitabine|capecitabine|mesh-list
19884265|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19884266|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
19884267|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884268|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884269|NCT00977431|Temozolomide|temozolomide|mesh-list
19884270|NCT00977431|Afatinib|afatinib|mesh-list
19884271|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19884272|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
19884273|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884274|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884275|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884276|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884277|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
19884278|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19884279|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884280|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884281|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884282|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884283|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
19884284|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19884285|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19884286|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884287|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20536167|NCT01824524|Narcotics|narcotics|mesh-ancestor
19884288|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19884289|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884290|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884291|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884292|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884293|NCT00977561|Cisplatin|cisplatin|mesh-list
19884294|NCT00977561|Carboplatin|carboplatin|mesh-list
19884295|NCT00977561|Etoposide|etoposide|mesh-list
19884296|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
19884297|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884298|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19884299|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19884300|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19884301|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884302|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884303|NCT00977665|Rasagiline|rasagiline|mesh-list
19884304|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19884305|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884306|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884307|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19884308|NCT00977665|Protective Agents|protective agents|mesh-ancestor
19884309|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884310|NCT00977769|Oxytocin|oxytocin|mesh-list
19884311|NCT00977769|Carbetocin|carbetocin|mesh-list
19884312|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
19884313|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19884314|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884315|NCT00977938|Aspirin|aspirin|mesh-list
19884316|NCT00977938|Clopidogrel|clopidogrel|mesh-list
19884317|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19884318|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19884319|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19884320|NCT00977938|Analgesics|analgesics|mesh-ancestor
19884321|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
19884322|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884323|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884324|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19884325|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884326|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19884327|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19884328|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884329|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19884330|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19884331|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884332|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
19884333|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19884334|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19884335|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19884336|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
19884337|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884338|NCT00978068|Ritonavir|ritonavir|mesh-list
19884339|NCT00978068|Lopinavir|lopinavir|mesh-list
19884340|NCT00978068|Nevirapine|nevirapine|mesh-list
19884341|NCT00978068|Efavirenz|efavirenz|mesh-list
19884342|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19884343|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19884344|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19884345|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
19884346|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884347|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884348|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19884349|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19884350|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
19884351|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884352|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19884353|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19884354|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19884355|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19884356|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19884357|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19884358|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19884359|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19884360|NCT00978120|Vaccines|vaccines|mesh-list
19884361|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
19884362|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884363|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
19884364|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
19884365|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884366|NCT00978341|Pregabalin|pregabalin|mesh-list
19884367|NCT00978341|Analgesics|analgesics|mesh-ancestor
19884368|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
19884369|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884370|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884371|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
19884372|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19884373|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884374|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884375|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19884376|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19884377|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19884378|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884379|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19884380|NCT00978432|Everolimus|everolimus|mesh-list
19884381|NCT00978432|Panobinostat|panobinostat|mesh-list
19884382|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884383|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884384|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
19884385|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884386|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19884387|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884388|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884389|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19884390|NCT00978562|Hematinics|hematinics|mesh-ancestor
19884391|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19884392|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19884393|NCT00978627|Insulin|insulin|mesh-list
19884394|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19884395|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
19884396|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
19884397|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19884398|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
19884399|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19884400|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884401|NCT00978731|Dasatinib|dasatinib|mesh-list
19884402|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884403|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884404|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884405|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884406|NCT00978757|Ketamine|ketamine|mesh-list
19884407|NCT00978757|Analgesics|analgesics|mesh-ancestor
19884408|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
19884409|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884410|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884411|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19884412|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19884413|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
19884414|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
19884415|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884416|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19884417|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19884418|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884419|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884420|NCT00979017|Bevacizumab|bevacizumab|mesh-list
19884421|NCT00979017|Irinotecan|irinotecan|mesh-list
19884422|NCT00979017|Temozolomide|temozolomide|mesh-list
19884423|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19884424|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884425|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884426|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884427|NCT00979017|Growth Substances|growth substances|mesh-ancestor
19884428|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884429|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884430|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19884431|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19884432|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884433|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884434|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19884435|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
19884436|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19884437|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19884438|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19884439|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
19884440|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884441|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19884442|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20536168|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536169|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536170|NCT01824524|Analgesics|analgesics|mesh-ancestor
20536171|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
20536172|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536173|NCT01824615|Sunitinib|sunitinib|mesh-list
20536174|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884443|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884444|NCT00979212|Paclitaxel|paclitaxel|mesh-list
19884445|NCT00979212|Carboplatin|carboplatin|mesh-list
19884446|NCT00979212|Panitumumab|panitumumab|mesh-list
19884447|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19884448|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884449|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884450|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884451|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884452|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884453|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19884454|NCT00979407|Vaccines|vaccines|mesh-list
19884455|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
19884456|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884457|NCT00979576|Pemetrexed|pemetrexed|mesh-list
19884458|NCT00979576|Nintedanib|nintedanib|mesh-list
19884459|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884460|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884461|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884462|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19884463|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19884464|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19970693|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970694|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970695|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19970696|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
19970697|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19970698|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19970699|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
19970700|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970701|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970702|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19970703|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
19970704|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19970705|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19970706|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19970707|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
19970708|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970709|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970710|NCT01787188|Meloxicam|meloxicam|mesh-list
19970711|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19970712|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20257491|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257492|NCT00480142|Analgesics|analgesics|mesh-ancestor
20257493|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
20257494|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970713|NCT01787188|Analgesics|analgesics|mesh-ancestor
19970714|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
19970715|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970716|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970717|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970718|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970719|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19970720|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19970721|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970722|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970723|NCT01787240|Citalopram|citalopram|mesh-list
19970724|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19970725|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19970726|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19970727|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970728|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970729|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
19970730|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970731|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19970732|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
19970733|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19970734|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19970735|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
19970736|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970737|NCT01787331|Itraconazole|itraconazole|mesh-list
19970738|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
19970739|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970740|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20257495|NCT00480181|Nabilone|nabilone|mesh-list
20257496|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
19884465|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19884466|NCT00979615|Azelastine|azelastine|mesh-list
19884467|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19884468|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19884469|NCT00979615|Analgesics|analgesics|mesh-ancestor
19884470|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
19884471|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884472|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884473|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19884474|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884475|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19884476|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19884477|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19884478|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
19884479|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
19884480|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884481|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884482|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19884483|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
19884484|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19884485|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
19884486|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19884487|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884488|NCT00979628|Insulin|insulin|mesh-list
19884489|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19884490|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
19884491|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
19884492|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19884493|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884494|NCT00979654|Sifalimumab|sifalimumab|mesh-list
19884495|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
19884496|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884497|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
19884498|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19884499|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884500|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
19884501|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884502|NCT00979732|Protective Agents|protective agents|mesh-ancestor
19884503|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884504|NCT00979745|Afamelanotide|afamelanotide|mesh-list
19884505|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
19884506|NCT00979875|Insulin|insulin|mesh-list
19884507|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19884508|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
19884509|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
19884510|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
19884511|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20257497|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
19884512|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884513|NCT00979940|Atorvastatin|atorvastatin|mesh-list
19884514|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19884515|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19884516|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
19884517|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884518|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19884519|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19884520|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884521|NCT00979953|Oxycodone|oxycodone|mesh-list
19884522|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884523|NCT00979953|Narcotics|narcotics|mesh-ancestor
19884524|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884525|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884526|NCT00979953|Analgesics|analgesics|mesh-ancestor
20257498|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257499|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257500|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20257501|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20257502|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20257503|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257504|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20257505|NCT00480194|Xylometazoline|xylometazoline|mesh-list
20257506|NCT00480194|Bromides|bromides|mesh-list
20257507|NCT00480194|Ipratropium|ipratropium|mesh-list
19884527|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
19884528|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884529|NCT00979992|Sunitinib|sunitinib|mesh-list
20257508|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
20257509|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20257510|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
20257511|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257512|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257513|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19884530|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884531|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884532|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884533|NCT00979992|Growth Substances|growth substances|mesh-ancestor
19884534|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884535|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884536|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884537|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884538|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884539|NCT00980044|Tramadol|tramadol|mesh-list
19884540|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884541|NCT00980044|Narcotics|narcotics|mesh-ancestor
19884542|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884543|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884544|NCT00980044|Analgesics|analgesics|mesh-ancestor
19884545|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
19884546|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884547|NCT00980148|Azithromycin|azithromycin|mesh-list
19884548|NCT00980148|Doxycycline|doxycycline|mesh-list
19884549|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19884550|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884551|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
19884552|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19884553|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19884554|NCT00980174|Denosumab|denosumab|mesh-list
19884555|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19884556|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884557|NCT00980330|Ribavirin|ribavirin|mesh-list
19884558|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19884559|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
19884560|NCT00980330|Simeprevir|simeprevir|mesh-list
19884561|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
19884562|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884563|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
19884564|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884565|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884566|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
19884567|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884568|NCT00980395|Rituximab|rituximab|mesh-list
19884569|NCT00980395|Bortezomib|bortezomib|mesh-list
19884570|NCT00980395|Cladribine|cladribine|mesh-list
19884571|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19884572|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884573|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
19884574|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884575|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884576|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884577|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19884578|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
19884579|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
19884580|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884581|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19884582|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
19884583|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19884584|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19884585|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884586|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884587|NCT00980785|Ramipril|ramipril|mesh-list
19884588|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19884589|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
19884590|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884591|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884592|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19884593|NCT00980798|Hydromorphone|hydromorphone|mesh-list
20257514|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
20257515|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19884594|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884595|NCT00980798|Narcotics|narcotics|mesh-ancestor
20257516|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
20257517|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257518|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257519|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
20257520|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20257521|NCT00480207|Folic Acid|folic acid|mesh-list
19884596|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884597|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884598|NCT00980798|Analgesics|analgesics|mesh-ancestor
19884599|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
19884600|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884601|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
19884602|NCT00980980|Mupirocin|mupirocin|mesh-list
19884603|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19884604|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884605|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
19884606|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19884607|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19884608|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884609|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884610|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19884611|NCT00981045|Hematinics|hematinics|mesh-ancestor
19884612|NCT00981084|Modafinil|modafinil|mesh-list
19884613|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19884614|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884615|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19884616|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19884617|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19884618|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257522|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
20257523|NCT00480207|Hematinics|hematinics|mesh-ancestor
20257524|NCT00480207|Vitamins|vitamins|mesh-ancestor
20257525|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
20257526|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257527|NCT00480246|Perphenazine|perphenazine|mesh-list
20257528|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20257529|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20257530|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536175|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884619|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20257531|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884620|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19884621|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19884622|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884623|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884624|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884625|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884626|NCT00981149|Analgesics|analgesics|mesh-ancestor
19884627|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
19884628|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884629|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
19884630|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19884631|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
19884632|NCT00981214|Pancrelipase|pancrelipase|mesh-list
19884633|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19884634|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19884635|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
19884636|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19884637|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19884638|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884639|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884640|NCT00981409|Heparin|heparin|mesh-list
19884641|NCT00981409|Calcium heparin|calcium heparin|mesh-list
19884642|NCT00981409|PENTA|penta|mesh-list
19884643|NCT00981409|Fondaparinux|fondaparinux|mesh-list
19884644|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
19884645|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19884646|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19884647|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884648|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19884649|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
19884650|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19884651|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
19884652|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884653|NCT00981435|Prednisolone|prednisolone|mesh-list
19884654|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
19884655|NCT00981435|Ketorolac|ketorolac|mesh-list
19884656|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
19884657|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19884658|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
19884659|NCT00981435|Hormones|hormones|mesh-ancestor
19884660|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19884661|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884662|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19884663|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884664|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884665|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19884666|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19884667|NCT00981435|Analgesics|analgesics|mesh-ancestor
19884668|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
19884669|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884670|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19884671|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884672|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884673|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19884674|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19884675|NCT00981526|Telmisartan|telmisartan|mesh-list
19884676|NCT00981526|Olanzapine|olanzapine|mesh-list
19884677|NCT00981526|Clozapine|clozapine|mesh-list
19884678|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
19884679|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
19884680|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884681|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884682|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19884683|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19884684|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19884685|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884686|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19884687|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19884688|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19884689|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884690|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884691|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884692|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
19884693|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19884694|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19884695|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19884696|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19884697|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
19884698|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
19884699|NCT00981669|Vaccines|vaccines|mesh-list
19884700|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
19884701|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884702|NCT00981747|Losartan|losartan|mesh-list
19884703|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
19884704|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19884705|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19884706|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19884707|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19884708|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884709|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
19884710|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19884711|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19884712|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884713|NCT00981747|Urological Agents|urological agents|mesh-ancestor
19884714|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
19884715|NCT00981799|Methotrexate|methotrexate|mesh-list
19884716|NCT00981799|Etoposide|etoposide|mesh-list
19884717|NCT00981799|Lenograstim|lenograstim|mesh-list
19884718|NCT00981799|Sargramostim|sargramostim|mesh-list
19884719|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884720|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
19884721|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884722|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884723|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19884724|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
19884725|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884726|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884727|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19884728|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19884729|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
19884730|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19884731|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19884732|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
19884733|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
19884734|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884735|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20257532|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19884736|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19884737|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19884738|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19884739|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19884740|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19884741|NCT00981825|Listerine|listerine|mesh-list
19884742|NCT00981825|Triclosan|triclosan|mesh-list
19884743|NCT00981825|Fluorides|fluorides|mesh-list
19884744|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
19884745|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
19884746|NCT00981825|Protective Agents|protective agents|mesh-ancestor
19884747|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884748|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19884749|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884750|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19884751|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19884752|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
19884753|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884754|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19884755|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
19884756|NCT00982007|Hematinics|hematinics|mesh-ancestor
19884757|NCT00982020|Olanzapine|olanzapine|mesh-list
19884758|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
19884759|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
19884760|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884761|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884762|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19884763|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19884764|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19884765|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884766|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19884767|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19884768|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19884769|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884770|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884771|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884772|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
19884773|NCT00982072|Prednisolone|prednisolone|mesh-list
19884774|NCT00982072|Tacrolimus|tacrolimus|mesh-list
19884775|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884776|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
19884777|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884778|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19884779|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884780|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884781|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19884782|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
19884783|NCT00982072|Hormones|hormones|mesh-ancestor
19884784|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19884785|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19884786|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884787|NCT00982189|Lisinopril|lisinopril|mesh-list
19884788|NCT00982189|Pravastatin|pravastatin|mesh-list
19884789|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19884790|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19884791|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
19884792|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884793|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19884794|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19884795|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884796|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19884797|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
19884798|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19884799|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20257533|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20257534|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
19884800|NCT00982189|Protective Agents|protective agents|mesh-ancestor
19884801|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884802|NCT00982228|Insulin|insulin|mesh-list
20257535|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536176|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20536177|NCT01824615|Growth Substances|growth substances|mesh-ancestor
20536178|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536179|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
20536180|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884803|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19884804|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
19884805|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
19884806|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19884807|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884808|NCT00982280|Tapentadol|tapentadol|mesh-list
20257536|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257537|NCT00480272|Prednisone|prednisone|mesh-list
20257538|NCT00480272|Adalimumab|adalimumab|mesh-list
20257539|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19884809|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884810|NCT00982280|Narcotics|narcotics|mesh-ancestor
19884811|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884812|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884813|NCT00982280|Analgesics|analgesics|mesh-ancestor
20257540|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
20257541|NCT00480272|Hormones|hormones|mesh-ancestor
20257542|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257543|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257544|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20257545|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884814|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
19884815|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884816|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19884817|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19884818|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884819|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884820|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
19884821|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884822|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19884823|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
19884824|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19884825|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19884826|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19884827|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884828|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884829|NCT00982423|Furosemide|furosemide|mesh-list
19884830|NCT00982423|Diuretics|diuretics|mesh-ancestor
19884831|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
19884832|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884833|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19884834|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884835|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884836|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
19884837|NCT00982488|Dasatinib|dasatinib|mesh-list
19884838|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884839|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884840|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884841|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884842|NCT00982553|Ribavirin|ribavirin|mesh-list
19884843|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
19884844|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
19884845|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536181|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884846|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
19884847|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884848|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19884849|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19884850|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19884851|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19884852|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884853|NCT00982592|Leucovorin|leucovorin|mesh-list
19884854|NCT00982592|Fluorouracil|fluorouracil|mesh-list
19884855|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
19884856|NCT00982592|Calcium|calcium|mesh-list
19884857|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
19884858|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19884859|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884860|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
19884861|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884862|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19884863|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884864|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19884865|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
19884866|NCT00982592|Antidotes|antidotes|mesh-ancestor
19884867|NCT00982592|Protective Agents|protective agents|mesh-ancestor
19884868|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
19884869|NCT00982592|Vitamins|vitamins|mesh-ancestor
19884870|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
19884871|NCT00982644|Insulin|insulin|mesh-list
19884872|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19884873|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
19884874|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19884875|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884876|NCT00982657|Sunitinib|sunitinib|mesh-list
19884877|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884878|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19884879|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19884880|NCT00982657|Growth Substances|growth substances|mesh-ancestor
19884881|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884882|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
19884883|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884884|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884885|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884886|NCT00982865|Niacinamide|niacinamide|mesh-list
20257546|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884887|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
19884888|NCT00982865|Vitamins|vitamins|mesh-ancestor
20257547|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
19884889|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
19884890|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884891|NCT00982878|Maraviroc|maraviroc|mesh-list
19884892|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19884893|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19884894|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884895|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19884896|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19884897|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
19884898|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884899|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19884900|NCT00982930|Tobramycin|tobramycin|mesh-list
19884901|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19884902|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884903|NCT00983073|Tapentadol|tapentadol|mesh-list
19884904|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884905|NCT00983073|Narcotics|narcotics|mesh-ancestor
19884906|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884907|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884908|NCT00983073|Analgesics|analgesics|mesh-ancestor
19884909|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
19884910|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884911|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19884912|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19884913|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884914|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884915|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
19884916|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884917|NCT00983216|Ketoconazole|ketoconazole|mesh-list
19884918|NCT00983216|Colchicine|colchicine|mesh-list
19884919|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
19884920|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884921|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884922|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884923|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884924|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884925|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884926|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
19884927|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19884928|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19884929|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19884930|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884931|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19884932|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
19884933|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19884934|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884935|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19884936|NCT00983242|Colchicine|colchicine|mesh-list
19884937|NCT00983242|Verapamil|verapamil|mesh-list
19884938|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
19884939|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884940|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884941|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884942|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884943|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884944|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884945|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19884946|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19884947|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884948|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19884949|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884950|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
19884951|NCT00983294|Azithromycin|azithromycin|mesh-list
19884952|NCT00983294|Colchicine|colchicine|mesh-list
19884953|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20257548|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20257549|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20257550|NCT00480298|Prednisolone|prednisolone|mesh-list
20257551|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
20257552|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20257553|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
20257554|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257555|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
19884954|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257556|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
19884955|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
19884956|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884957|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884958|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884959|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884960|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884961|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884962|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19884963|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884964|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19884965|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19884966|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884967|NCT00983346|Bortezomib|bortezomib|mesh-list
19884968|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884969|NCT00983372|Colchicine|colchicine|mesh-list
19884970|NCT00983372|Diltiazem|diltiazem|mesh-list
19884971|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
19884972|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19884973|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
19884974|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
19884975|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
19884976|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884977|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19884978|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19884979|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19884980|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884981|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19884982|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884983|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
19884984|NCT00983385|Tapentadol|tapentadol|mesh-list
19884985|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19884986|NCT00983385|Narcotics|narcotics|mesh-ancestor
19884987|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19884988|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19884989|NCT00983385|Analgesics|analgesics|mesh-ancestor
19884990|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
19884991|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19884992|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19884993|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19884994|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19884995|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19884996|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
19884997|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19884998|NCT00983515|Ritonavir|ritonavir|mesh-list
19884999|NCT00983515|Colchicine|colchicine|mesh-list
19885000|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19885001|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19885002|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
19885003|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885004|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885005|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19885006|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19885007|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
19885008|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885009|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19885010|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19885011|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
19885012|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885013|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
19885014|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
19885015|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
19885016|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885017|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
19885018|NCT00983528|Clofarabine|clofarabine|mesh-list
19885019|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19885020|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885021|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19885022|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
19885023|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885024|NCT00983541|Gemcitabine|gemcitabine|mesh-list
19885025|NCT00983541|Fluorouracil|fluorouracil|mesh-list
19885026|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19885027|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
19885028|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885029|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885030|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
19885031|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885032|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885033|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885034|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
19885035|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885036|NCT00983580|Aspirin|aspirin|mesh-list
19885037|NCT00983580|Eflornithine|eflornithine|mesh-list
19885038|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19885039|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19885040|NCT00983580|Analgesics|analgesics|mesh-ancestor
19885041|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
19885042|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885043|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885044|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885045|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885046|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19885047|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19885048|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885049|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19885050|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19885051|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885052|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
19885053|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885054|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19885055|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19885056|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19885057|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885058|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19885059|NCT00983619|Rituximab|rituximab|mesh-list
19885060|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19885061|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885062|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
19885063|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885064|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885065|NCT00983853|Ribavirin|ribavirin|mesh-list
19885066|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19885067|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
19885068|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885069|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
19885070|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885071|NCT00983905|Colchicine|colchicine|mesh-list
19885072|NCT00983905|Theophylline|theophylline|mesh-list
19885073|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
19885074|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885075|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
19885076|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
19885077|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
19885078|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885079|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885080|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19885081|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
19885082|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885083|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885084|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19885085|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
19885086|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19885087|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885088|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
19885089|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19885090|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19885091|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
19885092|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885093|NCT00983918|Propofol|propofol|mesh-list
19885094|NCT00983918|Sevoflurane|sevoflurane|mesh-list
19885095|NCT00983918|Desflurane|desflurane|mesh-list
19885096|NCT00983918|Isoflurane|isoflurane|mesh-list
19885097|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19885098|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885099|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885100|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19885101|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
19885102|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
19885103|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19885104|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19885105|NCT00983931|Cyclosporine|cyclosporine|mesh-list
19885106|NCT00983931|Colchicine|colchicine|mesh-list
19885107|NCT00983931|Cyclosporins|cyclosporins|mesh-list
19885108|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885109|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885110|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885111|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
19885112|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885113|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
19885114|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885115|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885116|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885117|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19885118|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
19885119|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
19885120|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
19885121|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19885122|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885123|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
19885124|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19885125|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19885126|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
19885127|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19885128|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885129|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19885130|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19885131|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19885132|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19885133|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885134|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19885135|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19885136|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885137|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885138|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970741|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19970742|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970743|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970744|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19970745|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
19970746|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970747|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970748|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19970749|NCT01787916|Liraglutide|liraglutide|mesh-list
19970750|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19970751|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970752|NCT01787916|Incretins|incretins|mesh-ancestor
19970753|NCT01787916|Hormones|hormones|mesh-ancestor
19970754|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970755|NCT01788215|Doxycycline|doxycycline|mesh-list
19970756|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970757|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970758|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
19970759|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19970760|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19970761|NCT01788228|Vaccines|vaccines|mesh-list
19970762|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
19970763|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970764|NCT01788358|Candesartan|candesartan|mesh-list
19970765|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
19970766|NCT01788358|Nifedipine|nifedipine|mesh-list
19970767|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19970768|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19970769|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19970770|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970771|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19970772|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19970773|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19970774|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970775|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
19970776|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
19970777|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19970778|NCT01788566|Gemcitabine|gemcitabine|mesh-list
19970779|NCT01788566|Necitumumab|necitumumab|mesh-list
19970780|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970781|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19885139|NCT00984009|Colchicine|colchicine|mesh-list
19885140|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
19885141|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885142|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
19885143|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
19885144|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
19885145|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885146|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885147|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19885148|NCT00984022|Laxatives|laxatives|mesh-ancestor
19885149|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885150|NCT00984061|Clarithromycin|clarithromycin|mesh-list
19885151|NCT00984061|Colchicine|colchicine|mesh-list
19885152|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19885153|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885154|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19885155|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885156|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885157|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19885158|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19885159|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
19885160|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885161|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
19885162|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
19885163|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
19885164|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885165|NCT00984126|Factor VIII|factor viii|mesh-list
19885166|NCT00984126|Coagulants|coagulants|mesh-ancestor
19885167|NCT00984139|Vaccines|vaccines|mesh-list
19885168|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
19885169|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257557|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257558|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257559|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885170|NCT00984256|Atovaquone|atovaquone|mesh-list
19885171|NCT00984256|Proguanil|proguanil|mesh-list
19885172|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19885173|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885174|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
19885175|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19885176|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19885177|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885178|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885179|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
19885180|NCT00984282|Sorafenib|sorafenib|mesh-list
19885181|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885182|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19885183|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885184|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885185|NCT00984334|Naloxone|naloxone|mesh-list
19885186|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19885187|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885188|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
19885189|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885190|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19885191|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19885192|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
19885193|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885194|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885195|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19885196|NCT00984568|Prednisolone|prednisolone|mesh-list
19885197|NCT00984568|Mesalamine|mesalamine|mesh-list
19885198|NCT00984568|Azathioprine|azathioprine|mesh-list
19449623|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19449624|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19449625|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449626|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
19449627|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449628|NCT03433807|Idebenone|idebenone|mesh-list
19449629|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
19449630|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449631|NCT03433807|Protective Agents|protective agents|mesh-ancestor
19449632|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449633|NCT03433586|Aspirin|aspirin|mesh-list
19449634|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19885199|NCT00984568|Infliximab|infliximab|mesh-list
19885200|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885201|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
19885202|NCT00984568|Hormones|hormones|mesh-ancestor
19885203|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885204|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885205|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19885206|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885207|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885208|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885209|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885210|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885211|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
19885212|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885213|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19885214|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885215|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
19885216|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
19885217|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19885218|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885219|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19885220|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19885221|NCT00984568|Analgesics|analgesics|mesh-ancestor
19885222|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
19885223|NCT00984620|Interferons|interferons|mesh-list
19885224|NCT00984620|Ribavirin|ribavirin|mesh-list
19885225|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
19885226|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885227|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
19885228|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885229|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
19885230|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885231|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
19885232|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885233|NCT00984659|Fluticasone|fluticasone|mesh-list
19885234|NCT00984659|Xhance|xhance|mesh-list
19885235|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19885236|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885237|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19885238|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
19885239|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885240|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885241|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19885242|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
19885243|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885244|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19885245|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19885246|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19885247|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19885248|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
19885249|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885250|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885251|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
19885252|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19885253|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885254|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19885255|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885256|NCT00985192|Everolimus|everolimus|mesh-list
19885257|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885258|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885259|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
19885260|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885261|NCT00985426|Vaccines|vaccines|mesh-list
19885262|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
19885263|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885264|NCT00985439|Celecoxib|celecoxib|mesh-list
19885265|NCT00985439|Diclofenac|diclofenac|mesh-list
19885266|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19885267|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19885268|NCT00985439|Analgesics|analgesics|mesh-ancestor
19885269|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
19885270|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449635|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449636|NCT03433586|Analgesics|analgesics|mesh-ancestor
19885271|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885272|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885273|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885274|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19885275|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19885276|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885277|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885278|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19885279|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
19885280|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885281|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19885282|NCT00985504|Citalopram|citalopram|mesh-list
19885283|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19885284|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19885285|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885286|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885287|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885288|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
19885289|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885290|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19885291|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
19885292|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19885293|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885294|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19885295|NCT00985504|Analgesics|analgesics|mesh-ancestor
19885296|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
19885297|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
19885298|NCT00985543|Ritonavir|ritonavir|mesh-list
19885299|NCT00985543|Lopinavir|lopinavir|mesh-list
19885300|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19885301|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19885302|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
19885303|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885304|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885305|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19885306|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19885307|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
19885308|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885309|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19885310|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19885311|NCT00985621|Oxycodone|oxycodone|mesh-list
19885312|NCT00985621|Tanezumab|tanezumab|mesh-list
19885313|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19885314|NCT00985621|Narcotics|narcotics|mesh-ancestor
19885315|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885316|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885317|NCT00985621|Analgesics|analgesics|mesh-ancestor
19885318|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
19885319|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885320|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
19885321|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19885322|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885323|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19885324|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19885325|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885326|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19885327|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19885328|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885329|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885330|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
19885331|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885332|NCT00985751|Vaccines|vaccines|mesh-list
19885333|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19885334|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
19885335|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885336|NCT00985907|Bortezomib|bortezomib|mesh-list
19885337|NCT00985907|Melphalan|melphalan|mesh-list
19885338|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19885339|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885340|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19885341|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
19885342|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885343|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19885344|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885345|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
19885346|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885347|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19885348|NCT00985946|Panobinostat|panobinostat|mesh-list
19885349|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885350|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19885351|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885352|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885353|NCT00985959|Prednisolone|prednisolone|mesh-list
19885354|NCT00985959|Bortezomib|bortezomib|mesh-list
19885355|NCT00985959|Melphalan|melphalan|mesh-list
19885356|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885357|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19885358|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
19885359|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885360|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19885361|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885362|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
19885363|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885364|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885365|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
19885366|NCT00985959|Hormones|hormones|mesh-ancestor
19885367|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885368|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19885369|NCT00985985|Nicotine|nicotine|mesh-list
19885370|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19885371|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
19885372|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885373|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885374|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19885375|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19885376|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
19885377|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885378|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885379|NCT00986102|Doripenem|doripenem|mesh-list
19885380|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19885381|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885382|NCT00986154|Heparin|heparin|mesh-list
19885383|NCT00986154|Calcium heparin|calcium heparin|mesh-list
19885384|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19885385|NCT00986154|Tinzaparin|tinzaparin|mesh-list
19885386|NCT00986154|Dalteparin|dalteparin|mesh-list
19885387|NCT00986154|Warfarin|warfarin|mesh-list
19885388|NCT00986154|Edoxaban|edoxaban|mesh-list
19885389|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
19885390|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19885391|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19885392|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885393|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19885394|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
19885395|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19885396|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
19885397|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885398|NCT00986180|Oxycodone|oxycodone|mesh-list
19885399|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19885400|NCT00986180|Narcotics|narcotics|mesh-ancestor
19885401|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885402|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885403|NCT00986180|Analgesics|analgesics|mesh-ancestor
19885404|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
19885405|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885406|NCT00986245|Ropinirole|ropinirole|mesh-list
19885407|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19885408|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19885409|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
19885410|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
19885411|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885412|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885413|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885414|NCT00986258|Tapentadol|tapentadol|mesh-list
19885415|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19885416|NCT00986258|Narcotics|narcotics|mesh-ancestor
19885417|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885418|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885419|NCT00986258|Analgesics|analgesics|mesh-ancestor
19885420|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
19885421|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885422|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19885423|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19885424|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885425|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885426|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
19885427|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885428|NCT00986401|Metformin|metformin|mesh-list
19885429|NCT00986401|Trospium chloride|trospium chloride|mesh-list
19885430|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19885431|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885432|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
19885433|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
19885434|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257560|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
20257561|NCT00480298|Hormones|hormones|mesh-ancestor
20257562|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257563|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20257564|NCT00480298|Protective Agents|protective agents|mesh-ancestor
20257565|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20257566|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257567|NCT00480363|Dexamethasone|dexamethasone|mesh-list
20257568|NCT00480363|Lenalidomide|lenalidomide|mesh-list
20257569|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257570|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
20257571|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
19885435|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19885436|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19885437|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
19885438|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970782|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
19885439|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885440|NCT00986401|Urological Agents|urological agents|mesh-ancestor
19885441|NCT00986427|Cyclosporine|cyclosporine|mesh-list
19885442|NCT00986427|Cyclosporins|cyclosporins|mesh-list
19885443|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885444|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885445|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885446|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
19885447|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885448|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
19885449|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885450|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885451|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885452|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19885453|NCT00986440|Efatutazone|efatutazone|mesh-list
19885454|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885455|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
19885456|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19885457|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19885458|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19885459|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885460|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885461|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
19885462|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885463|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885464|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19885465|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885466|NCT00986583|Succinylcholine|succinylcholine|mesh-list
19885467|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19885468|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19885469|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19885470|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885471|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885472|NCT00986674|Paclitaxel|paclitaxel|mesh-list
19885473|NCT00986674|Carboplatin|carboplatin|mesh-list
19885474|NCT00986674|Cetuximab|cetuximab|mesh-list
19885475|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19885476|NCT00986674|Antibodies|antibodies|mesh-list
19885477|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
19885478|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19885479|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19885480|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885481|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
19885482|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19885483|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19885484|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885485|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
19885486|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885487|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
19885488|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19885489|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885490|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19885491|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885492|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885493|NCT00986921|Mifepristone|mifepristone|mesh-list
19885494|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19885495|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
19885496|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19885497|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885498|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19885499|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19885500|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19885501|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
19885502|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19885503|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19885504|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
20536182|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536183|NCT01824758|Lidocaine|lidocaine|mesh-list
20536184|NCT01824758|Rocuronium|rocuronium|mesh-list
20536185|NCT01824758|Esmolol|esmolol|mesh-list
20536186|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
20536187|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
20536188|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885505|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885506|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
19885507|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19885508|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19885509|NCT00986986|Niacin|niacin|mesh-list
19885510|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19885511|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
19885512|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885513|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19885514|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
19885515|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
20257572|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257573|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257574|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20257575|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
20257576|NCT00480363|Hormones|hormones|mesh-ancestor
20257577|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257578|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19885516|NCT00986986|Vitamins|vitamins|mesh-ancestor
19885517|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
19885518|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885519|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
19885520|NCT00987389|Hormones|hormones|mesh-ancestor
19885521|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885522|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885523|NCT00987402|Ethanol|ethanol|mesh-list
19885524|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19885525|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885526|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257579|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885527|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885528|NCT00987415|Allopurinol|allopurinol|mesh-list
19885529|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
19885530|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885531|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885532|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
20257580|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
19885533|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20257581|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19449637|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
19885534|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19885535|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
19449638|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449639|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449640|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449641|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885536|NCT00987415|Protective Agents|protective agents|mesh-ancestor
19885537|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885538|NCT00987467|Cyclosporine|cyclosporine|mesh-list
19885539|NCT00987467|Cyclosporins|cyclosporins|mesh-list
19885540|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885541|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885542|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885543|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
19885544|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885545|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
19885546|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885547|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885548|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885549|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20536189|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885550|NCT00987480|Cyclosporine|cyclosporine|mesh-list
19885551|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
19885552|NCT00987480|Busulfan|busulfan|mesh-list
19885553|NCT00987480|Fludarabine|fludarabine|mesh-list
19885554|NCT00987480|Cyclosporins|cyclosporins|mesh-list
19885555|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885556|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
19885557|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257582|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19885558|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885559|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19885560|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
19885561|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885562|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885563|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19885564|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885565|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
19885566|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885567|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885568|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19885569|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19449642|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19885570|NCT00987558|Simvastatin|simvastatin|mesh-list
19885571|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19885572|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19885573|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
19885574|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885575|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19449643|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20257583|NCT00480363|Growth Substances|growth substances|mesh-ancestor
20257584|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
20257585|NCT00480376|Gentamicins|gentamicins|mesh-list
20257586|NCT00480376|Ofloxacin|ofloxacin|mesh-list
20257587|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20257588|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257589|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20257590|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257591|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257592|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20257593|NCT00480376|Renal Agents|renal agents|mesh-ancestor
20257594|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20257595|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20257596|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257597|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20257598|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20257599|NCT00480389|Sorafenib|sorafenib|mesh-list
19449644|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885576|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19885577|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885578|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
19885579|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19885580|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19885581|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885582|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19885583|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
19885584|NCT00987727|Glycerol|glycerol|mesh-list
19885585|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20257600|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885586|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
19885587|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885588|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
19885589|NCT00987727|Protective Agents|protective agents|mesh-ancestor
20257601|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257602|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257603|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257604|NCT00480402|Progesterone|progesterone|mesh-list
20257605|NCT00480402|Progestins|progestins|mesh-ancestor
20257606|NCT00480402|Hormones|hormones|mesh-ancestor
19449645|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19885590|NCT00987727|Laxatives|laxatives|mesh-ancestor
19885591|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885592|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19885593|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
19885594|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19885595|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885596|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
19885597|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
19885598|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885599|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885600|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885601|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
19885602|NCT00987831|Hormones|hormones|mesh-ancestor
19885603|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885604|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19885605|NCT00987831|Protective Agents|protective agents|mesh-ancestor
19885606|NCT00987935|Sorafenib|sorafenib|mesh-list
19449646|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19449647|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449648|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
19885607|NCT00987935|Nintedanib|nintedanib|mesh-list
19885608|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885609|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19885610|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885611|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885612|NCT00987948|Maraviroc|maraviroc|mesh-list
20257607|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257608|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885613|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19885614|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19885615|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885616|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19885617|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19885618|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
19885619|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885620|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19885621|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
19885622|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19885623|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
19885624|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885625|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
19449649|NCT03433534|Nivolumab|nivolumab|mesh-list
19449650|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19449651|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449652|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19885626|NCT00988091|Protective Agents|protective agents|mesh-ancestor
19885627|NCT00988117|Rivastigmine|rivastigmine|mesh-list
19885628|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19885629|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885630|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885631|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
19885632|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885633|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885634|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19885635|NCT00988117|Protective Agents|protective agents|mesh-ancestor
19885636|NCT00988143|Vaccines|vaccines|mesh-list
19885637|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
19885638|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885639|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19885640|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
19885641|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19885642|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19885643|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885644|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449653|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449654|NCT03433469|Osimertinib|osimertinib|mesh-list
19449655|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885645|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19885646|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885647|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19885648|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885649|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885650|NCT00988208|Prednisone|prednisone|mesh-list
19885651|NCT00988208|Docetaxel|docetaxel|mesh-list
19885652|NCT00988208|Lenalidomide|lenalidomide|mesh-list
19885653|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885654|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
19885655|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
19885656|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
19885657|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885658|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885659|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
19885660|NCT00988208|Hormones|hormones|mesh-ancestor
19885661|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885662|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885663|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19885664|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
19885665|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19885666|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19885667|NCT00988208|Growth Substances|growth substances|mesh-ancestor
19885668|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
19885669|NCT00988325|Oseltamivir|oseltamivir|mesh-list
19885670|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
19885671|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885672|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885673|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885674|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19885675|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
19885676|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19885677|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19885678|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885679|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885680|NCT00988533|Ivermectin|ivermectin|mesh-list
19885681|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19885682|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885683|NCT00988559|Imiquimod|imiquimod|mesh-list
19885684|NCT00988559|Vaccines|vaccines|mesh-list
19885685|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
19885686|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885687|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19885688|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885689|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
19970783|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970784|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
19970785|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970786|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970787|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970788|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
19970789|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970790|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19970791|NCT01788631|Regadenoson|regadenoson|mesh-list
19449656|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19970792|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19970793|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19970794|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
19970795|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
19885690|NCT00988637|Calcitriol|calcitriol|mesh-list
19885691|NCT00988637|Clobetasol|clobetasol|mesh-list
19885692|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19885693|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885694|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19885695|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885696|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885697|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19885698|NCT00988637|Vitamins|vitamins|mesh-ancestor
19885699|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
19885700|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19885701|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885702|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
19885703|NCT00988637|Hormones|hormones|mesh-ancestor
19885704|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885705|NCT00988832|Infliximab|infliximab|mesh-list
19885706|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885707|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885708|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885709|NCT00988858|Pemetrexed|pemetrexed|mesh-list
19885710|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885711|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885712|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885713|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19885714|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20257609|NCT00480454|Vaccines|vaccines|mesh-list
20257610|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
20257611|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257612|NCT00480558|Vaccines|vaccines|mesh-list
20257613|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
20257614|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885715|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
20257615|NCT00480571|Perphenazine|perphenazine|mesh-list
19885716|NCT00989092|Hematinics|hematinics|mesh-ancestor
19885717|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19885718|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19885719|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19885720|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885721|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885722|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885723|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885724|NCT00989157|Analgesics|analgesics|mesh-ancestor
19885725|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
19885726|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885727|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
19885728|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19885729|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
19885730|NCT00989196|Factor VIII|factor viii|mesh-list
19885731|NCT00989196|Coagulants|coagulants|mesh-ancestor
19885732|NCT00989235|Abatacept|abatacept|mesh-list
19885733|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19885734|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885735|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885736|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885737|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
19885738|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885739|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19885740|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19885741|NCT00989586|Veltuzumab|veltuzumab|mesh-list
19885742|NCT00989586|Antibodies|antibodies|mesh-list
19885743|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
19885744|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19885745|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
19885746|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885747|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885748|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
19885749|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885750|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
19885751|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19885752|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19885753|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19885754|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885755|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885756|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
19885757|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885758|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885759|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19885760|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885761|NCT00989781|Dexamethasone|dexamethasone|mesh-list
19885762|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19885763|NCT00989781|Hormones|hormones|mesh-list
19885764|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19885765|NCT00989781|Cosyntropin|cosyntropin|mesh-list
19885766|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19885767|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19885768|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
19885769|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885770|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
19885771|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
19885772|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885773|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885774|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885775|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
19885776|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885777|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19885778|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885779|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19885780|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885781|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885782|NCT00989833|Budesonide|budesonide|mesh-list
19885783|NCT00989833|Terbutaline|terbutaline|mesh-list
19885784|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
19885785|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885786|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19885787|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
19885788|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885789|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885790|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19885791|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
19885792|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
19885793|NCT00989833|Hormones|hormones|mesh-ancestor
19885794|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885795|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19885796|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19885797|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19885798|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
19885799|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885800|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885801|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
19885802|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
20257616|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
20257617|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
19885803|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19885804|NCT00989911|Bosentan|bosentan|mesh-list
19885805|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20257618|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257619|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536190|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
19885806|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20257620|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257621|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20257622|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19885807|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257623|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885808|NCT00989950|Methylphenidate|methylphenidate|mesh-list
19885809|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19885810|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885811|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19885812|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19885813|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885814|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885815|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
20536191|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885816|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885817|NCT00989963|Beraprost|beraprost|mesh-list
19885818|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19885819|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
19885820|NCT00989989|Ranibizumab|ranibizumab|mesh-list
19885821|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19885822|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19885823|NCT00989989|Growth Substances|growth substances|mesh-ancestor
19885824|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885825|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
19885826|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885827|NCT00990106|Prazosin|prazosin|mesh-list
19885828|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19885829|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19885830|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19885831|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20257624|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19885832|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
19885833|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885834|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885835|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885836|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19885837|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19885838|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19885839|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
19885840|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885841|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19885842|NCT00990236|Enoxaparin|enoxaparin|mesh-list
20257625|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20257626|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
20257627|NCT00480584|Gemcitabine|gemcitabine|mesh-list
20257628|NCT00480584|Capecitabine|capecitabine|mesh-list
19885843|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
19885844|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
19885845|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19885846|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19885847|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885848|NCT00990249|Busulfan|busulfan|mesh-list
19885849|NCT00990249|Clofarabine|clofarabine|mesh-list
19885850|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
19885851|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19885852|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
19885853|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885854|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885855|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
19885856|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885857|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19885858|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257629|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20257630|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20257631|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
20257632|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257633|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885859|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19885860|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19885861|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
19885862|NCT00990288|Thrombin|thrombin|mesh-list
19885863|NCT00990288|Hemostatics|hemostatics|mesh-list
19885864|NCT00990288|Coagulants|coagulants|mesh-ancestor
19885865|NCT00990314|Epoprostenol|epoprostenol|mesh-list
19885866|NCT00990314|Beraprost|beraprost|mesh-list
19885867|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19885868|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
19885869|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19885870|NCT00990561|Clobetasol|clobetasol|mesh-list
19885871|NCT00990561|Halobetasol|halobetasol|mesh-list
19885872|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19885873|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19885874|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
19885875|NCT00990561|Hormones|hormones|mesh-ancestor
19885876|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19885877|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449657|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885878|NCT00990652|Bortezomib|bortezomib|mesh-list
19885879|NCT00990652|Temozolomide|temozolomide|mesh-list
19885880|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885881|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19885882|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
19885883|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885884|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19885885|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19885886|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
19885887|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19885888|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885889|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19885890|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19885891|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19885892|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
19885893|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885894|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
19885895|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19885896|NCT00990704|Protective Agents|protective agents|mesh-ancestor
19885897|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885898|NCT00990769|Anesthetics|anesthetics|mesh-list
19885899|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885900|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885901|NCT00990821|Midazolam|midazolam|mesh-list
19885902|NCT00990821|Aprepitant|aprepitant|mesh-list
19885903|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
19885904|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19885905|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19885906|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885907|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885908|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19885909|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19885910|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19885911|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19885912|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
19885913|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
19885914|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
19885915|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
19885916|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885917|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885918|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
19885919|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
19885920|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885921|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19885922|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19885923|NCT00991029|Clopidogrel|clopidogrel|mesh-list
19885924|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19885925|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19885926|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19885927|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19885928|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
19885929|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885930|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885931|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885932|NCT00991081|Bupropion|bupropion|mesh-list
19885933|NCT00991081|Nicotine|nicotine|mesh-list
19885934|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19885935|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
19885936|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885937|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885938|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19885939|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19885940|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
19885941|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885942|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885943|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19885944|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
19885945|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19885946|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19885947|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19885948|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885949|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
19885950|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19885951|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19885952|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257634|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
19885953|NCT00991276|Pregabalin|pregabalin|mesh-list
19885954|NCT00991276|Pramipexole|pramipexole|mesh-list
19449658|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449659|NCT03433378|Tretinoin|tretinoin|mesh-list
19885955|NCT00991276|Analgesics|analgesics|mesh-ancestor
20257635|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257636|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257637|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257638|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
20257639|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257640|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257641|NCT00480597|Gemcitabine|gemcitabine|mesh-list
20257642|NCT00480597|Capecitabine|capecitabine|mesh-list
20257643|NCT00480597|Vinorelbine|vinorelbine|mesh-list
20257644|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257645|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20257646|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
20257647|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257648|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
19885956|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
19885957|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19885958|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885959|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
19885960|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20257649|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257650|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885961|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19885962|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885963|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20257651|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257652|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
20257653|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885964|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19885965|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19885966|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19885967|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19885968|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
19885969|NCT00991276|Protective Agents|protective agents|mesh-ancestor
19885970|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19885971|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19885972|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
19885973|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
19885974|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19885975|NCT00991289|Interferons|interferons|mesh-list
19885976|NCT00991289|Ribavirin|ribavirin|mesh-list
19885977|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
19885978|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
19885979|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19885980|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
19885981|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19885982|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
19885983|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885984|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
19885985|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885986|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
19885987|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885988|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19885989|NCT00991458|Cyclosporine|cyclosporine|mesh-list
19885990|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19885991|NCT00991458|Cyclosporins|cyclosporins|mesh-list
19885992|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19885993|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19885994|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19885995|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
19885996|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19885997|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
19885998|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19885999|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
19886000|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886001|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19886002|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19886003|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
19886004|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19886005|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886006|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19886007|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
19886008|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19886009|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886010|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886011|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886012|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
20257654|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20257655|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
19886013|NCT00991809|Promethazine|promethazine|mesh-list
20257656|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
20257657|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
20257658|NCT00480610|Tacrolimus|tacrolimus|mesh-list
20257659|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257660|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
20257661|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257662|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20257663|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257664|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257665|NCT00480623|Satraplatin|satraplatin|mesh-list
20257666|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257667|NCT00480649|Fluticasone|fluticasone|mesh-list
20257668|NCT00480649|Xhance|xhance|mesh-list
20257669|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20257670|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257671|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20257672|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
20257673|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257674|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257675|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20257676|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
20257677|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
20257678|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20257679|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20257680|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20257681|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20257682|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
20257683|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257684|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257685|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20536192|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20536193|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20536194|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20536195|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536196|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536197|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20536198|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20536199|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20536200|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20536201|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19886014|NCT00991809|Alfentanil|alfentanil|mesh-list
19886015|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19886016|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19886017|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886018|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886019|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
19886020|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
19886021|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
19886022|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886023|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
19886024|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
19886025|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19886026|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19886027|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
19886028|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
19886029|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886030|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886031|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19886032|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
19886033|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
19886034|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19886035|NCT00991809|Narcotics|narcotics|mesh-ancestor
19886036|NCT00991809|Analgesics|analgesics|mesh-ancestor
19886037|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19886038|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
19886039|NCT00991939|Dexamethasone|dexamethasone|mesh-list
19886040|NCT00991939|Prednisone|prednisone|mesh-list
19886041|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886042|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
19886043|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
19886044|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886045|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886046|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19886047|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
19886048|NCT00991939|Hormones|hormones|mesh-ancestor
19886049|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886050|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19886051|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886052|NCT00991952|Irinotecan|irinotecan|mesh-list
19886053|NCT00991952|Alvocidib|alvocidib|mesh-list
19886054|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19886055|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19886056|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886057|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886058|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886059|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
19886060|NCT00991952|Growth Substances|growth substances|mesh-ancestor
19886061|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886062|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19886063|NCT00992056|Metoprolol|metoprolol|mesh-list
19886064|NCT00992056|Nebivolol|nebivolol|mesh-list
19886065|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19886066|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19886067|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
20257686|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
19886068|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
20257687|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20257688|NCT00480675|Prednisolone|prednisolone|mesh-list
20257689|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
20257690|NCT00480675|Bupivacaine|bupivacaine|mesh-list
20257691|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20257692|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
20257693|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
20536202|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20536203|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
20536204|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536205|NCT01824836|Anastrozole|anastrozole|mesh-list
20536206|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20536207|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536208|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20536209|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20536210|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536211|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536212|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19886069|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886070|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886071|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19886072|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19886073|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19886074|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
19886075|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886076|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886077|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
19886078|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19886079|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19886080|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19886081|NCT00992108|Lidocaine|lidocaine|mesh-list
19886082|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
19886083|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
19886084|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886085|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886086|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
19886087|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886088|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19886089|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19886090|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19886091|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19886092|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886093|NCT00992394|Etanercept|etanercept|mesh-list
19886094|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19886095|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19886096|NCT00992394|Analgesics|analgesics|mesh-ancestor
19886097|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
19886098|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886099|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886100|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886101|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886102|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19886103|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886104|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
19886105|NCT00992407|Risperidone|risperidone|mesh-list
19886106|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19886107|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
19886108|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886109|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886110|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886111|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19886112|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19886113|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886114|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20257694|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
20257695|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257696|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257697|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
20257698|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257699|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257700|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
20257701|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
20257702|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20257703|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
20257704|NCT00480675|Hormones|hormones|mesh-ancestor
20257705|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257706|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20257707|NCT00480675|Protective Agents|protective agents|mesh-ancestor
20257708|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20257709|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257710|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
20257711|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
20257712|NCT00480844|Risperidone|risperidone|mesh-list
20257713|NCT00480844|Sertindole|sertindole|mesh-list
20257714|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20257715|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
20257716|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257717|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257718|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257719|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20257720|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20257721|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257722|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20257723|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20536213|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
19886115|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19886116|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
19886117|NCT00992446|Cytarabine|cytarabine|mesh-list
19886118|NCT00992446|Rituximab|rituximab|mesh-list
19886119|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19886120|NCT00992446|Etoposide|etoposide|mesh-list
19886121|NCT00992446|Bortezomib|bortezomib|mesh-list
19886122|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
19886123|NCT00992446|Melphalan|melphalan|mesh-list
19886124|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
19886125|NCT00992446|Vorinostat|vorinostat|mesh-list
19886126|NCT00992446|Carmustine|carmustine|mesh-list
19886127|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
19886128|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19886129|NCT00992446|Antibodies|antibodies|mesh-list
19886130|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
19886131|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19886132|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
19886133|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886134|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886135|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886136|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19886137|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19886138|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19886139|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886140|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886141|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19886142|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
19886143|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
19886144|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886145|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886146|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19886147|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
19886148|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19886149|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19886150|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
19886151|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
19886152|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
19886153|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
19886154|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
20536214|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536215|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536216|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
20536217|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20553712|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553713|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20553714|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553715|NCT01930864|Metformin|metformin|mesh-list
20553716|NCT01930864|Irinotecan|irinotecan|mesh-list
20553717|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20553718|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553719|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20553720|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20553721|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553722|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553723|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553724|NCT01930877|Lidocaine|lidocaine|mesh-list
20553725|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
20553726|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
20553727|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553728|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553729|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
20553730|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553731|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20553732|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20553733|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20553734|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20553735|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553736|NCT01930916|Anticoagulants|anticoagulants|mesh-list
20553737|NCT01930916|Antibodies|antibodies|mesh-list
20553738|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
19886155|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19886156|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886157|NCT00992511|Vaccines|vaccines|mesh-list
19886158|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
19886159|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886160|NCT00992589|Rabeprazole|rabeprazole|mesh-list
19886161|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19886162|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19886163|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19886164|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886165|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886166|NCT00992602|Cytarabine|cytarabine|mesh-list
19886167|NCT00992602|Methotrexate|methotrexate|mesh-list
19886168|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19886169|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
19886170|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19886171|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886172|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19886173|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
19886174|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886175|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886176|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
19886177|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886178|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19886179|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886180|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
19886181|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886182|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19886183|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
19886184|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886185|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
19886186|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886187|NCT00993031|Ritonavir|ritonavir|mesh-list
19886188|NCT00993031|Lopinavir|lopinavir|mesh-list
19886189|NCT00993031|Lamivudine|lamivudine|mesh-list
19886190|NCT00993031|Zidovudine|zidovudine|mesh-list
19886191|NCT00993031|Efavirenz|efavirenz|mesh-list
19886192|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19886193|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19886194|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
19886195|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886196|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886197|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19886198|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19886199|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
19886200|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886201|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19886202|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19886203|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19886204|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19886205|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
19886206|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19886207|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19886208|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19886209|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19886210|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19886211|NCT00993044|Bevacizumab|bevacizumab|mesh-list
19886212|NCT00993044|Irinotecan|irinotecan|mesh-list
19886213|NCT00993044|Vincristine|vincristine|mesh-list
19886214|NCT00993044|Temozolomide|temozolomide|mesh-list
19886215|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19886216|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886217|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19886218|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19886219|NCT00993044|Growth Substances|growth substances|mesh-ancestor
19886220|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886221|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
19886222|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19886223|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19886224|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886225|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886226|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19886227|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
19886228|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
19886229|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
19886230|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19886231|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
19886232|NCT00993148|Ritonavir|ritonavir|mesh-list
19886233|NCT00993148|Darunavir|darunavir|mesh-list
19886234|NCT00993148|Maraviroc|maraviroc|mesh-list
19886235|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19886236|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19886237|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
19886238|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886239|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886240|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19886241|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19886242|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
19886243|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886244|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19886245|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19886246|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19886247|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19886248|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19886249|NCT00993187|Metformin|metformin|mesh-list
19886250|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19886251|NCT00993187|Glimepiride|glimepiride|mesh-list
19886252|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19886253|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886254|NCT00993187|Incretins|incretins|mesh-ancestor
19886255|NCT00993187|Hormones|hormones|mesh-ancestor
19886256|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886257|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19886258|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
19886259|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886260|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886261|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19886262|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886263|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
19886264|NCT00993200|Warfarin|warfarin|mesh-list
19886265|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
19886266|NCT00993226|Bupivacaine|bupivacaine|mesh-list
19886267|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
19886268|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
19886269|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886270|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886271|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
19886272|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886273|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
19886274|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19886275|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
19886276|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886277|NCT00993265|Expectorants|expectorants|mesh-ancestor
19886278|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
19886279|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19886280|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
19886281|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886282|NCT00993265|Protective Agents|protective agents|mesh-ancestor
19886283|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886284|NCT00993265|Antidotes|antidotes|mesh-ancestor
19886285|NCT00993317|Methotrexate|methotrexate|mesh-list
19886286|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
19886287|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19886288|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
19886289|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19886290|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886291|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19886292|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
19886293|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886294|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886295|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
19886296|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886297|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19886298|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886299|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
19886300|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886301|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19886302|NCT00993421|Sibutramine|sibutramine|mesh-list
19886303|NCT00993421|Metoprolol|metoprolol|mesh-list
19886304|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19886305|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19886306|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
19886307|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
19886308|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886309|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886310|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19886311|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19886312|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19886313|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
19886314|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970796|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886315|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886316|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
19886317|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19886318|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
19886319|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19886320|NCT00993473|Insulin|insulin|mesh-list
19886321|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19886322|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
19886323|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
19886324|NCT00993473|Protamines|protamines|mesh-list
19886325|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19886326|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886327|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
19886328|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886329|NCT00993473|Coagulants|coagulants|mesh-ancestor
19886330|NCT00993499|Sirolimus|sirolimus|mesh-list
19886331|NCT00993499|Afatinib|afatinib|mesh-list
19886332|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19886333|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886334|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19886335|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886336|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
19886337|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886338|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
19886339|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886340|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19886341|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886342|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886343|NCT00993616|Carboplatin|carboplatin|mesh-list
19886344|NCT00993616|Belinostat|belinostat|mesh-list
19886345|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886346|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19886347|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886348|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886349|NCT00993655|Paclitaxel|paclitaxel|mesh-list
19886350|NCT00993655|Carboplatin|carboplatin|mesh-list
19886351|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19886352|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886353|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
19886354|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
19886355|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
19886356|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886357|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
19886358|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886359|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
19886360|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257724|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
20257725|NCT00480870|Donepezil|donepezil|mesh-list
20257726|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20257727|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257728|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257729|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
20257730|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257731|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257732|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
20257733|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20257734|NCT00480883|Allopurinol|allopurinol|mesh-list
20257735|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
20257736|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257737|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257738|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
20257739|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886361|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886362|NCT00993798|Bupivacaine|bupivacaine|mesh-list
19886363|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
19886364|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
19886365|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886366|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886367|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
19886368|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886369|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19886370|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19886371|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19886372|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
19886373|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886374|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19886375|NCT00993915|Atorvastatin|atorvastatin|mesh-list
19886376|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19886377|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19886378|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
19886379|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886380|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19886381|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19886382|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886383|NCT00993967|Idebenone|idebenone|mesh-list
19886384|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
19886385|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886386|NCT00993967|Protective Agents|protective agents|mesh-ancestor
19886387|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886388|NCT00994110|Pasireotide|pasireotide|mesh-list
19886389|NCT00994110|Hormones|hormones|mesh-ancestor
19886390|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886391|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886392|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19886393|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886394|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19886395|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886396|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886397|NCT00994175|Pioglitazone|pioglitazone|mesh-list
19886398|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19886399|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886400|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
19886401|NCT00994318|Hematinics|hematinics|mesh-ancestor
19970797|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970798|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970799|NCT01789047|Topiramate|topiramate|mesh-list
19970800|NCT01789047|Amantadine|amantadine|mesh-list
19970801|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
19970802|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19970803|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970804|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19970805|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19970806|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
19970807|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970808|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
19970809|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970810|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970811|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19970812|NCT01789047|Analgesics|analgesics|mesh-ancestor
19970813|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
19970814|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970815|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
19970816|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970817|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970818|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19970819|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19970820|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970821|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970822|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970823|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19970824|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19970825|NCT01789255|Cyclosporine|cyclosporine|mesh-list
19970826|NCT01789255|Methotrexate|methotrexate|mesh-list
19970827|NCT01789255|Vorinostat|vorinostat|mesh-list
19970828|NCT01789255|Tacrolimus|tacrolimus|mesh-list
19970829|NCT01789255|Cyclosporins|cyclosporins|mesh-list
19970830|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19970831|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
19970832|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20536218|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19886402|NCT00994422|Ivermectin|ivermectin|mesh-list
19886403|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19886404|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886405|NCT00994448|Bupropion|bupropion|mesh-list
19886406|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19886407|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
19886408|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19886409|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19886410|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19886411|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19886412|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886413|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
19886414|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886415|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886416|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19886417|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19886418|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886419|NCT00994461|Celecoxib|celecoxib|mesh-list
19886420|NCT00994461|Loxoprofen|loxoprofen|mesh-list
19886421|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19886422|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19886423|NCT00994461|Analgesics|analgesics|mesh-ancestor
19886424|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
19886425|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886426|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886427|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886428|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886429|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19886430|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19886431|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886432|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886433|NCT00994643|Aldesleukin|aldesleukin|mesh-list
19886434|NCT00994643|Rituximab|rituximab|mesh-list
19886435|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19886436|NCT00994643|Interleukin-2|interleukin-2|mesh-list
19886437|NCT00994643|Antibodies|antibodies|mesh-list
19886438|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
19886439|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19886440|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
19886441|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886442|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886443|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886444|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19886445|NCT00994643|Analgesics|analgesics|mesh-ancestor
19886446|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
19886447|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886448|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19886449|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19886450|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
19886451|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886452|NCT00994682|Pioglitazone|pioglitazone|mesh-list
19886453|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19886454|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886455|NCT00994760|Fentanyl|fentanyl|mesh-list
19886456|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19886457|NCT00994760|Narcotics|narcotics|mesh-ancestor
19886458|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886459|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886460|NCT00994760|Analgesics|analgesics|mesh-ancestor
19886461|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
19886462|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886463|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19886464|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19886465|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
19886466|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
19886467|NCT00994890|Tanezumab|tanezumab|mesh-list
19886468|NCT00994890|Analgesics|analgesics|mesh-ancestor
20257740|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20257741|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
20257742|NCT00480883|Protective Agents|protective agents|mesh-ancestor
20257743|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886469|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
19886470|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257744|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19886471|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886472|NCT00994929|Oprelvekin|oprelvekin|mesh-list
19886473|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886474|NCT00995007|Carboplatin|carboplatin|mesh-list
19886475|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886476|NCT00995072|Metoprolol|metoprolol|mesh-list
20257745|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20257746|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257747|NCT00480896|Tacrolimus|tacrolimus|mesh-list
20257748|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257749|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
20257750|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257751|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20257752|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257753|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257754|NCT00480935|Sunitinib|sunitinib|mesh-list
20257755|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257756|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20257757|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20257758|NCT00480935|Growth Substances|growth substances|mesh-ancestor
20257759|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257760|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
19449660|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449661|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
19449662|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
19449663|NCT03433352|Methimazole|methimazole|mesh-list
19449664|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
19449665|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
19449666|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
19886477|NCT00995072|Nebivolol|nebivolol|mesh-list
20257761|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20257762|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257763|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257764|NCT00481013|Valproic Acid|valproic acid|mesh-list
20257765|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
20257766|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257767|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257768|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
20257769|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257770|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257771|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
20257772|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19886478|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19886479|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19886480|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
19886481|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
19886482|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257773|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257774|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20257775|NCT00481091|Navitoclax|navitoclax|mesh-list
20257776|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257777|NCT00481143|Deferasirox|deferasirox|mesh-list
20257778|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20257779|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
20257780|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
20257781|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257782|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
20257783|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19886483|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886484|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19886485|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19886486|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19449667|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886487|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
19886488|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886489|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886490|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
19886491|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19886492|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19886493|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19886494|NCT00995085|Pyridoxine|pyridoxine|mesh-list
19886495|NCT00995085|Metadoxine|metadoxine|mesh-list
19886496|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19886497|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
19886498|NCT00995085|Vitamins|vitamins|mesh-ancestor
19886499|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
19886500|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886501|NCT00995475|Fluticasone|fluticasone|mesh-list
19886502|NCT00995475|Xhance|xhance|mesh-list
19886503|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886504|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19886505|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
19886506|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886507|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886508|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19886509|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
19886510|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19886511|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19886512|NCT00995488|Paclitaxel|paclitaxel|mesh-list
19886513|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19886514|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19886515|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886516|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
19886517|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
19886518|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
19886519|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886520|NCT00995501|Insulin|insulin|mesh-list
19886521|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19886522|NCT00995501|Dexamethasone|dexamethasone|mesh-list
19886523|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
19886524|NCT00995501|Anesthetics|anesthetics|mesh-list
19886525|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
19886526|NCT00995501|BB 1101|bb 1101|mesh-list
19886527|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19886528|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886529|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886530|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
19886531|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
19886532|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886533|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19886534|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
19886535|NCT00995501|Hormones|hormones|mesh-ancestor
19886536|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886537|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19886538|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886539|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
19886540|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886541|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886542|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886543|NCT00995501|Cathartics|cathartics|mesh-ancestor
19886544|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
19886545|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19886546|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886547|NCT00995670|Ascorbic Acid|ascorbic acid|mesh-list
19886548|NCT00995670|Sevoflurane|sevoflurane|mesh-list
19886549|NCT00995670|Simvastatin|simvastatin|mesh-list
19886550|NCT00995670|Vitamins|vitamins|mesh-ancestor
19886551|NCT00995670|Micronutrients|micronutrients|mesh-ancestor
19886552|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886553|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19886554|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19886555|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
19886556|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886557|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19886558|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19886559|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886560|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19886561|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19886562|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
19886563|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
19886564|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886565|NCT00995670|Antioxidants|antioxidants|mesh-ancestor
19886566|NCT00995670|Protective Agents|protective agents|mesh-ancestor
19886567|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19886568|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
19886569|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886570|NCT00995722|Prednisone|prednisone|mesh-list
19886571|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449668|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257784|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20257785|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
20257786|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257787|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257788|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20286787|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886572|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
19886573|NCT00995722|Hormones|hormones|mesh-ancestor
19886574|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886575|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886576|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19886577|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886578|NCT00995761|Cisplatin|cisplatin|mesh-list
19886579|NCT00995761|Docetaxel|docetaxel|mesh-list
19886580|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886581|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
19886582|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
19886583|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
19886584|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886585|NCT00996034|Nicotine|nicotine|mesh-list
19886586|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886587|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19886588|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
19886589|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286788|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20286789|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19886590|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19886591|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19886592|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
19886593|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886594|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886595|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
19886596|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
19886597|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886598|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19886599|NCT00996281|Olmesartan|olmesartan|mesh-list
19886600|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19886601|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
19886602|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19886603|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19886604|NCT00996281|Diuretics|diuretics|mesh-ancestor
19886605|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
19886606|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886607|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19886608|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19886609|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886610|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19886611|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19886612|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
19886613|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19886614|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
19886615|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886616|NCT00996346|Sirolimus|sirolimus|mesh-list
19886617|NCT00996346|Irinotecan|irinotecan|mesh-list
19886618|NCT00996346|Complement Factor H|complement factor h|mesh-list
19886619|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19886620|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19886621|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886622|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886623|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886624|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19886625|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886626|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19886627|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
19886628|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886629|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
19886630|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886631|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19886632|NCT00996437|Ranibizumab|ranibizumab|mesh-list
19886633|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19886634|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19886635|NCT00996437|Growth Substances|growth substances|mesh-ancestor
19886636|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886637|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
19886638|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886639|NCT00996476|Simeprevir|simeprevir|mesh-list
19886640|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
19886641|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886642|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
19886643|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886644|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886645|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
19886646|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19886647|NCT00996580|Estradiol|estradiol|mesh-list
19886648|NCT00996580|Estrogens|estrogens|mesh-ancestor
19886649|NCT00996580|Hormones|hormones|mesh-ancestor
19886650|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886651|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886652|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19886653|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
19886654|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19886655|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19886656|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19886657|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19886658|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19886659|NCT00996593|Iodine|iodine|mesh-list
19886660|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
19886661|NCT00996593|Antibodies|antibodies|mesh-list
19886662|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
19886663|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
19886664|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886665|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19886666|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886667|NCT00996593|Trace Elements|trace elements|mesh-ancestor
19886668|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
19886669|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886670|NCT00996658|Linagliptin|linagliptin|mesh-list
19886671|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19886672|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886673|NCT00996658|Incretins|incretins|mesh-ancestor
19886674|NCT00996658|Hormones|hormones|mesh-ancestor
19886675|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886676|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19886677|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
19886678|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886679|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886680|NCT00996736|Voriconazole|voriconazole|mesh-list
19886681|NCT00996736|Natamycin|natamycin|mesh-list
19886682|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
19886683|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886684|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19886685|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19886686|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886687|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886688|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19886689|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
19886690|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886691|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886692|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19886693|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19886694|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19886695|NCT00996801|Vitamin D|vitamin d|mesh-list
19886696|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
19886697|NCT00996801|Alendronate|alendronate|mesh-list
19886698|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
19886699|NCT00996801|Calcium|calcium|mesh-list
19886700|NCT00996801|Vitamins|vitamins|mesh-ancestor
19886701|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
19886702|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886703|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19886704|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19886705|NCT00996801|Antacids|antacids|mesh-ancestor
19886706|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886707|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19886708|NCT00996931|Lenalidomide|lenalidomide|mesh-list
19886709|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
19886710|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886711|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19886712|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19886713|NCT00996931|Growth Substances|growth substances|mesh-ancestor
19886714|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
19886715|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886716|NCT00996944|Ropinirole|ropinirole|mesh-list
19886717|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19886718|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19886719|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
19886720|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
19886721|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886722|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886723|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886724|NCT00996996|Iodine|iodine|mesh-list
19886725|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
19886726|NCT00996996|Antibodies|antibodies|mesh-list
19886727|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
19886728|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
19886729|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886730|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19886731|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886732|NCT00996996|Trace Elements|trace elements|mesh-ancestor
19886733|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
19886734|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886735|NCT00997035|Voriconazole|voriconazole|mesh-list
19886736|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
19886737|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886738|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19886739|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19886740|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886741|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886742|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19886743|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
19886744|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886745|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886746|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19886747|NCT00997113|Alfentanil|alfentanil|mesh-list
19886748|NCT00997113|Propofol|propofol|mesh-list
19886749|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19886750|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886751|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886752|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19886753|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
19886754|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
19886755|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19886756|NCT00997113|Narcotics|narcotics|mesh-ancestor
19886757|NCT00997113|Analgesics|analgesics|mesh-ancestor
19886758|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
19886759|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886760|NCT00997126|Alfentanil|alfentanil|mesh-list
19886761|NCT00997126|Propofol|propofol|mesh-list
19886762|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19886763|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886764|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886765|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19886766|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
19886767|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
19886768|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19886769|NCT00997126|Narcotics|narcotics|mesh-ancestor
19886770|NCT00997126|Analgesics|analgesics|mesh-ancestor
19886771|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
19886772|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886773|NCT00997139|Polymyxins|polymyxins|mesh-list
19886774|NCT00997139|Neomycin|neomycin|mesh-list
19886775|NCT00997139|Bacitracin|bacitracin|mesh-list
19886776|NCT00997139|Polymyxin B|polymyxin b|mesh-list
19886777|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
19886778|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19886779|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886780|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19886781|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886782|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886783|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19886784|NCT00997204|Icatibant|icatibant|mesh-list
19886785|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19886786|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19886787|NCT00997204|Analgesics|analgesics|mesh-ancestor
19886788|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
19886789|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886790|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886791|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886792|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886793|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19886794|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19886795|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886796|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19886797|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19886798|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
19886799|NCT00997243|Azacitidine|azacitidine|mesh-list
19886800|NCT00997243|Lintuzumab|lintuzumab|mesh-list
19886801|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19886802|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
19886803|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886804|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886805|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886806|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19886807|NCT00997321|Ketamine|ketamine|mesh-list
19886808|NCT00997321|Propofol|propofol|mesh-list
19886809|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19886810|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886811|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886812|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19886813|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
19886814|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
19886815|NCT00997321|Analgesics|analgesics|mesh-ancestor
19886816|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
19886817|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886818|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19886819|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19886820|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19886821|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886822|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886823|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19886824|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886825|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19886826|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886827|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886828|NCT00997373|Letrozole|letrozole|mesh-list
19886829|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886830|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19886831|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19886832|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886833|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886834|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19886835|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
19886836|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886837|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886838|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
19886839|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
19886840|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886841|NCT00997438|Protective Agents|protective agents|mesh-ancestor
19886842|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886843|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
19886844|NCT00997438|Vitamins|vitamins|mesh-ancestor
19886845|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
19886846|NCT00997503|Aspirin|aspirin|mesh-list
19886847|NCT00997503|Paclitaxel|paclitaxel|mesh-list
19886848|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19886849|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19886850|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886851|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
19886852|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
20257789|NCT00481182|Ritonavir|ritonavir|mesh-list
20257790|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
20257791|NCT00481182|Methadone|methadone|mesh-list
19886853|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
19886854|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886855|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19886856|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19886857|NCT00997503|Analgesics|analgesics|mesh-ancestor
19886858|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
19886859|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886860|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886861|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886862|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19886863|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19886864|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19886865|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19886866|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19886867|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886868|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
19886869|NCT00997620|Fluticasone|fluticasone|mesh-list
19886870|NCT00997620|Xhance|xhance|mesh-list
19886871|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19886872|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19886873|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
19886874|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886875|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886876|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19886877|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
19886878|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
19886879|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19886880|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
19886881|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
19886882|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19886883|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886884|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886885|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
19886886|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19886887|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19886888|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886889|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19886890|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19886891|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19886892|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
19886893|NCT00997893|Estradiol|estradiol|mesh-list
19886894|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19886895|NCT00997893|Estrogens|estrogens|mesh-list
19886896|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
19886897|NCT00997893|Hormones|hormones|mesh-ancestor
19886898|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19886899|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886900|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19886901|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
19886902|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19886903|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19886904|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19886905|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19886906|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19886907|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19886908|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19886909|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886910|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19886911|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
19886912|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
19886913|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19886914|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886915|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19886916|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19886917|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19886918|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19886919|NCT00997984|Guanfacine|guanfacine|mesh-list
19886920|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19886921|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19886922|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19886923|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19886924|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
19886925|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886926|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886927|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886928|NCT00998010|Bortezomib|bortezomib|mesh-list
19886929|NCT00998010|Temozolomide|temozolomide|mesh-list
19886930|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886931|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19886932|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
19886933|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886934|NCT00998049|Plerixafor|plerixafor|mesh-list
19886935|NCT00998049|Lenograstim|lenograstim|mesh-list
19886936|NCT00998049|Sargramostim|sargramostim|mesh-list
19886937|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19886938|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
19886939|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886940|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19886941|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19886942|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
19886943|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886944|NCT00998205|Atropine|atropine|mesh-list
19886945|NCT00998205|Dobutamine|dobutamine|mesh-list
19886946|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19886947|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19886948|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19886949|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
19886950|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19886951|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886952|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19886953|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
19886954|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
19886955|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
19886956|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19886957|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19886958|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
19886959|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19886960|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886961|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19886962|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
19886963|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19886964|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19886965|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19886966|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19886967|NCT00998205|Protective Agents|protective agents|mesh-ancestor
19886968|NCT00998296|Nintedanib|nintedanib|mesh-list
19886969|NCT00998296|Afatinib|afatinib|mesh-list
19886970|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19886971|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19886972|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886973|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19886974|NCT00998309|Azithromycin|azithromycin|mesh-list
19886975|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19886976|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886977|NCT00998335|Insulin|insulin|mesh-list
19886978|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19886979|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
19886980|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
19886981|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19886982|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
19886983|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19886984|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886985|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
19886986|NCT00998426|Antibodies|antibodies|mesh-list
19886987|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
19886988|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19886989|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19886990|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
19886991|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
19886992|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19886993|NCT00998582|Tenofovir|tenofovir|mesh-list
19886994|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
19886995|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19886996|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19886997|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19886998|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19886999|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887000|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19887001|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19887002|NCT00998946|Vitamins|vitamins|mesh-list
19887003|NCT00998946|Folic Acid|folic acid|mesh-list
19887004|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
19887005|NCT00998946|Hydroxocobalamin|hydroxocobalamin|mesh-list
19887006|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
19887007|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19887008|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
19887009|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887010|NCT00998946|Hematinics|hematinics|mesh-ancestor
19887011|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887012|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19887013|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887014|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887015|NCT00998985|Grazoprevir|grazoprevir|mesh-list
19887016|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
19887017|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887018|NCT00999037|Sevelamer|sevelamer|mesh-list
19887019|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
19887020|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
19887021|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887022|NCT00999102|Metoprolol|metoprolol|mesh-list
19887023|NCT00999102|Nebivolol|nebivolol|mesh-list
19887024|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19887025|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19887026|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
19887027|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
19887028|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887029|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887030|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19887031|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19887032|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19887033|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
19887034|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887035|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887036|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
19887037|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19887038|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19887039|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19970833|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970834|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970835|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
19970836|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970837|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970838|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
19970839|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970840|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19970841|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970842|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
19970843|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970844|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19970845|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19970846|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
19970847|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970848|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19970849|NCT01789281|Everolimus|everolimus|mesh-list
20257792|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20257793|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19970850|NCT01789281|Octreotide|octreotide|mesh-list
19970851|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970852|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970853|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
19970854|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970855|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19970856|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19970857|NCT01789320|Triamcinolone|triamcinolone|mesh-list
19970858|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19970859|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19970860|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19970861|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970862|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
19970863|NCT01789320|Hormones|hormones|mesh-ancestor
19970864|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970865|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970866|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970867|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
20257794|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
19887040|NCT00999518|Tanezumab|tanezumab|mesh-list
19887041|NCT00999518|Analgesics|analgesics|mesh-ancestor
19887042|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
19887043|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887044|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887045|NCT00999544|Oxycodone|oxycodone|mesh-list
19887046|NCT00999544|Aprepitant|aprepitant|mesh-list
19887047|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
19887048|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19887049|NCT00999544|Narcotics|narcotics|mesh-ancestor
19887050|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19887051|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257795|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257796|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257797|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20257798|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20257799|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
20257800|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257801|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20257802|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20257803|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20257804|NCT00481182|Narcotics|narcotics|mesh-ancestor
20257805|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257806|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257807|NCT00481182|Analgesics|analgesics|mesh-ancestor
20257808|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
20257809|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257810|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
20257811|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
20257812|NCT00481273|Azacitidine|azacitidine|mesh-list
19887052|NCT00999544|Analgesics|analgesics|mesh-ancestor
19887053|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
19887054|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887055|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
19887056|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
19887057|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19887058|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19887059|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887060|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887061|NCT00999713|Calfactant|calfactant|mesh-list
19887062|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19887063|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
19887064|NCT00999804|Trastuzumab|trastuzumab|mesh-list
19887065|NCT00999804|Letrozole|letrozole|mesh-list
19887066|NCT00999804|Lapatinib|lapatinib|mesh-list
19887067|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887068|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887069|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19887070|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19887071|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887072|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887073|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19887074|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
19887075|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887076|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887077|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19887078|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
19887079|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19887080|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
19887081|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887082|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887083|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19887084|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
19887085|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
19887086|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19887087|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
19887088|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887089|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887090|NCT00999921|Tamoxifen|tamoxifen|mesh-list
19887091|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
19887092|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19887093|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
19887094|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887095|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887096|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19887097|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887098|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19887099|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19887100|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19887101|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887102|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887103|NCT00999921|Analgesics|analgesics|mesh-ancestor
19887104|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
19887105|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887106|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887107|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887108|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19887109|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
19887110|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887111|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19887112|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
19887113|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19887114|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19887115|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887116|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19887117|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19887118|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19887119|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887120|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
19887121|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887122|NCT01000155|Vorinostat|vorinostat|mesh-list
19887123|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887124|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19887125|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887126|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887127|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
19887128|NCT01000285|Prednisone|prednisone|mesh-list
19887129|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
19887130|NCT01000285|Doxorubicin|doxorubicin|mesh-list
19887131|NCT01000285|Etoposide|etoposide|mesh-list
19887132|NCT01000285|Vincristine|vincristine|mesh-list
19887133|NCT01000285|Bortezomib|bortezomib|mesh-list
19887134|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887135|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
19887136|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887137|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887138|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19887139|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
19887140|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887141|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887142|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19887143|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19887144|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19887145|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19887146|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887147|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887148|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
19887149|NCT01000285|Hormones|hormones|mesh-ancestor
19887150|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887151|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19887152|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19887153|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
19887154|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
19887155|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
19887156|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19887157|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19887158|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
19887159|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887160|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19887161|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19887162|NCT01000311|Vaccines|vaccines|mesh-list
19887163|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19887164|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
19887165|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887166|NCT01000337|Propofol|propofol|mesh-list
19887167|NCT01000337|Sevoflurane|sevoflurane|mesh-list
19887168|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19887169|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19887170|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887171|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19887172|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
19887173|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
19887174|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19887175|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19887176|NCT01000376|Ketoconazole|ketoconazole|mesh-list
19887177|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
19887178|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887179|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19887180|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19887181|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887182|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887183|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19887184|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
19887185|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887186|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887187|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19887188|NCT01000480|Pemetrexed|pemetrexed|mesh-list
19887189|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887190|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887191|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887192|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19887193|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19887194|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
19887195|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19887196|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19887197|NCT01000610|Prednisolone|prednisolone|mesh-list
19887198|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
19887199|NCT01000610|Rituximab|rituximab|mesh-list
19887200|NCT01000610|Methotrexate|methotrexate|mesh-list
19887201|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19887202|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
19887203|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887204|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887205|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
19887206|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887207|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887208|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19887209|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
19887210|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19887211|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19887212|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
19887213|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887214|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
19887215|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887216|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19887217|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887218|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19887219|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887220|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
19887221|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
19887222|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887223|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19887224|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
19887225|NCT01000610|Hormones|hormones|mesh-ancestor
19887226|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887227|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19887228|NCT01000610|Protective Agents|protective agents|mesh-ancestor
19887229|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19887230|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19887231|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19887232|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
19887233|NCT01000649|Vasopressins|vasopressins|mesh-list
19887234|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
19887235|NCT01000649|Coagulants|coagulants|mesh-ancestor
19887236|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19887237|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19887238|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
19887239|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887240|NCT01000727|Darapladib|darapladib|mesh-list
19887241|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19887242|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887243|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887244|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19887245|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19887246|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19887247|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19887248|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887249|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887250|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887251|NCT01000805|Analgesics|analgesics|mesh-ancestor
19887252|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
19887253|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887254|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
19887255|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19887256|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
19887257|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
19887258|NCT01000818|Omeprazole|omeprazole|mesh-list
19887259|NCT01000818|Famotidine|famotidine|mesh-list
19887260|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19887261|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19887262|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19887263|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887264|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887265|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19887266|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19887267|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
19887268|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887269|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19887270|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19887271|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19887272|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
19887273|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
19887274|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887275|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887276|NCT01000961|Cysteamine|cysteamine|mesh-list
19887277|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19887278|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887279|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19887280|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
19887281|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887282|NCT01000987|Varenicline|varenicline|mesh-list
19887283|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19887284|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19887285|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
19887286|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887287|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887288|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887289|NCT01001052|Colchicine|colchicine|mesh-list
19887290|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
19887291|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887292|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
19887293|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
19887294|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
19887295|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887296|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887297|NCT01001104|Dulaglutide|dulaglutide|mesh-list
19887298|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19887299|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887300|NCT01001195|Bimatoprost|bimatoprost|mesh-list
19887301|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19887302|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19887303|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19887304|NCT01001208|Etanercept|etanercept|mesh-list
19887305|NCT01001208|Methotrexate|methotrexate|mesh-list
19887306|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19887307|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
19887308|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19887309|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887310|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19887311|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
19887312|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887313|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887314|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
19887315|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887316|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19887317|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887318|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
19887319|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887320|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19887321|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887322|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887323|NCT01001208|Analgesics|analgesics|mesh-ancestor
19887324|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
19887325|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887326|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887327|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19887328|NCT01001221|Gemcitabine|gemcitabine|mesh-list
19887329|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19887330|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
19887331|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887332|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887333|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
19887334|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887335|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887336|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887337|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
19887338|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887339|NCT01001377|Cetuximab|cetuximab|mesh-list
19887340|NCT01001377|Panitumumab|panitumumab|mesh-list
19887341|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887342|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887343|NCT01001403|Nafamostat|nafamostat|mesh-list
19887344|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887345|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887346|NCT01001403|Analgesics|analgesics|mesh-ancestor
19887347|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
19887348|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887349|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887350|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887351|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887352|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
19887353|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
19887354|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887355|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887356|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19887357|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19887358|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19887359|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887360|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
19887361|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
19887362|NCT01001429|Propofol|propofol|mesh-list
19887363|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19887364|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19887365|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887366|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19887367|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
19887368|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
19887369|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887370|NCT01001429|Analgesics|analgesics|mesh-ancestor
19887371|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
19887372|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887373|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19887374|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19887375|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19887376|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
19887377|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887378|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887379|NCT01001442|Maytansine|maytansine|mesh-list
19887380|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19887381|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887382|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19887383|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19887384|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19887385|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887386|NCT01001494|Bromides|bromides|mesh-list
19887387|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
19887388|NCT01001520|Tolcapone|tolcapone|mesh-list
19887389|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19887390|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19887391|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19887392|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887393|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887394|NCT01001559|Norepinephrine|norepinephrine|mesh-list
19887395|NCT01001559|Serotonin|serotonin|mesh-list
19887396|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19887397|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
19887398|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19887399|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19887400|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
19887401|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887402|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887403|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887404|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
19887405|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
19887406|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887407|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19887408|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19887409|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
19887410|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19887411|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19887412|NCT01001572|Amlodipine|amlodipine|mesh-list
19887413|NCT01001572|Valsartan|valsartan|mesh-list
19887414|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19887415|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19887416|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19887417|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887418|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19887419|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887420|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
19887421|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19887422|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19887423|NCT01001598|Danazol|danazol|mesh-list
19887424|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19887425|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
19887426|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887427|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887428|NCT01001702|Aripiprazole|aripiprazole|mesh-list
19887429|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
19887430|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19887431|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19887432|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19887433|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19887434|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887435|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
19887436|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
19887437|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887438|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887439|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19887440|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19887441|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
19887442|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19887443|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19887444|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19887445|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19887446|NCT01001806|Ketorolac|ketorolac|mesh-list
19887447|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19887448|NCT01001806|Nepafenac|nepafenac|mesh-list
19887449|NCT01001806|Bromfenac|bromfenac|mesh-list
19887450|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887451|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887452|NCT01001806|Analgesics|analgesics|mesh-ancestor
19887453|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
19887454|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887455|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887456|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887457|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887458|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19887459|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887460|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887461|NCT01001832|Abatacept|abatacept|mesh-list
19887462|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19887463|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887464|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887465|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887466|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
19887467|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887468|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887469|NCT01001910|Carboplatin|carboplatin|mesh-list
19887470|NCT01001910|Pemetrexed|pemetrexed|mesh-list
19887471|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887472|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887473|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887474|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19887475|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19887476|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
19887477|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19887478|NCT01001975|Protective Agents|protective agents|mesh-ancestor
19887479|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887480|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
19887481|NCT01002105|Baclofen|baclofen|mesh-list
19887482|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19887483|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887484|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19887485|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887486|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19887487|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
19887488|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
19887489|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257813|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20257814|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
20257815|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257816|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257817|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257818|NCT00481312|Midazolam|midazolam|mesh-list
20257819|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
20257820|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20257821|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20257822|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257823|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20257824|NCT00481312|Analgesics|analgesics|mesh-ancestor
20257825|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
20257826|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257827|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20257828|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20257829|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20257830|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
20257831|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257832|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257833|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20536219|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20536220|NCT01824992|Interferons|interferons|mesh-list
20536221|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887490|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887491|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
19887492|NCT01002339|Cyclosporine|cyclosporine|mesh-list
19887493|NCT01002339|Prednisone|prednisone|mesh-list
19887494|NCT01002339|Tacrolimus|tacrolimus|mesh-list
19887495|NCT01002339|Basiliximab|basiliximab|mesh-list
19887496|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887497|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
19887498|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887499|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19887500|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970868|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887501|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887502|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19887503|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887504|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19887505|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
19887506|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19887507|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887508|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887509|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
19887510|NCT01002339|Hormones|hormones|mesh-ancestor
19887511|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887512|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19887513|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
19887514|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
19887515|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887516|NCT01002547|Vitamins|vitamins|mesh-list
19887517|NCT01002547|Vitamin E|vitamin e|mesh-list
19887518|NCT01002547|Tocopherols|tocopherols|mesh-list
19887519|NCT01002547|Tocotrienols|tocotrienols|mesh-list
19887520|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
19887521|NCT01002547|Pioglitazone|pioglitazone|mesh-list
19887522|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
19887523|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887524|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19887525|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
19887526|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887527|NCT01002547|Protective Agents|protective agents|mesh-ancestor
19887528|NCT01002573|Acetaminophen|acetaminophen|mesh-list
19887529|NCT01002573|Ibuprofen|ibuprofen|mesh-list
19887530|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887531|NCT01002573|Analgesics|analgesics|mesh-ancestor
19887532|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
19887533|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887534|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887535|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
19887536|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887537|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887538|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887539|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19887540|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887541|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887542|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
19887543|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19887544|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887545|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19887546|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
19887547|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19887548|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887549|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887550|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887551|NCT01002755|Lenalidomide|lenalidomide|mesh-list
19887552|NCT01002755|Ofatumumab|ofatumumab|mesh-list
19887553|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19887554|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
19887555|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887556|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19887557|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19887558|NCT01002755|Growth Substances|growth substances|mesh-ancestor
19887559|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
19887560|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887561|NCT01003080|Hemostatics|hemostatics|mesh-list
19887562|NCT01003080|Coagulants|coagulants|mesh-ancestor
19887563|NCT01003106|Ranibizumab|ranibizumab|mesh-list
19887564|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19887565|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19887566|NCT01003106|Growth Substances|growth substances|mesh-ancestor
19887567|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887568|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
19887569|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887570|NCT01003184|Exenatide|exenatide|mesh-list
19887571|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
19887572|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19887573|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887574|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19887575|NCT01003184|Incretins|incretins|mesh-ancestor
19887576|NCT01003184|Hormones|hormones|mesh-ancestor
20257834|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19887577|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887578|NCT01003249|Baclofen|baclofen|mesh-list
19887579|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19887580|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887581|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19887582|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887583|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19887584|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
19887585|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
19887586|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887587|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887588|NCT01003301|Omalizumab|omalizumab|mesh-list
19887589|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20257835|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20257836|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20257837|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20257838|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
20257839|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
20257840|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
20257841|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
20257842|NCT00481364|Atorvastatin|atorvastatin|mesh-list
20257843|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20257844|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20257845|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
20257846|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257847|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20257848|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19887590|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19887591|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
19887592|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19887593|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
19887594|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887595|NCT01003639|Aspirin|aspirin|mesh-list
19887596|NCT01003639|Acetaminophen|acetaminophen|mesh-list
19887597|NCT01003639|Ibuprofen|ibuprofen|mesh-list
19887598|NCT01003639|Naproxen|naproxen|mesh-list
19887599|NCT01003639|Acetazolamide|acetazolamide|mesh-list
19887600|NCT01003639|Codeine|codeine|mesh-list
19887601|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887602|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887603|NCT01003639|Analgesics|analgesics|mesh-ancestor
19887604|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
19887605|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887606|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887607|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887608|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887609|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19887610|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19887611|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887612|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19887613|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19887614|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887615|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
19887616|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
19887617|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
19887618|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19887619|NCT01003639|Diuretics|diuretics|mesh-ancestor
19887620|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
19887621|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19887622|NCT01003639|Narcotics|narcotics|mesh-ancestor
19887623|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19887624|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
19887625|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
19887626|NCT01003769|Acetic Acid|acetic acid|mesh-list
19887627|NCT01003769|Lenalidomide|lenalidomide|mesh-list
19887628|NCT01003769|Retinol acetate|retinol acetate|mesh-list
19887629|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
19887630|NCT01003769|Gossypol|gossypol|mesh-list
19887631|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
19887632|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887633|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19887634|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20257849|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887635|NCT01003769|Growth Substances|growth substances|mesh-ancestor
19887636|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
19887637|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887638|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19887639|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887640|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19887641|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19887642|NCT01003769|Protective Agents|protective agents|mesh-ancestor
19887643|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19887644|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
19887645|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19887646|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19887647|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19887648|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19887649|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19887650|NCT01003886|Doxazosin|doxazosin|mesh-list
19887651|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19887652|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19887653|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19887654|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19887655|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
19887656|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887657|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887658|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887659|NCT01003899|Afatinib|afatinib|mesh-list
19887660|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887661|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19887662|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887663|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887664|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19887665|NCT01003938|Topotecan|topotecan|mesh-list
19887666|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887667|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19887668|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887669|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887670|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19887671|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19887672|NCT01003990|Ritonavir|ritonavir|mesh-list
19887673|NCT01003990|Lopinavir|lopinavir|mesh-list
19887674|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19887675|NCT01003990|Tenofovir|tenofovir|mesh-list
19887676|NCT01003990|Emtricitabine|emtricitabine|mesh-list
19887677|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19887678|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19887679|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
19887680|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887681|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887682|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19887683|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19887684|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
19887685|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887686|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19887687|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19887688|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19887689|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19887690|NCT01004003|Sorafenib|sorafenib|mesh-list
19887691|NCT01004003|Nintedanib|nintedanib|mesh-list
19887692|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887693|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19887694|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887695|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887696|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19887697|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19887698|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19887699|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
19887700|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887701|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887702|NCT01004029|Progestins|progestins|mesh-ancestor
19887703|NCT01004029|Hormones|hormones|mesh-ancestor
19887704|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
19887705|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19887706|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19887707|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19887708|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19887709|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887710|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
19887711|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887712|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887713|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19887714|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887715|NCT01004159|Irinotecan|irinotecan|mesh-list
20257850|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
20257851|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20257852|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257853|NCT00481442|Phenylephrine|phenylephrine|mesh-list
20257854|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
20257855|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20257856|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
20257857|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
20257858|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257859|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257860|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
20257861|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20257862|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
20257863|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
20257864|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20257865|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20257866|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20257867|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
20257868|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257869|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257870|NCT00481442|Protective Agents|protective agents|mesh-ancestor
20257871|NCT00481455|Temozolomide|temozolomide|mesh-list
20257872|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
20257873|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20257874|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
20257875|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257876|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257877|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
20257878|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
20257879|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
20257880|NCT00481481|Tacrolimus|tacrolimus|mesh-list
20257881|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257882|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
20257883|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257884|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20257885|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257886|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257887|NCT00481533|Oxytocin|oxytocin|mesh-list
20257888|NCT00481533|Ergonovine|ergonovine|mesh-list
20257889|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
20257890|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20257891|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257892|NCT00481572|Terlipressin|terlipressin|mesh-list
20257893|NCT00481572|Vasopressins|vasopressins|mesh-list
20257894|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
20257895|NCT00481572|Norepinephrine|norepinephrine|mesh-list
19887716|NCT01004159|Cetuximab|cetuximab|mesh-list
19887717|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19887718|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19887719|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887720|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887721|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887722|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887723|NCT01004172|Bevacizumab|bevacizumab|mesh-list
19887724|NCT01004172|Trastuzumab|trastuzumab|mesh-list
19887725|NCT01004172|Carboplatin|carboplatin|mesh-list
19887726|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887727|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887728|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19887729|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19887730|NCT01004172|Growth Substances|growth substances|mesh-ancestor
19887731|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887732|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
19887733|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19887734|NCT01004185|Mesalamine|mesalamine|mesh-list
19887735|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887736|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887737|NCT01004185|Analgesics|analgesics|mesh-ancestor
19887738|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
20257896|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20257897|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19887739|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887740|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887741|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887742|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887743|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
19887744|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19887745|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887746|NCT01004250|Bevacizumab|bevacizumab|mesh-list
19887747|NCT01004250|Pemetrexed|pemetrexed|mesh-list
19887748|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887749|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887750|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19887751|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19887752|NCT01004250|Growth Substances|growth substances|mesh-ancestor
19887753|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887754|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
19887755|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887756|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887757|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19887758|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19887759|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
19887760|NCT01004354|Vitamin D|vitamin d|mesh-list
19887761|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19887762|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887763|NCT01004354|Vitamins|vitamins|mesh-ancestor
19887764|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
19887765|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19887766|NCT01004393|Bromides|bromides|mesh-list
19887767|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
19887768|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
19887769|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19887770|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887771|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
19887772|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887773|NCT01004406|Atorvastatin|atorvastatin|mesh-list
19887774|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19887775|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19887776|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19887777|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
19887778|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887779|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19887780|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887781|NCT01004432|Golimumab|golimumab|mesh-list
19887782|NCT01004432|Methotrexate|methotrexate|mesh-list
19887783|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19887784|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19887785|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
19887786|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19887787|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887788|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19887789|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
19887790|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887791|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887792|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
19887793|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887794|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19887795|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887796|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
19887797|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887798|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19887799|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19887800|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970869|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970870|NCT01789606|Ibuprofen|ibuprofen|mesh-list
19970871|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19970872|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19970873|NCT01789606|Analgesics|analgesics|mesh-ancestor
19970874|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
19970875|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970876|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970877|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19970878|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970879|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19887801|NCT01004614|Amlodipine|amlodipine|mesh-list
19887802|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19887803|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19887804|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19887805|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887806|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19887807|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887808|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
19887809|NCT01004705|Aspirin|aspirin|mesh-list
19887810|NCT01004705|Ramipril|ramipril|mesh-list
19887811|NCT01004705|Simvastatin|simvastatin|mesh-list
19887812|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19887813|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19887814|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
19887815|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887816|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19887817|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19887818|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887819|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19887820|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19887821|NCT01004705|Analgesics|analgesics|mesh-ancestor
19887822|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
19887823|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887824|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887825|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887826|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887827|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19887828|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19887829|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19887830|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19887831|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
19887832|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19887833|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
19887834|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19887835|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
19887836|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19887837|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19887838|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887839|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
19887840|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
19887841|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887842|NCT01004744|Anastrozole|anastrozole|mesh-list
19887843|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19887844|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887845|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19887846|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19887847|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887848|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887849|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19887850|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
19887851|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887852|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887853|NCT01004939|PENTA|penta|mesh-list
19887854|NCT01004939|Fondaparinux|fondaparinux|mesh-list
19887855|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19887856|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
19887857|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19887858|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
19887859|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887860|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887861|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
19887862|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19887863|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19887864|NCT01004991|Prednisone|prednisone|mesh-list
19887865|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
19887866|NCT01004991|Rituximab|rituximab|mesh-list
19887867|NCT01004991|Doxorubicin|doxorubicin|mesh-list
19887868|NCT01004991|Vincristine|vincristine|mesh-list
19887869|NCT01004991|Azacitidine|azacitidine|mesh-list
19887870|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887871|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
19887872|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887873|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19887874|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19887875|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
19887876|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887877|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887878|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19887879|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887880|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19887881|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19887882|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19887883|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887884|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887885|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
19887886|NCT01004991|Hormones|hormones|mesh-ancestor
19887887|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887888|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19887889|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19887890|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
19887891|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
19887892|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
19887893|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19887894|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
19887895|NCT01005251|Lesogaberan|lesogaberan|mesh-list
19887896|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19887897|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19887898|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
19887899|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
19887900|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19887901|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887902|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887903|NCT01005290|Ramipril|ramipril|mesh-list
19887904|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19887905|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
19887906|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887907|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887908|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19887909|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
19887910|NCT01005316|Prednisone|prednisone|mesh-list
19887911|NCT01005316|Tacrolimus|tacrolimus|mesh-list
19887912|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
19887913|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19887914|NCT01005316|Antibodies|antibodies|mesh-list
19887915|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
19887916|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19887917|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19887918|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
19887919|NCT01005316|Hormones|hormones|mesh-ancestor
19887920|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19887921|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887922|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19887923|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887924|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887925|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
19887926|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19887927|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887928|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887929|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19887930|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19887931|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
19887932|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19887933|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887934|NCT01005329|Paclitaxel|paclitaxel|mesh-list
19887935|NCT01005329|Bevacizumab|bevacizumab|mesh-list
19887936|NCT01005329|Cisplatin|cisplatin|mesh-list
19887937|NCT01005329|Carboplatin|carboplatin|mesh-list
19887938|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19887939|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19887940|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
19887941|NCT01005329|Antibodies|antibodies|mesh-list
19887942|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
19887943|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19887944|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
19887945|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19887946|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887947|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
19887948|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
19887949|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
19887950|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887951|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19887952|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19887953|NCT01005329|Growth Substances|growth substances|mesh-ancestor
19887954|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887955|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
19887956|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
19887957|NCT01005355|Ramucirumab|ramucirumab|mesh-list
19887958|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887959|NCT01005407|Vaccines|vaccines|mesh-list
19887960|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
19887961|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887962|NCT01005459|Bupivacaine|bupivacaine|mesh-list
19887963|NCT01005459|Tetracaine|tetracaine|mesh-list
19887964|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
19887965|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
19887966|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19887967|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887968|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
19887969|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19887970|NCT01005576|Fludarabine|fludarabine|mesh-list
19887971|NCT01005576|Melphalan|melphalan|mesh-list
19887972|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
19887973|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887974|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887975|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887976|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
19887977|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887978|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19887979|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
19887980|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19887981|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19887982|NCT01005602|Digoxin|digoxin|mesh-list
19887983|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19887984|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19887985|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887986|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887987|NCT01005602|Protective Agents|protective agents|mesh-ancestor
19887988|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19887989|NCT01005680|Gemcitabine|gemcitabine|mesh-list
19887990|NCT01005680|Pemetrexed|pemetrexed|mesh-list
19887991|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19887992|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19887993|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
19887994|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19887995|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
19887996|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19887997|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19887998|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19887999|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
19888000|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888001|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19888002|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19888003|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
19888004|NCT01005706|Sirolimus|sirolimus|mesh-list
19888005|NCT01005706|Tacrolimus|tacrolimus|mesh-list
19888006|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888007|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
19888008|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888009|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19888010|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888011|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888012|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19888013|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888014|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19888015|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
19888016|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888017|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888018|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
19888019|NCT01005719|Omeprazole|omeprazole|mesh-list
19888020|NCT01005719|Lansoprazole|lansoprazole|mesh-list
19888021|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
19888022|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19888023|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19888024|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19888025|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888026|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888027|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
19888028|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19888029|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
19888030|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888031|NCT01005810|Expectorants|expectorants|mesh-ancestor
19888032|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
19888033|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19888034|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
19888035|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888036|NCT01005810|Protective Agents|protective agents|mesh-ancestor
19888037|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888038|NCT01005810|Antidotes|antidotes|mesh-ancestor
19888039|NCT01005875|Sorafenib|sorafenib|mesh-list
19888040|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888041|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19888042|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888043|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888044|NCT01005888|Complement C1s|complement c1s|mesh-list
19888045|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19888046|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19888047|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
19888048|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888049|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19888050|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888051|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
19888052|NCT01005901|Bromides|bromides|mesh-list
19888053|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
19888054|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19888055|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19888056|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19888057|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
19888058|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888059|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888060|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888061|NCT01005966|Listerine|listerine|mesh-list
19888062|NCT01005966|Fluorides|fluorides|mesh-list
19888063|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
19888064|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
19888065|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
19888066|NCT01005966|Protective Agents|protective agents|mesh-ancestor
19888067|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888068|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19888069|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888070|NCT01006252|Paclitaxel|paclitaxel|mesh-list
19888071|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19888072|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888073|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888074|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888075|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888076|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888077|NCT01006291|Insulin|insulin|mesh-list
19888078|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19888079|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
19888080|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
19888081|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19888082|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888083|NCT01006356|Hydromorphone|hydromorphone|mesh-list
19888084|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19888085|NCT01006356|Narcotics|narcotics|mesh-ancestor
19888086|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888087|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888088|NCT01006356|Analgesics|analgesics|mesh-ancestor
19888089|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
19888090|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888091|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
19888092|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
19888093|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19888094|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19888095|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888096|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888097|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449669|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
19888098|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888099|NCT01006538|Ranibizumab|ranibizumab|mesh-list
19888100|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19888101|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19888102|NCT01006538|Growth Substances|growth substances|mesh-ancestor
19888103|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888104|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
19888105|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888106|NCT01006590|Metformin|metformin|mesh-list
19888107|NCT01006590|Saxagliptin|saxagliptin|mesh-list
19888108|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19888109|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888110|NCT01006590|Incretins|incretins|mesh-ancestor
19888111|NCT01006590|Hormones|hormones|mesh-ancestor
19888112|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888113|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19888114|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
19888115|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888116|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888117|NCT01006603|Glimepiride|glimepiride|mesh-list
19888118|NCT01006603|Saxagliptin|saxagliptin|mesh-list
19888119|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19888120|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19888121|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888122|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888123|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
19888124|NCT01006603|Incretins|incretins|mesh-ancestor
19888125|NCT01006603|Hormones|hormones|mesh-ancestor
19888126|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888127|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19888128|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
19888129|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888130|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888131|NCT01006629|Palivizumab|palivizumab|mesh-list
19888132|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
19888133|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888134|NCT01006655|Beclomethasone|beclomethasone|mesh-list
19888135|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888136|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
19888137|NCT01006655|Hormones|hormones|mesh-ancestor
19888138|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888139|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888140|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19888141|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
19888142|NCT01006707|Ondansetron|ondansetron|mesh-list
19888143|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
19888144|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
19888145|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888146|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888147|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19888148|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
19888149|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19888150|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19888151|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
19888152|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888153|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888154|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19888155|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19888156|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888157|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19888158|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19888159|NCT01006889|Exenatide|exenatide|mesh-list
19888160|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19888161|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888162|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19888163|NCT01006889|Incretins|incretins|mesh-ancestor
19888164|NCT01006889|Hormones|hormones|mesh-ancestor
19888165|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888166|NCT01006980|Dacarbazine|dacarbazine|mesh-list
19888167|NCT01006980|Vemurafenib|vemurafenib|mesh-list
19888168|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888169|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
19888170|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888171|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888172|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19888173|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888174|NCT01007071|Hormones|hormones|mesh-list
19888175|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888176|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888177|NCT01007149|Omalizumab|omalizumab|mesh-list
19888178|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19888179|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19888180|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
19888181|NCT01007253|Fluticasone|fluticasone|mesh-list
19888182|NCT01007253|Xhance|xhance|mesh-list
19888183|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19888184|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19888185|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888186|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19888187|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
19888188|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888189|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888190|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19888191|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
19888192|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
19888193|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19888194|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19888195|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19888196|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19888197|NCT01007253|Analgesics|analgesics|mesh-ancestor
19888198|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
19888199|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888200|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19888201|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19888202|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
19888203|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
19888204|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888205|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888206|NCT01007435|Methotrexate|methotrexate|mesh-list
19888207|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19888208|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
19888209|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19888210|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888211|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19888212|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
19888213|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888214|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888215|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
19888216|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888217|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19888218|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888219|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
19888220|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888221|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19888222|NCT01007448|Bexarotene|bexarotene|mesh-list
19888223|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888224|NCT01007552|Gemcitabine|gemcitabine|mesh-list
19888225|NCT01007552|Bevacizumab|bevacizumab|mesh-list
19888226|NCT01007552|Capecitabine|capecitabine|mesh-list
19888227|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888228|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888229|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19888230|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19888231|NCT01007552|Growth Substances|growth substances|mesh-ancestor
19888232|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888233|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
19888234|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19888235|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
19888236|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888237|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
19888238|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888239|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888240|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888241|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
19888242|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
19888243|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888244|NCT01007942|Trastuzumab|trastuzumab|mesh-list
19888245|NCT01007942|Everolimus|everolimus|mesh-list
19888246|NCT01007942|Vinorelbine|vinorelbine|mesh-list
19888247|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888248|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888249|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888250|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
19888251|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888252|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19888253|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888254|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888255|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888256|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888257|NCT01007994|Propranolol|propranolol|mesh-list
19888258|NCT01007994|Enalapril|enalapril|mesh-list
19888259|NCT01007994|Isradipine|isradipine|mesh-list
19888260|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19888261|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19888262|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
19888263|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888264|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888265|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888266|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19888267|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19888268|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
19888269|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19888270|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
19888271|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888272|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19888273|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19888274|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19888275|NCT01008059|Alfentanil|alfentanil|mesh-list
19888276|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19888277|NCT01008059|Narcotics|narcotics|mesh-ancestor
19888278|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888279|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888280|NCT01008059|Analgesics|analgesics|mesh-ancestor
19888281|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
19888282|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888283|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19888284|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
19888285|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
19888286|NCT01008150|Paclitaxel|paclitaxel|mesh-list
19888287|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
19888288|NCT01008150|Doxorubicin|doxorubicin|mesh-list
19888289|NCT01008150|Trastuzumab|trastuzumab|mesh-list
19888290|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19888291|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888292|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888293|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888294|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888295|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888296|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888297|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
19888298|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888299|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888300|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888301|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
19888302|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19888303|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19888304|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19888305|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19888306|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888307|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888308|NCT01008280|Baclofen|baclofen|mesh-list
19888309|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19888310|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888311|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19888312|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888313|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19888314|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
19888315|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
19888316|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888317|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888318|NCT01008319|Citric Acid|citric acid|mesh-list
19888319|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
19888320|NCT01008319|Clomiphene|clomiphene|mesh-list
19888321|NCT01008319|Enclomiphene|enclomiphene|mesh-list
19888322|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
19888323|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
19888324|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19888325|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
19888326|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
19888327|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888328|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19888329|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
19888330|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888331|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888332|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19888333|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
19888334|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19888335|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19888336|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19888337|NCT01008410|Budesonide|budesonide|mesh-list
19888338|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888339|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19888340|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
19888341|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888342|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888343|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19888344|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
19888345|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
19888346|NCT01008410|Hormones|hormones|mesh-ancestor
19888347|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888348|NCT01008423|Budesonide|budesonide|mesh-list
19888349|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888350|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19888351|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
19888352|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888353|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888354|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19888355|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
19888356|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
19888357|NCT01008423|Hormones|hormones|mesh-ancestor
19888358|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888359|NCT01008462|Cytarabine|cytarabine|mesh-list
19888360|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
19888361|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
19888362|NCT01008462|Melphalan|melphalan|mesh-list
19888363|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
19888364|NCT01008462|Carmustine|carmustine|mesh-list
19888365|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19888366|NCT01008462|Fludarabine|fludarabine|mesh-list
19888367|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
19888368|NCT01008462|Etoposide|etoposide|mesh-list
19888369|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
19888370|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
19888371|NCT01008462|Tacrolimus|tacrolimus|mesh-list
19888372|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888373|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
19888374|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888375|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888376|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888377|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
20257898|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
20257899|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257900|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888378|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888379|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888380|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19888381|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19888382|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
19888383|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19888384|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19888385|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19888386|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888387|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
19888388|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888389|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19888390|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19888391|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19888392|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
19888393|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888394|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
19888395|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
19888396|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888397|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888398|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888399|NCT01008475|Irinotecan|irinotecan|mesh-list
19888400|NCT01008475|Cetuximab|cetuximab|mesh-list
19888401|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19888402|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19888403|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257901|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257902|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
20257903|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
20257904|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257905|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20257906|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
20257907|NCT00481572|Coagulants|coagulants|mesh-ancestor
20257908|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20257909|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
20257910|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20257911|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
20257912|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
20257913|NCT00481624|Hematinics|hematinics|mesh-ancestor
20257914|NCT00481663|Metformin|metformin|mesh-list
20257915|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20257916|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20257917|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257918|NCT00481663|Incretins|incretins|mesh-ancestor
20257919|NCT00481663|Hormones|hormones|mesh-ancestor
20257920|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257921|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20257922|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
20257923|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257924|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257925|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
20257926|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20257927|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257928|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20257929|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20257930|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257931|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257932|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257933|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19888404|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888405|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888406|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888407|NCT01008553|Fentanyl|fentanyl|mesh-list
19888408|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19888409|NCT01008553|Narcotics|narcotics|mesh-ancestor
19888410|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888411|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888412|NCT01008553|Analgesics|analgesics|mesh-ancestor
19888413|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
19888414|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888415|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19888416|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19888417|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
19888418|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
19888419|NCT01008618|Fentanyl|fentanyl|mesh-list
19888420|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19888421|NCT01008618|Narcotics|narcotics|mesh-ancestor
19888422|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888423|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888424|NCT01008618|Analgesics|analgesics|mesh-ancestor
19888425|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
20536222|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
19888426|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888427|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19888428|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19888429|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
19888430|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
19888431|NCT01008696|Rabeprazole|rabeprazole|mesh-list
19888432|NCT01008696|Lansoprazole|lansoprazole|mesh-list
19888433|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
19888434|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19888435|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19888436|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19888437|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888438|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888439|NCT01008748|Nicotine|nicotine|mesh-list
19888440|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19888441|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
19888442|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888443|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888444|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19888445|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19888446|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
19888447|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888448|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888449|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
19888450|NCT01008904|Antacids|antacids|mesh-ancestor
19888451|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888452|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19888453|NCT01008995|Ustekinumab|ustekinumab|mesh-list
19888454|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
19888455|NCT01009047|Aripiprazole|aripiprazole|mesh-list
19888456|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19888457|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
19888458|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19888459|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19888460|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19888461|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888462|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888463|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
19888464|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
19888465|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888466|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888467|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19888468|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19888469|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
19888470|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19888471|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19888472|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19888473|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19888474|NCT01009086|Ustekinumab|ustekinumab|mesh-list
19888475|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
19888476|NCT01009203|Sirolimus|sirolimus|mesh-list
19888477|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19888478|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888479|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19888480|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888481|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888482|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888483|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888484|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19888485|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
19888486|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888487|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
19888488|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888489|NCT01009346|Cisplatin|cisplatin|mesh-list
19888490|NCT01009346|Carboplatin|carboplatin|mesh-list
19888491|NCT01009346|Cetuximab|cetuximab|mesh-list
19888492|NCT01009346|Everolimus|everolimus|mesh-list
19888493|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888494|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888495|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888496|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
19888497|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888498|NCT01009515|Paclitaxel|paclitaxel|mesh-list
19888499|NCT01009515|Carboplatin|carboplatin|mesh-list
19888500|NCT01009515|Temozolomide|temozolomide|mesh-list
19888501|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19888502|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888503|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888504|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888505|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888506|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888507|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888508|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
19888509|NCT01009554|Listerine|listerine|mesh-list
19888510|NCT01009554|Fluorides|fluorides|mesh-list
19888511|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
19888512|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
19888513|NCT01009554|Protective Agents|protective agents|mesh-ancestor
19888514|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888515|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19888516|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888517|NCT01009580|Insulin|insulin|mesh-list
19888518|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19888519|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
19888520|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
19888521|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19888522|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
19888523|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19888524|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19888525|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888526|NCT01009619|Azithromycin|azithromycin|mesh-list
19888527|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888528|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888529|NCT01009814|Ritonavir|ritonavir|mesh-list
19888530|NCT01009814|Fostemsavir|fostemsavir|mesh-list
19888531|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19888532|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19888533|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
19888534|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888535|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888536|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19888537|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19888538|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
19888539|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888540|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19888541|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19888542|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19888543|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19970880|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970881|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970882|NCT01789814|Clopidogrel|clopidogrel|mesh-list
19970883|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19970884|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19970885|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19970886|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19970887|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19970888|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
19970889|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970890|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970891|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970892|NCT01789905|Tigecycline|tigecycline|mesh-list
19970893|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970894|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19970895|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19970896|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970897|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970898|NCT01789970|Hydrocodone|hydrocodone|mesh-list
19970899|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19970900|NCT01789970|Narcotics|narcotics|mesh-ancestor
19970901|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19970902|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970903|NCT01789970|Analgesics|analgesics|mesh-ancestor
19970904|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
19970905|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970906|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
19970907|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
19970908|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19970909|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19970910|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970911|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20257934|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20257935|NCT00481702|Metronidazole|metronidazole|mesh-list
20257936|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
20257937|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257938|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20257939|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20257940|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20257941|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20257942|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20257943|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20257944|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
20257945|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257946|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257947|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257948|NCT00481728|Urological Agents|urological agents|mesh-ancestor
19888544|NCT01009840|Bortezomib|bortezomib|mesh-list
19888545|NCT01009840|Busulfan|busulfan|mesh-list
19888546|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888547|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
19888548|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888549|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888550|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
19888551|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888552|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888553|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19888554|NCT01009918|Carvedilol|carvedilol|mesh-list
19888555|NCT01009918|Lisinopril|lisinopril|mesh-list
19888556|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19888557|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19888558|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
19888559|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888560|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888561|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888562|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19888563|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
19888564|NCT01009918|Protective Agents|protective agents|mesh-ancestor
19888565|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19888566|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19888567|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19888568|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
19888569|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19888570|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19888571|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19888572|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
19888573|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888574|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19888575|NCT01009983|Paclitaxel|paclitaxel|mesh-list
19888576|NCT01009983|Carboplatin|carboplatin|mesh-list
19888577|NCT01009983|Panitumumab|panitumumab|mesh-list
19888578|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19888579|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888580|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888581|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888582|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888583|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888584|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888585|NCT01010009|Resveratrol|resveratrol|mesh-list
19888586|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
19888587|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888588|NCT01010009|Protective Agents|protective agents|mesh-ancestor
19888589|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888590|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888591|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19888592|NCT01010061|Rituximab|rituximab|mesh-list
19888593|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
19888594|NCT01010061|Chlorambucil|chlorambucil|mesh-list
19888595|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888596|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888597|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
19888598|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888599|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888600|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888601|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
19888602|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888603|NCT01010126|Sirolimus|sirolimus|mesh-list
19888604|NCT01010126|Bevacizumab|bevacizumab|mesh-list
19888605|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19888606|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
19888607|NCT01010126|Antibodies|antibodies|mesh-list
19888608|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
19888609|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19888610|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
19888611|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888612|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19888613|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19888614|NCT01010126|Growth Substances|growth substances|mesh-ancestor
19888615|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888616|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
19888617|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
19888618|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888619|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888620|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19888621|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
19888622|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888623|NCT01010204|Varenicline|varenicline|mesh-list
19888624|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19888625|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19888626|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
19888627|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888628|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888629|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888630|NCT01010217|Vidarabine|vidarabine|mesh-list
19888631|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
19888632|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
19888633|NCT01010217|Melphalan|melphalan|mesh-list
19888634|NCT01010217|Thiotepa|thiotepa|mesh-list
19888635|NCT01010217|Rituximab|rituximab|mesh-list
19888636|NCT01010217|Fludarabine|fludarabine|mesh-list
19888637|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
19888638|NCT01010217|Tacrolimus|tacrolimus|mesh-list
19888639|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888640|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
19888641|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888642|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888643|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888644|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
19888645|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888646|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888647|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19888648|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888649|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19888650|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
19888651|NCT01010217|Antiviral Agents|antiviral agents|mesh-ancestor
19888652|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888653|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19888654|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888655|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19888656|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19888657|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
19888658|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888659|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19888660|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
19888661|NCT01010282|Glycerol|glycerol|mesh-list
19888662|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19888663|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19888664|NCT01010282|Laxatives|laxatives|mesh-ancestor
19888665|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19888666|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19888667|NCT01010282|Protective Agents|protective agents|mesh-ancestor
19888668|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888669|NCT01010399|Ritonavir|ritonavir|mesh-list
19888670|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
19888671|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19888672|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19888673|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
19888674|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888675|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888676|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19888677|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19888678|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
19888679|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888680|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19888681|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19888682|NCT01010477|Nicotine|nicotine|mesh-list
19888683|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19888684|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
19888685|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888686|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888687|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19888688|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19888689|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
19888690|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536223|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536224|NCT01825031|Azithromycin|azithromycin|mesh-list
20536225|NCT01825031|Isoniazid|isoniazid|mesh-list
20536226|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
20536227|NCT01825031|Fluconazole|fluconazole|mesh-list
20536228|NCT01825031|Albendazole|albendazole|mesh-list
20536229|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20536230|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888691|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888692|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19888693|NCT01010568|Ofatumumab|ofatumumab|mesh-list
19888694|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19888695|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19888696|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
19888697|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888698|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888699|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
19888700|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888701|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19888702|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19888703|NCT01010750|Amphetamine|amphetamine|mesh-list
19888704|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19888705|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19888706|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888707|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
19888708|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
19888709|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888710|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
19888711|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888712|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888713|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
19888714|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19888715|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19888716|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19888717|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19888718|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19888719|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19888720|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19888721|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888722|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888723|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19888724|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19888725|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19888726|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
19888727|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888728|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888729|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19888730|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19888731|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
19888732|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19888733|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
19888734|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
19888735|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888736|NCT01010971|Ciclesonide|ciclesonide|mesh-list
19888737|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
20536231|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19888738|NCT01010971|Hormones|hormones|mesh-ancestor
19888739|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888740|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888741|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19888742|NCT01010984|Doxorubicin|doxorubicin|mesh-list
19888743|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19888744|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888745|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19888746|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19888747|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888748|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888749|NCT01011049|Vaccines|vaccines|mesh-list
19888750|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
19888751|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888752|NCT01011075|Paclitaxel|paclitaxel|mesh-list
19888753|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
19888754|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19888755|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888756|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888757|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888758|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888759|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888760|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19888761|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888762|NCT01011218|Modafinil|modafinil|mesh-list
19888763|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19888764|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888765|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19888766|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19888767|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19888768|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888769|NCT01011283|Azacitidine|azacitidine|mesh-list
19888770|NCT01011283|Decitabine|decitabine|mesh-list
19888771|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19888772|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
19888773|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888774|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888775|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888776|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
19888777|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19888778|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19888779|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888780|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
19888781|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19888782|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
19888783|NCT01011413|Efavirenz|efavirenz|mesh-list
19888784|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19888785|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19888786|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888787|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888788|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
19888789|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888790|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19888791|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19888792|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19888793|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19888794|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19888795|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19888796|NCT01011439|Maleic acid|maleic acid|mesh-list
19888797|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888798|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888799|NCT01011465|Oxytocin|oxytocin|mesh-list
19888800|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
19888801|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19888802|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888803|NCT01011556|Teriparatide|teriparatide|mesh-list
19888804|NCT01011556|Hormones|hormones|mesh-list
19888805|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
19888806|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888807|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888808|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19888809|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19888810|NCT01011673|Ketorolac|ketorolac|mesh-list
19888811|NCT01011673|Metoclopramide|metoclopramide|mesh-list
19888812|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19888813|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19888814|NCT01011673|Analgesics|analgesics|mesh-ancestor
19888815|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
19888816|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888817|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888818|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888819|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888820|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19888821|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888822|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888823|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
19888824|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
19888825|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19888826|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19888827|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19888828|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
19888829|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888830|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19888831|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
19888832|NCT01011816|Coagulants|coagulants|mesh-ancestor
19888833|NCT01011829|Varenicline|varenicline|mesh-list
20257949|NCT00481741|Hemostatics|hemostatics|mesh-list
20257950|NCT00481741|Coagulants|coagulants|mesh-ancestor
20257951|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
20257952|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
20257953|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20257954|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20257955|NCT00481819|Prednisolone|prednisolone|mesh-list
20257956|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
20257957|NCT00481819|Tacrolimus|tacrolimus|mesh-list
20257958|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20257959|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
20257960|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20257961|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
20257962|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257963|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20257964|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20257965|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257966|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20257967|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20257968|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20257969|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
20257970|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20257971|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20257972|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20257973|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
20257974|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
20257975|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20257976|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20257977|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
20257978|NCT00481819|Hormones|hormones|mesh-ancestor
20257979|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257980|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20257981|NCT00481819|Protective Agents|protective agents|mesh-ancestor
20257982|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20257983|NCT00481884|Petrolatum|petrolatum|mesh-list
20257984|NCT00481884|Emollients|emollients|mesh-ancestor
20257985|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
20257986|NCT00481923|Rimonabant|rimonabant|mesh-list
20257987|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20257988|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20257989|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20257990|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20257991|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20257992|NCT00481923|Hormones|hormones|mesh-ancestor
20257993|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20257994|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20257995|NCT00481962|Tigecycline|tigecycline|mesh-list
19888834|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19888835|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20257996|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888836|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
19888837|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888838|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888839|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888840|NCT01011868|Empagliflozin|empagliflozin|mesh-list
19888841|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19888842|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888843|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19888844|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888845|NCT01011894|Lenalidomide|lenalidomide|mesh-list
19888846|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
19888847|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888848|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19888849|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19888850|NCT01011894|Growth Substances|growth substances|mesh-ancestor
19888851|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
19888852|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888853|NCT01011907|Varenicline|varenicline|mesh-list
20536232|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20536233|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
20536234|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20536235|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20536236|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888854|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19888855|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19888856|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
19888857|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888858|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888859|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888860|NCT01012037|Linagliptin|linagliptin|mesh-list
19888861|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19888862|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888863|NCT01012037|Incretins|incretins|mesh-ancestor
19888864|NCT01012037|Hormones|hormones|mesh-ancestor
19888865|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888866|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19888867|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
19888868|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888869|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888870|NCT01012089|Daptomycin|daptomycin|mesh-list
19888871|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19888872|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888873|NCT01012219|Aspirin|aspirin|mesh-list
19888874|NCT01012219|Niacin|niacin|mesh-list
20257997|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888875|NCT01012219|Clopidogrel|clopidogrel|mesh-list
19888876|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19888877|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19888878|NCT01012219|Analgesics|analgesics|mesh-ancestor
19888879|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
19888880|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888881|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888882|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888883|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888884|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19888885|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19888886|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888887|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19888888|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19888889|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888890|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
19888891|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20553739|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
20553740|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
20553741|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553742|NCT01930955|Amoxicillin|amoxicillin|mesh-list
20553743|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553744|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555031|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888892|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19888893|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19888894|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
19888895|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888896|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19888897|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
19888898|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19888899|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
19888900|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
19888901|NCT01012219|Vitamins|vitamins|mesh-ancestor
19888902|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
19732141|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732142|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
19732143|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
19732144|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732145|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
19732146|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19732147|NCT04577027|Travoprost|travoprost|mesh-list
19732148|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19732149|NCT04577040|Tadalafil|tadalafil|mesh-list
19732150|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
19732151|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19732152|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19732153|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732154|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732155|NCT04577040|Urological Agents|urological agents|mesh-ancestor
19732156|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
19732157|NCT04576975|Ketamine|ketamine|mesh-list
19732158|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19732159|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732160|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732161|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732162|NCT04576975|Analgesics|analgesics|mesh-ancestor
19732163|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
19732164|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732165|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19888903|NCT01012258|Cetuximab|cetuximab|mesh-list
19888904|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19888905|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888906|NCT01012297|Gemcitabine|gemcitabine|mesh-list
19888907|NCT01012297|Bevacizumab|bevacizumab|mesh-list
19888908|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19888909|NCT01012297|Docetaxel|docetaxel|mesh-list
19888910|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
19888911|NCT01012297|Antibodies|antibodies|mesh-list
19888912|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
19888913|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19888914|NCT01012297|Lenograstim|lenograstim|mesh-list
19888915|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
19888916|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888917|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19888918|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19888919|NCT01012297|Growth Substances|growth substances|mesh-ancestor
19888920|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888921|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
19888922|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
19888923|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19888924|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
19888925|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888926|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
19888927|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19888928|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19888929|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888930|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
19888931|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
19888932|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
19888933|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19888934|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
19888935|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
19888936|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888937|NCT01012336|Dexamethasone|dexamethasone|mesh-list
19888938|NCT01012336|Aprepitant|aprepitant|mesh-list
19888939|NCT01012336|Ramosetron|ramosetron|mesh-list
19888940|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888941|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
19888942|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
19888943|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888944|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888945|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19888946|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
19888947|NCT01012336|Hormones|hormones|mesh-ancestor
19888948|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888949|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19888950|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888951|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19888952|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888953|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888954|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19888955|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
19888956|NCT01012492|Abatacept|abatacept|mesh-list
19888957|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19888958|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888959|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19888960|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19888961|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
19888962|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888963|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19888964|NCT01012622|Methylphenidate|methylphenidate|mesh-list
19888965|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19888966|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888967|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19888968|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19888969|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19888970|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888971|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
19888972|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19888973|NCT01012661|Lidocaine|lidocaine|mesh-list
19888974|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
19888975|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
19888976|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19888977|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888978|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
19888979|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19888980|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19888981|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19888982|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19888983|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19888984|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888985|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19888986|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
19888987|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
19888988|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19888989|NCT01012713|Calcitriol|calcitriol|mesh-list
19888990|NCT01012713|Clobetasol|clobetasol|mesh-list
19888991|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19888992|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
19888993|NCT01012713|Hormones|hormones|mesh-ancestor
19888994|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19888995|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19888996|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19888997|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19888998|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19888999|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889000|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19889001|NCT01012713|Vitamins|vitamins|mesh-ancestor
19889002|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
19889003|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19889004|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
19889005|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19889006|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
19889007|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889008|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889009|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19889010|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
19889011|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
19889012|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19889013|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
19889014|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970912|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889015|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889016|NCT01012973|Aflibercept|aflibercept|mesh-list
19889017|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19889018|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19889019|NCT01012973|Growth Substances|growth substances|mesh-ancestor
19889020|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889021|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
19889022|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889023|NCT01012999|Sufentanil|sufentanil|mesh-list
19889024|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19889025|NCT01012999|Narcotics|narcotics|mesh-ancestor
19889026|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889027|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889028|NCT01012999|Analgesics|analgesics|mesh-ancestor
19889029|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
19889030|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889031|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19889032|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19889033|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
19889034|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
19889035|NCT01013285|Bevacizumab|bevacizumab|mesh-list
19889036|NCT01013285|Temozolomide|temozolomide|mesh-list
19889037|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20257998|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20257999|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258000|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889038|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889039|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19889040|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19889041|NCT01013285|Growth Substances|growth substances|mesh-ancestor
19889042|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889043|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
19889044|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19889045|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
19889046|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889047|NCT01013597|Panobinostat|panobinostat|mesh-list
19889048|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889049|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19889050|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889051|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889052|NCT01013740|Capecitabine|capecitabine|mesh-list
19889053|NCT01013740|Vinorelbine|vinorelbine|mesh-list
19889054|NCT01013740|Lapatinib|lapatinib|mesh-list
19889055|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19889056|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
19889057|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889058|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889059|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19889060|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889061|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889062|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889063|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19889064|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889065|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
19889066|NCT01013753|Olodaterol|olodaterol|mesh-list
19889067|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19889068|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
19889069|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889070|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889071|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19889072|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
19889073|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19889074|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19889075|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20258001|NCT00481975|Rimonabant|rimonabant|mesh-list
19889076|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
20258002|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20258003|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20258004|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20258005|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258006|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258007|NCT00481975|Hormones|hormones|mesh-ancestor
20258008|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258009|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258010|NCT00482027|Vaccines|vaccines|mesh-list
20258011|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
20258012|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258013|NCT00482066|Abatacept|abatacept|mesh-list
20258014|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20258015|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258016|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258017|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258018|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
20536237|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536238|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
20536239|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20258019|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536240|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19889077|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536241|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20536242|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
20536243|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536244|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536245|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20536246|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20536247|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
20536248|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20536249|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20536250|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
20536251|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20536252|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
19889078|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889079|NCT01013870|Atorvastatin|atorvastatin|mesh-list
19889080|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19889081|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19889082|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
19889083|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889084|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19889085|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19889086|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889087|NCT01013961|Rituximab|rituximab|mesh-list
19889088|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
19889089|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19889090|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889091|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
19889092|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889093|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889094|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
19889095|NCT01014013|Ertapenem|ertapenem|mesh-list
19889096|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889097|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889098|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
19889099|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19889100|NCT01014143|Triclosan|triclosan|mesh-list
19889101|NCT01014143|Fluorides|fluorides|mesh-list
19889102|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
19889103|NCT01014143|Protective Agents|protective agents|mesh-ancestor
19889104|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889105|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19889106|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889107|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
19889108|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889109|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19889110|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19889111|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
19889112|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889113|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19889114|NCT01014208|Rituximab|rituximab|mesh-list
19889115|NCT01014208|Ofatumumab|ofatumumab|mesh-list
19889116|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19889117|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889118|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
19889119|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889120|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889121|NCT01014351|Paclitaxel|paclitaxel|mesh-list
19889122|NCT01014351|Carboplatin|carboplatin|mesh-list
19889123|NCT01014351|Everolimus|everolimus|mesh-list
19889124|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19889125|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889126|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889127|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889128|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889129|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889130|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889131|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
19889132|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889133|NCT01014403|Enoxaparin|enoxaparin|mesh-list
19889134|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
19889135|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19889136|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19889137|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889138|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
19889139|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19889140|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889141|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19889142|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
19889143|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889144|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889145|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889146|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889147|NCT01014533|Gabapentin|gabapentin|mesh-list
19889148|NCT01014533|Analgesics|analgesics|mesh-ancestor
19889149|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
19889150|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889151|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889152|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
19889153|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19889154|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19889155|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889156|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889157|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19889158|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19889159|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889160|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889161|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
19889162|NCT01014585|Milnacipran|milnacipran|mesh-list
19889163|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
19889164|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19889165|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19889166|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889167|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889168|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889169|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889170|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19889171|NCT01014585|Analgesics|analgesics|mesh-ancestor
19889172|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
19889173|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889174|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
19889175|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889176|NCT01014624|Clopidogrel|clopidogrel|mesh-list
19889177|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19889178|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19889179|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19889180|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19889181|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19889182|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
19889183|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889184|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889185|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889186|NCT01014689|Lymecycline|lymecycline|mesh-list
19889187|NCT01014689|Adapalene|adapalene|mesh-list
19889188|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19889189|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19889190|NCT01014689|Analgesics|analgesics|mesh-ancestor
19889191|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
19889192|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889193|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889194|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19889195|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889196|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889197|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889198|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889199|NCT01014728|Propofol|propofol|mesh-list
19889200|NCT01014728|Sevoflurane|sevoflurane|mesh-list
19889201|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19889202|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889203|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889204|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19889205|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
19889206|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
19889207|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19889208|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19889209|NCT01014741|Ibutilide|ibutilide|mesh-list
19889210|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19889211|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
19889212|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19889213|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19889214|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19889215|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889216|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889217|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
19889218|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889219|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889220|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19889221|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889222|NCT01014936|Tepotinib|tepotinib|mesh-list
19889223|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970913|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
19970914|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19970915|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
19970916|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19970917|NCT01790438|Insulin|insulin|mesh-list
19970918|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19970919|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
19970920|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
19970921|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
19970922|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19970923|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970924|NCT01790490|Ketamine|ketamine|mesh-list
19970925|NCT01790490|Lorazepam|lorazepam|mesh-list
19970926|NCT01790490|Analgesics|analgesics|mesh-ancestor
19970927|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
19970928|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970929|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889224|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
19889225|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19889226|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19889227|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889228|NCT01014988|Zanamivir|zanamivir|mesh-list
19889229|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
19889230|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889231|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889232|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889233|NCT01015118|Paclitaxel|paclitaxel|mesh-list
19889234|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19889235|NCT01015118|Carboplatin|carboplatin|mesh-list
19889236|NCT01015118|Nintedanib|nintedanib|mesh-list
19889237|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19889238|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889239|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889240|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889241|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889242|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889243|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19889244|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889245|NCT01015131|Alovudine|alovudine|mesh-list
19889246|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
19889247|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889248|NCT01015170|Bupropion|bupropion|mesh-list
19889249|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19889250|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
19889251|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889252|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19889253|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19889254|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889255|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889256|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
19889257|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889258|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889259|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19889260|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19889261|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889262|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19889263|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19889264|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
19889265|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889266|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
19889267|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889268|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889269|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19889270|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
19889271|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889272|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889273|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19889274|NCT01015534|Temozolomide|temozolomide|mesh-list
19889275|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19889276|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
19889277|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889278|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889279|NCT01015560|Antibodies|antibodies|mesh-list
19889280|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19889281|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
19889282|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889283|NCT01015586|Lamotrigine|lamotrigine|mesh-list
19889284|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
19889285|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19889286|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889287|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889288|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19889289|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889290|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19889291|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19889292|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889293|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889294|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19889295|NCT01015638|Clindamycin|clindamycin|mesh-list
19889296|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
19889297|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
19889298|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19889299|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889300|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889301|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19889302|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889303|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889304|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889305|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19889306|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19889307|NCT01015677|Estradiol|estradiol|mesh-list
19889308|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19889309|NCT01015677|Estrogens|estrogens|mesh-ancestor
19889310|NCT01015677|Hormones|hormones|mesh-ancestor
19889311|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19889312|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889313|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19889314|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
19889315|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19889316|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19889317|NCT01015807|Clonidine|clonidine|mesh-list
19889318|NCT01015807|Bupivacaine|bupivacaine|mesh-list
19889319|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
19889320|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
19889321|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889322|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889323|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
19889324|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889325|NCT01015807|Analgesics|analgesics|mesh-ancestor
19889326|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19889327|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
19889328|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
19889329|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19889330|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19889331|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19889332|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
19889333|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889334|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889335|NCT01016015|Sirolimus|sirolimus|mesh-list
19889336|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19889337|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889338|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889339|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19889340|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889341|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
19889342|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889343|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
19889344|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889345|NCT01016262|Mesalamine|mesalamine|mesh-list
19889346|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19889347|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19889348|NCT01016262|Analgesics|analgesics|mesh-ancestor
19889349|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
19889350|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889351|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889352|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19889353|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889354|NCT01016483|Gemcitabine|gemcitabine|mesh-list
19889355|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19889356|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
19889357|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889358|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889359|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
19889360|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889361|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889362|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889363|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
19889364|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889365|NCT01016600|Lenalidomide|lenalidomide|mesh-list
19889366|NCT01016600|Azacitidine|azacitidine|mesh-list
19889367|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
19889368|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889369|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19889370|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19889371|NCT01016600|Growth Substances|growth substances|mesh-ancestor
19889372|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
19889373|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889374|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19889375|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
19889376|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889377|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889378|NCT01016678|Naproxen|naproxen|mesh-list
19889379|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19889380|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19889381|NCT01016678|Analgesics|analgesics|mesh-ancestor
19889382|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
19889383|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889384|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889385|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19889386|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889387|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
19889388|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20258020|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258021|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20258022|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20258023|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258024|NCT00482079|Incretins|incretins|mesh-ancestor
19889389|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889390|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889391|NCT01016691|Bimatoprost|bimatoprost|mesh-list
19889392|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19889393|NCT01016769|Sirolimus|sirolimus|mesh-list
19889394|NCT01016769|Paclitaxel|paclitaxel|mesh-list
19889395|NCT01016769|Carboplatin|carboplatin|mesh-list
19889396|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19889397|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258025|NCT00482079|Hormones|hormones|mesh-ancestor
20258026|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258027|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20258028|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
20258029|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258030|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258031|NCT00482183|Pioglitazone|pioglitazone|mesh-list
20258032|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20536253|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19889398|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889399|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889400|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889401|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889402|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889403|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889404|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19889405|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
19889406|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889407|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
19889408|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889409|NCT01016834|Sumatriptan|sumatriptan|mesh-list
19889410|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19889411|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19889412|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19889413|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
19889414|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889415|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889416|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889417|NCT01016912|Ribavirin|ribavirin|mesh-list
19889418|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19889419|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
19889420|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889421|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
19889422|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889423|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
19889424|NCT01016977|Clindamycin|clindamycin|mesh-list
19889425|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
19889426|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
19889427|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19889428|NCT01016977|Tazarotene|tazarotene|mesh-list
19889429|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889430|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889431|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19889432|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889433|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889434|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889435|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
19889436|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
19889437|NCT01016977|Vitamins|vitamins|mesh-ancestor
19889438|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
19889439|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889440|NCT01017003|Colchicine|colchicine|mesh-list
19889441|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
19889442|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889443|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889444|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889445|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889446|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889447|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889448|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
19889449|NCT01017029|Everolimus|everolimus|mesh-list
19889450|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889451|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889452|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
19889453|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889454|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19889455|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19889456|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
19889457|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889458|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889459|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889460|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889461|NCT01017042|Colchicine|colchicine|mesh-list
19889462|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
19889463|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889464|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889465|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889466|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889467|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889468|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889469|NCT01017120|Tazarotene|tazarotene|mesh-list
19889470|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889471|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
19889472|NCT01017146|Tazarotene|tazarotene|mesh-list
19889473|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889474|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
19889475|NCT01017237|Midazolam|midazolam|mesh-list
19889476|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
19889477|NCT01017237|Ketamine|ketamine|mesh-list
19889478|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19889479|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889480|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889481|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19889482|NCT01017237|Analgesics|analgesics|mesh-ancestor
19889483|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
19889484|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889485|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19889486|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19889487|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19889488|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
19889489|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889490|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889491|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19889492|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19889493|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
19889494|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
19889495|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19889496|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19889497|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19889498|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19889499|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19889500|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889501|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
19889502|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
19889503|NCT01017250|Bevacizumab|bevacizumab|mesh-list
19889504|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19889505|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889506|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19889507|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19889508|NCT01017250|Growth Substances|growth substances|mesh-ancestor
19889509|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889510|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
19889511|NCT01017575|Ribavirin|ribavirin|mesh-list
19889512|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19889513|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
19889514|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889515|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
19889516|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889517|NCT01017653|Irinotecan|irinotecan|mesh-list
19889518|NCT01017653|Panitumumab|panitumumab|mesh-list
19889519|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19889520|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19889521|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889522|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889523|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889524|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19889525|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
19889526|NCT01017731|Promethazine|promethazine|mesh-list
19889527|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
19889528|NCT01017731|Ramucirumab|ramucirumab|mesh-list
19889529|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889530|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889531|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19889532|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19889533|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889534|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889535|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889536|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889537|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19889538|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19889539|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889540|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
19889541|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
19889542|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
19889543|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889544|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
19889545|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
19889546|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19889547|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19889548|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
19889549|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
19889550|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889551|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19889552|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
19889553|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889554|NCT01017874|Pemetrexed|pemetrexed|mesh-list
19889555|NCT01017874|Gefitinib|gefitinib|mesh-list
19889556|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889557|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889558|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889559|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19889560|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19889561|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19889562|NCT01018056|Riluzole|riluzole|mesh-list
19889563|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
19889564|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19889565|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19889566|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889567|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889568|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889569|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19889570|NCT01018056|Protective Agents|protective agents|mesh-ancestor
19889571|NCT01018095|Metronidazole|metronidazole|mesh-list
19889572|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889573|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889574|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19889575|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19889576|NCT01018134|Desoximetasone|desoximetasone|mesh-list
19889577|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19889578|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
19889579|NCT01018134|Hormones|hormones|mesh-ancestor
19889580|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19889581|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889582|NCT01018186|Fluticasone|fluticasone|mesh-list
19889583|NCT01018186|Xhance|xhance|mesh-list
19889584|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19889585|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19889586|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
19889587|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889588|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889589|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20258033|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258034|NCT00482209|Misoprostol|misoprostol|mesh-list
20258035|NCT00482209|Mifepristone|mifepristone|mesh-list
20258036|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20258037|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
20258038|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20258039|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258040|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20258041|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258042|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
20258043|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20258044|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20258045|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20258046|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20258047|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
20258048|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20258049|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20258050|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
20258051|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258052|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
20258053|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20258054|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20258055|NCT00482222|Leucovorin|leucovorin|mesh-list
20258056|NCT00482222|Fluorouracil|fluorouracil|mesh-list
20258057|NCT00482222|Capecitabine|capecitabine|mesh-list
20258058|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
20258059|NCT00482222|Cetuximab|cetuximab|mesh-list
20258060|NCT00482222|Calcium|calcium|mesh-list
20258061|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
20258062|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20258063|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258064|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
20258065|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258066|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20258067|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258068|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258069|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
20258070|NCT00482222|Antidotes|antidotes|mesh-ancestor
20258071|NCT00482222|Protective Agents|protective agents|mesh-ancestor
20258072|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
20258073|NCT00482222|Vitamins|vitamins|mesh-ancestor
20258074|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
20258075|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258076|NCT00482248|Omalizumab|omalizumab|mesh-list
20258077|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20258078|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20258079|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
20258080|NCT00482261|Aspirin|aspirin|mesh-list
19889590|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
20258081|NCT00482261|Dexamethasone|dexamethasone|mesh-list
20258082|NCT00482261|Lenalidomide|lenalidomide|mesh-list
20258083|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19889591|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889592|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19889593|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
19889594|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19889595|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19889596|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
19889597|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889598|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889599|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889600|NCT01018264|Urological Agents|urological agents|mesh-ancestor
19889601|NCT01018394|Nicotine|nicotine|mesh-list
19889602|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19889603|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
19889604|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889605|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889606|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19889607|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19889608|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
19889609|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889610|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889611|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
19889612|NCT01018420|Colchicine|colchicine|mesh-list
19889613|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889614|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889615|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19889616|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19889617|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889618|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889619|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889620|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
19889621|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889622|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889623|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889624|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889625|NCT01018511|Tamsulosin|tamsulosin|mesh-list
19889626|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
19889627|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19889628|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19889629|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19889630|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
19889631|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889632|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889633|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889634|NCT01018511|Urological Agents|urological agents|mesh-ancestor
19889635|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19889636|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19889637|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
19889638|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19889639|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19889640|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19889641|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889642|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889643|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889644|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889645|NCT01018680|Analgesics|analgesics|mesh-ancestor
19889646|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
19889647|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889648|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
19889649|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889650|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
19889651|NCT01018732|Lactitol|lactitol|mesh-list
19889652|NCT01018732|Cathartics|cathartics|mesh-ancestor
19889653|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19889654|NCT01018862|Azelastine|azelastine|mesh-list
19889655|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19889656|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
19889657|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889658|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889659|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19889660|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
19889661|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19889662|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889663|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889664|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19889665|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19889666|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19889667|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
19889668|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
19889669|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889670|NCT01019317|Vidarabine|vidarabine|mesh-list
19889671|NCT01019317|Cytarabine|cytarabine|mesh-list
19889672|NCT01019317|Fludarabine|fludarabine|mesh-list
19889673|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
19889674|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889675|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19889676|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
19889677|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889678|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889679|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
19889680|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889681|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
19889682|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889683|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19889684|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
19889685|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19889686|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19889687|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19889688|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
19889689|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19889690|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889691|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20536254|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
20536255|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20536256|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20536257|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20536258|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20536259|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20536260|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536261|NCT01825044|Cyclosporine|cyclosporine|mesh-list
20536262|NCT01825044|Cyclosporins|cyclosporins|mesh-list
19889692|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19889693|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19889694|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19889695|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889696|NCT01019486|Regadenoson|regadenoson|mesh-list
19889697|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19889698|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19889699|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19889700|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
19889701|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
19889702|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889703|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889704|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889705|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19889706|NCT01019694|Albuterol|albuterol|mesh-list
19889707|NCT01019694|Ipratropium|ipratropium|mesh-list
19889708|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19889709|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
19889710|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889711|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889712|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19889713|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
19889714|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
19889715|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19889716|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19889717|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19889718|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19889719|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
19889720|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889721|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889722|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19889723|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
19889724|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19889725|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19889726|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19889727|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889728|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536263|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889729|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
19889730|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889731|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889732|NCT01020006|Gemcitabine|gemcitabine|mesh-list
19889733|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19889734|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
19889735|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889736|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889737|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
19889738|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889739|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889740|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889741|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
19889742|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889743|NCT01020019|Lofexidine|lofexidine|mesh-list
19889744|NCT01020019|Dronabinol|dronabinol|mesh-list
19889745|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
19889746|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889747|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889748|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19889749|NCT01020019|Analgesics|analgesics|mesh-ancestor
19889750|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
19889751|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889752|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19889753|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19889754|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889755|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889756|NCT01020019|Hormones|hormones|mesh-ancestor
19889757|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19889758|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19889759|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19889760|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19889761|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19889762|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19889763|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19889764|NCT01020123|Glipizide|glipizide|mesh-list
19889765|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19889766|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889767|NCT01020305|Sirolimus|sirolimus|mesh-list
19889768|NCT01020305|Bicalutamide|bicalutamide|mesh-list
19889769|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889770|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889771|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19889772|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889773|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
19889774|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19889775|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
19889776|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889777|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
19889778|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
19889779|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19889780|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19889781|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
19889782|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19889783|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
19889784|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19889785|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889786|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19889787|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19889788|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889789|NCT01020474|Pregabalin|pregabalin|mesh-list
19889790|NCT01020474|Analgesics|analgesics|mesh-ancestor
19889791|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
19889792|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889793|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889794|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
19889795|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19889796|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889797|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889798|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19889799|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19889800|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19889801|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889802|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889803|NCT01020526|Pregabalin|pregabalin|mesh-list
19889804|NCT01020526|Analgesics|analgesics|mesh-ancestor
19889805|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
19889806|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889807|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889808|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
19889809|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19889810|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889811|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889812|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19889813|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19889814|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19889815|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889816|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889817|NCT01020747|Bevacizumab|bevacizumab|mesh-list
19889818|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19889819|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889820|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19889821|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19889822|NCT01020747|Growth Substances|growth substances|mesh-ancestor
19889823|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889824|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
19889825|NCT01020786|Carboplatin|carboplatin|mesh-list
19889826|NCT01020786|Pemetrexed|pemetrexed|mesh-list
19889827|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889828|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889829|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889830|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19889831|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19889832|NCT01020799|Citalopram|citalopram|mesh-list
19889833|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19889834|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19889835|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889836|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889837|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889838|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
19889839|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889840|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19889841|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
19889842|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889843|NCT01020877|Metronidazole|metronidazole|mesh-list
19889844|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889845|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889846|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19889847|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19889848|NCT01021020|Colchicine|colchicine|mesh-list
19889849|NCT01021020|Probenecid|probenecid|mesh-list
19889850|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
19889851|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889852|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889853|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889854|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889855|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889856|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889857|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
19889858|NCT01021020|Renal Agents|renal agents|mesh-ancestor
19889859|NCT01021215|Celecoxib|celecoxib|mesh-list
19889860|NCT01021215|Zileuton|zileuton|mesh-list
19889861|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19889862|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19889863|NCT01021215|Analgesics|analgesics|mesh-ancestor
19889864|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
19889865|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889866|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889867|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19889868|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19889869|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19889870|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19889871|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889872|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889873|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19889874|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19889875|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
19889876|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19970930|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19970931|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19970932|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
19970933|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
19970934|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19970935|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19970936|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19970937|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19970938|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970939|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
19970940|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
19970941|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
19970942|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19970943|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19970944|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19970945|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19970946|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19970947|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
19970948|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
19970949|NCT01790503|Temozolomide|temozolomide|mesh-list
19970950|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19970951|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
19970952|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970953|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970954|NCT01790516|Cetuximab|cetuximab|mesh-list
19970955|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970956|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19970957|NCT01790568|Methotrexate|methotrexate|mesh-list
19970958|NCT01790568|Vorinostat|vorinostat|mesh-list
19970959|NCT01790568|Tacrolimus|tacrolimus|mesh-list
19970960|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19970961|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
19970962|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19970963|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970964|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970965|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
19970966|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970967|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970968|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
19970969|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970970|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19970971|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970972|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
19970973|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19970974|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19970975|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19970976|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19970977|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
19970978|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
19970979|NCT01790594|Abatacept|abatacept|mesh-list
19970980|NCT01790594|Tacrolimus|tacrolimus|mesh-list
19970981|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
19970982|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19970983|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19970984|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
19970985|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19970986|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19970987|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19970988|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19970989|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19970990|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970991|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19970992|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
20258084|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
19970993|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19970994|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889877|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19889878|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19889879|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19889880|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19889881|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889882|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889883|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889884|NCT05396014|Analgesics|analgesics|mesh-ancestor
19889885|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
19889886|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19889887|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
19889888|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889889|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
19889890|NCT05395962|Carboplatin|carboplatin|mesh-list
19889891|NCT05395962|Bleomycin|bleomycin|mesh-list
19889892|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889893|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19889894|NCT05395910|Paclitaxel|paclitaxel|mesh-list
19889895|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19889896|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889897|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
19889898|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
19889899|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
19889900|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889901|NCT05395702|Interferons|interferons|mesh-list
19889902|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
19889903|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889904|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
19889905|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889906|NCT05395533|Antibodies|antibodies|mesh-list
19889907|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19889908|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
19889909|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889910|NCT05395507|Interferons|interferons|mesh-list
19889911|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
19889912|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
19889913|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19889914|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19889915|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
19889916|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889917|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
19889918|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258085|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
20258086|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258087|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258088|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258089|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
20258090|NCT00482261|Hormones|hormones|mesh-ancestor
20258091|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258092|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20258093|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258094|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258095|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258096|NCT00482261|Analgesics|analgesics|mesh-ancestor
20258097|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
20258098|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258099|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20258100|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20258101|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258102|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20258103|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19889919|NCT05395494|Cycloserine|cycloserine|mesh-list
19889920|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19889921|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889922|NCT05395494|Renal Agents|renal agents|mesh-ancestor
20536264|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536265|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536266|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
20536267|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536268|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
20536269|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889923|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19889924|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
19889925|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19889926|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
19889927|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889928|NCT05395299|Ethylene|ethylene|mesh-list
19889929|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19889930|NCT05395299|Growth Substances|growth substances|mesh-ancestor
19889931|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889932|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
19889933|NCT05395195|Hematinics|hematinics|mesh-ancestor
19889934|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
19889935|NCT05395143|Astringents|astringents|mesh-ancestor
19889936|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889937|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19889938|NCT05395117|Digoxin|digoxin|mesh-list
19889939|NCT05395117|Midazolam|midazolam|mesh-list
19889940|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19889941|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19889942|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19889943|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889944|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889945|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19889946|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19889947|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889948|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19889949|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
19889950|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
19889951|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
19889952|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
19889953|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889954|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889955|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19889956|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19889957|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
19889958|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19889959|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19889960|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19889961|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19889962|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19889963|NCT05395117|Protective Agents|protective agents|mesh-ancestor
19889964|NCT05395104|Midazolam|midazolam|mesh-list
19889965|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19889966|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19889967|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19889968|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889969|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19889970|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19889971|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19889972|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19889973|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
19889974|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
19889975|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
19889976|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
19889977|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19889978|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19889979|NCT05395091|Denosumab|denosumab|mesh-list
19889980|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19889981|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889982|NCT05395065|Listerine|listerine|mesh-list
19889983|NCT05395065|Fluorides|fluorides|mesh-list
19889984|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
19889985|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
19889986|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
19889987|NCT05395065|Protective Agents|protective agents|mesh-ancestor
19889988|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19889989|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19889990|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19889991|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
19889992|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
19889993|NCT05395052|Nivolumab|nivolumab|mesh-list
19889994|NCT05395052|Trastuzumab|trastuzumab|mesh-list
19889995|NCT05395052|Fludarabine|fludarabine|mesh-list
19889996|NCT05395052|Cetuximab|cetuximab|mesh-list
19889997|NCT05395052|Atezolizumab|atezolizumab|mesh-list
19889998|NCT05395052|Interleukin-2|interleukin-2|mesh-list
19889999|NCT05395052|Avelumab|avelumab|mesh-list
19890000|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19890001|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
20536270|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
19890002|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890003|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19890004|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19890005|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
19890006|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890007|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890008|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19890009|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890010|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19890011|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19890012|NCT05395052|Analgesics|analgesics|mesh-ancestor
19890013|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
19890014|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890015|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
19890016|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19890017|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
19890018|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
19890019|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890020|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890021|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19890022|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
19890023|NCT05394909|Hormones|hormones|mesh-ancestor
19890024|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19890025|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19890026|NCT05394909|Protective Agents|protective agents|mesh-ancestor
19890027|NCT05394740|Leucovorin|leucovorin|mesh-list
19890028|NCT05394740|Fluorouracil|fluorouracil|mesh-list
19890029|NCT05394740|Capecitabine|capecitabine|mesh-list
19890030|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
19890031|NCT05394740|Nivolumab|nivolumab|mesh-list
19890032|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
20258104|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258105|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
20258106|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
20258107|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20258108|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20258109|NCT00482261|Growth Substances|growth substances|mesh-ancestor
20258110|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
20258111|NCT00482313|Methylphenidate|methylphenidate|mesh-list
20258112|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20258113|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258114|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20258115|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258116|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258117|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258118|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
20258119|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258120|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
20258121|NCT00482378|Pamidronate|pamidronate|mesh-list
20258122|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20258123|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258124|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
20258125|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20258126|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
20258127|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
20258128|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258129|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258130|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258131|NCT00482456|Analgesics|analgesics|mesh-ancestor
20258132|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
20258133|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258134|NCT00482495|Bevacizumab|bevacizumab|mesh-list
20258135|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258136|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258137|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20258138|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20258139|NCT00482495|Growth Substances|growth substances|mesh-ancestor
19890033|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890034|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19890035|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890036|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19890037|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
19890038|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890039|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890040|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19890041|NCT05394740|Antidotes|antidotes|mesh-ancestor
19890042|NCT05394740|Protective Agents|protective agents|mesh-ancestor
19890043|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
19890044|NCT05394740|Vitamins|vitamins|mesh-ancestor
19890045|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
19890046|NCT05394727|Insulin|insulin|mesh-list
19890047|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19890048|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19890049|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890050|NCT05394493|Avelumab|avelumab|mesh-list
19890051|NCT05394493|Axitinib|axitinib|mesh-list
19890052|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890053|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890054|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19890055|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890056|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890057|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
19890058|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19890059|NCT05394415|Paclitaxel|paclitaxel|mesh-list
19890060|NCT05394415|Carboplatin|carboplatin|mesh-list
19890061|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19890062|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890063|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890064|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890065|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
19890066|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890067|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
19890068|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890069|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890072|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19890073|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19890074|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890075|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
19890076|NCT05394233|Bevacizumab|bevacizumab|mesh-list
19890077|NCT05394233|Pemetrexed|pemetrexed|mesh-list
19890078|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890079|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890080|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19890081|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19890082|NCT05394233|Growth Substances|growth substances|mesh-ancestor
19890083|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890084|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
19890085|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890086|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890087|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19890088|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19890089|NCT05394142|Metformin|metformin|mesh-list
19890090|NCT05394142|Pioglitazone|pioglitazone|mesh-list
19890091|NCT05394142|Spironolactone|spironolactone|mesh-list
19890092|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19890093|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890094|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19890095|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
19890096|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19890097|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19890098|NCT05394142|Diuretics|diuretics|mesh-ancestor
19890099|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
19890100|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19890101|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19890102|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258140|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258141|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
20258142|NCT00482508|Omalizumab|omalizumab|mesh-list
20258143|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19890137|NCT05388500|Paclitaxel|paclitaxel|mesh-list
19890138|NCT05388500|Trastuzumab|trastuzumab|mesh-list
19890139|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19890140|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890141|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890142|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890143|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
19890144|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890145|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890146|NCT05388487|Complement Factor H|complement factor h|mesh-list
19890147|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19890148|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19890149|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
20258144|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20258145|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
20258146|NCT00482521|Pomalidomide|pomalidomide|mesh-list
20258147|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
20258148|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258149|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20258150|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20258151|NCT00482521|Growth Substances|growth substances|mesh-ancestor
20258152|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
20258153|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258154|NCT00482573|Epinephrine|epinephrine|mesh-list
20258155|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20536271|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20536272|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20536273|NCT01825083|Ketamine|ketamine|mesh-list
20536274|NCT01825083|Analgesics|analgesics|mesh-ancestor
20536275|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
20536276|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536277|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536278|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20536279|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20536280|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
20536281|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
19890150|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890151|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
19890152|NCT05387759|Aticaprant|aticaprant|mesh-list
19890153|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19890154|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890155|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19890156|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19890157|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890158|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890159|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890160|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890161|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19890162|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
19890163|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890164|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19890165|NCT05386888|Paclitaxel|paclitaxel|mesh-list
19890166|NCT05386888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19890167|NCT05386888|Carboplatin|carboplatin|mesh-list
19890168|NCT05386888|Pemetrexed|pemetrexed|mesh-list
19890169|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19890170|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890171|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890172|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890173|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
19890174|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890175|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890176|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19890177|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19890178|NCT05386459|Interferons|interferons|mesh-list
19890179|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
19890180|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890181|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
19890182|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890183|NCT05382104|Maribavir|maribavir|mesh-list
19890184|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
19890185|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258156|NCT00482573|Anesthetics|anesthetics|mesh-list
19890233|NCT05349838|Dolutegravir|dolutegravir|mesh-list
19890234|NCT05349838|Rilpivirine|rilpivirine|mesh-list
19890235|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
19890236|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19890237|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19890238|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890239|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890240|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19890241|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19890242|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
19890243|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890244|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19890245|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19890246|NCT05343572|Plerixafor|plerixafor|mesh-list
19890247|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19890248|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19890249|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
19890250|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890277|NCT05317689|Psilocybin|psilocybin|mesh-list
19890278|NCT05317689|Psilocin|psilocin|mesh-list
19890279|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
19890280|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890281|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19890282|NCT05307926|Lenvatinib|lenvatinib|mesh-list
19890283|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19890284|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890285|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20258157|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258158|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258159|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20258160|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20258161|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
20258162|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286790|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286791|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19890286|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890287|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890288|NCT05303064|Olanzapine|olanzapine|mesh-list
19890289|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
19890290|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
19890291|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890292|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890293|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19890294|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19890295|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20536282|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536283|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20536284|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20536285|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536286|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536287|NCT01825109|Vaccines|vaccines|mesh-list
20536288|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
20536289|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536290|NCT01825395|Amifampridine|amifampridine|mesh-list
20536291|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20536292|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536293|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553745|NCT01931033|Oxytocin|oxytocin|mesh-list
19890296|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19890297|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19890298|NCT05303064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19890299|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19890300|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19890301|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890302|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890303|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
19890304|NCT05292209|Riluzole|riluzole|mesh-list
19890305|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
19890306|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19890307|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19890308|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890309|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890310|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890311|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19890312|NCT05292209|Protective Agents|protective agents|mesh-ancestor
20286792|NCT02278887|Analgesics|analgesics|mesh-ancestor
20286793|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
20286794|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286795|NCT02224144|Vitamin D|vitamin d|mesh-list
20286796|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
20286797|NCT02224144|Calcitriol|calcitriol|mesh-list
20286798|NCT02224144|Vitamins|vitamins|mesh-ancestor
20286799|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
20286800|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536294|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20536295|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536296|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536297|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20536298|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536299|NCT01825447|Naltrexone|naltrexone|mesh-list
20536300|NCT01825447|Oxycodone|oxycodone|mesh-list
20536301|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20536302|NCT01825447|Narcotics|narcotics|mesh-ancestor
20536303|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536304|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536305|NCT01825447|Analgesics|analgesics|mesh-ancestor
20536306|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
20536307|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536308|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20536309|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20536310|NCT01825473|Erythromycin|erythromycin|mesh-list
20536311|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
20536312|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20536313|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
20536314|NCT01825473|Phenobarbital|phenobarbital|mesh-list
20536315|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20536316|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536317|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20536318|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20536319|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536320|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536321|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
20536322|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20536323|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536324|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536325|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20536326|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20536327|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536328|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
20536329|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
20536330|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20536331|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20536332|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20536333|NCT01825551|Sargramostim|sargramostim|mesh-list
20536334|NCT01825551|Lenograstim|lenograstim|mesh-list
19890351|NCT05261399|Carboplatin|carboplatin|mesh-list
19890352|NCT05261399|Pemetrexed|pemetrexed|mesh-list
19890353|NCT05261399|Osimertinib|osimertinib|mesh-list
20536335|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
19890354|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890355|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890356|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890357|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19890358|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19890359|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19890360|NCT05250895|Misonidazole|misonidazole|mesh-list
19890361|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890362|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19890363|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19890364|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890365|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19890366|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890367|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890368|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
19890369|NCT05244070|Fludarabine|fludarabine|mesh-list
19890370|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19890371|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
19890372|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890373|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19890374|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19890375|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
19890376|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890377|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890378|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19890379|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
19732166|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19732167|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19732168|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
19732169|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732170|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732171|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19890380|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20258163|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258164|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20258165|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20258166|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
20258167|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258168|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20258169|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
20258170|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
20258171|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
20258172|NCT00482690|Nicotine|nicotine|mesh-list
20258173|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20258174|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
20258175|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258176|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258177|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20258178|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20258179|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
20258180|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258181|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258182|NCT00482716|Iron|iron|mesh-list
20258183|NCT00482716|Dextrans|dextrans|mesh-list
20258184|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
20258185|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20258186|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
20258187|NCT00482716|Trace Elements|trace elements|mesh-ancestor
20258188|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
20258189|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258190|NCT00482716|Hematinics|hematinics|mesh-ancestor
20258191|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
20258192|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
20258193|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
20258194|NCT00482755|Sunitinib|sunitinib|mesh-list
19732172|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19732173|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
19732174|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
19732175|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19732176|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19732177|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
19732178|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19732179|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732180|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732181|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732182|NCT04577430|Analgesics|analgesics|mesh-ancestor
19732183|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
19732184|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732185|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19732186|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19732187|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19732188|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19732189|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732190|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735694|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19735695|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19735696|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19735697|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19735698|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
19735699|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890381|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
19890382|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890383|NCT05241262|Expectorants|expectorants|mesh-ancestor
19890384|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
19890385|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19890386|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
19890387|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890388|NCT05241262|Protective Agents|protective agents|mesh-ancestor
19890389|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890390|NCT05241262|Antidotes|antidotes|mesh-ancestor
19890391|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19890392|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19890393|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890394|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
19890395|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
19890396|NCT05231980|Clomiphene|clomiphene|mesh-list
19890397|NCT05231980|Enclomiphene|enclomiphene|mesh-list
19890398|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
19890399|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890400|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19890401|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
19890402|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19890403|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890404|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19890405|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
19890406|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19890407|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19890408|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19890409|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
19890410|NCT05231980|Protective Agents|protective agents|mesh-ancestor
19890411|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
19890412|NCT05231980|Vitamins|vitamins|mesh-ancestor
19890413|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
19890414|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19890415|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890416|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19890417|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19890418|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
19890419|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19890420|NCT05222984|Decitabine|decitabine|mesh-list
19890421|NCT05222984|Venetoclax|venetoclax|mesh-list
19890422|NCT05222984|Navitoclax|navitoclax|mesh-list
19890423|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19890424|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
19890425|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890426|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890427|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890428|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
19890429|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19890430|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19890431|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19890432|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19890433|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
19890434|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19890435|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20536336|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536337|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20536338|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
19890436|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19890437|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536339|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20536340|NCT01825603|Gemcitabine|gemcitabine|mesh-list
20536341|NCT01825603|Cisplatin|cisplatin|mesh-list
20536342|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536343|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20536344|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
20536345|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536346|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
20536347|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536348|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536349|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536350|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
20536351|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536352|NCT01825616|Vitamin D|vitamin d|mesh-list
20536353|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
20536354|NCT01825616|Vitamins|vitamins|mesh-ancestor
20536355|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
19890438|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890439|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
19890440|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890441|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890442|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19890443|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536356|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536357|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20536358|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20536359|NCT01825720|Insulin|insulin|mesh-list
20536360|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20536361|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536362|NCT01825733|Palonosetron|palonosetron|mesh-list
20536363|NCT01825733|Ramosetron|ramosetron|mesh-list
20536364|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
20536365|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
19890464|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19890465|NCT05206500|Amoxicillin|amoxicillin|mesh-list
19890466|NCT05206500|Metronidazole|metronidazole|mesh-list
19890467|NCT05206500|Clindamycin|clindamycin|mesh-list
19890468|NCT05206500|Linezolid|linezolid|mesh-list
20258195|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258196|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20258197|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20258198|NCT00482755|Growth Substances|growth substances|mesh-ancestor
20258199|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258200|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
20258201|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20258202|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258203|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258204|NCT00482807|Docetaxel|docetaxel|mesh-list
20258205|NCT00482807|Goserelin|goserelin|mesh-list
20258206|NCT00482807|Bicalutamide|bicalutamide|mesh-list
20258207|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258208|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890469|NCT05206500|Tetracycline|tetracycline|mesh-list
20258209|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890470|NCT05206500|Penicillins|penicillins|mesh-list
20536366|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536367|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890471|NCT05206500|Ampicillin|ampicillin|mesh-list
19890472|NCT05206500|Fosfomycin|fosfomycin|mesh-list
19890473|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
19890474|NCT05206500|Cephalosporins|cephalosporins|mesh-list
19890475|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
19890476|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890477|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19890478|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19890479|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19890480|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536368|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20536369|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20536370|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20536371|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
20536372|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536373|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536374|NCT01825850|Irbesartan|irbesartan|mesh-list
20536375|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19890481|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890482|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19890483|NCT05206500|Renal Agents|renal agents|mesh-ancestor
19890484|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19890485|NCT05203172|Cetuximab|cetuximab|mesh-list
19890486|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890487|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890488|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
19890489|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890490|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19890491|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890492|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890493|NCT05197426|Azacitidine|azacitidine|mesh-list
19890494|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19890495|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
19890496|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890497|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890498|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536376|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20536377|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20536378|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536379|NCT01825863|Ropivacaine|ropivacaine|mesh-list
20536380|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
20536381|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
19890506|NCT05173987|Paclitaxel|paclitaxel|mesh-list
19890507|NCT05173987|Docetaxel|docetaxel|mesh-list
19890508|NCT05173987|Carboplatin|carboplatin|mesh-list
19890509|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
19890510|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19890511|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890512|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890513|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890514|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
19890515|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890516|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20536382|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536383|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536384|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
20536385|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536386|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20536387|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20536388|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536389|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20536390|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19890520|NCT05161208|Varenicline|varenicline|mesh-list
19890521|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19890522|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19890523|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
19890524|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890525|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890526|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890535|NCT05149131|Leuprolide|leuprolide|mesh-list
19890536|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19890537|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
19890538|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19890539|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890540|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19890541|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890548|NCT05147805|Treprostinil|treprostinil|mesh-list
19890549|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19890550|NCT05145413|Xanomeline|xanomeline|mesh-list
19890551|NCT05145413|Trospium chloride|trospium chloride|mesh-list
19890552|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
19890553|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
19890554|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890555|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536391|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20536392|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536393|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536394|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19890556|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19890557|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19890558|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
19890559|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890560|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890561|NCT05145413|Urological Agents|urological agents|mesh-ancestor
19890562|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19890563|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19890564|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19890565|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19890566|NCT05116189|Paclitaxel|paclitaxel|mesh-list
19890567|NCT05116189|Docetaxel|docetaxel|mesh-list
19890568|NCT05116189|Bevacizumab|bevacizumab|mesh-list
19890569|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
19890570|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19890571|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890572|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890573|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890574|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
19890575|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890576|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890577|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19890578|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20536395|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20536396|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20536397|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
20536398|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536399|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536400|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19890579|NCT05116189|Growth Substances|growth substances|mesh-ancestor
19890580|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890581|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19890582|NCT05112601|Nivolumab|nivolumab|mesh-list
19890583|NCT05112601|Ipilimumab|ipilimumab|mesh-list
19890584|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890585|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890586|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19890587|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890588|NCT05109728|Temozolomide|temozolomide|mesh-list
20536401|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20536402|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
20536403|NCT01825993|Morphine|morphine|mesh-list
20536404|NCT01825993|Bupivacaine|bupivacaine|mesh-list
20536405|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
19890589|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19890590|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19890591|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19890592|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
19890593|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890594|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890595|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
19890596|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
19890597|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19890598|NCT05109234|Brivaracetam|brivaracetam|mesh-list
19890599|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
19890604|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
19890605|NCT05104567|Cetuximab|cetuximab|mesh-list
19890606|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890607|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890608|NCT05086224|Lidocaine|lidocaine|mesh-list
19890609|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
19890610|NCT05086224|Anesthetics|anesthetics|mesh-list
19890611|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19890612|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890613|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
19890614|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890615|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19890616|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19890617|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19890618|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19890619|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890625|NCT05077904|Alprazolam|alprazolam|mesh-list
19890626|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19890627|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19890628|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890629|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19890630|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19890631|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19890632|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
19890633|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
20536406|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
20536407|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536408|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890634|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890635|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890636|NCT05076617|Alprazolam|alprazolam|mesh-list
19890637|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19890638|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19890639|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890640|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19890641|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19890642|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19890643|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
19890644|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
19890645|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536409|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
20536410|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536411|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20536412|NCT01825993|Narcotics|narcotics|mesh-ancestor
20536413|NCT01825993|Analgesics|analgesics|mesh-ancestor
20536414|NCT01826149|Propofol|propofol|mesh-list
20536415|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20553746|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
20536416|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536417|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536418|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20536419|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
20536420|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
20536421|NCT01826175|Clopidogrel|clopidogrel|mesh-list
20536422|NCT01826175|Ticagrelor|ticagrelor|mesh-list
20536423|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20536424|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20536425|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20536426|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20536427|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
20536428|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536429|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536430|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536431|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20536432|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
20536433|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
19890646|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890651|NCT05065411|Everolimus|everolimus|mesh-list
19890652|NCT05065411|Fulvestrant|fulvestrant|mesh-list
19890653|NCT05065411|Exemestane|exemestane|mesh-list
19890654|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890655|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536434|NCT01826279|Resveratrol|resveratrol|mesh-list
20536435|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
20536436|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536437|NCT01826279|Protective Agents|protective agents|mesh-ancestor
20536438|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536439|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536440|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20536441|NCT01826396|Irinotecan|irinotecan|mesh-list
20536442|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20536443|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20536444|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536445|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536446|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536447|NCT01826526|Taurolidine|taurolidine|mesh-list
20536448|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536449|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20536450|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553747|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553748|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553749|NCT01931085|Triclabendazole|triclabendazole|mesh-list
20553750|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20553751|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
20553752|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20553753|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553754|NCT01931098|Topotecan|topotecan|mesh-list
20553755|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20553756|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20553757|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553758|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553759|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553760|NCT01931137|Insulin|insulin|mesh-list
20553761|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20553762|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553763|NCT01931189|Infliximab|infliximab|mesh-list
20553764|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
20553765|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553766|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553767|NCT01931215|Clonidine|clonidine|mesh-list
20553768|NCT01931215|Morphine|morphine|mesh-list
20553769|NCT01931215|Ropivacaine|ropivacaine|mesh-list
20553770|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
20553771|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553772|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553773|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20553774|NCT01931215|Narcotics|narcotics|mesh-ancestor
19890656|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
19890657|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553775|NCT01931215|Analgesics|analgesics|mesh-ancestor
20553776|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
20536451|NCT01826747|Progesterone|progesterone|mesh-list
19890658|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19890659|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19890660|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19890661|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
19890662|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19890663|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19890664|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19890665|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890666|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890670|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
19890671|NCT05061420|Cetuximab|cetuximab|mesh-list
19890672|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890673|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890674|NCT05061134|Durvalumab|durvalumab|mesh-list
19890675|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890676|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536452|NCT01826747|Progestins|progestins|mesh-ancestor
20536453|NCT01826747|Hormones|hormones|mesh-ancestor
20536454|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536455|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536456|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
20536457|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536458|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536459|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
20536460|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536461|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890698|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
19890699|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19890700|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19890701|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19890702|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19890703|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890704|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
19890705|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890706|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890707|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19890708|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536462|NCT01826864|Sargramostim|sargramostim|mesh-list
20536463|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
20536464|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536465|NCT01826916|Ecallantide|ecallantide|mesh-list
20536466|NCT01826916|Analgesics|analgesics|mesh-ancestor
20536467|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
20536468|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536469|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536470|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20536471|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20536472|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20536473|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19890730|NCT05022394|Nivolumab|nivolumab|mesh-list
19890731|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890732|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890733|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19890734|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890735|NCT05021978|Pramoxine|pramoxine|mesh-list
19890736|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
19890737|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
19890738|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19890739|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890740|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
19890741|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890742|NCT05017584|Bupivacaine|bupivacaine|mesh-list
19890743|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
19890744|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
19890745|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19890746|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890747|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
19890748|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890757|NCT05009992|TIC10 compound|tic10 compound|mesh-list
19890758|NCT05009992|Dopamine|dopamine|mesh-list
19890759|NCT05009992|GDC-0084|gdc-0084|mesh-list
19890760|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19890761|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
19890762|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
19890763|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890764|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890765|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
19890766|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890767|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890768|NCT05009992|Protective Agents|protective agents|mesh-ancestor
19890769|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890770|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536474|NCT01827007|Polygeline|polygeline|mesh-list
20536475|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
20536476|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
20536477|NCT01827020|Lidocaine|lidocaine|mesh-list
20536478|NCT01827020|Ketamine|ketamine|mesh-list
20536479|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
20536480|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
19890774|NCT05008913|Adavosertib|adavosertib|mesh-list
19890775|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890776|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536481|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536482|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536483|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
20536484|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536485|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20536486|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20536487|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20536488|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536489|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536490|NCT01827020|Analgesics|analgesics|mesh-ancestor
20536491|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20536492|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20536493|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
20536494|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20536495|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20536496|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536497|NCT01827059|Bosentan|bosentan|mesh-list
20536498|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20536499|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20536500|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536501|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
20536502|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
20536503|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536504|NCT01827124|Oxytocin|oxytocin|mesh-list
19890788|NCT04999332|Leucovorin|leucovorin|mesh-list
19890789|NCT04999332|Docetaxel|docetaxel|mesh-list
19890790|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
19890791|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
19890792|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890793|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890794|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890795|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
19890796|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890797|NCT04999332|Antidotes|antidotes|mesh-ancestor
19890798|NCT04999332|Protective Agents|protective agents|mesh-ancestor
19890799|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890800|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
19890801|NCT04999332|Vitamins|vitamins|mesh-ancestor
19890802|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
19890803|NCT04998617|Curcumin|curcumin|mesh-list
19890804|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19890805|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19890806|NCT04998617|Analgesics|analgesics|mesh-ancestor
19890807|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
20536505|NCT01827124|Carbetocin|carbetocin|mesh-list
20536506|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
20536507|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20536508|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536509|NCT01827137|Lenalidomide|lenalidomide|mesh-list
20536510|NCT01827137|Molgramostim|molgramostim|mesh-list
20536511|NCT01827137|Sargramostim|sargramostim|mesh-list
20536512|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
20536513|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536514|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20536515|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20536516|NCT01827137|Growth Substances|growth substances|mesh-ancestor
20536517|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
20536518|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536519|NCT01827202|Candesartan|candesartan|mesh-list
20536520|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20536521|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20536522|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20536523|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536524|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
19890808|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890809|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536525|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
20536526|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536527|NCT01827280|Vildagliptin|vildagliptin|mesh-list
20536528|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20536529|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536530|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20536531|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
20536532|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536533|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536534|NCT01827293|Promethazine|promethazine|mesh-list
20536535|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
20536536|NCT01827293|Lorazepam|lorazepam|mesh-list
20536537|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
20536538|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
20536539|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
20536540|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536541|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536542|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20536543|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20536544|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536545|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19890810|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19890811|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19890812|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890813|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890814|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890815|NCT04990388|Acetaminophen|acetaminophen|mesh-list
19890816|NCT04990388|Antipyretics|antipyretics|mesh-list
19890817|NCT04990388|Cetirizine|cetirizine|mesh-list
19890818|NCT04990388|Ibuprofen|ibuprofen|mesh-list
19890819|NCT04990388|Famotidine|famotidine|mesh-list
19890820|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19890821|NCT04990388|Analgesics|analgesics|mesh-ancestor
19890822|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
19890823|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890824|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890825|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19890826|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19890827|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19890828|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19890829|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890830|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890831|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19890832|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258210|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
20258211|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258212|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20258213|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
20258214|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
20258215|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258216|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258217|NCT00482846|Melphalan|melphalan|mesh-list
20258218|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20258219|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
20258220|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258221|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258222|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20258223|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258224|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
20258225|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286801|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20286802|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20286803|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20286804|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20286805|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286806|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20286807|NCT02151981|Osimertinib|osimertinib|mesh-list
20286808|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286809|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20286810|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286811|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286812|NCT02030990|Fluorometholone|fluorometholone|mesh-list
20286813|NCT02030990|Mitomycins|mitomycins|mesh-list
20258226|NCT00482963|Efavirenz|efavirenz|mesh-list
20536546|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20536547|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20536548|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
20536549|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
20536550|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536551|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536552|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
20536553|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
20536554|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20536555|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
20536556|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
20536557|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20536558|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20536559|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
20536560|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
20536561|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
20536562|NCT01827345|Vitamin D|vitamin d|mesh-list
20536563|NCT01827345|Vitamins|vitamins|mesh-ancestor
20536564|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
20536565|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536566|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20536567|NCT01827397|Vaccines|vaccines|mesh-list
20536568|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
20536569|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536570|NCT01827540|Dolutegravir|dolutegravir|mesh-list
19890833|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19890834|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
19890835|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
19890836|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890837|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19890838|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19890839|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19890840|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
19890841|NCT04989803|Fludarabine|fludarabine|mesh-list
19890842|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19890843|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
20258227|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
20258228|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20258229|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20258230|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258231|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258232|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
20258233|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258234|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20258235|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20258236|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20258237|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20258238|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20258239|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20258240|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20258241|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
20258242|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20258243|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258244|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20258245|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20258246|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20258247|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
20258248|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258249|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258250|NCT00482989|Sifalimumab|sifalimumab|mesh-list
20258251|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
20258252|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258253|NCT00483028|Donepezil|donepezil|mesh-list
20258254|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20258255|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258256|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258257|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
20258258|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258259|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258260|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
20536571|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
20536572|NCT01827540|Midazolam|midazolam|mesh-list
19890844|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536573|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20536574|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19890845|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19890846|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19890847|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
19890848|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890849|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890850|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19890851|NCT04988035|Remdesivir|remdesivir|mesh-list
19890852|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
20536575|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536576|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536577|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20536578|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20536579|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20536580|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20536581|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
20536582|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
20536583|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
20536584|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
20536585|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536586|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536587|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20536588|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20536589|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536590|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19890853|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890854|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
19890855|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19890856|NCT04973345|Terbutaline|terbutaline|mesh-list
19890857|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19890858|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
19890859|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19890860|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890861|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19890862|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
19890863|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
19890864|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
19890865|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19890866|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19890867|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19890868|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19890869|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
19890870|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19890871|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890872|NCT04965597|Methotrexate|methotrexate|mesh-list
19890873|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
19890874|NCT04965597|Fludarabine|fludarabine|mesh-list
19890875|NCT04965597|Treosulfan|treosulfan|mesh-list
19890876|NCT04965597|Busulfan|busulfan|mesh-list
19890877|NCT04965597|Tacrolimus|tacrolimus|mesh-list
19890878|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
19890879|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19890880|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
19890881|NCT04965597|Antibodies|antibodies|mesh-list
19890882|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
20258261|NCT00483054|Efavirenz|efavirenz|mesh-list
20258262|NCT00483054|Nevirapine|nevirapine|mesh-list
20258263|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20258264|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20258265|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890883|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19890884|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19890885|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19890886|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
19890887|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20258266|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258267|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
20258268|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258269|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20258270|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20258271|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20258272|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20258273|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19890888|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258274|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19890889|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19890890|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
19890891|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890892|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890893|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
19890894|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890895|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19890896|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19890897|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
19890898|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19890899|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19890900|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19890901|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19890902|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
19890903|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20536591|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20536592|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
20536593|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536594|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20536595|NCT01827553|Gemcitabine|gemcitabine|mesh-list
20536596|NCT01827553|Folfirinox|folfirinox|mesh-list
20536597|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20536598|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
20536599|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536600|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536601|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
20536602|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536603|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536604|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536605|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
20536606|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536607|NCT01827618|Sirolimus|sirolimus|mesh-list
20536608|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20536609|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536610|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20536611|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536612|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
20536613|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536614|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
20536615|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536616|NCT01827722|Dexamethasone|dexamethasone|mesh-list
20536617|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
20536618|NCT01827722|Ranibizumab|ranibizumab|mesh-list
20536619|NCT01827722|BB 1101|bb 1101|mesh-list
20536620|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19890904|NCT04964063|Listerine|listerine|mesh-list
19890905|NCT04964063|Fluorides|fluorides|mesh-list
19890906|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
20536621|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
20536622|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
20536623|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536624|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890907|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
19890908|NCT04964063|Protective Agents|protective agents|mesh-ancestor
19890909|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19890910|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19890911|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536625|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20536626|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
19890932|NCT04956692|Paclitaxel|paclitaxel|mesh-list
19890933|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19890934|NCT04956692|Carboplatin|carboplatin|mesh-list
19890935|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
19890936|NCT04956692|Pemetrexed|pemetrexed|mesh-list
19890937|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19890938|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19890939|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
19890940|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
19890941|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
19890942|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19890943|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890944|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19890945|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19890946|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19890947|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
19890948|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19890949|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536627|NCT01827722|Hormones|hormones|mesh-ancestor
20536628|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536629|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20536630|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536631|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
20536632|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536633|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536634|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20536635|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20536636|NCT01827722|Growth Substances|growth substances|mesh-ancestor
20536637|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
20536638|NCT01827735|Aldesleukin|aldesleukin|mesh-list
20536639|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536640|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20536641|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20536642|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
20536643|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536644|NCT01827865|Etodolac|etodolac|mesh-list
20536645|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20536646|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20536647|NCT01827865|Analgesics|analgesics|mesh-ancestor
20536648|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
20536649|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536650|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536651|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20536652|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20536653|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20536654|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20536655|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536656|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536657|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20536658|NCT01827878|Lisinopril|lisinopril|mesh-list
20536659|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
20536660|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20536661|NCT01827878|Diuretics|diuretics|mesh-ancestor
20536662|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
20536663|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536664|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20536665|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536666|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536667|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20536668|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
19891023|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
19891024|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258275|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20286814|NCT02030990|Mitomycin|mitomycin|mesh-list
20286815|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20286816|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286817|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
20286818|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286819|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20286820|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286821|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19891025|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891026|NCT04895358|Paclitaxel|paclitaxel|mesh-list
19891027|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19891028|NCT04895358|Doxorubicin|doxorubicin|mesh-list
19891029|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19891030|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
19891031|NCT04895358|Capecitabine|capecitabine|mesh-list
19891032|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891033|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891034|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891035|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891036|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891037|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891038|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19891039|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19891040|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19891041|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891042|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891043|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891044|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
20536669|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536670|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20536671|NCT01827878|Protective Agents|protective agents|mesh-ancestor
20536672|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20536673|NCT01828125|Glucagon|glucagon|mesh-list
20536674|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20536675|NCT01828125|Hormones|hormones|mesh-ancestor
20536676|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536677|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536678|NCT01828203|Minocycline|minocycline|mesh-list
20536679|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20536680|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536681|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
20536682|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20536683|NCT01828294|Antibodies|antibodies|mesh-list
20536684|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
20536685|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536686|NCT01828346|Azacitidine|azacitidine|mesh-list
20536687|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20536688|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
20536689|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536690|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536691|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258276|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20258277|NCT00483067|Cytarabine|cytarabine|mesh-list
20258278|NCT00483067|Cladribine|cladribine|mesh-list
20258279|NCT00483067|Sargramostim|sargramostim|mesh-list
20258280|NCT00483067|Lenograstim|lenograstim|mesh-list
20258281|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19970995|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258282|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
20286822|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
20286823|NCT02030990|Hormones|hormones|mesh-ancestor
20286824|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286825|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286826|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20286827|NCT01972217|Prednisone|prednisone|mesh-list
20286828|NCT01972217|Prednisolone|prednisolone|mesh-list
20286829|NCT01972217|Olaparib|olaparib|mesh-list
20286830|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286831|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
20286832|NCT01972217|Hormones|hormones|mesh-ancestor
20286833|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536692|NCT01828359|Losartan|losartan|mesh-list
20536693|NCT01828359|Amlodipine|amlodipine|mesh-list
20536694|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20536695|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19891061|NCT04881799|Topiramate|topiramate|mesh-list
19891062|NCT04881799|Phentermine|phentermine|mesh-list
19891063|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
19891064|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19891065|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891066|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19891067|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
19891068|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19891069|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
19891070|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
19891071|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19891072|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
19891073|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19891074|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891075|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
19891076|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891077|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
19891078|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891079|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
19891080|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891081|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891082|NCT04869943|Exemestane|exemestane|mesh-list
20536696|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536697|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536698|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20536699|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732191|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
19891083|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891084|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19891085|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19891086|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891087|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891088|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19891089|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
19891090|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19891091|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732192|NCT04576364|Analgesics|analgesics|mesh-ancestor
19732193|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
19732194|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732195|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732196|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
19732197|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732198|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20258283|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258284|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258285|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
20258286|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258287|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258288|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
20258289|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258290|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20258291|NCT00483093|Cisplatin|cisplatin|mesh-list
20258292|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258293|NCT00483106|Methylphenidate|methylphenidate|mesh-list
20258294|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20258295|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258296|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20258297|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258298|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258299|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258300|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
20258301|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258302|NCT00483132|Interferons|interferons|mesh-list
20258303|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
20258304|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
20258305|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258306|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
20258307|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258308|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
20258309|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258310|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20258311|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20258312|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20258313|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
20258314|NCT00483158|Finafloxacin|finafloxacin|mesh-list
20258315|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20258316|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258317|NCT00483158|Renal Agents|renal agents|mesh-ancestor
20258318|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20258319|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20258320|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20258321|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258322|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258323|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258324|NCT00483210|Fenofibrate|fenofibrate|mesh-list
20258325|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20258326|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
20258327|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258328|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20258329|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
20258330|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19891127|NCT04835805|Atezolizumab|atezolizumab|mesh-list
19891128|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258331|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20536700|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
20536701|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20536702|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20536703|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20536704|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
20536705|NCT01828385|Analgesics|analgesics|mesh-ancestor
20536706|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
20536707|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536708|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536709|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
20536710|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536711|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20536712|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
20258332|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536713|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20536714|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536715|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536716|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20536717|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
20536718|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553777|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553778|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
20553779|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20553780|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
20553781|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
20553782|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20553783|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19891129|NCT04822597|Lidocaine|lidocaine|mesh-list
19891130|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
19891131|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
19891132|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19891133|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891134|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
19891135|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19891136|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19891137|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19891138|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19891139|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19891140|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891158|NCT04794790|Buprenorphine|buprenorphine|mesh-list
19891159|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19891160|NCT04794790|Naloxone|naloxone|mesh-list
19891161|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19891162|NCT04794790|Narcotics|narcotics|mesh-ancestor
19891163|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19891164|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891165|NCT04794790|Analgesics|analgesics|mesh-ancestor
19891166|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
19891167|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19891168|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19891169|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
19891170|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891171|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
19891172|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891173|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19891174|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
19891175|NCT04740307|Lenvatinib|lenvatinib|mesh-list
19891176|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891177|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891178|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19891179|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891180|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891198|NCT04729959|Atezolizumab|atezolizumab|mesh-list
19891199|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
19891200|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19891201|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
19891202|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891203|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
19891204|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891210|NCT04708054|Fludarabine|fludarabine|mesh-list
19891211|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
19891212|NCT04708054|Busulfan|busulfan|mesh-list
19891213|NCT04708054|Venetoclax|venetoclax|mesh-list
19891214|NCT04708054|Thiotepa|thiotepa|mesh-list
19891215|NCT04708054|Cladribine|cladribine|mesh-list
19891216|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19891217|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891218|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891219|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
19891220|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891221|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891222|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
19891223|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891224|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
19891225|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19891226|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19891227|NCT04697628|Gemcitabine|gemcitabine|mesh-list
19891228|NCT04697628|Irinotecan|irinotecan|mesh-list
19891229|NCT04697628|Pemetrexed|pemetrexed|mesh-list
19891230|NCT04697628|Topotecan|topotecan|mesh-list
20536719|NCT01828437|Pyridoxine|pyridoxine|mesh-list
20536720|NCT01828437|Prednisolone|prednisolone|mesh-list
20536721|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20536722|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
20536723|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19891231|NCT04697628|Vinorelbine|vinorelbine|mesh-list
19891232|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
20258333|NCT00483275|Vitamins|vitamins|mesh-ancestor
20258334|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
20258335|NCT00483301|Sorafenib|sorafenib|mesh-list
20258336|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20258337|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258338|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20258339|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258340|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258341|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
20258342|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20258343|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
20258344|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258345|NCT00483314|Expectorants|expectorants|mesh-ancestor
20258346|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
20258347|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20258348|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
20258349|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258350|NCT00483314|Protective Agents|protective agents|mesh-ancestor
20258351|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258352|NCT00483314|Antidotes|antidotes|mesh-ancestor
20258353|NCT00483366|Gemcitabine|gemcitabine|mesh-list
20258354|NCT00483366|Capecitabine|capecitabine|mesh-list
20258355|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
19891233|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891234|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
19891235|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891236|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891237|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
20258356|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20258357|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
19891238|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19891239|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891240|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891241|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
19891242|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891243|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19891244|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19891245|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19891246|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19891247|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891248|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891249|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891250|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891251|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891252|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
19891253|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
19891254|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
19891255|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19891256|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891257|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
19891258|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19891259|NCT04671667|Cisplatin|cisplatin|mesh-list
19891260|NCT04671667|Carboplatin|carboplatin|mesh-list
19891261|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
19891262|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891263|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891264|NCT04662086|Camostat|camostat|mesh-list
19891265|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
19891266|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891267|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891268|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19891269|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19891270|NCT04662073|Camostat|camostat|mesh-list
19891271|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
19891272|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891273|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891274|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19891275|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19891288|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
19891289|NCT04639245|Fludarabine|fludarabine|mesh-list
19891290|NCT04639245|Atezolizumab|atezolizumab|mesh-list
19891291|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19891292|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19891293|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891294|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
19891295|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891296|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19891297|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19891298|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
19891299|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258358|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258359|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258360|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
20258361|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258362|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258363|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891300|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891301|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19891302|NCT04634877|Paclitaxel|paclitaxel|mesh-list
19891303|NCT04634877|Docetaxel|docetaxel|mesh-list
19891304|NCT04634877|Cisplatin|cisplatin|mesh-list
19891305|NCT04634877|Carboplatin|carboplatin|mesh-list
19891306|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
19891307|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891308|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891309|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891310|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891311|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
20536724|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
20536725|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20536726|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
20536727|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20536728|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
20536729|NCT01828437|Hormones|hormones|mesh-ancestor
20536730|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536731|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536732|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20536733|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536734|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
19891312|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891313|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20536735|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
20536736|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536737|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19891327|NCT04629547|Suvorexant|suvorexant|mesh-list
19891328|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19891329|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19891330|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19891331|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891332|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19891333|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19891334|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891335|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
20536738|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20536739|NCT01828437|Protective Agents|protective agents|mesh-ancestor
20536740|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
20536741|NCT01828437|Vitamins|vitamins|mesh-ancestor
20536742|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
20536743|NCT01828463|Nitisinone|nitisinone|mesh-list
20536744|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891336|NCT04626518|Lenvatinib|lenvatinib|mesh-list
19891337|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891338|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891339|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19891340|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891341|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891342|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
19891343|NCT04626479|Lenvatinib|lenvatinib|mesh-list
19891344|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891345|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891346|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19891347|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891348|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891349|NCT04605094|Benralizumab|benralizumab|mesh-list
19891350|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19891351|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
19891357|NCT04586231|Lenvatinib|lenvatinib|mesh-list
19891358|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970996|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
20553784|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19891359|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19891360|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891361|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891362|NCT04582383|Doxycycline|doxycycline|mesh-list
19891363|NCT04582383|Spironolactone|spironolactone|mesh-list
19891364|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19891365|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19891366|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
19891367|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19891368|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19891369|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19891370|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
19891371|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19891372|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891373|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19891374|NCT04582383|Diuretics|diuretics|mesh-ancestor
19891375|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
20536745|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536746|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
20536747|NCT01828489|Analgesics|analgesics|mesh-ancestor
20536748|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
20536749|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536750|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536751|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536752|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20536753|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19970997|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
20536754|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536755|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536756|NCT01828606|Monensin|monensin|mesh-list
20536757|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
20536758|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536759|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20536760|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20536761|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
20536762|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
20536763|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
20536764|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536765|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536766|NCT01828606|Ionophores|ionophores|mesh-ancestor
20536767|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536768|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
20536769|NCT01828710|Folic Acid|folic acid|mesh-list
20536770|NCT01828710|Inositol|inositol|mesh-list
20536771|NCT01828710|Hematinics|hematinics|mesh-ancestor
20536772|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
20536773|NCT01828710|Vitamins|vitamins|mesh-ancestor
20536774|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
20536775|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536776|NCT01828736|Gemcitabine|gemcitabine|mesh-list
20536777|NCT01828736|Cisplatin|cisplatin|mesh-list
20536778|NCT01828736|Carboplatin|carboplatin|mesh-list
20536779|NCT01828736|Trastuzumab|trastuzumab|mesh-list
20536780|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536781|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20536782|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
20536783|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536784|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
20536785|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536786|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536787|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536788|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
20536789|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536790|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20536791|NCT01828788|Ropivacaine|ropivacaine|mesh-list
20536792|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
20536793|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
20536794|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536795|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536796|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
20536797|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536798|NCT01828879|Tacrolimus|tacrolimus|mesh-list
20536799|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891397|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
19891398|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891399|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891407|NCT04499248|Bimatoprost|bimatoprost|mesh-list
19891408|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19891409|NCT04498117|Paclitaxel|paclitaxel|mesh-list
19891410|NCT04498117|Carboplatin|carboplatin|mesh-list
19891411|NCT04498117|Oregovomab|oregovomab|mesh-list
19891412|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891413|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891414|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891415|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891416|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891417|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891418|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891423|NCT04493138|Azacitidine|azacitidine|mesh-list
20536800|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
20536801|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536802|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19891424|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891425|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
19891426|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891427|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891428|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891434|NCT04468360|Pregnanolone|pregnanolone|mesh-list
19891435|NCT04468360|Brexanolone|brexanolone|mesh-list
19891436|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
19891437|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19891438|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891439|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
20536803|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536804|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536805|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20536806|NCT01828892|Vancomycin|vancomycin|mesh-list
20536807|NCT01828892|Meropenem|meropenem|mesh-list
20536808|NCT01828892|Ceftazidime|ceftazidime|mesh-list
20536809|NCT01828892|Cefotaxime|cefotaxime|mesh-list
20536810|NCT01828892|Cefoxitin|cefoxitin|mesh-list
20536811|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536812|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
20536813|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19891440|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536814|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536815|NCT01829178|Cisplatin|cisplatin|mesh-list
20536816|NCT01829178|Docetaxel|docetaxel|mesh-list
20536817|NCT01829178|Fluorouracil|fluorouracil|mesh-list
20536818|NCT01829178|Silymarin|silymarin|mesh-list
20536819|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536820|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
20536821|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
20536822|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
20536823|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536824|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
20536825|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20536826|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536827|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
20536828|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891441|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891442|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
19891443|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
19891444|NCT04455815|Gabexate|gabexate|mesh-list
19891445|NCT04455815|Camostat|camostat|mesh-list
19891446|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
19891447|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891448|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891449|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19891450|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19891451|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
19891459|NCT04447768|Venetoclax|venetoclax|mesh-list
19891460|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
19891461|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891462|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20536829|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
20536830|NCT01829178|Protective Agents|protective agents|mesh-ancestor
20536831|NCT01829334|Listerine|listerine|mesh-list
20536832|NCT01829334|Fluorides|fluorides|mesh-list
20536833|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
20536834|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
20536835|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
20536836|NCT01829334|Protective Agents|protective agents|mesh-ancestor
20536837|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536838|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20536839|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536840|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
20536841|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20536842|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
20536843|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536844|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
20536845|NCT01829451|Protective Agents|protective agents|mesh-ancestor
20536846|NCT01829529|Amoxicillin|amoxicillin|mesh-list
20536847|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20536848|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536849|NCT01829659|Ticagrelor|ticagrelor|mesh-list
20536850|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20536851|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20536852|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20536853|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20536854|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
20536855|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536856|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536857|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536858|NCT01829685|Entecavir|entecavir|mesh-list
20536859|NCT01829685|Adefovir|adefovir|mesh-list
20536860|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
20536861|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536862|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20536863|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20536864|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536865|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536866|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20536867|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20536868|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20536869|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
20536870|NCT01829711|Protective Agents|protective agents|mesh-list
20536871|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536872|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536873|NCT01829802|Ritonavir|ritonavir|mesh-list
20536874|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20536875|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
20536876|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20536877|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20536878|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
20536879|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536880|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536881|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20536882|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20536883|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
20536884|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536885|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20536886|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20536887|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20536888|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20536889|NCT01829841|Sunitinib|sunitinib|mesh-list
20536890|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536891|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20536892|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20536893|NCT01829841|Growth Substances|growth substances|mesh-ancestor
20536894|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536895|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
20536896|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20536897|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536898|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536899|NCT01829893|Tamsulosin|tamsulosin|mesh-list
20536900|NCT01829893|Finasteride|finasteride|mesh-list
20536901|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20536902|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20536903|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20536904|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
20536905|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20536906|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536907|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536908|NCT01829893|Urological Agents|urological agents|mesh-ancestor
19891489|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
19891490|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20536909|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20536910|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20536911|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536912|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
20536913|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20536914|NCT01830101|Temozolomide|temozolomide|mesh-list
20536915|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20536916|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
20536917|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536918|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536919|NCT01830153|Everolimus|everolimus|mesh-list
20536920|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536921|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536922|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
20536923|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553785|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
20553786|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553787|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553788|NCT01931293|Folic Acid|folic acid|mesh-list
20553789|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
20553790|NCT01931293|Vitamins|vitamins|mesh-ancestor
20553791|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
20553792|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553793|NCT01931293|Hematinics|hematinics|mesh-ancestor
20553794|NCT01931306|Afatinib|afatinib|mesh-list
20553795|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553796|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553797|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553798|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553799|NCT01931319|Baclofen|baclofen|mesh-list
20553800|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20553801|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553802|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20553803|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553804|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20258364|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
20258365|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258366|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20258367|NCT00483392|Metformin|metformin|mesh-list
20258368|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
20258369|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20258370|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258371|NCT00483431|Vitamin MK 7|vitamin mk 7|mesh-list
20258372|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
20258373|NCT00483431|Coagulants|coagulants|mesh-ancestor
20258374|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20258375|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258376|NCT00483470|Vaccines|vaccines|mesh-list
20258377|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
20258378|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258379|NCT00483600|PENTA|penta|mesh-list
20258380|NCT00483600|Fondaparinux|fondaparinux|mesh-list
20258381|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20258382|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
20258383|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20258384|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
20258385|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258386|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258387|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
20258388|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20553805|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
20553806|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
20553807|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553808|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553809|NCT01931332|Heroin|heroin|mesh-list
20553810|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20553811|NCT01931332|Narcotics|narcotics|mesh-ancestor
20553812|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553813|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553814|NCT01931332|Analgesics|analgesics|mesh-ancestor
20553815|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
20553816|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553817|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20553818|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553819|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553820|NCT01931410|Misoprostol|misoprostol|mesh-list
20553821|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20553822|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
20553823|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553824|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258389|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20553825|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20553826|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258390|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
20258391|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
20536924|NCT01830218|Anesthetics|anesthetics|mesh-list
20536925|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536926|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536927|NCT01830244|Paclitaxel|paclitaxel|mesh-list
19891491|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891492|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19891493|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
20536928|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20536929|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536930|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
20536931|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
20536932|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891494|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19891495|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19891496|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891497|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891498|NCT04434040|Atezolizumab|atezolizumab|mesh-list
19891499|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891500|NCT04418167|Dabrafenib|dabrafenib|mesh-list
19891501|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891502|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19891503|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891504|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891505|NCT04416269|Insulin|insulin|mesh-list
19891506|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19891507|NCT04416269|Metformin|metformin|mesh-list
19891508|NCT04416269|Pioglitazone|pioglitazone|mesh-list
19891509|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19891510|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19891511|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891512|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
19891513|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891514|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891515|NCT04411654|Sirolimus|sirolimus|mesh-list
19891516|NCT04411654|Prednisone|prednisone|mesh-list
20536933|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536934|NCT01830270|Paclitaxel|paclitaxel|mesh-list
20536935|NCT01830270|Epirubicin|epirubicin|mesh-list
20536936|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20536937|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536938|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
20536939|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
20536940|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
20536941|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536942|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20536943|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20536944|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20536945|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536946|NCT01830296|Morphine|morphine|mesh-list
20536947|NCT01830296|Remifentanil|remifentanil|mesh-list
19891517|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
19891518|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19891519|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19891520|NCT04411654|Prednisolone|prednisolone|mesh-list
19891521|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
19891522|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19891523|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
20258392|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20258393|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20258394|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258395|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258396|NCT00483626|Urological Agents|urological agents|mesh-ancestor
20258397|NCT00483730|Actovegin|actovegin|mesh-list
20258398|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20258399|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258400|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20258401|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19891524|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19891525|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
19891526|NCT04411654|Hormones|hormones|mesh-ancestor
19891527|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19891528|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891529|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19891530|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536948|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20536949|NCT01830296|Narcotics|narcotics|mesh-ancestor
20536950|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20536951|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536952|NCT01830296|Analgesics|analgesics|mesh-ancestor
20536953|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
20536954|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20536955|NCT01830322|Gemcitabine|gemcitabine|mesh-list
20536956|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20536957|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
20536958|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536959|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536960|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
20536961|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536962|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536963|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20536964|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
20536965|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536966|NCT01830335|Indomethacin|indomethacin|mesh-list
20536967|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19891531|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19891532|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20536968|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20536969|NCT01830335|Analgesics|analgesics|mesh-ancestor
20536970|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
20536971|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19891533|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19891534|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
19891535|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891536|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
19891537|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
19891538|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
19891539|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19891540|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19891541|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19891542|NCT04411654|Protective Agents|protective agents|mesh-ancestor
19891543|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
19891544|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19891545|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19891546|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891547|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
19891548|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19891549|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258402|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
20258403|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258404|NCT00483730|Protective Agents|protective agents|mesh-ancestor
20258405|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20258406|NCT00483743|Budesonide|budesonide|mesh-list
20258407|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258408|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20258409|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
20258410|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258411|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258412|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20258413|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
20258414|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
20258415|NCT00483743|Hormones|hormones|mesh-ancestor
20258416|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258417|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
20258418|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20258419|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258420|NCT00483782|Paclitaxel|paclitaxel|mesh-list
20258421|NCT00483782|Bevacizumab|bevacizumab|mesh-list
20258422|NCT00483782|Carboplatin|carboplatin|mesh-list
20258423|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20258424|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891550|NCT04402788|Atezolizumab|atezolizumab|mesh-list
19891551|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19891552|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891553|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
19891554|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891558|NCT04395079|Durvalumab|durvalumab|mesh-list
19891559|NCT04395079|Ipilimumab|ipilimumab|mesh-list
20258425|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891560|NCT04395079|Tremelimumab|tremelimumab|mesh-list
20536972|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536973|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20536974|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20536975|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
20536976|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
20536977|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20536978|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20536979|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536980|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536981|NCT01830361|Midostaurin|midostaurin|mesh-list
20536982|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536983|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20536984|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20536985|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536986|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20536987|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
20536988|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20536989|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20536990|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20536991|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20536992|NCT01830465|Rituximab|rituximab|mesh-list
20536993|NCT01830465|Bortezomib|bortezomib|mesh-list
19891561|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
19891562|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19891563|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
19891564|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891565|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891566|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
19891567|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891568|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19891569|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891570|NCT04374903|Sirolimus|sirolimus|mesh-list
19891571|NCT04374903|Azithromycin|azithromycin|mesh-list
20536994|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20536995|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20536996|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
20536997|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20536998|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20536999|NCT01830478|Rituximab|rituximab|mesh-list
20537000|NCT01830478|Lenalidomide|lenalidomide|mesh-list
20537001|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537002|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537003|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
20537004|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537005|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537006|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20537007|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20537008|NCT01830478|Growth Substances|growth substances|mesh-ancestor
20537009|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
20537010|NCT01830491|Aspirin|aspirin|mesh-list
20537011|NCT01830491|Clopidogrel|clopidogrel|mesh-list
20537012|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20537013|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537014|NCT01830491|Analgesics|analgesics|mesh-ancestor
20537015|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
20537016|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537017|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537018|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537019|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19891572|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
19891573|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19891574|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19891575|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19891576|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891577|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
19891578|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891579|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
19891580|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891581|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
19891582|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19891583|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19891584|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891585|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891586|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537020|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20537021|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20537022|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537023|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20537024|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20537025|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537026|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
20553827|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
19891601|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19891602|NCT04341883|Paclitaxel|paclitaxel|mesh-list
19891603|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19891604|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891605|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891606|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891607|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891608|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891609|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258426|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
20258427|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
20258428|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258429|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258430|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20258431|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20258432|NCT00483782|Growth Substances|growth substances|mesh-ancestor
20258433|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258434|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
20258435|NCT00483795|Citric Acid|citric acid|mesh-list
20258436|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
20258437|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
20258438|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20258439|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
20258440|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
20258441|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258442|NCT00483834|Bevacizumab|bevacizumab|mesh-list
19891638|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
20537027|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20537028|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20537029|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20537030|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
20537031|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537032|NCT01830517|Losartan|losartan|mesh-list
20537033|NCT01830517|Amlodipine|amlodipine|mesh-list
19891639|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
19891640|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19891641|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19891642|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891643|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19891644|NCT04320342|Beclomethasone|beclomethasone|mesh-list
19891645|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
19891646|NCT04320342|Bromides|bromides|mesh-list
19891647|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
19891648|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19891649|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
19891650|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19891651|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891652|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19891653|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
19891654|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19891655|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19891656|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19891657|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
19891658|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19891659|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891660|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
19891661|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19891662|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
19891663|NCT04320342|Hormones|hormones|mesh-ancestor
19891664|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537034|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19891665|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19891666|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19891667|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19891668|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
19891682|NCT04267848|Gemcitabine|gemcitabine|mesh-list
19891683|NCT04267848|Paclitaxel|paclitaxel|mesh-list
19891684|NCT04267848|Cisplatin|cisplatin|mesh-list
19891685|NCT04267848|Carboplatin|carboplatin|mesh-list
19891686|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
19891687|NCT04267848|Pemetrexed|pemetrexed|mesh-list
19891688|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20537035|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20537036|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537037|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537038|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20537039|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537040|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
20537041|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20537042|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20537043|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20537044|NCT01830530|Telmisartan|telmisartan|mesh-list
20537045|NCT01830530|Nifedipine|nifedipine|mesh-list
20537046|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537047|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20537048|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20537049|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537050|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20537051|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537052|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20537053|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537054|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
20537055|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
20537056|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20537057|NCT01830556|Cetuximab|cetuximab|mesh-list
20537058|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537059|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537060|NCT01830777|Cytarabine|cytarabine|mesh-list
20537061|NCT01830777|Etoposide|etoposide|mesh-list
20537062|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
20537063|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20537064|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20537065|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537066|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20537067|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20537068|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537069|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891689|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891690|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891691|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891692|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891693|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891694|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891695|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891696|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
19891697|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
19891698|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19891699|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537070|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20537071|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
20537072|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
20537073|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537074|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891700|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891701|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
20258443|NCT00483834|Capecitabine|capecitabine|mesh-list
20537075|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
20537076|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449670|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449671|NCT03433326|Grazoprevir|grazoprevir|mesh-list
19449672|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
19449673|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449674|NCT03433313|Trastuzumab|trastuzumab|mesh-list
19449675|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258444|NCT00483834|Irinotecan|irinotecan|mesh-list
20258445|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258446|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258447|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20258448|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20258449|NCT00483834|Growth Substances|growth substances|mesh-ancestor
20258450|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258451|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
20258452|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20258453|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
20258454|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258455|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20258456|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20258457|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258458|NCT00483860|Topotecan|topotecan|mesh-list
20258459|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20258460|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20258461|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258462|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258463|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258464|NCT00483886|Prucalopride|prucalopride|mesh-list
20258465|NCT00483886|Laxatives|laxatives|mesh-ancestor
20258466|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258467|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20537077|NCT01830777|Analgesics|analgesics|mesh-ancestor
20553828|NCT01931501|Montelukast|montelukast|mesh-list
20537078|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
20537079|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537080|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537081|NCT01830829|Tamsulosin|tamsulosin|mesh-list
20537082|NCT01830829|Dutasteride|dutasteride|mesh-list
20537083|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20537084|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20537085|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20537086|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537087|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537088|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537089|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537090|NCT01830829|Urological Agents|urological agents|mesh-ancestor
20537091|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20537092|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20537093|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537094|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
20537095|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537096|NCT01830868|Zonisamide|zonisamide|mesh-list
20537097|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
20537098|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20537099|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537100|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537101|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20537102|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537103|NCT01830907|Vitamins|vitamins|mesh-list
20537104|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
20537105|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537106|NCT01830946|Caseins|caseins|mesh-list
20537107|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
20537108|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
20537109|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537110|NCT01831011|Aspirin|aspirin|mesh-list
20537111|NCT01831011|Cinepazide|cinepazide|mesh-list
20537112|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
19891702|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891703|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891704|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19891705|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19891706|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19891707|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
19891708|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891709|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
19891710|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891711|NCT04251533|Paclitaxel|paclitaxel|mesh-list
19891712|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20258468|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19891713|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891714|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
20258469|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
20258470|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258471|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258472|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258473|NCT00483964|Olanzapine|olanzapine|mesh-list
20258474|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
20258475|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
20258476|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258477|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258478|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258479|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20258480|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20258481|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258482|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20258483|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20258484|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258485|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258486|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258487|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258488|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
20258489|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19891715|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891716|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891717|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891718|NCT04241185|Gemcitabine|gemcitabine|mesh-list
19891719|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
19891720|NCT04241185|Fluorouracil|fluorouracil|mesh-list
19891721|NCT04241185|Mitomycins|mitomycins|mesh-list
19891722|NCT04241185|Mitomycin|mitomycin|mesh-list
19891723|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891724|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891725|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
19891726|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891727|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
19891728|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19891729|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891730|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891731|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
19891732|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891733|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891734|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19891735|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
19891736|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19891757|NCT04225390|Dacarbazine|dacarbazine|mesh-list
19891758|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19891759|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
19891760|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891761|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891762|NCT04221945|Cisplatin|cisplatin|mesh-list
19891763|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
19891764|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891765|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891799|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
19891800|NCT04210115|Leucovorin|leucovorin|mesh-list
19891801|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
19891802|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
19891803|NCT04210115|Calcium|calcium|mesh-list
19891804|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
19891805|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891806|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19891807|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258490|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
20258491|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
20258492|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258493|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258494|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
20258495|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258496|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20258497|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
20258498|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19891808|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19891809|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891810|NCT04210115|Antidotes|antidotes|mesh-ancestor
19891811|NCT04210115|Protective Agents|protective agents|mesh-ancestor
19891812|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
19891813|NCT04210115|Vitamins|vitamins|mesh-ancestor
19891814|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
20537113|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258499|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258500|NCT00484003|Analgesics|analgesics|mesh-ancestor
20258501|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
20258502|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258503|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258504|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258505|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258506|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
20258507|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258508|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
20258509|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20258510|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258511|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258512|NCT00484055|Gentamicins|gentamicins|mesh-list
20258513|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20258514|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258515|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20258516|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258517|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258518|NCT00484068|Enalapril|enalapril|mesh-list
20258519|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20258520|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
20258521|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258522|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258523|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20258524|NCT00484107|Estrogens|estrogens|mesh-list
20258525|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20258526|NCT00484107|Hormones|hormones|mesh-ancestor
20258527|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258528|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258529|NCT00484120|Diclofenac|diclofenac|mesh-list
20258530|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258531|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258532|NCT00484120|Analgesics|analgesics|mesh-ancestor
20258533|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
20258534|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258535|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258536|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258537|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258538|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20537114|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537115|NCT01831011|Analgesics|analgesics|mesh-ancestor
20537116|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
20537117|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537118|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537119|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537120|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537121|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20537122|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20537123|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537124|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20537125|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20537126|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537127|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
20537128|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
20537129|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20537130|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
20537131|NCT01831050|Vaccines|vaccines|mesh-list
20537132|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
20537133|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537134|NCT01831193|Curcumin|curcumin|mesh-list
20537135|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20537136|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537137|NCT01831193|Analgesics|analgesics|mesh-ancestor
20537138|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
20537139|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537140|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537141|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537142|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537143|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537144|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537145|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537146|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20537147|NCT01831323|Rifaximin|rifaximin|mesh-list
20537148|NCT01831323|Mesalamine|mesalamine|mesh-list
20537149|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20537150|NCT01831323|Psyllium|psyllium|mesh-list
20537151|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537152|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19891828|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
19891829|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891830|NCT04194203|Paclitaxel|paclitaxel|mesh-list
19891831|NCT04194203|Bevacizumab|bevacizumab|mesh-list
19891832|NCT04194203|Carboplatin|carboplatin|mesh-list
19891833|NCT04194203|Pemetrexed|pemetrexed|mesh-list
19891834|NCT04194203|Atezolizumab|atezolizumab|mesh-list
19891835|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891836|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891837|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
19891838|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
19891839|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
19891840|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891841|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891842|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19891843|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19891844|NCT04194203|Growth Substances|growth substances|mesh-ancestor
19891845|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891846|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
19891847|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891848|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19891849|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20537153|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20537154|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19891855|NCT04161885|Azacitidine|azacitidine|mesh-list
19891856|NCT04161885|Venetoclax|venetoclax|mesh-list
19891857|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891858|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
19891859|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891860|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891861|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891862|NCT04158739|Cytarabine|cytarabine|mesh-list
19891863|NCT04158739|Antibodies|antibodies|mesh-list
19891864|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
19891865|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19891866|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
19891867|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891868|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19891869|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
19891870|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891871|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891872|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
19891873|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19891874|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891875|NCT04147416|Propofol|propofol|mesh-list
19891876|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19891877|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19891878|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891879|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19891880|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
19891881|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
19891882|NCT04143724|Luspatercept|luspatercept|mesh-list
20537155|NCT01831323|Analgesics|analgesics|mesh-ancestor
20537156|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
20537157|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537158|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537159|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537160|NCT01831323|Cathartics|cathartics|mesh-ancestor
20537161|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
20537162|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20537163|NCT01831479|Olmesartan|olmesartan|mesh-list
20537164|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20537165|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20537166|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20537167|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20537168|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
20537169|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537170|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20537171|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20537172|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537173|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537174|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20537175|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20537176|NCT01831505|Prednisolone|prednisolone|mesh-list
20537177|NCT01831505|Rituximab|rituximab|mesh-list
20537178|NCT01831505|Doxorubicin|doxorubicin|mesh-list
20537179|NCT01831505|Vincristine|vincristine|mesh-list
20537180|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20537181|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537182|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537183|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
20537184|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537185|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537186|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20537187|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20537188|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19891883|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19891884|NCT04143724|Hematinics|hematinics|mesh-ancestor
19891885|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
19891886|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537189|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891909|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
19891910|NCT04134325|Nivolumab|nivolumab|mesh-list
19891911|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891912|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891913|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19891914|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891915|NCT04121455|Bevacizumab|bevacizumab|mesh-list
19891916|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
19891917|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891918|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891919|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19891920|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19891921|NCT04121455|Growth Substances|growth substances|mesh-ancestor
19891922|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891923|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
19891940|NCT04101838|Vaccines|vaccines|mesh-list
19891941|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
19891942|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891943|NCT04099251|Nivolumab|nivolumab|mesh-list
20537190|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537191|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19891944|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891945|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891946|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19891947|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19891948|NCT04098432|Nivolumab|nivolumab|mesh-list
19891949|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891950|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891951|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19891952|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258539|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19891965|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
19891966|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891967|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
19891968|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891969|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537192|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
20537193|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
20537194|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
20537195|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537196|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
20537197|NCT01831505|Hormones|hormones|mesh-ancestor
20537198|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537199|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20537200|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20537201|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
20537202|NCT01831622|Methylphenidate|methylphenidate|mesh-list
20537203|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20537204|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537205|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20537206|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20537207|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537208|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537209|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
20537210|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537211|NCT01831661|Metformin|metformin|mesh-list
20537212|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20537213|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537214|NCT01831674|Metformin|metformin|mesh-list
20537215|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20537216|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537217|NCT01831687|Etodolac|etodolac|mesh-list
20537218|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20537219|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537220|NCT01831687|Analgesics|analgesics|mesh-ancestor
20537221|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
20537222|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537223|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537224|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537225|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537226|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20537227|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20537228|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537229|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537230|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20537231|NCT01831700|Lisinopril|lisinopril|mesh-list
20537232|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
20537233|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537234|NCT01831700|Diuretics|diuretics|mesh-ancestor
20537235|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
20537236|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537237|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20537238|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537239|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537240|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20537241|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
20537242|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537243|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20537244|NCT01831700|Protective Agents|protective agents|mesh-ancestor
20553829|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20553830|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
20553831|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19732199|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
19732200|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19732201|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732202|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732203|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19732204|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
19732205|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19732206|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
19732207|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732208|NCT04576143|Paclitaxel|paclitaxel|mesh-list
19732209|NCT04576143|Docetaxel|docetaxel|mesh-list
19891970|NCT04053634|Benralizumab|benralizumab|mesh-list
20537245|NCT01831947|Ranibizumab|ranibizumab|mesh-list
20537246|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20537247|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20537248|NCT01831947|Growth Substances|growth substances|mesh-ancestor
20537249|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537250|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
20537251|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537252|NCT01832051|Trastuzumab|trastuzumab|mesh-list
20537253|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537254|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537255|NCT01832129|Vitamins|vitamins|mesh-list
20537256|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
20537257|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
20537258|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
20537259|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
20537260|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537261|NCT01832129|Hematinics|hematinics|mesh-ancestor
20537262|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
20537263|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20537264|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19891971|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19891972|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
20537265|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537266|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537267|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20537268|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20537269|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20537270|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537271|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537272|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537273|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
20537274|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20537275|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
20537276|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20537277|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20537278|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537279|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20537280|NCT01832311|Ketorolac|ketorolac|mesh-list
19891973|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
19891974|NCT04047628|Ofatumumab|ofatumumab|mesh-list
19891975|NCT04047628|Cladribine|cladribine|mesh-list
19891976|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
20537281|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20537282|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537283|NCT01832311|Analgesics|analgesics|mesh-ancestor
20537284|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
20537285|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537286|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537287|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537288|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19891977|NCT04047628|Natalizumab|natalizumab|mesh-list
19891978|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19891979|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19891980|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
19891981|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19891982|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19891998|NCT04021264|Sufentanil|sufentanil|mesh-list
19891999|NCT04021264|Ropivacaine|ropivacaine|mesh-list
19892000|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
19892001|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
20537289|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19892002|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19892003|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892004|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
19892005|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19892006|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19892007|NCT04021264|Narcotics|narcotics|mesh-ancestor
19892008|NCT04021264|Analgesics|analgesics|mesh-ancestor
19892009|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19892010|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19892011|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
19892012|NCT04005716|Cisplatin|cisplatin|mesh-list
19892013|NCT04005716|Carboplatin|carboplatin|mesh-list
19892014|NCT04005716|Etoposide|etoposide|mesh-list
19892015|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
19892016|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892017|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892018|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19892019|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19892020|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892021|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537290|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537291|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537292|NCT01832350|Quinidine|quinidine|mesh-list
20537293|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
20537294|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
20537295|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
20537296|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20537297|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20537298|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537299|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537300|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537301|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20537302|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20537303|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537304|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20537305|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
20537306|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20537307|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20537308|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892057|NCT03972488|Octreotide|octreotide|mesh-list
20537309|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537310|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20537311|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20537312|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
19892058|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19892059|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19892060|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19892061|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537313|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20537314|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20537315|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537316|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20537317|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19892062|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19892063|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892064|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19892065|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19892066|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892067|NCT03970447|Temozolomide|temozolomide|mesh-list
19892068|NCT03970447|Lomustine|lomustine|mesh-list
19892069|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
19892070|NCT03970447|GDC-0084|gdc-0084|mesh-list
19892071|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19892072|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
19892073|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892074|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892075|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892076|NCT03968653|Carboplatin|carboplatin|mesh-list
19892077|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258540|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258541|NCT00484133|Dobutamine|dobutamine|mesh-list
20258542|NCT00484133|Dopamine|dopamine|mesh-list
20258543|NCT00484133|Enoximone|enoximone|mesh-list
20258544|NCT00484133|Norepinephrine|norepinephrine|mesh-list
20258545|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
20258546|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
20258547|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20258548|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
20258549|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
20258550|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258551|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537318|NCT01832363|Xenon|xenon|mesh-list
20537319|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20537320|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
20537321|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
20537322|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537323|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537324|NCT01832415|Bevacizumab|bevacizumab|mesh-list
20537325|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537326|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537327|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19892124|NCT03952585|Cisplatin|cisplatin|mesh-list
19892125|NCT03952585|Nivolumab|nivolumab|mesh-list
19892126|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892127|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892128|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892129|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892130|NCT03941288|Cannabidiol|cannabidiol|mesh-list
19892131|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
20258552|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20258553|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20258554|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20258555|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
20258556|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258557|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258558|NCT00484133|Protective Agents|protective agents|mesh-ancestor
20258559|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
20258560|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20258561|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20258562|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20258563|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20258564|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258565|NCT00484237|Etanercept|etanercept|mesh-list
20258566|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258567|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258568|NCT00484237|Analgesics|analgesics|mesh-ancestor
20258569|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
20258570|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258571|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258572|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258573|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258574|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258575|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258576|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
20258577|NCT00484250|Metronidazole|metronidazole|mesh-list
20258578|NCT00484250|Doxycycline|doxycycline|mesh-list
20258579|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258580|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20258581|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20258582|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20258583|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
20258584|NCT00484328|Ribavirin|ribavirin|mesh-list
20258585|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
20258586|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892148|NCT03933397|Morphine|morphine|mesh-list
19892149|NCT03933397|Hydromorphone|hydromorphone|mesh-list
19892150|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19892151|NCT03933397|Narcotics|narcotics|mesh-ancestor
19892152|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19892153|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892154|NCT03933397|Analgesics|analgesics|mesh-ancestor
19892155|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
19892156|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19892157|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
19892158|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892159|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892160|NCT03921008|Paclitaxel|paclitaxel|mesh-list
19892161|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20537328|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20537329|NCT01832415|Growth Substances|growth substances|mesh-ancestor
20537330|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537331|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
20537332|NCT01832467|Cetuximab|cetuximab|mesh-list
20537333|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537334|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537335|NCT01832558|Eplerenone|eplerenone|mesh-list
20537336|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20537337|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
20537338|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537339|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537340|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19892162|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892163|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892164|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
20537341|NCT01832558|Diuretics|diuretics|mesh-ancestor
20537342|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
20537343|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537344|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20537345|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20537346|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20537347|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537348|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537349|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
20537350|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537351|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20537352|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20537353|NCT01832623|Vitamin D|vitamin d|mesh-list
20537354|NCT01832623|Vitamins|vitamins|mesh-ancestor
20537355|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
20537356|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892165|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892166|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892167|NCT03918278|Gemcitabine|gemcitabine|mesh-list
19892168|NCT03918278|Paclitaxel|paclitaxel|mesh-list
19892169|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19892170|NCT03918278|Carboplatin|carboplatin|mesh-list
19892171|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
19892172|NCT03918278|Pemetrexed|pemetrexed|mesh-list
19892173|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892174|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892175|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892176|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892177|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892178|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892179|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892180|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
19892181|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
19892182|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892183|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892184|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892185|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
19892186|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892187|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892188|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19892189|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19892190|NCT03914612|Paclitaxel|paclitaxel|mesh-list
19892191|NCT03914612|Carboplatin|carboplatin|mesh-list
19892192|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
19892193|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19892194|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892195|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892196|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892197|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
20258587|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
20258588|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258589|NCT00484341|Doxorubicin|doxorubicin|mesh-list
20258590|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20258591|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258592|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20258593|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20258594|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258595|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258596|NCT00484432|Doxorubicin|doxorubicin|mesh-list
20258597|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20258598|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258599|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20258600|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20258601|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258602|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258603|NCT00484484|Ketamine|ketamine|mesh-list
20258604|NCT00484484|Analgesics|analgesics|mesh-ancestor
20258605|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
20258606|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258607|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258608|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20258609|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20258610|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
20258611|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
20258612|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258613|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19892198|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892199|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892200|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537357|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20537358|NCT01832662|Caffeine|caffeine|mesh-list
20537359|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20537360|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537361|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20537362|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537363|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537364|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20537365|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20537366|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
20537367|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537368|NCT01832675|Bupivacaine|bupivacaine|mesh-list
20537369|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
20537370|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
20537371|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537372|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537373|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
20537374|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537375|NCT01832870|Ipilimumab|ipilimumab|mesh-list
20537376|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537377|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537378|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20537379|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537380|NCT01832896|Ecallantide|ecallantide|mesh-list
20537381|NCT01832896|Analgesics|analgesics|mesh-ancestor
20537382|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
20537383|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537384|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537385|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20537386|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537387|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537388|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537389|NCT01832922|Rituximab|rituximab|mesh-list
20537390|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20537391|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537392|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537393|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
20537394|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537395|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537396|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20537397|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
20537398|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537399|NCT01832935|Insulin|insulin|mesh-list
20537400|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20537401|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
20537402|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
20537403|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
20537404|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
20537405|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20537406|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892232|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
19892233|NCT03907852|Nivolumab|nivolumab|mesh-list
19892234|NCT03907852|Fludarabine|fludarabine|mesh-list
19892235|NCT03907852|Ipilimumab|ipilimumab|mesh-list
19892236|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892237|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
19892238|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892239|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19892240|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19892241|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
19892242|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892243|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892244|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20258614|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20258615|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258616|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258617|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
20258618|NCT00484510|Vitamins|vitamins|mesh-ancestor
20258619|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
20258620|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258621|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
20258622|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258623|NCT00484510|Protective Agents|protective agents|mesh-ancestor
20258624|NCT00484575|Propofol|propofol|mesh-list
20258625|NCT00484575|Sevoflurane|sevoflurane|mesh-list
20258626|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20258627|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537407|NCT01832948|Leucovorin|leucovorin|mesh-list
19892245|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892246|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892247|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19892248|NCT03907488|Nivolumab|nivolumab|mesh-list
19892249|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19892250|NCT03907488|Doxorubicin|doxorubicin|mesh-list
19892251|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20537408|NCT01832948|Folic Acid|folic acid|mesh-list
20537409|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
20537410|NCT01832948|Endostar protein|endostar protein|mesh-list
20537411|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
20537412|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537413|NCT01832948|Antidotes|antidotes|mesh-ancestor
20537414|NCT01832948|Protective Agents|protective agents|mesh-ancestor
20537415|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537416|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
20537417|NCT01832948|Vitamins|vitamins|mesh-ancestor
20537418|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
20537419|NCT01832948|Hematinics|hematinics|mesh-ancestor
20537420|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20537421|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20537422|NCT01832948|Growth Substances|growth substances|mesh-ancestor
19892252|NCT03907488|Dacarbazine|dacarbazine|mesh-list
19892253|NCT03907488|Vinblastine|vinblastine|mesh-list
19892254|NCT03907488|Antibodies|antibodies|mesh-list
19892255|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
19892256|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19892257|NCT03907488|Lenograstim|lenograstim|mesh-list
19892258|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
19892259|NCT03907488|Imidazole|imidazole|mesh-list
19892260|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
19892261|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892262|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892263|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19892264|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19892265|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19892266|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892267|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892268|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892269|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19892270|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19892271|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
19892272|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892273|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892274|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892275|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892276|NCT03891953|Spartalizumab|spartalizumab|mesh-list
19892277|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892278|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892279|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892280|NCT03871257|Carboplatin|carboplatin|mesh-list
19892281|NCT03871257|Vincristine|vincristine|mesh-list
19892282|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892283|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892284|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892285|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892286|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892287|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892288|NCT03869190|Gemcitabine|gemcitabine|mesh-list
20537423|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
20537424|NCT01832987|Trimethoprim|trimethoprim|mesh-list
20537425|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20537426|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
20537427|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20537428|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537429|NCT01832987|Renal Agents|renal agents|mesh-ancestor
20537430|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
20537431|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19892289|NCT03869190|Atezolizumab|atezolizumab|mesh-list
19892290|NCT03869190|Niraparib|niraparib|mesh-list
19892291|NCT03869190|Magrolimab|magrolimab|mesh-list
19892292|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892293|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892294|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
19892295|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892296|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
20537432|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20537433|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20537434|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892297|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892298|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892299|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892300|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
19892301|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892302|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19892303|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892304|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
19892305|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892306|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892307|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
19892308|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892309|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892310|NCT03866837|Micronutrients|micronutrients|mesh-list
19892311|NCT03866837|Trace Elements|trace elements|mesh-list
19892312|NCT03866837|Lactoferrin|lactoferrin|mesh-list
19892313|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892314|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892344|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
19892345|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537435|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537436|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20537437|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20537438|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20537439|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19892346|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
19892347|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
19892348|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
19892352|NCT03839823|Gemcitabine|gemcitabine|mesh-list
20537440|NCT01833221|Lidocaine|lidocaine|mesh-list
20537441|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
20537442|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
20537443|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537444|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537445|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
20537446|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537447|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20537448|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20537449|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20537450|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537451|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892353|NCT03839823|Paclitaxel|paclitaxel|mesh-list
19892354|NCT03839823|Vinorelbine|vinorelbine|mesh-list
20537452|NCT01833299|Sorafenib|sorafenib|mesh-list
20537453|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
20537454|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537455|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20537456|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537457|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537458|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20537459|NCT01833299|Estrogens|estrogens|mesh-ancestor
20537460|NCT01833299|Hormones|hormones|mesh-ancestor
20537461|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537462|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892355|NCT03839823|Docetaxel|docetaxel|mesh-list
19892356|NCT03839823|Capecitabine|capecitabine|mesh-list
19892357|NCT03839823|Letrozole|letrozole|mesh-list
19892358|NCT03839823|Anastrozole|anastrozole|mesh-list
19892359|NCT03839823|Goserelin|goserelin|mesh-list
19892360|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892361|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892362|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892363|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892364|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892365|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892366|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892367|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
19892368|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
19892369|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892370|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892371|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892372|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
19892373|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892374|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19892375|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20537463|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20537464|NCT01833312|Meperidine|meperidine|mesh-list
20537465|NCT01833312|Buspirone|buspirone|mesh-list
20537466|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20537467|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20537468|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537469|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537470|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20537471|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20537472|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
20537473|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537474|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537475|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20537476|NCT01833312|Narcotics|narcotics|mesh-ancestor
20537477|NCT01833312|Analgesics|analgesics|mesh-ancestor
20537478|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
20537479|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537480|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20537481|NCT01833351|Vitamins|vitamins|mesh-list
20537482|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
20537483|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
20537484|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537485|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
19892376|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19892377|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
19892378|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19892379|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19892380|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
19892381|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892382|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892383|NCT03824938|Aspirin|aspirin|mesh-list
20537486|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537487|NCT01833351|Protective Agents|protective agents|mesh-ancestor
20537488|NCT01833559|Insulin|insulin|mesh-list
20537489|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20537490|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
20537491|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20537492|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537493|NCT01833572|Gefitinib|gefitinib|mesh-list
20537494|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537495|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20537496|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537497|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892384|NCT03824938|Acetaminophen|acetaminophen|mesh-list
20537498|NCT01833611|Entecavir|entecavir|mesh-list
20537499|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
20537500|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537501|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
20537502|NCT01833663|Estrogens|estrogens|mesh-list
20537503|NCT01833663|Hormones|hormones|mesh-ancestor
20537504|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537505|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537506|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20537507|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20537508|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
20537509|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537510|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537511|NCT01833663|Urological Agents|urological agents|mesh-ancestor
20537512|NCT01833676|Sevoflurane|sevoflurane|mesh-list
20537513|NCT01833676|Desflurane|desflurane|mesh-list
20537514|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19892385|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19892386|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19892387|NCT03824938|Analgesics|analgesics|mesh-ancestor
20537515|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20537516|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
20537517|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
20537518|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537519|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553832|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553833|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553834|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553835|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20553836|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20553837|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553838|NCT01931514|Montelukast|montelukast|mesh-list
20553839|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20553840|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
20553841|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20553842|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553843|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553844|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553845|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20553846|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20553847|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553848|NCT01931592|Gentamicins|gentamicins|mesh-list
20553849|NCT01931592|Colistin|colistin|mesh-list
20553850|NCT01931592|Fosfomycin|fosfomycin|mesh-list
19892388|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
19892389|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19892390|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892391|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19892392|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19892393|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19892394|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19892395|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892396|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19892397|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19892398|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892399|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
19892400|NCT03816358|Gemcitabine|gemcitabine|mesh-list
19892401|NCT03816358|Nivolumab|nivolumab|mesh-list
19892402|NCT03816358|Ipilimumab|ipilimumab|mesh-list
19892403|NCT03816358|Maytansine|maytansine|mesh-list
19892404|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892405|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
19892406|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892407|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892408|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
19892409|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258628|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258629|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20258630|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
20258631|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
20258632|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20258633|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20258634|NCT00484601|Doxorubicin|doxorubicin|mesh-list
19449676|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449677|NCT03433235|Edoxaban|edoxaban|mesh-list
19449678|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19449679|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
19449680|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20258635|NCT00484601|Ifosfamide|ifosfamide|mesh-list
20258636|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20258637|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258638|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20258639|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20258640|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258641|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258642|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20258643|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
20258644|NCT00484640|Warfarin|warfarin|mesh-list
20258645|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
20258646|NCT00484692|Bupropion|bupropion|mesh-list
20258647|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20258648|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
20258649|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20258650|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20258651|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258652|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258653|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258654|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
20258655|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537520|NCT01833715|Morphine|morphine|mesh-list
20537521|NCT01833715|Methadone|methadone|mesh-list
20537522|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20537523|NCT01833715|Narcotics|narcotics|mesh-ancestor
20537524|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537525|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537526|NCT01833715|Analgesics|analgesics|mesh-ancestor
19449681|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
19892410|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892411|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892412|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
19892413|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892414|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892415|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892416|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892417|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892418|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892419|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892420|NCT03816163|Gemcitabine|gemcitabine|mesh-list
19892421|NCT03816163|Paclitaxel|paclitaxel|mesh-list
19892422|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892423|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892424|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892425|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892426|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892427|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892428|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892429|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
19892430|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
19892431|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892432|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892433|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892434|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
19892435|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258656|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258657|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20537527|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
20537528|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537529|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
20537530|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
20537531|NCT01833728|Acetaminophen|acetaminophen|mesh-list
20537532|NCT01833728|Propacetamol|propacetamol|mesh-list
20537533|NCT01833728|Nefopam|nefopam|mesh-list
20537534|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537535|NCT01833728|Analgesics|analgesics|mesh-ancestor
20537536|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
20537537|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537538|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537539|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258658|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20258659|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286834|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286835|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286836|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286837|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20286838|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286839|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286840|NCT01898793|Vidarabine|vidarabine|mesh-list
20286841|NCT01898793|Aldesleukin|aldesleukin|mesh-list
20286842|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
20286843|NCT01898793|Fludarabine|fludarabine|mesh-list
20286844|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
20286845|NCT01898793|Interleukin-2|interleukin-2|mesh-list
20286846|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537540|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537541|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537542|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
20286847|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
20286848|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286849|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286850|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20286851|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
20286852|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286853|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286854|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20286855|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20286856|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
20286857|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
20286858|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286859|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20286860|NCT01898793|Analgesics|analgesics|mesh-ancestor
20286861|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
20286862|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286863|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20286864|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20286865|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
20286866|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20286867|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20537543|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
20537544|NCT01833767|Interleukin-2|interleukin-2|mesh-list
19449682|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449683|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449684|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
19449685|NCT03433222|Coal Tar|coal tar|mesh-list
19449686|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
19449687|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
19449688|NCT03433196|Atorvastatin|atorvastatin|mesh-list
19449689|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19449690|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20258660|NCT00484731|Bupivacaine|bupivacaine|mesh-list
20258661|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
20258662|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
20258663|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258664|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258665|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
20258666|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258667|NCT00484744|Acetaminophen|acetaminophen|mesh-list
20537545|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537546|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
20537547|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537548|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537549|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20537550|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
20537551|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537552|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537553|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20537554|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537555|NCT01833767|Analgesics|analgesics|mesh-ancestor
20537556|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
20537557|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537558|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
20537559|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20537560|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
20537561|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20537562|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537563|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20537564|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20537565|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20537566|NCT01833819|Lidocaine|lidocaine|mesh-list
20537567|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
20537568|NCT01833819|Remifentanil|remifentanil|mesh-list
20537569|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
20537570|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
20258668|NCT00484744|Ibuprofen|ibuprofen|mesh-list
20258669|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537571|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537572|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537573|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
20537574|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537575|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20537576|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20537577|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20537578|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258670|NCT00484744|Analgesics|analgesics|mesh-ancestor
19449691|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
20258671|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
20537579|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537580|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20537581|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537582|NCT01833819|Analgesics|analgesics|mesh-ancestor
20537583|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20537584|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20537585|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20537586|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537587|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537588|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20537589|NCT01833819|Narcotics|narcotics|mesh-ancestor
20537590|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20537591|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20537592|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537593|NCT01834014|Bevacizumab|bevacizumab|mesh-list
20537594|NCT01834014|Cetuximab|cetuximab|mesh-list
20537595|NCT01834014|Fluorouracil|fluorouracil|mesh-list
20537596|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
20537597|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537598|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537599|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20537600|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20537601|NCT01834014|Growth Substances|growth substances|mesh-ancestor
20537602|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537603|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
20537604|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
20537605|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537606|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20537607|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537608|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
20537609|NCT01834170|Gemcitabine|gemcitabine|mesh-list
20537610|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892483|NCT03765918|Cisplatin|cisplatin|mesh-list
19892484|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
19892485|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892486|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892487|NCT03760263|Tacrolimus|tacrolimus|mesh-list
19892488|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892489|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
19892490|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537611|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
20537612|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537613|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537614|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
20537615|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537616|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537617|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537618|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
20537619|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537620|NCT01834183|Gemcitabine|gemcitabine|mesh-list
20537621|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20537622|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
20537623|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537624|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537625|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
20537626|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537627|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537628|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537629|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
20537630|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537631|NCT01834209|Prednisone|prednisone|mesh-list
20537632|NCT01834209|Prednisolone|prednisolone|mesh-list
20537633|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
20537634|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537635|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
20537636|NCT01834209|Hormones|hormones|mesh-ancestor
20258672|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19892491|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19892492|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892493|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892494|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
19892495|NCT03747484|Avelumab|avelumab|mesh-list
20537637|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19892496|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
19892497|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
19892498|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19892499|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892500|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892501|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
19892502|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892519|NCT03739411|Temozolomide|temozolomide|mesh-list
19892520|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19892521|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
19892522|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892523|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537638|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537639|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20537640|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537641|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20537642|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537643|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537644|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
20537645|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20537646|NCT01834235|Gemcitabine|gemcitabine|mesh-list
20537647|NCT01834235|Paclitaxel|paclitaxel|mesh-list
20537648|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892535|NCT03708237|Gabapentin|gabapentin|mesh-list
19892536|NCT03708237|Ropinirole|ropinirole|mesh-list
19892537|NCT03708237|Analgesics|analgesics|mesh-ancestor
19892538|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
19892539|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19892540|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892541|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
19892542|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19892543|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19892544|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19892545|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19892546|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19892547|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19892548|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19892549|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892550|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
19892551|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19892552|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19892553|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
19892554|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
19892555|NCT03688178|Temozolomide|temozolomide|mesh-list
20537649|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537650|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892556|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20537651|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
20537652|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
20537653|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537654|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20537655|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
20537656|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
20537657|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892557|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
19892558|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892559|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892560|NCT03686124|Nivolumab|nivolumab|mesh-list
19892561|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892562|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892563|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892564|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892565|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19892566|NCT03678350|Trioxsalen|trioxsalen|mesh-list
19892567|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892568|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
19892569|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20537658|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537659|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537660|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
20537661|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537662|NCT01834248|Poly I-C|poly i-c|mesh-list
20537663|NCT01834248|Decitabine|decitabine|mesh-list
20537664|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19892597|NCT03629171|Cytarabine|cytarabine|mesh-list
19892598|NCT03629171|Daunorubicin|daunorubicin|mesh-list
19892599|NCT03629171|Venetoclax|venetoclax|mesh-list
19892600|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892601|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
19892602|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537665|NCT01834248|Poly ICLC|poly iclc|mesh-list
20537666|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20537667|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
20537668|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537669|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537670|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537671|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
20537672|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
20537673|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537674|NCT01834248|Laxatives|laxatives|mesh-ancestor
20537675|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20537676|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
20537677|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537678|NCT01834508|Entecavir|entecavir|mesh-list
19892603|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537679|NCT01834508|Adefovir|adefovir|mesh-list
20537680|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
20537681|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537682|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20537683|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20537684|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537685|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537686|NCT01834547|Methylphenidate|methylphenidate|mesh-list
20537687|NCT01834547|Caffeine|caffeine|mesh-list
20537688|NCT01834547|Modafinil|modafinil|mesh-list
20537689|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20537690|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537691|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20537692|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20537693|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537694|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537695|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
20537696|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537697|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20537698|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537699|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20537700|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20537701|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
20537702|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20537703|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20537704|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20537705|NCT01834768|Eplerenone|eplerenone|mesh-list
20537706|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20537707|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
20537708|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537709|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537710|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20537711|NCT01834768|Diuretics|diuretics|mesh-ancestor
20537712|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
20537713|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537714|NCT01834820|Dexamethasone|dexamethasone|mesh-list
20537715|NCT01834820|Epinephrine|epinephrine|mesh-list
20537716|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537717|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
20537718|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
20537719|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537720|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892604|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
19892605|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892606|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892607|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
19892608|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892609|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19892610|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19892611|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19892612|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892613|NCT03628209|Nivolumab|nivolumab|mesh-list
19892614|NCT03628209|Azacitidine|azacitidine|mesh-list
19892615|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892616|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892617|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892618|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892619|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892620|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
19892621|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537721|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20537722|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
20537723|NCT01834820|Hormones|hormones|mesh-ancestor
20537724|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537725|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20537726|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537727|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20537728|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20537729|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537730|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537731|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537732|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20537733|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20537734|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20537735|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
20537736|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
20537737|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
20537738|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20537739|NCT01834885|Fluticasone|fluticasone|mesh-list
20537740|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20537741|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20537742|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537743|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20537744|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
20537745|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537746|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537747|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20537748|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
20537749|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
20537750|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20537751|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20537752|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20537753|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20537754|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537755|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537756|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537757|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
20537758|NCT01834885|Hormones|hormones|mesh-ancestor
20537759|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537760|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
20537761|NCT01834898|Oxycodone|oxycodone|mesh-list
20537762|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20537763|NCT01834898|Narcotics|narcotics|mesh-ancestor
20537764|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537765|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537766|NCT01834898|Analgesics|analgesics|mesh-ancestor
20537767|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
20537768|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537769|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
20537770|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20537771|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20537772|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537773|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537774|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537775|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537776|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537777|NCT01834963|Interferons|interferons|mesh-list
20537778|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
20537779|NCT01834963|Cisplatin|cisplatin|mesh-list
20537780|NCT01834963|Fluorouracil|fluorouracil|mesh-list
20537781|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537782|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
20537783|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258673|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258674|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
20258675|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258676|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258677|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258678|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20537784|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20537785|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537786|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
19892633|NCT03591510|Cytarabine|cytarabine|mesh-list
20258679|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258680|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258681|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20258682|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
20258683|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258684|NCT00484809|Etanercept|etanercept|mesh-list
20258685|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258686|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258687|NCT00484809|Analgesics|analgesics|mesh-ancestor
20258688|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
20258689|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258690|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258691|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258692|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258693|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258694|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258695|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
20258696|NCT00484822|Heparin|heparin|mesh-list
20258697|NCT00484822|Calcium heparin|calcium heparin|mesh-list
20258698|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
20258699|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20258700|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20258701|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258702|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20258703|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
20258704|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20258705|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20258706|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258707|NCT00484926|Aspirin|aspirin|mesh-list
20258708|NCT00484926|Clopidogrel|clopidogrel|mesh-list
20258709|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258710|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19892634|NCT03591510|Fludarabine|fludarabine|mesh-list
19892635|NCT03591510|Etoposide|etoposide|mesh-list
20258711|NCT00484926|Analgesics|analgesics|mesh-ancestor
20258712|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
20258713|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258714|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258715|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258716|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258717|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20258718|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20258719|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258720|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20258721|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20258722|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258723|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
20258724|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20258725|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20258726|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20258727|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
20258728|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258729|NCT00484991|Verapamil|verapamil|mesh-list
20258730|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20258731|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20258732|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258733|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258734|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20258735|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892636|NCT03591510|Daunorubicin|daunorubicin|mesh-list
19892637|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
19892638|NCT03591510|Idarubicin|idarubicin|mesh-list
19892639|NCT03591510|Midostaurin|midostaurin|mesh-list
19892640|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892641|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892642|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
19892643|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892644|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892645|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
19892646|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892647|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892648|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19892649|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19892650|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892651|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
19892652|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892653|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19892654|NCT03591510|Analgesics|analgesics|mesh-ancestor
19892655|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
20258736|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
19892656|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19892657|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19892658|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
19892659|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
19892660|NCT03570827|Androgens|androgens|mesh-list
20537787|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537788|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
20537789|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537790|NCT01834989|Mitogens|mitogens|mesh-list
20537791|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
20537792|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537793|NCT01835067|Ranibizumab|ranibizumab|mesh-list
20537794|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20537795|NCT01835067|Plasminogen|plasminogen|mesh-list
20537796|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20537797|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20537798|NCT01835067|Growth Substances|growth substances|mesh-ancestor
20537799|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537800|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
20537801|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537802|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20537803|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20537804|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537805|NCT01835184|Vemurafenib|vemurafenib|mesh-list
20258737|NCT00485004|Sirolimus|sirolimus|mesh-list
20258738|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20258739|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258740|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20258741|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258742|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
20258743|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258744|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
20258745|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537806|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537807|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20537808|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537809|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537810|NCT01835197|Abrocitinib|abrocitinib|mesh-list
20537811|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19892661|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19892662|NCT03570827|Hormones|hormones|mesh-ancestor
19892663|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19892664|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892665|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
19892666|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537812|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537813|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537814|NCT01835236|Paclitaxel|paclitaxel|mesh-list
20537815|NCT01835236|Vinorelbine|vinorelbine|mesh-list
20537816|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20537817|NCT01835236|Trastuzumab|trastuzumab|mesh-list
20537818|NCT01835236|Pertuzumab|pertuzumab|mesh-list
20537819|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20537820|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537821|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
20537822|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
20537823|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
20537824|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537825|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20537826|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
20537827|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537828|NCT01835314|Stiripentol|stiripentol|mesh-list
20537829|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
20537830|NCT01835340|Anesthetics|anesthetics|mesh-list
20537831|NCT01835340|Propofol|propofol|mesh-list
20537832|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19892667|NCT03570827|Protective Agents|protective agents|mesh-ancestor
19892668|NCT03570827|Vitamins|vitamins|mesh-ancestor
19892669|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
20537833|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537834|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20537835|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19892670|NCT03570827|Estrogens|estrogens|mesh-ancestor
20258746|NCT00485030|Sirolimus|sirolimus|mesh-list
20258747|NCT00485030|Everolimus|everolimus|mesh-list
20537836|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
20537837|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20537838|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20553851|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553852|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553853|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19892671|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19892672|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892673|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
20553854|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553855|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553856|NCT01931657|Mifepristone|mifepristone|mesh-list
20553857|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
20553858|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20553859|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
20553860|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553861|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553862|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20537839|NCT01835418|Amlodipine|amlodipine|mesh-list
20537840|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537841|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20537842|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537843|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537844|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20537845|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537846|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
19892733|NCT03467373|Prednisone|prednisone|mesh-list
19892734|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
19892735|NCT03467373|Rituximab|rituximab|mesh-list
19892736|NCT03467373|Doxorubicin|doxorubicin|mesh-list
19892737|NCT03467373|Vincristine|vincristine|mesh-list
19892738|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
19892739|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892740|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
19892741|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892742|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19892743|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19892744|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
19892745|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892746|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892747|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19892748|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892749|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20537847|NCT01835561|Thalidomide|thalidomide|mesh-list
20537848|NCT01835561|Pomalidomide|pomalidomide|mesh-list
20537849|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
20537850|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537851|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20537852|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20537853|NCT01835561|Growth Substances|growth substances|mesh-ancestor
20537854|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
20537855|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537856|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537857|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
20537858|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20537859|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20537860|NCT01835639|Vitamin D|vitamin d|mesh-list
20537861|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
20537862|NCT01835639|Vitamins|vitamins|mesh-ancestor
20537863|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
20537864|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537865|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20537866|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20537867|NCT01835665|Nimodipine|nimodipine|mesh-list
20537868|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537869|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19892750|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19892751|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19892752|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892753|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19892754|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
19892755|NCT03467373|Hormones|hormones|mesh-ancestor
19892756|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19892757|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19892758|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19892759|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
20537870|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20537871|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537872|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19892760|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892761|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892762|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19892763|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
19892764|NCT03461406|Coagulants|coagulants|mesh-ancestor
19892776|NCT03442751|Riboflavin|riboflavin|mesh-list
19892777|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19892778|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19892779|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
19892780|NCT03442751|Vitamins|vitamins|mesh-ancestor
19892781|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
19892782|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892783|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20537873|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537874|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
20537875|NCT01835678|Linagliptin|linagliptin|mesh-list
20537876|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20537877|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537878|NCT01835678|Incretins|incretins|mesh-ancestor
20537879|NCT01835678|Hormones|hormones|mesh-ancestor
20537880|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537881|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20537882|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
20537883|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537884|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537885|NCT01835691|Vitamin D|vitamin d|mesh-list
19732210|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
19892784|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
19892795|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
19892796|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892797|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892798|NCT03420521|Nivolumab|nivolumab|mesh-list
19892799|NCT03420521|Ipilimumab|ipilimumab|mesh-list
19892800|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19892801|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19892802|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892803|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892804|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
20258748|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258749|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258750|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
20258751|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258752|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20258753|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258754|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20258755|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
19732211|NCT04576143|Epirubicin|epirubicin|mesh-list
20258756|NCT00485056|Pioglitazone|pioglitazone|mesh-list
20258757|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20258758|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258759|NCT00485108|Prednisolone|prednisolone|mesh-list
20258760|NCT00485108|Ketorolac|ketorolac|mesh-list
20258761|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
20258762|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20258763|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
19732212|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19732213|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732214|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
19732215|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
19732216|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
19732217|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732218|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537886|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
20537887|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
20537888|NCT01835691|Vitamins|vitamins|mesh-list
20537889|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
20537890|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537891|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20537892|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20537893|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20537894|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537895|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20537896|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537897|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537898|NCT01836016|Fluticasone|fluticasone|mesh-list
20537899|NCT01836016|Xhance|xhance|mesh-list
20537900|NCT01836016|Albuterol|albuterol|mesh-list
20537901|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
20537902|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20537903|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20537904|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537905|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20537906|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
20537907|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537908|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537909|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20537910|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20537911|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
20537912|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20537913|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20537914|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20537915|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20537916|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537917|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537918|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537919|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
20537920|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20537921|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
20537922|NCT01836016|Hormones|hormones|mesh-ancestor
19892805|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19892806|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19892807|NCT03413202|Protective Agents|protective agents|mesh-ancestor
19892808|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537923|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20537924|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
20537925|NCT01836094|Methylene Blue|methylene blue|mesh-list
20537926|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537927|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537928|NCT01836120|Docetaxel|docetaxel|mesh-list
20537929|NCT01836120|Raltitrexed|raltitrexed|mesh-list
20537930|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537931|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
20537932|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
20537933|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
20537934|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537935|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20537936|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
20537937|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20537938|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537939|NCT01836224|Terlipressin|terlipressin|mesh-list
20537940|NCT01836224|Norepinephrine|norepinephrine|mesh-list
20537941|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20537942|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20537943|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20537944|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20537945|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
20537946|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20537947|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537948|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537949|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
20537950|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
20537951|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537952|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
20537953|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20537954|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
20537955|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537956|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537957|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20537958|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
20537959|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537960|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537961|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20537962|NCT01836328|Methadone|methadone|mesh-list
20537963|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20537964|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20537965|NCT01836328|Narcotics|narcotics|mesh-ancestor
20537966|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20537967|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537968|NCT01836328|Analgesics|analgesics|mesh-ancestor
20537969|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
20537970|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537971|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
20537972|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
20537973|NCT01836341|Carboplatin|carboplatin|mesh-list
20537974|NCT01836341|Pemetrexed|pemetrexed|mesh-list
20537975|NCT01836341|Afatinib|afatinib|mesh-list
20537976|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20537977|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537978|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537979|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20537980|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20537981|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20537982|NCT01836406|Ketorolac|ketorolac|mesh-list
20537983|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20537984|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20537985|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20537986|NCT01836406|Analgesics|analgesics|mesh-ancestor
20537987|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
20537988|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20537989|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20537990|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20537991|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20537992|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20537993|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20537994|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537995|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20537996|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20553863|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20537997|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20537998|NCT01836536|Bevacizumab|bevacizumab|mesh-list
20537999|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20538000|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538001|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20538002|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20538003|NCT01836536|Growth Substances|growth substances|mesh-ancestor
20538004|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538005|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
20538006|NCT01836575|Carboplatin|carboplatin|mesh-list
20538007|NCT01836575|Pemetrexed|pemetrexed|mesh-list
20538008|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538009|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538010|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538011|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20538012|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20538013|NCT01836614|Lidocaine|lidocaine|mesh-list
20538014|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538015|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
20538016|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538017|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538018|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
20538019|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538020|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20538021|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20538022|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20538023|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538024|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538025|NCT01836653|Bevacizumab|bevacizumab|mesh-list
20538026|NCT01836653|Cetuximab|cetuximab|mesh-list
20538027|NCT01836653|Fluorouracil|fluorouracil|mesh-list
20538028|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
20538029|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20538030|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538031|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20538032|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20538033|NCT01836653|Growth Substances|growth substances|mesh-ancestor
20538034|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538035|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
20538036|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
20538037|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538038|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20538039|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538040|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
20538041|NCT01836679|Paclitaxel|paclitaxel|mesh-list
20538042|NCT01836679|Carboplatin|carboplatin|mesh-list
20538043|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20538044|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538045|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538046|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
20538047|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
20538048|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538049|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
20538050|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538051|NCT01836900|Hemostatics|hemostatics|mesh-list
20538052|NCT01836900|Coagulants|coagulants|mesh-ancestor
20553864|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20553865|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
20553866|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20553867|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20553868|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553869|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553870|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
20553871|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20553872|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20553873|NCT01931683|Remifentanil|remifentanil|mesh-list
20553874|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20553875|NCT01931683|Narcotics|narcotics|mesh-ancestor
20553876|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553877|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553878|NCT01931683|Analgesics|analgesics|mesh-ancestor
20553879|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
20553880|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553881|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
20538053|NCT01837043|Cyclosporine|cyclosporine|mesh-list
20538054|NCT01837043|Abatacept|abatacept|mesh-list
20538055|NCT01837043|Tacrolimus|tacrolimus|mesh-list
20538056|NCT01837043|Cyclosporins|cyclosporins|mesh-list
20538057|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20538058|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538059|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
20538060|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538061|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538062|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538063|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
20538064|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538065|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
20538066|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20538067|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20538068|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538069|NCT01837108|Eplerenone|eplerenone|mesh-list
20538070|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20538071|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
20538072|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20538073|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538074|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20538075|NCT01837108|Diuretics|diuretics|mesh-ancestor
20538076|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
20538077|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20538078|NCT01837199|Amoxicillin|amoxicillin|mesh-list
20538079|NCT01837199|Metronidazole|metronidazole|mesh-list
20538080|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20538081|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538082|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20538083|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20538084|NCT01837251|Bevacizumab|bevacizumab|mesh-list
20538085|NCT01837251|Carboplatin|carboplatin|mesh-list
20538086|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20538087|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538088|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20538089|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20538090|NCT01837251|Growth Substances|growth substances|mesh-ancestor
20538091|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538092|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
20538093|NCT01837290|Midazolam|midazolam|mesh-list
20538094|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
20538095|NCT01837290|Bupivacaine|bupivacaine|mesh-list
20538096|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538097|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
20538098|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538099|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538100|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
20538101|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538102|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20538103|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20538104|NCT01837290|Analgesics|analgesics|mesh-ancestor
20538105|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20538106|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20538107|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20538108|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
20538109|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538110|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538111|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20538112|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20538113|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20538114|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20538115|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20538116|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
20538117|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
20538118|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
20538119|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20538120|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
20538121|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
20538122|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892827|NCT03404661|Secretin|secretin|mesh-list
19892828|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19892829|NCT03404661|Hormones|hormones|mesh-ancestor
19892830|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19892831|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892832|NCT03398356|Metformin|metformin|mesh-list
19892833|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19892834|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258764|NCT00485108|Hormones|hormones|mesh-ancestor
20538123|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538124|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20538125|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20538126|NCT01837329|Growth Substances|growth substances|mesh-ancestor
20538127|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538128|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
20538129|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538130|NCT01837394|Acetaminophen|acetaminophen|mesh-list
20538131|NCT01837394|Morphine|morphine|mesh-list
20538132|NCT01837394|Ondansetron|ondansetron|mesh-list
20258765|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258766|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258767|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20258768|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258769|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258770|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258771|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258772|NCT00485108|Analgesics|analgesics|mesh-ancestor
20258773|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
20258774|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258775|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20258776|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258777|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258778|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20258779|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20258780|NCT00485121|Ezetimibe|ezetimibe|mesh-list
20258781|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20258782|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20258783|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
20258784|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258785|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20258786|NCT00485160|Ibuprofen|ibuprofen|mesh-list
20258787|NCT00485160|Indomethacin|indomethacin|mesh-list
20258788|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20258789|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20258790|NCT00485160|Analgesics|analgesics|mesh-ancestor
20258791|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
20258792|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258793|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538133|NCT01837394|Metoclopramide|metoclopramide|mesh-list
20538134|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20538135|NCT01837394|Narcotics|narcotics|mesh-ancestor
20538136|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538137|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538138|NCT01837394|Analgesics|analgesics|mesh-ancestor
20538139|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
20538140|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538141|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20538142|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
20538143|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
20538144|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
20538145|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20538146|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
20538147|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
20538148|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20538149|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
20538150|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538151|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538152|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20538153|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20538154|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20538155|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20538156|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20538157|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20538158|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
20538159|NCT01837433|Prednisone|prednisone|mesh-list
20538160|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
20538161|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538162|NCT01837433|Hormones|hormones|mesh-ancestor
20538163|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20538164|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538165|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20538166|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538167|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
20538168|NCT01837446|Promethazine|promethazine|mesh-list
20538169|NCT01837446|Lidocaine|lidocaine|mesh-list
20538170|NCT01837446|Morphine|morphine|mesh-list
20538171|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20538172|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
20538173|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538174|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
20538175|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538176|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538177|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
20538178|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538179|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20538180|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20538181|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20538182|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538183|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538184|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19892859|NCT03365791|Spartalizumab|spartalizumab|mesh-list
19892860|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19892861|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892862|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538185|NCT01837446|Narcotics|narcotics|mesh-ancestor
20538186|NCT01837446|Analgesics|analgesics|mesh-ancestor
20538187|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20538188|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20538189|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
20538190|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
20538191|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20538192|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20538193|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
20538194|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
20538195|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538196|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20538197|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
20538198|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
20538199|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20538200|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
20538201|NCT01837446|Antacids|antacids|mesh-ancestor
20538202|NCT01837498|Neostigmine|neostigmine|mesh-list
20538203|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20538204|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538205|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538206|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
20538207|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538208|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538209|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20538210|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
20538211|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538212|NCT01837576|Calcipotriene|calcipotriene|mesh-list
20538213|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
20538214|NCT01837628|Lidocaine|lidocaine|mesh-list
20538215|NCT01837628|Mineral Oil|mineral oil|mesh-list
20538216|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538217|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
20538218|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538219|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538220|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
20538221|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538222|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20538223|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20538224|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20538225|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538226|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538227|NCT01837628|Emollients|emollients|mesh-ancestor
20538228|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
20538229|NCT01837667|Docetaxel|docetaxel|mesh-list
20538230|NCT01837667|LB100|lb100|mesh-list
20538231|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538232|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538233|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
20538234|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
20538235|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538236|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538237|NCT01837810|Ibuprofen|ibuprofen|mesh-list
20538238|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20538239|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20538240|NCT01837810|Analgesics|analgesics|mesh-ancestor
20538241|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
20538242|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538243|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538244|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538245|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20538246|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20538247|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538248|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538249|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
20538250|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
20538251|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20538252|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
20538253|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538254|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538255|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20538256|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538257|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
20538258|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20538259|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
20538260|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538261|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538262|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20538263|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20538264|NCT01837992|Primaquine|primaquine|mesh-list
20538265|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
20538266|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20538267|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20538268|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538269|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
20538270|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20538271|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538272|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
20538273|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20538274|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
20538275|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538276|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
20538277|NCT01838252|Protective Agents|protective agents|mesh-ancestor
20538278|NCT01838330|Psyllium|psyllium|mesh-list
20538279|NCT01838330|Cathartics|cathartics|mesh-ancestor
20538280|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20538281|NCT01838395|Cytarabine|cytarabine|mesh-list
20538282|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20538283|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
20538284|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538285|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538286|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
20538287|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538288|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538289|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
20538290|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538291|NCT01838434|Lenalidomide|lenalidomide|mesh-list
20538292|NCT01838434|Idelalisib|idelalisib|mesh-list
20538293|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
20538294|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538295|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20538296|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20538297|NCT01838434|Growth Substances|growth substances|mesh-ancestor
20538298|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
20538299|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538300|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538301|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538302|NCT01838460|Lobeline|lobeline|mesh-list
20538303|NCT01838460|Nicotine|nicotine|mesh-list
20538304|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20538305|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
20538306|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538307|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538308|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20538309|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20538310|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
20538311|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538312|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538313|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538314|NCT01838473|Lobeline|lobeline|mesh-list
20538315|NCT01838473|Nicotine|nicotine|mesh-list
20538316|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20538317|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
20538318|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538319|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538320|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20538321|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20538322|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
20538323|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538324|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538325|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538326|NCT01838538|Paclitaxel|paclitaxel|mesh-list
20538327|NCT01838538|Bevacizumab|bevacizumab|mesh-list
20538328|NCT01838538|Carboplatin|carboplatin|mesh-list
20538329|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20538330|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538331|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538332|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
20538333|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
20538334|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538335|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20538336|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20538337|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20538338|NCT01838538|Growth Substances|growth substances|mesh-ancestor
20538339|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538340|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
20538341|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20538342|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
20538343|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538344|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
20538345|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538346|NCT01838707|Fentanyl|fentanyl|mesh-list
20538347|NCT01838707|Morphine|morphine|mesh-list
20538348|NCT01838707|Bupivacaine|bupivacaine|mesh-list
20258794|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538349|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538350|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
20538351|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538352|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538353|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
20538354|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538355|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20538356|NCT01838707|Narcotics|narcotics|mesh-ancestor
20538357|NCT01838707|Analgesics|analgesics|mesh-ancestor
20538358|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20538359|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20538360|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
20538361|NCT01838772|Interferons|interferons|mesh-list
20538362|NCT01838772|Ribavirin|ribavirin|mesh-list
20538363|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538364|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
20538365|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538366|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
20538367|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538368|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20538369|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20538370|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20538371|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20538372|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538373|NCT01838902|Primaquine|primaquine|mesh-list
20538374|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
20538375|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20538376|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20538377|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538378|NCT01838928|Bupivacaine|bupivacaine|mesh-list
20538379|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538380|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
20538381|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538382|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538383|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
20538384|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538385|NCT01838993|Lidocaine|lidocaine|mesh-list
20538386|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538387|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
20538388|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538389|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538390|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
20538391|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538392|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20538393|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20538394|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20538395|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538396|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538397|NCT01839032|Vinorelbine|vinorelbine|mesh-list
20538398|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538399|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20538400|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538401|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
20538402|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
20538403|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538404|NCT01839084|Isoflurane|isoflurane|mesh-list
20538405|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20538406|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
20538407|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
20538408|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538409|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538410|NCT01839097|Prednisone|prednisone|mesh-list
20538411|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
20538412|NCT01839097|Doxorubicin|doxorubicin|mesh-list
20538413|NCT01839097|Vincristine|vincristine|mesh-list
20538414|NCT01839097|Belinostat|belinostat|mesh-list
20538415|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538416|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
20538417|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538418|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20538419|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20538420|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
20538421|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538422|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538423|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20538424|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20538425|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20538426|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20538427|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538428|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538429|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
20538430|NCT01839097|Hormones|hormones|mesh-ancestor
20538431|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20538432|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20538433|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20538434|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538435|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
20538436|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
20538437|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20538438|NCT01839149|Oxytocin|oxytocin|mesh-list
20538439|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
20538440|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20538441|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538442|NCT01839175|Vaccines|vaccines|mesh-list
20538443|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20538444|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
20538445|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538446|NCT01839240|Cytarabine|cytarabine|mesh-list
20538447|NCT01839240|Azacitidine|azacitidine|mesh-list
20538448|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
20538449|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20538450|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
20538451|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538452|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538453|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
19892969|NCT03178552|Gemcitabine|gemcitabine|mesh-list
19892970|NCT03178552|Bevacizumab|bevacizumab|mesh-list
19892971|NCT03178552|Carboplatin|carboplatin|mesh-list
19892972|NCT03178552|Docetaxel|docetaxel|mesh-list
19892973|NCT03178552|Pemetrexed|pemetrexed|mesh-list
19892974|NCT03178552|Atezolizumab|atezolizumab|mesh-list
19892975|NCT03178552|Vemurafenib|vemurafenib|mesh-list
19892976|NCT03178552|Entrectinib|entrectinib|mesh-list
20538454|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538455|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538456|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
20538457|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538458|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538459|NCT01839240|Analgesics|analgesics|mesh-ancestor
20538460|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
20538461|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538462|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20258795|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20258796|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20258797|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258798|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258799|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
20258800|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
20258801|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20258802|NCT00485238|Acetazolamide|acetazolamide|mesh-list
20258803|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
20258804|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20258805|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258806|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258807|NCT00485238|Diuretics|diuretics|mesh-ancestor
20258808|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
20258809|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258810|NCT00485342|Interferons|interferons|mesh-list
20258811|NCT00485342|Ribavirin|ribavirin|mesh-list
20258812|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
20258813|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
20258814|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20258815|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258816|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
20258817|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258818|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
20258819|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258820|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
20258821|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258822|NCT00485368|Perindopril|perindopril|mesh-list
20258823|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20258824|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
20258825|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258826|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258827|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20258828|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20258829|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20258830|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258831|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258832|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258833|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
20538463|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20538464|NCT01839253|Atenolol|atenolol|mesh-list
20538465|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20538466|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20538467|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20538468|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
20538469|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
20538470|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538471|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538472|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20538473|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20538474|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20538475|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
19892977|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258834|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19892978|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538476|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19892979|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20258835|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258836|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20258837|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20258838|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258839|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258840|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258841|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
20258842|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258843|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258844|NCT00485498|Olanzapine|olanzapine|mesh-list
20258845|NCT00485498|Risperidone|risperidone|mesh-list
20258846|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20258847|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
20258848|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258849|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258850|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258851|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20258852|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20258853|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258854|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20258855|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20258856|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
20258857|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
20258858|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
20258859|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538477|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538478|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
20538479|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538480|NCT01839344|Acarbose|acarbose|mesh-list
20538481|NCT01839344|Quercetin|quercetin|mesh-list
20538482|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20538483|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538484|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538485|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20538486|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538487|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
20538488|NCT01839344|Protective Agents|protective agents|mesh-ancestor
20538489|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
20538490|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20538491|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
20538492|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20538493|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
20538494|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538495|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538496|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
20538497|NCT01839370|Pramlintide|pramlintide|mesh-list
20538498|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20538499|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538500|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
20538501|NCT01839383|Calcium|calcium|mesh-list
20538502|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20538503|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538504|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20538505|NCT01839500|Trastuzumab|trastuzumab|mesh-list
20538506|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20538507|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538508|NCT01839552|Fentanyl|fentanyl|mesh-list
20538509|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20538510|NCT01839552|Narcotics|narcotics|mesh-ancestor
20538511|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538512|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538513|NCT01839552|Analgesics|analgesics|mesh-ancestor
20538514|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
20538515|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538516|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20538517|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20538518|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
20538519|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
20538520|NCT01839578|Heparin|heparin|mesh-list
20538521|NCT01839578|Calcium heparin|calcium heparin|mesh-list
20538522|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
20538523|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538524|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20538525|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20538526|NCT01839630|Sorafenib|sorafenib|mesh-list
20538527|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538528|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20538529|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538530|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538531|NCT01839643|Meloxicam|meloxicam|mesh-list
20538532|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20538533|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20538534|NCT01839643|Analgesics|analgesics|mesh-ancestor
20538535|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
20538536|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538537|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538538|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538539|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20538540|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20538541|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20538542|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538543|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538544|NCT01839734|Lubiprostone|lubiprostone|mesh-list
20538545|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20538546|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538547|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538548|NCT01839773|Paclitaxel|paclitaxel|mesh-list
20538549|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20538550|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20538551|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538552|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538553|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
20538554|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
20538555|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538556|NCT01839812|Cosyntropin|cosyntropin|mesh-list
20538557|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20538558|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20538559|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
20538560|NCT01839812|Hormones|hormones|mesh-ancestor
20538561|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20538562|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538563|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538564|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538565|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
20538566|NCT01839851|Hormones|hormones|mesh-ancestor
20553882|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
20538567|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20538568|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538569|NCT01839890|Paclitaxel|paclitaxel|mesh-list
20538570|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20538571|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538572|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538573|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20538574|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
20538575|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538576|NCT01839929|Tacrolimus|tacrolimus|mesh-list
20538577|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538578|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
19892980|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19892981|NCT03178552|Growth Substances|growth substances|mesh-ancestor
19892982|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19892983|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
19892984|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19892985|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
19892986|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19892987|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
19892988|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19892989|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19892990|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19892991|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
19892992|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
19892993|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
19892994|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
19892995|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19892996|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19892997|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19893006|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
19893007|NCT03172416|Nivolumab|nivolumab|mesh-list
19893008|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893009|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19893010|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19893011|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893019|NCT03159897|Doxorubicin|doxorubicin|mesh-list
19893020|NCT03159897|Bleomycin|bleomycin|mesh-list
19893021|NCT03159897|Dacarbazine|dacarbazine|mesh-list
19893022|NCT03159897|Vinblastine|vinblastine|mesh-list
19893023|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19893024|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893025|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19893026|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19893027|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893028|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893029|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19893030|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
19893031|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19893032|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
19893033|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
19893034|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
19893035|NCT03150693|Cytarabine|cytarabine|mesh-list
19893036|NCT03150693|Dexamethasone|dexamethasone|mesh-list
19893037|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
19893038|NCT03150693|Rituximab|rituximab|mesh-list
19893039|NCT03150693|Doxorubicin|doxorubicin|mesh-list
19893040|NCT03150693|Methotrexate|methotrexate|mesh-list
19893041|NCT03150693|Vincristine|vincristine|mesh-list
19893042|NCT03150693|Daunorubicin|daunorubicin|mesh-list
19893043|NCT03150693|Asparaginase|asparaginase|mesh-list
19893044|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
19893045|NCT03150693|Thioguanine|thioguanine|mesh-list
19893046|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19893047|NCT03150693|Pegaspargase|pegaspargase|mesh-list
19893048|NCT03150693|Allopurinol|allopurinol|mesh-list
19893049|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19893050|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
19893051|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893052|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19893053|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19893054|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
19893055|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893056|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893057|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19893058|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19893059|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19893060|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
19893061|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
19893062|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893063|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19893064|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
19893065|NCT03150693|Hormones|hormones|mesh-ancestor
19893066|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19893067|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19893068|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19893069|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19893070|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19893071|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893072|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19893073|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
19893074|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19893075|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19893076|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
19893077|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
19893078|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19893079|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19893080|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
19893081|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19893082|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19893083|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
19893084|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
19893085|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
19893086|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
19893087|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19893088|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
19893089|NCT03150693|Protective Agents|protective agents|mesh-ancestor
19893090|NCT03126916|Vitamin A|vitamin a|mesh-list
19893091|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
19893092|NCT03126916|Melphalan|melphalan|mesh-list
19893093|NCT03126916|Busulfan|busulfan|mesh-list
19893094|NCT03126916|Thiotepa|thiotepa|mesh-list
19893095|NCT03126916|Cisplatin|cisplatin|mesh-list
19893096|NCT03126916|Carboplatin|carboplatin|mesh-list
19893097|NCT03126916|Doxorubicin|doxorubicin|mesh-list
19893098|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19893099|NCT03126916|Etoposide|etoposide|mesh-list
19893100|NCT03126916|Vincristine|vincristine|mesh-list
19893101|NCT03126916|Topotecan|topotecan|mesh-list
19893102|NCT03126916|Tretinoin|tretinoin|mesh-list
19893103|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
19893104|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19893105|NCT03126916|Dinutuximab|dinutuximab|mesh-list
19893106|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
19893107|NCT03126916|Razoxane|razoxane|mesh-list
19893108|NCT03126916|Isotretinoin|isotretinoin|mesh-list
19893109|NCT03126916|Sargramostim|sargramostim|mesh-list
19893110|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19893111|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
19893112|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893113|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19893114|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19893115|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
19893116|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893117|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893118|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19893119|NCT03126916|Vitamins|vitamins|mesh-ancestor
19893120|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
19893121|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19893122|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19893123|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19893124|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893125|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19893126|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
19893127|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
19893128|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
19893129|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19893130|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
19893131|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
19893132|NCT03126916|Protective Agents|protective agents|mesh-ancestor
19893133|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19893134|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19893135|NCT03115047|Meperidine|meperidine|mesh-list
19893136|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
19893137|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19893138|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19893139|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893140|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19893141|NCT03115047|Analgesics|analgesics|mesh-ancestor
19893142|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
19893143|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893144|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19893145|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19893146|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19893147|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
19893148|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19893149|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893150|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19893151|NCT03115047|Narcotics|narcotics|mesh-ancestor
19893152|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20538579|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538580|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20538581|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538582|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538583|NCT01839955|Quinacrine|quinacrine|mesh-list
20538584|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20538585|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538586|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20538587|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538588|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538589|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
19893177|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
19893178|NCT03105336|Fludarabine|fludarabine|mesh-list
19893179|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19893180|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
19893181|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893182|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19893183|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19893184|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
19893185|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893186|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893187|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19893188|NCT03099265|Leucovorin|leucovorin|mesh-list
19893189|NCT03099265|Fluorouracil|fluorouracil|mesh-list
19893190|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
19893191|NCT03099265|Irinotecan|irinotecan|mesh-list
19893192|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
19893193|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893194|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19893195|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893196|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19893197|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
19893198|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893199|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19893200|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19893201|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893202|NCT03099265|Antidotes|antidotes|mesh-ancestor
19893203|NCT03099265|Protective Agents|protective agents|mesh-ancestor
19893204|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
19893205|NCT03099265|Vitamins|vitamins|mesh-ancestor
19893206|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
19893225|NCT03083353|Isradipine|isradipine|mesh-list
19893226|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19893227|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19893228|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19893229|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893230|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19893231|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893232|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
19893259|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
19893260|NCT03071861|Hematinics|hematinics|mesh-ancestor
19893309|NCT02975882|Sirolimus|sirolimus|mesh-list
19893310|NCT02975882|Irinotecan|irinotecan|mesh-list
19893311|NCT02975882|Camptothecin|camptothecin|mesh-list
19893312|NCT02975882|Temozolomide|temozolomide|mesh-list
19893313|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19893314|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19893315|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893316|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893317|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893318|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19893319|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
19893320|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19893321|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19893322|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19893323|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
19893324|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19893325|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
19893326|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893327|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19893335|NCT02955823|Dexamethasone|dexamethasone|mesh-list
19893336|NCT02955823|Rituximab|rituximab|mesh-list
19893337|NCT02955823|Lenalidomide|lenalidomide|mesh-list
19893338|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19893339|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893340|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
19893341|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893342|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19893343|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19893344|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
19893345|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
19893346|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893347|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19893348|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
19893349|NCT02955823|Hormones|hormones|mesh-ancestor
19893350|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19893351|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19893352|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19893353|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19893354|NCT02955823|Growth Substances|growth substances|mesh-ancestor
19893355|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
19893356|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
19893357|NCT02940509|Ketamine|ketamine|mesh-list
19893358|NCT02940509|Analgesics|analgesics|mesh-ancestor
19893359|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
19893360|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893361|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893362|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19893363|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19893364|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
19893365|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
19893366|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19893367|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19893368|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19893369|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19893370|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893371|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19893372|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
19893373|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19893374|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19893375|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19893376|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
19893377|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20258860|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258861|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20258862|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258863|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258864|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
20258865|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258866|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
20258867|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258868|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258869|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20258870|NCT00485550|Methylphenidate|methylphenidate|mesh-list
20258871|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20258872|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20258873|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258874|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20258875|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258876|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20286868|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20258877|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258878|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
20258879|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258880|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20258881|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
20258882|NCT00485576|Eculizumab|eculizumab|mesh-list
20258883|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20258884|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20258885|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
20258886|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258887|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20258888|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20258889|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258890|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258891|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258892|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
20258893|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258894|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258895|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
20258896|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20258897|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20258898|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20258899|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20258900|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258901|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258902|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20258903|NCT00485680|Olanzapine|olanzapine|mesh-list
20258904|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
20258905|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
20258906|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
20258907|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258908|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258909|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258910|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20258911|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20258912|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258913|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20258914|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20258915|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258916|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258917|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258918|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258919|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
20258920|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
20258921|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258922|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
20258923|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
20258924|NCT00485706|Calcium|calcium|mesh-list
20258925|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20258926|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258927|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20258928|NCT00485771|Lamotrigine|lamotrigine|mesh-list
20258929|NCT00485771|Olanzapine|olanzapine|mesh-list
20258930|NCT00485771|Fluoxetine|fluoxetine|mesh-list
20258931|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
20258932|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
20258933|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258934|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258935|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258936|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20258937|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20258938|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258939|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20258940|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19732219|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
19735700|NCT04536961|BMS-986165|bms-986165|mesh-list
19893416|NCT02875223|Itraconazole|itraconazole|mesh-list
19893417|NCT02875223|Rifampin|rifampin|mesh-list
19893418|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
19893419|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
19893420|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19893421|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19893422|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19893423|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893424|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893425|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19893426|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
19893427|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19893428|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893429|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19893430|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19893431|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
19893432|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19893433|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
19893434|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19893435|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19893436|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19893437|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19893438|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19893439|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19893440|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19893441|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893458|NCT02847559|Bevacizumab|bevacizumab|mesh-list
19893459|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19893460|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
19893461|NCT02847559|Antibodies|antibodies|mesh-list
19893462|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
19893463|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19893464|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
19893465|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893466|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19893467|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19893468|NCT02847559|Growth Substances|growth substances|mesh-ancestor
19893469|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893470|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
19893471|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
19893488|NCT02829723|Spartalizumab|spartalizumab|mesh-list
19893489|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19893490|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893491|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893492|NCT02823145|Fenfluramine|fenfluramine|mesh-list
19893493|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19893494|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19893495|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19893496|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893497|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19893498|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
19893499|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258941|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19893522|NCT02819440|Tadalafil|tadalafil|mesh-list
19893523|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
19893524|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19893525|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19893526|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893527|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893528|NCT02819440|Urological Agents|urological agents|mesh-ancestor
19893529|NCT02808364|Vaccines|vaccines|mesh-list
19893530|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
19893531|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538590|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20538591|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
20538592|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20538593|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19893584|NCT02754141|Nivolumab|nivolumab|mesh-list
19893585|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19893586|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893587|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19893588|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893589|NCT02722616|Pancrelipase|pancrelipase|mesh-list
19893590|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19893591|NCT02709616|Vaccines|vaccines|mesh-list
19893592|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
19893593|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893598|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
19893599|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893600|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258942|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258943|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258944|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258945|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
20258946|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20258947|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
20258948|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20258949|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20258950|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20258951|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
20258952|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20258953|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20258954|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20258955|NCT00485797|Methylphenidate|methylphenidate|mesh-list
20258956|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20258957|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258958|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20258959|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258960|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258961|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258962|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
19732220|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732221|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732222|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19893616|NCT02641028|Aticaprant|aticaprant|mesh-list
19893617|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19893618|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893619|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
19893620|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732223|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
19732224|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19732225|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19732226|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19732227|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19732228|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732229|NCT04576390|Ondansetron|ondansetron|mesh-list
19732230|NCT04576390|Palonosetron|palonosetron|mesh-list
19732231|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
19732232|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
19732233|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732234|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732235|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19893644|NCT02617277|Durvalumab|durvalumab|mesh-list
19893645|NCT02617277|Adavosertib|adavosertib|mesh-list
19893646|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20258963|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258964|NCT00485810|Olanzapine|olanzapine|mesh-list
20258965|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
20258966|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
20258967|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893647|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893648|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893649|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893667|NCT02530697|Miltefosine|miltefosine|mesh-list
19893668|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19893669|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
19893670|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19893671|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893672|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893673|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19893674|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19893675|NCT02530697|Protective Agents|protective agents|mesh-ancestor
19893676|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893677|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
19893678|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19893679|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
19893680|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
19893681|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19893682|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893683|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19893684|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19893685|NCT02516670|Vitamins|vitamins|mesh-list
19893686|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
19893687|NCT02516670|Docetaxel|docetaxel|mesh-list
19893688|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
19893689|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893690|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893691|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
19893692|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
19893693|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
19893694|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893695|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
19893696|NCT02516670|Protective Agents|protective agents|mesh-ancestor
19893701|NCT02485691|Prednisone|prednisone|mesh-list
19893702|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
19893703|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19893704|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
19893705|NCT02485691|Hormones|hormones|mesh-ancestor
19893706|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20258968|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893707|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893708|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19893709|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893710|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19893711|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893712|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893713|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
19893714|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20258969|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19893726|NCT02466074|Acetazolamide|acetazolamide|mesh-list
19893727|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
19893728|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19893729|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893730|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893731|NCT02466074|Diuretics|diuretics|mesh-ancestor
19893732|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
19893733|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258970|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20258971|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20258972|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258973|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20258974|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20258975|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258976|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258977|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258978|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258979|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
20258980|NCT00485823|Olanzapine|olanzapine|mesh-list
20258981|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
20258982|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
20258983|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20258984|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20258985|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20258986|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20258987|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20258988|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20258989|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20258990|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20258991|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258992|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20258993|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20258994|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20258995|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
19893753|NCT02406222|Dexamethasone|dexamethasone|mesh-list
19893754|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
19893755|NCT02406222|Pomalidomide|pomalidomide|mesh-list
19893756|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19893757|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
19893758|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893759|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19893760|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19893761|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
19893762|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893763|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893764|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19893765|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19893766|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
19893767|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
19893768|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893769|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19893770|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
19893771|NCT02406222|Hormones|hormones|mesh-ancestor
19893772|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19893773|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19893774|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19893775|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19893776|NCT02406222|Growth Substances|growth substances|mesh-ancestor
19893777|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
20258996|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20258997|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20258998|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20258999|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259000|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259001|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259002|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259003|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259004|NCT00485862|Sertraline|sertraline|mesh-list
20259005|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20259006|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259007|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259008|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20259009|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259010|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259011|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259012|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259013|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
20259014|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259015|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20259016|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259017|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19893800|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
19893801|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19893802|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893848|NCT02201251|Topiramate|topiramate|mesh-list
19893849|NCT02201251|Levetiracetam|levetiracetam|mesh-list
20259018|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19893850|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
19893851|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19893852|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893853|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
19893857|NCT02187198|Buprenorphine|buprenorphine|mesh-list
19893858|NCT02187198|Naloxone|naloxone|mesh-list
19893859|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19893860|NCT02187198|Narcotics|narcotics|mesh-ancestor
19893861|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19893862|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893863|NCT02187198|Analgesics|analgesics|mesh-ancestor
19893864|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
19893865|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893866|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19893877|NCT02150785|Streptokinase|streptokinase|mesh-list
19893878|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19893879|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19893880|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893881|NCT02144831|Aspirin|aspirin|mesh-list
19893882|NCT02144831|Clopidogrel|clopidogrel|mesh-list
19893883|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19893884|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19893885|NCT02144831|Analgesics|analgesics|mesh-ancestor
19893886|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
19893887|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893888|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893889|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19893890|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19893891|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19893892|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19893893|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19893894|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19893895|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19893896|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893897|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
19893898|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19893899|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19893900|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19893901|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
19893902|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19893946|NCT02099591|Naloxegol|naloxegol|mesh-list
19893947|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19893948|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893949|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
19893950|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19893961|NCT02000596|Trastuzumab|trastuzumab|mesh-list
19893962|NCT02000596|Pertuzumab|pertuzumab|mesh-list
19893963|NCT02000596|Fulvestrant|fulvestrant|mesh-list
19893964|NCT02000596|Anastrozole|anastrozole|mesh-list
19893965|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19893966|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19893967|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19893968|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19893969|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19893970|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
19893971|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19893972|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19893973|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19893974|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19893975|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19893976|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538594|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
19894045|NCT01884922|Vinblastine|vinblastine|mesh-list
19894046|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19894047|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894048|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
19894049|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
19894050|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
19894051|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894119|NCT01788020|Dexamethasone|dexamethasone|mesh-list
19894120|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
19894121|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
19894122|NCT01788020|Rituximab|rituximab|mesh-list
19894123|NCT01788020|Bortezomib|bortezomib|mesh-list
19894124|NCT01788020|BB 1101|bb 1101|mesh-list
19894125|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19894126|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
19894127|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894128|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894129|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19894130|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
19894131|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894132|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894133|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19894134|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19894135|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19894136|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
19894137|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
19894138|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894139|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19894140|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
19894141|NCT01788020|Hormones|hormones|mesh-ancestor
19894142|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894143|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19894144|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
19894145|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894154|NCT01711632|Vemurafenib|vemurafenib|mesh-list
19894155|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894156|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19894157|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894158|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894179|NCT01608893|Metoprolol|metoprolol|mesh-list
19894180|NCT01608893|Carvedilol|carvedilol|mesh-list
19894181|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19894182|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19894183|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
19894184|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
19894185|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259019|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19894186|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894187|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19894188|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19894189|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19894190|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
19894191|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19894192|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894193|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
19894194|NCT01608893|Protective Agents|protective agents|mesh-ancestor
19894195|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19894196|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19894197|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19894198|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
19894199|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19894200|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19894218|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
19894219|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19894220|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
19894221|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894222|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894223|NCT01517451|Androgens|androgens|mesh-list
19894224|NCT01517451|Hormones|hormones|mesh-ancestor
19894225|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894226|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894229|NCT01502917|Antibodies|antibodies|mesh-list
19894230|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19894231|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
19894232|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538595|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20259020|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259021|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259022|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259023|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259024|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894417|NCT00929253|Buprenorphine|buprenorphine|mesh-list
19894418|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19894419|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19894420|NCT00929253|Narcotics|narcotics|mesh-ancestor
19894421|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19894422|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894423|NCT00929253|Analgesics|analgesics|mesh-ancestor
19894424|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
19894425|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894426|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19449692|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449693|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20538596|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
20538597|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20538598|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20538599|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
20538600|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
20555032|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19449694|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19449695|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449696|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
19449697|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19449698|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19449699|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259025|NCT00485888|Citalopram|citalopram|mesh-list
19449700|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
19449701|NCT03433144|Coagulants|coagulants|mesh-ancestor
19449702|NCT03433092|Carotenoids|carotenoids|mesh-list
19894444|NCT00834093|Vaccines|vaccines|mesh-list
19894445|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
19894446|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894447|NCT00812032|Aspirin|aspirin|mesh-list
19894448|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19894449|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19894450|NCT00812032|Analgesics|analgesics|mesh-ancestor
19894451|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
19894452|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894453|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894454|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19894455|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894456|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19894457|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19894458|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894459|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19894460|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19894461|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894462|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
19894463|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
19894464|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
19894465|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19894466|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19894467|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894470|NCT00657241|Valsartan|valsartan|mesh-list
19894471|NCT00657241|Carvedilol|carvedilol|mesh-list
19894472|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19894473|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19894474|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19894475|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894476|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19894477|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19894478|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
19894479|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19894480|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894481|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
19894482|NCT00657241|Protective Agents|protective agents|mesh-ancestor
19894483|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19894484|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19894485|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19894486|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
19894487|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19894488|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19894489|NCT00529763|Dasatinib|dasatinib|mesh-list
19894490|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894491|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19894492|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894493|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894494|NCT00478465|Valganciclovir|valganciclovir|mesh-list
19894495|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
19894496|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894497|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
19894498|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19894499|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894500|NCT00417664|Midazolam|midazolam|mesh-list
19894501|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
19894502|NCT00417664|Propofol|propofol|mesh-list
19894503|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19894504|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19894505|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894506|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19894507|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
19894508|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
19894509|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19894510|NCT00417664|Analgesics|analgesics|mesh-ancestor
19894511|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
19894512|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894513|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19894514|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19894515|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19894516|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
19449703|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
19894517|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19894518|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894519|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19894520|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19894521|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19894522|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19894523|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
19894524|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
19894616|NCT00042341|Clofarabine|clofarabine|mesh-list
19894617|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19894618|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
19894619|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894620|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19970998|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19970999|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971000|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
19971001|NCT01790594|Hormones|hormones|mesh-ancestor
19971002|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971003|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19971004|NCT01790594|Protective Agents|protective agents|mesh-ancestor
19971005|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19971006|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971007|NCT01790659|Gentamicins|gentamicins|mesh-list
19971008|NCT01790659|Paromomycin|paromomycin|mesh-list
19971009|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971010|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971011|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19971012|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259026|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20259027|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259028|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259029|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259030|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259031|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
20259032|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971013|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971014|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19971015|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19971016|NCT01790685|Dexamethasone|dexamethasone|mesh-list
19971017|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971018|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
19971019|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
19971020|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971021|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971022|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971023|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
19971024|NCT01790685|Hormones|hormones|mesh-ancestor
19971025|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971026|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19971027|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971028|NCT01790828|Factor VIII|factor viii|mesh-list
19971029|NCT01790828|Coagulants|coagulants|mesh-ancestor
19971030|NCT01791153|Prednisone|prednisone|mesh-list
19971031|NCT01791153|Methotrexate|methotrexate|mesh-list
19971032|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971033|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
19971034|NCT01791153|Hormones|hormones|mesh-ancestor
19971035|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971036|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971037|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19971038|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971039|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19971040|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
19971041|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19971042|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19971043|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
19971044|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971045|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
19971046|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971047|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19971048|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971049|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
19971050|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971051|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20259033|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19894680|NCT01021332|Tamsulosin|tamsulosin|mesh-list
19894681|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
19894682|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19894683|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19894684|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19894685|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
19894686|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19894687|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894688|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894689|NCT01021332|Urological Agents|urological agents|mesh-ancestor
19894690|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19894691|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19894692|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
19894693|NCT01021423|Lenalidomide|lenalidomide|mesh-list
19894694|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
19894695|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894696|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19894697|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19894698|NCT01021423|Growth Substances|growth substances|mesh-ancestor
19894699|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
19894700|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894701|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
19894702|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19894703|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894704|NCT01021618|Dipyridamole|dipyridamole|mesh-list
19894705|NCT01021618|Regadenoson|regadenoson|mesh-list
19894706|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19894707|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19894708|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
19894709|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
19894710|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19894711|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894712|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894713|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19894714|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894715|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19894716|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
19894717|NCT01021683|Itraconazole|itraconazole|mesh-list
19894718|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
19894719|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894720|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19894721|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19894722|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894723|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894724|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19894725|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
19894726|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894727|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894728|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19894729|NCT01021761|Ketorolac|ketorolac|mesh-list
19894730|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19894731|NCT01021761|Nepafenac|nepafenac|mesh-list
19894732|NCT01021761|Bromfenac|bromfenac|mesh-list
19894733|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19894734|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19894735|NCT01021761|Analgesics|analgesics|mesh-ancestor
19894736|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
19894737|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894738|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894739|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19894740|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894741|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19894742|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894743|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894744|NCT01021813|Suvorexant|suvorexant|mesh-list
19894745|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19894746|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19894747|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19894748|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894749|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19894750|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538601|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894751|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894752|NCT01021878|Icodextrin|icodextrin|mesh-list
19894753|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
19894754|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19894755|NCT01022190|Etoricoxib|etoricoxib|mesh-list
19894756|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19894757|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19894758|NCT01022190|Analgesics|analgesics|mesh-ancestor
19894759|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
19894760|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894761|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894762|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19894763|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894764|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19894765|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19894766|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894767|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894768|NCT01022424|Tolvaptan|tolvaptan|mesh-list
19894769|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19894770|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894771|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
19894772|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894773|NCT01022567|Ertapenem|ertapenem|mesh-list
19894774|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19894775|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894776|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19894777|NCT01022580|Calfactant|calfactant|mesh-list
19894778|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
19894779|NCT01022762|Repaglinide|repaglinide|mesh-list
19894780|NCT01022762|Gliclazide|gliclazide|mesh-list
19894781|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19894782|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894783|NCT01022853|Nintedanib|nintedanib|mesh-list
19894784|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894785|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19894786|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894787|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894788|NCT01022996|Everolimus|everolimus|mesh-list
19894789|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894790|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259034|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259035|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259036|NCT00485901|Haloperidol|haloperidol|mesh-list
20259037|NCT00485901|Olanzapine|olanzapine|mesh-list
20259038|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
20259039|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
20259040|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
20259041|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259042|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259043|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20259044|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20259045|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20259046|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259047|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259048|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20259049|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259050|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259051|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259052|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538602|NCT01839981|Protective Agents|protective agents|mesh-ancestor
20538603|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538604|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
20538605|NCT01839981|Vitamins|vitamins|mesh-ancestor
20538606|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
20538607|NCT01839994|Androgens|androgens|mesh-list
20538608|NCT01839994|Hormones|hormones|mesh-ancestor
20538609|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894791|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
19894792|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894793|NCT01023035|Ribavirin|ribavirin|mesh-list
19894794|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19894795|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
19894796|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
20259053|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
20259054|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20259055|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
19894797|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894798|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
19894799|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894800|NCT01023035|Hematinics|hematinics|mesh-ancestor
19894801|NCT01023061|Prednisone|prednisone|mesh-list
19894802|NCT01023061|Leuprolide|leuprolide|mesh-list
19894803|NCT01023061|Goserelin|goserelin|mesh-list
19894804|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
19894805|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19894806|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
19894807|NCT01023061|Hormones|hormones|mesh-ancestor
19894808|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894809|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894810|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19894811|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894812|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19894813|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
19894814|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20259056|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20259057|NCT00485940|Prucalopride|prucalopride|mesh-list
20259058|NCT00485940|Laxatives|laxatives|mesh-ancestor
20259059|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20259060|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20259061|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20259062|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
20259063|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259064|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259065|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259066|NCT00485979|Docetaxel|docetaxel|mesh-list
20259067|NCT00485979|Trastuzumab|trastuzumab|mesh-list
20259068|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259069|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
20259070|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
20259071|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
20259072|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259073|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20259074|NCT00486005|Olanzapine|olanzapine|mesh-list
20259075|NCT00486005|Nizatidine|nizatidine|mesh-list
20259076|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
20259077|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
20259078|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259079|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259080|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20259081|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20259082|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20259083|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259084|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259085|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20259086|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20538610|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538611|NCT01840007|Metformin|metformin|mesh-list
20538612|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20538613|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538614|NCT01840046|Interleukin-2|interleukin-2|mesh-list
20538615|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538616|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20538617|NCT01840046|Analgesics|analgesics|mesh-ancestor
20538618|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
20538619|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538620|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538621|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
20538622|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20538623|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20538624|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20538625|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538626|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
20538627|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20538628|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538629|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538630|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20538631|NCT01840254|Analgesics|analgesics|mesh-ancestor
20538632|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
20538633|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538634|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20538635|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20259087|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259088|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259089|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19894815|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19894816|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894817|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894818|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
19894819|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19894820|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19894821|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19894822|NCT01023178|Estradiol|estradiol|mesh-list
19894823|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19894824|NCT01023178|Estrogens|estrogens|mesh-list
19894825|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19894826|NCT01023178|Progesterone|progesterone|mesh-list
19894827|NCT01023178|Hormones|hormones|mesh-ancestor
19894828|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894829|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894830|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19894831|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
19894832|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19894833|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19894834|NCT01023178|Progestins|progestins|mesh-ancestor
19894835|NCT01023217|Lamivudine|lamivudine|mesh-list
19894836|NCT01023217|Adefovir|adefovir|mesh-list
19894837|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19894838|NCT01023217|Entecavir|entecavir|mesh-list
19894839|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19894840|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19894841|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894842|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894843|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
19894844|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894845|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19894846|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19894847|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19894848|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
19894849|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894850|NCT01023308|Dexamethasone|dexamethasone|mesh-list
19894851|NCT01023308|Bortezomib|bortezomib|mesh-list
19894852|NCT01023308|Panobinostat|panobinostat|mesh-list
19894853|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19894854|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
19894855|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
19894856|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894857|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894858|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19894859|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
19894860|NCT01023308|Hormones|hormones|mesh-ancestor
19894861|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894862|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19894863|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894864|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19894865|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894866|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894867|NCT01023477|Chloroquine|chloroquine|mesh-list
19894868|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19894869|NCT01023477|Amebicides|amebicides|mesh-ancestor
19894870|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19894871|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19894872|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894873|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
19894874|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894875|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19894876|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19894877|NCT01023477|Analgesics|analgesics|mesh-ancestor
19894878|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
19894879|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894880|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894881|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259090|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
19894882|NCT01023477|Filaricides|filaricides|mesh-ancestor
19894883|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
19894884|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
19894885|NCT01023581|Metformin|metformin|mesh-list
19894886|NCT01023581|Alogliptin|alogliptin|mesh-list
19894887|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19894888|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894889|NCT01023581|Incretins|incretins|mesh-ancestor
19894890|NCT01023581|Hormones|hormones|mesh-ancestor
19894891|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19894892|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19894893|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
19894894|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894895|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894896|NCT01023659|Bupropion|bupropion|mesh-list
19894897|NCT01023659|Varenicline|varenicline|mesh-list
19894898|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19894899|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
19894900|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19894901|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19894902|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19894903|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19894904|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894905|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
19894906|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19894907|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894908|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19894909|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19894910|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894911|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19894912|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19894913|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
19894914|NCT01023672|Modafinil|modafinil|mesh-list
19894915|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19894916|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894917|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19894918|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19894919|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19894920|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894921|NCT01023711|Vaccines|vaccines|mesh-list
19894922|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
19894923|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894924|NCT01023724|Ketorolac|ketorolac|mesh-list
19894925|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19894926|NCT01023724|Bromfenac|bromfenac|mesh-list
19894927|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19894928|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19894929|NCT01023724|Analgesics|analgesics|mesh-ancestor
19894930|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
19894931|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894932|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894933|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19894934|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894935|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19894936|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894937|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894938|NCT01023776|Vaccines|vaccines|mesh-list
19894939|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
19894940|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894941|NCT01023815|Cyclosporine|cyclosporine|mesh-list
19894942|NCT01023815|Everolimus|everolimus|mesh-list
19894943|NCT01023815|Cyclosporins|cyclosporins|mesh-list
19894944|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894945|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894946|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19894947|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
19894948|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894949|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
19894950|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894951|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19894952|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894953|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19894954|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894955|NCT01023841|Bimatoprost|bimatoprost|mesh-list
19894956|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19894957|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19894958|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20259091|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20259092|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20259093|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
20259094|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
20259095|NCT00486083|Methylphenidate|methylphenidate|mesh-list
20259096|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20259097|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20259098|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259099|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20259100|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259101|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538636|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20538637|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
20538638|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538639|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538640|NCT01840384|Micronutrients|micronutrients|mesh-list
19894959|NCT01024010|Vidarabine|vidarabine|mesh-list
19894960|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
19894961|NCT01024010|Ofatumumab|ofatumumab|mesh-list
19894962|NCT01024010|Pentostatin|pentostatin|mesh-list
19894963|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19894964|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19894965|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
19894966|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894967|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19894968|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19894969|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
19894970|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894971|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894972|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19894973|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19894974|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19894975|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
19894976|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
19894977|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19894978|NCT01024036|Siltuximab|siltuximab|mesh-list
19894979|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894980|NCT01024231|Nivolumab|nivolumab|mesh-list
19894981|NCT01024231|Ipilimumab|ipilimumab|mesh-list
19894982|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19894983|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19894984|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19894985|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19894986|NCT01024335|Naltrexone|naltrexone|mesh-list
19894987|NCT01024335|Dronabinol|dronabinol|mesh-list
19894988|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19894989|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19894990|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19894991|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
19894992|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19894993|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
19894994|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20538641|NCT01840384|Trace Elements|trace elements|mesh-list
20538642|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538643|NCT01840423|Levodopa|levodopa|mesh-list
20538644|NCT01840423|Carbidopa|carbidopa|mesh-list
20538645|NCT01840423|Entacapone|entacapone|mesh-list
20538646|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20538647|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20538648|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
20538649|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538650|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538651|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538652|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19732236|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
19732237|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732238|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19732239|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
19732240|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732241|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732242|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19732243|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19732244|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732245|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19894995|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19894996|NCT01024335|Analgesics|analgesics|mesh-ancestor
19894997|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19894998|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19732246|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19894999|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895000|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895001|NCT01024335|Hormones|hormones|mesh-ancestor
19895002|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895003|NCT01024686|Vaccines|vaccines|mesh-list
19895004|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
19895005|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895006|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
19895007|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19895008|NCT01024738|Triclosan|triclosan|mesh-list
19895009|NCT01024738|Fluorides|fluorides|mesh-list
19895010|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
19895011|NCT01024738|Protective Agents|protective agents|mesh-ancestor
19895012|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895013|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19895014|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895015|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
19895016|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895017|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19895018|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19895019|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
19895020|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895021|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19895022|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19895023|NCT01024920|Sunitinib|sunitinib|mesh-list
19895024|NCT01024920|Nintedanib|nintedanib|mesh-list
19895025|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895026|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19895027|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19895028|NCT01024920|Growth Substances|growth substances|mesh-ancestor
19895029|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895030|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
19895031|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895032|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895033|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895034|NCT01024946|Everolimus|everolimus|mesh-list
19895035|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895036|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895037|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
19895038|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895039|NCT01024972|Mannitol|mannitol|mesh-list
19895040|NCT01024972|Dantrolene|dantrolene|mesh-list
19895041|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19895042|NCT01024972|Diuretics|diuretics|mesh-ancestor
19895043|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
19895044|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895045|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19732247|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19732248|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
19732249|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19732250|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732251|NCT04575688|Bupivacaine|bupivacaine|mesh-list
19732252|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
19732253|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
19732254|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732255|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732256|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
19732257|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895046|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19895047|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895048|NCT01025154|Cytarabine|cytarabine|mesh-list
19895049|NCT01025154|Clofarabine|clofarabine|mesh-list
19895050|NCT01025154|Idarubicin|idarubicin|mesh-list
19895051|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19895052|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
19895053|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895054|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895055|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
19895056|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895057|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895058|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
19895059|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895060|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895061|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19895062|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19895063|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895064|NCT01025193|Belimumab|belimumab|mesh-list
19895065|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895066|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
19895067|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895068|NCT01025232|Ranibizumab|ranibizumab|mesh-list
19895069|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19895070|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19895071|NCT01025232|Growth Substances|growth substances|mesh-ancestor
19895072|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895073|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
19895074|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895075|NCT01025284|Sargramostim|sargramostim|mesh-list
19895076|NCT01025284|Lenograstim|lenograstim|mesh-list
19895077|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
19895078|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895079|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19895080|NCT01025427|Tenofovir|tenofovir|mesh-list
19895081|NCT01025427|Emtricitabine|emtricitabine|mesh-list
19895082|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
19895083|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
19895084|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895085|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19895086|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19895087|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895088|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895089|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19895090|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19895091|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19895092|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19895093|NCT01025453|Sirolimus|sirolimus|mesh-list
19895094|NCT01025453|Sorafenib|sorafenib|mesh-list
19895095|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895096|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895097|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895098|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895099|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895100|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895101|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895102|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
19895103|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895104|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
19895105|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895106|NCT01025635|Azelaic acid|azelaic acid|mesh-list
19895107|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895108|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895109|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
19895110|NCT01025817|Everolimus|everolimus|mesh-list
19895111|NCT01025817|Tacrolimus|tacrolimus|mesh-list
19895112|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895113|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
19895114|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895115|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19895116|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895117|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895118|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895119|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895120|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19895121|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
19895122|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895123|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895124|NCT01025830|Lamivudine|lamivudine|mesh-list
19895125|NCT01025830|Nevirapine|nevirapine|mesh-list
19895126|NCT01025830|Stavudine|stavudine|mesh-list
19895127|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
19895128|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19895129|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19895130|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895131|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895132|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
19895133|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895134|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19895135|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19895136|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19895137|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19895138|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
19895139|NCT01025843|Candesartan|candesartan|mesh-list
19895140|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
19895141|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19895142|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19895143|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19895144|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895145|NCT01026012|Regadenoson|regadenoson|mesh-list
19895146|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19895147|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19895148|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
19895149|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
19895150|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895151|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895152|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895153|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19895154|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
19895155|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895156|NCT01026142|Capecitabine|capecitabine|mesh-list
19895157|NCT01026142|Trastuzumab|trastuzumab|mesh-list
19895158|NCT01026142|Pertuzumab|pertuzumab|mesh-list
19895159|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19895160|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
19895161|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895162|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895163|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19895164|NCT01026194|Pioglitazone|pioglitazone|mesh-list
19895165|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895166|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895167|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
19895168|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895169|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895170|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895171|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19895172|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
19895173|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
19895174|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895175|NCT01026454|Valacyclovir|valacyclovir|mesh-list
19895176|NCT01026454|Acyclovir|acyclovir|mesh-list
19895177|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
19895178|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895179|NCT01026493|Temozolomide|temozolomide|mesh-list
19895180|NCT01026493|Veliparib|veliparib|mesh-list
19895181|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19895182|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
19895183|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259102|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259103|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
20259104|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259105|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20259106|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259107|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20259108|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20259109|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259110|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259111|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895184|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538653|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538654|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20553883|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553884|NCT01931787|Protective Agents|protective agents|mesh-ancestor
20553885|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553886|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
20553887|NCT01931787|Vitamins|vitamins|mesh-ancestor
20553888|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
19895185|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19895186|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895187|NCT01026623|Sirolimus|sirolimus|mesh-list
19895188|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19895189|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895190|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895191|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895192|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895193|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
19895194|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553889|NCT01931982|Liraglutide|liraglutide|mesh-list
20553890|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20553891|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553892|NCT01931982|Incretins|incretins|mesh-ancestor
20553893|NCT01931982|Hormones|hormones|mesh-ancestor
20553894|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553895|NCT01932151|Terlipressin|terlipressin|mesh-list
20553896|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20553897|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20553898|NCT01932177|Everolimus|everolimus|mesh-list
19895195|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
19895196|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895197|NCT01026792|Sirolimus|sirolimus|mesh-list
19895198|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895199|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895200|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895201|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895202|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
19895203|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895204|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
19895205|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895206|NCT01026818|Tadalafil|tadalafil|mesh-list
19895207|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
19895208|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19895209|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19895210|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895211|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895212|NCT01026818|Urological Agents|urological agents|mesh-ancestor
19895213|NCT01026831|Timolol|timolol|mesh-list
19895214|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19895215|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19895216|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
19895217|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895218|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895219|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895220|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19895221|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19895222|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
19895223|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19895224|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895225|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895226|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895227|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895228|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
19895229|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19895230|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19895231|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895232|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19895233|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19895234|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971052|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19971053|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
19971054|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19971055|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19971056|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20553899|NCT01932177|Sorafenib|sorafenib|mesh-list
20555033|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
19895235|NCT01026948|Dinoprostone|dinoprostone|mesh-list
19895236|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
19895237|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19895238|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895239|NCT01027000|Sirolimus|sirolimus|mesh-list
19895240|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
19895241|NCT01027000|Busulfan|busulfan|mesh-list
19895242|NCT01027000|Rituximab|rituximab|mesh-list
19895243|NCT01027000|Methotrexate|methotrexate|mesh-list
19895244|NCT01027000|Fludarabine|fludarabine|mesh-list
19895245|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
19895246|NCT01027000|Tacrolimus|tacrolimus|mesh-list
19895247|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895248|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
19895249|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895250|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19895251|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19895252|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
19895253|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895254|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895255|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19895256|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19895257|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19895258|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
19895259|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19895260|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19895261|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
19895262|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895263|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895264|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19895265|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19895266|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19895267|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895268|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895269|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895270|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
19895271|NCT01027351|Vaccines|vaccines|mesh-list
19895272|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
19895273|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895274|NCT01027416|Tamoxifen|tamoxifen|mesh-list
19895275|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19895276|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
19895277|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895278|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895279|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19895280|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895281|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19895282|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19895283|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19895284|NCT01027468|Bevacizumab|bevacizumab|mesh-list
19895285|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19895286|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895287|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19895288|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19895289|NCT01027468|Growth Substances|growth substances|mesh-ancestor
19895290|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895291|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
19895292|NCT01027559|Sertraline|sertraline|mesh-list
19895293|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
19895294|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19895295|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19895296|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19895297|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19895298|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895299|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895300|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
19895301|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895302|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19895303|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895304|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895305|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895306|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895307|NCT01027650|Dexamethasone|dexamethasone|mesh-list
19895308|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19895309|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
19895310|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
19895311|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895312|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895313|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19895314|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
19895315|NCT01027650|Hormones|hormones|mesh-ancestor
19895316|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895317|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19895318|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895319|NCT01027754|Varenicline|varenicline|mesh-list
19895320|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19895321|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19895322|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
19895323|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895324|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895325|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895326|NCT01027793|Tretinoin|tretinoin|mesh-list
19895327|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895328|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
19895329|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895330|NCT01027806|Montelukast|montelukast|mesh-list
19895331|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19895332|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
19895333|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19895334|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
19895335|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895336|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895337|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19895338|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19895339|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895340|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19895341|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
19895342|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895343|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
19895344|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895345|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895346|NCT01027884|Idebenone|idebenone|mesh-list
19895347|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
19895348|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895349|NCT01027884|Protective Agents|protective agents|mesh-ancestor
19895350|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895351|NCT01027897|Doripenem|doripenem|mesh-list
19895352|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895353|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895354|NCT01027910|Doxorubicin|doxorubicin|mesh-list
19895355|NCT01027910|Abexinostat|abexinostat|mesh-list
19895356|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895357|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895358|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19895359|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19895360|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895361|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895362|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19895363|NCT01027949|Treprostinil|treprostinil|mesh-list
19895364|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19895365|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
19895366|NCT01028014|Ephedrine|ephedrine|mesh-list
20259112|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259113|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259114|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259115|NCT00486174|Methylene Blue|methylene blue|mesh-list
20259116|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259117|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259118|NCT00486187|Metformin|metformin|mesh-list
20259119|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
20259120|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20259121|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259122|NCT00486213|Pyridoxine|pyridoxine|mesh-list
20259123|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
20259124|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
20259125|NCT00486213|Vitamins|vitamins|mesh-ancestor
20259126|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
20259127|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259128|NCT00486317|Calcitonin|calcitonin|mesh-list
20259129|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
19895367|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
19895368|NCT01028014|Imipramine|imipramine|mesh-list
19895369|NCT01028014|Tamsulosin|tamsulosin|mesh-list
19895370|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
19895371|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19895372|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19895373|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19895374|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
19895375|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895376|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895377|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895378|NCT01028014|Urological Agents|urological agents|mesh-ancestor
19895379|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19895380|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19895381|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
19895382|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19895383|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
19895384|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895385|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19895386|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
19895387|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
19895388|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19895389|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19895390|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
19895391|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19895392|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
19895393|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19895394|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19895395|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19895396|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19895397|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19895398|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19895399|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19895400|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19895401|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19895402|NCT01028027|Tobramycin|tobramycin|mesh-list
19895403|NCT01028027|Dexamethasone|dexamethasone|mesh-list
19895404|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19895405|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
19895406|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
19895407|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895408|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895409|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19895410|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
19895411|NCT01028027|Hormones|hormones|mesh-ancestor
19895412|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895413|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19895414|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895415|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895416|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895417|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19895418|NCT01028053|Flutemetamol|flutemetamol|mesh-list
19895419|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19895420|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895421|NCT01028222|Dacarbazine|dacarbazine|mesh-list
19895422|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19895423|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
19895424|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895425|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895426|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19895427|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19895428|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19895429|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19895430|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895431|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895432|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895433|NCT01028352|Analgesics|analgesics|mesh-ancestor
19895434|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
19895435|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895436|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
19895437|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19895438|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
19895439|NCT01028391|Metformin|metformin|mesh-list
19895440|NCT01028391|Pioglitazone|pioglitazone|mesh-list
19895441|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19895442|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895443|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895444|NCT01028391|Incretins|incretins|mesh-ancestor
19895445|NCT01028391|Hormones|hormones|mesh-ancestor
19895446|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895447|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19895448|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
19895449|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895450|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895451|NCT01028651|Treprostinil|treprostinil|mesh-list
19895452|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19895453|NCT01028677|Oxytocin|oxytocin|mesh-list
19895454|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
19895455|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19895456|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895457|NCT01028820|Aripiprazole|aripiprazole|mesh-list
19895458|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
19895459|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19895460|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19895461|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19895462|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19895463|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895464|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
19895465|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
19895466|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895467|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895468|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19895469|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19895470|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
19895471|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19895472|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19895473|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19895474|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19895475|NCT01029054|Dexamethasone|dexamethasone|mesh-list
19895476|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
19895477|NCT01029054|Lenalidomide|lenalidomide|mesh-list
19895478|NCT01029054|BB 1101|bb 1101|mesh-list
19895479|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19895480|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
19895481|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
19895482|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895483|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895484|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19895485|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
19895486|NCT01029054|Hormones|hormones|mesh-ancestor
19895487|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895488|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19895489|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895490|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
19895491|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895492|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895493|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
19895494|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19895495|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19895496|NCT01029054|Growth Substances|growth substances|mesh-ancestor
19895497|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
19895498|NCT01029262|Lenalidomide|lenalidomide|mesh-list
19895499|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
19895500|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895501|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19895502|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19895503|NCT01029262|Growth Substances|growth substances|mesh-ancestor
19895504|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
19895505|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895506|NCT01029340|Factor VIII|factor viii|mesh-list
19895507|NCT01029340|Coagulants|coagulants|mesh-ancestor
19895508|NCT01029392|Vitamin D|vitamin d|mesh-list
19895509|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
19895510|NCT01029392|Vitamins|vitamins|mesh-ancestor
19895511|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
19895512|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895513|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19895514|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19895515|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
19895516|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19895517|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
19895518|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895519|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
19895520|NCT01029535|Protective Agents|protective agents|mesh-ancestor
19895521|NCT01029587|Eculizumab|eculizumab|mesh-list
19895522|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19895523|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895524|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
19895525|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895526|NCT01029652|Triamcinolone|triamcinolone|mesh-list
19895527|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19895528|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19895529|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19895530|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19895531|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19895532|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
19895533|NCT01029652|Hormones|hormones|mesh-ancestor
19895534|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895535|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895536|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895537|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
19895538|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895539|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895540|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19895541|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895542|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895543|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895544|NCT01029730|Rituximab|rituximab|mesh-list
19895545|NCT01029730|Bortezomib|bortezomib|mesh-list
19895546|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19895547|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19895548|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895549|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
19895550|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895551|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19895552|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19895553|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
19895554|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895555|NCT01029782|Cefazolin|cefazolin|mesh-list
19895556|NCT01029782|Cephalexin|cephalexin|mesh-list
19895557|NCT01029782|Probenecid|probenecid|mesh-list
19895558|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895559|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895560|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
19895561|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
19895562|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19895563|NCT01029782|Renal Agents|renal agents|mesh-ancestor
19895564|NCT01029795|Glyburide|glyburide|mesh-list
19895565|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895566|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895567|NCT01029886|Liraglutide|liraglutide|mesh-list
19895568|NCT01029886|Exenatide|exenatide|mesh-list
19895569|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895570|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895571|NCT01029886|Incretins|incretins|mesh-ancestor
19895572|NCT01029886|Hormones|hormones|mesh-ancestor
19895573|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895574|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19895575|NCT01030458|Amlodipine|amlodipine|mesh-list
19895576|NCT01030458|Valsartan|valsartan|mesh-list
19895577|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19895578|NCT01030458|Bisoprolol|bisoprolol|mesh-list
19895579|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19895580|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19895581|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19895582|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895583|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19895584|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895585|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
19895586|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19895587|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19895588|NCT01030458|Diuretics|diuretics|mesh-ancestor
19895589|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
19895590|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19895591|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
19895592|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
19895593|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895594|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19895595|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19895596|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19895597|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
19895598|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895599|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
19895600|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895601|NCT01030653|Voriconazole|voriconazole|mesh-list
19895602|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
19895603|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895604|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19895605|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19895606|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895607|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895608|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19895609|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
19895610|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895611|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895612|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19895613|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
19895614|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19895615|NCT01030666|Doxycycline|doxycycline|mesh-list
19895616|NCT01030666|Ibuprofen|ibuprofen|mesh-list
19895617|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19895618|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19895619|NCT01030666|Analgesics|analgesics|mesh-ancestor
19895620|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
19895621|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895622|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895623|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19895624|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19895625|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19895626|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895627|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895628|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19895629|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895630|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
19895631|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895632|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895633|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
19895634|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19895635|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19895636|NCT01030718|Dasatinib|dasatinib|mesh-list
19895637|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895638|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895639|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895640|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895641|NCT01030783|Sorafenib|sorafenib|mesh-list
19895642|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895643|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895644|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895645|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895646|NCT01030822|Vaccines|vaccines|mesh-list
19895647|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19895648|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
19895649|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895650|NCT01030952|Acarbose|acarbose|mesh-list
19895651|NCT01030952|Nateglinide|nateglinide|mesh-list
19895652|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19895653|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895654|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895655|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895656|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895657|NCT01031043|Bethanechol|bethanechol|mesh-list
19895658|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19895659|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
19895660|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895661|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895662|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19895663|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19895664|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
19895665|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895666|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895667|NCT01031069|Vaccines|vaccines|mesh-list
19895668|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
20259130|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20259131|NCT00486317|Katacalcin|katacalcin|mesh-list
20259132|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20259133|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259134|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20259135|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
20259136|NCT00486343|Zileuton|zileuton|mesh-list
20259137|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20259138|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20259139|NCT00486343|Analgesics|analgesics|mesh-ancestor
20259140|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
20259141|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259142|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259143|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259144|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259145|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20259146|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259147|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259148|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20259149|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
20259150|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259151|NCT00486356|Carboplatin|carboplatin|mesh-list
20259152|NCT00486356|Capecitabine|capecitabine|mesh-list
20259153|NCT00486356|Epirubicin|epirubicin|mesh-list
20259154|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259155|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20259156|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
20259157|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259158|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20259159|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20259160|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20259161|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259162|NCT00486369|Calcitonin|calcitonin|mesh-list
20259163|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
20259164|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20259165|NCT00486369|Katacalcin|katacalcin|mesh-list
20259166|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20259167|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259168|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20259169|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
20286869|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20286870|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286871|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
20286872|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286873|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286874|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20286875|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286876|NCT01773707|Abatacept|abatacept|mesh-list
20286877|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286878|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286879|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286880|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286881|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
20538655|NCT01840449|Lanreotide|lanreotide|mesh-list
19971057|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
19895669|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895670|NCT01031381|Bevacizumab|bevacizumab|mesh-list
19895671|NCT01031381|Everolimus|everolimus|mesh-list
19895672|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19895673|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895674|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19895675|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19895676|NCT01031381|Growth Substances|growth substances|mesh-ancestor
19895677|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895678|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
19895679|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895680|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
19895681|NCT01031420|Doxorubicin|doxorubicin|mesh-list
19895682|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19895683|NCT01031420|Methotrexate|methotrexate|mesh-list
19895684|NCT01031420|Vinblastine|vinblastine|mesh-list
19895685|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895686|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895687|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19895688|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19895689|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895690|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895691|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19895692|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
19895693|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19895694|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895695|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19895696|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
19895697|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895698|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19895699|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895700|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
19895701|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19895702|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19895703|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19895704|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19895705|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19895706|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19895707|NCT01031446|Paclitaxel|paclitaxel|mesh-list
19895708|NCT01031446|Everolimus|everolimus|mesh-list
19895709|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19895710|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895711|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
19895712|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
19895713|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
19895714|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895715|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19895716|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
19895717|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895718|NCT01031498|Ondansetron|ondansetron|mesh-list
19895719|NCT01031498|Palonosetron|palonosetron|mesh-list
19895720|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
19895721|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
19895722|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895723|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895724|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19895725|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
19895726|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895727|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19895728|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
19895729|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895730|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895731|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19895732|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19895733|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19895734|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19895735|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19895736|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19895737|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
19895738|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19895739|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895740|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895741|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895742|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
19895743|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
19895744|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19895745|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19895746|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895747|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895748|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19895749|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19895750|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19895751|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895752|NCT01031836|Sifalimumab|sifalimumab|mesh-list
19895753|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19895754|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
19895755|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895756|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
19895757|NCT01031953|Aprepitant|aprepitant|mesh-list
19895758|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
19895759|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
19895760|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895761|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895762|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19895763|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19895764|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895765|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895766|NCT01031979|Yohimbine|yohimbine|mesh-list
19895767|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
19895768|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
19895769|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895770|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895771|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19895772|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19895773|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19895774|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
19895775|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895776|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895777|NCT01031979|Urological Agents|urological agents|mesh-ancestor
19895778|NCT01032018|Bupropion|bupropion|mesh-list
19895779|NCT01032018|Citalopram|citalopram|mesh-list
19895780|NCT01032018|Sertraline|sertraline|mesh-list
19895781|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19895782|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
19895783|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19895784|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19895785|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19895786|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19895787|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895788|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
19895789|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895790|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895791|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19895792|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19895793|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895794|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19895795|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
19895796|NCT01032070|Etoposide|etoposide|mesh-list
19895797|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19895798|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19895799|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895800|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19895801|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19895802|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895803|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895804|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895805|NCT01032174|Azithromycin|azithromycin|mesh-list
19895806|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895807|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895808|NCT01032200|Modafinil|modafinil|mesh-list
19895809|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19895810|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895811|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19895812|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19895813|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19895814|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895815|NCT01032239|Baclofen|baclofen|mesh-list
19895816|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19895817|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895818|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19895819|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895820|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19895821|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
19895822|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
19895823|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895824|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895825|NCT01032291|Lenalidomide|lenalidomide|mesh-list
19895826|NCT01032291|Cetuximab|cetuximab|mesh-list
19895827|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
19895828|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895829|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19895830|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19895831|NCT01032291|Growth Substances|growth substances|mesh-ancestor
19895832|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
19895833|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895834|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19895835|NCT01032382|Gentamicins|gentamicins|mesh-list
19895836|NCT01032382|Paromomycin|paromomycin|mesh-list
19895837|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895838|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895839|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19895840|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895841|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895842|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19895843|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19895844|NCT01032629|Canagliflozin|canagliflozin|mesh-list
19895845|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19895846|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895847|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895848|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971058|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19971059|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971060|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19971061|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19971062|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19971063|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19971064|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971065|NCT01791465|Exenatide|exenatide|mesh-list
19971066|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19971067|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971068|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19971069|NCT01791465|Incretins|incretins|mesh-ancestor
19971070|NCT01791465|Hormones|hormones|mesh-ancestor
19971071|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971072|NCT01791491|Abatacept|abatacept|mesh-list
19971073|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19971074|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971075|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971076|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971077|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
19971078|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971079|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975340|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19975341|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19975342|NCT01847638|Analgesics|analgesics|mesh-ancestor
19975343|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
19975344|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975345|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975346|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975347|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975348|NCT01848041|Phenylephrine|phenylephrine|mesh-list
19975349|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
19975350|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19975351|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19975352|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19975353|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19975354|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975355|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259170|NCT00486421|Prednisone|prednisone|mesh-list
19895849|NCT01032694|Azithromycin|azithromycin|mesh-list
19895850|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895851|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895852|NCT01032759|Memantine|memantine|mesh-list
19895853|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19895854|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19895855|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
19895856|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895857|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895858|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895859|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19895860|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19895861|NCT01032837|Oseltamivir|oseltamivir|mesh-list
19895862|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
19895863|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895864|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895865|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895866|NCT01032850|Capecitabine|capecitabine|mesh-list
19895867|NCT01032850|Sorafenib|sorafenib|mesh-list
19895868|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19895869|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
19895870|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895871|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259171|NCT00486421|Rituximab|rituximab|mesh-list
20259172|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20259173|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259174|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
20259175|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259176|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259177|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259178|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
20259179|NCT00486421|Hormones|hormones|mesh-ancestor
20538656|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538657|NCT01840683|Heparin|heparin|mesh-list
20538658|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
20538659|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20538660|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20538661|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538662|NCT01840696|Regadenoson|regadenoson|mesh-list
20538663|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20538664|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20538665|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
20538666|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
20538667|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538668|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895872|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895873|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895874|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
19895875|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19895876|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19895877|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19895878|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
19895879|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895880|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
19895881|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19895882|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19895883|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895884|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
19895885|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19895886|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895887|NCT01032993|Ubiquinone|ubiquinone|mesh-list
19895888|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
19895889|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
19895890|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895891|NCT01032993|Vitamins|vitamins|mesh-ancestor
19895892|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19895893|NCT01033071|Olmesartan|olmesartan|mesh-list
19895894|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19895895|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
19895896|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19895897|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20286882|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895898|NCT01033071|Diuretics|diuretics|mesh-ancestor
19895899|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
20286883|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286884|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
19895900|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895901|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19895902|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19895903|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895904|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19895905|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19895906|NCT01033240|Sorafenib|sorafenib|mesh-list
19895907|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895908|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19895909|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895910|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895911|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19895912|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
19895913|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895914|NCT01033565|Melatonin|melatonin|mesh-list
19895915|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
19895916|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895917|NCT01033565|Protective Agents|protective agents|mesh-ancestor
19895918|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895919|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19895920|NCT01033734|Oseltamivir|oseltamivir|mesh-list
19895921|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
19895922|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895923|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895924|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895925|NCT01033747|Deferasirox|deferasirox|mesh-list
19895926|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19895927|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
19895928|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
19895929|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895930|NCT01033773|Metformin|metformin|mesh-list
19895931|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19895932|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895933|NCT01033825|Ciclesonide|ciclesonide|mesh-list
19895934|NCT01033825|Dexamethasone|dexamethasone|mesh-list
19895935|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
19895936|NCT01033825|BB 1101|bb 1101|mesh-list
19895937|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19895938|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
19895939|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
19895940|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19895941|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895942|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19895943|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
19895944|NCT01033825|Hormones|hormones|mesh-ancestor
19895945|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895946|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19895947|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895948|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
19895949|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895950|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895951|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19895952|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
19895953|NCT01033864|Prednisone|prednisone|mesh-list
19895954|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19895955|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
19895956|NCT01033864|Hormones|hormones|mesh-ancestor
19895957|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895958|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895959|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19895960|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895961|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19895962|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19895963|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
19895964|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19895965|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895966|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895967|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895968|NCT01033942|Tenofovir|tenofovir|mesh-list
19895969|NCT01033942|Emtricitabine|emtricitabine|mesh-list
20259180|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286885|NCT01724866|Docetaxel|docetaxel|mesh-list
19895970|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
19895971|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19895972|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19895973|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19895974|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895975|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895976|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19895977|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19895978|NCT01034111|Metformin|metformin|mesh-list
20538669|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538670|NCT01840774|Ketamine|ketamine|mesh-list
20538671|NCT01840774|Analgesics|analgesics|mesh-list
19895979|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19895980|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19895981|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895982|NCT01034111|Incretins|incretins|mesh-ancestor
19895983|NCT01034111|Hormones|hormones|mesh-ancestor
19895984|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19895985|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19895986|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
19895987|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19895988|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895989|NCT01034137|Methotrexate|methotrexate|mesh-list
19895990|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19895991|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
19895992|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19895993|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19895994|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19895995|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
19895996|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19895997|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19895998|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
19895999|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896000|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19896001|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896002|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
19896003|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896004|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19896005|NCT01034163|Panobinostat|panobinostat|mesh-list
19896006|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896007|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19896008|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896009|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896010|NCT01034176|Levofloxacin|levofloxacin|mesh-list
19896011|NCT01034176|Ofloxacin|ofloxacin|mesh-list
19896012|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19896013|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896014|NCT01034176|Renal Agents|renal agents|mesh-ancestor
19896015|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19896016|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19896017|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20259181|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20259182|NCT00486460|Gemcitabine|gemcitabine|mesh-list
20538672|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
19732258|NCT04575779|Cyclosporine|cyclosporine|mesh-list
19732259|NCT04575779|Cyclosporins|cyclosporins|mesh-list
19732260|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732261|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732262|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732263|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
19732264|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732265|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
19896018|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896019|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896020|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896021|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19896022|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19896023|NCT01034462|Milnacipran|milnacipran|mesh-list
19896024|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
19896025|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19896026|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19896027|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19896028|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896029|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896030|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896031|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
19896032|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19896033|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896034|NCT01034462|Analgesics|analgesics|mesh-ancestor
19896035|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
19896036|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896037|NCT01034553|Bortezomib|bortezomib|mesh-list
19896038|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896039|NCT01034592|Lenalidomide|lenalidomide|mesh-list
19896040|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
19896041|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896042|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19896043|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19896044|NCT01034592|Growth Substances|growth substances|mesh-ancestor
19896045|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
19896046|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896047|NCT01034631|Everolimus|everolimus|mesh-list
19896048|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896049|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896050|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
19896051|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896052|NCT01034657|Panobinostat|panobinostat|mesh-list
19896053|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
20259183|NCT00486460|Curcumin|curcumin|mesh-list
20259184|NCT00486460|Celecoxib|celecoxib|mesh-list
20259185|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20259186|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
20259187|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259188|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259189|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
20259190|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259191|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259192|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259193|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
20259194|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259195|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19896054|NCT01034657|Hematinics|hematinics|mesh-ancestor
19896055|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896056|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19896057|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896058|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896059|NCT01035099|Letrozole|letrozole|mesh-list
19896060|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896061|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19896062|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19896063|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971080|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20259196|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20259197|NCT00486460|Analgesics|analgesics|mesh-ancestor
20259198|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
20259199|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259200|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259201|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259202|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20259203|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20259204|NCT00486486|Timolol|timolol|mesh-list
20259205|NCT00486486|Bimatoprost|bimatoprost|mesh-list
20259206|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20259207|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20259208|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259209|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538673|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896064|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896065|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19896066|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
19896067|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896068|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896069|NCT01035229|Everolimus|everolimus|mesh-list
19896070|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896071|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896072|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
19896073|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896074|NCT01035255|Enalapril|enalapril|mesh-list
19896075|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19896076|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19896077|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
19896078|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896079|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896080|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19896081|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19896082|NCT01035333|Orlistat|orlistat|mesh-list
19896083|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896084|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896085|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19896086|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19896087|NCT01035346|Ibuprofen|ibuprofen|mesh-list
19896088|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19896089|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896090|NCT01035346|Analgesics|analgesics|mesh-ancestor
19896091|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
19896092|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896093|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896094|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896095|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896096|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19896097|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896098|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896099|NCT01035463|Cytarabine|cytarabine|mesh-list
19896100|NCT01035463|Rituximab|rituximab|mesh-list
19896101|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19896102|NCT01035463|Etoposide|etoposide|mesh-list
19896103|NCT01035463|Lenalidomide|lenalidomide|mesh-list
19896104|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
19896105|NCT01035463|Melphalan|melphalan|mesh-list
19896106|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
19896107|NCT01035463|Carmustine|carmustine|mesh-list
19896108|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
19896109|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19896110|NCT01035463|Antibodies|antibodies|mesh-list
19896111|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
19896112|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19896113|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
19896114|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896115|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896116|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896117|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19896118|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19896119|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19896120|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896121|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896122|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19896123|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
19896124|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
19896125|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896126|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896127|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19896128|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19896129|NCT01035463|Growth Substances|growth substances|mesh-ancestor
19896130|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
19896131|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19896132|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
19896133|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19896134|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
19896135|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
19896136|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
19896137|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
19896138|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
19896139|NCT01035658|Doxorubicin|doxorubicin|mesh-list
19896140|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19896141|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19896142|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896143|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19896144|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19896145|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896146|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896147|NCT01035749|Vaccines|vaccines|mesh-list
19896148|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
19896149|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896150|NCT01036594|Ketoconazole|ketoconazole|mesh-list
19896151|NCT01036594|Dexamethasone|dexamethasone|mesh-list
19896152|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
19896153|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
19896154|NCT01036594|BB 1101|bb 1101|mesh-list
19896155|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896156|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
19896157|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
19896158|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896159|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896160|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896161|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
19896162|NCT01036594|Hormones|hormones|mesh-ancestor
19896163|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896164|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19896165|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896166|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
19896167|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896168|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896169|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
19896170|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896171|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19896172|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19896173|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19896174|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
19896175|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19896176|NCT01036802|Warfarin|warfarin|mesh-list
19896177|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
19896178|NCT01037127|Trametinib|trametinib|mesh-list
19896179|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896180|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19896181|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896182|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896183|NCT01037192|Vancomycin|vancomycin|mesh-list
19896184|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19896185|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896186|NCT01037218|Udenafil|udenafil|mesh-list
19896187|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19896188|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19896189|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896190|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896191|NCT01037244|Udenafil|udenafil|mesh-list
19896192|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19896193|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19896194|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896195|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896196|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
19896197|NCT01037452|Lansoprazole|lansoprazole|mesh-list
19896198|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
19896199|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
19896200|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
19896201|NCT01037452|Calcium|calcium|mesh-list
19896202|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19896203|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896204|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19896205|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19896206|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896207|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19896208|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896209|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896210|NCT01037452|Antacids|antacids|mesh-ancestor
19896211|NCT01037790|Palbociclib|palbociclib|mesh-list
19896212|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896213|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19896214|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896215|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896216|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
19896217|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19896218|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896219|NCT01037881|Analgesics|analgesics|mesh-ancestor
19896220|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
20259210|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896221|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896222|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896223|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896224|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896225|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
19896226|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896227|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
19896228|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19896229|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896230|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896231|NCT01038128|Memantine|memantine|mesh-list
19896232|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19896233|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19896234|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
19896235|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896236|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896237|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896238|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19896239|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19896240|NCT01038323|Milnacipran|milnacipran|mesh-list
19896241|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
19896242|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19896243|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19896244|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19896245|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896246|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896247|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896248|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896249|NCT01038323|Analgesics|analgesics|mesh-ancestor
19896250|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
19896251|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896252|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
19896253|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19896254|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
19896255|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896256|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
19896257|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19896258|NCT01038609|Acetaminophen|acetaminophen|mesh-list
19896259|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19896260|NCT01038609|Morphine|morphine|mesh-list
19896261|NCT01038609|Hydrocodone|hydrocodone|mesh-list
19896262|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19896263|NCT01038609|Narcotics|narcotics|mesh-ancestor
19896264|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896265|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896266|NCT01038609|Analgesics|analgesics|mesh-ancestor
19896267|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
19896268|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896269|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896270|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
19896271|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
19896272|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
19896273|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19735701|NCT04536961|Famotidine|famotidine|mesh-list
19735702|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19735703|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19735704|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19735705|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
19735706|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
19735707|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735708|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896274|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896275|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896276|NCT01038635|Lenalidomide|lenalidomide|mesh-list
19896277|NCT01038635|Azacitidine|azacitidine|mesh-list
19896278|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
19896279|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896280|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19896281|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19896282|NCT01038635|Growth Substances|growth substances|mesh-ancestor
19896283|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
19896284|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896285|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19896286|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
19896287|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896288|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896289|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19896290|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896291|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19896292|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896293|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896294|NCT01038869|Azelaic acid|azelaic acid|mesh-list
19896295|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896296|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
19896297|NCT01038921|Melatonin|melatonin|mesh-list
19896298|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
19896299|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896300|NCT01038921|Protective Agents|protective agents|mesh-ancestor
19896301|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896302|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896303|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19896304|NCT01039207|Rilotumumab|rilotumumab|mesh-list
19896305|NCT01039207|Antibodies|antibodies|mesh-list
19896306|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
19896307|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19896308|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
19896309|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896310|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896311|NCT01039376|Ofatumumab|ofatumumab|mesh-list
19896312|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896313|NCT01039584|Butoconazole|butoconazole|mesh-list
19896314|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
19896315|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971081|NCT01791803|Nicotine|nicotine|mesh-list
19971082|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19971083|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
19971084|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971085|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971086|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19971087|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19971088|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
19971089|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971090|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971091|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
19971092|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971093|NCT01791972|Albuterol|albuterol|mesh-list
19971094|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19971095|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
19971096|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971097|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971098|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19971099|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971100|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
19971101|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19971102|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19971103|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19971104|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19971105|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
19971106|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971107|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971108|NCT01792115|Vitamins|vitamins|mesh-list
19971109|NCT01792115|Vitamin E|vitamin e|mesh-list
19971110|NCT01792115|Tocopherols|tocopherols|mesh-list
19971111|NCT01792115|Tocotrienols|tocotrienols|mesh-list
19971112|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
19896316|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
19896317|NCT01039688|Tofacitinib|tofacitinib|mesh-list
19896318|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19896319|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896320|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896321|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
19896322|NCT01039792|Vitamins|vitamins|mesh-ancestor
19896323|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
19896324|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896325|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
19896326|NCT01040130|Olodaterol|olodaterol|mesh-list
19896327|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19896328|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
19896329|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896330|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896331|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19896332|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
19896333|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
19896334|NCT01040169|Calcium|calcium|mesh-list
19896335|NCT01040169|Fluorides|fluorides|mesh-list
19896336|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19896337|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896338|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
19896339|NCT01040169|Protective Agents|protective agents|mesh-ancestor
19896340|NCT01040169|Antacids|antacids|mesh-ancestor
19896341|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896342|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896343|NCT01040260|Nicotine|nicotine|mesh-list
19896344|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19896345|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
19896346|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896347|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896348|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19896349|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19896350|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
19896351|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896352|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896353|NCT01040403|Bromides|bromides|mesh-list
19896354|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
19896355|NCT01040403|Olodaterol|olodaterol|mesh-list
19896356|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19896357|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
19896358|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896359|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896360|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19896361|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
19896362|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
19896363|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19896364|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
19896365|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896366|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896367|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
19896368|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
19896369|NCT01040689|Olodaterol|olodaterol|mesh-list
19896370|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19896371|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
19896372|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896373|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896374|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19896375|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
19896376|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
19896377|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19896378|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
19896379|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896380|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896381|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
19896382|NCT01040728|Olodaterol|olodaterol|mesh-list
19896383|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19896384|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
19896385|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896386|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896387|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19896388|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
19896389|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
19896390|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19896391|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
20259211|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259212|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20259213|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20259214|NCT00486564|Nifurtimox|nifurtimox|mesh-list
20259215|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20259216|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20259217|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20259218|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259219|NCT00486668|Paclitaxel|paclitaxel|mesh-list
20259220|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
20259221|NCT00486668|Doxorubicin|doxorubicin|mesh-list
20259222|NCT00486668|Trastuzumab|trastuzumab|mesh-list
20259223|NCT00486668|Lapatinib|lapatinib|mesh-list
20259224|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20259225|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259226|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
20538674|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896392|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896393|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896394|NCT01040780|Gefitinib|gefitinib|mesh-list
19896395|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896396|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19896397|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896398|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896399|NCT01040793|Olodaterol|olodaterol|mesh-list
19896400|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19896401|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
19896402|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896403|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896404|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19896405|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
19896406|NCT01040819|Pioglitazone|pioglitazone|mesh-list
19896407|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19896408|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896409|NCT01040832|Cetuximab|cetuximab|mesh-list
19896410|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19896411|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896412|NCT01040845|Colchicine|colchicine|mesh-list
19896413|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19896414|NCT01040845|Norethindrone|norethindrone|mesh-list
19896415|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
19896416|NCT01040845|Estradiol|estradiol|mesh-list
19896417|NCT01040845|Estrogens|estrogens|mesh-ancestor
19896418|NCT01040845|Hormones|hormones|mesh-ancestor
19896419|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896420|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896421|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19896422|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
19896423|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19896424|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19896425|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
19896426|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896427|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19896428|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
19896429|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
19896430|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896431|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896432|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19896433|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19896434|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19896435|NCT01040871|Prednisone|prednisone|mesh-list
19896436|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
19896437|NCT01040871|Rituximab|rituximab|mesh-list
19896438|NCT01040871|Doxorubicin|doxorubicin|mesh-list
19896439|NCT01040871|Vincristine|vincristine|mesh-list
19896440|NCT01040871|Bortezomib|bortezomib|mesh-list
19896441|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896442|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
19896443|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896444|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896445|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19896446|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
19896447|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896448|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259227|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
20259228|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
19896449|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19896450|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19896451|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19896452|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19896453|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19896454|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896455|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896456|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
19896457|NCT01040871|Hormones|hormones|mesh-ancestor
19896458|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896459|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19896460|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19896461|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
19896462|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
19896463|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
19896464|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19896465|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896466|NCT01041274|Citalopram|citalopram|mesh-list
19896467|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19896468|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19896469|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19896470|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896471|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896472|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
19896473|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896474|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19896475|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
19896476|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19896477|NCT01041287|Metoprolol|metoprolol|mesh-list
19896478|NCT01041287|Nebivolol|nebivolol|mesh-list
19896479|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19896480|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19896481|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
19896482|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
19896483|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896484|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896485|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19896486|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19896487|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19896488|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
19896489|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896490|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896491|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
19896492|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19896493|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19896494|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19896495|NCT01041404|Fluorouracil|fluorouracil|mesh-list
19896496|NCT01041404|Capecitabine|capecitabine|mesh-list
19896497|NCT01041404|Trastuzumab|trastuzumab|mesh-list
19896498|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896499|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
19896500|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896501|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19896502|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896503|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
19896504|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896505|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19896506|NCT01041417|Molgramostim|molgramostim|mesh-list
19896507|NCT01041417|Sargramostim|sargramostim|mesh-list
19896508|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
19896509|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896510|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896511|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
19896512|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19896513|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
19896514|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19896515|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19896516|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896517|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19896518|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896519|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20286886|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896520|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896521|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19896522|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
19896523|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896524|NCT01041638|Vitamin A|vitamin a|mesh-list
19896525|NCT01041638|Aldesleukin|aldesleukin|mesh-list
19896526|NCT01041638|Interleukin-2|interleukin-2|mesh-list
19896527|NCT01041638|Tretinoin|tretinoin|mesh-list
19896528|NCT01041638|Dinutuximab|dinutuximab|mesh-list
19896529|NCT01041638|Isotretinoin|isotretinoin|mesh-list
19896530|NCT01041638|Sargramostim|sargramostim|mesh-list
19896531|NCT01041638|Vitamins|vitamins|mesh-ancestor
19896532|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
19896533|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896534|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896535|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896536|NCT01041638|Analgesics|analgesics|mesh-ancestor
19896537|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
19896538|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896539|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
19896540|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19896541|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19896542|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
19896543|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896544|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
19896545|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
19896546|NCT01041781|Gemcitabine|gemcitabine|mesh-list
19896547|NCT01041781|Celecoxib|celecoxib|mesh-list
19896548|NCT01041781|Carboplatin|carboplatin|mesh-list
19896549|NCT01041781|Pemetrexed|pemetrexed|mesh-list
19896550|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896551|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19896552|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
19896553|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896554|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
19896555|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896556|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896557|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896558|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
19896559|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896560|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19896561|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19896562|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19896563|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896564|NCT01041781|Analgesics|analgesics|mesh-ancestor
19896565|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
19896566|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896567|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896568|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896569|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19896570|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19896571|NCT01041859|Tapentadol|tapentadol|mesh-list
19896572|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19896573|NCT01041859|Narcotics|narcotics|mesh-ancestor
19896574|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896575|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896576|NCT01041859|Analgesics|analgesics|mesh-ancestor
19896577|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
19896578|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896579|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19896580|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19896581|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19896582|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896583|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
19896584|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896585|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19896586|NCT01042093|Clonidine|clonidine|mesh-list
19896587|NCT01042093|Epinephrine|epinephrine|mesh-list
19896588|NCT01042093|Ropivacaine|ropivacaine|mesh-list
19896589|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
19896590|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
19896591|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896592|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896593|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
19896594|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896595|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19896596|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19896597|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
19896598|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896599|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896600|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19896601|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19896602|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
19896603|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19896604|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
19896605|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
19896606|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
19896607|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19896608|NCT01042093|Analgesics|analgesics|mesh-ancestor
19896609|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19896610|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
19896611|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19896612|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19896613|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896614|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896615|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896616|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19896617|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896618|NCT01042145|Dexamethasone|dexamethasone|mesh-list
19896619|NCT01042145|Prednisone|prednisone|mesh-list
19896620|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896621|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
19896622|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
19896623|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896624|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896625|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896626|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
19896627|NCT01042145|Hormones|hormones|mesh-ancestor
19896628|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896629|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19896630|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896631|NCT01042158|Ambrisentan|ambrisentan|mesh-list
19896632|NCT01042158|Tadalafil|tadalafil|mesh-list
19896633|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
19896634|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19896635|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19896636|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896637|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896638|NCT01042158|Urological Agents|urological agents|mesh-ancestor
19896639|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19896640|NCT01042236|Fesoterodine|fesoterodine|mesh-list
19896641|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19896642|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19896643|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
19896644|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896645|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896646|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896647|NCT01042236|Urological Agents|urological agents|mesh-ancestor
19896648|NCT01042288|Carboplatin|carboplatin|mesh-list
19896649|NCT01042288|Pemetrexed|pemetrexed|mesh-list
19896650|NCT01042288|Panitumumab|panitumumab|mesh-list
19896651|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896652|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896653|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896654|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19896655|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19896656|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19896657|NCT01042366|Vaccines|vaccines|mesh-list
19896658|NCT01042366|Immunologic Factors|immunologic factors|mesh-ancestor
19896659|NCT01042366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896660|NCT01042392|Ramipril|ramipril|mesh-list
19896661|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19896662|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
19896663|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896664|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896665|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19896666|NCT01042496|Lamotrigine|lamotrigine|mesh-list
19896667|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
19896668|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19896669|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19896670|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896671|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19896672|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896673|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19896674|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19896675|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896676|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19896677|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19896678|NCT01042509|Rituximab|rituximab|mesh-list
19896679|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
19896680|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19896681|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896682|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
19896683|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896684|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896685|NCT01042535|Tryptophan|tryptophan|mesh-list
19896686|NCT01042535|Vaccines|vaccines|mesh-list
19896687|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
19896688|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896689|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19896690|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
19896691|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19896692|NCT01042795|Sunitinib|sunitinib|mesh-list
19896693|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896694|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19896695|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19896696|NCT01042795|Growth Substances|growth substances|mesh-ancestor
19896697|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896698|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19896699|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19896700|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896701|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896702|NCT01042938|Curcumin|curcumin|mesh-list
19896703|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19896704|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896705|NCT01042938|Analgesics|analgesics|mesh-ancestor
19896706|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
19896707|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896708|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896709|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896710|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896711|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896712|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896713|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896714|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
19896715|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19896716|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896717|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19896718|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896719|NCT01043094|Pitavastatin|pitavastatin|mesh-list
19896720|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19896721|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19896722|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19896723|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
20538675|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20538676|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20538677|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
20538678|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
20538679|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538680|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20538681|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20538682|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538683|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538684|NCT01840800|Ropivacaine|ropivacaine|mesh-list
20538685|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538686|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
20538687|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538688|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538689|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
20538690|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538691|NCT01840813|Misoprostol|misoprostol|mesh-list
20538692|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20538693|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
19896724|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896725|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896726|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19896727|NCT01043185|Lesogaberan|lesogaberan|mesh-list
19896728|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896729|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19896730|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
19896731|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
19896732|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896733|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896734|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896735|NCT01043393|Desoximetasone|desoximetasone|mesh-list
19896736|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896737|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
19896738|NCT01043393|Hormones|hormones|mesh-ancestor
19896739|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896740|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896741|NCT01043640|Cyclosporine|cyclosporine|mesh-list
19896742|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
19896743|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
19896744|NCT01043640|Busulfan|busulfan|mesh-list
20259229|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259230|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259231|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
20259232|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259233|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259234|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20259235|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
20259236|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20259237|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20259238|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20259239|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20259240|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259241|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20259242|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20259243|NCT00486694|Artesunate|artesunate|mesh-list
20259244|NCT00486694|Chloroquine|chloroquine|mesh-list
20259245|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
20259246|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
19896745|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
19896746|NCT01043640|Cyclosporins|cyclosporins|mesh-list
19896747|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896748|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
19896749|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896750|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896751|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20259247|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20259248|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
20259249|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20259250|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20259251|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259252|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259253|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
20259254|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
20259255|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20259256|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
20259257|NCT00486694|Amebicides|amebicides|mesh-ancestor
20259258|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259259|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20259260|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259261|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259262|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20259263|NCT00486694|Renal Agents|renal agents|mesh-ancestor
20259264|NCT00486772|Calcium|calcium|mesh-list
20259265|NCT00486772|Sevelamer|sevelamer|mesh-list
20259266|NCT00486772|Calcium acetate|calcium acetate|mesh-list
19896752|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
19896753|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896754|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896755|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19896756|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896757|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
20538694|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19896758|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896759|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
20259267|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19896760|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19896761|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19896762|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19896763|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
19896764|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19896765|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19896766|NCT01043926|Suvorexant|suvorexant|mesh-list
19896767|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19896768|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19896769|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896770|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896771|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19896772|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896773|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896774|NCT01044212|Psyllium|psyllium|mesh-list
19896775|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
19896776|NCT01044212|Cathartics|cathartics|mesh-ancestor
19896777|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896778|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
19896779|NCT01044264|Clindamycin|clindamycin|mesh-list
19896780|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
19896781|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
19896782|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19896783|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19896784|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896785|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19896786|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896787|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896788|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
19896789|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
19896790|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19896791|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896792|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19896793|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
19896794|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19896795|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896796|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896797|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896798|NCT01044433|Capecitabine|capecitabine|mesh-list
19896799|NCT01044433|Lapatinib|lapatinib|mesh-list
19896800|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19896801|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
19896802|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896803|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896804|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19896805|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896806|NCT01044459|Bromides|bromides|mesh-list
19896807|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
19896808|NCT01044498|Norinyl|norinyl|mesh-list
19896809|NCT01044498|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19896810|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19896811|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19896812|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19896813|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
19896814|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19896815|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896816|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19896817|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19896818|NCT01044498|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19896819|NCT01044498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19896820|NCT01044693|Metoprolol|metoprolol|mesh-list
19896821|NCT01044693|Nebivolol|nebivolol|mesh-list
19896822|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
19896823|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19896824|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19896825|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19896826|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896827|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896828|NCT01044693|Urological Agents|urological agents|mesh-ancestor
19896829|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19896830|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19896831|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
19896832|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
19896833|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896834|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896835|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19896836|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19896837|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19896838|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
19896839|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896840|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19896841|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19896842|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19896843|NCT01044706|Bicalutamide|bicalutamide|mesh-list
19896844|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
19896845|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
19896846|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896847|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896848|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896849|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
19896850|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
19896851|NCT01044745|Busulfan|busulfan|mesh-list
19896852|NCT01044745|Rituximab|rituximab|mesh-list
19896853|NCT01044745|Fludarabine|fludarabine|mesh-list
19896854|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
19896855|NCT01044745|Tacrolimus|tacrolimus|mesh-list
19896856|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
19896857|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19896858|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19896859|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
19896860|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896861|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896862|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19896863|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
19896864|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896865|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896866|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19896867|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19896868|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19896869|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
19896870|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19896871|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896872|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19896873|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19896874|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
19896875|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19896876|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896877|NCT01044758|Levetiracetam|levetiracetam|mesh-list
19896878|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
19896879|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
19896880|NCT01044771|Tenofovir|tenofovir|mesh-list
19896881|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
19896882|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
19896883|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896884|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19896885|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19896886|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896887|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896888|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19896889|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19896890|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19896891|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19896892|NCT01044862|Letrozole|letrozole|mesh-list
19896893|NCT01044862|Clomiphene|clomiphene|mesh-list
19896894|NCT01044862|Enclomiphene|enclomiphene|mesh-list
19896895|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
19896896|NCT01044862|Hormones|hormones|mesh-list
19896897|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19896898|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19896899|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896900|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19896901|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896902|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896903|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19896904|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896905|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19896906|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
19896907|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19896908|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
19896909|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19896910|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19896911|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19896912|NCT01044966|Temozolomide|temozolomide|mesh-list
19896913|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19896914|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
19896915|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896916|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896917|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
19896918|NCT01045096|Lansoprazole|lansoprazole|mesh-list
19896919|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19896920|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896921|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19896922|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896923|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896924|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
19896925|NCT01045122|Propofol|propofol|mesh-list
19896926|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19896927|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19896928|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896929|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19896930|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
19896931|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
19896932|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896933|NCT01045122|Analgesics|analgesics|mesh-ancestor
19896934|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
19896935|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896936|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19896937|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19896938|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19896939|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
19896940|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19896941|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896942|NCT01045161|Bromides|bromides|mesh-list
19896943|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
19896944|NCT01045447|Insulin|insulin|mesh-list
19896945|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19896946|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
19896947|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
19896948|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19896949|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896950|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
19896951|NCT01045460|Melphalan|melphalan|mesh-list
19896952|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19896953|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
19896954|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896955|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896956|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19896957|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
19896958|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896959|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19896960|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19896961|NCT01045551|Apremilast|apremilast|mesh-list
19896962|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19896963|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19896964|NCT01045551|Analgesics|analgesics|mesh-ancestor
19896965|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
19896966|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896967|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896968|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19896969|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19896970|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19896971|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19896972|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896973|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896974|NCT01045707|Insulin|insulin|mesh-list
19896975|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19896976|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
19896977|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
19896978|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19896979|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896980|NCT01045798|Caspofungin|caspofungin|mesh-list
19896981|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
19896982|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19896983|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896984|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896985|NCT01045967|Lansoprazole|lansoprazole|mesh-list
19896986|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
19896987|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19896988|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19896989|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19896990|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19896991|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19896992|NCT01045993|Analgesics|analgesics|mesh-list
19896993|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
19896994|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19896995|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19896996|NCT01046084|Lansoprazole|lansoprazole|mesh-list
19896997|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
19896998|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19896999|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897000|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19897001|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897002|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971113|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
19971114|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971115|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
19971116|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259268|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259269|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
20259270|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
20259271|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259272|NCT00486785|Alfuzosin|alfuzosin|mesh-list
20259273|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20259274|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20259275|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20259276|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259277|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259278|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259279|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259280|NCT00486785|Urological Agents|urological agents|mesh-ancestor
20259281|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20259282|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259283|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259284|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20259285|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20259286|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259287|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259288|NCT00486876|Tofisopam|tofisopam|mesh-list
20259289|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259290|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259291|NCT00486980|Peramivir|peramivir|mesh-list
20259292|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
20259293|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259294|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259295|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259296|NCT00487032|Fluticasone|fluticasone|mesh-list
20259297|NCT00487032|Xhance|xhance|mesh-list
20259298|NCT00487032|Prazosin|prazosin|mesh-list
20259299|NCT00487032|Phenylephrine|phenylephrine|mesh-list
20259300|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
20259301|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259302|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20259303|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
20259304|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259305|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259306|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20259307|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
20259308|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
20259309|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20259310|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20259311|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20259312|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259313|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259314|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259315|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
20259316|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
20259317|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20259318|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20259319|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
20259320|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20259321|NCT00487032|Protective Agents|protective agents|mesh-ancestor
19897003|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19897004|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19897005|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897006|NCT01046110|Incretins|incretins|mesh-ancestor
19897007|NCT01046110|Hormones|hormones|mesh-ancestor
19897008|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897009|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19897010|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
19897011|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897012|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897013|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
19897014|NCT01046136|Guaifenesin|guaifenesin|mesh-list
19897015|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19897016|NCT01046136|Expectorants|expectorants|mesh-ancestor
19897017|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
19897018|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19897019|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19897020|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
19897021|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897022|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897023|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897024|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
19897025|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19897026|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
19897027|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
19897028|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897029|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
19897030|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19897031|NCT01046253|Lansoprazole|lansoprazole|mesh-list
19897032|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
19897033|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19897034|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897035|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19897036|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897037|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897038|NCT01046396|Adapalene|adapalene|mesh-list
19897039|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897040|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897041|NCT01046396|Analgesics|analgesics|mesh-ancestor
19897042|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
19897043|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897044|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897045|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897046|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897047|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
19897048|NCT01046565|Adapalene|adapalene|mesh-list
19897049|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897050|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897051|NCT01046565|Analgesics|analgesics|mesh-ancestor
19897052|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
19897053|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897054|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897055|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897056|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897057|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
19897058|NCT01046643|Estradiol|estradiol|mesh-list
19897059|NCT01046643|Progesterone|progesterone|mesh-list
19897060|NCT01046643|Estrogens|estrogens|mesh-ancestor
19897061|NCT01046643|Hormones|hormones|mesh-ancestor
19897062|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897063|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897064|NCT01046643|Progestins|progestins|mesh-ancestor
19897065|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19897066|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897067|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897068|NCT01046682|Analgesics|analgesics|mesh-ancestor
19897069|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
19897070|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897071|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897072|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897073|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897074|NCT01046903|Dalteparin|dalteparin|mesh-list
19897075|NCT01046903|Tinzaparin|tinzaparin|mesh-list
19897076|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19897077|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
19897078|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19897079|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19897080|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897081|NCT01047007|Cisplatin|cisplatin|mesh-list
19897082|NCT01047007|Adavosertib|adavosertib|mesh-list
19897083|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897084|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897085|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897086|NCT01047189|Clindamycin|clindamycin|mesh-list
19897087|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
19897088|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
19897089|NCT01047189|Tretinoin|tretinoin|mesh-list
19897090|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19897091|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897092|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19897093|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897094|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897095|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897096|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
19897097|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
19897098|NCT01047241|Sufentanil|sufentanil|mesh-list
19897099|NCT01047241|Ketamine|ketamine|mesh-list
19897100|NCT01047241|Analgesics|analgesics|mesh-ancestor
19897101|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
19897102|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897103|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897104|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19897105|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19897106|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
19897107|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
19897108|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897109|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19897110|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19897111|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897112|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897113|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19897114|NCT01047241|Narcotics|narcotics|mesh-ancestor
19897115|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19897116|NCT01047293|Leucovorin|leucovorin|mesh-list
19897117|NCT01047293|Bevacizumab|bevacizumab|mesh-list
19897118|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
19897119|NCT01047293|Everolimus|everolimus|mesh-list
19897120|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19897121|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897122|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19897123|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19897124|NCT01047293|Growth Substances|growth substances|mesh-ancestor
19897125|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897126|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
19897127|NCT01047293|Antidotes|antidotes|mesh-ancestor
19897128|NCT01047293|Protective Agents|protective agents|mesh-ancestor
19897129|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
19897130|NCT01047293|Vitamins|vitamins|mesh-ancestor
19897131|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
19897132|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897133|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
19897134|NCT01047358|Exemestane|exemestane|mesh-list
19897135|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897136|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19897137|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19897138|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897139|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897140|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19897141|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
19897142|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897143|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897144|NCT01047436|Artemether|artemether|mesh-list
19897145|NCT01047436|Quinine|quinine|mesh-list
19897146|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
19897147|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19897148|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19897149|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897150|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19897151|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897152|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19897153|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897154|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897155|NCT01047436|Analgesics|analgesics|mesh-ancestor
19897156|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
19897157|NCT01047527|Nicotine|nicotine|mesh-list
19897158|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19897159|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
19897160|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897161|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897162|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19897163|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19897164|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
19897165|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897166|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897167|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
19897168|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19897169|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
19897170|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897171|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897172|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19897173|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
19897174|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19897175|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19897176|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19897177|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
19897178|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897179|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897180|NCT01048099|Trastuzumab|trastuzumab|mesh-list
19897181|NCT01048099|Pertuzumab|pertuzumab|mesh-list
19897182|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19897183|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897184|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
19897185|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19897186|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19897187|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
19897188|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897189|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897190|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19897191|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
19897192|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19897193|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19897194|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19897195|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
19897196|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897197|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897198|NCT01048502|Fenofibrate|fenofibrate|mesh-list
19897199|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19897200|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
19897201|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897202|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19897203|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
19897204|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19897205|NCT01048606|Estrogens|estrogens|mesh-ancestor
19897206|NCT01048606|Hormones|hormones|mesh-ancestor
19897207|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897208|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897209|NCT01048658|Sevoflurane|sevoflurane|mesh-list
19897210|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19897211|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19897212|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
19897213|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
19897214|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897215|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897216|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
19897217|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19897218|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19897219|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
19897220|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897221|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19897222|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19897223|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897224|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897225|NCT01048697|Ethambutol|ethambutol|mesh-list
19897226|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
19897227|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19897228|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897229|NCT01048788|Tolvaptan|tolvaptan|mesh-list
19897230|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19897231|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897232|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
19897233|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897234|NCT01048866|Acetaminophen|acetaminophen|mesh-list
19897235|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
19897236|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897237|NCT01048866|Analgesics|analgesics|mesh-ancestor
19897238|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
19897239|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897240|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897241|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
19897242|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897243|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897244|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897245|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19897246|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897247|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897248|NCT01048879|Oseltamivir|oseltamivir|mesh-list
19897249|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
19897250|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19897251|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
19897252|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897253|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897254|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897255|NCT01048944|Bupropion|bupropion|mesh-list
19897256|NCT01048944|Nicotine|nicotine|mesh-list
19897257|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19897258|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
19897259|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897260|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897261|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19897262|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19897263|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
19897264|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897265|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259322|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20259323|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20259324|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20259325|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20259326|NCT00487110|Acetaminophen|acetaminophen|mesh-list
20259327|NCT00487110|Tropisetron|tropisetron|mesh-list
19897266|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19897267|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259328|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897268|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897269|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19897270|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19897271|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897272|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
19897273|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19897274|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19897275|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897276|NCT01049009|Metoprolol|metoprolol|mesh-list
19897277|NCT01049009|Nebivolol|nebivolol|mesh-list
19897278|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19897279|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19897280|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
19897281|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
19897282|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897283|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897284|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19897285|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19897286|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19897287|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
19897288|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897289|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897290|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
19897291|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19897292|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19897293|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19897294|NCT01049217|Pregabalin|pregabalin|mesh-list
19897295|NCT01049217|Analgesics|analgesics|mesh-ancestor
19897296|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
19897297|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897298|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897299|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
19897300|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19897301|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897302|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897303|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19897304|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19897305|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19897306|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897307|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897308|NCT01049243|Fluocinonide|fluocinonide|mesh-list
19897309|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897310|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
19897311|NCT01049243|Hormones|hormones|mesh-ancestor
19897312|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897313|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897314|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19897315|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
19897316|NCT01049334|Analgesics|analgesics|mesh-ancestor
19897317|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
19897318|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897319|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897320|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897321|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897322|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897323|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897324|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19897325|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897326|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897327|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
19897328|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19897329|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
19897330|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897331|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897332|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20259329|NCT00487110|Analgesics|analgesics|mesh-ancestor
20259330|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
20259331|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259332|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259333|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
20259334|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
20259335|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
20259336|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286887|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
19897333|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
19897334|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19897335|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19897336|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19897337|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
19897338|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897339|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897340|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
19897341|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19897342|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897343|NCT01049503|Fluorides|fluorides|mesh-list
19897344|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
19897345|NCT01049503|Protective Agents|protective agents|mesh-ancestor
19897346|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897347|NCT01049945|Dexamethasone|dexamethasone|mesh-list
19897348|NCT01049945|Lenalidomide|lenalidomide|mesh-list
19897349|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19897350|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897351|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
19897352|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
19897353|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897354|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897355|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897356|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
19897357|NCT01049945|Hormones|hormones|mesh-ancestor
19897358|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897359|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19897360|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897361|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
19897362|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19897363|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19897364|NCT01049945|Growth Substances|growth substances|mesh-ancestor
19897365|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
19897366|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19897367|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
19897368|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897369|NCT01049984|Rasagiline|rasagiline|mesh-list
19897370|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19897371|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897372|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897373|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19897374|NCT01049984|Protective Agents|protective agents|mesh-ancestor
19897375|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897376|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19897377|NCT01050062|Telmisartan|telmisartan|mesh-list
19897378|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19897379|NCT01050062|Diuretics|diuretics|mesh-ancestor
19897380|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
19897381|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897382|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19897383|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897384|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897385|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19897386|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19897387|NCT01050153|Aspirin|aspirin|mesh-list
19897388|NCT01050153|Dalteparin|dalteparin|mesh-list
19897389|NCT01050153|Tinzaparin|tinzaparin|mesh-list
19897390|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19897391|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897392|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897393|NCT01050153|Analgesics|analgesics|mesh-ancestor
20538695|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538696|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20538697|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20538698|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
20538699|NCT01841008|Tacrolimus|tacrolimus|mesh-list
19897394|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
19897395|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897396|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897397|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897398|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20538700|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538701|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
19897399|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19897400|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19897401|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897402|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19897403|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19897404|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897405|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
19897406|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
19897407|NCT01050257|Oseltamivir|oseltamivir|mesh-list
19897408|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
19897409|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897410|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897411|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897412|NCT01050530|Tolvaptan|tolvaptan|mesh-list
19897413|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19897414|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897415|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
19897416|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897417|NCT01050543|Neostigmine|neostigmine|mesh-list
19897418|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19897419|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897420|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897421|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
19897422|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897423|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897424|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19897425|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
19897426|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897427|NCT01050569|Nicotine|nicotine|mesh-list
19897428|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19897429|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
19897430|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897431|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897432|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19897433|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19897434|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
19897435|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897436|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897437|NCT01050582|Risperidone|risperidone|mesh-list
19897438|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
19897439|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19897440|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
19897441|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897442|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897443|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897444|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19897445|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897446|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897447|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19897448|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
19897449|NCT01050634|Exemestane|exemestane|mesh-list
19897450|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897451|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19897452|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19897453|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897454|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897455|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19897456|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
19897457|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897458|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897459|NCT01050647|Castor Oil|castor oil|mesh-list
19897460|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19897461|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19897462|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19897463|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
19897464|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897465|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897466|NCT01050647|Progestins|progestins|mesh-ancestor
19897467|NCT01050647|Hormones|hormones|mesh-ancestor
19897468|NCT01050647|Cathartics|cathartics|mesh-ancestor
19897469|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897470|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19897471|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19897472|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19897473|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19897474|NCT01050764|Vidarabine|vidarabine|mesh-list
19897475|NCT01050764|Fludarabine|fludarabine|mesh-list
19897476|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
19897477|NCT01050764|Melphalan|melphalan|mesh-list
19897478|NCT01050764|Thiotepa|thiotepa|mesh-list
19897479|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
19897480|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19897481|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897482|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19897483|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
19897484|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897485|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897486|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
19897487|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897488|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
19897489|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897490|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19897491|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
19897492|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19897493|NCT01050790|Lenalidomide|lenalidomide|mesh-list
19897494|NCT01050790|Azacitidine|azacitidine|mesh-list
19897495|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
19897496|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897497|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19897498|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19897499|NCT01050790|Growth Substances|growth substances|mesh-ancestor
19897500|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
19897501|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897502|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19897503|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
19897504|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897505|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897506|NCT01050907|Miltefosine|miltefosine|mesh-list
19897507|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
19897508|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897509|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897510|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19897511|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19897512|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
19897513|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19897514|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897515|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
19897516|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897517|NCT01051349|Daclizumab|daclizumab|mesh-list
19897518|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897519|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
19897520|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897521|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19897522|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19897523|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897524|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19897525|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19897526|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897527|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897528|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
19897529|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897530|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19897531|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19897532|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19897533|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897534|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897535|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897536|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897537|NCT01051466|Analgesics|analgesics|mesh-ancestor
19897538|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
19897539|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897540|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
19897541|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897542|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
19897543|NCT01051557|Sirolimus|sirolimus|mesh-list
19897544|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19897545|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897546|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19897547|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897548|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
19897549|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897550|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
19897551|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897552|NCT01051570|Prednisone|prednisone|mesh-list
19897553|NCT01051570|Carboplatin|carboplatin|mesh-list
19897554|NCT01051570|Everolimus|everolimus|mesh-list
19897555|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897556|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897557|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
19897558|NCT01051570|Hormones|hormones|mesh-ancestor
19897559|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897560|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897561|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19897562|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897563|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
19897564|NCT01051596|Temozolomide|temozolomide|mesh-list
19897565|NCT01051596|Veliparib|veliparib|mesh-list
19897566|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19897567|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
19897568|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897569|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897570|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19897571|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897572|NCT01051661|Vaccines|vaccines|mesh-list
19897573|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
19897574|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897575|NCT01051778|Aspirin|aspirin|mesh-list
19897576|NCT01051778|Heparin|heparin|mesh-list
19897577|NCT01051778|Enoxaparin|enoxaparin|mesh-list
19897578|NCT01051778|Calcium heparin|calcium heparin|mesh-list
19897579|NCT01051778|Calcium|calcium|mesh-list
19897580|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19897581|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897582|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897583|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897584|NCT01051778|Analgesics|analgesics|mesh-ancestor
19897585|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
19897586|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897587|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897588|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897589|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19897590|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19897591|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897592|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19897593|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19897594|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897595|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
19897596|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
19897597|NCT01051791|Everolimus|everolimus|mesh-list
19897598|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897599|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897600|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
19897601|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897602|NCT01051960|Ambrisentan|ambrisentan|mesh-list
19897603|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19897604|NCT01052012|Bupivacaine|bupivacaine|mesh-list
19897605|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
19897606|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
19897607|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897608|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897609|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
19897610|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897611|NCT01052038|Dexamethasone|dexamethasone|mesh-list
19897612|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
19897613|NCT01052038|BB 1101|bb 1101|mesh-list
19897614|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897615|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
19897616|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
19897617|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897618|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897619|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897620|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
19897621|NCT01052038|Hormones|hormones|mesh-ancestor
19897622|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897623|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19897624|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897625|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
19897626|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897627|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897628|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
19897629|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897630|NCT01052103|Olanzapine|olanzapine|mesh-list
19897631|NCT01052103|Antiemetics|antiemetics|mesh-ancestor
19897632|NCT01052103|Autonomic Agents|autonomic agents|mesh-ancestor
19897633|NCT01052103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897634|NCT01052103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897635|NCT01052103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897636|NCT01052103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19897637|NCT01052103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19897638|NCT01052103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897639|NCT01052103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897640|NCT01052103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19897641|NCT01052103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19897642|NCT01052103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897643|NCT01052103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897644|NCT01052103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897645|NCT01052103|Serotonin Agents|serotonin agents|mesh-ancestor
19897646|NCT01052272|Allopurinol|allopurinol|mesh-list
19897647|NCT01052272|Candesartan|candesartan|mesh-list
19897648|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
19897649|NCT01052272|Ramipril|ramipril|mesh-list
19897650|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19897651|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19897652|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19897653|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259337|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20259338|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20259339|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
20259340|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259341|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259342|NCT00487123|Valsartan|valsartan|mesh-list
20259343|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20259344|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20259345|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20259346|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20259347|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259348|NCT00487123|Diuretics|diuretics|mesh-ancestor
20259349|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
20259350|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259351|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20259352|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259353|NCT00487136|Warfarin|warfarin|mesh-list
20259354|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20259355|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
20259356|NCT00487136|Fenofibrate|fenofibrate|mesh-list
20538702|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538703|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20538704|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538705|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538706|NCT01841099|Mesalamine|mesalamine|mesh-list
19897654|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19897655|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
19897656|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897657|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
19897658|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
19897659|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897660|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19897661|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
20538707|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20538708|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20538709|NCT01841099|Analgesics|analgesics|mesh-ancestor
20538710|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
20538711|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538712|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538713|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538714|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20538715|NCT01841112|BI 409306|bi 409306|mesh-list
19897662|NCT01052272|Protective Agents|protective agents|mesh-ancestor
19897663|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971117|NCT01792115|Protective Agents|protective agents|mesh-ancestor
19971118|NCT01792284|Insulin|insulin|mesh-list
19971119|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19971120|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
19971121|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19971122|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971123|NCT01792518|Linagliptin|linagliptin|mesh-list
19971124|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19971125|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971126|NCT01792518|Incretins|incretins|mesh-ancestor
19971127|NCT01792518|Hormones|hormones|mesh-ancestor
19971128|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971129|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19971130|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
19971131|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971132|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971133|NCT01792830|Metformin|metformin|mesh-list
19971134|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
19971135|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19971136|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971137|NCT01793051|Minocycline|minocycline|mesh-list
19971138|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971139|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971140|NCT01793285|Etanercept|etanercept|mesh-list
19971141|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19971142|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19971143|NCT01793285|Analgesics|analgesics|mesh-ancestor
19971144|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
19971145|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971146|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971147|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971148|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971149|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971150|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971151|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
19971152|NCT01793688|Ampicillin|ampicillin|mesh-list
19971153|NCT01793688|Sulbactam|sulbactam|mesh-list
19971154|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971155|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971156|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19971157|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971158|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971159|NCT01793883|Laninamivir|laninamivir|mesh-list
19971160|NCT01793883|Zanamivir|zanamivir|mesh-list
19971161|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
19971162|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971163|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971164|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971165|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19971166|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19971167|NCT01794039|Dexamethasone|dexamethasone|mesh-list
19971168|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
19971169|NCT01794039|Lenalidomide|lenalidomide|mesh-list
19971170|NCT01794039|Pomalidomide|pomalidomide|mesh-list
19971171|NCT01794039|Ichthammol|ichthammol|mesh-list
19971172|NCT01794039|BB 1101|bb 1101|mesh-list
19971173|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971174|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
19971175|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
19971176|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971177|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971178|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971179|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
19971180|NCT01794039|Hormones|hormones|mesh-ancestor
19971181|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971182|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19971183|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971184|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
19971185|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19971186|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19971187|NCT01794039|Growth Substances|growth substances|mesh-ancestor
19971188|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
19971189|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
19971190|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538716|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19971191|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897664|NCT01052428|Metoprolol|metoprolol|mesh-list
19897665|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19897666|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19897667|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
19897668|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
19897669|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897670|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897671|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19897672|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19897673|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19897674|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
19897675|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897676|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897677|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
19897678|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897679|NCT01052493|Hormones|hormones|mesh-ancestor
19897680|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897681|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897682|NCT01052662|Memantine|memantine|mesh-list
19897683|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19897684|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19897685|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
19897686|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897687|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897688|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897689|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19897690|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19897691|NCT01052701|Ribavirin|ribavirin|mesh-list
19897692|NCT01052701|Abacavir|abacavir|mesh-list
19897693|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
19897694|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897695|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
19897696|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897697|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19897698|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19897699|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897700|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19897701|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19897702|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19897703|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19897704|NCT01052779|Hematinics|hematinics|mesh-ancestor
19897705|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19897706|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19897707|NCT01052831|Naltrexone|naltrexone|mesh-list
19897708|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19897709|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19897710|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538717|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538718|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538719|NCT01841125|Citalopram|citalopram|mesh-list
20538720|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20538721|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20538722|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538723|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897711|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
19897712|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897713|NCT01052844|Gabapentin|gabapentin|mesh-list
19897714|NCT01052844|Analgesics|analgesics|mesh-ancestor
19897715|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
19897716|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897717|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897718|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
19897719|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19897720|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19897721|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897722|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897723|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19897724|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19897725|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897726|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897727|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
19897728|NCT01053000|Tazarotene|tazarotene|mesh-list
19897729|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
19897730|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
19897731|NCT01053078|Naltrexone|naltrexone|mesh-list
19897732|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19897733|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19897734|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897735|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
19897736|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897737|NCT01053156|Minocycline|minocycline|mesh-list
19897738|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19897739|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897740|NCT01053247|Tacrolimus|tacrolimus|mesh-list
19897741|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897742|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
19897743|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897744|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19897745|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897746|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897747|NCT01053312|Flutemetamol|flutemetamol|mesh-list
19897748|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19897749|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897750|NCT01053429|Ziprasidone|ziprasidone|mesh-list
19897751|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19897752|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
19897753|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897754|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897755|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897756|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19897757|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19897758|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897759|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19897760|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19897761|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
19897762|NCT01053507|Naproxen|naproxen|mesh-list
19897763|NCT01053507|Sumatriptan|sumatriptan|mesh-list
19897764|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897765|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897766|NCT01053507|Analgesics|analgesics|mesh-ancestor
19897767|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
19897768|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897769|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897770|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897771|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897772|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
19897773|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19897774|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897775|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897776|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19897777|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19897778|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19897779|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
19897780|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897781|NCT01053663|Oseltamivir|oseltamivir|mesh-list
19897782|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
19897783|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897784|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897785|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897786|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
19897787|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19897788|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19897789|NCT01053819|Etanercept|etanercept|mesh-list
19897790|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897791|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897792|NCT01053819|Analgesics|analgesics|mesh-ancestor
19897793|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
19897794|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897795|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897796|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897797|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897798|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897799|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897800|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
19897801|NCT01053962|Plecanatide|plecanatide|mesh-list
19897802|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19897803|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
19897804|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897805|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897806|NCT01054079|Cinacalcet|cinacalcet|mesh-list
19897807|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19897808|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897809|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19897810|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
19897811|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897812|NCT01054144|Dexamethasone|dexamethasone|mesh-list
19897813|NCT01054144|Prednisone|prednisone|mesh-list
19897814|NCT01054144|Lenalidomide|lenalidomide|mesh-list
19897815|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897816|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
19897817|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
19897818|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897819|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897820|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19897821|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
19897822|NCT01054144|Hormones|hormones|mesh-ancestor
19897823|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897824|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19897825|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897826|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
19897827|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19897828|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19897829|NCT01054144|Growth Substances|growth substances|mesh-ancestor
19897830|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
19897831|NCT01054222|Fesoterodine|fesoterodine|mesh-list
19897832|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19897833|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19897834|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
19897835|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897836|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897837|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897838|NCT01054222|Urological Agents|urological agents|mesh-ancestor
19897839|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
19897840|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19897841|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897842|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19897843|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897844|NCT01054404|Furosemide|furosemide|mesh-list
19897845|NCT01054404|Diuretics|diuretics|mesh-ancestor
19897846|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
19897847|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897848|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19897849|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897850|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897851|NCT01054573|Interferons|interferons|mesh-list
19897852|NCT01054573|Ribavirin|ribavirin|mesh-list
19897853|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897854|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
19897855|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897856|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
19897857|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897858|NCT01054599|Memantine|memantine|mesh-list
19897859|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19897860|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19897861|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
19897862|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897863|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897864|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897865|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19897866|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19897867|NCT01054625|Zalutumumab|zalutumumab|mesh-list
19897868|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19897869|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897870|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
19897871|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
19897872|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897873|NCT01054742|Ribavirin|ribavirin|mesh-list
19897874|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19897875|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
19897876|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897877|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
19897878|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19897879|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
19897880|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
19897881|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
19897882|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897883|NCT01054768|Protective Agents|protective agents|mesh-ancestor
19897884|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897885|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
19897886|NCT01054768|Vitamins|vitamins|mesh-ancestor
19897887|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
19897888|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
19897889|NCT01054820|Diclofenac|diclofenac|mesh-list
19897890|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
19897891|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19897892|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19897893|NCT01054820|Analgesics|analgesics|mesh-ancestor
19897894|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
19897895|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897896|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897897|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19897898|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259357|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20259358|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19897899|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19897900|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897901|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897902|NCT01054911|Sunitinib|sunitinib|mesh-list
19897903|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897904|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19897905|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19897906|NCT01054911|Growth Substances|growth substances|mesh-ancestor
19897907|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897908|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
19897909|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19897910|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897911|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897912|NCT01054976|Galantamine|galantamine|mesh-list
19897913|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19897914|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897915|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897916|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
19897917|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897918|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897919|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19897920|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
19897921|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19897922|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
19897923|NCT01055028|Paclitaxel|paclitaxel|mesh-list
19897924|NCT01055028|Bevacizumab|bevacizumab|mesh-list
19897925|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19897926|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897927|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
19897928|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
19897929|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
19897930|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897931|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19897932|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19897933|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19897934|NCT01055028|Growth Substances|growth substances|mesh-ancestor
19897935|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897936|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
19897937|NCT01055171|Propranolol|propranolol|mesh-list
19897938|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19897939|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19897940|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259359|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
20259360|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259361|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20259362|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20259363|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259364|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
20259365|NCT00487175|Tramadol|tramadol|mesh-list
20259366|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20259367|NCT00487175|Narcotics|narcotics|mesh-ancestor
20259368|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19897941|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19897942|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897943|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897944|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19897945|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19897946|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
19897947|NCT01055184|Vaccines|vaccines|mesh-list
19897948|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
19897949|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897950|NCT01055223|Troglitazone|troglitazone|mesh-list
19897951|NCT01055223|Amiloride|amiloride|mesh-list
19897952|NCT01055223|Spironolactone|spironolactone|mesh-list
19897953|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19897954|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
19897955|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19897956|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897957|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19897958|NCT01055223|Diuretics|diuretics|mesh-ancestor
19897959|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
19897960|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19897961|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19897962|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19897963|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897964|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19897965|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19897966|NCT01055314|Dactinomycin|dactinomycin|mesh-list
19897967|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
19897968|NCT01055314|Temozolomide|temozolomide|mesh-list
19897969|NCT01055314|Ifosfamide|ifosfamide|mesh-list
19897970|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
19897971|NCT01055314|Doxorubicin|doxorubicin|mesh-list
19897972|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19897973|NCT01055314|Irinotecan|irinotecan|mesh-list
19897974|NCT01055314|Etoposide|etoposide|mesh-list
19897975|NCT01055314|Vincristine|vincristine|mesh-list
19897976|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
19897977|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
19897978|NCT01055314|Camptothecin|camptothecin|mesh-list
19897979|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19897980|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19897981|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
19897982|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19897983|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19897984|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19897985|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
19897986|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19897987|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19897988|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19897989|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19897990|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19897991|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19897992|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19897993|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19897994|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19897995|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
19897996|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
19897997|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
19897998|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
19897999|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898000|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898001|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898002|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19898003|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19898004|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19898005|NCT01055496|Gemcitabine|gemcitabine|mesh-list
19898006|NCT01055496|Dexamethasone|dexamethasone|mesh-list
19898007|NCT01055496|Prednisone|prednisone|mesh-list
19898008|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
19898009|NCT01055496|Rituximab|rituximab|mesh-list
20259369|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259370|NCT00487175|Analgesics|analgesics|mesh-ancestor
20538724|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898010|NCT01055496|Vincristine|vincristine|mesh-list
19898011|NCT01055496|Cisplatin|cisplatin|mesh-list
19898012|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19898013|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898014|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
20538725|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
20538726|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538727|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20538728|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
20538729|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20538730|NCT01841164|Montelukast|montelukast|mesh-list
20538731|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20538732|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538733|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20538734|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
20538735|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20538736|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538737|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20538738|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20538739|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538740|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
20538741|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
20538742|NCT01841242|Povidone|povidone|mesh-list
20538743|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20538744|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538745|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
20538746|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
20538747|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
20538748|NCT01841294|Lidocaine|lidocaine|mesh-list
20538749|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538750|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
20538751|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538752|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538753|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
20538754|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538755|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20538756|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19898015|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898016|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898017|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19898018|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
19898019|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898020|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898021|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19898022|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898023|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898024|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
19898025|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
19898026|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898027|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898028|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
19898029|NCT01055496|Hormones|hormones|mesh-ancestor
19898030|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898031|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19898032|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19898033|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
19898034|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
19898035|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898036|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898037|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19898038|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
19898039|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
19898040|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
19898041|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19898042|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19898043|NCT01055704|Naltrexone|naltrexone|mesh-list
19898044|NCT01055704|Codeine|codeine|mesh-list
19898045|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
19898046|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19898047|NCT01055704|Narcotics|narcotics|mesh-ancestor
19898048|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898049|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898050|NCT01055704|Analgesics|analgesics|mesh-ancestor
19898051|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
19898052|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898053|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
19898054|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
19898055|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19898056|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19898057|NCT01055769|Linezolid|linezolid|mesh-list
19898058|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898059|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898060|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19898061|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898062|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898063|NCT01055834|Eszopiclone|eszopiclone|mesh-list
19898064|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19898065|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898066|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898067|NCT01055886|Nicotine|nicotine|mesh-list
19898068|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19898069|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
19898070|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898071|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898072|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19898073|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19898074|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
19898075|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898076|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898077|NCT01056107|Glucagon|glucagon|mesh-list
19898078|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19898079|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898080|NCT01056107|Hormones|hormones|mesh-ancestor
19898081|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898082|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898083|NCT01056107|Incretins|incretins|mesh-ancestor
19898084|NCT01056263|Axitinib|axitinib|mesh-list
19898085|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898086|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19898087|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898088|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898089|NCT01056276|Dexamethasone|dexamethasone|mesh-list
19898090|NCT01056276|Bortezomib|bortezomib|mesh-list
19898091|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19898092|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898093|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
19898094|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
19898095|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898096|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898097|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898098|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
19898099|NCT01056276|Hormones|hormones|mesh-ancestor
19898100|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898101|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19898102|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898103|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19898104|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
19898105|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898106|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19898107|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19898108|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19898109|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19898110|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259371|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
20538757|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20538758|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538759|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538760|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
20538761|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
20538762|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
19449704|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449705|NCT03433092|Protective Agents|protective agents|mesh-ancestor
19449706|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449707|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
19449708|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
20259372|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259373|NCT00487227|Caffeine|caffeine|mesh-list
20259374|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20259375|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259376|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20259377|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898111|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898112|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898113|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
19898114|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19898115|NCT01056341|Propranolol|propranolol|mesh-list
19898116|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19898117|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19898118|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898119|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898120|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898121|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898122|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19898123|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19898124|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
19898125|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
19898126|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19898127|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898128|NCT01056510|Rituximab|rituximab|mesh-list
19898129|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19898130|NCT01056510|Chlorambucil|chlorambucil|mesh-list
19898131|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898132|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898133|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
19898134|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898135|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20538763|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538764|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20538765|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20538766|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538767|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20538768|NCT01841320|Methadone|methadone|mesh-list
20538769|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19898136|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19898137|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
19898138|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898139|NCT01056523|Cytarabine|cytarabine|mesh-list
19898140|NCT01056523|Ribavirin|ribavirin|mesh-list
19898141|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19898142|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
19898143|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898144|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898145|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
19898146|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898147|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898148|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
19898149|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898150|NCT01056601|Bortezomib|bortezomib|mesh-list
19898151|NCT01056601|Panobinostat|panobinostat|mesh-list
19898152|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898153|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19898154|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898155|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898156|NCT01056718|Nebivolol|nebivolol|mesh-list
19898157|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19898158|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
20538770|NCT01841320|Narcotics|narcotics|mesh-ancestor
20538771|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898159|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19898160|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19898161|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19898162|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898163|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898164|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898165|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898166|NCT01057017|Panitumumab|panitumumab|mesh-list
19898167|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898168|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898169|NCT01057225|Thalidomide|thalidomide|mesh-list
19898170|NCT01057225|Dexamethasone|dexamethasone|mesh-list
19898171|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
19898172|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898173|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
19898174|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898175|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971192|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898176|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19898177|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
19898178|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898179|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898180|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19898181|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898182|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
19898183|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
19898184|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898185|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898186|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
19898187|NCT01057225|Hormones|hormones|mesh-ancestor
19898188|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898189|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19898190|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
19898191|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898192|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898193|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19898194|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19898195|NCT01057225|Growth Substances|growth substances|mesh-ancestor
19898196|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
19898197|NCT01057251|Nebivolol|nebivolol|mesh-list
19898198|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19898199|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
19898200|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19898201|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19898202|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19898203|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898204|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898205|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898206|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898207|NCT01057277|Everolimus|everolimus|mesh-list
19898208|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538772|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538773|NCT01841320|Analgesics|analgesics|mesh-ancestor
20538774|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
20538775|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538776|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
20538777|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538778|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
20538779|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538780|NCT01841411|Metronidazole|metronidazole|mesh-list
20538781|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
20538782|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20538783|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538784|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898209|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898210|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
19898211|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898212|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
19898213|NCT01057381|Morphine|morphine|mesh-list
19898214|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19898215|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898216|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898217|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19898218|NCT01057381|Analgesics|analgesics|mesh-ancestor
19898219|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
19898220|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898221|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19898222|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19898223|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19898224|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898225|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259378|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538785|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19898226|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898227|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19898228|NCT01057381|Narcotics|narcotics|mesh-ancestor
19898229|NCT01057433|Ritonavir|ritonavir|mesh-list
19898230|NCT01057433|Lopinavir|lopinavir|mesh-list
19898231|NCT01057433|Pitavastatin|pitavastatin|mesh-list
19898232|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19898233|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19898234|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
20538786|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19898235|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898236|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898237|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19898238|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19898239|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
19898240|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898241|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19898242|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19898243|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19898244|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19898245|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19898246|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
19898247|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19898248|NCT01057589|Folic Acid|folic acid|mesh-list
19898249|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
19898250|NCT01057589|Hydroxocobalamin|hydroxocobalamin|mesh-list
19898251|NCT01057589|Pemetrexed|pemetrexed|mesh-list
19898252|NCT01057589|Cetuximab|cetuximab|mesh-list
19898253|NCT01057589|Vitamins|vitamins|mesh-ancestor
19898254|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
19898255|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898256|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898257|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898258|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898259|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19898260|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19898261|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898262|NCT01057589|Hematinics|hematinics|mesh-ancestor
19898263|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
19898264|NCT01057693|Pregabalin|pregabalin|mesh-list
19898265|NCT01057693|Analgesics|analgesics|mesh-ancestor
19898266|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
19898267|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898268|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898269|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
19898270|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19898271|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19898272|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898273|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19898274|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19898275|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19898276|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898277|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19898278|NCT01057810|Ipilimumab|ipilimumab|mesh-list
19898279|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898280|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898281|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19898282|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898283|NCT01057862|Naltrexone|naltrexone|mesh-list
19898284|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20538787|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
20538788|NCT01841411|Expectorants|expectorants|mesh-ancestor
20538789|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538790|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19898285|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19898286|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898287|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
19898288|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971193|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19971194|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971195|NCT01794455|Candesartan|candesartan|mesh-list
19971196|NCT01794455|Sertraline|sertraline|mesh-list
19971197|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
19971198|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19971199|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19971200|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19971201|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971202|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971203|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971204|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
19971205|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971206|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19971207|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20538791|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
19898289|NCT01058005|Interferons|interferons|mesh-list
19898290|NCT01058005|Interferon-beta|interferon-beta|mesh-list
19898291|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
19898292|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
19898293|NCT01058005|Natalizumab|natalizumab|mesh-list
19898294|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
19898295|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898296|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
19898297|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898298|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
19898299|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898300|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19898301|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898302|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898303|NCT01058096|Cariprazine|cariprazine|mesh-list
20538792|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538793|NCT01841411|Protective Agents|protective agents|mesh-ancestor
20538794|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538795|NCT01841411|Antidotes|antidotes|mesh-ancestor
20538796|NCT01841424|Benzocaine|benzocaine|mesh-list
19898304|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19898305|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19898306|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898307|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898308|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19898309|NCT01058239|Rituximab|rituximab|mesh-list
19898310|NCT01058239|Bortezomib|bortezomib|mesh-list
19898311|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898312|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898313|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
19898314|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898315|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898316|NCT01058395|Minocycline|minocycline|mesh-list
19898317|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898318|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898319|NCT01058655|Everolimus|everolimus|mesh-list
19898320|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898321|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898322|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
19898323|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898324|NCT01058668|Cariprazine|cariprazine|mesh-list
19898325|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19898326|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19898327|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898328|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898329|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19898330|NCT01058863|Albuterol|albuterol|mesh-list
19898331|NCT01058863|Procaterol|procaterol|mesh-list
19898332|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19898333|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
19898334|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538797|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538798|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
20538799|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538800|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538801|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
20259379|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20259380|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20259381|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
20259382|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259383|NCT00487253|Miltefosine|miltefosine|mesh-list
19898335|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898336|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19898337|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
19898338|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
20538802|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538803|NCT01841463|Vemurafenib|vemurafenib|mesh-list
20538804|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538805|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20538806|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538807|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538808|NCT01841502|Paroxetine|paroxetine|mesh-list
20538809|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20538810|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20538811|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538812|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538813|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538814|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
20538815|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538816|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20538817|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
20538818|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20538819|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20538820|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20538821|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538822|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20538823|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
20538824|NCT01841515|Coagulants|coagulants|mesh-ancestor
20538825|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20538826|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
20538827|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538828|NCT01841658|Folic Acid|folic acid|mesh-list
20538829|NCT01841658|Hematinics|hematinics|mesh-ancestor
20538830|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
20538831|NCT01841658|Vitamins|vitamins|mesh-ancestor
20538832|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
20538833|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538834|NCT01841684|Anacetrapib|anacetrapib|mesh-list
20538835|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20538836|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20538837|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
20538838|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538839|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20538840|NCT01841775|Interferons|interferons|mesh-list
20538841|NCT01841775|Ribavirin|ribavirin|mesh-list
20538842|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538843|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
20538844|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538845|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
20538846|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898339|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19898340|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19898341|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19898342|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19898343|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898344|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898345|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898346|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
19898347|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
19898348|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
19898349|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898350|NCT01058941|Protective Agents|protective agents|mesh-ancestor
20538847|NCT01841827|Cilostazol|cilostazol|mesh-list
20538848|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20538849|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
20538850|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538851|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898351|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898352|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
19898353|NCT01058941|Vitamins|vitamins|mesh-ancestor
19898354|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
19898355|NCT01058993|Plerixafor|plerixafor|mesh-list
19898356|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19898357|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19898358|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
19898359|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898360|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19898361|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898362|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19898363|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898364|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538852|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20538853|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538854|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20538855|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20538856|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538857|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20538858|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
20538859|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20538860|NCT01841827|Protective Agents|protective agents|mesh-ancestor
20538861|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20538862|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19898365|NCT01059318|Everolimus|everolimus|mesh-list
19898366|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898367|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898368|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
19898369|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898370|NCT01059526|Ecallantide|ecallantide|mesh-list
19898371|NCT01059526|Analgesics|analgesics|mesh-ancestor
19898372|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
19898373|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898374|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898375|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19898376|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19898377|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898378|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898379|NCT01059539|Cariprazine|cariprazine|mesh-list
19898380|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19898381|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19898382|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898383|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898384|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19898385|NCT01059617|Vaccines|vaccines|mesh-list
19898386|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
19898387|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898388|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19898389|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
19898390|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19898391|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
19898392|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898393|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898394|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898395|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
19898396|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19898397|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19898398|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
19898399|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538863|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538864|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20538865|NCT01842074|Bortezomib|bortezomib|mesh-list
20538866|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538867|NCT01842087|Iproplatin|iproplatin|mesh-list
20538868|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538869|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20538870|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538871|NCT01842113|Rifaximin|rifaximin|mesh-list
20538872|NCT01842113|Lactulose|lactulose|mesh-list
20538873|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20538874|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538875|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898400|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20538876|NCT01842139|Poly I-C|poly i-c|mesh-list
20538877|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20538878|NCT01842139|Poly ICLC|poly iclc|mesh-list
20538879|NCT01842139|Basiliximab|basiliximab|mesh-list
20538880|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
20538881|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
20538882|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538883|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538884|NCT01842139|Laxatives|laxatives|mesh-ancestor
19898401|NCT01059773|Methotrexate|methotrexate|mesh-list
19898402|NCT01059773|Ustekinumab|ustekinumab|mesh-list
19898403|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19898404|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
19898405|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19898406|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898407|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19898408|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
19898409|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898410|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898411|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898412|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898413|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19898414|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898415|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
19898416|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898417|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19898418|NCT01059799|Insulin|insulin|mesh-list
19898419|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19898420|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
19898421|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898422|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898423|NCT01059812|Insulin|insulin|mesh-list
19898424|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20538885|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20538886|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
19898425|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
19898426|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
19898427|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19898428|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
19898429|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19898430|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898431|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898432|NCT01059825|Metformin|metformin|mesh-list
19898433|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20538887|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553900|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553901|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553902|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
20553903|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553904|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553905|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553906|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898434|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
19898435|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898436|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898437|NCT01059825|Incretins|incretins|mesh-ancestor
19898438|NCT01059825|Hormones|hormones|mesh-ancestor
19898439|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898440|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19898441|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
19898442|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898443|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898444|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19898445|NCT01059851|Suvorexant|suvorexant|mesh-list
19898446|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19898447|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19898448|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898449|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898450|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19898451|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898452|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898453|NCT01059864|Atorvastatin|atorvastatin|mesh-list
19898454|NCT01059864|Tofacitinib|tofacitinib|mesh-list
19898455|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19898456|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19898457|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
19898458|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898459|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19898460|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19898461|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898462|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19898463|NCT01059903|Rotigotine|rotigotine|mesh-list
19898464|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
19898465|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
19898466|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898467|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898468|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553907|NCT01932203|Aspirin|aspirin|mesh-list
20553908|NCT01932203|Cilostazol|cilostazol|mesh-list
20553909|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20553910|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20553911|NCT01932203|Analgesics|analgesics|mesh-ancestor
20553912|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
20553913|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553914|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553915|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20553916|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553917|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20553918|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20553919|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553920|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20553921|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20553922|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553923|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
19898469|NCT01059929|Fentanyl|fentanyl|mesh-list
19898470|NCT01059929|Midazolam|midazolam|mesh-list
19898471|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
19898472|NCT01059929|Propofol|propofol|mesh-list
19898473|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19898474|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898475|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553924|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19898476|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19898477|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
19898478|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
19898479|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19898480|NCT01059929|Analgesics|analgesics|mesh-ancestor
19898481|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
19898482|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898483|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20538888|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20538889|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20538890|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538891|NCT01842230|Niacin|niacin|mesh-list
20538892|NCT01842230|Amlodipine|amlodipine|mesh-list
20538893|NCT01842230|Telmisartan|telmisartan|mesh-list
20538894|NCT01842230|Atorvastatin|atorvastatin|mesh-list
20538895|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20538896|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20538897|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
19898484|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19898485|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19898486|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898487|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898488|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898489|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19898490|NCT01059929|Narcotics|narcotics|mesh-ancestor
19898491|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19898492|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19898493|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19898494|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19898495|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
19898496|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
19898497|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
19898498|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
19898499|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19898500|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19898501|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898502|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898503|NCT01059994|Urological Agents|urological agents|mesh-ancestor
20538898|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538899|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20538900|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19898504|NCT01060007|Leucovorin|leucovorin|mesh-list
19898505|NCT01060007|Fluorouracil|fluorouracil|mesh-list
19898506|NCT01060007|Capecitabine|capecitabine|mesh-list
19898507|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
19898508|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
19898509|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898510|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19898511|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898512|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898513|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
19898514|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898515|NCT01060007|Antidotes|antidotes|mesh-ancestor
19898516|NCT01060007|Protective Agents|protective agents|mesh-ancestor
19898517|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
19898518|NCT01060007|Vitamins|vitamins|mesh-ancestor
19898519|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
19898520|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
19898521|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
19898522|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19898523|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19898524|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898525|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898526|NCT01060020|Urological Agents|urological agents|mesh-ancestor
19898527|NCT01060059|Exenatide|exenatide|mesh-list
19898528|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898529|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898530|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19898531|NCT01060059|Incretins|incretins|mesh-ancestor
19898532|NCT01060059|Hormones|hormones|mesh-ancestor
19898533|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898534|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19898535|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19898536|NCT01060098|Adalimumab|adalimumab|mesh-list
20538901|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898537|NCT01060098|Etanercept|etanercept|mesh-list
19898538|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20553925|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
19898539|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898540|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19898541|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19898542|NCT01060098|Analgesics|analgesics|mesh-ancestor
19898543|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
19898544|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898545|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898546|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898547|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898548|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
19898549|NCT01060111|Topiramate|topiramate|mesh-list
19898550|NCT01060111|Propranolol|propranolol|mesh-list
19898551|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19898552|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19898553|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898554|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898555|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898556|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898557|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19898558|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19898559|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
19898560|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
19898561|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898562|NCT01060124|Fentanyl|fentanyl|mesh-list
19898563|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19898564|NCT01060124|Narcotics|narcotics|mesh-ancestor
19898565|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898566|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538902|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20538903|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20538904|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538905|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20538906|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538907|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
19732266|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732267|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
20538908|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20538909|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20538910|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
20538911|NCT01842230|Vitamins|vitamins|mesh-ancestor
20538912|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
20538913|NCT01842256|Amlodipine|amlodipine|mesh-list
20538914|NCT01842256|Telmisartan|telmisartan|mesh-list
20538915|NCT01842256|Atorvastatin|atorvastatin|mesh-list
20538916|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20538917|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20538918|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
20538919|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538920|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19732268|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732269|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19732270|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
19732271|NCT04575675|Valsartan|valsartan|mesh-list
19732272|NCT04575675|Carvedilol|carvedilol|mesh-list
19732273|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19732274|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19732275|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
19732276|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19732277|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19732278|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19732279|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19732280|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732281|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19732282|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19732283|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732284|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19732285|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
19732286|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732287|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
19732288|NCT04575675|Protective Agents|protective agents|mesh-ancestor
19732289|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19732290|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732291|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20538921|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20538922|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538923|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20538924|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20538925|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538926|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20538927|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538928|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
20538929|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20538930|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20538931|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
20538932|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20538933|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898567|NCT01060124|Analgesics|analgesics|mesh-ancestor
19898568|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
19898569|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898570|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19898571|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19898572|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
19898573|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
19898574|NCT01060150|Methylphenidate|methylphenidate|mesh-list
19898575|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19898576|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898577|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19898578|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19898579|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19898580|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898581|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
19898582|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898583|NCT01060384|Lenalidomide|lenalidomide|mesh-list
19898584|NCT01060384|Ofatumumab|ofatumumab|mesh-list
19898585|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
19898586|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898587|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19898588|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19898589|NCT01060384|Growth Substances|growth substances|mesh-ancestor
19898590|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
19898591|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898592|NCT01061034|Aspirin|aspirin|mesh-list
19898593|NCT01061034|Omeprazole|omeprazole|mesh-list
19898594|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19898595|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19898596|NCT01061034|Analgesics|analgesics|mesh-ancestor
19898597|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
19898598|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898599|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898600|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898601|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898602|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19898603|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19898604|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898605|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19898606|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19898607|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898608|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
19898609|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19898610|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898611|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19898612|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
19898613|NCT01061333|Nedocromil|nedocromil|mesh-list
19898614|NCT01061333|Montelukast|montelukast|mesh-list
19898615|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19898616|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
19898617|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19898618|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
19898619|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898620|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898621|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19898622|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19898623|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898624|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898625|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898626|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19898627|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19898628|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
19898629|NCT01061359|Epirubicin|epirubicin|mesh-list
19898630|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19898631|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898632|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19898633|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19898634|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898635|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898636|NCT01061528|Nicotine|nicotine|mesh-list
19898637|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19898638|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
19898639|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898640|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898641|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19898642|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19898643|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
19898644|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898645|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898646|NCT01061606|Sirolimus|sirolimus|mesh-list
19898647|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898648|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898649|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20538934|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20538935|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
20538936|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20538937|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538938|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538939|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898650|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898651|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
19898652|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898653|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
19898654|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898655|NCT01061671|Simvastatin|simvastatin|mesh-list
19898656|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19898657|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19898658|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
19898659|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898660|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19898661|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19898662|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898663|NCT01061710|Varenicline|varenicline|mesh-list
19898664|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19898665|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19898666|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
19898667|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898668|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898669|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898670|NCT01061736|Folic Acid|folic acid|mesh-list
19898671|NCT01061736|Methotrexate|methotrexate|mesh-list
19898672|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19898673|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
19898674|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19898675|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898676|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19898677|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
19898678|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898679|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898680|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898681|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898682|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19898683|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898684|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
20538940|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
20538941|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538942|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20538943|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538944|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538945|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553926|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19898685|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259384|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20538946|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20538947|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538948|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19898686|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19898687|NCT01061736|Hematinics|hematinics|mesh-ancestor
19898688|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
19898689|NCT01061736|Vitamins|vitamins|mesh-ancestor
19898690|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
19898691|NCT01061775|Exenatide|exenatide|mesh-list
19898692|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898693|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898694|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19898695|NCT01061775|Incretins|incretins|mesh-ancestor
19898696|NCT01061775|Hormones|hormones|mesh-ancestor
19898697|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898698|NCT01061866|Thalidomide|thalidomide|mesh-list
19898699|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898700|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
19898701|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898702|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
19898703|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898704|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898705|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19898706|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19898707|NCT01061866|Growth Substances|growth substances|mesh-ancestor
19898708|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
19898709|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898710|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
19898711|NCT01062009|Astringents|astringents|mesh-ancestor
19898712|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898713|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898714|NCT01062113|Celecoxib|celecoxib|mesh-list
19898715|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19898716|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19898717|NCT01062113|Analgesics|analgesics|mesh-ancestor
19898718|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
19898719|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898720|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898721|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898722|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898723|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19898724|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19898725|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898726|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898727|NCT01062165|Caspofungin|caspofungin|mesh-list
19898728|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
19898729|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898730|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898731|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898732|NCT01062230|Bortezomib|bortezomib|mesh-list
19898733|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898734|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
19898735|NCT01062256|Guaifenesin|guaifenesin|mesh-list
19898736|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19898737|NCT01062256|Expectorants|expectorants|mesh-ancestor
20538949|NCT01842373|Lidocaine|lidocaine|mesh-list
20538950|NCT01842373|Tetracaine|tetracaine|mesh-list
20538951|NCT01842373|Benzocaine|benzocaine|mesh-list
20538952|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
20538953|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
20538954|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538955|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538956|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
20538957|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538958|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20538959|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20538960|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20538961|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538962|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538963|NCT01842516|Delpazolid|delpazolid|mesh-list
20538964|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
20538965|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20538966|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20538967|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19898738|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
20538968|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538969|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538970|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
20538971|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20538972|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20538973|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538974|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
20538975|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20538976|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538977|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
20538978|NCT01842672|Clofarabine|clofarabine|mesh-list
20538979|NCT01842672|Analgesics|analgesics|mesh-ancestor
20538980|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
20538981|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538982|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538983|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20538984|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20538985|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20538986|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20538987|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20538988|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20538989|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
20538990|NCT01842893|Fentanyl|fentanyl|mesh-list
20538991|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19898739|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19898740|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19898741|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898742|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898743|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898744|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898745|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
19898746|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19898747|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
19898748|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
19898749|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898750|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
19898751|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19898752|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
19898753|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19898754|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19898755|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
19898756|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898757|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19898758|NCT01062399|Everolimus|everolimus|mesh-list
19898759|NCT01062399|Temozolomide|temozolomide|mesh-list
19898760|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898761|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20538992|NCT01842893|Narcotics|narcotics|mesh-ancestor
20538993|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20538994|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20538995|NCT01842893|Analgesics|analgesics|mesh-ancestor
20538996|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
20538997|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20538998|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20538999|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20539000|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
20539001|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
20539002|NCT01842932|Bromides|bromides|mesh-list
20539003|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20539004|NCT01842932|Cimetropium|cimetropium|mesh-list
20539005|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
20539006|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
20539007|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539008|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539009|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539010|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
20539011|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
20539012|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539013|NCT01843010|Parecoxib|parecoxib|mesh-list
20539014|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20539015|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20539016|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539017|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539018|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19898762|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
19898763|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898764|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19898765|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
19898766|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898767|NCT01062555|Cyclosporine|cyclosporine|mesh-list
19898768|NCT01062555|Sirolimus|sirolimus|mesh-list
19898769|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
19898770|NCT01062555|Tacrolimus|tacrolimus|mesh-list
19898771|NCT01062555|Cyclosporins|cyclosporins|mesh-list
19898772|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898773|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
19898774|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898775|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19898776|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898777|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898778|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
19898779|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259385|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
20259386|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898780|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898781|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898782|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19898783|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898784|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19898785|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
19898786|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19898787|NCT01062568|Dexamethasone|dexamethasone|mesh-list
19898788|NCT01062568|Cosyntropin|cosyntropin|mesh-list
19898789|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19898790|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19898791|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
19898792|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19898793|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
19898794|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
19898795|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898796|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898797|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898798|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
19898799|NCT01062568|Hormones|hormones|mesh-ancestor
19898800|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898801|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19898802|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898803|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898804|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898805|NCT01062763|Spironolactone|spironolactone|mesh-list
19898806|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19898807|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
19898808|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19898809|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898810|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19898811|NCT01062763|Diuretics|diuretics|mesh-ancestor
19898812|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
19898813|NCT01062971|Timolol|timolol|mesh-list
19898814|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19898815|NCT01062971|Dorzolamide|dorzolamide|mesh-list
19898816|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19898817|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19898818|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898819|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539019|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20539020|NCT01843010|Analgesics|analgesics|mesh-ancestor
20539021|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
20539022|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539023|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539024|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539025|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539026|NCT01843075|Liraglutide|liraglutide|mesh-list
20539027|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898820|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898821|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898822|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19898823|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20259387|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898824|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19898825|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19898826|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19898827|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19898828|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898829|NCT01063036|Tenofovir|tenofovir|mesh-list
19898830|NCT01063036|Entecavir|entecavir|mesh-list
19898831|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
19898832|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898833|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20539028|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539029|NCT01843075|Incretins|incretins|mesh-ancestor
20539030|NCT01843075|Hormones|hormones|mesh-ancestor
20539031|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539032|NCT01843088|Mannitol|mannitol|mesh-list
20539033|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20539034|NCT01843088|Diuretics|diuretics|mesh-ancestor
20539035|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
20539036|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539037|NCT01843127|Exenatide|exenatide|mesh-list
20539038|NCT01843127|Ranolazine|ranolazine|mesh-list
20539039|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20539040|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898834|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19898835|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898836|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898837|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19898838|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19898839|NCT01063049|Bisacodyl|bisacodyl|mesh-list
19898840|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19898841|NCT01063049|Cathartics|cathartics|mesh-ancestor
19898842|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19898843|NCT01063049|Laxatives|laxatives|mesh-ancestor
19898844|NCT01063062|Methotrexate|methotrexate|mesh-list
19898845|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19898846|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
19898847|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19898848|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898849|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19898850|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
19898851|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539041|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20539042|NCT01843127|Incretins|incretins|mesh-ancestor
20539043|NCT01843127|Hormones|hormones|mesh-ancestor
20539044|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539045|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19898852|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898853|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
19898854|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898855|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19898856|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898857|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
19898858|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19898859|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19898860|NCT01063075|Carboplatin|carboplatin|mesh-list
19898861|NCT01063075|Cetuximab|cetuximab|mesh-list
19898862|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898863|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898864|NCT01063153|Methylphenidate|methylphenidate|mesh-list
19898865|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19898866|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898867|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19898868|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19898869|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19898870|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898871|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
19898872|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898873|NCT01063283|Bevacizumab|bevacizumab|mesh-list
19898874|NCT01063283|Carboplatin|carboplatin|mesh-list
19898875|NCT01063283|Pemetrexed|pemetrexed|mesh-list
19898876|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19898877|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898878|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19898879|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19898880|NCT01063283|Growth Substances|growth substances|mesh-ancestor
19898881|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898882|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19898883|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898884|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898885|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19898886|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19898887|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
19898888|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19898889|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
19898890|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898891|NCT01063348|Expectorants|expectorants|mesh-ancestor
19898892|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
19898893|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19898894|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
19898895|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898896|NCT01063348|Protective Agents|protective agents|mesh-ancestor
19898897|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898898|NCT01063348|Antidotes|antidotes|mesh-ancestor
19898899|NCT01063764|Levetiracetam|levetiracetam|mesh-list
20539046|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20539047|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539048|NCT01843153|Ropivacaine|ropivacaine|mesh-list
20539049|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
20539050|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
20539051|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539052|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539053|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
20539054|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539055|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20539056|NCT01843166|Estrogens|estrogens|mesh-ancestor
19898900|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
19898901|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
19898902|NCT01063829|Letermovir|letermovir|mesh-list
19898903|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19898904|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898905|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898906|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898907|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
19898908|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898909|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19898910|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19898911|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898912|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898913|NCT01063868|Oxycodone|oxycodone|mesh-list
19898914|NCT01063868|Tapentadol|tapentadol|mesh-list
19898915|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19898916|NCT01063868|Narcotics|narcotics|mesh-ancestor
19898917|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898918|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539057|NCT01843166|Hormones|hormones|mesh-ancestor
20539058|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539059|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539060|NCT01843179|Cytarabine|cytarabine|mesh-list
20539061|NCT01843179|Sulindac|sulindac|mesh-list
20539062|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539063|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
20539064|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539065|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898919|NCT01063868|Analgesics|analgesics|mesh-ancestor
19898920|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
19898921|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19898922|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19898923|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19898924|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19898925|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898926|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
19898927|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971208|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19971209|NCT01794689|Morphine|morphine|mesh-list
19971210|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19971211|NCT01794689|Narcotics|narcotics|mesh-ancestor
19971212|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259388|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19898928|NCT01063907|Bortezomib|bortezomib|mesh-list
19898929|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898930|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
19898931|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19898932|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19898933|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898934|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
19898935|NCT01064167|Coagulants|coagulants|mesh-ancestor
19898936|NCT01064284|Factor VIII|factor viii|mesh-list
19898937|NCT01064284|Coagulants|coagulants|mesh-ancestor
19898938|NCT01064297|Lamotrigine|lamotrigine|mesh-list
19898939|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
19898940|NCT01064297|Valproic Acid|valproic acid|mesh-list
19898941|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19898942|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19898943|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898944|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19898945|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898946|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19898947|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19898948|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19898949|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19898950|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19898951|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898952|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
19898953|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19898954|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
19898955|NCT01064310|Sunitinib|sunitinib|mesh-list
19898956|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19898957|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19898958|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19898959|NCT01064310|Growth Substances|growth substances|mesh-ancestor
19898960|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898961|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
19898962|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19898963|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898964|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898965|NCT01064362|Heparin|heparin|mesh-list
19898966|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19898967|NCT01064362|Tinzaparin|tinzaparin|mesh-list
19898968|NCT01064362|Dalteparin|dalteparin|mesh-list
19898969|NCT01064362|PENTA|penta|mesh-list
19898970|NCT01064362|Fondaparinux|fondaparinux|mesh-list
19898971|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
19898972|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19898973|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19898974|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898975|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19898976|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
19898977|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19898978|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
19898979|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19898980|NCT01064401|Interferons|interferons|mesh-list
19898981|NCT01064401|Interferon-beta|interferon-beta|mesh-list
19898982|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
19898983|NCT01064401|Daclizumab|daclizumab|mesh-list
19898984|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539066|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
20539067|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539068|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539069|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
19898985|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
19898986|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19898987|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
19898988|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898989|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19898990|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19898991|NCT01064414|Canagliflozin|canagliflozin|mesh-list
19898992|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19898993|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19898994|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19898995|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898996|NCT01064622|Gemcitabine|gemcitabine|mesh-list
20539070|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19898997|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
19898998|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19898999|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
19971213|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899000|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899001|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899002|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
19899003|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899004|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899005|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19899006|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
19899007|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899008|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899009|NCT01064687|Metformin|metformin|mesh-list
19899010|NCT01064687|Pioglitazone|pioglitazone|mesh-list
19899011|NCT01064687|Exenatide|exenatide|mesh-list
19899012|NCT01064687|Dulaglutide|dulaglutide|mesh-list
19899013|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899014|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899015|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19899016|NCT01064687|Incretins|incretins|mesh-ancestor
19899017|NCT01064687|Hormones|hormones|mesh-ancestor
19899018|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899019|NCT01064830|Cyclosporine|cyclosporine|mesh-list
20539071|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20539072|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20539073|NCT01843179|Analgesics|analgesics|mesh-ancestor
20539074|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
19899020|NCT01064830|Cyclosporins|cyclosporins|mesh-list
19899021|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899022|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899023|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19899024|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
19899025|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899026|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
19899027|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899028|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
19899029|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539075|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899030|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19899031|NCT01064856|Adalimumab|adalimumab|mesh-list
19899032|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899033|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899034|NCT01064882|Bimatoprost|bimatoprost|mesh-list
19899035|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19899036|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19899037|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19899038|NCT01064947|Retapamulin|retapamulin|mesh-list
19899039|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19899040|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899041|NCT01065350|Ketamine|ketamine|mesh-list
19899042|NCT01065350|Propofol|propofol|mesh-list
19899043|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19899044|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899045|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539076|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539077|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539078|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20539079|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539080|NCT01843257|Ethanol|ethanol|mesh-list
20539081|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20539082|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539083|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539084|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539085|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
20539086|NCT01843296|Fentanyl|fentanyl|mesh-list
20539087|NCT01843296|Bupivacaine|bupivacaine|mesh-list
20539088|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
19449709|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
19449710|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449711|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899046|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20539089|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
20539090|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539091|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539092|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
19899047|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
19449712|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
19899048|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
19899049|NCT01065350|Analgesics|analgesics|mesh-ancestor
19899050|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
20539093|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539094|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20539095|NCT01843296|Narcotics|narcotics|mesh-ancestor
20539096|NCT01843296|Analgesics|analgesics|mesh-ancestor
20539097|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20539098|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20539099|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
20539100|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20539101|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
20539102|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20539103|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19899051|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899052|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19899053|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19899054|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19899055|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899056|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899057|NCT01065506|Nicotine|nicotine|mesh-list
19899058|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19899059|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
19899060|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899061|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899062|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19899063|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19899064|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
19899065|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899066|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899067|NCT01065558|Ecopipam|ecopipam|mesh-list
19899068|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19899069|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19899070|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899071|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899072|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19899073|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19899074|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
19899075|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899076|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899077|NCT01065766|Metformin|metformin|mesh-list
19899078|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19899079|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899080|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899081|NCT01065766|Incretins|incretins|mesh-ancestor
19899082|NCT01065766|Hormones|hormones|mesh-ancestor
19899083|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899084|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19899085|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
19899086|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899087|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899088|NCT01065844|Nelfinavir|nelfinavir|mesh-list
19899089|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19899090|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19899091|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
19899092|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899093|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899094|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19899095|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19899096|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
19899097|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899098|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
19899099|NCT01066000|Hematinics|hematinics|mesh-ancestor
19899100|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
19899101|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19899102|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
20539104|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539105|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19899103|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899104|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
19899105|NCT01066026|Protective Agents|protective agents|mesh-ancestor
19899106|NCT01066039|Bisoprolol|bisoprolol|mesh-list
19899107|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19899108|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
19899109|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
19899110|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899111|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539106|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
19899112|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19899113|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19899114|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19899115|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899116|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899117|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899118|NCT01066104|Omalizumab|omalizumab|mesh-list
19899119|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19899120|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19899121|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19899122|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
19899123|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
19899124|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899125|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19899126|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
19899127|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19899128|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19899129|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19899130|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899131|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899132|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19899133|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
19899134|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19899135|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19899136|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19899137|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899138|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899139|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19899140|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19899141|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19899142|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
19899143|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899144|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19899145|NCT01066520|Diclofenac|diclofenac|mesh-list
19899146|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19899147|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19899148|NCT01066520|Analgesics|analgesics|mesh-ancestor
19899149|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
19899150|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899151|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899152|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899153|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899154|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19899155|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899156|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899157|NCT01066585|Ivermectin|ivermectin|mesh-list
19899158|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19899159|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899160|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19899161|NCT01066624|Calcium|calcium|mesh-list
19899162|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19899163|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899164|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19899165|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19899166|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
19899167|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899168|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19899169|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19899170|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
19899171|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899172|NCT01066897|Pramipexole|pramipexole|mesh-list
19899173|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
19899174|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899175|NCT01066897|Protective Agents|protective agents|mesh-ancestor
19899176|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899177|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19899178|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19899179|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
19899180|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
19899181|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899182|NCT01066923|Aspirin|aspirin|mesh-list
19899183|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19899184|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19899185|NCT01066923|Analgesics|analgesics|mesh-ancestor
19899186|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
19899187|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899188|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899189|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899190|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899191|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19899192|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19899193|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899194|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19899195|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19899196|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899197|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
19899198|NCT01067105|Ciclesonide|ciclesonide|mesh-list
19899199|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
19899200|NCT01067105|Hormones|hormones|mesh-ancestor
19899201|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899202|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899203|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19899204|NCT01067339|Darapladib|darapladib|mesh-list
19899205|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
19899206|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899207|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899208|NCT01067352|Hormones|hormones|mesh-list
19899209|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899210|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899211|NCT01067469|Bevacizumab|bevacizumab|mesh-list
19899212|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19899213|NCT01067469|Lomustine|lomustine|mesh-list
19899214|NCT01067469|Antibodies|antibodies|mesh-list
19899215|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
20539107|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20539108|NCT01843309|Spironolactone|spironolactone|mesh-list
20539109|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20539110|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
20539111|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539112|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539113|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20539114|NCT01843309|Diuretics|diuretics|mesh-ancestor
20539115|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
20539116|NCT01843439|Pyridoxine|pyridoxine|mesh-list
20539117|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
20539118|NCT01843439|Vitamins|vitamins|mesh-ancestor
20539119|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
20539120|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899216|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19899217|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899218|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20539121|NCT01843452|Capecitabine|capecitabine|mesh-list
20539122|NCT01843452|Mitomycins|mitomycins|mesh-list
20539123|NCT01843452|Mitomycin|mitomycin|mesh-list
20539124|NCT01843452|Panitumumab|panitumumab|mesh-list
20539125|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539126|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
20539127|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539128|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539129|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20539130|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
20539131|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20539132|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539133|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20539134|NCT01843530|Cortisone|cortisone|mesh-list
20539135|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539136|NCT01843556|Donepezil|donepezil|mesh-list
20539137|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20539138|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539139|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539140|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
20539141|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539142|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539143|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
20539144|NCT01843647|Cisplatin|cisplatin|mesh-list
20539145|NCT01843647|Vinorelbine|vinorelbine|mesh-list
20539146|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539147|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19899219|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539148|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
20539149|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
19899220|NCT01067469|Growth Substances|growth substances|mesh-ancestor
19899221|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899222|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
19899223|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
19899224|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19899225|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
19899226|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899227|NCT01067846|Cycloserine|cycloserine|mesh-list
19899228|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19899229|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899230|NCT01067846|Renal Agents|renal agents|mesh-ancestor
19899231|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19899232|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
19899233|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19899234|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
19899235|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899236|NCT01068158|Ivermectin|ivermectin|mesh-list
19899237|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19899238|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899239|NCT01068418|Vitamin D|vitamin d|mesh-list
19899240|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
19899241|NCT01068418|Vitamins|vitamins|mesh-ancestor
19899242|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
19899243|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899244|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19899245|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19899246|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19899247|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19899248|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19899249|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
19899250|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899251|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19899252|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19899253|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899254|NCT01068652|Insulin|insulin|mesh-list
19899255|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19899256|NCT01068652|Metformin|metformin|mesh-list
19899257|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
19899258|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
19899259|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19899260|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
19899261|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
19899262|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20539150|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539151|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539152|NCT01843699|Topiramate|topiramate|mesh-list
20539153|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
20539154|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20539155|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539156|NCT01843725|Capecitabine|capecitabine|mesh-list
20539157|NCT01843725|Aflibercept|aflibercept|mesh-list
20539158|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539159|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
20539160|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539161|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899263|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899264|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899265|NCT01068665|Insulin|insulin|mesh-list
19899266|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19899267|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
19899268|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899269|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899270|NCT01068678|Insulin|insulin|mesh-list
19899271|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19899272|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
19899273|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899274|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899275|NCT01068717|Metformin|metformin|mesh-list
19899276|NCT01068717|Saxagliptin|saxagliptin|mesh-list
19899277|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899278|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899279|NCT01068717|Incretins|incretins|mesh-ancestor
20539162|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19899280|NCT01068717|Hormones|hormones|mesh-ancestor
19899281|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971214|NCT01794689|Analgesics|analgesics|mesh-ancestor
19899282|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19899283|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
19899284|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899285|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899286|NCT01068730|Metformin|metformin|mesh-list
19899287|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899288|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899289|NCT01068743|Metformin|metformin|mesh-list
19899290|NCT01068743|Saxagliptin|saxagliptin|mesh-list
19899291|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899292|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899293|NCT01068743|Incretins|incretins|mesh-ancestor
19899294|NCT01068743|Hormones|hormones|mesh-ancestor
19899295|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899296|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19899297|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
19899298|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899299|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899300|NCT01068860|Insulin|insulin|mesh-list
19899301|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19899302|NCT01068860|Metformin|metformin|mesh-list
19899303|NCT01068860|Glimepiride|glimepiride|mesh-list
19899304|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
19899305|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
19899306|NCT01068860|Glyburide|glyburide|mesh-list
19899307|NCT01068860|Glipizide|glipizide|mesh-list
19899308|NCT01068860|Troglitazone|troglitazone|mesh-list
19899309|NCT01068860|Tolbutamide|tolbutamide|mesh-list
19899310|NCT01068860|Acetohexamide|acetohexamide|mesh-list
19899311|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
19899312|NCT01068860|Tolazamide|tolazamide|mesh-list
19899313|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
19899314|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19899315|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899316|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899317|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19899318|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19899319|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
19899320|NCT01068873|Ritonavir|ritonavir|mesh-list
19899321|NCT01068873|Lopinavir|lopinavir|mesh-list
19899322|NCT01068873|Maraviroc|maraviroc|mesh-list
19899323|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19899324|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19899325|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
20259389|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20259390|NCT00487422|Prucalopride|prucalopride|mesh-list
20259391|NCT00487422|Laxatives|laxatives|mesh-ancestor
19899326|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899327|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899328|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19899329|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19899330|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
19899331|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899332|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19899333|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899334|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19899335|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19899336|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19899337|NCT01068912|Favipiravir|favipiravir|mesh-list
19899338|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
19899339|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899340|NCT01068964|Timolol|timolol|mesh-list
19899341|NCT01068964|Bimatoprost|bimatoprost|mesh-list
19899342|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19899343|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19899344|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19899345|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19899346|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899347|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899348|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899349|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899350|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19899351|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19899352|NCT01069172|Dipivefrin|dipivefrin|mesh-list
20259392|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899353|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19899354|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899355|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259393|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19899356|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899357|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899358|NCT01069289|Budesonide|budesonide|mesh-list
19899359|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
19899360|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19899361|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899362|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19899363|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
19899364|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899365|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899366|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19899367|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
19899368|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
19899369|NCT01069289|Hormones|hormones|mesh-ancestor
19899370|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899371|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19899372|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19899373|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19899374|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899375|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899376|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899377|NCT01069341|Ranibizumab|ranibizumab|mesh-list
19899378|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19899379|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19899380|NCT01069341|Growth Substances|growth substances|mesh-ancestor
19899381|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899382|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
19899383|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899384|NCT01069354|Lidocaine|lidocaine|mesh-list
19899385|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
19899386|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
19899387|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899388|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899389|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
19899390|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899391|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19899392|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20539163|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539164|NCT01843725|Growth Substances|growth substances|mesh-ancestor
20539165|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539166|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
20539167|NCT01843738|Vemurafenib|vemurafenib|mesh-list
20539168|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539169|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20539170|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539171|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539172|NCT01843829|Paclitaxel|paclitaxel|mesh-list
20539173|NCT01843829|Carboplatin|carboplatin|mesh-list
20539174|NCT01843829|Capecitabine|capecitabine|mesh-list
20539175|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
20539176|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539177|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899393|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19899394|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19899395|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539178|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
19899396|NCT01069510|Spironolactone|spironolactone|mesh-list
19899397|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19899398|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
19899399|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899400|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899401|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19899402|NCT01069510|Diuretics|diuretics|mesh-ancestor
19899403|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
19899404|NCT01069523|Guanfacine|guanfacine|mesh-list
19899405|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19899406|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19899407|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19899408|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19899409|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899410|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539179|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
19899411|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899412|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899413|NCT01069627|Bevacizumab|bevacizumab|mesh-list
19899414|NCT01069627|Fotemustine|fotemustine|mesh-list
19899415|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19899416|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899417|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19899418|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19899419|NCT01069627|Growth Substances|growth substances|mesh-ancestor
19899420|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899421|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
19899422|NCT01069705|Tobramycin|tobramycin|mesh-list
19899423|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19899424|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899425|NCT01069900|Amoxicillin|amoxicillin|mesh-list
19899426|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
19899427|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
19899428|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
19899429|NCT01069900|Ertapenem|ertapenem|mesh-list
19899430|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19899431|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19899432|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19899433|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899434|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19899435|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19899436|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899437|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899438|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899439|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19899440|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
19899441|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19899442|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899443|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19899444|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19899445|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19899446|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19899447|NCT01069939|Esomeprazole|esomeprazole|mesh-list
19899448|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19899449|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899450|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19899451|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899452|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899453|NCT01070043|Amlodipine|amlodipine|mesh-list
19899454|NCT01070043|Valsartan|valsartan|mesh-list
19899455|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19899456|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19899457|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19899458|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539180|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539181|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539182|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539183|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
20539184|NCT01843868|Prednisolone|prednisolone|mesh-list
19899459|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19899460|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899461|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
19899462|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19899463|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19971215|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
19971216|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971217|NCT01794702|Cytarabine|cytarabine|mesh-list
19971218|NCT01794702|Decitabine|decitabine|mesh-list
19971219|NCT01794702|Clofarabine|clofarabine|mesh-list
19971220|NCT01794702|Idarubicin|idarubicin|mesh-list
19449713|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539185|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
20539186|NCT01843868|Doxorubicin|doxorubicin|mesh-list
20539187|NCT01843868|Vincristine|vincristine|mesh-list
19971221|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19971222|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
19971223|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971224|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971225|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
19971226|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539188|NCT01843868|Lorazepam|lorazepam|mesh-list
20539189|NCT01843868|Ondansetron|ondansetron|mesh-list
20539190|NCT01843868|Aprepitant|aprepitant|mesh-list
20539191|NCT01843868|Palonosetron|palonosetron|mesh-list
20539192|NCT01843868|Metoclopramide|metoclopramide|mesh-list
20539193|NCT01843868|Granisetron|granisetron|mesh-list
20539194|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
20539195|NCT01843868|Tropisetron|tropisetron|mesh-list
20539196|NCT01843868|Antiemetics|antiemetics|mesh-list
19899464|NCT01070303|Adalimumab|adalimumab|mesh-list
19899465|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899466|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899467|NCT01070316|Everolimus|everolimus|mesh-list
19899468|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899469|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19899470|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
19899471|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899472|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19899473|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19899474|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19899475|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19899476|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899477|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899478|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899479|NCT01070329|Analgesics|analgesics|mesh-ancestor
19899480|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
19899481|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899482|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
19899483|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19899484|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
19899485|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19899486|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19899487|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899488|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19899489|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19899490|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19899491|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899492|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
19899493|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899494|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19899495|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
19899496|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899497|NCT01070784|Budesonide|budesonide|mesh-list
19899498|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
19899499|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19899500|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899501|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19899502|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
19899503|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899504|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899505|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19899506|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
19899507|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
19899508|NCT01070784|Hormones|hormones|mesh-ancestor
19899509|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899510|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19899511|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19899512|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19899513|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899514|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899515|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899516|NCT01070810|Thiamine|thiamine|mesh-list
19899517|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
19899518|NCT01070810|Vitamins|vitamins|mesh-ancestor
19899519|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
19899520|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899521|NCT01070888|Budesonide|budesonide|mesh-list
19899522|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
19899523|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899524|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19899525|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
19899526|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539197|NCT01843868|Emetics|emetics|mesh-list
20539198|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539199|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
20539200|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899527|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899528|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19899529|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
19899530|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
19899531|NCT01070888|Hormones|hormones|mesh-ancestor
19899532|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899533|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19899534|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19899535|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19899536|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899537|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899538|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899539|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19899540|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19899541|NCT01070979|Estradiol|estradiol|mesh-list
19899542|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19899543|NCT01070979|Estrogens|estrogens|mesh-list
19899544|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19899545|NCT01070979|Hormones|hormones|mesh-ancestor
19899546|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899547|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899548|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19899549|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
19899550|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19899551|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19899552|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19899553|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19899554|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899555|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19899556|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19899557|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19899558|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899559|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
19899560|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899561|NCT01071083|Interferons|interferons|mesh-list
19899562|NCT01071083|Interferon-beta|interferon-beta|mesh-list
19899563|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
19899564|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
19899565|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
19899566|NCT01071083|Natalizumab|natalizumab|mesh-list
19899567|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
19899568|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899569|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
19899570|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899571|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899572|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
19899573|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
19899574|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899575|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899576|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899577|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
19899578|NCT01071083|Hormones|hormones|mesh-ancestor
20539201|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539202|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20539203|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
20539204|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539205|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899579|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899580|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19899581|NCT01071083|Protective Agents|protective agents|mesh-ancestor
19899582|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
19899583|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19899584|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19899585|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899586|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
19899587|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19899588|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19899589|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19899590|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19899591|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899592|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
19899593|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899594|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899595|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19899596|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899597|NCT01071200|Hormones|hormones|mesh-list
20539206|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20539207|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20539208|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20539209|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20539210|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539211|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539212|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
20539213|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
20539214|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539215|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539216|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
20539217|NCT01843868|Hormones|hormones|mesh-ancestor
20539218|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539219|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20539220|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
20539221|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539222|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539223|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
20539224|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
20539225|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20539226|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
20539227|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899598|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19899599|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899600|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899601|NCT01071317|Naproxen|naproxen|mesh-list
19899602|NCT01071317|Sumatriptan|sumatriptan|mesh-list
19899603|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19899604|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19899605|NCT01071317|Analgesics|analgesics|mesh-ancestor
19899606|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
19899607|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899608|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899609|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899610|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899611|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
19899612|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19899613|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899614|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539228|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20539229|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20539230|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539231|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20539232|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20539233|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20539234|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20539235|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20539236|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20539237|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
20539238|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
20539239|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20539240|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
19449714|NCT03433001|Dexamethasone|dexamethasone|mesh-list
19449715|NCT03433001|Lenalidomide|lenalidomide|mesh-list
19899615|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19449716|NCT03433001|Ixazomib|ixazomib|mesh-list
19899616|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19899617|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19899618|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
19899619|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899620|NCT01071395|Amantadine|amantadine|mesh-list
19899621|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19899622|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19899623|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
19899624|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899625|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
19899626|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899627|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899628|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899629|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19899630|NCT01071395|Analgesics|analgesics|mesh-ancestor
19449717|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899631|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
19899632|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899633|NCT01071512|Natalizumab|natalizumab|mesh-list
19899634|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
19899635|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899636|NCT01071538|Buprenorphine|buprenorphine|mesh-list
19899637|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19899638|NCT01071538|Narcotics|narcotics|mesh-ancestor
19899639|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899640|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899641|NCT01071538|Analgesics|analgesics|mesh-ancestor
19899642|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
19899643|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899644|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19899645|NCT01071798|Rituximab|rituximab|mesh-list
19899646|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19899647|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899648|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
19899649|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899650|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899651|NCT01072136|Azithromycin|azithromycin|mesh-list
19899652|NCT01072136|Cefixime|cefixime|mesh-list
19899653|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19899654|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899655|NCT01072149|Fluticasone|fluticasone|mesh-list
19899656|NCT01072149|Xhance|xhance|mesh-list
19899657|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899658|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19899659|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
19899660|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899661|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899662|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19899663|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
19899664|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
19899665|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19899666|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
19899667|NCT01072188|Calcium|calcium|mesh-list
19899668|NCT01072188|Fluorides|fluorides|mesh-list
19899669|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19899670|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899671|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
19899672|NCT01072188|Protective Agents|protective agents|mesh-ancestor
19899673|NCT01072188|Antacids|antacids|mesh-ancestor
20539241|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
20539242|NCT01843998|Sirolimus|sirolimus|mesh-list
20539243|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539244|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539245|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19899674|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899675|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899676|NCT01072201|Triclosan|triclosan|mesh-list
19899677|NCT01072201|Fluorides|fluorides|mesh-list
19899678|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
19899679|NCT01072201|Protective Agents|protective agents|mesh-ancestor
19899680|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899681|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19899682|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899683|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19899684|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19899685|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
20539246|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899686|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899687|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20539247|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
20539248|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539249|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
20539250|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553927|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
20553928|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
20553929|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20539251|NCT01844024|Misoprostol|misoprostol|mesh-list
20539252|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19899688|NCT01072357|Bevacizumab|bevacizumab|mesh-list
19899689|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19899690|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20539253|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
20539254|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19899691|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899692|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19899693|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19899694|NCT01072357|Growth Substances|growth substances|mesh-ancestor
19899695|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899696|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
19899697|NCT01072357|Laxatives|laxatives|mesh-ancestor
19899698|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899699|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
19899700|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19899701|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
19899702|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899703|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899704|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19899705|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
19899706|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
19899707|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19899708|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
19899709|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899710|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899711|NCT01072539|Tigecycline|tigecycline|mesh-list
19899712|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19899713|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899714|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19899715|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899716|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899717|NCT01072630|Modafinil|modafinil|mesh-list
19899718|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19899719|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539255|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899720|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19899721|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19899722|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19899723|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899724|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
19899725|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19899726|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899727|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899728|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19899729|NCT01072643|Analgesics|analgesics|mesh-ancestor
19899730|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
19899731|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899732|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19899733|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19899734|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19899735|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899736|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899737|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899738|NCT01072669|Ambrisentan|ambrisentan|mesh-list
19899739|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19899740|NCT01072773|Dexamethasone|dexamethasone|mesh-list
20539256|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20539257|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539258|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
20539259|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
20539260|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899741|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
19899742|NCT01072773|Bortezomib|bortezomib|mesh-list
19899743|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19899744|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
19899745|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899746|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899747|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19899748|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
20539261|NCT01844141|Ethanol|ethanol|mesh-list
20539262|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
20539263|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19899749|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899750|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899751|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19899752|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19899753|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
20539264|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20539265|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539266|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539267|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539268|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
20539269|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
20539270|NCT01844323|Palbociclib|palbociclib|mesh-list
20539271|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539272|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20539273|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539274|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539275|NCT01844401|Albuterol|albuterol|mesh-list
20539276|NCT01844401|Procaterol|procaterol|mesh-list
19899754|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
19899755|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899756|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899757|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
19899758|NCT01072773|Hormones|hormones|mesh-ancestor
19899759|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899760|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19899761|NCT01072877|Polidocanol|polidocanol|mesh-list
19899762|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19899763|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19899764|NCT01072929|Modafinil|modafinil|mesh-list
19899765|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19899766|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539277|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20539278|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
20539279|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539280|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539281|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20539282|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
20539283|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
20539284|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20539285|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20539286|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20539287|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20539288|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
20539289|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539290|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539291|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
20539292|NCT01844427|Memantine|memantine|mesh-list
20259394|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20259395|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
20259396|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259397|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259398|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259399|NCT00487448|Cytarabine|cytarabine|mesh-list
20259400|NCT00487448|Fludarabine|fludarabine|mesh-list
20259401|NCT00487448|Idarubicin|idarubicin|mesh-list
20259402|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259403|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20259404|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
20259405|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259406|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259407|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
20259408|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899767|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19899768|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19899769|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19899770|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899771|NCT01073163|Rituximab|rituximab|mesh-list
19899772|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19899773|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19899774|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899775|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
20259409|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
20539293|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20539294|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19899776|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899777|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19899778|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19899779|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
19899780|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899781|NCT01073566|Insulin|insulin|mesh-list
19899782|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19899783|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899784|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899785|NCT01073618|Voriconazole|voriconazole|mesh-list
19899786|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
19899787|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899788|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19899789|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899790|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899791|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899792|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19899793|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
19899794|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899795|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899796|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19899797|NCT01073631|Voriconazole|voriconazole|mesh-list
19899798|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
19899799|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899800|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19899801|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899802|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899803|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899804|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19899805|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
19899806|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19899807|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899808|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19899809|NCT01073865|Goserelin|goserelin|mesh-list
19899810|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19899811|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899812|NCT01073930|Bisacodyl|bisacodyl|mesh-list
19899813|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
19899814|NCT01073930|Cathartics|cathartics|mesh-ancestor
19899815|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20259410|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259411|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20259412|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20539295|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
20539296|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539297|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539298|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539299|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20539300|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20539301|NCT01844622|Domperidone|domperidone|mesh-list
20539302|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
20539303|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
20539304|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539305|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539306|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539307|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19449718|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
19449719|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
20259413|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20259414|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259415|NCT00487591|Simvastatin|simvastatin|mesh-list
20259416|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20259417|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20259418|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
20259419|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259420|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20259421|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20259422|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539308|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
19449720|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449721|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449722|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539309|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539310|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539311|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
20539312|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
20539313|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539314|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539315|NCT01844648|Tropicamide|tropicamide|mesh-list
20539316|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
20539317|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
20539318|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539319|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539320|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20539321|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20539322|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
20539323|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539324|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539325|NCT01844674|Vemurafenib|vemurafenib|mesh-list
20539326|NCT01844674|Tizanidine|tizanidine|mesh-list
20539327|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539328|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20539329|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539330|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539331|NCT01844674|Analgesics|analgesics|mesh-ancestor
20539332|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
20539333|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539334|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899816|NCT01073930|Laxatives|laxatives|mesh-ancestor
19899817|NCT01073943|Bisacodyl|bisacodyl|mesh-list
19899818|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
19899819|NCT01073943|Cathartics|cathartics|mesh-ancestor
19899820|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899821|NCT01073943|Laxatives|laxatives|mesh-ancestor
19899822|NCT01074008|Ritonavir|ritonavir|mesh-list
19899823|NCT01074008|Ribavirin|ribavirin|mesh-list
19899824|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19899825|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19899826|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19899827|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
19899828|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899829|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899830|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19899831|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19899832|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
19899833|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899834|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19899835|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899836|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
19899837|NCT01074047|Azacitidine|azacitidine|mesh-list
19899838|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19899839|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
19899840|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899841|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899842|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899843|NCT01074177|Afatinib|afatinib|mesh-list
19899844|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899845|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19899846|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539335|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
20539336|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19899847|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899848|NCT01074216|Vitamin D|vitamin d|mesh-list
20539337|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20539338|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
20539339|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
19899849|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
19899850|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
19899851|NCT01074216|Vitamins|vitamins|mesh-list
19899852|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
19899853|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899854|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19899855|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19899856|NCT01074229|Ropivacaine|ropivacaine|mesh-list
19899857|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
19899858|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
19899859|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539340|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20539341|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19899860|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899861|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
19899862|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899863|NCT01074255|Aprepitant|aprepitant|mesh-list
19899864|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
19899865|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
20539342|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20539343|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
20539344|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539345|NCT01844791|Gemcitabine|gemcitabine|mesh-list
20539346|NCT01844791|Pentamidine|pentamidine|mesh-list
20539347|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539348|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
20539349|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539350|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539351|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
20539352|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539353|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539354|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539355|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
20539356|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539357|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
20539358|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20539359|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20539360|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20539361|NCT01844804|Infliximab|infliximab|mesh-list
20539362|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
20539363|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539364|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539365|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
20539366|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539367|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539368|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20539369|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539370|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539371|NCT01844947|Sorafenib|sorafenib|mesh-list
19899866|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899867|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899868|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19899869|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19899870|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899871|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899872|NCT01074268|Insulin|insulin|mesh-list
19899873|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19899874|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
19899875|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
19899876|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19899877|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899878|NCT01074307|Bisoprolol|bisoprolol|mesh-list
19899879|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19899880|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
19899881|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
19899882|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899883|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899884|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19899885|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19899886|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19899887|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
19899888|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899889|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899890|NCT01074450|Pramipexole|pramipexole|mesh-list
19899891|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
19899892|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899893|NCT01074450|Protective Agents|protective agents|mesh-ancestor
19899894|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899895|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19899896|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19899897|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
19899898|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
19899899|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899900|NCT01074463|Pramipexole|pramipexole|mesh-list
19899901|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
19899902|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539372|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553930|NCT01932203|Protective Agents|protective agents|mesh-ancestor
19899903|NCT01074463|Protective Agents|protective agents|mesh-ancestor
19899904|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899905|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19899906|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19899907|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
19899908|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
19899909|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19899910|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19899911|NCT01074554|Azithromycin|azithromycin|mesh-list
19899912|NCT01074554|Levofloxacin|levofloxacin|mesh-list
19899913|NCT01074554|Rifampin|rifampin|mesh-list
20539373|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20539374|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539375|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539376|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
20539377|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20539378|NCT01845038|Timolol|timolol|mesh-list
20539379|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20539380|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20539381|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
20539382|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539383|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539384|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539385|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20539386|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20539387|NCT01845064|Kallikreins|kallikreins|mesh-list
20539388|NCT01845064|Coagulants|coagulants|mesh-ancestor
20539389|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
20539390|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
20539391|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20539392|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899914|NCT01074554|Ethambutol|ethambutol|mesh-list
19899915|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899916|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19899917|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
19899918|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19899919|NCT01074554|Renal Agents|renal agents|mesh-ancestor
19899920|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19899921|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20539393|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
20539394|NCT01845090|Calcium|calcium|mesh-list
20539395|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20539396|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539397|NCT01845090|Antacids|antacids|mesh-ancestor
20539398|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899922|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899923|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899924|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899925|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19899926|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899927|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
19899928|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19899929|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19899930|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19899931|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19899932|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19899933|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19899934|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19899935|NCT01074931|Ritonavir|ritonavir|mesh-list
19899936|NCT01074931|Lopinavir|lopinavir|mesh-list
19899937|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19899938|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19899939|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
19899940|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899941|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899942|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19899943|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19899944|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
19899945|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899946|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19899947|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899948|NCT01074944|Eliglustat|eliglustat|mesh-list
19899949|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971227|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19899950|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899951|NCT01075048|Irinotecan|irinotecan|mesh-list
19899952|NCT01075048|Cetuximab|cetuximab|mesh-list
19899953|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19899954|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19899955|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899956|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539399|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539400|NCT01845142|Vitamin D|vitamin d|mesh-list
20539401|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
19899957|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899958|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19899959|NCT01075087|Ropivacaine|ropivacaine|mesh-list
19899960|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
19899961|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
19899962|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19899963|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19899964|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
19899965|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19899966|NCT01075100|Carboplatin|carboplatin|mesh-list
19899967|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19899968|NCT01075152|Lamivudine|lamivudine|mesh-list
19899969|NCT01075152|Zidovudine|zidovudine|mesh-list
19899970|NCT01075152|Efavirenz|efavirenz|mesh-list
19899971|NCT01075152|Stavudine|stavudine|mesh-list
19899972|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19899973|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19899974|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899975|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899976|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
19899977|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899978|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19899979|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19899980|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
19899981|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19899982|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899983|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19899984|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19899985|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19899986|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19899987|NCT01075204|Clarithromycin|clarithromycin|mesh-list
19899988|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539402|NCT01845142|Vitamins|vitamins|mesh-ancestor
20539403|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
20539404|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539405|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20539406|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20539407|NCT01845194|Metoprolol|metoprolol|mesh-list
19899989|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19899990|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19899991|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19899992|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19899993|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19899994|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19899995|NCT01075243|Acetaminophen|acetaminophen|mesh-list
19899996|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19899997|NCT01075243|Analgesics|analgesics|mesh-ancestor
19899998|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
19899999|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900000|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900001|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
19900002|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
19900003|NCT01075256|Calcium|calcium|mesh-list
19900004|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19900005|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900006|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19900007|NCT01075282|Metformin|metformin|mesh-list
19900008|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
19900009|NCT01075282|Glimepiride|glimepiride|mesh-list
19900010|NCT01075282|Dulaglutide|dulaglutide|mesh-list
19900011|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19900012|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900013|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19900014|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539408|NCT01845194|Talinolol|talinolol|mesh-list
20539409|NCT01845194|Torsemide|torsemide|mesh-list
19900015|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
19900016|NCT01075321|Lenalidomide|lenalidomide|mesh-list
19900017|NCT01075321|Everolimus|everolimus|mesh-list
19900018|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
19900019|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900020|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900021|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19900022|NCT01075321|Growth Substances|growth substances|mesh-ancestor
19900023|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900024|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539410|NCT01845194|Midazolam|midazolam|mesh-list
20539411|NCT01845194|Codeine|codeine|mesh-list
20539412|NCT01845194|Caffeine|caffeine|mesh-list
20539413|NCT01845194|Pravastatin|pravastatin|mesh-list
20539414|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20539415|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20539416|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19900025|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900026|NCT01075399|Imidazole|imidazole|mesh-list
19900027|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900028|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900029|NCT01075646|Ropivacaine|ropivacaine|mesh-list
19900030|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19900031|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
19900032|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
19900033|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19900034|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900035|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
19900036|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971228|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
19971229|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971230|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971231|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19971232|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19971233|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19971234|NCT01794741|Fluticasone|fluticasone|mesh-list
19971235|NCT01794741|Xhance|xhance|mesh-list
20539417|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539418|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20539419|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20539420|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20539421|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20539422|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
20539423|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
20539424|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
20539425|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
20539426|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539427|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539428|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20539429|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20539430|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539431|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20539432|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20539433|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
20539434|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20539435|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19971236|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971237|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19971238|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
19971239|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971240|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971241|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19971242|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971243|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
19971244|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19971245|NCT01794780|Fluticasone|fluticasone|mesh-list
19971246|NCT01794780|Budesonide|budesonide|mesh-list
19971247|NCT01794780|Theophylline|theophylline|mesh-list
19971248|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
19971249|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
19971250|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19971251|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971252|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20539436|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
19971253|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
19971254|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259423|NCT00487682|Valacyclovir|valacyclovir|mesh-list
20539437|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
19900037|NCT01075763|Interferons|interferons|mesh-list
19900038|NCT01075763|Interferon-beta|interferon-beta|mesh-list
19900039|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
19900040|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900041|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
20539438|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539439|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20539440|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20539441|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20539442|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
20539443|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20539444|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20539445|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
20539446|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20539447|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20539448|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20539449|NCT01845194|Narcotics|narcotics|mesh-ancestor
20539450|NCT01845194|Analgesics|analgesics|mesh-ancestor
20539451|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
20539452|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
20539453|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
20539454|NCT01845194|Diuretics|diuretics|mesh-ancestor
20539455|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
20539456|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20539457|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19900042|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539458|NCT01845246|Colistin|colistin|mesh-list
20539459|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539460|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539461|NCT01845259|Liraglutide|liraglutide|mesh-list
20539462|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20539463|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539464|NCT01845259|Incretins|incretins|mesh-ancestor
20539465|NCT01845259|Hormones|hormones|mesh-ancestor
20539466|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539467|NCT01845272|Amlodipine|amlodipine|mesh-list
20539468|NCT01845272|Candesartan|candesartan|mesh-list
20539469|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
20539470|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20539471|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20539472|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20539473|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539474|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20539475|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539476|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
20539477|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20539478|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20539479|NCT01845298|Rifampin|rifampin|mesh-list
20539480|NCT01845298|Rifamycins|rifamycins|mesh-list
20539481|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19900043|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
19900044|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900045|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19900046|NCT01075815|Hormones|hormones|mesh-list
19900047|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19900048|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900049|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900050|NCT01075971|Buprenorphine|buprenorphine|mesh-list
19900051|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19900052|NCT01075971|Narcotics|narcotics|mesh-ancestor
19900053|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19900054|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900055|NCT01075971|Analgesics|analgesics|mesh-ancestor
19900056|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
19900057|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900058|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19900059|NCT01075984|Posaconazole|posaconazole|mesh-list
19900060|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
19900061|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900062|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19900063|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19900064|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19900065|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20539482|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
19449723|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
19900066|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19900067|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900068|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900069|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19900070|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
19900071|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900072|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539483|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539484|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900073|NCT01076010|Sorafenib|sorafenib|mesh-list
19900074|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900075|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19900076|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900077|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900078|NCT01076075|Metformin|metformin|mesh-list
19900079|NCT01076075|Pioglitazone|pioglitazone|mesh-list
19900080|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19900081|NCT01076075|Glimepiride|glimepiride|mesh-list
19900082|NCT01076075|Gliclazide|gliclazide|mesh-list
19900083|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19900084|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900085|NCT01076075|Incretins|incretins|mesh-ancestor
19900086|NCT01076075|Hormones|hormones|mesh-ancestor
19900087|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900088|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19900089|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
19900090|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900091|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900092|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19900093|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900094|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
19900095|NCT01076088|Metformin|metformin|mesh-list
19900096|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19900097|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19900098|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900099|NCT01076088|Incretins|incretins|mesh-ancestor
19900100|NCT01076088|Hormones|hormones|mesh-ancestor
19900101|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900102|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19900103|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
19900104|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900105|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900106|NCT01076153|Clarithromycin|clarithromycin|mesh-list
19900107|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19900108|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900109|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19900110|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900111|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900112|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19900113|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19900114|NCT01076166|Clarithromycin|clarithromycin|mesh-list
19900115|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20259424|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
20259425|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259426|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
19900116|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900117|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19900118|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900119|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900120|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20259427|NCT00487734|Testosterone|testosterone|mesh-list
20259428|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
20259429|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
20259430|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20259431|NCT00487734|Androgens|androgens|mesh-ancestor
20259432|NCT00487734|Hormones|hormones|mesh-ancestor
20259433|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259434|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259435|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20259436|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259437|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
20259438|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
20259439|NCT00487773|Budesonide|budesonide|mesh-list
20539485|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
20539486|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20539487|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900121|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19900122|NCT01076231|Etoposide|etoposide|mesh-list
19900123|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
19900124|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
19900125|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900126|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19900127|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19900128|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19900129|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900130|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900131|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
19900132|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
19900133|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
19900134|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
19900135|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
19900136|NCT01076270|Plerixafor|plerixafor|mesh-list
19900137|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19900138|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20539488|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539489|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20539490|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20539491|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20539492|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20539493|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20539494|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20539495|NCT01845337|Capecitabine|capecitabine|mesh-list
20539496|NCT01845337|Tegafur|tegafur|mesh-list
20539497|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539498|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
19900139|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
19900140|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900141|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
19900142|NCT01076283|Baclofen|baclofen|mesh-list
19900143|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19900144|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900145|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19900146|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900147|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19900148|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
19900149|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
19900150|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900151|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900152|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
19900153|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
20539499|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539500|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539501|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
20539502|NCT01845363|Cefazolin|cefazolin|mesh-list
20539503|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20539504|NCT01845376|Anesthetics|anesthetics|mesh-list
20539505|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539506|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539507|NCT01845428|Pravastatin|pravastatin|mesh-list
19900154|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900155|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19900156|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
19900157|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
19900158|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19900159|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
19900160|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19900161|NCT01076335|Docetaxel|docetaxel|mesh-list
19900162|NCT01076335|Leuprolide|leuprolide|mesh-list
19900163|NCT01076335|Goserelin|goserelin|mesh-list
19900164|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900165|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
19900166|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
19900167|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
19900168|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900169|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19900170|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
20539508|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19900171|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19900172|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900173|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900174|NCT01076400|Topotecan|topotecan|mesh-list
19900175|NCT01076400|Adavosertib|adavosertib|mesh-list
19900176|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900177|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19900178|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19900179|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900180|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900181|NCT01076504|Carboplatin|carboplatin|mesh-list
19900182|NCT01076504|Amrubicin|amrubicin|mesh-list
19900183|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900184|NCT01076543|Sirolimus|sirolimus|mesh-list
19900185|NCT01076543|Lenalidomide|lenalidomide|mesh-list
19900186|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
19900187|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539509|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20539510|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
20539511|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539512|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20539513|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20539514|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539515|NCT01845493|Sulforaphane|sulforaphane|mesh-list
20539516|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20539517|NCT01845493|Protective Agents|protective agents|mesh-ancestor
20539518|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539519|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539520|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20539521|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
19900188|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900189|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19900190|NCT01076543|Growth Substances|growth substances|mesh-ancestor
19900191|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900192|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900193|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19900194|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900195|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19900196|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
19900197|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900198|NCT01076647|Insulin|insulin|mesh-list
19900199|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19900200|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
19900201|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19900202|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900203|NCT01076972|Ritonavir|ritonavir|mesh-list
19900204|NCT01076972|Lopinavir|lopinavir|mesh-list
19900205|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19900206|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19900207|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
19900208|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900209|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539522|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
20539523|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539524|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539525|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
20539526|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539527|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20539528|NCT01845558|Wobenzym|wobenzym|mesh-list
20539529|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20539530|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
20539531|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900210|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19900211|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19900212|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
19900213|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900214|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19900215|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19900216|NCT01076985|Ritonavir|ritonavir|mesh-list
19900217|NCT01076985|Lopinavir|lopinavir|mesh-list
19900218|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19900219|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19900220|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
20539532|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
19900221|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900222|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900223|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19900224|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19900225|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
19900226|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900227|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19900228|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19900229|NCT01077076|Omeprazole|omeprazole|mesh-list
19900230|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
19900231|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19900232|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900233|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19900234|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900235|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539533|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20539534|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
20539535|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20539536|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
20539537|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539538|NCT01845610|Manganese|manganese|mesh-list
20539539|NCT01845610|Trace Elements|trace elements|mesh-ancestor
20539540|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
20539541|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539542|NCT01845675|Temozolomide|temozolomide|mesh-list
20539543|NCT01845675|Dacarbazine|dacarbazine|mesh-list
20539544|NCT01845675|Endostatins|endostatins|mesh-list
20539545|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20539546|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
20539547|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539548|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539549|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20539550|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539551|NCT01845675|Growth Substances|growth substances|mesh-ancestor
20539552|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900236|NCT01077154|Denosumab|denosumab|mesh-list
19900237|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20539553|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
20539554|NCT01845688|Losartan|losartan|mesh-list
20539555|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20539556|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20539557|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20259440|NCT00487773|Albuterol|albuterol|mesh-list
20259441|NCT00487773|Montelukast|montelukast|mesh-list
20259442|NCT00487773|Vitamins|vitamins|mesh-ancestor
20259443|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
20259444|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259445|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259446|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20259447|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
20259448|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259449|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20259450|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
20259451|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
19900238|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259452|NCT00487773|Hormones|hormones|mesh-ancestor
20286888|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286889|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286890|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20286891|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
20286892|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286893|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286894|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20286895|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286896|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286897|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286898|NCT01711021|Amphetamine|amphetamine|mesh-list
20286899|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
20286900|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20286901|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286902|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
20286903|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
20286904|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286905|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
20286906|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539558|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20539559|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900239|NCT01077284|Allopurinol|allopurinol|mesh-list
19900240|NCT01077284|Febuxostat|febuxostat|mesh-list
20539560|NCT01845701|Artesunate|artesunate|mesh-list
20539561|NCT01845701|Lumefantrine|lumefantrine|mesh-list
20539562|NCT01845701|Artemether|artemether|mesh-list
20539563|NCT01845701|Piperaquine|piperaquine|mesh-list
20539564|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20539565|NCT01845701|Amodiaquine|amodiaquine|mesh-list
20539566|NCT01845701|Artenimol|artenimol|mesh-list
20539567|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
20539568|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20539569|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20539570|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539571|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539572|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
20539573|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
20539574|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20539575|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
20539576|NCT01845727|Amphotericin B|amphotericin b|mesh-list
20539577|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20539578|NCT01845727|Amebicides|amebicides|mesh-ancestor
20539579|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19900241|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
19900242|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900243|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900244|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
19900245|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900246|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19900247|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
19900248|NCT01077284|Protective Agents|protective agents|mesh-ancestor
19900249|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900250|NCT01077310|Naltrexone|naltrexone|mesh-list
19900251|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19900252|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19900253|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900254|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
19900255|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900256|NCT01077323|Exenatide|exenatide|mesh-list
19900257|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19900258|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900259|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19900260|NCT01077323|Incretins|incretins|mesh-ancestor
19900261|NCT01077323|Hormones|hormones|mesh-ancestor
19900262|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900263|NCT01077362|Ustekinumab|ustekinumab|mesh-list
19900264|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
19900265|NCT01077375|Milnacipran|milnacipran|mesh-list
19900266|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
19900267|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19900268|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19900269|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19900270|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900271|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900272|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900273|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19900274|NCT01077375|Analgesics|analgesics|mesh-ancestor
19900275|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
19900276|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900277|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
19900278|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19900279|NCT01077401|Ranibizumab|ranibizumab|mesh-list
19900280|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900281|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19900282|NCT01077401|Growth Substances|growth substances|mesh-ancestor
19900283|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900284|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900285|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900286|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19900287|NCT01077518|Ofatumumab|ofatumumab|mesh-list
19900288|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19900289|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20539580|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19900290|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
19900291|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539581|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900292|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900293|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
19900294|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900295|NCT01077596|Bupropion|bupropion|mesh-list
19900296|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
19900297|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
20539582|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539583|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
20553931|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20553932|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20553933|NCT01932229|Afatinib|afatinib|mesh-list
20553934|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553935|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553936|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553937|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900298|NCT01077596|Serotonin|serotonin|mesh-list
19900299|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19900300|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19900301|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20553938|NCT01932268|Rifampin|rifampin|mesh-list
20553939|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20553940|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
20553941|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553942|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900302|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19900303|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19900304|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19900305|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900306|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
20259453|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259454|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20259455|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
20259456|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19900307|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900308|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900309|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19900310|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19900311|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900312|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19900313|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
19900314|NCT01077622|Ofatumumab|ofatumumab|mesh-list
19900315|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900316|NCT01077713|Gemcitabine|gemcitabine|mesh-list
19900317|NCT01077713|Bevacizumab|bevacizumab|mesh-list
19900318|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19900319|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900320|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900321|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19900322|NCT01077713|Growth Substances|growth substances|mesh-ancestor
19900323|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900324|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900325|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19900326|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
19900327|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900328|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
19900329|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900330|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259457|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20259458|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259459|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
20259460|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20259461|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19900331|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900332|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
19900333|NCT01077739|Leucovorin|leucovorin|mesh-list
19900334|NCT01077739|Bevacizumab|bevacizumab|mesh-list
19900335|NCT01077739|Fluorouracil|fluorouracil|mesh-list
19900336|NCT01077739|Capecitabine|capecitabine|mesh-list
19900337|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
19900338|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19900339|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900340|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900341|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539584|NCT01845805|Gemcitabine|gemcitabine|mesh-list
20539585|NCT01845805|Azacitidine|azacitidine|mesh-list
20539586|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539587|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
19900342|NCT01077739|Growth Substances|growth substances|mesh-ancestor
19900343|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900344|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900345|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
19900346|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900347|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19900348|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900349|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
19900350|NCT01077739|Antidotes|antidotes|mesh-ancestor
19900351|NCT01077739|Protective Agents|protective agents|mesh-ancestor
19900352|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
19900353|NCT01077739|Vitamins|vitamins|mesh-ancestor
19900354|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
19900355|NCT01077921|Propranolol|propranolol|mesh-list
19900356|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19900357|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19900358|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900359|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539588|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539589|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539590|NCT01845805|Antiviral Agents|antiviral agents|mesh-ancestor
20539591|NCT01845805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539592|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539593|NCT01845805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539594|NCT01845805|Immunologic Factors|immunologic factors|mesh-ancestor
20539595|NCT01845805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539596|NCT01845844|Ranibizumab|ranibizumab|mesh-list
20539597|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20539598|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539599|NCT01845844|Growth Substances|growth substances|mesh-ancestor
19900360|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900361|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539600|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539601|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
20539602|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539603|NCT01846026|Vitamin D|vitamin d|mesh-list
20539604|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
20539605|NCT01846026|Vitamins|vitamins|mesh-ancestor
20539606|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
20539607|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539608|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20539609|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20539610|NCT01846117|Vitamin D|vitamin d|mesh-list
20539611|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
20539612|NCT01846117|Vitamins|vitamins|mesh-ancestor
20539613|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
20539614|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539615|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20539616|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
19900362|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19900363|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19900364|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
19900365|NCT01077960|Hormones|hormones|mesh-list
19900366|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539617|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20539618|NCT01846117|Estrogens|estrogens|mesh-ancestor
20539619|NCT01846117|Hormones|hormones|mesh-ancestor
20539620|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539621|NCT01846143|Poly ICLC|poly iclc|mesh-list
20539622|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
20539623|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539624|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
19900367|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900368|NCT01077973|Ibuprofen|ibuprofen|mesh-list
19900369|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20539625|NCT01846273|Ranibizumab|ranibizumab|mesh-list
20539626|NCT01846273|Verteporfin|verteporfin|mesh-list
20539627|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20539628|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539629|NCT01846273|Growth Substances|growth substances|mesh-ancestor
20539630|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539631|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
20553943|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
20539632|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539633|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19900370|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19900371|NCT01077973|Analgesics|analgesics|mesh-ancestor
19900372|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
19900373|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539634|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
20539635|NCT01846325|Vitamin E|vitamin e|mesh-list
20539636|NCT01846325|Vitamins|vitamins|mesh-ancestor
20539637|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
20539638|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539639|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
20539640|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449724|NCT03433001|Hormones|hormones|mesh-ancestor
20539641|NCT01846325|Protective Agents|protective agents|mesh-ancestor
20539642|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
20539643|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20539644|NCT01846364|Protective Agents|protective agents|mesh-ancestor
20539645|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539646|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539647|NCT01846390|Gemcitabine|gemcitabine|mesh-list
20539648|NCT01846390|Dexamethasone|dexamethasone|mesh-list
20539649|NCT01846390|Romidepsin|romidepsin|mesh-list
20539650|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539651|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539652|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
20539653|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
20539654|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539655|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539656|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539657|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
20539658|NCT01846390|Hormones|hormones|mesh-ancestor
20539659|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539660|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20539661|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539662|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
20539663|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539664|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
20539665|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539666|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539667|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539668|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
20539669|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20539670|NCT01846559|Clopidogrel|clopidogrel|mesh-list
20539671|NCT01846559|Ticagrelor|ticagrelor|mesh-list
20539672|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20539673|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20539674|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20539675|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20539676|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
20539677|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539678|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539679|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539680|NCT01846650|Capecitabine|capecitabine|mesh-list
20539681|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539682|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
20539683|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539684|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539685|NCT01846806|Rifaximin|rifaximin|mesh-list
20539686|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539687|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732292|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
19732293|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19732294|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19732295|NCT04575675|Hormones|hormones|mesh-ancestor
19732296|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732297|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
19732298|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19732299|NCT04575675|Diuretics|diuretics|mesh-ancestor
19732300|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
19732301|NCT04575922|Nivolumab|nivolumab|mesh-list
19732302|NCT04575922|Ipilimumab|ipilimumab|mesh-list
19732303|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19732304|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732305|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20539688|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539689|NCT01846832|Interferons|interferons|mesh-list
20539690|NCT01846832|Ribavirin|ribavirin|mesh-list
20539691|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
20539692|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
20539693|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20539694|NCT01846832|Simeprevir|simeprevir|mesh-list
20539695|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539696|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
20539697|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539698|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
20539699|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539700|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
20539701|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539702|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
20539703|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539704|NCT01846962|Fluticasone|fluticasone|mesh-list
20539705|NCT01846962|Budesonide|budesonide|mesh-list
20539706|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539707|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20539708|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
20539709|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539710|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539711|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20539712|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
20539713|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
20539714|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20539715|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
19900374|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900375|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900376|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900377|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20539716|NCT01846962|Hormones|hormones|mesh-ancestor
20539717|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539718|NCT01846975|Abatacept|abatacept|mesh-list
20539719|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20539720|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539721|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539722|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539723|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
20539724|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539725|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539726|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20539727|NCT01847144|Gliclazide|gliclazide|mesh-list
20539728|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20539729|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20539730|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539731|NCT01847144|Incretins|incretins|mesh-ancestor
20539732|NCT01847144|Hormones|hormones|mesh-ancestor
20539733|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539734|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
20539735|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539736|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539737|NCT01847157|Anesthetics|anesthetics|mesh-list
20539738|NCT01847157|Prilocaine|prilocaine|mesh-list
19900378|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900379|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900380|NCT01078168|Acitretin|acitretin|mesh-list
19900381|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
19900382|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
19900383|NCT01078298|Varenicline|varenicline|mesh-list
19900384|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19900385|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19900386|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
19900387|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900388|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900389|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900390|NCT01078363|Ramipril|ramipril|mesh-list
19900391|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19900392|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
20259462|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20259463|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19900393|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900394|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539739|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19900395|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19900396|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19900397|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19900398|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19900399|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900400|NCT01078389|Febuxostat|febuxostat|mesh-list
19900401|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
19900402|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900403|NCT01078441|Dexamethasone|dexamethasone|mesh-list
20539740|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539741|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
20539742|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
20539743|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539744|NCT01847235|Temozolomide|temozolomide|mesh-list
20539745|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20539746|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
20539747|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539748|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539749|NCT01847326|Paclitaxel|paclitaxel|mesh-list
20539750|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20539751|NCT01847326|Carboplatin|carboplatin|mesh-list
20539752|NCT01847326|Fluorouracil|fluorouracil|mesh-list
20539753|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
20539754|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539755|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539756|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20539757|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20539758|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539759|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539760|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
20539761|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539762|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449725|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900404|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
19900405|NCT01078441|Doxorubicin|doxorubicin|mesh-list
19900406|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19900407|NCT01078441|Bortezomib|bortezomib|mesh-list
19900408|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900409|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
19900410|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900411|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900412|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19900413|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
19900414|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900415|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900416|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19900417|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900418|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
19900419|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
19900420|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900421|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900422|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
19900423|NCT01078441|Hormones|hormones|mesh-ancestor
19900424|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900425|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900426|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19900427|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19900428|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19900429|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900430|NCT01078545|Leuprolide|leuprolide|mesh-list
19900431|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19900432|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
19900433|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19900434|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900435|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900436|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900437|NCT01078571|Adalimumab|adalimumab|mesh-list
19900438|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900439|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900440|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
19900441|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20539763|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
20539764|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539765|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
20539766|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539767|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20539768|NCT01847339|Bupivacaine|bupivacaine|mesh-list
20539769|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
20539770|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
20539771|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539772|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900442|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
19900443|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900444|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900445|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19900446|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
19900447|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19900448|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19900449|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19900450|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900451|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900452|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900453|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
19900454|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19900455|NCT01078675|Calcium|calcium|mesh-list
19900456|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19900457|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900458|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19900459|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19900460|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19900461|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
19900462|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900463|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19900464|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19900465|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900466|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19900467|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
19900468|NCT01078753|Coagulants|coagulants|mesh-ancestor
19900469|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19900470|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
19900471|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900472|NCT01078805|Teriparatide|teriparatide|mesh-list
19900473|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19900474|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900475|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20539773|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
19900476|NCT01078922|Ofatumumab|ofatumumab|mesh-list
19900477|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900478|NCT01078974|Dexamethasone|dexamethasone|mesh-list
20539774|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539775|NCT01847404|Aspirin|aspirin|mesh-list
20539776|NCT01847404|Pantoprazole|pantoprazole|mesh-list
20539777|NCT01847404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20539778|NCT01847404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20539779|NCT01847404|Analgesics|analgesics|mesh-ancestor
20539780|NCT01847404|Sensory System Agents|sensory system agents|mesh-ancestor
20539781|NCT01847404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539782|NCT01847404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900479|NCT01078974|Rituximab|rituximab|mesh-list
19900480|NCT01078974|Pomalidomide|pomalidomide|mesh-list
19900481|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19900482|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900483|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
19900484|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900485|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900486|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900487|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
19900488|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
19900489|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900490|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900491|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
19900492|NCT01078974|Hormones|hormones|mesh-ancestor
19900493|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900494|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900495|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900496|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19900497|NCT01078974|Growth Substances|growth substances|mesh-ancestor
19900498|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900499|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19900500|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19900501|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
19900502|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900503|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900504|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20539783|NCT01847404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539784|NCT01847404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539785|NCT01847404|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20539786|NCT01847404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20539787|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539788|NCT01847404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20539789|NCT01847404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20539790|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539791|NCT01847404|Antipyretics|antipyretics|mesh-ancestor
20539792|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20539793|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539794|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20539795|NCT01847417|Pantoprazole|pantoprazole|mesh-list
20539796|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20539797|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20539798|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20539799|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539800|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539801|NCT01847456|Insulin|insulin|mesh-list
20539802|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20539803|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20539804|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539805|NCT01847495|Irinotecan|irinotecan|mesh-list
20539806|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20539807|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20539808|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539809|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539810|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539811|NCT01847521|Quercetin|quercetin|mesh-list
20539812|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
20539813|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539814|NCT01847521|Protective Agents|protective agents|mesh-ancestor
20539815|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539816|NCT01847599|Capecitabine|capecitabine|mesh-list
20539817|NCT01847599|Lapatinib|lapatinib|mesh-list
19900505|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
19900506|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20539818|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20539819|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
20539820|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539821|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539822|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20539823|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539824|NCT01847612|Methylene Blue|methylene blue|mesh-list
20539825|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539826|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553944|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20553945|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553946|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553947|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20553948|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20553949|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20553950|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20553951|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20553952|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20553953|NCT01932320|Ketoconazole|ketoconazole|mesh-list
19449726|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19449727|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449728|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
19449729|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19449730|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19449731|NCT03433001|Growth Substances|growth substances|mesh-ancestor
19900507|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19900508|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19900509|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900510|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900511|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900512|NCT01079143|Cyclosporine|cyclosporine|mesh-list
19900513|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
19900514|NCT01079143|Everolimus|everolimus|mesh-list
19900515|NCT01079143|Cyclosporins|cyclosporins|mesh-list
19900516|NCT01079143|Basiliximab|basiliximab|mesh-list
19900517|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900518|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900519|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900520|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
19900521|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900522|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
19900523|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900524|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19900525|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900526|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19900527|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900528|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19900529|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19900530|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
19900531|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19900532|NCT01079234|Insulin|insulin|mesh-list
19900533|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19900534|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
19900535|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
19900536|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19900537|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259464|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259465|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259466|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20259467|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20259468|NCT00487786|Docetaxel|docetaxel|mesh-list
20259469|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259470|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
20259471|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
20259472|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
20259473|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259474|NCT00487799|Ularitide|ularitide|mesh-list
20259475|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20259476|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
20259477|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259478|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259479|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19449732|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
19449733|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
19900538|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
19449734|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449735|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449736|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
19900539|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19900540|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900541|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
19900542|NCT01079741|Poly I-C|poly i-c|mesh-list
19900543|NCT01079741|Mineral Oil|mineral oil|mesh-list
19900544|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19900545|NCT01079741|Poly ICLC|poly iclc|mesh-list
19900546|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
19900547|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
19900548|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
19900549|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900550|NCT01079741|Laxatives|laxatives|mesh-ancestor
19900551|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900552|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
19900553|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900554|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19900555|NCT01079741|Emollients|emollients|mesh-ancestor
19900556|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
19900557|NCT01079806|Entecavir|entecavir|mesh-list
19900558|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
19900559|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900560|NCT01079936|Lenalidomide|lenalidomide|mesh-list
19900561|NCT01079936|Melphalan|melphalan|mesh-list
19900562|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
19449737|NCT03432975|Povidone|povidone|mesh-list
19449738|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
19449739|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
19449740|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19449741|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539827|NCT01847664|Rifamycins|rifamycins|mesh-list
20539828|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
20539829|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539830|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539831|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539832|NCT01847677|Paclitaxel|paclitaxel|mesh-list
20539833|NCT01847677|Bevacizumab|bevacizumab|mesh-list
20539834|NCT01847677|Carboplatin|carboplatin|mesh-list
20539835|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539836|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539837|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
19900563|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259480|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
20259481|NCT00487799|Diuretics|diuretics|mesh-ancestor
20259482|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
20259483|NCT00487812|Dobutamine|dobutamine|mesh-list
20259484|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20259485|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
20259486|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
20259487|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259488|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259489|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20259490|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20259491|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20259492|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259493|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259494|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259495|NCT00487812|Protective Agents|protective agents|mesh-ancestor
20259496|NCT00487994|Atorvastatin|atorvastatin|mesh-list
20259497|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20259498|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20259499|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
19900564|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20259500|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539838|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
20539839|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539840|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539841|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20539842|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19449742|NCT03432923|Benzocaine|benzocaine|mesh-list
20259501|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19900565|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539843|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20539844|NCT01847677|Growth Substances|growth substances|mesh-ancestor
19900566|NCT01079936|Growth Substances|growth substances|mesh-ancestor
19900567|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900568|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539845|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539846|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
20539847|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
20539848|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539849|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
20539850|NCT01847768|Miotics|miotics|mesh-ancestor
20539851|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
20539852|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539853|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539854|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20539855|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20539856|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
20539857|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20539858|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19900569|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19900570|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
19900571|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900572|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19900573|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539859|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
20539860|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539861|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539862|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20539863|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
20539864|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539865|NCT01847872|Vaccines|vaccines|mesh-list
20539866|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
20539867|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539868|NCT01847976|Doxycycline|doxycycline|mesh-list
20539869|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20539870|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539871|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
20539872|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20539873|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20539874|NCT01848106|Bivalirudin|bivalirudin|mesh-list
20539875|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
20539876|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20539877|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
20539878|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539879|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900574|NCT01079949|Cetrorelix|cetrorelix|mesh-list
19900575|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19900576|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19900577|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
19900578|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19900579|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900580|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
19900581|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900582|NCT01079962|Atenolol|atenolol|mesh-list
19900583|NCT01079962|Bisoprolol|bisoprolol|mesh-list
19900584|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20539880|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
20539881|NCT01848119|Gabapentin|gabapentin|mesh-list
20539882|NCT01848119|Analgesics|analgesics|mesh-ancestor
20539883|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
20539884|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539885|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539886|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
20539887|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20539888|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20539889|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20539890|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20539891|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20539892|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19900585|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20539893|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539894|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539895|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
20259502|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20259503|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259504|NCT00488137|Prucalopride|prucalopride|mesh-list
20259505|NCT00488137|Laxatives|laxatives|mesh-ancestor
20259506|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20259507|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20259508|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20259509|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
20259510|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539896|NCT01848132|Prednisone|prednisone|mesh-list
19900586|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
19900587|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
19900588|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900589|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900590|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19900591|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19900592|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20539897|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
20539898|NCT01848132|Rituximab|rituximab|mesh-list
20539899|NCT01848132|Doxorubicin|doxorubicin|mesh-list
20539900|NCT01848132|Vincristine|vincristine|mesh-list
20539901|NCT01848132|Bortezomib|bortezomib|mesh-list
20539902|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20539903|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
20539904|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539905|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539906|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20539907|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
20539908|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539909|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539910|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20539911|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20539912|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20539913|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20539914|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20539915|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539916|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20539917|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
20539918|NCT01848132|Hormones|hormones|mesh-ancestor
20539919|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539920|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20539921|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539922|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
20539923|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
20539924|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539925|NCT01848197|Paclitaxel|paclitaxel|mesh-list
20539926|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539927|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539928|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
20539929|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
20539930|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539931|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539932|NCT01848236|Vitamin D|vitamin d|mesh-list
19900593|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900594|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900595|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900596|NCT01079988|Cyclosporine|cyclosporine|mesh-list
19900597|NCT01079988|Methotrexate|methotrexate|mesh-list
19900598|NCT01079988|Cyclosporins|cyclosporins|mesh-list
19900599|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19900600|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
19900601|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19900602|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900603|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19900604|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
19900605|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900606|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900607|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
20539933|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
20539934|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
20539935|NCT01848236|Vitamins|vitamins|mesh-list
20539936|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
20539937|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539938|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20539939|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20539940|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20539941|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
20539942|NCT01848301|Acetylcholine|acetylcholine|mesh-list
20539943|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
20539944|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20539945|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
20539946|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539947|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539948|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539949|NCT01848340|Cabotegravir|cabotegravir|mesh-list
19900608|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900609|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19900610|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900611|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
19900612|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900613|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19900614|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
19900615|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900616|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19971255|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971256|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19971257|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971258|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
19971259|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19971260|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
19971261|NCT01794780|Hormones|hormones|mesh-ancestor
19971262|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971263|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19971264|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19971265|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19971266|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
19971267|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20539950|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20539951|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20539952|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539953|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539954|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19971268|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971269|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
19971270|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20539955|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20539956|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
20539957|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20539958|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20539959|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539960|NCT01848613|Vinorelbine|vinorelbine|mesh-list
20259511|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259512|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259513|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20259514|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20259515|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259516|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259517|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259518|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259519|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259520|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259521|NCT00488176|Cetirizine|cetirizine|mesh-list
20259522|NCT00488176|Montelukast|montelukast|mesh-list
20259523|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20259524|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
20259525|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20259526|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
20539961|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20539962|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20539963|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
19971271|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
19971272|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19971273|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539964|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
20539965|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
20539966|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539967|NCT01848639|Spironolactone|spironolactone|mesh-list
20539968|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20539969|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
20539970|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20539971|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539972|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20539973|NCT01848639|Diuretics|diuretics|mesh-ancestor
20539974|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
20539975|NCT01848652|Doxorubicin|doxorubicin|mesh-list
20539976|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20539977|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900617|NCT01080131|Triamcinolone|triamcinolone|mesh-list
20539978|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20539979|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20539980|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539981|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539982|NCT01848665|Indomethacin|indomethacin|mesh-list
20539983|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20539984|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20539985|NCT01848665|Analgesics|analgesics|mesh-ancestor
20539986|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
19900618|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19900619|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19900620|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19900621|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19900622|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900623|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
19900624|NCT01080131|Hormones|hormones|mesh-ancestor
19900625|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900626|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900627|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900628|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
19900629|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900630|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900631|NCT01080248|Gemcitabine|gemcitabine|mesh-list
19900632|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19900633|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
19900634|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900635|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900636|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
19900637|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900638|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900639|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900640|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
19900641|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900642|NCT01080300|Gabapentin|gabapentin|mesh-list
19900643|NCT01080300|Analgesics|analgesics|mesh-ancestor
19900644|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
19900645|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900646|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900647|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
19900648|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19900649|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19900650|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19900651|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19900652|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19900653|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19900654|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900655|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900656|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
19900657|NCT01080391|Dexamethasone|dexamethasone|mesh-list
19900658|NCT01080391|Lenalidomide|lenalidomide|mesh-list
19900659|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900660|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
19900661|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
19900662|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900663|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900664|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900665|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
19900666|NCT01080391|Hormones|hormones|mesh-ancestor
19971274|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
19900667|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900668|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900669|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900670|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
19900671|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900672|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19900673|NCT01080391|Growth Substances|growth substances|mesh-ancestor
19900674|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900675|NCT01080625|Phenylephrine|phenylephrine|mesh-list
19900676|NCT01080625|Epinephrine|epinephrine|mesh-list
19900677|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
19900678|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19900679|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19900680|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900681|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900682|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900683|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900684|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19900685|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19900686|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
19900687|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900688|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19900689|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
19900690|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
19900691|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
19900692|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19900693|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19900694|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
19900695|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19900696|NCT01080625|Protective Agents|protective agents|mesh-ancestor
19900697|NCT01080677|Propranolol|propranolol|mesh-list
19900698|NCT01080677|Caffeine|caffeine|mesh-list
19900699|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19900700|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900701|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19900702|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900703|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900704|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19900705|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19900706|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
19900707|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900708|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19900709|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19900710|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900711|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19900712|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19900713|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
19900714|NCT01080716|Vaccines|vaccines|mesh-list
19900715|NCT01080716|Complement Factor H|complement factor h|mesh-list
19900716|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
19900717|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539987|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20539988|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20539989|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900718|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19900719|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900720|NCT01080807|Modafinil|modafinil|mesh-list
19900721|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19900722|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900723|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20539990|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20539991|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
20539992|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
20539993|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20539994|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20539995|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20539996|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20539997|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
20539998|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
20539999|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540000|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
20540001|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540002|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540003|NCT01848743|Tenofovir|tenofovir|mesh-list
19900724|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20540004|NCT01848743|Lamivudine|lamivudine|mesh-list
20540005|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
20540006|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540007|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19900725|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19900726|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900727|NCT01081041|Carboplatin|carboplatin|mesh-list
20540008|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20540009|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540010|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540011|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20540012|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20540013|NCT01848769|Beclomethasone|beclomethasone|mesh-list
20540014|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
20540015|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20540016|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
19900728|NCT01081041|Fluorouracil|fluorouracil|mesh-list
19900729|NCT01081041|Cetuximab|cetuximab|mesh-list
19900730|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900731|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
19900732|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900733|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19900734|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900735|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
19900736|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900737|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19900738|NCT01081132|Guanfacine|guanfacine|mesh-list
19900739|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19900740|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19900741|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19900742|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19900743|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900744|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900745|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900746|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900747|NCT01081145|Guanfacine|guanfacine|mesh-list
19900748|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19900749|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19900750|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19900751|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19900752|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900753|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900754|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900755|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900756|NCT01081249|Oxytocin|oxytocin|mesh-list
19900757|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
19900758|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19900759|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900760|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19900761|NCT01081626|Hormones|hormones|mesh-ancestor
19900762|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900763|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900764|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19900765|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
19900766|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19900767|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259527|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540017|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540018|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540019|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20540020|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540021|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20540022|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20540023|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20540024|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
20540025|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540026|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540027|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20540028|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
20540029|NCT01848769|Hormones|hormones|mesh-ancestor
20540030|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540031|NCT01848808|Wobenzym|wobenzym|mesh-list
20540032|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20540033|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
20540034|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540035|NCT01848873|Amlodipine|amlodipine|mesh-list
20540036|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20540037|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20540038|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20540039|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540040|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540041|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540042|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
20540043|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
20540044|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540045|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
20540046|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540047|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540048|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20540049|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
20540050|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20540051|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
20540052|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540053|NCT01849016|Expectorants|expectorants|mesh-ancestor
20540054|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540055|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20540056|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
20540057|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540058|NCT01849016|Protective Agents|protective agents|mesh-ancestor
20540059|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540060|NCT01849016|Antidotes|antidotes|mesh-ancestor
20540061|NCT01849042|Donepezil|donepezil|mesh-list
20540062|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20540063|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540064|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900768|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900769|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19900770|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19900771|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19900772|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
19900773|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900774|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900775|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19900776|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19900777|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
19900778|NCT01081795|Topiramate|topiramate|mesh-list
19900779|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
19900780|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19900781|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900782|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19900783|NCT01081834|Canagliflozin|canagliflozin|mesh-list
19900784|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19900785|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900786|NCT01081834|Incretins|incretins|mesh-ancestor
19900787|NCT01081834|Hormones|hormones|mesh-ancestor
19900788|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900789|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20540065|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
20540066|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540067|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540068|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
20259528|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259529|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19900790|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
19900791|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900792|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900793|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19900794|NCT01081873|Leuprolide|leuprolide|mesh-list
19900795|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19900796|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
19900797|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19900798|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900799|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900800|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900801|NCT01081912|Hydrocodone|hydrocodone|mesh-list
19900802|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19900803|NCT01081912|Narcotics|narcotics|mesh-ancestor
19900804|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19900805|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900806|NCT01081912|Analgesics|analgesics|mesh-ancestor
19900807|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
19900808|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900809|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
19900810|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
19900811|NCT01082081|Acetaminophen|acetaminophen|mesh-list
20540069|NCT01849094|Milrinone|milrinone|mesh-list
20540070|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20540071|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20540072|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
20540073|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20540074|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20540075|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540076|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540077|NCT01849094|Protective Agents|protective agents|mesh-ancestor
20540078|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540079|NCT01849211|Rocuronium|rocuronium|mesh-list
20540080|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20540081|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19900812|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19900813|NCT01082081|Analgesics|analgesics|mesh-ancestor
19900814|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
19900815|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900816|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900817|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
19900818|NCT01082380|Crizotinib|crizotinib|mesh-list
20540082|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20540083|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540084|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553954|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
20553955|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553956|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20553957|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20553958|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553959|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553960|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19900819|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900820|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19900821|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900822|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900823|NCT01082588|Pravastatin|pravastatin|mesh-list
19900824|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19900825|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19900826|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
19900827|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900828|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19900829|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19900830|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900831|NCT01082640|Febuxostat|febuxostat|mesh-list
19900832|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
19900833|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900834|NCT01082874|Aspirin|aspirin|mesh-list
19900835|NCT01082874|Clonidine|clonidine|mesh-list
19900836|NCT01082874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20259530|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20259531|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259532|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20259533|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20259534|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20259535|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
20259536|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
20259537|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259538|NCT00488189|Tazobactam|tazobactam|mesh-list
20259539|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20259540|NCT00488189|Piperacillin|piperacillin|mesh-list
20259541|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19900837|NCT01082874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19900838|NCT01082874|Analgesics|analgesics|mesh-ancestor
19900839|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
20540085|NCT01849406|Budesonide|budesonide|mesh-list
20540086|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20540087|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20540088|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
20540089|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540090|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540091|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20540092|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540093|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
20540094|NCT01849406|Hormones|hormones|mesh-ancestor
20540095|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540096|NCT01849640|Piperaquine|piperaquine|mesh-list
20540097|NCT01849640|Primaquine|primaquine|mesh-list
20540098|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
20540099|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20540100|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20540101|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540102|NCT01849666|Vemurafenib|vemurafenib|mesh-list
20540103|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
20540104|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540105|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20540106|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540107|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540108|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
20540109|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
19900840|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900841|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900842|NCT01082874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900843|NCT01082874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900844|NCT01082874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19900845|NCT01082874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19900846|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900847|NCT01082874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19900848|NCT01082874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19900849|NCT01082874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900850|NCT01082874|Antipyretics|antipyretics|mesh-ancestor
19900851|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19900852|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
19900853|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
19900854|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19900855|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19900856|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19900857|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
19900858|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900859|NCT01082939|Vidarabine|vidarabine|mesh-list
19900860|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
19900861|NCT01082939|Rituximab|rituximab|mesh-list
19900862|NCT01082939|Fludarabine|fludarabine|mesh-list
19900863|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
19900864|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
19900865|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900866|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
19900867|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900868|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19900869|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19900870|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
19900871|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900872|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540110|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20540111|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20540112|NCT01849835|Menthol|menthol|mesh-list
20540113|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
20540114|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540115|NCT01849861|Methimazole|methimazole|mesh-list
20540116|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
20540117|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
20540118|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540119|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540120|NCT01849926|Amdinocillin|amdinocillin|mesh-list
20540121|NCT01849926|Ibuprofen|ibuprofen|mesh-list
20540122|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19900873|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19900874|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19900875|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20540123|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20540124|NCT01849926|Analgesics|analgesics|mesh-ancestor
20540125|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
19900876|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
19900877|NCT01082939|Antiviral Agents|antiviral agents|mesh-ancestor
19900878|NCT01082939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900879|NCT01082965|Donepezil|donepezil|mesh-list
19900880|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19900881|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900882|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900883|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
19900884|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19900885|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900886|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
19900887|NCT01083316|Dexamethasone|dexamethasone|mesh-list
19900888|NCT01083316|Bortezomib|bortezomib|mesh-list
19900889|NCT01083316|Melphalan|melphalan|mesh-list
19900890|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900891|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
19900892|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
19900893|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900894|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900895|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900896|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
19900897|NCT01083316|Hormones|hormones|mesh-ancestor
19900898|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540126|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540127|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540128|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20540129|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20540130|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20540131|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540132|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540133|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20540134|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540135|NCT01849926|Renal Agents|renal agents|mesh-ancestor
20540136|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540137|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20540138|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
20540139|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540140|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
20540141|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19900899|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900900|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900901|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19900902|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
19900903|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900904|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19900905|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900906|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
19900907|NCT01083368|Sirolimus|sirolimus|mesh-list
19900908|NCT01083368|Bevacizumab|bevacizumab|mesh-list
19900909|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19900910|NCT01083368|Antibodies|antibodies|mesh-list
19900911|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
19900912|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19900913|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900914|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19900915|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20540142|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540143|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540144|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20540145|NCT01850017|Analgesics|analgesics|mesh-ancestor
20540146|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
20540147|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900916|NCT01083368|Growth Substances|growth substances|mesh-ancestor
19900917|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900918|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
19900919|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
19900920|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19900921|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900922|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19900923|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
19900924|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19900925|NCT01083485|Oxycodone|oxycodone|mesh-list
19900926|NCT01083485|Naloxone|naloxone|mesh-list
19900927|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19900928|NCT01083485|Narcotics|narcotics|mesh-ancestor
20540148|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20540149|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20540150|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20540151|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
20540152|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540153|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540154|NCT01850095|Azelaic acid|azelaic acid|mesh-list
20540155|NCT01850095|Estradiol|estradiol|mesh-list
20540156|NCT01850095|Estrogens|estrogens|mesh-ancestor
20540157|NCT01850095|Hormones|hormones|mesh-ancestor
20540158|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540159|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540160|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540161|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540162|NCT01850121|Infliximab|infliximab|mesh-list
20540163|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540164|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540165|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20540166|NCT01850147|Sunitinib|sunitinib|mesh-list
20540167|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540168|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20540169|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20540170|NCT01850147|Growth Substances|growth substances|mesh-ancestor
20540171|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540172|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
20540173|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20540174|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540175|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540176|NCT01850160|Valsartan|valsartan|mesh-list
20540177|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
19900929|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19900930|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900931|NCT01083485|Analgesics|analgesics|mesh-ancestor
19900932|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
20540178|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
20540179|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
20540180|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20540181|NCT01850160|Diuretics|diuretics|mesh-list
20540182|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20540183|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20540184|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540185|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
20540186|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540187|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20540188|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20540189|NCT01850251|Vitamin D|vitamin d|mesh-list
20540190|NCT01850251|Vitamins|vitamins|mesh-ancestor
20540191|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
20540192|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540193|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20540194|NCT01850277|Amiodarone|amiodarone|mesh-list
20540195|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20540196|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
20540197|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20540198|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20540199|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540200|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20540201|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20540202|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20540203|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540204|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20540205|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20540206|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20540207|NCT01850303|Gemcitabine|gemcitabine|mesh-list
20540208|NCT01850303|Pemetrexed|pemetrexed|mesh-list
20540209|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20540210|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
20540211|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540212|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540213|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
20540214|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540215|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540216|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540217|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
20540218|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540219|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19900933|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900934|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19900935|NCT01083576|Gentamicins|gentamicins|mesh-list
19900936|NCT01083576|Paromomycin|paromomycin|mesh-list
19900937|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19900938|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900939|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19900940|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900941|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900942|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19900943|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19900944|NCT01083602|Dexamethasone|dexamethasone|mesh-list
19900945|NCT01083602|Bortezomib|bortezomib|mesh-list
20540220|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20540221|NCT01850511|Phenylephrine|phenylephrine|mesh-list
20540222|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
20540223|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20540224|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20540225|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
20540226|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540227|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540228|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540229|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
20540230|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
20540231|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540232|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
20540233|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20540234|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540235|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20540236|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
20540237|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20540238|NCT01850511|Protective Agents|protective agents|mesh-ancestor
20540239|NCT01850628|Paclitaxel|paclitaxel|mesh-list
20540240|NCT01850628|Trastuzumab|trastuzumab|mesh-list
20540241|NCT01850628|Pertuzumab|pertuzumab|mesh-list
20540242|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20540243|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900946|NCT01083602|Panobinostat|panobinostat|mesh-list
19900947|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19900948|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
19900949|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
19900950|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19900951|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900952|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19900953|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
19900954|NCT01083602|Hormones|hormones|mesh-ancestor
19900955|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900956|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19900957|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540244|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
20540245|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
20540246|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
20540247|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540248|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20540249|NCT01850680|Folic Acid|folic acid|mesh-list
20540250|NCT01850680|Methotrexate|methotrexate|mesh-list
20540251|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20540252|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
20540253|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20540254|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540255|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20540256|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
20540257|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540258|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540259|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540260|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540261|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20540262|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540263|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
20540264|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20540265|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20540266|NCT01850680|Hematinics|hematinics|mesh-ancestor
20540267|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
20540268|NCT01850680|Vitamins|vitamins|mesh-ancestor
20540269|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
20540270|NCT01850940|Tolvaptan|tolvaptan|mesh-list
20540271|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20540272|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540273|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
20540274|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540275|NCT01850953|Varenicline|varenicline|mesh-list
20540276|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20540277|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20540278|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
20540279|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540280|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540281|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540282|NCT01850979|Tacrolimus|tacrolimus|mesh-list
20540283|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540284|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
20540285|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19900958|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19900959|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900960|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900961|NCT01083641|Estradiol|estradiol|mesh-list
19900962|NCT01083641|Estrogens|estrogens|mesh-ancestor
19900963|NCT01083641|Hormones|hormones|mesh-ancestor
19900964|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19900965|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540286|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20540287|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540288|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540289|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
20540290|NCT01851005|Remifentanil|remifentanil|mesh-list
20540291|NCT01851005|Anesthetics|anesthetics|mesh-list
20540292|NCT01851005|Propofol|propofol|mesh-list
20540293|NCT01851005|Sevoflurane|sevoflurane|mesh-list
20540294|NCT01851005|Rocuronium|rocuronium|mesh-list
20540295|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540296|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540297|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20540298|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20540299|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
20540300|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20540301|NCT01851005|Analgesics|analgesics|mesh-ancestor
20540302|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
20540303|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540304|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20540305|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20540306|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20540307|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
20540308|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540309|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540310|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19900966|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
19900967|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
19900968|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19900969|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19900970|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900971|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19900972|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900973|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900974|NCT01083706|Azacitidine|azacitidine|mesh-list
19900975|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19900976|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
19900977|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900978|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19900979|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900980|NCT01083732|Dabigatran|dabigatran|mesh-list
19900981|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
19900982|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20540311|NCT01851005|Narcotics|narcotics|mesh-ancestor
20540312|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20540313|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19900983|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
19900984|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900985|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900986|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
19900987|NCT01083810|Ritonavir|ritonavir|mesh-list
19900988|NCT01083810|Lopinavir|lopinavir|mesh-list
19900989|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19900990|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19900991|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
19900992|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19900993|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19900994|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19900995|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19900996|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
20540314|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20540315|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20540316|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20553961|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553962|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553963|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553964|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20553965|NCT01932372|Etanercept|etanercept|mesh-list
20553966|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
20553967|NCT01932372|Tofacitinib|tofacitinib|mesh-list
20553968|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20553969|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19900997|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19900998|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19900999|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19901000|NCT01084005|Linagliptin|linagliptin|mesh-list
19901001|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19901002|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901003|NCT01084005|Incretins|incretins|mesh-ancestor
19901004|NCT01084005|Hormones|hormones|mesh-ancestor
19901005|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901006|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19901007|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
20553970|NCT01932372|Analgesics|analgesics|mesh-ancestor
20553971|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
20553972|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553973|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553974|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20553975|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553976|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553977|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
20553978|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553979|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553980|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553981|NCT01932385|Sorafenib|sorafenib|mesh-list
20553982|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553983|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553984|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553985|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553986|NCT01932424|Propofol|propofol|mesh-list
20553987|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20553988|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553989|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901008|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901009|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901010|NCT01084083|Paclitaxel|paclitaxel|mesh-list
19901011|NCT01084083|Cetuximab|cetuximab|mesh-list
19901012|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19901013|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901014|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19901015|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19901016|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
19901017|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553990|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20553991|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
20553992|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
20553993|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
20553994|NCT01932502|Clobazam|clobazam|mesh-list
20540317|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
20540318|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20540319|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
20540320|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540321|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540322|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540323|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20540324|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20540325|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540326|NCT01851265|Olaparib|olaparib|mesh-list
20540327|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20540328|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540329|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540330|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540331|NCT01851278|Triamcinolone|triamcinolone|mesh-list
20540332|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20540333|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20540334|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20540335|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20540336|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
20540337|NCT01851278|Hormones|hormones|mesh-ancestor
20540338|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540339|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540340|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540341|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
20540342|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540343|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540344|NCT01851408|Sirolimus|sirolimus|mesh-list
20540345|NCT01851408|Sorafenib|sorafenib|mesh-list
20540346|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540347|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20540348|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540349|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540350|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540351|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540352|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20540353|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
20540354|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540355|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
20540356|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540357|NCT01851473|Quinine|quinine|mesh-list
20540358|NCT01851473|Acetazolamide|acetazolamide|mesh-list
20540359|NCT01851473|Cocaine|cocaine|mesh-list
20540360|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
20540361|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20540362|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540363|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540364|NCT01851473|Diuretics|diuretics|mesh-ancestor
20540365|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
20540366|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901018|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901019|NCT01084135|Rivastigmine|rivastigmine|mesh-list
19901020|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19901021|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901022|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901023|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901024|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901025|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901026|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19901027|NCT01084135|Protective Agents|protective agents|mesh-ancestor
19901028|NCT01084148|V0034CR|v0034cr|mesh-list
19901029|NCT01084148|Emollients|emollients|mesh-ancestor
20540367|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
20540368|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
20540369|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540370|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
20540371|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540372|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20540373|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20540374|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20540375|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20540376|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
19901030|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901031|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20540377|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540378|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
20540379|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20540380|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20540381|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540382|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20540383|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20540384|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20540385|NCT01851473|Analgesics|analgesics|mesh-ancestor
20540386|NCT01851486|Clonidine|clonidine|mesh-list
20540387|NCT01851486|Naloxone|naloxone|mesh-list
20540388|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20540389|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540390|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
20540391|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540392|NCT01851486|Analgesics|analgesics|mesh-ancestor
20540393|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20540394|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
20540395|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
20540396|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20540397|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20540398|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20540399|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
20540400|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540401|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540402|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20540403|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20540404|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540405|NCT01851551|Rituximab|rituximab|mesh-list
20540406|NCT01851551|Vincristine|vincristine|mesh-list
20540407|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20540408|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540409|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
20540410|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540411|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20540412|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20540413|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
20540414|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
20540415|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
20540416|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540417|NCT01851642|Albuterol|albuterol|mesh-list
20540418|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20540419|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
20540420|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540421|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540422|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20540423|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540424|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
20540425|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20540426|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20540427|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20540428|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19449743|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
19901032|NCT01084265|Hormones|hormones|mesh-list
19901033|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19901034|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901035|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901036|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19901037|NCT01084278|Colchicine|colchicine|mesh-list
19901038|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
19901039|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901040|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
19901041|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
19901042|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
19901043|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901044|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901045|NCT01084499|Letrozole|letrozole|mesh-list
19901046|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901047|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19901048|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19901049|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901050|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901051|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19901052|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
20540429|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
19901053|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901054|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901055|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
19901056|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540430|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540431|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540432|NCT01851681|Amoxicillin|amoxicillin|mesh-list
20540433|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540434|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540435|NCT01851733|Doxorubicin|doxorubicin|mesh-list
20540436|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20540437|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732306|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732307|NCT04575558|Azithromycin|azithromycin|mesh-list
19732308|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
19732309|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19732310|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732311|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
19732312|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19732313|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19901057|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901058|NCT01084538|Vitamins|vitamins|mesh-ancestor
19901059|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
19901060|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20540438|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19901061|NCT01084603|Nicotine|nicotine|mesh-list
19901062|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19901063|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
19901064|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901065|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901066|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19901067|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19901068|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901069|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901070|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901071|NCT01084655|Prednisone|prednisone|mesh-list
19901072|NCT01084655|Docetaxel|docetaxel|mesh-list
19901073|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901074|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
19901075|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
19901076|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
19901077|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901078|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901079|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
19901080|NCT01084655|Hormones|hormones|mesh-ancestor
19901081|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901082|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901083|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19901084|NCT01084707|Nicotine|nicotine|mesh-list
19901085|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19901086|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
19901087|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901088|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901089|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19901090|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19901091|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901092|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901093|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901094|NCT01084759|Etoposide|etoposide|mesh-list
19901095|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
19901096|NCT01084759|Testosterone|testosterone|mesh-list
20540439|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20540440|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540441|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540442|NCT01851759|Cinepazide|cinepazide|mesh-list
20540443|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
20540444|NCT01851824|Vemurafenib|vemurafenib|mesh-list
20540445|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
20540446|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540447|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20540448|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540449|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540450|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
20540451|NCT01851850|Opicapone|opicapone|mesh-list
20540452|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20540453|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540454|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540455|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20540456|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20540457|NCT01851941|Leucovorin|leucovorin|mesh-list
20540458|NCT01851941|Folic Acid|folic acid|mesh-list
20540459|NCT01851941|Fluorouracil|fluorouracil|mesh-list
20540460|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
20540461|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
20540462|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
20540463|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540464|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20540465|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540466|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540467|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
20540468|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540469|NCT01851941|Antidotes|antidotes|mesh-ancestor
20540470|NCT01851941|Protective Agents|protective agents|mesh-ancestor
20540471|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
20540472|NCT01851941|Vitamins|vitamins|mesh-ancestor
20540473|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
20540474|NCT01851941|Hematinics|hematinics|mesh-ancestor
20540475|NCT01851954|Clarithromycin|clarithromycin|mesh-list
20540476|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19901097|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
20540477|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540478|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20540479|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540480|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901098|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
19901099|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19901100|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19901101|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901102|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20540481|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20540482|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20540483|NCT01851980|Furosemide|furosemide|mesh-list
20540484|NCT01851980|Diuretics|diuretics|mesh-ancestor
20540485|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
20540486|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540487|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20540488|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20540489|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901103|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19901104|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901105|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901106|NCT01084759|Androgens|androgens|mesh-ancestor
19901107|NCT01084759|Hormones|hormones|mesh-ancestor
19901108|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901109|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901110|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19901111|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
19901112|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
19901113|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19901114|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19901115|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901116|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
19901117|NCT01085006|Coagulants|coagulants|mesh-ancestor
19901118|NCT01085045|Bromides|bromides|mesh-list
19901119|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
19901120|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
19901121|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19901122|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
19901123|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901124|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901125|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19901126|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
19901127|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19901128|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19901129|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19901130|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
19901131|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901132|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901133|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
19901134|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19901135|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901136|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
19901137|NCT01085136|Afatinib|afatinib|mesh-list
19901138|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901139|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19901140|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901141|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901142|NCT01085201|Regadenoson|regadenoson|mesh-list
19901143|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19901144|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19901145|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
19901146|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
19901147|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901148|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901149|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901150|NCT01085344|Factor VIII|factor viii|mesh-list
19901151|NCT01085344|Coagulants|coagulants|mesh-ancestor
19901152|NCT01085591|Vancomycin|vancomycin|mesh-list
19901153|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540490|NCT01851993|Ondansetron|ondansetron|mesh-list
20540491|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
19901154|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901155|NCT01085630|Pemetrexed|pemetrexed|mesh-list
19901156|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901157|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540492|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
20540493|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540494|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540495|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540496|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
20540497|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540498|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20540499|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
20540500|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540501|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540502|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20540503|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20540504|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540505|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20540506|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20540507|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
20540508|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20540509|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20540510|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540511|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
20540512|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540513|NCT01852266|Vaccines|vaccines|mesh-list
20540514|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
20540515|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540516|NCT01852318|Fexofenadine|fexofenadine|mesh-list
20540517|NCT01852318|Pregabalin|pregabalin|mesh-list
20540518|NCT01852318|Analgesics|analgesics|mesh-ancestor
20540519|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
20540520|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540521|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540522|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
20540523|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20540524|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20540525|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540526|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540527|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20540528|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20540529|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540530|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20540531|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20540532|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20540533|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20540534|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
20540535|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
20540536|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540537|NCT01852409|Bevacizumab|bevacizumab|mesh-list
20540538|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20540539|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540540|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20540541|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20540542|NCT01852409|Growth Substances|growth substances|mesh-ancestor
20540543|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540544|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
20540545|NCT01852461|Poractant alfa|poractant alfa|mesh-list
20540546|NCT01852461|Beractant|beractant|mesh-list
20540547|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20540548|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540549|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
20540550|NCT01852539|Propofol|propofol|mesh-list
20540551|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20540552|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540553|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540554|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20540555|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
20540556|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
20540557|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20540558|NCT01852539|Analgesics|analgesics|mesh-ancestor
20540559|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
20540560|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540561|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20540562|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20540563|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20540564|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
20540565|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540566|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540567|NCT01852565|Diltiazem|diltiazem|mesh-list
20540568|NCT01852565|Darapladib|darapladib|mesh-list
20540569|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20540570|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20540571|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20540572|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540573|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540574|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540575|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
20540576|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20540577|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540578|NCT01852604|Interferons|interferons|mesh-list
20540579|NCT01852604|Ritonavir|ritonavir|mesh-list
20540580|NCT01852604|Ribavirin|ribavirin|mesh-list
20540581|NCT01852604|Simeprevir|simeprevir|mesh-list
20540582|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540583|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
20540584|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540585|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20540586|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20540587|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
20540588|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540589|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540590|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20540591|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20540592|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20540593|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20540594|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
20540595|NCT01852630|Imipenem|imipenem|mesh-list
20540596|NCT01852630|Cefepime|cefepime|mesh-list
20540597|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540598|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540599|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
20540600|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
20540601|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20540602|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20540603|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540604|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20540605|NCT01852903|Vitamins|vitamins|mesh-list
20540606|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
20540607|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
20540608|NCT01852903|Calcium|calcium|mesh-list
20540609|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
20540610|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540611|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540612|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
20540613|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540614|NCT01852903|Protective Agents|protective agents|mesh-ancestor
20553995|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
20553996|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20553997|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20553998|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553999|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554000|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554001|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20554002|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
20554003|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
20554004|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554005|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554006|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20554007|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20554008|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20554009|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554010|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554011|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554012|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20554013|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20554014|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20554015|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
20554016|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554017|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554018|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20554019|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20554020|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
19449744|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
20540615|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
20540616|NCT01852994|Testosterone|testosterone|mesh-list
20259542|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259543|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20259544|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259545|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259546|NCT00488215|Prucalopride|prucalopride|mesh-list
20259547|NCT00488215|Laxatives|laxatives|mesh-ancestor
20259548|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20259549|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20259550|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20259551|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
20259552|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259553|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259554|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286907|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286908|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
20286909|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20286910|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20286911|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20286912|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20286913|NCT01670877|Trastuzumab|trastuzumab|mesh-list
20286914|NCT01670877|Fulvestrant|fulvestrant|mesh-list
20286915|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286916|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286917|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286918|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20286919|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20286920|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
20286921|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286922|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286923|NCT01602380|Fulvestrant|fulvestrant|mesh-list
20286924|NCT01602380|Anastrozole|anastrozole|mesh-list
20286925|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286926|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286927|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20286928|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20286929|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
20286930|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286931|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286932|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20286933|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20286934|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286935|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286936|NCT01518556|Idarubicin|idarubicin|mesh-list
20540617|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
20540618|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
20540619|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20540620|NCT01852994|Androgens|androgens|mesh-ancestor
20540621|NCT01852994|Hormones|hormones|mesh-ancestor
20540622|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540623|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540624|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20540625|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540626|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
20540627|NCT01853111|Aldesleukin|aldesleukin|mesh-list
20540628|NCT01853111|Interleukin-2|interleukin-2|mesh-list
20540629|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540630|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20540631|NCT01853111|Analgesics|analgesics|mesh-ancestor
20540632|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
20540633|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540634|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540635|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20540636|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20540637|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
20540638|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540639|NCT01853306|Veliparib|veliparib|mesh-list
20540640|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20540641|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540642|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540643|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901158|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901159|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19901160|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19901161|NCT01085734|Bevacizumab|bevacizumab|mesh-list
19901162|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901163|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901164|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19901165|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19901166|NCT01085734|Growth Substances|growth substances|mesh-ancestor
19901167|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901168|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19901169|NCT01085760|Metronidazole|metronidazole|mesh-list
19901170|NCT01085760|Vancomycin|vancomycin|mesh-list
19901171|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901172|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19901173|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19901174|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19901175|NCT01085786|Amoxicillin|amoxicillin|mesh-list
19901176|NCT01085786|Metronidazole|metronidazole|mesh-list
19901177|NCT01085786|Clarithromycin|clarithromycin|mesh-list
19901178|NCT01085786|Esomeprazole|esomeprazole|mesh-list
19901179|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19901180|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901181|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19901182|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19901183|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19901184|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19901185|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19901186|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901187|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901188|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19901189|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19901190|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19971275|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19971276|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19971277|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
19971278|NCT01794845|Docetaxel|docetaxel|mesh-list
19971279|NCT01794845|Cetuximab|cetuximab|mesh-list
19971280|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971281|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19971282|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
19971283|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
19971284|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971285|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19971286|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
19971287|NCT01795495|Remifentanil|remifentanil|mesh-list
19971288|NCT01795495|Methadone|methadone|mesh-list
19971289|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19971290|NCT01795495|Narcotics|narcotics|mesh-ancestor
19971291|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971292|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971293|NCT01795495|Analgesics|analgesics|mesh-ancestor
19971294|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
19971295|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971296|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
19971297|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19971298|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
19971299|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19971300|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971301|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971302|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19971303|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
19971304|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19971305|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
19971306|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971307|NCT01795547|Aripiprazole|aripiprazole|mesh-list
19971308|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19971309|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
19971310|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19971311|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19971312|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19971313|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971314|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971315|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
19971316|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
19971317|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901191|NCT01085812|Milnacipran|milnacipran|mesh-list
19901192|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
19901193|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19901194|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19901195|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19901196|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901197|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901198|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901199|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
19901200|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19901201|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901202|NCT01085812|Analgesics|analgesics|mesh-ancestor
19901203|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
19901204|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901205|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19901206|NCT01085903|Modafinil|modafinil|mesh-list
19901207|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19901208|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901209|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19901210|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19901211|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19901212|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901213|NCT01086150|Lidocaine|lidocaine|mesh-list
19901214|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
19901215|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
19901216|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901217|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901218|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
19901219|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901220|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19901221|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19901222|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19901223|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19901224|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901225|NCT01086358|Naproxen|naproxen|mesh-list
19901226|NCT01086358|Sumatriptan|sumatriptan|mesh-list
19901227|NCT01086358|Naratriptan|naratriptan|mesh-list
19901228|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
19901229|NCT01086358|Rizatriptan|rizatriptan|mesh-list
19901230|NCT01086358|Eletriptan|eletriptan|mesh-list
19901231|NCT01086358|Almotriptan|almotriptan|mesh-list
19901232|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19901233|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901234|NCT01086358|Analgesics|analgesics|mesh-ancestor
19901235|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
19901236|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901237|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901238|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901239|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901240|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
19901241|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19901242|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901243|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901244|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19901245|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19901246|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19901247|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
19901248|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901249|NCT01086384|Fluticasone|fluticasone|mesh-list
19901250|NCT01086384|Xhance|xhance|mesh-list
19901251|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901252|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19901253|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
19901254|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901255|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901256|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19901257|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
19901258|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901259|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19901260|NCT01086410|Fluticasone|fluticasone|mesh-list
19901261|NCT01086410|Xhance|xhance|mesh-list
19901262|NCT01086410|Prednisolone|prednisolone|mesh-list
20540644|NCT01853423|Sirolimus|sirolimus|mesh-list
19901263|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901264|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19901265|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
19901266|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901267|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901268|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19901269|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
19901270|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901271|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19901272|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
19901273|NCT01086410|Hormones|hormones|mesh-ancestor
19901274|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901275|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19901276|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901277|NCT01086475|Cycloserine|cycloserine|mesh-list
19901278|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19901279|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901280|NCT01086475|Renal Agents|renal agents|mesh-ancestor
19901281|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19901282|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
19901283|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19901284|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
19901285|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901286|NCT01086540|Acetaminophen|acetaminophen|mesh-list
19901287|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
19901288|NCT01086540|Promethazine|promethazine|mesh-list
19901289|NCT01086540|Prednisone|prednisone|mesh-list
19901290|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
19901291|NCT01086540|Rituximab|rituximab|mesh-list
19901292|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901293|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901294|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
19901295|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901296|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901297|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901298|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
19901299|NCT01086540|Hormones|hormones|mesh-ancestor
19901300|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901301|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19901302|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901303|NCT01086540|Analgesics|analgesics|mesh-ancestor
19901304|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
19901305|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901306|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
19901307|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
19901308|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
19901309|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19901310|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19901311|NCT01086540|Protective Agents|protective agents|mesh-ancestor
19901312|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19901313|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19901314|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901315|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
19901316|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
19901317|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19901318|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
19901319|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
19901320|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901321|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901322|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19901323|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
19901324|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901325|NCT01086605|Pixantrone|pixantrone|mesh-list
19901326|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19449745|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449746|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449747|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
19449748|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449749|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
19449750|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
19449751|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19449752|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449753|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19449754|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19449755|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901327|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19901328|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901329|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901330|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901331|NCT01087489|Lidocaine|lidocaine|mesh-list
19901332|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
19901333|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
19901334|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901335|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901336|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
19901337|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901338|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19901339|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19901340|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19901341|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19901342|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901343|NCT01087502|Glimepiride|glimepiride|mesh-list
19901344|NCT01087502|Linagliptin|linagliptin|mesh-list
19901345|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19901346|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19901347|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901348|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901349|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
19901350|NCT01087502|Incretins|incretins|mesh-ancestor
19901351|NCT01087502|Hormones|hormones|mesh-ancestor
19901352|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901353|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19901354|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
19901355|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901356|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901357|NCT01087723|Heparin|heparin|mesh-list
19901358|NCT01087723|Bivalirudin|bivalirudin|mesh-list
19901359|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
19901360|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19901361|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19901362|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901363|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
19901364|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19901365|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
19901366|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901367|NCT01087736|Topiramate|topiramate|mesh-list
19901368|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
19901369|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19901370|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901371|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
19901372|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901373|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
19901374|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901375|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901376|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
19901377|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901378|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
19901379|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901380|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901381|NCT01087814|Efavirenz|efavirenz|mesh-list
19901382|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19901383|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19901384|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901385|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901386|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
19901387|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901388|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19901389|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19901390|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19901391|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19901392|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19901393|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19901394|NCT01087905|Nicotine|nicotine|mesh-list
19901395|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19901396|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
19901397|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901398|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901399|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19901400|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20540645|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540646|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901401|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901402|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901403|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901404|NCT01087931|Bupivacaine|bupivacaine|mesh-list
19901405|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
19901406|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
19901407|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901408|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901409|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
19901410|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901411|NCT01087970|Carboplatin|carboplatin|mesh-list
19901412|NCT01087970|Pemetrexed|pemetrexed|mesh-list
19901413|NCT01087970|Cetuximab|cetuximab|mesh-list
19901414|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901415|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901416|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901417|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19901418|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19901419|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901420|NCT01088048|Rituximab|rituximab|mesh-list
19901421|NCT01088048|Fludarabine|fludarabine|mesh-list
19901422|NCT01088048|Lenalidomide|lenalidomide|mesh-list
19901423|NCT01088048|Everolimus|everolimus|mesh-list
19901424|NCT01088048|Bortezomib|bortezomib|mesh-list
19901425|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19901426|NCT01088048|Ofatumumab|ofatumumab|mesh-list
19901427|NCT01088048|Idelalisib|idelalisib|mesh-list
19901428|NCT01088048|Chlorambucil|chlorambucil|mesh-list
19901429|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901430|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901431|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
19901432|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901433|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901434|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901435|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901436|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19901437|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19901438|NCT01088048|Growth Substances|growth substances|mesh-ancestor
19901439|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
19901440|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19901441|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
19901442|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901443|NCT01088243|Mesalamine|mesalamine|mesh-list
19901444|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19901445|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901446|NCT01088243|Analgesics|analgesics|mesh-ancestor
19901447|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
19901448|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901449|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901450|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901451|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901452|NCT01088295|Telmisartan|telmisartan|mesh-list
19901453|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19901454|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19901455|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19901456|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901457|NCT01088464|Necitumumab|necitumumab|mesh-list
19901458|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19901459|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901460|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901461|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
19901462|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901463|NCT01088529|Prednisone|prednisone|mesh-list
19901464|NCT01088529|Leuprolide|leuprolide|mesh-list
19901465|NCT01088529|Goserelin|goserelin|mesh-list
19901466|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
19901467|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901468|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
19901469|NCT01088529|Hormones|hormones|mesh-ancestor
19901470|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901471|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901472|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20540647|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19901473|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901474|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20540648|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901475|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
19901476|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19901477|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19901478|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901479|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901480|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
19901481|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19901482|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19901483|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19901484|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
19901485|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901486|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901487|NCT01088997|Milrinone|milrinone|mesh-list
19901488|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19901489|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19901490|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
19901491|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19901492|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19901493|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901494|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901495|NCT01088997|Protective Agents|protective agents|mesh-ancestor
19901496|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901497|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
19901498|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19901499|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
19901500|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
19901501|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901502|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901503|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901504|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901505|NCT01089062|Analgesics|analgesics|mesh-ancestor
19901506|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
19901507|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901508|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19901509|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19901510|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
19901511|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901512|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901513|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19901514|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
19901515|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19901516|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19901517|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19901518|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
19901519|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901520|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901521|NCT01089361|Ketamine|ketamine|mesh-list
19901522|NCT01089361|Analgesics|analgesics|mesh-ancestor
19901523|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
19901524|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901525|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901526|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19901527|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19901528|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
19901529|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
19901530|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901531|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19901532|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19901533|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901534|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901535|NCT01089413|Bevacizumab|bevacizumab|mesh-list
19901536|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20259555|NCT00488306|Tigecycline|tigecycline|mesh-list
20259556|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20259557|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259558|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20259559|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259560|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259561|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20259562|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
20259563|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259564|NCT00488384|Acitretin|acitretin|mesh-list
20259565|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
19901537|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901538|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19901539|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19901540|NCT01089413|Growth Substances|growth substances|mesh-ancestor
19901541|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901542|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
19901543|NCT01089504|Phenobarbital|phenobarbital|mesh-list
19901544|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
19901545|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19901546|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901547|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901548|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19901549|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19901550|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901551|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901552|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
19901553|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
19901554|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19901555|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19901556|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19901557|NCT01089517|Ranibizumab|ranibizumab|mesh-list
19901558|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19901559|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19901560|NCT01089517|Growth Substances|growth substances|mesh-ancestor
19901561|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901562|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
19901563|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901564|NCT01089543|Rabeprazole|rabeprazole|mesh-list
19901565|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19901566|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19901567|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19901568|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901569|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901570|NCT01089556|Pregabalin|pregabalin|mesh-list
19901571|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19901572|NCT01089556|Analgesics|analgesics|mesh-ancestor
19901573|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
19901574|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901575|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901576|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
19901577|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19901578|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19901579|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901580|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19901581|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19901582|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19901583|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901584|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19901585|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19901586|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19901587|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901588|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
19901589|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
19901590|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
19901591|NCT01089569|Exenatide|exenatide|mesh-list
19901592|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19901593|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259566|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732314|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732315|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732316|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732317|NCT04575519|Aspirin|aspirin|mesh-list
19732318|NCT04575519|Ibuprofen|ibuprofen|mesh-list
19732319|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19732320|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732321|NCT04575519|Analgesics|analgesics|mesh-ancestor
19732322|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
19732323|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732324|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732325|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732326|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732327|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19732328|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901594|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19901595|NCT01089569|Incretins|incretins|mesh-ancestor
19901596|NCT01089569|Hormones|hormones|mesh-ancestor
19901597|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901598|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
19901599|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901600|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19901601|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901602|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901603|NCT01089608|Azithromycin|azithromycin|mesh-list
19901604|NCT01089608|Povidone|povidone|mesh-list
19901605|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19901606|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901607|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
19901608|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
19901609|NCT01089647|Budesonide|budesonide|mesh-list
19901610|NCT01089647|Montelukast|montelukast|mesh-list
19901611|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901612|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19901613|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
19901614|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901615|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901616|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19901617|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
19901618|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
19901619|NCT01089647|Hormones|hormones|mesh-ancestor
19901620|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901621|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19901622|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
19901623|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19901624|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19901625|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901626|NCT01089725|Tanezumab|tanezumab|mesh-list
19901627|NCT01089725|Analgesics|analgesics|mesh-ancestor
19901628|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
19901629|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901630|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901631|NCT01089751|Trospium chloride|trospium chloride|mesh-list
19901632|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
19901633|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
19901634|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901635|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901636|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19901637|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19901638|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901639|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901640|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901641|NCT01089751|Urological Agents|urological agents|mesh-ancestor
19901642|NCT01090011|Cetuximab|cetuximab|mesh-list
19901643|NCT01090011|Afatinib|afatinib|mesh-list
19901644|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901645|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901646|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19901647|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901648|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901649|NCT01090050|Naproxen|naproxen|mesh-list
19901650|NCT01090050|Sumatriptan|sumatriptan|mesh-list
19901651|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19901652|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901653|NCT01090050|Analgesics|analgesics|mesh-ancestor
19901654|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
19901655|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901656|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901657|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901658|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901659|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
19901660|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19901661|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901662|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901663|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19901664|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19901665|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19901666|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
19901667|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901668|NCT01090063|Ustekinumab|ustekinumab|mesh-list
19901669|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901670|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
19901671|NCT01090102|Mesalamine|mesalamine|mesh-list
19901672|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19901673|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901674|NCT01090102|Analgesics|analgesics|mesh-ancestor
19901675|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
19901676|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901677|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901678|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901679|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901680|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
19901681|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19901682|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901683|NCT01090180|Dexamethasone|dexamethasone|mesh-list
19901684|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901685|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
19901686|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
19901687|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901688|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901689|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19901690|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
19901691|NCT01090180|Hormones|hormones|mesh-ancestor
19901692|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901693|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19901694|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901695|NCT01090323|Deferasirox|deferasirox|mesh-list
19901696|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19901697|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
19901698|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
19901699|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901700|NCT01090414|Idelalisib|idelalisib|mesh-list
19901701|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901702|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901703|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901704|NCT01090427|Ustekinumab|ustekinumab|mesh-list
19901705|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901706|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19901707|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
19901708|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901709|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
19901710|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19901711|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901712|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
19901713|NCT01090752|Metformin|metformin|mesh-list
19901714|NCT01090752|Pioglitazone|pioglitazone|mesh-list
19901715|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19901716|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901717|NCT01090921|Bortezomib|bortezomib|mesh-list
19901718|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901719|NCT01090973|Panobinostat|panobinostat|mesh-list
19901720|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19901721|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901722|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901723|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901724|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
19901725|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19901726|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19901727|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901728|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19901729|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901730|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
19901731|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901732|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
19901733|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901734|NCT01091259|Bevacizumab|bevacizumab|mesh-list
19901735|NCT01091259|Irinotecan|irinotecan|mesh-list
19901736|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901737|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901738|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19901739|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19901740|NCT01091259|Growth Substances|growth substances|mesh-ancestor
19901741|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901742|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
19901743|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19901744|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19901745|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901746|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901747|NCT01091428|Paclitaxel|paclitaxel|mesh-list
19901748|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19901749|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901750|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19901751|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19901752|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19901753|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901754|NCT01091454|Cisplatin|cisplatin|mesh-list
19901755|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901756|NCT01091519|Fesoterodine|fesoterodine|mesh-list
19901757|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19901758|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19901759|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901760|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901761|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901762|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901763|NCT01091519|Urological Agents|urological agents|mesh-ancestor
19901764|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19901765|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
19901766|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19901767|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19901768|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19901769|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901770|NCT01091675|Etoricoxib|etoricoxib|mesh-list
19901771|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19901772|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901773|NCT01091675|Analgesics|analgesics|mesh-ancestor
20540649|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
20540650|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540651|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
20540652|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540653|NCT01853449|Fentanyl|fentanyl|mesh-list
20540654|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20540655|NCT01853449|Narcotics|narcotics|mesh-ancestor
20540656|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901774|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
19901775|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901776|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901777|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901778|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901779|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19901780|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19901781|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901782|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901783|NCT01091974|Modafinil|modafinil|mesh-list
19901784|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19901785|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901786|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19901787|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19901788|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19901789|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901790|NCT01092182|Prednisone|prednisone|mesh-list
19901791|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
19901792|NCT01092182|Rituximab|rituximab|mesh-list
19901793|NCT01092182|Doxorubicin|doxorubicin|mesh-list
19901794|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19901795|NCT01092182|Etoposide|etoposide|mesh-list
19901796|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
19901797|NCT01092182|Vincristine|vincristine|mesh-list
19901798|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901799|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
19901800|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901801|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901802|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19901803|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
19901804|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540657|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901805|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901806|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19901807|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19901808|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19901809|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19901810|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19901811|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901812|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901813|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
19901814|NCT01092182|Hormones|hormones|mesh-ancestor
19901815|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901816|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19901817|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19901818|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
19901819|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
19901820|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
19971318|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971319|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19971320|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19971321|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
19971322|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19971323|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19971324|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19971325|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19971326|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
20259567|NCT00488436|Cyclosporine|cyclosporine|mesh-list
20259568|NCT00488436|Cyclosporins|cyclosporins|mesh-list
20259569|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20259570|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259571|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259572|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259573|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
20259574|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259575|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
20259576|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259577|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
20259578|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259579|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20259580|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
20259581|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20259582|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259583|NCT00488540|Acetaminophen|acetaminophen|mesh-list
20259584|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20259585|NCT00488540|Analgesics|analgesics|mesh-ancestor
20259586|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
20259587|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259588|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971327|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971328|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20259589|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
20259590|NCT00488566|Lamotrigine|lamotrigine|mesh-list
20259591|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
20259592|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20259593|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259594|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540658|NCT01853449|Analgesics|analgesics|mesh-ancestor
19971329|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971330|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971331|NCT01795898|Fentanyl|fentanyl|mesh-list
19971332|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19971333|NCT01795898|Narcotics|narcotics|mesh-ancestor
19971334|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971335|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971336|NCT01795898|Analgesics|analgesics|mesh-ancestor
19971337|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
19971338|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971339|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19971340|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19971341|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
19971342|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
19971343|NCT01795937|Itraconazole|itraconazole|mesh-list
19971344|NCT01795937|Atorvastatin|atorvastatin|mesh-list
19971345|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20259595|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540659|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
19901821|NCT01092338|Vitamin D|vitamin d|mesh-list
19901822|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
19901823|NCT01092338|Vitamins|vitamins|mesh-ancestor
19901824|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
19901825|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901826|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19901827|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19901828|NCT01092507|Vaccines|vaccines|mesh-list
19901829|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
19901830|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901831|NCT01092546|Flutemetamol|flutemetamol|mesh-list
19901832|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19901833|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901834|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
19901835|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19901836|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
19901837|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901838|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901839|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19901840|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
19901841|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19901842|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
19901843|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901844|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901845|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19901846|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
19901847|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
19901848|NCT01092559|Protective Agents|protective agents|mesh-ancestor
19901849|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19901850|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19901851|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19901852|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901853|NCT01092663|Incretins|incretins|mesh-ancestor
19901854|NCT01092663|Hormones|hormones|mesh-ancestor
19901855|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901856|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19901857|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
19901858|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901859|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901860|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19901861|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19901862|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
19901863|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19901864|NCT01092676|Ibuprofen|ibuprofen|mesh-list
19901865|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19901866|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19901867|NCT01092676|Analgesics|analgesics|mesh-ancestor
19901868|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
19901869|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19901870|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901871|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19901872|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901873|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19901874|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901875|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901876|NCT01092702|Varenicline|varenicline|mesh-list
19901877|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19901878|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19901879|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901880|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901881|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901882|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901883|NCT01092728|Dasatinib|dasatinib|mesh-list
19901884|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901885|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19901886|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901887|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901888|NCT01092780|Modafinil|modafinil|mesh-list
19901889|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19901890|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901891|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19901892|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19901893|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19901894|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901895|NCT01092832|Voriconazole|voriconazole|mesh-list
19901896|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
19901897|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901898|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19901899|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19901900|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901901|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901902|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19901903|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
19901904|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19901905|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901906|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19901907|NCT01092923|Sevoflurane|sevoflurane|mesh-list
19901908|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19901909|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19901910|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
19901911|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
19901912|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19901913|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901914|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
19901915|NCT01093183|Lenalidomide|lenalidomide|mesh-list
19901916|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901917|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
19901918|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901919|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901920|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19901921|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
19901922|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901923|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901924|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19901925|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19901926|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19901927|NCT01093183|Growth Substances|growth substances|mesh-ancestor
19901928|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
19901929|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19901930|NCT01093222|Sorafenib|sorafenib|mesh-list
19901931|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901932|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19901933|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901934|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901935|NCT01093417|Vitamin D|vitamin d|mesh-list
19901936|NCT01093417|Vitamins|vitamins|mesh-ancestor
19901937|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
19901938|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901939|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19901940|NCT01093469|Decanoic acid|decanoic acid|mesh-list
19901941|NCT01093469|Petrolatum|petrolatum|mesh-list
19901942|NCT01093469|Emollients|emollients|mesh-ancestor
19901943|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901944|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
19901945|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901946|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
19901947|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19901948|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901949|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901950|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
19901951|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19901952|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19901953|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
19901954|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19901955|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901956|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901957|NCT01093534|Urological Agents|urological agents|mesh-ancestor
19901958|NCT01093573|Azacitidine|azacitidine|mesh-list
19901959|NCT01093573|Midostaurin|midostaurin|mesh-list
19901960|NCT01093573|Staurosporine|staurosporine|mesh-list
19901961|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19901962|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
19901963|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901964|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901965|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901966|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19901967|NCT01093586|Cyclosporine|cyclosporine|mesh-list
19901968|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
19901969|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
19901970|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19901971|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19901972|NCT01093586|Prednisolone|prednisolone|mesh-list
19901973|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
19901974|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
19901975|NCT01093586|Busulfan|busulfan|mesh-list
19901976|NCT01093586|Cyclosporins|cyclosporins|mesh-list
19901977|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
19901978|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19901979|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19901980|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
19901981|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19901982|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
19901983|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19901984|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19901985|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19901986|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
19901987|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19901988|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19901989|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19901990|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19901991|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
19901992|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19901993|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
19901994|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19901995|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19901996|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19901997|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
19901998|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19901999|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19902000|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
19902001|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
19902002|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902003|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19902004|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
19902005|NCT01093586|Hormones|hormones|mesh-ancestor
19902006|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902007|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19902008|NCT01093586|Protective Agents|protective agents|mesh-ancestor
19902009|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19902010|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19902011|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902012|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902013|NCT01093651|Incretins|incretins|mesh-ancestor
19902014|NCT01093651|Hormones|hormones|mesh-ancestor
19902015|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540660|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540661|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20540662|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20540663|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
20540664|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
20540665|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
20540666|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
20540667|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20540668|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20540669|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540670|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540671|NCT01853540|Urological Agents|urological agents|mesh-ancestor
20540672|NCT01853566|Hormones|hormones|mesh-list
20540673|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902016|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19902017|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902018|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902019|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902020|NCT01093690|Metoclopramide|metoclopramide|mesh-list
19902021|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
19902022|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
19902023|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902024|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902025|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540674|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902026|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19902027|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19902028|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
19902029|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902030|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902031|NCT01093755|Omeprazole|omeprazole|mesh-list
19902032|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
19902033|NCT01093755|Lansoprazole|lansoprazole|mesh-list
19902034|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19902035|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19902036|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19902037|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902038|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902039|NCT01093794|Metformin|metformin|mesh-list
19902040|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19902041|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902042|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902043|NCT01093794|Incretins|incretins|mesh-ancestor
19902044|NCT01093794|Hormones|hormones|mesh-ancestor
19902045|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902046|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19902047|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902048|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259596|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259597|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20259598|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20259599|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259600|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259601|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20259602|NCT00488605|Leucovorin|leucovorin|mesh-list
20259603|NCT00488605|Prednisone|prednisone|mesh-list
20259604|NCT00488605|Methotrexate|methotrexate|mesh-list
20259605|NCT00488605|Vinblastine|vinblastine|mesh-list
20259606|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
20259607|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259608|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
20259609|NCT00488605|Hormones|hormones|mesh-ancestor
20259610|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259611|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259612|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20259613|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259614|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20259615|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
20259616|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20259617|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20259618|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
20259619|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259620|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
20259621|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259622|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20259623|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259624|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
20259625|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259626|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20259627|NCT00488605|Antidotes|antidotes|mesh-ancestor
20259628|NCT00488605|Protective Agents|protective agents|mesh-ancestor
20259629|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
20259630|NCT00488605|Vitamins|vitamins|mesh-ancestor
20259631|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
20259632|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20259633|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
20259634|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
20259635|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
20259636|NCT00488670|Citalopram|citalopram|mesh-list
20259637|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20259638|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259639|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259640|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259641|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259642|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
20259643|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259644|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20259645|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259646|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19902049|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902050|NCT01093885|Ambrisentan|ambrisentan|mesh-list
20259647|NCT00488709|Cytarabine|cytarabine|mesh-list
20259648|NCT00488709|Fludarabine|fludarabine|mesh-list
19902051|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19902052|NCT01093976|Dronabinol|dronabinol|mesh-list
19902053|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
19902054|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902055|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19902056|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19902057|NCT01093976|Analgesics|analgesics|mesh-ancestor
19902058|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
19902059|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902060|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19902061|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19902062|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902063|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902064|NCT01093976|Hormones|hormones|mesh-ancestor
19902065|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902066|NCT01094106|Ropivacaine|ropivacaine|mesh-list
19902067|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
19902068|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
19902069|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902070|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902071|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
19902072|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902073|NCT01094184|Paclitaxel|paclitaxel|mesh-list
19902074|NCT01094184|Docetaxel|docetaxel|mesh-list
19902075|NCT01094184|Bevacizumab|bevacizumab|mesh-list
19902076|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19902077|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902078|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
19902079|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
19902080|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
19902081|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902082|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19902083|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19902084|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19902085|NCT01094184|Growth Substances|growth substances|mesh-ancestor
19902086|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902087|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
19902088|NCT01094288|Docetaxel|docetaxel|mesh-list
19902089|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902090|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
19902091|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
19902092|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
19902093|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902094|NCT01094522|Morphine|morphine|mesh-list
19902095|NCT01094522|Methadone|methadone|mesh-list
19902096|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902097|NCT01094522|Narcotics|narcotics|mesh-ancestor
19902098|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902099|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902100|NCT01094522|Analgesics|analgesics|mesh-ancestor
19902101|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
19902102|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902103|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
19902104|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
19902105|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
19902106|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902107|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
19902108|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902109|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902110|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19902111|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
19902112|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902113|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902114|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19902115|NCT01094574|Propranolol|propranolol|mesh-list
19902116|NCT01094574|Alfentanil|alfentanil|mesh-list
19902117|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19902118|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19902119|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259649|NCT00488709|Topotecan|topotecan|mesh-list
20259650|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259651|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20259652|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
19902120|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259653|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902121|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902122|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902123|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19902124|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19902125|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
19902126|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902127|NCT01094574|Narcotics|narcotics|mesh-ancestor
19902128|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902129|NCT01094574|Analgesics|analgesics|mesh-ancestor
19902130|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
19902131|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902132|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19902133|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
19902134|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
19902135|NCT01094717|Tazarotene|tazarotene|mesh-list
19902136|NCT01094717|Acitretin|acitretin|mesh-list
19902137|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
19902138|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
19902139|NCT01094808|Pregabalin|pregabalin|mesh-list
19902140|NCT01094808|Analgesics|analgesics|mesh-ancestor
19902141|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
19902142|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902143|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902144|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
19902145|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19902146|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902147|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902148|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19902149|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19902150|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19902151|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902152|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19902153|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
19902154|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19902155|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
19902156|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19902157|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902158|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902159|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902160|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
19902161|NCT01095094|Ritonavir|ritonavir|mesh-list
19902162|NCT01095094|Lopinavir|lopinavir|mesh-list
19902163|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19902164|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19902165|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902166|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902167|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902168|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902169|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902170|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
19902171|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902172|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19902173|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19902174|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19902175|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19902176|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902177|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
19902178|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902179|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19902180|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19902181|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902182|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
19902183|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902184|NCT01095653|Metformin|metformin|mesh-list
19902185|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
19902186|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902187|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902188|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19902189|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902190|NCT01095666|Metformin|metformin|mesh-list
19902191|NCT01095666|Pioglitazone|pioglitazone|mesh-list
19902192|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
20259654|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902193|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902194|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902195|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19902196|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902197|NCT01095757|Plerixafor|plerixafor|mesh-list
19902198|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902199|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902200|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
19902201|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902202|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19902203|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19902204|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19902205|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19902206|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902207|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902208|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
19902209|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902210|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902211|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902212|NCT01095835|Interferons|interferons|mesh-list
19902213|NCT01095835|Lamivudine|lamivudine|mesh-list
19902214|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19902215|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
19902216|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902217|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
19902218|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902219|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19902220|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19902221|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902222|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902223|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902224|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902225|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
19902226|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902227|NCT01095887|Eculizumab|eculizumab|mesh-list
19902228|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19902229|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902230|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
19902231|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902232|NCT01095978|Clarithromycin|clarithromycin|mesh-list
19902233|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19902234|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902235|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19902236|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902237|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902238|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19902239|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19902240|NCT01096017|Albuterol|albuterol|mesh-list
19902241|NCT01096017|Terbutaline|terbutaline|mesh-list
19902242|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19902243|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
19902244|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902245|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259655|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
20259656|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259657|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
20259658|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259659|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20259660|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20259661|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902246|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19902247|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
19902248|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
19902249|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19902250|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19902251|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19902252|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19902253|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
19902254|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902255|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902256|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
19902257|NCT01096056|Vaccines|vaccines|mesh-list
19902258|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
19902259|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902260|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19902261|NCT01096186|Carbidopa|carbidopa|mesh-list
19902262|NCT01096186|Levodopa|levodopa|mesh-list
19902263|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19902264|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
19902265|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902266|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19902267|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19902268|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
19902269|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
19902270|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902271|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902272|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19902273|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902274|NCT01096290|Lubiprostone|lubiprostone|mesh-list
19902275|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19902276|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902277|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902278|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
19902279|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19902280|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902281|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902282|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19902283|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
19902284|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19902285|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19902286|NCT01096589|Monensin|monensin|mesh-list
19902287|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
19902288|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902289|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19902290|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19902291|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
19902292|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
19902293|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
19902294|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902295|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902296|NCT01096589|Ionophores|ionophores|mesh-ancestor
19902297|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902298|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
19902299|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
19902300|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19902301|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19902302|NCT01096667|Diuretics|diuretics|mesh-ancestor
19902303|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
19902304|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902305|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19902306|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902307|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902308|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19902309|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902310|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19902311|NCT01096680|Modafinil|modafinil|mesh-list
19902312|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19902313|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902314|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19902315|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19902316|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902317|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902318|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
19902319|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902320|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19902321|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19902322|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19902323|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19902324|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19902325|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19902326|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19902327|NCT01096784|Mecasermin|mecasermin|mesh-list
19902328|NCT01096784|Growth Substances|growth substances|mesh-ancestor
19902329|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902330|NCT01096849|Levofloxacin|levofloxacin|mesh-list
19902331|NCT01096849|Ofloxacin|ofloxacin|mesh-list
20259662|NCT00488722|Goserelin|goserelin|mesh-list
19902332|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19902333|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902334|NCT01096849|Renal Agents|renal agents|mesh-ancestor
19902335|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19902336|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19902337|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19902338|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902339|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902340|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902341|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19902342|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19902343|NCT01096875|Atorvastatin|atorvastatin|mesh-list
19902344|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19902345|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19902346|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
19902347|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902348|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19902349|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19902350|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902351|NCT01096992|Vidarabine|vidarabine|mesh-list
19902352|NCT01096992|Rituximab|rituximab|mesh-list
19902353|NCT01096992|Fludarabine|fludarabine|mesh-list
19902354|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
19902355|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19902356|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19902357|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902358|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
19902359|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902360|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902361|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19902362|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
19902363|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902364|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902365|NCT01096992|Antiviral Agents|antiviral agents|mesh-ancestor
19902366|NCT01096992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902367|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19902368|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
19902369|NCT01097044|Afamelanotide|afamelanotide|mesh-list
19902370|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
19902371|NCT01097057|Plerixafor|plerixafor|mesh-list
19902372|NCT01097057|Rituximab|rituximab|mesh-list
19902373|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19902374|NCT01097057|Carboplatin|carboplatin|mesh-list
19902375|NCT01097057|Etoposide|etoposide|mesh-list
19902376|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
19902377|NCT01097057|Ifosfamide|ifosfamide|mesh-list
19902378|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
19902379|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
19902380|NCT01097057|Antibodies|antibodies|mesh-list
19902381|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
19902382|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19902383|NCT01097057|Lenograstim|lenograstim|mesh-list
19902384|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
19902385|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902386|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902387|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902388|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19902389|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19449756|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449757|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449758|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19449759|NCT03432871|Niacinamide|niacinamide|mesh-list
19449760|NCT03432871|Niacin|niacin|mesh-list
19449761|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
19449762|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
19449763|NCT03432871|Vitamins|vitamins|mesh-ancestor
19449764|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
19449765|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449766|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19449767|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
19902390|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19902391|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902392|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449768|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902393|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19902394|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19449769|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19449770|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
19449771|NCT03432793|Itraconazole|itraconazole|mesh-list
19449772|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
19449773|NCT03432793|Caffeine|caffeine|mesh-list
19449774|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19449775|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449776|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19449777|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449778|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449779|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19449780|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19449781|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
19449782|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449783|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
19449784|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449785|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19902395|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
19902396|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902397|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902398|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
19902399|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902400|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
19902401|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
19902402|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
19902403|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
19902404|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
19902405|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19902406|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19902407|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19902408|NCT01097330|Amiodarone|amiodarone|mesh-list
19902409|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19902410|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
19902411|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19902412|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902413|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902414|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19902415|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19902416|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19902417|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902418|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19902419|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19902420|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19902421|NCT01097343|Clopidogrel|clopidogrel|mesh-list
19902422|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19902423|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19902424|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19902425|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19902426|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
19902427|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902428|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902429|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902430|NCT01097395|Ribavirin|ribavirin|mesh-list
19902431|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
19902432|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902433|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
19902434|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902435|NCT01097421|Pramipexole|pramipexole|mesh-list
19902436|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
19902437|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902438|NCT01097421|Protective Agents|protective agents|mesh-ancestor
19902439|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902440|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19902441|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19902442|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
19902443|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
19902444|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902445|NCT01097460|Trastuzumab|trastuzumab|mesh-list
19902446|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19902447|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902448|NCT01097577|Pregabalin|pregabalin|mesh-list
19902449|NCT01097577|Analgesics|analgesics|mesh-ancestor
19902450|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
19902451|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902452|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902453|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
19902454|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19902455|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902456|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902457|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19902458|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19902459|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19902460|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902461|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19902462|NCT01097616|Suvorexant|suvorexant|mesh-list
19902463|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19902464|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19902465|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902466|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902467|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19902468|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902469|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902470|NCT01097629|Suvorexant|suvorexant|mesh-list
19902471|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19902472|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19902473|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902474|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902475|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19902476|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902477|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902478|NCT01097642|Cetuximab|cetuximab|mesh-list
19902479|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19902480|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902481|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
19902482|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902483|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19902484|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902485|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902486|NCT01097785|Simvastatin|simvastatin|mesh-list
19902487|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19902488|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19902489|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
19902490|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902491|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19902492|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19902493|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971346|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19971347|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19971348|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
19971349|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971350|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19971351|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19971352|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971353|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
19971354|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971355|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19971356|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19971357|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19971358|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
19971359|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971360|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971361|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19971362|NCT01796301|Teriparatide|teriparatide|mesh-list
19971363|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19971364|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971365|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19971366|NCT01796470|Idelalisib|idelalisib|mesh-list
19971367|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971368|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971369|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971370|NCT01796665|Clindamycin|clindamycin|mesh-list
19971371|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
19971372|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
19971373|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19902494|NCT01098097|Ribavirin|ribavirin|mesh-list
19902495|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
19902496|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902497|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
19902498|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902499|NCT01098305|Varenicline|varenicline|mesh-list
19902500|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20259663|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20259664|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259665|NCT00488761|Tigecycline|tigecycline|mesh-list
20259666|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20259667|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259668|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20259669|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259670|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259671|NCT00488787|Ketamine|ketamine|mesh-list
20259672|NCT00488787|Analgesics|analgesics|mesh-ancestor
19902501|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19902502|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
20259673|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
20259674|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902503|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902504|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902505|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902506|NCT01098318|Sertraline|sertraline|mesh-list
19902507|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
19902508|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19902509|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19902510|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19902511|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259675|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259676|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20259677|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20540675|NCT01853709|Bisacodyl|bisacodyl|mesh-list
20540676|NCT01853709|Cathartics|cathartics|mesh-ancestor
20540677|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540678|NCT01853709|Laxatives|laxatives|mesh-ancestor
20540679|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
20540680|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20540681|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20540682|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
20540683|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540684|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540685|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20540686|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540687|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19902512|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259678|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
20259679|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
19902513|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902514|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
19902515|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902516|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
19902517|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19902518|NCT01098461|Incretins|incretins|mesh-ancestor
19902519|NCT01098461|Hormones|hormones|mesh-ancestor
19902520|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902521|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902522|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19902523|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
19902524|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902525|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19902526|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
19902527|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902528|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902529|NCT01098539|Incretins|incretins|mesh-ancestor
19902530|NCT01098539|Hormones|hormones|mesh-ancestor
19902531|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902532|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19902533|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902534|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902535|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902536|NCT01098747|Ibuprofen|ibuprofen|mesh-list
19902537|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19902538|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19902539|NCT01098747|Analgesics|analgesics|mesh-ancestor
19902540|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
19902541|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902542|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902543|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19902544|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902545|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19902546|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902547|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902548|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
19902549|NCT01099202|Hematinics|hematinics|mesh-ancestor
19902550|NCT01099358|Fluorouracil|fluorouracil|mesh-list
19902551|NCT01099358|Cetuximab|cetuximab|mesh-list
19902552|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902553|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
19902554|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902555|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19902556|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902557|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
19902558|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902559|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19902560|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
19902561|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
19902562|NCT01099449|Calcium|calcium|mesh-list
19902563|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19902564|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902565|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902566|NCT01099449|Analgesics|analgesics|mesh-ancestor
19902567|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
19902568|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902569|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
19902570|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902571|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19902572|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
19902573|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19902574|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259680|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259681|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20259682|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20259683|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259684|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259685|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20259686|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
20259687|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259688|NCT00488813|Cephalosporins|cephalosporins|mesh-list
20259689|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20259690|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902575|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902576|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
19902577|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19902578|NCT01099579|Ritonavir|ritonavir|mesh-list
19902579|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19902580|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19902581|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19902582|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902583|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902584|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902585|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902586|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902587|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
19902588|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902589|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19902590|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19902591|NCT01099618|Metformin|metformin|mesh-list
19902592|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19902593|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902594|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902595|NCT01099618|Incretins|incretins|mesh-ancestor
19902596|NCT01099618|Hormones|hormones|mesh-ancestor
19902597|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902598|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19902599|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902600|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902601|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902602|NCT01099709|Oxycodone|oxycodone|mesh-list
19902603|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902604|NCT01099709|Narcotics|narcotics|mesh-ancestor
19902605|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902606|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902607|NCT01099709|Analgesics|analgesics|mesh-ancestor
19902608|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
19902609|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902610|NCT01099774|Bimatoprost|bimatoprost|mesh-list
19902611|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19902612|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19902613|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19902614|NCT01100034|Etanercept|etanercept|mesh-list
19902615|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19902616|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19902617|NCT01100034|Analgesics|analgesics|mesh-ancestor
19902618|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
19902619|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902620|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902621|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19902622|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902623|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19902624|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902625|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
19902626|NCT01100086|Oxycodone|oxycodone|mesh-list
19902627|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902628|NCT01100086|Narcotics|narcotics|mesh-ancestor
19902629|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902630|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902631|NCT01100086|Analgesics|analgesics|mesh-ancestor
19902632|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
19902633|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902634|NCT01100112|Budesonide|budesonide|mesh-list
19902635|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19902636|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19902637|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
19902638|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902639|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902640|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19902641|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
19902642|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
19902643|NCT01100112|Hormones|hormones|mesh-ancestor
19902644|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902645|NCT01100242|Bortezomib|bortezomib|mesh-list
19902646|NCT01100242|Sorafenib|sorafenib|mesh-list
19902647|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902648|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19902649|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259691|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19902650|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902651|NCT01100255|Ketamine|ketamine|mesh-list
19902652|NCT01100255|Analgesics|analgesics|mesh-ancestor
19902653|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
19902654|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902655|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902656|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19902657|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19902658|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
19902659|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
19902660|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902661|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19902662|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19902663|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902664|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902665|NCT01100268|Methylphenidate|methylphenidate|mesh-list
19902666|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19902667|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902668|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19902669|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19902670|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902671|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902672|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
19902673|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902674|NCT01100320|Oxycodone|oxycodone|mesh-list
19902675|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902676|NCT01100320|Narcotics|narcotics|mesh-ancestor
19902677|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902678|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902679|NCT01100320|Analgesics|analgesics|mesh-ancestor
19902680|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
19902681|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902682|NCT01100437|Naltrexone|naltrexone|mesh-list
19902683|NCT01100437|Morphine|morphine|mesh-list
19902684|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902685|NCT01100437|Narcotics|narcotics|mesh-ancestor
19902686|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902687|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902688|NCT01100437|Analgesics|analgesics|mesh-ancestor
19902689|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
19902690|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902691|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19902692|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19902693|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19902694|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19902695|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902696|NCT01100528|Interferons|interferons|mesh-list
19902697|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
19902698|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
19902699|NCT01100528|Dacarbazine|dacarbazine|mesh-list
19902700|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902701|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
19902702|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902703|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
19902704|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902705|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19902706|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
19902707|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902708|NCT01100606|Pancrelipase|pancrelipase|mesh-list
19902709|NCT01100606|Pancreatin|pancreatin|mesh-list
19902710|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19902711|NCT01100723|Vitamin D|vitamin d|mesh-list
19902712|NCT01100723|Calcitriol|calcitriol|mesh-list
19902713|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
19902714|NCT01100723|Cinacalcet|cinacalcet|mesh-list
19902715|NCT01100723|Vitamins|vitamins|mesh-ancestor
19902716|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
19902717|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902718|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19902719|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19902720|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19902721|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902722|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259692|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
20259693|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19902723|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19902724|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19902725|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
19902726|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902727|NCT01100853|Naltrexone|naltrexone|mesh-list
19902728|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19902729|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19902730|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902731|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
19902732|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902733|NCT01100931|Paclitaxel|paclitaxel|mesh-list
19902734|NCT01100931|Carboplatin|carboplatin|mesh-list
19902735|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19902736|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902737|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
19902738|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
19902739|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
19902740|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902741|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
19902742|NCT01100944|Doxorubicin|doxorubicin|mesh-list
19902743|NCT01100944|Belinostat|belinostat|mesh-list
19902744|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902745|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
19902746|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902747|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902748|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19902749|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
19902750|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902751|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902752|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19902753|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19902754|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19902755|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19902756|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902757|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19902758|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19902759|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19902760|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902761|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19902762|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19902763|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902764|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902765|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
19902766|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902767|NCT01101035|Allopurinol|allopurinol|mesh-list
19902768|NCT01101035|Febuxostat|febuxostat|mesh-list
19902769|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
19902770|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902771|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902772|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
19902773|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902774|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19902775|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
19902776|NCT01101035|Protective Agents|protective agents|mesh-ancestor
19902777|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902778|NCT01101100|Brodalumab|brodalumab|mesh-list
19902779|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
19902780|NCT01101165|Oxycodone|oxycodone|mesh-list
19902781|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902782|NCT01101165|Narcotics|narcotics|mesh-ancestor
19902783|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902784|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902785|NCT01101165|Analgesics|analgesics|mesh-ancestor
19902786|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
19902787|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902788|NCT01101178|Oxycodone|oxycodone|mesh-list
19902789|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902790|NCT01101178|Narcotics|narcotics|mesh-ancestor
19902791|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902792|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902793|NCT01101178|Analgesics|analgesics|mesh-ancestor
19902794|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
19902795|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902796|NCT01101191|Oxycodone|oxycodone|mesh-list
19902797|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902798|NCT01101191|Narcotics|narcotics|mesh-ancestor
19902799|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902800|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902801|NCT01101191|Analgesics|analgesics|mesh-ancestor
19902802|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
19902803|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902804|NCT01101308|Oxycodone|oxycodone|mesh-list
19902805|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902806|NCT01101308|Narcotics|narcotics|mesh-ancestor
19902807|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902808|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902809|NCT01101308|Analgesics|analgesics|mesh-ancestor
19902810|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
19902811|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902812|NCT01101321|Oxycodone|oxycodone|mesh-list
19902813|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19902814|NCT01101321|Narcotics|narcotics|mesh-ancestor
19902815|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902816|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902817|NCT01101321|Analgesics|analgesics|mesh-ancestor
19902818|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
19902819|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902820|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19902821|NCT01101334|Efatutazone|efatutazone|mesh-list
19902822|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902823|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19902824|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902825|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902826|NCT01101750|Vaccines|vaccines|mesh-list
19902827|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
19902828|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902829|NCT01101841|Paroxetine|paroxetine|mesh-list
19902830|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19902831|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19902832|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902833|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902834|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902835|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
19902836|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902837|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19902838|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
19902839|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19902840|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19902841|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19902842|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902843|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
19902844|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
19902845|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19902846|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902847|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259694|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259695|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259696|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19902848|NCT01101880|Cytarabine|cytarabine|mesh-list
19902849|NCT01101880|Clofarabine|clofarabine|mesh-list
19902850|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19902851|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
19902852|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902853|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902854|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
19902855|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902856|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19902857|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
19902858|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902859|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
19902860|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
19902861|NCT01102218|Hematinics|hematinics|mesh-ancestor
19902862|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19902863|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902864|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902865|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19902866|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19902867|NCT01102218|Protective Agents|protective agents|mesh-ancestor
19902868|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902869|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
19902870|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19902871|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
19902872|NCT01102231|Cetuximab|cetuximab|mesh-list
19902873|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19902874|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902875|NCT01102270|Eszopiclone|eszopiclone|mesh-list
19902876|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19902877|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19902878|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902879|NCT01102374|Vitamin D|vitamin d|mesh-list
19902880|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
19902881|NCT01102374|Vitamins|vitamins|mesh-list
19902882|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
19902883|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902884|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19902885|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19902886|NCT01102426|Dexamethasone|dexamethasone|mesh-list
19902887|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19902888|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
19902889|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
19902890|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902891|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902892|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19902893|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
19902894|NCT01102426|Hormones|hormones|mesh-ancestor
19902895|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902896|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19902897|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902898|NCT01102491|Ramosetron|ramosetron|mesh-list
19902899|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
19902900|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
19902901|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19902902|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902903|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19902904|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19902905|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
19902906|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902907|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902908|NCT01102803|Cycloserine|cycloserine|mesh-list
19902909|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19902910|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902911|NCT01102803|Renal Agents|renal agents|mesh-ancestor
19902912|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19902913|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
19902914|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19902915|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
19902916|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902917|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19902918|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19902919|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19902920|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19902921|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902922|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902923|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
19902924|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902925|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902926|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902927|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19902928|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19902929|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
19902930|NCT01103063|Azithromycin|azithromycin|mesh-list
19902931|NCT01103063|Chloroquine|chloroquine|mesh-list
19902932|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
19902933|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
19902934|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19902935|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19902936|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902937|NCT01103063|Amebicides|amebicides|mesh-ancestor
19902938|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19902939|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19902940|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
19902941|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19902942|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19902943|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19902944|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902945|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19902946|NCT01103063|Renal Agents|renal agents|mesh-ancestor
19902947|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19902948|NCT01103245|Spironolactone|spironolactone|mesh-list
19902949|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19902950|NCT01103245|Diuretics|diuretics|mesh-ancestor
19902951|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
19902952|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902953|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19902954|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19902955|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902956|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19902957|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
19902958|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19902959|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19902960|NCT01103414|Pioglitazone|pioglitazone|mesh-list
19902961|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19902962|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902963|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
19902964|NCT01103440|Tirofiban|tirofiban|mesh-list
19902965|NCT01103440|Ticlopidine|ticlopidine|mesh-list
19902966|NCT01103440|Abciximab|abciximab|mesh-list
19902967|NCT01103440|Clopidogrel|clopidogrel|mesh-list
19902968|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20259697|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20259698|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20259699|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
20259700|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259701|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259702|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20259703|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20259704|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
20259705|NCT00488969|Morphine|morphine|mesh-list
20259706|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20259707|NCT00488969|Narcotics|narcotics|mesh-ancestor
20259708|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259709|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259710|NCT00488969|Analgesics|analgesics|mesh-ancestor
20259711|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
20259712|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259713|NCT00488995|Tremelimumab|tremelimumab|mesh-list
20259714|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259715|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20259716|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20259717|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259718|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259719|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259720|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259721|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259722|NCT00489073|Analgesics|analgesics|mesh-ancestor
20259723|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
20259724|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259725|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259726|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259727|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
20259728|NCT00489099|Vaccines|vaccines|mesh-list
20259729|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
20259730|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259731|NCT00489138|Ertapenem|ertapenem|mesh-list
20259732|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20259733|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259734|NCT00489151|Lamivudine|lamivudine|mesh-list
20259735|NCT00489151|Adefovir|adefovir|mesh-list
20259736|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20259737|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20259738|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20259739|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259740|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259741|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
19902969|NCT01103440|Cangrelor|cangrelor|mesh-list
20259742|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259743|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19902970|NCT01103440|Eptifibatide|eptifibatide|mesh-list
19902971|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19902972|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19902973|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19902974|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19902975|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
19902976|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19902977|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19902978|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19902979|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
19902980|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19902981|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19902982|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19902983|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
19902984|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19902985|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19902986|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
19902987|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902988|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
19902989|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19902990|NCT01103440|Protective Agents|protective agents|mesh-ancestor
19902991|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19902992|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19902993|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971374|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971375|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971376|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19971377|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971378|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971379|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
19971380|NCT01796964|Aflibercept|aflibercept|mesh-list
19971381|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19971382|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19971383|NCT01796964|Growth Substances|growth substances|mesh-ancestor
19971384|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971385|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
19971386|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971387|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
19971388|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19971389|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19971390|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19971391|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971392|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971393|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
19971394|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971395|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971396|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19971397|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971398|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
19971399|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19971400|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19971401|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19971402|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971403|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971404|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
19971405|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971406|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971407|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19971408|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971409|NCT01797120|Everolimus|everolimus|mesh-list
19971410|NCT01797120|Fulvestrant|fulvestrant|mesh-list
19971411|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971412|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971413|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
19971414|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971415|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19971416|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19971417|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19971418|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
19971419|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971420|NCT01797302|Vitamin D|vitamin d|mesh-list
19971421|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
19971422|NCT01797302|Vitamins|vitamins|mesh-ancestor
19971423|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
20259744|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19902994|NCT01103713|Azithromycin|azithromycin|mesh-list
19902995|NCT01103713|Chloroquine|chloroquine|mesh-list
19902996|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19902997|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19902998|NCT01103713|Amebicides|amebicides|mesh-ancestor
19902999|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19903000|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19903001|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
19903002|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19903003|NCT01103778|Bortezomib|bortezomib|mesh-list
19903004|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903005|NCT01103934|Vitamin D|vitamin d|mesh-list
19903006|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
19903007|NCT01103934|Fluticasone|fluticasone|mesh-list
19903008|NCT01103934|Xhance|xhance|mesh-list
19903009|NCT01103934|Vitamins|vitamins|mesh-ancestor
19903010|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
19903011|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903012|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19903013|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19903014|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19903015|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
19903016|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903017|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19903018|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
19903019|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
19903020|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19903021|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19903022|NCT01103960|Amlodipine|amlodipine|mesh-list
19903023|NCT01103960|Telmisartan|telmisartan|mesh-list
19903024|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903025|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19903026|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903027|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903028|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19903029|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903030|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
19903031|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19903032|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19903033|NCT01104025|Dexamethasone|dexamethasone|mesh-list
19903034|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
19903035|NCT01104025|Methotrexate|methotrexate|mesh-list
19903036|NCT01104025|Etoposide|etoposide|mesh-list
20540688|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20540689|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20540690|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
20540691|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540692|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540693|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
20540694|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20540695|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
20540696|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20540697|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
20540698|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540699|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540700|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
19903037|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
19903038|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19903039|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
19903040|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
19903041|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903042|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903043|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19903044|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
19903045|NCT01104025|Hormones|hormones|mesh-ancestor
19903046|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903047|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19903048|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903049|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19903050|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
19903051|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19903052|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19903053|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
19903054|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903055|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540701|NCT01853813|Bevacizumab|bevacizumab|mesh-list
20540702|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19903056|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903057|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19903058|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903059|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
19903060|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19903061|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19903062|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19903063|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19903064|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19903065|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19903066|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903067|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19903068|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903069|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903070|NCT01104246|Testosterone|testosterone|mesh-list
19903071|NCT01104246|Androgens|androgens|mesh-ancestor
19903072|NCT01104246|Hormones|hormones|mesh-ancestor
19903073|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903074|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903075|NCT01104376|Efavirenz|efavirenz|mesh-list
19903076|NCT01104376|Voriconazole|voriconazole|mesh-list
19903077|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19903078|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19903079|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903080|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903081|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
19903082|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903083|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19903084|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19903085|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19903086|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19903087|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19903088|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19903089|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
19903090|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19903091|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19903092|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
19903093|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903094|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903095|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19903096|NCT01104558|Bisoprolol|bisoprolol|mesh-list
19903097|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903098|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
19903099|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
19903100|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903101|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903102|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19903103|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19903104|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19903105|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
19903106|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903107|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903108|NCT01104636|Varenicline|varenicline|mesh-list
19903109|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19903110|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19903111|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
19903112|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903113|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903114|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903115|NCT01104662|Vancomycin|vancomycin|mesh-list
19903116|NCT01104662|Daptomycin|daptomycin|mesh-list
19903117|NCT01104662|Penicillins|penicillins|mesh-list
19903118|NCT01104662|Cloxacillin|cloxacillin|mesh-list
19903119|NCT01104662|Oxacillin|oxacillin|mesh-list
19903120|NCT01104662|Nafcillin|nafcillin|mesh-list
19903121|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19903122|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903123|NCT01104701|Exenatide|exenatide|mesh-list
19903124|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903125|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903126|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19903127|NCT01104701|Incretins|incretins|mesh-ancestor
19903128|NCT01104701|Hormones|hormones|mesh-ancestor
19903129|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903130|NCT01104766|Aripiprazole|aripiprazole|mesh-list
19903131|NCT01104766|Cariprazine|cariprazine|mesh-list
19903132|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903133|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903134|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19903135|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19903136|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903137|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903138|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
19903139|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
19903140|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903141|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903142|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19903143|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19903144|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
19903145|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19903146|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19903147|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19903148|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19903149|NCT01104779|Cariprazine|cariprazine|mesh-list
19903150|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19903151|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19903152|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903153|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903154|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903155|NCT01104792|Cariprazine|cariprazine|mesh-list
19903156|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19903157|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19903158|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903159|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903160|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903161|NCT01104870|Treprostinil|treprostinil|mesh-list
19903162|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903163|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19903164|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903165|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19903166|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19903167|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19903168|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
19903169|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903170|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903171|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903172|NCT01105091|Epoprostenol|epoprostenol|mesh-list
19903173|NCT01105091|Tezosentan|tezosentan|mesh-list
19903174|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903175|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19903176|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
19903177|NCT01105117|Epoprostenol|epoprostenol|mesh-list
19903178|NCT01105117|Tezosentan|tezosentan|mesh-list
19903179|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903180|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19903181|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
19903182|NCT01105312|Letrozole|letrozole|mesh-list
19903183|NCT01105312|Panobinostat|panobinostat|mesh-list
19903184|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903185|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19903186|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19903187|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903188|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903189|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19903190|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
19903191|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903192|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903193|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19903194|NCT01105377|Azacitidine|azacitidine|mesh-list
19903195|NCT01105377|Entinostat|entinostat|mesh-list
19903196|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19903197|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19903198|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
19903199|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903200|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903201|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903202|NCT01105650|Cyclosporine|cyclosporine|mesh-list
19903203|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
19903204|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19903205|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19903206|NCT01105650|Prednisolone|prednisolone|mesh-list
19903207|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
19903208|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
19903209|NCT01105650|Fludarabine|fludarabine|mesh-list
19903210|NCT01105650|Interleukin-2|interleukin-2|mesh-list
19903211|NCT01105650|Cyclosporins|cyclosporins|mesh-list
19903212|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19903213|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
19903214|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903215|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
19903216|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903217|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19903218|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19903219|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
19903220|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903221|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903222|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19903223|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903224|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
19903225|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903226|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
19903227|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19903228|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19903229|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
19903230|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
19903231|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903232|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19903233|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
19903234|NCT01105650|Hormones|hormones|mesh-ancestor
19903235|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903236|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19903237|NCT01105650|Protective Agents|protective agents|mesh-ancestor
19903238|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19903239|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19903240|NCT01105650|Analgesics|analgesics|mesh-ancestor
19903241|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
19903242|NCT01105702|Bevacizumab|bevacizumab|mesh-list
19903243|NCT01105702|Temozolomide|temozolomide|mesh-list
19903244|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
19903245|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19903246|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903247|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19903248|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19903249|NCT01105702|Growth Substances|growth substances|mesh-ancestor
19903250|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903251|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
19903252|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19903253|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
19903254|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903255|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903256|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903257|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903258|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
19903259|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19903260|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903261|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
19903262|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19903263|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19903264|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903265|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
19903266|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
19903267|NCT01105936|Acetaminophen|acetaminophen|mesh-list
19903268|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19903269|NCT01105936|Analgesics|analgesics|mesh-ancestor
19903270|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
19903271|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903272|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903273|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
19903274|NCT01105975|Atorvastatin|atorvastatin|mesh-list
19903275|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19903276|NCT01105975|Simvastatin|simvastatin|mesh-list
19903277|NCT01105975|Evacetrapib|evacetrapib|mesh-list
19903278|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19903279|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19903280|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
19903281|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903282|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19903283|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19903284|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903285|NCT01106014|Selexipag|selexipag|mesh-list
19903286|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903287|NCT01106027|Eculizumab|eculizumab|mesh-list
19903288|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19903289|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903290|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
19903291|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903292|NCT01106092|Vaccines|vaccines|mesh-list
19903293|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
19903294|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903295|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
19903296|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
19903297|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903298|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903299|NCT01106352|Docetaxel|docetaxel|mesh-list
19903300|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19903301|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903302|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
19903303|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
19903304|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
19903305|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903306|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19903307|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19903308|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19903309|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19903310|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903311|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903312|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19903313|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903314|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903315|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19903316|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19903317|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
19903318|NCT01106586|Ritonavir|ritonavir|mesh-list
19903319|NCT01106586|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19903320|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19903321|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19903322|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19903323|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
19903324|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903325|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903326|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19903327|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19903328|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
19903329|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903330|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19903331|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19903332|NCT01106586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19903333|NCT01106586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19903334|NCT01106625|Metformin|metformin|mesh-list
19903335|NCT01106625|Canagliflozin|canagliflozin|mesh-list
19903336|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903337|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903338|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19903339|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903340|NCT01106651|Canagliflozin|canagliflozin|mesh-list
19903341|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19903342|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19903343|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903344|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903345|NCT01106677|Metformin|metformin|mesh-list
19903346|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19903347|NCT01106677|Canagliflozin|canagliflozin|mesh-list
19903348|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903349|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903350|NCT01106677|Incretins|incretins|mesh-ancestor
20259745|NCT00489164|Sirolimus|sirolimus|mesh-list
19903351|NCT01106677|Hormones|hormones|mesh-ancestor
19903352|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903353|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19903354|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
19903355|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903356|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903357|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19903358|NCT01106690|Metformin|metformin|mesh-list
19903359|NCT01106690|Pioglitazone|pioglitazone|mesh-list
19903360|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19903361|NCT01106690|Canagliflozin|canagliflozin|mesh-list
19903362|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903363|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903364|NCT01106690|Incretins|incretins|mesh-ancestor
19903365|NCT01106690|Hormones|hormones|mesh-ancestor
19903366|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903367|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19903368|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
19903369|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903370|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903371|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19903372|NCT01106833|Sirolimus|sirolimus|mesh-list
19903373|NCT01106833|Prednisone|prednisone|mesh-list
19903374|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19903375|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19903376|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
19903377|NCT01106833|Hormones|hormones|mesh-ancestor
19903378|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903379|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903380|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19903381|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903382|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19903383|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903384|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19903385|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
19903386|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903387|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
19903388|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903389|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903390|NCT01106846|Ketamine|ketamine|mesh-list
19903391|NCT01106846|Analgesics|analgesics|mesh-ancestor
19903392|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
19903393|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903394|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903395|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19903396|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19903397|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
19903398|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
19903399|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903400|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19903401|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19903402|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903403|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903404|NCT01106859|Zolpidem|zolpidem|mesh-list
19903405|NCT01106859|Zopiclone|zopiclone|mesh-list
19903406|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19903407|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19903408|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903409|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903410|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19903411|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
19903412|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
19903413|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903414|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903415|NCT01106898|Paclitaxel|paclitaxel|mesh-list
19903416|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
19903417|NCT01106898|Trastuzumab|trastuzumab|mesh-list
19903418|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19903419|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903420|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
19903421|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
19903422|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
20259746|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20259747|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903423|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903424|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903425|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
19903426|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903427|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19903428|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19903429|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
19903430|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19903431|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19903432|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
19903433|NCT01106950|Fludarabine|fludarabine|mesh-list
19903434|NCT01106950|Interleukin-2|interleukin-2|mesh-list
19903435|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
19903436|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903437|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
19903438|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903439|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19903440|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19903441|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
19903442|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903443|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903444|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19903445|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19903446|NCT01106950|Analgesics|analgesics|mesh-ancestor
19903447|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
19903448|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903449|NCT01107353|Imipramine|imipramine|mesh-list
19903450|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19903451|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903452|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903453|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19903454|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19903455|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903456|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903457|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
19903458|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903459|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903460|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
19903461|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19903462|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19903463|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19903464|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903465|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903466|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
19903467|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903468|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903469|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19903470|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903471|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19903472|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19903473|NCT01107444|Docetaxel|docetaxel|mesh-list
19903474|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903475|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
19903476|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
19903477|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
19903478|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903479|NCT01107457|Ixekizumab|ixekizumab|mesh-list
19903480|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
19903481|NCT01107535|Palivizumab|palivizumab|mesh-list
19903482|NCT01107535|Antibodies|antibodies|mesh-list
19903483|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19903484|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
19903485|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903486|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
19903487|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903488|NCT01107626|Paclitaxel|paclitaxel|mesh-list
19903489|NCT01107626|Bevacizumab|bevacizumab|mesh-list
19903490|NCT01107626|Carboplatin|carboplatin|mesh-list
19903491|NCT01107626|Pemetrexed|pemetrexed|mesh-list
19903492|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19903493|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903494|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
19903495|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
19903496|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
19903497|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903498|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19903499|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19903500|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19903501|NCT01107626|Growth Substances|growth substances|mesh-ancestor
19903502|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903503|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
19903504|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903505|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19903506|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19903507|NCT01107665|Paclitaxel|paclitaxel|mesh-list
19903508|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19903509|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903510|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
19903511|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
19903512|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
19903513|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903514|NCT01107730|Ascorbic Acid|ascorbic acid|mesh-list
19903515|NCT01107730|Vitamins|vitamins|mesh-ancestor
19903516|NCT01107730|Micronutrients|micronutrients|mesh-ancestor
19903517|NCT01107730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903518|NCT01107730|Antioxidants|antioxidants|mesh-ancestor
19903519|NCT01107730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903520|NCT01107730|Protective Agents|protective agents|mesh-ancestor
19903521|NCT01107743|Amlodipine|amlodipine|mesh-list
19903522|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19903523|NCT01107743|Atorvastatin|atorvastatin|mesh-list
19903524|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19903525|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19903526|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
19903527|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903528|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19903529|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19903530|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903531|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903532|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19903533|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903534|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20259748|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20259749|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903535|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903536|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
19903537|NCT01107886|Saxagliptin|saxagliptin|mesh-list
19903538|NCT01107886|Incretins|incretins|mesh-ancestor
19903539|NCT01107886|Hormones|hormones|mesh-ancestor
19903540|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903541|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903542|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19903543|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
19903544|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903545|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903546|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903547|NCT01107899|Clopidogrel|clopidogrel|mesh-list
19903548|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19903549|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19903550|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19903551|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19903552|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19903553|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
19903554|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903555|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903556|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903557|NCT01107912|Clopidogrel|clopidogrel|mesh-list
19903558|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19903559|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19903560|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20259750|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
19903561|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19903562|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19903563|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
19903564|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903565|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903566|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903567|NCT01107925|Clopidogrel|clopidogrel|mesh-list
19903568|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19903569|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19903570|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19903571|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19903572|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19903573|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
19903574|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903575|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903576|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903577|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
19903578|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903579|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903580|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903581|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903582|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
19903583|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19903584|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903585|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903586|NCT01108094|Itraconazole|itraconazole|mesh-list
19903587|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
19903588|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903589|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19903590|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19903591|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903592|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903593|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19903594|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
19903595|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903596|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903597|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19903598|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19903599|NCT01108341|Ofatumumab|ofatumumab|mesh-list
19903600|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19903601|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
19903602|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903603|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903604|NCT01108445|Everolimus|everolimus|mesh-list
19903605|NCT01108445|Sunitinib|sunitinib|mesh-list
19903606|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540703|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903607|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903608|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
19903609|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903610|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19903611|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19903612|NCT01108445|Growth Substances|growth substances|mesh-ancestor
19903613|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
19903614|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19903615|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903616|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903617|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19903618|NCT01108458|Pertuzumab|pertuzumab|mesh-list
19903619|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903620|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19903621|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903622|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903623|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19903624|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19903625|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19903626|NCT01108510|Cobicistat|cobicistat|mesh-list
19903627|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19903628|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19903629|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903630|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903631|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
19903632|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903633|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19903634|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19903635|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19903636|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19903637|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
19903638|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19903639|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19903640|NCT01108731|Milnacipran|milnacipran|mesh-list
19903641|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
19903642|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19903643|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19903644|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903645|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903646|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903647|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903648|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19903649|NCT01108731|Analgesics|analgesics|mesh-ancestor
19903650|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
19903651|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903652|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903653|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19971424|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971425|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19971426|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19971427|NCT01797432|Triamcinolone|triamcinolone|mesh-list
19971428|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19971429|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19971430|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19971431|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971432|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
19971433|NCT01797432|Hormones|hormones|mesh-ancestor
19971434|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971435|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971436|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971437|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
19971438|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971439|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971440|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19971441|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19971442|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19971443|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
19971444|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971445|NCT01797484|Ranolazine|ranolazine|mesh-list
19971446|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19971447|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971448|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971449|NCT01797575|Aspirin|aspirin|mesh-list
19971450|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
19971451|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19971452|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19971453|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19971454|NCT01797575|Analgesics|analgesics|mesh-ancestor
19971455|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
19971456|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971457|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971458|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971459|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971460|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19971461|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19971462|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971463|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19971464|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19971465|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971466|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
19971467|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
19971468|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971469|NCT01797575|Expectorants|expectorants|mesh-ancestor
19971470|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971471|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19903654|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19903655|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19903656|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903657|NCT01108757|Renal Agents|renal agents|mesh-ancestor
19903658|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19903659|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
19903660|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19903661|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19903662|NCT01108809|Telmisartan|telmisartan|mesh-list
19903663|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903664|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19903665|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19903666|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903667|NCT01109056|Cyclosporine|cyclosporine|mesh-list
19903668|NCT01109056|Cyclosporins|cyclosporins|mesh-list
19903669|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903670|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903671|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903672|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
19903673|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903674|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
19903675|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903676|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
19903677|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19903678|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19903679|NCT01109173|Nepafenac|nepafenac|mesh-list
19903680|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19903681|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19903682|NCT01109173|Analgesics|analgesics|mesh-ancestor
19903683|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
19903684|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903685|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903686|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19903687|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19903688|NCT01109316|Insulin|insulin|mesh-list
19903689|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19903690|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
19903691|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
19903692|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903693|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903694|NCT01109524|Cetuximab|cetuximab|mesh-list
19903695|NCT01109524|Vinorelbine|vinorelbine|mesh-list
19903696|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903697|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20259751|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259752|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
20259753|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259754|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
20259755|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20259756|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259757|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
20259758|NCT00489229|Ramipril|ramipril|mesh-list
20259759|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20259760|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259761|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20259762|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
20259763|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903698|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19903699|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
19903700|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
19903701|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
19903702|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903703|NCT01109849|Methylphenidate|methylphenidate|mesh-list
19903704|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
19903705|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903706|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19903707|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19903708|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903709|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903710|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
19903711|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903712|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19903713|NCT01109979|Drospirenone|drospirenone|mesh-list
19903714|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19903715|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19903716|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
19903717|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19903718|NCT01109979|Estradiol|estradiol|mesh-list
19903719|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19903720|NCT01109979|Estrogens|estrogens|mesh-ancestor
19903721|NCT01109979|Hormones|hormones|mesh-ancestor
19903722|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903723|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903724|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19903725|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
19903726|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19903727|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19903728|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19903729|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19903730|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19903731|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19903732|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19903733|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903734|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19903735|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
19903736|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19903737|NCT01109979|Diuretics|diuretics|mesh-ancestor
19903738|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
19903739|NCT01109992|Regadenoson|regadenoson|mesh-list
19903740|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19903741|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19903742|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
19903743|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
19903744|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903745|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903746|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903747|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19903748|NCT01110135|Dexamethasone|dexamethasone|mesh-list
19903749|NCT01110135|Etoposide|etoposide|mesh-list
19903750|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
19903751|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19903752|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19903753|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
19903754|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
19903755|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903756|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903757|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19903758|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
19903759|NCT01110135|Hormones|hormones|mesh-ancestor
19903760|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903761|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19903762|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903763|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19903764|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19903765|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19903766|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903767|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903768|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19903769|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
19903770|NCT01110187|Lacosamide|lacosamide|mesh-list
19903771|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
19903772|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
19903773|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19903774|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19903775|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903776|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903777|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19903778|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19903779|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19903780|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
19903781|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903782|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903783|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19903784|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
19903785|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19903786|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19903787|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19903788|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
19903789|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903790|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903791|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
19903792|NCT01110200|Hormones|hormones|mesh-ancestor
19903793|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903794|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
19903795|NCT01110330|Ketoconazole|ketoconazole|mesh-list
19903796|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
19903797|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903798|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19903799|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19903800|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903801|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903802|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19903803|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
19903804|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903805|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903806|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19903807|NCT01110382|Amoxicillin|amoxicillin|mesh-list
19903808|NCT01110382|Meropenem|meropenem|mesh-list
19903809|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
19903810|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
19903811|NCT01110382|Doripenem|doripenem|mesh-list
19903812|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19903813|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19903814|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903815|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19903816|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903817|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903818|NCT01110408|Amoxicillin|amoxicillin|mesh-list
19903819|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
19903820|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
19903821|NCT01110408|Cefepime|cefepime|mesh-list
19903822|NCT01110408|Doripenem|doripenem|mesh-list
19903823|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19903824|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19903825|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903826|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19903827|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903828|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903829|NCT01110421|Amoxicillin|amoxicillin|mesh-list
19903830|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
19903831|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
19903832|NCT01110421|Cefepime|cefepime|mesh-list
19903833|NCT01110421|Doripenem|doripenem|mesh-list
19903834|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19903835|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19903836|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903837|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19903838|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903839|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903840|NCT01110434|Topiramate|topiramate|mesh-list
19903841|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
19903842|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903843|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903844|NCT01110499|Bimatoprost|bimatoprost|mesh-list
19903845|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19903846|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19903847|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19903848|NCT01110707|Hormones|hormones|mesh-list
19903849|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19903850|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903851|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903852|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19903853|NCT01110876|Temozolomide|temozolomide|mesh-list
19903854|NCT01110876|Vorinostat|vorinostat|mesh-list
19903855|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903856|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19903857|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903858|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903859|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19903860|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
19903861|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19903862|NCT01111058|Everolimus|everolimus|mesh-list
19903863|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903864|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903865|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
19903866|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903867|NCT01111123|Halobetasol|halobetasol|mesh-list
19903868|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19903869|NCT01111149|Bupropion|bupropion|mesh-list
19903870|NCT01111149|Varenicline|varenicline|mesh-list
19903871|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19903872|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903873|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903874|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19903875|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19903876|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903877|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903878|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
19903879|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903880|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903881|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19903882|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19903883|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903884|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19903885|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19903886|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
19903887|NCT01111162|Vaccines|vaccines|mesh-list
19903888|NCT01111162|Immunologic Factors|immunologic factors|mesh-ancestor
19903889|NCT01111162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903890|NCT01111292|Inositol|inositol|mesh-list
19903891|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
19903892|NCT01111292|Vitamins|vitamins|mesh-ancestor
19903893|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
19903894|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903895|NCT01111318|Empagliflozin|empagliflozin|mesh-list
19903896|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19903897|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903898|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903899|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903900|NCT01111331|Empagliflozin|empagliflozin|mesh-list
19903901|NCT01111331|Warfarin|warfarin|mesh-list
19903902|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
19903903|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19903904|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903905|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19903906|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903907|NCT01111461|Lenvatinib|lenvatinib|mesh-list
19903908|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903909|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19903910|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903911|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903912|NCT01111526|Panobinostat|panobinostat|mesh-list
19903913|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903914|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19903915|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903916|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903917|NCT01111539|Aripiprazole|aripiprazole|mesh-list
19903918|NCT01111539|Citalopram|citalopram|mesh-list
19903919|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19903920|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19903921|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903922|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903923|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903924|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
19903925|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903926|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19903927|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903928|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903929|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19903930|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19903931|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903932|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
19903933|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
19903934|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19903935|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19903936|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19903937|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19903938|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19903939|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19903940|NCT01111552|Aripiprazole|aripiprazole|mesh-list
19903941|NCT01111552|Citalopram|citalopram|mesh-list
19903942|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19903943|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19903944|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19903945|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903946|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903947|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
19903948|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903949|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19903950|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
19903951|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19903952|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19903953|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19903954|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19903955|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
19903956|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
19903957|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19903958|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19903959|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19903960|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19903961|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19903962|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19903963|NCT01111604|Ramucirumab|ramucirumab|mesh-list
19903964|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903965|NCT01111825|Sirolimus|sirolimus|mesh-list
19903966|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19903967|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19903968|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19903969|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903970|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
19903971|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19903972|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
19903973|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903974|NCT01111851|Dexamethasone|dexamethasone|mesh-list
19903975|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
19903976|NCT01111851|Ondansetron|ondansetron|mesh-list
19903977|NCT01111851|Aprepitant|aprepitant|mesh-list
19903978|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
19903979|NCT01111851|BB 1101|bb 1101|mesh-list
19903980|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19903981|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
19903982|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
19903983|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19903984|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19903985|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19903986|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
19903987|NCT01111851|Hormones|hormones|mesh-ancestor
19903988|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19903989|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19903990|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19903991|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
19903992|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19903993|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19903994|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
19903995|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
19903996|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19903997|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
19903998|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19903999|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19904000|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19904001|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904002|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19904003|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19904004|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19904005|NCT01112059|Doxycycline|doxycycline|mesh-list
19904006|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19904007|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904008|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
19904009|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19904010|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19904011|NCT01112241|Albuterol|albuterol|mesh-list
19904012|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
19904013|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19904014|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
19904015|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904016|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904017|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19904018|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904019|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
19904020|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19904021|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
19904022|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904023|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904024|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
19904025|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19904026|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19904027|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19904028|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19904029|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
19904030|NCT01112267|Acetaminophen|acetaminophen|mesh-list
19904031|NCT01112267|Tramadol|tramadol|mesh-list
19904032|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19904033|NCT01112267|Analgesics|analgesics|mesh-ancestor
19904034|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
19904035|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904036|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904037|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
19904038|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19904039|NCT01112267|Narcotics|narcotics|mesh-ancestor
19904040|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904041|NCT01112358|Cetrorelix|cetrorelix|mesh-list
19904042|NCT01112358|Progesterone|progesterone|mesh-list
19904043|NCT01112358|Progestins|progestins|mesh-ancestor
19904044|NCT01112358|Hormones|hormones|mesh-ancestor
19904045|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904046|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904047|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19904048|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
19904049|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19904050|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
19904051|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19904052|NCT01112670|Atorvastatin|atorvastatin|mesh-list
19904053|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19904054|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19904055|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
19904056|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904057|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19904058|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19904059|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904060|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19904061|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259764|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259765|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20259766|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
20259767|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20259768|NCT00489372|Protective Agents|protective agents|mesh-ancestor
20259769|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259770|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259771|NCT00489385|Ribavirin|ribavirin|mesh-list
20259772|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
20259773|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259774|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
20259775|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259776|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20259777|NCT00489398|Epinastine|epinastine|mesh-list
20259778|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20259779|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20259780|NCT00489398|Analgesics|analgesics|mesh-ancestor
20259781|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
20259782|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259783|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259784|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904062|NCT01112670|Incretins|incretins|mesh-ancestor
19904063|NCT01112670|Hormones|hormones|mesh-ancestor
19904064|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904065|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19904066|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
19904067|NCT01112683|Memantine|memantine|mesh-list
19904068|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19904069|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19904070|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
19904071|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904072|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904073|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904074|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19904075|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19904076|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19904077|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
19904078|NCT01112735|Coagulants|coagulants|mesh-ancestor
19904079|NCT01112982|Colchicine|colchicine|mesh-list
19904080|NCT01112982|Febuxostat|febuxostat|mesh-list
19904081|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
19904082|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904083|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
19904084|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
19904085|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
19904086|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904087|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904088|NCT01113398|Bevacizumab|bevacizumab|mesh-list
19904089|NCT01113398|Rilotumumab|rilotumumab|mesh-list
19904090|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904091|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904092|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19904093|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19904094|NCT01113398|Growth Substances|growth substances|mesh-ancestor
19904095|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904096|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
19904097|NCT01113541|Ziprasidone|ziprasidone|mesh-list
19904098|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19904099|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
19904100|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904101|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904102|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259785|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20259786|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20259787|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20259788|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20259789|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
20259790|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
20259791|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259792|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259793|NCT00489437|Heparin|heparin|mesh-list
20259794|NCT00489437|Antibodies|antibodies|mesh-list
20259795|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
20259796|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259797|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
20259798|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20259799|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20259800|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259801|NCT00489528|Hormones|hormones|mesh-list
20259802|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259803|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259804|NCT00489593|Olanzapine|olanzapine|mesh-list
20259805|NCT00489593|Fluoxetine|fluoxetine|mesh-list
20259806|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
20259807|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
20259808|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259809|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259810|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20259811|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20259812|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20259813|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20259814|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259815|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20259816|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259817|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259818|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904103|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19904104|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19904105|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904106|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19904107|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19904108|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
19904109|NCT01113632|Ofatumumab|ofatumumab|mesh-list
19904110|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904111|NCT01113710|Rotigotine|rotigotine|mesh-list
19904112|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
19904113|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
19904114|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904115|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904116|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904117|NCT01113931|Doxycycline|doxycycline|mesh-list
19904118|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19904119|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904120|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
19904121|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19904122|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19904123|NCT01114360|Melatonin|melatonin|mesh-list
19904124|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
19904125|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904126|NCT01114360|Protective Agents|protective agents|mesh-ancestor
19904127|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904128|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904129|NCT01114373|Melatonin|melatonin|mesh-list
19904130|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
19904131|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904132|NCT01114373|Protective Agents|protective agents|mesh-ancestor
19904133|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904134|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904135|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
19904136|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19904137|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19904138|NCT01114503|Prednisolone|prednisolone|mesh-list
19904139|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
19904140|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19904141|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
19904142|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904143|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
19904144|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
19904145|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904146|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904147|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904148|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
19904149|NCT01114503|Hormones|hormones|mesh-ancestor
19904150|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904151|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19904152|NCT01114503|Protective Agents|protective agents|mesh-ancestor
19904153|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19904154|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904155|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19904156|NCT01114516|Clindamycin|clindamycin|mesh-list
19904157|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
19904158|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
19904159|NCT01114516|Cefazolin|cefazolin|mesh-list
19904160|NCT01114516|Indomethacin|indomethacin|mesh-list
19904161|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904162|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19904163|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904164|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904165|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19904166|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19904167|NCT01114516|Analgesics|analgesics|mesh-ancestor
19904168|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
19904169|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904170|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904171|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904172|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904173|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
19904174|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
19904175|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19904176|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19904177|NCT01114529|Cyclosporine|cyclosporine|mesh-list
20259819|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259820|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
19904178|NCT01114529|Everolimus|everolimus|mesh-list
20259821|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19904179|NCT01114529|Tacrolimus|tacrolimus|mesh-list
19904180|NCT01114529|Cyclosporins|cyclosporins|mesh-list
19904181|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19904182|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
19904183|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904184|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19904185|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904186|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904187|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
19904188|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904189|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
19904190|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904191|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904192|NCT01114555|Bevacizumab|bevacizumab|mesh-list
19904193|NCT01114555|Irinotecan|irinotecan|mesh-list
19904194|NCT01114555|Temozolomide|temozolomide|mesh-list
19904195|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904196|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904197|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19904198|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19904199|NCT01114555|Growth Substances|growth substances|mesh-ancestor
19904200|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904201|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
19904202|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19904203|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19904204|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904205|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904206|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19904207|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
19904208|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
19904209|NCT01114581|Guaifenesin|guaifenesin|mesh-list
19904210|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19904211|NCT01114581|Expectorants|expectorants|mesh-ancestor
19904212|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904213|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19904214|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19904215|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19904216|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904217|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904218|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904219|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
19904220|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19904221|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
19904222|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
19904223|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904224|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
19904225|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19904226|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
19904227|NCT01114672|Vitamin D|vitamin d|mesh-list
19904228|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19904229|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904230|NCT01114672|Vitamins|vitamins|mesh-ancestor
19904231|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
19904232|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19904233|NCT01114737|Verapamil|verapamil|mesh-list
19904234|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19904235|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19904236|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904237|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904238|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19904239|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904240|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
19904241|NCT01114828|Tolvaptan|tolvaptan|mesh-list
19904242|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19904243|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904244|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
19904245|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971472|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
19971473|NCT01797575|Protective Agents|protective agents|mesh-ancestor
19971474|NCT01797575|Antidotes|antidotes|mesh-ancestor
19971475|NCT01797822|Dexamethasone|dexamethasone|mesh-list
19971476|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
19971477|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971478|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
19971479|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
19971480|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904246|NCT01114880|Adalimumab|adalimumab|mesh-list
19904247|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904248|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904249|NCT01114893|Travoprost|travoprost|mesh-list
19904250|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19904251|NCT01114971|Labetalol|labetalol|mesh-list
19904252|NCT01114971|Fentanyl|fentanyl|mesh-list
19904253|NCT01114971|Esmolol|esmolol|mesh-list
19904254|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19904255|NCT01114971|Narcotics|narcotics|mesh-ancestor
19904256|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904257|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904258|NCT01114971|Analgesics|analgesics|mesh-ancestor
19904259|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
19904260|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904261|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19904262|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19904263|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
19904264|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
19904265|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19904266|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19904267|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19904268|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
19904269|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904270|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904271|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19904272|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
19904273|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
19904274|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19904275|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19904276|NCT01114997|Lidocaine|lidocaine|mesh-list
19904277|NCT01114997|Esmolol|esmolol|mesh-list
19904278|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
19904279|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
19904280|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904281|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904282|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
19904283|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904284|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19904285|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19904286|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19904287|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904288|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904289|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19904290|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19904291|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19904292|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
19904293|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904294|NCT01115101|Pirinitramide|pirinitramide|mesh-list
19904295|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19904296|NCT01115101|Narcotics|narcotics|mesh-ancestor
19904297|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904298|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904299|NCT01115101|Analgesics|analgesics|mesh-ancestor
19904300|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
19904301|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904302|NCT01115491|Bevacizumab|bevacizumab|mesh-list
19904303|NCT01115491|Temozolomide|temozolomide|mesh-list
19904304|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904305|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904306|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19904307|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19904308|NCT01115491|Growth Substances|growth substances|mesh-ancestor
19904309|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904310|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
19904311|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19904312|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
19904313|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904314|NCT01115517|Bevacizumab|bevacizumab|mesh-list
19904315|NCT01115517|Mitomycins|mitomycins|mesh-list
19904316|NCT01115517|Mitomycin|mitomycin|mesh-list
19904317|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904318|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904319|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19904320|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19904321|NCT01115517|Growth Substances|growth substances|mesh-ancestor
19904322|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904323|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
19904324|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19904325|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
19904326|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904327|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19904328|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904329|NCT01115556|Ranibizumab|ranibizumab|mesh-list
19904330|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19904331|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19904332|NCT01115556|Growth Substances|growth substances|mesh-ancestor
19904333|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904334|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
19904335|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904336|NCT01115569|Hydrocodone|hydrocodone|mesh-list
19904337|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19904338|NCT01115569|Narcotics|narcotics|mesh-ancestor
19904339|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904340|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904341|NCT01115569|Analgesics|analgesics|mesh-ancestor
19904342|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
19904343|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904344|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
19904345|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904346|NCT01115582|Cholic Acids|cholic acids|mesh-list
19904347|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904348|NCT01115673|Acetaminophen|acetaminophen|mesh-list
19904349|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19904350|NCT01115673|Analgesics|analgesics|mesh-ancestor
19904351|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
19904352|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904353|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904354|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
19904355|NCT01115738|Clopidogrel|clopidogrel|mesh-list
19904356|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19904357|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19904358|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19904359|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19904360|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19904361|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
19904362|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904363|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904364|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904365|NCT01115803|Everolimus|everolimus|mesh-list
19904366|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19904367|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904368|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19904369|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
19904370|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904371|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19904372|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904373|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904374|NCT01115855|Eplerenone|eplerenone|mesh-list
19904375|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19904376|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
19904377|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904378|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904379|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19904380|NCT01115855|Diuretics|diuretics|mesh-ancestor
19904381|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
19904382|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19904383|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19904384|NCT01116401|Leuprolide|leuprolide|mesh-list
19904385|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19904386|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
19904387|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19904388|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904389|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19904390|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904391|NCT01116427|Abatacept|abatacept|mesh-list
19904392|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19904393|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904394|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904395|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259822|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259823|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20259824|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20259825|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259826|NCT00489645|Pramlintide|pramlintide|mesh-list
20259827|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20259828|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20259829|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259830|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
20259831|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20259832|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
20259833|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259834|NCT00489658|Eflornithine|eflornithine|mesh-list
20259835|NCT00489658|Nifurtimox|nifurtimox|mesh-list
20259836|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259837|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20259838|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20259839|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20259840|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259841|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
20259842|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259843|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259844|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20259845|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259846|NCT00489723|Tamsulosin|tamsulosin|mesh-list
20259847|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20259848|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20259849|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20259850|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259851|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259852|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259853|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259854|NCT00489723|Urological Agents|urological agents|mesh-ancestor
20259855|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20259856|NCT00489775|Paroxetine|paroxetine|mesh-list
20259857|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20540704|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20540705|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19904396|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
19904397|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904398|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904399|NCT01116687|R04929097|r04929097|mesh-list
19904400|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540706|NCT01853813|Growth Substances|growth substances|mesh-ancestor
20540707|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540708|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
20540709|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
20540710|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
20540711|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540712|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540713|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540714|NCT01853956|Alprazolam|alprazolam|mesh-list
20540715|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20540716|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540717|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904401|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904402|NCT01116739|Fluorides|fluorides|mesh-list
19904403|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
19904404|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
19904405|NCT01116739|Protective Agents|protective agents|mesh-ancestor
19904406|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904407|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19904408|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904409|NCT01116986|Nicotine|nicotine|mesh-list
19904410|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19904411|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
19904412|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904413|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904414|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19904415|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19904416|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
19904417|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904418|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904419|NCT01117012|Ivacaftor|ivacaftor|mesh-list
19904420|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19904421|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904422|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904423|NCT01117051|Prucalopride|prucalopride|mesh-list
19904424|NCT01117051|Laxatives|laxatives|mesh-ancestor
19904425|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904426|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19904427|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19904428|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
19904429|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904430|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904431|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904432|NCT01117181|Methylphenidate|methylphenidate|mesh-list
19904433|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19904434|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904435|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19904436|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19904437|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904438|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904439|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
19904440|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904441|NCT01117350|Metformin|metformin|mesh-list
19904442|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
19904443|NCT01117350|Liraglutide|liraglutide|mesh-list
19904444|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19904445|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904446|NCT01117350|Incretins|incretins|mesh-ancestor
19904447|NCT01117350|Hormones|hormones|mesh-ancestor
19904448|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904449|NCT01117454|Flecainide|flecainide|mesh-list
19904450|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19904451|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19904452|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19904453|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904454|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904455|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904456|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19904457|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19904458|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19904459|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904460|NCT01117766|Pregabalin|pregabalin|mesh-list
19904461|NCT01117766|Analgesics|analgesics|mesh-ancestor
19904462|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
19904463|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904464|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904465|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
19904466|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19904467|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904468|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904469|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19904470|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19904471|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19904472|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904473|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19904474|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19904475|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19904476|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19904477|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904478|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904479|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904480|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904481|NCT01117857|Analgesics|analgesics|mesh-ancestor
19904482|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
19904483|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904484|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
19904485|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19904486|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
19904487|NCT01117948|Lornoxicam|lornoxicam|mesh-list
19904488|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19904489|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19904490|NCT01117948|Analgesics|analgesics|mesh-ancestor
19904491|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
19904492|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540718|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20540719|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20540720|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20540721|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
20540722|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
20540723|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540724|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540725|NCT01854021|Anesthetics|anesthetics|mesh-list
20540726|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540727|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904493|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904494|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904495|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904496|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
19904497|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904498|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19904499|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904500|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904501|NCT01118091|Aldesleukin|aldesleukin|mesh-list
19904502|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904503|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19904504|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19904505|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
19904506|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904507|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
19904508|NCT01118273|Promethazine|promethazine|mesh-list
19904509|NCT01118273|Ibuprofen|ibuprofen|mesh-list
19904510|NCT01118273|Naproxen|naproxen|mesh-list
19904511|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904512|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19904513|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19904514|NCT01118273|Analgesics|analgesics|mesh-ancestor
19904515|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
19904516|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904517|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904518|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904519|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904520|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19904521|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904522|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
19904523|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19904524|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19904525|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904526|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
19904527|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
19904528|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
19904529|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
19904530|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904531|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19904532|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
19904533|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
19904534|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904535|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19904536|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
19904537|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
19904538|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
19904539|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20540728|NCT01854073|Scopolamine|scopolamine|mesh-list
20540729|NCT01854073|Bromides|bromides|mesh-list
20540730|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20540731|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
20540732|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19904540|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
19904541|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19904542|NCT01118325|Clopidogrel|clopidogrel|mesh-list
19904543|NCT01118325|Ticagrelor|ticagrelor|mesh-list
19904544|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19904545|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20540733|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
20540734|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
20540735|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904546|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19904547|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19904548|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
19904549|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904550|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904551|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904552|NCT01118351|Sunitinib|sunitinib|mesh-list
19904553|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904554|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19904555|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19904556|NCT01118351|Growth Substances|growth substances|mesh-ancestor
19904557|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904558|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
19904559|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19904560|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904561|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904562|NCT01118377|Capecitabine|capecitabine|mesh-list
19904563|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19904564|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
19904565|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904566|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904567|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
19904568|NCT01118520|Amlodipine|amlodipine|mesh-list
19904569|NCT01118520|Perindopril|perindopril|mesh-list
19904570|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19904571|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19904572|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904573|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904574|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19904575|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904576|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
19904577|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19904578|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
19904579|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904580|NCT01118624|Vitamins|vitamins|mesh-list
19904581|NCT01118624|Folic Acid|folic acid|mesh-list
19904582|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
19904583|NCT01118624|Hydroxocobalamin|hydroxocobalamin|mesh-list
19904584|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
19904585|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19904586|NCT01118624|Aminopterin|aminopterin|mesh-list
19904587|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
19904588|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904589|NCT01118624|Hematinics|hematinics|mesh-ancestor
19904590|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19904591|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904592|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904593|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904594|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
19904595|NCT01118663|Edetic Acid|edetic acid|mesh-list
19904596|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19904597|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
19904598|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
19904599|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904600|NCT01118663|Expectorants|expectorants|mesh-ancestor
19904601|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904602|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19904603|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
19904604|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904605|NCT01118663|Protective Agents|protective agents|mesh-ancestor
20259858|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20259859|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20259860|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259861|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259862|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259863|NCT00489775|Analgesics|analgesics|mesh-ancestor
20259864|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
20259865|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259866|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
20259867|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20259868|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
20259869|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20259870|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
20259871|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20259872|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19904606|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904607|NCT01118663|Antidotes|antidotes|mesh-ancestor
19904608|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
19904609|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19904610|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
19904611|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
19904612|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19904613|NCT01118741|Disulfiram|disulfiram|mesh-list
19904614|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19904615|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19904616|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904617|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904618|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19904619|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19904620|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19904621|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904622|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904623|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904624|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904625|NCT01118780|Analgesics|analgesics|mesh-ancestor
19904626|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
19904627|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904628|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
19904629|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19904630|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
19904631|NCT01118845|Rituximab|rituximab|mesh-list
19904632|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19904633|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904634|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904635|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
19904636|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904637|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904638|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19904639|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
19904640|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904641|NCT01118949|Lacosamide|lacosamide|mesh-list
19904642|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
19904643|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19904644|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19904645|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904646|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904647|NCT01118962|Lacosamide|lacosamide|mesh-list
19904648|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
19904649|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19904650|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19904651|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19904652|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904653|NCT01118975|Lapatinib|lapatinib|mesh-list
19904654|NCT01118975|Vorinostat|vorinostat|mesh-list
19904655|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904656|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19904657|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904658|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904659|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19904660|NCT01119105|Vancomycin|vancomycin|mesh-list
19904661|NCT01119105|Lefamulin|lefamulin|mesh-list
19904662|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19904663|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904664|NCT01119131|Vitamin D|vitamin d|mesh-list
19904665|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
19904666|NCT01119131|Calcium|calcium|mesh-list
19904667|NCT01119131|Vitamins|vitamins|mesh-ancestor
19904668|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
19904669|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904670|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19904671|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19904672|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
19904673|NCT01119222|Promethazine|promethazine|mesh-list
19904674|NCT01119222|Morphine|morphine|mesh-list
19904675|NCT01119222|Gabapentin|gabapentin|mesh-list
19904676|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19904677|NCT01119222|Narcotics|narcotics|mesh-ancestor
19904678|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904679|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904680|NCT01119222|Analgesics|analgesics|mesh-ancestor
19904681|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
19904682|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904683|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
19904684|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19904685|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19904686|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19904687|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19904688|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19904689|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904690|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904691|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
19904692|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19904693|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19904694|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
19904695|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
19904696|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
19904697|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
19904698|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904699|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19904700|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
19904701|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
19904702|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19904703|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
19904704|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
19904705|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19904706|NCT01119287|Dexamethasone|dexamethasone|mesh-list
19904707|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19904708|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904709|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
19904710|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
19904711|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904712|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904713|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904714|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
19904715|NCT01119287|Hormones|hormones|mesh-ancestor
19904716|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904717|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19904718|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904719|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19904720|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19904721|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19904722|NCT01119287|Analgesics|analgesics|mesh-ancestor
19904723|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
19904724|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904725|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19904726|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19904727|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19904728|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
19904729|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
19904730|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904731|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904732|NCT01119508|Temozolomide|temozolomide|mesh-list
19904733|NCT01119508|Ipilimumab|ipilimumab|mesh-list
19904734|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19904735|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
19904736|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904737|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904738|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904739|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19904740|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19904741|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
19904742|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904743|NCT01119703|Vaccines|vaccines|mesh-list
19904744|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
19904745|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904746|NCT01119768|Esomeprazole|esomeprazole|mesh-list
19904747|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19904748|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904749|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19904750|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904751|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904752|NCT01119794|Bortezomib|bortezomib|mesh-list
19904753|NCT01119794|Ofatumumab|ofatumumab|mesh-list
19904754|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904755|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19904756|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19904757|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904758|NCT01119846|Incretins|incretins|mesh-ancestor
19904759|NCT01119846|Hormones|hormones|mesh-ancestor
19904760|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904761|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19904762|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
19904763|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904764|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904765|NCT01119859|Adalimumab|adalimumab|mesh-list
19904766|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904767|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971481|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971482|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971483|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
19971484|NCT01797822|Hormones|hormones|mesh-ancestor
19971485|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971486|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19971487|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971488|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19971489|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19971490|NCT01797965|Daclizumab|daclizumab|mesh-list
19971491|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971492|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
19971493|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971494|NCT01798056|Vaccines|vaccines|mesh-list
19971495|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
19971496|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971497|NCT01798225|Doxycycline|doxycycline|mesh-list
19971498|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971499|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971500|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
19971501|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19971502|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19971503|NCT01798264|Exenatide|exenatide|mesh-list
19971504|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19971505|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971506|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19971507|NCT01798264|Incretins|incretins|mesh-ancestor
19971508|NCT01798264|Hormones|hormones|mesh-ancestor
19971509|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971510|NCT01798316|Acetaminophen|acetaminophen|mesh-list
19971511|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19971512|NCT01798316|Analgesics|analgesics|mesh-ancestor
19971513|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
19971514|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971515|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971516|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
19971517|NCT01798394|Progesterone|progesterone|mesh-list
19971518|NCT01798394|Progestins|progestins|mesh-ancestor
19971519|NCT01798394|Hormones|hormones|mesh-ancestor
19971520|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971521|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971522|NCT01798485|Docetaxel|docetaxel|mesh-list
19971523|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971524|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
19971525|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
19971526|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
19971527|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971528|NCT01798550|Enoxaparin|enoxaparin|mesh-list
19971529|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
19971530|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19971531|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19971532|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971533|NCT01798706|Lixisenatide|lixisenatide|mesh-list
19971534|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19971535|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971536|NCT01798992|Metoprolol|metoprolol|mesh-list
19971537|NCT01798992|Carvedilol|carvedilol|mesh-list
19971538|NCT01798992|Doxazosin|doxazosin|mesh-list
19971539|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19971540|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19971541|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
19971542|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
19971543|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971544|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971545|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20259873|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20259874|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971546|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19904768|NCT01119898|Diclofenac|diclofenac|mesh-list
19904769|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19904770|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19904771|NCT01119898|Analgesics|analgesics|mesh-ancestor
19904772|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
19904773|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904774|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904775|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19904776|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19904777|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19904778|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904779|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904780|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
19904781|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
19904782|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20259875|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
20259876|NCT00489840|Anecortave|anecortave|mesh-list
20259877|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20259878|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20259879|NCT00489840|Growth Substances|growth substances|mesh-ancestor
20259880|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259881|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
20259882|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259883|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259884|NCT00489892|Modafinil|modafinil|mesh-list
20259885|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20259886|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259887|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20259888|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20259889|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20259890|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259891|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
20540736|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540737|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540738|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
20540739|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20540740|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
20540741|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540742|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540743|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20540744|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
20540745|NCT01854086|Diphosphonates|diphosphonates|mesh-list
20540746|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20540747|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540748|NCT01854203|Gemcitabine|gemcitabine|mesh-list
20540749|NCT01854203|Cisplatin|cisplatin|mesh-list
20540750|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540751|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20540752|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
20540753|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540754|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
20540755|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540756|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540757|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540758|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
20540759|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540760|NCT01854216|Rotigotine|rotigotine|mesh-list
20540761|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
20540762|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
20540763|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540764|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540765|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540766|NCT01854255|Cisplatin|cisplatin|mesh-list
20540767|NCT01854255|Doxorubicin|doxorubicin|mesh-list
20540768|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20540769|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540770|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20540771|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20540772|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20540773|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540774|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540775|NCT01854411|Analgesics|analgesics|mesh-list
19904783|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
20540776|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
19904784|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904785|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904786|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19904787|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904788|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
19904789|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19904790|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
19904791|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904792|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904793|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19904794|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19904795|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
19904796|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19904797|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19904798|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19904799|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
19904800|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904801|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904802|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904803|NCT01119963|Castor Oil|castor oil|mesh-list
19904804|NCT01119963|Progesterone|progesterone|mesh-list
19904805|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
19904806|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
19904807|NCT01119963|Progestins|progestins|mesh-ancestor
19904808|NCT01119963|Hormones|hormones|mesh-ancestor
19904809|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904810|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904811|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19904812|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
19904813|NCT01119963|Cathartics|cathartics|mesh-ancestor
19904814|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904815|NCT01120028|Sirolimus|sirolimus|mesh-list
19904816|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
19904817|NCT01120028|Tacrolimus|tacrolimus|mesh-list
19904818|NCT01120028|Basiliximab|basiliximab|mesh-list
19904819|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19904820|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
19904821|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904822|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19904823|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904824|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904825|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19904826|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904827|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19904828|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904829|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
19904830|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904831|NCT01120093|Bromides|bromides|mesh-list
19904832|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
19904833|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19904834|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
19904835|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904836|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904837|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19904838|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904839|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19904840|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19904841|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19904842|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
19904843|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904844|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904845|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
19904846|NCT01120184|Paclitaxel|paclitaxel|mesh-list
19904847|NCT01120184|Maytansine|maytansine|mesh-list
19904848|NCT01120184|Docetaxel|docetaxel|mesh-list
19904849|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19904850|NCT01120184|Trastuzumab|trastuzumab|mesh-list
19904851|NCT01120184|Pertuzumab|pertuzumab|mesh-list
19904852|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19904853|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904854|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
19904855|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
19904856|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
19904857|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904858|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19904859|NCT01120236|Leuprolide|leuprolide|mesh-list
19904860|NCT01120236|Goserelin|goserelin|mesh-list
19904861|NCT01120236|Bicalutamide|bicalutamide|mesh-list
19904862|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19904863|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19904864|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
19904865|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19904866|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904867|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19904868|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904869|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
19904870|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
19904871|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904872|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
19904873|NCT01120275|R04929097|r04929097|mesh-list
19904874|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904875|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904876|NCT01120405|Sevoflurane|sevoflurane|mesh-list
19904877|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19904878|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19904879|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
19904880|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
19904881|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19904882|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904883|NCT01120600|Vitamin D|vitamin d|mesh-list
19904884|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
19904885|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
19904886|NCT01120600|Calcium|calcium|mesh-list
19904887|NCT01120600|Vitamins|vitamins|mesh-ancestor
19904888|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
19904889|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904890|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19904891|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19904892|NCT01120600|Antacids|antacids|mesh-ancestor
19904893|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904894|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19904895|NCT01120626|Donepezil|donepezil|mesh-list
19904896|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19904897|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904898|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904899|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
19904900|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904901|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904902|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
19904903|NCT01120639|Temozolomide|temozolomide|mesh-list
19904904|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19904905|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
19904906|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904907|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904908|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
19904909|NCT01120691|Albuterol|albuterol|mesh-list
19904910|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
19732329|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732330|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19732331|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19732332|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19732333|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
19732334|NCT04575194|Liraglutide|liraglutide|mesh-list
19732335|NCT04575194|Naltrexone|naltrexone|mesh-list
19732336|NCT04575194|Bupropion|bupropion|mesh-list
19732337|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19732338|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19904911|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19904912|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
19904913|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904914|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904915|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19904916|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
19904917|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
19904918|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19904919|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
19904920|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904921|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904922|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
19904923|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19904924|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19904925|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19904926|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19904927|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
19904928|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19904929|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19904930|NCT01120704|Nicotine|nicotine|mesh-list
19904931|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19904932|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
19904933|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19904934|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904935|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19904936|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19904937|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
19904938|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904939|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904940|NCT01120834|Azacitidine|azacitidine|mesh-list
19904941|NCT01120834|Vorinostat|vorinostat|mesh-list
19904942|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19904943|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
19904944|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904945|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904946|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904947|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19904948|NCT01120899|Minocycline|minocycline|mesh-list
19904949|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19904950|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904951|NCT01121211|Testosterone|testosterone|mesh-list
19904952|NCT01121211|Androgens|androgens|mesh-ancestor
19904953|NCT01121211|Hormones|hormones|mesh-ancestor
19904954|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19904955|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904956|NCT01121224|Clopidogrel|clopidogrel|mesh-list
19904957|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19904958|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19904959|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19904960|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19904961|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
19904962|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19904963|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904964|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904965|NCT01121393|Gemcitabine|gemcitabine|mesh-list
19904966|NCT01121393|Afatinib|afatinib|mesh-list
19904967|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904968|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19904969|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
19904970|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904971|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
19904972|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904973|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904974|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19904975|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
19904976|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904977|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19904978|NCT01121406|Gemcitabine|gemcitabine|mesh-list
19904979|NCT01121406|Paclitaxel|paclitaxel|mesh-list
19904980|NCT01121406|Doxorubicin|doxorubicin|mesh-list
19904981|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19904982|NCT01121406|Topotecan|topotecan|mesh-list
19904983|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19904984|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19904985|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
19904986|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
19904987|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
19904988|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19904989|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19904990|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
19904991|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
19904992|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19904993|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19904994|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19904995|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
19904996|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19904997|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19904998|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19904999|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19905000|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19905001|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19905002|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19905003|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905004|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905005|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905006|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905007|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905008|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
19905009|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905010|NCT01121536|Modafinil|modafinil|mesh-list
19905011|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19905012|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905013|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19905014|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19905015|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19905016|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905017|NCT01121549|Exemestane|exemestane|mesh-list
19905018|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905019|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19905020|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19905021|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905022|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905023|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19905024|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
19905025|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905026|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905027|NCT01121562|Sunitinib|sunitinib|mesh-list
19905028|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905029|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19905030|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19905031|NCT01121562|Growth Substances|growth substances|mesh-ancestor
19905032|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905033|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
19905034|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19905035|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905036|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905037|NCT01121575|Crizotinib|crizotinib|mesh-list
19905038|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905039|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19905040|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905041|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905042|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19905043|NCT01121666|Hormones|hormones|mesh-ancestor
19905044|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905045|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905046|NCT01121757|Lenalidomide|lenalidomide|mesh-list
19905047|NCT01121757|Azacitidine|azacitidine|mesh-list
19905048|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
19905049|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905050|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20259892|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20259893|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259894|NCT00489944|Tamoxifen|tamoxifen|mesh-list
20259895|NCT00489944|Sunitinib|sunitinib|mesh-list
20259896|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259897|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259898|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20259899|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20259900|NCT00489944|Growth Substances|growth substances|mesh-ancestor
20259901|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259902|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
20259903|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20259904|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259905|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20259906|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
20259907|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259908|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20259909|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20259910|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20259911|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19905051|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19905052|NCT01121757|Growth Substances|growth substances|mesh-ancestor
19905053|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
19905054|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905055|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19905056|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
19905057|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905058|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905059|NCT01121900|Trazodone|trazodone|mesh-list
19905060|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19905061|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19905062|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905063|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905064|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905065|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19905066|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905067|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905068|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905069|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905070|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
19905071|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19905072|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
19905073|NCT01121913|Trazodone|trazodone|mesh-list
19905074|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19905075|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19905076|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905077|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905078|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905079|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19905080|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905081|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905082|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905083|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905084|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
19905085|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19905086|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
19905087|NCT01121926|Trazodone|trazodone|mesh-list
19905088|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19905089|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19905090|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905091|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905092|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905093|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19905094|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905095|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905096|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905097|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905098|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
19905099|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19905100|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
19905101|NCT01121939|Bevacizumab|bevacizumab|mesh-list
19905102|NCT01121939|Pertuzumab|pertuzumab|mesh-list
19905103|NCT01121939|Octreotide|octreotide|mesh-list
19905104|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905105|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905106|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19905107|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19905108|NCT01121939|Growth Substances|growth substances|mesh-ancestor
19905109|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905110|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
19905111|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19905112|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19905113|NCT01121991|Hormones|hormones|mesh-list
19905114|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905115|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905116|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19905117|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
19905118|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19905119|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19905120|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
19905121|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259912|NCT00489983|Gemcitabine|gemcitabine|mesh-list
19905122|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19905123|NCT01122160|Omeprazole|omeprazole|mesh-list
19905124|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19905125|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19905126|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19905127|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905128|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905129|NCT01122238|Nicotine|nicotine|mesh-list
19905130|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19905131|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
19905132|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905133|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905134|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19905135|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19905136|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
19905137|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905138|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905139|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
19905140|NCT01122264|Tadalafil|tadalafil|mesh-list
19905141|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905142|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
19905143|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19905144|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19905145|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905146|NCT01122264|Urological Agents|urological agents|mesh-ancestor
19905147|NCT01122316|Metformin|metformin|mesh-list
19905148|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905149|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905150|NCT01122680|Bromides|bromides|mesh-list
19905151|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
19905152|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19905153|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
19905154|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905155|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905156|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19905157|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
19905158|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
19905159|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19905160|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
19905161|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905162|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905163|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
19905164|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
19905165|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19905166|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905167|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
19905168|NCT01122901|R04929097|r04929097|mesh-list
19905169|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259913|NCT00489983|Pemetrexed|pemetrexed|mesh-list
20259914|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20259915|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
20259916|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259917|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259918|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
19905170|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905171|NCT01122927|Aripiprazole|aripiprazole|mesh-list
19905172|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
19905173|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905174|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19905175|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19905176|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905177|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905178|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
19905179|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
19905180|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905181|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905182|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19905183|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19905184|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
19905185|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19905186|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19905187|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19905188|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19905189|NCT01123070|Rituximab|rituximab|mesh-list
20259919|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905190|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905191|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905192|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
19905193|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905194|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905195|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
19905196|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
19905197|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905198|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905199|NCT01123356|Lenalidomide|lenalidomide|mesh-list
19905200|NCT01123356|Ofatumumab|ofatumumab|mesh-list
19905201|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
20259920|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259921|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259922|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
20259923|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259924|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20259925|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20259926|NCT00489996|Gemcitabine|gemcitabine|mesh-list
20259927|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259928|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20259929|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
20259930|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259931|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
19905202|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905203|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19905204|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19905205|NCT01123356|Growth Substances|growth substances|mesh-ancestor
19905206|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
19905207|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905208|NCT01123395|Colchicine|colchicine|mesh-list
19905209|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
19905210|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905211|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
19905212|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
19905213|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
19905214|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905215|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905216|NCT01123889|Lidocaine|lidocaine|mesh-list
19905217|NCT01123889|Ropivacaine|ropivacaine|mesh-list
19905218|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
19905219|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
19905220|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905221|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905222|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
19905223|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905224|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19905225|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19905226|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20259932|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20259933|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20259934|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20259935|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
20259936|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259937|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
20259938|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20259939|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
20259940|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20259941|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259942|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20259943|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20259944|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20259945|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
19905227|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905228|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905229|NCT01123980|Insulin|insulin|mesh-list
19905230|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19905231|NCT01123980|Metformin|metformin|mesh-list
19905232|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
19905233|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
19905234|NCT01123980|Glimepiride|glimepiride|mesh-list
19905235|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
19905236|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19905237|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905238|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905239|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19905240|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905241|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
19905242|NCT01124045|Prednisolone|prednisolone|mesh-list
19905243|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19905244|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
19905245|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19905246|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
19905247|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19905248|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
19905249|NCT01124045|Difluprednate|difluprednate|mesh-list
19905250|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19905251|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
19905252|NCT01124045|Hormones|hormones|mesh-ancestor
19905253|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905254|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905255|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19905256|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905257|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
19905258|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
19905259|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905260|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19905261|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19905262|NCT01124045|Protective Agents|protective agents|mesh-ancestor
19905263|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19905264|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
19905265|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19905266|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19905267|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905268|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905269|NCT01124149|Mesalamine|mesalamine|mesh-list
19905270|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19905271|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19905272|NCT01124149|Analgesics|analgesics|mesh-ancestor
19905273|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
19905274|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905275|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905276|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19905277|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905278|NCT01124162|Losartan|losartan|mesh-list
19905279|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19905280|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19905281|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19905282|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19905283|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905284|NCT01124175|Losartan|losartan|mesh-list
19905285|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19905286|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19905287|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19905288|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19905289|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905290|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19905291|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19905292|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905293|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905294|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905295|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905296|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905297|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19905298|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
19905299|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905300|NCT01124422|Fluticasone|fluticasone|mesh-list
19905301|NCT01124422|Xhance|xhance|mesh-list
19905302|NCT01124422|Bromides|bromides|mesh-list
19905303|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
19905304|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19905305|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19905306|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19905307|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
19905308|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905309|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905310|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19905311|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
19905312|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
19905313|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19905314|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
19905315|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19905316|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
19905317|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905318|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905319|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19905320|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19905321|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19905322|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
19905323|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
19905324|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
19905325|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
19905326|NCT01124448|Growth Substances|growth substances|mesh-ancestor
19905327|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905328|NCT01124604|Tapentadol|tapentadol|mesh-list
19905329|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19905330|NCT01124604|Narcotics|narcotics|mesh-ancestor
19905331|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905332|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905333|NCT01124604|Analgesics|analgesics|mesh-ancestor
19905334|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
19905335|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905336|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19905337|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905338|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905339|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905340|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
19905341|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905342|NCT01124617|Tapentadol|tapentadol|mesh-list
19905343|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19905344|NCT01124617|Narcotics|narcotics|mesh-ancestor
19905345|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905346|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905347|NCT01124617|Analgesics|analgesics|mesh-ancestor
19905348|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
19905349|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905350|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19905351|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905352|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905353|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905354|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
19905355|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905356|NCT01124734|Temozolomide|temozolomide|mesh-list
19905357|NCT01124734|Interleukin-2|interleukin-2|mesh-list
19905358|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19905359|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
19905360|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905361|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905362|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19905363|NCT01124734|Analgesics|analgesics|mesh-ancestor
19905364|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
19905365|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905366|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905367|NCT01124786|Gemcitabine|gemcitabine|mesh-list
19905368|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19905369|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
19905370|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905371|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905372|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
19905373|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905374|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905375|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905376|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
19905377|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905378|NCT01124838|Prednisone|prednisone|mesh-list
19905379|NCT01124838|Adalimumab|adalimumab|mesh-list
19905380|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19905381|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
19905382|NCT01124838|Hormones|hormones|mesh-ancestor
19905383|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905384|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905385|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19905386|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905387|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905388|NCT01125046|Bevacizumab|bevacizumab|mesh-list
19905389|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19905390|NCT01125046|Antibodies|antibodies|mesh-list
19905391|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
19905392|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19905393|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905394|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19905395|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19905396|NCT01125046|Growth Substances|growth substances|mesh-ancestor
19905397|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905398|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
19905399|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
19971547|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19971548|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
19971549|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971550|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971551|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
19971552|NCT01798992|Protective Agents|protective agents|mesh-ancestor
19971553|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19971554|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971555|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19971556|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
19971557|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19971558|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19971559|NCT01799213|Meloxicam|meloxicam|mesh-list
19971560|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19971561|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19971562|NCT01799213|Analgesics|analgesics|mesh-ancestor
19971563|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
19971564|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971565|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971566|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971567|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971568|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19971569|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19971570|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971571|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971572|NCT01799226|Triclosan|triclosan|mesh-list
19971573|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19971574|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971575|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19971576|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19971577|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
19971578|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971579|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19975356|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975357|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975358|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
19975359|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
19975360|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975361|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
19975362|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19975363|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
19975364|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19975365|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
19975366|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19975367|NCT01848041|Protective Agents|protective agents|mesh-ancestor
19975368|NCT01848054|Buprenorphine|buprenorphine|mesh-list
19975369|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19905400|NCT01125098|Amoxicillin|amoxicillin|mesh-list
19905401|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
19905402|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19905403|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19905404|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905405|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19905406|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905407|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905408|NCT01125163|Iron|iron|mesh-list
19905409|NCT01125163|Trace Elements|trace elements|mesh-ancestor
19905410|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
19905411|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905412|NCT01125189|Interferons|interferons|mesh-list
19905413|NCT01125189|Ribavirin|ribavirin|mesh-list
19905414|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
19905415|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
19905416|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19905417|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905418|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
19905419|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905420|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
19905421|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905422|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
19905423|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905424|NCT01125293|Rituximab|rituximab|mesh-list
19905425|NCT01125293|Everolimus|everolimus|mesh-list
19905426|NCT01125293|Bortezomib|bortezomib|mesh-list
19905427|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905428|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905429|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
19905430|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905431|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905432|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905433|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
19905434|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19732339|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732340|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
19732341|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732342|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19732343|NCT04575194|Incretins|incretins|mesh-ancestor
19732344|NCT04575194|Hormones|hormones|mesh-ancestor
19732345|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732346|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19732347|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
19732348|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19732349|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19732350|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19732351|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735709|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905435|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905436|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905437|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905438|NCT05308056|Anesthetics|anesthetics|mesh-list
19905439|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905440|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905441|NCT05307835|Molgramostim|molgramostim|mesh-list
19905442|NCT05307835|Sargramostim|sargramostim|mesh-list
19905443|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
19905444|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905445|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905446|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19905447|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19905448|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905449|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905450|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
19905451|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905452|NCT05307718|Anticoagulants|anticoagulants|mesh-list
19905453|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
19905454|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19905455|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19905456|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
19905457|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19905458|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19905459|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
19905460|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905461|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905462|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19905463|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19905464|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19905465|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
19905466|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905467|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905468|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
19905469|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19905470|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
19905471|NCT05307627|Naltrexone|naltrexone|mesh-list
19905472|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19905473|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19905474|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905475|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
19905476|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905477|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
19905478|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19905479|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19905480|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905481|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19905482|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19905483|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905484|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905485|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905486|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19905487|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
19905488|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19905489|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905490|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19905491|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19905492|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19905493|NCT05307458|Buprenorphine|buprenorphine|mesh-list
19905494|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19905495|NCT05307458|Naloxone|naloxone|mesh-list
19905496|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19905497|NCT05307458|Narcotics|narcotics|mesh-ancestor
19905498|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905499|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905500|NCT05307458|Analgesics|analgesics|mesh-ancestor
19905501|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
19905502|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905503|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19905504|NCT05307341|Sufentanil|sufentanil|mesh-list
19905505|NCT05307341|Dsuvia|dsuvia|mesh-list
19905506|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19905507|NCT05307341|Narcotics|narcotics|mesh-ancestor
19905508|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905509|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905510|NCT05307341|Analgesics|analgesics|mesh-ancestor
19905511|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
19905512|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905513|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19905514|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19905515|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
19905516|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
19905517|NCT05307042|Vasopressins|vasopressins|mesh-list
19905518|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
19905519|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19905520|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
19905521|NCT05307042|Coagulants|coagulants|mesh-ancestor
19905522|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19905523|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19905524|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
19905525|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905526|NCT05306990|Atorvastatin|atorvastatin|mesh-list
19905527|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19905528|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19905529|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19905530|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
19905531|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905532|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19905533|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19905534|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905535|NCT05306587|Daratumumab|daratumumab|mesh-list
19905536|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905537|NCT05306431|Biguanides|biguanides|mesh-list
19905538|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19905539|NCT05306431|Polihexanide|polihexanide|mesh-list
19905540|NCT05306431|Eusol|eusol|mesh-list
19905541|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
19905542|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905543|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905544|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905545|NCT05306405|Misoprostol|misoprostol|mesh-list
19905546|NCT05306405|Estradiol|estradiol|mesh-list
19905547|NCT05306405|Estrogens|estrogens|mesh-ancestor
19905548|NCT05306405|Hormones|hormones|mesh-ancestor
19905549|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905550|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905551|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19905552|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19905553|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
19905554|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19905555|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19905556|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
19905557|NCT05306301|Ponatinib|ponatinib|mesh-list
19905558|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905559|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19905560|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905561|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905562|NCT05306223|Levofloxacin|levofloxacin|mesh-list
19905563|NCT05306223|Ofloxacin|ofloxacin|mesh-list
19905564|NCT05306223|Cycloserine|cycloserine|mesh-list
19905565|NCT05306223|Linezolid|linezolid|mesh-list
19905566|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
19905567|NCT05306223|Bedaquiline|bedaquiline|mesh-list
19905568|NCT05306223|Clofazimine|clofazimine|mesh-list
19905569|NCT05306223|Prothionamide|prothionamide|mesh-list
19905570|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19905571|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905572|NCT05306223|Renal Agents|renal agents|mesh-ancestor
20259946|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
20259947|NCT00490113|Vitamins|vitamins|mesh-ancestor
20259948|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
20259949|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286937|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20286938|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286939|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20286940|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20286941|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286942|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286943|NCT01412333|Interferons|interferons|mesh-list
20286944|NCT01412333|Interferon-beta|interferon-beta|mesh-list
20286945|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
20286946|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
20286947|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286948|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
20286949|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286950|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
20286951|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735710|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
19735711|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19735712|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19735713|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
19735714|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19735715|NCT04536805|Metformin|metformin|mesh-list
19735716|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19735717|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735718|NCT04536831|Vitamin D|vitamin d|mesh-list
19735719|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
19735720|NCT04536831|Vitamins|vitamins|mesh-list
19735721|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
19735722|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735723|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19735724|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19735725|NCT04536558|Olanzapine|olanzapine|mesh-list
19735726|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
19905573|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19905574|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19905575|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19905576|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905577|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905578|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905579|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19905580|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19905581|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19905582|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19905583|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
19905584|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
19905585|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19905586|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
19905587|NCT05305508|Mannitol|mannitol|mesh-list
19905588|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
19905589|NCT05305508|Calcium|calcium|mesh-list
19905590|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19905591|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905592|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19905593|NCT05305508|Diuretics|diuretics|mesh-ancestor
19905594|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
19905595|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
19905596|NCT05305508|Coagulants|coagulants|mesh-ancestor
19905597|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
19905598|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905599|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905600|NCT05299866|Ketamine|ketamine|mesh-list
19905601|NCT05299866|Esketamine|esketamine|mesh-list
19905602|NCT05299866|Analgesics|analgesics|mesh-ancestor
19905603|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
19905604|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905605|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905606|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19905607|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19905608|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
19905609|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
19905610|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905611|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19905612|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19905613|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905614|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905615|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
19905616|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905617|NCT05296460|Dapsone|dapsone|mesh-list
19905618|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905619|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
19905620|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19905621|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19905622|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19905623|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905624|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905625|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
19905626|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971580|NCT01799590|Topiramate|topiramate|mesh-list
19971581|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
19971582|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19971583|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971584|NCT01799941|Quinidine|quinidine|mesh-list
19971585|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
19971586|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
19971587|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971588|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19971589|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19971590|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971591|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971592|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971593|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19971594|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19971595|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
19971596|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19971597|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
19971598|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19971599|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19971600|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971601|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905627|NCT05289856|Avelumab|avelumab|mesh-list
19905628|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905629|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905630|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
19905631|NCT05289167|Bortezomib|bortezomib|mesh-list
19905632|NCT05289167|Abatacept|abatacept|mesh-list
19905633|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905634|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
19905635|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905636|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905637|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19905638|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
19905639|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905640|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905641|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19905642|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19905643|NCT05273320|Dronabinol|dronabinol|mesh-list
19905644|NCT05273320|Nabilone|nabilone|mesh-list
19905645|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
19905646|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
19905647|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905648|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905649|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19905650|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19905651|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19905652|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905653|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905654|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
19905655|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19905656|NCT05273320|Analgesics|analgesics|mesh-ancestor
19905657|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
19905658|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19905659|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19905660|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905661|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905662|NCT05273320|Hormones|hormones|mesh-ancestor
19905663|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905664|NCT05272397|Methylphenidate|methylphenidate|mesh-list
19905665|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19905666|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905667|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19905668|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905669|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905670|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905671|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
19905672|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905673|NCT05269628|Dronabinol|dronabinol|mesh-list
19905674|NCT05269628|Cannabidiol|cannabidiol|mesh-list
19905675|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
19905676|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
19905677|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905678|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905679|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19905680|NCT05269628|Analgesics|analgesics|mesh-ancestor
19905681|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
19905682|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905683|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19905684|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19905685|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905686|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905687|NCT05269628|Hormones|hormones|mesh-ancestor
19905688|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905689|NCT05254418|Dulaglutide|dulaglutide|mesh-list
19905690|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905691|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905692|NCT05243953|Cromakalim|cromakalim|mesh-list
19905693|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19905694|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19905695|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
19905696|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905697|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905698|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19905699|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
19905700|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
19905701|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
19905702|NCT05223335|Clopidogrel|clopidogrel|mesh-list
19905703|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19905704|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19905705|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19905706|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19905707|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19905708|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
19905709|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905710|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905711|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905712|NCT05215067|Docetaxel|docetaxel|mesh-list
19905713|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905714|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
19905715|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
19905716|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
19905717|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905718|NCT05204134|Insulin|insulin|mesh-list
19905719|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905720|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905721|NCT05183048|Panitumumab|panitumumab|mesh-list
19905722|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905723|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905724|NCT05179772|Olanzapine|olanzapine|mesh-list
19905725|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
19905726|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
19905727|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905728|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905729|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19905730|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19905731|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19905732|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905733|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905734|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19905735|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19905736|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905737|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905738|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905739|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
19905740|NCT05177510|Mifepristone|mifepristone|mesh-list
19905741|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19905742|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
19905743|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19905744|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905745|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19905746|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19905747|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19905748|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
19905749|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19905750|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19905751|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
19905752|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905753|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
19905754|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19905755|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19905756|NCT05160987|Midazolam|midazolam|mesh-list
19905757|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19905758|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19905759|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905760|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905761|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19905762|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19905763|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19905764|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19905765|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
19905766|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
19905767|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
19905768|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
19905769|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905770|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905771|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
19905772|NCT05106296|Etoposide|etoposide|mesh-list
19905773|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905774|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
19905775|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905776|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905777|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19905778|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
19905779|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905780|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905781|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19905782|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19905783|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19905784|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19905785|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905786|NCT05042648|Buprenorphine|buprenorphine|mesh-list
19905787|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19905788|NCT05042648|Narcotics|narcotics|mesh-ancestor
19905789|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905790|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905791|NCT05042648|Analgesics|analgesics|mesh-ancestor
19905792|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
19905793|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905794|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19905795|NCT05010590|Denosumab|denosumab|mesh-list
19905796|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19905797|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971602|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19971603|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19971604|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
19971605|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19971606|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19971607|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971608|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19971609|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19971610|NCT01799993|Amikacin|amikacin|mesh-list
19971611|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971612|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971613|NCT01800838|Silicon|silicon|mesh-list
19971614|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
19971615|NCT01800838|Trace Elements|trace elements|mesh-ancestor
19971616|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
19971617|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971618|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
19971619|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19971620|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19971621|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971622|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
19971623|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19971624|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
19971625|NCT01800877|Phenylephrine|phenylephrine|mesh-list
19971626|NCT01800877|Dopamine|dopamine|mesh-list
19971627|NCT01800877|Vasopressins|vasopressins|mesh-list
19971628|NCT01800877|Epinephrine|epinephrine|mesh-list
19971629|NCT01800877|Norepinephrine|norepinephrine|mesh-list
19971630|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19971631|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19971632|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19971633|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
19971634|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971635|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971636|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971637|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19971638|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19971639|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
19971640|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971641|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19971642|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971643|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
19971644|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
19971645|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19971646|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
19971647|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19971648|NCT01800877|Protective Agents|protective agents|mesh-ancestor
19971649|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
19971650|NCT01800877|Coagulants|coagulants|mesh-ancestor
19971651|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19971652|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
19971653|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
19971654|NCT01800968|Liraglutide|liraglutide|mesh-list
19971655|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905798|NCT05004025|Nivolumab|nivolumab|mesh-list
19905799|NCT05004025|Ipilimumab|ipilimumab|mesh-list
19905800|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905801|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905802|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19905803|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905804|NCT04989816|Trastuzumab|trastuzumab|mesh-list
19905805|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905806|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905807|NCT04974151|Folic Acid|folic acid|mesh-list
19905808|NCT04974151|Amlodipine|amlodipine|mesh-list
19905809|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19905810|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19905811|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905812|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905813|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19905814|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905815|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
19905816|NCT04974151|Hematinics|hematinics|mesh-ancestor
19905817|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
19905818|NCT04974151|Vitamins|vitamins|mesh-ancestor
19905819|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
19905820|NCT04974138|Folic Acid|folic acid|mesh-list
19905821|NCT04974138|Amlodipine|amlodipine|mesh-list
19905822|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19905823|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19905824|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905825|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905826|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19905827|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905828|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
19905829|NCT04974138|Hematinics|hematinics|mesh-ancestor
19905830|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
19905831|NCT04974138|Vitamins|vitamins|mesh-ancestor
19905832|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
19905833|NCT04973982|Tacrolimus|tacrolimus|mesh-list
19905834|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19905835|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
19905836|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905837|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19905838|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905839|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905840|NCT04969887|Nivolumab|nivolumab|mesh-list
19905841|NCT04969887|Ipilimumab|ipilimumab|mesh-list
19905842|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905843|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905844|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19905845|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905846|NCT04944654|Emtricitabine|emtricitabine|mesh-list
19905847|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
19905848|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905849|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19905850|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19905851|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905852|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905853|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19905854|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19905855|NCT04928703|Ketamine|ketamine|mesh-list
19905856|NCT04928703|Analgesics|analgesics|mesh-ancestor
19905857|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
19905858|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905859|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905860|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19905861|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19905862|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
19905863|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
19905864|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905865|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19905866|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19905867|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905868|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905869|NCT04910815|Rifaximin|rifaximin|mesh-list
19905870|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19905871|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905872|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19905873|NCT04880850|Insulin|insulin|mesh-list
19905874|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19905875|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
19905876|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
19905877|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19905878|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905879|NCT04822363|Aspirin|aspirin|mesh-list
19905880|NCT04822363|Clopidogrel|clopidogrel|mesh-list
19905881|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19905882|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19905883|NCT04822363|Analgesics|analgesics|mesh-ancestor
19905884|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
19905885|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905886|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905887|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19905888|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905889|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19905890|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19905891|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905892|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19905893|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19905894|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905895|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
19905896|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19905897|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19905898|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19905899|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
19905900|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905901|NCT04766437|Ticagrelor|ticagrelor|mesh-list
19905902|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19905903|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19905904|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19905905|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19905906|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19905907|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
19905908|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905909|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905910|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905911|NCT04763408|Sorafenib|sorafenib|mesh-list
19905912|NCT04763408|Lenvatinib|lenvatinib|mesh-list
19905913|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905914|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19905915|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905916|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905917|NCT04762160|Rituximab|rituximab|mesh-list
19905918|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19905919|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905920|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
19905921|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259950|NCT00490178|Metformin|metformin|mesh-list
20259951|NCT00490178|Fenofibrate|fenofibrate|mesh-list
20259952|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20259953|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259954|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20259955|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
20259956|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259957|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20259958|NCT00490204|Cetirizine|cetirizine|mesh-list
20259959|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20259960|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20259961|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20259962|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
20259963|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
20259964|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259965|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259966|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259967|NCT00490243|Budesonide|budesonide|mesh-list
20259968|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
20259969|NCT00490243|Montelukast|montelukast|mesh-list
20259970|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20259971|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20259972|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
20259973|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20259974|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259975|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19905922|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905923|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
19905924|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19905925|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
19905926|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905927|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
19905928|NCT04704531|Protective Agents|protective agents|mesh-ancestor
19905929|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
19905930|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
19905931|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905932|NCT04573322|Protective Agents|protective agents|mesh-ancestor
19905933|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905934|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19905935|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905936|NCT04552288|Benralizumab|benralizumab|mesh-list
19905937|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19905938|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
19905939|NCT04513145|Ropivacaine|ropivacaine|mesh-list
19905940|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
19905941|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
19905942|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905943|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905944|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
19905945|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905946|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
19905947|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
19905948|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19905949|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19905950|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905951|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19905952|NCT04498351|Analgesics|analgesics|mesh-ancestor
19905953|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
19905954|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19905955|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19905956|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19905957|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19905958|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
19905959|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19905960|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905961|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
19905962|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19905963|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
19905964|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19905965|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19905966|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19905967|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
19905968|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19905969|NCT04497584|Prednisone|prednisone|mesh-list
19905970|NCT04497584|Afatinib|afatinib|mesh-list
19905971|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19905972|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
19905973|NCT04497584|Hormones|hormones|mesh-ancestor
20259976|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
20259977|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
20259978|NCT00490243|Hormones|hormones|mesh-ancestor
20259979|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259980|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20259981|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20259982|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20259983|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
20259984|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20259985|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259986|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20259987|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
20259988|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20259989|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20259990|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20259991|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20259992|NCT00490308|Estradiol|estradiol|mesh-list
19905974|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19905975|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905976|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19905977|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19905978|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19905979|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905980|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905981|NCT04478084|Vaccines|vaccines|mesh-list
19905982|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
19905983|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19905984|NCT04478084|Antibodies|antibodies|mesh-list
19905985|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
19905986|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19905987|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
19905988|NCT04447534|Chloroquine|chloroquine|mesh-list
19905989|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19905990|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
19905991|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19905992|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19905993|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19905994|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19905995|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19905996|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19905997|NCT04447534|Amebicides|amebicides|mesh-ancestor
19905998|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19905999|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19906000|NCT04447534|Analgesics|analgesics|mesh-ancestor
19906001|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
19906002|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906003|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906004|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906005|NCT04447534|Filaricides|filaricides|mesh-ancestor
19906006|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
19906007|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
19906008|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19906009|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19906010|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19906011|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19906012|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906013|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906014|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906015|NCT04395001|Analgesics|analgesics|mesh-ancestor
19906016|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
19906017|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906018|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
19906019|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19906020|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
19906021|NCT04394663|Omeprazole|omeprazole|mesh-list
19906022|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19906023|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906024|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19906025|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906026|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906027|NCT04391309|Remdesivir|remdesivir|mesh-list
19906028|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
19906029|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906030|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
19906031|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906032|NCT04361656|Lubiprostone|lubiprostone|mesh-list
19906033|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19906034|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19906035|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906036|NCT04354155|Enoxaparin|enoxaparin|mesh-list
19906037|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
19906038|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19906039|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19906040|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906041|NCT04332341|Niacinamide|niacinamide|mesh-list
19906042|NCT04332341|Niacin|niacin|mesh-list
19906043|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
19906044|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
19906045|NCT04332341|Vitamins|vitamins|mesh-ancestor
19906046|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
19906047|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906048|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19906049|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
19906050|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906051|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19906052|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
19906053|NCT04312139|Lincomycin|lincomycin|mesh-list
19906054|NCT04312139|Calcium|calcium|mesh-list
19906055|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19906056|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906057|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19906058|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906059|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19906060|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906061|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971656|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971657|NCT01800968|Incretins|incretins|mesh-ancestor
19971658|NCT01800968|Hormones|hormones|mesh-ancestor
19971659|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971660|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19971661|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971662|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19971663|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971664|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971665|NCT01801124|Bupivacaine|bupivacaine|mesh-list
19971666|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
19971667|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
19971668|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971669|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971670|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
19971671|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971672|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
19971673|NCT01801280|Pantoprazole|pantoprazole|mesh-list
19971674|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19971675|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971676|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19971677|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
19971678|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971679|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971680|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971681|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971682|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19971683|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971684|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19971685|NCT01801436|Bortezomib|bortezomib|mesh-list
19971686|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971687|NCT01801449|Rilonacept|rilonacept|mesh-list
19971688|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971689|NCT01801475|Ondansetron|ondansetron|mesh-list
19971690|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
19971691|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
19971692|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971693|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971694|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971695|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
19971696|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19971697|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19971698|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
19971699|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971700|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971701|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19971702|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19971703|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971704|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19971705|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19971706|NCT01801735|Meloxicam|meloxicam|mesh-list
19971707|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19971708|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19971709|NCT01801735|Analgesics|analgesics|mesh-ancestor
19971710|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
19971711|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971712|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971713|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971714|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971715|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19971716|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19971717|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971718|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906062|NCT04255602|Ticagrelor|ticagrelor|mesh-list
19906063|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19906064|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19906065|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19906066|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19906067|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
19906068|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906069|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906070|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906071|NCT04238637|Durvalumab|durvalumab|mesh-list
19906072|NCT04238637|Tremelimumab|tremelimumab|mesh-list
19906073|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906074|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906075|NCT04224766|Bupivacaine|bupivacaine|mesh-list
19906076|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
19906077|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
19906078|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906079|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906080|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
19906081|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906082|NCT04187352|Cisplatin|cisplatin|mesh-list
19906083|NCT04187352|Fluorouracil|fluorouracil|mesh-list
19906084|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906085|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
19906086|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906087|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906088|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906089|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
19906090|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906091|NCT04142892|Onapristone|onapristone|mesh-list
19906092|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906093|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19906094|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
19906095|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19906096|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906097|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
19906098|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906099|NCT04071977|Antioxidants|antioxidants|mesh-list
19906100|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906101|NCT04071977|Protective Agents|protective agents|mesh-ancestor
19906102|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906103|NCT04055909|Nangibotide|nangibotide|mesh-list
19906104|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906105|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
19906106|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906107|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
19906108|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906109|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
19906110|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
19906111|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19906112|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906113|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19906114|NCT04037241|Leucovorin|leucovorin|mesh-list
19906115|NCT04037241|Gemcitabine|gemcitabine|mesh-list
19906116|NCT04037241|Paclitaxel|paclitaxel|mesh-list
19906117|NCT04037241|Capecitabine|capecitabine|mesh-list
19906118|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19906119|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906120|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
19906121|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
19906122|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
19906123|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906124|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906125|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
19906126|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
19906127|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906128|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906129|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906130|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
19906131|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906132|NCT04037241|Antidotes|antidotes|mesh-ancestor
19906133|NCT04037241|Protective Agents|protective agents|mesh-ancestor
19906134|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
19906135|NCT04037241|Vitamins|vitamins|mesh-ancestor
19906136|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
19906137|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
19906138|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19906139|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906140|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19906141|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906142|NCT03983824|Cytarabine|cytarabine|mesh-list
19906143|NCT03983824|Etoposide|etoposide|mesh-list
19906144|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
19906145|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
19906146|NCT03983824|Peposertib|peposertib|mesh-list
19906147|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19906148|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906149|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19906150|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19906151|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906152|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906153|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906154|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
19906155|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
19906156|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906157|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906158|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
19906159|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906160|NCT03983824|Analgesics|analgesics|mesh-ancestor
19906161|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
19906162|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906163|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19906170|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
19906171|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
19906172|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
19906173|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906174|NCT03886649|Venetoclax|venetoclax|mesh-list
19906175|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906176|NCT03880019|Temozolomide|temozolomide|mesh-list
19906177|NCT03880019|Olaparib|olaparib|mesh-list
19906178|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19906179|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19906180|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
19906181|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906182|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906183|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906184|NCT03877991|Cannabidiol|cannabidiol|mesh-list
19906185|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
19906186|NCT03872947|Leucovorin|leucovorin|mesh-list
19906187|NCT03872947|Gemcitabine|gemcitabine|mesh-list
19906188|NCT03872947|Bevacizumab|bevacizumab|mesh-list
19906189|NCT03872947|Carboplatin|carboplatin|mesh-list
19906190|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
19906191|NCT03872947|Nivolumab|nivolumab|mesh-list
19906192|NCT03872947|Irinotecan|irinotecan|mesh-list
19906193|NCT03872947|Topotecan|topotecan|mesh-list
19906194|NCT03872947|Imiquimod|imiquimod|mesh-list
19906195|NCT03872947|Ramucirumab|ramucirumab|mesh-list
19906196|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906197|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906198|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906199|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19906200|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19906201|NCT03872947|Growth Substances|growth substances|mesh-ancestor
19906202|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906203|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
19906204|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906205|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
19906206|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
19906207|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906208|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906209|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906210|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
19906211|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19906212|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19906213|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19906214|NCT03872947|Antidotes|antidotes|mesh-ancestor
19906215|NCT03872947|Protective Agents|protective agents|mesh-ancestor
19906216|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
19906217|NCT03872947|Vitamins|vitamins|mesh-ancestor
19906218|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
19906219|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19906220|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
19906221|NCT03872388|Capecitabine|capecitabine|mesh-list
19906222|NCT03872388|Atorvastatin|atorvastatin|mesh-list
19906223|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906224|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
19906225|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906226|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906227|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19906228|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19906229|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19906230|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19906231|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906232|NCT03835949|Atezolizumab|atezolizumab|mesh-list
19906233|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906234|NCT03815890|Nivolumab|nivolumab|mesh-list
19906235|NCT03815890|Ipilimumab|ipilimumab|mesh-list
19906236|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906237|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906238|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19906239|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906240|NCT03809780|Dexamethasone|dexamethasone|mesh-list
19906241|NCT03809780|Lenalidomide|lenalidomide|mesh-list
19906242|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906243|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
19906244|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
19906245|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906246|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906247|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906248|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
19906249|NCT03809780|Hormones|hormones|mesh-ancestor
19906250|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906251|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906252|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906253|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
19906254|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19906255|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19906256|NCT03809780|Growth Substances|growth substances|mesh-ancestor
19906257|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
19906258|NCT03807856|Dabigatran|dabigatran|mesh-list
19906259|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
19906260|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19906261|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
19906262|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906263|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906264|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
19906265|NCT03780543|Tenofovir|tenofovir|mesh-list
19906266|NCT03780543|Entecavir|entecavir|mesh-list
19906267|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
19906268|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906269|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19906270|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19906271|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906272|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906273|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19906274|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19906275|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19906276|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19906277|NCT03769025|Narcotics|narcotics|mesh-ancestor
19906278|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906279|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906280|NCT03769025|Analgesics|analgesics|mesh-ancestor
19906281|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
19906282|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906283|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19906284|NCT03715465|Melatonin|melatonin|mesh-list
19906285|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
19906286|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906287|NCT03715465|Protective Agents|protective agents|mesh-ancestor
20259993|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19906288|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20259994|NCT00490308|Estrogens|estrogens|mesh-ancestor
19906289|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906290|NCT03713528|Vancomycin|vancomycin|mesh-list
19906291|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19906292|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906293|NCT03709459|Doxycycline|doxycycline|mesh-list
19906294|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19906295|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906296|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
19906297|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19906298|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19906299|NCT03702374|Antioxidants|antioxidants|mesh-list
19906300|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906301|NCT03702374|Protective Agents|protective agents|mesh-ancestor
19906302|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906303|NCT03697356|Dexamethasone|dexamethasone|mesh-list
19906304|NCT03697356|Rituximab|rituximab|mesh-list
19906305|NCT03697356|Lenalidomide|lenalidomide|mesh-list
19906306|NCT03697356|Bortezomib|bortezomib|mesh-list
19906307|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906308|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906309|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
19906310|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906311|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906312|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906313|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
19906314|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
19906315|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906316|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906317|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
19906318|NCT03697356|Hormones|hormones|mesh-ancestor
19906319|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906320|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906321|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19906322|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19906323|NCT03697356|Growth Substances|growth substances|mesh-ancestor
19906324|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
19906325|NCT03690544|Apremilast|apremilast|mesh-list
19906326|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19906327|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19906328|NCT03690544|Analgesics|analgesics|mesh-ancestor
19906329|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
19906330|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906331|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906332|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906333|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906334|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19906335|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19906336|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906337|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971719|NCT01801917|Siponimod|siponimod|mesh-list
19971720|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19971721|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971722|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971723|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
19971724|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971725|NCT01802073|Vancomycin|vancomycin|mesh-list
19971726|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971727|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971728|NCT01802216|Minocycline|minocycline|mesh-list
19971729|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19971730|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971731|NCT01802333|Cytarabine|cytarabine|mesh-list
19971732|NCT01802333|Daunorubicin|daunorubicin|mesh-list
19971733|NCT01802333|Vorinostat|vorinostat|mesh-list
19971734|NCT01802333|Idarubicin|idarubicin|mesh-list
19971735|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19971736|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
19971737|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971738|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971739|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
19971740|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971741|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971742|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
20259995|NCT00490308|Hormones|hormones|mesh-ancestor
19971743|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971744|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19906338|NCT03683524|Darunavir|darunavir|mesh-list
19906339|NCT03683524|Dolutegravir|dolutegravir|mesh-list
19906340|NCT03683524|Cobicistat|cobicistat|mesh-list
19906341|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19906342|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19906343|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
19906344|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906345|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906346|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19906347|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19906348|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
19906349|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906350|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19906351|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19906352|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19906353|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19906354|NCT03672292|Voriconazole|voriconazole|mesh-list
19906355|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
19906356|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
19906357|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906358|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19906359|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19906360|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906361|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906362|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19906363|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
19906364|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906365|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906366|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19906367|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
19906368|NCT03660683|Saxagliptin|saxagliptin|mesh-list
19906369|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19906370|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906371|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19906372|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906373|NCT03660683|Incretins|incretins|mesh-ancestor
19906374|NCT03660683|Hormones|hormones|mesh-ancestor
19906375|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906376|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19906377|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
19906378|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906379|NCT03621696|Cisplatin|cisplatin|mesh-list
19906380|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906381|NCT03616782|Ixazomib|ixazomib|mesh-list
19906382|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906383|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
19906384|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906385|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906386|NCT03574571|Docetaxel|docetaxel|mesh-list
19906387|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20259996|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20259997|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540777|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540778|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540779|NCT01854463|Vitamin D|vitamin d|mesh-list
20540780|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
20540781|NCT01854463|Vitamins|vitamins|mesh-ancestor
20540782|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
20540783|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540784|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540785|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20540786|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
20540787|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20540788|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20540789|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20259998|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20259999|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
20260000|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20260001|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20260002|NCT00490360|Gemcitabine|gemcitabine|mesh-list
20260003|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260004|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20260005|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
19906388|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
19906389|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
19906390|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
19906391|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906392|NCT03465527|Prednisolone|prednisolone|mesh-list
19906393|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906394|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
19906395|NCT03465527|Hormones|hormones|mesh-ancestor
19906396|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906397|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906398|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906399|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906400|NCT03450343|Azacitidine|azacitidine|mesh-list
19906401|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906402|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
19906403|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906404|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906405|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906406|NCT03418805|Ibuprofen|ibuprofen|mesh-list
19906407|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19906408|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19906409|NCT03418805|Analgesics|analgesics|mesh-ancestor
19906410|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
19906411|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906412|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906413|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906414|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906415|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19906416|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906417|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906418|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
19906419|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19906420|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906421|NCT03399981|Natalizumab|natalizumab|mesh-list
19906422|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
19906423|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906424|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
19906425|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19906426|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19906427|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906428|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
19906429|NCT03385928|Coagulants|coagulants|mesh-ancestor
19906430|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
19906431|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19906432|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260006|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260007|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
20260008|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260009|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260010|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260011|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
20260012|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260013|NCT00490373|Pemetrexed|pemetrexed|mesh-list
20260014|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260015|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260016|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260017|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20260018|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20260019|NCT00490399|Gemcitabine|gemcitabine|mesh-list
20260020|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260021|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20260022|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
20260023|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260024|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
20260025|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260026|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260027|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260028|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
20260029|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260030|NCT00490412|Vitamin D|vitamin d|mesh-list
19906433|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906434|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
19906435|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906436|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906437|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
19906438|NCT03375385|Propofol|propofol|mesh-list
19906439|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19906440|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906441|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906442|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19906443|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
19906444|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
19906445|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19906446|NCT03375385|Analgesics|analgesics|mesh-ancestor
19906447|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
19906448|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906449|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19906450|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19906451|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19906452|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
19906453|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906454|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906455|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
19906456|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19906457|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906458|NCT03358693|Infliximab|infliximab|mesh-list
19906459|NCT03358693|Upadacitinib|upadacitinib|mesh-list
19906460|NCT03358693|Ustekinumab|ustekinumab|mesh-list
19906461|NCT03358693|Ixekizumab|ixekizumab|mesh-list
19906462|NCT03358693|Brodalumab|brodalumab|mesh-list
19906463|NCT03358693|Abrocitinib|abrocitinib|mesh-list
19906464|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
19906465|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906466|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906467|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19906468|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19906469|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906470|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906471|NCT03340675|Ifetroban|ifetroban|mesh-list
19906472|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19906473|NCT03329001|Niraparib|niraparib|mesh-list
19906474|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19906475|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906476|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906477|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906478|NCT03319667|Dexamethasone|dexamethasone|mesh-list
19906479|NCT03319667|Lenalidomide|lenalidomide|mesh-list
19906480|NCT03319667|Bortezomib|bortezomib|mesh-list
19906481|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906482|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
19906483|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
19906484|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906485|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906486|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906487|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
19906488|NCT03319667|Hormones|hormones|mesh-ancestor
19906489|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906490|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906491|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906492|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
19906493|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19906494|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19906495|NCT03319667|Growth Substances|growth substances|mesh-ancestor
19906496|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
19906497|NCT03270176|Avelumab|avelumab|mesh-list
19906498|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906499|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906500|NCT03245489|Aspirin|aspirin|mesh-list
19906501|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
19906502|NCT03245489|Clopidogrel|clopidogrel|mesh-list
19906503|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906504|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906505|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19906506|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19906507|NCT03245489|Analgesics|analgesics|mesh-ancestor
19906508|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
19906509|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906510|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906511|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906512|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906513|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19906514|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19906515|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906516|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19906517|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19906518|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906519|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
19906520|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19906521|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19906522|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19906523|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
19906524|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906525|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
19906526|NCT03199053|Saxagliptin|saxagliptin|mesh-list
19906527|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19906528|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906529|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19906530|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906531|NCT03199053|Incretins|incretins|mesh-ancestor
19906532|NCT03199053|Hormones|hormones|mesh-ancestor
19906533|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906534|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19906535|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
19906536|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906537|NCT03164057|Cytarabine|cytarabine|mesh-list
19906538|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
19906539|NCT03164057|Methotrexate|methotrexate|mesh-list
19906540|NCT03164057|Azacitidine|azacitidine|mesh-list
19906541|NCT03164057|Decitabine|decitabine|mesh-list
19906542|NCT03164057|Fludarabine|fludarabine|mesh-list
19906543|NCT03164057|Etoposide|etoposide|mesh-list
19906544|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
19906545|NCT03164057|Sorafenib|sorafenib|mesh-list
19906546|NCT03164057|Daunorubicin|daunorubicin|mesh-list
19906547|NCT03164057|Asparaginase|asparaginase|mesh-list
19906548|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
19906549|NCT03164057|Idarubicin|idarubicin|mesh-list
19906550|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
19906551|NCT03164057|Razoxane|razoxane|mesh-list
19906552|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19906553|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
19906554|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19906555|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906556|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906557|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
19906558|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906559|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906560|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
19906561|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906562|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19906563|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906564|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
19906565|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906566|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19906567|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19906568|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19906569|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19906570|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
19906571|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906572|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19906573|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906574|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19906575|NCT03164057|Analgesics|analgesics|mesh-ancestor
19906576|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
19906577|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906578|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19906579|NCT03164057|Protective Agents|protective agents|mesh-ancestor
19906580|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
19906581|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
19906582|NCT03112993|Neostigmine|neostigmine|mesh-list
19906583|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19906584|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906585|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906586|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
19906587|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906588|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906589|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19906590|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
19906591|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906592|NCT03110315|Suvorexant|suvorexant|mesh-list
19906593|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19906594|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19906595|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906596|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906597|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19906598|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906599|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906600|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19906601|NCT03088137|Hormones|hormones|mesh-ancestor
19906602|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906603|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906604|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
19906605|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
19906606|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906607|NCT02930044|Insulin|insulin|mesh-list
19906608|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19906609|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
19906610|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19906611|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906612|NCT02926222|Lomustine|lomustine|mesh-list
19906613|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19906614|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
19906615|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906616|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906617|NCT02926196|Avelumab|avelumab|mesh-list
19906618|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906619|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906620|NCT02819024|Alovudine|alovudine|mesh-list
19906621|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
19906622|NCT02819024|Dexamethasone|dexamethasone|mesh-list
19906623|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
19906624|NCT02819024|Ichthammol|ichthammol|mesh-list
19906625|NCT02819024|BB 1101|bb 1101|mesh-list
19906626|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906627|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
19906628|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
19906629|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906630|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906631|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906632|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
19906633|NCT02819024|Hormones|hormones|mesh-ancestor
19906634|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906635|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906636|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906637|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
19906638|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906639|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906640|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
19906641|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
19906642|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906643|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
19906644|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19906645|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19906646|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
19906647|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19906648|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906649|NCT02733185|Vitamins|vitamins|mesh-list
19906650|NCT02733185|Edetic Acid|edetic acid|mesh-list
19906651|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
19906652|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
19906653|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906654|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
19906655|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19906656|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
19906657|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
19906658|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906659|NCT02733185|Antidotes|antidotes|mesh-ancestor
19906660|NCT02733185|Protective Agents|protective agents|mesh-ancestor
19906661|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19906662|NCT02647437|Levetiracetam|levetiracetam|mesh-list
19906663|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
19906664|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
19906665|NCT02623426|Dexamethasone|dexamethasone|mesh-list
19906666|NCT02623426|Methotrexate|methotrexate|mesh-list
19906667|NCT02623426|Ranibizumab|ranibizumab|mesh-list
19906668|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906669|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
19906670|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
19906671|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906672|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906673|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906674|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
19906675|NCT02623426|Hormones|hormones|mesh-ancestor
19906676|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906677|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906678|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906679|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19906680|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
19906681|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19906682|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906683|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
19906684|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906685|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
19906686|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906687|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19906688|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906689|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
19906690|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906691|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19906692|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19906693|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19906694|NCT02623426|Growth Substances|growth substances|mesh-ancestor
19906695|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
19971745|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19971746|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19971747|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971748|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19971749|NCT01802385|Sertraline|sertraline|mesh-list
19971750|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
19971751|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19971752|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19971753|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19971754|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971755|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971756|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971757|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
19971758|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971759|NCT01802437|Fluoxetine|fluoxetine|mesh-list
19971760|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19971761|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19971762|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971763|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975370|NCT01848054|Naloxone|naloxone|mesh-list
19735727|NCT04536558|Aprepitant|aprepitant|mesh-list
19735728|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
19735729|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
19735730|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735731|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735732|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19735733|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19735734|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19735735|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735736|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19906696|NCT02451943|Doxorubicin|doxorubicin|mesh-list
19906697|NCT02451943|Olaratumab|olaratumab|mesh-list
19906698|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19906699|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906700|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19906701|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19906702|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906703|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906704|NCT02436733|Pemetrexed|pemetrexed|mesh-list
19906705|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906706|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906707|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906708|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19906709|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19906710|NCT02410512|Atezolizumab|atezolizumab|mesh-list
19906711|NCT02410512|Antibodies|antibodies|mesh-list
19906712|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
19906713|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19906714|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
19906715|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906716|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906717|NCT02390427|Paclitaxel|paclitaxel|mesh-list
19906718|NCT02390427|Maytansine|maytansine|mesh-list
19906719|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19906720|NCT02390427|Trastuzumab|trastuzumab|mesh-list
19906721|NCT02390427|Pertuzumab|pertuzumab|mesh-list
19906722|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19906723|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906724|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
19906725|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
19906726|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
19906727|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906728|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906729|NCT02242942|Venetoclax|venetoclax|mesh-list
19906730|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
19906731|NCT02242942|Chlorambucil|chlorambucil|mesh-list
19906732|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906733|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906734|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19906735|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
19906736|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906737|NCT02205047|Fluorouracil|fluorouracil|mesh-list
19906738|NCT02205047|Capecitabine|capecitabine|mesh-list
19906739|NCT02205047|Trastuzumab|trastuzumab|mesh-list
19906740|NCT02205047|Pertuzumab|pertuzumab|mesh-list
19906741|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906742|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
19906743|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906744|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906745|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906746|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
19906747|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906748|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906749|NCT02193191|Plerixafor|plerixafor|mesh-list
19906750|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19906751|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19906752|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
19906753|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906754|NCT02185209|Amoxicillin|amoxicillin|mesh-list
19906755|NCT02185209|Metronidazole|metronidazole|mesh-list
19906756|NCT02185209|Penicillin V|penicillin v|mesh-list
19906757|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19906758|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906759|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19906760|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19906761|NCT02066623|Everolimus|everolimus|mesh-list
19906762|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906763|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906764|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
19906765|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906766|NCT01924819|Leucovorin|leucovorin|mesh-list
19906767|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19906768|NCT01924819|Cisplatin|cisplatin|mesh-list
19906769|NCT01924819|Docetaxel|docetaxel|mesh-list
19906770|NCT01924819|Fluorouracil|fluorouracil|mesh-list
19906771|NCT01924819|Capecitabine|capecitabine|mesh-list
19906772|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
19906773|NCT01924819|Epirubicin|epirubicin|mesh-list
19906774|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
19906775|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906776|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
19906777|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
19906778|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
19906779|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906780|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
19906781|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906782|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19906783|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
19906784|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906785|NCT01924819|Antidotes|antidotes|mesh-ancestor
19906786|NCT01924819|Protective Agents|protective agents|mesh-ancestor
19906787|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
19906788|NCT01924819|Vitamins|vitamins|mesh-ancestor
19906789|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
19906790|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19906791|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19906792|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19906793|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906794|NCT01861314|Bortezomib|bortezomib|mesh-list
19906795|NCT01861314|Sorafenib|sorafenib|mesh-list
19906796|NCT01861314|Decitabine|decitabine|mesh-list
19906797|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906798|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19906799|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906800|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906801|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906802|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
19906803|NCT01749969|Dexamethasone|dexamethasone|mesh-list
19906804|NCT01749969|Lenalidomide|lenalidomide|mesh-list
19906805|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906806|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
19906807|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
19906808|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906809|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906810|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19906811|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
19906812|NCT01749969|Hormones|hormones|mesh-ancestor
19906813|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906814|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906815|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906816|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
19906817|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19906818|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19906819|NCT01749969|Growth Substances|growth substances|mesh-ancestor
19906820|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
19906821|NCT01126255|Clobetasol|clobetasol|mesh-list
19906822|NCT01126255|Progesterone|progesterone|mesh-list
19906823|NCT01126255|Progestins|progestins|mesh-ancestor
19906824|NCT01126255|Hormones|hormones|mesh-ancestor
19906825|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906826|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906827|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19906828|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
19906829|NCT00433589|Tamoxifen|tamoxifen|mesh-list
19906830|NCT00433589|Docetaxel|docetaxel|mesh-list
19906831|NCT00433589|Capecitabine|capecitabine|mesh-list
19906832|NCT00433589|Letrozole|letrozole|mesh-list
19906833|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906834|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
19906835|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
19906836|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
19906837|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906838|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19906839|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
19906840|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19906841|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19906842|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906843|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19906844|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
19906845|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19906846|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906847|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19906848|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19906849|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19975371|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19906850|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19906851|NCT00308685|Albuterol|albuterol|mesh-list
19906852|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19906853|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
19906854|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906855|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906856|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19906857|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
19906858|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
19906859|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19906860|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19906861|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19906862|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19906863|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
19906864|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906865|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906866|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19906867|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19906868|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19906869|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19906870|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906871|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
19906872|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906873|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906874|NCT01125514|Furosemide|furosemide|mesh-list
19906875|NCT01125514|Diuretics|diuretics|mesh-ancestor
19906876|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
19906877|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906878|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19906879|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19906880|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906881|NCT01125566|Trastuzumab|trastuzumab|mesh-list
19906882|NCT01125566|Vinorelbine|vinorelbine|mesh-list
19906883|NCT01125566|Afatinib|afatinib|mesh-list
19906884|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906885|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906886|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19906887|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
19906888|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
19906889|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
19906890|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906891|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19906892|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19906893|NCT01125748|Omalizumab|omalizumab|mesh-list
19906894|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19906895|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19906896|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
19906897|NCT01125813|Factor VIII|factor viii|mesh-list
19906898|NCT01125813|Coagulants|coagulants|mesh-ancestor
19906899|NCT01125917|Buprenorphine|buprenorphine|mesh-list
19906900|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19906901|NCT01125917|Narcotics|narcotics|mesh-ancestor
19906902|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906903|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906904|NCT01125917|Analgesics|analgesics|mesh-ancestor
19906905|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
19906906|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906907|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19906908|NCT01125930|Tretinoin|tretinoin|mesh-list
19906909|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906910|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
19906911|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
19906912|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19906913|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
19906914|NCT01126060|Coagulants|coagulants|mesh-ancestor
19906915|NCT01126099|Prazosin|prazosin|mesh-list
19906916|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19906917|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19906918|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19906919|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19906920|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
19906921|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260031|NCT00490412|Vitamins|vitamins|mesh-ancestor
19906922|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906923|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906924|NCT01126268|Retapamulin|retapamulin|mesh-list
19906925|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19906926|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19906927|NCT01126359|Lidocaine|lidocaine|mesh-list
19906928|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
19906929|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
19906930|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906931|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906932|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
19906933|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906934|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19906935|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19906936|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19906937|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19906938|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906939|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
19906940|NCT01126424|Oxybutynin|oxybutynin|mesh-list
19906941|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19906942|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19449786|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20260032|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
20260033|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260034|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19906943|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
19906944|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19906945|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906946|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906947|NCT01126424|Urological Agents|urological agents|mesh-ancestor
19906948|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
19906949|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
19906950|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906951|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
19906952|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19906953|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
20260035|NCT00490464|Nicardipine|nicardipine|mesh-list
20260036|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20260037|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20260038|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260039|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260040|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540790|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
19449787|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19449788|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
19449789|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449790|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19449791|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19449792|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19449793|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449794|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19449795|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19906954|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906955|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906956|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19906957|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
19906958|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
19906959|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19906960|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
19906961|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540791|NCT01854476|Coagulants|coagulants|mesh-ancestor
20540792|NCT01854489|Rifampin|rifampin|mesh-list
20540793|NCT01854489|Buprenorphine|buprenorphine|mesh-list
20540794|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20540795|NCT01854489|Narcotics|narcotics|mesh-ancestor
20540796|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906962|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906963|NCT01126541|Rituximab|rituximab|mesh-list
19906964|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19906965|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19906966|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
19906967|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906968|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19906969|NCT01126580|Metformin|metformin|mesh-list
19906970|NCT01126580|Dulaglutide|dulaglutide|mesh-list
19906971|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19906972|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906973|NCT01126593|Bupivacaine|bupivacaine|mesh-list
19906974|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
19906975|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
19906976|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906977|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906978|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
19906979|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19906980|NCT01126671|Vitamin D|vitamin d|mesh-list
19906981|NCT01126671|Vitamins|vitamins|mesh-ancestor
19906982|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
19906983|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906984|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19906985|NCT01127165|Zonisamide|zonisamide|mesh-list
19906986|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
19906987|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19906988|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19906989|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19906990|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19906991|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906992|NCT01127438|Fospropofol|fospropofol|mesh-list
19906993|NCT01127438|Propofol|propofol|mesh-list
19906994|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19906995|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19906996|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19906997|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19906998|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
19906999|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
19907000|NCT01127581|Dinoprostone|dinoprostone|mesh-list
19907001|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
19907002|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19907003|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907004|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19907005|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19907006|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907007|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19907008|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19907009|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907010|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907011|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
19907012|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907013|NCT01127646|Methylphenidate|methylphenidate|mesh-list
19907014|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19907015|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19907016|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907017|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19907018|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19907019|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907020|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907021|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
19907022|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907023|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19907024|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
19907025|NCT01127659|Testosterone|testosterone|mesh-list
19907026|NCT01127659|Androgens|androgens|mesh-ancestor
19907027|NCT01127659|Hormones|hormones|mesh-ancestor
19907028|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907029|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907030|NCT01127763|Carboplatin|carboplatin|mesh-list
19907031|NCT01127763|Everolimus|everolimus|mesh-list
19907032|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907033|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907034|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
19907035|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907036|NCT01127893|Tanezumab|tanezumab|mesh-list
19907037|NCT01127893|Analgesics|analgesics|mesh-ancestor
19907038|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
19907039|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907040|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907041|NCT01128153|Saxagliptin|saxagliptin|mesh-list
19907042|NCT01128153|Incretins|incretins|mesh-ancestor
19907043|NCT01128153|Hormones|hormones|mesh-ancestor
19907044|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907045|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907046|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19907047|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
19907048|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907049|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907050|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907051|NCT01128192|Pasireotide|pasireotide|mesh-list
19907052|NCT01128192|Hormones|hormones|mesh-ancestor
19907053|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907054|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907055|NCT01128244|Pyridoxine|pyridoxine|mesh-list
19907056|NCT01128244|Pyridoxal|pyridoxal|mesh-list
19907057|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
19907058|NCT01128244|Vitamins|vitamins|mesh-ancestor
19907059|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
19907060|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907061|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
19907062|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
19907063|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19907064|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907065|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907066|NCT01128296|Gemcitabine|gemcitabine|mesh-list
19907067|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
19907068|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19907069|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
19907070|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907071|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907072|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
19907073|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907074|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907075|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907076|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
19907077|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907078|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
19907079|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19907080|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19907081|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907082|NCT01128387|Panitumumab|panitumumab|mesh-list
19907083|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907084|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907085|NCT01128543|Vinorelbine|vinorelbine|mesh-list
19907086|NCT01128543|Lapatinib|lapatinib|mesh-list
19907087|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19907088|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907089|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
19907090|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
19907091|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
19907092|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907093|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907094|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907095|NCT01128569|Fluticasone|fluticasone|mesh-list
19907096|NCT01128569|Xhance|xhance|mesh-list
19907097|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907098|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19907099|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
19907100|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907101|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907102|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19907103|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
19907104|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
19907105|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19449796|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19907106|NCT01128595|Fluticasone|fluticasone|mesh-list
19907107|NCT01128595|Xhance|xhance|mesh-list
19907108|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449797|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907109|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19907110|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
19907111|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907112|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907113|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19907114|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
19907115|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
19907116|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19907117|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19907118|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907119|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907120|NCT01128621|Incretins|incretins|mesh-ancestor
19907121|NCT01128621|Hormones|hormones|mesh-ancestor
19907122|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907123|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19907124|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
19907125|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907126|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907127|NCT01128842|Capecitabine|capecitabine|mesh-list
19907128|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19907129|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
19907130|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907131|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907132|NCT01128894|Liraglutide|liraglutide|mesh-list
19907133|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
19907134|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907135|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907136|NCT01128894|Incretins|incretins|mesh-ancestor
19907137|NCT01128894|Hormones|hormones|mesh-ancestor
19907138|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907139|NCT01128959|Carbamazepine|carbamazepine|mesh-list
19907140|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
19907141|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
19907142|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19907143|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907144|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907145|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19907146|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19907147|NCT01128959|Analgesics|analgesics|mesh-ancestor
19907148|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
19907149|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907150|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19907151|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907152|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907153|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19907154|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19971764|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971765|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
19971766|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971767|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19971768|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
19971769|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19971770|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19971771|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19971772|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971773|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19971774|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19971775|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19971776|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19971777|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971778|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
19971779|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971780|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971781|NCT01802580|Fluocinonide|fluocinonide|mesh-list
19971782|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971783|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
19971784|NCT01802580|Hormones|hormones|mesh-ancestor
19971785|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971786|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971787|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19971788|NCT01802775|Aspirin|aspirin|mesh-list
19971789|NCT01802775|Edoxaban|edoxaban|mesh-list
19971790|NCT01802775|Clopidogrel|clopidogrel|mesh-list
20540797|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907155|NCT01128972|Listerine|listerine|mesh-list
19907156|NCT01128972|Fluorides|fluorides|mesh-list
19907157|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
19907158|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
19907159|NCT01128972|Protective Agents|protective agents|mesh-ancestor
19907160|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907161|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19907162|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907163|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
19907164|NCT01129206|Docetaxel|docetaxel|mesh-list
19907165|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19907166|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907167|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
19907168|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
19907169|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
19907170|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907171|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19907172|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
19907173|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
19907174|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907175|NCT01129245|Celecoxib|celecoxib|mesh-list
19907176|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19907177|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19907178|NCT01129245|Analgesics|analgesics|mesh-ancestor
19907179|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
19907180|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907181|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907182|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907183|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907184|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19907185|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19907186|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907187|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907188|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19907189|NCT01129284|Hormones|hormones|mesh-ancestor
19907190|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907191|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907192|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
19907193|NCT01129336|Diphosphonates|diphosphonates|mesh-list
19907194|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19907195|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907196|NCT01129440|Fluorides|fluorides|mesh-list
19907197|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
19907198|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
19907199|NCT01129440|Protective Agents|protective agents|mesh-ancestor
19907200|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907201|NCT01129557|Valsartan|valsartan|mesh-list
19907202|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19907203|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19907204|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19907205|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907206|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
19907207|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19907208|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19907209|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19907210|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907211|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907212|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
19907213|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907214|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907215|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19907216|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907217|NCT01129622|Letrozole|letrozole|mesh-list
19907218|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907219|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19907220|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19907221|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907222|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907223|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19907224|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
19907225|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907226|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907227|NCT01129778|Omeprazole|omeprazole|mesh-list
19907228|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19907229|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
19907230|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19907231|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19907232|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907233|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907234|NCT01129882|Aripiprazole|aripiprazole|mesh-list
19907235|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
19907236|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19907237|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19907238|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19907239|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907240|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907241|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
19907242|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
19907243|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907244|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907245|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19907246|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19907247|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
19907248|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19907249|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19907250|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19907251|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19907252|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19907253|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
19907254|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19907255|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19907256|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907257|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907258|NCT01130051|Colchicine|colchicine|mesh-list
19907259|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
19907260|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907261|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
19907262|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
19907263|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
19907264|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907265|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907266|NCT01130103|Paroxetine|paroxetine|mesh-list
19907267|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19907268|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19907269|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907270|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907271|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907272|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
19907273|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907274|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19907275|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
19907276|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19907277|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19907278|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19907279|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907280|NCT01130168|Amlodipine|amlodipine|mesh-list
19907281|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19907282|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19907283|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907284|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907285|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19907286|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907287|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
19907288|NCT01130272|Eluxadoline|eluxadoline|mesh-list
19907289|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19907290|NCT01130337|Capecitabine|capecitabine|mesh-list
19907291|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
19907292|NCT01130337|Trastuzumab|trastuzumab|mesh-list
19907293|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19907294|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
19907295|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907296|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907297|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907298|NCT01130493|Levodopa|levodopa|mesh-list
19907299|NCT01130493|Carbidopa|carbidopa|mesh-list
19907300|NCT01130493|Entacapone|entacapone|mesh-list
19907301|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19907302|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19907303|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19907304|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
19907305|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907306|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907307|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907308|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19907309|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907310|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19907311|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19907312|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
19907313|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
19907314|NCT01130532|Tadalafil|tadalafil|mesh-list
19907315|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
19907316|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19907317|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19907318|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907319|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907320|NCT01130532|Urological Agents|urological agents|mesh-ancestor
19907321|NCT01130597|Spironolactone|spironolactone|mesh-list
19907322|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19907323|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
19907324|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907325|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907326|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19907327|NCT01130597|Diuretics|diuretics|mesh-ancestor
19907328|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
19907329|NCT01130844|Mesalamine|mesalamine|mesh-list
19907330|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19907331|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19907332|NCT01130844|Analgesics|analgesics|mesh-ancestor
19907333|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
19907334|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907335|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907336|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907337|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907338|NCT01131052|Insulin|insulin|mesh-list
19907339|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19907340|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
19907341|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
19907342|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907343|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907344|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
19907345|NCT01131065|Antibodies|antibodies|mesh-list
19907346|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
19907347|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19907348|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19907349|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
19907350|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907351|NCT01131078|Bevacizumab|bevacizumab|mesh-list
19907352|NCT01131078|Capecitabine|capecitabine|mesh-list
19907353|NCT01131078|Irinotecan|irinotecan|mesh-list
19907354|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907355|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907356|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19907357|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19907358|NCT01131078|Growth Substances|growth substances|mesh-ancestor
19907359|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907360|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
19907361|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19907362|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
19907363|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907364|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19449798|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
19449799|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19449800|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
19449801|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19449802|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19907365|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19907366|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907367|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
19907368|NCT01131104|Tadalafil|tadalafil|mesh-list
19907369|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
19907370|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19907371|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
19907372|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19907373|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907374|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907375|NCT01131104|Urological Agents|urological agents|mesh-ancestor
19907376|NCT01131182|Metformin|metformin|mesh-list
19907377|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19907378|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19449803|NCT03432780|Docetaxel|docetaxel|mesh-list
19449804|NCT03432780|Hormones|hormones|mesh-list
19449805|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449806|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
19449807|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
19449808|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20260041|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260042|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
20260043|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
20260044|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260045|NCT00490633|Ethanol|ethanol|mesh-list
20260046|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
20260047|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20260048|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260049|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540798|NCT01854489|Analgesics|analgesics|mesh-ancestor
20540799|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
20540800|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540801|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20540802|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20540803|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
20540804|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540805|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540806|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
20540807|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20540808|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540809|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540810|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20540811|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20540812|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20540813|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20540814|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20540815|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20540816|NCT01854502|Fluorides|fluorides|mesh-list
20540817|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
20540818|NCT01854502|Protective Agents|protective agents|mesh-ancestor
20540819|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540820|NCT01854515|Dexamethasone|dexamethasone|mesh-list
20540821|NCT01854515|Budesonide|budesonide|mesh-list
20540822|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
20540823|NCT01854515|BB 1101|bb 1101|mesh-list
20540824|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20540825|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
20540826|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
20540827|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540828|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540829|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540830|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
20540831|NCT01854515|Hormones|hormones|mesh-ancestor
20540832|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540833|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20540834|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540835|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20540836|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20540837|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
20540838|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
20540839|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449809|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907379|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540840|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907380|NCT01131182|Incretins|incretins|mesh-ancestor
19907381|NCT01131182|Hormones|hormones|mesh-ancestor
19907382|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907383|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19907384|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
19907385|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907386|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907387|NCT01131507|Pancrelipase|pancrelipase|mesh-list
19907388|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19907389|NCT01131585|Ranibizumab|ranibizumab|mesh-list
19907390|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19907391|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19907392|NCT01131585|Growth Substances|growth substances|mesh-ancestor
19907393|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907394|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
19907395|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907396|NCT01131676|Empagliflozin|empagliflozin|mesh-list
19907397|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19907398|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907399|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907400|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907401|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
19907402|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
19907403|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19907404|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19907405|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907406|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907407|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907408|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907409|NCT01132313|Ribavirin|ribavirin|mesh-list
19907410|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
19907411|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907412|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
19907413|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907414|NCT01132326|Droxidopa|droxidopa|mesh-list
19907415|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19907416|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19907417|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
19907418|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
19907419|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19907420|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19907421|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907422|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907423|NCT01132482|Urological Agents|urological agents|mesh-ancestor
19907424|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
19907425|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
19907426|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
19907427|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19907428|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19907429|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
19907430|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
19907431|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907432|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907433|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907434|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19907435|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
19907436|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19907437|NCT01132664|Capecitabine|capecitabine|mesh-list
19907438|NCT01132664|Trastuzumab|trastuzumab|mesh-list
19907439|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19907440|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
19907441|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907442|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907443|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907444|NCT01132807|Prednisone|prednisone|mesh-list
19907445|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
19907446|NCT01132807|Dacarbazine|dacarbazine|mesh-list
19907447|NCT01132807|Doxorubicin|doxorubicin|mesh-list
19907448|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19907449|NCT01132807|Etoposide|etoposide|mesh-list
19907450|NCT01132807|Bleomycin|bleomycin|mesh-list
19907451|NCT01132807|Vinblastine|vinblastine|mesh-list
19907452|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
19907453|NCT01132807|Procarbazine|procarbazine|mesh-list
19907454|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19907455|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907456|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
19907457|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907458|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907459|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19907460|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
19907461|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907462|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907463|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19907464|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19907465|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19907466|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19907467|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907468|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907469|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
19907470|NCT01132807|Hormones|hormones|mesh-ancestor
19907471|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907472|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19907473|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19907474|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19907475|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
19907476|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
19907477|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
19907478|NCT01132820|Cediranib|cediranib|mesh-list
19907479|NCT01132820|Maleic acid|maleic acid|mesh-list
19907480|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907481|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907482|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907483|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907484|NCT01132846|Dopamine|dopamine|mesh-list
19907485|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19907486|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19907487|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
19907488|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
19907489|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907490|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907491|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
19907492|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907493|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907494|NCT01132846|Protective Agents|protective agents|mesh-ancestor
19907495|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
19907496|NCT01133158|Dexamethasone|dexamethasone|mesh-list
19907497|NCT01133158|Rituximab|rituximab|mesh-list
19907498|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19907499|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
19907500|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907501|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907502|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
19907503|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907504|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907505|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907506|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
19907507|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
19907508|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907509|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19907510|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
19907511|NCT01133158|Hormones|hormones|mesh-ancestor
19907512|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907513|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19907514|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19907515|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
19907516|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907517|NCT01133158|Analgesics|analgesics|mesh-ancestor
19907518|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
19907519|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19907520|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19907521|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907522|NCT01133275|Prednisone|prednisone|mesh-list
19907523|NCT01133275|Lenalidomide|lenalidomide|mesh-list
19907524|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907525|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
19907526|NCT01133275|Hormones|hormones|mesh-ancestor
19907527|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260050|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975372|NCT01848054|Narcotics|narcotics|mesh-ancestor
19907528|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907529|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19907530|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907531|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
19907532|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19907533|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19907534|NCT01133275|Growth Substances|growth substances|mesh-ancestor
19907535|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
19907536|NCT01133379|Fluorides|fluorides|mesh-list
19907537|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
19907538|NCT01133379|Protective Agents|protective agents|mesh-ancestor
19907539|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907540|NCT01133392|Insulin|insulin|mesh-list
19907541|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19907542|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
19907543|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907544|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907545|NCT01133522|Evolocumab|evolocumab|mesh-list
19907546|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19907547|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19907548|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
19907549|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907550|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19907551|NCT01133626|Prednisone|prednisone|mesh-list
19907552|NCT01133626|Beclomethasone|beclomethasone|mesh-list
19907553|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907554|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
19907555|NCT01133626|Hormones|hormones|mesh-ancestor
19907556|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907557|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907558|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19907559|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907560|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19907561|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
19907562|NCT01133665|Lenalidomide|lenalidomide|mesh-list
19907563|NCT01133665|Cetuximab|cetuximab|mesh-list
19907564|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
19907565|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907566|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19907567|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19907568|NCT01133665|Growth Substances|growth substances|mesh-ancestor
19907569|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
19907570|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907571|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907572|NCT01133678|Paclitaxel|paclitaxel|mesh-list
19907573|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19907574|NCT01133678|Cisplatin|cisplatin|mesh-list
19907575|NCT01133678|Cetuximab|cetuximab|mesh-list
19907576|NCT01133678|Everolimus|everolimus|mesh-list
19907577|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19907578|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907579|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
19907580|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
19907581|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
19907582|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907583|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907584|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907585|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
19907586|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907587|NCT01133756|Gemcitabine|gemcitabine|mesh-list
19907588|NCT01133756|Carboplatin|carboplatin|mesh-list
19907589|NCT01133756|Lenvatinib|lenvatinib|mesh-list
19907590|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907591|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19907592|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
19907593|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907594|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
19907595|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907596|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907597|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907598|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
19907599|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907600|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907601|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19907602|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
19907603|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19907604|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19907605|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19907606|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907607|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907608|NCT01133847|Guanfacine|guanfacine|mesh-list
19907609|NCT01133847|Methylphenidate|methylphenidate|mesh-list
19907610|NCT01133847|Amphetamine|amphetamine|mesh-list
19907611|NCT01133847|Adderall|adderall|mesh-list
19907612|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19907613|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19907614|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907615|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19907616|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19907617|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907618|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907619|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
19907620|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907621|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19907622|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
19449810|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449811|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452669|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19907623|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
19907624|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
19907625|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907626|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19907627|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19907628|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19907629|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19907630|NCT01133977|Lenvatinib|lenvatinib|mesh-list
19907631|NCT01133977|Dacarbazine|dacarbazine|mesh-list
19907632|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907633|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907634|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907635|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907636|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19907637|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
19907638|NCT01134042|Fluticasone|fluticasone|mesh-list
19907639|NCT01134042|Xhance|xhance|mesh-list
19907640|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907641|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19907642|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
19907643|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907644|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907645|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19907646|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
19907647|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
19907648|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19907649|NCT01134055|Ranibizumab|ranibizumab|mesh-list
19907650|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19907651|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19907652|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19907653|NCT01134055|Growth Substances|growth substances|mesh-ancestor
19907654|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907655|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
19907656|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907657|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19907658|NCT01134107|Insulin|insulin|mesh-list
19907659|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19907660|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
19907661|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
19907662|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907663|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907664|NCT01134198|Mifepristone|mifepristone|mesh-list
19907665|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19907666|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
19907667|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20260051|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
20260052|NCT00490659|Gemcitabine|gemcitabine|mesh-list
20260053|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260054|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20260055|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
20260056|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260057|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
20260058|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260059|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260060|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260061|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
20260062|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260063|NCT00490685|Sorafenib|sorafenib|mesh-list
20260064|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260065|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20260066|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260067|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260068|NCT00490711|Gemcitabine|gemcitabine|mesh-list
20260069|NCT00490711|Paclitaxel|paclitaxel|mesh-list
20260070|NCT00490711|Carboplatin|carboplatin|mesh-list
20260071|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20260072|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260073|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
20260074|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
20260075|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
20260076|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260077|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20260078|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
20260079|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
20260080|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260081|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260082|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260083|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
20260084|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260085|NCT00490737|Daptomycin|daptomycin|mesh-list
20260086|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20260087|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260088|NCT00490789|Sirolimus|sirolimus|mesh-list
20540841|NCT01854606|Everolimus|everolimus|mesh-list
20540842|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540843|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20540844|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
20540845|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540846|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
20540847|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20540848|NCT01854684|Temoporfin|temoporfin|mesh-list
20540849|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540850|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20540851|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540852|NCT01854723|Insulin|insulin|mesh-list
20540853|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20540854|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
20540855|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
20540856|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
20540857|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
20540858|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20540859|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540860|NCT01854749|Cisplatin|cisplatin|mesh-list
20540861|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540862|NCT01854762|Ritonavir|ritonavir|mesh-list
20540863|NCT01854762|Lopinavir|lopinavir|mesh-list
20540864|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
20540865|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20540866|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20540867|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
20540868|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540869|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907668|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907669|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19907670|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19907671|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19907672|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
19907673|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19907674|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20260089|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20540870|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20540871|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20540872|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
19907675|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
19907676|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907677|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
19907678|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19907679|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19907680|NCT01134263|Vaccines|vaccines|mesh-list
19907681|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
19907682|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907683|NCT01134315|Calcitriol|calcitriol|mesh-list
19907684|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19907685|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907686|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19907687|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907688|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907689|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19907690|NCT01134315|Vitamins|vitamins|mesh-ancestor
19449812|NCT03432728|Anesthetics|anesthetics|mesh-list
19449813|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449814|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449815|NCT03432689|Cycloserine|cycloserine|mesh-list
19449816|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19449817|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449818|NCT03432689|Renal Agents|renal agents|mesh-ancestor
19449819|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19449820|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
19449821|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19449822|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
19907691|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
19907692|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19907693|NCT01134393|Amlodipine|amlodipine|mesh-list
19907694|NCT01134393|Telmisartan|telmisartan|mesh-list
19907695|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19907696|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19907697|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19907698|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907699|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907700|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19907701|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907702|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
19907703|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19907704|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19907705|NCT01134510|Complement C1s|complement c1s|mesh-list
19907706|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19907707|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19907708|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
19907709|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907710|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19907711|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971791|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19971792|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19971793|NCT01802775|Analgesics|analgesics|mesh-ancestor
19971794|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
19971795|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971796|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971797|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971798|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971799|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19971800|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19971801|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971802|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19971803|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19971804|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971805|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
19971806|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19971807|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19971808|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19971809|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
19971810|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971811|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19971812|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
19971813|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19971814|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
19907712|NCT01129011|Naproxen|naproxen|mesh-list
19907713|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19907714|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19907715|NCT01129011|Analgesics|analgesics|mesh-ancestor
19907716|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
19907717|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907718|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907719|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907720|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907721|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
19907722|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19907723|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907724|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907725|NCT01134575|Rituximab|rituximab|mesh-list
19907726|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19907727|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907728|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907729|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
19907730|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907731|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907732|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19907733|NCT01134627|Minocycline|minocycline|mesh-list
19907734|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19907735|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907736|NCT01134705|Beclomethasone|beclomethasone|mesh-list
19907737|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907738|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
19907739|NCT01134705|Hormones|hormones|mesh-ancestor
19907740|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907741|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907742|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19907743|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
19907744|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19907745|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19907746|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907747|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19907748|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907749|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907750|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19907751|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19907752|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19907753|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
19907754|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907755|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19907756|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19907757|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
19907758|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
19907759|NCT01134952|Sirolimus|sirolimus|mesh-list
19907760|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19907761|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907762|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19907763|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
19907764|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19907765|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907766|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907767|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907768|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
19907769|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907770|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
19907771|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907772|NCT01135017|Dronedarone|dronedarone|mesh-list
19907773|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19907774|NCT01135069|Tretinoin|tretinoin|mesh-list
19907775|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907776|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
19907777|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
19907778|NCT01135186|Verapamil|verapamil|mesh-list
19907779|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19907780|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19907781|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260090|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260091|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20260092|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260093|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
20260094|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260095|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
20260096|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260097|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
20260098|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20260099|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20260100|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20260101|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260102|NCT00490854|Insulin|insulin|mesh-list
20260103|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20260104|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
20260105|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
19907782|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907783|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19907784|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907785|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
19907786|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
19907787|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
19907788|NCT01135329|Busulfan|busulfan|mesh-list
19907789|NCT01135329|Fludarabine|fludarabine|mesh-list
19907790|NCT01135329|Tacrolimus|tacrolimus|mesh-list
19907791|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907792|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
19907793|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907794|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19907795|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19907796|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
19907797|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907798|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907799|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19907800|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19907801|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907802|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19907803|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19907804|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
19907805|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19907806|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907807|NCT01135368|Lansoprazole|lansoprazole|mesh-list
19907808|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
19907809|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19907810|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19907811|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19907812|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907813|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907814|NCT01135394|Pioglitazone|pioglitazone|mesh-list
19907815|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907816|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907817|NCT01135498|Bevacizumab|bevacizumab|mesh-list
19907818|NCT01135498|Capecitabine|capecitabine|mesh-list
19907819|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19907820|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
19907821|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19907822|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907823|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19907824|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19907825|NCT01135498|Growth Substances|growth substances|mesh-ancestor
19907826|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907827|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
19907828|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19907829|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
19907830|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907831|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907832|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907833|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19907834|NCT01135511|Tofacitinib|tofacitinib|mesh-list
20260106|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
20260107|NCT00490854|Protamines|protamines|mesh-list
19907835|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
19907836|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19907837|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907838|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907839|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907840|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19907841|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
19907842|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907843|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
19907844|NCT01135511|Protective Agents|protective agents|mesh-ancestor
19907845|NCT01135524|Buprenorphine|buprenorphine|mesh-list
19907846|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19907847|NCT01135524|Narcotics|narcotics|mesh-ancestor
19907848|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907849|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907850|NCT01135524|Analgesics|analgesics|mesh-ancestor
19907851|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
19907852|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907853|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19907854|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
19907855|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19907856|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
19907857|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907858|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907859|NCT01135914|Ranibizumab|ranibizumab|mesh-list
19907860|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19907861|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19907862|NCT01135914|Growth Substances|growth substances|mesh-ancestor
19907863|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907864|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
19907865|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907866|NCT01135992|Insulin|insulin|mesh-list
19907867|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19907868|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
19907869|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907870|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907871|NCT01136174|Nintedanib|nintedanib|mesh-list
19907872|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907873|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907874|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907875|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907876|NCT01136226|Leuprolide|leuprolide|mesh-list
19907877|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19907878|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
19907879|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19907880|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907881|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19907882|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907883|NCT01136356|Morphine|morphine|mesh-list
19907884|NCT01136356|Buprenorphine|buprenorphine|mesh-list
19907885|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19907886|NCT01136356|Narcotics|narcotics|mesh-ancestor
19907887|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907888|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907889|NCT01136356|Analgesics|analgesics|mesh-ancestor
19907890|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
19907891|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907892|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19907893|NCT01136382|Budesonide|budesonide|mesh-list
19907894|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907895|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19907896|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
19907897|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907898|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907899|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19907900|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
19907901|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
19907902|NCT01136382|Hormones|hormones|mesh-ancestor
19907903|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907904|NCT01136408|Warfarin|warfarin|mesh-list
19907905|NCT01136408|Dabigatran|dabigatran|mesh-list
19907906|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
19907907|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
19907908|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19907909|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
19907910|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907911|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907912|NCT01136655|Budesonide|budesonide|mesh-list
19907913|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
19907914|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19907915|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19907916|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19907917|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
19907918|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907919|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907920|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19907921|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
19907922|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
19907923|NCT01136655|Hormones|hormones|mesh-ancestor
19907924|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907925|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19907926|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19907927|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19907928|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
19907929|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907930|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907931|NCT01136733|Everolimus|everolimus|mesh-list
19907932|NCT01136733|Lenvatinib|lenvatinib|mesh-list
19907933|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19907934|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19907935|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
19907936|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907937|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19907938|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907939|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907940|NCT01136746|Insulin|insulin|mesh-list
19907941|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19907942|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
19907943|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
19907944|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907945|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907946|NCT01136772|Haloperidol|haloperidol|mesh-list
19907947|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19907948|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
19907949|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19907950|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19907951|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19907952|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907953|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19907954|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19907955|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19907956|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
19907957|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19907958|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907959|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19907960|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19907961|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
19907962|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
19907963|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
19907964|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19907965|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19907966|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19907967|NCT01136798|Exenatide|exenatide|mesh-list
19907968|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19907969|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907970|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19907971|NCT01136798|Incretins|incretins|mesh-ancestor
19907972|NCT01136798|Hormones|hormones|mesh-ancestor
19907973|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907974|NCT01136954|Zonisamide|zonisamide|mesh-list
19907975|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
19907976|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19907977|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19907978|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907979|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19907980|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907981|NCT01137071|Antibodies|antibodies|mesh-list
19907982|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19907983|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
19907984|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907985|NCT01137292|Voriconazole|voriconazole|mesh-list
19907986|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
19907987|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19907988|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19907989|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19907990|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19907991|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19907992|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19907993|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
19907994|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19907995|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19907996|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19907997|NCT01137396|Modafinil|modafinil|mesh-list
19907998|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19907999|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908000|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19908001|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19908002|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19908003|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908004|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
19908005|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19908006|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908007|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19908008|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908009|NCT01137604|Bevacizumab|bevacizumab|mesh-list
19908010|NCT01137604|Lenvatinib|lenvatinib|mesh-list
19908011|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19908012|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908013|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19908014|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19908015|NCT01137604|Growth Substances|growth substances|mesh-ancestor
19908016|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908017|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
19908018|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19908019|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908020|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908021|NCT01137682|Octreotide|octreotide|mesh-list
19908022|NCT01137682|Lanreotide|lanreotide|mesh-list
19908023|NCT01137682|Pasireotide|pasireotide|mesh-list
19908024|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19908025|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19908026|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908027|NCT01137682|Hormones|hormones|mesh-ancestor
19908028|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908029|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908030|NCT01137812|Metformin|metformin|mesh-list
19908031|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19908032|NCT01137812|Canagliflozin|canagliflozin|mesh-list
19908033|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19908034|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908035|NCT01137812|Incretins|incretins|mesh-ancestor
19908036|NCT01137812|Hormones|hormones|mesh-ancestor
19908037|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908038|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19908039|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
19908040|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908041|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908042|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19908043|NCT01137890|Zonisamide|zonisamide|mesh-list
19908044|NCT01137890|Cocaine|cocaine|mesh-list
19908045|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
19908046|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19908047|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908048|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908049|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19908050|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908051|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
19908052|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
19908053|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908054|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
19908055|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908056|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19908057|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19908058|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19908059|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
19908060|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908061|NCT01138046|Paclitaxel|paclitaxel|mesh-list
19908062|NCT01138046|Lapatinib|lapatinib|mesh-list
19908063|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19908064|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908065|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
19908066|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
19908067|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
19908068|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908069|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19908070|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908071|NCT01138124|Gabapentin|gabapentin|mesh-list
19908072|NCT01138124|Analgesics|analgesics|mesh-ancestor
19908073|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
19908074|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908075|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908076|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
19908077|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19908078|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908079|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908080|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908081|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19908082|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19908083|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260108|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20260109|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449823|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449824|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
19908084|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908085|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
19908086|NCT01138150|Naproxen|naproxen|mesh-list
19908087|NCT01138150|Sumatriptan|sumatriptan|mesh-list
19908088|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19908089|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19908090|NCT01138150|Analgesics|analgesics|mesh-ancestor
19908091|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
19908092|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908093|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908094|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908095|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908096|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
19908097|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19908098|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908099|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908100|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19908101|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19908102|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19908103|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
19908104|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908105|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
19908106|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19908107|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908108|NCT01138475|Vitamins|vitamins|mesh-ancestor
19908109|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
19908110|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19908111|NCT01138501|Factor VIII|factor viii|mesh-list
19908112|NCT01138501|Coagulants|coagulants|mesh-ancestor
19908113|NCT01138514|Clindamycin|clindamycin|mesh-list
19908114|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
19908115|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
19908116|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19908117|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908118|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908119|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19908120|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908121|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908122|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908123|NCT01138657|Prednisone|prednisone|mesh-list
19908124|NCT01138657|Adalimumab|adalimumab|mesh-list
19908125|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908126|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
19908127|NCT01138657|Hormones|hormones|mesh-ancestor
19908128|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908129|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908130|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19908131|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908132|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908133|NCT01138735|Adapalene|adapalene|mesh-list
19908134|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19908135|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19908136|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908137|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19908138|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19908139|NCT01138735|Analgesics|analgesics|mesh-ancestor
19908140|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
19908141|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908142|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908143|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908144|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908145|NCT01138826|Amlodipine|amlodipine|mesh-list
19908146|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19908147|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19908148|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908149|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908150|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19908151|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908152|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
19908153|NCT01138969|Esomeprazole|esomeprazole|mesh-list
19908154|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19908155|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19908156|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19908157|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908158|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908159|NCT01139008|Metronidazole|metronidazole|mesh-list
19908160|NCT01139008|Azelaic acid|azelaic acid|mesh-list
19908161|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908162|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908163|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19908164|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19908165|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908166|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908167|NCT01139047|Metronidazole|metronidazole|mesh-list
19908168|NCT01139047|Azelaic acid|azelaic acid|mesh-list
19908169|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908170|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908171|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19908172|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19908173|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908174|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908175|NCT01139190|Naproxen|naproxen|mesh-list
19908176|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19908177|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19908178|NCT01139190|Analgesics|analgesics|mesh-ancestor
19908179|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
19908180|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908181|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908182|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908183|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908184|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
19908185|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19908186|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908187|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908188|NCT01139450|Tacrolimus|tacrolimus|mesh-list
19908189|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908190|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
19908191|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908192|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19908193|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908194|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908195|NCT01139515|Eletriptan|eletriptan|mesh-list
19908196|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19908197|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
19908198|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908199|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908200|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908201|NCT01139580|Calcipotriene|calcipotriene|mesh-list
19908202|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908203|NCT01139762|Tadalafil|tadalafil|mesh-list
19908204|NCT01139762|Finasteride|finasteride|mesh-list
19908205|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
19908206|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19908207|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19908208|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908209|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908210|NCT01139762|Urological Agents|urological agents|mesh-ancestor
19908211|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19908212|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19908213|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
19908214|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908215|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908216|NCT01139775|Pemetrexed|pemetrexed|mesh-list
19908217|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908218|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908219|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908220|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19908221|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908222|NCT01139801|Misoprostol|misoprostol|mesh-list
19908223|NCT01139801|Oxytocin|oxytocin|mesh-list
19908224|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
19908225|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19908226|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908227|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19908228|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
19908229|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19908230|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19908231|NCT01140061|MK 0873|mk 0873|mesh-list
19908232|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19908233|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19908234|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908235|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908236|NCT01140191|Gentamicins|gentamicins|mesh-list
19908237|NCT01140191|Paromomycin|paromomycin|mesh-list
19908238|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908239|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908240|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19908241|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908242|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908243|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19908244|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19908245|NCT01140347|Ramucirumab|ramucirumab|mesh-list
19908246|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908247|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
19908248|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908249|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19908250|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908251|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908252|NCT01140503|Apremilast|apremilast|mesh-list
19908253|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19908254|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19908255|NCT01140503|Analgesics|analgesics|mesh-ancestor
19908256|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
19908257|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908258|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908259|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908260|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908261|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19908262|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19908263|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908264|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908265|NCT01140880|Tenofovir|tenofovir|mesh-list
19908266|NCT01140880|Emtricitabine|emtricitabine|mesh-list
19908267|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19908268|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
19908269|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908270|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19908271|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908272|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908273|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908274|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19908275|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19908276|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19908277|NCT01140906|Vortioxetine|vortioxetine|mesh-list
19908278|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19908279|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19908280|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908281|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908282|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908283|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908284|NCT01140906|Analgesics|analgesics|mesh-ancestor
19908285|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
19908286|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908287|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
19908288|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908289|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
19908290|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19908291|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908292|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908293|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19908294|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
19908295|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19908296|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19908297|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19908298|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19971815|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
19971816|NCT01802879|Panobinostat|panobinostat|mesh-list
19971817|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971818|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19971819|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971820|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971821|NCT01803074|Ritonavir|ritonavir|mesh-list
19971822|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19971823|NCT01803074|Tenofovir|tenofovir|mesh-list
19971824|NCT01803074|Emtricitabine|emtricitabine|mesh-list
19971825|NCT01803074|BMS-955176|bms-955176|mesh-list
19971826|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19971827|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19971828|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
19971829|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971830|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971831|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19971832|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19971833|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
19971834|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971835|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19971836|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19971837|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19971838|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19971839|NCT01803269|Topotecan|topotecan|mesh-list
19908299|NCT01141049|Gabapentin|gabapentin|mesh-list
19908300|NCT01141049|Analgesics|analgesics|mesh-ancestor
19908301|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
19908302|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908303|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908304|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
19908305|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19908306|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908307|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908308|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19449825|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19449826|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449827|NCT03432663|Amiodarone|amiodarone|mesh-list
19449828|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19449829|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
19449830|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19449831|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19449832|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449833|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19449834|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19449835|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19449836|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449837|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20260110|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
20260111|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260112|NCT00490854|Coagulants|coagulants|mesh-ancestor
20260113|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
20260114|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
20260115|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260116|NCT00490867|Protective Agents|protective agents|mesh-ancestor
20260117|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260118|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
20260119|NCT00490867|Vitamins|vitamins|mesh-ancestor
20260120|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
20260121|NCT00490880|Gemcitabine|gemcitabine|mesh-list
20260122|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260123|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20260124|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
20260125|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260126|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
20260127|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260128|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260129|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260130|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
20260131|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260132|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
20260133|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20260134|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260135|NCT00490906|Interferons|interferons|mesh-list
20260136|NCT00490906|Interferon-beta|interferon-beta|mesh-list
20260137|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
20260138|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
20260139|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
20260140|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
20260141|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540873|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540874|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20540875|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20540876|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20540877|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20540878|NCT01854970|Esomeprazole|esomeprazole|mesh-list
20540879|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20540880|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540881|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20540882|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540883|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554021|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20554022|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20554023|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
20554024|NCT01932554|Ibuprofen|ibuprofen|mesh-list
20554025|NCT01932554|Fentanyl|fentanyl|mesh-list
20554026|NCT01932554|Morphine|morphine|mesh-list
19908309|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20260142|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
20554027|NCT01932554|Hydromorphone|hydromorphone|mesh-list
20554028|NCT01932554|Narcotics|narcotics|mesh-list
20554029|NCT01932554|Abciximab|abciximab|mesh-list
19908310|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19908311|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908312|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908313|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
19908314|NCT01141283|Buprenorphine|buprenorphine|mesh-list
19908315|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19908316|NCT01141283|Narcotics|narcotics|mesh-ancestor
19908317|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908318|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908319|NCT01141283|Analgesics|analgesics|mesh-ancestor
19908320|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
19908321|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908322|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19908323|NCT01141478|Sorafenib|sorafenib|mesh-list
19908324|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908325|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19908326|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908327|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908328|NCT01141491|Vaccines|vaccines|mesh-list
19908329|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
19908330|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
19908331|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908332|NCT01141569|R04929097|r04929097|mesh-list
19908333|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908334|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908335|NCT01141595|Verapamil|verapamil|mesh-list
19908336|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19908337|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19908338|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908339|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908340|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19908341|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908342|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
19908343|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19908344|NCT01141725|Idarubicin|idarubicin|mesh-list
19908345|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19908346|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
19449838|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19449839|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19449840|NCT03432650|Dexamethasone|dexamethasone|mesh-list
19449841|NCT03432650|Bupivacaine|bupivacaine|mesh-list
19449842|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449843|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
19449844|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
19449845|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449846|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449847|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19449848|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
19449849|NCT03432650|Hormones|hormones|mesh-ancestor
19449850|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449851|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19449852|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449853|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
19449854|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
19449855|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449856|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
19449857|NCT03432637|Anesthetics|anesthetics|mesh-list
19449858|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449859|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449860|NCT03432598|Gemcitabine|gemcitabine|mesh-list
19449861|NCT03432598|Paclitaxel|paclitaxel|mesh-list
19449862|NCT03432598|Etoposide|etoposide|mesh-list
19449863|NCT03432598|Carboplatin|carboplatin|mesh-list
19449864|NCT03432598|Pemetrexed|pemetrexed|mesh-list
19449865|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19449866|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449867|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
19449868|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
19449869|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
19449870|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449871|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19449872|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
19908347|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908348|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19449873|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
19908349|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19908350|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19908351|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19908352|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908353|NCT01142089|Rifamycins|rifamycins|mesh-list
19908354|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
19908355|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908356|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908357|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908358|NCT01142193|Topiramate|topiramate|mesh-list
19908359|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
19908360|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19908361|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908362|NCT01142232|Lenalidomide|lenalidomide|mesh-list
19908363|NCT01142232|Melphalan|melphalan|mesh-list
19908364|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
19908365|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908366|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19908367|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19908368|NCT01142232|Growth Substances|growth substances|mesh-ancestor
19908369|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
19908370|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908371|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19908372|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
19908373|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908374|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19908375|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908376|NCT01142310|Lamotrigine|lamotrigine|mesh-list
19908377|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
19908378|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19908379|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908380|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908381|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19908382|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908383|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19908384|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908385|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908386|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908387|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19908388|NCT01142323|Fenofibrate|fenofibrate|mesh-list
19908389|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19908390|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
19908391|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908392|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19908393|NCT01142336|Simvastatin|simvastatin|mesh-list
19908394|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19908395|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19908396|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
19908397|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908398|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19908399|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19908400|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908401|NCT01142466|Interferons|interferons|mesh-list
19908402|NCT01142466|Interferon-beta|interferon-beta|mesh-list
19908403|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
19908404|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908405|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
19908406|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908407|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
19908408|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908409|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19908410|NCT01142726|Methotrexate|methotrexate|mesh-list
19908411|NCT01142726|Abatacept|abatacept|mesh-list
19908412|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19908413|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
19908414|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19908415|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908416|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19908417|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
19908418|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908419|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908420|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
20260143|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260144|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
20260145|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908421|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260146|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20260147|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260148|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20260149|NCT00490958|Telmisartan|telmisartan|mesh-list
20260150|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20260151|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20260152|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20260153|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260154|NCT00490997|Ketamine|ketamine|mesh-list
20260155|NCT00490997|Propofol|propofol|mesh-list
20260156|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20260157|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20260158|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260159|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20260160|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
20260161|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
20260162|NCT00490997|Analgesics|analgesics|mesh-ancestor
19908422|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19908423|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908424|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
19908425|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908426|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908427|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19908428|NCT01142947|Beclomethasone|beclomethasone|mesh-list
19908429|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908430|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
19908431|NCT01142947|Hormones|hormones|mesh-ancestor
19908432|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908433|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908434|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19908435|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
19908436|NCT01143051|Epinephrine|epinephrine|mesh-list
19908437|NCT01143051|Racepinephrine|racepinephrine|mesh-list
19908438|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
19908439|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19908440|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19908441|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908442|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908443|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908444|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908445|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19908446|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19908447|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
19908448|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908449|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19908450|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
19908451|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
19908452|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
19908453|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19908454|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19908455|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19908456|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908457|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908458|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908459|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908460|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19908461|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19908462|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19908463|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908464|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908465|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908466|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19908467|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19908468|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
19908469|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19908470|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19908471|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
19908472|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19908473|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19908474|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19971840|NCT01803269|Camptothecin|camptothecin|mesh-list
20260163|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
20540884|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
20540885|NCT01855009|Vitamin D|vitamin d|mesh-list
19908475|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908476|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908477|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908478|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19908479|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19908480|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19908481|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908482|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908483|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908484|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19908485|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19908486|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
19908487|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19908488|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19908489|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
19908490|NCT01143181|Brincidofovir|brincidofovir|mesh-list
19908491|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
19908492|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908493|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19908494|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
19908495|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19908496|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19908497|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19908498|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
19908499|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19908500|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908501|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19908502|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19908503|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19908504|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19908505|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908506|NCT01143259|Alvimopan|alvimopan|mesh-list
19908507|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19908508|NCT01143337|Methotrexate|methotrexate|mesh-list
19908509|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19908510|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
19908511|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19908512|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908513|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19908514|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
19908515|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908516|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908517|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908518|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908519|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19908520|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908521|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
19908522|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908523|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908524|NCT01143389|Riboflavin|riboflavin|mesh-list
19908525|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
19908526|NCT01143389|Vitamins|vitamins|mesh-ancestor
19908527|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
19908528|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908529|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19908530|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908531|NCT01143402|Temozolomide|temozolomide|mesh-list
19908532|NCT01143402|Dacarbazine|dacarbazine|mesh-list
19908533|NCT01143402|Imidazole|imidazole|mesh-list
19908534|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19908535|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
19908536|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908537|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908538|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908539|NCT01143688|Albuterol|albuterol|mesh-list
19908540|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19908541|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
19908542|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908543|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908544|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19908545|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
19908546|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
19908547|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19908548|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19908549|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19908550|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19908551|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908552|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908553|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908554|NCT01143714|Petrolatum|petrolatum|mesh-list
19908555|NCT01143714|Emollients|emollients|mesh-ancestor
19908556|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908557|NCT01143766|Gabapentin|gabapentin|mesh-list
19908558|NCT01143766|Analgesics|analgesics|mesh-ancestor
19908559|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
19908560|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908561|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908562|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
19908563|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19908564|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908565|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908566|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908567|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19908568|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19908569|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908570|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908571|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
19908572|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
19908573|NCT01143818|Testosterone|testosterone|mesh-list
19908574|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
19908575|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
19908576|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19908577|NCT01143818|Androgens|androgens|mesh-ancestor
19908578|NCT01143818|Hormones|hormones|mesh-ancestor
19908579|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908580|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908581|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19908582|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908583|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
19908584|NCT01144052|Interferons|interferons|mesh-list
19908585|NCT01144052|Interferon-beta|interferon-beta|mesh-list
19908586|NCT01144052|Natalizumab|natalizumab|mesh-list
19908587|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
19908588|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908589|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
19908590|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908591|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
19908592|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908593|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19908594|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
19908595|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19908596|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19908597|NCT01144143|Prednisolone|prednisolone|mesh-list
19908598|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
19908599|NCT01144143|Infliximab|infliximab|mesh-list
19908600|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19908601|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
19908602|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908603|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
19908604|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
19908605|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908606|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908607|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19908608|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
19908609|NCT01144143|Hormones|hormones|mesh-ancestor
19908610|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908611|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19908612|NCT01144143|Protective Agents|protective agents|mesh-ancestor
19908613|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19908614|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908615|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
19908616|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908617|NCT01144338|Exenatide|exenatide|mesh-list
19908618|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19908619|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908620|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19908621|NCT01144338|Incretins|incretins|mesh-ancestor
19908622|NCT01144338|Hormones|hormones|mesh-ancestor
19908623|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908624|NCT01144364|Rituximab|rituximab|mesh-list
19908625|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19908626|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908627|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
19908628|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908629|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908630|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
19908631|NCT01144403|Rituximab|rituximab|mesh-list
19908632|NCT01144403|Fludarabine|fludarabine|mesh-list
19908633|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
19908634|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908635|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
19908636|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908637|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908638|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19908639|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
19908640|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908641|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908642|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19908643|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19908644|NCT01144403|Analgesics|analgesics|mesh-ancestor
19908645|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
19908646|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908647|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19908648|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19908649|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908650|NCT01144442|Paclitaxel|paclitaxel|mesh-list
19908651|NCT01144442|Carboplatin|carboplatin|mesh-list
19908652|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19908653|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908654|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
19908655|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
19908656|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
19908657|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908658|NCT01144455|Gemcitabine|gemcitabine|mesh-list
19908659|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
19908660|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19908661|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
19908662|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908663|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908664|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
19908665|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908666|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908667|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908668|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
19908669|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908670|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19908671|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
19908672|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19908673|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
19908674|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19908675|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19908676|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19908677|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19908678|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908679|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908680|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908681|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908682|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19908683|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19908684|NCT01144949|Silodosin|silodosin|mesh-list
19908685|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19908686|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19908687|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19908688|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908689|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908690|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908691|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908692|NCT01144949|Urological Agents|urological agents|mesh-ancestor
19908693|NCT01145001|Nicotine|nicotine|mesh-list
19908694|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19908695|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
19908696|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908697|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908698|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19908699|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19908700|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
19908701|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908702|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908703|NCT01145066|Borage oil|borage oil|mesh-list
19908704|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908705|NCT01145183|Doxazosin|doxazosin|mesh-list
19908706|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19908707|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19908708|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19908709|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19908710|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908711|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908712|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908713|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908714|NCT01145222|Midazolam|midazolam|mesh-list
19908715|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19908716|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19908717|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908718|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908719|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19908720|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908721|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908722|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19908723|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
19908724|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
19908725|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
19908726|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
19908727|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908728|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908729|NCT01145352|Etanercept|etanercept|mesh-list
19908730|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19908731|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19908732|NCT01145352|Analgesics|analgesics|mesh-ancestor
19908733|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
19908734|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908735|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908736|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908737|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908738|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20260164|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260165|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20260166|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20260167|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20260168|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260169|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260170|NCT00491049|Levofloxacin|levofloxacin|mesh-list
20260171|NCT00491049|Ofloxacin|ofloxacin|mesh-list
20260172|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20260173|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20260174|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20260175|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260176|NCT00491049|Renal Agents|renal agents|mesh-ancestor
20260177|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20260178|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20260179|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20260180|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260181|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260182|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260183|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20260184|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20260185|NCT00491114|Gemcitabine|gemcitabine|mesh-list
20260186|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20260187|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
20260188|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260189|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260190|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
20260191|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260192|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260193|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260194|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
20260195|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260196|NCT00491127|Gemcitabine|gemcitabine|mesh-list
19908739|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908740|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
19908741|NCT01145417|Pregabalin|pregabalin|mesh-list
19908742|NCT01145417|Analgesics|analgesics|mesh-ancestor
19908743|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
19908744|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908745|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908746|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
19908747|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19908748|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908749|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908750|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19908751|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19908752|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19908753|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908754|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908755|NCT01145482|Insulin|insulin|mesh-list
19908756|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
19908757|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19908758|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260197|NCT00491127|Dexamethasone|dexamethasone|mesh-list
20260198|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260199|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260200|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
20260201|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
20260202|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260203|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260204|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20260205|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
20260206|NCT00491127|Hormones|hormones|mesh-ancestor
20260207|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260208|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20260209|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20260210|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
20260211|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260212|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
20260213|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260214|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260215|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260216|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
20260217|NCT00491166|Bromfenac|bromfenac|mesh-list
20260218|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20260219|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20260220|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20260221|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20260222|NCT00491166|Analgesics|analgesics|mesh-ancestor
20260223|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
20260224|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260225|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260226|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260227|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20260228|NCT00491192|Diclofenac|diclofenac|mesh-list
20260229|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20260230|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20260231|NCT00491192|Analgesics|analgesics|mesh-ancestor
20260232|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
20260233|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260234|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260235|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260236|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20260237|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20260238|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260239|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260240|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19908759|NCT01145508|Metronidazole|metronidazole|mesh-list
19908760|NCT01145508|Prednisone|prednisone|mesh-list
19908761|NCT01145508|Cortisone|cortisone|mesh-list
19908762|NCT01145508|Docetaxel|docetaxel|mesh-list
19908763|NCT01145508|Vaccines|vaccines|mesh-list
19908764|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
19908765|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908766|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908767|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
19908768|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
19908769|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
19908770|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908771|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19908772|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
19908773|NCT01145508|Hormones|hormones|mesh-ancestor
19908774|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19908775|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19908776|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908777|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908778|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19908779|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19908780|NCT01145625|Minoxidil|minoxidil|mesh-list
19908781|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19908782|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
19908783|NCT01145638|Iron|iron|mesh-list
19908784|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19908785|NCT01145638|Trace Elements|trace elements|mesh-ancestor
19908786|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
19908787|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908788|NCT01145638|Hematinics|hematinics|mesh-ancestor
19908789|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19908790|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19908791|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20260241|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20260242|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20260243|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260244|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260245|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260246|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260247|NCT00491348|Analgesics|analgesics|mesh-ancestor
20260248|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
20260249|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260250|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
20540886|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
20540887|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
20540888|NCT01855009|Calcium|calcium|mesh-list
20540889|NCT01855009|Vitamins|vitamins|mesh-ancestor
20540890|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
20540891|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540892|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540893|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20540894|NCT01855009|Antacids|antacids|mesh-ancestor
20540895|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540896|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20540897|NCT01855061|Midazolam|midazolam|mesh-list
20540898|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20540899|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20540900|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540901|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540902|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20540903|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20540904|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20540905|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20540906|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
20540907|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
20540908|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
20540909|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
20540910|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540911|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540912|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
20540913|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20540914|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
20540915|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20540916|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
20540917|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540918|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540919|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
20540920|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
20540921|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20540922|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
20540923|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20540924|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
20540925|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554030|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19908792|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908793|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908794|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908795|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908796|NCT01145755|Analgesics|analgesics|mesh-ancestor
19908797|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
19908798|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908799|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
19908800|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19908801|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
19908802|NCT01145898|Timolol|timolol|mesh-list
19908803|NCT01145898|Dorzolamide|dorzolamide|mesh-list
19908804|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19908805|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19908806|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
19908807|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908808|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908809|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908810|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19908811|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19908812|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19908813|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908814|NCT01146054|Gemcitabine|gemcitabine|mesh-list
19908815|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19908816|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19908817|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
19908818|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908819|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908820|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
19908821|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908822|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908823|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908824|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
19908825|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908826|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19908827|NCT01146288|Furosemide|furosemide|mesh-list
19908828|NCT01146288|Acetazolamide|acetazolamide|mesh-list
19908829|NCT01146288|Diuretics|diuretics|mesh-ancestor
19908830|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
19908831|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908832|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19908833|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908834|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908835|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
19908836|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19908837|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908838|NCT01146457|Morphine|morphine|mesh-list
19908839|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19908840|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19908841|NCT01146457|Narcotics|narcotics|mesh-ancestor
19908842|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19908843|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908844|NCT01146457|Analgesics|analgesics|mesh-ancestor
19908845|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
19908846|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908847|NCT01146561|Tanezumab|tanezumab|mesh-list
19908848|NCT01146561|Analgesics|analgesics|mesh-ancestor
19908849|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
19908850|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19908851|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908852|NCT01146600|Clarithromycin|clarithromycin|mesh-list
19908853|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908854|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908855|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19908856|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908857|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908858|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19908859|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19908860|NCT01146613|Varenicline|varenicline|mesh-list
19908861|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19908862|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19908863|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
19908864|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19908865|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908866|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971841|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19971842|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20260251|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19971843|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908867|NCT01146795|Paclitaxel|paclitaxel|mesh-list
19908868|NCT01146795|Bevacizumab|bevacizumab|mesh-list
19908869|NCT01146795|Carboplatin|carboplatin|mesh-list
19908870|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19908871|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908872|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
19908873|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
19908874|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
19908875|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908876|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19908877|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19908878|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19908879|NCT01146795|Growth Substances|growth substances|mesh-ancestor
19908880|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908881|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19908882|NCT01146808|Adefovir|adefovir|mesh-list
19908883|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19908884|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
19908885|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908886|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19908887|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908888|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908889|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908890|NCT01146834|Plerixafor|plerixafor|mesh-list
19908891|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
19908892|NCT01146834|Bortezomib|bortezomib|mesh-list
19908893|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908894|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
19908895|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908896|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908897|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19908898|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
19908899|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908900|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908901|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19908902|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19908903|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19908904|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
19908905|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908906|NCT01146873|Ritonavir|ritonavir|mesh-list
19908907|NCT01146873|Lopinavir|lopinavir|mesh-list
19908908|NCT01146873|Abacavir|abacavir|mesh-list
19908909|NCT01146873|Stavudine|stavudine|mesh-list
19908910|NCT01146873|Efavirenz|efavirenz|mesh-list
19908911|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19908912|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19908913|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
19908914|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908915|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908916|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19908917|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19908918|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
19908919|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908920|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19908921|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19908922|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19908923|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908924|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19908925|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19908926|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19908927|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19908928|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19908929|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
19908930|NCT01146951|Rufinamide|rufinamide|mesh-list
19908931|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
19908932|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19908933|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19908934|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19908935|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908936|NCT01147055|Rifampin|rifampin|mesh-list
19908937|NCT01147055|Crizotinib|crizotinib|mesh-list
19908938|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19908939|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
19908940|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19908941|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908942|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
19908943|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908944|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908945|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908946|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19908947|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19908948|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19908949|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19908950|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19908951|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19908952|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19908953|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19908954|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
19908955|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
19908956|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
19908957|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908958|NCT01147107|Efavirenz|efavirenz|mesh-list
19908959|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
19908960|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19908961|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19908962|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19908963|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19908964|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
19908965|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19908966|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19908967|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19908968|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19908969|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19908970|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19908971|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19908972|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19908973|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19908974|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19908975|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19908976|NCT01147250|Lixisenatide|lixisenatide|mesh-list
19908977|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19908978|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908979|NCT01147302|Complement C1s|complement c1s|mesh-list
19908980|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19908981|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19908982|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
19908983|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908984|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19908985|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908986|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
19908987|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19908988|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
19908989|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908990|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19908991|NCT01147380|Vaccines|vaccines|mesh-list
19908992|NCT01147380|Immunologic Factors|immunologic factors|mesh-ancestor
19908993|NCT01147380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19908994|NCT01147458|Naproxen|naproxen|mesh-list
19908995|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19908996|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19908997|NCT01147458|Analgesics|analgesics|mesh-ancestor
19908998|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
19908999|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909000|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909001|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909002|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19909003|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
19909004|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19909005|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909006|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909007|NCT01147497|Misoprostol|misoprostol|mesh-list
19909008|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19909009|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
19909010|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19909011|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909012|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19909013|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909014|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
19909015|NCT01147601|Timolol|timolol|mesh-list
19909016|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19909017|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19909018|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
19909019|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909020|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909021|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909022|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19909023|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19909024|NCT01147627|Insulin|insulin|mesh-list
19909025|NCT01147627|Pioglitazone|pioglitazone|mesh-list
19909026|NCT01147627|Exenatide|exenatide|mesh-list
19909027|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
19909028|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19909029|NCT01147627|Protamines|protamines|mesh-list
19909030|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19909031|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909032|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19909033|NCT01147627|Incretins|incretins|mesh-ancestor
19909034|NCT01147627|Hormones|hormones|mesh-ancestor
19909035|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909036|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
19909037|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909038|NCT01147627|Coagulants|coagulants|mesh-ancestor
19909039|NCT01147640|Metronidazole|metronidazole|mesh-list
19909040|NCT01147640|Meropenem|meropenem|mesh-list
19909041|NCT01147640|Tazobactam|tazobactam|mesh-list
19909042|NCT01147640|Ceftolozane|ceftolozane|mesh-list
19909043|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909044|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909045|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19909046|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19909047|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19909048|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909049|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909050|NCT01147744|Fluticasone|fluticasone|mesh-list
19909051|NCT01147744|Xhance|xhance|mesh-list
19909052|NCT01147744|Montelukast|montelukast|mesh-list
19909053|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909054|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19909055|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
19909056|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909057|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909058|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19909059|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
19909060|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
19909061|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19909062|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19909063|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909064|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909065|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19909066|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19909067|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909068|NCT01147848|Fluticasone|fluticasone|mesh-list
19909069|NCT01147848|Xhance|xhance|mesh-list
19909070|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19909071|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909072|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19909073|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
19909074|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909075|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909076|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19909077|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
19909078|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
19909079|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19909080|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19909081|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19909082|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19909083|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
19909084|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909085|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909086|NCT01147926|Prucalopride|prucalopride|mesh-list
19909087|NCT01147926|Laxatives|laxatives|mesh-ancestor
19909088|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909089|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19909090|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19909091|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
19909092|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909093|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909094|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909095|NCT01148225|Adalimumab|adalimumab|mesh-list
19909096|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909097|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19909098|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19909099|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
19909100|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19909101|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19909102|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19909103|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
19909104|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19909105|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909106|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20260252|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
20260253|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
20260254|NCT00491413|Hematinics|hematinics|mesh-ancestor
20260255|NCT00491426|Metronidazole|metronidazole|mesh-list
20260256|NCT00491426|Tazobactam|tazobactam|mesh-list
20260257|NCT00491426|Piperacillin|piperacillin|mesh-list
20260258|NCT00491426|Amphotericin B|amphotericin b|mesh-list
20260259|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20260260|NCT00491426|Acyclovir|acyclovir|mesh-list
20260261|NCT00491426|Ampicillin|ampicillin|mesh-list
20260262|NCT00491426|Caspofungin|caspofungin|mesh-list
20260263|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
20260264|NCT00491426|Anidulafungin|anidulafungin|mesh-list
20260265|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260266|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20260267|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20260268|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20260269|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20260270|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260271|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260272|NCT00491426|Amebicides|amebicides|mesh-ancestor
20260273|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
20260274|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
20260275|NCT00491478|Sertraline|sertraline|mesh-list
20260276|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
20260277|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20260278|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20260279|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20260280|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260281|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260282|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260283|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
20260284|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260285|NCT00491517|Sirolimus|sirolimus|mesh-list
20260286|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909107|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19909108|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19909109|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19909110|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909111|NCT01148459|Vaccines|vaccines|mesh-list
19909112|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
19909113|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909114|NCT01148511|Ranibizumab|ranibizumab|mesh-list
19909115|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19909116|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19909117|NCT01148511|Growth Substances|growth substances|mesh-ancestor
19909118|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909119|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
19909120|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909121|NCT01148524|Vaccines|vaccines|mesh-list
19909122|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
19909123|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909124|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
19909125|NCT01148537|Buprenorphine|buprenorphine|mesh-list
19909126|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19909127|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909128|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909129|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19909130|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19909131|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909132|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909133|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909134|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19909135|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
19909136|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19909137|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909138|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19909139|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19909140|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19909141|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19909142|NCT01148537|Narcotics|narcotics|mesh-ancestor
19909143|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909144|NCT01148537|Analgesics|analgesics|mesh-ancestor
19909145|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
19909146|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909147|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19909148|NCT01148693|Gentamicins|gentamicins|mesh-list
19909149|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909150|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909151|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19909152|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909153|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909154|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19909155|NCT01148745|Hematinics|hematinics|mesh-ancestor
19909156|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19909157|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19909158|NCT01148771|Ertapenem|ertapenem|mesh-list
19909159|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909160|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909161|NCT01148810|Siponimod|siponimod|mesh-list
19909162|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19909163|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909164|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909165|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
19909166|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909167|NCT01148836|Ubiquinone|ubiquinone|mesh-list
19909168|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
19909169|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
19909170|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909171|NCT01148836|Vitamins|vitamins|mesh-ancestor
19909172|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19909173|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19909174|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909175|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19909176|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19909177|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909178|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909179|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
19909180|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909181|NCT01149096|Lenograstim|lenograstim|mesh-list
19909182|NCT01149096|Sargramostim|sargramostim|mesh-list
19909183|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19909184|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
19909185|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909186|NCT01149369|Aprepitant|aprepitant|mesh-list
19909187|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
19449874|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449875|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449876|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449877|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
19449878|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449879|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19449880|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19449881|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19449882|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19449883|NCT03432572|Riboflavin|riboflavin|mesh-list
19909188|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
19909189|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909190|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909191|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909192|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19909193|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909194|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909195|NCT01149421|Dulaglutide|dulaglutide|mesh-list
19909196|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19909197|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909198|NCT01149434|Everolimus|everolimus|mesh-list
19909199|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909200|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909201|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
19909202|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909203|NCT01149460|Valacyclovir|valacyclovir|mesh-list
19909204|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
19909205|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909206|NCT01149473|Losartan|losartan|mesh-list
19909207|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19909208|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19909209|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19909210|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19909211|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19909212|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909213|NCT01149473|Diuretics|diuretics|mesh-ancestor
19909214|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
19909215|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909216|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19909217|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909218|NCT01149486|Losartan|losartan|mesh-list
19909219|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19909220|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19909221|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19909222|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19909223|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19909224|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909225|NCT01149486|Diuretics|diuretics|mesh-ancestor
19909226|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
19909227|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909228|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19909229|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909230|NCT01149538|Choline|choline|mesh-list
19909231|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
19909232|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19909233|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
19909234|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909235|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909236|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19909237|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
19909238|NCT01149616|Dexamethasone|dexamethasone|mesh-list
19909239|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909240|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
19909241|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
19909242|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909243|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449884|NCT03432572|Thiamine|thiamine|mesh-list
19909244|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909245|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
19909246|NCT01149616|Hormones|hormones|mesh-ancestor
19909247|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909248|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19449885|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
19449886|NCT03432572|Vitamins|vitamins|mesh-ancestor
19449887|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
19449888|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449889|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19449890|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19449891|NCT03432468|Valsartan|valsartan|mesh-list
19449892|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19449893|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19449894|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19449895|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909249|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909250|NCT01149655|Aripiprazole|aripiprazole|mesh-list
19909251|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
19909252|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19909253|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19909254|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19909255|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909256|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909257|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
19909258|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
19909259|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909260|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909261|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19909262|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19909263|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
19909264|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19909265|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19909266|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19909267|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19909268|NCT01149733|Tamsulosin|tamsulosin|mesh-list
19909269|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19909270|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19909271|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19909272|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
19909273|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909274|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909275|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909276|NCT01149733|Urological Agents|urological agents|mesh-ancestor
19909277|NCT01149759|Cyclosporine|cyclosporine|mesh-list
19909278|NCT01149759|Cyclosporins|cyclosporins|mesh-list
19909279|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909280|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909281|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909282|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
19909283|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909284|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
19909285|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909286|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
19909287|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19909288|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19909289|NCT01149785|Ketoconazole|ketoconazole|mesh-list
19909290|NCT01149785|Crizotinib|crizotinib|mesh-list
19909291|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
19909292|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909293|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19909294|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19909295|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909296|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909297|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909298|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909299|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909300|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909301|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19909302|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909303|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19449896|NCT03432442|Ivermectin|ivermectin|mesh-list
19449897|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19909304|NCT01149863|Plerixafor|plerixafor|mesh-list
19909305|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19909306|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19909307|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
19909308|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909309|NCT01149876|Tretinoin|tretinoin|mesh-list
19909310|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909311|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
19909312|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
19909313|NCT01150097|Everolimus|everolimus|mesh-list
19909314|NCT01150097|Tacrolimus|tacrolimus|mesh-list
19909315|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909316|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
19909317|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909318|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19909319|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909320|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909321|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909322|NCT01150123|Vaccines|vaccines|mesh-list
19909323|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
19909324|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909325|NCT01150461|Losartan|losartan|mesh-list
19909326|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
19909327|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19909328|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19909329|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19909330|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19909331|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909332|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19909333|NCT01150500|Sirolimus|sirolimus|mesh-list
19909334|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909335|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909336|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19909337|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909338|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
19909339|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909340|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
19909341|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909342|NCT01150760|Alvimopan|alvimopan|mesh-list
19909343|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909344|NCT01150838|Propofol|propofol|mesh-list
19909345|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19909346|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909347|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909348|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19909349|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
19909350|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
19909351|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
19909352|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19909353|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260287|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260288|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20260289|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260290|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
20260291|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260292|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
20260293|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260294|NCT00491582|Hormones|hormones|mesh-list
20260295|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260296|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260297|NCT00491634|Treosulfan|treosulfan|mesh-list
20260298|NCT00491634|Busulfan|busulfan|mesh-list
20260299|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20260300|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
20260301|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260302|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260303|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260304|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
20260305|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260306|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20260307|NCT00491712|Triamcinolone|triamcinolone|mesh-list
20260308|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260309|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
20260310|NCT00491712|Hormones|hormones|mesh-ancestor
19909354|NCT01151046|Exemestane|exemestane|mesh-list
19909355|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909356|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20260311|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909357|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909358|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909359|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909360|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19909361|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909362|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909363|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909364|NCT01151085|Voriconazole|voriconazole|mesh-list
19909365|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
19909366|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909367|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19909368|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19909369|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909370|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909371|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909372|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909373|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909374|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909375|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19909376|NCT01151098|Buprenorphine|buprenorphine|mesh-list
19909377|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19909378|NCT01151098|Narcotics|narcotics|mesh-ancestor
19909379|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909380|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909381|NCT01151098|Analgesics|analgesics|mesh-ancestor
19909382|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
19909383|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909384|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19909385|NCT01151137|Dronedarone|dronedarone|mesh-list
19909386|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19909387|NCT01151215|Anastrozole|anastrozole|mesh-list
19909388|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19909389|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909390|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19909391|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909392|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909393|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909394|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19909395|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909396|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909397|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909398|NCT01151410|Enalapril|enalapril|mesh-list
19909399|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19909400|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
19909401|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909402|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909403|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19909404|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
19909405|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19909406|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
19909407|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909408|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
19909409|NCT01151436|Protective Agents|protective agents|mesh-ancestor
19909410|NCT01151449|R04929097|r04929097|mesh-list
19909411|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909412|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909413|NCT01151540|Rufinamide|rufinamide|mesh-list
19909414|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
19909415|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19909416|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19909417|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909418|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909419|NCT01151579|Albuterol|albuterol|mesh-list
19909420|NCT01151579|Ipratropium|ipratropium|mesh-list
19909421|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19909422|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
19909423|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909424|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909425|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19909426|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
19909427|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
19909428|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19909429|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19909430|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19909431|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19909432|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
19909433|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909434|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909435|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19909436|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
19909437|NCT01151761|Gemcitabine|gemcitabine|mesh-list
19909438|NCT01151761|Cisplatin|cisplatin|mesh-list
19909439|NCT01151761|Carboplatin|carboplatin|mesh-list
19909440|NCT01151761|Fluorouracil|fluorouracil|mesh-list
19909441|NCT01151761|Capecitabine|capecitabine|mesh-list
19909442|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909443|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19909444|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
19909445|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909446|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
19909447|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909448|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909449|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909450|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
19909451|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909452|NCT01151813|Varenicline|varenicline|mesh-list
19909453|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19909454|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19909455|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
19909456|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909457|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909458|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909459|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
19909460|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909461|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19909462|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909463|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909464|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
19909465|NCT01152021|Propofol|propofol|mesh-list
19909466|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19909467|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909468|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909469|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19909470|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
19909471|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
19909472|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19909473|NCT01152021|Analgesics|analgesics|mesh-ancestor
19909474|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
19909475|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909476|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19909477|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19909478|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19909479|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
19909480|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909481|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971844|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971845|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971846|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19971847|NCT01803282|Leucovorin|leucovorin|mesh-list
19971848|NCT01803282|Gemcitabine|gemcitabine|mesh-list
19971849|NCT01803282|Paclitaxel|paclitaxel|mesh-list
19971850|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19971851|NCT01803282|Bevacizumab|bevacizumab|mesh-list
19971852|NCT01803282|Carboplatin|carboplatin|mesh-list
19971853|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
19971854|NCT01803282|Irinotecan|irinotecan|mesh-list
19971855|NCT01803282|Pemetrexed|pemetrexed|mesh-list
19971856|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19971857|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971858|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
19909482|NCT01152190|Tadalafil|tadalafil|mesh-list
19909483|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
19909484|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19909485|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19909486|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909487|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909488|NCT01152190|Urological Agents|urological agents|mesh-ancestor
19909489|NCT01152437|Cetuximab|cetuximab|mesh-list
19909490|NCT01152437|Afatinib|afatinib|mesh-list
19909491|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19909492|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909493|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19909494|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909495|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909496|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
19909497|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19909498|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
19909499|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909500|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909501|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19909502|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
19909503|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
19909504|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19909505|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
19909506|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909507|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909508|NCT01152515|Remifentanil|remifentanil|mesh-list
19909509|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19909510|NCT01152515|Narcotics|narcotics|mesh-ancestor
19909511|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909512|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909513|NCT01152515|Analgesics|analgesics|mesh-ancestor
19909514|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
19909515|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909516|NCT01152580|Melatonin|melatonin|mesh-list
19909517|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
19909518|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909519|NCT01152580|Protective Agents|protective agents|mesh-ancestor
19909520|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909521|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909522|NCT01152697|Haloperidol|haloperidol|mesh-list
19909523|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
19909524|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
19909525|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
19909526|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909527|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909528|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909529|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19909530|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19909531|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909532|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19909533|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19909534|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
19909535|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909536|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909537|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19909538|NCT01152788|Dacarbazine|dacarbazine|mesh-list
19909539|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19909540|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
19909541|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909542|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909543|NCT01152996|Vortioxetine|vortioxetine|mesh-list
19909544|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
19909545|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19909546|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19909547|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19909548|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909549|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909550|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19909551|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20260312|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260313|NCT00491725|Metformin|metformin|mesh-list
19909552|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909553|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909554|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909555|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
19909556|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19909557|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19909558|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19909559|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19909560|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19909561|NCT01153009|Vortioxetine|vortioxetine|mesh-list
19909562|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19909563|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19909564|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909565|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909566|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909567|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909568|NCT01153009|Analgesics|analgesics|mesh-ancestor
19909569|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
19909570|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909571|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
19909572|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19909573|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
19909574|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19909575|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19909576|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909577|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19909578|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
19909579|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19909580|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19909581|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19909582|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19909583|NCT01153269|Ritonavir|ritonavir|mesh-list
19909584|NCT01153269|Lopinavir|lopinavir|mesh-list
19909585|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19909586|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19909587|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
19909588|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909589|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909590|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19909591|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19909592|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
19909593|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909594|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19909595|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19909596|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
19909597|NCT01153425|Teriparatide|teriparatide|mesh-list
19909598|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19909599|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909600|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19909601|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19909602|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19909603|NCT01153581|Estradiol|estradiol|mesh-list
19909604|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19909605|NCT01153581|Progesterone|progesterone|mesh-list
19909606|NCT01153581|Ganirelix|ganirelix|mesh-list
19909607|NCT01153581|Estrogens|estrogens|mesh-ancestor
19909608|NCT01153581|Hormones|hormones|mesh-ancestor
19909609|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909610|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909611|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19909612|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
19909613|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19909614|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19909615|NCT01153581|Progestins|progestins|mesh-ancestor
19909616|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909617|NCT01153620|Polihexanide|polihexanide|mesh-list
19909618|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
19909619|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909620|NCT01153672|Letrozole|letrozole|mesh-list
19909621|NCT01153672|Vorinostat|vorinostat|mesh-list
19909622|NCT01153672|Anastrozole|anastrozole|mesh-list
19909623|NCT01153672|Exemestane|exemestane|mesh-list
19909624|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909625|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19909626|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909627|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909628|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909629|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19909630|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909631|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909632|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909633|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19909634|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19909635|NCT01153698|Dabigatran|dabigatran|mesh-list
19909636|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
19909637|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19909638|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
19909639|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909640|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909641|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
19909642|NCT01153711|Ketoconazole|ketoconazole|mesh-list
19909643|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
19909644|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909645|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19909646|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19909647|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909648|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909649|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909650|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909651|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909652|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909653|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19909654|NCT01153724|Fluconazole|fluconazole|mesh-list
19909655|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
19909656|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909657|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19909658|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19909659|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909660|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909661|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909662|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909663|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909664|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909665|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19909666|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19909667|NCT01153763|Dabrafenib|dabrafenib|mesh-list
19909668|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909669|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19449898|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449899|NCT03432312|Nicotine|nicotine|mesh-list
19909670|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909671|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909672|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
19909673|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19909674|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19909675|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19909676|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909677|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909678|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
19909679|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909680|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909681|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19909682|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909683|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19909684|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
19909685|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909686|NCT01153958|Metronidazole|metronidazole|mesh-list
19909687|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
19909688|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909689|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909690|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19909691|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19909692|NCT01153971|Rituximab|rituximab|mesh-list
19909693|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19909694|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909695|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
19909696|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909697|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19909698|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19909699|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909700|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19909701|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909702|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909703|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
19909704|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19909705|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19909706|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19909707|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
19909708|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909709|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909710|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909711|NCT01154153|Loratadine|loratadine|mesh-list
19909712|NCT01154153|Triamcinolone|triamcinolone|mesh-list
19909713|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19909714|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19909715|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19909716|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909717|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
19909718|NCT01154153|Hormones|hormones|mesh-ancestor
19909719|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909720|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909721|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909722|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
19909723|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909724|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909725|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
19909726|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
19449900|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19909727|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19909728|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19909729|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19909730|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
19909731|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
19909732|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909733|NCT01154166|Ropinirole|ropinirole|mesh-list
19909734|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19909735|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19909736|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
19909737|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
19909738|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909739|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909740|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909741|NCT01154192|Dexamethasone|dexamethasone|mesh-list
19909742|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19909743|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909744|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
19909745|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
19909746|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909747|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909748|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909749|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
19909750|NCT01154192|Hormones|hormones|mesh-ancestor
19909751|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909752|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19909753|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909754|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19909755|NCT01154218|Crizotinib|crizotinib|mesh-list
19909756|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909757|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19909758|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909759|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909760|NCT01154452|R04929097|r04929097|mesh-list
19909761|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909762|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909763|NCT01154673|Ritonavir|ritonavir|mesh-list
19909764|NCT01154673|Lopinavir|lopinavir|mesh-list
19909765|NCT01154673|Tenofovir|tenofovir|mesh-list
19909766|NCT01154673|Emtricitabine|emtricitabine|mesh-list
19909767|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
19909768|NCT01154673|Maraviroc|maraviroc|mesh-list
19909769|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19909770|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20260314|NCT00491725|Repaglinide|repaglinide|mesh-list
20260315|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20260316|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260317|NCT00491790|Montelukast|montelukast|mesh-list
20260318|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20260319|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
20260320|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20260321|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
20260322|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260323|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260324|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20260325|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20260326|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260327|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
20260328|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
20260329|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20260330|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20260331|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260332|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260333|NCT00491803|Urological Agents|urological agents|mesh-ancestor
20260334|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20260335|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260336|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20260337|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260338|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260339|NCT00491855|Paclitaxel|paclitaxel|mesh-list
20260340|NCT00491855|Bevacizumab|bevacizumab|mesh-list
20260341|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
20260342|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20260343|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260344|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
20260345|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
20260346|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
20260347|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909771|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
19909772|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909773|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909774|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19909775|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19909776|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
19909777|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909778|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19909779|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19909780|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19909781|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19909782|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19909783|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19909784|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19909785|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19909786|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19909787|NCT01155063|Exemestane|exemestane|mesh-list
19909788|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909789|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19909790|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19909791|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909792|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909793|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19909794|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909795|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909796|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909797|NCT01155154|Clindamycin|clindamycin|mesh-list
19909798|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
19909799|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
19909800|NCT01155154|Cephalexin|cephalexin|mesh-list
19909801|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909802|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20540926|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540927|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
20540928|NCT01855256|Oxybutynin|oxybutynin|mesh-list
20540929|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
20540930|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
19909803|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19909804|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909805|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909806|NCT01155167|Lidocaine|lidocaine|mesh-list
19909807|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
19909808|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
19909809|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
19909810|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909811|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909812|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
19909813|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909814|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19909815|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19909816|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19909817|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909818|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909819|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
19909820|NCT01155219|Latanoprost|latanoprost|mesh-list
19909821|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19909822|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19909823|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19909824|NCT01155284|Lansoprazole|lansoprazole|mesh-list
19909825|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
19909826|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19909827|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909828|NCT01155284|Incretins|incretins|mesh-ancestor
19909829|NCT01155284|Hormones|hormones|mesh-ancestor
19909830|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909831|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19909832|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
19909833|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909834|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909835|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19909836|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909837|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19909838|NCT01155466|Rasagiline|rasagiline|mesh-list
19909839|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19909840|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909841|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909842|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19909843|NCT01155466|Protective Agents|protective agents|mesh-ancestor
19909844|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909845|NCT01155479|Rasagiline|rasagiline|mesh-list
19909846|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19909847|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909848|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909849|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19909850|NCT01155479|Protective Agents|protective agents|mesh-ancestor
19909851|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909852|NCT01155531|Sertraline|sertraline|mesh-list
19909853|NCT01155531|Telenzepine|telenzepine|mesh-list
19909854|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
19909855|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19909856|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19909857|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19909858|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909859|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909860|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909861|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
19909862|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909863|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
19909864|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
19909865|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909866|NCT01155583|Dexamethasone|dexamethasone|mesh-list
19909867|NCT01155583|Lenalidomide|lenalidomide|mesh-list
19909868|NCT01155583|Azacitidine|azacitidine|mesh-list
19909869|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909870|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
19909871|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
19909872|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909873|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909874|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19909875|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
19909876|NCT01155583|Hormones|hormones|mesh-ancestor
19909877|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909878|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20540931|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540932|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540933|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20540934|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20540935|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
20540936|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20540937|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540938|NCT01855256|Urological Agents|urological agents|mesh-ancestor
20540939|NCT01855321|Vitamin D|vitamin d|mesh-list
20540940|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
20540941|NCT01855321|Vitamins|vitamins|mesh-ancestor
19909879|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19909880|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
19909881|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19909882|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19909883|NCT01155583|Growth Substances|growth substances|mesh-ancestor
19909884|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
19909885|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19909886|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
19909887|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909888|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909889|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
19909890|NCT01155661|Serotonin|serotonin|mesh-list
19909891|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19909892|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19909893|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
19909894|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909895|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909896|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909897|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19909898|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19909899|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19909900|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909901|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
19909902|NCT01155869|Naltrexone|naltrexone|mesh-list
19909903|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19909904|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19909905|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909906|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
19909907|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909908|NCT01155999|Tobramycin|tobramycin|mesh-list
19909909|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909910|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909911|NCT01156051|Guanfacine|guanfacine|mesh-list
19909912|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19909913|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19909914|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19909915|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19909916|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
19909917|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909918|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909919|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909920|NCT01156142|Doxepin|doxepin|mesh-list
19909921|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19909922|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19909923|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909924|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909925|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19909926|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
19909927|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19909928|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
20260348|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20260349|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20260350|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20260351|NCT00491855|Growth Substances|growth substances|mesh-ancestor
20260352|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260353|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
20260354|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
20260355|NCT00491868|Hematinics|hematinics|mesh-ancestor
20260356|NCT00491907|Folic Acid|folic acid|mesh-list
20260357|NCT00491907|Hematinics|hematinics|mesh-ancestor
20260358|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
20260359|NCT00491907|Vitamins|vitamins|mesh-ancestor
20260360|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
20260361|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260362|NCT00491920|Vitamin D|vitamin d|mesh-list
20260363|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
20260364|NCT00491920|Vitamins|vitamins|mesh-ancestor
20260365|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
20260366|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260367|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20260368|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20260369|NCT00491946|Dactinomycin|dactinomycin|mesh-list
20260370|NCT00491946|Vincristine|vincristine|mesh-list
20260371|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20260372|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260373|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
20260374|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
20260375|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
20260376|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260377|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19909929|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
19909930|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19909931|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909932|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19909933|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
19909934|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19909935|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
19909936|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909937|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
19909938|NCT01156363|Hematinics|hematinics|mesh-ancestor
19909939|NCT01156376|Listerine|listerine|mesh-list
19909940|NCT01156376|Fluorides|fluorides|mesh-list
19909941|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
19909942|NCT01156376|Protective Agents|protective agents|mesh-ancestor
19909943|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909944|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19909945|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909946|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
19909947|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19909948|NCT01156571|Clopidogrel|clopidogrel|mesh-list
19909949|NCT01156571|Cangrelor|cangrelor|mesh-list
19909950|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19909951|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19909952|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19909953|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19909954|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
19909955|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971859|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
20260378|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260379|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19909956|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909957|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909958|NCT01156597|Pioglitazone|pioglitazone|mesh-list
19909959|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19909960|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909961|NCT01156701|Zanamivir|zanamivir|mesh-list
19909962|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
19909963|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19909964|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19909965|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909966|NCT01156792|Montelukast|montelukast|mesh-list
19909967|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19909968|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
19909969|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19909970|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
19909971|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19909972|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909973|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19909974|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19909975|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19909976|NCT01157065|Ranibizumab|ranibizumab|mesh-list
19909977|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19909978|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19909979|NCT01157065|Growth Substances|growth substances|mesh-ancestor
19909980|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909981|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
19909982|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971860|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
19971861|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971862|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19971863|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19971864|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19971865|NCT01803282|Growth Substances|growth substances|mesh-ancestor
19971866|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971867|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
19971868|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19971869|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
19971870|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
19971871|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971872|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971873|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971874|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
19971875|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19971876|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19971877|NCT01803282|Antidotes|antidotes|mesh-ancestor
19971878|NCT01803282|Protective Agents|protective agents|mesh-ancestor
19971879|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
19971880|NCT01803282|Vitamins|vitamins|mesh-ancestor
19971881|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
19971882|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19971883|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19971884|NCT01804036|Zolpidem|zolpidem|mesh-list
19971885|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19971886|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19971887|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971888|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971889|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19971890|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
19971891|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
19971892|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19971893|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971894|NCT01804049|Metformin|metformin|mesh-list
19971895|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19971896|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971897|NCT01804075|Morphine|morphine|mesh-list
19971898|NCT01804075|Methadone|methadone|mesh-list
19971899|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19971900|NCT01804075|Narcotics|narcotics|mesh-ancestor
19971901|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971902|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971903|NCT01804075|Analgesics|analgesics|mesh-ancestor
19971904|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
20540942|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
19971905|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909983|NCT01157117|Omalizumab|omalizumab|mesh-list
19909984|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19909985|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19909986|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19909987|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
19909988|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
19909989|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909990|NCT01157169|Buprenorphine|buprenorphine|mesh-list
19909991|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19909992|NCT01157169|Narcotics|narcotics|mesh-ancestor
19909993|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19909994|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19909995|NCT01157169|Analgesics|analgesics|mesh-ancestor
19909996|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
19909997|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19909998|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19909999|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19910000|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19910001|NCT01157182|Norethindrone|norethindrone|mesh-list
19910002|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
19910003|NCT01157182|Estradiol|estradiol|mesh-list
19910004|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19910005|NCT01157182|Estrogens|estrogens|mesh-ancestor
19910006|NCT01157182|Hormones|hormones|mesh-ancestor
19910007|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19910008|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910009|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19910010|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
19910011|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910012|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19910013|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19910014|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19910015|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19910016|NCT01157234|Metoprolol|metoprolol|mesh-list
19910017|NCT01157234|Nebivolol|nebivolol|mesh-list
19910018|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19910019|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19910020|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
19910021|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
19910022|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910023|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910024|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19910025|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19910026|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19910027|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
19910028|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910029|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910030|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
19910031|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19910032|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19910033|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19910034|NCT01157351|Olanzapine|olanzapine|mesh-list
19910035|NCT01157351|Risperidone|risperidone|mesh-list
19910036|NCT01157351|Aripiprazole|aripiprazole|mesh-list
19910037|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19910038|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19910039|NCT01157351|Perphenazine|perphenazine|mesh-list
19910040|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19910041|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
19971906|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
19910042|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910043|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910044|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910045|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19910046|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910047|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910048|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910049|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19910050|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
19910051|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
19910052|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
19910053|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910054|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19910055|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19910056|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19910057|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19910058|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
19910059|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
19910060|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19910061|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19910062|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19910063|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19910064|NCT01157364|Bimatoprost|bimatoprost|mesh-list
19910065|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19910066|NCT01157416|Cycloserine|cycloserine|mesh-list
19910067|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19910068|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910069|NCT01157416|Renal Agents|renal agents|mesh-ancestor
19910070|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19910071|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
19910072|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910073|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
19910074|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910075|NCT01157429|Cycloserine|cycloserine|mesh-list
19910076|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19910077|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910078|NCT01157429|Renal Agents|renal agents|mesh-ancestor
19910079|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19910080|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
19910081|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910082|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
19910083|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910084|NCT01158118|Plerixafor|plerixafor|mesh-list
19910085|NCT01158118|Sargramostim|sargramostim|mesh-list
19910086|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
19910087|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910088|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19910089|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19910090|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
19910091|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910092|NCT01158222|Sunitinib|sunitinib|mesh-list
19910093|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910094|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19910095|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19910096|NCT01158222|Growth Substances|growth substances|mesh-ancestor
19910097|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910098|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
19910099|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19910100|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910101|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910102|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19910103|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
19910104|NCT01158261|Coagulants|coagulants|mesh-ancestor
19910105|NCT01158534|Interferons|interferons|mesh-list
19910106|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
19910107|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
19910108|NCT01158534|Celecoxib|celecoxib|mesh-list
19910109|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910110|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
19910111|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910112|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
19910113|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910114|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19910115|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910116|NCT01158534|Analgesics|analgesics|mesh-ancestor
19910117|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
19910118|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910119|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910120|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910121|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19910122|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19910123|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910124|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910125|NCT01158651|Everolimus|everolimus|mesh-list
19910126|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910127|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910128|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
19910129|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910130|NCT01158703|Aspirin|aspirin|mesh-list
19910131|NCT01158703|Clopidogrel|clopidogrel|mesh-list
19910132|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19910133|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910134|NCT01158703|Analgesics|analgesics|mesh-ancestor
19910135|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
19910136|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910137|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910138|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910139|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910140|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19910141|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19910142|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910143|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19910144|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19910145|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910146|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
19910147|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19910148|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19910149|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19910150|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
19910151|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910152|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
19910153|NCT01158820|Fentanyl|fentanyl|mesh-list
19910154|NCT01158820|Midazolam|midazolam|mesh-list
19910155|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
19910156|NCT01158820|Ketamine|ketamine|mesh-list
19910157|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19910158|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910159|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910160|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910161|NCT01158820|Analgesics|analgesics|mesh-ancestor
19910162|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
19910163|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910164|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19910165|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19910166|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19910167|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
19910168|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910169|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910170|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19910171|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19910172|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
19910173|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
19910174|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19910175|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19910176|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19910177|NCT01158820|Narcotics|narcotics|mesh-ancestor
19910178|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19910179|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19910180|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910181|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910182|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
19910183|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
19910184|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19910185|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
19910186|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
19910187|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
19910188|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19910189|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19910190|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
19910191|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
19910192|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19910193|NCT01158885|Cytarabine|cytarabine|mesh-list
19910194|NCT01158885|Methotrexate|methotrexate|mesh-list
19910195|NCT01158885|Clofarabine|clofarabine|mesh-list
20260380|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20260381|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260382|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20260383|NCT00491985|Vaccines|vaccines|mesh-list
20260384|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
20260385|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286952|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20286953|NCT01247324|Interferons|interferons|mesh-list
20286954|NCT01247324|Interferon-beta|interferon-beta|mesh-list
20286955|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
20286956|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
20286957|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286958|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
20286959|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286960|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
20286961|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286962|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20286963|NCT01208662|Dexamethasone|dexamethasone|mesh-list
20286964|NCT01208662|Lenalidomide|lenalidomide|mesh-list
20286965|NCT01208662|Bortezomib|bortezomib|mesh-list
20286966|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286967|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
20286968|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
20286969|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286970|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286971|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286972|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
20286973|NCT01208662|Hormones|hormones|mesh-ancestor
20286974|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286975|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286976|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286977|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
20286978|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20286979|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20286980|NCT01208662|Growth Substances|growth substances|mesh-ancestor
20286981|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
20286982|NCT01198522|Gemcitabine|gemcitabine|mesh-list
20540943|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540944|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20540945|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20540946|NCT01855334|Spironolactone|spironolactone|mesh-list
20540947|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20540948|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
20540949|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540950|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540951|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20540952|NCT01855334|Diuretics|diuretics|mesh-ancestor
20540953|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
20540954|NCT01855386|Liver Extracts|liver extracts|mesh-list
20540955|NCT01855386|Hematinics|hematinics|mesh-ancestor
20540956|NCT01855451|Cetuximab|cetuximab|mesh-list
20540957|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540958|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20540959|NCT01855490|Exenatide|exenatide|mesh-list
19910196|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19910197|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
19910198|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910199|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910200|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910201|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
19910202|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910203|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910204|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
19910205|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910206|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910207|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910208|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
19910209|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910210|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19910211|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
19910212|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286983|NCT01198522|Antibodies|antibodies|mesh-list
20286984|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20286985|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
20260386|NCT00491998|Entacapone|entacapone|mesh-list
19449901|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
19449902|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449903|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449904|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19910213|NCT01158950|Tolcapone|tolcapone|mesh-list
19910214|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19910215|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19910216|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19910217|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910218|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910219|NCT01159054|Niacin|niacin|mesh-list
19910220|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
19910221|NCT01159054|Niacinamide|niacinamide|mesh-list
19910222|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19910223|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
19910224|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910225|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19910226|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
19910227|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
19910228|NCT01159054|Vitamins|vitamins|mesh-ancestor
19910229|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
19910230|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910231|NCT01159067|Deferasirox|deferasirox|mesh-list
19910232|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20260387|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20260388|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20260389|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20260390|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260391|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260392|NCT00492037|Conivaptan|conivaptan|mesh-list
20260393|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20260394|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260395|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
20260396|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260397|NCT00492102|Montelukast|montelukast|mesh-list
20260398|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20260399|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
20260400|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20260401|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
20260402|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260403|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260404|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20260405|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20260406|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260407|NCT00492128|Losartan|losartan|mesh-list
20260408|NCT00492128|Amlodipine|amlodipine|mesh-list
20260409|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20260410|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20260411|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20260412|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260413|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260414|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20260415|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260416|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
20260417|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20260418|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20260419|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20260420|NCT00492128|Diuretics|diuretics|mesh-ancestor
20260421|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
20260422|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20540960|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20540961|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540962|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20540963|NCT01855490|Incretins|incretins|mesh-ancestor
20540964|NCT01855490|Hormones|hormones|mesh-ancestor
20540965|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20540966|NCT01855516|Heparin|heparin|mesh-list
20540967|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
20540968|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20540969|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19910233|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
19910234|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
20260423|NCT00492141|Temozolomide|temozolomide|mesh-list
20260424|NCT00492141|Camptothecin|camptothecin|mesh-list
20260425|NCT00492141|Rubitecan|rubitecan|mesh-list
20260426|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20260427|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
20260428|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910235|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910236|NCT01159171|Bevacizumab|bevacizumab|mesh-list
19910237|NCT01159171|Capecitabine|capecitabine|mesh-list
19910238|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
19910239|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910240|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910241|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19910242|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19910243|NCT01159171|Growth Substances|growth substances|mesh-ancestor
19910244|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910245|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
19910246|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910247|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
19910248|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910249|NCT01159262|Fentanyl|fentanyl|mesh-list
19910250|NCT01159262|Midazolam|midazolam|mesh-list
19910251|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
19910252|NCT01159262|Morphine|morphine|mesh-list
19910253|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19910254|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910255|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910256|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910257|NCT01159262|Analgesics|analgesics|mesh-ancestor
19910258|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
19910259|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910260|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19910261|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19910262|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19910263|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
19910264|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910265|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910266|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19910267|NCT01159262|Narcotics|narcotics|mesh-ancestor
19910268|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19910269|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19910270|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
19910271|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
19910272|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19910273|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910274|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910275|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
19910276|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
19910277|NCT01159574|Clarithromycin|clarithromycin|mesh-list
19910278|NCT01159574|Dexamethasone|dexamethasone|mesh-list
19910279|NCT01159574|Pomalidomide|pomalidomide|mesh-list
19910280|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910281|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
19910282|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
19910283|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910284|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910285|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19910286|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
19910287|NCT01159574|Hormones|hormones|mesh-ancestor
19910288|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19910289|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19910290|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910291|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910292|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910293|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19910294|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910295|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910296|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19910297|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19910298|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
19910299|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19910300|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19910301|NCT01159574|Growth Substances|growth substances|mesh-ancestor
19910302|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
19910303|NCT01159600|Empagliflozin|empagliflozin|mesh-list
20260429|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910304|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19910305|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910306|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19910307|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910308|NCT01159665|Plasminogen|plasminogen|mesh-list
19910309|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
19910310|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19910311|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19910312|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910313|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19910314|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19910315|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19910316|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19910317|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910318|NCT01159769|Analgesics|analgesics|mesh-ancestor
19910319|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
19910320|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910321|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910322|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910323|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910324|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19910325|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19910326|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19910327|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
19910328|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
19910329|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910330|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910331|NCT01159912|Fluticasone|fluticasone|mesh-list
19910332|NCT01159912|Xhance|xhance|mesh-list
19910333|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910334|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19910335|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
19910336|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910337|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910338|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19910339|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
19910340|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19910341|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19910342|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
19910343|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19910344|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910345|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
19910346|NCT01160198|Chelating Agents|chelating agents|mesh-list
19910347|NCT01160198|Glycine|glycine|mesh-list
19910348|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
19910349|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910350|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
19910351|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910352|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910353|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
19910354|NCT01160198|Protective Agents|protective agents|mesh-ancestor
19910355|NCT01160198|Vitamins|vitamins|mesh-ancestor
19910356|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
19910357|NCT01160211|Trastuzumab|trastuzumab|mesh-list
19910358|NCT01160211|Lapatinib|lapatinib|mesh-list
19910359|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19910360|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910361|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910362|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19910363|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910364|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910365|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19910366|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19910367|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
19910368|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19910369|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910370|NCT01160289|Tadalafil|tadalafil|mesh-list
19910371|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
19910372|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19910373|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19910374|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910375|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910376|NCT01160289|Urological Agents|urological agents|mesh-ancestor
19910377|NCT01160354|Plerixafor|plerixafor|mesh-list
19910378|NCT01160354|Clofarabine|clofarabine|mesh-list
19910379|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910380|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
19910381|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910382|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910383|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19910384|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19910385|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
19910386|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910387|NCT01160380|Modafinil|modafinil|mesh-list
19910388|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19910389|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910390|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19910391|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19910392|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19910393|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910394|NCT01160445|Aldesleukin|aldesleukin|mesh-list
19910395|NCT01160445|Zanolimumab|zanolimumab|mesh-list
19910396|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910397|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19910398|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19910399|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
19910400|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910401|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910402|NCT01160484|Lenalidomide|lenalidomide|mesh-list
19910403|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
19910404|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910405|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19910406|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19910407|NCT01160484|Growth Substances|growth substances|mesh-ancestor
19910408|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
19910409|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910410|NCT01160614|Oxycodone|oxycodone|mesh-list
19910411|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19910412|NCT01160614|Narcotics|narcotics|mesh-ancestor
19910413|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910414|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910415|NCT01160614|Analgesics|analgesics|mesh-ancestor
19910416|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
19910417|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910418|NCT01160640|Metronidazole|metronidazole|mesh-list
19910419|NCT01160640|Doxycycline|doxycycline|mesh-list
19910420|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
19910421|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910422|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910423|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19910424|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19910425|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
19910426|NCT01160744|Gemcitabine|gemcitabine|mesh-list
19910427|NCT01160744|Carboplatin|carboplatin|mesh-list
19910428|NCT01160744|Pemetrexed|pemetrexed|mesh-list
19910429|NCT01160744|Ramucirumab|ramucirumab|mesh-list
19910430|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19910431|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910432|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910433|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
19910434|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910435|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
19910436|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910437|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910438|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910439|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
19910440|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910441|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910442|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19910443|NCT01160770|Clobazam|clobazam|mesh-list
19910444|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
19910445|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19910446|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910447|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910448|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910449|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910450|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19910451|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
19910452|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
19910453|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910454|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910455|NCT01160822|Naproxen|naproxen|mesh-list
19910456|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19910457|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19910458|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910459|NCT01160822|Analgesics|analgesics|mesh-ancestor
19910460|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
19910461|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910462|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910463|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910464|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910465|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
19910466|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19910467|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910468|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910469|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
19910470|NCT01160848|Ethanol|ethanol|mesh-list
19910471|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19910472|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910473|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910474|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910475|NCT01161121|Adenosine|adenosine|mesh-list
19910476|NCT01161121|Regadenoson|regadenoson|mesh-list
19910477|NCT01161121|Analgesics|analgesics|mesh-ancestor
19910478|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
19910479|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910480|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910481|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19910482|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
19910483|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19910484|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
19910485|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
19910486|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910487|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910488|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19910489|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19910490|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910491|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19910492|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910493|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910494|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
19910495|NCT01161407|Calcium|calcium|mesh-list
19910496|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19910497|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910498|NCT01161407|Antacids|antacids|mesh-ancestor
19910499|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910500|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19910501|NCT01161446|Antibodies|antibodies|mesh-list
19910502|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
19910503|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
19910504|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910505|NCT01161472|Alprazolam|alprazolam|mesh-list
19910506|NCT01161472|Fesoterodine|fesoterodine|mesh-list
19910507|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19910508|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910509|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910510|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19910511|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910512|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910513|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
19910514|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
19910515|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910516|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910517|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19910518|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19910519|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
19910520|NCT01161472|Urological Agents|urological agents|mesh-ancestor
19910521|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19910522|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910523|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910524|NCT01161537|Ivacaftor|ivacaftor|mesh-list
19910525|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19910526|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19910527|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910528|NCT01161563|Leuprolide|leuprolide|mesh-list
19910529|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19449905|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19449906|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19449907|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449908|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449909|NCT03432273|Nicotine|nicotine|mesh-list
19449910|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19449911|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
19449912|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449913|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910530|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19910531|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
19910532|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910533|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910534|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19910535|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910536|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
19910537|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19910538|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
19910539|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19910540|NCT01161628|Rituximab|rituximab|mesh-list
19910541|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910542|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910543|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
19910544|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910545|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910546|NCT01161862|Glucagon|glucagon|mesh-list
19910547|NCT01161862|Pancrelipase|pancrelipase|mesh-list
19910548|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910549|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19910550|NCT01161862|Hormones|hormones|mesh-ancestor
19910551|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19910552|NCT01162005|Tacrolimus|tacrolimus|mesh-list
19910553|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910554|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
19910555|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910556|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19910557|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910558|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910559|NCT01162122|Vaccines|vaccines|mesh-list
19910560|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
19910561|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910562|NCT01162135|Digoxin|digoxin|mesh-list
19910563|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19910564|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19910565|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910566|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910567|NCT01162135|Protective Agents|protective agents|mesh-ancestor
19910568|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910569|NCT01162239|Varenicline|varenicline|mesh-list
19910570|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19910571|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19910572|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
19910573|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910574|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910575|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910576|NCT01162421|Adalimumab|adalimumab|mesh-list
19910577|NCT01162421|Methotrexate|methotrexate|mesh-list
19910578|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19910579|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
19910580|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910581|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910582|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910583|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
20260430|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19910584|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910585|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910586|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
19910587|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910588|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910589|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910590|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
19910591|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910592|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19449914|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19910593|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910594|NCT01162473|Caseins|caseins|mesh-list
19910595|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
19910596|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
19910597|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910598|NCT01162486|Rifampin|rifampin|mesh-list
20260431|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20260432|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20260433|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260434|NCT00492219|Cimetidine|cimetidine|mesh-list
20260435|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20260436|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20260437|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20260438|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
20260439|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
20260440|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260441|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260442|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260443|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20260444|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20260445|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260446|NCT00492245|Mitomycins|mitomycins|mesh-list
20260447|NCT00492245|Mitomycin|mitomycin|mesh-list
20260448|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20260449|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260450|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
20540970|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540971|NCT01855529|Ropivacaine|ropivacaine|mesh-list
20540972|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
20540973|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
20540974|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540975|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540976|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
20540977|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20540978|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
20540979|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20540980|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20540981|NCT01855555|Propofol|propofol|mesh-list
20540982|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20540983|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20540984|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540985|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20540986|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
20540987|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
20540988|NCT01855568|Methotrexate|methotrexate|mesh-list
20540989|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20540990|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
20540991|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20540992|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20540993|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20540994|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
20540995|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20540996|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20540997|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
20540998|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20540999|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910599|NCT01162486|Rifapentine|rifapentine|mesh-list
19910600|NCT01162486|Midazolam|midazolam|mesh-list
19910601|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19910602|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19910603|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910604|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910605|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19910606|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910607|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910608|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19910609|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
19910610|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
19910611|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
19910612|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
19910613|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910614|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910615|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19910616|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
19910617|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910618|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910619|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
19910620|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19910621|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910622|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19910623|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19910624|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19910625|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19910626|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19910627|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19910628|NCT01162551|Sirolimus|sirolimus|mesh-list
19910629|NCT01162551|Methotrexate|methotrexate|mesh-list
19910630|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19910631|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
19910632|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910633|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910634|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910635|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
19910636|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910637|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910638|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
19910639|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910640|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910641|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910642|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
19910643|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910644|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19910645|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910646|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910647|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19910648|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
19910649|NCT01162733|Vancomycin|vancomycin|mesh-list
19910650|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910651|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910652|NCT01162863|Lubiprostone|lubiprostone|mesh-list
19910653|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19910654|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19910655|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910656|NCT01163097|Heparin|heparin|mesh-list
19910657|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
19910658|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19910659|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19910660|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910661|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
19910662|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
19910663|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910664|NCT01163214|Ropivacaine|ropivacaine|mesh-list
19910665|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
19910666|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
19910667|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910668|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910669|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
19910670|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910671|NCT01163253|Tofacitinib|tofacitinib|mesh-list
19910672|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19910673|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910674|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910675|NCT01163266|Vortioxetine|vortioxetine|mesh-list
19910676|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
19910677|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910678|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19910679|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910680|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910681|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910682|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19910683|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19910684|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19910685|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910686|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910687|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
19910688|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19910689|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19910690|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19910691|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19971907|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
19971908|NCT01804101|Cytarabine|cytarabine|mesh-list
19971909|NCT01804101|Daunorubicin|daunorubicin|mesh-list
19971910|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19971911|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
19971912|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971913|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971914|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
19971915|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971916|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19971917|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
19971918|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971919|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19971920|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19971921|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19971922|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971923|NCT01804465|Ipilimumab|ipilimumab|mesh-list
19971924|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19971925|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971926|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20260451|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260452|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20260453|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260454|NCT00492258|Sorafenib|sorafenib|mesh-list
20260455|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260456|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19971927|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971928|NCT01804673|Fentanyl|fentanyl|mesh-list
19971929|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19971930|NCT01804673|Narcotics|narcotics|mesh-ancestor
19971931|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971932|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971933|NCT01804673|Analgesics|analgesics|mesh-ancestor
19971934|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
19971935|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971936|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19971937|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19971938|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
19971939|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
19971940|NCT01804946|Oseltamivir|oseltamivir|mesh-list
19971941|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
19971942|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19971943|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971944|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971945|NCT01805037|Rituximab|rituximab|mesh-list
19971946|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19971947|NCT01805037|Antibodies|antibodies|mesh-list
19971948|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
19971949|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19971950|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
19971951|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
19971952|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971953|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19971954|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971955|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971956|NCT01805089|Melatonin|melatonin|mesh-list
19971957|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
19971958|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971959|NCT01805089|Protective Agents|protective agents|mesh-ancestor
19971960|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971961|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19971962|NCT01805297|Aflibercept|aflibercept|mesh-list
19971963|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19971964|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19971965|NCT01805297|Growth Substances|growth substances|mesh-ancestor
19971966|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971967|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
19971968|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971969|NCT01805323|Dexamethasone|dexamethasone|mesh-list
19971970|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971971|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
19971972|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
19971973|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910692|NCT01163604|Aspirin|aspirin|mesh-list
19910693|NCT01163604|Argatroban|argatroban|mesh-list
19910694|NCT01163604|Clopidogrel|clopidogrel|mesh-list
19910695|NCT01163604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19910696|NCT01163604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910697|NCT01163604|Analgesics|analgesics|mesh-ancestor
19910698|NCT01163604|Sensory System Agents|sensory system agents|mesh-ancestor
19910699|NCT01163604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910700|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910701|NCT01163604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910702|NCT01163604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910703|NCT01163604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19910704|NCT01163604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19910705|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910706|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19910707|NCT01163604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19910708|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910709|NCT01163604|Antipyretics|antipyretics|mesh-ancestor
19910710|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19910711|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19910712|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19910713|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
19910714|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910715|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
19910716|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19910717|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
19910718|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
19910719|NCT01163617|Adalimumab|adalimumab|mesh-list
19449915|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19449916|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
19449917|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449918|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449919|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19449920|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19449921|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19910720|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910721|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910722|NCT01163656|Cobalt|cobalt|mesh-list
19910723|NCT01163656|Trace Elements|trace elements|mesh-ancestor
19910724|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
19910725|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910726|NCT01163721|Ranolazine|ranolazine|mesh-list
19910727|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19910728|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19910729|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910730|NCT01163747|Methotrexate|methotrexate|mesh-list
19910731|NCT01163747|Vaccines|vaccines|mesh-list
19910732|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19910733|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
19910734|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910735|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19910736|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
19910737|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910738|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910739|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
19910740|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910741|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910742|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
19910743|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910744|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910745|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910746|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910747|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19910748|NCT01163786|Bortezomib|bortezomib|mesh-list
19910749|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910750|NCT01163851|Bococizumab|bococizumab|mesh-list
19449922|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19449923|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449924|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449925|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449926|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
19449927|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19449928|NCT03432195|Donepezil|donepezil|mesh-list
19449929|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19910751|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19910752|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19910753|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
19910754|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910755|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19910756|NCT01164007|Bevacizumab|bevacizumab|mesh-list
19910757|NCT01164007|Dacarbazine|dacarbazine|mesh-list
19910758|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910759|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910760|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19910761|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19910762|NCT01164007|Growth Substances|growth substances|mesh-ancestor
19910763|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910764|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
19910765|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19910766|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
19910767|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910768|NCT01164098|Rituximab|rituximab|mesh-list
19910769|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910770|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910771|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
19910772|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910773|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910774|NCT01164475|Plerixafor|plerixafor|mesh-list
19910775|NCT01164475|Sargramostim|sargramostim|mesh-list
19910776|NCT01164475|Lenograstim|lenograstim|mesh-list
19910777|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
19910778|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910779|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19910780|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19910781|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19910782|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
19910783|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910784|NCT01164501|Empagliflozin|empagliflozin|mesh-list
19910785|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19910786|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910787|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19910788|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910789|NCT01164579|Methotrexate|methotrexate|mesh-list
19910790|NCT01164579|Tofacitinib|tofacitinib|mesh-list
19910791|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19910792|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
19910793|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910794|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910795|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910796|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
19910797|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910798|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910799|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
19910800|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910801|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910802|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910803|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
19910804|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910805|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19910806|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19910807|NCT01164956|Methylphenidate|methylphenidate|mesh-list
19910808|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19910809|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910810|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19910811|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19910812|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19910813|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910814|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
19910815|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260457|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260458|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260459|NCT00492388|Ketamine|ketamine|mesh-list
20260460|NCT00492388|Analgesics|analgesics|mesh-ancestor
20260461|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
20260462|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260463|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260464|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19910816|NCT01165021|Folic Acid|folic acid|mesh-list
19910817|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
19910818|NCT01165021|Hydroxocobalamin|hydroxocobalamin|mesh-list
19910819|NCT01165021|Dexamethasone|dexamethasone|mesh-list
19910820|NCT01165021|Pemetrexed|pemetrexed|mesh-list
19910821|NCT01165021|Vitamins|vitamins|mesh-ancestor
19910822|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
19910823|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910824|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910825|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910826|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
19910827|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
19910828|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910829|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19910830|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
19910831|NCT01165021|Hormones|hormones|mesh-ancestor
19910832|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19910833|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19910834|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910835|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910836|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910837|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19910838|NCT01165021|Hematinics|hematinics|mesh-ancestor
19910839|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
19910840|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
19910841|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19910842|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
19910843|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910844|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910845|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19910846|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
19910847|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19910848|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
19910849|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910850|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910851|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19910852|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
19910853|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
19910854|NCT01165047|Protective Agents|protective agents|mesh-ancestor
19910855|NCT01165112|Rituximab|rituximab|mesh-list
19910856|NCT01165112|Carboplatin|carboplatin|mesh-list
19910857|NCT01165112|Etoposide|etoposide|mesh-list
19910858|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19910859|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910860|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910861|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
19910862|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910863|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910864|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19910865|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19910866|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19910867|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910868|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910869|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19910870|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
19910871|NCT01165138|Fluticasone|fluticasone|mesh-list
19910872|NCT01165138|Xhance|xhance|mesh-list
19910873|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910874|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19910875|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
19910876|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910877|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910878|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19910879|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
19910880|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
19910881|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19910882|NCT01165203|Vaccines|vaccines|mesh-list
19910883|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
19910884|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910885|NCT01165216|Paclitaxel|paclitaxel|mesh-list
19910886|NCT01165216|Carboplatin|carboplatin|mesh-list
19910887|NCT01165216|Ipilimumab|ipilimumab|mesh-list
19910888|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19910889|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910890|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
19910891|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
19910892|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
19910893|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910894|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19910895|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19910896|NCT01165281|Oxycodone|oxycodone|mesh-list
19910897|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19910898|NCT01165281|Narcotics|narcotics|mesh-ancestor
19910899|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910900|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910901|NCT01165281|Analgesics|analgesics|mesh-ancestor
19910902|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
19910903|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910904|NCT01165307|Naproxen|naproxen|mesh-list
19910905|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
19910906|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
19910907|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
19910908|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19910909|NCT01165307|Estradiol|estradiol|mesh-list
19910910|NCT01165307|Estrogens|estrogens|mesh-ancestor
19910911|NCT01165307|Hormones|hormones|mesh-ancestor
19910912|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19910913|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910914|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19910915|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19910916|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19910917|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19910918|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19910919|NCT01165307|Analgesics|analgesics|mesh-ancestor
19910920|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
19910921|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19910922|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910923|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910924|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
19910925|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19910926|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910927|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910928|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19910929|NCT01165320|Caspofungin|caspofungin|mesh-list
19910930|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
19910931|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910932|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910933|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910934|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19910935|NCT01165541|Mirtazapine|mirtazapine|mesh-list
19910936|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
19910937|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19910938|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19910939|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19910940|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19910941|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910942|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19910943|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
19910944|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
19910945|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19910946|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910947|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19910948|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19910949|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19910950|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19910951|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
19910952|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19910953|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19910954|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
19910955|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19910956|NCT01165554|Flutemetamol|flutemetamol|mesh-list
19910957|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19910958|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910959|NCT01165684|Insulin|insulin|mesh-list
19910960|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19910961|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
19910962|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
19910963|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19910964|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
19910965|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19910966|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910967|NCT01165840|Dapsone|dapsone|mesh-list
19910968|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910969|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
19910970|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19910971|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19910972|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19910973|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910974|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910975|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
19910976|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910977|NCT01165996|Decitabine|decitabine|mesh-list
19910978|NCT01165996|Azacitidine|azacitidine|mesh-list
19910979|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19910980|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
19910981|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19910982|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910983|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19910984|NCT01166126|Sirolimus|sirolimus|mesh-list
19910985|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19910986|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19910987|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19910988|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19910989|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
19910990|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19910991|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
19910992|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19910993|NCT01166282|Adalimumab|adalimumab|mesh-list
19910994|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19910995|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19910996|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
20260465|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20260466|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
20260467|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
20260468|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20260469|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20260470|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20260471|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260472|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260473|NCT00492414|Paroxetine|paroxetine|mesh-list
20260474|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20260475|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20260476|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260477|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260478|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260479|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
20260480|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260481|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20260482|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
20260483|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20260484|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20260485|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20260486|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260487|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
20260488|NCT00492427|Hematinics|hematinics|mesh-ancestor
20260489|NCT00492466|Interferons|interferons|mesh-list
20260490|NCT00492466|Interferon-beta|interferon-beta|mesh-list
20260491|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
20260492|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
20260493|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260494|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
20260495|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260496|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260497|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
20260498|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
19910997|NCT01166438|Trospium chloride|trospium chloride|mesh-list
19910998|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
19910999|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19911000|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19911001|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19911002|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911003|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911004|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
19911005|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911006|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911007|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19911008|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911009|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19911010|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19911011|NCT01166438|Urological Agents|urological agents|mesh-ancestor
19911012|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
19911013|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
19911014|NCT01166646|Clobetasol|clobetasol|mesh-list
19911015|NCT01166646|Halobetasol|halobetasol|mesh-list
19911016|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19911017|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19911018|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
19911019|NCT01166646|Hormones|hormones|mesh-ancestor
19911020|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911021|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911022|NCT01166763|Vitamin D|vitamin d|mesh-list
19911023|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
19911024|NCT01166763|Vitamins|vitamins|mesh-ancestor
19911025|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
19911026|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911027|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19911028|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911029|NCT01166945|Amoxicillin|amoxicillin|mesh-list
19911030|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
19911031|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
19911032|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19911033|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911034|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911035|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19911036|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260499|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260500|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260501|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20260502|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
20260503|NCT00492466|Hormones|hormones|mesh-ancestor
20260504|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260505|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20260506|NCT00492466|Protective Agents|protective agents|mesh-ancestor
20260507|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
20260508|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20260509|NCT00492479|Kinetin|kinetin|mesh-list
20260510|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20260511|NCT00492479|Growth Substances|growth substances|mesh-ancestor
20260512|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260513|NCT00492505|Tamoxifen|tamoxifen|mesh-list
20260514|NCT00492505|Sorafenib|sorafenib|mesh-list
20260515|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260516|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260517|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20260518|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260519|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20260520|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
20260521|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260522|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260523|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20260524|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20260525|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20260526|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20260527|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
20260528|NCT00492518|Theophylline|theophylline|mesh-list
20260529|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20260530|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
20260531|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541000|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541001|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
20541002|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541003|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20541004|NCT01855581|Ketamine|ketamine|mesh-list
20541005|NCT01855581|Propofol|propofol|mesh-list
19911037|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911038|NCT01166958|Teriparatide|teriparatide|mesh-list
20541006|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19911039|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19911040|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911041|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911042|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19911043|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19911044|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
19911045|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911046|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19911047|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19911048|NCT01166997|Heparin|heparin|mesh-list
19911049|NCT01166997|Calcium heparin|calcium heparin|mesh-list
19911050|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
19911051|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19911052|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19911053|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911054|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19911055|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19911056|NCT01167153|Amlodipine|amlodipine|mesh-list
19911057|NCT01167153|Valsartan|valsartan|mesh-list
19911058|NCT01167153|Nifedipine|nifedipine|mesh-list
19911059|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19911060|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19911061|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911062|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911063|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911064|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911065|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
19911066|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19911067|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19911068|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
19911069|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19911070|NCT01167192|Carboplatin|carboplatin|mesh-list
19911071|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911072|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
19911073|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19911074|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19911075|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19911076|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911077|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911078|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
19911079|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911080|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911081|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19911082|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911083|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
19911084|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
19911085|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19911086|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
19911087|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911088|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19911089|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911090|NCT01167452|Trimethoprim|trimethoprim|mesh-list
19911091|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19911092|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
19911093|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19911094|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911095|NCT01167452|Renal Agents|renal agents|mesh-ancestor
19911096|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
19911097|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19911098|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19911099|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19911100|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911101|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911102|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19911103|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19911104|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19911105|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911106|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
19911107|NCT01167569|Vitamins|vitamins|mesh-ancestor
19911108|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
19911109|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911110|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
19911111|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911112|NCT01167569|Protective Agents|protective agents|mesh-ancestor
19911113|NCT01167712|Paclitaxel|paclitaxel|mesh-list
19911114|NCT01167712|Bevacizumab|bevacizumab|mesh-list
19911115|NCT01167712|Carboplatin|carboplatin|mesh-list
19911116|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19911117|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19911118|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
19911119|NCT01167712|Antibodies|antibodies|mesh-list
19911120|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
19911121|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19911122|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
19911123|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19911124|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911125|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
19911126|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
19911127|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
19911128|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911129|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19911130|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19911131|NCT01167712|Growth Substances|growth substances|mesh-ancestor
19911132|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911133|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
19911134|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
19911135|NCT01167829|Testosterone|testosterone|mesh-list
19911136|NCT01167829|Acyline|acyline|mesh-list
19911137|NCT01167829|Androgens|androgens|mesh-ancestor
19911138|NCT01167829|Hormones|hormones|mesh-ancestor
19911139|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911140|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911141|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
19911142|NCT01167881|Glimepiride|glimepiride|mesh-list
19911143|NCT01167881|Empagliflozin|empagliflozin|mesh-list
19911144|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19911145|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19911146|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911147|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19911148|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
19911149|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19911150|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911151|NCT01167907|Ropivacaine|ropivacaine|mesh-list
19911152|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
19911153|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
19911154|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911155|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911156|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
19911157|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911158|NCT01168232|Epothilones|epothilones|mesh-list
19911159|NCT01168232|Epothilone B|epothilone b|mesh-list
19911160|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
19911161|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
19911162|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
19911163|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911164|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911165|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
19911166|NCT01168349|Hematinics|hematinics|mesh-ancestor
19911167|NCT01168596|Rasagiline|rasagiline|mesh-list
19449930|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449931|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911168|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19911169|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260532|NCT00492518|Expectorants|expectorants|mesh-ancestor
20260533|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
20260534|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20260535|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
20260536|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260537|NCT00492518|Protective Agents|protective agents|mesh-ancestor
20260538|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260539|NCT00492518|Antidotes|antidotes|mesh-ancestor
19449932|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
19911170|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911171|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19911172|NCT01168596|Protective Agents|protective agents|mesh-ancestor
19911173|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911174|NCT01168674|Ziprasidone|ziprasidone|mesh-list
19911175|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19911176|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
19911177|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911178|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911179|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911180|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19911181|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19911182|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911183|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19911184|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19911185|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
19911186|NCT01168687|Levetiracetam|levetiracetam|mesh-list
19911187|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
19911188|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
19911189|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
19911190|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
19911191|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19911192|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19911193|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911194|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911195|NCT01168908|Urological Agents|urological agents|mesh-ancestor
19911196|NCT01168934|Crizotinib|crizotinib|mesh-list
19911197|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911198|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19911199|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911200|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911201|NCT01168973|Docetaxel|docetaxel|mesh-list
19911202|NCT01168973|Ramucirumab|ramucirumab|mesh-list
19911203|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19911204|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911205|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
19911206|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
19911207|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
19911208|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911209|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
19911210|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911211|NCT01169038|Azithromycin|azithromycin|mesh-list
19911212|NCT01169038|Rifampin|rifampin|mesh-list
19911213|NCT01169038|Ethambutol|ethambutol|mesh-list
19911214|NCT01169038|Levofloxacin|levofloxacin|mesh-list
19911215|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911216|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911217|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19911218|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
19911219|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
19911220|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19911221|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911222|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911223|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19911224|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19911225|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19911226|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19911227|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19911228|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19911229|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19911230|NCT01169038|Renal Agents|renal agents|mesh-ancestor
19911231|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19911232|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19911233|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911234|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19911235|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19911236|NCT01169103|Hormones|hormones|mesh-list
19911237|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911238|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911239|NCT01169337|Lenalidomide|lenalidomide|mesh-list
19911240|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
19911241|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449933|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911242|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19911243|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19911244|NCT01169337|Growth Substances|growth substances|mesh-ancestor
19911245|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
19911246|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911247|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19911248|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19911249|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911250|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
19911251|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19911252|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911253|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911254|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19911255|NCT01169467|Analgesics|analgesics|mesh-ancestor
19911256|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
19911257|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911258|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19911259|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19911260|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19911261|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911262|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911263|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971974|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971975|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19971976|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
19971977|NCT01805323|Hormones|hormones|mesh-ancestor
19971978|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971979|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19971980|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19971981|NCT01805687|Zileuton|zileuton|mesh-list
19971982|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19971983|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19971984|NCT01805687|Analgesics|analgesics|mesh-ancestor
19971985|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
19971986|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19971987|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19971988|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19971989|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19971990|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19971991|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19971992|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19971993|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19971994|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
19971995|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19971996|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
19971997|NCT01805882|Ledipasvir|ledipasvir|mesh-list
19971998|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
19971999|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972000|NCT01805895|Minocycline|minocycline|mesh-list
19972001|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19972002|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972003|NCT01806064|Axitinib|axitinib|mesh-list
19972004|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972005|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19972006|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972007|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972008|NCT01806259|Ketorolac|ketorolac|mesh-list
19972009|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19972010|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19972011|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19972012|NCT01806259|Analgesics|analgesics|mesh-ancestor
19972013|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
19972014|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972015|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972016|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972017|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972018|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19911264|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
19911265|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
19911266|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19911267|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19911268|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911269|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911270|NCT01169519|Urological Agents|urological agents|mesh-ancestor
19911271|NCT01169532|Vorinostat|vorinostat|mesh-list
19911272|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911273|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19911274|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911275|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911276|NCT01169558|Bevacizumab|bevacizumab|mesh-list
19911277|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19911278|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911279|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19911280|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19911281|NCT01169558|Growth Substances|growth substances|mesh-ancestor
19911282|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911283|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
19911284|NCT01169636|Carboplatin|carboplatin|mesh-list
19911285|NCT01169636|Etoposide|etoposide|mesh-list
19911286|NCT01169636|Ifosfamide|ifosfamide|mesh-list
19911287|NCT01169636|Panobinostat|panobinostat|mesh-list
19911288|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911289|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19911290|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19911291|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19911292|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911293|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911294|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19911295|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
19911296|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19911297|NCT01169675|Pemetrexed|pemetrexed|mesh-list
19911298|NCT01169675|Afatinib|afatinib|mesh-list
19911299|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911300|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911301|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911302|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19911303|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19911304|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19911305|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
19911306|NCT01169701|Everolimus|everolimus|mesh-list
19911307|NCT01169701|Tacrolimus|tacrolimus|mesh-list
19911308|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19911309|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
19911310|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911311|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19911312|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911313|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911314|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911315|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19911316|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19911317|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
19911318|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911319|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911320|NCT01169779|Metformin|metformin|mesh-list
19911321|NCT01169779|Lixisenatide|lixisenatide|mesh-list
19911322|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19911323|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911324|NCT01170039|Lubiprostone|lubiprostone|mesh-list
19911325|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19911326|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911327|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911328|NCT01170065|Nintedanib|nintedanib|mesh-list
19911329|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911330|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19911331|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911332|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911333|NCT01170117|Olanzapine|olanzapine|mesh-list
19911334|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
19911335|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
19911336|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260540|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20260541|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
19911337|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911338|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19911339|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19911340|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19911341|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911342|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19911343|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19911344|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19911345|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911346|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911347|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911348|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
19911349|NCT01170208|Insulin|insulin|mesh-list
19911350|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19911351|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911352|NCT01170221|Linezolid|linezolid|mesh-list
19911353|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
19911354|NCT01170221|Tedizolid|tedizolid|mesh-list
19911355|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911356|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911357|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19911358|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911359|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911360|NCT01170247|Ketamine|ketamine|mesh-list
19911361|NCT01170247|Analgesics|analgesics|mesh-ancestor
19911362|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
19911363|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911364|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911365|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19911366|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19911367|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
19911368|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
19911369|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911370|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19911371|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19911372|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911373|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911374|NCT01170273|Vitamin D|vitamin d|mesh-list
19911375|NCT01170273|Vitamins|vitamins|mesh-ancestor
19911376|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
19911377|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911378|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19911379|NCT01170364|Sibutramine|sibutramine|mesh-list
19911380|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
19911381|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19911382|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
19911383|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19911384|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19911385|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19911386|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
19911387|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19911388|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19911389|NCT01170390|Estradiol|estradiol|mesh-list
19911390|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20260542|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260543|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20260544|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20260545|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260546|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
20260547|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20260548|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20260549|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
20260550|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260551|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20260552|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
20260553|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20260554|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20260555|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260556|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260557|NCT00492635|Urological Agents|urological agents|mesh-ancestor
20260558|NCT00492661|Tacrolimus|tacrolimus|mesh-list
20260559|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260560|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
20541007|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911391|NCT01170390|Estrogens|estrogens|mesh-ancestor
19911392|NCT01170390|Hormones|hormones|mesh-ancestor
19911393|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911394|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911395|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19911396|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
19911397|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19911398|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19911399|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19911400|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19911401|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19911402|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19911403|NCT01170533|Omeprazole|omeprazole|mesh-list
20260561|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260562|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20260563|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260564|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260565|NCT00492687|Tamoxifen|tamoxifen|mesh-list
20260566|NCT00492687|Carboplatin|carboplatin|mesh-list
20260567|NCT00492687|Temozolomide|temozolomide|mesh-list
20260568|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260569|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260570|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20260571|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
20260572|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20260573|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
20260574|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260575|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260576|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20260577|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20260578|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20260579|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20260580|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
20260581|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20260582|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260583|NCT00492739|Vaccines|vaccines|mesh-list
20260584|NCT00492739|Immunologic Factors|immunologic factors|mesh-ancestor
20260585|NCT00492739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260586|NCT00492765|Interferons|interferons|mesh-list
20260587|NCT00492765|Interferon-beta|interferon-beta|mesh-list
20260588|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
20260589|NCT00492765|Simvastatin|simvastatin|mesh-list
20260590|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260591|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
20260592|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260593|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20260594|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20260595|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
20260596|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260597|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20260598|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20260599|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260600|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
20260601|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260602|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20260603|NCT00492778|Cisplatin|cisplatin|mesh-list
20260604|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260605|NCT00492830|Antibodies|antibodies|mesh-list
20260606|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19911404|NCT01170533|Pantoprazole|pantoprazole|mesh-list
19911405|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19911406|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19911407|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19911408|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911409|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911410|NCT01170663|Paclitaxel|paclitaxel|mesh-list
20260607|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
20260608|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260609|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
20260610|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20260611|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260612|NCT00492934|Menotropins|menotropins|mesh-list
20260613|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20260614|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
19911411|NCT01170663|Ramucirumab|ramucirumab|mesh-list
19911412|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19911413|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911414|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
19911415|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
19911416|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
19911417|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911418|NCT01170715|Etanercept|etanercept|mesh-list
19911419|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19911420|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19911421|NCT01170715|Analgesics|analgesics|mesh-ancestor
19911422|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
19911423|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911424|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911425|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19911426|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911427|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19911428|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19911429|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
19911430|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19911431|NCT01170754|Laxatives|laxatives|mesh-ancestor
19911432|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19911433|NCT01170884|Timolol|timolol|mesh-list
19911434|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19911435|NCT01170884|Bimatoprost|bimatoprost|mesh-list
19911436|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19911437|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19911438|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19911439|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19911440|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911441|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911442|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911443|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911444|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19911445|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19911446|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19911447|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19911448|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19911449|NCT01170949|Miltefosine|miltefosine|mesh-list
19911450|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
19911451|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911452|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911453|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19911454|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19911455|NCT01170962|Ribavirin|ribavirin|mesh-list
19911456|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19911457|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
19911458|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911459|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
19911460|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911461|NCT01171118|Physostigmine|physostigmine|mesh-list
19911462|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19911463|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911464|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911465|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
19911466|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911467|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911468|NCT01171118|Miotics|miotics|mesh-ancestor
19911469|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
19911470|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911471|NCT01171183|Carvedilol|carvedilol|mesh-list
19911472|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19911473|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19911474|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911475|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911476|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911477|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911478|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19911479|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
19911480|NCT01171183|Protective Agents|protective agents|mesh-ancestor
19911481|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19911482|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911483|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911484|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
19911485|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19911486|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19911487|NCT01171690|Teriparatide|teriparatide|mesh-list
19911488|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911489|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911490|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19911491|NCT01171794|Ibuprofen|ibuprofen|mesh-list
19911492|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19911493|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19911494|NCT01171794|Analgesics|analgesics|mesh-ancestor
19911495|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
19911496|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911497|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911498|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19911499|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911500|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19911501|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911502|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911503|NCT01171963|Vaccines|vaccines|mesh-list
19911504|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
19911505|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911506|NCT01171976|Ranibizumab|ranibizumab|mesh-list
19911507|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19911508|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19911509|NCT01171976|Growth Substances|growth substances|mesh-ancestor
19911510|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911511|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
19911512|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911513|NCT01172145|Modafinil|modafinil|mesh-list
19911514|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19911515|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911516|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19911517|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19911518|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19911519|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911520|NCT01172197|Ropivacaine|ropivacaine|mesh-list
19911521|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
19911522|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
19911523|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
19911524|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911525|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911526|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
19911527|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911528|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
19911529|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19911530|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
19911531|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911532|NCT01172275|Expectorants|expectorants|mesh-ancestor
19911533|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
19911534|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19911535|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
19911536|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911537|NCT01172275|Protective Agents|protective agents|mesh-ancestor
19911538|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911539|NCT01172275|Antidotes|antidotes|mesh-ancestor
19911540|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
19911541|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19911542|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
19911543|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911544|NCT01172288|Expectorants|expectorants|mesh-ancestor
19911545|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
19911546|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19911547|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
19911548|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911549|NCT01172288|Protective Agents|protective agents|mesh-ancestor
19911550|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911551|NCT01172288|Antidotes|antidotes|mesh-ancestor
19911552|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
19911553|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
19911554|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19911555|NCT01172418|Daclizumab|daclizumab|mesh-list
19911556|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
19911557|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911558|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19911559|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19911560|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911561|NCT01172522|Fexofenadine|fexofenadine|mesh-list
19911562|NCT01172522|Terfenadine|terfenadine|mesh-list
19911563|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19911564|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19911565|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19911566|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
19911567|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
19911568|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911569|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911570|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911571|NCT01172535|Ritonavir|ritonavir|mesh-list
19911572|NCT01172535|Lopinavir|lopinavir|mesh-list
19911573|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19911574|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19911575|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
19911576|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911577|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911578|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19911579|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19911580|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
19911581|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911582|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19911583|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19911584|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
19911585|NCT01172600|Entonox|entonox|mesh-list
19911586|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19911587|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
19911588|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
19911589|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911590|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911591|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19911592|NCT01172600|Analgesics|analgesics|mesh-ancestor
19911593|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
19911594|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911595|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19911596|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
19911597|NCT01172639|Prednisone|prednisone|mesh-list
19911598|NCT01172639|Methotrexate|methotrexate|mesh-list
19911599|NCT01172639|Leflunomide|leflunomide|mesh-list
19911600|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19911601|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
19449934|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449935|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
19449936|NCT03432091|Melatonin|melatonin|mesh-list
19449937|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
19449938|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911602|NCT01172639|Hormones|hormones|mesh-ancestor
19911603|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911604|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911605|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19911606|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911607|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19911608|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
19911609|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19911610|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19911611|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
19911612|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911613|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
19911614|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911615|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19911616|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449939|NCT03432091|Protective Agents|protective agents|mesh-ancestor
19911617|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
19911618|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911619|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19911620|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911621|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19911622|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19911623|NCT01172639|Analgesics|analgesics|mesh-ancestor
19911624|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
19911625|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911626|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19911627|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
19911628|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19911629|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19911630|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
19911631|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911632|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911633|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19911634|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
19911635|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
19911636|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19911637|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
19911638|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911639|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911640|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19911641|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19911642|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19911643|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911644|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
19911645|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19911646|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19911647|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
19911648|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911649|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911650|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19911651|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
19911652|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
19911653|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19911654|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
19911655|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911656|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911657|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19911658|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20260615|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19911659|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19911660|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911661|NCT01172847|Oseltamivir|oseltamivir|mesh-list
19911662|NCT01172847|Rimantadine|rimantadine|mesh-list
19911663|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
19911664|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911665|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911666|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911667|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19911668|NCT01172873|Cycloserine|cycloserine|mesh-list
19911669|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19911670|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911671|NCT01172873|Renal Agents|renal agents|mesh-ancestor
19911672|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19911673|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
19911674|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911675|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
19911676|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911677|NCT01172938|Thalidomide|thalidomide|mesh-list
19911678|NCT01172938|Apremilast|apremilast|mesh-list
19911679|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19911680|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19911681|NCT01172938|Analgesics|analgesics|mesh-ancestor
19911682|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
19911683|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911684|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911685|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19911686|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911687|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19911688|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19911689|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911690|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911691|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19911692|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
19911693|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
19911694|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911695|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260616|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911696|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19911697|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19911698|NCT01172938|Growth Substances|growth substances|mesh-ancestor
19911699|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
19911700|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911701|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
19911702|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
19911703|NCT01173029|Diuretics|diuretics|mesh-list
19911704|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19911705|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20260617|NCT00492986|Sorafenib|sorafenib|mesh-list
20260618|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260619|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20260620|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260621|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260622|NCT00493077|Interferons|interferons|mesh-list
20260623|NCT00493077|Interferon-beta|interferon-beta|mesh-list
20260624|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
20260625|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260626|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
20260627|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260628|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
20260629|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260630|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20260631|NCT00493116|Interferons|interferons|mesh-list
20260632|NCT00493116|Interferon-beta|interferon-beta|mesh-list
20260633|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
20260634|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
20260635|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260636|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
20260637|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260638|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260639|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
20260640|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
20260641|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260642|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260643|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20260644|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
20260645|NCT00493116|Hormones|hormones|mesh-ancestor
20260646|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260647|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20260648|NCT00493116|Protective Agents|protective agents|mesh-ancestor
20260649|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
20260650|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20541008|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541009|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20541010|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
20541011|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
20541012|NCT01855581|Analgesics|analgesics|mesh-ancestor
20541013|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
20541014|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541015|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20541016|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20541017|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20541018|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541019|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541020|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
20541021|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
20541022|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20541023|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911706|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
19911707|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19911708|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911709|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911710|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
19911711|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911712|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
19911713|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911714|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911715|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
19911716|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911717|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19911718|NCT01173055|Milnacipran|milnacipran|mesh-list
19911719|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
20260651|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
20260652|NCT00493129|Interleukin-2|interleukin-2|mesh-list
20260653|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911720|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19911721|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19911722|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911723|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911724|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911725|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911726|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19911727|NCT01173055|Analgesics|analgesics|mesh-ancestor
19911728|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
19911729|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911730|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
19911731|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19911732|NCT01173120|Abatacept|abatacept|mesh-list
19911733|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19911734|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911735|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911736|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19911737|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
19911738|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911739|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911740|NCT01173211|Vaccines|vaccines|mesh-list
19911741|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
19911742|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911743|NCT01173471|Niacinamide|niacinamide|mesh-list
19911744|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
19911745|NCT01173471|Vitamins|vitamins|mesh-ancestor
19911746|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
19911747|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911748|NCT01173601|Serotonin|serotonin|mesh-list
19911749|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19911750|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19911751|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
19911752|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911753|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911754|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911755|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19911756|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911757|NCT01173679|Rituximab|rituximab|mesh-list
19911758|NCT01173679|Fludarabine|fludarabine|mesh-list
19911759|NCT01173679|Dasatinib|dasatinib|mesh-list
19911760|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19911761|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911762|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
19911763|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911764|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911765|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911766|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19911767|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911768|NCT01173692|Minocycline|minocycline|mesh-list
19911769|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911770|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911771|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
19911772|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
19911773|NCT01173848|Vitamin D|vitamin d|mesh-list
19911774|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911775|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911776|NCT01173848|Vitamins|vitamins|mesh-ancestor
19911777|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
19911778|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19911779|NCT01174004|Pimavanserin|pimavanserin|mesh-list
19911780|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19911781|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19911782|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19911783|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19911784|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911785|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911786|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19911787|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19911788|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19911789|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
19911790|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911791|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911792|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19911793|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911794|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19911795|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911796|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911797|NCT01174082|Vaccines|vaccines|mesh-list
19911798|NCT01174082|Sargramostim|sargramostim|mesh-list
19911799|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
19911800|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911801|NCT01174173|Ranolazine|ranolazine|mesh-list
19911802|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19911803|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911804|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911805|NCT01174186|Adalimumab|adalimumab|mesh-list
19911806|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19911807|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911808|NCT01174238|Paclitaxel|paclitaxel|mesh-list
19911809|NCT01174238|Carboplatin|carboplatin|mesh-list
19911810|NCT01174238|Axitinib|axitinib|mesh-list
19911811|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19911812|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911813|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
19911814|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
19911815|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
19911816|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911817|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19911818|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911819|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
19911820|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19911821|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19911822|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19911823|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19911824|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19911825|NCT01175135|Risperidone|risperidone|mesh-list
19911826|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19911827|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
19911828|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911829|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911830|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911831|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19911832|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19911833|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911834|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19911835|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19911836|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
19911837|NCT01175148|Atorvastatin|atorvastatin|mesh-list
19911838|NCT01175148|Calcium|calcium|mesh-list
19911839|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911840|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911841|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19911842|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19911843|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
19911844|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911845|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19911846|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19911847|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911848|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19911849|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
19911850|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19911851|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
19911852|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972019|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972020|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972021|NCT01806298|Hormones|hormones|mesh-list
19972022|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972023|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972024|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19972025|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
19972026|NCT01806545|Coagulants|coagulants|mesh-ancestor
19972027|NCT01806571|Cytarabine|cytarabine|mesh-list
19972028|NCT01806571|Daunorubicin|daunorubicin|mesh-list
19972029|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19972030|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
19972031|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972032|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972033|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
19972034|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911853|NCT01175343|R04929097|r04929097|mesh-list
19911854|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911855|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911856|NCT01175382|Tamsulosin|tamsulosin|mesh-list
20260654|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20260655|NCT00493129|Analgesics|analgesics|mesh-ancestor
20260656|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
20260657|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260658|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260659|NCT00493194|Cyclosporine|cyclosporine|mesh-list
20260660|NCT00493194|Sirolimus|sirolimus|mesh-list
20260661|NCT00493194|Cyclosporins|cyclosporins|mesh-list
20260662|NCT00493194|Daclizumab|daclizumab|mesh-list
20260663|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260664|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260665|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260666|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
20260667|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260668|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
20260669|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260670|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
20260671|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20260672|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20260673|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20260674|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20260675|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260676|NCT00493233|Olanzapine|olanzapine|mesh-list
20260677|NCT00493233|Risperidone|risperidone|mesh-list
20260678|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20260679|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
20260680|NCT00493233|Clozapine|clozapine|mesh-list
20260681|NCT00493233|Perphenazine|perphenazine|mesh-list
20260682|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20260683|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
20260684|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260685|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260686|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260687|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20260688|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20260689|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20260690|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20260691|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
20260692|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
20260693|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
20260694|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260695|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20260696|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20260697|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20260698|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260699|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
19911857|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19911858|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19911859|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19911860|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19911861|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911862|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911863|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911864|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911865|NCT01175382|Urological Agents|urological agents|mesh-ancestor
19911866|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19911867|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19911868|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
19911869|NCT01175395|Triamcinolone|triamcinolone|mesh-list
19911870|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19911871|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19911872|NCT01175395|Ranibizumab|ranibizumab|mesh-list
19911873|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19911874|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19911875|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
19911876|NCT01175395|Hormones|hormones|mesh-ancestor
19911877|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911878|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260700|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
19911879|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260701|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
20260702|NCT00493298|Natalizumab|natalizumab|mesh-list
19911880|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
19911881|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911882|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911883|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19911884|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19911885|NCT01175395|Growth Substances|growth substances|mesh-ancestor
19911886|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
19911887|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911888|NCT01175473|Metformin|metformin|mesh-list
19911889|NCT01175473|Liraglutide|liraglutide|mesh-list
19911890|NCT01175473|Lixisenatide|lixisenatide|mesh-list
19911891|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19911892|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911893|NCT01175473|Incretins|incretins|mesh-ancestor
19911894|NCT01175473|Hormones|hormones|mesh-ancestor
19911895|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19911896|NCT01175590|Besifloxacin|besifloxacin|mesh-list
19911897|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911898|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911899|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19911900|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19911901|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911902|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911903|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911904|NCT01175668|Clonidine|clonidine|mesh-list
19911905|NCT01175668|Phenobarbital|phenobarbital|mesh-list
19911906|NCT01175668|Analgesics|analgesics|mesh-ancestor
19911907|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
19911908|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19911909|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911910|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19911911|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
19911912|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
19911913|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19911914|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19911915|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19911916|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911917|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911918|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911919|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
19911920|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19911921|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19911922|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19911923|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19911924|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
19911925|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
19911926|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19911927|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19911928|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19911929|NCT01175707|Vancomycin|vancomycin|mesh-list
19911930|NCT01175707|Daptomycin|daptomycin|mesh-list
19911931|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19911932|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911933|NCT01175798|Vitamin D|vitamin d|mesh-list
19911934|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
19911935|NCT01175798|Vitamins|vitamins|mesh-ancestor
19911936|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
19911937|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911938|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19911939|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911940|NCT01175811|Insulin|insulin|mesh-list
19911941|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19911942|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
19911943|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
19911944|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
19911945|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
19911946|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
19911947|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19911948|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911949|NCT01175824|Insulin|insulin|mesh-list
19911950|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19911951|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
19911952|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
19911953|NCT01175824|Protamines|protamines|mesh-list
19911954|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19911955|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911956|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
19911957|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911958|NCT01175824|Coagulants|coagulants|mesh-ancestor
19911959|NCT01175902|Timolol|timolol|mesh-list
19911960|NCT01175902|Dorzolamide|dorzolamide|mesh-list
19911961|NCT01175902|Latanoprost|latanoprost|mesh-list
19911962|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19911963|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19911964|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
19911965|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19911966|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911967|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911968|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19911969|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19911970|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19911971|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19911972|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19911973|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911974|NCT01175980|Vorinostat|vorinostat|mesh-list
19911975|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19911976|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19911977|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19911978|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911979|NCT01176032|Losartan|losartan|mesh-list
19911980|NCT01176032|Amlodipine|amlodipine|mesh-list
19911981|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19911982|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19911983|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19911984|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19911985|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19911986|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19911987|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19911988|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
19911989|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19911990|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19911991|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19911992|NCT01176032|Diuretics|diuretics|mesh-ancestor
19911993|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
19911994|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19911995|NCT01176058|Fluconazole|fluconazole|mesh-list
19911996|NCT01176058|Anidulafungin|anidulafungin|mesh-list
19911997|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
19911998|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19911999|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19912000|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19912001|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912002|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912003|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19912004|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912005|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912006|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912007|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19912008|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19912009|NCT01176240|Mannitol|mannitol|mesh-list
19912010|NCT01176240|Droxidopa|droxidopa|mesh-list
19912011|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19912012|NCT01176240|Diuretics|diuretics|mesh-ancestor
19912013|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
19912014|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912015|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19912016|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19912017|NCT01176435|Levodopa|levodopa|mesh-list
19912018|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19912019|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19912020|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
19912021|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912022|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912023|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912024|NCT01176565|Nicardipine|nicardipine|mesh-list
19912025|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19912026|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19912027|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912028|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912029|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19912030|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912031|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
19912032|NCT01176591|Aprepitant|aprepitant|mesh-list
19912033|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
19912034|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
19912035|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
19912036|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912037|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912038|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19912039|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19912040|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912041|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912042|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
19912043|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19912044|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
19912045|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912046|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
19912047|NCT01176773|Protective Agents|protective agents|mesh-ancestor
19912048|NCT01176916|Exemestane|exemestane|mesh-list
19912049|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912050|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19912051|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19912052|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912053|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912054|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19912055|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912056|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912057|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912058|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19912059|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
19912060|NCT01176968|Eplerenone|eplerenone|mesh-list
19912061|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19912062|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912063|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912064|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912065|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19912066|NCT01176968|Diuretics|diuretics|mesh-ancestor
19912067|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
19912068|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19912069|NCT01176981|Methotrexate|methotrexate|mesh-list
19912070|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19912071|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
19912072|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19912073|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912074|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19912075|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
19912076|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912077|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912078|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
19912079|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912080|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19912081|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912082|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
19912083|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912084|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19912085|NCT01177098|Timolol|timolol|mesh-list
19912086|NCT01177098|Bimatoprost|bimatoprost|mesh-list
19912087|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19912088|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19912089|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19912090|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19912091|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912092|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912093|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912094|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912095|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19912096|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19912097|NCT01177189|Ascorbic Acid|ascorbic acid|mesh-list
19912098|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
19912099|NCT01177189|Vitamins|vitamins|mesh-ancestor
19912100|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
19912101|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912102|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
19912103|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912104|NCT01177189|Protective Agents|protective agents|mesh-ancestor
19912105|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
19912106|NCT01177228|Vedolizumab|vedolizumab|mesh-list
19912107|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19912108|NCT01177293|Amlodipine|amlodipine|mesh-list
19912109|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19912110|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19912111|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912112|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912113|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19912114|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912115|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
19912116|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19912117|NCT01177384|Glimepiride|glimepiride|mesh-list
19912118|NCT01177384|Acarbose|acarbose|mesh-list
19912119|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912120|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912121|NCT01177384|Incretins|incretins|mesh-ancestor
19912122|NCT01177384|Hormones|hormones|mesh-ancestor
19912123|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912124|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19912125|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912126|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912127|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912128|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19912129|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912130|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
19912131|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19912132|NCT01177410|Mesalamine|mesalamine|mesh-list
19912133|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19912134|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19912135|NCT01177410|Analgesics|analgesics|mesh-ancestor
19912136|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
19912137|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912138|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912139|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19912140|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912141|NCT01177709|Metformin|metformin|mesh-list
19912142|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912143|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912144|NCT01177722|Vaccines|vaccines|mesh-list
19912145|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
19912146|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912147|NCT01177735|Pomalidomide|pomalidomide|mesh-list
19912148|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
19912149|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912150|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19912151|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19912152|NCT01177735|Growth Substances|growth substances|mesh-ancestor
19912153|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
19912154|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912155|NCT01177800|Infliximab|infliximab|mesh-list
19912156|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
19912157|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19912158|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912159|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19912160|NCT01177813|Empagliflozin|empagliflozin|mesh-list
19912161|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912162|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912163|NCT01177813|Incretins|incretins|mesh-ancestor
19912164|NCT01177813|Hormones|hormones|mesh-ancestor
19912165|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912166|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19912167|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912168|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912169|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912170|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19912171|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19912172|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19912173|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19912174|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912175|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912176|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912177|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912178|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912179|NCT01177956|Fluorouracil|fluorouracil|mesh-list
19912180|NCT01177956|Cetuximab|cetuximab|mesh-list
19912181|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912182|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
19912183|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912184|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19912185|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912186|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
19912187|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912188|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20260703|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
20260704|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260705|NCT00493324|Alefacept|alefacept|mesh-list
19912189|NCT01178073|Ambrisentan|ambrisentan|mesh-list
19912190|NCT01178073|Tadalafil|tadalafil|mesh-list
19912191|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
19912192|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19912193|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19912194|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912195|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912196|NCT01178073|Urological Agents|urological agents|mesh-ancestor
19912197|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20260706|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20260707|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
20260708|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260709|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
20260710|NCT00493363|Artesunate|artesunate|mesh-list
19912198|NCT01178086|Rituximab|rituximab|mesh-list
19912199|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19912200|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912201|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
19912202|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912203|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912204|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19912205|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19912206|NCT01178138|Prazosin|prazosin|mesh-list
19912207|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19912208|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20260711|NCT00493363|Mefloquine|mefloquine|mesh-list
20260712|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
20260713|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20260714|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20260715|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260716|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260717|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
20260718|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
20260719|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20260720|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
20260721|NCT00493389|Hormones|hormones|mesh-list
20260722|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20260723|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912209|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19912210|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19912211|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912212|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912213|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912214|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912215|NCT01178216|Rituximab|rituximab|mesh-list
19912216|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19912217|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912218|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
19912219|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912220|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912221|NCT01178281|Thalidomide|thalidomide|mesh-list
19912222|NCT01178281|Pomalidomide|pomalidomide|mesh-list
19912223|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
19912224|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912225|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19912226|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19912227|NCT01178281|Growth Substances|growth substances|mesh-ancestor
19912228|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
19912229|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912230|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912231|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
19912232|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19912233|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912234|NCT01178528|Carvedilol|carvedilol|mesh-list
19912235|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19912236|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19912237|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912238|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912239|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912240|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912241|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19912242|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
19912243|NCT01178528|Protective Agents|protective agents|mesh-ancestor
19912244|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19912245|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912246|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19912247|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
19912248|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19912249|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19912250|NCT01178671|Mirtazapine|mirtazapine|mesh-list
19912251|NCT01178671|Sertraline|sertraline|mesh-list
19912252|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
19912253|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19912254|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19912255|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19912256|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912257|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912258|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912259|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
19912260|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912261|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19912262|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
19912263|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
19912264|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19912265|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19912266|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19912267|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19912268|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19912269|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19912270|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912271|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19912272|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19912273|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19912274|NCT01178762|Azithromycin|azithromycin|mesh-list
19912275|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19912276|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912277|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
20260724|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912278|NCT01178827|Oxybutynin|oxybutynin|mesh-list
19912279|NCT01178827|Trospium chloride|trospium chloride|mesh-list
19912280|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
19912281|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
19912282|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912283|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912284|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19912285|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19912286|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
19912287|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912288|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912289|NCT01178827|Urological Agents|urological agents|mesh-ancestor
19912290|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19912291|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912292|NCT01178827|Renal Agents|renal agents|mesh-ancestor
19912293|NCT01178853|Warfarin|warfarin|mesh-list
19912294|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19912295|NCT01178853|Pitavastatin|pitavastatin|mesh-list
19912296|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19912297|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19912298|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
19912299|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912300|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19912301|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19912302|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912303|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
19912304|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
19912305|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19912306|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912307|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19912308|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912309|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912310|NCT01179048|Liraglutide|liraglutide|mesh-list
19912311|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912312|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912313|NCT01179048|Incretins|incretins|mesh-ancestor
19912314|NCT01179048|Hormones|hormones|mesh-ancestor
19912315|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912316|NCT01179113|Esmolol|esmolol|mesh-list
19912317|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19912318|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19912319|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19912320|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912321|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912322|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912323|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912324|NCT01179191|Naltrexone|naltrexone|mesh-list
19912325|NCT01179191|Morphine|morphine|mesh-list
19912326|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19912327|NCT01179191|Narcotics|narcotics|mesh-ancestor
19912328|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19912329|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912330|NCT01179191|Analgesics|analgesics|mesh-ancestor
19912331|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
19912332|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912333|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19912334|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19912335|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
19912336|NCT01179334|Riociguat|riociguat|mesh-list
20260725|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
20260726|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20260727|NCT00493402|Estrogens|estrogens|mesh-ancestor
20260728|NCT00493402|Hormones|hormones|mesh-ancestor
20260729|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260730|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260731|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19912337|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
19912338|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19912339|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19912340|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912341|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912342|NCT01179334|Urological Agents|urological agents|mesh-ancestor
19912343|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
19912344|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
19912345|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19912346|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
19912347|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912348|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260732|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912349|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19912350|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
19912351|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
19912352|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19912353|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
19912354|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912355|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912356|NCT01179490|Prednisolone|prednisolone|mesh-list
19912357|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19912358|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
19912359|NCT01179490|Hormones|hormones|mesh-ancestor
19912360|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912361|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912362|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19912363|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912364|NCT01179516|Vortioxetine|vortioxetine|mesh-list
19912365|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
19912366|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19912367|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19912368|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19912369|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19912370|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912371|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19912372|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19912373|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912374|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912375|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912376|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
19912377|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19912378|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19912379|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19912380|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19912381|NCT01179568|Citalopram|citalopram|mesh-list
19912382|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19912383|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19912384|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912385|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912386|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912387|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
19912388|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912389|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19912390|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
19912391|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19912392|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19912393|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19912394|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19912395|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912396|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912397|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19449940|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449941|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449942|NCT03431987|Ethanol|ethanol|mesh-list
19912398|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912399|NCT01179672|Analgesics|analgesics|mesh-ancestor
19912400|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
19912401|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912402|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
19912403|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19912404|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
19912405|NCT01179919|Oseltamivir|oseltamivir|mesh-list
19912406|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
19912407|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912408|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912409|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912410|NCT01180036|Cyclosporine|cyclosporine|mesh-list
19912411|NCT01180036|Rituximab|rituximab|mesh-list
19912412|NCT01180036|Cyclosporins|cyclosporins|mesh-list
19912413|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19912414|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912415|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
19912416|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912417|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912418|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912419|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912420|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912421|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
19912422|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912423|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
19912424|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19912425|NCT01180049|Sirolimus|sirolimus|mesh-list
19912426|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19912427|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912428|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19912429|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912430|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
19912431|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912432|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
19912433|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912434|NCT01180296|Progesterone|progesterone|mesh-list
19912435|NCT01180296|Progestins|progestins|mesh-ancestor
19912436|NCT01180296|Hormones|hormones|mesh-ancestor
19912437|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912438|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912439|NCT01180647|Naltrexone|naltrexone|mesh-list
19912440|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19912441|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19912442|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912443|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
19912444|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912445|NCT01180660|Lidocaine|lidocaine|mesh-list
19912446|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
19912447|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
19912448|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19912449|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912450|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
19912451|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912452|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19912453|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19912454|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19912455|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912456|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912457|NCT01180790|Interferons|interferons|mesh-list
19912458|NCT01180790|Ribavirin|ribavirin|mesh-list
19912459|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
19912460|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
19912461|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20260733|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
20260734|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
20260735|NCT00493428|Baclofen|baclofen|mesh-list
20260736|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20260737|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260738|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20260739|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260740|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20260741|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
20260742|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
20260743|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260744|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260745|NCT00493480|Propranolol|propranolol|mesh-list
20260746|NCT00493480|Carvedilol|carvedilol|mesh-list
20260747|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20260748|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20541024|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912462|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912463|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
19912464|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912465|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
19912466|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912467|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
19912468|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912469|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19912470|NCT01180894|Hematinics|hematinics|mesh-ancestor
19912471|NCT01181011|Amlodipine|amlodipine|mesh-list
19912472|NCT01181011|Telmisartan|telmisartan|mesh-list
20260749|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912473|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19912474|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19912475|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19912476|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912477|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912478|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19912479|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912480|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
19912481|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19912482|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19912483|NCT01181102|Enoxaparin|enoxaparin|mesh-list
19912484|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
19912485|NCT01181102|Edoxaban|edoxaban|mesh-list
19912486|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
19912487|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19912488|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19912489|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912490|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19912491|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
19912492|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19912493|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912494|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972035|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19972036|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
19972037|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972038|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19972039|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19972040|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19972041|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972042|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19972043|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
19972044|NCT01806584|Coagulants|coagulants|mesh-ancestor
19972045|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19972046|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
19972047|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972048|NCT01806623|Fluconazole|fluconazole|mesh-list
19972049|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
19972050|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972051|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19972052|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19972053|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972054|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972055|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19972056|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
20541025|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
20541026|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20541027|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972057|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972058|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972059|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19972060|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19972061|NCT01806662|Ustekinumab|ustekinumab|mesh-list
19972062|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
19972063|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19972064|NCT01806675|Glycine|glycine|mesh-list
19972065|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19972066|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972067|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
19972068|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972069|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972070|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19972071|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
19972072|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
20541028|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912495|NCT01181128|Factor VIII|factor viii|mesh-list
19912496|NCT01181128|Coagulants|coagulants|mesh-ancestor
19912497|NCT01181141|Enoxaparin|enoxaparin|mesh-list
19912498|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
19912499|NCT01181141|Edoxaban|edoxaban|mesh-list
19912500|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
19912501|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19912502|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19912503|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912504|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19912505|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
19912506|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19912507|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912508|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912509|NCT01181167|Enoxaparin|enoxaparin|mesh-list
19912510|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
19912511|NCT01181167|Edoxaban|edoxaban|mesh-list
19912512|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
19912513|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19912514|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19912515|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912516|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19912517|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
19912518|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19912519|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912520|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912521|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
19912522|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
19912523|NCT01181258|Rituximab|rituximab|mesh-list
19912524|NCT01181258|Fludarabine|fludarabine|mesh-list
19912525|NCT01181258|Interleukin-2|interleukin-2|mesh-list
19912526|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912527|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
19912528|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912529|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912530|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19912531|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
19912532|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912533|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912534|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19912535|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19912536|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19912537|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
19912538|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
19912539|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912540|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19912541|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
19912542|NCT01181258|Hormones|hormones|mesh-ancestor
19912543|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912544|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19912545|NCT01181258|Protective Agents|protective agents|mesh-ancestor
19912546|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19912547|NCT01181258|Analgesics|analgesics|mesh-ancestor
19912548|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
19912549|NCT01181271|Sirolimus|sirolimus|mesh-list
19912550|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
19912551|NCT01181271|Busulfan|busulfan|mesh-list
19912552|NCT01181271|Methotrexate|methotrexate|mesh-list
19912553|NCT01181271|Fludarabine|fludarabine|mesh-list
19912554|NCT01181271|Etoposide|etoposide|mesh-list
19912555|NCT01181271|Tacrolimus|tacrolimus|mesh-list
19912556|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912557|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
19912558|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912559|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912560|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19912561|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
19912562|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912563|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912564|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19912565|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19912566|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
19912567|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19912568|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19912569|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
19912570|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
19912571|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912572|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19912573|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19912574|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20260750|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912575|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19912576|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19912577|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20260751|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260752|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260753|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20260754|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20260755|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
20260756|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
20260757|NCT00493480|Protective Agents|protective agents|mesh-ancestor
20260758|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20260759|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260760|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20260761|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20260762|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20260763|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
20260764|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20260765|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912578|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19912579|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912580|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19912581|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
19912582|NCT01181323|Vaccines|vaccines|mesh-list
19912583|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
19912584|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912585|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19912586|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19912587|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912588|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912589|NCT01181531|Vitamin D|vitamin d|mesh-list
19912590|NCT01181531|Cinacalcet|cinacalcet|mesh-list
19912591|NCT01181531|Vitamins|vitamins|mesh-ancestor
20260766|NCT00493545|Poly ICLC|poly iclc|mesh-list
20260767|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
20260768|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
20260769|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260770|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
20260771|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20260772|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
20260773|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260774|NCT00493610|Expectorants|expectorants|mesh-ancestor
20260775|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
20260776|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20260777|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
20260778|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260779|NCT00493610|Protective Agents|protective agents|mesh-ancestor
20260780|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260781|NCT00493610|Antidotes|antidotes|mesh-ancestor
20260782|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
20260783|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20260784|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260785|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
20260786|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20260787|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
20260788|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260789|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
20260790|NCT00493662|Protective Agents|protective agents|mesh-ancestor
20260791|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
19912592|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
19912593|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912594|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19912595|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19912596|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19912597|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912598|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912599|NCT01181609|Bevacizumab|bevacizumab|mesh-list
19912600|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19912601|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912602|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19912603|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19912604|NCT01181609|Growth Substances|growth substances|mesh-ancestor
19912605|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912606|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
19912607|NCT01181674|Insulin|insulin|mesh-list
19912608|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19912609|NCT01181674|Metformin|metformin|mesh-list
19912610|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
19912611|NCT01181674|Acarbose|acarbose|mesh-list
19912612|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912613|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912614|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19912615|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912616|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912617|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19912618|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19912619|NCT01181726|Norethindrone|norethindrone|mesh-list
19912620|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
19912621|NCT01181726|Estradiol|estradiol|mesh-list
19912622|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19912623|NCT01181726|Estrogens|estrogens|mesh-ancestor
19912624|NCT01181726|Hormones|hormones|mesh-ancestor
19912625|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912626|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260792|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20260793|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
20260794|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912627|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19912628|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
19912629|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19912630|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19912631|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19912632|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19912633|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19912634|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19912635|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19912636|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
19912637|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912638|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912639|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19912640|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
19912641|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19912642|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19912643|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19912644|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
19912645|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912646|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912647|NCT01181986|Exenatide|exenatide|mesh-list
19912648|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912649|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912650|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19912651|NCT01181986|Incretins|incretins|mesh-ancestor
19912652|NCT01181986|Hormones|hormones|mesh-ancestor
19912653|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912654|NCT01182181|Anastrozole|anastrozole|mesh-list
19912655|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19912656|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912657|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19912658|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19912659|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912660|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912661|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19912662|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912663|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912664|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912665|NCT01182194|Drospirenone|drospirenone|mesh-list
19912666|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19912667|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19912668|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19912669|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19912670|NCT01182194|Estradiol|estradiol|mesh-list
19912671|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19912672|NCT01182194|Estrogens|estrogens|mesh-ancestor
20260795|NCT00493727|Expectorants|expectorants|mesh-ancestor
19912673|NCT01182194|Hormones|hormones|mesh-ancestor
19912674|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912675|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912676|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19912677|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
19912678|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19912679|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19912680|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19912681|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19912682|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19912683|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912684|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19912685|NCT01182194|Diuretics|diuretics|mesh-ancestor
19912686|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
19912687|NCT01182207|Drospirenone|drospirenone|mesh-list
19912688|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19912689|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19912690|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19912691|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
19912692|NCT01182207|Estradiol|estradiol|mesh-list
19912693|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19912694|NCT01182207|Estrogens|estrogens|mesh-ancestor
19912695|NCT01182207|Hormones|hormones|mesh-ancestor
19912696|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912697|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912698|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19912699|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
19912700|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19912701|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19912702|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19912703|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19912704|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19912705|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912706|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19912707|NCT01182207|Diuretics|diuretics|mesh-ancestor
19912708|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
19912709|NCT01182285|Valproic Acid|valproic acid|mesh-list
19912710|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
19912711|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912712|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912713|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
19912714|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912715|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912716|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
19912717|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19912718|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19912719|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19912720|NCT01182350|Bevacizumab|bevacizumab|mesh-list
19912721|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19912722|NCT01182350|Temozolomide|temozolomide|mesh-list
19912723|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19912724|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912725|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19912726|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19912727|NCT01182350|Growth Substances|growth substances|mesh-ancestor
19912728|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912729|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
19912730|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19912731|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912732|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912733|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19912734|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
19912735|NCT01182376|Dronedarone|dronedarone|mesh-list
19912736|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19912737|NCT01182441|Warfarin|warfarin|mesh-list
19912738|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
19912739|NCT01182493|Insulin|insulin|mesh-list
19912740|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912741|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912742|NCT01182675|Plerixafor|plerixafor|mesh-list
19912743|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
19912744|NCT01182675|Lenograstim|lenograstim|mesh-list
19912745|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19912746|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
19912747|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912748|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19912749|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912750|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19912751|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19912752|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
19912753|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912754|NCT01183013|Pioglitazone|pioglitazone|mesh-list
19912755|NCT01183013|Linagliptin|linagliptin|mesh-list
19912756|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912757|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912758|NCT01183013|Incretins|incretins|mesh-ancestor
19912759|NCT01183013|Hormones|hormones|mesh-ancestor
19912760|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912761|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19912762|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912763|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912764|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912765|NCT01183065|Folic Acid|folic acid|mesh-list
19912766|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
19912767|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
19912768|NCT01183065|Vitamins|vitamins|mesh-ancestor
19912769|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
19912770|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912771|NCT01183065|Hematinics|hematinics|mesh-ancestor
19912772|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
19912773|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19912774|NCT01183104|Glimepiride|glimepiride|mesh-list
19912775|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912776|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912777|NCT01183104|Incretins|incretins|mesh-ancestor
19912778|NCT01183104|Hormones|hormones|mesh-ancestor
19912779|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912780|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19912781|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912782|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912783|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912784|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19912785|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912786|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
19912787|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19912788|NCT01183143|Hormones|hormones|mesh-ancestor
19912789|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912790|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912791|NCT01183169|Ribavirin|ribavirin|mesh-list
19912792|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19912793|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
19912794|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912795|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
19912796|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912797|NCT01183234|Methylphenidate|methylphenidate|mesh-list
19912798|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19912799|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912800|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19912801|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19912802|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19912803|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912804|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
19912805|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912806|NCT01183312|Flumazenil|flumazenil|mesh-list
19912807|NCT01183312|Antidotes|antidotes|mesh-ancestor
20260796|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
20260797|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20260798|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
20260799|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260800|NCT00493727|Protective Agents|protective agents|mesh-ancestor
20260801|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260802|NCT00493727|Antidotes|antidotes|mesh-ancestor
20260803|NCT00493766|Panobinostat|panobinostat|mesh-list
20260804|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260805|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20260806|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260807|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260808|NCT00493831|Nicotine|nicotine|mesh-list
20260809|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20260810|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
20260811|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260812|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912808|NCT01183312|Protective Agents|protective agents|mesh-ancestor
19912809|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912810|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
19912811|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
19912812|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912813|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912814|NCT01183390|Anastrozole|anastrozole|mesh-list
19912815|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19912816|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912817|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19912818|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19912819|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912820|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912821|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19912822|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
19912823|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19912824|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912825|NCT01183481|Aprepitant|aprepitant|mesh-list
19912826|NCT01183481|Granisetron|granisetron|mesh-list
19912827|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
19912828|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
19912829|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912830|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912831|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19912832|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19912833|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912834|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912835|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19912836|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
19912837|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19912838|NCT01183533|Plasminogen|plasminogen|mesh-list
19912839|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19912840|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19912841|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912842|NCT01183559|Paclitaxel|paclitaxel|mesh-list
19912843|NCT01183559|Carboplatin|carboplatin|mesh-list
19912844|NCT01183559|Fluorouracil|fluorouracil|mesh-list
19912845|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19912846|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912847|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
19912848|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
19912849|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
19912850|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912851|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
19912852|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19912853|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912854|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
19912855|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912856|NCT01183650|Tadalafil|tadalafil|mesh-list
19912857|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
19912858|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19912859|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19912860|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912861|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912862|NCT01183650|Urological Agents|urological agents|mesh-ancestor
19912863|NCT01183780|Leucovorin|leucovorin|mesh-list
19912864|NCT01183780|Folic Acid|folic acid|mesh-list
19912865|NCT01183780|Fluorouracil|fluorouracil|mesh-list
19912866|NCT01183780|Irinotecan|irinotecan|mesh-list
19912867|NCT01183780|Ramucirumab|ramucirumab|mesh-list
19912868|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
19912869|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
19912870|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912871|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19912872|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912873|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912874|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
19912875|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912876|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19912877|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19912878|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912879|NCT01183780|Antidotes|antidotes|mesh-ancestor
19912880|NCT01183780|Protective Agents|protective agents|mesh-ancestor
19912881|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
19912882|NCT01183780|Vitamins|vitamins|mesh-ancestor
19912883|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
19912884|NCT01183780|Hematinics|hematinics|mesh-ancestor
19912885|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19912886|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912887|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19912888|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912889|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912890|NCT01184014|Insulin|insulin|mesh-list
19912891|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19449943|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19449944|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19449945|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449946|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449947|NCT03431974|Aminopterin|aminopterin|mesh-list
19449948|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19449949|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449950|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912892|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
19912893|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
19912894|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
19912895|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
19912896|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
19912897|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19912898|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912899|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
19912900|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912901|NCT01184079|Vaccines|vaccines|mesh-list
19912902|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
19912903|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912904|NCT01184118|Fluticasone|fluticasone|mesh-list
19912905|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19912906|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19912907|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
19912908|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912909|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912910|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19912911|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
19912912|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
19912913|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19912914|NCT01184326|Everolimus|everolimus|mesh-list
19912915|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912916|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912917|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
19912918|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912919|NCT01184417|Phenobarbital|phenobarbital|mesh-list
19912920|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
19912921|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19912922|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19912923|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912924|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19912925|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19912926|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912927|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912928|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
19912929|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
19912930|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19912931|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19912932|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19912933|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
19912934|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19912935|NCT01184846|Antibodies|antibodies|mesh-list
19912936|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
19912937|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912938|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19912939|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
19912940|NCT01184859|Coagulants|coagulants|mesh-ancestor
19912941|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19912942|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
19912943|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912944|NCT01184872|Vancomycin|vancomycin|mesh-list
19912945|NCT01184872|Daptomycin|daptomycin|mesh-list
19912946|NCT01184872|Penicillins|penicillins|mesh-list
19912947|NCT01184872|Floxacillin|floxacillin|mesh-list
19912948|NCT01184872|Cloxacillin|cloxacillin|mesh-list
19912949|NCT01184872|Oxacillin|oxacillin|mesh-list
19912950|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19912951|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912952|NCT01184885|Sirolimus|sirolimus|mesh-list
19912953|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
19912954|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19912955|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912956|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912957|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19912958|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912959|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
19912960|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912961|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
19912962|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912963|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19912964|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19912965|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
19912966|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19912967|NCT01184898|Cytarabine|cytarabine|mesh-list
19912968|NCT01184898|Sirolimus|sirolimus|mesh-list
19912969|NCT01184898|Etoposide|etoposide|mesh-list
19912970|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
19912971|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
19912972|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19912973|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19912974|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19912975|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19912976|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912977|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912978|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19912979|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
19912980|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
19912981|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19912982|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19912983|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
19912984|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19912985|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19912986|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19912987|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
20260813|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20260814|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20260815|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
20260816|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260817|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260818|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
20260819|NCT00493857|Antibodies|antibodies|mesh-list
20260820|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20260821|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
20260822|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260823|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20260824|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260825|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
20260826|NCT00493870|Docetaxel|docetaxel|mesh-list
20260827|NCT00493870|Doxorubicin|doxorubicin|mesh-list
20260828|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20260829|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
20260830|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260831|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20260832|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20260833|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
20260834|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260835|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260836|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20260837|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
20260838|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
20260839|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
20260840|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20260841|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20541029|NCT01855607|Menthol|menthol|mesh-list
20541030|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
20541031|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
20541032|NCT01855711|Alosetron|alosetron|mesh-list
20541033|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541034|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20541035|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
20541036|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19912988|NCT01184898|Analgesics|analgesics|mesh-ancestor
20541037|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541038|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541039|NCT01855724|Gemcitabine|gemcitabine|mesh-list
19912989|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
19912990|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19912991|NCT01184989|Dabigatran|dabigatran|mesh-list
19912992|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
19912993|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19912994|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
19912995|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19912996|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19912997|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
19912998|NCT01185028|Interferons|interferons|mesh-list
19912999|NCT01185028|Ribavirin|ribavirin|mesh-list
19913000|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
19913001|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913002|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
19913003|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913004|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
19913005|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913006|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19913007|NCT01185080|Adenosine|adenosine|mesh-list
19913008|NCT01185080|Analgesics|analgesics|mesh-ancestor
19913009|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
19913010|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913011|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913012|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19913013|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
19913014|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19913015|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
19913016|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
19913017|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913018|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913019|NCT01185171|Gefitinib|gefitinib|mesh-list
19913020|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913021|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19913022|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913023|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913024|NCT01185288|Adalimumab|adalimumab|mesh-list
19913025|NCT01185288|Methotrexate|methotrexate|mesh-list
19913026|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19913027|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
19913028|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913029|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913030|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913031|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
19913032|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913033|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913034|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913035|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913036|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19913037|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913038|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
19913039|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913040|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19913041|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913042|NCT01185301|Adalimumab|adalimumab|mesh-list
19913043|NCT01185301|Methotrexate|methotrexate|mesh-list
19913044|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19913045|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
19913046|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913047|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913048|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913049|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
19913050|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913051|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913052|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913053|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913054|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19913055|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913056|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
19913057|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913058|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19913059|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913060|NCT01185340|Serotonin|serotonin|mesh-list
19913061|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20541040|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913062|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19913063|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
19913064|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913065|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913066|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913067|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19913068|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913069|NCT01185353|Methotrexate|methotrexate|mesh-list
19913070|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19913071|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
19913072|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913073|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913074|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913075|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
19913076|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913077|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913078|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913079|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913080|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19913081|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913082|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
19913083|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913084|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19913085|NCT01185366|Everolimus|everolimus|mesh-list
19913086|NCT01185366|Sunitinib|sunitinib|mesh-list
19913087|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913088|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913089|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
19913090|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913091|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19913092|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19913093|NCT01185366|Growth Substances|growth substances|mesh-ancestor
19913094|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
19913095|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19913096|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913097|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913098|NCT01185509|Trastuzumab|trastuzumab|mesh-list
19913099|NCT01185509|Vinorelbine|vinorelbine|mesh-list
19913100|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19913101|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913102|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19913103|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
19913104|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
19913105|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
19913106|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913107|NCT01185548|Tolbutamide|tolbutamide|mesh-list
19913108|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913109|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913110|NCT01185704|Cetrorelix|cetrorelix|mesh-list
19913111|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19913112|NCT01185704|Hormones|hormones|mesh-list
19913113|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19913114|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913115|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913116|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19913117|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
19913118|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913119|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
19913120|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
19913121|NCT01185782|Hormones|hormones|mesh-list
19913122|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19913123|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913124|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913125|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19913126|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
19913127|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913128|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19913129|NCT01185821|Siponimod|siponimod|mesh-list
19913130|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19913131|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913132|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913133|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
19913134|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913135|NCT01185964|Doxorubicin|doxorubicin|mesh-list
19913136|NCT01185964|Olaratumab|olaratumab|mesh-list
19913137|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19913138|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913139|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19913140|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19913141|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913142|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913143|NCT01186250|Pioglitazone|pioglitazone|mesh-list
19913144|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913145|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913146|NCT01186328|Cytarabine|cytarabine|mesh-list
19913147|NCT01186328|Prednisone|prednisone|mesh-list
19913148|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
19913149|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19913150|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19913151|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19913152|NCT01186328|Cortisone|cortisone|mesh-list
19913153|NCT01186328|Doxorubicin|doxorubicin|mesh-list
19913154|NCT01186328|Methotrexate|methotrexate|mesh-list
19913155|NCT01186328|Vincristine|vincristine|mesh-list
19913156|NCT01186328|Asparaginase|asparaginase|mesh-list
19913157|NCT01186328|Pegaspargase|pegaspargase|mesh-list
19913158|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19913159|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913160|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19913161|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19913162|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913163|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913164|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913165|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
19913166|NCT01186328|Hormones|hormones|mesh-ancestor
19913167|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913168|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913169|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19913170|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19913171|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
19913172|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913173|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913174|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
19913175|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913176|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19913177|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913178|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
19913179|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913180|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19913181|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
19913182|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913183|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19913184|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
19913185|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
19913186|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
19913187|NCT01186406|Bevacizumab|bevacizumab|mesh-list
19913188|NCT01186406|Temozolomide|temozolomide|mesh-list
19913189|NCT01186406|Carmustine|carmustine|mesh-list
19913190|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19913191|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913192|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19913193|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19913194|NCT01186406|Growth Substances|growth substances|mesh-ancestor
19913195|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913196|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
19913197|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20541041|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
20541042|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541043|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541044|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
20541045|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541046|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541047|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541048|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
20541049|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541050|NCT01855737|Warfarin|warfarin|mesh-list
19913198|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
20541051|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
19913199|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913200|NCT01186458|Rituximab|rituximab|mesh-list
19913201|NCT01186458|Fludarabine|fludarabine|mesh-list
19913202|NCT01186458|Bortezomib|bortezomib|mesh-list
19913203|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19913204|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913205|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
19913206|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913207|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913208|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19913209|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913210|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913211|NCT01186562|Incretins|incretins|mesh-ancestor
19913212|NCT01186562|Hormones|hormones|mesh-ancestor
19913213|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913214|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19913215|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
19913216|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913217|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913218|NCT01186744|Tofacitinib|tofacitinib|mesh-list
19913219|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19913220|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913221|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913222|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
19913223|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19913224|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913225|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
19913226|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913227|NCT01186796|Fulvestrant|fulvestrant|mesh-list
19913228|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19913229|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913230|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19913231|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19913232|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
19913233|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913234|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972073|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972074|NCT01806779|Bupropion|bupropion|mesh-list
19972075|NCT01806779|Nicotine|nicotine|mesh-list
19972076|NCT01806779|Varenicline|varenicline|mesh-list
19972077|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19972078|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
19972079|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972080|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972081|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19972082|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19972083|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
19972084|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972085|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972086|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19972087|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
19972088|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19972089|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19972090|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19972091|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972092|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
19972093|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19972094|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19972095|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972096|NCT01806857|Quinidine|quinidine|mesh-list
19972097|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
19972098|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
19972099|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
19972100|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19972101|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19972102|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972103|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972104|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972105|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19972106|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19972107|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541052|NCT01855763|Insulin|insulin|mesh-list
19913235|NCT01186939|Azacitidine|azacitidine|mesh-list
19913236|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913237|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
19913238|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913239|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913240|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913241|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
19913242|NCT01187017|Fludarabine|fludarabine|mesh-list
19913243|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913244|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
19913245|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913246|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20260842|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20260843|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286986|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286987|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20286988|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
20286989|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286990|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286991|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
20286992|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286993|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286994|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286995|NCT01134250|Paclitaxel|paclitaxel|mesh-list
20286996|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20286997|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286998|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286999|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287000|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287001|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287002|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
20287003|NCT00588185|Testosterone|testosterone|mesh-list
20287004|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
20287005|NCT00588185|Androgens|androgens|mesh-ancestor
20287006|NCT00588185|Hormones|hormones|mesh-ancestor
20287007|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287008|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287009|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
20287010|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287011|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
20287012|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287013|NCT05333289|Vaccines|vaccines|mesh-list
20287014|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
20287015|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287016|NCT05333250|Modafinil|modafinil|mesh-list
20287017|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20287018|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287019|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20287020|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20287021|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20287022|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287023|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20287024|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
20287025|NCT05333159|Empagliflozin|empagliflozin|mesh-list
20287026|NCT05333159|Canagliflozin|canagliflozin|mesh-list
20287027|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
20287028|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287029|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20287030|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287031|NCT05332821|Bevacizumab|bevacizumab|mesh-list
20287032|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20287033|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287034|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287035|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20287036|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20287037|NCT05332821|Growth Substances|growth substances|mesh-ancestor
20287038|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287039|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
20287040|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287041|NCT05332795|Metformin|metformin|mesh-list
20287042|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20287043|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287044|NCT05332730|Golimumab|golimumab|mesh-list
20541053|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19913247|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19913248|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
19913249|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913250|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913251|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19913252|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19913253|NCT01187381|Trastuzumab|trastuzumab|mesh-list
19913254|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19913255|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913256|NCT01187407|Serotonin|serotonin|mesh-list
19913257|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19913258|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19913259|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
19913260|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913261|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913262|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913263|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19913264|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913265|NCT01187446|Vorinostat|vorinostat|mesh-list
19913266|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913267|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19913268|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913269|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913270|NCT01187498|Oxybutynin|oxybutynin|mesh-list
19913271|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
19913272|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
19913273|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913274|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913275|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19913276|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19913277|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
19913278|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913279|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913280|NCT01187498|Urological Agents|urological agents|mesh-ancestor
19913281|NCT01187550|Hormones|hormones|mesh-list
19913282|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913283|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913284|NCT01187901|Sulindac|sulindac|mesh-list
19913285|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19913286|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913287|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19913288|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913289|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913290|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19913291|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19913292|NCT01187901|Analgesics|analgesics|mesh-ancestor
19913293|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
19913294|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913295|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913296|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913297|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913298|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19913299|NCT01187953|Tacrolimus|tacrolimus|mesh-list
19913300|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913301|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
19913302|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913303|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19913304|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913305|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913306|NCT01188109|Gemcitabine|gemcitabine|mesh-list
19913307|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913308|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913309|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
19913310|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913311|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
19913312|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913313|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913314|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913315|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
19913316|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913317|NCT01188369|Simendan|simendan|mesh-list
19913318|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19913319|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
19913320|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19913321|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19913322|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913323|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913324|NCT01188369|Protective Agents|protective agents|mesh-ancestor
19913325|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913326|NCT01188421|Clonidine|clonidine|mesh-list
19913327|NCT01188421|Buprenorphine|buprenorphine|mesh-list
19913328|NCT01188421|Tramadol|tramadol|mesh-list
19913329|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19913330|NCT01188421|Naloxone|naloxone|mesh-list
19913331|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19913332|NCT01188421|Narcotics|narcotics|mesh-ancestor
19913333|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913334|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913335|NCT01188421|Analgesics|analgesics|mesh-ancestor
19913336|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
19913337|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913338|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19913339|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19913340|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
19913341|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
19913342|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19913343|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19913344|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19913345|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
19913346|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913347|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913348|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19913349|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19913350|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19913351|NCT01188538|Analgesics|analgesics|mesh-ancestor
19913352|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
19913353|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913354|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913355|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913356|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913357|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913358|NCT01188551|Fentanyl|fentanyl|mesh-list
19913359|NCT01188551|Midazolam|midazolam|mesh-list
19913360|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
19913361|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19913362|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913363|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913364|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19913365|NCT01188551|Analgesics|analgesics|mesh-ancestor
19913366|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
19913367|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913368|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19913369|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19913370|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19913371|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
19913372|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913373|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913374|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19913375|NCT01188551|Narcotics|narcotics|mesh-ancestor
19913376|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19913377|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19913378|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
19913379|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
19913380|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19913381|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19913382|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19913383|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
19913384|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
19913385|NCT01188577|Epinephrine|epinephrine|mesh-list
19913386|NCT01188577|Racepinephrine|racepinephrine|mesh-list
19913387|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
19913388|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19913389|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19913390|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
19913391|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913392|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913393|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913394|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20260844|NCT00493961|Hormones|hormones|mesh-list
19913395|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19913396|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
19913397|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913398|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19913399|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
19913400|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
19913401|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
19913402|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19913403|NCT01188655|Etanercept|etanercept|mesh-list
19913404|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19913405|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19913406|NCT01188655|Analgesics|analgesics|mesh-ancestor
19913407|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
19913408|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913409|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913410|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913411|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913412|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19913413|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913414|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
19913415|NCT01188668|Aripiprazole|aripiprazole|mesh-list
19913416|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19913417|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
19913418|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19913419|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19913420|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19913421|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913422|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913423|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
19913424|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
19913425|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913426|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913427|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19913428|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19913429|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
19913430|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19913431|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19913432|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19913433|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19913434|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19913435|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19913436|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913437|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19913438|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
19913439|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19913440|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
19913441|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913442|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913443|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
19913444|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913445|NCT01188694|Methylene Blue|methylene blue|mesh-list
19913446|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913447|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913448|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
19913449|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
19913450|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913451|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
19913452|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
19913453|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913454|NCT01188811|Protective Agents|protective agents|mesh-ancestor
19913455|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913456|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
19913457|NCT01188811|Vitamins|vitamins|mesh-ancestor
19913458|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
19913459|NCT01188876|Folic Acid|folic acid|mesh-list
19913460|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
19913461|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
19913462|NCT01188876|Carboplatin|carboplatin|mesh-list
19913463|NCT01188876|Vitamins|vitamins|mesh-ancestor
19913464|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
19913465|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541054|NCT01855763|Metformin|metformin|mesh-list
19913466|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913467|NCT01188876|Hematinics|hematinics|mesh-ancestor
19913468|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
19913469|NCT01188928|Betamethasone|betamethasone|mesh-list
19913470|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
19913471|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19913472|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
19913473|NCT01188928|Calcipotriene|calcipotriene|mesh-list
19913474|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19913475|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913476|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
19913477|NCT01188928|Hormones|hormones|mesh-ancestor
19913478|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913479|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913480|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19913481|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
19913482|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913483|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19913484|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19913485|NCT01189201|Linagliptin|linagliptin|mesh-list
19913486|NCT01189201|Empagliflozin|empagliflozin|mesh-list
19913487|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913488|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913489|NCT01189201|Incretins|incretins|mesh-ancestor
19913490|NCT01189201|Hormones|hormones|mesh-ancestor
19913491|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913492|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19913493|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
19913494|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913495|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913496|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19913497|NCT01189240|Bevacizumab|bevacizumab|mesh-list
19913498|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19913499|NCT01189240|Antibodies|antibodies|mesh-list
19913500|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
19913501|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19913502|NCT01189240|R04929097|r04929097|mesh-list
19913503|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913504|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19913505|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19913506|NCT01189240|Growth Substances|growth substances|mesh-ancestor
19913507|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913508|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
19913509|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
19913510|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913511|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260845|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260846|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260847|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
20260848|NCT00493987|Testosterone|testosterone|mesh-list
20260849|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
20260850|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
20260851|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20260852|NCT00493987|Dutasteride|dutasteride|mesh-list
20260853|NCT00493987|Androgens|androgens|mesh-ancestor
20260854|NCT00493987|Hormones|hormones|mesh-ancestor
20260855|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260856|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260857|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20260858|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260859|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
20260860|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20260861|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20260862|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260863|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260864|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
20260865|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
20260866|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
20260867|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20260868|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20260869|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260870|NCT00494104|Vitamin D|vitamin d|mesh-list
20260871|NCT00494104|Vitamins|vitamins|mesh-ancestor
20260872|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
20260873|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913512|NCT01189266|Vorinostat|vorinostat|mesh-list
19913513|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913514|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19913515|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913516|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913517|NCT01189279|Bimatoprost|bimatoprost|mesh-list
19913518|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19913519|NCT01189292|Dexamethasone|dexamethasone|mesh-list
19913520|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913521|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
19913522|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
19913523|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913524|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913525|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19913526|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
19913527|NCT01189292|Hormones|hormones|mesh-ancestor
19913528|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913529|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19913530|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913531|NCT01189370|Sorafenib|sorafenib|mesh-list
19913532|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913533|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19913534|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913535|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913536|NCT01189409|Sennosides|sennosides|mesh-list
19913537|NCT01189409|Laxatives|laxatives|mesh-ancestor
19913538|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19913539|NCT01189487|Ampicillin|ampicillin|mesh-list
19913540|NCT01189487|Sulbactam|sulbactam|mesh-list
19913541|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19913542|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913543|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19913544|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913545|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913546|NCT01189500|Tamoxifen|tamoxifen|mesh-list
19913547|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19913548|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19913549|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
19913550|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913551|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913552|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19913553|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913554|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19913555|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19913556|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19913557|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19913558|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19913559|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913560|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913561|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913562|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
19913563|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19913564|NCT01189604|Propofol|propofol|mesh-list
19913565|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19913566|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913567|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913568|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19913569|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
19913570|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
19913571|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19913572|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19913573|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19913574|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913575|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913576|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19913577|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913578|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913579|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
19913580|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913581|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19913582|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19913583|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19913584|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913585|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913586|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19913587|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913588|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913589|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
19913590|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913591|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
19913592|NCT01189812|Citalopram|citalopram|mesh-list
19913593|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
19913594|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19913595|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913596|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913597|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
19913598|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19913599|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913600|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913601|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19913602|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19913603|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913604|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913605|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
19913606|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19913607|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19913608|NCT01189890|Glimepiride|glimepiride|mesh-list
19913609|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913610|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913611|NCT01189890|Incretins|incretins|mesh-ancestor
19913612|NCT01189890|Hormones|hormones|mesh-ancestor
19913613|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913614|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19913615|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
19913616|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913617|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913618|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19913619|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913620|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
19913621|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
19913622|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19913623|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19913624|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
19913625|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913626|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19913627|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19913628|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19913629|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913630|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19913631|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913632|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19913633|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913634|NCT01190020|Lubiprostone|lubiprostone|mesh-list
19913635|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19913636|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913637|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913638|NCT01190098|Lacosamide|lacosamide|mesh-list
19913639|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
19913640|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19913641|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19913642|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913643|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913644|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
19913645|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19913646|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19913647|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913648|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
19913649|NCT01190150|Coagulants|coagulants|mesh-ancestor
19913650|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
19913651|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913652|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
19913653|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913654|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913655|NCT01190436|Bisoprolol|bisoprolol|mesh-list
19913656|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19913657|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
19913658|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
19913659|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913660|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913661|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19913662|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19913663|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19913664|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
19913665|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913666|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913667|NCT01190449|Ofatumumab|ofatumumab|mesh-list
19913668|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913669|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19913670|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19913671|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19913672|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19913673|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913674|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913675|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913676|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
19913677|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19913678|NCT01190813|Levodopa|levodopa|mesh-list
20260874|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20260875|NCT00494156|Aspirin|aspirin|mesh-list
20260876|NCT00494156|Heparin|heparin|mesh-list
20260877|NCT00494156|Clopidogrel|clopidogrel|mesh-list
20260878|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20260879|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20260880|NCT00494156|Analgesics|analgesics|mesh-ancestor
20260881|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
20260882|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260883|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260884|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260885|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20260886|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20260887|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20260888|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541055|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20541056|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541057|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20541058|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
20541059|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541060|NCT01855971|Protective Agents|protective agents|mesh-ancestor
20541061|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541062|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20541063|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20541064|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541065|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20541066|NCT01855984|Tocotrienols|tocotrienols|mesh-list
20541067|NCT01855984|Vitamin E|vitamin e|mesh-list
20541068|NCT01855984|Tocopherols|tocopherols|mesh-list
20541069|NCT01855984|Tocovid|tocovid|mesh-list
20541070|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
20541071|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541072|NCT01855984|Protective Agents|protective agents|mesh-ancestor
20541073|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541074|NCT01855984|Vitamins|vitamins|mesh-ancestor
20541075|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
20541076|NCT01856023|Aldesleukin|aldesleukin|mesh-list
20541077|NCT01856023|Ipilimumab|ipilimumab|mesh-list
20260889|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20287045|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20287046|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20287047|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287048|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20287049|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
20287050|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287051|NCT05332717|Ascorbic Acid|ascorbic acid|mesh-list
20287052|NCT05332717|Melatonin|melatonin|mesh-list
20287053|NCT05332717|Vitamins|vitamins|mesh-ancestor
20287054|NCT05332717|Micronutrients|micronutrients|mesh-ancestor
20287055|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287056|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
20287057|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287058|NCT05332717|Protective Agents|protective agents|mesh-ancestor
20287059|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287060|NCT05332561|Trastuzumab|trastuzumab|mesh-list
19913679|NCT01190813|Carbidopa|carbidopa|mesh-list
19913680|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19913681|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19913682|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
19913683|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913684|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913685|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913686|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19913687|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913688|NCT01190839|Infliximab|infliximab|mesh-list
19913689|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913690|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19913691|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913692|NCT01190878|Bromfenac|bromfenac|mesh-list
19913693|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19913694|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19913695|NCT01190878|Analgesics|analgesics|mesh-ancestor
19913696|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
19913697|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913698|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913699|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913700|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913701|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
19913702|NCT01190930|Leucovorin|leucovorin|mesh-list
19913703|NCT01190930|Folic Acid|folic acid|mesh-list
19913704|NCT01190930|Cytarabine|cytarabine|mesh-list
19913705|NCT01190930|Dexamethasone|dexamethasone|mesh-list
19913706|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
19913707|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
19913708|NCT01190930|Doxorubicin|doxorubicin|mesh-list
19913709|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19913710|NCT01190930|Methotrexate|methotrexate|mesh-list
19913711|NCT01190930|Vincristine|vincristine|mesh-list
19913712|NCT01190930|Asparaginase|asparaginase|mesh-list
19913713|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
19913714|NCT01190930|Pegaspargase|pegaspargase|mesh-list
19913715|NCT01190930|Thioguanine|thioguanine|mesh-list
19913716|NCT01190930|BB 1101|bb 1101|mesh-list
19913717|NCT01190930|Calcium|calcium|mesh-list
19913718|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
19913719|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
19913720|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913721|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
19913722|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913723|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19913724|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19913725|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
19913726|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913727|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913728|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19913729|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913730|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
19913731|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
19913732|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913733|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19913734|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
19913735|NCT01190930|Hormones|hormones|mesh-ancestor
19913736|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913737|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19913738|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
19913739|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913740|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19913741|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19913742|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19913743|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19913744|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19913745|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19913746|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
19913747|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913748|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913749|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
19913750|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913751|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19913752|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19913753|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
19913754|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913755|NCT01190930|Antidotes|antidotes|mesh-ancestor
19913756|NCT01190930|Protective Agents|protective agents|mesh-ancestor
19913757|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
19913758|NCT01190930|Vitamins|vitamins|mesh-ancestor
19913759|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
19913760|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19913761|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
19913762|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
19913763|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
19913764|NCT01190930|Hematinics|hematinics|mesh-ancestor
19913765|NCT01191008|Timolol|timolol|mesh-list
19913766|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19913767|NCT01191008|Latanoprost|latanoprost|mesh-list
19913768|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19913769|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19913770|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19913771|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
19913772|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913773|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913774|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913775|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19913776|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19913777|NCT01191086|Topiramate|topiramate|mesh-list
19913778|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
19913779|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913780|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913781|NCT01191190|Ofatumumab|ofatumumab|mesh-list
19913782|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913783|NCT01191255|Sevelamer|sevelamer|mesh-list
19913784|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
19913785|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
19913786|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913787|NCT01191268|Insulin|insulin|mesh-list
19913788|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19913789|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
19913790|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
19913791|NCT01191268|Dulaglutide|dulaglutide|mesh-list
19913792|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913793|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913794|NCT01191320|Enclomiphene|enclomiphene|mesh-list
19913795|NCT01191320|Clomiphene|clomiphene|mesh-list
19913796|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
19913797|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19913798|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
19913799|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913800|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913801|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19913802|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
19913803|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19913804|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19913805|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19913806|NCT01191398|Atropine|atropine|mesh-list
19913807|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
19913808|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19913809|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19913810|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19913811|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
19913812|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913813|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913814|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19913815|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
19913816|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
19913817|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
19913818|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19913819|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19913820|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
19913821|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913822|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913823|NCT01191476|Propofol|propofol|mesh-list
19913824|NCT01191476|Sevoflurane|sevoflurane|mesh-list
19913825|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19913826|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913827|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913828|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19913829|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
19913830|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
19913831|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19913832|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19913833|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
19913834|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19913835|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913836|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19913837|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19913838|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913839|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913840|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913841|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
19913842|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19913843|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913844|NCT01191762|Sevelamer|sevelamer|mesh-list
19913845|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
19913846|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
19913847|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972108|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19972109|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
19972110|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19972111|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19972112|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972113|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972114|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19972115|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19972116|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
19972117|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20260890|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20260891|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260892|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
20260893|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20260894|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20260895|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20260896|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
20260897|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972118|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19972119|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972120|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19972121|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19972122|NCT01807000|Prucalopride|prucalopride|mesh-list
19972123|NCT01807000|Laxatives|laxatives|mesh-ancestor
19972124|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19972125|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19972126|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19972127|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
19972128|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972129|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972130|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975373|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975374|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975375|NCT01848054|Analgesics|analgesics|mesh-ancestor
19975376|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
19975377|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975378|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19975379|NCT01848067|Prednisone|prednisone|mesh-list
19975380|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
19975381|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975382|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
19975383|NCT01848067|Hormones|hormones|mesh-ancestor
19975384|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975385|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975386|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19975387|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260898|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
20260899|NCT00494208|Testosterone|testosterone|mesh-list
20260900|NCT00494208|Androgens|androgens|mesh-ancestor
20260901|NCT00494208|Hormones|hormones|mesh-ancestor
20260902|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260903|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260904|NCT00494247|Antibodies|antibodies|mesh-list
20541078|NCT01856023|Interleukin-2|interleukin-2|mesh-list
20541079|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541080|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541081|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20541082|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260905|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
20260906|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260907|NCT00494312|Pioglitazone|pioglitazone|mesh-list
20260908|NCT00494312|Glyburide|glyburide|mesh-list
20260909|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20260910|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260911|NCT00494338|Docetaxel|docetaxel|mesh-list
20260912|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260913|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
20260914|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
20260915|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
20541083|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541084|NCT01856023|Analgesics|analgesics|mesh-ancestor
20541085|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
20541086|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541087|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541088|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20541089|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20541090|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
20541091|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541092|NCT01856062|Dexamethasone|dexamethasone|mesh-list
20541093|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913848|NCT01191801|Cytarabine|cytarabine|mesh-list
19913849|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19913850|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
19913851|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913852|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913853|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
19913854|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913855|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913856|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
19913857|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913858|NCT01191840|Vancomycin|vancomycin|mesh-list
19913859|NCT01191840|Cefazolin|cefazolin|mesh-list
19913860|NCT01191840|Daptomycin|daptomycin|mesh-list
19913861|NCT01191840|Cloxacillin|cloxacillin|mesh-list
19913862|NCT01191840|Oxacillin|oxacillin|mesh-list
19913863|NCT01191840|Nafcillin|nafcillin|mesh-list
19913864|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19913865|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19913866|NCT01191944|Pramipexole|pramipexole|mesh-list
19913867|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
19913868|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913869|NCT01191944|Protective Agents|protective agents|mesh-ancestor
19913870|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913871|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19913872|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19913873|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
19913874|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
19913875|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913876|NCT01192139|Metformin|metformin|mesh-list
19913877|NCT01192139|Saxagliptin|saxagliptin|mesh-list
19913878|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913879|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913880|NCT01192139|Incretins|incretins|mesh-ancestor
19913881|NCT01192139|Hormones|hormones|mesh-ancestor
19913882|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913883|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19913884|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
19913885|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913886|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913887|NCT01192152|Metformin|metformin|mesh-list
19913888|NCT01192152|Saxagliptin|saxagliptin|mesh-list
19913889|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913890|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913891|NCT01192152|Incretins|incretins|mesh-ancestor
19913892|NCT01192152|Hormones|hormones|mesh-ancestor
19913893|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913894|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19913895|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
19449951|NCT03431961|Triamcinolone|triamcinolone|mesh-list
19449952|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19449953|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19449954|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19913896|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972131|NCT01807221|Eplerenone|eplerenone|mesh-list
20260916|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541094|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
20541095|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
19449955|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19449956|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
19913897|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913898|NCT01192178|Fluticasone|fluticasone|mesh-list
19913899|NCT01192178|Xhance|xhance|mesh-list
19913900|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19913901|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19913902|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913903|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19913904|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
19913905|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913906|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913907|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19913908|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
19913909|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913910|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19913911|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19913912|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19913913|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19913914|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
19913915|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913916|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913917|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
19913918|NCT01192178|Hormones|hormones|mesh-ancestor
19913919|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913920|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
19913921|NCT01192191|Fluticasone|fluticasone|mesh-list
19913922|NCT01192191|Xhance|xhance|mesh-list
19913923|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913924|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19913925|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
19913926|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913927|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913928|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19913929|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
19913930|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19913931|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19913932|NCT01192295|Oxycodone|oxycodone|mesh-list
19913933|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19913934|NCT01192295|Narcotics|narcotics|mesh-ancestor
19913935|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913936|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913937|NCT01192295|Analgesics|analgesics|mesh-ancestor
19913938|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
19913939|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913940|NCT01192399|Eculizumab|eculizumab|mesh-list
19913941|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19913942|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19913943|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
19913944|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913945|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19913946|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913947|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19913948|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19913949|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913950|NCT01193049|Prednisone|prednisone|mesh-list
19913951|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913952|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
19913953|NCT01193049|Hormones|hormones|mesh-ancestor
19913954|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913955|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913956|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19913957|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913958|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19913959|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19913960|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913961|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19913962|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19913963|NCT01193127|Mydriatics|mydriatics|mesh-list
19913964|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
19913965|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19913966|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260917|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19449957|NCT03431961|Hormones|hormones|mesh-ancestor
19913967|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19449958|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19449959|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449960|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19449961|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
19449962|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449963|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449964|NCT03431909|Aspirin|aspirin|mesh-list
19449965|NCT03431909|Kallikreins|kallikreins|mesh-list
19449966|NCT03431909|Clopidogrel|clopidogrel|mesh-list
19449967|NCT03431909|Atorvastatin|atorvastatin|mesh-list
19449968|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19449969|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19449970|NCT03431909|Analgesics|analgesics|mesh-ancestor
19449971|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
19449972|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19449973|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449974|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913968|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19913969|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19913970|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19913971|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913972|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19913973|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19913974|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19913975|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
19913976|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19913977|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913978|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19913979|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19913980|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
19913981|NCT01193218|Empagliflozin|empagliflozin|mesh-list
19913982|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19913983|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19913984|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19913985|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913986|NCT01193244|Prednisone|prednisone|mesh-list
19913987|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913988|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
19913989|NCT01193244|Hormones|hormones|mesh-ancestor
19913990|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913991|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19913992|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19913993|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19913994|NCT01193257|Prednisone|prednisone|mesh-list
19913995|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19913996|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
19913997|NCT01193257|Hormones|hormones|mesh-ancestor
19913998|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19913999|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914000|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19914001|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914002|NCT01193283|Cyclosporine|cyclosporine|mesh-list
19914003|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
19914004|NCT01193283|Cyclosporins|cyclosporins|mesh-list
19914005|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914006|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
19914007|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260918|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20260919|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20260920|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20260921|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260922|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260923|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260924|NCT00494377|Analgesics|analgesics|mesh-ancestor
20260925|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
20260926|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260927|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
20260928|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20260929|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
20260930|NCT00494429|Morphine|morphine|mesh-list
20260931|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20260932|NCT00494429|Narcotics|narcotics|mesh-ancestor
19914008|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914009|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19914010|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
19914011|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914012|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914013|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19914014|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914015|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
19914016|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914017|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
19914018|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19914019|NCT01193335|Vaccines|vaccines|mesh-list
19914020|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19914021|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
19914022|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914023|NCT01193348|Eculizumab|eculizumab|mesh-list
19914024|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19914025|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914026|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
19914027|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914028|NCT01193517|Capecitabine|capecitabine|mesh-list
19914029|NCT01193517|Azacitidine|azacitidine|mesh-list
20260933|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20260934|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260935|NCT00494429|Analgesics|analgesics|mesh-ancestor
20260936|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
20260937|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260938|NCT00494468|Zolpidem|zolpidem|mesh-list
20260939|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20260940|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20260941|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20260942|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260943|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20260944|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
20260945|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
20260946|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20260947|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260948|NCT00494533|Treprostinil|treprostinil|mesh-list
20260949|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20260950|NCT00494559|Pioglitazone|pioglitazone|mesh-list
20260951|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20260952|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260953|NCT00494572|Montelukast|montelukast|mesh-list
20260954|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20260955|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
20260956|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20260957|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
20260958|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260959|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260960|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20260961|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20260962|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260963|NCT00494598|Sufentanil|sufentanil|mesh-list
20260964|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20260965|NCT00494598|Narcotics|narcotics|mesh-ancestor
20260966|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20260967|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260968|NCT00494598|Analgesics|analgesics|mesh-ancestor
20541096|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914030|NCT01193517|Decitabine|decitabine|mesh-list
19914031|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
19914032|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914033|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
19914034|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914035|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914036|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914037|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19914038|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
19914039|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914040|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
19914041|NCT01193660|Hematinics|hematinics|mesh-ancestor
19914042|NCT01193868|R04929097|r04929097|mesh-list
19914043|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914044|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914045|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19914046|NCT01193920|Vaccines|vaccines|mesh-list
19914047|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
19914048|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914049|NCT01194089|Nicotine|nicotine|mesh-list
19914050|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19914051|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
19914052|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914053|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914054|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19914055|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19914056|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
19914057|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914058|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914059|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
19914060|NCT01194154|Hematinics|hematinics|mesh-ancestor
19914061|NCT01194245|Insulin|insulin|mesh-list
19914062|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19914063|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
19914064|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
19914065|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
19914066|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
19914067|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19914068|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914069|NCT01194258|Insulin|insulin|mesh-list
19914070|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19914071|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
19914072|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
19914073|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
19914074|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
19914075|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19914076|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914077|NCT01194271|Ipilimumab|ipilimumab|mesh-list
19914078|NCT01194271|Leuprolide|leuprolide|mesh-list
19914079|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914080|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914081|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19914082|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914083|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19914084|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
19914085|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19914086|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914087|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19914088|NCT01194297|Vaccines|vaccines|mesh-list
19914089|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
19914090|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914091|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
19914092|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
19914093|NCT01194440|Letrozole|letrozole|mesh-list
19914094|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914095|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19914096|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19914097|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914098|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914099|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19914100|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
19914101|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260969|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
19914102|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914103|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19914104|NCT01194453|Folic Acid|folic acid|mesh-list
19914105|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
19914106|NCT01194453|Hydroxocobalamin|hydroxocobalamin|mesh-list
19914107|NCT01194453|Gemcitabine|gemcitabine|mesh-list
19914108|NCT01194453|Dexamethasone|dexamethasone|mesh-list
19914109|NCT01194453|Cisplatin|cisplatin|mesh-list
19914110|NCT01194453|Vitamins|vitamins|mesh-ancestor
19914111|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
19914112|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914113|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914114|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914115|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
19914116|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
19914117|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914118|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19914119|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
19914120|NCT01194453|Hormones|hormones|mesh-ancestor
19914121|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914122|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19914123|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914124|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
19914125|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914126|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
19914127|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914128|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914129|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914130|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
19914131|NCT01194453|Hematinics|hematinics|mesh-ancestor
19914132|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
19914133|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
19914134|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19914135|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
19914136|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914137|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914138|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19914139|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
19914140|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19914141|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19914142|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19914143|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
19914144|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914145|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914146|NCT01194674|Plasminogen|plasminogen|mesh-list
19914147|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19914148|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19914149|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914150|NCT01194804|Eculizumab|eculizumab|mesh-list
19914151|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19914152|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914153|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
19914154|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914155|NCT01194830|Linagliptin|linagliptin|mesh-list
19914156|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19914157|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914158|NCT01194830|Incretins|incretins|mesh-ancestor
19914159|NCT01194830|Hormones|hormones|mesh-ancestor
19914160|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914161|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19914162|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
19914163|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914164|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914165|NCT01194869|Paclitaxel|paclitaxel|mesh-list
19914166|NCT01194869|Cisplatin|cisplatin|mesh-list
19914167|NCT01194869|Sorafenib|sorafenib|mesh-list
19914168|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914169|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914170|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914171|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914172|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914173|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914174|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19914175|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914176|NCT01194973|Eculizumab|eculizumab|mesh-list
19914177|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19914178|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914179|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
19914180|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914181|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19914182|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
19914183|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
19914184|NCT01195090|Pioglitazone|pioglitazone|mesh-list
19914185|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19914186|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19914187|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914188|NCT01195090|Incretins|incretins|mesh-ancestor
19914189|NCT01195090|Hormones|hormones|mesh-ancestor
19914190|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914191|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19914192|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
19914193|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914194|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914195|NCT01195103|Fentanyl|fentanyl|mesh-list
19914196|NCT01195103|Midazolam|midazolam|mesh-list
19914197|NCT01195103|Propofol|propofol|mesh-list
19914198|NCT01195103|Fospropofol|fospropofol|mesh-list
19914199|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19914200|NCT01195103|Narcotics|narcotics|mesh-ancestor
19914201|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19914202|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914203|NCT01195103|Analgesics|analgesics|mesh-ancestor
19914204|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
19914205|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914206|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19914207|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19914208|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
19914209|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
19914210|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19914211|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19914212|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19914213|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19914214|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
19914215|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
19914216|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914217|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914218|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
19914219|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19914220|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19914221|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914222|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914223|NCT01195116|Analgesics|analgesics|mesh-ancestor
19914224|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
19914225|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914226|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19914227|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19914228|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19914229|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
19914230|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914231|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914232|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19914233|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
19914234|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19914235|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19914236|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19914237|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19914238|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914239|NCT01195415|Gemcitabine|gemcitabine|mesh-list
19914240|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914241|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
19914242|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914243|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914244|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
19914245|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914246|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914247|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914248|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
19914249|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914250|NCT01195467|Tenofovir|tenofovir|mesh-list
19914251|NCT01195467|Emtricitabine|emtricitabine|mesh-list
19914252|NCT01195467|Efavirenz|efavirenz|mesh-list
19914253|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
19914254|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19914255|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
19914256|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914257|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19914258|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19914259|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914260|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914261|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19914262|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19914263|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19914264|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19914265|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19914266|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19914267|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19914268|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19914269|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19914270|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19914271|NCT01195597|Nicotine|nicotine|mesh-list
19914272|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19914273|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
19914274|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914275|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914276|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19914277|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19914278|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
19914279|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914280|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914281|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
19914282|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19914283|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914284|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19914285|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914286|NCT01195675|Empagliflozin|empagliflozin|mesh-list
19914287|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
19914288|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19914289|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914290|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19914291|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19914292|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914293|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914294|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914295|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914296|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19914297|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19914298|NCT01195779|Vaccines|vaccines|mesh-list
19914299|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
19914300|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914301|NCT01195831|Calcipotriene|calcipotriene|mesh-list
19914302|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
19914303|NCT01195922|Sirolimus|sirolimus|mesh-list
19914304|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19914305|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914306|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19914307|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914308|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
19914309|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914310|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
19914311|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914312|NCT01196052|Trastuzumab|trastuzumab|mesh-list
19914313|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19914314|NCT01196052|Maytansine|maytansine|mesh-list
19914315|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914316|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914317|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914318|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914319|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914320|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914321|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914322|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19914323|NCT01196078|Vinorelbine|vinorelbine|mesh-list
19914324|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914325|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19914326|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914327|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914328|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914329|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914330|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914331|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914332|NCT01196091|Antimalarials|antimalarials|mesh-list
19914333|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19914334|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19914335|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19914336|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914337|NCT01196091|Analgesics|analgesics|mesh-ancestor
19914338|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
19914339|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914340|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914341|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914342|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
19914343|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19914344|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19914345|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914346|NCT01196104|Insulin|insulin|mesh-list
19914347|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19914348|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
19914349|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
19914350|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19914351|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914352|NCT01196377|Albuterol|albuterol|mesh-list
19914353|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19914354|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
19914355|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914356|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914357|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19914358|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
19914359|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
19914360|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19914361|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19914362|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19914363|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19914364|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
19914365|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914366|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914367|NCT01196416|Cisplatin|cisplatin|mesh-list
19914368|NCT01196416|Temozolomide|temozolomide|mesh-list
19914369|NCT01196416|Vinblastine|vinblastine|mesh-list
19914370|NCT01196416|R04929097|r04929097|mesh-list
19914371|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914372|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19914373|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
19914374|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914375|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914376|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914377|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914378|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914379|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914380|NCT01196429|Sirolimus|sirolimus|mesh-list
19914381|NCT01196429|Paclitaxel|paclitaxel|mesh-list
19914382|NCT01196429|Docetaxel|docetaxel|mesh-list
19914383|NCT01196429|Carboplatin|carboplatin|mesh-list
19914384|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19914385|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914386|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260970|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20260971|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20260972|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20260973|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
20260974|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
20260975|NCT00494611|Cetuximab|cetuximab|mesh-list
20260976|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20260977|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260978|NCT00494624|Prednisolone|prednisolone|mesh-list
20260979|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20260980|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
20260981|NCT00494624|Hormones|hormones|mesh-ancestor
20260982|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260983|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260984|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20260985|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20260986|NCT00494663|Ketoconazole|ketoconazole|mesh-list
20260987|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
20260988|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20260989|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20260990|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20260991|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20260992|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20260993|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20260994|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
20260995|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20260996|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20260997|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20260998|NCT00494715|Valsartan|valsartan|mesh-list
20260999|NCT00494715|Benazepril|benazepril|mesh-list
20261000|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19914387|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914388|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914389|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914390|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914391|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19914392|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914393|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19914394|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
19914395|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914396|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
19914397|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914398|NCT01196741|Paclitaxel|paclitaxel|mesh-list
19914399|NCT01196741|Saracatinib|saracatinib|mesh-list
19914400|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914401|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914402|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914403|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914404|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914405|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914406|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914407|NCT01196975|Vaccines|vaccines|mesh-list
19914408|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
19914409|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914410|NCT01196988|Vaccines|vaccines|mesh-list
19914411|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
19914412|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914413|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
19914414|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19914415|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972132|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19972133|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
19972134|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972135|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972136|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19972137|NCT01807221|Diuretics|diuretics|mesh-ancestor
19972138|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
19972139|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19972140|NCT01807234|Ketorolac|ketorolac|mesh-list
19972141|NCT01807234|Sumatriptan|sumatriptan|mesh-list
19972142|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19972143|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19972144|NCT01807234|Analgesics|analgesics|mesh-ancestor
19972145|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
19972146|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972147|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972148|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972149|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972150|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19972151|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972152|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972153|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19972154|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19972155|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19972156|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
19972157|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972158|NCT01807455|Lidocaine|lidocaine|mesh-list
19972159|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
19972160|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
19972161|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972162|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972163|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
20541097|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449975|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19449976|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19449977|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19449978|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19449979|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19449980|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19449981|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19449982|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
19449983|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19449984|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19449985|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
19449986|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19449987|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19449988|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19914416|NCT01197378|Cysteamine|cysteamine|mesh-list
19914417|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19914418|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914419|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
19914420|NCT01197417|Analgesics|analgesics|mesh-ancestor
19914421|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
19914422|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914423|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914424|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
19914425|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19914426|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19914427|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
19914428|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19914429|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19914430|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914431|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19914432|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
19914433|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19914434|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
19914435|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19914436|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
19914437|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914438|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
19914439|NCT01197495|Protective Agents|protective agents|mesh-ancestor
19914440|NCT01197560|Gemcitabine|gemcitabine|mesh-list
19914441|NCT01197560|Rituximab|rituximab|mesh-list
19914442|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
19914443|NCT01197560|Etoposide|etoposide|mesh-list
19914444|NCT01197560|Lenalidomide|lenalidomide|mesh-list
19914445|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914446|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914447|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
19914448|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914449|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914450|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914451|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
19914452|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914453|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
19914454|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914455|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914456|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914457|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914458|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19914459|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19914460|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19914461|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19914462|NCT01197560|Growth Substances|growth substances|mesh-ancestor
19914463|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
19914464|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19914465|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19914466|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20261001|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20261002|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20261003|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261004|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20261005|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
20261006|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261007|NCT00494728|Nicotine|nicotine|mesh-list
20261008|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20261009|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
20261010|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261011|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261012|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20261013|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20261014|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
20261015|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261016|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261017|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
20261018|NCT00494741|Azathioprine|azathioprine|mesh-list
20261019|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20261020|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261021|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20261022|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
20261023|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19914467|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914468|NCT01197612|Budesonide|budesonide|mesh-list
19914469|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914470|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19914471|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
19914472|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914473|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914474|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19914475|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
19914476|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
19914477|NCT01197612|Hormones|hormones|mesh-ancestor
19914478|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914479|NCT01197833|Polidocanol|polidocanol|mesh-list
19914480|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19914481|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20261024|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261025|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261026|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261027|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
20261028|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261029|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261030|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
20261031|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261032|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20261033|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
20261034|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20261035|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261036|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261037|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20261038|NCT00494832|Analgesics|analgesics|mesh-ancestor
20261039|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
20541098|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541099|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
20541100|NCT01856062|Hormones|hormones|mesh-ancestor
20541101|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541102|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20541103|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541104|NCT01856101|Dactolisib|dactolisib|mesh-list
20541105|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541106|NCT01856127|Sertraline|sertraline|mesh-list
20541107|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20541108|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
20541109|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20541110|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20541111|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20541112|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541113|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541114|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541115|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
20541116|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541117|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20541118|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20541119|NCT01856166|Sufentanil|sufentanil|mesh-list
20541120|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
20541121|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
20541122|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
19449989|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20541123|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541124|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541125|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
20541126|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541127|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20541128|NCT01856166|Narcotics|narcotics|mesh-ancestor
20541129|NCT01856166|Analgesics|analgesics|mesh-ancestor
20541130|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20541131|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20541132|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
20541133|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
19914482|NCT01198002|Methotrexate|methotrexate|mesh-list
19914483|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19914484|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
19914485|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19914486|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914487|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914488|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
19914489|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914490|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914491|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
19914492|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914493|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19914494|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914495|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
19914496|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914497|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19914498|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19914499|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914500|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19914501|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914502|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914503|NCT01198132|Vitamin D|vitamin d|mesh-list
19914504|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
19914505|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
19914506|NCT01198132|Vitamins|vitamins|mesh-list
19914507|NCT01198132|Interferons|interferons|mesh-list
19914508|NCT01198132|Interferon-beta|interferon-beta|mesh-list
19914509|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
19914510|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
19914511|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914512|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19914513|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19914514|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914515|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
19914516|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914517|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
19914518|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19914519|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
19914520|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914521|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19914522|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914523|NCT01198145|Analgesics|analgesics|mesh-ancestor
19914524|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
19914525|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914526|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914527|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914528|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914529|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19914530|NCT01198158|Bevacizumab|bevacizumab|mesh-list
19914531|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19914532|NCT01198158|Everolimus|everolimus|mesh-list
19914533|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
19914534|NCT01198158|Antibodies|antibodies|mesh-list
19914535|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
19914536|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19914537|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
19914538|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914539|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19914540|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19914541|NCT01198158|Growth Substances|growth substances|mesh-ancestor
19914542|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914543|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
19914544|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
19914545|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914546|NCT01198275|Amiodarone|amiodarone|mesh-list
19914547|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19914548|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
19914549|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19914550|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19914551|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914552|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19914553|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19914554|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19914555|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914556|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19914557|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19914558|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19914559|NCT01198327|Ranibizumab|ranibizumab|mesh-list
19914560|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19914561|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19914562|NCT01198327|Growth Substances|growth substances|mesh-ancestor
19914563|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914564|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
19914565|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914566|NCT01198509|Vancomycin|vancomycin|mesh-list
19914567|NCT01198509|Doxycycline|doxycycline|mesh-list
19914568|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19914569|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914570|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
19914571|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19914572|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19914573|NCT01198574|Vitamins|vitamins|mesh-list
19914574|NCT01198574|Folic Acid|folic acid|mesh-list
19914575|NCT01198574|Vitamin A|vitamin a|mesh-list
19914576|NCT01198574|Iron|iron|mesh-list
19914577|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
19914578|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
19914579|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914580|NCT01198574|Trace Elements|trace elements|mesh-ancestor
19914581|NCT01198574|Hematinics|hematinics|mesh-ancestor
19914582|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
19914583|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
19914584|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914585|NCT01198574|Protective Agents|protective agents|mesh-ancestor
19914586|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19914587|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914588|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
19914589|NCT01198587|Astringents|astringents|mesh-ancestor
19914590|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914591|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
20261040|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914592|NCT01198756|Vaccines|vaccines|mesh-list
19914593|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
19914594|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914595|NCT01198795|Citalopram|citalopram|mesh-list
19914596|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19914597|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19914598|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19914599|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914600|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914601|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
19914602|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914603|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19914604|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
19914605|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19914606|NCT01198873|Dronedarone|dronedarone|mesh-list
19914607|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19914608|NCT01199055|Paclitaxel|paclitaxel|mesh-list
19914609|NCT01199055|Carboplatin|carboplatin|mesh-list
19914610|NCT01199055|Efatutazone|efatutazone|mesh-list
19914611|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914612|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914613|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914614|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914615|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914616|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914617|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19914618|NCT01199068|Efatutazone|efatutazone|mesh-list
19914619|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914620|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19914621|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914622|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914623|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
19914624|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914625|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19914626|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914627|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914628|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
19914629|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914630|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261041|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19914631|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19914632|NCT01199198|Tolvaptan|tolvaptan|mesh-list
19914633|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19914634|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914635|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
19914636|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914637|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
19914638|NCT01199237|Sevoflurane|sevoflurane|mesh-list
19914639|NCT01199237|Desflurane|desflurane|mesh-list
19914640|NCT01199237|Rocuronium|rocuronium|mesh-list
19914641|NCT01199237|Neostigmine|neostigmine|mesh-list
19914642|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19914643|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19914644|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
19914645|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
19914646|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19914647|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914648|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19914649|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19914650|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19914651|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914652|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19914653|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914654|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914655|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
19914656|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914657|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19914658|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
19914659|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19914660|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19914661|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19914662|NCT01199263|Paclitaxel|paclitaxel|mesh-list
19914663|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19914664|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914665|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914666|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914667|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914668|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914669|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914670|NCT01199289|Brodalumab|brodalumab|mesh-list
19914671|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
19914672|NCT01199575|Rituximab|rituximab|mesh-list
19914673|NCT01199575|Lenalidomide|lenalidomide|mesh-list
19914674|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914675|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914676|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
19914677|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914678|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914679|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19914680|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19914681|NCT01199575|Growth Substances|growth substances|mesh-ancestor
19914682|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
19914683|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
19914684|NCT01199705|Antibodies|antibodies|mesh-list
19914685|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
19914686|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19449990|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19449991|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
19449992|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914687|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19914688|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
19914689|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914690|NCT01199731|Etravirine|etravirine|mesh-list
19914691|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19914692|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19914693|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914694|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914695|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
19914696|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914697|NCT01199744|Zanamivir|zanamivir|mesh-list
19914698|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
19914699|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914700|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914701|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914702|NCT01199822|Olaratumab|olaratumab|mesh-list
19914703|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914704|NCT01199861|Vaccines|vaccines|mesh-list
19914705|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19914706|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
19914707|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914708|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19914709|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914710|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914711|NCT01199926|Vitamin D|vitamin d|mesh-list
19914712|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
19914713|NCT01199926|Vitamins|vitamins|mesh-ancestor
19914714|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
19914715|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914716|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19914717|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19914718|NCT01199939|Ritonavir|ritonavir|mesh-list
19914719|NCT01199939|Darunavir|darunavir|mesh-list
19914720|NCT01199939|Etravirine|etravirine|mesh-list
19914721|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19914722|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19914723|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
19914724|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914725|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914726|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19914727|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19914728|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
19914729|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914730|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19914731|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19914732|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19914733|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19914734|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
19914735|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19914736|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
19914737|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
19914738|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914739|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914740|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914741|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914742|NCT01199965|Analgesics|analgesics|mesh-ancestor
19914743|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
19914744|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914745|NCT01200069|Ibuprofen|ibuprofen|mesh-list
19914746|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19914747|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914748|NCT01200069|Analgesics|analgesics|mesh-ancestor
19914749|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
19914750|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914751|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914752|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914753|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914754|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19914755|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914756|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914757|NCT01200160|Niacin|niacin|mesh-list
19914758|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19914759|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
19914760|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914761|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19914762|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
19914763|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
19914764|NCT01200160|Vitamins|vitamins|mesh-ancestor
19914765|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
19914766|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914767|NCT01200329|Gemcitabine|gemcitabine|mesh-list
19914768|NCT01200329|Melphalan|melphalan|mesh-list
19914769|NCT01200329|Busulfan|busulfan|mesh-list
19914770|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914771|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
19914772|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914773|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914774|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
19914775|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914776|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914777|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914778|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
19914779|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261042|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20261043|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20261044|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
20261045|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261046|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261047|NCT00494884|Vildagliptin|vildagliptin|mesh-list
20261048|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20261049|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261050|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20261051|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
20261052|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261053|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261054|NCT00494897|Cytarabine|cytarabine|mesh-list
20261055|NCT00494897|Prednisone|prednisone|mesh-list
20261056|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
20261057|NCT00494897|Methotrexate|methotrexate|mesh-list
20261058|NCT00494897|Vincristine|vincristine|mesh-list
20261059|NCT00494897|Daunorubicin|daunorubicin|mesh-list
20261060|NCT00494897|Asparaginase|asparaginase|mesh-list
20261061|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
20261062|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261063|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
20261064|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261065|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20261066|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20261067|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
20261068|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261069|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261070|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20261071|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20261072|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
20261073|NCT00494897|Hormones|hormones|mesh-ancestor
20261074|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261075|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20261076|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20261077|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
20261078|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261079|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261080|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
20261081|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
20261082|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261083|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20261084|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20261085|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
20261086|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261087|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20261088|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261089|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
20261090|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261091|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20261092|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20261093|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20261094|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20261095|NCT00494988|Insulin|insulin|mesh-list
20261096|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20261097|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
20261098|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
20261099|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
20261100|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
19914780|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19914781|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
19914782|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19914783|NCT01200342|Paclitaxel|paclitaxel|mesh-list
19914784|NCT01200342|Carboplatin|carboplatin|mesh-list
19914785|NCT01200342|Oblimersen|oblimersen|mesh-list
19914786|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914787|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914788|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914789|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914790|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261101|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20261102|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914791|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261103|NCT00495027|Vaccines|vaccines|mesh-list
19914792|NCT01200355|Posaconazole|posaconazole|mesh-list
19914793|NCT01200355|Micafungin|micafungin|mesh-list
19914794|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
19914795|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914796|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19914797|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19914798|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19914799|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19914800|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19914801|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914802|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914803|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19914804|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
19914805|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914806|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914807|NCT01200368|Vaccines|vaccines|mesh-list
19914808|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19914809|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
19914810|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914811|NCT01200407|Amlodipine|amlodipine|mesh-list
19914812|NCT01200407|Olmesartan|olmesartan|mesh-list
19914813|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19914814|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19914815|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19914816|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19914817|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914818|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19914819|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914820|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
19914821|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19914822|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19914823|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
19914824|NCT01200433|Propofol|propofol|mesh-list
19914825|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19914826|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19914827|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914828|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19914829|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
19914830|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
19914831|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914832|NCT01200433|Analgesics|analgesics|mesh-ancestor
19914833|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
19914834|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914835|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19914836|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19914837|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19914838|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19914839|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19914840|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914841|NCT01200485|Allopurinol|allopurinol|mesh-list
19914842|NCT01200485|Rasburicase|rasburicase|mesh-list
19914843|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
19914844|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914845|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914846|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
19914847|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914848|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19914849|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
19914850|NCT01200485|Protective Agents|protective agents|mesh-ancestor
19914851|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914852|NCT01200589|Rituximab|rituximab|mesh-list
19914853|NCT01200589|Ofatumumab|ofatumumab|mesh-list
19914854|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19914855|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914856|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914857|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
19914858|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914859|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914860|NCT01200758|Prednisone|prednisone|mesh-list
19914861|NCT01200758|Prednisolone|prednisolone|mesh-list
19914862|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
19914863|NCT01200758|Rituximab|rituximab|mesh-list
19914864|NCT01200758|Doxorubicin|doxorubicin|mesh-list
19914865|NCT01200758|Vincristine|vincristine|mesh-list
19914866|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914867|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
19914868|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914869|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914870|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19914871|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
19914872|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914873|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914874|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19914875|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914876|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19914877|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19914878|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19914879|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914880|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914881|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
19914882|NCT01200758|Hormones|hormones|mesh-ancestor
19914883|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914884|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19914885|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19914886|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
19914887|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
19914888|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
19914889|NCT01200810|Bicalutamide|bicalutamide|mesh-list
19914890|NCT01200810|R04929097|r04929097|mesh-list
19914891|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
19914892|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
19914893|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914894|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914895|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914896|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914897|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914898|NCT01200992|Mitomycins|mitomycins|mesh-list
19914899|NCT01200992|Mitomycin|mitomycin|mesh-list
19914900|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19914901|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914902|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
19914903|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914904|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19914905|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914906|NCT01201265|Gemcitabine|gemcitabine|mesh-list
19914907|NCT01201265|Bevacizumab|bevacizumab|mesh-list
19914908|NCT01201265|Carboplatin|carboplatin|mesh-list
19914909|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914910|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914911|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19914912|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19914913|NCT01201265|Growth Substances|growth substances|mesh-ancestor
19914914|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914915|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
19914916|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914917|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
19914918|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914919|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
19914920|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914921|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914922|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914923|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
19914924|NCT01201343|Interferons|interferons|mesh-list
19914925|NCT01201343|Interferon-beta|interferon-beta|mesh-list
19914926|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
19914927|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914928|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
19914929|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19914930|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
19914931|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914932|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19914933|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19914934|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19914935|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914936|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19914937|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
19914938|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914939|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19914940|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
19914941|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19914942|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914943|NCT01201759|Analgesics|analgesics|mesh-ancestor
19914944|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
19914945|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914946|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914947|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914948|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914949|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19914950|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914951|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914952|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19914953|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19914954|NCT01201785|Aspirin|aspirin|mesh-list
19914955|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19914956|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19914957|NCT01201785|Analgesics|analgesics|mesh-ancestor
19914958|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
19914959|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914960|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914961|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914962|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19914963|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19914964|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19914965|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914966|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19914967|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19914968|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914969|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
19914970|NCT01201798|Prednisolone|prednisolone|mesh-list
19914971|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19914972|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
19914973|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19914974|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
19914975|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19914976|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
19914977|NCT01201798|Difluprednate|difluprednate|mesh-list
19914978|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19914979|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
19914980|NCT01201798|Hormones|hormones|mesh-ancestor
19914981|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19914982|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19914983|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19914984|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914985|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
19914986|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
19914987|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19914988|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19914989|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19914990|NCT01201798|Protective Agents|protective agents|mesh-ancestor
19914991|NCT01201811|Azacitidine|azacitidine|mesh-list
19914992|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19914993|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
19914994|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19914995|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19914996|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19914997|NCT01201850|Bevacizumab|bevacizumab|mesh-list
19914998|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19914999|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915000|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915001|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19915002|NCT01201850|Growth Substances|growth substances|mesh-ancestor
19915003|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915004|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915005|NCT01201863|Testosterone|testosterone|mesh-list
19915006|NCT01201863|Androgens|androgens|mesh-ancestor
19915007|NCT01201863|Hormones|hormones|mesh-ancestor
19915008|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915009|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915010|NCT01202071|Rabeprazole|rabeprazole|mesh-list
19915011|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19915012|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19915013|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19915014|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915015|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915016|NCT01202162|Sevoflurane|sevoflurane|mesh-list
19915017|NCT01202162|Desflurane|desflurane|mesh-list
19915018|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19915019|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19915020|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
19915021|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
19915022|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915023|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915024|NCT01202175|Nebivolol|nebivolol|mesh-list
19915025|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19915026|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
19915027|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19915028|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19915029|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19915030|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
19915031|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915032|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915033|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915034|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
19915035|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
19915036|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19915037|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
19915038|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915039|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915040|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19915041|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
19915042|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
19915043|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19915044|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
19915045|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915046|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915047|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19915048|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19972164|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972165|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19972166|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19972167|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19972168|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972169|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972170|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19972171|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
19972172|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972173|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19972174|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
19972175|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19972176|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972177|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
19972178|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972179|NCT01807624|Phenylephrine|phenylephrine|mesh-list
19972180|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
19972181|NCT01807624|Tetracaine|tetracaine|mesh-list
19972182|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
19972183|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
19972184|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972185|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972186|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
19972187|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972188|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19972189|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19972190|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
19972191|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972192|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972193|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
19972194|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
19972195|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
19972196|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19972197|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
19972198|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19972199|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
19972200|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19972201|NCT01807624|Protective Agents|protective agents|mesh-ancestor
19915049|NCT01202227|Pregabalin|pregabalin|mesh-list
19915050|NCT01202227|Analgesics|analgesics|mesh-ancestor
19915051|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
19915052|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915053|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915054|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
19915055|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19915056|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915057|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915058|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19915059|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19915060|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915061|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915062|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915063|NCT01202253|Anidulafungin|anidulafungin|mesh-list
19915064|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
19915065|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915066|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
19915067|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
19915068|NCT01202279|Guaifenesin|guaifenesin|mesh-list
19915069|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19915070|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19915071|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
19915072|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915073|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915074|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19915075|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
19915076|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
19915077|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19915078|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
19915079|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
19915080|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915081|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915082|NCT01202279|Expectorants|expectorants|mesh-ancestor
19915083|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19915084|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19915085|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
19915086|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19915087|NCT01202409|Panitumumab|panitumumab|mesh-list
19915088|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19915089|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915090|NCT01202591|Fulvestrant|fulvestrant|mesh-list
19915091|NCT01202591|Exemestane|exemestane|mesh-list
19915092|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19915093|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915094|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19915095|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19915096|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
19915097|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915098|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915099|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19915100|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19915101|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915102|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915103|NCT01202721|Atenolol|atenolol|mesh-list
19915104|NCT01202721|Telmisartan|telmisartan|mesh-list
19915105|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19915106|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19915107|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19915108|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915109|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19915110|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
19915111|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
19915112|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915113|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915114|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19915115|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19915116|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19915117|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
19915118|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915119|NCT01202877|Azacitidine|azacitidine|mesh-list
19915120|NCT01202877|Midostaurin|midostaurin|mesh-list
19915121|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19915122|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
19915123|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915124|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915125|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915126|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915127|NCT01202903|Omalizumab|omalizumab|mesh-list
19915128|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20261104|NCT00495027|Immunologic Factors|immunologic factors|mesh-ancestor
20261105|NCT00495027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261106|NCT00495066|Ipilimumab|ipilimumab|mesh-list
20261107|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20261108|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261109|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20261110|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541134|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20541135|NCT01856205|Antibodies|antibodies|mesh-list
20541136|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
20541137|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20541138|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
20541139|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541140|NCT01856348|Vitamin D|vitamin d|mesh-list
20541141|NCT01856348|Vitamins|vitamins|mesh-ancestor
20541142|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
20541143|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541144|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20541145|NCT01856374|Sirolimus|sirolimus|mesh-list
20541146|NCT01856374|Everolimus|everolimus|mesh-list
20541147|NCT01856374|Atorvastatin|atorvastatin|mesh-list
20541148|NCT01856374|Pravastatin|pravastatin|mesh-list
20541149|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20541150|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20541151|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
20541152|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541153|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20541154|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20541155|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541156|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541157|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541158|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
20541159|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541160|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20541161|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541162|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20541163|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
20541164|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
20541165|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
20541166|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541167|NCT01856517|Clonidine|clonidine|mesh-list
20541168|NCT01856517|Analgesics|analgesics|mesh-ancestor
19915129|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19915130|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
19915131|NCT01202955|Tolcapone|tolcapone|mesh-list
19915132|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19915133|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20261111|NCT00495092|Biperiden|biperiden|mesh-list
20261112|NCT00495092|Caffeine|caffeine|mesh-list
20261113|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20261114|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261115|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20261116|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261117|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261118|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20261119|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20261120|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
20261121|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261122|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20261123|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20261124|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
20261125|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
20261126|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261127|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20261128|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20261129|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
20261130|NCT00495118|Risperidone|risperidone|mesh-list
20261131|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20261132|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
20541169|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
19915134|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19915135|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915136|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915137|NCT01202994|Flutemetamol|flutemetamol|mesh-list
19915138|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19915139|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915140|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19915141|NCT01203046|Ertapenem|ertapenem|mesh-list
19915142|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915143|NCT01203072|Edoxaban|edoxaban|mesh-list
19915144|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19915145|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
19915146|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19915147|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
19915148|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915149|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915150|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
19915151|NCT01203098|Enoxaparin|enoxaparin|mesh-list
19915152|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
19915153|NCT01203098|Edoxaban|edoxaban|mesh-list
19915154|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
19915155|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19915156|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19915157|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915158|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19915159|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
19915160|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19915161|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
19915162|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915163|NCT01203189|Ketoconazole|ketoconazole|mesh-list
19915164|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
19915165|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915166|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19915167|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19915168|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915169|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915170|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19915171|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
19915172|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915173|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915174|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19915175|NCT01203319|Vaccines|vaccines|mesh-list
19915176|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
19915177|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915178|NCT01203644|Bupivacaine|bupivacaine|mesh-list
19915179|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
19915180|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
19915181|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915182|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915183|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
19915184|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915185|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
19915186|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915187|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915188|NCT01203787|Sorafenib|sorafenib|mesh-list
19915189|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915190|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915191|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915192|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915193|NCT01203852|Metoprolol|metoprolol|mesh-list
19915194|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
19915195|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19915196|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19915197|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
19915198|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
19915199|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915200|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915201|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19915202|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19915203|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19915204|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
19915205|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915206|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915207|NCT01203852|Diuretics|diuretics|mesh-ancestor
19915208|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
19915209|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19915210|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915211|NCT01203878|Imiquimod|imiquimod|mesh-list
19915212|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19915213|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19915214|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
19915215|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915216|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915217|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
20261133|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261134|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261135|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261136|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20261137|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915218|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19915219|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
19915220|NCT01203917|Gefitinib|gefitinib|mesh-list
19915221|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915222|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915223|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915224|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915225|NCT01203930|Rituximab|rituximab|mesh-list
19915226|NCT01203930|Idelalisib|idelalisib|mesh-list
19915227|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19915228|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915229|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
19915230|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915231|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915232|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915233|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915234|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
19915235|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19915236|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915237|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
19915238|NCT01204255|Promethazine|promethazine|mesh-list
19915239|NCT01204255|Lorazepam|lorazepam|mesh-list
19915240|NCT01204255|Haloperidol|haloperidol|mesh-list
19915241|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
19915242|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19915243|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19915244|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915245|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915246|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
19915247|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
19915248|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
19915249|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915250|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
19915251|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
19915252|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19915253|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19915254|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
19915255|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
19915256|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972202|NCT01807871|Nicotine|nicotine|mesh-list
19915257|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915258|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19915259|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
19915260|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
19915261|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19915262|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915263|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915264|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19915265|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
19915266|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19915267|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
19915268|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19915269|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
19915270|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
19915271|NCT01204294|Metformin|metformin|mesh-list
19915272|NCT01204294|Linagliptin|linagliptin|mesh-list
19915273|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915274|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915275|NCT01204294|Incretins|incretins|mesh-ancestor
19915276|NCT01204294|Hormones|hormones|mesh-ancestor
19915277|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915278|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19915279|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
19915280|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915281|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915282|NCT01204398|Amlodipine|amlodipine|mesh-list
19915283|NCT01204398|Telmisartan|telmisartan|mesh-list
19915284|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19915285|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19915286|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19915287|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915288|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915289|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19915290|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915291|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
19915292|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19915293|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19915294|NCT01204658|Vaccines|vaccines|mesh-list
19915295|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19915296|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
19915297|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915298|NCT01204671|Vaccines|vaccines|mesh-list
19915299|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
19915300|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915301|NCT01204697|Docetaxel|docetaxel|mesh-list
19915302|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19915303|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915304|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
19915305|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
19915306|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
19915307|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915308|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915309|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915310|NCT01204710|Prednisone|prednisone|mesh-list
19915311|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
19915312|NCT01204710|Olaratumab|olaratumab|mesh-list
19915313|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915314|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
19915315|NCT01204710|Hormones|hormones|mesh-ancestor
19915316|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915317|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915318|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19915319|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287061|NCT05332561|Pertuzumab|pertuzumab|mesh-list
19915320|NCT01204710|Analgesics|analgesics|mesh-ancestor
19915321|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
19915322|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915323|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19915324|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19915325|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915326|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915327|NCT01204775|Metformin|metformin|mesh-list
19915328|NCT01204775|Saxagliptin|saxagliptin|mesh-list
19915329|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915330|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915331|NCT01204775|Incretins|incretins|mesh-ancestor
19915332|NCT01204775|Hormones|hormones|mesh-ancestor
19915333|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915334|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19915335|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
19915336|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915337|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915338|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
19915339|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19915340|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915341|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
19915342|NCT01204905|Maraviroc|maraviroc|mesh-list
19915343|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19915344|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19915345|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
19915346|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915347|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19915348|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19915349|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915350|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915351|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19915352|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19915353|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19915354|NCT01204918|Riluzole|riluzole|mesh-list
19915355|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
19915356|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19915357|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19915358|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915359|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915360|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915361|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19915362|NCT01204918|Protective Agents|protective agents|mesh-ancestor
19915363|NCT01205035|Ranibizumab|ranibizumab|mesh-list
19915364|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915365|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19915366|NCT01205035|Growth Substances|growth substances|mesh-ancestor
19915367|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915368|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915369|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915370|NCT01205126|Oxycodone|oxycodone|mesh-list
19915371|NCT01205126|Hydromorphone|hydromorphone|mesh-list
19915372|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19915373|NCT01205126|Narcotics|narcotics|mesh-ancestor
19915374|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915375|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915376|NCT01205126|Analgesics|analgesics|mesh-ancestor
19915377|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
19915378|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915379|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
19915380|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19915381|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19915382|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19915383|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915384|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915385|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
19915386|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915387|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915388|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19915389|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915390|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
19915391|NCT01205503|Doxorubicin|doxorubicin|mesh-list
19915392|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19915393|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
19915394|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915395|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915396|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19915397|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
19915398|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915399|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915400|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19915401|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19915402|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19915403|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19915404|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915405|NCT01205529|Procainamide|procainamide|mesh-list
19915406|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19915407|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19915408|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19915409|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915410|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915411|NCT01205581|Vaccines|vaccines|mesh-list
19915412|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
19915413|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915414|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
19915415|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19915416|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915417|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19915418|NCT01205685|Letrozole|letrozole|mesh-list
19915419|NCT01205685|Goserelin|goserelin|mesh-list
19915420|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915421|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915422|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915423|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915424|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19915425|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19915426|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19915427|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
19915428|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915429|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915430|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19915431|NCT01205828|Temozolomide|temozolomide|mesh-list
19915432|NCT01205828|Veliparib|veliparib|mesh-list
19915433|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19915434|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
19915435|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915436|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915437|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19915438|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915439|NCT01206140|Sirolimus|sirolimus|mesh-list
19915440|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19915441|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915442|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19915443|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915444|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
19915445|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19915446|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
19915447|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915448|NCT01206322|Insulin|insulin|mesh-list
19915449|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915450|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915451|NCT01206387|Desoximetasone|desoximetasone|mesh-list
19915452|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915453|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
19915454|NCT01206387|Hormones|hormones|mesh-ancestor
19915455|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915456|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915457|NCT01206452|Prednisone|prednisone|mesh-list
19915458|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915459|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
19915460|NCT01206452|Hormones|hormones|mesh-ancestor
19915461|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915462|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915463|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19915464|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915465|NCT01206465|Fluorouracil|fluorouracil|mesh-list
19915466|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
19915467|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915468|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19915469|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915470|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19915471|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
19915472|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915473|NCT01206478|Megestrol|megestrol|mesh-list
19915474|NCT01206478|Amitriptyline|amitriptyline|mesh-list
19915475|NCT01206478|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19915476|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19915477|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
19915478|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915479|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19915480|NCT01206478|Analgesics|analgesics|mesh-ancestor
19915481|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
19915482|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915483|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915484|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19915485|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19915486|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915487|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915488|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
19915489|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915490|NCT01206478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19915491|NCT01206478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915492|NCT01206478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915493|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19915494|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19915495|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19915496|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
19915497|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19915498|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19915499|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19915500|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19915501|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915502|NCT01206595|Bupivacaine|bupivacaine|mesh-list
19915503|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
19915504|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
19915505|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915506|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915507|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
19915508|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915509|NCT01206608|Bupivacaine|bupivacaine|mesh-list
19915510|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
19915511|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
19915512|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261138|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261139|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20261140|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20261141|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
20261142|NCT00495183|Biperiden|biperiden|mesh-list
20261143|NCT00495183|Caffeine|caffeine|mesh-list
20261144|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20261145|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261146|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20261147|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915513|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915514|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
19915515|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915516|NCT01206660|Desoximetasone|desoximetasone|mesh-list
19915517|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915518|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
19915519|NCT01206660|Hormones|hormones|mesh-ancestor
19915520|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915521|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915522|NCT01206764|Everolimus|everolimus|mesh-list
19915523|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915524|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19915525|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
19915526|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915527|NCT01206777|Rituximab|rituximab|mesh-list
19915528|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19915529|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915530|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
19915531|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915532|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915533|NCT01206816|Afatinib|afatinib|mesh-list
19915534|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915535|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915536|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915537|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915538|NCT01207388|Blinatumomab|blinatumomab|mesh-list
19915539|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915540|NCT01207401|Lidocaine|lidocaine|mesh-list
19915541|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
19915542|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
19915543|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915544|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915545|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
19915546|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915547|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19915548|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19915549|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19915550|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915551|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915552|NCT01207414|Iloperidone|iloperidone|mesh-list
19915553|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19915554|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915555|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915556|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915557|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915558|NCT01207440|Ponatinib|ponatinib|mesh-list
19915559|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915560|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915561|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915562|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915563|NCT01207453|Milnacipran|milnacipran|mesh-list
19915564|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
19915565|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19915566|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20261148|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261149|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20261150|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20261151|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
20261152|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261153|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20261154|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20261155|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
20261156|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
20261157|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261158|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20261159|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20261160|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
20261161|NCT00495287|Cytarabine|cytarabine|mesh-list
20261162|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261163|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
20261164|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261165|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261166|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
19449993|NCT03431909|Coagulants|coagulants|mesh-ancestor
19915567|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19915568|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915569|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915570|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915571|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19915572|NCT01207453|Analgesics|analgesics|mesh-ancestor
19915573|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
19915574|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915575|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
19915576|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915577|NCT01207596|Hydromorphone|hydromorphone|mesh-list
19915578|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19915579|NCT01207596|Narcotics|narcotics|mesh-ancestor
19915580|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915581|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915582|NCT01207596|Analgesics|analgesics|mesh-ancestor
19915583|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
19915584|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915585|NCT01207687|Bevacizumab|bevacizumab|mesh-list
19915586|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19915587|NCT01207687|Antibodies|antibodies|mesh-list
19915588|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
19915589|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19915590|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915591|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915592|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19915593|NCT01207687|Growth Substances|growth substances|mesh-ancestor
19915594|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915595|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915596|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
19915597|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19915598|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
19915599|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19915600|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19915601|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
19915602|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915603|NCT01207908|Mecasermin|mecasermin|mesh-list
19915604|NCT01207908|Growth Substances|growth substances|mesh-ancestor
19915605|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915606|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
19915607|NCT01208038|Testosterone|testosterone|mesh-list
19915608|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
19915609|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
19915610|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19915611|NCT01208038|Androgens|androgens|mesh-ancestor
19915612|NCT01208038|Hormones|hormones|mesh-ancestor
19915613|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915614|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915615|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19915616|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915617|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
19915618|NCT01208051|Lenalidomide|lenalidomide|mesh-list
19915619|NCT01208051|Cediranib|cediranib|mesh-list
19915620|NCT01208051|Maleic acid|maleic acid|mesh-list
19915621|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
19915622|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915623|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915624|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19915625|NCT01208051|Growth Substances|growth substances|mesh-ancestor
19915626|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915627|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915628|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915629|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915630|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915631|NCT01208103|Bevacizumab|bevacizumab|mesh-list
19915632|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19915633|NCT01208103|Capecitabine|capecitabine|mesh-list
19915634|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
19915635|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
19915636|NCT01208103|Antibodies|antibodies|mesh-list
19915637|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
19915638|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19915639|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
19915640|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915641|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915642|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20261167|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915643|NCT01208103|Growth Substances|growth substances|mesh-ancestor
19915644|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915645|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915646|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
19915647|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19915648|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
19915649|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915650|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
19915651|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19915652|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19915653|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915654|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915655|NCT01208324|Estrogens|estrogens|mesh-list
19915656|NCT01208324|Hormones|hormones|mesh-ancestor
19915657|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915658|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972203|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19972204|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
19972205|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972206|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972207|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19972208|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19972209|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
19972210|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972211|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972212|NCT01807923|Ivacaftor|ivacaftor|mesh-list
19972213|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19972214|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972215|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972216|NCT01807949|Ivacaftor|ivacaftor|mesh-list
19972217|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19972218|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972219|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972220|NCT01808092|Meropenem|meropenem|mesh-list
19972221|NCT01808092|Ceftazidime|ceftazidime|mesh-list
19972222|NCT01808092|Avibactam|avibactam|mesh-list
19972223|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19972224|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19972225|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972226|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19972227|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972228|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972229|NCT01808118|Adalimumab|adalimumab|mesh-list
19972230|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972231|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972232|NCT01808144|Febuxostat|febuxostat|mesh-list
19972233|NCT01808144|Lesinurad|lesinurad|mesh-list
19972234|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
19972235|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972236|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
19972237|NCT01808144|Renal Agents|renal agents|mesh-ancestor
19972238|NCT01808196|Losartan|losartan|mesh-list
19972239|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
19972240|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19972241|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19972242|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19732352|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732353|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
19732354|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732355|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19732356|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19732357|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732358|NCT04575233|Ropivacaine|ropivacaine|mesh-list
19732359|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
19732360|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
19732361|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732362|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732363|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
19732364|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732365|NCT04575415|Bevacizumab|bevacizumab|mesh-list
19732366|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19732367|NCT04575415|Gefitinib|gefitinib|mesh-list
19732368|NCT04575415|Osimertinib|osimertinib|mesh-list
19732369|NCT04575415|Afatinib|afatinib|mesh-list
19732370|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19732371|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732372|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915659|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
19915660|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19915661|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915662|NCT01208402|Esmolol|esmolol|mesh-list
19915663|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19915664|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19915665|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19915666|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
19915667|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915668|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915669|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915670|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
19915671|NCT01208922|Rifamycins|rifamycins|mesh-list
19915672|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
19915673|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19915674|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915675|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19915676|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19915677|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915678|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915679|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915680|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19915681|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19915682|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915683|NCT01209078|Linezolid|linezolid|mesh-list
19915684|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19915685|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915686|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19915687|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915688|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915689|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
19915690|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20261168|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261169|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
20261170|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261171|NCT00495313|Metronidazole|metronidazole|mesh-list
20261172|NCT00495313|Doxycycline|doxycycline|mesh-list
20261173|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261174|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261175|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20261176|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20261177|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
20261178|NCT00495326|Efavirenz|efavirenz|mesh-list
20261179|NCT00495326|Nevirapine|nevirapine|mesh-list
20261180|NCT00495326|Rifampin|rifampin|mesh-list
20261181|NCT00495326|Isoniazid|isoniazid|mesh-list
20261182|NCT00495326|Ethambutol|ethambutol|mesh-list
20261183|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20261184|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19732373|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19732374|NCT04575415|Growth Substances|growth substances|mesh-ancestor
19732375|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732376|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
19732377|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19732378|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732379|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732380|NCT04575389|Uric Acid|uric acid|mesh-list
19732381|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
19732382|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732383|NCT04575389|Protective Agents|protective agents|mesh-ancestor
19732384|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732385|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
19732386|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19732387|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732388|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19732389|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19915691|NCT01209143|Norethindrone|norethindrone|mesh-list
19915692|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
19915693|NCT01209143|Estradiol|estradiol|mesh-list
19915694|NCT01209143|Estrogens|estrogens|mesh-ancestor
19915695|NCT01209143|Hormones|hormones|mesh-ancestor
19915696|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915697|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915698|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19915699|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
19915700|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19915701|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19915702|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915703|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19915704|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19915705|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19915706|NCT01209195|Paclitaxel|paclitaxel|mesh-list
19915707|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19915708|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915709|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
19915710|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
19915711|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
19915712|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915713|NCT01209286|Blinatumomab|blinatumomab|mesh-list
19915714|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915715|NCT01209442|Bevacizumab|bevacizumab|mesh-list
19915716|NCT01209442|Temozolomide|temozolomide|mesh-list
19915717|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19915718|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915719|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915720|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19915721|NCT01209442|Growth Substances|growth substances|mesh-ancestor
19915722|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915723|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915724|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19915725|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
19915726|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915727|NCT01209598|Palbociclib|palbociclib|mesh-list
19915728|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915729|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915730|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915731|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915732|NCT01209832|Midazolam|midazolam|mesh-list
19915733|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19915734|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19915735|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915736|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915737|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19915738|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915739|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915740|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19915741|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
19915742|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
19915743|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
19915744|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
19915745|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915746|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915747|NCT01209949|Adapalene|adapalene|mesh-list
19915748|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19915749|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
19915750|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19915751|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19915752|NCT01209949|Analgesics|analgesics|mesh-ancestor
19915753|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
19915754|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915755|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915756|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915757|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915758|NCT01210001|Empagliflozin|empagliflozin|mesh-list
19915759|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19915760|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915761|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915762|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915763|NCT01210079|Gabapentin|gabapentin|mesh-list
19915764|NCT01210079|Analgesics|analgesics|mesh-ancestor
19915765|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
19915766|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915767|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915768|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
19915769|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19915770|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915771|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915772|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915773|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19915774|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19915775|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915776|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915777|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
19915778|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19915779|NCT01210144|Hormones|hormones|mesh-list
19915780|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19915781|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915782|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915783|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19915784|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
19915785|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915786|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
19915787|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19915788|NCT01210222|Trebananib|trebananib|mesh-list
19915789|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915790|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19915791|NCT01210222|Growth Substances|growth substances|mesh-ancestor
19915792|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915793|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915794|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915795|NCT01210352|Oxymorphone|oxymorphone|mesh-list
19915796|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19915797|NCT01210352|Narcotics|narcotics|mesh-ancestor
19915798|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915799|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915800|NCT01210352|Analgesics|analgesics|mesh-ancestor
19915801|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
19915802|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915803|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19915804|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
19915805|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19915806|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915807|NCT01210495|Axitinib|axitinib|mesh-list
19915808|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915809|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915810|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915811|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915812|NCT01210560|Tolvaptan|tolvaptan|mesh-list
19915813|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19915814|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915815|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
19915816|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915817|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
19915818|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
19915819|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19915820|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19915821|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
19915822|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915823|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915824|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915825|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915826|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19915827|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915828|NCT01211197|Metformin|metformin|mesh-list
19915829|NCT01211197|Empagliflozin|empagliflozin|mesh-list
19915830|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915831|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915832|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19915833|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915834|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19915835|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915836|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19915837|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261185|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915838|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915839|NCT01211522|Haloperidol|haloperidol|mesh-list
19915840|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
19915841|NCT01211522|Ziprasidone|ziprasidone|mesh-list
19915842|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
19915843|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
19915844|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915845|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915846|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19915847|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19915848|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19915849|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19915850|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19915851|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19915852|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
19915853|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915854|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915855|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19915856|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19915857|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
19915858|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19915859|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
19915860|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19915861|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19915862|NCT01211665|Prednisolone|prednisolone|mesh-list
19915863|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
19915864|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19915865|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
19915866|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915867|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
19915868|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
19915869|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915870|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915871|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19915872|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
19915873|NCT01211665|Hormones|hormones|mesh-ancestor
19915874|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915875|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19915876|NCT01211665|Protective Agents|protective agents|mesh-ancestor
19915877|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19915878|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915879|NCT01211730|Insulin|insulin|mesh-list
19915880|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19915881|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19915882|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915883|NCT01211769|Naltrexone|naltrexone|mesh-list
19915884|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19915885|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19915886|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915887|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
19915888|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915889|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19915890|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
19915891|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
19915892|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915893|NCT01212094|Rituximab|rituximab|mesh-list
19915894|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19915895|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915896|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
19915897|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915898|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915899|NCT01212185|Oxytocin|oxytocin|mesh-list
19915900|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
19915901|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19915902|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915903|NCT01212302|Aspirin|aspirin|mesh-list
19915904|NCT01212302|Clopidogrel|clopidogrel|mesh-list
19915905|NCT01212302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19915906|NCT01212302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19915907|NCT01212302|Analgesics|analgesics|mesh-ancestor
19915908|NCT01212302|Sensory System Agents|sensory system agents|mesh-ancestor
19915909|NCT01212302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261186|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261187|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
20261188|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915910|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915911|NCT01212302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915912|NCT01212302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915913|NCT01212302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19915914|NCT01212302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19915915|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915916|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19915917|NCT01212302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19915918|NCT01212302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915919|NCT01212302|Antipyretics|antipyretics|mesh-ancestor
19915920|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19915921|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19915922|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19915923|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
19915924|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915925|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19915926|NCT01212445|Laxatives|laxatives|mesh-list
19915927|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19915928|NCT01212471|Bromfenac|bromfenac|mesh-list
19915929|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19915930|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19915931|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19915932|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19915933|NCT01212471|Analgesics|analgesics|mesh-ancestor
19915934|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
19915935|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915936|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915937|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915938|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915939|NCT01212484|Carbidopa|carbidopa|mesh-list
19915940|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19915941|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19915942|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
19915943|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19915944|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915945|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915946|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19915947|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915948|NCT01212588|Mifepristone|mifepristone|mesh-list
19915949|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19915950|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
19915951|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19915952|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915953|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19915954|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19915955|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19915956|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
19915957|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19915958|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19915959|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
19915960|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19915961|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
19915962|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19915963|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19915964|NCT01212757|Thalidomide|thalidomide|mesh-list
19915965|NCT01212757|Apremilast|apremilast|mesh-list
19915966|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19915967|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20261189|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19915968|NCT01212757|Analgesics|analgesics|mesh-ancestor
19915969|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
19915970|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261190|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20261191|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19915971|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915972|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915973|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915974|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19915975|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19915976|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19915977|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19915978|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19915979|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
19915980|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
19915981|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19915982|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19915983|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19915984|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19915985|NCT01212757|Growth Substances|growth substances|mesh-ancestor
19915986|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
19915987|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19915988|NCT01212770|Thalidomide|thalidomide|mesh-list
19915989|NCT01212770|Apremilast|apremilast|mesh-list
19915990|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19915991|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19915992|NCT01212770|Analgesics|analgesics|mesh-ancestor
20261192|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20261193|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20261194|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20541170|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541171|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541172|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20541173|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
20541174|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
20541175|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20541176|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20541177|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20541178|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541179|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541180|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541181|NCT01856556|Glycine|glycine|mesh-list
20541182|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
20541183|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541184|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541185|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541186|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20541187|NCT01856621|Charcoal|charcoal|mesh-list
20541188|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20541189|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
20541190|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541191|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19449994|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19449995|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
20541192|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20541193|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541194|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
20541195|NCT01856621|Hormones|hormones|mesh-ancestor
20541196|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541197|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
20541198|NCT01856621|Antidotes|antidotes|mesh-ancestor
20541199|NCT01856621|Protective Agents|protective agents|mesh-ancestor
20541200|NCT01856738|Rivastigmine|rivastigmine|mesh-list
20541201|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20541202|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541203|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541204|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
20541205|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541206|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261195|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20261196|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20261197|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20261198|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
20261199|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261200|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
20261201|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20261202|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20261203|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19915993|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
19915994|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19915995|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19915996|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19915997|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19915998|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19915999|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19916000|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916001|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916002|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19916003|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
19916004|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
19916005|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19916006|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916007|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916008|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916009|NCT01212770|Growth Substances|growth substances|mesh-ancestor
19916010|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916011|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916012|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
19916013|NCT01212874|Esmolol|esmolol|mesh-list
19916014|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
19916015|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19916016|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19916017|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19916018|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916019|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916020|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916021|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916022|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19916023|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19916024|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19916025|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
19916026|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916027|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916028|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19916029|NCT01212952|Dexamethasone|dexamethasone|mesh-list
19916030|NCT01212952|Bortezomib|bortezomib|mesh-list
19916031|NCT01212952|Pomalidomide|pomalidomide|mesh-list
19916032|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916033|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
19916034|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
19916035|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916036|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916037|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19916038|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
19916039|NCT01212952|Hormones|hormones|mesh-ancestor
19916040|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916041|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19916042|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916043|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
19916044|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916045|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916046|NCT01212952|Growth Substances|growth substances|mesh-ancestor
19916047|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916048|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
19916049|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19916050|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916051|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916052|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19916053|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19916054|NCT01213082|Bevacizumab|bevacizumab|mesh-list
19916055|NCT01213082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19916056|NCT01213082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916057|NCT01213082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916058|NCT01213082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916059|NCT01213082|Growth Substances|growth substances|mesh-ancestor
19916060|NCT01213082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916061|NCT01213082|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916062|NCT01213173|Metoprolol|metoprolol|mesh-list
19916063|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19916064|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19916065|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
19916066|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
19916067|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916068|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916069|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19916070|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19916071|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19916072|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916073|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916074|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916075|NCT01213199|Adapalene|adapalene|mesh-list
19916076|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19916077|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19916078|NCT01213199|Analgesics|analgesics|mesh-ancestor
19916079|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
19916080|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916081|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916082|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916083|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19916084|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916085|NCT01213264|Anesthetics|anesthetics|mesh-list
19916086|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916087|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916088|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
19916089|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19916090|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19916091|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
19916092|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916093|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19916094|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19916095|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916096|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916097|NCT01213524|Nicotine|nicotine|mesh-list
19916098|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19916099|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
19916100|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916101|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916102|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19916103|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19916104|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
19916105|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916106|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916107|NCT01213576|Ivermectin|ivermectin|mesh-list
19916108|NCT01213576|Albendazole|albendazole|mesh-list
19916109|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19916110|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916111|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
19916112|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
19916113|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19916114|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19916115|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
19916116|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
19916117|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
19916118|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916119|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916120|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19916121|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
19916122|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19916123|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19916124|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19916125|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916126|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916127|NCT01213966|Artefenomel|artefenomel|mesh-list
19916128|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
19916129|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19916130|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19916131|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916132|NCT01214044|Dexetimide|dexetimide|mesh-list
19916133|NCT01214044|Citalopram|citalopram|mesh-list
19916134|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19916135|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19916136|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19916137|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916138|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916139|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
19916140|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916141|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19916142|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
19916143|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19916144|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19916145|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19916146|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
19916147|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
19916148|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916149|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19916150|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19916151|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
19916152|NCT01214057|Remifentanil|remifentanil|mesh-list
19916153|NCT01214057|Propofol|propofol|mesh-list
19916154|NCT01214057|Sevoflurane|sevoflurane|mesh-list
19916155|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19916156|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916157|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916158|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19916159|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
19916160|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
19916161|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19916162|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19916163|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19916164|NCT01214057|Narcotics|narcotics|mesh-ancestor
19916165|NCT01214057|Analgesics|analgesics|mesh-ancestor
19916166|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
19916167|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916168|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
19916169|NCT01214083|Naltrexone|naltrexone|mesh-list
19916170|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19916171|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19916172|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19916173|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916174|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
19916175|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916176|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
19916177|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916178|NCT01214083|Expectorants|expectorants|mesh-ancestor
19916179|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
19916180|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19916181|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
19916182|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916183|NCT01214083|Protective Agents|protective agents|mesh-ancestor
19916184|NCT01214083|Antidotes|antidotes|mesh-ancestor
19916185|NCT01214109|Pramipexole|pramipexole|mesh-list
19916186|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
19916187|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916188|NCT01214109|Protective Agents|protective agents|mesh-ancestor
19916189|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916190|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19916191|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19916192|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
19916193|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
19916194|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916195|NCT01214161|Lidocaine|lidocaine|mesh-list
19916196|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
19916197|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
19916198|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916199|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916200|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
19916201|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916202|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19916203|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19916204|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19916205|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19916206|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916207|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
19916208|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
19916209|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916210|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
19916211|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916212|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916213|NCT01214239|Linagliptin|linagliptin|mesh-list
20261204|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19916214|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916215|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916216|NCT01214239|Incretins|incretins|mesh-ancestor
19916217|NCT01214239|Hormones|hormones|mesh-ancestor
19916218|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916219|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19916220|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
19916221|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916222|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916223|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
19916224|NCT01214317|Analgesics|analgesics|mesh-ancestor
19916225|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
19916226|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916227|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916228|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916229|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19916230|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19916231|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916232|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916233|NCT01214356|Vitamin D|vitamin d|mesh-list
19916234|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
19916235|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
19916236|NCT01214356|Vitamins|vitamins|mesh-list
19916237|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
19916238|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916239|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19916240|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19972243|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19972244|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972245|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19972246|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
19972247|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
19972248|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972249|NCT01808313|Ambrisentan|ambrisentan|mesh-list
19972250|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19972251|NCT01808326|Chlorambucil|chlorambucil|mesh-list
19972252|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19972253|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
19972254|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972255|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972256|NCT01808339|Fluticasone|fluticasone|mesh-list
19972257|NCT01808339|Xhance|xhance|mesh-list
19972258|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972259|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19972260|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
19972261|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972262|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972263|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19972264|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
19972265|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
19972266|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19972267|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
19972268|NCT01808534|Ifosfamide|ifosfamide|mesh-list
19972269|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19972270|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
19972271|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972272|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972273|NCT01808547|Bromfenac|bromfenac|mesh-list
19972274|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19972275|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19972276|NCT01808547|Analgesics|analgesics|mesh-ancestor
19972277|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
19972278|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972279|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972280|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972281|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972282|NCT01808573|Capecitabine|capecitabine|mesh-list
19972283|NCT01808573|Lapatinib|lapatinib|mesh-list
19972284|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19972285|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
19972286|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972287|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972288|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19972289|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972290|NCT01808612|Fluoxetine|fluoxetine|mesh-list
20541207|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20541208|NCT01856738|Protective Agents|protective agents|mesh-ancestor
20541209|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
20541210|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19916241|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
19916242|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19916243|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916244|NCT01214421|Tolvaptan|tolvaptan|mesh-list
19916245|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19916246|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916247|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
19916248|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916249|NCT01214434|Emollients|emollients|mesh-list
19916250|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916251|NCT01214616|Vinorelbine|vinorelbine|mesh-list
19916252|NCT01214616|Afatinib|afatinib|mesh-list
19916253|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19916254|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916255|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
19916256|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
19916257|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
19916258|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916259|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19916260|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916261|NCT01214668|Doxorubicin|doxorubicin|mesh-list
19916262|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19916263|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19916264|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916265|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19916266|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19916267|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916268|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916269|NCT01214720|Bevacizumab|bevacizumab|mesh-list
19916270|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19916271|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916272|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916273|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916274|NCT01214720|Growth Substances|growth substances|mesh-ancestor
19916275|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916276|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916277|NCT01214759|Tenofovir|tenofovir|mesh-list
19916278|NCT01214759|Emtricitabine|emtricitabine|mesh-list
19916279|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
19916280|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19916281|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
19916282|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916283|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19916284|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19916285|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916286|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916287|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19916288|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19916289|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19916290|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19916291|NCT01214850|Vaccines|vaccines|mesh-list
19916292|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
19916293|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916294|NCT01214915|Anagrelide|anagrelide|mesh-list
19916295|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19916296|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19916297|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916298|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19916299|NCT01215032|Metformin|metformin|mesh-list
19916300|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916301|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916302|NCT01215097|Linagliptin|linagliptin|mesh-list
19916303|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916304|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916305|NCT01215097|Incretins|incretins|mesh-ancestor
19916306|NCT01215097|Hormones|hormones|mesh-ancestor
19916307|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916308|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19916309|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
19916310|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541211|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
19916311|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916312|NCT01215110|Bedaquiline|bedaquiline|mesh-list
19916313|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
19916314|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19916315|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916316|NCT01215123|Bevacizumab|bevacizumab|mesh-list
19916317|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19916318|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916319|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916320|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916321|NCT01215123|Growth Substances|growth substances|mesh-ancestor
19916322|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916323|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916324|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19916325|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
19916326|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916327|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19916328|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
19916329|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916330|NCT01215227|Rasagiline|rasagiline|mesh-list
19916331|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19916332|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916333|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916334|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19916335|NCT01215227|Protective Agents|protective agents|mesh-ancestor
19916336|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916337|NCT01215253|Ranolazine|ranolazine|mesh-list
19916338|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19916339|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19916340|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916341|NCT01215292|Ketoconazole|ketoconazole|mesh-list
19916342|NCT01215292|Anastrozole|anastrozole|mesh-list
19916343|NCT01215292|Testosterone|testosterone|mesh-list
19916344|NCT01215292|Dutasteride|dutasteride|mesh-list
19916345|NCT01215292|Acyline|acyline|mesh-list
19916346|NCT01215292|Androgens|androgens|mesh-ancestor
19916347|NCT01215292|Hormones|hormones|mesh-ancestor
19916348|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916349|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916350|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19916351|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916352|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19916353|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19916354|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916355|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916356|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19916357|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
19916358|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
19916359|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916360|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19916361|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19916362|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19916363|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19916364|NCT01215318|Silicon|silicon|mesh-list
19916365|NCT01215318|Trace Elements|trace elements|mesh-ancestor
19916366|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
19916367|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916368|NCT01215344|Diphosphonates|diphosphonates|mesh-list
19916369|NCT01215344|Dexamethasone|dexamethasone|mesh-list
19916370|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
19916371|NCT01215344|Doxorubicin|doxorubicin|mesh-list
19916372|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19916373|NCT01215344|Lenalidomide|lenalidomide|mesh-list
19916374|NCT01215344|Bortezomib|bortezomib|mesh-list
19916375|NCT01215344|BB 1101|bb 1101|mesh-list
19916376|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916377|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
19916378|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
19916379|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916380|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916381|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19916382|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
19916383|NCT01215344|Hormones|hormones|mesh-ancestor
19916384|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916385|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20261205|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20261206|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
20261207|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20261208|NCT00495339|Levofloxacin|levofloxacin|mesh-list
20261209|NCT00495339|Ofloxacin|ofloxacin|mesh-list
20261210|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20261211|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261212|NCT00495339|Renal Agents|renal agents|mesh-ancestor
20261213|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261214|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20261215|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20261216|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261217|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261218|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261219|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20261220|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20261221|NCT00495352|Bupropion|bupropion|mesh-list
20261222|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20261223|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
20261224|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20261225|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20261226|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20261227|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20261228|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261229|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
20261230|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261231|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261232|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20261233|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20261234|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261235|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
20261236|NCT00495365|Hematinics|hematinics|mesh-ancestor
20261237|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
20261238|NCT00495378|Hematinics|hematinics|mesh-ancestor
20261239|NCT00495508|Lumefantrine|lumefantrine|mesh-list
19916386|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916387|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
19916388|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916389|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916390|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19916391|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19916392|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19916393|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
19916394|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916395|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916396|NCT01215344|Growth Substances|growth substances|mesh-ancestor
19916397|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916398|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19916399|NCT01215357|Ecopipam|ecopipam|mesh-list
19916400|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19916401|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19916402|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916403|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916404|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19916405|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20261240|NCT00495508|Artemether|artemether|mesh-list
20261241|NCT00495508|Quinine|quinine|mesh-list
20261242|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20261243|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
19916406|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
19916407|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916408|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916409|NCT01215435|Insulin|insulin|mesh-list
19916410|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19916411|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
19916412|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
19916413|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19916414|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
19916415|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19916416|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
20261244|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20261245|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20261246|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916417|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916418|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916419|NCT01215643|Ribavirin|ribavirin|mesh-list
19916420|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19916421|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
19916422|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916423|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
19916424|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916425|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
19916426|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19916427|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19916428|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
19916429|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916430|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916431|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916432|NCT01215721|Urological Agents|urological agents|mesh-ancestor
19916433|NCT01215734|Vaccines|vaccines|mesh-list
19916434|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
19916435|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916436|NCT01215786|Timolol|timolol|mesh-list
19916437|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19916438|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19916439|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19916440|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19916441|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916442|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916443|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916444|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916445|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19916446|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19916447|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
19916448|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
19916449|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19916450|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916451|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19916452|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19916453|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916454|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916455|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916456|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
19916457|NCT01215916|Pemetrexed|pemetrexed|mesh-list
19916458|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916459|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916460|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916461|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19916462|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19916463|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
19916464|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19916465|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916466|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19916467|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19916468|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19916469|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916470|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
19916471|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916472|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
19916473|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916474|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916475|NCT01215968|Dulaglutide|dulaglutide|mesh-list
19916476|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916477|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916478|NCT01215981|Vaccines|vaccines|mesh-list
19916479|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
19916480|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916481|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19916482|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
19916483|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19916484|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916485|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19916486|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
19916487|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287062|NCT05332561|Atezolizumab|atezolizumab|mesh-list
19916488|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19916489|NCT01216163|Acetaminophen|acetaminophen|mesh-list
19916490|NCT01216163|Ibuprofen|ibuprofen|mesh-list
19916491|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19916492|NCT01216163|Analgesics|analgesics|mesh-ancestor
19916493|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
19916494|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916495|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916496|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
19916497|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19916498|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916499|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19916500|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19916501|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916502|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916503|NCT01216176|Anastrozole|anastrozole|mesh-list
19916504|NCT01216176|Saracatinib|saracatinib|mesh-list
19916505|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19916506|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916507|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19916508|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19916509|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916510|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916511|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19916512|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
19916513|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916514|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916515|NCT01216241|Daptomycin|daptomycin|mesh-list
19916516|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19916517|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916518|NCT01216332|Vaccines|vaccines|mesh-list
19916519|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
19916520|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916521|NCT01216397|Metformin|metformin|mesh-list
19916522|NCT01216397|Linagliptin|linagliptin|mesh-list
20261247|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20261248|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261249|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20261250|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261251|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20261252|NCT00495508|Analgesics|analgesics|mesh-ancestor
20261253|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
20261254|NCT00495547|Azacitidine|azacitidine|mesh-list
20261255|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
20261256|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261257|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
20261258|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261259|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261260|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261261|NCT00495547|Hematinics|hematinics|mesh-ancestor
20261262|NCT00495560|Misoprostol|misoprostol|mesh-list
20261263|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20261264|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
20261265|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261266|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261267|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20261268|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20261269|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
20261270|NCT00495573|Acyclovir|acyclovir|mesh-list
20261271|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
20261272|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261273|NCT00495651|Isoniazid|isoniazid|mesh-list
20261274|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20261275|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
20261276|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261277|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261278|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20261279|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20261280|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
20261281|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261282|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20261283|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
20261284|NCT00495729|Simvastatin|simvastatin|mesh-list
20261285|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20261286|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20261287|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
20261288|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261289|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19916523|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916524|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916525|NCT01216397|Incretins|incretins|mesh-ancestor
19916526|NCT01216397|Hormones|hormones|mesh-ancestor
19916527|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916528|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19916529|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
19916530|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916531|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916532|NCT01216410|Phenylephrine|phenylephrine|mesh-list
19916533|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
19916534|NCT01216410|Ondansetron|ondansetron|mesh-list
19916535|NCT01216410|Metoclopramide|metoclopramide|mesh-list
19916536|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
19916537|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
19916538|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916539|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916540|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19916541|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
19916542|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916543|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19916544|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
19916545|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916546|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916547|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19916548|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19916549|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916550|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19916551|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19916552|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19916553|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
19916554|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
19916555|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19916556|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
19916557|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
19916558|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19916559|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19916560|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19916561|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916562|NCT01216410|Protective Agents|protective agents|mesh-ancestor
19916563|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19916564|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19916565|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
19916566|NCT01216735|Fluticasone|fluticasone|mesh-list
19916567|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916568|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19916569|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
19916570|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916571|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916572|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19916573|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
20261290|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19916574|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916575|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19916576|NCT01216761|Iodine|iodine|mesh-list
19916577|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
19916578|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19916579|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
19916580|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
19916581|NCT01216761|Povidone|povidone|mesh-list
19916582|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19916583|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19916584|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
19916585|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916586|NCT01216761|Trace Elements|trace elements|mesh-ancestor
19916587|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
19916588|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916589|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
19916590|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
19916591|NCT01216943|Timolol|timolol|mesh-list
19916592|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19916593|NCT01216943|Bimatoprost|bimatoprost|mesh-list
19916594|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19916595|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19916596|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19916597|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19916598|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916599|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916600|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916601|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916602|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19916603|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19916604|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19916605|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19916606|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19916607|NCT01217073|Metformin|metformin|mesh-list
19916608|NCT01217073|Pioglitazone|pioglitazone|mesh-list
19916609|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916610|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916611|NCT01217112|Cannabidiol|cannabidiol|mesh-list
19916612|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
19916613|NCT01217190|Ondansetron|ondansetron|mesh-list
19916614|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
19916615|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
19916616|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916617|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916618|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19916619|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
19916620|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916621|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19916622|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
19916623|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916624|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916625|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19916626|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19916627|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916628|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19916629|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19916630|NCT01217307|Metformin|metformin|mesh-list
19916631|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916632|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916633|NCT01217411|R04929097|r04929097|mesh-list
19916634|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916635|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916636|NCT01217437|Bevacizumab|bevacizumab|mesh-list
19916637|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19916638|NCT01217437|Irinotecan|irinotecan|mesh-list
19916639|NCT01217437|Temozolomide|temozolomide|mesh-list
19916640|NCT01217437|Camptothecin|camptothecin|mesh-list
19916641|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
19916642|NCT01217437|Antibodies|antibodies|mesh-list
19916643|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
19916644|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19916645|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
19916646|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916647|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916648|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916649|NCT01217437|Growth Substances|growth substances|mesh-ancestor
19916650|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916651|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916652|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
19916653|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19916654|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19916655|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916656|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916657|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19916658|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
19916659|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19916660|NCT01217515|Diltiazem|diltiazem|mesh-list
19916661|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19916662|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19916663|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19916664|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916665|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19916666|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916667|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
19916668|NCT01217606|Timolol|timolol|mesh-list
19916669|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19916670|NCT01217606|Bimatoprost|bimatoprost|mesh-list
19916671|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19916672|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19916673|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19916674|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19916675|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916676|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916677|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916678|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916679|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19916680|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19916681|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19916682|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19916683|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19916684|NCT01217749|Ofatumumab|ofatumumab|mesh-list
19916685|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916686|NCT01217801|Ondansetron|ondansetron|mesh-list
19916687|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
19916688|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
19916689|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916690|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916691|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19916692|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
19916693|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916694|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19916695|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
19916696|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916697|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916698|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19916699|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19916700|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916701|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19916702|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19916703|NCT01217814|Leucovorin|leucovorin|mesh-list
19916704|NCT01217814|Folic Acid|folic acid|mesh-list
19916705|NCT01217814|Golimumab|golimumab|mesh-list
19916706|NCT01217814|Methotrexate|methotrexate|mesh-list
19916707|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
19916708|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19916709|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
19916710|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19916711|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916712|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19916713|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
19916714|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916715|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916716|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916717|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916718|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19916719|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19916720|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
19916721|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19916722|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19916723|NCT01217814|Antidotes|antidotes|mesh-ancestor
19916724|NCT01217814|Protective Agents|protective agents|mesh-ancestor
19916725|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
19916726|NCT01217814|Vitamins|vitamins|mesh-ancestor
19916727|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
19916728|NCT01217814|Hematinics|hematinics|mesh-ancestor
19916729|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19916730|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916731|NCT01217840|Vitamin D|vitamin d|mesh-list
19916732|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
19916733|NCT01217840|Vitamins|vitamins|mesh-ancestor
19916734|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
19916735|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916736|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19916737|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19916738|NCT01217892|Metformin|metformin|mesh-list
19916739|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
19916740|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19916741|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916742|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19916743|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916744|NCT01217944|Ranibizumab|ranibizumab|mesh-list
19916745|NCT01217944|Verteporfin|verteporfin|mesh-list
19916746|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916747|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916748|NCT01217944|Growth Substances|growth substances|mesh-ancestor
19916749|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916750|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916751|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916752|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19916753|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
19916754|NCT01217957|Dexamethasone|dexamethasone|mesh-list
19916755|NCT01217957|Lenalidomide|lenalidomide|mesh-list
19916756|NCT01217957|Ixazomib|ixazomib|mesh-list
19916757|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916758|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
19916759|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
19916760|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916761|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916762|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19916763|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
19916764|NCT01217957|Hormones|hormones|mesh-ancestor
19916765|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916766|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19916767|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916768|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
19916769|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916770|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916771|NCT01217957|Growth Substances|growth substances|mesh-ancestor
19916772|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916773|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
19916774|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916775|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916776|NCT01218009|Albuterol|albuterol|mesh-list
19916777|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19916778|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
19916779|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916780|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916781|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19916782|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
19916783|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
19916784|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19916785|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19916786|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19916787|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19916788|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916789|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916790|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916791|NCT01218048|Carboplatin|carboplatin|mesh-list
19916792|NCT01218048|Cetuximab|cetuximab|mesh-list
19916793|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916794|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19916795|NCT01218100|Lisinopril|lisinopril|mesh-list
19916796|NCT01218100|Nebivolol|nebivolol|mesh-list
19916797|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19916798|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
19916799|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916800|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916801|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19916802|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19916803|NCT01218100|Protective Agents|protective agents|mesh-ancestor
20261291|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261292|NCT00495781|Iron|iron|mesh-list
20261293|NCT00495781|Trace Elements|trace elements|mesh-ancestor
19916804|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916805|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
19916806|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19916807|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19916808|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19916809|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
19916810|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19916811|NCT01218204|Atorvastatin|atorvastatin|mesh-list
19916812|NCT01218204|Ezetimibe|ezetimibe|mesh-list
19916813|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19916814|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19916815|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
19916816|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916817|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19916818|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19916819|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916820|NCT01218308|Vaccines|vaccines|mesh-list
19916821|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
19916822|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916823|NCT01218399|Budesonide|budesonide|mesh-list
19916824|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19916825|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916826|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19916827|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
19916828|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916829|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916830|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19916831|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
19916832|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
19916833|NCT01218399|Hormones|hormones|mesh-ancestor
19916834|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916835|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19916836|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
19916837|NCT01218438|Antibodies|antibodies|mesh-list
19916838|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
19916839|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19916840|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19916841|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
19916842|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
19916843|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916844|NCT01218477|Dasatinib|dasatinib|mesh-list
19916845|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916846|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19916847|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916848|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916849|NCT01218516|Paclitaxel|paclitaxel|mesh-list
19916850|NCT01218516|Carboplatin|carboplatin|mesh-list
19916851|NCT01218516|Pemetrexed|pemetrexed|mesh-list
19916852|NCT01218516|Farletuzumab|farletuzumab|mesh-list
19916853|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19916854|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916855|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
19916856|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
19916857|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
19916858|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916859|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916860|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19916861|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20261294|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
20261295|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287063|NCT05332561|Olaparib|olaparib|mesh-list
19916862|NCT01218594|Endostatins|endostatins|mesh-list
19916863|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916864|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916865|NCT01218594|Growth Substances|growth substances|mesh-ancestor
19916866|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916867|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916868|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916869|NCT01218646|Vaccines|vaccines|mesh-list
19916870|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
19916871|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916872|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19916873|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19916874|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19916875|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
19916876|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916877|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19916878|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19916879|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19916880|NCT01218867|Aldesleukin|aldesleukin|mesh-list
19916881|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
19916882|NCT01218867|Fludarabine|fludarabine|mesh-list
19916883|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19916884|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
19916885|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916886|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19916887|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19916888|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
19916889|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916890|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916891|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19916892|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19916893|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19916894|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
19916895|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972291|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19972292|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19972293|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972294|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972295|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972296|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
19972297|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972298|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19972299|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
19972300|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19972301|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19972302|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19972303|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972304|NCT01808651|Fluoxetine|fluoxetine|mesh-list
19972305|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19972306|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19972307|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972308|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972309|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972310|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
19972311|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972312|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19972313|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
19972314|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19972315|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19972316|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19972317|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972318|NCT01808690|Metformin|metformin|mesh-list
19972319|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972320|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972321|NCT01808755|Trimethoprim|trimethoprim|mesh-list
19972322|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
19972323|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19972324|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972325|NCT01808755|Renal Agents|renal agents|mesh-ancestor
19972326|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
19972327|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19972328|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19972329|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19916896|NCT01218958|Naltrexone|naltrexone|mesh-list
19916897|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19916898|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19916899|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916900|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
19916901|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916902|NCT01218971|Naltrexone|naltrexone|mesh-list
19916903|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19916904|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19916905|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916906|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
19916907|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916908|NCT01218984|Naltrexone|naltrexone|mesh-list
19916909|NCT01218984|Hydromorphone|hydromorphone|mesh-list
19916910|NCT01218984|Naloxone|naloxone|mesh-list
19916911|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19916912|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19916913|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916914|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
19916915|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916916|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19916917|NCT01218984|Narcotics|narcotics|mesh-ancestor
19916918|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916919|NCT01218984|Analgesics|analgesics|mesh-ancestor
19916920|NCT01218997|Naltrexone|naltrexone|mesh-list
19916921|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19916922|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19916923|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916924|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
19916925|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916926|NCT01219738|Budesonide|budesonide|mesh-list
19916927|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916928|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19916929|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
19916930|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261296|NCT00495846|Octreotide|octreotide|mesh-list
20261297|NCT00495846|Lanreotide|lanreotide|mesh-list
19916931|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916932|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19916933|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
19916934|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
19916935|NCT01219738|Hormones|hormones|mesh-ancestor
20261298|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20261299|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20261300|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261301|NCT00495872|Lenalidomide|lenalidomide|mesh-list
20261302|NCT00495872|Sunitinib|sunitinib|mesh-list
20261303|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20261304|NCT00495872|Sorafenib|sorafenib|mesh-list
20261305|NCT00495872|Dasatinib|dasatinib|mesh-list
20261306|NCT00495872|Lapatinib|lapatinib|mesh-list
20541212|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541213|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554031|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554032|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554033|NCT01932554|Analgesics|analgesics|mesh-ancestor
20554034|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
19916936|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916937|NCT01219777|Paclitaxel|paclitaxel|mesh-list
19916938|NCT01219777|Bevacizumab|bevacizumab|mesh-list
19916939|NCT01219777|Carboplatin|carboplatin|mesh-list
19916940|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19916941|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916942|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261307|NCT00495872|Valproic Acid|valproic acid|mesh-list
20554035|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554036|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19732390|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732391|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732392|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732393|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19732394|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19732395|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
19732396|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19732397|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732398|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732399|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20261308|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
20261309|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261310|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916943|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
19916944|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
19916945|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19916946|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19916947|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19916948|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19916949|NCT01219777|Growth Substances|growth substances|mesh-ancestor
19916950|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916951|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
19916952|NCT01219881|Sevoflurane|sevoflurane|mesh-list
19916953|NCT01219881|Desflurane|desflurane|mesh-list
19916954|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19916955|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19916956|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
19916957|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
19916958|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916959|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916960|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
19916961|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19916962|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19916963|NCT01219933|Prednisolone|prednisolone|mesh-list
19916964|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
19916965|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19916966|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
19916967|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19916968|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
19916969|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
19916970|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916971|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916972|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19916973|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
19916974|NCT01219933|Hormones|hormones|mesh-ancestor
19916975|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19916976|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19916977|NCT01219933|Protective Agents|protective agents|mesh-ancestor
19916978|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19916979|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19916980|NCT01219959|Icodextrin|icodextrin|mesh-list
20261311|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20261312|NCT00495872|Growth Substances|growth substances|mesh-ancestor
19916981|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
19916982|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19916983|NCT01220024|Bupivacaine|bupivacaine|mesh-list
19916984|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
19916985|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
19916986|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19916987|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19916988|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
19916989|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19916990|NCT01220128|Paclitaxel|paclitaxel|mesh-list
19916991|NCT01220128|Docetaxel|docetaxel|mesh-list
19916992|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
19916993|NCT01220128|Carboplatin|carboplatin|mesh-list
19916994|NCT01220128|Doxorubicin|doxorubicin|mesh-list
19916995|NCT01220128|Fluorouracil|fluorouracil|mesh-list
19916996|NCT01220128|Trastuzumab|trastuzumab|mesh-list
19916997|NCT01220128|Epirubicin|epirubicin|mesh-list
19916998|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19916999|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19917000|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917001|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
19917002|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
19917003|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
19917004|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917005|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917006|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
19917007|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917008|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19917009|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19917010|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
19917011|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19917012|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19917013|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19917014|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19917015|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917016|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
19917017|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19917018|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19917019|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19917020|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19917021|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
19917022|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19917023|NCT01220167|Ondansetron|ondansetron|mesh-list
19917024|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
19917025|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
19917026|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917027|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917028|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19917029|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
19917030|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
19917031|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19917032|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
19917033|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917034|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917035|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19917036|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19917037|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261313|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
20261314|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261315|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261316|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261317|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261318|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
19917038|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19917039|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19917040|NCT01220180|Pregabalin|pregabalin|mesh-list
19917041|NCT01220180|Analgesics|analgesics|mesh-ancestor
19917042|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
19917043|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917044|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917045|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
19917046|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19917047|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917048|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917049|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917050|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19917051|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19917052|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917053|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19917054|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
19917055|NCT01220297|Sirolimus|sirolimus|mesh-list
19917056|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
19917057|NCT01220297|Carmustine|carmustine|mesh-list
19917058|NCT01220297|Etoposide|etoposide|mesh-list
19917059|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
19917060|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917061|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
19917062|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917063|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19917064|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19917065|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
19917066|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917067|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917068|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19917069|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19917070|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19917071|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19917072|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917073|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19917074|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19917075|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
19917076|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19917077|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917078|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
19917079|NCT01220414|Naltrexone|naltrexone|mesh-list
19917080|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19917081|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19917082|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917083|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
19917084|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917085|NCT01220557|Insulin|insulin|mesh-list
19917086|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19917087|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917088|NCT01220609|Epothilones|epothilones|mesh-list
19917089|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
19917090|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
19917091|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
19917092|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917093|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917094|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
19917095|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19917096|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
19917097|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917098|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917099|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19917100|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
19917101|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19917102|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
19917103|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917104|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917105|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19917106|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
19917107|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
19917108|NCT01220687|Protective Agents|protective agents|mesh-ancestor
19917109|NCT01220973|Celecoxib|celecoxib|mesh-list
19917110|NCT01220973|Atorvastatin|atorvastatin|mesh-list
19917111|NCT01220973|Calcium|calcium|mesh-list
19917112|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917113|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917114|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19917115|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19917116|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
19917117|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917118|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19917119|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19917120|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917121|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19917122|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19917123|NCT01220973|Analgesics|analgesics|mesh-ancestor
19917124|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
19917125|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917126|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19917127|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19917128|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19917129|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19917130|NCT01221181|Eculizumab|eculizumab|mesh-list
19917131|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19917132|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917133|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
19917134|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917135|NCT01221207|Calpastatin|calpastatin|mesh-list
19917136|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19917137|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
19917138|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917139|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917140|NCT01221272|Ranolazine|ranolazine|mesh-list
19917141|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19917142|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917143|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917144|NCT01221298|Ritonavir|ritonavir|mesh-list
19917145|NCT01221298|Ribavirin|ribavirin|mesh-list
19917146|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19917147|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19917148|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
19917149|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917150|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917151|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19917152|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19917153|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
19917154|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917155|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19917156|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19917157|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
19917158|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
19917159|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
19917160|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917161|NCT01221350|Protective Agents|protective agents|mesh-ancestor
19917162|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917163|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
19917164|NCT01221350|Vitamins|vitamins|mesh-ancestor
19917165|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
19917166|NCT01221727|Denosumab|denosumab|mesh-list
19917167|NCT01221727|Midazolam|midazolam|mesh-list
19917168|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19917169|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19917170|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917171|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917172|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19917173|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19917174|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19917175|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19917176|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
19917177|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
19917178|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
19917179|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
19917180|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917181|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917182|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19917183|NCT01221753|Carboplatin|carboplatin|mesh-list
19917184|NCT01221753|Docetaxel|docetaxel|mesh-list
19917185|NCT01221753|Fluorouracil|fluorouracil|mesh-list
19917186|NCT01221753|Cetuximab|cetuximab|mesh-list
19917187|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917188|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
19917189|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
19917190|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
19917191|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917192|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
19917193|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19917194|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917195|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
19917196|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917197|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19917198|NCT01222091|Propranolol|propranolol|mesh-list
19917199|NCT01222091|Remifentanil|remifentanil|mesh-list
19917200|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19917201|NCT01222091|Narcotics|narcotics|mesh-ancestor
19917202|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917203|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917204|NCT01222091|Analgesics|analgesics|mesh-ancestor
19917205|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
19917206|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917207|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19917208|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19917209|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
19917210|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917211|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917212|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19917213|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917214|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
19917215|NCT01222117|Plasminogen|plasminogen|mesh-list
19917216|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19917217|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
19917218|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19917219|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19917220|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917221|NCT01222195|Lenalidomide|lenalidomide|mesh-list
19917222|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
19917223|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
19917224|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917225|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19917226|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19917227|NCT01222195|Growth Substances|growth substances|mesh-ancestor
19917228|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
19917229|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917230|NCT01222195|Hematinics|hematinics|mesh-ancestor
19917231|NCT01222234|Vitamin D|vitamin d|mesh-list
19917232|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
19917233|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
19917234|NCT01222234|Calcitriol|calcitriol|mesh-list
19917235|NCT01222234|Vitamins|vitamins|mesh-list
19917236|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
19917237|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917238|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19917239|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917240|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19917241|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917242|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917243|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19917244|NCT01222260|Dexamethasone|dexamethasone|mesh-list
19917245|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19917246|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19917247|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
19917248|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
19917249|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917250|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917251|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19917252|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
19917253|NCT01222260|Hormones|hormones|mesh-ancestor
19917254|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19917255|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19917256|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917257|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19917258|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
19917259|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917260|NCT01222273|Vitamin D|vitamin d|mesh-list
19917261|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
19917262|NCT01222273|Vitamins|vitamins|mesh-ancestor
19917263|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
19917264|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917265|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19917266|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917267|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
19917268|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19917269|NCT01222403|Vaccines|vaccines|mesh-list
19917270|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
19917271|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
19917272|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917273|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19917274|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19917275|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917276|NCT01222520|Amlodipine|amlodipine|mesh-list
19917277|NCT01222520|Telmisartan|telmisartan|mesh-list
19917278|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19917279|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917280|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19917281|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917282|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917283|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917284|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917285|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
19917286|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19917287|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19917288|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
19917289|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19917290|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
19917291|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917292|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917293|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19917294|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
19917295|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
19917296|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19917297|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
19917298|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917299|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917300|NCT01222572|Etoposide|etoposide|mesh-list
19917301|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917302|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19917303|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19917304|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19917305|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917306|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917307|NCT01222585|Metronidazole|metronidazole|mesh-list
19917308|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917309|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19917310|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19917311|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19917312|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19917313|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917314|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19917315|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917316|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917317|NCT01222715|Sirolimus|sirolimus|mesh-list
19917318|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
19917319|NCT01222715|Bevacizumab|bevacizumab|mesh-list
19917320|NCT01222715|Vinorelbine|vinorelbine|mesh-list
19917321|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19917322|NCT01222715|Antibodies|antibodies|mesh-list
19917323|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
19917324|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19917325|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
19917326|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
19917327|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917328|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
19917329|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917330|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19917331|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19917332|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
19917333|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917334|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917335|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19917336|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19917337|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19917338|NCT01222715|Growth Substances|growth substances|mesh-ancestor
19917339|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
19917340|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19917341|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917342|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19917343|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
19917344|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19917345|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
19917346|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
19917347|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
19917348|NCT01222832|Bacitracin|bacitracin|mesh-list
19917349|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19917350|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917351|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19917352|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19917353|NCT01222884|Hematinics|hematinics|mesh-ancestor
19917354|NCT01223027|Sorafenib|sorafenib|mesh-list
20261319|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
20261320|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261321|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
20261322|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20261323|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261324|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20261325|NCT00495898|Sirolimus|sirolimus|mesh-list
20261326|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261327|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261328|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20261329|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261330|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
20261331|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261332|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
20261333|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261334|NCT00496002|Adefovir|adefovir|mesh-list
20261335|NCT00496002|Clevudine|clevudine|mesh-list
20261336|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
20261337|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261338|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20261339|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20261340|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261341|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261342|NCT00496028|Paclitaxel|paclitaxel|mesh-list
20541214|NCT01856946|Vitamin D|vitamin d|mesh-list
20541215|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
20541216|NCT01856946|Vitamins|vitamins|mesh-ancestor
20541217|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
20541218|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541219|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20541220|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20541221|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
20541222|NCT01856959|Albuterol|albuterol|mesh-list
20541223|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20541224|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
20541225|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541226|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541227|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20541228|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541229|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
20541230|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20541231|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20541232|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20541233|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20541234|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541235|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541236|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541237|NCT01856959|Analgesics|analgesics|mesh-ancestor
20541238|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
20541239|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
20541240|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541241|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20541242|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
20541243|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20541244|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541245|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20541246|NCT01856985|Misoprostol|misoprostol|mesh-list
20541247|NCT01856985|Mifepristone|mifepristone|mesh-list
20541248|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20541249|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
20541250|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20541251|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917355|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261343|NCT00496028|Carboplatin|carboplatin|mesh-list
19917356|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19917357|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917358|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917359|NCT01223196|Pioglitazone|pioglitazone|mesh-list
19917360|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19917361|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917362|NCT01223235|Bevacizumab|bevacizumab|mesh-list
19917363|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20261344|NCT00496028|Saracatinib|saracatinib|mesh-list
20261345|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20261346|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261347|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261348|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
20261349|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261350|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261351|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261352|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20261353|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
20261354|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261355|NCT00496158|Adefovir|adefovir|mesh-list
20261356|NCT00496158|Clevudine|clevudine|mesh-list
20261357|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
20261358|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261359|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20261360|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20261361|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261362|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261363|NCT00496184|Nifedipine|nifedipine|mesh-list
20261364|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20261365|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20261366|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261367|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20261368|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261369|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
20261370|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
20261371|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261372|NCT00496223|Sunitinib|sunitinib|mesh-list
20261373|NCT00496223|Dacarbazine|dacarbazine|mesh-list
20261374|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261375|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20261376|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20261377|NCT00496223|Growth Substances|growth substances|mesh-ancestor
20261378|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261379|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
20261380|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261381|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261382|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261383|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20261384|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
20261385|NCT00496275|Gemcitabine|gemcitabine|mesh-list
20261386|NCT00496275|Cisplatin|cisplatin|mesh-list
20261387|NCT00496275|Vinorelbine|vinorelbine|mesh-list
20261388|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261389|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261390|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
20261391|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261392|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
20261393|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261394|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261395|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261396|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
20261397|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261398|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20261399|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261400|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
20261401|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261402|NCT00496301|Gemcitabine|gemcitabine|mesh-list
20261403|NCT00496301|Capecitabine|capecitabine|mesh-list
20261404|NCT00496301|Sorafenib|sorafenib|mesh-list
20261405|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261406|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
20261407|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261408|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261409|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
19917364|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917365|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19917366|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19917367|NCT01223235|Growth Substances|growth substances|mesh-ancestor
19917368|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917369|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
19917370|NCT01223352|Bosentan|bosentan|mesh-list
19917371|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917372|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19917373|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917374|NCT01223365|Hydrocodone|hydrocodone|mesh-list
19917375|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19917376|NCT01223365|Narcotics|narcotics|mesh-ancestor
19917377|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917378|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917379|NCT01223365|Analgesics|analgesics|mesh-ancestor
19917380|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
19917381|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917382|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
19917383|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
19917384|NCT01223378|Latanoprost|latanoprost|mesh-list
19917385|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19917386|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19917387|NCT01223404|Mecamylamine|mecamylamine|mesh-list
19917388|NCT01223404|Nicotine|nicotine|mesh-list
19917389|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19917390|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
19917391|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917392|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917393|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19917394|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19917395|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
19917396|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917397|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917398|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917399|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19917400|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19917401|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19917402|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19917403|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
19917404|NCT01223937|Coagulants|coagulants|mesh-ancestor
19917405|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19917406|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
19917407|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917408|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19917409|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19917410|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19917411|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917412|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917413|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19917414|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917415|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917416|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
19917417|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917418|NCT01224145|Bupivacaine|bupivacaine|mesh-list
19917419|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
19917420|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
19917421|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917422|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917423|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
19917424|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917425|NCT01224171|Vedolizumab|vedolizumab|mesh-list
19917426|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19917427|NCT01224210|Ambrisentan|ambrisentan|mesh-list
19917428|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917429|NCT01224431|Lidocaine|lidocaine|mesh-list
19917430|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
19917431|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
19917432|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917433|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917434|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
19917435|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917436|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19917437|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19917438|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19917439|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917440|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917441|NCT01224626|Linezolid|linezolid|mesh-list
19917442|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19917443|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917444|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19917445|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917446|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917447|NCT01224639|Vaccines|vaccines|mesh-list
19917448|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
19917449|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917450|NCT01224678|Vitamin D|vitamin d|mesh-list
19917451|NCT01224678|Vitamins|vitamins|mesh-ancestor
19917452|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
19917453|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917454|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19917455|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
19917456|NCT01224821|Antibodies|antibodies|mesh-list
19917457|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
19917458|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917459|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917460|NCT01225055|Teriparatide|teriparatide|mesh-list
19917461|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917462|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917463|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19917464|NCT01225068|Milnacipran|milnacipran|mesh-list
19917465|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
19917466|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19917467|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19917468|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917469|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917470|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917471|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917472|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19917473|NCT01225068|Analgesics|analgesics|mesh-ancestor
19917474|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
19917475|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917476|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
19917477|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19917478|NCT01225146|Ranibizumab|ranibizumab|mesh-list
19917479|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19917480|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19917481|NCT01225146|Growth Substances|growth substances|mesh-ancestor
19917482|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917483|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
19917484|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972330|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972331|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972332|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19972333|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19972334|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19972335|NCT01809054|Aspirin|aspirin|mesh-list
19972336|NCT01809054|Fondaparinux|fondaparinux|mesh-list
19972337|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19972338|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19972339|NCT01809054|Analgesics|analgesics|mesh-ancestor
19972340|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
19972341|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972342|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972343|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972344|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972345|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19972346|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19972347|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972348|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19972349|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19972350|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972351|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
19972352|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19972353|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
19972354|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19972355|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
19972356|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
19972357|NCT01809106|Fentanyl|fentanyl|mesh-list
19917485|NCT01225172|Letrozole|letrozole|mesh-list
19917486|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917487|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19917488|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19917489|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917490|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917491|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19917492|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
19917493|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19917494|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917495|NCT01225211|Ivacaftor|ivacaftor|mesh-list
19917496|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19917497|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917498|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917499|NCT01225263|Vitamin D|vitamin d|mesh-list
19917500|NCT01225263|Simvastatin|simvastatin|mesh-list
19917501|NCT01225263|Vitamins|vitamins|mesh-ancestor
19917502|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
19917503|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917504|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19917505|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19917506|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19917507|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
19917508|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917509|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19917510|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19917511|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917512|NCT01225289|Vitamin A|vitamin a|mesh-list
19917513|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
19917514|NCT01225289|Vitamins|vitamins|mesh-ancestor
19917515|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
19917516|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917517|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
19917518|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917519|NCT01225289|Protective Agents|protective agents|mesh-ancestor
19917520|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19917521|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917522|NCT01225354|Calcium|calcium|mesh-list
19917523|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917524|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917525|NCT01225549|Budesonide|budesonide|mesh-list
19917526|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19917527|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19917528|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
19917529|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917530|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917531|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19917532|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
19917533|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
19917534|NCT01225549|Hormones|hormones|mesh-ancestor
19917535|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19917536|NCT01225562|Ticagrelor|ticagrelor|mesh-list
19917537|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19917538|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19917539|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19917540|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19917541|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
19917542|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917543|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917544|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917545|NCT01225822|Enoxaparin|enoxaparin|mesh-list
19917546|NCT01225822|Dabigatran|dabigatran|mesh-list
19917547|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
19917548|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19917549|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19917550|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917551|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
19917552|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19917553|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
19917554|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917555|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19917556|NCT01225835|Cetrorelix|cetrorelix|mesh-list
19917557|NCT01225835|Menotropins|menotropins|mesh-list
19917558|NCT01225835|Progesterone|progesterone|mesh-list
19917559|NCT01225835|Progestins|progestins|mesh-ancestor
19917560|NCT01225835|Hormones|hormones|mesh-ancestor
19917561|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19917562|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917563|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19917564|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19917565|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
19917566|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
19917567|NCT01225887|Nintedanib|nintedanib|mesh-list
19917568|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917569|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19917570|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917571|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917572|NCT01225991|Milnacipran|milnacipran|mesh-list
19917573|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
19917574|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19917575|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19917576|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917577|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917578|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917579|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917580|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19917581|NCT01225991|Analgesics|analgesics|mesh-ancestor
19917582|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
19917583|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917584|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
19917585|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19917586|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
19917587|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19917588|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917589|NCT01226420|Alefacept|alefacept|mesh-list
19917590|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
19917591|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
19917592|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917593|NCT01226459|Minoxidil|minoxidil|mesh-list
19917594|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917595|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
19917596|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
19917597|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917598|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19917599|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19917600|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19917601|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917602|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917603|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917604|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917605|NCT01226511|Analgesics|analgesics|mesh-ancestor
19917606|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
19917607|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917608|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
19917609|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19917610|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
19917611|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
19917612|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19917613|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19917614|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19917615|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917616|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917617|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
19917618|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917619|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917620|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19917621|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917622|NCT01226719|Leucovorin|leucovorin|mesh-list
19917623|NCT01226719|Fluorouracil|fluorouracil|mesh-list
19917624|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
19917625|NCT01226719|Irinotecan|irinotecan|mesh-list
19917626|NCT01226719|Panitumumab|panitumumab|mesh-list
19917627|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
19917628|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917629|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19917630|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917631|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917632|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
19917633|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917634|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19917635|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19917636|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917637|NCT01226719|Antidotes|antidotes|mesh-ancestor
19917638|NCT01226719|Protective Agents|protective agents|mesh-ancestor
19917639|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
19917640|NCT01226719|Vitamins|vitamins|mesh-ancestor
19917641|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
19917642|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19917643|NCT01226745|Ceralifimod|ceralifimod|mesh-list
19917644|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19917645|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917646|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917647|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
19917648|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261410|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261411|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261412|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261413|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
20261414|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261415|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261416|NCT00496392|Fentanyl|fentanyl|mesh-list
20261417|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20261418|NCT00496392|Narcotics|narcotics|mesh-ancestor
20261419|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261420|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261421|NCT00496392|Analgesics|analgesics|mesh-ancestor
20261422|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
20261423|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261424|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20261425|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20261426|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
20261427|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
20261428|NCT00496405|Bevacizumab|bevacizumab|mesh-list
20261429|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20261430|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261431|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20261432|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20261433|NCT00496405|Growth Substances|growth substances|mesh-ancestor
20261434|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261435|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
20261436|NCT00496444|Azacitidine|azacitidine|mesh-list
20261437|NCT00496444|Valproic Acid|valproic acid|mesh-list
20261438|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261439|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
20541252|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19917649|NCT01227044|Naltrexone|naltrexone|mesh-list
19917650|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19917651|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19917652|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541253|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541254|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
20541255|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20541256|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20541257|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20541258|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20541259|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
20541260|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20541261|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20541262|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
20541263|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541264|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
20541265|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20541266|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19917653|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
19917654|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917655|NCT01227278|Benralizumab|benralizumab|mesh-list
19917656|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19917657|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
19917658|NCT01227395|Azithromycin|azithromycin|mesh-list
19917659|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19917660|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917661|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
19917662|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20261440|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917663|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917664|NCT01227434|Palbociclib|palbociclib|mesh-list
19917665|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917666|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19917667|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917668|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917669|NCT01227512|Tolvaptan|tolvaptan|mesh-list
19917670|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19917671|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917672|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
19917673|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917674|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
19917675|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19917676|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
19917677|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917678|NCT01227629|Warfarin|warfarin|mesh-list
19917679|NCT01227629|Dabigatran|dabigatran|mesh-list
19917680|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
19917681|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
19917682|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19917683|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
19917684|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917685|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917686|NCT01227655|Levodopa|levodopa|mesh-list
19917687|NCT01227655|Carbidopa|carbidopa|mesh-list
19917688|NCT01227655|Opicapone|opicapone|mesh-list
19917689|NCT01227655|Benserazide|benserazide|mesh-list
19917690|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19917691|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19917692|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
19917693|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917694|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917695|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917696|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19917697|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917698|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19917699|NCT01227668|Aripiprazole|aripiprazole|mesh-list
19917700|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
19917701|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19917702|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19917703|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19917704|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917705|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917706|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
19917707|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
19917708|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917709|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732400|NCT04574960|Gemcitabine|gemcitabine|mesh-list
19732401|NCT04574960|Carboplatin|carboplatin|mesh-list
19732402|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732403|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19732404|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
19732405|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732406|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
19732407|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732408|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732409|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917710|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19917711|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19917712|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
19917713|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19917714|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19917715|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19917716|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19917717|NCT01227707|Leucovorin|leucovorin|mesh-list
19917718|NCT01227707|Bevacizumab|bevacizumab|mesh-list
19917719|NCT01227707|Fluorouracil|fluorouracil|mesh-list
19917720|NCT01227707|Capecitabine|capecitabine|mesh-list
19917721|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19917722|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917723|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19917724|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19917725|NCT01227707|Growth Substances|growth substances|mesh-ancestor
19732410|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
19917726|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917727|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
19917728|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
19917729|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917730|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19917731|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917732|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
19917733|NCT01227707|Antidotes|antidotes|mesh-ancestor
19917734|NCT01227707|Protective Agents|protective agents|mesh-ancestor
19917735|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
19917736|NCT01227707|Vitamins|vitamins|mesh-ancestor
19917737|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
19917738|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
19917739|NCT01227824|Dolutegravir|dolutegravir|mesh-list
19917740|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19917741|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19917742|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
19917743|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917744|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19917745|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19917746|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917747|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917748|NCT01227889|Dacarbazine|dacarbazine|mesh-list
19917749|NCT01227889|Dabrafenib|dabrafenib|mesh-list
19917750|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19917751|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
19917752|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917753|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917754|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19917755|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917756|NCT01227902|Ezogabine|ezogabine|mesh-list
19917757|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
19917758|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917759|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917760|NCT01227967|Ribavirin|ribavirin|mesh-list
19917761|NCT01227967|Oseltamivir|oseltamivir|mesh-list
19917762|NCT01227967|Amantadine|amantadine|mesh-list
19917763|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
19917764|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917765|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
19917766|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19917767|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917768|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19917769|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19917770|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
19917771|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917772|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917773|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19917774|NCT01227967|Analgesics|analgesics|mesh-ancestor
19917775|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
19917776|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917777|NCT01227993|Finasteride|finasteride|mesh-list
19917778|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19917779|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19917780|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917781|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917782|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
19917783|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19917784|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917785|NCT01227993|Urological Agents|urological agents|mesh-ancestor
19917786|NCT01228019|Niacin|niacin|mesh-list
19917787|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19917788|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
19917789|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917790|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19917791|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
19917792|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
19917793|NCT01228019|Vitamins|vitamins|mesh-ancestor
19917794|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
19917795|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917796|NCT01228071|Testosterone|testosterone|mesh-list
19917797|NCT01228071|Androgens|androgens|mesh-ancestor
20261441|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261442|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917798|NCT01228071|Hormones|hormones|mesh-ancestor
19917799|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261443|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
19917800|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917801|NCT01228084|Sulforaphane|sulforaphane|mesh-list
19917802|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19917803|NCT01228084|Protective Agents|protective agents|mesh-ancestor
19917804|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917805|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917806|NCT01228149|Acetazolamide|acetazolamide|mesh-list
19917807|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
19917808|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20261444|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
20261445|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261446|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261447|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
20261448|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20261449|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261450|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20261451|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
20261452|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261453|NCT00496600|Everolimus|everolimus|mesh-list
20261454|NCT00496600|Epothilone B|epothilone b|mesh-list
20261455|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261456|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261457|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
20261458|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261459|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261460|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
20261461|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261462|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261463|NCT00496652|Zalutumumab|zalutumumab|mesh-list
20261464|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20261465|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261466|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
20261467|NCT00496665|Methotrexate|methotrexate|mesh-list
20261468|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261469|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
20261470|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261471|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20261472|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20261473|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
20261474|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261475|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541267|NCT01856998|Propofol|propofol|mesh-list
20541268|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20541269|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541270|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541271|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20541272|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
20541273|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
20541274|NCT01857011|Iron|iron|mesh-list
20541275|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20541276|NCT01857011|Teferrol|teferrol|mesh-list
20541277|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
20541278|NCT01857011|Trace Elements|trace elements|mesh-ancestor
20541279|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
20541280|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541281|NCT01857011|Hematinics|hematinics|mesh-ancestor
20541282|NCT01857024|Sevelamer|sevelamer|mesh-list
20541283|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
20541284|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
20541285|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541286|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
20541287|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20541288|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541289|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541290|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541291|NCT01857141|Analgesics|analgesics|mesh-ancestor
20541292|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
20541293|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541294|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20541295|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20541296|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20541297|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541298|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917809|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261476|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20541299|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917810|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917811|NCT01228149|Diuretics|diuretics|mesh-ancestor
19917812|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
19917813|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917814|NCT01228175|Riboflavin|riboflavin|mesh-list
19917815|NCT01228175|Varenicline|varenicline|mesh-list
19917816|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19917817|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19917818|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
19917819|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917820|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917821|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917822|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
19917823|NCT01228175|Vitamins|vitamins|mesh-ancestor
19917824|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
19917825|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19917826|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
19917827|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
19917828|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19917829|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917830|NCT01228734|Leucovorin|leucovorin|mesh-list
19917831|NCT01228734|Folic Acid|folic acid|mesh-list
19917832|NCT01228734|Fluorouracil|fluorouracil|mesh-list
19917833|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
19917834|NCT01228734|Cetuximab|cetuximab|mesh-list
19917835|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
19917836|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
19917837|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917838|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19917839|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917840|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917841|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
19917842|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917843|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19917844|NCT01228734|Antidotes|antidotes|mesh-ancestor
19917845|NCT01228734|Protective Agents|protective agents|mesh-ancestor
19917846|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
19917847|NCT01228734|Vitamins|vitamins|mesh-ancestor
19917848|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
19917849|NCT01228734|Hematinics|hematinics|mesh-ancestor
19917850|NCT01228747|Levetiracetam|levetiracetam|mesh-list
19917851|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
19917852|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
19917853|NCT01228903|Allopurinol|allopurinol|mesh-list
19917854|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
19917855|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917856|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917857|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
19917858|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19917859|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19917860|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
19917861|NCT01228903|Protective Agents|protective agents|mesh-ancestor
19917862|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917863|NCT01229111|Leucovorin|leucovorin|mesh-list
19917864|NCT01229111|Fluorouracil|fluorouracil|mesh-list
19917865|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
19917866|NCT01229111|Cediranib|cediranib|mesh-list
19917867|NCT01229111|Calcium|calcium|mesh-list
19917868|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
19917869|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19917870|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917871|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
19917872|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917873|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19917874|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917875|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19917876|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
19917877|NCT01229111|Antidotes|antidotes|mesh-ancestor
19917878|NCT01229111|Protective Agents|protective agents|mesh-ancestor
19917879|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
19917880|NCT01229111|Vitamins|vitamins|mesh-ancestor
20261477|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19917881|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
19917882|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917883|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19917884|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19917885|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19917886|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19917887|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917888|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917889|NCT01229176|Vaccines|vaccines|mesh-list
19917890|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19917891|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
19917892|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917893|NCT01229228|Naproxen|naproxen|mesh-list
19917894|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19917895|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19917896|NCT01229228|Analgesics|analgesics|mesh-ancestor
19917897|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
19917898|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917899|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917900|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19917901|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19917902|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
19917903|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19917904|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917905|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917906|NCT01229254|Amiodarone|amiodarone|mesh-list
19917907|NCT01229254|Betrixaban|betrixaban|mesh-list
19917908|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20261478|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
20261479|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261480|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261481|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
20261482|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
20261483|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261484|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20261485|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20261486|NCT00496704|Gemcitabine|gemcitabine|mesh-list
20261487|NCT00496704|Capecitabine|capecitabine|mesh-list
20261488|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
20261489|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261490|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
20261491|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261492|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261493|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
20261494|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261495|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261496|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261497|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
20261498|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261499|NCT00496795|Docetaxel|docetaxel|mesh-list
20261500|NCT00496795|Epirubicin|epirubicin|mesh-list
20261501|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261502|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261503|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
20261504|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261505|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261506|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20261507|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20261508|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19917909|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
19917910|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19917911|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19917912|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917913|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19917914|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19917915|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19917916|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917917|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19917918|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19917919|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19917920|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19917921|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
19917922|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19917923|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
19917924|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
19917925|NCT01229267|Vaccines|vaccines|mesh-list
19917926|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
19917927|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917928|NCT01229371|Vaccines|vaccines|mesh-list
19917929|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
20261509|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917930|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917931|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19917932|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917933|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19917934|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19917935|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19917936|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
19917937|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917938|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917939|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917940|NCT01229423|Bimatoprost|bimatoprost|mesh-list
19917941|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917942|NCT01229449|Acetaminophen|acetaminophen|mesh-list
19917943|NCT01229449|Ibuprofen|ibuprofen|mesh-list
19917944|NCT01229449|Codeine|codeine|mesh-list
19917945|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19917946|NCT01229449|Analgesics|analgesics|mesh-ancestor
19917947|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
19917948|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917949|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917950|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
19917951|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19917952|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19917953|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19917954|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19917955|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19917956|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917957|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19917958|NCT01229449|Narcotics|narcotics|mesh-ancestor
19917959|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917960|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
19917961|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
19917962|NCT01229462|Timolol|timolol|mesh-list
19917963|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19917964|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19917965|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19917966|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19917967|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19917968|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
19917969|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19917970|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19917971|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917972|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19917973|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19917974|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19917975|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19917976|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19917977|NCT01229527|Meperidine|meperidine|mesh-list
19917978|NCT01229527|Remifentanil|remifentanil|mesh-list
19917979|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19917980|NCT01229527|Narcotics|narcotics|mesh-ancestor
19917981|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19917982|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917983|NCT01229527|Analgesics|analgesics|mesh-ancestor
19917984|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
19917985|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19917986|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19917987|NCT01229735|Topiramate|topiramate|mesh-list
19917988|NCT01229735|Levetiracetam|levetiracetam|mesh-list
19917989|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
19917990|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19917991|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917992|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
19917993|NCT01229891|Vitamin D|vitamin d|mesh-list
19917994|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
19917995|NCT01229891|Vitamins|vitamins|mesh-list
19917996|NCT01229891|Calcium|calcium|mesh-list
19917997|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
19917998|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19917999|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19918000|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19918001|NCT01230177|Etanercept|etanercept|mesh-list
19918002|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19918003|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19918004|NCT01230177|Analgesics|analgesics|mesh-ancestor
19918005|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
19972358|NCT01809106|Morphine|morphine|mesh-list
19918006|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918007|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918008|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918009|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918010|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918011|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918012|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
19918013|NCT01230424|Triamcinolone|triamcinolone|mesh-list
19918014|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19918015|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19918016|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19918017|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918018|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
19918019|NCT01230424|Hormones|hormones|mesh-ancestor
19918020|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918021|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918022|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918023|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
19918024|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918025|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918026|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
19918027|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19918028|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918029|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19918030|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
19918031|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918032|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918033|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918034|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918035|NCT01230593|Tobramycin|tobramycin|mesh-list
19918036|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
19918037|NCT01230593|Dexamethasone|dexamethasone|mesh-list
19918038|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
19918039|NCT01230593|BB 1101|bb 1101|mesh-list
19918040|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918041|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
19918042|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
19918043|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918044|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918045|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918046|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
19918047|NCT01230593|Hormones|hormones|mesh-ancestor
19918048|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918049|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19918050|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918051|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
19918052|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918053|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918054|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918055|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918056|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19918057|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19918058|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19918059|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918060|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19918061|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918062|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918063|NCT01230749|Pioglitazone|pioglitazone|mesh-list
19918064|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19918065|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918066|NCT01230814|Metronidazole|metronidazole|mesh-list
19918067|NCT01230814|Miconazole|miconazole|mesh-list
19918068|NCT01230814|Clotrimazole|clotrimazole|mesh-list
19918069|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918070|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918071|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19918072|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19918073|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
19918074|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19918075|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20541300|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
20541301|NCT01857154|Vitamin D|vitamin d|mesh-list
19918076|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918077|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918078|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19732411|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732412|NCT04574947|Lidocaine|lidocaine|mesh-list
19732413|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
19732414|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
19732415|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732416|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732417|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
19732418|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732419|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19732420|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19732421|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19918079|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
19918080|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918081|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918082|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19918083|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19918084|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19972359|NCT01809106|Oxycodone|oxycodone|mesh-list
19972360|NCT01809106|Buprenorphine|buprenorphine|mesh-list
19972361|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19972362|NCT01809106|Narcotics|narcotics|mesh-ancestor
19972363|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972364|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972365|NCT01809106|Analgesics|analgesics|mesh-ancestor
19972366|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
19972367|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972368|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19972369|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19972370|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
19972371|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
19972372|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19972373|NCT01809132|Zinc|zinc|mesh-list
19972374|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
19972375|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19972376|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19972377|NCT01809132|Prednisolone|prednisolone|mesh-list
19972378|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
19972379|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19972380|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
19972381|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
19972382|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19972383|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
19972384|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972385|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
19972386|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
19972387|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972388|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972389|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19972390|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
19972391|NCT01809132|Hormones|hormones|mesh-ancestor
19972392|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972393|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19972394|NCT01809132|Protective Agents|protective agents|mesh-ancestor
19972395|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19972396|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972397|NCT01809132|Trace Elements|trace elements|mesh-ancestor
19972398|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
19972399|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972400|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19972401|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972402|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972403|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19972404|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19972405|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
19972406|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19972407|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
19972408|NCT01809132|Astringents|astringents|mesh-ancestor
19972409|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
19972410|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19972411|NCT01809210|Gemcitabine|gemcitabine|mesh-list
19972412|NCT01809210|Carboplatin|carboplatin|mesh-list
19972413|NCT01809210|Pemetrexed|pemetrexed|mesh-list
20541302|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
19972414|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972415|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19972416|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
19918085|NCT01230827|Golimumab|golimumab|mesh-list
19918086|NCT01230827|Methotrexate|methotrexate|mesh-list
19918087|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19918088|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
19918089|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19918090|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918091|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918092|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
19918093|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918094|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918095|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918096|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918097|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19918098|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918099|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
19918100|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918101|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19918102|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19918103|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918104|NCT01230892|Atenolol|atenolol|mesh-list
19918105|NCT01230892|Nebivolol|nebivolol|mesh-list
19918106|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19918107|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19918108|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
19918109|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
19918110|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918111|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918112|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19918113|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19918114|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19918115|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
19918116|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918117|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918118|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
19918119|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19918120|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19918121|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19918122|NCT01231230|Fluticasone|fluticasone|mesh-list
19918123|NCT01231230|Xhance|xhance|mesh-list
19918124|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19918125|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19918126|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918127|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19918128|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
19918129|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918130|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918131|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19918132|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
19918133|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918134|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19918135|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19918136|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19918137|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19918138|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
19918139|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918140|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918141|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
19918142|NCT01231230|Hormones|hormones|mesh-ancestor
19918143|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918144|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
19918145|NCT01231321|Adalimumab|adalimumab|mesh-list
19918146|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918147|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918148|NCT01231334|Clindamycin|clindamycin|mesh-list
19918149|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
19918150|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
19918151|NCT01231334|Dapsone|dapsone|mesh-list
19918152|NCT01231334|Adapalene|adapalene|mesh-list
19918153|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19918154|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918155|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918156|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19918157|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918158|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918159|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918160|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19918161|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19918162|NCT01231334|Analgesics|analgesics|mesh-ancestor
19918163|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
19918164|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918165|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918166|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918167|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918168|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
19918169|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19918170|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19918171|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19918172|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
19918173|NCT01231373|Polidocanol|polidocanol|mesh-list
19918174|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19918175|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19918176|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
19918177|NCT01231399|Leucovorin|leucovorin|mesh-list
19918178|NCT01231399|Fluorouracil|fluorouracil|mesh-list
19918179|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
19918180|NCT01231399|Everolimus|everolimus|mesh-list
19918181|NCT01231399|Calcium|calcium|mesh-list
19918182|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
19918183|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19918184|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918185|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19918186|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
19918187|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918188|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918189|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261510|NCT00497003|Metoprolol|metoprolol|mesh-list
20261511|NCT00497003|Carvedilol|carvedilol|mesh-list
20261512|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20261513|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20261514|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
20261515|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
20261516|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261517|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261518|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20261519|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20261520|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20261521|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
20261522|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261523|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261524|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
20261525|NCT00497003|Protective Agents|protective agents|mesh-ancestor
20261526|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20261527|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20261528|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20261529|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
20261530|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20261531|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20261532|NCT00497016|Atorvastatin|atorvastatin|mesh-list
20261533|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20261534|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20261535|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
20261536|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261537|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20261538|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20261539|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261540|NCT00497029|Fluorides|fluorides|mesh-list
20261541|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
20261542|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
20541303|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
19918190|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918191|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
19918192|NCT01231399|Antidotes|antidotes|mesh-ancestor
19918193|NCT01231399|Protective Agents|protective agents|mesh-ancestor
19918194|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
19918195|NCT01231399|Vitamins|vitamins|mesh-ancestor
19918196|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
19918197|NCT01231412|Cyclosporine|cyclosporine|mesh-list
19918198|NCT01231412|Sirolimus|sirolimus|mesh-list
19918199|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
19918200|NCT01231412|Fludarabine|fludarabine|mesh-list
20541304|NCT01857154|Calcium|calcium|mesh-list
19918201|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
19918202|NCT01231412|Cyclosporins|cyclosporins|mesh-list
19918203|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918204|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918205|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
19918206|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918207|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918208|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
19918209|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918210|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918211|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
19918212|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918213|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918214|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918215|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19918216|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19918217|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19918218|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
19918219|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918220|NCT01231464|Fluticasone|fluticasone|mesh-list
19918221|NCT01231464|Xhance|xhance|mesh-list
19918222|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918223|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19918224|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
19918225|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918226|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918227|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19918228|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
19918229|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918230|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19918231|NCT01231503|Vaccines|vaccines|mesh-list
19918232|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
19918233|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918234|NCT01231555|Efavirenz|efavirenz|mesh-list
19918235|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19918236|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19918237|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918238|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918239|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
19918240|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918241|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19918242|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19918243|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19918244|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19918245|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19918246|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19918247|NCT01231581|Gemcitabine|gemcitabine|mesh-list
19918248|NCT01231581|Trametinib|trametinib|mesh-list
19918249|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918250|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
19918251|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918252|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918253|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
19918254|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918255|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918256|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918257|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
19918258|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261543|NCT00497029|Protective Agents|protective agents|mesh-ancestor
20261544|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261545|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
20261546|NCT00497107|Leucovorin|leucovorin|mesh-list
20261547|NCT00497107|Calcium|calcium|mesh-list
20261548|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
20261549|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20261550|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261551|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20261552|NCT00497107|Antidotes|antidotes|mesh-ancestor
20261553|NCT00497107|Protective Agents|protective agents|mesh-ancestor
20261554|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
20261555|NCT00497107|Vitamins|vitamins|mesh-ancestor
20261556|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
20261557|NCT00497120|Acetazolamide|acetazolamide|mesh-list
20261558|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
20261559|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20261560|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287064|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19918259|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19918260|NCT01231607|Finasteride|finasteride|mesh-list
19918261|NCT01231607|Dutasteride|dutasteride|mesh-list
19918262|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19918263|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19918264|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918265|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918266|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
19918267|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918268|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918269|NCT01231607|Urological Agents|urological agents|mesh-ancestor
19918270|NCT01231620|Oseltamivir|oseltamivir|mesh-list
19918271|NCT01231620|Zanamivir|zanamivir|mesh-list
19918272|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
19918273|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918274|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918275|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918276|NCT01231633|Dexamethasone|dexamethasone|mesh-list
19918277|NCT01231633|Bevacizumab|bevacizumab|mesh-list
19918278|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20261561|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261562|NCT00497120|Diuretics|diuretics|mesh-ancestor
20261563|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
20261564|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261565|NCT00497172|Sirolimus|sirolimus|mesh-list
20261566|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261567|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261568|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20261569|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261570|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
20261571|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261572|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
20261573|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261574|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20261575|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261576|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261577|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261578|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261579|NCT00497237|Fluticasone|fluticasone|mesh-list
20261580|NCT00497237|Beclomethasone|beclomethasone|mesh-list
20261581|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
20261582|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20261583|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20261584|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20261585|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
20261586|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261587|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261588|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20261589|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
20261590|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
20261591|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20261592|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20261593|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20261594|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20261595|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
20261596|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261597|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261598|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
20261599|NCT00497237|Hormones|hormones|mesh-ancestor
20261600|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261601|NCT00497250|Gefitinib|gefitinib|mesh-list
20261602|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261603|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261604|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261605|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261606|NCT00497315|Pemetrexed|pemetrexed|mesh-list
20261607|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261608|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261609|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261610|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20261611|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20261612|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
19918279|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918280|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19918281|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19918282|NCT01231633|Growth Substances|growth substances|mesh-ancestor
19918283|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918284|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
19918285|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918286|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
19918287|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
19918288|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918289|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918290|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
19918291|NCT01231633|Hormones|hormones|mesh-ancestor
19918292|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918293|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19918294|NCT01231659|Everolimus|everolimus|mesh-list
19918295|NCT01231659|Letrozole|letrozole|mesh-list
19918296|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918297|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918298|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
19918299|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918300|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19918301|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19918302|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918303|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918304|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19918305|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
19918306|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918307|NCT01231841|Cyclosporine|cyclosporine|mesh-list
19918308|NCT01231841|Cyclosporins|cyclosporins|mesh-list
19918309|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
19918310|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19918311|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
19918312|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918313|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918314|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918315|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
19918316|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918317|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
19918318|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918319|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918320|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918321|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19918322|NCT01232127|Ritonavir|ritonavir|mesh-list
19918323|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19918324|NCT01232127|Tenofovir|tenofovir|mesh-list
19918325|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19918326|NCT01232127|Famotidine|famotidine|mesh-list
19918327|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19918328|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19918329|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
19918330|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918331|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918332|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19918333|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19918334|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
19918335|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918336|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19918337|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19918338|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19918339|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19918340|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918341|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19918342|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
19918343|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
19918344|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918345|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918346|NCT01232205|Micronutrients|micronutrients|mesh-list
19918347|NCT01232205|Trace Elements|trace elements|mesh-list
19918348|NCT01232205|Antioxidants|antioxidants|mesh-list
19918349|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918350|NCT01232205|Protective Agents|protective agents|mesh-ancestor
19918351|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918352|NCT01232296|Sorafenib|sorafenib|mesh-list
19918353|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918354|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19918355|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975388|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19918356|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918357|NCT01232452|Pemetrexed|pemetrexed|mesh-list
19918358|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918359|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918360|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918361|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19918362|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19918363|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
19918364|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19918365|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918366|NCT01232504|Molgramostim|molgramostim|mesh-list
19918367|NCT01232504|Sargramostim|sargramostim|mesh-list
19918368|NCT01232504|Lenograstim|lenograstim|mesh-list
19918369|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
19918370|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918371|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19918372|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918373|NCT01232556|Gemcitabine|gemcitabine|mesh-list
19918374|NCT01232556|Rituximab|rituximab|mesh-list
19918375|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19918376|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19918377|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19918378|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918379|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
19918380|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918381|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918382|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918383|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
19918384|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918385|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
19918386|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918387|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918388|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918389|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19918390|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
19918391|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19918392|NCT01232738|Rasagiline|rasagiline|mesh-list
19918393|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19918394|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918395|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918396|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19918397|NCT01232738|Protective Agents|protective agents|mesh-ancestor
19918398|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918399|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
19918400|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19918401|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
19918402|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918403|NCT01232790|Expectorants|expectorants|mesh-ancestor
19918404|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
19918405|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19918406|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
19918407|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918408|NCT01232790|Protective Agents|protective agents|mesh-ancestor
19918409|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918410|NCT01232790|Antidotes|antidotes|mesh-ancestor
19918411|NCT01232829|R04929097|r04929097|mesh-list
19918412|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918413|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918414|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
19918415|NCT01232920|Methotrexate|methotrexate|mesh-list
19918416|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19918417|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
19918418|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19918419|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918420|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918421|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
19918422|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918423|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918424|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918425|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918426|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19918427|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918428|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
19918429|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918430|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19918431|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19918432|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19918433|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
19918434|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918435|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918436|NCT01232946|Insulin|insulin|mesh-list
19918437|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19918438|NCT01232946|Liraglutide|liraglutide|mesh-list
19918439|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
19918440|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19918441|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918442|NCT01232946|Incretins|incretins|mesh-ancestor
19918443|NCT01232946|Hormones|hormones|mesh-ancestor
19918444|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918445|NCT01233050|Ethanol|ethanol|mesh-list
19918446|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
19918447|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19918448|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19918449|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918450|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19918451|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918452|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
19918453|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918454|NCT01233258|Factor VIII|factor viii|mesh-list
19918455|NCT01233258|Coagulants|coagulants|mesh-ancestor
19918456|NCT01233284|Bromides|bromides|mesh-list
19918457|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
19918458|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19918459|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
19918460|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918461|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918462|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19918463|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
19918464|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
19918465|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19918466|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
19918467|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918468|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918469|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
19918470|NCT01233609|Valproic Acid|valproic acid|mesh-list
19918471|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
19918472|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918473|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918474|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
19918475|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918476|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918477|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
19918478|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19918479|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19918480|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19918481|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19918482|NCT01233687|Rilotumumab|rilotumumab|mesh-list
19918483|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918484|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19918485|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918486|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918487|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19918488|NCT01233921|Mitogens|mitogens|mesh-list
19918489|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
19918490|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918491|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
19918492|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19918493|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19918494|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19918495|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918496|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918497|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
19918498|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918499|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918500|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19918501|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918502|NCT01234337|Capecitabine|capecitabine|mesh-list
19918503|NCT01234337|Sorafenib|sorafenib|mesh-list
19918504|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918505|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
19975389|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918506|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918507|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918508|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19918509|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918510|NCT01234402|Capecitabine|capecitabine|mesh-list
19918511|NCT01234402|Ramucirumab|ramucirumab|mesh-list
19918512|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918513|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
19918514|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918515|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918516|NCT01234467|Rituximab|rituximab|mesh-list
19918517|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19918518|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19918519|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918520|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
19918521|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918522|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918523|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19918524|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
19918525|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918526|NCT01234649|Metformin|metformin|mesh-list
19918527|NCT01234649|Liraglutide|liraglutide|mesh-list
19918528|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19918529|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918530|NCT01234649|Incretins|incretins|mesh-ancestor
19918531|NCT01234649|Hormones|hormones|mesh-ancestor
19918532|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918533|NCT01234675|Milnacipran|milnacipran|mesh-list
19918534|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
19918535|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19918536|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19918537|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918538|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918539|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918540|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918541|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19918542|NCT01234675|Analgesics|analgesics|mesh-ancestor
19918543|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
19918544|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918545|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
19918546|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19918547|NCT01234714|Liver Extracts|liver extracts|mesh-list
19918548|NCT01234714|Hematinics|hematinics|mesh-ancestor
19918549|NCT01234766|Rituximab|rituximab|mesh-list
19918550|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19918551|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19918552|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918553|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
19918554|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918555|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918556|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19918557|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
19918558|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918559|NCT01234870|Adenosine|adenosine|mesh-list
20261613|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20261614|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
20261615|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261616|NCT00497328|Expectorants|expectorants|mesh-ancestor
20261617|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
20261618|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20261619|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
20261620|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261621|NCT00497328|Protective Agents|protective agents|mesh-ancestor
20261622|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261623|NCT00497328|Antidotes|antidotes|mesh-ancestor
20261624|NCT00497341|Cefuroxime|cefuroxime|mesh-list
20261625|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
20261626|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261627|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261628|NCT00497354|Anesthetics|anesthetics|mesh-list
20261629|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
20261630|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19918560|NCT01234870|Analgesics|analgesics|mesh-ancestor
19918561|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
20261631|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918562|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918563|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918564|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19918565|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
19918566|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19918567|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
19918568|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
19918569|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918570|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918571|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
19918572|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19918573|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19918574|NCT01234922|Losartan|losartan|mesh-list
19918575|NCT01234922|Ramipril|ramipril|mesh-list
19918576|NCT01234922|Lisinopril|lisinopril|mesh-list
19918577|NCT01234922|Benazepril|benazepril|mesh-list
19918578|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19918579|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19918580|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19918581|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19918582|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918583|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19918584|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
19918585|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918586|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19918587|NCT01234922|Protective Agents|protective agents|mesh-ancestor
19918588|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918589|NCT01235195|Sertraline|sertraline|mesh-list
19918590|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
19918591|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19918592|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19918593|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19918594|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918595|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918596|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918597|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
19918598|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918599|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19918600|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19918601|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19918602|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19918603|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918604|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918605|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918606|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918607|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19918608|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
19918609|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19918610|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19918611|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19918612|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
19918613|NCT01235351|Clopidogrel|clopidogrel|mesh-list
19918614|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19918615|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19918616|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19918617|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19918618|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
19918619|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918620|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918621|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918622|NCT01235403|Lacosamide|lacosamide|mesh-list
19918623|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
19918624|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19918625|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19918626|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918627|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918628|NCT01235442|Etanercept|etanercept|mesh-list
19918629|NCT01235442|Clobetasol|clobetasol|mesh-list
19918630|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19918631|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19918632|NCT01235442|Analgesics|analgesics|mesh-ancestor
19918633|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
19918634|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918635|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918636|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918637|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918638|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918639|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918640|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
19918641|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
19918642|NCT01235442|Hormones|hormones|mesh-ancestor
19918643|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918644|NCT01235507|Methotrexate|methotrexate|mesh-list
19918645|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19918646|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
19918647|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19918648|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918649|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918650|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
19918651|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918652|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918653|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918654|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918655|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19918656|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918657|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
19918658|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918659|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19918660|NCT01235546|Azithromycin|azithromycin|mesh-list
19918661|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918662|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918663|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
19918664|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918665|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
19918666|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918667|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918668|NCT01235689|Prednisone|prednisone|mesh-list
19918669|NCT01235689|Adalimumab|adalimumab|mesh-list
19918670|NCT01235689|Azathioprine|azathioprine|mesh-list
19918671|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918672|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
19918673|NCT01235689|Hormones|hormones|mesh-ancestor
19918674|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918675|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918676|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19918677|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918678|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918679|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
19918680|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918681|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918682|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918683|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
19918684|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19918685|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
19918686|NCT01235715|Coagulants|coagulants|mesh-ancestor
19918687|NCT01235728|Calcitriol|calcitriol|mesh-list
19918688|NCT01235728|MK 0873|mk 0873|mesh-list
19918689|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19918690|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918691|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19918692|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918693|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918694|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19918695|NCT01235728|Vitamins|vitamins|mesh-ancestor
19918696|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
19918697|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19918698|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19918699|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19918700|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918701|NCT01235741|Pramlintide|pramlintide|mesh-list
19918702|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19918703|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918704|NCT01235793|Temozolomide|temozolomide|mesh-list
19918705|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19918706|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
19918707|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918708|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918709|NCT01235897|Paclitaxel|paclitaxel|mesh-list
19918710|NCT01235897|Trastuzumab|trastuzumab|mesh-list
19918711|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19918712|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918713|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
19918714|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
19918715|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
19918716|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918717|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19918718|NCT01235910|Cyclosporine|cyclosporine|mesh-list
19918719|NCT01235910|Cyclosporins|cyclosporins|mesh-list
19918720|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918721|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918722|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918723|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
19918724|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918725|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
19918726|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918727|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918728|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918729|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19918730|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
19918731|NCT01235923|Hematinics|hematinics|mesh-ancestor
19918732|NCT01235949|Acetaminophen|acetaminophen|mesh-list
19918733|NCT01235949|Ibuprofen|ibuprofen|mesh-list
19918734|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19918735|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19918736|NCT01235949|Analgesics|analgesics|mesh-ancestor
19918737|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
19918738|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918739|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918740|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918741|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918742|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19918743|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918744|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918745|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
19918746|NCT01236001|Lacosamide|lacosamide|mesh-list
19918747|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
19918748|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19918749|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19918750|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918751|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918752|NCT01236053|Gabapentin|gabapentin|mesh-list
19918753|NCT01236053|Analgesics|analgesics|mesh-ancestor
19918754|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
19918755|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918756|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918757|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
19918758|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19918759|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19918760|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19918761|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19918762|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19918763|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19918764|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918765|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918766|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
19918767|NCT01236105|Charcoal|charcoal|mesh-list
19918768|NCT01236105|Antidotes|antidotes|mesh-ancestor
19918769|NCT01236105|Protective Agents|protective agents|mesh-ancestor
19918770|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918771|NCT01236118|Ixekizumab|ixekizumab|mesh-list
19918772|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
19918773|NCT01236365|Atorvastatin|atorvastatin|mesh-list
19918774|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19918775|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19918776|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
19918777|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918778|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19918779|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19918780|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918781|NCT01236378|Sirolimus|sirolimus|mesh-list
19918782|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19918783|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918784|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19918785|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918786|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
19918787|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918788|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
19918789|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918790|NCT01236521|Analgesics|analgesics|mesh-list
19918791|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
19918792|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918793|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918794|NCT01236534|Lubiprostone|lubiprostone|mesh-list
19918795|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19918796|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918797|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918798|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
19918799|NCT01236573|Fludarabine|fludarabine|mesh-list
19918800|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918801|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
19918802|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918803|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918804|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19918805|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
19918806|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918807|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918808|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19972417|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972418|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
19972419|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972420|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972421|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19972422|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
19972423|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972424|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19972425|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19972426|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
19972427|NCT01809314|Hematinics|hematinics|mesh-ancestor
19972428|NCT01809327|Metformin|metformin|mesh-list
19972429|NCT01809327|Canagliflozin|canagliflozin|mesh-list
19972430|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972431|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972432|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19972433|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972434|NCT01809639|Progesterone|progesterone|mesh-list
19972435|NCT01809639|Progestins|progestins|mesh-ancestor
19972436|NCT01809639|Hormones|hormones|mesh-ancestor
19972437|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972438|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972439|NCT01810016|Poly I-C|poly i-c|mesh-list
19972440|NCT01810016|Ipilimumab|ipilimumab|mesh-list
19972441|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19972442|NCT01810016|Vaccines|vaccines|mesh-list
19972443|NCT01810016|Poly ICLC|poly iclc|mesh-list
19972444|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
19972445|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972446|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19972447|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972448|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19972449|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972450|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
19972451|NCT01810016|Laxatives|laxatives|mesh-ancestor
19972452|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19972453|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
19972454|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972455|NCT01810042|Ranibizumab|ranibizumab|mesh-list
19972456|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19972457|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19972458|NCT01810042|Growth Substances|growth substances|mesh-ancestor
19972459|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972460|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
19972461|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972462|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19972463|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
19972464|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
19972465|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19972466|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19918809|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
19918810|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
19918811|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
19918812|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19918813|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918814|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19918815|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19918816|NCT01237041|Niacin|niacin|mesh-list
19918817|NCT01237041|Niacinamide|niacinamide|mesh-list
19918818|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
19918819|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19918820|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
19918821|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918822|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19918823|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
19918824|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
19918825|NCT01237041|Vitamins|vitamins|mesh-ancestor
19918826|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
19918827|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918828|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19918829|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19918830|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918831|NCT01237197|Exenatide|exenatide|mesh-list
20261632|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
20261633|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261634|NCT00497458|Testosterone|testosterone|mesh-list
20261635|NCT00497458|Androgens|androgens|mesh-ancestor
20261636|NCT00497458|Hormones|hormones|mesh-ancestor
20261637|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261638|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261639|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
20261640|NCT00497471|Dapsone|dapsone|mesh-list
20261641|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
20261642|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20261643|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20261644|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261645|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20261646|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261647|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261648|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
20261649|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261650|NCT00497497|Bevacizumab|bevacizumab|mesh-list
20261651|NCT00497497|Cetuximab|cetuximab|mesh-list
20261652|NCT00497497|Irinotecan|irinotecan|mesh-list
20261653|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20261654|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261655|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20261656|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20261657|NCT00497497|Growth Substances|growth substances|mesh-ancestor
20261658|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261659|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
20261660|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20261661|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20261662|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261663|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261664|NCT00497523|Beclomethasone|beclomethasone|mesh-list
20261665|NCT00497523|Albuterol|albuterol|mesh-list
20261666|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20261667|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
19918832|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19918833|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918834|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19918835|NCT01237197|Incretins|incretins|mesh-ancestor
19918836|NCT01237197|Hormones|hormones|mesh-ancestor
19918837|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918838|NCT01237223|Amlodipine|amlodipine|mesh-list
19918839|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19918840|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19918841|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918842|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918843|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19918844|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918845|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
19918846|NCT01237327|Exemestane|exemestane|mesh-list
20261668|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541305|NCT01857154|Vitamins|vitamins|mesh-ancestor
19918847|NCT01237327|Megestrol|megestrol|mesh-list
19918848|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
19918849|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918850|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19918851|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19918852|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918853|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918854|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19918855|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
19918856|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918857|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918858|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19918859|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19918860|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19918861|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
19918862|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19918863|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19918864|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19918865|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19918866|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
19918867|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19918868|NCT01237353|Rabeprazole|rabeprazole|mesh-list
19918869|NCT01237353|Betaine|betaine|mesh-list
19918870|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19918871|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918872|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19918873|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918874|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918875|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
19918876|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19918877|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
19918878|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19918879|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20261669|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261670|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20261671|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
20261672|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
20261673|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261674|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19918880|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19918881|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19918882|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918883|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918884|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918885|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918886|NCT01237587|Analgesics|analgesics|mesh-ancestor
19918887|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
19918888|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918889|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
19918890|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19918891|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
19918892|NCT01237678|Carboplatin|carboplatin|mesh-list
19918893|NCT01237678|Etoposide|etoposide|mesh-list
19918894|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
19918895|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918896|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19918897|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19918898|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19918899|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918900|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918901|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19918902|NCT01237899|Eplerenone|eplerenone|mesh-list
19918903|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19918904|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
19918905|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918906|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918907|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19918908|NCT01237899|Diuretics|diuretics|mesh-ancestor
19918909|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
19918910|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19918911|NCT01237951|Gemcitabine|gemcitabine|mesh-list
19918912|NCT01237951|Dexamethasone|dexamethasone|mesh-list
19918913|NCT01237951|Melphalan|melphalan|mesh-list
19918914|NCT01237951|Busulfan|busulfan|mesh-list
19918915|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918916|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
19918917|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
19918918|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918919|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918920|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918921|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
19918922|NCT01237951|Hormones|hormones|mesh-ancestor
19918923|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918924|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19918925|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918926|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19918927|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
19918928|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918929|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
19918930|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19918931|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918932|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19918933|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
19918934|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19918935|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
19918936|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19918937|NCT01238120|Ibuprofen|ibuprofen|mesh-list
19918938|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19918939|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19918940|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19918941|NCT01238120|Analgesics|analgesics|mesh-ancestor
19918942|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
19918943|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918944|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918945|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19918946|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19918947|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19918948|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918949|NCT01238471|Propranolol|propranolol|mesh-list
19918950|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19918951|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19918952|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
19918953|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918954|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918955|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918956|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19918957|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19918958|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
19918959|NCT01238536|Dexamethasone|dexamethasone|mesh-list
19918960|NCT01238536|Betamethasone|betamethasone|mesh-list
19918961|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19918962|NCT01238536|Lidocaine|lidocaine|mesh-list
19918963|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
19918964|NCT01238536|Anesthetics|anesthetics|mesh-list
19918965|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19918966|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
19918967|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
19918968|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19918969|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918970|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19918971|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
19918972|NCT01238536|Hormones|hormones|mesh-ancestor
19918973|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19918974|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19918975|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19918976|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918977|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19918978|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
19918979|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19918980|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19918981|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19918982|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19918983|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19918984|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
19918985|NCT01238575|Guanfacine|guanfacine|mesh-list
20261675|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20261676|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19918986|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19918987|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19918988|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19918989|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19918990|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
19918991|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19918992|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918993|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19918994|NCT01238588|Sevelamer|sevelamer|mesh-list
19918995|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
19918996|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
19918997|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19918998|NCT01238640|Nicotine|nicotine|mesh-list
19918999|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19919000|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
19919001|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919002|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919003|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19919004|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19919005|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
19919006|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919007|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919008|NCT01238822|Methylphenidate|methylphenidate|mesh-list
19919009|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19919010|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919011|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19919012|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19919013|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919014|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919015|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
19919016|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919017|NCT01238861|Benralizumab|benralizumab|mesh-list
19919018|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19919019|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
19919020|NCT01239212|Levetiracetam|levetiracetam|mesh-list
19919021|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
19919022|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
19919023|NCT01239342|Everolimus|everolimus|mesh-list
19919024|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919025|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919026|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
19919027|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919028|NCT01239394|Ofatumumab|ofatumumab|mesh-list
19919029|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919030|NCT01239472|Everolimus|everolimus|mesh-list
19919031|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919032|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919033|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
19919034|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919035|NCT01239732|Paclitaxel|paclitaxel|mesh-list
19919036|NCT01239732|Bevacizumab|bevacizumab|mesh-list
19919037|NCT01239732|Carboplatin|carboplatin|mesh-list
19919038|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19919039|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919040|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
19919041|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
19919042|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
19919043|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919044|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19919045|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919046|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919047|NCT01239732|Growth Substances|growth substances|mesh-ancestor
19919048|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919049|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919050|NCT01239745|Exemestane|exemestane|mesh-list
19919051|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919052|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19919053|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19919054|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919055|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919056|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19919057|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
20261677|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
19919058|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919059|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919060|NCT01239797|Dexamethasone|dexamethasone|mesh-list
19919061|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
19919062|NCT01239797|Lenalidomide|lenalidomide|mesh-list
19919063|NCT01239797|Elotuzumab|elotuzumab|mesh-list
19919064|NCT01239797|BB 1101|bb 1101|mesh-list
19919065|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919066|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
19919067|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
19919068|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919069|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919070|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19919071|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
19919072|NCT01239797|Hormones|hormones|mesh-ancestor
19919073|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919074|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19919075|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919076|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
19919077|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919078|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919079|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
19919080|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919081|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919082|NCT01239797|Growth Substances|growth substances|mesh-ancestor
19919083|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919084|NCT01239992|Niacin|niacin|mesh-list
19919085|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19919086|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
19919087|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919088|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19919089|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
19919090|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
19919091|NCT01239992|Vitamins|vitamins|mesh-ancestor
19919092|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
19919093|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919094|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19919095|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
19919096|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19919097|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919098|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19919099|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19919100|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
19919101|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19919102|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
19919103|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919104|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
19919105|NCT01240382|Protective Agents|protective agents|mesh-ancestor
19919106|NCT01240590|Cisplatin|cisplatin|mesh-list
19919107|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919108|NCT01240746|Vaccines|vaccines|mesh-list
19919109|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
19919110|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919111|NCT01240785|Metformin|metformin|mesh-list
19919112|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19919113|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919114|NCT01240811|Copper|copper|mesh-list
19919115|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
19919116|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19919117|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
19919118|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19919119|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919120|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19919121|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19919122|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19919123|NCT01240811|Trace Elements|trace elements|mesh-ancestor
19919124|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
19919125|NCT01240863|Hydrocodone|hydrocodone|mesh-list
19919126|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19919127|NCT01240863|Narcotics|narcotics|mesh-ancestor
20261678|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919128|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919129|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919130|NCT01240863|Analgesics|analgesics|mesh-ancestor
19919131|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
19919132|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919133|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
20541306|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
19919134|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
19919135|NCT01241240|Timolol|timolol|mesh-list
19919136|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19919137|NCT01241240|Bimatoprost|bimatoprost|mesh-list
19919138|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19919139|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19919140|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19919141|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19919142|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
19919143|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919144|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919145|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919146|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19919147|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19919148|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19919149|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19919150|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19919151|NCT01241292|Elotuzumab|elotuzumab|mesh-list
19919152|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919153|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
19919154|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19919155|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19919156|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19919157|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
19919158|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
19919159|NCT01241344|Brincidofovir|brincidofovir|mesh-list
19919160|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
19919161|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261679|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261680|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20261681|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
20261682|NCT00497523|Hormones|hormones|mesh-ancestor
20261683|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261684|NCT00497536|Insulin|insulin|mesh-list
20261685|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20261686|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
20261687|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
20261688|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20261689|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20261690|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261691|NCT00497562|Tramadol|tramadol|mesh-list
19919162|NCT01241539|Dabigatran|dabigatran|mesh-list
19919163|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
19919164|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19919165|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
19919166|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919167|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919168|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
19919169|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19919170|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
19919171|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919172|NCT01241591|Etanercept|etanercept|mesh-list
19919173|NCT01241591|Tofacitinib|tofacitinib|mesh-list
19919174|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19919175|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19919176|NCT01241591|Analgesics|analgesics|mesh-ancestor
19919177|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
19919178|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919179|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919180|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919181|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19919182|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19919183|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919184|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
19919185|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19919186|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919187|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919188|NCT01241760|Interferons|interferons|mesh-list
19919189|NCT01241760|Ribavirin|ribavirin|mesh-list
19919190|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
19919191|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
19919192|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19919193|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919194|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
19919195|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19919196|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
20261692|NCT00497562|Amitriptyline|amitriptyline|mesh-list
19919197|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919198|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
19919199|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919200|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19919201|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19919202|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19919203|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
19919204|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919205|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19919206|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19919207|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919208|NCT01242176|Empagliflozin|empagliflozin|mesh-list
19919209|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19919210|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919211|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19919212|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919213|NCT01242241|Propofol|propofol|mesh-list
19919214|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19919215|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919216|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919217|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19919218|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
19919219|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
19919220|NCT01242644|Ketorolac|ketorolac|mesh-list
19919221|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19919222|NCT01242644|Morphine|morphine|mesh-list
19919223|NCT01242644|Ropivacaine|ropivacaine|mesh-list
19919224|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19919225|NCT01242644|Narcotics|narcotics|mesh-ancestor
19919226|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919227|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919228|NCT01242644|Analgesics|analgesics|mesh-ancestor
19919229|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
19919230|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919231|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
19919232|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
19919233|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19919234|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19919235|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919236|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19919237|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19919238|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919239|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919240|NCT01242748|Goserelin|goserelin|mesh-list
19919241|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19919242|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919243|NCT01243112|Lidocaine|lidocaine|mesh-list
19919244|NCT01243112|Epinephrine|epinephrine|mesh-list
19919245|NCT01243112|Racepinephrine|racepinephrine|mesh-list
19919246|NCT01243112|Bupivacaine|bupivacaine|mesh-list
19919247|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
19919248|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
19919249|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
19919250|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919251|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919252|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
19919253|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919254|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19919255|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19919256|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19919257|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919258|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919259|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19919260|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19919261|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
19919262|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919263|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19919264|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19919265|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
19919266|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19919267|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
19919268|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
19919269|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
19919270|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19919271|NCT01243151|Bococizumab|bococizumab|mesh-list
19919272|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19919273|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19919274|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
19919275|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919276|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19919277|NCT01243177|Lacosamide|lacosamide|mesh-list
19919278|NCT01243177|Carbamazepine|carbamazepine|mesh-list
19919279|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
19919280|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19919281|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19919282|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919283|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919284|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
19919285|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19919286|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919287|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919288|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919289|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19919290|NCT01243177|Analgesics|analgesics|mesh-ancestor
19919291|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
19919292|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919293|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19919294|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19919295|NCT01243242|Metadoxine|metadoxine|mesh-list
19919296|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19919297|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19919298|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19919299|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19919300|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19919301|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919302|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
19919303|NCT01243333|Alovudine|alovudine|mesh-list
19919304|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
19919305|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19919306|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19919307|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919308|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
19919309|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
19919310|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19919311|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19919312|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19919313|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919314|NCT01243424|Glimepiride|glimepiride|mesh-list
19919315|NCT01243424|Linagliptin|linagliptin|mesh-list
19919316|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19919317|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19919318|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919319|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919320|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
19919321|NCT01243424|Incretins|incretins|mesh-ancestor
19919322|NCT01243424|Hormones|hormones|mesh-ancestor
19919323|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919324|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19919325|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
19919326|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919327|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919328|NCT01243450|Tretinoin|tretinoin|mesh-list
19919329|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919330|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
19919331|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
19919332|NCT01243567|Timolol|timolol|mesh-list
19919333|NCT01243567|Bimatoprost|bimatoprost|mesh-list
19919334|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19919335|NCT01243567|Latanoprost|latanoprost|mesh-list
19919336|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19919337|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19919338|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19919339|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
19919340|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261693|NCT00497562|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20261694|NCT00497562|Fluoxetine|fluoxetine|mesh-list
19919341|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919342|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919343|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20261695|NCT00497562|Hormones|hormones|mesh-list
19919344|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19919345|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
19919346|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
19919347|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19919348|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
19919349|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19919350|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919351|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19919352|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19919353|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19919354|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19919355|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19919356|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919357|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919358|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919359|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19919360|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19919361|NCT01243593|Anesthetics|anesthetics|mesh-list
19919362|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919363|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972467|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19972468|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972469|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972470|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
19972471|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972472|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972473|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
19972474|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
19972475|NCT01810432|Evacetrapib|evacetrapib|mesh-list
19972476|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19972477|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19972478|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
19972479|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972480|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19972481|NCT01810666|Factor VIII|factor viii|mesh-list
19972482|NCT01810666|Coagulants|coagulants|mesh-ancestor
19972483|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
19972484|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19972485|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
19972486|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972487|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972488|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19972489|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
19972490|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
19972491|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19972492|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
19972493|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972494|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972495|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
19972496|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
19972497|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972498|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972499|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972500|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
19972501|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
19972502|NCT01810952|Insulin|insulin|mesh-list
19972503|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19972504|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
19972505|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
19972506|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
19972507|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
19972508|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
19972509|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972510|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972511|NCT01811147|Norepinephrine|norepinephrine|mesh-list
19972512|NCT01811147|Serotonin|serotonin|mesh-list
19972513|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19972514|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19972515|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19972516|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
19972517|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972518|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972519|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972520|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
19972521|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
19919364|NCT01243671|Adalimumab|adalimumab|mesh-list
19919365|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919366|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19919367|NCT01243775|Docetaxel|docetaxel|mesh-list
19919368|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
19919369|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919370|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
19919371|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
19919372|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
19919373|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919374|NCT01243944|Lenalidomide|lenalidomide|mesh-list
19919375|NCT01243944|Pomalidomide|pomalidomide|mesh-list
19919376|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
19919377|NCT01243944|Pipobroman|pipobroman|mesh-list
19919378|NCT01243944|Anagrelide|anagrelide|mesh-list
19919379|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
19919380|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919381|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919382|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919383|NCT01243944|Growth Substances|growth substances|mesh-ancestor
19919384|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919385|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919386|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
19919387|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919388|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919389|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19919390|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19919391|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19919392|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19919393|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19919394|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
19919395|NCT01243957|Fluoxetine|fluoxetine|mesh-list
19919396|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19919397|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19919398|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919399|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919400|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919401|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
19919402|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919403|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19919404|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
19919405|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919406|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19919407|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19919408|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919409|NCT01244061|Varenicline|varenicline|mesh-list
19919410|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19919411|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19919412|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
19919413|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919414|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919415|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919416|NCT01244126|Fentanyl|fentanyl|mesh-list
19919417|NCT01244126|Morphine|morphine|mesh-list
20261696|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261697|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261698|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20261699|NCT00497562|Narcotics|narcotics|mesh-ancestor
20261700|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261701|NCT00497562|Analgesics|analgesics|mesh-ancestor
20261702|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
20261703|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261704|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20261705|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20261706|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20261707|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261708|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261709|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
20261710|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20261711|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
20261712|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919418|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19919419|NCT01244126|Narcotics|narcotics|mesh-ancestor
19919420|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919421|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919422|NCT01244126|Analgesics|analgesics|mesh-ancestor
19919423|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
19919424|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919425|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19919426|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19919427|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
19919428|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
19919429|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19919430|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919431|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19919432|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919433|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919434|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19919435|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
19919436|NCT01244425|Coagulants|coagulants|mesh-ancestor
19919437|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19919438|NCT01244451|Ofatumumab|ofatumumab|mesh-list
19919439|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19919440|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
19919441|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919442|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919443|NCT01244490|Guanfacine|guanfacine|mesh-list
19919444|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19919445|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19919446|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19919447|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919448|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919449|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19919450|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919451|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919452|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19919453|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19919454|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19919455|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19919456|NCT01244633|Ecopipam|ecopipam|mesh-list
19919457|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19919458|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19919459|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919460|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919461|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919462|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19919463|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
19919464|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919465|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919466|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19919467|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
19919468|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919469|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19919470|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19919471|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919472|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919473|NCT01244724|Citalopram|citalopram|mesh-list
19919474|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19919475|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19919476|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919477|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919478|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919479|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
19919480|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919481|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19919482|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
19919483|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919484|NCT01244984|Fluticasone|fluticasone|mesh-list
19919485|NCT01244984|Xhance|xhance|mesh-list
19919486|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919487|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19919488|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
19919489|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919490|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919491|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19919492|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
19919493|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
19919494|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19919495|NCT01245062|Trametinib|trametinib|mesh-list
19919496|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919497|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19919498|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919499|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919500|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
19919501|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19919502|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19919503|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
19919504|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19919505|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19919506|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19919507|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919508|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919509|NCT01245140|Alitretinoin|alitretinoin|mesh-list
19919510|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919511|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
19919512|NCT01245595|Aminophylline|aminophylline|mesh-list
19919513|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19919514|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
19919515|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919516|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919517|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19919518|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
19919519|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19919520|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19919521|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919522|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919523|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19919524|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19919525|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
19919526|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919527|NCT01245595|Protective Agents|protective agents|mesh-ancestor
19919528|NCT01245647|Naltrexone|naltrexone|mesh-list
19919529|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19919530|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19919531|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919532|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
19919533|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919534|NCT01245673|Lenalidomide|lenalidomide|mesh-list
19919535|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19919536|NCT01245673|Poly ICLC|poly iclc|mesh-list
19919537|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
19919538|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919539|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919540|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919541|NCT01245673|Growth Substances|growth substances|mesh-ancestor
19919542|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919543|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919544|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
19919545|NCT01246063|Dexamethasone|dexamethasone|mesh-list
19919546|NCT01246063|Doxorubicin|doxorubicin|mesh-list
19919547|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19919548|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919549|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
19919550|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
19919551|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919552|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919553|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19919554|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
19919555|NCT01246063|Hormones|hormones|mesh-ancestor
19919556|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919557|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19919558|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919559|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19919560|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19919561|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19919562|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919563|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919564|NCT01246076|Lenalidomide|lenalidomide|mesh-list
19919565|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
19919566|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919567|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919568|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919569|NCT01246076|Growth Substances|growth substances|mesh-ancestor
19919570|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919571|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919572|NCT01246206|Tacrolimus|tacrolimus|mesh-list
19919573|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
19919574|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919575|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
19919576|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919577|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19919578|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919579|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919580|NCT01246401|Naltrexone|naltrexone|mesh-list
19919581|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19919582|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19919583|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919584|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
19919585|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919586|NCT01246583|Tofacitinib|tofacitinib|mesh-list
19919587|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19919588|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919589|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919590|NCT01246713|Acetaminophen|acetaminophen|mesh-list
19919591|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19919592|NCT01246713|Analgesics|analgesics|mesh-ancestor
19919593|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
19919594|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919595|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919596|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
20261713|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20261714|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20261715|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261716|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20261717|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20261718|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20261719|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
20261720|NCT00497562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20261721|NCT00497562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20287065|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287066|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20287067|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541307|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541308|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20541309|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20541310|NCT01857154|Antacids|antacids|mesh-ancestor
20541311|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541312|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541313|NCT01857193|Everolimus|everolimus|mesh-list
20541314|NCT01857193|Exemestane|exemestane|mesh-list
20541315|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541316|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541317|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
20541318|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541319|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20541320|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20541321|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541322|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541323|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20541324|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
20541325|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541326|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
20541327|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20541328|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20541329|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541330|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
20541331|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541332|NCT01857349|Ethanol|ethanol|mesh-list
19919597|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19919598|NCT01246791|Norethindrone|norethindrone|mesh-list
19919599|NCT01246791|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19919600|NCT01246791|Norinyl|norinyl|mesh-list
19919601|NCT01246791|Estradiol|estradiol|mesh-list
20541333|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
19919602|NCT01246791|Estrogens|estrogens|mesh-ancestor
19919603|NCT01246791|Hormones|hormones|mesh-ancestor
19919604|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919605|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919606|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19919607|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
19919608|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19919609|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19919610|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19919611|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19919612|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19919613|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19919614|NCT01246791|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19919615|NCT01246960|Leucovorin|leucovorin|mesh-list
19919616|NCT01246960|Fluorouracil|fluorouracil|mesh-list
19919617|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
19919618|NCT01246960|Ramucirumab|ramucirumab|mesh-list
19919619|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
19919620|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919621|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19919622|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919623|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919624|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
19919625|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919626|NCT01246960|Antidotes|antidotes|mesh-ancestor
19919627|NCT01246960|Protective Agents|protective agents|mesh-ancestor
19919628|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
19919629|NCT01246960|Vitamins|vitamins|mesh-ancestor
19919630|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
19919631|NCT01246973|Curcumin|curcumin|mesh-list
19919632|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19919633|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19919634|NCT01246973|Analgesics|analgesics|mesh-ancestor
19919635|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
19919636|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919637|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919638|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919639|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19919640|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919641|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919642|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919643|NCT01246986|Sorafenib|sorafenib|mesh-list
19919644|NCT01246986|Ramucirumab|ramucirumab|mesh-list
19919645|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919646|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19919647|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919648|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919649|NCT01246999|Vaccines|vaccines|mesh-list
19919650|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
19919651|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919652|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19919653|NCT01247090|Vasopressins|vasopressins|mesh-list
19919654|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
19919655|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
19919656|NCT01247090|Coagulants|coagulants|mesh-ancestor
19919657|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19919658|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19919659|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
19919660|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919661|NCT01247220|Ranibizumab|ranibizumab|mesh-list
19919662|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919663|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919664|NCT01247220|Growth Substances|growth substances|mesh-ancestor
19919665|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919666|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919667|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919668|NCT01247272|Fluoxetine|fluoxetine|mesh-list
19919669|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19919670|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19919671|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919672|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919673|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919674|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
19919675|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919676|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19919677|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
19919678|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919679|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19919680|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19919681|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919682|NCT01247285|Fluoxetine|fluoxetine|mesh-list
19919683|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19919684|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19919685|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919686|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919687|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919688|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
19919689|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919690|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19919691|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
19919692|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19919693|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19919694|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19919695|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919696|NCT01247363|Globalagliatin|globalagliatin|mesh-list
19919697|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
19919698|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919699|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19919700|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919701|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19919702|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919703|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919704|NCT01248065|Vitamin D|vitamin d|mesh-list
19919705|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
19919706|NCT01248065|Ciclesonide|ciclesonide|mesh-list
19919707|NCT01248065|Vitamins|vitamins|mesh-ancestor
19919708|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
19919709|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919710|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19919711|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19919712|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
19919713|NCT01248065|Hormones|hormones|mesh-ancestor
19919714|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919715|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19919716|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
19919717|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
19919718|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19919719|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19919720|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919721|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
19919722|NCT01248104|Coagulants|coagulants|mesh-ancestor
19919723|NCT01248364|Empagliflozin|empagliflozin|mesh-list
19919724|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19919725|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919726|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19919727|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919728|NCT01248416|Letrozole|letrozole|mesh-list
19919729|NCT01248416|Anastrozole|anastrozole|mesh-list
19919730|NCT01248416|Hormones|hormones|mesh-list
19919731|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19919732|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919733|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919734|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919735|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19919736|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919737|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919738|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19919739|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
19919740|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19919741|NCT01248468|Aspirin|aspirin|mesh-list
19919742|NCT01248468|Acetaminophen|acetaminophen|mesh-list
19919743|NCT01248468|Sumatriptan|sumatriptan|mesh-list
19919744|NCT01248468|Caffeine|caffeine|mesh-list
19919745|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19919746|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19919747|NCT01248468|Analgesics|analgesics|mesh-ancestor
19919748|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
19919749|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261722|NCT00497601|Amphotericin B|amphotericin b|mesh-list
19919750|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919751|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919752|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19919753|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19919754|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19919755|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919756|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19919757|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19919758|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919759|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
19919760|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19919761|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19919762|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19919763|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19919764|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
19919765|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919766|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19919767|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19919768|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19919769|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
19919770|NCT01248585|Dexamethasone|dexamethasone|mesh-list
19919771|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919772|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
19919773|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
19919774|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919775|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919776|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19919777|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
19919778|NCT01248585|Hormones|hormones|mesh-ancestor
19919779|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919780|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19919781|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919782|NCT01248715|Oseltamivir|oseltamivir|mesh-list
19919783|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
19919784|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19919785|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919786|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919787|NCT01248780|Golimumab|golimumab|mesh-list
19919788|NCT01248780|Methotrexate|methotrexate|mesh-list
19919789|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19919790|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
19919791|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19919792|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919793|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19919794|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
19919795|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919796|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919797|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
19919798|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919799|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19919800|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919801|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
19919802|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19919803|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19919804|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19919805|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919806|NCT01248793|Golimumab|golimumab|mesh-list
19919807|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19919808|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19919809|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919810|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919811|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
19919812|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919813|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19919814|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
19919815|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919816|NCT01248949|Paclitaxel|paclitaxel|mesh-list
19919817|NCT01248949|Bevacizumab|bevacizumab|mesh-list
19919818|NCT01248949|Carboplatin|carboplatin|mesh-list
19919819|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19919820|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919821|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
20541334|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19919822|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19919823|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19919824|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919825|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19919826|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919827|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919828|NCT01248949|Growth Substances|growth substances|mesh-ancestor
19919829|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919830|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919831|NCT01248962|Carboplatin|carboplatin|mesh-list
19919832|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919833|NCT01249027|Everolimus|everolimus|mesh-list
19919834|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919835|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19919836|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
19919837|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919838|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
19919839|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19919840|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919841|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919842|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19919843|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19919844|NCT01249092|Protective Agents|protective agents|mesh-ancestor
19919845|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919846|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
19919847|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19919848|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
19919849|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
19919850|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
19919851|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19919852|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919853|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919854|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19919855|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919856|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19919857|NCT01249274|Progesterone|progesterone|mesh-list
19919858|NCT01249274|Progestins|progestins|mesh-ancestor
19919859|NCT01249274|Hormones|hormones|mesh-ancestor
19919860|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919861|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919862|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
19919863|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19919864|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19919865|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19919866|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919867|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919868|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
19919869|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919870|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919871|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19919872|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919873|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
19919874|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19919875|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19919876|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19919877|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919878|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919879|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
19919880|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919881|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919882|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19919883|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972522|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972523|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19972524|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19972525|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
19972526|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19972527|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972528|NCT01811186|Oxycodone|oxycodone|mesh-list
19972529|NCT01811186|Naloxone|naloxone|mesh-list
19972530|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19972531|NCT01811186|Narcotics|narcotics|mesh-ancestor
19972532|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972533|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919884|NCT01249651|Esomeprazole|esomeprazole|mesh-list
19919885|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19919886|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19919887|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19919888|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919889|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919890|NCT01249664|Aflibercept|aflibercept|mesh-list
19919891|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919892|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919893|NCT01249664|Growth Substances|growth substances|mesh-ancestor
19919894|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919895|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919896|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919897|NCT01249833|Oseltamivir|oseltamivir|mesh-list
19919898|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
19919899|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19919900|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19919901|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919902|NCT01249872|Morphine|morphine|mesh-list
19919903|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
19919904|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20261723|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20261724|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20261725|NCT00497601|Amebicides|amebicides|mesh-ancestor
20261726|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20261727|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20261728|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261729|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261730|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
20261731|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20261732|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20261733|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20261734|NCT00497614|Adalimumab|adalimumab|mesh-list
20261735|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20261736|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20261737|NCT00497744|Cefepime|cefepime|mesh-list
20261738|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261739|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261740|NCT00497809|Lenograstim|lenograstim|mesh-list
20261741|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20261742|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
20261743|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261744|NCT00497900|Vitamin D|vitamin d|mesh-list
20261745|NCT00497900|Vitamins|vitamins|mesh-ancestor
20261746|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
20261747|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261748|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20261749|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
20261750|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20261751|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20261752|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20261753|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20261754|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261755|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
20261756|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261757|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261758|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20261759|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261760|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
20261761|NCT00497939|Urological Agents|urological agents|mesh-ancestor
20261762|NCT00498004|Risperidone|risperidone|mesh-list
20261763|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20261764|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20261765|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
20261766|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261767|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261768|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261769|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20261770|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20261771|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261772|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20261773|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20261774|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
19919905|NCT01249872|Narcotics|narcotics|mesh-ancestor
19919906|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261775|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
20261776|NCT00498108|Rotigotine|rotigotine|mesh-list
19919907|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919908|NCT01249872|Analgesics|analgesics|mesh-ancestor
19919909|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
19919910|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919911|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
19919912|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
19919913|NCT01250002|Lidocaine|lidocaine|mesh-list
19919914|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
19919915|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
19919916|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919917|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919918|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
19919919|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919920|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19919921|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19919922|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19919923|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919924|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919925|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19919926|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919927|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261777|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
20261778|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
20261779|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261780|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261781|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261782|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
20261783|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20261784|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261785|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261786|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20261787|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20261788|NCT00498134|Analgesics|analgesics|mesh-ancestor
20261789|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
20261790|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261791|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261792|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20261793|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20261794|NCT00498225|Gemcitabine|gemcitabine|mesh-list
20261795|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261796|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
20261797|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261798|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261799|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
20261800|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261801|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261802|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261803|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
20261804|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261805|NCT00498251|Albuterol|albuterol|mesh-list
20261806|NCT00498251|Ipratropium|ipratropium|mesh-list
20261807|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20261808|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
20261809|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261810|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261811|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20261812|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
20261813|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
20261814|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261815|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20261816|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20261817|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20261818|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
20261819|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261820|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261821|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20261822|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
20261823|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
20261824|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
20261825|NCT00498316|Melphalan|melphalan|mesh-list
20261826|NCT00498316|Busulfan|busulfan|mesh-list
19919928|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261827|NCT00498316|Rituximab|rituximab|mesh-list
19972534|NCT01811186|Analgesics|analgesics|mesh-ancestor
20261828|NCT00498316|Fludarabine|fludarabine|mesh-list
19919929|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919930|NCT01250145|Teriparatide|teriparatide|mesh-list
19919931|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19919932|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919933|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19919934|NCT01250184|Lidocaine|lidocaine|mesh-list
19919935|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
19919936|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
19919937|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919938|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919939|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
19919940|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919941|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19919942|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19919943|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19919944|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19919945|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919946|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
19919947|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19919948|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19919949|NCT01250210|Estradiol|estradiol|mesh-list
19919950|NCT01250210|Estrogens|estrogens|mesh-ancestor
19919951|NCT01250210|Hormones|hormones|mesh-ancestor
19919952|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919953|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919954|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19919955|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
19919956|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19919957|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19919958|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19919959|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19919960|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19919961|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19919962|NCT01250379|Bevacizumab|bevacizumab|mesh-list
19919963|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19919964|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19919965|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19919966|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19919967|NCT01250379|Growth Substances|growth substances|mesh-ancestor
19919968|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919969|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
19919970|NCT01250418|Ketamine|ketamine|mesh-list
19919971|NCT01250418|Analgesics|analgesics|mesh-ancestor
19919972|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
19919973|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919974|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919975|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19919976|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19919977|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
19919978|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
19919979|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19919980|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19919981|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19919982|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19919983|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19919984|NCT01250717|Dexamethasone|dexamethasone|mesh-list
19919985|NCT01250717|Goserelin|goserelin|mesh-list
19919986|NCT01250717|Estramustine|estramustine|mesh-list
19919987|NCT01250717|Docetaxel|docetaxel|mesh-list
19919988|NCT01250717|Bicalutamide|bicalutamide|mesh-list
19919989|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19919990|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
19919991|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
19919992|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19919993|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19919994|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19919995|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
19919996|NCT01250717|Hormones|hormones|mesh-ancestor
19919997|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19919998|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19919999|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920000|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261829|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
19920001|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
19920002|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
19920003|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920004|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
19920005|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
19920006|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19920007|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
19920008|NCT01250730|Crizotinib|crizotinib|mesh-list
19920009|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920010|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19920011|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920012|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920013|NCT01250756|Vaccines|vaccines|mesh-list
19920014|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19920015|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
19920016|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920017|NCT01250834|Dulaglutide|dulaglutide|mesh-list
19920018|NCT01250834|Atorvastatin|atorvastatin|mesh-list
19920019|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19920020|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19920021|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
19920022|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920023|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19920024|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19920025|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920026|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19920027|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920028|NCT01250873|Sertraline|sertraline|mesh-list
19920029|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
19920030|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920031|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19920032|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19920033|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920034|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920035|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920036|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
19920037|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920038|NCT01250899|Vitamin D|vitamin d|mesh-list
19920039|NCT01250899|Vitamins|vitamins|mesh-ancestor
19920040|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
19920041|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920042|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19920043|NCT01250977|Donepezil|donepezil|mesh-list
19920044|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19920045|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920046|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920047|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
19920048|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920049|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920050|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
19920051|NCT01250990|Niacin|niacin|mesh-list
19920052|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19920053|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
19920054|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920055|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19920056|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
19920057|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
19920058|NCT01250990|Vitamins|vitamins|mesh-ancestor
19920059|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
19920060|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920061|NCT01251146|Atenolol|atenolol|mesh-list
19920062|NCT01251146|Bisoprolol|bisoprolol|mesh-list
19920063|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19920064|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920065|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
19920066|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
19920067|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920068|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920069|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19920070|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19920071|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19920072|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
19920073|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920074|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920075|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
19920076|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19920077|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
19920078|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920079|NCT01251315|Expectorants|expectorants|mesh-ancestor
19920080|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
19920081|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19920082|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
19920083|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920084|NCT01251315|Protective Agents|protective agents|mesh-ancestor
19920085|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920086|NCT01251315|Antidotes|antidotes|mesh-ancestor
19920087|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
19920088|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19920089|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19920090|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19920091|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920092|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920093|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
19920094|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920095|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920096|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19920097|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920098|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
19920099|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19920100|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19920101|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19920102|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920103|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920104|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
19920105|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920106|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920107|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19920108|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920109|NCT01251393|Biperiden|biperiden|mesh-list
19920110|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19920111|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19920112|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
19920113|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
19920114|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920115|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920116|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19920117|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19920118|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
19920119|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920120|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920121|NCT01251536|Cetuximab|cetuximab|mesh-list
19920122|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19920123|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920124|NCT01251575|Cyclosporine|cyclosporine|mesh-list
19920125|NCT01251575|Sirolimus|sirolimus|mesh-list
19920126|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
19920127|NCT01251575|Fludarabine|fludarabine|mesh-list
19920128|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
19920129|NCT01251575|Cyclosporins|cyclosporins|mesh-list
19920130|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920131|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19920132|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
19920133|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920134|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920135|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
19920136|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920137|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920138|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
19920139|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920140|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
19920141|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920142|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19920143|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19920144|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19920145|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
19920146|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19920147|NCT01251614|Adalimumab|adalimumab|mesh-list
19920148|NCT01251614|Methotrexate|methotrexate|mesh-list
19920149|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19920150|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
19920151|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920152|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920153|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19920154|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
19920155|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920156|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920157|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
20261830|NCT00498316|Clofarabine|clofarabine|mesh-list
20261831|NCT00498316|Tacrolimus|tacrolimus|mesh-list
20261832|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
20261833|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20261834|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541335|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20541336|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541337|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541338|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541339|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
20541340|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
20541341|NCT01857375|Insulin|insulin|mesh-list
20541342|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19920158|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920159|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19920160|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920161|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
19920162|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920163|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19920164|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19920165|NCT01251653|Gemcitabine|gemcitabine|mesh-list
19920166|NCT01251653|Docetaxel|docetaxel|mesh-list
19920167|NCT01251653|Afatinib|afatinib|mesh-list
19920168|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19920169|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
19920170|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920171|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920172|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
19920173|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920174|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920175|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920176|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
19920177|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920178|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
19920179|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
19920180|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
19920181|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19920182|NCT01251978|Ranibizumab|ranibizumab|mesh-list
19920183|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19920184|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19920185|NCT01251978|Growth Substances|growth substances|mesh-ancestor
19920186|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920187|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
19920188|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920189|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19920190|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
19920191|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
19920192|NCT01252186|Desogestrel|desogestrel|mesh-list
19920193|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
19920194|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920195|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920196|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19920197|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19920198|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19920199|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19920200|NCT01252186|Progestins|progestins|mesh-ancestor
19920201|NCT01252186|Hormones|hormones|mesh-ancestor
20261835|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
20261836|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261837|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20261838|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20261839|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
20261840|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261841|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261842|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20261843|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20261844|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261845|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
19920202|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920203|NCT01252238|Amlodipine|amlodipine|mesh-list
19920204|NCT01252238|Valsartan|valsartan|mesh-list
19920205|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920206|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19920207|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920208|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920209|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19920210|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920211|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
19920212|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19920213|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19920214|NCT01252251|Everolimus|everolimus|mesh-list
19920215|NCT01252251|Pasireotide|pasireotide|mesh-list
19920216|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920217|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920218|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
19920219|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920220|NCT01252251|Hormones|hormones|mesh-ancestor
19920221|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920222|NCT01252355|Interferons|interferons|mesh-list
19920223|NCT01252355|Interferon-beta|interferon-beta|mesh-list
19920224|NCT01252355|Teriflunomide|teriflunomide|mesh-list
19920225|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920226|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
19920227|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920228|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
19920229|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920230|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19920231|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920232|NCT01252355|Analgesics|analgesics|mesh-ancestor
19920233|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
19920234|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920235|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19920236|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920237|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920238|NCT01252563|Amlodipine|amlodipine|mesh-list
19920239|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920240|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19920241|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920242|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920243|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19920244|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920245|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
19920246|NCT01252667|Cyclosporine|cyclosporine|mesh-list
19920247|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
19920248|NCT01252667|Clofarabine|clofarabine|mesh-list
19920249|NCT01252667|Cyclosporins|cyclosporins|mesh-list
19920250|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920251|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920252|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920253|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
19920254|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920255|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
19920256|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920257|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
19920258|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920259|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19920260|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19920261|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920262|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19920263|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
19920264|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19920265|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19920266|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
19920267|NCT01252732|Vancomycin|vancomycin|mesh-list
19920268|NCT01252732|Oritavancin|oritavancin|mesh-list
19920269|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19920270|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920271|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
19920272|NCT01252745|Testosterone|testosterone|mesh-list
19920273|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
19920274|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
19920275|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19920276|NCT01252745|Androgens|androgens|mesh-ancestor
19920277|NCT01252745|Hormones|hormones|mesh-ancestor
19920278|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920279|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920280|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19920281|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920282|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
19920283|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
19920284|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
19920285|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920286|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19920287|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19920288|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920289|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920290|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19920291|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19920292|NCT01253135|Petrolatum|petrolatum|mesh-list
19920293|NCT01253135|Emollients|emollients|mesh-ancestor
19920294|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
19920295|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
19920296|NCT01253174|Drospirenone|drospirenone|mesh-list
19920297|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19920298|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
19920299|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920300|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920301|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19920302|NCT01253174|Diuretics|diuretics|mesh-ancestor
19920303|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
19920304|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
19920305|NCT01253174|Vitamins|vitamins|mesh-ancestor
19920306|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
19920307|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
19920308|NCT01253187|Drospirenone|drospirenone|mesh-list
19920309|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19920310|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
19920311|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920312|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920313|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19920314|NCT01253187|Diuretics|diuretics|mesh-ancestor
19920315|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
19920316|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
19920317|NCT01253187|Vitamins|vitamins|mesh-ancestor
19920318|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
19920319|NCT01253200|Acifluorfen|acifluorfen|mesh-list
19920320|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920321|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920322|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19920323|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
19920324|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920325|NCT01253265|Ixekizumab|ixekizumab|mesh-list
19920326|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
19920327|NCT01253304|Dulaglutide|dulaglutide|mesh-list
19920328|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19920329|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920330|NCT01253317|Mecasermin|mecasermin|mesh-list
19920331|NCT01253317|Growth Substances|growth substances|mesh-ancestor
19920332|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920333|NCT01253408|Dronabinol|dronabinol|mesh-list
19920334|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
19920335|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920336|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920337|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920338|NCT01253408|Analgesics|analgesics|mesh-ancestor
19920339|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
19920340|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920341|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19920342|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19920343|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920344|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920345|NCT01253408|Hormones|hormones|mesh-ancestor
19920346|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920347|NCT01253421|Amisulpride|amisulpride|mesh-list
19920348|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19920349|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20261846|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261847|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19920350|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920351|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920352|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920353|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19920354|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
19920355|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920356|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920357|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19920358|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
19920359|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
19920360|NCT01253460|Rituximab|rituximab|mesh-list
19920361|NCT01253460|Sapacitabine|sapacitabine|mesh-list
19920362|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920363|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
19920364|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920365|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920366|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19920367|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
19920368|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920369|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920370|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19920371|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19920372|NCT01253525|Paclitaxel|paclitaxel|mesh-list
19920373|NCT01253525|Ramucirumab|ramucirumab|mesh-list
19920374|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19920375|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920376|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
19920377|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
19920378|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
19920379|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920380|NCT01253642|Docetaxel|docetaxel|mesh-list
19920381|NCT01253642|Phenelzine|phenelzine|mesh-list
19920382|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920383|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
19920384|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
19920385|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
19920386|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920387|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
19920388|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920389|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19920390|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920391|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19920392|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19920393|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19920394|NCT01253824|Norethindrone|norethindrone|mesh-list
19920395|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
19920396|NCT01253824|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19920397|NCT01253824|Norinyl|norinyl|mesh-list
19920398|NCT01253824|Mestranol|mestranol|mesh-list
19920399|NCT01253824|Estradiol|estradiol|mesh-list
19920400|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19920401|NCT01253824|Estrogens|estrogens|mesh-ancestor
19920402|NCT01253824|Hormones|hormones|mesh-ancestor
19920403|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920404|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920405|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19920406|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
19920407|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920408|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19920409|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19920410|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19920411|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19920412|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19920413|NCT01253824|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19920414|NCT01253902|Bimatoprost|bimatoprost|mesh-list
19920415|NCT01253902|Travoprost|travoprost|mesh-list
19920416|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19920417|NCT01253902|Latanoprost|latanoprost|mesh-list
19920418|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19920419|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920420|NCT01253980|Amoxicillin|amoxicillin|mesh-list
19920421|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19920422|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920423|NCT01254045|Oxytocin|oxytocin|mesh-list
19920424|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
19920425|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920426|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920427|NCT01254227|Deferasirox|deferasirox|mesh-list
19920428|NCT01254227|Deferoxamine|deferoxamine|mesh-list
19920429|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19920430|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
19920431|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
19920432|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920433|NCT01254227|Siderophores|siderophores|mesh-ancestor
19920434|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
19920435|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19920436|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
19920437|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920438|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920439|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19920440|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19920441|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19920442|NCT01254305|Milnacipran|milnacipran|mesh-list
19920443|NCT01254305|Sertraline|sertraline|mesh-list
19920444|NCT01254305|Fluoxetine|fluoxetine|mesh-list
19920445|NCT01254305|Paroxetine|paroxetine|mesh-list
19920446|NCT01254305|Citalopram|citalopram|mesh-list
19920447|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
19920448|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
19920449|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920450|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19920451|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19920452|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920453|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920454|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920455|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
19920456|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920457|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19920458|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19920459|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19920460|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920461|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920462|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19920463|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920464|NCT01254305|Analgesics|analgesics|mesh-ancestor
19920465|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
19920466|NCT01254344|Metronidazole|metronidazole|mesh-list
19920467|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
19920468|NCT01254344|Ertapenem|ertapenem|mesh-list
19920469|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920470|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19920471|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19920472|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19920473|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
19920474|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
20261848|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261849|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20261850|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20261851|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
20261852|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20261853|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
20261854|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20261855|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
20261856|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261857|NCT00498342|Expectorants|expectorants|mesh-ancestor
20261858|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
20261859|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20261860|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
20261861|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261862|NCT00498342|Protective Agents|protective agents|mesh-ancestor
20261863|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261864|NCT00498342|Antidotes|antidotes|mesh-ancestor
20261865|NCT00498537|Spironolactone|spironolactone|mesh-list
20261866|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20261867|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
20261868|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261869|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261870|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19920475|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19920476|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19920477|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920478|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920479|NCT01254396|Urological Agents|urological agents|mesh-ancestor
19920480|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19920481|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
19920482|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
19920483|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920484|NCT01254604|Timolol|timolol|mesh-list
19920485|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19920486|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19920487|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
19920488|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920489|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920490|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920491|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19920492|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19972535|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
19972536|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972537|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19972538|NCT01811225|Progesterone|progesterone|mesh-list
19972539|NCT01811225|Progestins|progestins|mesh-ancestor
19972540|NCT01811225|Hormones|hormones|mesh-ancestor
20261871|NCT00498537|Diuretics|diuretics|mesh-ancestor
20261872|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
20261873|NCT00498589|Methotrexate|methotrexate|mesh-list
20261874|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20261875|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
20261876|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261877|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261878|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261879|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
20261880|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261881|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261882|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
20261883|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261884|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20261885|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261886|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
20261887|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541343|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541344|NCT01857453|Etoposide|etoposide|mesh-list
19972541|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972542|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972543|NCT01811238|Oxycodone|oxycodone|mesh-list
19972544|NCT01811238|Naloxone|naloxone|mesh-list
19972545|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19972546|NCT01811238|Narcotics|narcotics|mesh-ancestor
19972547|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972548|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972549|NCT01811238|Analgesics|analgesics|mesh-ancestor
19972550|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
19972551|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972552|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19972553|NCT01811355|Mexiletine|mexiletine|mesh-list
19972554|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19972555|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19972556|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19972557|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972558|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972559|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
19972560|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19972561|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
19972562|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972563|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
19972564|NCT01811654|Protective Agents|protective agents|mesh-ancestor
19972565|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
19972566|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
19972567|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
19972568|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19972569|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20261888|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20541345|NCT01857453|Carboplatin|carboplatin|mesh-list
19920493|NCT01254630|Vaccines|vaccines|mesh-list
19920494|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
19920495|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920496|NCT01254656|Efavirenz|efavirenz|mesh-list
19920497|NCT01254656|Etravirine|etravirine|mesh-list
19920498|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19920499|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19920500|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920501|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920502|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
19920503|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920504|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19920505|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19920506|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19920507|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19920508|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19920509|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19920510|NCT01254669|Vaccines|vaccines|mesh-list
19920511|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
19920512|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920513|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19920514|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
19920515|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920516|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19920517|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19920518|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920519|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920520|NCT01254877|Ondansetron|ondansetron|mesh-list
19920521|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
19920522|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
19920523|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920524|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920525|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19920526|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
19920527|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
19920528|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19920529|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
19920530|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920531|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920532|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19920533|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19920534|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19449996|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19449997|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
19449998|NCT03431831|Naltrexone|naltrexone|mesh-list
19449999|NCT03431831|Bupropion|bupropion|mesh-list
19450000|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19450001|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19920535|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920536|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19920537|NCT01254890|Azacitidine|azacitidine|mesh-list
19920538|NCT01254890|Sorafenib|sorafenib|mesh-list
19920539|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19920540|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
19920541|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920542|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920543|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920544|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19920545|NCT01255137|Axitinib|axitinib|mesh-list
19920546|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920547|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19920548|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920549|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920550|NCT01255163|Exenatide|exenatide|mesh-list
19920551|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19920552|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920553|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19920554|NCT01255163|Incretins|incretins|mesh-ancestor
19920555|NCT01255163|Hormones|hormones|mesh-ancestor
19920556|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920557|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19920558|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920559|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20261889|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
19920560|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19920561|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19920562|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
19920563|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920564|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920565|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920566|NCT01255423|Diclofenac|diclofenac|mesh-list
19920567|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19920568|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920569|NCT01255423|Analgesics|analgesics|mesh-ancestor
19920570|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
19920571|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920572|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920573|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19920574|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920575|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19920576|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920577|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920578|NCT01255449|Albuterol|albuterol|mesh-list
19920579|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19920580|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
19920581|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920582|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920583|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19920584|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
19920585|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
19920586|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920587|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19920588|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19920589|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19920590|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
20261890|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20261891|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
20261892|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20261893|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20261894|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261895|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261896|NCT00498680|Urological Agents|urological agents|mesh-ancestor
20261897|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
20261898|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20261899|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
20261900|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261901|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261902|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20261903|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20261904|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20261905|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20261906|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20261907|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20261908|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
20261909|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20261910|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261911|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261912|NCT00498888|Urological Agents|urological agents|mesh-ancestor
20261913|NCT00498901|Letrozole|letrozole|mesh-list
20261914|NCT00498901|Leuprolide|leuprolide|mesh-list
20261915|NCT00498901|Goserelin|goserelin|mesh-list
20261916|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261917|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20261918|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20261919|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261920|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261921|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20261922|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
20261923|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20261924|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920591|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920592|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920593|NCT01255670|Metronidazole|metronidazole|mesh-list
19920594|NCT01255670|Penicillins|penicillins|mesh-list
19920595|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920596|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19920597|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19920598|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19920599|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
19920600|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920601|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
19920602|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920603|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920604|NCT01255787|Vortioxetine|vortioxetine|mesh-list
19920605|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
19920606|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920607|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19920608|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19920609|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920610|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920611|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19920612|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19920613|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920614|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920615|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920616|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
19920617|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19920618|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19920619|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19920620|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19920621|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
19920622|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
19920623|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19920624|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920625|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920626|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920627|NCT01255904|Analgesics|analgesics|mesh-ancestor
19920628|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
19920629|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920630|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19920631|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19920632|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19920633|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19920634|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920635|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920636|NCT01256060|Oxytocin|oxytocin|mesh-list
19920637|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
19920638|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920639|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920640|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19920641|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19920642|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
19920643|NCT01256164|Coagulants|coagulants|mesh-ancestor
19920644|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19920645|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
19920646|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920647|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19920648|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19920649|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920650|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920651|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19920652|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
19920653|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
19920654|NCT01256190|Coagulants|coagulants|mesh-ancestor
19920655|NCT01256294|Tacrolimus|tacrolimus|mesh-list
19920656|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920657|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
19920658|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920659|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19920660|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920661|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920662|NCT01256385|Sirolimus|sirolimus|mesh-list
19920663|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19920664|NCT01256385|Cetuximab|cetuximab|mesh-list
19920665|NCT01256385|Antibodies|antibodies|mesh-list
19920666|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
19920667|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19920668|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
19920669|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920670|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920671|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19920672|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920673|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19920674|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
19920675|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920676|NCT01256411|Amlodipine|amlodipine|mesh-list
19920677|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19920678|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19920679|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920680|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19920681|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920682|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920683|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19920684|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920685|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
19920686|NCT01256411|Diuretics|diuretics|mesh-ancestor
19920687|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
19920688|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19920689|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19920690|NCT01256450|Buprenorphine|buprenorphine|mesh-list
19920691|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19920692|NCT01256450|Narcotics|narcotics|mesh-ancestor
19920693|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920694|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920695|NCT01256450|Analgesics|analgesics|mesh-ancestor
19920696|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
19920697|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920698|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19920699|NCT01256476|Pravastatin|pravastatin|mesh-list
19920700|NCT01256476|Pitavastatin|pitavastatin|mesh-list
19920701|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19920702|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19920703|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
19920704|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920705|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19920706|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19920707|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920708|NCT01256567|Docetaxel|docetaxel|mesh-list
19920709|NCT01256567|Ramucirumab|ramucirumab|mesh-list
19920710|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920711|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
19920712|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
19920713|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
19920714|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920715|NCT01256593|Pregabalin|pregabalin|mesh-list
19920716|NCT01256593|Analgesics|analgesics|mesh-ancestor
19920717|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
19920718|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920719|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920720|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
19920721|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19920722|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19920723|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920724|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19920725|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19920726|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19920727|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920728|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19920729|NCT01256658|Lumefantrine|lumefantrine|mesh-list
19920730|NCT01256658|Artemether|artemether|mesh-list
19920731|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19920732|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
19920733|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19920734|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19920735|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920736|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19920737|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19920738|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
19920739|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920740|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19920741|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19920742|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
19920743|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920744|NCT01256879|Cimetidine|cimetidine|mesh-list
19920745|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19920746|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19920747|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19920748|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
19920749|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
19920750|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920751|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920752|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920753|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19920754|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19920755|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920756|NCT01257087|Insulin|insulin|mesh-list
19920757|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19920758|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
19920759|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19920760|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920761|NCT01257204|Interferons|interferons|mesh-list
19920762|NCT01257204|Ribavirin|ribavirin|mesh-list
19920763|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
19920764|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
19920765|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19920766|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920767|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
19920768|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920769|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
19920770|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920771|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
19920772|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920773|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
19920774|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19920775|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
19920776|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920777|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920778|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19920779|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
19920780|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
19920781|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19920782|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
19920783|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920784|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920785|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19920786|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
19920787|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19920788|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
19920789|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920790|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920791|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19920792|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19920793|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920794|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
19920795|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
19920796|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
19920797|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19920798|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19920799|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920800|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920801|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920802|NCT01257581|Tamoxifen|tamoxifen|mesh-list
19920803|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19920804|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
19920805|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920806|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920807|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19920808|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920809|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19920810|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19920811|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19920812|NCT01257698|Timolol|timolol|mesh-list
19920813|NCT01257698|Dorzolamide|dorzolamide|mesh-list
19920814|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19920815|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19920816|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19920817|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
19920818|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19920819|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920820|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920821|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19920822|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920823|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19920824|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920825|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19920826|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19920827|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920828|NCT01257802|Leuprolide|leuprolide|mesh-list
19920829|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19920830|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
19920831|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19920832|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920833|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19920834|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920835|NCT01258049|Artemether|artemether|mesh-list
19920836|NCT01258049|Quinine|quinine|mesh-list
19920837|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
19920838|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19920839|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19920840|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920841|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19920842|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920843|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19920844|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920845|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920846|NCT01258049|Analgesics|analgesics|mesh-ancestor
19920847|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
19920848|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19920849|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19920850|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19920851|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
19920852|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920853|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19920854|NCT01258101|Ribavirin|ribavirin|mesh-list
19920855|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19920856|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
19920857|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
19920858|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920859|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
19920860|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920861|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
19920862|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920863|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19920864|NCT01258153|MEN 11420|men 11420|mesh-list
19920865|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19920866|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
19920867|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920868|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920869|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19920870|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
19920871|NCT01258348|Sunitinib|sunitinib|mesh-list
19920872|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920873|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19920874|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19920875|NCT01258348|Growth Substances|growth substances|mesh-ancestor
19920876|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920877|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
19920878|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19920879|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920880|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920881|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
19920882|NCT01258374|Darunavir|darunavir|mesh-list
19920883|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19920884|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19920885|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
19920886|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920887|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19920888|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19920889|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920890|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920891|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20261925|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19920892|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19920893|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
19920894|NCT01258387|Mitogens|mitogens|mesh-list
19920895|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
19920896|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920897|NCT01258595|Vaccines|vaccines|mesh-list
19920898|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
19920899|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920900|NCT01258608|Sorafenib|sorafenib|mesh-list
19920901|NCT01258608|Mapatumumab|mapatumumab|mesh-list
19920902|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920903|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19920904|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920905|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920906|NCT01258660|Folic Acid|folic acid|mesh-list
19920907|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
19920908|NCT01258660|Drospirenone|drospirenone|mesh-list
19920909|NCT01258660|Hematinics|hematinics|mesh-ancestor
19920910|NCT01258660|Vitamins|vitamins|mesh-ancestor
19920911|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
19920912|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920913|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19920914|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
19920915|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920916|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19920917|NCT01258660|Diuretics|diuretics|mesh-ancestor
19920918|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
19920919|NCT01258738|Etanercept|etanercept|mesh-list
19920920|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19920921|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920922|NCT01258738|Analgesics|analgesics|mesh-ancestor
19920923|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
19920924|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920925|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920926|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19920927|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19920928|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19920929|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920930|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
19920931|NCT01258855|Aldesleukin|aldesleukin|mesh-list
19920932|NCT01258855|Aflibercept|aflibercept|mesh-list
19920933|NCT01258855|Interleukin-2|interleukin-2|mesh-list
19920934|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
19920935|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19920936|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19920937|NCT01258855|Growth Substances|growth substances|mesh-ancestor
19920938|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920939|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
19920940|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920941|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19920942|NCT01258855|Analgesics|analgesics|mesh-ancestor
19920943|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
19920944|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920945|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19920946|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19920947|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
19920948|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920949|NCT01259063|Gemcitabine|gemcitabine|mesh-list
19920950|NCT01259063|Everolimus|everolimus|mesh-list
19920951|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19920952|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
19920953|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920954|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920955|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
19920956|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920957|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920958|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19920959|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
19920960|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261926|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
20261927|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20261928|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20261929|NCT00498953|Carboplatin|carboplatin|mesh-list
20261930|NCT00498953|Docetaxel|docetaxel|mesh-list
20261931|NCT00498953|Fluorouracil|fluorouracil|mesh-list
20261932|NCT00498953|Lapatinib|lapatinib|mesh-list
19920961|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19920962|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261933|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20261934|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19920963|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261935|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
20261936|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
20261937|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261938|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261939|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
20261940|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20261941|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20261942|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
20261943|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261944|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20261945|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20261946|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20261947|NCT00498979|Interferons|interferons|mesh-list
20261948|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
20261949|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
20261950|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20261951|NCT00498979|Dacarbazine|dacarbazine|mesh-list
20261952|NCT00498979|Vinblastine|vinblastine|mesh-list
20261953|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261954|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
20261955|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20261956|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
20261957|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261958|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20261959|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
20261960|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261961|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20261962|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
20541346|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20541347|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541348|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20541349|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541350|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541351|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541352|NCT01857479|Amphotericin B|amphotericin b|mesh-list
20541353|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20541354|NCT01857479|Budesonide|budesonide|mesh-list
20541355|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541356|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20541357|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
20541358|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541359|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541360|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20541361|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541362|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
20541363|NCT01857479|Hormones|hormones|mesh-ancestor
20541364|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541365|NCT01857479|Amebicides|amebicides|mesh-ancestor
20541366|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20541367|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20541368|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541369|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20541370|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
20541371|NCT01857544|Aflibercept|aflibercept|mesh-list
20541372|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20541373|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20541374|NCT01857544|Growth Substances|growth substances|mesh-ancestor
20541375|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541376|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
20541377|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541378|NCT01857596|Trazodone|trazodone|mesh-list
19920964|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920965|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920966|NCT01259102|Buprenorphine|buprenorphine|mesh-list
19920967|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19920968|NCT01259102|Narcotics|narcotics|mesh-ancestor
19920969|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920970|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920971|NCT01259102|Analgesics|analgesics|mesh-ancestor
19920972|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
19920973|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920974|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19920975|NCT01259115|Ketoconazole|ketoconazole|mesh-list
20261963|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
19920976|NCT01259115|Buprenorphine|buprenorphine|mesh-list
19920977|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19920978|NCT01259115|Narcotics|narcotics|mesh-ancestor
19920979|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19920980|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19920981|NCT01259115|Analgesics|analgesics|mesh-ancestor
19920982|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
19920983|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19920984|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19920985|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
19920986|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19920987|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19920988|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19920989|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19920990|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19920991|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19920992|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
19920993|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19920994|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19920995|NCT01259297|Amlodipine|amlodipine|mesh-list
19920996|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19920997|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19920998|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19920999|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921000|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921001|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19921002|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921003|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
19921004|NCT01259297|Diuretics|diuretics|mesh-ancestor
19921005|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
19921006|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19921007|NCT01259375|Amrubicin|amrubicin|mesh-list
19921008|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921009|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
19921010|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
19921011|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921012|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921013|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921014|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
19921015|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19921016|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921017|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921018|NCT01259466|Nicotine|nicotine|mesh-list
19921019|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19921020|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
19921021|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921022|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921023|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19921024|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19921025|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
19921026|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921027|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921028|NCT01259492|Methylphenidate|methylphenidate|mesh-list
19921029|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19921030|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921031|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19921032|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19921033|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921034|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921035|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
19921036|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921037|NCT01259713|Amphotericin B|amphotericin b|mesh-list
19921038|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19921039|NCT01259713|Amebicides|amebicides|mesh-ancestor
19921040|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19921041|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19921042|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921043|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19921044|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
19921045|NCT01259856|Aspirin|aspirin|mesh-list
19921046|NCT01259856|Interferons|interferons|mesh-list
19921047|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
19921048|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
19921049|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19921050|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
19921051|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921052|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
19921053|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921054|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19921055|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19921056|NCT01259856|Analgesics|analgesics|mesh-ancestor
19921057|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
19921058|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921059|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921060|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921061|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921062|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19921063|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19921064|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921065|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19921066|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19921067|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921068|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
19921069|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
19921070|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
19921071|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19972570|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972571|NCT01811732|Vancomycin|vancomycin|mesh-list
19972572|NCT01811732|Aztreonam|aztreonam|mesh-list
19972573|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19972574|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972575|NCT01811940|Topiramate|topiramate|mesh-list
19972576|NCT01811940|Adderall|adderall|mesh-list
19972577|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
19972578|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972579|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972580|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19972581|NCT01811953|Metformin|metformin|mesh-list
19972582|NCT01811953|Empagliflozin|empagliflozin|mesh-list
19972583|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972584|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972585|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19972586|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972587|NCT01812005|Rituximab|rituximab|mesh-list
19972588|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19972589|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972590|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
19972591|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972592|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972593|NCT01812044|Lidocaine|lidocaine|mesh-list
19972594|NCT01812044|Bupivacaine|bupivacaine|mesh-list
19972595|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
19972596|NCT01812044|Anesthetics|anesthetics|mesh-list
19732422|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732423|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732424|NCT04574778|Acetaminophen|acetaminophen|mesh-list
19732425|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732426|NCT04574778|Analgesics|analgesics|mesh-ancestor
19732427|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
19732428|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732429|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972597|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972598|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972599|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
19972600|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972601|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19972602|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19972603|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19972604|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972605|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972606|NCT01812057|Dexamethasone|dexamethasone|mesh-list
19972607|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972608|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
19972609|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
19972610|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972611|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972612|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19972613|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
19972614|NCT01812057|Hormones|hormones|mesh-ancestor
19921072|NCT01260142|Propofol|propofol|mesh-list
19921073|NCT01260142|Fospropofol|fospropofol|mesh-list
19921074|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19921075|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921076|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921077|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19921078|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
19921079|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
19921080|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19921081|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921082|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19921083|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921084|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921085|NCT01260194|Trastuzumab|trastuzumab|mesh-list
19921086|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19921087|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921088|NCT01260311|Fesoterodine|fesoterodine|mesh-list
19921089|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19921090|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19921091|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
19921092|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921093|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921094|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921095|NCT01260311|Urological Agents|urological agents|mesh-ancestor
19921096|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
19921097|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
19921098|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921099|NCT01260454|Capsaicin|capsaicin|mesh-list
19921100|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
19921101|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
19921102|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
19921103|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921104|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921105|NCT01260467|Memantine|memantine|mesh-list
19921106|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19921107|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19921108|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
19921109|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921110|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921111|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921112|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19921113|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19921114|NCT01260584|Clopidogrel|clopidogrel|mesh-list
19921115|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19921116|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19921117|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19921118|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19921119|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19921120|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
19921121|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921122|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921123|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921124|NCT01260649|Ketamine|ketamine|mesh-list
19921125|NCT01260649|Anesthetics|anesthetics|mesh-list
19921126|NCT01260649|Analgesics|analgesics|mesh-ancestor
19921127|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
19921128|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921129|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921130|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19921131|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19921132|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
19921133|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921134|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19921135|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19921136|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921137|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921138|NCT01260662|Ketamine|ketamine|mesh-list
19921139|NCT01260662|Propofol|propofol|mesh-list
19921140|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19921141|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921142|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921143|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19921144|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
19921145|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
19921146|NCT01260662|Analgesics|analgesics|mesh-ancestor
19921147|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
19921148|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921149|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19921150|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19921151|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19921152|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921153|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261964|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
20261965|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20261966|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20261967|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
20261968|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20261969|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
20261970|NCT00498992|Vitamin E|vitamin e|mesh-list
20261971|NCT00498992|Lidocaine|lidocaine|mesh-list
20261972|NCT00498992|Vitamins|vitamins|mesh-ancestor
20261973|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
20261974|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261975|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
20261976|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
20261977|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20261978|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
20261979|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20261980|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20261981|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20261982|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20261983|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20261984|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20261985|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
20261986|NCT00498992|Protective Agents|protective agents|mesh-ancestor
20261987|NCT00499005|Carbetocin|carbetocin|mesh-list
20261988|NCT00499005|Oxytocin|oxytocin|mesh-list
20261989|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
20261990|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19921154|NCT01260688|Dasatinib|dasatinib|mesh-list
19921155|NCT01260688|Cediranib|cediranib|mesh-list
19921156|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20261991|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20261992|NCT00499018|Cytarabine|cytarabine|mesh-list
20261993|NCT00499018|Prednisone|prednisone|mesh-list
20261994|NCT00499018|Rituximab|rituximab|mesh-list
20261995|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
20261996|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
20261997|NCT00499018|Vincristine|vincristine|mesh-list
20261998|NCT00499018|Doxorubicin|doxorubicin|mesh-list
20261999|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20262000|NCT00499018|Lenograstim|lenograstim|mesh-list
20262001|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262002|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262003|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
20262004|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262005|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262006|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262007|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
20262008|NCT00499018|Hormones|hormones|mesh-ancestor
20262009|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262010|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20262011|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262012|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
20262013|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921157|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19921158|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921159|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921160|NCT01260883|Ketorolac|ketorolac|mesh-list
19921161|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19921162|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19921163|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19921164|NCT01260883|Analgesics|analgesics|mesh-ancestor
19921165|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
19921166|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262014|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
20262015|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262016|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262017|NCT00499018|Analgesics|analgesics|mesh-ancestor
20262018|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
20262019|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921167|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921168|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921169|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921170|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19921171|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921172|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921173|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19921174|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19921175|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19921176|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921177|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921178|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921179|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921180|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19921181|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
19921182|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921183|NCT01260922|Donepezil|donepezil|mesh-list
19921184|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19921185|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921186|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921187|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
19921188|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921189|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921190|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
19921191|NCT01260948|Donepezil|donepezil|mesh-list
19921192|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19921193|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921194|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921195|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
19921196|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921197|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921198|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
19921199|NCT01261325|Brivaracetam|brivaracetam|mesh-list
19921200|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
19921201|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
19921202|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19921203|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19921204|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
19921205|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921206|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19921207|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
19921208|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19921209|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19921210|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19921211|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921212|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921213|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
19921214|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921215|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921216|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19921217|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921218|NCT01261793|Epratuzumab|epratuzumab|mesh-list
19921219|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19921220|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921221|NCT01262092|Buprenorphine|buprenorphine|mesh-list
19921222|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19921223|NCT01262092|Narcotics|narcotics|mesh-ancestor
19921224|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921225|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921226|NCT01262092|Analgesics|analgesics|mesh-ancestor
19921227|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
19921228|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921229|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19921230|NCT01262118|Tofacitinib|tofacitinib|mesh-list
19921231|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19921232|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921233|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921234|NCT01262287|Dutasteride|dutasteride|mesh-list
19921235|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19921236|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19921237|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921238|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921239|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
19921240|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921241|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921242|NCT01262352|Ivacaftor|ivacaftor|mesh-list
19921243|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19921244|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921245|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921246|NCT01262365|Epratuzumab|epratuzumab|mesh-list
19921247|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19921248|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921249|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19921250|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
19921251|NCT01262456|Coagulants|coagulants|mesh-ancestor
19921252|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19921253|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
19921254|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921255|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
19921256|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19921257|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
19921258|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921259|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19921260|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921261|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921262|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921263|NCT01262651|Nabiximols|nabiximols|mesh-list
19921264|NCT01262651|Analgesics|analgesics|mesh-ancestor
19921265|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
19921266|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921267|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921268|NCT01262677|Pregabalin|pregabalin|mesh-list
19921269|NCT01262677|Analgesics|analgesics|mesh-ancestor
19921270|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
19921271|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921272|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921273|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
19921274|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19921275|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921276|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921277|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19921278|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19921279|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19921280|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921281|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921282|NCT01262872|Vaccines|vaccines|mesh-list
19921283|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19921284|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
19921285|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921286|NCT01263015|Lamivudine|lamivudine|mesh-list
19921287|NCT01263015|Abacavir|abacavir|mesh-list
19921288|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
20262020|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20262021|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262022|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262023|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20262024|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
20262025|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20262026|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20262027|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20262028|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
20262029|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
20262030|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
20262031|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20262032|NCT00499135|Alovudine|alovudine|mesh-list
20262033|NCT00499135|Sunitinib|sunitinib|mesh-list
20262034|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262035|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20262036|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20262037|NCT00499135|Growth Substances|growth substances|mesh-ancestor
20262038|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262039|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
20262040|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262041|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262042|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262043|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
19921289|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19921290|NCT01263015|Dolutegravir|dolutegravir|mesh-list
19921291|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19921292|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19921293|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921294|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921295|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
19921296|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921297|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19921298|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19921299|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
19921300|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19921301|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19921302|NCT01263093|Clopidogrel|clopidogrel|mesh-list
19921303|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19921304|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19921305|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19921306|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19921307|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
19921308|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921309|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921310|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921311|NCT01263106|Theophylline|theophylline|mesh-list
19921312|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19921313|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
19921314|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921315|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921316|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19921317|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
19921318|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19921319|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921320|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921321|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
19921322|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19921323|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19921324|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
19921325|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921326|NCT01263119|Warfarin|warfarin|mesh-list
19921327|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
19921328|NCT01263132|Thiamine|thiamine|mesh-list
19921329|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
19921330|NCT01263132|Gabapentin|gabapentin|mesh-list
19921331|NCT01263132|Analgesics|analgesics|mesh-ancestor
19921332|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
19921333|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921334|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921335|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
19921336|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19921337|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19921338|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921339|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921340|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19921341|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19921342|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921343|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921344|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
19921345|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
19921346|NCT01263132|Vitamins|vitamins|mesh-ancestor
19921347|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
19921348|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
19921349|NCT01263197|Propranolol|propranolol|mesh-list
19921350|NCT01263197|Albuterol|albuterol|mesh-list
19921351|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19921352|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
19921353|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921354|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921355|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19921356|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
19921357|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
19921358|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19921359|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19921360|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19921361|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19921362|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
19921363|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921364|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921365|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19921366|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19921367|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19921368|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19921369|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
19921370|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19921371|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921372|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
19921373|NCT01263444|Timolol|timolol|mesh-list
19921374|NCT01263444|Bimatoprost|bimatoprost|mesh-list
19921375|NCT01263444|Travoprost|travoprost|mesh-list
19921376|NCT01263444|Latanoprost|latanoprost|mesh-list
19921377|NCT01263444|Brinzolamide|brinzolamide|mesh-list
19921378|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19921379|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19921380|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
19921381|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921382|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921383|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921384|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19921385|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19921386|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19921387|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20262044|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262045|NCT00499265|Gemcitabine|gemcitabine|mesh-list
20262046|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
20262047|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
20262048|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262049|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
20262050|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262051|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262052|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
20262053|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262054|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262055|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541379|NCT01857596|Bupropion|bupropion|mesh-list
20541380|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20541381|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
20541382|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20541383|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20541384|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20541385|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541386|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541387|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
20541388|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541389|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541390|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20541391|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20541392|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541393|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20541394|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20541395|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541396|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20541397|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
20541398|NCT01857609|Metformin|metformin|mesh-list
20541399|NCT01857609|Rabeprazole|rabeprazole|mesh-list
20541400|NCT01857609|Pantoprazole|pantoprazole|mesh-list
20541401|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20541402|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541403|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20541404|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541405|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20541406|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541407|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541408|NCT01857726|Doxorubicin|doxorubicin|mesh-list
20541409|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541410|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20541411|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20541412|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541413|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921388|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20262056|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
19921389|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921390|NCT01263470|Alogliptin|alogliptin|mesh-list
19921391|NCT01263470|Voglibose|voglibose|mesh-list
19921392|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921393|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921394|NCT01263470|Incretins|incretins|mesh-ancestor
19921395|NCT01263470|Hormones|hormones|mesh-ancestor
19921396|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921397|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19921398|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
19921399|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921400|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921401|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19921402|NCT01263483|Inositol|inositol|mesh-list
19921403|NCT01263483|Alogliptin|alogliptin|mesh-list
19921404|NCT01263483|Voglibose|voglibose|mesh-list
19921405|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921406|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921407|NCT01263483|Incretins|incretins|mesh-ancestor
19921408|NCT01263483|Hormones|hormones|mesh-ancestor
19921409|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921410|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19921411|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
19921412|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921413|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921414|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19921415|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
19921416|NCT01263483|Vitamins|vitamins|mesh-ancestor
19921417|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
19921418|NCT01263496|Alogliptin|alogliptin|mesh-list
19921419|NCT01263496|Voglibose|voglibose|mesh-list
19921420|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921421|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921422|NCT01263496|Incretins|incretins|mesh-ancestor
19921423|NCT01263496|Hormones|hormones|mesh-ancestor
19921424|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921425|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19921426|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
19921427|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921428|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921429|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19921430|NCT01263509|Inositol|inositol|mesh-list
19921431|NCT01263509|Alogliptin|alogliptin|mesh-list
19921432|NCT01263509|Voglibose|voglibose|mesh-list
19921433|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921434|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921435|NCT01263509|Incretins|incretins|mesh-ancestor
19921436|NCT01263509|Hormones|hormones|mesh-ancestor
19921437|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921438|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19921439|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
19921440|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921441|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921442|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19921443|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
19921444|NCT01263509|Vitamins|vitamins|mesh-ancestor
19921445|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
19921446|NCT01263691|Vaccines|vaccines|mesh-list
19921447|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
19921448|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921449|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
19921450|NCT01263704|Rituximab|rituximab|mesh-list
19921451|NCT01263704|Fludarabine|fludarabine|mesh-list
19921452|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19921453|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
19921454|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921455|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921456|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19921457|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
19921458|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921459|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921460|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19921461|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19921462|NCT01263717|Hormones|hormones|mesh-list
19921463|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19921464|NCT01263717|Tesamorelin|tesamorelin|mesh-list
19921465|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921466|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921467|NCT01263717|Growth Substances|growth substances|mesh-ancestor
19921468|NCT01263782|Bevacizumab|bevacizumab|mesh-list
19921469|NCT01263782|Carboplatin|carboplatin|mesh-list
19921470|NCT01263782|Pemetrexed|pemetrexed|mesh-list
19921471|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19921472|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921473|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19921474|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19921475|NCT01263782|Growth Substances|growth substances|mesh-ancestor
19921476|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921477|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
19921478|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921479|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921480|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19921481|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19921482|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
19921483|NCT01263925|Alprostadil|alprostadil|mesh-list
19921484|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19921485|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921486|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921487|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19921488|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19921489|NCT01263925|Protective Agents|protective agents|mesh-ancestor
19921490|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921491|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
19921492|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19921493|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
19921494|NCT01263925|Urological Agents|urological agents|mesh-ancestor
19921495|NCT01263938|Atorvastatin|atorvastatin|mesh-list
19921496|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19921497|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19921498|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
19921499|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921500|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19921501|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19921502|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921503|NCT01264081|Lapatinib|lapatinib|mesh-list
19921504|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921505|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19921506|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921507|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921508|NCT01264705|Sorafenib|sorafenib|mesh-list
20262057|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262058|NCT00499291|Paclitaxel|paclitaxel|mesh-list
20262059|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20262060|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20262061|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262062|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
20262063|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
20262064|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
20262065|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287068|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287069|NCT05332496|Bevacizumab|bevacizumab|mesh-list
20287070|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20287071|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287072|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287073|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19921509|NCT01264705|Bavituximab|bavituximab|mesh-list
19921510|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19921511|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921512|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19921513|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921514|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921515|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19921516|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
19921517|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921518|NCT01264770|Adalimumab|adalimumab|mesh-list
19921519|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921520|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921521|NCT01264887|Tapentadol|tapentadol|mesh-list
19921522|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19921523|NCT01264887|Narcotics|narcotics|mesh-ancestor
19921524|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921525|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921526|NCT01264887|Analgesics|analgesics|mesh-ancestor
19921527|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
19921528|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921529|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19921530|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19921531|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921532|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921533|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
19921534|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921535|NCT01264939|Omalizumab|omalizumab|mesh-list
19921536|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
19921537|NCT01264939|Promethazine|promethazine|mesh-list
19921538|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
19921539|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19921540|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
19921541|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19921542|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19921543|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
19921544|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19921545|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19921546|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921547|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921548|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
19921549|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
19921550|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
19921551|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921552|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
19921553|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
19921554|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19921555|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
19921556|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921557|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921558|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
19921559|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
19921560|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
19921561|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921562|NCT01265056|Gabapentin|gabapentin|mesh-list
19921563|NCT01265056|Analgesics|analgesics|mesh-ancestor
19921564|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
19921565|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921566|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921567|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
19921568|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19921569|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19921570|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921571|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921572|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19921573|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19921574|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921575|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921576|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
19921577|NCT01265394|Flutemetamol|flutemetamol|mesh-list
19921578|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19921579|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921580|NCT01265446|Lidocaine|lidocaine|mesh-list
19921581|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
19921582|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
19921583|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921584|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921585|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
19921586|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921587|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19921588|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19921589|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19921590|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921591|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921592|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19921593|NCT01265498|Cathartics|cathartics|mesh-ancestor
19921594|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19921595|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19921596|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
19921597|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972615|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972616|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19972617|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972618|NCT01812668|Fluorides|fluorides|mesh-list
19972619|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
19972620|NCT01812668|Protective Agents|protective agents|mesh-ancestor
19972621|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972622|NCT01812707|Atorvastatin|atorvastatin|mesh-list
19972623|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19972624|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19972625|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19972626|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
19972627|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972628|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19972629|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19972630|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972631|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
19972632|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972633|NCT01812759|Fentanyl|fentanyl|mesh-list
19972634|NCT01812759|Hydromorphone|hydromorphone|mesh-list
19972635|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19972636|NCT01812759|Narcotics|narcotics|mesh-ancestor
19972637|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972638|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972639|NCT01812759|Analgesics|analgesics|mesh-ancestor
19972640|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
19972641|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972642|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19972643|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19972644|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
19972645|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
19972646|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19972647|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19972648|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
19972649|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
19972650|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19972651|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19972652|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972653|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
19972654|NCT01813058|Coagulants|coagulants|mesh-ancestor
19972655|NCT01813149|Clonidine|clonidine|mesh-list
19972656|NCT01813149|Phenylephrine|phenylephrine|mesh-list
19972657|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
19972658|NCT01813149|Anesthetics|anesthetics|mesh-list
19972659|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
19972660|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972661|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972662|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
19972663|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972664|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19972665|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
19972666|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
19972667|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
19972668|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19972669|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
19972670|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
19972671|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19972672|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19972673|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19972674|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
19972675|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972676|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972677|NCT01813149|Protective Agents|protective agents|mesh-ancestor
19972678|NCT01813149|Analgesics|analgesics|mesh-ancestor
19972679|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19972680|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
19972681|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19972682|NCT01813214|Vemurafenib|vemurafenib|mesh-list
19972683|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972684|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19972685|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972686|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972687|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19972688|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19972689|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19921598|NCT01265537|Tacrolimus|tacrolimus|mesh-list
19921599|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19921600|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
19921601|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921602|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19921603|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921604|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921605|NCT01265550|Baclofen|baclofen|mesh-list
19921606|NCT01265550|Desipramine|desipramine|mesh-list
19921607|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19921608|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921609|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19921610|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921611|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19921612|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
19921613|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
19921614|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921615|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921616|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19921617|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
19921618|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921619|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921620|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19921621|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19921622|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921623|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
19921624|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
19921625|NCT01265563|Silybin|silybin|mesh-list
19921626|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19921627|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
19921628|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921629|NCT01265563|Expectorants|expectorants|mesh-ancestor
19921630|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
19921631|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19921632|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
19921633|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921634|NCT01265563|Protective Agents|protective agents|mesh-ancestor
19921635|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921636|NCT01265563|Antidotes|antidotes|mesh-ancestor
19921637|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19921638|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921639|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
19921640|NCT01265615|Calcitriol|calcitriol|mesh-list
19921641|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19921642|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921643|NCT01265615|Vitamins|vitamins|mesh-ancestor
19921644|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
19921645|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19921646|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19921647|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921648|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921649|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19921650|NCT01265823|Adalimumab|adalimumab|mesh-list
19921651|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921652|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921653|NCT01265875|Secretin|secretin|mesh-list
19921654|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19921655|NCT01265875|Hormones|hormones|mesh-ancestor
19921656|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921657|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921658|NCT01265953|Sulforaphane|sulforaphane|mesh-list
19921659|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19921660|NCT01265953|Protective Agents|protective agents|mesh-ancestor
19921661|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921662|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921663|NCT01266148|Cyclosporine|cyclosporine|mesh-list
19921664|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
19921665|NCT01266148|Everolimus|everolimus|mesh-list
19921666|NCT01266148|Cyclosporins|cyclosporins|mesh-list
19921667|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19921668|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921669|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921670|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19921671|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
19921672|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921673|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
19921674|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921675|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
19921676|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921677|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19921678|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921679|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19921680|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19921681|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
19921682|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19921683|NCT01266161|Ibuprofen|ibuprofen|mesh-list
19921684|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19921685|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19921686|NCT01266161|Analgesics|analgesics|mesh-ancestor
19921687|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
19921688|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921689|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921690|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921691|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921692|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19921693|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921694|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921695|NCT01266265|Treprostinil|treprostinil|mesh-list
19921696|NCT01266265|Bosentan|bosentan|mesh-list
19921697|NCT01266265|Ambrisentan|ambrisentan|mesh-list
19921698|NCT01266265|Epoprostenol|epoprostenol|mesh-list
19921699|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
19921700|NCT01266265|Tadalafil|tadalafil|mesh-list
19921701|NCT01266265|Iloprost|iloprost|mesh-list
19921702|NCT01266265|Tezosentan|tezosentan|mesh-list
19921703|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
19921704|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
19921705|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19921706|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921707|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921708|NCT01266265|Urological Agents|urological agents|mesh-ancestor
19921709|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19921710|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19921711|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19921712|NCT01266291|Vigabatrin|vigabatrin|mesh-list
19921713|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
19921714|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921715|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921716|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
19921717|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921718|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921719|NCT01266317|Rituximab|rituximab|mesh-list
19921720|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19921721|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921722|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
19921723|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921724|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921725|NCT01266447|Topotecan|topotecan|mesh-list
19921726|NCT01266447|Veliparib|veliparib|mesh-list
19921727|NCT01266447|Lenograstim|lenograstim|mesh-list
19921728|NCT01266447|Sargramostim|sargramostim|mesh-list
19921729|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19921730|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
19921731|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921732|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19921733|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19921734|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921735|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921736|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921737|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19921738|NCT01266460|Vaccines|vaccines|mesh-list
19921739|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
19921740|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921741|NCT01266590|Digoxin|digoxin|mesh-list
19921742|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19921743|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19921744|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921745|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921746|NCT01266590|Protective Agents|protective agents|mesh-ancestor
19921747|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921748|NCT01266603|Aldesleukin|aldesleukin|mesh-list
19921749|NCT01266603|Interleukin-2|interleukin-2|mesh-list
19921750|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921751|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19921752|NCT01266603|Analgesics|analgesics|mesh-ancestor
19921753|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
19921754|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921755|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921756|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19921757|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19921758|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
19921759|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921760|NCT01266902|Rilpivirine|rilpivirine|mesh-list
19921761|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19921762|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19921763|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921764|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921765|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
19921766|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19921767|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19921768|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19921769|NCT01266967|Dabrafenib|dabrafenib|mesh-list
19921770|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921771|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19921772|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921773|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921774|NCT01267136|Acetaminophen|acetaminophen|mesh-list
19921775|NCT01267136|Tramadol|tramadol|mesh-list
19921776|NCT01267136|Codeine|codeine|mesh-list
19921777|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19921778|NCT01267136|Analgesics|analgesics|mesh-ancestor
19921779|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
19921780|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921781|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921782|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
19921783|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19921784|NCT01267136|Narcotics|narcotics|mesh-ancestor
19921785|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921786|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
19921787|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
19921788|NCT01267175|Insulin|insulin|mesh-list
19921789|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921790|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921791|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
19921792|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19921793|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19921794|NCT01267201|Prednisolone|prednisolone|mesh-list
19921795|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
19921796|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19921797|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
19921798|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921799|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
19921800|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
19921801|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921802|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921803|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19921804|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
19921805|NCT01267201|Hormones|hormones|mesh-ancestor
19921806|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921807|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19921808|NCT01267201|Protective Agents|protective agents|mesh-ancestor
19921809|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19921810|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921811|NCT01267240|Capecitabine|capecitabine|mesh-list
19921812|NCT01267240|Vorinostat|vorinostat|mesh-list
19921813|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19921814|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
19921815|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921816|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921817|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19921818|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921819|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
19921820|NCT01267266|Saracatinib|saracatinib|mesh-list
19921821|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921822|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921823|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921824|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921825|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
19921826|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19921827|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921828|NCT01267292|Buspirone|buspirone|mesh-list
19921829|NCT01267292|Methylphenidate|methylphenidate|mesh-list
19921830|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19921831|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921832|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19921833|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19921834|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921835|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921836|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
19921837|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921838|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19921839|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19921840|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921841|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921842|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19921843|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
19921844|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19921845|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
19921846|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19921847|NCT01267864|Ketorolac|ketorolac|mesh-list
19921848|NCT01267864|Valproic Acid|valproic acid|mesh-list
19921849|NCT01267864|Metoclopramide|metoclopramide|mesh-list
19921850|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19921851|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19921852|NCT01267864|Analgesics|analgesics|mesh-ancestor
19921853|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
19921854|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921855|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921856|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921857|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262066|NCT00499525|Paclitaxel|paclitaxel|mesh-list
20262067|NCT00499525|Sorafenib|sorafenib|mesh-list
20262068|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20262069|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262070|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
20262071|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
20262072|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
20262073|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262074|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262075|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262076|NCT00499577|Vaccines|vaccines|mesh-list
20262077|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20262078|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
20262079|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262080|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
20262081|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20262082|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262083|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20262084|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262085|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262086|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262087|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262088|NCT00499668|Ondansetron|ondansetron|mesh-list
20262089|NCT00499668|Aprepitant|aprepitant|mesh-list
20262090|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
20262091|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
20262092|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262093|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262094|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262095|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
20262096|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
20262097|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20262098|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
20262099|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921858|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19921859|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921860|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921861|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
19921862|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
19921863|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921864|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
19921865|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19921866|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20262100|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921867|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19921868|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
19921869|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
19921870|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19921871|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19921872|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19921873|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
19921874|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19921875|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921876|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19921877|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19921878|NCT01268046|Estradiol|estradiol|mesh-list
19921879|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19921880|NCT01268046|Estrogens|estrogens|mesh-list
19921881|NCT01268046|Hormones|hormones|mesh-ancestor
19921882|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921883|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921884|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19921885|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
19921886|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19921887|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19921888|NCT01268059|Paclitaxel|paclitaxel|mesh-list
19921889|NCT01268059|Carboplatin|carboplatin|mesh-list
19921890|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19921891|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921892|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
19921893|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
19921894|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
19921895|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921896|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
19921897|NCT01268111|Vitamin D|vitamin d|mesh-list
19921898|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19921899|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921900|NCT01268111|Vitamins|vitamins|mesh-ancestor
19921901|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
19921902|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19921903|NCT01268293|Lenvatinib|lenvatinib|mesh-list
19921904|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921905|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19921906|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921907|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921908|NCT01268527|Calcipotriene|calcipotriene|mesh-list
19921909|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
19921910|NCT01268553|Treprostinil|treprostinil|mesh-list
19921911|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19921912|NCT01268683|Glyburide|glyburide|mesh-list
19921913|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921914|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921915|NCT01268891|Rasagiline|rasagiline|mesh-list
19921916|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19921917|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19921918|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921919|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19921920|NCT01268891|Protective Agents|protective agents|mesh-ancestor
19921921|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921922|NCT01268943|Capecitabine|capecitabine|mesh-list
19921923|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19921924|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
19921925|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921926|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921927|NCT01269047|Exenatide|exenatide|mesh-list
19921928|NCT01269047|Pramlintide|pramlintide|mesh-list
19921929|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19921930|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921931|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19921932|NCT01269047|Incretins|incretins|mesh-ancestor
19921933|NCT01269047|Hormones|hormones|mesh-ancestor
19921934|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921935|NCT01269125|Leuprolide|leuprolide|mesh-list
19921936|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19921937|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
19921938|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19921939|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921940|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19921941|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921942|NCT01269385|Rituximab|rituximab|mesh-list
19972690|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
19921943|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19921944|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
19921945|NCT01269385|Antibodies|antibodies|mesh-list
19921946|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
19921947|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19921948|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
19921949|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921950|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921951|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19921952|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
19921953|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19921954|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19921955|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19921956|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19921957|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921958|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
19921959|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921960|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921961|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19921962|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921963|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
19921964|NCT01269918|Remifentanil|remifentanil|mesh-list
19921965|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19921966|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19921967|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921968|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19921969|NCT01269918|Analgesics|analgesics|mesh-ancestor
19921970|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
19921971|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921972|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19921973|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19921974|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19921975|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
19921976|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19921977|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19921978|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19921979|NCT01269918|Narcotics|narcotics|mesh-ancestor
19921980|NCT01270256|Budesonide|budesonide|mesh-list
19921981|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19921982|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19921983|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
19921984|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19921985|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921986|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19921987|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
19921988|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
19921989|NCT01270256|Hormones|hormones|mesh-ancestor
19921990|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19921991|NCT01270321|Everolimus|everolimus|mesh-list
19921992|NCT01270321|Pasireotide|pasireotide|mesh-list
19921993|NCT01270321|Somatostatin|somatostatin|mesh-list
19921994|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19921995|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19921996|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
19921997|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19921998|NCT01270321|Hormones|hormones|mesh-ancestor
19921999|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922000|NCT01270464|Reslizumab|reslizumab|mesh-list
19922001|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19922002|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
19922003|NCT01270542|Bevacizumab|bevacizumab|mesh-list
19922004|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922005|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922006|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20262101|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20262102|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20262103|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922007|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19922008|NCT01270542|Growth Substances|growth substances|mesh-ancestor
19922009|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922010|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
19922011|NCT01270555|Bupropion|bupropion|mesh-list
19922012|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19922013|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
19922014|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19922015|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19922016|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19922017|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922018|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922019|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
19922020|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922021|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922022|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19922023|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19922024|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922025|NCT01270620|Propofol|propofol|mesh-list
19922026|NCT01270620|Desflurane|desflurane|mesh-list
19922027|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19922028|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922029|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922030|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19922031|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
19922032|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
19922033|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19922034|NCT01270659|Acetaminophen|acetaminophen|mesh-list
19922035|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19922036|NCT01270659|Fentanyl|fentanyl|mesh-list
19922037|NCT01270659|Oxycodone|oxycodone|mesh-list
19922038|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19922039|NCT01270659|Narcotics|narcotics|mesh-ancestor
19922040|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922041|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922042|NCT01270659|Analgesics|analgesics|mesh-ancestor
19922043|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
19922044|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922045|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19922046|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19922047|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
19922048|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
19922049|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19922050|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
19922051|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19922052|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922053|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922054|NCT01270802|Tenofovir|tenofovir|mesh-list
19922055|NCT01270802|Emtricitabine|emtricitabine|mesh-list
19922056|NCT01270802|Efavirenz|efavirenz|mesh-list
19922057|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
19922058|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
19922059|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922060|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19922061|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19922062|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922063|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922064|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19922065|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19922066|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19922067|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19922068|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19922069|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19922070|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19922071|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19922072|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19922073|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19922074|NCT01270828|Pregabalin|pregabalin|mesh-list
19922075|NCT01270828|Analgesics|analgesics|mesh-ancestor
19922076|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
19922077|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922078|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922079|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
19922080|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19922081|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922082|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922083|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922084|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19922085|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19922086|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922087|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19922088|NCT01270841|Enclomiphene|enclomiphene|mesh-list
19922089|NCT01270841|Clomiphene|clomiphene|mesh-list
19922090|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
19922091|NCT01270841|Testosterone|testosterone|mesh-list
19922092|NCT01270841|Androgens|androgens|mesh-ancestor
19922093|NCT01270841|Hormones|hormones|mesh-ancestor
19922094|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922095|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922096|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19922097|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
19922098|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19922099|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
19922100|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19922101|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19922102|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19922103|NCT01270971|Tavaborole|tavaborole|mesh-list
19922104|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19922105|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
19922106|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922107|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
19922108|NCT01271010|Rituximab|rituximab|mesh-list
19922109|NCT01271010|Fludarabine|fludarabine|mesh-list
19922110|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922111|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
19922112|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922113|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922114|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19922115|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
19922116|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922117|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922118|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19922119|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922120|NCT01271244|Citalopram|citalopram|mesh-list
19922121|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19922122|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19922123|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922124|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922125|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922126|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
19922127|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922128|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19922129|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
19922130|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19922131|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
19922132|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19922133|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19922134|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19922135|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922136|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922137|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
19922138|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922139|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922140|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19922141|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922142|NCT01271504|Sorafenib|sorafenib|mesh-list
19922143|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922144|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19922145|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922146|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972691|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972692|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19972693|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19972694|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972695|NCT01813422|Evolocumab|evolocumab|mesh-list
19972696|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19972697|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19972698|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
19972699|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972700|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19975390|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975391|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
19975392|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19975393|NCT01848145|Ofatumumab|ofatumumab|mesh-list
19975394|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922147|NCT01271686|Bimatoprost|bimatoprost|mesh-list
19922148|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19922149|NCT01271725|Paclitaxel|paclitaxel|mesh-list
19922150|NCT01271725|Vinorelbine|vinorelbine|mesh-list
19922151|NCT01271725|Afatinib|afatinib|mesh-list
19922152|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19922153|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922154|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
19922155|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
19922156|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
19922157|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922158|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19922159|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922160|NCT01271803|Vemurafenib|vemurafenib|mesh-list
19922161|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922162|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19922163|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922164|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922165|NCT01271855|Glycerol|glycerol|mesh-list
19922166|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922167|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19922168|NCT01271855|Protective Agents|protective agents|mesh-ancestor
19922169|NCT01271907|Aldesleukin|aldesleukin|mesh-list
19922170|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
19922171|NCT01271907|Fludarabine|fludarabine|mesh-list
19922172|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922173|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
20262104|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20262105|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20262106|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20262107|NCT00499707|Metformin|metformin|mesh-list
20262108|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
19922174|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922175|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922176|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19922177|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
19922178|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922179|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922180|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19922181|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19922182|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19922183|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
19922184|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922185|NCT01271933|Pregabalin|pregabalin|mesh-list
19922186|NCT01271933|Analgesics|analgesics|mesh-ancestor
19922187|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
19922188|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922189|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922190|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
19922191|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19922192|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922193|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262109|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922194|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922195|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19922196|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19922197|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922198|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19922199|NCT01272180|Vaccines|vaccines|mesh-list
19922200|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
19922201|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922202|NCT01272193|Insulin|insulin|mesh-list
19922203|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19922204|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
19922205|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
19922206|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922207|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922208|NCT01272219|Liraglutide|liraglutide|mesh-list
19922209|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922210|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922211|NCT01272219|Incretins|incretins|mesh-ancestor
19922212|NCT01272219|Hormones|hormones|mesh-ancestor
19922213|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922214|NCT01272232|Liraglutide|liraglutide|mesh-list
19922215|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922216|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922217|NCT01272232|Incretins|incretins|mesh-ancestor
19922218|NCT01272232|Hormones|hormones|mesh-ancestor
19922219|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922220|NCT01272245|Cytarabine|cytarabine|mesh-list
19922221|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
19922222|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19922223|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
19922224|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922225|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922226|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
19922227|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922228|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922229|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
19922230|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922231|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19922232|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19922233|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922234|NCT01272388|Tadalafil|tadalafil|mesh-list
19922235|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
19922236|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19922237|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19922238|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922239|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922240|NCT01272388|Urological Agents|urological agents|mesh-ancestor
19922241|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19922242|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922243|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922244|NCT01272583|Incretins|incretins|mesh-ancestor
19922245|NCT01272583|Hormones|hormones|mesh-ancestor
19922246|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922247|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19922248|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
19922249|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922250|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922251|NCT01272635|Azithromycin|azithromycin|mesh-list
19922252|NCT01272635|Prednisolone|prednisolone|mesh-list
19922253|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19922254|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
19922255|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19922256|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
19922257|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19922258|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
19922259|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922260|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
19922261|NCT01272635|Hormones|hormones|mesh-ancestor
19922262|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922263|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922264|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19922265|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922266|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
19922267|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
19922268|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922269|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922270|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19922271|NCT01272635|Protective Agents|protective agents|mesh-ancestor
19922272|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20262110|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262111|NCT00499720|Aztreonam|aztreonam|mesh-list
20262112|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20262113|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262114|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
20262115|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262116|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
20262117|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262118|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262119|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20262120|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
20262121|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262122|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262123|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20262124|NCT00499811|Vorinostat|vorinostat|mesh-list
20262125|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262126|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19922273|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922274|NCT01272908|Rituximab|rituximab|mesh-list
19972701|NCT01813474|Olaparib|olaparib|mesh-list
19922275|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922276|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922277|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
19922278|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922279|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922280|NCT01272921|Bupivacaine|bupivacaine|mesh-list
19922281|NCT01272921|Ropivacaine|ropivacaine|mesh-list
19922282|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
19922283|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
20262127|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262128|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262129|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20262130|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
20262131|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20262132|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20262133|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
20262134|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262135|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262136|NCT00499850|Leucovorin|leucovorin|mesh-list
20262137|NCT00499850|Fluorouracil|fluorouracil|mesh-list
20262138|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
20262139|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
20262140|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262141|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262142|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262143|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262144|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
20262145|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262146|NCT00499850|Antidotes|antidotes|mesh-ancestor
20262147|NCT00499850|Protective Agents|protective agents|mesh-ancestor
20262148|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
20262149|NCT00499850|Vitamins|vitamins|mesh-ancestor
20262150|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
20262151|NCT00499876|Mefloquine|mefloquine|mesh-list
20262152|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
20262153|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20262154|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20262155|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262156|NCT00499993|Lanreotide|lanreotide|mesh-list
20262157|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262158|NCT00500006|Dasatinib|dasatinib|mesh-list
20262159|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262160|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262161|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541414|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541415|NCT01857752|Temozolomide|temozolomide|mesh-list
20541416|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20541417|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
20541418|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541419|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541420|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20541421|NCT01857804|Amoxicillin|amoxicillin|mesh-list
20541422|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
20541423|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20541424|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541425|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20541426|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
20541427|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
20541428|NCT01857817|Etodolac|etodolac|mesh-list
20541429|NCT01857817|Propranolol|propranolol|mesh-list
20541430|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20541431|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20541432|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541433|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541434|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541435|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541436|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20541437|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20541438|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
20541439|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20541440|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541441|NCT01857817|Analgesics|analgesics|mesh-ancestor
20541442|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
20541443|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922284|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20262162|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922285|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922286|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
19922287|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922288|NCT01272934|Diclofenac|diclofenac|mesh-list
19922289|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19922290|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19922291|NCT01272934|Analgesics|analgesics|mesh-ancestor
19922292|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
19922293|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922294|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922295|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922296|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922297|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19922298|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922299|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922300|NCT01272947|Diclofenac|diclofenac|mesh-list
19922301|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19922302|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19922303|NCT01272947|Analgesics|analgesics|mesh-ancestor
19922304|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
19922305|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922306|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922307|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922308|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922309|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19922310|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922311|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922312|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
19922313|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19922314|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
19922315|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19922316|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922317|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19922318|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19922319|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19922320|NCT01273155|Belinostat|belinostat|mesh-list
19922321|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922322|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19922323|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922324|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922325|NCT01273181|Aldesleukin|aldesleukin|mesh-list
19922326|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
19922327|NCT01273181|Fludarabine|fludarabine|mesh-list
19922328|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922329|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
19922330|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922331|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922332|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19922333|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
19922334|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922335|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922336|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19922337|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19922338|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19922339|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
19922340|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922341|NCT01273207|Cyclosporine|cyclosporine|mesh-list
19922342|NCT01273207|Cyclosporins|cyclosporins|mesh-list
19922343|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922344|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922345|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922346|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
19922347|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922348|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
19922349|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922350|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
19922351|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922352|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19922353|NCT01273766|Deferasirox|deferasirox|mesh-list
19922354|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20262163|NCT00500058|Rituximab|rituximab|mesh-list
20262164|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262165|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262166|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
20262167|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922355|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
19922356|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
19922357|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922358|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
19922359|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
19922360|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19922361|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19922362|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922363|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922364|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922365|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922366|NCT01273818|Gentamicins|gentamicins|mesh-list
19922367|NCT01273818|Cefazolin|cefazolin|mesh-list
19922368|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19922369|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922370|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19922371|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922372|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922373|NCT01274182|Rituximab|rituximab|mesh-list
19922374|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922375|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922376|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
19922377|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922378|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922379|NCT01274338|Interferons|interferons|mesh-list
19922380|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
19922381|NCT01274338|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19922382|NCT01274338|Ipilimumab|ipilimumab|mesh-list
19922383|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922384|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
19922385|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922386|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922387|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19922388|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922389|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
19922390|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922391|NCT01274637|Dalteparin|dalteparin|mesh-list
19922392|NCT01274637|Tinzaparin|tinzaparin|mesh-list
19922393|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19922394|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
19922395|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19922396|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19922397|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922398|NCT01274897|Lactitol|lactitol|mesh-list
19922399|NCT01274897|Cathartics|cathartics|mesh-ancestor
19922400|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922401|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
19922402|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922403|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922404|NCT01275144|Lorazepam|lorazepam|mesh-list
19922405|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
19922406|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
19922407|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
19922408|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922409|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922410|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922411|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19922412|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20262168|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262169|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20262170|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
20262171|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20262172|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20262173|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
20262174|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262175|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922413|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19922414|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19922415|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19922416|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
19922417|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
19922418|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262176|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
19922419|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922420|NCT01275170|Imipenem|imipenem|mesh-list
19922421|NCT01275170|Relebactam|relebactam|mesh-list
19922422|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
19922423|NCT01275170|Midazolam|midazolam|mesh-list
19922424|NCT01275170|Caffeine|caffeine|mesh-list
19922425|NCT01275170|Omeprazole|omeprazole|mesh-list
19922426|NCT01275170|Cilastatin|cilastatin|mesh-list
19922427|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19922428|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19922429|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922430|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922431|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19922432|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19922433|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19922434|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19922435|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
19922436|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
19922437|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
19922438|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
19922439|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922440|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922441|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20262177|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262178|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262179|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262180|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262181|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
20262182|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
20262183|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20262184|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
20262185|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262186|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262187|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20262188|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
20262189|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19922442|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922443|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19922444|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922445|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19922446|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19922447|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19922448|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19922449|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
19922450|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19922451|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922452|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
19922453|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19922454|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
19922455|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922456|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19922457|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922458|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922459|NCT01275222|Everolimus|everolimus|mesh-list
19922460|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
19922461|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922462|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922463|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
19922464|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922465|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19922466|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922467|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922468|NCT01275300|Aspirin|aspirin|mesh-list
19922469|NCT01275300|Niacin|niacin|mesh-list
19922470|NCT01275300|Niacinamide|niacinamide|mesh-list
19922471|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
19922472|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19922473|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19922474|NCT01275300|Analgesics|analgesics|mesh-ancestor
19922475|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
19922476|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922477|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922478|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922479|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922480|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19922481|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19922482|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922483|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19922484|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19922485|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922486|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
19922487|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19922488|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
19922489|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19922490|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
19922491|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
19922492|NCT01275300|Vitamins|vitamins|mesh-ancestor
19922493|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
19922494|NCT01275339|Tadalafil|tadalafil|mesh-list
19922495|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
19922496|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19922497|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19922498|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922499|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922500|NCT01275339|Urological Agents|urological agents|mesh-ancestor
19922501|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
19922502|NCT01275365|Testosterone|testosterone|mesh-list
20262190|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
20262191|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922503|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
19922504|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
19922505|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19922506|NCT01275365|Androgens|androgens|mesh-ancestor
19922507|NCT01275365|Hormones|hormones|mesh-ancestor
19922508|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922509|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922510|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19922511|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922512|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
19922513|NCT01275625|Maraviroc|maraviroc|mesh-list
19922514|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19922515|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19922516|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922517|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19922518|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19922519|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
19922520|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922521|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19922522|NCT01275664|Dexamethasone|dexamethasone|mesh-list
19922523|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
19922524|NCT01275664|Cisplatin|cisplatin|mesh-list
19922525|NCT01275664|Carboplatin|carboplatin|mesh-list
19922526|NCT01275664|Aprepitant|aprepitant|mesh-list
19922527|NCT01275664|Granisetron|granisetron|mesh-list
19922528|NCT01275664|Ichthammol|ichthammol|mesh-list
19922529|NCT01275664|BB 1101|bb 1101|mesh-list
19922530|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922531|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922532|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
19922533|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
19922534|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922535|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922536|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922537|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
19922538|NCT01275664|Hormones|hormones|mesh-ancestor
19922539|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922540|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19922541|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
19922542|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922543|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922544|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19922545|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922546|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
19922547|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19922548|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
19922549|NCT01276041|Paclitaxel|paclitaxel|mesh-list
19922550|NCT01276041|Trastuzumab|trastuzumab|mesh-list
19922551|NCT01276041|Pertuzumab|pertuzumab|mesh-list
19922552|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19922553|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922554|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
19922555|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
19922556|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
19922557|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922558|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922559|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
19922560|NCT01276223|Difluprednate|difluprednate|mesh-list
19922561|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
19922562|NCT01276223|Hormones|hormones|mesh-ancestor
19922563|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922564|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922565|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922566|NCT01276236|Maraviroc|maraviroc|mesh-list
20262192|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262193|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20262194|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
20262195|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
20262196|NCT00500253|Protective Agents|protective agents|mesh-ancestor
20262197|NCT00500253|Miotics|miotics|mesh-ancestor
20262198|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20262199|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20262200|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20262201|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20262202|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
20262203|NCT00500279|Celecoxib|celecoxib|mesh-list
20262204|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262205|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20262206|NCT00500279|Analgesics|analgesics|mesh-ancestor
20262207|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
19922567|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19922568|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19922569|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922570|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19922571|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19922572|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
19922573|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262208|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262209|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262210|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262211|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262212|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20262213|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20262214|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262215|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922574|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19922575|NCT01276288|Empagliflozin|empagliflozin|mesh-list
19922576|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20262216|NCT00500344|Ranibizumab|ranibizumab|mesh-list
20262217|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20262218|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20262219|NCT00500344|Growth Substances|growth substances|mesh-ancestor
20262220|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262221|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
20262222|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262223|NCT00500409|Vitamin D|vitamin d|mesh-list
20262224|NCT00500409|Vitamins|vitamins|mesh-ancestor
20262225|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
20262226|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922577|NCT01276288|Torsemide|torsemide|mesh-list
19922578|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19922579|NCT01276288|Diuretics|diuretics|mesh-ancestor
20262227|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20262228|NCT00500422|Gemcitabine|gemcitabine|mesh-list
19922580|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
19922581|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922582|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19922583|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922584|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922585|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19922586|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922587|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19922588|NCT01276301|Empagliflozin|empagliflozin|mesh-list
19922589|NCT01276301|Verapamil|verapamil|mesh-list
19922590|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19922591|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922592|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922593|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262229|NCT00500422|Doxorubicin|doxorubicin|mesh-list
20262230|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19922594|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19922595|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19922596|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922597|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922598|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
19922599|NCT01276314|Prednisolone|prednisolone|mesh-list
19922600|NCT01276314|Etanercept|etanercept|mesh-list
19922601|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922602|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
19922603|NCT01276314|Hormones|hormones|mesh-ancestor
19922604|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262231|NCT00500422|Bortezomib|bortezomib|mesh-list
20262232|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262233|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
20262234|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262235|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262236|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
19922605|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922606|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19922607|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922608|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922609|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922610|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19922611|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19922612|NCT01276314|Analgesics|analgesics|mesh-ancestor
19922613|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
19922614|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922615|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922616|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
19922617|NCT01276327|Pioglitazone|pioglitazone|mesh-list
19922618|NCT01276327|Linagliptin|linagliptin|mesh-list
19922619|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922620|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922621|NCT01276327|Incretins|incretins|mesh-ancestor
19922622|NCT01276327|Hormones|hormones|mesh-ancestor
19922623|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922624|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19922625|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
19922626|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922627|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922628|NCT01276353|Donepezil|donepezil|mesh-list
19922629|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19922630|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922631|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922632|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
19922633|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922634|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922635|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
19922636|NCT01276379|Leucovorin|leucovorin|mesh-list
19922637|NCT01276379|Folic Acid|folic acid|mesh-list
19922638|NCT01276379|Fluorouracil|fluorouracil|mesh-list
19922639|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
19922640|NCT01276379|Irinotecan|irinotecan|mesh-list
19922641|NCT01276379|Cetuximab|cetuximab|mesh-list
19922642|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
19922643|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
19922644|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922645|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19922646|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922647|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922648|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
19922649|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922650|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19922651|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19922652|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922653|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262237|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922654|NCT01276379|Antidotes|antidotes|mesh-ancestor
19922655|NCT01276379|Protective Agents|protective agents|mesh-ancestor
19922656|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
19922657|NCT01276379|Vitamins|vitamins|mesh-ancestor
19922658|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
20262238|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922659|NCT01276379|Hematinics|hematinics|mesh-ancestor
19922660|NCT01276457|Cyclosporine|cyclosporine|mesh-list
19922661|NCT01276457|Everolimus|everolimus|mesh-list
19922662|NCT01276457|Cyclosporins|cyclosporins|mesh-list
19922663|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922664|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922665|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922666|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
19922667|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922668|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
19922669|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922670|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
19922671|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922672|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19922673|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922674|NCT01276639|Tofacitinib|tofacitinib|mesh-list
19922675|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19922676|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922677|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922678|NCT01276756|Interferons|interferons|mesh-list
19922679|NCT01276756|Ribavirin|ribavirin|mesh-list
19922680|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
19922681|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
19922682|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19922683|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
19922684|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922685|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
19922686|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922687|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
19922688|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922689|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
19922690|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922691|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19922692|NCT01276821|Epinephrine|epinephrine|mesh-list
19922693|NCT01276821|Racepinephrine|racepinephrine|mesh-list
19922694|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
19922695|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19922696|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19922697|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
19922698|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922699|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922700|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922701|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19922702|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19922703|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
19922704|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922705|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19922706|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
19922707|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
19922708|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
19922709|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19922710|NCT01276847|Etanercept|etanercept|mesh-list
19922711|NCT01276847|Ustekinumab|ustekinumab|mesh-list
20262239|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262240|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
20262241|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922712|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19922713|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20262242|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20262243|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20262244|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262245|NCT00500552|Perhexiline|perhexiline|mesh-list
20262246|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20262247|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20262248|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262249|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20262250|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262251|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
20262252|NCT00500565|Bupivacaine|bupivacaine|mesh-list
20262253|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
20262254|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
20262255|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20262256|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262257|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
20262258|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262259|NCT00500604|Valsartan|valsartan|mesh-list
19922714|NCT01276847|Analgesics|analgesics|mesh-ancestor
19922715|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
19922716|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975395|NCT01848210|Troxerutin|troxerutin|mesh-list
19922717|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922718|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922719|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922720|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922721|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922722|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
19922723|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
19922724|NCT01277081|Acetaminophen|acetaminophen|mesh-list
19922725|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19922726|NCT01277081|Analgesics|analgesics|mesh-ancestor
19922727|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
20262260|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20262261|NCT00500604|Irbesartan|irbesartan|mesh-list
20262262|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20262263|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20262264|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20262265|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262266|NCT00500604|Diuretics|diuretics|mesh-ancestor
20262267|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
20262268|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262269|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20262270|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20262271|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
20262272|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20262273|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262274|NCT00500721|Desipramine|desipramine|mesh-list
20262275|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20262276|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
20262277|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20262278|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262279|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262280|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20262281|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20262282|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20262283|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
20262284|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541444|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541445|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541446|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20541447|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20541448|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541449|NCT01857843|Everolimus|everolimus|mesh-list
20541450|NCT01857843|Simvastatin|simvastatin|mesh-list
20541451|NCT01857843|Ezetimibe|ezetimibe|mesh-list
20541452|NCT01857843|Pravastatin|pravastatin|mesh-list
20541453|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541454|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541455|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
19922728|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922729|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922730|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
19922731|NCT01277159|Dexamethasone|dexamethasone|mesh-list
20541456|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541457|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20541458|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20541459|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
20541460|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541461|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20541462|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20541463|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541464|NCT01857856|Eplerenone|eplerenone|mesh-list
20541465|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20541466|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
20554037|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19922732|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
19922733|NCT01277159|Buprenorphine|buprenorphine|mesh-list
19922734|NCT01277159|BB 1101|bb 1101|mesh-list
19922735|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922736|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
19922737|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
19922738|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922739|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922740|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922741|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
19922742|NCT01277159|Hormones|hormones|mesh-ancestor
19975396|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
19922743|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19922744|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19922745|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922746|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
19922747|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922748|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922749|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19922750|NCT01277159|Narcotics|narcotics|mesh-ancestor
19922751|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922752|NCT01277159|Analgesics|analgesics|mesh-ancestor
19922753|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
19922754|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19922755|NCT01277302|Ranibizumab|ranibizumab|mesh-list
19922756|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19922757|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19922758|NCT01277302|Growth Substances|growth substances|mesh-ancestor
19922759|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922760|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
19922761|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922762|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
19922763|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19922764|NCT01277510|Cinacalcet|cinacalcet|mesh-list
19922765|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922766|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922767|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19922768|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
19922769|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972702|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19972703|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972704|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972705|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972706|NCT01813734|Ponatinib|ponatinib|mesh-list
19972707|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972708|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19972709|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972710|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972711|NCT01813890|Tapentadol|tapentadol|mesh-list
19972712|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19972713|NCT01813890|Narcotics|narcotics|mesh-ancestor
19972714|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972715|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972716|NCT01813890|Analgesics|analgesics|mesh-ancestor
19972717|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
19972718|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972719|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19972720|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19972721|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972722|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972723|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
19972724|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972725|NCT01814046|Aldesleukin|aldesleukin|mesh-list
19972726|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
19972727|NCT01814046|Fludarabine|fludarabine|mesh-list
19972728|NCT01814046|Interleukin-2|interleukin-2|mesh-list
19972729|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19972730|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
19972731|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972732|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972733|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19972734|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
19972735|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972736|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972737|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19972738|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19972739|NCT01814046|Analgesics|analgesics|mesh-ancestor
19972740|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
19972741|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972742|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19972743|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19972744|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
19972745|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972746|NCT01814137|Insulin|insulin|mesh-list
19972747|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19972748|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
19922770|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
19922771|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19922772|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
19922773|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922774|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922775|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19922776|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
19922777|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
19922778|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19922779|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
19922780|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922781|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922782|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19922783|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
19922784|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922785|NCT01277718|Rabeprazole|rabeprazole|mesh-list
19922786|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19922787|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922788|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19922789|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922790|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922791|NCT01277744|Cisplatin|cisplatin|mesh-list
19922792|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922793|NCT01277861|Fentanyl|fentanyl|mesh-list
19922794|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19922795|NCT01277861|Narcotics|narcotics|mesh-ancestor
19922796|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922797|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922798|NCT01277861|Analgesics|analgesics|mesh-ancestor
19922799|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
19922800|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922801|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19922802|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19922803|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
19922804|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
19922805|NCT01278160|Insulin|insulin|mesh-list
19922806|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19922807|NCT01278160|Metformin|metformin|mesh-list
19922808|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
19922809|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
19922810|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19922811|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
19922812|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19922813|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
19922814|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922815|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922816|NCT01278173|Vigabatrin|vigabatrin|mesh-list
19922817|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
19922818|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922819|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922820|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
19922821|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922822|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922823|NCT01278342|Octreotide|octreotide|mesh-list
19922824|NCT01278342|Cabergoline|cabergoline|mesh-list
19922825|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922826|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19922827|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922828|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19922829|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19922830|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
19922831|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
19922832|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922833|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922834|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922835|NCT01278394|Tavaborole|tavaborole|mesh-list
19922836|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
19922837|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922838|NCT01278407|Donepezil|donepezil|mesh-list
19922839|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19922840|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922841|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922842|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
19922843|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19922844|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922845|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
19922846|NCT01278745|Rituximab|rituximab|mesh-list
19922847|NCT01278745|Tacrolimus|tacrolimus|mesh-list
19922848|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922849|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922850|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
19922851|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922852|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922853|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922854|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19922855|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922856|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922857|NCT01278797|Amlodipine|amlodipine|mesh-list
19922858|NCT01278797|Telmisartan|telmisartan|mesh-list
19922859|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19922860|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19922861|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19922862|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922863|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922864|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922865|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922866|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
19922867|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19922868|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19922869|NCT01279057|Fluticasone|fluticasone|mesh-list
19922870|NCT01279057|Xhance|xhance|mesh-list
19922871|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922872|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19922873|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
19922874|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922875|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922876|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19922877|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
19922878|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
19922879|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19922880|NCT01279187|Teriparatide|teriparatide|mesh-list
19922881|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922882|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922883|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19922884|NCT01279317|Acetic Acid|acetic acid|mesh-list
19922885|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19922886|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19922887|NCT01279343|Misoprostol|misoprostol|mesh-list
19922888|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19922889|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
19922890|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19922891|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922892|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19922893|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922894|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
19922895|NCT01279447|Bupivacaine|bupivacaine|mesh-list
19922896|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
19922897|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
19922898|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922899|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922900|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
19922901|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922902|NCT01279681|Leucovorin|leucovorin|mesh-list
19922903|NCT01279681|Bevacizumab|bevacizumab|mesh-list
19922904|NCT01279681|Fluorouracil|fluorouracil|mesh-list
19922905|NCT01279681|Capecitabine|capecitabine|mesh-list
19922906|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
19922907|NCT01279681|Calcium|calcium|mesh-list
19922908|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
19922909|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19922910|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922911|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19922912|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19922913|NCT01279681|Growth Substances|growth substances|mesh-ancestor
19922914|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922915|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19922916|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922917|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
19922918|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922919|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19922920|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922921|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
19922922|NCT01279681|Antidotes|antidotes|mesh-ancestor
19732430|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
19732431|NCT04574791|Tizanidine|tizanidine|mesh-list
19732432|NCT04574791|Analgesics|analgesics|mesh-ancestor
19732433|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
19732434|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732435|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732436|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
19732437|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19732438|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19732439|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
19732440|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
19732441|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19732442|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19732443|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19922923|NCT01279681|Protective Agents|protective agents|mesh-ancestor
19922924|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
20262285|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262286|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
20262287|NCT00500864|Analgesics|analgesics|mesh-ancestor
19922925|NCT01279681|Vitamins|vitamins|mesh-ancestor
19922926|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
19922927|NCT01279850|Pregabalin|pregabalin|mesh-list
19922928|NCT01279850|Analgesics|analgesics|mesh-ancestor
19922929|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
19922930|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922931|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922932|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
20262288|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
20262289|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262290|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262291|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
20262292|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20262293|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20262294|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
20262295|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20262296|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20262297|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262298|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20262299|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
20262300|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20262301|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
20262302|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20262303|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262304|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
20262305|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20262306|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262307|NCT00501098|Caspofungin|caspofungin|mesh-list
20262308|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
20262309|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262310|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262311|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262312|NCT00501111|Donepezil|donepezil|mesh-list
20262313|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20262314|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262315|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262316|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
20262317|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262318|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262319|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
19922933|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19922934|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922935|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922936|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20262320|NCT00501124|Clevudine|clevudine|mesh-list
20262321|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
20262322|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262323|NCT00501137|Vaccines|vaccines|mesh-list
20262324|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
20262325|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262326|NCT00501150|Linezolid|linezolid|mesh-list
19922937|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19922938|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19922939|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19922940|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554038|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
19732444|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
20262327|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19922941|NCT01279954|Abatacept|abatacept|mesh-list
19922942|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19922943|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922944|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922945|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19922946|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
19922947|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922948|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922949|NCT01280058|Paclitaxel|paclitaxel|mesh-list
19922950|NCT01280058|Carboplatin|carboplatin|mesh-list
19922951|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19922952|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19922953|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19922954|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
19922955|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
19922956|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
19922957|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922958|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20262328|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262329|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20262330|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262331|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262332|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
20262333|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20262334|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287074|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20287075|NCT05332496|Growth Substances|growth substances|mesh-ancestor
20287076|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287077|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
20287078|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287079|NCT05332483|Megestrol|megestrol|mesh-list
20287080|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
20287081|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20287082|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20287083|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20287084|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
20287085|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20287086|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287087|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20541467|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541468|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922959|NCT01280110|Laxatives|laxatives|mesh-ancestor
19922960|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19922961|NCT01280123|Pioglitazone|pioglitazone|mesh-list
19922962|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922963|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922964|NCT01280266|Amlodipine|amlodipine|mesh-list
19922965|NCT01280266|Udenafil|udenafil|mesh-list
19922966|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19922967|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19922968|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19922969|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922970|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19922971|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922972|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
19922973|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19922974|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19922975|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922976|NCT01280409|Metformin|metformin|mesh-list
19922977|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19922978|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922979|NCT01280591|Naproxen|naproxen|mesh-list
19922980|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19922981|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19922982|NCT01280591|Analgesics|analgesics|mesh-ancestor
20541469|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20541470|NCT01857856|Diuretics|diuretics|mesh-ancestor
20541471|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
20541472|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20541473|NCT01857895|Exenatide|exenatide|mesh-list
19922983|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
19922984|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19922985|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19922986|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19922987|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19922988|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
19922989|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19922990|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19922991|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922992|NCT01280604|Fenofibrate|fenofibrate|mesh-list
19922993|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19922994|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
19922995|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19922996|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19922997|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
19922998|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19922999|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
19923000|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923001|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923002|NCT01280656|Interferons|interferons|mesh-list
19923003|NCT01280656|Ribavirin|ribavirin|mesh-list
19923004|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19923005|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19923006|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923007|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
19923008|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923009|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
19923010|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923011|NCT01280695|Pioglitazone|pioglitazone|mesh-list
19923012|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19923013|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923014|NCT01280721|Tolvaptan|tolvaptan|mesh-list
19923015|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19923016|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923017|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
19923018|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923019|NCT01280955|Plerixafor|plerixafor|mesh-list
19923020|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19923021|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19923022|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
19923023|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923024|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19923025|NCT01280968|Vaccines|vaccines|mesh-list
19923026|NCT01280968|Nicotine|nicotine|mesh-list
19923027|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
19923028|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923029|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19923030|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
19923031|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923032|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19923033|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19923034|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
19923035|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262335|NCT00501241|ATI 7505|ati 7505|mesh-list
20262336|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20262337|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20262338|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
20262339|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262340|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262341|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262342|NCT00501254|Aspirin|aspirin|mesh-list
19923036|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923037|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19923038|NCT01280968|Antacids|antacids|mesh-ancestor
19923039|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19923040|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
19923041|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19923042|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19923043|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923044|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
19923045|NCT01280981|Coagulants|coagulants|mesh-ancestor
19923046|NCT01281007|Acyclovir|acyclovir|mesh-list
20262343|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
19923047|NCT01281007|Famciclovir|famciclovir|mesh-list
19923048|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
19923049|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923050|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19923051|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923052|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923053|NCT01281189|Pramipexole|pramipexole|mesh-list
19923054|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
19923055|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923056|NCT01281189|Protective Agents|protective agents|mesh-ancestor
19923057|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923058|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19923059|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19923060|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
19923061|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
19923062|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923063|NCT01281202|Vigabatrin|vigabatrin|mesh-list
19923064|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
19923065|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923066|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923067|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
19923068|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923069|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923070|NCT01281306|Valsartan|valsartan|mesh-list
19923071|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19923072|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19923073|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19923074|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19923075|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923076|NCT01281475|Levodopa|levodopa|mesh-list
19923077|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19923078|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19923079|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
19923080|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923081|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923082|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923083|NCT01281501|Scopolamine|scopolamine|mesh-list
19923084|NCT01281501|Pantoprazole|pantoprazole|mesh-list
19923085|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
19923086|NCT01281501|Antacids|antacids|mesh-list
19923087|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19923088|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19923089|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19923090|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923091|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923092|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19923093|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
19923094|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
19923095|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923096|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923097|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
19923098|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19923099|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
19923100|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923101|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19923102|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
19923103|NCT01281839|Ribavirin|ribavirin|mesh-list
19923104|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19923105|NCT01281839|Simeprevir|simeprevir|mesh-list
19923106|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
19923107|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923108|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
19923109|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923110|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923111|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923112|NCT01281865|Everolimus|everolimus|mesh-list
19923113|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
19923114|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923115|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923116|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
19923117|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923118|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19923119|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923120|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923121|NCT01281917|Sirolimus|sirolimus|mesh-list
19923122|NCT01281917|Bortezomib|bortezomib|mesh-list
19923123|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923124|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19923125|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923126|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19923127|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
19923128|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923129|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
19923130|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923131|NCT01281956|Naluzotan|naluzotan|mesh-list
19923132|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19923133|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19923134|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
19923135|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923136|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923137|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923138|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
19923139|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19923140|NCT01281969|Antibodies|antibodies|mesh-list
19923141|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
19923142|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19923143|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
19923144|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923145|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19923146|NCT01282138|Dextrans|dextrans|mesh-list
19923147|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19923148|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19923149|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
19923150|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
19923151|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
19923152|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262344|NCT00501254|Salicylates|salicylates|mesh-list
20262345|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262346|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
20262347|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
20262348|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
19923153|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19923154|NCT01282138|Analgesics|analgesics|mesh-ancestor
19923155|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
19923156|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923157|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923158|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923159|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923160|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19923161|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19923162|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19923163|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
19923164|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
19923165|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923166|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923167|NCT01282164|Insulin|insulin|mesh-list
19923168|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19923169|NCT01282164|Glucagon|glucagon|mesh-list
19923170|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19923171|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19923172|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923173|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19923174|NCT01282164|Hormones|hormones|mesh-ancestor
19923175|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262349|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262350|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20262351|NCT00501254|Analgesics|analgesics|mesh-ancestor
20262352|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
20262353|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262354|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923176|NCT01282164|Incretins|incretins|mesh-ancestor
19923177|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19923178|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19923179|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19923180|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923181|NCT01282424|Idelalisib|idelalisib|mesh-list
19923182|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923183|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923184|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923185|NCT01282463|Docetaxel|docetaxel|mesh-list
19923186|NCT01282463|Ramucirumab|ramucirumab|mesh-list
19923187|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923188|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
19923189|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
20262355|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923190|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
20262356|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262357|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20262358|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262359|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923191|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923192|NCT01282476|Rituximab|rituximab|mesh-list
19923193|NCT01282476|Panobinostat|panobinostat|mesh-list
19923194|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19923195|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923196|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
19923197|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923198|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923199|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19923200|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923201|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923202|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19923203|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19923204|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19923205|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19923206|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923207|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923208|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923209|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19923210|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
19923211|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19923212|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19923213|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19923214|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19923215|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19923216|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923217|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923218|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923219|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19923220|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
19923221|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19923222|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
19923223|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19923224|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20262360|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20262361|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20262362|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20262363|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
20262364|NCT00501267|Oxybutynin|oxybutynin|mesh-list
20262365|NCT00501267|Solabegron|solabegron|mesh-list
20262366|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
20262367|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
20262368|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262369|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262370|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20262371|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19923225|NCT01283009|Prednisolone|prednisolone|mesh-list
19923226|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
19923227|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19923228|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
19923229|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923230|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
19923231|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
19923232|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923233|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262372|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
20262373|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262374|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262375|NCT00501267|Urological Agents|urological agents|mesh-ancestor
20262376|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20262377|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20262378|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20262379|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
20262380|NCT00501384|Satavaptan|satavaptan|mesh-list
20262381|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20262382|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262383|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
19923234|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19923235|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
19923236|NCT01283009|Hormones|hormones|mesh-ancestor
19923237|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19923238|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19923239|NCT01283009|Protective Agents|protective agents|mesh-ancestor
19923240|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19923241|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923242|NCT01283139|Sifalimumab|sifalimumab|mesh-list
19923243|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19923244|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
19923245|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923246|NCT01283152|Lactulose|lactulose|mesh-list
19923247|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19923248|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19923249|NCT01283152|Laxatives|laxatives|mesh-ancestor
19923250|NCT01283282|Clopidogrel|clopidogrel|mesh-list
19923251|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19923252|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19923253|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19923254|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19923255|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
19923256|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923257|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923258|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923259|NCT01283334|Carboplatin|carboplatin|mesh-list
19923260|NCT01283334|Cetuximab|cetuximab|mesh-list
19923261|NCT01283334|Everolimus|everolimus|mesh-list
19923262|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923263|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19923264|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923265|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
19923266|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923267|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
19923268|NCT01283386|Chlorambucil|chlorambucil|mesh-list
19923269|NCT01283386|Rituximab|rituximab|mesh-list
19923270|NCT01283386|Fludarabine|fludarabine|mesh-list
19923271|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923272|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
19923273|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923274|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923275|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19923276|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
19923277|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923278|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923279|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19923280|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19923281|NCT01283464|Vitamin A|vitamin a|mesh-list
19923282|NCT01283464|Tretinoin|tretinoin|mesh-list
19923283|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923284|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
19923285|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
19923286|NCT01283464|Vitamins|vitamins|mesh-ancestor
19923287|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
19923288|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923289|NCT01283516|Ceritinib|ceritinib|mesh-list
19923290|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923291|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19923292|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923293|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923294|NCT01283542|Pasireotide|pasireotide|mesh-list
19923295|NCT01283542|Hormones|hormones|mesh-ancestor
19923296|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19923297|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923298|NCT01283555|Tenofovir|tenofovir|mesh-list
19923299|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
19923300|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923301|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19923302|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19923303|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923304|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923305|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19923306|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19972749|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
19972750|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19923307|NCT01283581|Vancomycin|vancomycin|mesh-list
19923308|NCT01283581|Linezolid|linezolid|mesh-list
19923309|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19923310|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923311|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19923312|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923313|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923314|NCT01283971|Adalimumab|adalimumab|mesh-list
19923315|NCT01283971|Methotrexate|methotrexate|mesh-list
19923316|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19923317|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
19923318|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19923319|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923320|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19923321|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
19923322|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923323|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923324|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
19923325|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923326|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19923327|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923328|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
19923329|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923330|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19923331|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923332|NCT01284296|Lidocaine|lidocaine|mesh-list
19923333|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
19923334|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
19923335|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19923336|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923337|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
19923338|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923339|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19923340|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19923341|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19923342|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19923343|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923344|NCT01284335|Gemcitabine|gemcitabine|mesh-list
19923345|NCT01284335|Docetaxel|docetaxel|mesh-list
19923346|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19923347|NCT01284335|Temozolomide|temozolomide|mesh-list
19923348|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923349|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19923350|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
19923351|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923352|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
19923353|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923354|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923355|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923356|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
19923357|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923358|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
19923359|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
19923360|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
19923361|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19923362|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19923363|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
19923364|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19923365|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19923366|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19923367|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19923368|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923369|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19923370|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19923371|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19923372|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19923373|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
19923374|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923375|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923376|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19923377|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19923378|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
19923379|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19923380|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19923381|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
19923382|NCT01284621|Empagliflozin|empagliflozin|mesh-list
19923383|NCT01284621|Ramipril|ramipril|mesh-list
19923384|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19923385|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923386|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923387|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923388|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19923389|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19923390|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19923391|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923392|NCT01284634|Cannabidiol|cannabidiol|mesh-list
19923393|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
19923394|NCT01284959|Risperidone|risperidone|mesh-list
19923395|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19923396|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19923397|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
19923398|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923399|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923400|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923401|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19923402|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20262384|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262385|NCT00501397|Ketoconazole|ketoconazole|mesh-list
20262386|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
20262387|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262388|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19923403|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19923404|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19923405|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19923406|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
19923407|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19923408|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19923409|NCT01285050|Tenofovir|tenofovir|mesh-list
19923410|NCT01285050|Emtricitabine|emtricitabine|mesh-list
19923411|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
19923412|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19923413|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
19923414|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923415|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19923416|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19923417|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923418|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923419|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19923420|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19923421|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19923422|NCT01285310|Thalidomide|thalidomide|mesh-list
19923423|NCT01285310|Apremilast|apremilast|mesh-list
19923424|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19923425|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19923426|NCT01285310|Analgesics|analgesics|mesh-ancestor
19923427|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
19923428|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923429|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923430|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923431|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923432|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19923433|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19923434|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923435|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923436|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923437|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
19923438|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
19923439|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19923440|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923441|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19923442|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19923443|NCT01285310|Growth Substances|growth substances|mesh-ancestor
19923444|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
19923445|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923446|NCT01285323|Reslizumab|reslizumab|mesh-list
19923447|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20262389|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19923448|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
19923449|NCT01285401|Interferons|interferons|mesh-list
19923450|NCT01285401|Interferon-beta|interferon-beta|mesh-list
19923451|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
19923452|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923453|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
19923454|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923455|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
19923456|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923457|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19923458|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
19923459|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20262390|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262391|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262392|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20262393|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
19923460|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
19923461|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923462|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923463|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19923464|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
19923465|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
19923466|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19923467|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
19923468|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923469|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923470|NCT01285609|Paclitaxel|paclitaxel|mesh-list
19923471|NCT01285609|Carboplatin|carboplatin|mesh-list
19923472|NCT01285609|Ipilimumab|ipilimumab|mesh-list
19923473|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19923474|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923475|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
19923476|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
19923477|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
19923478|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923479|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19923480|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19923481|NCT01285635|Docetaxel|docetaxel|mesh-list
19923482|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923483|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
19923484|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
19923485|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
19923486|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923487|NCT01285908|Norepinephrine|norepinephrine|mesh-list
19923488|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19923489|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19923490|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
19923491|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923492|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923493|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923494|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
19923495|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
19923496|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923497|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19923498|NCT01286077|Bortezomib|bortezomib|mesh-list
19923499|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923500|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
19923501|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19923502|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19923503|NCT01286168|Eusol|eusol|mesh-list
19923504|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19923505|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19923506|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923507|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
19923508|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
19923509|NCT01286259|Disulfiram|disulfiram|mesh-list
19923510|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19923511|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19923512|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923513|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923514|NCT01286402|Bupropion|bupropion|mesh-list
19923515|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19923516|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
19923517|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19923518|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19972751|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20287088|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19923519|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19923520|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19923521|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923522|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
19923523|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923524|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923525|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19923526|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19923527|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923528|NCT01286454|Fesoterodine|fesoterodine|mesh-list
19923529|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19923530|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19923531|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
19923532|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923533|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923534|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923535|NCT01286454|Urological Agents|urological agents|mesh-ancestor
19923536|NCT01286558|Amlodipine|amlodipine|mesh-list
19923537|NCT01286558|Telmisartan|telmisartan|mesh-list
19923538|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19923539|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19923540|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19923541|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923542|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19923543|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923544|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
19923545|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19923546|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19923547|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
19923548|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
19923549|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923550|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19923551|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19923552|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923553|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923554|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19923555|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19923556|NCT01286753|Vemurafenib|vemurafenib|mesh-list
19923557|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923558|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19923559|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923560|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923561|NCT01286805|Bupivacaine|bupivacaine|mesh-list
19923562|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
19923563|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
19923564|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19923565|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923566|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
19923567|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923568|NCT01286818|Leucovorin|leucovorin|mesh-list
19923569|NCT01286818|Fluorouracil|fluorouracil|mesh-list
19923570|NCT01286818|Irinotecan|irinotecan|mesh-list
19923571|NCT01286818|Ramucirumab|ramucirumab|mesh-list
19923572|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19923573|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
19923574|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
19923575|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923576|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19923577|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923578|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923579|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
19923580|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923581|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19923582|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19923583|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923584|NCT01286818|Antidotes|antidotes|mesh-ancestor
19923585|NCT01286818|Protective Agents|protective agents|mesh-ancestor
19923586|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
19923587|NCT01286818|Vitamins|vitamins|mesh-ancestor
19923588|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
19923589|NCT01286987|Talazoparib|talazoparib|mesh-list
19923590|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19923591|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923592|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923593|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923594|NCT01287039|Reslizumab|reslizumab|mesh-list
19923595|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19923596|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
19923597|NCT01287078|Cyclosporine|cyclosporine|mesh-list
19923598|NCT01287078|Cyclosporins|cyclosporins|mesh-list
19923599|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923600|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923601|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923602|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
19923603|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923604|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
19923605|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923606|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
19923607|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923608|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19923609|NCT01287117|Omalizumab|omalizumab|mesh-list
19923610|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19923611|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19923612|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
19923613|NCT01287195|Omeprazole|omeprazole|mesh-list
19923614|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
19923615|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19923616|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19923617|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19923618|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923619|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923620|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
19923621|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923622|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923623|NCT01287221|Riboflavin|riboflavin|mesh-list
19923624|NCT01287221|Rifampin|rifampin|mesh-list
19923625|NCT01287221|Vitamins|vitamins|mesh-ancestor
19923626|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
19923627|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923628|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
19923629|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19923630|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
19923631|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19923632|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923633|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
19923634|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19923635|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923636|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923637|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19923638|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19923639|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19923640|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19923641|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19923642|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19923643|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19923644|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
19923645|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
19923646|NCT01287364|Ciclesonide|ciclesonide|mesh-list
19923647|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923648|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
19923649|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19923650|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
19923651|NCT01287364|Hormones|hormones|mesh-ancestor
19923652|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19923653|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923654|NCT01287377|Nicotine|nicotine|mesh-list
19923655|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19923656|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
19923657|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923658|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923659|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19923660|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19923661|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
19923662|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923663|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923664|NCT01287520|Carboplatin|carboplatin|mesh-list
19450002|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19923665|NCT01287520|Pemetrexed|pemetrexed|mesh-list
19923666|NCT01287520|Ranitidine|ranitidine|mesh-list
19923667|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19923668|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923669|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923670|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923671|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19923672|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19923673|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19923674|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19923675|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19923676|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
19923677|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
19923678|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923679|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923680|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19923681|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923682|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19923683|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923684|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923685|NCT01287832|Vancomycin|vancomycin|mesh-list
19923686|NCT01287832|Daptomycin|daptomycin|mesh-list
19923687|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19923688|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923689|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19923690|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19923691|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19923692|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19923693|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923694|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923695|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923696|NCT01288079|Analgesics|analgesics|mesh-ancestor
19923697|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
19923698|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923699|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
19923700|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19923701|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
19923702|NCT01288209|Ribavirin|ribavirin|mesh-list
19923703|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19923704|NCT01288209|Simeprevir|simeprevir|mesh-list
19923705|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
19923706|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923707|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
19923708|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923709|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923710|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923711|NCT01288443|Atorvastatin|atorvastatin|mesh-list
19923712|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19923713|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19923714|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19923715|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
19923716|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923717|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19923718|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19923719|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923720|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
19923721|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262394|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262395|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262396|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20262397|NCT00501410|Leucovorin|leucovorin|mesh-list
20262398|NCT00501410|Fluorouracil|fluorouracil|mesh-list
20262399|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
20262400|NCT00501410|Cetuximab|cetuximab|mesh-list
20262401|NCT00501410|Dasatinib|dasatinib|mesh-list
20262402|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
20262403|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262404|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262405|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262406|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262407|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
20262408|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262409|NCT00501410|Antidotes|antidotes|mesh-ancestor
20262410|NCT00501410|Protective Agents|protective agents|mesh-ancestor
20262411|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
19923722|NCT01288469|Atorvastatin|atorvastatin|mesh-list
19923723|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19923724|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19923725|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19923726|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
19923727|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923728|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19923729|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19923730|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923731|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
19923732|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923733|NCT01288521|Ketoconazole|ketoconazole|mesh-list
19923734|NCT01288521|Tacrolimus|tacrolimus|mesh-list
19923735|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923736|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
19923737|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923738|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19923739|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923740|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923741|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
19923742|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923743|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19923744|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19923745|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19923746|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
19923747|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19450003|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450004|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
19450005|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450006|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19450007|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
19450008|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19450009|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19450010|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19450011|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19450012|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450013|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
19450014|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450015|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19450016|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19450017|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450018|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
19450019|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19450020|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19450021|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450022|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
19450023|NCT03431805|Coagulants|coagulants|mesh-ancestor
19450024|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
19450025|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19450026|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450027|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
19450028|NCT03431714|Artesunate|artesunate|mesh-list
19450029|NCT03431714|Piperaquine|piperaquine|mesh-list
19450030|NCT03431714|Amodiaquine|amodiaquine|mesh-list
19450031|NCT03431714|Artenimol|artenimol|mesh-list
19450032|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
19450033|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19450034|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19450035|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923748|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19923749|NCT01288781|Acetazolamide|acetazolamide|mesh-list
19923750|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
19923751|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19923752|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923753|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923754|NCT01288781|Diuretics|diuretics|mesh-ancestor
19923755|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
19923756|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923757|NCT01288807|Milnacipran|milnacipran|mesh-list
19923758|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19923759|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19923760|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541474|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19923761|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923762|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923763|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923764|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19923765|NCT01288807|Analgesics|analgesics|mesh-ancestor
19923766|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
19923767|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923768|NCT01288859|Curcumin|curcumin|mesh-list
19923769|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19923770|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19923771|NCT01288859|Analgesics|analgesics|mesh-ancestor
19923772|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
19923773|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923774|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923775|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923776|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923777|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923778|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262412|NCT00501410|Vitamins|vitamins|mesh-ancestor
20262413|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
20262414|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262415|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262416|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262417|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
20262418|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20262419|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262420|NCT00501514|Hormones|hormones|mesh-list
20262421|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262422|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262423|NCT00501566|Satavaptan|satavaptan|mesh-list
20262424|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20262425|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262426|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
20262427|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262428|NCT00501579|Prednisolone|prednisolone|mesh-list
20262429|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20262430|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
20262431|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20262432|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
20262433|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20262434|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
20262435|NCT00501579|Difluprednate|difluprednate|mesh-list
20262436|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262437|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
20262438|NCT00501579|Hormones|hormones|mesh-ancestor
20262439|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262440|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262441|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20262442|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262443|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
20262444|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
20262445|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262446|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262447|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20262448|NCT00501579|Protective Agents|protective agents|mesh-ancestor
20262449|NCT00501605|Cediranib|cediranib|mesh-list
20262450|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262451|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262452|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262453|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262454|NCT00501618|Clozapine|clozapine|mesh-list
20262455|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20262456|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
19923779|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923780|NCT01288911|Bicalutamide|bicalutamide|mesh-list
19923781|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
19923782|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
19923783|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19923784|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923785|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923786|NCT01288937|Milnacipran|milnacipran|mesh-list
19923787|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
19972752|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541475|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923788|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19923789|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19923790|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19923791|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923792|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923793|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923794|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19923795|NCT01288937|Analgesics|analgesics|mesh-ancestor
19923796|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
19923797|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923798|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
19923799|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19923800|NCT01289067|Satraplatin|satraplatin|mesh-list
19923801|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923802|NCT01289119|Metformin|metformin|mesh-list
19923803|NCT01289119|Pioglitazone|pioglitazone|mesh-list
19923804|NCT01289119|Alogliptin|alogliptin|mesh-list
19923805|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19923806|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923807|NCT01289119|Incretins|incretins|mesh-ancestor
19923808|NCT01289119|Hormones|hormones|mesh-ancestor
19923809|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19923810|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19923811|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923812|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923813|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923814|NCT01289275|Nicotine|nicotine|mesh-list
19923815|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19923816|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
19923817|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923818|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923819|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19923820|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19923821|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
19923822|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923823|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262457|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262458|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262459|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262460|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20262461|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20262462|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20262463|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20262464|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
20262465|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
20262466|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20262467|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20262468|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262469|NCT00501657|Incretins|incretins|mesh-ancestor
20262470|NCT00501657|Hormones|hormones|mesh-ancestor
20262471|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262472|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20262473|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
20262474|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923824|NCT01289353|Carboplatin|carboplatin|mesh-list
19923825|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972753|NCT01814371|Mupirocin|mupirocin|mesh-list
19972754|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19972755|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972756|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19972757|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972758|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972759|NCT01814397|Letrozole|letrozole|mesh-list
19972760|NCT01814397|Anastrozole|anastrozole|mesh-list
19972761|NCT01814397|Exemestane|exemestane|mesh-list
19972762|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972763|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19972764|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19972765|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972766|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972767|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19972768|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
19972769|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19923826|NCT01289457|Cytarabine|cytarabine|mesh-list
19923827|NCT01289457|Fludarabine|fludarabine|mesh-list
19923828|NCT01289457|Idarubicin|idarubicin|mesh-list
19923829|NCT01289457|Clofarabine|clofarabine|mesh-list
19923830|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923831|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19923832|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
19923833|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923834|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923835|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
19923836|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923837|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
19923838|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923839|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19923840|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19923841|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19923842|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923843|NCT01289522|Cetuximab|cetuximab|mesh-list
19923844|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19923845|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923846|NCT01289639|Pioglitazone|pioglitazone|mesh-list
19923847|NCT01289639|Fenofibrate|fenofibrate|mesh-list
19923848|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19923849|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923850|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19923851|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
19923852|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923853|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19923854|NCT01289678|Interleukin-2|interleukin-2|mesh-list
19923855|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923856|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19923857|NCT01289678|Analgesics|analgesics|mesh-ancestor
19923858|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
19923859|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923860|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923861|NCT01289782|Ribavirin|ribavirin|mesh-list
19923862|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19923863|NCT01289782|Simeprevir|simeprevir|mesh-list
19923864|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
19923865|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923866|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
19923867|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923868|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923869|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923870|NCT01289821|Leucovorin|leucovorin|mesh-list
19923871|NCT01289821|Folic Acid|folic acid|mesh-list
19923872|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
19923873|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
19923874|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923875|NCT01289821|Antidotes|antidotes|mesh-ancestor
19923876|NCT01289821|Protective Agents|protective agents|mesh-ancestor
19923877|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923878|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
19923879|NCT01289821|Vitamins|vitamins|mesh-ancestor
19923880|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
19923881|NCT01289821|Hematinics|hematinics|mesh-ancestor
19923882|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
19923883|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19923884|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19923885|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
19923886|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923887|NCT01289912|Everolimus|everolimus|mesh-list
19923888|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923889|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19923890|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
19923891|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923892|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19923893|NCT01289990|Empagliflozin|empagliflozin|mesh-list
19923894|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19923895|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923896|NCT01289990|Incretins|incretins|mesh-ancestor
19923897|NCT01289990|Hormones|hormones|mesh-ancestor
19923898|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262475|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923899|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19923900|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923901|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923902|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923903|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19923904|NCT01290029|Cinacalcet|cinacalcet|mesh-list
19923905|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19923906|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923907|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19923908|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
19923909|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19923910|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
19923911|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19923912|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923913|NCT01290237|Vancomycin|vancomycin|mesh-list
19923914|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19923915|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923916|NCT01290263|Bevacizumab|bevacizumab|mesh-list
19923917|NCT01290263|Trebananib|trebananib|mesh-list
19923918|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19923919|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923920|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19923921|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19923922|NCT01290263|Growth Substances|growth substances|mesh-ancestor
19923923|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923924|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
19923925|NCT01290315|Dextrans|dextrans|mesh-list
19923926|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19923927|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
19923928|NCT01290315|Hematinics|hematinics|mesh-ancestor
19923929|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
19923930|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
19923931|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
19923932|NCT01290341|Naftifine|naftifine|mesh-list
19923933|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
19923934|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923935|NCT01290445|Varenicline|varenicline|mesh-list
19923936|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19923937|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19923938|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
19923939|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19923940|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923941|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923942|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
19923943|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
19923944|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19923945|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19923946|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923947|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923948|NCT01290484|Urological Agents|urological agents|mesh-ancestor
19923949|NCT01290601|Chloroquine|chloroquine|mesh-list
19923950|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19923951|NCT01290601|Primaquine|primaquine|mesh-list
19923952|NCT01290601|Tafenoquine|tafenoquine|mesh-list
19923953|NCT01290601|Amebicides|amebicides|mesh-ancestor
19923954|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19923955|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19923956|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923957|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
19923958|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19923959|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19923960|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19923961|NCT01290601|Analgesics|analgesics|mesh-ancestor
19923962|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
19923963|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19923964|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19923965|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19923966|NCT01290601|Filaricides|filaricides|mesh-ancestor
19923967|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
19923968|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
19923969|NCT01290679|Ribavirin|ribavirin|mesh-list
19923970|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19923971|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19923972|NCT01290679|Simeprevir|simeprevir|mesh-list
19923973|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
19923974|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450036|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923975|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
19923976|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923977|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923978|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923979|NCT01290731|Interferons|interferons|mesh-list
19923980|NCT01290731|Ribavirin|ribavirin|mesh-list
19923981|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19923982|NCT01290731|Simeprevir|simeprevir|mesh-list
19923983|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19923984|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
19923985|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19923986|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
19923987|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923988|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923989|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923990|NCT01290757|Dabigatran|dabigatran|mesh-list
19923991|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
19923992|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19923993|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
19923994|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19923995|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19923996|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
19923997|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
19923998|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
19923999|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19924000|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19924001|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
19924002|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924003|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924004|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19924005|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
19924006|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19924007|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19924008|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19924009|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
19924010|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924011|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924012|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
19924013|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19924014|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
19924015|NCT01290887|Reslizumab|reslizumab|mesh-list
19924016|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19924017|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
19924018|NCT01290913|Omalizumab|omalizumab|mesh-list
19924019|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19924020|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19924021|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
19924022|NCT01291017|Palbociclib|palbociclib|mesh-list
19924023|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924024|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19924025|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924026|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924027|NCT01291056|Clomiphene|clomiphene|mesh-list
19924028|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19924029|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
19924030|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924031|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924032|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19924033|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
19924034|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924035|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19924036|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19924037|NCT01291108|Bimatoprost|bimatoprost|mesh-list
20262476|NCT00501696|Naltrexone|naltrexone|mesh-list
20262477|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20262478|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20262479|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924038|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19924039|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19924040|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19924041|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924042|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19924043|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19924044|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19924045|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924046|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
19924047|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924048|NCT01291784|Antibodies|antibodies|mesh-list
20262480|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
20262481|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924049|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19924050|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
19924051|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924052|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
19924053|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19924054|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924055|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924056|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19924057|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19924058|NCT01292005|Protective Agents|protective agents|mesh-ancestor
19924059|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924060|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
19924061|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19924062|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
19924063|NCT01292057|Aripiprazole|aripiprazole|mesh-list
19924064|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
19924065|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19924066|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19924067|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19924068|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924069|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924070|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
19924071|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
19924072|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924073|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924074|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19924075|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20262482|NCT00501722|Satavaptan|satavaptan|mesh-list
20262483|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20262484|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924076|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
19924077|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19924078|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19924079|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19924080|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19924081|NCT01292187|Calcitonin|calcitonin|mesh-list
19924082|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
19924083|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19924084|NCT01292187|Katacalcin|katacalcin|mesh-list
19924085|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19924086|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924087|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19924088|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
19924089|NCT01292226|Cyclosporine|cyclosporine|mesh-list
19924090|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
19924091|NCT01292226|Antibodies|antibodies|mesh-list
19924092|NCT01292226|Cyclosporins|cyclosporins|mesh-list
19924093|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
19924094|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924095|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924096|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924097|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924098|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
19924099|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924100|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
19924101|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924102|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19924103|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19924104|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924105|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19924106|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
19924107|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19924108|NCT01292239|Ribavirin|ribavirin|mesh-list
19924109|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19924110|NCT01292239|Simeprevir|simeprevir|mesh-list
19924111|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
19924112|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924113|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
19924114|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924115|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
19924116|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924117|NCT01292252|Teriparatide|teriparatide|mesh-list
19924118|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
19924119|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924120|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19924121|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19924122|NCT01292304|Tolvaptan|tolvaptan|mesh-list
19924123|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19924124|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924125|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
19924126|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924127|NCT01292447|Lidocaine|lidocaine|mesh-list
19924128|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
19924129|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
19924130|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924131|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924132|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
19924133|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924134|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19924135|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19924136|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19924137|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19924138|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924139|NCT01292473|Omalizumab|omalizumab|mesh-list
19924140|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19924141|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19924142|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
19924143|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
19924144|NCT01292603|Rituximab|rituximab|mesh-list
19924145|NCT01292603|Fludarabine|fludarabine|mesh-list
19924146|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924147|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
19924148|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924149|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924150|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19924151|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
19924152|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924153|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924154|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19924155|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19924156|NCT01292642|Nicotine|nicotine|mesh-list
19924157|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19924158|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
19924159|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924160|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924161|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19924162|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19924163|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
19924164|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924165|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924166|NCT01292798|Ranibizumab|ranibizumab|mesh-list
19924167|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19924168|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19924169|NCT01292798|Growth Substances|growth substances|mesh-ancestor
19924170|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924171|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
19924172|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924173|NCT01292837|Levetiracetam|levetiracetam|mesh-list
19924174|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
19924175|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
19924176|NCT01293006|Suvorexant|suvorexant|mesh-list
19924177|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19924178|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19924179|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924180|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924181|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19924182|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924183|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924184|NCT01293032|Tamoxifen|tamoxifen|mesh-list
19924185|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19924186|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924187|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19924188|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
19924189|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924190|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924191|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19924192|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975397|NCT01848457|Methotrexate|methotrexate|mesh-list
19924193|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19924194|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19924195|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19924196|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20262485|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
20262486|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262487|NCT00501748|Rituximab|rituximab|mesh-list
20262488|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541476|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20541477|NCT01857895|Incretins|incretins|mesh-ancestor
20541478|NCT01857895|Hormones|hormones|mesh-ancestor
20541479|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541480|NCT01857921|Trimetazidine|trimetazidine|mesh-list
20541481|NCT01857921|Atorvastatin|atorvastatin|mesh-list
20541482|NCT01857921|Pravastatin|pravastatin|mesh-list
20541483|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20541484|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20541485|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
20541486|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541487|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20541488|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20541489|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541490|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
20541491|NCT01857999|Losartan|losartan|mesh-list
20541492|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20541493|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20541494|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20541495|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20541496|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541497|NCT01858025|Fluorouracil|fluorouracil|mesh-list
20541498|NCT01858025|Mitomycins|mitomycins|mesh-list
20541499|NCT01858025|Mitomycin|mitomycin|mesh-list
20541500|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
20541501|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541502|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20541503|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541504|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541505|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
20541506|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541507|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20541508|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
20541509|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20541510|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541511|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
20541512|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20541513|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541514|NCT01858051|Vitamins|vitamins|mesh-ancestor
20541515|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
20541516|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20541517|NCT01858077|Everolimus|everolimus|mesh-list
20541518|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541519|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541520|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
20541521|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541522|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
19450037|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
19924197|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924198|NCT01293396|Insulin|insulin|mesh-list
19924199|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19924200|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
19924201|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
19924202|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19924203|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19924204|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924205|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262489|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262490|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
20262491|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262492|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262493|NCT00501787|Metformin|metformin|mesh-list
20262494|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20262495|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541523|NCT01858090|Promethazine|promethazine|mesh-list
20541524|NCT01858090|Diclofenac|diclofenac|mesh-list
20541525|NCT01858090|Atropine|atropine|mesh-list
19924206|NCT01293539|Melphalan|melphalan|mesh-list
19924207|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19924208|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
19924209|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924210|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924211|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19924212|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924213|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
19924214|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924215|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19924216|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924217|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924218|NCT01293825|Ziprasidone|ziprasidone|mesh-list
19924219|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19924220|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
19924221|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924222|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924223|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924224|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19924225|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19924226|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924227|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19924228|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19924229|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
19924230|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
19924231|NCT01293968|Promethazine|promethazine|mesh-list
19924232|NCT01293968|Ibuprofen|ibuprofen|mesh-list
19924233|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19924234|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19924235|NCT01293968|Analgesics|analgesics|mesh-ancestor
19924236|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
19924237|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924238|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924239|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19924240|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924241|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19924242|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924243|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924244|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19924245|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19924246|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924247|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
19924248|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
19924249|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
19924250|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
19924251|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924252|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19924253|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
19924254|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
19924255|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924256|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19924257|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
19924258|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
19924259|NCT01294098|Bupivacaine|bupivacaine|mesh-list
19924260|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
19924261|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
19924262|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924263|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924264|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
19924265|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924266|NCT01294163|Propofol|propofol|mesh-list
19924267|NCT01294163|Sevoflurane|sevoflurane|mesh-list
19924268|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19924269|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924270|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924271|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19924272|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
19924273|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
19924274|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19924275|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19924276|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19924277|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924278|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19924279|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972770|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924280|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924281|NCT01294319|Dexamethasone|dexamethasone|mesh-list
19924282|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
19924283|NCT01294319|Spironolactone|spironolactone|mesh-list
19924284|NCT01294319|Mifepristone|mifepristone|mesh-list
19924285|NCT01294319|BB 1101|bb 1101|mesh-list
19924286|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541526|NCT01858090|Ephedrine|ephedrine|mesh-list
20541527|NCT01858090|Fentanyl|fentanyl|mesh-list
20541528|NCT01858090|Sufentanil|sufentanil|mesh-list
20541529|NCT01858090|Meperidine|meperidine|mesh-list
20541530|NCT01858090|Metoclopramide|metoclopramide|mesh-list
20541531|NCT01858090|Propofol|propofol|mesh-list
20541532|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
20541533|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20541534|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541535|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541536|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20541537|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
20541538|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
20541539|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20541540|NCT01858090|Narcotics|narcotics|mesh-ancestor
19924287|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
19924288|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
19924289|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924290|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924291|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924292|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
19924293|NCT01294319|Hormones|hormones|mesh-ancestor
19924294|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924295|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19924296|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924297|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
19924298|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924299|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924300|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19924301|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
19924302|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19924303|NCT01294319|Diuretics|diuretics|mesh-ancestor
19924304|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
19924305|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19924306|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
19924307|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924308|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19924309|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19924310|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19924311|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
19924312|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19924313|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19924314|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
19924315|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19924316|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19924317|NCT01294358|Gemcitabine|gemcitabine|mesh-list
19924318|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19924319|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
19924320|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924321|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924322|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
19924323|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924324|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924325|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924326|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
19924327|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924328|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19924329|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19924330|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19924331|NCT01294384|Laxatives|laxatives|mesh-ancestor
19924332|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924333|NCT01294397|Denosumab|denosumab|mesh-list
19924334|NCT01294397|Etanercept|etanercept|mesh-list
19924335|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19924336|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19924337|NCT01294397|Analgesics|analgesics|mesh-ancestor
19924338|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
20541541|NCT01858090|Analgesics|analgesics|mesh-ancestor
20541542|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
20541543|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924339|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924340|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924341|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19924342|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924343|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924344|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924345|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
19924346|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19924347|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
19924348|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19924349|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924350|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924351|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924352|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
19924353|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19924354|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924355|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924356|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924357|NCT01294449|Cytarabine|cytarabine|mesh-list
19924358|NCT01294449|Dexamethasone|dexamethasone|mesh-list
19924359|NCT01294449|Methotrexate|methotrexate|mesh-list
19924360|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19924361|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
19924362|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924363|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924364|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
19924365|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924366|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924367|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
19924368|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924369|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19924370|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
19924371|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
19924372|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924373|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924374|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
19924375|NCT01294449|Hormones|hormones|mesh-ancestor
19924376|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924377|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19924378|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19924379|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
19924380|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924381|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
19924382|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924383|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19924384|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924385|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19924386|NCT01294462|Aspirin|aspirin|mesh-list
19924387|NCT01294462|Clopidogrel|clopidogrel|mesh-list
19924388|NCT01294462|Ticagrelor|ticagrelor|mesh-list
19924389|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19924390|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19924391|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19924392|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19924393|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
19924394|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924395|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924396|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924397|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19924398|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19924399|NCT01294462|Analgesics|analgesics|mesh-ancestor
19924400|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
19924401|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924402|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19924403|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924404|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19924405|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19924406|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19924407|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924408|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
19924409|NCT01294553|Metformin|metformin|mesh-list
19924410|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
19924411|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924412|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924413|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19924414|NCT01294579|Ofatumumab|ofatumumab|mesh-list
19924415|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19924416|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
19924417|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924418|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924419|NCT01294592|Tamsulosin|tamsulosin|mesh-list
19924420|NCT01294592|Dutasteride|dutasteride|mesh-list
19924421|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19924422|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19924423|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19924424|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
19924425|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924426|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924427|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924428|NCT01294592|Urological Agents|urological agents|mesh-ancestor
19924429|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19924430|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19924431|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924432|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
20262496|NCT00501839|Clomiphene|clomiphene|mesh-list
20262497|NCT00501839|Enclomiphene|enclomiphene|mesh-list
20262498|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
20262499|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20262500|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
20262501|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262502|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262503|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20262504|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
19924433|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924434|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
19924435|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19924436|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19972771|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19972772|NCT01814553|Afatinib|afatinib|mesh-list
19972773|NCT01814553|Loperamide|loperamide|mesh-list
19972774|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
19972775|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972776|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19972777|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972778|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972779|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19972780|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
19972781|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19972782|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19972783|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19972784|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972785|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972786|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
19972787|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972788|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972789|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19972790|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972791|NCT01814748|Metformin|metformin|mesh-list
19972792|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972793|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972794|NCT01814761|Bimatoprost|bimatoprost|mesh-list
19972795|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19972796|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
19972797|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
19972798|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972799|NCT01814813|Bevacizumab|bevacizumab|mesh-list
19972800|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19972801|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972802|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19972803|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19972804|NCT01814813|Growth Substances|growth substances|mesh-ancestor
19972805|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972806|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
19972807|NCT01814878|Acetaminophen|acetaminophen|mesh-list
19972808|NCT01814878|Tramadol|tramadol|mesh-list
19972809|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19972810|NCT01814878|Analgesics|analgesics|mesh-ancestor
19972811|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
20262505|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924437|NCT01294683|Niacin|niacin|mesh-list
19924438|NCT01294683|Niacinamide|niacinamide|mesh-list
19924439|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
19924440|NCT01294683|Simvastatin|simvastatin|mesh-list
19924441|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19924442|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19924443|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
19924444|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924445|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19924446|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19924447|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924448|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
19924449|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
19924450|NCT01294683|Vitamins|vitamins|mesh-ancestor
19924451|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
19924452|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924453|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
19924454|NCT01294787|Bromides|bromides|mesh-list
19924455|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
19924456|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19924457|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
19924458|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924459|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924460|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19924461|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
19924462|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
19924463|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19924464|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
19924465|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924466|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924467|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
19924468|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19924469|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19924470|NCT01295034|Vitamin D|vitamin d|mesh-list
19924471|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
19924472|NCT01295034|Vitamins|vitamins|mesh-list
19924473|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
19924474|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924475|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19924476|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19924477|NCT01295112|Dexamethasone|dexamethasone|mesh-list
19924478|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
19924479|NCT01295112|Bevacizumab|bevacizumab|mesh-list
19924480|NCT01295112|BB 1101|bb 1101|mesh-list
19924481|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19924482|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924483|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19924484|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19924485|NCT01295112|Growth Substances|growth substances|mesh-ancestor
19924486|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924487|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
19924488|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19924489|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
19924490|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
19924491|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924492|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924493|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
19924494|NCT01295112|Hormones|hormones|mesh-ancestor
19924495|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924496|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19924497|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19924498|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924499|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924500|NCT01295515|Interferons|interferons|mesh-list
19924501|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
19924502|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
19924503|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19924504|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924505|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
19924506|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924507|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
20262506|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19924508|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924509|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
19924510|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19924511|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
19924512|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924513|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924514|NCT01295814|Adalimumab|adalimumab|mesh-list
19924515|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19924516|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924517|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
19924518|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19924519|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924520|NCT01295879|Vitamin D|vitamin d|mesh-list
19924521|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
19924522|NCT01295879|Vitamins|vitamins|mesh-ancestor
19924523|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
19924524|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924525|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19924526|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19924527|NCT01296035|Panitumumab|panitumumab|mesh-list
19924528|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19924529|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924530|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19924531|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
19924532|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19924533|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19924534|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19924535|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
19924536|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924537|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924538|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19924539|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19924540|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19924541|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19924542|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924543|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
19924544|NCT01296191|Besifloxacin|besifloxacin|mesh-list
19924545|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19924546|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924547|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19924548|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19924549|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924550|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924551|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924552|NCT01296347|Ketamine|ketamine|mesh-list
19924553|NCT01296347|Analgesics|analgesics|mesh-ancestor
19924554|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
19924555|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924556|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924557|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19924558|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19924559|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
19924560|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
19924561|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924562|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19924563|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19924564|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924565|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924566|NCT01296412|Metformin|metformin|mesh-list
19924567|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19924568|NCT01296412|Liraglutide|liraglutide|mesh-list
19924569|NCT01296412|Glimepiride|glimepiride|mesh-list
19924570|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924571|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924572|NCT01296412|Incretins|incretins|mesh-ancestor
19924573|NCT01296412|Hormones|hormones|mesh-ancestor
19924574|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924575|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19924576|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
19924577|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924578|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924579|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19924580|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924581|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
19924582|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
19924583|NCT01296542|Besifloxacin|besifloxacin|mesh-list
19924584|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19924585|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924586|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19924587|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19924588|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924589|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924590|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924591|NCT01296568|Gemcitabine|gemcitabine|mesh-list
19924592|NCT01296568|Pemetrexed|pemetrexed|mesh-list
19924593|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19924594|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
19924595|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924596|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924597|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
19924598|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924599|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924600|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924601|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
19924602|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924603|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19924604|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19924605|NCT01296646|Naltrexone|naltrexone|mesh-list
19924606|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19924607|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19924608|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924609|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
19924610|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924611|NCT01296672|Finasteride|finasteride|mesh-list
19924612|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19924613|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19924614|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924615|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924616|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
19924617|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924618|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924619|NCT01296672|Urological Agents|urological agents|mesh-ancestor
19924620|NCT01296698|Nicotine|nicotine|mesh-list
19924621|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19924622|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
20262507|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20262508|NCT00501878|Phenylephrine|phenylephrine|mesh-list
20262509|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
20262510|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20262511|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
20262512|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
20262513|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262514|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262515|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
20262516|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19924623|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924624|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924625|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19924626|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19924627|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
19924628|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924629|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924630|NCT01296763|Irinotecan|irinotecan|mesh-list
19924631|NCT01296763|Olaparib|olaparib|mesh-list
19924632|NCT01296763|Mitomycins|mitomycins|mesh-list
19924633|NCT01296763|Mitomycin|mitomycin|mesh-list
19924634|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924635|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19924636|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19924637|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924638|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924639|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19924640|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19924641|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
19924642|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19924643|NCT01296815|Bevacizumab|bevacizumab|mesh-list
19924644|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19924645|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924646|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20262517|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
19924647|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19924648|NCT01296815|Growth Substances|growth substances|mesh-ancestor
19924649|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262518|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
20262519|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20262520|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19924650|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
19924651|NCT01296932|BI 836826|bi 836826|mesh-list
19924652|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19924653|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924654|NCT01297062|Exenatide|exenatide|mesh-list
19924655|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
19924656|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19924657|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924658|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19924659|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19924660|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924661|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924662|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924663|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924664|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924665|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19924666|NCT01297062|Incretins|incretins|mesh-ancestor
19924667|NCT01297062|Hormones|hormones|mesh-ancestor
19924668|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924669|NCT01297335|Clonidine|clonidine|mesh-list
19924670|NCT01297335|Analgesics|analgesics|mesh-ancestor
19924671|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
19924672|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924673|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924674|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19924675|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
19924676|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
19924677|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19924678|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19924679|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19924680|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
19924681|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924682|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924683|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19924684|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19924685|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
19924686|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19924687|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
19924688|NCT01297348|Norinyl|norinyl|mesh-list
19924689|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
19924690|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
20262521|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20262522|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
20262523|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262524|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262525|NCT00501878|Protective Agents|protective agents|mesh-ancestor
20262526|NCT00501904|Metformin|metformin|mesh-list
20262527|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924691|NCT01297348|Estradiol|estradiol|mesh-list
20262528|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262529|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
20262530|NCT00501917|Hematinics|hematinics|mesh-ancestor
20262531|NCT00501982|Poractant alfa|poractant alfa|mesh-list
20262532|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20262533|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
20262534|NCT00502034|Interferons|interferons|mesh-list
20262535|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
20262536|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
20262537|NCT00502034|Interleukin-2|interleukin-2|mesh-list
19924692|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19924693|NCT01297348|Estrogens|estrogens|mesh-ancestor
19924694|NCT01297348|Hormones|hormones|mesh-ancestor
20262538|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924695|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924696|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924697|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19924698|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924699|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19924700|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19924701|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20262539|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
20262540|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262541|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
20554039|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
19924702|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19924703|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
19924704|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19924705|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19924706|NCT01297465|Hormones|hormones|mesh-ancestor
19924707|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924708|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924709|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924710|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19924711|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19924712|NCT01297517|Brinzolamide|brinzolamide|mesh-list
19924713|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19924714|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19924715|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19924716|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19924717|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19924718|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
19924719|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924720|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924721|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924722|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19924723|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924724|NCT01297595|Crizotinib|crizotinib|mesh-list
19924725|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924726|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19924727|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924728|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924729|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19924730|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19924731|NCT01297920|Brinzolamide|brinzolamide|mesh-list
19924732|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19924733|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19924734|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19924735|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19924736|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19924737|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
19924738|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924739|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924740|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924741|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19924742|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924743|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19924744|NCT01298063|Afatinib|afatinib|mesh-list
19924745|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924746|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19924747|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924748|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924749|NCT01298128|NuvaRing|nuvaring|mesh-list
19924750|NCT01298128|Desogestrel|desogestrel|mesh-list
19924751|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19924752|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
19450038|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
19450039|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19450040|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
19450041|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19450042|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
19450043|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450044|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19450045|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
19450046|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
19450047|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19450048|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450049|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19450050|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19450051|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450052|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450053|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450054|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19450055|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19450056|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
19450057|NCT03431649|Beraprost|beraprost|mesh-list
19450058|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450059|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
19924753|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924754|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924755|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19924756|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19924757|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19924758|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19924759|NCT01298128|Progestins|progestins|mesh-ancestor
19924760|NCT01298128|Hormones|hormones|mesh-ancestor
19924761|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924762|NCT01298193|Phenothiazine|phenothiazine|mesh-list
19924763|NCT01298193|Droperidol|droperidol|mesh-list
19924764|NCT01298193|Haloperidol|haloperidol|mesh-list
19924765|NCT01298193|Aprepitant|aprepitant|mesh-list
19924766|NCT01298193|Metoclopramide|metoclopramide|mesh-list
19924767|NCT01298193|Domperidone|domperidone|mesh-list
19924768|NCT01298193|Alizapride|alizapride|mesh-list
19924769|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
19924770|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
19924771|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
19924772|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924773|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924774|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924775|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19924776|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924777|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924778|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19924779|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19924780|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924781|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19924782|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19924783|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
19924784|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19924785|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19924786|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19924787|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19924788|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
19924789|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19924790|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19924791|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924792|NCT01298219|Lubiprostone|lubiprostone|mesh-list
19924793|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19924794|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19924795|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924796|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19924797|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19924798|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924799|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924800|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19924801|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
19924802|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924803|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924804|NCT01298531|Etanercept|etanercept|mesh-list
19924805|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19924806|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19924807|NCT01298531|Analgesics|analgesics|mesh-ancestor
19924808|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
19924809|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924810|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924811|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19924812|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924813|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19924814|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924815|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
19924816|NCT01298570|Leucovorin|leucovorin|mesh-list
19924817|NCT01298570|Fluorouracil|fluorouracil|mesh-list
19924818|NCT01298570|Irinotecan|irinotecan|mesh-list
19924819|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
19924820|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
19924821|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924822|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19924823|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924824|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262542|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262543|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19924825|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
19924826|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924827|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19924828|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19924829|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924830|NCT01298570|Antidotes|antidotes|mesh-ancestor
19924831|NCT01298570|Protective Agents|protective agents|mesh-ancestor
19924832|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
19924833|NCT01298570|Vitamins|vitamins|mesh-ancestor
19924834|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
19924835|NCT01298700|Bimatoprost|bimatoprost|mesh-list
19924836|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19924837|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19924838|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19924839|NCT01298765|Buprenorphine|buprenorphine|mesh-list
19924840|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19924841|NCT01298765|Narcotics|narcotics|mesh-ancestor
19924842|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924843|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924844|NCT01298765|Analgesics|analgesics|mesh-ancestor
19924845|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
19924846|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924847|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19924848|NCT01298778|Acetaminophen|acetaminophen|mesh-list
19924849|NCT01298778|Morphine|morphine|mesh-list
19924850|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19924851|NCT01298778|Analgesics|analgesics|mesh-ancestor
19924852|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
19924853|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924854|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924855|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
19924856|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19924857|NCT01298778|Narcotics|narcotics|mesh-ancestor
19924858|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924859|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19924860|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19924861|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19924862|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
19924863|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924864|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19924865|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19924866|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924867|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
19924868|NCT01299116|Etonogestrel|etonogestrel|mesh-list
19924869|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
19924870|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19924871|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924872|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19924873|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19924874|NCT01299272|Serotonin|serotonin|mesh-list
19924875|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19924876|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19924877|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
19924878|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924879|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924880|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924881|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19924882|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19924883|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19924884|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19924885|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19924886|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924887|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924888|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19924889|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19924890|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19924891|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
19924892|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924893|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924894|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19924895|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19924896|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
19924897|NCT01299480|Vaccines|vaccines|mesh-list
19924898|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
19924899|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924900|NCT01299571|Dutasteride|dutasteride|mesh-list
19924901|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19924902|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19924903|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924904|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924905|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
19924906|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924907|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924908|NCT01299584|Remifentanil|remifentanil|mesh-list
19924909|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19924910|NCT01299584|Narcotics|narcotics|mesh-ancestor
19924911|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924912|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924913|NCT01299584|Analgesics|analgesics|mesh-ancestor
19924914|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
19924915|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924916|NCT01299805|Vortioxetine|vortioxetine|mesh-list
19924917|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
19924918|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19924919|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19924920|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19924921|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19924922|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924923|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19924924|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19924925|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19924926|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924927|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924928|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
19924929|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19924930|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19924931|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19924932|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19924933|NCT01299896|Bupropion|bupropion|mesh-list
19924934|NCT01299896|Nicotine|nicotine|mesh-list
19924935|NCT01299896|Varenicline|varenicline|mesh-list
19924936|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19924937|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
19924938|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924939|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924940|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19924941|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19924942|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
19924943|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19924944|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924945|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19924946|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
19924947|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19924948|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19924949|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19924950|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19924951|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
19924952|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19924953|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19924954|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924955|NCT01299961|Abatacept|abatacept|mesh-list
19924956|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19924957|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924958|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924959|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924960|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
19924961|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924962|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924963|NCT01300234|Tenofovir|tenofovir|mesh-list
19924964|NCT01300234|Adefovir|adefovir|mesh-list
19924965|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
19924966|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
19924967|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19924968|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20262544|NCT00502034|Analgesics|analgesics|mesh-ancestor
20262545|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
20262546|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19924969|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19924970|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19924971|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924972|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19924973|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19924974|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
19924975|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19924976|NCT01300247|Fludarabine|fludarabine|mesh-list
19924977|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
19924978|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19924979|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
19924980|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262547|NCT00502060|Cediranib|cediranib|mesh-list
20262548|NCT00502060|Gefitinib|gefitinib|mesh-list
20262549|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262550|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262551|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262552|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262553|NCT00502073|Cyclosporine|cyclosporine|mesh-list
20262554|NCT00502073|Cyclosporins|cyclosporins|mesh-list
20262555|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262556|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262557|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262558|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
20262559|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262560|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
20262561|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262562|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
20262563|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262564|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20262565|NCT00502099|Interferons|interferons|mesh-list
20262566|NCT00502099|Ribavirin|ribavirin|mesh-list
20262567|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
20262568|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
20262569|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20262570|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20262571|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262572|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
20262573|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262574|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
20541544|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19924981|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19924982|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19924983|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
19924984|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19924985|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19924986|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19924987|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19924988|NCT01300260|Dulaglutide|dulaglutide|mesh-list
19924989|NCT01300260|Glucagon|glucagon|mesh-list
19924990|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19924991|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19924992|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19924993|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541545|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20541546|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541547|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541548|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541549|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20541550|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541551|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541552|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20541553|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20541554|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
20541555|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20541556|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541557|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
20541558|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
20541559|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20541560|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20541561|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
20541562|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541563|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20541564|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
20541565|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
20262575|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262576|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
19924994|NCT01300260|Hormones|hormones|mesh-ancestor
19924995|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19924996|NCT01300260|Incretins|incretins|mesh-ancestor
19972812|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972813|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972814|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
19972815|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19972816|NCT01814878|Narcotics|narcotics|mesh-ancestor
19972817|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972818|NCT01815008|Aspirin|aspirin|mesh-list
19972819|NCT01815008|Clopidogrel|clopidogrel|mesh-list
19972820|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19972821|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19972822|NCT01815008|Analgesics|analgesics|mesh-ancestor
19972823|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
19972824|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972825|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972826|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972827|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972828|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19972829|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19972830|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972831|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19972832|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19972833|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972834|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
19972835|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19972836|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19972837|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19972838|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
19972839|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972840|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19972841|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19972842|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972843|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19972844|NCT01815333|Hematinics|hematinics|mesh-ancestor
19972845|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19972846|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19972847|NCT01815424|Tofacitinib|tofacitinib|mesh-list
19972848|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19972849|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972850|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972851|NCT01815736|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19972852|NCT01815736|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19972853|NCT01815736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19972854|NCT01815736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19972855|NCT01815736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972856|NCT01815736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972857|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
19972858|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972859|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19972860|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19972861|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
19972862|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972863|NCT01816048|Listerine|listerine|mesh-list
19972864|NCT01816048|Fluorides|fluorides|mesh-list
19972865|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
19972866|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
19972867|NCT01816048|Protective Agents|protective agents|mesh-ancestor
19972868|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972869|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19972870|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972871|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19972872|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19972873|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972874|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19972875|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19972876|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19972877|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972878|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
19972879|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972880|NCT01816243|Fentanyl|fentanyl|mesh-list
19924997|NCT01300351|Fulvestrant|fulvestrant|mesh-list
19924998|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19924999|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925000|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19925001|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19925002|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
19925003|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925004|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925005|NCT01300455|Suvorexant|suvorexant|mesh-list
19925006|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19925007|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19925008|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925009|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925010|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19925011|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925012|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925013|NCT01300546|Naproxen|naproxen|mesh-list
19925014|NCT01300546|Sumatriptan|sumatriptan|mesh-list
19925015|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19925016|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19925017|NCT01300546|Analgesics|analgesics|mesh-ancestor
19925018|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
19925019|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925020|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925021|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925022|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925023|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
19925024|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19925025|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925026|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925027|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19925028|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19925029|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19925030|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
19925031|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925032|NCT01300572|Cyclosporine|cyclosporine|mesh-list
19925033|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
19925034|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19925035|NCT01300572|Fludarabine|fludarabine|mesh-list
19925036|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
19925037|NCT01300572|Antibodies|antibodies|mesh-list
19925038|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
19925039|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19925040|NCT01300572|Cyclosporins|cyclosporins|mesh-list
19925041|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
19925042|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925043|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925044|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19925045|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
19925046|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925047|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19925048|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925049|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
19925050|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925051|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19925052|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925053|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19925054|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19925055|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19925056|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
19925057|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19925058|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19925059|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925060|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
19925061|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
19925062|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925063|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
19925064|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
19925065|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925066|NCT01300819|Rotigotine|rotigotine|mesh-list
19925067|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
19925068|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
19925069|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925070|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925071|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925072|NCT01300923|Acamprosate|acamprosate|mesh-list
19925073|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19925074|NCT01301001|Gabapentin|gabapentin|mesh-list
19925075|NCT01301001|Analgesics|analgesics|mesh-ancestor
19925076|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
19925077|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925078|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925079|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
19925080|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19925081|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19925082|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925083|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19925084|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19925085|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19925086|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925087|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925088|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
19925089|NCT01301027|Pioglitazone|pioglitazone|mesh-list
19925090|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925091|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925092|NCT01301066|Pravastatin|pravastatin|mesh-list
19925093|NCT01301066|Pitavastatin|pitavastatin|mesh-list
19925094|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19925095|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19925096|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
19925097|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925098|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19925099|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19925100|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925101|NCT01301079|Ketamine|ketamine|mesh-list
19925102|NCT01301079|Analgesics|analgesics|mesh-ancestor
19925103|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
19925104|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925105|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925106|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19925107|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19925108|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
19925109|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
19925110|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925111|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19925112|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19925113|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925114|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925115|NCT01301092|Dulaglutide|dulaglutide|mesh-list
19732445|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732446|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732447|NCT04575064|Remdesivir|remdesivir|mesh-list
19732448|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
19925116|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925117|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925118|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19925119|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19925120|NCT01301183|Estradiol|estradiol|mesh-list
19925121|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20262577|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262578|NCT00502112|Lenalidomide|lenalidomide|mesh-list
19925122|NCT01301183|Mecasermin|mecasermin|mesh-list
19925123|NCT01301183|Estrogens|estrogens|mesh-ancestor
19925124|NCT01301183|Hormones|hormones|mesh-ancestor
19925125|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925126|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925127|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19925128|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
19925129|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19925130|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19925131|NCT01301183|Growth Substances|growth substances|mesh-ancestor
19925132|NCT01301391|Maleic acid|maleic acid|mesh-list
19925133|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262579|NCT00502112|Lintuzumab|lintuzumab|mesh-list
19972881|NCT01816243|Morphine|morphine|mesh-list
19732449|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732450|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
19732451|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735737|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19925134|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925135|NCT01301729|Paclitaxel|paclitaxel|mesh-list
19925136|NCT01301729|Docetaxel|docetaxel|mesh-list
19925137|NCT01301729|Trastuzumab|trastuzumab|mesh-list
19925138|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19925139|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925140|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
19925141|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
19925142|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
19925143|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925144|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925145|NCT01301742|Empagliflozin|empagliflozin|mesh-list
19925146|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
19925147|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19925148|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925149|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925150|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925151|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19925152|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
19925153|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19925154|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19925155|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19925156|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925157|NCT01301833|Biguanides|biguanides|mesh-list
19925158|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
19925159|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925160|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925161|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925162|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925163|NCT01302054|Fesoterodine|fesoterodine|mesh-list
19925164|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19925165|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19925166|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
19925167|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925168|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925169|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925170|NCT01302054|Urological Agents|urological agents|mesh-ancestor
19925171|NCT01302067|Fesoterodine|fesoterodine|mesh-list
20262580|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
20262581|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925172|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19925173|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19925174|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
19925175|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925176|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925177|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925178|NCT01302067|Urological Agents|urological agents|mesh-ancestor
19925179|NCT01302080|Sertraline|sertraline|mesh-list
19925180|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
19925181|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19925182|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19925183|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19925184|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925185|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925186|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925187|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
19925188|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925189|NCT01302119|Tavaborole|tavaborole|mesh-list
19925190|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19925191|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
19925192|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925193|NCT01302379|Metformin|metformin|mesh-list
19925194|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925195|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925196|NCT01302483|Lidocaine|lidocaine|mesh-list
19925197|NCT01302483|Phenylephrine|phenylephrine|mesh-list
19925198|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
19925199|NCT01302483|Tetracaine|tetracaine|mesh-list
19925200|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
19925201|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
19925202|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925203|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925204|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
19925205|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925206|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19925207|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19925208|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19925209|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925210|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262582|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20262583|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20262584|NCT00502112|Growth Substances|growth substances|mesh-ancestor
20262585|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
20262586|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262587|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262588|NCT00502138|Pramlintide|pramlintide|mesh-list
20262589|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
20262590|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20262591|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262592|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
20262593|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20262594|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
20262595|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262596|NCT00502164|Cediranib|cediranib|mesh-list
20262597|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262598|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262599|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262600|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262601|NCT00502190|Silicon|silicon|mesh-list
20262602|NCT00502190|Trace Elements|trace elements|mesh-ancestor
20262603|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
20262604|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262605|NCT00502229|Metformin|metformin|mesh-list
20262606|NCT00502229|Clomiphene|clomiphene|mesh-list
20262607|NCT00502229|Enclomiphene|enclomiphene|mesh-list
20262608|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
20262609|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20262610|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262611|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20262612|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
20262613|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262614|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20262615|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
20262616|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20262617|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20262618|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20262619|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20262620|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
19925211|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19925212|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19925213|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
19925214|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925215|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
19925216|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
19925217|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
19925218|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19925219|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
19925220|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19925221|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
19925222|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19925223|NCT01302483|Protective Agents|protective agents|mesh-ancestor
19925224|NCT01302691|Losartan|losartan|mesh-list
19925225|NCT01302691|Amlodipine|amlodipine|mesh-list
19925226|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19925227|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19925228|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19925229|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925230|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925231|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19925232|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925233|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
19925234|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19925235|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19925236|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19925237|NCT01302691|Diuretics|diuretics|mesh-ancestor
19925238|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
20262621|NCT00502268|Vitamins|vitamins|mesh-ancestor
20262622|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
19925239|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19925240|NCT01302743|Metformin|metformin|mesh-list
19925241|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925242|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925243|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19925244|NCT01302808|Romidepsin|romidepsin|mesh-list
19925245|NCT01302808|Antiemetics|antiemetics|mesh-list
19925246|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925247|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19925248|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925249|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925250|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19925251|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
19925252|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925253|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925254|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19925255|NCT01302834|Cetuximab|cetuximab|mesh-list
19925256|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925257|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925258|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19925259|NCT01302899|Ramipril|ramipril|mesh-list
19925260|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19925261|NCT01302899|Diuretics|diuretics|mesh-ancestor
19925262|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
19925263|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925264|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19925265|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925266|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925267|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19925268|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
19925269|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925270|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19925271|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19925272|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19925273|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
19925274|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925275|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925276|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925277|NCT01302938|Urological Agents|urological agents|mesh-ancestor
19925278|NCT01302964|Mirtazapine|mirtazapine|mesh-list
19925279|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
19925280|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19925281|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19925282|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
19925283|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
19925284|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925285|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925286|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925287|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19925288|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19925289|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925290|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19925291|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19925292|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19925293|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
19925294|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19925295|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19925296|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
19925297|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19925298|NCT01303172|Gemcitabine|gemcitabine|mesh-list
19925299|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19925300|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
19925301|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925302|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925303|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
19925304|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925305|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925306|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19925307|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
19925308|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925309|NCT01303406|Idebenone|idebenone|mesh-list
19925310|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
19972882|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19925311|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925312|NCT01303406|Protective Agents|protective agents|mesh-ancestor
19925313|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925314|NCT01303445|Omeprazole|omeprazole|mesh-list
19925315|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
19925316|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19925317|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19925318|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19925319|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925320|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262623|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262624|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20262625|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20262626|NCT00502294|Visilizumab|visilizumab|mesh-list
20262627|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
20262628|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262629|NCT00502385|Cediranib|cediranib|mesh-list
20262630|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262631|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262632|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262633|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262634|NCT00502411|Doxorubicin|doxorubicin|mesh-list
20262635|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20262636|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20262637|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262638|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20262639|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262640|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262641|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262642|NCT00502437|Granisetron|granisetron|mesh-list
20262643|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
20262644|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
20541566|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541567|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20541568|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
20541569|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
20541570|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20541571|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
20541572|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
20541573|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20541574|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20541575|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
20541576|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20541577|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
20541578|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20541579|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541580|NCT01858155|Melatonin|melatonin|mesh-list
20541581|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
20541582|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541583|NCT01858155|Protective Agents|protective agents|mesh-ancestor
20541584|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541585|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541586|NCT01858168|Irinotecan|irinotecan|mesh-list
20541587|NCT01858168|Temozolomide|temozolomide|mesh-list
20541588|NCT01858168|Olaparib|olaparib|mesh-list
20541589|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20541590|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541591|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541592|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541593|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541594|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20541595|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
20541596|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19925321|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19925322|NCT01303627|Remifentanil|remifentanil|mesh-list
19925323|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19925324|NCT01303627|Narcotics|narcotics|mesh-ancestor
19925325|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925326|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925327|NCT01303627|Analgesics|analgesics|mesh-ancestor
19925328|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
19925329|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925330|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
19925331|NCT01303744|Analgesics|analgesics|mesh-ancestor
20541597|NCT01858207|Doxorubicin|doxorubicin|mesh-list
19925332|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
19925333|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925334|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925335|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19925336|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19925337|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925338|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925339|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19925340|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925341|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925342|NCT01303835|Naltrexone|naltrexone|mesh-list
19925343|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19925344|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19925345|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925346|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
19925347|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925348|NCT01303861|Bupropion|bupropion|mesh-list
19925349|NCT01303861|Nicotine|nicotine|mesh-list
19925350|NCT01303861|Varenicline|varenicline|mesh-list
19925351|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19925352|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
19925353|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925354|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925355|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19925356|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19925357|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
19925358|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925359|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925360|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19925361|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
19925362|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19925363|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19925364|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19925365|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925366|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
19925367|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19925368|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19925369|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925370|NCT01303965|Sirolimus|sirolimus|mesh-list
19925371|NCT01303965|Lenalidomide|lenalidomide|mesh-list
19925372|NCT01303965|Tacrolimus|tacrolimus|mesh-list
19925373|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19925374|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
19925375|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925376|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19925377|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925378|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925379|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19925380|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19925381|NCT01303965|Growth Substances|growth substances|mesh-ancestor
20262645|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925382|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
19925383|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925384|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19925385|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925386|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19925387|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
20262646|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925388|NCT01304082|Lidocaine|lidocaine|mesh-list
19925389|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
19925390|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
19925391|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925392|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925393|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
19925394|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925395|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19925396|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19925397|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19925398|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925399|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925400|NCT01304147|Ketamine|ketamine|mesh-list
19925401|NCT01304147|Analgesics|analgesics|mesh-ancestor
19925402|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
19925403|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925404|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925405|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19925406|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19925407|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
19925408|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
19925409|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925410|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19925411|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19925412|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925413|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925414|NCT01304238|PENTA|penta|mesh-list
19925415|NCT01304238|Lepirudin|lepirudin|mesh-list
19925416|NCT01304238|Danaparoid|danaparoid|mesh-list
19925417|NCT01304238|Fondaparinux|fondaparinux|mesh-list
19925418|NCT01304238|Argatroban|argatroban|mesh-list
19925419|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19925420|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
19925421|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19925422|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
19925423|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925424|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925425|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
19925426|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19925427|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19925428|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19925429|NCT01304329|Empagliflozin|empagliflozin|mesh-list
19925430|NCT01304329|Simvastatin|simvastatin|mesh-list
19925431|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19925432|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19925433|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
19925434|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925435|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19925436|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19925437|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925438|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19925439|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925440|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925441|NCT01304407|Calcium|calcium|mesh-list
19925442|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19925443|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925444|NCT01304498|Vaccines|vaccines|mesh-list
19925445|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
19925446|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925447|NCT01304589|Milnacipran|milnacipran|mesh-list
19925448|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
19925449|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19925450|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19925451|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925452|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925453|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925454|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925455|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19925456|NCT01304589|Analgesics|analgesics|mesh-ancestor
19925457|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
19925458|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925459|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
19925460|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19925461|NCT01304641|Atorvastatin|atorvastatin|mesh-list
19925462|NCT01304641|Simvastatin|simvastatin|mesh-list
19925463|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19925464|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19925465|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
19925466|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925467|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19925468|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19925469|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925470|NCT01304693|Ranibizumab|ranibizumab|mesh-list
19925471|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19925472|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19925473|NCT01304693|Growth Substances|growth substances|mesh-ancestor
19925474|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925475|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
19925476|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925477|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
19925478|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925479|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
19925480|NCT01304706|Hormones|hormones|mesh-ancestor
19925481|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925482|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925483|NCT01305200|Calcium|calcium|mesh-list
19925484|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19925485|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925486|NCT01305213|Bevacizumab|bevacizumab|mesh-list
19925487|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19925488|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
19925489|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
19925490|NCT01305213|Antibodies|antibodies|mesh-list
19925491|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
19925492|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19925493|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
19925494|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925495|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19925496|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19925497|NCT01305213|Growth Substances|growth substances|mesh-ancestor
19925498|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262647|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262648|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20262649|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
20262650|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262651|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262652|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
20262653|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20262654|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262655|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
20262656|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
20262657|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20262658|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20262659|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262660|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20262661|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925499|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
19925500|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
19925501|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19925502|NCT01305239|Exemestane|exemestane|mesh-list
19925503|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925504|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19925505|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19925506|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925507|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925508|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19925509|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
19925510|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925511|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925512|NCT01305252|Treprostinil|treprostinil|mesh-list
19925513|NCT01305252|Tadalafil|tadalafil|mesh-list
19925514|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
19925515|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19925516|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19925517|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925518|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925519|NCT01305252|Urological Agents|urological agents|mesh-ancestor
19925520|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19925521|NCT01305408|Modafinil|modafinil|mesh-list
19925522|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19925523|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925524|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19925525|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19925526|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19925527|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925528|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
19925529|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19925530|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19925531|NCT01305772|Panitumumab|panitumumab|mesh-list
19925532|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262662|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
20262663|NCT00502541|Hormones|hormones|mesh-ancestor
19925533|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925534|NCT01305941|Trastuzumab|trastuzumab|mesh-list
19925535|NCT01305941|Everolimus|everolimus|mesh-list
19925536|NCT01305941|Vinorelbine|vinorelbine|mesh-list
19925537|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925538|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925539|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19925540|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
19925541|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925542|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19925543|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
20262664|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262665|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262666|NCT00502567|Leucovorin|leucovorin|mesh-list
20262667|NCT00502567|Docetaxel|docetaxel|mesh-list
20262668|NCT00502567|Fluorouracil|fluorouracil|mesh-list
20262669|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
20262670|NCT00502567|Irinotecan|irinotecan|mesh-list
20262671|NCT00502567|Pemetrexed|pemetrexed|mesh-list
20262672|NCT00502567|Cetuximab|cetuximab|mesh-list
20262673|NCT00502567|Cediranib|cediranib|mesh-list
20262674|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262675|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
20262676|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
20262677|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
20262678|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262679|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
20262680|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262681|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262682|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
20262683|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262684|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20262685|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262686|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262687|NCT00502567|Antidotes|antidotes|mesh-ancestor
20262688|NCT00502567|Protective Agents|protective agents|mesh-ancestor
20262689|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
20262690|NCT00502567|Vitamins|vitamins|mesh-ancestor
20262691|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
20262692|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20262693|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20262694|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262695|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262696|NCT00502658|Vitamins|vitamins|mesh-list
20262697|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
20262698|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262699|NCT00502684|Etodolac|etodolac|mesh-list
20262700|NCT00502684|Propranolol|propranolol|mesh-list
20262701|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20262702|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20262703|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
20262704|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262705|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262706|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262707|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20262708|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20262709|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
20262710|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262711|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19925544|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
19925545|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
19925546|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925547|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
19925548|NCT01306032|Veliparib|veliparib|mesh-list
19925549|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262712|NCT00502684|Analgesics|analgesics|mesh-ancestor
20262713|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
20541598|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20541599|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541600|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20541601|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19732452|NCT04574141|Melatonin|melatonin|mesh-list
19732453|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
19732454|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732455|NCT04574141|Protective Agents|protective agents|mesh-ancestor
19732456|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732457|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925550|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
19925551|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925552|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925553|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19925554|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
19925555|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925556|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925557|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19925558|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19925559|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925560|NCT01306058|Sorafenib|sorafenib|mesh-list
19925561|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925562|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19925563|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925564|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925565|NCT01306162|Dronedarone|dronedarone|mesh-list
19925566|NCT01306162|Dabigatran|dabigatran|mesh-list
19925567|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
19925568|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19925569|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
19925570|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925571|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925572|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
19925573|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19925574|NCT01306175|Empagliflozin|empagliflozin|mesh-list
19925575|NCT01306175|Digoxin|digoxin|mesh-list
19925576|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19925577|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19925578|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925579|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925580|NCT01306175|Protective Agents|protective agents|mesh-ancestor
19925581|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925582|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19925583|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925584|NCT01306214|Empagliflozin|empagliflozin|mesh-list
19925585|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19925586|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925587|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19925588|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972883|NCT01816243|Narcotics|narcotics|mesh-ancestor
19972884|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972885|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972886|NCT01816243|Analgesics|analgesics|mesh-ancestor
19972887|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
19972888|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972889|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19972890|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19972891|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
19972892|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
19972893|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
19972894|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19972895|NCT01816295|Testosterone|testosterone|mesh-list
19972896|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
19972897|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
19972898|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19972899|NCT01816295|Androgens|androgens|mesh-ancestor
19972900|NCT01816295|Hormones|hormones|mesh-ancestor
19972901|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972902|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972903|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19972904|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972905|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
19972906|NCT01816477|Ropivacaine|ropivacaine|mesh-list
19972907|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
19972908|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
19972909|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19972910|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972911|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
19972912|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262714|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972913|NCT01816594|Paclitaxel|paclitaxel|mesh-list
19972914|NCT01816594|Trastuzumab|trastuzumab|mesh-list
19972915|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19972916|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925589|NCT01306331|Nonoxynol|nonoxynol|mesh-list
19925590|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
19925591|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19925592|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925593|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19925594|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
19925595|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19925596|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19925597|NCT01306617|Ritonavir|ritonavir|mesh-list
19925598|NCT01306617|Ribavirin|ribavirin|mesh-list
19925599|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19925600|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19925601|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
19925602|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925603|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925604|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19925605|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19925606|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
19925607|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925608|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19925609|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19925610|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
19925611|NCT01306643|Idelalisib|idelalisib|mesh-list
19925612|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925613|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925614|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925615|NCT01306656|Vitamin D|vitamin d|mesh-list
19925616|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
19925617|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
19925618|NCT01306656|Vitamins|vitamins|mesh-list
19925619|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
19925620|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925621|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19925622|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19925623|NCT01306942|Paclitaxel|paclitaxel|mesh-list
19925624|NCT01306942|Trastuzumab|trastuzumab|mesh-list
19925625|NCT01306942|Dasatinib|dasatinib|mesh-list
19925626|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19925627|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925628|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
19925629|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
19925630|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
19925631|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925632|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925633|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19925634|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925635|NCT01307007|Dextrans|dextrans|mesh-list
19925636|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
19925637|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
19925638|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
19925639|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
19925640|NCT01307007|Hematinics|hematinics|mesh-ancestor
19925641|NCT01307020|Ibuprofen|ibuprofen|mesh-list
19925642|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19925643|NCT01307020|Ketoprofen|ketoprofen|mesh-list
19925644|NCT01307020|Tramadol|tramadol|mesh-list
19925645|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19925646|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19925647|NCT01307020|Analgesics|analgesics|mesh-ancestor
19925648|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
19925649|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925650|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925651|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925652|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925653|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19925654|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925655|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925656|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19925657|NCT01307020|Narcotics|narcotics|mesh-ancestor
19925658|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925659|NCT01307111|Misoprostol|misoprostol|mesh-list
19925660|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19925661|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
19925662|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19925663|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925664|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19925665|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19925666|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
19925667|NCT01307267|Rituximab|rituximab|mesh-list
19925668|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19925669|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
19925670|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925671|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925672|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
19925673|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925674|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925675|NCT01307319|Beclomethasone|beclomethasone|mesh-list
19925676|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925677|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
19925678|NCT01307319|Hormones|hormones|mesh-ancestor
19925679|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925680|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925681|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19925682|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541602|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925683|NCT01307397|Vemurafenib|vemurafenib|mesh-list
19925684|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925685|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19925686|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925687|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925688|NCT01307423|Thalidomide|thalidomide|mesh-list
19925689|NCT01307423|Apremilast|apremilast|mesh-list
19925690|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19925691|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19925692|NCT01307423|Analgesics|analgesics|mesh-ancestor
19925693|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
19925694|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925695|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925696|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925697|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925698|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19925699|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19925700|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925701|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925702|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19925703|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
19925704|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
19925705|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19925706|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925707|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19925708|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19925709|NCT01307423|Growth Substances|growth substances|mesh-ancestor
19925710|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
19925711|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925712|NCT01307449|Vaccines|vaccines|mesh-list
19925713|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19925714|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
19925715|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925716|NCT01307462|Fluticasone|fluticasone|mesh-list
19925717|NCT01307462|Xhance|xhance|mesh-list
19925718|NCT01307462|Azithromycin|azithromycin|mesh-list
19925719|NCT01307462|Montelukast|montelukast|mesh-list
19925720|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925721|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19925722|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
19925723|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925724|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925725|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19925726|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
19925727|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
19925728|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19925729|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19925730|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925731|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19925732|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
19925733|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925734|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19925735|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19925736|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925737|NCT01307579|Fluconazole|fluconazole|mesh-list
19925738|NCT01307579|Caspofungin|caspofungin|mesh-list
19925739|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
19925740|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925741|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19925742|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19925743|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925744|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925745|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19925746|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
19925747|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925748|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925749|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19925750|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19925751|NCT01307618|Interleukin-12|interleukin-12|mesh-list
19925752|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19925753|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
19925754|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925755|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19925756|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19925757|NCT01307618|Growth Substances|growth substances|mesh-ancestor
19925758|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
19925759|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925760|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19925761|NCT01307891|Paclitaxel|paclitaxel|mesh-list
19925762|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925763|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19925764|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
19925765|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
19925766|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
19925767|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925768|NCT01307930|Anidulafungin|anidulafungin|mesh-list
19925769|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
19925770|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925771|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
19925772|NCT01307956|Leucovorin|leucovorin|mesh-list
19925773|NCT01307956|Folic Acid|folic acid|mesh-list
19925774|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19925775|NCT01307956|Panitumumab|panitumumab|mesh-list
19925776|NCT01307956|Fluorouracil|fluorouracil|mesh-list
19925777|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
19925778|NCT01307956|Antibodies|antibodies|mesh-list
19925779|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
19925780|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19925781|NCT01307956|Calcium|calcium|mesh-list
19925782|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
19925783|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
19925784|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925785|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925786|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19925787|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19925788|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
19925789|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925790|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19925791|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19925792|NCT01307956|Antidotes|antidotes|mesh-ancestor
19925793|NCT01307956|Protective Agents|protective agents|mesh-ancestor
19925794|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
19925795|NCT01307956|Vitamins|vitamins|mesh-ancestor
19925796|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
19925797|NCT01307956|Hematinics|hematinics|mesh-ancestor
19925798|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
19925799|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19925800|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19925801|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19925802|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925803|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925804|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
19925805|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925806|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925807|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19925808|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925809|NCT01308294|Vaccines|vaccines|mesh-list
19925810|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
19925811|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925812|NCT01308567|Prednisone|prednisone|mesh-list
19925813|NCT01308567|Docetaxel|docetaxel|mesh-list
19925814|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925815|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
19925816|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
19925817|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
20262715|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262716|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262717|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20262718|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20262719|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262720|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
20262721|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20262722|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262723|NCT00502762|Topotecan|topotecan|mesh-list
20262724|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20262725|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262726|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262727|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262728|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262729|NCT00502788|Ribavirin|ribavirin|mesh-list
20262730|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20262731|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
20262732|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262733|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
20262734|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262735|NCT00502879|Etanercept|etanercept|mesh-list
20262736|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262737|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20262738|NCT00502879|Analgesics|analgesics|mesh-ancestor
20262739|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
20262740|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262741|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262742|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262743|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262744|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262745|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262746|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
20262747|NCT00502892|Carboplatin|carboplatin|mesh-list
20262748|NCT00502892|Topotecan|topotecan|mesh-list
20262749|NCT00502892|Ifosfamide|ifosfamide|mesh-list
20262750|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262751|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20262752|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262753|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262754|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262755|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20262756|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
20287089|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287090|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287091|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
20287092|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20287093|NCT05332470|Lamivudine|lamivudine|mesh-list
20287094|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20287095|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20287096|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287097|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287098|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
20287099|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287100|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20287101|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20288562|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20288563|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20288564|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
20288565|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288566|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20288567|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19925818|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925819|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925820|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
19925821|NCT01308567|Hormones|hormones|mesh-ancestor
19925822|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925823|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288568|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925824|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19925825|NCT01308580|Prednisone|prednisone|mesh-list
20262757|NCT00502970|Interferons|interferons|mesh-list
20541603|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541604|NCT01858311|Tocotrienols|tocotrienols|mesh-list
20541605|NCT01858311|Vitamin E|vitamin e|mesh-list
20541606|NCT01858311|Tocopherols|tocopherols|mesh-list
20541607|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
20541608|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541609|NCT01858311|Protective Agents|protective agents|mesh-ancestor
20541610|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925826|NCT01308580|Prednisolone|prednisolone|mesh-list
19925827|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925828|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
19925829|NCT01308580|Hormones|hormones|mesh-ancestor
19925830|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925831|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925832|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19925833|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925834|NCT01308619|Doxycycline|doxycycline|mesh-list
20541611|NCT01858311|Vitamins|vitamins|mesh-ancestor
20541612|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
20541613|NCT01858402|Acetaminophen|acetaminophen|mesh-list
20541614|NCT01858402|Dipyrone|dipyrone|mesh-list
20541615|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541616|NCT01858402|Analgesics|analgesics|mesh-ancestor
20541617|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
20541618|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541619|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541620|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
20541621|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20541622|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541623|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541624|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
20541625|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541626|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20541627|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541628|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541629|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
20541630|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541631|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541632|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20541633|NCT01858571|Thalidomide|thalidomide|mesh-list
20541634|NCT01858571|Celecoxib|celecoxib|mesh-list
20541635|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
20541636|NCT01858571|Etoposide|etoposide|mesh-list
20541637|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541638|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
20541639|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541640|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541641|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20541642|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
20541643|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541644|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541645|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20541646|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20541647|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20541648|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541649|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541650|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20541651|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541652|NCT01858571|Analgesics|analgesics|mesh-ancestor
19925835|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19925836|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262758|NCT00502970|Ribavirin|ribavirin|mesh-list
20262759|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
20262760|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262761|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
20262762|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262763|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
20262764|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262765|NCT00502970|Hematinics|hematinics|mesh-ancestor
20262766|NCT00503126|Bivalirudin|bivalirudin|mesh-list
20262767|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
20262768|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20262769|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
20262770|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925837|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
19925838|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19925839|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19925840|NCT01308736|Varenicline|varenicline|mesh-list
19925841|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19925842|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19925843|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
19925844|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925845|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925846|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925847|NCT01308749|Oxytocin|oxytocin|mesh-list
19925848|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
19925849|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19925850|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925851|NCT01308814|Estradiol|estradiol|mesh-list
19925852|NCT01308814|Estrogens|estrogens|mesh-ancestor
19925853|NCT01308814|Hormones|hormones|mesh-ancestor
19925854|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925855|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925856|NCT01308840|Gemcitabine|gemcitabine|mesh-list
19925857|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
19925858|NCT01308840|Panitumumab|panitumumab|mesh-list
19925859|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19925860|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
19925861|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925862|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925863|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
19925864|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925865|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925866|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19925867|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
19925868|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925869|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925870|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19925871|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19925872|NCT01309204|Brinzolamide|brinzolamide|mesh-list
19925873|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19925874|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19925875|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19925876|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19925877|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19925878|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
19925879|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925880|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925881|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925882|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19925883|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925884|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19925885|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19925886|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19925887|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925888|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925889|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
19925890|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19925891|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19925892|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19925893|NCT01309360|Midazolam|midazolam|mesh-list
19925894|NCT01309360|Prilocaine|prilocaine|mesh-list
19925895|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19925896|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20262771|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262772|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
19925897|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925898|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925899|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19925900|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19925901|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19925902|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19925903|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
19925904|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
19925905|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
19925906|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
19925907|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925908|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925909|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
19925910|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
19925911|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925912|NCT01309386|Morphine|morphine|mesh-list
19925913|NCT01309386|Tapentadol|tapentadol|mesh-list
19925914|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19925915|NCT01309386|Narcotics|narcotics|mesh-ancestor
19925916|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19925917|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925918|NCT01309386|Analgesics|analgesics|mesh-ancestor
19925919|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
19925920|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925921|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19925922|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19925923|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925924|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925925|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
19925926|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925927|NCT01309451|Dexamethasone|dexamethasone|mesh-list
19925928|NCT01309451|Bevacizumab|bevacizumab|mesh-list
19925929|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925930|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925931|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19925932|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19925933|NCT01309451|Growth Substances|growth substances|mesh-ancestor
19925934|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925935|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
19925936|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19925937|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
19925938|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
19925939|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925940|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19925941|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
19925942|NCT01309451|Hormones|hormones|mesh-ancestor
19925943|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19925944|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19925945|NCT01309659|Iron|iron|mesh-list
19925946|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19925947|NCT01309659|Trace Elements|trace elements|mesh-ancestor
19925948|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
19925949|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925950|NCT01309659|Hematinics|hematinics|mesh-ancestor
19925951|NCT01309737|Tofacitinib|tofacitinib|mesh-list
20262773|NCT00503152|Valsartan|valsartan|mesh-list
20262774|NCT00503152|Benazepril|benazepril|mesh-list
20262775|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20262776|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20262777|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20262778|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262779|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20262780|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
20262781|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262782|NCT00503204|Cediranib|cediranib|mesh-list
20262783|NCT00503204|Lomustine|lomustine|mesh-list
19925952|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19925953|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925954|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925955|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
20262784|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262785|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262786|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262787|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262788|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20262789|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
19925956|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20262790|NCT00503243|Mesalamine|mesalamine|mesh-list
19925957|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19925958|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19925959|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925960|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925961|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
19925962|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19925963|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925964|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19925965|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925966|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19925967|NCT01309828|Olmesartan|olmesartan|mesh-list
19925968|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19925969|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
19925970|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19925971|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19925972|NCT01309828|Diuretics|diuretics|mesh-ancestor
19925973|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
19925974|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925975|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19925976|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19925977|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925978|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20262791|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262792|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20262793|NCT00503243|Analgesics|analgesics|mesh-ancestor
20262794|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
20262795|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262796|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262797|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262798|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262799|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
20541653|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
20541654|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541655|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541656|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20541657|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20541658|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
20541659|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20541660|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541661|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19925979|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19925980|NCT01309841|Naloxegol|naloxegol|mesh-list
19925981|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19925982|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925983|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
19925984|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19925985|NCT01309997|Rituximab|rituximab|mesh-list
19925986|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
19925987|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19925988|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925989|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
19925990|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19925991|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19925992|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19925993|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925994|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19925995|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19925996|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19925997|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19925998|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19925999|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926000|NCT01310127|Nepafenac|nepafenac|mesh-list
19926001|NCT01310127|Bromfenac|bromfenac|mesh-list
19926002|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19926003|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19926004|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19926005|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19926006|NCT01310127|Analgesics|analgesics|mesh-ancestor
19926007|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
19926008|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926009|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926010|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926011|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926012|NCT01310179|Fludarabine|fludarabine|mesh-list
19926013|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
19926014|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926015|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19926016|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
19926017|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926018|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926019|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
19972917|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
19926020|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926021|NCT01310231|Metformin|metformin|mesh-list
19926022|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926023|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926024|NCT01310582|Sevoflurane|sevoflurane|mesh-list
19926025|NCT01310582|Desflurane|desflurane|mesh-list
19926026|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20262800|NCT00503321|Tegafur|tegafur|mesh-list
20262801|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262802|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
20262803|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262804|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262805|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20262806|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
20262807|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262808|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20262809|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
20262810|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262811|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
20262812|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20262813|NCT00503321|Protective Agents|protective agents|mesh-ancestor
20262814|NCT00503347|Bavituximab|bavituximab|mesh-list
20262815|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20262816|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262817|NCT00503386|Palonosetron|palonosetron|mesh-list
20262818|NCT00503386|Granisetron|granisetron|mesh-list
20262819|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
20262820|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
20262821|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262822|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262823|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262824|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20262825|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20262826|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
20262827|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262828|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262829|NCT00503412|Cediranib|cediranib|mesh-list
20262830|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262831|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20541662|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20541663|NCT01858571|Growth Substances|growth substances|mesh-ancestor
20541664|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
20554040|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20554041|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20554042|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554043|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554044|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20554045|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554046|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554047|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
20554048|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20554049|NCT01932580|Docetaxel|docetaxel|mesh-list
20554050|NCT01932580|Fluorouracil|fluorouracil|mesh-list
20554051|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
20554052|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554053|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
20554054|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
20554055|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
20554056|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554057|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
20554058|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20554059|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554060|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
20554061|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555034|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20555035|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555036|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555037|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555038|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
20555039|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555040|NCT01938417|Tobramycin|tobramycin|mesh-list
20555041|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926027|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20262832|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287102|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
19926028|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
19926029|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
19926030|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19926031|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926032|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19926033|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19926034|NCT01310777|Brinzolamide|brinzolamide|mesh-list
19926035|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19926036|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19926037|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19926038|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19926039|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19926040|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
19926041|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926042|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926043|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926044|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19926045|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926046|NCT01310855|Gefitinib|gefitinib|mesh-list
19926047|NCT01310855|Cediranib|cediranib|mesh-list
19926048|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926049|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926050|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926051|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19926052|NCT01310868|Carmustine|carmustine|mesh-list
19926053|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19926054|NCT01310868|Levulinic acid|levulinic acid|mesh-list
19926055|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19926056|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
19926057|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926058|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926059|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926060|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19926061|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926062|NCT01311024|Vaccines|vaccines|mesh-list
19926063|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
19926064|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926065|NCT01311102|Lidocaine|lidocaine|mesh-list
19926066|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
19926067|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
19926068|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19926069|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926070|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
19926071|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926072|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19926073|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19926074|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19926075|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926076|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926077|NCT01311505|Rifampin|rifampin|mesh-list
19926078|NCT01311505|Isoniazid|isoniazid|mesh-list
19926079|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19926080|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
19926081|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926082|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926083|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
19926084|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19926085|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926086|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926087|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19926088|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19926089|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19926090|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19926091|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19926092|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20262833|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262834|NCT00503451|Panobinostat|panobinostat|mesh-list
20262835|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262836|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20262837|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288569|NCT05304663|Lomustine|lomustine|mesh-list
19926093|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19926094|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19926095|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
19926096|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19926097|NCT01311648|Factor VIII|factor viii|mesh-list
19926098|NCT01311648|Coagulants|coagulants|mesh-ancestor
19926099|NCT01311661|Olodaterol|olodaterol|mesh-list
19926100|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926101|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
19926102|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926103|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926104|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926105|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926106|NCT01311674|Vaccines|vaccines|mesh-list
19926107|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
19926108|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926109|NCT01311687|Dexamethasone|dexamethasone|mesh-list
19926110|NCT01311687|Pomalidomide|pomalidomide|mesh-list
19926111|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926112|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
19926113|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
19926114|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926115|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926116|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926117|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
19926118|NCT01311687|Hormones|hormones|mesh-ancestor
19926119|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926120|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19926121|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926122|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
19926123|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19926124|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19926125|NCT01311687|Growth Substances|growth substances|mesh-ancestor
19926126|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
19926127|NCT01311895|Hydromorphone|hydromorphone|mesh-list
19926128|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19926129|NCT01311895|Narcotics|narcotics|mesh-ancestor
19926130|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19926131|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926132|NCT01311895|Analgesics|analgesics|mesh-ancestor
19926133|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
19926134|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926135|NCT01312038|Simethicone|simethicone|mesh-list
19926136|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
19926137|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926138|NCT01312038|Emollients|emollients|mesh-ancestor
19926139|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926140|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
19926141|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926142|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19926143|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19926144|NCT01312129|Analgesics|analgesics|mesh-ancestor
19926145|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
19926146|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926147|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926148|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926149|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926150|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926151|NCT01312272|Oxytocin|oxytocin|mesh-list
19926152|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
19926153|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19926154|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926155|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19926156|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
19926157|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926158|NCT01312467|Metformin|metformin|mesh-list
19926159|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926160|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926161|NCT01312766|Menotropins|menotropins|mesh-list
19926162|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19926163|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
19926164|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19926165|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926166|NCT01312818|Dexamethasone|dexamethasone|mesh-list
19926167|NCT01312818|Methotrexate|methotrexate|mesh-list
19926168|NCT01312818|Bortezomib|bortezomib|mesh-list
19926169|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
19926170|NCT01312818|Vorinostat|vorinostat|mesh-list
19926171|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926172|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
19926173|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
19926174|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926175|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262838|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262839|NCT00503477|Cediranib|cediranib|mesh-list
20262840|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262841|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262842|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262843|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926176|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926177|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
19926178|NCT01312818|Hormones|hormones|mesh-ancestor
19926179|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926180|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19926181|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926182|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19926183|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
20262844|NCT00503490|Levofloxacin|levofloxacin|mesh-list
20262845|NCT00503490|Ofloxacin|ofloxacin|mesh-list
20262846|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20262847|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262848|NCT00503490|Renal Agents|renal agents|mesh-ancestor
20262849|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20262850|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20262851|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20262852|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262853|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262854|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262855|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20262856|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20262857|NCT00503503|Etanercept|etanercept|mesh-list
20262858|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262859|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20262860|NCT00503503|Analgesics|analgesics|mesh-ancestor
20262861|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
20262862|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262863|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262864|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262865|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262866|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262867|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262868|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
20262869|NCT00503516|Megestrol|megestrol|mesh-list
20262870|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
20262871|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20262872|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20262873|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20262874|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
19926184|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19926185|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19926186|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
19926187|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926188|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926189|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926190|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19926191|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926192|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
19926193|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926194|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19926195|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19926196|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19972918|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
19972919|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
19972920|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972921|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19972922|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19972923|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972924|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19972925|NCT01816984|Cetuximab|cetuximab|mesh-list
19972926|NCT01816984|Antibodies|antibodies|mesh-list
19972927|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
19972928|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19972929|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
19926197|NCT01312844|Scopolamine|scopolamine|mesh-list
19926198|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19926199|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19926200|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
19926201|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
20262875|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20262876|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262877|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20262878|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20262879|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20262880|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262881|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
20262882|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20262883|NCT00503542|Metronidazole|metronidazole|mesh-list
20262884|NCT00503542|Clindamycin|clindamycin|mesh-list
20262885|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
20262886|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
20262887|NCT00503542|Fluconazole|fluconazole|mesh-list
20262888|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20262889|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20262890|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20262891|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20262892|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20262893|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262894|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262895|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
20262896|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20262897|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20262898|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20262899|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
20262900|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20262901|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262902|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20262903|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20262904|NCT00503568|Vaccines|vaccines|mesh-list
20262905|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
20262906|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262907|NCT00503594|Cytarabine|cytarabine|mesh-list
20262908|NCT00503594|Methotrexate|methotrexate|mesh-list
20262909|NCT00503594|Vincristine|vincristine|mesh-list
20262910|NCT00503594|Temozolomide|temozolomide|mesh-list
20262911|NCT00503594|Procarbazine|procarbazine|mesh-list
20262912|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20262913|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
20262914|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20262915|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262916|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262917|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
20262918|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262919|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262920|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
20262921|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262922|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20262923|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20262924|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
20262925|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262926|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19926202|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926203|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926204|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262927|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
20262928|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926205|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
19926206|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19926207|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926208|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926209|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926210|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19926211|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
19926212|NCT01312909|Varenicline|varenicline|mesh-list
19926213|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19926214|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19926215|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926216|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926217|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926218|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926219|NCT01312961|Fluticasone|fluticasone|mesh-list
19926220|NCT01312961|Xhance|xhance|mesh-list
19926221|NCT01312961|Albuterol|albuterol|mesh-list
19926222|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19926223|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19926224|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19926225|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926226|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926227|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
19926228|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926229|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926230|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926231|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926232|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926233|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19926234|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19926235|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19926236|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19926237|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
19926238|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926239|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926240|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
19926241|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19926242|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
19926243|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
19926244|NCT01312961|Hormones|hormones|mesh-ancestor
19926245|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926246|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
19926247|NCT01313078|Asparaginase|asparaginase|mesh-list
19926248|NCT01313078|Pegaspargase|pegaspargase|mesh-list
19926249|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926250|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
19926251|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
19926252|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926253|NCT01313117|Protective Agents|protective agents|mesh-ancestor
19926254|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926255|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
19926256|NCT01313117|Vitamins|vitamins|mesh-ancestor
19926257|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
19926258|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
19926259|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19926260|NCT01313182|Mupirocin|mupirocin|mesh-list
19926261|NCT01313182|Povidone|povidone|mesh-list
19926262|NCT01313182|Calcium|calcium|mesh-list
19926263|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19926264|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926265|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
19926266|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
19926267|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926268|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926269|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19926270|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926271|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926272|NCT01313208|Etanercept|etanercept|mesh-list
19926273|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19926274|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19926275|NCT01313208|Analgesics|analgesics|mesh-ancestor
19926276|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
19926277|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926278|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926279|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926280|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926281|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926282|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926283|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
19926284|NCT01313221|Etanercept|etanercept|mesh-list
19926285|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19926286|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19926287|NCT01313221|Analgesics|analgesics|mesh-ancestor
19926288|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
19926289|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541665|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19926290|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926291|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926292|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926293|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262929|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20262930|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
20541666|NCT01858610|Irbesartan|irbesartan|mesh-list
19926294|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926295|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
19926296|NCT01313286|Globalagliatin|globalagliatin|mesh-list
19926297|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
19926298|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926299|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
19926300|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19926301|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19926302|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19926303|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926304|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926305|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
20262931|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
20262932|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
20541667|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20541668|NCT01858610|Diuretics|diuretics|mesh-ancestor
20541669|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
20541670|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541671|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20541672|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541673|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541674|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20541675|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20541676|NCT01858623|Losartan|losartan|mesh-list
20541677|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20541678|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20541679|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20541680|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20541681|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20541682|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541683|NCT01858623|Diuretics|diuretics|mesh-ancestor
20541684|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
20541685|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541686|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20541687|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541688|NCT01858649|Bevacizumab|bevacizumab|mesh-list
20541689|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
20541690|NCT01858649|Irinotecan|irinotecan|mesh-list
20541691|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541692|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541693|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20541694|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20541695|NCT01858649|Growth Substances|growth substances|mesh-ancestor
20541696|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541697|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
20541698|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20541699|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541700|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541701|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541702|NCT01858662|Leucovorin|leucovorin|mesh-list
20541703|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
20541704|NCT01858662|Irinotecan|irinotecan|mesh-list
20541705|NCT01858662|Cetuximab|cetuximab|mesh-list
20541706|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541707|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20541708|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541709|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541710|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541711|NCT01858662|Antidotes|antidotes|mesh-ancestor
20262933|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20262934|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
20262935|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20262936|NCT00503607|Laxatives|laxatives|mesh-ancestor
20262937|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262938|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
20262939|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20262940|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20262941|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20262942|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926306|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926307|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926308|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19926309|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926310|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
19926311|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19926312|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19926313|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19926314|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926315|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926316|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926317|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926318|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926319|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19926320|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926321|NCT01313494|Albuterol|albuterol|mesh-list
19926322|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926323|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
19926324|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926325|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926326|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926327|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926328|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
19926329|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19926330|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19926331|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19926332|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19926333|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
19926334|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926335|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926336|NCT01313520|Infliximab|infliximab|mesh-list
19926337|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926338|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926339|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926340|NCT01313559|Everolimus|everolimus|mesh-list
19926341|NCT01313559|Pasireotide|pasireotide|mesh-list
19926342|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926343|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926344|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
19926345|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926346|NCT01313559|Hormones|hormones|mesh-ancestor
19926347|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926348|NCT01313637|Bromides|bromides|mesh-list
19926349|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
19926350|NCT01313663|Pemetrexed|pemetrexed|mesh-list
19926351|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926352|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926353|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926354|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19926355|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19926356|NCT01313676|Fluticasone|fluticasone|mesh-list
19926357|NCT01313676|Xhance|xhance|mesh-list
19926358|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926359|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926360|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
19926361|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926362|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926363|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926364|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926365|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926366|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19926367|NCT01313728|Dapsone|dapsone|mesh-list
19926368|NCT01313728|Tretinoin|tretinoin|mesh-list
19926369|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926370|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
19926371|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926372|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926373|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
19926374|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19926375|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19926376|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19926377|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926378|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926379|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
19926380|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926381|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
19926382|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19926383|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19926384|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19926385|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926386|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926387|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926388|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926389|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926390|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19926391|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926392|NCT01313780|Oxycodone|oxycodone|mesh-list
19926393|NCT01313780|Naloxone|naloxone|mesh-list
19926394|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19926395|NCT01313780|Narcotics|narcotics|mesh-ancestor
19926396|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19926397|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926398|NCT01313780|Analgesics|analgesics|mesh-ancestor
19926399|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
19926400|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926401|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19926402|NCT01313858|Golimumab|golimumab|mesh-list
19926403|NCT01313858|Methotrexate|methotrexate|mesh-list
19926404|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19926405|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
19926406|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19926407|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926408|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19926409|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
19926410|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926411|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926412|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926413|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926414|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19926415|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926416|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
19926417|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926418|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19926419|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19926420|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926421|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
19926422|NCT01313884|Temozolomide|temozolomide|mesh-list
19926423|NCT01313884|Doxorubicin|doxorubicin|mesh-list
19926424|NCT01313884|Irinotecan|irinotecan|mesh-list
19926425|NCT01313884|Vincristine|vincristine|mesh-list
19926426|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926427|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
19926428|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926429|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926430|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19926431|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
19926432|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926433|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926434|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19926435|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19926436|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19926437|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19926438|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926439|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19926440|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19926441|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
19926442|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
19926443|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
19926444|NCT01313897|Bortezomib|bortezomib|mesh-list
19926445|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926446|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19926447|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926448|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926449|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926450|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19926451|NCT01314001|Nicotine|nicotine|mesh-list
19926452|NCT01314001|Varenicline|varenicline|mesh-list
19926453|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20541712|NCT01858662|Protective Agents|protective agents|mesh-ancestor
19926454|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
19926455|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926456|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926457|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19926458|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19926459|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926460|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926461|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926462|NCT01314105|Carboplatin|carboplatin|mesh-list
19926463|NCT01314105|Nintedanib|nintedanib|mesh-list
19926464|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926465|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19926466|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926467|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926468|NCT01314261|Interferons|interferons|mesh-list
19926469|NCT01314261|Ribavirin|ribavirin|mesh-list
19926470|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926471|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
19926472|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926473|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
19926474|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926475|NCT01314417|Methotrexate|methotrexate|mesh-list
19926476|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19926477|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
20262943|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262944|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
20262945|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262946|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262947|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20262948|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262949|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
20262950|NCT00503659|Miotics|miotics|mesh-ancestor
20262951|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
20262952|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262953|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262954|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20262955|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20262956|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
20262957|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20262958|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20262959|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
20262960|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20262961|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262962|NCT00503763|Simvastatin|simvastatin|mesh-list
20262963|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20262964|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20262965|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
20262966|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262967|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20262968|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20262969|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262970|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20262971|NCT00503815|Laxatives|laxatives|mesh-ancestor
20262972|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20262973|NCT00503828|Naproxen|naproxen|mesh-list
20262974|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20262975|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20262976|NCT00503828|Analgesics|analgesics|mesh-ancestor
20262977|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
20262978|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20262979|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20262980|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20262981|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20262982|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
20262983|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20262984|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262985|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262986|NCT00503932|Capecitabine|capecitabine|mesh-list
20262987|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20262988|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
20262989|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262990|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20262991|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20262992|NCT00503971|Vorinostat|vorinostat|mesh-list
20262993|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541713|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926478|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19926479|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926480|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19926481|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
19926482|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926483|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926484|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926485|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926486|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19926487|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926488|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
19926489|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926490|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19926491|NCT01314443|Vitamin E|vitamin e|mesh-list
19926492|NCT01314443|Tocopherols|tocopherols|mesh-list
19926493|NCT01314443|Tocotrienols|tocotrienols|mesh-list
19926494|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
19926495|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
19926496|NCT01314443|Nicotine|nicotine|mesh-list
19926497|NCT01314443|Vitamins|vitamins|mesh-ancestor
19926498|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
19926499|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926500|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19926501|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
19926502|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926503|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19926504|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19926505|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926506|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926507|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926508|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
19926509|NCT01314443|Protective Agents|protective agents|mesh-ancestor
20262994|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20262995|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20262996|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20262997|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20262998|NCT00504062|Fluticasone|fluticasone|mesh-list
20262999|NCT00504062|Budesonide|budesonide|mesh-list
20263000|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263001|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20263002|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
20263003|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263004|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263005|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20263006|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263007|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
20263008|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20263009|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
20263010|NCT00504062|Hormones|hormones|mesh-ancestor
20263011|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263012|NCT00504101|Bortezomib|bortezomib|mesh-list
20263013|NCT00504101|Melphalan|melphalan|mesh-list
20263014|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
20263015|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263016|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20263017|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
20263018|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263019|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20263020|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263021|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
20263022|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263023|NCT00504127|Naproxen|naproxen|mesh-list
20263024|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
20263025|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20263026|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20263027|NCT00504127|Analgesics|analgesics|mesh-ancestor
20263028|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
20263029|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263030|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263031|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263032|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263033|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
20263034|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20263035|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926510|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19926511|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19926512|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19926513|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926514|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926515|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926516|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926517|NCT01314872|Urological Agents|urological agents|mesh-ancestor
19926518|NCT01314911|Oseltamivir|oseltamivir|mesh-list
19926519|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
19926520|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926521|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926522|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926523|NCT01315002|Nicotine|nicotine|mesh-list
19926524|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19926525|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
19926526|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926527|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926528|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19926529|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19926530|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926531|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926532|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926533|NCT01315158|Fentanyl|fentanyl|mesh-list
19926534|NCT01315158|Midazolam|midazolam|mesh-list
19926535|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
19926536|NCT01315158|Propofol|propofol|mesh-list
19926537|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19926538|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19926539|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926540|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19926541|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
19926542|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
19926543|NCT01315158|Narcotics|narcotics|mesh-ancestor
19926544|NCT01315158|Analgesics|analgesics|mesh-ancestor
19926545|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
19926546|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926547|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19926548|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19926549|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19926550|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19926551|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
19926552|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
19926553|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926554|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926555|NCT01315236|Amikacin|amikacin|mesh-list
19926556|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926557|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926558|NCT01315249|Fluticasone|fluticasone|mesh-list
19926559|NCT01315249|Xhance|xhance|mesh-list
19926560|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
19926561|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19926562|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19926563|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926564|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926565|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
19926566|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926567|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926568|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926569|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926570|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926571|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19926572|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19926573|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19926574|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19926575|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
19926576|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926577|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926578|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19926579|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19926580|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19926581|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926582|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
19926583|NCT01315249|Hormones|hormones|mesh-ancestor
20263036|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926584|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926585|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
19926586|NCT01315574|Travoprost|travoprost|mesh-list
19926587|NCT01315574|Latanoprost|latanoprost|mesh-list
19926588|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19926589|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19926590|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19926591|NCT01315665|Sulforaphane|sulforaphane|mesh-list
19926592|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19926593|NCT01315665|Protective Agents|protective agents|mesh-ancestor
19926594|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926595|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926596|NCT01315678|Tobramycin|tobramycin|mesh-list
19926597|NCT01315678|Amikacin|amikacin|mesh-list
19926598|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926599|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926600|NCT01316042|Metformin|metformin|mesh-list
19926601|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926602|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926603|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
19926604|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19926605|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926606|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926607|NCT01316263|Olaratumab|olaratumab|mesh-list
19926608|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926609|NCT01316276|Amikacin|amikacin|mesh-list
19926610|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926611|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926612|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19926613|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19926614|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19926615|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926616|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926617|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926618|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926619|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
19926620|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19926621|NCT01316341|Empagliflozin|empagliflozin|mesh-list
19926622|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19926623|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926624|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926625|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926626|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
19926627|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926628|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
19926629|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926630|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926631|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926632|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926633|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
19926634|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19926635|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926636|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926637|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926638|NCT01316419|Amlodipine|amlodipine|mesh-list
19926639|NCT01316419|Telmisartan|telmisartan|mesh-list
19926640|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19926641|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19926642|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926643|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926644|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19926645|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926646|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
19926647|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19926648|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19926649|NCT01316770|Dexamethasone|dexamethasone|mesh-list
19926650|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926651|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
19926652|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
19926653|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926654|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926655|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926656|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
19926657|NCT01316770|Hormones|hormones|mesh-ancestor
19926658|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926659|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19926660|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926661|NCT01316900|Bromides|bromides|mesh-list
19926662|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
19926663|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926664|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
19926665|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926666|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926667|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926668|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926669|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
19926670|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19926671|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926672|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926673|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926674|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
19926675|NCT01316913|Bromides|bromides|mesh-list
19926676|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
20263037|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20263038|NCT00504140|Interferons|interferons|mesh-list
20263039|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
20263040|NCT00504140|Etoposide|etoposide|mesh-list
20263041|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20263042|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263043|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20263044|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263045|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263046|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263047|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
20541714|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
20541715|NCT01858662|Vitamins|vitamins|mesh-ancestor
20541716|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
20541717|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541718|NCT01858792|Belimumab|belimumab|mesh-list
20541719|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541720|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
20541721|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541722|NCT01858831|Atovaquone|atovaquone|mesh-list
20541723|NCT01858831|Proguanil|proguanil|mesh-list
20541724|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20541725|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541726|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
20541727|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20541728|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20541729|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541730|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541731|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
20541732|NCT01858870|Lacosamide|lacosamide|mesh-list
20541733|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
20541734|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20541735|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20541736|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541737|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541738|NCT01858909|Melatonin|melatonin|mesh-list
20541739|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
20541740|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541741|NCT01858909|Protective Agents|protective agents|mesh-ancestor
20541742|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541743|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541744|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20541745|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
20541746|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20541747|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20541748|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19732458|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
19732459|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19732460|NCT04573855|Antibodies|antibodies|mesh-list
19732461|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
19732462|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732463|NCT04573803|Phenytoin|phenytoin|mesh-list
19732464|NCT04573803|Levetiracetam|levetiracetam|mesh-list
19732465|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
19732466|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
19732467|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19732468|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19732469|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732470|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926677|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19926678|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
19926679|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926680|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926681|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19926682|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
19926683|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
19926684|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19926685|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
19926686|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926687|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926688|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
19926689|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19926690|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
19926691|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19926692|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926693|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926694|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
19926695|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926696|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19926697|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
19926698|NCT01317472|Lansoprazole|lansoprazole|mesh-list
19926699|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19926700|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926701|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19926702|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926703|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926704|NCT01317550|Minocycline|minocycline|mesh-list
19926705|NCT01317550|Modafinil|modafinil|mesh-list
19926706|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926707|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926708|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19926709|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926710|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19926711|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19926712|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19926713|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926714|NCT01317615|Paclitaxel|paclitaxel|mesh-list
19926715|NCT01317615|Carboplatin|carboplatin|mesh-list
19926716|NCT01317615|Everolimus|everolimus|mesh-list
19926717|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20263048|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263049|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
20263050|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263051|NCT00504192|Gemcitabine|gemcitabine|mesh-list
20263052|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
19926718|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926719|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
19926720|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
19926721|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
20263053|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263054|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
20541749|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541750|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541751|NCT01858961|Interferons|interferons|mesh-list
20541752|NCT01858961|Ribavirin|ribavirin|mesh-list
20541753|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541754|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
20541755|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541756|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
20541757|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541758|NCT01859234|Bevacizumab|bevacizumab|mesh-list
20541759|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20541760|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541761|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541762|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19926722|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926723|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926724|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
19926725|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926726|NCT01317667|Vaccines|vaccines|mesh-list
19926727|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
19926728|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541763|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19926729|NCT01317901|Rituximab|rituximab|mesh-list
19926730|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19926731|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19926732|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926733|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
19926734|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926735|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926736|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19926737|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
19926738|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926739|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
19926740|NCT01317940|Vitamin D|vitamin d|mesh-list
19926741|NCT01317940|Calcitriol|calcitriol|mesh-list
19926742|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19926743|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
19926744|NCT01317940|Calcium|calcium|mesh-list
19926745|NCT01317940|Vitamins|vitamins|mesh-ancestor
19926746|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
19926747|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926748|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19926749|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19926750|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926751|NCT01317940|Antacids|antacids|mesh-ancestor
19926752|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926753|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19926754|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926755|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19926756|NCT01318070|Pioglitazone|pioglitazone|mesh-list
19926757|NCT01318070|Alogliptin|alogliptin|mesh-list
19926758|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926759|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926760|NCT01318070|Incretins|incretins|mesh-ancestor
19926761|NCT01318070|Hormones|hormones|mesh-ancestor
19926762|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926763|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19926764|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
19926765|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926766|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926767|NCT01318083|Glimepiride|glimepiride|mesh-list
19926768|NCT01318083|Alogliptin|alogliptin|mesh-list
19926769|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19926770|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926771|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926772|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926773|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
19926774|NCT01318083|Incretins|incretins|mesh-ancestor
19926775|NCT01318083|Hormones|hormones|mesh-ancestor
19926776|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926777|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19926778|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
19926779|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926780|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926781|NCT01318109|Metformin|metformin|mesh-list
19926782|NCT01318109|Alogliptin|alogliptin|mesh-list
19926783|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926784|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926785|NCT01318109|Incretins|incretins|mesh-ancestor
19926786|NCT01318109|Hormones|hormones|mesh-ancestor
19926787|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926788|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19926789|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
19926790|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926791|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926792|NCT01318122|Pioglitazone|pioglitazone|mesh-list
19926793|NCT01318122|Alogliptin|alogliptin|mesh-list
19926794|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926795|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926796|NCT01318122|Incretins|incretins|mesh-ancestor
19926797|NCT01318122|Hormones|hormones|mesh-ancestor
19926798|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926799|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19926800|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
19926801|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926802|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926803|NCT01318135|Metformin|metformin|mesh-list
19926804|NCT01318135|Glimepiride|glimepiride|mesh-list
19926805|NCT01318135|Alogliptin|alogliptin|mesh-list
19926806|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926807|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926808|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19926809|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926810|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
19926811|NCT01318135|Incretins|incretins|mesh-ancestor
19926812|NCT01318135|Hormones|hormones|mesh-ancestor
19926813|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926814|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19926815|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
19926816|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926817|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926818|NCT01318278|Dopamine|dopamine|mesh-list
19926819|NCT01318278|Vasopressins|vasopressins|mesh-list
19926820|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
19926821|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926822|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
19926823|NCT01318278|Coagulants|coagulants|mesh-ancestor
20263055|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263056|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263057|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
20263058|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263059|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263060|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263061|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
20263062|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263063|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
20263064|NCT00504244|Azathioprine|azathioprine|mesh-list
20263065|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
20263066|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263067|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263068|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263069|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263070|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
20263071|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926824|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19926825|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19926826|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
19926827|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19926828|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
19926829|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
19926830|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926831|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
19926832|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19926833|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926834|NCT01318278|Protective Agents|protective agents|mesh-ancestor
19926835|NCT01318356|Doxycycline|doxycycline|mesh-list
19926836|NCT01318356|Tetracycline|tetracycline|mesh-list
19926837|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926838|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926839|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
19926840|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19926841|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19926842|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19926843|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926844|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926845|NCT01318408|Levetiracetam|levetiracetam|mesh-list
19926846|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
19926847|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
19926848|NCT01318499|Nepafenac|nepafenac|mesh-list
19926849|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19926850|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20263072|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263073|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20263074|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20263075|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
20263076|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20263077|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263078|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263079|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20263080|NCT00504283|Morphine|morphine|mesh-list
20263081|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20263082|NCT00504283|Narcotics|narcotics|mesh-ancestor
19926851|NCT01318499|Analgesics|analgesics|mesh-ancestor
19926852|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
19926853|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926854|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926855|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926856|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972930|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972931|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19972932|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
19972933|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19972934|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19972935|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19972936|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
19972937|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
19972938|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19972939|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19972940|NCT01817530|Norethindrone|norethindrone|mesh-list
19972941|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
19972942|NCT01817530|Estradiol|estradiol|mesh-list
19972943|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19972944|NCT01817530|Estrogens|estrogens|mesh-ancestor
19972945|NCT01817530|Hormones|hormones|mesh-ancestor
19972946|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19972947|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972948|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19972949|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
19972950|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19972951|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19972952|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19972953|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19972954|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19972955|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19972956|NCT01817582|Cyclosporine|cyclosporine|mesh-list
19972957|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19972958|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
19972959|NCT01817582|Cyclosporins|cyclosporins|mesh-list
19972960|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19972961|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972962|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19972963|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
19972964|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263083|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263084|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263085|NCT00504283|Analgesics|analgesics|mesh-ancestor
20263086|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
20263087|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263088|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20263089|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20263090|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263091|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263092|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20263093|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263094|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263095|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20263096|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263097|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263098|NCT00504400|Ranibizumab|ranibizumab|mesh-list
20263099|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20263100|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20263101|NCT00504400|Growth Substances|growth substances|mesh-ancestor
20263102|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263103|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
20263104|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263105|NCT00504413|Digoxin|digoxin|mesh-list
20263106|NCT00504413|Midazolam|midazolam|mesh-list
20263107|NCT00504413|Methadone|methadone|mesh-list
20263108|NCT00504413|Bupropion|bupropion|mesh-list
20263109|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20263110|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20263111|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263112|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263113|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20263114|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20263115|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20263116|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19972965|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
19972966|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926857|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19926858|NCT01318694|Ribavirin|ribavirin|mesh-list
19926859|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19926860|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
19926861|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926862|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
19926863|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926864|NCT01318811|Heparin|heparin|mesh-list
19926865|NCT01318811|Calcium heparin|calcium heparin|mesh-list
19926866|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
19926867|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19926868|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19926869|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926870|NCT01318902|Dexamethasone|dexamethasone|mesh-list
19926871|NCT01318902|Ixazomib|ixazomib|mesh-list
19926872|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926873|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
19926874|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
19926875|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19926876|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926877|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19926878|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
19926879|NCT01318902|Hormones|hormones|mesh-ancestor
19926880|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19926881|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19926882|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926883|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
19926884|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926885|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926886|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
19926887|NCT01318915|Sirolimus|sirolimus|mesh-list
19926888|NCT01318915|Rituximab|rituximab|mesh-list
19926889|NCT01318915|Tacrolimus|tacrolimus|mesh-list
19926890|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
19926891|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19926892|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19926893|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926894|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
19926895|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926896|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926897|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926898|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19926899|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263117|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
20263118|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
19926900|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926901|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19926902|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19926903|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
19926904|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926905|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926906|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
19926907|NCT01318967|Furosemide|furosemide|mesh-list
19926908|NCT01318967|Diuretics|diuretics|mesh-ancestor
19926909|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
19926910|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926911|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19926912|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19926913|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926914|NCT01319045|Iloprost|iloprost|mesh-list
19926915|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19926916|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
19926917|NCT01319110|Ubiquinone|ubiquinone|mesh-list
19926918|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
19926919|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
19926920|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926921|NCT01319110|Vitamins|vitamins|mesh-ancestor
19926922|NCT01319383|Vorinostat|vorinostat|mesh-list
19926923|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926924|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19926925|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926926|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926927|NCT01319422|Pomalidomide|pomalidomide|mesh-list
19926928|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
19926929|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926930|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20263119|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
19926931|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19926932|NCT01319422|Growth Substances|growth substances|mesh-ancestor
19926933|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
19926934|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926935|NCT01319721|Mitomycins|mitomycins|mesh-list
19926936|NCT01319721|Mitomycin|mitomycin|mesh-list
19926937|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19926938|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19926939|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
19926940|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926941|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19926942|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926943|NCT01319773|Cyclosporine|cyclosporine|mesh-list
19926944|NCT01319773|Cyclosporins|cyclosporins|mesh-list
19926945|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926946|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926947|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19926948|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
19926949|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926950|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
19926951|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926952|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926953|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926954|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19926955|NCT01319851|Alefacept|alefacept|mesh-list
19926956|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
19926957|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
19926958|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926959|NCT01319994|Metformin|metformin|mesh-list
19926960|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19926961|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926962|NCT01320033|Doxycycline|doxycycline|mesh-list
19926963|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19926964|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19926965|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
19926966|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19926967|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19926968|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
19926969|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19926970|NCT01320293|Adalimumab|adalimumab|mesh-list
19926971|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19926972|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926973|NCT01320722|Vitamin D|vitamin d|mesh-list
19926974|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
19926975|NCT01320722|Vitamins|vitamins|mesh-list
20263120|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
20263121|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263122|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263123|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20263124|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
20263125|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20263126|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20263127|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263128|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
20263129|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20263130|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20263131|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263132|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20263133|NCT00504413|Narcotics|narcotics|mesh-ancestor
20263134|NCT00504413|Analgesics|analgesics|mesh-ancestor
20263135|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
20263136|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263137|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
20263138|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263139|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20263140|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20263141|NCT00504413|Protective Agents|protective agents|mesh-ancestor
20263142|NCT00504439|Simvastatin|simvastatin|mesh-list
20263143|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20263144|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20263145|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
20263146|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926976|NCT01320722|Allopurinol|allopurinol|mesh-list
19926977|NCT01320722|Probenecid|probenecid|mesh-list
19926978|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
19926979|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926980|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19926981|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19926982|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
19926983|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926984|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19926985|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
19926986|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19926987|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19926988|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
19926989|NCT01320722|Protective Agents|protective agents|mesh-ancestor
19926990|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
19926991|NCT01320722|Renal Agents|renal agents|mesh-ancestor
19926992|NCT01321073|Treprostinil|treprostinil|mesh-list
19926993|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19926994|NCT01321151|Resveratrol|resveratrol|mesh-list
19926995|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
19926996|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19926997|NCT01321151|Protective Agents|protective agents|mesh-ancestor
19926998|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19926999|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927000|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19927001|NCT01321437|Axitinib|axitinib|mesh-list
19927002|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927003|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19927004|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927005|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927006|NCT01321541|Gemcitabine|gemcitabine|mesh-list
19927007|NCT01321541|Rituximab|rituximab|mesh-list
19927008|NCT01321541|Pixantrone|pixantrone|mesh-list
19927009|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19927010|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927011|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
19927012|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927013|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927014|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19927015|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
19927016|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927017|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
19927018|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927019|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927020|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19927021|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19927022|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19927023|NCT01321554|Lenvatinib|lenvatinib|mesh-list
19927024|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927025|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19927026|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927027|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927028|NCT01321710|Acetaminophen|acetaminophen|mesh-list
19927029|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927030|NCT01321710|Analgesics|analgesics|mesh-ancestor
19927031|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
19927032|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927033|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927034|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
19927035|NCT01321723|Teriparatide|teriparatide|mesh-list
19927036|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19927037|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927038|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19927039|NCT01321879|Telavancin|telavancin|mesh-list
19927040|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19927041|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927042|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
19927043|NCT01322009|Probenecid|probenecid|mesh-list
19927044|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19927045|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
19927046|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927047|NCT01322009|Expectorants|expectorants|mesh-ancestor
19927048|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927049|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19927050|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
19927051|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927052|NCT01322009|Protective Agents|protective agents|mesh-ancestor
19927053|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927054|NCT01322009|Antidotes|antidotes|mesh-ancestor
19927055|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
19927056|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
19927057|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927058|NCT01322009|Renal Agents|renal agents|mesh-ancestor
19927059|NCT01322048|Propranolol|propranolol|mesh-list
19927060|NCT01322048|Clonidine|clonidine|mesh-list
19927061|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19927062|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19927063|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927064|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927065|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927066|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927067|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19927068|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19927069|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
19927070|NCT01322048|Analgesics|analgesics|mesh-ancestor
19927071|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
19927072|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927073|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
19927074|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
20263147|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20263148|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20263149|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263150|NCT00504465|Dinoprostone|dinoprostone|mesh-list
20263151|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
20263152|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20263153|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263154|NCT00504491|Rituximab|rituximab|mesh-list
20263155|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
19927075|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19927076|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19927077|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19927078|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
19927079|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19927080|NCT01322360|Morphine|morphine|mesh-list
19927081|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19927082|NCT01322360|Narcotics|narcotics|mesh-ancestor
19927083|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927084|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927085|NCT01322360|Analgesics|analgesics|mesh-ancestor
19927086|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
19927087|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927088|NCT01322386|Vancomycin|vancomycin|mesh-list
19927089|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19927090|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927091|NCT01322490|Molgramostim|molgramostim|mesh-list
19927092|NCT01322490|Sargramostim|sargramostim|mesh-list
19927093|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
19927094|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927095|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927096|NCT01322815|Leucovorin|leucovorin|mesh-list
19927097|NCT01322815|Fluorouracil|fluorouracil|mesh-list
19927098|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
19927099|NCT01322815|Irinotecan|irinotecan|mesh-list
20263156|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20263157|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263158|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
20263159|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263160|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263161|NCT00504543|Everolimus|everolimus|mesh-list
20263162|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263163|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
20263164|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263165|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263166|NCT00504634|Bortezomib|bortezomib|mesh-list
20263167|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263168|NCT00504673|Insulin|insulin|mesh-list
20263169|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19927100|NCT01322815|Bevacizumab|bevacizumab|mesh-list
19927101|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
19927102|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
19927103|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927104|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19927105|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263170|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
20263171|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
19927106|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263172|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
19927107|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
20263173|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
19927108|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263174|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
19927109|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19927110|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19927111|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927112|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19927113|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19927114|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19927115|NCT01322815|Growth Substances|growth substances|mesh-ancestor
19927116|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
19927117|NCT01322815|Antidotes|antidotes|mesh-ancestor
19927118|NCT01322815|Protective Agents|protective agents|mesh-ancestor
19927119|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
19927120|NCT01322815|Vitamins|vitamins|mesh-ancestor
19927121|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
19927122|NCT01323010|Albuterol|albuterol|mesh-list
19927123|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19927124|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
19927125|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927126|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927127|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19927128|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927129|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
19927130|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19927131|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19927132|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19927133|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19927134|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927135|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927136|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927137|NCT01323140|Testosterone|testosterone|mesh-list
19927138|NCT01323140|Androgens|androgens|mesh-ancestor
19927139|NCT01323140|Hormones|hormones|mesh-ancestor
19927140|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927141|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927142|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
19927143|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19927144|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19927145|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
19927146|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927147|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19927148|NCT01323478|Vortioxetine|vortioxetine|mesh-list
19927149|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
19927150|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20263175|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20263176|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263177|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
20263178|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287103|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20287104|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
20287105|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287106|NCT05332314|Ibuprofen|ibuprofen|mesh-list
20287107|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20287108|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287109|NCT05332314|Analgesics|analgesics|mesh-ancestor
20287110|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
19927151|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19927152|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19927153|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927154|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927155|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19927156|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20287111|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287112|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927157|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927158|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927159|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927160|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
19927161|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19927162|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19927163|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19927164|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19927165|NCT01323517|Dactinomycin|dactinomycin|mesh-list
19927166|NCT01323517|Ipilimumab|ipilimumab|mesh-list
19927167|NCT01323517|Melphalan|melphalan|mesh-list
19927168|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19927169|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927170|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19927171|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927172|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19927173|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
19927174|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19927175|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19927176|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
19927177|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927178|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19927179|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927180|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19927181|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19927182|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927183|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19927184|NCT01323530|Capecitabine|capecitabine|mesh-list
19927185|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19927186|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
19927187|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927188|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927189|NCT01323582|Azithromycin|azithromycin|mesh-list
19927190|NCT01323582|Erythromycin|erythromycin|mesh-list
19927191|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
19927192|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19927193|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
19927194|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19927195|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927196|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19927197|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19927198|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927199|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927200|NCT01323595|Celecoxib|celecoxib|mesh-list
19927201|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19927202|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927203|NCT01323595|Analgesics|analgesics|mesh-ancestor
19927204|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
19927205|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927206|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927207|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927208|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927209|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19927210|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19927211|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927212|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927213|NCT01323621|Fluticasone|fluticasone|mesh-list
19927214|NCT01323621|Xhance|xhance|mesh-list
19927215|NCT01323621|Albuterol|albuterol|mesh-list
19927216|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19927217|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927218|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19927219|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
19927220|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927221|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927222|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19927223|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927224|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927225|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19927226|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19927227|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19927228|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19927229|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927230|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927231|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927232|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
19927233|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19927234|NCT01323634|Fluticasone|fluticasone|mesh-list
19927235|NCT01323634|Xhance|xhance|mesh-list
19927236|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19927237|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927238|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19927239|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
19927240|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927241|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927242|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19927243|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927244|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927245|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19927246|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19927247|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19927248|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19927249|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927250|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927251|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927252|NCT01323673|Clobetasol|clobetasol|mesh-list
19927253|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927254|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
19927255|NCT01323673|Hormones|hormones|mesh-ancestor
19927256|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927257|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927258|NCT01323790|Naloxegol|naloxegol|mesh-list
19927259|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19927260|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927261|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
19927262|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927263|NCT01323920|Methotrexate|methotrexate|mesh-list
19927264|NCT01323920|Bortezomib|bortezomib|mesh-list
19927265|NCT01323920|Tacrolimus|tacrolimus|mesh-list
19927266|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19927267|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
19927268|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19927269|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927270|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19927271|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
19927272|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927273|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927274|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927275|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927276|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19927277|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19927278|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
19927279|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927280|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19927281|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19927282|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19927283|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19927284|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927285|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19927286|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19927287|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263179|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
20263180|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20263181|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20263182|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20263183|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
20263184|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20263185|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263186|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20263187|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20263188|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
20263189|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20263190|NCT00504855|Calpastatin|calpastatin|mesh-list
20263191|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20263192|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
20263193|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263194|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263195|NCT00504933|Cetirizine|cetirizine|mesh-list
20263196|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20263197|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20263198|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20263199|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
20263200|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
20263201|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263202|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263203|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927288|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927289|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
19927290|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927291|NCT01324128|Iron|iron|mesh-list
19927292|NCT01324128|Sevelamer|sevelamer|mesh-list
19927293|NCT01324128|Trace Elements|trace elements|mesh-ancestor
19927294|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
19927295|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927296|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
19927297|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
19927298|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927299|NCT01324141|Fluorouracil|fluorouracil|mesh-list
19927300|NCT01324141|Mitomycins|mitomycins|mesh-list
19927301|NCT01324141|Mitomycin|mitomycin|mesh-list
19927302|NCT01324141|Tempol|tempol|mesh-list
19927303|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
19927304|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927305|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19927306|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927307|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19927308|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
19927309|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927310|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20263204|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
20263205|NCT00504946|Prednisone|prednisone|mesh-list
20263206|NCT00504946|Budesonide|budesonide|mesh-list
20263207|NCT00504946|Montelukast|montelukast|mesh-list
20263208|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263209|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
20263210|NCT00504946|Hormones|hormones|mesh-ancestor
20263211|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263212|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263213|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20263214|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263215|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20263216|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263217|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20263218|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
20263219|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20263220|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20541764|NCT01859234|Growth Substances|growth substances|mesh-ancestor
20541765|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541766|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
20541767|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20541768|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541769|NCT01859377|Ibuprofen|ibuprofen|mesh-list
20541770|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20541771|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541772|NCT01859377|Analgesics|analgesics|mesh-ancestor
20541773|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
20541774|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541775|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541776|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541777|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541778|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20541779|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541780|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541781|NCT01859455|Atorvastatin|atorvastatin|mesh-list
20541782|NCT01859455|Simvastatin|simvastatin|mesh-list
20541783|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20541784|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20541785|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
20541786|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541787|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19927311|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
19927312|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19927313|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927314|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
19927315|NCT01324141|Protective Agents|protective agents|mesh-ancestor
19927316|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19927317|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19927318|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19927319|NCT01324232|Quinidine|quinidine|mesh-list
19927320|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
19927321|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
19927322|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
20554062|NCT01932918|Ketorolac|ketorolac|mesh-list
19927323|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19927324|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19927325|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927326|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927327|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927328|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19927329|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19927330|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927331|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19927332|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
19927333|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19927334|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19927335|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927336|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927337|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19927338|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19927339|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
19927340|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19927341|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19927342|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927343|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19927344|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19927345|NCT01324310|Ketoconazole|ketoconazole|mesh-list
19927346|NCT01324310|Romidepsin|romidepsin|mesh-list
19927347|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
19927348|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927349|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19927350|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19927351|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927352|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927353|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19927354|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
19927355|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927356|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927357|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19927358|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19927359|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927360|NCT01324323|Rifampin|rifampin|mesh-list
19927361|NCT01324323|Romidepsin|romidepsin|mesh-list
19927362|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19927363|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
19927364|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19927365|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927366|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
19927367|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19927368|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927369|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927370|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19927371|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19927372|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19927373|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19927374|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19927375|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19927376|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19927377|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927378|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19927379|NCT01324349|Hemostatics|hemostatics|mesh-list
19927380|NCT01324349|Coagulants|coagulants|mesh-ancestor
19927381|NCT01324388|Dulaglutide|dulaglutide|mesh-list
19927382|NCT01324388|Metoprolol|metoprolol|mesh-list
19927383|NCT01324388|Lisinopril|lisinopril|mesh-list
19927384|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19927385|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19927386|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
19927387|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
19927388|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927389|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927390|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19927391|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19927392|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19927393|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927394|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927395|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927396|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19927397|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
19927398|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927399|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19927400|NCT01324388|Protective Agents|protective agents|mesh-ancestor
19927401|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972967|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
19972968|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19972969|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19972970|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19972971|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19972972|NCT01817764|Fluticasone|fluticasone|mesh-list
19972973|NCT01817764|Xhance|xhance|mesh-list
19972974|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19972975|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972976|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19972977|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
19972978|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972979|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972980|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19972981|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
19972982|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
19972983|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19972984|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19972985|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19972986|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19972987|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
19972988|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19972989|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19972990|NCT01817777|Metformin|metformin|mesh-list
19972991|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19972992|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19972993|NCT01817790|Fluticasone|fluticasone|mesh-list
19972994|NCT01817790|Xhance|xhance|mesh-list
19972995|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19972996|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19972997|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
19972998|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19972999|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973000|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19973001|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
19973002|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
19973003|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19973004|NCT01817855|AZD7624|azd7624|mesh-list
19973005|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973006|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973007|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973008|NCT01817907|Trazodone|trazodone|mesh-list
19973009|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19973010|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19973011|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973012|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973013|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19973014|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19973015|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19973016|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973017|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973018|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973019|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
19973020|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19973021|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
19973022|NCT01818063|Paclitaxel|paclitaxel|mesh-list
19973023|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
19973024|NCT01818063|Carboplatin|carboplatin|mesh-list
19973025|NCT01818063|Doxorubicin|doxorubicin|mesh-list
19973026|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19973027|NCT01818063|Veliparib|veliparib|mesh-list
19973028|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19973029|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973030|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
19973031|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
19973032|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
19973033|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973034|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19927402|NCT01324570|Buprenorphine|buprenorphine|mesh-list
19927403|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19927404|NCT01324570|Narcotics|narcotics|mesh-ancestor
19927405|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927406|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927407|NCT01324570|Analgesics|analgesics|mesh-ancestor
19927408|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
19927409|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927410|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19927411|NCT01324700|Dexetimide|dexetimide|mesh-list
19927412|NCT01324700|Citalopram|citalopram|mesh-list
19927413|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19927414|NCT01324700|Serotonin|serotonin|mesh-list
19927415|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19927416|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927417|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927418|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927419|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
19927420|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927421|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19927422|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
19927423|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19927424|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19927425|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19927426|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
19927427|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
19927428|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927429|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19927430|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19927431|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
19927432|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19927433|NCT01324947|Pomalidomide|pomalidomide|mesh-list
19927434|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
19927435|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927436|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19927437|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20263221|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263222|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20263223|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
20263224|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263225|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20263226|NCT00504946|Vitamins|vitamins|mesh-ancestor
20263227|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
20263228|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20263229|NCT00504959|Ranibizumab|ranibizumab|mesh-list
20263230|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20263231|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20263232|NCT00504959|Growth Substances|growth substances|mesh-ancestor
19927438|NCT01324947|Growth Substances|growth substances|mesh-ancestor
19927439|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
19927440|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927441|NCT01324999|Tadalafil|tadalafil|mesh-list
19927442|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
19927443|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19927444|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19927445|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927446|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927447|NCT01324999|Urological Agents|urological agents|mesh-ancestor
19927448|NCT01325181|Ranibizumab|ranibizumab|mesh-list
19927449|NCT01325181|Verteporfin|verteporfin|mesh-list
19927450|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19927451|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19927452|NCT01325181|Growth Substances|growth substances|mesh-ancestor
19927453|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263233|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263234|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
20263235|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927454|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
19927455|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927456|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19927457|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927458|NCT01325207|Trastuzumab|trastuzumab|mesh-list
19927459|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19927460|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927461|NCT01325311|Vitamin D|vitamin d|mesh-list
20263236|NCT00505037|Sevelamer|sevelamer|mesh-list
19927462|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
19927463|NCT01325311|Genistein|genistein|mesh-list
19927464|NCT01325311|Vitamins|vitamins|mesh-ancestor
20263237|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
19927465|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
19927466|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927467|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19927468|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19927469|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19927470|NCT01325311|Protective Agents|protective agents|mesh-ancestor
19927471|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927472|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19927473|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927474|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927475|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
19927476|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19927477|NCT01325311|Estrogens|estrogens|mesh-ancestor
19927478|NCT01325311|Hormones|hormones|mesh-ancestor
19927479|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927480|NCT01325337|Bimatoprost|bimatoprost|mesh-list
20263238|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
20263239|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263240|NCT00505063|Vaccines|vaccines|mesh-list
20263241|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20263242|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
20263243|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263244|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20541788|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20541789|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541790|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
20541791|NCT01859468|Calcium|calcium|mesh-list
20541792|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20541793|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541794|NCT01859468|Antacids|antacids|mesh-ancestor
20541795|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541796|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541797|NCT01859481|Eletriptan|eletriptan|mesh-list
20541798|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20541799|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
20541800|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541801|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541802|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541803|NCT01859585|Ketorolac|ketorolac|mesh-list
20541804|NCT01859585|Parecoxib|parecoxib|mesh-list
20541805|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20541806|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541807|NCT01859585|Analgesics|analgesics|mesh-ancestor
20541808|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
20541809|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541810|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927481|NCT01325337|Minoxidil|minoxidil|mesh-list
19927482|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19927483|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19927484|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
19927485|NCT01325350|Bimatoprost|bimatoprost|mesh-list
19927486|NCT01325350|Minoxidil|minoxidil|mesh-list
19927487|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19927488|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19927489|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
19927490|NCT01325428|Vinorelbine|vinorelbine|mesh-list
19927491|NCT01325428|Afatinib|afatinib|mesh-list
19927492|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19927493|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541811|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541812|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541813|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20541814|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541815|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541816|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20541817|NCT01859624|Albuterol|albuterol|mesh-list
20541818|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20541819|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
20541820|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927494|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19927495|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19927496|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19927497|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927498|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19927499|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927500|NCT01325493|Ketamine|ketamine|mesh-list
19927501|NCT01325493|Analgesics|analgesics|mesh-ancestor
19927502|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
19927503|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927504|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927505|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19927506|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19927507|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
19927508|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
19927509|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927510|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19927511|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19927512|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927513|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927514|NCT01326026|Insulin|insulin|mesh-list
19927515|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19927516|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
19927517|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19927518|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927519|NCT01326481|Capecitabine|capecitabine|mesh-list
19927520|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19927521|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
19927522|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927523|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927524|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
19927525|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
19927526|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19927527|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19927528|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927529|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927530|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927531|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927532|NCT01326546|Entecavir|entecavir|mesh-list
19927533|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
19927534|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927535|NCT01326702|Rituximab|rituximab|mesh-list
19927536|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19927537|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19927538|NCT01326702|Veliparib|veliparib|mesh-list
19927539|NCT01326702|Antibodies|antibodies|mesh-list
19927540|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
19927541|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19927542|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
19927543|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927544|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927545|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927546|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19927547|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
19927548|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927549|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19927550|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927551|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
19927552|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927553|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
19927554|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
19927555|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927556|NCT01327300|Mesalamine|mesalamine|mesh-list
19927557|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19927558|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927559|NCT01327300|Analgesics|analgesics|mesh-ancestor
20263245|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
19927560|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
19927561|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927562|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927563|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927564|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927565|NCT01327339|Ropinirole|ropinirole|mesh-list
19927566|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19927567|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19927568|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
20263246|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927569|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
19927570|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927571|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927572|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927573|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
19927574|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19927575|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19927576|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
19927577|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927578|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19927579|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19927580|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927581|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927582|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
19927583|NCT01327495|Testosterone|testosterone|mesh-list
19927584|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
19927585|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
19927586|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19927587|NCT01327495|Acyline|acyline|mesh-list
19927588|NCT01327495|Androgens|androgens|mesh-ancestor
19927589|NCT01327495|Hormones|hormones|mesh-ancestor
19927590|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927591|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927592|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19927593|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927594|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
19927595|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
19927596|NCT01327547|Maraviroc|maraviroc|mesh-list
19927597|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19927598|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19927599|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927600|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19927601|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19927602|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
19927603|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927604|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19927605|NCT01327573|Eculizumab|eculizumab|mesh-list
19927606|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19927607|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19927608|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
19927609|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927610|NCT01327599|Timolol|timolol|mesh-list
19927611|NCT01327599|Travoprost|travoprost|mesh-list
19927612|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19927613|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19927614|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19927615|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19927616|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927617|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927618|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927619|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927620|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19927621|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19927622|NCT01327612|Leucovorin|leucovorin|mesh-list
19927623|NCT01327612|Bevacizumab|bevacizumab|mesh-list
19927624|NCT01327612|Conatumumab|conatumumab|mesh-list
20263247|NCT00505102|Everolimus|everolimus|mesh-list
19927625|NCT01327612|Fluorouracil|fluorouracil|mesh-list
19927626|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
19927627|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19927628|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927629|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19927630|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19927631|NCT01327612|Growth Substances|growth substances|mesh-ancestor
19927632|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927633|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
19927634|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
19927635|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927636|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19927637|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19927638|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
19927639|NCT01327612|Antidotes|antidotes|mesh-ancestor
19927640|NCT01327612|Protective Agents|protective agents|mesh-ancestor
19927641|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
19927642|NCT01327612|Vitamins|vitamins|mesh-ancestor
20263248|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927643|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
19927644|NCT01327651|Tenofovir|tenofovir|mesh-list
19927645|NCT01327651|Emtricitabine|emtricitabine|mesh-list
19927646|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
19927647|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927648|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19927649|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19927650|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927651|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927652|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19927653|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19927654|NCT01327677|Fentanyl|fentanyl|mesh-list
19927655|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19927656|NCT01327677|Narcotics|narcotics|mesh-ancestor
19927657|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927658|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927659|NCT01327677|Analgesics|analgesics|mesh-ancestor
19927660|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
19927661|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927662|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19927663|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19927664|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
19927665|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
19927666|NCT01327703|Pancreatin|pancreatin|mesh-list
19927667|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19927668|NCT01327885|Dacarbazine|dacarbazine|mesh-list
19927669|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19927670|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
19927671|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927672|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927673|NCT01328002|Milnacipran|milnacipran|mesh-list
19927674|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
20541821|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541822|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20541823|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541824|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
19927675|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19927676|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19927677|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927678|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927679|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927680|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927681|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927682|NCT01328002|Analgesics|analgesics|mesh-ancestor
19927683|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
19927684|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927685|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
19927686|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19927687|NCT01328041|Dolutegravir|dolutegravir|mesh-list
19927688|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19927689|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19927690|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927691|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927692|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19927693|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19927694|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
19927695|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927696|NCT01328054|Lapatinib|lapatinib|mesh-list
19927697|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927698|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19927699|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927700|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263249|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263250|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
20263251|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263252|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20263253|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20263254|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20263255|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
20263256|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263257|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20263258|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20263259|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263260|NCT00505167|Memantine|memantine|mesh-list
19927701|NCT01328184|Empagliflozin|empagliflozin|mesh-list
20263261|NCT00505167|Donepezil|donepezil|mesh-list
19927702|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
19927703|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19927704|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19927705|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19927706|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19927707|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
19927708|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19927709|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927710|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19927711|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19927712|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19927713|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19927714|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927715|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19927716|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19927717|NCT01328184|Estrogens|estrogens|mesh-ancestor
19927718|NCT01328184|Hormones|hormones|mesh-ancestor
19927719|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927720|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19927721|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19927722|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19927723|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19927724|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
19927725|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19927726|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927727|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927728|NCT01328535|Temozolomide|temozolomide|mesh-list
19927729|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19927730|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
19927731|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927732|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927733|NCT01328548|Vaccines|vaccines|mesh-list
19927734|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
19927735|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927736|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19450060|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19450061|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19450062|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450063|NCT03431649|Urological Agents|urological agents|mesh-ancestor
19450064|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19450065|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
19450066|NCT03431623|Hematinics|hematinics|mesh-ancestor
19450067|NCT03431597|Micronutrients|micronutrients|mesh-list
19450068|NCT03431597|Trace Elements|trace elements|mesh-list
19450069|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450070|NCT03431558|Lactoferrin|lactoferrin|mesh-list
19450071|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450072|NCT03431285|Ketamine|ketamine|mesh-list
19450073|NCT03431285|Morphine|morphine|mesh-list
19927737|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19927738|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927739|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19927740|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19927741|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927742|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927743|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
19927744|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927745|NCT01328769|Febuxostat|febuxostat|mesh-list
19927746|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
19927747|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927748|NCT01328782|Acetaminophen|acetaminophen|mesh-list
19927749|NCT01328782|Oxycodone|oxycodone|mesh-list
19927750|NCT01328782|Bupivacaine|bupivacaine|mesh-list
19927751|NCT01328782|Ropivacaine|ropivacaine|mesh-list
19927752|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
19927753|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
19927754|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927755|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927756|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
19927757|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927758|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927759|NCT01328782|Analgesics|analgesics|mesh-ancestor
19927760|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
19927761|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19450074|NCT03431285|Analgesics|analgesics|mesh-ancestor
19927762|NCT01328782|Narcotics|narcotics|mesh-ancestor
19927763|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19927764|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927765|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19927766|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927767|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927768|NCT01328964|Fluticasone|fluticasone|mesh-list
19927769|NCT01328964|Xhance|xhance|mesh-list
19927770|NCT01328964|Budesonide|budesonide|mesh-list
19927771|NCT01328964|Montelukast|montelukast|mesh-list
19927772|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927773|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19927774|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
19927775|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927776|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927777|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19927778|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927779|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927780|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19927781|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
19927782|NCT01328964|Hormones|hormones|mesh-ancestor
19927783|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927784|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19927785|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
19927786|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19927787|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19927788|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927789|NCT01329185|Valganciclovir|valganciclovir|mesh-list
19927790|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
19927791|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927792|NCT01329263|Menthol|menthol|mesh-list
19927793|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
19927794|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927795|NCT01329419|Adefovir|adefovir|mesh-list
19927796|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20263262|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20263263|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263264|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263265|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20263266|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263267|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263268|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
20263269|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20263270|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20263271|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
20263272|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20263273|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20263274|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20263275|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
20263276|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263277|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
20263278|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
20263279|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20263280|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263281|NCT00505336|Eplerenone|eplerenone|mesh-list
20263282|NCT00505336|Atorvastatin|atorvastatin|mesh-list
20263283|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20263284|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20263285|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
20263286|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263287|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20263288|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20263289|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263290|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20263291|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
20263292|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263293|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263294|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20263295|NCT00505336|Diuretics|diuretics|mesh-ancestor
20263296|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
20263297|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20263298|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
20263299|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
19927797|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
19927798|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927799|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19927800|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19927801|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927802|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927803|NCT01329562|Naproxen|naproxen|mesh-list
19927804|NCT01329562|Sumatriptan|sumatriptan|mesh-list
19927805|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19927806|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927807|NCT01329562|Analgesics|analgesics|mesh-ancestor
19927808|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
19927809|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927810|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927811|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927812|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927813|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
19927814|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19927815|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927816|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927817|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19927818|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19927819|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19927820|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
19450075|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
19450076|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450077|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450078|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19450079|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19927821|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927822|NCT01329900|Etoposide|etoposide|mesh-list
19927823|NCT01329900|Ifosfamide|ifosfamide|mesh-list
19927824|NCT01329900|Ofatumumab|ofatumumab|mesh-list
19927825|NCT01329900|Sargramostim|sargramostim|mesh-list
19927826|NCT01329900|Lenograstim|lenograstim|mesh-list
19927827|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19927828|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927829|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19927830|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19927831|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927832|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927833|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19927834|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
19927835|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
19927836|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927837|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19927838|NCT01329939|Montelukast|montelukast|mesh-list
19927839|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19927840|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927841|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19927842|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
19927843|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19927844|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927845|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19927846|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19927847|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927848|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
19927849|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
19927850|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927851|NCT01330017|Loratadine|loratadine|mesh-list
19927852|NCT01330017|Phenylephrine|phenylephrine|mesh-list
19927853|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
19927854|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19927855|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
19927856|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
19927857|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927858|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927859|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
19927860|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19927861|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
19927862|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927863|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19927864|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19927865|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19927866|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
19927867|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263300|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927868|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927869|NCT01330017|Protective Agents|protective agents|mesh-ancestor
19927870|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
19927871|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
19927872|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19927873|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20263301|NCT00505427|Protective Agents|protective agents|mesh-ancestor
19927874|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19927875|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
19927876|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
19927877|NCT01330030|Selegiline|selegiline|mesh-list
19927878|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
19927879|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19927880|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19927881|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19927882|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19927883|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927884|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927885|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19927886|NCT01330030|Protective Agents|protective agents|mesh-ancestor
19927887|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927888|NCT01330043|Bupropion|bupropion|mesh-list
19927889|NCT01330043|Nicotine|nicotine|mesh-list
19927890|NCT01330043|Varenicline|varenicline|mesh-list
19927891|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19927892|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
19927893|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927894|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927895|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19927896|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19927897|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
19927898|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927899|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927900|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19927901|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
20263302|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263303|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
20263304|NCT00505427|Vitamins|vitamins|mesh-ancestor
20263305|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
20263306|NCT00505492|Paclitaxel|paclitaxel|mesh-list
20263307|NCT00505492|Cisplatin|cisplatin|mesh-list
20263308|NCT00505492|Carboplatin|carboplatin|mesh-list
20263309|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20263310|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263311|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
20263312|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
20263313|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
20263314|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263315|NCT00505505|Insulin|insulin|mesh-list
20263316|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20263317|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19927902|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19927903|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19927904|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19927905|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927906|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
19927907|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19927908|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19927909|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927910|NCT01330108|Ambrisentan|ambrisentan|mesh-list
19927911|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19927912|NCT01330134|Lidocaine|lidocaine|mesh-list
19927913|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
19927914|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
19927915|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927916|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927917|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
19927918|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927919|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19927920|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19927921|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19927922|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263318|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927923|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927924|NCT01330290|Rotigotine|rotigotine|mesh-list
19927925|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
19927926|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
19927927|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927928|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927929|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927930|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
19927931|NCT01330355|Besifloxacin|besifloxacin|mesh-list
19927932|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19927933|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19927934|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19927935|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19927936|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19927937|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19927938|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927939|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927940|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19927941|NCT01330381|Prucalopride|prucalopride|mesh-list
19927942|NCT01330381|Laxatives|laxatives|mesh-ancestor
19927943|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19927944|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19927945|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19927946|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
19927947|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927948|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927949|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973035|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
19973036|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973037|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973038|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19973039|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
19973040|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19973041|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19973042|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19973043|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19973044|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973045|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19973046|NCT01818141|Vancomycin|vancomycin|mesh-list
19973047|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
19973048|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973049|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973050|NCT01818258|Ritonavir|ritonavir|mesh-list
19973051|NCT01818258|Lopinavir|lopinavir|mesh-list
19973052|NCT01818258|Lamivudine|lamivudine|mesh-list
19973053|NCT01818258|Zidovudine|zidovudine|mesh-list
19973054|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19973055|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19973056|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
19973057|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973058|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973059|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19973060|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19973061|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
19973062|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973063|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19973064|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19973065|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19973066|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19973067|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
19973068|NCT01818284|Plerixafor|plerixafor|mesh-list
19973069|NCT01818284|Lenograstim|lenograstim|mesh-list
19973070|NCT01818284|Sargramostim|sargramostim|mesh-list
19973071|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19973072|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
19973073|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973074|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19973075|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19973076|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
19973077|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973078|NCT01818336|Amoxicillin|amoxicillin|mesh-list
19973079|NCT01818336|Penicillins|penicillins|mesh-list
19973080|NCT01818336|Penicillin G|penicillin g|mesh-list
19973081|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973082|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973083|NCT01818414|Vitamins|vitamins|mesh-list
19973084|NCT01818414|Folic Acid|folic acid|mesh-list
19927950|NCT01330459|Acetaminophen|acetaminophen|mesh-list
19927951|NCT01330459|Ibuprofen|ibuprofen|mesh-list
19927952|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19927953|NCT01330459|Lidocaine|lidocaine|mesh-list
19927954|NCT01330459|Hydrocodone|hydrocodone|mesh-list
19927955|NCT01330459|Lorazepam|lorazepam|mesh-list
19927956|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
19927957|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
19927958|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19927959|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927960|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
19927961|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927962|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19927963|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19927964|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19927965|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19927966|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19927967|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927968|NCT01330459|Analgesics|analgesics|mesh-ancestor
19927969|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
19927970|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19927971|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927972|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927973|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19927974|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19927975|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19927976|NCT01330459|Narcotics|narcotics|mesh-ancestor
19927977|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
19927978|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
19927979|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
19927980|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
19927981|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
19927982|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19927983|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19927984|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19927985|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19927986|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19927987|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
19927988|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
19927989|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19927990|NCT01331005|Nepafenac|nepafenac|mesh-list
19927991|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19927992|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19927993|NCT01331005|Analgesics|analgesics|mesh-ancestor
19927994|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
19927995|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19927996|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19927997|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19927998|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19927999|NCT01331109|Milnacipran|milnacipran|mesh-list
19928000|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
19732471|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19732472|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19732473|NCT04573426|Acetaminophen|acetaminophen|mesh-list
19732474|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732475|NCT04573426|Analgesics|analgesics|mesh-ancestor
19732476|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
19732477|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732478|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928001|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19928002|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19928003|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928004|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928005|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928006|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928007|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928008|NCT01331109|Analgesics|analgesics|mesh-ancestor
19928009|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
19928010|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928011|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
19928012|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928013|NCT01331161|Vaccines|vaccines|mesh-list
20263319|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
19928014|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
19928015|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928016|NCT01331213|Pregabalin|pregabalin|mesh-list
19928017|NCT01331213|Analgesics|analgesics|mesh-ancestor
19928018|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
19928019|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928020|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928021|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
19928022|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19928023|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928024|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928025|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19928026|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19928027|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928028|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928029|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928030|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19928031|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
19928032|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928033|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19928034|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928035|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928036|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928037|NCT01331681|Aflibercept|aflibercept|mesh-list
19928038|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19928039|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19928040|NCT01331681|Growth Substances|growth substances|mesh-ancestor
19928041|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928042|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
19928043|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928044|NCT01331694|Fluticasone|fluticasone|mesh-list
19928045|NCT01331694|Bromides|bromides|mesh-list
19928046|NCT01331694|Albuterol|albuterol|mesh-list
19928047|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
19928048|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19928049|NCT01331694|Ipratropium|ipratropium|mesh-list
19928050|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19928051|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928052|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19928053|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
19928054|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928055|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928056|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19928057|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928058|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928059|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928060|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
19928061|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19928062|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
19928063|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928064|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928065|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19928066|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19928067|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19928068|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
19928069|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
19928070|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
19928071|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19928072|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
19928073|NCT01331694|Hormones|hormones|mesh-ancestor
19928074|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928075|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
19928076|NCT01331824|Amrubicin|amrubicin|mesh-list
19928077|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928078|NCT01331837|Etanercept|etanercept|mesh-list
19928079|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19928080|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928081|NCT01331837|Analgesics|analgesics|mesh-ancestor
19928082|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
19928083|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928084|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928085|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928086|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928087|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19928088|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19928089|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
19928090|NCT01332019|Interferons|interferons|mesh-list
19928091|NCT01332019|Interferon-beta|interferon-beta|mesh-list
19928092|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
19928093|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928094|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
19928095|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928096|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
19928097|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928098|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19928099|NCT01332071|Metformin|metformin|mesh-list
19928100|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
19928101|NCT01332071|Maleic acid|maleic acid|mesh-list
19928102|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19928103|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928104|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928105|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928106|NCT01332149|Pregabalin|pregabalin|mesh-list
19928107|NCT01332149|Analgesics|analgesics|mesh-ancestor
19928108|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
19928109|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928110|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928111|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
19928112|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19928113|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928114|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928115|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19928116|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19928117|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928118|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928119|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928120|NCT01332188|Cetirizine|cetirizine|mesh-list
19928121|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928122|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19928123|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19928124|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
19928125|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
19928126|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928127|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928128|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928129|NCT01332227|Ritonavir|ritonavir|mesh-list
19928130|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19928131|NCT01332227|Tenofovir|tenofovir|mesh-list
19928132|NCT01332227|Emtricitabine|emtricitabine|mesh-list
19928133|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
19928134|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19928135|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19928136|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
19928137|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928138|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928139|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19928140|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19928141|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
19928142|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928143|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19928144|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19928145|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19928146|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19928147|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19928148|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19928149|NCT01332253|Ibuprofen|ibuprofen|mesh-list
19928150|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19928151|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928152|NCT01332253|Analgesics|analgesics|mesh-ancestor
19928153|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
19928154|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928155|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928156|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928157|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928158|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19928159|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928160|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928161|NCT01332292|Fluticasone|fluticasone|mesh-list
19928162|NCT01332292|Xhance|xhance|mesh-list
19928163|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19450080|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
19928164|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19928165|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
19928166|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928167|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928168|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19928169|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928170|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928171|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928172|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
19928173|NCT01332318|Promethazine|promethazine|mesh-list
19928174|NCT01332318|Gabapentin|gabapentin|mesh-list
19928175|NCT01332318|Analgesics|analgesics|mesh-ancestor
19928176|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
19928177|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928178|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928179|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
19928180|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19928181|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928182|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928183|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928184|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19928185|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19928186|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928187|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928188|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
19928189|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19928190|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19928191|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
19928192|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
19928193|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
19928194|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
19928195|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19928196|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19928197|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
19928198|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
19928199|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928200|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
19928201|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928202|NCT01332331|Ambrisentan|ambrisentan|mesh-list
19928203|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19928204|NCT01332357|Fluticasone|fluticasone|mesh-list
19928205|NCT01332357|Xhance|xhance|mesh-list
19928206|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19928207|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19928208|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928209|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19928210|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
19928211|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928212|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928213|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19928214|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928215|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928216|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928217|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19928218|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19928219|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19928220|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
19928221|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928222|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928223|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
19928224|NCT01332357|Hormones|hormones|mesh-ancestor
19928225|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928226|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
19928227|NCT01332461|Fluticasone|fluticasone|mesh-list
19928228|NCT01332461|Xhance|xhance|mesh-list
19928229|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19928230|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928231|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19928232|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
19928233|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928234|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263320|NCT00505531|Tramadol|tramadol|mesh-list
20263321|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20263322|NCT00505531|Narcotics|narcotics|mesh-ancestor
19928235|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19928236|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263323|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928237|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928238|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928239|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19928240|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19928241|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19928242|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
19928243|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928244|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928245|NCT01332500|Naproxen|naproxen|mesh-list
19928246|NCT01332500|Sumatriptan|sumatriptan|mesh-list
19928247|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19928248|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928249|NCT01332500|Analgesics|analgesics|mesh-ancestor
19928250|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
19928251|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928252|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928253|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928254|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928255|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
19928256|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19928257|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928258|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928259|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19928260|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19928261|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19928262|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
19928263|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928264|NCT01332578|Acetaminophen|acetaminophen|mesh-list
19928265|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
19928266|NCT01332578|Phenylephrine|phenylephrine|mesh-list
19928267|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
19928268|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928269|NCT01332578|Analgesics|analgesics|mesh-ancestor
19928270|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
19928271|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928272|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928273|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
19928274|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
19928275|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928276|NCT01332578|Protective Agents|protective agents|mesh-ancestor
19928277|NCT01332578|Vitamins|vitamins|mesh-ancestor
19928278|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
19928279|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19928280|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
19928281|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
20263324|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263325|NCT00505531|Analgesics|analgesics|mesh-ancestor
20263326|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
20263327|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263328|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20263329|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20263330|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
20263331|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
20263332|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
20541825|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20541826|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20541827|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20541828|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20541829|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541830|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541831|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541832|NCT01859728|Gemcitabine|gemcitabine|mesh-list
20541833|NCT01859728|Cisplatin|cisplatin|mesh-list
20541834|NCT01859728|Irinotecan|irinotecan|mesh-list
20541835|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541836|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20541837|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
20541838|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541839|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
20541840|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928282|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
19928283|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19928284|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
19928285|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928286|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20263333|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
20541841|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928287|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19928288|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19928289|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
19928290|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928291|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
19928292|NCT01332630|Dexamethasone|dexamethasone|mesh-list
19928293|NCT01332630|Ranitidine|ranitidine|mesh-list
19928294|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19928295|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928296|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
19928297|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
19928298|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928299|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928300|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19928301|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
19928302|NCT01332630|Hormones|hormones|mesh-ancestor
19928303|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928304|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19928305|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928306|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19928307|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19928308|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928309|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
19928310|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
19928311|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
19928312|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19928313|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
19928314|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
19928315|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928316|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928317|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928318|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19928319|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19928320|NCT01332721|Bevacizumab|bevacizumab|mesh-list
19928321|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19928322|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928323|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19928324|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19928325|NCT01332721|Growth Substances|growth substances|mesh-ancestor
19928326|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928327|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
19928328|NCT01332994|Rituximab|rituximab|mesh-list
19928329|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19928330|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928331|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
19928332|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928333|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928334|NCT01333033|Leucovorin|leucovorin|mesh-list
20263334|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20263335|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19928335|NCT01333033|Paclitaxel|paclitaxel|mesh-list
19928336|NCT01333033|Carboplatin|carboplatin|mesh-list
19928337|NCT01333033|Fluorouracil|fluorouracil|mesh-list
19928338|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
19928339|NCT01333033|Calcium|calcium|mesh-list
19928340|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
19928341|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19928342|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928343|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
19928344|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
19928345|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
19928346|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928347|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19928348|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928349|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
19928350|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19928351|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19928352|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
19928353|NCT01333033|Antidotes|antidotes|mesh-ancestor
19928354|NCT01333033|Protective Agents|protective agents|mesh-ancestor
19928355|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
19928356|NCT01333033|Vitamins|vitamins|mesh-ancestor
20263336|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
20263337|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
20263338|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928357|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
19928358|NCT01333059|Fentanyl|fentanyl|mesh-list
20554063|NCT01932918|Morphine|morphine|mesh-list
19928359|NCT01333059|Midazolam|midazolam|mesh-list
19928360|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20263339|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263340|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20263341|NCT00505700|Cytarabine|cytarabine|mesh-list
20263342|NCT00505700|Bortezomib|bortezomib|mesh-list
20263343|NCT00505700|Idarubicin|idarubicin|mesh-list
19450081|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
19450082|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450083|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19450084|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19450085|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450086|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450087|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19928361|NCT01333059|Narcotics|narcotics|mesh-ancestor
19928362|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928363|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928364|NCT01333059|Analgesics|analgesics|mesh-ancestor
19928365|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
19928366|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928367|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19928368|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19928369|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
19928370|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
19928371|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19928372|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19928373|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928374|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928375|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
19928376|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
19928377|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928378|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928379|NCT01333072|Risperidone|risperidone|mesh-list
19928380|NCT01333072|Aripiprazole|aripiprazole|mesh-list
19928381|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19928382|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
19928383|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928384|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928385|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928386|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19928387|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928388|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928389|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928390|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19928391|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
19928392|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
19928393|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
19928394|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19928395|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19928396|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19928397|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19928398|NCT01333098|Mifepristone|mifepristone|mesh-list
19928399|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19928400|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
19928401|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19450088|NCT03431285|Narcotics|narcotics|mesh-ancestor
19450089|NCT03431272|Lifitegrast|lifitegrast|mesh-list
19450090|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19450091|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19450092|NCT03431194|Midodrine|midodrine|mesh-list
19450093|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
19928402|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263344|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263345|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
20263346|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928403|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19928404|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19928405|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19928406|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
19928407|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19928408|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19928409|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
19928410|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263347|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450094|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
19928411|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
19928412|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19928413|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19928414|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
19928415|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19928416|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19928417|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19928418|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928419|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928420|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
19928421|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263348|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
20263349|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263350|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263351|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
20263352|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263353|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20263354|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20263355|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263356|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263357|NCT00505739|Mifepristone|mifepristone|mesh-list
20263358|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20263359|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
20263360|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20263361|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263362|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20541842|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541843|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
20541844|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541845|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20541846|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541847|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
20541848|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20541849|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20541850|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
20541851|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541852|NCT01859819|Cytarabine|cytarabine|mesh-list
20541853|NCT01859819|Rituximab|rituximab|mesh-list
20541854|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541855|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541856|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
20541857|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541858|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541859|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20541860|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
20541861|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541862|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
20541863|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541864|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20541865|NCT01859858|Curcumin|curcumin|mesh-list
20541866|NCT01859858|Irinotecan|irinotecan|mesh-list
20541867|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20541868|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541869|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541870|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541871|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541872|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20541873|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20541874|NCT01859858|Analgesics|analgesics|mesh-ancestor
20541875|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
20541876|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541877|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541878|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541879|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20541880|NCT01860014|Poractant alfa|poractant alfa|mesh-list
20541881|NCT01860014|Beractant|beractant|mesh-list
20541882|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20541883|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541884|NCT01860066|Fluticasone|fluticasone|mesh-list
20541885|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20541886|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20541887|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20541888|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20541889|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
20541890|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928422|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928423|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19928424|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928425|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
19928426|NCT01333488|Analgesics|analgesics|mesh-ancestor
19928427|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
19928428|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928429|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928430|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
19928431|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928432|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19928433|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
19928434|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19928435|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928436|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928437|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19928438|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
19928439|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19928440|NCT01333501|Interferons|interferons|mesh-list
19928441|NCT01333501|Interferon-beta|interferon-beta|mesh-list
19928442|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19928443|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
19928444|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928445|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
19928446|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928447|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
19928448|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928449|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20263363|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20263364|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20263365|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
20263366|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20263367|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20263368|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
20263369|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541891|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541892|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20541893|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
20541894|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
20541895|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20541896|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20541897|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20541898|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20541899|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
20541900|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541901|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541902|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
20541903|NCT01860066|Hormones|hormones|mesh-ancestor
20541904|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20541905|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
20541906|NCT01860105|Clopidogrel|clopidogrel|mesh-list
20541907|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20541908|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20541909|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20541910|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20541911|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
20541912|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541913|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541914|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541915|NCT01860144|Bevacizumab|bevacizumab|mesh-list
20541916|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541917|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263370|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
20263371|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20263372|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20263373|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20263374|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
20263375|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263376|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
20263377|NCT00505804|Haloperidol|haloperidol|mesh-list
20263378|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
20263379|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19928450|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928451|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19928452|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19928453|NCT01333592|Mitiglinide|mitiglinide|mesh-list
19928454|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19928455|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928456|NCT01333722|Acetaminophen|acetaminophen|mesh-list
19928457|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19928458|NCT01333722|Hydrocodone|hydrocodone|mesh-list
19928459|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928460|NCT01333722|Analgesics|analgesics|mesh-ancestor
19928461|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
19928462|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928463|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928464|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
19928465|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19928466|NCT01333722|Narcotics|narcotics|mesh-ancestor
19928467|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928468|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
19928469|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928470|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19928471|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928472|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928473|NCT01333865|Memantine|memantine|mesh-list
19928474|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19928475|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19928476|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
19928477|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928478|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928479|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928480|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19928481|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19928482|NCT01333956|Pregabalin|pregabalin|mesh-list
19928483|NCT01333956|Analgesics|analgesics|mesh-ancestor
19928484|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
19928485|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928486|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928487|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
19928488|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19928489|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928490|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928491|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19928492|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19928493|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928494|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928495|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928496|NCT01334086|Aprepitant|aprepitant|mesh-list
19928497|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
19928498|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
19928499|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928500|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928501|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19928502|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19928503|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928504|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928505|NCT01334125|Metformin|metformin|mesh-list
19928506|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19928507|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928508|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19928509|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19928510|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928511|NCT01334229|Incretins|incretins|mesh-ancestor
19928512|NCT01334229|Hormones|hormones|mesh-ancestor
19928513|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928514|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19928515|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
19928516|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928517|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928518|NCT01334515|Isotretinoin|isotretinoin|mesh-list
19928519|NCT01334515|Sargramostim|sargramostim|mesh-list
19928520|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928521|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
19928522|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928523|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
19928524|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
19928525|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20263380|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263381|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263382|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20263383|NCT00505804|Analgesics|analgesics|mesh-ancestor
20263384|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
20263385|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263386|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20263387|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19928526|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19928527|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928528|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928529|NCT01334554|Urological Agents|urological agents|mesh-ancestor
19928530|NCT01334710|Sorafenib|sorafenib|mesh-list
19928531|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928532|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19928533|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928534|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928535|NCT01334723|Finasteride|finasteride|mesh-list
19928536|NCT01334723|Dutasteride|dutasteride|mesh-list
19928537|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
20263388|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20263389|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
20263390|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263391|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263392|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
20263393|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
20263394|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20263395|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20263396|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20263397|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20263398|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20263399|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
20263400|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20263401|NCT00505817|Leuprolide|leuprolide|mesh-list
20263402|NCT00505817|Cetrorelix|cetrorelix|mesh-list
20263403|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20263404|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
20263405|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20263406|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263407|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20263408|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263409|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
20263410|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263411|NCT00505843|Levodopa|levodopa|mesh-list
20263412|NCT00505843|Carbidopa|carbidopa|mesh-list
20263413|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20263414|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20263415|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
20263416|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263417|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263418|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263419|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20263420|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263421|NCT00505882|Pramlintide|pramlintide|mesh-list
20263422|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20263423|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928538|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19928539|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928540|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263424|NCT00505947|Infliximab|infliximab|mesh-list
20263425|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928541|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
19928542|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928543|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928544|NCT01334723|Urological Agents|urological agents|mesh-ancestor
19928545|NCT01334918|Regadenoson|regadenoson|mesh-list
19928546|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19928547|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20263426|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20263427|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263428|NCT00506051|Pemetrexed|pemetrexed|mesh-list
19928548|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19928549|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
19928550|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
19928551|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928552|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928553|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928554|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19928555|NCT01334944|Ibuprofen|ibuprofen|mesh-list
19928556|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19928557|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928558|NCT01334944|Analgesics|analgesics|mesh-ancestor
19928559|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
19928560|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928561|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928562|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928563|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928564|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19928565|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928566|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928567|NCT01334957|Ibuprofen|ibuprofen|mesh-list
19928568|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19928569|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928570|NCT01334957|Analgesics|analgesics|mesh-ancestor
19928571|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
19928572|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928573|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928574|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928575|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928576|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19928577|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928578|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928579|NCT01335009|Antibodies|antibodies|mesh-list
19928580|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19928581|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
19928582|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928583|NCT01335204|Bavituximab|bavituximab|mesh-list
19928584|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19928585|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928586|NCT01335464|Nintedanib|nintedanib|mesh-list
19928587|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928588|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19928589|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928590|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928591|NCT01335477|Nintedanib|nintedanib|mesh-list
19928592|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928593|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19928594|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928595|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928596|NCT01335620|Tenofovir|tenofovir|mesh-list
19928597|NCT01335620|Emtricitabine|emtricitabine|mesh-list
19928598|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
19928599|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
19928600|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928601|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19928602|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19928603|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928604|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928605|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19928606|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19928607|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19928608|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19928609|NCT01335698|Ritonavir|ritonavir|mesh-list
19928610|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19928611|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19928612|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19928613|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
19928614|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928615|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928616|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19928617|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19928618|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
19928619|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928620|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19928621|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19928622|NCT01335724|Diclofenac|diclofenac|mesh-list
19928623|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19928624|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928625|NCT01335724|Analgesics|analgesics|mesh-ancestor
19928626|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
19928627|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928628|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928629|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928630|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928631|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19928632|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928633|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928634|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19928635|NCT01335789|Oxytocin|oxytocin|mesh-list
19928636|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
19928637|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19928638|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928639|NCT01335867|Vigabatrin|vigabatrin|mesh-list
19928640|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
19928641|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928642|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928643|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
19928644|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928645|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928646|NCT01335932|Ganciclovir|ganciclovir|mesh-list
19928647|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
19928648|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
19928649|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928650|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19928651|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928652|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928653|NCT01335971|Sulforaphane|sulforaphane|mesh-list
19928654|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19928655|NCT01335971|Protective Agents|protective agents|mesh-ancestor
19928656|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928657|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928658|NCT01336023|Insulin|insulin|mesh-list
19928659|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19928660|NCT01336023|Liraglutide|liraglutide|mesh-list
19928661|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
19928662|NCT01336023|Xultophy|xultophy|mesh-list
19928663|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19928664|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928665|NCT01336023|Incretins|incretins|mesh-ancestor
19928666|NCT01336023|Hormones|hormones|mesh-ancestor
19928667|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928668|NCT01336140|Aminophylline|aminophylline|mesh-list
19928669|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19928670|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
19928671|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928672|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928673|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19928674|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928675|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19928676|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19928677|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928678|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928679|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19928680|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19928681|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
19928682|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928683|NCT01336140|Protective Agents|protective agents|mesh-ancestor
19928684|NCT01336205|Naloxegol|naloxegol|mesh-list
19928685|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19928686|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928687|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
19928688|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928689|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
19928690|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19928691|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928692|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19928693|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
19928694|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19928695|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928696|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928697|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263429|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263430|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263431|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263432|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20263433|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20263434|NCT00506168|Capecitabine|capecitabine|mesh-list
20263435|NCT00506168|Irinotecan|irinotecan|mesh-list
20541918|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20541919|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20541920|NCT01860144|Growth Substances|growth substances|mesh-ancestor
20541921|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541922|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
20541923|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
20541924|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20541925|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541926|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20541927|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
20541928|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20541929|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541930|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541931|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541932|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20541933|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20554064|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19732479|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
19928698|NCT01336569|Timolol|timolol|mesh-list
19928699|NCT01336569|Travoprost|travoprost|mesh-list
19928700|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19928701|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19928702|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
19928703|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928704|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928705|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928706|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19928707|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19928708|NCT01336608|Fluticasone|fluticasone|mesh-list
19928709|NCT01336608|Xhance|xhance|mesh-list
19928710|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928711|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19928712|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
19928713|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928714|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928715|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19928716|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928717|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928718|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928719|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
19928720|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19928721|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
19928722|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19928723|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928724|NCT01336738|Incretins|incretins|mesh-ancestor
19928725|NCT01336738|Hormones|hormones|mesh-ancestor
19928726|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928727|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19928728|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
19928729|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928730|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928731|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
19928732|NCT01336738|Vitamins|vitamins|mesh-ancestor
20263436|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19928733|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
19928734|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19928735|NCT01336803|Hematinics|hematinics|mesh-ancestor
19732480|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
19732481|NCT04573686|Hematinics|hematinics|mesh-ancestor
19732482|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
19732483|NCT04573153|Sorbitol|sorbitol|mesh-list
19732484|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
19732485|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19732486|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19732487|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732488|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928736|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19928737|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19973085|NCT01818414|Misoprostol|misoprostol|mesh-list
19973086|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
19973087|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973088|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19973089|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
19973090|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19973091|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19973092|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19973093|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
19973094|NCT01818414|Hematinics|hematinics|mesh-ancestor
19973095|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
19973096|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19973097|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19973098|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19973099|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
19973100|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973101|NCT01818700|Buprenorphine|buprenorphine|mesh-list
20263437|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
20263438|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263439|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263440|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20263441|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263442|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263443|NCT00506194|Gliclazide|gliclazide|mesh-list
20263444|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20263445|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263446|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
20263447|NCT00506207|Irinotecan|irinotecan|mesh-list
20263448|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263449|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20263450|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263451|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263452|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263453|NCT00506246|Propofol|propofol|mesh-list
20263454|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20263455|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263456|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263457|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20263458|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
20263459|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
20263460|NCT00506259|Melatonin|melatonin|mesh-list
20263461|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
20263462|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263463|NCT00506259|Protective Agents|protective agents|mesh-ancestor
20263464|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263465|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263466|NCT00506272|Insulin|insulin|mesh-list
20263467|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20263468|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263469|NCT00506298|Diflunisal|diflunisal|mesh-list
20263470|NCT00506298|Bezafibrate|bezafibrate|mesh-list
20263471|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20263472|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
20263473|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263474|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20263475|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20263476|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20263477|NCT00506298|Analgesics|analgesics|mesh-ancestor
20263478|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
20263479|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263480|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263481|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263482|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263483|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20263484|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263485|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20263486|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
20263487|NCT00506311|Coagulants|coagulants|mesh-ancestor
20263488|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
20263489|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20263490|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
19973102|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19973103|NCT01818700|Narcotics|narcotics|mesh-ancestor
20263491|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263492|NCT00506506|Expectorants|expectorants|mesh-ancestor
19928738|NCT01336933|Prednisone|prednisone|mesh-list
19928739|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
19928740|NCT01336933|Etoposide|etoposide|mesh-list
19928741|NCT01336933|Vincristine|vincristine|mesh-list
19928742|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
19928743|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19928744|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
19928745|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928746|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928747|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19928748|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
19928749|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928750|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928751|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19928752|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928753|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
19928754|NCT01336933|Hormones|hormones|mesh-ancestor
19928755|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263493|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263494|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20263495|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
20263496|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263497|NCT00506506|Protective Agents|protective agents|mesh-ancestor
20263498|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263499|NCT00506506|Antidotes|antidotes|mesh-ancestor
20263500|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20263501|NCT00506532|Calfactant|calfactant|mesh-list
20263502|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263503|NCT00506545|Rolapitant|rolapitant|mesh-list
20263504|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20263505|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263506|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263507|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263508|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
20263509|NCT00506571|Irinotecan|irinotecan|mesh-list
20263510|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263511|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20263512|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541934|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541935|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541936|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20541937|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541938|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541939|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
20541940|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541941|NCT01860235|Anesthetics|anesthetics|mesh-list
20541942|NCT01860235|Benzocaine|benzocaine|mesh-list
20541943|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
20541944|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541945|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541946|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
20541947|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20541948|NCT01860300|Amoxicillin|amoxicillin|mesh-list
20541949|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
20541950|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
20541951|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20541952|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20541953|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20541954|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20541955|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541956|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541957|NCT01860391|Fluorides|fluorides|mesh-list
20541958|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
20541959|NCT01860391|Protective Agents|protective agents|mesh-ancestor
20541960|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541961|NCT01860417|Mepivacaine|mepivacaine|mesh-list
20541962|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
20541963|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
20541964|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20541965|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541966|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
20541967|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928756|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20541968|NCT01860469|Vancomycin|vancomycin|mesh-list
20263513|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928757|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19928758|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19928759|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19928760|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928761|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
19928762|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
19928763|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
19928764|NCT01336972|Tolvaptan|tolvaptan|mesh-list
19928765|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19928766|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928767|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
19928768|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928769|NCT01337089|Nabiximols|nabiximols|mesh-list
19928770|NCT01337089|Analgesics|analgesics|mesh-ancestor
19928771|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
19928772|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928773|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928774|NCT01337115|Ropivacaine|ropivacaine|mesh-list
19928775|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
19928776|NCT01337115|Anesthetics|anesthetics|mesh-list
19928777|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928778|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928779|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
19928780|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928781|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19928782|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
19928783|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928784|NCT01337336|Fluticasone|fluticasone|mesh-list
19928785|NCT01337336|Xhance|xhance|mesh-list
19928786|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
19928787|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19928788|NCT01337336|Ipratropium|ipratropium|mesh-list
19928789|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19928790|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19928791|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19928792|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
19928793|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928794|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928795|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19928796|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
19928797|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928798|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19928799|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
19928800|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
19928801|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928802|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928803|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19928804|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19928805|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19928806|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
19928807|NCT01337635|Vitamin D|vitamin d|mesh-list
19928808|NCT01337635|Vitamins|vitamins|mesh-ancestor
19928809|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
19928810|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928811|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19928812|NCT01337674|Metoprolol|metoprolol|mesh-list
19928813|NCT01337674|Amlodipine|amlodipine|mesh-list
19928814|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19928815|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19928816|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928817|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928818|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19928819|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928820|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
19928821|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19928822|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
19928823|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
19928824|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928825|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19928826|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19928827|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19928828|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
19928829|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928830|NCT01337687|Oxytocin|oxytocin|mesh-list
19928831|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
19928832|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19928833|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928834|NCT01337700|Milnacipran|milnacipran|mesh-list
19928835|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
19928836|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19928837|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19928838|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928839|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928840|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928841|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928842|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19928843|NCT01337700|Analgesics|analgesics|mesh-ancestor
19928844|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
19928845|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928846|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
19928847|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928848|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
19928849|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19928850|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928851|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928852|NCT01338025|Lamivudine|lamivudine|mesh-list
19928853|NCT01338025|Emtricitabine|emtricitabine|mesh-list
19928854|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19928855|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19928856|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928857|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928858|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
19928859|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928860|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19928861|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19928862|NCT01338298|Aripiprazole|aripiprazole|mesh-list
19928863|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
19928864|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928865|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19928866|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19928867|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928868|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928869|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
19928870|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
19928871|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928872|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928873|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19928874|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19928875|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
19928876|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19928877|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19928878|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19928879|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19928880|NCT01338415|Bosentan|bosentan|mesh-list
19928881|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19928882|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19928883|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928884|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19928885|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19928886|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
19928887|NCT01338792|Pemetrexed|pemetrexed|mesh-list
19928888|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928889|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928890|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928891|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19928892|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19928893|NCT01338818|Methylphenidate|methylphenidate|mesh-list
19928894|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19928895|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263514|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263515|NCT00506623|Capecitabine|capecitabine|mesh-list
20263516|NCT00506623|Irinotecan|irinotecan|mesh-list
20263517|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263518|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
20263519|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263520|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263521|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19928896|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19928897|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19928898|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928899|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928900|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
19928901|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928902|NCT01338857|Sorafenib|sorafenib|mesh-list
19928903|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928904|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19928905|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928906|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928907|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
19928908|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19928909|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
19928910|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19928911|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928912|NCT01338870|Incretins|incretins|mesh-ancestor
19928913|NCT01338870|Hormones|hormones|mesh-ancestor
19928914|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928915|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19928916|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
19928917|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928918|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928919|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
19928920|NCT01338870|Vitamins|vitamins|mesh-ancestor
19928921|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
19928922|NCT01338987|Alovudine|alovudine|mesh-list
19928923|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
19928924|NCT01338987|Busulfan|busulfan|mesh-list
19928925|NCT01338987|Methotrexate|methotrexate|mesh-list
19928926|NCT01338987|Fludarabine|fludarabine|mesh-list
19928927|NCT01338987|Leuprolide|leuprolide|mesh-list
19928928|NCT01338987|Tacrolimus|tacrolimus|mesh-list
19928929|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19928930|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
19928931|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928932|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19928933|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19928934|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
19928935|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928936|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19928937|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19928938|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19928939|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
19928940|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19928941|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19928942|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
19928943|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
19928944|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928945|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19928946|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19928947|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19928948|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19928949|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
19928950|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19928951|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
19928952|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928953|NCT01339000|Vaccines|vaccines|mesh-list
19928954|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19928955|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
19928956|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928957|NCT01339013|Anesthetics|anesthetics|mesh-list
19928958|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19928959|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928960|NCT01339091|Vancomycin|vancomycin|mesh-list
19928961|NCT01339091|Linezolid|linezolid|mesh-list
19928962|NCT01339091|Dalbavancin|dalbavancin|mesh-list
19928963|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19928964|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928965|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19928966|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263522|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20541969|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19928967|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928968|NCT01339247|Halofantrine|halofantrine|mesh-list
19450095|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450096|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450097|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19450098|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19450099|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19928969|NCT01339247|Paroxetine|paroxetine|mesh-list
19928970|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19928971|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19928972|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19928973|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19928974|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19928975|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
19928976|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928977|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19928978|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
19928979|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19928980|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19928981|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19928982|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928983|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
19928984|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19928985|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19928986|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19928987|NCT01339260|Dexamethasone|dexamethasone|mesh-list
19928988|NCT01339260|Palonosetron|palonosetron|mesh-list
19928989|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263523|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19928990|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
19928991|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
19928992|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19928993|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19928994|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19928995|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
19928996|NCT01339260|Hormones|hormones|mesh-ancestor
19928997|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19928998|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19928999|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929000|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19929001|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19929002|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
19929003|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929004|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929005|NCT01339273|Anesthetics|anesthetics|mesh-list
19929006|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
19929007|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929008|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929009|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
19929010|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929011|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19929012|NCT01339299|Hormones|hormones|mesh-list
19929013|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929014|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929015|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19929016|NCT01339559|Brivaracetam|brivaracetam|mesh-list
19929017|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
19929018|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
19929019|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19929020|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
19929021|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929022|NCT01339858|Expectorants|expectorants|mesh-ancestor
19929023|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929024|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19929025|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
19929026|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929027|NCT01339858|Protective Agents|protective agents|mesh-ancestor
19929028|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929029|NCT01339858|Antidotes|antidotes|mesh-ancestor
19929030|NCT01339910|Vidarabine|vidarabine|mesh-list
19929031|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
19929032|NCT01339910|Melphalan|melphalan|mesh-list
19929033|NCT01339910|Busulfan|busulfan|mesh-list
19929034|NCT01339910|Fludarabine|fludarabine|mesh-list
19450100|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19929035|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
19929036|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929037|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
19929038|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929039|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929040|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19929041|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
19929042|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929043|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929044|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19929045|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19929046|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
19929047|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
19929048|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929049|NCT01339923|Vaccines|vaccines|mesh-list
19929050|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
19929051|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929052|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19929053|NCT01339936|Glycerol|glycerol|mesh-list
19929054|NCT01339936|Laxatives|laxatives|mesh-ancestor
19929055|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19929056|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19929057|NCT01339936|Protective Agents|protective agents|mesh-ancestor
19929058|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929059|NCT01340014|Timolol|timolol|mesh-list
19929060|NCT01340014|Dorzolamide|dorzolamide|mesh-list
19929061|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19929062|NCT01340014|Brinzolamide|brinzolamide|mesh-list
19929063|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19929064|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19929065|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19929066|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929067|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929068|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929069|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929070|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19929071|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19929072|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19929073|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929074|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
19929075|NCT01340027|Mirabegron|mirabegron|mesh-list
19929076|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19929077|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19929078|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
19929079|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929080|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929081|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929082|NCT01340027|Urological Agents|urological agents|mesh-ancestor
19929083|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19929084|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19929085|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19929086|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929087|NCT01340196|Tenofovir|tenofovir|mesh-list
19929088|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
19929089|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929090|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19929091|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19929092|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929093|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929094|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19929095|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19929096|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
19929097|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19929098|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
19929099|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929100|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929101|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19929102|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929103|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
19929104|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19929105|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
19929106|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929107|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929108|NCT01340300|Metformin|metformin|mesh-list
19929109|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19929110|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929111|NCT01340586|Apixaban|apixaban|mesh-list
19929112|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19929113|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
19929114|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19929115|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
19929116|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929117|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263524|NCT00506701|Tadalafil|tadalafil|mesh-list
20263525|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
20263526|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20263527|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20263528|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263529|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263530|NCT00506701|Urological Agents|urological agents|mesh-ancestor
20263531|NCT00506727|Amphetamine|amphetamine|mesh-list
20263532|NCT00506727|Adderall|adderall|mesh-list
19929118|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
19929119|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20263533|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20263534|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20263535|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20263536|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263537|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263538|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
20263539|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263540|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263541|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20263542|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
20263543|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
20263544|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263545|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
20263546|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20263547|NCT00506844|Capecitabine|capecitabine|mesh-list
20263548|NCT00506844|Irinotecan|irinotecan|mesh-list
20263549|NCT00506844|Cetuximab|cetuximab|mesh-list
20263550|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263551|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
20263552|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263553|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263554|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20263555|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263556|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263557|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20263558|NCT00506935|Vigabatrin|vigabatrin|mesh-list
20263559|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
20263560|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263561|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263562|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
20263563|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263564|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263565|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20263566|NCT00506961|Simvastatin|simvastatin|mesh-list
20263567|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20263568|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20263569|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
20263570|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263571|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20263572|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20263573|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263574|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
20263575|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20263576|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20263577|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
20263578|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
20263579|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263580|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263581|NCT00507000|Vitamin D|vitamin d|mesh-list
20263582|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
20263583|NCT00507000|Vitamins|vitamins|mesh-ancestor
20263584|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
20263585|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263586|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20263587|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19929120|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20263588|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
19929121|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19929122|NCT01340625|Norethindrone|norethindrone|mesh-list
19929123|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
19929124|NCT01340625|Estradiol|estradiol|mesh-list
19929125|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19929126|NCT01340625|Estrogens|estrogens|mesh-ancestor
19929127|NCT01340625|Hormones|hormones|mesh-ancestor
19929128|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929129|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929130|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19929131|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
19929132|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19929133|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19929134|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19929135|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19929136|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19929137|NCT01340664|Metformin|metformin|mesh-list
19929138|NCT01340664|Canagliflozin|canagliflozin|mesh-list
19929139|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19929140|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929141|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19929142|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929143|NCT01340768|Metformin|metformin|mesh-list
19929144|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19929145|NCT01340768|Glimepiride|glimepiride|mesh-list
19929146|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19929147|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929148|NCT01340768|Incretins|incretins|mesh-ancestor
19929149|NCT01340768|Hormones|hormones|mesh-ancestor
19929150|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929151|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19929152|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
19929153|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929154|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929155|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19929156|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929157|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
19929158|NCT01340872|Ferric maltol|ferric maltol|mesh-list
19929159|NCT01340872|Hematinics|hematinics|mesh-ancestor
19929160|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19929161|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
19929162|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929163|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
19929164|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
19929165|NCT01341301|Tacrolimus|tacrolimus|mesh-list
19929166|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929167|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
19929168|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929169|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929170|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19929171|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
19929172|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929173|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929174|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19929175|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19929176|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929177|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19929178|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19929179|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
19929180|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19929181|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929182|NCT01341457|Gemcitabine|gemcitabine|mesh-list
19929183|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19929184|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
19929185|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929186|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929187|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
19929188|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929189|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929190|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929191|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
19929192|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929193|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19929194|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
20263589|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20263590|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
19929195|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929196|NCT01341652|Molgramostim|molgramostim|mesh-list
19929197|NCT01341652|Sargramostim|sargramostim|mesh-list
19929198|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
19929199|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929200|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929201|NCT01341730|Pioglitazone|pioglitazone|mesh-list
19929202|NCT01341730|Atorvastatin|atorvastatin|mesh-list
19929203|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19929204|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19929205|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
19929206|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929207|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19929208|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19929209|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929210|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19929211|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929212|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
19929213|NCT01341782|Calcitriol|calcitriol|mesh-list
19929214|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
19929215|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19929216|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929217|NCT01341782|Vitamins|vitamins|mesh-ancestor
19929218|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
19929219|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19929220|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929221|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929222|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19929223|NCT01341782|Protective Agents|protective agents|mesh-ancestor
19929224|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19929225|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929226|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929227|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19929228|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19929229|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19929230|NCT01342029|Ranolazine|ranolazine|mesh-list
19929231|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19929232|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929233|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929234|NCT01342081|Timolol|timolol|mesh-list
19929235|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19929236|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19929237|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19929238|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19929239|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929240|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929241|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929242|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929243|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19929244|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19929245|NCT01342094|Timolol|timolol|mesh-list
19929246|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19929247|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19929248|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19929249|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19929250|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929251|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929252|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929253|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929254|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19929255|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19929256|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19929257|NCT01342172|Lenalidomide|lenalidomide|mesh-list
19929258|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
19929259|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929260|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19929261|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19929262|NCT01342172|Growth Substances|growth substances|mesh-ancestor
19929263|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
19929264|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929265|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19929266|NCT01342211|Bococizumab|bococizumab|mesh-list
19929267|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19929268|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19929269|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
19929270|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929271|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929272|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19929273|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
19929274|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19929275|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929276|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19929277|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929278|NCT01342367|Bicalutamide|bicalutamide|mesh-list
19929279|NCT01342367|Finasteride|finasteride|mesh-list
19929280|NCT01342367|Dutasteride|dutasteride|mesh-list
19929281|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
19929282|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
19929283|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929284|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929285|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929286|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19929287|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19929288|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929289|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929290|NCT01342367|Urological Agents|urological agents|mesh-ancestor
19929291|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19929292|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19929293|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929294|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19929295|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19929296|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929297|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929298|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
20263591|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263592|NCT00507052|Expectorants|expectorants|mesh-ancestor
20263593|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263594|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20263595|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
20263596|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263597|NCT00507052|Protective Agents|protective agents|mesh-ancestor
20263598|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263599|NCT00507052|Antidotes|antidotes|mesh-ancestor
20541970|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554065|NCT01932918|Narcotics|narcotics|mesh-ancestor
20554066|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554067|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554068|NCT01932918|Analgesics|analgesics|mesh-ancestor
20554069|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
20554070|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554071|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20554072|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20554073|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554074|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554075|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20554076|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554077|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554078|NCT01932931|Vitamin D|vitamin d|mesh-list
20554079|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
20554080|NCT01932931|Vitamins|vitamins|mesh-ancestor
20554081|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
20554082|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554083|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20554084|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20554085|NCT01933022|Leuprolide|leuprolide|mesh-list
19929299|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929300|NCT01342484|Linagliptin|linagliptin|mesh-list
19929301|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19929302|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929303|NCT01342484|Incretins|incretins|mesh-ancestor
19929304|NCT01342484|Hormones|hormones|mesh-ancestor
19929305|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929306|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19929307|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
20554086|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19929308|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929309|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929310|NCT01342510|Lidocaine|lidocaine|mesh-list
19929311|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
19929312|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
19929313|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
19929314|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929315|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929316|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
19929317|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929318|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19929319|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19929320|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19929321|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929322|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929323|NCT01342510|Analgesics|analgesics|mesh-ancestor
19929324|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
19929325|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19929326|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19929327|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
19929328|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19929329|NCT01342523|Nicotine|nicotine|mesh-list
19929330|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19929331|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
19929332|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929333|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929334|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19929335|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19929336|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
19929337|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929338|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929339|NCT01342549|Naltrexone|naltrexone|mesh-list
19929340|NCT01342549|Valproic Acid|valproic acid|mesh-list
19929341|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19929342|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19929343|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929344|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
19929345|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929346|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
19929347|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929348|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929349|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
19929350|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929351|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
19929352|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19929353|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929354|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19929355|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
19929356|NCT01342640|Hematinics|hematinics|mesh-ancestor
19973104|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973105|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973106|NCT01818700|Analgesics|analgesics|mesh-ancestor
19973107|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
19973108|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973109|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20263600|NCT00507065|Amphetamine|amphetamine|mesh-list
20263601|NCT00507065|Adderall|adderall|mesh-list
19973110|NCT01818726|Deferasirox|deferasirox|mesh-list
19973111|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19973112|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
19973113|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
19973114|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973115|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19973116|NCT01818752|Prednisone|prednisone|mesh-list
19973117|NCT01818752|Bortezomib|bortezomib|mesh-list
19973118|NCT01818752|Melphalan|melphalan|mesh-list
19973119|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973120|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
19973121|NCT01818752|Hormones|hormones|mesh-ancestor
19973122|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19973123|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973124|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19973125|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973126|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19973127|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
19929357|NCT01342757|Temozolomide|temozolomide|mesh-list
19929358|NCT01342757|Vorinostat|vorinostat|mesh-list
19929359|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19929360|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
19929361|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929362|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929363|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19929364|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929365|NCT01342770|Pioglitazone|pioglitazone|mesh-list
19929366|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19929367|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929368|NCT01342796|Vaccines|vaccines|mesh-list
19929369|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
19929370|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929371|NCT01342887|Cyclosporine|cyclosporine|mesh-list
19929372|NCT01342887|Etoposide|etoposide|mesh-list
19929373|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
19929374|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
19929375|NCT01342887|Pravastatin|pravastatin|mesh-list
19929376|NCT01342887|Cyclosporins|cyclosporins|mesh-list
19929377|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19929378|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929379|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19929380|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19929381|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929382|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929383|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929384|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
19929385|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929386|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
19929387|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929388|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929389|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929390|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19929391|NCT01342887|Analgesics|analgesics|mesh-ancestor
19929392|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
19929393|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929394|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19929395|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19929396|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
19929397|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19929398|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19929399|NCT01342913|Fluticasone|fluticasone|mesh-list
19929400|NCT01342913|Xhance|xhance|mesh-list
19929401|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19929402|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19929403|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19929404|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
19929405|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929406|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929407|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19929408|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929409|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929410|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19929411|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19929412|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19929413|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19929414|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929415|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929416|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929417|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19929418|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929419|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19929420|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929421|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929422|NCT01343004|Teriparatide|teriparatide|mesh-list
19929423|NCT01343004|Abaloparatide|abaloparatide|mesh-list
19929424|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19929425|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929426|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19929427|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
19929428|NCT01343043|Fludarabine|fludarabine|mesh-list
19929429|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929430|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
19929431|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929432|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929433|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19929434|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
19929435|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929436|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929437|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19929438|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19929439|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19929440|NCT01343277|Dacarbazine|dacarbazine|mesh-list
19929441|NCT01343277|Trabectedin|trabectedin|mesh-list
19929442|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19929443|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
19929444|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929445|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929446|NCT01343368|Leuprolide|leuprolide|mesh-list
19929447|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19929448|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
19929449|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19929450|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929451|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19929452|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929453|NCT01343823|Ecallantide|ecallantide|mesh-list
19929454|NCT01343823|Analgesics|analgesics|mesh-ancestor
19929455|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
19929456|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929457|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929458|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19929459|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19929460|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19929461|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929462|NCT01343901|Bevacizumab|bevacizumab|mesh-list
19929463|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19929464|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929465|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19929466|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19929467|NCT01343901|Growth Substances|growth substances|mesh-ancestor
19929468|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929469|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
19929470|NCT01344161|Vitamin D|vitamin d|mesh-list
19929471|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
19929472|NCT01344161|Vitamins|vitamins|mesh-ancestor
19929473|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
19929474|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929475|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19929476|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19929477|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19929478|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20263602|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20263603|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263604|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
20263605|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
20263606|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263607|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
20263608|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263609|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263610|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
20263611|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19929479|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19929480|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19929481|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19929482|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19929483|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19929484|NCT01344369|Norethindrone|norethindrone|mesh-list
19929485|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
19929486|NCT01344369|Estradiol|estradiol|mesh-list
19929487|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19929488|NCT01344369|Estrogens|estrogens|mesh-ancestor
19929489|NCT01344369|Hormones|hormones|mesh-ancestor
19929490|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929491|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929492|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19929493|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
19929494|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19929495|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19929496|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19929497|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19929498|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19929499|NCT01344629|Telmisartan|telmisartan|mesh-list
19929500|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19929501|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19929502|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19929503|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929504|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
19929505|NCT01344759|Propofol|propofol|mesh-list
19929506|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19929507|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929508|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929509|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19929510|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
19929511|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
19929512|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19929513|NCT01344759|Analgesics|analgesics|mesh-ancestor
19929514|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
19929515|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929516|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19929517|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19929518|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19929519|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929520|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929521|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929522|NCT01344824|Bevacizumab|bevacizumab|mesh-list
19929523|NCT01344824|Carboplatin|carboplatin|mesh-list
19929524|NCT01344824|Pemetrexed|pemetrexed|mesh-list
19450101|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929525|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19929526|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19929527|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929528|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19929529|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19929530|NCT01344824|Growth Substances|growth substances|mesh-ancestor
19929531|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929532|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
19929533|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929534|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929535|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19929536|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19929537|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19929538|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
19929539|NCT01345019|Denosumab|denosumab|mesh-list
19929540|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19929541|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929542|NCT01345058|Lacosamide|lacosamide|mesh-list
19929543|NCT01345058|Levetiracetam|levetiracetam|mesh-list
19929544|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
19929545|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
19929546|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19929547|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19929548|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929549|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929550|NCT01345162|Ketorolac|ketorolac|mesh-list
19929551|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19929552|NCT01345162|Tramadol|tramadol|mesh-list
19929553|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19929554|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19929555|NCT01345162|Analgesics|analgesics|mesh-ancestor
19929556|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
19929557|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929558|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929559|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19929560|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929561|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19929562|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929563|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929564|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19929565|NCT01345162|Narcotics|narcotics|mesh-ancestor
19975398|NCT01848457|Pantoprazole|pantoprazole|mesh-list
19929566|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929567|NCT01345188|Ranolazine|ranolazine|mesh-list
19929568|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19929569|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929570|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929571|NCT01345253|Belimumab|belimumab|mesh-list
19929572|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929573|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
19929574|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929575|NCT01345292|Listerine|listerine|mesh-list
19929576|NCT01345292|Fluorides|fluorides|mesh-list
19929577|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
19929578|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
19929579|NCT01345292|Protective Agents|protective agents|mesh-ancestor
19929580|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929581|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19929582|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929583|NCT01345630|Ritonavir|ritonavir|mesh-list
19929584|NCT01345630|Darunavir|darunavir|mesh-list
19929585|NCT01345630|Tenofovir|tenofovir|mesh-list
19929586|NCT01345630|Emtricitabine|emtricitabine|mesh-list
19929587|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19929588|NCT01345630|Maraviroc|maraviroc|mesh-list
19929589|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19929590|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19929591|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
19929592|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929593|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929594|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19929595|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19929596|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
19929597|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929598|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19929599|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19929600|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19929601|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19929602|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19929603|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19929604|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19929605|NCT01345669|Afatinib|afatinib|mesh-list
19929606|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929607|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19929608|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929609|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929610|NCT01345682|Methotrexate|methotrexate|mesh-list
19929611|NCT01345682|Afatinib|afatinib|mesh-list
19929612|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19929613|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
19929614|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19929615|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929616|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19929617|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
19929618|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929619|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929620|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929621|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929622|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19929623|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929624|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
19929625|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929626|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19929627|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19929628|NCT01345929|Levofloxacin|levofloxacin|mesh-list
19929629|NCT01345929|Ofloxacin|ofloxacin|mesh-list
19929630|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19929631|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929632|NCT01345929|Renal Agents|renal agents|mesh-ancestor
19929633|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19929634|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19929635|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19929636|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929637|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929638|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929639|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20541971|NCT01860482|Rabeprazole|rabeprazole|mesh-list
19929640|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19929641|NCT01346059|Vancomycin|vancomycin|mesh-list
19929642|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19929643|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929644|NCT01346072|Tolvaptan|tolvaptan|mesh-list
19929645|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19929646|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929647|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
19929648|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929649|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
19929650|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
19929651|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929652|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929653|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19929654|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
19929655|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19929656|NCT01346397|Cyclosporine|cyclosporine|mesh-list
19929657|NCT01346397|Tacrolimus|tacrolimus|mesh-list
19929658|NCT01346397|Cyclosporins|cyclosporins|mesh-list
19929659|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929660|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
19929661|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929662|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19929663|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929664|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929665|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
19929666|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929667|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929668|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929669|NCT01346475|Valacyclovir|valacyclovir|mesh-list
19929670|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
19929671|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929672|NCT01346540|Nintedanib|nintedanib|mesh-list
19929673|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929674|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19929675|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929676|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929677|NCT01346592|Vaccines|vaccines|mesh-list
19929678|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
19929679|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929680|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
19929681|NCT01347008|Citric Acid|citric acid|mesh-list
19929682|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
19929683|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
19929684|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19929685|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
19929686|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
19929687|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929688|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
19929689|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19929690|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19929691|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929692|NCT01347008|Urological Agents|urological agents|mesh-ancestor
19929693|NCT01347060|Fluticasone|fluticasone|mesh-list
19929694|NCT01347060|Xhance|xhance|mesh-list
19929695|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19929696|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19929697|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19929698|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
19929699|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929700|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929701|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19929702|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929703|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929704|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19929705|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20263612|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20263613|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263614|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19929706|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19929707|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19929708|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929709|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929710|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929711|NCT01347073|Glycerol|glycerol|mesh-list
19929712|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19929713|NCT01347073|Protective Agents|protective agents|mesh-ancestor
19929714|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929715|NCT01347112|Varenicline|varenicline|mesh-list
19929716|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19929717|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19929718|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
19929719|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929720|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929721|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929722|NCT01347255|Betamethasone|betamethasone|mesh-list
19929723|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
19929724|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19929725|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
19929726|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19929727|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19929728|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
19929729|NCT01347255|Hormones|hormones|mesh-ancestor
19929730|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929731|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929732|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19929733|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929734|NCT01347554|Everolimus|everolimus|mesh-list
19929735|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929736|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929737|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
19929738|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929739|NCT01347580|Ticagrelor|ticagrelor|mesh-list
19929740|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19929741|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19929742|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19929743|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19929744|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
19929745|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929746|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929747|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929748|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19929749|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
19929750|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19929751|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929752|NCT01347762|Nabilone|nabilone|mesh-list
19929753|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
19929754|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
19929755|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929756|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929757|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19929758|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19929759|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19929760|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929761|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19929762|NCT01347866|Irinotecan|irinotecan|mesh-list
19929763|NCT01347866|Gedatolisib|gedatolisib|mesh-list
19929764|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19929765|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19929766|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929767|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929768|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929769|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19929770|NCT01348100|Iloperidone|iloperidone|mesh-list
19929771|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19929772|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19929773|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929774|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929775|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19929776|NCT01348139|AZD-3199|azd-3199|mesh-list
19929777|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19929778|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19929779|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19929780|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929781|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929782|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929783|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929784|NCT01348542|Trazodone|trazodone|mesh-list
19929785|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19929786|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19929787|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929788|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929789|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19929790|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19929791|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19929792|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929793|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929794|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929795|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
19929796|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19929797|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
19973128|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973129|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19973130|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973131|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
19973132|NCT01819129|Insulin|insulin|mesh-list
19973133|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19973134|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
19973135|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
19973136|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
19973137|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19973138|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19973139|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973140|NCT01819415|Bevacizumab|bevacizumab|mesh-list
19973141|NCT01819415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19973142|NCT01819415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973143|NCT01819415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19973144|NCT01819415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19973145|NCT01819415|Growth Substances|growth substances|mesh-ancestor
19973146|NCT01819415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973147|NCT01819415|Growth Inhibitors|growth inhibitors|mesh-ancestor
19973148|NCT01819935|Vancomycin|vancomycin|mesh-list
19973149|NCT01819935|Linezolid|linezolid|mesh-list
19973150|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973151|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973152|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19973153|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973154|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975399|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19975400|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
19975401|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19975402|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975403|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19975404|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
19975405|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975406|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975407|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
19975408|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975409|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19975410|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19975411|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
19975412|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975413|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19975414|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19975415|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19975416|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19975417|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
19975418|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19975419|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975420|NCT01848899|Bivalirudin|bivalirudin|mesh-list
19975421|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
19975422|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19975423|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
19975424|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975425|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975426|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
19975427|NCT01848990|Insulin|insulin|mesh-list
19975428|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19975429|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
19975430|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
19975431|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
19975432|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19929798|NCT01348607|Methylphenidate|methylphenidate|mesh-list
19929799|NCT01348607|Modafinil|modafinil|mesh-list
19929800|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19929801|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929802|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19929803|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19929804|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929805|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929806|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
19929807|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929808|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19929809|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19929810|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19929811|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19929812|NCT01348763|Maraviroc|maraviroc|mesh-list
19929813|NCT01348763|Darunavir|darunavir|mesh-list
19929814|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19929815|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19929816|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929817|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929818|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
19450102|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450103|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450104|NCT03431142|Aspirin|aspirin|mesh-list
19450105|NCT03431142|Clopidogrel|clopidogrel|mesh-list
19450106|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19450107|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19450108|NCT03431142|Analgesics|analgesics|mesh-ancestor
19450109|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
19450110|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450111|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450112|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19450113|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450114|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19450115|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19450116|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450117|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19450118|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19450119|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450120|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
19450121|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19450122|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19450123|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19450124|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
19450125|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452670|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452671|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19452672|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
19452673|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452674|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19452675|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
19452676|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19452677|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19452678|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929819|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929820|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19929821|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19929822|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19929823|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19929824|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19929825|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20263615|NCT00507091|Leucovorin|leucovorin|mesh-list
20263616|NCT00507091|Fluorouracil|fluorouracil|mesh-list
20263617|NCT00507091|Irinotecan|irinotecan|mesh-list
20263618|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
20263619|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263620|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263621|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263622|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263623|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
20263624|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263625|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19929826|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19929827|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
19929828|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
19929829|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19929830|NCT01349192|Minocycline|minocycline|mesh-list
19929831|NCT01349192|Rifampin|rifampin|mesh-list
19929832|NCT01349192|Trimethoprim|trimethoprim|mesh-list
19929833|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
19929834|NCT01349192|Mupirocin|mupirocin|mesh-list
19929835|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19929836|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929837|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
19929838|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929839|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19929840|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19929841|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
19929842|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
19929843|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19929844|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929845|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929846|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19929847|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19929848|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19929849|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19929850|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19929851|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19929852|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19929853|NCT01349192|Renal Agents|renal agents|mesh-ancestor
19929854|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
19929855|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19929856|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19929857|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19929858|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19929859|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19929860|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19929861|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19929862|NCT01349231|Ketamine|ketamine|mesh-list
19929863|NCT01349231|Analgesics|analgesics|mesh-ancestor
19929864|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
19929865|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929866|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929867|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19929868|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19929869|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
19929870|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
19929871|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19929872|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19929873|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19929874|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929875|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929876|NCT01349491|Ranolazine|ranolazine|mesh-list
19929877|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19929878|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19929879|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929880|NCT01349569|Lenalidomide|lenalidomide|mesh-list
19929881|NCT01349569|Vaccines|vaccines|mesh-list
19929882|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
19929883|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929884|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19929885|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19929886|NCT01349569|Growth Substances|growth substances|mesh-ancestor
19929887|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
19929888|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929889|NCT01349660|Bevacizumab|bevacizumab|mesh-list
19929890|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19929891|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450126|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
19929892|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19929893|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19929894|NCT01349660|Growth Substances|growth substances|mesh-ancestor
19929895|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929896|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
19929897|NCT01349673|Budesonide|budesonide|mesh-list
19929898|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19929899|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19929900|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
19929901|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929902|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929903|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19929904|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929905|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
19929906|NCT01349673|Hormones|hormones|mesh-ancestor
19929907|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19929908|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
19929909|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19929910|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
19929911|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929912|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929913|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19929914|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929915|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19929916|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19929917|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19929918|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
19929919|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929920|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929921|NCT01349920|Infliximab|infliximab|mesh-list
19929922|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
19929923|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19929924|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929925|NCT01349972|Cytarabine|cytarabine|mesh-list
19929926|NCT01349972|Daunorubicin|daunorubicin|mesh-list
19929927|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
19929928|NCT01349972|Alvocidib|alvocidib|mesh-list
19929929|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19929930|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
19929931|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929932|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929933|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
19929934|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929935|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929936|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
19929937|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929938|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19929939|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19929940|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19929941|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929942|NCT01349972|Analgesics|analgesics|mesh-ancestor
19929943|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
19929944|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929945|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
19929946|NCT01349972|Growth Substances|growth substances|mesh-ancestor
19929947|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19929948|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
19929949|NCT01350102|Bacitracin|bacitracin|mesh-list
19929950|NCT01350102|Vitamins|vitamins|mesh-ancestor
19929951|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
19929952|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929953|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
19929954|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929955|NCT01350102|Protective Agents|protective agents|mesh-ancestor
19929956|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19929957|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929958|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19929959|NCT01350128|Bromides|bromides|mesh-list
19929960|NCT01350128|Ipratropium|ipratropium|mesh-list
19929961|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
19929962|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19929963|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
19929964|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19929965|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929966|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19929967|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
19929968|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19929969|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
19929970|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929971|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929972|NCT01350141|Bococizumab|bococizumab|mesh-list
19929973|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19929974|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20263626|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263627|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263628|NCT00507091|Antidotes|antidotes|mesh-ancestor
20263629|NCT00507091|Protective Agents|protective agents|mesh-ancestor
20263630|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
20263631|NCT00507091|Vitamins|vitamins|mesh-ancestor
20263632|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
20263633|NCT00507117|Eszopiclone|eszopiclone|mesh-list
20263634|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20263635|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263636|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263637|NCT00507143|Irinotecan|irinotecan|mesh-list
20263638|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20263639|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263640|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263641|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263642|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263643|NCT00507195|Midazolam|midazolam|mesh-list
20263644|NCT00507195|Propofol|propofol|mesh-list
20263645|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20263646|NCT00507195|Sevoflurane|sevoflurane|mesh-list
20263647|NCT00507195|Desflurane|desflurane|mesh-list
20263648|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263649|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263650|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20263651|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
20263652|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
20263653|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20263654|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20263655|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20263656|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20263657|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
20263658|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
20263659|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263660|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263661|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20263662|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20263663|NCT00507221|Albendazole|albendazole|mesh-list
20263664|NCT00507221|Praziquantel|praziquantel|mesh-list
20263665|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
20263666|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20263667|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263668|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
20263669|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20263670|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20263671|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
20263672|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
20263673|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
20263674|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263675|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263676|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
20263677|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20263678|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
20263679|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263680|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263681|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20263682|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
20263683|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20263684|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20263685|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20263686|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
20263687|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19929975|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
19929976|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929977|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19929978|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
19929979|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
20263688|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263689|NCT00507247|Daptomycin|daptomycin|mesh-list
20263690|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19929980|NCT01350245|Tacrolimus|tacrolimus|mesh-list
19929981|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19929982|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
19929983|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19929984|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19929985|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19929986|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
19732489|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732490|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732491|NCT04573153|Cathartics|cathartics|mesh-ancestor
19929987|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19929988|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19929989|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19929990|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19929991|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19929992|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19929993|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19929994|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
19929995|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19929996|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19929997|NCT01350271|Mebendazole|mebendazole|mesh-list
19929998|NCT01350271|Piperazine|piperazine|mesh-list
19929999|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
19930000|NCT01350271|DMP 777|dmp 777|mesh-list
19930001|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
19930002|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
19930003|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19930004|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930005|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
19930006|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
19930007|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
19930008|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930009|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930010|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930011|NCT01350388|Febuxostat|febuxostat|mesh-list
19930012|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
19930013|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930014|NCT01350804|Abatacept|abatacept|mesh-list
19930015|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19930016|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930017|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930018|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930019|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
19930020|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930021|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930022|NCT01350947|Azacitidine|azacitidine|mesh-list
19930023|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19930024|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
19930025|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930026|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930027|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930028|NCT01351025|Atorvastatin|atorvastatin|mesh-list
19930029|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19930030|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19930031|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
19930032|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930033|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19930034|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19930035|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930036|NCT01351090|Ketorolac|ketorolac|mesh-list
19930037|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19930038|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19930039|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19930040|NCT01351090|Analgesics|analgesics|mesh-ancestor
19930041|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
19930042|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930043|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930044|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732492|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732493|NCT04573192|Lomustine|lomustine|mesh-list
19732494|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19732495|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
19732496|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732497|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732498|NCT04573049|Simendan|simendan|mesh-list
19930045|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930046|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19930047|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930048|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930049|NCT01351350|Paclitaxel|paclitaxel|mesh-list
19930050|NCT01351350|Trastuzumab|trastuzumab|mesh-list
19930051|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19930052|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930053|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
19930054|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
19930055|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
19930056|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930057|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19930058|NCT01351415|Bevacizumab|bevacizumab|mesh-list
19930059|NCT01351415|Docetaxel|docetaxel|mesh-list
19930060|NCT01351415|Pemetrexed|pemetrexed|mesh-list
19930061|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19930062|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19732499|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19732500|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
19732501|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19732502|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19732503|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732504|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732505|NCT04573049|Protective Agents|protective agents|mesh-ancestor
19732506|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732507|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
19732508|NCT04572698|Growth Substances|growth substances|mesh-ancestor
19732509|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930063|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930064|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19930065|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19930066|NCT01351415|Growth Substances|growth substances|mesh-ancestor
19930067|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930068|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
19930069|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
19930070|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
19930071|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
19930072|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930073|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930074|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19930075|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19930076|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19930077|NCT01351480|Abatacept|abatacept|mesh-list
19930078|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19930079|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930080|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930081|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930082|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
19930083|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930084|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930085|NCT01351740|Ritonavir|ritonavir|mesh-list
19930086|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19930087|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19930088|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19930089|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930090|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930091|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930092|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19930093|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19930094|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
19930095|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930096|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19930097|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930098|NCT01351753|Metformin|metformin|mesh-list
19930099|NCT01351753|Topiramate|topiramate|mesh-list
19930100|NCT01351753|Orlistat|orlistat|mesh-list
19930101|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19930102|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930103|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
19930104|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930105|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930106|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19930107|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19930108|NCT01351805|Vitamin D|vitamin d|mesh-list
19930109|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
19930110|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
19930111|NCT01351805|Vitamins|vitamins|mesh-list
19930112|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
19930113|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930114|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19930115|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19930116|NCT01352117|Tenofovir|tenofovir|mesh-list
19930117|NCT01352117|Emtricitabine|emtricitabine|mesh-list
19930118|NCT01352117|Efavirenz|efavirenz|mesh-list
19930119|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19930120|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19930121|NCT01352117|Etoposide|etoposide|mesh-list
19930122|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19930123|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930124|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19930125|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19930126|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930127|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930128|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
19930129|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930130|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19930131|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19930132|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19930133|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19930134|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19930135|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930136|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19930137|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19930138|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19930139|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19930140|NCT01352182|Pioglitazone|pioglitazone|mesh-list
19930141|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19930142|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930143|NCT01352221|Ferric maltol|ferric maltol|mesh-list
19930144|NCT01352221|Hematinics|hematinics|mesh-ancestor
19930145|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
19930146|NCT01352507|Tadalafil|tadalafil|mesh-list
19930147|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
19930148|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19930149|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19930150|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930151|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930152|NCT01352507|Urological Agents|urological agents|mesh-ancestor
19930153|NCT01352585|Anagrelide|anagrelide|mesh-list
19930154|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19930155|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19930156|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930157|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19930158|NCT01352637|Cycloserine|cycloserine|mesh-list
19930159|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19930160|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930161|NCT01352637|Renal Agents|renal agents|mesh-ancestor
19930162|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19930163|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
19930164|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19930165|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
19930166|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930167|NCT01352715|Ritonavir|ritonavir|mesh-list
19930168|NCT01352715|Lopinavir|lopinavir|mesh-list
19930169|NCT01352715|Tenofovir|tenofovir|mesh-list
19930170|NCT01352715|Lamivudine|lamivudine|mesh-list
19930171|NCT01352715|Zidovudine|zidovudine|mesh-list
19930172|NCT01352715|Emtricitabine|emtricitabine|mesh-list
19930173|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
19930174|NCT01352715|Abacavir|abacavir|mesh-list
19930175|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19930176|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
19930177|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19930178|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19930179|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930180|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930181|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930182|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19930183|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19930184|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
19930185|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930186|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19930187|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930188|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19930189|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19930190|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
19930191|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19930192|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19930193|NCT01352741|Pregabalin|pregabalin|mesh-list
19930194|NCT01352741|Tapentadol|tapentadol|mesh-list
19930195|NCT01352741|Analgesics|analgesics|mesh-ancestor
19930196|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
19930197|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930198|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930199|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
19930200|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19930201|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930202|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930203|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19930204|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19930205|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19930206|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930207|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930208|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19930209|NCT01352741|Narcotics|narcotics|mesh-ancestor
19930210|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19930211|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19450127|NCT03431077|Giapreza|giapreza|mesh-list
19930212|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
19930213|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930214|NCT01353144|Aspirin|aspirin|mesh-list
19930215|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19930216|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19930217|NCT01353144|Analgesics|analgesics|mesh-ancestor
19930218|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
19930219|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930220|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930221|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930222|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930223|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19930224|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19930225|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930226|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19930227|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19930228|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930229|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
19930230|NCT01353508|Valsartan|valsartan|mesh-list
19930231|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19930232|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19930233|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19930234|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19930235|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930236|NCT01353664|Romidepsin|romidepsin|mesh-list
19930237|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19930238|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930239|NCT01353859|Methotrexate|methotrexate|mesh-list
19930240|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19930241|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
19930242|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19930243|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930244|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19930245|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
19930246|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930247|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930248|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
19930249|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930250|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19930251|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930252|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
19930253|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930254|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19930255|NCT01353911|Interferons|interferons|mesh-list
19930256|NCT01353911|Ribavirin|ribavirin|mesh-list
19930257|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
19930258|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
19930259|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19930260|NCT01353911|Grazoprevir|grazoprevir|mesh-list
19930261|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930262|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
19930263|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930264|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
19930265|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930266|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
19930267|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930268|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19930269|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19930270|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19930271|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930272|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930273|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930274|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930275|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930276|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930277|NCT01353976|Econazole|econazole|mesh-list
19930278|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
19930279|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930280|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19930281|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930282|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930283|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930284|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19930285|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
19930286|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930287|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930288|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
19930289|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19930290|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
19930291|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930292|NCT01354132|Expectorants|expectorants|mesh-ancestor
19930293|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
19930294|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19930295|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
19930296|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930297|NCT01354132|Protective Agents|protective agents|mesh-ancestor
19930298|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930299|NCT01354132|Antidotes|antidotes|mesh-ancestor
19930300|NCT01354145|Celecoxib|celecoxib|mesh-list
19930301|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19930302|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19930303|NCT01354145|Analgesics|analgesics|mesh-ancestor
19930304|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
19930305|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930306|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930307|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930308|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930309|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19930310|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19930311|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930312|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930313|NCT01354314|Fluconazole|fluconazole|mesh-list
19930314|NCT01354314|Paroxetine|paroxetine|mesh-list
19930315|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19930316|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19930317|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930318|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930319|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930320|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
19930321|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930322|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19930323|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930324|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930325|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19930326|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930327|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930328|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
19930329|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930330|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19930331|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19930332|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
19930333|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930334|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19930335|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19930336|NCT01354353|Aripiprazole|aripiprazole|mesh-list
19930337|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930338|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930339|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19930340|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20263691|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263692|NCT00507286|Alprostadil|alprostadil|mesh-list
20263693|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20263694|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
20263695|NCT00507286|Urological Agents|urological agents|mesh-ancestor
20263696|NCT00507403|Infliximab|infliximab|mesh-list
20263697|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
20263698|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20263699|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263700|NCT00507494|Pioglitazone|pioglitazone|mesh-list
20263701|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20263702|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263703|NCT00507585|Leucovorin|leucovorin|mesh-list
20263704|NCT00507585|Bevacizumab|bevacizumab|mesh-list
20263705|NCT00507585|Fluorouracil|fluorouracil|mesh-list
20263706|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
20263707|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20263708|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263709|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20263710|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20263711|NCT00507585|Growth Substances|growth substances|mesh-ancestor
20263712|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263713|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
20263714|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
20263715|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263716|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263717|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263718|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
20263719|NCT00507585|Antidotes|antidotes|mesh-ancestor
20263720|NCT00507585|Protective Agents|protective agents|mesh-ancestor
20263721|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
20263722|NCT00507585|Vitamins|vitamins|mesh-ancestor
20263723|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
20263724|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
20263725|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20263726|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20263727|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20263728|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20263729|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20541972|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20541973|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20541974|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20541975|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541976|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541977|NCT01860508|Carboplatin|carboplatin|mesh-list
20541978|NCT01860508|Pemetrexed|pemetrexed|mesh-list
20541979|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541980|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541981|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541982|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20541983|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20541984|NCT01860625|Donepezil|donepezil|mesh-list
20263730|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263731|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
20263732|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541985|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19930341|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930342|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930343|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
19930344|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
19930345|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930346|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930347|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19930348|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19930349|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
19930350|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19930351|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19930352|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19930353|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19930354|NCT01354444|Carvedilol|carvedilol|mesh-list
19930355|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19930356|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19930357|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
19930358|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930359|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930360|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930361|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19930362|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
19930363|NCT01354444|Protective Agents|protective agents|mesh-ancestor
19930364|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19930365|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930366|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19930367|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
19930368|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19930369|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19930370|NCT01354652|Lamivudine|lamivudine|mesh-list
19930371|NCT01354652|Entecavir|entecavir|mesh-list
19930372|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19930373|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19930374|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930375|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930376|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
19930377|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930378|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19930379|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19973155|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19973156|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
19973157|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19973158|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19973159|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973160|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973161|NCT01820572|Cyclosporine|cyclosporine|mesh-list
19973162|NCT01820572|Abatacept|abatacept|mesh-list
19973163|NCT01820572|Tacrolimus|tacrolimus|mesh-list
19973164|NCT01820572|Cyclosporins|cyclosporins|mesh-list
19973165|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973166|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
19973167|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973168|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19973169|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973170|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973171|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
19973172|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973173|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19973174|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973175|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19973176|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973177|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19973178|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
19973179|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19973180|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19973181|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973182|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973183|NCT01820637|Paclitaxel|paclitaxel|mesh-list
19973184|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19973185|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973186|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
19973187|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
19930380|NCT01354938|Clarithromycin|clarithromycin|mesh-list
19930381|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19930382|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930383|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19930384|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930385|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930386|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19930387|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930388|NCT01354964|Vitamin D|vitamin d|mesh-list
19930389|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
19930390|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
19930391|NCT01354964|Vitamins|vitamins|mesh-list
19930392|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
19930393|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930394|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19930395|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19930396|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19930397|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19930398|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930399|NCT01354990|Incretins|incretins|mesh-ancestor
19930400|NCT01354990|Hormones|hormones|mesh-ancestor
19930401|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930402|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19930403|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930404|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930405|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930406|NCT01355068|Phenytoin|phenytoin|mesh-list
19930407|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
19930408|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19930409|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19930410|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930411|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930412|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19930413|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19930414|NCT01355081|Vortioxetine|vortioxetine|mesh-list
19930415|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930416|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930417|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20263733|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263734|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20263735|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263736|NCT00507663|Atenolol|atenolol|mesh-list
20263737|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20263738|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20263739|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
20263740|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
20263741|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263742|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263743|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20263744|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20263745|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20263746|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
20263747|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263748|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263749|NCT00507793|Cyclosporine|cyclosporine|mesh-list
20263750|NCT00507793|Sirolimus|sirolimus|mesh-list
20263751|NCT00507793|Cyclosporins|cyclosporins|mesh-list
20263752|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263753|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263754|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263755|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
20263756|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263757|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
19930418|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19930419|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930420|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930421|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19930422|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19930423|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930424|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930425|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930426|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
19930427|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19930428|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19930429|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19930430|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19930431|NCT01355159|Folic Acid|folic acid|mesh-list
19930432|NCT01355159|Hematinics|hematinics|mesh-ancestor
19930433|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
19930434|NCT01355159|Vitamins|vitamins|mesh-ancestor
19930435|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
19930436|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930437|NCT01355289|Interferons|interferons|mesh-list
19930438|NCT01355289|Ribavirin|ribavirin|mesh-list
19930439|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930440|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
19930441|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930442|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
19930443|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930444|NCT01355302|Capecitabine|capecitabine|mesh-list
19930445|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930446|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19930447|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
19930448|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930449|NCT01355523|Melatonin|melatonin|mesh-list
19930450|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
19930451|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930452|NCT01355523|Protective Agents|protective agents|mesh-ancestor
19930453|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930454|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930455|NCT01355575|Rifaximin|rifaximin|mesh-list
19930456|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19930457|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930458|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19930459|NCT01355588|Ketorolac|ketorolac|mesh-list
19930460|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19930461|NCT01355588|Lidocaine|lidocaine|mesh-list
19930462|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
19930463|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
19930464|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930465|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930466|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
19930467|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930468|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19930469|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19930470|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19930471|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930472|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930473|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19930474|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19930475|NCT01355588|Analgesics|analgesics|mesh-ancestor
19930476|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930477|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930478|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19930479|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930480|NCT01355705|Aspirin|aspirin|mesh-list
19930481|NCT01355705|Dexamethasone|dexamethasone|mesh-list
19930482|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
19930483|NCT01355705|Lenalidomide|lenalidomide|mesh-list
19930484|NCT01355705|Amrubicin|amrubicin|mesh-list
19930485|NCT01355705|BB 1101|bb 1101|mesh-list
19930486|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930487|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
19930488|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
19930489|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930490|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930491|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19930492|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
19930493|NCT01355705|Hormones|hormones|mesh-ancestor
19930494|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930495|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19930496|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930497|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930498|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930499|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930500|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19930501|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19930502|NCT01355705|Analgesics|analgesics|mesh-ancestor
19930503|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
19930504|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930505|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19930506|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19930507|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19930508|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19930509|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
19930510|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
19930511|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19930512|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19930513|NCT01355705|Growth Substances|growth substances|mesh-ancestor
19930514|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
19930515|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
19930516|NCT01356407|Cathartics|cathartics|mesh-ancestor
19930517|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19930518|NCT01356602|Triamcinolone|triamcinolone|mesh-list
19930519|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19930520|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19930521|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19930522|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19930523|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930524|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
19930525|NCT01356602|Hormones|hormones|mesh-ancestor
19930526|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930527|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930528|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930529|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
19930530|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930531|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930532|NCT01356628|Palbociclib|palbociclib|mesh-list
19930533|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930534|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19930535|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930536|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930537|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
19930538|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19930539|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930540|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930541|NCT01356966|Folic Acid|folic acid|mesh-list
19930542|NCT01356966|Hematinics|hematinics|mesh-ancestor
19930543|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
19930544|NCT01356966|Vitamins|vitamins|mesh-ancestor
19930545|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
19930546|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930547|NCT01357135|Metformin|metformin|mesh-list
19930548|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19930549|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19930550|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930551|NCT01357135|Incretins|incretins|mesh-ancestor
19930552|NCT01357135|Hormones|hormones|mesh-ancestor
19930553|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930554|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19930555|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930556|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930557|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930558|NCT01357148|Metformin|metformin|mesh-list
19930559|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19930560|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19930561|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930562|NCT01357148|Incretins|incretins|mesh-ancestor
19930563|NCT01357148|Hormones|hormones|mesh-ancestor
19930564|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930565|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19930566|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930567|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930568|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930569|NCT01357161|Paclitaxel|paclitaxel|mesh-list
19930570|NCT01357161|Carboplatin|carboplatin|mesh-list
19930571|NCT01357161|Adavosertib|adavosertib|mesh-list
19930572|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19930573|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930574|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
19930575|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
19930576|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
19930577|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930578|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930579|NCT01357616|Timolol|timolol|mesh-list
19930580|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19930581|NCT01357616|Brinzolamide|brinzolamide|mesh-list
19930582|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19930583|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19930584|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19930585|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
19930586|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930587|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930588|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930589|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19930590|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19930591|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19930592|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930593|NCT01357655|Dasatinib|dasatinib|mesh-list
19930594|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930595|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19930596|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930597|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930598|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
19930599|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19930600|NCT01357889|Incretins|incretins|mesh-ancestor
19930601|NCT01357889|Hormones|hormones|mesh-ancestor
19930602|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930603|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930604|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
19930605|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19930606|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19930607|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19930608|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930609|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930610|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
20263758|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263759|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
20263760|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263761|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20263762|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20263763|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20263764|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263765|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
20263766|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20263767|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20263768|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20263769|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
20263770|NCT00507832|Tacrolimus|tacrolimus|mesh-list
20263771|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263772|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20263773|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20263774|NCT00507832|Analgesics|analgesics|mesh-ancestor
20263775|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
20263776|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263777|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263778|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20263779|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
20263780|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263781|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
20263782|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20263783|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263784|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263785|NCT00507845|Felodipine|felodipine|mesh-list
20263786|NCT00507845|Ramipril|ramipril|mesh-list
20263787|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20263788|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930611|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930612|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930613|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19930614|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930615|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19930616|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
19930617|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930618|NCT01358266|Sirolimus|sirolimus|mesh-list
19930619|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20263789|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287113|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930620|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930621|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19930622|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930623|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
19930624|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930625|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
19930626|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930627|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19930628|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19930629|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19930630|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930631|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930632|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930633|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19930634|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19930635|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19930636|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
19930637|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930638|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930639|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19930640|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19930641|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
19930642|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19930643|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19930644|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
19930645|NCT01358526|Oxycodone|oxycodone|mesh-list
19930646|NCT01358526|Naloxone|naloxone|mesh-list
19930647|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19930648|NCT01358526|Narcotics|narcotics|mesh-ancestor
19930649|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930650|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930651|NCT01358526|Analgesics|analgesics|mesh-ancestor
19450128|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
19450129|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19450130|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19450131|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
19450132|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930652|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
19930653|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930654|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19930655|NCT01358578|Etanercept|etanercept|mesh-list
19930656|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19930657|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19930658|NCT01358578|Analgesics|analgesics|mesh-ancestor
19930659|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
19930660|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930661|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450133|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450134|NCT03430947|Vemurafenib|vemurafenib|mesh-list
19450135|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450136|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19450137|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450138|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450139|NCT03430817|Amantadine|amantadine|mesh-list
19450140|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19450141|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19450142|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19450143|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
19450144|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930662|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930663|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930664|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19930665|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930666|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
19930667|NCT01358721|Nivolumab|nivolumab|mesh-list
19930668|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19930669|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930670|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19930671|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930672|NCT01358734|Lenalidomide|lenalidomide|mesh-list
19930673|NCT01358734|Azacitidine|azacitidine|mesh-list
19930674|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
19930675|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930676|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19930677|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19930678|NCT01358734|Growth Substances|growth substances|mesh-ancestor
19930679|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
19930680|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930681|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19930682|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
19930683|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930684|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930685|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19930686|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19930687|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
19930688|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930689|NCT01358864|Interferons|interferons|mesh-list
19930690|NCT01358864|Ribavirin|ribavirin|mesh-list
19930691|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
19930692|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930693|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
19930694|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930695|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
19930696|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930697|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
19930698|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930699|NCT01358968|Gemcitabine|gemcitabine|mesh-list
19930700|NCT01358968|Pemetrexed|pemetrexed|mesh-list
19930701|NCT01358968|Desipramine|desipramine|mesh-list
19930702|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19930703|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
19930704|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930705|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930706|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
19930707|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930708|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930709|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930710|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
19930711|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930712|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19930713|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19930714|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19930715|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930716|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930717|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19930718|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19930719|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930720|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
19930721|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930722|NCT01359007|Leucovorin|leucovorin|mesh-list
19930723|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
19930724|NCT01359007|Irinotecan|irinotecan|mesh-list
19930725|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930726|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19930727|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19930728|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930729|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930730|NCT01359007|Antidotes|antidotes|mesh-ancestor
19930731|NCT01359007|Protective Agents|protective agents|mesh-ancestor
19930732|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930733|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
19930734|NCT01359007|Vitamins|vitamins|mesh-ancestor
19930735|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
19930736|NCT01359150|Tofacitinib|tofacitinib|mesh-list
19930737|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19930738|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930739|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930740|NCT01359592|Prednisone|prednisone|mesh-list
19930741|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
19930742|NCT01359592|Rituximab|rituximab|mesh-list
19930743|NCT01359592|Doxorubicin|doxorubicin|mesh-list
19930744|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19930745|NCT01359592|Vincristine|vincristine|mesh-list
19930746|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19930747|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19930748|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
19930749|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930750|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930751|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19930752|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
19930753|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930754|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930755|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19930756|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19930757|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19930758|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19930759|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19930760|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930761|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930762|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
19930763|NCT01359592|Hormones|hormones|mesh-ancestor
19930764|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930765|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19930766|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19930767|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
19930768|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
19930769|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
19930770|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19930771|NCT01359644|Ribavirin|ribavirin|mesh-list
19930772|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
19930773|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
19930774|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930775|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
19930776|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930777|NCT01359735|Bacitracin|bacitracin|mesh-list
19930778|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19930779|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930780|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19930781|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
19930782|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19930783|NCT01359956|Interferons|interferons|mesh-list
19930784|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
19930785|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
19930786|NCT01359956|Dacarbazine|dacarbazine|mesh-list
19930787|NCT01359956|Fotemustine|fotemustine|mesh-list
19930788|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930789|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
19930790|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930791|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
19930792|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930793|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19930794|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
19930795|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930796|NCT01360021|Budesonide|budesonide|mesh-list
19930797|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19930798|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930799|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19930800|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
19930801|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930802|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930803|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19930804|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
19930805|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
19930806|NCT01360021|Hormones|hormones|mesh-ancestor
19930807|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19930808|NCT01360450|Clonidine|clonidine|mesh-list
19930809|NCT01360450|Analgesics|analgesics|mesh-ancestor
19930810|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
19930811|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930812|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930813|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19930814|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
19930815|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
19930816|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20263790|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263791|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20263792|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20263793|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20263794|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263795|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20287114|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450145|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
19930817|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19930818|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19930819|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
19930820|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930821|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930822|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19930823|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930824|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19930825|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930826|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930827|NCT01360762|Pentamidine|pentamidine|mesh-list
19930828|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
19930829|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930830|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19930831|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19930832|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19930833|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19930834|NCT01360866|Citalopram|citalopram|mesh-list
19930835|NCT01360866|Fluoxetine|fluoxetine|mesh-list
19930836|NCT01360866|Paroxetine|paroxetine|mesh-list
20263796|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263797|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
20263798|NCT00507858|Dexamethasone|dexamethasone|mesh-list
20263799|NCT00507858|Pemetrexed|pemetrexed|mesh-list
20263800|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263801|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
20263802|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
20263803|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263804|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263805|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20263806|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
20263807|NCT00507858|Hormones|hormones|mesh-ancestor
20263808|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263809|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20263810|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263811|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263812|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263813|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20263814|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20263815|NCT00507949|Megestrol|megestrol|mesh-list
20263816|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
20263817|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20541986|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20541987|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20541988|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
20541989|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20541990|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20541991|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
20541992|NCT01860638|Bevacizumab|bevacizumab|mesh-list
20541993|NCT01860638|Temozolomide|temozolomide|mesh-list
20541994|NCT01860638|Lomustine|lomustine|mesh-list
20541995|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20541996|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20541997|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20541998|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20541999|NCT01860638|Growth Substances|growth substances|mesh-ancestor
20542000|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542001|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
20542002|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20542003|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
20542004|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542005|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
20542006|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542007|NCT01860690|Methotrexate|methotrexate|mesh-list
20542008|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20542009|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
20542010|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20542011|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542012|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20542013|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
20542014|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542015|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542016|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
20542017|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542018|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20542019|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542020|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
19930837|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19930838|NCT01360866|Sertraline|sertraline|mesh-list
20542021|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554087|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
19930839|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19930840|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19930841|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930842|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930843|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930844|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
19930845|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930846|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19930847|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930848|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930849|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930850|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19930851|NCT01360866|Analgesics|analgesics|mesh-ancestor
19930852|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
19930853|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
19930854|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19930855|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930856|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930857|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
19930858|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
19930859|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19930860|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930861|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19930862|NCT01361009|Pramipexole|pramipexole|mesh-list
19930863|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
19930864|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930865|NCT01361009|Protective Agents|protective agents|mesh-ancestor
19930866|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930867|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19930868|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19930869|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
19930870|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
19930871|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930872|NCT01361048|Metronidazole|metronidazole|mesh-list
19930873|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930874|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19930875|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19930876|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19930877|NCT01361217|Midazolam|midazolam|mesh-list
19930878|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
19930879|NCT01361217|Caffeine|caffeine|mesh-list
19930880|NCT01361217|Fluoxetine|fluoxetine|mesh-list
19930881|NCT01361217|Omeprazole|omeprazole|mesh-list
19930882|NCT01361217|Lovastatin|lovastatin|mesh-list
19930883|NCT01361217|L 647318|l 647318|mesh-list
19930884|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
19930885|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19930886|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19930887|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930888|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930889|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19930890|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19930891|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930892|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19930893|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
19930894|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
19930895|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
19930896|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
19930897|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930898|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930899|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19930900|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19930901|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19930902|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930903|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19930904|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19930905|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19930906|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19930907|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
19930908|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19930909|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19930910|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930911|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
19930912|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20263818|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19930913|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930914|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19930915|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930916|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
19930917|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
19930918|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19930919|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20263819|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20263820|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
20263821|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20263822|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263823|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20263824|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20263825|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20263826|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263827|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
20263828|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20263829|NCT00507962|Cisplatin|cisplatin|mesh-list
20263830|NCT00507962|Doxorubicin|doxorubicin|mesh-list
20263831|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20263832|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263833|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20263834|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20263835|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20263836|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263837|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263838|NCT00507975|Nicotine|nicotine|mesh-list
20263839|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20263840|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
20263841|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263842|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263843|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20263844|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20263845|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
20263846|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263847|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263848|NCT00508040|Interferons|interferons|mesh-list
20263849|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
20263850|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
20263851|NCT00508040|Prednisone|prednisone|mesh-list
20263852|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20263853|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
20263854|NCT00508040|Hormones|hormones|mesh-ancestor
20263855|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263856|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263857|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20263858|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263859|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
20263860|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263861|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
20263862|NCT00508092|Anesthetics|anesthetics|mesh-list
20263863|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
20263864|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20263865|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263866|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
20263867|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263868|NCT00508209|Bortezomib|bortezomib|mesh-list
20263869|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263870|NCT00508222|Lopinavir|lopinavir|mesh-list
20263871|NCT00508222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20263872|NCT00508222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20263873|NCT00508222|Protease Inhibitors|protease inhibitors|mesh-ancestor
19930920|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19930921|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19930922|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
19930923|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19930924|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19930925|NCT01361308|Paroxetine|paroxetine|mesh-list
19930926|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19930927|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19930928|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19930929|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263874|NCT00508222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930930|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19930931|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
19930932|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930933|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19930934|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
19930935|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19930936|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19930937|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19930938|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930939|NCT01361464|Tipifarnib|tipifarnib|mesh-list
19930940|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930941|NCT01361594|Insulin|insulin|mesh-list
19930942|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19930943|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19930944|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930945|NCT01361607|Nabiximols|nabiximols|mesh-list
19930946|NCT01361607|Analgesics|analgesics|mesh-ancestor
19930947|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
19930948|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930949|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930950|NCT01361620|Aspirin|aspirin|mesh-list
19930951|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19930952|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19930953|NCT01361620|Analgesics|analgesics|mesh-ancestor
19930954|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
19930955|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19930956|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930957|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19930958|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19930959|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19930960|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19930961|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930962|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19930963|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19930964|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19930965|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
19973188|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
19973189|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973190|NCT01820754|Paclitaxel|paclitaxel|mesh-list
19973191|NCT01820754|Carboplatin|carboplatin|mesh-list
19973192|NCT01820754|Ipilimumab|ipilimumab|mesh-list
19973193|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19973194|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973195|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
19973196|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
19973197|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
19973198|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973199|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19973200|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19973201|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19973202|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19973203|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973204|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19973205|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19973206|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19973207|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973208|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973209|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19973210|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19973211|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19973212|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19973213|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
19973214|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973215|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973216|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19973217|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19973218|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
19973219|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20263875|NCT00508222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263876|NCT00508222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20263877|NCT00508222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19973220|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19973221|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
19930966|NCT01361633|Cycloserine|cycloserine|mesh-list
19930967|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19930968|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930969|NCT01361633|Renal Agents|renal agents|mesh-ancestor
19930970|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19930971|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
19930972|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19930973|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
19930974|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19930975|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19930976|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
19930977|NCT01361711|Ofatumumab|ofatumumab|mesh-list
19930978|NCT01361711|Antibodies|antibodies|mesh-list
19930979|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
19930980|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19930981|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
19930982|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19930983|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930984|NCT01362127|Cisplatin|cisplatin|mesh-list
19930985|NCT01362127|Carboplatin|carboplatin|mesh-list
19930986|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
19930987|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19930988|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
19930989|NCT01362140|Hematinics|hematinics|mesh-ancestor
19930990|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
19930991|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19930992|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19930993|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19930994|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
19930995|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
19930996|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
19930997|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19930998|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19930999|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931000|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931001|NCT01362205|Analgesics|analgesics|mesh-ancestor
19931002|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
19931003|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931004|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19931005|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19931006|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19931007|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19931008|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931009|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931010|NCT01362296|Docetaxel|docetaxel|mesh-list
19931011|NCT01362296|Trametinib|trametinib|mesh-list
19931012|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931013|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
19931014|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
19931015|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
19931016|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931017|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19931018|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931019|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19931020|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19931021|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19931022|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19931023|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931024|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931025|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931026|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931027|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19931028|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19931029|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
19931030|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931031|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931032|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19931033|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19931034|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
19931035|NCT01362491|Ibuprofen|ibuprofen|mesh-list
19931036|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931037|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931038|NCT01362491|Analgesics|analgesics|mesh-ancestor
19931039|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
19931040|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931041|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931042|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931043|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931044|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19931045|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931046|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931047|NCT01362530|Ondansetron|ondansetron|mesh-list
19931048|NCT01362530|Aprepitant|aprepitant|mesh-list
19931049|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
19931050|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
19931051|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
19931052|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931053|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931054|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931055|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
19931056|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931057|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19931058|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
19732510|NCT04572867|Diuretics|diuretics|mesh-list
19732511|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
19732512|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931059|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931060|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931061|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19931062|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931063|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931064|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931065|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19931066|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19931067|NCT01362608|Triamcinolone|triamcinolone|mesh-list
20263878|NCT00508222|Antiviral Agents|antiviral agents|mesh-ancestor
20263879|NCT00508222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263880|NCT00508222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20263881|NCT00508222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20263882|NCT00508287|Exenatide|exenatide|mesh-list
20263883|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20263884|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263885|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20263886|NCT00508287|Incretins|incretins|mesh-ancestor
20263887|NCT00508287|Hormones|hormones|mesh-ancestor
20263888|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263889|NCT00508326|Paclitaxel|paclitaxel|mesh-list
20263890|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20263891|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263892|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20263893|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20263894|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20263895|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263896|NCT00508365|Carvedilol|carvedilol|mesh-list
20263897|NCT00508365|Lisinopril|lisinopril|mesh-list
20263898|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20263899|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20263900|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
20263901|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263902|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931068|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19931069|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19931070|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19732513|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19732514|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19732515|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19732516|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732517|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732518|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19732519|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19732520|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19732521|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
19732522|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732523|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732524|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19732525|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19732526|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
19732527|NCT04572724|Valsartan|valsartan|mesh-list
19732528|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19732529|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19931071|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931072|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
19931073|NCT01362608|Hormones|hormones|mesh-ancestor
19931074|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931075|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931076|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931077|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
19931078|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931079|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931080|NCT01362686|Rivastigmine|rivastigmine|mesh-list
19931081|NCT01362686|Donepezil|donepezil|mesh-list
19931082|NCT01362686|Galantamine|galantamine|mesh-list
19931083|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19931084|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931085|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931086|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
19931087|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931088|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931089|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
19931090|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19931091|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
19931092|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931093|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19931094|NCT01362686|Protective Agents|protective agents|mesh-ancestor
19931095|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
19931096|NCT01362790|Pentostatin|pentostatin|mesh-list
19931097|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19931098|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931099|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
19931100|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931101|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931102|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19931103|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
19931104|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931105|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931106|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19931107|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
19931108|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931109|NCT01362959|Nicotine|nicotine|mesh-list
19931110|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19931111|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
19931112|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931113|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931114|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19931115|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19931116|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
19931117|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931118|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931119|NCT01363011|Darunavir|darunavir|mesh-list
19931120|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19931121|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19931122|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19931123|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
19931124|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931125|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931126|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19931127|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19931128|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
19931129|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931130|NCT01363050|Ketorolac|ketorolac|mesh-list
19931131|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19931132|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931133|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931134|NCT01363050|Analgesics|analgesics|mesh-ancestor
19931135|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
19931136|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931137|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931138|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931139|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931140|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19931141|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931142|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931143|NCT01363076|Ketorolac|ketorolac|mesh-list
19931144|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19931145|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931146|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931147|NCT01363076|Analgesics|analgesics|mesh-ancestor
19931148|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
19931149|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931150|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931151|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931152|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931153|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19931154|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931155|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931156|NCT01363128|Cytarabine|cytarabine|mesh-list
19931157|NCT01363128|Dexamethasone|dexamethasone|mesh-list
19931158|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
19931159|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
19931160|NCT01363128|Doxorubicin|doxorubicin|mesh-list
19931161|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19931162|NCT01363128|Methotrexate|methotrexate|mesh-list
19931163|NCT01363128|Vincristine|vincristine|mesh-list
19931164|NCT01363128|Ofatumumab|ofatumumab|mesh-list
19931165|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19931166|NCT01363128|BB 1101|bb 1101|mesh-list
19931167|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931168|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
19931169|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931170|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931171|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19931172|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
19931173|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931174|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931175|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19931176|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931177|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
19931178|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
19931179|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931180|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931181|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
19931182|NCT01363128|Hormones|hormones|mesh-ancestor
19931183|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931184|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19931185|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19931186|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19931187|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19931188|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931189|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19931190|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
19931191|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19931192|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19931193|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
19931194|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931195|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19931196|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19931197|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
20263903|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263904|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20263905|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
20263906|NCT00508365|Protective Agents|protective agents|mesh-ancestor
20263907|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20263908|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263909|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20263910|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
20263911|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20263912|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20263913|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20263914|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
20263915|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263916|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20263917|NCT00508456|Temozolomide|temozolomide|mesh-list
20263918|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20263919|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
20263920|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931198|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931199|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19931200|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
19931201|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
19931202|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
19931203|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
19931204|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19931205|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19931206|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931207|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19931208|NCT01363349|Risperidone|risperidone|mesh-list
19931209|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19931210|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
19931211|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931212|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931213|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931214|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19931215|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931216|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931217|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931218|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19931219|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
19931220|NCT01363440|Aflibercept|aflibercept|mesh-list
19931221|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19931222|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19931223|NCT01363440|Growth Substances|growth substances|mesh-ancestor
19931224|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931225|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
19931226|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931227|NCT01363479|Dexamethasone|dexamethasone|mesh-list
19931228|NCT01363479|Palonosetron|palonosetron|mesh-list
19931229|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931230|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
19931231|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
19931232|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931233|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931234|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931235|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
19931236|NCT01363479|Hormones|hormones|mesh-ancestor
19931237|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931238|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19931239|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931240|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19931241|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19931242|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
19931243|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931244|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931245|NCT01363661|Molsidomine|molsidomine|mesh-list
19931246|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
19931247|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19931248|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931249|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19931250|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19931251|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19931252|NCT01363700|Epinastine|epinastine|mesh-list
19931253|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931254|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931255|NCT01363700|Analgesics|analgesics|mesh-ancestor
19931256|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
19931257|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931258|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931259|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931260|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931261|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19931262|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19931263|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19931264|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
19931265|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
19931266|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931267|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931268|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19931269|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19931270|NCT01363843|Leucovorin|leucovorin|mesh-list
19931271|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
19931272|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931273|NCT01363843|Antidotes|antidotes|mesh-ancestor
19931274|NCT01363843|Protective Agents|protective agents|mesh-ancestor
19931275|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931276|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
19931277|NCT01363843|Vitamins|vitamins|mesh-ancestor
19931278|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
19931279|NCT01363986|Trastuzumab|trastuzumab|mesh-list
19931280|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19931281|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931282|NCT01363999|Atorvastatin|atorvastatin|mesh-list
19931283|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
19931284|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19931285|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19931286|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
19931287|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931288|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19931289|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19931290|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931291|NCT01364090|Interferons|interferons|mesh-list
19931292|NCT01364090|Ribavirin|ribavirin|mesh-list
19931293|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
19931294|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
19931295|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19931296|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931297|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
19931298|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931299|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
19931300|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931301|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
19931302|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931303|NCT01364259|Amifostine|amifostine|mesh-list
19931304|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19931305|NCT01364259|Protective Agents|protective agents|mesh-ancestor
19931306|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931307|NCT01364298|Pregabalin|pregabalin|mesh-list
19931308|NCT01364298|Gabapentin|gabapentin|mesh-list
19931309|NCT01364298|Analgesics|analgesics|mesh-ancestor
19931310|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
19931311|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931312|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931313|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
19931314|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19931315|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19931316|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931317|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19931318|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19931319|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931320|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931321|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931322|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19931323|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19931324|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931325|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
19931326|NCT01364389|Prednisone|prednisone|mesh-list
19931327|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931328|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
19931329|NCT01364389|Hormones|hormones|mesh-ancestor
19931330|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931331|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931332|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19931333|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931334|NCT01364428|Insulin|insulin|mesh-list
19931335|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19931336|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
19931337|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19931338|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931339|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
19931340|NCT01364467|Guaifenesin|guaifenesin|mesh-list
19931341|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19931342|NCT01364467|Expectorants|expectorants|mesh-ancestor
19931343|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
19931344|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19931345|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19931346|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
19931347|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931348|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931349|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931350|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
19931351|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19931352|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
19931353|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
19931354|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931355|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
19931356|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19931357|NCT01364558|Diazepam|diazepam|mesh-list
19931358|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19931359|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
19931360|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
19931361|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
19931362|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931363|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931364|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931365|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19931366|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931367|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19931368|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19931369|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19931370|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931371|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931372|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19931373|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
19931374|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
19931375|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
19931376|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
19931377|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931378|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931379|NCT01364584|Exenatide|exenatide|mesh-list
19931380|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19931381|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931382|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19931383|NCT01364584|Incretins|incretins|mesh-ancestor
19931384|NCT01364584|Hormones|hormones|mesh-ancestor
19931385|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931386|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
19931387|NCT01364623|Testosterone|testosterone|mesh-list
19931388|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
19931389|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
19931390|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19931391|NCT01364623|Androgens|androgens|mesh-ancestor
19931392|NCT01364623|Hormones|hormones|mesh-ancestor
19931393|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931394|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931395|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19931396|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931397|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
19931398|NCT01364649|Vortioxetine|vortioxetine|mesh-list
19931399|NCT01364649|Citalopram|citalopram|mesh-list
19931400|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19931401|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19931402|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19931403|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931404|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931405|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
19931406|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931407|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19931408|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
19931409|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931410|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19931411|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931412|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931413|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19931414|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19931415|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19931416|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19931417|NCT01364727|Amrubicin|amrubicin|mesh-list
19931418|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931419|NCT01364922|Acetaminophen|acetaminophen|mesh-list
19931420|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19931421|NCT01364922|Hydrocodone|hydrocodone|mesh-list
19931422|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931423|NCT01364922|Analgesics|analgesics|mesh-ancestor
19931424|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
19931425|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931426|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931427|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
19931428|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19931429|NCT01364922|Narcotics|narcotics|mesh-ancestor
19931430|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931431|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
19931432|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
19931433|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931434|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931435|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931436|NCT01365052|Naproxen|naproxen|mesh-list
19931437|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931438|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931439|NCT01365052|Analgesics|analgesics|mesh-ancestor
20263921|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263922|NCT00508495|Acetaminophen|acetaminophen|mesh-list
20263923|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20263924|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20263925|NCT00508495|Analgesics|analgesics|mesh-ancestor
20263926|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
20263927|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20263928|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542022|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20542023|NCT01860716|Melatonin|melatonin|mesh-list
20542024|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
20542025|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931440|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
19931441|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931442|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931443|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931444|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931445|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
19931446|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19931447|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931448|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931449|NCT01365091|Metformin|metformin|mesh-list
19931450|NCT01365091|Saxagliptin|saxagliptin|mesh-list
19931451|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19931452|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931453|NCT01365091|Incretins|incretins|mesh-ancestor
19931454|NCT01365091|Hormones|hormones|mesh-ancestor
19931455|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20263929|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
20542026|NCT01860716|Protective Agents|protective agents|mesh-ancestor
20542027|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542028|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542029|NCT01860729|Anacetrapib|anacetrapib|mesh-list
20542030|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20542031|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20542032|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
19931456|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19931457|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
19931458|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931459|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931460|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19931461|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
19931462|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931463|NCT01365468|Everolimus|everolimus|mesh-list
19931464|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931465|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931466|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
19931467|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931468|NCT01365481|Amlodipine|amlodipine|mesh-list
19931469|NCT01365481|Valsartan|valsartan|mesh-list
19931470|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19931471|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19931472|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19931473|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19931474|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931475|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19931476|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931477|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
19931478|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19931479|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19931480|NCT01365481|Diuretics|diuretics|mesh-ancestor
19931481|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
19931482|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19931483|NCT01365507|Insulin|insulin|mesh-list
19931484|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
19931485|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19931486|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931487|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
19931488|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931489|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
19931490|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19931491|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19931492|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263930|NCT00508664|Docetaxel|docetaxel|mesh-list
20263931|NCT00508664|Fluorouracil|fluorouracil|mesh-list
20263932|NCT00508664|Cetuximab|cetuximab|mesh-list
20263933|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20263934|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
20263935|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
20263936|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
20263937|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263938|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
20263939|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20263940|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20263941|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
19931493|NCT01365585|Urological Agents|urological agents|mesh-ancestor
19931494|NCT01365611|Fluticasone|fluticasone|mesh-list
20263942|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542033|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542034|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20542035|NCT01860742|Interferons|interferons|mesh-list
19931495|NCT01365611|Xhance|xhance|mesh-list
19931496|NCT01365611|Ketorolac|ketorolac|mesh-list
19931497|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19931498|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931499|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19931500|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
19931501|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931502|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931503|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19931504|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
19931505|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931506|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19931507|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931508|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931509|NCT01365611|Analgesics|analgesics|mesh-ancestor
19931510|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
19931511|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931512|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19931513|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931514|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931515|NCT01365624|Ketorolac|ketorolac|mesh-list
19931516|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19931517|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931518|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931519|NCT01365624|Analgesics|analgesics|mesh-ancestor
19931520|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
19931521|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931522|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931523|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931524|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931525|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19931526|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931527|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931528|NCT01365650|Fluticasone|fluticasone|mesh-list
19931529|NCT01365650|Xhance|xhance|mesh-list
19931530|NCT01365650|Ketorolac|ketorolac|mesh-list
19931531|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19931532|NCT01365650|Phenylephrine|phenylephrine|mesh-list
20263943|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20263944|NCT00508690|Metronidazole|metronidazole|mesh-list
20263945|NCT00508690|Kanamycin|kanamycin|mesh-list
20263946|NCT00508690|Cefmetazole|cefmetazole|mesh-list
20263947|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263948|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20263949|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20263950|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20263951|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20263952|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20263953|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263954|NCT00508859|Sertraline|sertraline|mesh-list
20263955|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
20263956|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20263957|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20263958|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20263959|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263960|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263961|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20263962|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
20263963|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263964|NCT00508885|Niacinamide|niacinamide|mesh-list
20263965|NCT00508885|Niacin|niacin|mesh-list
20263966|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
20263967|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
20263968|NCT00508885|Vitamins|vitamins|mesh-ancestor
20263969|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
20263970|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263971|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20263972|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
20263973|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263974|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20263975|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
20263976|NCT00508898|Calcitriol|calcitriol|mesh-list
20263977|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20263978|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263979|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20263980|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20263981|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20263982|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20263983|NCT00508898|Vitamins|vitamins|mesh-ancestor
20263984|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
20263985|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20263986|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
20263987|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
20263988|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20263989|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20263990|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20263991|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
20263992|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20263993|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20263994|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20263995|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
20263996|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20263997|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
20263998|NCT00508976|Lidocaine|lidocaine|mesh-list
20263999|NCT00508976|Bupivacaine|bupivacaine|mesh-list
20264000|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
20264001|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
19931533|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
19931534|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931535|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20264002|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264003|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264004|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
20264005|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264006|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20264007|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20264008|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20264009|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20264010|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264011|NCT00509015|Artesunate|artesunate|mesh-list
20264012|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
20264013|NCT00509015|Primaquine|primaquine|mesh-list
20264014|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
20264015|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20264016|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
20264017|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20264018|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20264019|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264020|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264021|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
20264022|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
20264023|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20264024|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
20264025|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20264026|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264027|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264028|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20264029|NCT00509015|Renal Agents|renal agents|mesh-ancestor
20264030|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20264031|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20264032|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
20264033|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264034|NCT00509158|Antacids|antacids|mesh-ancestor
20264035|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264036|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264037|NCT00509184|Rituximab|rituximab|mesh-list
20264038|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20264039|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931536|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
20264040|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
20264041|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264042|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264043|NCT00509327|Bisacodyl|bisacodyl|mesh-list
20264044|NCT00509327|Cathartics|cathartics|mesh-ancestor
20264045|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264046|NCT00509327|Laxatives|laxatives|mesh-ancestor
20264047|NCT00509353|Irinotecan|irinotecan|mesh-list
20264048|NCT00509353|Vincristine|vincristine|mesh-list
20264049|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20264050|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20264051|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264052|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264053|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264054|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264055|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20264056|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264057|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264058|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264059|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20264060|NCT00509379|Rituximab|rituximab|mesh-list
20264061|NCT00509379|Bortezomib|bortezomib|mesh-list
20264062|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20264063|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931537|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931538|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931539|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19931540|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
19931541|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931542|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19931543|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20264064|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
20264065|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264066|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931544|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931545|NCT01365650|Analgesics|analgesics|mesh-ancestor
19931546|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
19931547|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931548|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19931549|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931550|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931551|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19931552|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19931553|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19931554|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931555|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
19931556|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
19931557|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19931558|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19931559|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
19931560|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19931561|NCT01365650|Protective Agents|protective agents|mesh-ancestor
19931562|NCT01365819|Varenicline|varenicline|mesh-list
19931563|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19931564|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19931565|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
19931566|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931567|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931568|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931569|NCT01366196|Pregabalin|pregabalin|mesh-list
19931570|NCT01366196|Analgesics|analgesics|mesh-ancestor
19931571|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
19931572|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931573|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931574|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
19931575|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19931576|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19931577|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931578|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19931579|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19931580|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931581|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931582|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931583|NCT01366209|Pirfenidone|pirfenidone|mesh-list
19931584|NCT01366209|Analgesics|analgesics|mesh-ancestor
19931585|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
19931586|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931587|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931588|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931589|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931590|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931591|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931592|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931593|NCT01366534|Vaccines|vaccines|mesh-list
19931594|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
19931595|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931596|NCT01366638|Ribavirin|ribavirin|mesh-list
19931597|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19931598|NCT01366638|Simeprevir|simeprevir|mesh-list
19931599|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
19931600|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931601|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
19931602|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931603|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
19931604|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931605|NCT01366885|Vitamin D|vitamin d|mesh-list
19931606|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
19931607|NCT01366885|Vitamins|vitamins|mesh-ancestor
19931608|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
19931609|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931610|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19931611|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19931612|NCT01366976|Acetaminophen|acetaminophen|mesh-list
19931613|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931614|NCT01366976|Analgesics|analgesics|mesh-ancestor
19931615|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
20264067|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
19931616|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931617|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931618|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
20264068|NCT00509405|Diuretics|diuretics|mesh-ancestor
19931619|NCT01367119|Ketamine|ketamine|mesh-list
19931620|NCT01367119|Methohexital|methohexital|mesh-list
19931621|NCT01367119|Analgesics|analgesics|mesh-ancestor
19931622|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
19931623|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931624|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931625|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19931626|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19931627|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
19931628|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
19931629|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931630|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19931631|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19931632|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931633|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931634|NCT01367158|Vaccines|vaccines|mesh-list
19931635|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
19931636|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931637|NCT01367249|Bromfenac|bromfenac|mesh-list
19931638|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19931639|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19931640|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19931641|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931642|NCT01367249|Analgesics|analgesics|mesh-ancestor
19931643|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
19931644|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931645|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931646|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931647|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973222|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19973223|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19973224|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
19973225|NCT01821560|Baclofen|baclofen|mesh-list
19973226|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19973227|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973228|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19973229|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973230|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19973231|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
19973232|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
19973233|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973234|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973235|NCT01821729|Leucovorin|leucovorin|mesh-list
19973236|NCT01821729|Fluorouracil|fluorouracil|mesh-list
19973237|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
19450146|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450147|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450148|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264069|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
20264070|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264071|NCT00509405|Expectorants|expectorants|mesh-ancestor
20264072|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
20264073|NCT00509431|Sirolimus|sirolimus|mesh-list
20264074|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20264075|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264076|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264077|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264078|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264079|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264080|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264081|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20264082|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
20264083|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264084|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
20264085|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264086|NCT00509470|Amlodipine|amlodipine|mesh-list
20264087|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20264088|NCT00509470|Telmisartan|telmisartan|mesh-list
20264089|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20264090|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20264091|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20264092|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264093|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19973238|NCT01821729|Folfirinox|folfirinox|mesh-list
20264094|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450149|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19450150|NCT03430817|Analgesics|analgesics|mesh-ancestor
19450151|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
19450152|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450153|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
19450154|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19931648|NCT01367275|Irinotecan|irinotecan|mesh-list
19931649|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19931650|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19931651|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931652|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931653|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931654|NCT01367457|Sirolimus|sirolimus|mesh-list
19931655|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19931656|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931657|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19931658|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931659|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
19931660|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931661|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
19931662|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931663|NCT01367834|Hormones|hormones|mesh-list
19931664|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931665|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931666|NCT01367886|Fesoterodine|fesoterodine|mesh-list
19931667|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19931668|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19931669|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
19931670|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931671|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931672|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931673|NCT01367886|Urological Agents|urological agents|mesh-ancestor
19931674|NCT01368081|Metformin|metformin|mesh-list
19931675|NCT01368081|Empagliflozin|empagliflozin|mesh-list
19931676|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19931677|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931678|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19931679|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931680|NCT01368263|Letrozole|letrozole|mesh-list
19931681|NCT01368263|Anastrozole|anastrozole|mesh-list
19931682|NCT01368263|Goserelin|goserelin|mesh-list
19931683|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931684|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19931685|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19931686|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931687|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931688|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19931689|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
19931690|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931691|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931692|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19931693|NCT01368276|Molgramostim|molgramostim|mesh-list
19931694|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19931695|NCT01368276|Sargramostim|sargramostim|mesh-list
19931696|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
19931697|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931698|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931699|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19931700|NCT01368432|Citalopram|citalopram|mesh-list
19931701|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19931702|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19931703|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19931704|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931705|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931706|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
19931707|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931708|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19931709|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
19931710|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931711|NCT01368536|Amlodipine|amlodipine|mesh-list
19931712|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
19931713|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19931714|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19931715|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19931716|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931717|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19931718|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931719|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
19931720|NCT01368536|Diuretics|diuretics|mesh-ancestor
19931721|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
19931722|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19931723|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
19931724|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19931725|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931726|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
19931727|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931728|NCT01368653|Nicotine|nicotine|mesh-list
19931729|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19931730|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
19931731|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931732|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931733|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19931734|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19931735|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
19931736|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931737|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264095|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
20264096|NCT00509470|Diuretics|diuretics|mesh-ancestor
20264097|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
20264098|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20264099|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20264100|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20264101|NCT00509561|Capecitabine|capecitabine|mesh-list
20264102|NCT00509561|Cetuximab|cetuximab|mesh-list
20264103|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264104|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20264105|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
20264106|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264107|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20264108|NCT00509613|Sirolimus|sirolimus|mesh-list
20264109|NCT00509613|Sorafenib|sorafenib|mesh-list
20264110|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264111|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264112|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264113|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264114|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264115|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264116|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20264117|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
20264118|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264119|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
20264120|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264121|NCT00509639|Metronidazole|metronidazole|mesh-list
20264122|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264123|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264124|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20264125|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20264126|NCT00509678|Rituximab|rituximab|mesh-list
20264127|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20264128|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264129|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
20264130|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542036|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
20542037|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
20542038|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
20542039|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542040|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
20542041|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542042|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
20542043|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542044|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20542045|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542046|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20542047|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20542048|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20542049|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931738|NCT01368809|Fentanyl|fentanyl|mesh-list
20542050|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931739|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19931740|NCT01368809|Narcotics|narcotics|mesh-ancestor
19931741|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931742|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931743|NCT01368809|Analgesics|analgesics|mesh-ancestor
19931744|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
19931745|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931746|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19931747|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19931748|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
19931749|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
19931750|NCT01369069|Insulin|insulin|mesh-list
19931751|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19931752|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19931753|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931754|NCT01369329|Ustekinumab|ustekinumab|mesh-list
19931755|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931756|NCT01369342|Ustekinumab|ustekinumab|mesh-list
19931757|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931758|NCT01369355|Ustekinumab|ustekinumab|mesh-list
19931759|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931760|NCT01369433|Sirolimus|sirolimus|mesh-list
19931761|NCT01369433|Paclitaxel|paclitaxel|mesh-list
19931762|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19931763|NCT01369433|Capecitabine|capecitabine|mesh-list
19931764|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19931765|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931766|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
19931767|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
19931768|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
19931769|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931770|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19931771|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
19931772|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19931773|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931774|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19931775|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
19931776|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931777|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
19931778|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931779|NCT01369485|Caffeine|caffeine|mesh-list
19931780|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19931781|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931782|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19931783|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931784|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931785|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19931786|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20264131|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264132|NCT00509743|Diclofenac|diclofenac|mesh-list
20264133|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20264134|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20264135|NCT00509743|Analgesics|analgesics|mesh-ancestor
20264136|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
20264137|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264138|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264139|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264140|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264141|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20542051|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931787|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
19931788|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931789|NCT01369615|Oxycodone|oxycodone|mesh-list
19931790|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19931791|NCT01369615|Narcotics|narcotics|mesh-ancestor
19931792|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931793|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931794|NCT01369615|Analgesics|analgesics|mesh-ancestor
19931795|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
19931796|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931797|NCT01369680|Ketamine|ketamine|mesh-list
19931798|NCT01369680|Analgesics|analgesics|mesh-ancestor
19931799|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
19931800|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931801|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931802|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19931803|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19931804|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
19931805|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
19931806|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931807|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19931808|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19931809|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931810|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931811|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
19931812|NCT01369732|Hematinics|hematinics|mesh-ancestor
19931813|NCT01369745|Prednisone|prednisone|mesh-list
19931814|NCT01369745|Prednisolone|prednisolone|mesh-list
19931815|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19931816|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
19931817|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19931818|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
19931819|NCT01369745|Dipyridamole|dipyridamole|mesh-list
19931820|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19931821|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
19931822|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931823|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
19931824|NCT01369745|Hormones|hormones|mesh-ancestor
19931825|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931826|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931827|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19931828|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931829|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
19931830|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
19931831|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931832|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931833|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19931834|NCT01369745|Protective Agents|protective agents|mesh-ancestor
19931835|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19931836|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931837|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931838|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19931839|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
19931840|NCT01369849|Rituximab|rituximab|mesh-list
19931841|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19931842|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19931843|NCT01369849|Antibodies|antibodies|mesh-list
19931844|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
19931845|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19931846|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
19931847|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931848|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732530|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19732531|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732532|NCT04572997|Apremilast|apremilast|mesh-list
19931849|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931850|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19931851|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
19931852|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931853|NCT01369875|Aldesleukin|aldesleukin|mesh-list
19931854|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
19931855|NCT01369875|Fludarabine|fludarabine|mesh-list
19931856|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931857|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
19931858|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931859|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931860|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19931861|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
19931862|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931863|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931864|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19931865|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19931866|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19732533|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19732534|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732535|NCT04572997|Analgesics|analgesics|mesh-ancestor
19732536|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
19732537|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732538|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732539|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732540|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931867|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
19931868|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931869|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
19931870|NCT01369888|Fludarabine|fludarabine|mesh-list
19931871|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931872|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
19931873|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931874|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19931875|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19931876|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
19931877|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931878|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931879|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19931880|NCT01370005|Empagliflozin|empagliflozin|mesh-list
19931881|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19931882|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931883|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19931884|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931885|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
19931886|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19931887|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931888|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931889|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19931890|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19931891|NCT01370213|Interleukin-2|interleukin-2|mesh-list
19931892|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19931893|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931894|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19931895|NCT01370213|Analgesics|analgesics|mesh-ancestor
19931896|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
19931897|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931898|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931899|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
19931900|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19931901|NCT01370265|Adenosine|adenosine|mesh-list
19931902|NCT01370265|Regadenoson|regadenoson|mesh-list
19931903|NCT01370265|Analgesics|analgesics|mesh-ancestor
19931904|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
19931905|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931906|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931907|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19931908|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
19931909|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19931910|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
19931911|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
19931912|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931913|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931914|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19931915|NCT01370356|Varenicline|varenicline|mesh-list
19931916|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19931917|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19931918|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
19931919|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931920|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931921|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931922|NCT01370369|Testosterone|testosterone|mesh-list
19931923|NCT01370369|Androgens|androgens|mesh-ancestor
19931924|NCT01370369|Hormones|hormones|mesh-ancestor
19931925|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931926|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931927|NCT01370408|Dexamethasone|dexamethasone|mesh-list
19931928|NCT01370408|Ondansetron|ondansetron|mesh-list
19931929|NCT01370408|Palonosetron|palonosetron|mesh-list
19931930|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19931931|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
19931932|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
19931933|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931934|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931935|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931936|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
19931937|NCT01370408|Hormones|hormones|mesh-ancestor
19931938|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19931939|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19931940|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19931941|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
19931942|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
19931943|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19931944|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
19931945|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931946|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931947|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19931948|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19931949|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19931950|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19931951|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19931952|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19931953|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
19931954|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19931955|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19931956|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931957|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
19931958|NCT01370460|Coagulants|coagulants|mesh-ancestor
19931959|NCT01370499|Serotonin|serotonin|mesh-list
19931960|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19931961|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19931962|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
19931963|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19931964|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931965|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931966|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19931967|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19931968|NCT01370525|Esomeprazole|esomeprazole|mesh-list
19931969|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19931970|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931971|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19931972|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931973|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931974|NCT01370538|Esomeprazole|esomeprazole|mesh-list
19931975|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19931976|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19931977|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19931978|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931979|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931980|NCT01370564|Diuretics|diuretics|mesh-list
19931981|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
19931982|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931983|NCT01370616|Amoxicillin|amoxicillin|mesh-list
19931984|NCT01370616|Tazobactam|tazobactam|mesh-list
19931985|NCT01370616|Piperacillin|piperacillin|mesh-list
19931986|NCT01370616|Ertapenem|ertapenem|mesh-list
19931987|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19931988|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264142|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264143|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264144|NCT00509834|Lactoferrin|lactoferrin|mesh-list
20264145|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264146|NCT00509847|Lactoferrin|lactoferrin|mesh-list
20264147|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264148|NCT00509860|Irinotecan|irinotecan|mesh-list
20264149|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20264150|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264151|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264152|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264153|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264154|NCT00509938|Lactoferrin|lactoferrin|mesh-list
20264155|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264156|NCT00509964|Irinotecan|irinotecan|mesh-list
20264157|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20264158|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264159|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264160|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264161|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264162|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
20264163|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20264164|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20264165|NCT00509990|Analgesics|analgesics|mesh-ancestor
20264166|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
20264167|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19931989|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264168|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19931990|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19931991|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19931992|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931993|NCT01370642|Ribavirin|ribavirin|mesh-list
19931994|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
19931995|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19931996|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
19931997|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19931998|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19931999|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19932000|NCT01370655|Diuretics|diuretics|mesh-ancestor
19932001|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
19932002|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932003|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19932004|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19932005|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932006|NCT01370694|Prednisolone|prednisolone|mesh-list
19932007|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
19932008|NCT01370694|Vincristine|vincristine|mesh-list
19932009|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932010|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
19932011|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932012|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19932013|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19932014|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
19932015|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932016|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932017|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19932018|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19932019|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
19932020|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
19932021|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
19932022|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932023|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
19932024|NCT01370694|Hormones|hormones|mesh-ancestor
19932025|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932026|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932027|NCT01371110|Midazolam|midazolam|mesh-list
19932028|NCT01371110|Ketamine|ketamine|mesh-list
19932029|NCT01371110|Analgesics|analgesics|mesh-ancestor
19932030|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
19932031|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932032|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932033|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19932034|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20264169|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264170|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264171|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
20264172|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264173|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
20264174|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20264175|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264176|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264177|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
20264178|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20264179|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20264180|NCT00510003|Analgesics|analgesics|mesh-ancestor
20264181|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
20264182|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264183|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264184|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264185|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264186|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
20264187|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264188|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
20264189|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20264190|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264191|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264192|NCT00510016|Clonidine|clonidine|mesh-list
20264193|NCT00510016|Analgesics|analgesics|mesh-ancestor
20264194|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
19932035|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
19932036|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
20264195|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932037|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19932038|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19932039|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19932040|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932041|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932042|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19932043|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19932044|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19932045|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19932046|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19932047|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
19932048|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
19932049|NCT01371565|Mifepristone|mifepristone|mesh-list
19932050|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19932051|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
19932052|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19932053|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932054|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19932055|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19932056|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19932057|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
19932058|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19932059|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19932060|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
20264196|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264197|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20264198|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
20264199|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
20264200|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20264201|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20264202|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20264203|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
20264204|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264205|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264206|NCT00510081|Calcium|calcium|mesh-list
20264207|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20264208|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264209|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
20264210|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264211|NCT00510159|Artesunate|artesunate|mesh-list
20264212|NCT00510159|Sulfalene|sulfalene|mesh-list
20264213|NCT00510159|Praziquantel|praziquantel|mesh-list
20264214|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
20264215|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20264216|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20264217|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264218|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264219|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
20264220|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
20264221|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20264222|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
20264223|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20264224|NCT00510159|Renal Agents|renal agents|mesh-ancestor
20264225|NCT00510172|Epoprostenol|epoprostenol|mesh-list
20264226|NCT00510172|Tezosentan|tezosentan|mesh-list
20264227|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20264228|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20264229|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
20264230|NCT00510211|Olanzapine|olanzapine|mesh-list
20264231|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
20264232|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
20264233|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264234|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264235|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264236|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20264237|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264238|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264239|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264240|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20264241|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20264242|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20264243|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264244|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973239|NCT01821729|Losartan|losartan|mesh-list
20264245|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
20264246|NCT00510250|Sorafenib|sorafenib|mesh-list
19932061|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932062|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
19932063|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19932064|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19932065|NCT01371643|Octreotide|octreotide|mesh-list
19932066|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19932067|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932068|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932069|NCT01371656|Levofloxacin|levofloxacin|mesh-list
19932070|NCT01371656|Ofloxacin|ofloxacin|mesh-list
19932071|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19932072|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932073|NCT01371656|Renal Agents|renal agents|mesh-ancestor
19932074|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932075|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19932076|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19932077|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932078|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932079|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932080|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19932081|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19932082|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19932083|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19932084|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19932085|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19932086|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932087|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932088|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932089|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
19932090|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19932091|NCT01371747|Losartan|losartan|mesh-list
19932092|NCT01371747|Spironolactone|spironolactone|mesh-list
19932093|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19932094|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19932095|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19932096|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19932097|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932098|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20264247|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264248|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264249|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264250|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264251|NCT00510263|Valacyclovir|valacyclovir|mesh-list
20264252|NCT00510263|Prednisolone|prednisolone|mesh-list
20264253|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20264254|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
20264255|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20264256|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
20264257|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20264258|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
20264259|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264260|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
20264261|NCT00510263|Hormones|hormones|mesh-ancestor
20264262|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20264263|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264264|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20264265|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264266|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
20264267|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
20264268|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264269|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264270|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20264271|NCT00510263|Protective Agents|protective agents|mesh-ancestor
20264272|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
20264273|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542052|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20542053|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20542054|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
20542055|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542056|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542057|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20542058|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19932099|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
19932100|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932101|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932102|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19932103|NCT01371747|Diuretics|diuretics|mesh-ancestor
19932104|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
19932105|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
19932106|NCT01371786|Ciclesonide|ciclesonide|mesh-list
19932107|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932108|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
19932109|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19932110|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
19932111|NCT01371786|Hormones|hormones|mesh-ancestor
19932112|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932113|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932114|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
19932115|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19932116|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932117|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932118|NCT01371851|Doxazosin|doxazosin|mesh-list
19932119|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19932120|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19932121|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19932122|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19932123|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
19932124|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932125|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932126|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932127|NCT01371877|Vitamin D|vitamin d|mesh-list
19932128|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
19932129|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
19932130|NCT01371877|Vitamins|vitamins|mesh-list
19932131|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
19932132|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932133|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19932134|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19932135|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
19932136|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19932137|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19932138|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
19932139|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932140|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932141|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932142|NCT01371994|Urological Agents|urological agents|mesh-ancestor
19932143|NCT01372150|Fluoxetine|fluoxetine|mesh-list
19932144|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19932145|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19932146|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19932147|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19932148|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932149|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932150|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
19932151|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932152|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19932153|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
19932154|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19932155|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19932156|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19932157|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932158|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19932159|NCT01372202|Paclitaxel|paclitaxel|mesh-list
19932160|NCT01372202|Fluorouracil|fluorouracil|mesh-list
19932161|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
19932162|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19932163|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932164|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
19932165|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
19932166|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
19932167|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932168|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
19932169|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19932170|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932171|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
19932172|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932173|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19932174|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932175|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19932176|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932177|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932178|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
19932179|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19932180|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
19932181|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932182|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932183|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19932184|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
19932185|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
19932186|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19932187|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
19932188|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932189|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932190|NCT01372995|Vitamin D|vitamin d|mesh-list
19932191|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
19932192|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
19932193|NCT01372995|Vitamins|vitamins|mesh-list
19932194|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
19932195|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932196|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19932197|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19973240|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
19973241|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973242|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973243|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973244|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973245|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
19973246|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973247|NCT01821729|Antidotes|antidotes|mesh-ancestor
19973248|NCT01821729|Protective Agents|protective agents|mesh-ancestor
19973249|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
19973250|NCT01821729|Vitamins|vitamins|mesh-ancestor
19973251|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
19973252|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19973253|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19973254|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19973255|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19973256|NCT01822132|Naltrexone|naltrexone|mesh-list
19973257|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19973258|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19973259|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973260|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
19973261|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973262|NCT01822496|Paclitaxel|paclitaxel|mesh-list
19973263|NCT01822496|Etoposide|etoposide|mesh-list
19973264|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
19973265|NCT01822496|Cisplatin|cisplatin|mesh-list
19973266|NCT01822496|Carboplatin|carboplatin|mesh-list
19973267|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19973268|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19973269|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
19973270|NCT01822496|Crizotinib|crizotinib|mesh-list
19973271|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19973272|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973273|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
19973274|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
19973275|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
19973276|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973277|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19973278|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19973279|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973280|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973281|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
19973282|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
19973283|NCT01822535|Midodrine|midodrine|mesh-list
19973284|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
19973285|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
19973286|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264274|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
19973287|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973288|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19932198|NCT01373164|Gemcitabine|gemcitabine|mesh-list
19932199|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19932200|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
19932201|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932202|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932203|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
19932204|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932205|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932206|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932207|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
19932208|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932209|NCT01373229|Plerixafor|plerixafor|mesh-list
19932210|NCT01373229|Rituximab|rituximab|mesh-list
19932211|NCT01373229|Lenalidomide|lenalidomide|mesh-list
19932212|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19932213|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932214|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
19932215|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932216|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19932217|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20264275|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264276|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264277|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264278|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264279|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
19932218|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19932219|NCT01373229|Growth Substances|growth substances|mesh-ancestor
19932220|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
19932221|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19932222|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19932223|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
19932224|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932225|NCT01373294|Lenalidomide|lenalidomide|mesh-list
19932226|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
19932227|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
19932228|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932229|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19932230|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19932231|NCT01373294|Growth Substances|growth substances|mesh-ancestor
19932232|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
20264280|NCT00510367|Doxorubicin|doxorubicin|mesh-list
20264281|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20264282|NCT00510367|Fluorouracil|fluorouracil|mesh-list
20264283|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264284|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
20264285|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264286|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264287|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20264288|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
20264289|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264290|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264291|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20264292|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20264293|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20264294|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264295|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264296|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
20264297|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20264298|NCT00510393|Everolimus|everolimus|mesh-list
20264299|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264300|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264301|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
20264302|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264303|NCT00510406|Tamsulosin|tamsulosin|mesh-list
20264304|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
20264305|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20264306|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20264307|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20264308|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
20264309|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264310|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264311|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542059|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
19932233|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932234|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20542060|NCT01860833|Ibuprofen|ibuprofen|mesh-list
19932235|NCT01373450|Liraglutide|liraglutide|mesh-list
19932236|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19932237|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932238|NCT01373450|Incretins|incretins|mesh-ancestor
19932239|NCT01373450|Hormones|hormones|mesh-ancestor
19932240|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932241|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19932242|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19932243|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19932244|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19932245|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
19932246|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19932247|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932248|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932249|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19932250|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19932251|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932252|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932253|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932254|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19932255|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
19932256|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19932257|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932258|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19932259|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19932260|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19932261|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19932262|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
19932263|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19932264|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
19932265|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19932266|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932267|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19932268|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932269|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932270|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
19932271|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19932272|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932273|NCT01374217|Clarithromycin|clarithromycin|mesh-list
19932274|NCT01374217|Dexamethasone|dexamethasone|mesh-list
19932275|NCT01374217|Lenalidomide|lenalidomide|mesh-list
19932276|NCT01374217|Tadalafil|tadalafil|mesh-list
19932277|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932278|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
19932279|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
19932280|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932281|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932282|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19932283|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
19932284|NCT01374217|Hormones|hormones|mesh-ancestor
19932285|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932286|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932287|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932288|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
19932289|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19932290|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19932291|NCT01374217|Growth Substances|growth substances|mesh-ancestor
19932292|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
19932293|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932294|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932295|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19932296|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932297|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932298|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19932299|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19932300|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
19932301|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19932302|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19932303|NCT01374217|Urological Agents|urological agents|mesh-ancestor
19932304|NCT01374269|Acetaminophen|acetaminophen|mesh-list
19932305|NCT01374269|Celecoxib|celecoxib|mesh-list
19932306|NCT01374269|Naproxen|naproxen|mesh-list
19932307|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19932308|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19932309|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19932310|NCT01374269|Analgesics|analgesics|mesh-ancestor
19932311|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
19932312|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932313|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932314|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
19932315|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19932316|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19932317|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19932318|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932319|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932320|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
19932321|NCT01374425|Leucovorin|leucovorin|mesh-list
19932322|NCT01374425|Bevacizumab|bevacizumab|mesh-list
19932323|NCT01374425|Fluorouracil|fluorouracil|mesh-list
19932324|NCT01374425|Capecitabine|capecitabine|mesh-list
19932325|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
19932326|NCT01374425|Irinotecan|irinotecan|mesh-list
19932327|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19932328|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932329|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19932330|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19932331|NCT01374425|Growth Substances|growth substances|mesh-ancestor
19932332|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932333|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
19932334|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
19932335|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932336|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19932337|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932338|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
19932339|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19932340|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19932341|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932342|NCT01374425|Antidotes|antidotes|mesh-ancestor
19932343|NCT01374425|Protective Agents|protective agents|mesh-ancestor
19932344|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
19932345|NCT01374425|Vitamins|vitamins|mesh-ancestor
19932346|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
19932347|NCT01374451|Everolimus|everolimus|mesh-list
19932348|NCT01374451|Pasireotide|pasireotide|mesh-list
19932349|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264312|NCT00510406|Urological Agents|urological agents|mesh-ancestor
20264313|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20264314|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20264315|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
20264316|NCT00510419|Sumatriptan|sumatriptan|mesh-list
20264317|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20264318|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20264319|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20264320|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
20264321|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264322|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264323|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264324|NCT00510445|Imetelstat|imetelstat|mesh-list
20264325|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
20264326|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264327|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264328|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264329|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
20264330|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20264331|NCT00510471|Antibodies|antibodies|mesh-list
20264332|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20264333|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
20264334|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287115|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20287116|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287117|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287118|NCT05332106|Dienogest|dienogest|mesh-list
20287119|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20287120|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20287121|NCT05332106|Estradiol|estradiol|mesh-list
20287122|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20287123|NCT05332106|Nandrolone|nandrolone|mesh-list
20287124|NCT05332106|Estrogens|estrogens|mesh-ancestor
19932350|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932351|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
19932352|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287125|NCT05332106|Hormones|hormones|mesh-ancestor
19932353|NCT01374451|Hormones|hormones|mesh-ancestor
19932354|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932355|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19932356|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19932357|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932358|NCT01374568|Incretins|incretins|mesh-ancestor
19932359|NCT01374568|Hormones|hormones|mesh-ancestor
19932360|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932361|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19932362|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
19932363|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932364|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932365|NCT01374802|Ritonavir|ritonavir|mesh-list
19932366|NCT01374802|Darunavir|darunavir|mesh-list
19932367|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19932368|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19932369|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
19932370|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932371|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932372|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19932373|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19932374|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
19932375|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932376|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19932377|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19932378|NCT01374906|Pasireotide|pasireotide|mesh-list
19932379|NCT01374906|Hormones|hormones|mesh-ancestor
19932380|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932381|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932382|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19932383|NCT01374919|Hematinics|hematinics|mesh-ancestor
19932384|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19932385|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19932386|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
19932387|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932388|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
19932389|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932390|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19932391|NCT01375010|Vitamin D|vitamin d|mesh-list
19932392|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
19932393|NCT01375010|Vitamins|vitamins|mesh-list
19932394|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
19932395|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932396|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19932397|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19932398|NCT01375049|Aztreonam|aztreonam|mesh-list
19932399|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932400|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932401|NCT01375075|Atorvastatin|atorvastatin|mesh-list
19932402|NCT01375075|Evacetrapib|evacetrapib|mesh-list
19932403|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19932404|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19932405|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
19932406|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932407|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19932408|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19932409|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932410|NCT01375127|Tofacitinib|tofacitinib|mesh-list
19932411|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19932412|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932413|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932414|NCT01375140|Prednisone|prednisone|mesh-list
19932415|NCT01375140|Lenalidomide|lenalidomide|mesh-list
19932416|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932417|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
19932418|NCT01375140|Hormones|hormones|mesh-ancestor
19932419|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932420|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932421|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932422|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932423|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
20264335|NCT00510536|Acetaminophen|acetaminophen|mesh-list
20264336|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20264337|NCT00510536|Analgesics|analgesics|mesh-ancestor
20264338|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
19932424|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19932425|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19932426|NCT01375140|Growth Substances|growth substances|mesh-ancestor
19932427|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
19932428|NCT01375374|Lacosamide|lacosamide|mesh-list
19932429|NCT01375374|Levetiracetam|levetiracetam|mesh-list
19932430|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
19932431|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
19932432|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19932433|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19932434|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19932435|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932436|NCT01375491|Doxycycline|doxycycline|mesh-list
19932437|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264339|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264340|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264341|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
20264342|NCT00510588|Metformin|metformin|mesh-list
20264343|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264344|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264345|NCT00510614|Tinidazole|tinidazole|mesh-list
20264346|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
20264347|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264348|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264349|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264350|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20264351|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20264352|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20264353|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
20542061|NCT01860833|Celecoxib|celecoxib|mesh-list
20542062|NCT01860833|Diclofenac|diclofenac|mesh-list
20542063|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20542064|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20542065|NCT01860833|Analgesics|analgesics|mesh-ancestor
20542066|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
20542067|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542068|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542069|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542070|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20542071|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20542072|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542073|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542074|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20542075|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
20542076|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542077|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542078|NCT01861015|Vasopressins|vasopressins|mesh-list
20542079|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
20542080|NCT01861015|Epinephrine|epinephrine|mesh-list
20542081|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20542082|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20542083|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
20542084|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542085|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542086|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542087|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20542088|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20542089|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
20542090|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542091|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20542092|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
20542093|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
20542094|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
20542095|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20542096|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
20542097|NCT01861015|Coagulants|coagulants|mesh-ancestor
20542098|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20542099|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
20542100|NCT01861041|Bupivacaine|bupivacaine|mesh-list
20542101|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
20542102|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
20542103|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542104|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932438|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932439|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
19932440|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20264354|NCT00510627|Irinotecan|irinotecan|mesh-list
19932441|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19932442|NCT01375608|Decitabine|decitabine|mesh-list
19932443|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19932444|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
20542105|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
20542106|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932445|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932446|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932447|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932448|NCT01375660|Vitamin D|vitamin d|mesh-list
19932449|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
19932450|NCT01375660|Vitamins|vitamins|mesh-ancestor
19932451|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
19932452|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932453|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19932454|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19932455|NCT01375751|Evolocumab|evolocumab|mesh-list
19932456|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19932457|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19932458|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
19932459|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932460|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19932461|NCT01375764|Ezetimibe|ezetimibe|mesh-list
19932462|NCT01375764|Evolocumab|evolocumab|mesh-list
19932463|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19932464|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19932465|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19932466|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
19932467|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932468|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19932469|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
19932470|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932471|NCT01375777|Ezetimibe|ezetimibe|mesh-list
19932472|NCT01375777|Evolocumab|evolocumab|mesh-list
19932473|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19932474|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19932475|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19932476|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
19932477|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932478|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19932479|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
19932480|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932481|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
19932482|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19932483|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932484|NCT01376167|Chloroquine|chloroquine|mesh-list
19932485|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19932486|NCT01376167|Primaquine|primaquine|mesh-list
19932487|NCT01376167|Tafenoquine|tafenoquine|mesh-list
19932488|NCT01376167|Amebicides|amebicides|mesh-ancestor
19932489|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19932490|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19932491|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932492|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
19932493|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19932494|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19932495|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19932496|NCT01376167|Analgesics|analgesics|mesh-ancestor
19932497|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
19932498|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932499|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932500|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932501|NCT01376167|Filaricides|filaricides|mesh-ancestor
19932502|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
19932503|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
19932504|NCT01376245|Fluticasone|fluticasone|mesh-list
19932505|NCT01376245|Xhance|xhance|mesh-list
19932506|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932507|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19932508|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
20264355|NCT00510627|Cetuximab|cetuximab|mesh-list
19932509|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932510|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932511|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19932512|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
19932513|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
19932514|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20264356|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932515|NCT01376297|Dexamethasone|dexamethasone|mesh-list
19932516|NCT01376297|Aprepitant|aprepitant|mesh-list
19932517|NCT01376297|Palonosetron|palonosetron|mesh-list
19932518|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932519|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
19932520|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
19932521|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932522|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932523|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19932524|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
19932525|NCT01376297|Hormones|hormones|mesh-ancestor
20264357|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20264358|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264359|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264360|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264361|NCT00510627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20264362|NCT00510640|Sunitinib|sunitinib|mesh-list
20264363|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264364|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20264365|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20264366|NCT00510640|Growth Substances|growth substances|mesh-ancestor
20264367|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264368|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
20264369|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264370|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264371|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264372|NCT00510666|Tramadol|tramadol|mesh-list
20264373|NCT00510666|Butorphanol|butorphanol|mesh-list
20264374|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20264375|NCT00510666|Narcotics|narcotics|mesh-ancestor
20264376|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264377|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264378|NCT00510666|Analgesics|analgesics|mesh-ancestor
20264379|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
20542107|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
20542108|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542109|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
20542110|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20542111|NCT01861223|Afatinib|afatinib|mesh-list
20542112|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
20542113|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542114|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20542115|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542116|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542117|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20542118|NCT01861340|Dexamethasone|dexamethasone|mesh-list
20542119|NCT01861340|Lenalidomide|lenalidomide|mesh-list
20542120|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542121|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
20542122|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
20542123|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542124|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542125|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542126|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
20542127|NCT01861340|Hormones|hormones|mesh-ancestor
20542128|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542129|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542130|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542131|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
20542132|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20542133|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20542134|NCT01861340|Growth Substances|growth substances|mesh-ancestor
20542135|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
20542136|NCT01861535|Imiquimod|imiquimod|mesh-list
20542137|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20542138|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
20542139|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542140|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542141|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
20542142|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
20542143|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542144|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
20542145|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542146|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19452679|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
19932526|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932527|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932528|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932529|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19932530|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932531|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932532|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19932533|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19932534|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
19932535|NCT01376310|Gemcitabine|gemcitabine|mesh-list
19932536|NCT01376310|Paclitaxel|paclitaxel|mesh-list
19932537|NCT01376310|Docetaxel|docetaxel|mesh-list
19932538|NCT01376310|Carboplatin|carboplatin|mesh-list
19932539|NCT01376310|Pemetrexed|pemetrexed|mesh-list
19932540|NCT01376310|Everolimus|everolimus|mesh-list
19932541|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19932542|NCT01376310|Trametinib|trametinib|mesh-list
19932543|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19932544|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932545|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
19932546|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
19932547|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
19932548|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932549|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19932550|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
19932551|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
19932552|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932553|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932554|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932555|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
19932556|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932557|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19932558|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19932559|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19932560|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19932561|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19932562|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
19932563|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932564|NCT01376362|Interferons|interferons|mesh-list
19932565|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
19932566|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932567|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
19932568|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932569|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19932570|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19932571|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932572|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19932573|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932574|NCT01376700|Factor VIII|factor viii|mesh-list
19932575|NCT01376700|Coagulants|coagulants|mesh-ancestor
19932576|NCT01376804|Valganciclovir|valganciclovir|mesh-list
19932577|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
19932578|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932579|NCT01377194|Milnacipran|milnacipran|mesh-list
19932580|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
19932581|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19932582|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19932583|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19932584|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932585|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932586|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932587|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
19932588|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19932589|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19932590|NCT01377194|Analgesics|analgesics|mesh-ancestor
19932591|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
19932592|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932593|NCT01377389|Ipilimumab|ipilimumab|mesh-list
19932594|NCT01377389|Leuprolide|leuprolide|mesh-list
19932595|NCT01377389|Goserelin|goserelin|mesh-list
19932596|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19932597|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932598|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19932599|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932600|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19932601|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
19932602|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19932603|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932604|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932605|NCT01377467|Denosumab|denosumab|mesh-list
19932606|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19932607|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932608|NCT01377480|Posaconazole|posaconazole|mesh-list
19932609|NCT01377480|Benzonidazole|benzonidazole|mesh-list
19932610|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
19932611|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932612|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19932613|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19932614|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19932615|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19932616|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19932617|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932618|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932619|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19932620|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
19932621|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932622|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932623|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932624|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
19932625|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
19932626|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19932627|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19932628|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932629|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19932630|NCT01377623|Analgesics|analgesics|mesh-ancestor
19932631|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
19932632|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932633|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19932634|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19932635|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19932636|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
19932637|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932638|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932639|NCT01377636|Isoproterenol|isoproterenol|mesh-list
19932640|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19932641|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19932642|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
19932643|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932644|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932645|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932646|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19932647|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
19932648|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932649|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19932650|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
19932651|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19932652|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
19932653|NCT01377636|Protective Agents|protective agents|mesh-ancestor
19932654|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
19932655|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19932656|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932657|NCT01377922|Amifampridine|amifampridine|mesh-list
19932658|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19932659|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932660|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932661|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19932662|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19932663|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932664|NCT01377987|Acetazolamide|acetazolamide|mesh-list
19932665|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
19932666|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19932667|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932668|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932669|NCT01377987|Diuretics|diuretics|mesh-ancestor
19932670|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
19932671|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932672|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19932673|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
19932674|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
19932675|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932676|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
19932677|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932678|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
19932679|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19932680|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
19932681|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19932682|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932683|NCT01378117|Incretins|incretins|mesh-ancestor
19932684|NCT01378117|Hormones|hormones|mesh-ancestor
19932685|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932686|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19932687|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
19932688|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932689|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932690|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
19932691|NCT01378273|Hematinics|hematinics|mesh-ancestor
19932692|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
19932693|NCT01378299|Testosterone|testosterone|mesh-list
19932694|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
19932695|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
19932696|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19932697|NCT01378299|Androgens|androgens|mesh-ancestor
19932698|NCT01378299|Hormones|hormones|mesh-ancestor
19932699|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932700|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932701|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19932702|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932703|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
19932704|NCT01378325|Phenylephrine|phenylephrine|mesh-list
19932705|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
19932706|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19932707|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
19932708|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
19932709|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932710|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932711|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
19932712|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19932713|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
19932714|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
19932715|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19932716|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19932717|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19932718|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
19932719|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932720|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932721|NCT01378325|Protective Agents|protective agents|mesh-ancestor
19932722|NCT01378377|Niacinamide|niacinamide|mesh-list
19932723|NCT01378377|Sirolimus|sirolimus|mesh-list
19932724|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932725|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932726|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19932727|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932728|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
19932729|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932730|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
19932731|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932732|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
19932733|NCT01378377|Vitamins|vitamins|mesh-ancestor
19932734|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
19932735|NCT01378416|Decitabine|decitabine|mesh-list
19932736|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19932737|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
19932738|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932739|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932740|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932741|NCT01378429|Ciclesonide|ciclesonide|mesh-list
19932742|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
19932743|NCT01378429|Hormones|hormones|mesh-ancestor
19932744|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932745|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932746|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19932747|NCT01378520|Ketoconazole|ketoconazole|mesh-list
19932748|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
19932749|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932750|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19932751|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19932752|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932753|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932754|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19932755|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
19932756|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932757|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932758|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19932759|NCT01378858|Varenicline|varenicline|mesh-list
19932760|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19932761|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19932762|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
19932763|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932764|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932765|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932766|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19932767|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932768|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19932769|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932770|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932771|NCT01378975|Vemurafenib|vemurafenib|mesh-list
19932772|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932773|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19932774|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932775|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932776|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
19932777|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19932778|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19932779|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932780|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19932781|NCT01378988|Analgesics|analgesics|mesh-ancestor
19932782|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
19932783|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932784|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19932785|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19932786|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19932787|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
19932788|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932789|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932790|NCT01379183|Erythromycin|erythromycin|mesh-list
19932791|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
19932792|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19932793|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
19932794|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932795|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932796|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19932797|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19932798|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932799|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932800|NCT01379508|Tenofovir|tenofovir|mesh-list
19932801|NCT01379508|Telbivudine|telbivudine|mesh-list
19932802|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
19932803|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932804|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19932805|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19932806|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932807|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932808|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19932809|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19932810|NCT01379521|Everolimus|everolimus|mesh-list
19932811|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450155|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19450156|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450157|NCT03430661|Clopidogrel|clopidogrel|mesh-list
19450158|NCT03430661|Ticagrelor|ticagrelor|mesh-list
19450159|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19932812|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932813|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
19932814|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932815|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
19932816|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
19932817|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19932818|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19932819|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932820|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932821|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932822|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19932823|NCT01379664|Sevoflurane|sevoflurane|mesh-list
19932824|NCT01379664|Isoflurane|isoflurane|mesh-list
19932825|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19932826|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19932827|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
19932828|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
19932829|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19932830|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932831|NCT01379937|Vaccines|vaccines|mesh-list
19932832|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
19932833|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932834|NCT01380080|Efavirenz|efavirenz|mesh-list
19932835|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19932836|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19932837|NCT01380080|Rifampin|rifampin|mesh-list
19932838|NCT01380080|Isoniazid|isoniazid|mesh-list
19932839|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
19932840|NCT01380080|Ethambutol|ethambutol|mesh-list
19932841|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
19932842|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19932843|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19932844|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932845|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932846|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
19932847|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932848|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19932849|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20264380|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264381|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
20264382|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
20264383|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20264384|NCT00510705|Metformin|metformin|mesh-list
20264385|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264386|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264387|NCT00510913|Tacrolimus|tacrolimus|mesh-list
20264388|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264389|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
20264390|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264391|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20264392|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264393|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264394|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
20264395|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932850|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20264396|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264397|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264398|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264399|NCT00510939|Bortezomib|bortezomib|mesh-list
20264400|NCT00510939|Tipifarnib|tipifarnib|mesh-list
20264401|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264402|NCT00510965|Ranibizumab|ranibizumab|mesh-list
19932851|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19932852|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19932853|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19932854|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19932855|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19932856|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19932857|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
19932858|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932859|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
19932860|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19932861|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19932862|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20264403|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20264404|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19932863|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19932864|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19932865|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
19932866|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19932867|NCT01380093|Naltrexone|naltrexone|mesh-list
19932868|NCT01380093|Morphine|morphine|mesh-list
19932869|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19932870|NCT01380093|Narcotics|narcotics|mesh-ancestor
19932871|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19932872|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932873|NCT01380093|Analgesics|analgesics|mesh-ancestor
19932874|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
19932875|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932876|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19932877|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19932878|NCT01380106|Lenalidomide|lenalidomide|mesh-list
19932879|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
19932880|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932881|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19932882|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19932883|NCT01380106|Growth Substances|growth substances|mesh-ancestor
19932884|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
19932885|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973289|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19973290|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19973291|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19973292|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
19973293|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973294|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973295|NCT01822548|Metformin|metformin|mesh-list
19973296|NCT01822548|Vildagliptin|vildagliptin|mesh-list
19973297|NCT01822548|Glyburide|glyburide|mesh-list
19973298|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19973299|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973300|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19973301|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
19973302|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973303|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973304|NCT01822561|Eplerenone|eplerenone|mesh-list
19973305|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19973306|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
19973307|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19973308|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973309|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19973310|NCT01822561|Diuretics|diuretics|mesh-ancestor
19973311|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
19973312|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19973313|NCT01822587|Propranolol|propranolol|mesh-list
19973314|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19973315|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19973316|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
19973317|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973318|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973319|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973320|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19973321|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19973322|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
19973323|NCT01822665|Acetaminophen|acetaminophen|mesh-list
19973324|NCT01822665|Ibuprofen|ibuprofen|mesh-list
19973325|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20542147|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20542148|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
20542149|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542150|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542151|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20542152|NCT01861626|Isotretinoin|isotretinoin|mesh-list
20542153|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
19973326|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19973327|NCT01822665|Analgesics|analgesics|mesh-ancestor
19973328|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
19973329|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973330|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973331|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973332|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19932886|NCT01380184|Sirolimus|sirolimus|mesh-list
19932887|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19932888|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932889|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19932890|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932891|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
19932892|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932893|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
19932894|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932895|NCT01380197|Morphine|morphine|mesh-list
19932896|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19932897|NCT01380197|Narcotics|narcotics|mesh-ancestor
19932898|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19932899|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932900|NCT01380197|Analgesics|analgesics|mesh-ancestor
19932901|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
19932902|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932903|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
19932904|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932905|NCT01380366|Hormones|hormones|mesh-list
19932906|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932907|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932908|NCT01380535|Methoxsalen|methoxsalen|mesh-list
19932909|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19932910|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
19932911|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
19932912|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19932913|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932914|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
19932915|NCT01380730|Evolocumab|evolocumab|mesh-list
19932916|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19932917|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19932918|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19932919|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
19932920|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932921|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19932922|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
19932923|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932924|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
19932925|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
19932926|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19932927|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932928|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932929|NCT01380782|Nintedanib|nintedanib|mesh-list
19932930|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932931|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19932932|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932933|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932934|NCT01380990|Busulfan|busulfan|mesh-list
19932935|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
19932936|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932937|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19932938|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
19932939|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932940|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19932941|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19932942|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19932943|NCT01381016|Hormones|hormones|mesh-list
19932944|NCT01381016|Estradiol|estradiol|mesh-list
19932945|NCT01381016|Progesterone|progesterone|mesh-list
19932946|NCT01381016|Estrogens|estrogens|mesh-list
19973333|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19732541|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19732542|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19732543|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732544|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732545|NCT04572620|Rituximab|rituximab|mesh-list
19732546|NCT04572620|Abatacept|abatacept|mesh-list
19732547|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19732548|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732549|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
19732550|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732551|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732552|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19732553|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932947|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19932948|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932949|NCT01381016|Progestins|progestins|mesh-ancestor
19932950|NCT01381120|Acetaminophen|acetaminophen|mesh-list
19932951|NCT01381120|Oxycodone|oxycodone|mesh-list
19932952|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
19932953|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19932954|NCT01381120|Analgesics|analgesics|mesh-ancestor
19932955|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
19932956|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932957|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932958|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
19932959|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19932960|NCT01381120|Narcotics|narcotics|mesh-ancestor
19932961|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19932962|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19932963|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19932964|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
19932965|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932966|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932967|NCT01381120|Urological Agents|urological agents|mesh-ancestor
19932968|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
19932969|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19932970|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
19932971|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932972|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932973|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19932974|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
19932975|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
19932976|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19932977|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
19732554|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732555|NCT04572542|Paclitaxel|paclitaxel|mesh-list
19732556|NCT04572542|Apatinib|apatinib|mesh-list
19732557|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19732558|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732559|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
19732560|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
19732561|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
19732562|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732563|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19732564|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19932978|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932979|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932980|NCT01381471|Fluticasone|fluticasone|mesh-list
19932981|NCT01381471|Xhance|xhance|mesh-list
19932982|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19932983|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19932984|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19932985|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
19932986|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19932987|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19932988|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19932989|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
19932990|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
19932991|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19932992|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19932993|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19932994|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19932995|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
19932996|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19932997|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19932998|NCT01381549|Imipenem|imipenem|mesh-list
19932999|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
19933000|NCT01381549|Cilastatin|cilastatin|mesh-list
19933001|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19933002|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933003|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933004|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933005|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933006|NCT01381562|Meropenem|meropenem|mesh-list
19933007|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19933008|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933009|NCT01381692|Sirolimus|sirolimus|mesh-list
19933010|NCT01381692|Dexamethasone|dexamethasone|mesh-list
19732565|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19933011|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
19933012|NCT01381692|Rituximab|rituximab|mesh-list
19933013|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19933014|NCT01381692|Bortezomib|bortezomib|mesh-list
19933015|NCT01381692|Antibodies|antibodies|mesh-list
19933016|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
19933017|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19933018|NCT01381692|BB 1101|bb 1101|mesh-list
19933019|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
19933020|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933021|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933022|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933023|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933024|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
19933025|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
19933026|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933027|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933028|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
19933029|NCT01381692|Hormones|hormones|mesh-ancestor
19933030|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20264405|NCT00510965|Growth Substances|growth substances|mesh-ancestor
20264406|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264407|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
20264408|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264409|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20264410|NCT00511017|Vitamins|vitamins|mesh-ancestor
20264411|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
20264412|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264413|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20264414|NCT00511069|Bortezomib|bortezomib|mesh-list
20264415|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264416|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20264417|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
20264418|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264419|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264420|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264421|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264422|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
20264423|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264424|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
20264425|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20264426|NCT00511212|Antibodies|antibodies|mesh-list
20264427|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
20264428|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20264429|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
20264430|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264431|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
20264432|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20264433|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264434|NCT00511225|Vitamins|vitamins|mesh-ancestor
20264435|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
20264436|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20264437|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20264438|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
20264439|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264440|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20264441|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264442|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264443|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264444|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
20264445|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264446|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264447|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264448|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264449|NCT00511316|Montelukast|montelukast|mesh-list
20264450|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20264451|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
20264452|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20264453|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
20264454|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20264455|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264456|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19933031|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19933032|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
20264457|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20288570|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19933033|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933034|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933035|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19933036|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933037|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19933038|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
19933039|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933040|NCT01381718|Modafinil|modafinil|mesh-list
19933041|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19933042|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933043|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19933044|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19933045|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19933046|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933047|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19933048|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
19933049|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933050|NCT01381874|Prednisone|prednisone|mesh-list
19933051|NCT01381874|Prednisolone|prednisolone|mesh-list
19933052|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19933053|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
19933054|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19933055|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
19933056|NCT01381874|Exemestane|exemestane|mesh-list
19933057|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
19933058|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19933059|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
19933060|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933061|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
19933062|NCT01381874|Hormones|hormones|mesh-ancestor
19933063|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933064|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933065|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19933066|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933067|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
19933068|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
19933069|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933070|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933071|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19933072|NCT01381874|Protective Agents|protective agents|mesh-ancestor
19933073|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19933074|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19933075|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933076|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933077|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19933078|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
19933079|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19933080|NCT01381900|Metformin|metformin|mesh-list
19933081|NCT01381900|Canagliflozin|canagliflozin|mesh-list
19933082|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19933083|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933084|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19933085|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933086|NCT01381926|Exenatide|exenatide|mesh-list
19933087|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19933088|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933089|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19933090|NCT01381926|Incretins|incretins|mesh-ancestor
19933091|NCT01381926|Hormones|hormones|mesh-ancestor
19933092|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933093|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19933094|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
19933095|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19933096|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19933097|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
19933098|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933099|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
19933100|NCT01382225|Protective Agents|protective agents|mesh-ancestor
19933101|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
19933102|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19933103|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933104|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933105|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19933106|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19933107|NCT01382303|Protective Agents|protective agents|mesh-ancestor
19933108|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933109|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
19933110|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19933111|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
19933112|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
19933113|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19933114|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19933115|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933116|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
19933117|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933118|NCT01382940|Acetaminophen|acetaminophen|mesh-list
19933119|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
19933120|NCT01382940|Rituximab|rituximab|mesh-list
19933121|NCT01382940|Methotrexate|methotrexate|mesh-list
19933122|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
19933123|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19933124|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19933125|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933126|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
19933127|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933128|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933129|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19933130|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
19933131|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19933132|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19933133|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
19933134|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933135|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933136|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933137|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19933138|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933139|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933140|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933141|NCT01382940|Analgesics|analgesics|mesh-ancestor
19933142|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
19933143|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933144|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
19933145|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933146|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
19933147|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
19933148|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933149|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
19933150|NCT01382940|Hormones|hormones|mesh-ancestor
19933151|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933152|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19933153|NCT01382940|Protective Agents|protective agents|mesh-ancestor
19933154|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
19933155|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933156|NCT01383096|Artefenomel|artefenomel|mesh-list
19933157|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19933158|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
19933159|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19933160|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19933161|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933162|NCT01383161|Curcumin|curcumin|mesh-list
19933163|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19933164|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933165|NCT01383161|Analgesics|analgesics|mesh-ancestor
19933166|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
19933167|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933168|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933169|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933170|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933171|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933172|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933173|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933174|NCT01383200|Lidocaine|lidocaine|mesh-list
19933175|NCT01383200|Tetracaine|tetracaine|mesh-list
19933176|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
19933177|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
19933178|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933179|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933180|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
19933181|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933182|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19973334|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933183|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19933184|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19933185|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933186|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933187|NCT01383356|Metformin|metformin|mesh-list
19933188|NCT01383356|Linagliptin|linagliptin|mesh-list
19933189|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19933190|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933191|NCT01383356|Incretins|incretins|mesh-ancestor
20264458|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264459|NCT00511446|Docetaxel|docetaxel|mesh-list
19933192|NCT01383356|Hormones|hormones|mesh-ancestor
19933193|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933194|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19933195|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933196|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933197|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933198|NCT01383486|Naproxen|naproxen|mesh-list
19933199|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19933200|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933201|NCT01383486|Analgesics|analgesics|mesh-ancestor
19933202|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
19933203|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933204|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933205|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933206|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933207|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
19933208|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19933209|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933210|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933211|NCT01383499|Bromides|bromides|mesh-list
19933212|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
19933213|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19933214|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
19933215|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933216|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933217|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19933218|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
19933219|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
19933220|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19933221|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
19933222|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933223|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933224|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
19933225|NCT01383707|Leucovorin|leucovorin|mesh-list
19933226|NCT01383707|Bevacizumab|bevacizumab|mesh-list
19933227|NCT01383707|Fluorouracil|fluorouracil|mesh-list
19933228|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
19933229|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
19933230|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19933231|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933232|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19933233|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19933234|NCT01383707|Growth Substances|growth substances|mesh-ancestor
19933235|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933236|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
19933237|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
19933238|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933239|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19933240|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933241|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
19933242|NCT01383707|Antidotes|antidotes|mesh-ancestor
19933243|NCT01383707|Protective Agents|protective agents|mesh-ancestor
19933244|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
19933245|NCT01383707|Vitamins|vitamins|mesh-ancestor
19933246|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
19933247|NCT01383759|Dexamethasone|dexamethasone|mesh-list
19933248|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
19933249|NCT01383759|Bortezomib|bortezomib|mesh-list
19933250|NCT01383759|BB 1101|bb 1101|mesh-list
19933251|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933252|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
19933253|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
20264460|NCT00511446|Capecitabine|capecitabine|mesh-list
19933254|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264461|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
19933255|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933256|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933257|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
19933258|NCT01383759|Hormones|hormones|mesh-ancestor
20264462|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264463|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264464|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264465|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264466|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264467|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20264468|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
20264469|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
20264470|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
20264471|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20542154|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
20542155|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
20542156|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542157|NCT01861951|Doxorubicin|doxorubicin|mesh-list
20542158|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20542159|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542160|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20542161|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20542162|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542163|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542164|NCT01861990|Valproic Acid|valproic acid|mesh-list
20542165|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
20542166|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542167|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542168|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
20542169|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542170|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542171|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
20542172|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20542173|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542174|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20542175|NCT01862003|Leucovorin|leucovorin|mesh-list
20542176|NCT01862003|Folic Acid|folic acid|mesh-list
20542177|NCT01862003|Fluorouracil|fluorouracil|mesh-list
20542178|NCT01862003|Irinotecan|irinotecan|mesh-list
20542179|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
20542180|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
20542181|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542182|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20542183|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542184|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542185|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
20542186|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542187|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20542188|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20542189|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542190|NCT01862003|Antidotes|antidotes|mesh-ancestor
20542191|NCT01862003|Protective Agents|protective agents|mesh-ancestor
20542192|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
20542193|NCT01862003|Vitamins|vitamins|mesh-ancestor
20542194|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
20542195|NCT01862003|Hematinics|hematinics|mesh-ancestor
20542196|NCT01862081|Paclitaxel|paclitaxel|mesh-list
20542197|NCT01862081|Docetaxel|docetaxel|mesh-list
20542198|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20542199|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542200|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
20542201|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
19933259|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933260|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19933261|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933262|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933263|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933264|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933265|NCT01383928|Dexamethasone|dexamethasone|mesh-list
19933266|NCT01383928|Lenalidomide|lenalidomide|mesh-list
19933267|NCT01383928|Ixazomib|ixazomib|mesh-list
19933268|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933269|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
20542202|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
20542203|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542204|NCT01862120|Interleukin-2|interleukin-2|mesh-list
19452680|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933270|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
19933271|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933272|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933273|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933274|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
19933275|NCT01383928|Hormones|hormones|mesh-ancestor
19933276|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933277|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19933278|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933279|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
19933280|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19933281|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19933282|NCT01383928|Growth Substances|growth substances|mesh-ancestor
19933283|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
19933284|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933285|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933286|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933287|NCT01383954|Diclofenac|diclofenac|mesh-list
19933288|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19933289|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933290|NCT01383954|Analgesics|analgesics|mesh-ancestor
19933291|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
19933292|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933293|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933294|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933295|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933296|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19933297|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933298|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933299|NCT01383993|Voriconazole|voriconazole|mesh-list
19933300|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
19933301|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933302|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19933303|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19933304|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933305|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933306|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19933307|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
20264472|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20264473|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264474|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264475|NCT00511498|Urological Agents|urological agents|mesh-ancestor
20264476|NCT00511576|Docetaxel|docetaxel|mesh-list
20264477|NCT00511576|Mocetinostat|mocetinostat|mesh-list
20264478|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542205|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542206|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20542207|NCT01862120|Analgesics|analgesics|mesh-ancestor
20542208|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
20542209|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542210|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542211|NCT01862263|Vildagliptin|vildagliptin|mesh-list
20542212|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542213|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542214|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20542215|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
20542216|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542217|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554088|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20554089|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554090|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19933308|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933309|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933310|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19933311|NCT01384292|Naloxegol|naloxegol|mesh-list
19933312|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19933313|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933314|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
19933315|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933316|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
19933317|NCT01384539|Calcitriol|calcitriol|mesh-list
19933318|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19933319|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933320|NCT01384539|Vitamins|vitamins|mesh-ancestor
19933321|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
19933322|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19933323|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19933324|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933325|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933326|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19933327|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
19933328|NCT01384591|Losartan|losartan|mesh-list
19933329|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19933330|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19933331|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19933332|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19933333|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19933334|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933335|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
19933336|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933337|NCT01384591|Expectorants|expectorants|mesh-ancestor
19933338|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
19933339|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19933340|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
19933341|NCT01384591|Protective Agents|protective agents|mesh-ancestor
19933342|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933343|NCT01384591|Antidotes|antidotes|mesh-ancestor
19933344|NCT01384734|Ritonavir|ritonavir|mesh-list
19933345|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19933346|NCT01384734|Tenofovir|tenofovir|mesh-list
19933347|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
19933348|NCT01384734|Fostemsavir|fostemsavir|mesh-list
19933349|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19933350|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19933351|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933352|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933353|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933354|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19933355|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19933356|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
19933357|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933358|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19933359|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19933360|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19933361|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933362|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19933363|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19933364|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19933365|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19933366|NCT01384877|Lidocaine|lidocaine|mesh-list
19933367|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
19933368|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
19933369|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933370|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933371|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
19933372|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933373|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19933374|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19933375|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19933376|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933377|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933378|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
19933379|NCT01385098|Vitamin D|vitamin d|mesh-list
19933380|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
19933381|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
19933382|NCT01385098|Vitamins|vitamins|mesh-list
19933383|NCT01385098|Calcium|calcium|mesh-list
19933384|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
19933385|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933386|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19933387|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19933388|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19933389|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19933390|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
19933391|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933392|NCT01385189|Antacids|antacids|mesh-ancestor
19933393|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933394|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933395|NCT01385566|Vaccines|vaccines|mesh-list
20264479|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264480|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264481|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264482|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264483|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20264484|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264485|NCT00511602|Insulin|insulin|mesh-list
20264486|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264487|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264488|NCT00511628|Risperidone|risperidone|mesh-list
20264489|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20264490|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
20264491|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264492|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264493|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264494|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20264495|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264496|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264497|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264498|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20264499|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
20264500|NCT00511654|Midazolam|midazolam|mesh-list
20264501|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20264502|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20264503|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264504|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264505|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20264506|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264507|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264508|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20264509|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
20264510|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
20264511|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
20264512|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
20264513|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264514|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264515|NCT00511719|Insulin|insulin|mesh-list
20264516|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20264517|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264518|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264519|NCT00511732|Insulin|insulin|mesh-list
20264520|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264521|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264522|NCT00511771|Tegaserod|tegaserod|mesh-list
20264523|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20264524|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
20264525|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264526|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264527|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264528|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
20264529|NCT00511823|Granisetron|granisetron|mesh-list
20264530|NCT00511823|Casopitant|casopitant|mesh-list
20264531|NCT00511823|Dolasetron|dolasetron|mesh-list
20264532|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264533|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264534|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
20264535|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
20264536|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264537|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933396|NCT01385566|Immunoglobulins|immunoglobulins|mesh-list
19933397|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
19933398|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933399|NCT01385748|Clonidine|clonidine|mesh-list
19933400|NCT01385748|Analgesics|analgesics|mesh-ancestor
19933401|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
19933402|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933403|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933404|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19933405|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
20264538|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20264539|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
20264540|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264541|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933406|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
20264542|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19933407|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19933408|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19933409|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19933410|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
19933411|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933412|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933413|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19933414|NCT01386554|Hormones|hormones|mesh-ancestor
19933415|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933416|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933417|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
19933418|NCT01386606|Enclomiphene|enclomiphene|mesh-list
19933419|NCT01386606|Clomiphene|clomiphene|mesh-list
19933420|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
19933421|NCT01386606|Testosterone|testosterone|mesh-list
19933422|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
19933423|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
19933424|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19933425|NCT01386606|Androgens|androgens|mesh-ancestor
19933426|NCT01386606|Hormones|hormones|mesh-ancestor
19933427|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933428|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933429|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19933430|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933431|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
19933432|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19933433|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
19933434|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19933435|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
19933436|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19933437|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19933438|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19933439|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
19933440|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19933441|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
19933442|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933443|NCT01386645|Expectorants|expectorants|mesh-ancestor
19933444|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
19933445|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20264543|NCT00511849|Paclitaxel|paclitaxel|mesh-list
20264544|NCT00511849|Carboplatin|carboplatin|mesh-list
20264545|NCT00511849|Sunitinib|sunitinib|mesh-list
20264546|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20264547|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264548|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264549|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264550|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264551|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264552|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20264553|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20264554|NCT00511849|Growth Substances|growth substances|mesh-ancestor
20264555|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264556|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
20264557|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264558|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264559|NCT00511940|Acamprosate|acamprosate|mesh-list
20264560|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20264561|NCT00511953|Gabapentin|gabapentin|mesh-list
20264562|NCT00511953|Analgesics|analgesics|mesh-ancestor
20264563|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
20264564|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264565|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264566|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
20264567|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20264568|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264569|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264570|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264571|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20264572|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20264573|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264574|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264575|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
19933446|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
19933447|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933448|NCT01386645|Protective Agents|protective agents|mesh-ancestor
19933449|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933450|NCT01386645|Antidotes|antidotes|mesh-ancestor
19933451|NCT01386970|Lamivudine|lamivudine|mesh-list
19933452|NCT01386970|Zidovudine|zidovudine|mesh-list
19933453|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19933454|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19933455|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933456|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933457|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933458|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
19933459|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933460|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19933461|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19933462|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
19933463|NCT01386983|Finasteride|finasteride|mesh-list
19933464|NCT01386983|Dutasteride|dutasteride|mesh-list
19933465|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19933466|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19933467|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933468|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933469|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
19933470|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933471|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933472|NCT01386983|Urological Agents|urological agents|mesh-ancestor
19933473|NCT01387022|Tenofovir|tenofovir|mesh-list
19933474|NCT01387022|Lamivudine|lamivudine|mesh-list
19933475|NCT01387022|Efavirenz|efavirenz|mesh-list
19933476|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
19933477|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933478|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19933479|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933480|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933481|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933482|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19933483|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19933484|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19933485|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19933486|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19933487|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19933488|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19933489|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19933490|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
19933491|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19933492|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19933493|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19933494|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933495|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933496|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
19933497|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933498|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933499|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19933500|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933501|NCT01387139|Ketamine|ketamine|mesh-list
19933502|NCT01387139|Propofol|propofol|mesh-list
19933503|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19933504|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933505|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933506|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19933507|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
19933508|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
19933509|NCT01387139|Analgesics|analgesics|mesh-ancestor
19933510|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
19933511|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933512|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19933513|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19933514|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19933515|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933516|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933517|NCT01387178|Fluticasone|fluticasone|mesh-list
19933518|NCT01387178|Xhance|xhance|mesh-list
19933519|NCT01387178|Bromides|bromides|mesh-list
19933520|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
19933521|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19933522|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933523|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19933524|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
19933525|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933526|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933527|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19933528|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
19933529|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933530|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19933531|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
19933532|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19933533|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
19933534|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933535|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933536|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19933537|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19933538|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19933539|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
19933540|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
19933541|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19933542|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19973335|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973336|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
19973337|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19973338|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
19973339|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19973340|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19973341|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973342|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973343|NCT01822756|Gemcitabine|gemcitabine|mesh-list
19973344|NCT01822756|Paclitaxel|paclitaxel|mesh-list
19973345|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19973346|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973347|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
19973348|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
19973349|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
19973350|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973351|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973352|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
19973353|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
19973354|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973355|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973356|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973357|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
19973358|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973359|NCT01822821|Acetaminophen|acetaminophen|mesh-list
19973360|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19973361|NCT01822821|Analgesics|analgesics|mesh-ancestor
19973362|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
19973363|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973364|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973365|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
19973366|NCT01822886|Gemcitabine|gemcitabine|mesh-list
19973367|NCT01822886|Romidepsin|romidepsin|mesh-list
19973368|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973369|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
19973370|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973371|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973372|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
19973373|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973374|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973375|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973376|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
19973377|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973378|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19973379|NCT01822899|Fluticasone|fluticasone|mesh-list
19973380|NCT01822899|Xhance|xhance|mesh-list
19973381|NCT01822899|Bromides|bromides|mesh-list
19973382|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19973383|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973384|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19973385|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
19973386|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973387|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973388|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19973389|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
19933543|NCT01387464|Bromfenac|bromfenac|mesh-list
19933544|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19933545|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933546|NCT01387464|Analgesics|analgesics|mesh-ancestor
19933547|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
19933548|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933549|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933550|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933551|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933552|NCT01387516|Nicotine|nicotine|mesh-list
19933553|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19933554|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
19933555|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933556|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933557|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19933558|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19933559|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
19933560|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933561|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933562|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19933563|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19933564|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19933565|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933566|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933567|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19933568|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19933569|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19933570|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
19933571|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933572|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933573|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19933574|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19933575|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
19933576|NCT01387607|Pregabalin|pregabalin|mesh-list
19933577|NCT01387607|Analgesics|analgesics|mesh-ancestor
19933578|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
19933579|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933580|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933581|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
19933582|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19933583|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933584|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933585|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19933586|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19933587|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19933588|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933589|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19933590|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
19933591|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
19933592|NCT01387815|Adalimumab|adalimumab|mesh-list
19933593|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933594|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264576|NCT00511966|Rabeprazole|rabeprazole|mesh-list
20264577|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20264578|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264579|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20264580|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264581|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264582|NCT00511979|Insulin|insulin|mesh-list
20264583|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20264584|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264585|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264586|NCT00512044|Anesthetics|anesthetics|mesh-list
20264587|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264588|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264589|NCT00512057|Allopurinol|allopurinol|mesh-list
20264590|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
20264591|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264592|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264593|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
20264594|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264595|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20264596|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
20264597|NCT00512057|Protective Agents|protective agents|mesh-ancestor
20264598|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933595|NCT01387932|Doxorubicin|doxorubicin|mesh-list
19933596|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
19933597|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19933598|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933599|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19933600|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19933601|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933602|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933603|NCT01388335|Warfarin|warfarin|mesh-list
19933604|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
19933605|NCT01388361|Insulin|insulin|mesh-list
19933606|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19933607|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
19933608|NCT01388361|Liraglutide|liraglutide|mesh-list
19933609|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19933610|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933611|NCT01388361|Incretins|incretins|mesh-ancestor
19933612|NCT01388361|Hormones|hormones|mesh-ancestor
19933613|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933614|NCT01388478|Pramipexole|pramipexole|mesh-list
19933615|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
20264599|NCT00512070|Olanzapine|olanzapine|mesh-list
20264600|NCT00512070|Melatonin|melatonin|mesh-list
20264601|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
19933616|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933617|NCT01388478|Protective Agents|protective agents|mesh-ancestor
19933618|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933619|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19933620|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19933621|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
19933622|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
19933623|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264602|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264603|NCT00512070|Protective Agents|protective agents|mesh-ancestor
20264604|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264605|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264606|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
20264607|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
20264608|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264609|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264610|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20264611|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264612|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264613|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20264614|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20542218|NCT01862302|Haloperidol|haloperidol|mesh-list
20542219|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
20542220|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
20542221|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
20542222|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542223|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542224|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542225|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20542226|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20542227|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542228|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20542229|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20542230|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
20542231|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542232|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542233|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20542234|NCT01862315|Gemcitabine|gemcitabine|mesh-list
20542235|NCT01862315|Dexamethasone|dexamethasone|mesh-list
20542236|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
20542237|NCT01862315|Floxuridine|floxuridine|mesh-list
20542238|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542239|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
20542240|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
20542241|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542242|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542243|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933624|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19933625|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20542244|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
19933626|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20264615|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542245|NCT01862315|Hormones|hormones|mesh-ancestor
20554091|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933627|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933628|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933629|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933630|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19933631|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19933632|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
19933633|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933634|NCT01388647|Carboplatin|carboplatin|mesh-list
19933635|NCT01388647|Trastuzumab|trastuzumab|mesh-list
19933636|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933637|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19933638|NCT01388790|Cetuximab|cetuximab|mesh-list
19933639|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933640|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19933641|NCT01388946|Ropivacaine|ropivacaine|mesh-list
19933642|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
19933643|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
19933644|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933645|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933646|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
19933647|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933648|NCT01388985|Vaccines|vaccines|mesh-list
19933649|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
19933650|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933651|NCT01389076|Methotrexate|methotrexate|mesh-list
19933652|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
19933653|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19933654|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
19933655|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19933656|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933657|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19933658|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
19933659|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933660|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933661|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933662|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933663|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19933664|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933665|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
19933666|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933667|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933668|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19933669|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19933670|NCT01389102|Estradiol|estradiol|mesh-list
19933671|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19933672|NCT01389102|Estrogens|estrogens|mesh-ancestor
19933673|NCT01389102|Hormones|hormones|mesh-ancestor
19933674|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933675|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933676|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19933677|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
19933678|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19933679|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19933680|NCT01389284|Naproxen|naproxen|mesh-list
19933681|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19933682|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933683|NCT01389284|Analgesics|analgesics|mesh-ancestor
19933684|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
19933685|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933686|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933687|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933688|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933689|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
19933690|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19933691|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933692|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933693|NCT01389323|Interferons|interferons|mesh-list
19933694|NCT01389323|Ribavirin|ribavirin|mesh-list
19933695|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
19933696|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
19933697|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19933698|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933699|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
19933700|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933701|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
19973390|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933702|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933703|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
19933704|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933705|NCT01389596|Pregabalin|pregabalin|mesh-list
19933706|NCT01389596|Analgesics|analgesics|mesh-ancestor
19933707|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
19933708|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933709|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933710|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
19933711|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19933712|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933713|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933714|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19933715|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19933716|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19933717|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933718|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19933719|NCT01389752|Charcoal|charcoal|mesh-list
19933720|NCT01389752|Antidotes|antidotes|mesh-ancestor
19933721|NCT01389752|Protective Agents|protective agents|mesh-ancestor
19933722|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933723|NCT01389856|Bosentan|bosentan|mesh-list
19933724|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19933725|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19933726|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933727|NCT01389973|Ustekinumab|ustekinumab|mesh-list
19933728|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933729|NCT01390064|Vaccines|vaccines|mesh-list
19933730|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
19933731|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933732|NCT01390077|Nitisinone|nitisinone|mesh-list
19933733|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933734|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933735|NCT01390220|Midazolam|midazolam|mesh-list
19933736|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19933737|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19933738|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19933739|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933740|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19933741|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19933742|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19933743|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19933744|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
19933745|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
19933746|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
19933747|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
19933748|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933749|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933750|NCT01390233|Dinoprostone|dinoprostone|mesh-list
19933751|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
19933752|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19933753|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933754|NCT01390246|Bupropion|bupropion|mesh-list
19933755|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19933756|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
19933757|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19933758|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19933759|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19933760|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933761|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933762|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
19933763|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933764|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933765|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19933766|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19933767|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933768|NCT01390389|Ubiquinone|ubiquinone|mesh-list
19933769|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
19933770|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
19933771|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933772|NCT01390389|Vitamins|vitamins|mesh-ancestor
19933773|NCT01390402|Aldesleukin|aldesleukin|mesh-list
19933774|NCT01390402|Methotrexate|methotrexate|mesh-list
19933775|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
19933776|NCT01390402|Fludarabine|fludarabine|mesh-list
19933777|NCT01390402|Busulfan|busulfan|mesh-list
19933778|NCT01390402|Interleukin-2|interleukin-2|mesh-list
19933779|NCT01390402|Tacrolimus|tacrolimus|mesh-list
19933780|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
19933781|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19933782|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19933783|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
19933784|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19933785|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933786|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19933787|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
19933788|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933789|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933790|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933791|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933792|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19933793|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933794|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
19933795|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933796|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933797|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
19933798|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933799|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19933800|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
19933801|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19933802|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19933803|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933804|NCT01390402|Analgesics|analgesics|mesh-ancestor
19933805|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
19933806|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933807|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19933808|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19933809|NCT01390428|Grazoprevir|grazoprevir|mesh-list
19933810|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
19933811|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933812|NCT01390441|Acetaminophen|acetaminophen|mesh-list
19933813|NCT01390441|Loratadine|loratadine|mesh-list
19933814|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
19933815|NCT01390441|Rituximab|rituximab|mesh-list
19933816|NCT01390441|Methotrexate|methotrexate|mesh-list
19933817|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19933818|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933819|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
19933820|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933821|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933822|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19933823|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
19933824|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19933825|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19933826|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
19933827|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933828|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933829|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933830|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19933831|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933832|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933833|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19933834|NCT01390441|Analgesics|analgesics|mesh-ancestor
19933835|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
19933836|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933837|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
19933838|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933839|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
19933840|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
19933841|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933842|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
19933843|NCT01390441|Hormones|hormones|mesh-ancestor
19933844|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933845|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19933846|NCT01390441|Protective Agents|protective agents|mesh-ancestor
19933847|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
20264616|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264617|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
20264618|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
20264619|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19933848|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20554092|NCT01933061|Paclitaxel|paclitaxel|mesh-list
19933849|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19933850|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19933851|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
19933852|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
19933853|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933854|NCT01390584|Prednisone|prednisone|mesh-list
19933855|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
19933856|NCT01390584|Dacarbazine|dacarbazine|mesh-list
19933857|NCT01390584|Doxorubicin|doxorubicin|mesh-list
19933858|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19933859|NCT01390584|Etoposide|etoposide|mesh-list
19933860|NCT01390584|Vincristine|vincristine|mesh-list
19933861|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
19933862|NCT01390584|Bleomycin|bleomycin|mesh-list
19933863|NCT01390584|Vinblastine|vinblastine|mesh-list
19933864|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
19933865|NCT01390584|Procarbazine|procarbazine|mesh-list
19933866|NCT01390584|Imidazole|imidazole|mesh-list
19933867|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933868|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
19933869|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933870|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19933871|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19933872|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
19933873|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933874|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933875|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19933876|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19933877|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19933878|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19933879|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933880|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19933881|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
19933882|NCT01390584|Hormones|hormones|mesh-ancestor
19933883|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19933884|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19933885|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19933886|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
19933887|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
19933888|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
19933889|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
19933890|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
19933891|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19933892|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
19933893|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933894|NCT01390818|Niacinamide|niacinamide|mesh-list
19933895|NCT01390818|Sirolimus|sirolimus|mesh-list
19933896|NCT01390818|Elafin|elafin|mesh-list
19933897|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933898|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933899|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933900|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
19933901|NCT01390818|Vitamins|vitamins|mesh-ancestor
19933902|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
19933903|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933904|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19933905|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933906|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19933907|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933908|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
19933909|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19933910|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
19933911|NCT01390844|Ribavirin|ribavirin|mesh-list
19933912|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19933913|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
19933914|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933915|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
19933916|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933917|NCT01390857|Valacyclovir|valacyclovir|mesh-list
19933918|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
19933919|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933920|NCT01390870|Alfuzosin|alfuzosin|mesh-list
19933921|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933922|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933923|NCT01390870|Urological Agents|urological agents|mesh-ancestor
19933924|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19933925|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19933926|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19933927|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
19933928|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933929|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
19933930|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
19933931|NCT01390909|Lactitol|lactitol|mesh-list
19933932|NCT01390909|Cathartics|cathartics|mesh-ancestor
19933933|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19933934|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933935|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933936|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19933937|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19933938|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19933939|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19933940|NCT01390948|Bevacizumab|bevacizumab|mesh-list
19933941|NCT01390948|Temozolomide|temozolomide|mesh-list
19933942|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19933943|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933944|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19933945|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19933946|NCT01390948|Growth Substances|growth substances|mesh-ancestor
19933947|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933948|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
19933949|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19933950|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
19933951|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933952|NCT01391013|Ritonavir|ritonavir|mesh-list
19933953|NCT01391013|Darunavir|darunavir|mesh-list
19933954|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19933955|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19933956|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19933957|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
19933958|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933959|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933960|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19933961|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19933962|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
19933963|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19933964|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19933965|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19933966|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19933967|NCT01391130|Sunitinib|sunitinib|mesh-list
19933968|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19933969|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19933970|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19933971|NCT01391130|Growth Substances|growth substances|mesh-ancestor
19933972|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933973|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
19933974|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19933975|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19933976|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933977|NCT01391273|Bimatoprost|bimatoprost|mesh-list
19933978|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19933979|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19933980|NCT01391286|Bimatoprost|bimatoprost|mesh-list
19933981|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19933982|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19933983|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
19933984|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19933985|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19933986|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19933987|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933988|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19933989|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
19933990|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19933991|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19933992|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19933993|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19933994|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
19933995|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19933996|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19933997|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19933998|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19933999|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934000|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934001|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934002|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934003|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19934004|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934005|NCT01391325|Allopurinol|allopurinol|mesh-list
19934006|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
19934007|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934008|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934009|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
19934010|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934011|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19934012|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
19934013|NCT01391325|Protective Agents|protective agents|mesh-ancestor
19934014|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934015|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19934016|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19934017|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
19934018|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19934019|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
19934020|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934021|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934022|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19934023|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934024|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19934025|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19934026|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20264620|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
20264621|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264622|NCT00512265|Expectorants|expectorants|mesh-ancestor
20264623|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
20264624|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20264625|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
20264626|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264627|NCT00512265|Protective Agents|protective agents|mesh-ancestor
20264628|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264629|NCT00512265|Antidotes|antidotes|mesh-ancestor
20264630|NCT00512291|Olanzapine|olanzapine|mesh-list
20264631|NCT00512291|Fluoxetine|fluoxetine|mesh-list
20264632|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
20264633|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
20264634|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264635|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264636|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264637|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20264638|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264639|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264640|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264641|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20264642|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20264643|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20264644|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264645|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264646|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
20264647|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20264648|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
20264649|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20264650|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20264651|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287126|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287127|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287128|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20287129|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
20287130|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20287131|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20287132|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20287133|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20287134|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20287135|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
20287136|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287137|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287138|NCT05332106|Androgens|androgens|mesh-ancestor
19934027|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
19934028|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287139|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
19934029|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934030|NCT01391663|Alogliptin|alogliptin|mesh-list
19934031|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19934032|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934033|NCT01391663|Incretins|incretins|mesh-ancestor
19934034|NCT01391663|Hormones|hormones|mesh-ancestor
19934035|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934036|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19934037|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
19934038|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934039|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934040|NCT01391793|Dexamethasone|dexamethasone|mesh-list
19934041|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934042|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
19934043|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
19934044|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934045|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934046|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934047|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
19934048|NCT01391793|Hormones|hormones|mesh-ancestor
19934049|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934050|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19934051|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934052|NCT01391858|Pregabalin|pregabalin|mesh-list
19934053|NCT01391858|Analgesics|analgesics|mesh-ancestor
19934054|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
19934055|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934056|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934057|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
19934058|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19934059|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934060|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934061|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19934062|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19934063|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19934064|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934065|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19934066|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
19934067|NCT01392183|Sirolimus|sirolimus|mesh-list
19934068|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19934069|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934070|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19934071|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934072|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
19934073|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934074|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
19934075|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934076|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19934077|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19934078|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934079|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
19934080|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
19934081|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
19934082|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934083|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
19934084|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
19934085|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934086|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19934087|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
19934088|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
19934089|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934090|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934091|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19934092|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19934093|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19934094|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934095|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934096|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19934097|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934098|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934099|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934100|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934101|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19934102|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
19934103|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934104|NCT01392378|Acetaminophen|acetaminophen|mesh-list
19934105|NCT01392378|Ibuprofen|ibuprofen|mesh-list
19934106|NCT01392378|Vaccines|vaccines|mesh-list
19934107|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19934108|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
19934109|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934110|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19934111|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19934112|NCT01392378|Analgesics|analgesics|mesh-ancestor
19934113|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
19934114|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934115|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934116|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934117|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19934118|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934119|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934120|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
19934121|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
19934122|NCT01392469|Bosentan|bosentan|mesh-list
19934123|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
19934124|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934125|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934126|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934127|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934128|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
19934129|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19934130|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19934131|NCT01392469|Urological Agents|urological agents|mesh-ancestor
19934132|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19934133|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19934134|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
19934135|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934136|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934137|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934138|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934139|NCT01392560|Empagliflozin|empagliflozin|mesh-list
19934140|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19934141|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934142|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19934143|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934144|NCT01392573|Insulin|insulin|mesh-list
19934145|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19934146|NCT01392573|Liraglutide|liraglutide|mesh-list
19934147|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
19934148|NCT01392573|Xultophy|xultophy|mesh-list
19934149|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19934150|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934151|NCT01392573|Incretins|incretins|mesh-ancestor
19934152|NCT01392573|Hormones|hormones|mesh-ancestor
19934153|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934154|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
19934155|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19934156|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934157|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19934158|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934159|NCT01392703|Dasatinib|dasatinib|mesh-list
19934160|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934161|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934162|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934163|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934164|NCT01392859|Levocetirizine|levocetirizine|mesh-list
19934165|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19934166|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19934167|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
19934168|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
19934169|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934170|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934171|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934172|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
19934173|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19934174|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19934175|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19934176|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934177|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934178|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934179|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934180|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934181|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19934182|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934183|NCT01392989|Cyclosporine|cyclosporine|mesh-list
19934184|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
19934185|NCT01392989|Cyclosporins|cyclosporins|mesh-list
19934186|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
19934187|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19934188|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934189|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934190|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934191|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
19934192|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934193|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
19732566|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19732567|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19732568|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732569|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732570|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19732571|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732572|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732573|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934194|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934195|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
19934196|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934197|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19934198|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19934199|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934200|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19934201|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
19934202|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19934203|NCT01393106|Idelalisib|idelalisib|mesh-list
19934204|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934205|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934206|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934207|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20264652|NCT00512395|Fentanyl|fentanyl|mesh-list
20264653|NCT00512395|Ropivacaine|ropivacaine|mesh-list
20264654|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20264655|NCT00512395|Narcotics|narcotics|mesh-ancestor
20264656|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264657|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264658|NCT00512395|Analgesics|analgesics|mesh-ancestor
20264659|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
20264660|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264661|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20264662|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20264663|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
20264664|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
20264665|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
20264666|NCT00512408|Testosterone|testosterone|mesh-list
20264667|NCT00512408|Androgens|androgens|mesh-ancestor
20264668|NCT00512408|Hormones|hormones|mesh-ancestor
20264669|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20264670|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264671|NCT00512473|Hormones|hormones|mesh-list
20264672|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20264673|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264674|NCT00512486|Benralizumab|benralizumab|mesh-list
20264675|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20264676|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
20264677|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
20264678|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264679|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264680|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20264681|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19934208|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20264682|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20287140|NCT05332067|Omalizumab|omalizumab|mesh-list
19934209|NCT01393158|Apremilast|apremilast|mesh-list
19934210|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19934211|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19934212|NCT01393158|Analgesics|analgesics|mesh-ancestor
19934213|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
19934214|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934215|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934216|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934217|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934218|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19934219|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19934220|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934221|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973391|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19973392|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19973393|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19973394|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19973395|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
19973396|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973397|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973398|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
19973399|NCT01823146|Oxytocin|oxytocin|mesh-list
19973400|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
20264683|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20264684|NCT00512668|Sirolimus|sirolimus|mesh-list
20264685|NCT00512668|Leuprolide|leuprolide|mesh-list
20264686|NCT00512668|Goserelin|goserelin|mesh-list
20264687|NCT00512668|Flutamide|flutamide|mesh-list
20264688|NCT00512668|Bicalutamide|bicalutamide|mesh-list
20264689|NCT00512668|Nilutamide|nilutamide|mesh-list
20264690|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20264691|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
20264692|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20264693|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264694|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20264695|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264696|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264697|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264698|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20264699|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
20542246|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542247|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542248|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542249|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20542250|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
20542251|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542252|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
20542253|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542254|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542255|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542256|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
20542257|NCT01862354|Anesthetics|anesthetics|mesh-list
20542258|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542259|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542260|NCT01862497|Carvedilol|carvedilol|mesh-list
20542261|NCT01862497|Prazosin|prazosin|mesh-list
20542262|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20542263|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20542264|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
20542265|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542266|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542267|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542268|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20542269|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
20542270|NCT01862497|Protective Agents|protective agents|mesh-ancestor
20542271|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20542272|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542273|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542274|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
20542275|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20542276|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20542277|NCT01862523|Capsaicin|capsaicin|mesh-list
20264700|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934222|NCT01393392|Methadone|methadone|mesh-list
19934223|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19934224|NCT01393392|Narcotics|narcotics|mesh-ancestor
19934225|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934226|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934227|NCT01393392|Analgesics|analgesics|mesh-ancestor
19934228|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
19934229|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934230|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
19934231|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934232|NCT01393405|Methotrexate|methotrexate|mesh-list
19934233|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19934234|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
19934235|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19934236|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934237|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19934238|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
19934239|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934240|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934241|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
19934242|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934243|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19934244|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934245|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
19934246|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934247|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19934248|NCT01393457|Levodopa|levodopa|mesh-list
19934249|NCT01393457|Carbidopa|carbidopa|mesh-list
19934250|NCT01393457|Ropinirole|ropinirole|mesh-list
19934251|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19934252|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19934253|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
19934254|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934255|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934256|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934257|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19934258|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934259|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
19934260|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
19934261|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19934262|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19934263|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934264|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934265|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
19934266|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934267|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934268|NCT01393626|Tofacitinib|tofacitinib|mesh-list
19934269|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934270|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934271|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934272|NCT01393704|Vasopressins|vasopressins|mesh-list
19934273|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
19934274|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
19934275|NCT01393704|Coagulants|coagulants|mesh-ancestor
19934276|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19934277|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19934278|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
19934279|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934280|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19934281|NCT01393717|Antibodies|antibodies|mesh-list
19934282|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
19934283|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19934284|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
19934285|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
19934286|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934287|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19934288|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934289|NCT01393730|Prednisone|prednisone|mesh-list
19934290|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
19934291|NCT01393730|Dutasteride|dutasteride|mesh-list
19934292|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934293|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
19934294|NCT01393730|Hormones|hormones|mesh-ancestor
19934295|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934296|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934297|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19934298|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934299|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19934300|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934301|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934302|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
19934303|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19934304|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19934305|NCT01393899|Tofacitinib|tofacitinib|mesh-list
19934306|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934307|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934308|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934309|NCT01393964|Dexamethasone|dexamethasone|mesh-list
19934310|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
19934311|NCT01393964|Lenalidomide|lenalidomide|mesh-list
19934312|NCT01393964|Elotuzumab|elotuzumab|mesh-list
19934313|NCT01393964|BB 1101|bb 1101|mesh-list
19934314|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934315|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
19934316|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
19934317|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934318|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934319|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934320|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
19934321|NCT01393964|Hormones|hormones|mesh-ancestor
19934322|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934323|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19934324|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934325|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
19934326|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934327|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934328|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
19934329|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19934330|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19934331|NCT01393964|Growth Substances|growth substances|mesh-ancestor
19934332|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
19934333|NCT01393990|Tamoxifen|tamoxifen|mesh-list
19934334|NCT01393990|Midazolam|midazolam|mesh-list
19934335|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19934336|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19934337|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934338|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934339|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19934340|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19934341|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19934342|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19934343|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
19934344|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
19934345|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
19934346|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
19934347|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934348|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934349|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19934350|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
19934351|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934352|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19934353|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934354|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19934355|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19934356|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19934357|NCT01394185|Dronabinol|dronabinol|mesh-list
19934358|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
19934359|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934360|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19934361|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19934362|NCT01394185|Analgesics|analgesics|mesh-ancestor
19934363|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
19934364|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934365|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19934366|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19934367|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934368|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934369|NCT01394185|Hormones|hormones|mesh-ancestor
19934370|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934371|NCT01394250|Lidocaine|lidocaine|mesh-list
19934372|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
19934373|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
19934374|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934375|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934376|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
19934377|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934378|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19934379|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19934380|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19934381|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934382|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934383|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
19934384|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19934385|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
19732574|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732575|NCT04572373|SMOFlipid|smoflipid|mesh-list
19732576|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19732577|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19732578|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19735738|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19735739|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934386|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934387|NCT01394510|Expectorants|expectorants|mesh-ancestor
19934388|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934389|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19934390|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
19934391|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934392|NCT01394510|Protective Agents|protective agents|mesh-ancestor
19934393|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934394|NCT01394510|Antidotes|antidotes|mesh-ancestor
19934395|NCT01394523|Bupivacaine|bupivacaine|mesh-list
19934396|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
19934397|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
19934398|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934399|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934400|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
19934401|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934402|NCT01394614|Vaccines|vaccines|mesh-list
19934403|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
19934404|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934405|NCT01394627|Eplerenone|eplerenone|mesh-list
19934406|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19934407|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
20264701|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
20264702|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
20264703|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
20264704|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20264705|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
20264706|NCT00512681|Irinotecan|irinotecan|mesh-list
20264707|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264708|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20264709|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264710|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264711|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264712|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
20264713|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
20264714|NCT00512811|Furosemide|furosemide|mesh-list
20264715|NCT00512811|Diuretics|diuretics|mesh-ancestor
20264716|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
20264717|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264718|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20264719|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20264720|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264721|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
20264722|NCT00512824|Calcium|calcium|mesh-list
20264723|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20264724|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264725|NCT00512824|Antacids|antacids|mesh-ancestor
20264726|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264727|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20264728|NCT00512850|Folic Acid|folic acid|mesh-list
20264729|NCT00512850|Hematinics|hematinics|mesh-ancestor
20264730|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
20264731|NCT00512850|Vitamins|vitamins|mesh-ancestor
20264732|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
19934408|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934409|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934410|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19934411|NCT01394627|Diuretics|diuretics|mesh-ancestor
19934412|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
19934413|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19934414|NCT01394718|Acetaminophen|acetaminophen|mesh-list
19934415|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19934416|NCT01394718|Analgesics|analgesics|mesh-ancestor
19934417|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
19934418|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934419|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934420|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
19934421|NCT01394939|Irinotecan|irinotecan|mesh-list
19934422|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19934423|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19934424|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934425|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934426|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934427|NCT01394952|Dulaglutide|dulaglutide|mesh-list
19934428|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19934429|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934430|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
19934431|NCT01394991|Hematinics|hematinics|mesh-ancestor
19934432|NCT01395017|Dasatinib|dasatinib|mesh-list
19934433|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934434|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934435|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934436|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934437|NCT01395030|Choline|choline|mesh-list
19934438|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
19934439|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19934440|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
19934441|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934442|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934443|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19934444|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
19934445|NCT01395043|Epinephrine|epinephrine|mesh-list
19934446|NCT01395043|Bupivacaine|bupivacaine|mesh-list
19934447|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
19934448|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
19934449|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934450|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934451|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
19934452|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934453|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19934454|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19934455|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
19934456|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934457|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934458|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19934459|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19934460|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
19934461|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19934462|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934463|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
19934464|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
19934465|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19934466|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
19934467|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19934468|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934469|NCT01395329|Metoprolol|metoprolol|mesh-list
19934470|NCT01395329|Nebivolol|nebivolol|mesh-list
19934471|NCT01395329|Nitroprusside|nitroprusside|mesh-list
19934472|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
19934473|NCT01395329|BQ 788|bq 788|mesh-list
19934474|NCT01395329|Acetylcholine|acetylcholine|mesh-list
19934475|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19934476|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19934477|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
19934478|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
19934479|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934480|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934481|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19934482|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19934483|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19934484|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
19934485|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934486|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934487|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
19934488|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19934489|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19934490|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19934491|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19934492|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19934493|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934494|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19934495|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19934496|NCT01395524|Naloxegol|naloxegol|mesh-list
19934497|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19934498|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934499|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
19934500|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934501|NCT01395537|Paclitaxel|paclitaxel|mesh-list
19934502|NCT01395537|Carboplatin|carboplatin|mesh-list
19934503|NCT01395537|Lapatinib|lapatinib|mesh-list
19934504|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19934505|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934506|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
19934507|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
19934508|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
19934509|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934510|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934511|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934512|NCT01395758|Gemcitabine|gemcitabine|mesh-list
19934513|NCT01395758|Docetaxel|docetaxel|mesh-list
19934514|NCT01395758|Pemetrexed|pemetrexed|mesh-list
19934515|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19934516|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19934517|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
19934518|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934519|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934520|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
19934521|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934522|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934523|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934524|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
19934525|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934526|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
19934527|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
19934528|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
19934529|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19934530|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19934531|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934532|NCT01395784|Pioglitazone|pioglitazone|mesh-list
19934533|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19934534|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934535|NCT01395797|Pioglitazone|pioglitazone|mesh-list
19934536|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19934537|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934538|NCT01395823|Vitamin D|vitamin d|mesh-list
19934539|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
19934540|NCT01395823|Vitamins|vitamins|mesh-ancestor
19934541|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
19934542|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934543|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19934544|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19934545|NCT01395888|Fluticasone|fluticasone|mesh-list
19934546|NCT01395888|Xhance|xhance|mesh-list
19934547|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
19934548|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934549|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19934550|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
19934551|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934552|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934553|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19934554|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934555|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
19934556|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19934557|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
19934558|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19934559|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934560|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934561|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934562|NCT01395901|Ondansetron|ondansetron|mesh-list
19934563|NCT01395901|Palonosetron|palonosetron|mesh-list
19934564|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
19934565|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
19934566|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934567|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934568|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934569|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
19934570|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
19934571|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19934572|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
19934573|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934574|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934575|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19934576|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19934577|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934578|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19934579|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19934580|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19934581|NCT01396005|Buprenorphine|buprenorphine|mesh-list
19934582|NCT01396005|Methadone|methadone|mesh-list
19934583|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19934584|NCT01396005|Naloxone|naloxone|mesh-list
19934585|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19934586|NCT01396005|Narcotics|narcotics|mesh-ancestor
19934587|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934588|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934589|NCT01396005|Analgesics|analgesics|mesh-ancestor
19934590|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
19934591|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934592|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19934593|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
19934594|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934595|NCT01396057|Dexamethasone|dexamethasone|mesh-list
19934596|NCT01396057|Ranibizumab|ranibizumab|mesh-list
19934597|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934598|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
19934599|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
19934600|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934601|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934602|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934603|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
19934604|NCT01396057|Hormones|hormones|mesh-ancestor
19934605|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934606|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19934607|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934608|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19934609|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19934610|NCT01396057|Growth Substances|growth substances|mesh-ancestor
19934611|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
19934612|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19934613|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19934614|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934615|NCT01396083|Dexamethasone|dexamethasone|mesh-list
19934616|NCT01396083|Ranibizumab|ranibizumab|mesh-list
19934617|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934618|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
19934619|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
19934620|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934621|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934622|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934623|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
20264733|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264734|NCT00512863|Adalimumab|adalimumab|mesh-list
20264735|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264736|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264737|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
20264738|NCT00512928|Vitamin K|vitamin k|mesh-list
20264739|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
20264740|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
20264741|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20264742|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19934624|NCT01396083|Hormones|hormones|mesh-ancestor
20264743|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934625|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934626|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19934627|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264744|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
20264745|NCT00512928|Coagulants|coagulants|mesh-ancestor
20264746|NCT00512928|Vitamins|vitamins|mesh-ancestor
20264747|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
20264748|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264749|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
20264750|NCT00512980|Gemcitabine|gemcitabine|mesh-list
20264751|NCT00512980|Prednisone|prednisone|mesh-list
20264752|NCT00512980|Doxorubicin|doxorubicin|mesh-list
20264753|NCT00512980|Vinblastine|vinblastine|mesh-list
20264754|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20264755|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
20264756|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264757|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542278|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
20542279|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
20542280|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
20542281|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542282|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542283|NCT01862835|Anastrozole|anastrozole|mesh-list
20542284|NCT01862835|Testosterone|testosterone|mesh-list
20542285|NCT01862835|Estrogens|estrogens|mesh-list
20542286|NCT01862835|Androgens|androgens|mesh-ancestor
20542287|NCT01862835|Hormones|hormones|mesh-ancestor
20542288|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542289|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542290|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542291|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542292|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20542293|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20542294|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542295|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542296|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20542297|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
20542298|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
20542299|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20542300|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542301|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20542302|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20542303|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542304|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542305|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542306|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
20542307|NCT01862926|Rituximab|rituximab|mesh-list
20542308|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542309|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
20542310|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542311|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20542312|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20542313|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
20542314|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542315|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542316|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20542317|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20542318|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
20542319|NCT01862978|Heparin|heparin|mesh-list
20542320|NCT01862978|Nadroparin|nadroparin|mesh-list
20542321|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
19934628|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19934629|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19934630|NCT01396083|Growth Substances|growth substances|mesh-ancestor
19934631|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
19934632|NCT01396148|Sunitinib|sunitinib|mesh-list
19934633|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934634|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19934635|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19934636|NCT01396148|Growth Substances|growth substances|mesh-ancestor
19934637|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934638|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
19934639|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264758|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
20264759|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264760|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287141|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20542322|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20542323|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19934640|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934641|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934642|NCT01396265|Rifampin|rifampin|mesh-list
19934643|NCT01396265|Afatinib|afatinib|mesh-list
19934644|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19934645|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
19934646|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19934647|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934648|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
19934649|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19934650|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934651|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934652|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19934653|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19934654|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19934655|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19934656|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19934657|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19934658|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934659|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934660|NCT01396395|Nicorandil|nicorandil|mesh-list
19934661|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19934662|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19934663|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
19934664|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
19934665|NCT01396395|Vitamins|vitamins|mesh-ancestor
19934666|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
19934667|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934668|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
19934669|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
19934670|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934671|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934672|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934673|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
19934674|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
19934675|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19934676|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
19934677|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934678|NCT01396447|Cariprazine|cariprazine|mesh-list
19934679|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19934680|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19934681|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934682|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934683|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19934684|NCT01396486|Inositol|inositol|mesh-list
19934685|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
19934686|NCT01396486|Vitamins|vitamins|mesh-ancestor
19934687|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
19934688|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934689|NCT01396512|Vaccines|vaccines|mesh-list
19934690|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
19934691|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934692|NCT01397084|Esomeprazole|esomeprazole|mesh-list
19934693|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19934694|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934695|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19934696|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934697|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934698|NCT01397409|Ranibizumab|ranibizumab|mesh-list
19934699|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19934700|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19934701|NCT01397409|Growth Substances|growth substances|mesh-ancestor
19934702|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934703|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
19934704|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934705|NCT01397422|Amantadine|amantadine|mesh-list
19934706|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19934707|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19934708|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
19934709|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934710|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
19934711|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934712|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934713|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934714|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19934715|NCT01397422|Analgesics|analgesics|mesh-ancestor
19934716|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
19934717|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934718|NCT01397448|Rabeprazole|rabeprazole|mesh-list
19934719|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19934720|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934721|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19934722|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934723|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934724|NCT01397461|Retapamulin|retapamulin|mesh-list
19934725|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19934726|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934727|NCT01397591|Bortezomib|bortezomib|mesh-list
19934728|NCT01397591|Ofatumumab|ofatumumab|mesh-list
19934729|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934730|NCT01397825|Rituximab|rituximab|mesh-list
19934731|NCT01397825|Vincristine|vincristine|mesh-list
19934732|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19934733|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934734|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
19934735|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934736|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934737|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19934738|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
19934739|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
19934740|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
19934741|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934742|NCT01397890|Budesonide|budesonide|mesh-list
19934743|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
19934744|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
19934745|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19934746|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934747|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19934748|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
19934749|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934750|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934751|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19934752|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934753|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
19934754|NCT01397890|Hormones|hormones|mesh-ancestor
19934755|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19934756|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19934757|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19934758|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19934759|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
19934760|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934761|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934762|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
19934763|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19934764|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934765|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
19934766|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19934767|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19934768|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934769|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
19934770|NCT01398280|Coagulants|coagulants|mesh-ancestor
19934771|NCT01398410|Rabeprazole|rabeprazole|mesh-list
19934772|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19934773|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19934774|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19934775|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934776|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934777|NCT01398514|Citalopram|citalopram|mesh-list
19934778|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19934779|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19934780|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934781|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934782|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934783|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
19934784|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934785|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19934786|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
19934787|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19934788|NCT01398943|Antioxidants|antioxidants|mesh-list
20287142|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19934789|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934790|NCT01398943|Protective Agents|protective agents|mesh-ancestor
19934791|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934792|NCT01398956|Levetiracetam|levetiracetam|mesh-list
19934793|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
19934794|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
19973401|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19973402|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973403|NCT01823224|Acetaminophen|acetaminophen|mesh-list
19973404|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19973405|NCT01823224|Analgesics|analgesics|mesh-ancestor
19973406|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
19973407|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973408|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973409|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
19973410|NCT01823289|Itraconazole|itraconazole|mesh-list
19973411|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
19973412|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973413|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19973414|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20264761|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264762|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
20264763|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264764|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20264765|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20264766|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264767|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264768|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
20264769|NCT00512980|Hormones|hormones|mesh-ancestor
20264770|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20264771|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542324|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542325|NCT01863004|Bortezomib|bortezomib|mesh-list
20542326|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542327|NCT01863069|Interferons|interferons|mesh-list
20542328|NCT01863069|Interferon-beta|interferon-beta|mesh-list
20542329|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
20542330|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542331|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
20542332|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542333|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
20542334|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542335|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20542336|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20542337|NCT01863147|Acarbose|acarbose|mesh-list
20542338|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542339|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542340|NCT01863147|Incretins|incretins|mesh-ancestor
20542341|NCT01863147|Hormones|hormones|mesh-ancestor
20542342|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542343|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20542344|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
20542345|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542346|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542347|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20542348|NCT01863173|Metoprolol|metoprolol|mesh-list
20542349|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20542350|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20542351|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
20542352|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
20542353|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542354|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542355|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20542356|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20542357|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20542358|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
20542359|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542360|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542361|NCT01863199|Ranibizumab|ranibizumab|mesh-list
20542362|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20542363|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20542364|NCT01863199|Growth Substances|growth substances|mesh-ancestor
19973415|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973416|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934795|NCT01398982|Bupivacaine|bupivacaine|mesh-list
19934796|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19934797|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
19934798|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934799|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934800|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
19934801|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934802|NCT01399008|Colchicine|colchicine|mesh-list
19934803|NCT01399008|Allopurinol|allopurinol|mesh-list
19934804|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
19934805|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934806|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
19934807|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
19934808|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
19934809|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934810|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934811|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
19934812|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934813|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19934814|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
19934815|NCT01399008|Protective Agents|protective agents|mesh-ancestor
19934816|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934817|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
19934818|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19934819|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934820|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19934821|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
19934822|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19934823|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934824|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934825|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934826|NCT01399125|Rivastigmine|rivastigmine|mesh-list
19934827|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19934828|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934829|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934830|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934831|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934832|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934833|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19934834|NCT01399125|Protective Agents|protective agents|mesh-ancestor
19934835|NCT01399190|Bevacizumab|bevacizumab|mesh-list
19934836|NCT01399190|Capecitabine|capecitabine|mesh-list
19934837|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
19934838|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19934839|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934840|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19934841|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19934842|NCT01399190|Growth Substances|growth substances|mesh-ancestor
19934843|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934844|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
19934845|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19934846|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
19934847|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934848|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
19934849|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19934850|NCT01399372|Cytarabine|cytarabine|mesh-list
19934851|NCT01399372|Rituximab|rituximab|mesh-list
19934852|NCT01399372|Methotrexate|methotrexate|mesh-list
19934853|NCT01399372|Vincristine|vincristine|mesh-list
19934854|NCT01399372|Procarbazine|procarbazine|mesh-list
19934855|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19934856|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934857|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
19934858|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934859|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934860|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19934861|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
19934862|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19934863|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19934864|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
19934865|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934866|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
19934867|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934868|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19934869|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934870|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19934871|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
19934872|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934873|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19934874|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
19934875|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
19934876|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
19934877|NCT01399593|Eculizumab|eculizumab|mesh-list
19934878|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19934879|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934880|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
19934881|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934882|NCT01399697|Methotrexate|methotrexate|mesh-list
19934883|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19934884|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
19934885|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19934886|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934887|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19934888|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
19934889|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934890|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934891|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
19934892|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934893|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19934894|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19934895|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
19934896|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19934897|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19934898|NCT01399723|Amoxicillin|amoxicillin|mesh-list
19934899|NCT01399723|Penicillins|penicillins|mesh-list
19934900|NCT01399723|Penicillin G|penicillin g|mesh-list
19934901|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19934902|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
19934903|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19934904|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934905|NCT01399827|Methylphenidate|methylphenidate|mesh-list
19934906|NCT01399827|Amphetamine|amphetamine|mesh-list
19934907|NCT01399827|Adderall|adderall|mesh-list
19934908|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
19934909|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
19934910|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19934911|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19934912|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934913|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19934914|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19934915|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19934916|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934917|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
19934918|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934919|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19934920|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
19934921|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
19934922|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
19934923|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934924|NCT01399866|Cycloserine|cycloserine|mesh-list
19934925|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19934926|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934927|NCT01399866|Renal Agents|renal agents|mesh-ancestor
19934928|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19934929|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
19934930|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19934931|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
19934932|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934933|NCT01399905|Carbidopa|carbidopa|mesh-list
19934934|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19934935|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19934936|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
19934937|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934938|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934939|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934940|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19934941|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934942|NCT01400113|Asenapine|asenapine|mesh-list
19934943|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19934944|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19934945|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934946|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934947|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19934948|NCT01400139|Hydrocodone|hydrocodone|mesh-list
19934949|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19934950|NCT01400139|Narcotics|narcotics|mesh-ancestor
19934951|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19934952|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934953|NCT01400139|Analgesics|analgesics|mesh-ancestor
19934954|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
19934955|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934956|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
19934957|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
19934958|NCT01400243|Nicotine|nicotine|mesh-list
19934959|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19934960|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
19934961|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19934962|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19934963|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19934964|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19934965|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
19934966|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19934967|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934968|NCT01400412|Ritonavir|ritonavir|mesh-list
19934969|NCT01400412|Darunavir|darunavir|mesh-list
19934970|NCT01400412|Tenofovir|tenofovir|mesh-list
19934971|NCT01400412|Emtricitabine|emtricitabine|mesh-list
19934972|NCT01400412|Maraviroc|maraviroc|mesh-list
19934973|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19934974|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19934975|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
19934976|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934977|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934978|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19934979|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19934980|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
19934981|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19934982|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19934983|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19934984|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20264772|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20264773|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264774|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264775|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264776|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
20264777|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20264778|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264779|NCT00513032|Methylene Blue|methylene blue|mesh-list
20264780|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264781|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264782|NCT00513058|Vinorelbine|vinorelbine|mesh-list
20264783|NCT00513058|Lapatinib|lapatinib|mesh-list
20264784|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20264785|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264786|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264787|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264788|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264789|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264790|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20264791|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264792|NCT00513110|Caffeine|caffeine|mesh-list
20264793|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20264794|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264795|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20264796|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264797|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264798|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20264799|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20264800|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
20264801|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264802|NCT00513149|Clopidogrel|clopidogrel|mesh-list
20264803|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20264804|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19934985|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20288571|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
19934986|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19934987|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19934988|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19934989|NCT01400451|Ipilimumab|ipilimumab|mesh-list
19934990|NCT01400451|Vemurafenib|vemurafenib|mesh-list
19934991|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19934992|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934993|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19934994|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19934995|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19934996|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19934997|NCT01400503|Siltuximab|siltuximab|mesh-list
19934998|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19934999|NCT01400516|Vitamin D|vitamin d|mesh-list
19935000|NCT01400516|Teriparatide|teriparatide|mesh-list
19935001|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19935002|NCT01400516|Calcium|calcium|mesh-list
19935003|NCT01400516|Vitamins|vitamins|mesh-ancestor
19935004|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
19935005|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935006|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19935007|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19935008|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935009|NCT01400906|Fluticasone|fluticasone|mesh-list
19935010|NCT01400906|Xhance|xhance|mesh-list
19935011|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935012|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19935013|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
19935014|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935015|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935016|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19935017|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
19935018|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
19935019|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19935020|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19935021|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
19935022|NCT01400958|Modafinil|modafinil|mesh-list
19935023|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19935024|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935025|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19935026|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19935027|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19935028|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935029|NCT01401010|Doripenem|doripenem|mesh-list
19935030|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935031|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935032|NCT01401023|Tigecycline|tigecycline|mesh-list
19935033|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935034|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935035|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19935036|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935037|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935038|NCT01401166|Trastuzumab|trastuzumab|mesh-list
19935039|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19935040|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935041|NCT01401322|Lenalidomide|lenalidomide|mesh-list
19935042|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
19935043|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935044|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19935045|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19935046|NCT01401322|Growth Substances|growth substances|mesh-ancestor
19935047|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
19935048|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935049|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
19935050|NCT01401465|Ciclesonide|ciclesonide|mesh-list
19935051|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935052|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
19935053|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19935054|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
19935055|NCT01401465|Hormones|hormones|mesh-ancestor
19935056|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935057|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935058|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
19935059|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935060|NCT01401543|Tadalafil|tadalafil|mesh-list
19935061|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
19935062|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19935063|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19935064|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935065|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935066|NCT01401543|Urological Agents|urological agents|mesh-ancestor
19935067|NCT01401595|Dexetimide|dexetimide|mesh-list
19935068|NCT01401595|Citalopram|citalopram|mesh-list
19935069|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19935070|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19935071|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935072|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935073|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935074|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
19935075|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935076|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19935077|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
19935078|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19935079|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19935080|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19935081|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
19935082|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
19935083|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935084|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19935085|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19935086|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
19935087|NCT01401647|Lidocaine|lidocaine|mesh-list
19935088|NCT01401647|Amiodarone|amiodarone|mesh-list
19935089|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
19935090|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
19935091|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935092|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935093|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
19935094|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935095|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19935096|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19935097|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19935098|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20264805|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20264806|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20264807|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
20264808|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264809|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264810|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264811|NCT00513162|Etoposide|etoposide|mesh-list
20264812|NCT00513162|Valproic Acid|valproic acid|mesh-list
19935099|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935100|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
19935101|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19935102|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20264813|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20264814|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264815|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20264816|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264817|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264818|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264819|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
20264820|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
20264821|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264822|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264823|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
20264824|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20264825|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20264826|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20264827|NCT00513188|Leucovorin|leucovorin|mesh-list
20264828|NCT00513188|Cytarabine|cytarabine|mesh-list
20264829|NCT00513188|Prednisone|prednisone|mesh-list
20264830|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
20264831|NCT00513188|Doxorubicin|doxorubicin|mesh-list
20542365|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935103|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19935104|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935105|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19935106|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19935107|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19935108|NCT01401959|Trastuzumab|trastuzumab|mesh-list
19935109|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19935110|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935111|NCT01402011|Lidocaine|lidocaine|mesh-list
19935112|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
19935113|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
19935114|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935115|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935116|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
19935117|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935118|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19935119|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19935120|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19935121|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935122|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935123|NCT01402050|Dinoprostone|dinoprostone|mesh-list
19935124|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
19935125|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19935126|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935127|NCT01402063|Temozolomide|temozolomide|mesh-list
19935128|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
19935129|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19935130|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
19935131|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264832|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20264833|NCT00513188|Methotrexate|methotrexate|mesh-list
20264834|NCT00513188|Vincristine|vincristine|mesh-list
20264835|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
20264836|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
20264837|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264838|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
20264839|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264840|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20264841|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20264842|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
20264843|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264844|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264845|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20264846|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20264847|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20264848|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264849|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542366|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
20542367|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542368|NCT01863225|Atorvastatin|atorvastatin|mesh-list
20542369|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20542370|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20542371|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20542372|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
20542373|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542374|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20542375|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20542376|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542377|NCT01863238|Ivacaftor|ivacaftor|mesh-list
20542378|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20542379|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542380|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542381|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20542382|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20542383|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20542384|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542385|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542386|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
20542387|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542388|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542389|NCT01863277|Melatonin|melatonin|mesh-list
20542390|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
20542391|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542392|NCT01863277|Protective Agents|protective agents|mesh-ancestor
20542393|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542394|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542395|NCT01863355|Fentanyl|fentanyl|mesh-list
20264850|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935132|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935133|NCT01402284|Dexamethasone|dexamethasone|mesh-list
19935134|NCT01402284|Lenalidomide|lenalidomide|mesh-list
19935135|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935136|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
19935137|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
19935138|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935139|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935140|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935141|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
19935142|NCT01402284|Hormones|hormones|mesh-ancestor
19935143|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935144|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19935145|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935146|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
19935147|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19935148|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19935149|NCT01402284|Growth Substances|growth substances|mesh-ancestor
19935150|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
19935151|NCT01402375|Acetaminophen|acetaminophen|mesh-list
19935152|NCT01402375|Oxycodone|oxycodone|mesh-list
19935153|NCT01402375|Hydrocodone|hydrocodone|mesh-list
19935154|NCT01402375|Codeine|codeine|mesh-list
19935155|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19935156|NCT01402375|Analgesics|analgesics|mesh-ancestor
19935157|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
19935158|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935159|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935160|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
19935161|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19935162|NCT01402375|Narcotics|narcotics|mesh-ancestor
19935163|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935164|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
19935165|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
19935166|NCT01402427|Verapamil|verapamil|mesh-list
19935167|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19935168|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19935169|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935170|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935171|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19935172|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935173|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
19935174|NCT01402492|Naltrexone|naltrexone|mesh-list
19935175|NCT01402492|Buprenorphine|buprenorphine|mesh-list
19935176|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19935177|NCT01402492|Naloxone|naloxone|mesh-list
19935178|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19935179|NCT01402492|Narcotics|narcotics|mesh-ancestor
19935180|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935181|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935182|NCT01402492|Analgesics|analgesics|mesh-ancestor
19935183|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
19935184|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935185|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19935186|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19935187|NCT01402544|Ranibizumab|ranibizumab|mesh-list
19935188|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19935189|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19935190|NCT01402544|Growth Substances|growth substances|mesh-ancestor
19935191|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935192|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
19935193|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935194|NCT01402817|Sunitinib|sunitinib|mesh-list
19935195|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935196|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19935197|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19935198|NCT01402817|Growth Substances|growth substances|mesh-ancestor
19935199|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935200|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
19935201|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19935202|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264851|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
20264852|NCT00513188|Hormones|hormones|mesh-ancestor
20264853|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935203|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935204|NCT01402869|Lidocaine|lidocaine|mesh-list
19935205|NCT01402869|Epinephrine|epinephrine|mesh-list
19935206|NCT01402869|Prilocaine|prilocaine|mesh-list
19935207|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
19935208|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
19935209|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935210|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935211|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
19935212|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935213|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19935214|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19935215|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19935216|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935217|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935218|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19935219|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19935220|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
19935221|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935222|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19935223|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19935224|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
19935225|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19935226|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
19935227|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
19935228|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
19935229|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19935230|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
19935231|NCT01402947|Mesalamine|mesalamine|mesh-list
19935232|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935233|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935234|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19935235|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19935236|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935237|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935238|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935239|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19935240|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19935241|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19935242|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19935243|NCT01402947|Analgesics|analgesics|mesh-ancestor
19935244|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
19935245|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935246|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935247|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935248|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935249|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19935250|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
19935251|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935252|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
19935253|NCT01403051|Vitamin D|vitamin d|mesh-list
19935254|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
20264854|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20264855|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20264856|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
20264857|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20264858|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20264859|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
20264860|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
20264861|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20264862|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20264863|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
20264864|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264865|NCT00513188|Antidotes|antidotes|mesh-ancestor
20264866|NCT00513188|Protective Agents|protective agents|mesh-ancestor
20264867|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
20264868|NCT00513188|Vitamins|vitamins|mesh-ancestor
20264869|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
20264870|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20264871|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264872|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264873|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264874|NCT00513201|Insulin|insulin|mesh-list
20264875|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20264876|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264877|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264878|NCT00513253|Lapatinib|lapatinib|mesh-list
19935255|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
20264879|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935256|NCT01403051|Vitamins|vitamins|mesh-list
19935257|NCT01403051|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19935258|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
19935259|NCT01403051|Calcium|calcium|mesh-list
19935260|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
19935261|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935262|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19935263|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19935264|NCT01403051|Antacids|antacids|mesh-ancestor
19935265|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935266|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935267|NCT01403051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19935268|NCT01403051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19935269|NCT01403051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935270|NCT01403051|Antiviral Agents|antiviral agents|mesh-ancestor
19935271|NCT01403051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935272|NCT01403051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19935273|NCT01403051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19935274|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
19935275|NCT01403116|Testosterone|testosterone|mesh-list
19935276|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
19935277|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
19935278|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19935279|NCT01403116|Androgens|androgens|mesh-ancestor
19935280|NCT01403116|Hormones|hormones|mesh-ancestor
19935281|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935282|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935283|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19935284|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935285|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
19935286|NCT01403246|Lenalidomide|lenalidomide|mesh-list
19935287|NCT01403246|Chlorambucil|chlorambucil|mesh-list
19935288|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
19935289|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935290|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19935291|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19935292|NCT01403246|Growth Substances|growth substances|mesh-ancestor
19935293|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
19935294|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935295|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19935296|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
19935297|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935298|NCT01403376|Interferons|interferons|mesh-list
19935299|NCT01403376|Interferon-beta|interferon-beta|mesh-list
19935300|NCT01403376|Teriflunomide|teriflunomide|mesh-list
19935301|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
19935302|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935303|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
19935304|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935305|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19935306|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
19935307|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935308|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19935309|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19935310|NCT01403376|Analgesics|analgesics|mesh-ancestor
19935311|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
19935312|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935313|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935314|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935315|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935316|NCT01403610|Bevacizumab|bevacizumab|mesh-list
19935317|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
19935318|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19935319|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935320|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19935321|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19935322|NCT01403610|Growth Substances|growth substances|mesh-ancestor
19935323|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935324|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
19935325|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19935326|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
19935327|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935328|NCT01403805|Vaccines|vaccines|mesh-list
20264880|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19935329|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19935330|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
19935331|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935332|NCT01404208|Cycloserine|cycloserine|mesh-list
19935333|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19935334|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935335|NCT01404208|Renal Agents|renal agents|mesh-ancestor
19935336|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19935337|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
19935338|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935339|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
19935340|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935341|NCT01404260|Gemcitabine|gemcitabine|mesh-list
19935342|NCT01404260|Carboplatin|carboplatin|mesh-list
19935343|NCT01404260|Gefitinib|gefitinib|mesh-list
19935344|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935345|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19935346|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
19935347|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935348|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
19935349|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935350|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935351|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935352|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
19935353|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935354|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19935355|NCT01404325|Everolimus|everolimus|mesh-list
19935356|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935357|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935358|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
19935359|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935360|NCT01404429|Methotrexate|methotrexate|mesh-list
19935361|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19935362|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
19935363|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19935364|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935365|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19935366|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
19935367|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935368|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935369|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
19935370|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935371|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19935372|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935373|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
19935374|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935375|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19935376|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19935377|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19935378|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19935379|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
19935380|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935381|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935382|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20264881|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264882|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264883|NCT00513266|Leucovorin|leucovorin|mesh-list
20264884|NCT00513266|Bevacizumab|bevacizumab|mesh-list
20264885|NCT00513266|Cetuximab|cetuximab|mesh-list
20264886|NCT00513266|Fluorouracil|fluorouracil|mesh-list
20264887|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
20264888|NCT00513266|Irinotecan|irinotecan|mesh-list
20264889|NCT00513266|Calcium|calcium|mesh-list
20264890|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
20264891|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20264892|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264893|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20264894|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20264895|NCT00513266|Growth Substances|growth substances|mesh-ancestor
20264896|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264897|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
20264898|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19935383|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19935384|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
20264899|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
20287143|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19935385|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973417|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19973418|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
19973419|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19973420|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973421|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19973422|NCT01823328|Ketamine|ketamine|mesh-list
19973423|NCT01823328|Etomidate|etomidate|mesh-list
19973424|NCT01823328|Analgesics|analgesics|mesh-ancestor
19973425|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
19973426|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973427|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973428|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19732579|NCT04571879|Lidocaine|lidocaine|mesh-list
19732580|NCT04571879|Midazolam|midazolam|mesh-list
19732581|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
19973429|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19973430|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
19973431|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
19973432|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973433|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19973434|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19973435|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973436|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973437|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19973438|NCT01823497|Morphine|morphine|mesh-list
19973439|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19973440|NCT01823497|Narcotics|narcotics|mesh-ancestor
19973441|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973442|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973443|NCT01823497|Analgesics|analgesics|mesh-ancestor
19973444|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
19973445|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973446|NCT01823510|Aspirin|aspirin|mesh-list
19973447|NCT01823510|Clopidogrel|clopidogrel|mesh-list
19973448|NCT01823510|Ticagrelor|ticagrelor|mesh-list
19973449|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19973450|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19973451|NCT01823510|Analgesics|analgesics|mesh-ancestor
19973452|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
19973453|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973454|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973455|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973456|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973457|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19973458|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19973459|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973460|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19973461|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19973462|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973463|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
19973464|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19973465|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19973466|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19973467|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
19973468|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973469|NCT01823679|Capecitabine|capecitabine|mesh-list
19973470|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973471|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
19973472|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973473|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973474|NCT01823835|Palbociclib|palbociclib|mesh-list
19973475|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973476|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973477|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973478|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973479|NCT01824290|Tadalafil|tadalafil|mesh-list
19973480|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
20542396|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19732582|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
19732583|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732584|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732585|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
19732586|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935386|NCT01404832|Lansoprazole|lansoprazole|mesh-list
19935387|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
19935388|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19935389|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935390|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19935391|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935392|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935393|NCT01404923|Mebeverine|mebeverine|mesh-list
19935394|NCT01404923|Alverine|alverine|mesh-list
19935395|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
19935396|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
19935397|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935398|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935399|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
19935400|NCT01404936|Interferons|interferons|mesh-list
19935401|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
19935402|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
19935403|NCT01404936|Doxorubicin|doxorubicin|mesh-list
19935404|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19935405|NCT01404936|Bleomycin|bleomycin|mesh-list
19935406|NCT01404936|Dacarbazine|dacarbazine|mesh-list
19935407|NCT01404936|Vinblastine|vinblastine|mesh-list
19935408|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19935409|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935410|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19935411|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19935412|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935413|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935414|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
19935415|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935416|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
19935417|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935418|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19935419|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
19935420|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19935421|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
19935422|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
19935423|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
19935424|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
19935425|NCT01404949|Tretinoin|tretinoin|mesh-list
19935426|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935427|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
19935428|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
19935429|NCT01405027|Interferons|interferons|mesh-list
19935430|NCT01405027|Ribavirin|ribavirin|mesh-list
19935431|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
19935432|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
19935433|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19935434|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19935435|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935436|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
19935437|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935438|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
19935439|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935440|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
19935441|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935442|NCT01405053|Rufinamide|rufinamide|mesh-list
19935443|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
20264900|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264901|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20264902|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264903|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
19935444|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19935445|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19935446|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935447|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935448|NCT01405456|Eplerenone|eplerenone|mesh-list
19935449|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19935450|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
19935451|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935452|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935453|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19935454|NCT01405456|Diuretics|diuretics|mesh-ancestor
19935455|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
19935456|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19935457|NCT01405508|Brivaracetam|brivaracetam|mesh-list
19935458|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
19935459|NCT01405560|Ribavirin|ribavirin|mesh-list
19935460|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
19935461|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935462|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
19935463|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935464|NCT01405742|Factor VIII|factor viii|mesh-list
19935465|NCT01405742|Coagulants|coagulants|mesh-ancestor
19935466|NCT01405768|Lidocaine|lidocaine|mesh-list
19935467|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
19935468|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
19935469|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935470|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935471|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
19935472|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935473|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20264904|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20264905|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20264906|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264907|NCT00513266|Antidotes|antidotes|mesh-ancestor
20264908|NCT00513266|Protective Agents|protective agents|mesh-ancestor
20264909|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
20264910|NCT00513266|Vitamins|vitamins|mesh-ancestor
20264911|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
20264912|NCT00513383|Paclitaxel|paclitaxel|mesh-list
20264913|NCT00513383|Docetaxel|docetaxel|mesh-list
20264914|NCT00513383|Carboplatin|carboplatin|mesh-list
20264915|NCT00513383|Fluorouracil|fluorouracil|mesh-list
20264916|NCT00513383|Panitumumab|panitumumab|mesh-list
20264917|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20264918|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264919|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
20264920|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
20264921|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
20264922|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264923|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
20264924|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20264925|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20264926|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
20264927|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264928|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20264929|NCT00513396|Isoniazid|isoniazid|mesh-list
20264930|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
20264931|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264932|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264933|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20264934|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20264935|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
20264936|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264937|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20264938|NCT00513487|Fluticasone|fluticasone|mesh-list
20264939|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
20264940|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264941|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20264942|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
20264943|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20264944|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264945|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20264946|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
20264947|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
20264948|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20264949|NCT00513487|Miotics|miotics|mesh-ancestor
20264950|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20264951|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20264952|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20264953|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20264954|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
20264955|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20264956|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264957|NCT00513513|Ritonavir|ritonavir|mesh-list
20264958|NCT00513513|Darunavir|darunavir|mesh-list
20264959|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20264960|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20264961|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
19935474|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20264962|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20264963|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20264964|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19935475|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19935476|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935477|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935478|NCT01405820|Natalizumab|natalizumab|mesh-list
19935479|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
19935480|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935481|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19935482|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19935483|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935484|NCT01405911|Incretins|incretins|mesh-ancestor
19935485|NCT01405911|Hormones|hormones|mesh-ancestor
19935486|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935487|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19935488|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
19935489|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935490|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935491|NCT01405924|Dexamethasone|dexamethasone|mesh-list
19935492|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
19935493|NCT01405924|Aprepitant|aprepitant|mesh-list
19935494|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935495|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
19935496|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
19935497|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935498|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935499|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935500|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
19935501|NCT01405924|Hormones|hormones|mesh-ancestor
19935502|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935503|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19935504|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935505|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19935506|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935507|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935508|NCT01405937|Ribavirin|ribavirin|mesh-list
19935509|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
19935510|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935511|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
19935512|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935513|NCT01405950|Clonidine|clonidine|mesh-list
19935514|NCT01405950|Tizanidine|tizanidine|mesh-list
19935515|NCT01405950|Analgesics|analgesics|mesh-ancestor
19935516|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
19935517|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935518|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935519|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
19935520|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19935521|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19935522|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
19935523|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
19935524|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19935525|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19935526|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19935527|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19935528|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935529|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935530|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20264965|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20264966|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
20264967|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264968|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20264969|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20264970|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
20264971|NCT00513539|Trioxsalen|trioxsalen|mesh-list
20264972|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20264973|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
20264974|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20264975|NCT00513552|Clarithromycin|clarithromycin|mesh-list
20264976|NCT00513552|Rifabutin|rifabutin|mesh-list
20264977|NCT00513552|Clofazimine|clofazimine|mesh-list
20264978|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20264979|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20264980|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20264981|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935531|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
20264982|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935532|NCT01406015|Spironolactone|spironolactone|mesh-list
19935533|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19935534|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
19935535|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935536|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935537|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19935538|NCT01406015|Diuretics|diuretics|mesh-ancestor
19935539|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
19935540|NCT01406223|Bupropion|bupropion|mesh-list
19935541|NCT01406223|Nicotine|nicotine|mesh-list
19935542|NCT01406223|Varenicline|varenicline|mesh-list
19935543|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19935544|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
19935545|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935546|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935547|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19935548|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19935549|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
19935550|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935551|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935552|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19935553|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
19935554|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19935555|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19935556|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19935557|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935558|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
19935559|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19935560|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19935561|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935562|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
19935563|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19935564|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935565|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935566|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19935567|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935568|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19935569|NCT01406795|Heparin|heparin|mesh-list
19935570|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
19935571|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19935572|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19935573|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935574|NCT01406873|Mexiletine|mexiletine|mesh-list
19935575|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19935576|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19935577|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19935578|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935579|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935580|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19935581|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
19935582|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935583|NCT01407094|Sertraline|sertraline|mesh-list
19935584|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
19935585|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19732587|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19732588|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19732589|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19732590|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732591|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732592|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19732593|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19732594|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19732595|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19732596|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19732597|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19732598|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
19935586|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19935587|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19935588|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935589|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935590|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935591|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
19935592|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935593|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
19935594|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
19935595|NCT01407523|Levetiracetam|levetiracetam|mesh-list
19935596|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
19935597|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
19935598|NCT01407575|Buprenorphine|buprenorphine|mesh-list
19935599|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19935600|NCT01407575|Narcotics|narcotics|mesh-ancestor
19935601|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935602|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935603|NCT01407575|Analgesics|analgesics|mesh-ancestor
19935604|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
19935605|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935606|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19935607|NCT01408030|Bevacizumab|bevacizumab|mesh-list
19935608|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
19935609|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
19935610|NCT01408030|Estrogens|estrogens|mesh-list
19935611|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19935612|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935613|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19935614|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19935615|NCT01408030|Growth Substances|growth substances|mesh-ancestor
19935616|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935617|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
19935618|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19935619|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19935620|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935621|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
19935622|NCT01408030|Coagulants|coagulants|mesh-ancestor
19935623|NCT01408030|Hormones|hormones|mesh-ancestor
19935624|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935625|NCT01408043|Plerixafor|plerixafor|mesh-list
19935626|NCT01408043|Etoposide|etoposide|mesh-list
19935627|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
19935628|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19935629|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935630|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19935631|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19935632|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935633|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935634|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19935635|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19935636|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
19935637|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935638|NCT01408563|Fludarabine|fludarabine|mesh-list
19935639|NCT01408563|Melphalan|melphalan|mesh-list
19935640|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935641|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935642|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935643|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
19935644|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935645|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19935646|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
19935647|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19935648|NCT01408576|Epratuzumab|epratuzumab|mesh-list
19935649|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19935650|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935651|NCT01408628|Insulin|insulin|mesh-list
19935652|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19935653|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935654|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
19935655|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19935656|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19935657|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19935658|NCT01408888|Dulaglutide|dulaglutide|mesh-list
19935659|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19935660|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935661|NCT01408888|Incretins|incretins|mesh-ancestor
19935662|NCT01408888|Hormones|hormones|mesh-ancestor
19935663|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935664|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19935665|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
19935666|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935667|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935668|NCT01408901|Molgramostim|molgramostim|mesh-list
19935669|NCT01408901|Sargramostim|sargramostim|mesh-list
19935670|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
19935671|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935672|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935673|NCT01408914|Rifampin|rifampin|mesh-list
19935674|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19935675|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
19935676|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935677|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935678|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
19935679|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19935680|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935681|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935682|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19935683|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19935684|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19935685|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19935686|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19935687|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19935688|NCT01409239|Insulin|insulin|mesh-list
19935689|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19935690|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19935691|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264983|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20264984|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20264985|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20264986|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
20264987|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20264988|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
20264989|NCT00513578|Sargramostim|sargramostim|mesh-list
20542397|NCT01863355|Narcotics|narcotics|mesh-ancestor
20542398|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542399|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542400|NCT01863355|Analgesics|analgesics|mesh-ancestor
20542401|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
20542402|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542403|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20542404|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20542405|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
20542406|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
20542407|NCT01863407|Metronidazole|metronidazole|mesh-list
20542408|NCT01863407|Dexamethasone|dexamethasone|mesh-list
20542409|NCT01863407|Allantoin|allantoin|mesh-list
20542410|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542411|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
20542412|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
20542413|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542414|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542415|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542416|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
20542417|NCT01863407|Hormones|hormones|mesh-ancestor
20542418|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542419|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542420|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542421|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542422|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20542423|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20542424|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20542425|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
20542426|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20542427|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20542428|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542429|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20542430|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20542431|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542432|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542433|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
19935692|NCT01409564|Cilostazol|cilostazol|mesh-list
19935693|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20542434|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542435|NCT01863485|Vorolanib|vorolanib|mesh-list
20542436|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19935694|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
19935695|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935696|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935697|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19935698|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
19935699|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19935700|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19935701|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935702|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19935703|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
19935704|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19935705|NCT01409564|Protective Agents|protective agents|mesh-ancestor
19935706|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19935707|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19935708|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935709|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
19935710|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19935711|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935712|NCT01409837|Lisinopril|lisinopril|mesh-list
19935713|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19935714|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
19935715|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935716|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935717|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19935718|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19935719|NCT01409837|Protective Agents|protective agents|mesh-ancestor
19935720|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935721|NCT01409915|Molgramostim|molgramostim|mesh-list
19935722|NCT01409915|Sargramostim|sargramostim|mesh-list
19935723|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
19935724|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935725|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935726|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
19935727|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
19935728|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19935729|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19935730|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935731|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935732|NCT01409993|Urological Agents|urological agents|mesh-ancestor
19935733|NCT01410058|Efavirenz|efavirenz|mesh-list
19935734|NCT01410058|Nevirapine|nevirapine|mesh-list
19935735|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19935736|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19935737|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935738|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935739|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
19935740|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935741|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19935742|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19935743|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19935744|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19935745|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19935746|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19935747|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19935748|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19935749|NCT01410084|Vitamin D|vitamin d|mesh-list
19935750|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
19935751|NCT01410084|Vitamins|vitamins|mesh-list
19935752|NCT01410084|Vitamin E|vitamin e|mesh-list
19935753|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
19935754|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935755|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19935756|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19935757|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
19935758|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935759|NCT01410084|Protective Agents|protective agents|mesh-ancestor
19935760|NCT01410227|Factor VIII|factor viii|mesh-list
19935761|NCT01410227|Coagulants|coagulants|mesh-ancestor
19935762|NCT01410240|Hemostatics|hemostatics|mesh-list
19935763|NCT01410240|Coagulants|coagulants|mesh-ancestor
19935764|NCT01410344|Vidarabine|vidarabine|mesh-list
19935765|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
19935766|NCT01410344|Melphalan|melphalan|mesh-list
19935767|NCT01410344|Busulfan|busulfan|mesh-list
19935768|NCT01410344|Fludarabine|fludarabine|mesh-list
19935769|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
19935770|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935771|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
20264990|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
20264991|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
20264992|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264993|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20264994|NCT00513630|Metformin|metformin|mesh-list
20264995|NCT00513630|Glipizide|glipizide|mesh-list
20264996|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20264997|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20264998|NCT00513643|Insulin|insulin|mesh-list
20264999|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20265000|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
20265001|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20265002|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265003|NCT00513656|Oxycodone|oxycodone|mesh-list
20265004|NCT00513656|Naloxone|naloxone|mesh-list
20265005|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20265006|NCT00513656|Narcotics|narcotics|mesh-ancestor
20265007|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265008|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265009|NCT00513656|Analgesics|analgesics|mesh-ancestor
20265010|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
20265011|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265012|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20265013|NCT00513786|Paclitaxel|paclitaxel|mesh-list
20265014|NCT00513786|Bevacizumab|bevacizumab|mesh-list
20265015|NCT00513786|Carboplatin|carboplatin|mesh-list
20265016|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20265017|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265018|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
20265019|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
20265020|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
20265021|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265022|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20265023|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20265024|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20265025|NCT00513786|Growth Substances|growth substances|mesh-ancestor
20265026|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265027|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
20265028|NCT00513864|Morphine|morphine|mesh-list
20265029|NCT00513864|Codeine|codeine|mesh-list
20265030|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
20265031|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20265032|NCT00513864|Narcotics|narcotics|mesh-ancestor
20265033|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265034|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265035|NCT00513864|Analgesics|analgesics|mesh-ancestor
20265036|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
20265037|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265038|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
20265039|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
20265040|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20265041|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20265042|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265043|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265044|NCT00513877|Bortezomib|bortezomib|mesh-list
20265045|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265046|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
20265047|NCT00513929|Astringents|astringents|mesh-ancestor
20265048|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265049|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265050|NCT00513955|Prednisolone|prednisolone|mesh-list
20265051|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
20265052|NCT00513955|Doxorubicin|doxorubicin|mesh-list
20265053|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20265054|NCT00513955|Vincristine|vincristine|mesh-list
19935772|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935773|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935774|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19935775|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
19935776|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265055|NCT00513955|Bortezomib|bortezomib|mesh-list
20265056|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542437|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265057|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
20265058|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935777|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935778|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19935779|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19935780|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
19935781|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
19935782|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935783|NCT01410409|Acetaminophen|acetaminophen|mesh-list
19935784|NCT01410409|Pantoprazole|pantoprazole|mesh-list
19935785|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19935786|NCT01410409|Analgesics|analgesics|mesh-ancestor
19935787|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
19935788|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935789|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935790|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
19935791|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19935792|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935793|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19935794|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935795|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935796|NCT01410448|Cyclosporine|cyclosporine|mesh-list
19935797|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
19935798|NCT01410448|Everolimus|everolimus|mesh-list
19935799|NCT01410448|Cyclosporins|cyclosporins|mesh-list
19935800|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935801|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935802|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935803|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
19935804|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935805|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
19935806|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935807|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19935808|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935809|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19935810|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935811|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19935812|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19935813|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
19935814|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935815|NCT01410565|Apaziquone|apaziquone|mesh-list
19935816|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935817|NCT01410604|Metformin|metformin|mesh-list
19935818|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19935819|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935820|NCT01411085|Risperidone|risperidone|mesh-list
19935821|NCT01411085|Desipramine|desipramine|mesh-list
19935822|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19935823|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
19935824|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935825|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935826|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935827|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19935828|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19935829|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935830|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19935831|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19935832|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
19935833|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19935834|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
19935835|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935836|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19935837|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19935838|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935839|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
19935840|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19935841|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19935842|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
19935843|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935844|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19935845|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19935846|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
19935847|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
19935848|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935849|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554093|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19935850|NCT01411215|Etanercept|etanercept|mesh-list
19935851|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19935852|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19935853|NCT01411215|Analgesics|analgesics|mesh-ancestor
19935854|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
19935855|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935856|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935857|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935858|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935859|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935860|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935861|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
19935862|NCT01411501|Mosapride|mosapride|mesh-list
19935863|NCT01411501|Citric Acid|citric acid|mesh-list
19935864|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
19935865|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
19935866|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19935867|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
20265059|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265060|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265061|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
20265062|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265063|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265064|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20265065|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20265066|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20265067|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20265068|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265069|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20265070|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
20265071|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
20265072|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
20265073|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20265074|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
20265075|NCT00513955|Hormones|hormones|mesh-ancestor
20265076|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20265077|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20265078|NCT00513968|Adefovir|adefovir|mesh-list
20265079|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
20265080|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265081|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20265082|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20265083|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265084|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265085|NCT00513981|Leucovorin|leucovorin|mesh-list
20265086|NCT00513981|Methotrexate|methotrexate|mesh-list
20265087|NCT00513981|Calcium|calcium|mesh-list
20265088|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
20265089|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20265090|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265091|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20265092|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
20265093|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20265094|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265095|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
20265096|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265097|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265098|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265099|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265100|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20542438|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542439|NCT01863511|Tolvaptan|tolvaptan|mesh-list
20542440|NCT01863511|Diuretics|diuretics|mesh-list
20542441|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20542442|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
20542443|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542444|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20542445|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542446|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542447|NCT01863589|Adefovir|adefovir|mesh-list
20542448|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
20542449|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542450|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19935868|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
19935869|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935870|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935871|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19935872|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
19935873|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19935874|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973481|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19973482|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19973483|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973484|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973485|NCT01824290|Urological Agents|urological agents|mesh-ancestor
19973486|NCT01824342|Denosumab|denosumab|mesh-list
19973487|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19973488|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973489|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19973490|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
19973491|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19973492|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19973493|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973494|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973495|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
19973496|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
19973497|NCT01824693|Melphalan|melphalan|mesh-list
19973498|NCT01824693|Busulfan|busulfan|mesh-list
19973499|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
19973500|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19973501|NCT01824693|Fludarabine|fludarabine|mesh-list
19973502|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
19973503|NCT01824693|Tacrolimus|tacrolimus|mesh-list
19973504|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973505|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
19973506|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973507|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973508|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19973509|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
19973510|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973511|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973512|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19973513|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973514|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
19973515|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19973516|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973517|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19973518|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19973519|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
19973520|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973521|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973522|NCT01824823|Afatinib|afatinib|mesh-list
19973523|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973524|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973525|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973526|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973527|NCT01824901|Docetaxel|docetaxel|mesh-list
19973528|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973529|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
19973530|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
19973531|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
19973532|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973533|NCT01825122|Nadolol|nadolol|mesh-list
19973534|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19973535|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19973536|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
19973537|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973538|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973539|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973540|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19973541|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19935875|NCT01411696|Dexamethasone|dexamethasone|mesh-list
19935876|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935877|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
19935878|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
19935879|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935880|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935881|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935882|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
19935883|NCT01411696|Hormones|hormones|mesh-ancestor
19935884|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935885|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19935886|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935887|NCT01411774|Cycloserine|cycloserine|mesh-list
19935888|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19935889|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935890|NCT01411774|Renal Agents|renal agents|mesh-ancestor
19935891|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19935892|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
19935893|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935894|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
19935895|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935896|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
19935897|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19935898|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935899|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
19935900|NCT01411995|Lidocaine|lidocaine|mesh-list
19935901|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
19935902|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
19935903|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935904|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935905|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
19935906|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935907|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19935908|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19935909|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19935910|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19935911|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935912|NCT01412060|Cariprazine|cariprazine|mesh-list
19935913|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19935914|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19935915|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19935916|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935917|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19935918|NCT01412164|Sirolimus|sirolimus|mesh-list
19935919|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19935920|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19935921|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19935922|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935923|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
19935924|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935925|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
19935926|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935927|NCT01412229|Paclitaxel|paclitaxel|mesh-list
19935928|NCT01412229|Carboplatin|carboplatin|mesh-list
19935929|NCT01412229|Cetuximab|cetuximab|mesh-list
19935930|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19935931|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935932|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
19935933|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
19935934|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
19935935|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935936|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19935937|NCT01412281|Vaccines|vaccines|mesh-list
19935938|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
19935939|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935940|NCT01412372|Mesalamine|mesalamine|mesh-list
19935941|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19935942|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19935943|NCT01412372|Analgesics|analgesics|mesh-ancestor
19935944|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
19935945|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935946|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265101|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973542|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
20265102|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
19935947|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935948|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935949|NCT01412424|Octreotide|octreotide|mesh-list
19935950|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265103|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265104|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20265105|NCT00513981|Antidotes|antidotes|mesh-ancestor
20265106|NCT00513981|Protective Agents|protective agents|mesh-ancestor
20265107|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
20265108|NCT00513981|Vitamins|vitamins|mesh-ancestor
20265109|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
19935951|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19935952|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935953|NCT01412710|Vitamin D|vitamin d|mesh-list
19935954|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
19935955|NCT01412710|Vitamins|vitamins|mesh-ancestor
19935956|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
19935957|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935958|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19935959|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19935960|NCT01412879|Leucovorin|leucovorin|mesh-list
19935961|NCT01412879|Cytarabine|cytarabine|mesh-list
19935962|NCT01412879|Dexamethasone|dexamethasone|mesh-list
19935963|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
19935964|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19935965|NCT01412879|Rituximab|rituximab|mesh-list
19935966|NCT01412879|Doxorubicin|doxorubicin|mesh-list
19935967|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19935968|NCT01412879|Methotrexate|methotrexate|mesh-list
19935969|NCT01412879|Vincristine|vincristine|mesh-list
19935970|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
19935971|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19935972|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
19935973|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19935974|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19935975|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19935976|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
19935977|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19935978|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19935979|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19935980|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19935981|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19935982|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
19935983|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
19935984|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19935985|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19935986|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
19935987|NCT01412879|Hormones|hormones|mesh-ancestor
19935988|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19935989|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19935990|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19935991|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19935992|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19935993|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19935994|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19935995|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
19935996|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19935997|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19935998|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
19935999|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
19936000|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19936001|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19936002|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
19936003|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936004|NCT01412879|Antidotes|antidotes|mesh-ancestor
19936005|NCT01412879|Protective Agents|protective agents|mesh-ancestor
19936006|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
19936007|NCT01412879|Vitamins|vitamins|mesh-ancestor
19936008|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
19936009|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19936010|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
19936011|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
20265110|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
19936012|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
19936013|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20265111|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
20265112|NCT00514072|Vaccines|vaccines|mesh-list
19936014|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
19936015|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936016|NCT01412957|Panitumumab|panitumumab|mesh-list
19936017|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936018|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936019|NCT01413178|Melphalan|melphalan|mesh-list
19936020|NCT01413178|Busulfan|busulfan|mesh-list
19936021|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19936022|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
19936023|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936024|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936025|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19936026|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936027|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
19936028|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936029|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19936030|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
19936031|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936032|NCT01413360|Vitamins|vitamins|mesh-list
19936033|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
19936034|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
19936035|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936036|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
19936037|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936038|NCT01413360|Protective Agents|protective agents|mesh-ancestor
19936039|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19936040|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936041|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936042|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936043|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19936044|NCT01413516|Varenicline|varenicline|mesh-list
19936045|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19936046|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19936047|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
19936048|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936049|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936050|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936051|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19936052|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19936053|NCT01413542|Enalaprilat|enalaprilat|mesh-list
19936054|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19936055|NCT01413542|Bradykinin|bradykinin|mesh-list
19936056|NCT01413542|Glucagon|glucagon|mesh-list
19936057|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19936058|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19936059|NCT01413542|Substance P|substance p|mesh-list
19936060|NCT01413542|Neurokinin A|neurokinin a|mesh-list
19936061|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19936062|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936063|NCT01413542|Incretins|incretins|mesh-ancestor
19936064|NCT01413542|Hormones|hormones|mesh-ancestor
19936065|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936066|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
19936067|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936068|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936069|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936070|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
19936071|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
19936072|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19936073|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265113|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
20265114|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
20265115|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265116|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20287144|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
20287145|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
20287146|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287147|NCT05332028|Fentanyl|fentanyl|mesh-list
20287148|NCT05332028|Bupivacaine|bupivacaine|mesh-list
20287149|NCT05332028|Propofol|propofol|mesh-list
20287150|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
20287151|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
20287152|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287153|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936074|NCT01413750|Paclitaxel|paclitaxel|mesh-list
20287154|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
19936075|NCT01413750|Carboplatin|carboplatin|mesh-list
19936076|NCT01413750|Vorinostat|vorinostat|mesh-list
19936077|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19936078|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936079|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
19936080|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
19936081|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19936082|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936083|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19936084|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936085|NCT01413958|Loratadine|loratadine|mesh-list
19936086|NCT01413958|Phenylephrine|phenylephrine|mesh-list
19936087|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
19936088|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19936089|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
19936090|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
19936091|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936092|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936093|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
19936094|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19936095|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
19936096|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
19936097|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19936098|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19936099|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19936100|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
19936101|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936102|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936103|NCT01413958|Protective Agents|protective agents|mesh-ancestor
19936104|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
19936105|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
19936106|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19936107|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19936108|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19936109|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
19936110|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
19936111|NCT01414010|Amoxicillin|amoxicillin|mesh-list
19936112|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19936113|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936114|NCT01414075|Iron|iron|mesh-list
19936115|NCT01414075|Trace Elements|trace elements|mesh-ancestor
19936116|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
19936117|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936118|NCT01414153|Bevacizumab|bevacizumab|mesh-list
19936119|NCT01414153|Ranibizumab|ranibizumab|mesh-list
19936120|NCT01414153|Aflibercept|aflibercept|mesh-list
19936121|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19936122|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936123|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936124|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19936125|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19936126|NCT01414153|Growth Substances|growth substances|mesh-ancestor
19936127|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936128|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
19936129|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
19936130|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
19936131|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936132|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936133|NCT01414257|Methotrexate|methotrexate|mesh-list
19936134|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19936135|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
19936136|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936137|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936138|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19936139|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
19936140|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936141|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936142|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
19936143|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265117|NCT00514111|Interferons|interferons|mesh-list
20265118|NCT00514111|Ribavirin|ribavirin|mesh-list
19936144|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19936145|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936146|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
19936147|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936148|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19936149|NCT01414855|Prednisone|prednisone|mesh-list
19936150|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
19936151|NCT01414855|Doxorubicin|doxorubicin|mesh-list
19936152|NCT01414855|Vincristine|vincristine|mesh-list
19936153|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
19936154|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936155|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
19936156|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936157|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936158|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19936159|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
19936160|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936161|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936162|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19936163|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19936164|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19936165|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19936166|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936167|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936168|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
19936169|NCT01414855|Hormones|hormones|mesh-ancestor
19936170|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936171|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19936172|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19936173|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
19936174|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
19936175|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
19936176|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936177|NCT01415349|Omeprazole|omeprazole|mesh-list
19936178|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19936179|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936180|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19936181|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936182|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936183|NCT01415401|Timolol|timolol|mesh-list
19936184|NCT01415401|Brinzolamide|brinzolamide|mesh-list
19936185|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19936186|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19936187|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
19936188|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936189|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936190|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936191|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19936192|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19936193|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936194|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19936195|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19936196|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19936197|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542451|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19936198|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19936199|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19936200|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936201|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936202|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
19936203|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936204|NCT01415518|Budesonide|budesonide|mesh-list
19936205|NCT01415518|Theophylline|theophylline|mesh-list
19936206|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
19936207|NCT01415518|Ipratropium|ipratropium|mesh-list
19936208|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19936209|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936210|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19936211|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
19936212|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936213|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936214|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19936215|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
19936216|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
19936217|NCT01415518|Hormones|hormones|mesh-ancestor
19936218|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936219|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19936220|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19936221|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19936222|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
19936223|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936224|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936225|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20265119|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265120|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
20265121|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265122|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
20265123|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265124|NCT00514163|Gemcitabine|gemcitabine|mesh-list
20265125|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265126|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
20265127|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265128|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265129|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
20265130|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265131|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265132|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265133|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
20265134|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265135|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
20265136|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20265137|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265138|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20265139|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20265140|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265141|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265142|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
20265143|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265144|NCT00514228|Sunitinib|sunitinib|mesh-list
20265145|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265146|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20265147|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20265148|NCT00514228|Growth Substances|growth substances|mesh-ancestor
20265149|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265150|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
20265151|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20265152|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265153|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265154|NCT00514293|Carboplatin|carboplatin|mesh-list
20265155|NCT00514293|Docetaxel|docetaxel|mesh-list
20265156|NCT00514293|Capecitabine|capecitabine|mesh-list
20265157|NCT00514293|Tretinoin|tretinoin|mesh-list
20265158|NCT00514293|Bexarotene|bexarotene|mesh-list
20265159|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265160|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
20265161|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
20265162|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
20265163|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265164|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265165|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
20265166|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
20265167|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265168|NCT00514397|Temozolomide|temozolomide|mesh-list
19936226|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
19936227|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19936228|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936229|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
19936230|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19936231|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19936232|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
19936233|NCT01415531|Nebivolol|nebivolol|mesh-list
19936234|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19936235|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
19936236|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19936237|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19936238|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19936239|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
19936240|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936241|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936242|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936243|NCT01415583|Dexamethasone|dexamethasone|mesh-list
19936244|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936245|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
19936246|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
19936247|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936248|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936249|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936250|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
19936251|NCT01415583|Hormones|hormones|mesh-ancestor
20265169|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
20265170|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265171|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
20265172|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265173|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936252|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936253|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19936254|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936255|NCT01415921|Bromides|bromides|mesh-list
19936256|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19936257|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
19936258|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19936259|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936260|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936261|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
19936262|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936263|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936264|NCT01415960|Leuprolide|leuprolide|mesh-list
19936265|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19936266|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
19936267|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936268|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936269|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19936270|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936271|NCT01416155|Natalizumab|natalizumab|mesh-list
19936272|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
19936273|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936274|NCT01416181|Natalizumab|natalizumab|mesh-list
19936275|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
19936276|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936277|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
19936278|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
19936279|NCT01416194|Diphosphonates|diphosphonates|mesh-list
19936280|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19936281|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
19936282|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936283|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936284|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19936285|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19936286|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19936287|NCT01416389|Lenograstim|lenograstim|mesh-list
19936288|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19936289|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
19936290|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936291|NCT01416441|Aripiprazole|aripiprazole|mesh-list
19936292|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
19936293|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936294|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19936295|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936296|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936297|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936298|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
19936299|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
19936300|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936301|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936302|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19936303|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19936304|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
19936305|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19936306|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19936307|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19936308|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19936309|NCT01416584|Methadone|methadone|mesh-list
19936310|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19936311|NCT01416584|Narcotics|narcotics|mesh-ancestor
19936312|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936313|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936314|NCT01416584|Analgesics|analgesics|mesh-ancestor
19936315|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
19936316|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936317|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
19936318|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
19936319|NCT01416636|Treprostinil|treprostinil|mesh-list
19936320|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19936321|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
19936322|NCT01417000|Pancrelipase|pancrelipase|mesh-list
19936323|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936324|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
19936325|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936326|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936327|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19936328|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
19936329|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936330|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936331|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19936332|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936333|NCT01417026|Oxytocin|oxytocin|mesh-list
19936334|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
19936335|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936336|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936337|NCT01417078|Diazepam|diazepam|mesh-list
19936338|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19936339|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
19936340|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
19936341|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
19936342|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936343|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936344|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936345|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19936346|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265174|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20265175|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265176|NCT00514410|Folic Acid|folic acid|mesh-list
20265177|NCT00514410|Hematinics|hematinics|mesh-ancestor
20265178|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
20265179|NCT00514410|Vitamins|vitamins|mesh-ancestor
20265180|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
20265181|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265182|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20265183|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
20265184|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265185|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
20265186|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265187|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20265188|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265189|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265190|NCT00514527|Oritavancin|oritavancin|mesh-list
20265191|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20265192|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265193|NCT00514605|Antibodies|antibodies|mesh-list
20265194|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
20265195|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
20265196|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265197|NCT00514618|Misoprostol|misoprostol|mesh-list
20265198|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20542452|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542453|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542454|NCT01863602|Lamotrigine|lamotrigine|mesh-list
20542455|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
20542456|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20542457|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542458|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542459|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542460|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542461|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20542462|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20542463|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542464|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936347|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19936348|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20265199|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
20265200|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936349|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19936350|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936351|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936352|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19936353|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
19936354|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
19936355|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
19936356|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
19936357|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936358|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936359|NCT01417156|Nintedanib|nintedanib|mesh-list
19936360|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936361|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19936362|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936363|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936364|NCT01417195|Menotropins|menotropins|mesh-list
19936365|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19936366|NCT01417195|Hormones|hormones|mesh-ancestor
19936367|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936368|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936369|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19936370|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
19936371|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936372|NCT01417481|Glycine|glycine|mesh-list
19936373|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
19936374|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936375|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936376|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936377|NCT01418001|Gemcitabine|gemcitabine|mesh-list
19936378|NCT01418001|Docetaxel|docetaxel|mesh-list
19936379|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19936380|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
19936381|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936382|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936383|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
19936384|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936385|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936386|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936387|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
19936388|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936389|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
19936390|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
19936391|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
19936392|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19936393|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19936394|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19936395|NCT01418209|Estradiol|estradiol|mesh-list
19936396|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19936397|NCT01418209|Progesterone|progesterone|mesh-list
19936398|NCT01418209|Estrogens|estrogens|mesh-ancestor
19936399|NCT01418209|Hormones|hormones|mesh-ancestor
19936400|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936401|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936402|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19936403|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
19936404|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936405|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19936406|NCT01418209|Progestins|progestins|mesh-ancestor
19936407|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19936408|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19936409|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936410|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936411|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936412|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19936413|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
19936414|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936415|NCT01418339|Aripiprazole|aripiprazole|mesh-list
19936416|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
19936417|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936418|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19936419|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936420|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936421|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936422|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
19936423|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
19936424|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936425|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936426|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19936427|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19936428|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
19936429|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19936430|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19936431|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20265201|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265202|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20265203|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265204|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
20265205|NCT00514657|Mitogens|mitogens|mesh-list
20265206|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
20265207|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265208|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
20265209|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20265210|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265211|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
20265212|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20265213|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20265214|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20265215|NCT00514748|Analgesics|analgesics|mesh-ancestor
20265216|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
20265217|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265218|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265219|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20265220|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265221|NCT00514761|Capecitabine|capecitabine|mesh-list
20265222|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265223|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
20265224|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265225|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265226|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20265227|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20265228|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265229|NCT00514891|Vitamin A|vitamin a|mesh-list
20265230|NCT00514891|Vitamins|vitamins|mesh-ancestor
20265231|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
20265232|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265233|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
20265234|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265235|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20265236|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265237|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265238|NCT00514982|Adalimumab|adalimumab|mesh-list
20265239|NCT00514982|Mesalamine|mesalamine|mesh-list
20265240|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
20265241|NCT00514982|Infliximab|infliximab|mesh-list
20265242|NCT00514982|Tacrolimus|tacrolimus|mesh-list
20265243|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265244|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
20265245|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265246|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20265247|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265248|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265249|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20265250|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265251|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265252|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265253|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
20265254|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265255|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265256|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20265257|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20265258|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20265259|NCT00514982|Analgesics|analgesics|mesh-ancestor
20265260|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
20265261|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265262|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
20265263|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20265264|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20265265|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
20265266|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
20265267|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936432|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19936433|NCT01418352|Aripiprazole|aripiprazole|mesh-list
19936434|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
19936435|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936436|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19936437|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936438|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936439|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936440|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
19936441|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
19936442|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936443|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936444|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19936445|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19936446|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
19936447|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19936448|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19936449|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19936450|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19936451|NCT01418365|Metronidazole|metronidazole|mesh-list
19936452|NCT01418365|Mesalamine|mesalamine|mesh-list
19936453|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936454|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19936455|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19450160|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19450161|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19450162|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19450163|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19450164|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
19450165|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450166|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450167|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450168|NCT03430609|Hormones|hormones|mesh-list
19450169|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19450170|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450171|NCT03430596|Pramipexole|pramipexole|mesh-list
19450172|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
19450173|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
19450174|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450175|NCT03430596|Protective Agents|protective agents|mesh-ancestor
19450176|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450177|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19450178|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19450179|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
19450180|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
19450181|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450182|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19450183|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19936456|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19936457|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19936458|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19936459|NCT01418365|Analgesics|analgesics|mesh-ancestor
19936460|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
19936461|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936462|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936463|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936464|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973543|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
19973544|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973545|NCT01825408|Azithromycin|azithromycin|mesh-list
19973546|NCT01825408|Doxycycline|doxycycline|mesh-list
19973547|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19973548|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973549|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973550|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
19973551|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19973552|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19973553|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19973554|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973555|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973556|NCT01825512|Deferasirox|deferasirox|mesh-list
19973557|NCT01825512|Deferiprone|deferiprone|mesh-list
19973558|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19973559|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
19936465|NCT01419184|Vancomycin|vancomycin|mesh-list
19936466|NCT01419184|Daptomycin|daptomycin|mesh-list
19936467|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19936468|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936469|NCT01419197|Trastuzumab|trastuzumab|mesh-list
19936470|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19936471|NCT01419197|Maytansine|maytansine|mesh-list
19936472|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936473|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936474|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19936475|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
19936476|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
19936477|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
19936478|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936479|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19936480|NCT01419236|Testosterone|testosterone|mesh-list
19936481|NCT01419236|Androgens|androgens|mesh-ancestor
19936482|NCT01419236|Hormones|hormones|mesh-ancestor
19936483|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936484|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936485|NCT01419275|Xenon|xenon|mesh-list
19936486|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19936487|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
19936488|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
19936489|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936490|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936491|NCT01419535|Mifepristone|mifepristone|mesh-list
19936492|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19936493|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
19936494|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936495|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936496|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19936497|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19936498|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19936499|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
19936500|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19936501|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19936502|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
19936503|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936504|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
19936505|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19936506|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19936507|NCT01419639|Everolimus|everolimus|mesh-list
19936508|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936509|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936510|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
19936511|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936512|NCT01419665|Rituximab|rituximab|mesh-list
19936513|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936514|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936515|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
19936516|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936517|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936518|NCT01419717|Denosumab|denosumab|mesh-list
19936519|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19936520|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265268|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265269|NCT00515138|Rituximab|rituximab|mesh-list
20265270|NCT00515138|Carboplatin|carboplatin|mesh-list
20265271|NCT00515138|Etoposide|etoposide|mesh-list
20265272|NCT00515138|Bortezomib|bortezomib|mesh-list
20265273|NCT00515138|Ifosfamide|ifosfamide|mesh-list
20265274|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20265275|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265276|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
20265277|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265278|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265279|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20265280|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20265281|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20265282|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265283|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936521|NCT01419795|Rituximab|rituximab|mesh-list
19936522|NCT01419795|Lenalidomide|lenalidomide|mesh-list
19973560|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
19936523|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936524|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936525|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
19936526|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936527|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936528|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19936529|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19936530|NCT01419795|Growth Substances|growth substances|mesh-ancestor
19936531|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
19936532|NCT01419977|Dalteparin|dalteparin|mesh-list
19936533|NCT01419977|Tinzaparin|tinzaparin|mesh-list
19936534|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19936535|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
19936536|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19936537|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19936538|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936539|NCT01420081|Gedatolisib|gedatolisib|mesh-list
19936540|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19936541|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936542|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936543|NCT01420146|Trastuzumab|trastuzumab|mesh-list
19936544|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936545|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936546|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
19936547|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936548|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
19936549|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
19936550|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
19936551|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19936552|NCT01420549|Simvastatin|simvastatin|mesh-list
19936553|NCT01420549|Ezetimibe|ezetimibe|mesh-list
19936554|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19936555|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19936556|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
19936557|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936558|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19936559|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19936560|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936561|NCT01420653|Acetaminophen|acetaminophen|mesh-list
19936562|NCT01420653|Ibuprofen|ibuprofen|mesh-list
19936563|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19936564|NCT01420653|Analgesics|analgesics|mesh-ancestor
19936565|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
19936566|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936567|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936568|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
19936569|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19936570|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936571|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936572|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19936573|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936574|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936575|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
19936576|NCT01420679|Aminopterin|aminopterin|mesh-list
19936577|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19936578|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936579|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265284|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265285|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
20265286|NCT00515151|Ethanol|ethanol|mesh-list
20265287|NCT00515151|Octenidine|octenidine|mesh-list
20265288|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20265289|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936580|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936581|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
19936582|NCT01421017|Imiquimod|imiquimod|mesh-list
19936583|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936584|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
19936585|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936586|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936587|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19936588|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
19936589|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936590|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265290|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936591|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19936592|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19936593|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
19936594|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19936595|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19936596|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936597|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936598|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936599|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936600|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19936601|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19936602|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19936603|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19936604|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936605|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936606|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19936607|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19936608|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
19936609|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19936610|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19936611|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
19936612|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
19936613|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19936614|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265291|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265292|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
20265293|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265294|NCT00515229|Amitriptyline|amitriptyline|mesh-list
20265295|NCT00515229|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20265296|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20265297|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
20265298|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265299|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20265300|NCT00515229|Analgesics|analgesics|mesh-ancestor
20542465|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20542466|NCT01863615|Isotretinoin|isotretinoin|mesh-list
20542467|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
20542468|NCT01863641|Calcitriol|calcitriol|mesh-list
20542469|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542470|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542471|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20542472|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542473|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542474|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20542475|NCT01863641|Vitamins|vitamins|mesh-ancestor
20542476|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
20542477|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20542478|NCT01863654|Montelukast|montelukast|mesh-list
20542479|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20542480|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
20542481|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20542482|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
20542483|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542484|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542485|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20542486|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20542487|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936615|NCT01421186|Dexamethasone|dexamethasone|mesh-list
19936616|NCT01421186|Lenalidomide|lenalidomide|mesh-list
19936617|NCT01421186|Pomalidomide|pomalidomide|mesh-list
19936618|NCT01421186|Felzartamab|felzartamab|mesh-list
19936619|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936620|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
19936621|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
19936622|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936623|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936624|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936625|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
19936626|NCT01421186|Hormones|hormones|mesh-ancestor
19936627|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936628|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19936629|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936630|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
19936631|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19936632|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19936633|NCT01421186|Growth Substances|growth substances|mesh-ancestor
19936634|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
19936635|NCT01421225|Insulin|insulin|mesh-list
19936636|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19936637|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19936638|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936639|NCT01421303|Etanercept|etanercept|mesh-list
19936640|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19936641|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19936642|NCT01421303|Analgesics|analgesics|mesh-ancestor
19936643|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
19936644|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936645|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936646|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936647|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936648|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936649|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19936650|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
19936651|NCT01421342|Aripiprazole|aripiprazole|mesh-list
19936652|NCT01421342|Bupropion|bupropion|mesh-list
19936653|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
19936654|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19936655|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936656|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19936657|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19936658|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936659|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936660|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
19936661|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936662|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936663|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19936664|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19936665|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936666|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20265301|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
20265302|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265303|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265304|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20265305|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20265306|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265307|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265308|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
20265309|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265310|NCT00515229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19936667|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936668|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936669|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
19936670|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19936671|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19936672|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
19936673|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19936674|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19936675|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19936676|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19936677|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19936678|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19936679|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19936680|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
19936681|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936682|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936683|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19936684|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19936685|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
19936686|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936687|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
19936688|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19936689|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936690|NCT01421472|Paclitaxel|paclitaxel|mesh-list
19936691|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19936692|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936693|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
19936694|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
19936695|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
19936696|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936697|NCT01421498|Lifitegrast|lifitegrast|mesh-list
19936698|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19936699|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19936700|NCT01421511|Linezolid|linezolid|mesh-list
19936701|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20265311|NCT00515229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20265312|NCT00515229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542488|NCT01863706|Misoprostol|misoprostol|mesh-list
20542489|NCT01863706|Oxytocin|oxytocin|mesh-list
20542490|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
20542491|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20542492|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542493|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20542494|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
20542495|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20542496|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542497|NCT01863719|Colistin|colistin|mesh-list
20542498|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20542499|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542500|NCT01863810|Pregabalin|pregabalin|mesh-list
20542501|NCT01863810|Analgesics|analgesics|mesh-ancestor
20542502|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
20542503|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542504|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542505|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
20542506|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20542507|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542508|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542509|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542510|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20542511|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20542512|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542513|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20542514|NCT01863823|Amoxicillin|amoxicillin|mesh-list
20542515|NCT01863823|Tetracycline|tetracycline|mesh-list
20542516|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20542517|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542518|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20542519|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542520|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542521|NCT01863888|Teriflunomide|teriflunomide|mesh-list
20542522|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
20542523|NCT01863888|Charcoal|charcoal|mesh-list
20542524|NCT01863888|Antidotes|antidotes|mesh-ancestor
20542525|NCT01863888|Protective Agents|protective agents|mesh-ancestor
20542526|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542527|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20542528|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20542529|NCT01863888|Analgesics|analgesics|mesh-ancestor
19936702|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936703|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19936704|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936705|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936706|NCT01421589|Hormones|hormones|mesh-list
19936707|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936708|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936709|NCT01421641|Lidocaine|lidocaine|mesh-list
20265313|NCT00515255|Minocycline|minocycline|mesh-list
20265314|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20265315|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265316|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
20265317|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20265318|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20265319|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265320|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265321|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
20265322|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20265323|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
20542530|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
20542531|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936710|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
19936711|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
19936712|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936713|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936714|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
19936715|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936716|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19936717|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19936718|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19936719|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936720|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936721|NCT01421667|Rituximab|rituximab|mesh-list
19936722|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19936723|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19936724|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936725|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
19936726|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936727|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265324|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265325|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265326|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20265327|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
20265328|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20265329|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
20265330|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936728|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19936729|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19936730|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936731|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936732|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19936733|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936734|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936735|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
19936736|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936737|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
19936738|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936739|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936740|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
19936741|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19936742|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19936743|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936744|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936745|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
19936746|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936747|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936748|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19936749|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936750|NCT01422200|Vaccines|vaccines|mesh-list
19936751|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
19936752|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936753|NCT01422213|Vortioxetine|vortioxetine|mesh-list
19936754|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
19936755|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936756|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19936757|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936758|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936759|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936760|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19936761|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19936762|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936763|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936764|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936765|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
19936766|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19936767|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19936768|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19936769|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19936770|NCT01422226|Alprostadil|alprostadil|mesh-list
19936771|NCT01422226|Misoprostol|misoprostol|mesh-list
19936772|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20265331|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936773|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
19936774|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19936775|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936776|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19936777|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936778|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
19936779|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19936780|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
19936781|NCT01422226|Urological Agents|urological agents|mesh-ancestor
19936782|NCT01422304|Atropine|atropine|mesh-list
19936783|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
19936784|NCT01422304|Neostigmine|neostigmine|mesh-list
19936785|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19936786|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19936787|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19936788|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
19936789|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936790|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936791|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19936792|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19936793|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
19936794|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
19936795|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19936796|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19936797|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
19936798|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936799|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936800|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19936801|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936802|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19936803|NCT01422369|Ritonavir|ritonavir|mesh-list
19936804|NCT01422369|Darunavir|darunavir|mesh-list
19936805|NCT01422369|Pitavastatin|pitavastatin|mesh-list
19936806|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19936807|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19936808|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
19936809|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936810|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936811|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19936812|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19936813|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
19936814|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936815|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19936816|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19936817|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19936818|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19936819|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19936820|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
20265332|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20265333|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
20265334|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
20265335|NCT00515281|Protective Agents|protective agents|mesh-ancestor
20265336|NCT00515320|Fluoxetine|fluoxetine|mesh-list
20265337|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20265338|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20265339|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265340|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265341|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265342|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
20265343|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542532|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542533|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20542534|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542535|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
20542536|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20542537|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19936821|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19936822|NCT01422382|Diltiazem|diltiazem|mesh-list
20542538|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
20542539|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542540|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20542541|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20542542|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19936823|NCT01422382|Pitavastatin|pitavastatin|mesh-list
19936824|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19936825|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19936826|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936827|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936828|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19936829|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936830|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
19936831|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19936832|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19936833|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19936834|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
19936835|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936836|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19936837|NCT01422408|Fluocinonide|fluocinonide|mesh-list
19936838|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936839|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
19936840|NCT01422408|Hormones|hormones|mesh-ancestor
19936841|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936842|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936843|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19936844|NCT01422434|Calcitriol|calcitriol|mesh-list
19936845|NCT01422434|Betamethasone|betamethasone|mesh-list
19936846|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
19936847|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19936848|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
19936849|NCT01422434|Calcipotriene|calcipotriene|mesh-list
19936850|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19936851|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936852|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
19936853|NCT01422434|Hormones|hormones|mesh-ancestor
19936854|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936855|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936856|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19936857|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
19936858|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
19936859|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19936860|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20265344|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20265345|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
20265346|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265347|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20265348|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20265349|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265350|NCT00515359|Propofol|propofol|mesh-list
20265351|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20265352|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265353|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265354|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20265355|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
20265356|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
20265357|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
20265358|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20265359|NCT00515450|Antibodies|antibodies|mesh-list
20265360|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
20265361|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20265362|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
20265363|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265364|NCT00515489|Risperidone|risperidone|mesh-list
20265365|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20265366|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
20265367|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265368|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265369|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265370|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20265371|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20265372|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265373|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265374|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20265375|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
20265376|NCT00515554|Rituximab|rituximab|mesh-list
20265377|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20265378|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936861|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936862|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936863|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19936864|NCT01422434|Vitamins|vitamins|mesh-ancestor
19936865|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
19936866|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19936867|NCT01422538|Mannitol|mannitol|mesh-list
19936868|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19936869|NCT01422538|Diuretics|diuretics|mesh-ancestor
19936870|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
19936871|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936872|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19936873|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
19936874|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19936875|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19936876|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19936877|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936878|NCT01422876|Linagliptin|linagliptin|mesh-list
19936879|NCT01422876|Empagliflozin|empagliflozin|mesh-list
19936880|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19936881|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936882|NCT01422876|Incretins|incretins|mesh-ancestor
19936883|NCT01422876|Hormones|hormones|mesh-ancestor
19936884|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936885|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19936886|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
19936887|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936888|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936889|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19936890|NCT01422915|Colestipol|colestipol|mesh-list
19936891|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19936892|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
19936893|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936894|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19936895|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
19936896|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
19936897|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
19936898|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936899|NCT01423162|Protective Agents|protective agents|mesh-ancestor
19936900|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936901|NCT01423162|Vitamins|vitamins|mesh-ancestor
19936902|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
19936903|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19936904|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19936905|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19936906|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19936907|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936908|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19936909|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19936910|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19936911|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19936912|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
19936913|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936914|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936915|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19936916|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19936917|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
19936918|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19936919|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19936920|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
19936921|NCT01423604|Capecitabine|capecitabine|mesh-list
19936922|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19936923|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
19936924|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936925|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936926|NCT01423812|Ritonavir|ritonavir|mesh-list
19936927|NCT01423812|Darunavir|darunavir|mesh-list
19936928|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19936929|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19936930|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
19936931|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265379|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
20265380|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265381|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19936932|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936933|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19936934|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19936935|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
19936936|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936937|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19936938|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19936939|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
19936940|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19936941|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936942|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19936943|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19936944|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19936945|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936946|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936947|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
19936948|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19936949|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
19936950|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19936951|NCT01424033|Expectorants|expectorants|mesh-ancestor
19936952|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
19936953|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19936954|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
19936955|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936956|NCT01424033|Protective Agents|protective agents|mesh-ancestor
19936957|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936958|NCT01424033|Antidotes|antidotes|mesh-ancestor
19936959|NCT01424228|Prucalopride|prucalopride|mesh-list
19936960|NCT01424228|Laxatives|laxatives|mesh-ancestor
19936961|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19936962|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19936963|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19936964|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
19936965|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936966|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936967|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936968|NCT01424566|Nabiximols|nabiximols|mesh-list
19936969|NCT01424566|Analgesics|analgesics|mesh-ancestor
19936970|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
19936971|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936972|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936973|NCT01424644|Vaccines|vaccines|mesh-list
19936974|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
19936975|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936976|NCT01424813|Albuterol|albuterol|mesh-list
19936977|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19936978|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
19936979|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19936980|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265382|NCT00515593|Hormones|hormones|mesh-list
20265383|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
20265384|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20265385|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265386|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20265387|NCT00515684|Bevacizumab|bevacizumab|mesh-list
20265388|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20265389|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265390|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20265391|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20265392|NCT00515684|Growth Substances|growth substances|mesh-ancestor
20265393|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265394|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
20265395|NCT00515736|Vitamins|vitamins|mesh-list
20265396|NCT00515736|Vitamin E|vitamin e|mesh-list
20265397|NCT00515736|Thiamine|thiamine|mesh-list
20265398|NCT00515736|Zinc|zinc|mesh-list
20265399|NCT00515736|Selenium|selenium|mesh-list
20265400|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
20265401|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265402|NCT00515736|Trace Elements|trace elements|mesh-ancestor
20265403|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
20265404|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265405|NCT00515736|Protective Agents|protective agents|mesh-ancestor
20265406|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
20265407|NCT00515788|Cytarabine|cytarabine|mesh-list
20265408|NCT00515788|Temozolomide|temozolomide|mesh-list
20265409|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265410|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
20265411|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265412|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265413|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
20265414|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265415|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732599|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
19732600|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
19732601|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732602|NCT04571437|Capecitabine|capecitabine|mesh-list
19732603|NCT04571437|Letrozole|letrozole|mesh-list
19936981|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19936982|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
19936983|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
19936984|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19732604|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19732605|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
20265416|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
20265417|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265418|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265419|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
20265420|NCT00515801|Glyburide|glyburide|mesh-list
19936985|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19936986|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19936987|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19936988|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
19936989|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19936990|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19936991|NCT01424930|Prednisone|prednisone|mesh-list
19936992|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19936993|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
19936994|NCT01424930|Hormones|hormones|mesh-ancestor
19936995|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19936996|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19936997|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19936998|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19936999|NCT01425203|Ribavirin|ribavirin|mesh-list
19937000|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19937001|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
19937002|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937003|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
19937004|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937005|NCT01425229|Bosentan|bosentan|mesh-list
19937006|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19937007|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19937008|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937009|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
19937010|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937011|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
19937012|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937013|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937014|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19937015|NCT01425359|Ranolazine|ranolazine|mesh-list
19937016|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19937017|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937018|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937019|NCT01425463|Glycine|glycine|mesh-list
19937020|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
19937021|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265421|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542543|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20542544|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
19732606|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732607|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732608|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19732609|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19732610|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732611|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19732612|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
19732613|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732614|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732615|NCT04571489|Gemcitabine|gemcitabine|mesh-list
19732616|NCT04571489|Tegafur|tegafur|mesh-list
20265422|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265423|NCT00515866|Gemcitabine|gemcitabine|mesh-list
20265424|NCT00515866|Olaparib|olaparib|mesh-list
20265425|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20265426|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265427|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
19937022|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937023|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973561|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973562|NCT01825577|Methylphenidate|methylphenidate|mesh-list
19973563|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19973564|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973565|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19973566|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19973567|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973568|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973569|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
19973570|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973571|NCT01825655|Cetirizine|cetirizine|mesh-list
19973572|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19973573|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19973574|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19973575|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
19973576|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
19973577|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973578|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973579|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973580|NCT01825798|Metformin|metformin|mesh-list
19973581|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19973582|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973583|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19973584|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
19973585|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19973586|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19973587|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973588|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973589|NCT01825876|Warfarin|warfarin|mesh-list
19973590|NCT01825876|Evacetrapib|evacetrapib|mesh-list
19973591|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
19973592|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19973593|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19973594|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
19973595|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973596|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19973597|NCT01825889|Evacetrapib|evacetrapib|mesh-list
19973598|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19973599|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19973600|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
20265428|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265429|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265430|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
20265431|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265432|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265433|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265434|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
20265435|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265436|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
20265437|NCT00515892|Antibodies|antibodies|mesh-list
20265438|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
20265439|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19973601|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973602|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19973603|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
19973604|NCT01825941|Promethazine|promethazine|mesh-list
19973605|NCT01825941|Metoclopramide|metoclopramide|mesh-list
19973606|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19973607|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19973608|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973609|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973610|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
20265440|NCT00515892|Immunotoxins|immunotoxins|mesh-list
19973611|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
20265441|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
19937024|NCT01425281|Everolimus|everolimus|mesh-list
19937025|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937026|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19937027|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
19937028|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937029|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
19937030|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19937031|NCT01425801|Albuterol|albuterol|mesh-list
19937032|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19937033|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
19937034|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937035|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937036|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19937037|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937038|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
19937039|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19937040|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19937041|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19937042|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19937043|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
19937044|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937045|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937046|NCT01425853|Celecoxib|celecoxib|mesh-list
19937047|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19937048|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19937049|NCT01425853|Analgesics|analgesics|mesh-ancestor
19937050|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
19937051|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937052|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937053|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937054|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937055|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19937056|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19937057|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937058|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937059|NCT01426009|Bromides|bromides|mesh-list
19937060|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
19937061|NCT01426009|Ipratropium|ipratropium|mesh-list
19937062|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19937063|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
19937064|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937065|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937066|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19937067|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937068|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
20265442|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265443|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265444|NCT00515905|Propofol|propofol|mesh-list
20265445|NCT00515905|Sevoflurane|sevoflurane|mesh-list
20265446|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20265447|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265448|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265449|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20265450|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
20265451|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
20265452|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20265453|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20265454|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
19732617|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19732618|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
19732619|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732620|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732621|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
19732622|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732623|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732624|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732625|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
19732626|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732627|NCT04571996|Acetaminophen|acetaminophen|mesh-list
19732628|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732629|NCT04571996|Analgesics|analgesics|mesh-ancestor
19732630|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
19732631|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732632|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732633|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
19732634|NCT04571580|Reteplase|reteplase|mesh-list
19732635|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19732636|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19732637|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19732638|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732639|NCT04571606|Bupivacaine|bupivacaine|mesh-list
19732640|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
19732641|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
19732642|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732643|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732644|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
19732645|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937069|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19937070|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
19937071|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937072|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937073|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
19937074|NCT01426269|Metronidazole|metronidazole|mesh-list
19937075|NCT01426269|Doxycycline|doxycycline|mesh-list
19937076|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937077|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937078|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19937079|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19937080|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
19937081|NCT01426347|Vitamin D|vitamin d|mesh-list
19937082|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
19937083|NCT01426347|Vitamins|vitamins|mesh-ancestor
19937084|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
19937085|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937086|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19937087|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19937088|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
19937089|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19937090|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19937091|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19937092|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
19937093|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937094|NCT01426438|Aspirin|aspirin|mesh-list
19937095|NCT01426438|Niacin|niacin|mesh-list
19937096|NCT01426438|Fenofibrate|fenofibrate|mesh-list
19937097|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19937098|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19937099|NCT01426438|Analgesics|analgesics|mesh-ancestor
19937100|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
19937101|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937102|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937103|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937104|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937105|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19937106|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19937107|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937108|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19937109|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19937110|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937111|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
19937112|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19937113|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
19937114|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19937115|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
19937116|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
19937117|NCT01426438|Vitamins|vitamins|mesh-ancestor
19937118|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
19937119|NCT01426763|Complement C1s|complement c1s|mesh-list
19937120|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19937121|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19937122|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
19937123|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937124|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19937125|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19937126|NCT01426854|Nepafenac|nepafenac|mesh-list
19937127|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19937128|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20554094|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19732646|NCT04571164|Rotigotine|rotigotine|mesh-list
19937129|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19937130|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19937131|NCT01426854|Analgesics|analgesics|mesh-ancestor
19937132|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
19937133|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937134|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937135|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937136|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265455|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20265456|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20265457|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20265458|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265459|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265460|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
20265461|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265462|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937137|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19937138|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19937139|NCT01426867|Brinzolamide|brinzolamide|mesh-list
19937140|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19937141|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19937142|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19937143|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19937144|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19937145|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
19937146|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937147|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937148|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937149|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19937150|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937151|NCT01426958|Ritonavir|ritonavir|mesh-list
19937152|NCT01426958|Afatinib|afatinib|mesh-list
19937153|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19937154|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19937155|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
19937156|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937157|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937158|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19937159|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19937160|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
19937161|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937162|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19937163|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19937164|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937165|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19937166|NCT01427309|Vaccines|vaccines|mesh-list
19937167|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
19937168|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937169|NCT01427504|Etravirine|etravirine|mesh-list
19937170|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19937171|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19937172|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937173|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937174|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
19937175|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937176|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
19937177|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19937178|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
19937179|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937180|NCT01427517|Expectorants|expectorants|mesh-ancestor
19937181|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937182|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19937183|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
19937184|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937185|NCT01427517|Protective Agents|protective agents|mesh-ancestor
19937186|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937187|NCT01427517|Antidotes|antidotes|mesh-ancestor
19937188|NCT01427595|Metformin|metformin|mesh-list
19937189|NCT01427595|Progesterone|progesterone|mesh-list
19937190|NCT01427595|Estradiol|estradiol|mesh-list
19937191|NCT01427595|Estrogens|estrogens|mesh-list
19937192|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937193|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937194|NCT01427595|Progestins|progestins|mesh-ancestor
19937195|NCT01427595|Hormones|hormones|mesh-ancestor
19937196|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937197|NCT01427608|Olanzapine|olanzapine|mesh-list
19937198|NCT01427608|Sertraline|sertraline|mesh-list
19937199|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
19937200|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
19937201|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937202|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937203|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19937204|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19937205|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19937206|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937207|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937208|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19937209|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19937210|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937211|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937212|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937213|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
19937214|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
19937215|NCT01427738|Nystatin|nystatin|mesh-list
20265463|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20265464|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265465|NCT00515957|Antibodies|antibodies|mesh-list
20265466|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
20265467|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265468|NCT00516009|Dexamethasone|dexamethasone|mesh-list
20265469|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20265470|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
20265471|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
20265472|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265473|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265474|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265475|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
20265476|NCT00516009|Hormones|hormones|mesh-ancestor
20265477|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20265478|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20265479|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287155|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287156|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20287157|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20287158|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
20287159|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20287160|NCT05332028|Narcotics|narcotics|mesh-ancestor
20287161|NCT05332028|Analgesics|analgesics|mesh-ancestor
20287162|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20287163|NCT05331781|Morphine|morphine|mesh-list
20287164|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20287165|NCT05331781|Narcotics|narcotics|mesh-ancestor
20287166|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287167|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287168|NCT05331781|Analgesics|analgesics|mesh-ancestor
20287169|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
20287170|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287171|NCT05331768|Terlipressin|terlipressin|mesh-list
20287172|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20287173|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20287174|NCT05331690|Dexamethasone|dexamethasone|mesh-list
20287175|NCT05331690|Nepafenac|nepafenac|mesh-list
20287176|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287177|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
20287178|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
20287179|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287180|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287181|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20287182|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
20287183|NCT05331690|Hormones|hormones|mesh-ancestor
20287184|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287185|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287186|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287187|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20287188|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287189|NCT05331690|Analgesics|analgesics|mesh-ancestor
20287190|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
20287191|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287192|NCT05324215|Fentanyl|fentanyl|mesh-list
20287193|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20287194|NCT05324215|Narcotics|narcotics|mesh-ancestor
20287195|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937216|NCT01427738|Gentian Violet|gentian violet|mesh-list
19937217|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937218|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937219|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
19937220|NCT01427738|Ionophores|ionophores|mesh-ancestor
19937221|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937222|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937223|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19937224|NCT01427751|Dexamethasone|dexamethasone|mesh-list
19937225|NCT01427751|Ranibizumab|ranibizumab|mesh-list
19937226|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937227|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
19937228|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
19937229|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937230|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937231|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19937232|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
19937233|NCT01427751|Hormones|hormones|mesh-ancestor
19937234|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937235|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19937236|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937237|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19937238|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19937239|NCT01427751|Growth Substances|growth substances|mesh-ancestor
19937240|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
19937241|NCT01427803|Naproxen|naproxen|mesh-list
19937242|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19937243|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19937244|NCT01427803|Analgesics|analgesics|mesh-ancestor
19937245|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
19937246|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937247|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937248|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937249|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937250|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
19937251|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19937252|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937253|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937254|NCT01427881|Cyclosporine|cyclosporine|mesh-list
19937255|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
19937256|NCT01427881|Busulfan|busulfan|mesh-list
19937257|NCT01427881|Fludarabine|fludarabine|mesh-list
19937258|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
19937259|NCT01427881|Cyclosporins|cyclosporins|mesh-list
19937260|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19937261|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
19937262|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937263|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937264|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19937265|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
19937266|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937267|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937268|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19937269|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19937270|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
19937271|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937272|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
19937273|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937274|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
19937275|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19937276|NCT01427907|Calcium|calcium|mesh-list
19937277|NCT01427907|Sevelamer|sevelamer|mesh-list
19937278|NCT01427907|Calcium acetate|calcium acetate|mesh-list
19937279|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19937280|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937281|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
19937282|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
19937283|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937284|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
19937285|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
19937286|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19937287|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937288|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937289|NCT01427933|Ramucirumab|ramucirumab|mesh-list
19937290|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937291|NCT01427972|Eplerenone|eplerenone|mesh-list
19937292|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19937293|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
19937294|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937295|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937296|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19937297|NCT01427972|Diuretics|diuretics|mesh-ancestor
19937298|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
19937299|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19937300|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
19937301|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19937302|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
19937303|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937304|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
19937305|NCT01428024|Protective Agents|protective agents|mesh-ancestor
19937306|NCT01428063|Interferons|interferons|mesh-list
19937307|NCT01428063|Ribavirin|ribavirin|mesh-list
19937308|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
19937309|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
19937310|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19937311|NCT01428063|Asunaprevir|asunaprevir|mesh-list
19937312|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937313|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
19937314|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937315|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
19937316|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265480|NCT00516100|Pemetrexed|pemetrexed|mesh-list
20265481|NCT00516100|Bortezomib|bortezomib|mesh-list
20542545|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542546|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20542547|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20542548|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554095|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554096|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
20554097|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
20554098|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
20554099|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554100|NCT01933152|Ranibizumab|ranibizumab|mesh-list
20554101|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20554102|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20554103|NCT01933152|Growth Substances|growth substances|mesh-ancestor
20554104|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554105|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
20554106|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554107|NCT01933347|Gefitinib|gefitinib|mesh-list
20554108|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554109|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20554110|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554111|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554112|NCT01933360|Misoprostol|misoprostol|mesh-list
20554113|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20554114|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
20554115|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20554116|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554117|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20554118|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554119|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
20554120|NCT01933412|Vaccines|vaccines|mesh-list
20554121|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
20554122|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554123|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
20554124|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20554125|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554126|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20554127|NCT01933503|Cathartics|cathartics|mesh-ancestor
20265482|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265483|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265484|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265485|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20265486|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20265487|NCT00516113|Paroxetine|paroxetine|mesh-list
20265488|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19937317|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
19937318|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265489|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19937319|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
19937320|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937321|NCT01428076|Polidocanol|polidocanol|mesh-list
19937322|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19937323|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19937324|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
19937325|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937326|NCT01428193|Flutamide|flutamide|mesh-list
19937327|NCT01428193|Estradiol|estradiol|mesh-list
19937328|NCT01428193|Progesterone|progesterone|mesh-list
19937329|NCT01428193|Estrogens|estrogens|mesh-ancestor
19937330|NCT01428193|Hormones|hormones|mesh-ancestor
19937331|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937332|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937333|NCT01428193|Progestins|progestins|mesh-ancestor
19937334|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
19937335|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
19937336|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19937337|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937338|NCT01428245|Estradiol|estradiol|mesh-list
19937339|NCT01428245|Estrogens|estrogens|mesh-list
19937340|NCT01428245|Progesterone|progesterone|mesh-list
19937341|NCT01428245|Hormones|hormones|mesh-ancestor
19937342|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937343|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937344|NCT01428245|Progestins|progestins|mesh-ancestor
19937345|NCT01428258|Coal Tar|coal tar|mesh-list
19937346|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
19937347|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
19937348|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19937349|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19937350|NCT01428336|Cosyntropin|cosyntropin|mesh-list
19937351|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
19937352|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937353|NCT01428336|Hormones|hormones|mesh-ancestor
19937354|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937355|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937356|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937357|NCT01428583|Naltrexone|naltrexone|mesh-list
19937358|NCT01428583|Oxycodone|oxycodone|mesh-list
19937359|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19937360|NCT01428583|Narcotics|narcotics|mesh-ancestor
19937361|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937362|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937363|NCT01428583|Analgesics|analgesics|mesh-ancestor
19937364|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
19937365|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937366|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19937367|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19937368|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
19937369|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
19937370|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
19937371|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19937372|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19937373|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19937374|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937375|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
19937376|NCT01428713|Coagulants|coagulants|mesh-ancestor
19937377|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19937378|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937379|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19937380|NCT01428882|Midazolam|midazolam|mesh-list
19937381|NCT01428882|Propofol|propofol|mesh-list
19937382|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19937383|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937384|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265490|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542549|NCT01864057|Thiamine|thiamine|mesh-list
19937385|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19937386|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
19937387|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
19937388|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19937389|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19937390|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19937391|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937392|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
20265491|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265492|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265493|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
20265494|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265495|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20265496|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
20265497|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265498|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20265499|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20265500|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265501|NCT00516152|Methotrexate|methotrexate|mesh-list
20265502|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
20265503|NCT00516152|Fludarabine|fludarabine|mesh-list
20265504|NCT00516152|Busulfan|busulfan|mesh-list
20265505|NCT00516152|Tacrolimus|tacrolimus|mesh-list
20542550|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
20542551|NCT01864057|Vitamins|vitamins|mesh-ancestor
20542552|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
20542553|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542554|NCT01864070|Everolimus|everolimus|mesh-list
20542555|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542556|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542557|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
20542558|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542559|NCT01864083|Fluorides|fluorides|mesh-list
20542560|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
20542561|NCT01864083|Protective Agents|protective agents|mesh-ancestor
20542562|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542563|NCT01864096|Metformin|metformin|mesh-list
20542564|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542565|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542566|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
20542567|NCT01864109|Temozolomide|temozolomide|mesh-list
20542568|NCT01864109|Ifosfamide|ifosfamide|mesh-list
20542569|NCT01864109|Doxorubicin|doxorubicin|mesh-list
20542570|NCT01864109|Irinotecan|irinotecan|mesh-list
20542571|NCT01864109|Etoposide|etoposide|mesh-list
20542572|NCT01864109|Vincristine|vincristine|mesh-list
20542573|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
20542574|NCT01864109|Razoxane|razoxane|mesh-list
20542575|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542576|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
20542577|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542578|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20542579|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20542580|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
20542581|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542582|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542583|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20542584|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20542585|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20542586|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20542587|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542588|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20542589|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20542590|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
20542591|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
20542592|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
20542593|NCT01864109|Protective Agents|protective agents|mesh-ancestor
20542594|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20542595|NCT01864161|Iron|iron|mesh-list
20542596|NCT01864161|Trace Elements|trace elements|mesh-ancestor
20542597|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
19937393|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
19937394|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937395|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937396|NCT01429051|Fentanyl|fentanyl|mesh-list
19937397|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20542598|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937398|NCT01429051|Narcotics|narcotics|mesh-ancestor
20542599|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
20542600|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20542601|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542602|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542603|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19937399|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937400|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937401|NCT01429051|Analgesics|analgesics|mesh-ancestor
19937402|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
19937403|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937404|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19937405|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19937406|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
19937407|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
19937408|NCT01429077|Levodopa|levodopa|mesh-list
19937409|NCT01429077|Carbidopa|carbidopa|mesh-list
19937410|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19937411|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19937412|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
19937413|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937414|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937415|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937416|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19937417|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937418|NCT01429259|Meropenem|meropenem|mesh-list
19937419|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937420|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937421|NCT01429272|Aspirin|aspirin|mesh-list
19937422|NCT01429272|Minocycline|minocycline|mesh-list
19937423|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19937424|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19937425|NCT01429272|Analgesics|analgesics|mesh-ancestor
19937426|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
19937427|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937428|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937429|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937430|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937431|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19937432|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19937433|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937434|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19937435|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19937436|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937437|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
19937438|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937439|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937440|NCT01429285|Hydromorphone|hydromorphone|mesh-list
19937441|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19937442|NCT01429285|Narcotics|narcotics|mesh-ancestor
20265506|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20265507|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
20265508|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20265509|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265510|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265511|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
20265512|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265513|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265514|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265515|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937443|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937444|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937445|NCT01429285|Analgesics|analgesics|mesh-ancestor
19937446|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
19937447|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937448|NCT01429298|Hydromorphone|hydromorphone|mesh-list
19937449|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19937450|NCT01429298|Narcotics|narcotics|mesh-ancestor
19937451|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937452|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937453|NCT01429298|Analgesics|analgesics|mesh-ancestor
19937454|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
19937455|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937456|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19937457|NCT01429350|Plasminogen|plasminogen|mesh-list
19937458|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19937459|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19937460|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937461|NCT01429584|Bupivacaine|bupivacaine|mesh-list
19937462|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
19937463|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
19937464|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937465|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937466|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
19937467|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937468|NCT01429792|Ribavirin|ribavirin|mesh-list
19937469|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19937470|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
19937471|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937472|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
19937473|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937474|NCT01429987|Plecanatide|plecanatide|mesh-list
19937475|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20265516|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20265517|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265518|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
20265519|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265520|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20265521|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19937476|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
19937477|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937478|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265522|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
20265523|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265524|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20265525|NCT00516191|Doxorubicin|doxorubicin|mesh-list
20265526|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19937479|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19937480|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19937481|NCT01430104|Teriparatide|teriparatide|mesh-list
19937482|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19937483|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937484|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19937485|NCT01430182|Morphine|morphine|mesh-list
19937486|NCT01430182|Methadone|methadone|mesh-list
19937487|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19937488|NCT01430182|Narcotics|narcotics|mesh-ancestor
19937489|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937490|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937491|NCT01430182|Analgesics|analgesics|mesh-ancestor
19937492|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
19937493|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732647|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
19732648|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
19732649|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732650|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732651|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265527|NCT00516191|Bortezomib|bortezomib|mesh-list
20265528|NCT00516191|Melphalan|melphalan|mesh-list
20265529|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20265530|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265531|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20265532|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20265533|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265534|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265535|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265536|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
20265537|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20542604|NCT01864187|Analgesics|analgesics|mesh-ancestor
19732652|NCT04571151|Halobetasol|halobetasol|mesh-list
19732653|NCT04571151|Calcipotriene|calcipotriene|mesh-list
19732654|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732655|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19732656|NCT04571229|Mifamurtide|mifamurtide|mesh-list
19732657|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19732658|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
19732659|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732660|NCT04570956|Tamoxifen|tamoxifen|mesh-list
19732661|NCT04570956|Afimoxifene|afimoxifene|mesh-list
19732662|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19732663|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
19937494|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
19937495|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937496|NCT01430403|Fluticasone|fluticasone|mesh-list
19937497|NCT01430403|Xhance|xhance|mesh-list
19937498|NCT01430403|Omalizumab|omalizumab|mesh-list
19937499|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19732664|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732665|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732666|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19732667|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732668|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19732669|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19732670|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19732671|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
19732672|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19732673|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732674|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19732675|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732676|NCT04570592|Dexamethasone|dexamethasone|mesh-list
19732677|NCT04570592|Granisetron|granisetron|mesh-list
20265538|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265539|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
20265540|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265541|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20265542|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
19732678|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19732679|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732680|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
19732681|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
19732682|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732683|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732684|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732685|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
19937500|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937501|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19937502|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
19937503|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937504|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937505|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19937506|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937507|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
19937508|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19937509|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
19937510|NCT01430442|Sumatriptan|sumatriptan|mesh-list
19937511|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19937512|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19937513|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19937514|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
19937515|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937516|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937517|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937518|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
19937519|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
19937520|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937521|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19937522|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937523|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937524|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19937525|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19937526|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937527|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937528|NCT01430559|Meloxicam|meloxicam|mesh-list
19937529|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19937530|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19937531|NCT01430559|Analgesics|analgesics|mesh-ancestor
19937532|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
19937533|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937534|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937535|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937536|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265543|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265544|NCT00516243|Protective Agents|protective agents|mesh-ancestor
20265545|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265546|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20265547|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20265548|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265549|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20265550|NCT00516282|Temozolomide|temozolomide|mesh-list
19937537|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19937538|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19937539|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937540|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937541|NCT01430585|Letrozole|letrozole|mesh-list
19937542|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937543|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19937544|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19937545|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937546|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937547|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19937548|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
19937549|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937550|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937551|NCT01430611|Vaccines|vaccines|mesh-list
19937552|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
19937553|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937554|NCT01430819|Vaccines|vaccines|mesh-list
19937555|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
19937556|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937557|NCT01431014|Dexamethasone|dexamethasone|mesh-list
19937558|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
19937559|NCT01431014|BB 1101|bb 1101|mesh-list
20265551|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265552|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
20265553|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265554|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265555|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
20265556|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20265557|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265558|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
20265559|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
20265560|NCT00516399|Natamycin|natamycin|mesh-list
20265561|NCT00516399|Povidone|povidone|mesh-list
20265562|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20265563|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20265564|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
20265565|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
20265566|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20265567|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265568|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20265569|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
20265570|NCT00516412|Everolimus|everolimus|mesh-list
20265571|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265572|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265573|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
20265574|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265575|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
20265576|NCT00516425|Doxorubicin|doxorubicin|mesh-list
20265577|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20265578|NCT00516425|Epirubicin|epirubicin|mesh-list
20265579|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265580|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
20265581|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265582|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265583|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265584|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
20265585|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265586|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265587|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20265588|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20265589|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20265590|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20265591|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265592|NCT00516438|Topotecan|topotecan|mesh-list
20265593|NCT00516438|Olaparib|olaparib|mesh-list
20265594|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20265595|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20265596|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20265597|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265598|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265599|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265600|NCT00516464|Ranibizumab|ranibizumab|mesh-list
19937560|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937561|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
20265601|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19937562|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
19937563|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937564|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937565|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19937566|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
19937567|NCT01431014|Hormones|hormones|mesh-ancestor
19937568|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937569|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19937570|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937571|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
19937572|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937573|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937574|NCT01431105|Atorvastatin|atorvastatin|mesh-list
19937575|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19937576|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19937577|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
19937578|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937579|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19937580|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19937581|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937582|NCT01431170|Trimethoprim|trimethoprim|mesh-list
19937583|NCT01431170|Polymyxins|polymyxins|mesh-list
19937584|NCT01431170|Polymyxin B|polymyxin b|mesh-list
19937585|NCT01431170|Besifloxacin|besifloxacin|mesh-list
19937586|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
19937587|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19937588|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937589|NCT01431170|Renal Agents|renal agents|mesh-ancestor
19937590|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
19937591|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19937592|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19937593|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19937594|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937595|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937596|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19937597|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19937598|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19937599|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937600|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19937601|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19937602|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937603|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19937604|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
19937605|NCT01431274|Olodaterol|olodaterol|mesh-list
19937606|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19937607|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
19937608|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937609|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937610|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19937611|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937612|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
19937613|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19937614|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
19937615|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937616|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937617|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
19937618|NCT01431287|Olodaterol|olodaterol|mesh-list
19937619|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19937620|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
19937621|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937622|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937623|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19937624|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937625|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
19937626|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19937627|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
19937628|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937629|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973612|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
19973613|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973614|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
19973615|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
19973616|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19973617|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19937630|NCT01431339|Vancomycin|vancomycin|mesh-list
19937631|NCT01431339|Linezolid|linezolid|mesh-list
19937632|NCT01431339|Dalbavancin|dalbavancin|mesh-list
19937633|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937634|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937635|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19937636|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937637|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937638|NCT01431391|Leuprolide|leuprolide|mesh-list
19937639|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19937640|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
19937641|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19937642|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937643|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20265602|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20265603|NCT00516464|Growth Substances|growth substances|mesh-ancestor
20265604|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265605|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
20265606|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265607|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19937644|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937645|NCT01431521|Pioglitazone|pioglitazone|mesh-list
19937646|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937647|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937648|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
19937649|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
19937650|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937651|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937652|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937653|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
19937654|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19937655|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937656|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937657|NCT01431716|Epoprostenol|epoprostenol|mesh-list
19937658|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19937659|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19937660|NCT01431755|Lidocaine|lidocaine|mesh-list
19937661|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
19937662|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
19937663|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
19937664|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937665|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937666|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
19937667|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937668|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19937669|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19937670|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19937671|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937672|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937673|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19937674|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
19937675|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
19937676|NCT01431755|Protective Agents|protective agents|mesh-ancestor
19937677|NCT01431794|Gemcitabine|gemcitabine|mesh-list
19937678|NCT01431794|Paclitaxel|paclitaxel|mesh-list
19937679|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19937680|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937681|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
19937682|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
19937683|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
19937684|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937685|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19937686|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
19937687|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
19937688|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265608|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
20265609|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20265610|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
20265611|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20265612|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265613|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20265614|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20265615|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937689|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937690|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19937691|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
19937692|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937693|NCT01431950|Fluticasone|fluticasone|mesh-list
19937694|NCT01431950|Xhance|xhance|mesh-list
19937695|NCT01431950|Albuterol|albuterol|mesh-list
19937696|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937697|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19937698|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
19937699|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937700|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937701|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19937702|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
19937703|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
19937704|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19937705|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
19937706|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19937707|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19937708|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19937709|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19937710|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19937711|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937712|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937713|NCT01431963|Lamotrigine|lamotrigine|mesh-list
19937714|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
19937715|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19937716|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937717|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937718|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19937719|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937720|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19937721|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19937722|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937723|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937724|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19937725|NCT01431976|Lamotrigine|lamotrigine|mesh-list
19937726|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
19937727|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19937728|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937729|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937730|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19937731|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937732|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19937733|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20265616|NCT00516542|Letrozole|letrozole|mesh-list
20265617|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265618|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20265619|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20265620|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265621|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265622|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20265623|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
20265624|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20265625|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265626|NCT00516607|Temozolomide|temozolomide|mesh-list
20265627|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265628|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
20265629|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265630|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265631|NCT00516672|Lapatinib|lapatinib|mesh-list
20265632|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265633|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20265634|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265635|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265636|NCT00516711|Sevoflurane|sevoflurane|mesh-list
20265637|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20265638|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20265639|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
20265640|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
20265641|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265642|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265643|NCT00516750|Doxorubicin|doxorubicin|mesh-list
20542605|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
19937734|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937735|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937736|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19937737|NCT01431989|Amoxicillin|amoxicillin|mesh-list
19937738|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937739|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937740|NCT01432015|Aprepitant|aprepitant|mesh-list
19937741|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
19937742|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
19937743|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
19937744|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937745|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937746|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19937747|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19937748|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937749|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937750|NCT01432145|Methotrexate|methotrexate|mesh-list
19937751|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
19937752|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19937753|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
19937754|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19937755|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937756|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19937757|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
19937758|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937759|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937760|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
19937761|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937762|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19937763|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19937764|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
19937765|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937766|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19937767|NCT01432171|Lacosamide|lacosamide|mesh-list
19937768|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
19937769|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19937770|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19937771|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937772|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265644|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20265645|NCT00516750|Methotrexate|methotrexate|mesh-list
20265646|NCT00516750|Vinblastine|vinblastine|mesh-list
20265647|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265648|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20265649|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20265650|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20265651|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265652|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937773|NCT01432236|Pregabalin|pregabalin|mesh-list
19937774|NCT01432236|Analgesics|analgesics|mesh-ancestor
19937775|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
19937776|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937777|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937778|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
19937779|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19937780|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937781|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937782|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19937783|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19937784|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19937785|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937786|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937787|NCT01432262|Vaccines|vaccines|mesh-list
19937788|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19937789|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
19937790|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937791|NCT01432275|Insulin|insulin|mesh-list
19937792|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937793|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937794|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
19937795|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19937796|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19937797|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20265653|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19937798|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937799|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937800|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
19937801|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937802|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937803|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19937804|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937805|NCT01432405|Pioglitazone|pioglitazone|mesh-list
19937806|NCT01432405|Exenatide|exenatide|mesh-list
19937807|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937808|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937809|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19937810|NCT01432405|Incretins|incretins|mesh-ancestor
19937811|NCT01432405|Hormones|hormones|mesh-ancestor
19937812|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937813|NCT01432444|Aripiprazole|aripiprazole|mesh-list
19937814|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
19937815|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937816|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19937817|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19937818|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937819|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937820|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
19937821|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
19937822|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937823|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937824|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19937825|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19937826|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
19937827|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19937828|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19937829|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19937830|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19937831|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19937832|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19937833|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19937834|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937835|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937836|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19937837|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937838|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
19937839|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19937840|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19937841|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
19937842|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265654|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
20265655|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20265656|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265657|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265658|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
20265659|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265660|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20265661|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265662|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
20265663|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265664|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20542606|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542607|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20542608|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20542609|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20542610|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
20542611|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542612|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542613|NCT01864213|Tetracaine|tetracaine|mesh-list
20542614|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
20542615|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
20542616|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542617|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542618|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
20542619|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542620|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
20542621|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
19937843|NCT01432561|Cysteamine|cysteamine|mesh-list
20265665|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20265666|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
20265667|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
20265668|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19937844|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19937845|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937846|NCT01432574|Vaccines|vaccines|mesh-list
19937847|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
19937848|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937849|NCT01432600|Dexamethasone|dexamethasone|mesh-list
19937850|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
19937851|NCT01432600|Pomalidomide|pomalidomide|mesh-list
19937852|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19937853|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
20265669|NCT00516802|Olaparib|olaparib|mesh-list
20265670|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20265671|NCT00516802|Dacarbazine|dacarbazine|mesh-list
20265672|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265673|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265674|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265675|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20265676|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
20265677|NCT00516828|Cytarabine|cytarabine|mesh-list
20265678|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20265679|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
20265680|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265681|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265682|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
20265683|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265684|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265685|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
20265686|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265687|NCT00516841|Volociximab|volociximab|mesh-list
20265688|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20265689|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20265690|NCT00516841|Growth Substances|growth substances|mesh-ancestor
20265691|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265692|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
20265693|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265694|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
20265695|NCT00516854|Clidinium|clidinium|mesh-list
20265696|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20265697|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20265698|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265699|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265700|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20265701|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20265702|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265703|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
20265704|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
20265705|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265706|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265707|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
20265708|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
20265709|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265710|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
20265711|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20265712|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265713|NCT00516945|Lamivudine|lamivudine|mesh-list
20265714|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20265715|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20265716|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265717|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265718|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
20265719|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265720|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20265721|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20265722|NCT00516958|Levofloxacin|levofloxacin|mesh-list
20265723|NCT00516958|Ofloxacin|ofloxacin|mesh-list
20265724|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20265725|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20265726|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542622|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
19937854|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265727|NCT00516958|Renal Agents|renal agents|mesh-ancestor
20265728|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20265729|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20265730|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20265731|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265732|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265733|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265734|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20265735|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20265736|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
20265737|NCT00516971|Esomeprazole|esomeprazole|mesh-list
20265738|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19937855|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937856|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19937857|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
19937858|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937859|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937860|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19937861|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19937862|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
19937863|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
19937864|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937865|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19937866|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
19937867|NCT01432600|Hormones|hormones|mesh-ancestor
19973618|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
20265739|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265740|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20265741|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265742|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265743|NCT00517062|Hormones|hormones|mesh-list
20265744|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20265745|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265746|NCT00517114|Rabeprazole|rabeprazole|mesh-list
20265747|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20265748|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265749|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20265750|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265751|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265752|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
20265753|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
20265754|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20265755|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20265756|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265757|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265758|NCT00517179|Urological Agents|urological agents|mesh-ancestor
20265759|NCT00517218|Oblimersen|oblimersen|mesh-list
20265760|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265761|NCT00517257|Atorvastatin|atorvastatin|mesh-list
20265762|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20265763|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20265764|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
20265765|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265766|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20265767|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20265768|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265769|NCT00517270|Rabeprazole|rabeprazole|mesh-list
20265770|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20265771|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20265772|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20542623|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542624|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
20542625|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542626|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20542627|NCT01864551|Lamotrigine|lamotrigine|mesh-list
20542628|NCT01864551|Olanzapine|olanzapine|mesh-list
20542629|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
20542630|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
20542631|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542632|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542633|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542634|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20542635|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20542636|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542637|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20542638|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19937868|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937869|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19937870|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19937871|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19937872|NCT01432600|Growth Substances|growth substances|mesh-ancestor
19937873|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
19937874|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19937875|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937876|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937877|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937878|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19937879|NCT01432938|Dulaglutide|dulaglutide|mesh-list
19937880|NCT01432938|Warfarin|warfarin|mesh-list
19937881|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
19937882|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937883|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937884|NCT01433055|Minocycline|minocycline|mesh-list
19937885|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937886|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937887|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
19937888|NCT01433081|Analgesics|analgesics|mesh-ancestor
19937889|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
19937890|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937891|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937892|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
19937893|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19937894|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19937895|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
19937896|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19937897|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19937898|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937899|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19937900|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
19937901|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19937902|NCT01433107|Terbinafine|terbinafine|mesh-list
19937903|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
19937904|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937905|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937906|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937907|NCT01433172|Vaccines|vaccines|mesh-list
19937908|NCT01433172|Immunologic Factors|immunologic factors|mesh-ancestor
19937909|NCT01433172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937910|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19937911|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
19937912|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937913|NCT01433913|Metformin|metformin|mesh-list
19937914|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937915|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937916|NCT01433978|Maleic acid|maleic acid|mesh-list
19937917|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937918|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937919|NCT01433991|Lenvatinib|lenvatinib|mesh-list
19937920|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937921|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19937922|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937923|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937924|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
19937925|NCT01434121|Vitamins|vitamins|mesh-ancestor
19937926|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
19937927|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937928|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
19937929|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937930|NCT01434121|Protective Agents|protective agents|mesh-ancestor
19937931|NCT01434186|Metformin|metformin|mesh-list
19937932|NCT01434186|Saxagliptin|saxagliptin|mesh-list
19937933|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19937934|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937935|NCT01434186|Incretins|incretins|mesh-ancestor
19937936|NCT01434186|Hormones|hormones|mesh-ancestor
19937937|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19937938|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19937939|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
19937940|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937941|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937942|NCT01434342|Nicotine|nicotine|mesh-list
19937943|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19937944|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
19937945|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19937946|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937947|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19937948|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19937949|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
19937950|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450184|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
19450185|NCT03430544|Cariprazine|cariprazine|mesh-list
19450186|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19450187|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19450188|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450189|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450190|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19450191|NCT03430531|Lidocaine|lidocaine|mesh-list
19450192|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
19450193|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
19450194|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450195|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450196|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
19450197|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450198|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19450199|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19450200|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19937951|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937952|NCT01434472|Vidarabine|vidarabine|mesh-list
19937953|NCT01434472|Cyclosporine|cyclosporine|mesh-list
19937954|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
19937955|NCT01434472|Rituximab|rituximab|mesh-list
19937956|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19937957|NCT01434472|Fludarabine|fludarabine|mesh-list
19937958|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
19937959|NCT01434472|Antibodies|antibodies|mesh-list
19937960|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
19937961|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19937962|NCT01434472|Cyclosporins|cyclosporins|mesh-list
19937963|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
19937964|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19937965|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937966|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19937967|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19937968|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
19937969|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937970|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19937971|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
19937972|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19937973|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937974|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
19937975|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
19937976|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19937977|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19937978|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19937979|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
19937980|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19937981|NCT01435018|Tenofovir|tenofovir|mesh-list
19937982|NCT01435018|Emtricitabine|emtricitabine|mesh-list
19937983|NCT01435018|Efavirenz|efavirenz|mesh-list
19937984|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19937985|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19937986|NCT01435018|Paclitaxel|paclitaxel|mesh-list
19937987|NCT01435018|Etoposide|etoposide|mesh-list
19937988|NCT01435018|Vincristine|vincristine|mesh-list
19937989|NCT01435018|Bleomycin|bleomycin|mesh-list
19937990|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19937991|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19937992|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
19937993|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
19937994|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
19937995|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19937996|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20265773|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937997|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19937998|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19937999|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
19938000|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938001|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19938002|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19938003|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19938004|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19938005|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19938006|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19938007|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19938008|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19938009|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19938010|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19938011|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19938012|NCT01435122|Axitinib|axitinib|mesh-list
19938013|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265774|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265775|NCT00517283|Exenatide|exenatide|mesh-list
19938014|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19938015|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938016|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938017|NCT01435174|Ranolazine|ranolazine|mesh-list
19938018|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
19938019|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19938020|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19938021|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938022|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938023|NCT01435382|Bococizumab|bococizumab|mesh-list
19938024|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19938025|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19938026|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
19938027|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938028|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19938029|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19938030|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19938031|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19938032|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19938033|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19938034|NCT01435460|Analgesics|analgesics|mesh-ancestor
19938035|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
19938036|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938037|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938038|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938039|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938040|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19938041|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19938042|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
19938043|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
19938044|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938045|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938046|NCT01435577|Tapentadol|tapentadol|mesh-list
19938047|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19938048|NCT01435577|Narcotics|narcotics|mesh-ancestor
19938049|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938050|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938051|NCT01435577|Analgesics|analgesics|mesh-ancestor
19938052|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
19938053|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938054|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19938055|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19938056|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938057|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938058|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938059|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938060|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
19938061|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19938062|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938063|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19938064|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
19938065|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938066|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19938067|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973619|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
19938068|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19938069|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19938070|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938071|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938072|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
19938073|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938074|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
19938075|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
19938076|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938077|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19938078|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19938079|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938080|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938081|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938082|NCT01435824|Amoxicillin|amoxicillin|mesh-list
19938083|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19938084|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938085|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19938086|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19938087|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19938088|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938089|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938090|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938091|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19938092|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19938093|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19938094|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938095|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938096|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938097|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19938098|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19938099|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
19938100|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19938101|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19938102|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
19938103|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
19938104|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19938105|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938106|NCT01436071|Fluticasone|fluticasone|mesh-list
19938107|NCT01436071|Xhance|xhance|mesh-list
20265776|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20265777|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265778|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20265779|NCT00517283|Incretins|incretins|mesh-ancestor
20265780|NCT00517283|Hormones|hormones|mesh-ancestor
20265781|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20265782|NCT00517309|Vaccines|vaccines|mesh-list
20265783|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
20265784|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265785|NCT00517322|Ramipril|ramipril|mesh-list
20265786|NCT00517322|Irbesartan|irbesartan|mesh-list
20265787|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20265788|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
20265789|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265790|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265791|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20265792|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20265793|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20265794|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20265795|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
20265796|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265797|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20265798|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20265799|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20265800|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265801|NCT00517426|Acetazolamide|acetazolamide|mesh-list
20265802|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
20265803|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20265804|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265805|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265806|NCT00517426|Diuretics|diuretics|mesh-ancestor
20265807|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
20265808|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938108|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938109|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19938110|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
19938111|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938112|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938113|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938114|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938115|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938116|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19938117|NCT01436110|Fluticasone|fluticasone|mesh-list
19938118|NCT01436110|Xhance|xhance|mesh-list
19938119|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938120|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19938121|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
19938122|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938123|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938124|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938125|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938126|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938127|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19938128|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19938129|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19938130|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938131|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19938132|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19938133|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938134|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938135|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
19938136|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938137|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19938138|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
19938139|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938140|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19938141|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938142|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20265809|NCT00517491|Lanreotide|lanreotide|mesh-list
20265810|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265811|NCT00517504|Methylphenidate|methylphenidate|mesh-list
20265812|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20265813|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265814|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20265815|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20265816|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265817|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265818|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
20265819|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265820|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
20265821|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
19938143|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19938144|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938145|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938146|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
19938147|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938148|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19938149|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
19938150|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938151|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19938152|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938153|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19938154|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19938155|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938156|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938157|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
19938158|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938159|NCT01436201|Dulaglutide|dulaglutide|mesh-list
19938160|NCT01436201|Digoxin|digoxin|mesh-list
19938161|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19938162|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19938163|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938164|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265822|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
20265823|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265824|NCT00517582|Icatibant|icatibant|mesh-list
20265825|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20265826|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20265827|NCT00517582|Analgesics|analgesics|mesh-ancestor
20265828|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
20265829|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265830|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265831|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20265832|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265833|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20265834|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20265835|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265836|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20265837|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938165|NCT01436201|Protective Agents|protective agents|mesh-ancestor
19938166|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938167|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19938168|NCT01436266|Folic Acid|folic acid|mesh-list
19938169|NCT01436266|Misoprostol|misoprostol|mesh-list
19938170|NCT01436266|Vitamins|vitamins|mesh-ancestor
19938171|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
19938172|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938173|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19938174|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
19938175|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19938176|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19938177|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938178|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
19938179|NCT01436266|Hematinics|hematinics|mesh-ancestor
19938180|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
19938181|NCT01436279|Mifepristone|mifepristone|mesh-list
19938182|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19938183|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
19938184|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19938185|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938186|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19938187|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19938188|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19938189|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
19938190|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19938191|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19938192|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
19938193|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938194|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
19938195|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19938196|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19938197|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
19938198|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
19938199|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
19938200|NCT01436305|Abatacept|abatacept|mesh-list
19938201|NCT01436305|Tacrolimus|tacrolimus|mesh-list
19938202|NCT01436305|Basiliximab|basiliximab|mesh-list
19938203|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938204|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
19938205|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938206|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19938207|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938208|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938209|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19938210|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938211|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20265838|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
20265839|NCT00517621|Paclitaxel|paclitaxel|mesh-list
19938212|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
19938213|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19938214|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938215|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938216|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
19938217|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
19938218|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938219|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938220|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
19938221|NCT01436305|Hormones|hormones|mesh-ancestor
19938222|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938223|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19938224|NCT01436305|Protective Agents|protective agents|mesh-ancestor
19938225|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19938226|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20265840|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20265841|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265842|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
20265843|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
20265844|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
20265845|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265846|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
20265847|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542639|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20542640|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542641|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542642|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542643|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
20542644|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
20542645|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20542646|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542647|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20542648|NCT01864616|Vitamin D|vitamin d|mesh-list
20542649|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
20542650|NCT01864616|Vitamins|vitamins|mesh-ancestor
20542651|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
20542652|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542653|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20542654|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542655|NCT01864655|Saracatinib|saracatinib|mesh-list
20542656|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542657|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542658|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542659|NCT01864681|Metformin|metformin|mesh-list
20542660|NCT01864681|Gefitinib|gefitinib|mesh-list
19938227|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938228|NCT01436370|Vaccines|vaccines|mesh-list
19938229|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
19938230|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938231|NCT01436500|Ifetroban|ifetroban|mesh-list
19938232|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19973620|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973621|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542661|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542662|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542663|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542664|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20542665|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542666|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542667|NCT01864772|Cetuximab|cetuximab|mesh-list
20542668|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20542669|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542670|NCT01864798|Denosumab|denosumab|mesh-list
20542671|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20542672|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542673|NCT01864824|Vitamins|vitamins|mesh-list
20542674|NCT01864824|Folic Acid|folic acid|mesh-list
20542675|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
20542676|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
20542677|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
20542678|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
20542679|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542680|NCT01864824|Hematinics|hematinics|mesh-ancestor
20542681|NCT01864863|Bosentan|bosentan|mesh-list
20542682|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19973622|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20265848|NCT00517725|Carvedilol|carvedilol|mesh-list
20265849|NCT00517725|Nebivolol|nebivolol|mesh-list
20265850|NCT00517725|Bisoprolol|bisoprolol|mesh-list
20265851|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20265852|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20265853|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
20265854|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265855|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265856|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265857|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20265858|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
20265859|NCT00517725|Protective Agents|protective agents|mesh-ancestor
20265860|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20265861|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265862|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20265863|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
20265864|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20265865|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20265866|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20265867|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20265868|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20265869|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
20265870|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
20265871|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265872|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20265873|NCT00517764|Citalopram|citalopram|mesh-list
20265874|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20265875|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20265876|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265877|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265878|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265879|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
20265880|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265881|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20265882|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
20265883|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265884|NCT00517803|Micronutrients|micronutrients|mesh-list
20265885|NCT00517803|Trace Elements|trace elements|mesh-list
20265886|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287196|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287197|NCT05324215|Analgesics|analgesics|mesh-ancestor
20287198|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
20287199|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287200|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20287201|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20287202|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
20287203|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
20287204|NCT05320991|Ketamine|ketamine|mesh-list
20287205|NCT05320991|Analgesics|analgesics|mesh-ancestor
20287206|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
20287207|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287208|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287209|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20287210|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20287211|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
20287212|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
20287213|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287214|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20287215|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20287216|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287217|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287218|NCT05315024|Imiquimod|imiquimod|mesh-list
20287219|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20287220|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
20287221|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287222|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287223|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
20287224|NCT05287360|Apatinib|apatinib|mesh-list
20287225|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287226|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287227|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287228|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287229|NCT05280743|Oxycodone|oxycodone|mesh-list
20287230|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20265887|NCT00517946|Cetirizine|cetirizine|mesh-list
20265888|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
20265889|NCT00517946|Ephedrine|ephedrine|mesh-list
20265890|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20265891|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20265892|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20265893|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
20265894|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
20265895|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265896|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265897|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265898|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20265899|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
20265900|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265901|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938233|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
19938234|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19938235|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
19938236|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19938237|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
19938238|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938239|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938240|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
19938241|NCT01436643|Fluoxetine|fluoxetine|mesh-list
19938242|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19938243|NCT01436643|Citalopram|citalopram|mesh-list
19938244|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19938245|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19938246|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19938247|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938248|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938249|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938250|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
19938251|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938252|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19938253|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
19938254|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938255|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19938256|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19938257|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938258|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19938259|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19938260|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938261|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
19938262|NCT01436799|Alfentanil|alfentanil|mesh-list
19938263|NCT01436799|Propofol|propofol|mesh-list
19938264|NCT01436799|Desflurane|desflurane|mesh-list
19938265|NCT01436799|Rocuronium|rocuronium|mesh-list
19938266|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19938267|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938268|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938269|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19938270|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
19938271|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
19938272|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19938273|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19938274|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19938275|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938276|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20265902|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
20265903|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
19938277|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19938278|NCT01436799|Narcotics|narcotics|mesh-ancestor
19938279|NCT01436799|Analgesics|analgesics|mesh-ancestor
19938280|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
19938281|NCT01437267|Vaccines|vaccines|mesh-list
19938282|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19938283|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
19938284|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938285|NCT01437397|Bromides|bromides|mesh-list
19938286|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
19938287|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19938288|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
19938289|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938290|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938291|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938292|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
20265904|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20265905|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20265906|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
20265907|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
20265908|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20265909|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19732686|NCT04570592|Hormones|hormones|mesh-ancestor
19732687|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732688|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19732689|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265910|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20265911|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265912|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265913|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265914|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265915|NCT00517985|Analgesics|analgesics|mesh-ancestor
20265916|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
20265917|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265918|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
20265919|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20265920|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
20265921|NCT00518102|Becaplermin|becaplermin|mesh-list
20265922|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
20265923|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
20265924|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20265925|NCT00518102|Growth Substances|growth substances|mesh-ancestor
20265926|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265927|NCT00518141|Aspirin|aspirin|mesh-list
20265928|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
20265929|NCT00518141|Salicylates|salicylates|mesh-list
20265930|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265931|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
20265932|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
20265933|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
20265934|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20265935|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20265936|NCT00518141|Analgesics|analgesics|mesh-ancestor
20265937|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
20265938|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20265939|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265940|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20265941|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20265942|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20265943|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265944|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265945|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20265946|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20265947|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20265948|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
20265949|NCT00518193|Cetuximab|cetuximab|mesh-list
20265950|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20265951|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265952|NCT00518232|Methylphenidate|methylphenidate|mesh-list
20265953|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20265954|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265955|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20265956|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20265957|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20265958|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265959|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
20265960|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265961|NCT00518245|Enoxaparin|enoxaparin|mesh-list
20265962|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
20265963|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20265964|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19732690|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19732691|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
19732692|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732693|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732694|NCT04570475|Vitamin D|vitamin d|mesh-list
19732695|NCT04570475|Vitamins|vitamins|mesh-ancestor
19732696|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
19732697|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732698|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19732699|NCT04570683|Nivolumab|nivolumab|mesh-list
19732700|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19732701|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732702|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19732703|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732704|NCT04570449|Fluoxetine|fluoxetine|mesh-list
19732705|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19732706|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19732707|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732708|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732709|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732710|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
19732711|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732712|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19732713|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
19732714|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19732715|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19732716|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19732717|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732718|NCT04570410|Gemcitabine|gemcitabine|mesh-list
19732719|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732720|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19732721|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
19732722|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732723|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
19732724|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938293|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19938294|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19938295|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19938296|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938297|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938298|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938299|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
19938300|NCT01437449|Carboplatin|carboplatin|mesh-list
19938301|NCT01437449|Docetaxel|docetaxel|mesh-list
19938302|NCT01437449|Cetuximab|cetuximab|mesh-list
19938303|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938304|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
19938305|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
19938306|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
19938307|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938308|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19938309|NCT01437540|Bromides|bromides|mesh-list
19938310|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
19938311|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19938312|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
19938313|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938314|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938315|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938316|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938317|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19938318|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19938319|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19938320|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938321|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938322|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938323|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
19938324|NCT01437605|Poly I-C|poly i-c|mesh-list
19938325|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
19938326|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
19938327|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938328|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
19938329|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938330|NCT01437878|Iloprost|iloprost|mesh-list
19938331|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19938332|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
19938333|NCT01437995|Fluticasone|fluticasone|mesh-list
19938334|NCT01437995|Xhance|xhance|mesh-list
19938335|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19938336|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19938337|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938338|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19938339|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
19938340|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938341|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938342|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938343|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938344|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938345|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19938346|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19938347|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19938348|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19938349|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938350|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938351|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938352|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
19938353|NCT01437995|Hormones|hormones|mesh-ancestor
19938354|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938355|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
19938356|NCT01438060|Aripiprazole|aripiprazole|mesh-list
19938357|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
19938358|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938359|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19938360|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19938361|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938362|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938363|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
19938364|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
19938365|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938366|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450201|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19450202|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450203|NCT03430518|Durvalumab|durvalumab|mesh-list
19450204|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19450205|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450206|NCT03430505|Albuterol|albuterol|mesh-list
19450207|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19450208|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
19450209|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450210|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450211|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19450212|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
19450213|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
19450214|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19450215|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19450216|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19450217|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19938367|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19938368|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19938369|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
19938370|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19938371|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19938372|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19938373|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19938374|NCT01438151|Infliximab|infliximab|mesh-list
19938375|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938376|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938377|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938378|NCT01438177|Chloroquine|chloroquine|mesh-list
19938379|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
19938380|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19938381|NCT01438177|Bortezomib|bortezomib|mesh-list
19938382|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938383|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
19938384|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938385|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938386|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19938387|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
19938388|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938389|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938390|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19938391|NCT01438177|Amebicides|amebicides|mesh-ancestor
19938392|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19938393|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19938394|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938395|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
19938396|NCT01438411|Cholic Acids|cholic acids|mesh-list
19938397|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938398|NCT01438424|Lamivudine|lamivudine|mesh-list
19938399|NCT01438424|Entecavir|entecavir|mesh-list
19938400|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19938401|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19938402|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938403|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938404|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
20265965|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938405|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938406|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19938407|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19938408|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19938409|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
19938410|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938411|NCT01438710|Tacrolimus|tacrolimus|mesh-list
19938412|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938413|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
19938414|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938415|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19938416|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938417|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938418|NCT01438814|Metformin|metformin|mesh-list
19938419|NCT01438814|Linagliptin|linagliptin|mesh-list
19938420|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19938421|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938422|NCT01438814|Incretins|incretins|mesh-ancestor
19938423|NCT01438814|Hormones|hormones|mesh-ancestor
19938424|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938425|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19938426|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
19938427|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938428|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938429|NCT01438840|Maleic acid|maleic acid|mesh-list
19938430|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938431|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938432|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
19938433|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19938434|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938435|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938436|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19938437|NCT01438957|Analgesics|analgesics|mesh-ancestor
19938438|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
19938439|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938440|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20265966|NCT00518271|Sirolimus|sirolimus|mesh-list
20265967|NCT00518271|Tacrolimus|tacrolimus|mesh-list
20265968|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20265969|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
20265970|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20265971|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20265972|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287231|NCT05280743|Narcotics|narcotics|mesh-ancestor
20287232|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287233|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287234|NCT05280743|Analgesics|analgesics|mesh-ancestor
20287235|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
20287236|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287237|NCT05273541|Vaccines|vaccines|mesh-list
20287238|NCT05273541|Immunologic Factors|immunologic factors|mesh-ancestor
20287239|NCT05273541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287240|NCT05263453|Vemurafenib|vemurafenib|mesh-list
20287241|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287242|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287243|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287244|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287245|NCT05242874|Dexamethasone|dexamethasone|mesh-list
20287246|NCT05242874|Olanzapine|olanzapine|mesh-list
20287247|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
20287248|NCT05242874|Aprepitant|aprepitant|mesh-list
19938441|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19938442|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19938443|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938444|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938445|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938446|NCT01439009|Tolvaptan|tolvaptan|mesh-list
19938447|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19938448|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938449|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
19938450|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938451|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
19938452|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19938453|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19938454|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938455|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19938456|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19938457|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
19938458|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19938459|NCT01439126|Clonidine|clonidine|mesh-list
19938460|NCT01439126|Analgesics|analgesics|mesh-ancestor
19938461|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
19938462|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938463|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938464|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19938465|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
19938466|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
19938467|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19938468|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19938469|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19938470|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938471|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20265973|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265974|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19938472|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938473|NCT01439204|Abatacept|abatacept|mesh-list
19938474|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19938475|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938476|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938477|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938478|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
19938479|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938480|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938481|NCT01439282|Capecitabine|capecitabine|mesh-list
19938482|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19938483|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
19938484|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938485|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938486|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19938487|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
19938488|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938489|NCT01439373|Interferons|interferons|mesh-list
19938490|NCT01439373|Ribavirin|ribavirin|mesh-list
19938491|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
19938492|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
19938493|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20265975|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265976|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20265977|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20265978|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
20265979|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
20265980|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20265981|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20265982|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20265983|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
20265984|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20265985|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20265986|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20265987|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265988|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265989|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20265990|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20265991|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
19938494|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938495|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
19938496|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938497|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
19938498|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938499|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
19938500|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938501|NCT01439555|Simvastatin|simvastatin|mesh-list
19938502|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19938503|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19938504|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
19938505|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938506|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19938507|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19938508|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938509|NCT01439568|Carboplatin|carboplatin|mesh-list
19938510|NCT01439568|Etoposide|etoposide|mesh-list
19938511|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938512|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19938513|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19938514|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19938515|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938516|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938517|NCT01439672|Insulin|insulin|mesh-list
19938518|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19938519|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938520|NCT01439711|Letrozole|letrozole|mesh-list
19938521|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938522|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19938523|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19938524|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938525|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938526|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19938527|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
19938528|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938529|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938530|NCT01439815|Fluticasone|fluticasone|mesh-list
19938531|NCT01439815|Xhance|xhance|mesh-list
19938532|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938533|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19938534|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
19938535|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938536|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938537|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938538|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938539|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938540|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19938541|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
19938542|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20265992|NCT00518375|Cyclosporine|cyclosporine|mesh-list
20265993|NCT00518375|Sirolimus|sirolimus|mesh-list
20265994|NCT00518375|Cyclosporins|cyclosporins|mesh-list
20265995|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20265996|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20265997|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938543|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938544|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19938545|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938546|NCT01439867|Cinacalcet|cinacalcet|mesh-list
19938547|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19938548|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938549|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19938550|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
19938551|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938552|NCT01439880|Evolocumab|evolocumab|mesh-list
19938553|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19938554|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19938555|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
19938556|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938557|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19938558|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
20265998|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
20265999|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266000|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
19938559|NCT01439945|Antacids|antacids|mesh-ancestor
19938560|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938561|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938562|NCT01440101|Natalizumab|natalizumab|mesh-list
19938563|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
19938564|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938565|NCT01440569|Darunavir|darunavir|mesh-list
19938566|NCT01440569|Cobicistat|cobicistat|mesh-list
19938567|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19938568|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19938569|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
19938570|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938571|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938572|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19938573|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19732725|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732726|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732727|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
19938574|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
19938575|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938576|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19938577|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20266001|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266002|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
20266003|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266004|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20266005|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20266006|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20266007|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938578|NCT01440764|Furosemide|furosemide|mesh-list
19938579|NCT01440764|Diuretics|diuretics|mesh-ancestor
19938580|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
19938581|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938582|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19938583|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938584|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938585|NCT01440803|Teriparatide|teriparatide|mesh-list
19938586|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19938587|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938588|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19938589|NCT01440816|Interleukin-12|interleukin-12|mesh-list
19938590|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19938591|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
19938592|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938593|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19938594|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19938595|NCT01440816|Growth Substances|growth substances|mesh-ancestor
19938596|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
19938597|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938598|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19938599|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
19938600|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938601|NCT01441037|Danazol|danazol|mesh-list
19938602|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19938603|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
19938604|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19973623|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
20266008|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
19732728|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732729|NCT04570397|Ravulizumab|ravulizumab|mesh-list
19732730|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19732731|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732732|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
19732733|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732734|NCT04570345|Aspirin|aspirin|mesh-list
19732735|NCT04570345|Ticagrelor|ticagrelor|mesh-list
19732736|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19732737|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732738|NCT04570345|Analgesics|analgesics|mesh-ancestor
19732739|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
19732740|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732741|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732742|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732743|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266009|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266010|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938605|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938606|NCT01441063|Zidovudine|zidovudine|mesh-list
19938607|NCT01441063|Valganciclovir|valganciclovir|mesh-list
19938608|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
19938609|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938610|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19938611|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19938612|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938613|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
19938614|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938615|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19938616|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19938617|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19938618|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938619|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
19938620|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
19938621|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938622|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19938623|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19938624|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938625|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938626|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938627|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
19938628|NCT01441180|Ribavirin|ribavirin|mesh-list
19938629|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
19938630|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938631|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
19938632|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938633|NCT01441245|Furosemide|furosemide|mesh-list
19938634|NCT01441245|Diuretics|diuretics|mesh-ancestor
19938635|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
19938636|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938637|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19938638|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938639|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938640|NCT01441401|Gabapentin|gabapentin|mesh-list
19938641|NCT01441401|Analgesics|analgesics|mesh-ancestor
19938642|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
19938643|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938644|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938645|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
19938646|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19938647|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19938648|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938649|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938650|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19938651|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19938652|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938653|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938654|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
19938655|NCT01441414|Axitinib|axitinib|mesh-list
19938656|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938657|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19938658|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938659|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938660|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19938661|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20266011|NCT00518466|Topiramate|topiramate|mesh-list
20266012|NCT00518466|Phentermine|phentermine|mesh-list
20266013|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
20266014|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266015|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266016|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20266017|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
20266018|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20266019|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
20266020|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
20266021|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266022|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
20266023|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266024|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266025|NCT00518479|Amlodipine|amlodipine|mesh-list
19938662|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19938663|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938664|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938665|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938666|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938667|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19938668|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
19938669|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938670|NCT01441570|Metoprolol|metoprolol|mesh-list
19938671|NCT01441570|Nebivolol|nebivolol|mesh-list
19938672|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19938673|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19938674|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
19938675|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
19938676|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938677|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938678|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19938679|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19938680|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19938681|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
19938682|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938683|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938684|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
20266026|NCT00518479|Valsartan|valsartan|mesh-list
20266027|NCT00518479|Moxonidine|moxonidine|mesh-list
20266028|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
20266029|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20266030|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20266031|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266032|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266033|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20266034|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266035|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
20266036|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20266037|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20266038|NCT00518479|Diuretics|diuretics|mesh-ancestor
20266039|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
20266040|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20266041|NCT00518570|Levetiracetam|levetiracetam|mesh-list
20266042|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
20266043|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
20266044|NCT00518583|Paclitaxel|paclitaxel|mesh-list
20266045|NCT00518583|Doxorubicin|doxorubicin|mesh-list
20266046|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20266047|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20266048|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266049|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
20266050|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
20266051|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
20266052|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266053|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20266054|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20266055|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20266056|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266057|NCT00518635|Insulin|insulin|mesh-list
20266058|NCT00518635|Hormones|hormones|mesh-list
20266059|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266060|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266061|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20266062|NCT00518895|Dacarbazine|dacarbazine|mesh-list
20266063|NCT00518895|Oblimersen|oblimersen|mesh-list
20266064|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20266065|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
20266066|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266067|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266068|NCT00518908|Sevoflurane|sevoflurane|mesh-list
20266069|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20266070|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20266071|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
20266072|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
20266073|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973624|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938685|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19938686|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19938687|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19938688|NCT01441596|Vinorelbine|vinorelbine|mesh-list
19938689|NCT01441596|Afatinib|afatinib|mesh-list
19938690|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19938691|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938692|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
19938693|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
19938694|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19938695|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938696|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19938697|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938698|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19938699|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19938700|NCT01441635|Norethindrone|norethindrone|mesh-list
19938701|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
19938702|NCT01441635|Estradiol|estradiol|mesh-list
19938703|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19938704|NCT01441635|Progesterone|progesterone|mesh-list
19938705|NCT01441635|Estrogens|estrogens|mesh-ancestor
19938706|NCT01441635|Hormones|hormones|mesh-ancestor
19938707|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938708|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938709|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19938710|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
19938711|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19938712|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19938713|NCT01441635|Progestins|progestins|mesh-ancestor
19938714|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19938715|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19938716|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19938717|NCT01441765|Pidilizumab|pidilizumab|mesh-list
19938718|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19938719|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938720|NCT01441843|Lorazepam|lorazepam|mesh-list
19938721|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
19938722|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
19938723|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
19938724|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938725|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938726|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938727|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19938728|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938729|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19938730|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19938731|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938732|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
19938733|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
19938734|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938735|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938736|NCT01441882|Dasatinib|dasatinib|mesh-list
19938737|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938738|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19938739|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938740|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938741|NCT01441960|Rocuronium|rocuronium|mesh-list
19938742|NCT01441960|Succinylcholine|succinylcholine|mesh-list
19938743|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19938744|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19938745|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19938746|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938747|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938748|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19938749|NCT01441973|Elotuzumab|elotuzumab|mesh-list
19938750|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938751|NCT01442038|Ranolazine|ranolazine|mesh-list
19938752|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19938753|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938754|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938755|NCT01442064|Ranibizumab|ranibizumab|mesh-list
19938756|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19938757|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19938758|NCT01442064|Growth Substances|growth substances|mesh-ancestor
19938759|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938760|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
19938761|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938762|NCT01442155|Capecitabine|capecitabine|mesh-list
19938763|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
19938764|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19938765|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
19938766|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938767|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973625|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19973626|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19973627|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
19973628|NCT01826370|Linagliptin|linagliptin|mesh-list
19973629|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19973630|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973631|NCT01826370|Incretins|incretins|mesh-ancestor
19973632|NCT01826370|Hormones|hormones|mesh-ancestor
19973633|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19973634|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19973635|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
19973636|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973637|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973638|NCT01826448|Vemurafenib|vemurafenib|mesh-list
19973639|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973640|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973641|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973642|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973643|NCT01826851|Bupivacaine|bupivacaine|mesh-list
19973644|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
20266074|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542683|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20542684|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542685|NCT01864915|Prucalopride|prucalopride|mesh-list
20542686|NCT01864915|Laxatives|laxatives|mesh-ancestor
20542687|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19973645|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
19973646|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973647|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973648|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
19973649|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973650|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
19973651|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
19973652|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973653|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19973654|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19973655|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19973656|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975433|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975434|NCT01849055|Celecoxib|celecoxib|mesh-list
19975435|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19975436|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19975437|NCT01849055|Analgesics|analgesics|mesh-ancestor
19975438|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
19975439|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542688|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20542689|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20542690|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
19975440|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975441|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975442|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975443|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20266075|NCT00518947|Verapamil|verapamil|mesh-list
20266076|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
20266077|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
20266078|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266079|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266080|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266081|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
20266082|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20266083|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266084|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266085|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20266086|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20266087|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938768|NCT01442376|Ondansetron|ondansetron|mesh-list
19938769|NCT01442376|Palonosetron|palonosetron|mesh-list
19938770|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
19938771|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
19938772|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938773|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938774|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938775|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
19938776|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938777|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19938778|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
19938779|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938780|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938781|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19938782|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19938783|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938784|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19938785|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19938786|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19938787|NCT01442493|Methadone|methadone|mesh-list
19938788|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19938789|NCT01442493|Narcotics|narcotics|mesh-ancestor
19938790|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938791|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938792|NCT01442493|Analgesics|analgesics|mesh-ancestor
19938793|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
19938794|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938795|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
19938796|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938797|NCT01442688|Amoxicillin|amoxicillin|mesh-list
19938798|NCT01442688|Mesalamine|mesalamine|mesh-list
19938799|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19938800|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938801|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19938802|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19938803|NCT01442688|Analgesics|analgesics|mesh-ancestor
19938804|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
19938805|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938806|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938807|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938808|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938809|NCT01442714|Lenalidomide|lenalidomide|mesh-list
19938810|NCT01442714|Azacitidine|azacitidine|mesh-list
19938811|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
19938812|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938813|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19938814|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19938815|NCT01442714|Growth Substances|growth substances|mesh-ancestor
19938816|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
19938817|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938818|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19938819|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
19938820|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938821|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938822|NCT01442779|Interferons|interferons|mesh-list
19938823|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
19938824|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938825|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
19938826|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938827|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
19938828|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938829|NCT01443026|Lycopene|lycopene|mesh-list
19938830|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938831|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
19938832|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938833|NCT01443026|Protective Agents|protective agents|mesh-ancestor
19938834|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938835|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19938836|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19938837|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938838|NCT01443078|Gemcitabine|gemcitabine|mesh-list
19938839|NCT01443078|Carboplatin|carboplatin|mesh-list
19938840|NCT01443078|Docetaxel|docetaxel|mesh-list
19938841|NCT01443078|Pemetrexed|pemetrexed|mesh-list
19938842|NCT01443078|Vinorelbine|vinorelbine|mesh-list
19938843|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938844|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19938845|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
19938846|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938847|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
19938848|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266088|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20266089|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
20266090|NCT00519012|Sertraline|sertraline|mesh-list
20266091|NCT00519012|Paroxetine|paroxetine|mesh-list
20266092|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
20266093|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266094|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20266095|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20266096|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266097|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266098|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266099|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
20266100|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266101|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20266102|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20266103|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20266104|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266105|NCT00519051|Fluoxetine|fluoxetine|mesh-list
20266106|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
20266107|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20266108|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20266109|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266110|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266111|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266112|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
20266113|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266114|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20266115|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266116|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20266117|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20266118|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266119|NCT00519116|Sirolimus|sirolimus|mesh-list
20266120|NCT00519116|Tacrolimus|tacrolimus|mesh-list
20266121|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266122|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
20266123|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266124|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20266125|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266126|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266127|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20266128|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266129|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20266130|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266131|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
20266132|NCT00519181|Valproic Acid|valproic acid|mesh-list
19938849|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938850|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938851|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
19938852|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938853|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
19938854|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
19938855|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
19938856|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19938857|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19938858|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19938859|NCT01443130|Chloroquine|chloroquine|mesh-list
19938860|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
19938861|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
19938862|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19938863|NCT01443130|Amebicides|amebicides|mesh-ancestor
19938864|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19938865|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19938866|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938867|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
19938868|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938869|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19938870|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973657|NCT01827163|Paclitaxel|paclitaxel|mesh-list
19938871|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938872|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19938873|NCT01443130|Renal Agents|renal agents|mesh-ancestor
19938874|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
19938875|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938876|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
19938877|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938878|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938879|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19938880|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
19938881|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19938882|NCT01443546|Leuprolide|leuprolide|mesh-list
19938883|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19938884|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
19938885|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19938886|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938887|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19938888|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938889|NCT01443858|Meclizine|meclizine|mesh-list
19938890|NCT01443858|Nicotine|nicotine|mesh-list
19938891|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19938892|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
19938893|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938894|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938895|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19938896|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19938897|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
19938898|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19938899|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938900|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
19938901|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19938902|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19938903|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
19938904|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
19938905|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19938906|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
19938907|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19938908|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19938909|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938910|NCT01444430|Budesonide|budesonide|mesh-list
19938911|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19938912|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938913|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19938914|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
19938915|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938916|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938917|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19938918|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
19938919|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
19938920|NCT01444430|Hormones|hormones|mesh-ancestor
19938921|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938922|NCT01444651|Tadalafil|tadalafil|mesh-list
19938923|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
19938924|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19938925|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19938926|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938927|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938928|NCT01444651|Urological Agents|urological agents|mesh-ancestor
19938929|NCT01444716|Ofatumumab|ofatumumab|mesh-list
19938930|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19938931|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938932|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
19938933|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938934|NCT01444742|Cytarabine|cytarabine|mesh-list
19938935|NCT01444742|Clofarabine|clofarabine|mesh-list
19938936|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19938937|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
19938938|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938939|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938940|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
19938941|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19938942|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938943|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
19938944|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938945|NCT01444781|Vaccines|vaccines|mesh-list
19938946|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19938947|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
19938948|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938949|NCT01444898|Exenatide|exenatide|mesh-list
19938950|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19938951|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938952|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19938953|NCT01444898|Incretins|incretins|mesh-ancestor
19938954|NCT01444898|Hormones|hormones|mesh-ancestor
19938955|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938956|NCT01444924|Bupivacaine|bupivacaine|mesh-list
19938957|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
19938958|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
19938959|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19938960|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938961|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
19938962|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19938963|NCT01445028|Isotretinoin|isotretinoin|mesh-list
19938964|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
19938965|NCT01445080|Sorafenib|sorafenib|mesh-list
19938966|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938967|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19938968|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938969|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938970|NCT01445535|Prednisone|prednisone|mesh-list
19938971|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
19938972|NCT01445535|Rituximab|rituximab|mesh-list
19938973|NCT01445535|Doxorubicin|doxorubicin|mesh-list
19938974|NCT01445535|Etoposide|etoposide|mesh-list
19938975|NCT01445535|Vincristine|vincristine|mesh-list
19938976|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19938977|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
19938978|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19938979|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19938980|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19938981|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
19938982|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19938983|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19938984|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19938985|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19938986|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19938987|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19938988|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19938989|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19938990|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19938991|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
19938992|NCT01445535|Hormones|hormones|mesh-ancestor
19938993|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19938994|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19938995|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19938996|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
19938997|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
19938998|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
19938999|NCT01445548|Sirolimus|sirolimus|mesh-list
19939000|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19939001|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939002|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19939003|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939004|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
19939005|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939006|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
19939007|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939008|NCT01445626|Dexamethasone|dexamethasone|mesh-list
19939009|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939010|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
20266133|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
20266134|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266135|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266136|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
20266137|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266138|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939011|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
19939012|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939013|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939014|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266139|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
19939015|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
19939016|NCT01445626|Hormones|hormones|mesh-ancestor
19939017|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939018|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19939019|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939020|NCT01445678|Metronidazole|metronidazole|mesh-list
19939021|NCT01445678|Meropenem|meropenem|mesh-list
19939022|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939023|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19939024|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19939025|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19939026|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
19939027|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19939028|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
19939029|NCT01445821|Fludarabine|fludarabine|mesh-list
19939030|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
19939031|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939032|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
19939033|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939034|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19939035|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19939036|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
19939037|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939038|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939039|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19939040|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939041|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
19939042|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
19939043|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939044|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939045|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
19939046|NCT01445821|Hormones|hormones|mesh-ancestor
19939047|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939048|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19939049|NCT01445821|Protective Agents|protective agents|mesh-ancestor
19939050|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19939051|NCT01445847|Lidocaine|lidocaine|mesh-list
19939052|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
19939053|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
19939054|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939055|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939056|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
19939057|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939058|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19939059|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19939060|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19939061|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19939062|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939063|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
19939064|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19939065|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939066|NCT01445886|Calcitriol|calcitriol|mesh-list
19939067|NCT01445886|Calcipotriene|calcipotriene|mesh-list
19939068|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939069|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19939070|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939071|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19939072|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19939073|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939074|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19939075|NCT01445886|Vitamins|vitamins|mesh-ancestor
19939076|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
19939077|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19939078|NCT01445951|Insulin|insulin|mesh-list
19939079|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19939080|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
19939081|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939082|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939083|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
19939084|NCT01446042|Testosterone|testosterone|mesh-list
19939085|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
19939086|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
20266140|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20266141|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266142|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19939087|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19939088|NCT01446042|Androgens|androgens|mesh-ancestor
19939089|NCT01446042|Hormones|hormones|mesh-ancestor
19939090|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939091|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939092|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19939093|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939094|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
19939095|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19939096|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19939097|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939098|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939099|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19939100|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
19939101|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939102|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939103|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19939104|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939105|NCT01446809|Doxorubicin|doxorubicin|mesh-list
19939106|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19939107|NCT01446809|Ifosfamide|ifosfamide|mesh-list
19939108|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
19939109|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19939110|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939111|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19939112|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19939113|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939114|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939115|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19939116|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
19939117|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
19939118|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19939119|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939120|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
19939121|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
19939122|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19939123|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939124|NCT01447225|Gemcitabine|gemcitabine|mesh-list
19939125|NCT01447225|Carboplatin|carboplatin|mesh-list
19939126|NCT01447225|Pemetrexed|pemetrexed|mesh-list
19939127|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939128|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19939129|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
19939130|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939131|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
19939132|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939133|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939134|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939135|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
19939136|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939137|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19939138|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19939139|NCT01447407|Vaccines|vaccines|mesh-list
19939140|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
19939141|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
19939142|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939143|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19939144|NCT01447420|Ribavirin|ribavirin|mesh-list
19939145|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19939146|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
19939147|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939148|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
19939149|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939150|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
19939151|NCT01447433|Calcium|calcium|mesh-list
19939152|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19939153|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939154|NCT01447433|Antacids|antacids|mesh-ancestor
19939155|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939156|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939157|NCT01447446|Ribavirin|ribavirin|mesh-list
19939158|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
19939159|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
19939160|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19939161|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19939162|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19939163|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
19939164|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939165|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
19939166|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939167|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
19939168|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939169|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939170|NCT01447511|Rifampin|rifampin|mesh-list
20266143|NCT00519207|Lidocaine|lidocaine|mesh-list
20266144|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
20266145|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
20266146|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266147|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266148|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
20266149|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266150|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20266151|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20266152|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20266153|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266154|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266155|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20266156|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
20266157|NCT00519246|Narcotics|narcotics|mesh-ancestor
20266158|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266159|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266160|NCT00519246|Analgesics|analgesics|mesh-ancestor
20266161|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
20266162|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266163|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266164|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266165|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266166|NCT00519259|Lobeline|lobeline|mesh-list
20266167|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20266168|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
20266169|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266170|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266171|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20266172|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20266173|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
20266174|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266175|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266176|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
20266177|NCT00519298|Donepezil|donepezil|mesh-list
20266178|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20266179|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266180|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266181|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
20266182|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266183|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266184|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
20266185|NCT00519324|Everolimus|everolimus|mesh-list
20266186|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266187|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266188|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
20266189|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266190|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
20266191|NCT00519337|Vitamins|vitamins|mesh-ancestor
20266192|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
20266193|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266194|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
20266195|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266196|NCT00519337|Protective Agents|protective agents|mesh-ancestor
20266197|NCT00519363|Atorvastatin|atorvastatin|mesh-list
20266198|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20266199|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20266200|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
20266201|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266202|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20266203|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20266204|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266205|NCT00519467|Artesunate|artesunate|mesh-list
20266206|NCT00519467|Dapsone|dapsone|mesh-list
20266207|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
19939171|NCT01447511|Fluconazole|fluconazole|mesh-list
20266208|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
19939172|NCT01447511|Warfarin|warfarin|mesh-list
19939173|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
19939174|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19939175|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
19939176|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19939177|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939178|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
19939179|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19939180|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939181|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939182|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19939183|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19939184|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19939185|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19939186|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19939187|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19939188|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
19939189|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19939190|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19939191|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19939192|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
19939193|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939194|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939195|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19939196|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19939197|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
19939198|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19939199|NCT01447706|Paclitaxel|paclitaxel|mesh-list
19939200|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19939201|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939202|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
19939203|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
19939204|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
19939205|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939206|NCT01447849|Lubiprostone|lubiprostone|mesh-list
19939207|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19939208|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19939209|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939210|NCT01447888|Morphine|morphine|mesh-list
19939211|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19939212|NCT01447888|Narcotics|narcotics|mesh-ancestor
19939213|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939214|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939215|NCT01447888|Analgesics|analgesics|mesh-ancestor
19939216|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
20266209|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20266210|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20266211|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266212|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266213|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
20266214|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
20266215|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20266216|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
20266217|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20266218|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266219|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266220|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
20266221|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20266222|NCT00519480|Metformin|metformin|mesh-list
20266223|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266224|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266225|NCT00519519|Omeprazole|omeprazole|mesh-list
20266226|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20266227|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266228|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20266229|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266230|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287249|NCT05242874|Antiemetics|antiemetics|mesh-list
20287250|NCT05242874|Tropisetron|tropisetron|mesh-list
20287251|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287252|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
20287253|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287254|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939217|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939218|NCT01447927|Metformin|metformin|mesh-list
19939219|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939220|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939221|NCT01448044|Interferons|interferons|mesh-list
19939222|NCT01448044|Ribavirin|ribavirin|mesh-list
19939223|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
19939224|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
19939225|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19939226|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939227|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
19939228|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939229|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
19939230|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939231|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
19939232|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939233|NCT01448057|Acetaminophen|acetaminophen|mesh-list
19939234|NCT01448057|Dimethindene|dimethindene|mesh-list
19939235|NCT01448057|Phenylephrine|phenylephrine|mesh-list
19939236|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
19939237|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19939238|NCT01448057|Analgesics|analgesics|mesh-ancestor
19939239|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
19939240|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939241|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939242|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
19939243|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939244|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19939245|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
19939246|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
19939247|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
19939248|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19939249|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
19939250|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
19939251|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19939252|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19939253|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19939254|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
19939255|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939256|NCT01448057|Protective Agents|protective agents|mesh-ancestor
19939257|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
19939258|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939259|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19939260|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
19939261|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
19939262|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19939263|NCT01448213|Fluorometholone|fluorometholone|mesh-list
19939264|NCT01448213|Prednisolone|prednisolone|mesh-list
19939265|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19939266|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
19939267|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19939268|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
19939269|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19939270|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
19939271|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939272|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
19939273|NCT01448213|Hormones|hormones|mesh-ancestor
19939274|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939275|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939276|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19939277|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939278|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
19939279|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
19939280|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939281|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939282|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19939283|NCT01448213|Protective Agents|protective agents|mesh-ancestor
19939284|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19939285|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
19939286|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19939287|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19939288|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
19939289|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939290|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19939291|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19939292|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939293|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939294|NCT01448525|Bimatoprost|bimatoprost|mesh-list
19939295|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19939296|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19939297|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19939298|NCT01448616|Tenofovir|tenofovir|mesh-list
19939299|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
19939300|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939301|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19939302|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19939303|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939304|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939305|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19939306|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19939307|NCT01448707|Ritonavir|ritonavir|mesh-list
19939308|NCT01448707|Darunavir|darunavir|mesh-list
19939309|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19939310|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19939311|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939312|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939313|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939314|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19939315|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19939316|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
19939317|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939318|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19939319|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19939320|NCT01448824|Ketoconazole|ketoconazole|mesh-list
19939321|NCT01448824|Evacetrapib|evacetrapib|mesh-list
19939322|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
19939323|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939324|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19939325|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19939326|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939327|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939328|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19939329|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
19939330|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939331|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939332|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19939333|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19939334|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19939335|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
19939336|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19939337|NCT01449006|Maraviroc|maraviroc|mesh-list
19939338|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19939339|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19939340|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939341|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19939342|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19939343|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
19939344|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939345|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19939346|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
19939347|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
19939348|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
19939349|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939350|NCT01449279|Ipilimumab|ipilimumab|mesh-list
19939351|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19939352|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939353|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19939354|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939355|NCT01449370|Serabelisib|serabelisib|mesh-list
19939356|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939357|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939358|NCT01449630|Celecoxib|celecoxib|mesh-list
19939359|NCT01449630|LY3031207|ly3031207|mesh-list
19939360|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19939361|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19939362|NCT01449630|Analgesics|analgesics|mesh-ancestor
19939363|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
19939364|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939365|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973658|NCT01827163|Trastuzumab|trastuzumab|mesh-list
20266231|NCT00519675|Alitretinoin|alitretinoin|mesh-list
19939366|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939367|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19939368|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19939369|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19939370|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939371|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939372|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
19939373|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
19939374|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19973659|NCT01827163|Lapatinib|lapatinib|mesh-list
19973660|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19973661|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973662|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19973663|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19973664|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19973665|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973666|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19973667|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973668|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266232|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542691|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542692|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542693|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542694|NCT01865110|Prednisone|prednisone|mesh-list
20542695|NCT01865110|Rituximab|rituximab|mesh-list
20542696|NCT01865110|Lenalidomide|lenalidomide|mesh-list
20542697|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
20542698|NCT01865110|Vincristine|vincristine|mesh-list
20542699|NCT01865110|Doxorubicin|doxorubicin|mesh-list
20542700|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20542701|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542702|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
20542703|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542704|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20542705|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20542706|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20542707|NCT01865110|Growth Substances|growth substances|mesh-ancestor
20542708|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
20542709|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542710|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20542711|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
20542712|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542713|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20542714|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542715|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
20542716|NCT01865110|Hormones|hormones|mesh-ancestor
20542717|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542718|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542719|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20542720|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
20542721|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
19973669|NCT01827254|Sunitinib|sunitinib|mesh-list
19973670|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973671|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19973672|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19973673|NCT01827254|Growth Substances|growth substances|mesh-ancestor
19973674|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973675|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
19973676|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20266233|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
20266234|NCT00519688|Thalidomide|thalidomide|mesh-list
20266235|NCT00519688|Tegafur|tegafur|mesh-list
20266236|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266237|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
20266238|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266239|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
20266240|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20266241|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266242|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20266243|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20266244|NCT00519688|Growth Substances|growth substances|mesh-ancestor
20266245|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
20266246|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939375|NCT01449682|Dexamethasone|dexamethasone|mesh-list
19939376|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
19939377|NCT01449682|BB 1101|bb 1101|mesh-list
19939378|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939379|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
19939380|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
19939381|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939382|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939383|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939384|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
19939385|NCT01449682|Hormones|hormones|mesh-ancestor
20266247|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20266248|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
20266249|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266250|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
20266251|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266252|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
20266253|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266254|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266255|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20266256|NCT00519753|Timolol|timolol|mesh-list
20266257|NCT00519753|Travoprost|travoprost|mesh-list
20266258|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20266259|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20266260|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20266261|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20266262|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
20266263|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542722|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
19939386|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939387|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542723|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20542724|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20542725|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20542726|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542727|NCT01865175|Iron|iron|mesh-list
20542728|NCT01865175|Trace Elements|trace elements|mesh-ancestor
20542729|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
20542730|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542731|NCT01865188|Amlodipine|amlodipine|mesh-list
20542732|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20542733|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20542734|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20542735|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542736|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542737|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542738|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542739|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
20542740|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20542741|NCT01865201|Mannitol|mannitol|mesh-list
20542742|NCT01865201|Edaravone|edaravone|mesh-list
20542743|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20542744|NCT01865201|Diuretics|diuretics|mesh-ancestor
20542745|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
20542746|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939388|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939389|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939390|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939391|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939392|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19939393|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939394|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939395|NCT01449747|Incretins|incretins|mesh-ancestor
19939396|NCT01449747|Hormones|hormones|mesh-ancestor
19939397|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939398|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19939399|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939400|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939401|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939402|NCT01449929|Ritonavir|ritonavir|mesh-list
19939403|NCT01449929|Darunavir|darunavir|mesh-list
19939404|NCT01449929|Dolutegravir|dolutegravir|mesh-list
19939405|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19973677|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542747|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19939406|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19939407|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939408|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939409|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939410|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19939411|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19939412|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
19939413|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939414|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19939415|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19939416|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19939417|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19939418|NCT01449955|Sirolimus|sirolimus|mesh-list
19939419|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19939420|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939421|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20266264|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266265|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266266|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20266267|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20266268|NCT00519805|Dalteparin|dalteparin|mesh-list
20266269|NCT00519805|Tinzaparin|tinzaparin|mesh-list
20266270|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20266271|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
20266272|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20266273|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20266274|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266275|NCT00519870|Losartan|losartan|mesh-list
20266276|NCT00519870|Nifedipine|nifedipine|mesh-list
20266277|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20266278|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20266279|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20266280|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20266281|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266282|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20266283|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266284|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20266285|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266286|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
20266287|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
20266288|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20266289|NCT00519909|Calcium|calcium|mesh-list
20266290|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20266291|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266292|NCT00519987|Ketamine|ketamine|mesh-list
20266293|NCT00519987|Analgesics|analgesics|mesh-ancestor
20266294|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
20266295|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266296|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266297|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20266298|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20542748|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
20554128|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939422|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939423|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
19939424|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939425|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
19939426|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939427|NCT01450007|Dexamethasone|dexamethasone|mesh-list
19939428|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
19939429|NCT01450007|Ropivacaine|ropivacaine|mesh-list
19939430|NCT01450007|BB 1101|bb 1101|mesh-list
19939431|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939432|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
19939433|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
19939434|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939435|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939436|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939437|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
19939438|NCT01450007|Hormones|hormones|mesh-ancestor
19939439|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939440|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19939441|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939442|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939443|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939444|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939445|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
19939446|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
19939447|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939448|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
19939449|NCT01450098|Evacetrapib|evacetrapib|mesh-list
19939450|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
19939451|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19939452|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19939453|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
19939454|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939455|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19939456|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
19939457|NCT01450098|Protective Agents|protective agents|mesh-ancestor
19939458|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939459|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
19939460|NCT01450137|Hormones|hormones|mesh-ancestor
19939461|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939462|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939463|NCT01450189|Tenofovir|tenofovir|mesh-list
19939464|NCT01450189|Emtricitabine|emtricitabine|mesh-list
19939465|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
19939466|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19939467|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
19939468|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939469|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19939470|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19939471|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939472|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939473|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19939474|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19939475|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19939476|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19939477|NCT01450306|Cycloserine|cycloserine|mesh-list
19939478|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19939479|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939480|NCT01450306|Renal Agents|renal agents|mesh-ancestor
19939481|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19939482|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
19939483|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19939484|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
19939485|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939486|NCT01450319|Cetuximab|cetuximab|mesh-list
19939487|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19939488|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939489|NCT01450683|Itraconazole|itraconazole|mesh-list
19939490|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
19939491|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939492|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19939493|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19939494|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939495|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939496|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19939497|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
19939498|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939499|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939500|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19939501|NCT01450696|Capecitabine|capecitabine|mesh-list
19939502|NCT01450696|Trastuzumab|trastuzumab|mesh-list
19939503|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939504|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19939505|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
19939506|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939507|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19939508|NCT01450761|Carboplatin|carboplatin|mesh-list
19939509|NCT01450761|Etoposide|etoposide|mesh-list
19939510|NCT01450761|Ipilimumab|ipilimumab|mesh-list
19939511|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939512|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19939513|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19939514|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19939515|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939516|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939517|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19939518|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19939519|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
19939520|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19939521|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939522|NCT01450800|Renal Agents|renal agents|mesh-ancestor
19939523|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19939524|NCT01450813|Bromides|bromides|mesh-list
19939525|NCT01450813|Rocuronium|rocuronium|mesh-list
19939526|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
19939527|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19939528|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19939529|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19939530|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939531|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939532|NCT01450826|Ondansetron|ondansetron|mesh-list
19939533|NCT01450826|Aprepitant|aprepitant|mesh-list
19939534|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
19939535|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
19939536|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939537|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939538|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939539|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
19939540|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939541|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19939542|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
19939543|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939544|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939545|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19939546|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19939547|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939548|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19939549|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19939550|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19939551|NCT01451203|Methotrexate|methotrexate|mesh-list
19939552|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
19939553|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19939554|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
19939555|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19939556|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939557|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19939558|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
19939559|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939560|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939561|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939562|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939563|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19939564|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939565|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
19939566|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19939567|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19939568|NCT01451398|Insulin|insulin|mesh-list
19939569|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939570|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939571|NCT01451411|Conivaptan|conivaptan|mesh-list
19939572|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19939573|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939574|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
19939575|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939576|NCT01451541|Ciclesonide|ciclesonide|mesh-list
19939577|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
19939578|NCT01451541|Hormones|hormones|mesh-ancestor
19939579|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939580|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939581|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19939582|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19939583|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19939584|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19939585|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19939586|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939587|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939588|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939589|NCT01451606|Analgesics|analgesics|mesh-ancestor
19939590|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
19939591|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939592|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
19939593|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19939594|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
19939595|NCT01451632|Irinotecan|irinotecan|mesh-list
19939596|NCT01451632|Cetuximab|cetuximab|mesh-list
19939597|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19939598|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19939599|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939600|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939601|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939602|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19939603|NCT01451645|Colchicine|colchicine|mesh-list
19939604|NCT01451645|Allopurinol|allopurinol|mesh-list
19939605|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
19939606|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19939607|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
19939608|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
19939609|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
19939610|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939611|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939612|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
19939613|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939614|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19939615|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
19939616|NCT01451645|Protective Agents|protective agents|mesh-ancestor
20266299|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
20266300|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
20266301|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266302|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20266303|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20266304|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266305|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266306|NCT00520000|Carboplatin|carboplatin|mesh-list
20266307|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20266308|NCT00520000|Paclitaxel|paclitaxel|mesh-list
20266309|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266310|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20266311|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
20266312|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
20266313|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
20266314|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266315|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
20266316|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
20266317|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266318|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266319|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266320|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
20266321|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20266322|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266323|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266324|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
20266325|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20266326|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266327|NCT00520091|Celecoxib|celecoxib|mesh-list
20266328|NCT00520091|Irinotecan|irinotecan|mesh-list
20266329|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266330|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20266331|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20266332|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266333|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266334|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20266335|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266336|NCT00520091|Analgesics|analgesics|mesh-ancestor
20266337|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
20266338|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266339|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266340|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266341|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266342|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20266343|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20266344|NCT00520104|Ketamine|ketamine|mesh-list
19939617|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939618|NCT01451749|Donepezil|donepezil|mesh-list
19939619|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19939620|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939621|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939622|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
19939623|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939624|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939625|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
19939626|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
19939627|NCT01451762|Promethazine|promethazine|mesh-list
19939628|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19939629|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19939630|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939631|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939632|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
19939633|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
19939634|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
19939635|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939636|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
19939637|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
19939638|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19939639|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19939640|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
19939641|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
19939642|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939643|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939644|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19939645|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
19939646|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939647|NCT01451775|Empagliflozin|empagliflozin|mesh-list
19939648|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19939649|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939650|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939651|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939652|NCT01451814|Nicotine|nicotine|mesh-list
19939653|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19939654|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
19939655|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939656|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939657|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19939658|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20266345|NCT00520104|Analgesics|analgesics|mesh-ancestor
20266346|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
20266347|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266348|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266349|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20266350|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20266351|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
20266352|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
20266353|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266354|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20266355|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20266356|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266357|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266358|NCT00520169|Ketamine|ketamine|mesh-list
20266359|NCT00520169|Analgesics|analgesics|mesh-ancestor
20266360|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
20266361|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266362|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266363|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19939659|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
19939660|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939661|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939662|NCT01451827|Tolvaptan|tolvaptan|mesh-list
19939663|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19939664|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939665|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
19939666|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939667|NCT01451996|Loratadine|loratadine|mesh-list
19939668|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
19939669|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939670|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19939671|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19939672|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19939673|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
19939674|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
19939675|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939676|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939677|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939678|NCT01452126|Ropivacaine|ropivacaine|mesh-list
19939679|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
19939680|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
19939681|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939682|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939683|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
19939684|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939685|NCT01452347|Warfarin|warfarin|mesh-list
19939686|NCT01452347|Dabigatran|dabigatran|mesh-list
19939687|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
19939688|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
19939689|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19939690|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939691|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939692|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939693|NCT01452529|Hydrocodone|hydrocodone|mesh-list
19939694|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19939695|NCT01452529|Narcotics|narcotics|mesh-ancestor
19939696|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939697|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939698|NCT01452529|Analgesics|analgesics|mesh-ancestor
19939699|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
19939700|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939701|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
19939702|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
19939703|NCT01452789|Morphine|morphine|mesh-list
19939704|NCT01452789|Buprenorphine|buprenorphine|mesh-list
19939705|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19939706|NCT01452789|Narcotics|narcotics|mesh-ancestor
19939707|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939708|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939709|NCT01452789|Analgesics|analgesics|mesh-ancestor
19939710|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
19939711|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939712|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19939713|NCT01453023|Fluticasone|fluticasone|mesh-list
19939714|NCT01453023|Xhance|xhance|mesh-list
19939715|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939716|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19939717|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
19939718|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939719|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939720|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19939721|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
19939722|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
19939723|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19939724|NCT01453049|Glimepiride|glimepiride|mesh-list
19939725|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
19939726|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19939727|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939728|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939729|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939730|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
19939731|NCT01453075|Valacyclovir|valacyclovir|mesh-list
19939732|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
19939733|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939734|NCT01453153|Gemcitabine|gemcitabine|mesh-list
19939735|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19939736|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
19939737|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939738|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939739|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
19939740|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939741|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939742|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939743|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
19939744|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939745|NCT01453205|Rituximab|rituximab|mesh-list
19939746|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19939747|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939748|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
19939749|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939750|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19939751|NCT01453348|Vaccines|vaccines|mesh-list
19939752|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
19939753|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939754|NCT01453374|Naltrexone|naltrexone|mesh-list
19939755|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19939756|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19939757|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939758|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
19939759|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939760|NCT01453595|Dactolisib|dactolisib|mesh-list
19939761|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939762|NCT01453725|Golimumab|golimumab|mesh-list
19939763|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19939764|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939765|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939766|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
19939767|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939768|NCT01453855|Travoprost|travoprost|mesh-list
19939769|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19939770|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19939771|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19939772|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19939773|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
19939774|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939775|NCT01454076|Clarithromycin|clarithromycin|mesh-list
19939776|NCT01454076|Rifampin|rifampin|mesh-list
19939777|NCT01454076|Ketoconazole|ketoconazole|mesh-list
19939778|NCT01454076|Ixazomib|ixazomib|mesh-list
19939779|NCT01454076|Glycine|glycine|mesh-list
19939780|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19939781|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939782|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19939783|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939784|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939785|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19939786|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19939787|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19939788|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
19939789|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
19939790|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19939791|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19939792|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19939793|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19939794|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19939795|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19939796|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19939797|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
19939798|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19939799|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19939800|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
19939801|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939802|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939803|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939804|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939805|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
19939806|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939807|NCT01454102|Gemcitabine|gemcitabine|mesh-list
19939808|NCT01454102|Paclitaxel|paclitaxel|mesh-list
19939809|NCT01454102|Bevacizumab|bevacizumab|mesh-list
20266364|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20266365|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
20266366|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
20266367|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266368|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20266369|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20266370|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266371|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266372|NCT00520247|Folic Acid|folic acid|mesh-list
20266373|NCT00520247|Enalapril|enalapril|mesh-list
20266374|NCT00520247|Hematinics|hematinics|mesh-ancestor
20266375|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
20266376|NCT00520247|Vitamins|vitamins|mesh-ancestor
20266377|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
20266378|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266379|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20266380|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939810|NCT01454102|Carboplatin|carboplatin|mesh-list
19939811|NCT01454102|Nivolumab|nivolumab|mesh-list
19939812|NCT01454102|Pemetrexed|pemetrexed|mesh-list
19939813|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19939814|NCT01454102|Ipilimumab|ipilimumab|mesh-list
19939815|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19939816|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939817|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
19939818|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
19939819|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
19939820|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939821|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19939822|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19939823|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19939824|NCT01454102|Growth Substances|growth substances|mesh-ancestor
19939825|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939826|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
19939827|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19939828|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
19939829|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
19939830|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939831|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939832|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939833|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
19939834|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19939835|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19939836|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19939837|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19939838|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
19939839|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939840|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939841|NCT01454362|Nicotine|nicotine|mesh-list
19939842|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19939843|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
19939844|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939845|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939846|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19939847|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19939848|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
19939849|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939850|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939851|NCT01454414|Permethrin|permethrin|mesh-list
19939852|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266381|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266382|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266383|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19939853|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939854|NCT01454596|Aldesleukin|aldesleukin|mesh-list
19939855|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
19939856|NCT01454596|Fludarabine|fludarabine|mesh-list
19939857|NCT01454596|Mitogens|mitogens|mesh-list
19939858|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939859|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
19939860|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939861|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19939862|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19939863|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
19939864|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939865|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939866|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19939867|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19939868|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19939869|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19939870|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
19939871|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939872|NCT01454739|Factor VIII|factor viii|mesh-list
19939873|NCT01454739|Coagulants|coagulants|mesh-ancestor
19939874|NCT01454778|Paclitaxel|paclitaxel|mesh-list
19939875|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19939876|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939877|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
19939878|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
19939879|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
19939880|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266384|NCT00520260|Ketorolac|ketorolac|mesh-list
19939881|NCT01454791|Diclofenac|diclofenac|mesh-list
20266385|NCT00520260|Bromfenac|bromfenac|mesh-list
19939882|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19939883|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19939884|NCT01454791|Analgesics|analgesics|mesh-ancestor
19939885|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
19939886|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939887|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939888|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19939889|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19939890|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19939891|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939892|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939893|NCT01454934|Gemcitabine|gemcitabine|mesh-list
19939894|NCT01454934|Docetaxel|docetaxel|mesh-list
19939895|NCT01454934|Pemetrexed|pemetrexed|mesh-list
19939896|NCT01454934|Vinorelbine|vinorelbine|mesh-list
19939897|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19939898|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
19939899|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939900|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939901|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
19939902|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939903|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939904|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19939905|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
20266386|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20266387|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266388|NCT00520260|Analgesics|analgesics|mesh-ancestor
20266389|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
20266390|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542749|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542750|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20542751|NCT01865201|Protective Agents|protective agents|mesh-ancestor
20542752|NCT01865279|Insulin|insulin|mesh-list
20542753|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20542754|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
20542755|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
20542756|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
20266391|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266392|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266393|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266394|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20266395|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266396|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266397|NCT00520325|Lectins|lectins|mesh-list
20266398|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
20266399|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
20266400|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266401|NCT00520325|Coagulants|coagulants|mesh-ancestor
20542757|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
20542758|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542759|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542760|NCT01865292|Insulin|insulin|mesh-list
20542761|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19939906|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939907|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
19939908|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
19939909|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
19939910|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19939911|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20542762|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
20542763|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542764|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542765|NCT01865305|Insulin|insulin|mesh-list
20542766|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20542767|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
20542768|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
20542769|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20542770|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
20542771|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20542772|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
20542773|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939912|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19939913|NCT01455012|Rotigotine|rotigotine|mesh-list
19939914|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
19939915|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
20266402|NCT00520338|Celecoxib|celecoxib|mesh-list
19939916|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19939917|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939918|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973678|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973679|NCT01827267|Sirolimus|sirolimus|mesh-list
19973680|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973681|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973682|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19973683|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973684|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
19973685|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973686|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
19973687|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973688|NCT01827332|Oxytocin|oxytocin|mesh-list
19973689|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
19973690|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19973691|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973692|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
19973693|NCT01827358|Mupirocin|mupirocin|mesh-list
19973694|NCT01827358|Calcium|calcium|mesh-list
19973695|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19973696|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973697|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19973698|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973699|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973700|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19973701|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973702|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973703|NCT01827462|Vaccines|vaccines|mesh-list
19973704|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
19973705|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973706|NCT01827475|Acetaminophen|acetaminophen|mesh-list
19973707|NCT01827475|Ibuprofen|ibuprofen|mesh-list
19973708|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19973709|NCT01827475|Analgesics|analgesics|mesh-ancestor
19973710|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
19973711|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973712|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973713|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
19973714|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19973715|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973716|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973717|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19973718|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973719|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973720|NCT01827670|Fluorides|fluorides|mesh-list
19973721|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
19973722|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
19973723|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
19973724|NCT01827670|Protective Agents|protective agents|mesh-ancestor
19973725|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973726|NCT01827839|Vaccines|vaccines|mesh-list
19973727|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
19450218|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
19450219|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450220|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450221|NCT03430466|Fulvestrant|fulvestrant|mesh-list
19450222|NCT03430466|Tremelimumab|tremelimumab|mesh-list
19450223|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19732744|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19973728|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973729|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
19973730|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973731|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973732|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973733|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973734|NCT01827943|Sirolimus|sirolimus|mesh-list
19973735|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19973736|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732745|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19732746|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732747|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19732748|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19732749|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732750|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
19939919|NCT01455194|Ciclesonide|ciclesonide|mesh-list
19939920|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
19939921|NCT01455194|Hormones|hormones|mesh-ancestor
19939922|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939923|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939924|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19939925|NCT01455220|Natalizumab|natalizumab|mesh-list
19939926|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
19939927|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939928|NCT01455415|Pregabalin|pregabalin|mesh-list
19939929|NCT01455415|Analgesics|analgesics|mesh-ancestor
19939930|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
19939931|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939932|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939933|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
19939934|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19939935|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19939936|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939937|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19939938|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19939939|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19939940|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939941|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19939942|NCT01455428|Pregabalin|pregabalin|mesh-list
19939943|NCT01455428|Analgesics|analgesics|mesh-ancestor
19939944|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
19939945|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939946|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939947|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
19939948|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19939949|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19939950|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939951|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19939952|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19939953|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19939954|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939955|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19939956|NCT01455519|Hydromorphone|hydromorphone|mesh-list
19939957|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19939958|NCT01455519|Narcotics|narcotics|mesh-ancestor
19939959|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939960|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939961|NCT01455519|Analgesics|analgesics|mesh-ancestor
19939962|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
19939963|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19939964|NCT01456039|Romidepsin|romidepsin|mesh-list
19939965|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19939966|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19939967|NCT01456130|Alogliptin|alogliptin|mesh-list
19939968|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
19939969|NCT01456130|Secretagogues|secretagogues|mesh-list
19939970|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19939971|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939972|NCT01456130|Incretins|incretins|mesh-ancestor
19939973|NCT01456130|Hormones|hormones|mesh-ancestor
19939974|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19939975|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19939976|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
19939977|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19939978|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939979|NCT01456143|Proflavine|proflavine|mesh-list
19939980|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19939981|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19939982|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
19939983|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19939984|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19939985|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19939986|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19939987|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19939988|NCT01456169|Diuretics|diuretics|mesh-ancestor
19939989|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
19939990|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939991|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19939992|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19939993|NCT01456299|Remifentanil|remifentanil|mesh-list
19939994|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19939995|NCT01456299|Narcotics|narcotics|mesh-ancestor
19939996|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19939997|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19939998|NCT01456299|Analgesics|analgesics|mesh-ancestor
19939999|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
19940000|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940001|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19940002|NCT01456780|Tobramycin|tobramycin|mesh-list
19940003|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
19940004|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940005|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940006|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19940007|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19940008|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19940009|NCT01456936|Bupropion|bupropion|mesh-list
19940010|NCT01456936|Nicotine|nicotine|mesh-list
19940011|NCT01456936|Varenicline|varenicline|mesh-list
19940012|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19940013|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
19940014|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940015|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940016|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19940017|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19940018|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
19940019|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940020|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940021|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19940022|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
20266403|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20266404|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266405|NCT00520338|Analgesics|analgesics|mesh-ancestor
20266406|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
20266407|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266408|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266409|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266410|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266411|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20266412|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20266413|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266414|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266415|NCT00520442|Ibuprofen|ibuprofen|mesh-list
20266416|NCT00520442|Codeine|codeine|mesh-list
20266417|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20266418|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266419|NCT00520442|Analgesics|analgesics|mesh-ancestor
20266420|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
20266421|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266422|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266423|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266424|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266425|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20266426|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266427|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266428|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20266429|NCT00520442|Narcotics|narcotics|mesh-ancestor
20266430|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266431|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
20266432|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
20266433|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
20266434|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20266435|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
20266436|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20266437|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266438|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20266439|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20266440|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20266441|NCT00520507|Olanzapine|olanzapine|mesh-list
20266442|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
20266443|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
20266444|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940023|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19940024|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19940025|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19940026|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940027|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
19940028|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19940029|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19940030|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940031|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
19940032|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940033|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19940034|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19940035|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940036|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940037|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19940038|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19940039|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940040|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19940041|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19940042|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940043|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940044|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
19940045|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940046|NCT01457430|Icatibant|icatibant|mesh-list
19940047|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19940048|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19940049|NCT01457430|Analgesics|analgesics|mesh-ancestor
19940050|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
19940051|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940052|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940053|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19940054|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940055|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19940056|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19940057|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940058|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19940059|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19940060|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
19940061|NCT01457521|Ibuprofen|ibuprofen|mesh-list
19940062|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19940063|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19940064|NCT01457521|Analgesics|analgesics|mesh-ancestor
19940065|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
19940066|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940067|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940068|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266445|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266446|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266447|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20266448|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20266449|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266450|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266451|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20266452|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20266453|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266454|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266455|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266456|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
20266457|NCT00520585|Atorvastatin|atorvastatin|mesh-list
20266458|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20266459|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20266460|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
20266461|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266462|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20266463|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20266464|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266465|NCT00520650|Aripiprazole|aripiprazole|mesh-list
20266466|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
20266467|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266468|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20266469|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20542774|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940069|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940070|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19940071|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940072|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940073|NCT01457573|Tamsulosin|tamsulosin|mesh-list
19940074|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
19940075|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19940076|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19940077|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19940078|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
19940079|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940080|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940081|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940082|NCT01457573|Urological Agents|urological agents|mesh-ancestor
19940083|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19940084|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19940085|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
19940086|NCT01457703|Letrozole|letrozole|mesh-list
19940087|NCT01457703|Cetrorelix|cetrorelix|mesh-list
19940088|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19940089|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940090|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19940091|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19940092|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940093|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940094|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19940095|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
19940096|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940097|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940098|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19940099|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
19940100|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19940101|NCT01457703|Hormones|hormones|mesh-ancestor
19940102|NCT01457846|Paclitaxel|paclitaxel|mesh-list
19940103|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19940104|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940105|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19940106|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19940107|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19940108|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940109|NCT01457885|Busulfan|busulfan|mesh-list
19940110|NCT01457885|Clofarabine|clofarabine|mesh-list
19940111|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
19940112|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940113|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19940114|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
19940115|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940116|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19940117|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940118|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19940119|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19940120|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
19940121|NCT01457924|Ofatumumab|ofatumumab|mesh-list
19940122|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19940123|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940124|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
19940125|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940126|NCT01457950|Denosumab|denosumab|mesh-list
19940127|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19940128|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940129|NCT01458106|Factor VIII|factor viii|mesh-list
19940130|NCT01458106|Coagulants|coagulants|mesh-ancestor
19940131|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
19940132|NCT01458171|Antibodies|antibodies|mesh-list
19940133|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
19940134|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19940135|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19940136|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
19940137|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940138|NCT01458210|Dulaglutide|dulaglutide|mesh-list
19940139|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
19940140|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19940141|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19940142|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940143|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940144|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940145|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19940146|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19940147|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940148|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940149|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940150|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19940151|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
19940152|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19940153|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19940154|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19940155|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19940156|NCT01458275|Ciclesonide|ciclesonide|mesh-list
19940157|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
19940158|NCT01458275|Hormones|hormones|mesh-ancestor
19940159|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940160|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940161|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19940162|NCT01458366|Carboplatin|carboplatin|mesh-list
19940163|NCT01458366|Etoposide|etoposide|mesh-list
19940164|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
19940165|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19940166|NCT01458366|Ofatumumab|ofatumumab|mesh-list
19940167|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940168|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19940169|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19940170|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19940171|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940172|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940173|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19940174|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
19940175|NCT01458418|Montelukast|montelukast|mesh-list
19940176|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19940177|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
19940178|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19940179|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
19940180|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940181|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940182|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19940183|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19940184|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940185|NCT01458522|Lacosamide|lacosamide|mesh-list
19940186|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
19940187|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
19940188|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19940189|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19940190|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940191|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940192|NCT01458535|Ritonavir|ritonavir|mesh-list
19940193|NCT01458535|Ribavirin|ribavirin|mesh-list
19940194|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19940195|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19940196|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
19940197|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940198|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940199|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19940200|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19940201|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
19940202|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940203|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19940204|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19940205|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
19940206|NCT01458561|Thrombin|thrombin|mesh-list
19940207|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19940208|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
19940209|NCT01458561|Coagulants|coagulants|mesh-ancestor
19940210|NCT01458574|Tofacitinib|tofacitinib|mesh-list
19940211|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19940212|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940213|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940214|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19940215|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20266470|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940216|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
19940217|NCT01458639|Xenon|xenon|mesh-list
19940218|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19940219|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
19940220|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
19940221|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940222|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940223|NCT01458951|Tofacitinib|tofacitinib|mesh-list
19940224|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19940225|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940226|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940227|NCT01458990|Omeprazole|omeprazole|mesh-list
19940228|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19940229|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19940230|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19940231|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940232|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940233|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19940234|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19940235|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
19940236|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19940237|NCT01459588|Laxatives|laxatives|mesh-ancestor
19940238|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19940239|NCT01459614|Gemcitabine|gemcitabine|mesh-list
20266471|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266472|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
20266473|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
20266474|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266475|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266476|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20266477|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20266478|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
20266479|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20266480|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20266481|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20266482|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20266483|NCT00520754|Levocetirizine|levocetirizine|mesh-list
20266484|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20266485|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20266486|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
20266487|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
20266488|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266489|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266490|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266491|NCT00520806|Methocarbamol|methocarbamol|mesh-list
20266492|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20266493|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266494|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20266495|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542775|NCT01865318|Insulin|insulin|mesh-list
20542776|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542777|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542778|NCT01865331|Insulin|insulin|mesh-list
20542779|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20542780|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
20542781|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
20542782|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20542783|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542784|NCT01865500|Prednisolone|prednisolone|mesh-list
20542785|NCT01865500|Budesonide|budesonide|mesh-list
20542786|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542787|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
20542788|NCT01865500|Hormones|hormones|mesh-ancestor
20542789|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542790|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542791|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542792|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542793|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
20542794|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542795|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20542796|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19940240|NCT01459614|Docetaxel|docetaxel|mesh-list
19940241|NCT01459614|Capecitabine|capecitabine|mesh-list
20266496|NCT00520819|Antioxidants|antioxidants|mesh-list
20542797|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
19940242|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940243|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19940244|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
19940245|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940246|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
19940247|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940248|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940249|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19940250|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
19940251|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940252|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
19940253|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
19940254|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
19940255|NCT01459718|Deferasirox|deferasirox|mesh-list
19940256|NCT01459718|Deferoxamine|deferoxamine|mesh-list
19940257|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19940258|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
19940259|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
19940260|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940261|NCT01459718|Siderophores|siderophores|mesh-ancestor
19940262|NCT01459796|Rilonacept|rilonacept|mesh-list
19940263|NCT01459796|Allopurinol|allopurinol|mesh-list
19940264|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
19940265|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940266|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940267|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
19940268|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940269|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19940270|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
19940271|NCT01459796|Protective Agents|protective agents|mesh-ancestor
19940272|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940273|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19940274|NCT01459913|Interferons|interferons|mesh-list
19940275|NCT01459913|Ribavirin|ribavirin|mesh-list
19940276|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
19940277|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
19940278|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19940279|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940280|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
19940281|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940282|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
19940283|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940284|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
19940285|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940286|NCT01460225|Lubiprostone|lubiprostone|mesh-list
19940287|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19940288|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940289|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940290|NCT01460290|Asenapine|asenapine|mesh-list
19940291|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19940292|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19940293|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940294|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940295|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266497|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266498|NCT00520819|Protective Agents|protective agents|mesh-ancestor
20266499|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266500|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
20266501|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20266502|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20266503|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
20266504|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266505|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20266506|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20266507|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266508|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266509|NCT00520949|Amoxicillin|amoxicillin|mesh-list
20266510|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20266511|NCT00520949|Furazolidone|furazolidone|mesh-list
20266512|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20266513|NCT00520949|Esomeprazole|esomeprazole|mesh-list
20266514|NCT00520949|Bismuth|bismuth|mesh-list
20266515|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940296|NCT01460342|Tadalafil|tadalafil|mesh-list
19940297|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
19940298|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19940299|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19940300|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940301|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940302|NCT01460342|Urological Agents|urological agents|mesh-ancestor
19940303|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
19940304|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940305|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940306|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19940307|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19940308|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940309|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940310|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940311|NCT01460381|Quinidine|quinidine|mesh-list
19940312|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
19940313|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19940314|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19940315|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
19940316|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940317|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940318|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940319|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19940320|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
19940321|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19940322|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19940323|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940324|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940325|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19940326|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19940327|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
19940328|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19940329|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19940330|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940331|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19940332|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19940333|NCT01460407|Clarithromycin|clarithromycin|mesh-list
19940334|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940335|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940336|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19940337|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940338|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940339|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19940340|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19940341|NCT01460628|Modafinil|modafinil|mesh-list
19940342|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19940343|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940344|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19940345|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19940346|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19940347|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732751|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19732752|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19732753|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19732754|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
19732755|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732756|NCT04570293|Lidocaine|lidocaine|mesh-list
19732757|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
19732758|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
19732759|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732760|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732761|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
19732762|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732763|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19732764|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19732765|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19732766|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19732767|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732768|NCT04570254|Vitamins|vitamins|mesh-list
19732769|NCT04570254|Vitamin E|vitamin e|mesh-list
19732770|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
19732771|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
19732772|NCT04570254|Melatonin|melatonin|mesh-list
19732773|NCT04570254|Antioxidants|antioxidants|mesh-list
19732774|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19732775|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
19732776|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732777|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732778|NCT04570254|Protective Agents|protective agents|mesh-ancestor
19732779|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732780|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19732781|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732782|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19940348|NCT01460719|Vaccines|vaccines|mesh-list
19940349|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
19940350|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940351|NCT01460875|Interferons|interferons|mesh-list
19940352|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
19940353|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
19940354|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940355|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
19940356|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940357|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
19940358|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940359|NCT01460940|Lenalidomide|lenalidomide|mesh-list
19940360|NCT01460940|Panobinostat|panobinostat|mesh-list
19940361|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19940362|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
19940363|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940364|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19940365|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19940366|NCT01460940|Growth Substances|growth substances|mesh-ancestor
19940367|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
19940368|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940369|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940370|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940371|NCT01461057|Capecitabine|capecitabine|mesh-list
19940372|NCT01461057|Trastuzumab|trastuzumab|mesh-list
19940373|NCT01461057|Pertuzumab|pertuzumab|mesh-list
19940374|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940375|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19940376|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
19940377|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940378|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19940379|NCT01461096|Vaccines|vaccines|mesh-list
19940380|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
19940381|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940382|NCT01461369|Diclofenac|diclofenac|mesh-list
19940383|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19940384|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19940385|NCT01461369|Analgesics|analgesics|mesh-ancestor
19940386|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
19940387|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940388|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940389|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19940390|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940391|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19940392|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940393|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940394|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19940395|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940396|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19940397|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19940398|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19940399|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732783|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19732784|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
19732785|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19732786|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
19732787|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732788|NCT04570254|Expectorants|expectorants|mesh-ancestor
19732789|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
19732790|NCT04570254|Antidotes|antidotes|mesh-ancestor
19732791|NCT04570150|Neostigmine|neostigmine|mesh-list
19732792|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19732793|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732794|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732795|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
19732796|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732797|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940400|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
19940401|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940402|NCT01461551|Propofol|propofol|mesh-list
19940403|NCT01461551|Sevoflurane|sevoflurane|mesh-list
19940404|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19940405|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266516|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266517|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20266518|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266519|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20266520|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266521|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266522|NCT00520949|Antacids|antacids|mesh-ancestor
20266523|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20266524|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20266525|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20266526|NCT00520949|Renal Agents|renal agents|mesh-ancestor
20266527|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20266528|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20266529|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20266530|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20266531|NCT00521040|Levocetirizine|levocetirizine|mesh-list
20266532|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20266533|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20266534|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
20266535|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
20266536|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732798|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19732799|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
19732800|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732801|NCT04570306|Belimumab|belimumab|mesh-list
19732802|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732803|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
19732804|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732805|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
19732806|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19732807|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735740|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940406|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266537|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266538|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266539|NCT00521092|Sunitinib|sunitinib|mesh-list
20266540|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266541|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20266542|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20266543|NCT00521092|Growth Substances|growth substances|mesh-ancestor
20266544|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266545|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
20266546|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20266547|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266548|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266549|NCT00521131|Levocetirizine|levocetirizine|mesh-list
20266550|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20542798|NCT01865630|Etanercept|etanercept|mesh-list
20542799|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19940407|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19940408|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
19940409|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
19940410|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19940411|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19940412|NCT01461668|Retapamulin|retapamulin|mesh-list
19940413|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940414|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940415|NCT01461733|Amiodarone|amiodarone|mesh-list
19940416|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19940417|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
19940418|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19940419|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940420|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940421|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19940422|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19940423|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19940424|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940425|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19940426|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19940427|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19940428|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19940429|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
19940430|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19940431|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19940432|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19940433|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
19940434|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19940435|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940436|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19940437|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19940438|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19940439|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19940440|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940441|NCT01461928|Rituximab|rituximab|mesh-list
19940442|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19940443|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940444|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
19940445|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940446|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973737|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19973738|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973739|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
19973740|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973741|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
19973742|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973743|NCT01828034|Gemcitabine|gemcitabine|mesh-list
19973744|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973745|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973746|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
19973747|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973748|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
19973749|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973750|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973751|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973752|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
19973753|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973754|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
19973755|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19973756|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19973757|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
19973758|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973759|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19973760|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19973761|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973762|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973763|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
19973764|NCT01828476|Navitoclax|navitoclax|mesh-list
19973765|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
19973766|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19973767|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19973768|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973769|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973770|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973771|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973772|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973773|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
19973774|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19973775|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973776|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
19973777|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19973778|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19973779|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19973780|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973781|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973782|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973783|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
19973784|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973785|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19973786|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19973787|NCT01828554|Capecitabine|capecitabine|mesh-list
19940447|NCT01462227|Naltrexone|naltrexone|mesh-list
19940448|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19940449|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19940450|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940451|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
19940452|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940453|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
19940454|NCT01462253|Clofarabine|clofarabine|mesh-list
19940455|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19940456|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
19940457|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940458|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940459|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19940460|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
19940461|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940462|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940463|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19940464|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19940465|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
19940466|NCT01462266|Metformin|metformin|mesh-list
19940467|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
19940468|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19940469|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19940470|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940471|NCT01462266|Incretins|incretins|mesh-ancestor
19940472|NCT01462266|Hormones|hormones|mesh-ancestor
19940473|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940474|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19940475|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
19940476|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940477|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940478|NCT01462279|Thiamine|thiamine|mesh-list
19940479|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
19940480|NCT01462279|Vitamins|vitamins|mesh-ancestor
19940481|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
19940482|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940483|NCT01462318|Vitamin K|vitamin k|mesh-list
19940484|NCT01462318|Midazolam|midazolam|mesh-list
19940485|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
19940486|NCT01462318|Caffeine|caffeine|mesh-list
19940487|NCT01462318|Omeprazole|omeprazole|mesh-list
19940488|NCT01462318|Warfarin|warfarin|mesh-list
19940489|NCT01462318|Daclizumab|daclizumab|mesh-list
19940490|NCT01462318|Vitamins|vitamins|mesh-ancestor
19940491|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
19940492|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940493|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19940494|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19940495|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940496|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19940497|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19940498|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19940499|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19940500|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
19940501|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
19940502|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
19940503|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
19940504|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940505|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940506|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
19940507|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19940508|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19940509|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19940510|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940511|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19940512|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19940513|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19940514|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19940515|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
19940516|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19940517|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19940518|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
19940519|NCT01462318|Coagulants|coagulants|mesh-ancestor
19940520|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
19940521|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
19940522|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19940523|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19940524|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19940525|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
19940526|NCT01462344|Fluticasone|fluticasone|mesh-list
19940527|NCT01462344|Xhance|xhance|mesh-list
19940528|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19940529|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19940530|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
19940531|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940532|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940533|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19940534|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
19940535|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
19940536|NCT01462344|Hormones|hormones|mesh-ancestor
19940537|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940538|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
19940539|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19940540|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
19940541|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19940542|NCT01462435|Celecoxib|celecoxib|mesh-list
19940543|NCT01462435|Diclofenac|diclofenac|mesh-list
19940544|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19940545|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19940546|NCT01462435|Analgesics|analgesics|mesh-ancestor
19940547|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
19940548|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940549|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940550|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19940551|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940552|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19940553|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19940554|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940555|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940556|NCT01462565|Epoprostenol|epoprostenol|mesh-list
19940557|NCT01462565|Tezosentan|tezosentan|mesh-list
19940558|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19940559|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19940560|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
19940561|NCT01462695|Sunitinib|sunitinib|mesh-list
19940562|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940563|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19940564|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19940565|NCT01462695|Growth Substances|growth substances|mesh-ancestor
19940566|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940567|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
19940568|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19940569|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940570|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940571|NCT01462773|Interferons|interferons|mesh-list
20266551|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20266552|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
20266553|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
20266554|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266555|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266556|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266557|NCT00521157|Naltrexone|naltrexone|mesh-list
20266558|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20266559|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20266560|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266561|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
20266562|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266563|NCT00521170|Levocetirizine|levocetirizine|mesh-list
20266564|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20266565|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20266566|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
20266567|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
20266568|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266569|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266570|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266571|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
20266572|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
20266573|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266574|NCT00521222|Fluticasone|fluticasone|mesh-list
20266575|NCT00521222|Xhance|xhance|mesh-list
20266576|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20266577|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19940572|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
19940573|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
19940574|NCT01462773|Bortezomib|bortezomib|mesh-list
19940575|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940576|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
19940577|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940578|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
19940579|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940580|NCT01462812|Sumatriptan|sumatriptan|mesh-list
19940581|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19940582|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19940583|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19940584|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
19940585|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940586|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940587|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940588|NCT01462877|Fenofibrate|fenofibrate|mesh-list
19940589|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19940590|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
19940591|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940592|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19940593|NCT01462929|Bromides|bromides|mesh-list
19940594|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
19940595|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19940596|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
19940597|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940598|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940599|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19940600|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
19940601|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
19940602|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19940603|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
19940604|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940605|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940606|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
19940607|NCT01462942|Bromides|bromides|mesh-list
19940608|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
19940609|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19940610|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
19940611|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940612|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266578|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266579|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20266580|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
20266581|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266582|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266583|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20266584|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
20266585|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
20266586|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20266587|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20266588|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20266589|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20266590|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
20266591|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266592|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266593|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
20266594|NCT00521222|Hormones|hormones|mesh-ancestor
20266595|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20266596|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
20266597|NCT00521248|Morphine|morphine|mesh-list
20266598|NCT00521248|Buprenorphine|buprenorphine|mesh-list
20266599|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20266600|NCT00521248|Narcotics|narcotics|mesh-ancestor
20266601|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266602|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542800|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20542801|NCT01865630|Analgesics|analgesics|mesh-ancestor
20542802|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
20542803|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542804|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542805|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20542806|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940613|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19940614|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
20266603|NCT00521248|Analgesics|analgesics|mesh-ancestor
19940615|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19940616|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19940617|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19940618|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
19940619|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940620|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940621|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
19940622|NCT01463033|Levetiracetam|levetiracetam|mesh-list
19940623|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
19940624|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
19940625|NCT01463098|Zolpidem|zolpidem|mesh-list
19940626|NCT01463098|Lemborexant|lemborexant|mesh-list
19940627|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19940628|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19940629|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940630|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940631|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19940632|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
19940633|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
19940634|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940635|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940636|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19940637|NCT01463111|Lamotrigine|lamotrigine|mesh-list
19940638|NCT01463111|Valproic Acid|valproic acid|mesh-list
19940639|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19940640|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940641|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940642|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
19940643|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19940644|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940645|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940646|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
19940647|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19940648|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940649|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19940650|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19940651|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19940652|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
19940653|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940654|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19940655|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
19940656|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19940657|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19940658|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19940659|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
19940660|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19940661|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940662|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19940663|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19940664|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19940665|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19940666|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940667|NCT01463306|Pregabalin|pregabalin|mesh-list
19940668|NCT01463306|Analgesics|analgesics|mesh-ancestor
19940669|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
19940670|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940671|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940672|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
19940673|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19940674|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940675|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940676|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19940677|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19940678|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19940679|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940680|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19940681|NCT01463384|Minocycline|minocycline|mesh-list
19940682|NCT01463384|Tetracycline|tetracycline|mesh-list
19940683|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940684|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940685|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19940686|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940687|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940688|NCT01463982|Capecitabine|capecitabine|mesh-list
19940689|NCT01463982|Irinotecan|irinotecan|mesh-list
19940690|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19940691|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
19732808|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19732809|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19732810|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
19732811|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732812|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732813|NCT04569877|Molgramostim|molgramostim|mesh-list
19940692|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940693|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940694|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19940695|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19940696|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940697|NCT01464190|Sevelamer|sevelamer|mesh-list
19940698|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
19940699|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
19940700|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940701|NCT01464229|Iloperidone|iloperidone|mesh-list
19940702|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19940703|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19940704|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940705|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940706|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19940707|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19940708|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19940709|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940710|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940711|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19940712|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940713|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940714|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
19940715|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940716|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
19940717|NCT01464359|Busulfan|busulfan|mesh-list
19940718|NCT01464359|Fludarabine|fludarabine|mesh-list
19940719|NCT01464359|Interleukin-2|interleukin-2|mesh-list
19940720|NCT01464359|Allopurinol|allopurinol|mesh-list
19940721|NCT01464359|Levetiracetam|levetiracetam|mesh-list
19940722|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19940723|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
19940724|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940725|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940726|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19940727|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
19940728|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940729|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940730|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19940731|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
19940732|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19940733|NCT01464359|Analgesics|analgesics|mesh-ancestor
19940734|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
19940735|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940736|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
19940737|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
19940738|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940739|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
19940740|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19940741|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
19940742|NCT01464359|Protective Agents|protective agents|mesh-ancestor
19940743|NCT01464424|Bimatoprost|bimatoprost|mesh-list
19940744|NCT01464424|Travoprost|travoprost|mesh-list
19940745|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19940746|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19940747|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19940748|NCT01464697|Progesterone|progesterone|mesh-list
19940749|NCT01464697|Progestins|progestins|mesh-ancestor
19940750|NCT01464697|Hormones|hormones|mesh-ancestor
19940751|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940752|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940753|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19940754|NCT01464788|Argatroban|argatroban|mesh-list
19940755|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19940756|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19732814|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19732815|NCT04569877|Sargramostim|sargramostim|mesh-list
19732816|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732817|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
19732818|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732819|NCT04569916|Irinotecan|irinotecan|mesh-list
19732820|NCT04569916|Apatinib|apatinib|mesh-list
19732821|NCT04569916|Antibodies|antibodies|mesh-list
19732822|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
19732823|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266604|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
20266605|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266606|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20266607|NCT00521261|Antibodies|antibodies|mesh-list
20266608|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20266609|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
20266610|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266611|NCT00521274|Docetaxel|docetaxel|mesh-list
20266612|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266613|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
20266614|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
20266615|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
20266616|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266617|NCT00521300|Octreotide|octreotide|mesh-list
20266618|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266619|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20266620|NCT00521300|Antineoplastic Agents|antineoplas